
12 in (case)
revealed benefits (dobj)
23390 or (cc)
doxorubicin ( (punct)
weight patient (nmod:poss)
neuropathy sensory (amod)
stimulated that (mark)
effects induced (amod)
doses used (acl)
intake prolonged (amod)
actions have (acl:relcl)
reduced treatment (nmod)
ca ( (punct)
injury functional (amod)
involvement development (nmod)
mg/kg seizures (conj)
diagnosis alternatives (conj)
years who (nsubj)
recognize reaction (dobj)
incomplete were (cop)
leak may (aux)
compared duration (nmod)
fischer in (case)
criteria 106 (nummod)
horn l1-l2 (nmod)
propranolol mg (amod)
patients years (nmod)
regardless degree (nmod)
conclusion demonstrate (dep)
tizanidine agonist (appos)
raises question (dobj)
60 over (advmod)
responsible treatment (nsubj)
penicillins reassuringly (advmod)
dysfunction accompanies (acl:relcl)
made presentation (nsubjpass)
desogestrel for (case)
mg val/hctz (compound)
water supplemented (acl)
discontinued . (punct)
treatment arabinoside (compound)
accepted this (nsubjpass)
29 vs. (cc)
thrombophlebitis pelvic (amod)
tizanidine of (case)
cholesterol ( (punct)
ck-mb > (punct)
study histopathological (amod)
chromosome strain (nmod)
supplemented weeks (nmod)
depressed release (nsubjpass)
% 43.7 (nummod)
syndrome reconstitution (compound)
mean time (nmod)
combining information (dobj)
ratio 1.0 (dep)
lower control (nmod)
plasticity the (det)
model f344 (compound)
induced effects (nsubjpass)
points response (nmod)
questioning patient (dobj)
common presented (conj)
infusion 24-hour (amod)
factors autism (nmod)
therapy desferrioxamine (compound)
ecg patients (nmod)
associated complications (nmod)
mechanisms anemia (nmod)
cyclophosphamide years (compound)
protocol rnfl (compound)
component an (det)
icv rats (nsubj)
34 +/- (cc)
follow-up at (case)
associated supplements (nmod)
remains infection (nsubj)
pointes . (punct)
overload chronic (amod)
taking of (mark)
factors exacerbating (compound)
shown factor (xcomp)
recommenced drug (nsubjpass)
threshold ct (appos)
16 0.7 (conj)
conscious fully (advmod)
administered months (nmod:npmod)
breathing decrease (dobj)
randomization after (case)
active is (cop)
measured fluid (nmod)
fasciculation , (punct)
cisplatin and (cc)
% 15.6 (nummod)
positive trends (nsubj)
reduced proteins (nsubjpass)
coadministered t (nsubjpass)
tolerated adhd (nmod)
0.03 0.1 (conj)
i.v. n=12 (dep)
enhanced catalepsy (dobj)
expression growth (nmod)
2 cases (nmod)
contributed cytopenia (nmod)
sirolimus rapamycin (appos)
elevated mm (nmod)
woman 77-year-old (amod)
increase + (cc)
noted distress (nsubjpass)
had scores (nmod)
increased morphine (nmod)
escalation dose (compound)
proteinuria substantial (amod)
summarizes research (dobj)
sensation smelling (advcl)
found decades (nmod)
patients ill (amod)
transformation pseudocystic (amod)
leading activities (nmod)
prosthesis valve (compound)
all them (nmod)
containing fanft (dobj)
activator chat (compound)
tci ( (punct)
0.66 ) (punct)
involves functions (nmod)
investigation this (det)
june 2003 (nummod)
found reduced (ccomp)
k(atp ) (punct)
inducing turnover (dobj)
catalepsy apomorphine (conj)
consent biopsy (appos)
300 of (case)
toxicity complicating (acl)
suggest mechanisms (dobj)
growth any (det)
blinded drug (nmod)
junction corticosteroids (appos)
% 74.8 (nummod)
dilated idiopathic (amod)
rise the (det)
14 8 (compound)
43 ) (punct)
complexes transport (compound)
samples urine (compound)
determine activity (dobj)
influence influence (conj)
inhibition nte (compound)
clarify and (cc)
defect function (nmod)
induced production (dobj)
mutants these (det)
ro4368554 ) (punct)
marked sometimes (advmod)
use review (dep)
processes of (case)
comprised , (punct)
occurred although (mark)
manifesting propylthiouracil-induced (amod)
signs g/dl (amod)
rate growth (compound)
oestrogens placebo (conj)
showed animals (nsubj)
underline need (dobj)
deaths 9 (nummod)
established been (cop)
caused alprazolam (nsubj)
levels circulating (amod)
id50 a (det)
grade 4 (nummod)
was characterize (xcomp)
cin in (case)
ages period (nmod)
effects oxide (nmod)
improve deficit (dobj)
nsclc advanced (amod)
produced death (dobj)
agents treatment (nmod)
stabilized . (punct)
sertraline of (case)
course clinical (amod)
behavior binding (conj)
patients snhl (nmod)
reducing percentage (dobj)
glaucoma acute (amod)
suggesting involvement (dobj)
safe remarkably (advmod)
hospitalization of (case)
initiated had (aux)
methods using (dep)
pi compared (case)
post-exposure hr (compound)
assessment scale (nmod)
carry bleeding (advcl)
amphetamine adulthood (nmod)
patients 458 (nummod)
continued finished (advcl)
group microg (nmod)
sensation unpleasant (amod)
giving before (mark)
female donor (nsubj)
agency products (compound)
pregnant that (nsubj)
17.6-fold value (nmod)
prevention incapacity (nmod)
seems approach (nsubj)
hypoactivity morphine-induced (amod)
seizure flurothyl (nsubj)
myalgia between (case)
activity on (case)
regard very-low-birth-weight (nmod)
suggest suggest (conj)
was subjects (nmod)
areas some (det)
bradycardia 37 (nummod)
residues dna (nmod)
microl , (punct)
confirmed study (dobj)
hormone because (case)
attenuated preference (dobj)
replacement with (nmod)
women 5408 (nummod)
se ) (punct)
prolapse mitral (amod)
likelihood higher (amod)
epiphenomena process (nmod)
support reports (dobj)
content stability (conj)
lithium-induced be (cop)
electrolyte normal (amod)
mechanisms carbachol (amod)
csa srl (conj)
interval : (punct)
reduction test (nmod)
sensitive resistant (conj)
administration levodopa/carbidopa (amod)
15 of (case)
raises experience (nsubj)
secretion increased (amod)
lowering increasing (conj)
blocked all (dep)
carries transplantation (nsubj)
% 67.1 (nummod)
six and (cc)
dose ranging (acl)
morning days (nmod)
dup losartan (appos)
forty-six year-old (acl)
effects heart (nmod)
prevalent degree (advcl)
reversal previously (advmod)
toxicity kidney (compound)
developed mg/day (nmod)
suggesting useful (ccomp)
best correlation (nsubj)
5.6+/-0.9 to (mark)
exposed levels (nmod)
toxicity chemotherapeutic (amod)
given be (auxpass)
function hepatic (amod)
saline- morphine/rg1-treated (conj)
given became (conj)
database collected (amod)
pod 9 (nummod)
developed telangiectasia (dobj)
treated have (conj)
helps that (mark)
deficits loss (conj)
10 50 (conj)
developed ingesting (advcl)
increases use (nsubj)
model pain-induced (amod)
mv 5.6 (nummod)
counts 65 (conj)
relieved and (cc)
a part (compound)
history days (nmod:poss)
effects antileukemia (compound)
regimen controlled (amod)
increased dosage (nsubjpass)
demonstrated animals (advcl)
visualized microscopy (nsubj)
testing deprivation (compound)
fed % (conj)
using collagenase (dobj)
toxicity unacceptable (amod)
achieved can (aux)
fatiguability , (punct)
delivered setting (nmod)
gemcitabine age (dep)
therapy lithium (compound)
acted tp (nsubj)
risk myopathy (nmod)
mg/kg 50/12.5 (amod)
zone in (case)
mmol/l 120 (nummod)
glomerulopathies as (cc)
elevated was (conj)
dextran antibiotics (conj)
years 70 (nummod)
pellet ) (punct)
rls ) (punct)
puromycin aminonucleoside-induced (amod)
most levels (nmod)
layer gyrus (nmod)
terbutaline mg/kg (appos)
2.1 +/- (cc)
produces cimetidine (nsubj)
leads complete (xcomp)
pharmacology capecitabine (nmod)
ich ( (punct)
suggested sufficient (ccomp)
cord into (case)
pattern with (case)
use srl (nmod)
weight a (det)
rna of (case)
hypersensitivity . (punct)
receiving doses (dobj)
parameters with (case)
induced spasm (nmod)
min injection (nmod)
factors without (case)
apnoea respiratory (amod)
actions and (cc)
others group (appos)
role androgens (nmod)
rats p (dep)
characterized defects (nmod)
response rates (conj)
t60 ) (punct)
identified increases (nsubjpass)
overactivation area (nmod)
induced 6-ohda (nmod)
potential of (case)
crisis scleroderma (compound)
spectrum haart (nmod)
reported pain (nmod)
basis manifestation (nmod)
induced pain (nsubjpass)
complication disabling (amod)
became cramps (nsubj)
function of (case)
side-effect chemotherapy (nmod)
combined 5-fu (nmod)
due junction (nmod)
presence upon (case)
2 5 (prep)
reflex through (case)
taqib ) (punct)
failed ability (nsubj)
enhanced whereas (mark)
biopsy ) (punct)
reversible toxicity (nsubj)
insight better (amod)
correlate monitoring (nmod)
proportion vaccinated (acl:relcl)
methods design (dep)
drug well-tolerated (conj)
effects toxicity (nmod)
consumption increased (amod)
seems crucial (xcomp)
sweating facial (amod)
pills was (cop)
rhythm arrhythmia (nmod)
acidosis inhibitors (nmod)
sensitivity % (appos)
l/m2 clearance (conj)
those used (acl)
illustrates case (nsubj)
potentiation transmission (nmod)
m ; (punct)
targets pathways (dobj)
hbig with (case)
carried tumor (nmod)
hemodialysis of (case)
rediscovery with (case)
production of (case)
13/52 in (case)
model disease (conj)
lower sbp (nmod)
disorder behavioral (amod)
observed anemia (nsubjpass)
development pathology (nmod)
comparable numbers (nsubj)
regimens treatment (compound)
3 5 (conj)
haloperidol such (case)
troublesome complaints (nsubj)
d1 stage (compound)
progression had (amod)
reviving nephrotoxicity (nsubj)
vasculitis methylphenidate (compound)
us by (case)
expression na(+)/k(+)-atpase (nmod)
involved 5-ht (nsubjpass)
observations . (punct)
cells to (case)
cardiac on (case)
respond microglia (nsubj)
transplant baseline (nmod)
diffusion mechanism (nsubj)
concentrations various (amod)
patients n/n=62/92 (dep)
segment cerebral (amod)
analysis stereologic (amod)
ranging months (nmod)
peaked and (cc)
attributable hypotension (nsubj)
confounds that (mark)
sham-operated ovariectomized (conj)
determined points (nmod)
exhibits inhibition (dobj)
iu/l 2218 (nummod)
1-chloro-1,2,2,2-tetrafluoroethane hcfc (appos)
development gradual (amod)
inhibitors cox (compound)
diet diet (appos)
ccr ( (punct)
18 8 (compound)
developed syndrome (dobj)
% 10 (nummod)
assessment onset (nmod)
opioids oral (amod)
mother cocaine-addicted (amod)
concerned obese (ccomp)
analysis : (punct)
measuring levels (dobj)
investigations electron (compound)
have deficits (dobj)
0 for (case)
elucidated mechanism(s (nsubjpass)
rat phenobarbitone-primed (amod)
bradycardia induced (acl)
rhuepo iu/kg (appos)
up-regulation function (nmod)
included behaviour (dobj)
consideration reactions (nmod)
block extradural (amod)
modulation the (det)
dose interactions (conj)
use usa (nmod)
8 , (punct)
included . (punct)
tacrolimus prednisolone (conj)
characteristics five (nummod)
dcf ) (punct)
occurs exclusively (advmod)
patency circuit (nmod)
complication that (mark)
paralleled it (nsubjpass)
interpolates map (xcomp)
given results (dep)
require monitoring (dobj)
recovered acuity (dobj)
transformation microglia (nmod)
found thyroxine (conj)
gliomas system (nmod)
interventions and (cc)
vein the (det)
delay with (case)
rage , (punct)
rct and (cc)
p two-sided (amod)
coma alpha (compound)
characterize dyskinesia (nmod)
choose % (nsubj)
treatment neuralgia (nmod)
sludge , (punct)
myocardium and (cc)
mpo-anca clinical (conj)
projections via (case)
abusers opioid (compound)
39.6 vs. (cc)
explore was (cop)
mg/kg s.c. (amod)
infusion drug (compound)
hds with (case)
palsy femoral (amod)
taking pentoxifylline (dobj)
antagonist with (case)
diseases seen (advcl)
months an (det)
rats non-diabetic (amod)
a patient(s (compound)
likely interaction (dobj)
likely experience (xcomp)
effects nicotine (nmod)
proved which (nsubj)
appeared akinetic (xcomp)
1.036 0.003 (conj)
infarctions women (conj)
flunitrazepam of (case)
dyscrasias these (det)
inhibits bioactivation (dobj)
treatment double-blind (amod)
receiving day (nmod)
prompted speculate (conj)
scale wechsler (compound)
lysozymuria 2147 (nmod:tmod)
recalled and (cc)
losartan ) (punct)
benzodiazepines clonazepam (appos)
neuroradiologists 2 (nummod)
test screening (amod)
reported - (punct)
picture with (case)
ameliorated hypotension (nsubjpass)
injections dysfunction (nmod)
ameliorated impairment (dobj)
fell significantly (advmod)
membrane cell (nmod)
effects all (predet)
70 to (dep)
provocation prostigmine-morphine (amod)
stomatitis and (cc)
dimension wall (compound)
increased declined (conj)
evoked response (dobj)
subjects nine (nummod)
agent remoxipride (appos)
28 30 (conj)
adsd , (punct)
response allodynia (conj)
3-hydroxymethyl-5,5-diphenylhydantoin of (case)
syndrome report (dep)
mitochondria for (case)
different not (neg)
= 6 (dep)
dosage ribavirin (compound)
effects cardiotoxicity (nmod)
period investigation (compound)
100mg/kg metformin (nmod)
disintegrin adam (appos)
contributes observations (nmod)
0.52 , (punct)
variables age (nmod)
effect deteriorating (amod)
markers anemia (conj)
therapy tamoxifen (conj)
remember to (mark)
significance statistical (amod)
atropine 10 (nummod)
indications conversion (nmod)
risks consumption (nmod)
test result (ccomp)
monitoring index (compound)
option initial (amod)
hypotension patients (nmod)
linked inhibition (nmod)
teams care (compound)
pharmacology acc-9653 (nmod)
outcome to (case)
neurotoxicity mellitus (conj)
measured time (nmod)
undergoing repair (dobj)
co-administered rats (nmod)
product ( (punct)
routes groups (nmod)
achieved maintained (conj)
mdp with (case)
effect system (compound)
observation of (case)
consolidation , (punct)
inhibition to (mark)
decreases therapy (nmod)
syndrome are (cop)
dysphonia . (punct)
potently methoctramine (nmod)
accompanied bradycardia (nmod)
seven the (det)
has profile (dobj)
microm 55+/-29 (nummod)
sequence the (det)
parameters application (nmod)
change furthermore (advmod)
particles platelet (compound)
showed , (punct)
effects modafinil (nmod)
patients 650 (nummod)
self-limiting effects (nsubj)
svrs ( (punct)
prevent myoclonus (dobj)
children 8 (nummod)
distribution interrupted (amod)
od > (dep)
that hours (dep)
nodes the (det)
hr 19.2 (nummod)
antagonizing in (mark)
limited , (punct)
overload iron (compound)
headache migraineurs (nmod)
cases leading (acl)
count subset (compound)
generation excitotoxicity (conj)
hydrocortisone after (case)
patients few (amod)
nephropathy against (case)
effects anti-dementia (amod)
evaluation pre-treatment (amod)
lethality chronic (amod)
phase characterized (acl)
divided days (nmod)
administration groups (nmod)
mmol deficit (nsubj)
tolerance effect (nmod)
edetate and (cc)
inhibition cyclase (compound)
% -40 (nummod)
studies published (acl)
obvious either (cc:preconj)
lasted improvements (nsubj)
equal were (cop)
high is (cop)
pointes supports (dep)
arise sheath (nsubj)
fraction response (conj)
antagonists beta-adrenoceptor (compound)
stereotypy and (cc)
six more (amod)
were decreases (nsubj)
flexion deformations (nsubj)
center at (case)
dosage etomidate (nmod)
suppress measured (advcl)
effect pro-arrhythmic (amod)
postswitch to (case)
percent attained (acl:relcl)
disorder common (amod)
use sirolimus (nmod)
side-effect adverse (conj)
pressure hemodynamics (conj)
report knowledge (nmod)
exchanges for (case)
g 32 (nummod)
etoricoxib with (case)
instituted improves (ccomp)
encapsulated phases (nmod)
register swedish (amod)
represents . (punct)
sequelae those (det)
quality similar (amod)
4107 3722 (conj)
diagnoses , (punct)
focus models (nmod)
characteristics mechanisms (conj)
had performed (conj)
apoptosis puromycin (compound)
8 15 (conj)
helps implant (nsubj)
persons 700,000 (nummod)
affinity catecholamines (nmod)
promote reduce (conj)
cases severity (nmod)
was either (advmod)
had domains (conj)
propagated transmission (nmod)
bepridil medium (nmod)
submitted challenge (nmod)
blockers both (det)
restoration plasticity (nmod)
positive rast (nsubj)
day 1.8-fold (dep)
annuals the (det)
study 2 (nummod)
determine correlated (ccomp)
hypertension american (amod)
colitis use (conj)
shrinkage masked (acl)
rats 344 (nummod)
tr(- in (case)
number regimens (nmod)
identify mm (dep)
levels baseline (compound)
tolerance patients (nmod)
use epinephrine (nmod)
reduction conversion (conj)
extract sinensis (nmod)
half-life final (amod)
communication and (cc)
ventricles into (case)
patient , (punct)
dose micrograms (nmod)
changes alt (dep)
dose infusion (nmod)
toxicities for (case)
took recovery (nsubj)
myopathy . (punct)
calculated they (nsubj)
mass proteinuria (conj)
modifications for (case)
protocol front-line (amod)
thresholds discrimination (compound)
flow women (nmod)
injection)+ritanserin before (case)
completing remd (nmod)
effect hypolipidemic (amod)
centre was (cop)
artery saphenous (amod)
dose optimal (amod)
bradycardia on (case)
investigation is (cop)
binding cells (nmod)
complexes and (cc)
glomerulosclerosis adult (amod)
saline low (amod)
measurement angiography (nmod)
carried instructed (conj)
replicate that (mark)
magnitude p<0.05 (dep)
determined chromatography (nmod)
differ haloperidol (nsubj)
blockade mglur1 (nmod)
same the (det)
ineffectiveness treatments (nmod)
agent experimental (amod)
plasma non-detectable (conj)
lung of (case)
16 ( (punct)
alendronate oral (amod)
administered animals (nmod)
days exposure (dep)
patients drug (appos)
occlusion sinus (compound)
out-patients ( (punct)
bobbing , (punct)
3269 380 (conj)
helpful analysis (nsubj)
dfc -18.9 (conj)
lithium anomaly (dep)
history suspicion (conj)
correlated mg/m2/d (advcl)
characteristics fiber (nsubj)
test passive (amod)
induces that (mark)
quantitated permeability (nsubjpass)
minimize . (punct)
melphalan patients (nmod)
states normal (amod)
blockade hypotension (nmod)
clentiazem with (case)
remains one (attr)
used associated (conj)
requiring of (mark)
died girl (nsubj)
significantly p (dep)
four-week randomized (conj)
levodopa and (cc)
levels phenytoin (compound)
measured men (nmod)
play therapy (nmod)
control alone (advmod)
detection flow (compound)
higher adjusting (advcl)
analyzed hyperemia (nmod)
used probably (advmod)
studies analysis (conj)
had years (nmod)
criterion or (cc)
unclear , (punct)
had that (nsubj)
compared as (mark)
received enhance (advcl)
sulfate s.c. (appos)
sumatriptan subcutaneous (amod)
stomach intestine (conj)
acclimatization of (case)
range titres (nsubj)
neurons intact (amod)
pilocarpine- seizures (dep)
2 5 (dep)
aware , (punct)
trial acid (nmod)
background presents (appos)
lidocaine min (dep)
effects two (nmod)
pressure or (cc)
normalization responder (conj)
consisted paclitaxel (nmod)
use heavy (amod)
following immediately (advmod)
had anemia (dobj)
groups percentage (nmod)
greater 1 (nsubj)
rectified , (punct)
deacetylation apap (compound)
represent changes (nsubj)
application signal (nmod)
decreased all (nmod)
courses regimen (nmod)
stimulation both (cc:preconj)
similar have (conj)
adjusted age (nmod)
minimize effect (dobj)
weight g (dep)
showed missing (conj)
applied group (nmod)
phenylhydrazine with (case)
therapy terbinafine (compound)
telaprevir and (cc)
hazards toxicity (nmod)
studied relationships (nsubjpass)
intensity map (nmod)
organization administration (conj)
hypersensitivity pentobarbital (nmod)
methylatropine with (case)
desogestrel plus (cc)
factors activation (nsubj)
analyzed also (advmod)
presented had (parataxis)
dsm-iv based (case)
n. , (punct)
carcinostatics added (acl)
haematuria symptoms (conj)
known stimulate (xcomp)
26 and (cc)
episode after (case)
withdrawing ml (dobj)
study surveillance (compound)
elevated average (nmod)
afford protection (nsubj)
frame within (case)
abruptness the (det)
started patients (nmod)
myocarditis the (det)
knife nor (cc)
frequent mb (nsubj)
medications her (nmod:poss)
amounted . (punct)
reserpine haloperidol (conj)
documentation little (amod)
manifestation a (det)
estimated was (auxpass)
drug antidepressant (amod)
pain changes (conj)
process arytenoid (nmod)
change icp (nsubj)
concentrations chp (nmod)
upper both (cc:preconj)
mm 17 (nummod)
one other (appos)
rs6693503 , (punct)
ought in (prep)
catecholamines , (punct)
cured who (nsubjpass)
annuloplasty mitral (amod)
intensity respiration (compound)
homeostasis redox (compound)
precluded use (dobj)
minutes one (nummod)
reactions n-induced (amod)
administration clotiazepam (nmod)
occurred starting (advcl)
intervenes pathway (acl:relcl)
dextromethorphan of (case)
interventions sedation (dep)
4,957 vs. (cc)
function and (cc)
safety treatment (nmod)
suffering and (cc)
increase susceptibility (dobj)
9/106 ) (punct)
describe tolerance (dobj)
prevented proportion (nsubjpass)
audiograms conduction (compound)
floor medical (amod)
ms hplc (compound)
occurrence infarction (nmod)
dystonia omd (appos)
enzyme involved (acl:relcl)
characterized binding (nmod)
restricted ) (punct)
effect (-)-cibenzoline (nmod)
proteins 67 (nummod)
injected locally (advmod)
patients % (compound)
psychological physical (conj)
elevations creatine (compound)
markers camkiia (dep)
known 2 (dep)
scopolamine pentobarbital (conj)
determined morphologically (advmod)
study cases (nmod)
group 24 (nummod)
p ' (punct)
= 34 (dep)
% 59.6 (nummod)
annuloplasty ventricle (nmod)
model included (acl:relcl)
seen remained (advcl)
solely almost (advmod)
mg/kg 160 (nummod)
cytochrome-p450 human (amod)
use models (nmod)
period acute (amod)
pattern consistent (amod)
interviewed examine (advcl)
severity moderate (amod)
c-4-epimer ) (punct)
activity seizure-like (amod)
clinical developmental (conj)
limitations prophylaxis (nmod)
= 25 (dep)
rheumatology of (case)
lna > (dep)
events thromboembolic (compound)
fq nociceptin/orphanin (compound)
effective protecting (advcl)
titrating dosage (dobj)
rats body (dep)
model hematotoxicity (nmod)
needed treated (conj)
capsaicin to (case)
therapy uninterrupted (amod)
fever and (cc)
girl 1/2-year-old (amod)
changes low-grade (amod)
csa csa (conj)
complication an (det)
hemisphere of (case)
hh 34.33 (dep)
decreased mm (dep)
cholate of (case)
deterioration report (appos)
injection pan (appos)
society , (punct)
medulla outer (amod)
has efficacy (dobj)
served patients (nsubj)
parameters behavioral (amod)
identified late (advmod)
seems value (xcomp)
appearance activity (nmod)
lymphopenia ) (punct)
contractility cardiac (amod)
received studied (conj)
tamoxifen atac (appos)
greater asenapine (nmod)
caused differences (nsubjpass)
suggesting seen (ccomp)
followed has (aux)
load microfilarial (amod)
effects study (dep)
result it (nsubj)
development months (nmod)
higher statistically (advmod)
inhibit enzyme (dobj)
initiated respectively (advmod)
lumens there (conj)
used board-certified (conj)
showed blotting (nsubj)
concentration hypotension (nmod)
pneumonia . (punct)
human rh (dep)
allodynia brush-evoked (amod)
adjuvant in (case)
inhibition cardiotoxicity (nmod)
grams of (case)
initiated determine (advcl)
activity seizures (nmod)
heterozygous normal (amod)
develop test (dobj)
continues . (punct)
vehicle injections (conj)
divided occurred (advcl)
aspects models (nmod)
newborn lip (nmod)
15/44 sgk1(-/- (nmod)
exhibits it (nsubj)
prolactin testosterone (conj)
bilirubin 4.36 (nummod)
0.006 p (dep)
highest proportion (nsubj)
amphetamine an (det)
that with (case)
desensitisation to (case)
needed , (punct)
mediate fibrosis (dobj)
changes biopsy (nmod)
identified links (dobj)
measure variations (dobj)
rtms placebo (appos)
were time (nmod)
drainage due (case)
includes often (advmod)
arteries mm (appos)
interpretation eeg (nmod)
medium mg(2+)-free (compound)
enflurane isoflurane (conj)
apply phenomenon (nmod)
183 about (advmod)
background causes (dep)
hippocampus of (case)
associated activation (nmod)
staining cresyl (compound)
months % (appos)
receptor for (case)
induce effect (nmod)
investigated incidence (nmod)
death exposure (nmod)
mandatory is (cop)
appear " (punct)
decrease threshold (nmod)
snps five (nummod)
administration prostaglandins (nmod)
men older (amod)
synthase caspase-3 (conj)
dose maintenance (compound)
evidence repair (nmod)
indicated measurement (nsubj)
defined insufficiency (nsubjpass)
criterion combination (conj)
therapy rescue (conj)
observed pain (nsubjpass)
therapy indinavir (compound)
clotiazepam and (cc)
measured 8th (nmod)
hibiscus of (case)
group contrast (nmod)
rating conners (nmod:poss)
developed obesity (dobj)
s((1/2 0.440 (nummod)
microg/side ) (punct)
group acetaminophen (compound)
% ci=22.5 (amod)
biopsy stainings (conj)
therapy angiotensin-converting (amod)
discussion cessation (compound)
presented hypoxia (dobj)
checked electrolytes (nsubj)
9-months after (case)
11 13 (conj)
chicks any (det)
transferred . (punct)
loss b (dep)
alpha-configuration with (case)
identify to (mark)
dose picrotoxin (nmod)
review cases (dobj)
thromboembolism thalidomide (conj)
reported show (conj)
effect dose-response (amod)
has cml (nsubj)
present was (cop)
related capture (nmod)
infection secondary (amod)
injection 10-second (amod)
factors presumable (amod)
obvious insufficient (conj)
ug 750 (nummod)
believe represent (ccomp)
modulated is (auxpass)
risk thrombotic (amod)
found blocked (ccomp)
manifestations ocular (amod)
collagen plus (cc)
showed contrast (nmod)
ethanol with (case)
ptpro ( (punct)
pharmacy computerized (amod)
lower amplitude (nsubj)
had patient (nsubj)
omeprazole which (det)
chain of (case)
study effects (dobj)
incidence thyroid (nmod)
patients 32 (nummod)
dysrhythmogenicity the (det)
latencies training (compound)
higher lower (conj)
thromboembolic complications (conj)
latency in (case)
% 60+/-9 (nummod)
effects use (nmod)
month for (case)
unavailable are (cop)
measured animals (nmod)
that convulsions (nmod)
ml 1 (nummod)
affect osmolality (dobj)
unclear affecting (ccomp)
owing damage (nmod)
developing countries (dobj)
treated patients (nmod)
loss rather (cc)
studied while (mark)
dosed rats (nsubjpass)
studied role (dobj)
thickening bowel (compound)
type contraceptives (conj)
none cows (nmod)
ulcer to (case)
lamivudine-na selected (amod)
c57bl/6 strains (conj)
less value (nsubj)
reduces . (punct)
reductions % (amod)
had fast (xcomp)
it of (case)
response alpha-methyldopa (nmod)
injury rats (nmod)
misoprostol of (case)
discriminates effect (dobj)
platform of (case)
relieve may (aux)
expression male (nmod)
mbp of (case)
differed ; (punct)
pilocarpine to (case)
enabling blockade (dobj)
discussed terms (nmod)
% 0.25 (compound)
significant ( (punct)
crisis septicemia (nmod)
case is (advcl)
antinociceptive markedly (advmod)
worsening all (nmod)
injection subarachnoid (amod)
strength function (conj)
history abuse (nmod)
tachycardia block (nmod)
cardiotoxicity , (punct)
appear did (aux)
use cns (nmod)
insufficiency recurrence (dep)
mechanisms complications (nmod)
affinity in (case)
exposed tmp-smz (nmod)
% residues (nmod)
year , (punct)
mechanisms genetics (conj)
minor grade (dep)
-18.48 ( (punct)
nature progressive (amod)
minutes within (case)
therapy glucocorticoid (compound)
impairment effectiveness (nmod)
sections rats (nmod)
map out (compound:prt)
phenomenon of (case)
cardiomyocytes pluripotent (amod)
progression reached (acl)
studies plasma (compound)
common with (mark)
eaca with (case)
inserted all (nmod)
tremor , (punct)
degeneration only (advmod)
evaluation long-term (amod)
echocardiography dogs (nmod)
related nephropathy (nsubj)
diet nx (conj)
deposition bilirubin (compound)
il-3 of (case)
up-regulation abundance (nmod)
reliability keeping (nmod)
surge percentage (conj)
were aims (nsubj)
diminish prevent (conj)
patients 29 (conj)
study rat (nmod)
signs all (det)
dependence substance (compound)
role occurrence (nmod)
prevent allopurinol (nsubj)
remained lowered (parataxis)
detected follow-up (nmod)
contained four (nmod)
found = (dep)
bfu-e splenic (amod)
dorsum food (compound)
d-ribose of (case)
haemorrhages warfarin-induced (amod)
may 2012 (nummod)
lens contact (compound)
role oxidase (nmod)
presence drugs (nmod)
work in (case)
hepatotoxicity mice (nmod)
indicate involve (conj)
method induced (appos)
nodosa of (case)
phenyl-2(5h)-furanon ) (punct)
agents by (case)
disappearance brain (nmod)
patients osteoarthritis (nmod)
developed were (auxpass)
clentiazem of (case)
antagonist beta-adrenoceptor (amod)
times minutes (appos)
interacted week (nmod)
response therapy (nmod)
reported trial (nsubj)
observed decreases (nsubjpass)
dose day (appos)
diagnoses benign (nmod)
notable concentration (nmod)
tomography single (amod)
ca2 activity (conj)
palsy abnormalities (conj)
amplitude uv (appos)
consistent vasoconstriction (nmod)
correlates how (advmod)
vision eyes (nmod)
reversing dysfunction (dobj)
commissure horn (conj)
marker fever (nsubj)
30 50 (conj)
therapy misoprostol (compound)
risk ototoxicity (nmod)
crisis abnormalities (conj)
deemed were (auxpass)
recorded scale (nmod)
ranged mononucleate (nmod)
remains lithium (nsubj)
hypotension postural (amod)
administration boy (nmod)
european west (compound)
areas animals (nmod)
using opsonized (dobj)
showing synergistic (ccomp)
doses respectively (amod)
discontinued hours (nmod)
disorder depression (compound)
ro4368554 i.p. (cc)
agents neuromuscular (amod)
examine was (ccomp)
consciousness impaired (amod)
effects dronedarone (nmod)
defined msdbp (nmod)
state normal (amod)
infusion dobutamine (nmod)
increases movements (nmod)
vp-16 213 (nummod)
death observed (acl)
gamma-hch , (punct)
impaired attenuated (conj)
instituted based (prep)
kytril pharmaceuticals (conj)
speaking such (mark)
prescribed po (dep)
output camp (compound)
endothelia of (case)
rw the (det)
changes signal (nmod)
disease heart (compound)
leukoencephalopathy carmofur-induced (amod)
recurrence hbv (nmod)
adr(6 , (punct)
methotrexate preservative-free (amod)
administration benzodiazepines (nmod)
case anemia (nmod)
woman 65-year-old (amod)
increment the (det)
prevalence effects (nmod)
wall , (punct)
caused concentrations (dobj)
performed surgeries (nsubjpass)
fev1 in (case)
compared phenylhydrazine (nmod)
toxicity transient (amod)
expression transgene (nmod)
greatest and (cc)
exhibited test (nmod)
if and (cc)
unmasked amisulpride (advmod)
mice hippocampus (compound)
leakage cerebrospinal (amod)
occurred changes (nsubj)
received nine (nsubj)
bicuspid baseline (compound)
undergoing induction (dobj)
ventralis the (det)
extracts disease (nmod)
evaluated responses (nsubjpass)
30 350 (appos)
found patients (nmod)
developed akathisia (dobj)
reports and (cc)
led urine (nmod)
chloride of (case)
increased implicated (conj)
variable distribution (nsubj)
number problems (nmod)
benserazide i.p. (advmod)
has though (mark)
patients encephalopathic (amod)
recurrence no (det)
factors digoxin (conj)
patients ages (dep)
movement and (cc)
synapses cell (compound)
observation good (amod)
mrna cd36 (compound)
vegf receptor (conj)
escalated and (cc)
phenylhydrazine phz (appos)
enhanced correlated (conj)
challenge by (case)
experienced disease (dobj)
factors improve (acl:relcl)
nortriptyline ) (punct)
reduced enalapril (nsubj)
assays granulocyte-macrophage (amod)
scale conners (nmod:poss)
250 titer (nsubj)
burns for (case)
2 24 (conj)
words at (case)
vehicle to (case)
found severity (nmod)
discontinued excluded (conj)
suggest factors (ccomp)
withheld while (mark)
offers considered (conj)
salts uric (amod)
give hypothesis (nmod)
preceded death (dobj)
kind any (det)
compared data (nsubjpass)
reaction use (nmod)
analysis cycle (compound)
associated ciprofloxacin (nsubjpass)
bonding gln223 (nmod)
states behavioral (amod)
rats vcm-treated (amod)
severity time (conj)
administration vasopressor (compound)
treatment combined (amod)
associated treatment (nsubjpass)
medication fluoxetine (compound)
hexachloride benzene (compound)
organization from (case)
consistent level (nmod)
e4031 terfenadine (conj)
one-third patients (nmod)
use their (nmod:poss)
dogs dysrhythmias (nmod)
cancer between (case)
selective more (advmod)
left atrial (xcomp)
enzyme-linked immunosorbent (dep)
produced rechallenge (nsubj)
tablet mg (appos)
extract an (det)
abuse injury (nmod)
hemorrhagic . (punct)
regulation transporters (nmod)
basis regular (amod)
frequent children (nmod)
making diagnosis (dobj)
injury epinephrine-induced (amod)
reduced bnpp (nsubj)
vpa ) (punct)
monitoring evidence (nmod)
suggested but (cc)
heparin low-molecular (amod)
sensitized are (auxpass)
position 6 (nummod)
pretreatment naloxazone (compound)
varied initiation (nmod)
caused movements (nsubj)
declines attention (nmod)
attention control (conj)
disequilibrium linkage (compound)
stimulation 2-hz (amod)
resulted stenosis (nsubj)
we and (cc)
angina spontaneous (amod)
mm 200 (nummod)
loci trait (compound)
design double-blind (amod)
mm lna+hca (appos)
experienced reactions (dobj)
hbig ) (punct)
achieves induces (conj)
exposure cutaneous (amod)
protected completely (advmod)
quantified ) (punct)
presence stimulation (nmod)
nucleotide-gated cyclic (amod)
consisted of (case)
myoclonus infusion (nmod)
sample addicts (nmod)
smaller those (nmod)
points efficacy (compound)
reducing nausea (dobj)
had abusers (nsubj)
showed markers (nmod)
risk additional (amod)
98 9 (conj)
stage take (conj)
hearts than (case)
problem challenging (amod)
present acidosis (nsubj)
associated cardiovascular (nmod)
reduced gfr (nsubjpass)
consistent disorder (nmod)
cells activated (amod)
diagnoses seen (advcl)
associated population (nmod)
relieved were (auxpass)
man 31-year-old (amod)
20 only (advmod)
lethality s.c.)-induced (amod)
iowa in (case)
hyperalgesia punctate-evoked (amod)
67.4 bupropion (nmod)
involvement vesicoprostatic (amod)
contribution changes (nmod)
examination technical (amod)
drug acid (nsubj)
incidence significant (amod)
prevented injection (nsubj)
blockade sulfate (nmod)
ventricle catheters (conj)
differences groups (nmod)
proliferators peroxisome (compound)
treatment cytosine (compound)
nephrosis with (case)
created 1994 (nmod)
effective controlling (advcl)
data epidemiological (amod)
c group (compound)
titrating achieve (xcomp)
cytoskeleton cardiomyocyte (compound)
helpful rate (nsubj)
analysis dosing (nmod)
develop ectopically (advmod)
showed enlargement (dobj)
materials schedules (dep)
mediated action (nsubjpass)
arousal in (case)
therapy anti-inflammatory (amod)
exacerbation paranoid (amod)
rate objective (amod)
admission therapy (dobj)
completion ct (nmod)
occurred mg (nmod)
mortality seizure-related (amod)
rendered mpep (nmod)
reduction standard (nsubj)
patients randomized (amod)
increment at (case)
blockage reabsorption (nmod)
implanted subcutaneously (advmod)
ketamine reliably (advmod)
exacerbation disorder (nmod)
intravenously and (cc)
dyskinesia disabling (amod)
patterns altered (amod)
anaemia observed (acl)
symptoms aggravate (amod)
mj ) (punct)
peptides by (case)
tasks recruiting (acl)
seem patients (nsubj)
conditions bleeding (nmod)
increased sustained (conj)
chloride ttc (appos)
increase ck (compound)
properties enflurane (nmod)
increases compared (advcl)
differences group (compound)
levels resting (amod)
licking and/or (cc)
patients cyclosporine (compound)
icp and (cc)
used then (advmod)
trial a (det)
resulting anoxia (nmod)
hoarseness ( (punct)
followed months (nsubjpass)
ldlr of (case)
signs dyskinesias (conj)
important that (mark)
risk treatment (nmod)
pallidotomy disease (nmod)
induced viruses (nmod)
june september (conj)
decreased 79 (nmod)
blockade after (case)
moving % (dobj)
maintaining homeostasis (dobj)
ratio rr (dep)
seem predisposed (xcomp)
blocked saralasin (nmod)
those rofecoxib (nmod)
nocistatin , (punct)
system oxide (compound)
explanation effects (nmod)
0.05 . (punct)
develop model (dobj)
decrease triglycerides (nmod)
effects metolachlor (nmod)
results experienced (appos)
blockade neuronal (amod)
troponin cardiac (amod)
patients younger (amod)
decrease torr (nmod)
seizures spontaneous (amod)
region a10 (compound)
gliosis including (case)
period follow-up (amod)
influenced barely (advmod)
patient of (case)
invasion this (det)
eyes 12 (nummod)
25 six (compound)
anorectics in (case)
shortening and (cc)
extended tracts (nmod)
head exencephalic (amod)
plasma , (punct)
suffering disorder (nmod)
administration verapamil (compound)
morbidity increased (amod)
parameters laboratory (compound)
toxin alcohol (conj)
certain it (nsubj)
maintenance rhythm (nmod)
19.3 2.6 (conj)
demonstrated agent (ccomp)
admission their (nmod:poss)
n=2.4+/-0.7 ( (punct)
therapy (bort)-dexamethasone (nsubj)
elf such (case)
evaluation class (nmod)
group separate (amod)
difference incidence (nmod)
norepinephrine and (cc)
inhibition a (det)
levels cyclosporine- (compound)
injury neuronal (amod)
occurrence dogs (nmod)
receive mg/kg/d (dobj)
mmol/l mg/dl (dep)
appear hypertension (nsubj)
reduction usually (advmod)
treated septicemia (nmod)
abundant . (punct)
enalapril progression (nmod)
measurement time (nmod)
regimens combined (amod)
segments nacl-treated (amod)
22 a (nmod)
cause anemia (dobj)
factor strong (amod)
motion were (cop)
alternative be (cop)
misjudgment execution (nmod)
nephrotoxicity outcome (conj)
cases requiring (acl)
actin and (cc)
ranges bis (compound)
variability regional (amod)
needed research (nsubjpass)
psa a (det)
warrant evaluation (dobj)
curative . (punct)
less effect (nsubj)
increases dyskinesia (nmod)
specimen hepatectomy (compound)
marker with (case)
membrane-cytoskeleton and (cc)
morphine neuraxial (amod)
cells m (dep)
shortage the (det)
attention increased (amod)
receptors at (case)
activity acid (nmod)
indicated falls (advcl)
result above (amod)
frequency an (det)
kg-1 i.v. (nummod)
restored impairment (dobj)
failure finally (advmod)
recorded using (xcomp)
toxicity bladder (nmod)
suspected thus (advmod)
leading uremia (nmod)
tobramycin with (case)
observed scored (conj)
higher risk (nsubj)
participants seventy-one (compound)
area the (det)
machinery signaling (amod)
wakefulness and (cc)
rats dose (nsubj)
presented hemianopia (nmod)
doses calculated (acl)
neuroleptics haloperidol (nmod)
treatments amantadine (compound)
mechanisms receptor (compound)
appearance morphological (amod)
cases rupture (nmod)
block prior (advmod)
collected blood (nsubjpass)
g ml/100 (amod)
compared effects (nsubjpass)
development behavior (appos)
effects deteriorating (amod)
glycoprotein an (det)
those compared (case)
occurred bolus (nmod)
induce that (mark)
alter gain (dobj)
continued was (auxpass)
delivery hampshire (compound)
response no (neg)
cutaneous , (punct)
particles in (case)
cysts of (case)
mm p (dep)
diversion long-term (amod)
reported man (nmod)
pressing down (compound:prt)
activity k)-atpase (compound)
bevacizumab/irinotecan of (case)
unclear . (punct)
meth mptp (conj)
areas in (case)
methamphetamine or (cc)
have gemcitabine (nsubj)
potent more (advmod)
propranolol by (case)
tests factor (compound)
breakdown , (punct)
fields various (amod)
atenolol after (case)
study treatment (nmod)
indicated majority (nmod)
drop levels (nmod)
departments patients (nmod)
exposure information (conj)
created purpose (nmod)
dose exercise (conj)
nicergoline of (case)
growth by (case)
minimize in (mark)
metabolism drug (compound)
used tumours (nmod)
call would (aux)
women gout (conj)
caused reduction (conj)
volumes higher (amod)
apomorphine antagonized (amod)
lovastatin of (case)
requires possibility (nsubj)
therapy frozen (amod)
extends inhibition (dobj)
alterations neurobehavioral (amod)
jumping seizure (dobj)
infarcts use (nmod)
dips of (case)
return with (case)
treated week (nmod)
blockade ) (punct)
discussed enabling (nsubjpass)
capillary peritubular (amod)
243.4 and (cc)
anuria lasted (acl:relcl)
inserted resuscitation (nmod)
velocity tail (nmod)
affected whereas (mark)
autism in (case)
analyses neurons (nmod)
episode an (det)
york new (compound)
fibres sensory (amod)
different regardless (advmod)
experienced reduction (dobj)
hydration aggressive (amod)
antagonism mice (nmod)
severity preventability (conj)
reports for (case)
microphthalmos optic (conj)
sign bilateral (amod)
ms desorption/ionization (conj)
or=7.18 19.708 (nummod)
showed electrograms (nsubj)
department , (punct)
intraperitoneal intracerebroventricular (conj)
determine nucleoside (dobj)
connections its (nmod:poss)
scanning and (cc)
infections recovery (nmod)
compared littermates (nmod)
effects most (amod)
recovered was (auxpass)
discharge at (case)
asymptomatic episodes (nsubj)
therapy was (cop)
size borderline (compound)
fluvoxamine given (acl)
torsade fluconazole-associated (amod)
findings angiographic (amod)
dysfunction seen (acl)
infarction pregnancy (nmod)
headache aura (nmod)
antagonist hydrobromide (conj)
antagonist gr (dep)
made weeks (nmod)
potentiation nicotine (compound)
pathogens respective (amod)
comparison diclofenac (nmod)
eruption maculopapular (amod)
children treatment (nmod)
resistant are (cop)
subjected s (dep)
sarcolemma of (case)
discussion , (punct)
increased concomitant (conj)
doses cimetidine (nmod)
oltx after (case)
blockers ) (punct)
monotherapy each (det)
recorded complications (nmod)
extraction forearm (nmod)
libitum chow (conj)
t(9:22 ) (punct)
proliferation hepatocyte (compound)
treated altering (advcl)
addressed study (nsubj)
regression ( (punct)
maintained effectiveness (nsubjpass)
results doses (nmod)
dosing both (cc:preconj)
inhibition reuptake (compound)
describe is (cop)
activity model (nmod)
decreased reduced (conj)
spite barrier (nmod)
inhibited action (dobj)
neurosci al. (dep)
profiles affinity (compound)
neurotoxicity lindane (amod)
junctions tight (amod)
studied effects (nsubjpass)
effects des (nmod)
design placebo-controlled (amod)
dose-dependent that (mark)
segments left (amod)
argatroban thrombolysis (dep)
acid inhibitor (compound)
present woman (dobj)
score coma (compound)
raises also (advmod)
m 0.5 (compound)
exercise- and (cc)
greater relaxation (nsubj)
prevented movements (dobj)
hypertension human (amod)
present expression (nsubj)
spironolactone those (nmod)
starting infusions (dobj)
hypertension glaucoma (conj)
method obtunding (advcl)
dcf either (det)
accompanied retention (nmod)
uveitis with (case)
disorder affective (amod)
clearance simvastatin (amod)
rule " (punct)
level sensitivities (nmod)
role causing (acl)
paralysis chemical (amod)
related pathophysiology (nsubj)
blind a (det)
activation brainstem (nmod)
selective system (nmod)
pressure stable (amod)
resistance consumption (conj)
propofol target-controlled (amod)
had mice (nsubj)
interfere that (nsubj)
risk at (case)
substantial size (nsubj)
rhythm sleep-wake (amod)
transition of (case)
randomized prospective (amod)
asked patients (nsubjpass)
predictive abuse (nsubj)
deafened were (auxpass)
combination fentanyl (nmod)
decreased titres (nsubj)
observed suppression (nsubjpass)
increase odds (nmod)
treatment parallel (compound)
solid malignancies (dep)
op ( (punct)
problem often (advmod)
absent mrp2 (nsubj)
led reintroduction (nsubj)
agents pharmacotherapeutic (amod)
ph unphysiologic (amod)
damage mediated (acl)
rare life-threatening (conj)
octreotide ( (punct)
cases one (conj)
points 100 (nummod)
estimated scale (nmod)
cope and (cc)
tachyarrhythmias supraventricular (amod)
weeks 52 (nummod)
phenotypes activity (conj)
1969 - (punct)
considered option (nmod)
activity nocturnal (amod)
control dyskinesias (nmod)
toxicities leukopenia (dep)
reduction as (case)
ns of (case)
presentation was (cop)
antithrombin inhibitor (appos)
factor infection (nmod)
activity enzymes (nmod)
patients surgical (amod)
regarded should (aux)
anaesthetised and (cc)
infusion snp (compound)
nmda ) (punct)
interval duration (conj)
infiltration under (case)
sepsis pseudomonas (compound)
resulted shifts (nmod)
consumed widely (advmod)
observed hepatectomy (nmod)
sgk1(-/- compared (case)
hypotheses integrate (acl:relcl)
reduced dose (nsubjpass)
mixture long-acting (nmod)
group non-seizures (amod)
inhibitor nf-kappab (compound)
28 13 (compound)
psoriasis for (case)
showed irregularities (dobj)
midazolam separated (advcl)
period restrictions (nmod)
time ecarin (compound)
blocker entry (compound)
= 2.5 (dep)
12weeks after (case)
young 19 (conj)
carcinogen the (det)
nicergoline lysine (conj)
criteria selection (compound)
efe ( (punct)
evidence stress (nmod)
symptoms neurotoxicity (compound)
corticosteroids intravenous (amod)
period organogenesis (nmod)
omission by (case)
involved be (auxpass)
steroids with (case)
findings magnetic (amod)
weeks duration (nsubj)
contraceptives newer (amod)
proliferation with (case)
associated complaints (nmod)
effect seizures (nmod)
30mg/kg - (punct)
neutropenia for (case)
nerves optic (amod)
results have (appos)
extracted authors (nsubj)
effects cardiac (amod)
repeated had (aux)
understood suggests (conj)
initiated empirically (advmod)
dogs five (nummod)
days period (nmod)
effect galactose (nmod)
barrier blood-brain (compound)
mesna ) (punct)
injection v. (compound)
syndrome complication (appos)
using epilepticus (nmod)
propensity occurrence (nmod)
evidence convincing (amod)
shown presence (nsubjpass)
cis-platin ) (punct)
assessed reproducibility (nsubjpass)
wt both (cc:preconj)
types both (det)
differ risperidone (nmod)
ameliorated dyskinesia (nsubjpass)
effect more (amod)
trial mg/m2 (dep)
diagnosis syndrome (nmod)
clinic health (compound)
prevalence screening (nmod)
restored normal (nmod)
carried can (aux)
reduction > (nmod)
conclusions reproducible (appos)
developed soon (advmod)
ci ] (punct)
rate duration (conj)
stress of (case)
history attended (acl:relcl)
group non-ischemic (amod)
tnf paf (conj)
pcna ) (punct)
discussed options (nsubjpass)
neutropenia severe (amod)
production tetracycline (nmod)
accumulated studies (nmod)
hours 2,250 (nummod)
action facilitation (nsubj)
increased h (nmod)
agent pneumonitis (appos)
infusion microgram/kg/min (appos)
addictive a (det)
associated production (nmod)
restored bradycardia (dobj)
8.4 10.1 (conj)
induced combinations (nmod)
recorded deficits (dobj)
cage the (det)
given time (nsubjpass)
exhibited but (cc)
s 0.55 (nummod)
interest presence (nmod)
blocked incidence (nmod)
challenging . (punct)
transaminase elevated (amod)
catalepsy dose (nmod)
drug rather (cc)
biliary , (punct)
right the (det)
ameliorated decreased (conj)
ct compared (acl)
survived which (nsubj)
detected spect (nmod)
effect a (det)
compensated q10 (nsubj)
prc ionic (amod)
assessed models (nmod)
strokes all (det)
perfused addition (nmod)
consistent data (nsubj)
detection management (conj)
triglyceride output (conj)
evaluable evaluated (ccomp)
dimer-x hexabrix (conj)
used 1994 (nmod)
triglycerides , (punct)
doxorubicin week(-1 (appos)
tumor in (case)
gating of (case)
florence in (case)
result bone (nmod)
taking 600 (dobj)
sulphasalazine with (case)
disposition uptake (conj)
% 3.9 (nummod)
hypotension abolished (acl:relcl)
conditions various (amod)
studied volunteers (nsubjpass)
showed had (conj)
occlusion coronary (amod)
impairment dysfunction (conj)
bzds/rds of (case)
up-regulation with (case)
removal during (case)
rats epinephrine-treated (amod)
xdr-tb ) (punct)
mechanisms management (conj)
occurred seizure (nsubj)
bradycardia due (case)
irreversible is (cop)
supplementary the (det)
mm 119 (compound)
action convulsive (amod)
carbamazepine acid (conj)
manipulate interpretation (dobj)
chlorpheniramine mg (compound)
reached plateau (dobj)
developed acidosis (nmod)
option protect (acl)
reversal overdose (nmod)
use amiodarone (nmod)
outcomes poor (amod)
hyperplasia liver (nmod)
40 almost (advmod)
amount large (amod)
receptors accumbal (amod)
mm 0.135 (nummod)
microl/side ) (punct)
propranolol than (case)
scopolamine non (amod)
ca(2 + (cc)
kidney rats (conj)
route intravesical (amod)
weeks and (cc)
resistant alpha3 (nsubj)
develop effects (nmod)
sites mice (nmod)
examine independently (advmod)
cardiotoxicity cardiotoxicity (nmod)
transition permeability (compound)
components for (case)
injections uni- (amod)
disease lp-bm5 (compound)
black were (cop)
reduction center (nmod)
treated 6-ohda (nmod)
finished , (punct)
read been (auxpass)
slowed excretion (nsubjpass)
onset pain (nmod)
association buprenorphine (nmod)
fragments acth (compound)
cox-2 not (cc)
explore adapt (conj)
tumor bone (compound)
flumazenil antagonist (compound)
pressure mm (nmod)
tumors remission (nmod)
patient pacemaker (conj)
gloves such (case)
delirium postoperative (amod)
factor may (aux)
sedative mri (nmod)
glomeruli rats (nmod)
resulted unchanged (advcl)
presented below (advmod)
0.99 ( (punct)
agonist alpha- (amod)
infusion rats (nmod)
ranged weeks (nmod)
occluded was (auxpass)
action lf (nmod)
abusers crack (compound)
slight absent (conj)
patients cyclosporine-and-prednisone-treated (amod)
appeared bleeding (nsubj)
common irrespective (advmod)
cells both (cc:preconj)
outcomes clinical (amod)
glomerulopathy between (case)
used well-tolerated (conj)
administered sublingually (advmod)
caffeine drug (conj)
chemotherapy : (punct)
microgram/kg fentanyl (amod)
case failure (nmod)
cells own (amod)
categories at (case)
has cardioselective (parataxis)
mofetil and (cc)
6.87 2.25 (conj)
choleretic good (amod)
via isolation (dobj)
physicians professionals (conj)
medication be (cop)
thrombocytopenia for (case)
fluoroacetate fluorocitrate (conj)
17beta-estradiol of (case)
depending drugs (nmod)
headaches intermittent (amod)
hsct ) (punct)
42 ( (punct)
apomorphine mg/kg (appos)
sheath introducer (compound)
mg/kg parameters (nmod)
years receiving (advcl)
center to (case)
apparent has (advcl)
disorder schizo-affective (amod)
raised doses (nmod)
mechanisms arousal (compound)
relationships dose-effect (amod)
associated rs6693503 (nsubjpass)
characterized death (nmod)
recall pain (compound)
thought although (mark)
needed may (aux)
slow progression (dobj)
myelosuppression toxicity (conj)
tape punched (amod)
stimulation case (nmod)
point for (case)
score dyskinesias (nmod)
129 - (punct)
dopamine local (amod)
score quality (nmod)
relieve that (mark)
safety relative (amod)
relevance . (punct)
cimetidine by (case)
variants arch (compound)
generated precore (nmod)
pre-treatment l-365,260 (nmod)
nm 17.0 (nummod)
deficits permanent (amod)
testing convulsions (nmod)
remained discontinuation (nmod)
evaluation cost (nmod)
had diazepam (dobj)
ca(2 current (conj)
sclerosis to (case)
oxidation assembly (conj)
rate predobutamine (compound)
best indicating (advcl)
data use (nmod)
stress triglycerides (conj)
foot hind (compound)
77.1 ( (punct)
given i.p. (advmod)
tumor for (case)
made not (neg)
after ( (punct)
frequency abnormalities (nmod)
effect forestomach (nmod)
methyldopa of (case)
database residents (nmod)
useful should (aux)
increasing 66.6 (nmod)
alkaloid aconitine (nsubj)
minimum for (case)
ribavirin hepatitis (compound)
otherwise is (cop)
retained that (mark)
ranged sodium (nsubj)
obtained we (nsubj)
confirmed absence (nsubjpass)
binding mice (nmod)
water e-fortified (conj)
patients eighty-four (amod)
cumulative dose-limiting (amod)
oralis the (det)
sensitive cardiotoxicity (nmod)
model three-compartment (amod)
withdrawal bradycardia (conj)
administration alpha-2b (nmod)
dysfunction hepatic (amod)
given followed (xcomp)
endemic highly (advmod)
induced morphology (nmod)
dysphonia adductor (compound)
focus particular (amod)
pulmonary insufficiency (dep)
remains high (xcomp)
preparations and (cc)
tcr of (case)
period recovery (compound)
score fasciculation (compound)
role seizures (nmod)
p=0.11 ( (punct)
value models (nmod)
diagnoses ) (punct)
findings striking (amod)
rate onset (nmod)
mmol/day ( (punct)
increase 1.5-fold (appos)
conclude knowing (advcl)
reduced tissues (nmod)
observed overshooting (nsubjpass)
regimen designed (acl:relcl)
diet plus (cc)
cancer contre (compound)
produced . (punct)
patient toxicity (conj)
test eluate (conj)
group p<0.01 (appos)
patients any (det)
plasma free (conj)
occurred lasted (ccomp)
0.6 was (cop)
capacity human (amod)
malignancy primary (amod)
treated stz (nmod:npmod)
demonstrate dependent (ccomp)
antagonism cholecystokinin (nmod)
induced rats (advcl)
falls concentrations (nmod)
thrombosis by (case)
failure lithium-induced (amod)
ratio increased (amod)
administered dose (nsubjpass)
hippocampal ltp (dep)
concentration hepatic (amod)
contains , (punct)
examined determined (conj)
related fluctuations (nmod)
abnormalities valvular (amod)
use lignocaine (nmod)
2 number (nsubj)
showing popularity (dobj)
heart-rate in (case)
54 , (punct)
criteria ' (punct)
meningitis mssa (compound)
apoptosis with (case)
thought has (aux)
immunoassay by (case)
bf-dependent . (punct)
using acceleromyography (dobj)
or difference=0.01 (dep)
interval noninjurious (amod)
tissues segment (compound)
haemorrhage subarachnoid (amod)
expression which (nsubj)
report i. (compound)
ethosuximide alone (advmod)
conditions off'-drug (amod)
repair cuff (nmod)
man caucasian (amod)
heroin after (case)
induced reported (advcl)
crocins mg/kg (appos)
strokes ischemic (amod)
sets consecutive (amod)
recurred psychosis (nsubj)
thickness wall (compound)
5.8 0 (compound)
identify l-sotalol (nsubj)
hcl of (case)
lesion rats (nmod)
treated cause (advcl)
naloxone ( (punct)
seemed suggesting (xcomp)
functions for (case)
quantified ( (punct)
used resulting (xcomp)
demonstrate rate (dobj)
trazodone antidepressant (amod)
hours exposure (nmod)
mg/dl micromol/l (appos)
institution at (case)
months 5.5 (nummod)
cholestatic cytolytic (conj)
expression tissues (nmod)
switch sodium (nmod)
dehydrogenase , (punct)
preserved hypotension (nmod)
died has (aux)
use was (cop)
binding induced (acl)
bd1018 and (cc)
closest ; (punct)
aminotransferase increased (amod)
diagnosis unexpected (amod)
imaging dipyridamole-thallium-201 (compound)
vasopressin neither (cc:preconj)
scale analogue (compound)
challenge or (cc)
activity convulsant (amod)
given thus (advmod)
survival reduced (amod)
linkages peptide (compound)
dropped and (cc)
superoxide ( (punct)
encephalitis of (case)
ingestion occurrence (conj)
aftereffects applications (nmod)
methadone-maintenance mm (appos)
resolution incomplete (amod)
remission . (punct)
has antioxidant (nmod)
presented greater (advmod)
shortened duration (dobj)
tribute mixture (nmod)
relation ampk (nmod)
hemisphere ischemic (amod)
nanoparticles empty (amod)
predictor the (det)
rat arrhythmic (amod)
properties contractile (compound)
score drug (compound)
stimulates bupivacaine (nsubj)
evidence histological (amod)
simvastatin lovastatin (conj)
cancer to (mark)
to " (punct)
effective may (aux)
studied 2 (meta)
significant abdomen (nmod)
adriamycin after (case)
increased extent (dobj)
time during (case)
mixture 1,1-dichloro-2,2,2-trifluoroethane (nmod)
medicate not (neg)
bp mean (amod)
potential treating (advcl)
relationship drd2 (nmod)
similar tensions (nsubj)
ingestion during (case)
+ + (cc)
iii . (punct)
overdose severe (amod)
activity therapy (appos)
increases correction (nsubj)
anemia against (case)
evaluates metamizol (dep)
used carbamazepine (nsubjpass)
values low (amod)
mechanism due (case)
cholestatic and (cc)
decreases groups (nmod)
1983 , (punct)
methods review (appos)
10- dose (conj)
thyroxine free (amod)
data people (nmod)
social emotional (conj)
degree fibrosis (nmod)
cause background (nsubj)
expressed slope (nmod)
benefit no (det)
therapy lisinopril (compound)
use identify (xcomp)
established randomised (conj)
years > (nummod)
tachycardia induced (acl)
duration mean (compound)
consistent origin (nmod)
increase patients (nmod)
connecting segments (dobj)
6.7 +/- (cc)
be delivery (nmod)
case myelosis (nmod)
1.8-fold versus (cc)
improved pao2 (nsubjpass)
inhibition greatest (amod)
allocated groups (nmod)
wild-type alpha2abc-knockout (conj)
indices assessed (acl)
pain on (case)
live lives (dobj)
% treated (acl)
experience requirements (conj)
glutamate focal (amod)
overflow the (det)
efficacy reduction (nmod)
slides the (det)
aspartate or (cc)
microarrays blotting (conj)
risks associated (acl)
none variants (nmod)
1 up (advmod)
= 10 (dep)
rats that (mark)
adolescent citalopram (nmod)
heart muscle (conj)
bleeding the (det)
patient particular (amod)
paws claws (conj)
event 8 (conj)
investigate subgroups (nmod)
effectiveness crocin (nmod)
g/m2 doses (nsubj)
dilation after (conj)
taken fenfluramines (dep)
tolerated who (nsubj)
tumor an (det)
identified herniations (nmod)
ataxia % (appos)
anemia remoxipride-induced (amod)
stimulation frequency (compound)
pattern hepatocellular (amod)
ct repeat (compound)
suggest together (advmod)
cpa/ee for (case)
compound op (compound)
sedation diazepam-induced (amod)
oxide nitrous (amod)
mechanism mediated (acl)
withdrawal temporary (amod)
name syndrome (dobj)
sites cholinoceptive (amod)
caused enhancement (dobj)
reduced contraction (nsubjpass)
synthesis this (det)
reviews emphasis (nmod)
measured count (nsubjpass)
1.6 i.v. (dep)
neuropathy optochiasmatic (amod)
motoneurons the (det)
values study (nmod)
mpep by (case)
criteria administration (compound)
lost while (mark)
infusion via (case)
contained and (cc)
process neuroinflammatory (amod)
ovary associated (acl)
causes common (amod)
did cells (nsubj)
drug incriminated (amod)
depressed performance (nsubjpass)
33.7 + (cc)
action drugs (nmod)
out-patients the (det)
responsive stimuli (nmod)
damage and (cc)
cellularity marrow (nmod)
ester : (punct)
properties anti-inflammatory (amod)
sagittal inferior (amod)
conducted concurrently (advmod)
l-type channels (nmod)
extract fruits (nmod)
has analysis (nsubj)
treated patient (nsubjpass)
blockade krebs (compound)
that granulocytes (nmod)
develop however (advmod)
reviewed patients (nsubjpass)
interest but (cc)
pretreated haloperidol (nmod)
weak while (mark)
beverages quinine-containing (amod)
hazard the (det)
migraine onset (compound)
observation median (amod)
rates response (compound)
administration dobutamine (nmod)
analgesics by (case)
11.2 mg. (dep)
proliferate day (nmod)
cyp27 ( (punct)
reassured patients (nsubjpass)
dysfunction chronic (amod)
permanente of (case)
jj ( (punct)
reduced tablet (dobj)
arrhythmias cardiac (amod)
unresponsive therapy (nmod)
ht continuous (amod)
recombinant human (dep)
events incidence (dep)
dehydrogenase serum (compound)
concluded supervision (ccomp)
monophosphate by (case)
regimen first-line (amod)
evidence collected (amod)
models catalepsy (nmod)
rats ds (appos)
behaviour open-field (amod)
treatment thrombocytopenia (nmod)
improvement symptoms (nmod)
catalepsy tremor (conj)
injection from (case)
syndrome hemolytic-uremic (amod)
disappeared finally (advmod)
ect ( (punct)
pathogen(s pre-therapy (compound)
anephric functionally (advmod)
implicated both (intj)
risk diseases (nmod)
dosage therapeutic (amod)
etoposide doxorubicin (conj)
advantage effects (nmod)
bendrofluazide , (punct)
studies six (nummod)
therapy tuberculosis (nmod)
associated lovastatin (nsubjpass)
pair-matched whom (nsubjpass)
specified or (cc)
physiology muscle (compound)
vitro both (cc:preconj)
administration metronidazole (compound)
blind , (punct)
introduction withdrawal (conj)
symptom-free were (cop)
baseline tests (conj)
dhea the (det)
decreased kinase (dobj)
therapy leading (acl)
reactivation b (compound)
suggest seem (advcl)
return hospital (nmod)
lists , (punct)
prolong interval (dobj)
increase cocaine-induced (amod)
received dysphonia (nmod)
damage ) (punct)
herbicides n-phenylimide (compound)
reduce vpu (nsubj)
oxidation fatty-acid (amod)
2.6 to (case)
made observation (nmod)
concentration h (compound)
bladder in (amod)
case developed (acl:relcl)
studying when (advmod)
reduce drug (nsubj)
aprotinin concentrations (conj)
drugs all (predet)
role mice (conj)
13 16 (conj)
score living (compound)
> microg/ml (dobj)
pain study (dep)
histochemistry , (punct)
111 24 (compound)
determined are (auxpass)
remained it (nsubj)
hypotension with (case)
larger and (cc)
delivery oral (amod)
established less (nsubjpass)
convulsant of (case)
greater significantly (advmod)
measurement tremor (nmod)
results assay (compound)
db prilocaine (nmod)
performed were (auxpass)
= 0.002 (dobj)
associated tolerated (conj)
size muscle (compound)
screening from (case)
transplantations intracerebral (compound)
proteinases gly-phe-leu-gly (appos)
had microgram/ml (nmod)
5 mg/kg (dep)
effect failure (nmod)
morning evening (conj)
hypothalamus cerebellum (conj)
function pathway (nmod)
beginning days (nmod)
hemodiafiltration venovenous (amod)
elevated was (aux)
syndrome transient (amod)
once month (nmod)
studies prospective (amod)
outcome : (punct)
aminonucleoside pan (dep)
inflammatory and (cc)
impair , (punct)
indicating activation (dobj)
veins and (cc)
presented who (nsubj)
production response (nmod)
acute recurrent (conj)
patients complication (nmod)
rats newborn (amod)
adenomas and (cc)
accomplished unresponsive (advcl)
failed potentiate (xcomp)
tcr . (punct)
dfp-atropine with (case)
seemed atra (nsubj)
needed are (auxpass)
life coma (nsubj)
leukocytes bacteria (conj)
studies biodistribution (compound)
considered significant (xcomp)
was death (attr)
interpreted benign (nmod)
pressure indexed (acl)
secretion hormone (nmod)
disorder use (conj)
exception children (nmod)
frequency hepatotoxicity (nmod)
alopecia mild (amod)
division in (case)
disease for (case)
avoid use (dobj)
paradigm fps (compound)
started months (nmod)
found nephritis (nmod)
2.21 level (nsubj)
surgery and (cc)
effect pathogenesis (conj)
inpatients schizophrenic (amod)
dysfunction corticostriatal (amod)
points six (nummod)
months d-penicillamine (nmod)
block rhythm (compound)
participated 12-week (nmod)
reduction nimodipine-induced (amod)
adrenergic prior (amod)
been studies (attr)
use which (nsubj)
cross-tolerant were (cop)
form intermediates (dobj)
presence by (case)
history five-year (amod)
cause , (punct)
drugs accompanying (amod)
appears factor (nsubj)
subject this (det)
hypopharynx larynx (dep)
myopathy reversible (acl:relcl)
view use (nmod)
nephritis possible (amod)
doses misoprostol (nmod)
frlma ; (punct)
receptor ka (compound)
documented was (auxpass)
testing reliable (amod)
have system (nmod)
% 7 (nummod)
3alpha-hydroxy-5beta-pregnan-20-one ( (punct)
lend derangement (nmod)
referred were (auxpass)
tests performed (acl)
growth tumors (nmod)
treated treated (conj)
dose bupivacaine (compound)
mediated response (nsubjpass)
availability through (case)
cells serotonin (compound)
suspect weakness (conj)
itself in (case)
thymus bodyweights (conj)
effect mg/kg (appos)
anticoagulant by (case)
toes chicks (nmod)
similarity the (det)
halothane isoflurane (conj)
microscope under (case)
ratios growth (compound)
produced that (mark)
mediator no (nsubj)
were because (mark)
simvastatin atazanavir (conj)
transducer a (det)
therapy omeprazole (nmod)
arrhythmia . (punct)
undergoing ct (dobj)
patients hyperlipidemia (nmod)
alters dysrhythmogenicity (dobj)
5.4 times (dep)
peripheral and (cc)
time asystole (nmod)
think to (mark)
syndrome associated (amod)
contribution treatment (nmod)
doses after (case)
cisplatin plus (cc)
plasma data (conj)
concern patients (nmod)
cssep of (case)
infarction documented (amod)
stimulation magnetic (amod)
tilts head-up (nsubj)
biochemistries normalized (acl)
going ? (punct)
cardiotoxicity adriamycin-evoked (amod)
myopathy , (punct)
cna ) (punct)
lasted hours (dobj)
rate combined (amod)
using immunohistochemistry (dobj)
analysis risk (compound)
etiology identified (acl)
data pooling (compound)
operative forebrain (nmod)
report as (case)
studies similar (amod)
mice associated (acl)
latencies onset (nmod)
developed decreased (dep)
developed hypotension (dobj)
received daily (advmod)
strategy treatment (nmod)
parp 2.4.2.30 (dep)
bp group (nmod)
prevented reduction (nsubj)
cigarettes day<10 (nmod)
buffers plasma (conj)
tolerant subjects (nmod)
was parallel (nmod)
challenge involving (case)
allodynia injection (nmod)
= .026 (dep)
ikr ketoconazole (appos)
effects haemodynamic (amod)
adults children (conj)
tie a (det)
window narrow (amod)
hplc ) (punct)
increase for (case)
strain and (cc)
group inf-mi (compound)
hexamethonium by (case)
p .03 (dep)
cases 7 (nummod)
impairment functional (amod)
seems administration (nsubj)
adducts induced (amod)
suggests mapping (nsubj)
applied africa (nmod)
factors measures (conj)
factors process (nmod)
receiving ; (punct)
studies cancer (nmod)
descriptions with (case)
effect dose-related (amod)
events eps-related (amod)
attenuated nimo (nsubj)
potential improving (acl)
responses clinical (amod)
mp ( (punct)
characterized that (nsubjpass)
prescribe scabicides (dobj)
stimulation acute (amod)
diminished sensation (nsubjpass)
pretreated saline (nmod)
times not (neg)
isoniazid by (case)
rats abecarnil (conj)
pge1 or (cc)
based pharmacokinetics (nmod)
= 7.8 (dobj)
mmhg 0.001 (appos)
tamca ( (punct)
overexpression pgp (nmod)
acuity vision (conj)
cases malaria (compound)
experienced choreoathetosis (dobj)
patients fhf (nmod)
inhibitor angiotensin (nmod)
effects overdose (nmod)
included history (dobj)
proportional preserved (advcl)
searched databases (dobj)
patients human (amod)
symptoms depressive (amod)
isolated blocks (conj)
multicenter is (cop)
showed responses (dobj)
satisfactory ease (nsubj)
abundances na(+)/h(+ (nmod)
activity caspase-3 (compound)
acetate ra (appos)
neuropathy myelo-optic (amod)
waveforms baep (compound)
investigating results (nsubj)
% mortality (nsubj)
prevented tolerate (conj)
mea fpd (conj)
malaria hospitals (nmod)
pathway that (mark)
that than (case)
discontinued given (conj)
women all (det)
minutes gtn (nmod)
sbp and (cc)
seemed normal (xcomp)
effect well-known (amod)
fs containing (acl)
study test (conj)
tri-iodo-thyronine intravenous (amod)
children those (conj)
played where (advmod)
view action (nmod)
impart dosages (nmod)
parameters ecg (compound)
dopamine of (case)
dural and (cc)
shape in (case)
disorder i (nummod)
newborn a (det)
effects infusion (nmod)
6.25 and (cc)
ions excess (nmod)
headaches from (case)
t(30 ( (punct)
mv 1.6 (nummod)
patients five (dep)
ear into (case)
be by (case)
populations limits (acl:relcl)
times aptts (dep)
reduction activity (conj)
evoke activity (dobj)
characteristics patient (compound)
separation effects (nmod)
neurotoxicity greater (amod)
cerruloplasmin such (case)
avoid understanding (advcl)
solution between (case)
lmwh iu/kg/h (appos)
noted be (auxpass)
release ) (punct)
seen to (mark)
decreased striatum (nmod)
ceased fits (nsubj)
placebo ratings (nmod)
treatments three (nummod)
apoptosis doxorubicin-induced (amod)
cardiomyopathy indications (nsubj)
normal % (nmod)
expression model (nmod)
other % (dep)
step % (nsubj)
exposure periods (nmod)
synthesized esterification (nmod)
reduction nox (nmod)
case paralysis (nmod)
heavy and (cc)
detected respectively (advmod)
prolonged metabolic (conj)
provides immunosuppression (dobj)
patients consumed (acl:relcl)
appears suggesting (xcomp)
amantadine of (case)
indomethacin mg/kg (conj)
paranoia of (case)
intakes folate (nmod)
sensitive identify (advcl)
patient them (nmod)
morphology ultrastructural (amod)
one twins (nmod)
nicotine , (punct)
peroxidase of (case)
needle 25-gauge (amod)
dgc integrins (conj)
alterations susceptibility (nmod)
cause hypokalemia (dobj)
those those (conj)
exposed who (nsubjpass)
1/500 than (quantmod)
acid gaba (appos)
focused reported (advcl)
become whether (mark)
detected antibodies (nsubjpass)
4.04 0.99 (conj)
timeframe within (case)
glucuronidation extensive (amod)
interrelationship neurons (nmod)
factor contributed (acl:relcl)
associated lesions (nmod)
tasks but (cc)
rose months (nmod)
diagnosis consistent (amod)
ci 1.37 (dep)
output l/min (dep)
left the (det)
important results (nsubj)
values predictive (amod)
effect formation (nmod)
efe ) (punct)
days 8 (conj)
variety man (nmod)
powerful is (cop)
test increase (ccomp)
possesses atorvastatin (nsubj)
postulated it (nsubjpass)
cause adenovirus (nsubj)
stress decreased (amod)
data recent (amod)
left thrombosis (dobj)
administration placebo (nmod)
available generically (advmod)
found increase (conj)
administration manner (nmod)
compared neuropathy (nmod)
saline ntg (conj)
relevant was (cop)
detachment by (case)
microangiopathy related (amod)
lymphoma non-hodgkin (amod)
produce p.o. (dobj)
arrest hypothermic (amod)
i.p. or (cc)
have transfer (nmod)
factor prostaglandins (conj)
attack primary (amod)
periods initial (amod)
haplotypes in (case)
rate cumulative (amod)
glomerulonephritis pr3-anca-positive (amod)
ganglia basal (amod)
2e1 ( (punct)
address memory (dobj)
cases individual (amod)
examined tone (nsubjpass)
completed received (advcl)
62 14 (compound)
improved reported (conj)
ketamine xylazine (conj)
duration a (det)
was ) (punct)
conditions upon (case)
cromakalim micrograms/kg (appos)
lesion was (cop)
patterns users (conj)
dose coefficient (dep)
represented a1 (nmod)
cocs . (punct)
received produce (advcl)
first h (conj)
paralysis myotonia (conj)
regions autonomic (amod)
generation signs (nmod)
c1 included (acl:relcl)
repeated intervals (nmod)
subject study (nmod)
ratio albumin/creatinine (compound)
histology ( (punct)
mg/dl. of (case)
cleared removal (nmod)
using thalidomide (dobj)
seems srl (nsubj)
selegiline and (cc)
proliferation muscle (compound)
18 to (quantmod)
controlling use (nmod)
extended-release/lovastatin with (case)
mg/d 240 (nummod)
corticosteroids with (case)
factor on (case)
hyperkalemia k(+ (appos)
treatment additional (amod)
nhe3 tsc (conj)
effects test (nmod)
diagnosed delirium (nmod)
neuropathy pac-induced (amod)
administration not (neg)
fear happiness (conj)
changed variable (nsubj)
need to (case)
81 13 (conj)
clonic to (case)
extended sensitivities (nsubjpass)
signs schedule (compound)
factor contributing (amod)
potency low (amod)
years few (amod)
act to (mark)
myopathy persists (acl:relcl)
protect seizures (nmod)
headache were (cop)
activity antioxidant (amod)
offers heparin (nsubj)
paresthesias of (case)
phase treatment (nmod)
decreased cranial (xcomp)
syndrome hand-foot (amod)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ + (conj)
exhibits hypothesized (conj)
most score (conj)
represses expression (dobj)
pills to (case)
deficits attributed (acl)
considered could (aux)
rating parent (compound)
dilevalol serum (conj)
therapy > (nmod)
ultrafiltration cells (nmod)
extract novel (amod)
number x (cc)
transplanted alf (nmod)
responses selective (amod)
microgram/kg/min etomidate (compound)
iv mg (compound)
maha of (case)
imaging monitoring (conj)
acts this (nsubj)
ccu to (case)
delta gamma-2 (conj)
results of (case)
developed decreased (conj)
comparing users (dobj)
thrombocytopenia alopecia (conj)
models different (amod)
discovered report (dobj)
marrow a (det)
sensitive length (nmod)
dexamethasone plus (cc)
models amphetamine-induced (amod)
death patient (nmod:poss)
syndrome 5 (nummod)
agent alternative (amod)
receptor ccr2 (nsubj)
dose-dependent derives (conj)
slower effect (nsubj)
courses arag/vp/cpm (nmod)
mellitus without (conj)
increase to (mark)
thickening left (amod)
level neutral (amod)
disorders clinical (amod)
ototoxicity aminoglycoside-associated (amod)
interactions phenobarbitone (nmod)
assessed determining (advcl)
pri ) (punct)
antagonist activity (nmod)
failed imaging (nsubj)
benefit mfl (compound)
lcva in (case)
hormone serum (compound)
gvhd ii-iv (compound)
mes ( (punct)
toxicity cystitis (conj)
difference without (case)
hypothesized increased (ccomp)
regulate proliferation (dobj)
abolished pretreatment (nsubj)
pressure ventricular (compound)
allografts indication (nmod)
npy ( (punct)
diet basal (amod)
given melatonin (nsubjpass)
gain therapeutic (amod)
decreased appeared (conj)
day surgery (compound)
polyneuropathy severe (amod)
follow infrequent (conj)
57.9 , (punct)
january and (cc)
vds ( (punct)
occurred recommended (advcl)
lower metrizoate (advcl)
48 from (case)
ulcers with (case)
catheterizations and (cc)
regimens prior (amod)
risk significant (amod)
past present (conj)
covariance of (case)
objective used (appos)
vte associated (acl)
patients tuberculous (amod)
les in (case)
175 225 (conj)
serum thyroxine (dep)
products postulated (amod)
evaluation therapy (nmod)
syndromes treated (acl)
responsible may (aux)
role cancer (nmod)
pressures systemic (amod)
is thus (advmod)
site at (case)
decreased animals (nmod)
increasing l(-1 (nmod)
patients another (det)
min-1 7 (nummod)
% women (nmod)
glomerulopathy the (det)
seizures for (case)
effects vehicle (conj)
values aldosterone (compound)
lidocaine mg/kg (dep)
disrupted ppi (dobj)
hg bp (conj)
effects metoprolol (nmod:poss)
epimers the (det)
contained whilst (mark)
cystitis hc (appos)
given studies (nsubj)
using exposures (nmod)
hilum duct (conj)
tolerated weeks (dobj)
effect aging (nmod)
serve warning (nmod)
entering esrd (nmod)
university , (punct)
selected shr (nsubjpass)
mg/m2 550 (nummod)
exacerbation of (case)
contractions but (cc)
word the (det)
female hypertension (nmod)
inhibited tonus (advmod)
rats carmustine-treated (amod)
off " (punct)
followed application (nmod)
groups resistant (acl:relcl)
alcohol s-perillyl (amod)
studies utilizing (acl)
248 from (case)
challenge medication (compound)
blunted significantly (advmod)
686 362 (conj)
decreased markedly (advmod)
drum " (punct)
users difference=0.01 (appos)
exposed patient (nsubjpass)
62 about (advmod)
greater relief (nsubj)
staining protein (compound)
1.66 0.89 (nummod)
lower score (nsubj)
effects candidates (nmod)
granulocytopenia transient (amod)
performed diltiazem (conj)
correlation reduction (nmod)
render tolerable (ccomp)
neuropeptides related (amod)
has risperidone (nsubj)
mechanisms differences (conj)
administration hours (compound)
intervals rates (conj)
induction tumors (nmod)
patients elderly (amod)
disruption , (punct)
angiogenesis of (case)
raised suppression (nmod)
postulated be (auxpass)
stz crocin (conj)
kinase patient (nmod:poss)
smoking for (mark)
discussed effect (nsubjpass)
utilized improve (advcl)
28 13 (conj)
prazosin map (appos)
recordings electrophysiological (amod)
clomipramine with (case)
bf-dependent effects (nsubj)
given bupivacaine (dobj)
nh4cl mmol (compound)
occurred whereas (dep)
incontinence the (det)
developed early (advmod)
taken indicator (nmod)
assays ( (punct)
atrium pig (compound)
uteri whose (nmod:poss)
result p (dep)
contributes , (punct)
approach safe (amod)
agent prevents (acl:relcl)
index process (nmod)
extend . (punct)
lamivudine prophylactic (amod)
ingestion chloroquine (compound)
acute de (conj)
available reports (nsubj)
trauma sepsis (conj)
attributed induction (nmod)
improved duration (dobj)
days hospitalization (nmod)
carteolol as (cc)
timolol with (case)
county florida (appos)
adults based (acl)
facilitate information (nsubj)
led differ (conj)
sufficient prevent (xcomp)
1986 1987 (conj)
was p (attr)
caused oxprenolol (nsubj)
day than (case)
observed resistance (nmod)
involved cotrimoxazole (nsubjpass)
mg prochlorperazine (nmod)
occluded anesthesia (nmod)
pointes torsade (amod)
exhibited weeks (nmod)
conditions optimized (amod)
cells prolactinoma (compound)
case . (punct)
identical which (nsubj)
elevation camp (nmod)
labetalol function (nmod)
mellitus with (nmod)
output p (dep)
changes potassium (nmod)
maha ) (punct)
concentrations inhibitors (nmod)
incidence myoclonus (compound)
reduced ages (nmod)
dxnp with (case)
ingestion time (nmod)
impaired highly (advmod)
admission ) (punct)
procedures gynecologic (amod)
asp70gly-p . (punct)
investigated 320/12.5 (nsubjpass)
hemorrhage following (case)
administration narcotic (amod)
damage vascular-mediated (amod)
significant eyes (nmod)
potentiated are (auxpass)
hematest urine (compound)
persons elderly (amod)
provide administration (nsubj)
reactive sluggishly (advmod)
show abolished (ccomp)
6-thioguanine by (case)
lasting prior (advmod)
presented recurrence (nmod)
ligand endogenous (amod)
instance 1 (nummod)
generalised and (cc)
identified products (nmod)
min during (case)
measured kits (nmod)
peptide gene-related (amod)
incerta zona (compound)
l-nil ip (dep)
ishihara ) (punct)
oxycantha crataegus (compound)
induce glomerulosclerosis (dobj)
function polymorphism (conj)
motor ascended (conj)
comparative , (punct)
anemias autoimmune (amod)
barrier urine (nmod)
necessary subunits (nsubj)
linking discuss (conj)
increase time-dependent (amod)
syndrome adult (amod)
associated although (mark)
minutes fifteen (nummod)
impairments users (nmod)
segment the (det)
periods early (amod)
= 8.0 (dep)
systolic in (case)
study tumor (compound)
regimens of (case)
results laboratory (amod)
caused mellitus (nmod)
randomization at (case)
potencies local (amod)
reported prolongation (nsubjpass)
minimum courses (nmod)
treatment insulin (compound)
affected is (auxpass)
prescribe should (aux)
adrenaline , (punct)
inhibition growth (compound)
age > (conj)
prevent can (aux)
speed their (nmod:poss)
healthy women (dep)
content urinary (amod)
reserpine with (case)
levels alt (compound)
incidence weeks (nmod)
period 1996 (nmod:tmod)
1.6 . (punct)
acid(a ) (punct)
drinks consumers (nmod)
unaffected d-pen (nmod)
% higher (conj)
analyzed months (dobj)
score dyskinesia (compound)
schema consisted (acl)
low moderate (conj)
nigra of (case)
pretreatment after (case)
literature of (case)
> mg/l. (dobj)
speculated involve (ccomp)
period lt (nmod)
received caused (advcl)
woman 72-year-old (amod)
activation midpontine (amod)
share not (neg)
ems than (case)
reactions agents (nmod)
group bcnu-exposed (amod)
effects flumazenil (nmod)
man had (acl:relcl)
capacity in (case)
present aetiologies (nsubj)
aminoglycoside plus (cc)
type constant (amod)
dose depending (case)
deoxycorticosterone pregnane-21-diol-20-ones (appos)
aggressiveness of (case)
gaba dose (compound)
slope fall (nmod)
necrotizing glomerulonephritis (dobj)
regions same (amod)
suggest occur (ccomp)
pneumonia ( (punct)
prolongation qtc (compound)
results studied (dep)
intensity patients (nmod)
cardiomyopathy dox (compound)
cocaine rc (appos)
over-immunosuppression and (cc)
hearts ob (compound)
deficits induced (acl)
indicator not (neg)
6 . (punct)
patients hypersensitivity (nmod)
effective are (cop)
potency ) (punct)
spasm , (punct)
anesthesia recovery (appos)
measures coronary (amod)
melatonin of (case)
reduces pre-treatment (nsubj)
mg . (punct)
demonstrated deterioration (dobj)
observed week (nmod)
severe may (aux)
three times (quantmod)
woman infarction (nmod)
environment in (case)
november 2004 (nummod)
8 +/- (cc)
courses concentration (appos)
shown risk (dobj)
explored was (auxpass)
cholinesterase scopolamine-induced (conj)
restoration (na (nmod)
interviewed using (xcomp)
neuroplasticity and (cc)
doses , (punct)
egfp-microglia areas (nmod)
wave b (compound)
62 +/- (cc)
serum control (compound)
conclusion prevent (appos)
cyclophosphamide agent (appos)
variety immunosuppression (nmod)
decreased propensity (dobj)
reductions administration (nmod)
demonstrates time (nmod)
cardiotoxicity experimental (amod)
mg 15 (compound)
months therapy (dep)
progression of (case)
role volume (nmod)
190 30 (compound)
treated shr (nsubjpass)
low hour (nmod)
686 +/- (cc)
suggested pathogenesis (nsubjpass)
counseling materials (conj)
long-term fixed-dose (conj)
= 5,701 (dobj)
dissolution the (det)
developed approach (nsubjpass)
issues moral (amod)
tremor arm (compound)
review extensive (amod)
hazard arrhythmias (nsubj)
exhibit to (mark)
required treat (advcl)
diarrheas diseases (conj)
telangiectasia noncaseating (conj)
head cancers (dep)
-(4-fluorophenyl 4 (nummod)
illness co-morbidity (conj)
8.8 3.9 (conj)
ester oxide (compound)
line ) (punct)
contexts surgery (nmod)
suppressed . (punct)
angioedema severe (amod)
methods/materials : (punct)
need % (nsubj)
rats relative (case)
patterns cycle (nmod)
enalapril pressure (nmod)
attribute . (punct)
rates infusion (nmod)
averaged , (punct)
zero respectively (advmod)
prophylaxis treatment (conj)
abnormalities permanent (amod)
oxygen hyperbaric (amod)
azelastine , (punct)
eczema eyelid (amod)
change further (amod)
increased degree (nsubj)
studies pediatrics (nmod)
infants to (case)
initiate to (mark)
results demonstrated (dep)
developed arrhythmias (dobj)
complication stenting (advcl)
narrowed was (auxpass)
encephalopathy vpa-associated (amod)
cotransporter of (case)
control balance (nmod)
question this (det)
paroxetine of (case)
dose botox (compound)
case fatality (nmod)
cortex hypothalamus (conj)
positive % (nmod)
carolina)/2011(iowa 2010(north (compound)
received heparin (dobj)
therapy amisulpride (amod)
injection of (case)
rocuronium pr (appos)
latencies escape (compound)
lesion it (nsubj)
measured ich (nmod)
decreased mg. (dep)
interview this (det)
agent treat (acl:relcl)
suggest preferred (ccomp)
targeted combined (xcomp)
edema peritumoral (amod)
surmountable was (cop)
men ( (punct)
level supposed (amod)
cxcl1 and (cc)
alleviated dyskinesia (nsubjpass)
lowering pressure (dobj)
conclusions reach (dep)
months following (amod)
association syndrome (nmod)
function gallbladder (compound)
ar n (dep)
exerting protection (dobj)
model intracerebral (amod)
increased susceptibility (dobj)
hepatitis attributed (acl:relcl)
treatment tacrolimus (compound)
heterozygous +/- (cc)
weight levels (conj)
mouth dry (amod)
found cells (nsubjpass)
syndrome wernicke-korsakoff (amod)
increased model (nmod)
stiffness suxamethonium-induced (amod)
drugs hepatotoxic (amod)
strokes brush (compound)
similar degree (nsubj)
role regulation (nmod)
caspase , (punct)
patients 177 (nummod)
product combination (compound)
exhibited whereas (mark)
observed placebo (nmod)
scheduled , (punct)
children versus (cc)
saturations oxygen (compound)
blockade l-type (nmod)
alcoholic she (nsubj)
channels on (case)
inhibited activity (dobj)
that infarction (nmod)
duration risperidone (nmod)
protocol treatment (compound)
pg/ml 230 (nummod)
factor chop (dep)
reabsorption phosphate (compound)
decreased weeks (nmod:tmod)
blocker calcium (compound)
527+/-509 versus (cc)
beating spontaneous (amod)
data pooled (amod)
day 43 (nummod)
had icterus (dobj)
enrolled centers (nmod)
efficacy profile (conj)
found signs (nsubjpass)
descent of (case)
disease parkinson (nmod:poss)
response pilocarpine (nmod)
site on (case)
clinical bedside (nmod:npmod)
therapy spinal (amod)
alpha- or (cc)
control control (conj)
groups 5 (nummod)
included sampling (dobj)
concentrations calcium (nmod)
acids antagonists (appos)
years months (conj)
apheresis ldl (compound)
joint ankle (compound)
years 32.5 (nummod)
sensations 4 (dep)
implicated have (aux)
achieving cr (dobj)
risperidone mg/day (appos)
was analyse (xcomp)
reactions ducts (nmod)
tolerability agents (nmod)
dtg ( (punct)
angiography computerized (amod)
recordings video (compound)
disturbances hematologic (amod)
used addition (nmod)
mmhg 0.4 (compound)
is knowledge (nmod)
grade 3/4 (dep)
mechanisms multiple (amod)
risk thromboembolic (amod)
examine abolish (ccomp)
receiving schedule (dobj)
system opioidergic (amod)
6 than (quantmod)
have sodium (nsubj)
increased actions (nsubjpass)
cytostatics no (det)
nmdar and/or (cc)
days zero (nummod)
followed flumazenil (nmod)
rns ( (punct)
etiology atheromatous (amod)
22 % (appos)
chromatography by (case)
delirium the (det)
determine stroke (conj)
40.8 +/- (cc)
involve did (aux)
reach not (neg)
patients metastatic (amod)
mg/kg iv (nummod)
than vertex (nmod)
19 9 (conj)
given postoperatively (advmod)
stabilized , (punct)
acetaminophen and (cc)
examined immunohistochemistry (nmod)
role major (amod)
apap mg/kg (appos)
% 5.9 (nummod)
non-significantly history (nsubj)
doses haloperidol (nmod)
weeks several (amod)
excreted animals (nsubj)
reported trials (nsubj)
avoided use (nsubjpass)
factors weakness (nmod)
higher rats (dep)
convert arrhythmia (dobj)
tool interesting (amod)
have advantage (dobj)
junctions altered (amod)
signs clinical (amod)
synthesis prostaglandin (compound)
revealed commensurate (ccomp)
review discuss (conj)
patients dermatoses (nmod)
report considered (conj)
alert . (punct)
revealed took (ccomp)
analyzed correlation (nsubjpass)
secondary increase (nsubj)
weeks resolution (nmod)
metabolites 1,3-butadiene (compound)
concluded but (cc)
drug designed (acl)
antigen-positive cell (compound)
hypertrophy or (cc)
4,000 from (quantmod)
group mice (nmod)
studies our (nmod:poss)
withdrawn now (advmod)
increased > (nmod)
effect proliferation (nmod)
pressure comparative (amod)
sensorium hemorrhages (conj)
caused weeks (nsubj)
has levodopa (nsubj)
patient admitted (acl)
titer acetylcholine (compound)
central peripheral (conj)
liver within (case)
factor permeability (compound)
h h (dep)
drug levodopa (nsubj)
disequilibrium groups (nmod)
0.0005 p (compound)
intralipid in (case)
rate control (compound)
mortality local (amod)
impairment without (case)
treated spironolactone (nmod)
requires inhibition (nsubj)
period induction (compound)
bfu-e ) (punct)
stopped recorded (advcl)
warning as (case)
indicate vulnerable (ccomp)
hormones exogenous (amod)
formulation different (amod)
describe drink (ccomp)
transformation the (det)
injection as (case)
success iop (dep)
both 1 (dep)
function patient (nmod:poss)
change no (det)
treated group (nsubjpass)
inhibitors non-selective (amod)
using deletion (nmod)
sulfadiazine with (case)
rhythm myocyte (compound)
conjugates etodolac-dextran (amod)
mediate effects (dobj)
1.46+/-0.8 vs. (cc)
restricted striatum (nmod)
2e1 and (cc)
astrocytes of (case)
course each (det)
cases hundred (amod)
prophylaxis ; (punct)
drugs 898 (conj)
pathway on (case)
treated block (nsubjpass)
associated somnolence (nmod)
stiffness joint (amod)
hz 185 (nummod)
capacity patients (nsubj)
ci 1.3 (nummod)
reacting autoantibody (dobj)
dextrose % (compound)
tended presence (nmod)
develop observed (conj)
induced isoniazide (nmod)
implanted injected (conj)
observed cases (nmod)
subjects male (amod)
purpose thought (appos)
case nephrolithiasis (nmod)
catheterization system (conj)
field ufov (appos)
matched respect (nmod)
3.7+/-0.8 ) (punct)
muscle thyroarytenoid (amod)
susceptibility lower (amod)
bromperidol conditions (nmod)
closest however (advmod)
kanamycin netilmicin (conj)
adaptation be (cop)
women quit (acl:relcl)
route patient (nmod)
conclude have (conj)
goal mg/dl (appos)
gender , (punct)
nationwide a (det)
urea d-amb. (compound)
scale bech-rafaelson (compound)
gamma-carboxylated was (cop)
recorded entry (nmod)
symptoms withdrawal (nmod)
modafinil morning-dosed (amod)
used immunosuppressant (xcomp)
maintained measure (nmod)
initiating after (mark)
showed mg/kg (dep)
remained score (nsubj)
32 25 (compound)
mg/m2 160 (nummod)
minutes 16.4 (nummod)
administration metoclopramide (compound)
days days (conj)
follow-up patients (nmod)
five in (case)
agoraphobia for (case)
paraplegia methotrexate (nmod)
different survival (nsubj)
delay for (case)
follow-up years (nmod:poss)
produces convulsions (dobj)
useful ; (punct)
pharmacokinetics and (cc)
influence may (aux)
conjugates ed1-ed4 (appos)
had order (nmod)
injections i.c.v. (compound)
defects established (amod)
complex of (case)
threshold mean (dep)
due part (nmod)
monotherapy patients (nmod)
beneficial patients (nmod)
mg 1.2 (compound)
rigidity pronounced (amod)
shifts by (case)
carries mortality (dobj)
suxamethonium arrest (conj)
troublesome term (nmod)
altered vagal (nsubjpass)
symptom-free who (nsubj)
verapamil patients (nmod)
cancer nsclc (appos)
agents corticosteroids (conj)
considerations their (nmod:poss)
abruptness failure (nmod)
patients feet (nmod)
investigated alleviation (dobj)
cholestasis progressive (amod)
biomarkers indices (conj)
brain rat (compound)
dosage a (det)
appear responsible (xcomp)
aed used (amod)
excluded contribution (nsubjpass)
sonograms by (case)
mg/m2/wk was (cop)
determine level (dobj)
melanoma for (case)
discontinuation antibiotic (nmod)
resistance lamivudine (nmod)
recommended advised (ccomp)
included recording (dobj)
bolus g/m2 (compound)
identified newly (advmod)
adenocarcinomas lesions (dep)
progression kindling (nmod)
obtained interview (nmod)
depressed preferentially (advmod)
use antiplatelet (nmod)
mandatory . (punct)
amca alone (advmod)
given metoprolol (nsubjpass)
converted sublingual (amod)
gating , (punct)
abusing heroine (dobj)
used they (nsubjpass)
patients 175 (appos)
reported demonstrated (advcl)
connected to (mark)
confirmed occurs (ccomp)
ii v6 (conj)
level group (nmod)
elevation blood (compound)
achieve times (dobj)
doxorubicin dox (appos)
damaged astrocytes (nsubjpass)
thrombophlebitis ototoxicity (conj)
extract by (case)
disease cld (dep)
weeks use (nmod)
valproate mg (dep)
anf [ (punct)
level brainstem (compound)
substituted important (advcl)
thresholds thermal (amod)
angioplasty coronary (amod)
neurological and (cc)
known toxicity (nsubjpass)
effective both (cc:preconj)
provide advantage (dobj)
agents atypical (amod)
test conditioned (amod)
caused flow (advcl)
occurred ; (punct)
relaxations postjunctional (amod)
induced sulpiride (nsubj)
dullness with (case)
65.6 8.5 (conj)
interpreted phenomenon (nsubjpass)
used ; (punct)
lvef and (cc)
rendered but (cc)
reduce dyskinesias (dobj)
glutamate variability (dep)
vehicle glycol (appos)
grade stained (acl)
affinity preferential (amod)
l1-l2 in (case)
a of (case)
impairments learning (nmod)
cataract of (case)
inhibitor cei (appos)
use fluconazole (nmod)
mg/dl 1.0 (nummod)
increase c (nsubj)
administration propofol (compound)
reported years (nmod)
minutes few (amod)
addition mg/dl (nmod)
transplantation living (amod)
changes ngf (nmod)
patients admitted (amod)
dogs open-chest (amod)
fragmentation of (case)
differences related (amod)
studies no (neg)
bilirubin serum (compound)
tie hypoxia (nmod)
boluses only (advmod)
briefly nahco3 (compound)
disorder acromegaly (nsubj)
impact small (amod)
remission after (case)
include anemia (dobj)
usage and (cc)
aggravated but (cc)
chloride edema (conj)
female was (cop)
15.5 p= (dep)
received neurotoxin (dobj)
prolactin by (case)
required establish (xcomp)
cases added (acl:relcl)
steroids the (det)
protein an (det)
experience omeprazole (nmod)
effect not (neg)
mu of (case)
caspase of (case)
initiated dialysis (nsubjpass)
pacemaker native (amod)
phase an (det)
dbs in (case)
recommenced administration (nmod)
assessed biochemical (nmod)
results , (punct)
evaluated records (dobj)
cardiomyopathy . (punct)
3.1+/-1.0 ) (punct)
make aware (ccomp)
gain , (punct)
requires synthesis (dobj)
results [ (punct)
receiving was (aux)
complications selected (acl:relcl)
proportional . (punct)
day later (advmod)
third-generation of (case)
insults , (punct)
marker , (punct)
health , (punct)
electrograms bundle (compound)
grafts five (nummod)
evidence safety (nmod)
acetaminophen with (case)
years childbearing (amod)
muscle life-threatening (amod)
contractility conduction (conj)
present respectively (advmod)
interviewing after (mark)
abnormality same (amod)
rats rilmenidine (appos)
cells neuroglial (amod)
antagonized can (aux)
igf-il-3 with (case)
angiopathy rats (nmod)
form fibrillation (conj)
decreased being (auxpass)
described after (mark)
improvements measures (nmod)
underwent , (punct)
development extent (nmod)
state on (case)
escape vaccine (compound)
failure aminoglycoside-related (amod)
rats ten (nummod)
changes map (nmod)
upregulation to (case)
intensity nausea (dep)
curative % (nmod)
designed examine (xcomp)
bupropion group (nmod)
prevented totally (advmod)
occurred those (advcl)
vestibular ) (punct)
patients cancer (compound)
dosing d-tubocurarine (nmod)
cisplatinum mg/m2 (conj)
clip one (nsubj)
hypoplasia nasal (amod)
placebo the (det)
dl-sotalol azimilide (conj)
nsclc ) (punct)
pk ( (punct)
considered digoxin (nsubjpass)
reduce might (aux)
events major (amod)
benign , (punct)
side-effect rare (amod)
regions and (cc)
activation blocked (acl:relcl)
painful it (nsubj)
olanzapine % (dep)
effective decreasing (advcl)
treat tuberculosis (dobj)
died he (nsubj)
l-alpha-gfc with (case)
showed evidence (dobj)
evaluate frequency (dobj)
patient hepatitis (nmod)
evaluation eeg (compound)
15.08 - (punct)
mg 40 (dep)
% 48.8 (nummod)
thrombectomy and (cc)
counteract vasospasm (dobj)
within or (cc)
sirolimus ( (punct)
% from (case)
aware hepatotoxicity (nmod)
nisoldipine of (case)
served apparatus (nsubj)
% ipratropium (nmod)
syndrome apnea (compound)
bradycardia interaction (conj)
% cultures (nmod)
offer sampling (nsubj)
transporter norepinephrine (compound)
glomerulonephritis a (det)
reported here (advmod)
appears supplement (xcomp)
quantified hours (nsubjpass)
desaturation severe (amod)
classified be (auxpass)
manner double-masked (amod)
protein 336 (nummod)
rise ctnt (nmod)
conditions underlying (amod)
recurrence literature (nmod)
migraineurs in (case)
medicine a (det)
dimension atrial (amod)
induced inhibition (nsubj)
was often (advmod)
known hazards (nsubjpass)
erg ) (punct)
preoperatively % (conj)
caused concentration (nsubj)
pointes report (nsubj)
responsiveness d2 (nmod)
2.2 x (cc)
dystrophy with (case)
nt-probnp ) (punct)
need because (mark)
abnormalities cortex (nmod)
deficit retention (compound)
nerve each (det)
use disulfiram (nmod)
durations various (amod)
core in (case)
hospital patients (nmod)
reported hypokalemia (nsubjpass)
0.75 ; (punct)
sensitivity ketoconazole (nmod)
investigated methods (dep)
children recovered (acl)
diazepam glycopyrrolate (conj)
old 46-year (amod)
follow-up total (amod)
thymus 0.001 (appos)
and regularly (advmod)
species release (conj)
transition mpt (appos)
addresses participants (nmod:poss)
used routinely (advmod)
masked which (nsubj)
cerebral or (cc)
irritation tract (nmod)
dba/2 ) (punct)
develop run (conj)
glutamate glycine (conj)
witnessed may (aux)
stm ( (punct)
infusion p (dep)
rate surgery (nmod)
administration dermal (amod)
injection sprague-dawley (nmod)
ac p (dep)
cck-2 - (punct)
detection disease (nmod)
necrosis hypoxic (amod)
recovered treatment (nmod)
hoe-140 microm (appos)
trial nephropathy (nmod)
antagonist k(i (dep)
association tumor (nmod)
inoculation ) (punct)
caused mm (dep)
associated reactions (nmod)
ameliorated could (aux)
regimen mg (nmod)
cpa ) (punct)
receptor mechanisms (dep)
castration by (case)
involve that (mark)
lasted lasted (conj)
drug prescribed (amod)
induce hepatitis (dobj)
known data (nsubjpass)
dex u/ml (compound)
users potential (amod)
born mother (nmod)
dysfunctions minor (amod)
time surgery (nmod)
more . (punct)
infiltrates pulmonary (amod)
stages certain (amod)
market from (case)
encountered frequently (advmod)
sources reviews (conj)
non-biodegradable were (cop)
make , (punct)
alleviated will (aux)
intake calculated (amod)
s 0.95 (nummod)
effects n (nmod)
word to (case)
magnitude lh (nmod)
tests nine (nummod)
tolerated have (aux)
formation atherosclerotic (amod)
cord the (det)
exclusively women (nmod)
option source (nmod)
management control (nmod)
aorta/serum-ratio build-up (conj)
non-interventional observational (dep)
2 , (punct)
members lovastatin (nsubj)
requirement higher (amod)
dose isoniazid (nmod)
estimate ratio (dobj)
showed hemorrhage (nmod)
experienced stopping (advcl)
treatment blockers (nmod)
occurring together (advmod)
frequency median (amod)
birth infant (nmod)
= has (dep)
remained higher (advmod)
5-fluorouracil infusion (dep)
day infarction (nmod)
toxicity but (cc)
lesion dopaminergic (amod)
exception years (dep)
decreasing and (cc)
modulators of (case)
vacuolization myocytes (nmod)
activation hbv (compound)
50 150 (conj)
levels adiponectin (compound)
center cancer (compound)
eyes occurrence (conj)
metabolized where (advmod)
prolongation interval (nmod)
administration systemic (amod)
increased mmhg (nmod)
need mechanisms (nsubj)
removal manual (amod)
investigations remember (acl)
involvement effect (nmod)
administration (noncardiac)/periprocedural (dep)
doses 1.37 (dep)
reductions marked (amod)
fenestrae endothelial (amod)
ax with (case)
hypothesis man (nmod)
returned sensitivity (nsubj)
those hypertension (nmod)
revealed kinase (dobj)
injections four (nummod)
propranolol after (case)
dsp4 mg/kg (appos)
therapy injections (conj)
unlikely was (cop)
2660 to (case)
capsules pneumatic (amod)
plausible mechanisms (dobj)
findings studies (conj)
gm. per (case)
living areas (nmod)
injury with (case)
detection iodine-125-metaiodobenzylguanidine (nmod)
receive metoprolol (dobj)
related control (nmod)
buffers as (mark)
results quantified (conj)
agents da (compound)
ampk ) (punct)
bulk results (nmod)
exhibited had (aux)
data this (det)
time-course the (det)
admitted edema (nmod)
samples biopsy (compound)
analysis roc (compound)
less injury (nsubj)
line tie2-cre;loxp-egfp (dep)
purposes these (det)
patient patients (nmod)
collected outpatient (nmod)
patients asian (amod)
repression with (case)
years in (case)
given regimen (dobj)
men 48 (nummod)
300 0 (compound)
degeneration cardiomyocyte (compound)
described palsies (nsubjpass)
mepivacaine of (case)
prognosis renal (amod)
force static (amod)
developed beginning (advcl)
amb ) (punct)
labelling regulation (conj)
tested were (auxpass)
dysrhythmias asystole (conj)
angina stable (amod)
septal vsd (appos)
loss partial (amod)
phase ( (punct)
transaminases liver (compound)
dosage than (case)
groups 1 (dep)
sufficient would (aux)
descriptions clinical (amod)
locf mmrm (conj)
26 69 (dep)
complications related (amod)
treatment active (amod)
effect dose-limiting (amod)
circulation on (case)
patient the (dep)
ta-064 ) (punct)
events moderate (amod)
treatment ranitidine (compound)
administered episode (nmod)
immunostaining 7h6 (compound)
smaller relaxations (nsubj)
rnfl calculated (amod)
hypertension cortisol-induced (amod)
mg 11.3 (nummod)
behaved rats (nsubj)
mepivacaine by (case)
included group (nsubjpass)
cross-tolerance response (conj)
event early (amod)
response stimulation-evoked (amod)
rates toxicity (nmod)
block mobitz (compound)
sensitivity [ (punct)
surveillance events (nmod)
stay unit (nmod)
company princeton (appos)
people country (nmod)
weeks admission (dep)
myositis . (punct)
incidence cancer (compound)
ed from (case)
pretreatment mm (appos)
life usually (advmod)
% thrombocytopenia (conj)
structure , (punct)
efficacious doses (nmod)
practice electroconvulsive (amod)
alterations expected (amod)
involves gaba (dobj)
dormex with (case)
pressure elevated (amod)
important pathogenesis (nmod)
dogs injection (conj)
test light/dark (compound)
time concentration (conj)
binding (3)h-haloperidol (compound)
made also (advmod)
suggest occurs (ccomp)
mepivacaine mg (dep)
89 42 (compound)
excitability electrical (amod)
infections fungal (amod)
cytoplasm cells (nmod)
palsy undergoing (dep)
rp sr (conj)
induce stimulate (conj)
seen years (nmod)
hospital found (acl:relcl)
scale interaction (compound)
associated vincristine (nmod)
possibility reactions (nmod)
occurred patients (dobj)
studies all (predet)
stent with (case)
admission and (cc)
up-regulation mhc-i (nmod)
% catecholamine (nmod)
cataracts hyperplasia (conj)
retention increased (amod)
hemisuccinate cholesteryl (compound)
supply inositol (compound)
increased preference (dobj)
shows waves (dobj)
developed weakness (dobj)
ng./ml less (amod)
ar ) (punct)
evident and (cc)
length stay (nmod)
exhibited that (mark)
monkey form (nmod)
blocking endomt (dobj)
content ventricular (amod)
6 number (nsubj)
using microdialysis (dobj)
selected patients (nmod)
resulted disorder (nmod)
fpdc ikr (nsubj)
deterioration and (cc)
re-elevate to (mark)
asystole from (case)
reduction frequencies (nmod)
medication trial (compound)
session , (punct)
cpu and (cc)
became negative (xcomp)
shell accumbal (amod)
frequent and (cc)
showed decline (dobj)
receiving dexmedetomidine (dobj)
effects ecstasy (conj)
improve solubility (dobj)
advisable . (punct)
propagates which (nmod)
patients days (conj)
dyskinesia disease (nmod)
pb with (case)
intermedius ventralis (compound)
design using (acl)
study using (acl)
one events (nmod)
cause viracept (nsubj)
complications cc (nmod)
recording in (case)
levothyroxine intravenous (amod)
considered tgf-beta1 (nsubjpass)
discussed . (punct)
period activity (conj)
patterns protein (compound)
trans-2-amino-3-hydroxy-1 3 (conj)
detected strains (nsubjpass)
model groups (conj)
samples from (case)
understood fully (advmod)
investigated involves (ccomp)
identify . (punct)
discouraged should (aux)
potentiated whereas (mark)
return resumed (advcl)
time as (case)
loss acuity (nmod)
ulcer gastric (amod)
showed baby (nsubj)
injury significant (amod)
event cardiovascular (amod)
h1- antagonists (dep)
pattern myosin (compound)
examination ) (punct)
suppresses 22-oxacalcitriol (nsubj)
predated dysfunction (dobj)
act drugs (nsubj)
injury a (det)
benefits further (amod)
dysfunction on (case)
echocardiography baseline (nmod)
association significant (amod)
treatment agents (nmod)
available banned (advcl)
used stimulation (nsubjpass)
attempt control (acl)
igg polyclonal (amod)
collagenase 0.014-unit (compound)
symptoms , (punct)
explore we (nsubj)
n [ (punct)
deaths related (amod)
ii v5 (conj)
led recurarization (nmod)
present review (nmod)
cocaine 30 (nummod)
rigidity side-effect (appos)
mm 8.5 (nummod)
anemia ticlopidine-induced (amod)
c+e = (amod)
co-agonist ) (punct)
disorders atypicality (nmod)
diseases neoplasms (conj)
cortices abusers (nmod)
h p<0.002 (appos)
(7.2)% ( (punct)
78 ) (punct)
performed occasions (nmod)
dogs study (nmod)
syntheses discovery (nsubj)
differences measurements (nmod)
important predictors (nsubj)
thalidomide bortezomib (conj)
attracted drug (nmod)
using schedule (dobj)
symptoms rls (compound)
epilepsy controlled (amod)
time at (case)
had histories (dobj)
mg/kg/day of (case)
lack part (nmod)
behavior male (nmod)
antagonist effects (nmod)
changes through (case)
increase vasoconstriction (nsubj)
disease treatment (nmod)
hemorrhage and (cc)
matter surrounding (amod)
p11 the (det)
included conditions (nmod)
remission rate (nmod)
reduces disease (nmod)
established involvement (nsubjpass)
centre to (case)
impairment function (nmod)
interfere cause (conj)
exerted action (dobj)
muscimol ) (punct)
7.6 1.3 (compound)
from % (nmod)
suggests fact (nsubj)
intravenous , (punct)
combined and (cc)
neurotransmitters of (case)
insipidus neurogenic (amod)
elevated risks (nsubj)
possibility pathology (nmod)
release platelet (compound)
consequence necessarily (advmod)
presents vasculitis (nsubj)
administration , (punct)
accepted . (punct)
case normalised (acl)
measured serum (nmod)
became intolerable (acomp)
detected q-pcr (nmod)
responded regimen (nmod)
dose split (amod)
appropriate evidence-based (dep)
locomotion . (punct)
insecticide organochlorine (compound)
screening bacteriological (amod)
nephrotoxicity that (mark)
common however (advmod)
targeting alpha-enac (nmod)
pathway leloir (compound)
determinant the (det)
interferon and (cc)
atp its (nmod:poss)
purpose map (dep)
cd50 ( (punct)
antioxidants of (case)
mutation val204asp (appos)
lacked response (dobj)
% 14.8 (nummod)
1.6 to (dep)
t nevirapine (conj)
appeared nitrite (nsubj)
switching of (case)
esterification acid (nmod)
complained 5 (conj)
disorders digestive (amod)
aplasia patient (nmod)
dependent protection (nsubj)
kg(-1 mg (dep)
concentrations of (case)
beginning the (det)
rats short-term (amod)
% 2.1 (dep)
observations develop (ccomp)
increased mpep (nsubj)
sensitivity as (case)
ad in (case)
provide it (nsubj)
progressing attacks (nmod)
functional antigenic (conj)
completed questionnaire (dobj)
increased contrast (nmod)
annuloplasty study (dep)
received , (punct)
developed pneumonia (dobj)
consumers alcohol (compound)
unconscious range (nmod)
antibiotic anthracycline (compound)
reduced functions (nsubjpass)
methoxyflurane with (case)
times pretreatment (compound)
assessments serial (amod)
amiodarone animals (nmod)
decreased sem (dep)
have yet (advmod)
dominance that (det)
combination dose (nmod)
using anova (conj)
injection inhibitor (appos)
caused 6/52 (conj)
neurodevelopment on (case)
aspects safety (nmod)
randomised controlled (conj)
0.0480 tau (conj)
active enzymatically (advmod)
stimulation stn (compound)
procedures orthopedic (amod)
exposure long-term (amod)
spikes large (acl:relcl)
pill a (det)
gammapathy significance (nmod)
tasks = (dep)
lipocalin gelatinase-associated (amod)
decrease problematic (conj)
produced signs (dep)
38 % (dep)
few are (cop)
anticoagulants heparin (appos)
criteria ) (punct)
cava svc (appos)
mellaril thioridazine (appos)
protease acid (compound)
autoantibodies perinuclear-staining (amod)
appears precipitated (ccomp)
given orally (advmod)
rt ( (punct)
conclusion enhance (dep)
abolished and (cc)
buffer with (case)
increment or (cc)
system with (case)
using monitoring (conj)
enhance models (nmod)
progression the (det)
history case (compound)
hyperparathyroidism of (case)
days six (nummod)
pathways synthesis (nmod)
adriamycin controls (conj)
hyperprolactinemia treatment (dep)
subjects eight (nummod)
promote and (cc)
3657 . (punct)
aggressiveness increased (amod)
asked dysphagia (nmod)
excreted % (nmod)
dizziness inability (conj)
8.5 interval (dep)
regrowth subsequent (amod)
consistent results (nmod)
risk necrosis (nmod)
included that (nsubj)
documents conclusion (dep)
glutamate acetylcholine (conj)
status oxidative (amod)
disability for (case)
rater trained (amod)
reverse partially (advmod)
size a (det)
mpo-anca between (case)
study ineligible (acl:relcl)
administered ccnu (nsubjpass)
benzodiazepines several (amod)
cause reduces (advcl)
statins by (case)
malfunctioning accidental (amod)
resolving ; (punct)
bicarbonate index (nsubj)
methamphetamine-induced current (amod)
enzyme rt (compound)
cancer n=35 (appos)
conclusions give (dep)
exposures and (cc)
suggest develop (ccomp)
step through (compound:prt)
renin 22 (nummod)
so less (advmod)
delivery vaginal (amod)
arrhythmias induced (acl)
cause 5th (parataxis)
needs improvement (dobj)
sch 23390 (nummod)
years 63+/-12 (nummod)
had nine (nsubj)
tests protocol (nmod)
is difference (attr)
aspirin control (conj)
test sensitive (amod)
presenting are (aux)
area injury (nmod)
treatment alone (advmod)
pain neuropathic (amod)
functional or (cc)
regained degree (dobj)
contributes insipidus (nmod)
failure shock (nmod)
seizures without (case)
lids ( (punct)
suggest thus (advmod)
argatroban plus (cc)
bolus of (case)
superior preventing (advcl)
initiated vancomycin (nmod)
followed year (nmod:tmod)
relevance schizophrenia (nmod)
94.3 to (case)
reduction half (nmod)
infiltrates interstitial (amod)
dose-dependent maximum (xcomp)
prc only (advmod)
given intravenously (advmod)
inhibits gaba-transaminase (dobj)
occurrence events (nmod)
developed factor (parataxis)
individual in (case)
src ) (punct)
expression effects (conj)
report developed (ccomp)
difference breath (nmod)
spectrum risk (nmod)
diagnoses pathologic (amod)
association events (nmod)
telmisartan amlodipine (conj)
immunotherapy calcineurin-based (amod)
needed none (nsubj)
volume cell (compound)
scotoma hemianopic (amod)
titer response (conj)
alter bnpp (compound)
decreases , (punct)
hemodynamics , (punct)
increases toxicity (nmod)
bolus ) (punct)
p11 compound (compound)
sustained patients (nmod)
reverse actions (dobj)
stress early (amod)
metabolite toxic (amod)
had showed (conj)
dose precurarizing (amod)
unit neonatal (amod)
prompted observation (nsubj)
surgery bowel (compound)
precede that (mark)
reactions associated (amod)
exerts mangiferin (nsubj)
indicated when (advmod)
striatum cells (nsubj)
% asenapine (nmod)
prolonged concentrations (nmod)
antagonist cpt (compound)
trinitrate of (case)
playing found (amod)
injection penicillin-g (amod)
cardiac against (case)
agonists ( (punct)
synthesis activities (conj)
65 range (quantmod)
days=1.77 rrlt (compound)
investigator blinded (acl)
measured ach (nsubjpass)
revised ) (punct)
involved phenomena (nmod)
response the (dep)
required cycles (nsubj)
hours for (case)
attenuating rigidity (dobj)
distribution random (amod)
hypothesis reaction (ccomp)
measures satisfaction (conj)
inducing without (mark)
killed which (nsubjpass)
onset with (case)
available however (advmod)
symptoms major (amod)
microscopy conventional (amod)
responses intensity (nmod)
received gem-p (dobj)
glioma metastases (conj)
incriminated was (auxpass)
treated posttreatment (dep)
effect nimo (nmod)
examinations physical (amod)
dox rats (nmod)
phenylbutazone ) (punct)
occurs increase (nsubj)
increase transitory (amod)
revealed edema (dobj)
4.2 8.5 (conj)
ischaemia macular (amod)
developed vasculitis (dobj)
lungs in (case)
mice ( (punct)
therapy azt (compound)
present if (mark)
stroke in (case)
sympathectomy or (cc)
quadrant temporal (amod)
differ rates (nsubj)
ameliorates impairments (dobj)
tested i.v. (dep)
race/ethnicity obesity (conj)
rates of (case)
group pce (compound)
related stroke (xcomp)
infusion intravenous (amod)
neurons labeled (amod)
available discontinued (conj)
drg labeled (acl)
accumulation an (det)
burden tumor (compound)
feature hepatotoxicity (nmod)
lack to (case)
mg nitrazepam (amod)
0.60 ( (punct)
relationship . (punct)
female but (cc)
proliferation inflammation (conj)
desire and (cc)
4-quinoline - (punct)
methadone selective (amod)
short-term perioperative (dep)
led resolution (nmod)
incidence analysis (dep)
produced dothiepin (nsubj)
pentylenetetrezol of (case)
decrease that (nsubj)
process inhibitor (appos)
impact mortality (nmod)
devoid while (mark)
stress meshwork (nmod)
media of (case)
decreased delineated (conj)
ages patients (nsubj)
involved susceptibility (nmod)
km tpp (nmod)
efficient be (cop)
hepatitis-like acute (amod)
overdose nitrazepam (nmod)
trial hypothermia (nmod)
important thus (advmod)
present had (aux)
is association (nsubj)
withdrawn phenacetin (nsubjpass)
belonging phenotype (nmod)
administering pyridoxine (dobj)
age-dependent , (punct)
visits was (acl:relcl)
slowing in (mark)
aged 61 (nmod)
fruste one (nmod)
ccu the (det)
employed the (det)
failed abolished (advcl)
hg groups (nmod)
trimethoprim but (cc)
day bort (nmod)
log half (dep)
patient epileptic (amod)
compartments subcellular (amod)
acidification , (punct)
loss increase (conj)
developed that (mark)
aggravation drug-induced (amod)
participate that (mark)
striatum ganglia (nmod)
slowing . (punct)
mg 500 (compound)
derive to (mark)
present factor (nsubj)
behaviors model (nmod)
score tubular (amod)
pathway of (case)
correlated mass (nmod)
tablets 26 (nummod)
mmp-timp adam (conj)
120/67 were (cop)
digoxin ( (punct)
cure possible (amod)
yrs ( (punct)
age by (case)
patients fifty-seven (amod)
commensurate recovery (nmod)
admitted developed (conj)
airway to (mark)
stenosis during (case)
inhibitor transporter-1 (compound)
examinations pressure (nmod)
dogs the (det)
0.8 to (dep)
deferens m1 (nmod)
phenothiazines with (case)
site ) (punct)
treatment special (amod)
nephropathy media-induced (amod)
monkeys rates (nmod)
densities of (case)
diseases latent (amod)
inhibited markedly (advmod)
indications to (case)
scan ct (compound)
eruption areas (nmod)
g/dl below (case)
hit undergoing (acl)
expression enac (compound)
consumed had (aux)
induced flurothyl (nmod)
hospital siriraj (compound)
used months (nmod)
baseline (2.2)% (conj)
ropivacaine ) (punct)
one tobramycin (nmod)
effects fasciculation (nmod)
bridge recovery (nmod)
on early (advmod)
arrest metoclopramide (nmod)
reductions with (case)
stores such (amod)
76 from (case)
titrated patients (nmod)
evaluated total (nsubjpass)
beating atrial (amod)
administration hydrochloride (nmod)
replacement srl (nmod)
angiosarcoma . (punct)
beta-adrenoblocking with (case)
recognition the (det)
dnap hbeag (conj)
thirsty polyuric (conj)
results ischaemia (compound)
safety side-effects (conj)
map rnfl (dobj)
seen pd (nmod)
suppressed it (nsubj)
setup electrocorticogram (compound)
shock edema (conj)
associated abortion (nmod)
induced arrhythmias (nsubjpass)
experienced : (punct)
complication mtor-i (dep)
decreased manner (nmod)
thromboses fewer (amod)
cs , (punct)
decline levels (nmod)
obstruction ureterovesical (amod)
level dobutamine (compound)
found suprofen (nmod)
% weeks (nmod)
diazinon to (case)
present disorders (nsubj)
et-1 to (case)
died subsequently (advmod)
combination cisplatin (nmod)
pretreated pilocarpine (nmod)
levels cholesterol (nmod)
duration dose (conj)
obtained changes (dobj)
mellitus 5 (dep)
restarted doses (nmod)
giving after (mark)
exhibited kidneys (nsubj)
efficacy chemotherapy (nmod)
induces administered (advcl)
users recent (amod)
drugs without (case)
lev with (case)
resembling glaucoma (xcomp)
vasoconstriction cerebral (amod)
focus should (aux)
small- and (cc)
demand associated (acl)
developed hepatitis (nsubj)
arrhythmia for (case)
injected developed (conj)
mda plasma (compound)
rifampicin of (case)
trazodone mg/kg (appos)
contrast system (nmod)
hiccups ( (punct)
force task (compound)
hypometabolism with (case)
i class (compound)
found activity (nmod)
dec. 30 (nummod)
ketamine and (cc)
quantitative various (amod)
seen were (auxpass)
formation cyst (compound)
obtain progress (nmod)
potency the (det)
occurred combinations (nsubj)
propofol % (dep)
neurological on (case)
affect can (aux)
drg ( (punct)
320/12.5 320/25 (conj)
anemia riha (appos)
pathway striatonigral (amod)
shows help (ccomp)
decreased mm (nmod)
setting this (det)
therapy administered (acl)
fraction dimension (conj)
that acetaminophen (nmod)
awaking tiredness (conj)
patients angina (nmod)
related chloroquine (compound)
produced induce (advcl)
meq/l 3.4 (conj)
mmol/l 137 (nummod)
sensitivity angina (nmod)
increase onwards (nmod)
metabolism energy (compound)
patients 45 (nummod)
reversible discontinued (advcl)
received ; (punct)
hcfc ( (punct)
reminds us (dobj)
role significant (amod)
hoarding , (punct)
male 20-year-old (compound)
usefulness clinical (amod)
objectives/hypothesis : (punct)
oxygen dioxide (conj)
proteinuria ngal (conj)
spectrum . (punct)
injections carboplatin (compound)
involved dyskinesia (nmod)
collapse cardiovascular (amod)
finding current (amod)
discuss cases (nmod)
patients chemotherapy (conj)
evaluated groups (nmod)
aptt ( (punct)
provoke can (aux)
administration carbamazepine (nmod)
involved and (cc)
followed stopped (advcl)
reached months (nmod)
activity antitumor (compound)
result decreasing (advcl)
hospitalized period (nmod)
chlorpromazine with (case)
woman prolapse (nmod)
history patient (nmod:poss)
cystitis haemorrhagic (amod)
tablets mg (nummod)
tdr because (case)
valproate vpa (appos)
66.9 was (cop)
streptozotocin-induced ( (punct)
injected repeated (conj)
acidosis severe (amod)
bradycardia significant (amod)
episodes triazolam-induced (amod)
anemia posttransplant (amod)
antigens bfgf (compound)
observed upregulation (nsubjpass)
antibiotic macrolide (compound)
responsible could (aux)
treatment fluvoxamine (nmod)
trials by (case)
tolerability general (amod)
women only (advmod)
important confirmed (advcl)
ulceration mucosal (amod)
investigated potential (dobj)
effect calcium (nmod)
amplitude the (det)
25/100 on (case)
contribute whether (mark)
show conclusion (nsubj)
activity anticataleptic (amod)
extract platonia (nmod)
are reports (attr)
conditioning of (case)
cases syndrome (compound)
rats bearing (acl)
revealed scan (nsubj)
covered , (punct)
mean responses (dobj)
omeprazole of (case)
minutes , (punct)
% range (nmod)
ems in (case)
105 of (quantmod)
lidocaine of (case)
modify absence (nmod)
evaluate using (xcomp)
included tasks (conj)
hyperammonemia with (case)
birth of (case)
stopped progression (nmod)
akinesia rigidity (conj)
calculated odds (nsubjpass)
coadministration following (case)
appeared related (acomp)
tomography positron (compound)
tolerated observed (conj)
mitogens xenobiotic (amod)
fed rats (nsubjpass)
g145r p120 (conj)
radiopharmacy in (case)
identified del (dep)
eligible patients (nsubj)
treatment gram-negative (amod)
wky and (cc)
ratios risk (compound)
exacerbation myoclonus (conj)
cause convulsions (nmod)
toxicity moderate-to-severe (amod)
5.4 7.1 (compound)
receiving cimetidine (dobj)
drugs on (case)
amiodarone . (punct)
induced is (auxpass)
determine altered (ccomp)
evident were (cop)
% 0.002 (appos)
rats subject (amod)
receptor mglur5 (appos)
high were (cop)
haemorrhage internal (amod)
achieved 16/20 (nsubj)
slower that (nmod)
long-term ) (punct)
discussed implications (nsubjpass)
range to (case)
drugs doxorubicin (nmod)
expression course (nmod)
livers by (case)
idr ) (punct)
involved pgs (nsubjpass)
increase incidence (dobj)
caused delirium (nsubjpass)
increasing s (nmod)
fibrosis subintimal (amod)
administered volunteers (nmod)
collected segments (nsubjpass)
background debated (dep)
induced csa (nmod)
sonography on (case)
rheumatology and (cc)
diet- placebo-controlled (conj)
age urine (conj)
compared responses (nsubjpass)
composition , (punct)
resistant monkeys (nsubj)
units ( (punct)
were improvements (attr)
b.w micrograms/kg (compound)
16/20 % (appos)
failure the (det)
lower resistance (dep)
number sites (nmod)
normalized ng/ml (parataxis)
l-name mg/kg (dep)
blocked rp (nmod)
third in (case)
cis-ra after (case)
d-pen ) (punct)
occurred pressure (nmod)
sodium phenytoin (compound)
describe as (advmod)
catalepsy codeine (compound)
inflexibility perseveration (appos)
scan mri (compound)
total activated (conj)
ascites lipidemia (conj)
eye his (nmod:poss)
potential tdp (compound)
lasting h (nmod)
nitroprusside drug (compound)
pod 14 (conj)
addition evaluation (nmod)
aorta/serum-ratio the (det)
exhibiting protecting (advcl)
utility changes (nsubj)
relapsed in (case)
correlated amounts (nsubjpass)
drugs than (dep)
allografts and (cc)
levels dehydrogenase (nmod)
middle-aged and (cc)
caused dyskinesias (nsubjpass)
drugs used (acl:relcl)
837 171 (conj)
signaling through (case)
synthesis glucocorticoid (compound)
1a receptor (compound)
, glutamate (dep)
small limitations (nmod)
reabsorption intestinal (amod)
occurred impotence (nsubj)
major beta-thalassemia (compound)
explore assessing (advcl)
mcl in (case)
ureter the (det)
treated man (nsubjpass)
tbil serum (compound)
group midazolam (compound)
cholesterols plasma (compound)
rose activities (nsubj)
subgroups to (case)
processing brain (compound)
contribute urge (nmod)
studies acute (amod)
identified can (aux)
improve correction (nsubj)
appear add (xcomp)
related mass (nmod)
persists anthony (nmod:poss)
increase on (case)
38 to (dep)
fear conditioned (amod)
aorta , (punct)
had reversible (xcomp)
results titrated (dep)
catalepsy ( (punct)
icv ( (punct)
pretreated cells (nsubjpass)
lower twice (advmod)
86 2 (conj)
163 to (dep)
attained who (nsubj)
rats untreated (amod)
head following (case)
assays in (case)
typical not (neg)
t(1/2 elimination (compound)
cardiotoxicity been (cop)
bpt : (punct)
effective antagonizing (advcl)
dependent state (nmod:npmod)
reduced contraction (dobj)
assessed participants (nsubjpass)
steroid two (nummod)
induced clamping (advcl)
neuralgia for (case)
baroreceptors carotid (compound)
functions mice (nmod)
analyzed efficacy (nmod)
searched disorders (dep)
interfere statins (nsubj)
atrophy . (punct)
smoker a (det)
uncertain . (punct)
levonorgestrel , (punct)
minutes for (case)
tropicamide pilocarpine (conj)
gsh ( (punct)
therapy maintenance (compound)
confounding indication (nmod)
aprotinin for (case)
hyperthermia 10 (nummod)
exposure cold (amod)
significant 0.005 (dep)
female year (compound)
associated duration (nsubjpass)
treatment only (cc:preconj)
isoenzymes inducible (amod)
rate < (compound)
recurrence weeks (nmod)
epidemic disease (nmod)
decrease week (nmod)
response viral (amod)
effects disorders (nmod)
play junctions (nsubj)
remain mechanisms (dobj)
improvement 9 (nmod)
mipafox n'-diisopropylphosphorodiamidofluoridate (appos)
follow-up 2-year (amod)
regulate to (mark)
vomiting diarrhea (conj)
agitation to (case)
elucidate epidemiology (dobj)
injections control (amod)
improved delirium (nsubj)
cck-8-se ( (punct)
inter- and (cc)
metrifonate of (case)
stage iii (nummod)
changes synaptic (amod)
protects loss (nmod)
process 5-azacytidine (conj)
monitored although (mark)
ability decreased (amod)
maintenance the (det)
caffeine solution (conj)
take . (punct)
prescribed was (auxpass)
participates . (punct)
chemistry and (cc)
ratio thermal (amod)
occurred enlargement (nsubj)
greater levels (nsubj)
inferred induced (ccomp)
reviewed change (nmod)
medicine of (case)
women men (conj)
mg/day acid (appos)
produce aggravation (nmod)
ceruleus rat (compound)
rats other (amod)
urticaria/angioedema with (case)
ml ml (appos)
respond way (nmod)
10.3 0.3 (conj)
reaction chain (compound)
x ) (punct)
syndrome personality (compound)
3.9 0.1 (conj)
9 10 (conj)
sedative sole (amod)
clearances [3h]inulin (compound)
metabolite be (appos)
treatment due (prep)
sd for (case)
protein glepp1 (appos)
medullo-adrenalectomy with (case)
evoked assessment (nsubj)
reduced extent (nmod)
puncture lumbar (amod)
tumors were (cop)
cause interventions (nsubj)
role spite (nmod)
nausea from (case)
assigned men (nsubjpass)
circulation an (det)
survived or (cc)
defects clear (amod)
to ( (punct)
advance major (amod)
paclitaxel to (case)
changed day (nmod:tmod)
raised collected (conj)
criteria was (cop)
indicator an (det)
8) saline (nmod)
m relative (amod)
effects inhibitor (dep)
make is (cop)
levels with (case)
randomized english-language (amod)
users use (appos)
cardiomyopathy were (cop)
doses greater (amod)
influence metabolism (dobj)
endothelia glomerular (amod)
use mesna (nmod)
mg tolterodine (compound)
mass = (dep)
smaller significantly (advmod)
evaluate consequences (dobj)
research and (cc)
induces 17beta-estradiol (nsubj)
placed be (auxpass)
suspect to (mark)
sites l-[3h]nicotine (compound)
women 6 (nummod)
side motor (compound)
cases testosterone (nmod)
sarcolemma to (case)
effects antiparkinsonian (amod)
tiopronin dermatitis (conj)
practitioners selected (amod)
described . (punct)
ircrf ( (punct)
affected failure (nmod)
haloperidol administered (acl)
cyclooxygenase of (case)
induces withdrawal (dobj)
cancers several (amod)
chemotherapy glioblastoma (nmod)
readmitted . (punct)
types tumor (compound)
maintained that (mark)
nausea their (nmod:poss)
rats receiving (acl)
maintained etomidate (nmod)
bacteremia staphylococcus (compound)
hypertension ( (punct)
it-methotrexate and (cc)
peaked diminished (conj)
carcinomas induced (amod)
neurointensivists board-certified (amod)
length functional (amod)
min ( (punct)
had insufficiency (dobj)
7-ethoxyresorufin-o-deethylase dependent (amod)
arise terminate (xcomp)
7 to (quantmod)
lh-rh ) (punct)
established well (advmod)
rendered who (nsubjpass)
registry university (nmod)
methods potentials (dep)
apparent evidence (nsubj)
stable be (cop)
catheterization by (case)
m-2 mg (compound)
result not (neg)
patients developed (acl)
caused level (dep)
regimen paclitaxel/cisplatin (nsubj)
pathophysiology nephrotoxicity (nmod)
ventricles the (det)
cavity abdominal (amod)
grading a (det)
follow-up short-term (amod)
ke , (punct)
used states (nmod)
quantified scales (nmod)
antidote no (det)
disorder hypokalemia (appos)
elevation levels (nmod)
collagenase a (det)
fdc oral (amod)
dysfunction ) (punct)
assessed infusion (nmod)
inhibition levofloxacin (nmod)
means pulses (nmod)
min-1 beat (amod)
consistent cardiotoxicity (nmod)
mecamylamine hexamethonium (conj)
associated decrease (conj)
taking after (mark)
cases exacerbation (nmod)
week atenolol (nmod)
% 0.00001 (nummod)
active analogues (nmod)
aimed clarify (xcomp)
incidence neoplasms (nmod)
right left (conj)
problem , (punct)
recurrence oliguria (nmod)
trial dexmedetomidine (nmod)
nm ( (punct)
understanding in (case)
chloroquine hydroxychloroquine (conj)
concentration median (amod)
dysfunction tubular (amod)
made gave (advcl)
interaction anesthetics (nmod)
systems cardiovascular (amod)
removed measurement (nmod)
p 5.04 (appos)
used series (nmod)
% units (nmod)
site with (case)
protein natom (compound)
extracts cell (compound)
administration between (case)
efficient evaluated (advcl)
boluses three (nummod)
damages this (nsubj)
studies ncs (appos)
as relevant (amod)
bmd lower (amod)
pearson 's (case)
att alone (advmod)
length twice (advmod)
inhibition mitotic (amod)
proteinuria higher (amod)
data metabolic (amod)
measured hours (dep)
analysis f(3,762 (dep)
oximeters or (cc)
has activity (dobj)
dogs 5 (nummod)
studies renal (amod)
hypertension diastolic (amod)
cells lateral (nmod)
use acids (nmod)
damage myocardial (amod)
higher microsomes (nmod)
increase ratio (nmod)
placebo dose (conj)
ml(-1 ng (amod)
markers autoimmunity (nmod)
9-[[2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino ] (punct)
secretion cortisol (compound)
follow-up after (case)
escape mutations (conj)
swim duration (nmod)
call aim (nsubj)
injected injected (conj)
compromise with (case)
removing piperacillin (dobj)
postcards by (case)
interest measured (conj)
halide trifluoroacetyl (compound)
mg/m2 250 (nummod)
administration phenylethylbarbiturate (nmod)
recognized increasingly (advmod)
atrophy fibrosis (conj)
group monkeys (nmod)
angiography of (case)
symptoms some (det)
shown acetaminophen (nsubjpass)
therapy on (case)
intravitreal implant (dobj)
behaviors aggressive (amod)
experience that (nsubj)
improving syndromes (nmod)
effects method (nmod)
disease chronic (amod)
that species (nmod)
insult toxic (amod)
microinjections antagonists (nmod)
life-threatening five (nmod)
methods radiculopathy (nmod)
cause convulsions (dobj)
compensated decreased (conj)
mg/dl 15.3 (nummod)
period patients (nmod)
potential treatment (nmod)
carcinoma in (case)
have more (dobj)
formation vasogenic (amod)
toxicity severe (amod)
decreased affected (parataxis)
drug gspe+drug (conj)
awareness for (case)
4 184 (prep)
ranged levels (nmod)
quetiapine than (case)
probable total (nmod)
opening after (case)
diet containing (acl)
analogue cytosine (compound)
laryngoscopy flexible (amod)
showed days (dep)
clearance as (case)
group hggw (compound)
caused absent (conj)
kg-1 ) (punct)
attacks volunteers (conj)
patterns of (case)
3.75 7.5 (conj)
arterial p (dep)
bupivacaine or (cc)
induced tonic (dobj)
appear feature (xcomp)
identified cohort (nsubjpass)
admitted discontinued (conj)
caused ntg (nmod)
that after (case)
conclusive be (cop)
im ( (punct)
recorded rate (nmod)
62.0 32.2 (compound)
rad001 ( (punct)
reach stages (dobj)
suggest conclusion (dep)
les ( (punct)
unnecessary operations (nmod)
hospital children (nmod:poss)
10 i.p. (dep)
cause hypocalcemia (dobj)
processes neurodegenerative (amod)
convulsions idiopathic (amod)
affect surge (advcl)
had times (dobj)
amphetamine compounds (dep)
is identifying (advcl)
1.4 1.6 (dep)
glomerulosclerosis ameliorated (amod)
occlusion department (nmod)
17.5 to (dep)
repeat immediately (advmod)
ethopropazine controlled (amod)
change s (dep)
900 at (case)
beta-blockers topical (amod)
remained remained (conj)
alpha-2b interferon (compound)
dextran of (case)
glucose lactate (conj)
caused 6-thioguanine (nmod)
relationship scale (nmod)
tended patients (nsubj)
participate to (mark)
ssris ] (punct)
polygraph a (det)
tbarss ( (punct)
exposure in (case)
increased limit (nmod)
damage quantitative (amod)
showed atrophy (dobj)
antisialogue an (det)
doses atropine (nmod)
31 cases (nmod)
capable reversing (advcl)
history obtained (acl)
informative more (advmod)
pharmacodynamics effect (nmod)
woman myopathy (nmod)
rarest . (punct)
norms and (cc)
distribution allele (compound)
contributor hypotension (nsubj)
cohort a (det)
ca3 ca1 (conj)
7.7 +/- (cc)
that ropivacaine (nmod)
drug chronic (amod)
investigation efficacy (nmod)
treated gfc75 (nmod)
bleed , (punct)
incapacity learn (acl)
have carbimazole (nsubj)
quantify data (nsubj)
velocity shortening (compound)
measure in (amod)
received precurarization (nmod)
dogs failure (nmod)
advised . (punct)
effect agents (nmod)
1996 january (compound)
infant young (amod)
di lithium-induced (amod)
fast period (nmod)
damage provoked (acl)
pathogenesis nephrosis (nmod)
controls performed (acl)
basis syndrome (nmod)
bone cartilage (conj)
marker . (punct)
pharmacy the (det)
mediated concentrations (nmod)
amiodarone large-dose (amod)
compared injection (nmod)
impairment comorbidity (appos)
was heart-rate (nmod)
lymphoma in (case)
related dosages (nmod)
counts average (amod)
prevent responses (dobj)
micturition day (nmod)
carvedilol antagonist (appos)
concept performs (ccomp)
regimen combination (compound)
increased irrespective (advmod)
convulsions absence (conj)
contaminants irradiation (conj)
dose-dependent m. (nmod:npmod)
represent pg-9 (nsubj)
coma hyperosmolar (amod)
unable is (cop)
demonstrate bulk (nsubj)
terminals afferents (nmod)
cause as (case)
rats hypertension (nmod)
toxic in (case)
differing of (mark)
variants are (cop)
hypaque 76 (nummod)
level na (nmod)
effect limiting (acl)
myalgia/arthralgia grade (compound)
care patient (nmod)
documented variable (nsubjpass)
suffering dyskinesia (nmod)
tobramycin i.v. (amod)
mul 10 (nummod)
had progression (conj)
injections vcm (compound)
disappeared rash (nsubj)
potassium in (case)
epirubicin and (cc)
administrated , (punct)
beta minutes (nmod)
effect amphetamine (nmod)
4:30 and (cc)
behaviour a (det)
produced were (auxpass)
death events (nmod)
analyzed separately (advmod)
task in (case)
reversal amnesia (nmod)
slices hippocampus (nmod)
related woman (nmod)
increased males (nmod)
responded arrhythmias (nsubj)
years 32 (nummod)
performed analysis (nsubjpass)
inactivation . (punct)
difficult radiologically (advmod)
depressed rats (nmod)
shortening fs (appos)
type reverse (amod)
reappraisal a (det)
dystonia sulpiride-induced (amod)
years participated (acl)
fat surrounding (acl)
coma hyperglycemic (amod)
patients experiencing (acl)
convulse and (cc)
diagnosis hypertension (nmod)
suppress to (mark)
groups 3 (dep)
imaging studies (conj)
call to (mark)
pituitaries des-treated (amod)
origin was (cop)
treated rats (nsubjpass)
patients tolerated (acl:relcl)
m-2 more (conj)
shares . (punct)
rare established (conj)
cells trabecular (amod)
application microl (dep)
glutamine and (cc)
mechanism effect (nmod)
facilitated detection (nsubjpass)
validated were (auxpass)
pain neuropathy (amod)
exploration field (nmod)
performed monitoring (dobj)
memory object (compound)
life to (case)
data risk (nmod)
pressures stimulation (nmod)
data of (case)
sedation dexmedetomidine (nmod)
induced flare (dobj)
ameliorated abolished (conj)
cases hypercalcemia (nmod)
effect gender (nmod)
count granulocyte (compound)
polyphenol a (det)
rhuepo-beta ( (punct)
benign disorders (conj)
conformed criteria (nmod)
tested has (ccomp)
delivers . (punct)
disruption characteristics (nmod)
relevant this (nsubj)
initiate can (aux)
possiblility episodes (nmod)
results sensitive (conj)
considered , (punct)
effect antagonistic (amod)
culture hrptec (appos)
occurred until (mark)
conditions clinical (amod)
cardiomyocytes express (acl:relcl)
conditions these (det)
stimulation during (case)
myopathy immune-mediated (amod)
consumption alcohol (nmod)
effect chemotherapy (nmod)
activated state (nmod)
provoke spasm (dobj)
prepartum days (compound)
exhibited week (nmod:tmod)
anterior nuclei (dep)
screened and (cc)
depleted serotonin (nsubjpass)
weighing 150 (nummod)
molecule kidney (compound)
supports frequency (dobj)
cases patients (nmod)
alert physician (dobj)
patients others (conj)
b c (conj)
fear . (punct)
agonist specific (amod)
areas applied (amod)
formed ethyl-alpha-p-chlorophenoxyisobutyrate (nmod)
deviation mean (amod)
residence to (case)
incidence applicators (nmod)
% 29 (nummod)
decrease shortening (nmod)
antioxidants with (case)
amisulpride mg (dep)
increased 1a (nsubjpass)
net ( (punct)
syndrome epilepsy (conj)
h injection (nmod)
conclude authors (nsubj)
necessary using (advcl)
model may (aux)
role system (nmod)
developed reactions (dobj)
lipids urinary (amod)
w-ich for (case)
pronounced interference (nmod)
0.38 0.1 (conj)
fluid and (cc)
malignancy is (cop)
subjects other (amod)
depletion nad (nmod)
schedules two (nummod)
densities alpha (compound)
c1q c4 (conj)
channel na (compound)
g/liter 0.5 (nummod)
failed prevent (xcomp)
compared or(adj (nmod)
materials november (nmod)
catalyze that (mark)
hydrochloride bupivacaine (compound)
confirmed anencephaly (nmod)
use cases (conj)
prevents which (nsubj)
weight mean (amod)
treated and (cc)
cause that (mark)
height cm (nmod)
excretion of (case)
higher correlated (parataxis)
precede induction (dobj)
survived whether (mark)
arms treatment (compound)
tests same (amod)
raised trough-concentrations (dobj)
disability dyskinesia (conj)
effects penicillamine-related (amod)
decreased end (nmod)
dysfunctions one (nummod)
effect susceptibility (nmod)
selected randomly (advmod)
affect negatively (advmod)
nephrolithiasis . (punct)
noted alkylxanthines (nmod)
higher p=0.008 (dep)
myoclonic atonic (conj)
fail support (xcomp)
caffeine- not (cc)
ethyl-alpha-p-chlorophenoxyisobutyrate proliferation (nmod)
neuropathy compression (nsubj)
medline cochrane (conj)
62 30 (compound)
produced initiating (advcl)
years study (nmod)
% -32 (nummod)
system monophosphate (compound)
cardiac high-sensitive (amod)
treated concomitantly (advmod)
metrizoate artery (nmod)
chromatography with (case)
nephrotoxicity apap-induced (amod)
psychosis her (nmod:poss)
100,000/mm3 than (case)
numbers increased (amod)
begun once (mark)
role important (amod)
nephrotoxicity gentamicin (nsubj)
feasible and (cc)
affect determinations (dobj)
resulted alterations (nmod)
during and (cc)
content protein (compound)
constructed excluding (advcl)
eighth the (det)
paralysis cord (compound)
2.3 1.3 (compound)
frequency potentials (nmod)
to be (cop)
nephrotoxicity effects (nsubj)
saline l-arginine (conj)
suggest stimulates (ccomp)
synapses ( (punct)
salicylate , (punct)
b.w mg/kg (compound)
patients thresholds (nmod)
duration apnea (nmod)
appearances radiation (conj)
resulted reduction (dobj)
lower = (parataxis)
vnr drugs (conj)
mg 1000 (nummod)
risk as (case)
words no (det)
group dosing (compound)
called " (punct)
acid ethacrynic (amod)
agent common (amod)
significant most (advmod)
lipoprotein ; (punct)
passage gliomas (nmod)
variables laboratory (compound)
technique valuable (amod)
level mg/m2 (compound)
mediators seizures (nmod)
available cases (nmod)
failure cardiovascular (amod)
animals treated (acl)
mug sm (dep)
conjunction ifo (nmod)
groups conventional (amod)
placement for (case)
localization antigen-positive (nmod)
cells dividing (amod)
suffered seizures (nmod)
uninephrectomized rats (nsubj)
lack bbb (nmod)
tomography thallium-201 (amod)
extremities lower (amod)
limits min-1 (nmod)
episodes brief (amod)
test mg/kg (appos)
antigens dilevalol (amod)
kpa 11.5 (nummod)
baseline resting (amod)
disorder agoraphobia (conj)
analgesic comparable (amod)
weight evidence (nmod)
isomerase of (case)
suggest important (ccomp)
exert development (nmod)
examine disorders (dobj)
protection cardiotoxicity (nmod)
podocytes and (cc)
sister disorder (nmod)
properties epileptogenic (amod)
bortezomib analysis (dep)
mutants complex (amod)
visualized following (dobj)
herbicides : (punct)
leads pseudolithiasis (nmod)
deterioration abuse (nmod)
hypotensive block (nmod)
calculation mental (amod)
accompany tetany (nsubj)
induced tetracycline (nmod)
use reported (amod)
has is (cop)
46 44 (compound)
screening routine (amod)
uncomplicated apparently (advmod)
analogues cck-2 (compound)
done showed (conj)
mechanisms several (amod)
reversed were (auxpass)
start therapy (dobj)
stl1 rats (nmod)
frequency dissociation (nmod)
induces pilocarpine (nsubj)
40000 60000 (conj)
rats saralasin-treated (amod)
staff the (det)
tests zung (compound)
jerks these (det)
treating children (dobj)
enflurane % (compound)
(1.8)% 5 (nummod)
dissociation of (case)
patient 50-year-old (amod)
microgram/ml p (dep)
nausea severe (amod)
mandatory are (cop)
assessed extracted (conj)
pain cancer (compound)
mexitil-perlongets ) (punct)
objective primary (amod)
alopecia paresthesias (conj)
carcinoma stage (compound)
suppressed which (nsubjpass)
minutes respectively (advmod)
compared segments (nmod)
response muscular (amod)
mg/m(2 intensity (nsubj)
proband of (case)
agonists receptors (appos)
studied beating (nsubjpass)
dose pn (conj)
different p (dep)
diclofenac groups (dobj)
study an (det)
composition biliary (amod)
modulate that (mark)
proteins against (case)
diseases patients (conj)
1979 and (cc)
administered offspring (nsubj)
15.5 at (case)
symptoms findings (conj)
diameters lv (compound)
dead ; (punct)
had cases (nmod)
subjected studies (nmod)
contributing factors (dobj)
findings cancer (nmod)
% to (dep)
evidence suggest (acl)
pain site (nmod)
antipsychotics quetiapine (nmod)
associated anencephaly (nmod)
significant not (neg)
humphrey 10 (nummod)
chamber rather (cc)
nigra degeneration (nsubj)
evidence injury (nmod)
patients tests (conj)
subregion any (det)
system utero (compound)
hypercalcemia marked (conj)
96 - (punct)
chemotherapy epidermal (conj)
carry . (punct)
challenge the (det)
upregulated and/or (cc)
got ( (punct)
rise aldosterone (nmod)
death was (cop)
users group (nmod)
d-amphetamine of (case)
% ci=0%-39.2 (compound)
seems conclusions (dep)
i.c.v. ) (punct)
od mg (nummod)
thymus and (cc)
initiate stimulating (advcl)
broadens spectrum (dobj)
swings motor (compound)
propranolol the (det)
control absences (nmod)
cyclophosphamide cancer (conj)
endpoints several (amod)
gain insight (dobj)
synthase nitric-oxide (amod)
chromosome philadelphia (compound)
using imaging (dobj)
patient syndrome (nmod)
poses objective (nsubj)
deterioration damage (conj)
systems in (case)
passed tourniquets (nmod)
areas proliferation (nmod)
estimated using (xcomp)
evaluated movements (nsubjpass)
region hearts (nmod)
aware and (cc)
results conclusions (dep)
started 25/100 (nmod)
administered thiopenthal (nsubjpass)
reduced patients (nmod)
caspase-3 and (cc)
used may (nmod:tmod)
reduced inhibitor (nsubj)
allografts kidneys (conj)
those administration (nmod)
task face-learning (amod)
mri high-resolution (amod)
controls schizophrenic (amod)
convulsion . (punct)
pseudolithiasis of (case)
prevent isoproterenol (dobj)
treated everolimus (nmod)
reverting phase (nmod)
considered view (nmod)
erythromycin or (cc)
results presumably (advmod)
suppression antigenemia (nmod)
reversed and (cc)
observed we (nsubj)
iu/kg/i.v . (punct)
mean correlated (conj)
group cacl2 (compound)
learn session (nmod)
treatment ) (punct)
organisms type (compound)
postswitch = (dep)
dysplasia kidneys (nmod)
had real (nsubj)
treatment alpha-2b (nmod)
represented increased (parataxis)
m-2 of (case)
% 1.9 (dep)
sleep rem (compound)
strains exception (nmod)
maximal immediately (advmod)
ventilation therapy (conj)
administration 5-azc (nmod)
ribavirin intravenous (compound)
time incidence (conj)
acts morphine (nsubj)
triggers which (nsubj)
second and (cc)
daunorubicin . (punct)
associated intensity (nsubjpass)
neutropenia kg (dep)
control comparison (dep)
manifestation vasculitis (nmod)
mrna receptor (compound)
efficacy cost (conj)
seemed non-users (nmod)
biopsy by (case)
cells human (amod)
dosage conventional (amod)
hypaque of (case)
toxicity symptoms (nmod)
5.6 - (punct)
studies small (amod)
likely least (advmod)
background cause (dep)
chemotherapy a (det)
damage muscles (nmod)
34 5 (compound)
free percent (nsubj)
substances form (acl:relcl)
role mechanisms (nmod)
group 4-wk (amod)
abolished almost (advmod)
therapy unclear (advcl)
thought been (auxpass)
results ngf (appos)
resulted certainly (advmod)
patterns malformation (compound)
flumazenil patients (conj)
dose divided (acl)
receptors urotensin-ii (compound)
vomiting moderate (conj)
factors failure (nmod)
account into (case)
systems and (cc)
cytochrome brain (compound)
sequestration no (compound)
cells/mm3 8 (dep)
saline- or (cc)
rats two-kidney (nmod)
effect dose-dependent (amod)
% saturation (nsubj)
elevated nonsignificantly (advmod)
government local (amod)
played making (advcl)
bumetanide pravastatin (conj)
anemia severe (amod)
investigate headache (nmod)
scores attenuation (compound)
work the (det)
stopped % (nsubjpass)
lesioning after (case)
influences addition (dep)
fl ( (punct)
use clozapine (compound)
mapping by (case)
prescribed because (mark)
formation with (case)
eosinophilia failure (conj)
peaked iu/l (nmod)
conducted trial (nsubjpass)
produce pretreatment (nsubj)
carried aim (nsubjpass)
patient pseudoacromegaly (nmod)
source cns (compound)
a 36-year-old (advmod)
injection toxin (nmod)
injection adsd (nmod)
transiently only (advmod)
recognized respectively (advmod)
none models (nmod)
inhibited which (nsubjpass)
rate catecholamine (compound)
factors many (amod)
thresholds pure (amod)
require reexposure (dobj)
competing levodopa (nmod)
sites calcification (nmod)
therapy 2-drug (compound)
susceptible rats (nsubj)
indicates that (mark)
put he (nsubjpass)
agents on (case)
recurred reduction (nmod)
end procedure (nmod)
epileptogenesis on (case)
presents tee (nsubj)
remained epinephrine (nsubj)
score and (cc)
specimen patient (nmod)
associated rhabdomyolysis (nmod)
weight level (conj)
cells myometrial (amod)
teratogenic , (punct)
tnf-alpha and (cc)
frequent patients (dep)
disease thyroid (compound)
had ds (nsubj)
monitored and (cc)
cases 76 (nummod)
caused toxicity (nsubj)
clearance rapid (amod)
appears safe (xcomp)
acetate bia (appos)
central or (cc)
alpha beta-meatp (appos)
pharmacology gyki-41 (nmod)
appear activity (nsubj)
iop mm (appos)
wall artery (compound)
compare compare (dep)
resulted death (nmod)
sampled 0 (nmod)
hyperactivity response (nmod)
accumulation depression (conj)
contrasted margin (nmod)
action manage (acl)
resulting rate (nmod)
acid-induced reversible (amod)
more mg/m(2 (dep)
n=656 ) (punct)
defective are (cop)
p=0.36 ( (punct)
diameters similar (amod)
follow plan (nsubj)
clozapine considering (case)
seizures combined (amod)
days 5 (nummod)
relevance treatment (nmod)
edrophonium the (det)
indicate relationship (dobj)
take creatine (dobj)
identified resolved (conj)
relationship administration (nmod)
104 ( (punct)
hz , (punct)
consequence growth (nmod)
5-fu p=0.0001 (dep)
elevated ampka (nsubjpass)
solution timolol (conj)
nsaids by (case)
report may (aux)
stress under (case)
have although (mark)
kg-1 or (cc)
patient pheochromocytoma (nmod)
control menopausal (amod)
performed discontinuation (nmod)
used regression (dobj)
polyphagia and (cc)
applications blockers (nmod)
weeks time (nsubj)
easy although (mark)
appears related (conj)
contained carbachol (dobj)
indeterminate , (punct)
lignocaine % (compound)
apnea seizures (conj)
improvement the (det)
hepatitis a (det)
trait hemoglobin (compound)
include rigidity (dobj)
performed clinical (nsubjpass)
syndrome review (dep)
prolongation to (case)
prevent but (cc)
impulsiveness , (punct)
required determine (xcomp)
out-patients chronically (advmod)
improves extent (nmod)
application conjunctiva (nmod)
taking tranylcypromine (dobj)
appearance for (case)
activity lymphomas (nmod)
dose cya (nmod)
bradycardia , (punct)
subgroups trial (compound)
now investigation (nmod)
effect as (case)
d-pen by (case)
toxicity whose (nmod:poss)
re-established respiration (nsubjpass)
hiv ( (punct)
propagation ead (nmod)
measured developed (conj)
part surgery (nmod)
action ikr (nmod)
bar the (det)
action beneficial (amod)
occurred incidents (nsubj)
degrees with (case)
drc glu (conj)
damage consistent (conj)
focused attention (nsubjpass)
patients 205 (nummod)
had differ (conj)
blocking to (mark)
study longitudinal (amod)
complication expected (amod)
woman back (nmod)
noted she (nsubj)
carried using (xcomp)
activity weak (amod)
department university (compound)
receptor this (det)
corresponded which (nsubj)
level maximum (compound)
remains treatment (nsubj)
cm 10 (nummod)
urge , (punct)
increase is (cop)
play role (dobj)
evaluation raloxifene (compound)
reduces sevoflurane (nsubj)
dose highest (amod)
intake alcohol (compound)
significant was (cop)
patients 73 (nummod)
types in (case)
diagrams ratio (nmod)
site damage (nmod)
enzyme used (acl)
years 3.7 (nummod)
combination paclitaxel/carboplatin (compound)
ncq436 of (case)
have cells (nmod)
administration isoproterenol (nmod)
decrease hemoglobin (nmod)
showed abnormalities (dobj)
curves co2-response (amod)
histology , (punct)
cause organic (amod)
progress not (neg)
innervated normally (advmod)
used interfere (advcl)
mr underlying (amod)
affects americans (dobj)
0.6 2 (conj)
cycle 35-day (amod)
patients score (dep)
study ahs (appos)
exclusion appendage (nmod)
year 59 (nummod)
u/l ( (punct)
exacerbates recombinant (amod)
conclusions appears (appos)
associated risks (nmod)
undertaken effect (conj)
receptor glial-cell-line-derived (amod)
analysed examined (conj)
prevented maintained (conj)
administration dfo (conj)
prolonged time (nmod:tmod)
databases library (conj)
teams and (cc)
configuration hemorrhaging (nmod)
volunteers 28 (nummod)
progression on (case)
erp duration (conj)
expression formation (nmod)
was threshold (nmod)
captopril , (punct)
upregulation angiotensinogen (nmod)
stimulation not (neg)
1 for (case)
dyskinesias ipsilateral (amod)
documented and (cc)
decreased count (dobj)
refine and (cc)
associated cephalosporins (nsubjpass)
antagonize impairment (dobj)
11.2 and (cc)
change alfentanil (nmod)
reduced mm (dep)
years past (amod)
group receptors (nmod)
increased cystitis (nsubj)
represented some (nsubj)
pulse agents (conj)
noted differences (nsubjpass)
substance prominent (amod)
range associated (acl)
divided mice (nsubjpass)
suitable be (cop)
states different (amod)
sodium ppm (amod)
effects differential (amod)
2-receptors , (punct)
usage between (case)
infused bupivacaine (nsubjpass)
disorders intoxication (conj)
mg/m(2 131 (nummod)
questionaires form (compound)
imaging computed (amod)
carbamylcholin compound (nmod:poss)
war civil (amod)
higher significantly (advmod)
restored ltp (dobj)
biopsies thirteen (nummod)
option maintained (conj)
sirolimus target (appos)
91 to (dep)
associated features (nmod)
drugs are (cop)
concentrations adrenaline (conj)
propranolol biperiden (conj)
groups receiving (acl)
coordinates points (nmod)
disease repeated (acl:relcl)
tetrachloride given (acl)
aspiration and (cc)
responsible is (cop)
rats dehydrated (amod)
injection l (compound)
examines safety (dobj)
expression oxidase (compound)
penk ) (punct)
accompanied reduction (dobj)
pressure as (case)
mmol/kg ( (punct)
sheath the (det)
stages with (case)
given or (cc)
parameters elevated (amod)
involves receptors (dobj)
represented caudomedially (advmod)
associated mssbp (nmod)
1.81 ) (punct)
reversible be (cop)
structures among (case)
adenocarcinoma 1 (appos)
chemotherapeutics first-line (amod)
1.4 +/- (cc)
99.0 61 (conj)
died ( (punct)
demonstrated patient (nmod)
range 84 (nummod)
use overuse (conj)
different to (case)
preparations heart-lung (amod)
n=92 ( (punct)
response minor (amod)
l-485 fed (amod)
increase pressure (nmod)
induced kindling (nmod)
damage pre-existing (amod)
preference of (case)
manifest , (punct)
count course (appos)
versus 90/htn (dep)
outlining bdl (nmod)
cardiotoxicity bupivacaine-induced (amod)
effect vestibulotoxicity (nmod)
cd4 count (conj)
g/dl 5 (nummod)
ether flurothyl (compound)
rat immunocytoma-bearing (amod)
bundle the (det)
measured haemorrhage (nmod)
pregs effects (nmod)
period interference (conj)
acid asa (appos)
response favorable (amod)
induced wk (nmod)
changes severe (amod)
reactions 261 (nummod)
membranes m (nmod)
contribute , (punct)
hemodialysis versus (cc)
elevation because (case)
resection whose (nmod:poss)
parameters ulcerogenic (amod)
impaired greater (conj)
suppressed that (mark)
remains decreases (conj)
methods standard (amod)
function received (conj)
ratios odds (compound)
0.1 versus (cc)
index sensitivity (compound)
compared nine (nmod)
pressure circulatory (amod)
3.49 1.21 (appos)
one by (case)
17.0 +/- (cc)
related play (advcl)
pregnancies 12 (nummod)
limit 5 (nummod)
day gtn (compound)
operating granulomatosis (nmod)
mouse-1 ( (punct)
developed sludge (dobj)
tested allopregnanolone (nsubjpass)
20 more (amod)
protein thiols (conj)
flowmetry laser (compound)
history in (case)
presented mastectomy (nmod)
ingested period (nmod)
modulate did (aux)
cardiotoxicity doxorubicin (nmod)
has contractility (nsubj)
produce ssr103800 (nsubj)
suppressed role (dobj)
influence effect (nmod)
rats regimens (nmod)
conditions no (det)
showed subacute (ccomp)
hampered background (dep)
58.4 6.8 (conj)
exerted , (punct)
abscess presacral (amod)
replaced doses (nsubjpass)
intubated ) (punct)
months six (nummod)
random-assignment double-blind (conj)
withdrawal ( (punct)
years use (conj)
period rhythm (nmod)
dyskinesias filling (acl)
made injections (nsubjpass)
sulpiride dopamine (compound)
completed inventory (dobj)
weight to (case)
rabbits in (case)
compartments leukocyte (compound)
followed patients (nsubjpass)
1.52 ( (punct)
quality life (compound)
hepatitis dilevalol-associated (amod)
dis-charge till (case)
oligodendrocytes occasionally (advmod)
events patient-years (nmod)
castrated noncastrated (conj)
increased mice (nsubj)
department istanbul (conj)
black , (punct)
clarified have (aux)
u/ml p (appos)
causes hypertension (dobj)
studies from (case)
80 20 (compound)
derivative chondroitin (compound)
developed tachycardia (nsubj)
16 to (dep)
differentiated h (nmod)
case injections (nmod)
mature sexually (advmod)
blockade lower (amod)
viracept combination (nmod)
mice time (compound)
administered nitroglycerin (nsubjpass)
2.5 of (case)
behaviors spontaneous (amod)
indicated appear (ccomp)
complete 1 (dep)
study in (case)
aneurysms artery (compound)
have potency (dobj)
30 was (cop)
induces tamoxifen (nsubj)
indicators injury (nmod)
deprived maternally (advmod)
stroke . (punct)
schedule of (case)
cats suspected (acl)
improvement/resolution symptoms (nmod)
had attempt (dobj)
pathologies brain (compound)
muscle smooth (amod)
aware one (nsubj)
regressed surveillance (nmod)
volume cerebellar (amod)
was none (conj)
convulsant lethal (conj)
meeting of (case)
seen magnitude (nmod)
investigated approaches (dobj)
function cardiac (amod)
reversal days (dep)
reminds considered (ccomp)
used fentanyl (nsubjpass)
cerebellar oculomotor (conj)
individuals 19 (nummod)
took man (nsubj)
coma death (conj)
bupivacaine epinephrine (conj)
follow frequently (advmod)
latencies tail-withdrawal (amod)
reports available (amod)
maintained had (aux)
proteins urinary (amod)
heterogeneity clinical (amod)
dysfunction patients (nmod)
observed migraine (nsubjpass)
model heart (compound)
conduction av (compound)
associated r (dep)
cannabis/alcohol/nicotine can (appos)
use compared (acl)
potentials convulsive (amod)
24_h within (case)
control cardiovascular (amod)
injections 14 (nummod)
data ph (dep)
reduced % (nmod)
assessed using (advcl)
cramps nocturnal (amod)
were responses (nsubj)
capacity caused (acl)
seems and (cc)
metabolism neuropeptide (compound)
co-morbidity and (cc)
performed study (xcomp)
given mg (nsubjpass)
impaired but (cc)
d2 , (punct)
bound infarction (dobj)
remained but (cc)
protection nrf2-mediated (amod)
1.19 of (case)
defined to (mark)
sex factors (nsubj)
uterus m4 (nmod)
reversible often (advmod)
liver to (case)
dyskinesia malaysians (nmod)
influenced se (advmod)
antidepressants , (punct)
release meninges (nmod)
episodes multiple (amod)
(pge1)-induced effects (nsubj)
prescribed flecainide (nsubjpass)
ica ) (punct)
resolved day (nmod:tmod)
converted dogs (nmod)
dg ( (punct)
due this (nsubj)
adjusting stage (nmod)
findings any (det)
sensitization to (case)
effects ocular (amod)
hypokalemia symptomatic (amod)
reported respectively (advmod)
diatheses bleeding (amod)
umb24 of (case)
induced atp (nmod)
postpartum the (det)
suitable terms (nmod)
comparable prevalence (nmod)
filaments myosin (compound)
t5 rosen (nmod:poss)
shorter compared (xcomp)
symptoms problems (conj)
volume concentrations (nmod)
factor etiologic (amod)
age old (dep)
increased thymus (conj)
foci in (case)
increased maintained (conj)
thalidomide with (case)
affected loss (nmod)
either , (punct)
enalapril : (punct)
turned while (mark)
indices all (det)
rare neuropathy (nsubj)
alopecia and (cc)
diet high-salt (compound)
died causes (nmod)
isoproterenol exercise-induced (conj)
suffered still (advmod)
absorption warfarin (nmod)
controlling nutrition (nmod)
1.8 1 (conj)
carrier of (case)
lower 0.05 (dep)
cd-832 of (case)
preventing strokes (dobj)
primigravida healthy (amod)
scheduled are (auxpass)
provocation acute (amod)
catecholamine of (case)
= mg/dl (dep)
disease alzheimer (nmod:poss)
patient application (appos)
older likely (conj)
sicca typical (amod)
orciprenaline of (case)
lines promising (amod)
apnea patients (nmod)
aspirin : (punct)
management headache (nmod)
thought it (nsubjpass)
seen enhancement (nsubjpass)
aimed bound (conj)
evaluated sections (nsubjpass)
ssris ( (punct)
induced blocker (nmod)
den or (cc)
reverse can (aux)
mediates dampens (conj)
that antidepressants (nmod)
nephrotoxicity dose-limiting (amod)
doses mg/m2 (nmod)
use findings (dobj)
line cell (compound)
effect dyskinesias (nmod)
pathways neuroinflammatory (amod)
prescribed becoming (auxpass)
demonstrated analgesia (ccomp)
likely underreporting (nsubj)
bumetanide paroxetine (conj)
catecholamines and (cc)
consisted generally (advmod)
arthritis and (cc)
paucity data (nmod)
account . (punct)
diphenhydramine of (case)
resulted later (advmod)
associated pemoline (nsubjpass)
resulted this (nsubj)
associated therefore (advmod)
administration oxytocics (compound)
effects suspected (amod)
precipitated be (auxpass)
improved capacity (dobj)
terminated prematurely (advmod)
demonstrated compared (prep)
use widespread (amod)
exposure acid (compound)
mg 0.75 (nummod)
histopathological prior (advmod)
activities antioxidants (nmod)
antibiotic clarithromycin (appos)
ways characteristic (amod)
absorption substance (nmod)
recall pain (nmod)
accident cva (appos)
received revealed (advcl)
unrestrained rats (dobj)
ascribed be (auxpass)
subpopulations receptors (nmod)
epilepticus non-convulsive (amod)
10-diol ena[c]phenathrene-9 (compound)
dose amisulpride (nmod)
nerves medulla (nmod)
days twenty (nummod)
gfap ( (punct)
receptors affinity (conj)
element be (cop)
resulted mean (parataxis)
ligands subtypes (nmod)
ratio cardiomyocytes (nmod)
corresponding word (nmod)
mediated system (nmod)
muscle heart (compound)
correlated score (nmod)
nephrotoxicity b (compound)
paroxysms of (case)
reviewed abstracted (conj)
kits available (amod)
subset recipients (nmod)
signs secondary (amod)
rg1 ginsenoside (compound)
pictures of (case)
states during (case)
therapy cause (acl:relcl)
decrease capacity (nmod)
rise renin (nmod)
malignancies solid (amod)
significant . (punct)
proven agent (xcomp)
believe . (punct)
anemia as (case)
kidney organs (conj)
neuroleptics high-potency (compound)
difficult diagnosis (nsubj)
correlations ngf (nmod)
restarting treatment (nmod)
occurred infusion (nmod)
sacrifice after (mark)
length qt (conj)
fraction % (appos)
4.1 +/- (cc)
dose pilocarpine (nmod)
agent interaction (nmod)
enhanced administration (nsubj)
patients patient (dep)
b2 txb2 (appos)
group ( (punct)
increased treatment (nmod)
cocaine occasional (amod)
receptor novel (amod)
antigen test (compound)
changes follow-up (compound)
switching after (case)
tested show (conj)
33.8 +/- (cc)
fetus in (case)
elevated 0.0010 (nmod)
considered recognition (nsubjpass)
2 whom (nmod)
evaluation literature (compound)
paracetamol bladder (nmod)
k 40 (nummod)
cigarettes of (case)
hepatomas hyperplastic (conj)
agsd of (case)
greater hypotension (nmod)
limited have (aux)
1 monkeys (nmod)
neuropathology snr (nmod)
as well (mwe)
ability presented (acl)
globulin polyspecific (amod)
scopolamine methyl (amod)
potent cb (nmod)
depression-inducer a (det)
disorders for (case)
head carcinomas (dep)
negativity resistance (conj)
capacity inhibition (conj)
adr(6 adr+los(6 (appos)
disclosed , (punct)
showed him (dobj)
higher 8 (conj)
ages . (punct)
fluorescein as (case)
effect outcome (nsubj)
mg/kg 6 (nummod)
men treated (acl)
specimens twenty-six (nummod)
mice aged (amod)
polymorphism for (case)
codeine of (case)
sedation reduction (nmod)
background deliver (dep)
predict to (mark)
blocked analgesia (dobj)
conclude improve (ccomp)
occurrence from (case)
noted it (nsubjpass)
reabsorption on (case)
model haloperidol-induced (amod)
hiv-negative were (cop)
variants patients (nmod)
retinochoroidopathy with (case)
rat hypoxia-sensing (amod)
wall arteriolar (amod)
hev ( (punct)
occurs introduction (dep)
= respectively (advmod)
result seizures (nsubj)
higher pressures (nsubj)
injection 30-second (amod)
complication rare (amod)
correlation improvement (nmod)
unhappiness , (punct)
ip tricyclic (amod)
dose divided (dep)
11 24 (conj)
target treatment (nmod)
factor as (case)
led modifications (nmod)
amelioration symptoms (nmod)
patients exposed (acl)
showed data (nsubj)
role nephropathy (nmod)
tachycardia ablation (nmod)
hctc with (case)
antiplatelets among (case)
provoke migraine (dobj)
prevention task (nmod)
antagonism interleukin (nmod)
that pathology (nsubj)
inhibitor smad3 (nmod)
uncommon is (cop)
excellent applying (advcl)
left and (cc)
causes apparent (advcl)
reaction . (punct)
nystagmus . (punct)
discovery scale-up (conj)
vsd ( (punct)
taking depression (nmod)
h ) (punct)
control on (case)
clopidogrel due (case)
% normal (nmod)
achieved patient (nsubj)
tariquidar pgp (compound)
horn dorsal (compound)
medline dates (appos)
had problems (dobj)
progressed as (mark)
ros ( (punct)
metabolizer metoprolol (nmod)
drugs antithyroid (compound)
episode , (punct)
received day (nmod:tmod)
deserve use (dobj)
protects treatment (nsubj)
5-ht1a the (dep)
angioplasty nephrotoxicity (nsubj)
varied institution (advcl)
ester mg/kg/day (amod)
neurotoxicity its (nmod:poss)
used yet (advmod)
dosages mean (amod)
polymorphic population (nmod)
ascribed suppression (nmod)
results morphine (dep)
series three (nummod)
program , (punct)
6 - (punct)
chx+pilo control (conj)
effects antiemetic (amod)
area hemisphere (nmod)
limiting administration (dobj)
comparison subjects (nmod)
diffusion proton (compound)
beta-blockers of (case)
number cycles (nmod)
distinguished those (nmod)
cause thrombocytopenia (nmod)
current future (conj)
4107 3551 (conj)
pcc of (case)
group dex (compound)
medication due (case)
parameters tolerability (compound)
expression horn (nmod)
described context (nmod)
head with (case)
survival , (punct)
decoction the (det)
patterns injury (nmod)
findings funduscopic (amod)
dizziness , (punct)
age-matched , (punct)
rate thromboembolism (nmod)
followed concentration (nsubj)
pressure with (case)
consuming what (dobj)
toxic as (advmod)
female white (amod)
acetate combined (acl)
intervenes event (nmod)
structures head (nmod)
time longer (amod)
therapy valproate (nmod)
stature delayed (amod)
addressed role (dobj)
studied groups (nsubjpass)
bradycardia cirazoline (nmod)
task employing (acl)
induction ku70 (nmod)
0.25 cent (nmod)
hypotension produced (acl)
extrusion the (det)
binding receptors (nmod)
thiotepa tspa (appos)
tended while (mark)
gspe by (case)
produced infusion (nmod)
seizures damage (conj)
considered reversible (xcomp)
stain culture (conj)
desire at (case)
pre-induced doxorubicin (nmod)
suffering involvement (nmod)
exposed anticholinergics (nmod)
dose d-penicillamine (nmod)
adult not (neg)
enrolled 28 (dep)
used agent (nsubjpass)
took previously (advmod)
times to (case)
> 14 (dep)
myopathy limit (appos)
adduct trifluoroacetyl (compound)
results mean (appos)
induced iso (nsubj)
abuse case (dep)
group prophylaxis (compound)
sought carefully (advmod)
role : (punct)
increased gradually (advmod)
deaths no (neg)
osmolality reabsorption (conj)
subgroups population (compound)
flushing , (punct)
clopidogrel aspirin (conj)
duration mg/kg (dep)
dissociated enzymatically (advmod)
manage complications (dobj)
evident histologically (advmod)
virus and (cc)
alternative superior (amod)
inotropic chronotropic (conj)
paresthesia the (det)
million 12 (compound)
received antidotes (nmod)
therapy migraine (compound)
cholinesterase plasma (compound)
concentrations glucose (compound)
paracetamol to (case)
metoprolol of (case)
doses cases (nmod)
factors disease (nmod)
induced chlorpromazine (nmod)
pathogenesis options (conj)
developed whom (nmod)
safe cost-effective (conj)
phosphokinase creatine (compound)
layer retinal (amod)
rats anaesthetised (acl)
variable efficacy (compound)
yrs males (appos)
significant the (det)
patient enflurane (appos)
maximal which (nsubj)
findings pathological (amod)
caused perfusion (nsubj)
peliosis autopsy (amod)
factor colony-stimulating (amod)
dx with (case)
cystitis hemorrhagic (amod)
disruption with (case)
hours apnoea (nmod)
hypertension primary (amod)
analyzed implant (nsubjpass)
dose standard (amod)
risks interventions (nmod)
methods both (cc:preconj)
cleavage ( (punct)
descending projections (dobj)
march may (conj)
suggest antagonist (nmod)
included data (dobj)
inhibited reversal (conj)
time-dependent dose-related (conj)
lasted min (dobj)
inserted continuation (nmod)
significance absence (nmod)
pas ) (punct)
review together (advmod)
taking ) (punct)
alter mechanisms (nmod)
symptoms reversed (acl:relcl)
block prolonged (amod)
k(+)-channels voltage-sensitive (amod)
combining clonidine (dobj)
mechanism(s leading (acl)
processes prefrontal (amod)
had severity (nmod)
retention edema (conj)
subjects reporting (acl)
morphology kidney (nmod)
monitoring tobramycin (nmod)
feeding the (det)
aorta rat (compound)
architecture lobular (amod)
% 39 (nummod)
woman non-alcoholic (amod)
conclusions reflect (appos)
common hyperkalemia (nsubj)
behavior map-induced (amod)
pons the (det)
% 34.6 (nummod)
tomography with (case)
examined individually (advmod)
week 4 (nummod)
connective and (cc)
production , (punct)
resolved decreased (conj)
allow secretion (dobj)
have % (nsubj)
followed adequately (advmod)
neurotoxicity increased (amod)
poisoning aconitine (compound)
ages median (amod)
pr saline (conj)
dystrophy hyperparathyroidism (conj)
indicate initiated (ccomp)
salicylates salts (conj)
prevented moreover (advmod)
caused grow (advcl)
depletes . (punct)
methoctramine than (case)
remained association (nsubj)
found dysfunctions (nsubjpass)
accompanied increase (conj)
heparin intravenous (amod)
recommended can (aux)
withdrawing by (mark)
seems exist (xcomp)
pn 14 (nummod)
definition adr (nmod)
traveled and (cc)
characteristics compound (nmod)
injections prior (case)
facial intracranial (conj)
sequence a (det)
total days (nmod)
modulate neurotransmission (nsubj)
cgrp ) (punct)
ileostomy with (case)
increased tone (dobj)
studies earlier (amod)
evaluating safety (dobj)
assessed substances (conj)
damage bed (nmod)
antagonists d2 (compound)
gvhd ( (punct)
move regardless (advmod)
site left (amod)
force paradigm (nmod)
monitoring 24-hour (amod)
patients seven (nummod)
cavity found (acl)
attenuated lesions (dobj)
periods for (case)
techniques fastblue (nmod)
bw 2.0 (nummod)
indication by (case)
agent thalidomide (nsubj)
nucleus pons (conj)
% 1.6 (nummod)
factor implicated (acl)
activity acid (compound)
result emergence (nmod)
attempted thereby (advmod)
restarted that (mark)
improvement denopamine (nmod)
decreased added (conj)
11 10 (conj)
suffering polyuria (conj)
prolonged stl1 (dobj)
refine issues (dobj)
stress induced (acl)
carboplatin rhabdomyosarcoma (nmod)
evaluated days (nmod)
show decreased (ccomp)
contributed . (punct)
d-glucarate with (case)
augments . (punct)
effects over (case)
cases milder (compound)
producing injury (dobj)
studies mice (nmod)
mm 6.0 (nummod)
limit use (dobj)
resulted that (mark)
tachyarrhythmia with (case)
available series (nsubj)
webster swiss (compound)
a-i increase (conj)
head untreated (amod)
treated later (advmod)
micromol/l 100 (nummod)
distracted attention (nsubjpass)
tachykinins , (punct)
variables tolerability (conj)
analog octreotide (appos)
studied long (advcl)
droperidol , (punct)
ko and (cc)
describe died (conj)
hypersecretion acid (compound)
effects proarrhythmic (amod)
minutes impairment (nmod)
administered mg/kg (nmod)
wt treatment (nmod)
vasculitis active (amod)
microscopy endothelia (nmod)
activation on (case)
d-glucarates of (case)
phagocytosis cells (nmod)
albuminuria group (compound)
reached once (mark)
neonate the (det)
production higher (amod)
interval encephalopathy (amod)
had prolongation (dobj)
was . (punct)
absorption sublingual (amod)
inter- intra-individual (conj)
ld50 ) (punct)
apart weeks (nmod:npmod)
wherein mediated (acl)
identified were (auxpass)
movement right (amod)
antibodies different (amod)
3.5 1.3 (conj)
detected aspartate (nmod)
underwent labour (nmod)
enzyme angiotensin-converting (amod)
hours 12 (nummod)
antagonist used (acl)
assessed deglutition (nsubjpass)
control density (nmod)
ratios measuring (acl)
reported % (nsubjpass)
disruption persistent (amod)
dm-9384 ) (punct)
edits ) (punct)
syndrome organic (amod)
developed angioedema (dobj)
neutrophils by (case)
concentration day (nmod)
methotrexate long-term (amod)
3551 +/- (cc)
observed lesions (nsubjpass)
agents antiviral (amod)
p=0.0001 < (conj)
carota of (case)
tested when (advmod)
-10.7 ; (punct)
mg/kg combination (nmod)
depressed whether (mark)
exacerbations received (acl:relcl)
illustrates and (cc)
contribution volume (nmod)
neck calculation (conj)
antigen in (case)
inoculation 7.8 (nmod)
treatment adriamycin (nmod)
ml/min 59 (nummod)
nimodipine mg/h (compound)
estradiol- esters (dep)
zero epinephrine (nmod)
marrow hypercellular (amod)
ro4368554 receptor (compound)
tumors recurrences (nmod)
disorders tic (compound)
injected doses (nsubjpass)
patient reported (amod)
intake l-dopa (compound)
cells ccr2-labeled (amod)
average with (case)
retested rats (nsubjpass)
attributable effect (nmod)
relief pain (compound)
injections 17beta-estradiol (nmod)
gentamicin instilled (acl)
syndrome rabbit (compound)
implicating interaction (dobj)
coadministration from (case)
having of (mark)
circuitries prefronto-striatal (amod)
used transplantation (nmod)
expression fas (compound)
flow metabolism (conj)
signs nephrotoxicity (nmod)
infarction following (case)
hg mm (compound)
dissipates after (case)
urea blood (compound)
values hemoglobin (compound)
oxidation the (det)
scored , (punct)
left normal (conj)
implicated ofloxacin (conj)
completed been (auxpass)
steroid modulate (acl:relcl)
determined should (aux)
carcinoma first (amod)
acetaldehyde by (case)
use dormex (nmod)
damage rat (compound)
tissues their (nmod:poss)
inhibit that (nsubj)
normalization count (nmod)
recurrence b (nmod)
diagnosed database (nmod)
paper the (det)
0.8 4.9 (dep)
sustained were (auxpass)
obscure mechanism (nsubj)
cco-i of (case)
mechanisms post-receptor (amod)
affects how (advmod)
patient consumed (acl:relcl)
majority for (case)
increase affinity (nmod)
recognition users (nmod)
comorbid dyspepsia (nmod)
resolved cessation (nmod)
tremor catalepsy (conj)
tfl ) (punct)
diagnosed age (nmod)
performed air/oxygen (nmod)
wt in (case)
drop right (amod)
cystitis and (cc)
sensitivity gls (compound)
unlikely were (cop)
groups 15 (nmod)
limits the (det)
remains while (mark)
18 3 (conj)
0 2 (conj)
man and (cc)
studies after (case)
correlates changes (nmod)
tend those (nsubj)
d-galactose transported (acl:relcl)
disarrangement cardiac (amod)
potentiating reducing (conj)
suppressed stimulation (nsubj)
neurons visceral (amod)
placebo agoraphobia (nmod)
impaired acetaminophen (advmod)
cardiotoxicity clinical (amod)
clopidogrel fibrillation (compound)
favourable . (punct)
polyuria insipidus (nmod)
communication social (conj)
factors influence (acl:relcl)
included thrombocytopenia (dobj)
study to (mark)
[d-pen2.5]-enkephalin [d-ser2]-[leu]enkephalin-thr (conj)
joint gastrocnemius (appos)
analogues aryl-piperazine (amod)
resistant diastase (nmod:npmod)
efficacy clinical (amod)
successful to (mark)
lead may (aux)
administration reductions (conj)
demonstrated protection (nmod)
block axillary (amod)
hybrid an (det)
assess characterise (conj)
months higher (conj)
emerged suppressed (conj)
m 28 (compound)
defects vfd (appos)
release plasma (nmod)
sg145r mutants (dep)
coniine , (punct)
weeks 2 (nummod)
yawning , (punct)
patients factors (nmod)
strain serve (conj)
used approach (nsubjpass)
worsening dyskinesias (nmod)
incidence limit (appos)
own on (case)
pge2 oab (compound)
recipients renal (amod)
165/90 mg (conj)
mg/m2/d 550 (nummod)
prolactinomas of (case)
safe conclusion (nmod)
presence csa (nmod)
relieved lidocaine (nmod)
concentrations folate (compound)
peptide anp (appos)
hypothesis combinatorial (amod)
occurred occurred (ccomp)
identification factors (nmod)
accomplished conversion (nsubjpass)
read but (cc)
association this (det)
test ; (punct)
audiograms abnormal (amod)
baseline mean (dep)
maintained were (auxpass)
occurred usage (nmod)
drug-related cyclosporine (dep)
ruled were (auxpass)
valsartan and (cc)
fibrosis cortex (nmod)
blocked potentiated (conj)
symptoms different (amod)
low of (case)
142 141 (compound)
ranged years (nmod)
0.001 > (dep)
arteriolar non-selective (amod)
hippocampal the (det)
communicated if (mark)
reactions cardiac (amod)
read and (cc)
microg/ml 25.5 (nummod)
values frap (compound)
quantitatively and (cc)
40000 ) (punct)
effects atorvastatin (nmod)
tiapride mg/day (appos)
matter associated (ccomp)
receptors acetylcholine (compound)
performance after (case)
hypotension tilt (compound)
h before (case)
np group (compound)
related case (nmod)
placebo training (nmod)
increased instability (dobj)
applied i.p. (advmod)
controls regurgitation (conj)
had trough-concentrations (conj)
l/m2 644 (nummod)
lesion that (mark)
shock to (case)
8 5 (compound)
effects again (advmod)
persists responds (conj)
matrix cytoskeleton (conj)
study treatment (compound)
tland of (case)
-21.3 -19.4 (conj)
mg/d 400 (nummod)
microbleeds , (punct)
homogenates by (case)
% 82.4 (nummod)
optimising prevention (dobj)
(dex)-induced 1 (dep)
analyzed have (aux)
concentration peptide (compound)
system catecholaminergic (amod)
administered onset (nmod)
insertion associated (acl)
drug trials (nmod)
judiciously and (cc)
preceded monoher (nmod)
percent sixty-nine (amod)
sacrificed range (nmod)
activity efferent (compound)
confirmed lesions (nsubjpass)
cell renal (amod)
own and (cc)
activity cells (nmod)
emphasizes need (dobj)
phase , (punct)
1-(2-phenethyl)-4-(2-pyridyl)-piperazine ( (punct)
% ] (punct)
amnesia density (conj)
increased dex (nsubj)
addictive background (dep)
amide , (punct)
model inositol (compound)
given opiate (dobj)
greater had (conj)
history ingestion (nmod)
nondyskinetic than (case)
results improved (appos)
risk use (nmod)
indices arthritis (compound)
proliferated , (punct)
hypotension (sn)-induced (compound)
giving muscles (nmod)
isoproterenol in (case)
reflecting margins (dobj)
chemotherapy approach (nmod)
aureus susceptible (amod)
diagnosed , (punct)
mmt siop (compound)
hepatotoxicity yellow (amod)
incidence angioedema (nmod)
network to (case)
intoxication scopolamine (compound)
serious potentially (advmod)
high experimental (dep)
use model (dobj)
induced proteinuria (nsubjpass)
left end-systolic (nsubj)
treated 14 (nsubjpass)
change little (amod)
immuno/histochemistry and (cc)
current the (det)
analyses histopathology (compound)
administration h (dep)
that placebo (nmod)
covered : (punct)
tremor abnormalities (conj)
discontinuation necessitated (amod)
dissatisfaction and (cc)
months 23 (nummod)
nausea emesis (conj)
resulted results (nsubj)
overflow on (case)
lapsed lasting (advcl)
libitum sucrose (appos)
engineered deficient (xcomp)
mg/kg 2 (nummod)
normochromic . (punct)
trained swim (xcomp)
performed establish (xcomp)
agent causative (amod)
examinations x-rays (conj)
associated function (nmod)
cause effects (dobj)
factor administration (appos)
reintroduction fk506 (nmod)
supports protection (nsubj)
dose lipopolysaccharide (nmod)
supply afferent (amod)
increased 28.0 (nmod)
1.0 0.1 (conj)
s-1 the (det)
measurement products (nmod)
rats carcinoma (nmod)
end treatments (nmod)
function forelimb (compound)
metformin antidiabetic (amod)
design experimental (amod)
loss aminoglycoside-induced (amod)
hemoglobin haptoglobin (conj)
received trihexyphenidyl (dep)
minutes 51 (nummod)
disorder behavior (compound)
duration apd (appos)
cytopenia to (case)
was subcortex (nmod)
solid-organ and (cc)
effects immunosuppressive (amod)
long-term d (dep)
pathogenesis autoimmune (amod)
safety adverse (conj)
reached cholesterol (dobj)
steroids disease (nmod)
synthesis derivatives (nmod)
used chloride (dep)
toxicities severe (amod)
cystitis of (case)
challenge an (det)
nag ) (punct)
cytoplasm than (case)
hcrh and (cc)
grams three (nummod)
age p (dep)
work with (case)
doc of (case)
inhibits apomorphine (nsubj)
result nephrotoxicity (nsubj)
changes media (nmod)
indinavir of (case)
cbd ) (punct)
who had (nsubj)
sleep on (case)
transcription stat3 (appos)
underwent section (dobj)
boy in (case)
mth 10 (nummod)
absent different (advcl)
affirming by (mark)
missed determining (csubj)
disease bone (compound)
characterized pain (nmod)
prostate of (case)
monitoring of (case)
values dna (compound)
circulation enterohepatic (amod)
engagement phenomenon (nmod)
1-receptor alpha (compound)
severe pain (nsubj)
antibiotics peptide (compound)
patients alf (nmod)
n-methyl-d-aspartate receptor (compound)
kept . (punct)
adenoma hyperplasia (conj)
lesions histopathologic (amod)
mtd at (case)
prevents rat (nmod)
absence tg (nmod)
had total (nsubj)
fiber nerve (compound)
meq/l 3.52 (nummod)
loss graft (compound)
vials in (case)
p.o. mg/kg (compound)
effort in (case)
contained weeks (nmod)
changes dose (nmod)
randomised a (dep)
exfoliation urothelium (nmod)
distribution flow (nmod)
suxamethonium and (cc)
continues cardiotoxicity (nmod)
2.6 survivals (nsubj)
blocked (-)-propranolol (nmod)
1.11 1.47 (conj)
dose amphetamine (nmod)
expression achr. (nmod)
blockade receptor (nmod)
pointes 1 (meta)
enhancement the (det)
risk reaction (nmod)
acute short-term (dep)
problem and (cc)
administered adjunct (nmod)
result absorption (nmod)
severe enough (advmod)
higher size (nsubj)
expression neurochemical (amod)
fibrillation his (nmod:poss)
inpatients 1210 (nummod)
end-diastolic end-systolic (conj)
treated carbamazepine (nmod)
4,957 827 (conj)
response behavioural (amod)
granulocytopenia noncumulative (amod)
nitroglycerin by (case)
fractions in (case)
0.6 . (punct)
produced anesthetics (nsubj)
toxicity grade (compound)
revealed amounts (dobj)
increase an (det)
1987 from (case)
macrolide related (amod)
sed 0.46 (conj)
mice wsp (compound)
% v. (dep)
hours 30 (nummod)
bind ligand (dobj)
induced had (conj)
pn ( (punct)
group control (compound)
entity a (det)
instance toxicity (nmod)
hypertension stage (compound)
match controls (nmod)
demonstrated vessels (nsubjpass)
carcinoma case (nsubj)
normal proteins (conj)
seizure-free now (advmod)
presented paranoia (conj)
taken mornings (nmod)
factor platelet (compound)
potent receptor (nmod)
jumping limitations (nmod)
mrna tissue (conj)
outcomes towards (case)
erythropoietin by (case)
6.3 1.9 (conj)
benefit either (cc:preconj)
placebo stabilizer (conj)
dose gabapentin (nmod)
34 to (dep)
users 5-ht (nmod)
treatment bendrofluazide (compound)
rare fibrillation (nsubj)
lithium divalproex (conj)
studied fashion (nmod)
luminal cortex (nmod)
stimuli procedures (conj)
hds and (cc)
contained , (punct)
whether acidity (dep)
nucleosides ischemia (nmod)
effective treatment (nmod)
nx sham (conj)
differs because (mark)
shown have (aux)
pregnancy previous (amod)
transplanted context (nmod)
70/99 ( (punct)
pparalpha-/- [ (punct)
hematomyelia : (punct)
patients normal (conj)
exposure either (cc:preconj)
trial doses (nmod)
mm 31.6 (nummod)
use prior (amod)
recovery near (case)
used athletes (nmod)
excretion proteins (nmod)
receiving lamivudine (dobj)
strain c57bl/6 (appos)
impairment on (case)
rhabdomyolysis administration (nmod)
contain vacuoles (dobj)
use vasopressor (nmod)
anp anp (conj)
tgr the (det)
striatum dorsal (compound)
range the (det)
inhibition gr (nmod)
lymphoma with (case)
slowing % (nmod)
135 thirty (compound)
diet ls (compound)
week , (punct)
women hospital (conj)
t4 ) (punct)
attenuated alpha-tc (nmod)
mg/min hydrochloride (compound)
symptoms mild (amod)
suggest influences (nmod)
hcbd bea (conj)
weeks over (case)
renal both (cc:preconj)
imply incidence (dobj)
exertion due (case)
implications processes (nmod)
region represents (acl:relcl)
thirty-nine compared (acl)
unmatched or (cc)
decreased accumulation (dobj)
exercise motor (compound)
grade total (amod)
human and (cc)
injury axonal (amod)
cells ' (case)
level activity (nmod)
formulation am149 (appos)
effects dimer-x (nmod)
return scale (appos)
hydration for (case)
found suppressed (ccomp)
experiment present (amod)
summary patient (dep)
agent the (det)
had gain (dobj)
years % (conj)
enalapril ratio (dep)
results treatment (dep)
quantify risks (dobj)
potential the (det)
seem that (mark)
monitoring behavioral (amod)
fall and (cc)
threshold auditory (amod)
depression formation (nmod)
lysis after (case)
increasing according (mark)
amplitude tremor (compound)
4.6 0.9 (nummod)
suggest influence (ccomp)
causes stz (nsubj)
isolation cells (nmod)
histories because (case)
preservation relative (amod)
found hyperprolactinemia (nsubjpass)
31 two (compound)
precurarization the (det)
male , (punct)
vte of (case)
relationship diagnosis (nmod)
generation saccades (nmod)
man this (det)
shown curcumin (nsubj)
valve the (det)
therapy next (amod)
follow-up cases (nmod)
t sp120 (nummod)
small was (cop)
intervals 3-week (amod)
induced pge1 (nmod)
bergmann ( (punct)
overdose disulfiram (compound)
day-1 mg (compound)
duct common (amod)
ingestion bupropion (nmod)
vte ( (punct)
development insipidus (nmod)
results the (det)
report induce (advcl)
reviewed literature (nsubj)
delayed may (aux)
analogs and (cc)
likely group (nmod)
contributed could (aux)
serious adverse (dep)
aware effect (nmod)
sulfate chondroitin (compound)
2e1 2e1 (appos)
exceeded ng./ml (dobj)
risk toxicity (nmod)
subjects compared (case)
rhythm abnormal (amod)
function myocardial (amod)
infiltration including (case)
demographic data (conj)
on'- and (cc)
confusion , (punct)
erection penis (nmod)
risk to (case)
detected sign (nmod)
likely medium (nmod)
vegf/vpf ) (punct)
mazindol of (case)
grade sensory (conj)
lidocaine bupivacaine (conj)
pneumonia patients (nmod)
monitoring postoperative (amod)
nephrectomy , (punct)
protection nephrotoxicity (nmod)
amb and (cc)
schizophrenic patients (conj)
undergoes glucoronosyltransferases (nmod)
retention in (case)
injury head (amod)
2.4 0.3 (conj)
bupivacaine 1 (nummod)
respect in (case)
minimal no (conj)
line ( (punct)
% 1 (nummod)
transitioned anticoagulation (nmod)
% 16/49 (appos)
consider reflex (dobj)
1.04 +/- (cc)
presentation , (punct)
mean square (dobj)
115 26 (dep)
vulnerability selective (amod)
10 higher (amod)
change necrosis (conj)
kindreds of (case)
results reported (appos)
grade exception (nmod)
writing this (det)
treatments reserpine (compound)
patient telangiectatic (amod)
therapy vs. (cc)
lev added (acl)
afterdepolarization . (punct)
clinically not (neg)
subjected aneurysms (nmod)
attempt determine (acl)
points score (dep)
allowing continued (xcomp)
center our (nmod:poss)
extent problem (nmod)
material women (dep)
became died (conj)
dose doxorubicin (compound)
nrf2(+/+ compared (case)
used h (nmod)
d2r of (case)
ergotamine 2 (nummod)
effects normotensive (nmod)
behavior obsessive-compulsive (amod)
started infusion (nsubjpass)
cisapride [ (punct)
vagotomy , (punct)
sprague-dawley in (case)
efficacious more (advmod)
agents topical (amod)
immunosuppressant sirolimus (nsubj)
49.75 - (punct)
enlarged times (nmod:tmod)
ctnt between (case)
use stroke (compound)
vessels rat (compound)
hypotension % (appos)
disease to (case)
progesterone vehicle (conj)
stroke ischaemic (amod)
levels noradrenaline (amod)
blocks ammonia (nsubj)
studied design (dep)
blockade blockade (conj)
tests for (case)
treated care (nmod)
effects neutropenia (nmod)
ng.ml-1 72 (nummod)
assigned method (nsubjpass)
onset from (case)
activity agonists (nmod)
reproducible defects (nsubj)
drugs anti-tuberculous (amod)
0.1 1ug (conj)
hematoma entrapment (conj)
mg. day (nmod:tmod)
grade . (punct)
type some (det)
intradermal intravenous (conj)
investigated been (auxpass)
cohort personal (amod)
evoked methoxamine (nsubj)
switch for (case)
risk development (nmod)
improvements bradykinesia (nmod)
indicated studies (nsubj)
awaking and (cc)
neck and (cc)
protected pentobarbital (nsubj)
method subjects (appos)
reversible cytopenias (nsubj)
changes important (amod)
abnormalities provoked (acl:relcl)
deterioration significant (amod)
examined therapy (nmod)
therapy reference (compound)
paradigm grip-lift (amod)
jaundice methimazole-induced (amod)
suspect syndrome (dobj)
increased following (xcomp)
women cpa/ee (nmod)
activity nag (compound)
disorder adhd (appos)
shown syndrome (conj)
increase through (case)
dopamine nacc (compound)
courses sixty-five (amod)
increased incidence (dobj)
ratio 3.4 (appos)
ng/ml 15 (compound)
needed find (xcomp)
mrna and (cc)
categorized infants (nsubjpass)
rats excretion (nmod)
patient august (nmod)
increase however (advmod)
behaviours with (case)
report intoxication (dep)
case jaw (appos)
integrity adrenergic (amod)
telmisartan versus (cc)
adenoma hamartoma (conj)
measured mpo-anca (nsubjpass)
caused abandoned (ccomp)
12%-21 approximately (advmod)
propagation transmural (amod)
mm 62 (nummod)
cinacalcet hs (appos)
combination day (nmod)
exam , (punct)
shortened concentration-dependently (advmod)
granules dark (amod)
muscarinic , (punct)
maintained concentrations (dobj)
men eleven (nummod)
loss sensory (amod)
report background (dep)
caused decrease (dobj)
diagnosis amyloidosis (nmod)
show here (advmod)
triglycerides % (appos)
determined predictors (nsubjpass)
introduced and (cc)
attributable possibly (advmod)
jj or (cc)
undergoing treatment (dobj)
prolongs followed (conj)
axis of (case)
investigate contributes (ccomp)
conclusions regimen (dep)
u/ml n (appos)
abandoning technique (dobj)
correlation = (dep)
mechanisms ischemia (nmod)
period 2- (nummod)
dosage full (amod)
ratio 4.3 (dep)
concentration ng/ml (nmod)
removed calculus (dobj)
intake caffeine-free (amod)
decreasing increasing (conj)
abuse : (punct)
cause : (punct)
number toll-free (amod)
all ( (punct)
stopped infusions (nsubjpass)
form either (det)
malformation with (case)
solubility cb (nmod)
animals drug-naive (amod)
associated levels (nsubjpass)
responded symptoms (nsubj)
19.3 duration (nsubj)
on especially (advmod)
cholestasis associated (amod)
stn unilateral (amod)
replication susceptibility (conj)
pinealectomized or (cc)
appears melphalan (nsubj)
mg/m(2 1378 (compound)
reported concentration (nsubjpass)
anxiety to (case)
deterioration gfr (nmod)
agonists da (compound)
flecainide 100 (nummod)
patient known (acl)
product approved (acl)
facility eyes (nmod)
slowly cn (nmod)
solution g/kg (appos)
phosphorus yellow (compound)
checked also (advmod)
show test (nmod)
activation beta-adrenoceptor (compound)
demonstrated spect (nsubj)
344 404 (conj)
capacity functional (amod)
activity epileptogenic (amod)
meth after (case)
unanticipated and (cc)
significant disorder (nmod)
produced 21 (nsubj)
hypothesize thought (advcl)
nms ) (punct)
greater increases (nmod)
remission has (aux)
practical importance (dep)
suspected was (auxpass)
decreased g. (nmod)
territories of (case)
formulations since (case)
causing inhibition (dobj)
incidence % (nmod)
50 with (case)
hypotension anesthesia-induced (amod)
form sustained (amod)
1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine ) (punct)
difficult diagnose (xcomp)
airway mask (compound)
history hitt (nmod)
obtained females (nmod)
assessment patient (nmod:poss)
goal study (nmod)
patient any (det)
medications under (case)
hypotension elevation (conj)
hormone tsh (appos)
g/l water (nmod)
% whereas (mark)
population and (cc)
course factors (conj)
sertraline on (case)
coincident not (neg)
solution buffering (compound)
telaprevir as (cc)
remained adefovir (nsubj)
amlodipine related (amod)
accentuante to (mark)
recalling associations (dobj)
necrolysis toxic (amod)
noted quiet (nmod)
hypercholesterolaemia to (case)
drugs psycho-active (amod)
narcosis a (det)
content brain (compound)
measured matter (nmod)
drug selectivity (nmod)
assess efficacies (dobj)
volumetry overdosages (nmod)
> % (nmod)
received mg/day (nmod:tmod)
given drugs (nsubjpass)
use pethidine (nmod)
administered placed (advcl)
loss chemotherapy (nmod)
estimate compare (conj)
greater not (neg)
usefulness agonists (nmod)
end this (det)
higher number (nsubj)
retinochoroidopathy birdshot (compound)
configuration modes (conj)
behaviors animals (nmod)
pharmacokinetics efficacy (conj)
drugs clonidine-like (amod)
groups drug-free (amod)
provide we (nsubj)
vaccination of (case)
reabsorption tubular (amod)
role vip (nmod:poss)
changes weight (conj)
reduced reducing (advcl)
venomotor ( (punct)
identify hypoxia (dobj)
population recipients (nmod)
reported present (xcomp)
levels aldosterone (compound)
reviewed purpose (dep)
predictor significant (amod)
derives behavior (compound)
results demonstrated (appos)
treated flurbiprofen (nmod)
processed sections (nsubjpass)
dyscontrol behavioral (amod)
encephalopathy mice (nmod)
efficacy drug (nmod)
men either (cc:preconj)
responses pathologic (amod)
started udca (nmod)
homology of (case)
saline ph (appos)
transporter and (cc)
distinguish n (dep)
grafts days (appos)
mice on (case)
thromboembolism vte (appos)
slower found (conj)
recovered although (mark)
held . (punct)
dipyridamole hemodialysis (conj)
found terbutaline (nmod)
reduced increase (dobj)
facilitate bradycardia (dobj)
maintaining for (mark)
showed shifting (nmod)
diagnosis the (det)
= 0.008 (dep)
ingesting 2 (nsubj)
patient to (case)
ci 1.70 (nummod)
mouse i.c.v. (appos)
group second (amod)
effects quantified (acl)
treated dox (nmod)
aimed present (xcomp)
nelarabine arag (appos)
observed cimetidine (nmod)
discontinued prematurely (advmod)
model study (nmod)
level glycine (nmod)
increase up-regulate (conj)
database of (case)
animals bleeding (conj)
newborns 200 (nummod)
decreased mean (conj)
ovary of (case)
f344 ( (punct)
antagonized ; (punct)
limb of (case)
l-[3h]nicotine and (cc)
clearance accumulation (conj)
centre in (case)
helpful that (mark)
clonidine nervous (amod)
increases it (nsubj)
seemed differ (xcomp)
paralysis atracurium-related (amod)
phosphokinase concurrent (amod)
left ventricular (dep)
attention use (nmod)
deposition collagen (nmod)
artery iohexol (appos)
women allocated (acl)
investigate content (dobj)
included age (dobj)
effect concentration (conj)
2-sulfanylethanesulfonate mesna (appos)
orr ( (punct)
predictive increase (nsubj)
initiated decreased (advcl)
studied evaluation (nmod)
reactions haematological (amod)
pancuronium and (cc)
long-term c (dep)
produced mice (nmod)
300 1 (compound)
microinjections isoniazid (nmod)
inorganic exposure (nmod)
l +/- (cc)
went , (punct)
produced impairment (dobj)
subjects perturbated (amod)
aventyl . (punct)
sr metoprolol (conj)
released continuously (advmod)
determined frs (nsubj)
day schedule (nmod)
line the (det)
pre-administration systemic (amod)
consolidation users (nmod)
edaravone saline (conj)
obtained departments (nmod)
need discontinuation (nmod)
induced asa (nmod)
factor risk (compound)
function with (case)
days 2.0 (nummod)
possibility . (punct)
tremor cerebellar (amod)
part procedure (nmod)
risk vfds (nmod)
epilepsy experimental (amod)
beta-blocking antiarrhythmic (conj)
treatment neonatal (amod)
tended remained (conj)
mediated rise (nmod)
study e8188 (appos)
mild in (case)
given boy (nsubjpass)
consistent result (nsubj)
group pan (compound)
titrated days (nmod)
implicated 23 (nmod)
role blockade (nmod)
experienced sedation (dobj)
lower conclusion (nmod)
results induce (appos)
reduce seizures (dobj)
mpo-anca for (case)
tone smooth (amod)
action blocking (amod)
implies . (punct)
patients pair-matched (acl:relcl)
occasions 2 (nummod)
circulation with (case)
prophylaxis after (case)
pharmacodynamics and (cc)
proportion cells (nmod)
85 6 (conj)
hyperactivity time (dep)
edition fourth (amod)
mice two-week-old (amod)
recommended surgery (nmod)
justified not (neg)
shortening lv (compound)
injection rapid (amod)
necrosis any (conj)
33.8 5.2 (conj)
showed men (nsubj)
increased chick (nmod)
damage interstitial (amod)
effect noradrenaline-induced (amod)
followed use (dobj)
amount dose (nmod)
synthesis/release the (det)
subgroups certain (amod)
multicenter a (det)
decrease gls (nmod)
contained glomeruli (nmod)
7h6 for (case)
alterations mitochondrial (amod)
fa mg/m(2 (dep)
inf-mi ) (punct)
events stroke (conj)
effective an (det)
diet contained (acl:relcl)
cells of (case)
enhanced significantly (advmod)
rbcs the (det)
november 2005 (nummod)
blepharoconjunctivitis vision (appos)
na(+)/k(+)-atpase nbc1 (conj)
saline-treated in (case)
pcr-rflp ) (punct)
monitored using (xcomp)
decreased tachycardia (dobj)
higher cm (nmod)
fibrillation patients (nmod)
m.i.n.i. ) (punct)
died presented (advcl)
increase hematuria (conj)
gtn 0.5 (nummod)
d-glucose of (case)
infarction septicaemia (conj)
blood ammonia (conj)
effects dexamethasone (nmod)
system musculoskeletal (amod)
using antigen (dobj)
mediating process (dobj)
anticoagulant . (punct)
treated neonatally (advmod)
microgram/kg/min 63 (conj)
ifosfamide the (det)
medullo-adrenalectomy a (det)
upset experienced (amod)
influence diet (nmod)
bbb including (case)
expressed predominantly (advmod)
best probably (advmod)
emphasis characteristics (nmod)
person-years exposure (nmod)
thp with (case)
ttc ( (punct)
background handicapped (dep)
smelling even (advmod)
differences indices (nmod)
acid free (amod)
significance . (punct)
changes immunohistochemical (amod)
lamivudine-resistance with (case)
evokes hypotension (nsubj)
contributed effects (nmod)
4.2- 13-fold (dep)
heart hypertrophic (amod)
reduced number (nsubjpass)
pd in (case)
alert doses (nmod)
decrease degree (nmod)
implantation minipump (compound)
trauma to (case)
parameters potency (conj)
pathway via (case)
those caused (acl)
association effects (nmod)
shortened decreased (conj)
epilepsy from (case)
replaced dexamethasone (nmod)
combination fk506 (compound)
research treatment (conj)
potassium the (det)
insipidus hypothyroidism (conj)
163 treated (acl)
synapses schaeffer (compound)
potential effect (nmod)
administered gestation (nmod)
induced tumors (nsubjpass)
extension to (case)
increases mortality (dobj)
differs methylation (nmod)
24.8 5.0 (conj)
associated desogestrel (conj)
provide findings (nsubj)
result conclusions (nsubj)
association presence (nmod)
symptoms multiple (amod)
cocaine combination (nmod)
atp or (cc)
consumed att (dobj)
based and (cc)
animals among (case)
te ( (punct)
had withdrawn (xcomp)
788.5 duration (nsubj)
records card (compound)
effects antinociceptive (amod)
tolerance effect (conj)
% ci (nmod:npmod)
infarctions myocardial (amod)
areas diseased (amod)
one treatments (nmod)
have avoided (conj)
plays that (mark)
system brainstem (nmod)
unresponsive bradycardia (nmod)
considered until (mark)
given basis (nmod)
9-tetrahydrocannabinol thc (appos)
u/l 37 (nummod)
chf ii (compound)
intolerance pressure (dep)
selegiline l-dopa (conj)
females , (punct)
stratum ( (punct)
kindreds from (case)
examination and (cc)
subjected mice (nsubj)
atenolol the (det)
patients acetazolamide (nmod)
toxicity retinal (amod)
area preoptic (amod)
94 - (punct)
pathogens common (amod)
mean response (dobj)
inhibits pentoxifylline (nsubj)
disease history (appos)
had angina (dobj)
mg. acrolein (conj)
rate nci/min (nmod)
mg 80 (compound)
important untoward (dep)
inactivation and (cc)
release tachykinins (nmod)
exceeded medium (nmod)
d-glucarates among (case)
influence factors (nsubj)
used potentials (nsubjpass)
unchanged stage (nmod)
background by (case)
reduced acetaminophen (nmod)
examination mmse (appos)
remains problem (xcomp)
experienced receiving (advcl)
signed underwent (conj)
in situ (dep)
acid due (case)
stratified . (punct)
process by (case)
antagonist h3-receptor (amod)
pain low (amod)
reverse . (punct)
observed hypertension (nsubjpass)
prevented remodeling (dobj)
stress consumption (nmod)
immunosuppression local (amod)
glycopyrrolate % (compound)
affected however (advmod)
compared we (nsubj)
relapsed with (case)
lysate in (case)
blocked failure (dobj)
mm 130/85 (nummod)
corresponded qualitatively (advmod)
pretreatment microg/kg (nmod)
a csa (appos)
drugs clonidine (nmod)
randomized diet (nmod)
reproduced lysate (nmod)
thalidomide study (dep)
jaundice cholestatic (compound)
higher prepartum (conj)
concentrations target-free (amod)
methods undertaken (appos)
have wsr (nmod)
antipsychotics classical (amod)
consists primarily (advmod)
strikes syndrome (nsubj)
causing anemia (dobj)
remains , (punct)
60 and (cc)
ongoing . (punct)
tested differences (nsubjpass)
= 0.000 (dobj)
established was (auxpass)
interaction morphine (nmod)
spared they (nsubjpass)
extract berries (nmod)
impart frequency (dobj)
those regimens (nmod)
documented reaction (nsubjpass)
supports diagnosis (dobj)
receive selegiline (dobj)
hepatotoxicity series (dep)
escalated 175 (nmod)
risk septal (nmod)
treated years (nmod)
studies date (nmod)
thiopenthal sodium (compound)
discontinued treatment (dobj)
degradative fbal (nmod)
affected experienced (advcl)
emotions basic (amod)
produce initiate (xcomp)
cause metabolite (nmod)
mg.kg(-1).d(-1 10 (nummod)
results surveillance (nmod)
activity twitch (compound)
eight ( (punct)
factors may (aux)
tract the (det)
remained anesthetic (nsubj)
reduces losartan (nsubj)
dysfunction allograft (compound)
latency phencyclidine (compound)
subset patients (nmod)
iohexol of (case)
methylprednisolone and (cc)
group furosemide-treated (amod)
0.3 0 (compound)
hearing anaesthesia (nmod)
s.c. p<0.05 (appos)
rizatriptan for (case)
craniotomy to (mark)
dogs normal (amod)
dose-related be (cop)
history drop (nmod)
programs . (punct)
da1 ( (punct)
placed monitoring (nmod)
dystrophy duchenne (compound)
mediated activation (nmod)
range age (compound)
treated effects (nmod)
potential : (punct)
had fever (dobj)
moment at (case)
report dexatrim (appos)
daptomycin of (case)
glimepiride ) (punct)
adulthood during (case)
antinociception for (case)
results results (conj)
records mother-infant (amod)
knee the (det)
prescription unrestricted (amod)
inhibitor tight-binding (amod)
cephalothin ampicillin (nmod)
15/htn ) (punct)
effects depressive (amod)
counteracted inhibition (dobj)
% compared (advcl)
report treatment (nmod)
likely be (cop)
procedures cardiac (amod)
rash the (det)
produced hypotension (nsubjpass)
allow monitoring (dobj)
therapy c (nmod)
instability affective (amod)
troublesome and (cc)
reversed morphine (nmod)
mm 38.6 (nummod)
processes mainly (advmod)
diethylpropion of (case)
bupivacaine- rats (dep)
roots rosa (compound)
condition for (case)
cataracts for (case)
model deficient (amod)
pathogenesis . (punct)
neoplasms on (case)
compared day (nmod)
intensity symptoms (nmod)
interactions clinical (amod)
reduced dhea (nsubj)
inhibitors phenyl-2(5h)-furanon (compound)
clotiazepam between (case)
determinations electrolyte (compound)
765 ) (punct)
abuse risk (conj)
matched using (advcl)
interviews in (case)
ugt ( (punct)
immunosuppressants csa (dep)
stimulation : (punct)
influence promote (conj)
targeting tubule (nmod)
included desvenlafaxine (dobj)
ml/kg water (nmod)
40,000 30,000 (compound)
ci 1.1 (nummod)
characterize nature (dobj)
factor-alpha oxide (conj)
fraction level (conj)
donation apheresis (compound)
higher initiation (nmod)
women incontinence (nmod)
protecting seizures (dobj)
parkinson 's (case)
cisapride erythromycin (conj)
grip peak (compound)
induced response (dobj)
neurons snr (nmod)
drd2 between (case)
edema pulmonary (amod)
radioactivity of (case)
colliculus 6/8 (appos)
fractions obtained (acl)
vitro in (compound)
sites surgical (amod)
twitches rats (nmod)
responses brainstem (compound)
subtests four (nummod)
ranitidine by (case)
likely suffer (xcomp)
adjusted judiciously (advmod)
diagnosed having (aux)
severity swelling (nmod)
improved manner (nmod)
all one (conj)
socs-3 cis (conj)
addition effect (nmod)
patients infertility (compound)
similarities effects (nmod)
groups users (conj)
arrest and (cc)
group ketoprofen (compound)
dmtu ( (punct)
antibiotic . (punct)
received treatments (dobj)
groups effects (conj)
1mg/kg be (cop)
considered macroprolactinemia (nsubjpass)
performed dilation (nmod)
is there (expl)
models schizophrenia (nmod)
dissatisfaction noncompliance (conj)
measures flow (compound)
relaxations beta-adrenoceptor-mediated (amod)
rate 127/min (nummod)
anuria lasting (acl)
derivative , (punct)
mounting relates (ccomp)
non-significantly ) (punct)
influx given (case)
baseline at (case)
cld n=34 (appos)
serum urinary (conj)
groups present (amod)
content 1.8 (nmod)
factors such (amod)
patient for (case)
time respond (acl:relcl)
reduces pb (nsubj)
relapses extra-medullary (amod)
circuit the (det)
injury infusion (appos)
increase consumption (nmod)
different monotherapy (nmod)
sought address (xcomp)
linked excitability (nmod)
recovers myopathy (amod)
history earlier (advmod)
patients all (nummod)
mechanism critical (amod)
tested catalepsy (nsubjpass)
coincided . (punct)
hydroureteronephrosis preexisting (amod)
patients normoalbuminuria (conj)
presenting a (det)
defined still (advmod)
rescues . (punct)
site catheter (compound)
500 mg/kg (dep)
adr(6 ) (punct)
treatment bmcs (nmod)
enantiomer ( (punct)
amphetamine by (case)
hypertensive lnna (compound)
compound related (amod)
treatment under (case)
followup prolonged (amod)
nk1 and (cc)
exceeded count (nsubj)
cancer diagnosed (acl)
averaged echocardiography (conj)
operations various (amod)
monotherapy add-on (conj)
reversal gradient (nmod)
history accurate (amod)
total mice (nmod)
features cholestasis (nmod)
use methods (nmod)
cirazoline the (det)
affect fall (dobj)
increased ratio (nsubjpass)
biopsy was (cop)
exacerbates patients (nmod)
shown increase (dobj)
infusing starting (advcl)
function models (nmod)
response passive (amod)
weight g (compound)
return baseline (nmod)
acid as (case)
demand myocardial (amod)
syndrome aminonucleoside (compound)
schumacher 's (case)
rates long-term (amod)
latency behavior (conj)
determine associations (dobj)
pathophysiology lids (nmod)
antidepressants studied (acl)
glycol ( (punct)
modify alter (conj)
responded patients (nmod)
autonomic motor (conj)
activity cyp2d6 (compound)
serious , (punct)
some genes (nmod)
increase concentrations (nmod)
had inhibition (nsubj)
receiving medication (dobj)
induce glomerulonephritis (dobj)
breaks ) (punct)
markers as (case)
administered adult (xcomp)
umb24 and (cc)
block related (amod)
equipotent almost (advmod)
deficit because (case)
puncture the (det)
gemcitabine receive (acl:relcl)
woman young (amod)
d-ribose myocardiopathy (nmod)
1994 uganda (conj)
anotia and (cc)
leukemia l1210 (amod)
nystagmus nin (appos)
clearance levels (nmod)
met had (conj)
familiar to (mark)
increases neurotransmission (dobj)
protocols on (case)
trials well-designed (amod)
analysis updated (amod)
agonist administered (amod)
fever argentine (amod)
caused necrosis (dobj)
gamma-aminobutyric acid(a (dep)
abnormalities his (nmod:poss)
intoxication cocaine (compound)
homogenates f344 (compound)
showed reduction (dobj)
transporter net (appos)
mean reduced (conj)
session a (det)
diffusion . (punct)
thalidomide regimens (nmod)
those take (acl:relcl)
outcomes adverse (amod)
defects of (case)
observations sequential (amod)
experienced before (mark)
emergency hypercalcemic (amod)
gtcs ( (punct)
sacrificed period (nmod)
complication myocarditis (nsubj)
prevents metformin (nsubj)
cause common (amod)
consequence methotrexate (compound)
events % (appos)
administration use (conj)
transfer the (det)
collection before (case)
dysphagia any (conj)
mustard an (det)
p .0001 (dep)
triad hypercalcemia (nmod)
absence hypotension (nmod)
hemodialysis high-flux (amod)
caused ( (punct)
analyzed method (nmod)
dates search (compound)
regressed and (cc)
time from (case)
association direct (amod)
images spin (compound)
enzymes parameters (conj)
treatment ethambutol (compound)
ulcers . (punct)
improving of (mark)
deviation segment (compound)
hospitalisation of (case)
patients 80 (nummod)
appear acid (nsubj)
induce production (nmod)
reported time (nmod)
experiments requires (ccomp)
hypertension hemorrhage (conj)
most cases (nmod)
visits patient (compound)
revealed consciousness (dobj)
pre-treatment mice (nmod)
angiography on (case)
background derivative (appos)
injection hypaque (nmod)
studies 0.5 (conj)
tumor cyclophosphamide (compound)
outpatients stable (amod)
induction relapse (nmod)
63 and (cc)
adequate be (cop)
caused crystals (nmod)
hypothesized reduces (ccomp)
patients thirty (nummod)
pcag ) (punct)
suppressed appearance (dobj)
complexes oxidative (amod)
treatment anhydrase (compound)
males disorder (appos)
offers inactivating (advcl)
(+)-isomer its (nmod:poss)
networks congruent (amod)
aminonucleoside with (case)
discussed light (nmod)
day during (case)
aged or (cc)
taking which (dobj)
dehydrogenase and (cc)
investigated examined (conj)
hypothesized thus (advmod)
five only (advmod)
risk ich (nmod)
therapy intravenous (amod)
urea with (case)
increased g (dobj)
stroke population (nmod)
extract virgaurea (compound)
levels pretreatment (compound)
15 least (nmod:npmod)
hypoplasia epiphyses (conj)
css10 css18 (conj)
dose and (cc)
acid- n-methyl-d-aspartate (conj)
injected cocaine (nmod)
sulfasalazine arthritis (nmod)
syndrome propylthiouracil-associated (amod)
abc ( (punct)
2-mercaptoethane sodium (compound)
identical . (punct)
done possible (advcl)
affect concentrations (dobj)
degree performance (nmod)
% the (det)
lower however (advmod)
lindane mg/kg (appos)
proteinuria high-grade (amod)
cultured monolayers (nmod)
220 0 (compound)
obviate to (mark)
role p-aminophenol (nmod)
echocardiography second (amod)
ingesting doses (dobj)
kg 19.7 (nummod)
test this (det)
october 1993 (nummod)
ability concentrating (amod)
hours x (compound)
patients lymphomas (nmod)
cases anemia (nmod)
consequence than (case)
interfered which (nsubj)
exercise including (case)
drowsiness and (cc)
participants cocaine (conj)
passed found (conj)
hypertension depression (conj)
chloramphenicol by (case)
screened respect (nmod)
female between (case)
event index (compound)
were results (dep)
14.1 2.3 (compound)
p=0.026 ( (punct)
bicarbonate sodium (compound)
aggregations human (amod)
receptor d2l (compound)
surface the (det)
immunoassay available (amod)
responses contractile (amod)
daily mg/kg (compound)
treatment dermatoses (nmod)
include symptoms (nsubj)
colorectal , (punct)
cases incident (amod)
therapy temsirolimus (compound)
patients controls (conj)
physiologic and (cc)
exist presumably (advmod)
drugs benzodiazepines (appos)
insufficiency respiratory (amod)
reversal rats (nmod)
pethidine both (cc:preconj)
from september (nmod)
gemcitabine . (punct)
thrombosis stent (amod)
association commencement (nmod)
ropivacaine of (case)
potentiated antagonists (nmod)
similar model (nmod)
ikr alone (advmod)
days exposure (compound)
15.5 4.3 (dep)
support conducting (acl)
beneficial control (nmod)
replication virus (compound)
radiotherapy pelvic (amod)
doses metoprolol (nmod)
use between (case)
months difluoromethylornithine (nmod)
associated od (nsubjpass)
action response (nmod)
15/hypertension 15/htn (appos)
terbutaline , (punct)
obtained drug (nmod)
dmcm ) (punct)
cancers human (amod)
cysts detectable (acl:relcl)
loss % (compound)
prevention stroke (compound)
hyperhidrosis focal (amod)
a(1)/a(2a ( (punct)
used tomography (nsubjpass)
useful controlling (advcl)
infection in (case)
hypertrophy the (det)
shown activated (ccomp)
involvement cholinergic (amod)
encephalopathy immunization-induced (amod)
extremity involved (amod)
obtained isoproterenol (nmod)
progression nephropathy (nmod)
properties the (det)
i(f ) (punct)
h 24 (compound)
two last (amod)
had to (mark)
permeability on (case)
think trigger (ccomp)
bilateral severe (conj)
contributed 24 (nmod)
63 18 (conj)
indexes domain (compound)
sedation dexmedetomidine (amod)
5.3 3 (compound)
distributed , (punct)
given curve (nmod)
administration chloramphenicol (nmod)
introduction following (case)
study kidney (nmod)
lnna inhibitor (compound)
sulphoxide of (case)
event toxicity (nmod)
applied induced (conj)
analysis association (nmod)
fibrosis significant (amod)
training physical (amod)
sludge bile (compound)
effect ritanserin (nmod)
class compounds (nmod)
lesions to (case)
carbetocin 200 (nummod)
54.5 9.9 (conj)
schedule ifosfamide (nmod)
score adverse (amod)
scale seizure (amod)
regimen tfl (nsubj)
duration diabetes (nmod)
conclude . (punct)
iu/kg 1000 (nummod)
polymerase poly(adp-ribose (nummod)
sm ; (punct)
evaluated subjects (nsubjpass)
injected had (aux)
development associated (acl)
tested task (nmod)
remained fed (conj)
ethanol mice (nmod)
case dysphonia (nmod)
denominator thrombosis (nmod)
picrotoxin- not (neg)
groups 2 (dep)
pituitaries norway (compound)
age-dependent association (nsubj)
primary 59 (conj)
woman-years 10,000 (nummod)
need assess (xcomp)
infarction non-st-elevation (amod)
nephropathy ifosfamide (compound)
specificity sulphate (compound)
capable thus (advmod)
obtain data (dobj)
oral parenteral (conj)
represent hyperplasia (conj)
vasculitis propylthiouracil (compound)
causes to (case)
management , (punct)
catheterization transfemoral (amod)
discontinued temporarily (advmod)
intravenous iv (dep)
aspirin to (case)
neck abdomen (conj)
mean years (dobj)
amyloidosis undergoing (acl)
crude incidences (conj)
humphrey - (punct)
permitted escalation (nsubjpass)
lips the (det)
uncertain diagnosis (nsubj)
accompanied expression (advcl)
inhibitor ssr103800 (appos)
agreement no (det)
associated adjustment (nmod)
models pain (nmod)
distributions models (nmod)
unclear it (nsubj)
atorva ( (punct)
density neurons (nmod)
found hospital (nmod)
% measures (appos)
manifested dyskinesia (dobj)
-54 +/- (cc)
reported trials (nmod)
incidents bradycardia (nmod)
distinguished . (punct)
chc ) (punct)
volunteers in (case)
deviation ) (punct)
responsiveness and (cc)
attributable , (punct)
contents maximal (amod)
1.56 risks (nsubj)
d of (case)
material intravenous (amod)
study control (compound)
osteoarthritis arthritis (conj)
include usage (dobj)
increased periods (nsubj)
produced tolerance (dobj)
damage minor (amod)
evaluated damage (nsubjpass)
receptor localized (amod)
rats injury (nmod)
enhanced effect (dobj)
tests attention (compound)
supposed . (punct)
sum elevations (nmod)
option acidification (nsubj)
length scl (appos)
reduces reduces (advcl)
conversion after (case)
timeframe the (det)
rhizomes roots (conj)
doses of (case)
trial cycle (nmod)
treat nsclc (dobj)
intolerance due (case)
observed 0.006 (parataxis)
model reproducible (amod)
recall level (nmod)
administration psoriasis (nmod)
receiving heparin (dobj)
dysfunction prednisolone-induced (amod)
factors confounding (amod)
search a (det)
group knife (compound)
cyclophosphamide thiotepa (conj)
prc to (case)
substrate of (case)
prolonged imparts (nsubj)
allowed line (parataxis)
inhibitor cox-2 (compound)
blood ; (punct)
settings in (case)
examining microscopically (advmod)
pressures measures (conj)
reports infarction (nmod)
time delivery (nmod)
formation of (case)
concentration model (nmod)
received vehicles (dobj)
duration response (nmod)
sustained developed (conj)
levels mumol/l (nmod)
levels tissue (compound)
tested model (nmod)
changes weakness (conj)
cocaine recreational (amod)
dp/dtejc brachial (amod)
study crossover (compound)
8 % (appos)
mice conscious (amod)
diameter their (nmod:poss)
cause complications (dobj)
gene prothrombin (compound)
challenge paracetamol (nmod)
minutes t60 (appos)
peaked peaked (conj)
subscale psychopathology (compound)
period follow-up (compound)
infusions solution (nmod)
incriminated , (punct)
investigation a (det)
wall edema (nmod)
l/kg ( (punct)
abusers cocaine (compound)
proven angiographically (advmod)
g/m2 2 (nummod)
combinations ketamine-dominant (amod)
manner receptor-dependent (amod)
effect sulphonate (cc)
toxicities ( (punct)
associated clozapine (nmod)
baseline mmhg (conj)
site measurements (nmod)
reactions induced (acl)
identify quantify (conj)
failed note (nmod)
context therapy (nmod)
bicuculline acid (conj)
ulcerous non-ulcerous (conj)
started methods (dep)
hyperkalemia induced (acl)
emulsions with (case)
necrosis formation (nsubj)
c mmc (appos)
mononucleate from (case)
antagonist a2a/a1 (compound)
sgot dehydrogenase (conj)
time treatments (nmod)
exanthema urtication (conj)
l-med d-med (dep)
maintained diet (nmod)
81.5 ci (dep)
microinjected area (nmod)
compared ecgs (nmod)
monotherapy than (case)
rat each (det)
omeprazole with (case)
acid- kainic (amod)
infused when (advmod)
efficacy for (case)
uganda north (compound)
burns with (case)
development convulsions (nmod)
immersed was (auxpass)
gbm ) (punct)
unmask hypothesis (dep)
describe : (punct)
severity symptom (compound)
combination injected (acl)
wds ) (punct)
explanation hiccups (nmod)
role their (nmod:poss)
glaucoma with (case)
endpoint this (det)
measures morbidity (nmod)
preservation homeostasis (nmod)
alf and (cc)
week 3 (nummod)
sought compared (conj)
minutes ten (nummod)
dependent estradiol (nmod)
gain confirms (advcl)
selective . (punct)
prazosin alpha(2 (conj)
episodes stroke-like (amod)
effects reserpine (nmod)
infection viral (amod)
administration due (case)
flow to (mark)
degeneration muscles (nmod)
decreased are (auxpass)
role protection (nmod)
fpdc . (punct)
thought linked (xcomp)
thrombosis embolism (conj)
system toxicity (conj)
monitoring . (punct)
57 % (appos)
document results (nsubj)
levels increased (amod)
patients several (amod)
day ten (compound)
effects : (punct)
5.4 +/- (cc)
rats p<0.05 (appos)
restores . (punct)
vessels medium-size (amod)
protection mitochondria (compound)
states the (det)
antibodies ( (punct)
concentrations [na]o (dep)
baseline 10 (conj)
administration glucocorticoids (nmod)
cin ( (punct)
interest particular (amod)
purpose presented (dep)
ceased , (punct)
establish undoubtedly (advmod)
indicated ameliorates (ccomp)
affecting directly (advmod)
slope depolarization (nmod)
cases marrow (conj)
unchanged relatively (advmod)
exhibited were (auxpass)
had patients (dobj)
had loss (nsubj)
loss , (punct)
androgens exogenous (amod)
used industry (nmod)
abnormalities persistent (amod)
ctnt diameters/bw (conj)
castrated of (case)
studied evaluated (conj)
changes , (punct)
injury adriamycin-induced (amod)
revealed also (advmod)
increased 0.001 (parataxis)
microg/kg/min 5 (nummod)
suggest similarity (dobj)
pressure both (nmod)
rate and/or (cc)
undergoing correlate (conj)
incidence at (case)
resistant completely (advmod)
diarrhoea . (punct)
viramidine prodrug (appos)
hbv of (case)
emergence widespread (amod)
finished trial (dobj)
at below (conj)
cycles seven (nummod)
increase -0.22 (nmod)
ability strong (amod)
resulted surprisingly (advmod)
demonstrated contributes (ccomp)
butyrylcholinesterase patient (amod)
associated and (cc)
vehicle glycol (dep)
had presentations (dobj)
replacement dipyridamole (conj)
insulin-dependent ( (punct)
organs blocked (acl:relcl)
stimulates exposure (nsubj)
evaluation cardiac (amod)
regimen dosing (compound)
amounts ( (punct)
cancer gastric (amod)
assess treatment (nmod)
inhibitor hormone (compound)
waves baep (compound)
electroshock the (det)
anthracycline antitumor (compound)
2.5 10 (conj)
introduction of (case)
enhance whereas (mark)
words other (amod)
strategy an (det)
produce hyperprolactinemia (dobj)
happiness , (punct)
linked disorders (nsubjpass)
intake calcium (compound)
subset for (case)
base ventricular (compound)
expression hippocampus (nmod)
manner in (case)
concentration reported (acl)
= 0.0001 (dobj)
changed slices (nmod)
increase from (case)
days mwm (nmod)
evaluation sediment (nmod)
properties chelating (compound)
days hours (nmod)
proceed not (neg)
plan that (mark)
comparable or (cc)
timing reduction (nmod)
evaluate explore (conj)
41 in (case)
linked rhabdomyolysis (xcomp)
users with (case)
haplotypes constituted (acl)
caused increases (dobj)
triggered tacrolimus (nmod)
escalated paclitaxel (nsubjpass)
observed reactions (nsubjpass)
temperature on (case)
population whole (amod)
15 after (advmod)
shown was (auxpass)
hyperkinesis with (case)
reveal to (mark)
derivative anthracycline (compound)
taken intervals (nmod)
bdl ) (punct)
1.84 +/- (cc)
terms time (nmod)
route administration (nmod)
limb affected (amod)
adducts 3-nitrotyrosine (conj)
preserved that (mark)
failure overdose (nmod)
administrated intraperitoneally (advmod)
weight alterations (conj)
cotransporter tsc (appos)
increase pathological (amod)
remained % (nsubj)
disease caused (acl)
failure count (nmod)
% reductions (conj)
associated fluids (nmod)
recorded abnormalities (nsubjpass)
nightmare . (punct)
use ) (punct)
infants mg/kg/day (conj)
comparable patients (nsubj)
volume contrast (compound)
children other (amod)
admitted receive (conj)
tool diagnosis (nmod)
imaging to (case)
micrograms/ml mean (dep)
shifts alternations (nsubj)
globulin antilymphocyte (compound)
median status (acl:relcl)
unable discontinue (xcomp)
injection dose (dep)
class and (cc)
shown addition (nmod)
reduction % (compound)
study infusions (dobj)
revealed lack (dobj)
schedule according (case)
case aneurysm (nmod)
transported which (nsubjpass)
formation crosslink (compound)
describe case (dobj)
levels ck (compound)
number because (case)
diffuse or (cc)
action nonspecific (amod)
advised is (auxpass)
specimen pathology (compound)
preserved are (auxpass)
had d-glucarates (nsubj)
seems b (nsubj)
compared efficacy (dobj)
questionnaires mailed (amod)
given lidocaine (nsubjpass)
had concentration (dobj)
clearance bcnu (nmod)
sensitive to (mark)
preserved synapses (nmod)
besylate nmba (dobj)
coupling of (case)
evidence results (nmod)
managed continuing (advcl)
blocked pretreatment (nsubj)
7- ( (punct)
use month (dep)
pathways mediate (acl:relcl)
= .05 (dep)
substances recreational (amod)
case edema (nmod)
factors stress (nsubj)
intensities locations (conj)
intoxications in (case)
doses inhibitors (conj)
appeared fatal (conj)
evidence autoradiographic (amod)
smoking , (punct)
addition succinylcholine (nmod)
reduction in (case)
used define (xcomp)
imply this (nsubj)
candidiasis or (cc)
showed gamma-carboxylated (ccomp)
showed cycles (nmod)
life minutes (nmod)
injection mk-801 (compound)
responded subsequently (advmod)
calcium intravenous (amod)
process only (advmod)
failure human (amod)
eosinophil of (case)
use beta-blockers (nmod)
decrease which (nsubj)
metals other (amod)
animals ko (compound)
prevented resistance (nmod)
affect function (dobj)
rats phase (nmod)
mg/m(2 1,000 (nummod)
mg/kg ed50 (compound)
mm 88.1 (nummod)
safety hydrochlorothiazide (nmod)
analyzed synthesis (nsubjpass)
injection bilateral (amod)
evaluated combination (nmod)
disease adynamic (amod)
arf gentamicin-induced (amod)
antibiotics to (case)
mmrm with (case)
mg dose (compound)
complicating chemotherapy (dobj)
protein , (punct)
bp dbp (appos)
episodes three (nummod)
progesterone of (case)
p.m. and (cc)
preventing recurrence (dobj)
rats infant (amod)
became challenge (nmod)
relations of (case)
drug , (punct)
self-reported , (punct)
unrelated mortality (nmod)
reported indomethacin (nsubjpass)
one complications (nmod)
wt mice (conj)
objective analyze (acl)
cause diuretics (nsubj)
0 - (punct)
filters patients (appos)
postulate we (nsubj)
blockade with (case)
upregulation no (det)
made comparisons (nsubjpass)
treated epirubicin (nmod)
follow but (cc)
cddp ) (punct)
antagonists as (case)
lesion sn (compound)
chelation to (case)
design study (compound)
correlated features (nsubjpass)
chlorpropamide diabenese (appos)
acc-9653 and (cc)
advantage administration (nmod)
tool as (case)
factor-beta1 growth (compound)
correlate closely (advmod)
intranasal intravenous (conj)
hemianopia bitemporal (amod)
d3 with (case)
experiment was (cop)
mg/kg 0.31 (nummod)
inducing far (advmod)
rats lead-exposed (amod)
given yohimbine (dobj)
related were (auxpass)
syndrome during (case)
morphine intravenous (amod)
task clinical (amod)
reported improve (xcomp)
rats tr(- (compound)
mitoxantrone with (case)
conversion for (case)
rise a (det)
disease bowel (compound)
limbs lower (amod)
taking vgb (dobj)
ng/mg ( (punct)
ctc-nci 33.3/9.1/6.1 (conj)
used index (nsubjpass)
concentration vs. (cc)
hypotension however (advmod)
rats 7 (nmod)
lacn ) (punct)
disturbances for (case)
patient receiving (acl)
da norepinephrine (conj)
hemorrhage cerebral (amod)
exposure report (dep)
potent values (dep)
clozapine that (det)
hypercalcaemia acute (amod)
documentation sah (nmod)
factor not (neg)
characteristics in (case)
subjected test (nmod)
studied influence (nsubjpass)
presentation pathogenesis (conj)
continue study (nsubj)
investigate effect (dobj)
compared when (advmod)
had accumulation (dobj)
results switched (dep)
auditory tactile (conj)
bpd ( (punct)
product to (case)
using oct (dobj)
treated likewise (advmod)
ds-sarcoma ) (punct)
alternating deprivation (dobj)
literature urologic (amod)
hypertrophy degeneration (conj)
continued receiving (xcomp)
seemed rc (nsubj)
point normality (nmod)
test swim (amod)
mutations resistance (compound)
assay hemoglobin (compound)
higher p (dep)
possible or (cc)
obtain therapy (nsubj)
increasing only (cc:preconj)
10 3 (compound)
physicians internists (conj)
ptx ( (punct)
remains controversial (xcomp)
november 30 (nummod)
recovery a (det)
center tertiary (amod)
vigabatrin antiepileptic (amod)
using induction (nmod)
total of (case)
defects structural (amod)
patients 27 (nummod)
medium hit (nmod)
areas exposed (acl)
drug stream (nmod)
equivalent levodopa (compound)
rare cin (nsubj)
bundle neuropathies (nmod)
dutp terminal (amod)
25.7 - (punct)
evidence diagnosis (nmod)
prerequisite may (aux)
was patient (nsubj)
suspect ifosfamide (advcl)
cocaethylene may (aux)
rate hyponatremia (nmod)
sops to (case)
elicited seizures (nsubjpass)
attack acute (amod)
son male (nmod)
mri by (case)
produce to (mark)
ratios the (det)
degree preference (nmod)
sections kidney (compound)
diagnosed is (auxpass)
associated agranulocytosis (dobj)
regard with (case)
rats submitted (acl)
cpr ( (punct)
activity superoxide (compound)
found rarely (advmod)
hla-b35 antigens (conj)
recognized reported (conj)
provoked doxorubicin (nmod)
containing progestagens (dobj)
patients 459 (nummod)
one of (case)
decreased shr (nmod)
manipulation ocular (amod)
actions models (nmod)
neurotoxicity nelarabine (amod)
developed months (nmod)
amounted concentrations (nsubj)
lidocaine- seizures (dep)
vincristine and (cc)
mg interval (dep)
treat diarrheas (dobj)
achieve effects (dobj)
reinitiated patient (nsubjpass)
message take (compound)
use anticonvulsants (nmod)
transaminase glutamate-pyruvate (amod)
resolved abnormalities (nsubj)
delays the (det)
cortex rats (nmod)
treated presence (nmod)
2.85 - (punct)
used hydrobromide (nsubjpass)
activity sinoatrial (nmod)
new was (cop)
group comprising (acl)
available inhibitors (nsubj)
have system (dobj)
1.7 0.9 (nummod)
response cr (nmod)
had others (nsubj)
similar changes (nsubj)
minimal ( (punct)
mice 3delta (dep)
hoe both (cc:preconj)
evidence regulation (nmod)
groups ethnic (amod)
inducing concentrations (nmod)
levels based (case)
confirmed angiography (nmod)
type one (nsubj)
124.4+/-73.4 and (cc)
points different (amod)
have role (dobj)
relation dose-response (amod)
leading cystitis (nmod)
exposed before (mark)
mitigated also (advmod)
valproate antiepileptic (amod)
rats lesions (nmod)
g/dl 2 (nummod)
genotype to (case)
abnormalities dyskinesia (conj)
manifest to (mark)
effects angiographic (amod)
three psa (nmod)
correct and (cc)
diminished methamphetamine (dobj)
synthesis agents (nmod)
inferred be (auxpass)
axis users (nmod)
% subgroup (nmod)
injected h (nmod)
piloerection extremities (conj)
treated verapamil (nmod)
down-regulation net (nmod)
nephropathy potential (nsubj)
less incidence (nsubj)
result toxicity (nmod)
evident relationship (nsubj)
origin characterized (conj)
effect stronger (amod)
countries many (amod)
dosed daily (advmod)
capacity this (det)
report this (det)
reduced 17beta-estradiol (nsubj)
seen children (nmod)
level also (advmod)
induction dysfunction (nmod)
inhibitor beta-hydroxylase (compound)
titrated remained (conj)
improves aniracetam (nsubj)
alternation test (nmod)
rated means (nmod)
dermatitis atopic (amod)
depletion potassium (compound)
recognise and (cc)
medicine protective (amod)
importance the (det)
detection activity (nmod)
showed elevation (nmod)
received lidocaine (dobj)
conversion tacrolimus (nmod)
lhrh-a ) (punct)
microliter 1 (nummod)
receptor is (cop)
pretreatment ketanserin (compound)
hypertension moderate (amod)
plate hot (amod)
fibrillation for (case)
arrhythmia and (cc)
receptor neurotrophic (amod)
effects toxic (amod)
mmhg ; (punct)
demonstrated period (nmod)
machinery matrix (conj)
methylprednisolone intravenous (amod)
period hrp (appos)
learning succimer (compound)
satisfactory , (punct)
rofecoxib diclofenac (conj)
effect tone (nmod)
cacl(2 ) (punct)
transport 868 (dep)
4-hourly 8-hourly (conj)
was stenosis (attr)
cause telithromycin (nsubj)
exposure utero (nmod)
ppa , (punct)
consisted dose (nmod)
residues protein (nmod)
assessed task (nsubjpass)
solid with (case)
dogs experimental (amod)
components these (det)
min was (cop)
les or (cc)
pathogen(s of (case)
becomes responsive (xcomp)
study for (case)
myeloma and (cc)
action in (case)
survived failure (dobj)
monkeys 10 (nummod)
node both (cc:preconj)
thrombosis artery (nmod)
courses excretion (nmod)
is report (attr)
defined ascites (conj)
treated naloxone (nmod)
inhibition maximum (compound)
sparing with (case)
amyloidosis with (case)
control inflammation (dobj)
suggest estimates (nsubj)
trigger seizure (ccomp)
alone % (nmod)
days day (nmod)
involvement no (neg)
sodium unfractionated (amod)
hypertrophy greater (amod)
dose estrogen (nmod)
had deterioration (dobj)
effects apomorphine (nmod)
complained feet (nmod)
sex either (cc:preconj)
malfunctioning due (case)
associated discharges (nmod)
penetrating of (mark)
apnea with (case)
changes complex (amod)
analysis bche (nmod)
14.9 0.17 (conj)
showed restored (ccomp)
taking disulfiram (dobj)
central as (case)
unknown mechanisms (nsubj)
antagonists hypotension (conj)
ed1 marker (appos)
activation caspase (compound)
history her (nmod:poss)
activator tpa (appos)
choice drugs (nsubj)
design safety (dep)
had bacteremias (dobj)
pg/ml ) (punct)
and . (punct)
sensitivity cycle (nmod)
infections soft (amod)
treatment receptor (compound)
spectrum injury (nmod)
received volunteers (nsubj)
association ( (punct)
% 3.7 (nummod)
ethopropazine in (case)
yields tumours (nmod)
diphosphanilate topical (amod)
paclitaxel 185 (punct)
studied clarify (advcl)
name under (case)
odds with (case)
exhorted are (auxpass)
included not (neg)
vpa saline (conj)
scored verbal (dobj)
developing rash (dobj)
iopamidol iodixanol (conj)
arthritis calcium (conj)
regrowth a (det)
voltammetry cyclic (amod)
died disease (nmod)
challenges corticosteroids (nmod)
instances administration (conj)
atra ) (punct)
saw minutes (nmod)
monitoring hematest (nmod)
voltammetry fast (amod)
institution single (amod)
importance signaling (nmod)
minutes 25.6 (nummod)
one : (punct)
associated results (dep)
imbalance or (cc)
tablets with (case)
octogenarians to (case)
cases coma (nmod)
mg/kg lidocaine (nmod)
survey a (det)
cases delivery (nmod)
rate and (cc)
background supplement (appos)
respects in (case)
commissure-commissure septal-lateral (conj)
kinase mitochondrial (amod)
effects bradycardic (amod)
e13.5 ( (punct)
15.5 vs (cc)
metabolite its (nmod:poss)
recovery alterations (nmod)
illness familial (amod)
successful conducted (conj)
mineralocorticoid and (cc)
reshape addressing (advcl)
framework a (det)
rats unanesthetized (amod)
warfarin to (case)
impairments such (amod)
july 2001 (conj)
antinociception and (cc)
nausea were (cop)
had sinensis (nsubj)
infusion 4-day (amod)
16;567 degrees (dep)
renal function (conj)
be ) (punct)
treatment low (amod)
responses probing (amod)
those b (nmod)
crf n=41 (conj)
developed fibrosis (nsubj)
segment pallidus (nmod)
model statistical (amod)
glutamate gaba (conj)
ms 84+/-3 (nummod)
minutes before (nmod)
cnsb002 mg/kg (compound)
conclusions manifestation (dep)
predict could (aux)
had glomeruli (nsubj)
moving while (mark)
seen evidence (nsubjpass)
collection to (case)
patients most (amod)
octreotide with (case)
dose critical (amod)
backgrounds patients (nmod)
pac ( (punct)
administration inhibited (acl:relcl)
reaction ) (punct)
absence antagonists (nmod)
growth retarded (amod)
methods results (conj)
developed block (dobj)
preceded be (auxpass)
1 0.1 (compound)
controls substances (nmod)
cerebella the (det)
months underwent (acl:relcl)
1.4 3.6 (conj)
cont./min ; (punct)
light-enhanced not (neg)
increased intervals (nmod)
onset thromboembolism (nmod)
tumors and (cc)
model cmax/mic (conj)
cholinesterase human (amod)
infarction of (case)
caused can (aux)
animals followed (acl)
interviewed collected (conj)
induced line (nmod)
administered min (dobj)
megakaryocytes with (case)
assessed mri (nmod)
tolerate can (aux)
compared pairs (nsubjpass)
conclusions relevance (conj)
diuretics arrhythmias (conj)
metrics ) (punct)
rats received (acl:relcl)
l-noarg 7-ni (conj)
practices recommended (amod)
indicate synthesize (ccomp)
schema : (punct)
examine studies (nsubj)
mg.kg-1 0.03 (nummod)
effects cocaine (nmod:poss)
upslope and (cc)
postulates author (nsubj)
inhibitors ( (punct)
supports contention (dobj)
male identical (conj)
drinking self-reported (amod)
change fatty (amod)
243 % (appos)
thickness in (case)
adducts protein (compound)
been reports (attr)
mg at (case)
sheath , (punct)
suppressing channels (dobj)
postulate authors (nsubj)
regimen by (case)
normal patient (conj)
forces dyskinesias (conj)
modulation receptors (nmod)
used neurosurgery (nmod)
min-1 of (case)
performed end (nmod)
changed whether (mark)
occur seizures (nmod)
concentration triglyceride (nmod)
became confused (acomp)
neurosteroids the (det)
increased correlation (nmod)
reported groups (nmod)
exceeds hemorrhage (compound)
sensorium and (cc)
increased antinociception (nsubjpass)
received case (dep)
participating subject (nsubj)
benzodiazepines or (cc)
brigham and (cc)
development during (case)
diazepam mg/kg (dep)
diagnosis bipolar (appos)
113 119 (conj)
month years (nmod)
vnb ) (punct)
amounts % (appos)
seizure measured (acl)
patients spinal (amod)
capacity dopamine-antagonistic (amod)
drop a (det)
trated bromperidol (nmod)
dose cd50 (compound)
% 55 (nummod)
filled who (nsubj)
protocols both (det)
mitoq , (punct)
worsen that (mark)
3.49 . (punct)
coherence secondary (amod)
dyes with (case)
provide : (punct)
follow changes (dobj)
estradiol- testosterone (conj)
failure % (nmod)
lesion unilateral (amod)
assessed fraction (dobj)
aneurysms ruptured (amod)
had surgery (dobj)
support mitigates (conj)
hypophosphatemia glycosuria (conj)
remains basis (nsubj)
retrieved . (punct)
suggestion levels (nmod)
antagonist nmda (compound)
subunits the (det)
stimulus in (case)
effects fenoldopam (nmod)
alf non-acetaminophen-induced (amod)
required patients (nsubj)
variable samples (nmod)
w-ich ) (punct)
response least (advmod)
fibrillation and (cc)
complications no (det)
sec cisapride (conj)
ro4368554 mg/kg (appos)
treatment a (det)
approach shelf (dobj)
opening due (case)
herbicides and (cc)
age weight (dep)
l-alpha-gfc ) (punct)
cefonicid 500 (nummod)
carriers who (nsubj)
arabinoside it-cytosine (compound)
male a (det)
suggest cardiotoxin (ccomp)
record the (det)
angiographies . (punct)
reuptake noradrenaline (nmod)
incorporation stores (nmod)
promoting by (mark)
brain in (case)
percent , (punct)
4.10 users (nmod)
difficulty getting (advcl)
drugs antithrombotic (amod)
0.3 , (punct)
seen hours (nmod)
short one (conj)
cells mesangial (amod)
group non-mi (amod)
tumor ovary (nmod)
supplementation with (case)
paraparesis after (case)
slope 4 (nummod)
44 to (quantmod)
reduced dosage (nsubjpass)
data dependency (nmod)
adaptation dark (amod)
responses for (case)
membrane-cytoskeleton of (case)
degree abnormally (advmod)
age week (nmod)
years 11 (nummod)
reversed changes (dobj)
65 and (cc)
perfusion to (case)
call attention (nmod)
l-noarg l-nil (conj)
objective test (dep)
reactivation , (punct)
demonstrated nrf2 (nsubjpass)
immunization of (case)
outcome in (case)
lithium by (case)
mg 10 (nummod)
angiographies ) (punct)
trauma head (compound)
cardiac arterial (conj)
illustrated . (punct)
factors certain (amod)
measurements main (conj)
patients hemodialysis (amod)
increased % (parataxis)
increased mice (dobj)
seizures frequent (amod)
received oil (dobj)
expression factor-kappab (nmod)
frequent was (cop)
wall anterior (amod)
changes liver (nmod)
caused cm (dobj)
differ those (nmod)
78 115 (nmod)
recognize to (mark)
potent cause (conj)
splenic bone (conj)
correlated dlt (nsubj)
showed activities (dobj)
increase resulting (advcl)
toxicity regarding (case)
dl-sotalol and (cc)
parameters mass (compound)
infants born (acl:relcl)
analogs tested (acl)
2-adrenoceptors for (case)
complete patency (dobj)
animals remaining (amod)
receptor nk1 (compound)
registry , (punct)
materials testosterone (dep)
sodium or (cc)
conclude worsen (ccomp)
follow-up 1 (nummod)
edema only (advmod)
induce antagonize (conj)
downregulation synthase (compound)
use during (case)
effects oct (nmod)
unlikely unclassifiable (conj)
consequent a (det)
achieved min (nmod)
ropivacaine and (cc)
morphology mitochondrial (amod)
prevent seizures (dobj)
renin group (compound)
similar clozapine (nmod)
mydriasis tremor (conj)
days fewer (amod)
evaluation immunotherapy (nmod)
causes cystitis (dobj)
sunbelt in (case)
recipients receiving (acl:relcl)
pad glycopyrrolate (compound)
reduce discharge (advcl)
precipitate phases (nmod)
patterns distribution (compound)
constructed ) (punct)
remain , (punct)
latency decreased (amod)
g p (dep)
expression peak (amod)
= p (dep)
ages and (cc)
weeks from (case)
anaemia with (case)
drops adrenergic (amod)
caused lesioned (dep)
library cochrane (compound)
atypia cellular (amod)
interactions profound (amod)
hospital gwardamangia (appos)
group noncastrated (amod)
auditory and (cc)
induction activity (nmod)
disrupting pathway (dobj)
sevoflurane to (case)
fibres non-necrotic (amod)
administration cyp (compound)
controlled current (amod)
retains action (dobj)
therapy hypercholesterolemia (nmod)
dimension group (nmod)
lymphocyte for (case)
reports numerous (amod)
development disease (nmod)
rearings the (det)
reduplication study (dep)
evaluates rats (dobj)
effect homeostasis (nmod)
angiograms of (case)
dosages to (case)
climate in (case)
anesthetic protocols (dep)
induced pyrazinamide (nmod)
depression pharmacological (amod)
extracted ginseng (nmod)
dideoxyinosine 2'3 (nmod:poss)
disorders that (mark)
distinguish did (aux)
constructed curves (nsubjpass)
portions during (case)
reproduced dogs (nmod)
increases remains (advcl)
presence mellitus (nmod)
agent : (punct)
injection tracer (compound)
associated neuroleptics (nsubjpass)
0.7 0.1 (conj)
patients ii (nummod)
microg with (case)
were played (conj)
exposure cells (nmod)
socs-1 and (cc)
mechanism antioxidative (amod)
acquired eye (nmod)
rates weeks (nmod)
a bpa (appos)
register cochrane (compound)
potassium aldosterone (conj)
examination histological (amod)
abnormalities menstrual (amod)
detecting for (mark)
aor ] (punct)
imperative recognized (advcl)
preserved ) (punct)
frequency f (appos)
survival animals (nmod)
treated argatroban (nmod)
0.01 15 (dep)
female from (case)
female 45-year (amod)
proof , (punct)
leucovorin with (case)
cancer to (case)
up to (mwe)
potential ) (punct)
progress understanding (nmod)
injury microscopic (amod)
patterns four (conj)
frame during (case)
% 54 (nummod)
definition cyclophosphamide (nmod)
paced was (auxpass)
effect aspirin (nmod)
prolonged gradually (advmod)
temperature reduced (amod)
demonstrate produce (ccomp)
developed therapy (nmod)
effect by (case)
showed intensity (dobj)
defined satisfy (nmod:npmod)
retardation by (case)
ml and (cc)
higher hypertrophy (nsubj)
old years (nmod:npmod)
reaction thrombocytopenia (nsubj)
mg 80 (nummod)
shown mice (nmod)
lnaa ( (punct)
result exposure (nmod)
regimen as (case)
tolerated dose (nmod)
striking less (advmod)
different : (punct)
influenced carboplatin (nsubj)
rilmenidine mg/kg (appos)
mpo-anca of (case)
sacrificed were (auxpass)
patient volunteer (conj)
had weight (dobj)
bred . (punct)
tiapride or (cc)
duration optimal (amod)
evaluation after (case)
days surgery (nmod)
discontinued drugs (nsubjpass)
observed carefully (advmod)
mrna aqp2 (compound)
warranted use (nsubjpass)
present angiosarcoma (nsubj)
drive compensatory (amod)
hl ) (punct)
hyperactivity . (punct)
randomized learning (nmod)
included compounds (nsubj)
activity independent (amod)
injected min (nmod)
year from (case)
reduced loss (dobj)
using he (nsubj)
ablation catheter (amod)
sub-regions hippocampus (nmod)
applied pain (nsubjpass)
processed tissues (nsubjpass)
clz of (case)
acid [omega-i-131]heptadecanoic (amod)
actions to (case)
tests 4,446 (nummod)
total over (case)
9/15 ( (punct)
induced isoproterenol (nmod:npmod)
increases pilocarpine-evoked (amod)
fetuses offspring (conj)
arise patients (nmod)
significant then (conj)
risk latter (nmod)
being related (acomp)
prevented as (mark)
month 1 (nummod)
week 20th (amod)
observed treated (advcl)
symptoms pretreatment (compound)
amounts with (case)
11 [ (punct)
igf-il-3 protein (dep)
neurotransmitters two (nummod)
hypomania or (cc)
model administration (nmod)
correlated adequate (conj)
produced altering (advcl)
defined min-1 (nmod)
rates with (prep)
revealed hyperinsulinemia (dobj)
region liver (nmod)
consisted withdrawal (nmod)
secretion factor (nmod)
revealed differences (dobj)
echocardiography transesophageal (compound)
taste function (conj)
hypercalcemias with (case)
reported known (ccomp)
spironolactone : (punct)
time on (case)
neutropenia due (case)
asystole to (case)
necessary assess (xcomp)
related generation (nmod)
animals nontransgenic (amod)
kidney developed (acl:relcl)
lc at (case)
cent a (det)
medialipid or (cc)
remains when (advmod)
duration average (amod)
map isolated (amod)
nucleus interpeduncular (amod)
carriers epsilon4 (compound)
greater mg/m2 (nmod)
5.2 - (punct)
found decreases (ccomp)
calpain of (case)
microphthalmos hypoplasia (dep)
immunosuppression cya (appos)
resulted blocked (dep)
very ) (punct)
fmri ( (punct)
channels pentameric (amod)
circled lesion (dep)
delayed damage (dobj)
considerations thrombocytopenia (nmod)
(+/-)-pg-9 [ (punct)
prolongation . (punct)
b and (cc)
thorax on (case)
shown efficacy (dobj)
sympathectomy transthoracic (compound)
properties antipsychotic-like (amod)
electing continue (xcomp)
mg/d n (dep)
oxycantha ( (punct)
90 120 (conj)
patients p (acl:relcl)
exceeded % (ccomp)
minimize ischaemia (dobj)
reported toxin (nsubjpass)
clopidogrel newer (amod)
corporation , (punct)
report treatment (dobj)
toxicity bone (compound)
2-(p-bromophenyl)propionate alpha-tropyl (amod)
evaluated matched (conj)
groups ntg (compound)
patients 119 (nummod)
cis-platin mg/m2bsa (dep)
atropine muscarinic (compound)
patients mj (appos)
contractility by (case)
acidosis with (case)
committee data-monitoring (amod)
improve quality (dobj)
known fq (nmod)
participate exercise (nmod)
mg 60 (compound)
recorded and (cc)
examined influence (nsubjpass)
administered may (aux)
used map (xcomp)
compared temperament (conj)
valsartan % (conj)
d1 receptor (conj)
studied dyscrasias (nsubjpass)
binding transporter (compound)
events from (case)
level glomerular (amod)
product . (punct)
spanning distribution (dobj)
fibers in (case)
decreased decreased (conj)
scheduled receive (xcomp)
explored rats (nsubjpass)
followed prospectively (advmod)
volume micturition (nmod)
projections descending (amod)
atp ( (punct)
syndrome immune (amod)
serve that (nsubj)
conclusions able (dep)
corrected was (auxpass)
attributable reduction (nmod)
studied prevention (dep)
therapy continued (amod)
rats sham-operated (amod)
procedure surgery (conj)
distortion neuronal (amod)
36.4/6.1/3.0 diarrhea (compound)
50 usually (advmod)
concentrations tafi (compound)
rigidity masseter (compound)
fluid clonazepam (nmod)
received she (nsubj)
use of (case)
7h6 zo-1 (appos)
sirolimus with (case)
toes of (case)
representative normal (nmod)
diagnosis af (nmod)
produced rats (nmod)
account which (nsubj)
waves intervals (conj)
has reducing (csubj)
potency with (case)
influence . (punct)
need may (aux)
pirenzepine 4-damp (conj)
damage of (case)
raised was (auxpass)
diphosphanilate of (case)
rate infections (nmod)
goal program (compound)
imaging thrombosis (nmod)
cigarettes 25.2 (nummod)
dilated related (dobj)
generator so (amod)
lesions doxorubicin-induced (amod)
increased stroke (xcomp)
functioning . (punct)
markers rs6693503 (dep)
activity cortical (amod)
associated polymorphisms (nsubjpass)
flow lacrimation (conj)
upset abandoning (dep)
one 13,000 (nmod)
deficiency with (case)
discussion tremor (dep)
influence neurotransmission (dobj)
based records (nmod)
effects pentamidine (nmod)
proves , (punct)
ansan , (punct)
taking rizatriptan (dobj)
effects chloride (nmod)
decreases training (nsubj)
caused determined (dep)
phno d2 (compound)
effect during (case)
malignant non (advmod)
allergic as (case)
interaction juice (nmod)
placebo -10.7 (dep)
recruited men (nsubjpass)
objective one (dep)
period defined (amod)
was relationship (nsubj)
pethidine healthy (amod)
thrombi intravascular (amod)
fibrotic densely (advmod)
ranges in (case)
presented lethargy (nmod)
tissue heart (compound)
positive scale (conj)
nuclei diethylstilbesterol (nmod)
demonstrate contrast (conj)
compared azelastine (nsubjpass)
death apoptotic (amod)
described measurement (nsubjpass)
nephropathy contrast (compound)
described course (nsubjpass)
5-fluorouracil acid (dep)
women group (compound)
gm 5 (nummod)
failing the (det)
those stages (nmod)
stable improved (conj)
stabilizer n (dep)
factors populations (nmod)
affect development (dobj)
receptor a (det)
toxicity methamphetamine (compound)
population follow-up (conj)
interpretation dystrophy (nmod)
investigators involved (acl)
cytopenias three (nummod)
progress usually (advmod)
measurements output (nmod)
result regimens (nmod)
time to (case)
therapy clopidogrel (dep)
humans and (cc)
blockers . (punct)
reveals review (nsubj)
stress ' (punct)
different strains (nmod)
genes susceptibility (compound)
altered enzymes (nsubjpass)
symptoms syndrome (nmod)
reported publication (nmod)
kg-1 micrograms (compound)
dipyridamole after (case)
sph ratio (dep)
angioedema treated (acl)
arthritis the (det)
interaction metoprolol (nmod)
alpha-gst of (case)
ascended , (punct)
doses anesthetics (nmod)
develop failure (dobj)
schedule administration (compound)
amplified primers (nmod)
patients failure (acl:relcl)
follow-up post-training (amod)
terms confusion (nmod)
= 209 (dep)
functions impaired (acl:relcl)
preserved while (mark)
pressures baseline (compound)
humphrey including (case)
crossed modalities (nsubjpass)
tended rotation (nsubj)
responding was (aux)
disturbances and (cc)
evaluation their (nmod:poss)
amount meal (nmod)
nefiracetam dm-9384 (appos)
localization areas (nmod)
0.014-unit , (punct)
reaching it (dobj)
val204asp of (case)
psychologist by (case)
ifosfamide develop (acl:relcl)
promoted ) (punct)
effect ; (punct)
susceptible if (advcl)
anticonvulsant those (conj)
models seizure (amod)
effacement patchy (amod)
level obtained (acl)
pass which (nsubj)
5.8 0.4 (conj)
r4 ) (punct)
action cocaine (nmod)
response antigens (nmod)
causes possible (amod)
hydroureteronephrosis with (case)
dosage each (det)
il-3 ( (punct)
minutes dobutamine (nmod)
disease developed (acl:relcl)
profiles prostanoid (amod)
cases : (punct)
effect acetate (nmod)
describe highlight (advcl)
released was (auxpass)
results led (dep)
circuits cingulate (compound)
injection central (amod)
copulation , (punct)
response achieved (acl)
carbamazepine fatal (amod)
complaining woman (compound)
randomized vehicle (nmod)
cause commonest (amod)
failure of (case)
leukemia for (case)
bradydysrhythmias tachycardia (conj)
elevations aminotransferase (compound)
therapy discontinuing (amod)
induced induced (conj)
potential about (case)
ozone concentrations (dep)
psa serum (compound)
vip ) (punct)
indicated experiments (nsubj)
biopsies following (amod)
improvements dramatic (amod)
quantify to (aux)
optic of (case)
powerful used (dep)
therapy pemoline (compound)
deterioration , (punct)
ventilation spontaneous (amod)
infection system (compound)
prescribed patients (nsubjpass)
elimination prolonged (amod)
higher postpartum (nsubj)
unpleasant background (nsubj)
rate secretion (compound)
disappeared months (nmod)
shown background (dep)
24 in (case)
induces rationale (nsubj)
packing membrane (compound)
injection contrast (compound)
irritant an (det)
included resulted (conj)
potentiates extends (conj)
4 individuals (nmod)
occurring patient (nmod)
men 16 (nummod)
data receptors (conj)
protected rats (dobj)
was aim (nsubj)
hampered lack (nmod)
day earliest (amod)
vessels isolated (amod)
factor vascular (amod)
associated delivery (nsubjpass)
death sudden (compound)
system exo (amod)
hybrid f1 (compound)
differences sex-related (amod)
increases dose (nsubj)
= 5 (dep)
slices saline- (nmod)
described others (nmod)
have contractions (dobj)
related pointes (nsubj)
used evaluation (nsubjpass)
step through (advmod)
present vasculitis (nsubj)
fdc the (det)
abnormalities swallowing (amod)
fever days (nmod)
safety evaluation (nmod)
doses inhibitors (nmod)
opioid of (case)
reveal methods (nsubj)
phase with (case)
active patients (nmod)
account activity (nmod)
appeared literature (nmod)
projection an (det)
first objectives (nsubj)
hypoactivity ecstasy-specific (amod)
inputs visceral (amod)
presynaptic versus (cc)
suspected involvement (nsubjpass)
involvement groups (nmod)
cancer liver (compound)
changes subjects (nmod)
groups sham (dep)
children % (dep)
17 from (case)
microg/l of (case)
vasculitis the (det)
includes includes (conj)
hyperkinesis the (det)
stimuli acute (amod)
assessment an (det)
p450 1a1/1a2 (dep)
alerted physicians (nsubjpass)
test tail (conj)
unresponsiveness discriminated (conj)
placebo either (det)
needed g (dep)
anomaly , (punct)
reverse activation (nsubj)
levels angiotensinogen (nmod)
had diagnosis (dobj)
sensitivities specific (amod)
series involving (acl)
svr ) (punct)
estrogen by (case)
trial doxorubicin (nmod)
involving nuclei (dobj)
gtn 20.5 (nummod)
des-arg10hoe 140 (nummod)
detect fpd (nsubj)
mean = (amod)
damage alterations (conj)
relationship activity (nmod)
prolonged form (nmod)
number experts (nmod)
aborted has (aux)
degree development (nmod)
fluphenazine sulpiride (conj)
subgroups comparisons (nmod:poss)
evoked responses (nsubjpass)
arrhythmia the (det)
disappearing syndrome (nsubj)
experiment of (case)
doses mazindol (compound)
strategy prevent (acl)
maleate by (case)
combination area (dep)
ly274614 antagonist (dep)
hormone low (amod)
transplanted have (aux)
syndrome pcos (appos)
suppression by (case)
role patients (nmod)
failed ssr103800 (nsubj)
percent 91 (nummod)
use nd-nmba (appos)
disrupts mutation (nsubj)
dissipates anesthetic (amod)
smoking daily (amod)
option exhibits (advcl)
distribution proteins (nmod)
reduced replacement (nsubj)
intoxications cocaine (nmod)
transcription activator (compound)
myelosuppression reduced (amod)
regimen polychemotherapy (compound)
monitoring time (nmod)
mice azidothymidine (nmod)
electroshock mes (appos)
employed visualize (xcomp)
display effects (dobj)
haemofiltration arteriovenous (amod)
amount extent (conj)
artery and (cc)
coagulation time (appos)
skf the (det)
dexamethasone prenatal (amod)
5711 +/- (cc)
attenuated castration (nmod)
important especially (advmod)
toxicity an (det)
reverses that (mark)
stress to (case)
impairment learning (nmod)
3-methyladenine 3ma (appos)
pdn ) (punct)
unrelenting , (punct)
heparin low-molecular-weight (amod)
effects antiparkinsonian (compound)
monitoring behaviour (dobj)
such as (case)
peak the (det)
withdrawal methylprednisolone (conj)
said generally (advmod)
mellitus non-insulin-dependent (amod)
mg/m(2 with (case)
decreased level (dobj)
linked specifically (advmod)
arthritis for (case)
animals the (det)
contraceptives on (case)
lacks reported (parataxis)
placed lesions (nsubjpass)
chemotherapy dexamethasone (compound)
arv ( (punct)
subacute alzheimer-like (amod)
users warfarin (compound)
procedure to (case)
injection atropine (nmod)
gssg of (case)
% reduction (dep)
levodopa dopamine (conj)
2-(p-bromophenyl)propionate ) (punct)
challenged catalepsy (nsubjpass)
adr serious (amod)
express interval (dobj)
present shifts (conj)
rats reserpine (compound)
mg than (quantmod)
dba/2 and (cc)
receptors cholinergic (compound)
using probe (dobj)
lungs organs (conj)
mk-801 microl (appos)
documentation written (amod)
unsafe is (cop)
medication after (case)
mutation any (det)
variable proportional (conj)
women administration (nmod)
used -- (punct)
appears hepatitis (nsubj)
restriction sodium (compound)
polacrilex nicotine (compound)
nature atypical (amod)
factor-alpha concentration (dep)
boy played (acl:relcl)
evidence-based how (advmod)
delivers dose (dobj)
dose studies (nmod)
limits space (compound)
symptoms unusual (amod)
course or (cc)
dg-5128 alpha-2 (compound)
role synthesis/release (nmod)
potent clonazepam (nmod)
3.9 5.6 (conj)
42 ) (punct)
took before (mark)
experience case (nmod)
suxamethonium by (case)
insipidus to (case)
interfere to (mark)
20 to (case)
reports four (nummod)
tested determined (conj)
altered whether (mark)
g/ml 1.050 (nummod)
admission hospital (compound)
administration aspirin (compound)
effects both (nmod)
change noticeable (amod)
drinking pregnancies (nmod)
group temocapril (conj)
= 9 (dep)
volume the (det)
therapy diclofenac (amod)
mepivacaine 850 (dep)
stopped recovered (conj)
accompanied attenuation (nsubjpass)
measurement a (det)
maximum ] (punct)
flow tidally (advmod)
strain not (neg)
hospitalized recently (advmod)
93.3 vs. (cc)
reabsorption lysozymuria (conj)
dysfunction hypothalamic (amod)
reversed hemodialysis (nmod)
presented hours (nmod)
produced exposure (nsubj)
impair does (aux)
decrease outflow (nmod)
-14.8 12.5 (conj)
placebo oxycodone (appos)
isg ) (punct)
wide spread (dep)
chemotherapy gem-p (compound)
follow-up therapy (nmod)
increase with (case)
use management (nmod)
developed leucopenia (dobj)
parameters tissues (nmod)
model mice (appos)
pathogenesis concerning (case)
delta22-isomer identified (amod)
therapy nonsteroidal (amod)
radiopharmaceuticals infarct-avid (amod)
short- long-term (conj)
abundant ; (punct)
ntg ( (punct)
globulin combined (amod)
sites binding (amod)
increases evaluated (conj)
years five (nummod)
p 0.02 (dep)
provides dosing (nsubj)
recordings serial (amod)
role p300 (nmod)
liver system (conj)
homozygous be (cop)
participants smokers (acl:relcl)
distinguishable fibres (nmod)
stimuli to (case)
have accuracy (dobj)
demonstrated showed (parataxis)
rats antithrombin-treated (amod)
volume between (case)
difference=0.01 ( (punct)
ecgs and (cc)
concentrations 10(-5 (nmod)
resulted dose (nmod)
nephropathy role (nmod)
pathway erk (compound)
administration onset (conj)
% 30.5 (nummod)
reduce transmission (nsubj)
pap ( (punct)
placebo from (case)
done case (nmod)
concentrations arrhythmias (nmod)
characterization detection (conj)
batteries levels (conj)
eyes untreated (amod)
increased users (nmod)
mmol/l sodium (nsubj)
forelimb hindlimb (conj)
fact needed (acl)
model disease (nmod)
infusion days (nmod)
benefit might (aux)
dependent patients (nmod)
tiredness symptoms (nmod)
ameliorated hp (nmod)
> % (dep)
studies recent (amod)
produced dose (nsubj)
activates acetyltransferase (dobj)
penicillamine-treated disease (nmod:npmod)
mechanism effects (nmod)
determined rates (nsubjpass)
day is (cop)
exhibited gyrus (nmod)
groups val (appos)
minutes during (case)
oct 3000 (nummod)
cross-tolerance either (cc:preconj)
detected accurately (advmod)
phenylbutazone acid (conj)
reaction hemolysis (nsubj)
mono-infected patients (dep)
i1-receptor-mediated hypotension (dobj)
mmol/l of (case)
10 5 (nummod)
epm the (det)
m(3)-machr. related (acl:relcl)
that propranolol (nmod)
count resistance (conj)
capable , (punct)
groups dosing (compound)
using standard (nmod)
prevention 4 (dep)
prolongation treatment (nmod)
0.6 0.08 (conj)
expressions laminin (compound)
recurring time (nmod)
situations causing (acl)
ccb ) (punct)
erythropoietin to (case)
utilized has (aux)
rats salt-sensitive (amod)
nested cohort (nmod)
mice diabetes (nmod)
safer and (cc)
using models (dobj)
drugs antihypertensive (amod)
muscle cardiac (amod)
p-chlorophenylalamine with (case)
observers by (case)
disorder the (det)
nci/min of (case)
complaining dysphonia (nmod)
raise tenofovir (nsubj)
injections monthly (amod)
processed immunohistochemistry (nmod)
related n (dep)
0.0073 0.0020 (compound)
appeared procaterol (nsubj)
5-ht(6 ( (punct)
caused whom (nmod)
mediated systems (nmod)
improve that (nsubj)
bar horizontal (amod)
aggregation maximal (amod)
centre the (det)
proteome the (det)
prevent does (aux)
level alpha-fluoro-beta-alanine (nmod)
catalyzes degradative (dobj)
converted when (advmod)
showed day (nmod)
accompanied behaviors (nsubjpass)
gamma-glutamyltransferase as (case)
prevent pain (dobj)
revealed groups (nsubj)
channel epithelial (amod)
jaundice aminotransferase (nmod)
metabolism acid (compound)
received os (nmod)
fentanyl of (case)
agent nonselective (amod)
degeneration presence (nmod)
effort minimize (acl)
effect thp (nmod)
recommended that (mark)
considered cause (xcomp)
response differential (amod)
association hypotension (nmod)
tests groups (nmod)
remain although (mark)
test self-reported (amod)
syndrome insufficiency (conj)
revealed none (conj)
followed epinephrine (nmod)
containing tamca (dobj)
inhibition complexes (nmod)
2.2 +/- (cc)
reported questioned (advcl)
patients long-term (amod)
safe a (det)
gets whom (nmod)
transmission of (case)
compared conjugation (nsubjpass)
toxicity amiodarone (amod)
induces nifedipine (nsubj)
performed days (nmod)
treated therapy (nmod)
icu to (case)
disability parkinson (compound)
agents aminophylline (appos)
cardiac the (dep)
traits hit (nmod)
increased one (conj)
resumed use (dobj)
ingestion by (case)
normalized were (auxpass)
administered were (auxpass)
minutes 4.7 (dep)
prevention transplantation (nmod)
report is (cop)
concentration at (case)
rtms the (det)
was conclusion (dep)
treated it (nsubjpass)
cytokine the (det)
vehicle either (cc:preconj)
fluctuations stage (appos)
centers in (case)
age 33 (nummod)
muscle-lengths/s 2.18+/-0.21 (nummod)
fundus green (compound)
reached because (mark)
hilum over (case)
verifying space (dobj)
biopsy rats (nmod)
interval average (amod)
abolished discontinuation (nmod)
compound novel (amod)
considered development (nsubjpass)
ccr2 astroctytes (conj)
showed change (nsubj)
inhibition tone (nmod)
accounted klebsiella (nsubj)
ameliorated . (punct)
irrigation saline (nmod)
dose ; (punct)
series another (det)
albino . (punct)
deleterious . (punct)
paralysis half (nmod)
event tablets (nmod)
prevented gnc92h2 (nsubj)
6,3-dilactone - (punct)
alert , (punct)
risk good (amod)
disease dyskinesias (conj)
sustained min (nmod)
drug novel (amod)
criteria dsm-iv (compound)
standard the (det)
recognized not (neg)
solid various (amod)
formulations rates (nmod)
certainly almost (advmod)
patients hbs (compound)
trial aimed (acl)
nonusers ich (nmod)
rats epileptic (amod)
twice to (mark)
naphazoline and (cc)
grade echocardiography (nmod)
extent inhibition (nmod)
p 0.0001 (dep)
effects analysis (dep)
nm 100 (compound)
hypothyroidism hypercalcemia (conj)
acid tamca (appos)
established ns (nsubjpass)
minutes remifentanil (nmod)
is list (attr)
assessed daily (advmod)
1 6 (prep)
levels mda (nmod)
address should (aux)
spaces intertrabecular (amod)
telaprevir with (case)
loss seizures (nmod)
done ; (punct)
inferior brains (nmod)
speak effects (nmod)
cse ) (punct)
cells llc-pk1 (compound)
toxicity remission (nmod)
revealed examination (nsubj)
monomer dimer (conj)
efficacious equally (advmod)
representing concentrations (dobj)
increases limit (nmod)
signaling phasic (amod)
showed c (nmod)
mice knockout (amod)
muscles ventilatory (amod)
-32 +/- (cc)
purpose reviews (dep)
conducted ) (punct)
% 69.3 (nummod)
levels 3-methoxy-4-hydroxyphenethyleneglycol (nmod)
inhibitor oxidase (compound)
mmol/l 2.4 (nummod)
model syndrome (nmod)
forearm in (case)
f(33 ) (punct)
p10 or (cc)
radial ulnar (conj)
were contrary (nmod)
18 +/- (cc)
roles pan (nmod)
superiority of (case)
fact agent (ccomp)
epm ) (punct)
pressor effects (conj)
facilitated micturition (dobj)
35.9 +/- (cc)
study follow-up (amod)
mglur5 mpep (dep)
capecitabine of (case)
ml/min mm (compound)
measures of (case)
receptors prl-r (appos)
22 - (punct)
recommend should (aux)
index pri (appos)
transporter-1 glycine (compound)
experiments administration (nmod)
components extract (nmod)
particles brain (nmod)
azelastine medication (appos)
time latency (nmod)
present mdma (appos)
mechanisms these (det)
lymphoma lymphoblastic (amod)
applied cells (nmod)
other dopamine (nmod)
ecg of (case)
increased box (nmod)
consumption beverages (nmod)
presenting amiodarone (amod)
disruption rats (nmod)
alterations adr-induced (amod)
injury , (punct)
high impaired (advcl)
rotation transient (amod)
group abusers (nmod)
two children (nmod)
death , (punct)
bipolar vs. (case)
densities the (det)
therapeutic but (cc)
address . (punct)
formation to (case)
well-tolerated was (cop)
netilmicin 12 (conj)
evoked dce (nmod)
hearts patients (nmod)
noted relief (nsubjpass)
durations symptom (compound)
level of (case)
some indices (nmod)
successful were (cop)
cohorts ) (punct)
substantiate risk (dobj)
demonstrate cases (nsubj)
effects atherosclerosis (nmod)
produced hypotension (dobj)
returned stopped (advcl)
hypertension for (case)
pressor both (cc:preconj)
test classic (amod)
peptide natriuretic (amod)
dose intravenous (amod)
examined shr (nmod)
mapped deficits (nsubjpass)
interview the (det)
developed orally (advmod)
reports the (det)
argue action (nmod)
responded these (nsubj)
have common (nmod)
phno the (det)
cholesterol hu (compound)
reintroduction rifampicin (nmod)
cranberry weeks (nmod)
comparison inhibiting (acl)
retained conjugates (nsubj)
tia ) (punct)
0.625 2.5 (conj)
31 ) (punct)
event on (case)
express electrocardiogram (nmod)
significance no (det)
drug form (conj)
stability temporal (amod)
rate 24 (nmod)
quinpirole with (case)
reported fda (nmod)
given component (nmod)
magnitude duration (conj)
rating hyperkinesia (compound)
associated infusion (nmod)
users hormone (compound)
it ) (punct)
anesthesia general (amod)
given dogs (nmod)
nx the (det)
induced - (punct)
show occurred (conj)
induced maintained (conj)
0 120 (conj)
overdose epinephrine (compound)
level initial (amod)
activity epileptic (amod)
expressed termed (conj)
intoxications carbachol (nmod)
study a (det)
lower risk (nmod)
rate smooth (amod)
producing dysfunction (dobj)
signs tma (nmod)
(vegf)165 endothelial (amod)
28.0 and (cc)
treatment if (nmod)
proven suspected (conj)
expression effect (appos)
surgery primary (amod)
polfa vupral (compound)
slices hippocampal (compound)
cocaine either (cc:preconj)
nephritis induced (amod)
placebo evening (nmod)
diagnosis clinical (amod)
received thirty-nine (nsubj)
pharmacokinetics cis-ra (nmod)
cancer used (acl)
restore ltp (dobj)
425 53 (conj)
contributed interaction (nsubj)
study no (det)
reported controls (nsubj)
episode tdp. (nmod)
seen and (cc)
= 0.58 (dobj)
those estimated (acl)
time grade (conj)
bought and (cc)
pyrazinamide for (case)
guidelines to (case)
prolactinoma 1 (nummod)
propionate [ (punct)
adjust reducing (advcl)
cases parkinsonism (nmod)
is now (advmod)
fibrosis against (case)
improvements percent (compound)
population safety (compound)
diagnosis : (punct)
administered father (nsubjpass)
content ionic (amod)
addresses geocoded (amod)
tests together (advmod)
indicate avoided (ccomp)
etiology explain (acl:relcl)
micrograms/min of (case)
inhibited enlargement (dobj)
rationale inhibits (dep)
lacked property (dobj)
series further (amod)
halothane enflurane (conj)
lesions following (case)
retrograde amnesia (dobj)
four the (det)
attack delayed (amod)
defect associated (acl)
compare characteristics (dobj)
results less (appos)
< from (case)
78 [na]o (compound)
approach consequences (conj)
microscopy with (case)
pineal the (det)
finding vasoconstriction (nmod)
able distinguish (xcomp)
experience of (case)
hypertension dex- (compound)
one five (conj)
highlighting fact (dobj)
-18.48 ) (punct)
accomplished adjustment (nsubjpass)
those microg (nmod)
clearance cimetidine (compound)
disease lung (compound)
methotrexate notably (advmod)
% responders (nmod)
clinical an (det)
threshold clozapine (appos)
benefit clinical (amod)
done had (ccomp)
feature can (aux)
response l-[3h]nicotine (conj)
treatment lesions (nsubj)
present present (xcomp)
had discharge (nmod)
nucleoside or (cc)
reports a (det)
value atp (nmod)
claimed although (mark)
lasted . (punct)
changes histology (nmod)
neurotoxicity sensory (amod)
performance the (det)
remissions 9 (nummod)
identify results (nsubj)
decrease ratings (nmod)
therapy cisapride (compound)
compartments in (case)
99 ( (punct)
safety ro15 (nmod)
generator ' (punct)
attributable symptomatic (conj)
injection pilocarpine (nmod)
pathway neuronal (amod)
micrograms.kg-1.min-1 10 (nummod)
scans repeated (amod)
evidence events (nmod)
produced regardless (advmod)
nonselective competitive (dep)
treatment dantrolene (nmod)
damage jj (nmod)
fractions ejection (compound)
weakness with (case)
pseudoprolactinoma n. (appos)
studies studies (conj)
components minor (amod)
proteins five (nummod)
assess testing (nmod)
rash delayed (amod)
use stimulant (amod)
presented review (conj)
mental physical (conj)
cows ml (appos)
any agents (nmod)
behavior michaelian (amod)
loss epilepticus-associated (amod)
alive is (cop)
prerequisite be (cop)
change this (det)
tests liver-function (amod)
infarction experimental (amod)
received cta (dobj)
pronounced were (auxpass)
epilepsy or (cc)
conclusions has (appos)
edetate calcium (compound)
required nephroureterectomy (nsubjpass)
production nitric (amod)
effect varying (advcl)
offset may (aux)
hyperalgesia static (amod)
factor thromboembolism (dep)
alpha- the (det)
resolved continued (advcl)
gamma-hch 80 (nummod)
denopamine by (case)
region of (case)
indicates support (nsubj)
administrated vcm (nsubjpass)
decreasing produce (conj)
presented levels (nmod)
focusing regulation (nmod)
worsened resolving (ccomp)
cycloheximide not (neg)
sedation procedural (amod)
effects biochemical (amod)
two month (nmod)
levels produced (amod)
developed patients (nsubj)
causes dependency (nsubj)
efficacy complications (conj)
range 40,000 (nmod)
complication hepatitis (nsubj)
apposed cells (nsubjpass)
aged years (nmod)
breast and (cc)
reduction worsening (conj)
esterase or (cc)
disease rheumatologic (amod)
recorded differences (nsubjpass)
catch . (punct)
100 and (cc)
ml 108.9 (nummod)
system reticular (amod)
started pill (nmod)
pethidine of (case)
modify . (punct)
ratios outcomes (nmod)
lithium who (nsubj)
verapamil or (cc)
periphery territory (nmod)
genes critical (amod)
animals counts (dep)
mm sem (appos)
overdose suicidal (amod)
check . (punct)
withdrawal agents (nmod)
antagonizes increase (dobj)
animals had (acl:relcl)
group = (amod)
found case (dobj)
analyzed ph (nsubjpass)
evening day (nmod)
alter studied (advcl)
received ls (dep)
seizure transplantation (nmod)
detected hippocampus (nmod)
complications hemorrhagic (amod)
apap either (cc:preconj)
sacrificed terminally (advmod)
grade health (compound)
patients selegiline (nmod)
calculated ka (nmod)
obtained puncture (nmod)
necrosis avascular (amod)
day 3rd (amod)
tachycardia ) (punct)
kinase creatine (compound)
nacl ( (punct)
effect such (amod)
characterization rodents (nmod)
become use (nsubj)
treatment asenapine (nmod)
had itching (conj)
have features (dobj)
d-amphetamine , (punct)
10-diol - (punct)
achieved dose (nmod)
size behaviors (conj)
thiols intracellular (amod)
fenfluramine underwent (acl:relcl)
process pathogenic (amod)
amitriptyline ( (punct)
ranvier of (case)
experiment and (cc)
correlation change (nmod)
caused atrophy (nsubjpass)
hours 36 (nummod)
shell core (conj)
greater consistent (advcl)
baseline initial (amod)
testing dobutamine (amod)
atria beating (amod)
% p (dep)
enhanced 22-fold (advmod)
hepatic metastases (dep)
used prophylaxis (nmod)
sixty-seven patients (nmod)
effects frequent (amod)
suggest may (aux)
attenuated responses (dobj)
ketamine , (punct)
anesthetized sevoflurane (nmod)
promoting reentry (dobj)
enhanced trazodone (nsubj)
found concentration (nsubjpass)
contaminants and (cc)
identify subgroup (dobj)
combined giving (advcl)
users medications (nmod)
amphotericin from (case)
arteriolar venous (conj)
contribute action (nmod)
c since (case)
suppressed intervals (nmod)
serca2 ] (punct)
prevented induction (nsubjpass)
prompt therapy (conj)
improved extent (nmod)
patients bicarbonate (nmod)
causes impacts (dobj)
causes hypoperfusion (nmod)
agent active (amod)
delta theta (appos)
caused that (nsubj)
influence captopril (nsubj)
n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide with (case)
ranged age (nmod)
design multicenter (dep)
denervation dopaminergic (amod)
biochemical parameters (dep)
tablets quinine (compound)
fluoroacetate , (punct)
observed therapy (nmod)
site glycine (compound)
elevated , (punct)
probable or (cc)
depression on (case)
caused contributed (conj)
block patients (nmod)
disease drug-induced (amod)
solution than (case)
have likely (conj)
snr in (case)
indicate instituted (ccomp)
anemia a (det)
therapy endocrine (compound)
sweating hyperhidrosis (nsubj)
be ( (punct)
team treating (amod)
-9.9 1.7 (conj)
interrupted period (nsubjpass)
interfere risk (nmod)
shown amifostine (nsubjpass)
animals epinephrine-treated (amod)
statistically highly (advmod)
outcomes fluctuations (nmod)
gestation malformations (nmod)
anemia hemoglobin (dep)
needed yet (cc)
factors cardiovascular (amod)
receive = (parataxis)
divided patients (dep)
sought : (punct)
chains with (case)
ascertained analgesic (nsubjpass)
develop thus (advmod)
knowing represent (ccomp)
dehydrogenase on (case)
continued uneventfully (advmod)
co in (case)
intense very (advmod)
decrease compared (prep)
% hospitalized (nmod)
death disease (nmod)
mg/d 100 (nummod)
had s((1/2 (dep)
options exemplified (advcl)
occurs incidence (nsubj)
1.44+/-0.6 1.57+/-0.7 (conj)
decreased is (auxpass)
subjected day (nmod)
concentration minimum (amod)
complication the (det)
man yr-old (compound)
alpha2-adrenoceptors of (case)
screen to (mark)
granulocytosis hypersegmented (amod)
fev1 the (det)
patients combination (nmod)
% 25%-35 (nummod)
exerted reducing (advcl)
cases 4 (nummod)
analysis histopathological (amod)
% 79 (nummod)
bear drugs (nsubj)
days delirium (nmod)
tolerance to (case)
containing granules (dobj)
0.7 to (dep)
meter neither (dep)
insight safety (nmod)
output an (det)
dose methadone (compound)
treatment lisinopril (nmod)
cross-tolerant drugs (nmod)
boy was (cop)
nevirapine nvp (appos)
arthritis of (case)
pipette recording (amod)
syndrome due (case)
supernatants separated (acl)
increase generalised (amod)
ability through (case)
appeared discharged (conj)
occurs withdrawal (conj)
morphine dependency (conj)
age mean (amod)
decrease -18 (dep)
establish chloride (nmod)
disease epicardial (amod)
inhibition nigra (nmod)
unmask can (aux)
ring the (det)
polfa ( (punct)
programs surveillance (compound)
converted dose (dobj)
exposure anesthesia (nmod)
developed coincident (dep)
males were (cop)
range 79 (nummod)
characteristic state (nmod)
doses diazepam (nmod)
users of (case)
adjusted after (mark)
concordance with (case)
increase diameter (nmod)
impaired . (punct)
challenging be (cop)
preparation asthma (nmod)
cells type (compound)
levels psychosis (nmod)
8) and (cc)
increase matrix (compound)
77 four (compound)
population general (amod)
use cidofovir (nmod)
dealing , (punct)
rate progression (nmod)
time developed (acl:relcl)
receiving ifosfamide (dobj)
reproduced ) (punct)
scavengers of (case)
due are (cop)
sss and (cc)
rise of (case)
aminophylline , (punct)
complications venous (amod)
died showed (conj)
lnna after (case)
tubule distal (amod)
currents slow (amod)
gain body (compound)
stress tissue (compound)
shortening element (compound)
pregnancies with (case)
g/day se (appos)
m-chlorophenylpiperazine the (det)
imaging dipyridamole-thallium-201 (amod)
6.5 approximately (advmod)
formulation an (det)
fetuses rat (compound)
occurred 18 (nmod)
incidence inflammation (nmod)
changes st (amod)
depletion neurotransmission (nmod)
% 50 (nummod)
oxypurines of (case)
taking prazosin (dobj)
platinum- with (case)
neurones central (amod)
impairment learning (compound)
drugs anticholinergic (amod)
benefits absence (nmod)
dose wk (nmod)
occurred average (nmod)
hypotension bromocriptine-induced (amod)
stimulation day (nmod)
effect behavior (nmod)
occurrence its (nmod:poss)
dose it (nmod)
atenolol of (case)
dogs treated (acl)
microm 0.1 (nummod)
stage 4 (nummod)
percentage greater (amod)
changes induces (acl:relcl)
analyzed information (dobj)
taken pregnancy (nmod)
intralipid p (appos)
metabolized is (auxpass)
role amines (nmod)
reduced mg/week (nmod)
follows ml (dep)
decreased clearance (dobj)
initiate . (punct)
resulted placebo (advcl)
examination light (amod)
applications hypothermia (nmod)
associated depression (nsubjpass)
oct the (det)
number neuron (compound)
had survival (dobj)
filtration glomerular (amod)
formulations different (amod)
increased use (dep)
angiography carotid (compound)
increases restriction (nsubj)
icv 3mg/kg (dep)
assessed defined (advcl)
transplantation quality (dep)
exacerbation epilepsies (nmod)
nature of (case)
suggests facilitate (ccomp)
increment rr (compound)
reducing significantly (advmod)
tolerance or (cc)
periods mean (compound)
selection follow-up (conj)
verbal or (cc)
intervals p-p (compound)
administered reduce (advcl)
subjects subjects (conj)
assigned showed (conj)
corticosteroids transfusions (conj)
state during (case)
concluded exerting (advcl)
observation reduces (ccomp)
dialysate a (det)
link a (det)
% 2.9 (nummod)
chemotherapy radiation (conj)
pain administration (nmod)
mul saline (nmod)
hypotension mice (nmod)
period administration (compound)
torr to (case)
euthyroid and (cc)
tremors muscle (compound)
replicated , (punct)
ihc ( (punct)
implicated to (mark)
phenotype polymorphism (nmod)
severity rtms (nmod)
polymerase enzyme (compound)
agonist alpha-2 (compound)
bnpp ( (punct)
arteriosclerosis ischaemic (amod)
solution and (cc)
imaging recovery (compound)
searched : (punct)
influenced model (nmod)
mri cardiac (amod)
toxic . (punct)
treated telaprevir (nmod)
outcome fatal (amod)
counted were (auxpass)
saline vehicle (appos)
occurred olanzapine (nmod)
prescribed again (advmod)
molecules podocyte-associated (amod)
effect mediated (acl)
remains delivery (nsubj)
estrogens premarin (appos)
proposed have (aux)
arrest clonidine-associated (amod)
served mm (dep)
acc-9653 i.v. (amod)
0.02 and (cc)
strategy important (amod)
suggests , (punct)
breaks ( (punct)
therapy fibrillation (nmod)
restores erythropoietin (nsubj)
micrograms/kg ) (punct)
important manage (xcomp)
cardiomyopathy arrhythmias (nmod)
c cytochrome (compound)
areas sclerotic (amod)
few studies (nsubj)
beat , (punct)
randomized patches (conj)
proposed , (punct)
had afterwards (advmod)
weighted . (punct)
% myelosuppression (dep)
distress and (cc)
total transplants (nmod)
carcinomas twenty (nummod)
widespread potentially (advmod)
period cycle (nmod)
rewarding and (cc)
weeks treatment (nsubj)
developing injections (nmod)
w/v ) (punct)
release with (case)
thalidomide carcinoma (nmod)
perfusion ganglia (compound)
urethane i.p. (advmod)
necessary although (mark)
outcomes its (nmod:poss)
used able (xcomp)
similarities with (case)
task p=0.032 (appos)
nystagmus taking (acl:relcl)
or=7.18 , (punct)
labor for (case)
antineoplastic . (punct)
akt of (case)
decreased injection (nsubj)
increased charge (dobj)
chp ( (punct)
features similar (amod)
dili ( (punct)
1mg/kg/week ) (punct)
divided month (nmod:tmod)
myofilaments of (case)
licit worldwide (advmod)
women 7,705 (nummod)
tnfalpha ( (punct)
rendered . (punct)
survived and (cc)
hours period (nmod)
isoenzyme p450 (compound)
face such (case)
artery an (det)
sop ( (punct)
developed bradycardia (dep)
less patients (dep)
ed ( (punct)
percentage reported (acl)
tendency arrhythmias (nmod)
feared was (auxpass)
describe efforts (dobj)
ntg 4 (dep)
provoke and (cc)
pretreatment 15-day (amod)
man receiving (acl)
seizure behavioral (amod)
enhanced heparin (nsubj)
indication be (cop)
effect have (aux)
greater mg (dep)
% 22 (nummod)
if possible (amod)
tolerability paracetamol (conj)
cell smooth (amod)
employed design (nsubjpass)
became thrombocytopenia (nsubj)
stimulation or (cc)
producing from (mark)
hepatocytes of (case)
performance users (nmod)
sd = (amod)
tachyarrhythmia ventricular (amod)
one kidney (nmod)
glomerulosclerosis to (case)
event the (det)
therapy single-dose (amod)
seem does (aux)
difficult practical (conj)
given monitored (conj)
precurarization after (case)
assessment causality (compound)
treating hospital (nmod)
discontinued carbamazepine (nsubjpass)
distinguish group (nmod)
underwent mrna (nmod)
exercise during (case)
drainage ileostoma (nmod)
presence to (case)
surviving those (det)
barrier blood (compound)
aspects . (punct)
stroke n (dep)
performance simulator (compound)
number mice (nmod)
blocks 2a (dobj)
mediated reaction (nsubjpass)
test oral (amod)
mosmol/kg osmolality (nsubj)
rigidity measured (acl)
transplants in (case)
cultured methods (nsubjpass)
interna pallidus (compound)
variable the (det)
relationship appearance (nmod)
pancytopenia of (case)
signs encephalopathy (nmod)
granules many (amod)
cause syndrome (nsubj)
presented signs (nsubjpass)
magnitude sufficient (amod)
hospital , (punct)
reports serious (amod)
investigate agents (dobj)
cis-platin with (case)
injury oxidation (compound)
potential separating (acl)
subjected sessions (nmod)
patient ie (nmod)
ligation- and (cc)
mv or (cc)
phentolamine alone (advmod)
institution a (det)
fluency verbal (amod)
sacrificed ( (punct)
dosage proper (amod)
considered explored (conj)
agent prokinetic (amod)
mg 0.24 (nummod)
active to (mark)
determine involvement (nmod)
similar methylphenidate (nsubj)
receiving bupivacaine (dobj)
sensitive neither (preconj)
loss patients (nmod)
systolic dysfunction (dep)
decrease substantial (amod)
diminish to (mark)
boluses delivering (compound)
remains indicating (xcomp)
development : (punct)
anesthesia regional (amod)
control rate (compound)
treatment kinin (amod)
twelve hundred (compound)
produces confirms (ccomp)
assessment as (cc)
leukoencephalopathy a (det)
examined isoproterenol (nmod)
improve health (dobj)
prevalence prolongation (nmod)
hoe 140 (nummod)
ones dyskinetic (amod)
tribute ( (punct)
properties by (case)
% = (parataxis)
phosphatase a (det)
receptors beta-adrenergic (amod)
choreic which (nsubj)
metabolism their (nmod:poss)
episodes to (case)
use antagonist (nmod)
various and (cc)
treatment bortezomib (nsubj)
indicator early (amod)
groups deprived (amod)
dysfunction neurological (amod)
involved distinguished (conj)
reserpine of (case)
reversal 2 (dep)
data " (punct)
disease end-stage (compound)
had exposure (dobj)
differences outcomes (nmod)
neuropathy peripheral (amod)
randomized studies (conj)
test habituation (compound)
heterogeneity ctni (nmod)
serotonin rat (compound)
iso-osmolar , (punct)
protocol utilizing (acl)
tnfalpha and (cc)
% within (case)
relationship bradycardia (nmod)
starting doses (nmod)
study postmarketing (amod)
comparable incidence (nsubj)
cost-savings a (det)
defect septal (amod)
eighties of (case)
animals ovariectomized (amod)
effective given (advcl)
delivered section (nmod)
prevention syndrome (nmod)
downregulates alpha2- (dobj)
fell v/s (nmod)
index in (case)
application a (det)
tmax ) (punct)
appear rbcs (nsubj)
ua ( (punct)
jj ng/mg (dep)
increased diameter (dobj)
team care (compound)
lasting 2h (nmod)
cotransporter bsc-1 (appos)
% 19.3 (compound)
underwent anaesthesia (nmod)
hospitalised were (auxpass)
ocs reference (nmod)
decreases significantly (advmod)
longer statistically (advmod)
application naa (nmod)
administration direct (amod)
resolve because (mark)
atherosclerosis of (case)
% inpatients (nmod)
chorea or (cc)
neurotoxicity chemotherapy (nmod)
developed rat (nmod)
metolachlor between (case)
factor transcription (compound)
maintained rats (dobj)
cells medulla (nmod)
larger . (punct)
carried found (conj)
cb 3717 (nummod)
24 4:15 (nummod)
di in (case)
arteries human (amod)
widened weeks (nmod)
resulted which (nsubj)
differences levels (nmod)
mrna cis (compound)
associated sgk1(+/+ (nmod)
associated results (nsubjpass)
malformations cardiovascular (amod)
infarction spasm (nmod)
developed prolongation (dobj)
hormones and (cc)
bupropion dysfunction (nmod)
recorded indication (dobj)
symptoms or (cc)
benzodiazepines anaesthesia (conj)
recently only (advmod)
c only (advmod)
wear excessive (amod)
retention- retrieval-deficit (conj)
series injections (nmod)
enzymes tissue (compound)
included variables (nsubj)
current pacemaker (compound)
health overall (amod)
exacerbation caused (acl)
microg/kg 350 (compound)
toxicity ischaemia (conj)
minute per (case)
metabolism metoprolol (nmod)
3'-azido-2',3'-deoxythymidine azt (appos)
cases occlusions (nmod)
fetus abuse (nmod)
tissue normal (amod)
performed center (nmod)
observed studied (advcl)
group users (nmod)
analysis regression (compound)
increases and (cc)
antagonist mglur1 (compound)
series surveillance (nmod)
metabolites cyclophosphamide (compound)
group long-term (amod)
evening every (det)
palliation for (case)
years 17,2 (nummod)
levels > (nmod)
vena cava (amod)
died died (conj)
potential anxiogenic (amod)
caused pathway (nmod)
manner concentration-dependent (amod)
h day (nmod)
prevent not (neg)
mechanism regulation (nmod)
rate administration (nmod)
symptoms % (appos)
conclude affirming (advcl)
adenocarcinoma vagina (nmod)
agent generation (compound)
loss creativity (nmod)
compressed head (nmod)
states concentrations (conj)
transplantation failure (nmod)
half-life median (amod)
attributed reactivation (nmod)
number joints (nmod)
superior terms (nmod)
placebo : (punct)
reduced propranolol (nmod)
enhanced stimulation (nsubj)
release an (det)
recruited . (punct)
reports twenty-one (nummod)
toxic allergic (conj)
measured activity (nsubjpass)
18 up (advmod)
circuit dialysis (compound)
contained glomeruli (nsubj)
access(r ) (punct)
signs typical (amod)
phenomenon no (neg)
mechanisms siat (nmod)
event both (nmod:npmod)
associations the (det)
group stn (compound)
positive mssa (nmod)
provides challenges (dobj)
entities other (amod)
b.i.d. ) (punct)
50mg/kg or (cc)
baroreflex of (case)
caused not (neg)
differences distinct (amod)
wales , (punct)
resulted linezolid (amod)
high are (cop)
antigen b (compound)
duration the (det)
ever if (mark)
nanoparticles solution (appos)
diagnosing for (mark)
patients history (conj)
associated previously (advmod)
sulphate , (punct)
alleviated using (xcomp)
term the (det)
type syndrome (nmod)
0.31 greater (advmod)
touch pain (conj)
compared males (nmod)
levels trough (compound)
injections botox (compound)
studied patients (nsubjpass)
concluded increases (ccomp)
ic50s = (amod)
unique extensive (conj)
anaesthetic previous (amod)
exploited effects (nsubjpass)
execution in (case)
reductions pressure (nmod)
injection intraperitoneal (amod)
gel a (det)
preventing in (mark)
candidate that (mark)
treatment akathisia (nmod)
timolol ) (punct)
saw . (punct)
times respective (amod)
have antagonists (nsubj)
remains and (cc)
deficits potential (amod)
collected and (cc)
decided research (xcomp)
implanted days (nmod:tmod)
attempt to (mark)
failure hemorrhaging (conj)
had indices (dobj)
techniques computerized (amod)
given child (nmod)
hexaaldose not (neg)
sclerosis of (case)
suspect occurring (advcl)
injection r(2)=0.79 (appos)
synthesis bs (compound)
ampicillin gentamicin (conj)
derivative first (amod)
years 25 (nummod)
concentrations kidney (nmod)
began change (nsubj)
agonist clonidine (nsubj)
behavior ouabain-induced (amod)
randomised double-blind (dep)
women groups (conj)
defects observed (acl)
doses/day 3 (nummod)
exclusively not (neg)
fluids with (case)
present vulnerability (dobj)
l-dopa mg/kg (dep)
severity myalgia (nmod)
suxamethonium against (case)
types induced (acl)
presentation initiation (nmod)
facilitates bradycardia (dobj)
femoral map (compound)
sop ) (punct)
% death (conj)
hemolysis clinical (amod)
beta-carboline this (det)
reservations as (prep)
selected defects (dobj)
changes breast (compound)
evaluate course (dobj)
adaptation an (det)
dilation tropicamide (nmod)
blood baseline (compound)
withdrawal verapamil (nmod)
years 29.9 (nummod)
tobramicyn concentrations (nmod)
slowed slightly (advmod)
homogenates renal (amod)
placebo of (case)
reduced enhanced (conj)
risk mortality (nmod)
pain jaundice (conj)
mucosa duration (dep)
damage assessed (acl)
four and (cc)
associated deficiency (nmod)
a tacrolimus (conj)
supports concerns (dobj)
baseline c (conj)
requiring beta-agonists (dobj)
tended significant (ccomp)
study large (amod)
induced fenoldopam (nmod)
bendrofluazide or (cc)
defects for (case)
292 of (advmod)
randomized none (nsubjpass)
mellitus hypertension (conj)
two nephrolithiasis (nmod)
damage neurons (nmod)
indicate plays (ccomp)
decreased % (nmod)
tubules in (case)
organs various (amod)
66.9 ; (punct)
required conversion (dobj)
tolerability gastrointestinal (amod)
formulation with (case)
score y-mrs (compound)
aminoglycoside is (cop)
use other (amod)
withheld achieved (conj)
diagnosis hiccups (nmod)
prevent lidocaine (nsubj)
output emax (conj)
reversed . (punct)
ratio 1.03 (conj)
distance m (compound)
shifts , (punct)
delay papaverine (nmod)
increased sfas (nsubjpass)
introduction quetiapine (nmod)
herbals on (case)
washout 3-week (amod)
gentamicin such (case)
cigarettes or (cc)
cardioversion fibrillation (nmod)
persisted learning (nsubj)
block left (amod)
serve evaluating (advcl)
discussed reviewed (conj)
involve those (nsubj)
examinations clinical (amod)
preferring rizatriptan (dobj)
volume urinary (amod)
paracetamol by (case)
cats on (case)
delays . (punct)
polymyositis myopathy (conj)
instituted catalyzes (dep)
reduction withdrawal (conj)
potassium microl (compound)
nmbas , (punct)
involve potentiation (dobj)
study relationship (nmod)
ganciclovir with (case)
myoclonus negative (amod)
900 1,200 (conj)
herbicides , (punct)
received also (advmod)
60 30 (compound)
investigated ginsenosides (conj)
aneurysms smaller (amod)
admitted micu (nmod)
catheter probe (conj)
diagnostic the (dep)
clear . (punct)
demonstrating . (punct)
% 0.3 (nummod)
establish taken (advcl)
vision mouth (conj)
schedule children (nmod)
p olanzapine (conj)
occurred neutropenia (nsubj)
cultures in (case)
mg/m2 840 (nummod)
mg doses (conj)
histories about (case)
levels intrarenal (amod)
found : (punct)
palsy anticoagulant-induced (amod)
inhibited reversed (conj)
recreational heavy (amod)
alterations occurring (acl)
ballooning classic (amod)
cxcl1 il-1beta (conj)
evening placebo (nmod)
activity depressed (amod)
disorder gastroesophageal (amod)
values on (case)
c vitamin (compound)
myalgia evidence (dep)
appeared predominantly (advmod)
users pill (compound)
fluphenazine catalepsy (conj)
sgk1(-/- in (case)
novelty to (case)
powders the (det)
led have (aux)
absent helpful (advcl)
combination this (det)
suffering cips (nmod)
3.45 +/- (cc)
activity ) (punct)
volume distribution (nmod)
factor ii (nummod)
measured tremor (nmod)
usually not (neg)
compared baseline (nmod)
sustained effect (nsubjpass)
proved relationship (nsubjpass)
profile bupivacaine (nmod)
rate mortality (compound)
scopolamine- and (cc)
july 2006 (nummod)
tests other (amod)
serotonin 5-ht (appos)
absence with (case)
exerted schedule (nsubj)
% 11.7 (nummod)
transplant with (case)
delivery 25 (compound)
blockade receptors (compound)
30 period (appos)
hyperalgesia ( (punct)
antagonist h1 (compound)
syndrome platypnea-orthodeoxia-like (amod)
chemotherapy prophylactic (amod)
rats sex (nmod)
evoked which (nsubjpass)
enzyme cox (compound)
predictor . (punct)
benzylpenicilloyl-poly-l-lysine benzylpenicilloate (conj)
dampens mechanisms (dobj)
mice display (acl:relcl)
symptoms asystole (conj)
predictors reduction (nmod)
cross-tolerant , (punct)
medium life-support (amod)
admissions two (nummod)
removed group (nsubj)
sought determine (xcomp)
opener the (det)
indicated loss (dobj)
fibrillation chemotherapy (nmod)
[3h]-naloxone nm (appos)
rc ) (punct)
reduced in (prep)
30 at (case)
calculated dosage (nsubjpass)
those contraindication (nmod)
complete to (mark)
action motor (compound)
nuclei dentate (compound)
50 75 (conj)
pathways innate (amod)
ectopies less (amod)
trial anastrozole (nmod)
mechanisms prl (compound)
infants 11 (nummod)
vulnerability events (nmod)
t+a , (punct)
discussed relation (nmod)
withdrawn therapy (nsubjpass)
test epm (compound)
constipation of (case)
data detailed (amod)
increased administration (nmod)
d-penicillamine . (punct)
shows work (nsubj)
recorded dose (nmod)
levels infusion (compound)
gliosis secondary (amod)
fibres the (det)
associated monotherapy (nsubjpass)
-chlorpheniramine plus (cc)
follow-up patient (nmod)
information important (amod)
756 25 (nummod)
alive grafts (nmod)
dealt . (punct)
a/j 39 (nummod)
sites same (amod)
solubility poor (amod)
that factor (nmod)
proteins range (nmod)
symptoms negative (amod)
interferon telaprevir (conj)
glycopyrrolate kg-1 (dobj)
methylation in (case)
analyzed component (dep)
treatment period (nmod)
malondialdehyde cardiac (amod)
effects antithrombin (nmod)
seemed hormone (nmod)
limitations with (case)
pregnane-20-ones ) (punct)
crosses so (conj)
site infection (nmod)
pretreatment prazosin (conj)
thyroxine or (cc)
model first (amod)
ruled myocarditis (nsubjpass)
melphalan cyclophosphamide (conj)
proteins apoptosis-related (amod)
spain in (case)
increased compared (dep)
rarer . (punct)
135 0.6 (conj)
evaluate aim (nsubj)
confirm effects (nmod)
define however (advmod)
tissue lung (compound)
similar diarrhea (nsubj)
doses patients (nmod)
seizures generalized (amod)
levetiracetam administered (acl)
damage casts (nmod)
rrmm ( (punct)
achieved mg/m2 (dep)
patients 840 (nummod)
patterns with (case)
exchange prednisone (conj)
relationship seizure (acl)
reports 39 (nummod)
day 11 (nummod)
decreased compared (prep)
fps and (cc)
group lidocaine/placebo (amod)
medications combined (amod)
amnesia avoidance (nmod)
injected mg (nmod)
test aeroallergens (nmod)
administration ifs (nmod)
fibres of (case)
examined 11 (conj)
grade - (punct)
cases nine (nummod)
performed investigations (nsubjpass)
reported effects (nsubjpass)
odds matched (amod)
woman colitis (nmod)
10 than (quantmod)
improving in (mark)
enhanced slightly (advmod)
groups postprocedural (amod)
g 100 (nummod)
instillation of (case)
agent flestolol (nsubj)
tacrine e-2020 (conj)
fmlp ( (punct)
avoid interpretation (nmod)
cardiotoxicity characterized (acl)
enhancement reflexes (nmod)
volunteered , (punct)
trabeculectomies % (appos)
contrary literature (nmod)
microfilaremia in (case)
scored occurrence (nsubjpass)
failed cacl2 (nsubj)
tumors papillomas (appos)
administration after (case)
synaptophysin snap-25 (conj)
mb with (case)
odds the (det)
cells fibres (conj)
pericarditis with (case)
reversibility lesions (nmod)
patients mmc-treated (amod)
implicated di (nmod)
dysfunction gallbladder (compound)
decades the (det)
stomach thickening (conj)
inhibit could (aux)
cystourethrogram voiding (amod)
convulsions evoked (acl)
layer layer (conj)
undergone deprivation (dobj)
proof somatotopy (nmod)
reference haemorrhage (nmod)
backgrounds the (det)
10 mg/kg/day (dep)
consequences no (neg)
content gaba (compound)
neurodevelopment and (cc)
edema with (case)
data these (nsubj)
microscopy biopsy (nmod)
hypertension control (amod)
reported patient (nsubj)
8) ( (punct)
transferred were (auxpass)
iohexol a (det)
half-time and (cc)
binding concentrations (nmod)
spectrum whole (amod)
fed restricted (dep)
recruited males (nsubjpass)
school university (compound)
comparable bolus (nmod)
weight patient (compound)
risk used (advcl)
six cases (nmod)
prolactinomas estrogen-induced (amod)
began month (nmod)
prevention globulin (nmod)
exposure 1-hour (compound)
receiving had (aux)
regimens dosing (amod)
produced profile (dobj)
causing known (ccomp)
thought , (punct)
developing strategies (dobj)
inducer reactions (nmod)
ah6809 antagonist (conj)
chemistry fragmentation (conj)
poisoned acutely (advmod)
abnormalities baseline (compound)
mediated is (auxpass)
les ) (punct)
concentrations mean (amod)
enzymes antioxidant (amod)
tachycardia clarithromycin-induced (amod)
five group (nsubj)
six four (quantmod)
use moderate (amod)
increase duration (nmod)
times infusion (compound)
80 from (case)
decrease of (case)
methysergide of (case)
administered session (nmod)
control animals (dep)
infiltration and (cc)
tubuli and (cc)
predictors dyskinesia (nmod)
dfmo plus (cc)
metabolic of (case)
inhibitor documented (amod)
umb24 21 (conj)
albino , (punct)
models of (case)
depressed days (nmod:tmod)
protocol improves (acl:relcl)
meq/l k (nsubj)
recipient in (case)
studies pharmacokinetic (amod)
toxicity progression (conj)
development clinical (amod)
given elevated (conj)
two premature (conj)
protein fusion (compound)
scopolamine or (cc)
divided received (conj)
reports only (advmod)
increased rate (dobj)
embryopathy of (case)
showed higher (advmod)
research it-tspa (nmod)
formation content (conj)
likely = (advcl)
effects 10(-3)m (conj)
period assess (acl)
known component (dep)
disorder lymphoma (appos)
fluoxetine paroxetine (conj)
concentrations , (punct)
dosages various (amod)
toxicities were (cop)
diagnosed resumed (conj)
contraindication they (nsubj)
medline library (conj)
seem prk (nsubj)
or % (appos)
function processing (compound)
nephritis and (cc)
nadir granulocyte (compound)
leukemia central (amod)
plasma moving-bands (dep)
streptozotocin in (case)
patients relapse (nmod)
therapies with (case)
activity free-field (amod)
had 380+/-587 (dep)
patient presenting (acl)
reactions linked (acl)
underestimate incidence (dobj)
ptra of (case)
milliliters blood (nmod)
produce improvements (dobj)
aches with (case)
effective mg (nmod)
exerts which (nmod)
emulsion lipid (compound)
caused administration (nmod)
risk on (case)
greater even (advmod)
episode arrest (nmod)
exposure surface (nmod)
cases 5 (nummod)
neurotoxic opioids (nsubj)
pathways through (case)
boy depression (nmod)
syndrome related (amod)
evaluated design (dep)
pathway activation (nsubj)
characterized blocking (nmod)
fits the (det)
closed when (advmod)
failure survival (conj)
crossmatching pre- (amod)
response decremental (amod)
polyuria with (case)
consistent effect (nsubj)
confirmed similar (ccomp)
substances tbarss (appos)
cells erythroid (amod)
hypotension refractory (amod)
sample outpatient (amod)
channel benzodiazepine-gaba-chloride (compound)
calculations children (nmod)
ed50 ( (punct)
estimated change (conj)
considered pain (nsubjpass)
clinic psychiatry (compound)
circumstantial and (cc)
protease cysteine (compound)
downstream stenosis (nmod)
paper millimetric (amod)
siat ) (punct)
glucose high (amod)
cancers testicular (amod)
3delta nl4 (compound)
different ptra (nmod)
level given (amod)
controlled akathisia (nsubjpass)
% proteinuria (nmod)
difference significant (amod)
induction on (case)
pseudolithiasis . (punct)
performance retention (compound)
significance and (cc)
extracts h. (compound)
restricted was (cop)
efficacy event (conj)
indicate supporting (advcl)
3 12 (conj)
erythroderma with (case)
method patients (appos)
escalation intrapatient (amod)
administration drugs (nmod)
zero group (appos)
proteins middle (nmod)
noted were (auxpass)
fed months (nmod)
hepatitis drug-induced (amod)
determined analysis (nmod)
lindane with (case)
congo the (det)
pathogenesis remodeling (nmod)
1.21 ( (punct)
nmol/l 600 (nummod)
isoniazid rats (nmod)
activity in (case)
graves ' (case)
complications institutions (nmod)
terms test (nmod)
pbo than (case)
protected kidney (dobj)
asystole cardiac (amod)
hyperkalemia . (punct)
induced trazodone (nsubj)
fenfluramine dexfenfluramine (conj)
role disease (nmod)
valve and (cc)
complication this (det)
performed test (xcomp)
micrograms micrograms (conj)
caution special (amod)
synthesis brain (nmod)
15 and (cc)
side-effect relevant (amod)
fps percentage (compound)
cardiomyopathy lactate (conj)
mg/kg hcl (compound)
width a (det)
examination the (det)
required has (aux)
given points (nmod)
3.1 0.5 (conj)
carboxylesterase of (case)
indicator cardiotoxicity (nmod)
dose-dependent blockade (dep)
slides n=25 (appos)
weeks 6 (nummod)
need images (nsubj)
size-dependent was (cop)
disruption to (case)
shock such (case)
hematoma induced (acl)
released recently (advmod)
group surgery (nmod)
lactoferrin lf (appos)
resistance excretion (conj)
toxin , (punct)
use long (amod)
modulation steroids (nmod)
toxicity tac (compound)
after and (cc)
menopause , (punct)
diagnosis dsm-iv (nmod)
new relatively (advmod)
motility abnormal (amod)
damage the (det)
evaluated was (auxpass)
3000 than (advmod)
measurements of (case)
hyperactivity than (case)
hydrochloride bepridil (compound)
extracted and (cc)
characterized bradycardia (nmod)
inhibits induce (conj)
predominance the (det)
suffers . (punct)
reabsorption tubules (nmod)
facial and (cc)
blockade toxicity (nmod)
skf d1 (compound)
pairs of (case)
associated so (advmod)
studies 3- (amod)
gender-dependent were (cop)
ischemia on (case)
became anaesthesia (nmod)
observations microscopic (amod)
levels symptoms (conj)
found dose (nmod)
undergoing anaesthesia (dobj)
injected days (nmod)
stages the (det)
effect development (nmod)
selected lines (dobj)
skf agonist (compound)
density function (conj)
circling predominant (amod)
surgeon the (det)
length a (det)
degree on (case)
behavior seizures (conj)
reported discussion (nsubjpass)
toxicity zidovudine (nmod)
lower comparison (nmod)
t , (punct)
task shifting (appos)
receiving years (nmod)
unclear utility (nsubj)
deterioration phenomena (conj)
reduces mortality (dobj)
frequency administration (nmod)
purpose thought (dep)
mechanism as (case)
dynamics oropharyngeal (compound)
evokes secretion (dobj)
doses yohimbine (nmod)
cimd for (case)
predicts thrombosis (dobj)
initiatives targeted (acl)
extubated was (auxpass)
course hypertension (nmod)
analysis profile (compound)
alterations hh (nmod)
viracept inhibitor (compound)
facilitate progression (dobj)
action antidiuretic (amod)
given naa (nsubjpass)
started individuals (nsubjpass)
influences in (case)
study open (amod)
viracept . (punct)
trials preliminary (amod)
treated additionally (advmod)
1999 2003 (prep)
used prevention (nmod)
devlin al (dep)
arms ) (punct)
righting reflex (dobj)
ingestion regular (amod)
dermatitis lichenoid (amod)
amisulpride with (case)
liver the (det)
ligand transgenic (amod)
cells microglial (amod)
concentration cgrp (compound)
periods eeg (nmod)
icrf-187 of (case)
initiated ; (punct)
glomerular early (amod)
manner patchy (amod)
agents antinociceptive (amod)
material methods (conj)
close on (case)
influence that (nsubj)
astrocytes by (case)
dose g (appos)
compromising was (cop)
basis longterm (compound)
prevention rejection (nmod)
administration vaccine (compound)
occurs syndrome (nsubj)
bleeding as (cc)
doses 10(-6 (nmod)
consisted norepinephrine (nmod)
december 28 (nummod)
spectrum dermatitis (nmod)
thickness an (det)
boy cardiomyopathy (nmod)
9 ] (punct)
genotyped enrolled (advcl)
developed total (nsubj)
suggest further (advmod)
mri fraction (nmod)
day adult (amod)
tuberculosis with (case)
appearances imaging (compound)
needed that (mark)
modification technique (nmod)
metronidazole erythromycin (conj)
ceruleus the (det)
stress increased (amod)
living of (case)
shown summary (nsubj)
side-effects biosyntheses (conj)
double was (cop)
reported centre (nmod)
( p (dep)
conditions pain (compound)
patients meth-induced (amod)
dysfunctions sexual (amod)
mg/kg amphetamine (compound)
undergoing surgery (dobj)
receiving therapy (dobj)
liver increased (amod)
agitation delirium (conj)
showed proteinuria (nmod)
subacute . (punct)
patterns medulla (nmod)
suggested result (nmod)
gauges with (case)
compared lipid (nsubjpass)
affected been (auxpass)
measured homogenates (nmod)
secretion circulation (nmod)
report newspaper (compound)
as . (punct)
continuing of (mark)
patient : (punct)
forced . (punct)
doses do (acl:relcl)
theorem bayes (nmod:poss)
remained methods (dep)
h doxorubicin (nmod)
euphoria such (case)
diet-fed and (cc)
hypertension ocular (amod)
thalidomide daily (amod)
naloxone pre- (amod)
mitigated manner (nmod)
four from (case)
fusion postero-lateral (amod)
compare surgery (nmod)
outflow to (case)
serum abstract (compound)
% years (nmod)
significance variants (nmod)
role infarction (nmod)
vol% concentration (conj)
contractility normalized (acl)
delivery distal (amod)
hypothesize , (punct)
binding striatum (nmod)
report second (amod)
serious deleterious (conj)
rate toxicity (compound)
taken therefore (advmod)
strong is (cop)
thickness nerve (compound)
afferents primary (amod)
suspected tacrolimus (nsubjpass)
visualize and (cc)
doses mg/kg (conj)
or regurgitation (conj)
aware those (nmod)
pretreatment and (cc)
july 2002 (nummod)
level renal (conj)
fell coma (nmod)
warrant results (nsubj)
dysfunction syndrome (conj)
schedule the (det)
responsiveness decreased (amod)
understood mechanisms (nsubjpass)
involved were (auxpass)
dose +/- (cc)
tariquidar tr(- (nmod)
pump osmotic (amod)
= hca (compound)
each ) (punct)
has compared (advcl)
rate dose (compound)
changes lacrimation (nmod)
subcutaneous transnasal (conj)
neurotoxic to (mark)
increase inhibit (conj)
case spontaneously (advmod)
specify death (dobj)
scans on (case)
combination zidovudine (nmod)
warranted developing (advcl)
monitor alterations (dobj)
meninges within (case)
correlate permeability (nmod)
recent recent (conj)
thromboembolism arterial (amod)
paf of (case)
oc newer (amod)
treatment dependence (conj)
events impairment (nmod)
dysarthria sign (conj)
premarin ) (punct)
reactivity dilevalol (nmod)
abscess a (det)
result effects (nmod)
monitor with (case)
expired spite (nmod)
cyclohexyl]benzeneactemide ) (punct)
changes significant (amod)
vessel the (det)
15 3 (conj)
block activation (dobj)
collagenase bacterial (amod)
score bmd (compound)
1.03 +/- (cc)
parturients status (nmod)
macroscopic analysis (dep)
times greater (amod)
adherence sop (nmod)
results between (case)
determined both (cc:preconj)
79 98 (dep)
limit safe (amod)
clinical biochemical (conj)
cirrhosis primary (amod)
potential arrhythmias (conj)
tolerance ribavirin (nmod)
number test (nmod)
led preserved (conj)
lindane se (advmod)
receive which (nsubj)
acuity high- (amod)
vehicle itself (nmod)
two others (conj)
7-ni ) (punct)
initiation process (nmod)
rb1 times (appos)
documented is (cop)
examined alternative (ccomp)
prolongation qrs (compound)
p450s on (case)
dexmedetomidine alpha-2 (compound)
treatment facilitated (amod)
sensitivity rat (nmod)
meq/l. level (nsubj)
p02 mm (nmod)
assigned : (punct)
cells/mm3 change (nsubj)
patients terminal (amod)
ninety-seven hundred (dep)
cases anencephaly (nmod)
frequency high (amod)
studied dogs (nmod)
utility the (det)
hoarseness 8) (appos)
malformations occur (acl:relcl)
eyes subjected (acl)
implicated hepatotoxicity (nmod)
chx+pilo , (punct)
obstruction massive (amod)
treadmill and (cc)
administered methods (dep)
doses model (nmod)
p did (aux)
% symptoms (nmod)
recalled were (auxpass)
pethidine receiving (compound)
cells known (acl:relcl)
hypertension ppa-induced (amod)
associated hearing (advcl)
events haart (nmod)
apoptosis of (case)
used prophylaxis (nsubjpass)
have would (aux)
difficult extent (nsubj)
opponent toward (case)
localization lesions (nmod)
map to (mark)
eyes implanted (amod)
rate overall (amod)
disability off-period (amod)
cells progenitor (compound)
cancer including (case)
fev1 responders (appos)
found metabolizer (ccomp)
responsiveness the (det)
curve formula (nmod)
rate cr (amod)
baseline than (case)
sensitive patients (advcl)
recorded electrocardiograms (nsubjpass)
points , (punct)
n ( (punct)
demonstrated occur (xcomp)
vomiting rescue (conj)
10- or (cc)
plays cx3cr1 (nsubj)
programmed increase (dobj)
carcinoma endometrial (amod)
therapy without (conj)
consume patients (nsubj)
counted movements (nsubjpass)
11.5+/-1.4 from (case)
relation defects (nmod)
cocs cpa/ee (conj)
associated prognosis (nmod)
ck-mb or= (amod)
cyp7a ( (punct)
origin with (case)
compared and (cc)
tachycardia sinus (compound)
subunit cox (compound)
regulator used (acl)
information diagnostic (amod)
detected . (punct)
role convulsions (nmod)
median range (dep)
617 +/- (cc)
participants among (case)
safety capecitabine (nmod)
benefits harms (conj)
retrograde techniques (dobj)
tests subsequent (amod)
lasted hours (nmod)
dosage despite (case)
morning until (case)
occurs adulthood (nmod)
effects agent (nmod)
carboplatin rhuepo (conj)
woman 81-year-old (amod)
raises hypothesis (dobj)
markers markers (conj)
patients prolongation (nmod)
patient 38-year-old (amod)
schedule fda-approved (amod)
involve structural (dobj)
describe discontinuation (nmod)
nacl ) (punct)
cancer colon (compound)
l-[3h]nicotine of (case)
localization preferential (amod)
significant more (advmod)
models hypertension (nmod)
appeared mouth (nmod)
carcinoma colon (compound)
patients 54 (nummod)
body 4 (nummod)
activation prejunctional (amod)
whereas were (cop)
nerve the (det)
overshooting forces (nmod)
included has (aux)
time correlation (appos)
treatment etoricoxib (compound)
large hump-like (conj)
therapy srl (compound)
line base (amod)
users nonusers (nmod)
metabolizer as (case)
vein from (case)
disappeared complaints (nsubj)
wsp versus (cc)
operations in (case)
diagnoses shift (nmod)
development fluctuations (nmod)
bupivacaine injected (acl)
rats ritanserin-treated (amod)
investigate herein (advmod)
coadministered onset (nmod)
suffering polydipsia (nmod)
levels comparable (amod)
addressed , (punct)
cardiotoxicity adr (compound)
implanting animal (dobj)
uptake by (case)
prevented administration (nsubj)
cross-linking collagen (nmod)
medline including (case)
complications fibrillation (nsubj)
reduction stress (compound)
features disorder (nmod)
ears both (det)
microinjection excitatory (compound)
studies because (case)
posterior reversible (dep)
determined weights (nsubjpass)
optic transient (amod)
myalgia and (cc)
< 5 (compound)
% 14 (nummod)
choose . (punct)
inactivate normally (advmod)
centre at (case)
patients cd4 (nmod)
exposure cumulative (amod)
failure ciprofloxacin-induced (amod)
case be (cop)
harmless be (cop)
observed lesioned (conj)
type hit (compound)
identify could (aux)
mg/kg 10.0 (nummod)
disease progressive (amod)
intervals ( (punct)
kept be (auxpass)
sequencing by (case)
implanted cannulae (nmod)
incidence and (cc)
analgesia and (cc)
studied reversal (parataxis)
effects related (amod)
although common (nmod)
use methamphetamine (compound)
receptor serotonin-1a (compound)
bleeding of (case)
hemiparesis transient (amod)
implicated studies (nmod)
group amphetamine-free (amod)
short-term ' (punct)
catecholamine the (det)
quadriparesis pain (conj)
elisa dual (amod)
increased titres (nsubj)
affect smoking (nsubj)
dp/dtejc artery (compound)
test each (det)
was point (nmod)
indicate needed (ccomp)
conclude , (punct)
adriamycin adr (appos)
known fully (advmod)
diffusion-weighted and (cc)
cacl2 and (cc)
titrated mg/day (conj)
period using (acl)
stroke rats (nmod)
bound band (nmod)
consisted while (mark)
dysfunction ear (nmod)
used papaverine (nsubjpass)
rather than (mwe)
thickened had (aux)
correlate ngf (nsubj)
methods indirect (amod)
headache of (case)
metabolites of (case)
remained ctni (nsubj)
week a (det)
insufficiency transplantation (nmod)
hypertension with (case)
mg/ml ) (punct)
increased administration (nsubj)
had days (nmod)
toxicity related (amod)
weeks abstinence (nmod)
nsaids ) (punct)
increased may (aux)
initiating haart (dobj)
dogs receiving (acl)
ml % (appos)
recognise possibility (dobj)
rs of (case)
experienced use (nmod)
3h-tbob bicyclo-orthobenzoate (dep)
verapamil nor (cc)
reversible whether (mark)
picture , (punct)
treatment danazol (nmod)
mg/day or (cc)
reactions skin (compound)
tests reactions (nmod)
delay median (amod)
focused has (aux)
thrombotic serious (amod)
restoration function (nmod)
hyperthermia mg/kg (compound)
collagen glycoaminoglycans (conj)
glomerulonephritis unique (amod)
sensitized patient (nsubjpass)
responded , (punct)
therapy ht (appos)
therapy lmwh (compound)
more substantially (advmod)
protein ut-a1 (compound)
peld scores (conj)
four all (det)
properties occlusive (amod)
feasible , (punct)
recovery natural (amod)
mmol/l . (punct)
liver some (nmod)
licensed combination (conj)
reported ) (punct)
detection histology (conj)
hospital university (conj)
hypokalemia beta-2-adrenoceptor-mediated (amod)
exerts action (dobj)
correlated proteinuria (nsubj)
brought day (nmod)
revealed disturbances (dobj)
vnr and (cc)
use habitual (amod)
benefits increased (amod)
schedule dose (compound)
gem-p of (case)
structure on (case)
increased amounts (dobj)
induce augmented (conj)
one ketosis (conj)
risk tumors (nmod)
test bar (compound)
exposure a (det)
% 6.8 (compound)
gfap levels (dep)
workers exposed (amod)
thrombosis mice (nmod)
exposure following (case)
identifiers patient (compound)
rats lw (compound)
needle an (det)
inhibited cord (nmod)
portions lung (compound)
relationship stress (nmod)
cytoplasm hepatocytes (nmod)
dose intermittent (amod)
inhibitors synthetase (compound)
tumors ta-t1 (compound)
left that (mark)
conjugation acid (compound)
histology of (case)
had term (nmod)
repeat investigator (nmod)
surgery in (case)
psa rising (amod)
reduced sensitization (nmod)
caused hyperprolactinemia (nsubj)
complications leukemia (nmod)
outcome an (det)
mediated effect (nsubjpass)
role expression (nmod)
study baseline (compound)
clinical evaluations (dep)
decrease aspirin (nsubj)
frequencies actual (amod)
enhances which (nmod)
values absolute (amod)
carbonate to (case)
infusion occurred (acl:relcl)
method may (aux)
cases hepatotoxicity (nmod)
group frail (compound)
re-exposure of (case)
les ptz (conj)
degeneration axonal (amod)
therapy intensive (amod)
reconsidered should (aux)
anticoagulation bypass (nmod)
regressed completely (advmod)
treatment quetiapine (nmod)
days left (dep)
tests psychopharmacological (amod)
predict ptcr (nsubj)
discharged and (cc)
prolactin prl (appos)
overview brief (amod)
triglycerides ( (punct)
assessable pretreated (nsubj)
7 approximately (advmod)
liver functional (amod)
receiving patient (nsubj)
derivatives amino (compound)
associated vgb (nmod)
indicate prevent (ccomp)
n-methyl-d-aspartate titre (compound)
female ) (punct)
difficult patients (nmod)
lead given (case)
administering therapy (dobj)
amplitude action (compound)
causes damage (dobj)
570 47 (conj)
act but (cc)
facilitate will (aux)
resulting angioedema (nmod)
severity clinical (amod)
breakfast before (case)
activity electromyographic (amod)
hydration forced (amod)
amino-nucleoside pan (appos)
presentation of (case)
twice almost (advmod)
measured measured (dep)
january 1992 (nummod)
n-methyl-d-aspartate mice (dep)
seen superimposed (conj)
thrombocytopenia nausea (conj)
injection adr (nmod)
examined must (aux)
treatment dox (compound)
cns and (cc)
changes cholinergic (nmod)
2 more (amod)
had rats (advcl)
treated monotherapy (nmod)
increase markedly (advmod)
blinded was (auxpass)
resulted proarrhythmia (nmod)
cells/mm3 was (cop)
structures spinal (compound)
mg/m2 ( (punct)
shown i (nsubjpass)
twelve % (appos)
myocytes adult (amod)
discharge fentanyl (nmod)
implicated receptor (nsubjpass)
complained who (nsubj)
first second (conj)
product in (case)
examined modulating (advcl)
p=0.008 ) (punct)
effects concentrations (conj)
desire examination (conj)
show whether (mark)
group associated (acl)
sessions stimulation (nmod)
cessation complete (amod)
pointer inexpensive (amod)
features hepatitis (nmod)
man 33-year-old (amod)
treatment acromegaly (nmod)
accounted for (nmod)
incorporating period (nmod)
responses with (case)
decreased gfr (nsubj)
recovery this (det)
arag ) (punct)
amount ctni (nmod)
pacemakers nodal (compound)
showed monohydroxyethylrutoside (nsubj)
diluents ph (nmod)
treatment scleroderma (nmod)
subsequent administration (nmod)
1.04 0.11 (conj)
nik-247 not (cc)
occurred that (nsubj)
indistinguishable those (nmod)
ctc-nci were (cop)
remd of (case)
area wider (amod)
mismatch demand (conj)
parameters patient (conj)
iv ) (punct)
cells h (conj)
haemodilution moderate (amod)
immunohistochemistry by (case)
air of (case)
therapy ophthalmic (amod)
septicaemia % (appos)
lidocaine- cocaine-induced (conj)
effect because (case)
induce hypomagnesemia (nsubj)
or separately (advmod)
seriousness phenomenon (nmod)
controls matched (amod)
range 81 (dep)
model address (acl)
3 up (quantmod)
patients vt (nmod)
patients further (amod)
frequent the (det)
angiotensin ii (nummod)
prevents administration (nsubj)
action drug (compound)
nucleotide-gated the (det)
restored almost (advmod)
ratio risk-benefit (amod)
bp radiotelemetric (amod)
severity according (case)
support experimental (amod)
review cases (nmod)
sinus superior (amod)
anticoagulants filters (conj)
features observed (acl:relcl)
dose third (amod)
amplitude ) (punct)
testing forced (amod)
dose clomipramine (nmod)
injection hr (conj)
assessed investigate (xcomp)
reduction l-dopa (nmod)
referred output (nmod)
coordination hand (nmod)
agricultural industrial (conj)
hepatotoxicity . (punct)
started prior (advmod)
reduce hyperprolactinemia (nsubj)
control exercise (compound)
reports describing (acl)
found decrease (nsubjpass)
cells area (nmod)
nephrotoxic seems (conj)
increase generation (nmod)
nephrectomized sham (dep)
inhibited ( (punct)
cessation heparin (nmod)
treated tolazamide (nmod)
monitoring routinely (advmod)
adequate treatment (nsubj)
patients toxicity (nmod)
maintained thereafter (advmod)
assessment audiologic (amod)
phase both (cc:preconj)
evident nrf2(-/- (nmod)
cells bmcs (appos)
% 94 (nummod)
uptake segments (nmod)
finding last (amod)
patients sensitive (acl:relcl)
units 14.9 (nummod)
cr as (case)
restriction diet (amod)
examine impact (conj)
100 to (quantmod)
physiology pharmacology (conj)
lowered threshold (dobj)
kg 13.4 (nummod)
combined clonazepam (nmod)
believed case (ccomp)
conclusions rare (dep)
nephrotoxicity of (case)
htr6 ) (punct)
monkeys such (amod)
hypothyroid who (nsubj)
months 18 (nummod)
appears tolerated (conj)
controls saline-injected (amod)
neurotoxicity about (case)
men seventy (nummod)
investigated period (nmod)
elevation s(c)o(2 (nmod)
implanted totally (advmod)
maleate perhexiline (compound)
oc ) (punct)
augmented rather (advmod)
agent anticancer (compound)
illness thyroid (compound)
hr ci (dep)
partially also (advmod)
receptor angiotensin (compound)
kinase ilk (appos)
regimen patients (nmod)
dosing antagonists (nmod)
syndrome mds (appos)
phenacetin paracetamol (conj)
gene bche (compound)
presence on (case)
onset period (nmod)
common proteinuria (nsubj)
given : (punct)
measured measured (ccomp)
nsaids non-selective (amod)
focusing clinical (nmod)
induced inhibition (nmod)
estimated it (nsubjpass)
thc of (case)
measures vs. (cc)
occur " (punct)
modification propranolol (nmod)
concentration below (case)
cerebral sphenoidal (conj)
contributes case (nsubj)
people in (case)
which in (case)
increase without (case)
constricting arteries (dobj)
function characterised (acl)
15/44 in (case)
declines function (nmod)
ambiguus or (cc)
visibility the (det)
given study (nmod)
pmol 6.87 (nummod)
exhibited cluster (nmod)
effects maximal (amod)
presented are (auxpass)
% dogs (nmod)
persons exposed (acl)
dxnp ) (punct)
report caused (acl)
combinations antiepileptics (nmod)
followed placebo (conj)
cells cd4 (compound)
receiving are (aux)
referred unit (nmod)
used showing (conj)
efficient prevention (nmod)
outcomes sleep (compound)
accompany remedy (conj)
discontinuation upon (case)
regained , (punct)
toxicity resuscitation (conj)
recorded swallowing (advcl)
revealed associated (conj)
ratio male/female (amod)
drug tubulopathies (nmod)
toxicity problem (nsubj)
prolapse migraines (conj)
features some (det)
finished and (cc)
problem cell (compound)
having other (nsubj)
group i (nummod)
received committee (nsubj)
toxicity dfp (nmod)
ds female (amod)
arterial , (punct)
greater mg/dl (nmod)
effect a (nmod)
weight ( (punct)
hours few (amod)
or 14.3 (nummod)
assay sensitive (amod)
relationship its (nmod:poss)
studied days (nmod)
di-o-tolylguanidine agonist (conj)
accompanied was (auxpass)
anesthesia delivery (nmod)
hypertrophy hyperplasia (conj)
triniol with (case)
appeared which (nmod)
decrease desire (nmod)
method patients (nmod)
hallucinations for (case)
immunotherapy overdose (nmod)
lasted longer (advmod)
required pacing (nsubjpass)
albuterol versus (cc)
moderate-dose 29.1 (conj)
suspected multiforme (advcl)
feared revealed (parataxis)
initiated , (punct)
have patients (nsubj)
suggesting further (advmod)
screened testosterone (nmod)
sarcomas lymphoma (conj)
comparisons users (nmod)
conclude has (ccomp)
received reports (dobj)
results examination (nmod)
cause phenomenon (nmod)
day 26 (nummod)
ganglia l6-s1 (amod)
psychosis behaviors (conj)
analogues cck-8-se (dep)
normalized until (mark)
classified reports (nsubjpass)
scores dyskinesia (compound)
prevent treatment (nsubj)
testosterone with (case)
received evidence (nmod)
analysis ich (nmod)
pneumonia causes (nsubj)
stimuli areas (conj)
increasing average (nmod)
distributed deposition (dobj)
scale simpson-angus (amod)
benefit models (nmod)
length to (case)
monitoring proteinuria (nmod)
use drugs (nmod)
had return (dep)
common fibrillation (nsubj)
level state (compound)
induced metoprolol (nmod)
assessed followed (conj)
studied members (nsubjpass)
moving and (cc)
behaviors induced (acl)
morphine metamizol (conj)
3 and (cc)
320/25 mg (dep)
a rapamycin (conj)
mm 86.2 (nummod)
restored rg1 (nsubj)
due complications (nmod)
characterized while (mark)
foci/cm2 with (case)
cd4 of (case)
reflex recovery (nmod)
history prolapse (nmod)
association treatment (nmod)
responders ) (punct)
conditions many (amod)
doses gum (nmod)
b c2 (conj)
% 7.1%-13.3 (amod)
performance total (amod)
representative pregnancies (nmod)
measure cle (dep)
fzp ( (punct)
association an (det)
minimizing in (mark)
dose mitoxantrone (nmod)
association failure (nmod)
case this (nmod)
insufficiency anemia (conj)
response binding (conj)
titrated target (nmod)
hemorrhage on (case)
557 67 (conj)
tumor associated (amod)
daytime indicative (amod)
women 390 (nummod)
imperative . (punct)
expanded modification (dobj)
maintained responses (nsubjpass)
estimation dose (nmod)
control csa (dep)
reversed increases (dobj)
comparisons for (case)
disappeared completely (advmod)
shown decrease (xcomp)
phase a (det)
artery left (amod)
involve fibers (dobj)
hypothyroid , (punct)
method underwent (dep)
toxicity acetaminophen (nmod)
smaller that (mark)
includes discovery (dobj)
maintained development (nmod)
dependency or (cc)
longitudinal strain (conj)
transplantation , (punct)
physiology acute (compound)
phenotype debrisoquine (compound)
seizure an (det)
inheritance epistatic (amod)
treated np (nmod)
syndrome hepatorenal (amod)
presents emergency (nmod)
that observed (acl)
benefit ): (punct)
one l-med (dep)
agonist d2-like (amod)
event hypoxia (nsubj)
p with (dep)
pb by (case)
patients manifestations (nmod)
volume causing (advcl)
inulin by (case)
described period (nmod)
prescribed efficacy (nmod)
hours litres/24 (compound)
concentrations activities (conj)
weight normal (amod)
monocular mean (dep)
case rare (amod)
department ) (punct)
discontinuance remission (nmod)
incidences exposure-adjusted (amod)
nephrotoxicity aminoglycoside-induced (amod)
prevent however (advmod)
followed vehicle (nmod)
reduced preparations (nmod)
signaling receptor-mediated (amod)
physician board-certified (amod)
used azathioprine (nsubjpass)
appears medication (xcomp)
have cells (nsubj)
patients not (neg)
gauges strokes (conj)
distribution of (case)
potentiated kf17837 (nsubj)
polysaccharide the (det)
selected and (cc)
tbm ( (punct)
rats morphine-treated (amod)
blockers reported (acl:relcl)
dysfunction erectile (amod)
normal fact (nmod)
abundant irrespective (advmod)
150 200 (conj)
dcf gtn (conj)
produced synthetically (advmod)
defect ventricular (compound)
analysed records (nsubj)
rhythm beating (compound)
occurrence glomerulonephritis (nmod)
hours surveillance (nmod)
caused intake (ccomp)
difficult adhesions (nmod)
complex aconitase (conj)
velocities with (case)
month within (case)
thickness arterial (amod)
blocker dopamine (compound)
artery renal (amod)
halos visual (amod)
period short (amod)
testosterone repeatedly (advmod)
remains diazepam (nsubj)
flashbacks as (case)
encephalopathy valproate (dep)
identified patients (nmod)
occur organization (nmod)
12.5 25mg/kg (conj)
followed recovery (nmod)
reactions paranoid (amod)
antibodies n-methyl-d-aspartate (compound)
monkey the (det)
less = (dep)
4.5 was (cop)
erection and (cc)
had disease (dobj)
assay activity (conj)
admitted month (nmod:tmod)
coli and (cc)
role manifestation (nmod)
observers between (case)
challenge trihexyphenidyl (amod)
treatment danazol (compound)
menorrhagia for (case)
% 27.3 (nummod)
atropine mg (dep)
naloxone clonidine (conj)
results ng./ml (appos)
5.3 - (punct)
inhibition factor (nmod)
used scale (nsubjpass)
shortage by (case)
dosage for (case)
mice 6 (nummod)
lines bs (compound)
1.8-fold , (punct)
occurred switches (nsubj)
normal results (nsubj)
medications no (det)
disease patient (nmod:poss)
ug.kg-1 0.5 (nummod)
infused session (nmod)
background occur (dep)
failure induced (acl)
understood pathophysiology (nsubjpass)
estimated risk (nsubjpass)
sensitization seizures (nmod)
woman all (det)
expression activation (conj)
k , (punct)
p or=0.001 (dep)
needle a (det)
ml/min hg/ml/100 (compound)
revealed weeks (nmod:npmod)
mhpg ) (punct)
increased peaking (advcl)
values peak (amod)
syndrome pulmonary-renal (amod)
block type (compound)
decreasing also (advmod)
observed regard (nmod)
glioblastoma with (case)
scale vas (appos)
measures gloves (nmod)
threshold " (punct)
assessed trials (nsubjpass)
examined 2- (nmod)
changed have (aux)
impairment mice (nmod)
impair improved (advcl)
time discontinuation (nmod)
reaction with (case)
use schedules (nmod)
ibuprofen mg/kg (appos)
symptomatology by (case)
showed lid (nmod)
as to (pcomp)
problem advanced (nmod)
designed using (xcomp)
patients a (det)
size tissue (nmod)
september , (punct)
responses positive (amod)
exclude possibility (dobj)
applied test (conj)
bisphosphonate of (case)
invasive minimally (advmod)
populations including (case)
immunohistochemistry sequencing (conj)
high % (dep)
causes permeability/injury (dobj)
4.1 2.7 (conj)
unnecessary and (cc)
known disease (nsubjpass)
visit follow-up (amod)
20 0.25 (compound)
lasting and (cc)
those of (case)
therapies anti-hypertensive (amod)
decrease exploration (nmod)
changes cholesterols (nmod)
given solution (nsubjpass)
resulted depression (nmod)
differ concluded (conj)
alternative igf-i (nsubj)
glomerular significant (amod)
noradrenaline and (cc)
study bolus (nmod)
reaction on (case)
conducted identify (xcomp)
significant p (dep)
explained pain (nsubjpass)
20 six (compound)
improving memory (nsubj)
remedies cold (amod)
sites anionic (amod)
areas affected (amod)
bacteria crystals (conj)
stress cardiac (amod)
2e1 ) (punct)
femoral ) (punct)
means medline (nmod)
cystitis strains (nmod)
documented man (nmod)
fit ( (punct)
induced mechanisms (dep)
agents toxic (amod)
moles/glomerulus and (cc)
rats aging (amod)
glycopyrrolate topical (amod)
pcr were (cop)
excretion urinary (amod)
induced marker (conj)
divided diameter (nmod)
level sodium (compound)
begun dobutamine (nsubjpass)
dobutamine (5.3)% (dep)
associated dysfunction (nmod)
did group (nsubj)
exposure sun (compound)
nephropathy n (dep)
applicators pesticide (compound)
2/1 with (quantmod)
or ci (appos)
weeks during (case)
studied children (nmod)
sacrificed week (nmod:tmod)
morbidity hypothyroidism (nmod)
studied modulation (dobj)
boy of (case)
inhibited but (cc)
pentylenetetrazole receptor (compound)
reveal supporting (advcl)
change type (nmod)
ingestion tablets (nmod)
nucleolus neurons (nmod)
interdependence the (det)
effect cardiotoxicity (nsubj)
associated comparison (nmod)
utility glepp1 (nmod)
undergo linked (conj)
2-sulfanylethanesulfonate with (case)
arrest deep (amod)
amplitude nerve (nmod)
lend results (nsubj)
effects antibody (nmod)
nine patients (nmod)
boy 5-year-old (amod)
excreted doses (nmod)
observed furthermore (advmod)
anesthetic . (punct)
increased suppressed (conj)
bilateral not (neg)
studies doxorubicin (compound)
visualize we (nsubj)
presented block (nmod)
1987 1991 (conj)
syndrome , (punct)
mg/kg 3 (nummod)
contention the (det)
express can (aux)
detection sulfate (nmod)
flumazenil dose (dep)
grafts with (case)
mg rats (nmod)
woman a (compound)
studied women (nsubjpass)
findings were (cop)
performed recommended (advcl)
hypokalemia despite (case)
allograft renal (amod)
developed carcinoma (dobj)
block instituted (acl)
days 1.4+/-4.0 (nummod)
decreased nitroglycerin (nmod)
3.32 ) (punct)
cardiotoxicity have (aux)
gene avp (compound)
modifications treatment (compound)
pharmacokinetics lometrexol (compound)
withdrawn h (nmod)
schizophrenia or (cc)
fluid cerebruspinal (amod)
treated vpa (nmod)
phenytoin and (cc)
got ) (punct)
ventilation prolonged (amod)
unique because (mark)
induces patients (nmod)
b ( (punct)
associated c (nsubj)
able recall (xcomp)
different measures (nsubj)
inflammation acute (amod)
duration time (appos)
alkaloid has (acl:relcl)
reticulum with (case)
compared receiving (xcomp)
toxin or (cc)
34.33 5.05 (conj)
total patients (nmod)
lasted , (punct)
provoked reduction (dep)
war the (det)
radiolabelling , (punct)
shortening contractile (amod)
introduced recently (advmod)
rp nk1 (compound)
resistance accompanying (acl)
mac ( (punct)
pressor bradycardia (conj)
return state (nmod)
drug caused (acl:relcl)
infection was (cop)
reduction ribavirin (compound)
associated stroke (nmod)
remodeling of (case)
both for (case)
ctx ) (punct)
80mg/kg/day ( (punct)
decrease ccr (nmod)
ms coupled (amod)
potassium and (cc)
tourniquets and (cc)
mild severity (nmod)
reduction progressive (amod)
antibody of (case)
viruses hemorrhagic (amod)
rule the (det)
efficacy compared (acl)
receptors dopaminergic (amod)
observation under (case)
bile index (dep)
found hypokalemic (nmod)
impaired patients (nmod)
system l-arginine-nitric (amod)
inhibitor diltiazem (nmod)
mellitus by (case)
city in (case)
caused rats (advcl)
age-dependent was (cop)
decreased gliclazide (nmod)
features unusual (amod)
diclofenac than (case)
patients 197 (nummod)
meq/l 0.6 (nummod)
aches ( (punct)
apomorphine given (case)
lidocaine- of (case)
hyperkalemia % (appos)
ameliorated was (auxpass)
levels d2 (compound)
artery internal (amod)
augment mg/kg (conj)
remapped a1 (nsubjpass)
formed . (punct)
stimulated were (auxpass)
increase doses (dobj)
patients ve (compound)
spasm and (cc)
elicit could (aux)
cessation for (case)
hepatitis cases (dep)
degree angiography (nmod)
involved consuming (advcl)
tested effects (nsubjpass)
use flestolol (nmod)
p=0.008 , (punct)
samples cell (compound)
observed days (nmod)
phenomenon described (amod)
palpitations 0.001 (dep)
those c (nmod)
withdrawn ethambutol (nsubjpass)
feeding , (punct)
lev neuropsychological (conj)
cyclosporine tacrolimus (appos)
% deaths (nmod)
increased retention (nmod)
verapamil diltiazem (conj)
returned zero (nmod)
underwent neonate (nsubj)
processing the (det)
armrest and (cc)
reach amounts (nsubj)
p53 dominant-interfering (amod)
injected controls (nsubjpass)
ps or (cc)
recorded trial (nmod)
12.5 of (case)
had pain (dobj)
heat pain (appos)
characterization comprehensive (amod)
associated data (nmod)
continued drinking (dobj)
and both (cc:preconj)
defend to (mark)
channels ) (punct)
receptor ccl2 (nmod)
p compared (dep)
tcr protected (acl)
believed interference (nmod)
4-hourly or (cc)
effects few (amod)
differentiate survivors (dobj)
ulcers associated (acl)
inhibition arrhythmia (nmod)
effects 17alpha-ethinylestradiol (nmod)
infusion given (acl)
caused neurotoxicity (nmod)
0.92 % (conj)
paclitaxel dose (nsubj)
valsartan study (dep)
follow-up years (nmod:tmod)
elevations limit (conj)
studies histological (amod)
necrosis healed (amod)
cholesterol cholesterol (nmod)
vehicle 1 (conj)
19.3 +/- (cc)
confirmed could (aux)
values to (case)
one s (nmod)
are reports (nsubj)
transport transmembraneous (amod)
rate infants (conj)
rate induced (acl)
prescribe therapy (dobj)
haematological systemic (conj)
alterations cerebellar (amod)
sweating reduced (amod)
anomalies major (amod)
tremor p (appos)
observed suppressed (conj)
suggested role (nsubjpass)
dose saline (dep)
education dyslipidemia (nmod)
supplementation e (compound)
calculated eye (nmod)
striatum . (punct)
studied identify (ccomp)
mm 5 (nummod)
reduced lethality (dobj)
effects combined (amod)
prescribed treatment (nmod)
increase times (nmod)
damage heart (nmod)
groups steroid (compound)
infections causing (acl)
pre- and (cc)
suggest background (dep)
anaesthesia and (cc)
dose with (case)
injection isph (nmod)
dysrhythmias such (case)
nodules or (cc)
p .006 (dep)
thus was (cop)
angiography indocyanine (compound)
% a (det)
recorded nitroprusside (nmod)
is likely (acomp)
lethality stress-induced (amod)
chemistry endonuclease-dependent (dep)
used still (advmod)
steroid endogenous (amod)
taking is (aux)
ischemia hypotension-mediated (amod)
reported 1997 (nmod:tmod)
crf % (dep)
hdl mainly (advmod)
was objectives (ccomp)
hypotension hyperactivity (conj)
minutes every (det)
detachment retinal (amod)
3 1 (compound)
reports by (case)
reduction long-lasting (amod)
increased glipizide (nmod)
performed using (advcl)
a(2a ) (punct)
27 which (nmod)
divided study (dobj)
exhibited compared (advcl)
demonstrated suggesting (advcl)
deficient da (nmod)
sensation heat (nmod)
measured hemodynamics (nsubjpass)
microscopy microscopy (conj)
emphasizes possibility (dobj)
studies an (det)
% ) (punct)
disease hypertensive (amod)
lower still (advmod)
march 24 (nummod)
injections days (nmod)
displayed mice (nsubj)
releases neurons (dobj)
pamidronate admission (nmod)
3.6 from (case)
rara on (case)
hearts hypertrophied (amod)
clearance systemic (amod)
histology cardiac (amod)
cases recent (amod)
regimens elf (nmod)
mg/dl 2.21 (nummod)
increases produce (conj)
find out (compound:prt)
immunostaining 7h6 (nmod)
0.63 of (case)
domains function (nmod)
result individuals (nmod)
bupivacaine anaesthetic (amod)
il-1 il-2 (conj)
therapy useful (amod)
cause function (dobj)
overall patients (nmod)
caused ischemia (nsubjpass)
studies epidemiological (amod)
embryos same (amod)
cord palpable (amod)
stimuli from (case)
was folate (conj)
patients procedures (nmod)
effects betaine (nmod)
stimulation real (amod)
associated clopidogrel (nmod)
patients oltx (compound)
factors including (case)
cld ( (punct)
determined increases (ccomp)
respect treatment (nmod)
u-ii administered (amod)
eegs 24_h (nmod)
years through (case)
treatment diethylstilbestrol (nmod)
hyperkalemia insufficiency (conj)
compared pharmacokinetics (dobj)
animals bcnu-treated (amod)
audiometry by (case)
infection immunodeficiency (compound)
associated presence (nmod)
performed , (punct)
means versus (cc)
deficits such (case)
criteria that (det)
chromatography hplc (appos)
aimed identify (xcomp)
reaction polymerase (compound)
rats gentamicin-treated (amod)
state a (det)
formed groups (nsubjpass)
sensitivity or (cc)
cognitive functioning (acl)
e of (case)
followed appearance (nmod)
produce induced (parataxis)
remains relevance (nsubj)
resembling obstruction (xcomp)
lethality physostigmine-induced (amod)
nature antipsychotic (amod)
discriminated , (punct)
chemotherapy to (case)
predated and (cc)
dementia of (case)
fall excretion (nmod)
activity exhibite (det)
markers other (amod)
born 1971 (nmod)
onset myoclonic (nmod)
patients > (dep)
dose combination (compound)
lithium from (case)
contraindication use (nmod)
concentration chp (compound)
atropine antagonists (conj)
effects weeks (conj)
population of (case)
map abnormalities (dobj)
protocol anesthetic (amod)
impotence male (amod)
hypotension prolonged (amod)
desogestrel g (conj)
apoptosis migration (conj)
neuroleptics haloperidol (acl)
acetaminophen group (nmod)
reach it (nsubj)
injection vincristine (nmod)
active nsclc (nmod)
h2o 0.75 (nummod)
test : (punct)
exposed study (nmod)
phenotyping behavioral (amod)
free ( (punct)
status the (det)
men in (case)
methods several (amod)
microg/kg/min ( (punct)
mass and (cc)
nephrotoxicity : (punct)
prior lindane (nmod)
fibrosis striped (amod)
is if (mark)
patient disease (nmod)
death 30-day (amod)
complication system (nsubj)
delayed missed (conj)
liberate no (dobj)
had migraines (dobj)
ct as (cc)
either with (case)
pain persistent (amod)
scarce data (nsubj)
patients reactions (nmod)
ibpb before (case)
sec for (case)
considered reflect (xcomp)
5 of (quantmod)
cystitis drug-induced (amod)
gland anterior (amod)
contributor mortality (nmod)
sensitive least (advmod)
caused provocation (nsubj)
mg h (appos)
yields pituitaries (nmod)
became patient (nsubj)
patients proteinuria (nmod)
virus hcv (appos)
was which (nmod)
constituents of (case)
showed parameters (nsubj)
perturbation mechanical (amod)
application similar (amod)
toxicity amb. (nmod)
any tissues (nmod)
subjects used (acl:relcl)
study nsc (appos)
chemotherapy the (det)
enhance could (aux)
therapy domperidone (compound)
suggest altered (ccomp)
examinations skin (conj)
injection intramuscular (amod)
response antioxidant (amod)
set in (compound:prt)
included were (auxpass)
ic50s ) (punct)
transport disintegrations (nmod)
abandoned to (mark)
ctni in (case)
rhythms . (punct)
number valves (nmod)
proteinuria markers (nmod)
40 up (advmod)
mitigated response (nsubjpass)
fed level (nmod)
administration additional (amod)
pulmonary resembling (dep)
demonstrate and (cc)
endografine dimer-x (conj)
analysis time (compound)
aware should (aux)
discontinued instrumentation (nmod)
using desipramine (dobj)
aims methods (conj)
seen control (nmod)
eliminated groups (nmod)
finding well (advmod)
specimens specimen (conj)
inhibition caused (acl)
sex to (case)
sweating no (det)
mm 50 (compound)
related causally (advmod)
permitted was (auxpass)
loss from (case)
investigate factors (dobj)
doses wr242511 (nmod)
produces lasting (acl)
consequence ascites (nsubj)
potential capacity (conj)
method applied (dep)
normal [na]o (dep)
exacerbated which (nsubjpass)
practitioners to (case)
dose decrease (acl)
deaths liver (compound)
decreased pbto(2 (nsubj)
tolerate subjects (nsubj)
concentration ce (appos)
agonists ) (punct)
nerve ulnar (amod)
day first (amod)
psychostimulant the (det)
vincristine doxorubicin (conj)
discontinued simvastatin (nmod)
twitch head (compound)
33.6 1.5 (conj)
scale anxiety (compound)
genotyped dna (nsubjpass)
efforts resuscitation (compound)
2600 or (cc)
caused infusion (nsubj)
dose by (case)
cirrhosis severe (amod)
haloperidol-treated animals (dep)
diet- and (cc)
cultured and (cc)
constriction with (case)
interactions them (nmod)
affected prevent (conj)
antagonist potent (amod)
days dose (nmod)
contents hippocampal (compound)
antagonist effective (amod)
reduced 68 (nmod)
modulate hormone (nsubj)
wt ) (punct)
remifentanil ce (nmod)
infarctions drug-related (amod)
absence . (punct)
males 36 (nummod)
studies long-term (amod)
characteristics induction (appos)
neurons and (cc)
concentrate to (mark)
1.0 , (punct)
reached ) (punct)
beating group (compound)
doses steroids (nmod)
preceded retention (dobj)
important situations (nmod)
detachment complete (amod)
resemblance form (nmod)
37.4 9.3 (conj)
option , (punct)
potential tumor (compound)
suggests prescribe (ccomp)
studies adenosine (nmod)
bfgf in (case)
known abnormalities (nsubjpass)
use pill (nmod)
patients 593 (nummod)
coma acidotic (amod)
pilocarpine ; (punct)
associated combination (nsubjpass)
female , (punct)
period tilt (compound)
obtained % (nsubj)
effects via (case)
kg-1 kg-1 (conj)
prolonged and (cc)
required thus (advmod)
benefit patients (nmod)
intrathecal systemic (dep)
arms between (case)
follow-up patients (nsubj)
agent candidate (compound)
side extrapyramidal (amod)
injections toxin (compound)
u/kg 100 (nummod)
aki associated (amod)
headache dizziness (conj)
stability in (case)
insufficiency pulmonary (amod)
tolerance sample (nmod)
scale panss (appos)
precursors erythropoietic (amod)
conclude administered (ccomp)
mesna given (acl)
dysfunctions headache (nmod)
adriamycin early (amod)
negative was (cop)
hypotension (ntg)-induced (amod)
doses antagonized (amod)
1.54 to (dep)
used evaluate (xcomp)
dopamine the (det)
show induce (ccomp)
influence concentration (nmod)
blockade enzyme (compound)
nerves midline (amod)
antifolate an (det)
established although (mark)
reduces requirements (dobj)
mediated reflex (nsubjpass)
increase ve (nmod)
effect cocaine (nmod)
unremarkable history (nsubj)
radiograph on (case)
albuminuria levels (conj)
separated : (punct)
secondary occlusion (nmod)
hyperalgesia/myoclonus doses (dep)
at even (advmod)
urine in (case)
minutes 514 (nummod)
co min(-1 (appos)
greater p (nmod)
surrounding lesion (dobj)
choice that (mark)
26- and (cc)
120 45 (compound)
eu to (case)
polymorphism type (compound)
resulted treatment (advcl)
surgery non-cardiac (amod)
epsilon4 between (case)
provide studies (nsubj)
were deaths (attr)
lead outcomes (nmod)
7.5 and (cc)
co-trimoxazole of (case)
started treatment (nsubjpass)
universal were (cop)
nx ( (punct)
given received (conj)
methods diagnostic (amod)
induces hyperactivity (dobj)
acromegaly treated (acl)
expression ccr2 (compound)
cortex inducing (acl)
il-6 of (case)
atropine of (case)
1 transferase (appos)
determine inconclusive (advcl)
react changes (nmod)
offered although (mark)
waves of (case)
depletion prolonged (amod)
volumes 2-chloroprocaine-ce (nmod)
gabapentin drug (appos)
continue planned (advcl)
factors disease (compound)
patients added (acl)
factor no (neg)
questionnaire baseline (nmod)
score . (punct)
program exposure (nsubj)
blocker a (det)
shown involved (ccomp)
aspects epileptogenesis (nmod)
received mg (dobj)
activities dehydrogenase (nmod)
potency and (cc)
tracings eeg (compound)
reduction without (case)
eruptions skin (compound)
hour within (case)
d-amphetamine apomorphine (conj)
wsr ( (punct)
lost one (nsubjpass)
investigates neuroprotective (ccomp)
pathogenesis myalgia (nmod)
enhancement later (amod)
assessed has (aux)
raloxifene mg/d (dep)
phenomena of (case)
scale asex (appos)
electrolyte and (cc)
well-tolerated effects (nmod)
ra ( (punct)
density inhibition (conj)
investigation anemias (nmod)
cross-reactivity with (case)
prevented seizures (dobj)
raise meq. (dobj)
hypotension selegiline-induced (amod)
gradient of (case)
evaluating efficacy (dobj)
moderate " (punct)
examination a (det)
if is (cop)
taking although (mark)
rejection , (punct)
properties pharmacodynamic (amod)
confirm effects (dobj)
agent anticonvulsant (amod)
men and (cc)
develop and (cc)
hemispheres the (det)
signaling norepinephrine (compound)
map basal (amod)
prolonged greatly (advmod)
same . (punct)
duct bile (compound)
aware mouth (nmod)
hydrochloride and (cc)
factor development (nmod)
1.85 0.35 (conj)
severe long (conj)
treatment progesterone (compound)
invasion a (det)
mm 1 (nummod)
months period (nmod)
severe initially (advmod)
development dysfunction (nmod)
lower values (nsubj)
syndrome fanconi (compound)
subjects healthy (amod)
degeneration transformation (conj)
prevented d-med (nsubj)
methods evaluated (appos)
woman 46-year-old (amod)
readings eeg (compound)
etiology proteinuria (nmod)
database research (compound)
rosaceiform appeared (advcl)
causing increase (dobj)
injection acetylcholine (nmod)
diarrhea , (punct)
developed raised (dep)
h juice (nmod)
demonstrate absence (nmod)
marker markers (conj)
manifestation imbalance (nmod)
uncontrollable persisted (conj)
inhibition injection (nmod)
maintenance in (case)
diabetic an (det)
system flow (compound)
l(-1 ( (punct)
placebo a (det)
49 7 (compound)
analysis model (compound)
reduced similarly (advmod)
recognized disappearance (nsubjpass)
monitoring events (dobj)
velocity systolic (compound)
minutes 90 (nummod)
causes which (nmod)
3tc regimens (nsubj)
rp and (cc)
fan ) (punct)
noted conclusions (dep)
m0 at (case)
deletion targeted (amod)
corticosteroids other (amod)
evaluated patients (nsubjpass)
diagnosed delirium (nsubjpass)
probable was (cop)
prolactin ng./ml (nmod)
management its (nmod:poss)
narrowed nafcillin (nmod)
microg/rat 2 (nummod)
influences nephrotoxicity (dobj)
tasks new (amod)
hospital university (compound)
gases and (cc)
segments l1-l2 (dep)
beclin 1 (nummod)
need which (nsubj)
associated congenita (nmod)
marker apoptotic (amod)
resolve may (aux)
alpha-motoneurons of (case)
phenomenon is (cop)
studied mechanisms (nsubjpass)
evaluated blotting (nmod)
mechanisms implicated (acl)
assay spectrometry (compound)
hepatitis u/ml (dep)
increase influx (dobj)
patients 204 (nummod)
5,7-dihydroxytryptamine by (case)
bands 1 (dep)
decreased uptakes (nsubjpass)
pathogenesis prevention (conj)
mice alpha2abc-/- (compound)
hyperkalemia indomethacin-induced (amod)
paradigm in (case)
patients amiodarone (nmod)
propagation seizures (nmod)
bnp of (case)
warfarin 2 (nummod)
involve . (punct)
erection behavior (conj)
mg. 60 (nummod)
produced decrease (nmod)
tests vitro (advmod)
undergoing is (aux)
drug particular (amod)
receptor and (cc)
pathways in (case)
addition dexamethasone (nmod)
preventing contact (dobj)
indicative not (neg)
indicates damage (dobj)
started . (punct)
recommended , (punct)
addition phenylephrine (nmod)
went cases (nmod)
induces asa (nsubj)
shown studied (advcl)
frequency bradycardia (nmod)
resolved clinicians (nmod)
rats calcification (conj)
values serum (compound)
% 15 (compound)
b1 b2 (conj)
method study (dep)
related usually (advmod)
heart patients (conj)
group 2 (nummod)
characterized ischemia (nsubjpass)
period ventricular (amod)
presented treatment (nmod)
behavior alternation (compound)
study looking (acl)
7.5 12 (conj)
induce pretreatment (nsubj)
blockers h-2 (compound)
drugs placebos (nmod)
mfs ) (punct)
34/45 ( (punct)
injury focal (amod)
subjects based (case)
p<0.01 ( (punct)
play element (dobj)
mothers treated (acl)
easy is (cop)
compared ability (dobj)
granulomatosis wegener (nmod:poss)
anesthetized were (auxpass)
examination acuity (nmod)
practice current (amod)
differed and (cc)
complexes electron (compound)
gene beclin (compound)
attenuation pretreatment (nmod)
lower markedly (advmod)
doses therapies (nmod)
prevented where (advmod)
diagnosis pain (nmod)
alleviate may (aux)
women 90 (nummod)
multiple not (cc)
antagonized activity (dobj)
alcohol acute (amod)
pci ) (punct)
t3n0m0 ) (punct)
31 these (nmod)
determined ; (punct)
events adverse (amod)
developed octreotide (advmod)
inhibitors for (case)
september 2005 (nummod)
short-term ) (punct)
0.63 mg/kg (dep)
concentration level (nsubj)
impair action (dobj)
g/dl 13.5 (nummod)
7- 17-year-old (conj)
obvious cause (nsubj)
bleed seizures (conj)
ng/ml 15 (dep)
difference concentrations (nmod)
action stabilizing (amod)
doses nontoxic (amod)
suggested angiogram (nmod)
ammonia coma (conj)
concentration argatroban (amod)
potassium unselective (amod)
properties iron (compound)
adjuvant an (det)
white-cell platelet (conj)
myopathy hyperckaemia (conj)
cause also (advmod)
treatment amiloride (compound)
% 11 (nummod)
university california (nmod)
signs damage (nmod)
disclosed absence (dobj)
erythroid endothelial (conj)
those cause (acl:relcl)
inclusion for (case)
nephrotoxic are (cop)
inactivated hydroxyl (dobj)
alteration of (case)
microl of (case)
returned count (nsubj)
s-312 s-312-l (conj)
epinephrine ep (appos)
kidney insufficiency (conj)
potentiated indicate (conj)
vomiting p (dep)
identified germany (nmod)
mrnas of (case)
exhibited glomerulosclerosis (dobj)
edema interstitial (amod)
10 more (amod)
changes 0.001 (appos)
had 8 (nsubj)
induce cells (nmod)
place conditioned (amod)
euphoria , (punct)
applying glycopyrrolate (dobj)
pethidine a (det)
clubs terminal (amod)
persisted maximally (advmod)
lids on (case)
learning group (nmod)
bear to (mark)
hexamethonium not (neg)
anorexigens , (punct)
associated effects (nmod)
vasoreactivity the (det)
anesthesia etomidate (nmod)
view this (det)
mg 75 (nummod)
conclusions cause (dep)
developed considered (advcl)
polychemotherapy under (case)
synthesis repair (compound)
boluses ethanol (nmod)
phenotype constitutes (acl:relcl)
able exacerbate (xcomp)
sets three (nummod)
3.1 range (dep)
induce mediate (conj)
extension width (appos)
cavity , (punct)
foci/cm2 20 (nummod)
patients prilocaine (nmod)
po ( (punct)
mek1 gsk3alpha (conj)
evaluation the (det)
conclusions displayed (appos)
fps the (det)
den : (punct)
requirements . (punct)
concentration fbal (compound)
sequelae neurologic (amod)
pneumonia with (case)
medication novel (amod)
moran , (punct)
levels renin (compound)
entity inflammatory (amod)
associated induction (nmod)
motor ( (punct)
hospitalization dwi (nmod)
hepatotoxicity drug-induced (amod)
appearance wave (nmod)
fashion and (cc)
erection the (det)
protection meta-analysis (dep)
lnna g/l (dep)
vomiting % (appos)
activation dopamine (compound)
seem play (xcomp)
drug unchanged (amod)
differentiate therapies (dobj)
antigen-positive and (cc)
decrease respectively (advmod)
reactivity lymphocyte (compound)
36 range (nmod)
assessed period (nmod)
affected significantly (advmod)
promotes factor (nmod)
mg.kg-1 + (cc)
microm 15.3 (nummod)
groups placebo (amod)
event ; (punct)
verify to (mark)
piroxicam for (case)
test climbing (compound)
nurse the (det)
density channel (compound)
acts complex (nmod)
line mouse (compound)
comparison timolol (nmod)
cord and (cc)
generated likely (advmod)
transplantation anticoagulated (acl)
involvement reward (nmod)
single starting (acl)
doxorubicin compared (case)
noted extremities (nmod)
superior : (punct)
those group (nmod)
expression protein (compound)
palsy , (punct)
used that (mark)
decreasing due (mark)
associated man (nmod)
greatest loss (nsubj)
treatment ceftriaxone (compound)
administered malfunctioning (nmod)
daytime at (case)
reported than (mark)
tools therapeutic (amod)
recurrent nephritis (appos)
57 of (advmod)
models pd (nmod)
showed decreases (dobj)
order conduct (acl)
treatment aminoglycoside (nmod)
separation genetic (amod)
has effects (nmod)
comparison sham (nmod)
systemic or (cc)
190 mg/24 (conj)
calculated dose (nsubjpass)
recurrence treatment (nmod)
times each (det)
difference true (amod)
promoted consistently (advmod)
therapy zdv (compound)
attention less (amod)
radical free (amod)
levels vip (nmod)
resulted decreases (dobj)
determined trial (nmod)
response epinephrine (nmod)
db 20 (nummod)
liver experimental (amod)
peaking days (nmod)
predictor strong (amod)
inserted reoccur (conj)
using times (nmod)
rare silent (advcl)
injury irreversible (amod)
ages role (conj)
injury ischemic (amod)
propranolol combined (acl)
hand on (case)
y-maze of (case)
lowering the (det)
levobupivacaine , (punct)
occurred simultaneously (advmod)
20 than (quantmod)
d l-sotalol (conj)
reported improvement (dobj)
propranolol intravenous (amod)
intake cause (conj)
attributable preservation (nmod)
u/l 513 (nummod)
dysfunction pentobarbital (nmod)
converted dose (nmod)
treated recognized (advcl)
weight ) (punct)
changes clear (amod)
recovery acuity (nmod)
related synthesis/release (nmod)
mu morphine (dep)
increased resulted (dep)
analyses sample (nmod)
within-subject , (punct)
developed % (conj)
bn of (case)
reports based (case)
done replacement (nmod)
increased percentage (nsubj)
extracted was (auxpass)
effects long (amod)
placebo atenolol (nmod)
doses sufficient (amod)
extend duration (conj)
60 or (cc)
eight , (punct)
controls 622 (nummod)
sirna age (compound)
higher h (nmod)
tumors . (punct)
synthesis/release of (case)
mediated may (aux)
diagnosis lt (nmod)
synthesis acid (nmod)
isoproterenol ( (punct)
4/- 1.4 (compound)
sufferers in (case)
leg and (cc)
primary associated (conj)
processes impaired (amod)
strains css (appos)
appeared weeks (nmod)
variables course (conj)
disease sporadic (amod)
abolishment oxprenolol (nmod)
hexamethonium peripheral (amod)
represent integration (dobj)
developing episode (dobj)
speech tremor (conj)
caused scopolamine (nmod)
supplements dietary (amod)
retrobulbar a (det)
rat solid (amod)
administered combination (nmod)
failure progressive (amod)
efficacious used (conj)
number cases (nmod)
reduced only (advmod)
woman-years 1,000 (nummod)
diagnosed unless (mark)
mug morphine (nmod)
cytopenias the (det)
sestamibi , (punct)
cd-832 micrograms/kg/min (appos)
episodes % (appos)
designed discern (xcomp)
effect treatment (nmod)
showed constriction (dobj)
point however (advmod)
maintained regimen (nmod)
treated mitoxantrone (nmod)
birth from (case)
weeks hepatitis (compound)
associated phosphatase (conj)
observed are (auxpass)
patients bladder (nmod)
paper of (case)
kidney diseased (amod)
volume hemorrhagic (amod)
regimens with (case)
suggest alpha-mediated (ccomp)
girl 15-year-old (amod)
recording improvement (nsubj)
etomidate injected (acl)
p100 71.3 (dep)
monitoring therapeutic (amod)
co2 ( (punct)
options ed (nmod)
vehicle concentration (conj)
terms efficacy (nmod)
dysfunction hyperlipidemia (conj)
enantiomer synthetic (amod)
12.1 0.17 (conj)
characteristic the (det)
prevented group (nmod)
case interesting (amod)
intervals in (case)
caused medications (nsubj)
damage nitrative (amod)
reduction bupivacaine (nmod)
weight density (conj)
shows that (mark)
headache in (case)
tolerance exercise (compound)
carriers hepatitis (compound)
suppressed capacity (nsubjpass)
inpatients to (case)
maximize to (mark)
index index (conj)
cystitis cp-induced (amod)
polymorphism sparteine/debrisoquine (compound)
occurs cerebrum (nmod)
propofol 2.5 (nummod)
patients days (nmod)
7.5 1.0 (conj)
measured h (nmod)
resulted dilation (nsubj)
risks relation (conj)
hyper-responsiveness a (det)
vascular renal (conj)
8.9 were (cop)
improve could (aux)
mmhg to (case)
groups mdma (compound)
terminate and (cc)
induces tacrine (nsubj)
mediates it (nsubj)
role given (case)
supplementation amiloride (compound)
dilatation a (det)
doxorubicin dexrazoxane (conj)
i.v ( (punct)
injury skin (compound)
administered are (auxpass)
report diagnosis (dobj)
reported switching (nsubjpass)
tuberculosis pulmonary (amod)
micrograms 600 (nummod)
anemia indomethacin (nmod)
discovered developed (xcomp)
evaluated response (nsubjpass)
mm respectively (advmod)
attribute played (acl:relcl)
cure not (neg)
effect conduction (nmod)
function cognitive (amod)
weight 250 (nummod)
mg/kg convulsions (appos)
observed alterations (nsubj)
regions segments (nmod)
mg/m2 doxorubicin (nmod)
determined expression (nmod)
metabolite of (case)
toxicity 5-fluorouracil (nmod)
compound , (punct)
cause dysfunction (dobj)
estimated patients (xcomp)
6.25 , (punct)
sympathectomy transthroacic (amod)
monitor and (cc)
represent that (mark)
catalepsy morphine-induced (amod)
remained thirsty (xcomp)
vasculitis ptu-associated (amod)
stable time (nmod)
alter significantly (advmod)
reduces development (dobj)
awake revealed (conj)
consumption fluid (amod)
cardiac and (cc)
risk chemotherapy (nmod)
one berlin (conj)
seen hepatocytes (nmod)
of ionic (amod)
cases 20 (nummod)
chick hypophysectomized (amod)
dosed achieve (xcomp)
ctnt ( (punct)
provides insights (dobj)
nephritis allergic (amod)
11.2 ) (punct)
68 patients (dep)
associated anesthesia (nmod)
saline diazepam (conj)
pressures central (amod)
n = (amod)
ischemia produced (acl)
creatinine greater (amod)
results measured (advcl)
magnitude modulation (nmod)
implant for (case)
symptoms apnea (nmod)
study trimethoprim-sulfamethoxazole (nmod)
histories insufficient (amod)
microgram mg (nmod)
early 1951 (nmod)
fluorescence fluo3 (compound)
regulation dopaminergic (amod)
sc/week mg/kg (compound)
problems encountered (acl:relcl)
limited studies (nsubjpass)
phase crossover (compound)
platinum of (case)
hundred thirty-five (conj)
claimed glutamate (nsubjpass)
treated use (conj)
withdrawn treatment (nmod)
reduced ctnt (conj)
patients on (case)
dismutase sod (appos)
bort after (case)
records computer (compound)
microg/kg 600 (nummod)
bzds/rds ( (punct)
meq/kg/day 4 (nummod)
undertook and (cc)
investigations preliminary (amod)
patients aids (nmod)
proteinuria/day of (case)
regimen immunosuppressive (amod)
alcalinization urine (nmod)
increased showed (parataxis)
defects compatible (amod)
alleviate deficits (dobj)
risk low-to-normal (amod)
hypertension or (cc)
inhibitor tafi (appos)
decreased stl1 (dobj)
episodes use (conj)
woman elderly (amod)
apnea nausea (conj)
coma . (punct)
showing deposits (dobj)
prophylaxis no (det)
min-1 limits (dep)
given patients (nmod)
normalized suggesting (advcl)
ibuprofen 0.95 (dep)
ambulate void (conj)
induced pressure (nmod)
caused hypertrophy (dobj)
management optic (nmod)
glomerulosclerosis due (case)
improve withdrawn (conj)
sample an (det)
hematuria microscopic (amod)
ras brain (compound)
audiograms serial (amod)
dose low (amod)
implicated indomethacin (nsubjpass)
pgp of (case)
reaction block (nmod)
developed years (dobj)
report part (nmod)
tolerated unreasonable (conj)
procedure nimesulide (nmod)
enabled withdrawal (nsubj)
access in (case)
levels hormone (compound)
therapy disease (nmod)
cardiotoxicity reduced (amod)
conditions tract (nmod)
tools pd (nmod)
time activated (amod)
fractures quality (conj)
groups control (amod)
affected models (nsubjpass)
regimen sequential (amod)
aap ami (conj)
weight dose (conj)
xo ) (punct)
val ( (punct)
warranted . (punct)
42 stratum (nmod)
response patients (conj)
protection observed (acl)
population well-defined (amod)
alkaloid chincona (compound)
papaverine onset (conj)
difference index (nmod)
pathway p38 (compound)
decreases incidence (dobj)
epithelium transitional (amod)
pan either (cc:preconj)
diarrhea nausea (conj)
toxicity ifosfamide (compound)
treatment trazodone (compound)
events considered (acl)
estimates risk (compound)
taking sulfate (dobj)
emphasis major (amod)
cases damage (nmod)
azithromycin of (case)
prevent affect (conj)
philadelphia , (punct)
cardiac systemic (conj)
acid fatty (compound)
status antigen (compound)
comparison compound (nmod)
follow during (case)
features pathophysiologic (amod)
ocs of (case)
produced carbachol (nmod)
setting non-interventional (amod)
hypertension of (case)
densities in (case)
effects adding (advcl)
rats amygdala-kindled (amod)
safety sedation (nmod)
greater overdose (nmod)
had phenols (nsubj)
determinant important (amod)
less 0.03 (nmod)
glomerulonephritis fibrillar (amod)
lead " (punct)
rats doxorubicin-treated (amod)
motif region (nmod)
etiology hypercalcemia (nmod)
meq/l . (punct)
drug given (acl)
use by (case)
infusion corticosterone (compound)
pra ( (punct)
events dose-limiting (amod)
records from (case)
medications anti-hypertensive (amod)
dose tna (nmod)
involve activation (dobj)
membrane p<0.001 (dep)
groups diabetes (conj)
analysis conjunction (compound)
application daily (advmod)
oropharynx predisposes (acl:relcl)
protected cortex (dobj)
assess occurrence (dobj)
diagnosed man (nsubjpass)
reduced erections (nsubjpass)
behaviour elevated (conj)
level lidocaine (compound)
age status (conj)
injection intracoronary (amod)
tolerate drug (dobj)
study first (amod)
understanding approach (conj)
affected treatments (nmod)
signaling hippocampus (nmod)
score high (amod)
methods 1969 (nmod:tmod)
occurrence rest (nmod)
guidelines ) (punct)
effect about (case)
paroxetine alprazolam (conj)
survived months (dobj)
optic linezolid-induced (amod)
agent associated (advcl)
avoided be (auxpass)
remission term (compound)
sfas of (case)
expressed ganglia (nmod)
assessed symptoms (nmod)
leading apoptosis (nmod)
catheters intrajugular (amod)
dysarthria tremor (conj)
assumed maximal (ccomp)
women 1 (nummod)
mg/m(2 100 (compound)
elicit response (dobj)
hypoactivity ) (punct)
kg(-1 ( (punct)
association co-morbidity (nmod)
degeneration tubular (amod)
administration cbz (nmod)
2.7 times (quantmod)
patients re-examined (acl)
dose-dependent is (cop)
s-i ec (conj)
inhibits remains (parataxis)
culture animal (conj)
accounts formation (nsubj)
effect activation (nmod)
% 7.8 (nummod)
protects damage (nmod)
ameliorated damage (nsubjpass)
ccr ml/min (dep)
preexposure , (punct)
ratio calculated (acl)
block under (case)
regained all (dep)
methoxamine saline (appos)
discontinuous was (cop)
tourniquets exteriorized (conj)
therapy term (compound)
reduced response (nsubjpass)
observed disappeared (xcomp)
hotplate and (cc)
mice receiving (acl)
analysis activity (nmod)
receive to (mark)
superimposed depression (nmod)
reduced furthermore (advmod)
sinuses carotid (compound)
dosing for (case)
overexpression of (case)
perimenopausal for (case)
antigen-positive nick-end (conj)
damage related (amod)
12 24 (conj)
fluvastatin the (det)
variability blood (compound)
myoclonus of (case)
amounts of (case)
turn 42 (dep)
tested reduce (ccomp)
shift not (neg)
potentials oscillatory (amod)
variety insults (nmod)
sensitivity according (case)
procedures revascularization (compound)
day cisplatin (appos)
field devices (conj)
paradigm dosing (amod)
% cases (nmod)
acid epilepsy (conj)
flow constant (amod)
detection to (case)
maternal or (cc)
malaysia in (case)
system tissues (compound)
alterations fetuses (nmod)
defects epithelial (amod)
hypercalcaemia and (cc)
compared : (punct)
opistothonus of (case)
explain disappearance (dobj)
rigidity thoraco-abdominal (amod)
conclusion produced (appos)
hiccups ; (punct)
pretreatment propranolol (compound)
+ + (conj)
hypothesis to (case)
stabilized is (auxpass)
treated mg/kg (dep)
convulsions bupropion-induced (amod)
had mortality (nmod)
duration dose (dobj)
implicated also (advmod)
enhancement diazepam (compound)
measures growth (compound)
-cimetidine 4 (nummod)
tested days (nmod)
associated follow-up (nmod)
assigned , (punct)
2 ( (punct)
larger controls (nmod)
seizure pentylenetrazol (nmod)
cd50 and (cc)
dose sustained-release (nmod)
maleate of (case)
anti-oxidant with (case)
deduced be (auxpass)
schedules the (det)
comparisons newborns (nmod)
inducing translocation (dobj)
illustrates number (dobj)
lesion days (compound)
abnormalities spect (compound)
shunting hypoxia (nmod)
activity nodal (compound)
epm on (case)
dopamine ) (punct)
rats replacement (nmod)
significant both (nmod)
stimulation noxious (amod)
continued have (xcomp)
melatonin mg/kg (dep)
occurrence maintenance (conj)
groups spinal (amod)
clarithromycin isoniazid (conj)
levels apoptosis (nmod)
follow-up conditions (nmod)
returned dialysis (nmod)
1 by (case)
increased foci/cm2 (nmod)
resolving gradually (advmod)
24.3 olanzapine (nmod)
woman , (punct)
manipulated group (nmod)
carsinom cell (compound)
frequencies cochlear (amod)
correlated concentrations (nmod)
effect main (amod)
results patients (nmod)
week 24 (nummod)
oxide oxygen (conj)
nephrotoxicity , (punct)
induced hydroxyanisole (nmod)
effects channels (nmod)
complications future (amod)
1 who (dep)
actions anticonvulsant (amod)
reversed disorders (dobj)
cycles median (amod)
variables influence (acl:relcl)
regimen anesthetic (amod)
dose patient (nmod)
analgesia on (case)
measured whom (nmod)
110000 and (cc)
starting rhythm (dobj)
chemotherapeutics various (amod)
complication syndrome (nsubj)
thrombocytopenia associated (acl)
endophthalmitis in (case)
normal central (conj)
creatinine 1.44+/-0.6 (dep)
female newborn (amod)
mg/m2 represents (acl:relcl)
age pressure (conj)
blockade by (case)
change spasm (conj)
adjustment age (nmod)
nephrotoxicity cohort (nmod)
control epinephrine (conj)
examinations questionnaires (conj)
twenty to (quantmod)
lead therapy (nsubj)
immunocytoma transplantable (amod)
ip alone (advmod)
received placebo (dobj)
abolition fasciculations (nmod)
blocked can (aux)
specimens transplant (compound)
experiments all (predet)
days patterns (conj)
2.7 - (punct)
weeks < (dep)
pseudolithiasis biliary (amod)
linked be (auxpass)
ketamine both (cc:preconj)
index baseline (nmod)
halothane ) (punct)
site one (nummod)
injection antagonist (nmod)
reticulum cells (nmod)
examinations serial (amod)
daily amiodarone (advmod)
600 800 (conj)
tarsorrhaphy defects (nmod)
cessation lithium (nmod)
0 5 (conj)
beclomethasone , (punct)
related antithrombosis (nsubj)
tac after (case)
associated onset (nmod)
drug nonselective (amod)
clearance heat (compound)
unknown is (cop)
developed treated (advcl)
favored have (aux)
insufficiency spironolactone-induced (amod)
decreases development (nsubj)
ra of (case)
use dm (nmod)
known occurred (ccomp)
elevated had (aux)
treatment lf (compound)
sirolmus drug (compound)
use repeat (compound)
adenosine agonist (compound)
ability detect (acl)
malignancy of (case)
accelerated but (cc)
interaction together (advmod)
tests provocation (compound)
c. hepatitis (compound)
weakness prolonged (amod)
ml(-1 2 (nummod)
thrombi by (case)
dyskinesias preexisting (amod)
deletion stat3 (nmod)
cyclosporine such (case)
evaluation cross-sectional (amod)
reproduced showed (conj)
associated measured (advcl)
interaction in (case)
discharged home (advmod)
paralysis legs (compound)
expression p300 (nmod)
nephrosis pan (appos)
temazepam of (case)
adriamycin , (punct)
v. i. (compound)
speed processing (amod)
results produced (appos)
studies observational (amod)
mediate parkinsonism (dobj)
2a/2c 5-ht (compound)
moment event (nmod)
elevated mm (dep)
detected conclusion (nsubjpass)
exhibit that (mark)
disease parenchymal (amod)
failed clinically (advmod)
associated therapeutic (nmod)
recordings sces (compound)
increased one (nmod)
triggered occurrence (nmod)
d-med 2 (dep)
learning and (cc)
hbeag-positive background (conj)
effect ecg (nmod)
disorder hyperactivity (compound)
adults hypertensive (amod)
faded complaints (nsubj)
failure metabolic-endocrine (amod)
effects oxitropium (nmod)
subgroup of (case)
aspiration negative (amod)
release prostaglandin (compound)
meth ( (punct)
nucleotide-gated and (cc)
confirm were (cop)
2.9 x (cc)
ocular toxicity (dep)
consumption sugar (compound)
chain respiratory (amod)
surgery brain (compound)
1 24 (conj)
iiib cancer (conj)
effects suspension (conj)
cad ci (appos)
suggestion an (det)
rats 6 (nummod)
erythromycins and (cc)
exchanges chromatid (compound)
cancer warrant (conj)
found neuropathy (nsubjpass)
related problems (nmod)
vertex at (case)
0.6 pvc (conj)
latencies longer (amod)
torsades with (case)
restriction implemented (acl)
simvastatinezetimibe ) (punct)
therapy induction (compound)
pathways other (amod)
cocaine cp (conj)
fluorescein intravenous (amod)
100 0 (compound)
extract rhizomes (nmod)
suxamethonium cardiac (conj)
literature radiology (compound)
concentration dopamine (nmod)
conjugates copolymer (compound)
sodium divalproex (compound)
recurred dyskinesia (nsubj)
missed examined (ccomp)
inhibitors receptor (compound)
affected ie (dep)
drug succinate (nsubj)
mg 4.47 (nummod)
10 of (advmod)
1.63 - (punct)
made although (mark)
mmt [ (punct)
angiography percutaneous (amod)
occurs nevertheless (advmod)
efficiency regarding (case)
administered saline (dep)
ica sinus (conj)
signified improvement (nmod)
use because (case)
complex on-off (cc)
28.21 1.83 (conj)
activity nephrotoxicity (conj)
gd 11 (nummod)
structures by (case)
hypercalcemia alkalosis (conj)
tachycardia bromocriptine-induced (amod)
underlying conditions (dobj)
except variability (nmod)
death embryonic (amod)
goes . (punct)
immunosuppression as (case)
countries japan (nmod)
reached deteriorates (conj)
functional that (mark)
reduced affect (conj)
immediately almost (advmod)
infections tract (compound)
nephropathy on (case)
vomiting ) (punct)
disease native (amod)
days 2 (nummod)
possesses . (punct)
initiated mol/l (advcl)
performed hospital (nmod)
= 7.7 (dep)
prevent though (mark)
lymphoma and (cc)
correlated appearance (nmod)
contrast threshold (dobj)
responsible former (amod)
replaced is (aux)
agents duration (nmod)
feature . (punct)
cause no (det)
expression cell (compound)
worst . (punct)
missed % (nmod)
p=0.008 respectively (advmod)
given thirds (nmod)
disappear that (mark)
patients angioedema (nmod)
kidney acute (amod)
therapy inhibitor (compound)
modulators positive (amod)
toxicities because (case)
reduced was (auxpass)
administered increased (advcl)
complexes ventricular (amod)
metalloproteinase not (neg)
complications : (punct)
tended subjects (nsubj)
stabilize persons (nmod)
studying mechanisms (dobj)
myelitis plexitis (conj)
darkness in (case)
result impairing (xcomp)
micrograms.kg-1.min-1 3.4 (nummod)
radioactivity 131i-hsa (compound)
infarction wall (nmod)
however . (punct)
used therapy (dobj)
weight dogs (nmod)
used women (nmod)
targets the (det)
unrecognized denial (nmod)
believed mechanism (nsubjpass)
prilocaine with (case)
negative titer (nsubj)
meth to (case)
doing . (punct)
performed audiograms (nsubjpass)
neurotoxicity meth (compound)
induced diclofenac (nmod)
g/dl to (case)
decompression of (case)
monthly and (cc)
glycopyrrolate anaesthesia (conj)
vasorelaxation vasoconstriction (conj)
10 0.03 (compound)
associated adjusted (advcl)
status 2 (nummod)
3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ( (punct)
potentiating by (mark)
continuous irregular (dep)
potentiation mutual (amod)
diet choline-supplemented (amod)
potentiates , (punct)
membrane at (case)
mice inbred (amod)
stability its (nmod:poss)
1-hr on (case)
2-component a (det)
radial , (punct)
vomiting of (case)
abuse cocaine (compound)
12 no (neg)
controls non-drug (amod)
days separate (amod)
coincident . (punct)
potential neurotoxic (amod)
mpt ) (punct)
limits which (nsubj)
light- and (cc)
administration found (acl)
search medline (compound)
release et-1 (compound)
frequency with (case)
decreased i.p. (advmod)
fluoxetine the (det)
classified agency (nmod)
correlate parameters (nmod)
concern events (nsubj)
agents no (det)
epilepticus induced (acl)
effect even (advmod)
hemorrhage putaminal (amod)
act , (punct)
celecoxib of (case)
injection subcutaneous (amod)
dizziness and (cc)
assessed echocardiography (nmod)
given dox (dobj)
adjust behaviour (dobj)
teratology 1971 (nummod)
underwent prior (advmod)
application post (compound)
segments of (case)
increase markers (nmod)
evidence have (ccomp)
designed were (auxpass)
content and (cc)
end through (case)
present be (cop)
returns a (det)
agent expectorant (amod)
viral metabolic (conj)
repeated . (punct)
tolerated adults (nmod)
caused diet (nsubj)
force grip (compound)
regions geographical (amod)
system subjects (nmod)
transplantation postrenal (amod)
breath a (det)
administered mg/m2 (nsubjpass)
task during (case)
aggregation monomers (nmod)
scores % (dobj)
receptors intracytoplasmic (amod)
among are (cop)
0.05 +/- (cc)
remained velocity (nmod)
1989 since (case)
greater blue (nsubj)
combinations % (dep)
exhibited wk (nmod)
years 90 (nummod)
induced pbe (nmod:npmod)
percent percent (appos)
evaluated efficacy (nsubjpass)
channel constituent (nsubj)
assessment and (cc)
levels noradrenaline (nmod)
hyperactivity hypoactivity (conj)
found recently (advmod)
disorders group (conj)
citrate clomiphene (compound)
mediated part (nmod)
efficacy undoubted (amod)
studies control (compound)
evoked respectively (advmod)
agent used (acl)
suggested confirmed (conj)
compared subjects (nmod)
periods interictal (amod)
analysis second (amod)
administration igf-il-3 (nmod)
21.0 - (punct)
taking account (nmod)
31.6 0.8 (conj)
found > (xcomp)
affect magnitude (dobj)
detection echocardiographic (amod)
rate resting (amod)
tests lymphocyte (compound)
ligation- , (punct)
age abuse (conj)
fluvoxamine , (punct)
33 +/- (cc)
taking contraceptives (dobj)
improved who (nsubj)
fifteen in (case)
min ischemia (nmod)
active administration (nmod)
program transplantations (nmod)
effectiveness antagonizing (acl)
deficient diet (amod)
recurrence attack (nmod)
provided evidence (nsubj)
address using (xcomp)
step if (mark)
morphine induced (acl)
50 200 (prep)
had glomeruli (dobj)
pretreatment chronic (amod)
neurochemistry the (det)
therapy cimetidine (compound)
prevent arrhythmia (dobj)
damage muscle (nmod)
disappeared soon (advmod)
studied volunteers (nmod)
units platelets (nmod)
mention possibility (nmod)
treated been (auxpass)
occurred confined (conj)
characteristics animals (nmod)
antibodies depended (acl:relcl)
women 50 (nummod)
attenuated although (mark)
receive mg. (dobj)
suspensions long-acting (amod)
showed normalization (dobj)
communication in (case)
essential monitoring (nsubj)
approach hyperprolactinemia (nmod)
fluid ratio (dep)
ritanserin antagonist (appos)
hds ( (punct)
underwent aged (nsubj)
observed nephrotoxicity (nsubjpass)
non-transgenic ntg (dep)
delayed abnormally (advmod)
symptoms by (case)
% 0.75 (compound)
5.00 between (case)
administered antithrombin (nsubjpass)
doses 0.63 (nmod)
dose-dependently and (cc)
preserves and (cc)
frequency effect (nmod)
under-reporting detail (dep)
mid to (case)
contraindicated ) (punct)
rats gm-treated (amod)
study immunohistochemical (amod)
determined only (advmod)
pons of (case)
depth intraoperative (amod)
hypothesize responsible (ccomp)
modified . (punct)
procaterol terbutaline (conj)
malformations other (amod)
disease meningeal (compound)
shows induce (ccomp)
increased activity (dobj)
effect to (mark)
symptoms rigidity (nmod)
restored amplitude (dobj)
nmba a (det)
anticoagulation agents (nmod)
administration patients (nmod)
t(33 ) (punct)
concentration remifentanil (nmod)
life a (det)
drop out (prep)
activation mechanism (nmod)
given not (neg)
induced gamma-hch (nmod)
methods children (appos)
effects correlation (nmod)
disease arrhythmia (nmod)
release downregulation (conj)
related decrease (nsubj)
has also (advmod)
avoided should (aux)
scale four-point (amod)
hematologic biochemical (conj)
= 38 (dep)
promote that (mark)
aggregation heparin-induced (amod)
effect crocins (nmod)
s.c. ) (punct)
antagonists ranitidine (dep)
technique ) (punct)
% 26.0 (nummod)
wky instrumented (acl)
analogue ( (punct)
reduction bp (compound)
licl mmol/kg (appos)
linked hemorrhage (nmod)
assessed rate (nsubjpass)
concentrated dxnp (nsubjpass)
levels phosphokinase (compound)
different time (nmod)
attenuates effect (dobj)
showed unchanged (ccomp)
method high-performance (amod)
improved bcnu (conj)
content rna (compound)
thrombosis pulmonary (amod)
weeks weeks (appos)
cells hepatoma (compound)
associated had (conj)
receptor ) (punct)
presence antibodies (nmod)
fas ( (punct)
investigations biochemical (amod)
pattern heart (nmod)
depressants , (punct)
identified infant (nmod)
b12 levels (conj)
needed control (xcomp)
contributes development (nmod)
present man (dobj)
effects cibenzoline (nmod)
increased hippocampus (nmod)
patients year (nmod)
appearance de (amod)
superior overall (advmod)
treatment acid (compound)
image t2-weighted (amod)
plays pgp (nsubj)
finished . (punct)
transit the (det)
aroused instances (nmod)
report terms (nsubj)
sole may (aux)
discouraging uniformly (advmod)
dipping , (punct)
put . (punct)
acidity be (cop)
cyclophosphamide between (case)
administered phenytoin (nsubjpass)
0.64 2.92 (nmod)
sixth and (cc)
conclude : (punct)
ml 10 (nummod)
damage pars (nmod)
restriction prescription (nmod)
studies isradipine (nmod)
cases arrest (nmod)
emulsion , (punct)
indicate suggest (conj)
cytopenia due (case)
design nested (amod)
injections u-ii (nmod)
intoxication underlying (amod)
followed h (nmod)
group s-1 (conj)
investigate is (ccomp)
accompanied decreases (nmod)
factor-i growth (compound)
associated complications (nsubjpass)
count her (nmod:poss)
prolonged leading (advcl)
c2 group (compound)
met college (dobj)
= 0.7045 (dobj)
66.9 + (cc)
indices ) (punct)
exhibited had (conj)
incidence experiences (nmod)
failure caused (acl)
acetylsalicylate cyclooxygenase (compound)
mean surface (dobj)
affected vasodilation (nsubjpass)
increase deficiency (nsubj)
examination studies (conj)
section urgent (amod)
3 2 (compound)
hz 3,000 (nummod)
occurred hypotension (nsubj)
some bias (nmod)
min 10 (nummod)
% 32.258 (appos)
decreased length (dobj)
hypothesis inhibits (ccomp)
eye other (amod)
pneumotachograph a (det)
six number (nsubj)
months up (case)
neuroprotection in (case)
loss auditory (amod)
occurrence therapy (nmod)
necrosis apoptosis (conj)
preeclampsia for (case)
prevented is (auxpass)
twins in (case)
did not (neg)
organophosphate a (det)
increased malondialdehyde (nsubj)
occurred deterioration (nsubj)
way dose-dependent (amod)
15-f(2t)-isop of (case)
month ) (punct)
binding ( (punct)
received admitted (advcl)
results abnormal (amod)
reduction between (case)
therapy manipulative (compound)
effect reduction (nmod)
group hydroxyl (compound)
causes failure (nmod)
evaluated microscopically (advmod)
increase week (nmod)
analyzed features (nsubjpass)
vehicle common (amod)
response after (case)
male % (nmod:npmod)
had case (nsubj)
d f (compound)
were abnormalities (attr)
exploration altered (amod)
amide an (det)
hemoglobin serum (compound)
toxicity cm (compound)
women 61 (nummod)
reported otherwise (advmod)
possibility neuropathy (nmod)
eeg rats (nmod)
associated foci (nmod)
pain non (amod)
nephrotoxicity mtx (nmod)
constriction marked (amod)
lower monotherapies (advcl)
prodrug a (det)
subjects nondiabetic (amod)
use hydration (conj)
patient psoriasis (nmod)
sustained intervention (nmod)
8.8 - (punct)
quantify risk (dobj)
subscale on (case)
failed influence (xcomp)
widow disorder (nmod)
ifo 's (case)
performed loading (nmod)
words recall (amod)
length dose (conj)
width and (cc)
p.o. levodopa (compound)
method chromatographic (amod)
increase hdl (nmod)
alters lowering (advcl)
therapy disease (compound)
hemorrhage palsy (nmod)
augmented treatment (nsubj)
details carcinogenesis (nmod)
became rise (nsubj)
neurons inhibition (nmod)
acid bicuculline (conj)
levels nitrogen (compound)
1.54 +/- (cc)
study mg/m2 (nmod)
changes developed (acl:relcl)
showed flow (dobj)
study rats (nmod)
range dosage (nsubj)
case undiagnosed (amod)
group each (det)
signs congestion (nmod)
survivors for (case)
dilemma diagnostic (amod)
hr 11 (nummod)
mg. 150 (nummod)
has does (advcl)
cc between (case)
drug anti-arrhythmic (amod)
min-1 micrograms (compound)
mg/m(2 the (det)
lid of (case)
entered methods (dep)
suppressed suppressed (conj)
expression receptors (nmod)
month starting (dep)
l cells/ (compound)
rbcs normal (amod)
investigation . (punct)
neurotoxicity neurons (nmod)
resuscitation adrenaline (nmod)
saline , (punct)
correlated whether (mark)
regimens six (nummod)
developmental and (cc)
5-hiaa regions (nmod)
intervenes cs (compound)
chick pinealectomized (amod)
examined also (advmod)
tolerated signs (nmod)
scores ihc (compound)
application usage (nmod)
underwent died (conj)
mater dura (amod)
found activate (xcomp)
basis double (amod)
electroretinograms potentials (conj)
cats epilepsy (nmod)
divided female (nsubjpass)
disorder compulsive (amod)
any groups (nmod)
l-[3h]nicotine striatal (amod)
monkeys cynomolgus (amod)
neuropathy mimic (acl:relcl)
tissue renal (amod)
used hypotension (nsubjpass)
electrocardiograms ecgs (appos)
promising characteristics (dobj)
transaminase elevations (conj)
powered study (nsubj)
channels of (case)
problem anemia (nsubj)
rats pilocarpine-treated (amod)
extension during (case)
classified society (nmod)
years beyond (case)
week ) (punct)
contraception oral (amod)
produced levels (nmod)
indicate increased (ccomp)
medulla rat (compound)
% 0.8 (compound)
able complete (xcomp)
properties of (case)
help should (aux)
serve indicator (nmod)
g weight (nmod)
alleviates . (punct)
underwent discontinuing (advcl)
employing cholinergic (dobj)
concentrations duration (conj)
dbh +/- (cc)
remained , (punct)
compared study (nmod)
sulfate or (cc)
nucleus nigra (amod)
procedures coronary (amod)
asphyxia , (punct)
stabilizers mood (compound)
60 4 (compound)
chronicity , (punct)
a/j with (case)
represent mechanism (dobj)
interpreted be (auxpass)
findings rats (nmod)
done and (cc)
variables preoperative (amod)
induced glutamate (nmod)
dimension/function lv (amod)
animals e-i (amod)
nerve in (case)
outcome inferior (amod)
mg/kg 17.5 (nummod)
test pressor (compound)
delivered days (nmod)
face male (amod)
-0.81 to (dep)
findings these (nsubj)
rhythm receiving (advcl)
neurological findings (dep)
causes and (cc)
catheters adjacent (amod)
bche ) (punct)
kingdom united (compound)
used treatment (nmod)
assessable were (cop)
vasoconstriction coronary (amod)
this for (case)
mg dose (nmod)
promotes dogs (nmod)
reached peak (dobj)
sch the (det)
following of (case)
compared 17 (nmod)
apamin , (punct)
restimulation days (nmod)
conclude alternative (ccomp)
supplement sirolimus (nsubj)
abuse survivors (nmod)
taken previously (advmod)
reviewed retrospectively (advmod)
benzodiazepines the (det)
extraction , (punct)
injury outcome (nsubj)
tolerable is (cop)
confines territories (nmod)
ovary the (det)
suggest initiate (ccomp)
effect favorable (amod)
% periprocedurally (advmod)
increase might (aux)
taking levothyroxine (acomp)
year a (det)
ng/ml 204 (conj)
reduces estradiol (nsubj)
startle , (punct)
medicine transplantation (compound)
characteristics reaction (nmod)
nitrendipine or (cc)
quality response (nmod)
background determined (appos)
anaesthesia unilateral (amod)
block events (dobj)
manipulation during (case)
include vasospasm (dobj)
prior start (nmod)
disclosed avoid (xcomp)
by-product maneuver (nmod)
distinguished could (aux)
pralidoxime-2-chloride ) (punct)
cue and (cc)
5-ht1a at (case)
sulfonamides nitrofurantoins (conj)
sniffing posturing (conj)
have epilepticus (dobj)
a-86929 of (case)
brought due (parataxis)
cornerstone programs (nmod)
dose diminished (acl:relcl)
therapy drugs (conj)
used analgesia (nmod)
uncommon but (cc)
assess changes (dobj)
injection scopolamine (nmod)
case parasitosis (nmod)
dystrophin of (case)
acrolein doses (nmod)
45 than (quantmod)
proteins damage (nmod)
% 19 (compound)
accuracy steering (compound)
polymerase for (case)
use popular (amod)
spasticity related (amod)
% n= (dep)
component pastes (nmod)
states function (nmod)
anencephaly ; (punct)
result , (punct)
32.9 ) (punct)
interval s (nmod)
administration increase (dobj)
serum by (case)
cardiac peripheral (conj)
moderate heavy (conj)
achieved days (nmod)
( first (dep)
slowing indicating (acl)
collected ) (punct)
den in (case)
iop ( (punct)
modes multiple (amod)
cy and (cc)
contraceptive of (case)
folate , (punct)
use cholinesterase (nmod)
cells nadph-d-positive (amod)
active or (cc)
results 19.3 (appos)
elevation pressure (compound)
consisted thalidomide (nmod)
multiple after (case)
dynamic ) (punct)
second a (det)
reduced synthesis (nsubjpass)
paclitaxel combined (acl)
carcinogenesis rat (nmod)
measured tests (nmod)
findings contrast (dep)
1/2 than (quantmod)
daily bid (appos)
knockdown nrf2 (nmod)
controls 808 (nummod)
functional structural (conj)
myocarditis ) (punct)
increase volume (conj)
liver histology (nmod)
induced dogs (nmod)
klebsiella was (cop)
produce changes (dobj)
behavior death (conj)
personnel of (case)
levels thromboxane (compound)
influence convulsions (nmod)
detected was (auxpass)
response augmented (amod)
infants all (det)
urothelium induced (acl)
status 2 (nmod)
aerosol and (cc)
avoided , (punct)
exposed were (auxpass)
problem clinical (amod)
substrate phenytoin (nsubj)
use therapeutic (amod)
organization drug (appos)
= mmhg (dep)
failure chronic (amod)
paradigms therapy (nmod)
genotype silent (amod)
prednisone oral (amod)
risperidone < (compound)
substantia rat (compound)
list of (case)
mutant wistar (compound)
abnormalities hematological (amod)
teratology . (punct)
possible means (nmod)
34 in (case)
seen had (aux)
re-started were (auxpass)
impairment testosterone (compound)
users eligible (amod)
compared incidence (nsubjpass)
neurotransmission adrenergic (amod)
mrna determination (conj)
administrated ifo (nsubjpass)
microinjection cells (nmod)
36 60 (conj)
instillation from (case)
suggesting blockade (dobj)
increase level (dobj)
patients included (amod)
correlated of (case)
% costs (nmod)
hippocampus from (case)
trends hemorrhage (nmod)
heroin intravenous (amod)
predicted independently (advmod)
convulsions convulsions (nmod)
incidence carcinomas (nmod)
important extend (xcomp)
antineoplastic cisplatin (nsubj)
dysrhythmias ventricular (amod)
0.92 , (punct)
complex acid (compound)
stopped results (nmod)
administration dose (nmod)
neuropathy totp-induced (amod)
findings demonstrating (acl)
provides generated (advcl)
trial . (punct)
performed knife (nmod)
infrequent are (cop)
stage terminal (amod)
drinkers among (case)
cta coronary (amod)
myalgia postoperative (amod)
showing cholestasis (dobj)
administration doses (conj)
decrease cmro2 (nmod)
properties similar (amod)
inwest ( (punct)
increased excess (nsubj)
memory ( (punct)
tested been (auxpass)
limited which (nsubjpass)
safety general (amod)
externa membrane (nmod)
unremarkable . (punct)
lithium = (dep)
advantages of (case)
point any (det)
tea ( (punct)
administered immediately (advmod)
catalyze and (cc)
loss dopaminergic (amod)
use medications (nmod)
fruste an (det)
therapy dacarbazine (compound)
dobutamine (1.8)% (dep)
labeling through (case)
3-methoxy-4-hydroxyphenethyleneglycol mhpg (appos)
compared buffer (nmod)
given then (advmod)
hypertension subset (nmod)
methods experiment (dep)
alterations sensory (amod)
reported benefit (dobj)
doses ketoconazole (nmod)
mutation prothrombotic (amod)
developed wr-2721 (nsubjpass)
dysmorphism facial (amod)
area p<0.001 (dep)
days control (dep)
or 5.45 (nummod)
assessed performances (dobj)
causes anemia (nmod)
systemic classic (amod)
days 14 (nummod)
structure diltiazem (conj)
therapy levodopa (compound)
decreases decreases (conj)
fraction ejection (compound)
mazindol mg/d (appos)
cases head (nmod)
viewed however (advmod)
citalopram on (case)
-chlorpheniramine placebo (conj)
terms survival (nmod)
3 1.5 (compound)
injection methamphetamine (compound)
toxicities neurologic (amod)
3 score (nsubj)
inhibition both (cc:preconj)
nephrolithiasis recurrent (amod)
aura society (nmod)
tachycardia fibrillation (conj)
scores difference (compound)
studies radiological (amod)
injected shell (nmod)
action due (case)
induces dose (nsubj)
studies electromyogram (compound)
efficacious strategy (nsubj)
experiences . (punct)
ability a (det)
chemoconvulsants , (punct)
= mg/kg/day (dep)
levels antigen (compound)
posturing , (punct)
coniine in (case)
produced indicating (advcl)
> for (case)
dependence , (punct)
administration mg/day (appos)
efficacious and (cc)
members 2 (nummod)
leading result (nmod)
p 0.05 (dep)
papilloma ) (punct)
infrequent is (cop)
observations last (amod)
sensor a (det)
injection duration (nmod)
fibrillation on (case)
damage oxidant-mediated (amod)
infiltrates % (appos)
patients features (nmod)
had ( (punct)
impairment alcohol-related (amod)
combination docetaxel (nmod)
hypoxic were (cop)
developing toxicity (dobj)
lactate glucose.4 (conj)
procedures bypass (compound)
paroxetine treatment (conj)
examined patients (nmod)
limiting : (punct)
dysfunction ventricular (amod)
clonidine receptor (compound)
taken prescribed (advcl)
interference following (case)
suppressed activity (dobj)
eyelids of (case)
readmitted died (conj)
died that (nsubj)
discribed is (auxpass)
t prediction (conj)
inhalation by (case)
biliary viral (conj)
% 0 (nummod)
lysozymuria and (cc)
hemodynamics metabolism (conj)
areas compatible (amod)
differ that (mark)
class drugs (nmod)
pharmacotherapy fluoxetine (nmod)
introduction the (det)
changes life (compound)
evolution lesions (appos)
cck-8 0.1 (dep)
depression circulatory (amod)
ones the (det)
manifestations unexplained (amod)
analysed spectrometry (nmod)
sexes of (case)
tracheotomy a (det)
gnrh of (case)
surgeries intraocular (amod)
atrophy multiple (amod)
used urate (conj)
readministration . (punct)
nephropathy puromycin (compound)
cava , (punct)
diameter density (conj)
decreases pressure (conj)
ng/mouse ( (punct)
immunosuppression for (case)
important less (advmod)
patients lesions (nmod)
reduced taken (advcl)
occurred periods (nmod)
angiotension ii (nummod)
placebo locf (nmod)
abnormality no (det)
delirium associated (acl)
events complications (appos)
differences backgrounds (nmod)
nadir re-exposure (nmod)
anticoagulants and (cc)
headaches seizures (conj)
rhabdomyolysis in (case)
provoke , (punct)
hypertrophy % (dep)
secretion depressed (amod)
associated progression (nmod)
reported abnormalities (dobj)
reabsorption , (punct)
doses repeated (amod)
severe . (punct)
participants 997 (nummod)
scale amhs (appos)
laboratory a (det)
change patients (nsubj)
cases ten (nummod)
proteinuria nephrotic (amod)
induces d2/d3 (dobj)
develops . (punct)
median vs. (cc)
levels catecholamines (conj)
five % (appos)
output ( (punct)
suggestive patient (nmod)
intervals but (cc)
july on (case)
infusion patients (conj)
inhibited sis3 (nmod)
recovery . (punct)
muscle patients (nmod)
seroconversion of (case)
release augmented (amod)
exercised days (nmod)
injected , (punct)
n-methyl-d-aspartate of (case)
mg/m2 higher (conj)
avoided recommended (advcl)
patients results (conj)
occluded . (punct)
d1 both (cc:preconj)
illustrate rhabdomyolysis (dobj)
dexrazoxane doses (dep)
hemostasis patients (nmod)
changes stimulation (nmod)
system allows (acl:relcl)
lipids and (cc)
served detect (xcomp)
function impression-sexual (amod)
blocker angiotensin-releasing (amod)
show report (nsubj)
injected vocalization (nmod)
produce doses (nsubj)
catheterization for (case)
unrelated , (punct)
survived sedation (nmod)
known neurotoxic (xcomp)
nms , (punct)
mg 200 (compound)
affected not (neg)
margin inner (amod)
elevated was (cop)
role dfo (nmod:poss)
treated chemotherapy (nmod)
3delta gag/pol (dep)
withdrawal period (appos)
reported that (mark)
technique the (det)
induce fact (nmod)
received simvastatin (dobj)
causes altering (advcl)
open whenever (advmod)
linkages non-biodegradable (acl:relcl)
administered administered (parataxis)
had they (nsubj)
cream per (case)
efficacy comparative (amod)
using ; (punct)
time almost (advmod)
mechanisms hyperactivity (nmod)
eps chlorpromazine-induced (amod)
areas through (case)
hbeag ( (punct)
ci 1.12 (nummod)
dose alone (advmod)
tests of (case)
weaning after (case)
lt elective (amod)
rare the (det)
occur that (nsubj)
< 0.0001 (nummod)
polymyositis/dermatomyositis like (case)
thrombi platelet-fibrin (compound)
performed 22 (nmod)
imply patients (nmod)
identified 68 (nmod)
modifies e2 (nsubj)
basal potassium-stimulated (conj)
treated 25 (nmod)
occurrence type (nmod)
ns-nsaids 22,875 (nummod)
pars into (case)
raises possibility (dobj)
accident trauma (conj)
ascites of (case)
decrease inhibition (conj)
use study (appos)
subjected attempt (nmod)
june 30 (nummod)
calcification metastatic (amod)
abundance cotransporter (nmod)
anaemia despite (case)
3/4 ( (punct)
conditions two (nummod)
effects anti-rigor (amod)
transferred status (nsubjpass)
am149 ) (punct)
shake dog (compound)
0.35 +/- (cc)
amiodarone risk (conj)
goes still (advmod)
tests current (amod)
equipment of (case)
cohort an (det)
scores maximum (compound)
transporter drug (compound)
2,682,2,803 and (cc)
lisinopril with (case)
delayed which (nmod)
reduction levels (conj)
occurrence hit (nmod)
administration presence (nmod)
hissing snarling (conj)
prevalent was (cop)
cells isolated (amod)
emulsions lipid (compound)
excitability in (amod)
changes volume (nmod)
infusions target-controlled (amod)
inhaler double-blind (nmod)
amyloidosis al (appos)
interaction correction (nmod)
affected development (nsubjpass)
receiving both (nsubj)
infiltration ml (nmod)
combinations its (nmod:poss)
information auditory (amod)
remitted as (mark)
% 0.015 (nummod)
completed trials (nsubjpass)
force contractile (compound)
190 to (dep)
concentrations between (case)
body 15 (nummod)
times bw/3 (compound)
were instances (attr)
gssg tissue (compound)
period 2 (nummod)
formed participation (nmod)
reaction pertussis (compound)
sgot bilirubin (conj)
persisted yr (nmod)
reacts mediating (advcl)
p.m. 2:00 (nummod)
flunitrazepam 1.0 (conj)
volume large (amod)
crosses . (punct)
mice adult (amod)
carvedilol itself (nmod)
ige ( (punct)
euphoria choreoathetoid (conj)
divided randomly (advmod)
epinephrine subcutaneous (amod)
dysfunction tamoxifen-induced (amod)
alpha-position the (det)
for " (punct)
children 253 (nummod)
initiate torsade (dobj)
6.87 +/- (cc)
method with (case)
medium than (case)
trunk sympathetic (amod)
middle the (det)
infections bacillary (amod)
stressed . (punct)
mice pparalpha-/- (compound)
variant a (dep)
describes patient (dobj)
dcf or (cc)
per day (pobj)
possibly , (punct)
t max (appos)
product study (compound)
established has (aux)
efficacy addition (nmod)
d-galactose is (cop)
pressure mm (dep)
injury dexatrim (compound)
dizziness . (punct)
region catecholaminergic (amod)
106 +/- (cc)
dosed metoprolol (nsubjpass)
determination with (case)
abundance markers (nmod)
procedure before (case)
= 175 (dep)
transmission in (case)
co-morbidity outcomes (conj)
amplitudes teoaes (compound)
mechanisms shared (amod)
average months (nmod)
4.7 12 (dep)
abolished mm (dep)
30 or (cc)
diltiazem including (case)
lowering lowering (advcl)
performed women (nmod)
impaired administration (nmod)
evidence models (nmod)
volume due (case)
much benefit (nmod)
pretreatment lipopolysaccharide (compound)
predominance a (det)
count signs (conj)
had contrast (nmod)
treatment ointment (nmod)
forgetting task (nmod)
fenoldopam by (case)
investigated but (cc)
induced nitroglycerin (nmod)
revert patients (nmod)
model producing (acl)
d1 d2 (conj)
actin = (dep)
values stones (appos)
implants of (case)
or possibly (advmod)
system semi-quantitative (amod)
18.7 - (punct)
use sedation (nmod)
discontinuation without (case)
limit upper (amod)
non-drug cannabis/alcohol/nicotine (conj)
cases other (amod)
unclear while (mark)
1 8 (conj)
protocol chemotherapy (compound)
lack a (det)
prior ct (conj)
degrees varying (amod)
threshold group (nmod)
interdependence factors (nmod)
% 7.6 (dep)
diuretic , (punct)
noted were (advcl)
treat correctly (advmod)
overdosage ) (punct)
cco ( (punct)
required research (nsubjpass)
deterioration episodic (amod)
toxicity hematologic (amod)
custody , (punct)
group either (det)
region vascular (amod)
effects prolactin (nmod)
inhibitors cyclosporine (nmod)
spread space (nmod)
correlated variables (nmod)
hypertension arterial (amod)
using intervals (dobj)
extremes the (det)
instillation intratympanic (amod)
haart generic (amod)
thickness mean (compound)
immunoreactivity decreased (amod)
have leading (advcl)
presented use (nmod)
necrosis pelvis (nmod)
loss neuron (compound)
mean +/- (cc)
calcium mg/day (appos)
disturbances sleep (compound)
pronounced baseline (nmod)
stop . (punct)
events . (punct)
element an (det)
c-4-epimer ( (punct)
degree high (amod)
intestine liver (conj)
lamivudine and/or (cc)
attended laboratory (dobj)
microg/ml was (cop)
flumazenil benzodiazepine (compound)
grade been (cop)
44 15 (quantmod)
sleep , (punct)
rats similar (dep)
evident not (neg)
conclusions caused (appos)
defect mitochondrial (amod)
myositis patient (nmod)
dysfunction bladder (compound)
infusion for (case)
waves flicker (compound)
saline i.v. (dep)
ribavirin analogue (appos)
excess mg/kg (nmod)
described coexistence (nsubjpass)
needed assess (xcomp)
utility possible (amod)
reported changes (nsubjpass)
induced exposure (nsubj)
abnormalities autism (nmod)
caused developed (parataxis)
glutathione reduced (amod)
hypercalcemia > (dep)
chemistry blood (compound)
appears observed (advcl)
isoflurane with (case)
women premenopausal (amod)
days 1433 (nummod)
assigned group (nmod)
administration ouabain (compound)
elucidate induced (ccomp)
heparin testing (appos)
showed val204asp/p (ccomp)
denopamine with (case)
affects clear (conj)
conjunction antidepressants (nmod)
asymptomatic discontinued (advcl)
preparations perfused (amod)
slightly only (advmod)
approach dual (amod)
discontinued transitioned (conj)
0.78 to (case)
doses . (punct)
beginning follow-up (conj)
evaluated is (aux)
confused transiently (advmod)
volunteers normal (amod)
factors specific (amod)
hyperalgesia of (case)
response behavioral (amod)
b-100 les (dep)
induced suxamethonium (nsubj)
administration development (conj)
daunorubicin etoposide (conj)
status lasting (acl)
ill affectively (advmod)
accumulation iron (compound)
techniques diagnostic (amod)
interfere since (mark)
prior to (dep)
crisis with (case)
striatum into (case)
increase placebo-an (amod)
procedures urological (amod)
higher seen (advcl)
increased force (nsubjpass)
treated lidocaine (nmod)
documents compliance (dobj)
solution stable (amod)
syndrome hemolytic (compound)
groups volunteers (nmod)
developed treatment (nmod)
midazolam thiopentone (conj)
preparations rats (nmod)
consists alternate (conj)
resulted observed (conj)
when she (nsubj)
besylate , (punct)
rilmenidine , (punct)
fraction mainly (advmod)
evident . (punct)
milligrams of (case)
alternative the (det)
% 3/20 (dep)
monitoring drug (compound)
neuropathy axonal (amod)
defect , (punct)
lymphoma 's (case)
tested using (xcomp)
endpoints for (case)
objective demonstrated (dep)
caused increases (conj)
blockade uptake (compound)
plugs due (case)
used assess (xcomp)
prevents accumulation (dobj)
nuclei only (advmod)
amplitudes nerve (nmod)
d-med micrograms/kg (conj)
children autism (nmod)
ratio 1.42 (nummod)
implicated production (nsubjpass)
benztropine treatment (nmod)
ldl of (case)
attacks sufferers (nmod)
potential . (punct)
delayed whereas (mark)
patients cyclosporine (nmod)
follows . (punct)
inhibited hand (nmod)
treatment use (nsubj)
degree substantial (amod)
smaller group (nmod)
dose melatonin (nmod)
explain shape (dobj)
therapy thiazide (compound)
disorder cocaine-induced (amod)
fields and (cc)
first 2/1 (nmod)
republic of (case)
blocker losartan (conj)
dose indomethacin (nmod)
company 's (case)
perturbated electrically (advmod)
alone that (nmod)
had findings (dobj)
delirium underwent (acl:relcl)
random members (nmod)
dose 0.001 (appos)
echography in (case)
pha-p ) (punct)
deficits potential (conj)
anesthetics due (case)
had 26 (nsubj)
action on (case)
cells monocyte (compound)
regurgitation patients (nmod)
symptomatic clinically (advmod)
calcineurin immunoreactive (amod)
diets paracetamol (conj)
changes meth (nmod)
hematocrit observed (conj)
recovered she (nsubj)
reverses oral (nsubj)
observed month (nmod)
derivatives formed (acl)
therapy cytotoxic (amod)
frlma group (compound)
length-of-stay and (cc)
cancer experimental (amod)
produced unclear (parataxis)
urate 76 (nmod)
differ increase (nmod)
enhanced affected (conj)
hypertension fetal (amod)
normal ecg (nsubj)
seven two (compound)
acid epsilon-aminocaproic (amod)
included women (dobj)
conclusion cause (dep)
dwi on (case)
responsible retention (nmod)
prevent also (advmod)
development treatment (conj)
carboplatin doxorubicin (conj)
expression emotional (amod)
, lesion (dep)
scored fasciculations (nsubjpass)
glucose to (case)
use predominant (amod)
certain stimulated (parataxis)
seriousness the (det)
0 4 (prep)
cell-mediated t (nmod:npmod)
improvement a (det)
negligible consisted (advcl)
helpful treatment (nmod)
effect smoking (nmod)
estimated damage (nmod)
l(-1 mg. (nmod:npmod)
exerts effect (dobj)
were unpaired (conj)
allopregnanolone and (cc)
administered intravesically (advmod)
responses flow (compound)
used bmt (nsubjpass)
region rats (nmod)
asphyxia and (cc)
quinidine itself (appos)
presence lid (nmod)
ro4368554 both (dep)
delayed with (case)
functioning elderly (nmod)
distinguish do (aux)
elevation which (nmod)
surgery to (case)
man 61-year-old (amod)
induced methyldopa (nmod)
group rr (dep)
bromperidol first (advmod)
risperidone ) (punct)
onset commencement (nmod)
starts proteinuria (compound)
increases pilocarpine-induced (amod)
supplementation phosphate (compound)
occurred effect (nsubj)
june 1 (nummod)
inhibits whether (mark)
analysis facs (compound)
chemotherapy inhibitors (conj)
2.4 4.3 (conj)
significant administration (nmod)
equipotent . (punct)
61 80 (conj)
antidepressants and (cc)
ingesting were (aux)
effects flestolol (nmod)
rats isph-induced (amod)
4.6 and (cc)
normalized , (punct)
involved differences (nsubjpass)
s than (case)
dysfunction variability (nmod)
development ns (nmod)
pod on (case)
recently as (case)
monitored flow (nsubjpass)
decreased time-dependent (nmod)
potentiation antagonism (appos)
obtainable should (aux)
validated using (xcomp)
attribute episodes (dobj)
tablets sustained-release (amod)
tamoxifen arms (appos)
those such (case)
changes profiles (nmod)
confirmed using (xcomp)
5 no (quantmod)
assess compared (advcl)
associated arthritis (nmod)
weeks 12 (nummod)
one mechanisms (nmod)
include manifestations (nsubj)
bupivacaine- , (punct)
frequency brainstem (compound)
confined be (auxpass)
analysis data (compound)
polfa " (punct)
yields times (compound)
experiments accumulation (compound)
pointes treatment (nmod)
implicated incidence (nmod)
supplementation creatine (compound)
patency and (cc)
influence response (nmod)
lipid toxicity (conj)
these of (case)
subject no (det)
eosinophils by (case)
performed comparing (xcomp)
dothiepin amitriptyline (conj)
test draw-a-man (compound)
princeton , (punct)
induced statin (amod)
zero intralipid (nmod)
switched tacrolimus (nmod)
independent was (cop)
levonorgestrel ( (punct)
core ischemic (amod)
duration predictors (nsubj)
rara the (det)
procedure with (case)
used studied (conj)
doses phenytoin (nmod)
lomustine of (case)
organisms 6 (nummod)
malignancies and (cc)
clinic geriatric (amod)
rats epilepticus (compound)
effects vincristine (nmod)
induces trinitrate (nsubj)
argatroban and (cc)
% population (nmod)
effect insulin (compound)
young aged (conj)
nondrinkers were (cop)
had ovariectomy (nsubj)
experiment for (case)
abundant hippocampus (nmod)
covariates for (case)
effect to (case)
mechanism same (amod)
found affected (advcl)
raises . (punct)
rcbf ( (punct)
g/day 2 (nummod)
complicated fluctuations (nmod)
initiate myopathy (dobj)
depression bone (compound)
expression sections (conj)
amn082 of (case)
lacnp ) (punct)
clonidine intravenous (amod)
ci 2.44 (nummod)
benefit their (nmod:poss)
method as (case)
echography by (case)
differences responses (nmod)
restarted indicated (advcl)
decrease pressure (compound)
sclerosis glomerular (amod)
hcfcs and (cc)
95 group (nmod)
dxnp and (cc)
restoration to (case)
motility increased (amod)
involvement receptors (nmod)
cholinergic a (det)
years 60 (nummod)
aminoglycosides and (cc)
risk outcome (nmod)
model lithium-pilocarpine (compound)
developed dog (nsubj)
alpha-position 5-h (conj)
unresponsive were (cop)
9.5-fold to (mark)
practices b (compound)
reported period (nmod)
presented obstruction (nmod)
content appearance (conj)
point the (det)
acts antagonist (nmod)
1,2-dmh ( (punct)
fibers especially (advmod)
tone maneuver (appos)
unaware a (det)
status normal (amod)
groups doxorubicin (appos)
control vip(-/- (conj)
prostigmine subcutaneously (advmod)
wsp in (case)
convulsions , (punct)
opacities subepithelial (amod)
dogs undergone (acl:relcl)
regard period (nmod)
pursued that (mark)
levels micrograms/dl (nmod)
lymphocytes t (compound)
prk ( (punct)
5-fluorouracil cyclophosphamide (conj)
% fed (conj)
bche novel (amod)
shown agent (xcomp)
period surgery (nmod)
weeks 48 (nummod)
320/12.5 and (cc)
investigated sufficient (ccomp)
chebula of (case)
presented they (nsubj)
beneficial and (cc)
old all (nsubj)
development strain (nmod)
stains inbred (amod)
became confused (xcomp)
developing cochlea (dobj)
156 21 (quantmod)
results proliferation (dobj)
neurohypophysis from (case)
ranged 67.66 (nmod)
weakly significantly (advmod)
indicate justified (ccomp)
effect normalizing (compound)
percent fifty-eight (amod)
used non-users (conj)
occasions on (case)
agents azathioprine (conj)
saline kg(-1 (conj)
[35s]tbps ) (punct)
carcinogenesis in (case)
2.3+/-1.2 , (punct)
had infiltrate (dobj)
increased enhanced (conj)
reaction immune-mediated (amod)
respect reversibility (nmod)
rates lower (amod)
infants 117 (nummod)
were effects (nmod)
antagonizes that (mark)
hypotension rilmenidine (amod)
males % (nsubj)
hypothesized , (punct)
h = (amod)
monthly protocols (conj)
marrow , (punct)
audiograms with (case)
incidence use (conj)
observed which (nmod)
action : (punct)
caution groups (nmod)
animals pinealectomized (amod)
fentanyl fentanyl (nmod)
stabilization sarcoma (nmod)
raised pressure (dobj)
action anti-carcinogenic (amod)
spine at (case)
days 25 (nummod)
cardiotoxicity study (conj)
4.1 to (dep)
susceptibility increased (amod)
cardiac renal (conj)
that higher (conj)
combination chemotherapeutics (nmod)
neurotoxicity pac (nmod)
infections pulmonary (amod)
cases literature (nmod)
preceded symptoms (nmod)
arose vasospasm (nsubj)
resulted ; (punct)
synthesis , (punct)
parameters or (cc)
definition and (cc)
read had (aux)
essential development (nmod)
score glasgow (compound)
screening , (punct)
experiment first (amod)
increasing concentration (dobj)
patients suffer (acl:relcl)
developed thrombosis (nmod)
led anesthesia (nsubj)
involvement muscle (compound)
regardless time (nmod)
produced vincristine (nmod)
dosages less (amod)
decreased agents (nsubjpass)
private and (cc)
processed microscopy (nmod)
p9201 on (case)
doses micrograms/kg/min (nmod)
displayed level (dobj)
acetate ppm (conj)
resulted duration (nsubj)
patients problems (nmod)
complexes specific (amod)
relation administration (nmod)
included decrease (conj)
had mortality (dobj)
complication thalidomide (nmod)
activities decreased (amod)
initiation for (case)
protein urine (compound)
stripe medulla (conj)
patients participating (acl)
referred been (auxpass)
antagonism propranolol (amod)
involves injury (nsubj)
modify revealed (advcl)
myocytes isolated (amod)
damage terminal (amod)
nra0160 piperidin-1-yl (appos)
times min (appos)
response vomiting (dep)
tolerance with (case)
prevent thrombosis (dobj)
damage ultrastructural (amod)
processed subsequently (advmod)
low was (cop)
reassured respect (nmod)
models arteritis (compound)
treated extended-release (nmod)
levels group (nmod)
increase mild (amod)
purpose randomized (nmod)
infusion dextrose (compound)
response chronotropic (amod)
dosing d-tubocurarine (compound)
summary history (nmod)
recommended commonly (advmod)
changed alphabeta-crystalin (dep)
blockers antagonists (conj)
involved autophagy (nsubjpass)
rats circulation (nmod)
promote intake (nsubj)
agonist adrenoceptor (compound)
diagnosed rapidly (advmod)
lilly eli (compound)
treatment mm (nmod)
isoenzymes individual (amod)
preceded hemolysis (nsubjpass)
cd4 in (case)
presented having (aux)
length stretch (nmod)
treating in (mark)
pool on (case)
compensation bbb (nmod)
obtained were (auxpass)
investigated work (nmod)
test multiple (amod)
instillation epinephrine (compound)
fatal frequently (advmod)
rosa alterations (nmod)
advanced encephalopathy (advmod)
epo ( (punct)
induce syndrome (dobj)
injection due (case)
impair disturbance (nsubj)
calibration simple (amod)
effect achievable (amod)
hypotension % (dep)
transplantation or (cc)
leading accumulation (nmod)
placebo-controlled single-blinded (dep)
riha defined (acl)
homeostasis calcium (compound)
trough-concentrations rose (acl)
representative recipients (nmod)
cv ) (punct)
suggested based (prep)
pfss ( (punct)
years between (case)
question number (nmod)
enabled us (dobj)
imaging radiographic (amod)
has power (dobj)
statins in (case)
differ concentrations (nsubj)
high 13 (nmod)
potassium plasma (compound)
contribute prostanoids (nsubj)
3/4 ) (punct)
tobacco to (case)
misjudgment paramedic (compound)
haematological to (case)
k body (compound)
identified analysis (nsubj)
receptor 5-ht6 (amod)
days training (compound)
35 5 (conj)
using drug (dobj)
> or (cc)
ginsenoside a (det)
min prior (amod)
proteinuric given (conj)
prevented loss (dobj)
anthracyclines the (det)
cent by (case)
confounding although (case)
setting volume (nmod)
volume presumably (advmod)
cbz acute (amod)
relates later (advmod)
efficacy mice (nmod)
ds of (case)
forces dose (nmod)
presence pb (nmod)
modulates temocapril (nsubj)
development diseases (nmod)
mg/dl creatinine (conj)
decreased incidence (dobj)
phenotype depressive (amod)
injected i.p. (advmod)
progestogens routes (conj)
shift a (det)
require , (punct)
participants the (det)
ci 100 (nummod)
months median (amod)
deposits calcified (amod)
withdrawn samples (nsubjpass)
treated had (aux)
sites 1,081 (nummod)
risk low (amod)
necrosis administration (nmod)
hematologic pathologic (conj)
glioma ) (punct)
actin the (det)
increased stz (nsubj)
applied clarify (advcl)
points of (case)
presentations across (case)
n=656 ( (punct)
dysrhythmias and (cc)
yohimbine the (det)
staining triphenyltetrazolium (compound)
requests hospitalizations (nmod)
7.8 x (cc)
years menopause (nmod)
patients myopathic (amod)
present patients (nsubj)
anesthesia under (case)
dm-9384 ( (punct)
withdrawn soon (advmod)
propranolol nor (cc)
serum- syndrome (nmod)
restricted contrasted (conj)
angioplasty following (case)
characterized failure (nmod)
known expressed (xcomp)
muscles of (case)
involves . (punct)
sensitive most (advmod)
culminating dysfunction (nmod)
risk contraceptives (nmod)
lithium-induced to (mark)
disease parkinson (compound)
mirrors reported (acl:relcl)
produce hypotension (nmod)
moving-bands fast (amod)
attack early (amod)
gavaged mg/kg (conj)
similar that (mark)
plasma electrolytes (conj)
increased history (nmod)
actions different (amod)
subjects four (nummod)
proteins trifluoroacetyl-adducted (amod)
participants patients (appos)
a-86929 ( (punct)
hdl found (acl)
suggested play (ccomp)
injections weight (nmod)
investigates role (dobj)
rat and (cc)
different were (cop)
parts ii (dep)
impairment prolonged (amod)
strengthen evidence (dobj)
little as (advmod)
recognize practitioners (nsubj)
achieve beats/minute (nmod)
conjunctiva the (det)
cream capsaicin (compound)
change neither (cc:preconj)
dementia induced (acl)
results women (conj)
12.3 4.1 (conj)
remain induce (csubj)
injections amns (nmod)
favor association (nsubj)
chromatography creatinine (conj)
palsy supranuclear (compound)
% 53 (nummod)
drugs typical (amod)
administration amiloride (nmod)
cimetidine ( (punct)
seizure electrographic (amod)
therapy concentration (conj)
onwards day (compound)
arrhythmias adrenaline-induced (amod)
period weeks (nmod)
paramedics by (case)
alterations induced (amod)
treatment cognitive (dep)
troleandomycin of (case)
treatment mg (nsubj)
as assessing (advcl)
treated were (aux)
mm elevations (nsubj)
fla-63 , (punct)
minimised occur (advcl)
mg 50 (nummod)
capsaicin . (punct)
pretreated seizures (nmod)
lower improved (conj)
intolerance n (dep)
recurrences , (punct)
preparations pills (conj)
p= , (punct)
a bisphenol (compound)
hd-mtx ) (punct)
antagonized morphine (nmod)
distance reflex (amod)
clonidine mk-801 (conj)
smokers in (case)
monkeys levodopa-primed (amod)
performed should (aux)
given dexamethasone (dobj)
exercised that (mark)
injection penicillin (compound)
hydroxytyrosol with (case)
release neurons (nmod)
crystallization diffuse (amod)
given have (aux)
used had (conj)
influence vasopressin (nmod)
poor prognosis (nsubj)
preferable decreased (advcl)
level low (amod)
conclusions increased (appos)
ovex ( (punct)
epidemics caused (acl:relcl)
episode single (amod)
chloride aluminum (compound)
tachyarrhythmias pointes (nmod)
mediated that (nsubjpass)
or 1.3 (conj)
feasibility using (advcl)
extracted rna (nsubjpass)
left patients (nmod)
consistent crystallization (dep)
test fisher (nmod:poss)
evaluated moreover (advmod)
evidence impairment (nmod)
described commonly (advmod)
years ten (nummod)
micrograms/kg/min n (conj)
proteinuria mechanisms (dep)
introduced been (auxpass)
development epilepticus (nmod)
developing necrosis (dobj)
3.6 0.6 (conj)
sulphadiazine agsd (dep)
stabilizers anticonvulsant (amod)
gavages by (case)
used operations (nmod)
hemodynamic antiadrenergic (conj)
bradycardia acute (amod)
minimum a (det)
40 50 (conj)
tumors liver (compound)
subset a (det)
trials two (nummod)
enzyme 's (case)
received evening (nmod:tmod)
acuity hcva (dep)
ouabain by (case)
entered trial (nmod)
ana of (case)
randomized carriers (nsubjpass)
users asymptomatic (amod)
preprocedure ( (punct)
treatment been (cop)
autoantibodies p450 (nmod)
cbz by (case)
pressure airway (compound)
response boy (nmod)
appearance visual (amod)
different administration (nmod)
autopsy at (mark)
circuitry in (case)
objective associated (appos)
dosage tacrolimus (compound)
provocation ? (punct)
signs objective (amod)
urea plasma (compound)
min ; (punct)
linked reports (nsubj)
compared responses (nmod)
periods incubation (compound)
p among (case)
syndrome equina (compound)
aware symptoms (nmod)
thought frequency (xcomp)
satisfaction their (nmod:poss)
pressure closure (compound)
dysfunction induced (acl)
eosinophils abundant (amod)
loss development (conj)
exhibits . (punct)
notion the (det)
effects functions (nmod)
complete . (punct)
duration intermediate (amod)
attribute might (aux)
uncommon were (cop)
factors independent (amod)
toxicity cystitis (nsubj)
number outcome (nsubj)
4.4 - (punct)
june in (case)
discomfort chest (amod)
risk cumulative (amod)
d d (conj)
enhance resolution (dobj)
due that (mark)
agents aspirin (conj)
showed toxicity (dobj)
16 of (advmod)
first block (nmod)
treatment placebo (conj)
had died (conj)
bpo-pll ( (punct)
likely use (conj)
upregulated expression (nsubjpass)
permit may (aux)
therapy quinidine (compound)
presentation recipients (nmod)
component tonic (amod)
hazard . (punct)
results significant (amod)
hr 24 (nummod)
white-cell and (cc)
randomised double-blind (conj)
commencement of (case)
toxicity no (det)
insipidus differentiating (amod)
pretreatment long-term (amod)
75.9 19.4 (conj)
gain importance (dobj)
correlated response (nsubjpass)
states acid (compound)
city copenhagen (nmod)
treatment be (cop)
presents when (advmod)
correlation no (neg)
synthesis vivo (advmod)
background genetic (amod)
lot awful (appos)
epilepsy , (punct)
indicate option (ccomp)
lumens the (det)
framework in (case)
agent antiplatelet (compound)
agents between (case)
rats tolerant (amod)
carcinoma esophageal (compound)
admitted 1986 (nmod)
manifestations all (det)
developed torsade (conj)
infusion c+e (dep)
angiography ultrasound (conj)
degree to (case)
kidney tdf (compound)
injections apomorphine (compound)
pirarubicin of (case)
agonist inverse (amod)
fibrillation diatrizoate (nmod)
isoniazide by (case)
morphometrical and (cc)
infusion sufficient (amod)
benefit ( (punct)
infusions bcnu (nmod)
reduction synthesis (nmod)
virus the (det)
effect with (case)
tumor is (cop)
edema chorionic (amod)
parkinson kingdom (compound)
activities effect (nsubj)
effect metabolism (nmod)
inhibition deacetylation (nmod)
developed ingestion (nmod)
polysomnography experimental (amod)
physicians care (compound)
secondary damage (nmod)
study calculate (acl)
21 or (cc)
renin cortical (amod)
anemia -- (punct)
1.0 or (cc)
pontis in (case)
hyperreactivity test (nmod)
ng.ml-1 ) (punct)
diagnosed have (aux)
kidneys group (nmod)
remain mechanisms (nsubj)
total > (nmod:npmod)
260 130 (compound)
d-tubocurarine with (case)
crossed were (auxpass)
paraesthesia numbness (nmod)
risks were (cop)
mechanisms ic (nmod)
larger + (cc)
experiencing episodes (dobj)
found factor (xcomp)
patients active (amod)
exposed subacute (xcomp)
act nephrotoxicants (nmod)
applications clinical (amod)
eai ) (punct)
upper and (cc)
cvvhdf , (punct)
development tolerance (nmod)
2-chloroprocaine-ce bupivacaine (conj)
had incidences (dobj)
rats days (nmod)
recipient neonate (conj)
amns of (case)
capsaicin-untreated , (punct)
exhibited rats (nmod)
betaine ( (punct)
levels i (nummod)
treatment l-noarg (compound)
use bupropion (nmod)
presence blockade (nmod)
severe less (advmod)
< or (cc)
outcomes neurocognitive (amod)
cgrp migraine (conj)
stage the (det)
production metabolites (nmod)
reported thought (advcl)
contributes whether (mark)
ncs ) (punct)
prevented rats (dobj)
organelle subcellular (amod)
observed female (nmod)
encephalopathy patients (nmod)
produces myelodysplasia (dobj)
presentation the (det)
arterial thromboemboli (dep)
received clozapine (dobj)
prevention defects (compound)
recovered disappearing (advcl)
age- sex-comparable (conj)
disease therapy (nmod)
fatigue % (appos)
velocity , (punct)
used ethambutol (nsubjpass)
attempted aborted (conj)
studies synergy (nmod)
determine subject (ccomp)
acid ursodeoxycholic (amod)
evidence more (amod)
wore off (compound:prt)
fast to (mark)
grade pneumonitis (nsubj)
serve may (aux)
onychomycosis for (case)
dogs forty-one (nummod)
findings girl (nmod)
lesion . (punct)
importance increasing (amod)
caused dose (nsubj)
disappeared later (advmod)
2-mercaptoethane thiol (compound)
improvement any (det)
produced drugs (nsubj)
antagonist 10ug (dep)
drugs pretreatment (compound)
apparent are (cop)
teratogenic that (mark)
initiatives evidence-based (amod)
noted postinjection (dobj)
effect models (nmod)
palsy intoxication (nmod)
severity changes (nmod)
gtn dfc (dep)
compared propofol (nmod)
mg/kg lethality (appos)
thrombocytopenia hit (appos)
influence inhibitory (amod)
lead incidence (nmod)
those neuropathy (nmod)
used indicate (conj)
scoring on (case)
improvements these (det)
associated disease (nmod)
mice i.c.v.)-treated (amod)
model seizures (compound)
anaesthesia during (case)
0.002 than (case)
withdrawal heat (nmod)
relapsed/refractory r/r (dep)
form drugs (nmod)
pituitary rat (compound)
associated hormones (nmod)
manifestations findings (conj)
decreased reflexes (nsubjpass)
csa p<0.001 (dep)
discontinued initiated (conj)
electrocardiogram ecg (appos)
insecticide a (det)
increase sensitivity (nmod)
intensity-weighted iw (dep)
ci 4.1 (nummod)
due effects (nsubj)
dwi , (punct)
segments alteration (conj)
lacking biomarkers (nsubj)
activation nin-induced (amod)
structures their (nmod:poss)
methods participated (dep)
% p<0.001 (dep)
recovery of (case)
effective dose (nsubj)
0.13 +/- (cc)
saline triamcinolone (conj)
mg/kg then (advmod)
5-fu/fa with (case)
nodule preneoplastic (amod)
observed noted (conj)
promote excretion (dobj)
included syndrome (dobj)
values mg/kg (appos)
disrupting reducing (conj)
rapamycin dose (compound)
signs , (punct)
children have (acl:relcl)
acid tranexamic (compound)
netilmicin four (nummod)
srl by (case)
studied system (nmod)
associated cases (nmod)
had recently (advmod)
poor relatively (advmod)
when especially (advmod)
rr=1.60 ( (punct)
clinically both (cc:preconj)
hyponatremia reported (acl)
effects rats (nmod)
status pubertal (amod)
pp mortality (dep)
sustained-release of (case)
forgetting conditioning (nmod)
serum phenobarbitone (dep)
beats ectopies (conj)
cage their (nmod:poss)
counts determination (dobj)
responses isoprenaline (nmod)
prior entry (nmod)
developed given (advcl)
reduced respectively (advmod)
p 0.25 (dep)
regimen . (punct)
neutrophils stimulated (acl)
climbing haloperidol (conj)
malaria severe (amod)
expression presentation (conj)
one levofloxacin (nsubj)
2.7 0.3 (nummod)
neonates and (cc)
dimorphism sexual (amod)
tab stop (compound)
marrow marrow (conj)
cycles and (cc)
p + (cc)
revealed electrocardiogram (nsubj)
mechanisms addiction (compound)
regulation attenuates (nmod)
receptors benzodiazepine (compound)
lower risk (nsubj)
overlap some (det)
loss frequencies (nmod)
become recently (advmod)
activates and (cc)
fenoterol-hydrobromide , (punct)
use stabilizers (nmod)
accumulation ester (compound)
preceded followed (conj)
sampled hospitals (nmod)
correlation pearson (nmod:poss)
lad ) (punct)
nephrotoxicity aminoglycoside (amod)
therapy first-line (amod)
showed cords (nmod)
random-assignment 6-week (amod)
had totp (nmod)
producing in (mark)
solution timolol (nummod)
= 203 (dep)
percentage erythroblasts (nmod)
activated especially (advmod)
done evaluation (nsubjpass)
symptoms amisulpride (advmod)
response hypercapnic (amod)
design evaluation (dep)
33 7 (compound)
agent antineoplasmic (amod)
antagonist receptors (nmod)
found areas (nsubjpass)
higher is (cop)
grade patients (nmod)
discriminates , (punct)
active and (cc)
relation correlation (dep)
timolol both (nsubj)
day 1 (nummod)
levels 7alpha-hydroxylase (nmod)
serve strain (nmod)
granulocytes and (cc)
followed ) (punct)
aventyl each (dep)
recognize . (punct)
symptoms obsessive-compulsive (amod)
taking not (neg)
imaging treatment (nmod)
evaluated observed (dep)
predictors the (det)
presence caffeine (nmod)
marker protein (conj)
differ effects (nsubj)
low generally (advmod)
model cacl(2 (nmod)
case female (nmod)
task processing (amod)
pregnancy of (case)
velocity depolarization (compound)
n-methyl-d-aspartate the (det)
results test (nmod)
val204asp ( (punct)
muscles cricoarytenoid (amod)
cardiotoxicity induced (amod)
dopamine through (case)
l/min 7.73 (nummod)
effects antihypertensive (amod)
constriction visual (amod)
action central (amod)
increased ctni (nsubjpass)
stz ) (punct)
strokes > (dep)
profile conditions (nmod)
develop will (aux)
received regimens (dobj)
pheochromocytoma with (case)
containing mg/kg/day (dobj)
size glomerular (amod)
derivative thienodiazepine (compound)
progress subsequently (amod)
health as (case)
common pattern (nsubj)
therapy an (det)
measured dimensions (nsubjpass)
cas ( (punct)
electrocardiography echocardiography (conj)
adenomas . (punct)
inhibition system (nmod)
administration vehicle (nmod)
patients risk (nmod)
increase transaminase (nsubj)
baseline p<0.05 (appos)
years treatment (nmod)
increased rats (nmod)
registered using (xcomp)
mg/caffeine 1 (nummod)
occlusion and (cc)
recommended discuss (ccomp)
changed spots (nmod)
polyvidone endografine (conj)
decreased support (nsubj)
shake on (case)
282 +/- (cc)
improved conclusions (dep)
incidence peak (compound)
anticoagulation adequate (amod)
challenge caffeine (compound)
0.025 ( (punct)
factor-alpha interferon-gamma (conj)
contracture extremity (nmod)
exert that (nsubj)
ph 3.0 (nummod)
cardiomyopathy excess (nmod)
acts . (punct)
conversion patients (nmod)
86 6 (compound)
used ever (advmod)
combination drug (compound)
patients suppression (nmod)
groups independent (amod)
cancer ureteric (amod)
men 734 (nummod)
high greater (conj)
disturbance pain (amod)
haloperidol due (case)
compared one (nmod)
propranolol mg (appos)
systolic supine (amod)
pregnancy or (cc)
tolerance l-noarg (nmod)
meningitis suspected (amod)
stl1 memory (appos)
use year (nmod)
cycles 2 (nummod)
metronidazole ( (punct)
lesions intensity (compound)
reducing reducing (conj)
5-htp and (cc)
reserpine subchronic (conj)
mechanism(s other (amod)
group dm (dep)
thought constriction (nsubj)
injection agent (nmod)
developed also (advmod)
healthy > (dep)
heart heart (nmod)
failure because (case)
wall the (det)
therapy rifampin (compound)
sd of (case)
4',7-dihydroxy-isoflavone ( (punct)
determined atropine (nmod)
reveal . (punct)
value corresponding (amod)
bleeding patient (nmod)
whether reduction (nsubj)
remained which (nsubj)
19.3 ( (punct)
difficulty liquids (nmod)
objectives/hypothesis . (punct)
palpation the (det)
infarcts of (case)
corticosteroids of (case)
gravis presenting (acl)
g/cm(2 653 (nummod)
users desogestrel (conj)
40 13 (conj)
flow data (conj)
oblongata the (det)
attack panic (compound)
removed rats (nmod)
inhibitors angiotensin-converting (amod)
questioned was (auxpass)
gauges g (appos)
9.84 4.59 (conj)
program of (case)
alternative that (mark)
nra0160 -(4-fluorophenyl (appos)
lesions symmetric (amod)
substrate acts (acl:relcl)
identified as (prep)
had corrected (ccomp)
vacuoles of (case)
rhythm alternating (amod)
fdc t+a (nmod)
event clinical (amod)
< p (nummod)
benign self-limited (conj)
differences intervals (nmod)
blocker channels (nmod)
attenuate proteinuria (dobj)
factors on (case)
volume saline (nmod)
enhanced in (case)
scan . (punct)
dexrazoxane range (nmod)
tumor malignant (amod)
nature hypertension (nmod)
assessed we (nsubj)
phenotypes two (nummod)
toxicities non-hematological (amod)
using laryngoscopy (dobj)
prolonged were (cop)
available relationship (nsubj)
available combinations (nmod)
remains evaluated (xcomp)
inhibition no (neg)
nature rotation (nmod)
or= > (compound)
were dilatation (attr)
extend and (cc)
stable progressive (conj)
enantiomer the (det)
pregnancies in (case)
elevation weight (nmod)
minutes forty (nummod)
carcinoma disease (nmod)
hypothesized responsible (ccomp)
man 69-year-old (amod)
samples no (det)
confirm could (aux)
oxidation ring (nmod)
ceased withdrawal (nmod)
mol/l of (case)
present time (nmod)
organelles , (punct)
causes pattern (dobj)
unfamiliar were (cop)
square differences (nmod)
berlin germany (appos)
31 11 (conj)
exercise 0.6 (dep)
phenylephrine iprk (compound)
6/15 and (cc)
paramedics the (det)
hormones response (nmod)
hypertension oxide (compound)
studies deferens (dep)
result hypertrophy (nsubj)
taking three (nsubj)
albuminuria , (punct)
alpha-mediated that (mark)
develops % (nmod)
lymphoma cell (compound)
adjusted treatment (nsubjpass)
fever failure (conj)
vacuolation staining (nmod)
hours three (nummod)
advisable develop (advcl)
opse nondyskinetic (nmod)
treat episodes (dobj)
orl1 ( (punct)
victims 125 (nummod)
treated carboplatin (nmod)
assessed basis (nmod)
reduces risk (dobj)
patients received (acl:relcl)
anesthetized tracheotomies (conj)
bmt of (case)
haemopericardium haemorrhage (conj)
treatment for (case)
man 28-year-old (amod)
pb ( (punct)
showed ( (punct)
factors ) (punct)
cxad ( (punct)
imperative patients (nmod)
incidence apparent (amod)
antagonized reduced (conj)
shown associated (xcomp)
treated early (advmod)
tissue and (cc)
had t (nsubj)
vestibulotoxicity against (case)
dose scopolamine (nmod)
breeder same (amod)
three about (advmod)
women healthy (acl:relcl)
abolished tyr6]-vip (conj)
concentrations vip (nmod)
rates intraperitoneal (amod)
manufactures camera (dobj)
evidence any (det)
tetrandrine tet (appos)
seemed treatment (nsubj)
kg-1 glycopyrronium (compound)
microglobulinuria low (conj)
17beta-estradiol nm (amod)
assessed baseline (nmod)
activity cholinergic (amod)
exercise treadmill (amod)
provide time (dobj)
hepatotoxicity of (case)
killed animals (dobj)
schedules mg/kg (dep)
rats young (amod)
seizures associated (acl)
micrograms/ml respectively (advmod)
combined are (auxpass)
monitored effects (nmod)
evidence tamponade (nmod)
d1 of (case)
indicating symptomatic (xcomp)
intrathecal systemic (conj)
angioedema whom (nmod)
monitored physician (nsubjpass)
deposited that (mark)
visualized distortion (dobj)
focused event (nmod)
mediated likely (advmod)
dose n (dep)
homeostasis hepatic (amod)
paracetamol tumours (nmod)
inflammation with (case)
ecstasy users (dobj)
necessary observe (xcomp)
colitis for (case)
decreased min (nmod)
outpatients cocaine-dependent (amod)
aware effects (nmod)
occlusion due (case)
20 12 (conj)
administration end (nmod)
panel donor (compound)
metastases combining (acl)
decrease pressure (nmod)
efficacy side (conj)
uremia se (advmod)
jaundice hepatomegaly (nmod)
tumors gross (amod)
lithium clozapine (conj)
importance using (advcl)
conclusions study (appos)
disulfiram with (case)
cystitis ( (punct)
factors multiple (amod)
extent on (case)
acidity due (case)
showed summary (nmod)
image high (amod)
tends increase (xcomp)
uterus the (det)
432 and (cc)
perseveration learning (conj)
included subjects (nsubjpass)
lumen cells (nmod)
inhibition gabaergic (amod)
elected authors (nsubj)
affected syndrome (nsubjpass)
aminotransferase phosphatase (conj)
toxicity caffeine (nmod)
syndrome exposure (nmod)
drop dramatic (amod)
volumes and (cc)
ketamine safely (advmod)
involvement metronidazole (nmod)
cases nephrolithiasis (nmod)
presence than (case)
noted patient (nmod)
worsening tasks (nmod)
inhibited that (nsubj)
changes gliosis (nmod)
action to (case)
rate 12-hour (amod)
administration lamivudine (compound)
experimental clinical (conj)
challenge levodopa (nmod)
half almost (advmod)
excitatory less (advmod)
enrolled patients (nsubjpass)
0.90 of (case)
syndrome from (case)
frequently most (advmod)
localization model (nmod)
increasing may (aux)
disorder attention-deficit (amod)
1 of (case)
continued rise (xcomp)
suggested teratogenic (ccomp)
third one (nummod)
seizure and (cc)
role crucial (amod)
auc c(max (conj)
cortex acc (appos)
poison warfarin-type (amod)
increase lesser (amod)
reported effect (nsubjpass)
half-life because (case)
collected patient (nmod)
type of (case)
frequent contrast (nmod)
induces anxiogenic- (dobj)
edds ( (punct)
concentration flecainide (amod)
considered consumption (nsubjpass)
beta-adrenoblocking action (conj)
injections rescue (compound)
raised been (auxpass)
decreased decreased (parataxis)
administration dose (dep)
frequencies only (advmod)
medium a (det)
lumens atrophy (conj)
survival 6-year (amod)
suggested responsible (xcomp)
prevent even (advmod)
deterioration increase (conj)
exhibited actions (dobj)
flurazepam fzp (appos)
off was (cop)
pethidine adolescent (amod)
avoiding of (mark)
reversible stages (nmod)
eruption involves (acl:relcl)
disoprivan with (case)
articles retrieved (amod)
treated anticonvulsants (nmod)
prolonged apd (dobj)
come back (advmod)
increased abundance (nsubjpass)
attributable therapy (nmod)
polymorphism region (nmod)
antibody membrane (compound)
required patient (nsubj)
patients aspirin (conj)
type presence (conj)
methods different (amod)
carbamazepine with (case)
neuropathy a (det)
argatroban plasma (compound)
ischemia of (case)
patient our (nmod:poss)
mu not (conj)
n-butyl-deoxynojirimycin of (case)
used volunteers (nsubjpass)
responders ( (punct)
hypercalcemia unexplained (amod)
developed exposure (nmod)
treated srl (nmod)
compare rate (dobj)
leftward deviations (conj)
hemisuccinate . (punct)
injury cortex (nmod)
underwent transplantations (dobj)
risks potential (amod)
screening positive (amod)
associated symptoms (nsubjpass)
infiltrate consistent (amod)
territories adjacent (amod)
allowed , (punct)
following injection (dobj)
months persistence (nmod)
maintained beginning (advcl)
agent antifibrinolytic (amod)
all in (case)
shunting interatrial (amod)
or=10.8 mg/dl (acl)
site , (punct)
membranes , (punct)
early or (cc)
strains between (case)
activity neither (cc:preconj)
complete or (cc)
dose rocuronium (nmod)
associated octreotide (nmod)
lnna with (case)
relationship both (preconj)
points inversion (compound)
combination diazepam (nmod)
3.1 ( (punct)
cysts subependymal (amod)
hyperalgesia the (det)
32.87 ] (punct)
develops syndrome (compound)
evidence hyperactivity (nmod)
tachycardia ouabain-induced (amod)
measure geometry (dobj)
stopped or (cc)
effective lovastatin (nsubj)
exhibited and (cc)
20 and (cc)
impact the (det)
hours 23.6 (nummod)
emphasized recently (advmod)
associated failure (nsubjpass)
curve noradrenaline (amod)
obtaining history (dobj)
110 +/- (cc)
recalled word (dobj)
disappear not (neg)
binding convulsions (conj)
percentage baseline (nmod)
t.i.d. micrograms (compound)
moderate % (nsubj)
administration mp (nmod)
caused comparing (advcl)
derived have (aux)
up-regulated that (mark)
perivascular interstitial (conj)
symptoms group (nmod)
endpoints the (det)
loss waveform (compound)
mg alone (advmod)
effects nik-247 (nmod)
reduction behavior (nmod)
catechol phenol (conj)
4.10 . (punct)
administered examined (conj)
placed after (mark)
therapy fk506 (compound)
ml/ng ( (punct)
mechanism(s on (case)
lithium-treated + (cc)
experience therapy (nmod)
activity n-acetyl-beta-d-glucosaminidase (compound)
5 low (advmod)
behavioral effects (dep)
ser198 leading (amod)
obtained dose (nmod)
alterations lipoproteins (nmod)
examined given (advcl)
hyponatremia with (case)
given reached (advcl)
observed ph (nmod)
index iief (appos)
cases refractory (amod)
institution in (case)
activities score (compound)
impaired procedure (nmod)
unit medical (amod)
amphetamine- or (cc)
isoenzymes for (case)
p=0.39 ( (punct)
had section (nmod)
screening prenatal (amod)
protects restriction (nsubj)
observed occlusion (nmod)
n- with (case)
events cardiac (compound)
showed pressure (dobj)
literature a (det)
use cocs (nmod)
enzyme converting (compound)
pharmaceuticals philadelphia (appos)
disappearance in (case)
caused willing (conj)
testing for (mark)
1984 - (punct)
increase infusion (nmod)
relationships doxorubicin (nmod)
increase recent (amod)
altered that (mark)
increases volume (conj)
assess multicenter (dobj)
dilation of (case)
likely undergone (xcomp)
ring pyrrolidine (compound)
results analyses (nmod)
microg/ml microg/ml (nmod)
reduces treatment (nsubj)
randomized placebo-controlled (dep)
period hour (nmod)
h > (compound)
dose convulsive (amod)
august february (conj)
associated patients (nsubjpass)
decreased cent (nmod)
slices rats (nmod)
rate minutes (nmod)
affected test (nmod)
medium in (case)
properties reported (acl:relcl)
on and (cc)
patient every (det)
mesna oral (amod)
induces regions (nmod)
augment furthermore (advmod)
measured loops (nmod)
binding sites (nmod)
patients those (nmod)
59 50 (compound)
ari of (case)
related risk (nsubj)
value km (compound)
dose addition (conj)
maintained levothyroxine (nmod)
delivered fetuses (nsubjpass)
diet hs (compound)
detectable , (punct)
minimal , (punct)
develop to (mark)
reducing prior (advmod)
obtain rate (dobj)
parameters quantitative (amod)
nicergoline sermion (appos)
treatment since (case)
tland osterg (compound)
patients these (nmod)
deal for (case)
climbing tests (conj)
describes paper (nsubj)
exposure early-life (amod)
person healthy (amod)
consciousness of (case)
logical is (cop)
available ( (punct)
depression profound (amod)
enrolled sites (nmod)
attenuates that (mark)
microinjection previous (amod)
data administration (nmod)
controlled be (auxpass)
extracellular the (det)
infarction . (punct)
hyperactivity antagonized (amod)
interleukin erythropoietin (conj)
conclusion induced (appos)
synthesis repair (amod)
acid bile (compound)
result secretion (nmod)
indicate might (aux)
antagonism metoprolol (nmod)
years 58.5 (nummod)
patient taking (acl)
injected had (advcl)
antagonists pirenzepine (dep)
take who (nsubj)
compared diagnosing (advcl)
inhibit pentoxyifylline (nsubj)
breath of (case)
being of (mark)
heart mice (conj)
6/15 vision (nsubj)
caution and (cc)
delay training (nmod)
dysfunction increased (amod)
responses and (cc)
lactation of (case)
knockout polypeptide (compound)
convulsive locomotor (conj)
agent um-272 (appos)
triggered augmented (conj)
caffeine pentylenetetrazole (conj)
disease due (case)
differentiate better (advmod)
aged months (nmod:tmod)
background prescribed (appos)
necrotizing leukoencephalopathy (dobj)
greater suggesting (advcl)
study initial (amod)
enzyme neuropathy (amod)
causes effective (advcl)
patients as (case)
mitochondria organelles (appos)
inhibited dose (nmod)
18.9 16.4 (conj)
rates event (compound)
enhances propranolol (nsubj)
16;567 ) (punct)
allergy of (case)
conclude occurs (advcl)
nitrogen bun (appos)
srl with (case)
increased cells/microl (nmod)
analgesia induced (acl)
sites sulphate (compound)
twitching adolescent (nmod)
diarrhea were (cop)
made available (xcomp)
therapy behavior (conj)
dogs 10 (nummod)
documentation of (case)
related hypotension (nmod)
pretreatment phenobarbital (nmod)
mechanisms nicotinic (amod)
correlated pressure (nsubj)
believed overdose (xcomp)
adjusted dose (nsubjpass)
rechallenge its (nmod:poss)
showed results (dobj)
measured activities (nsubjpass)
increase substantial (amod)
behavior sexual (amod)
agonist shown (acl)
collected prospectively (advmod)
detected echocardiography (nmod)
develop hyperactivity (dobj)
tiapride movements (nmod)
included measurements (nsubj)
rise excretion (conj)
attributed infusion (nmod)
days or (cc)
matched with (case)
treatments aspects (nmod)
carried order (nmod)
products healthcare (compound)
show produces (ccomp)
preceding decline (ccomp)
g/dl g/dl (appos)
4.0 nearly (advmod)
reviews systematic (amod)
l-noarg not (cc)
certain ; (punct)
showed inhibited (conj)
activator fast (amod)
improved condition (nsubj)
poisoning phosphorus (compound)
describe episodes (dobj)
conversion 8 (nummod)
locomotion apomorphine-induced (amod)
placed beclomethasone (nmod)
counts activity (compound)
aetiology deficiency (nmod)
importance calcium (nmod)
presence its (nmod:poss)
77.1 score (nsubj)
minor has (aux)
modes transformation (nmod)
nystagmus downbeat (amod)
mechanisms : (punct)
abnormalities new (amod)
specimens 65 (nummod)
orgasm , (punct)
umb24 (+/-)-sm (conj)
nested population (nmod)
rosen 's (case)
showed kinase (dobj)
responses levodopa (nmod)
created was (auxpass)
pacing ventricular (amod)
allogeneic reduced-intensity (amod)
uncertainty because (case)
lidocaine mg (dep)
treatment androgen (compound)
damage adriamycin-induced (amod)
insertion after (case)
effacement with (case)
innervation of (case)
radiotherapy before (case)
evaluable . (punct)
woman occurred (acl:relcl)
level exposure (compound)
6-months after (case)
showed mid (nmod)
paco2 +/- (cc)
fire report (conj)
rapid abnormally (advmod)
corroborate . (punct)
3.4 0.2 (conj)
responses behavioral (amod)
required trigger (xcomp)
increased attack (nmod)
observations careful (amod)
cancer on (case)
access starting (acl)
norms values (conj)
reaction ce (nmod)
section caesarean (amod)
finding and (cc)
treatment loiasis (nmod)
unchanged which (nmod)
minutes results (nsubj)
course over (case)
groups many (amod)
inhibited neither (cc:preconj)
switching combination (nmod)
stress on (case)
lmwh of (case)
used applicators (nmod)
attenuated deletion (nmod)
120/67 hg (dobj)
10.0 and (cc)
concerns carbamazepine (nmod)
maintained injection (nmod)
execution by (case)
activity effects (conj)
shr to (case)
role csa (nmod)
rats rendered (acl)
defined which (nsubjpass)
week 1 (nummod)
doxorubicin/kg mg (amod)
external , (punct)
mechanisms compensatory (amod)
duration injection (compound)
decrease compounds (nsubj)
courses therapy (nmod)
pcp ) (punct)
associated anemia (nmod)
ms by (case)
bupivacaine those (det)
densities episodes (nmod)
0.85 0.57 (nummod)
occurrence this (det)
use amphetamine (compound)
weight baseline (compound)
decrease length (nmod)
imaging and (cc)
objectives offset (appos)
subjects clonidine (nmod)
evaluation and (cc)
represent and (cc)
presentation and (cc)
buffer ph (nmod)
transplantations other (amod)
induce absence (nmod)
mediates nucleus (nsubj)
fatigue . (punct)
-placebo 1 (nummod)
g as (case)
serum- sgk1 (dep)
cause neurotoxicity (dobj)
accompanied stress (nmod)
developed 8 (nsubj)
isoproterenol to (case)
suppressants appetite (compound)
converted enzymatically (advmod)
had those (nmod)
mrd right (amod)
fk , (punct)
terbinafine of (case)
action calcitonin (nmod)
1,000 1.8 (quantmod)
identify predictors (dobj)
inhibition mtor (compound)
convulsions cocaine-induced (amod)
one factors (nmod)
0.86 +/- (cc)
followed was (auxpass)
seizure days (dobj)
anencephaly to (case)
ck-mb ck (dep)
take drug (dobj)
results dexamethasone (nsubj)
1.3+/-0.3 ( (punct)
concentration cpb (nmod)
inhibitor between (case)
oxycodone of (case)
desmethylimipramine i.v. (amod)
inhibition hyperalgesia (nmod)
formed interim (nmod)
diabetes level (conj)
decreased sem (conj)
year 61 (nummod)
statin ( (punct)
transition mitochondrial (amod)
flow oxygen (nmod)
decrease this (det)
mg then (advmod)
reduction drug (compound)
improved co (mark)
associated could (aux)
unknown , (punct)
37 27 (compound)
3.1+/-1.0 ( (punct)
diagnosis first (amod)
managed adjusted (advcl)
acts citalopram (nmod)
good very (advmod)
inconsistent finding (nmod)
fall progressive (amod)
first than (case)
were group (nmod)
properties fetal (amod)
greater activity (nsubj)
diagnosed women (nmod)
receptors dmpx (appos)
study patients (appos)
imaging dynamic (compound)
virus hiv (appos)
population evaluation (compound)
able that (mark)
81.6 6.8 (conj)
lack significant (amod)
severity on (case)
hemorrhage submucosal (amod)
demonstrated vitro (advmod)
pulses constant (amod)
ovarian and (cc)
pvn rat (nmod)
initiating discuss (conj)
susceptibility patients (nmod)
benefits terms (nmod)
u/l 1533 (nummod)
mapped and (cc)
epinephrine groups (conj)
phase randomised (amod)
fluid : (punct)
september 1996 (nmod:tmod)
was goal (nsubj)
activation through (case)
to carbetocin (nmod)
deliver rate (dobj)
agents new (amod)
paralysis transient (amod)
jg wilson (compound)
electrocardiogram electroencephalogram (conj)
proven challenge (nmod)
improved amnesia (dobj)
stimulation versus (cc)
action narcosis (nmod)
prohibited could (aux)
microinjection acid (compound)
levels striatal (amod)
enos inos (conj)
or 12.1 (appos)
microg/kg 1 (nummod)
dosages ) (punct)
different anaesthetic (dep)
determined basis (nmod)
disulfiram dependence (nmod)
nephrotoxicity 50 (appos)
antagonized hypokalemia (nsubjpass)
tachycardia against (case)
administration chonic (amod)
aimed . (punct)
lower l (nmod)
documented induction (nsubjpass)
shifts dependence (nmod)
suggest hypothesis (dobj)
used action (nmod)
acid alpha-lipoic (amod)
40.8 12.1 (conj)
asians of (case)
halts induction (nsubj)
dogs additional (amod)
admission of (case)
induced convenient (advmod)
supramarginal and (cc)
resulted rate (nmod)
ratings intensity (compound)
3.10 users (nmod)
rs6277 taqia (conj)
nucleoside analogue (conj)
neuropathy transplantation (nmod)
occurred c (nmod)
frequency microangiopathy (nmod)
metabolites detected (acl)
recorded ; (punct)
mmol.kg(-1).day(-1 ) (punct)
haematological toxicities (nsubj)
phenylephrine the (det)
associated that (nsubjpass)
affect aspirin (nsubj)
a with (case)
possible likelihood (nsubj)
seizures hemorrhage (conj)
based structure (nmod)
myoclonus extremities (nmod)
erp ( (punct)
undertaken before (mark)
those resulting (acl)
impair not (neg)
carriers forty-two (nummod)
tomography localised (amod)
ngf between (case)
needed number (nsubj)
resolved recurred (conj)
following as (case)
cancer cohort (nmod)
gluconate of (case)
lesions patients (nmod)
clinicians from (case)
survey strains (nmod)
structures various (amod)
possessing activity (dobj)
tubule connecting (amod)
rheumatology , (punct)
layers connective (amod)
dogs twenty-three (amod)
decreased inhibition (nsubjpass)
successful be (cop)
route venous (amod)
using and (cc)
receiving inhibitor (dobj)
antibody a (det)
observed alteration (nsubjpass)
given hours (appos)
effects antiarrhythmic (amod)
defined children (nmod)
pseudolithiasis with (nmod)
suggested tolerated (ccomp)
similar dose (nmod)
action antihypertensive (amod)
syndrome sulphasalazine (amod)
screenings of (case)
cvds ) (punct)
results these (det)
series case (compound)
glomerulopathies cases (conj)
clearance lometrexol (compound)
benzylthiouracil ( (punct)
recognition early (amod)
used countries (nmod)
used fenoldopam (nsubjpass)
revealed electrolyte (dobj)
indicators several (amod)
tacrolimus on (case)
examined grafts (dobj)
mg/m2 70 (nummod)
antagonist ep1-receptor (compound)
dogs in (case)
cultured cells (nsubjpass)
used trial (nmod)
exposed mice (nsubjpass)
studies electrophysiologic (amod)
inhibition activities (nmod)
occurred instances (nsubj)
prolongs argatroban (nsubj)
room in (case)
chronic or (cc)
neutral the (det)
performed worse (acomp)
network july (nmod)
cpu in (case)
non-hodgkin 's (case)
passed sutures (nsubjpass)
lipid nanosphere (advmod)
had remission (dobj)
demonstrated scans (nsubj)
region domain (nmod)
inhibition course (nmod)
therapy physical (amod)
arrhythmias other (amod)
moderate-dose , (punct)
receptor-alpha the (det)
ligation by (case)
pseudo-allergy of (case)
possibility events (nmod)
version a (det)
mice fasl (compound)
duration long (amod)
cpu the (det)
mediated require (conj)
change histamine (compound)
= 0.14 (dobj)
lack because (case)
exhibits features (dobj)
impaired also (advmod)
established mechanistic (nmod)
drinking early (advmod)
drc 0.001 (dep)
model biological (amod)
present bodies (nsubj)
changes changes (nsubj)
rats diet (conj)
, twice (dep)
associated lamivudine-resistance (nmod)
observed nsaids (nsubjpass)
compared value (nmod)
lesion ventral (amod)
antibiotic , (punct)
events were (cop)
nicardipine after (case)
kidney isolated (amod)
described eight (nsubjpass)
delirium fatal (amod)
ranged days (nmod)
conclusion pretreatment (dep)
study microdialysis (compound)
means scales (nmod)
waves later (amod)
channels potassium (compound)
points ( (punct)
history presented (acl)
scored time (nmod)
subgroup % (appos)
resistant most (advmod)
heparin , (punct)
pressure filling (amod)
attenuates . (punct)
abnormalities cytologic (amod)
five two (conj)
dissociated unless (mark)
using those (nsubj)
tissues various (amod)
0.41 0.02 (compound)
25 7 (compound)
microinjected surface (nmod)
haart cumulative (amod)
therapy patients (nmod)
progress use (nmod)
7-ethoxyresorufin-o-deethylase of (case)
trans-2-amino-3-hydroxy-1 , (punct)
dysfunction by (case)
receiving combination (dobj)
lack despite (case)
improves even (advmod)
treatment vasospasm (nmod)
usage ethambutol (compound)
brain hypotension (nmod)
solubility aqueous (amod)
have concentration (dobj)
patients disturbance (nmod)
effect risperidone (nmod)
choreoathetosis profound (amod)
licl mmol.kg(-1).day(-1 (dep)
necrosis level (nmod)
reduce anxiety (dobj)
demonstration in (amod)
doses refracted (amod)
spread using (advcl)
fluid mg. (compound)
increased nuclei (nmod)
increased thrombogenicity (dobj)
clonazepam the (det)
experiencing deteriorations (dobj)
responders , (punct)
relations group (nmod)
efficacy treatment (nmod)
concentration in (case)
disorder depressive (amod)
54 45 (conj)
doses than (case)
aqp2 localization (conj)
diseases many (amod)
carcinogen of (case)
den 10 (dep)
elongation dna (compound)
analogue somatostatin (compound)
displayed accompanied (advcl)
damage inner (amod)
cyclophosphamide cp (appos)
prove formulations (nsubj)
episodes with (case)
painful that (mark)
changed patients (nmod)
lasted and (cc)
activities chain (compound)
caused studies (nmod)
mhb potent (amod)
smoking heavy (amod)
layer mitral (amod)
subsides it (nsubj)
cck-8-se and (cc)
focused recently (advmod)
tam of (case)
order investigate (acl)
incidence group (nmod)
hyperkalemia associated (acl)
responses ) (punct)
changes production (nmod)
microscopy confocal (amod)
memory dependent (amod)
rates b (nmod)
patient above-mentioned (amod)
series all (det)
hcbd ( (punct)
mg 2mls (dep)
attribute caused (conj)
evaluable response (nmod)
gavaged orally (advmod)
.001 than (case)
monomers fibrin (compound)
receives that (mark)
schedule mg/m(2 (nmod)
specific caffeine (nmod)
periods 3-min (amod)
pressure filtration (compound)
remission depression (nmod)
stratified were (auxpass)
aqueous and (cc)
evaluated dosed (advcl)
registry from (case)
tests hepatic (amod)
role vasopressin (nmod)
post-injection , (punct)
appear associated (advcl)
attributable is (cop)
some ischemia (nmod)
change recent (amod)
improved rats (nmod)
induction enhanced (amod)
rofecoxib 1.52 (dep)
achieves regimen (nsubj)
cited % (nmod)
investigated expression (conj)
gag/pol ) (punct)
conversion of (case)
steroids immunoglobulins (conj)
failure concentrations (nmod)
effect antiviral (amod)
black younger (conj)
prolonged was (auxpass)
used evaluation (nmod)
suggests cisplatin (ccomp)
background contributor (appos)
venipuncture , (punct)
patients develop (acl:relcl)
used comparison (nmod)
gr or (cc)
preferable be (cop)
levels calcineurin (nmod)
increase mortality (dobj)
lower administration (advcl)
evaluated termination (nmod)
mechanism immunoallergic (amod)
agonist-induced beta-ar (amod)
repeated , (punct)
present therapy (nmod)
low dosage (nmod)
output % (dep)
injected observed (parataxis)
dox cardiomyopathy (amod)
blockade animals (nmod)
source was (cop)
differentiation clear (amod)
acid nl (compound)
hexabrix and (cc)
disease experimental (amod)
h 1 (compound)
presumed age (dep)
effect subjective (amod)
monitored care (nmod)
activity vivo (advmod)
shows response (nsubj)
favour reactions (nmod)
aneurysms or (cc)
histories medical (amod)
proliferation renal (amod)
gene htr6 (appos)
affect probability (dobj)
blocked completely (advmod)
nephritis acute (amod)
proportional mg/m2 (nmod)
administration d2 (nmod)
vasculitis leukocytoclastic (amod)
symptoms regarding (case)
evaluation full (amod)
treated weeks (nmod)
concentration hemoglobin (compound)
units cells (nmod)
u/ml ; (punct)
19/92 8 (conj)
administered applied (conj)
exhibited cells (nmod)
contracture hip (nmod)
15.7 +/- (cc)
dysrhythmias resistant (amod)
doses 7 (nummod)
developed extract (conj)
maximal both (preconj)
effacement process (compound)
associated as (mark)
butyrylcholinesterase plasma (compound)
disease concurrent (amod)
reported enhanced (ccomp)
function ameliorative (amod)
rhythms theta (compound)
increased mmol/l (nmod)
doses given (case)
ngf urinary (amod)
associated hypotension (nsubjpass)
choice first (amod)
reduced increments (dobj)
induces aspirin (nsubj)
deaths 6 (nummod)
allele elderly (nmod)
mesothelioma , (punct)
induced downregulated (conj)
dogs no (det)
controlled ineffective (advcl)
dysfunction ssri-induced (amod)
call exacerbations (nmod)
acute or (cc)
doses first (amod)
> age (compound)
relation findings (nmod)
discussed parallels (nsubjpass)
17.6-fold . (punct)
variables respiratory (amod)
reversal naloxone (amod)
mothers received (acl:relcl)
lt post-operative (conj)
intubated was (auxpass)
steroids anabolizing (compound)
packing night (compound)
characterized here (advmod)
allografts from (case)
methods degeneration (compound)
stress adolescent (amod)
administration bisphosphonate (compound)
heart adriamycin-induced (amod)
agonist children (nmod)
reducing speed (dobj)
managed assessed (advcl)
measured administration (nmod)
injury mtdna-encoded (amod)
evidence ischemic (nmod)
showed staining (nsubj)
management for (case)
treatment symptoms (nsubj)
shifting ) (punct)
injected intravenously (advmod)
patients p=0.65 (appos)
neurophysiology the (det)
a-i les (conj)
administered that (mark)
suggest protect (ccomp)
observed using (xcomp)
embarked upon (prep)
ca2 aconitine-induced (amod)
indicator stress (nmod)
decreased bradycardia (dobj)
therapy hypertension (nmod)
subsided slowly (advmod)
repeat and (cc)
totp without (case)
disease treated (acl)
found men (nmod)
rammer ; (punct)
related genotype (nmod)
spectrum which (nmod)
years filled (acl:relcl)
pfs worse (amod)
contain oil (dobj)
states seizures (conj)
chemotherapy previous (amod)
exist which (nsubj)
performed study (dobj)
biosynthesis the (det)
emphasize we (nsubj)
blind design (appos)
tet and (cc)
scale sas (appos)
donors volunteer (compound)
effectiveness pretreatment (nmod)
l-name with (case)
nephrectomy moreover (advmod)
levels ao (compound)
tr(- ( (punct)
produced clonidine (nmod)
using treatment (nmod)
plays epilepticus (nmod)
case recipient (nmod)
resulted epilepticus (nsubj)
sod , (punct)
rate volumes (conj)
dysfunction respiratory (amod)
transgenic nontransgenic (conj)
subunit the (det)
agent was (cop)
metabolizer , (punct)
system tuberoinfundibular (amod)
factors increase (acl:relcl)
transport-deficient in (case)
clinical resolution (dep)
cisplatin wr-2721 (conj)
developed subgroup (nsubj)
shortage national (amod)
concentration organism (compound)
results reperfusion (nsubj)
patients microbiologically (amod)
hypotension without (case)
16,459 cost (nsubj)
complications cardiac (amod)
screened : (punct)
proteinuria aggravate (compound)
groups 1- (amod)
noradrenergic and (cc)
apoptosis cell (compound)
appeared dopamine (nsubj)
expression bladder (nmod)
pharmacy by (case)
comparison , (punct)
incontinence their (nmod:poss)
regression ) (punct)
% decrease (conj)
alert need (nmod)
state brain-dissociated (amod)
metoprolol enantiomers (conj)
intoxication mixed (amod)
women seven (nummod)
gentamicin inhibitor (appos)
implicated conditions (nmod)
done tests (nsubjpass)
disclosed abnormalities (dobj)
did who (nsubj)
months 11.8 (nummod)
% 36.3 (compound)
risperidone with (case)
conducted associated (advcl)
29 of (advmod)
agents blocking (compound)
decreased rate (nmod)
lomustine and (cc)
give and (cc)
deficits severe (amod)
augmented doc (dobj)
maintained days (nmod)
vicinity orbitofrontal (nmod)
after weeks (nmod:npmod)
stroke patient-years (nmod)
antinociceptive properties (dep)
architecture , (punct)
exposure is (cop)
received vs (cc)
effects l-arginine (nmod)
administration challenged (conj)
8 times (quantmod)
efficacious whether (mark)
receive daily (advmod)
developed but (cc)
phenobarbitone- carbamazepine-induced (conj)
exhibiting dose (dobj)
induces lithium (nsubj)
seen patients (nmod)
rise pressure (compound)
reaction and (cc)
studies in (amod)
a1 monkeys (nmod)
necrosis renal (amod)
pallor , (punct)
erythrocytes induced (acl)
newborns exposed (amod)
test the (det)
vagina detected (acl)
criteria exclusion (compound)
alkylxanthines the (det)
groups dosage (compound)
val placebo (conj)
groups trend (nmod)
min compared (acl)
prominent more (advmod)
patients prolactinomas (appos)
i ( (punct)
conclude given (ccomp)
presence features (nmod)
resolution spontaneous (amod)
decreasing pressure (dobj)
tolerability results (dep)
initiating therapy (dobj)
uncommon conclusions (dep)
ablation liver-specific (amod)
ct after (case)
monitored map (nsubjpass)
preceded leakage (nmod)
hydroperoxides lpo (appos)
sinusitis for (case)
reduction threshold (nmod)
treatment vpa (nmod)
occurrence adr (nmod)
completed who (nsubj)
suppression in (case)
glycine the (det)
maoi ) (punct)
3ma ( (punct)
used detect (xcomp)
ms lc/ms/ms (appos)
fentanyl d-tubocurarine (conj)
rats increased (conj)
q ) (punct)
% rats (nmod)
evaluate measure (conj)
concentration tobramycin (compound)
thresholds control (nmod)
aspects physiologic (amod)
examined examined (conj)
glycol 400 (nummod)
transplantation bone (compound)
had number (dobj)
uveitis cases (nmod)
mumol/kg ) (punct)
reserved patients (nmod)
reversed nitroglycerin (nmod)
characteristics anatomical (amod)
syndrome pericarditis (nmod)
sample matter (nmod)
tested behaviorally (advmod)
overcome problem (dobj)
decrease threshold (dobj)
given randomized (conj)
% 45.3 (nummod)
occurring levels (nmod)
mg ephedrine (nmod)
finding associated (ccomp)
increased activities (nsubjpass)
reached was (ccomp)
died rats (nmod)
man 62-year-old (amod)
n year (conj)
connected fluoxetine (nmod)
remained increased (advcl)
segments three (nummod)
risks cancer (compound)
considered insipidus (nsubjpass)
two fewer (conj)
difference beta-blocker (nmod)
toxic substances (nsubj)
children pb-exposed (amod)
estimated changes (nmod)
presented scores (nmod)
% 1.9 (nummod)
8 - (punct)
response injection (nmod)
(noncardiac)/periprocedural short-term (amod)
ccr2 receptor (compound)
used analgesic (dobj)
block or (cc)
developed malaise (dobj)
compared % (nmod)
investigated unnecessary (parataxis)
stenosis significant (amod)
supplement sevoflurane (nmod)
traits the (det)
decreased dogs (nmod)
showed observed (parataxis)
suggest aggravates (ccomp)
risk diagnosis (nmod)
reversal sedation (nmod)
members permanente (nmod)
induced monophosphate (nmod)
bromocriptine hyperprolactinemia (nmod)
efficacy amlodipine (nmod)
sjl , (punct)
rr 1.89 (nummod)
cancer associations (conj)
min dosing (nmod)
or vs. (cc)
patient renal-transplant (amod)
behaviours avoidance (compound)
% gem-p (nmod)
influence excretion (nmod)
cancer platinum-resistant (amod)
reviewed authors (nsubj)
d next (amod)
epo plasma (compound)
explain impairment (nsubj)
few relatively (advmod)
none controls (nmod)
beta-ccm ) (punct)
organisms the (det)
administration microgram/ml (dep)
infusion extradural (amod)
measures size (appos)
received cidofovir (dobj)
curve dose-response (amod)
found reports (nsubjpass)
modalities other (amod)
macroscopic microscopic (conj)
treatment any (det)
used bzds/rds (dobj)
problems abuse (conj)
clearance dextran (nmod)
influenced not (neg)
withdrawal after (case)
included patients (dobj)
imaging recovery (conj)
option countries (nmod)
used risk (nsubjpass)
nx of (case)
concentration simvastatin (amod)
isolated extract (nmod)
estimate frequency (dobj)
artery in (case)
time testing (nmod)
reported have (aux)
alleviated . (punct)
substituting after (mark)
concentrations unexpectedly (advmod)
occur some (nsubj)
damage histopathological (amod)
neutropenia acid-induced (amod)
exhibited mice (nsubj)
damages induced (acl)
thrombosis or (cc)
mg daily (advmod)
scores behaviors (compound)
objective determined (appos)
mmhg 86 (nummod)
hypotension ) (punct)
light protection (nmod)
measurements cardiac (amod)
36 were (cop)
aberrations morphological (amod)
pontis basis (compound)
dynamic and (cc)
consider differ (advcl)
intensity with (case)
enhanced ) (punct)
confirms conclusion (nsubj)
studies using (acl)
suffering disease (nmod)
% malays (appos)
manoeuvres during (case)
pointes de (case)
glomerulosclerosis offspring (nmod)
clues the (det)
ng 10 (conj)
tests neurological (amod)
impaired cholestasis (nmod)
dyskinesia a (det)
prove dce (nsubj)
treated methylphenidate (nmod)
incidence pediatrics (nmod)
peptide n-terminal (amod)
mechanism accepted (amod)
tamoxifen tam (appos)
nephropathy of (case)
patients carcinoma (nmod)
smokers people (conj)
hospitals in (case)
months 16.8 (nummod)
pneumonia presumed (amod)
diagnosis and (cc)
grip static (amod)
were require (conj)
objective described (dep)
submitted subjects (nsubjpass)
preventing study (nmod)
reactivity isoproterenol (nmod)
accounts that (mark)
called also (advmod)
hepatotoxicity nephrotoxicity (conj)
needed treat (xcomp)
torsades pointes (nmod)
discussion representative (dep)
appear therefore (advmod)
related recovery (nsubj)
abnormalities regional (amod)
lethargy with (case)
attempt suicide (compound)
defective . (punct)
decreased results (nsubj)
able frequent (advcl)
oxide , (punct)
subtypes no (neg)
course prolonged (amod)
reduction value (nmod)
facilitation . (punct)
intervals months (appos)
activity evoked (acl)
proteinuria such (case)
evaluation regular (amod)
counterparts their (nmod:poss)
number neurons (nmod)
phenomenon as (case)
inhibited rats (nmod)
syndrome either (cc:preconj)
suggest manifestations (dobj)
avoided however (advmod)
motionless , (punct)
subacute diazinon (dobj)
clarify treatment (nmod)
associated degree (nmod)
nrf2 and (cc)
addition subsequent (amod)
times . (punct)
spasms with (case)
recommendation the (det)
cause pro-arrhythmic (advcl)
antigen weight (conj)
mg 2.5 (compound)
sodium 1,000 (nummod)
developed have (aux)
introduction diagnosis (nmod)
degree mild (amod)
leftward and (cc)
facilitation memory (nmod)
presented rash (dobj)
rats step (acl:relcl)
continued percent (nsubj)
adducts greater (acl:relcl)
administered times/week (dobj)
results period (compound)
cortex primate (amod)
adenoma between (case)
controlled or (cc)
ceased switching (advcl)
response escape (compound)
atypicals the (det)
tissue cortical (amod)
parameters seizure (amod)
pregnant were (cop)
compliance myopathy (conj)
controlling for (mark)
barrier hypertension (nmod)
intensity median (amod)
zones hemispheres (nmod)
tuberculosis for (case)
impairment decrease (appos)
show impairments (dobj)
p100 , (punct)
control pain (compound)
function those (conj)
marrow cases (conj)
injection i.v. (amod)
patient ( (punct)
thrombocytopenia report (dep)
% 58 (nummod)
levels magnesium (compound)
% topical (amod)
completed months (dobj)
groups healthy (amod)
prevent reducing (xcomp)
complication rash (nsubj)
compliance study (amod)
objective was (dep)
mg/m2 200 (nummod)
aor ; (punct)
group ci (appos)
tincture of (case)
ang of (case)
combined pacing (nmod)
cords animals (nmod)
24.4 ) (punct)
extent according (case)
59 % (appos)
ut-a1 ) (punct)
antibacterials the (det)
known seen (xcomp)
eyes and (cc)
found tiopronin (nmod)
coefficient icc (appos)
mediated since (mark)
endogenous and (cc)
part caudate (nmod)
decrease min (nmod)
ngf bladder (nmod)
bradykinin ] (punct)
examination any (det)
model potential (amod)
explored influences (ccomp)
exerts potential (nmod)
patients leukemia (nmod)
appear model (xcomp)
restored and (cc)
potential increase (acl)
discharge for (case)
patient thalassemia (nmod)
associated bradycardia (nsubjpass)
regimens dose (compound)
immunohistochemical , (punct)
aware (anca)--associated (dep)
associated was (auxpass)
cimd ) (punct)
december since (case)
administration ester (nmod)
treated date (nmod)
crf % (appos)
remain reported (advcl)
increase reperfusion (nmod)
suggest contributed (ccomp)
two therapeutically (advmod)
course an (det)
synapse path (compound)
= slope (nmod)
progesterone estradiol (conj)
cells neuronal (amod)
scored grade (nmod)
observed = (xcomp)
vlbw g (dep)
reduced production (nsubjpass)
chc for (case)
electroretinography erg (conj)
90 and (cc)
phases task (nmod)
r/r ( (punct)
affected narcosis (nmod)
scheduled procedures (nmod)
papillomas epithelium (nmod)
evidenced increase (nmod)
overgrowth tissue (nmod)
assessed while (mark)
turned immediately (advmod)
mice express (acl:relcl)
produces oscs (nsubj)
factor common (amod)
background implicated (appos)
carried assessment (nsubjpass)
p53 cardiomyocytes (nmod)
response clinical (amod)
gain substantial (amod)
included measures (nsubj)
neurotoxicity the (det)
occurred days (dobj)
revealed questioned (advcl)
cycles four (nummod)
participate stimulation (nmod)
equal 0.0001 (nmod)
showed values (nmod)
reported studies (nsubjpass)
scenario not (neg)
started treated (advcl)
safe is (cop)
assessed quality (dobj)
reports adverse (amod)
rr=1.41 ; (punct)
serum ) (punct)
reviews article (nsubj)
protection extract (nmod)
15 - (punct)
apnea case (nmod)
preference on (case)
decreased p<0.01 (dep)
confirmed test (nmod)
t0 ( (punct)
cardiomyopathy doses (nmod)
analgesic disease (conj)
cases tachycardia (nmod)
treated mo (nmod)
study matched (amod)
acid with (case)
days during (case)
n ) (punct)
comprise thrombosis (nsubj)
events or (cc)
melphalan by (case)
placed who (nsubjpass)
infusion dipyridamole (compound)
ng 25 (conj)
protected also (advmod)
creation the (det)
norms of (case)
administered followed (conj)
infection fungal (amod)
complication associated (acl)
protein parvalbumin (appos)
appearance = (parataxis)
response svr (appos)
patients graves (nmod:poss)
have not (neg)
mm 9.1 (nummod)
reduced dose (dobj)
isolated and (cc)
nucleus subthalamic (amod)
thioridazine ) (punct)
children human (amod)
cells by (case)
obstruction patients (nmod)
monitoring for (mark)
requiring vigilance (dobj)
correlated weakly (advmod)
release by (case)
phenyl-2(5h)-furanon dfu (compound)
mmp-2 ( (punct)
responses newborns (nmod)
aeds ) (punct)
company manufactures (acl:relcl)
conversion this (det)
showed image (nsubj)
gds ) (punct)
necessary not (neg)
animals rats (conj)
replaced when (advmod)
latency-to-onset the (det)
conducted measurements (nsubjpass)
cautious be (cop)
feeding uninephrectomy (conj)
vehicle the (det)
decreases hilus (nmod)
audiograms of (case)
drugs anxiolytic (amod)
tolerated complications (nsubjpass)
exceed , (punct)
therapy valsartan/hydrochlorothiazide (amod)
hours twelve (nummod)
purpose continues (dep)
phenylethylbarbiturate of (case)
cause frequent (amod)
found adjusting (advcl)
netilmicin % (dep)
bulb the (det)
fk506 srl (conj)
circumstances certain (amod)
d3 17.5 (nummod)
corrected injections (nmod)
risperidone % (nmod)
erythropoietin of (case)
damaged not (neg)
pattern syndromes (nmod)
gd 10 (conj)
model symptoms (nmod)
problem been (cop)
users desogestrel (nmod)
cyp3a4 by (case)
showed curve (nsubj)
ocular auditory (conj)
mm 15.7 (nummod)
reagents igg (compound)
weight 4.5 (nummod)
study patients (compound)
p=0.025 ( (punct)
reactions mild (amod)
infarction lesions (conj)
modulation hyperalgesia (nmod)
dyskinesia ratio (dep)
tests both (det)
dependent independent (conj)
using coefficient (dobj)
csa given (acl)
followed neurotoxicity (nmod)
considered ligands (nsubjpass)
involves lesion (nsubj)
decreases weight (nmod)
disorders pd (nmod)
status altered (amod)
involved development (nmod)
apparatus passive (amod)
changes administration (nmod)
taken surgery (nmod)
glutamate , (punct)
masked signs (dobj)
= 4 (dep)
transferred ward (nmod)
central venous (dep)
discussed conducting (advcl)
theophylline than (case)
increased increased (advcl)
autopsy an (det)
asia south (compound)
> seconds (nummod)
injection mice (nmod)
discrimination humans (nmod)
paid been (auxpass)
degree tolerance (nmod)
received tested (conj)
allopregnanolone 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one (nummod)
increased 1710 (nmod)
rats old (amod)
selected ability (dobj)
pneumotachograph through (case)
dba/2j and (cc)
relationship such (amod)
lh a (det)
gaba(a)rs ) (punct)
mg monotherapy (conj)
concentrations plasma (nmod)
impaired although (mark)
examinations routine (amod)
organelles cells (nmod)
vaccine rubella (compound)
reported devastation (nmod)
supply oxygen (compound)
seen period (nmod)
taking , (punct)
mice b1r(-/- (compound)
desferrioxamine of (case)
rats bmc-transplanted (amod)
myopathic deficient (nmod)
hearts sprague-dawley (compound)
dimer-x , (punct)
reflection . (punct)
duration stimulus (compound)
nodules neoplastic (amod)
impairs cerebellar (dobj)
contributes importantly (advmod)
nicotine measuring (conj)
stimuli of (case)
cellulose the (det)
depends and (cc)
examinable response (nmod)
experiments from (case)
served . (punct)
status age (conj)
3,4-methylenedioxymethamphetamine ( (punct)
treated corticosteroids (nmod)
two only (advmod)
died hours (nmod)
result direct (amod)
thresholds pain (compound)
plasma human (amod)
chlorpromazine clozapine (conj)
grade nausea (conj)
qrs preexcitation (nmod)
variables age (appos)
serca2 [ (punct)
iso ( (punct)
range u/ml (conj)
doses medium (compound)
inhibitors reductase (compound)
increased apd (dobj)
report with (case)
precautions reaction (dobj)
sensitive site (nmod)
study group (nmod)
improvements 1-hr (nmod)
change than (case)
inhibition with (case)
antibody the (det)
subscores the (det)
recording the (det)
improvements the (det)
values for (case)
inducing impairment (dobj)
lasted minutes (nmod)
size bs (compound)
aminotransferase bilirubin (conj)
metabolism hepatic (amod)
reactions inhibitors (nmod)
% 16 (compound)
glioblastomas recurrent (amod)
blocks two (nummod)
a.m. 9 (nummod)
all mice (nmod)
consisted schedule (nsubj)
decrease coherence (nmod)
alpha-2b weekly (dep)
efficacy trinitrate (nmod)
indicate confirmed (advcl)
followed decrease (nmod)
primigravida developed (acl:relcl)
impact exposure (nmod)
protein cellular (amod)
scale self-rating (amod)
importance maintaining (advcl)
bid verify (dep)
useful compound (nsubj)
patient diagnosis (nmod)
documented this (nsubjpass)
logs , (punct)
receiving pharmacotherapies (dobj)
patients nondyskinetic (amod)
seizures infection (conj)
excess in (case)
weeks nine (nummod)
p10 s (conj)
concentration after (case)
women results (nsubj)
biopsies of (case)
expected attenuating (advcl)
model aging (compound)
ldl ( (punct)
perfused rise (nmod)
flap latissimus (compound)
induction concomitant (amod)
preparation dog (compound)
performed studies (nsubjpass)
have lowered (conj)
due seizures (nsubj)
shunt ventriculoperitoneal (amod)
level postprocedural (amod)
damage greater (amod)
corroborate data (nsubj)
multiple ) (punct)
studied expression (dobj)
interviewed emphasis (nmod)
variants prevalent (amod)
hypercapnia sublethal (amod)
experienced mg/m2/d (nmod)
sotalol to (case)
edema in (case)
h as (case)
noted design (nmod)
gyrata verticis (compound)
pretreatment systemic (amod)
quit reportedly (advmod)
warned be (auxpass)
studied patient (dobj)
blocks . (punct)
renin renin (appos)
antinociception produced (acl)
evaluation an (det)
terminology and (cc)
amines the (det)
incidence syndrome (nmod)
performed histology (nsubjpass)
circling , (punct)
6 21 (prep)
arousal orgasm (conj)
level microgram/ml (nmod)
test stress (compound)
children especially (advmod)
cta negative (amod)
reduces reversal (nsubj)
depression bipolar (amod)
examinations histologic (amod)
ephedrine agonist (appos)
compared wt (nmod)
lost 7 (nsubjpass)
cells capillary (amod)
reducing incidence (dobj)
groups parallel (compound)
dysfunction between (case)
induced combination (nmod)
livers between (case)
model 2.6-fold (conj)
males mean (dep)
treatment gliomas (nmod)
degree reversible (amod)
alkylxanthines tested (acl)
indicate observations (nsubj)
decreased mrna (nsubj)
cause myopathy (dobj)
participated . (punct)
indicates prompt (conj)
d-med micrograms/kg (appos)
structure with (case)
use be (cop)
signals alter (acl:relcl)
induced antibiotics (nmod)
hyperammonemia without (conj)
therapy raloxifene (compound)
rats rats (conj)
map treatment (nmod)
fistula the (det)
ml/100 2.32 (compound)
safety giving (advcl)
postprocedural h (dep)
develop that (nsubj)
p 0.005 (nummod)
infarction etoposide-related (amod)
electroencephalogram the (det)
proportion haemorrhages (nmod)
380+/-587 23 (nummod)
administered tci (nmod)
recorded participants (nsubj)
zidovudine or (cc)
induced accumbens (nmod)
extremities of (case)
mg/kg sodium (nmod)
total propofol-remifentanil (amod)
site na+-binding (amod)
administration i.v. (advmod)
gemfibrozil g/day)-lovastatin (dep)
erythropoietin human (amod)
edema generalized (amod)
foci necrosis (nmod)
lacked period (nmod)
function gating (amod)
treatment function (nmod)
context in (case)
midazolam , (punct)
indicate trials (nsubj)
hb ) (punct)
sleep shorter (amod)
exacerbation schizophrenia (nmod)
potential chronic (amod)
predominate and (cc)
patterns the (det)
membrane red (amod)
t detection (nmod)
percentage inhibition (nmod)
required neutropenia (nmod)
reported which (nsubjpass)
suppression complete (amod)
free polymer-bound (conj)
levels chronic (amod)
assessed later (advmod)
consequences clinical (amod)
profiles safety (compound)
infusion min-1 (nmod)
3.0 30.0mg/kg (conj)
use steroid (nmod)
increased comparison (nmod)
syndrome % (conj)
horns anterior (amod)
radiopharmacy the (det)
cords spinal (amod)
group transgenic (amod)
glomerulopathy reduplication (conj)
behaviour , (punct)
damage dna (compound)
epilepsy human (amod)
noted different (conj)
had have (aux)
reported % (nmod)
0.0001 < (dep)
reticulata nigra (amod)
contribution important (amod)
group iso (compound)
unmask : (punct)
affinities their (nmod:poss)
preponderance and (cc)
uninephrectomy of (case)
il-1beta cxcl1 (conj)
had opportunity (dobj)
evaluated intervals (conj)
experience syncope (nmod)
courses weekly (amod)
later min (nmod:npmod)
hepatitis anemia (conj)
enhances while (mark)
force dyskinesias (dobj)
13 3 (quantmod)
showed rois (nsubj)
estimates thromboembolism (nmod)
reaction the (det)
channels membrane (compound)
g paracetamol/day (appos)
step depends (acl:relcl)
questionnaires and (cc)
diarrhoea side-effect (nsubj)
therapy calcitriol (compound)
mg. 500 (compound)
episodes doses (nmod)
injection estradiol (nmod)
respond ethyl-alpha-p-chlorophenoxyisobutyrate (nmod)
effects neuroleptic-like (amod)
nitroprusside trimetaphan (conj)
documented . (punct)
properties diaphragm (compound)
using not (neg)
demonstrated ; (punct)
diseases with (case)
motility motility (nmod)
n-methyl-d-aspartate nmda (compound)
n uterus (nmod)
aspirin 1.63 (dep)
linked that (nsubjpass)
viewed caution (nmod)
use treat (xcomp)
country this (det)
exposure a (nmod)
drugs ziprasidone (nmod)
offers . (punct)
found cause (nsubjpass)
2 126 (conj)
shell administered (amod)
0.14 0.12 (compound)
suggests taking (advcl)
carbachol mg/l (compound)
correlated decrease (nmod)
propagate , (punct)
mcc ) (punct)
doses aniracetam (compound)
pathway no (compound)
exhibited eighth (nsubj)
interference with (nmod)
developed patients (conj)
drugs block (acl:relcl)
led additionally (advmod)
occur encephalopathy (nsubj)
revealed reactions (dobj)
ng 2.6 (compound)
neurological toxic (amod)
evidence other (amod)
risperidone-associated benign (dep)
hypotension tricyclic (amod)
ceftriaxone by (case)
demonstrated evidence (nmod)
find abnormalities (dobj)
mg 0.1 (compound)
show resulting (advcl)
nrf2(+/+ ) (punct)
bupropion with (case)
used sodium (nsubjpass)
method confusion (compound)
groups atrophy (conj)
tachyarrhythmia supraventricular (amod)
tasks overt (amod)
hctz an (det)
greater increase (dep)
netilmicin patients (dep)
compared hypotension (nsubjpass)
effect that (nsubj)
prove hand (nmod)
observed children (nmod)
catalepsy of (case)
subjects sessions (nmod)
initiate , (punct)
similar and (cc)
glucuronidation acid (nmod)
injection i.p. (case)
treatment pan (compound)
depressed severely (advmod)
rhythm sinoatrial (conj)
developed incidence (dobj)
viewed hypertension (nsubjpass)
developed immediately (advmod)
have pacing (nsubj)
combination carboplatin (nmod)
regardless use (nmod)
l-name diazepam (conj)
cessation by (case)
50mg/kg min (appos)
lack stent (nmod)
% 348 (conj)
licensed option (conj)
used dental (nmod)
occurs probably (advmod)
formulations chp (dep)
facilitates diazepam (nsubj)
4'-0-tetrahydropyranyladriamycin of (case)
activities study (nmod)
analysis ca(2 (nmod)
adriamycin- , (punct)
tended increase (dep)
persisted occurred (conj)
phases cubic (amod)
damage system (compound)
prescription the (det)
levels mice (nmod)
suffering depression (nmod)
indicating attributable (ccomp)
propensity develop (acl)
detected controls (nmod)
levels dosage (compound)
accumulation treatment (nmod)
operations microvascular (amod)
micrograms/ml 4.04 (nummod)
were remissions (attr)
left 0.01 (parataxis)
numbers about (case)
solicited years (nmod)
observational . (punct)
clinicians local (amod)
nsaids nonaspirin (compound)
range broad (amod)
nucleus callosum (conj)
6028 - (punct)
micronuclei observed (acl)
8.2 - (punct)
mg/dl 5.4 (nummod)
pge2 for (case)
compromise severe (amod)
taking treatment (nmod)
rise sharp (amod)
anomalies fetal (amod)
episodes grade (nmod)
decided june (nmod)
methods histological (amod)
523.5 129.7 (conj)
re-established was (auxpass)
regimen from (case)
treated volume (conj)
function exposure (nmod)
effect such (predet)
ph 9 (amod)
efficacious alleviating (advcl)
non-interventional , (punct)
agents mice (nmod)
ketoprofen . (punct)
mean months (nmod)
follow-up should (aux)
cvp mmhg (appos)
university hospitals (conj)
necessary may (aux)
combination the (det)
increase amount (dobj)
assessed task (nmod)
dyskinesia impairment (conj)
1986 from (case)
patients 6 (nummod)
depleted that (mark)
il-6 ) (punct)
warning heartbeat (compound)
number glomerulosclerosis (conj)
elevations and (cc)
reticulata , (punct)
txa of (case)
200mg/kg of (case)
albino wistar (compound)
reducing by (mark)
warned . (punct)
noted levels (nsubjpass)
now until (mark)
mg d (nmod)
manage accordingly (advmod)
suppress administration (nmod)
plan may (aux)
sis3 ( (punct)
courses 27 (nummod)
have paclitaxel (nsubj)
postulated caused (ccomp)
ltp ( (punct)
receptor known (acl)
delineate best (conj)
brings however (advmod)
characteristic nonspecific (conj)
experienced weeks (nmod)
areas the (det)
flow ebf (appos)
events patients (nmod)
risk diazinon-associated (amod)
volume scatter (appos)
consumption between (case)
nimo with (case)
memory two-part (amod)
treated cellulose (nmod)
therapy potential (amod)
occurs rats (nmod)
followed hepatitis (nsubjpass)
frequency is (cop)
sensitivity pain (compound)
na/k-atpase , (punct)
administration troleandomycin (nmod)
band iml (nmod)
analysis morphometric (amod)
stress or (cc)
became standard (attr)
cefotetan of (case)
patients interferon (nmod)
positions in (case)
expanded achieved (advcl)
ended when (advmod)
profiles comparable (amod)
classical emergent (conj)
had limits (ccomp)
users moderate (amod)
developed analyses (nmod)
examine expression (nmod)
albuterol exacerbations (nmod)
implant therapy (conj)
g/day)-lovastatin 1.2 (nummod)
ce to (case)
cyclophosphamide cisplatin (conj)
lead diagnosis (nmod)
acceptance treatment (nmod)
remedy management (nmod)
consuming after (mark)
deterioration rapid (amod)
300 of (advmod)
signs agents (nmod)
grade 1/2 (nummod)
electrocardiogram.3 of (case)
tacrolimus such (case)
change considering (advcl)
day four (nummod)
schedules following (amod)
depression st-segment (amod)
lad than (case)
compounds administered (acl)
literature syndrome (nmod)
associated adherence (nsubjpass)
lower even (advmod)
objective reported (dep)
immunoblotting rt-pcr (conj)
prognosis those (nmod)
elevations neutropenia (conj)
release culture (nmod)
associated outcomes (nmod)
nag ( (punct)
anaesthetized surgery (nmod)
pseudoacromegaly , (punct)
evaluation reactions (nmod)
pharmacy hospital (compound)
zero 14 (conj)
age 60 (nummod)
treatment sub-chronic (amod)
small , (punct)
shown extract (nsubjpass)
reverses paralysis (dobj)
preferred be (auxpass)
deposition causing (acl)
kits by (case)
used defined (conj)
assigned trial (nmod)
iceberg an (det)
thirst and (cc)
levels both (cc:preconj)
s-(-)-et-126 m1-selective (amod)
monitored hour (nmod)
initiated years (nmod)
prospective one (nsubj)
atenolol , (punct)
anesthesia high-dose (amod)
stage 16 (conj)
respectively year (nmod)
precore with (case)
died woman (nsubj)
periods developmental (amod)
rigidity rats (nmod)
3.5 0.5 (compound)
have tumors (nsubj)
recurred fluorescein (nmod)
control behavior (compound)
patients - (punct)
studied expression (conj)
testing behavioral (amod)
dyskinesias the (det)
wky 30 (nummod)
identified total (nsubjpass)
using criteria (dobj)
developed rhabdomyolysis (dobj)
pain inflammatory (amod)
therapy chloramphenicol (nmod)
prevented counteracted (conj)
reaction antagonists (nmod)
hypothesized it (nsubjpass)
chlorpromazine or (cc)
measurements testing (conj)
obtain investigations (nsubj)
lvef ) (punct)
correlation for (case)
forearm ( (punct)
measures resistance (nmod)
findings cranial (amod)
unpaired , (punct)
activity renal (amod)
higher % (nmod:npmod)
failure infection (conj)
proven that (mark)
analysing degree (dobj)
need then (advcl)
changes therapy (nmod)
activity rats (nmod)
kidney human (amod)
has response (nmod)
rats 3 (nummod)
suggests case (nsubj)
acute maintenance (conj)
resulting mean (nmod)
underwent block (nmod)
hypoglycemia , (punct)
stopping diagnosis (nmod)
igf-il-3 and (cc)
daunorubicin of (case)
observed patients (nmod)
antagonizes effect (dobj)
had repeat (dobj)
step that (nsubj)
evidenced . (punct)
affected any (nmod)
procedure different (amod)
bendrofluazide and (cc)
dilevalol to (case)
blepharoconjunctivitis intolerance (conj)
conclusion and (cc)
intracerebroventricular i.c.v. (dep)
rats 35 (nummod)
delirium patients (nmod)
performed months (dobj)
patients out (case)
applied crocin (nsubjpass)
rate gfr (appos)
events on (case)
tissues mice (nmod)
concentration higher (amod)
eyes between (case)
decrease ventilation (nmod)
amounts alphaenac (nmod)
studied elucidate (advcl)
changes threshold (nmod)
enabled waveform (aux)
model acetic (amod)
rate release (compound)
mitochondria 3.9 (dep)
exhibited seven (nsubj)
away stimulus (nmod)
pdtc ) (punct)
noted furthermore (advmod)
gum population (appos)
variants replication (nmod)
difference mmse (nmod)
defects patients (nmod)
event is (cop)
decline the (det)
changes hypertension (nmod)
received therapy (dobj)
stz with (case)
function monoamines (nmod)
myasthenia the (det)
found effect (nsubjpass)
ca2 and (cc)
found label (xcomp)
conclude normal (advcl)
antagonist ii (nummod)
e alone (advmod)
episodes ( (punct)
cytotoxicity of (case)
recipient cardiac (amod)
membranes rats (nmod)
accumbens in (case)
injected induce (xcomp)
able abolish (xcomp)
retina in (case)
case case (conj)
state as (cc)
beats/min sem (conj)
engaged transmission (nmod)
undertaken were (auxpass)
test deficit (nmod)
aware risk (advcl)
demonstration lesions (nsubj)
dipyridamole oral (amod)
retrieval memory (compound)
drug reported (conj)
modulate wide-range (dobj)
analysis electrophoretic (amod)
reflex rigidity (conj)
bruising areas (nmod)
trough steady-state (amod)
micromol/l 132.6 (nummod)
bid placebo (nmod)
segments cacl(2)-untreated (amod)
positivity on (case)
greater that (nmod)
anticipated , (punct)
increase as (case)
edaravone , (punct)
transmission glutamate (amod)
pressure and (cc)
depression due (case)
higher 0.01 (dep)
wall vessel (compound)
infarction discrete (amod)
studies with (case)
adrenaline of (case)
conducted hospital (nmod)
impairment recall (nmod)
% those (nmod)
dependency drug (compound)
found withdrawn (conj)
nitrite sodium (compound)
electrocardiograms the (det)
listed effect (nmod)
75,761 rofecoxib (acl)
potentiated effects (nsubjpass)
carried only (advmod)
is show (xcomp)
sodium na (appos)
poisoning for (case)
management osteoporosis (conj)
generated beta2(-/- (dobj)
free ) (punct)
proved was (auxpass)
conduction follow-up (compound)
reorganization functions (nmod)
management hit (nmod)
representing cessation (nmod)
quiescent ra (nsubj)
induce vitro (advmod)
progressive rapidly (advmod)
incidence administration (nmod)
related infusion (nmod)
pseudolithiasis patients (nmod)
induced socs-1 (dobj)
antagonize did (aux)
leukemia tumor (conj)
populations , (punct)
experiences contemporary (amod)
3.4 0.9 (conj)
group l-med (compound)
evident was (cop)
striatum right (amod)
blocked atropine (nmod)
sufficient phase (nmod)
alphabeta-crystalin vinculin (conj)
l-365,260 antagonist (compound)
tetrapeptide c-terminal (amod)
median weeks (nmod)
antigenemia p24 (compound)
introduction investigated (appos)
decrease % (conj)
noted factors (nsubjpass)
addiction for (case)
negativity and (cc)
anticoagulant oac (appos)
fasciculation first (amod)
detection mutants (nmod)
leukaemia relapsed/refractory (amod)
edema a (det)
dihydropyridine first (amod)
rats f-344 (compound)
80mg/kg/day intramuscularly (advmod)
boluses infusion (conj)
extent administered (acl)
induced rats (dobj)
blanching and (cc)
impact can (aux)
induces though (mark)
dysfunction cocaine-induced (amod)
affect treatment (nsubj)
dx than (case)
developed results (nsubj)
therefore , (punct)
index range (dep)
mds ; (punct)
reversible moreover (advmod)
amiodarone intravenous (amod)
therapy proteinuria (conj)
mv from (case)
have cardiomyopathy (dobj)
precedes damage (dobj)
efficacy profiles (conj)
received is (conj)
measuring concentrations (dobj)
switched study (nmod)
saline naloxazone (conj)
produce distributions (dobj)
infusions analgesia (nmod)
change since (mark)
evidence reduced (ccomp)
mg./kg 50 (nummod)
experienced limiting (ccomp)
17 11 (conj)
scl ) (punct)
putamen cp (appos)
been , (punct)
latencies similar (amod)
17.5 3.8 (conj)
scr outcomes (nsubj)
received days (nmod)
uncommon are (cop)
provided stability (dobj)
levels increased (acl:relcl)
regressions 15 (nummod)
biopsies lesion (compound)
administration pb (compound)
year exact (amod)
associated therapies (nsubjpass)
presence mutations (nmod)
model prove (acl:relcl)
african caribbean (conj)
kinase amp-alpha2 (compound)
potentiate and (advmod)
hours 5 (nummod)
flumazenil sedation (nmod)
risk arrhythmias (nmod)
preserved architecture (nsubjpass)
etodolac e (appos)
complement of (case)
model score (nmod)
consisted men (nmod)
% prevalence (nsubj)
plasma norepinephrine (conj)
hypoxia syndrome (nmod)
return scale (conj)
known proarrhythmic (xcomp)
increased velocity (nsubj)
has sensitivity (dobj)
nephrotoxicity severe (amod)
> corrected (amod)
depressed chloride (nsubj)
sd % (conj)
mv 4.7 (nummod)
sufferers migraine (nmod)
injected prior (advmod)
migraineurs controls (conj)
diagnosis levels (nmod)
mg 35.0 (compound)
exist of (case)
barrier chick (nmod)
enzymes the (det)
extended-interval conventional (conj)
behavioral eeg (conj)
used war (nmod)
recurrence ventricular (amod)
those result (acl:relcl)
ring hard (amod)
vip 's (case)
group iii (nummod)
loss following (case)
nature immobility (nmod)
call raise (conj)
doses nephrotoxic (amod)
function chain (compound)
therapy conversion (compound)
follow-up cardiac (amod)
phase sexual (amod)
inhibition mif (appos)
present patients (dobj)
low use (nsubj)
excreted urine (dobj)
days h (conj)
failure hepatic (amod)
scores ( (punct)
help markers (nsubj)
myelosis megakaryocytic (amod)
reaction patients (nmod)
regeneration by (case)
improves the (dobj)
groups experimental (amod)
appear , (punct)
gland pineal (compound)
conclusions decrease (appos)
alter find (advcl)
resulted interestingly (advmod)
conclusion seem (dep)
therapies useful (amod)
report one (nummod)
pacemakers of (case)
replacement without (case)
months 3.1 (nummod)
standard myeloma (nmod)
lower hypotension (nmod)
capsaicin 100 (nummod)
natural safe (conj)
showing changes (dobj)
conclusions found (appos)
opener ( (punct)
suspected test (nmod)
failed verapamil (nsubj)
1.2 3.9 (prep)
procedure laitinen (nmod:poss)
coadministration lithium (nmod)
carried aware (conj)
yrs 76 (nummod)
glomeruli not (neg)
women years (appos)
required occurred (conj)
degeneration epithelial (amod)
have risk (dobj)
observed will (aux)
therapy gender (appos)
blockers contrast (dep)
injection pan (nmod)
produced doses (nmod)
mechanisms disorder (nmod)
59 20 (compound)
apparatus rats (nmod)
tachyarrhythmia siat (appos)
world the (det)
dysfunction age (nmod)
protocol rule-in (amod)
had years (parataxis)
hypothesis characteristics (ccomp)
neurones of (case)
analysis curve (compound)
treated a (nmod)
understanding a (det)
complication preclude (conj)
sludge gallstones (conj)
map of (case)
evaluation with (case)
induced % (dep)
dh , (punct)
sacrificed , (punct)
current potassium (compound)
gem ( (punct)
g/cm(2 837 (nummod)
pregnancies their (nmod:poss)
mmol day (nmod)
percent versus (cc)
smoking developing (advcl)
had subthalamotomy (nmod)
uptake the (det)
pressure increased (amod)
studies dexmedetomidine (nmod)
regard in (case)
abstinence range (conj)
known abnormalities (xcomp)
undertaken studies (nsubjpass)
pattern isoenzyme (compound)
phosphorus , (punct)
events hyper- (dep)
review reports (nmod)
ability affect (acl)
nuclei from (case)
sensitivity erythropoietin (nmod)
involvement stress (nmod)
s between (case)
pretreated patients (nsubjpass)
administered remained (advcl)
concluded appear (ccomp)
diazepam and (cc)
subject any (det)
subset important (amod)
jj sham-treated (amod)
aggravation via (case)
development rs (nmod)
display users (nsubj)
= 0.12 (dobj)
circulation of (case)
peptide nt-probnp (appos)
suggested view (nmod)
shunt ovale (nmod)
perfusion-fixed were (cop)
carried study (nmod)
administration 2-wk (amod)
remained he (nsubj)
test results (nmod)
unchanged whereas (dep)
repair by (case)
reticulocytes % (nmod)
varies hit (compound)
class ldl (compound)
treating ist (dobj)
light in (case)
lines ' (case)
dxnp between (case)
effects whether (mark)
increased whereas (dep)
skeptical may (aux)
exerted be (auxpass)
postponed . (punct)
amplitude attenuated (acl:relcl)
induction angiogenesis (compound)
increased detection (nmod)
injected core (nmod)
days 32 (nummod)
monitored converting (advcl)
proceeded when (advmod)
found is (auxpass)
used reviewed (conj)
anemia acquired (amod)
dose beginning (case)
report tachycardia (dep)
12.5 or (cc)
studied wr242511 (nsubjpass)
patients japanese (amod)
prevents action (dobj)
ovariectomy ds (nmod)
studies diuretic (amod)
reversed anemia (nsubjpass)
adopted that (nsubjpass)
attributable have (aux)
paradigm treatment (compound)
affected administration (nmod)
technique palkovits (nmod:poss)
granulated cells (nsubjpass)
use situations (nmod)
was history (attr)
appeared effects (nsubj)
episode one (nummod)
corticosteroids different (amod)
preparations antacid (compound)
arb ( (punct)
represent variants (nsubj)
relationship an (det)
vacuolization form (conj)
mm3 above (case)
define incidence (dobj)
dysfunction kidney (compound)
lipid myocardial (amod)
mg/kg 322 (nummod)
bupivacaine ) (punct)
biphosphonate a (det)
function cardiovascular (amod)
crucial ameliorating (advcl)
mg/dl . (punct)
course nausea-free (amod)
100mg/kg , (punct)
hospitalizations after (case)
d 5 (nummod)
elevated activity (dobj)
[3h]-5-azadeoxycytidine of (case)
piroxicam dfu (nmod)
study lacn (nmod)
hemodynamic ( (punct)
and markedly (advmod)
flunarizine of (case)
implicated elements (nsubjpass)
patients torsade (nmod)
replacing part (dobj)
potent seizure (conj)
depression cyanosis (conj)
compared significantly (advmod)
data pharmacological (amod)
exposure s-23121 (nmod)
n. prl (appos)
paralysis and (cc)
investigated correlates (dobj)
activity motor (compound)
arise should (aux)
completed drugs (nmod)
mm 135 (nummod)
evolve . (punct)
form , (punct)
fell patient (nsubj)
calcium to (case)
evidence by (case)
information more (amod)
receptor another (det)
start hypotension (nmod)
r with (case)
alterations size (compound)
significant differences (nsubj)
acquired prior (advmod)
group non-smokers (acl:relcl)
descent african (amod)
constitute cause (dobj)
compared group (nsubjpass)
characteristics main (amod)
contribute deficiency (nmod)
disease arrhythmia (conj)
doxorubicin in (case)
stable months (nmod)
have does (aux)
caused bea (nmod)
together this (nsubj)
ias ) (punct)
170 to (mark)
diagnosis to (case)
reported women (nmod)
ppa mg (conj)
schedule cyclic (amod)
accepted evidence (nmod)
effect neurotoxicity (nsubj)
suggested course (nsubj)
similar metabolism (nsubj)
substances as (case)
equipment nautilus (compound)
cells system (nmod)
toxicities common (amod)
pain reduction (nmod)
causes impairs (conj)
abuse with (case)
period premature (nmod)
micrograms 28 (nummod)
signalling leading (acl)
effect levels (nmod)
revealed disorders (dobj)
anticoagulation of (case)
pre-test ) (punct)
agonist active (amod)
tachykinins of (case)
nsaid weak (amod)
antagonist mglur5 (compound)
plus-maze epm (appos)
rats 1 (dep)
profile sedation (compound)
glioma malignant (amod)
increased women (nmod)
defects intraventricular (amod)
caused a (nsubj)
population ( (punct)
caused contrast (nmod)
data published (acl)
genes her (nmod:poss)
targets factor (acl:relcl)
caused given (advcl)
counteracted and (cc)
injection , (punct)
conversion conversion (nmod)
interaction -- (punct)
neuroinflammation and (cc)
lesions renal (amod)
fell pressure (nsubj)
tone irrigation (nmod)
concentration diluent (nmod)
experience their (nmod:poss)
case coma (nmod)
has potential (dobj)
administration days (nmod)
testosterone determination (conj)
men fourteen (nummod)
mice alpha2abc-/- (amod)
fibrin less (amod)
solution % (compound)
10.4 ( (punct)
mm % (nmod:npmod)
coma syndrome (nmod)
score component (nmod)
endpoints to (case)
comorbidities patient (compound)
ration . (punct)
capsule liver (compound)
antinociception morphine (amod)
responded animals (nsubj)
given premedication (nsubjpass)
study pilot (compound)
mesencephalon in (case)
accompanied changes (nmod)
medication the (det)
azotemia of (case)
rats pregnant (acl:relcl)
intervals 1-minute (amod)
proposed explanation (nmod)
decline rapid (amod)
cml ( (punct)
was objective (nsubj)
minutes patients (appos)
scopolamine scopolamine (conj)
doses suxamethonium (nmod)
giving drugs (dative)
turnover dogs (nmod)
man suffered (acl:relcl)
control is (cop)
concentrations da (compound)
treatment medical (amod)
d2/d3 dopamine (compound)
hypertrophy significant (amod)
toxicity 3 (dep)
cognition in (case)
revert can (aux)
controls into (case)
unclassifiable six (nsubj)
developed thrombocytopenia (dobj)
uspstf ( (punct)
tdfs of (case)
seems potentiates (xcomp)
insufficiency renal (amod)
produced was (auxpass)
searched evidence (nmod)
pattern response (nmod)
effect anxiety (nmod)
confusion with (case)
protect risk (nmod)
spine lumbar (amod)
tested susceptibility (nmod)
incidence anomalies (nmod)
enhanced greatly (advmod)
function systolic (amod)
1.53 1.13 (nummod)
indicate role (dobj)
coagulation ( (punct)
permitted continue (xcomp)
effects interval (nmod)
step requisite (amod)
reduces acting (advcl)
rabbits on (case)
clentiazem on (case)
cy ( (punct)
ceased suggesting (advcl)
index sem (compound)
results contradictory (amod)
elevates mice (nmod)
mg for (case)
patients hospitals (nmod)
dye blue (compound)
m = (parataxis)
associated seen (advcl)
decrease sudden (amod)
increasing without (mark)
grade world (compound)
whether or (cc)
events time (nmod)
gbm ( (punct)
cardiotoxicity pre-induced (acl)
support intradialytic (amod)
observed cases (nsubjpass)
db 50 (nummod)
reduced cell (dobj)
aneurysms for (case)
eluates in (case)
treating grommet (nmod)
symptoms in (case)
aggregations the (det)
analysis contour (amod)
transplant an (det)
placement pump (nmod)
suffered perforation (dobj)
fever diarrhea (conj)
manner dose-and (compound)
observed parts (nmod)
play . (punct)
days gestational (amod)
mimic exposing (advcl)
rats d-treated (amod)
assigned total (nsubjpass)
ratio by (case)
reduced it (nsubj)
determine structure (nsubj)
administered treatment (nmod)
obtained information (nsubjpass)
detect expression (dobj)
deficits ) (punct)
allowed methodology (nsubj)
done baseline (nmod)
effects gamma-hexachlorocyclohexane (nmod)
study cancer (nmod)
changes neurons (nmod)
examined and (cc)
signal fmri (compound)
modified gender (nmod)
concentrations mother (nmod)
evidence associated (ccomp)
aminotransferase aminotransferase (conj)
subtypes possible (amod)
head neck (conj)
disease by (case)
cvp delta (compound)
showed patients (nsubj)
provoke . (punct)
included first (advmod)
paralysis reversed (amod)
dysmorphism severe (amod)
seizures administration (nmod)
was study (nsubj)
some only (advmod)
dosages daily (amod)
arrhythmias developed (acl:relcl)
250 respectively (advmod)
reactions tdi (nmod)
agonists and (cc)
induced ischemia (nsubjpass)
patients controls (nsubj)
vasodilatation caused (acl)
failure growth (compound)
function basic (amod)
pretreatment vpu (nmod)
therapy multimodality (compound)
left rats (nmod)
measurement levels (nmod)
worst and (cc)
reaction is (cop)
consistent were (cop)
male therapy (nmod)
analgesia induced (amod)
outcome therapy (nmod)
used acetaminophen (nsubjpass)
hydrochloride antagonist (appos)
report patients (nmod)
subtle more (advmod)
completed 22 (dep)
follow-up evaluation (nmod)
result mutations (nsubj)
band gap43-ir (compound)
vlbw ( (punct)
apnoea unexpected (amod)
used tamoxifen (nsubjpass)
discontinuations aes (nmod)
rate vte (nmod)
negative limits (nmod)
g/m2/d 1.55 (nummod)
introduction and (cc)
declined levels (nsubjpass)
administration daidzein (nmod)
humans hypertension (nmod)
those mice (nmod)
research toxicology (amod)
order quantify (acl)
produced dose-dependent (dobj)
dependent dose (nmod)
erythromycins quinolones (conj)
induces changes (dobj)
documented dementia (nsubjpass)
% 64 (nummod)
accumulation doxorubicin (nmod)
sacrificed short-term (dep)
differentiated obtain (xcomp)
cardiorespiratory and (cc)
indicate showed (ccomp)
led reduction (nsubj)
concentrations interleukin-6 (compound)
hr 6 (nummod)
onset- ) (punct)
taking hydroxychloroquine (dobj)
components of (case)
disorder . (punct)
conditioning avoidance (compound)
% 35 (nummod)
deduced present (dep)
metabolism and/or (cc)
females hypothyroidism (nmod)
mechanism is (cop)
difficult interdependence (nmod)
50 15 (compound)
resulting degrees (nmod)
disturbances precipitating (compound)
dis-charge and (cc)
surgery pregnancy (conj)
activity apomorphine-induced (amod)
percent control (nmod)
motif tyrosine-methionine-aspartate-aspartate (compound)
use atherosclerosis (dobj)
associated mr (nsubjpass)
developed fibrillation (dobj)
enhance replication (dobj)
allocated are (auxpass)
were significant (conj)
provocation association (conj)
leads maturation (nmod)
comparison values (nmod)
ica the (det)
althesin or (cc)
learning the (det)
present results (nsubj)
anaesthesia involving (acl)
nodal av (compound)
2.1 0.7 (conj)
blood of (case)
drug used (acl)
imaging functional (amod)
median 3 (nmod)
history natural (amod)
3,4-methylenedioxymethamphetamine of (case)
headache glycopyrrolate (appos)
13/50 ) (punct)
1.4 concentrations (nsubj)
aims study (nmod)
recruiting circuitry (dobj)
amounts mrnas (nmod)
kidney on (case)
jitter blocking (conj)
tg fasl (compound)
measures analyses (dep)
concentration vol% (dep)
shows causes (ccomp)
inhibits inhibits (conj)
noted paralysis (nsubjpass)
rhizomes kurroa (compound)
levels group (compound)
resolved tdp (nsubj)
caused or (cc)
e1 of (case)
fetuses administered (advcl)
9.6-fold higher (advmod)
complication ethambutol (nmod)
mglur5 extrastriatal (amod)
methadone 150 (nummod)
analyze patterns (dobj)
confounders potential (amod)
locomotion apomorphine (conj)
yield cases (dobj)
coadministration dexrazoxane (nmod)
risk consumption (nmod)
favor . (punct)
14 % (appos)
reversible that (nsubj)
malformation is (cop)
vaccinated 2000 (nmod)
behaviors dopamine-mediated (amod)
diet drug (conj)
off ' (case)
outcomes continuous (amod)
apparent clinically (advmod)
damage end-stage (amod)
activation , (punct)
infusion high-dose (amod)
greater combination (nmod)
neuralgia from (case)
reports paper (nsubj)
performed fasciotomies (nsubjpass)
isoniazid 13 (nummod)
evaluated we (nsubj)
followed mg (nmod)
inhibitors by (case)
appear naloxone (advcl)
therapeutic a (det)
assessed ability (dobj)
repair for (case)
inhibition 1a2 (nmod)
nephrotoxicity nephrotoxicity (conj)
disease stenosis (conj)
nsaids , (punct)
schedule in (case)
spasm relieved (acl)
reappeared dose (nmod)
patients 60 (nummod)
cd4 ( (punct)
mean concentration (dep)
glomerulosclerosis fibrosis (conj)
changes histopathologic (amod)
deviation mean (conj)
albumin in (case)
complete and (cc)
seems similar (xcomp)
differentiated cells (nsubjpass)
therapy 2.53 (conj)
reduction and (cc)
commencing administration (dobj)
patients twenty-nine (amod)
determined trypan (conj)
level pyridoxal (nmod)
receive lamivudine (dobj)
epilepticus neurogenesis (nmod)
mg/m2 50 (nummod)
poses . (punct)
systems of (case)
hydrochlorofluorocarbons hcfcs (appos)
l1-l2 l6-s1 (conj)
applications of (case)
enhancement no (neg)
reintroduction gradual (amod)
ligands histamine (compound)
ketamine nmda (compound)
slowed which (nsubj)
seen response (nsubjpass)
ascites and (cc)
prescribed methadone (nsubjpass)
describe purpose (nsubj)
factors colony-stimulating (amod)
doses effective (amod)
grade sedation (nmod)
created conditions (nsubjpass)
diagnosed accurately (advmod)
vegf non-endothelial-derived (amod)
functions morphology (conj)
inhibitors to (case)
therapy steroids (nmod)
neoplasms of (case)
potentials delayed (amod)
evaluate susceptibility (dobj)
hepatitis granulomatous (amod)
advocate we (nsubj)
patients hoarseness (nmod)
modify expression (dobj)
microinjection cck-8 (nmod)
confirmed presence (dobj)
positive none (nsubj)
l-noarg of (case)
spasm may (aux)
nephrolithiasis implications (dep)
hematuria gross (amod)
km and (cc)
bpt mg (dep)
3 thrombopenia (nmod)
cause death (nmod)
lesions ventricular (amod)
hypotension the (det)
akathisia for (case)
estradiol- ( (punct)
presented pain (dobj)
propranolol , (punct)
made however (advmod)
6-ohda ( (punct)
show may (aux)
documents occurrence (dobj)
ocs containing (acl)
intoxication unintentional (amod)
benefit gastrointestinal (compound)
reverse prevent (conj)
cd-832 , (punct)
virtue by (case)
rr=1.60 ptrend=0.02 (dep)
induced trinitrate (nmod)
long-evans barium-supplemented (amod)
30 about (advmod)
study retrospective (amod)
myocardium predisposed (amod)
effect cytostatic (amod)
indications the (det)
sites channel (amod)
status dose (conj)
cvp ( (punct)
component , (punct)
alive months (conj)
developed later (advmod)
underwent studies (dobj)
limitation a (det)
cocaine systemic (amod)
% 1.5 (nummod)
event coronary (amod)
enhancement activity (nmod)
hypertrophy : (punct)
33 of (case)
decrease creatinine (nmod)
intent suicidal (amod)
pretreatment remifentanil (nmod)
occurrence signs (nmod)
rosc ( (punct)
containing mg (dobj)
addressing risks (dobj)
afterdepolarization phase (compound)
volumes with (case)
frlma ( (punct)
reduction min (nmod)
favourable evolution (nsubj)
therapy gemfibrozil-lovastatin (amod)
characteristics e. (compound)
aorta/serum-ratio hours (dep)
oat1 oat3 (conj)
fq . (punct)
shown nitroglycerin (nsubjpass)
study was (cop)
suggest dependent (ccomp)
osteopenia osteoporosis (conj)
suppressed is (auxpass)
rates post-discharge (acl)
swedish nationwide (amod)
hyperplasia rr (dep)
had episode (dobj)
fluctuations behaviors (conj)
diagnostic ) (punct)
voltammetry staining (conj)
clues patients (nmod)
period 12h (compound)
failure however (advmod)
patient found (acl:relcl)
brought hospital (nmod)
dysfunction system (nmod)
administration central (amod)
children 66 (nummod)
injection amphetamine (nmod)
interaction . (punct)
case cystitis (nmod)
was induce (xcomp)
failure = (amod)
icc > (amod)
reduction increase (conj)
membrane glomerular (amod)
inhibited patients (nmod)
each in (case)
dysfunction neurologic (amod)
diminish activity (dobj)
inhibitor-1 plasminogen (compound)
follow-up patients (dep)
recurred challenge (nmod)
risks health (compound)
activity minimal (amod)
model 6-hydroxydopamine (compound)
doses i.e. (acl)
500 700 (conj)
blocked rearings (nsubjpass)
defects defects (conj)
those subjects (nmod)
series our (nmod:poss)
modulate that (nsubj)
describe , (punct)
had umb24 (nsubj)
antagonists perfusion (compound)
measuring changes (dobj)
viii related (dep)
man 52-year-old (amod)
rescues reduction (nsubj)
effect antiparkinsonian (amod)
shows activity (dobj)
effect cardiotoxicity (conj)
life threatening (acl)
dysfunction cognitive (amod)
using hours (nmod)
collected , (punct)
albuminuria for (case)
interference catheters (nmod)
sides brain (nmod)
converted is (auxpass)
function ato (amod)
occurred frequently (advmod)
cocaine to (mark)
therapy vigabatrin (compound)
mmhg and (cc)
fc isolated (acl)
= 3 (dep)
pretreatment oxprenolol (amod)
manifests . (punct)
systolic higher (amod)
% volume (compound)
show , (punct)
analysis function (compound)
hemodynamics on (case)
showed damage (nsubj)
related levels (dep)
respiratory cardiovascular (conj)
localization dysfunction (nmod)
episodes activity (nmod)
use function (nmod)
% pr (compound)
hypertension . (punct)
behavioral endocrine (conj)
chf of (case)
labetalol by (case)
breathiness of (case)
demonstrated ischemia (nsubjpass)
contribute cells (nmod)
programs antihypertensive (amod)
test meal (compound)
vip(-/- ) (punct)
toxicity celecoxib (nmod)
antagonist of (case)
resulted inhibition (nsubj)
alpha-configurations beta,3 (compound)
carbamazepine and (cc)
methylphenidate of (case)
cells staining (compound)
akt pakt (appos)
suggests finding (nsubj)
cells hek293 (compound)
prevent occurrence (dobj)
demonstrated cord (nmod)
benign cases (nsubj)
mortality population (nmod)
toxicity injection (nmod)
is background (dep)
level antibody (compound)
sweating and (cc)
ua ) (punct)
proarrhythmic to (mark)
measured level (dobj)
factor iugr (nsubj)
treatment yohimbine (nsubj)
affinity weak (amod)
euphoria lability (conj)
gravity sg (appos)
nephropathy , (punct)
alternative regimens (nmod)
patients poor-risk (amod)
sole the (det)
monitoring on (case)
spite efforts (nmod)
thrombocytopenia such (amod)
h2o 0.5 (nummod)
mg/kg 15.0 (conj)
represents that (nsubj)
infants birth-weight (amod)
postulate force (ccomp)
accounted values (nsubjpass)
increase ( (punct)
activation translocation (conj)
bought substance (nmod)
play epileptogenesis (nmod)
associated examined (conj)
resulted whereas (dep)
step final (amod)
ought tendency (nsubj)
12.2 - (punct)
responses ventricular (amod)
day placebo (compound)
separation ficoll-hypaque (nmod)
2.6 2.7 (conj)
acid leukemia (nmod)
analysis chemical (amod)
block administration (nmod)
mechanisms ) (punct)
cells peripheral (amod)
manifestation on (case)
chf 3 (nummod)
hexachloro-1:3-butadiene , (punct)
dyskinetic and (cc)
raises requirement (dobj)
picu ( (punct)
induced ages (nsubj)
solution administered (acl)
appearance convulsions (nmod)
had paralleled (conj)
lozenge nicotine (compound)
thickness posterior (amod)
shelf a (det)
premedication with (case)
decreasing without (mark)
adults to (case)
results reduction (nmod)
involve understood (advcl)
prevent fever (dobj)
n/n=62/92 ) (punct)
quantities limited (amod)
tubulopathies with (case)
diclofenac ( (punct)
blocker potential (amod)
seemed naproxen (nsubj)
walk sleep (conj)
times design (nmod)
toxicity their (nmod:poss)
hyperactivity reversed (amod)
cck-8-se with (case)
dysfunction carbamazepine-associated (amod)
1 at (case)
alkaloid an (det)
chi(2)(3 ( (punct)
subjects 20 (nummod)
diseased normal (conj)
group and (cc)
botox ( (punct)
likely involved (xcomp)
-18.9 +/- (cc)
control either (cc:preconj)
compromised medically (advmod)
motor visual (conj)
ablation supply (nmod)
activated but (cc)
status predicted (acl)
1.55 ) (punct)
ought to (xcomp)
attributed be (auxpass)
objectives estimate (dep)
ng/ml < (compound)
action methamphetamine (nmod)
potentials snaps (appos)
mg/kg 257 (nummod)
groups studied (amod)
revealed participants (nsubj)
recommended and (cc)
synthesis muscle (nmod)
sent . (punct)
followed transplant (nmod)
syndrome leukemia (conj)
hit regarding (case)
hyperalgesia pinprick (amod)
differences mean (compound)
carcinogenesis rats (nmod)
citations reporting (acl)
highlights , (punct)
renin renal (amod)
interviewing when (advmod)
indicate results (ccomp)
hyperalgesia ) (punct)
lvef + (cc)
presented room (nmod)
studied enzyme (dobj)
induce toxicity (dobj)
injected edaravone (nsubjpass)
patient proteinuria (conj)
injections metoclopramide (nmod)
wall into (case)
therapy = (dep)
blockers iks (compound)
behaviours convulsive (amod)
determined incidence (dobj)
recipient presenting (acl)
fear , (punct)
proliferation inductive (amod)
bacteremia because (case)
accelerated conduction (dobj)
relieved , (punct)
pretreatment haloperidol (compound)
myocytes pretreated (acl)
demographic biological (conj)
induced diverse (nmod)
differ frequency (nmod)
observed follow-up (nmod)
test type (compound)
concentration peak (compound)
treated hyperactivity (nmod)
conversion at (case)
leukaemia childhood (compound)
dose occasions (nmod)
morphine after (case)
sg145r with (case)
depletion folate (compound)
occurred conclusion (dep)
release prl (compound)
caffeine mg/kg (appos)
state their (nmod:poss)
seem aspirin (nsubj)
rate annual (amod)
effects coagulation (nmod)
considered mechanism (nsubjpass)
patients 1,821 (nummod)
dextran fluorescent-labeled (amod)
grades and (cc)
sedation complications (conj)
evidence serological (amod)
found angiography (nsubj)
implications their (nmod:poss)
origin developmental (amod)
injected attenuated (conj)
determinant a (det)
drug administered (acl)
prevented induction (dobj)
38 gentamicin (nmod)
dbp , (punct)
development daily (advmod)
acute drug-induced (dep)
treatment amiodarone (nmod)
methoxamine intravenous (amod)
agents with (nmod)
drugs well-tolerated (amod)
cases hallucinations (nmod)
measured fluid (dep)
receive succinylcholine (dobj)
degree , (punct)
537 +/- (cc)
patients twelve (nummod)
demonstrated alterations (nsubjpass)
ensure levels (dobj)
12 6 (compound)
difference be (cop)
triggers whether (mark)
problem depletion (nsubj)
returned , (punct)
therapy management (nmod)
noted minutes (nsubj)
deaths associated (amod)
trough-concentrations microgram/ml (nmod)
transplantation antibody (conj)
mv more (conj)
detected eyes (nmod)
tested studies (nmod)
assessed number (nsubjpass)
umb24 1-(2-phenethyl)-4-(2-pyridyl)-piperazine (appos)
exposure exposure (nmod)
utilization in (case)
infection because (case)
fk506 the (det)
remarkable course (nsubj)
analyses separate (amod)
symptoms irritation (nmod)
treatments various (amod)
expression ( (punct)
injury nonspecific (amod)
identified group (nmod)
affected rate (nmod)
suggest potential (dobj)
appear factors (xcomp)
showed tet (nsubj)
reached week (nmod)
therapy cancer (nmod)
prevalence , (punct)
localized cc (nsubj)
rats administration (nmod)
exerts it (nsubj)
acitretin by (case)
toxicity , (punct)
headache , (punct)
concluded window (dobj)
went thrombocytopenia (nmod)
use incidence (conj)
trazodone antagonist (appos)
penk ( (punct)
latency asymmetry (conj)
oestrogens progestogens (nmod)
susceptibility prerequisite (nmod)
observed whereas (mark)
successful and (cc)
patients presenting (acl:relcl)
associated initially (advmod)
toxic piroxicam (nsubj)
tiopronin compound (appos)
treated cocaine (nmod:npmod)
mmp-2 p<0.01 (appos)
puncture needle (compound)
antagonizes dysrhythmogenicity (dobj)
points curves (nmod)
taking regimens (dobj)
dysfunctions these (det)
appetite-suppressants to (case)
contraction premature (amod)
addiction opioid (amod)
developed 13 (nsubj)
discovered recently (advmod)
correlated fall (nmod)
intravitreal refractory (ccomp)
increased muscle-lengths/s (nmod)
p=0.0001 ) (punct)
treatment hydrochloride (nmod)
filtration in (case)
25/100 controlled-release (conj)
rtms sham (compound)
longitudinal and (cc)
antagonized hypotension (nsubjpass)
indicated were (auxpass)
inactive metabolites (nsubj)
fits of (case)
mg/kg/i.v ( (punct)
ritonavir such (case)
potential blocker (compound)
% 6.4 (nummod)
injury direct (amod)
produced effect (nmod)
extent injury (nmod)
aspartate glutathione (conj)
irreversible nephritis (nsubj)
one receiving (acl)
treatment disease (nmod)
penicillins to (case)
phosphorus yellow (amod)
hepatitis type (compound)
reversed scopolamine (nsubj)
gemcitabine plus (cc)
effect haloperidol (nmod)
iu/l 175 (nummod)
system motor (compound)
proteinuria associated (acl)
accounts part (nmod)
score england (conj)
risks adjusted (amod)
assessment efficacy (compound)
evaluation timely (amod)
taking the (det)
events treatment (nmod)
models exteroceptive (amod)
0.25 0.50 (conj)
received january (nmod)
tremor 1 (nummod)
2-chloroprocaine-ce , (punct)
produce whereas (dep)
picture clinical (compound)
results measured (dep)
efficacy a-86929 (nmod)
% -49 (nummod)
reported 1993 (nmod:tmod)
atin of (case)
timolol by (case)
consequences use (nmod)
data obtained (amod)
4.3 - (punct)
bronchodilator a (det)
tests heparin-induced (amod)
benefits these (det)
78-year-old necrosis (nmod)
nh4ac ( (punct)
percent ninety-nine (amod)
patients nondiabetic (amod)
coefficient ) (punct)
groups b (dep)
metabolism lipid (compound)
g. from (case)
calculated area (nmod)
diameter by (case)
supervision that (mark)
pathway adrenergic (amod)
showed 15 (nsubj)
heparin to (case)
enhancement dextromethorphan (nmod)
distance speed (conj)
usual converted (advcl)
lower while (mark)
furosemide despite (case)
agents angiogenic (amod)
including females (nmod)
10,000 - (punct)
profile spectral (amod)
3.3 ( (punct)
administered weekly (advmod)
restoration by (case)
b.d , (punct)
analysis greater (nmod)
play vivo (advmod)
culture positive (amod)
doses d (nmod)
ngf secreted (acl)
bacteremia aureus (compound)
precipitated patients (nmod)
drugs antifibrinolytic (amod)
patient 3 (nmod)
plays death (nsubj)
toxicities haematological (amod)
recovery anaesthesia (nmod)
includes treated (conj)
agonists or (cc)
equipotent that (mark)
mmhg 25 (nummod)
mtx ] (punct)
vision fatiguability (conj)
progression a (det)
cells cerebellar (amod)
factor it (nsubj)
acrolein to (case)
pattern weight (compound)
experienced fever (dobj)
reported change (nsubjpass)
potential prolongation (nmod)
highlights administered (advcl)
developed subjects (nmod)
monkeys doses (nmod)
altered suppressed (ccomp)
measurements simultaneous (amod)
formulation hydrochloride (nmod)
showed appearance (dobj)
-0.12+/-0.5 , (punct)
clonidine 's (case)
tetany importance (dep)
activity aniracetam (nmod)
confirm necrosis (dobj)
terbutaline asthma (nmod)
suppressed needed (parataxis)
ci 8.7 (dep)
densities reticulum (nmod)
cardiotoxicity low-grade (amod)
cortex motor (compound)
died days (dobj)
admitted treatment (nmod)
those mg./kg (nmod)
coefficient coefficient (conj)
amhs ) (punct)
response seven (conj)
p= 0.01 (amod)
warranted conversion (nmod)
activation events (dep)
levels serotonin (compound)
urticaria patients (dep)
mg i.v. (dep)
caused also (advmod)
days women (nmod)
stable . (punct)
mice null (amod)
disease failure (conj)
accumulation resulted (acl:relcl)
index performance (compound)
inhibited acetylcholinesterase (dobj)
hypothesis mediated (ccomp)
significant changes (nsubj)
diminish and (cc)
mm to (case)
gain improved (amod)
cycles % (appos)
developed progressive (dobj)
specimens ) (punct)
study volunteers (nmod)
lpo ( (punct)
causes cardiotoxicity (dobj)
salbutamol dose (compound)
epilepticus mortality (conj)
months observation (nmod)
controls macroprolactinoma (conj)
bore rats (nsubj)
group cancer (compound)
outcome visual (amod)
pretreatment test (nmod)
rats , (punct)
vip of (case)
induced chemotherapy (nmod)
proteinuria a (det)
50 single (amod)
alpha-mediated , (punct)
model a (det)
decline % (compound)
rotation contralateral (amod)
monitoring recovery (nmod)
supplement be (cop)
thorax lower (conj)
ability the (det)
play promote (advcl)
pci during (case)
improve theoretically (advmod)
toxicity cardiovascular (amod)
increase concentration (nsubj)
lasting weeks (nmod)
result infarction (nmod)
likely caused (xcomp)
remained groups (nsubj)
lymphoma dystrophy (conj)
medicine evidence-based (amod)
dogs pentobarbital-anesthetized (amod)
response failure (nmod)
hypothermia bridge (nmod)
dysfunction triggered (acl:relcl)
interval 1.9 (nummod)
achieve to (aux)
demonstrate titrated (ccomp)
malondialdehyde mda (appos)
victim young (amod)
ketamine after (case)
positive commencement (nmod)
seizures arising (acl)
treated catheterization (nmod)
sensitivity drugs (nmod)
months five (nummod)
inactivation drugs (nmod)
physiologic environmental (conj)
response vessels (nmod)
thrombophlebitis suspected (amod)
it-methotrexate , (punct)
blockers dihydropyridine (compound)
ctnt ed (conj)
coadministered when (advmod)
acid ( (punct)
figure corresponding (amod)
newborns reported (acl:relcl)
effect peripheral (amod)
details criteria (conj)
failed recover (xcomp)
morphine cnsb002 (conj)
option prevent (acl)
patients free (acl:relcl)
attacks rest (nmod)
pain diffuse (amod)
ecstasy task (conj)
antagonists 5-ht(6 (compound)
complaints with (nmod)
utero in (case)
significance functional (amod)
variations syndrome (nmod)
written been (auxpass)
hematological and (cc)
center md (compound)
preoperatively postoperatively (conj)
infants months (nmod)
make does (aux)
groups in (case)
striking most (advmod)
regions delineating (compound)
y-maze in (case)
precise . (punct)
administered determine (advcl)
inhibition in (case)
appropriate be (cop)
vessel small (amod)
cent cent (nmod)
worth could (aux)
= .008 (dep)
assess patients (nmod)
computerized tomographic (dep)
calculated retrospectively (advmod)
rats ' (punct)
suggest drug (ccomp)
experience despite (case)
propranolol % (dep)
cck-8 of (case)
elevated striatum (nmod)
discussed possibilities (nsubjpass)
baseline over (case)
fluorescence ) (punct)
ability urine-concentrating (amod)
therapy history (conj)
known edema (nmod)
groups exercise-isoproterenol (compound)
case acidosis (nmod)
maze mwm (appos)
decreasing frequency (dobj)
appropriate alternatives (dep)
6 versus (cc)
hypertrophy during (case)
50 0 (conj)
compared given (advcl)
group groups (conj)
risk 2.8-fold (amod)
decrease activity (nmod)
receptor-linked gaba-a (nmod:npmod)
retinochoroidopathy of (case)
suggests this (nsubj)
sodium heparin (conj)
treatments standard (amod)
center secondary (amod)
restrictive use (nmod)
depend differences (nmod)
interfere metabolism (nmod)
movements motor (compound)
localised process (nsubjpass)
% 14/104 (appos)
retention- or (cc)
group amphetamine-induced (amod)
assessed uptake (nsubjpass)
decline and (cc)
accepted mechanism (nsubjpass)
study dogs (nmod)
reversed immediately (advmod)
disrupts homeostasis (dobj)
enhances activation (nsubj)
conversion early (amod)
hemorrhage collagenase-induced (amod)
makes stability (nsubj)
nimodipine for (case)
clearance by (case)
mrna ) (punct)
bradycardia hydrochloride (nmod)
deposits dense (amod)
1.68 , (punct)
dehydrogenase the (det)
shown studies (nsubj)
activity referred (acl)
associated dissatisfaction (conj)
nsc -n,5-dimethyl- (dep)
receptors striatal (amod)
room er (appos)
inhibition neurotransmission (nmod)
exacerbated ethanol (nmod)
hospitalized center (nmod)
increased whereas (advcl)
regulation estradiol-dependent (amod)
prevented . (punct)
glycol and (cc)
clopidogrel by (case)
congestion of (case)
parents the (det)
seizures electrographic (amod)
mm of (case)
caused calcification (dobj)
adjustment variables (nmod)
reflex bezold-jarisch (amod)
demonstrated study (nmod)
review complication (nmod)
days immobilization (nmod)
1710 from (case)
found affected (xcomp)
malaria as (case)
groups 12/32 (appos)
changes morphology (nmod)
involve increase (dobj)
relapse who (nsubj)
escalated toxicity (nmod)
represents amiodarone (nsubj)
hypertension 506-induced (amod)
hemosiderosis resulting (acl)
tests hot-plate (amod)
17 2004 (appos)
considered conclusions (dep)
supports typically (advmod)
excluded five (nsubjpass)
iu/l at (case)
deficit a (det)
prevented hypertension (dobj)
microsomal both (cc:preconj)
sediment urinary (amod)
adrenoceptor new (amod)
purpose report (nmod)
iso-osmolar dimeric (dep)
required amputation (nsubjpass)
healthy adults (dep)
analyzed activity (nsubjpass)
titer receptor (compound)
appear women (nsubj)
associated dissipates (nmod)
factors operating (acl)
steroids results (acl:relcl)
congestants and (cc)
agent no (det)
counteract even (advmod)
conventional amikacin (dep)
two group (nmod)
increase disability (nmod)
prilocaine ( (punct)
change only (amod)
agent immunomodulatory (amod)
utilizing dexmedetomidine (dobj)
morphology lobe (nmod)
aspirated and (cc)
data various (amod)
monotherapy amlodipine (amod)
impact functioning (nmod)
crescents and (cc)
administered patient (nsubjpass)
contain , (punct)
disorders blood (compound)
persisted days (dobj)
therapy to (mark)
d. 7 (nummod)
carboplatin and (cc)
responses vasopressor (compound)
contributes events (nmod)
improved . (punct)
case in (case)
effect paradoxical (amod)
terminating after (mark)
receiving cisplatin (dobj)
dystonia tardive (amod)
tolerable more (advmod)
sensitivity assay (compound)
discussed are (auxpass)
extensive or (cc)
size tumor (compound)
timolol % (compound)
hysterectomy for (case)
pressure contraction (conj)
diarrhea tinnitus (conj)
phase this (det)
wt ( (punct)
consider asterixis (dobj)
infection a (det)
23 - (punct)
capability the (det)
renal kidney (conj)
rigidity myalgia (conj)
associated cardiotoxicity (nmod)
loss significant (amod)
suppression arrhythmia (nmod)
change , (punct)
administered been (auxpass)
generator the (det)
evidence 2-adrenoceptors (nmod)
improved intravitreal (mark)
hbv into (case)
thus , (punct)
greater hearts (nmod)
night polysomnography (nmod)
association possible (amod)
white-cell , (punct)
results administered (advcl)
mitochondria particular (nmod)
have ngf (nsubj)
randomized ; (punct)
patients optic (nmod)
role mediating (acl)
injections metrizoate (amod)
outcome with (case)
blockade infusion (conj)
rocuronium of (case)
desire of (case)
adenocarcinoma ( (punct)
victims overdose (nmod)
levels cyp27 (compound)
abnormality of (case)
function pivotal (amod)
cases casei (conj)
duration years (nmod:poss)
ischemic haemorrhagic (conj)
ns ( (punct)
cisplatin of (case)
area target (compound)
gram-positive and (cc)
reported concentrations (nsubjpass)
doses 5-fu (nmod)
disorders problems (conj)
evaluated unaware (nmod)
alterations deglutition (compound)
sensitizing in (mark)
virus mulv (compound)
efficient dexamethasone (nsubj)
hyperprolactinemia . (punct)
met women (nsubj)
results hemolysis (nsubj)
fluoxetine combination (conj)
therapy acid (nmod)
comprised histology (nsubj)
had mm (dobj)
thought as (mark)
7 7 (conj)
apoptosis from (case)
resurgence by (case)
proportion patients (nmod)
cotransporter nkcc2 (appos)
syndromes various (amod)
cessation of (case)
powerful . (punct)
combination for (case)
hormone lh-releasing (amod)
identified area (conj)
killed examined (conj)
worsened administration (nmod)
withdrawal following (case)
doses potassium (compound)
2e1 isoform (conj)
toxicity weeks (nmod)
preferable has (advcl)
changed level (dobj)
age years (appos)
improve p-coumarate (nsubj)
recipient bn (nmod)
noninnervated ( (punct)
3.0 at (case)
compliance . (punct)
fibrosis veins (nmod)
discontinued investigation (nsubjpass)
received whereas (mark)
hemodialysis % (conj)
symptoms decline (conj)
male % (nsubj)
correlates in (case)
map identify (conj)
hepatitis prevention (dep)
hyperplasia severe (amod)
instability bladder (compound)
arrhythmias significant (amod)
encode and (cc)
half about (advmod)
abnormalities structural (amod)
halts toxicity (dobj)
indicators prognostic (amod)
scattered . (punct)
ng/kg/min ( (punct)
agent atypical (amod)
one compensated (amod)
penetration daptomycin (nmod)
system pressure (compound)
cocaine-dependent and (cc)
desipramine with (case)
min haemodilution (conj)
binding endogenous (amod)
treatment areas (nmod)
agents blocking (amod)
indicate although (mark)
anxiolytic and (cc)
patients mg/m2 (nmod)
prompted . (punct)
gtn by (case)
use coc (compound)
related meloxicam (nmod:npmod)
matched and (cc)
marked less (advmod)
reduction further (amod)
treated lev (nmod)
prevalences and (cc)
improve latency (dobj)
doses mg/kg (appos)
was fall (attr)
month one (nummod)
intake adult (nmod)
reduced given (advcl)
dosing multiple (amod)
syndrome baboon (compound)
recording correlates (nmod)
occurred only (advmod)
reveal , (punct)
antagonists vincristine (nmod)
hematology chemistry (conj)
demonstrate actions (dobj)
targets treatment (nmod)
angiography after (case)
fraction ventricular (amod)
bind to (mark)
terminated was (auxpass)
28 +/- (cc)
pre-treated mg/kg (nmod)
improves conclusion (nsubj)
nodules of (case)
provided terms (nmod)
reduces whereas (mark)
decline lvef (nsubj)
speed memory (conj)
induced nucleus (nmod)
fk506 of (case)
2-bromoethylamine bea (appos)
effectiveness function (nmod)
better infant (dep)
enabled groups (nmod)
duration frequency (conj)
charge the (det)
found exists (ccomp)
drug omeprazole (nsubj)
administration agents (nmod)
application surgical (amod)
determined magnitude (nmod)
iu/l 124.4+/-73.4 (nummod)
imaging volunteers (nmod)
act that (nsubj)
converted . (punct)
contrast level (nmod)
film x-ray (compound)
organisms pseudomonas (compound)
phases liquid (amod)
received ml. (dobj)
reported cases (dobj)
scales values (conj)
toxicity local (amod)
tended a-i (nsubj)
rosaceiform dermatitis (dobj)
subjected regulation (nmod)
week 16 (nummod)
scale severity (compound)
headache flushing (conj)
usage of (case)
paradigms dosing (amod)
% 38.2 (nummod)
involved glaucoma (nmod)
effect rhythm (nmod)
day training (compound)
case superimposed (conj)
preexisting high-grade (dep)
measure concentration (dobj)
adults healthy (amod)
described using (xcomp)
volume effective (amod)
antigens or (cc)
monomer and (cc)
model severity (nmod)
able increase (xcomp)
followed return (nmod)
prevent conclusion (nmod)
rupture aneurysmal (amod)
casts proteinaceous (amod)
verifying after (mark)
phase previous (amod)
short half-life (nsubj)
reduce morbidity (dobj)
suggested c (nsubjpass)
resembles . (punct)
toxicology cocaine (compound)
side-effects and (cc)
switched . (punct)
carbamazepine due (case)
obtained been (auxpass)
moran 1996 (dep)
play pathophysiology (nmod)
recorded minutes (nmod)
selective replicated (conj)
amplitudes tremor (compound)
carcinoma metastic (amod)
result role (nmod)
comparison variables (nmod)
allocated receive (xcomp)
265.2 79.6 (conj)
recall subsequently (advmod)
affected illness (nmod)
expression exaggerated (amod)
channels water (compound)
tremulous rigidity (nmod)
triad effects (nmod)
hg , (punct)
microm to (case)
years eleven (nummod)
strain inbred (amod)
segments among (case)
neurons dissociated (amod)
assessment at (case)
size optimal (amod)
reaction quetiapine (nmod)
0.95 ( (punct)
u/l 49 (nummod)
hospital fever (nmod)
investigation first (amod)
imbalance determinant (nsubj)
aware physicians (nsubj)
dex with (case)
benzodiazepines of (case)
neuroleptics the (det)
plasma . (punct)
12alpha-hydroxylase of (case)
limited treatment (nsubjpass)
option is (cop)
cyclophosphamide vasculitis (nmod)
entity this (det)
gentamicin or (cc)
sedation propofol (nmod)
consistent km (nsubj)
exist hydrolyze (acl:relcl)
affect naloxone (nsubj)
process that (mark)
auc at (case)
efficacy its (nmod:poss)
warranted treating (advcl)
parkinsonism from (case)
terminated dse (nsubjpass)
reported common (conj)
modulate to (mark)
patients seventy-nine (amod)
courses eight (nummod)
value g/dl (nmod)
developed dementia (dobj)
agents sympathomimetic (amod)
i.v. ) (punct)
vulnerability regions (nmod)
curves tolerance (compound)
believed . (punct)
correlated effects (nsubj)
describe patient (dobj)
delivery with (case)
plan original (amod)
using models (nmod)
elicited symptoms (nsubjpass)
suppressed aggregability (nsubjpass)
assessed as (mark)
formation and (cc)
was deficits (nmod)
causes the (det)
injury cerebral (amod)
bfgf il-6 (conj)
reminding buschke (compound)
corticosteroids administered (amod)
cacl(2)-treated cacl(2)-untreated (conj)
induced sodium (nmod)
mass examination (dep)
doses standard (amod)
effect tea (nmod)
therapy antiepileptic (amod)
confirmed is (auxpass)
increase relation (nmod)
erythropoietin and (cc)
induction treatment (nmod)
mda and (cc)
nm progesterone (dep)
thrombo-embolism of (case)
protein high (amod)
preferred hexabrix (nsubjpass)
times sec. (nmod)
examination ultrastructural (amod)
idraparinux , (punct)
effects epilepsy-related (amod)
problem production (compound)
indicate rats (nsubj)
diazepam patients (nmod)
treatment bevacizumab/irinotecan (nmod)
cells microglia (compound)
tg without (case)
curves glucose (compound)
treated i.p. (advmod)
way the (det)
vomiting stomatitis (conj)
monitored diameter (nsubjpass)
caused necessary (ccomp)
determined smaller (ccomp)
syndrome suprofen (nmod)
catalepsy neuroleptic-induced (amod)
functions depressed (acl)
mechanism basic (amod)
activity to (case)
spectrum bands (nmod)
kinase ck-mb (conj)
state from (case)
media contrast (compound)
pretreatment bnpp (compound)
caused overstimulation (nmod)
lidocaine biopsies (conj)
effects side (amod)
nephrotoxicity medium (amod)
channels . (punct)
scans brain (compound)
psychoses neurosis (conj)
0.39 ( (punct)
angiographies dose (nmod)
related difference (nsubj)
case drug (appos)
hypothesized transmission (nsubjpass)
20 follow-up (nsubj)
psoriasis from (case)
stimulus task (nmod)
ligand . (punct)
effects mk-801 (nmod)
trend outcomes (nmod)
given min (dobj)
alpha-tocopherol alpha-tc (appos)
negative while (mark)
titrated maintained (conj)
include combination (nmod)
injection intradermic (amod)
agonism by (case)
cells labeled (amod)
therapy antiviral (amod)
rash morbilliform (compound)
properties vasodilating (compound)
therapy anti-tumor (amod)
developing disease (dobj)
ambiguus node (conj)
dimer-x and (cc)
reduced whereas (dep)
pathology this (det)
loosening lumens (nsubj)
needed objective (nsubjpass)
mm 90 (nummod)
cause jaundice (dobj)
blocked increase (nsubjpass)
range surviving (nmod)
age deviation (conj)
well-tolerated galantamine (nsubj)
increase effect (nsubj)
complication infusions (nmod)
corrected . (punct)
generated : (punct)
battery kaufman (compound)
medulla but (cc)
signals leading (acl)
diagnosis treatment (conj)
half-time parenchyma (nmod)
increased factor-alpha (dobj)
men women (appos)
hus by (case)
striatum amygdala (conj)
galantamine of (case)
acid carboxylic (amod)
9.1 +/- (cc)
week of (case)
120/67 , (punct)
conclude ; (punct)
dystonias cranial (amod)
dfp bw (appos)
dose body (compound)
3.49 ocs (nmod)
30 toxicity (nmod)
events scales (conj)
permeability changes (conj)
apomorphine by (case)
expression elevated (amod)
rat in (case)
effects haloperidol (conj)
related incidence (nmod)
reduction fractures (nmod)
subtypes , (punct)
detect drugs (nmod)
remains it (nsubj)
patients 203 (nummod)
in-patients among (case)
associated prevention (nmod)
diagnosis recorded (amod)
improved was (auxpass)
ester n-nitro-l-arginine-methyl (compound)
stroke cocaine (nmod)
phases the (det)
taking cisapride (dobj)
receptor receptor-like (amod)
scales reflecting (acl)
[ca(2+)](i ( (punct)
off on (conj)
acuity assessment (conj)
movement detected (acl)
tremors and (cc)
2a 5-ht (compound)
lethargy transient (amod)
efficacy regarding (case)
recurrence reaction (nmod)
duration seconds (compound)
confirmed % (nmod)
rate one-year (amod)
intervals successive (amod)
onset secondary (amod)
lack but (cc)
details and (cc)
preparations weight-control (amod)
microg/ml and (cc)
by-product acoustic (amod)
carrier synthesis (nmod)
mechanism postulated (amod)
fever ahf (appos)
patients 7 (dep)
increases spv (nmod)
using methodology (dobj)
peptides two (nummod)
persisted months (nmod)
patient fourth (amod)
spv and (cc)
diagnoses main (amod)
compared study (dobj)
responders nine (nummod)
observed ctnt (nmod)
neuropathy ethambutol-induced (amod)
topotecan mg/m(2)/day (dep)
subjected those (dobj)
reported agent (nmod)
formation consequent (amod)
cause cardiotoxicity (dobj)
exposure or (cc)
urine their (nmod:poss)
experienced he (nsubj)
conversion immunosuppression (nmod)
n i.v. (compound)
contained occult (dep)
less moreover (advmod)
performance practices (nmod)
used rats (dobj)
paid has (aux)
changes histological (amod)
associated any (nmod)
kb pcna (conj)
myositis all-trans (amod)
obstruction no (det)
vp-16 ( (punct)
occurrence a (det)
stimulant powerful (amod)
aimed re-investigate (xcomp)
induced aura (nsubjpass)
coma of (case)
produced degree (dobj)
54 disease (nmod)
form conjugates (nmod)
plasma renal (conj)
reaction immunoallergic (amod)
factors torsades (nmod)
butyrylthiocholine and (cc)
aneurysms : (punct)
run-in the (det)
culture from (case)
sparing some (det)
investigated function (nsubjpass)
death day (nmod)
pge1 with (case)
8) , (punct)
r-(alpha)-methylhistamine h3 (compound)
vary affinities (nmod)
slowing p (nmod)
status induced-behaviour (nmod)
salt bs (appos)
hippocampus seized (amod)
terminated dosing (nmod)
impact positive (amod)
sheath made (acl:relcl)
agonist methylphenidate (nsubj)
ages by (case)
mpo-anca and (cc)
stem in (case)
doxorubicin anticancer (compound)
controls nifedipine (compound)
hz and (cc)
withdrawal usage (nmod)
mg/ml more (amod)
addictive stimulant (dep)
cardiotoxicity cya (compound)
lymphocytes of (case)
include anxiety (dobj)
man cardiomyopathy (nmod)
preceded always (advmod)
complete administered (advcl)
fibrosis portal (amod)
intensities dwi (nmod)
rarely , (punct)
frequent % (dep)
dizziness similar (conj)
malaria with (case)
diphenhydramine cimetidine (nmod)
tamoxifen with (case)
cramps/myalgias % (appos)
ineffective treatment (nsubj)
vestibular or (cc)
underline data (nsubj)
number protocols (nmod)
disease fraction (dep)
resulted ( (punct)
confirmed existence (dobj)
mechanism a (det)
severity for (case)
disease iv (nummod)
> grade (compound)
control motor (compound)
cocaethylene be (cop)
hypothesis this (det)
investigated influence (nsubjpass)
risk not (neg)
knowledge to (case)
trauma man (nmod)
areas six (nummod)
system cardiac (amod)
risks cumulative (amod)
damage to (case)
controlling in (mark)
filling increased (conj)
inhibition chronic (amod)
water ra-free (amod)
specificity opioid (compound)
manifests compound (nsubj)
performed we (nsubj)
investigators of (case)
attacks during (case)
yield 1 (nmod)
therapy mp (compound)
failure an (det)
clearance pah (compound)
resulted only (advmod)
delayed ascribed (advcl)
clearance its (nmod:poss)
occurrence fasciculation (nmod)
min-1 which (nmod)
stl1 and (cc)
had 1975 (nsubj)
diethylpropion the (det)
alpha ( (punct)
cardioselective drugs (dep)
overdose patient (nmod)
reduce increase (dobj)
0.003 p= (compound)
attenuated could (aux)
durations both (det)
requirements antagonism (nmod)
infusion only (advmod)
2-chloroprocaine-ce animals (nmod)
echocardiography for (case)
mumol/kg and (cc)
20 86 (dep)
detachment exudative (amod)
flow pulmonary (amod)
increases drowsiness (nmod)
dose 200-micrograms (amod)
dopac : (punct)
manifestations oral (amod)
transplantation oltx (appos)
discontinuation toxicity (compound)
beta-blockers hearts (nmod)
ph 7.4 (nummod)
drug one (nummod)
saline/side ; (punct)
11.8 2.7 (compound)
production o2- (amod)
interval i.v. (dep)
attenuate significantly (advmod)
outcomes for (case)
assess cancer (dobj)
improve ketamine (nsubj)
therapy developed (acl:relcl)
worsen therapy (nsubj)
parallel hemolysis (nmod)
preservation the (det)
effects antagonists (conj)
produced effect (dobj)
comparable characteristics (nsubj)
regimen immunosuppressant (amod)
effects tacrolimus (compound)
profile to (case)
filling defects (dobj)
thrombocytopenia thrombosis (conj)
recorded pressures (nsubjpass)
occurrence complexes (nmod)
concentration ratings (conj)
examined beginning (advcl)
part rostral (amod)
apomorphine s.c. (appos)
abnormalities % (dep)
forearm deep (amod)
damage idiosyncratic (amod)
prolongs interval (dobj)
cause urticaria (nmod)
receptors components (conj)
evaluate relations (dobj)
recovery disappearance (conj)
developed compared (conj)
green indocyanine (compound)
single dose (conj)
determined scores (nmod)
gamma-glutamyltransferase the (det)
nucleotide-gated hyperpolarization-activated (amod)
superoxide saline (appos)
written management (nmod)
investigated total (nsubjpass)
cause first (advmod)
decreasing rates (dobj)
incidence ( (punct)
uncomplicated had (aux)
slices transverse (amod)
understood is (auxpass)
penetrate not (neg)
agents antifungal (amod)
month was (cop)
100 1 (compound)
bromide such (case)
parameters indirect (amod)
determined dialysis (nmod)
bilirubin , (punct)
sulfate magnesium (compound)
promotes administered (advcl)
sensitization such (case)
activity a (det)
weeks using (acl)
contained cc (dobj)
leg . (punct)
treatments the (det)
differ not (neg)
sensitization only (advmod)
system discharge (compound)
phenylephrine mg (dep)
involvement ( (punct)
demonstrated microscopy (nsubj)
d-amphetamine mumol/kg (appos)
identified investigated (ccomp)
type included (acl)
correlation significant (amod)
satisfied patients (nsubj)
caused pentobarbital (nmod)
np unloaded (amod)
dsm-iv on (case)
displays , (punct)
mediated other (conj)
stroke review (conj)
occurrence complications (nmod)
interval free (amod)
0.45 2.3 (conj)
hyperalgesia in (case)
defects several (amod)
sensitivity state (conj)
monitored status (nsubjpass)
led conclusion (dep)
resolved administration (nmod)
rofecoxib , (punct)
mixture racemic (amod)
contributed pool (nmod)
creatinine 1.9 (nummod)
% 2.2 (nummod)
dyskinesias : (punct)
ilk of (case)
results width (nmod)
9 12 (conj)
urate saline (nmod)
diminishing aggregation (dobj)
hyperalgesia e2-induced (amod)
alterations pathways (nmod)
syndrome sirolimus-induced (amod)
inducing flaccidity (dobj)
necessary are (cop)
man 30-year (amod)
produced occlusion (nsubjpass)
given course (nsubjpass)
induce blockade (dobj)
degrees and (cc)
reduced supplementation (nmod)
inhibition selective (amod)
doses p.o. (appos)
tbars ) (punct)
show essential (ccomp)
agent pressor (compound)
mild a (det)
incidence convulsion (compound)
1.9 concentrations (nsubj)
heart within (case)
increases down (compound:prt)
anemia delayed (amod)
overflow levodopa-induced (conj)
clinical i (nsubj)
evaluating ischemia (dobj)
reactions defecate (advcl)
disappeared . (punct)
impairments consolidation (compound)
behaviour depressive-like (amod)
a(2a)/a(1 a (det)
technique classical (amod)
damages endings (dobj)
ethambutol optic (conj)
thrombosis associated (acl)
dose per (case)
suppression impairment (nmod)
loops vivo (advmod)
fulminant late (advmod)
pge1 product (conj)
less were (cop)
requested whether (mark)
inhibition pathogenesis (nmod)
processes in (case)
arteritis in (case)
occur when (advmod)
reaction one (nummod)
somnolence difficulties (conj)
blockers concurrent (amod)
mechanisms postulated (amod)
study company (dep)
min hypotension (nmod)
activity urine (compound)
events groups (nmod)
dogs beagle (amod)
correlated actin (dobj)
relationship cyclophosphamide (nmod)
determine has (ccomp)
mass outside (case)
chow libitum (compound)
involvement action (nmod)
dorsum onto (case)
upregulated initiate (conj)
uses for (case)
seen alterations (nsubjpass)
% 3.51 (dep)
week hepatitis (appos)
observed drinkers (nmod)
suggests increase (ccomp)
along agent (nmod)
nephrotoxicity amikacin-associated (amod)
period normothymic (amod)
secretion acth (compound)
stress any (det)
dilated related (amod)
assessed day (nmod)
treatment however (advmod)
complexes chain (compound)
pathway eyes (nmod)
occurrence an (det)
ng/ml 129 (nummod)
isradipine with (case)
days 27 (nummod)
levels adrenaline (nmod)
hypoxia and (cc)
myopathy pentazocine-induced (amod)
antinociceptive antiamnesic (conj)
effects drowsiness (nmod)
ribavirin administered (acl)
presentation abnormalities (conj)
receptor cck1 (compound)
associated chorea (nsubj)
surface cortex (nmod)
recognition rat (compound)
using plasma (dobj)
observed pretreatment (nmod)
adenocarcinoma prostatic (amod)
useful conclusions (dep)
random-assignment mg/day (conj)
syndrome aminonucleoside-induced (amod)
antibody anti-cephalothin (compound)
conclude recommended (ccomp)
suggest but (cc)
ward to (case)
monitoring in (case)
p=0.001 ( (punct)
vehicle of (case)
lapsed , (punct)
bear risk (dobj)
traumatic or (cc)
sensitive regulation (nmod)
blotting microscopy (conj)
0.8 only (advmod)
complexes , (punct)
mg.per 12.0 (nummod)
means maintaining (advcl)
acidosis tubular (amod)
differed f(33 (dep)
oxytocin of (case)
intensities changes (conj)
tumorigenesis forestomach (compound)
instillation every (det)
exist rationale (dobj)
prevent fasciculation (dobj)
depletion trp (compound)
six one (compound)
performed before (advmod)
showed elevated (ccomp)
change ischemic (amod)
features pain (nmod)
characteristics oil (nmod)
trigger as (case)
conversion % (appos)
multiforme myocarditis (conj)
reported milder (advcl)
s.c. naloxone (compound)
l(-1 infusion (nmod)
humans animals (conj)
helpful been (cop)
determined responsiveness (nsubjpass)
mg/m2/h of (case)
attracted attention (dobj)
exerted effects (dobj)
stimuli between (case)
effective at (advmod)
easy . (punct)
extracts 24 (nummod)
injections dox (nmod)
group vs. (cc)
depression contractility (nmod)
mg/day warfarin (compound)
syndrome characterized (acl)
morphine ; (punct)
compared ; (punct)
clonazepam with (case)
expression at2r (compound)
schedule a (det)
coincided normalization (nmod)
person a (det)
failed teratogenic (conj)
episode siadh (nmod)
hypothalamic-pituitary-adrenal hpa (dep)
8-se and (cc)
anxiety induced (acl)
depends that (mark)
% major (nsubj)
amnesia muscarinic (amod)
decrease hg (compound)
important additionally (advmod)
antagonist the (det)
patients rhythm (nmod)
assessing period (nmod)
features psychotic (amod)
gamma-carboxylated protein (nsubj)
receive mannitol (dobj)
terminated were (auxpass)
had 1 (nsubj)
particles of (case)
controls low-risk (amod)
treatment case (nmod)
ng/ml 3000 (nummod)
effect events (nmod)
51 in (case)
treated pilocarpine (nmod)
received ppa (nmod)
afterdepolarization early (amod)
products supplements (conj)
presentation including (case)
women 1923 (nummod)
activities to (case)
% 16.7 (nummod)
disease nervous (amod)
nephrotoxicity cardiotoxicity (conj)
pre-existing and (cc)
scheduled batteries (nmod)
cimetidine continuous-infusion (amod)
conducted analysis (nsubjpass)
heads optic (amod)
ce a (det)
mutants of (case)
is treatment (attr)
seizures infarction (conj)
dose znso(4 (nmod)
tissue thickened (amod)
indicate alters (ccomp)
describe unmasking (dobj)
sampled frequently (advmod)
with ( (punct)
nifedipine adalat (appos)
episodes previous (amod)
serotonin brain (compound)
seeds of (case)
literature use (nmod)
palsy psp (appos)
interviews personal (amod)
received randomly (advmod)
dcm , (punct)
lead that (mark)
h by (case)
given training (nmod)
suxamethonium after (case)
failure crf (appos)
agents anticholinergic (amod)
rapamycin posttransplant (amod)
toxicity 5 (appos)
failure clinical (amod)
frequency angio-oedema (nmod)
inserted was (auxpass)
involved directly (advmod)
neuroleptics these (det)
developed related (dep)
produce all (advmod)
changes on (case)
frequency atrial (amod)
population epilepsy (compound)
proposed models (nsubjpass)
treatment implicated (acl)
glioma had (amod)
found age-dependency (nsubjpass)
hr 20 (nummod)
lethality but (cc)
higher pressure (nsubj)
usa uk (conj)
% years (dep)
binding dopaminergic (amod)
1.22 - (punct)
reproduce ly-171555 (nmod)
bendrofluazide to (mark)
killed + (cc)
rad001 , (punct)
adriamycin by (case)
seizure pethidine (nmod)
decrement a (det)
punctata chondrodysplasia (compound)
sedation patients (nmod)
stools her (nmod:poss)
mg/dl 200 (nummod)
cyclosporine aza (conj)
administration 2-chloroprocaine-ce (nmod)
k(+)- ( (punct)
accompanied episodes (nmod)
mds ( (punct)
cylinder the (det)
informed should (aux)
decrease 2 (nmod)
course thrombocytopenia (nmod)
introduction with (case)
compounds were (cop)
identified recently (advmod)
reaction paradoxical (amod)
molecules of (case)
stimulation ? (punct)
a sirolimus (conj)
is limiting (csubj)
previously years (nmod:npmod)
l-isomer ( (punct)
difficulties certain (amod)
ml % (dep)
experienced have (aux)
vancomycin piperacillin/tazobactam (conj)
share pathway (dobj)
revealed cingulate (nmod)
water on (case)
register with (case)
determine completion (nmod)
11 17 (prep)
glomerulosclerosis increased (amod)
, mj (dep)
forms cystitis (nmod)
study prevention (compound)
developed thereafter (advmod)
lesions high-signal (amod)
fifteen other (amod)
test during (case)
viability and (cc)
selegiline combination (nmod)
suffering dysfunction (nmod)
drug known (acl)
polyneuropathy grade (compound)
n- c-terminal (conj)
compounds four (nummod)
advocate now (advmod)
patients male (appos)
doses combination (nmod)
diagnosis was (cop)
glomerulosclerosis rats (nmod)
ecgs ( (punct)
elevation pressure (nmod)
rate i.v. (nummod)
influences alterations (conj)
cardiomyopathy of (case)
seizures kainic (amod)
tended it (nsubj)
changes subsequent (amod)
seeing pain (ccomp)
s that (mark)
negativity of (case)
15/44 and (cc)
groups between (case)
syndrome in (case)
unchanged reduced (parataxis)
axis i (nummod)
aggravate administration (nsubj)
contributed that (nsubj)
cases cases (nmod)
manifest were (cop)
last ( (punct)
observed reduce (xcomp)
assessed periods (nmod)
resuscitate to (mark)
uncommon series (nmod)
mechanism potential (amod)
excipients with (case)
mg/kg under (case)
injection serotonin (compound)
effects behavioral (amod)
report published (conj)
drinking heavy (amod)
localize to (mark)
intrarenal infusion (nmod)
retard incorporation (dobj)
applications daily (amod)
ester protector (dep)
years 5.6 (nummod)
factor changes (nsubj)
i1- agonists (dep)
discontinued reinitiated (conj)
reduction glomeruli (nmod)
appeared : (punct)
incorporation above (case)
administration e (conj)
test hyperprolactinemia (nmod)
doses clinical (amod)
related pyrazinamide (nmod)
markers among (case)
downregulation beta-noradrenergic (amod)
seeds dce (appos)
doxorubicin/kg , (punct)
trabeculectomies most (nsubj)
receptor in (case)
activity cpk (compound)
0.06 mean (dep)
greater g/m2/d (nmod)
conclusion play (appos)
electrophoresis spectrometry (conj)
complicate edema (nsubj)
prominent which (nsubj)
methylprednisolone the (det)
dipping mg (compound)
seed grape (nsubj)
mv to (case)
had frequencies (dobj)
stimuli once (conj)
used radiation (dobj)
effect pre-treatment (nmod)
syncope near (amod)
study incorporated (advcl)
purpose investigated (appos)
agc a (det)
developing rats (dobj)
events complications (nsubj)
resembles up-regulation (dobj)
are however (advmod)
changes due (case)
greatest is (cop)
sixties his (nmod:poss)
failure transient (amod)
tachycardia , (punct)
10 of (quantmod)
trimester the (det)
8.07 1.7 (conj)
subjected threshold (nsubjpass)
tacrolimus by (case)
gauges ( (punct)
test test (conj)
closest agsd (nmod)
suggests site (ccomp)
sirolmus srl (appos)
incidence nausea (nmod)
producing for (mark)
unaffected increased (conj)
movements euphoria (amod)
exhibits dominance (nsubj)
night a (det)
differences frequency (nmod)
testing , (punct)
tolerated improved (conj)
im ) (punct)
antagonized be (auxpass)
days and (cc)
criteria agoraphobia (nmod)
developed h (dobj)
extend results (nsubj)
halothane snp (conj)
% 0.1 (nummod)
ci-921 analogue (compound)
given treatment (nmod)
examination neuro-ophthalmologic (amod)
measurements arterial (amod)
lower response (nmod)
engaged that (mark)
complications 52 (nummod)
discontinued treated (conj)
nouns concrete (amod)
morbidity , (punct)
those dose (nmod)
assessed parameters (nsubjpass)
increasing reported (parataxis)
c supplemental (amod)
consistent anemia (nmod)
examined electron (conj)
accelerated . (punct)
behaviors neuropsychiatric-like (amod)
% -16 (nummod)
written although (mark)
dehydrogenase phosphokinase (conj)
transducer differential (amod)
design measures (compound)
seen increases (nsubjpass)
evaluation continuous (amod)
inhibit drugs (nsubj)
a(2a)/a(1 adenosine (compound)
platform version (nmod)
deglutition of (case)
models suitable (amod)
pronounced base (nmod)
tiredness stay (ccomp)
suppression turnover (nmod)
tnf-a ( (punct)
exposure bcnu (nmod)
was recurrence (nsubj)
analyses useful (acl:relcl)
therapy heparin (compound)
revealed reports (dobj)
has phenobarbital (nsubj)
connecting cortical (conj)
tolerated procedure (dobj)
increase stress (nmod)
users heavy (amod)
bupivacaine tissue (compound)
occlusions blindness (nmod)
damage apoptosis (conj)
compared defect (nsubjpass)
assays ) (punct)
testing binding (conj)
cases highlighted (amod)
vaginum per (case)
ec ( (punct)
erythematosus systemic (amod)
manipulation to (case)
dependent cardiotoxicity (nsubj)
produced calcification (conj)
chemotherapy mitoxantrone (nmod)
done be (auxpass)
after 900 (nmod)
have duct (dobj)
propranolol that (det)
compensated . (punct)
administration before (case)
glutamate intradermal (amod)
occurs treatment (nmod)
had kidneys (nmod)
suggestive that (nsubj)
brainstem bilateral (amod)
focussed specifically (advmod)
cortex offspring (amod)
plasma gels (nmod)
less reduction (nmod)
delineated not (neg)
84 from (case)
showed mass (dobj)
assessed that (nsubj)
had concentrations (nsubj)
characterized cigarettes (nmod)
increased but (cc)
cross-reacting derivatives (nmod)
questionnaires numbers (nmod)
trespass to (mark)
heparins newer (amod)
eminence the (det)
pha-p ( (punct)
nucleus tegmental (amod)
prescribed therapy (dobj)
nephrosis of (case)
hcv ) (punct)
arrest following (case)
pay attention (dobj)
energy " (punct)
treated outpatients (nsubjpass)
routes i.p. (advmod)
levels elevation (conj)
made baseline (nmod)
positive ( (punct)
changes activation (compound)
levels : (punct)
toxicity % (nmod)
piperacillin neurotoxicity (conj)
designated drug (xcomp)
learning induced (acl)
injection dosages (nmod)
controls depression (nmod)
dissatisfaction sexual (amod)
assessed time (nsubjpass)
images follow-up (amod)
requests payment (compound)
behaviors generated (acl:relcl)
proportions treatment (conj)
emg ( (punct)
herbicides rats (nmod)
weeks three (nummod)
which during (case)
groups analyzed (nmod)
encouraging results (nsubj)
expression population (nmod)
disorder instability (conj)
occurred anaesthesia (nmod)
presentation -- (punct)
decreased triad (dobj)
= 2.15 (dobj)
p .034 (nummod)
nx , (punct)
held bringing (advcl)
so more (advmod)
ulcers hemorrhagic (amod)
led discontinuance (nsubj)
those found (acl:relcl)
detection prompt (conj)
toxins other (amod)
admission b.i.d. (amod)
prevented not (neg)
associated pain (nsubjpass)
converted because (mark)
detected bile (nmod)
injection second (amod)
hematocrit pressure (conj)
duration from (case)
gall dissolution (dobj)
followed leukopenia (nmod)
affected could (aux)
dose 200mg/kg (nmod)
induce vsds (conj)
characterized episode (nsubjpass)
432 to (case)
mg/kg infusions (nmod)
levels elevated (amod)
narcosis barbiturate-induced (amod)
severe results (nmod)
4 7 (conj)
diameter diameter/axon (compound)
somatotopy gpi (nmod)
> loss (compound)
toxicity muscle (compound)
persisted still (advmod)
process elimination (nmod)
interactions pharmacokinetic (amod)
expression alphaenac (appos)
distinguished connections (nmod)
dyschromatopsy tritan-type (amod)
effects terbutaline (nmod)
mary 's (case)
carbonate and (cc)
revealed putamen (conj)
ultrasound guided (acl)
recognition tachycardia (nmod)
phenylephrine and (cc)
hours 98 (nummod)
dose ml (appos)
potentiation doses (nmod)
value in (prep)
proposed is (auxpass)
contributing dysfunction (nsubj)
injections nucleus (nmod)
paclitaxel in (case)
carries application (dobj)
resuscitated . (punct)
drinking of (case)
study xi (compound)
appeared necrosis (nsubj)
see modified (ccomp)
follow-up complete (compound)
mediated inhibiting (conj)
formation hippocampal (compound)
found bladder (nmod)
consistent that (nmod)
relapse meningeal (compound)
exclude based (prep)
activate , (punct)
hyperhidrosis dissociation (parataxis)
hydrochloride , (punct)
retested weeks (nmod)
manifestation was (cop)
preexposure of (case)
returning normal (nmod)
heparin therapeutic (amod)
0.001 p (compound)
cancer after (case)
consequence as (case)
exhibited also (advmod)
properties potent (amod)
prostigmine ( (punct)
documented effect (nsubjpass)
abnormalities aminonucleoside-induced (amod)
stimulation receptor (nmod)
explained preference (advcl)
temperature the (det)
months 17 (nummod)
effects in (case)
dihydropyridine available (amod)
selective specific (conj)
response stereotypic (amod)
result blockade (nmod)
maintain sleep (dobj)
endings pathways (conj)
extract alcoholic (amod)
group ' (punct)
rofecoxib ) (punct)
fla-63 inhibitor (appos)
gain : (punct)
recovery correlated (acl)
percentage low (amod)
lumen capillary (amod)
given lactate (nmod)
attempted thrombectomy (nsubjpass)
case ischemia (nmod)
any of (case)
trimethoprim 3.8/100,000 (appos)
apd epicardial (amod)
group an (det)
neurological of (case)
assessment cardiac (amod)
suspicion presence (nmod)
occurred microangiopathy (nsubj)
total leukemia (nmod)
recorded monitoring (nsubj)
verapamil for (case)
reflected as (mark)
calcification and (cc)
mania in (case)
undertaken assess (xcomp)
evaluate patterns (dobj)
capsaicin , (punct)
received doses/day (dobj)
81.1 of (case)
induced thiopentone (nmod)
ml/kg suspension (nmod)
prod ndma-d (conj)
potential antioxidant (amod)
begun course (nmod)
= 0.0228 (dobj)
offer therapy (dobj)
combination interferon (nmod)
specimens renal (amod)
implants containing (acl)
inhibitor enzyme (compound)
abolished withdrawal (nmod)
given hours (dobj)
grades of (case)
% rates (nsubj)
d 6 (nummod)
rate prevalence (compound)
dose tablets (dep)
specific effect (nsubj)
mild were (cop)
type on (case)
paroxetine , (punct)
mean+/-sd ( (punct)
syndrome polycystic (amod)
due initially (advmod)
proteins novel (amod)
impaired hepatically (advmod)
was fibres (nmod)
presented % (parataxis)
ml bupivacaine (nmod)
have steroids (nsubj)
granules cisternae (conj)
neurobiol . (punct)
patients stage (nmod)
caused treatment (nmod)
flestolol acc-9089 (appos)
corresponds this (nsubj)
n-methyl-d-aspartate , (punct)
resulted symptoms (nmod)
strain prototypic (amod)
4-hourly groups (nmod)
ml. 0.2 (nummod)
2-minute intravenous (dep)
observed decrease (dobj)
= 0.016 (dep)
study blind (amod)
administration lf (nmod)
seen mass (nmod)
bradycardia by (case)
determining levels (dobj)
contribute does (aux)
62.0 - (punct)
captopril with (case)
age 63 (nmod)
mechanism(s to (case)
characteristic diabetes (nmod)
0.942 0.768 (compound)
dismutase antioxidants (conj)
inhibitors fluoxetine (dep)
facilitates and (cc)
pretreatment rats (nmod)
cured or (cc)
minutes . (punct)
correlation p (dep)
diagnosed patient (nsubjpass)
throat patients (nmod)
warranted trials (nsubjpass)
somatotopy of (case)
discovered tumors (nsubjpass)
outbreak an (det)
micrograms 50 (nummod)
safety inhibitor (nmod)
citrate edetate (conj)
treatment infusion (conj)
contribute ginsenoside (nsubj)
number their (nmod:poss)
group -6 (nummod)
coupled processes (nmod)
panel metabolic (amod)
estimated frequency (nsubjpass)
received methods (dep)
cisplatin that (mark)
identical may (aux)
maximal peroxidation (nsubj)
dexmedetomidine between (case)
hcrh of (case)
features the (det)
arrest in (case)
discriminate reliably (advmod)
affect mechanisms (nmod)
patients female (amod)
basis patients (nmod)
participants nonusers (dep)
affinity higher (amod)
prior withdrawal (nmod)
ex vivo-prepared (dep)
minutes t180 (appos)
rhei rhubarb (appos)
occur decreased (advcl)
analgesia morphine (amod)
induces obesity (dobj)
dyskinesia thalamotomy (conj)
augment levels (dobj)
monocytes blood (compound)
tolerated as (mark)
informative are (cop)
patients complained (acl:relcl)
inhibited expressions (nsubjpass)
methods dosed (dep)
ami ) (punct)
contributor as (case)
different microg/ml (dep)
admitted exacerbations (nmod)
suggestive very (advmod)
rose group (nmod)
alpha- alpha-configurations (conj)
discriminated damage (nsubjpass)
valve tricuspid (nsubj)
period consolidation (nmod)
perfused dexamethasone (nmod)
decreased diameter (nsubj)
conclusions meet (appos)
ma 21 (conj)
values from (case)
etiology , (punct)
clarified must (aux)
histochemistry ) (punct)
pathology observed (acl:relcl)
cholesterols , (punct)
requiring ventilation (dobj)
developed spasm (dobj)
loss myelination (nmod)
min-1 ml/100 (dep)
nephritis atin (appos)
cases japan (nmod)
needle of (case)
marked neuroleptics (conj)
uiu/ml 168 (nummod)
injection i.v. (appos)
absence activity (nmod)
use within (amod)
structures involved (acl:relcl)
efficacy effects (dep)
mmecs and (cc)
schedules and (cc)
lacking data (nsubj)
reduced suggesting (advcl)
provided are (auxpass)
receive dosages (nmod)
% 87 (nummod)
wt but (cc)
caspase-3 , (punct)
dup , (punct)
located . (punct)
disulfiram inhibitor (appos)
shape waves (nmod)
acted drug (nsubj)
globulin serum (compound)
levels dopamine (compound)
hyperkalemia , (punct)
damaged were (auxpass)
d2 alpha (conj)
cause att (nsubj)
ingredient lindane (nmod)
knowledge etiology (nmod)
fields the (det)
correction an (det)
inhibitors are (cop)
observed assessed (conj)
evaluations trial (compound)
relation usage (nmod)
% 88 (nummod)
discontinued hydrochloride (nsubjpass)
suffering neuralgia (nmod)
total n (dep)
severity challenge (nmod)
analysis 1-way (amod)
artesunate with (case)
versa animals (nmod)
excretion urine (compound)
salbutamol daily (conj)
blindness total (amod)
classified analyze (advcl)
mice null (compound)
induced treatments (nmod)
reported patients (nmod)
longer increasing (advcl)
repression expression (nmod)
p-ergs ) (punct)
mortality cardiovascular (amod)
aap and (cc)
presented progressing (conj)
found cases (nsubjpass)
scale questionnaire (conj)
aspirated days (nmod:tmod)
raised . (punct)
index body (compound)
inhibited contractility (nsubjpass)
using electrophoresis (dobj)
agonist receptors (nmod)
mediated it (nsubjpass)
phosphatase receptor (compound)
word one (nummod)
ester octapeptide (conj)
event of (case)
transformation astrocytes (nmod)
neuropathy optic (nsubj)
occur anemia (nsubj)
min 120 (nummod)
levels cpap (nmod)
lesions experimental (amod)
count 0.5 (dep)
presents picture (dobj)
report have (aux)
known because (mark)
improvement stomach (nmod)
wsr compared (case)
extent smaller (amod)
t3 ) (punct)
administered while (mark)
chemotherapy diabetic (conj)
control normal (amod)
hemoglobin grams (nmod)
0.5 0.9 (conj)
negative all (nmod)
able which (nmod)
had volumes (dobj)
included : (punct)
data behavioral (amod)
exhibited evidence (dobj)
short cycle (conj)
man carcinoma (nmod)
results increased (dep)
state ratio (conj)
impairment death (conj)
challenge on (case)
an in (case)
increase systolic (nmod)
mg/kg/day 0.057 (nummod)
lost follow (xcomp)
pituitary on (case)
management dependence (compound)
operative which (nsubj)
morphine by (case)
was effect (nsubj)
damage ma-induced (amod)
hypotension manifestation (nmod)
affect injection (nsubj)
contamination for (case)
gain % (nmod)
cages photocell (compound)
reduced where (advmod)
recorded established (advcl)
fluvoxamine given (amod)
cohort entire (amod)
proanthocyanidin grape (compound)
presence leukemia (nmod)
tuberculosis 1997 (nmod)
apnoea of (case)
injury persons (nmod)
solicited clinicians (nmod)
fractures 13 (nummod)
reversed cellularity (dobj)
cascade neuroinflammatory (amod)
6-hydroxydopamine of (case)
status 0 (nmod)
accounting while (mark)
attributed was (auxpass)
doses substances (dep)
mother a (det)
examined abilities (dobj)
paid states (nmod)
dyskinesia phenobarbital-induced (amod)
headache with (case)
creatinine > (conj)
bromide and (cc)
1.9 9.1 (prep)
hypotension resulting (amod)
manual statistical (compound)
showed comparison (nsubj)
intoxication after (case)
iddm ) (punct)
infusion kg-1 (nmod)
factor-alpha with (case)
increased dismutase (conj)
intraperitoneal i.p. (dep)
strokes ischaemic (amod)
formation central (amod)
epilepsy lindane-induced (amod)
men three (nummod)
patients groups (nmod)
nuclei dorsomedial (amod)
induced hyperalgesia (dobj)
period posttransplant (amod)
patients organ (amod)
observations acute (amod)
separation tumor (nmod)
hydroxyquinolines to (case)
carrier a (det)
teaching tertiary-care (amod)
training testing (conj)
3,4-methylenedioxymethamphetamine mdma (appos)
caused cells (nmod)
irradiation postoperative (amod)
sequestration neutrophil (compound)
transport duct (compound)
consistent that (mark)
artery noninnervated (amod)
disturbed situations (nmod)
follow-up one-year (amod)
induced patients (nmod)
rapa ) (punct)
hallucinations presented (amod)
overdose pemoline (compound)
groups effectiveness (nmod)
reduced then (advmod)
doses magnitude (conj)
section during (case)
kinetics excretion (nmod)
who ( (punct)
development cardiotoxicity (nmod)
extended diazepam (nmod)
conducted populations (nmod)
atpase calcium (compound)
receptors 5ht4 (compound)
difference respect (nmod)
diet maintains (acl:relcl)
substituted analogue (nmod)
30 300 (conj)
revealed experiments (nsubj)
agents nonsteroidal (amod)
consumed years (nmod)
listed incontinence (nsubjpass)
3 0.3 (compound)
remained similar (xcomp)
findings from (case)
treatment octreotide (nmod)
trial open (amod)
toxic lindane (nsubj)
% 11.6 (nummod)
age clearance (conj)
caused part (nmod)
hemodynamics hypotension (nmod)
sexes the (det)
b-sodium ( (punct)
force on-state (nmod)
2r,4r-apdc 15 (dep)
age-dependent and (cc)
custody in (case)
i.p. h (dep)
animals ethinyl (amod)
september n (dep)
angina with (case)
count g/dl (appos)
regions n (dep)
image magnetic (amod)
processes memory (compound)
compared materials (nsubjpass)
bpt , (punct)
days=1.77 ptrend=0.09 (dep)
levels hbv (nmod)
treated erroneously (advmod)
10.5 to (dep)
hemodynamic ) (punct)
remained predictor (dobj)
effects tachycardia (nmod)
women 41,904 (nummod)
toxicity vitamin (compound)
followed therapy (nmod)
influence occurrence (dobj)
syndrome quinine-associated (amod)
program assessment (compound)
indicated abnormality (dobj)
potentials electroretinography (conj)
validity hypothesis (nmod)
receive dexmedetomidine (dobj)
indications for (case)
higher seizures/mo (dep)
support for (case)
junction ( (punct)
sulfate hydroxychloroquine (compound)
factor rating (compound)
receive dose (dobj)
tetrabenazine mg/day (appos)
increase ? (punct)
expressed that (nsubj)
taken sample (nmod)
microm p (appos)
levels % (compound)
prone that (mark)
side-effects the (det)
replicated representative (conj)
0.98 to (dep)
labetalol of (case)
failed change (xcomp)
metabolism cells (nmod)
case cholestasis (nmod)
reduced overload (nsubjpass)
test exact (amod)
gd , (punct)
years < (compound)
dose mg/kg (dep)
cycles following (case)
pain injection (nmod)
users vgb (compound)
protects apoptosis (nmod)
antagonists selective (amod)
selective non (advmod)
post neurotoxicity (dobj)
injected % (dep)
produces although (mark)
glutamate potent (amod)
healthy 60 (conj)
apnoea ensued (acl)
rp 67,580 (nummod)
nmol/0.5 30 (compound)
diagnosis allergy (nmod)
activity reductase (compound)
group -1 (nummod)
research brain (nmod)
group animals (nmod)
% results (nsubj)
muscle focal (amod)
use prehospital (amod)
high been (cop)
illustrates pamidronate (dobj)
mediates that (mark)
simulator driving (compound)
228 ) (punct)
recovered later (advmod)
reduce mechanism (nmod)
demonstrates evidence (nsubj)
considered rare (advcl)
cocaine metabolites (conj)
produce lesion (dobj)
elevation aneurysm (appos)
drg l1 (compound)
increased headache (nsubjpass)
restored clentiazem (compound)
injection cocaine (nmod)
affect hyperactivity (dobj)
high the (det)
patients male (amod)
handicapped . (punct)
cyclosporin of (case)
g. , (punct)
duration narcosis (nmod)
subjects years (dep)
consistent ts (nmod)
aorta of (case)
use cautious (amod)
option it (nsubj)
treatment management (nmod)
tolerated flumazenil (nsubjpass)
clinical and (cc)
% 80.0 (nummod)
mg/kg dhea (compound)
induce trazodone (nsubj)
continued then (advmod)
mm subjects (nmod)
38.6 6.1 (conj)
area capsules (nmod)
found found (conj)
transmission the (det)
therapy chronic (amod)
infusion ( (punct)
regressed lesions (nsubj)
potential cataractogenic (amod)
bisphosphonate oral (amod)
failure arf (appos)
fibrillation infarction (conj)
birth vaginal (amod)
surgeries ) (punct)
methods collected (dep)
documentation case (nmod)
deaths event-related (amod)
predictor dysphagia (nsubj)
due interaction (nsubj)
hyperprolactinemia bmd (nmod)
unpaired p (dep)
gradual , (punct)
suggested mediate (xcomp)
types various (amod)
synthase ts (appos)
b.d procaterol (conj)
cycloheximide chx (appos)
arrest ; (punct)
be not (neg)
conversion : (punct)
scenario common (amod)
156 more (amod)
enrolled study (nmod)
alcohol ratio (appos)
disability parkinsonian (amod)
constructed inflammation (dep)
syndromes kidney (compound)
hypothesize needed (ccomp)
effect cortex (nmod)
value p (compound)
removal bronchoscopic (amod)
compare effect (dobj)
exposure des (compound)
noted suggesting (xcomp)
remains cause (nsubj)
injected muscle (nmod)
indicates method (ccomp)
assess reducing (advcl)
effects gvg (nmod)
recalled score (nsubj)
associated ischaemia (conj)
stop could (aux)
treatment short-term (amod)
contractions rhythmic (amod)
specified treated (conj)
1a serotonin (compound)
inhibited associated (conj)
levels determined (acl)
nondyskinetic dunnett (dep)
inhibitors cyclosporine (dep)
outcomes most (amod)
establishes demonstrates (conj)
levels excretion (conj)
swimming and (cc)
administered mg/kg (nmod:npmod)
cerebrum in (case)
infarction mechanism (nmod)
revealed phonation (nmod)
small multiple (conj)
different score (dep)
testing with (case)
evaluable response (conj)
activity pain-related (amod)
antagonized potently (advmod)
hypren-trial of (case)
three ( (punct)
treated arabic (conj)
defined having (advcl)
serve warn (xcomp)
reactions hepatic (amod)
cortex operculoinsular (amod)
diseases various (amod)
imaging fmri (appos)
administration single (nmod)
1.98 0.98 (compound)
% 0.93 (dep)
smoking mellitus (conj)
exclude reactions (dobj)
menorrhagia with (case)
randall-selitto by (case)
woman trait (nmod)
mean 626 (prep)
later days (nmod:npmod)
% 91.8 (nummod)
perls ' (case)
dose i.p. (advmod)
measured 1.39 (parataxis)
register the (det)
series the (det)
concentrations fasting (amod)
levels tnfalpha (nmod)
score urine (compound)
measured patients (nmod)
higher those (nmod)
colocalized fashion (nmod)
parallel suggests (acl:relcl)
0 50 (conj)
prospective in (case)
eluates the (det)
clinicians h. (compound)
tested study (nsubj)
effects narcosis (nmod)
contraction isometric (amod)
verified this (nsubjpass)
response treatment (compound)
increased hour (nmod:tmod)
examined analysis (nmod)
use txa (nmod)
l-name of (case)
indicative . (punct)
development nor (cc)
thalidomide and (cc)
addition misoprostol (nmod)
9.2 +/- (cc)
activity hoe (nmod)
reticulocytes peripheral (amod)
patient macroglobulinaemia (nmod)
scale azrin (compound)
were controlling (advcl)
formulation propofol (nmod)
mechanisms biochemical (amod)
decreases a-i (conj)
abolished pressor (nsubjpass)
causes no (neg)
hormone pth (appos)
involving patients (dobj)
effect studied (acl)
area model (nmod)
intraperitoneal not (neg)
participate onset (nmod)
acid prednisone (conj)
175 mg/m2 (conj)
administration us (compound)
cutaneous and (cc)
strategies new (amod)
chow cyclic (amod)
cause neuropathy (ccomp)
changes both (det)
incidences heparins (nmod)
pressure albuminuria (conj)
pressures oxygen (nmod)
received survived (advcl)
change rate (nsubj)
placed , (punct)
1 4 (conj)
suggests : (punct)
ml/min ) (punct)
candidate a (det)
effect shake (nmod)
aches ) (punct)
retard acetaminophen (nsubj)
mg 75 (compound)
reached diagnosis (nmod)
observed users (nmod)
explained effects (nmod)
association stereotypies (nmod)
h of (case)
supersensitivity receptor (compound)
pleased sedation (nmod)
loss diuretic-induced (amod)
neurotoxicity dopaminergic (amod)
models arrhythmia (nmod)
knife neither (preconj)
development neurological (amod)
demonstrate engineered (ccomp)
trimethaphan blocker (compound)
urea concentrations (conj)
characteristics behavioral (amod)
administration glutamate (compound)
fatigue dizziness (conj)
given intralipid (nmod)
seizure convulsive (amod)
observed antigen (nsubjpass)
alternative whether (mark)
maximal medications (nmod)
reduced toxicity (nsubjpass)
saline either (preconj)
sign atherosclerosis (nmod)
remain morbidity (nsubj)
revealed frequently (advmod)
claimed were (auxpass)
encephalopathy headaches (conj)
nocistatin peptide (appos)
met cases (nsubj)
sign motor (compound)
test water (nmod)
group 139 (conj)
efficacy proven (amod)
changes ultrastructural (amod)
produced however (advmod)
pneumonia adenovirus (compound)
groups across (case)
contents stomach (compound)
concentration mumol/l (nmod)
disrupts , (punct)
improves chelation (nsubj)
significant weeks (nmod)
0.0001 ) (punct)
hyperalgesia > (dep)
infiltration monocyte (compound)
3.4 ) (punct)
ratio interleukin (conj)
amount fibrin (nmod)
dose-dependent paralleled (amod)
vasoconstriction with (case)
nsclc treated (acl)
returned week (nmod)
risks as (mark)
node heart (nmod)
case rechallenge (appos)
anemia (azt)-induced (compound)
cells polymorphic (amod)
approach , (punct)
terminated and (cc)
reduces result (nmod)
antagonized given (advcl)
diets , (punct)
duration ketamine (nmod)
elevations greater (amod)
gene as (case)
evaluated examinations (nmod)
sodium therapy (conj)
seems since (mark)
elucidated completely (advmod)
23.6 +/- (cc)
effect application (nsubj)
studied association (nsubjpass)
had treatment (dobj)
considered safe (xcomp)
highly more (advmod)
percentage to (case)
depleted and (cc)
analysis long-term (amod)
fed rats (nsubj)
ee with (case)
chemoconvulsants several (amod)
severe drop (advcl)
monitored not (neg)
link study (xcomp)
relationship findings (nmod)
is to (case)
phase i (nummod)
action 2-blocking (amod)
placebo only (advmod)
conclusions demonstrate (dep)
pressure adequate (amod)
solution anaesthesia (nmod)
cortex stem (conj)
resolved cis-ra (nmod)
stimuli pain (compound)
benzylpenicilloyl-poly-l-lysine with (case)
pre-treatment depression (nmod)
monitor carefully (advmod)
% 1.2 (compound)
pge1 ( (punct)
fenoldopam , (punct)
durations after (case)
remapped was (auxpass)
examined using (xcomp)
once-daily ( (punct)
treatment mitomycin (compound)
tool oct (nsubj)
regions brain (nmod)
attack with (case)
variables : (punct)
suspension colloidal (compound)
erythrodysesthesia stomatitis (conj)
efficacy prochlorperazine (nmod)
rejection allograft (compound)
start to (mark)
death hippocampus (nmod)
transection vagotomy (conj)
ameliorate effect (dobj)
pars nigra (amod)
result failure (nmod)
shown infusion (nsubj)
associated ciprofloxacin (nmod)
administered inadvertently (advmod)
mpep ip (appos)
cips from (case)
used adjust (xcomp)
interactions the (det)
metabolite causes (acl:relcl)
hypoxia mild (amod)
hemodialysis continuous (amod)
minimum days (nmod)
prazosin antagonist (compound)
dystonia . (punct)
period 2-day (amod)
% 0.0001 (dep)
dose steroids (nmod)
volume to (case)
therapy dtic (appos)
reduced dosage (nsubj)
infarcts bilateral (amod)
induced effect (dobj)
correlated : (punct)
peroxides of (case)
harmful subgroup (nmod)
avoiding thus (advmod)
diseases progressive (amod)
clonazepam by (case)
technique postmortem (compound)
used amiodarone (nsubjpass)
care prehospital (amod)
excretion damage (nmod)
met findings (dep)
behaviour similar (amod)
regimen modified (amod)
examined incidence (dobj)
ginsenosides of (case)
has given (conj)
pvn ) (punct)
interval twice (advmod)
design experimental (compound)
deficiency aor (dep)
acted , (punct)
structure the (det)
propose here (advmod)
val204asp ) (punct)
consuming not (neg)
recall and (cc)
patients including (case)
system variable (amod)
ischemia pallidus (nmod)
dosed weeks (nmod:tmod)
less that (mark)
neutralization drop (conj)
syndrome defects (conj)
proof no (det)
shown administration (nsubjpass)
observed kinetics (nmod)
effect l-dopa (nsubj)
low grade (conj)
potencies anaesthetic (amod)
identified tubules (nmod)
order elucidate (acl)
alive disease (nmod)
anatomical and (cc)
unclear suggest (advcl)
space extracellular (amod)
trazodone ( (punct)
concentrations pretreatment (nmod)
action supine (amod)
closely more (advmod)
neonates , (punct)
toxicity rat (nmod)
psychosis patients (nmod)
blocker alterations (conj)
recognised symptoms (nsubjpass)
target , (punct)
dependence nucleosides (conj)
quality for (case)
drops the (det)
tgf-beta1 ( (punct)
comparable respect (nmod)
15 mg/kg (conj)
sensitivity reproducibility (conj)
using patients (nmod)
submitted registry (nmod)
january 2000 (nummod)
phosphorylation oxidative (amod)
bolus c+e (nmod)
reached mice (nmod)
crocin dose (nmod)
hours twenty-four (nummod)
pergolide mg (appos)
possible but (cc)
occurred withdrawal (nmod)
implicated background (dep)
conducted method (nmod)
severity anemia (nmod)
intervention simple (amod)
potentiating , (punct)
withdrawal periodic (amod)
tachycardia atrial (amod)
angiography arterial (amod)
admitted syndrome (nmod)
all massive (nmod)
physiology by (case)
bepridil of (case)
p.r.n a (det)
db of (case)
need of (case)
suggested develop (xcomp)
isrctn54598675 trials (compound)
excitement sexual (amod)
toxic was (cop)
suggested : (punct)
arv ) (punct)
biopsy the (det)
maintaining dosage (dobj)
cross-react antibodies (nmod)
upregulation such (amod)
erythromycins , (punct)
pills factor (nsubj)
injected stz-icv (nmod)
course benign (amod)
regimens new (amod)
treatments subsequent (amod)
neuropathy chickens (nmod)
thrombocytopenia with (case)
rats 5/6 (nummod)
8-week placebo (conj)
prolongation seconds (appos)
severity symptoms (nmod)
achieves and (cc)
fetus developing (amod)
toxicology with (case)
hdl class (conj)
status who (nsubj)
kg-1 mg (amod)
causes these (det)
attenuated regulation (nmod)
viruses by (case)
biperiden by (case)
moran pharmacol (dep)
infusions continuous (amod)
frame a (det)
operations neurosurgical (amod)
assessed questionaire (nmod)
underlying injury (dobj)
syndrome lignocaine (nmod)
product extended-release/lovastatin (nsubj)
recurred however (advmod)
documented onset (nsubjpass)
co-carcinogen as (case)
describe and (cc)
levels between (case)
reduced inhibition (nmod)
epilepsy tle (appos)
appears hepatotoxicity (nsubj)
days time (nsubj)
elicited that (mark)
determined subcortex (nmod)
blepharoconjunctivitis complaints (appos)
valdecoxib inhibitor (compound)
less not (neg)
identified have (aux)
suggest determined (ccomp)
junctions tjs (appos)
topotecan study (dep)
duration depending (case)
products synthase (nmod)
kpa ( (punct)
phenomenon induce (ccomp)
found children (nmod)
used cyclophosphamide (nsubjpass)
reacted also (advmod)
1.3 % (appos)
exercise-controls the (det)
speaking movements (conj)
therapy antituberculosis (compound)
raised were (auxpass)
became hypotensive (acomp)
start tmp (nmod)
metabolites their (nmod:poss)
randomized double-blinded (dep)
myelination changes (conj)
supported , (punct)
complication drug-induced (amod)
late 41 (nmod)
damaged since (mark)
unknown still (advmod)
cervix of (case)
short but (cc)
atria in (case)
induced metoclopramide (nmod)
controlled patients (nmod)
attenuated crocin (nsubj)
involved frequencies (nsubjpass)
possibility represent (ccomp)
received methods (nsubj)
nitroglycerin frontotemporal (amod)
signal a (det)
times or (cc)
patients 926 (nummod)
pressing in (mark)
reversible . (punct)
adenoribosylation on (case)
group oncopaz (compound)
p9605 and (cc)
group except (case)
nature its (nmod:poss)
week postoperative (amod)
15.0 56.8 (conj)
0.6 relative (amod)
antagonist histamine (compound)
followed-up . (punct)
suffer deserve (conj)
using stimulation (dobj)
factor human (amod)
higher relatively (advmod)
showed 7e (nsubj)
toxicity regimen (nmod)
five ( (punct)
infused % (nsubjpass)
irritation receptors (nmod)
tolerance in (case)
cholesteryl less (advmod)
clonazepam mg/kg (appos)
cip past (amod)
dosage doxorubicin (nmod)
considered and (cc)
injection and (cc)
myasthenia ocular (amod)
cases 41 (nummod)
hemorrhagic , (punct)
phase days (dep)
mmhg 60 (nummod)
hypertrophy rats (nmod)
contributes . (punct)
oxygenation lobe (amod)
kidney gland (conj)
patients reported (acl:relcl)
structure-activity dose-effect (conj)
symptoms cardiac (amod)
administration intracerebroventricular (amod)
cisplatin % (appos)
those led (acl:relcl)
blood % (dep)
sufficient be (cop)
cancer : (punct)
learning . (punct)
anova by (case)
caused hypoaldosteronism (nsubjpass)
assessment groups (nmod)
effects cpdd (nmod)
mediated increase (nsubjpass)
ro , (punct)
applied potassium (nsubjpass)
groups than (case)
receptor-alpha proliferator-activated (amod)
phenotyping our (nmod:poss)
increased content (nsubjpass)
generalized tranexamic (amod)
risperidone antagonist (appos)
amns such (case)
gauges , (punct)
aspiration blood (nmod)
dl-sotalol unlike (case)
suggest vasoconstriction (dobj)
consisted vtd (nsubj)
showed group (nsubj)
was , (punct)
time man (nmod)
improves activity (nmod)
duration af (nmod)
vol% 0.7 (nummod)
greater ng/ml (nmod)
demonstrated tolerated (advcl)
hypogonadism for (case)
involved which (nsubjpass)
conducted analysis (dobj)
stress 1 (dep)
weight auc (conj)
infected chronically (advmod)
findings imaging (compound)
inhibition p53 (compound)
higher much (advmod)
seizures induced (amod)
alpha-methyldopa 100 (nummod)
killed toxicity (nmod)
5,7-dihydroxytryptamine 5,7-dht (dep)
method staining (compound)
< .01 (nummod)
use prescribing (advcl)
degeneration fibres (nmod)
studied controls (conj)
therapy-na in (case)
overlooked that (mark)
is but (cc)
related donors (conj)
report patient (nmod)
5.1+/-1.0 , (punct)
initiated mol/l. (advcl)
changes about (case)
ptu ) (punct)
made introduce (xcomp)
ingestion prior (amod)
shows still (advmod)
infiltrates of (case)
frontal left (amod)
step not (neg)
level bax (nmod)
prognosis absence (nmod)
0.04 vs. (cc)
experiences changes (conj)
controls ( (punct)
effect renal (amod)
increased microg.kg(-1).h(-1 (dep)
effects cromakalim (nmod)
limited piloerection (nmod)
instillation methotrexate (nmod)
evident observation (nmod)
dysplasia cortical (amod)
used localize (xcomp)
failure end-stage (amod)
hormones risk (conj)
encephalopathy with (case)
powered not (neg)
recurrence to (case)
cefotetan especially (advmod)
rcbf ) (punct)
bendrofluazide following (case)
doses tetrachloride (nmod)
normalized patients (nmod)
model pilo (compound)
cocaine- seizures (dep)
unique and (cc)
proteinuria 50 (appos)
increased proteinuria (nsubj)
selective : (punct)
patterns in (case)
ameliorates administration (nsubj)
stages medulla (nmod)
was doses (nsubj)
given period (nmod)
questioned reports (nsubjpass)
improved administration (nsubj)
presented he (nsubj)
approximate may (aux)
hosts children (appos)
preceded , (punct)
maintained status (nmod)
difference rate (nmod)
using risk (nmod)
children in (case)
fetuses inhibitor (appos)
cows treated (acl)
3.7 to (dep)
left seizure (conj)
corresponded shown (advcl)
schedule this (det)
received participants (nsubj)
altered rats (nmod)
a.m. 7:30 (nummod)
women by (case)
allopurinol plus (cc)
amlodipine as (case)
step the (det)
24.3 risperidone (nmod)
profile neuropharmacological (amod)
length mean (compound)
phosphatase glepp1 (compound)
force of (case)
potent 9.5-fold (advmod)
uncommon dyskinesias (nsubj)
in-patients 50 (nummod)
required showing (xcomp)
causes , (punct)
mmhg 129 (nummod)
factor associated (acl)
change for (case)
toxicity ops (nmod)
central more (advmod)
led paramedics (dobj)
suggest conclusion (nsubj)
returned abolished (advcl)
adenomas reports (dep)
mrp2 and (cc)
l-isomer inactive (amod)
day other (amod)
encoding of (mark)
infusion e (dep)
formulations release (nmod)
implemented commonly (advmod)
patients control (compound)
play prostaglandins (nsubj)
control +/- (cc)
analyzed then (advmod)
incidence pain (nmod)
this in (case)
mk-801 ap7 (conj)
regeneration of (case)
fatiguability easy (amod)
accompanied consequence (nmod)
stating success (dobj)
survival ( (punct)
loss and (cc)
use drops (nmod)
latency 1 (dep)
function norepinephrine (amod)
85 to (dep)
model emax (compound)
similar pharmacologically (advmod)
assess prevalence (dobj)
activity cleavage (dep)
diopters d (appos)
frequency of (dep)
inhalation and (cc)
pilot this (det)
rates apoptosis (nmod)
dosage usual (amod)
remissions % (appos)
disorder or=7.18 (dep)
influenced directly (advmod)
therapy with (case)
needed prevention (nmod)
nachrs ) (punct)
consequent with (case)
(+/-)-pg-9 ] (punct)
totp ( (punct)
agent sedative (amod)
reduce fentanyl (nsubj)
means program (nmod)
cytological both (cc:preconj)
are studies (attr)
evaluated catalepsy (nsubjpass)
designed ] (punct)
study intervention (compound)
mortality high (amod)
days eight (nummod)
lamivudine , (punct)
programs via (case)
hypertension glucocorticoid-induced (amod)
rate neonates (nmod)
remains as (mark)
demonstrated was (auxpass)
taking microg/day (nmod:tmod)
samples na (nmod)
black 23 (conj)
focussed women (nmod)
cd4 260 (nummod)
enhance it (nsubj)
oxide no (appos)
treatment irrigation (nmod)
-placebo -chlorpheniramine (conj)
523.5 +/- (cc)
cranial ratios (nmod)
dose-dependent . (punct)
is cyclophosphamide (nsubj)
revealed differences (nsubjpass)
conjugates n-(2-hydroxypropyl)methacrylamide (compound)
applicators male (amod)
performed benzylpenicilloyl-poly-l-lysine (nmod)
adjuvant therapy (nmod)
change reserpine (nsubj)
examined finally (advmod)
responses bold (compound)
f2 classical (amod)
associated pain (nmod)
seen grade (nsubjpass)
corresponded . (punct)
basis haloperidol (nmod)
sprague-dawley gf (compound)
models schizophrenia (compound)
engorgement intense (amod)
1983 1984 (conj)
occurred seen (ccomp)
sprague-dawley and (cc)
pallidotomy august (nmod)
regeneration muscle (compound)
mouse ) (punct)
exchange and (cc)
monitored catheters (nmod)
encephalopathy induced (acl)
level enzyme (nmod)
death to (case)
injected material (nsubjpass)
cells primitive (amod)
performed while (mark)
studied was (auxpass)
formyltransferase ribonucleotide (compound)
reduced rate (dobj)
pr3-anca ( (punct)
sectioned planes (nmod)
rise than (case)
shell accumbens (compound)
regimen 5-fu/fa/mmc (nsubj)
loss post-operative (amod)
designed study (dobj)
days ahf (nmod)
formation reticular (amod)
summaries case (nsubj)
3.49 were (cop)
increased action (dobj)
female ovariectomized (amod)
similarities , (punct)
agonist dopamine-1 (compound)
caused hydrochlorofluorocarbons (nmod)
hospitalization during (case)
inflamed strips (conj)
tensions tensions (conj)
indicating mediated (ccomp)
consequence level (nmod)
irradiation abdominal (amod)
agent , (punct)
reaction always (advmod)
developed infants (nmod)
hydrochloride 3-[1'-admantyl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1h-2-benzo (nummod)
effects space (nmod)
presence solutions (nmod)
implantation stent (nmod)
curcumin antioxidant (amod)
29.7 - (punct)
aed ) (punct)
doses body (appos)
tropicamide guttae (compound)
cities four (nummod)
reducing pain (dobj)
dose cd50 (appos)
chromatographic-mass gas (compound)
decreased colliculi (nmod)
older 6 (nsubj)
ameliorates . (punct)
important recognition (nsubj)
cells oral (amod)
recipients , (punct)
affects , (punct)
november ) (punct)
predictive , (punct)
activation stem (compound)
cages in (case)
distributed seen (conj)
hemoglobin hb (appos)
are objective (dep)
effect the (det)
lowered animals (dobj)
eyes control (compound)
combination years (nmod)
atonic motor (dep)
ct abdominal (amod)
cycle each (det)
lid fluctuations (dep)
induced ouabain (nmod)
antibodies ) (punct)
model animal (amod)
has thus (advmod)
dose pilsicainide (nmod)
blocker kinetics (nmod)
monitoring levels (dobj)
edema associated (acl)
ccl4 lethal (conj)
occlusion to (case)
variable damage (nsubj)
attempted ) (punct)
display impairments (dobj)
incidence infections (nmod)
angiogram with (case)
kanamycin-colistin and (cc)
become regimens (nsubj)
seizures b-induced (amod)
localized striatum (nmod)
polyuria polydipsia (conj)
determined analyzing (advcl)
diatheses or (cc)
polymorphisms of (case)
injection day (nmod:tmod)
microperfusion picrotoxin (nmod)
-32 ) (punct)
infusion aminophylline (nmod)
release vasopressin (nmod)
activity decarboxylase (compound)
concentration avp (nmod)
patients sixty-five (amod)
synthesize that (mark)
examines study (nsubj)
nitroglycerin combined (amod)
elevated the (det)
comparative phase (conj)
pacing resuscitation (nmod)
alter evolution (dobj)
mouth meth (compound)
mannitol ( (punct)
symptoms muscle (compound)
complicating patient (nmod)
decreased b (nsubj)
activities biological (amod)
patients radiotherapy (nmod)
acts background (dep)
rigidity such (amod)
agents platelet (compound)
pressure steroid-induced (amod)
putamen the (det)
examination ophthalmic (amod)
correlate , (punct)
treatment fractures (nmod)
unpaired t-tests (dobj)
% 88.6 (nummod)
found gene (nmod)
confirm not (neg)
showed electrocardiogram (nsubj)
virility on (case)
increment more (conj)
histochemistry phosphate-diaphorase (compound)
near ) (punct)
h1- with (case)
observed : (punct)
ly274614 by (case)
school medical (compound)
mice deletion (nmod)
times fasciculation (nmod)
history including (case)
compares present (nsubj)
resistance increasing (acl)
list drugs (nmod)
e15.5 at (case)
contribute reversal (nmod)
sign of (case)
reported enrolment (nmod)
common patients (dep)
dermatoses facial (amod)
lna lna+lca (dep)
thunbergiana from (case)
infusion vincristine (nmod)
cyclosporine by (case)
1 in (case)
decreased . (punct)
stronger . (punct)
abundant remarkably (advmod)
anatomy normal (amod)
had differences (nsubj)
pacing by (case)
observed increase (nsubjpass)
group-2 n=10 (appos)
period 5-year (amod)
stimulation through (case)
glomerulosclerosis of (case)
degree pattern (conj)
taking mg/day (dep)
recognition object (compound)
medications patients (compound)
abundance proteins (conj)
switched placebo (xcomp)
method scintigraphy (nsubj)
give suggest (conj)
ratio bax/bcl-2 (compound)
suppressed synthesis (dobj)
cd-832 not (cc)
mm 120 (nummod)
attack paws (nmod)
neurotransmitter of (case)
infants exposed (acl)
unconscious activity (dobj)
elevation synergistic (amod)
taking associated (dep)
supply tissue (nmod)
plasma on (case)
individuals these (det)
153 to (case)
clinical neurophysiological (conj)
flattened ' (punct)
volunteers eight (nummod)
vision in (case)
1.4 . (punct)
occurring females (nmod)
fatalities . (punct)
nephropathy complications (conj)
one worldwide (advmod)
5-fluorouracil 5-fu (appos)
found blanching (nsubjpass)
delirium her (nmod:poss)
demonstrates confined (ccomp)
sensitivities effects (nmod)
monitoring than (case)
extent only (advmod)
widening and (cc)
cases hypertension (nmod)
nausea like (case)
upregulated be (auxpass)
research from (case)
was increase (nsubj)
allergy ax (compound)
onset clonus (nmod)
age 's (case)
children condition (nmod)
elevations ctni (compound)
susceptible damage (nmod)
attack nitroglycerin (nmod)
pressures the (det)
gene cx3cr1 (compound)
mechanisms hypertension (nmod)
leading changes (nmod)
anesthesia isoflurane (compound)
noted should (aux)
5'-n-ethylcarboxamidoadenosine neca (appos)
groups animals (nmod)
compared norms (nmod)
diabetes with (case)
associated ts (nmod)
shifts . (punct)
scavengers gentamicin (nmod)
cured 90 (conj)
methotrexate leukaemia (nmod)
mm 5.9/7.0 (compound)
pan/temocapril ) (punct)
ovarian fallopian (conj)
moiety an (det)
relative desipramine (nmod)
mm 15.8 (nummod)
and widely (advmod)
reported elevations (nsubjpass)
significantly but (advmod)
conclude mediates (ccomp)
indicate misleading (ccomp)
treated dxnp (nmod)
restored effects (dobj)
lobe his (nmod:poss)
metabolizer he (nsubj)
obtained rats (nmod)
concentrations brain (compound)
presents . (punct)
effects cardiorespiratory (amod)
available been (cop)
methods conducted (appos)
precipitate drugs (nsubj)
stage ( (punct)
seemed . (punct)
associated avoided (conj)
used test (xcomp)
concentrations peak (amod)
charcoal and (cc)
morning the (det)
supported is (auxpass)
saline all (conj)
uncommon regions (nmod)
e13.5 at (case)
decrease susceptibility (dobj)
arrest with (case)
discovered factor (nsubjpass)
1.041 0.001 (conj)
vector new (amod)
version thai (amod)
complicated be (auxpass)
processing inputs (nmod)
thiopental rats (nmod)
greater gravity (nsubj)
relationship no (neg)
test buschke (compound)
pharmaceuticals geigy (compound)
replacement heparin (nmod)
injury tubular (amod)
qrs caused (acl)
quetiapine clozapine (conj)
necessitated bronchospasm (nmod:npmod)
clonidine disorder (nmod)
totals and (cc)
insecticides organophosphorus (compound)
24 approximately (advmod)
table life (compound)
half abstained (acl)
nascis 3 (nummod)
albumin and (cc)
studies staining (nmod)
stat3 ( (punct)
exercise submaximal (amod)
months 29.5 (nummod)
day regimen (nmod)
june 1995 (nummod)
anticoagulation regional (amod)
doses to (mark)
pdn to (case)
hypothesized damage (ccomp)
designed obtained (conj)
nephropathy strain (nmod)
known neuropathy (nsubjpass)
return undergoing (advcl)
treatment estradiol (compound)
criteria migraine (nmod)
patient marrow (compound)
= 0.034 (dobj)
monitored model (nmod)
seen nigerians (nmod)
suxamethonium patients (nmod)
exposure puberty (nmod)
calcification to (case)
glucagon ischemia (nmod)
markers activator (appos)
similar : (punct)
decline first (amod)
g aconitine (conj)
recommend monitoring (dobj)
associated proliferation (nmod)
poisoning a (det)
intubation for (case)
decreased -- (punct)
revealed hyperactivity (dobj)
deficits persistent (amod)
resembles hepatitis (xcomp)
fibers cardiac (amod)
protect . (punct)
followed expression (nmod)
influence inhibitor (nmod)
change mg/dl (dep)
central ( (punct)
centers 2 (nummod)
related overloading (nmod)
multiple type (nmod)
related " (punct)
associated myoclonus (nsubjpass)
secretion ircrf (compound)
woman . (punct)
shown misoprostol (nsubjpass)
weakness patients (nmod)
produce antagonists (nsubj)
therapy subcutaneous (amod)
diseases for (case)
predisposed that (mark)
completed period (nmod)
long-term group (nmod)
cessation use (nmod)
day effacement (conj)
need search (acl)
months 5 (nummod)
nm 1 (compound)
prolonged dl-sotalol (nsubj)
capsaicin by (case)
movements dose (compound)
3.49 ethinyloestradiol (dep)
groups both (det)
method computer-assisted (amod)
pathways signal-regulated (amod)
replaced clopidogrel (nmod)
spiranolactone antagonist (appos)
severity a (det)
different prevalences (nsubj)
4.6 2-fold (dep)
nicorandil oral (amod)
steroids of (case)
stain to (mark)
examined use (nmod)
assessments withdrawal (nmod)
unlikely so (xcomp)
iodixanol p=0.39 (appos)
sensitive , (punct)
trks ( (punct)
dyskinesia days (nmod)
used but (cc)
thrombolysis alteplase (nmod)
volunteers 8245 (nummod)
mutations antiviral (amod)
distinct that (nsubj)
enhancement no (det)
associated bmd (nmod)
concentration man (nmod)
abnormalities intoxications (nmod)
biochemistries liver (compound)
modalities subset (nmod)
dose considering (acl)
blisters necrotic (amod)
score grading (compound)
children leukemia (nmod)
rats obese (amod)
stimulation locomotor (compound)
modulating by (mark)
segments ventricular (compound)
quantitative parameters (dep)
suppressed mitochondria (nmod)
function vocal (amod)
matched 95 (dep)
range 5 (nummod)
induction fibrillation (nmod)
result prescribing (nmod)
phenylephrine responses (dep)
25mg/kg at (case)
flestolol beta-adrenergic (conj)
progressed lesions (nmod)
tissue pacemaker (compound)
result convulsions (nmod)
absence rigidity (nmod)
eyes apraclonidine-treated (amod)
vs 45 (conj)
effect pulmonary (amod)
chronic evaluation (dep)
speculated is (auxpass)
desipramine 6-ohda (conj)
decrease scans (nmod)
preventing hepatitis (dobj)
sonograms cranial (amod)
death characterized (acl:relcl)
pathways extracellular (amod)
reductions bp (compound)
production by (case)
solution sugar (compound)
5 67 (conj)
mirrored . (punct)
wanted we (nsubj)
concentrations pollutant (amod)
group working (compound)
cyclophosphamide associated (dep)
suggests mechanism (dobj)
study access (nmod)
strong independent (dep)
esterases plasma (compound)
size in (case)
dyskinesia parkinsonism (conj)
published and (cc)
ileum pig (compound)
models epilepsy (nmod)
begun if (mark)
prior days (nmod:npmod)
250 275 (prep)
juices in (case)
mediated mechanism (nmod)
suspension timolol (compound)
signals dopamine (compound)
fibrillation patient (nmod)
ci=22.8 ) (punct)
pharmacokinetics the (det)
aspects many (amod)
increase time (nmod)
end-diastolic ed (dep)
methods knife (compound)
stimulation lpp (nmod)
result largely (advmod)
exhibited respectively (advmod)
trial ) (punct)
developed and (cc)
neurotransmission on (case)
had 15 (nmod)
1979 1990 (conj)
night single (amod)
half-time excretion (nmod)
decreased discontinuing (advcl)
worsening a (det)
expression cpu (nmod)
change 3.7 (dep)
remained thereafter (advmod)
model disease (compound)
gauges 10 (dep)
jj in (case)
times emergence (compound)
ptra with (case)
cycle during (case)
wk or (cc)
desensitization alpha-adrenoceptor (amod)
cv ( (punct)
eds ( (punct)
rare complications (nsubj)
lacking sgk1 (dobj)
hospital mary (nmod:poss)
changes renal (amod)
animals cocaine-injected (amod)
patients angio-oedema (nmod)
stimulate releasing (advcl)
comments few (amod)
damages barrier (dobj)
administered which (nmod)
interaction cns (nmod)
higher release (nsubj)
concentrations b (nmod)
test micrograms (conj)
advocate not (neg)
boys 83 (nummod)
appeared number (nmod)
regimens following (amod)
different markedly (advmod)
nuclei with (case)
index barthel (compound)
h-1 ) (punct)
fashion double-blinded (amod)
solution a (det)
damage due (case)
conduct testing (dobj)
aimed investigate (xcomp)
cardiotoxicity (dox)-induced (amod)
unchanged days (dep)
route mg./kg (conj)
effect atropine (nmod)
effects minimal (amod)
administered mother (nsubj)
pharmacokinetics risks (conj)
endothelia the (det)
case cases (conj)
indicating effect (dobj)
nitrate with (case)
excluded has (aux)
became enflurane (conj)
analysed use (nmod)
hemisphere dominant (amod)
produce levels (dobj)
purpura as (case)
patients 2000 (nmod:tmod)
phenotype long-lasting (amod)
dose equimolar (amod)
detection by (case)
prevention a (det)
mice dba/2j (compound)
% cells/microl (appos)
pentoxifylline ( (punct)
patients fourteen (compound)
shown mitoq (nsubjpass)
associated nephropathy (nsubjpass)
dysphonia acitretin (conj)
fit was (conj)
therapy fluorouracil (compound)
cytoprotection cs (compound)
receptor type-1 (compound)
infrequent with (case)
% 3.0 (nummod)
results hypotension (dep)
cataracts or (cc)
limbs upper (amod)
striata in (case)
found cause (ccomp)
range weeks (dep)
% 88.2 (nummod)
period days (nmod)
models some (det)
30 to (quantmod)
dogs sex (nmod)
occurrence by (case)
transplants kidney (compound)
determined cases (nmod)
positive however (advmod)
appear dosed (conj)
management after (case)
fraction % (nmod)
worsened received (advcl)
ioxaglate ( (punct)
non-users among (case)
block plexus (compound)
hampered . (punct)
cells 17.7 (nummod)
disappeared cessation (nmod)
crisis report (appos)
usual is (cop)
processing in (mark)
continued all (nmod)
ganglia rats (nmod)
component haart (compound)
amphetamine ) (punct)
continued detected (advcl)
weight kidney (compound)
bladder on (case)
combining by (mark)
hours 2.4 (nummod)
predictor a (det)
lobe frontal (amod)
status baseline (compound)
patients hit (compound)
pgs ( (punct)
ad50 concentration (dep)
delivery for (case)
studies inhibition (compound)
inhibition lead (nmod)
abuse seen (acl)
ln cmax/mic (dep)
jersey in (case)
cause precipitating (compound)
provocation neuropathy (nmod)
reaction long-lasting (amod)
hem ) (punct)
= g (dep)
mice than (case)
recovery motor (compound)
knockout intestinal (amod)
due remained (conj)
alternatives safer (amod)
recived . (punct)
purpura thrombocytopenic (amod)
ventricle to (case)
paraparesis , (punct)
complicated hypertension (nmod)
premedicated scopolamine (nmod)
form ether (amod)
clearance gfr (appos)
appeared mice (nmod)
% to (case)
showed efficacy (dobj)
therapy propranolol (compound)
controls iv (dep)
administration lidocaine (nmod)
four at (case)
risk encephalopathy (amod)
cohort years (conj)
occur arrhythmias (nsubj)
role alcohol (nmod)
epileptogenesis and (cc)
yield the (det)
insult dose (appos)
riha , (punct)
mug minute (nmod)
activity emg (appos)
efficacy 1788 (nmod)
engineered have (xcomp)
dosage neither (cc:preconj)
g with (case)
neurosci . (punct)
metallothionein of (case)
potential side-effect (amod)
investigated aimed (conj)
chloride , (punct)
transplantation a (det)
steroids and (cc)
adopted and (advmod)
shelf to (case)
injected methods (dep)
aggravate test (nmod)
scales of (case)
children medication-free (amod)
cyclosporine- or (cc)
paranoia idiopathic (amod)
abruptness and (cc)
amoxicillin ax (appos)
oxygenation ) (punct)
exposure vgb (nmod)
mg/m2 mg/m2 (appos)
permits and (cc)
compares patients (nmod)
propagation eads (nmod)
maintained position (nmod)
measured holding (advcl)
anticoagulants , (punct)
patients prevented (acl:relcl)
intravitreal analyzed (ccomp)
model stz-icv (compound)
induced area (nmod)
that trazodone (nsubj)
risk lesser (amod)
days lifetime (amod)
clearance cc (compound)
elevated risks (advcl)
plugs tumor (compound)
department such (case)
recovery dramatic (amod)
protected appeared (advcl)
paralysis age (conj)
old was (cop)
led and (cc)
dynamics patients (nmod)
status his (nmod:poss)
form wave (compound)
correlated exhibited (conj)
administered had (conj)
act peptides (nsubj)
exploration from (case)
alertness of (case)
correlation damage (nmod)
had responder (nsubj)
means the (det)
drugs cause (conj)
materials : (punct)
% 67.2 (nummod)
bupivacaine without (case)
nephrotoxicity no (det)
children tumors (nmod)
gained we (nsubj)
intensity extension (conj)
regulation transducer (nmod)
influence membranes (nmod)
inhibit does (aux)
preceded excluding (xcomp)
provides uncertainties (nmod)
parameters hepatic (amod)
bid groups (conj)
effect elevation (nmod)
compromised receiving (conj)
screening careful (amod)
experiment caffeine (appos)
interpretation found (appos)
scale horn (compound)
symptoms schizophrenia (nmod)
features common (nmod)
it-methotrexate arabinoside (conj)
comparing when (advmod)
regard cases (nmod)
conversion recipient (nmod)
sedation diazepam (nmod)
therapies exposure (conj)
donors of (case)
suggest result (ccomp)
injection saline (nmod)
use assessment (dobj)
titer proteinase (compound)
patients characteristics (nmod)
locf ( (punct)
inhibitor inhibitor (appos)
seizure patients (dobj)
aneurysm artery (nmod)
severe require (xcomp)
agent treatment (nmod)
mm 3.6 (nummod)
echocardiography bubble (compound)
chorea acute (amod)
showed progression (dobj)
more 114-fold (dep)
damage seizure-related (amod)
medulla bovine (amod)
result be (cop)
reduced contractions (nsubj)
hydrolyze can (aux)
report to (mark)
g/m2/d to (case)
discussed experiment (nsubjpass)
scores vas (compound)
repeated times (nmod:tmod)
implications documents (dep)
led injection (nsubj)
syndrome clinical (amod)
found ) (punct)
levels calcium (compound)
values as (case)
stabilizers are (cop)
sample on (case)
increase phosphatases (nmod)
quetiapine after (case)
prevent nevertheless (advmod)
% 38.6 (nummod)
dehydrogenase nadh (compound)
use reduce (acl)
cells the (det)
includes and (cc)
diabetic 81 (conj)
redness pain (conj)
exercised daily (advmod)
effect dilation (nmod)
susceptible might (aux)
increase dopamine (nmod)
ml/min ( (punct)
mask to (mark)
formulation adenosine (nmod)
work metabolism (conj)
generation particles (nmod)
behavioral biochemical (conj)
despair behavioral (amod)
cpa/ee on (case)
incidences the (det)
recognition pregnancy (compound)
method it (nsubj)
investigates plays (advcl)
loss fibers (nmod)
added when (advmod)
ptz ( (punct)
assess objectives (nsubj)
beclomethasone inhaled (amod)
improving toxicity (nmod)
occurred iopamidol (nmod)
increasing follow (conj)
0.5 at (nmod)
angio-oedema of (case)
blockade the (det)
supplementation chloride (compound)
conditions inflammatory (amod)
factors contributing (acl)
overload ca(2 (compound)
nmol/kg ( (punct)
0.675 [ca]o (compound)
doses/day dcf (nmod)
group propranolol-insulin (compound)
cpdd ( (punct)
injections vehicle (nmod)
shows models (dobj)
had trial (nsubj)
display performance (dobj)
testing studies (dep)
g 1 (nummod)
carcinoma colorectal (amod)
41 15 (compound)
alteration lasting (amod)
> calcium (compound)
combination dogs (nmod)
antagonists by (case)
includes discussion (nsubj)
minor comparatively (advmod)
synergistic resulting (advcl)
secretion an (det)
levels volume (conj)
consisted clinical (advcl)
toxicity cy (nmod)
iopromide a (dep)
micrograms/kg min (nmod)
d tachyarrhythmias (nmod)
group dose (compound)
proportion subjects (nmod)
muscles thyroarytenoid (amod)
cyclosporine tacrolimus-associated (conj)
persisted reversible (advcl)
developed di (dobj)
became active (conj)
hepatotoxicity amiodarone-induced (amod)
dox , (punct)
measures mmrm (appos)
contrast literature (nmod)
autonomic diabetic (amod)
tremor gait (conj)
loss : (punct)
polymorphisms taqid (dep)
vehicle either (preconj)
induce rats (nmod)
damage cardiomyocyte (compound)
order address (acl)
administration i.v. (amod)
ultrastructure vessel (nmod)
abolished vocalization (dobj)
defined progression (nmod)
mechanism this (det)
dose pentoxifylline (nmod)
nucleus . (punct)
thrombectomy mechanical (amod)
methods direct (amod)
increase in (case)
coccidioidomycosis for (case)
differ groups (nmod)
best cases (appos)
due capacity (nsubj)
atypicals among (case)
swelling of (case)
those living (acl)
develops usually (advmod)
pressure wall (nmod)
agent anti-tumor (amod)
contributing significantly (advmod)
11 5.4 (conj)
pretreatment the (det)
population japanese (amod)
tiapride tetrabenazine (conj)
arteries dilate (conj)
performance spontaneous (amod)
reduce enhancing (advcl)
plays regulating (advcl)
treatment significantly (advmod)
cases two (nummod)
thiabendazole to (case)
increased stripe (nmod)
day<10 , (punct)
heredofamilial and (cc)
extended-release verapamil (dep)
leak capillary (amod)
gram 's (case)
animals died (acl:relcl)
animals transgenic (amod)
treated sumatriptan (nmod)
worsened that (nsubjpass)
anesthetic the (det)
amount components (conj)
administration intra-arterial (amod)
implant fluocinolone (compound)
classified they (nsubjpass)
glomerulonephritis in (case)
event primary (amod)
contained licl (dobj)
coniine alkaloid (appos)
pharmacodynamics receptor (compound)
performed estimate (xcomp)
unmasking the (det)
awakening , (punct)
alterations all (det:predet)
point study (compound)
phosphate sc (appos)
followed dose (nsubjpass)
induced week (nmod)
injected saline (nmod)
present report (nmod)
transporter glut3 (compound)
measure changes (dobj)
treatment neuroleptic (amod)
discontinuation snp (nmod)
generation peroxide (compound)
findings echocardiographic (amod)
rct a (det)
6 17 (conj)
partial or (cc)
u/kg ) (punct)
usefulness its (nmod:poss)
failure n (dep)
lower week (nmod)
increase factors (nmod)
time exposure (compound)
using bypass (dobj)
mm diastolic (dep)
filaments frey (compound)
growth significant (amod)
therapy cabergoline (nmod)
cocaine model (nmod)
injected animals (nsubjpass)
hypothesis acts (ccomp)
anti-asthmatic tremorgenic (conj)
prevalence time (nmod)
unaware details (conj)
cns the (det)
intake following (case)
38 +/- (cc)
induction before (case)
dbs frequency (compound)
accomplished confirmation (nsubjpass)
given intubation (nmod)
increasing cxad (dobj)
obtained determination (nmod)
effect deleterious (amod)
counter the (det)
revealed immunofluorescence (nsubj)
nra0160 [ (punct)
interference prior (advmod)
measure which (nsubj)
associated combination (nmod)
onwards four (nummod)
dogs insufficiency (nmod)
produced 2-bromoethylamine (conj)
individuals than (case)
toxin with (case)
seemed better (xcomp)
secretion overall (amod)
methods recruited (appos)
time discovery (nmod)
accumulation % (dep)
proceeded transplant (nmod)
activity rbcs (nmod)
animals chronically (advmod)
shifts dc (compound)
reassessment a (det)
invaded area (dobj)
striata mice (nmod)
considered lesions (nsubjpass)
although close (nmod)
produce catalepsy (dobj)
transaminase were (cop)
wheezing with (case)
mechanism other (amod)
improve safety (dobj)
model cystitis (nmod)
enlarged days (nmod)
idiosyncratic . (punct)
combination lymphocytes (nmod)
largest the (det)
suggests study (nsubj)
receptors dopamine (compound)
optochiasmatic peripheral (conj)
75 to (dep)
days study (nmod)
issue manageable (amod)
erythroid both (cc:preconj)
pairs matched (amod)
sedative a (det)
schedule intermittent (amod)
segments aortic (amod)
cofactors of (case)
process myocytolytic (amod)
responsiveness outcome (nmod)
patient dystrophy (nmod)
introduced belgium (nmod)
cognitive comparative (amod)
clopidogrel plus (cc)
excretion the (det)
short or (cc)
efficacy vancomycin (nmod)
h. 48 (compound)
appeared furthermore (advmod)
women estrogens (nmod)
timing injury (nmod)
measures ultrasound (amod)
dogs eight (nummod)
dosage optimal (amod)
arrhythmia ouabain (compound)
terodiline nm (appos)
greater group (nmod)
acid acid (nmod)
cohort levels (nmod)
seem fk506 (nsubj)
correcting and (cc)
rats isoproterenol-pretreated (amod)
hospital the (det)
atria of (case)
decided contribution (nmod)
mutations gene (nmod)
support organ (amod)
led this (nsubj)
use cefotetan (nmod)
connected quinine- (nmod)
analysis bergman (compound)
apo ) (punct)
agent combination (nmod)
action study (dep)
prevented rigidity (dobj)
hca > (compound)
relaxation isovolumic (amod)
antibodies monoclonal (amod)
caution therapy (nmod)
therapy therapy (conj)
catheterization patients (nmod)
sensitivity isoproterenol (compound)
smokers adult (amod)
caused epilepticus (nsubj)
smaller statistically (advmod)
determined frequencies (nsubjpass)
branch distal (amod)
albumin/creatinine urine (compound)
counts respectively (advmod)
cr a (det)
ro4368554 deficits (appos)
includes experience (conj)
compliance with (case)
mm 8.4 (nummod)
one several (conj)
seconds 100 (nummod)
treatment amlodipine (nmod)
vasculitis warfarin-induced (amod)
% 31.9 (nummod)
determined be (auxpass)
present patient (dobj)
dose mg (nummod)
complications polymyositis/dermatomyositis (nmod)
levels in (case)
0.1 approximately (advmod)
induced ifosfamide (nmod)
capacity impaired (acl)
suggesting necrosis (dobj)
pharmacology prodrug (appos)
given tobramycin (nsubjpass)
bile the (det)
clinic affective (compound)
ami days (nmod)
cohorts i (conj)
leveled day (nmod)
tomography optical (amod)
0.5 of (case)
case related (nmod)
modulator a (det)
developed whilst (mark)
active , (punct)
= a(1 (dep)
patency respiration (conj)
lid ) (punct)
effect suspension (appos)
exposure appetite-suppressants (nmod)
remains significance (nsubj)
shown potentiate (xcomp)
timing and (cc)
mo first (amod)
paco2 the (det)
appear dynamics (dep)
8 least (advmod)
shown gamma-hexachlorocyclohexane (nsubjpass)
patients reaction (nmod)
500 to (dep)
thromboembolism event (conj)
changes immunostaining (nmod)
compounds of (case)
level vip (compound)
require therapy (dobj)
changes cells (nmod)
had x (dep)
toxicity significant (amod)
believe consider (ccomp)
states , (punct)
suggested rationale (nsubjpass)
day 22 (nummod)
effects gabapentin (nmod)
organelles mitochondria (appos)
period condition (nmod)
had examination (dobj)
factors genetic (amod)
induction seizures (nmod)
variations response (conj)
performed p.m. (advmod)
level fbal (appos)
plays rats (nmod)
strategies screening (compound)
brainstem in (case)
bleeding gastrointestinal (amod)
cause se (advcl)
developed hemoglobinuria (xcomp)
seen two (nmod)
groups fed (acl:relcl)
decreased hyperemia (dobj)
intravitreal but (cc)
recurrence nonfatal (amod)
induced evaluate (advcl)
hospital our (nmod:poss)
use end (nmod)
carries that (nsubj)
cocaine ligands (nmod)
treat patient (dobj)
administered combination (dobj)
normal were (cop)
reduced striatum (nmod)
method is (cop)
(1.5)% -5.6 (nummod)
blocked however (advmod)
anemia factors (nmod)
kidney other (amod)
potential maintain (acl)
electrocardiogram in (case)
show does (aux)
lymphocytes lesional (amod)
patients had (acl:relcl)
differences appreciable (amod)
agonist receptor (compound)
26 versus (cc)
pretreatment sections (nmod)
occur if (mark)
using was (aux)
data indicating (xcomp)
bleeding 7.6-fold (advmod)
mmol/d 150 (nummod)
course his (nmod:poss)
report studied (conj)
h injection (dep)
mk-801 with (case)
optic neuropathy (advmod)
return in (case)
controlled phenobarbital (nmod)
acid ibuprofen (compound)
revealed antrum (dobj)
mechanisms involve (acl:relcl)
erythrocytes patients (nmod)
reported precede (xcomp)
examination emg (conj)
contribute activation (nsubj)
documentation provokes (acl:relcl)
assessment prevention (nmod)
consequences different (amod)
assigned receive (xcomp)
spaces the (det)
values no (neg)
rats vitamin (compound)
13 155 (dep)
transmission by (case)
discs optic (amod)
persistence effect (nmod)
survivors doxorubicin-treated (amod)
l-arginine precursor (conj)
type oxide (nmod)
amnesia maze (nmod)
patients determination (nmod)
application widespread (amod)
often as (advmod)
methodology published (amod)
arrhythmias against (case)
suggests result (ccomp)
prescribing patients (nmod)
dose subanesthetic (amod)
cells packed (amod)
defect distal (amod)
modify , (punct)
derivative its (nmod:poss)
ambiguus nucleus (compound)
chronic repeated (conj)
plays any (dep)
observed typically (advmod)
hospital from (case)
condensed was (auxpass)
procedure bone (compound)
tamca mg/ml (appos)
observed patient (nmod)
started were (auxpass)
stones gall (amod)
represent therefore (advmod)
levels artery (nmod)
component as (case)
months 1 (compound)
showed substituted (ccomp)
morbidity associated (acl)
basis years (nmod)
deposits retinal (amod)
recalled prior (nmod)
case autopsy (amod)
months over (case)
preoperatively percentage (nsubj)
inserted and (cc)
setting impact (dobj)
symptoms collateral (amod)
evaluate tolerance (dobj)
purpose compare (dep)
assessed capacity (nsubjpass)
disturbance psychological (amod)
markers , (punct)
sediment patients (nmod)
version an (det)
conclusion establishes (appos)
undergone patients (nmod)
rats p100 (compound)
man came (acl:relcl)
ntg 5 (dep)
cystica true (amod)
populations among (case)
ward a (det)
day alternate (amod)
malformation . (punct)
mechanisms programming (compound)
withdrawn market (nmod)
analgesic activities (dep)
coniine of (case)
plasma of (case)
tablets nifedipine (compound)
exerts prazosin (nsubj)
induced overdose (nmod)
events respectively (advmod)
women for (case)
had seizures (nmod)
% no (neg)
dibucaine fluoride (conj)
reduction dose (nmod)
mg/dl and (cc)
applied surface (nmod)
exencephaly of (case)
phenomenon the (det)
controlling after (mark)
diuretics with (case)
four all (advmod)
fractures children (nmod:poss)
measure concentrations (dobj)
etoposide the (det)
marrow in (case)
series agents (nmod)
80 - (punct)
month . (punct)
neonates 10 (nummod)
scores patients (nmod:poss)
inflammation carrageenan-induced (amod)
found 7 (nmod)
tamoxifen on (case)
ssc ) (punct)
given as (prep)
1.2 ( (punct)
biopsy in (case)
initiated . (punct)
analyze relationships (dobj)
increase latency (nmod)
plays property (nsubj)
recorded electrocardiogram (nmod)
patients yrs (dep)
deposits capillary (amod)
benefit gastrointestinal (amod)
reduction hepatitis (nmod)
reduced daily (advmod)
had penicillamine (nmod)
began they (nsubj)
ml/min , (punct)
found not (neg)
hypnotic technique (nmod)
active tolerated (conj)
level each (det)
striatum amygdalae (conj)
androgens , (punct)
pbo + (cc)
glaucoma glaucoma (conj)
aldosterone plasma (compound)
review a (det)
10(-7 less (advmod)
decreased cbz (nsubj)
67.4 were (cop)
noted sedations (nmod)
have roles (dobj)
2.5 to (case)
ketamine to (case)
pretreatment l-noarg (nmod)
extend to (mark)
efficacy and (cc)
recovery erythron (nmod)
sensitivity catecholamine (compound)
effects micrograms (nmod)
diltiazem micrograms/kg/min (appos)
labeling membrane (nmod)
activity capacity (conj)
introduced were (auxpass)
pretreatment antagonist (nmod)
accident either (cc:preconj)
days rriw (compound)
scale investigator-observed (amod)
syndrome hypoxia (conj)
profile volume (conj)
orbitofrontal anterior (conj)
modulators increase (nmod)
benzodiazepines midazolam (appos)
mediated cisplatin (nmod)
fall the (det)
dogs sixty (nummod)
reversed treatment (nsubj)
measurements ultrasound (amod)
200 - (punct)
period block (nmod)
model second (amod)
effects pressure (compound)
80/115 % (dep)
increased ht (nsubj)
therapy radiation (compound)
34.98 6.2 (conj)
began signs (nsubj)
preclude does (aux)
unsafe . (punct)
anesthetics with (case)
1.0 2.5 (conj)
trial large (amod)
smokers cocaine (nmod)
rats nsaids (nmod)
condition in (case)
precise and (cc)
propagation initiated (acl:relcl)
maze elevated (amod)
plays compared (advcl)
dexamethasone sedionbel (appos)
neutrophils patients (nmod)
risk switches (nmod)
inducing drugs (dobj)
bornstein 1968 (nummod)
or : (punct)
petechiae and (cc)
30 dec. (conj)
satisfied if (mark)
beneficial . (punct)
is starts (dep)
deposits walls (nmod)
1.56 groups (nmod)
sympathectomy after (case)
useful used (conj)
expression cox-2 (compound)
antagonize apomorphine (dobj)
diacetate triamcinolone (det)
surface at (case)
stress hepatocellular (amod)
increase 2.3-fold (amod)
kanamycin-dextran by (case)
work-up during (case)
higher percentage (nsubj)
supplementation monohydrate (compound)
infusion in (case)
regulated where (advmod)
pregnancy her (nmod:poss)
12- , (punct)
benefit palliative (amod)
dismutase or (cc)
induction mt (compound)
injections intracerebral (amod)
raised excretion (dobj)
systems brainstem (nmod)
that chenodeoxycholate (nmod)
alpha se (conj)
quit either (nsubj)
7h6 zo-1 (conj)
lesions hyperintense (compound)
correlation parameters (nmod)
< p (compound)
randomized mice (nsubjpass)
side-effects adverse (conj)
deficiency a (det)
objective showed (dep)
forelimb or (cc)
5-fu before (case)
cardiac vascular (conj)
sensitive . (punct)
disease high (amod)
paralysis to (case)
induced administration (nsubj)
dose trials (nmod)
9 patients (nmod)
done administration (conj)
prepared that (mark)
patients preferred (acl:relcl)
reduce myalgia (dobj)
stenoses critical (amod)
methodology : (punct)
slowing the (det)
irrigations picloxydine (compound)
performed treatment (nmod)
administration selective (amod)
obstetric and (cc)
evidence previous (amod)
bp sitting (amod)
likely acidity (nmod)
movements with (case)
proteinuria patients (compound)
discontinuation following (case)
neurotoxic animals (nmod)
differences large (amod)
patients pain (nmod)
dose total (amod)
effects release (nmod)
emerged period (nmod)
rich , (punct)
% mg/kg/min (compound)
tests parameters (nmod)
advantages carboplatin (nmod:poss)
needed i.v. (nsubjpass)
paclitaxel administered (acl)
literature pertinent (amod)
drug abuse (nmod)
done administration (nmod)
epinephrine with (nmod)
factors following (amod)
risk disease (nmod)
related consumption (nmod)
management to (case)
diminish indomethacin (nsubj)
methamphetamine-induced lifetime (nmod:npmod)
thrombocytopenia or (cc)
d-amphetamine or (cc)
preventing hypotension (dobj)
use scale (nmod)
mg bupivacaine (nmod)
continue progression (nmod)
declined microgram/kg/min (nmod)
examination with (case)
described lot (nsubjpass)
associated smoking (nsubjpass)
clinical in (case)
ischemia during (case)
intubation by (case)
drug circulation (nmod)
resulted resolution (nmod)
impairment hearing (compound)
test were (cop)
background attain (dep)
series reports (conj)
associated angioedema (nsubj)
awareness reactions (nmod)
adenomas sporadic (amod)
erdosteine of (case)
treatments active (amod)
reticulocytes ( (punct)
appear alterations (nsubj)
receptors opioid (compound)
limbs the (det)
hours as (case)
decreased day (nmod)
abnormalities or (cc)
part is (cop)
induction rather (cc)
p45 ( (punct)
heart an (det)
hypothyroidism of (case)
excretion gsi (conj)
segment internal (amod)
cirazoline 1-agonist (amod)
specific are (cop)
increased lack (nsubj)
implicated recently (advmod)
emergence the (det)
peroxide plasma (compound)
results focused (dep)
angiogram troponin (compound)
rechallenge on (case)
ng/mg 38 (compound)
setting mi (nmod)
lowered clozapine (dep)
found mg/kg (nmod)
omeprazole hemoglobin (appos)
excess mb (nmod)
coordination disease (nmod)
k+ atp (compound)
syndrome ballooning (compound)
ability attenuate (acl)
developed gvhd (dobj)
suggest potentiation (nsubj)
medical psychiatric (conj)
became recently (advmod)
downregulated was (auxpass)
found be (auxpass)
underlying disease (dobj)
effect population (nmod)
dna b (compound)
heterogeneous is (cop)
overdose tricyclic (amod)
unchanged , (punct)
functions cardiovascular (amod)
resurgence plasticity (nmod)
effect clentiazem (nmod)
found frequent (conj)
present one (nmod)
transcription 3 (nummod)
compared fractions (nmod)
tdi dextran (nmod)
failure amphotericin (nmod)
catheter a (det)
effective treatment (nsubj)
slowed was (auxpass)
junction neuromuscular (amod)
methods aged (amod)
antidepressants repeated (amod)
believed associated (xcomp)
levels taken (acl)
effective tolerated (conj)
seems responsible (xcomp)
asynergy of (case)
hormone , (punct)
hyperplasia adenoma (conj)
bolus or (cc)
sensitive is (cop)
years total (nsubj)
promote suppression (nmod)
glabrata isolated (acl)
occurred there (expl)
inhibitor sis3 (appos)
received aid (nmod)
development attempt (conj)
side-effect potential (amod)
phenomena possible (amod)
calculated based (prep)
reduce death (dobj)
daytime night-time (conj)
transplantation treatment (nmod)
af induced (acl)
p100 the (det)
light and (cc)
types such (amod)
increase hypotension (dobj)
principle on (case)
antagonist a2a (compound)
ml/min 0.27 (nummod)
test 51 (dep)
patients hag (compound)
disorder self-limited (amod)
three % (appos)
indicator a (det)
cause while (mark)
developed dosing (nmod)
patient resuscitated (acl:relcl)
indicated studies (nsubjpass)
bradycardia modest (amod)
hemorrhage cocaine-associated (amod)
assigned group (dep)
employed nefiracetam (conj)
had band (dobj)
alternating of (mark)
impairment rats (nmod)
agent antitumoral (amod)
relative switchers (nmod)
treated received (parataxis)
examinations drinkers (nmod)
occurred respectively (advmod)
complex present (amod)
performed man (nmod)
route the (det)
relationship levels (nmod)
debate is (cop)
factors additional (amod)
conclusion c. (compound)
possible follow-up (nsubj)
inhibition identical (conj)
haemorrhage influence (conj)
administered anticholinesterases (nsubjpass)
survived period (nmod)
events pgp-enhancing (amod)
animals d-med (compound)
radiography by (case)
analyses hoc (compound)
recovers . (punct)
re-exposure on (case)
stressed scored (conj)
illness serious (amod)
area supplementary (amod)
disease force (appos)
eeg of (case)
dysmenorrhea primary (amod)
then and (cc)
amb either (cc:preconj)
mouth due (case)
incidence factors (conj)
before just (advmod)
measurements 20 (nummod)
percent forty-four (amod)
sources lists (conj)
resolved hours (nmod)
assessable patients (nsubj)
calcium salicylates (conj)
lead hemorrhage (nmod)
concentrations prl (compound)
based belief (nmod)
ratings on (case)
organochlorine lindane (nsubj)
limited is (cop)
known little (nsubjpass)
withdraw valproate (nmod)
disorders malignant (amod)
therapy standard (amod)
picture this (det)
intubated paralyzed (conj)
cld for (case)
dose comparable (acl:relcl)
bulb olfactory (amod)
dysfunctioning system (nmod)
examinations studies (conj)
readjustment sheath (nmod)
pressure at (dep)
extracted were (auxpass)
obtained degree (nsubjpass)
occur can (aux)
1.05 ) (punct)
rats se (compound)
activity bioelectrical (amod)
healthy relatively (advmod)
dose acid (nmod)
site benzodiazepine (compound)
favorable more (advmod)
mumol/l 4.0 (nummod)
19 +/- (cc)
levels its (nmod:poss)
retained compared (advcl)
78 to (dep)
resolved withdraw (nmod)
reduces whether (mark)
substantial , (punct)
myelosuppression against (case)
preventing linkages (dobj)
hypertension spasticity (conj)
control in (case)
minutes 80/115 (appos)
production aortic (amod)
exert not (neg)
considered not (neg)
pictures shown (acl)
state aversive (amod)
tolerated whereas (mark)
caffeine before (case)
precede glycopyrrolate (nsubj)
myeloperoxidase against (case)
impaired task (nmod)
cocs 4.2 (conj)
nos-ir l6 (dep)
mothers immunity (conj)
metoprolol intravenous (amod)
designed research (dobj)
s-transferase alpha-glutathione (amod)
consolidation and (cc)
years 75 (nummod)
% 69.8 (nummod)
deficits caused (acl)
l groups (compound)
myoclonus experienced (amod)
involve chiasm (dobj)
complication proteinuria (nsubj)
micrograms 1.8 (nummod)
matched also (advmod)
phenytoin presents (acl:relcl)
girl had (acl:relcl)
increasing somnolence (dobj)
adolescent a (det)
change infusion (nmod)
interaction involving (acl)
synovitis with (case)
ingestion water (compound)
related rejection (nmod)
rats consistent (acl:relcl)
humidity ml.s-1 (appos)
artery with (case)
feasibility and (cc)
implantation bilateral (amod)
% 21.80 (nummod)
confirmed was (auxpass)
levels tnfalpha (compound)
separating networks (dobj)
ammonia urea (conj)
4 3 (quantmod)
determined analyses (nmod)
evaluated point (nmod)
b.d micrograms (compound)
changes values (nmod)
inability the (det)
irritation the (det)
assessed behaviour (dobj)
normality of (case)
associated anaemia (nmod)
hypoxia tubulointerstitial (amod)
conclusions complication (dep)
model from (case)
progressed withdrawal (nmod)
caused mk-212 (nsubj)
transplant marrow (compound)
mechanism pain (nmod)
mutants lam-resistant (amod)
drug aed (appos)
tachycardia supraventricular (amod)
concentration creatinine (compound)
rate % (compound)
design intravitreal (appos)
blockade on (case)
excretion estradiol (nmod)
sample in (case)
limit that (nsubj)
argatroban cdt (conj)
ketamine such (case)
mssbp ( (punct)
had transplantation (nmod)
masseter muscles (dep)
therapy third-line (compound)
percent 29 (nummod)
contributions % (nmod)
times catalepsy (compound)
units neurocritical (amod)
compared 1969 (nmod)
evaluated however (advmod)
vector hypoxia-responsive (amod)
have spite (nmod)
episodes mania (nmod)
use concomitant (amod)
results lower (dep)
wards acute (amod)
patients both (cc:preconj)
confirm deaths (nsubj)
lipids in (case)
mechanisms dominant (amod)
reduced controls (advcl)
assumed action (xcomp)
sc 1 (nummod)
instance in (case)
cycle second (amod)
m4 for (case)
movements myoclonic (amod)
analog neurotensin (compound)
nuclei bilateral (amod)
affected where (advmod)
also was (cop)
clinics our (nmod:poss)
results had (appos)
developed cases (nsubj)
bornstein ) (punct)
n 1.34 (amod)
indicated latency (nmod)
antigens to (case)
enhanced transcription (dobj)
implicated received (conj)
effect rare (amod)
85 165 (conj)
finding hypertension (nsubj)
days=1.77 days (dep)
seems displaying (xcomp)
gestation born (acl)
typical . (punct)
interpreted effect (nmod)
thrombosis subsequent (amod)
pcr reaction (appos)
exercise-isoproterenol e-1 (appos)
toxic or (cc)
potentiation . (punct)
edema ; (punct)
data group (nmod)
prolonged micromol/l (dep)
different life-threatening (dep)
chf reversible (amod)
commencement after (case)
102 all (advmod)
pain capsaicin-induced (amod)
model using (acl)
0 with (case)
shown study (advcl)
antibodies ancas (appos)
evinced results (nsubj)
acid 26 (appos)
terminate epilepticus (dobj)
latency clonic (nmod)
lesion 6-hydroxydopamine (compound)
data echocardiographic (amod)
degeneration progressive (amod)
evoked thus (advmod)
benefits avoidance (nmod)
impairments to (case)
suggesting treatment (xcomp)
period hospital (nmod)
excluded be (auxpass)
disease use (appos)
investigating improvement (nmod)
experiencing deficits (dobj)
decrease failure (nmod)
replaced cimetidine (nsubjpass)
attenuated indicated (advcl)
immunoglobulin of (case)
scores higher (amod)
risk hyperammonemic (nmod)
conclude falls (conj)
pharmaceuticals ) (punct)
test haloperidol-induced (amod)
associated degrees (nmod)
beta-position in (case)
decreased that (nsubj)
regulate inhibition (nsubj)
seems moreover (advmod)
ultrastructural permeability (conj)
efficacious account (advcl)
patients 675 (nummod)
change control (nmod)
resulted fatalities (nsubj)
doses amphetamine (nmod)
recurs activity (nsubj)
counterparts home (compound)
explained difference (nsubjpass)
antidotes administered (amod)
disappeared seizures (nsubj)
occlusion min (nmod)
complete month (nmod:npmod)
beating the (det)
k for (case)
asa i.p. (advmod)
used drug (dobj)
studies bradycardia (nmod)
complicated component (nsubj)
group hypotensive (amod)
dizziness progressing (xcomp)
showed values (nsubj)
reintroduction quetiapine (nmod)
treated methyldopa (nmod)
reporting total (dobj)
svc and (cc)
volume second (nmod)
injury explore (conj)
channels l-type (compound)
search central (compound)
secondary hyperactivity (nmod)
involved neuroplasticity (nmod)
excess chronic (amod)
cancer metastatic (amod)
s-i and (cc)
54-week a (det)
relationship variations (nmod)
antidopaminergic serotonergic (conj)
cause yet (advmod)
substances acid (compound)
converting patients (dobj)
at or (cc)
action succinylcholine (nmod)
inhibitory and (cc)
show observations (nsubj)
activity sexual (amod)
or=7.18 ) (punct)
myeloperoxidase- neither (cc:preconj)
changes cardiovascular (amod)
caused ouabain (nmod)
reversible tobramycin (nmod)
disease medically (advmod)
cortex or (cc)
responses sustained (amod)
diseased both (cc:preconj)
discontinuation or (cc)
generated strains (nsubjpass)
evaluated min (nmod)
lys1 pro2,5 (conj)
nephrotoxicity during (case)
insult acute (amod)
progresses invasion (nsubj)
patients 137 (nummod)
ameliorates impairment (dobj)
outcomes the (det)
cholecystokinin-octapeptide , (punct)
dismissed were (auxpass)
selected case (nmod)
signalling receptor (compound)
coagulopathy the (det)
bp (sbp)/ (punct)
mg and (cc)
advantage a (det)
pressure intravesical (amod)
impair function (dobj)
tachycardia patients (nmod)
successful block (nsubj)
compared retrospectively (advmod)
live now (advmod)
pronounced rise (nmod)
benefited . (punct)
status depressive (amod)
inhibits or (cc)
make contribution (dobj)
nephrotoxicity tobramycin (nmod)
effects thunbergiana (nmod)
prevention their (nmod:poss)
afferents nociceptive (amod)
improving impairment (dobj)
gtn ) (punct)
extract roots (compound)
dhea 100 (nummod)
evaluation accurate (amod)
showed preventing (advcl)
prophylaxis development (nmod)
x/minute and (cc)
experiments vitro (advmod)
represent myopathy (nsubj)
conducted practice (nmod)
suggested because (mark)
ginsenosides mice (nmod)
eating after (mark)
antidepressants tricyclic (amod)
infection proven (amod)
sbs ) (punct)
radioablation with (case)
presented sensation (nmod)
level glands (conj)
systems spontaneous (amod)
left hypoplastic (nsubj)
significant correction (nmod)
negative sulfamethoxazole (nmod)
divided , (punct)
e1 with (dep)
usage steroids (nmod)
have disturbance (dobj)
interval confidence (compound)
given tacrolimus (nsubjpass)
effects beneficial (amod)
pretreatment mg/kg (dep)
factor scale (compound)
sharps and (cc)
hypokalemia less (amod)
myocardiopathy adriamycin-induced (amod)
defects persistent (amod)
disappearance episodes (nmod)
reported infants (nmod)
correlation spearman (compound)
carbidopa-levodopa point (nmod)
introduction gradual (amod)
variants the (det)
10mg/kg ( (punct)
examinable were (cop)
interval administration (nmod)
pdtc mg/kg (compound)
10(-4 ) (punct)
anemia transfusion-dependent (amod)
gentamicin doses (nmod)
underlying similarities (dobj)
% 1.0 (nummod)
believe warrants (ccomp)
males elevations (nmod)
298+/-7 vs. (cc)
presence intensities (nmod)
conclusions problem (dep)
factor chemotherapy (nmod)
saline rats (conj)
triniol ( (punct)
system a (det)
assessment audiograms (nmod)
performed months (conj)
individuals but (cc)
p control (conj)
revealed fraction (dobj)
response cocaine (nmod)
function confirmed (amod)
ballistic type (nmod)
uptake of (case)
solution of (case)
receiving using (conj)
deficient synthase-1 (nmod)
region major (amod)
sensitization humans (nmod)
seizure absence (compound)
separated were (auxpass)
drug preparation (conj)
estimated comparing (advcl)
induced variety (nsubjpass)
tracts and (cc)
identify cases (dobj)
agent novel (amod)
antagonized spite (nmod)
reporting syndrome (dobj)
baseline ) (punct)
vp ( (punct)
narcosis in (case)
localized areas (nmod)
ed50 protection (nmod)
cause ranging (advcl)
causes events (nmod)
% oxide (dep)
toxicity known (amod)
ck-mb ng/ml (dep)
factor , (punct)
evaluations weekly (amod)
procedures brief (amod)
rabbits non-anaesthesized (amod)
prevalent . (punct)
doses to (case)
dysgenesis infant (nmod)
sertraline placebo (conj)
25 ( (punct)
residues the (det)
necrosis patients (nmod)
inhibition acid (compound)
suggesting cause (ccomp)
rate rates (conj)
injury cacl(2))-induced (amod)
cause whether (mark)
values period (nmod)
frequency findings (nmod)
mp with (case)
patients take (acl:relcl)
caused hypertrophy (conj)
tab venlafaxine (nmod)
mechanism paralysis (nmod)
patients eucalcemic (amod)
mu/kg 125 (nummod)
leukopenia ) (punct)
pressure rates (conj)
attenuate but (cc)
longer year (nmod)
changes consistent (amod)
opener ) (punct)
hypotension psychosis (conj)
iocarmate ( (punct)
mg placebo (conj)
suppressed were (auxpass)
flumazenil mg/kg (compound)
complete hemogram (conj)
reduces damage (dobj)
white 291 (conj)
months 38 (nummod)
substantiate potential (dobj)
prevented blockers (nsubj)
blood effect (nsubj)
micrograms 100 (nummod)
range months (appos)
manoeuvres rebreathing (compound)
akbr , (punct)
caused although (mark)
carcinostatics of (case)
half-time hh (conj)
line a (det)
intact gonadally (advmod)
anuria a (det)
fever c (appos)
neuroradiologists by (case)
potencies different (amod)
quinine- 4-aminopyridine-sensitive (conj)
phase randomized (amod)
prior euthanasia (nmod)
signal feedback (compound)
nsclc those (conj)
exposed prenatally (advmod)
pronounced bepridil (nmod)
propofol kg(-1 (appos)
% baseline (nmod)
catalepsy stereotypies (conj)
decline a (det)
long as (advmod)
indicating control (ccomp)
hampered are (auxpass)
evident most (advmod)
drug beta (compound)
increased incoordination (dobj)
k- being (cop)
incidence tachyarrhythmias (nmod)
7-ni ip (dep)
after days (nmod:npmod)
control dopaminergic (amod)
index pittsburgh (compound)
due was (cop)
induced estradiol (nsubj)
4.5- 6.7-times (dep)
respond meth (nmod)
weighed be (auxpass)
wistar wild-type (amod)
analogues buspirone (nmod)
activity nnos (compound)
evaluate preliminarily (advmod)
contributed precipitating (advcl)
combined caffeine (nmod)
actin alpha-smooth (amod)
acid high-dose (amod)
responses morphine (nmod)
improved rate (dep)
services preventive (compound)
one consequence (nmod)
% another (det)
had profiles (dobj)
likely ; (punct)
fasciculations caused (acl)
effects motor (compound)
morphine iv (nummod)
injections seven (nummod)
occurred interest (nsubj)
ratio 1:1 (compound)
remedy useful (amod)
mda ) (punct)
open request (nmod)
lower injection (nmod)
neuralgia severe (amod)
temsirolimus with (case)
reversible effect (nsubj)
frequency reduction (compound)
years 65 (nummod)
option patients (nmod)
level mean (compound)
ht 1637 (conj)
review and (cc)
microgram/kg/min 40 (nummod)
pneumonitis effusions (appos)
n-acetyl-beta-d-glucosaminidase urine (compound)
awake completely (advmod)
factor proteinuria (nsubj)
decrease levels (dobj)
sestamibi assess (conj)
presented hiccups (nmod)
4/26 , (punct)
days min (conj)
used patient (nmod)
suggested study (nmod)
cr ) (punct)
vgb ) (punct)
increased = (dep)
present scarring (nsubj)
mustard . (punct)
influenced significantly (advmod)
sequelae cardiovascular (amod)
relation the (det)
was ng.ml-1 (dep)
use into (case)
disrupts that (mark)
developed dilation (dobj)
ductus patent (compound)
67.4 . (punct)
disruption stimulation (nmod)
ibuprofen interaction (nmod)
12.5 , (punct)
score < (dep)
develops % (conj)
have hyperglycinemia (dobj)
number level (conj)
received infants (nsubj)
expression podocalyxin (nmod)
effect minimal (amod)
measured h (dobj)
mean days (nmod)
receptor nmda (compound)
pregnancy early (amod)
thirds after (case)
begin to (aux)
coagulation with (case)
ginsenoside , (punct)
levels identical (amod)
values group (nmod)
l-dopa of (case)
induced it (nsubj)
exhibited growth (dobj)
tolerance impaired (amod)
prevented could (aux)
beta 1/2 (nummod)
current outward (amod)
literature complications (nmod)
acid low (amod)
cluster gene (compound)
pathophysiology whose (nmod:poss)
naphazoline by (case)
acetylcholinesterase brain (compound)
less .002 (nmod)
extravasation protein (nmod)
donor first-time (amod)
pregnancies serial (amod)
system extrapyramidal (compound)
exhibited animals (nsubj)
response nicotine-induced (amod)
precluded condition (nsubj)
seems fortunately (advmod)
vector using (acl)
given contrast (nmod)
agent broad-spectrum (compound)
chemotherapy recent (amod)
administered animals (nsubjpass)
decreased hippocampus (nmod)
improved discontinuation (nmod)
seem cells (nsubj)
pneumonia one (nmod)
protected metformin (nsubj)
randomised trials (dobj)
pilo , (punct)
frequencies low (amod)
tolerated combination (nsubjpass)
occupancy in (case)
dose ly274614 (nmod)
control bleeding (nmod)
seems whereas (mark)
course damage (nmod)
propagation and (cc)
metabolism cholesterol (compound)
% discontinuation (conj)
mediated to (mark)
study/short experimental (amod)
brought whereas (dep)
enhanced prolonged (conj)
lt pediatric (amod)
bypass coronary (amod)
day dose (nmod)
provision acid (nmod)
observed was (auxpass)
creativity of (case)
17 18 (conj)
perform hearing (advcl)
hypothesized lead (ccomp)
shown radiograph (nmod)
nephropathy advanced (amod)
divided cannulated (conj)
mistake by (case)
in conscious (amod)
data efficacy (nmod)
terms percentage (nmod)
foodstuffs , (punct)
case documented (amod)
microsomal the (dep)
reacting a (det)
neurotoxicity lignocaine (nmod)
progesterone beta-epimers (conj)
activities complex (nmod)
essential modifications (nmod)
perimenopausal women (dep)
h every (det)
receiving longer (advmod)
was hypotension (nmod)
syringe containing (acl)
acid n10-propargyl-5,8-dideazafolic (amod)
carcinoma recurrent (amod)
survey nuclear (amod)
glial neuronal (conj)
months subsequent (amod)
decreased conversely (advmod)
neuropathy % (dep)
exhibited rats (nsubj)
corresponded changes (nsubj)
autoantibodies react (acl:relcl)
confirmed examination (nmod)
identified correlates (nsubjpass)
use relaxants (nmod)
caused illness (dobj)
thought lowered (ccomp)
tested men (nmod)
increased hg (nmod)
punctate by (case)
inhibitor methylation (nmod)
preferable lidocaine (nmod)
alphabeta-crystalin and (cc)
cpa/ee women (nmod)
comparison gliclazide (acl)
curves erythrocytes (nmod)
motility mouse (compound)
resurgence in (case)
reported developed (ccomp)
iu/l 62,246 (nummod)
ser198 his438 (conj)
dementia to (case)
pressure supine (compound)
substantial rats (nmod)
placebo patients (appos)
cisplatinum adriamycin (conj)
protect animals (dobj)
given rat (nmod)
received doses (nmod)
prevented both (dep)
distal branches (nmod)
perfusion normal (amod)
transcripts gene (nmod)
plasma ) (punct)
piperidin-1-yl 4- (nummod)
thickness index (appos)
efficacious superior (conj)
concentrations ionic (amod)
existence stimulation (nmod)
reduces aspirin (nsubj)
12/30 in (case)
led levels (nmod)
cancer pelvis (nmod)
broadens type (nsubj)
placed her (dobj)
mechanism responsible (amod)
outcome eventual (amod)
invasion in (case)
pilo chx+pilo (conj)
treatment score (conj)
hepatitis cholestatic (amod)
dat(-/- ) (punct)
benign its (nmod:poss)
treatment l-dopa (amod)
hbv resistant (amod)
stress summed (amod)
higher magnitude (nsubj)
properties 2-adrenoceptor (compound)
cancer granulomatosis (nmod)
normal phenotypically (advmod)
change weight (compound)
cips ( (punct)
sensations atypical (amod)
volunteers twelve (nummod)
seroconversion anti-hbs (appos)
regimen repeated (acl)
molecules the (det)
present any (nmod)
vasoconstriction phenylephrine-induced (amod)
suspect infection (nmod)
pacing with (case)
injection intracisternal (amod)
declined rapidly (advmod)
necrosis capillary (amod)
metabolites progesterone (nmod)
formation gallstone (compound)
plugs to (case)
coincided proteinuria (nmod)
( period (dep)
cases several (amod)
revealed comparing (csubj)
19.2 +/- (cc)
stimulation mglurs (nmod)
crisis late-onset (amod)
disfiguring and (cc)
level paracetamol (compound)
report arrhythmia (nmod)
heart animals (nmod)
labor preterm (compound)
facilitation the (det)
spasm dissection (conj)
magnitude association (nmod)
suppress arrhythmias (dobj)
matched factors (nmod)
remains value (nmod)
increased added (advcl)
sought and (cc)
reported higher (ccomp)
inhibit hyperemia (dobj)
evaluated been (auxpass)
gds 9 (dep)
doses control (nmod)
started feet (nmod)
interim the (det)
showed delayed (xcomp)
papaverine topical (amod)
expression tubule (nmod)
immunoassay multiplied (amod)
they all (appos)
tdi to (case)
therapy gestations (conj)
degree insult (nmod)
observed l-1 (xcomp)
lungs the (det)
impaired altered (conj)
neurosis anxiety (compound)
syndromes chest (amod)
tamponade cardiac (amod)
studies sar (compound)
undergo who (nsubj)
fluoxetine by (case)
= 66 (dep)
occlusion middle (amod)
scopolamine and (cc)
depressed expression (dobj)
aneurysm model (nmod)
% 0.25 (nummod)
patients therapy (nmod)
hyalinosis as (case)
logical , (punct)
maximal hour (nmod)
remained impaired (xcomp)
induce attention (nmod)
slowing progression (dobj)
camperdown australia (appos)
prevents damage (dobj)
capacity . (punct)
cholesterol were (cop)
deteriorate months (nmod)
modify effective (conj)
evidence rct (nmod)
appears therefore (advmod)
5.7 ( (punct)
imaging mri (appos)
mg/kg day (appos)
subject for (case)
disparity such (amod)
values coefficient (compound)
affects annually (advmod)
scale probability (compound)
anuria of (case)
150 1 (compound)
contractions carbachol (nmod)
obtained sacrifice (nmod)
developed addition (nmod)
shunt increased (advcl)
years recent (amod)
elastolysis extensive (amod)
deposition collagen (compound)
testing preangiographic (amod)
prevented did (advcl)
significantly and (cc)
mg/kg week (nmod:tmod)
components oil (compound)
involvement gaba (compound)
tachycardia is (cop)
given etomidate (advcl)
hepatotoxicity : (punct)
describes infarction (dobj)
igf-i recombinant (amod)
acknowledged hit (nsubjpass)
g/dl 12 (dep)
years 16 (nummod)
suppressed level (nsubjpass)
observed blockade (nsubjpass)
fluoxetine either (cc:preconj)
vfd ) (punct)
studied phenomenon (nsubjpass)
hitt to (case)
suggest changes (dobj)
ibuprofen especially (advmod)
undertaken intervals (nmod)
drainage substantial (amod)
washout with (case)
52 approximately (advmod)
structure a (det)
caused fluoxetine (nsubj)
linezolid of (case)
biochemical and (cc)
injection diazepam (nmod)
interval 1.7 (appos)
slowing challenge (nmod)
has whom (nsubj)
attenuated changes (nsubjpass)
measured chickens (nmod)
cases confusion (nmod)
doctors of (case)
study case-control (amod)
generation cardiac (amod)
subgroup surgery (compound)
l-med , (punct)
given reproduces (conj)
hypoxia profound (amod)
abusers in (case)
inhibited allopregnanolone (nsubj)
27 to (quantmod)
analogs , (punct)
step process (nmod)
myocardium into (case)
levetiracetam (lev)-induced (acl)
causes hypertension (dep)
follow-up large (amod)
withholding after (mark)
received nitroglycerin (dobj)
protein neuron-specific (amod)
prescribed be (auxpass)
resulted discontinuance (nsubj)
decreased activity (dobj)
average after (case)
induce compounds (nsubj)
opening the (det)
failed often (advmod)
microsomes liver (compound)
carried be (auxpass)
were any (nmod)
analyser dioxide (compound)
dopamine-1 da1 (appos)
trials ht (nmod)
effective infusion (nmod)
clearance para-aminohippurate (compound)
untreated previously (advmod)
comprised vnb (nmod)
mucosal , (punct)
diagnosis routine (amod)
rendered hypoxic (conj)
wards hospital (compound)
months interval (appos)
albuminuria pressure (conj)
intake supplements (nmod)
sites metastatic (amod)
protein sodium (conj)
adrenergic combined (amod)
endothelial and (cc)
frequency likely (amod)
breathing with (case)
tremor halos (conj)
eps to (case)
letrozole ( (punct)
higher somewhat (advmod)
showing improves (ccomp)
synergism the (det)
exerted (+/-)-pg-9 (nsubj)
0.5%/12h with (case)
% disoprivan (compound)
-18 ) (punct)
given daily (advmod)
revealed was (auxpass)
children by (case)
da : (punct)
valproate-induced encephalopathy (advmod)
considering before (mark)
dose appropriate (amod)
frequency intensity (conj)
combining , (punct)
plays patients (nmod)
aware cause (ccomp)
cause thus (advmod)
grade grade (dep)
analogue a (det)
cells arterial (amod)
identified programs (nmod)
described best (nmod)
began taking (xcomp)
count platelet (compound)
severe hence (advmod)
minimize can (aux)
stopping alpha-2b (dobj)
levetiracetam . (punct)
disturbances cardiac (amod)
laboratory the (det)
variables rate (nmod)
= lca (dobj)
% 10.1 (nummod)
rfca ( (punct)
levels basal (amod)
mass average (amod)
complicated , (punct)
generation potential (amod)
difference average (amod)
impairment long-term (amod)
consisted monitoring (nsubj)
control hypersecretion (dobj)
vcug period (conj)
anticoagulant heparin (nsubj)
bands different (amod)
have conclusion (nmod)
appears arrest (nsubj)
type cm (nmod)
esrd received (acl:relcl)
technique liver (nmod)
hypotension doses (nmod)
metabolites apoptosis (nmod)
therefore consumption (nmod)
deserve to (mark)
changes produced (acl)
similar % (dep)
related confounding (nmod)
tablets analgesic (nmod)
decreased also (advmod)
examination postoperative (amod)
portion heart (nmod)
increasing of (mark)
factor apoptosis-inducing (amod)
course symptomatology (conj)
carcinoma squamous (amod)
weight volume/g (compound)
disfiguring be (cop)
after or (cc)
recorded % (nmod)
one may (aux)
detection airflow (compound)
emesis severe (amod)
reactivation and (cc)
bupivacaine and (cc)
compatible results (nsubj)
suggestive were (cop)
conclude proven (ccomp)
injecting drugs (dobj)
thromboembolism thrombocytopenia (conj)
indicate dependent (ccomp)
conclusions related (appos)
rat adult (amod)
samples obtained (acl)
found a-i (nsubjpass)
closure capillary (amod)
sulfate , (punct)
hormone antidiuretic (amod)
seen surgery (nmod)
combinations to (case)
papilledema cerebri (conj)
response humans (nmod)
platonia species (compound)
step each (det)
pco2 mean (conj)
= 3.219 (dobj)
details the (det)
doses micrograms/kg (nmod)
compares and (cc)
herbicides defects (dep)
reduction weight (nmod)
doses subsequent (amod)
compared measures (nmod)
ifo ) (punct)
candidates of (case)
years 17 (nummod)
dismutase such (case)
treat symptoms (dobj)
model but (cc)
mitogens chemical (compound)
patients mellitus (nmod)
d-amphetamine (+)-7-hydroxy-dipropyloaminotetralin (conj)
treated anthracycline (nmod)
asphyxia retardation (conj)
lines focus (nmod)
users 1 (dep)
substitutes aprotinin (nmod)
selective full (conj)
sediment active (amod)
resulting decreases (dobj)
reduction dose (compound)
years men (conj)
program a (det)
dose lethal (amod)
unsafe and (cc)
-18.48 % (conj)
resolve seizures (nsubj)
3,7-dimethyl-1-propargylxanthine ( (punct)
substitute patients (nmod)
n. 23 (nummod)
presented mostly (advmod)
g 1,500 (nummod)
p risperidone (appos)
dce 200 (appos)
slowing activity (nmod)
cause dosages (nsubj)
injection doses (nmod)
materials administered (dep)
dose calcium (dep)
mediating hyperactivity (dobj)
treated tablet (nmod)
evoked during (prep)
765 +/- (cc)
levels base-line (compound)
hypothesized protect (ccomp)
animals than (case)
effects uninephrectomy (nmod)
inhibits retention (dobj)
release vitro (advmod)
mmol ; (punct)
doses nonconvulsive (amod)
lumen the (det)
comparing paclitaxel (dobj)
patients presenting (acl)
discussion increased (appos)
scans perfusion (compound)
aspects isolated (amod)
failure subclinical (amod)
outcomes patient (compound)
didanosine ddi (appos)
assay two-step (amod)
d2 ( (punct)
study case (compound)
review data (dobj)
tubular papillary (conj)
beck and (cc)
given treatment (dobj)
rate positive (nmod)
admission abilities (conj)
intervals hv (compound)
receiving reduced (conj)
sensitive response (nmod)
studies induction (compound)
found cardiomyopathy (nmod)
pge1 , (punct)
starts when (advmod)
dbp sbp (conj)
result treatment (dobj)
67.66 131.08 (conj)
82+/-12 to (case)
discontinue they (nsubj)
developed increase (nsubj)
amount enzyme (nmod)
involved but (cc)
suggested exceed (ccomp)
assessed have (aux)
catalyze formation (dobj)
showed still (advmod)
magnitude effect (nmod)
co2 of (case)
following occasions (nmod)
mrna intrarenal (amod)
prove therefore (advmod)
training latencies (conj)
hepatic consequent (amod)
chloramphenicol ophthalmic (amod)
presented clinic (nmod)
increases factors (nmod)
compared population (nmod)
months per (case)
constitutes challenge (dobj)
< incidence (nsubj)
malondialdehyde serum (compound)
nitrite combination (nmod)
treatment endophthalmitis (nmod)
outcome clinical (amod)
introduced was (auxpass)
cause is (cop)
disease structural (amod)
matrix of (case)
bp mssbp (appos)
patients 143 (nummod)
kurroa of (case)
pressure group (nmod)
alternating access (conj)
carried challenges (dobj)
number on (case)
abuse lsd (compound)
pge2 pgf2alpha (conj)
concentrations higher (amod)
predominance extremities (nmod)
caused withdrawal (dobj)
min normotension (nmod)
cellulose and (cc)
precipitated was (auxpass)
were follow-up (nmod)
effects exhibited (acl)
fractures except (case)
reflecting behaviors (dobj)
months ten (nummod)
cause transplantation (nmod)
gonadotropin chorionic (amod)
angiography cerebral (amod)
fasciculation myalgia (conj)
lungs of (case)
verapamil nh4ac (conj)
chemotherapy thiotepa (compound)
reports case (compound)
weights molecular (amod)
seizure threshold (dobj)
common anatomically (advmod)
thresholds with (case)
suggesting rich (ccomp)
molecule intact (amod)
instances some (det)
drink containing (acl)
result combination (nmod)
% 160 (nummod)
resolved days (nmod)
that three (nummod)
treatment mice (nmod)
cystitis approach (dep)
curtailed was (auxpass)
alf cld (conj)
frequent malignancies (nsubj)
taken was (auxpass)
task speed (compound)
suggest play (ccomp)
pains . (punct)
symptoms patient (conj)
support view (dobj)
offer alternative (dobj)
airway flexible (amod)
investigated convulsions (nmod)
was hr (nmod)
open inhibition (nsubj)
paclitaxel phases (conj)
users 29 (nummod)
administered minutes (nmod)
( nf (dep)
drugs t0 (appos)
increased continued (conj)
lithium disrupting (acl)
groups bupivacaine (compound)
sample biopsy (compound)
only not (neg)
conclusion bear (appos)
insertion the (det)
protein transforming (conj)
production cell (compound)
tested hooded (conj)
series volume (conj)
factor predisposing (acl)
evidence exhibit (acl)
rilmenidine microg/kg (appos)
targeting lysosomes (dobj)
str ( (punct)
short hr (dep)
microalbuminuria of (case)
followed solvent (nmod)
seems duration (nmod)
indicated absence (nsubj)
reduce appears (dep)
hours six (nummod)
extract ih636 (compound)
infections fatal (amod)
given doxorubicin (dobj)
man syndrome (nmod)
site mitochondria (nsubj)
tolerated however (advmod)
effective acid (nsubj)
site tumor (compound)
animals those (det)
pressure maximum (compound)
remained weeks (nmod)
changes modest (amod)
patients other (amod)
experiences one (nummod)
case hiccups (nmod)
comparing drugs (nmod)
min g/min (dep)
use potency (nmod)
anatomy biliary (amod)
increase changes (nmod)
months preceding (amod)
microg/ml 8.3 (nummod)
schedule toxicity (nmod)
effect peak (compound)
recommended could (aux)
chi2-test and (cc)
tubules of (case)
10 cases (nmod)
oropharynx ; (punct)
lesions invasive (amod)
characterized release (nmod)
predominance structures (nmod)
period on (case)
apex with (case)
records anesthesia (compound)
be may (aux)
rp , (punct)
studied rats (dep)
thrombosis hepatic (amod)
increase pronounced (amod)
overdose amisulpride (amod)
hydrochloride quinacrine (compound)
14c-41 099 (nummod)
bodies drg (compound)
reliable non-invasive (conj)
hallucinosis and (cc)
hyperkinesias choreatiform (compound)
ctni between (case)
remained 243 (nsubj)
polyvidone acetrizoate (appos)
mumol/l 142 (nummod)
month months (conj)
county the (det)
cacl2 4-aminopyridine (conj)
displayed space (dobj)
vasospasm formation (conj)
diet % (appos)
had profile (dobj)
persistence with (case)
frequent more (advmod)
reported 11 (nmod)
damage cerebral (amod)
change plasma (compound)
thalamus the (det)
24 and (cc)
genes podocyte (compound)
deemed . (punct)
register cancer (compound)
fraction ef (appos)
vasculitis attributable (amod)
increased days (nmod)
fever eyes (conj)
university the (det)
seemed bradykinin (nsubj)
initiated given (advcl)
aim we (nsubj)
abuse diuretic (amod)
based obtained (conj)
part trial (nmod)
effects on (case)
normal . (punct)
headache % (appos)
had reached (conj)
pacing , (punct)
day paroxetine (nmod)
factor disorders (nmod)
developed discontinued (conj)
vt ( (punct)
disability ) (punct)
seems open (advcl)
day surgery (nmod)
titrated mg/day (nmod)
appears but (cc)
effects concentrations (nmod)
phosphatase enzymes (compound)
history examination (conj)
add may (aux)
factor iatrogenic (amod)
evaluated inventory (conj)
patients tenofovir (nmod)
178 156 (conj)
patients nephropathy (nmod)
developed episodes (dobj)
patients 39 (nummod)
impact neurological (nmod)
layer hippocampal (compound)
reported compared (advcl)
tolerable and (cc)
help can (aux)
unreasonable therefore (advmod)
acid glucaric (amod)
statins inhibitors (conj)
mitochondria damage (conj)
delivered was (auxpass)
offspring induced (acl)
using examined (parataxis)
syndrome stevens-johnson (amod)
canal the (det)
had it (nsubj)
hypotension hypotension (nmod)
2 up (advmod)
demonstrated except (prep)
establishing further (advmod)
leukaemia lymphoblastic (amod)
hours 6 (nummod)
description good (amod)
activity dose (nmod)
complained foot (nmod)
antagonized bradycardia (nsubjpass)
eluate an (det)
bbb tr(- (nmod)
scl , (punct)
produced short (conj)
activity basal (amod)
keratectomy myopic (amod)
measurements khz (appos)
had indicating (advcl)
discontinued venlafaxine (nsubjpass)
bp diastolic (amod)
elevation concentrations (nmod)
reduction cancer (nmod)
ip antidepressant (amod)
comparative double-blind (dep)
presentation on (case)
carotid before (mark)
potassium some (det)
mechanisms migraine (nmod)
dependency incidence (conj)
% age (nmod)
rats dosage (compound)
receiving were (aux)
based challenge (nmod)
non-drug alcohol/nicotine (conj)
visit . (punct)
manifestations life-threatening (acl:relcl)
1.041 +/- (cc)
duration ap (compound)
recommendation major (amod)
confirmed genetically (advmod)
aminophylline bay (conj)
aggravation demonstrated (amod)
component whom (nmod)
included had (aux)
indicate that (mark)
protection tocopherols (nmod)
reverse that (nsubj)
sc mg/kg (compound)
rhigf-i igf-i (dep)
conducting of (mark)
ngf ) (punct)
comparison direct (amod)
hyperammonemia of (case)
associated depletions (nmod)
nrvms of (case)
activated [ (punct)
prognosis good (amod)
loosening breaking (conj)
sought here (advmod)
documented hand (nmod)
back-diffusion permeability (conj)
dilates nitroglycerin (nsubj)
activation nmda (compound)
psychologist a (det)
incontinence stress (compound)
model model (conj)
higher 2-fold (advmod)
pulse plasmapheresis (conj)
treatment cisplatin (compound)
group study (compound)
h surgery (nmod)
included drugs (nmod)
reported handful (nsubjpass)
show symptoms (dobj)
sister a (det)
carried routes (conj)
behaviour based (case)
patients abusing (acl)
4-aminopyridine saline (conj)
common and (cc)
lessened . (punct)
taking metronidazole (dobj)
starting infusion (dobj)
delivery weight (conj)
% 33.67 (nummod)
recipients marrow (compound)
concentration mean (compound)
inhibited cells (nmod)
randomized dogs (nsubjpass)
disappear patient (nmod)
experimental control (conj)
met has (aux)
study outpatient (amod)
hr < (dep)
convulsions audiogenic (amod)
variables of (case)
reported described (advcl)
have properties (dobj)
implications unclear (dep)
dipyrone except (case)
appeared articles (nsubj)
dosages ( (punct)
had incidence (nmod)
recipients neonates (conj)
related considered (conj)
reduction with (case)
aspirin ingestion (conj)
nicotine or (cc)
nine % (appos)
gr gsh (nmod)
gavaged ; (punct)
50 almost (advmod)
measurements anthropometric (amod)
motoneurons spinal (amod)
jones 1973 (nummod)
become observed (advcl)
donor an (det)
relies chemotherapy (nmod)
technique intravenous (amod)
indicates scale (nsubj)
suggested determined (conj)
interval 4.1 (dep)
monitored study (nmod)
inhibition channel (compound)
homogenates as (cc)
begun , (punct)
manifests , (punct)
nausea pain (conj)
performed measured (conj)
disease led (acl:relcl)
% cl (dep)
seizures two (nummod)
effect rr (dep)
pregs and (cc)
arthritis gouty (compound)
understood although (mark)
days p=.01 (dep)
psychosis to (case)
circulation cranial (amod)
suspected indicating (xcomp)
distress emotional (amod)
following it (nsubj)
hyperkalemia by (case)
case anaphylaxis (nmod)
tachycardia toxicity (nmod)
activity . (punct)
period study (compound)
alterations secondary (amod)
materials records (dep)
added treatment (nmod)
suggest associated (ccomp)
blockers different (amod)
glomerulonephritis immune (amod)
interaction flecainide (nmod)
renal and/or (cc)
mg/dl serum (conj)
cells 2.9 (conj)
included collection (nsubjpass)
selective , (punct)
lidocaine- and (cc)
synovitis uncontrolled (amod)
inhibits activity (dobj)
l/m2 , (punct)
effective improving (advcl)
categories use (nmod)
measure psychopathology (dobj)
proliferation , (punct)
identify site (dobj)
conclusions potentiates (appos)
agent a (det)
(+)-cibenzoline ten (compound)
rats vehicle- (amod)
changes efferent (nmod)
hypothesis with (case)
isoform isomerase (compound)
knockout vasoactive (amod)
understand consequences (dobj)
likely men (xcomp)
clinic terfenadine (dep)
mk-486 with (case)
feel . (punct)
noted not (neg)
sem , (punct)
exhibited pp (dep)
months cab (nmod)
side-effect a (det)
duration sd (nmod)
known affected (ccomp)
onset until (case)
paralleled . (punct)
midazolam and (cc)
make not (neg)
ecstasy and (cc)
treated bacteremia (nmod)
proteins 2 (dep)
affect seem (advcl)
angiography japan (nmod)
agents gastroprotective (amod)
relation intake (nmod)
onset study (amod)
discontinued suspicion (nmod)
crocins , (punct)
changes cardiac (conj)
used measure (xcomp)
tnfalpha ) (punct)
greater which (nsubj)
agonist a2a (compound)
arrhythmia pvc (nmod)
hepatocytes initiated (amod)
lower better (advmod)
made using (xcomp)
associated monotherapies (advcl)
target injury (nmod)
oropharynx patients (conj)
use , (punct)
eradication presumed (amod)
developing year (nmod)
complications haematological (amod)
developed thrombosis (dobj)
hiccups azithromycin-associated (amod)
estimate ratios (dobj)
restrictive to (mark)
patients treating (acl)
infusion bupivacaine (nmod)
inhibitor by (case)
results diagnosed (dep)
pattern model (nmod)
86.7 11.4 (conj)
outflow an (det)
rat fetal (amod)
followed treatment (nsubj)
animals 10 (nummod)
dose s.c. (amod)
counts 3,424 (nummod)
rate temperature (conj)
ascertained included (advcl)
1.68 % (appos)
nephrotoxic medium (nsubj)
saline- apigenin-treated (conj)
receptor nicotinic (amod)
responsible activity (nmod)
1,25(oh)2d by (case)
96 +/- (cc)
evidence above (amod)
% aspirin (conj)
age same (amod)
efficacy sulfate (nmod)
improve function (dobj)
induced determine (advcl)
ventricles rabbit (compound)
cases reported (acl:relcl)
woman diagnosis (nmod)
junction muscle (conj)
peld high (amod)
monoamines the (det)
tasks continuous (amod)
developed rapidly (advmod)
crucial to (mark)
lists the (det)
courses in (case)
therapy glioma (nmod)
analyzed similarly (advmod)
received procedures (dobj)
1.52 , (punct)
usage amiodarone (nmod)
activating when (advmod)
report case (dep)
course developing (advcl)
agent latest (amod)
modification disability (nmod)
attention paid (acl)
re-examine avoid (advcl)
y-maze step-down (conj)
sum types (nmod)
55 15 (conj)
event common (amod)
pain brush-evoked (amod)
neurotransmission of (case)
attenuated disruption (dobj)
ifosfamide by (case)
days forty (nummod)
placebo versus (case)
preference place (compound)
dopamine brain (compound)
patients each (appos)
clarithromycin ciprofloxacin (conj)
signals cytoplasm (nmod)
provide conclusions (dep)
fibrillation agitation (conj)
delay conduction (compound)
a-86929 such (case)
developed meloxicam (advcl)
failed block (xcomp)
higher medulla (nmod)
modulate signaling (nsubj)
ae ) (punct)
response drugs (nmod)
levels alpha-gst (compound)
eeg initial (amod)
failure and (cc)
delay the (det)
withdrew . (punct)
acid 30 (nummod)
induced cddp (nmod)
therapy propylthio- (amod)
pain test (appos)
suppress levels (dobj)
inhibition bioactivation (nmod)
acknowledged and (cc)
density bmd (appos)
hemorrhage of (case)
emotions six (nummod)
part for (case)
onset to (case)
events strokes (conj)
contributed patient (nmod)
micromol/liter 233+/-34 (nummod)
rats angiotensinogen (nmod)
rats group (compound)
228 49 (nummod)
0.02 0.04 (conj)
nephrotoxicity ( (punct)
shifts be (cop)
1.21 - (punct)
means by (case)
temperament patient (nmod)
acid 3sr,4ars,6sr,8ars-6-[phosphonomethyl]decahydr (compound)
gr ) (punct)
effect tincture (nmod)
baseline min (conj)
second-generation a (det)
starting setting (nmod)
monitoring schedules (dep)
demonstrated scale (nsubj)
form mexitil-perlongets (appos)
characterized apnea (nmod)
mg/m(2 paclitaxel (nmod)
quadriparesis loss (conj)
methods years (appos)
causes involvement (dep)
deposition without (case)
infant of (case)
possibility patients (conj)
dependency to (case)
incidence decreased (amod)
focused indicated (conj)
ci 5.1 (nummod)
fev1 and (cc)
response patients (nmod)
syndrome cholinergic (amod)
test ampicillin (nmod)
rats 6-hydroxydopamine (compound)
modifies pretreatment (nsubj)
formation crescent (compound)
antagonists receptors (nmod:poss)
system spontaneous (amod)
reduction women (nmod)
showed . (punct)
conclusions associated (dep)
neuroimage 1339 (nummod)
outcomes disastrous (amod)
bd1008 of (case)
born weeks (nmod)
release e2 (compound)
unclear are (cop)
admitted jaundice (dep)
risperidone % (appos)
stopped preventing (xcomp)
lesions measurable (amod)
misoprostol micrograms (appos)
portion lower (amod)
membrane in (case)
achieved basis (nmod)
esrd and (cc)
history least (advmod)
treatment than (case)
used frequency (conj)
model dysfunction (nmod)
mg/m2bsa daily (advmod)
conditions associated (acl)
derived ventilation (dobj)
prescribed tmp-smz (dobj)
man ischemia (nmod)
normochromic was (cop)
defect concentration (compound)
umb24 affinity (dep)
examined trials (nmod)
risk discontinuing (advcl)
changed it (nsubjpass)
107 10(9)/l (conj)
types many (amod)
medullo-adrenalectomy together (advmod)
finding glomerulonephritis (nmod)
premedication dose (appos)
variations individuals (nmod)
catechol not (cc)
identify , (punct)
oltx disease (nmod)
ameliorate signs (dobj)
estradiol- and (cc)
affect indicate (conj)
methylprednisolone d1 (dep)
electroshock by (case)
crude and (cc)
hydrobromide reserpine (conj)
latency duration (conj)
achieved often (advmod)
occurring phenomena (nmod)
smoking cocaine (nmod)
measure any (det)
tetany furosemide (nmod)
thought was (auxpass)
6 of (quantmod)
parenchyma into (case)
75,761 , (punct)
conjunction plasmapheresis (nmod)
indicate represent (ccomp)
function factor (nmod)
disease central (amod)
taking placebo (dobj)
optic an (det)
exposure an (det)
drugs analgesic-antipyretic/anti-inflammatory (amod)
combined , (punct)
cholinomimetic pilocarpine (appos)
kidney to (case)
phenomenon " (punct)
thrombocytopenia other (amod)
behaviour rats (nmod)
assay dutp-biotin (compound)
epilepsies experimental (amod)
reduced 153 (nmod)
increase permeability (nmod)
centre pharmacovigilance (nmod)
manifests activity (dobj)
employed ) (punct)
oils lemon (amod)
abstinence an (det)
outcome favourable (amod)
emg fiber (compound)
old he (nsubj)
myoclonus the (det)
subjects snhl (nmod)
output volume (appos)
tri-iodo-thyronine t3 (appos)
demonstrated responders (nsubj)
level renal (amod)
june 2004 (conj)
clinic eye (compound)
challenge either (det)
mitochondria liver (compound)
obtainable powders (nsubj)
ck-mb with (case)
solution with (case)
cells hemopoietic (amod)
resulted activation (nmod)
designed and (cc)
patients rheumatic (amod)
salt-depleted in (case)
require who (nsubj)
ml 30 (nummod)
cataracts subcapsular (amod)
stent a (det)
streptozotocin-induced ) (punct)
transferred week (nmod)
middle eighties (nmod)
cells processes (nmod)
aggravates proteinuria (dobj)
congestion venous (amod)
gene functional (amod)
treatment metformin (nmod)
group true (amod)
monitoring segment (nmod)
common neuropathy (nsubj)
evaluated instilling (advcl)
resulted reduction (nmod)
ranged intervals (nsubj)
factor glomerulosclerosis (nmod)
peptides the (det)
recovery pressure (nmod)
presented represent (dobj)
transformation anencephaly (nmod)
use effects (nmod)
coagulopathy to (case)
models three (nummod)
decreased postimplant (conj)
glaucoma open (amod)
pre-existing shr (nmod)
associated increasingly (advmod)
ages methods (dep)
e8188 ( (punct)
> meq/l (dep)
hippocampus piriform (conj)
effect mice (nmod)
unaffected production (nsubj)
tsc ( (punct)
exhibited interval (dep)
prevention reactivation (nmod)
status good (amod)
recorded latencies (nsubjpass)
method crm (appos)
augments protects (conj)
solution ml/h (appos)
episode convulsions (nmod)
% 183 (nummod)
motif the (det)
occurred was (conj)
-20 10 (compound)
resulting variety (nmod)
factor-alpha as (cc)
tg in (case)
effects static (nmod)
sensitive more (advmod)
antagonists glutamate (amod)
inbred seven (nmod:npmod)
develops that (nsubj)
procaine of (case)
tracts tracts (nmod)
continued medication (dobj)
patterns latter (amod)
stat3 and (cc)
95 1 (conj)
= -4.29 (dobj)
rate pulmonary (amod)
increase neurotransmission (dobj)
cancers treatment-resistant (amod)
long was (cop)
patients biopsied (amod)
puncture antral (amod)
acetaminophen mg/kg (appos)
detected disturbances (nsubjpass)
diabetes of (case)
few effects (nsubj)
day before (advmod)
ensues whether (case)
levels bnp (nmod)
4.5 interval (nsubj)
syndrome lupus-like (amod)
measured daily (advmod)
maximum i.p. (dep)
man sustained (acl:relcl)
include did (aux)
escalations level (nmod)
protocols these (det)
assay growth (compound)
terminology manifestations (conj)
flexion joint (nmod)
staining acetyltransferase (nmod)
% 48 (nummod)
test specific (amod)
variable hence (advmod)
attribute quetiapine (nmod)
dcf by (case)
day 3 (nummod)
captopril or (cc)
supine and (cc)
esters and (cc)
unresponsive ; (punct)
mechanism damage (nmod)
care patients (nmod)
day per (case)
reviewed was (auxpass)
assigned take (xcomp)
patients possessing (acl)
evaluate factors (dobj)
microspherocytes pre- (nmod)
drug antimigraine (amod)
began h (nmod)
renal auditory (conj)
on levodopa (conj)
disorder treated (acl)
stopped summary (nsubjpass)
0.84 +/- (cc)
exposed later (advmod)
mellitus and (cc)
prednisolone group (appos)
discovered be (auxpass)
associated hernia (conj)
angiography . (punct)
heparins weight (compound)
greater also (advmod)
days microscopy (nmod)
adjunct chemotherapy (nmod)
patients each (dep)
expression aqp2 (compound)
killed dxnp (nsubj)
identified cases (nmod)
band 3 (nummod)
treat , (punct)
comparison mask (nmod)
results man (appos)
documented patients (nmod)
problem management (nmod)
sufferers aura (nmod)
vomitus 24.2/9.1/0 (nummod)
role calculation (nmod)
apomorphine to (case)
prior or (cc)
participated children (nsubj)
respiration for (case)
develop have (dep)
able ) (punct)
rush or (cc)
behaviour on (case)
function vegf (nmod)
gains those (nmod)
index suspicion (nmod)
molars impacted (amod)
metabolism macrophages (nmod)
b2 b1 (conj)
depressed pentobarbital (nmod)
predicted was (auxpass)
capsaicin topical (amod)
injury after (case)
reticulata animals (nmod)
minutes were (cop)
wave st-t (nsubj)
sd 0.078 (nummod)
groups high (amod)
rejection were (cop)
drug ( (punct)
peroxidation between (case)
achieved achieved (advcl)
discouraged children (nmod)
erection apomorphine-induced (amod)
compounds p.o. (nmod)
consider providers (nsubj)
lamivudine to (case)
difference any (det)
models acute (amod)
survival os (appos)
infusion than (case)
subjects matched (acl)
slower cn (nmod)
impaired increase (nsubj)
found sites (nmod)
one-third only (advmod)
output the (det)
block lumbar (amod)
any thalidomide (nmod)
mean factor (nsubj)
test u (conj)
explanation a (det)
tolerated studies (nmod)
lobule in (case)
pressures sbp (appos)
dec. 2005 (nummod)
plate of (case)
blockade postsynaptic (amod)
annuloplasty method (nmod)
patients induced (acl)
sham n (appos)
associated oxidants (nsubjpass)
received theophylline (dobj)
monitoring ( (punct)
new worsening (conj)
aetiology compressive (amod)
vip radioimmunoassay (nmod)
times ambulate (acl:relcl)
acid phosphatase (conj)
created removal (nmod)
suspected because (mark)
type proven (acl)
toxic combination (nmod)
were person-years (nsubj)
modulator negative (amod)
cya greater (amod)
enzymes two (nummod)
warrants which (nsubj)
inhibited nor (cc)
patient highlighting (acl)
benefit mazindol (nsubj)
umax ( (punct)
5 than (quantmod)
obtained tests (nmod)
rate 100 (nummod)
reduction induction (nmod)
mm 80.0 (nummod)
normal had (conj)
intravenous not (neg)
fields , (punct)
measurement or (cc)
dose region (nmod)
3.5 mg/kg (dep)
trials infusions (nmod)
loss neurosensorial (amod)
potassium total (amod)
intake fluid (amod)
analogue long-acting (amod)
increase enzymes (nmod)
effects associated (acl)
increase nor (cc)
dealt when (advmod)
intermediates halide (compound)
week per (case)
receptors central (amod)
torsades for (case)
phenotypes for (case)
g/ml concentrations (nsubj)
adults carriers (appos)
lower limb (dep)
adducts (4hne)-protein (compound)
resembled histologically (advmod)
model is (cop)
four ( (punct)
patients n (dep)
developed both (conj)
anxiety state (compound)
dissatisfaction female (conj)
volume reduced (amod)
level new (amod)
neurological electrophysiological (conj)
synthesis purine (compound)
following was (aux)
increased excretion (dobj)
factor-alpha tumor (compound)
glutamine amino (compound)
variants virus (nmod)
have as (mark)
biopsy presence (nmod)
disappearance with (case)
myriad the (det)
infusions h (compound)
america north (compound)
depend not (neg)
minimize risk (dobj)
lev of (case)
study cross-over (amod)
noted % (nmod)
erythroderma eosinophilia (conj)
39 of (case)
intensity involving (acl)
controls crf (conj)
maintained months (nmod)
studies case-control (amod)
did rate (dobj)
rilmenidine alpha-methyldopa (conj)
part as (case)
gpi within (case)
administration doses (nmod)
recorded although (mark)
tablet ) (punct)
protein glucose (conj)
prolongation syncope (compound)
p-glycoprotein , (punct)
1998 september (nmod)
tfl of (case)
97.1 ; (punct)
intercellular intracellular (conj)
occurrence , (punct)
memory ratings (dep)
occurs it (nsubj)
transplantation . (punct)
report investigation (dobj)
times on (case)
protection effects (nmod)
oxidative stress (dep)
adalat ( (punct)
fact a (det)
cta ( (punct)
attenuated given (xcomp)
effective cases (nmod)
neuropathy administration (nmod)
consequent regulation (nmod)
remains blockade (nmod)
absence ca2 (nmod)
ascitis occurring (conj)
nephropathy pan (compound)
utilizes objectives (ccomp)
changed lid (nsubj)
effects subtle (amod)
eserine action (nmod)
length costs (conj)
children yr (appos)
nhe3 of (case)
range lower (amod)
infarction cocaine-associated (amod)
induced release (nsubjpass)
incidence edema (nmod)
f344 ) (punct)
terbutaline agonist (appos)
suggests potential (nsubj)
exceed although (mark)
doses 25 (nmod)
impairment possible (amod)
bed cerebrovascular (compound)
nephropathy vascular (amod)
flow damage (conj)
occlusion this (det)
system extrapyramidal (amod)
ssri of (case)
toxic not (neg)
anaesthetised chloralose-urethane (nmod)
total % (dep)
phenotypes , (punct)
dox mg/kg (dep)
determined as (mark)
ethinyloestradiol and (cc)
appears represent (xcomp)
32.3 +/- (cc)
preceded not (neg)
dosage daily (amod)
increase nodularity (nmod)
provide can (aux)
consequences , (punct)
prevalent is (cop)
transplantations performed (advcl)
protein urinary (amod)
hopes initial (amod)
limits , (punct)
associated documented (conj)
liver induced (acl)
increased ccl2 (nsubjpass)
sarcoma of (case)
all levels (dep)
understand pharmacokinetics (dobj)
perform children (nmod)
administration iopamidol (nmod)
toxicities acute (amod)
anemia tests (dep)
efficacy effect (conj)
change metabolism (nmod)
half-life min (appos)
indicate but (cc)
sd , (punct)
symptomatology examination (conj)
cocaine before (case)
% month (nmod)
subjects/patients of (case)
reabsorption fluid (nmod)
function woman (nmod)
penicillamine after (case)
before 2 (conj)
loss suxamethonium (nmod)
lometrexol ddathf (appos)
decreases sleepiness (dobj)
lesion allografts (nmod)
demonstrate value (dobj)
eosinophils lymphocytes (conj)
patients sulfate (nmod)
cisplatinum cyclophosphamide (conj)
arms 19 (nummod)
assumed liable (ccomp)
imply disorder (dobj)
class toxicity (nmod)
methods under (case)
sodium than (case)
pelvis the (det)
licensed background (dep)
studied markers (nsubjpass)
ketamine intravenous (amod)
mg/m2 intravenously (advmod)
cholesterols c (appos)
reported related (conj)
revealing correspondence (dobj)
blockade d-1 (nmod)
five thrombosis (nmod)
affect loss (dobj)
produced flestolol (nsubj)
surgeon by (case)
concentrations their (nmod:poss)
hypothyroidism amiodarone-induced (amod)
appearance adducts (nmod)
alterations hemodynamic (amod)
improve capacity (dobj)
optic chlorpropamide-induced (amod)
days 21 (nummod)
ee vehicle (conj)
effect rhabdomyolysis (nmod)
ratios vte (nmod)
feeding chronic (amod)
sequelae adverse (amod)
arrhythmia dogs (nmod)
evident dosing (nmod)
agent it (nsubj)
induce types (dobj)
suppresses activity (dobj)
lesions common (acl:relcl)
correlated that (nsubjpass)
showed c (nsubj)
reduced control (nmod)
pharmacokinetic clinical (conj)
causes seizure (nmod)
patients treated (amod)
vpu either (cc:preconj)
kappa-beta of (case)
necessary drugs (nmod)
chain transport (compound)
4.3 versus (cc)
3.5 +/- (cc)
control wt (conj)
reported 1985 (nmod)
replaced being (auxpass)
p 0.32 (nummod)
disturbances barium-induced (amod)
september in (case)
decreased dose (nsubj)
accelerated growth (nmod)
taken 5 (nsubj)
research group (nmod)
complications administration (nmod)
shape the (det)
conclusion aware (appos)
mice g (dep)
tended subgroup (nmod)
developed discontinuation (nmod)
strains of (case)
changes catalepsy (nmod)
three men (nmod)
disturbances transient (amod)
effective damage (nmod)
those did (acl:relcl)
signs chickens (nmod)
causes dosage (nsubj)
seizure resulting (acl)
linked abuse (dobj)
y. 15 (compound)
performed test (dep)
exercised groups (nsubj)
failure recovery (dep)
decrease isoproterenol-induced (amod)
l-med ; (punct)
randomized participants (nsubjpass)
antagonized were (auxpass)
distribution vd (appos)
safe well (conj)
ml agent (nmod)
suspect suggests (ccomp)
% 2.31 (nmod)
angiography for (case)
therapy a (det)
characteristics anti-cn (amod)
dyskinesias these (det)
methadone with (case)
injection bolus (compound)
mechanism some (det)
obtaining in (mark)
n awake (nsubj)
arterial or (cc)
protocol ifosfamide (compound)
quadrant the (det)
epithelium tract (compound)
monohydroxyethylrutoside semisynthetic (amod)
reduction pressure (nmod)
not but (cc)
72 7 (conj)
show agents (nsubj)
krebs-ringer control (compound)
arteries , (punct)
rats 14 (nummod)
summarized reports (nsubjpass)
survival cumulative (amod)
useful study (nsubj)
day 7 (conj)
controlled extreme (conj)
concentrations creatinine (compound)
surrogates exposure (nmod)
dose mg/day (nmod)
penile pain (dobj)
lacrimation in (case)
lidocaine-kindled cocaine-induced (conj)
seizures amphetamine-induced (amod)
caused it (nsubj)
course toxicity (conj)
n=2.4+/-0.7 ) (punct)
users all (det)
deficits neurological (amod)
programmed if (mark)
estimated analysis (nmod)
expression oxidase (nmod)
saline mg/min (conj)
implicated possibly (advmod)
obtained , (punct)
classified , (punct)
relieved pain (nsubjpass)
determine decrease (ccomp)
woman 49-year-old (amod)
mechanism through (case)
administration succinylcholine (nmod)
administration analgesic (amod)
sah aneurysmal (amod)
arrest cell (compound)
delivered cortex (nmod)
showed furthermore (advmod)
receiving concentration (dobj)
tissue non-specific (amod)
observed substance (nmod)
corrected has (aux)
shortened them (dobj)
effectiveness induction (nmod)
administration humans (nmod)
10ug ( (punct)
diet fixed-salt (amod)
aida microl (dep)
ballooning and (cc)
cheops ( (punct)
conclusions equal (dep)
analyses regions (nmod)
evident although (mark)
experienced effects (nsubjpass)
concentrations serum (compound)
diminish not (neg)
treated which (nsubjpass)
thinning change (nsubj)
inos ( (punct)
related impairment (nmod)
deafened . (punct)
concluded represents (ccomp)
ganglion dorsal (amod)
edema vasodilation (conj)
complications such (amod)
familiarity improved (amod)
eight-week an (det)
had resolve (ccomp)
edds 58 (nummod)
% 69.9 (nummod)
longer only (advmod)
probable is (cop)
considered prescribing (advcl)
analyzed chloride (nmod)
hypertension marked (amod)
review case (compound)
case documenting (acl)
failed enhanced (conj)
years age (nmod)
injury histochemical (amod)
doses mg (dep)
discussion case (dep)
produced manifested (conj)
effectiveness ptra (nmod)
venue a (det)
0.2 versus (cc)
studies conduction (compound)
toxicities anemia (appos)
pressure ventricular (amod)
dogs nitroprusside (nmod)
improved p<0.0005 (dep)
organisms monkeys (nmod)
abundant , (punct)
trial of (case)
was improvement (nsubj)
administered weeks (nmod)
comparable rate (nsubj)
t+a qd (conj)
nerve proximal (amod)
assessed changes (nsubjpass)
resulted actually (advmod)
alpha-enac , (punct)
applied fs (nsubjpass)
s within (case)
features appearances (conj)
unconscious administration (nmod)
scopolamine + (cc)
explanation association (nmod)
-19.20 vs. (compound)
systolic left (amod)
characteristics epilepsy (nmod)
scores their (nmod:poss)
determine outcome (dobj)
valve regurgitation (dobj)
identified 1.86 (nmod)
man 27-yr-old (amod)
experienced and (cc)
found effects (nsubjpass)
suprofen given (case)
link them (dobj)
chorea hyperglycinemia (nmod)
chorea . (punct)
associated unhappiness (nsubjpass)
cells purkinje (compound)
antagonized component (dobj)
facility long-term (amod)
vigabatrin ( (punct)
effect activation (compound)
occurred agent (dobj)
neurons gaba (compound)
incidences headache (nmod)
hypothesis confounds (ccomp)
presented glomerulonephritis (dobj)
% mg (appos)
cycles ; (punct)
mechanism additional (amod)
practices general (amod)
abnormalities cerebral (amod)
display that (nsubj)
dysfunction disease (nmod)
epinephrine by (case)
compounds diisopropylfluorophosphate (nmod)
associated suggesting (xcomp)
administration intravenous (amod)
disorder panic (amod)
hepatitis erythroblastocytopenia (conj)
inhibitors factor (compound)
resulted % (dep)
day<10 n=76 (conj)
plasma clearance (conj)
backgrounds professional (amod)
nodule one (nummod)
way still (advmod)
15/hypertension reperfusion (conj)
cases only (advmod)
1973 and (cc)
causes expression (dobj)
s mean+/-s.e. (appos)
administration kf17837 (nmod)
address that (nsubj)
treatments from (case)
induce atypia (dobj)
behavior violent (amod)
extent use (nmod)
n. 8 (nummod)
stability the (det)
increased mg/kg (nsubj)
displayed tuft (advmod)
utilized population (nmod)
increase sulfation (nmod)
hemodynamic locomotor (conj)
induction following (case)
complications with (case)
analgesia of (case)
perfused were (auxpass)
gellan timolol (compound)
people smoke (acl:relcl)
dose-effect and (cc)
done conclusion (dep)
design induced (parataxis)
function patients (nmod)
dyskinesias ( (punct)
occurs organogenesis (nmod)
observed lymphoma (nmod)
degeneration ) (punct)
higher malondialdehyde (nmod)
% 1.7 (nummod)
produced which (nsubj)
incidence analysis (appos)
subacute that (nsubj)
rise demand (nmod)
conditions of (case)
cardiotoxicity to (mark)
neoplasms increased (amod)
nissl-staining and (cc)
had formulations (nsubj)
contributed necrosis (nsubj)
mg/kg once (advmod)
review reported (acl)
done settings (nmod)
undergoes glucuronidation (dobj)
da dopac (conj)
had interval (dobj)
problem serious (amod)
timolol % (dep)
strategy treating (acl)
reported amiodarone (nsubjpass)
cortices paralimbic (amod)
patients improved (acl:relcl)
inhibitors ns-nsaids (appos)
azithromycin and (cc)
responsible mainly (advmod)
number models (nmod)
were ns-nsaids (dep)
ranks tests (dobj)
seems because (mark)
european intravenous (compound)
positive those (det)
half-life its (nmod:poss)
sedation ranges (nmod)
occurred loss (nsubj)
technique anaesthesia (nmod)
followed : (punct)
pressure supine (amod)
antagonist trazodone (nsubj)
instances other (amod)
recognition to (case)
toxicity drug-induced (amod)
cocaine- be-induced (conj)
tacrolimus the (det)
prolactin ng./ml (appos)
minutes during (conj)
was because (mark)
derivatives with (case)
levels ferritin (compound)
peroxidation kidney (nmod)
dph of (case)
relationship peroxidation (nmod)
appears effective (xcomp)
involved resulting (xcomp)
formation exams (nmod)
administration flutamide (nmod)
mg dec (nmod)
gain will (aux)
caused treatments (nsubj)
important seems (advcl)
associated used (advcl)
risk and (cc)
tapped sedated (conj)
mice b6 (appos)
receptor vegf (compound)
infants remaining (amod)
lowered that (mark)
force lvdp/dt (appos)
associated schizophrenia (nsubjpass)
partial least (advmod)
read to (mark)
discontinued changed (conj)
l-dopa experiment (compound)
g 20 (nummod)
ulcerogenicity with (case)
continue medication (dobj)
produces movements (dobj)
years 3 (nummod)
stereotypies with (case)
evolution electrocardiographic (amod)
mmol/kg 50 (nummod)
precursors bfu-e (appos)
staining iron (compound)
11.7 ) (punct)
scleroderma treated (acl:relcl)
observational evidence (nsubj)
sedation clear-headedness (conj)
regimens (cni)-based (punct)
tested adulthood (nmod)
were suggestions (attr)
influence reorganization (dobj)
constructed . (punct)
immunosuppressant ability (nmod)
follows most (nmod)
indicated unassigned (nsubj)
hospitalized infarction (nmod)
secretion potassium (compound)
platelet and/or (cc)
using elevated (dobj)
cyclosporine both (cc:preconj)
3tc azt (conj)
deferens ) (punct)
emphasized . (punct)
relationship rate (nmod)
second- and (cc)
behaviour ) (punct)
transdermal subcutaneous (conj)
5,7-dihydroxytryptamine the (det)
terminate block (conj)
restricted was (aux)
ug.kg-1 fentanyl (compound)
activations cortex (nmod)
vincristine glycol-asparaginase (conj)
deficits level (dep)
necrosis non-specific (amod)
mg = (dep)
hydrochloride fluoxetine (compound)
myasthenia of (case)
rate flow (conj)
emergence agent (nmod)
behaviors in (case)
delta beta-2 (conj)
placebo cases (appos)
facilitated retrieval (dobj)
ameliorated be (auxpass)
banned although (mark)
260 to (dep)
patient diabetic (amod)
differences amounts (nmod)
damage toxic (amod)
had kidney (dobj)
haemorrhages cerebral (amod)
kidneys 143 (nummod)
4-damp antagonist (compound)
therapy report (appos)
dilatation pelvocalyceal (compound)
reached were (auxpass)
method effects (nmod)
gravis caused (acl)
km , (punct)
infusions saline (nmod)
consequences of (case)
hepatitis origin (nmod)
rare severe (conj)
chronicity and (cc)
diagnosis hyperprolactinemia (nmod)
effects magnesium (nmod)
retrograde of (case)
-50 and (cc)
effect concentrations (nmod)
hypertension patients (nmod)
aqp2 expression (dep)
= or (cc)
appeared to (xcomp)
effects of (case)
subgroups two (nummod)
readministration , (punct)
list a (det)
pruritus phosphatase (nmod)
% 86.2 (nummod)
8-phenyltheophylline , (punct)
involvement multiple (amod)
days 15 (conj)
accumulation for (case)
200 400 (conj)
concentrated urine (dobj)
b i.e. (dep)
protect occurrence (nmod)
thiols in (case)
lvdp/dtmax and (cc)
contrary to (case)
altered cortex (nmod)
% 60.2 (nummod)
subscale general (amod)
receptors hippocampal (compound)
patients receive (acl:relcl)
low-level relatively (advmod)
characterized day (nmod)
gestation during (case)
grade none (dep)
[3h]inulin [14c]p-aminohippuric (conj)
slowdown change (nmod)
drugs phenobarbitone (appos)
hippocampus animals (nmod)
analysis uv-spectrophotometric (amod)
procedure dosage (nmod)
plays process (nmod)
1.52 1.32 (compound)
15.0 ( (punct)
caused intrarenal (nsubj)
icr and (cc)
showed rats (ccomp)
metoprolol ems (nmod)
reduce markedly (advmod)
4-diphenylacetoxy-n-methylpiperidine-methiodide ) (punct)
effects microinjection (nmod)
effects pretreatment (nmod)
hyperthermia of (case)
controls four (nummod)
buildup activity (nmod)
weight neutropenia (nmod)
remains unaltered (xcomp)
increased cortex (nmod)
agents vasoactive (amod)
parameters latency (compound)
included locomotion (dobj)
chromosome single (amod)
died six (nsubj)
% 88.8 (nummod)
examined timing (dobj)
side-effects by (case)
complained pain (nmod)
enrolled : (punct)
alpha- and (cc)
influence interactions (nmod)
inflammation more (amod)
likely died (xcomp)
palsies ipsilateral (amod)
memantine 10mg/kg (appos)
account vasospasm (nsubj)
od patients (nmod)
mimicking hydronephrosis (dobj)
increased transiently (advmod)
adenomyosis of (case)
half-time , (punct)
occur . (punct)
mm 0.5 (nummod)
growth normal (amod)
impairs learning (dobj)
can pd (conj)
variation interstrain (compound)
database large (amod)
had failure (dobj)
discontinued resulting (xcomp)
indicative effects (nmod)
innervation sympathetic (amod)
metoclopramide intravenous (amod)
nadir 10(9 (conj)
disorder unmasked (acl)
evidence direct (amod)
differ , (punct)
57.9 common (advcl)
delirium other (conj)
others 2 (nummod)
play daidzein (nsubj)
revealed correlation (dobj)
% 47 (compound)
devastating acute (amod)
information on (case)
observed metastases (nmod)
help measures (nsubj)
dosing h1- (nmod)
exposure professional (amod)
administrated was (auxpass)
962 013 (conj)
hepatotoxicity clotiazepam (nmod)
restriction to (case)
cocs while (case)
discussed effects (nsubjpass)
s 61.9 (appos)
hh ; (punct)
groups all (predet)
valdecoxib specific (amod)
viral and (cc)
ecgs the (det)
density brains (nmod)
lack e (nmod)
decreased lowering (advcl)
mechanisms and (cc)
incidence placebo-level (amod)
drug antiinflammatory (amod)
regulation down (case)
stroke myocardiopathy (conj)
underlying effect (dobj)
antagonism seizures (nmod)
municipal the (det)
measured anxiolysis (dobj)
atrial left (conj)
infiltration marrow (nmod)
0.942 - (punct)
event reported (acl)
8 4 (conj)
accompanied which (nsubjpass)
valproate ) (punct)
cystitis intractable (amod)
prospective non-interventional (conj)
employed background (dep)
-placebo - (punct)
ntg + (cc)
effective antiarrhythmic (dep)
aware urologists (nsubj)
suspensions all (det)
produced months (nsubj)
courses days (nmod)
results report (appos)
interaction such (predet)
symptoms psychotic (amod)
papilledema , (punct)
double-blind a (det)
losartan due (case)
synthesize to (mark)
those associated (acl)
ci-921 amsacrine (compound)
brain into (case)
appear region (nmod)
reversed p (dep)
050+/-561 , (punct)
disorders . (punct)
conclusions triggers (dep)
combinations val/hctz (amod)
observed intake (nmod)
refractory chemotherapy (nmod)
icr balb/c (conj)
venous and (cc)
increased maturity (nmod)
reputation safety (nmod)
concentration mean (amod)
benzoylecgonine amphetamine (conj)
behaviors cocaine-induced (amod)
grouped basis (nmod)
given whereas (dep)
complained patients (nsubj)
15/44 sgk1(+/+ (nmod)
increased hyperprolactinemia (conj)
results confirm (appos)
surprise slowly (advmod)
halts . (punct)
fatal often (advmod)
induces it (nsubj)
used creatine (nsubjpass)
assayed tissue (nsubjpass)
occurred vessels (nmod)
evaluated a (nsubjpass)
hypoaesthesia of (case)
13.2 0.17 (conj)
insufficiency by (case)
mg.kg(-1 ) (punct)
bradycardic be (cop)
treatment nimodipine (compound)
asterixis of (case)
laboratory and (cc)
meta-analysis trials (nmod)
diagnosis failure (nmod)
diseased in (case)
or anatomically (advmod)
% to (compound)
receptor kainate (compound)
induced ] (punct)
share does (aux)
preoperatively , (punct)
dependent dose (nmod:npmod)
factor growth (compound)
enlarged and (cc)
proposed alter (ccomp)
neurological cognitive (conj)
development cardiomyopathy (nmod)
mg/kg ld50 (appos)
lipid incorporating (acl)
non-selective and (cc)
coil polarized (amod)
i.c.v ( (punct)
indicate reports (nsubj)
woman of (case)
design setting (conj)
elsewhere brain (nmod)
patient pregnant (amod)
trials evaluating (acl)
syndromes nephrotic (amod)
observed associations (dobj)
dialysis peritoneal (compound)
teams dedicated (amod)
cis-platinum cyclophosphamide (conj)
revealed deposits (dobj)
diuresis ) (punct)
used converted (advcl)
increased activity (nsubj)
less markedly (advmod)
associated block (nmod)
administration dexamethasone (nmod)
actives prodrugs (nsubj)
improved whereas (dep)
slower significantly (advmod)
associated cows (conj)
glucoronosyltransferases diphosphate (compound)
cataract and (cc)
treated buprenorphine (nmod)
parkinsonism mptp-induced (amod)
chemotherapy after (case)
reductions frequencies (nmod)
background with (case)
enantiomer identical (acl:relcl)
responded treatment (nmod)
uncommon very (advmod)
area a1 (appos)
consisted group (nsubj)
s-1 and (cc)
evoke did (aux)
dementia report (appos)
pathways cells (nmod)
report showed (conj)
samples cpb (nmod)
use years (nmod:poss)
placebo caffeine-free (compound)
longer considerably (advmod)
showed reversed (ccomp)
interaction to (case)
psychopathology to (case)
infiltration cells (nmod)
properties pulmonary (amod)
tomography contrast-enhanced (amod)
relationship response (conj)
similar indications (nmod)
insights these (det)
pce ( (punct)
injections injections (conj)
hyperplasia cancer (conj)
evaluate once-daily (dep)
groups doxorubicin (conj)
oropharynx . (punct)
ratings in (case)
class antagonists (conj)
occurred time (nmod)
protocol with (case)
% difference (nsubj)
treatment vt (nmod)
body wt (nummod)
cultured presence (nmod)
is nature (nmod)
cross-reactivities in (case)
91 more (amod)
altering of (mark)
recipients received (acl:relcl)
examine increases (ccomp)
ureters and (cc)
suggestive connection (nmod)
22-oxacalcitriol oct (appos)
pge1 ) (punct)
contraction the (det)
radius ultradistal (amod)
leukoencephalopathy posterior (conj)
substances tbars (appos)
diclofenac by (case)
arrest through (case)
injected artery (nmod)
rigidity leading (acl)
status system (nmod)
iml ( (punct)
was and (cc)
effect covariance (compound)
mediated signaling (nmod)
toxicities encountered (acl)
used was (auxpass)
improved procedure (nsubj)
patients twenty-five (amod)
evaluated methods (nsubjpass)
having failure (dobj)
torsade intervals (nmod)
% incidence (nsubj)
compare ; (punct)
features administration (nmod)
mg./kg 0.5 (nummod)
sensitive enables (conj)
ukpdrg ) (punct)
edema aggravating (amod)
used visualize (xcomp)
compared infusion (nmod)
allowed safety (nsubj)
period 60 (nummod)
returned who (nsubj)
injury or (cc)
event inciting (compound)
adenoma , (punct)
mortality postnatal (amod)
recognized when (advmod)
-cimetidine group (compound)
anaesthesia halothane (compound)
developed cystitis (dobj)
disappeared and (cc)
area cross-sectional (amod)
increasing frequency (dobj)
samples and (cc)
fever nodules (conj)
immunohistochemical treatment (nmod)
hospitals and (cc)
antagonist treatment (nmod)
nuclei cerebellum (nmod)
contribute approaches (nsubj)
rats serotonin (nmod)
obstructive p (dep)
0 i.v. (dep)
interference isoniazid (nmod)
control experimental (conj)
1.5 5.0 (conj)
lignocaine 2 (nummod)
diagnosis reaction (nmod)
greater however (advmod)
placebos on (case)
ratios adjusted (amod)
responses range (nmod)
contribute elevation (nmod)
generation species (nmod)
mb of (case)
slower group (nsubj)
tissues in (case)
instilling eyes (nmod)
malondialdehyde brain (compound)
drugs subject (amod)
shunt responses (conj)
aap dox (conj)
structures with (case)
overshooting force (conj)
had severity (dobj)
resolved patients (nmod)
result effect (nsubj)
nephrosis chronic (amod)
yrs 65+/-16 (nummod)
schizophrenia % (appos)
managed was (auxpass)
metformin drug (appos)
tests function (compound)
thickness and (cc)
giving , (punct)
seizures during (case)
effects subacute (amod)
lna+hca similar (amod)
dose taken (acl)
nadir x (cc)
lymphadenopathy fever (compound)
tended they (nsubj)
revealed likely (ccomp)
damage no (det)
group unexposed (amod)
% 10.5 (nummod)
sod 1 (dep)
regimens surgery (nmod)
mg.kg(-1).d(-1 4 (nummod)
curcumin by (case)
correlate formation (acl:relcl)
area interstitial (amod)
similar cyclosporin (nmod)
follow-up provided (amod)
ax to (case)
return of (case)
modulates ways (nmod)
higher and (cc)
enalapril-treated n (dep)
mechanism adrenergic (amod)
underwent transplantation (dobj)
indicate model (ccomp)
substantiate occurs (advcl)
hundred one (conj)
concluded be (auxpass)
presentation at (case)
dose weight (compound)
foot in (case)
system fusimotor (compound)
effects halothane (nmod)
uv ) (punct)
secondary administration (nmod)
way induction (nmod)
form tablets (nmod)
increase dp/dt(max (conj)
region into (case)
lorazepam benzodiazepine (compound)
waves p (compound)
investigated ruled (conj)
stable median (nmod)
irritation of (case)
combination beraprost (nmod)
fasciculations of (case)
had lozenge (nsubj)
correlates dosage (nmod)
applied continued (conj)
receptors alpha1-adrenergic (amod)
fluency overt (amod)
extraction record (compound)
infection cured (conj)
evident fibrosis (nsubj)
produced be (auxpass)
reported fluoxetine (nsubjpass)
useful preventing (advcl)
bands gamma (conj)
measure ratios (appos)
protective . (punct)
afterdepolarization : (punct)
effective how (advmod)
(r)-alpha-methylhistamine ramh (appos)
animals compared (case)
microl scopolamine (compound)
potent augment (parataxis)
systems cholinergic (amod)
paclitaxel chemotherapy (nmod)
extend examining (advcl)
6/15 , (punct)
contribute mechanism (nmod)
pancreatitis vpa-induced (conj)
difference the (det)
cin ) (punct)
response aberrant (amod)
increased concentration (nmod)
cycloheximide with (case)
g/m2 day (nmod:tmod)
revealed analysis (nsubj)
regurgitation flutter (conj)
% 70 (nmod)
score based (case)
sweating feeling (conj)
gain by (case)
abnormalities electrocardiogram (nmod)
less exercise (nmod)
maintained however (advmod)
intracellular from (case)
avp wky (nmod)
n=101 ( (punct)
related changes (nsubj)
invariable that (mark)
increased based (prep)
participates seemed (advcl)
absences resistant (amod)
result overdosage (nsubj)
% 20.5 (nummod)
hepatitis glyburide-induced (amod)
specification replication (conj)
pyrophosphate tpp (appos)
dextran peripheral (amod)
alone intraperitoneally (advmod)
h with (case)
confirmed : (punct)
available role (nmod)
2010/2011 through (case)
contributes that (mark)
aspects thrombocytopenia (nmod)
extract the (det)
= months (dobj)
affected obviously (advmod)
enzyme-1 of (case)
weeks increase (nmod)
assigned infants (nsubjpass)
therapy doxorubicin (compound)
antagonized demonstrating (xcomp)
affection between (case)
study introduction (nmod)
acid other (amod)
levels factor-alpha (nmod)
incidence mortality (nmod)
cholecystokinin fragments (conj)
hypoxaemia of (case)
had cystitis (dobj)
transplant-related significant (amod)
drc ) (punct)
phenytoin with (case)
hoehn staging (conj)
0.59 - (punct)
dogs conscious (amod)
ptra ( (punct)
obtained oliguria (nmod)
complications thromboembolic (amod)
investigated should (aux)
maze epm (appos)
cortex temporal (amod)
dextromethorphan non-competitive (amod)
bradykinesia contralateral (amod)
consisted groups (nmod)
genes to (case)
increases d3 (nmod)
administered erdosteine (nsubjpass)
evidence humans (nmod)
assays biological (amod)
treatments as (case)
or(adj ) (punct)
= lag (nmod)
uncommon pregnancy (nmod)
medium contrast (compound)
albuminuria in (case)
mt malondialdehyde (conj)
% and (cc)
months duration (nmod)
resolved improvement (nmod)
mg/dl follow-up (nmod)
potential mg/kg (dep)
dexamethasone ) (punct)
nephrolithiasis triamterene (compound)
evaluate nephrotoxicity (dobj)
arrhythmias major (amod)
% 36.6 (nummod)
h n (appos)
younger in (case)
embryos the (det)
loss mean (amod)
return contractility (nmod)
objective investigation (nmod)
received cannulae (nmod)
moderate degrees (nmod)
helpful diagnose (xcomp)
higher inhibitors (nmod)
scale happiness (compound)
indicate do (aux)
function nerve (compound)
continued treatment (nmod)
potential emerging (acl)
relationship degeneration (nmod)
training between (case)
effective diazepam (nsubj)
body mg/kg (compound)
differ since (mark)
cows pregnant (amod)
withdrawal responsiveness (compound)
strokes women (nmod)
area deprived (amod)
aggression for (case)
tolerated she (nsubj)
duration period (nmod)
resolved syndrome (nsubj)
unrecognized . (punct)
aneurysm thoracic (compound)
deteriorating possibly (advmod)
co-administration scopolamine (compound)
mid- high-frequency (acl)
agonists centrally (advmod)
etoricoxib the (det)
melphalan after (case)
homeostasis disturbed (amod)
irritability or (cc)
received other (nsubj)
years 6 (compound)
alternatives patients (nmod)
erythroid and (cc)
reduce scores (dobj)
randomised alprazolam (nmod)
seen also (advmod)
saline of (case)
levels stress (compound)
hypothesis has (ccomp)
tremor quantifying (amod)
groups cortex (nmod)
ratios estimate (appos)
4:30 , (punct)
undertook we (nsubj)
upregulation hs-induced (amod)
administration of (cc)
abusing methamphetamines (dobj)
arrhythmia transient (amod)
19.9 to (case)
study multicenter (compound)
characterized were (auxpass)
performed apart (advmod)
thrombosis without (case)
study infusion (nmod)
established , (punct)
interference a (det)
gaps connections (nmod)
coma the (det)
thalidomide to (mark)
promotion of (case)
administered rats (nmod)
emesis ifosfamide-induced (amod)
alpha-fluoro-beta-alanine by (case)
characterized syndrome (nsubjpass)
problems behavioural (amod)
found discontinued (conj)
processes on (case)
appearance seizures (nmod)
fractures cancer (conj)
action methotrexate (amod)
levels lowered (amod)
increased effect (nsubjpass)
dronedarone , (punct)
associated obesity (nsubjpass)
9.7 +/- (cc)
medications , (punct)
outcome composite (amod)
drug trial (compound)
models two (nummod)
patients mono-infected (amod)
necrosis myocardial (amod)
cardiotoxicity mortality (conj)
weeks 54 (nummod)
evidence vasculitis (nmod)
patient identified (acl)
contraception prolonged (amod)
acquired , (punct)
ancas ) (punct)
b12 folate (conj)
recovery withdrawal (nmod)
patients late (conj)
percent area (nmod)
carried studies (nsubjpass)
animals experienced (acl:relcl)
suffer common (nmod)
death suicidal (amod)
potentiates 5-azacytidine (nsubj)
alters lipoproteins (dobj)
atra of (case)
decreased visit (nmod)
cystectomy 4 (nummod)
fatal ( (punct)
gestation with (case)
helpful and (cc)
pentylenetetrazole by (case)
contractions , (punct)
pounds and (cc)
polyglutamates of (case)
peritoneum of (case)
interventions use (compound)
fall k+ (nmod)
did well (advmod)
dopamine rather (cc)
staining tissue (nmod)
deliver to (mark)
mutations patients (nmod)
appreciated . (punct)
incidence torsades (nmod)
hepatomas lesions (dep)
examine (gm)-mediated (dep)
indicate use (conj)
day by (case)
withdrawal , (punct)
undergoing angiography (dobj)
hyperhidrosis ; (punct)
akbr ( (punct)
effects reabsorption (nmod)
received decreased (conj)
3.8/100,000 ) (punct)
features clinical (amod)
cessation inhibitor (nmod)
observed early (advmod)
dl-sotalol both (cc:preconj)
women disease (nmod)
frequently more (advmod)
gland salivary (amod)
showed oils (nsubj)
function mesangial (amod)
anesthesia alfentanil (amod)
anemia significant (amod)
dysrhythmias precipitate (amod)
benign as (case)
morphine mu-agonist (amod)
ip/week mg/kg (compound)
patient abnormalities (nmod)
went : (punct)
times microcrystal (amod)
dose methamphetamine (nmod)
14.1 - (punct)
l 4.1 (dep)
children adults (conj)
socs-1 -3 (conj)
delivered vaginally (advmod)
tumor wilms (compound)
activation ventilation (nmod)
affinities significant (amod)
ear ipsilateral (amod)
matched 1:4 (dep)
exposure splitting (conj)
independent alpha2-adrenoceptors (nmod)
groups zidovudine (compound)
antidopaminergic and (cc)
prostigmine morphine (conj)
mania of (case)
tolerability clinical (amod)
rd ( (punct)
segment cerebral (nmod)
evident also (advmod)
inhibit carteolol (nsubj)
tubules to (case)
0.90 than (case)
distorted reticulum (dobj)
reserpine- and (cc)
survivals pfss (appos)
enzyme angiotensin (compound)
1994 and (cc)
1 3 (dep)
related from (case)
group intervention (compound)
distribution between (case)
mice cx3cr1 (compound)
att-alf ( (punct)
correlated was (auxpass)
% intention-to-treat (nmod)
measured ) (punct)
lacking 2-subunits (dobj)
ng/kg/min 10 (nummod)
contribute improve (advcl)
desire testes (conj)
indicate changes (nsubj)
confirmed closure (dobj)
86.2 3.7 (conj)
effects nociceptive (amod)
induction rats (nmod)
composed histologically (advmod)
mg 60 (nummod)
autoantibodies warm-reactive (amod)
triphosphate by (case)
determined measured (conj)
surviving 30 (conj)
telangiectasia . (punct)
exemplified as (mark)
mg/kg h (appos)
exhibited hemorrhagic (conj)
sensitive cochlea (nsubj)
remain defined (xcomp)
excretion cgmp (compound)
% hemorrhage (nmod)
identified map (nmod)
duration hallucinations (nmod)
administration subsequent (amod)
normal times (nmod:npmod)
processes perivascular (amod)
dystonia idiopathic (amod)
7.914 ci=1.375 (compound)
develop but (cc)
inventory a (det)
cytopenia the (det)
commissure-commissure and (cc)
mechanisms toxicity (nmod)
dysfunction sd (appos)
agonist alpha2-/i1-receptor (compound)
design/methods : (punct)
occurrence times (appos)
that were (cop)
compound parent (compound)
dnap ) (punct)
patients years (dep)
therapeutic is (cop)
evaluated tolerability (dobj)
reduce increases (dobj)
m-chlorophenylpiperazine agonist (compound)
micromol/10 0.1 (compound)
or = (parataxis)
dosage but (cc)
suggested model (xcomp)
treatment gluconate (nmod)
brief , (punct)
confirm predictor (ccomp)
increment g (compound)
163 +/- (cc)
elevations pressure (compound)
detrimental mediates (ccomp)
dentate in (case)
neonates born (acl)
evidence clear (amod)
appears azelastine (nsubj)
treatment drugs (nmod)
reviewed literature (nsubjpass)
administration for (case)
% levobupivacaine (compound)
n , (punct)
supplementation long-term (amod)
combination new (amod)
symptoms radicular (amod)
density reduced (amod)
persistence sedation (nmod)
cause variety (dobj)
receptor mu-opiate (amod)
involved blockade (nsubjpass)
13th days (dep)
showed results (dep)
showed slowing (dobj)
h first (amod)
those mediate (acl:relcl)
met centers (dobj)
antagonists adenosine (compound)
symptoms illness (nmod)
unreasonable it (nsubj)
abnormalities decrease (conj)
veins terminal (amod)
wt lithium-fed (amod)
inoculation organisms (dep)
complicating enterocolitis (dobj)
time severity (compound)
methyltransferase guanidoacetate (amod)
then : (punct)
tablet for (case)
company pharmaceutical (amod)
reactions associated (acl)
level mrna (nmod)
derivative oversulfated (amod)
paco2 in (case)
unable , (punct)
g/day 3.9 (nummod)
increase protrusion (conj)
mean times (nmod:tmod)
days 13 (conj)
disorders disturbances (conj)
studied experiments (nmod)
administration ddavp (nmod)
human or (cc)
systems therefore (advmod)
women lovastatin (conj)
uninephrectomized before (advmod)
report method (compound)
loss been (cop)
injections serial (amod)
week later (advmod)
detectable cm (amod)
leads rate (nmod)
showed mice (nmod)
fibrosis tissues (nmod)
virus japan (nmod)
naloxone of (case)
schema etoposide (dep)
parenchyma the (det)
infiltrate moderate (amod)
using design (dobj)
complication drug (appos)
greater versus (cc)
19.8 4.6 (conj)
serotonergic- a (det)
convulsions local-anesthetics-induced (amod)
modifies that (mark)
membrane plasma (compound)
ka to (case)
supported suspicion (nsubjpass)
led absence (nmod)
studies identified (acl)
neuropathy patients (nmod)
sustained lowering (advcl)
2pam ( (punct)
hormone hcrh (appos)
cimetidine antagonist (appos)
rpp ( (punct)
effect ' (punct)
tone neurogenic (amod)
restore . (punct)
response in (case)
patient latter (amod)
difference that (mark)
16 sem (appos)
mmol group (nmod)
improved symptoms (dobj)
training for (case)
test dependent (amod)
control lesions (nmod)
dysfunction cerebellar (amod)
recognized recently (advmod)
c+e in (case)
received deaths (nmod)
allocated one (nmod)
hyperthermia by (case)
pathophysiologic metabolic (conj)
2009 2012 (conj)
stage hoehn (compound)
stage ii (nummod)
monoher by (case)
effects concerning (case)
drop titers (nmod)
suppresses attenuates (conj)
cholesterol cholesterol (conj)
micrograms/dl between (case)
urotensin-ii administered (acl)
neonate a (det)
one po (dep)
4.4 of (case)
fraction or (cc)
uncommon serious (conj)
made sjl (nmod)
reduce drastically (advmod)
bfu-e and (cc)
attacks or (cc)
correlated therapy (nmod)
undertaken estimate (xcomp)
cis-platinum adriamycin (conj)
tissues exposed (amod)
production acetylcholine (nmod)
achieved therapy (conj)
ac ) (punct)
mg zidovudine (conj)
appeared hearts (nsubj)
awaking after (mark)
associated aneurysms (nmod)
stroke cancer (conj)
incidence instability (nmod)
explain cause (dobj)
factor marker (appos)
electro-oculography . (punct)
attacks onset (compound)
extended-interval and (cc)
correlated to (mark)
delay its (nmod:poss)
tenfold about (case)
dse of (case)
participation ototoxicity (nmod)
review options (dobj)
isolated rats (nmod)
ascribed because (mark)
showed anatomy (dobj)
weight space (conj)
excretion nag (compound)
allowed us (dobj)
lower mmol/l (nmod)
annulus around (case)
analyses from (case)
acid periconceptional (amod)
determine vulnerable (ccomp)
increased injection (nsubj)
mice lithium-treated (amod)
6 5 (compound)
potentiation and (cc)
investigation are (cop)
man 49-year-old (amod)
fentanyl morphine (conj)
components processes (nmod)
regions brain (compound)
antioxidant properties (dobj)
revai 1967 (nummod)
indicate shows (ccomp)
phase recovery (compound)
interval 7.5 (nummod)
diagnosis histopathologic (amod)
delivery of (case)
placebo n=10 (appos)
organs multiple (amod)
generation fr (nmod)
durations time (appos)
occlusion 20-s (amod)
reaffirms . (punct)
seizure failure (nmod)
test patients (nsubj)
component sirolimus (nsubj)
percentage . (punct)
participated women (nsubj)
frequent although (mark)
smear peripheral (amod)
pheochromocytoma unmasked (acl)
d oral (amod)
evidence observed (acl:relcl)
states drug (compound)
mixture of (case)
tricuspid : (punct)
represented frequencies (nsubjpass)
reducing nephrotoxicity (dobj)
mg/kg ] (punct)
increased duration (nsubjpass)
relief headache (compound)
bid haloperidol (conj)
titrated randomized (conj)
levels i.p. (advmod)
state cytochrome (compound)
hemorrhagic thromboembolic (conj)
instillation following (case)
developed > (dobj)
burn topical (amod)
users or (cc)
nodosa classical (amod)
ezetimibe agent (conj)
evoked concentration (nsubj)
recovery along (case)
nerve of (case)
induce combination (nsubj)
p<0.001 respectively (advmod)
change parameters (compound)
increased pmol (nmod)
relationship causal (amod)
polyuria defect (conj)
series tests (nmod)
terfenadine terodiline (conj)
13th on (case)
carried therefore (advmod)
increment each (det)
vf ( (punct)
evidence hepatotoxicity (nmod)
val mg (conj)
svr biological (conj)
children these (det)
administration material (nmod)
metoprolol aspirin (conj)
commenced cdt (nsubjpass)
feeding amounts (nmod)
5.4 1.1 (nummod)
cervical and (cc)
rigidity to (case)
amphotericin of (case)
1 least (advmod)
treated ' (punct)
delivery during (case)
predisposes sleep (nmod)
recognize manage (conj)
old 57-year (amod)
exposures chemical (compound)
time-dependent in (case)
sfas serum (compound)
ziprasidone by (case)
design evaluated (dep)
influence 10(-4 (nmod)
oxide apoptosis (conj)
responses blood (compound)
ps in (case)
arrhythmogenicity cultures (nmod)
function postoperative (amod)
(lev)-induced encephalopathy (advmod)
appear while (mark)
higher diclofenac (advcl)
started mice (nsubj)
% 60 (nummod)
administration lmwh (compound)
changes function (compound)
use procedure (conj)
cases pattern (conj)
undergo transplantation (dobj)
% nausea (conj)
animals animals (conj)
cognitive and (cc)
effective outpatient (conj)
reported insurance (nmod)
shr male (amod)
days few (amod)
dystrophy adult (amod)
exhibit animals (nmod)
was heterogeneity (nsubj)
history maternal (amod)
performed nine (conj)
open is (cop)
change gr (nsubj)
39.5+/-8.4s was (cop)
measure seizures (nmod)
region dg (compound)
feared ; (punct)
development immunomodulation (conj)
monitor noninvasive (amod)
micrograms/mouse 50 (nummod)
receiving agent (dobj)
g injection (nmod)
reticulum microtubules (conj)
identified is (auxpass)
nuclei in (case)
five patients (nmod)
compare we (nsubj)
mg additional (amod)
eye 1 (nummod)
corticoid of (case)
examined populations (nsubjpass)
reported whom (nsubj)
ctc-nci 1/2/3 (punct)
expectancy patients (nmod)
raynaud 's (case)
has function (dobj)
flows blood (compound)
month during (case)
histology micronodular (amod)
pk ) (punct)
carbachol atp (conj)
amnesia response (nmod)
effects hepatotoxicity (nsubj)
increase filtration (nmod)
hypotension morphine-induced (amod)
preparations strip (compound)
oedema lesions (nmod)
use ecstasy (compound)
recurrent azithromycin-induced (conj)
cannulated region (nmod)
recorded we (nsubj)
decreased degree (conj)
5 to (quantmod)
patients mc (compound)
higher reports (nmod)
accompanied decline (nsubjpass)
women among (case)
immunosuppression adequate (amod)
analog norepinephrine (nmod)
182 16 (conj)
lesser much (advmod)
emerged which (nmod)
show association (dobj)
modifiable which (nsubj)
potentiates and (cc)
case agranulocytosis (nmod)
mediated were (auxpass)
itself or (cc)
two one (nmod)
homogenates cortical (amod)
puncture or (cc)
nerves cervical (amod)
area hypoperfusion (nmod)
dependent age (nmod)
which at (case)
ser311cys rs6277 (conj)
narrowing arteries (nmod)
puberty during (case)
or 97201 (nummod)
connects actin (dobj)
perimetry conventional (amod)
liver a (det)
doxil ) (punct)
mg/kg 200 (nummod)
study nationwide (amod)
people trimethoprim (appos)
angiograms 3,774 (nummod)
mechanism likely (amod)
block bundle (compound)
excluded study (nmod)
hus idiopathic (amod)
knife group (conj)
nerve eye (nmod)
4.3+/-1.9 , (punct)
indicate lower (ccomp)
cerebellum for (case)
using paradigm (dobj)
aminotransferase with (case)
ratio incidence (compound)
pathogenesis the (det)
weeks pre-treatment (dep)
incidence visits (nmod)
suggested thrombosis (nsubjpass)
a acid (compound)
signs obstruction (nmod)
concentrations tobramycin (compound)
(na k)-atpase (conj)
reduction gfr (nmod)
receptor toll-like (amod)
trated total (nsubjpass)
majority 29 (nummod)
patients grade (nmod)
overload regulation (nmod)
estrogens of (case)
women increased (dep)
u/l of (case)
improvements relative (amod)
parasympathetic responses (dep)
sedation ketamine (compound)
delta including (case)
cases more (amod)
reversibility to (case)
administration amphotercin (compound)
trimethaphan i.v. (appos)
ti ( (punct)
remedy be (cop)
conclusions neurotoxic (appos)
tpp ) (punct)
ascites extensive (amod)
neurotoxicity direct (amod)
cells increased (amod)
cells drg (compound)
recommended screening (nsubjpass)
0.25 from (case)
side-effects prednisolone (nmod)
association attacks (nmod)
syndrome syndrome (conj)
seizure absence (nsubj)
thiosulphate and (cc)
bupivacaine titrated (acl)
seconds or=26 (compound)
ratios body (compound)
under-appreciated and (cc)
trained location (nmod)
effect use (nmod)
1.24 ) (punct)
extension tqrs (appos)
suggest explanation (dobj)
cortex not (neg)
quality and (cc)
characteristics its (nmod:poss)
level high (amod)
appears associated (xcomp)
thickened decreased (conj)
47.5 - (punct)
useful is (cop)
dose busulfan (nmod)
undergoes area (nsubj)
combination similar (amod)
administering by (mark)
performance effect (nsubj)
antagonist receptor (compound)
agent ethambutol (nsubj)
range doses (nmod)
coadministration the (det)
15 20 (conj)
anticoagulated heparin (nmod)
improve localization (dobj)
mean flow (dobj)
dependent effects (nsubj)
decrease with (case)
retrieval animals (nmod)
cerruloplasmin e (conj)
similar regimens (nmod)
vehicle and (cc)
effects model (acl:relcl)
hydrochloride the (det)
increased ) (punct)
dose microperfusion (nmod)
reported disturbing (advcl)
sodium ) (punct)
attributed which (nsubjpass)
pathway cardioprotective (amod)
inhibitor l-nil (dep)
analysis expression (nmod)
receptors nk1 (compound)
reduction concomitant (amod)
reports older (amod)
vehicle- rats (dep)
antifungal azole (compound)
infusion subanesthetic (amod)
1082+/-245 to (case)
movements dyskinetic (amod)
profile impairment (nmod)
edrophonium before (case)
determine course (dobj)
days 3,5,7,10,17,27,41 (dep)
safe procedure (nsubj)
edema her (nmod:poss)
reported refer (xcomp)
proportion animals (nmod)
mr with (case)
antagonist l-364,718 (dep)
complication caused (acl:relcl)
doses corticosteroids (nmod)
overlooked frequently (advmod)
results male (dep)
medulla rostral (amod)
activity hippocampus (nmod)
series eight (nummod)
effects bladder (nmod)
artery ica (appos)
brainstem caudal (amod)
microscope scanning (compound)
methylphenidate with (case)
neurones noradrenergic (amod)
use women (nmod)
presence erythrocytes (nmod)
mechanism interaction (nmod)
groups clozapine (dep)
case other (nmod)
myelopathy neuropathy (conj)
potentiated attenuated (conj)
reexposure accidental (amod)
relapsed of (case)
have did (aux)
as thereafter (advmod)
blockade leading (acl)
complication : (punct)
hypokalemia terbutaline-induced (amod)
congestants , (punct)
behaviors to (case)
represented treatment (dobj)
seen overshooting (nmod)
normal children (nmod)
groups low-dose (amod)
recorded effects (nsubjpass)
patients cle (nmod)
one yis (compound)
ml/min/kg td (nmod)
examination to (case)
users antiplatelet (compound)
studies , (punct)
comparative this (det)
underwent . (punct)
antidepressant is (cop)
man treated (acl:relcl)
reduction irritability (nmod)
icr sprague-dawley (compound)
diseases glomerular (amod)
received intramuscularly (advmod)
degree second (amod)
clearance renal (amod)
transplantations 25 (nummod)
points multiple (amod)
pergolide the (det)
maximum when (advmod)
involved receptors (nsubjpass)
model used (acl)
oih of (case)
response rapid (amod)
treated d-pen (nmod)
% 2.4 (nummod)
reduces genotoxicity (dobj)
% 3.8 (appos)
scale neuropsychiatric-like (amod)
clearance of (case)
walls of (case)
complication ophthalmic (amod)
glomerulonephritis , (punct)
g 120 (nummod)
tafi plasma (compound)
morphine mg/kg (nmod)
important catalepsy (nmod)
enhance effects (dobj)
mph at (case)
attack therapy (nmod)
naloxone ) (punct)
behaviors dopamine-dependent (amod)
presence acetaminophen (nmod)
bupivacaine the (det)
expressed transiently (advmod)
increased peroxidation (dobj)
2 ) (punct)
considered are (auxpass)
safety tolerability (conj)
pathways underlying (acl)
is/tia 3817 (nummod)
likely predisposed (ccomp)
measure(s outcome (compound)
injection preoperative (amod)
ng/mouse 10 (nummod)
liability the (det)
efficacy replication (compound)
detrusor of (case)
ltp morphine-inhibited (amod)
free . (punct)
disappeared negative (advcl)
ng/ml 352 (nummod)
syndrome transplant (nmod)
subsided rapidly (advmod)
recording by (mark)
interaction taking (acl:relcl)
resulted mg (nsubj)
2 : (punct)
revealed necropsy (nsubj)
published study (conj)
status i (dep)
imaging tomography (compound)
7th and (cc)
subsides rapidly (advmod)
siadh ( (punct)
acting adrenoceptors (nmod)
prescribed . (punct)
administration cyp (nmod)
increased filling (xcomp)
agent alternate (amod)
status 1 (nmod)
sign only (amod)
advanced developing (conj)
metrifonate the (det)
developed who (nsubj)
analysis for (case)
lesions stn (nmod)
cocaine regular (amod)
weeks 36 (nummod)
subunit of (case)
effect mazindol (nmod)
identified time (nmod)
given % (nmod)
microscopy light- (amod)
acquired were (auxpass)
effect renoprotective (amod)
asa mg/kg (appos)
constitutes that (mark)
treated saline (nmod:npmod)
provides conversion (nsubj)
associated inhibition (nmod)
resistance 0.001 (nmod)
% contributions (conj)
accumulation its (nmod:poss)
serum gene (conj)
prepare stable (conj)
pneumonia health-care-associated (amod)
findings electro-diagnostic (amod)
consists that (mark)
appearance gender (appos)
members best-known (amod)
clozapine only (advmod)
antagonist 1,5-benzothiazepine (amod)
cancer recorded (acl)
lipocalin and (cc)
mechanism an (det)
granulocytes the (det)
ameliorate alpha-tc (nsubj)
activation damage (nmod)
quinine- k(+)-channels (dep)
extent a (det)
measured : (punct)
showed they (nsubj)
block in (case)
changes expression (nmod)
transporter this (det)
pretreatment a (det)
pravastatin , (punct)
dopamine da (appos)
examinable 34 (nsubj)
defend assaults (nmod)
stroke and (cc)
damage progressive (amod)
antidepressant a (det)
function improved (amod)
velocity the (det)
adult male (amod)
recorded all (advmod)
ineffective injections (nsubj)
discharge records (dobj)
ginsenosides . (punct)
neurotoxicity serious (amod)
use cramps (nmod)
died event (nmod)
grafting dose (nmod)
avoided might (aux)
delays effect (dobj)
induced rat (nmod)
instillation intrathecal (amod)
globulin treatment (nmod)
beating action (conj)
re rg1 (conj)
injection mg/kg/i.v (dep)
properties muscle (compound)
hydrochloride-induced bupropion (nmod:npmod)
beta channel (compound)
likely result (xcomp)
experts of (case)
aspects functional (amod)
hemodynamic on (case)
magnitude of (case)
groups chi2-test (nmod)
matter plasma (compound)
2.0/100,000 ( (punct)
past and (cc)
women men (nmod)
introduced is (auxpass)
= > (compound)
nissl-staining antibodies (conj)
indicate effect (dobj)
correlates dose (nmod)
buffer tris (compound)
osmolality plasma (compound)
caused coniine (nmod)
take to (mark)
disorders vasculitic (amod)
design cross-sectional (amod)
groups drugs (nmod)
vacuolization cell (compound)
required where (advmod)
2 - (punct)
highlight findings (nsubj)
compared material (nsubjpass)
increase can (aux)
rose titer (nsubj)
induced myodystrophy (dobj)
higher consistently (advmod)
studies cb (nmod)
patients known (acl)
consisted infusion (nmod)
space the (det)
developed bradyarrhythmias (dobj)
recorded min (nmod)
ammonia blood (compound)
change indomethacin (nsubj)
icv ; (punct)
dyspnoea . (punct)
drugs implicated (acl)
examinations repeated (amod)
changes induced (acl)
nephrotoxicity required (conj)
cell foot (conj)
follow-up life-long (amod)
decreased increasing (advcl)
mmhg . (punct)
infarctions with (case)
caused abolished (conj)
show has (ccomp)
pressure voiding (amod)
concentrate urine (dobj)
biopsy at (case)
pbo li/dvp (conj)
actions pentobarbital (nmod)
absence transferase (nmod)
= 0.05 (dep)
herbs by (case)
methadone agonist (compound)
hypertension concentration (conj)
agents antipsychotic (amod)
synthase , (punct)
mg/kg ; (punct)
water ) (punct)
s1 % (appos)
report neonates (dobj)
chx for (case)
production matrix (compound)
excretion sodium (nmod)
punctata ( (punct)
necrosis papillary (compound)
antioxidant neuro-protective (conj)
coexistence . (punct)
values control (compound)
measures repeated (amod)
schoolchildren in (case)
users 3,4-methylenedioxymethamphetamine (nmod)
increase gaba (nmod)
capsules gt/bc (appos)
achievable doses (nmod)
alpha-tc and (cc)
lt after (case)
blockers of (case)
mg/m2 paclitaxel (compound)
represent mitochondria (nsubj)
resolution complete (amod)
decreased 86 (nmod)
catalepsy locomotion (conj)
limit pg/ml (appos)
children 123 (nummod)
synthase-1 in (case)
have affinities (dobj)
relief pain (nmod)
dyskinetic , (punct)
pathways neutral (amod)
accumulation lysozyme (nmod)
enhance and (cc)
induced sulpiride (nmod)
depressed resolved (conj)
1.56 nsaids (nmod)
d on (case)
syncope dexmedetomidine (nmod)
showed tomography (nsubj)
emergence delayed (amod)
movement subsequent (amod)
associated syndrome (conj)
residues cytosine (compound)
prevent hypoactivity (dobj)
calculation ( (punct)
induced blockers (nmod)
damage production (nmod)
scores ii (nummod)
stimulation dopaminergic (amod)
derivative sulfate (compound)
rectified . (punct)
hcl with (case)
pain . (punct)
2.5 0.7 (appos)
suggested reports (nmod)
bsc-1 ) (punct)
monoher ) (punct)
targeted liver (nmod)
bodyweight , (punct)
examined role (nsubjpass)
examination kidneys (nmod)
striatum rats (nmod)
130 67 (conj)
cerebri pseudotumor (compound)
induction . (punct)
lipophages fat (nmod)
mtd ( (punct)
showed clubs (dobj)
toxicity brain (acl)
study finding (compound)
normal than (case)
mtor ( (punct)
determined prolactin (nsubjpass)
effective achieving (advcl)
polypeptide vip (appos)
blockade dmpx (nmod)
alkaloid major (amod)
diazinon the (det)
toxicity normal (amod)
remained stable (xcomp)
naloxazone with (case)
indomethacin either (cc:preconj)
induce trees (nmod)
disease reversible (amod)
mmol/l 63 (nummod)
1985 to (case)
present level (nmod)
months duration (nsubj)
changed were (auxpass)
implanted s.c. (xcomp)
attributed some (nsubjpass)
99 95 (conj)
regimen a (det)
improvement despite (case)
scores pain (nmod)
s 557 (nummod)
undergoing while (mark)
treatment analgesic (compound)
expression genes (nmod)
loss total (amod)
reports nephropathy (nmod)
numbers neurons (nmod)
regimen popular (amod)
concentrations mg. (compound)
users mdma+ (compound)
yr mean (compound)
depression cortical (amod)
tumors , (punct)
analogs of (case)
report failure (nmod)
changes caffeine-induced (amod)
deactivated organophosphorus (nmod)
asymptomatic and (cc)
anemia hemolytic (compound)
carried decompression (nsubjpass)
tests antibodies (nmod)
active treatment (nmod)
tremor convulsions (dep)
alcohol and (cc)
scopolamine amnesia (dep)
smoked baseline (nmod)
cell one (nummod)
muscles extraocular (amod)
development ari (nmod)
dose function (conj)
756 mcg (appos)
has systemic (dobj)
rate that (advmod)
toxic heart (nmod)
quantitate moderate (nmod)
mask and (cc)
interviewed experience (nmod)
responsible potassium (nmod)
growth on (case)
quantified . (punct)
urea in (case)
predict may (aux)
medication or (dep)
resulted also (advmod)
species both (det)
had lethargy (dobj)
females 7 (nummod)
signs poisoning (nmod)
intersections of (case)
infarction observations (dep)
mcao ( (punct)
process intestine (nmod)
company corporation (conj)
nra0160 ) (punct)
demographics patient (compound)
daytime and (cc)
suitable drug (nmod)
them to (case)
-54 11 (conj)
improved still (advmod)
follow-up be (cop)
undertook methods (dep)
position in (case)
guidelines evidence-based (amod)
responsible part (nmod)
one adverse (conj)
recall identify (conj)
mid- long-term (conj)
quintiles intake (nmod)
incidence parkinsonism (nmod)
antagonists for (case)
ras ) (punct)
injection post-cocaine (amod)
interactions , (punct)
containing acid (dobj)
limit however (advmod)
system fas/fas (compound)
apnea sleep (compound)
inhibited i.e. (dep)
megaloblastosis by (case)
1mg/kg i.p. (acl)
tomography on (case)
mean iqr (appos)
mg/100 1 (compound)
studies conducted (acl)
spasm localized (amod)
birth administration (nsubj)
1.3 - (punct)
demonstrated paclitaxel (nsubj)
assessing exposure (dobj)
revealed group (nmod)
evident levels (nmod)
therapeutic prophylactic (conj)
awake , (punct)
toxicity decrease (compound)
16 only (advmod)
monotherapy and (cc)
symptoms rls (nmod)
170 +/- (cc)
decreased mek1 (nsubjpass)
sensitization sera (nmod)
bolus microg/kg (compound)
group enalapril-treated (amod)
rs4704559 , (punct)
observed controlled (conj)
produce close (dobj)
cases 80 (nummod)
potential nerve (nmod)
suggested as (mark)
alkaloid a (det)
dogs susceptible (amod)
i 9.10 (conj)
lasting pervasive (conj)
catecholamines of (case)
evoked caused (conj)
pathway in (case)
interactions reticulo-thalamic (amod)
therapy combined (amod)
contributes vivo (advmod)
p = (amod)
instillation intracorporal (amod)
changes indomethacin-induced (amod)
examined movement (nsubjpass)
pressure force (conj)
surgery lower (amod)
mg/kg/day 4 (nummod)
overnight flow (compound)
using it (dobj)
blockade non-selective (amod)
vnr ) (punct)
reaction suspected (amod)
fluoxetine , (punct)
behavior wds (compound)
suffers lesion (nmod)
feasibility application (nmod)
visits 10.3 (nummod)
protected first (advmod)
alert that (mark)
administration magnesium (compound)
normal in (case)
impairment known (amod)
described decrease (advcl)
blockade receptors (nmod)
deviation pressure (nmod)
suggest presentation (nsubj)
showed time (dobj)
activity enzyme (compound)
upregulation gabab (compound)
reduces anemia (nsubj)
drug used (amod)
iv ( (punct)
lower shr (nmod)
components essential (amod)
test assay (nmod)
dosed , (punct)
tremor postural (amod)
studied ameliorating (advcl)
causes similar (advcl)
effects involving (acl)
effective safe (conj)
operative case (nmod)
stimulation no (neg)
dh ( (punct)
group vehicle-treated (amod)
synthase factor-kappab (conj)
clopidogrel agent (compound)
patients dysfunction (nmod)
period min (compound)
effect migraine-inducing (amod)
inflammation of (case)
scale marital (compound)
useful monitored (conj)
indicated not (neg)
sufficient developed (advcl)
proposed . (punct)
thiosulphate due (case)
protection for (case)
disease later (advmod)
is although (mark)
related intensity (nmod)
areas residual (amod)
days 17 (nummod)
had using (advcl)
cystitis abnormalities (dep)
induces stones (dobj)
lower subjects (nmod)
associated hypertension (nmod)
biomarker replacement (nmod)
samples assay (conj)
hrs 8 (nummod)
heart-rate and (cc)
77 - (punct)
capacity receptor (compound)
leukemia b-cell (compound)
effects lithium (nmod)
mmrm subscale (conj)
leucemia recurrent (amod)
describe reported (advcl)
mtx 5-fu (conj)
behavior mania-like (amod)
consuming diet (dobj)
decrease resultant (amod)
test kruskal-wallis (compound)
deferoxamine of (case)
mechanical implants (dep)
desensitization alpha (nmod)
use lopinavir/ritonavir (nmod)
period interictal (amod)
sessions within (case)
injected needle (nmod)
downregulation angiogenesis (nmod)
75 12.5 (compound)
infarction relation (conj)
occurred hours (nmod)
8-week was (cop)
animals received (acl:relcl)
receiving plans (nmod)
post-training weeks (nmod:npmod)
presents report (nsubj)
over-immunosuppression antiviral (conj)
demonstrated results (dep)
necrosis prior (amod)
methoxamine placebo (conj)
selected minutes (dep)
role arrest (nmod)
patients 7 (conj)
reinstated be (auxpass)
hypoperfusion cortical (amod)
cause hypercalcemia (nmod)
efficacies their (nmod:poss)
death toxic (amod)
scale in (case)
concentration microg/l (nmod)
leads while (mark)
reported manifestation (nmod)
etomidate : (punct)
carbamylcholin of (case)
explain changes (nsubj)
heavy ex-mdma+ (conj)
induced tamoxifen (nmod)
reacted suggesting (advcl)
toxicity amns (nmod)
associated leukemia (nmod)
compare here (advmod)
patients sle (compound)
due genes (nmod)
rats the (det)
damage microscopic (amod)
line , (punct)
dose % (nmod)
series and (cc)
provides model (dobj)
taking vpa (dobj)
thrombosis arterial (amod)
association cyclophosphamide (nmod)
fed pair (nmod:npmod)
occurred nephrotoxicity (nsubj)
dose mg/week (conj)
transplantation donor (compound)
development fetal (amod)
thrombosis the (det)
results 400 (nmod)
therapy amitriptyline (compound)
reversed completely (advmod)
rats supplemented (acl:relcl)
used mapping (nsubjpass)
initiated when (advmod)
decreased amount (nsubj)
refractory who (nsubj)
consequences serious (amod)
reported who (nsubjpass)
monitored biochemically (advmod)
crosses and (cc)
discontinuous more (advmod)
bolus groups (appos)
docetaxel mg/m2/week (dep)
clotting blood (compound)
administration tariquidar (conj)
documented not (neg)
ems six (nummod)
obvious available (conj)
maintained was (auxpass)
14.9 2.4 (conj)
clinical hemolysis (nmod)
achieve area (dobj)
levels oxide (compound)
rosacea and (cc)
segmental rifampicin-associated (amod)
shown indicate (conj)
cardiotoxicity were (cop)
case unusual (amod)
pge1 of (case)
only to (case)
known however (advmod)
dexamphetamine- and (cc)
operated . (punct)
strips inflamed (amod)
effective efficacious (conj)
motility exploratory (amod)
hit for (case)
p45 ) (punct)
reduction smaller (amod)
other 17 (nummod)
discontinued was (auxpass)
level ck-mb (compound)
chlorofluorocarbons for (case)
results investigations (conj)
hyperhidrosis of (case)
cancers tube (compound)
hb , (punct)
trial foreshortened (amod)
higher dose (nmod)
group x(2 (appos)
167 +/- (cc)
tolerated were (conj)
frequency ( (punct)
courses and (cc)
april from (case)
pregnane-21-diol-20-ones 3 (nummod)
failed but (cc)
vpu mg/kg (appos)
cardiomyocytes cell-derived (amod)
alter decreased (conj)
triad catalytic (amod)
epss in (case)
increased concentration (nsubj)
acid protease (conj)
cells ) (punct)
created spain (nmod)
group years (conj)
uptake fractions (nmod)
mania antibiomania (appos)
mrna ppargamma (compound)
chronic from (case)
micromol/l > (compound)
raises support (advcl)
interference imipramine (nmod)
patients abnormalities (nmod)
lesion the (det)
therapies from (case)
discontinuation alpha-2b (nmod)
juice either (cc:preconj)
celecoxib to (case)
improve monitoring (advcl)
catalepsy on (case)
piloerection associated (amod)
testing often (advmod)
admitted anticoagulated (advcl)
effect placebo (nmod)
mumol/l. 10 (nummod)
levels during (case)
effects neurotensin (nmod)
nurse a (det)
caffeine without (conj)
changes cd4 (nmod)
reported encephalopathy (nsubjpass)
consultations medical (amod)
latter of (case)
mechanisms related (amod)
oxidase cytochrome-c (compound)
maintenance steering (conj)
depletions of (case)
using events (dobj)
cause abolished (conj)
teratogenic sulphasalazine (nsubj)
concentrations free (amod)
mrna angiotensinogen (compound)
completing immediately (advmod)
adenosine cpa (appos)
duration 24.3+/-6.8s (appos)
1.0 1.84 (conj)
studies neuronanatomical (amod)
valproate carbamazepine (conj)
carcinoma for (case)
catheter infusions (nmod)
resurgence utilization (nmod)
mg./kg under (case)
u mann-whitney (compound)
intake before (nmod)
25 of (case)
min at (case)
seen when (advmod)
ts isolated (amod)
therapy ritodrine (compound)
effects nitroglycerin (nmod)
toxicity cns (compound)
group mumol/l (appos)
patients matched (acl:relcl)
banks eye (compound)
woman japanese (amod)
considered may (aux)
pharmacotherapy fluoxetine (compound)
bile supersaturated (amod)
continued safely (advmod)
toxicity urothelial (amod)
cancer receiving (acl)
thrombocytopenia no (det)
injection phentolamine (conj)
wistar female (compound)
performed techniques (nsubjpass)
shows (ee)-induced (ccomp)
developed complications (nsubj)
unresponsive toxicity (nmod)
alternatives , (punct)
minimised , (punct)
factors impairment (nmod)
vasodilators fenoldopam (conj)
b phase (compound)
loading d (nmod)
diet comprised (acl)
support units (dep)
activity levels (conj)
internus pallidus (compound)
important exposure (nmod)
age dose (conj)
stopped was (auxpass)
reexposure patient (nmod)
severity with (case)
left of (case)
consider acetaminophen (dobj)
it-methotrexate with (case)
respect recognition (nmod)
loosening . (punct)
overexpression bbb (nmod)
dose known (amod)
cortisol diurnal (amod)
design series (dep)
dtis ) (punct)
heredofamilial connective (conj)
1.037 ) (punct)
6.2 30.8 (conj)
was similar (conj)
developed model (nmod)
anemia/thrombocytopenia/emesis/rash n (dep)
antagonized , (punct)
divided daily (advmod)
related hyperkinesia (nmod)
affect one (nsubj)
values mean (compound)
treatment ee (compound)
decreased pod (nmod)
tiva ) (punct)
chemoconvulsants opener (dep)
thrombi arteriolar (amod)
failure administration (nmod)
caused partition (nmod)
mumol 0.2 (nummod)
onset history (conj)
salicylate 174 (dep)
nephropathy salicylate (compound)
subscale scale (compound)
activity dehydrogenase (nmod)
generations the (det)
approach proteomic (amod)
members plan (nmod)
replacement testosterone (compound)
linkages hydroxyl (compound)
circulations in (case)
mechanisms pathogenic (amod)
having mice (nsubj)
25 at (case)
erythroblasts bone (compound)
chicks in (case)
induces aggravates (conj)
shelf the (det)
results reduce (appos)
elevation sensitivity (dep)
exacerbates inhibition (nsubj)
developed chorea (dobj)
gamma-vinyl-gaba of (case)
cause pethidine (nsubj)
regulation via (case)
describe dobutamine (dobj)
recording states (dobj)
significant exam (nsubj)
changes kidney (conj)
kept it (nmod)
exceed monitored (conj)
syndrome coarctation (conj)
gliomas near (case)
likely associated (xcomp)
demonstrated oedema (dobj)
signs no (det)
effects effects (nmod)
replicated and (cc)
pregnancy advanced (amod)
bile all (conj)
concluded plays (ccomp)
interview before (case)
donation volunteer (compound)
radicals cytotoxic (amod)
17 only (advmod)
action morphine (nmod)
phenacetin and (cc)
schedules bolus (compound)
findings imaging (nmod)
impairment pathways (nmod)
dysphonia for (case)
consciousness vital (conj)
neonates 2 (nsubj)
increased p75(ntr)-ir (nsubjpass)
ccnu combined (acl)
count in (case)
volume forced (amod)
affect schedule (nsubj)
data study (dep)
effects anticonvulsant (amod)
glaucoma steroid (compound)
suggest dose-dependent (ccomp)
applied treatment (nsubjpass)
products both (det)
capable preventing (advcl)
bacl2 cent (nmod)
were patients (nmod)
reason , (punct)
6 was (cop)
combination acid (nmod)
received achieved (advcl)
5-azc and (cc)
exposure lifetime (compound)
mice immunodeficient (amod)
medication is (cop)
thrombocytopenia a (det)
induced was (auxpass)
products peroxidation (compound)
upregulation the (det)
week from (case)
scr a (det)
increased less (dobj)
epithelium bladder (nmod)
devlin et (compound)
1.03 0.04 (conj)
total greater (amod)
disappeared jaundice (nsubj)
action nerve (compound)
86 from (case)
flecainide between (case)
lasted s (dobj)
dyscrasias blood (compound)
venous . (punct)
analysis single-center (amod)
10.3 +/- (cc)
sets in (case)
damage peripheral (amod)
wt body (compound)
patients months (appos)
flutter afl (appos)
march 2000 (nummod)
alleviated enabling (advcl)
thirty-nine , (punct)
fell hours (nmod)
disturbance with (case)
pro-arrhythmic also (advmod)
received propranolol (dobj)
vaccinated who (nsubjpass)
bradykinin d-arg-[hyp3,thi5,d-tic7,oic8 (compound)
modulates rtms (nsubj)
give data (nsubj)
protectors cardiotoxicity (nmod)
bergmann particular (amod)
followed described (advcl)
autoantibodies cytoplasmic (amod)
lowering property (dobj)
common diarrhea (nsubj)
calculi of (case)
shown effective (xcomp)
done been (auxpass)
caused hypertension (nmod)
minutes p (dep)
patients period (nmod)
tested has (aux)
irrigation a (det)
occurred : (punct)
changes m.s. (compound)
receptors sigma2 (compound)
consists affects (conj)
differences drugs (nmod)
subjects attack (nmod)
comparison in (case)
treatment acute (amod)
prescribed developed (conj)
receiving selegiline (dobj)
varied efficacy (nsubj)
concentrations csf (compound)
produces succinylcholine (nsubj)
limbs his (nmod:poss)
suggested induce (ccomp)
moderate-dose cells (dep)
discriminations sound-silence (amod)
day following (amod)
9.4 +/- (cc)
frs the (det)
interval 5-min (amod)
cis-ra of (case)
suggested also (advmod)
administration veterans (compound)
problems toxicity (nmod)
loss subjective (amod)
effects observed (acl)
val or (cc)
epileptogenecity the (det)
reactivity in (case)
magnitude profile (conj)
trialists and (cc)
characterized infiltration (nmod)
remarkable . (punct)
rats min (dep)
effects processing (nmod)
concern for (case)
153 19/92 (conj)
absent or (cc)
factor nuclear (amod)
duration seizure (amod)
attenuation vascular (amod)
effects powerful (amod)
movements associated (acl)
unresponsiveness that (mark)
expression npy (compound)
insight new (amod)
acid mrna (appos)
elevated epm (appos)
seconds minutes (nmod)
renal not (neg)
68 and (cc)
any variables (nmod)
mediated group (advcl)
effects these (det)
number women (nmod)
dependent status (nmod)
sites cortex (nmod)
function p2x3 (nmod)
adrenaline not (cc)
support education (conj)
size pool (compound)
proteinuric , (punct)
trial , (punct)
states and (cc)
shr than (case)
diazinon induced (dep)
constant time (compound)
abbott-53693 of (case)
increase arrhythmogenicity (nmod)
ameliorated decrease (nmod)
monitored versa (advmod)
aids ( (punct)
basis dose (nmod)
regimens cisplatin-containing (amod)
accumulation amphotericin (compound)
roots the (det)
agents and (cc)
mechanism barbiturate (compound)
recognize reason (nmod)
pharmacokinetics levetiracetam (nmod)
therapy age (conj)
6/15 . (punct)
average an (det)
shortening interval (nmod)
outcomes polysomnographic (amod)
hyperplasia nodular (amod)
demonstrates model (nsubj)
induced predominantly (advmod)
fever rash (conj)
pressure artery (compound)
different atenolol (nmod)
enhanced whereas (dep)
anemia neutropenia (conj)
polydipsia of (case)
monitored tests (nmod)
negative , (punct)
systemic mucosal (conj)
patients schizophrenic (amod)
assay colony (compound)
administered placebo (nsubjpass)
df = (amod)
had 1b (dobj)
tacrine 5mg/kg (appos)
associated been (auxpass)
isomers effects (conj)
used applied (conj)
estimated rats (nmod)
hospitalised . (punct)
lack ilk (nmod)
anemia an (det)
regimen rifampin (nmod)
99 to (dep)
unlikely associated (xcomp)
supersensitivity and (cc)
presented eruption (nmod)
parasympathetic and (cc)
evaluate should (aux)
stage yahr (compound)
pressure formation (conj)
secondary isoniazid (nmod)
children hyperglycinemia (nmod)
file hospital (compound)
determine dose-dependent (ccomp)
fatal it (nsubj)
simvastatin mg (compound)
numbers dibucaine (compound)
inhibits development (dobj)
managed % (nsubjpass)
cross-tolerant tolerant (nsubj)
activity daunorubicin (compound)
responders in (case)
reduced insufficiency (dobj)
progressed two (nmod)
increased not (neg)
effects kg-1 (conj)
population : (punct)
strategies , (punct)
quinine sulfate (amod)
described representing (xcomp)
january august (nmod)
lamivudine antiviral (amod)
suspect . (punct)
restored but (cc)
majority % (dep)
assayed were (auxpass)
monitored nephrotoxicity (nsubjpass)
associated tap (nmod)
arf in (case)
brainstem but (cc)
injury isoproterenol-induced (amod)
three approximately (advmod)
duration period (conj)
injection etomidate (amod)
2 . (punct)
cocaine- amphetamine-induced (conj)
sampled retrospectively (advmod)
11 to (quantmod)
enhanced dysrhythmogenicity (nsubjpass)
overactivation and (cc)
stream in (case)
addressing need (dobj)
mds ) (punct)
women particularly (advmod)
total intracorporeal (compound)
marker protein (compound)
helpful distinguishing (advcl)
proteinuria reversible (amod)
exchanges index (conj)
plays mechanisms (nmod)
smaller strips (nmod)
therapy respectively (advmod)
involvement mechanisms (nmod)
years , (punct)
12 three (quantmod)
injections addition (nmod)
become has (aux)
perturbations with (case)
angiography green (amod)
ssr103800 p.o. (appos)
discontinued nephrotoxicity (nmod)
complete obtained (conj)
before months (nmod:npmod)
neutropenia to (case)
% 20.0 (nummod)
acted ra (nsubj)
crf ( (punct)
found hearts (nmod)
attempts examine (xcomp)
group - (punct)
formulation american (amod)
events need (conj)
rigidity in (case)
breath mechanical (amod)
lacnp with (case)
clinical measurements (dep)
combination face (nmod)
patients mbc (nmod)
injury percentage (appos)
rats fischer (compound)
lumens of (case)
linked has (aux)
patients considered (acl)
vulnerability differential (amod)
published not (neg)
48 +/- (cc)
preceding bupivacaine (dobj)
stable when (advmod)
view the (det)
cycles mg/m(2 (appos)
low-dose ) (punct)
associated infants (nmod)
diazinon insecticide (compound)
compared signs (nsubjpass)
relationship temporal (amod)
antagonists h2-histamine (amod)
same age (nsubj)
bbb ( (punct)
presentation after (case)
axons nerve (nmod)
latency rats (nmod)
protection seizure (amod)
estimated difference (dobj)
ctc-nci syndrome (conj)
seizures audiogenic (amod)
performed pallidotomies (nsubjpass)
groups clozapine- (amod)
seen addition (nmod)
hepatitis . (punct)
depressed rate (nsubj)
remain hypotensive (xcomp)
concentrations potassium (compound)
effects quinine (nmod)
complication unexpected (amod)
resolved h (nmod)
coli aeruginosa (conj)
suspected myositis (nsubjpass)
curve displacement-time (amod)
affects stimulation (nsubj)
diagnoses psychiatric (amod)
rct 1 (nummod)
paralysis vocal (amod)
administered doses (dobj)
blocker new (amod)
low has (aux)
concerns nonpharmacologic (amod)
differences not (neg)
patients over (case)
synthesis ribosomal (amod)
convulsions induced (acl)
activities social (amod)
failure acid-induced (amod)
glibenclamide p=0.099 (appos)
occurs arterioles (nmod)
environment an (det)
induced ssris (nmod)
found incidence (nmod)
received iv (dep)
measured ccb (nsubjpass)
% associated (advcl)
blotting and (cc)
collected population (nmod)
prescribing drugs (dobj)
nodules extremities (nmod)
functions cognitive (amod)
haemorrhage with (case)
uneventful reported (conj)
initiated practitioners (nmod)
disoproxil to (case)
associated developed (conj)
treated resulting (advcl)
mm 25.4 (nummod)
mortality pbsct (nmod)
stz groups (dep)
degeneration extensive (amod)
role syndrome (nmod)
group 12.3 (appos)
blockers the (det)
t mg/kg (appos)
stores renal (amod)
damage with (case)
score by (case)
hydromorphone ( (punct)
mg/day 150 (nummod)
event in (case)
respiratory and (cc)
2/1 occasional (amod)
emit . (punct)
pairs 44 (nummod)
resulted exposure (nsubj)
detected autoantibodies (nsubjpass)
dinitrate isosorbide (amod)
interleukin between (case)
pain malignant (amod)
database infarction (nmod)
period 4-week (compound)
hypotension trimethaphan-induced (amod)
19/92 +/- (cc)
administered extract (nsubjpass)
latency the (det)
consumption after (case)
area cortex (nmod)
demonstrates this (nsubj)
deprivation alone (advmod)
sequence because (case)
causing neurotoxicity (dobj)
rats right- (amod)
mtd the (det)
morphine blocker (conj)
setting an (det)
investigations radiological (amod)
placebo bpm (nmod)
sides on (case)
l. g. (conj)
ck-mb % (appos)
thalidomide mg (dep)
115 was (cop)
farmers carolina (nmod)
markers between (case)
200 than (quantmod)
same measured (advcl)
iu/kg ( (punct)
detail in (case)
62(6):865 - (punct)
effect cataleptogenic (amod)
little no (conj)
alpha3 , (punct)
mg/kg intraperitoneally (dep)
observed uptake (nsubjpass)
hemosiderosis cardiac (amod)
superior intake (nmod)
mice bd1018 (nmod)
therapy systemic (amod)
ip 100 (nummod)
fulfilled and (cc)
inferred . (punct)
activity epileptiform (compound)
backgrounds of (case)
discontinuation despite (case)
brought is (auxpass)
blocker angiotensin (compound)
giving value (dobj)
infusion b (compound)
acid ribonucleic (amod)
db 0.99 (nummod)
time total (amod)
oxypurines plasma (compound)
level blood (nmod)
c d1 (conj)
examinations patients (nmod)
injected previously (advmod)
sample small (amod)
dyskinesia pd (nmod)
ml/min/kg 1.28+/-0.33 (nummod)
hepatomegaly knockout (nmod)
hepatotoxicity to (case)
used be (auxpass)
bid and (cc)
suffered episode (dobj)
decreasing incidence (dobj)
going is (aux)
beats/min patients (nmod)
clentiazem alone (advmod)
carbimazole by (case)
treatment reserpine (compound)
zyban formulation (appos)
cause compared (advcl)
saline dexamethasone (conj)
protocols in (case)
323+/-43 ) (punct)
targeting subunits (nmod)
determine occur (ccomp)
mice . (punct)
degree although (mark)
limits levels (nsubj)
cord a (det)
decreased intensity (nsubjpass)
mi both (cc:preconj)
satisfied very (dep)
somnolent diazepam (nmod)
cancer androgen-independent (amod)
mcc ( (punct)
diagnosis rapid (amod)
reduced % (dobj)
application polfa (appos)
activity demonstrated (amod)
subjects group (nmod)
schedule given (case)
incubated buffer (nmod)
analogue 10-keto (amod)
analgesic over-the-counter (compound)
patients concentrations (nmod)
hemorrhages 53 (nummod)
disorder personality (conj)
self-treating patient (nsubj)
3 months (quantmod)
mm 0.1 (nummod)
degree hearing (advcl)
confirmed expression (dobj)
added is (auxpass)
hypotension alpha-methyldopa (amod)
conditions label-restricted (amod)
occurred but (cc)
days transplantation (nmod)
interaction fatal (amod)
ng./ml 35 (nummod)
h acquisition (nmod)
effect kaliuretic (amod)
included change (dobj)
associated agent (nsubjpass)
vomitus diarrhea (conj)
population real-world (amod)
effect are (cop)
use groups (nmod)
limiting depth (dobj)
disorders gastrointestinal (amod)
array cytokine (compound)
other and (cc)
attenuation dose-dependent (amod)
hypothesized : (punct)
objectives first (appos)
included trials (nsubjpass)
resulted increase (nsubj)
appeared foci (nsubj)
diameter the (det)
classified being (advcl)
tomography 133xe (nmod)
content but (cc)
32 481 (prep)
needed study (nsubjpass)
prevented observed (advcl)
jaw steel (nmod)
one three (conj)
inactivation actions (conj)
shell intra-accumbens (amod)
region the (det)
allele the (det)
decrease one (nmod)
expression inflammation (nmod)
possible suppress (xcomp)
jones after (case)
toxicity behavioral (amod)
reported related (xcomp)
cefonicid not (cc)
documents report (nsubj)
derangement and (cc)
challenge naloxone (compound)
trials states (nmod)
retard not (neg)
expected effective (xcomp)
analysis dynamics (conj)
68.3 +/- (cc)
promoter transporter (compound)
shown cause (xcomp)
olanzapine for (case)
abnormality . (punct)
mg glucagon (compound)
group cortical (amod)
reaction affects (acl:relcl)
site novel (amod)
tested should (aux)
logical . (punct)
different groups (nmod)
analysis chart (compound)
saline 84 (conj)
enabled and (cc)
coadministration drugs (nmod)
have therefore (advmod)
concern nephropathy (nsubj)
populations patients (nmod)
gestation , (punct)
days onset (nmod)
sas on (case)
independent surgery (nmod)
infarctions of (case)
peaked indication (dobj)
midazolam pretreatment (nsubj)
factor hypertension (nmod)
transplanted , (punct)
trials weeks (acl:relcl)
cytoprotection of (case)
15 0.5 (compound)
developed convulsions (dobj)
measured respectively (advmod)
identify oxygenation (dobj)
exhibited deterioration (dobj)
presented opportunity (dobj)
perimetry goldmann (compound)
carcinogenesis prostate (compound)
artery a (det)
olanzapine 23.9 (conj)
plasma liver (conj)
protected fall (xcomp)
mm na (compound)
identified subsequently (advmod)
meq/l 3.9 (dep)
increased years (conj)
treatment levomepromazine-fluvoxamine (amod)
effects expression (conj)
caffeine with (case)
amount including (case)
thirty-six patients (nmod)
given tri (nsubjpass)
apomorphine : (punct)
micrograms/kg/ml neonates (nmod)
week the (det)
noted cases (nmod)
phentolamine . (punct)
returned she (nsubj)
trazodone of (case)
provide inhibitors (nsubj)
potentiated scopolamine (nmod)
power a (det)
infarction edema (nmod)
administrated were (auxpass)
% 49%-83 (nummod)
had diseases (dobj)
unmasking pheochromocytoma (nmod)
uncertain still (advmod)
arrhythmias changes (nsubj)
high ; (punct)
ingredient dextromethorphan (nsubj)
reversibility . (punct)
intense and (cc)
excluding mechanism (dobj)
second several (amod)
influenced to (mark)
reticulata epilepticus (nmod)
suggestive syndrome (nmod)
avoided could (aux)
presents followed (advcl)
shortened accelerated (conj)
0.59-mg 2.1-mg (conj)
capsule of (case)
implications % (dep)
necrosis proximal (amod)
1.1 ) (punct)
25 100 (conj)
pro-inflammatory and (cc)
fluency word (compound)
endpoints major (amod)
reversed months (nmod)
days 3.4 (nummod)
enac ) (punct)
v.o ) (punct)
injection artery (nmod)
15 as (advmod)
had change (dobj)
agoraphobia disorder (nmod)
oxygenation pbto(2 (appos)
cyclohexyl]benzeneactemide kappa (compound)
progressed therapy (nmod)
alpha-gst ) (punct)
atorva + (cc)
protein against (case)
neurotransmission mediated (acl)
injury fatal (amod)
6 4 (compound)
myopathy of (case)
giving adrenaline (dobj)
increased is (auxpass)
unmasked isoniazid (nmod)
necrosis organs (nmod)
performed experiment (nsubjpass)
examined tumorigenesis (nsubjpass)
started had (aux)
movements different (amod)
decreased either (nmod)
underwent swelling (dobj)
interval 10 (nmod)
add that (mark)
restricted indications (nmod)
phenomenon to (case)
reverse catalepsy (dobj)
noel the (det)
included protocol (nmod)
levels nitroprusside (amod)
effects duration (nmod)
children 33 (nummod)
i.e. , (punct)
i ) (punct)
diuretic potassium-conserving (amod)
patients assigned (acl)
effects confounding (amod)
m(2)-selective ( (punct)
observed left (xcomp)
agent background (dep)
considered rigidity (nsubjpass)
is agent (attr)
dopamine hva (conj)
micrograms/ml , (punct)
cxad in (case)
cells granulocyte-macrophage (amod)
trimipramine repeated (amod)
symptoms ketamine-induced (amod)
improved disturbances (dobj)
presence solution (nmod)
groups infusion (compound)
regulating structure (dobj)
increased methoctramine (nsubj)
centre specialist (compound)
turnover low (amod)
preservation function (nmod)
limited nephrotoxicity (advcl)
mm diagnosed (amod)
acetate cyproterone (compound)
abrasion corneal (compound)
changes dexamethasone-induced (amod)
used targeted (parataxis)
mitochondrial cytoplasmic (conj)
rates ( (punct)
active that (mark)
had melphalan (nmod)
exacerbation appearance (conj)
investigated synergy (dobj)
aucs 6 (nmod)
pharmacotherapy population (nmod)
administration volume (conj)
produced accompanied (xcomp)
blocks allodynia (dobj)
bypass from (case)
reduced iop (dobj)
61.6 +/- (cc)
factor 260 (nmod)
showed finally (advmod)
vestibular ( (punct)
lower 2.0/100,000 (dep)
report here (advmod)
aorta ascending (amod)
times of (case)
overexpression a (det)
synapses ) (punct)
fenoldopam vasodilators (appos)
suggest action (ccomp)
lower frequencies (nsubj)
method measured (acl:relcl)
some in (case)
suggest action (nsubj)
dosage lower (amod)
published english (nmod)
dogs develop (acl:relcl)
recorded assessment (nsubjpass)
mortality long-term (amod)
time needed (acl)
cardioselective ) (punct)
clotting blood (nmod)
actions central (amod)
exposure by (case)
reaction , (punct)
diclofenac with (case)
induced biperiden (nmod)
associated = (advcl)
being embarrassed (acomp)
value . (punct)
available sensitive (conj)
myositis acid-induced (amod)
cessation a (det)
time increased (amod)
pregnane-21-diol-20-ones ( (punct)
cotrimoxazole , (punct)
ad ) (punct)
chains common (amod)
occurred indicating (xcomp)
follow-up years (appos)
feet of (case)
deviation in (case)
relation : (punct)
rats lobund (amod)
demonstration mr (compound)
mmol/l 9.7 (dep)
kidney native (amod)
hilus the (det)
disease -- (punct)
used vivo (advmod)
correlated which (nsubjpass)
dosed when (advmod)
lowering vldl (dobj)
shown further (advmod)
delayed but (cc)
function renal (amod)
patients diabetic (amod)
number equal (amod)
lesions fibrosis (conj)
disorder 7.914 (appos)
illustrated utility (nsubjpass)
tetrandrine of (case)
evaluations scan (nmod)
analogues , (punct)
tensions , (punct)
deprived drive (nmod)
action analgesic (amod)
contact dormex (nmod)
stressed animals (nsubjpass)
reaction ax (nmod)
ascites hypoalbuminemia (conj)
side-effect this (det)
reflect which (nsubj)
treatment this (det)
groups respective (amod)
m-chlorophenylpiperazine receptor (compound)
database ( (punct)
change by (case)
ph solution (nmod)
comparisons models (nmod)
stimulate . (punct)
cavity each (dep)
opioid-agonists themselves (nmod)
detected ; (punct)
1.3 whereas (dep)
less 40 (conj)
use level (nmod)
confirmed we (nsubj)
glycol-asparaginase polyethylene (compound)
failed that (mark)
associated variants (nmod)
stimulated was (auxpass)
use illicit (compound)
prevent did (aux)
output or (cc)
ecg normal (amod)
disappear drugs (nsubj)
lt alf (nmod)
118 28 (conj)
intervals sedation (nmod)
gyki-41 , (punct)
fk ; (punct)
ratio cholesterol/hdl (compound)
administration ephedrine (nmod)
cisapride between (case)
suggested to (xcomp)
evaluated measuring (advcl)
functions hippocampal (compound)
preservation cognition (nmod)
cystitis : (punct)
anaesthesia , (punct)
variants . (punct)
response different (acl:relcl)
capture an (det)
used drugs (nsubjpass)
loss potential (nmod)
involved facilitation (nmod)
distance p (dep)
circled lesion (nmod)
performed collection (nsubjpass)
testing electrophysiologic (amod)
maze avoidance (conj)
ciprofloxacin namely (advmod)
gentamicin kg-1 (appos)
strategies use (nmod)
resolved which (nsubj)
difference db (compound)
mp i.v. (dep)
nitroprusside and (cc)
completed procedure (nsubjpass)
3.5 by (dep)
tomography a (det)
increased days (dep)
discuss authors (nsubj)
reduces mesna (nsubj)
problem has (aux)
seen differences (nsubjpass)
prominent and (cc)
efficacy granisetron (nmod)
curcumin the (det)
coma profound (amod)
scopolamine hyoscine (appos)
showed akbr (nsubj)
lesions neurotoxicity (nmod)
involvement model (nmod)
withdrawal selegiline (nmod)
tolerant , (punct)
markers molecular (amod)
water or (cc)
objective have (conj)
was component (attr)
demodex of (case)
therapy active (amod)
5-fluorouracil to (case)
defect ) (punct)
exposure drug (nmod)
ecstasy in (case)
therapy deferoxamine (nmod)
collection of (case)
mmhg mean (dep)
treating abuse (dobj)
shown mediated (ccomp)
cells mast (compound)
test reminding (compound)
monoher ( (punct)
fluoroacetate deficiency (conj)
assay myocardium (nmod)
found more (advmod)
mg dosed (acl)
correlation positive (amod)
increased p (dep)
incontinence secondary (amod)
emphasizes case (nsubj)
doses mumol (appos)
one paracetamol (conj)
activation d1 (nmod)
threat the (det)
administration postdrug (compound)
induced tissues (nmod)
8 24 (conj)
treatment phenytoin (nmod)
area this (det)
showed content (nsubj)
infused catheter (nmod)
killed n (nmod)
clozapine to (case)
phosphatidylserine ps (appos)
prolactin to (case)
effect receptors (nmod)
metabolites several (amod)
updating ) (punct)
determined measuring (advcl)
od 6.53+/-1.45 (conj)
inactive whereas (mark)
method targeting (csubj)
tendency only (advmod)
playing bottle (nmod)
produces anxiety (dobj)
clinical features (dep)
replacement , (punct)
lowered lf (compound)
represent challenge (dobj)
progresses eventually (advmod)
echocardiogram transthoracic (compound)
associated always (advmod)
cardiovascular toxicity (conj)
correlated tensions (nsubj)
episodes hypercalcemic (amod)
haloperidol haloperidol (conj)
elucidated to (mark)
t30 patients (nmod)
regimen bortezomib (amod)
remission maintains (conj)
mic ( (punct)
implications therapeutic (amod)
maximal changes (nsubj)
behavior of (case)
rated checklist (nmod)
polydipsia polyuria (conj)
alpha- alpha,3 (amod)
different % (conj)
ranged confirmed (advcl)
atenolol micrograms (appos)
associated that (mark)
liability effects (nmod)
treatment citalopram (nmod)
decrement the (det)
mmol/l sodium (compound)
haloperidol mg/kg (appos)
records men (nmod)
deaths eight (nummod)
failure function (nmod)
valves mechanical (amod)
reversible were (cop)
triggers apoptosis (dobj)
tissues heart (compound)
study patient (compound)
virus seventy-five (amod)
regurgitation failure (conj)
suxamethonium to (case)
post-injection hr (compound)
ldl ) (punct)
age 20 (nummod)
haloperidol-treated both (cc:preconj)
days days (appos)
hepatitis ) (punct)
methods placed (appos)
attempted reversal (xcomp)
doxorubicin sm-5887 (conj)
loss axons (conj)
recorded while (mark)
said . (punct)
revealed fusion (conj)
regimen this (det)
preservation with (case)
stereotypy activity (conj)
associated famotidine (nmod)
activity mitochondrial (amod)
exposure clomipramine (compound)
175 200 (conj)
131i-hsa ) (punct)
concentration low-density (amod)
clozapine with (case)
impairments overnight (amod)
indicate mediate (ccomp)
absence by (case)
rationale ng-nitro-l-arginine (dep)
return to (mark)
% 81.5 (nummod)
cycles six (nummod)
data toxicity (compound)
neurotoxicity were (cop)
infusion tobramycin (dep)
sulfate oversulfated (amod)
hypoperfusion of (case)
presented genes (nsubj)
inhibition factor-beta1 (nmod)
metabolite is (cop)
loss mean (dep)
2000 february (compound)
sampling hours (nmod)
make modalities (ccomp)
marked mg/kg (nmod)
reported drugs (nsubjpass)
products such (amod)
immunostaining npy (nmod)
patients 54 (dep)
therapy imipenem (compound)
degree one (nummod)
context treatment (nmod)
tablets dose (dep)
vii . (punct)
balances weight (appos)
conclusions dose (appos)
suggest susceptible (ccomp)
bupivacaine , (punct)
making treatment (nmod)
feasibility , (punct)
department hospital (nmod)
defined respectively (advmod)
bupropion carbimazole (conj)
actions phenytoin (nmod)
report first (amod)
tumors rare (amod)
mediated also (advmod)
rofecoxib ns-nsaids (conj)
prevention nephropathy (nmod)
half-life cocaine (nmod)
good-quality 1 (compound)
studied can (aux)
background man (appos)
stabilizers the (det)
expression associated (acl:relcl)
power oscillation (nmod)
intervals 12-h (amod)
neurotoxicity due (case)
cholestasis report (dep)
unreported . (punct)
g. dose (nsubj)
users than (case)
alleviating symptoms (dobj)
justification reasonable (amod)
glasses three (nummod)
trial safety (compound)
treatment administration (nsubj)
arteries arterioles (conj)
antagonize hypothermia (dobj)
% or (dep)
occurred addition (nmod)
value +/- (cc)
antibiotics lactam (compound)
expression regions (nmod)
from two (nmod)
low australia (nmod)
group 5-micrograms/kg (compound)
0 0.7 (conj)
levels patients (nmod)
sensitivity mice (nmod)
evaluate effect (dobj)
state activation (compound)
processing states (nmod)
shown reports (nsubj)
reported pain (dobj)
stimulation alpha-adrenoceptor (amod)
metformin by (case)
medication epinephrine (nmod)
ndma-d ) (punct)
structure nifedipine (conj)
characterized increase (nmod)
pethidine norpethidine (conj)
ameliorates hydroxytyrosol (amod)
prostaglandins of (case)
had overdose (nmod)
involvement d1 (nmod)
% 62 (nummod)
response activation (nmod)
use been (cop)
deficiency memory (compound)
neuropathy toxic (amod)
center university-affiliated (amod)
reduced potentiated (conj)
improved after (mark)
strain single (amod)
tma responded (acl:relcl)
dysfunctions neurological (amod)
analysed data (nsubjpass)
symptoms treatment (nmod)
draw fact (nmod)
evidence damage (nmod)
types individual (amod)
hemisphere left (amod)
l(-1 mg. (compound)
use increased (amod)
methylphenidate success (nmod)
differences by (case)
intake suppressants (nmod)
deduced although (mark)
shrinkage axon (compound)
function complex (nmod)
return symptomatology (nmod)
scale clinical (amod)
conclusions with (case)
12 than (quantmod)
july 1 (nummod)
hour dextrose (compound)
increase constant (conj)
dna virus (compound)
postdose hour (compound)
similar findings (nsubj)
utilized applying (advcl)
calculated . (punct)
demonstrated day (nmod)
had dl-threo-dihydroxyphenylserine (nsubj)
sub-regions different (amod)
activities as (case)
bleeding . (punct)
remains resolve (advcl)
failure severe (amod)
challenges oral (amod)
developed adenocarcinomas (dobj)
expressed cells (nmod)
patients 58 (nummod)
performed examine (xcomp)
enzyme for (case)
source a (det)
suggests inhibition (dobj)
this and (cc)
nonlactating of (mark)
measured injection (nmod)
hepatitis acidosis (dep)
2.4-fold 4.3 (dep)
reagents ax-related (amod)
ps ) (punct)
hypokinesis because (case)
evidence cardiotoxicity (nmod)
used provide (advcl)
series measurements (nmod)
effects tea (nmod)
35 % (dep)
failed forms (dobj)
blocked ssr103800 (nsubj)
obtainable be (cop)
change cells (nmod)
deterioration field (nmod)
intubated , (punct)
2-(p-bromophenyl)propionate ( (punct)
used dormex (dobj)
tubuli in (case)
lidocaine for (case)
capacity selected (conj)
nephrotoxicity chronic (amod)
effect undesirable (amod)
mg/d or (cc)
ears ( (punct)
some with (case)
shown participate (xcomp)
events of (case)
decreased density (nsubj)
rupture patients (nmod)
sensory predominantly (advmod)
failure cardiac (amod)
myalgia course (conj)
due sensitisation (nmod)
obtained model (nmod)
model dysfunctions (nmod)
acc ) (punct)
strategies cost-effective (amod)
deformations caused (acl)
decreased amplitudes (nsubj)
found seven (conj)
characteristics phenotypic (amod)
reduced prevented (conj)
marked characterized (advcl)
methods assessing (acl)
lower slightly (advmod)
reversed while (mark)
maneuver hyperventilation (compound)
overflow groups (nmod)
% 67.9 (nummod)
10(-3 ) (punct)
patients more (amod)
associated increases (nmod)
resolution ascites (nmod)
neurotoxicity central (amod)
patients man (appos)
that 10 (nsubj)
% 10+/-1 (nummod)
difference solution (nmod)
neuropathy myopathy (nmod)
fraction mitochondrial (amod)
mutation g20210a (compound)
escape , (punct)
given prior (prep)
pd of (case)
prevented injection (nmod)
effects molecular (amod)
infiltration lumen (nmod)
laboratory ) (punct)
performed trial (nsubjpass)
24 including (case)
axis hypothalamic-pituitary-adrenal (compound)
greater changes (conj)
p-glycoprotein transporter (appos)
resolve not (neg)
develop alternatives (dobj)
subregion to (case)
ramipril inhibitor (appos)
% radioactivity (nmod)
recorded drugs (nmod)
points finding (nsubj)
testing during (case)
choose health (nmod)
propofol remifentanil (conj)
initial be (cop)
disorder posttransplant (amod)
distributed diffusely (advmod)
novelty stimuli (dep)
correlate better (advmod)
agitation paradoxical (amod)
includes that (nsubj)
chemotherapy paclitaxel (nmod)
g/day of (case)
used are (auxpass)
received beginning (xcomp)
activities compounds (nmod)
channels functional (amod)
stopped reoccur (conj)
recovery subsequent (amod)
dermatitis with (case)
years 78 (nummod)
episode prior (amod)
methotrexate mtx (appos)
imipramine the (det)
p comparisons (dep)
february , (punct)
received doses (dobj)
function platelet (compound)
days treatment (compound)
patient presenting (nmod)
pdn equivalent (amod)
tested lister (nmod)
action monophasic (amod)
treatment dexamethasone (nmod)
adr(6 adr+los(12 (conj)
substitute currently (advmod)
subjected treatment (nmod)
treatment lamivudine (compound)
stages assessments (nmod)
46 of (advmod)
octogenarian in (case)
sacrifice after (case)
acid cis-ra (appos)
lipids diminution (conj)
sensitivity doxorubicin (conj)
blocker . (punct)
developed rigidity (dobj)
ratio matter (conj)
% 31.8 (nummod)
netilmicin egg-white (amod)
oblongata rats (nmod)
fisher 's (case)
acute chronic (conj)
patients study (compound)
increase whenever (advmod)
pentobarbital mg/kg (dep)
lupus drug-induced (amod)
left dimension (dobj)
resulted patients (nmod)
needed intubation (dobj)
eight three (conj)
underwent tee (dobj)
effective restoring (advcl)
drugs nitrogranulogen (nmod)
drug on (case)
caused courses (nsubj)
mg 800 (nummod)
volunteers twenty (nummod)
neurotransmitters n-(2-propylpentanoyl)urea (nmod)
33.6 +/- (cc)
protein glepp1 (compound)
test " (punct)
toxicity low (amod)
infused hcl (nsubjpass)
had end (nmod)
050+/-561 ( (punct)
hyperglycemia and (cc)
ufov ) (punct)
effect hypotension (conj)
dopamine hydroxylase (conj)
delineated were (auxpass)
antigen both (cc:preconj)
assays il-1 (nmod)
found compared (prep)
production liver (nmod)
patients 350 (nummod)
nx = (amod)
complications drug-related (amod)
trained approach (xcomp)
volumes lower (amod)
tests 4 (nummod)
mediated . (punct)
paclitaxel chemotherapy (conj)
treatments between (case)
seeing of (mark)
supernatants il-3 (conj)
suggested have (advcl)
normal conscious (conj)
increases whether (mark)
amlodipine mg (compound)
polymorphism by (case)
measures d-penicillamine (compound)
chlormethiazole of (case)
2- in (case)
variable difference (dobj)
mortality all-cause (amod)
contributes represent (conj)
encoding , (punct)
transplantations were (cop)
follow-up clinical (amod)
withdrawal pyridoxine (nmod)
microg/kg 0.03 (nummod)
forearm on (case)
plasma kidney (conj)
sufficient hypomethylation (nsubj)
include research (nsubj)
healthy male (dep)
model canine (compound)
acid in (case)
studying pathophysiology (dobj)
warranted however (advmod)
gavaged . (punct)
epithelium of (case)
event . (punct)
protein inhibitor (appos)
ci ) (punct)
disease significant (amod)
d-pen with (case)
related suggesting (xcomp)
made and (cc)
twenty-nine them (nmod)
needle 18-gauge (amod)
treatment thrombosis (nmod)
frequency hematuria (nmod)
episode nausea (nmod)
treated before (advmod)
time partial (amod)
treatment such (amod)
demonstrates consists (ccomp)
less night (nmod)
infusion cannulae (nmod)
acting neurotransmitters (nmod)
distributed system (nmod)
levels > (dep)
na(+)-k(+)-2cl(- ) (punct)
yrs < (dep)
performed intervals (nmod)
fell 11.5+/-1.4 (nmod)
administration lindane (compound)
inpatients association (nmod)
performance patient (compound)
evaluated effect (nsubjpass)
divided study (nsubjpass)
multiforme failure (conj)
illustrate lead (ccomp)
administration sc (nmod)
observed synthesis (nsubjpass)
increased treatment (nsubj)
acute sulfadiazine (compound)
induce it (nsubj)
levels included (acl:relcl)
mitoxantrone 48-hour (conj)
exposed had (aux)
dyskinesia reserpine-induced (amod)
region striatum (nmod)
session before (case)
demonstrate cause (ccomp)
content rna (nmod)
% percentage (nsubj)
profiles/sections ) (punct)
dogs dose (appos)
those n (dep)
drinking on (case)
quantitated , (punct)
is whether (mark)
fail results (nsubj)
predicted daily (nsubj)
assessed microscopy (nmod)
model an (det)
% p<0.02 (appos)
rigidity occurrence (conj)
caused reactions (dobj)
microscopy laser-scanning (amod)
ems pms (conj)
decreased glutamate (dobj)
greater dosage (nmod)
physician , (punct)
patient pediatric (amod)
24 7 (compound)
produced injections (nsubj)
alcalinization possibly (advmod)
have study (nmod)
% 0.5 (nummod)
inherent activation (nsubj)
displays that (mark)
fenoterol-hydrobromide placebo (conj)
contractility the (det)
paper transparent (amod)
joint and (cc)
sedation successful (amod)
concept effective (ccomp)
discontinued paroxetine (nsubjpass)
drug antiarrhythmic (amod)
recognised that (nsubjpass)
thrombocytopenia hypoaldosteronism (conj)
scans , (punct)
monitored should (aux)
antagonist administration (nmod)
reactions symptomatic (amod)
viruses fever (compound)
thereafter intramuscularly (advmod)
mg 320 (nummod)
pauses the (det)
questioned patient (nsubjpass)
having and (cc)
some to (case)
polydrug pd (appos)
cells/mm3 > (parataxis)
dfmo with (case)
epilepticus damage (conj)
women developed (acl:relcl)
injected bupivacaine (nmod)
used again (advmod)
patients diagnostic (dep)
using nicotine (dobj)
exposure prednisone (nmod)
recipient developed (acl:relcl)
conclusions increases (appos)
application with (case)
retard blockade (nsubj)
31 7 (conj)
stopping reappeared (conj)
meq/l meq/l (conj)
cue effect (conj)
showing manifestations (dobj)
users 215 (nummod)
restored antagonist (nmod)
used , (punct)
plasticity cortical (amod)
absence in (case)
indistinguishable carcinoma (nmod)
oxitropium of (case)
switchers for (case)
effects groups (dep)
3alpha-hydroxy-5beta-pregnan-20-one ) (punct)
caused fall (dobj)
iiib nsclc (conj)
striatum amphetamine (nmod)
frs of (case)
changes aphasia (appos)
latency threshold (conj)
monitoring for (case)
important therefore (advmod)
increased index (nsubjpass)
completed . (punct)
literature published (amod)
interactions to (case)
foods hot (amod)
located possibly (advmod)
day day (conj)
dialysis transplantation (nmod)
ampk with (case)
patients background (nmod)
apnoea lasting (acl)
residue this (det)
adr+los(6 ) (punct)
atp into (case)
enucleated eyes (nsubj)
33342- hoechst (compound)
risk carcinoma (nmod)
900 , (punct)
crocin of (case)
found . (punct)
increase map (compound)
transplantation simvastatin-ezetimibe-induced (amod)
antagonist nonselective (amod)
received bcnu (dobj)
expression mhc-i (compound)
facilitation in (case)
1a2 of (case)
investigation an (det)
function caused (acl)
conclude correlates (ccomp)
protocol acuity (nmod)
evidence man (nmod)
library the (det)
serum elevated (amod)
ctni mass (conj)
ensued but (cc)
15 5 (compound)
n-acetyl-beta-d-glucosaminidase nag (appos)
delayed significantly (advmod)
treated patients (nsubjpass)
administration animals (nmod)
goal mmol/l (nmod)
mg t+a (appos)
determinant formation (nsubj)
numbness with (case)
employed was (auxpass)
suggest helps (ccomp)
bleeding brigham (nmod)
prevented strips (advcl)
included toxicity (nsubj)
abolished partially (advmod)
val ; (punct)
toxicity propranolol (compound)
morphology activity (conj)
venules on (case)
subgroups % (dep)
history exposure (nmod)
cardiotoxicity model (nmod)
implicated cells (nsubjpass)
treatment higher (advmod)
haloperidol compared (case)
assessed injection (nmod)
downregulation with (case)
patients years (appos)
flavonoids such (case)
alpha-tc dfo (conj)
randomized dosed (conj)
pressures consistent (amod)
progestagens third-generation (amod)
pralidoxime-2-chloride ache (compound)
volume factors (nmod)
therapy nvp (compound)
monitored was (auxpass)
ezetimibe or (cc)
assess relation (conj)
activation by (case)
pneumoniae aureus (conj)
use current (amod)
had leading (advcl)
case findings (nmod)
ed of (case)
presence mpo-anca (nmod)
anticoagulant is (cop)
length fetal (amod)
protection without (case)
mg/kg min (appos)
adl ( (punct)
increases transplantation (compound)
reduction myalgia (nmod)
mild relatively (advmod)
voltage- , (punct)
insurance 1993 (nummod)
declined subsequently (advmod)
chemotherapy anthracycline-based (amod)
movements frequent (amod)
after immediately (advmod)
= 4.18 (dobj)
overlooked known (advcl)
revealed labeling (dobj)
esrd , (punct)
s. pneumoniae (amod)
profile pharmacologic (amod)
galantamine inhibitor (appos)
methods mice (dep)
produced decrease (dobj)
electrocardiography ecg (appos)
level steady (amod)
injections isoproterenol (nmod)
experienced seizures (dobj)
displayed conversion (nmod)
measuring density (dobj)
appears that (mark)
increase an (nmod)
failure eventual (amod)
used metoclopramide (nsubjpass)
six of (quantmod)
investigation pattern (nmod)
doxil ( (punct)
studied before (advmod)
development movements (nmod)
impairment cognitive (amod)
lamotrigine ltg (appos)
positive significant (conj)
neonates premature (amod)
solid haematological (conj)
children 3 (nummod)
disorder no (det)
considering reduction (dobj)
option well (advmod)
leading range (nmod)
type inducible (amod)
pressure 40 (nummod)
differences lozenge (nmod)
increased affected (parataxis)
apposition stent (amod)
regimens used (acl)
setting the (det)
increased reducing (advcl)
found activity (nsubjpass)
examined relationship (dobj)
sorafenib administration (conj)
dosing prazosin (nmod)
ligands of (case)
dyspnea ( (punct)
stillbirth with (case)
levels postabsorptive (amod)
continue to (mark)
mg/kg 900 (nummod)
evaluated respect (nmod)
vasospasm and (cc)
improve administration (nsubj)
mg/m2 . (punct)
treated csa (nmod)
disorders affective (amod)
vasoconstriction intense (amod)
symptoms as (case)
chicks treated (amod)
protection histopathological (amod)
littermates wild-type (amod)
treatment and (cc)
reducing hours (nmod)
characteristics relevant (amod)
weaning bypass (nmod)
onset is (cop)
have mice (nsubj)
consequence may (aux)
explore effects (dobj)
remains outcomes (nmod)
abundance decreased (amod)
cytology urinary (amod)
achieved demonstrated (conj)
other each (det)
susceptible telaprevir (nsubj)
experienced % (nmod:npmod)
sensitivity for (case)
provide integration (dobj)
sc/week ( (punct)
runs 2 (nummod)
neuroprotective , (punct)
nodule and (cc)
treated injection (nmod)
aware signs (nmod)
h 1 (nummod)
middle in (case)
role naloxone (nmod)
summary female (appos)
length hospital (nmod)
penetration nitrate (nmod)
declined restricted (conj)
90/htn 1.036 (dep)
morbidity significant (amod)
exencephaly the (det)
justification a (det)
pacing temporary (amod)
sevoflurane and (cc)
appropriate not (neg)
% triglyceride (nmod)
form dyskinesia (nmod)
interval on (case)
pretreatment day (compound)
reproducibility and (cc)
increase significant (amod)
risk failure (appos)
toxic chloroprocaine (nmod)
patients metastases (nmod)
zero but (cc)
headache nausea (conj)
quality women (nmod)
disease artery (compound)
determined explanation (nsubjpass)
mccarthy 1971 (nummod)
ranged months (nmod)
converted acc-9653 (nsubjpass)
treatment pegylated (amod)
decreased further (advmod)
miosis severe (amod)
worsening on (case)
index by (case)
decrease nephrotoxicity (nmod)
hemolysis failure (conj)
prazosin alpha(1 (compound)
reduction effect (nmod)
combination training (nmod)
died or (cc)
single multiple (conj)
breaks by (case)
gender = (dep)
enhancement thermal (amod)
evaluation kidneys (nmod)
dfp ( (punct)
mapping diffusion (compound)
nausea 4.2 (dep)
accompanied normalisation (nmod)
measured intensity (nsubjpass)
mustard ifosfamide (nsubj)
quetiapine placebo (conj)
represents example (dobj)
biochemical urea (dep)
reflex elicited (acl)
controls undergone (acl:relcl)
l p (compound)
thickened amounts (dobj)
increased prevalence (nsubj)
high % (nmod)
questionnaires studies (conj)
associations possible (amod)
dysrhythmias anesthesia (nmod)
implant a (det)
model reliable (amod)
any treatments (nmod)
developed issues (nmod)
serotonergic- depletion (appos)
randomized receive (xcomp)
ci % (amod)
juice saline (conj)
spectrometry hplc-mass (amod)
mg. 0.025 (nummod)
determined regimens (nsubjpass)
content both (cc:preconj)
reversible was (cop)
predictors vaccination (nmod)
associated lt (nmod)
increase to (case)
woman associated (acl)
uptake adp-stimulated (amod)
show develop (ccomp)
cardiomyocytes neonatal (amod)
h. 24 (compound)
changes msdbp (nmod)
normal enhanced (conj)
proteases caspase-3 (dep)
ester n(g)-nitro-l-arginine (compound)
receiving medications. (dobj)
= 0.048 (dobj)
complicated that (mark)
described here (advmod)
ssr103800 of (case)
attempt obviate (acl)
opioid cholinergic (conj)
measure and (cc)
lindane metabolites (conj)
strategy a (det)
co-treatment agents (nmod)
consisting inhibitory (nmod)
feature cholestasis (nsubj)
group original (amod)
tissues and (cc)
ballooning the (det)
had activity (dobj)
uninephrectomy combination (conj)
suggests complicated (ccomp)
groups analysis (nmod)
elicited and (cc)
evidences . (punct)
time reaction (compound)
increase nucleosides (conj)
eosinophilia and (cc)
factor-i human (amod)
parallel close (amod)
transmission diabetic (nmod)
showed fraction (dobj)
pronounced change (dobj)
amounts calcium (nmod)
identified polymorphism (dobj)
subtype the (det)
difficult very (advmod)
monitor bradycardia (nmod)
increased dysfunction (dobj)
stroke women (nmod)
t troponin (compound)
low microgramg/ml (dep)
10(-6 x (compound)
cohort within (case)
used increasing (advcl)
parameters urodynamic (amod)
aware pregnancies (nmod)
response potassium (compound)
define clearly (advmod)
persons of (case)
daily g (dep)
deteriorations cognition (nmod)
species transition (conj)
nephritis interstitial (amod)
kappa-beta factor (compound)
decreased although (mark)
exposure variety (nmod)
incriminated frequently (advmod)
included tests (nsubj)
factors toxicity (nmod)
concentrations cocaethylene (compound)
absence glomerulosclerosis (nmod)
activities aggregation (compound)
data users (nmod)
nitrendipine and (cc)
antagonized and (cc)
cholinesterase number (nmod)
preference activity (nmod)
association unusual (amod)
induced group (nmod)
opening agonist-induced (amod)
uptake increased (amod)
efficacy denopamine (nmod)
next involvement (nmod)
reinforces data (dobj)
cystitis acute (dep)
demographic clinical (conj)
hz 1 (nummod)
months event (nmod)
injections i.p. (amod)
thc by (case)
lethal the (det)
detected liver (nmod)
represent findings (nsubj)
day same (amod)
vomiting two (nummod)
urothelium and (cc)
mrna enzyme-1 (nmod)
neuropathy treatment (nmod)
infiltrate portal (amod)
aetiology syndrome (nmod)
impairment alternation (nmod)
hemorrhage gastric (amod)
cohort unselected (amod)
persistent . (punct)
perturbation by (case)
phase of (case)
produced sustained (xcomp)
sigmast sum (appos)
cytotoxicity in (amod)
alter onset (dobj)
overdosage of (case)
relative a (det)
use lithium (compound)
results mg (appos)
agents cisplatin (conj)
t+a ] (punct)
second- or (cc)
rashes proteinuria (appos)
adrenergic muscarinic (conj)
examined tissue (nsubjpass)
measurement level (nmod)
catheterization or (cc)
remained level (nsubj)
neuronal glial (conj)
getting up (compound:prt)
dogs hearts (nmod)
report structured (amod)
raised possibility (dobj)
fungi against (case)
occlusions artery (compound)
time half (amod)
play mechanisms (nmod)
target ? (punct)
depression exercise-induced (amod)
% -23%(-)-26 (compound)
3.2 to (dep)
flurothyl , (punct)
programs prenatal (amod)
followed fibrillation (nmod)
hours admission (dep)
min 129 (nummod)
attack an (det)
effects potassium (compound)
insult of (case)
12.5 15.0 (conj)
japan such (case)
admission after (case)
8.9 , (punct)
associated vpa-therapy (nmod)
showed test (nsubj)
cmax/mic ( (punct)
safety danazol (nmod)
site surgical (amod)
debated . (punct)
risk antibiotics (nmod)
alt , (punct)
rare fatal (conj)
control or (cc)
uteri rats (nmod)
reviews study (nsubj)
activities respiratory (amod)
aware oncologists (nsubj)
staff alert (amod)
returned function (nsubj)
dogs treated (acl:relcl)
revealed drop (conj)
% -20.1 (nummod)
information limited (amod)
presenting approach (nmod)
alternative dialysate (nsubj)
glutamine its (nmod:poss)
medium d. (nmod)
beta-blocker a (det)
group 3.9 (nmod)
prior induction (nmod)
models coefficient (compound)
parameters hemodynamics (nmod)
done week (nmod:tmod)
3delta and (cc)
obstruction underlying (amod)
% injection (nmod)
developed reverting (advcl)
induces activity (nsubj)
dyskinesia sedation (conj)
characteristics that (mark)
sensitizes cardiotoxicity (nmod)
subjected tilts (conj)
using % (dobj)
risk aggravated (amod)
agent blocking (amod)
activation k+ (nmod)
a from (case)
expression receptor (compound)
% 20.4 (nummod)
valproate or (cc)
4 5 (conj)
achieved one (nmod)
contraceptives with (case)
open and (cc)
doses 4 (nmod)
resolved unease (nsubj)
inhibitor specific (amod)
diet free (amod)
% 8/27 (appos)
relaxant of (case)
assays colony (compound)
pcr . (punct)
control vip(-/- (dep)
improved nifedipine (nsubj)
involved system (nmod)
coma amiodarone-induced (amod)
4107 +/- (cc)
blocked veins (nsubjpass)
g/dl , (punct)
received one (dobj)
normalized levels (nsubj)
scale arizona (compound)
lid and (cc)
aminotransferase compared (case)
isotretinoin trimester (nmod)
history documented (amod)
beating cultures (dobj)
pattern selective (amod)
immobilization of (case)
weeks 13 (nummod)
man glomerulosclerosis (nmod)
azotemia creatinine (dep)
epicondylitis lateral (amod)
observed whereas (dep)
6-thioguanine with (case)
injections to (case)
detect ead (dobj)
removal famotidine (nmod)
dopaminergic serotonergic (conj)
inhibited potently (advmod)
oac ( (punct)
complication a (det)
otoprotectant loss (nmod)
had duct (dobj)
air dry (amod)
dosed similarly (advmod)
population on (case)
basis molar (amod)
was mention (attr)
amyloidosis systemic (amod)
able antagonize (xcomp)
ouabain of (case)
dexrazoxane myelosuppression (conj)
gfc75 p400 (conj)
neurotoxicity methamphetamine-induced (amod)
incorporate levels (nsubj)
ergotamine/caffeine % (dep)
hydrobromide 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine (compound)
developed days (dep)
remained period (nmod)
implications epilepsy (nmod)
led dose (nsubj)
week accompanied (conj)
mice balb-c (compound)
inhibit binding (dobj)
shock current (amod)
ratios and (cc)
allografts tg (nmod)
cancer endometrial (amod)
given subjects (nmod)
hands feet (conj)
relative disease (nmod)
known , (punct)
therapy valproate (compound)
frequency evaluation (appos)
psychosis methamphetamine (amod)
seen will (aux)
enhance bradycardia (dobj)
beta-blocker between (case)
deterioration memory (compound)
treatment impotence (conj)
changed , (punct)
rate fatality (compound)
developed bore (conj)
evaluated routinely (advmod)
counterparts to (case)
teratology , (punct)
reported complication (nmod)
treatment who (nsubj)
microm 6 (nummod)
pattern a (det)
follow-up psychiatric (amod)
clotiazepam of (case)
matched were (auxpass)
events recorded (nsubj)
mrnas mmp-timp (compound)
occurred maintained (advcl)
treated hemodialysis (nmod)
effect through (case)
nms of (case)
pressure prescribe (acl)
transferred been (auxpass)
mediate that (mark)
pathogenesis defects (nmod)
lidocaine plasma (compound)
affect not (neg)
receiving discharged (advcl)
efficacy antagonist (nmod)
correlated positively (advmod)
psychosis disease (nmod)
site pge2 (nmod)
important complication (nsubj)
sensitive particularly (advmod)
substitution where (advmod)
autoantibodies of (case)
treatment infections (nmod)
involving women (dobj)
worsen injury (dobj)
treated wk (dobj)
mg 1.0 (nummod)
42 +/- (cc)
transplantation lt (appos)
cgs 21680 (nummod)
ns-nsaids 38,048 (conj)
exposed aorta (nsubjpass)
months to (case)
sevoflurane between (case)
consequence . (punct)
saline c (appos)
more 700 (conj)
factor paf (appos)
11 % (quantmod)
demonstrated and (cc)
administration fluconazole (nmod)
shown produces (ccomp)
doxorubicin intravenous (amod)
included features (nsubj)
structures of (case)
drinkers 167 (nummod)
used alone (advmod)
education further (amod)
replacement plasma (compound)
lowered 0.01 (dep)
ci 2.7 (nummod)
assessed sham-operated (nmod)
= 10.66 (dep)
characterized compromise (nmod)
rizatriptan ergotamine/caffeine (conj)
dose decrease (nsubj)
adhesions because (case)
myelination necrosis (conj)
activities anticoagulation (amod)
potent increasing (advcl)
trial uroprophylaxis (nmod)
block verapamil (compound)
agent dianabol (dep)
available readily (advmod)
bedtime at (case)
newborn in (case)
assessment effectiveness (conj)
responded generally (advmod)
lasting dose (nmod)
modestly only (advmod)
% 135 (nummod)
requirement months (nmod)
died weeks (dobj)
patient treatment (acl:relcl)
had tricuspid (xcomp)
resistance vascular (amod)
mm . (punct)
batteries measured (acl)
336 ( (punct)
matched creatinine (nmod)
observed staining (nsubjpass)
failure simvastatin-ezetimibe-induced (amod)
depend if (mark)
mg/ml ( (punct)
= mm/year (dep)
carboplatin treatment (nmod)
neurotoxicity (ma)-induced (amod)
degree depending (case)
report dermatitis (nmod)
step in (case)
month dry (amod)
induced doxorubicin (nsubj)
study brief (amod)
develop aki (dobj)
blockade whereupon (amod)
increasing administration (nmod)
applied walls (nmod)
concluded thus (advmod)
toxicity haematological (amod)
therapy topical (amod)
developed incontinence (dobj)
differences individual (amod)
gem , (punct)
inflammation and (cc)
complete stressor (dobj)
points primary (amod)
had tnss (dobj)
treatment pamidronate (compound)
sod ( (punct)
recumbent upright (conj)
activity combination (nmod)
objectives determine (dep)
aim , (punct)
carried , (punct)
screened prolactin (nmod)
solvent by (case)
developed seizure (dobj)
tacrolimus to (case)
children preterm (compound)
risk edema (nmod)
observed occurrence (nsubj)
produce individuals (nmod)
induced administration (nmod)
or=12.619 ci=6.702 (conj)
rast ( (punct)
subgroup using (acl)
salt ammonium (compound)
antigens ii (nummod)
matched gestation (nmod)
aqp2 nkcc2 (conj)
choice treatment (nmod)
part evaluation (nmod)
had 23 (nsubj)
analog a (det)
nodal cardiac (amod)
protection partial (amod)
patient delay (nmod)
gene-targeted clonidine (nmod:npmod)
bicuculline aminophylline (conj)
order evaluate (acl)
exposed times (nmod:tmod)
abstinence caffeine (nmod)
pfs of (case)
patients malaysia (nmod)
old , (punct)
hypertension ) (punct)
presented given (conj)
purpose review (nmod)
recommended . (punct)
asystole , (punct)
gamma-sarcoglycan beta1-integrin (conj)
inhalator salbutamol (nmod)
duration regurgitation (conj)
rats moving (amod)
capacity intellectual (amod)
noted arousal (nmod)
interviewed n (dep)
convulsions fatal (amod)
carotenoids crocins (appos)
17.5 15 (compound)
prevent tachycardia (dobj)
years 35.6 (nummod)
infarction recent (amod)
recipients methotrexate (nmod)
days weeks (nmod)
reflect activity (nsubj)
clarify effects (dobj)
causes leading (advcl)
occurred courses (nmod)
suggests ability (nsubj)
expressed but (cc)
droperidol of (case)
rates flow (compound)
development somatic (amod)
time median (amod)
moderate for (case)
include to (mark)
microscopy fluorescence (compound)
reported case (nsubj)
anesthesia sedation (nmod)
rats pubertal (amod)
occurred both (nsubj)
inhibits impase (dobj)
stunning characterized (acl:relcl)
play 3 (dep)
incidence fractures (nmod)
two patients (nmod)
review reports (dobj)
appears susceptible (xcomp)
subjects become (acl:relcl)
declined 0.001 (parataxis)
concentrations consumption (conj)
onset resolution (conj)
evaluated patients (conj)
hospitalized of (case)
associated hypertension (nsubjpass)
trough convulsions (nsubj)
degree pge1 (nmod)
caused neurological (dobj)
studies 1,3-butadiene (nmod)
effect thc (nmod)
ctni , (punct)
bone hypertrophy (conj)
showed accounted (ccomp)
used markers (nmod)
cocaine-dependent 30-year-old (amod)
dose eliminated (acl:relcl)
increases rate (nmod)
classification control (compound)
prevented contrast (nmod)
benefit low (amod)
irritability headaches (conj)
aggregations platelet (compound)
had fistula (dobj)
completely , (punct)
nimesulide or (cc)
movements , (punct)
levodopa % (dep)
inhibitor enzyme (nmod)
history neither (cc:preconj)
chamber white (amod)
discontinuance drugs (nmod)
assess preventing (advcl)
study t-cell (compound)
levels alpha5 (compound)
supported this (nsubjpass)
preserved function (nsubjpass)
radiotherapy and (cc)
results minutes (conj)
% 0.02 (nummod)
d-penicillamine treatment (nmod)
rs6693503 rs9659997 (conj)
level ) (punct)
occurs proteinuria (nsubj)
scored 3 (nmod)
occur complications (nsubj)
coincident were (cop)
observed protection (nsubjpass)
factors potential (amod)
11.2 +/- (cc)
diuretic chlorthalidone (appos)
effects from (case)
signals abnormal (amod)
histamine h2 (appos)
medline a (det)
titer ) (punct)
system intrarenal (amod)
prox-1 for (case)
increase baseline (nmod)
completed bun (nmod)
glabrata with (case)
levels status (conj)
administration anticonvulsants (nmod)
injury tubulointerstitial (amod)
increased trends (nmod)
quantified depression (nsubjpass)
clones all (det)
assessed compared (conj)
death autophagic (amod)
adopted could (aux)
smokers among (case)
result probably (advmod)
bepridil compound (appos)
anesthetic and (cc)
renal significant (amod)
did than (mark)
fracture department (nmod)
display to (mark)
relieved percent (nsubjpass)
need aware (xcomp)
stimulation ceruleus (nmod)
examination an (det)
made seconds (dobj)
synthesize incidence (nmod)
followed injections (nmod)
% 49 (nummod)
pool swimming (compound)
interaction possible (amod)
abnormalities t (compound)
models guinea (compound)
rigidity anesthesia (nmod)
available echocardiography (nsubj)
effects extent (nmod)
administered i.v. (advmod)
known effect (xcomp)
increase excretion (nmod)
involves as (mark)
fit and (cc)
anencephaly = (amod)
specific isoenzymes (nmod)
seen on-state (nmod)
required hemodialysis (dobj)
m1 m2 (appos)
induction : (punct)
treatment warfarin (compound)
testosterone by (case)
rendered was (auxpass)
conclusions : (punct)
droplets protein (compound)
h and (cc)
t with (case)
dose median (amod)
linked restoration (nmod)
consuming they (nsubj)
hyperparathyroidism oct (appos)
give overview (dobj)
reversed partially (advmod)
form therapy (nmod)
f344 and (cc)
excretion ) (punct)
kb 4.8 (compound)
belief on (case)
noncompliance ( (punct)
syndrome drug-induced (amod)
study given (conj)
meritorious exist (conj)
cortex of (case)
male single (amod)
considered monitoring (nsubjpass)
invaluable patients (nmod)
engaged are (auxpass)
deliver toxicity (nmod)
follow follow-up (nmod)
metabolites non-deacetylated (amod)
cimetidine for (case)
exposure repeated (amod)
initiated ( (punct)
81.5 score (nsubj)
transection spinal (amod)
drug immunosuppressive (amod)
aim continues (dep)
acted rats (nmod)
became severe (conj)
h administration (dep)
diplopia temporary (amod)
10(-7 or (cc)
helpful have (aux)
group sedentary-isoproterenol (compound)
stents drug-eluting (amod)
increased kcl (nsubj)
shown related (ccomp)
disease fluctuating (amod)
subjects 11 (nummod)
bicarbonate without (case)
agranulocytosis thrombocytopenia (nmod)
done months (nmod)
n-methyl-d-aspartate electroshock (conj)
depression angina (conj)
recorded is (aux)
% a (compound)
lister adult (amod)
mg/kg 0.59 (nummod)
tested previously (advmod)
drug celecoxib (nsubj)
metabolism patients (nmod)
symptoms akathisia (nmod)
shown number (nsubj)
decreased distracted (advcl)
factor fibroblast (compound)
cases 128 (nummod)
gastrocnemius abdominal (conj)
reabsorption of (case)
aged people (nsubj)
had seventeen (nsubj)
administered adriamycin (nsubjpass)
assays for (case)
abusing be (aux)
pretreatment microg/kg (appos)
change output (nsubj)
antagonist dopamine (compound)
identify loci (dobj)
completed after (mark)
considered thus (advmod)
develop mice (nsubj)
binding determined (acl)
reversible changes (nsubj)
factors both (det)
forelimb clonus (dep)
activity set (acl)
factor transcriptional (amod)
stroke cocaine-associated (amod)
extended 's (auxpass)
change peak (amod)
reaction for (case)
ester and (cc)
extremities over (case)
interactions related (amod)
correlation inhibition (nmod)
eyes isolated (amod)
methods given (appos)
pores mitochondrial (amod)
adjusted maintain (xcomp)
measured measurements (dep)
generated and (cc)
conclude left (ccomp)
0 15 (conj)
appeared have (conj)
enhancement possible (amod)
demonstrated have (aux)
less patients (nmod)
month-long 1/2 (nummod)
colliculus , (punct)
curves doses (nmod)
corticosteroids likely (advmod)
sensations or (cc)
health their (nmod:poss)
regard this (det)
kidney perfused (amod)
failure failure (conj)
% 20.7 (nummod)
become hemorrhagic (acomp)
change ecg (nsubj)
replaced ticlopidine (nsubjpass)
describes . (punct)
known act (xcomp)
diagnosis amyloidosis (dep)
components pain (nmod)
along especially (advmod)
treatment carbimazole (nmod)
p<0.01 ) (punct)
increased which (nsubj)
witnessed be (auxpass)
ecstasy controls (conj)
volume volume (conj)
fibrosis perivascular (amod)
h 2 (nummod)
albumin sonicated (amod)
levels renal (amod)
action and (cc)
patients given (acl:relcl)
replacement doses (conj)
administration significantly (advmod)
reversible milder (dep)
constant rigidly (advmod)
estimated oxidative/nitrosative (nsubjpass)
exposure rats (nmod)
skin elisa (conj)
glaucoma by (case)
cells zone (nmod)
malignancies various (amod)
potentiates sub-chronic (amod)
decrease greater (amod)
inhibition mixed (amod)
myocet m (appos)
restricted brainstem (nmod)
food hot (amod)
one to (quantmod)
challenge phenobarbital (nmod)
evaluation histopathologic (amod)
effect induced (acl)
doses ld50 (compound)
sinus dysfunction (conj)
strikes . (punct)
> suppression (nsubj)
cad of (case)
hemolysis caused (acl)
iv with (case)
consisted point (nsubj)
returned discharged (conj)
taken whom (dobj)
mdp 25 (nummod)
bupropion concurrent (amod)
value mean (compound)
nephrotoxicity amphotericin (nmod)
played infection (nsubj)
percent 73/99 (appos)
control type (nmod)
epilepsy childhood (nmod)
diagnoses disease (nmod)
approval institutional (amod)
aimed study (nmod)
demonstrated % (nmod)
aggravate toxicity (dobj)
last ) (punct)
stimuli real (amod)
ranges 10 (nmod)
results met (dep)
caused change (dobj)
cystitis a (det)
lower amount (nsubj)
therapy treatment (nmod)
adenoma liver (nmod)
decreased as (advmod)
results phenotyping (nmod)
smoking cochlea (nmod)
walls mesangium (conj)
injury ongoing (amod)
resuscitated arrest (nmod)
ifosfamide antineoplastic (amod)
mouth and (cc)
hypotension severe (amod)
rapamycin mtor (appos)
glomerulopathy tg (appos)
hitt and (cc)
protocols two (nummod)
pge2 by (case)
intravenous intratracheal (conj)
report reaction (nmod)
participants reported (acl:relcl)
development cancer (compound)
reorganization the (det)
0.1 0.5 (conj)
day 57 (nummod)
elicited tone-burst (advmod)
rct good-quality (amod)
spect on (case)
modification regimen (nmod)
recurarization of (case)
mmol.kg(-1).day(-1 4 (nummod)
41.8 +/- (cc)
papillary in (case)
tgf- , (punct)
variable could (aux)
23.5 - (punct)
= 11 (dep)
association progression (nmod)
failed who (nsubj)
inhibited exacerbation (nmod)
atorva or (cc)
experience in (case)
[na]o on (case)
remained markers (nsubj)
block secondary (amod)
demonstrated reported (conj)
microscopy laser (compound)
cell white (amod)
pbo % (appos)
dogs chest (amod)
rotation lesion (nmod)
chc ( (punct)
dyskinesia patients (nmod)
glaucoma murine (amod)
stay of (case)
administration ng/mouse (appos)
proved premedication (nmod)
hydroxyquinolines halogenated (amod)
emergence drugs (nmod)
3 more (amod)
groups ten (nmod)
change metabolite (appos)
usage frequent (amod)
push 2-minute (amod)
followed breakdown (nmod)
inhibitor dopa (compound)
unilateral during (case)
down-regulation day (nmod)
sgot phosphatase (conj)
parameters capacity (conj)
0 2 (prep)
plasma in (case)
observed studies (nmod)
apparatus the (det)
currents delayed (amod)
receiving tacrolimus (dobj)
performed stress (nsubjpass)
correlated sampled (conj)
onset acute (amod)
s and (cc)
abundances cotransporter (conj)
action cns (compound)
aplasia red (amod)
syndrome 3-week (amod)
agents psychopharmacologic (amod)
plausible discussion (advmod)
breast of (case)
suggest displays (ccomp)
daily atazanavir (compound)
blotting western (compound)
paws with (case)
that diazepam (nmod)
pressure continuous (amod)
functions normal (amod)
effects stimulation (nmod)
defined ) (punct)
hyperosmolar coma (dep)
kanamycin furosemide (conj)
ecstasy of (case)
thrombosis experimental (amod)
frontal and (cc)
tissues breast (compound)
phenobarbitone- impairment (dep)
9 ( (punct)
cases the (det)
adenocarcinomas treatments (nmod)
6.7 5.3 (conj)
perform examine (advcl)
octapeptides to (case)
has association (dobj)
activities transaminase (nmod)
choices y-maze (nmod)
combined regulation (nmod)
osmolality hour (conj)
moderate symptoms (nmod)
limits observations (nsubj)
noticed results (nmod)
prevention virus (nmod)
remain however (advmod)
hypothalamus in (case)
value a (det)
-9 - (punct)
examination mice (nmod)
accelerating in (mark)
seizures application (nmod)
activity pra (appos)
near-syncope as (case)
dizziness somnolence (conj)
day p (appos)
potential examinations (nmod)
mg flecainide (dep)
60 50 (compound)
using group (dobj)
potent as (case)
rats neonatal (amod)
did any (dobj)
concentrated was (auxpass)
included information (dobj)
dysfunction cardiomyopathy (conj)
minute time (nsubj)
vagotomy transection (conj)
performed of (mark)
recipients removing (acl)
use given (case)
developed then (advmod)
-8.1 +/- (cc)
arteries mater (nmod)
supported evidence (nmod)
% receiving (acl)
doses cocaine (nmod)
variability and (cc)
unchanged was (cop)
fk ( (punct)
lower weeks (nmod)
changes ability (nmod)
doc induced (acl)
receiving one (dobj)
thirst secretion (dep)
was elimination (attr)
plasma fresh-frozen (amod)
cpm ) (punct)
isoniazid implicating (compound)
mg. route (nmod)
likely those (nmod)
count cells/l (dep)
necessitate to (case)
pirenzepine antagonism (conj)
decrease microfilaremia (nmod)
higher than (advmod)
private commercial (conj)
dup of (case)
led mmhg (dep)
density increased (conj)
county tland (nmod)
memory proactive (amod)
pain induced (amod)
inhibited clonidine (nsubj)
activation hyperlipemia (conj)
observations few (amod)
association on (case)
dose paclitaxel (nmod)
randomised , (punct)
patients 142 (nummod)
phenomena the (det)
remained lower (acomp)
disability aggravating (amod)
myeloperoxidase- proteinase-3-antineutrophil (conj)
promoted control (nmod)
examined fields (nsubjpass)
measured removed (conj)
detected findings (nsubjpass)
received transplant (dobj)
35 11 (conj)
flair 7/8 (appos)
buffered area (nmod)
effects carboplatin (amod)
involvement subdivisions (nmod)
continues proportions (nmod)
long because (mark)
granulated reticulum (nmod)
oximeters pulse (compound)
concentrations toxicity (conj)
k- common (nsubj)
indicated markers (nsubj)
review cochrane (compound)
conclusions provided (appos)
extremities distal (amod)
permeability aortic (amod)
weeks surgery (dep)
locomotion climbing (conj)
increase simultaneously (advmod)
status % (nsubj)
cycles . (punct)
reduced species (dobj)
surgery man (nmod)
osmolality serum (compound)
cholinomimetic of (case)
suggest heterogeneous (ccomp)
fibrosis with (case)
thickening increase (conj)
remains however (advmod)
asked was (auxpass)
convulsions and (cc)
infused min (dep)
complaints with (case)
rats diabetic (amod)
ischemia for (case)
lobe . (punct)
hyperbilirubinemia progressive (amod)
seizures death-producing (amod)
had which (nsubj)
remained attacks (nmod)
effect strain-dependent (amod)
demographics arrhythmia (nmod)
use infection (nmod)
test described (acl)
cyclophosphamide intravenous (amod)
doses nitroglycerin (conj)
tone cardiac (amod)
disease on (case)
drugs etoposide (dep)
1.39 was (cop)
predictive ratios (nsubj)
mg/day ) (punct)
demographic to (case)
dosing factor (nmod)
vpa or (cc)
restricted be (auxpass)
toxicity cardiotoxicity (conj)
study 6-week (amod)
use nephroprotectant (nmod)
peptide(1 ) (punct)
corrected successfully (advmod)
lometrexol antipurine (compound)
higher were (cop)
steroids ovarian (amod)
reported notably (advmod)
entry to (case)
under-reporting cases (nmod)
admissions patient (compound)
mg s.c. (nmod)
behaviors levodopa-induced (amod)
nm ki=39 (compound)
roles factor (dep)
correlated correlate (conj)
effect apigenin (nmod)
revealed products (dobj)
version this (nsubj)
pronounced lna (nmod)
lower group (advcl)
demonstrated work (nsubj)
opistothonus dysfunction (conj)
loss thickness (nmod)
period animals (nmod)
authors for (case)
hypothalamus the (det)
success medication (nmod)
jaundice , (punct)
syndrome thrombosis (compound)
cases delirium (nmod)
delirium hyperkinetic (amod)
chlorofluorocarbons of (case)
group a (compound)
activation neuronal (amod)
controls matched (acl)
expression cardiac (amod)
represent . (punct)
lowering anticholinesterase (conj)
use precursor (nmod)
scale hoehn (conj)
failed provide (xcomp)
halothane oxide (conj)
shown unequivocally (advmod)
patients pretreated (acl)
common as (advmod)
children four (nummod)
injection iv (nummod)
handling of (case)
survived overdose (nmod)
conclusion reduces (appos)
effects abbott-53693 (nmod)
cholestasis ethinyl (amod)
d4.2 receptors (appos)
concordance high (amod)
agents anti-aggregating (amod)
option daptomycin (nsubj)
influenced is (auxpass)
u/ml 28.7 (nummod)
ami/gi vs (cc)
had concentrations (nmod)
taking and (cc)
combined paclitaxel (dobj)
rizatriptan and (cc)
% moles/glomerulus (dep)
symptoms dysfunction (conj)
overexpressing mice (nsubj)
volume blood (compound)
hypertension mainly (advmod)
encephalopathy treatment (nmod)
difficulty diagnostic (amod)
mg/kg mg/kg (conj)
change with (case)
% % (dep)
recovery myopathy (nmod)
crisis aplastic (amod)
known leads (ccomp)
concentration curve (conj)
problem microangiopathy (nsubj)
frequent when (ccomp)
sprague-dawley female (compound)
useful produce (xcomp)
didanosine and (cc)
snr ( (punct)
bolus doses (nmod)
caused decrease (advcl)
event patient (nmod)
outpatients hyperprolactinemia (nmod)
presented while (mark)
exposure development (nmod)
advanced stages (nmod)
evidence term (nmod)
kinetics slow (amod)
development agents (nmod)
levels apoptosis (conj)
outcomes cognitive (amod)
flurothyl and/or (cc)
300 ( (punct)
ability improve (acl)
stages to (case)
lesion differentiation (nmod)
platform and (cc)
pallidotomy knife (compound)
effects caa (nmod)
3nt ( (punct)
woman 25-year-old (amod)
aki of (case)
20 to (dep)
choice atra (nsubj)
discussion : (punct)
variables patient (nmod:poss)
acuity central (amod)
accompanied myoclonus (nmod)
used ketoprofen (nsubjpass)
group treated (amod)
increasing an (det)
avoided administration (nsubjpass)
recommended are (auxpass)
thought gap43 (nsubjpass)
one nephropathy (nsubj)
gene at2r (compound)
rats stimulations (nmod)
stimulation via (case)
used correct (xcomp)
mbp ) (punct)
exhibit evaluate (advcl)
scavenging and (cc)
have thirst (dobj)
use following (case)
carboplatin of (case)
80 10 (compound)
unremarkable tomography (nsubj)
process delayed (amod)
hyperprolactinemia experimental (amod)
cas 5 (dep)
experience pain (compound)
increasing production (dobj)
presence fasciculation (nmod)
treatment naturalistic (amod)
derivative trans-2-amino-3-hydroxy-1 (nmod)
showed percent (nsubj)
treated cream (conj)
putamen in (case)
exposure mixture (nmod)
patients adopted (acl:relcl)
calculated computer (nmod)
correlated nephrotoxicity (nmod)
subjects between (case)
metastasis liver (compound)
overt eeg-detectable (conj)
less that (nsubj)
pain experimental (amod)
remained cpk (nsubj)
placed mg (nmod)
caucasian 3 (nummod)
oil diazinon (conj)
prolonged treatment (nmod)
protocol dogs (nmod)
adults and (cc)
bobbing circling (conj)
establishment paradigm (nmod)
regimen agc (nmod)
disappear when (advmod)
binding greater (amod)
had elevation (nmod)
developed 5 (dobj)
sum segment (nmod)
case child (nmod)
glomeruli non-sclerotic (amod)
occlusion induction (nmod)
efficient was (cop)
analgesics rats (nmod)
fibrosis renal (amod)
rats 2 (dep)
immunosuppressants , (punct)
h. garavan (compound)
crf ) (punct)
stroke years (nmod)
considered polyvidone (nsubjpass)
seen generally (advmod)
rate effects (conj)
elements structural (amod)
difference percentage (nmod)
gestation mother (nmod)
salivation agitation (conj)
administered sessions (nmod)
adopted widely (advmod)
share effects (dobj)
imaging cranial (amod)
needed % (nmod)
factor-alpha and (cc)
injection thrombin (nmod)
neurotoxicity theophylline (nmod)
passage : (punct)
droperidol used (acl)
reported transplantation (nmod)
showing potentially (advmod)
ca mm (amod)
as group (nmod)
determined centrally (advmod)
responses efficacy (conj)
pressure diameter (conj)
fill rats (nsubj)
associated they (nsubjpass)
proteins weight (compound)
role renin (nmod)
tasks = (parataxis)
organization and (cc)
response ritonavir (nmod)
isradipine placebo (conj)
level micrograms/ml (appos)
differences half (appos)
headache light (amod)
test antiglobulin (compound)
administered co (advmod)
investigated hospital (nmod)
reported symptoms (nsubj)
cyanamide to (case)
alterations integrity (nmod)
experiments . (punct)
arteries the (det)
process another (det)
cows , (punct)
infants three (nummod)
vasculitis antineutrophil (compound)
captopril-treated lifetime (nmod:npmod)
food for (case)
decreased patient (nsubj)
performed ct (nsubjpass)
accumulation consequent (amod)
patients continue (acl:relcl)
resulted population (nmod)
expanded toxicities (nmod)
ci-921 of (case)
studies histopathological (amod)
demonstrated function (nsubjpass)
help , (punct)
appeared correlation (nsubj)
lna lca (dep)
day until (case)
occurrence in (case)
resulted dyskinesias (nmod)
effects activity (nmod)
collected interview (nmod)
adrenaline epinephrine (appos)
edema well-demarcated (amod)
obtained easily (advmod)
hours onset (nmod)
associated injection (nmod)
appears mediated (xcomp)
alpha- with (case)
interest of (case)
anticoagulation excessive (amod)
sings activation (nmod)
complication but (cc)
clinical findings (dep)
hbv-dna patients (dep)
anxiety of (case)
expressions mmp-2 (nmod)
deposition marked (amod)
aimed focus (nmod)
onset asystole (nmod)
associated effacement (nmod)
suitable reduction (nsubj)
ascribing osteoporosis (nmod)
diagnostic ed (nmod)
schiff pas (appos)
mg/m(2 mmc (compound)
confirm to (mark)
users bzd/rd (compound)
administration bpd (compound)
associated lamotrigine (nsubj)
t the (det)
effect dependent (amod)
model dysplasia (nmod)
reduction flow (nmod)
ctc-nci 45.5/18.2/6.1 (dep)
measured method (nmod)
participating was (aux)
meningitis in (case)
increase after (case)
menopause since (case)
pressure symptoms (conj)
observed incidence (nsubjpass)
controls 13 (nummod)
eeg ) (punct)
review data (nmod)
connection antibiotics (nmod)
alter morphine (nsubj)
derived trials (nmod)
wistar pregnant (compound)
group doctors (nmod)
discontinued thalidomide (nsubjpass)
reason possible (amod)
hematoma postoperative (amod)
pronounced effect (nsubj)
performed time (nmod)
provocation or (cc)
pph and (cc)
concentration maximum (compound)
chloride between (case)
interaction : (punct)
activity atpase (compound)
symptoms malaise (nmod)
rechallenge warfarin (nmod)
complications neurologic (amod)
pregnancies delivered (acl:relcl)
dyskinesia dose (compound)
causes patients (nmod)
providing form (dobj)
administered nocistatin (nsubj)
treat thrombosis (dobj)
availability cardiomyocytes (nmod)
unresolved increases (advcl)
injection humans (nmod)
e4031 nm (appos)
lead summary (nsubj)
gastrocnemius left (amod)
dosing intrathecal (amod)
toxicity more (amod)
mediated pathways (nmod)
symptoms hypotension (conj)
increases bodies (nmod)
moment the (det)
used setting (xcomp)
antagonist and (cc)
shown capacity (dobj)
system using (acl)
medulla renal (amod)
total the (det)
hypothesis results (ccomp)
111.0 133.1 (conj)
neoantigens hepatic (amod)
aware anaphylaxis (nmod)
upregulation a (det)
body lv (compound)
mg 150 (compound)
bringing about (compound:prt)
performed total (nmod)
terms the (det)
suggested contrast (nmod)
intestine in (case)
comparison by (case)
kinases mitogen-activated (amod)
reached common (nmod)
vehicles and (cc)
mechanisms pathogenetic (amod)
content reduced (amod)
monitored counts (nmod)
increases post-scr (compound)
variants atypical (amod)
frontal temporal (conj)
mortality rats (nmod)
trichotillomania , (punct)
groups pci (compound)
needed numbers (nsubjpass)
cases marrow (nmod)
movement involuntary (amod)
applicable group (nmod)
optochiasmatic and (cc)
withdrawal therapy (nmod)
lead it (nsubj)
phonological and (cc)
suggestive thrombosis (nmod)
administered fluoxetine (nsubjpass)
referred ) (punct)
seizures all (det)
effects metformin (nmod)
due . (punct)
adjacent function (nmod)
measured presence (nmod)
health-care direct (amod)
ecg ( (punct)
peak a (det)
induced prostigmine (dep)
enlargement rat (nmod)
rash neuropathy (conj)
defects with (nmod)
metabolism its (nmod:poss)
myalgia a (det)
examined study (nmod)
increases increasing (advcl)
cessation completion (conj)
129 57.5 (compound)
conclusions suggest (appos)
radiographic contrast (conj)
anticoagulants oral (amod)
effects fetal (amod)
treatment phenytoin (compound)
need inducing (advcl)
mainly after (mwe)
seen symptoms (nsubjpass)
women . (punct)
impaired were (auxpass)
non-selective selective (conj)
stereotypy dexamphetamine (compound)
prophylaxis thrombosis (nmod)
higher meningioma (nmod)
diseases ) (punct)
number studies (nmod)
systolic diastolic (conj)
expression decrease (compound)
those used (acl:relcl)
suggest treatment (ccomp)
increased day (nmod)
associated upslope (conj)
f. 97 (nummod)
serious was (cop)
dye evans (compound)
stature puberty (amod)
factor whether (mark)
identify level (nmod)
content mass (conj)
nsaid an (det)
responsible putatively (advmod)
patient demonstrating (acl)
observed frequently (advmod)
motoneurons to (case)
rats srl-treated (amod)
level signaling (nmod)
les a-ii (compound)
lacking information (nsubj)
follow-up during (case)
ortral and (cc)
measure to (mark)
affected hus (nmod)
raises prevalence (nsubj)
gtn : (punct)
vpu ( (punct)
tissues bbb (nmod)
angiopathy . (punct)
preservatives of (case)
potentiate domperidone (nsubj)
changes spasm (nmod)
mg mianserin (conj)
helpful strain (nsubj)
mg/kg morphine (compound)
attenuated injection (nmod)
treatment relies (acl:relcl)
challenge emerging (amod)
fertility and (cc)
decrease % (amod)
measured use (nmod)
1 into (case)
8.75 to (case)
studies . (punct)
effect risk (nmod)
mechanisms 2 (dep)
reperfusion normotensive (amod)
procedure transplant (compound)
defined response (nsubjpass)
diagnosing condition (dobj)
ua 280+/-17 (nummod)
case hepatitis (nmod)
scans serial (amod)
vasodilator is (cop)
understanding underlying (xcomp)
mg 1,000 (compound)
arteries small (amod)
day immunization (nmod)
essential that (mark)
change during (case)
dissipates the (det)
signals to (case)
lf of (case)
interneurons of (case)
found majority (dep)
uses methamphetamine (compound)
ten measures (nmod)
fps ( (punct)
2 during (case)
remains moreover (advmod)
greater rates (nsubj)
prolonged markedly (advmod)
test effects (ccomp)
diet 5-day (amod)
treated vincristine (nmod)
woman-years ( (punct)
testosterone tamoxifen (conj)
infusion as (cc)
catalepsy for (case)
stable tachy- (nmod)
nucleus area (conj)
amphetamine ( (punct)
possibility mediated (ccomp)
valsartan antagonist (appos)
theophylline after (case)
administration 5-fu (nmod)
seizure-free drugs (nmod)
discussed similarity (nsubjpass)
responsibility actual (amod)
conclusions occur (dep)
cidofovir disease (nmod)
observed increase (nmod)
demonstrated common (advcl)
streptomycin to (case)
mechanisms cause (acl:relcl)
caucasian and (cc)
mecamylamine by (case)
doubled approximately (advmod)
influence l-dopa (nmod)
carcinoma nonsmall (compound)
seems exposure (nsubj)
improved movements (nsubj)
starting pge1 (dobj)
g/dl g/dl (conj)
impairments treatment (nmod)
initiating for (mark)
nephrotoxicity apap (compound)
reduced reserpine (conj)
ventricles of (case)
initiating of (mark)
myelination from (case)
willing accept (xcomp)
doses those (nmod)
0.6 5.5 (dep)
confounders , (punct)
prevalent d-glucarates (nmod)
hypotension during (case)
approaches these (det)
different however (advmod)
those , (punct)
occurred algorithm (nmod)
act tissue (nmod)
dgc in (case)
ventilation for (case)
effects dynamic (nmod)
factor elevation (nsubj)
change thresholds (nmod)
increased 1 (dep)
decreasing numbers (dobj)
observed study (nmod)
suppressants to (case)
therapy unopposed (amod)
perception taste (compound)
responding initially (advmod)
months placebos (nmod)
results increased (appos)
flexion/extension speaking (acl)
marketed suprofen (nsubjpass)
bodyweight by (case)
enhanced volume (dobj)
upset one (appos)
related finding (nsubj)
butyrylcholinesterases bches (appos)
use chloride (nmod)
cardiac , (punct)
caa administration (nmod)
nonusers users (appos)
% -24.6 (nummod)
introduction dosage (conj)
dehydrogenase acid (conj)
expression gap43 (compound)
metabolizer poor (amod)
necrosis fatal (amod)
progression renal (amod)
responses muscle (compound)
incidence benefits (nsubj)
analysis including (case)
rofecoxib : (punct)
demonstrated who (nsubj)
preventing toxicity (dobj)
followed that (mark)
wave positive (amod)
micrograms 10 (nummod)
cause drugs (nsubj)
day 13th (amod)
cvd ( (punct)
32.4 2.6 (compound)
abundant 1 (nmod)
catarrhalis ( (punct)
woman angiogram (nmod)
lateral anterior (conj)
submitted shock (nmod)
complaints time (nmod)
has toxicity (dobj)
malondialdehyde group (compound)
treatment mirtazapine (nmod)
injury group (compound)
suggest that (nsubj)
totp or (cc)
results follows (appos)
effect anxiogenic (amod)
increase [ca]o (nmod)
suggest investigated (ccomp)
had mild (dobj)
achieved hypotension (nsubjpass)
patients neurocritical (amod)
prevented post-treatment (nsubj)
pills contraceptive (amod)
drinkers heavy (amod)
suggests etiology (nmod)
emg single (amod)
observations earlier (amod)
associated occasionally (advmod)
the later (advmod)
started electrocardiogram (conj)
known inhibitors (nsubjpass)
induces tacrolimus (nsubj)
processes three (nummod)
sma ( (punct)
0.25 1.0mg/kg (prep)
caused used (conj)
tachycardia no (neg)
naproxen mg (dep)
diseases prognosis (appos)
commensurate tasks (compound)
chemotherapy of (case)
failed concentrations (nsubj)
trial phase (compound)
lead discontinuation (nsubj)
differences major (amod)
inhibitor known (acl)
antiplatelet of (case)
augment not (neg)
nhe3 ) (punct)
concentrations lower (amod)
rats 10-month-old (amod)
7.8 % (quantmod)
cns depression (conj)
predictor tested (advcl)
improvement symptomatic (amod)
phases different (amod)
stiffness morning (compound)
therapy toxic (acl:relcl)
evaluate incidence (dobj)
phenylbutazone indomethacin (conj)
rare : (punct)
play factors (nsubj)
72 to (quantmod)
possibility that (ccomp)
had fruste (conj)
documented month (nmod:tmod)
blockers sucralfate (conj)
treated animals (nsubjpass)
cannulae subdural (amod)
ischemia observed (acl)
lysozymuria undetectable (amod)
receptor kinase (compound)
domain hepatocytes (nmod)
observed mg/day (nmod:tmod)
rats ip (dep)
given analyzed (conj)
reflex be (cop)
interval ; (punct)
longitudinal , (punct)
unclear suggested (parataxis)
withdrawal pergolide (compound)
complete block (dobj)
linked sprouting (nmod)
counted vacuoles (dobj)
patients hbsag (compound)
avoided using (advcl)
persisted hrs (nmod)
measured parameters (dobj)
chow , (punct)
neutral and (cc)
carbachol mug (appos)
patients acromegalic (amod)
production radical (amod)
drug risperidone (nsubj)
patients labor (nmod)
manifestations serve (acl:relcl)
indications in (case)
torr 83 (nummod)
evaluated have (ccomp)
recognition angioedema (nmod)
cardiotoxicity cocaine (nmod)
e.g. , (punct)
disarrangement and (cc)
administration succinylcholine (compound)
metoprolol 's (case)
aware clinician (nsubj)
patients 1/104 (nummod)
evoked , (punct)
commencement at (case)
abnormalities elevations (conj)
increased % (dep)
reported infusion (nsubjpass)
platelet the (det)
period administration (nmod)
agents chelating (compound)
use stroke (appos)
endophthalmitis for (case)
appears furthermore (advmod)
search reports (nmod)
0.899 0.295 (nummod)
improve situation (dobj)
understood result (nmod)
actin of (case)
treated protocol (nmod)
recommended observation (nsubjpass)
neurogenesis rat (compound)
focused study (nsubj)
addressed finally (advmod)
grade mainly (advmod)
withheld complete (conj)
cancer des (compound)
-cimetidine placebo (conj)
7 0.38 (conj)
variation difference (acl:relcl)
reducing upon (mark)
recordings from (case)
hospital teaching (compound)
nodules and (cc)
evaluate to (mark)
use cocaine (nmod)
statistically were (cop)
cause prescribed (advcl)
observed bleeding (nsubjpass)
reduction mean (compound)
co-morbidity with (case)
tbm in (case)
increase doses (nsubj)
obtund to (mark)
nodularity women (nmod)
results timolol (appos)
roles pivotal (amod)
fa ( (punct)
aged over (advmod)
aortic regurgitation (dep)
bleeding argatroban (nmod)
alternation of (case)
taking mg/day (dobj)
prevent dex-ht (dobj)
diagnosed cholestasis (nsubjpass)
converted rapidly (advmod)
manifestation levetiracetam (nmod)
studies post-mortem (amod)
group 3 (nummod)
gave children (nsubj)
alf ( (punct)
lids in (case)
damage cardiac (nmod)
limited expectancy (nsubjpass)
patient 65-year-old (amod)
rats dahl (compound)
dose therapeutic (amod)
gangrene with (case)
counteract dysfunction (dobj)
appearances and (cc)
7.4 3.0 (conj)
assessment echocardiography (nmod)
using kanamycin (dobj)
acetylsalicylate and (cc)
cycles three (nummod)
recordings wall (nmod)
energy natural (amod)
effects its (nmod:poss)
infections caused (acl)
myalgia to (case)
id50 widely-different (amod)
estimated also (advmod)
doses microg (dep)
triad the (det)
response lh-rh (nmod)
subjected compared (dep)
challenge to (case)
bp for (case)
72 - (punct)
negative when (advmod)
suppressing vitro (advmod)
class on (case)
site precise (amod)
chemotherapy trial (appos)
intervals , (punct)
published has (aux)
subjects control (compound)
unchanged alpha3 (nmod)
% accumulation (nsubj)
active had (conj)
highlight role (dobj)
surface erythrocyte (compound)
increased conversely (advmod)
abnormalities moderate (amod)
important aware (ccomp)
blockade mfs (nmod)
group dox (compound)
walk and (cc)
serum- the (det)
yield screening (nsubj)
neutropenia with (case)
features cases (nmod)
pattern histologic (amod)
associated cleft (conj)
examined correlation (nsubjpass)
heterogeneous socioeconomically (advmod)
made first (dep)
tet nor (cc)
mg/g ) (punct)
appt [ (punct)
bicuspid progressed (acl:relcl)
manage dosing (dobj)
19.3 and (cc)
box to (case)
deterioration metabolism (nmod)
deficits monoaminergic (amod)
action tnss (nmod)
attenuated response (dobj)
surgery unilateral (amod)
54 ) (punct)
% rare (amod)
suggest also (advmod)
drug-induced probably (advmod)
diet an (det)
four , (punct)
anuria this (det)
evoked ( (punct)
treatment from (case)
correlated strongly (advmod)
testosterone low (amod)
constituted disequilibrium (nmod)
viewed be (auxpass)
deaths cocaine-related (amod)
asymptomatic previously (advmod)
measure the (det)
environment the (det)
increase lesions (nmod)
activated enflurane (nmod)
rash events (nsubj)
overflow endogenous (amod)
hiccups with (case)
prevented estimation (dobj)
2.5 ) (punct)
syndrome aids (appos)
injected pilocarpine (nmod)
nigra , (punct)
(5.3)% -32 (nummod)
hypertension bradycardia (conj)
one marker (conj)
administered emergence (nmod)
incidence importance (conj)
recovery uneventful (amod)
recommended patients (nmod)
function vivo (advmod)
cbdca ) (punct)
particulate fine (amod)
known not (neg)
drugs linezolid (nmod)
occurred context (nmod)
resulted possibly (advmod)
required residues (nsubjpass)
systems midbrain (appos)
quotient diameter (nmod)
26- more (conj)
carried dosage (nsubjpass)
methamphetamine the (det)
reported times (nmod:tmod)
receptor-alpha peroxisome (compound)
subjected craniotomy (advcl)
using assay (dobj)
clearance plasma (compound)
pressure . (punct)
increase level (conj)
strongly most (advmod)
droperidol dose (compound)
discontinue , (punct)
regulation pressure (compound)
alf=0/35 and (cc)
illustrate . (punct)
gap43-ir in (case)
deferens vas (compound)
widely less (advmod)
intraventricularly ( (punct)
50mg/kg slightly (advmod)
angiodegeneration biopsies (dep)
novel potentially (advmod)
form combined (acl)
index % (appos)
studied society (dobj)
consider avoid (advcl)
change of (case)
heart 2 (conj)
changes respectively (advmod)
abstinence despite (case)
support do (aux)
carriers chinese (amod)
sbp than (case)
obstruction atherosclerotic (amod)
degrees fibrosis (nmod)
testing aggregation (compound)
neoplasms based (case)
discharge the (det)
erythematosus cutaneous (amod)
occurred increase (nmod)
injection botox (compound)
simple , (punct)
recommended as (mark)
effects stage (nmod)
decrease torr (conj)
insecticides the (det)
recorded groups (nsubj)
pathways signaling (compound)
transfusion red (amod)
lead consequences (nmod)
= 1188 (dep)
hospitalized centre (nmod)
mg doses (nmod)
generated that (nsubjpass)
onset cases (conj)
disappeared pain (nsubj)
marked were (auxpass)
determined administration (nmod)
dopamine serotonin (conj)
occurring that (nsubj)
ci=25.2 % (dep)
impact observed (amod)
absence caffeine (nmod)
myelosuppression neuropathy (conj)
sensitized , (punct)
disturbances as (case)
involvement coeruleus (nmod)
precise are (cop)
warranted profile (nmod)
attention careful (amod)
scleroderma localized (amod)
capsaicin intradermal (amod)
resemble those (dobj)
patient presentation (nmod)
anticoagulation with (case)
antagonist not (neg)
comprised methods (dep)
developed cholestasis (dobj)
assessed events (nmod)
arrested beating (dobj)
hampshire 's (case)
contracture a (det)
status between (case)
shown potentiated (conj)
scale y-mrs (appos)
events conclusion (nmod)
blot protection (conj)
quickly very (advmod)
lesions precancerous (amod)
myd88 ) (punct)
common associated (conj)
epileptogenic are (cop)
down-regulation . (punct)
continued available (advcl)
levels tpa (compound)
studied group (nmod)
differences naloxone (nmod)
hypertension fluoxetine-induced (amod)
min 150 (nummod)
amount capsaicin (nmod)
improved performance (dobj)
transcripts encoded (acl)
situations , (punct)
increased effects (nsubjpass)
cirazoline abbott-53693 (conj)
comprised gem (conj)
plasma brain (conj)
relapsed subsequently (advmod)
substantial treatment (nmod)
regimen tobramycin (nmod)
users injection (compound)
regulation density (nmod)
derangement reversible (amod)
uiu/ml to (mark)
received alone (advmod)
dose gd (nmod)
chemotherapy multiagent (amod)
tle ) (punct)
actin glomerular (amod)
uni- in (case)
powders calcium (compound)
seemed and (cc)
nephropathy a (det)
controls 763 (nummod)
preferred should (aux)
period p (dep)
irritability , (punct)
apparatus golgi (compound)
effects altered (amod)
tested analysis (nmod)
coagulation [ (punct)
technique anesthetic (amod)
stimuli and (cc)
revealed imaging (nsubj)
phase initial (amod)
-/- beta4 (nummod)
alter do (aux)
generation superoxide (compound)
patients between (case)
attention particular (amod)
chloride injury (appos)
rls with (case)
number seizure (amod)
studying involvement (dobj)
suppression of (case)
cells tumor (compound)
patients mg (dep)
ifo than (case)
examine to (mark)
acted agent (nmod)
aspirin update (appos)
attenuated dose-dependently (advmod)
all of (case)
patients analysis (nmod)
strain grs (appos)
stability and (cc)
war during (case)
site via (case)
preventing delirium (dobj)
g/d conversion (nmod)
greater occurred (conj)
symptoms patient (nmod)
induced observed (conj)
eruption drug- (amod)
attenuated indicating (advcl)
alpha-methyldopa mg/kg (compound)
acetonide fa (appos)
patterns drinking (compound)
that obtained (acl)
achr. of (case)
occlusion following (case)
become investigation (nsubj)
da ( (punct)
characteristics acuity (conj)
loss urinary (amod)
d2 prostaglandin (compound)
infiltration diffuse (amod)
passed this (conj)
patient compared (case)
disease system (compound)
occurs period (nmod)
diameter ( (punct)
4.1 1.5 (compound)
bilateral and (cc)
most improvement (nmod)
cause b (nsubj)
showed epileptiform (dobj)
compare susceptibility (dobj)
grouped were (auxpass)
plays cascade (nmod)
3h-tbob of (case)
development , (punct)
include controls (dobj)
compromised were (auxpass)
epilepticus model (nmod)
aspirated needed (conj)
160 140 (compound)
emboli with (case)
edema nausea (conj)
accelerated decreased (conj)
movement an (det)
receptors 5-ht2a (compound)
plasma ; (punct)
occurring samples (nmod)
surgery iop-lowering (amod)
assessed animals (nsubjpass)
mg 30 (nummod)
reversibility effects (nmod)
lactate biperiden (amod)
7-ethoxyresorufin-o-deethylase , (punct)
conclusions justify (appos)
occurred treat (xcomp)
northern of (case)
interval electrocardiogram (nmod)
circumstances mechanisms (conj)
had performance (dobj)
diabetes function (nmod)
wk ) (punct)
deterioration : (punct)
presence sharps (nmod)
increase glucose (nmod)
ci p=0.020 (appos)
scores group (nmod)
recovery and (cc)
responsible , (punct)
overcome effect (dobj)
sinus cavernous (amod)
slowing diffuse (amod)
corrected tendency (nsubjpass)
remain roles (nsubj)
toxicity d3 (nmod)
repeat anaesthetic (amod)
risk concentrations (nmod)
lower this (nsubj)
metabolite formed (acl)
dropped concentration (nsubj)
tobramycin nine (nummod)
management surgical (amod)
proteinuria mild (amod)
phenytoin vivo (advmod)
protects seizures (nmod)
cumulative cardiomyopathy (dep)
kinase ck (appos)
dex saline (conj)
hypotension nitroglycerin-induced (amod)
subjects with (case)
potentiation catalepsy (nmod)
affected verapamil (nsubj)
simulations dynamic (compound)
crocins ; (punct)
levels whole (amod)
investigation performance (nmod)
sections of (case)
provide blockade (nsubj)
case congenita (nmod)
fibrillation cycle (nmod)
prescribe and (cc)
scattered degeneration (conj)
cisapride versus (cc)
more confirmatory (nmod)
has oxide (nsubj)
trial b. (nmod)
toxicity from (case)
considered possible (xcomp)
gem-p ) (punct)
conclusions preferable (appos)
marketed months (nmod)
form adducts (dobj)
iop postoperative (amod)
analysis adducts (nmod)
group drug (compound)
hypercoagulability " (punct)
effect desipramine (nmod)
up now (advcl)
baeps ) (punct)
protective was (cop)
score spine (nmod)
assess inhibition (dobj)
time half-relaxation (amod)
histochemistry nicotinamide (compound)
hospital affiliated (amod)
subjects normal (amod)
higher marginally (advmod)
using treatment (nsubj)
modulation effects (nmod)
urotensin-ii of (case)
time induces (acl:relcl)
after-before ( (punct)
types for (case)
limitations design (nmod)
seizures maximal (amod)
symptoms " (punct)
fluctuating responders (dobj)
turnover da (compound)
succinylcholine n (dep)
proteins channel (compound)
pco2 ( (punct)
consequences apparent (amod)
modulation phenomena (nmod)
using rates (dobj)
dilates arteries (dobj)
exacerbations with (case)
17alpha-ethinylestradiol ee (appos)
intake nutritional (compound)
intolerant be (cop)
monitor progression (dobj)
different ; (punct)
combined dose (nmod)
prudent avoid (xcomp)
lesions patient (compound)
10 30 (prep)
continued appearance (nmod)
glutamate synaptosomal (amod)
failed drugs (nsubj)
dyskinesias parkinsonian (conj)
swelling tenderness (conj)
cultured . (punct)
f344 bn (conj)
protocols 2 (nummod)
median , (punct)
microgram/kg/min during (case)
260 of (case)
examined 6 (nmod)
resolution in (case)
correlation weak (amod)
rtm204i ( (punct)
developed d11 (nmod)
pressure at (case)
reversal toward (case)
group with (case)
summarizes article (nsubj)
reactions inflammatory (amod)
mechanisms underlie (acl:relcl)
occlusions retinal (amod)
treated methadone (nmod)
quantitated using (advcl)
toxicity ; (punct)
analyzed variable (amod)
discontinued nafcillin (nsubjpass)
developed necrosis (nmod)
dogs n (dep)
recognized has (aux)
reversed min (nmod)
bodies in (case)
serious occasionally (conj)
course prednisone (nmod)
aes ) (punct)
formation abscess (compound)
associated exposure (nmod)
cpb before (nmod)
administered catheter (nmod)
creatinine = (conj)
information race (nmod)
was demonstrate (xcomp)
conversion g/dl (nmod)
event children (nmod)
hydroxyquinolines of (case)
investigated syndrome (nsubjpass)
decreased treatment (conj)
infarction isoproterenol (compound)
nucleus dentate (compound)
evaluated 37 (nsubjpass)
mediated cortex (nmod)
induces function (nmod)
secretion prolactin (compound)
resulted proteinuria (nmod)
vesicles the (det)
h2-receptors histamine (compound)
concerns safety (nmod)
reaction heparin (nmod)
dystonia persistent (amod)
was subjects (advcl)
receiving amikacin (dobj)
treatment bort-dex (nsubj)
azelastine chlorpheniramine (conj)
fill not (neg)
decreased extent (conj)
attenuate days (nmod)
hypertriglyceridaemia women (nmod)
alterations to (case)
ngf , (punct)
common also (advmod)
reduce did (aux)
cirrhosis tetrachloride-induced (amod)
continence of (case)
requested when (advmod)
coma myxedemic (amod)
ic50s ( (punct)
sedation adequate (amod)
evoked fs (nsubj)
observed vesicles (nsubjpass)
ticlopidine with (case)
91.5 + (cc)
included hydration (dobj)
patients patient (conj)
high-dose cyclophosphamide-based (dep)
substantial whether (mark)
appeared prominent (xcomp)
be . (punct)
immunoreactive active (conj)
critical oxidation (nmod)
match to (mark)
reached day (nmod)
interval her (nmod:poss)
exposure and (cc)
model animal (compound)
inducing possibly (advmod)
influence response (dobj)
had ecg (dobj)
inhibition mip (compound)
has mechanism (dobj)
provided statistics (nsubjpass)
abolished mater (nmod)
experienced signs (dobj)
persisted symptoms (nsubj)
iml ) (punct)
atpase mg+2 (compound)
done carefully (advmod)
b6 of (case)
reduced tachycardia (dobj)
randomised receive (xcomp)
assessed stained (conj)
safe but (cc)
advised be (auxpass)
maculatum conium (compound)
tasks speaking (advcl)
design genetic (amod)
aminoglycosides patients (nmod)
lipid a (det)
years 14 (nummod)
aas ) (punct)
questionnaire dysexecutive (compound)
elevated aminotransferase (nsubj)
agents vasodilator (compound)
scales anxiety (compound)
substrates that (nsubj)
shock electroconvulsive (amod)
six in (case)
a n (appos)
content biosynthesis (conj)
results blonquist (compound)
therapy vpa (compound)
vestibulotoxicity pig (nmod)
arrhythmias concentrations (nsubj)
metaiodobenzylguanidine radiolabeled (amod)
using months (nmod)
hyperalgesia persistent (amod)
recipients organ (compound)
agent neuropathy (nmod)
increase area (nmod)
multiforme when (advmod)
infarctions a (nmod)
treatment doca-salt (amod)
tuberculosis proven (amod)
exposed suppressants (nmod)
weakness muscle (compound)
complexes of (case)
monotherapy hypertension (nmod)
carried investigate (xcomp)
antineoplastic used (amod)
showed rate (dobj)
complexes formed (acl)
importance inhibition (nsubj)
alpha-t alpha-tac (conj)
patients methods (meta)
surgeries pressure-lowering (amod)
nucleus directly (advmod)
tocolysis nifedipine (nmod)
20 than (dep)
severity disease (conj)
encode phases (dep)
positioning the (det)
joint at (case)
anotia ( (punct)
animals while (mark)
excluded participant (nsubjpass)
different although (mark)
11 ) (punct)
clotting and (cc)
antagonizes . (punct)
aneurysms with (case)
demonstrates damage (ccomp)
activity tachycardia (nmod)
rigidity of (case)
treatment hcl (compound)
13.2 of (case)
days injection (nmod)
seem did (aux)
subpopulation a (det)
complex generalized (conj)
sleep memory (conj)
confirmed methods (nmod)
showed study (nsubj)
risks ) (punct)
greater ctnt (nsubj)
prodrug is (cop)
period 30-day (amod)
linked use (nmod)
associated renoprotective (advcl)
s-limonene alcohol (conj)
rhigf-i micrograms/d (conj)
dose mg (compound)
administration levobupivacaine (nmod)
healthy and (cc)
modulator receptors (nmod)
hypotension symptomatic (amod)
prior initiation (nmod)
declined control (xcomp)
% 28.2 (nummod)
contributions vasculogenic (amod)
desogestrel , (punct)
rate glomerular (amod)
smaller same (advcl)
increases cocaine-induced (amod)
eyes of (case)
increase aspirin (nsubj)
revealed stimulation (nsubj)
needle use (conj)
found brain (nmod)
reduces 890 (nmod)
radiolabelling injection (nmod)
described randall-selitto (nmod)
neuropathy treated (advcl)
nincds of (case)
supplements literature (conj)
counteracted resulted (conj)
users 22 (nummod)
improvement rbf (nmod)
show benefits (dobj)
0.62 ratio (compound)
hypnotic the (det)
pilocarpine pilo (appos)
pituitaries bn (compound)
derivatives the (det)
possible nitrendipine (nmod)
syndrome q-t (compound)
cardiotoxic , (punct)
explained is (auxpass)
evaluation patients (nmod)
term at (case)
tends incidence (nsubj)
cases are (cop)
transferred was (auxpass)
adults treated (acl)
relevance physiological (amod)
platform suspended (amod)
ns-nsaids to (case)
m1 ) (punct)
findings eosinophilia (dep)
abnormalities these (det)
showed stimulation (nsubj)
developed this (nsubj)
cis-ra ) (punct)
closest was (cop)
revealed immunohistochemistry (nsubj)
agonist this (det)
shown measured (advcl)
site a (det)
objective evaluated (appos)
seems while (mark)
mediating injury (dobj)
produced tremor (dobj)
blocks women (nmod)
discontinued aborted (advcl)
hand , (punct)
interfere neurotransmission (nmod)
cyclophosphamide ifosfamide (conj)
mmhg 109 (nummod)
female 2 (nummod)
isoniazid bradycardia (nmod)
animals chx+pilo (amod)
induces neovascularization (dobj)
abolished effects (dobj)
occurred thrombophlebitis (nsubj)
propranolol sec/cm5 (dep)
present occurred (conj)
quetiapine add-on (amod)
undergoing cyclosporine (dobj)
role effect (dep)
injected rg1 (nsubjpass)
nicorandil of (case)
begun or (cc)
alphaenac betaenac (conj)
adjuvant safe (amod)
injection each (nmod)
stents studies (compound)
pralidoxime-2-chloride combinations (conj)
13/50 ( (punct)
value negative (amod)
therapy : (punct)
drugs tramadol (conj)
antagonizes caffeine- (dobj)
greater incidence (nsubj)
patients psoriatic (amod)
% 9 (nummod)
ml/100 0.5 (nummod)
mg/day 1200 (compound)
preserved tissue (nsubjpass)
parameters various (amod)
mesna without (case)
anova , (punct)
phenothiazines or (cc)
evaluate question (dobj)
transient cardiac (dep)
groups 3 (nummod)
littermates ) (punct)
existence process (nmod)
analyzed postoperatively (advmod)
used safer (advcl)
causes humans (nmod)
diseases relationship (nmod)
methotrexate following (case)
ameliorated treatment (nmod)
infection of (case)
a c (conj)
filling pressure (dobj)
suppressed injection (nsubj)
myocarditis haemorrhagic (amod)
duration months (amod)
treatment amphetamine (compound)
animals for (case)
results regimen (nsubj)
diclofenac ibuprofen (conj)
volume ) (punct)
blocks anaesthetic (amod)
nhe3 na-k-atpase (conj)
binding biochemical (conj)
higher cows (nmod)
modulated manipulation (nmod)
cr(edta of (case)
nephropathy mice (nmod)
systemic rapid (amod)
patients paediatric (amod)
comparisons inadequate (amod)
remissions sustained (amod)
asystole by (case)
effect nephrotoxicity (conj)
extend establishing (advcl)
reduction for (case)
bonding of (case)
delivery to (case)
agonist duration (nmod)
mechanisms development (nmod)
cs acid (conj)
rate week (nmod)
review on (case)
circuit of (case)
rate fell (acl:relcl)
reductions , (punct)
junctions hepatocyte (compound)
infusions drugs (nmod)
rbcs non-dapsone-exposed (amod)
implicated clearly (advmod)
monotherapy either (det)
report to (aux)
progression with (case)
performed lacking (conj)
factor either (dep)
rate hepatic (amod)
cg ) (punct)
ich in (case)
woman asymptomatic (amod)
patients fifty-eight (amod)
ratio interval (conj)
controls to (case)
bea ( (punct)
subjects genotyped (acl)
report syndrome (nmod)
woman 32-year-old (amod)
cortical collecting (conj)
reduced activations (dobj)
participation with (case)
efficacy valsartan (nmod)
prognosis poor (amod)
demonstrated activity (dobj)
acute fibrosis (conj)
presence hypertension (conj)
effects fluids (nmod)
progression median (amod)
sacrificed dissociated (conj)
receiving area (nmod)
study microscopic (amod)
neurons induced (acl)
testing for (case)
receptors nicotinic (amod)
series a (det)
drug fibrillation (nmod)
available facilities (nsubj)
33.6 ( (punct)
primarily 20 (dep)
mg/day 50 (nummod)
maintained patients (nsubjpass)
outcomes lesions (nmod)
suggest notwithstanding (advcl)
ratios pms (nmod)
centre national (amod)
dyskinesias choreic (amod)
groups rats (nmod)
referred study (nmod)
experiment quasi (amod)
produced first (advmod)
treated acutely (advmod)
tissues disorders (conj)
induces attacks (dobj)
contribute dysfunction (nmod)
60 13 (compound)
drugs active (amod)
level clotting (compound)
applying approaches (dobj)
association temporal (amod)
score total (amod)
interview standardized (amod)
experience syndrome (dobj)
hcn ( (punct)
related to (mark)
pronounced rise (nsubj)
medication this (det)
hypertension secondary (amod)
patterns between (case)
participate , (punct)
show can (aux)
constipation-predominant ; (punct)
events and (cc)
required studies (nmod)
returned weeks (nmod)
observed heart (nmod)
degree developed (advcl)
drug prevention (nmod)
carcinogen a (det)
relation and (cc)
arrest caused (acl)
postulated affected (ccomp)
galactose of (case)
specimens two (nummod)
weeks gestation (nmod)
imipramine with (case)
disease ulcer (compound)
mice non-transgenic (amod)
modulation for (case)
therapy rifampicin (compound)
channel may (aux)
effects cytoprotective (acl:relcl)
quinine- to (case)
stages terminal (amod)
assessed delirium (nsubjpass)
rats lifetime (compound)
contact following (case)
interval r-r (compound)
ritonavir to (case)
concluded we (nsubj)
patients weeks (dep)
hepatotoxicity 1 (nmod)
initiation and (cc)
revealed abnormalities (dobj)
assessed mice (nmod)
4 or (cc)
myofilaments gamma-sarcoglycan (conj)
causes unknown (ccomp)
intake mortality (conj)
leukaemia lp-bm5 (compound)
electroretinography ) (punct)
unknown as (mark)
rhubarb ) (punct)
meq. concentrations (compound)
causes of (case)
therapeutic supratherapeutic (conj)
showed prevent (ccomp)
or [ (punct)
flexion/extension , (punct)
neuropathy tacrolimus (nmod)
present syndrome (nsubj)
appear vary (xcomp)
superior subscale (nmod)
reversed anemia (dobj)
bolus recommended (nsubj)
occurrence effects (nmod)
deviation and (cc)
transmission glutamatergic (amod)
assessable , (punct)
300 600 (conj)
schizophrenia such (case)
new outcome (nsubj)
doxorubicin liposomal (amod)
raise staff (nmod)
neurotoxicity dose-dependent (amod)
increase minus (cc)
gellan placebo (compound)
doses apap (compound)
treatment timolol (compound)
injection intravenous (amod)
groups similar-sized (amod)
caused potentially (advmod)
inhibition phosphokinase (nmod)
determine ensues (conj)
disappearance a (det)
produced evidenced (advcl)
reduce nephrotoxicity (dobj)
administration agents (conj)
0.899 - (punct)
vary compounds (nsubj)
life-threatening five (conj)
taken conclusions (nsubjpass)
units sera (nmod)
wistar sd (conj)
incidence cumulative (amod)
signs cardiovascular (amod)
distinguishing malignancy (nmod)
gentamicin on (case)
hours over (case)
formyltransferase garft (appos)
chicago , (punct)
ct only (advmod)
infants born (acl)
rr 0.93 (nummod)
responses pressor (compound)
developed use (nmod)
dialysate dialysate (appos)
case necrolysis (nmod)
10(-5 5 (nummod)
intravenous but (cc)
assessed analyzing (advcl)
treatment amiodarone (compound)
individual from (case)
specification and (cc)
conclusions indicate (dep)
measure thus (advmod)
hyper-reactivity of (case)
other nicotine (nmod)
injected pilo (nsubj)
bound linkages (nmod)
micrograms subjects (appos)
spasm individuals (nmod)
women contraceptives (nmod)
use seizures (nmod)
related loss (nmod)
suitable , (punct)
ligands sigma (compound)
cardioprotection this (det)
abolished . (punct)
evolved as (mark)
die to (mark)
leukoencephalopathy neurotoxicity (nmod)
isoproterenol with (case)
treatment hyperhidrosis (nmod)
conclusions reports (nmod)
antibiotics aminoglycoside (compound)
supplements products (conj)
concentration e (compound)
clinic our (nmod:poss)
livers , (punct)
levodopa dopamine (compound)
myelopathy and (cc)
found reflexes (nsubjpass)
l-dopa+benserazide ) (punct)
factors tdp (nmod)
edema cystoid (amod)
users chronic (amod)
% 26.6 (nummod)
value measurement (nsubj)
rendered parkinsonian (xcomp)
myoclonia of (case)
hypertrophy dilatation (conj)
cochrane ovid (conj)
a nifedipine (conj)
volunteers elderly (amod)
pattern in (case)
stopped patients (nmod)
fatalities been (cop)
tablet last (amod)
cohort total (amod)
shortened ms (nmod)
hypokalemia digoxin (conj)
peroxidation puromycin (nmod)
failure sedation (compound)
sarin soman (conj)
exclude property (dobj)
db ; (punct)
lifetime methamphetamine-induced (conj)
phase oral (amod)
associated outcome (nmod)
odds ) (punct)
observations analysis (dep)
symptoms neuropathic (amod)
follow can (aux)
slowing stimulation (nmod)
adenocarcinoma biopsy-proven (amod)
reported first (advmod)
stoppage on (case)
occurs , (punct)
medication patients (nmod)
become who (nsubj)
properties advantageous (amod)
comparison effect (nmod)
min fifteen (nummod)
c(max ) (punct)
used understood (conj)
sacrificed and (cc)
injection 8 (nummod)
essential not (neg)
scored and (cc)
see we (nsubj)
withdrawn times (dep)
injection maleate (nmod)
vagina the (det)
ctc-nci ( (punct)
recovered hospital (nmod)
examination post-mortem (amod)
bid mg (amod)
characteristic stimulation (nsubj)
sole or (cc)
ctnt in (case)
developed vector (dobj)
used preceding (xcomp)
patients immunosuppressed (amod)
children of (case)
neurons cholinergic (amod)
phenylalanine , (punct)
published . (punct)
crucial be (cop)
plasma animals (nmod)
observation additional (amod)
aventyl nortriptyline (appos)
function recipients (nmod)
obtained before (advmod)
studies animals (nmod)
dep ( (punct)
calcitonin experiment (compound)
associated nystagmus (nsubjpass)
down-regulation alphaenac (nmod)
studies prior (amod)
76 x (cc)
unchanged delivery (nsubj)
infusion to (case)
persistent exhausting (conj)
indicates process (ccomp)
colocalized p75(ntr)-ir (nsubjpass)
significance : (punct)
rhythms as (case)
infarction inferior (amod)
smaller numerically (advmod)
regimen cmf (compound)
stratified use (nmod)
participate mediate (conj)
noted impairment (nsubjpass)
induced therapy (advcl)
effect therapeutic (amod)
deleterious furosemide (nsubj)
tie possible (amod)
ventricular right (amod)
dystrophy progressive (amod)
neuroadaptation or (cc)
dosed therapy (nmod)
methylprednisolone mg (dep)
used analysis (dobj)
improves , (punct)
pressure mmhg (nmod)
v/v ( (punct)
mutations associated (acl)
disparities despite (case)
contributed respectively (advmod)
results discontinuation (dep)
implications provision (nmod)
showed increased (ccomp)
myeloma refractory (amod)
multiple mixed (conj)
increase tissue (nmod)
reserved use (nsubjpass)
patients developed (acl:relcl)
administration inpatient (amod)
revealed reacting (conj)
significant significant (conj)
chloride-induced sodium (nmod:npmod)
show tolerated (xcomp)
joint that (det)
19.8 +/- (cc)
reduction ie (advmod)
binding theophylline (compound)
detected plasma (nmod)
experience costs (nsubj)
37 of (advmod)
effect supplementation (nmod)
related were (cop)
racine 's (case)
superior was (cop)
count a (det)
induced attacks (nsubjpass)
causes points (conj)
allocated then (advmod)
administration a-86929 (nmod)
continue evaluate (xcomp)
findings sonographic (amod)
ara-c and (cc)
0.002 ( (punct)
drugs nonselective (amod)
examined administration (nmod)
conclude alert (ccomp)
caused activity (conj)
identifiers without (case)
blocked cardioselective (nmod)
prevents dup (nsubj)
renography 131i-hippuran (amod)
feasibility the (det)
remained units/l (dobj)
followed-up total (nsubjpass)
cells h (dep)
activity nfkappab (compound)
records of (case)
consumption detected (acl)
halothane ( (punct)
randomized : (punct)
include questions (dobj)
decreased week (nmod)
dsm-iv ( (punct)
ratio elevated (amod)
known ameliorate (xcomp)
agent use (nmod)
cardioselective is (cop)
sensitivity detecting (acl)
metabolites formed (acl)
superiority the (det)
decrease agent (nsubj)
vicinity in (case)
experiment magnetic (amod)
reduced peroxidation (dobj)
deficits , (punct)
represents case (nsubj)
characteristic are (cop)
receptor dopamine (compound)
dexamethasone rd (appos)
neuropediatrician dysfunctions (nmod)
assay photometric (amod)
decreased suddenly (advmod)
model remnant (amod)
inhibit not (neg)
related caproate (xcomp)
woman 37-year-old (amod)
peg-asparaginase and (cc)
fpdc prolonged (amod)
myocarditis fatal (amod)
happiness ( (punct)
thrombocytopenia , (punct)
helodermin peptide (appos)
patients reabsorption (nmod)
99 90 (compound)
presentation advanced (acl)
recognized angio-oedema (conj)
patients dyskinesias (conj)
finding concerning (case)
systems cranial (amod)
results seconds (appos)
size on (case)
ir ( (punct)
minutes after (case)
evidence involvement (nmod)
secretion hbsag (compound)
guidelines clinical (amod)
exceeded were (conj)
control dbs (nsubj)
signs vincristine (compound)
april 1994 (nummod)
elevated they (nsubj)
comparable groups (nmod)
restriction with (case)
mm lna+lca (appos)
histories with (case)
factors are (cop)
dwi coefficient (conj)
role . (punct)
hypothesis our (nmod:poss)
boluses infusion (nmod)
increasing patients (nmod)
arose feeding (nmod)
respond administration (nmod)
limits use (dobj)
conclusions penicillins (appos)
prominent , (punct)
type ssri (nmod)
haematuria microscopic (amod)
, p.o. (dep)
normalization disappearance (nmod)
cisplatin before (nmod)
nature pharmacodynamic (amod)
0.2 0.4 (conj)
episodes 3 (nummod)
overdose of (case)
fk506 3.0 (nummod)
related extent (nsubj)
ds , (punct)
ratio high (amod)
dopaminomimetics of (case)
responses lasting (acl)
leukemia of (case)
increased blockade (nsubj)
improved although (mark)
testing users (nmod)
valves and (cc)
breaks 15 (nummod)
of cyclosporine (pobj)
550 225 (compound)
report patients (nsubj)
inversions wave (compound)
9.14 1.24 (appos)
studied which (nmod)
boluses boluses (conj)
ether by (case)
akathisia neuroleptic-induced (amod)
divided over (compound:prt)
result findings (nmod)
mean , (punct)
demonstrate role (dobj)
reduction sural (amod)
mass cardiac (amod)
30 more (amod)
globulin lamivudine (conj)
described was (auxpass)
speculated , (punct)
discussed be (auxpass)
administered caution (nmod)
.01 than (case)
rats mg/kg/day (dep)
studies administration (nmod)
affected ratio (nsubjpass)
doses following (case)
showed degree (nsubj)
improved 37.4 (nmod)
troublesome complications (nsubj)
support intensive (amod)
dismissed be (auxpass)
dystonia segmental (amod)
increases bp (dobj)
assessed consensus (nmod)
antigen ag (appos)
verapamil use (nmod)
associated dose (nmod)
subsets patients (nmod)
had persist (ccomp)
centers separate (amod)
reduction p<0.001 (dep)
strain host (appos)
obstructive and (cc)
observed inhibits (ccomp)
brains mice (nmod)
hematotoxicity cephalosporin (compound)
damage disease (nsubj)
tumours bladder (compound)
minute the (det)
aspects influence (conj)
binding [35s]tbps (appos)
decreased of (mark)
receptor achr (appos)
impact use (nmod)
higher mortality (nsubj)
moran mol (appos)
tolerability : (punct)
result levels (nmod)
uncontrolled medication (nmod)
prazosin , (punct)
suggests lack (nsubj)
associated score (nsubjpass)
data ir (compound)
levels pre-bed (amod)
reacted , (punct)
accomplished can (aux)
representative hypertensives (nmod)
prednisolone 10 (nummod)
sensitivity vasoreactivity (conj)
regimen 10-month (amod)
eminence median (amod)
manifestation lid (nmod)
implications . (punct)
prevention infarctions (nmod)
phase long-term (amod)
examined 27 (nsubjpass)
increased echocardiography (nmod)
iu/kg/i.v ) (punct)
indicating involved (ccomp)
nephropathy acid (compound)
p vs (cc)
activity nte (compound)
diameters/bw histological (conj)
any substances (nmod)
years women (compound)
assigned was (advcl)
celecoxib ( (punct)
cases reye (compound)
reverse amnesia (dobj)
anemia (cab)-induced (punct)
doses ranitidine (conj)
management abusers (nmod)
increase thickness (nmod)
call attention (dobj)
case best (advcl)
probability improving (advcl)
infusions chloride (nmod)
profiles/sections 0.7 (nummod)
potential putative (amod)
trh of (case)
bpm 150 (nummod)
completed 10 (conj)
identify is (cop)
investigated mechanisms (nsubjpass)
remains pathogenesis (nsubj)
trinitrate the (det)
drug immuno-suppressive (amod)
lessened dismutase (nsubj)
carbetocin of (case)
higher times (nmod:npmod)
patient therapy (nmod)
need model (nmod)
inclusions no (det)
architecture sleep (compound)
acquired discriminations (dobj)
received tamoxifen (dobj)
hyperfiltration failure (nmod)
entropion mechanical (amod)
to compensate (conj)
hypercholesterolemia of (case)
28 to (dep)
kidneys and (cc)
cannulae inserted (acl)
dec. . (punct)
proteinuria and/or (cc)
methyldopa by (case)
effectiveness = (dep)
weights lung (compound)
challenge . (punct)
rating or (cc)
determinants electrophysiological (amod)
arrest . (punct)
accomplished laboratory (nmod)
asenapine with (case)
number bfu-e (nmod)
application patients (appos)
accompanied that (nsubj)
susceptible be (cop)
performed recovery (nmod)
presenting load (nmod)
infarction healed (amod)
ptra groups (conj)
ingested doses (nsubjpass)
bundle forebrain (compound)
caused dosage (nmod)
impair did (aux)
had returned (advcl)
duration months (compound)
criterion single (amod)
event % (dep)
simulating abuse (dobj)
ingestion methysergide (nmod)
implants ( (punct)
clearance inulin (amod)
bradycardia associated (acl)
evoked carbachol (nmod)
stopped infusion (nsubjpass)
175 % (appos)
recipient a (det)
detection infusion (nmod)
expression ii (nummod)
p=0.48 ( (punct)
inhibitor 3-hydroxy-3-methylglutaryl (amod)
[ca(2+)](i ) (punct)
transport acid (nmod)
influence sevoflurane (nmod)
sulfate nicotine (compound)
information effects (nmod)
challenge intravenous (amod)
had treated (advcl)
site and (cc)
meq/l from (case)
recognized so (mark)
allocated women (nsubjpass)
compounds with (case)
multicenter comparison (conj)
blood was (cop)
22 out (advmod)
coefficient 0.72 (nummod)
effective 100mg/kg (nmod)
response hypertrophy (conj)
reduction intake (nmod)
amlodipine mg (nummod)
angioedema with (case)
deposits electron-dense (amod)
was 7 (nmod)
timolol ophthalmic (amod)
medium and (cc)
levobupivacaine block (nmod)
preparations heart (compound)
event to (case)
lymphomas relapsed (amod)
clarified incidence (nsubjpass)
infusion nephrotoxicity (conj)
2-component beta (compound)
changed cortex (nmod)
mice dbh (compound)
years 47 (nummod)
transport , (punct)
infusion dextran (nmod)
retarding and (cc)
conducted evaluation (nsubjpass)
antigens i (compound)
effects drugs (nmod)
reactions nsaids (nmod)
egfp-microglia with (case)
determine history (dobj)
100/mm3 than (case)
decreased administration (nmod)
peroxidation the (det)
lack response (nmod)
% 170/ (appos)
radiographic and (cc)
months 21 (nummod)
mg/dl. discharged (acl:relcl)
attenuated affected (advcl)
reported initial (xcomp)
pge2 and (cc)
usage anticholinergic (amod)
nsaids to (case)
arteries cerebral (amod)
nimesulide of (case)
acid-induced ethacrynic (amod)
planned administered (advcl)
data on (case)
group days (dep)
preventing suppression (dobj)
day 45 (nummod)
conclusions have (acl:relcl)
suggesting used (ccomp)
developed while (mark)
products noted (acl)
renin ( (punct)
improves and (cc)
outcome pallidotomy (nmod)
initiation patient (nmod)
received iodixanol (dobj)
demonstrate therapy (dobj)
gnc92h2 anticocaine (amod)
octreotide of (case)
level volume (conj)
mdma of (case)
ml(-1 6 (nummod)
similar is (cop)
channel be (cop)
analysis pharmacokinetic (amod)
polyuria marked (amod)
response one (nummod)
parameter hemodynamic (amod)
cases scleroderma (nmod)
doxorubicin such (case)
released , (punct)
alcoholic . (punct)
rilmenidine i1- (conj)
symptoms gain (conj)
acquire location (dobj)
group dysplasia (compound)
managed all (dep)
effective . (punct)
cancers carcinoma (conj)
transplantation dose (conj)
elevation discomfort (nmod)
increased relaxed (conj)
carry out (compound:prt)
studied repeatedly (advmod)
preparation theophylline (compound)
enhance concerns (nmod)
occurring anuria (nmod)
hyperthermia including (case)
determined subjects (nmod)
animals epilepsy (nmod)
ribavirin and (cc)
reactions with (case)
burden esrd (nmod)
factor two (nmod)
occurred resumption (nmod)
reversion the (det)
stage score (appos)
iii-v stages (compound)
decreased ; (punct)
effective weeks (nmod)
protect blockade (nsubj)
treatment risperidone (compound)
rats anesthetized (amod)
attended , (punct)
270 260 (compound)
hiccups and (cc)
accompany and (cc)
mg/kg days (appos)
atenolol propranolol (conj)
contributes endothelial-mesenchymal-transition (nsubj)
objective plays (dep)
% 2.3 (nummod)
achieved and (cc)
alleviated amnesia (dobj)
model mptp (compound)
institutions 32 (nummod)
infiltration wall (nmod)
animals t-treated (amod)
cells outer (amod)
placebo scores (nmod)
concordance localization (nmod)
16,459 . (punct)
dismutase dimethylthiourea (conj)
2008 through (case)
degree ( (punct)
sulfate bw (appos)
revealed t-tests (nsubj)
has metformin (nsubj)
antioxidant also (advmod)
sensations capsaicin-induced (amod)
coeruleus the (det)
volunteers within (case)
declines significant (amod)
induces expression (dobj)
regarded foodstuffs (nmod)
let re-observed (conj)
eyes receive (acl:relcl)
preponderance no (neg)
proteins ) (punct)
is listed (advcl)
outcomes acetonide (nmod)
54 +/- (cc)
role development (nmod)
produced paralleling (advcl)
examined carefully (advmod)
incidence neurotoxicity (nmod)
indicative myelitis (nmod)
treated lnna (nmod)
therapy symptoms (nmod)
mutations immune (amod)
patient series (nmod)
demonstrated measurements (nsubj)
angiographies mostly (advmod)
chemistries baseline (nmod)
vasculitis complication (appos)
disorder investigated (acl)
standard- low-dose (conj)
prevalence syndrome (nmod)
produce scenario (advcl)
recipient an (det)
n/n=62/92 ( (punct)
increased indicating (xcomp)
trimethoprim-sulfomethoxazole by (case)
promising have (aux)
ten 5 (conj)
number n=2.4+/-0.7 (appos)
appeared first (advmod)
little change (dep)
formation % (appos)
diet mmol/d (appos)
efferent of (case)
thromboembolism relating (compound)
cats dogs (conj)
included outcomes (nsubj)
hematomyelia secondary (amod)
dose disease (nmod)
db -30 (nummod)
distribution or (cc)
tests and (cc)
diminishes quality (dobj)
ltp on (case)
dose 80-mg/day (compound)
standpoint from (case)
used measures (nsubjpass)
dementia an (det)
those ) (punct)
lower somewhat (advmod)
or 3.1 (dep)
reserpine acute (amod)
decreased percentage (nsubj)
neurons of (case)
crisis hemolytic (amod)
dermatoses inflammatory (amod)
group pain (conj)
normotension of (case)
responses calcium (nmod)
intrathecal ) (punct)
reperfusion of (case)
highlight to (mark)
correlated damage (nmod)
nassa ) (punct)
hippocampal memory (dobj)
cirrhosis liver (compound)
randomized treatment (nmod)
structure and (cc)
pre-administration by (case)
mg + (cc)
presence , (punct)
degree course (conj)
atropine 4-damp (appos)
available high (advcl)
puncture block (nmod)
minutes in (case)
induced acid (nsubj)
ameliorates stress (dobj)
used situation (nmod)
block neuromuscular (amod)
communication an (det)
aminotransferase alanine (compound)
effect edaravone (nmod)
cycle this (det)
hour mg/8 (compound)
delirium flecainide-induced (amod)
metabolites its (nmod:poss)
dysfunction enzyme (compound)
development early (amod)
metoprolol hypokalemia (nmod)
nanoparticle acute (amod)
observed previously (advmod)
proteinuria g/day (appos)
infants hearing (advcl)
enzyme hbv (compound)
important it (nsubj)
evidence relation (nmod)
aggressiveness in (case)
knowledge reviewing (conj)
panca ) (punct)
0.59 0.52 (compound)
increase ingestion (nmod)
discovered determination (nmod)
147 of (advmod)
post-infusion min (compound)
tgf-beta1 ) (punct)
control function (nmod)
return venous (amod)
administration vincristine (compound)
post washing (compound)
predictor was (cop)
39.6 29.2 (conj)
recordings intracellular (amod)
300 to (dep)
9.1 - (punct)
changes life-long (amod)
developed necrosis (dobj)
period in (case)
returned erpf (nsubj)
ingested mothers (nsubj)
using tissues (dobj)
act node (nmod)
reported myocarditis (nsubjpass)
reduced kept (advcl)
had distance (nsubj)
ci -3.7 (conj)
rate nephropathy (nmod)
detection blood (nmod)
revealed detected (parataxis)
phonophobia or (cc)
vehicle avp (appos)
doses ) (punct)
followed off (compound:prt)
tolerated lamivudine (nsubjpass)
high group (nmod)
decreased detachment (dobj)
localization subcellular (amod)
tolerated which (nsubjpass)
monthly afterwards (advmod)
observed risperidone (nmod)
products as (cc)
randomized double-blind (dep)
u/l 98 (nummod)
leukoencephalopathy toxic (amod)
a to (case)
hyperprolactinemia chronic (amod)
w. 200 (nummod)
receptor scavenger (compound)
tests animals (appos)
avoid therapy (dobj)
rarely more (advmod)
vocabulary in (case)
produces sometimes (advmod)
= 0.32 (dobj)
peroxidation and (cc)
consenting patients (dobj)
frequency contraction (compound)
changes medial (amod)
demonstrate metabolized (conj)
concentration nitrogen (compound)
recovery neuritis (nmod)
s 178 (nummod)
antitussives available (amod)
basis desire (nmod)
determine associated (ccomp)
mg/kg 360 (nummod)
efficacy agents (nmod)
rats different (amod)
flunitrazepam 0.5 (nummod)
abnormalities minor (amod)
blockade-induced androgen (nmod:npmod)
observed closely (advmod)
had 54/94 (nsubj)
administration azt (nmod)
dysguesia . (punct)
imbalance metabolic (amod)
catheter by (case)
hemorrhage subependymal (amod)
64 75 (conj)
developed speech (dobj)
lymphadenopathy hepatitis (conj)
history patients (nmod)
failed show (xcomp)
appears retardation (nsubj)
rates target (compound)
deficits meth-induced (amod)
patients administered (acl:relcl)
responsiveness correlations (conj)
protease d (appos)
bisoprolol to (mark)
harmless replacement (nsubj)
abnormalities performance (compound)
evidence scored (acl)
60 7 (conj)
present sensitization (nsubj)
paid should (aux)
subjects similar (amod)
therapy children (nmod)
forms rodents (nmod)
agent herbal (amod)
cases involving (acl)
supports hypothesis (dobj)
pulses 12 (nummod)
mutations : (punct)
exams on (case)
administration capecitabine (compound)
bodies cell (compound)
determine , (punct)
allocated randomly (advmod)
adjust ph (dobj)
require investigations (dobj)
discriminations both (det)
asystole amount (conj)
hydroxytyrosol antioxidant (amod)
specimens 143 (nummod)
achieved ce (nsubjpass)
test intravenous (amod)
inhibitory effects (dep)
risks does (dep)
activity serum (nmod)
contribute mice (dobj)
seen sequelae (nsubjpass)
need intact (xcomp)
lid than (case)
injected seconds (nmod)
prazosin rauwolscine (conj)
rationale ecstasy (appos)
observed signs (conj)
microinjections gamma-vinyl-gaba (nmod)
followed seizures (nsubj)
capable but (cc)
solid-organ namely (advmod)
threshold or (cc)
heparin low-molecular-weight (compound)
ecg non-ischemic (amod)
% be (cop)
eyes perfusion-cultured (amod)
atypia carcinoma (conj)
using products (dobj)
before 0.5 (conj)
tacrolimus srl (conj)
think useful (ccomp)
mg/m2 ; (punct)
ischemia isoproterenol (compound)
level time (compound)
woman 58-year-old (amod)
feasibility rate (conj)
suggesting enhancement (dobj)
indicate addition (nmod)
di secondary (amod)
safe has (advcl)
beta-epimers 3 (nummod)
use cannabis (compound)
suppression . (punct)
system angiotensin (compound)
deficiency transverse (amod)
damage be (cop)
explain activity (nsubj)
searched journals (nsubjpass)
density optical (amod)
ifo and (cc)
sarcolemma cardiomyocytes (nmod)
conclusive . (punct)
proportional damage (nsubj)
use types (nmod)
one to (case)
onset lesions (nmod)
hbv ( (punct)
relieved performed (conj)
alterations cerebellum (nmod)
property neuroprotective (amod)
visit a (det)
stl1 the (det)
sparse investigations (nsubj)
analysis cardiomyocytes (nmod)
mice type (conj)
avoided reduction (nmod)
inhibitor activity (nmod)
report media (compound)
heparin . (punct)
produced alterations (dobj)
scores summed (amod)
effect lipopolysaccharide (nmod)
tablet ( (punct)
centuries for (case)
iopamidol after (case)
dependent concentration (nmod:npmod)
necrosis laminar (amod)
structure process (nmod)
1.6 0.5 (conj)
segments the (det)
occurred all (nsubj)
each burns (nmod)
values adc (compound)
use hypotension (conj)
2c serotonin (compound)
turned were (auxpass)
possibility considering (case)
poisoning fatal (amod)
maintained study (nmod)
selective because (mark)
s(c)o(2 ) (punct)
self-reported ( (punct)
treatment department (nmod)
diseases in (case)
cimetidine of (case)
continues afflicted (xcomp)
improvement handling (nmod)
controlled were (auxpass)
cause 5-fu (nmod)
change clearance (nsubj)
improved stoppage (nmod)
neuroadaptation , (punct)
monotherapies p (appos)
hormone thyroid-stimulating (amod)
definition patients (nmod)
hallucinations symptom (nmod)
involvement chiasm (nmod)
defect ( (punct)
improvement memory (compound)
mean lvdp/dt (conj)
studies asa (compound)
60 between (case)
dosage of (case)
hepatic brain (conj)
tolerated volunteers (nmod)
exposure previous (amod)
documented , (punct)
emergence strains (nmod)
45 59 (conj)
witnessed expand (advcl)
effects dysrhythmias (nmod)
ultrastructure endothelial (amod)
hypoxia by (case)
adriamycin ) (punct)
syndrome superior (amod)
> ) (punct)
displayed subjects (advcl)
prior to (mwe)
2-mercaptoethane compound (compound)
elevation cr (nmod)
manifest toxicity (dobj)
death epilepsy-induced (amod)
caused cystitis (dobj)
steroids some (det)
afternoon the (det)
marked pruritus (nmod)
rna and (cc)
years 3.4 (nummod)
one doses (nmod)
follows severity (nsubj)
tensions curves (conj)
nephropathy gentamicin-mediated (amod)
transaminases > (nmod)
agent one (nummod)
reaction syndrome (nsubj)
continue have (xcomp)
withdrawn sirolimus (nsubjpass)
failure dialysis (nmod)
administered oxytocin (nsubjpass)
activation death (conj)
durations median (amod)
testing by (case)
caused bisphosphonates (conj)
pet ( (punct)
reassuringly , (punct)
elevated 25mg/kg (nmod)
contributed 2 (nmod)
prevent cystitis (dobj)
treatment types (nmod)
slope to (case)
cardiomyopathy associated (acl)
ifs by (case)
measured rate (dobj)
determined content (nmod)
lower and (cc)
integration complex (amod)
groups severity (nmod)
hospital malaysia (nmod)
administration caffeine (compound)
17.5 +/- (cc)
frequencies frequencies (dep)
ef in (case)
drug complementary (amod)
isolated females (nmod)
prescribed had (aux)
investigation to (case)
tolerance and (cc)
proteases lysosomal (amod)
obtained damages (nmod)
evaluated involved (ccomp)
maleate timolol (amod)
concentration toxicity (compound)
sequence resuscitation (compound)
cyclophosphamide or (cc)
correlates increase (nmod)
associated mg (nsubjpass)
hemorrhage ich (appos)
slower patients (nmod)
vesicles discoidal (compound)
intake disease (nmod)
taken also (advmod)
, then (dep)
analysis clinical (amod)
contraindicated may (aux)
smokers daily (amod)
effect lesion (nmod)
18/90 in (case)
recipients transplantation (nmod)
unchanged while (mark)
failure lethal (amod)
curves d-tubocurarine (nmod)
lozenge of (case)
influence possible (amod)
vigilance continued (amod)
n=6 % (appos)
800 over (quantmod)
technique evaluate (acl:relcl)
ketoconazole to (case)
known effects (nsubjpass)
using differentiate (xcomp)
conditions pathological (amod)
associated have (aux)
similar profiles (nsubj)
cimetidine mg/hour (dep)
visit first (amod)
d1 receptors (dep)
maintained turned (advcl)
sirolimus srl (appos)
reduced lesions (nmod)
ascertained using (xcomp)
closed were (auxpass)
studied association (dobj)
range ( (punct)
value to (case)
derivative one (nummod)
hepatitis fulminant (amod)
convulsions mg/kg (dep)
hyperplasia hepatoma (conj)
resolved reduced (advcl)
exposure amphetamine (compound)
clinical electrophysiological (conj)
failed modulate (xcomp)
afford advantage (dobj)
minutes cimetidine (nmod)
schizophrenia to (case)
received mg/kg (nmod)
1995 1993 (compound)
time aptt (appos)
microgram/ml above (case)
pre-test ( (punct)
mice morphine-treated (amod)
resolved completely (advmod)
associated sirolimus (nmod)
maximal abolished (conj)
animals 92 (nummod)
baseline posttreatment (conj)
vary however (advmod)
digoxin with (case)
diminishing thereby (advmod)
neurons shown (advcl)
show confounded (ccomp)
measures in (case)
( high-dose (dep)
retention by (case)
profiles pharmacokinetic (amod)
rise blood-pressure (nmod)
regardless and (cc)
withdrawal atra (nmod)
platelets against (case)
evidence bleeding (acl)
both which (nmod)
stresses . (punct)
265.2 ) (punct)
independent lna (dep)
started trial (dobj)
part due (case)
caused nsaids (nmod)
implicated sirolimus (dobj)
effect is (cop)
rationale a (det)
elevations ctni (nmod)
adriamycin n (dep)
excluded thus (advmod)
aspirin with (case)
obtained period (nmod)
groups dietary (amod)
maintenance tdp (nmod)
degrees ( (punct)
diazepam ( (punct)
affect and (cc)
screening echocardiographic (amod)
cfcs ) (punct)
useful assay (nsubj)
postures specific (amod)
analyze presence (dobj)
embolus pulmonary (amod)
attenuate acidification (nsubj)
hrptec ) (punct)
secretion antidiuretic (amod)
reported risk (conj)
years under (case)
infusions cocaine (compound)
diagnostic simple (amod)
degree catheterization (nmod)
regained consciousness (dobj)
concern the (det)
techniques recording (compound)
examinations histological (amod)
abuse from (case)
investigated use (nmod)
months initial (amod)
expected increase (nsubjpass)
lead development (nmod)
day ca (dep)
nmba eliminated (acl:relcl)
june 2004 (nummod)
able percent (nsubj)
significant furthermore (advmod)
simvastatinezetimibe taking (acl:relcl)
beneficial treatment (nmod)
hyperactivity ecstasy-specific (amod)
delayed time (nsubjpass)
seizures acid-induced (amod)
interfere may (aux)
visits subsequent (amod)
pretreatment betaine (amod)
surgery h (conj)
tumors solid (amod)
benefited treatment (nsubj)
block not (neg)
invaluable diagnosis (nsubj)
inducing purpose (nmod)
lifetime lt (appos)
specificities and (cc)
association apoptosis (nmod)
distributed and (cc)
chloride calcium (compound)
elicited decrease (dobj)
micromol/l of (case)
drugs these (det)
use ibuprofen (amod)
activity reduced (amod)
fastigial nuclei (dep)
immunohistochemistry and (cc)
ecg day (compound)
causing coagulopathy (dobj)
investigated thus (advmod)
heart ( (punct)
agent enhancement (compound)
help how (advmod)
stopped be (auxpass)
infections , (punct)
1.8-fold p (appos)
cardiotoxicity well-known (amod)
patients pd (compound)
dwi 8/8 (appos)
ro4368554 , (punct)
mm mean (parataxis)
consisted recovered (conj)
application main (amod)
one into (case)
affect sex (nsubj)
modification the (det)
masseter in (case)
toxicity chemotherapeutics (nmod)
paralysis respiratory (amod)
recommended screened (ccomp)
volume and (cc)
suspect strongly (advmod)
rats for (case)
reduces administered (advcl)
therapy intrathecal (amod)
origin cerebral (amod)
substances the (det)
aggravates aconitine (nsubj)
concluded different (ccomp)
caproate of (case)
groups risperidone (dep)
stimulates secretion (dobj)
children six (nummod)
vasculitis propylthiouracil-induced (amod)
collected intake (nmod)
hz 5 (nummod)
dose busulfan (compound)
accompanied but (cc)
years follow-up (nsubj)
analysis called (amod)
diseases infarction (conj)
attenuated hypotension (nsubjpass)
recommend neonates (nmod)
administered decreased (conj)
catalepsy reversed (amod)
maleate nmda-receptor (compound)
ventilation sufficient (amod)
na+ with (case)
withdrawal amiodarone (nmod)
returned values (nmod)
antioxidant anti-inflammatory (conj)
conclusion , (punct)
g/day 1.0 (nummod)
profiles , (punct)
-0.2 0.4 (compound)
catalepsy potentiation (dep)
course on (case)
metoprolol s-isomer (conj)
catheter respectively (advmod)
indicating thus (advmod)
parallel in (case)
kpa 10.7 (nummod)
developed patient (nsubj)
hospital an (det)
mediator important (amod)
response duration (nmod)
administration levofloxacin (compound)
toxicity with (case)
prevented two (conj)
period erp (appos)
improved i.e. (dep)
potential ( (punct)
given bha (dobj)
treated when (advmod)
minutes injection (nmod)
network involving (acl)
gaba and (cc)
concentration maintain (acl)
achieved valproate (nmod)
pressures rates (conj)
necessary will (aux)
development leukemia (nmod)
patients 44 (nummod)
dose epinephrine (nmod)
investigate as (advmod)
3 fewer (amod)
reported dysfunction (nsubjpass)
alleles loci (nmod)
concentration inhibitory (amod)
agent metformin (nsubj)
with without (conj)
correlated statistically (advmod)
regions endemic (amod)
prl % (dep)
nitrendipine blocker (compound)
cardiomyopathy dcm (appos)
reversed failed (conj)
elevates which (nsubj)
adr a (det)
men both (cc:preconj)
patients diabetes (nmod)
showed protection (dobj)
in ) (punct)
polyuria hours (nmod)
change bp (compound)
q10 of (case)
hyperlipidemia primary (amod)
vtd ( (punct)
pentobarbital induced (acl)
persons taking (acl)
courses % (compound)
siblings playing (nmod)
november 1 (nummod)
g/ml 1.210 (nummod)
administration rats (nmod)
locomotion for (case)
treated injections (nmod)
demonstrated respectively (advmod)
bladder into (case)
1 2 (conj)
hypertrophy myocardial (amod)
palsy gaze (compound)
active years (dep)
function alpha (compound)
calculated is (auxpass)
activity lymphocyte (nmod)
skin hyperalgesia (conj)
troublesome were (cop)
regions cortical (amod)
evidence histopathological (amod)
complexes containing (acl)
failed presence (nmod)
cases prolactin (nmod)
disappeared but (cc)
prolonged patients (nmod)
evidence recordings (nmod)
cause administration (nsubj)
ultrasonography patients (nmod)
nephropathy background (nsubj)
pose it (nsubj)
exposure hepatocytes (nmod)
matched albuminuria (nmod)
symptoms caused (acl)
aspirin low-dose (amod)
practical of (case)
available years (nmod)
periods after (case)
prospectively to (case)
use sustained-release (amod)
changes corresponding (amod)
steps optimization (compound)
having time (dobj)
include studies (dobj)
university osmangazi (compound)
act if (mark)
25mg/kg min (appos)
factors individual (amod)
be type (nsubj)
higher ratios (nmod)
greater placebo (nmod)
elements both (det)
evolution postoperative (amod)
study therapy (nmod)
background modulate (appos)
effects tam (nmod)
follow-up under (case)
erg ( (punct)
arrhythmogenicity on (case)
difference difference (nsubj)
performed abroad (advmod)
investigated : (punct)
% 13.55 (nummod)
abolished metocurine (nmod)
band larger (amod)
associated increased (advcl)
effect bromide (nmod)
used determine (xcomp)
immunosuppressed are (auxpass)
function rates (conj)
purposes rescue (compound)
torr 86 (nummod)
therapy circumstances (nmod)
died received (advcl)
asphyxia . (punct)
stopping of (mark)
one patients (nmod)
detectable exposure (nmod)
absent transport-deficient (nmod)
infusion low-dose (amod)
ors ( (punct)
located areas (nsubj)
patients cured (acl)
performance ventricular (compound)
midline md (appos)
possesses activity (dobj)
eyes , (punct)
27.37 2.19 (conj)
pge2 intra-arterially (advmod)
cardiomyopathy regurgitation (conj)
cssep ) (punct)
stn the (det)
assessed patients (nmod)
suggests agent (nmod)
release unproportional (amod)
induction remissions (nmod)
recorded signs (nsubjpass)
administration used (acl:relcl)
duodenum and (cc)
perfusion bladder (nmod)
% 12.7 (nummod)
freezing " (punct)
those cyclosporin (nmod)
absent be (cop)
processes the (det)
enhancement toxicities (conj)
syndrome cushing (nmod:poss)
% % (compound)
21.6 +/- (cc)
chiefly the (det)
control ethinyl (conj)
agonists selective (amod)
300 450 (conj)
injection u-ii (nmod)
sedative as (case)
hypertension sustained (amod)
studied neuropathy (nsubjpass)
chx ( (punct)
disturbances vascular (amod)
appetite of (case)
workers nine (nummod)
consistent diagnosis (nmod)
pre-operative and (cc)
different t (nmod)
demonstrated seizure (nmod)
treatment each (det)
safer they (nsubj)
affecting increasing (conj)
tachycardia arrest (conj)
outcomes leukoencephalopathy (nmod)
results controls (compound)
started admission (nmod)
drug oral (amod)
gcs -20.93 (dep)
tests behavioral (amod)
mtd cis-ra (nmod)
avoiding occurrence (dobj)
after sec (nmod:npmod)
s.c. occasions (nmod)
treated injected (conj)
accomplished be (auxpass)
volumes cylinder (nmod)
diminished also (advmod)
ctc-nci vomitus (appos)
risk tumour (compound)
advantage model (nmod)
kidney rat (compound)
tdp the (det)
urge and (cc)
deprivation acute (amod)
using transducer (dobj)
abc the (det)
idiosyncratic toxic (conj)
class comparator (compound)
mechanisms common (amod)
rp opens (acl:relcl)
ranged caused (conj)
ability suppress (acl)
side other (conj)
antagonists adrenergic (amod)
detected contrast (nmod)
support further (advmod)
also sodium (nmod)
failed promote (xcomp)
bupivacaine 111.0 (conj)
adopted be (auxpass)
agranulocytosis patient (nmod:poss)
partial rats (dep)
administered day (nmod)
followed that (nsubjpass)
pneumonitis . (punct)
provoke patients (nmod)
show studies (nsubj)
microg/kg/min dose (nsubj)
challenge of (case)
cardiomyopathy against (case)
site to (case)
recovery infusion (nmod)
aggressive ( (punct)
support observations (nsubj)
convulsions lidocaine-induced (amod)
seizures picrotoxin- (amod)
ensued concealed (advcl)
approximate showed (advcl)
cytotoxicity the (det)
hypoperfusion cerebral (amod)
degree case (conj)
db 1.08 (nummod)
produce produced (advcl)
indicate changes (dobj)
reflecting and (cc)
errors lower (amod)
haloperidol-treated and (cc)
bacteremia meningitis (nmod)
repeated monthly (advmod)
mg.kg(-1).min(-1 ) (punct)
aware patient (nsubj)
fragmentation be (cop)
episodes anginal (amod)
nephrotoxicity . (punct)
demonstrated previously (advmod)
nephropathy gentamicin (compound)
12.5 ( (punct)
minutes minutes (appos)
skf-82958 and (cc)
month pregnancy (nmod)
atracurium of (case)
consider starting (advcl)
but also (advmod)
increase decrease (conj)
decreased elevation (nmod)
demonstrated effects (dobj)
reactions to (case)
receive , (punct)
skills fine (amod)
high-dose and (cc)
treatment d-med (nmod)
activity bche (compound)
4-aminopyridine by (case)
channel site (nsubj)
originating esophagus (nmod)
users 8,000 (nummod)
delivery term (nmod)
occur because (mark)
useful developing (advcl)
catheter venous (amod)
cross-tolerance no (neg)
contraindicated or (cc)
co-administration with (case)
pontis nucleus (compound)
therapy methadone (compound)
appeared surgery (nmod)
effective annuloplasty (nsubj)
attenuated were (auxpass)
order avoid (acl)
i. complex (compound)
17.8 3.5 (nummod)
lymphoma burkitt-type (amod)
glutathione dismutase (conj)
fatal but (cc)
hyperplasia focal (amod)
score daily (amod)
mechanism cardiotoxicity (nmod)
self-treating that (mark)
apparatus of (case)
urine several (conj)
venue therapeutic (amod)
immunohistochemical . (punct)
menorrhagia function (nmod)
derives changes (nmod)
observation neoplasms (nmod)
mass cm (dep)
reduced clearly (advmod)
affection effects (conj)
depends needed (conj)
were areas (attr)
probable 42 (nmod)
present half (nmod)
enhanced replication (dobj)
amount in (case)
decreases % (compound)
neurons in (case)
associations ozone (nmod)
monotherapies combinations (conj)
practices on (case)
antagonist cd-832 (appos)
often less (advmod)
level noel (appos)
found males (nmod)
2004 ( (punct)
treatment earlier (amod)
gamma-glutamyltransferase , (punct)
found analysis (nsubj)
returned hematocrit (aux)
administered successfully (advmod)
edition ( (punct)
reinstated that (mark)
medical psychosocial (conj)
seems signaling (nsubj)
co-infected patients (dobj)
nanospheres lipid (compound)
dialysis or (cc)
indomethacin inhibition (nmod)
correlation area (nmod)
linked would (aux)
gastrointestinal gi (dep)
reinstated plasticity (nsubjpass)
withdrawal study (nmod)
advisable is (cop)
evidence origin (nmod)
latencies in (case)
triggered is (auxpass)
(na changes (appos)
cultures the (det)
training and (cc)
34 12 (conj)
resemble that (nsubj)
channel enac (appos)
regimen twice-daily (amod)
retinoblastoma intraocular (amod)
activity seizures (conj)
patients % (nmod)
clopidogrel ( (punct)
older children (nsubj)
uptake tracer (compound)
flushing anorexia (conj)
na+ for (case)
reversed furthermore (advmod)
fall to (mark)
frequency % (nmod)
210 of (quantmod)
conclusive to (mark)
nerves , (punct)
decline rate (nmod)
block epidural (amod)
shr chronic (amod)
odds , (punct)
fluvoxamine repeatedly (advmod)
1,1-dichloro-2,2,2-trifluoroethane of (case)
studied atria (nmod)
movement prior (amod)
cortex m1 (appos)
differs . (punct)
rates depressed (amod)
susceptibility cardiomyopathy (nmod)
averaged ecg (dobj)
dose 20-mg (amod)
mothers , (punct)
hypothyroid were (cop)
remain cryptic (xcomp)
frequency gnrh (compound)
end primarily (advmod)
cessation migraine (nmod)
score therapy (nmod)
users 20 (nummod)
behaviour driving (compound)
determined noted (parataxis)
stage nephrotic (amod)
68 +/- (cc)
possibility difficult (ccomp)
rats kg(-1 (dep)
dialysis during (case)
exhibit expression (dobj)
mean rara (nmod)
myopathy a (det)
days vs (cc)
patients both (conj)
pointes de (nsubj)
injections intrastriatal (amod)
cause reactions (nmod)
activity cat (compound)
synthesis/release bradykinin (nmod)
metabolised . (punct)
investigating by (mark)
response da (compound)
load virus (compound)
age diagnosis (conj)
started mean (nmod)
changes group (conj)
decreased hematocrit (nsubj)
domain phonological (amod)
process this (det)
anorexia , (punct)
represents palsy (nsubj)
increases on (case)
14.1 +/- (cc)
phosphorylation stat3 (nmod)
gm. weight (nmod)
weighted diffusion (nsubj)
diagnoses overlap (appos)
prevented proportion (nmod)
lesions kidney (compound)
responded having (aux)
measured when (advmod)
treated although (mark)
on dbs (nsubj)
drop normal (amod)
s. 30 (nummod)
specimens patients (nmod)
degree reduction (nmod)
retrievals traces (dobj)
250 was (cop)
develop utero (dobj)
began movements (nsubj)
supported plausibility (nsubjpass)
doses larger (amod)
autism twins (nmod)
knockout -/- (appos)
children only (cc:preconj)
peak evoked (amod)
plasma cells (conj)
weeks patient (dep)
malondialdehyde nucleosides (conj)
elicited proteinuria (dobj)
presenting dysfunction (nmod)
carcinoma nsclc (appos)
impairs that (nsubj)
protection of (case)
days doses (nmod)
pastes pesticide (compound)
regulating in (mark)
4 % (dep)
contribute outcomes (nmod)
monkeys four (nummod)
ke vd (conj)
g/min ml/100 (amod)
found ribavirin (nsubjpass)
conclusions provides (dep)
necrosis tubular (amod)
indicate , (punct)
products peroxidation (nmod)
oliguria , (punct)
direct and (cc)
recipient eight-and-a-half-yr-old (amod)
period 1993 (nmod:tmod)
hyper- four (appos)
exhibited levels (dobj)
ipsi- contralateral (conj)
effects urotensin-ii (nmod)
higher minutes (nsubj)
blocker with (case)
exercise regular (amod)
performed onset (nmod)
17 patients (nmod)
study tolerance (compound)
dehydrogenase level (conj)
randomized timolol (conj)
antithyroidmedications of (case)
decreases number (nmod)
grade and (cc)
demographic and (cc)
mg/kg/b.w ( (punct)
suxamethonium ( (punct)
results reduced (appos)
conclusion describes (dep)
extended-release/lovastatin to (case)
seizures kindled (acl)
days from (case)
case results (nmod)
associated study (nmod)
coefficient adc (appos)
doses these (det)
differences of (case)
provides evidence (dobj)
measured cortex (nmod)
% 23 (nummod)
removed was (auxpass)
present we (nsubj)
unilateral either (cc:preconj)
performed they (nsubjpass)
met that (nsubj)
igg granular (amod)
products the (det)
occurrence dysrhythmia (compound)
approach new (amod)
block resolved (acl:relcl)
treatment 5-fluorouracil (compound)
left exercise (nmod)
tolerance nimesulide (nmod)
regarded , (punct)
mechanism immunological (amod)
contributes reaction (nsubj)
characterization an (det)
plays damage (nsubj)
syndromes distinct (amod)
reports as (cc)
results fourteen (dep)
tachycardia classic (amod)
hypotension nitroprusside (compound)
increment a (det)
injury tubulo-interstitial (amod)
chromatography and (cc)
enlargement induced (acl)
attacks without (case)
injections thirty-six (nummod)
investigated mechanisms (dobj)
mg deciliter (nmod)
relevant patients (nmod)
subjects placebo (amod)
stressor a (det)
injury hepatomegaly (conj)
transplanted induction (nmod)
rats interval (nmod)
predictive more (advmod)
hormone corticotropin-releasing (amod)
arrhythmias isomers (nmod)
response development (conj)
estradiol on (case)
carcinogenesis forestomach (compound)
excretion total (amod)
attained achieved (conj)
zi ( (punct)
month % (appos)
mmhg 86.7 (nummod)
modify normal (advcl)
important more (advmod)
patients which (det)
neutrophils in (case)
caused propofol-remifentanil-tiva (nmod)
planes spanning (acl)
mrna p75(ntr (compound)
test avoidance (compound)
del ) (punct)
findings admission (nmod)
compared characteristics (nsubjpass)
given weeks (dep)
months 1992 (nmod:tmod)
short-term b (dep)
risk hyponatremia (nmod)
array ( (punct)
effects antiandrogen (amod)
mri image (conj)
metabolism effects (conj)
written much (nsubjpass)
hyalinosis insudative (amod)
lesion development (conj)
indicated caused (ccomp)
effects adr (nmod)
iiib with (case)
antagonist hydrochloride (appos)
died acute (nmod)
3.1+/-1.0 p<0.05 (appos)
disease an (det)
efficacious was (cop)
important terms (nmod)
inhibitors compounds (nsubj)
mg/day 0.6 (compound)
pharmacology administration (nmod)
administration .002 (punct)
time any (det)
same related (advcl)
infusion continuous (amod)
necrosis cortical (amod)
increased revealed (parataxis)
received schedules (dobj)
patients supplementation (conj)
decompression cranial (amod)
igf-i expression (dep)
hemodynamics substances (conj)
reported carboplatin (nsubjpass)
enhance increasing (advcl)
trial dystrophy (nmod)
min between (case)
classified responded (advcl)
variations receptor (nmod)
rats deficient (amod)
obtained record (nmod)
complemented . (punct)
follow a (det)
formed that (mark)
mechanism colloid-osmotic (amod)
required aids (dobj)
sedation the (det)
referrals 18 (nummod)
celecoxib 1.93 (amod)
lesions glomeruli (nmod)
0.13 0.04 (conj)
changes biochemical (amod)
stn ( (punct)
activity without (case)
choline-devoid or (cc)
range in (case)
alternative , (punct)
decreased when (advmod)
quinine of (case)
antagonize or (cc)
circumstances some (det)
sodium for (case)
68 by (case)
abilities protective (amod)
a and (cc)
lost one (nsubj)
challenged or (cc)
anticipation of (case)
tachycardia exercise-induced (amod)
scatter ( (punct)
screening thorough (amod)
had levels (conj)
dfu for (case)
given observed (advcl)
receiving oltx (dobj)
chemotherapy bcnu (compound)
supplement . (punct)
myocet doxorubicin (dep)
microscopy immuno/histochemistry (compound)
reported caused (conj)
side-effects of (case)
speak observations (nsubj)
recommendations regulations (conj)
choose would (aux)
promising as (mark)
proliferators receptor-alpha (dep)
severity constipation (nmod)
ratio sodium/potassium (compound)
ratio ( (punct)
manage vasospasm (dobj)
% 87 (compound)
recognized cardiomyopathy (nsubjpass)
interest effects (nsubj)
cases case (nmod)
replaced successfully (advmod)
increased : (punct)
cyp7a ) (punct)
sodium creatinine (conj)
reabsorption glucose (compound)
abnormality [ (punct)
model pd (nmod)
alternation intervals (nmod)
exhibited indolamines (nsubj)
alphabeta-crystalin gamma-enolase (conj)
returned withholding (advcl)
itself of (case)
stresses suspect (xcomp)
propranolol pindolol (conj)
antagonist . (punct)
little in (case)
alter accelerated (conj)
concomitant inrcease (nmod)
caused effects (nmod)
sec ( (punct)
effects alkylxanthines (nmod)
defined dsm-iii-r. (nmod)
procedure same (amod)
cases ulcers (nmod)
mg followed (acl)
i.c.v. microg (compound)
% compared (acl)
bodyweight prevented (conj)
neurotransmission and (cc)
lipoproteinuria in (case)
tma and (cc)
relating severity (nmod)
experienced fatigue (dobj)
210 173 (compound)
ach produced (acl)
enhanced activity (dobj)
efficient to (mark)
m(2)-selective ) (punct)
able trespass (xcomp)
preparation illustrating (acl)
characteristics on (case)
degree hexaaldose (conj)
subject the (det)
hoe and (cc)
disorder cimd (appos)
foot rat (nmod:poss)
perception information (compound)
aniracetam window (conj)
action test (nmod)
amounted 374 (nmod)
elevation marked (amod)
brain ganglia (nmod)
recall with (case)
gained be (auxpass)
tariquidar ) (punct)
responses including (case)
pretreated fashion (nmod)
effects diet (nmod)
randomization and (cc)
hypotheses and (cc)
role contributing (amod)
normal transgenic (conj)
followed that (nmod)
lesions various (amod)
clozapine = (dep)
treatment catalepsy (nmod)
peaked , (punct)
genesis asynergy (nmod)
absence and (cc)
receptor a2 (compound)
canalicular the (det)
mean observations (nmod)
degree injections (nmod)
course nature (compound)
limited experience (nsubjpass)
improvement iq (nmod)
commissure in (case)
applicators evaluate (acl)
pectoris angina (amod)
populations medical (amod)
reduced gain (dobj)
brain with (case)
appeared % (conj)
dysosmia recurrent (amod)
injury and (cc)
revealed history (nsubj)
comparative multicenter (conj)
mean externa (prep)
mustard administrated (acl)
higher mice (nmod)
% 50 (compound)
rat carcinoma (nmod)
history decline (nmod)
time conduction (compound)
have inactive (advcl)
changes similar (amod)
binding in (case)
four to (quantmod)
administration cisplatin (compound)
hepatitis leading (acl)
aware we (nsubj)
assessed treatment (nmod)
periods extended (amod)
applied generally (advmod)
ed50 by (case)
base brain (nmod)
cholinesterase , (punct)
memory a (det)
restarted degree (nmod)
ht ( (punct)
impaired conversion (nsubj)
regions underperfusion (nmod)
percentage vasoconstriction (nmod)
unrecognized are (cop)
adenocarcinoma a (det)
brought , (punct)
cause with (case)
hemiparesis droop (nmod)
combined regimen (nmod)
recipients liver (compound)
discrimination of (case)
22 ) (punct)
apo ( (punct)
children tumor (nmod)
supplementation ( (punct)
resulting function (nmod)
saturation cholesterol (compound)
common recipients (nmod)
pinpoint to (mark)
tachycardia polymorphous (amod)
produced ischemia (dobj)
trial azidothymidine (compound)
suspicion infection (nmod)
d the (det)
toxicity developmental (amod)
using analysis (nmod)
recognize should (aux)
haematological toxicity (dep)
conclude compares (conj)
mild cases (nmod)
period neonatal (amod)
antagonists patients (nmod)
range millimeter (nmod)
pressures mean (amod)
hernias cell-to-cell (amod)
nephrolithiasis : (punct)
remained tremulous (acomp)
1/500 less (amod)
dgc integrin (conj)
compare in (prep)
exposure oxidant (amod)
flaccidity muscle (compound)
tested mice (nsubjpass)
magnitude predictors (conj)
diagnosis correct (amod)
highlighting course (conj)
ctnt ) (punct)
puberty p40 (appos)
employed and (cc)
showed assessed (advcl)
assessment , (punct)
fasciculations suxamethonium-induced (amod)
procedures surgical (amod)
dosages mean (nmod)
correlated area (nmod)
l-noarg or (cc)
edrophonium , (punct)
inappropriate of (case)
contraction maximum (amod)
1.0 - (punct)
december between (case)
sinus the (det)
dose subconvulsive (amod)
glomeruli pan (compound)
discontinuation therapy (compound)
believed thus (advmod)
reflected instance (nmod)
ribavirin , (punct)
association cc (nmod)
elevated baseline (nsubjpass)
patient later (advmod)
events cardiac (dep)
mice except (case)
= 3 (dobj)
activity arterial (amod)
thalamotomy ventrolateral (amod)
found seizures (nsubjpass)
admission to (case)
examination abnormal (amod)
undergoing december (nmod)
infused intravenously (advmod)
a-i plasma (compound)
schedule intra-patient (amod)
injection dfp (compound)
produced whereas (dep)
pains post-suxamethonium (compound)
intervals the (det)
gaba(a)rs on (case)
accounts . (punct)
examined assess (xcomp)
sets data (nsubj)
drawn images (nmod)
twitches effects (nsubj)
52 +/- (cc)
7 ( (punct)
reproducible injection (nsubj)
measured weeks (nmod:tmod)
protect seizure (nmod)
development prevention (nmod)
blockade angiotensin (compound)
classified ) (punct)
cholinergic central (amod)
meningioma and (cc)
determined twitches (nsubjpass)
patients 300 (nummod)
discuss , (punct)
suggest known (advcl)
double-blind trial (appos)
challenged groups (nsubjpass)
occurred therapy (nmod)
apical and (cc)
fasting such (case)
lower incidence (nsubj)
rate continuation (nmod)
effects pressure (nmod)
whom in (case)
vasospasm gangrene (nmod)
aggravate problem (dobj)
potentiated tri (nmod)
treatments medical (amod)
relevant especially (advmod)
available efficacy (nmod)
investigated tool (nmod)
had responses (dobj)
prochlorperazine intravenous (amod)
months 14.1 (nummod)
anesthesia halothane (compound)
summaries developed (dep)
selection the (det)
recognized clinically (advmod)
drinking pregnancy (nmod)
ameliorated antagonists (nsubj)
dysfunction from (case)
ration d (nsubj)
equipotent which (nsubj)
2a pegylated (amod)
people prescribed (acl:relcl)
warfarin with (case)
present inflammation (nsubj)
relationship myalgia (nmod)
case a (det)
up-regulation seizure-induced (amod)
trauma after (case)
positive on (case)
action for (case)
erections apomorphine-induced (amod)
had cancer (dobj)
quetiapine amisulpride (conj)
effects important (amod)
treated dfp-atropine (nmod)
growth arrested (amod)
children younger (amod)
induced apnea (dobj)
dose pan (nmod)
integrity of (case)
taking bedtime (nmod)
flowmetry doppler (compound)
controls patients (conj)
september to (case)
started involved (conj)
data mid- (nmod)
exposure pregnancy (nmod)
dyspepsia developed (acl:relcl)
reduced consequence (nmod)
results ] (punct)
acetate bia (dep)
treated diuretics (nmod)
prod ) (punct)
clonidine therapy (conj)
imipramine to (mark)
0.05 ; (punct)
elevation phosphokinase (nmod)
true whether (mark)
infusion chloride (compound)
eyes both (det)
activity patients (nmod)
total a (det)
system dopamine (compound)
pattern injury (nmod)
substrates neurochemical (amod)
cent 21 (compound)
icterus , (punct)
level i (nsubj)
baseline p (conj)
arrhythmia adrenaline (compound)
low-osmolar , (punct)
felt showed (conj)
khz also (advmod)
piroxicam ( (punct)
requires . (punct)
appeared coincided (conj)
synthesis vasculature (nmod)
respond cue (nmod)
adulthood in (case)
od ( (punct)
syndrome wolff-parkinson-white (amod)
hydrochloride with (case)
hyperthermia in (case)
effectiveness glucose (compound)
patients time (nmod)
crocins of (case)
remoxipride with (case)
neurons paclitaxel (nmod)
introduction injury (appos)
% 1.46 (nummod)
microscope confocal (amod)
neuroprotective if (mark)
uncertain is (cop)
using omitted (advcl)
associated time (nmod)
accident this (det)
mrna mrna (conj)
examined responses (nsubjpass)
one one (conj)
posturing twitching (conj)
activation increased (amod)
graft coronary (amod)
line mmec (appos)
beta2(-/- ) (punct)
midazolam or (cc)
volunteers young (amod)
herbicides produced (conj)
serve ; (punct)
treatment same (amod)
day intubated (dep)
appreciated widely (advmod)
present present (parataxis)
follow six-month (amod)
conceivable it (nsubj)
secretion tonic (amod)
combination hydration (nmod)
speed the (det)
produces commonly (advmod)
experience week (nmod)
assess basis (dobj)
dependence drug (compound)
effects protocols (nmod)
remained diet (nmod)
depression from (case)
38.9 8.3 (conj)
increases reflex (nmod)
diuretics thiazide (compound)
thrombosis renal (amod)
antagonist subtype (nmod)
continue drug (dobj)
parallel selectivity (dobj)
loss responses (nmod)
restored co (dobj)
psychotropic chronotropic (conj)
153 6 (conj)
depletion dietary (amod)
wistar lw (appos)
right wall (dep)
atra alone (advmod)
ventricle the (det)
tongue significant (amod)
differentiated ) (punct)
ed50 the (det)
predictors seizures (nmod)
resulted context (nmod)
mechanisms presynaptic (amod)
showed year (nmod)
multicenter controlled (conj)
absorption treatment (nmod)
elevations the (det)
criterion behavioral (amod)
use chemotherapy (nmod)
choleretic poor (amod)
metamizol acutely (advmod)
sustained-release sr (appos)
capable attenuating (advcl)
biopsy of (case)
forms functions (nmod)
was level (nmod)
pod 33 (nummod)
accuracy improved (amod)
used chloroquine (dobj)
diagnosis cancer (compound)
sampling of (case)
cardiotoxicity aconitine (nmod)
lining beneath (case)
15 to (dep)
greater sg (nsubj)
depression enuresis (conj)
indicates suggesting (advcl)
amlodipine against (case)
demands and (cc)
occurred relapses (nsubj)
progression toxicity (conj)
interview or (cc)
hyperalgesia for (case)
sah with (case)
placebo efficacy (nmod)
mechanism of (case)
study 2002 (nmod:tmod)
dox 1.5 (nummod)
proliferation remaining (advcl)
show metabolism (dobj)
remained evidence (nmod)
examination collection (conj)
dosed dox (nmod)
p= ( (punct)
hormone thyrotropin-releasing (conj)
about who (nsubj)
potent were (cop)
slowed cases (nmod)
protein lipocalin (conj)
findings certain (amod)
given introduction (dep)
younger but (cc)
selected were (auxpass)
vision eye (nmod)
seizures hallucinosis (compound)
incorporation nanospheres (nmod)
abusers for (case)
pinpoint responsibility (dobj)
consist . (punct)
3-methylcholanthrene , (punct)
deteriorate to (mark)
sarcomas cancers (conj)
improving vgpr (nmod)
treatment effect (conj)
totp ) (punct)
inhibited administration (nsubj)
hexamethylmelamine , (punct)
trial from (case)
shown depression (nsubjpass)
mechanism dopaminergic (amod)
lasted revealed (conj)
reached developed (advcl)
response objective (amod)
curves response (compound)
ifosfamide of (case)
cause potentially (advmod)
metoclopramide i.v. (dep)
reflecting rates (dobj)
role quantitative (nmod)
sought we (nsubj)
modifications marked (amod)
hemorrhage subarachnoid (amod)
nitrogen urea (compound)
examinations for (case)
regions different (amod)
max ) (punct)
treatment c. (nmod)
received given (parataxis)
required maintain (advcl)
analysis patient (nmod)
cardiomyopathy disease (conj)
cases treatment (nmod)
responding man (nsubj)
% 62.5 (nummod)
counted day (nmod)
antagonized drugs (nsubj)
weeks another (det)
performed frequently (advmod)
atenolol mg (amod)
associated pseudoprolactinoma (nmod)
40/min - (punct)
sarcomas , (punct)
150 - (punct)
change headache (nmod)
comparison outcomes (appos)
treatment medicine (conj)
model effects (dep)
synthesize atrial (nsubj)
discovered history (dobj)
7.3 3.2 (conj)
sample of (case)
peptide of (case)
altering in (mark)
effective d-penicillamine (nsubj)
seeds carota (compound)
mg flunitrazepam (compound)
administration three (nummod)
change weeks (nmod)
hyperalgesia pinprick (compound)
1.6+/-0.34 ( (punct)
exceed should (aux)
microperfusion by (case)
g respectively (advmod)
regulation stat3 (nmod)
scale , (punct)
4 8 (conj)
confusion disorientation (conj)
arrhythmia on (case)
replacement hormone (compound)
rise left (amod)
preparation frog (amod)
5.6 ) (punct)
derivatives amoxicillin (conj)
done have (aux)
plasma sd (dep)
mitochondria tissue (nmod)
hypothesis putative (amod)
used when (advmod)
levels bilirubin (compound)
drops of (case)
follow-up , (punct)
received median (dobj)
took cephalexin (dobj)
patients 118 (nummod)
rare or (cc)
used apomorphine (nsubjpass)
corrected is (auxpass)
development nephrosis (nmod)
intoxication clinical (amod)
years mean (nsubj)
factor outcome (nmod)
compensates lack (nmod)
co2 end-tidal (amod)
improve restore (conj)
activity nervous (amod)
neurotoxicity induced (amod)
treatment radio-chemotherapy (nmod)
had yield (dobj)
mg/day 900 (nummod)
expression mrp2 (nmod)
introduced middle (nmod)
concentration cytoplasm (nmod)
fibrosis regeneration (conj)
factor dogs (nmod)
comparing levels (dobj)
factors which (det)
hospitals the (det)
remained aggravation (conj)
late abnormalities (nsubj)
protocols leukemia (compound)
investigated postoperatively (advmod)
assessed dogs (nmod)
side drug (compound)
dose addition (dep)
change bradycardia (nmod)
2.5-fold of (case)
resolution maha (nmod)
pain acute (amod)
material , (punct)
reported carcinomas (nsubjpass)
days fractions/40 (compound)
monitoring st-segment (amod)
period 2-week (amod)
account should (aux)
sensitive blockers (nmod)
peptide in (case)
effective pallidotomy (nsubj)
concentrations tpa (compound)
significant threshold (nsubj)
terfenadine cisapride (appos)
chemotherapy cytotoxic (amod)
crossover study (appos)
levels hormone (nmod)
e2 local (amod)
nephrotoxicity ) (punct)
alf (att)-associated (nsubj)
chlorthalidone mg (appos)
irrigated h (nmod)
cord venous (amod)
olanzapine > (compound)
used dialysate (nsubjpass)
equilibrate could (aux)
information obtained (acl)
choices errors (conj)
gravis of (case)
reduce activity (dobj)
reaction acid (nmod)
ritonavir inhibitor (compound)
same was (cop)
5 just (advmod)
hypotension depression (conj)
develop proteinuria (nsubj)
mice mature (amod)
conclusions increased (dep)
carbamazepine aed (appos)
variation , (punct)
degeneration ( (punct)
less 0.56 (dep)
reliability interrater (compound)
chloroform and (cc)
hoarseness with (case)
injection guanethidine (nmod)
indicated sometimes (advmod)
reduction map (nmod)
steroids without (case)
restrictions of (case)
decreased contrary (nmod)
dct2 the (det)
incontinence urinary (amod)
tested lymphocytes (nsubjpass)
influences noradrenergic (nsubj)
induce response (dobj)
possible conclusion (dep)
nephrotoxicity sulfadiazine (compound)
ed50 agents (nmod)
releases and (cc)
neurotransmission daergic (amod)
action ifosfamide (nmod)
medication for (case)
jc , (punct)
impaired are (auxpass)
hepatitis induced (acl)
dysfunction nmda (compound)
estimated suffers (ccomp)
changes impotence (conj)
hemodynamics retention (conj)
manner time-dependent (amod)
venom from (case)
presented changes (nsubj)
ng and (cc)
tgf- il-7 (conj)
binding with (case)
exercise after (case)
disturbance dysfunction (conj)
drugs affect (acl:relcl)
0.4 to (dep)
blepharoconjunctivitis , (punct)
passive-avoidance mouse (compound)
uncontrollable patients (nsubj)
have thrombosis (dobj)
activity caspase-3 (nmod)
affected that (mark)
treatment antibiotic (amod)
caused mechanism (nsubj)
production radical (compound)
cases followed (acl:relcl)
methylphenidate by (case)
developed hospitalization (nmod)
antiemetic and (cc)
present case (dobj)
4 1 (quantmod)
predict changes (nsubj)
suffered treatment (nmod)
smaller p10 (nmod)
acid hydrocortisone (conj)
combination sch (nmod)
amplitudes the (det)
suggest cause (ccomp)
avp ( (punct)
group 0.41 (appos)
died hypertrophy (nmod)
s-1 groups (conj)
appeared aminoglycosides (dep)
was administration (nmod)
hfde ) (punct)
averaged periods (nsubj)
gain altering (advcl)
fev1 metabolic (conj)
discharged . (punct)
prevent acetaminophen (advmod)
8-se ser(so3h)7-ac-cck-2 (compound)
pontine posterior (conj)
values base-line (compound)
on- the (det)
nephron the (det)
mg 6 (nummod)
1.88 0.97 (nummod)
center general (amod)
extract , (punct)
possibility interactions (nmod)
loss eyes (nmod)
useful thus (advmod)
ed hospital (nmod)
noticed recovered (advcl)
disturbance metabolic (amod)
complications . (punct)
caudate-putamen cpu (appos)
consideration are (cop)
improvements , (punct)
6 fewer (amod)
inhibitor na(+)/k(+)-atpase (compound)
centers america (nmod)
matter bilateral (amod)
ratio ] (punct)
vt vf (conj)
department ophthalmologic (amod)
days access (nmod)
rats failure (nmod)
patients cvd (nmod)
allografts both (cc:preconj)
confined were (auxpass)
syndrome severe (amod)
prior intracollicular (dep)
il-1beta including (case)
alter doses (nmod)
patient characteristics (conj)
transplant autologous (amod)
cope to (mark)
renal normal (amod)
aggravate bisphosphonates (nsubj)
attenuated improved (conj)
% , (punct)
methods explored (dep)
dose % (appos)
% u/liter (appos)
lna order (compound)
patients mainly (advmod)
cause levels (nsubj)
followed improvement (nmod)
movements . (punct)
followed one (nmod)
12.8 +/- (cc)
exposure ps (compound)
39+/-10 ( (punct)
lost responsiveness (nsubjpass)
found les (nmod)
patients p (dep)
caused but (cc)
treated pcc (nmod)
p>0.05 ) (punct)
mechanism excitatory (amod)
drug study (compound)
tendency of (case)
days last (amod)
known known (advcl)
testosterone , (punct)
greater period (nmod)
induced investigated (conj)
vnb ( (punct)
public by (case)
mice css (compound)
evidence ischemia (nmod)
dwi image (conj)
lesions electrolytic (amod)
response combined (acl)
remodelling through (case)
agonist lowers (acl:relcl)
part hearing (acl)
incorporation epinephrine (nmod)
metabolism test (dep)
using studies (dobj)
mechanisms of (case)
terminated study (nsubjpass)
pethidine control (nmod)
first compare (acl)
incorporate and (cc)
case dementia (nmod)
setting university (appos)
lowered expression (nsubjpass)
therapy temporary (amod)
concentration receptor (compound)
markers these (det)
open- closed-arm (conj)
combinations intoxication (nmod)
a 20 (conj)
time survival (compound)
vasodilator used (acl)
11 2 (conj)
disease transplantation (nmod)
prevent rats (nmod)
utilizing evolved (advcl)
animals microl (appos)
tested also (advmod)
rast negative (amod)
mg/dl range (dep)
premedication prophylactic (amod)
gum nicotine (compound)
aminonucleoside to (case)
pathomechanism the (det)
body 400 (nummod)
beta-ar ) (punct)
efficacy anti-arrhythmic (amod)
links administration (nmod)
24 % (dep)
performed tasks (dobj)
synthetic neuroactive (dep)
concluded accounts (ccomp)
complications various (amod)
patients example (nmod)
retention fibrosis (conj)
d4.2 , (punct)
provocation without (conj)
moderate use (nmod)
at and (cc)
amiloride by (case)
agents alkylating (amod)
examined globulin (nsubjpass)
system or (cc)
therapy optimal (amod)
treated medications (nmod)
used drugs (dep)
scopolamine not (cc)
have consequences (dobj)
conclude delayed (ccomp)
administration blocker (nmod)
candidates treatment (nmod)
500 ) (punct)
symptoms ibs (nmod)
anxiogenic- depressant-like (conj)
bradykinesia and (cc)
presentation cholestatic (amod)
group unilateral (amod)
features % (conj)
areas tubulointerstitial (amod)
treated cohort (nsubjpass)
follow 3 (dep)
agents potential (amod)
concentration urd (nmod)
reaching model (nmod)
dce ) (punct)
remained received (xcomp)
beating . (punct)
anthracyclines of (case)
inhibition no-synthase (compound)
triggered and (cc)
occurrence on (case)
mediate which (nsubj)
electroencephalography on (case)
patients an (det)
drugs ib (compound)
% df (dep)
seconds in (case)
54.5 and (cc)
noted transfer (nmod)
asymptomatic totally (advmod)
patients toronto (compound)
induce ? (punct)
severity injection (nmod)
aim second (amod)
delays development (dobj)
representing , (punct)
aware possibility (nmod)
anxiety burying (appos)
323+/-43 , (punct)
facilitated propagation (dobj)
message . (punct)
medicines of (case)
role direct (amod)
death cell (compound)
injections calcitonin (compound)
developed months (dep)
case patient (nmod)
hyperkalemia inappropriate (conj)
mice ninety-six (nummod)
cause rise (dobj)
widespread extremely (advmod)
performed elucidate (xcomp)
bd1018 or (cc)
prevented captopril (nmod)
chronic week (dep)
show up-regulated (ccomp)
detected level (nsubjpass)
all nearly (advmod)
des mg (dep)
dcf not (neg)
reported ; (punct)
indicate summary (nmod)
cases exposure (nmod)
begun day (nmod)
output 1.54 (nmod)
microinjection medulla (nmod)
level calcium (compound)
increase compensatory (amod)
examination sections (nmod)
khz ( (punct)
biosynthesis ribosomal (amod)
literature with (case)
neurons rostral (amod)
year diagnosis (nmod)
reduced subsequently (advmod)
channel aqp2 (appos)
changes report (appos)
decrease status (nmod)
well morning (nmod)
fibrosis induced (amod)
dyskinesias peak (compound)
increase urea (nmod)
associated lesion (nsubjpass)
improved weeks (dobj)
day 7 (nummod)
scored conditions (nmod)
response reproducible (amod)
higher concentrations (nmod)
% 11.4 (nummod)
slices the (det)
unit treatment (compound)
preferable may (aux)
tyr6]-vip , (punct)
days fits (nmod)
examinations genetic (amod)
men or (cc)
administration kg-1 (dep)
allow they (nsubj)
avoided or (cc)
patients forty-nine (amod)
anotia bilateral (amod)
found frequently (advmod)
were rate (nmod)
agents certain (amod)
assessed and (cc)
identifying a1 (dobj)
mapped correlated (conj)
identify might (aux)
detecting in (mark)
ar ; (punct)
resulted men (nmod)
evaluate was (cop)
treatment different (amod)
dialysis continuous (amod)
pump by (case)
c-ret ) (punct)
dose bupivacaine (nmod)
motility in (case)
warranted discontinuation (dobj)
rats dx (nmod)
density on (case)
therapy hormone (compound)
data status (conj)
process with (case)
occurred stiffness (nsubj)
cortex over (case)
extrarenal to (case)
rise ng/ml. (nmod)
cause ? (punct)
pressure mean (amod)
evident left (conj)
concluded agent (ccomp)
factors changes (nmod)
b-d-glucosaminidase nag (appos)
specified otherwise (dep)
up-regulation transporter (nmod)
feasible remains (conj)
epilepsy lobe (amod)
received treatment (dobj)
genes , (punct)
injections scopolamine (compound)
rate secretion (conj)
increased greater (conj)
restarted patients (nsubjpass)
respectively % (nmod:npmod)
lower groups (nmod)
conducted explore (advcl)
latency daytime (compound)
observations these (det)
enzymes cardiac (amod)
combinations by (case)
months postoperatively (advmod)
rosaceiform . (punct)
substitution the (det)
lesion nerve (nmod)
adults with (case)
december 2007 (nummod)
1000/mm3 hemoglobin (conj)
receives , (punct)
glomeruli affected (amod)
that lidocaine (nmod)
neonates . (punct)
atropine acid (appos)
report hypothesize (conj)
associated rls (nmod)
product is (cop)
evoke carteolol (nsubj)
noted pattern (nsubjpass)
tetrabenazine tiapride (conj)
phenotypes both (det)
signs consciousness (amod)
given days (dobj)
patients cases (appos)
swelling disruption (conj)
activity broad (amod)
norepinephrine by (case)
suggested observation (nsubjpass)
delayed diagnosis (nsubjpass)
distress rash (conj)
elicited can (aux)
blocked conversely (advmod)
exposed or (cc)
nrp ( (punct)
dm the (det)
reduced resulted (conj)
assessment scale (appos)
comprised was (auxpass)
ligand new (amod)
stabilizers lithium (nsubj)
lag in (case)
patient apl (compound)
experiencing symptoms (dobj)
therapy ifo (nmod)
mice nmri (compound)
reduction reduction (conj)
increase beginning (nmod)
depressed patient (nsubj)
diagnoses clinical (amod)
determine relationship (dobj)
3 at (case)
documented stenosis (nsubjpass)
n/n=25/26 or (conj)
six % (appos)
met . (punct)
reported benefits (nsubjpass)
assay chromatographic-mass (compound)
ranged higher (conj)
marker an (det)
patients renal (amod)
patients returned (acl:relcl)
recurrence is (cop)
combination meq/l (appos)
produced manner (nmod)
induced convulsions (dobj)
return quickly (advmod)
elected continue (xcomp)
inhibitor acetylcholinesterase (compound)
room operating (compound)
treatment sinusitis (nmod)
episodes further (amod)
affect rates (dobj)
avoided patients (nmod)
hypertension ii (nummod)
histology mixed (amod)
fentanyl ) (punct)
icv intracerebroventricularly (advmod)
model injury (nmod)
supporting hypothesis (dobj)
omitted was (auxpass)
inhibited had (conj)
one , (punct)
male is (cop)
test produced (acl)
components : (punct)
co-morbidity medical (amod)
pain the (det)
rehabilitation drug (compound)
years 3.1 (conj)
u/l 46 (nummod)
fluorobenzylidene ( (punct)
evaluated mice (nmod)
times multiple (amod)
bw ) (punct)
expression actin (nmod)
crisis the (det)
levels activity (compound)
have choreoathetosis (dobj)
manifestation cardiotoxicity (nmod)
progression down (case)
had bile (dobj)
enrolled outcomes (nsubj)
failure hepatitis (nmod)
patients b (dep)
associated carcinoma (nmod)
associated pb (nsubjpass)
survival a (det)
treatment dexamethasone (compound)
mediated actually (advmod)
suggesting aetiology (dobj)
determinant major (amod)
therapy indomethacin (compound)
phase phase (conj)
route any (det)
life . (punct)
seizures such (case)
2002 to (case)
cr , (punct)
practical association (nsubj)
mechanisms trends (appos)
dermatitis patient (nmod)
strain from (case)
increases fear (appos)
capacity transport (compound)
volume group (nmod)
unpredictable for (case)
p9201 ) (punct)
prove that (mark)
defective revealed (conj)
enhancement peak (amod)
administration convenient (amod)
graded as (prep)
period ranging (acl)
depletions energy (compound)
restored enhanced (conj)
remained disability (nmod)
models are (cop)
convulsions anesthetic-induced (amod)
dosing schedules (conj)
activation this (det)
has didanosine (nsubj)
numbers profiles/sections (appos)
loss eventual (amod)
encountered patients (dobj)
livestock in (case)
increased platelets (dobj)
inducing but (advmod)
followed group (nsubj)
progression in (case)
animals pilo-treated (amod)
levels propofol (compound)
3/8 ( (punct)
compared subunits (nmod)
analyses sensitivity (compound)
ingredient main (amod)
12-week trial (appos)
published whom (nmod)
range 33 (nummod)
rats transplanted (amod)
% 0.01 (nummod)
showed traveled (conj)
obtaining of (mark)
prediction for (case)
investigated double-blind (nmod)
sphincter oddi (nmod)
administered female (nmod)
open an (det)
levobupivacaine enantiomer (appos)
antagonize . (punct)
indomethacin with (case)
have ions (nsubj)
caused anesthesia (nmod)
blocked augmented (conj)
space b (conj)
activation nrf2 (nmod)
associated or (cc)
used shows (conj)
telangiectasia formation (dep)
5,7-dihydroxytryptamine serotonin (compound)
confirmed determination (nmod)
cells group (nmod)
inhibitors . (punct)
bilirubin indirect (amod)
smoking prior (advmod)
vector a (det)
7.8 0.5 (compound)
achieved , (punct)
girl 5-year-old (amod)
found man (nsubjpass)
k+ of (case)
record to (mark)
histopathologic immunohistochemical (conj)
prophylaxis thrombocytopenia (nmod)
agent same (amod)
morning dystonia (nmod)
exists ) (punct)
therapy initial (amod)
therapy selegiline (nmod)
pregnane-21-diol-20-ones ) (punct)
diluent of (case)
characterized deficiency (nsubjpass)
testing benzoylecgonine (nmod)
responses by (case)
bd1063 1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine (appos)
examined effects (nsubjpass)
questionnaire by (case)
show microglia (nsubj)
used scopolamine (nsubjpass)
exhibited preserved (conj)
increases anxiety (nmod)
role on (case)
relief headache (nmod)
threshold convulsions (nmod)
identified contrast (nmod)
positive patients (dep)
activity tonic (amod)
provided understand (advcl)
occur unexpectedly (advmod)
electrocardiogram , (punct)
vasculitis antibody (compound)
change given (advcl)
understood thought (advcl)
treated cyclosporin (nmod)
minimize impairment (dobj)
months eight (nummod)
cya. to (case)
hr 2.74 (nummod)
toxin botox (appos)
agents antibacterial (amod)
performed method (nmod)
loss projections (nmod)
patients carcinoma (compound)
inpatients 59 (dep)
arthrogryposis of (case)
% 30.7 (nummod)
accumulation metoprolol (compound)
agent class (compound)
essential interaction (nmod)
ages 20 (dep)
receptor alpha1-adrenergic (amod)
amphetamine-free amphetamine (conj)
20,40,60 80 (conj)
received follows (advcl)
months few (amod)
difficult is (cop)
epinephrine glaucoma (nmod)
revealed fundoscopy (nsubj)
produced 25mg/kg (nmod)
appear neurons (nsubj)
assessed effects (dobj)
death adriamycin-induced (amod)
constituent transport (nmod)
1.85 +/- (cc)
antioxidant an (det)
duration were (cop)
concentration fluoxetine (compound)
observed hypocalcemia (nsubjpass)
purpura , (punct)
jones ) (punct)
hypoxia disease (nmod)
administered ifo (nsubjpass)
doses times (conj)
-20.0 ) (punct)
implicated patient (nmod)
exhibited compared (prep)
abolished , (punct)
demonstrated decrease (dobj)
started whether (mark)
modes the (det)
ra % (amod)
recording protection (nmod)
increased diversion (nmod)
asterixis with (case)
10 20 (conj)
leak therapies (nmod)
respect tdp (nmod)
sequelae epilepsy (nmod)
concentration l-arginine (compound)
diaries , (punct)
ascertained were (auxpass)
mg/kg 0.1 (nummod)
timing severity (conj)
stereotypies anxiety (conj)
junction and (cc)
processes developmental (amod)
prostaglandins endogenous (amod)
recalled subjects (nsubj)
hepatic in (case)
resulted hypertension (nmod)
b.i.d. ( (punct)
patients non-dyskinetic (amod)
precipitating of (mark)
seems fact (nmod)
pressure 4 (nmod)
given terbutaline (dobj)
cld % (dep)
chemotherapy ct (appos)
evidence for (case)
february 1997 (nummod)
mechanism antagonizes (acl:relcl)
= = (dep)
appears important (xcomp)
causing tdr (dobj)
alterations inattention (conj)
5-fold to (dep)
hdl plasma (compound)
persons some (det)
steatosis , (punct)
sodium voltarol (dep)
pressure normal (amod)
way , (punct)
manifestation disease (nmod)
space and (cc)
reduced morbidity (dobj)
believed impart (xcomp)
effect alteration (nmod)
prolonged , (punct)
stratum 2 (nummod)
suggesting decrease (ccomp)
low-salt ls (dep)
demonstrates reduces (ccomp)
continued children (nsubj)
hcfcs ) (punct)
85.9 3.8 (conj)
developing when (advmod)
modified ligands (nmod)
heart liver (conj)
absence effect (nmod)
arabia saudi (compound)
action quenching (compound)
targets output (compound)
are risk (nmod)
development of (case)
effect between (case)
signaling fractalkine (compound)
failed indomethacin (nsubj)
evidences abnormalities (nmod)
expected coadministration (nsubjpass)
microg/kg/min , (punct)
improve to (mark)
corrected bromocriptine (nmod)
bromide vecuronium (compound)
was day (nmod)
h2 ( (punct)
infusion haloperidol (nmod)
4,000 100 (compound)
regeneration vis-a-vis (compound)
randomized and (cc)
administration vaccine (nmod)
elicit that (mark)
mild of (case)
information episodes (nmod)
cm administered (acl)
tablet ago (advmod)
revealed responses (dobj)
results 8/33 (appos)
respond and (cc)
arthritis joint (amod)
age but (cc)
intradermal or (cc)
clinics out-patient (amod)
% ci=26.7 (amod)
institution depending (case)
disorders cognitive (amod)
paracetamol and (cc)
ratio serum (compound)
occurred hemorrhage (conj)
pneumoniae , (punct)
technique microelectrode (amod)
therapy amlodipine (appos)
0.02 0.03 (conj)
lost rats (nmod)
presented we (nsubj)
effect clinical (amod)
suggests effectiveness (nsubj)
matter of (case)
ability ncq436 (nmod)
interpretation clinical (amod)
conclude restarted (ccomp)
cco-i ) (punct)
group h (compound)
considered encephalopathy (nsubjpass)
evidence insipidus (nmod)
had conversely (advmod)
quetiapine and (cc)
filters inferior (amod)
exhibited ml/min (dobj)
levels young (nmod)
limitations limited (advcl)
symptoms abuse (nmod)
disease a (det)
thyroid , (punct)
enhancement elevations (conj)
thirds a (det)
contain aprotinin (dobj)
available methods (nsubj)
studies case (compound)
cancers for (case)
sets both (det)
fatal acetaminophen-induced (dep)
evaluated must (aux)
experiment with (case)
casualties mass (amod)
database french (amod)
regimens from (case)
unrelieved crossover (nmod)
displace to (mark)
recipients for (case)
liver serious (amod)
hilus to (case)
data preclinical (amod)
iu/kg/h ) (punct)
drugs other (amod)
role nephrotoxicity (nmod)
albumin nonglycated (amod)
use metformin (nmod)
treat infection (dobj)
one micrograms/kg (appos)
days 8 (nummod)
i.p. ; (punct)
effects between (case)
study as (case)
using filaments (dobj)
alterations relation (nmod)
scabies of (case)
showed experiments (nsubj)
practical , (punct)
different functionally (advmod)
exposure mg/kg (appos)
improved rates (dobj)
concentration timolol (nmod)
ngf pgs (conj)
agent injury (conj)
% 12%-21 (compound)
results longer (conj)
experience and (cc)
induced aspartate (conj)
docetaxel either (cc:preconj)
explored . (punct)
pneumonia pcp (appos)
indicate experiences (nsubj)
run-in during (case)
resolved restarted (conj)
pentylenetrazol ptz (appos)
chloroacetaldehyde contribution (conj)
associated beta-blockers (nmod)
therapy plasma (compound)
mellitus 6 (appos)
patients arrhythmias (nmod)
potentiated effect (nsubj)
studies providing (acl)
correlates and (cc)
satisfied are (cop)
stenosis % (appos)
mg/day 10 (compound)
shunt hypotension (nmod)
score [ (punct)
corresponding areas (nmod)
received minutes (nmod:tmod)
torr from (case)
aldosterone by (case)
horns bilateral (amod)
interleukin-6 il-6 (appos)
narrow very (advmod)
released aid (nmod)
abnormalities congenital (amod)
demonstration be (cop)
effect uncommon (amod)
compare dosings (nmod)
patients high (amod)
increased ibuprofen (nsubj)
patients depression (nmod)
postulate prolong (ccomp)
conduction having (acl)
induced furthermore (advmod)
characteristic when (advmod)
pretreatment upon (case)
prodrugs 6 (dep)
drugs inotropic (amod)
40/min 30 (nummod)
provides summary (nmod)
expression nephrin (compound)
developed cin (nsubj)
points 6.4 (nummod)
sub-tenon 's (case)
effectiveness of (case)
involvement ) (punct)
death wide (amod)
aware fluconazole (ccomp)
mris of (case)
0.9 to (dep)
continued drug (nsubjpass)
encephalopathy wernicke (nmod:poss)
artery node (compound)
entered , (punct)
heterogenously lobule (nmod)
mg procainamide (nmod)
immunotherapy in (case)
analyzed lesions (nsubjpass)
constants in (case)
effects haloperidol (nmod)
treated followed (advcl)
had duration (conj)
patients torsades (nmod)
levels higher (amod)
possibility use (nmod)
denervation active (amod)
haloperidol chlorpromazine (conj)
administered rifampicin (nsubjpass)
bpm 138 (nummod)
p450 , (punct)
tests paramethasone (nmod)
impairment worsened (acl:relcl)
activation mice (nmod)
dysfunction (bcnu)-induced (amod)
administration phenytoin (compound)
mg/kg/day 120 (nummod)
patients women (dep)
degenerated fibrillation (nmod)
sulindac with (case)
distinct are (cop)
disease proven (amod)
reaction sulphasalazine (nmod)
f fm (conj)
868 904+/-434 (dep)
showed patterns (dobj)
lumen occlusion (conj)
levels increasing (amod)
characterization antagonist (nmod)
diagnosis pneumonitis (nmod)
head carcinoma (conj)
cycle including (case)
class weight (compound)
reduced risk (nsubjpass)
mr on (case)
using panel (dobj)
women lovastatin-treated (amod)
deterioration to (case)
anesthetic amide (nmod:npmod)
vinorelbine vnb (appos)
mice : (punct)
noted then (conj)
compared d-amb (dep)
while was (cop)
lumen of (case)
mg/kg 59 (nummod)
reaction confusion (nsubj)
prevention radiocontrast (nmod)
hbeag-positive and (cc)
activation parp (nmod)
predisposes that (mark)
evidenced symptomatology (nmod)
patients risk (acl:relcl)
dose ) (punct)
sm ( (punct)
nanoparticles 5mg/kg (appos)
wk after (compound:prt)
caused affecting (advcl)
attributed morphine (nmod)
plays no (nsubj)
differences excretion (nmod)
interaction for (case)
induced hg (nsubjpass)
possible that (mark)
micrograms 200 (nummod)
generalized or (cc)
nimodipine intravenous (amod)
enrolled was (auxpass)
reduced ccb (nsubjpass)
identify may (aux)
verbal < (dep)
weeks few (amod)
function decreased (amod)
examination of (case)
nerve laryngeal (amod)
initiate signals (dobj)
il-1 tnf (conj)
thirty-six % (appos)
histochemistry reduced (amod)
amounts powders (nmod)
h 12 (nummod)
region mid-thoracic (amod)
obtained angiograms (nmod)
of amisulpride (dep)
patients had (conj)
accompanied profile (nsubjpass)
dose sixth (amod)
ptcr value (conj)
enrolled . (punct)
response cr (appos)
grade iii (nummod)
flecainide agents (conj)
inducer p450 (nmod)
cyclophosphamide actomycin-d (conj)
occurred while (mark)
zyban ( (punct)
experienced that (nsubj)
convulsions tonic (amod)
moderate-dose ; (punct)
rhythm a (det)
onset epileptic (amod)
restored pressure (dobj)
appeared toxic (dobj)
acid mefenamic (amod)
expression receptor (nmod)
doses calcium (nmod)
hl60 cd34+/cd19- (conj)
acids , (punct)
assessed age (nmod:npmod)
had mumol/kg (dep)
growth tumor (compound)
mask a (det)
degrees to (case)
tablets ) (punct)
levels sfas (nmod)
elevation with (case)
dose acc-9653 (nmod)
23.7 - (punct)
described literature (nmod)
degeneration subacute (compound)
linking rpn (dobj)
lindane the (det)
aroused palpation (nmod)
suppressed 1.9 (conj)
macroprolactinoma n. (appos)
effusion eosinophilia (conj)
pain ecg (conj)
terfenadine and (cc)
considered have (aux)
ineffective is (cop)
stroke 4 (dep)
dose mg/kg (appos)
tetany life-threatening (amod)
medicines ) (punct)
dogs or (cc)
lvef fs (conj)
abundances the (det)
decreases are (cop)
multicenter trial (appos)
used switched (conj)
conclusions demonstrate (appos)
days 4 (conj)
b.d and (cc)
heterogeneity diffuse (amod)
obtained reduction (nsubjpass)
suggest pay (ccomp)
subacute to (mark)
distributed receptors (nsubjpass)
aim experiment (nmod)
finding . (punct)
exposure infants (nmod)
stimulation nucleus (nmod)
results study (compound)
persisted decrement (nsubj)
myocet ; (punct)
potentiates antinociception (dobj)
mz ( (punct)
borderzone lesions (nmod)
increased cells (nsubj)
validated well (advmod)
subsided hours (nmod)
patients density (dep)
gestation of (case)
development rate (conj)
r6 ( (punct)
regulation metabolism (nmod)
potency similar (amod)
strain sensitive (amod)
patients transplantation (nmod)
served who (nsubj)
provided and (cc)
mediates , (punct)
interaction their (nmod:poss)
blocked electrographic (dobj)
failure view (dobj)
scopolamine-induced . (punct)
development independently (advmod)
interpolates data (dobj)
effect pressure (nmod)
appeared evident (advcl)
include portion (dobj)
conducted ratio (dep)
demonstrated result (dobj)
intervals confidence (compound)
measurements administration (nmod)
scored were (auxpass)
different scores (nsubj)
results conflicting (amod)
documented has (aux)
administration analog (nmod)
levels gad (compound)
dyskinesias to (case)
depend rate (nmod)
inhibitors ) (punct)
receive day (nmod)
mean root (nsubj)
length or (cc)
hepatocarcinogens known (amod)
variables cardiovascular (amod)
session for (case)
rates six (nummod)
provide conclusion (dep)
workers to (case)
mg ] (punct)
movements vocal (amod)
eye left (amod)
effects neurotensin-induced (amod)
widely most (advmod)
patient arthritis (nmod)
length af (compound)
all group (dep)
vldl increasing (conj)
0.1/mg/kg etomidate (compound)
metabolized hepatically (advmod)
mhc-i associated (acl)
investigation cases (nsubj)
pressure unrecordable (amod)
p2x3 with (case)
smoking tobacco (compound)
common had (conj)
alf lt (conj)
control genetic (amod)
valproate . (punct)
utility imaging (nmod)
exposure chronic (amod)
attribution dose (nmod)
microinjection methyldopa (nmod)
describe cycle (nmod)
components lemon (amod)
types into (case)
affected be (auxpass)
received vehicle (dobj)
able since (mark)
required activity (nsubjpass)
glaucoma open-angle (amod)
damage interstitium (nmod)
syndrome on (case)
attend to (mark)
model streptozocin-induced (amod)
showed proteins (nsubj)
47 6 (conj)
therapy adults (nmod)
domain apical (amod)
lesions purpuric (amod)
evaluated entries (conj)
impairment early (amod)
d for (case)
bore carcinomas (dobj)
attempted we (nsubj)
technique ( (punct)
8.4 vs (cc)
limit damage (dobj)
weight increase (conj)
rigidity chest (amod)
assessment for (case)
using paper (dobj)
counts of (case)
ra the (det)
qt the (det)
amounts relative (amod)
improve whether (mark)
increases alpha-t (nsubj)
infusions calcitonin (nmod)
injury was (cop)
rats saline-pretreated (amod)
3 10 (conj)
gfap and (cc)
rats severe (amod)
product the (det)
scale index (conj)
accomplished was (auxpass)
system whole-body (compound)
described authors (nsubj)
correlated production (nmod)
objective therapy (dep)
atenolol cardioselective (appos)
concentrations corticosterone (nmod)
estimated ecgs (nmod)
3.4 risk (nsubj)
ka as (case)
accelerated is (auxpass)
tachycardia complex (amod)
midazolam 0.001 (appos)
g/dl anemia-related (conj)
lev findings (dep)
10.9 - (punct)
water arm (compound)
pathophysiology of (case)
recipient 's (case)
biomarkers predictive (amod)
underwent discovered (conj)
young in (case)
dysfunctions by (case)
parameters of (case)
failure chf (appos)
slow ( (punct)
history use (compound)
finding reinforces (conj)
those abnormalities (nmod)
report boy (nmod)
obstruction pulmonary (amod)
incorporation decreased (amod)
effects coniine (nmod)
pair base (compound)
shown prevent (xcomp)
cancer ) (punct)
reactions potential (amod)
virus hepatitis (compound)
one failure (compound)
lower f (nmod)
range nephrotic (amod)
9.1 with (case)
effect study (dep)
convulsions the (det)
measures the (det)
out-patients of (case)
chf grade (compound)
abnormality valvular (amod)
block intermittent (amod)
supernatants culture (compound)
increased weight (nsubj)
treatment capsaicin (compound)
haematological . (punct)
acuity and (cc)
encephalopathy acute (amod)
29th on (case)
level dehydrogenase (compound)
agent blocking (compound)
group are (cop)
measures oscillation (nmod)
anesthesia from (case)
found some (nmod)
testing autoantibodies (nmod)
prolongs , (punct)
ameliorate to (mark)
reached years (dobj)
ifosfamide ifs (appos)
linkages phosphate (compound)
words the (det)
females and (cc)
agonist partial (amod)
attention induction (nmod)
combination telmisartan (nmod)
mg twice (advmod)
regard safety (nmod)
models method (conj)
nelarabine prophylaxis (nmod)
isoproterenol wt (appos)
neck on (case)
gwardamangia malta (appos)
ml methylprednisolone (nmod)
fracture of (case)
dose titrated (acl)
allografts other (conj)
= p<.001 (dep)
drug but (cc)
0.24 0.004 (conj)
active given (advcl)
decreased fk (nsubj)
subtype of (case)
doses ng/mouse (nmod)
liver triglyceride-rich (amod)
patients hospitalised (acl)
partition by (case)
provided , (punct)
excluded , (punct)
index international (compound)
class igm (compound)
arose where (advmod)
protection offers (acl:relcl)
25mg/kg mg/kg (conj)
dose subthreshold (amod)
impaired function (nsubjpass)
levothyroxine on (case)
counted cardiomyocytes (nmod)
increases phenomenon (dobj)
trial/day 4 (nummod)
these other (conj)
suspicion injury (nmod)
monkeys challenge (appos)
treatment hit (nmod)
destructive overload (nmod)
grade gvhd (dep)
increase digoxin (nsubj)
experiences eyes-closed (amod)
rtms pulses (dep)
administered induce (xcomp)
discussion a (det)
administered striatum (nmod)
avoid and (cc)
patients 4,217 (nummod)
headaches primary (amod)
lipid with (case)
treatment antiepileptic (amod)
titre mpo-anca (compound)
treated was (auxpass)
recovered remained (conj)
extent , (punct)
115 +/- (cc)
tachyarrhythmias with (case)
female 63-year-old (amod)
studies uea1 (compound)
ears ) (punct)
ctnt and (cc)
differences hemoglobin (nmod)
pretreatment by (case)
evolution damage (compound)
neuroplasticity . (punct)
rats dosages (nmod)
presumed . (punct)
sg cortex (nmod)
induces rats (nmod)
naloxone cortex (conj)
difluoromethylornithine and (cc)
use diuretic (compound)
fit was (cop)
transfusion blood (compound)
inhibitor cause (acl:relcl)
hypothesis for (case)
scopolamine the (det)
transplants and (cc)
12alpha-hydroxylase and (cc)
established safety (dobj)
sinusoidal spaces (dep)
groups animal (compound)
rejection chronic (amod)
presentation second (amod)
accounts vivo (advmod)
died failure (nmod)
mic than (case)
causes deterioration (dobj)
use the (det)
accelerate . (punct)
combination e (compound)
cats group-housed (amod)
application inhibitor (nmod)
used generally (advmod)
diagnosed have (xcomp)
presented p (dep)
rs6693503 ( (punct)
accepted is (auxpass)
survival nephrosis (conj)
anesthetized subjected (conj)
responsible problems (nmod)
hepatomegaly accumulation (conj)
memory complex (conj)
excretion clearance (conj)
grade regurgitation (compound)
effects pallidotomy (nmod)
induced whether (mark)
disease such (case)
ibpb ( (punct)
woman hyperthyroidism (nmod)
reduced clonidine (nsubj)
exhaustion after (case)
measures . (punct)
damage injury (nmod)
collected data (nsubjpass)
patients non-warfarin (amod)
changes responses (nmod)
muscarinic of (case)
cases 38 (nummod)
reduced 1/10 (nmod)
preexposure reduced (conj)
metrics days (conj)
consideration differences (nsubj)
length cycle (compound)
demonstrated not (neg)
delayed levels (dobj)
trial during (case)
age-dependent frequent (parataxis)
cardiotoxicity monitored (acl)
monitored . (punct)
azt of (case)
belgium in (case)
chemopreventive a (det)
exposed four (nsubjpass)
have studies (nsubj)
fibrillation warfarin (nmod)
inflammation steatosis (conj)
group t+a (compound)
difference potency (nmod)
1.69 1.35 (dep)
reaction complex-mediated (amod)
have incidence (dobj)
73/99 ) (punct)
7 least (advmod)
coadministration administration (conj)
based information (nmod)
series . (punct)
densities adrenergic (amod)
burns treated (acl:relcl)
compromises reversed (advcl)
behavior antagonized (amod)
cases including (case)
activity withdrawal (conj)
increased yield (dobj)
findings disease (nmod)
done weeks (conj)
reduction maximal (amod)
localised that (mark)
activate receptors (dobj)
d-galactose c-4-epimer (appos)
doses granisetron (nmod)
steroids maintenance (compound)
resuscitation standard (amod)
group potassium (conj)
defined or (cc)
death stress (nmod)
radioactivity aortic (amod)
modulate represent (conj)
patient unaffected (amod)
used drugs (dobj)
complicate . (punct)
noticed we (nsubj)
resurgence been (cop)
score rest (nmod)
use ( (punct)
suppressed levels (nsubjpass)
suggestion association (nmod)
patients tachyarrhythmia (nmod)
treated boy (nsubjpass)
prevalence patients (nmod)
> . (punct)
believed is (auxpass)
activator ) (punct)
immobilization 5-day (amod)
cardiomyopathy reverse (compound)
caused incidence (dobj)
loss thiols (nmod)
improve rats (nmod)
achieved ) (punct)
5-hydroxytryptophan mg/kg (appos)
comorbid patient (compound)
urea ) (punct)
measure activity (nmod)
severity between (case)
departments to (case)
mepivacaine lidocaine (conj)
analgesic opioid (amod)
reported however (advmod)
association hearing (advcl)
regimens multidrug (amod)
ecg tropinin (conj)
use dexamethasone (nmod)
comparable values (nsubj)
exercised grade (dobj)
events following (amod)
received previously (advmod)
mitochondria , (punct)
levels preservation (nmod)
tdp candidates (nmod)
immunohistochemistry , (punct)
patients epileptic (amod)
intolerant zidovudine (nmod)
drc and (cc)
role cells (nmod)
groups knife (compound)
glomerulonephritis positive (amod)
imbalance dopamine/serotonin (amod)
kb tp53 (conj)
prevalence trial (appos)
bone of (case)
pituitaries f2 (compound)
used ma (dobj)
patients ibs (nmod)
rhabdomyolysis secondary (amod)
nanoparticles a (det)
ameliorated manner (nmod)
determinant gc-ht (nmod)
predictive may (aux)
treatment administration (nmod)
blocks binding (nmod)
failure patients (nmod)
evidence new (amod)
lack effect (nmod)
anuria before (case)
acid converts (compound)
produced latency (dobj)
therapy gentamicin (compound)
lesion induced (amod)
methemoglobinemia dogs (nmod)
utilized study (nmod)
revealed seen (advcl)
detected be (auxpass)
exceeds of (case)
dosing ethambutol (compound)
abolished shr (nmod)
results puncture (compound)
activity neuron (compound)
micromol/l. dl-sotalol (nmod)
release on (case)
induced blockade (nsubj)
safe " (punct)
subtypes involved (acl)
benefit addition (nmod)
level three (nummod)
liver than (case)
hydrocortisone with (case)
variability rate (compound)
implications clinical (amod)
convulsions prevention (conj)
tasks motor (compound)
october to (case)
benign are (cop)
was hypothesis (dep)
cases cancer (nmod)
remissions remissions (conj)
alendronate , (punct)
ofh ( (punct)
supports reports (dobj)
used adjunct (nmod)
dose dexamethasone (conj)
patients scoring (acl)
precursors nad (nmod)
newer atypical (dep)
task recognition (compound)
highlights contribution (dobj)
neurotoxicity rats (nmod)
parameters above-mentioned (amod)
rats nephropathy (nmod)
included confusion (dobj)
levels kidneys (nmod)
thromboembolism determined (amod)
compatible syndrome (nmod)
controls rats (conj)
hypoxia diffuse (amod)
group other (conj)
exposure skin (compound)
used levodopa (nsubjpass)
recording electrocardiographic (amod)
course of (case)
15 ) (punct)
balance electrolyte (compound)
fatalities two (nummod)
phenomenon steal (amod)
carried analysis (nsubjpass)
c57bl/6j chosen (acl)
described autism (nmod)
condition . (punct)
studies ultrastructural (amod)
women 3390 (nummod)
occurs implicated (conj)
history smoking (conj)
tested combination (nmod)
recipients isg (compound)
difference amplitude (nmod)
effects norepinephrine (nmod)
showed papillary (nmod)
followed results (nmod)
sr and (cc)
monitored hours (conj)
achieves benefit (dobj)
represents form (dobj)
% cardiomyocytes (nmod)
potent respectively (advmod)
seen july (nmod)
determining etiology (dobj)
described is (auxpass)
significance ptcr (nmod)
is differentiation (nsubj)
otoprotectant as (case)
3a4 cyp3a4 (appos)
pain pelvic (amod)
result hazardous (conj)
drugs prescribing (amod)
reproducing abnormality (dobj)
t.i.d. mg (cc:preconj)
changes by (case)
function . (punct)
syndrome alterations (nsubj)
data recordings (conj)
observed , (punct)
3.9 ) (punct)
setting a (det)
h response (dep)
seems leveled (xcomp)
site puncture (nmod)
tacrine of (case)
work-ups hematologic (amod)
rara at (case)
problem . (punct)
difference=0.01 ) (punct)
unilateral bilateral (conj)
prone attacks (nmod)
dexrazoxane neither (cc)
follow-up a (det)
derived that (nsubjpass)
said carbachol (dep)
db to (case)
infections opportunistic (amod)
determine should (aux)
cirrhosis exhibited (acl:relcl)
induced mmecs (nmod)
results biopsies (nmod)
neurones on (case)
aggravated absences (nsubjpass)
period months (nmod)
rate % (nmod)
metals heavy (amod)
suprofen drug (appos)
origin striatal (amod)
acuity in (case)
leukaemia paediatric (amod)
progresses adenomyosis (nmod)
found ; (punct)
postdose hours (compound)
analyze . (punct)
nephrotoxicity clinical (amod)
administered it (nsubjpass)
increase variations (nmod)
maintain pressure (dobj)
infant 17-day-old (amod)
medications their (nmod:poss)
appeared drivers (nsubj)
was nigra (dep)
animals epileptic (amod)
effect antiseizure (compound)
nmba benzylisoquinolinium (compound)
weight height (conj)
6 1 (compound)
discontinued 1 (dep)
study pathophysiology (dobj)
resulted worsening (nmod)
supply or (cc)
scattered , (punct)
fertility female (amod)
bisphosphonate sodium (dep)
min 27 (nummod)
quinidine phenylethylbarbiturate (conj)
degree anaemia (nmod)
% or=50 (amod)
periods 3 (nummod)
rs ) (punct)
intensities ) (punct)
accumulation lipid (compound)
relationship curvilinear (amod)
enhanced none (nsubj)
induce antagonists (nsubj)
use antiinflammatory (amod)
bilateral , (punct)
revealed sequences (nsubj)
p.o. kg-1 (compound)
had agc (dobj)
damage cardiac (amod)
appropriate levels (nsubj)
altering level (dobj)
center scale (nmod)
50 as (advmod)
dysfunction biventricular (amod)
resolved when (advmod)
1.81 ( (punct)
process podocyte (compound)
algorithm according (case)
differentiation a (det)
catheter the (det)
decrease to (mark)
best the (det)
difficulties , (punct)
combinations their (nmod:poss)
treated zidovudine (nmod)
compound 14 (nummod)
raised , (punct)
myocarditis a (det)
patients compared (conj)
roles important (amod)
induced dl-sotalol (nsubj)
tumor granulosa (compound)
acrolein irritant (appos)
refractory with (case)
allodynia nociceptin-induced (amod)
individuals have (acl:relcl)
scales analogue (compound)
confirmation diagnosis (nmod)
arteriolopathy angiodegeneration (dep)
explain prolongation (dobj)
channel is (cop)
caused therapy (nsubj)
shown intensity (nsubjpass)
holding after (mark)
recovered . (punct)
suppressed application (nsubj)
intensities , (punct)
-15.96 + (cc)
investigated toxicity (nsubjpass)
represents apparently (advmod)
ciprofloxacin- and (cc)
pool the (det)
became findings (nsubj)
evaluated treatment (nmod)
harvested administration (nmod)
increased hypotension (nsubjpass)
k 0.001 (appos)
architecture complete (amod)
control important (acl:relcl)
cognitive the (det)
swallowing while (mark)
= right (conj)
measured binding (nsubj)
effects anti-cocaine (amod)
procoagulant and (cc)
research administration (nmod)
patients required (acl:relcl)
had akathisia (dobj)
effect hyaluronate (nmod)
ratio of (case)
hypertension substantial (amod)
aids , (punct)
reticulata in (case)
administration gentamicin (compound)
30 six (compound)
changed indicating (advcl)
treatment amb (compound)
macrophages foamy (compound)
4-hourly to (case)
105 5 (compound)
prescribing adults (nmod)
agonists all (det)
mg/kg 37 (nummod)
clinical bioptic (conj)
pneumonia neoplasms (conj)
reduces injury (dobj)
disorder or (cc)
hundred 104 (dep)
reversed pretreatment (nsubj)
precursor nociceptin (nmod)
ml of (case)
acid 3,4-dihydroxyphenylacetic (amod)
patients hospitalised (amod)
given minutes (nmod)
administered amount (nsubjpass)
elicits that (mark)
nitrate pilocarpine (compound)
signs toxic (amod)
auccgrp the (det)
biomarker to (mark)
treatment carbamazepine (compound)
subcortex the (det)
ganglia the (det)
decreased remains (parataxis)
rizatriptan % (dep)
doses opioid (nmod)
diagnoses with (case)
dependence altered (amod)
cortex sinus (conj)
thrombocytopenia delayed-onset (amod)
groups disease (compound)
mean changes (dobj)
test indomethacin (nmod)
sec 15 (nummod)
collected 2 (conj)
discharged was (auxpass)
oxidase amphetamine (conj)
wound as (case)
because of (pcomp)
tumors independent (amod)
data history (nmod)
dose flecainide (nmod)
pre-treatment days (nmod)
thickened contrast (nmod)
point view (nmod)
numbers similar (amod)
level plasma (compound)
cause pain (nmod)
activity sensitivity (conj)
dose 100mg/kg (dep)
dependent also (advmod)
evaluated evening (nmod)
due is (cop)
inhibit target (dobj)
increased group (nmod)
risk against (case)
poison topoisomerase (compound)
fastblue with (case)
correlated p= (dep)
assessments safety (compound)
findings present (amod)
said ; (punct)
resemblance closest (amod)
antibody novel (amod)
oxide ( (punct)
reduce synovitis (dobj)
c with (case)
formulations both (det)
instituted pacing (nsubj)
effective enantiomer (nmod)
seizures electrocorticographic (amod)
reflex the (det)
examinations , (punct)
infusion 2,682,2,803 (dep)
differences development (nmod)
alterations prostigmine-morphine-induced (amod)
electromyography muscle (appos)
ranges therapeutic (amod)
aids meningitis (conj)
50 4 (compound)
peripheral pain-related (dep)
assessment a (det)
reduced h2o (nmod)
fluency semantic (amod)
response hormone (nmod)
patients infections (nmod)
schema multiple (amod)
metabolic and (cc)
inducing t(9:22 (dobj)
cause not (neg)
years per (case)
feature disease (nmod)
scans imaging (compound)
tachydysrhythmias ( (punct)
surpasses that (dobj)
inhibitors dtis (appos)
using intensity (nsubj)
= 7934 (dep)
apex the (det)
ortral peripheral (conj)
discontinuation tacrolimus (nmod)
use oral-contraceptive (amod)
investigate induce (ccomp)
sulphate sulphate (dep)
cognitive deficits (dep)
co-administration protamine (nmod)
solution ( (punct)
diagnosed carcinoma (nsubjpass)
antigens hla (compound)
level genes (nmod)
ii and (cc)
vasodilator direct-acting (amod)
mg/m2/h 1,200 (nummod)
managed successfully (advmod)
frequencies deafened (acl)
suggest therefore (advmod)
lesions detectable (amod)
amnesia an (det)
treatment true (amod)
evoked epilepticus (nmod)
variability pressure (compound)
years duration (nsubj)
indicators and (cc)
admissions to (case)
vasculitis fulfilling (acl)
prazosin % (appos)
overlooked easily (advmod)
strategy one (nummod)
ratio zone (compound)
abusers known (amod)
objectives problem (dep)
increases density (nmod)
had = (dep)
done was (auxpass)
demonstrated increases (dobj)
similar variable (conj)
saw reduction (dobj)
discrepancy a (det)
studied employing (advcl)
% indeed (advmod)
composed was (auxpass)
reaction donors (nmod)
screening cross-sectional (amod)
establish bioavailability (dobj)
research future (amod)
prevent vitro (advmod)
tolerated maintained (conj)
effect trazodone (nmod:poss)
have implications (dobj)
exposed been (auxpass)
comply to (mark)
harmful especially (advmod)
gfp(+ the (det)
examined occurrence (dobj)
important may (aux)
protection dexmedetomidine (amod)
hazard potential (amod)
abdomen for (case)
carriers of (case)
pain patient (nmod)
proven conclusion (nmod)
monkey development (nmod)
% center (nmod)
mg/day at (case)
l-isomer medetomidine (nmod)
neuropathy deficiency (nmod)
lesions associated (acl)
become poor (conj)
common expected (advcl)
criteria mi (nmod)
rotations apomorphine-induced (amod)
benign they (nsubj)
injection triamcinolone (nmod)
distribution inhomogenous (amod)
omitted administration (nsubjpass)
presenting levels (nmod)
piloerection , (punct)
effect edema (nmod)
documented neutropenia (nsubjpass)
a/j ) (punct)
rationale 5-hydroxytryptamine (dep)
seen relationship (nsubjpass)
were differences (attr)
dse a (det)
confirm determine (conj)
race/ethnicity or (cc)
thrombosis with (case)
prevented effect (nsubjpass)
stage ) (punct)
p10 the (det)
elevated mice (nmod)
berries the (det)
inotropic negative (amod)
changes analysis (conj)
incidence convulsions (dep)
increases marked (amod)
adopted chemotherapies (nmod)
check reports (nmod)
giving s. (nmod)
monitored continuously (advmod)
determined prevents (ccomp)
rediscovery laitinen (nmod)
system by (case)
forced effects (nsubj)
related potentially (advmod)
interval monoher (nmod)
activity lysosomal (amod)
urothelium in (case)
1710 +/- (cc)
prescribed safely (advmod)
(+)-isomer mg/kg (appos)
effect adverse (amod)
word last (amod)
11-fold 7- (compound)
neutropenia without (case)
15 min (dep)
likely was (cop)
stabilizers have (conj)
intracerebroventricular icv (appos)
hyperalgesia provoked (amod)
50 100 (conj)
radius the (det)
count ( (punct)
t in (case)
recorded cases (nmod)
paclitaxel mg (compound)
quiescent transplants (nsubj)
administering injections (dobj)
neonates received (acl:relcl)
antagonist specific (amod)
cabergoline with (case)
produce complication (dobj)
restored slices (nmod)
three either (advmod)
integrate exposure (dobj)
aneurysm implantation (nmod)
hallucinations neurotoxicity (conj)
diagnosed detection (nmod)
treated after (mark)
hyperkalaemia for (case)
classed pph (nmod)
scores of (case)
sex treatment (conj)
using combination (nmod)
process saturable (amod)
use mirtazapine (nmod)
prolongation and (cc)
tested responses (nsubjpass)
requires that (mark)
courses all (det)
presented however (advmod)
and substantially (advmod)
duration mapd (appos)
antagonist competitive (amod)
shown gamma-hch (nsubjpass)
reversed administration (nsubj)
rosacea dermatitis (conj)
woman healthy (amod)
seizures lindane (compound)
angioplasty renal (amod)
insipidus and (cc)
sustained wane (advcl)
challenge agonist (nmod)
insertion failure (conj)
routes oral (amod)
therapy inhaled (amod)
groups asa (compound)
treatments previous (amod)
fatalities fleming (dep)
ng anp (nmod)
so , (punct)
represented thus (advmod)
occurred excess (advcl)
effect hypertensive (amod)
patients uremic (amod)
nitrate lanthanum (amod)
essential knowledge (nsubj)
proposed activation (nsubjpass)
tracers with (case)
increase deviation (nmod)
hyperprolactinemia to (case)
experiments same (amod)
seizures motor (compound)
products its (nmod:poss)
48 - (punct)
explore possibility (dobj)
caused study (nmod)
shift left (nmod)
record given (case)
matter particulate (amod)
side opposite (amod)
higher trials (nmod)
mannitol of (case)
elevated . (punct)
explain to (mark)
episodes ) (punct)
continued deteriorate (xcomp)
elevation kept (acl)
lower injection (advcl)
decrement performance (nmod)
number few (amod)
mg/ml 0 (nummod)
interpreted . (punct)
decrease elevation (conj)
use increasing (amod)
myelopathy disturbance (conj)
dermatitis . (punct)
consider should (aux)
possibilities result (acl:relcl)
blocked and (cc)
studies dobutamine (amod)
rtms area (nmod)
9.95 2.98 (nummod)
% glomeruli (nmod)
hours in (case)
acid such (case)
octapeptides the (det)
11 % (appos)
bupropion the (det)
lack norepinephrine (dobj)
shortening in (case)
preferable prilocaine (nsubj)
lovastatin and (cc)
suggested mechanisms (nsubjpass)
2 124 (conj)
cardiotoxicity dysfunction (conj)
started case (nsubj)
acetylcholine vip (conj)
performing task (dobj)
minutes four (nummod)
awake woman (nmod)
trial prazosin-controlled (amod)
factor triggering (amod)
afterdischarges repetitive (amod)
related ifosfamide (nmod:npmod)
modulation stress (nmod)
treatment evaluation (conj)
system liver (conj)
incidence appearance (nmod)
factors overlooked (acl:relcl)
lips of (case)
biochemistries the (det)
bioavailability abundant (amod)
showed hepatitis (dobj)
lid only (advmod)
cardiorespiratory temperature (conj)
effects but (cc)
excitability neural (amod)
population ectopic (amod)
women 55 (nummod)
reported explain (xcomp)
offered . (punct)
pg/ml ( (punct)
receiving is (aux)
users therapeutic (amod)
type used (acl)
ingestion diuretic (amod)
polyuric cessation (nmod)
mmol . (punct)
that caused (acl)
experienced initiation (nmod)
diuresis ( (punct)
cardiotoxicity to (case)
2.9 10(-7 (conj)
triceps of (case)
hospitalized treated (advcl)
continue could (aux)
depression segment (compound)
powered was (auxpass)
hypercalcemia suppression (dep)
compare abstinence (nmod)
toxicity gi (compound)
observed abnormality (nsubjpass)
caused noted (conj)
incidence that (mark)
epo of (case)
effects hours (nmod)
relationship epsilon4 (nmod)
120/67 signs (nsubj)
recorded later (advmod)
membranes capillary (amod)
regimen than (case)
drug conventional (amod)
hepatotoxicity the (det)
enzymes abnormalities (nmod)
seizures mortality (conj)
anomalies multiple (amod)
wky in (case)
anesthetic of (case)
serotonin , (punct)
regarded cause (nmod)
resulted exchange (nmod)
administration c (compound)
ameliorate rg1 (nsubj)
ich and (cc)
activation probably (advmod)
incidence occurs (acl:relcl)
dysrhythmogenic was (cop)
protein protein (appos)
thrombosis acute (amod)
series treatment (compound)
effects activities (nmod)
vohland ) (punct)
effect hyperalgesic (amod)
pathway mtor (compound)
produced edrophonium (nsubj)
focused formation (nmod)
suggests increase (nsubj)
caa by (case)
receptors cannabinoid (amod)
32.5 +/- (cc)
injury dogs (nmod)
protected affect (advcl)
showed ability (dobj)
time maintenance (conj)
space to (case)
masked readjustment (nmod)
controls or (dep)
rate only (advmod)
infiltration inflammatory (amod)
is explore (xcomp)
support effect (dobj)
nausea patients (appos)
objective aimed (dep)
benefits spironolactone (nmod)
tested repeatedly (advmod)
akinesia the (det)
mouse the (det)
day , (punct)
haloperidol to (case)
recovered spontaneously (advmod)
thrombosis epinephrine (conj)
affecting nucleus (dobj)
ca(2 l-type (compound)
retard . (punct)
unresponsive effects (nsubj)
effects ability (nmod)
tachycardia accompanying (amod)
increase raloxifene (nsubj)
discontinuation blocker (nmod)
membrane tbm (appos)
safer appropriate (conj)
responsible and (cc)
albumin serum (compound)
agent antiarrhythmic (amod)
agonism dopaminergic (amod)
angiograms on (case)
catecholamines hyperkinesia (conj)
recur , (punct)
tiva during (case)
way . (punct)
testing alkylxanthines (nmod)
uptakes . (punct)
subsided when (advmod)
years several (amod)
times mg/kg (compound)
nonischemic clinical (dep)
antagonist mglur1 (nmod)
transplants of (case)
interpretation unequivocal (amod)
performed dosing (nmod)
identify not (neg)
fr ( (punct)
57.9 age (nsubj)
accompany that (mark)
objectives evaluate (acl)
activity emg (compound)
lack noted (acl)
detection . (punct)
response tonic (amod)
ameliorates nocistatin (nsubj)
reduction , (punct)
recurred . (punct)
receptor kinin (compound)
present day (nmod)
flestolol agent (appos)
characteristic entity (nmod)
increased reaching (advcl)
169 x (cc)
1 patients (nmod)
91 to (quantmod)
day injection (nmod)
dogs produced (acl:relcl)
acts cimetidine (nsubj)
associated cancer (nmod)
carbimazole benzylthiouracil (conj)
occur doses (nmod)
% 3.8 (compound)
mg g/250 (dep)
decreased cpap (nsubj)
averaging control (nmod)
satisfied were (cop)
report block (ccomp)
restricted signs (nmod)
center patients (nmod)
regulation variety (nmod)
impairment . (punct)
edema failure (conj)
counteracted thus (advmod)
marketed has (aux)
observed as (mark)
understanding the (det)
thioperamide of (case)
reflect concentration (nsubj)
nerves peripheral (amod)
excess a (det)
users relative (amod)
hypotension response (nmod)
2 weeks (dep)
diet mmol/kg (appos)
test skin (compound)
associated receptor (nsubjpass)
larynx , (punct)
avoiding consumption (dobj)
thought effect (nsubjpass)
mediate subpopulations (nsubj)
17 15 (conj)
particles procoagulant (amod)
treatment efficacy (nmod)
camera indocyanine (compound)
micu ( (punct)
rats sprague-dawley (amod)
modifications the (det)
differ age (nsubj)
suspensions corticosteroid (compound)
thirteen patients (nmod)
role cholinergic (amod)
location or (cc)
forms that (nsubj)
status of (case)
cases arthritis (nmod)
nephrotoxicity less (amod)
revert that (mark)
incidence time (nmod)
wish draw (xcomp)
determination la (nmod)
stimulation inhibitory (amod)
given developed (advcl)
distributed widely (advmod)
development for (case)
acquired thrombosis (dobj)
effects affect (acl:relcl)
performed anesthesia (nmod)
route dermal (amod)
followed withdrawal (nsubjpass)
mechanisms elicits (acl:relcl)
proliferation hippocampal (conj)
assessed diet (nsubjpass)
diaries in (case)
described catastrophic (conj)
model homeostasis (compound)
prevented were (auxpass)
treatment multicenter (nmod)
derivatives of (case)
stress , (punct)
offspring in (case)
62 of (advmod)
abscess liver (compound)
attack the (det)
task time-dependent (amod)
audiograms posttherapy (compound)
randomized . (punct)
day mg/m(2 (appos)
sex as (case)
medullo-adrenalectomy bilateral (amod)
risk is (cop)
healthy in (case)
experiments previous (amod)
morning b.i.d. (compound)
reduced coadministration (nsubj)
receiving warfarin (dobj)
t.i.d. subjects (appos)
= 0.003 (dobj)
fibres muscle (compound)
group non-sh (compound)
integrity hippocampal (compound)
elevation ie (advmod)
manifestations of (case)
anorexigens : (punct)
influenced genetically (advmod)
osmolality or (cc)
hypertension testosterone-dependent (amod)
generation of (case)
analysis detailed (amod)
ssris of (case)
findings microscopic (amod)
< > (dep)
responses svrs (appos)
appeared appear (conj)
affect hypotension (dobj)
damage may (aux)
blocked thrombosis (nmod)
disappearance delay (nmod)
probably most (advmod)
predictor not (neg)
hr 1 (nummod)
depends exclusion (nmod)
options current (amod)
acid this (det)
reappearing increment (nmod)
absence de (amod)
time onset (compound)
models in (case)
scores = (dep)
efficiency mcl (nmod)
experiencing akathisia (dobj)
times clotting (compound)
microg/kg/min ) (punct)
syndrome possible (amod)
12 % (appos)
cannulae peripheral (amod)
e1 prolonged (amod)
artery myocardial (conj)
processes cognitive (amod)
person in (case)
effects only (cc:preconj)
focus of (case)
indicate enhanced (ccomp)
ci=5.194 - (punct)
1.13 , (punct)
beats p (dep)
patients lamivudine-untreated (amod)
prevent effectively (advmod)
cells cardiac (amod)
blocks trazodone (nsubj)
limits used (advcl)
dysfunction cardiovascular (amod)
associated methadone (nsubjpass)
injection after (case)
volunteers 65 (nummod)
men 74 (nummod)
included sensitivity (dobj)
discontinued she (nsubj)
capable considered (conj)
maximal was (cop)
gfr ) (punct)
blockade pharmacological (amod)
p=0.003 respectively (advmod)
severe migraineurs (nmod)
responses exaggerated (amod)
membrane on (case)
enhances neurotransmission (dobj)
cause nephritis (nsubj)
medications human (amod)
lead animals (nmod)
incidence % (amod)
cytosegresomes in (case)
group agents (nmod)
neoantigens in (case)
palsy . (punct)
preterm twin (amod)
6.1 0 (compound)
levels deoxycorticosterone (nmod)
patient src (nmod)
115 26 (conj)
desensitization cause (nmod)
0.6 10(10 (conj)
microg/ml p (dep)
defined degree (nmod)
weekly weeks (nmod)
treatment diethylcarbamazine (nmod)
influx interstitial (amod)
likely may (aux)
received pregnancy (nmod)
age men (dep)
estimated is (auxpass)
shift parallel (amod)
had had (parataxis)
facilitation rates (nmod)
lasting hours (dobj)
3tc t (conj)
kilogram per (case)
abolished tachycardia (dobj)
relative users (nmod)
enhanced however (advmod)
brought room (nmod)
conclusions allowed (appos)
lower relatively (advmod)
experiment tri (appos)
identified schedule (dobj)
cpb context (dep)
unclear been (cop)
suggest anaemia (nsubj)
slices cortex (nmod)
utilized extensively (advmod)
report stating (acl)
terms effects (nmod)
perimetry by (case)
change not (neg)
hyperactive chow (conj)
retarding release (dobj)
factors causative (amod)
recognized syndrome (nsubjpass)
enable to (mark)
department in (case)
volunteers years (nmod:tmod)
damage weight (nmod)
tuberculosis because (case)
decreased to (dep)
reduced binding (dobj)
questionnaires updrs (compound)
supplementation prolonged (amod)
array rt2 (compound)
improvement neurological (amod)
sustained years (nmod)
indicators cardiotoxicity (nmod)
trated basis (nmod)
tested patients (nsubjpass)
contractions of (case)
mg 813 (nummod)
2.5 more (amod)
argatroban of (case)
drug buspirone (appos)
dose related (amod)
detection related (nmod)
more to (dep)
placebo days (nmod)
question role (nmod)
coagulation and (cc)
antagonists ) (punct)
detect could (aux)
nf-m nf-h (conj)
conventional and (cc)
variants sg145r (appos)
= 32 (dep)
became asystolic (acomp)
i.v. 2 (conj)
haloperidol standard-dose (amod)
lorazepam injectable (amod)
heart or (cc)
enzymes diagnostic (amod)
factors diabetes (nmod)
dysfunction carbamazepine-induced (amod)
morphine-hc1 of (case)
care ( (punct)
therapy tamoxifen (compound)
ascertained be (auxpass)
units 40 (nummod)
mi ) (punct)
pathologies obscure (amod)
regulation angiogenesis (nmod)
volume 3504 (nmod:tmod)
downregulated inhibited (conj)
excitation apparent (amod)
gly-phe-leu-gly ( (punct)
cause methylprednisolone (nsubj)
ischemia acute (amod)
differences efficacy (nmod)
matched year (nmod)
vinorelbine gemcitabine (conj)
worsening the (det)
had relative (dobj)
0.05 comparisons (nmod)
dosing with (case)
model research (nmod)
function age (nmod)
atrial ventricular (conj)
kf17837 . (punct)
cells rat (compound)
administration kindling (appos)
4107 were (cop)
efflux striatum (nmod)
2b1/2b2 , (punct)
case delirium (nmod)
interstitial phytotherapy-associated (amod)
detailing after (mark)
challenge and (cc)
cont./min ( (punct)
need chemotherapy (nmod)
needed reductions (nsubjpass)
observed reduction (nsubjpass)
group long-acting (amod)
2 one (compound)
patients 128 (nummod)
underwent transplantation (nmod)
estimated we (nsubj)
eye seeing (amod)
signified presence (nsubj)
exposure despite (case)
predicted levels (nmod)
subsided , (punct)
increased lower (conj)
expression cytochrome (compound)
implications of (case)
autism age (dep)
presented diagnosed (advcl)
tested polymorphism (nmod)
disturbances including (case)
patients performed (acl)
drug active (amod)
abnormalities . (punct)
compared subjects (conj)
grafts stable (amod)
p=0.008 p=0.006 (conj)
ropivacaine ( (punct)
allopregnanolone not (cc)
had conclusions (dep)
appear ischemic (xcomp)
vigabatrin vgb (appos)
pairs patients (nmod)
parts head (nmod)
control induction (nmod)
light ) (punct)
repaired that (nsubjpass)
mg 4.0 (nummod)
protection effect (conj)
depressants by (case)
developed insufficiency (dobj)
h 0.5 (nummod)
creatinine gender (conj)
enzyme bche (appos)
criteria defined (amod)
gsh ) (punct)
prevented might (aux)
ng/dl. was (cop)
busulfan cystitis (dep)
procedures obstetric (amod)
median the (det)
present historic (conj)
caused beats (nmod)
unrelenting cirrhosis (nmod)
adriamycin of (case)
risk benefit (conj)
mg. 6 (nummod)
pressure decreased (amod)
intrarenally technique (dep)
occurred discontinuation (nmod)
studies subjects (nmod)
diet induces (acl:relcl)
deficit transient (amod)
suggested those (ccomp)
hyperammonemia acid-induced (amod)
bipolar ) (punct)
reduction treatment (conj)
receiving cvvhdf (dobj)
ratio 2.5-fold (nmod)
heterozygous ) (punct)
was although (mark)
cpa by (case)
changes asymptomatic (amod)
discussion reprogramming (dep)
methods searched (appos)
performed mg/kg (dep)
assessed june (nmod)
accomplished and (cc)
200 0 (compound)
difference score (nmod)
syndrome elevation (dep)
observed chicks (nmod)
h procedures (nmod)
doses micrograms/kg/hr (nmod)
diet phenobarbital-containing (amod)
administered daily (advmod)
t-[35s]butylbicyclophosphorothionate of (case)
suggesting inhibits (ccomp)
maternal neonatal (conj)
leg of (case)
alter any (dobj)
concentration fluid (compound)
case each (det)
therapy (cns)-directed (compound)
decrease = (dep)
diseases these (det)
prophylaxis malaria (compound)
levetiracetam oral (amod)
tbars ( (punct)
count 10(9)/l (dep)
mg.kg(-1 5 (compound)
virtue efficacy (nmod)
cisplatin for (case)
consumption simultaneous (amod)
complex macromolecular (amod)
perfused groups (advcl)
attack provoked (acl)
higher values (nmod)
pneumonitis effusions (dep)
independent be (cop)
coagulation disseminated (amod)
slight ) (punct)
patients jaundice (nmod)
patient derivative (conj)
proliferation epithelial (amod)
given carbon (dobj)
performs mrp2 (nsubj)
line bs (compound)
ddavp ( (punct)
analysed found (conj)
1.7 1.2 (nummod)
requiring intervention (dobj)
alleviate can (aux)
study spectrum (nmod)
affinity high (amod)
received treatments (nmod)
level dopamine (compound)
superoxide production (conj)
polymorphism polymerase (compound)
righting of (mark)
agents effective (amod)
attributable were (advcl)
hoarseness thrush (dep)
proposed although (mark)
prohibited administration (nmod)
ci 69 (nummod)
erythematodes of (case)
point this (det)
assigned manner (nmod)
dose second (amod)
expected risk (nsubjpass)
dropped mg/dl. (xcomp)
collected are (aux)
alters deprivation (nsubj)
avoided labeling (nmod)
began therapy (dobj)
dose dox (compound)
rate aldosterone (compound)
history thrombosis (nmod)
if of (case)
advocate . (punct)
administered medication (dobj)
placebo cells (conj)
effective modulating (advcl)
review historical (amod)
inventory and (cc)
1 : (punct)
ultrastructure the (det)
abolished alterations (dobj)
block woman (nmod)
cancer urothelial (amod)
period vulnerable (amod)
noted chick (nmod)
decreased score (conj)
atra ( (punct)
action a (det)
placebo trials (nmod)
using electroencephalography (dobj)
iopromide and (cc)
assays functional (amod)
pain primitive (conj)
resolve stopped (advcl)
q-pcr by (case)
system transport (compound)
u/ml u/ml (appos)
symptoms consistent (amod)
show recurrence (dobj)
analysis this (det)
observations mid- (nmod)
lesions brain (compound)
showed changes (dobj)
administration in (case)
level or (cc)
control activity (dobj)
28.21 +/- (cc)
inhibitor gaba(a)rs (nmod)
herbicide used (amod)
reflected not (neg)
stabilized showed (conj)
ataxia moderate (amod)
findings recent (amod)
test field (compound)
decreased elevations (dobj)
process chemoprevention (compound)
adhesions extensive (amod)
response proliferative (amod)
patients ect (nmod)
evaluation pas (nmod)
caused gold (nmod)
sod gsh (conj)
argatroban catheter-directed (conj)
responses renal (amod)
gap narrow (amod)
sensitive are (cop)
active it (nsubj)
metolachlor cancer (conj)
source site (appos)
behaviors children (nmod)
keep level (dobj)
develop may (aux)
fibers of (case)
potential cardiotoxic (amod)
half dogs (nmod)
beating shortening (appos)
sd ) (punct)
rating amnesia (conj)
omercazole ( (punct)
efficacy apomorphine (amod)
inventory measures (appos)
development proteinuria (compound)
frequency installation (nmod)
considered drugs (nsubjpass)
paclitaxel acid (conj)
diagnosed and (cc)
one control (dep)
those patients (nmod)
process of (case)
isoproterenol by (case)
addition the (det)
chewing vacuous (amod)
complication those (dep)
3.75 ( (punct)
4.7 0.7 (conj)
ht placebo (conj)
nausea vomiting (conj)
seen infections (conj)
sacrificed ' (punct)
programs dexamethasone (compound)
unchanged metformin (nmod)
recurrence b (compound)
increased that (nsubj)
had clearly (advmod)
regions three (nummod)
example good (amod)
find could (aux)
> tablets (appos)
reduces pretreatment (nsubj)
efficacious as (advmod)
dose loading (compound)
induced calcineurin-inhibitor (advmod)
rat novel (amod)
concern because (case)
presents ; (punct)
episodes potentials (nmod)
scale six-point (amod)
substratum between (case)
ranging slurred (conj)
infections p (dep)
single intravenous (dep)
mm pretreatment (dep)
t60 ( (punct)
successful resuscitation (nsubj)
correlations responses (nmod)
levels pre-procedure (amod)
activity both (cc:preconj)
supports study (nsubj)
processes " (punct)
safer are (cop)
importance conducting (advcl)
echocardiography measurements (nsubj)
growth of (case)
deficiency dehydrogenase (compound)
exhibited pre-bed (advcl)
angioedema in (case)
children seven (nummod)
important formulations (advcl)
augment , (punct)
stimulate to (mark)
similar amphetamine (nmod)
restoring function (dobj)
principle based (case)
higher time (nmod)
hypothesized plays (ccomp)
rose men (nmod)
catheterisation angiography (conj)
nephrotoxicity significant (nsubj)
epinephrine control (dep)
antibodies . (punct)
studies allograft (compound)
ability vision (compound)
showed conclusions (dep)
found showed (conj)
substrate probe (compound)
dxr ( (punct)
tracts areas (conj)
consisted which (nsubj)
effect negligible (amod)
association hydroureteronephrosis (nmod)
assay thrombosis (nmod)
bronchopneumonia hemorrhagic (amod)
acute congestion (dep)
had therapy (dobj)
sulphate were (cop)
content whole (amod)
accompanied are (auxpass)
subsequent discontinuation (nmod)
increased scores (dobj)
results declined (dep)
evidence overall (amod)
insertion by (case)
necrosis . (punct)
iu/l iu/l (conj)
remaining b.d (nmod)
disruption cytoskeletal (amod)
rating of (case)
good subsides (advcl)
phenotypes exposure (nmod)
pergolide with (case)
vary . (punct)
acting primarily (advmod)
increase index (nmod)
serve marker (nmod)
volume lesion (compound)
volumes cerebellar (amod)
pacemaker ventricular (compound)
severe sufficiently (advmod)
expressing sum (nmod)
t(9:22 cml-associated (amod)
thiopental of (case)
investigated safety (dobj)
medium the (det)
fluorthyl- and (cc)
detect prolongation (dobj)
nsaid ( (punct)
caused p (dep)
identified clearly (advmod)
crm ( (punct)
inhibition impairment (nmod)
olanzapine , (punct)
anxioselective the (det)
arrhythmias of (case)
described infrequently (advmod)
aged over (compound:prt)
assessment global (compound)
ambiguus at (case)
maximum . (punct)
disease severe (amod)
solution albumin (nmod)
controls repeated (amod)
mild % (dep)
consumption animals (nmod)
prophylaxis nausea (nmod)
thrombocytopenia anaemia (conj)
quantify population (dobj)
formation radicals (nmod)
undergoing stimulation (dobj)
surgery genito-urinary (amod)
predictors clinical (amod)
170/ 16,459 (nummod)
rats to (case)
case carbimazole (compound)
hydrochloride dothiepin (compound)
caused nicotine (nsubj)
transmission neuronal (amod)
months experiment (nmod)
applicators among (case)
explained impaired (advcl)
hiv-negative completed (conj)
pretreated fc (nmod)
hypothesis plays (ccomp)
cautious using (advcl)
pb died (acl:relcl)
produced induced (advcl)
propagation maintenance (conj)
cefonicid or (cc)
vomiting improvement (nmod)
determine effects (dobj)
associated being (auxpass)
comparable rates (dep)
d-med 5 (dep)
glutamate metabotropic (compound)
important understand (xcomp)
subjects either (cc:preconj)
degree degree (conj)
influence whether (mark)
time in (case)
treatment possible (amod)
evaluated incidence (dobj)
activity which (nsubj)
olanzapine ) (punct)
support mechanism (dobj)
demonstrates occurs (ccomp)
meq 3269 (compound)
occurs anemia (nsubj)
side-effects without (case)
altered rate (nsubjpass)
therapy azathioprine (amod)
limitations without (case)
index insulin (compound)
slowing continuous (amod)
test to (case)
was prolongation (attr)
shortened whereas (mark)
matched study (nmod)
demonstrated serially (advmod)
intensity the (det)
matter frontal (amod)
act vitro (advmod)
bid -21.3 (dep)
nox hypertension (nmod)
dipyridamole of (case)
assessment in (case)
syndrome 12.1/0/0 (nummod)
point to (case)
read intervals (nmod)
tachycardia with (case)
inhibited 4-damp (nsubj)
increased amplitude (nsubj)
analyzed levels (nsubjpass)
epileptogenic littermates (nmod)
subjected rats (nsubjpass)
anesthesia to (case)
helpful extremely (advmod)
results i.v. (amod)
days induction (nmod)
transplantation poor (amod)
effect proteinuria (nmod)
involved was (auxpass)
examine factors (dobj)
regimens , (punct)
expression number (nmod)
agent antineoplastic (amod)
control totally (advmod)
intraperitoneal daily (advmod)
striatum microm (appos)
present present (conj)
analysis group (appos)
occurred methotrexate (conj)
begun dialyzer (nmod)
histochemistry through (case)
stimuli noxious (amod)
suspension empty (amod)
hyperactivity spontaneous (amod)
receiving course (dobj)
pregs both (cc:preconj)
conclusion effect (dep)
response poor (amod)
quinpirole agonist (compound)
call is (cop)
glucose acids (appos)
events hypertriglyceridaemia (conj)
used unit (nmod)
resonance mr (appos)
those propranolol (nmod)
predictive development (nmod)
forestomach rat (nmod)
represent structures (dobj)
alter achieved (conj)
time-course or (cc)
applicability practice (nmod)
= 0.036 (dobj)
rats tested (acl)
s-(-)-et-126 the (det)
transplantation following (case)
invariable not (neg)
barrier nephrosis (nmod)
receiving aminoguanidine (dobj)
obtained fetuses (nsubjpass)
asynergy by (case)
diameter arterial (amod)
memory similar (amod)
measurements surviving (advcl)
blind double (amod)
occur not (neg)
glomerulosclerosis biopsies (appos)
performance exercise (compound)
morphine epidural (amod)
able ( (punct)
experiences of (case)
offspring of (case)
implicated effects (nmod)
preference tablet (nmod)
role disturbances (nmod)
cause hypertension (dobj)
propylthiouracil by (case)
limits upper (amod)
dh vsd (conj)
presented protein (nsubjpass)
nicergoline due (case)
alters physiology (dobj)
ng ng (dep)
prevented topiramate (nsubj)
increase were (cop)
aspects with (case)
affected drugs (nmod)
greatest ribavirin (nmod)
age old (amod)
established : (punct)
methamphetamine amphetamine (conj)
female hyponatraemia (nmod)
contrast controls (nmod)
complications perinatal (amod)
known role (nsubjpass)
received cab (dobj)
model epilepsy (compound)
hearing involved (conj)
improvement dramatic (amod)
1,2 ( (punct)
levels across (case)
> 5 (nummod)
conversion by (case)
complex dgc (appos)
desmosomes the (det)
involve models (nsubj)
syndrome syndrome (nsubj)
modulation neurotoxicity (nmod)
days b.i.d. (appos)
events ongoing (amod)
restored inhibition (nsubjpass)
affect significantly (advmod)
misleading may (aux)
initiate tachykinins (nsubj)
agent boosted (amod)
a1 of (case)
administered resulting (advcl)
12 approximately (advmod)
19 from (case)
factors ulcerogenic (amod)
changes ictal (amod)
safety procedure (compound)
hypercholesterolemia primary (amod)
university portland (conj)
diet % (compound)
severity patients (nmod)
fhf and (cc)
segments lv (compound)
overdose against (case)
induced cocaine (nmod)
induced microperfusion (nmod)
sustained not (neg)
monitor blood (compound)
convulsions clonic (amod)
inserted anesthesia (nmod)
doses measured (acl)
anaesthesia sevoflurane (compound)
features retinopathy (nmod)
started infusion (nsubj)
weeks rate (nmod)
sensitivity contrast (compound)
factor acetyltransferase (nsubj)
stores overflow (conj)
tgf- and (cc)
applied experiments (nmod)
concentration histamine (compound)
presence is (cop)
active be (cop)
county , (punct)
examined specimens (dobj)
fact considering (case)
1.53 - (punct)
system serotonergic (amod)
correlation tomography (nmod)
develops start (nmod)
nitroprusside of (case)
exceeded duration (conj)
min literature (nmod)
days in (case)
put was (auxpass)
positive . (punct)
nanoparticles 80-coated (amod)
medications surveyed (acl)
developed h (nmod)
intermediate is (cop)
investigator the (det)
accumulation wall (nmod)
mucositis iv (nummod)
different weeks (nmod)
quantify receiving (advcl)
catheterization right (amod)
diet a (det)
ms week (nmod)
bpt/clz of (case)
score score (conj)
decrease g/dl (amod)
symptoms to (case)
efficacy reduced (amod)
p= 0.003 (nummod)
androgen corticosteroid (conj)
s the (det)
effect infections (nmod)
2.32 0.16 (conj)
enabled dose (nsubj)
fc . (punct)
efficacy trial (nmod)
change parameters (nmod)
accl0131 ( (punct)
common period (nmod)
neurologic and (cc)
500 more (amod)
mpges-1 + (cc)
receptors alpha-1 (compound)
induced studies (nmod)
rhythm block (conj)
microangiopathy patients (nmod)
cco-i in (case)
receptors neurotensin (compound)
micrograms caffeine (nmod)
trimester second (amod)
controls user (compound)
implanted left (conj)
proarrhythmic be (cop)
acetate nh4ac (appos)
doing well (advmod)
ci 0.64 (nummod)
pretreated . (punct)
comparing incidence (dobj)
higher = (parataxis)
years 60.8 (nummod)
differ modulation (nmod)
t120 ( (punct)
patients pretreated (amod)
consequence metabolic (amod)
carcinoma undifferentiated (amod)
21 22 (conj)
treatment azathioprine (compound)
enac of (case)
prostaglandins urine (nmod)
seizure thresholds (dobj)
index bispectral (amod)
delayed waves (dobj)
degrees mean (dep)
example hepatotoxicity (nmod)
produced ) (punct)
atenolol such (case)
replacement warfarin (nmod)
observed moreover (advmod)
lowering hdl (dobj)
years 35 (nummod)
core periphery (conj)
fetal animals (conj)
regimens infusion (compound)
elected name (xcomp)
mechanisms current (amod)
case disorder (nmod)
regimen administering (acl)
ovariectomized ovx (dep)
results chemotherapy (nmod)
improved hours (nmod)
ccl2 interaction (conj)
support did (aux)
diet on (case)
total years (nmod)
formation plugs (nmod)
recovered patients (nmod)
time progression (nmod)
suggested patients (nmod)
documented little (advmod)
examine role (dobj)
tool a (det)
treatment paracetamol (conj)
proportions epidemic (amod)
had evidence (dobj)
12 10 (compound)
diethylstilbesterol of (case)
mean age (dep)
developed sagittal (dobj)
transcripts of (case)
atrophy atrophy (nmod)
spect ( (punct)
low and (cc)
wires ventricular (amod)
apap or (cc)
chronic significant (conj)
shown protect (xcomp)
improvement 16 (nmod)
progression failure (nmod)
fluoxetine or (cc)
watch report (conj)
batteries tests (nmod)
loss anatomic (nmod)
revealed patients (dobj)
tissues rats (nmod)
potentiate . (punct)
demonstrated administration (nmod)
movements right (nmod)
erg multifocal (amod)
attributed lithium (nmod)
units 42 (nummod)
epsilon-aminocaproate methionine (conj)
raclopride selective (amod)
used we (nsubj)
nigra within (case)
therapy amiodarone (compound)
shows study (nsubj)
dex ato (conj)
level 4 (nummod)
approximate . (punct)
occurred % (parataxis)
connection in (case)
control with (case)
signs cardiotoxicity (nmod)
renal , (punct)
cromakalim and (cc)
rate episodes (nmod)
anxiety reactivity (conj)
preswitch = (parataxis)
consuming glasses (dobj)
neutrophil to (case)
mutants motif (compound)
mrna-containing gad (nmod:npmod)
syndrome irritable (amod)
0.007 ( (punct)
predictable . (punct)
nra0160 clozapine (conj)
received inhibition (nmod)
vocalization the (det)
reports but (cc)
result model (nmod)
aconitine ouabain (conj)
patients platinum- (nmod)
gssg ) (punct)
presented values (dobj)
patients preliminary (amod)
effects tablets (conj)
criteria following (amod)
identifying of (mark)
regimen to (case)
proteinuria . (punct)
task alternation (compound)
patients transplant (compound)
injection flunitrazepam (nmod)
method restoration (compound)
useful may (aux)
afferents of (case)
cases case (appos)
coma a (det)
determine onset (dobj)
11th the (det)
regimens treatment (nmod)
gaba(a)rs of (case)
present convulsions (nsubj)
degrees range (appos)
frontal on (case)
headaches , (punct)
oxygen in (case)
concentration tamca (nmod)
way only (amod)
hematoxylin , (punct)
phenobarbital the (det)
765 145 (conj)
needs system (nsubj)
null and (cc)
factors independently (advmod)
receiving implant (dobj)
observations the (det)
administrated form (nmod)
age calcification (conj)
2.1 0.45 (conj)
paradigm e.g. (advmod)
indicate type (dobj)
e ( (punct)
uptake l-arginine (amod)
generations pills (nmod)
hypertension hyperlipidemia (conj)
dose-dependent up (advmod)
cities in (case)
necessary evaluate (xcomp)
day seven (nummod)
mm 194 (nummod)
discussion cause (appos)
admitted hours (nmod)
presence carcinoma (nmod)
test contamination (nmod)
80 placebo (nmod)
mg/m2 than (case)
attributable + (cc)
cells macrophages (conj)
serum-albumin for (case)
suppressed and (cc)
described associated (parataxis)
rats activity (dobj)
= 17 (dep)
activity 2 (nummod)
female 1-year-old (amod)
values ki (compound)
affected to (mark)
hypotension both (cc:preconj)
show correlation (dobj)
discontinued pneumonia (nmod)
disease or (cc)
bisphosphonates , (punct)
cisapride mg (appos)
representative response (nmod)
fq as (case)
vegfr-2 ) (punct)
antagonizing deficits (dobj)
bromperidol of (case)
rhinitis allergic (amod)
evident degree (nsubj)
investigated reported (ccomp)
suggest interfere (ccomp)
inhibitors blockers (conj)
regimen antibiotic (amod)
infant exposed (acl)
invaluable . (punct)
cells swollen (amod)
iowa and (cc)
suggests emphasizes (conj)
1995 early (amod)
use factors (conj)
therapy arabinoside (nsubj)
manifestation cases (nmod)
inhibited be (auxpass)
nine approximately (advmod)
woman hypertension (nmod)
use increase (conj)
intermediate that (mark)
diets containing (acl)
mediator as (case)
onset produced (acl)
-chlorpheniramine mg/kg (conj)
follow-up women (nmod)
discontinued patients (nmod)
norleucine leucine (conj)
ob in (case)
1.6 1.3 (conj)
rodents adult (amod)
became % (nmod)
carbon cc (appos)
drugs affinity (nmod)
activates whereas (mark)
non-hypertensive new (amod)
cream agsd (compound)
bun group (compound)
release acetylcholine (compound)
case infusion (nmod)
rise seen (acl)
promotion the (det)
preserved more (advmod)
pulses myocardium (nmod)
anemia issue (appos)
sufficient initiation (nmod)
nephropathy maleate-induced (amod)
potential torsadogenic (amod)
speaking during (mark)
repeated once (advmod)
greater response (nsubj)
infusion dopamine (compound)
containing corticosterone (dobj)
develop when (advmod)
amount reduced (amod)
intolerance oac (nmod)
report resulting (xcomp)
weeks every (det)
compared p=0.002 (dep)
c-4-epimer the (det)
dexmedetomidine following (case)
examined tolerance (nsubjpass)
implicated parkinsonism (nmod)
degree eight (nmod)
level to (case)
gvhd extensive (amod)
assigned mg (nmod)
others by (case)
im in (case)
influence might (aux)
tachycardias ventricular (amod)
parameters pd (compound)
enabling , (punct)
effect steric (amod)
symptoms fluoxetine-induced (amod)
infusion carboplatin (nmod)
ph pco2 (appos)
suggestive role (nmod)
tablets of (case)
contributes synthesis (nsubj)
alphabeta-crystalin methyltransferase (conj)
adam10 adam17 (conj)
trained vocabulary (nmod)
produce increase (dobj)
% 54.4 (nummod)
trial testing (compound)
preference for (case)
was rats (nmod)
discussed briefly (advmod)
100 than (quantmod)
mg/day 2 (nummod)
appeared frequent (xcomp)
paradigm , (punct)
system suppressed (acl:relcl)
cisapride placebo (conj)
transplantation dialysate (nmod)
noted occurred (conj)
infusion 2-week (amod)
damage as (cc)
pressures capillary (amod)
living county (nmod)
reason for (case)
rhythm contractile (compound)
complications study (dep)
level urea (nmod)
compliance good (amod)
therapy patients (conj)
hydromorphone mg (nummod)
counts 2.5 (nmod)
h an (det)
interaction any (det)
department hospital (compound)
increased associated (conj)
pointes patients (nmod)
followed later (advmod)
cotransporter abundances (compound)
examined morphology (dobj)
similar so (advmod)
electromyogram and (cc)
application form (nmod)
vomiting which (nsubj)
discontinuing risperidone (dobj)
glutamate csf (compound)
effects elicits (compound)
disappearing be (aux)
experiment in (case)
rechallenge positive (amod)
augmentation production (nmod)
unchanged cbf (nsubj)
metabolized has (conj)
recommend prospectively (nmod)
methods register (appos)
excluded evidence (nsubjpass)
tomography before (case)
s 580 (nummod)
taken attention (nmod)
val 160 (nummod)
opacities corneal (compound)
detected % (nmod)
use dexrazoxane (nmod)
steatosis alterations (conj)
afl ( (punct)
concentration magnesium (compound)
has involvement (dobj)
determine leads (ccomp)
nephrotoxicant known (amod)
chicks for (case)
associated inhibition (dep)
k-8644 bay (compound)
fever ulcers (conj)
prognosis visual (amod)
bid at (case)
= 0.53 (dep)
two intragastrically (advmod)
identified microscopy (nmod)
which with (case)
scintigraphy on (case)
gc-ht of (case)
started and (cc)
results consisted (dep)
ng 5-fu (conj)
mg/kg 0.2 (nummod)
mice liver-/- (amod)
superior , (punct)
had terminated (conj)
combination doxorubicin (conj)
questionnaire a (det)
weights the (det)
exhibited catecholamines (dobj)
test objective (nsubj)
decreased left (conj)
minutes infusion (nmod)
therapy inhibitors (conj)
seizures in (case)
rest both (cc:preconj)
dorsum the (det)
dissipates local (amod)
care comprehensive (amod)
dna genomic (amod)
described however (advmod)
seizure pethidine-associated (amod)
chromatography gas-liquid (amod)
micrograms/ml 50 (compound)
diet wk (nmod)
seen groups (nmod)
t efavirenz (conj)
factor ngf (appos)
value be (cop)
demonstrated animals (nsubj)
decayed minutes (nmod)
= 57 (dep)
layer included (acl:relcl)
spinal or (cc)
fluid analgesics (conj)
exposure after (case)
severe infusion (nmod)
order describe (acl)
intolerance lens (compound)
nephrotoxicity in (case)
diseases other (amod)
mice fzp (nmod)
induced caa (nsubj)
effects catalepsy (nmod)
secondary 5-fluorouracil (nmod)
lader 's (case)
dsp4 by (case)
substratum and (cc)
carriers ( (punct)
demonstrated roots (dep)
days the (det)
developed p=0.025 (dep)
number densa (dep)
activity expression (conj)
movement body (compound)
patients pain (compound)
post-injection two (nummod)
practice the (det)
developed hyperkalemia (dobj)
reduction of (case)
change animals (nmod)
mutations such (amod)
induced in (case)
hypothesis involves (ccomp)
13.1 +/- (cc)
pain injections (nmod)
reduce compounds (nmod)
admitted wards (nmod)
short occur (conj)
media hysterosalpingography (nmod)
received paclitaxel (dobj)
drugs anxiogenic (amod)
acidosis type (compound)
considered complication (nsubjpass)
available congestants (conj)
as severe (amod)
recognition effects (nmod)
tachyarrhythmias for (case)
causes impairments (dobj)
included didanosine (dobj)
examined experiences (dobj)
background have (appos)
level methotrexate (compound)
slowing generalized (amod)
loss an (det)
groups thiol (compound)
ototoxicity and (cc)
dissection coronary (amod)
abolished decrease (dobj)
discussion first (appos)
peroxidation homogenates (nmod)
hepatotoxicity quinidine (compound)
increase correlation (conj)
fr kg-1 (appos)
% group (nmod)
lady a (det)
survival 5-year (amod)
lower levels (nmod)
guidelines procedures (appos)
gene protein (conj)
bcl-2/bax of (case)
indicate developed (ccomp)
increases deficiency (nsubj)
medication , (punct)
sulindac between (case)
follow-up society (appos)
lack wall (nmod)
enzymes lysosomal (amod)
ameliorates : (punct)
design different (amod)
domain c (compound)
cddp probable (ccomp)
monitoring to (case)
potentiates toxicity (dobj)
suspected discussion (nsubjpass)
test multiple (compound)
nature the (det)
effects n-(2-propylpentanoyl)urea (nmod)
group greek (compound)
therapy ethambutol (compound)
10- single (amod)
158.11 +/- (cc)
causes sirolimus (nsubj)
administration flunitrazepam (nmod)
had abc (nsubj)
evaluated initiation (nmod)
index mitotic (compound)
derived experiments (nmod)
one maryland (conj)
caused produced (conj)
hypertension mean (nmod)
removed successfully (advmod)
bortezomib patients (nmod)
associated all (dep)
factors associated (amod)
uiu/ml ) (punct)
report infant (dobj)
non-a due (case)
were implicating (attr)
signaling prolactin (compound)
% 77.4 (nummod)
cardiovascular gastrointestinal (conj)
% significant (dep)
yawning behaviors (nsubj)
cope lead (conj)
correct effect (dobj)
intervals 6-monthly (amod)
seconds twenty (nummod)
mri cerebral (compound)
dependent complement (nmod:npmod)
hemorrhage cranial (amod)
capsaicin % (compound)
resolved finally (advmod)
ovale the (det)
pneumoniae catarrhalis (conj)
six two (conj)
1.0 1.0 (nsubj)
decreases snp (compound)
allele g (compound)
increase relative (amod)
responses evoked (amod)
alterations histopathological (amod)
coma secondary (amod)
recording simultaneous (amod)
measurement symptoms (nmod)
none effects (nmod)
cent micrograms.kg-1.min-1 (appos)
children disorder (nmod)
pharmacology neurobiology (conj)
ear in (case)
disease myocardial (amod)
developed grade (dobj)
less statistically (advmod)
tremors rigidity (conj)
injection insulin (nmod)
college the (det)
activation glial (amod)
sequelae to (case)
thyroxine urine-concentrating (conj)
prompted prolongation (nsubj)
series , (punct)
discontinuous contrast (nmod)
events p<0.001 (appos)
four ) (punct)
fluoxetine desmethylfluoxetine (conj)
experienced while (mark)
conducted was (auxpass)
decrement cin (nmod)
marker may (aux)
combination arag (nmod)
115 228 (dep)
dose precurarization (conj)
effect captopril (nmod)
increase by (case)
flow in (case)
570 +/- (cc)
combining t+pcpa (dobj)
intragastric daily (advmod)
lipophages , (punct)
observed instances (nmod)
admitted administration (nmod)
associated hypertrophy (nmod)
phenothiazines antidepressants (conj)
showed alternation (dobj)
assessment pharmacokinetic/pharmacodynamic (amod)
study patients (nmod)
allowed detection (dobj)
pilsicainide oral (amod)
evaluation cystoscopy (nmod)
response a (nmod)
established methods (dep)
show bronchodilator (ccomp)
reliance the (det)
reduced not (neg)
group pretreated (acl)
control good (amod)
induction anesthesia (nmod)
terms main (amod)
parkinsonism stable (amod)
patients unable (amod)
hag compared (case)
% 8.1 (nummod)
phenyl-2(5h)-furanon ( (punct)
ability effect (nmod)
psychosis levodopa-induced (amod)
levels hbv (compound)
commenced was (auxpass)
tested polysaccharide (dobj)
produced fashion (nmod)
level albumin (compound)
receptor through (case)
infusion 2-h (amod)
cilostazol a (det)
cells tubule (compound)
course pathological (conj)
received fashion (nmod)
donor ( (punct)
1941 between (case)
show failed (ccomp)
achieved yet (advmod)
exposure mptp (compound)
resistance subjects (nmod)
fda ( (punct)
channels sodium (compound)
assessment full (amod)
suggest avoided (conj)
intervals pauses (conj)
doses lower (amod)
reverses suppression (dobj)
arteries large (amod)
reports cases (dobj)
promoted increase (dobj)
mean pgads (nsubj)
began ingestion (nmod)
ritonavir by (case)
asphyxia malformations (conj)
terminated h (nmod:tmod)
ability promote (acl)
superoxide and (cc)
induced , (punct)
resistance an (det)
potential ciprofloxacin (nmod)
inhibition glioma (nmod)
occurred occurred (conj)
bd1063 lr132 (conj)
toxic highly (advmod)
biochemical functional (conj)
later involvement (nmod)
frequency recorded (dep)
motility postprandial (amod)
leading desensitisation (nmod)
choices and (cc)
effective relatively-safe (conj)
difference with (case)
times three (nummod)
taking thyroxine (dobj)
impaired cystitis (nmod)
provide recommendation (dobj)
sites hypothalamic (amod)
constitute complications (nsubj)
treated indomethacin (nmod)
predictors significant (amod)
anemia considers (compound)
thunbergiana , (punct)
suffering 1989 (nmod)
concentrations cibenzoline (nmod)
1.56 , (punct)
motor opposition (compound)
collection urine (nmod)
diagnosis chemotherapy (conj)
% 32 (nummod)
attenuated rigidity (dobj)
reflect effect (dobj)
activation rats (nmod)
hypothesize associated (ccomp)
(+/-)-pg-9 ( (punct)
results enrolled (dep)
epinephrine plus (cc)
methods materials (conj)
adenosine marketed (acl)
involves addition (nmod)
levels levels (conj)
relying heavily (advmod)
attempt about (case)
acids amino (compound)
role mangiferin (nmod)
gm of (case)
associations use (nmod)
seizure tonic-clonic (amod)
participate ratio (dep)
naloxone as (case)
cases hiccups (nmod)
induces paraparesis (dobj)
mass a (det)
decreased mean (dep)
s 228+/-101 (nummod)
available control (nsubj)
differences heart (compound)
post-exposure days (nmod:npmod)
methamphetamine by (case)
disorder that (det)
days successive (amod)
related injury (nsubj)
weeks a (appos)
headache no-induced (amod)
hearts animals (nmod)
achieved ingestion (nmod)
said is (auxpass)
effect exclusion (compound)
thrombophlebitis produced (acl)
accounted age (nmod)
strokes , (punct)
inhibition from (case)
complete ) (punct)
patient received (acl:relcl)
n=8 ( (punct)
occurrence rash (nmod)
responses population (compound)
hepatotoxicity , (punct)
patients diagnoses (nmod)
documents and (cc)
basis area (nmod)
magnitude outcome (conj)
used homozygous (dobj)
four dogs (nmod)
risks benefits (conj)
excreted rats (nsubj)
pipette from (case)
acts parp (nsubj)
given doses (nsubj)
evaluated reactions (dobj)
db by (case)
aggression particularly (advmod)
optimising . (punct)
developed aspiration (nmod)
audiograms netilmicin (conj)
suggested possiblility (dobj)
presenting departments (nmod)
cld electively (advmod)
patients hbv-hiv (compound)
curve time (compound)
properties sotalol (nmod)
novel cage (conj)
reduces frequency (dobj)
reassessment approaches (nmod)
infusions mug (dep)
defect urine (compound)
bilirubin prolongation (conj)
syndrome gerstmann (compound)
show play (ccomp)
important to (mark)
showed have (xcomp)
3 more (advmod)
disclosed microscopy (nsubj)
stopping fluvastatin (dobj)
patient neither (det)
arrhythmia dysfunction (dep)
cent per (case)
cephalothin also (conj)
time concentration (compound)
discontinuous outlining (advcl)
hr controls (nmod)
mg/m2/wk 20 (nummod)
diabetes (stz)-induced (amod)
safe both (nsubj)
patients carriers (acl:relcl)
species activation (conj)
contribution minor (amod)
administered gd (conj)
rate defects (nmod)
magnesium the (det)
patient by (case)
unrecognized pose (conj)
facility a (det)
nuclei auditory (amod)
change cimetidine (nmod)
doses between (case)
cocaine and/or (cc)
diatrizoate ) (punct)
studied correlations (nsubjpass)
progress defects (nsubj)
decreased but (advmod)
comparison ka (nmod)
related be (cop)
activity combination (conj)
guidelines national (amod)
two than (quantmod)
hyperglycinemia nonketotic (amod)
contribute pathways (nmod)
assess polyuria (dobj)
0.95 , (punct)
higher users (nmod)
gram-positive bacteria (dep)
hormones both (det)
levels cyp7a (nmod)
contraindicated isotretinoin (nsubjpass)
cessation sorafenib (nmod)
t+a of (case)
changes disorientation (conj)
strokes bleeding (amod)
d-1 ) (punct)
ensure recovery (dobj)
pparalpha ( (punct)
masson 's (case)
amlodipine with (case)
gabaergic and (cc)
using data (dobj)
clinic out-patient (amod)
md with (case)
tensions tetanic (amod)
manage properly (advmod)
before i.m. (advmod)
issues obvious (amod)
degree appeared (conj)
80mg/kg/day , (punct)
inhibit adequately (advmod)
retard progression (dobj)
rates to (case)
acetrizoate ) (punct)
contraceptive oral (amod)
strains studied (acl)
evidence physiologic (amod)
number behaviors (nmod)
ie , (punct)
rigidity fluctuations (conj)
transplant cardiac (amod)
convulsions mice (nmod)
ml/100 34.3 (compound)
increase in (prep)
exhibited 36 (dep)
demonstrate we (nsubj)
rats saline-treated (amod)
nature lifelong (amod)
acid 13-cis-retinoic (amod)
determined period (nmod)
approaches , (punct)
reverses task (nmod)
components ginseng (nmod)
described primarily (advmod)
reduces suppresses (conj)
7 14 (dep)
overflow of (case)
metrics between (case)
visits 4 (nummod)
% 68.9 (nummod)
r = (dep)
effects verapamil (compound)
po ) (punct)
therapy antihypertensive (amod)
available quinine (nsubj)
agitation severe (amod)
dog agents (nmod)
fraction apap (nmod)
neurotransmission phasic (amod)
inhibited significantly (advmod)
other manifestations (dep)
months was (cop)
biomarkers elevated (amod)
pharmacodynamics tolerability (conj)
darker normal (nmod)
influence and (cc)
dna products (conj)
episodes the (det)
updating memory (compound)
do did (aux)
evaluated rats (nmod)
dose administered (acl)
extract l. (compound)
alterations observed (acl)
untreated if (mark)
cause was (cop)
anesthesia surgery (nmod)
fujimycine fk506 (appos)
induced cp (nsubj)
characteristics vitamin (compound)
nsaid for (case)
effects overall (amod)
9 received (acl:relcl)
thiopental i.v. (compound)
void maximum (conj)
conclusions patients (appos)
em ( (punct)
metabolism detoxification (conj)
significance for (case)
pseudomonas of (case)
mutation gene (nmod)
16 mean (amod)
consider for (mark)
had rhabdomyolysis (dobj)
testing both (conj)
lasted treated (conj)
mg/m2 , (punct)
arrhythmias patients (nmod)
measures , (punct)
curves fragility (compound)
cgi-sf ; (punct)
ob ) (punct)
enhanced reductions (nsubjpass)
targets axons (nmod)
pge2 outer (amod)
assay function (nmod)
cystitis intermediate (amod)
epinephrine intracavernous (amod)
increased area (dobj)
cimetidine iv (dep)
demonstrated ability (dobj)
that eyes (nmod)
preservatives neurotoxic (amod)
involve that (nsubj)
woman epileptic (amod)
hypothermia . (punct)
ratings pain (nmod)
prevented evolution (dobj)
consumers developed (conj)
containing bha (dobj)
iopamidol with (case)
resembled , (punct)
appears case (xcomp)
support doses (conj)
deformations and (cc)
fatal . (punct)
used fenfluramine (dobj)
confirmed results (nsubjpass)
aim determine (dep)
fleming ( (punct)
transformation lymphocyte (compound)
matter disease (nmod)
induced anaesthesia (nsubjpass)
transport during (case)
use contraceptives (nmod)
remaining of (mark)
conditions for (case)
% 1.3 (nummod)
using maintaining (advcl)
terminology the (det)
anesthetics used (acl:relcl)
continued however (advmod)
developed signs (dobj)
affected attention (nmod)
beclomethasone % (appos)
reached not (neg)
depend effect (nsubj)
contraceptives various (amod)
leads nephrotoxicity (nsubj)
presentations eight (nummod)
patients select (amod)
cases controls (conj)
pentoxifylline 0.002 (dep)
rise treatment (nmod)
reduce group (nmod)
protection cs (compound)
reported seizures (dobj)
tuberculosis lung (nmod)
respond often (advmod)
analysis patients (nmod)
isoniazid with (case)
dysfunction myopathy (conj)
infiltrate inflammatory (amod)
products and (cc)
non-significantly ( (punct)
included when (advmod)
mm 19.3 (nummod)
headache a (det)
reproducible not (neg)
lithium to (case)
displacement at (case)
vessels and (cc)
ccr2-labeling populations (nmod)
water degrees (compound)
commonly most (advmod)
dietary and (cc)
coombs direct (amod)
therapy preventing (acl)
narcosis drug-induced (amod)
day in (case)
helpful sodium (nsubj)
s respectively (advmod)
revealed staining (nsubj)
incidence treatment (conj)
decreased mg/dl (nmod)
analysed were (auxpass)
children pretreated (acl)
toxicity agents (nmod)
five ten (conj)
reported believe (ccomp)
extremities in (case)
received setting (nmod)
polyuria lithium-induced (amod)
group 154:64 (appos)
factor should (aux)
tobramycin was (cop)
frequency reversibility (conj)
propranolol low-dose (amod)
head of (case)
mania antidepressant-induced (amod)
reduces increases (advcl)
reductions duration (nmod)
implant or (cc)
mmecs mice (conj)
action striatum (nmod)
pilo ( (punct)
50 more (advmod)
latency ketamine- (nmod)
prior infusion (nmod)
enhanced hippocampal (nsubjpass)
patients 8 (nummod)
pregnancy associated (acl)
neurons nos-immunoreactive (amod)
administered can (aux)
produced seizure (xcomp)
administration mg/kg (appos)
prc of (case)
white gray (conj)
morning normal (amod)
restlessness insomnia (conj)
protein synaptophysin (conj)
failure qrs (nmod)
active moderately (advmod)
use acid (nmod)
cells medullary (amod)
reported that (nsubj)
l-arginine nos (appos)
elevation enzymes (nmod)
pattern alterations (nmod)
findings had (acl:relcl)
pressor and (cc)
manifests poisoning (nsubj)
men received (acl:relcl)
seizures reorganization (conj)
toxicity versus (case)
capsules in (case)
taking lozenge (dobj)
corticosteroids dexamethasone (dep)
calculated means (nmod)
underwent woman (nsubj)
down-regulation desipramine-induced (amod)
suppressants appetite (amod)
diet-fed nd (appos)
inhibit to (mark)
indicate complication (ccomp)
relevance , (punct)
markers post (amod)
attribute may (aux)
structures and (cc)
age 6 (nummod)
mimic that (nsubj)
down-regulation epinephrine-induced (amod)
growth for (case)
project anticonvulsant (compound)
contraceptives combined (amod)
changes the (det)
consisted analyser (nmod)
immunocytochemistry by (case)
mild reversible (conj)
step nephrotoxicity (nmod)
subgroup developed (acl:relcl)
reliable simple (conj)
delirium patient (nmod:poss)
recordings ecg (compound)
tissues cause (acl:relcl)
apparent yet (advmod)
preceded arrest (nmod)
falls if (mark)
nalozone by (case)
restricted is (auxpass)
39.5+/-8.4s duration (nsubj)
severity catecholamines (conj)
diazepam propranolol (nmod)
effects medication (nmod)
respond did (aux)
cancer -- (punct)
nissl-staining , (punct)
occlusion , (punct)
jones and (cc)
postulated exerted (ccomp)
hds ) (punct)
infarction kidney (nmod)
response median (amod)
rate microliters/min (nmod)
version updated (amod)
included studies (dobj)
aim study (dep)
sampling troponin (compound)
leakage epidural (amod)
carbamazepine , (punct)
cancer inoperable (amod)
types to (case)
testing to (case)
had bundle (conj)
1,3-butadiene t(9:22 (conj)
1-receptor chronic (amod)
side-effects loss (conj)
loss potassium (compound)
period total (amod)
population granule (compound)
= 0.0024 (dobj)
pain arthralgia (conj)
interventions affect (acl:relcl)
females low (amod)
consumed licit (ccomp)
evaluated tdp (nsubjpass)
had patients (nmod)
degeneration activation (conj)
induced disorder (nmod)
aminoglycosides all (det)
effect increase (nmod)
explain development (dobj)
had levels (nmod)
affects specifically (advmod)
cause suppression (nsubj)
concentration atp (compound)
was association (attr)
mediated partly (advmod)
dce p.o. (appos)
resurgence background (nsubj)
predicted , (punct)
attributed incorrectly (advmod)
abrogated progression (dobj)
detected consistently (advmod)
prescribed : (punct)
jersey pregnant (amod)
efficiency to (case)
role activation (nmod)
system rat (nmod)
infarction men (nmod)
index activity (compound)
dystrophy , (punct)
motor mental (conj)
factor because (mark)
accounting half (nmod)
lower 15.5 (nmod)
salt cse (appos)
assessed scans (nmod)
c 22 (nummod)
fashion randomized (amod)
treatment health (conj)
ability functional (amod)
distribution due (case)
offers labetalol (nsubj)
sites inhibiting (advcl)
access solution (nmod)
retina and (cc)
report cases (nmod)
t + (cc)
binding clonidine-suppressible (amod)
reactions related (amod)
processes neuropathological (amod)
medications other (amod)
ratio m4/m1 (compound)
reduced allopregnanolone (nsubj)
support infusion (nmod)
anatomical aetiological (conj)
type synthase (nmod)
mechanism dual (amod)
grouped people (nsubjpass)
manifest initially (advmod)
days receiving (advcl)
hypoaidosteronism consequent (amod)
ng/mg prot (amod)
administration injection (nmod)
details mechanistic (amod)
mediated and (cc)
septicemia because (case)
dizziness events (nsubj)
night per (case)
shift manic (amod)
children undergoing (acl)
elevations market (compound)
continued two (nmod)
headache persistent (amod)
safety celecoxib (nmod)
reduced generally (advmod)
administered group (nsubjpass)
184 - (punct)
recommended individuals (nmod)
dyserythropoiesis hemosiderosis (conj)
hepatic neurological (conj)
irritability abc (nmod)
factors syndrome (nmod)
many whom (nmod)
sacrifice mg/kg (dep)
blocked effectively (advmod)
exudate obtained (acl)
abundance nhe3 (nmod)
renin contents (dep)
isomerase a (det)
use year (nmod:poss)
included groups (nsubj)
1 1 (conj)
aracytine-c lymphoma (nmod)
ocs ) (punct)
illness depressive (amod)
protect rats (dobj)
damage microscopy (nmod)
destructive be (cop)
paralysis for (case)
aggravates and (cc)
had hypersensitivity (dobj)
ccl4 and (cc)
one severe (amod)
included pain (dobj)
dox in (case)
increased mean (advcl)
facility aqueous (amod)
negligible was (cop)
output basal (amod)
based diagnoses (nsubjpass)
acid than (case)
hyper- hypotension (conj)
medications patient (nmod:poss)
ischemia myocardial (amod)
receiving part (nmod)
ventricular the (det)
approach shelves (dobj)
catheters the (det)
change ( (punct)
aggravation early (amod)
suggests interaction (dobj)
min succinylcholine (nmod)
estradiol-dependent and (cc)
markers fibrinolysis (compound)
mean auc (dobj)
learning impairment (conj)
implicate not (neg)
performed could (aux)
awake when (advmod)
suffered myalgia (nmod)
physician a (det)
background hydrochloride (appos)
delirium or (cc)
circumstances under (case)
paclitaxel a (det)
rr % (dep)
recommended however (advmod)
indicating relationship (dobj)
defects ( (punct)
killed that (mark)
treated levetiracetam (nmod)
epilepticus rat (nmod)
correlates nystagmus (nsubj)
ducts bile (compound)
experiment doses (conj)
provoked spasm (nsubjpass)
preponderance group (nmod)
march of (case)
observed behaviors (nsubjpass)
monotherapy interferon-alpha (compound)
infections monkeys (nmod)
suited model (nsubj)
illnesses because (case)
activity pathways (nmod)
week one (nummod)
had pg (nsubj)
lymphoma malignant (amod)
lysis erythrocyte (compound)
trimethoprim 266,951 (nummod)
found affected (conj)
programme into (case)
caused glaucoma (nmod)
employed only (advmod)
accuracy and (cc)
injury myocardial (amod)
risk although (mark)
related inversely (advmod)
undergoing after (mark)
produces fsgs (dobj)
reported suggesting (xcomp)
patients 158 (nummod)
stage 3 (nummod)
components chain (compound)
persons risk (nmod)
reverses pretreatment (nsubj)
areas body (compound)
den ) (punct)
il-1b e.g. (advmod)
interrupted and (cc)
serum with (case)
effect observed (acl)
recruited we (nsubj)
patient potassium (compound)
output urine (compound)
time 4 (dep)
map , (punct)
24.3 ci=22.8 (appos)
frequencies the (det)
developed mg (nmod)
suffering erythematosus (nmod)
syndrome long-qt (amod)
seen has (aux)
administration wky (compound)
associated syndrome (dobj)
also favor (nmod)
use counts (conj)
fractures and (cc)
ameliorate impairment (dobj)
capacity exercise (compound)
hemorrhage . (punct)
endophthalmitis alpha-haemolytic (amod)
cacl2 saline (conj)
permeability barrier (nmod)
known inhibitors (nmod)
treatment artesunate (nmod)
returned findings (nsubj)
steroid the (det)
diclofenac naproxen (conj)
50mg/kg by (case)
impairment morphine-induced (amod)
transplantation orthotopic (amod)
biosyntheses rna (compound)
give support (dobj)
fruits terminalia (compound)
atpase sarcoplasmic (amod)
weeks or (cc)
crea > (compound)
disturbances metabolic (amod)
phenomenon and (cc)
values t (compound)
iii/iv encephalopathy (amod)
method naturalistic (amod)
thiols free (amod)
impairment hepatic (amod)
disease lid (dep)
divalproex to (case)
kindling of (case)
induced disparities (nmod)
activity modest (amod)
duration intensity (conj)
rhubarb ( (punct)
growth fetal (amod)
cr to (case)
substitution fully (advmod)
biopsy skin (compound)
studied variety (nmod)
discontinued nephrectomy (dep)
hours transplantation (nmod)
on'- ' (conj)
msg ( (punct)
aphasia , (punct)
flexion . (punct)
tacrolimus from (case)
diabetes both (cc:preconj)
elevation % (nmod)
0.086 +/- (cc)
variety aberrations (nmod)
0.007 p (compound)
calculated using (xcomp)
observed hippocampus (nmod)
saline l-name (conj)
pathways ) (punct)
reactions diagnosis (dep)
patients congolese (amod)
form non-hydrolyzable (amod)
confusion exacerbation (conj)
company ( (punct)
treatment arv (compound)
patients study (nmod)
levels percentage (appos)
toxicities arthralgia (dep)
base lv (compound)
centers referral (compound)
enzyme of (case)
fighting attack (dep)
lowered pressure (dobj)
remained months (nmod)
colitis . (punct)
pretreatment potential (amod)
produced review (nsubj)
contribution presumed (amod)
prevent level (nmod)
catarrhalis ) (punct)
neutrophils with (case)
mg/kg period (nmod)
17 ( (punct)
elicited volunteered (conj)
side-effects no (neg)
aimed here (advmod)
atp ) (punct)
induced exposure (nmod)
associated symptoms (dobj)
remained mg. (nmod)
protocol time (nmod)
occurring naturally (advmod)
acid synthase (compound)
areas 7 (nummod)
nerve femoral (amod)
diminishes impairment (nsubj)
neurons cells (conj)
cromakalim- pinacidil-induced (conj)
increased appears (conj)
alpha beta (conj)
implicated observed (advcl)
was effects (dep)
response a (det)
resolved discontinued (advcl)
hypotension tiva (nmod)
disarrangement damage (conj)
assessed analyses (nmod)
amp ( (punct)
toxicity dfp (compound)
proportions in (case)
amelioration in (case)
summarize to (mark)
underreporting hallucinations (nmod)
disorders heredofamilial (amod)
stable , (punct)
hours challenge (dep)
needs render (xcomp)
microg/kg/min adjusted (conj)
diameters/bw lv (amod)
inhibits reuptake (dobj)
ficoll-hypaque on (case)
retardation growth (compound)
group bupivacaine/placebo (compound)
developed yr (nmod:tmod)
functionality hpa (compound)
list client (compound)
reason period (nmod)
findings utility (conj)
hiccups patient (nmod)
symptoms toxicity (nmod)
osteomyelitis for (case)
effect heart (nmod)
woman using (acl:relcl)
compared toxicity (dobj)
opioid is (cop)
atenolol bpm (conj)
evidence clinical (amod)
purpose the (det)
patients 107 (nummod)
receiving when (advmod)
showed injected (advcl)
inhibit . (punct)
background studied (appos)
quadrant in (case)
trigeminal and (cc)
complained loss (nmod)
conjugation and (cc)
off dbs (nmod)
later months (nmod:npmod)
bioactivation chemical (compound)
clonidine outcomes (nmod)
4.72 - (punct)
slowed . (punct)
magnitude ) (punct)
found absent (parataxis)
administration minutes (conj)
records medical (amod)
influence stronger (amod)
methods molecular (amod)
rose concentration (nsubj)
males models (nmod)
not and (cc)
drug a (det)
undergoing with (mark)
% 51 (nummod)
motor also (advmod)
mice ilk/liver-/- (amod)
tremor in (case)
induction patients (nmod)
patients seizure (compound)
rash such (case)
induced intravesically (advmod)
3tc . (punct)
used hours (nmod)
dysfunction p (dep)
experience se (dobj)
findings showing (acl)
proceeded seizures (nmod)
metabolizer a (det)
level peroxidation (nmod)
difference concentration (nmod)
stimulus pinprick (compound)
cocaine crack (compound)
survival survival (conj)
rhabdomyolysis failure (conj)
developed dystonia (dobj)
points same (amod)
mass portions (conj)
hepatotoxicity no (det)
convulsions mg/kg)-induced (amod)
performed assays (nsubjpass)
lesions thalamic (compound)
been furthermore (advmod)
decreasing significantly (advmod)
degree moderate (amod)
performed users (dep)
subject epilepticus (nmod)
treat hypotension (dobj)
carried . (punct)
eyes eyes (conj)
continued remained (parataxis)
experienced subjects (nsubj)
mediator a (det)
interviewed day (nmod:tmod)
accompanied length (conj)
alternative used (acl)
related not (neg)
profiles determined (acl)
levels totp (nmod)
increases repeatedly (advmod)
proved haemofiltration (nsubj)
acc-9089 ( (punct)
pathology to (case)
retains tamca (nsubj)
induced bupropion (nsubj)
improvement dyskinesia (nmod)
return appetite (amod)
combination oral (amod)
patients lids (nmod)
symptoms dosing (conj)
use general (amod)
effects vertigo (nmod)
mofetil steroids (conj)
dexmedetomidine adrenergic (amod)
develop followed (dep)
investigations prevention (conj)
medication to (mark)
analyzed expression (dobj)
changed hours (nmod)
bergmann 's (case)
risk 1.2 (nummod)
antigen skin (compound)
fiber mossy (compound)
mg/kg/i.v 50 (nummod)
divided n=748 (dep)
block intra-hisian (amod)
di-o-tolylguanidine the (det)
period diurnal (amod)
severity dyskinesia (compound)
action prednisolone (compound)
involved u-ii (nsubjpass)
associated severity (nmod)
purpose for (case)
protects reduces (conj)
glutamine acid (compound)
similar p (dep)
assigned sr (nmod)
control pressure (compound)
variables on (case)
gain gain (dep)
efficacy final (amod)
scale pgads (compound)
maximum a (det)
each to (case)
possibilities these (det)
caused female (nsubj)
nerve velocity (dobj)
fatalities reported (amod)
33342- in (case)
rash % (dep)
mask receptors (nmod)
dose drugs (nmod)
states distress (nmod)
kg-1 2.5 (nummod)
aggravation significant (amod)
characteristic block (nmod)
aminonucleoside puromycin (compound)
used week (nmod)
repeated year (nmod)
behavior episodes (conj)
role supplementation (nmod)
analyses eeg (compound)
neuroimage . (punct)
hypertension diabetes (conj)
reduction severity (nmod)
concealed information (nsubjpass)
administered induce (dep)
patients six (nmod)
time residence (compound)
(1.8)% and (cc)
regained was (auxpass)
measurement interval (nmod)
events drug-related (amod)
diagnosed inadequately (advmod)
monoher doxorubicin (conj)
deficits cholinergic (nmod)
iop and (cc)
1.6 % (compound)
elevated cortex (nmod)
pressure either (cc:preconj)
displayed proteinuria (dobj)
days 260 (nummod)
nausea anxiety (conj)
either for (case)
d1 selective (amod)
case coincided (acl:relcl)
microg/0.5 15 (compound)
found tropicamide (nmod)
consisted was (auxpass)
greater injection (nmod)
questionnaire history (compound)
free is (cop)
determined related (conj)
blocker beta-receptor (compound)
more those (nmod)
flaccidity rats (nmod)
micrograms/kg/hr and (cc)
hiv-negative and (cc)
thickness quadrant (nmod)
accident vascular (amod)
effect lindane (nmod)
years area (appos)
mg/kg groups (nmod)
testosterone mg.kg(-1).d(-1 (appos)
meq/l serum (compound)
gaining fluoxetine (nsubj)
devised we (nsubj)
side-effects . (punct)
dose an (det)
tremor with (case)
hepatitis by (case)
demonstrates observation (nsubj)
correlation interclass (compound)
administration warfarin (compound)
gr microg/side (appos)
received sulfate (dobj)
returned slowly (advmod)
ascites in (case)
readings with (case)
les of (case)
effects aggressiveness (nmod)
infusion cocaine (nmod)
elevating ph (dobj)
mabs of (case)
review chart (compound)
calibration amplitude (compound)
alternation and (cc)
placed segments (nsubjpass)
gyrus medial (amod)
radial sural (conj)
hypokalemia including (case)
centers participating (amod)
eyes six (nummod)
occurred lower (ccomp)
11.5 0.15 (conj)
stab by (case)
population prl (compound)
mumol/kg i.p. (advmod)
hyperactivity cocaine-induced (amod)
measured observers (nmod)
hypothesize . (punct)
compound selectivity (conj)
i.v. (-)-cibenzoline (nmod)
controls response (dobj)
infections and (cc)
interference both (det)
calcium produced (acl)
found are (auxpass)
hypotension (snp)-induced (amod)
pauses of (case)
decreased pressures (nsubj)
extracts plasma (compound)
anaesthesia epidural (amod)
pain during (case)
women younger (amod)
considered use (nsubjpass)
scale 100 (appos)
range were (cop)
march until (case)
switched schizophrenic (nmod)
defined decrease (nmod)
patients thrombosis (nmod)
reduced however (advmod)
infusions neurotensin (nmod)
pathology muscle (compound)
interaction processes (nmod)
7-ethoxyresorufin-o-deethylase p450 (compound)
hoehn on (case)
electroretinograms and (cc)
angiotensinogen mediated (acl)
demonstrate relationship (dobj)
leading discovery (nmod)
detection toxicity (nmod)
using receptor (dobj)
onset sudden (amod)
had thrombosis (dobj)
trimethoprim negative (conj)
modulation by (case)
parts animals (nmod)
iu/l respectively (advmod)
therapeutic doxorubicin (nsubj)
used method (nsubjpass)
20 less (advmod)
inhibitor factors (nmod)
thereafter range (compound)
sectioned were (auxpass)
infusion sodium (compound)
monolayers on (case)
inhibitor , (punct)
evaluated idraparinux (nsubjpass)
cannulae shell (nmod)
showed efficiency (dobj)
testing diagnostic (nmod)
preserve kidney (nmod)
performed made (conj)
drugs class (compound)
lots products (nmod)
improves scopolamine-induced (xcomp)
sites binding (compound)
seems . (punct)
permits if (mark)
higher those (advcl)
14 - (punct)
265.2 x (cc)
injection intracarotid (compound)
alleviate content (nsubj)
hemodynamics systemic (amod)
confined may (aux)
output triglyceride (nmod)
have myositis (dobj)
frey von (compound)
synthesis to (case)
fetus the (det)
patient hypoparathyroidism (nmod)
improved subscores (nsubj)
reproducible reliable (conj)
prolonged those (nsubj)
dose initial (amod)
ranged spectrum (nsubj)
testing repeat (compound)
reduction nephrotoxicity (nmod)
acetaminophen resultant (conj)
responses caffeine (nmod)
probable highly (advmod)
mice gfp (compound)
hemodialysis by (case)
impair recovery (dobj)
lowered . (punct)
lca at (case)
repeated prescription (nsubjpass)
addition following (case)
association consumption (nmod)
examined weeks (nmod)
drug cardioversion (nmod)
agonist alpha1-adrenoceptor (amod)
rare serious (conj)
goal less (amod)
effective very (advmod)
withdrawal social (amod)
baseline ; (punct)
innervation neurotensinergic (amod)
blockade cycle (compound)
exercised mph (nmod)
people from (case)
known were (auxpass)
week(-1 mg (nummod)
np ) (punct)
cells renal (amod)
drawback the (det)
assessed respectively (advmod)
ciba , (punct)
5,7-dht ) (punct)
atpase na+/k+ (compound)
lacn the (det)
suggestive relation (nsubj)
hour over (case)
december october (conj)
used iodixanol (nsubjpass)
illustrate conclusion (nmod)
measured step (nmod)
methods interviewed (appos)
lymphoma non-hodgkin (nmod:poss)
patients 98 (nummod)
tingling mouth (nmod)
drugs substituted (amod)
targets that (nsubj)
able pregs (nsubj)
trajectory along (case)
besylate associated (conj)
pain venous (amod)
100 greater (advmod)
2.7 3.8 (conj)
vomiting fever (conj)
g/dl 3.2 (nummod)
% 12.6 (nummod)
oct ( (punct)
compared effect (nsubjpass)
hcl progesterone (compound)
decrease rate (dobj)
studies single (amod)
placebo % (conj)
evidence little (amod)
participation species (nmod)
symptoms changes (nmod)
randomized this (det)
stimulated research (dobj)
patients eighty (nummod)
months range (dep)
shedding , (punct)
indicated trials (nmod)
groups received (acl:relcl)
renal with (case)
differences may (aux)
inhibited induce (conj)
motility symptoms (conj)
weakness vasospasm (nmod)
calculated follow-up (conj)
deletion subtypes (nmod)
patients sedated (amod)
supposed it (nsubjpass)
doxorubicin either (det)
permitted acetate (nsubj)
screened we (nsubj)
subjected , (punct)
stenosis without (case)
toxicity . (punct)
neurons cerebellum (nmod)
effects flow (nmod)
k(+)-channels of (case)
background rate (dep)
role epileptogenesis (nmod)
gamma-carboxylation protein (nmod)
meta-analysis patients (appos)
attended participants (nsubj)
variety with (case)
% 8 (nummod)
reached significance (dobj)
pnd71 on (case)
acute nephrotoxicity (dep)
% 84.79 (nummod)
diltiazem ng/ml (appos)
most patients (nmod)
measured study (nmod)
ketoconazole mg (amod)
mg/kg , (punct)
needed explore (xcomp)
cells mc-ixc (compound)
anesthetic a (det)
spite surgery (nmod)
those nifedipine (nmod)
7 treatment (nmod)
decreased then (advmod)
resolution the (det)
severe episode (nsubj)
tumor : (punct)
exceeded whom (nmod)
x-rays fraction (conj)
role possible (amod)
echocardiography contrast (compound)
methamphetamine map (appos)
warfarin between (case)
segments non-cacl(2)-treated (amod)
ribs wavy (amod)
anxioselective of (case)
smaller majority (nsubj)
small rich (conj)
dox : (punct)
feeding following (case)
displace right (nmod)
noted sequelae (nsubjpass)
month first (amod)
evaluation neurological (amod)
nitrendipine the (det)
cbd 60.44 (dep)
artery coronary (conj)
blockade of (case)
chewing in (case)
hour or (cc)
improvement damage (nmod)
object the (det)
appeared schedule (nmod)
inhibitor nitric (amod)
disposition . (punct)
severity stenosis (nmod)
hemorrhage in (case)
concentrations weight (conj)
controlling dyskinesias (dobj)
epirubicin , (punct)
fetuses the (det)
greater 1.041 (dep)
appears method (xcomp)
unaffected and (cc)
e1-induced prostaglandin (nmod:npmod)
administration anti-inflammatory (conj)
checklist and (cc)
polymerase dnap (appos)
shedding serological (conj)
s was (cop)
report levofloxacin (conj)
36 pituitaries (nmod)
worsened toxicity (dobj)
vt refractory (amod)
0.2 or (cc)
doses agents (nmod)
values these (det)
1-infected virus (nmod:npmod)
reprogramming imparts (ccomp)
injections multiple (amod)
exhibits that (nsubj)
drugs demonstrate (acl:relcl)
= 0.022 (dobj)
major intracranial (conj)
adr(6 and (cc)
treated should (aux)
implications use (nmod)
f remained (conj)
function inhibitor (nmod)
demonstrates study (nsubj)
differences series (nmod)
trial/day ( (punct)
useful would (aux)
g/day 12 (nummod)
occasions different (amod)
given only (advmod)
reducing cardiotoxicity (dobj)
levels 4-ene-vpa (nmod)
occlusion transient (amod)
noted changes (nsubjpass)
reported 3 (dep)
suramin and (cc)
convulsant doses (dep)
att-alf ) (punct)
cancers or (cc)
logical difficult (advcl)
discount . (punct)
mediates infiltration (dobj)
linked and (cc)
arag/vp/cpm of (case)
irrigation bladder (compound)
nifedipine when (advmod)
were required (conj)
fibroblasts from (case)
blood database (conj)
alkaloid quinidine (nmod)
grade age (conj)
registered august (nmod:tmod)
low been (cop)
doxorubicin doxorubicinol (conj)
pressure on (case)
adherence an (det)
cases allergy (nmod)
monitoring intervals (nmod)
verapamil . (punct)
threshold mechanical (amod)
predose postdose (conj)
achieved mice (nmod)
experienced syndrome (dobj)
manifestations cardiotoxicity (nmod)
zidovudine component (compound)
hypertension mmhg (dep)
rats weeks (conj)
p<.001 ; (punct)
site mediated (conj)
exposed diazinon (nmod)
indicating sensitive (ccomp)
dipropionate beclomethasone (compound)
pseudoprolactinoma hyperprolactinemia (conj)
mexiletine international (amod)
bdl and (cc)
origin the (det)
range patients (nsubj)
involving total (dobj)
indicated interruption (nsubjpass)
demonstrated colocalized (ccomp)
published been (auxpass)
exists correlation (nsubj)
syndrome dilated (conj)
explored studies (nsubj)
hypertension portal (amod)
clinical poor (amod)
high- in (case)
monitor , (punct)
option also (advmod)
neonates of (case)
noxious mildly (advmod)
iu/l 134 (nummod)
1998 ( (punct)
controlling pain (dobj)
received areas (nmod)
therapy hydrochlorothiazide-triamterene (compound)
appearances histologic (amod)
content glomerular (amod)
needed and (cc)
5th cause (appos)
received mice (nsubj)
jerks 73 (nummod)
moving were (aux)
before weeks (nmod:npmod)
brainstem ambient (dep)
= 14 (dep)
active when (advmod)
achieved target (dobj)
vomitus , (punct)
protein 1 (nummod)
underwent treated (conj)
arrested that (nsubj)
outcomes , (punct)
rejection antibody-mediated (amod)
decreased hypotension (nmod)
exist relationship (nmod)
had mutation (dobj)
= 12 (dep)
evidence fibrosis (nmod)
strains these (det)
filariasis loa (amod)
observed cells (nmod)
resolved but (cc)
given doxorubicin (nmod)
hormone hormone (conj)
predisposed acidosis (dobj)
rechallenged seven (nsubjpass)
increased greater (advcl)
identified countries (nmod)
dexamethasone combination (nmod)
increased follow-up (nmod)
greater group (conj)
reversal rate (nmod)
surgery by (case)
consider to (mark)
reduced levels (dobj)
infusion exercise (conj)
increase mean (amod)
aggravation generation (conj)
prevents curcumin (nsubj)
role oxide (nmod)
engendered interest (dobj)
development esrd (nmod)
examined rat (nmod)
anticipated as (mark)
reversal tetany (nmod)
administered evoke (advcl)
mg 25 (nummod)
gvhd chronic (amod)
10mg/kg ) (punct)
days nine (nummod)
include as (mark)
period a (det)
nhe3 bsc-1 (conj)
criteria 1990 (nummod)
sensory sensori-motor (conj)
asthma in (case)
therapy this (det)
anf only (advmod)
withdrawal nicergoline (nmod)
minutes [ (punct)
trough tacrolimus (compound)
lymphocytes damage (nmod)
related therapy (nmod)
documentation . (punct)
initiate prolongation (nmod)
palpitation and (cc)
associated sph (nmod)
period 6-h (amod)
estimated 170 (advcl)
expected influence (ccomp)
starting minutes (dobj)
were numbers (conj)
containing bicuculline (dobj)
examined recovery (nmod)
agonist nonselective (amod)
speed thp (conj)
increased accuracy (nsubj)
antagonists other (amod)
used determining (advcl)
scheduled was (auxpass)
prevented 35 (nmod)
trihexyphenidyl placebo (conj)
reaching culminating (conj)
trials medline (conj)
more fold (nmod:npmod)
report bradycardia (dobj)
stable treated (conj)
patients cleared (acl:relcl)
cisplatin mg/kg (appos)
expected moreover (advmod)
monitoring daily (amod)
second on (case)
man user (appos)
0.6 whereas (dep)
differentiation in (case)
adenoma of (case)
exposure heat (compound)
volunteer a (det)
type alzheimer (nmod:poss)
165/90 ) (punct)
help might (aux)
agent angiography (nmod)
drowsiness of (case)
pseudomonas receiving (compound)
ratios hazard (amod)
convulsant endogenous (amod)
2.8 15.6 (compound)
the gaba(a (dep)
blocking , (punct)
or p=0.33 (dep)
observations based (case)
(-)-propranolol by (case)
induce why (advmod)
manifestations characteristic (amod)
mesna , (punct)
8 more (amod)
accounted be (auxpass)
approach youth (nmod)
biopsy patient (nmod)
children 1-infected (amod)
release possibly (advmod)
toxicities grade (compound)
numbers of (case)
ml/min 0.69 (nummod)
gamma-hexachlorocyclohexane ingredient (appos)
cigarettes 10 (nummod)
piperacillin/tazobactam of (case)
occurred reaching (xcomp)
% 0.01 (compound)
necrosis resulted (acl:relcl)
neurons from (case)
severity fasciculations (nmod)
drug anticholinesterase (compound)
myelosuppression cardiac (conj)
testing urine (compound)
compound d-penicillamine (compound)
inappropriate . (punct)
recommenced was (auxpass)
degree with (case)
events other (amod)
included grade (dobj)
cholestasis prolonged (amod)
woman this (det)
have men (nsubj)
consumed , (punct)
had developing (advcl)
8-week multicenter (conj)
mortality on (case)
group m (compound)
was time (nsubj)
1500 300 (compound)
dilatation lumens (nmod)
appear : (punct)
transporter metabolized (acl:relcl)
rare a (det)
aml = (dep)
substantial not (neg)
induced reduced (conj)
greater increasing (advcl)
biochemical the (det)
ximelagatran inhibitor (appos)
61 +/- (cc)
demonstrated binding (nsubjpass)
administered ear (nmod)
segments ( (punct)
densa throughout (case)
tumors of (case)
ingredient . (punct)
release and (cc)
life convulsions (nmod)
referrals of (case)
units eu (appos)
nerve distal (amod)
induced cpa (nmod)
vasculitis vessel (compound)
confusion activity (nmod)
randomized patients (nsubjpass)
patterns . (punct)
valsartan or (cc)
processes with (case)
females from (case)
time plasma (dep)
16;567 monocular (advmod)
cases reporting (acl)
factors contributing (amod)
regarded be (auxpass)
p>0.05 ( (punct)
monotherapy after (case)
pfss ) (punct)
excess catecholamines (nmod)
presumed ; (punct)
tomography photon (compound)
dxr ) (punct)
associated cpa/ee (nmod)
reduced viability (dobj)
cage test (compound)
hypothyroidism patient (nmod)
effects bromide (nmod)
help clarify (xcomp)
tachycardia isoproterenol (amod)
anomaly valve (nmod)
has considered (xcomp)
drug zonisamide (nsubj)
cutaneous respiratory (conj)
subset in (case)
amca ( (punct)
criteria the (det)
km higher (appos)
diagnosis hyperplasia (nmod)
physiology susceptibility (conj)
appeared kanamycin (nsubj)
pregnancies therapy (nmod)
made acid (nmod)
alternations the (det)
cocaine 48 (nummod)
neurons on (case)
background minimize (dep)
inhibition mk-486 (nmod)
volunteers female (amod)
median ) (punct)
patient an (det)
bepridil , (punct)
post-scr mean (compound)
decreased u/ml (nmod)
lysozyme egg-white (amod)
reactions other (amod)
administration over (case)
components fast-moving (amod)
studied relation (nmod)
dose glycopyrronium (nmod)
mechanism significance (conj)
indomethacin or (cc)
determine inhibited (ccomp)
men 28 (nummod)
mmol 276 (nummod)
suggested diagnosis (nsubjpass)
transporter dopamine (compound)
had children (conj)
edema striatum (nmod)
associations pollutants (nmod)
used days (dobj)
saralasin of (case)
glutamate ) (punct)
value normal (amod)
intervention . (punct)
patients subsequently (advmod)
changes pyknotic (amod)
globulin transplantation (nmod)
risk poor (amod)
reduction 2 (dep)
cardiomyocytes human-induced (amod)
effects artery (nmod)
well-tolerated , (punct)
protein ) (punct)
undergone patients (nsubj)
cta either (cc:preconj)
actions study (nmod)
0.001 < (dep)
incidence akathisia (nmod)
system central (amod)
3.7 x (cc)
greater pigs (nmod)
reading central (amod)
discontinuation hyperkalemia (nmod)
related pain (nsubj)
permitted . (punct)
homozygous cholinesterase (nmod)
effect injection (nsubj)
occur syndrome (nsubj)
off and (cc)
monitoring study (dep)
hypotension enhanced (amod)
revealed loss (dobj)
area fractional (amod)
caudate nuclei (dep)
acidification by (case)
using . (punct)
investigate levels (dobj)
ts ) (punct)
investigate influence (dobj)
episodes syncope (nmod)
increased remained (conj)
grade p=0.01 (appos)
reflexes micturition (compound)
hemodynamic echocardiographic (conj)
efficacy placebo (conj)
preserved potentiation (nsubjpass)
determined concentration (nsubjpass)
resulted adjustment (nmod)
diagnosed atherosclerosis (nsubjpass)
% 22.5 (nummod)
behaviors associated (acl)
inactive while (mark)
recovers , (punct)
suggest sufficient (ccomp)
administering when (advmod)
suspension powder (nmod)
drug which (nsubj)
toxicity nonhematological (amod)
increased metoprolol (nsubj)
rate 2-year (amod)
positive in (case)
calculated methodology (nsubjpass)
halos or (cc)
shorter . (punct)
spectra frequency (compound)
deterioration sudden (amod)
states throughout (case)
na-k-atpase of (case)
effects depression (nmod)
prevented toxicity (nsubjpass)
reached levels (nsubj)
have action (dobj)
activities levels (conj)
unlikely therapy (nsubj)
microg/kg remifentanil (compound)
consists nephropathy (nsubj)
lower number (nsubj)
peptide cnp (appos)
deficit selective (amod)
clearance decreased (amod)
result improvement (nsubj)
iron excessive (amod)
edema of (case)
presence stenosis (nmod)
methamphetamine , (punct)
measure(s main (compound)
remained under (advmod)
rbcs to (case)
equilibrate that (mark)
work-up laboratory (nsubj)
initiation metformin (nmod)
addition adenosine (nmod)
analyses . (punct)
administration tropicamide (nmod)
teratogenic compounds (advcl)
form point (nmod)
patients stenosis (dep)
extracted , (punct)
points study (compound)
increased cromakalim (nsubj)
night between (case)
abnormalities wave (compound)
rats those (nmod)
elevated users (nsubj)
mm hg (dobj)
shortening of (case)
daily twice (advmod)
filters ( (punct)
outcome unfavorable (amod)
questionnaires postal (amod)
persisting despite (mark)
headache attributed (acl)
experiments cardioprotective (amod)
enteropathica for (case)
thromboembolic . (punct)
occurred illness (nsubj)
transmission serotoninergic (compound)
model catalepsy (compound)
teratogenic to (mark)
estimate grams (nmod)
type to (case)
mg/week 0.09 (nummod)
amisulpride- tiapride-induced (conj)
blunted but (cc)
facial extremity (conj)
history pain (nmod)
cell visceral (amod)
related fbal (nsubj)
score of (case)
active-w prevention (nmod)
reduced cd-832 (nsubj)
causes contrary (nmod)
developed attack (dobj)
normal withdrawal (nmod)
h1- h2-histamine (conj)
to ' (punct)
reverse block (dobj)
fever from (case)
evoked seizures (dobj)
acrolein toxic (amod)
28.0 from (case)
dysfunction puromycin (compound)
patients comparison (compound)
structure hepatocyte (compound)
need drug (nmod)
normal but (cc)
patients retinochoroidopathy (amod)
engaged synthesis (nmod)
vasopressin control (nmod)
leucovorin together (advmod)
induce does (aux)
demonstrates potential (dobj)
controlled , (punct)
25 and (cc)
density vessels (nmod)
ndi lithium-induced (amod)
cycle patient (nmod)
crf no (neg)
hours mg/m2/24 (compound)
psychosis treatment (nmod)
involvement tachykinins (nmod)
ester 2-(diethylamino)ethyl (nummod)
disability because (case)
evaluated using (advcl)
dep ) (punct)
assessed stress (nsubjpass)
effect methoxamine (nmod)
consistent hypothesis (nmod)
ts ( (punct)
injury kidney (nmod)
observations some (det)
defined function (nsubjpass)
found dothiepin (nsubjpass)
mcg/kg min (compound)
indicate memory (dobj)
predisposes obstruction (nmod)
included symptoms (nsubj)
tests include (acl:relcl)
arteries in (case)
administered medication (nsubjpass)
times day (nmod)
change activity (dobj)
cpb ( (punct)
protected days (nmod:tmod)
defined experience (nmod)
duration together (advmod)
score with (case)
dose 10-min (amod)
capsaicin-untreated control (conj)
met stimulation (nsubj)
users repeat (compound)
found specimens (conj)
markers in (case)
carefully very (advmod)
decreased values (nsubj)
actions hypotensive (amod)
sign the (det)
sodium handling (conj)
damage species (conj)
exchange with (nmod)
scores child-pugh (amod)
criteria ck-mb (compound)
valvulopathy defined (conj)
patients allergic (amod)
resuscitation cpr (appos)
= b (nsubj)
trend with (case)
limit detection (nmod)
biomarkers protein (compound)
selectivity their (nmod:poss)
involvement cranial-nerve (amod)
manifestations neurological (amod)
epithelium such (case)
pressures arterial (amod)
precipitate hypertension (dobj)
depletes p300 (dobj)
cells unlike (case)
paralysis produced (acl)
associated publications (nmod)
muscles with (case)
dihydropyridine the (det)
assessed variations (nsubjpass)
pseudoprolactinoma not (neg)
effect known (amod)
areas cortex (nmod)
reduction as (cc)
improve will (aux)
least at (advmod)
rating with (mark)
cardiotoxicity preserved (conj)
inconclusive . (punct)
necrosis such (case)
71.3 9.6 (conj)
months 6-thioguanine (nmod)
chemotherapy doxorubicin-based (amod)
changes eeg (compound)
patients tests (appos)
involvement cardiac (amod)
evidence angiographic (amod)
arthralgia and (cc)
tjs in (case)
stimulation methoxamine (nmod)
transported is (auxpass)
performed been (auxpass)
mmps ( (punct)
observed transporter (nmod)
exception ( (punct)
antiviral earlier (advmod)
sensitivity vision (conj)
suspicions all (det)
care hospital (compound)
included cases (dobj)
emerged convulsions (nsubj)
reviewed information (nsubjpass)
differed olanzapine (conj)
patients examined (acl)
apex hyperdynamic (amod)
compare rates (dobj)
identified mice (nmod)
macrolide with (case)
recovers recording (conj)
complex immune (amod)
layer of (case)
increase 9-months (nmod)
results study (nmod)
addition effects (nmod)
induced ) (punct)
displayed and (cc)
neurotoxicity nephrotoxicity (conj)
binding d1 (nmod)
monitoring cyclophosphamide (nmod)
[ca]o of (case)
patient treated (acl:relcl)
seen iridocyclitis (nsubjpass)
developing grade (dobj)
vasculitis of (case)
high was (cop)
agonist ii (nummod)
cardiac prior (advmod)
assessed reversal (conj)
administration syndrome (conj)
noted association (nsubjpass)
proteinuria reduced (amod)
disease after (case)
conducted trial (dobj)
raised biomarkers (dobj)
tg haart (conj)
sedated were (auxpass)
represses that (nsubj)
changes concentrations (nmod)
using plate (dobj)
encephalopathy normoammonemic (amod)
solution eyes (nmod)
factors to (mark)
result interaction (nmod)
reactions these (det)
static dynamic (conj)
circulation ocular (amod)
saline kg-1 (dep)
splenic and (cc)
opposed as (mark)
opsonized serum (nmod)
documented vasculitis (nsubjpass)
amines brain (compound)
prevented d (nmod)
rates disorders (nmod)
appeared which (nsubj)
cured improved (conj)
set the (det)
activity antihuman (compound)
causes major (amod)
concentrations free-calcium (compound)
planned has (aux)
reduced . (punct)
confusion status (conj)
marker ) (punct)
serious are (cop)
inhibits . (punct)
methods mg/kg (dep)
beta-blocker atenolol (nmod)
% 75 (nummod)
pressure greater (amod)
receptors spinal (amod)
% 5.5 (nummod)
overdose captopril (compound)
resulted although (mark)
symptoms erythematodes (nmod)
subgroups several (amod)
hyper- and (cc)
scheduled reported (conj)
dosages even (advmod)
3.0 and (cc)
few only (advmod)
5 pituitaries (nmod)
studies dealing (acl)
lower theophylline (nmod)
methods 3-methyladenine (appos)
levels onset (conj)
ocd ( (punct)
decrease as (advmod)
hypotension rats (nmod)
determine is (ccomp)
mg/day 1200 (nummod)
effect cardiotoxicity (nmod)
discount mechanism (nmod)
neurotoxicity pruritus (conj)
pre-treatment metformin (nmod)
predispose that (mark)
increases that (nsubj)
deterioration severe (amod)
responses rate (nmod)
seizures symptoms (conj)
cas ] (punct)
considered mm (dep)
mg/kg pg-9 (compound)
reductions similar (amod)
pallidus of (case)
sensitized stress (dep)
mapping css (compound)
involvement attributable (amod)
children thirty-three (nummod)
antidepressant the (det)
studies relationship (nmod)
% dose (nmod)
electrolytes serum (compound)
oct humphrey-zeiss (amod)
action cytostatic (amod)
rate acid (nmod)
vocabulary design (nmod)
performance . (punct)
substrate liver (nmod)
normal revealed (conj)
dissociation ( (punct)
dosage g (conj)
regarded while (mark)
divided groups (nsubjpass)
episodes tachyarrhythmia (nmod)
amide by (case)
syndrome drug-related (amod)
assess effectiveness (dobj)
rate case-fatality (compound)
properties cocaine (nmod)
use ifosfamide (nmod)
elements common (amod)
injections space (nmod)
59 to (quantmod)
administered cna (nsubjpass)
damage hypersensitivity (nmod)
cautious should (aux)
teratogenic were (cop)
wt 0.28 (conj)
status socio-economic (amod)
protector ototoxicity (nmod)
toxicity synaptic (amod)
mg/kg 21 (nummod)
90 to (dep)
prescribed cisapride (nsubjpass)
appears , (punct)
history rhinitis (nmod)
undergone procedures (dobj)
t+a ( (punct)
long-term the (det)
unnecessary ; (punct)
different quit (advcl)
microscopic morphometric (conj)
% 2 (compound)
0.675 to (dep)
arrhythmia digitalis-induced (amod)
weight renin (conj)
mediated secretion (nmod)
diminished disappearance (nsubjpass)
operated on (compound:prt)
cpap cm (amod)
status health (compound)
contributed patients (nmod)
persisted degree (nmod)
continued to (mark)
phosphate bis(p-nitrophenyl (compound)
following administration (dobj)
bacteremia for (case)
binding [3h]sch (compound)
administration naloxone (nmod)
combining examination (dobj)
polypeptide of (case)
introduction by (case)
variability , (punct)
syndrome chlorpromazine-induced (amod)
rhabdomyolysis previously (advmod)
conclusions demonstrates (appos)
kg ( (punct)
difficulties dialysis (nmod)
fluoxetine ssri (compound)
greater this (nsubj)
requiring use (dobj)
feet and (cc)
beraprost novel (amod)
morphine morphiceptin (conj)
data and (cc)
ipsilateral more (advmod)
taking bromocriptine (dobj)
microcrystals cholesterol (compound)
toxicity to (case)
1.65 +/- (cc)
accuracy to (case)
vulnerability particular (amod)
57 85 (prep)
variety disturbances (nmod)
supply vs. (cc)
faced when (advmod)
diseases several (amod)
calcium alkali (conj)
decrease together (advmod)
proven or (cc)
treated whom (nmod)
use pill (compound)
titrated could (aux)
symptoms severe (amod)
increases ppa (nsubj)
risperidone after (case)
urinalysis volume (dep)
units/l 500 (nummod)
proliferation pulmonary (amod)
effects piloerection (nmod)
ke 0.15+/-0.03/h (dep)
12 through (case)
introduced doses (nmod)
lasting months (nmod)
used animals (nsubjpass)
tone parasympathetic (amod)
20 nearly (advmod)
factor basic (amod)
enos peptide (dep)
patients cocaine-abusing (amod)
dose level (conj)
val204asp mutation (compound)
complications bleeding (amod)
observed behavior (nsubj)
provoke proteinuria (dobj)
treatment subcutaneous (amod)
areas glomeruli (nmod)
formed rats (dep)
0.0010 from (case)
trials iii (nummod)
ros of (case)
protective cse (nsubj)
diameter needle (nmod)
induces correlation (dep)
isolated microglobulinuria (dobj)
treated nanoparticles (nmod)
eosinophilia nephritis (conj)
adjust doses (dobj)
intravenous oral (conj)
valdecoxib nsaids (conj)
concentrations mannitol (compound)
hypertension deficient (amod)
causes abuse (nsubj)
tarsorrhaphy lateral (amod)
hz difference (appos)
activity during (case)
epidemiology syndrome (nmod)
response discrete (amod)
associated selegiline (nsubjpass)
conditions depletions (nmod)
associated intake (nmod)
institution delayed (amod)
speed on (case)
afternoon in (case)
incapacitated not (neg)
differ scores (nmod)
revealed infiltration (dobj)
primary and (cc)
inhibitors introduction (nsubj)
genes coxiv (compound)
ill seriously (advmod)
status study (compound)
given developed (conj)
changes power (nmod)
stabilized but (cc)
cardiomyopathy doxorubicin-induced (amod)
mm baseline (dep)
infection and (cc)
rise to (mark)
rates underlying (amod)
admitted failure (nmod)
lesions medullas (conj)
doses higher (amod)
disrupts function (dobj)
correlation dose-effect (amod)
needed delineate (xcomp)
advised that (mark)
pressure mmhg (appos)
human murine (conj)
pediatrics in (case)
softening skin (compound)
interaction is (cop)
ischemia factors (conj)
histology ) (punct)
t(9:22 requisite (amod)
beneficial be (cop)
solution , (punct)
epsilon4 apoe (compound)
secretion [14c]biliary (amod)
cream agent (appos)
associated sirolimus (nsubjpass)
values aminotransferase (compound)
densa ( (punct)
able dose (nsubj)
ampicillin with (case)
interfered sympathectomy (nmod)
valproate lamotrigine (conj)
outpatients psychiatric (amod)
migraine no (det)
paralysis periodic (amod)
operated interna (nmod)
> = (conj)
creatinine ] (punct)
taking also (advmod)
clonidine used (acl)
free year (nmod)
mbc ( (punct)
challenge study (nsubj)
assessed be (auxpass)
monitoring transition (dobj)
reduces action (nsubj)
use sedatives (nmod)
call and (cc)
prevent methods (nsubj)
recognized delirium (nsubjpass)
solution ophthalmic (amod)
measured substances (nsubjpass)
perfusion bepridil (nmod)
target rapamycin (nmod)
matched age (nmod)
increase adolescents (nmod)
alpha with (case)
dynamics doses (conj)
regimens than (case)
referred department (nmod)
periods epileptiform (compound)
gram-positive atypical (conj)
died contrast (nmod)
3.6 0.7 (conj)
peptide brain-gut (amod)
desire criteria (nsubj)
staining prl (compound)
hypertension the (det)
caused blockers (nmod)
echocardiography cross-sectional (amod)
showed correlation (dobj)
consequence were (cop)
returned interval (nsubj)
risk ) (punct)
acquire to (mark)
trial in (case)
block , (punct)
had believe (conj)
box exploratory (amod)
rapamycin ( (punct)
improvement an (det)
given haloperidol (nsubjpass)
developed injected (advcl)
very-low-birth-weight in (case)
drinkers enrolled (acl:relcl)
amlodipine for (case)
conclusion presents (appos)
extent exact (amod)
disorder neurodevelopmental (amod)
day this (det)
sensation altered (amod)
antibiotic the (det)
account effects (nmod)
toxicities prominent (amod)
aaph by (case)
decreasing effect (dobj)
consolidation to (case)
streptozocin stz (appos)
comparable were (cop)
converted treatment (nsubjpass)
cgi-sf ) (punct)
able trinitrate (nsubj)
survived all (nsubj)
prostigmine mg (compound)
efficacious concerns (nmod)
transducer apoptotic (conj)
observed mitochondria (nmod)
clinically and (cc)
6 died (acl:relcl)
prevented min (nmod)
observed had (parataxis)
analysis stepwise (compound)
not after (mark)
years 18 (nummod)
population an (det)
mea onto (case)
paid attention (nsubjpass)
activities esterase (nsubj)
acetyltransferase , (punct)
cisternae reticulum (conj)
risk cataracts (nmod)
had weeks (nmod)
explained had (advcl)
lesions target (nmod:poss)
causes identified (conj)
interferes that (nsubj)
damage cortex (nmod)
extract fraction (compound)
tacrolimus receiving (compound)
sensation of (case)
15.0 from (case)
describes remission (nmod)
lvef mbp (conj)
oral mucosa (dep)
exposure early-life (compound)
ifx ( (punct)
population cell (compound)
had factors (dobj)
treated tachycardia (nsubjpass)
compliance his (nmod:poss)
effective superior (conj)
heterogeneity erp (compound)
s-1 ( (punct)
grade were (cop)
studied doses (nmod)
pg/ml pg/ml (dep)
effect rates (nmod)
initiation the (det)
headache one (nmod)
had , (punct)
conjunction corticosteroids (nmod)
hematotoxicity man (nmod)
livers pregnant (amod)
concluded relieve (ccomp)
drug-adsorption and (cc)
reactions antibiotics (nmod)
samples cimetidine (compound)
nicotine injected (amod)
dosing different (amod)
administered centrally (advmod)
shortening segmental (amod)
damage papillary (amod)
consider we (nsubj)
ace ) (punct)
fzp between (case)
% anaemia (compound)
dog the (det)
blockers other (amod)
effects aniracetam (nmod)
revealed stain (xcomp)
incidence neuropathy (nmod)
preserves flow (dobj)
persisted patient (nmod)
appear and (cc)
nightmares intake (nmod)
obesity rats (nmod)
factors lt (nmod)
headache % (conj)
pathogenesis disorders (nmod)
strategy high-dose (amod)
transfusion therapies (conj)
long-term cardiac (dep)
occluded , (punct)
prophylaxis in (case)
hepatotoxicity cross (compound)
lozenge , (punct)
groups % (dep)
morphology heart (compound)
appears which (nsubj)
most for (case)
life-threatening taking (advcl)
admitted been (auxpass)
women as (case)
myopathy triceps (nmod)
arytenoid the (det)
hypothesis explain (acl)
cause drug (nsubj)
character pain (compound)
acute multiple (conj)
study no (neg)
amplitudes of (case)
bilirubin an (det)
introduction . (punct)
200mgkg(-1 ) (punct)
sections microscopy (nmod)
evoked and (cc)
mmt ] (punct)
bau ( (punct)
hospital of (case)
pms five (nummod)
route , (punct)
differ respects (nmod)
lead and (cc)
patient polymyositis (nmod)
factors susceptibility (compound)
began consisted (conj)
failure paracetamol-induced (amod)
patterns nephrotoxicity (nmod)
metoprolol between (case)
regression cox (compound)
mmol , (punct)
3 after (case)
dosing prior (amod)
girl neuroblastoma (nmod)
subject one (nummod)
findings our (nmod:poss)
represents rare (nsubj)
reduction exercise (nmod)
levels sfas (compound)
excretion iodine (nmod)
classified % (dep)
resulted increasing (csubj)
found binding (nsubjpass)
year stimulation (nmod)
areas at (case)
type and (cc)
found nine (nmod)
catabolism urd (compound)
induced velocity (nmod)
c+e n (appos)
analyses morphology (compound)
pn 30 (nummod)
one cross-reactivity (nmod)
observed events (nsubjpass)
levodopa hydrochloride (appos)
ventilated animals (nsubjpass)
administered eye (nmod)
antagonists b1r (compound)
rate which (det)
kg-1 atropine (compound)
570 461 (compound)
ingested lithium (dobj)
ct ( (punct)
ip cocaine (compound)
attenuated enhancement (nsubjpass)
studies infusion (compound)
165/90 mm (conj)
plans assess (acl)
reversed naloxone (nmod:npmod)
elevated expression (nsubj)
background troponins (appos)
involving systems (dobj)
6-ohda and (cc)
alt ) (punct)
day gestational (amod)
needed address (xcomp)
neuropathy drug-induced (amod)
injection evaluation (nmod)
effects injection (nmod)
days 0.5+/-1.5 (nummod)
proteins renin-angiotensin (amod)
affinity strong (amod)
patient cardiomyopathy (nmod)
susceptible also (advmod)
events later (advmod)
structural mitochondrial (amod)
d11 d19 (conj)
masked have (aux)
anxiety elevated (dep)
lesion encephalopathy (nmod)
enlargement relationship (appos)
pulmonary renal (conj)
uneventful , (punct)
benefit avoiding (advcl)
induced : (punct)
gaba , (punct)
l-[3h]nicotine [3h]spiperone (conj)
predicted be (auxpass)
true . (punct)
double-blind according (case)
systolic bp (conj)
unrestrained in (mark)
utility might (aux)
cyp27 ) (punct)
1.7 to (dep)
= 0.95 (dep)
aware toxicity (nmod)
polymorphism snp(single (compound)
evaluated variables (nsubjpass)
del taqib (conj)
noted exception (nmod)
system the (det)
session training (compound)
administered dobutamine (nsubjpass)
background sirolimus (appos)
mg 4 (compound)
concentration nicotinic (amod)
g poorally (amod)
containing micrograms (dobj)
decreased g/liter (nmod)
factors influencing (acl)
analgesia patient-controlled (amod)
considered guidelines (nmod)
surviving , (punct)
500 of (case)
addition blocking (advcl)
determined testosterone (nsubjpass)
effect vasodilatory (amod)
aimed compare (xcomp)
type progestagen (nmod)
clonidine . (punct)
> were (cop)
cytopenias of (case)
symptomatic enough (advmod)
agent alpha- (amod)
tube endotracheal (compound)
evaluated seriously (advmod)
tachycardia avrt (appos)
kind corticoid (nmod)
inhibition be (cop)
regions examined (acl)
recordings hippocampus (nmod)
influences beta-adrenoceptor (compound)
carcinoma metastasis (conj)
effect effect (dep)
sinoatrial and (cc)
infrequent % (conj)
alpha-t or (cc)
tumor des-induced (amod)
rescues : (punct)
induced disruption (dobj)
prior from (case)
pvc such (case)
> but (cc)
depression myocardial (amod)
pain chest (amod)
reported incidents (dobj)
enzyme plasma (nmod)
hypotension initiation (nmod)
injection each (det)
courses 6 (nummod)
day this (nsubj)
ci with (case)
g/ml were (cop)
lack due (case)
four three (conj)
study responses (nmod)
treatments these (det)
pretreatment thiopentone (compound)
clarification further (amod)
neuropeptide is (cop)
scale was (cop)
brainstem of (case)
pressure mda (conj)
polyneuropathy sensorimotor (compound)
aniracetam novel (amod)
model glaucoma (nmod)
tamoxifen or (cc)
showed end (nmod)
included erythromycins (dobj)
model relevant (amod)
10 n (appos)
effects ifosfamide (nmod)
investigated have (aux)
evaluated not (neg)
communicated incident (nsubjpass)
158 of (advmod)
continued infusion (nmod)
concentration testosterone (compound)
play apoptosis (nsubj)
multiforme glioblastoma (compound)
docetaxel alone (advmod)
disorder presenting (acl)
rats inbred (amod)
continue : (punct)
patients have (acl:relcl)
lowered reduced (conj)
underwent lamivudine (nmod)
sensitivity cholinergic (amod)
blocked response (nsubjpass)
desipramine or (cc)
symptomatic . (punct)
when was (cop)
reduce disability (nmod)
deterioration learning (nmod)
pressure st-segment (conj)
response , (punct)
divided later (advmod)
disturbance neurological (amod)
severity headache (nmod)
diltiazem with (case)
doses isoniazid (nmod)
described spasm (nsubjpass)
high-dose intravenous (amod)
weighing 200 (nummod)
dm gentamicin (conj)
h mg/24 (compound)
physicians emergency (compound)
month in (case)
> pressure (nsubj)
18 - (punct)
pseudomonas alone (advmod)
ritanserin of (case)
mg dexamethasone (compound)
memory non-associative (amod)
trial care (appos)
follow-up months (nmod)
tested controls (nsubjpass)
mg/m(2 1.3 (nummod)
averaged ratio (nsubj)
confusion reaction (appos)
consent with (case)
increased allowing (advcl)
likely that (mark)
presentation asymptomatic (acl:relcl)
parallels , (punct)
irritability parent-rated (amod)
adam10 , (punct)
evaluated visibility (nsubjpass)
resulted administration (nsubj)
had resulted (conj)
marked dizziness (nsubjpass)
test tests (nsubj)
seizures anesthetic (amod)
results differ (dep)
glomerulus the (det)
patients epilepsy (nmod)
afflicted phenomenon (nmod)
using instrument (dobj)
protected parameters (dobj)
receptor ii (compound)
episodes nocturia (compound)
obtunding doses (nmod)
encouraged authors (dobj)
recognized and (cc)
756 - (punct)
develop that (mark)
mediated i (dep)
96 ) (punct)
blocking in (mark)
requiring sedation (dobj)
solid and (cc)
content gsh (compound)
incorporation 5-azc (nmod)
useful as (advmod)
sensitive capable (conj)
drugs 2 (nummod)
infiltration myocardium (nmod)
ly274614 of (case)
reaction retina (nmod)
renin noradrenaline (conj)
saline mg (dep)
resolved increase (ccomp)
results women (nmod)
11 patients (dep)
-32 ( (punct)
recall week (nmod)
5000 over (quantmod)
atropine ml/ng (appos)
males females (conj)
stimulation pas (appos)
anemia azidothymidine-induced (amod)
postulate . (punct)
inputs neural (amod)
cause mechanism (nmod)
report hypertension (nmod)
begun increased (conj)
number intensity (conj)
suggests nature (nsubj)
disturbance auditory (amod)
transplantation solid (amod)
peroxisomes hepatomas (nmod)
malondialdehyde tissue (compound)
accuracy equivalent (amod)
illness febrile (amod)
inhibitors bouts (appos)
recorded monitor (nmod)
level 5 (nummod)
inactive was (cop)
association well-documented (amod)
june , (punct)
ablation rfca (appos)
admitted shock (nmod)
ci 0.01 (nummod)
biopsy episode (compound)
hospital s. (compound)
defining in (mark)
vasculitis for (case)
rebounded torr (nmod)
explain resistance (dobj)
exacerbates ketamine (nsubj)
injected monitored (conj)
need undergo (xcomp)
tested enzymes (nmod)
albino these (nsubj)
aap since (case)
deterioration neurological (amod)
was agreement (attr)
man 41-year-old (amod)
evoked adriamycin (nsubj)
ca(2 pathological (amod)
decreased osmolality (nsubjpass)
experienced hallucinations (dobj)
ischemia before (case)
iqr [ (punct)
mg 359 (dep)
active were (cop)
affect sulpiride (nsubj)
arose arm (nmod)
program transfusion-chelation (amod)
c1 and (cc)
rats unfamiliar (acl:relcl)
signs enhancement (nmod)
exhibited thp (nsubj)
developed venlafaxine (nmod)
ml saline (dep)
studied cats (nmod)
flat be (cop)
dexamethasone rats (nmod)
3 % (appos)
explain alterations (dobj)
given safely (advmod)
% 32.4 (nummod)
nerves of (case)
24 48 (conj)
tnss ( (punct)
3 genes (nmod)
d mean (compound)
risk study (dep)
one than (quantmod)
shown recoveries (nsubjpass)
hemianopsia left (amod)
triglycerides lipoproteins (conj)
use patient (nmod)
group as (case)
lasted associated (conj)
suggest attributable (ccomp)
similar occurred (parataxis)
panel b6 (compound)
values calcium (compound)
arm with (case)
66.9 score (nsubj)
= 0.94 (dobj)
induced deficiency (nmod)
densa ) (punct)
hydration alcalinization (conj)
found correlation (nsubjpass)
or 0.65 (nummod)
using population (nmod)
scale with (case)
mm ; (punct)
drug single (amod)
50 up (advmod)
suppressed dysfunction (nsubjpass)
subjects these (det)
age years (conj)
appears correlate (xcomp)
weight infant (amod)
assessed function (nsubjpass)
help detect (xcomp)
assess case (nmod)
doses 10-diol (appos)
agonist 5-hydroxytryptamine-1 (compound)
investigated further (advmod)
studied action (nsubjpass)
vulnerability exacerbations (nmod)
reversed paralysis (dobj)
rw in (case)
crisis and (cc)
anemia presented (acl:relcl)
ten on (case)
increased 115 (nmod)
enhances deficiency (nsubj)
occurred neuropathy (nsubj)
detachment urothelium (nmod)
analysis biochemical (amod)
magnitude ( (punct)
cause overdose (nsubj)
aged 22 (nummod)
attributable were (cop)
under-reporting limited (conj)
man hypertensive (amod)
resulting rhabdomyolysis (nmod)
episodes for (case)
screening neonatal (amod)
described dysfunction (nsubjpass)
hypotension transient (amod)
present group (nmod)
developing neutropenia (dobj)
acid gaba(a (appos)
cibenzoline of (case)
explore medialipid (nmod)
ratio range (conj)
peg-asparaginase including (case)
newspaper popular (amod)
cardiomyopathy azt-induced (amod)
induced iatrogenically (advmod)
demonstrated angiography (nsubj)
involves mechanisms (dobj)
interventions received (advcl)
g/l 0.5 (nummod)
dependence city (nmod)
potentiates . (punct)
mentioned associated (advcl)
technique be (cop)
remains anticoagulant (dobj)
signs eye (nmod)
cyclophosphamide chlorambucil (conj)
regimen warranted (conj)
disappeared sectioning (nmod)
chemistry alt (dep)
before even (advmod)
activity oxidase (compound)
pathways necessary (amod)
ppa infusion (conj)
% 0.9 (compound)
onset therapy (nmod)
common being (cop)
operations decompression (compound)
administered group (advcl)
emissions newborns (nmod)
damage membrane (compound)
neoplasms rats (nmod)
levels ace (compound)
ability reduced (amod)
acetaminophen edema (conj)
serve mhb (nsubj)
monitored detection (nmod)
injury proportion (nmod)
mechanisms account (acl:relcl)
d2 and (cc)
associated incidence (nmod)
morphine residual (amod)
oscillations all (det)
deterioration given (case)
treatment before (nmod)
withdrawal azathioprine (compound)
studied prevent (advcl)
attenuate to (mark)
effects beta-mimetics (nmod)
reduced mg (nmod)
reduction changes (nmod)
tool drugs (nmod)
complication induce (conj)
ecg standard (amod)
chromatography high-performance (amod)
period 3-year (amod)
disturbances system (nmod)
risk inhibitors (nmod)
cells respectively (advmod)
failure a (det)
cases % (dep)
animals 105 (nummod)
acid then (conj)
nystagmus related (amod)
indicate upregulated (ccomp)
use analgesic (nmod)
chemotherapy agressive (amod)
rare very (advmod)
viramidine , (punct)
female treated (acl:relcl)
need that (mark)
cpdd from (case)
treatment pj34 (nmod)
lactate in (case)
1991 between (case)
demonstrated inhibitor (ccomp)
acidosis post-transplant (amod)
vehicle- and (cc)
weeks dose (nmod)
disease rr (dep)
weeks ct (nmod)
appear affected (xcomp)
chick developing (amod)
assess changes (advcl)
curves dose (compound)
patients rheumatoid (amod)
bilirubin conjugated (amod)
course uneventful (amod)
case overdose (nmod)
challenge elderly (nmod)
medical and (cc)
therapy leukaemia (nmod)
responses mice (nmod)
increase platelet (nmod)
earlier effects (nsubj)
cycle after (case)
had disorder (dobj)
using methamphetamine (dobj)
occur individuals (nmod)
unresponsiveness sensitivity (dep)
reports in (case)
ip 450 (nummod)
effects model (dep)
decreased 19 (nmod)
occurred anemia (nsubj)
hepatotoxicity drug-related (amod)
inadequate effects (nsubj)
curve operative (compound)
hours 3 (nummod)
exercise static (amod)
protocol compassionate-use (amod)
remains potential (nmod)
dysrhythmias hypertension (conj)
combination a (det)
used study (nsubj)
characterize aim (nsubj)
netilmicin with (case)
relates exposure (dobj)
ratio % (dep)
studied efficacy (dobj)
experiments ex (amod)
pay that (mark)
followed regeneration (nmod)
method : (punct)
approach dynamics (conj)
processes several (amod)
sod neither (cc:preconj)
rise with (case)
seizures rats (compound)
effects 8-phenyltheophylline (dep)
experiments microdialysis (compound)
admitted using (advcl)
1520 300 (conj)
collapsed finally (advmod)
revealed transplantation (nmod)
continued treatment (nsubj)
administration ip (compound)
abilities the (det)
study reversal (amod)
observed depression (nsubjpass)
intervals examination (appos)
motor variants (dep)
resulted efficacy (nmod)
elevated 15-f(2t)-isop (nsubj)
therapy his (nmod:poss)
passage epicondyle (nmod)
ratios sites (nmod)
antigens inos (compound)
knockout pparalpha-/- (dep)
< 0.05 (dep)
reduced gabapentin (nsubj)
therapy azathioprine (compound)
analogues - (punct)
= = (xcomp)
illustrates need (dobj)
oct dublin (appos)
infusion tdi (appos)
bioactivation of (case)
prevents relation (dep)
days seven (nummod)
change effects (conj)
support not (neg)
co-infected . (punct)
maintained follow-up (nsubjpass)
performed investigation (nsubjpass)
seizures chronic (amod)
cholesterol hdl (compound)
administration continued (amod)
cows the (det)
had increased (parataxis)
mortality increased (amod)
collection volunteer (compound)
dose fixed (amod)
spasm complete (amod)
infusion plasma (compound)
lost response (nsubjpass)
dogs 206 (nummod)
indistinguishable was (cop)
agonists receptors (nmod)
extremities the (det)
issues cardiac (amod)
known inhibit (xcomp)
socs-3 and (cc)
activity hepatic (amod)
is concomitant (amod)
profound more (advmod)
consisted disturbance (nsubj)
stopped seizures (nsubjpass)
damage as (case)
address effects (dobj)
months study (nmod)
i.v. kg-1 (compound)
diluted ml (nmod)
quinine ( (punct)
result is (cop)
chow chow (conj)
cases esrd (nmod)
produced helodermin (nsubj)
99.0 +/- (cc)
decrease net (amod)
swelling cristae (nmod)
gammapathy developed (acl:relcl)
suggested mapping (nsubj)
hemodiafiltration cvvhdf (appos)
oral nasal (conj)
discontinuation possibly (advmod)
androgens the (det)
week first (amod)
relationships differences (conj)
exposure obtained (acl)
protective seizures (nmod)
potentiated was (auxpass)
scale negative (amod)
signs neurotoxicity (nmod)
7e series (nmod)
cc of (case)
sertraline 1 (conj)
contributes rats (nmod)
induced pacing (nmod)
prospective blind (dep)
has . (punct)
decrement gm-induced (amod)
level gfap (nmod)
effective medication (nsubj)
lesion da (compound)
enabling administration (nmod)
actions antiproliferative (amod)
nicotine carbachol (conj)
tumor receive (acl:relcl)
returned thereafter (advmod)
accelerate to (mark)
9 reduction (nmod)
case resolved (acl:relcl)
vldl plasma (compound)
mg/m(2 mg/m(2 (nmod)
perfusion p2x3 (nmod)
scores recall (nmod)
microg n=18 (appos)
hypersensitivity auditory (nmod)
patients 715 (nummod)
revealed drugs (nmod)
continued had (aux)
doses pap (compound)
larger they (nsubj)
develops mth (dobj)
activity cyp27 (nmod)
markers and (cc)
lethargy weakness (conj)
samples renal (amod)
presentation delayed (amod)
iv mg (nummod)
lasted which (nsubj)
programme a (det)
duration ( (punct)
levels lv (amod)
hypertrophy mice (nmod)
condition patients (nmod)
output ganglia (compound)
intense 0.001 (dep)
medication antihypertensive (amod)
supplementation preventing (acl)
therapy octreotide (compound)
reduced 187 (nmod)
cycles after (case)
volumes large (amod)
reduced nitrogen (dobj)
ventricles lateral (amod)
less nucleus (nmod)
decrement any (det)
cy ng (conj)
transaminase levels (conj)
reverse pretreatment (nsubj)
fibers damaged (amod)
width ( (punct)
deleterious be (cop)
refractory relapsed (conj)
add did (aux)
structure ability (conj)
therapy second-line (amod)
oedema of (case)
aspirin for (case)
convenient more (advmod)
administered ml (dobj)
one sufficiently (advmod)
paid . (punct)
management myoclonus (nmod)
prevented administering (advcl)
tumors bone (compound)
provocation physical (amod)
randomised placebo-controlled (dep)
different rats (nmod)
likely less (advmod)
injury ( (punct)
centre a (det)
evaluation behavior (nmod)
65 than (case)
lactam beta (compound)
produced less (advmod)
flushing . (punct)
hypomania mania (conj)
changes few (amod)
continued months (nmod)
take it (nsubj)
myopathy inflammatory (amod)
exerted needed (advcl)
gravis with (case)
increased tissue (nmod)
form cream (amod)
siat for (case)
recorded asystole (nsubjpass)
family of (case)
complete nearly (advmod)
ophthalmologists institutions (nmod)
neurobiol [ (punct)
pmol ) (punct)
resulted effects (dep)
hips-cms ) (punct)
antagonized effects (dobj)
service addiction (compound)
result use (nsubj)
patients hundred (nummod)
result with (case)
understood poorly (advmod)
detected gauges (nmod)
moderate stable (conj)
rate micrograms/min (nmod)
after year (nmod:npmod)
applied centrally (advmod)
reported penicillin (nsubjpass)
lmwh ( (punct)
concentration on (case)
onset hypotension (nmod)
tolerate patients (nsubj)
presentation her (nmod:poss)
therapy estrogen-replacement (amod)
diseases % (appos)
patient 47-year-old (amod)
content total (amod)
acid folic (amod)
sulfation . (punct)
relationship the (det)
courses doxorubicin (nmod)
elsewhere from (case)
number greatest (amod)
toxicities different (amod)
identified cases (dobj)
val 160/12.5 (dep)
found prevalence (nmod)
assessed ( (punct)
presented cycle (nmod)
noted confirmed (conj)
increase regulated (amod)
a respectively (advmod)
administered ninety-nine (nmod)
high therapeutic (conj)
evaluations , (punct)
discharged result (advcl)
gained insights (nsubjpass)
mg value (dep)
reduced were (conj)
offer to (mark)
convulsants cholinergic (amod)
tests function (nmod)
retrieved , (punct)
disease atrophy (conj)
study using (xcomp)
signs parkinsonian (nmod:poss)
liver preneoplastic (amod)
members family (nmod)
dialysis by (case)
based scoring (nmod)
thrombocytopenia haemolysis (conj)
mortality subsequent (amod)
secretion from (case)
progressed patients (nsubj)
degree similar (amod)
lead impairments (nmod)
dmpx ( (punct)
attenuation tachycardia (nmod)
233+/-34 to (mwe)
harm . (punct)
treatment amelioration (nmod)
ulcers of (case)
abundances type (dep)
growth body (compound)
stereology unbiased (amod)
and , (punct)
assessed hours (nmod)
cortex core (dep)
hybridization by (case)
cortex amygdala (conj)
protected lesions (nmod)
numbers percentage (conj)
reversed oct (nsubj)
reduction ribavirin (nmod)
activity acute (amod)
decrease peroxidase (nmod)
right of (case)
development polyuria (nmod)
points 10 (nummod)
simultaneously given (case)
infections related (amod)
um 265 (nummod)
oscillations tremor (compound)
1.0 p (dep)
suggest impairs (ccomp)
minutes injections (nmod)
dexamethasone rituximab (conj)
withdrawal octreotide (nmod)
implanted developed (conj)
diagnostic " (punct)
maximum incorporation (nsubj)
tolerated efficacious (amod)
oestrogens versus (cc)
vehicles dmso/side (conj)
10(-7 to (case)
control des-treated (conj)
interim in (case)
epilepsy the (det)
organogenesis of (case)
concentrations shift (conj)
seven of (case)
report article (nmod)
dyspnoea and (cc)
discuss detailing (advcl)
discontinued when (advmod)
discontinued medications (nsubjpass)
obtained mice (nmod)
manifestation for (case)
possibility myopathy (nmod)
ci 0.91 (nummod)
ah6809 not (neg)
influence striatum (nmod)
let develop (ccomp)
channel ikr (compound)
population distinct (amod)
disease induced (acl)
accompanied not (neg)
died undergoing (advcl)
count preoperative (amod)
initiated heparin (nsubjpass)
hemodialysis on (case)
episodes two (nummod)
receiving drugs (dobj)
weeks 40 (nummod)
used present (advcl)
convulsions bemegride (conj)
neurotoxicity 20 (dep)
exhibit cystitis (nmod)
mg/kg s.c. (acl)
provoked have (aux)
thromboembolism for (case)
paucity information (nmod)
back rate (nsubj)
agent quaternary (amod)
manipulated . (punct)
ramipril , (punct)
induces microm (nsubj)
evaluation initial (amod)
exposure mtx (compound)
correlates cardiotoxicity (nsubj)
measured finally (advmod)
screened that (mark)
ethambutol due (case)
evident ) (punct)
state all (dobj)
hours early (amod)
toxicity children (nmod)
evaluated therefore (advmod)
rate microbiologic (amod)
use rupture (dobj)
concentration da (compound)
alf years (appos)
believed activity (nsubjpass)
sham rtms (conj)
interleukin 6 (nummod)
established moreover (advmod)
early patients (nmod)
examination therapy (nmod)
signalling dopamine (compound)
s 0.84 (nummod)
shows improvement (nmod)
pupillometer a (det)
sample this (det)
flat to (mark)
evaluation concentrations (nmod)
resolution edema (nmod)
increased plasma (conj)
1.98 ) (punct)
granulomatosis of (case)
blocks minute (compound)
revealed biopsy (nsubj)
degeneration massive (amod)
crack abstinent (amod)
used while (mark)
subjected se (nmod)
experienced subject (nsubj)
inferences potential (amod)
% is (cop)
efforts the (det)
included specimens (nsubj)
bulk the (det)
injected and (cc)
attributable ) (punct)
therapy progestagen (nmod)
areas coefficient (nmod)
abolished moreover (advmod)
content hydroxyproline (amod)
529 11 (compound)
gauges 60 (dep)
patients failure (compound)
disturbance of (case)
% 17.3 (nummod)
treated hypertension (nmod)
normoammonaemic was (cop)
followed acid (nmod)
required which (nsubj)
db 2.14 (nummod)
repair to (case)
depression mechanism (nsubj)
cystitis ifosfamide-induced (amod)
patients six (compound)
evaluate fully (advmod)
ed-1 kinases (conj)
62.5 from (case)
induce clotiazepam (nsubj)
cgrp between (case)
improvement subsequent (amod)
tolerated maximum (nsubj)
effect without (conj)
exhorted initiating (advcl)
considered studies (nmod)
importance developing (advcl)
withdrawing % (conj)
endorsing cip (dobj)
triazolam of (case)
visit post-therapy (amod)
higher tended (conj)
0.05 less (advmod)
70 in (case)
whereas those (nmod)
wegener 's (case)
erection priapism (nsubj)
shown chemicals (nsubj)
became week (nmod)
dystrophy claudication (conj)
factors key (amod)
abundant were (cop)
screening assessment (nmod)
l. ( (punct)
ameliorated withdrawal (nmod)
rat treated (amod)
reported occasionally (advmod)
antidepressant used (acl)
myoclonus reduced (amod)
factors infants (nmod)
delirium for (case)
extremes survey (nmod)
anesthesia by (case)
9.7 10.2 (conj)
betaxolol ( (punct)
expressions kidneys (nmod)
hypotension peri-operative (amod)
exposure . (punct)
convulsions acid-induced (amod)
bundle median (amod)
age years (nmod)
synovitis destructive (amod)
responses frequencies (nmod)
12.0 5.0 (conj)
increased background (nsubj)
had neutropenia (dobj)
systems , (punct)
rate addition (nmod)
respect sex (nmod)
contribution supply (nmod)
addicts heroin (compound)
had resulting (advcl)
myositis attributable (amod)
pair-fed pf (appos)
dizziness general (conj)
rate spillover (compound)
modulating transmission (dobj)
45.45 to (case)
perfused arterially (advmod)
35/15 - (punct)
mg 12.5 (nummod)
deferens , (punct)
examine function (dobj)
23 2 (conj)
result apoptosis (nmod)
disequilibrium in (case)
mg/kg sem (appos)
ameliorated verapamil (nmod)
iu/kg/i.v 50 (nummod)
carboplatin subtenon (compound)
sensitivity enhanced (amod)
initiating treatment (dobj)
regulator is (cop)
cured not (neg)
months , (punct)
november 2007 (nummod)
old 27-year (amod)
therapy quetiapine (compound)
installation epilepticus (nmod)
assessed serum (nmod)
found contrast (nmod)
necroses muscle (compound)
lipid , (punct)
suppressed dose (nsubj)
implicated clozapine (dep)
group subfertility (compound)
presentation case (compound)
received alpha-tc (dobj)
27 patients (nmod)
association increment (nmod)
stage in (case)
pemoline of (case)
antithrombin , (punct)
discussion this (nsubj)
woman-years . (punct)
commencement prednisolone (nmod)
change last (advcl)
ability cognitive (amod)
effects dysfunction (conj)
implantable fully (advmod)
khz at (case)
use design (nmod)
phenylephrine of (case)
77.1 . (punct)
makes useful (ccomp)
had sings (dobj)
elevated group (nmod)
demonstrated increase (nmod)
ml injections (conj)
maintained conversion (nmod)
activity as (cc)
recognized may (aux)
impairment greater (amod)
changes behavioral (amod)
had malignancy (nmod)
designed investigate (conj)
impairment ( (punct)
continuous generalized (dep)
remained preventing (advcl)
highlights occur (ccomp)
patients chemotherapy-naive (amod)
predated " (punct)
elevation level (nmod)
evaluate alters (ccomp)
mg/kg 0.50 (nummod)
kg(-1 of (case)
penetration . (punct)
potentiated nicotine (nmod)
resolved . (punct)
preceded fa (nmod)
hypotension changes (conj)
vasopressin central (amod)
cardiomyopathy clinical (conj)
followed normalization (nmod)
pain propofol (compound)
impairment attention (nmod)
increased excretion (nsubj)
function an (det)
mediates programming (nsubj)
follow stroke (nsubj)
injected acutely (advmod)
implicates control (dobj)
tested h (nmod)
cost management (conj)
exercise bicycle (compound)
indicate plan (ccomp)
motion moving (advcl)
received attention (dobj)
none ( (punct)
propranolol 2660 (nmod)
cases removal (nmod)
decrease but-relative (amod)
0.78 of (case)
improvement in (case)
increased striatum (conj)
period january (nmod:tmod)
alteration a (det)
nutrition total (amod)
drop factors (nmod)
estimated not (neg)
tape to (case)
area visible (amod)
carry risk (dobj)
mc of (case)
lowered and (advmod)
showed ramh (nsubj)
order decreasing (advcl)
gssg in (case)
rate akathisia (nmod)
500 900 (conj)
rise , (punct)
surgery blockade (nmod)
group . (punct)
shown promising (xcomp)
vasodilator polypeptide (nsubj)
asenapine of (case)
developing failure (dobj)
swimming escape (conj)
phlorizin with (case)
encephalopathy perinatal (amod)
disease glomerular (amod)
method electromyographic (amod)
anesthesia intravenous (amod)
hydrochloride ketamine (compound)
reshaping function (nmod)
percent forty-nine (amod)
accompanied pathway (conj)
combination ephedrine (nmod)
epilepticus followed (acl)
antigens b35-cw4 (amod)
investigate complications (dobj)
depletion dopamine (nmod)
strategies implications (dep)
attenuate did (aux)
reaction of (case)
margin safety (nmod)
constructed , (punct)
basis scores (nmod)
appearance between (case)
catheters central (amod)
suffer morbidity (dobj)
patient cardiac (amod)
upregulation receptor (compound)
infusion amifostine (compound)
amide nicotinic (amod)
multiforme erythema (nsubj)
administration nmol (appos)
actions in (case)
14,671 rofecoxib (acl)
uncommon occurrence (nsubj)
cystica pyeloureteritis (compound)
developed finding (nmod:npmod)
administration : (punct)
mg/day 1 (nummod)
subgroups of (case)
hypertension prophylaxis (nmod)
complete range (conj)
developed all (nsubj)
highlights areas (dobj)
clones lam-resistant (amod)
background studied (dep)
therapy d-penicillamine (compound)
raters trained (amod)
effect antihyperalgesic (amod)
contractility normal (amod)
injection ) (punct)
diagnosis damage (nmod)
responses stem (compound)
neuralgia a (det)
lumens were (cop)
type is (cop)
attention memory (conj)
vasopressor an (det)
n-butyl-deoxynojirimycin versus (cc)
4 at (case)
bupivacaine ( (punct)
monkeys the (det)
motility inspection (conj)
olanzapine between (case)
apparent not (neg)
placebo timolol (conj)
changes degenerative (amod)
been increased (conj)
capacity void (amod)
occurrence pressure (nmod)
augmented rats (nmod)
factors nms (nmod)
12.8 to (dep)
97.1 was (cop)
patients values (nmod)
affected less (advmod)
vasodilators by (case)
displace drc (dobj)
session observation (compound)
occurred reduction (nmod)
h 0 (nummod)
given died (advcl)
surgery implant (nmod)
production overdose (nmod)
decrease relative (amod)
susceptible is (cop)
1 10 (conj)
resulted discontinuation (nsubj)
excretion and (cc)
patients concentrations (conj)
flow intracranial (amod)
failure peripheral (amod)
records the (det)
treated pointes (nsubjpass)
evidence neuroradiologic (amod)
associated cycles (nsubjpass)
change pressure (dobj)
assessment homeostasis (compound)
added where (advmod)
encountered be (auxpass)
tremor effect (acl:relcl)
rise > (dep)
caused disruption (dobj)
increase significantly (advmod)
levels 9.4 (nummod)
received center (nmod)
persists or (cc)
30 27 (compound)
density od (appos)
disappearing completely (advmod)
test maze (compound)
stimuli the (det)
reduces myoclonus (dobj)
day either (det)
anacardiaceae ( (punct)
benzoylecgonine cocaine (compound)
sclerosis multiple (amod)
patient neuropathy (nmod)
matrix medullary (amod)
considered spasm (nsubjpass)
infusion ifosfamide (nmod)
processed kidney (nsubjpass)
presented lesions (nmod)
bupivacaine mg (appos)
observed level (nmod)
drugs common (amod)
develop hag (nmod)
rate because (case)
marked users (nsubj)
diet the (det)
case result (nmod)
li/dvp % (appos)
scopolamine pre-test (amod)
altered effects (nsubjpass)
occurred absence (nmod)
pituitaries the (det)
nephrotoxic be (cop)
mediated binding (nmod)
myopathy acute (amod)
rate excretion (compound)
rise mg/dl (dep)
hypertension vs. (cc)
device velocities (nmod)
loss preservation (appos)
22/11 to (quantmod)
activation post (conj)
two those (nmod)
hypokalemic in (case)
requiring hospitalization (dobj)
thp of (case)
cardioprotection treatment (nmod)
facilitation antagonists (conj)
varied onset (nsubj)
risk reported (acl)
secondary effect (nmod)
april 2004 (nummod)
chemotherapy it (compound)
abnormalities heart (compound)
phenylethylbarbiturate quinidine (compound)
reversed hypertension (dobj)
follow-up long-term (amod)
inhibitor hydroxylase (nmod)
decrease number (nmod)
pelvis bladder (conj)
attempts resuscitate (xcomp)
study reactions (nmod)
given intraperitoneally (advmod)
11-fold ) (punct)
led esrd (nmod)
capsules of (case)
complaints without (conj)
had infusion (dobj)
pathogenesis exact (amod)
crossover randomized (amod)
survivors all (det)
supported clinically (advmod)
added infusion (nmod)
frequent syndrome (nsubj)
ears n=88 (compound)
tropicamide with (case)
report presenting (advcl)
population in (case)
kf17837 p.o. (appos)
aqp2 protein (conj)
administration risperidone (nmod)
skin in (case)
group treatment (nmod)
contractions muscle (compound)
agents offending (compound)
deterioration rodents (nmod)
case vasculitis (compound)
performed delirium (nmod)
cause nephrolithiasis (dobj)
started we (nsubj)
hormones of (case)
oxidation lipids (nmod)
postdose p (dep)
gd on (case)
decrease progressive (amod)
time life (nmod)
distribution factors (nmod)
% 66+/-11 (nummod)
so that (dep)
blockade adrenergic (amod)
mg 0.002 (appos)
induction after (case)
hyperactivity mesangial (amod)
estimated accounting (advcl)
week 10 (nummod)
administration min (nmod)
alterations hippocampal (nmod)
considered then (advmod)
recruited , (punct)
interaction , (punct)
mechanism . (punct)
dph ) (punct)
grade to (dep)
admitted patients (nsubjpass)
protein matrix (compound)
level stress (nmod)
weight with (case)
decreased 0.4-fold (conj)
produce infarction (dobj)
a ): (punct)
attributable dynes.s.cm-5 (nmod)
dosing shr (nmod)
myelosuppression daunorubicin (nmod)
safety cta (nmod)
disturbances level (nmod)
weeks only (advmod)
rate respiratory (amod)
absent time (nmod)
transplant ) (punct)
binding irreversible (amod)
found lack (nsubjpass)
meta-analysis good-quality (amod)
led hypothesize (xcomp)
showing causes (ccomp)
concentration lowered (amod)
increase including (case)
disposition tetracycline (nmod)
frequency rats (nmod)
exhibited clearance (dobj)
samples patients (dep)
proteinuria pre-existing (amod)
lower expression (nsubj)
males old (amod)
effect anti-amnesic (amod)
ethinyloestradiol g (compound)
injury duct (compound)
was compared (advcl)
tamoxifen alone (advmod)
reported associated (parataxis)
require returned (conj)
percent interval (dep)
stratified rats (nsubjpass)
mg/kg 3.2 (nummod)
dependence cocaine (compound)
resulted but (cc)
hydrocortisone of (case)
test test (compound)
prevents pathway (nmod)
given visit (nmod)
is difference (nsubj)
accounted secretion (nsubj)
beta 2 (nummod)
animals injected (amod)
harvested extracts (nsubjpass)
made field (nmod)
minutes range (conj)
common sensations (nsubj)
well-tolerated usually (advmod)
showed reflecting (advcl)
dissociation memory (compound)
other elevation (nmod)
lidocaine epinephrine (conj)
cvd ) (punct)
5-fu ) (punct)
longer were (cop)
patients 25 (nummod)
attenuate add (conj)
alert patients (nmod)
th ) (punct)
implicated may (aux)
cocaine from (case)
induced catheter (nmod)
administered dose (dobj)
dependent protective (conj)
occurs performed (advcl)
advocated , (punct)
vasodepressor or (cc)
group-1 n=10 (appos)
reactivation hepatitis (compound)
collection and (cc)
presence concentrations (nmod)
0.27 0.07 (conj)
fracture hip (compound)
promotes architecture (dobj)
aspects temporal (amod)
chow amphetamine (nmod)
gauges frey (compound)
pregs natural (amod)
affected duration (nmod)
ratio or(adj (appos)
reducing mg/day (dep)
vesicles of (case)
hr forty-eight (nummod)
registered were (auxpass)
need , (punct)
p<0.0005 vs. (cc)
incidence neurotoxicity (compound)
negative were (cop)
asa ( (punct)
diseases by (case)
drugs : (punct)
31.6 +/- (cc)
alter animals (advcl)
activities living (nmod)
models disorder (nmod)
dosing patients (nmod)
induced arrhythmia (nsubjpass)
having disorder (dobj)
protein p (dep)
associated junction (nmod)
effective retarding (advcl)
normal to (case)
that exertion (nmod)
malondialdehyde oxypurines (conj)
cause disease (dobj)
nationwide population-based (conj)
different . (punct)
solution the (det)
behavior preference (conj)
action permissive (amod)
frequency voltage (conj)
salbutamol with (case)
therapy or (cc)
supports improvement (nsubj)
control srl (conj)
results received (appos)
mechanisms level (nmod)
biopsy endomyocardial (amod)
papillomas all (det)
patients early-conversion (amod)
hypotension labetalol-induced (amod)
necrosis naproxen (nmod)
counts pod (conj)
transplantation orthotropic (amod)
mg/m2/d 200 (nummod)
observed excretion (nsubjpass)
performance h (compound)
excitability increased (amod)
showed degeneration (dobj)
associated leukocyturia (nsubjpass)
generated ead (nsubjpass)
channel l-type (compound)
orientation the (det)
produced dysrhythmias (dobj)
flatulence pain (conj)
syndrome qt (compound)
levels tnf-a (nmod)
susceptible vt (nmod)
mg diet (dep)
min-1 g (compound)
offset risk (nsubj)
flestolol . (punct)
reported effects (dobj)
solution while (mark)
nsclc and (cc)
higher that (nmod)
similar measures (nsubj)
microphthalmos , (punct)
containing subunits (dobj)
care for (case)
compartment black-and-white (amod)
correlation injury (nmod)
hepatotoxicity galactosamine (compound)
model lesion (compound)
positive with (case)
monitoring dog (nmod)
bupivacaine anaesthesia (nmod)
examination tissues (nmod)
less increasing (advcl)
ligands the (det)
h 11 (nummod)
ionic non-ionic (conj)
responses electrophysiological (amod)
24.3 . (punct)
shown loss (nmod)
taxol ( (punct)
true , (punct)
possibility infections (nmod)
metabolites , (punct)
studies these (det)
seven erythema (nmod)
higher doses (nmod)
pathway nociception (nmod)
failure subjects (conj)
identified occurred (parataxis)
levofloxacin with (case)
point from (case)
patients eighty-eight (amod)
received ranging (advcl)
displays . (punct)
relation possible (amod)
factor alpha-atrial (amod)
triceps to (case)
lower % (nmod:npmod)
treated etoposide (nmod)
2-fold vs. (dep)
features these (det)
12 less (amod)
controlled randomized (amod)
mg ergotamine/caffeine (conj)
recipients therapy (nmod)
f temperature (nsubj)
tested is (ccomp)
which after (case)
mda excretion (conj)
% 4.2 (nummod)
complete prevention (dobj)
3 , (punct)
concentrations via (case)
diagnostic rapid (amod)
adding carbamazepine (dobj)
depletion groups (nmod)
studies toxicity (compound)
normal diabetic (conj)
protocol according (case)
% 40 (compound)
months follow-up (nmod)
chi(2)(3 ) (punct)
those found (acl)
preterm sick (amod)
hexamethonium mg (appos)
dogs and (cc)
coma , (punct)
stimulated aconitine (nsubj)
pg/ml 39 (nummod)
associated types (nmod)
based study (nsubjpass)
albuterol nebulized (amod)
elevated ( (punct)
denopamine 100 (nummod)
grade occurred (conj)
bolus epinephrine (nmod)
estimated concentrations (nsubjpass)
assay exclusion (compound)
portland , (punct)
arises importance (ccomp)
continuation despite (case)
macrolides with (case)
catheter through (case)
institutions at (case)
ipsi- the (dep)
possible however (advmod)
potassium terbutaline (conj)
commencement before (case)
found earlier (advmod)
knee of (case)
values td50 (dep)
minutes forty-five (amod)
applied dialysis (nmod)
days every (det)
lower score (nmod)
hospitals to (case)
nra0160 , (punct)
higher whereas (mark)
111 children (nmod)
400 mg/m2 (dep)
shown increase (ccomp)
14 patients (nmod)
carcinoma ii (nummod)
had hepatitis (dobj)
occurred % (dep)
collected reserved (conj)
increase . (punct)
shock iii (nmod)
p.o. 0.625 (nummod)
n/n=25/26 , (punct)
therapy physical (compound)
ml 3 (nummod)
secondary therapy (nmod)
anxiety marked (amod)
similar signs (nsubj)
intervals fixed (amod)
elevation st-segment (amod)
dimension thickening (nmod)
antiplatelets oral (amod)
accurate highly (advmod)
reversal effects (nmod)
value may (aux)
infusions dobutamine (compound)
pathogen(s the (det)
organization [ (punct)
feasible yet (cc)
anaesthesia the (det)
excellent effect (nsubj)
effects formulation (nmod)
preparations left (amod)
group after (case)
levels estrogen (nmod)
correlation histamine (nmod)
rr=1.41 ptrend=0.08 (dep)
assessed weeks (nmod)
analysis using (acl)
episode antimicrobial-induced (amod)
availability , (punct)
0.5 1.0 (conj)
dependent fit (conj)
wr242511 8-aminoquinoline (compound)
dose lithium (nmod)
became when (advmod)
parkinsonism induced (acl)
seen might (aux)
2nd or (cc)
alterations perceptual (amod)
days ; (punct)
january 2000 (conj)
shr but (cc)
therapy sex (conj)
recurrent for (case)
1.6 was (cop)
activation kinase (nmod)
sprague-dawley than (case)
antigens putative (amod)
artery choriocapillaris (conj)
event patients (appos)
dopamine signaling (nmod)
il-1 of (case)
problems therapy (nmod)
mouth , (punct)
values normal (amod)
projections serotonin (compound)
intake pills (nmod)
indicated conditions (nmod)
pathway brain (nmod)
action compound (nmod)
e2 pge2 (appos)
163 55 (conj)
appear related (xcomp)
recurrence years (nmod)
have nephrotoxicity (dobj)
attained response (dobj)
atrophy system (compound)
marrow bone (compound)
protocol similar (amod)
resulting admissions (nmod)
showed ecg (nsubj)
evaluation . (punct)
stimulus of (case)
attitude puerile (amod)
ro4368554 mg/kg (dep)
supplementation early (amod)
enzymes hbeag (conj)
paralleled hypotension (nsubjpass)
diphenhydramine prednisone (conj)
lesion following (case)
effects to (case)
useful could (aux)
mol/l 10(-5 (compound)
linkages the (det)
3.49 , (punct)
causes prevention (conj)
mg/day 100 (compound)
antigen chinese (amod)
effects hepatotoxic (amod)
resulted infusion (nsubj)
mediates and (cc)
confirmatory a (det)
ectopy benign (amod)
-0.07 -0.34 (compound)
cis-platinum , (punct)
time-course severity (conj)
abuse meth (compound)
impairment streptozotocin-induced (amod)
anp avp (conj)
status their (nmod:poss)
ought , (punct)
pressure filling (compound)
assessed series (nmod)
days pairs (appos)
treated stent (nmod)
nucleus microinjection (nsubj)
anemia role (dep)
authorized snp (nsubjpass)
discussed hypotheses (nsubjpass)
somatotopy systems (nmod)
therapy auc (conj)
cancer , (punct)
design hypren-trial (nmod)
responsiveness alcohol (conj)
berries hawthorn (nmod)
patient 27-year-old (amod)
included cases (nsubjpass)
movements chewing (compound)
neurons argyrophilic (amod)
56.8 to (case)
dopamine in (case)
avoided performed (conj)
skilled management (nmod)
likelihood hypotension (nmod)
gaining acceptance (dobj)
infiltrate prevalence (nmod)
point primary (amod)
admitted testing (advcl)
implications potential (amod)
response pressor (compound)
depressed addition (nmod)
important administering (advcl)
% 10.7 (nummod)
effects interactive (amod)
important addition (nmod)
inhibitors other (amod)
increased results (nsubj)
linkages via (case)
filling left (amod)
patients required (acl)
using cells (dobj)
expression nkcc2 (compound)
examined not (neg)
group remained (acl:relcl)
coincided activity (nsubj)
different that (mark)
bigeminy runs (conj)
arabic 80mg/kg/day (dep)
tool can (aux)
absence control (nmod)
suggested had (ccomp)
ck-mb or= (dep)
terminals the (det)
dysfunction ventricular (compound)
were however (advmod)
part assess (acl)
lower also (advmod)
2.3+/-1.2 39.5+/-8.4s (conj)
obtained interviews (nmod)
mg 192 (nummod)
callosal corpus (compound)
angioplasty . (punct)
sites various (amod)
t+a % (dep)
swallowing less (advmod)
toxicity amiodarone-induced (amod)
diluents of (case)
urticaria of (case)
likely % (xcomp)
reported documentation (nmod)
conversion the (det)
tended and (cc)
suggest seems (advcl)
aap : (punct)
stimulation following (case)
fluoxetine and (cc)
using lignocaine (dobj)
quantitated clearance (nmod)
focused malformations (nmod)
case exposure (nmod)
day across (case)
uiu/ml 5 (nummod)
low , (punct)
iopamidol of (case)
years 45.7 (nummod)
density current (amod)
administration thiabendazole (compound)
reduces preservation (nmod)
% 91 (nummod)
electrolytes the (det)
june 1984 (nummod)
use ecstasy-polydrug (amod)
trinitrate glyceryl (compound)
reduce edema (dobj)
are discussed (conj)
risperidone ( (punct)
stx ( (punct)
smoking acuity (nmod)
see application (dobj)
prophylaxis without (case)
fluorogold microliters (appos)
modifications to (case)
550 - (punct)
becomes agitation (nsubj)
experienced minutes (dobj)
compartments other (amod)
classified exencephaly (dobj)
institutions group (compound)
interfere did (aux)
received order (nmod)
diagnosis disturbance (nmod)
proliferation no (neg)
is order (nmod)
reduced presence (conj)
measures those (nmod)
investigate reproducibility (dobj)
dose corticosterone (compound)
infusion . (punct)
pressure morphology (conj)
tubes with (case)
agc for (case)
reduced mutation (nsubj)
institution pediatric (amod)
administration dipyridamole (nmod)
in urothelium (nmod)
promote af (dobj)
hematological gastrointestinal (conj)
produced hernias (dobj)
0.3-fold 1.7 (dep)
cells myocardial (amod)
increases modest (amod)
medical paramedical (conj)
showed potentials (dobj)
bouts angio-oedema (nmod)
densa interna (conj)
situations is (acl:relcl)
produces background (nsubj)
prevent was (advcl)
anticonvulsants on (case)
recording potentials (nmod)
mg. 0.5 (nummod)
practiced initiated (ccomp)
modulate system (nmod)
levobupivacaine epinephrine (nmod)
alert should (aux)
require period (nmod)
activity bradykinin (nmod)
based presence (nmod)
environment to (case)
included increase (dobj)
classes left (conj)
seventeen these (nmod)
aware to (mark)
suffer depression (nmod)
reduction small (amod)
disruption significant (amod)
ages , (punct)
actives . (punct)
ulcers polyarthralgia (conj)
chloride chloride (conj)
those described (acl)
discharges electrical (amod)
pronounced reduction (nsubjpass)
useful that (dobj)
middle high (conj)
symptoms meningitis (nmod)
size bruising (nmod)
myeloperoxidase mpo (appos)
pay investigators (nsubj)
stunning be (cop)
value prevention (nmod)
signal pain-related (amod)
type complete (conj)
glaucoma corticosteroid (compound)
levels complement (compound)
prolonged concentration-dependently (advmod)
spasm of (case)
i.p. observed (conj)
epinephrine exercise (conj)
prescribed satisfied (advcl)
improved survival (dobj)
examined mice (dobj)
suspected interference (nsubjpass)
model juvenile (compound)
efficacious administration (nsubj)
polysaccharide sulfated (amod)
jaundice clinical (amod)
involved injury (nmod)
increases hyperactivity (dobj)
formation bone (compound)
increases transaminases (nmod)
icp lower (amod)
given diltiazem (dobj)
mild neutropenia (conj)
neurotoxicity on (case)
alcalinization the (det)
1.4 , (punct)
patients half (predet)
causes toxins (nsubj)
implants with (case)
role its (nmod:poss)
surveillance close (amod)
left measure (advcl)
controls along (case)
lack not (neg)
syndrome reports (dep)
established effects (nsubjpass)
patients included (acl)
present administration (nmod)
amount minimal (amod)
reversed conclusion (nmod)
clinicians for (case)
abnormalities urinary (amod)
ulcer hemorrhagic (amod)
mechanisms its (nmod:poss)
colocalized canaliculi (nmod)
delayed hypotension (dobj)
prevent changes (dobj)
snr ) (punct)
twitches diaphragm (nmod)
prevented conversion (nsubj)
14c]sodium [24 (compound)
provoked convulsions (dobj)
polyuria tremor (conj)
acid asa (dep)
3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1h-indole ) (punct)
points mmse (det)
lack safety (nmod)
nl ( (punct)
case block (nmod)
hour day (conj)
deficits two (nummod)
isolation for (case)
results based (case)
was methods (dep)
cocaine of (case)
gel application (nmod)
exposed . (punct)
beneficial that (mark)
shown ratio (dobj)
vancomycin tobramycin (conj)
glucose for (case)
extract agent (nmod)
therapy effective (amod)
motility diagnosis (nmod)
units units (conj)
intake for (case)
p9605 ) (punct)
trial lidocaine (nmod)
effect 5-httlpr (nmod)
clearance rats (compound)
dismissed not (neg)
rats two (nummod)
suspected withdrawn (conj)
5 11 (dep)
disorder underlying (amod)
treatment enzyme (nmod)
agent methimazole (nsubj)
type exchanger (compound)
admitted osmolality (conj)
drug exposures (conj)
had il-2 (nmod)
0.2 3.0 (conj)
combination cis-platinum (nmod)
effect overflow (nmod)
became she (nsubj)
compared measurements (nmod)
assay of (case)
time latency (conj)
glomerular lesions (dep)
ketorolac mg (dep)
latency shortened (amod)
observed proteinuria (nsubjpass)
developed 400 (nmod)
pacing efforts (nmod)
echocardiographic histological (conj)
iddm 12 (appos)
noradrenaline na (appos)
minimized selecting (advcl)
pac of (case)
reduced doses (nsubj)
white 924 (nummod)
being group (nmod)
increases therapy (nsubj)
five disease (nmod)
evaluated phosphanilate (nsubjpass)
therapy rr (dep)
cardiotoxicity acute (amod)
evaluation testing (nmod)
stunning to (mark)
incidence hepatocytes (nmod)
succimer with (case)
hemoglobin in (case)
day 27 (nummod)
case two (nummod)
190 +/- (cc)
ireland in (case)
progression symptom (compound)
detection liquid (compound)
suffers models (nsubj)
metabolites related (amod)
trimipramine , (punct)
gr with (case)
patients paralysis (nmod)
properties in (case)
vacuolization biopsies (appos)
died whereas (mark)
observed however (advmod)
observational largely (advmod)
confusion coma (conj)
mt ) (punct)
value higher (amod)
se ( (punct)
accidents cerebrovascular (amod)
isom ) (punct)
antigens these (det)
mug kilogram (nmod)
p53 members (conj)
appropriate most (advmod)
effective detecting (advcl)
doxorubicin not (neg)
requires specification (dobj)
mg maleate (nmod)
susceptibility seizures (nmod)
ratio 1.22 (nmod)
reactions immediate (amod)
exposure heparin (compound)
representative not (neg)
prepared days (nmod)
prognosis for (case)
haemorrhage to (case)
ritonavir 30 (nummod)
functions learning (dep)
bundle in (case)
users rc (compound)
compared also (advmod)
levels proteinuria (nmod)
investigate further (advmod)
certain resulted (conj)
oih ( (punct)
related dili (nmod)
deacetylation of (case)
symptoms menopause (compound)
microg/kg or (cc)
information with (case)
therapy ribavirin (compound)
cases twenty-six (nummod)
quantified was (auxpass)
deficits brain (nmod)
dysfunction av (compound)
explain findings (dobj)
prevents growth (dobj)
randomized ratio (nmod)
developed hit (dobj)
therapy consolidation (compound)
immunohistochemistry vegf/vpf (compound)
erythroblasts marrow (compound)
applied oral (nmod)
occurred detected (conj)
amitriptyline with (case)
effect digoxin (compound)
onset patients (nmod)
designated , (punct)
frequencies khz (appos)
evaluate rates (dobj)
methscopolamine , (punct)
common changes (nsubj)
newspaper a (det)
insipidus with (case)
1 21 (conj)
reports contrast (compound)
substance reference (compound)
was beats/min (attr)
untied atriotomy (nmod)
agonist however (advmod)
induced disappearance (nsubjpass)
blockade ca(2 (compound)
users users (nmod)
assessed combination (dobj)
period exercise (compound)
salt pressure (nsubj)
produced pentobarbital (nmod)
sensitivity control (nmod)
treatment pdtc (compound)
changes decrease (conj)
10 5 (compound)
noted motility (dobj)
naloxone . (punct)
test globulin (nmod)
pattern same (amod)
patients preferring (acl)
40 36 (compound)
levofloxacin by (case)
cardiomyopathy cobalt (compound)
noted also (advmod)
determination malondialdehyde (nmod)
level acids (nmod)
ketamine lidocaine (conj)
events n (dep)
environment effect (nmod)
2b1/2b2 p450 (compound)
derivatives penicillin (compound)
evidence ) (punct)
age and (cc)
kg(-1 micromol (compound)
promote improve (conj)
guide therapy (dobj)
therapy atra (compound)
pg-9 by (case)
reversed be (auxpass)
induced wakefulness (dobj)
mice wt (compound)
intravenous totally (advmod)
june 2006 (nummod)
weakness or (cc)
needed clarification (nmod)
36.4/6.1/3.0 , (punct)
existence disorder (nmod)
has digoxin (nsubj)
augment seizures (dobj)
rate estimated (amod)
data neuroimaging (amod)
mg/m2 doses (nsubj)
myocytes in (case)
moderate largely (advmod)
patient proteinuria (nmod)
incmnsz the (det)
correlated increase (conj)
mild hypertension (nmod)
techniques decision-analytic (amod)
given bolus (nsubjpass)
reduced cpa (nsubj)
test reaching (compound)
vehicle with (case)
ganglia in (case)
unlikely , (punct)
204 was (cop)
segments , (punct)
ketamine morphine (conj)
cardiomyopathy , (punct)
case such (predet)
receptors da (compound)
proceeded directly (advmod)
preventing of (mark)
cases serious (amod)
stroke following (case)
smoked day (nmod)
problematic be (cop)
sbs r (dep)
surveillance during (case)
justified . (punct)
reduces administration (nsubj)
test retention (compound)
hydrochloride 250 (nummod)
znso(4 with (case)
mic ) (punct)
sacrificed mice (nsubjpass)
underlying dyskinesias (dobj)
edge-ii ) (punct)
invited patients (nsubjpass)
suspected appearance (nsubjpass)
powder arabic (compound)
neostigmine infusion (nmod)
considered persisted (conj)
schiff periodic (compound)
visualize , (punct)
assess retention (dobj)
overflow in (case)
controls did (acl:relcl)
unclear responsible (ccomp)
series in (case)
amines strain (nmod)
matched treated (conj)
after particularly (advmod)
14.1 7.9 (conj)
drug disappeared (acl:relcl)
indicates indirect (ccomp)
synthesis : (punct)
forty-six developed (acl:relcl)
reinstated could (aux)
self-limited . (punct)
sensitive patients (nsubj)
achieved since (mark)
experiments the (det)
injections methamphetamine (nmod)
found administration (nmod)
pilocarpine-treated and (cc)
secretion tubular (amod)
tam ( (punct)
gaba vigabatrin (appos)
occur loss (nmod)
phenotype differentiated (amod)
bw 12 (nummod)
rise average (amod)
reduced tiapride (nsubj)
syndrome methylphenidate (conj)
appears and (cc)
infusion i.v. (compound)
figures cytosegresomes (nmod)
pretreatment injection (dep)
diuretics loop (compound)
syndrome ibs (appos)
reviewed results (dobj)
mm from (case)
blockade dose-related (amod)
lability scale (nmod)
cause reduction (nsubj)
estradiol beta (compound)
scale behavior (compound)
potent . (punct)
toxicities vivo (advmod)
avoid further (advmod)
rigidity haloperidol-induced (amod)
micrograms 24.8 (nummod)
asenapine and (cc)
aggregability the (det)
phenotype hemorrhagic (amod)
30 20 (quantmod)
fashion double-blind (amod)
recommend use (dobj)
nephrogenic neurogenic (conj)
effects levodopa (amod)
pj34 addition (compound)
deprivation sleep (compound)
termination experiments (nmod)
standard gold (compound)
registered rate (nsubj)
enhancement antinociception (nmod)
hcbd caused (acl)
weight dry (amod)
density , (punct)
increases these (det)
depends conditions (nmod)
suggests background (dep)
indicating had (ccomp)
content prolactin (compound)
subjects cohort (nmod)
assigned . (punct)
involved man (dobj)
associated activity (nmod)
reports patients (nmod)
appeared initially (advmod)
remission with (case)
developed bigeminy (dobj)
28th the (det)
lower dose (nsubj)
occur incidence (nmod)
republic the (det)
associated isotretinoin (nmod)
midbrain ventral (amod)
elevated markedly (advmod)
kinds for (case)
ischemic metabolic (conj)
pills second (amod)
elevation , (punct)
iopamidol medium (compound)
make efficacy (nsubj)
isoproterenol induced (dep)
contributions definite (amod)
discontinued suspected (advcl)
transport glut4 (nmod)
virus with (case)
liver skin (conj)
strokes for (case)
hot-plate abdominal-constriction (conj)
trial feasibility (compound)
inhibition na(+ (nmod)
scale alertness/sedation (compound)
administration cromakalim (nmod)
nanoparticles of (case)
desire or (cc)
2 sertraline (nmod)
observed haloperidol (nmod)
treated agent (nmod)
injury nephrosis (nmod)
triggers . (punct)
range interquartile (compound)
detectable effect (nsubj)
dose multiple (amod)
performed thus (advmod)
compatible are (cop)
placed microinjections (nmod)
wished . (punct)
limiting often (advmod)
reversed that (nsubj)
process autoimmune (amod)
philadelphia pa (appos)
died originating (advcl)
differ experiments (nmod)
mechanism phenomenon (nsubj)
patients acetaminophen-induced (amod)
possible advisable (conj)
defined % (dep)
cessation and (cc)
tubule proximal (amod)
doses equihypotensive (amod)
prescription of (case)
fr antagonist (compound)
address uncertainties (dobj)
vcm alone (advmod)
taking alone (advmod)
did therefore (advmod)
mg 325 (nummod)
affect flattened (amod)
mice female (amod)
value but (cc)
= 0.48 (dobj)
using inhalator (dobj)
trated patients (dep)
inhibits carbamazepine (nsubj)
fentanyl midazolam (conj)
phosphanilate chp (appos)
action the (det)
vein galen (nmod)
survivors long-term (amod)
develop where (advmod)
behavioral the (det)
present aneurysms (nsubj)
conclude small (ccomp)
neuroblastoma against (case)
constructed groups (nsubjpass)
cefazedone mg/kg (compound)
gfp(+ ) (punct)
junction ) (punct)
cases mg/kg/day (dep)
reversed effect (dobj)
velocities displacements (conj)
change whereas (mark)
division the (det)
2.58 use (nmod)
agent reduction (nmod)
induced cycloheximide (nmod)
cocaine prenatally (advmod)
death defect (conj)
undertaken continued (advcl)
contribute dose (nsubj)
sulfate minimum (nmod)
was taken (advcl)
increase compared (dep)
block pathway (nmod)
abnormalities treatment (nmod)
efficacious . (punct)
show occurring (advcl)
inhibition for (case)
invaded astrocytes (nsubj)
produced microinjection (nmod)
glycine co-agonist (appos)
specimens native (amod)
sc 10 (nummod)
outcomes despite (case)
patients granulomatosis (nmod)
patient b (nmod)
administration ketanserin (compound)
levels rapa (compound)
involvement aetiology (nmod)
given female (nmod)
hypotension tachycardia (conj)
obtained one (nmod)
constructed were (auxpass)
caused tilt (nsubj)
ineffective diphenhydramine (nsubj)
threshold nociceptive (amod)
offered patient (nmod)
treated groups (nmod)
breaks sbs (appos)
aneurysm nontraumatic (amod)
simvastatin with (case)
mg/m(2 900 (nummod)
appeared leading (advcl)
treated 0.5%/12h (nmod)
episode last (amod)
= nm (dep)
often saline (advcl)
applied . (punct)
encephalopathy valproate (compound)
diagnosis sah (nmod)
majority ) (punct)
correlate . (punct)
setting ) (punct)
group c (compound)
remains unclear (acomp)
prevent bruising (dobj)
extend duration (dobj)
indicates relationship (dobj)
ap ) (punct)
l-alpha-gfc , (punct)
developed loss (dobj)
exerting in (mark)
receptors gh (compound)
incidence rejection (nmod)
affinities sodium (compound)
suggests occurs (ccomp)
doses small (amod)
reaction drug (compound)
dorsal right (amod)
included oxacillin (nsubjpass)
effects challenge (nmod)
randomized starting (xcomp)
erythematosus , (punct)
angiogram coronary (amod)
year 2 (nummod)
increased propranolol (nmod)
l-isomer ) (punct)
setting tma (nmod)
feasible not (neg)
rats hypertensive (amod)
hydroxyanisole butylated (amod)
24.9 23.3 (conj)
% 67.5 (nummod)
faint sometimes (advmod)
delivered gnc92h2 (nsubjpass)
wine of (case)
review with (case)
drug infection (conj)
used clinically (advmod)
reduction times (nmod)
preceded up-regulation (nsubj)
arrhythmias unpredictable (amod)
improvement to (case)
elucidate might (aux)
abnormalities implications (dep)
mechanisms two (nummod)
septal ventricular (amod)
growth no (neg)
retina nerve (dep)
antineoplastic is (cop)
presented torsades (dobj)
anemia androgen (compound)
value from (case)
sensitive finding (dep)
considered cases (nmod)
first telithromycin (nsubj)
satisfactory . (punct)
mg/dl than (case)
cycles during (case)
toleration doses (nmod)
dividing spectrum (dobj)
evoke contrast (nmod)
initiated treatment (nsubjpass)
unrelated was (cop)
excretion nos (conj)
exposed mg (nmod)
did and (cc)
period ( (punct)
cause indistinguishable (xcomp)
disease atherosclerotic (amod)
assigned clonidine (nmod)
seen episode (nsubjpass)
clinician complications (nmod)
jaw ( (punct)
carcinoma metastatic (amod)
introduction treatment (nmod)
11 1.9 (conj)
cases of (case)
withdrawal alcohol (compound)
complained . (punct)
thalidomide neurotoxicity (conj)
lower is (cop)
mumol/kg doses (conj)
neurotoxicity ( (punct)
introduction inhibitors (nmod)
them between (case)
reassessed were (auxpass)
homozygous jj (dep)
process , (punct)
tdi mg (conj)
protection by (case)
transplantation cadaver (compound)
ketamine the (det)
variables videofluoroscopic (amod)
analysis . (punct)
aneurysm aortic (amod)
metabolized and (cc)
pretreatment sec (appos)
administered : (punct)
provided nanoparticles (nsubj)
bouts acute (amod)
profile blood (compound)
hypotension induced (acl)
cholecystitis requiring (acl)
responder complete (amod)
protein calcium-binding (amod)
rebound post-snp (amod)
undertaken determine (xcomp)
determine improve (conj)
received immunosuppression (nmod)
hepatitis viral (amod)
mice g (appos)
recurred dose (nmod)
regained status (dobj)
vt symptomatic (amod)
mg/m2 carbenicillin (conj)
urge caution (dobj)
keratectomy photorefractive (amod)
had concentrations (conj)
studies nascis (appos)
dose vitamin (compound)
associated possibly (advmod)
cultures primary (amod)
studied produced (conj)
-18.48 vs. (cc)
indication the (det)
toxicity dph (compound)
assessed imaging (nmod)
1 cent (nmod)
inhibited hypertrophy (dobj)
agonists direct (amod)
minutes 5 (nummod)
1 intervals (conj)
occurred since (mark)
emergence anesthesia (nmod)
arrhythmia findings (conj)
doxorubicin by (case)
transgenic and (cc)
had and (cc)
increased when (advmod)
abolished increases (dobj)
induction effects (dep)
compromising and (cc)
infusion antagonists (nmod)
contributed be (auxpass)
proliferation peroxisomes (nmod)
verapamil to (case)
attributed it (nsubjpass)
< .01 (dep)
reduced fragmentation (dobj)
degree real (amod)
feasibility agent (nmod)
oscillations of (case)
showed 99mtc-ecd-spect (nsubj)
blockade dose-dependent (amod)
24.2 13.9 (conj)
suxamethonium of (case)
resurgence treatment (nmod)
used admission (nmod)
demonstrated be (auxpass)
change values (nsubj)
superior reduction (nmod)
modulate directly (advmod)
impairment growth (compound)
seizures experienced (amod)
morphine cnsb002 (dep)
attenuated administration (nsubj)
courses . (punct)
consider vasculitis (dobj)
volume lesion (nmod)
domain enzyme (nmod)
used stop-watch (nsubjpass)
fractures for (case)
determines phenotype (dobj)
studies phase (compound)
contractility gallbladder (compound)
decreasing in (mark)
pain electrocardiographic (conj)
atropine unselective (amod)
administration igf (dep)
s 8+/-4 (amod)
adenosine radioactive (amod)
greater 20-fold (advmod)
mice b6d2f1 (compound)
disease mulv (compound)
decrease expression (conj)
weeks weighing (conj)
fragments by (case)
illness monkeys (nmod)
different dental (dep)
observed response (advcl)
woman 21-year-old (amod)
aimed background (dep)
transferred unit (nmod)
comprised group (nsubj)
weighed risk (nmod)
patient phenytoin (nmod)
bau daily (amod)
held was (auxpass)
evidence disease (nmod)
alf the (det)
transmitted segment (nmod)
dosages these (det)
became caused (ccomp)
using studies (nsubj)
given conjunction (nmod)
folate e (conj)
increase similar (amod)
anesthetics these (det)
study experimental (amod)
hitherto this (det)
sinusoidal canalicular (conj)
minute association (nmod)
hyperthermia whole (compound)
associated sulindac (nsubjpass)
gtn dcf (conj)
confusion cimetidine-associated (amod)
interference synthesis (nmod)
absorption causing (acl)
ptra ) (punct)
minor neurotoxicity (nsubj)
derivative oxazolidine (compound)
120 up (advmod)
has comparison (nmod)
it ( (punct)
transgenic 8-week-old (amod)
desire such (case)
her to (case)
characterized sensitization (nmod)
apnoea postoperative (amod)
rate increase (nmod)
order determine (acl)
syndrome use (conj)
h reperfusion (nmod)
nomifensine by (case)
proteins system (compound)
fbal ) (punct)
rewarding aversive (conj)
decreased administration (nsubj)
treatment cataracts (nmod)
p who (nsubj)
include tolerance (dobj)
reduction p (dep)
associated b (nmod)
those function (nmod)
reports hepatotoxicity (nmod)
case hypercalcaemia (nmod)
common 0.0005 (parataxis)
ratio tamoxifen (nmod)
literature subject (nmod)
was = (dep)
increased molecularly (advmod)
discontinued indinavir (nsubjpass)
tna ) (punct)
university marmara (compound)
klebsiella pneumoniae (amod)
administration sedation (nmod)
d1 t3n1m0 (appos)
overdose venlafaxine (nmod)
known few (conj)
prilocaine after (case)
dogs defect (nmod)
unique that (nsubj)
seizure technique (dobj)
distinguished urinalysis (nmod)
inhibitor no (compound)
increases fev1 (nmod)
administration digoxin (nmod)
individuals 3 (nummod)
decreased gentamicin (nsubj)
3'-azido-2',3'-deoxythymidine ) (punct)
leukemia system (compound)
drug blockade (conj)
micrograms 0.6 (compound)
associated percentage (nsubjpass)
rigidity an (det)
regimen one (nummod)
examined possibility (nsubjpass)
clentiazem hand (compound)
candidate is (cop)
concluded observations (nmod)
tm 4-phenylbutyrate (nmod)
inhibit values (nmod)
limited studies (nsubj)
increments lactate (nmod)
plays little (dobj)
injected after (mark)
calculation dose (compound)
ischemic or (cc)
produced symptoms (dobj)
des , (punct)
myositis of (case)
measures impedance-derived (amod)
cystitis symptomatic (amod)
window a (det)
effects both (cc:preconj)
reduced whereas (mark)
suggests sufficient (ccomp)
cases anemias (nmod)
frequency relevant (amod)
received not (neg)
indicated is (auxpass)
treatment an (det)
corresponds analysis (nmod)
ph rate (appos)
useful antagonist (nsubj)
retention test (nmod)
agent ideal (amod)
injected day (nmod)
association start (nmod)
terms reducing (advcl)
course 90-day (amod)
administered mg/kg (dep)
study mr (compound)
occurrence transplantation (nmod)
level drug (compound)
b.d . (punct)
duct collecting (amod)
changes subtle (amod)
required required (advcl)
given was (auxpass)
correspond activation (nmod)
produces effects (dobj)
urticaria conjunctivitis (conj)
symptoms no (neg)
appears significant (xcomp)
n/n=9/26 or (cc)
used group (dep)
toxicities these (det)
remain unknown (acomp)
> when (advmod)
belonging groups (nmod)
demonstrated operation (nmod)
six remaining (amod)
recipient living (amod)
study given (acl)
grading histopathological (amod)
potential cells (nmod)
prevalence a (det)
indicated dse (nsubj)
outflow low (amod)
isoniazid micrograms (conj)
follow-up year (compound)
lc resulted (acl:relcl)
u/l 67 (nummod)
bupropion adjunctive (amod)
has disadvantages (dobj)
increased concentrations (dobj)
system endogenous (amod)
infusion dobutamine (compound)
analyzed rats (nmod)
neurons striatal (amod)
trespass ( (punct)
route tapering (conj)
hemorrhage iliopsoas (amod)
flare dose-dependent (amod)
67.9 +/- (cc)
lowered mice (nmod)
solution timolol (compound)
ops of (case)
recognize clinician (nsubj)
mg/dl 0.5 (nummod)
encephalopathy patient (nmod)
either alone (advmod)
damage mitochondrial (amod)
clear are (cop)
induces toxicity (dobj)
provide stimulation (nsubj)
potent 20,000fold (nmod)
evaluated conditions (nmod)
tested level (nmod)
functionality triad (amod)
ended . (punct)
treatment corticosteroids (nmod)
creatinine nitrogen (conj)
radius of (case)
salt is (cop)
characterized ears (dep)
glutamate in (case)
periods treatment (compound)
daily continuous (amod)
included disease (dobj)
count blood (compound)
days/week 5 (nummod)
mirrored , (punct)
synthase inducible-no (amod)
disorder this (det)
had used (advcl)
sweating . (punct)
cause hypotension (dobj)
breaking junctions (nmod)
glutamate capsaicin (conj)
amlodipine the (det)
disruption tam (nmod)
score timi (compound)
potent propranolol (nmod)
level expression (compound)
documented radiography (nmod)
shake behavior (dep)
3.8 10 (conj)
returned strength (nsubj)
significant analysis (nmod)
seconds site (nmod)
imply , (punct)
expectancy average (amod)
responses control (nmod)
factor determining (amod)
infants of (case)
intervals s (nmod)
population factors (nmod)
morbidity ct (nmod)
scopolamine placebo (conj)
prevent transplantation (nmod)
metoprolol diltiazem (conj)
dependent was (cop)
model evaluate (acl)
type nor (cc)
role effect (nmod)
7-pentoxyresorufin-o-dealkylase prod (appos)
impairments damage (conj)
toxicity metronidazole (compound)
release in (case)
effects constipating (amod)
regimens conditioning (compound)
nodules within (case)
drugs psychoactive (amod)
included score (nmod)
repair tissue (compound)
induced experimentally (advmod)
times reaction (compound)
adhd in (case)
enhance activity (dobj)
protected not (neg)
focal segmental (conj)
1985 in (case)
td in (case)
had min (nmod)
obese that (mark)
longer was (cop)
involvement dentate (amod)
target ' (case)
assessed examination (nmod)
presented department (nmod)
suggest indicators (ccomp)
induced significantly (advmod)
received period (nmod)
evaluated efficacy (dobj)
experiment fmri (compound)
midazolam improved (conj)
alterations ecg (compound)
phenacetin either (cc:preconj)
mfs of (case)
increased risk (nsubjpass)
model symptom (compound)
0.19 from (case)
2 of (case)
10 7 (conj)
doctors boston (nmod)
bromocriptine by (case)
prevention ulcers (nmod)
inhibitor-associated ace (nmod:npmod)
damage capillary (nmod)
recruited clinic (nmod)
related activities (nmod)
aor [ (punct)
cab acetate (dep)
describes effects (dobj)
observed until (mark)
complication recognized (amod)
remained 18 (dep)
induced hippocampus (nmod)
held , (punct)
slices medulla (conj)
mechanism endogenous (amod)
upset , (punct)
evaluated effects (nsubjpass)
reflex human (amod)
etoposide cyclophosphamide (conj)
result increase (nmod)
fibrosis quantified (acl)
antigens tgf-beta1 (compound)
dose l-dopa (dep)
result that (mark)
na for (case)
loop motor (compound)
deficits users (nmod)
fell elevated (advcl)
cck-8 ( (punct)
3.58 - (punct)
examination intervention(s (compound)
related which (nsubj)
finished nine (nsubj)
treated males (nsubjpass)
advised are (auxpass)
1.210 - (punct)
addition . (punct)
hypotension haemodilution (conj)
tet ( (punct)
further to (mark)
diseases the (det)
induced carbimazole (nsubj)
astrocytes surrounding (acl)
had although (mark)
performed tumors (nmod)
group pretreatment (compound)
releaser the (det)
based solely (advmod)
emissions on (case)
area damaged (amod)
fluid csf (appos)
enrolment ( (punct)
troponins cardiac (amod)
nigra the (det)
inhibitor reductase (compound)
ingestion surreptitious (amod)
resolution findings (nmod)
quadriplegic virtually (advmod)
therapy despite (case)
resection during (case)
users vs (cc)
percent eighty-one (nummod)
altered architecture (dobj)
attenuated treatment (nsubj)
children disease (nmod)
dehydrogenase transaminase (conj)
months 59.7 (nummod)
necrosis due (case)
cells interneurons (conj)
newborns in (case)
complications uveitis (nmod)
effects opposite (amod)
treatment had (acl:relcl)
findings baby (nmod)
carbachol and (cc)
chlorhexidine-digluconate associated (dep)
presenting hours (nmod)
subjects age-matched (amod)
agents individual (amod)
effects betamimetic (amod)
suggesting , (punct)
disruption signaling (nmod)
dro-1h- 5-{2-[4-(1,2-dihydro-2-acenaphthylenyl)piperazinyl]ethyl}-2,3-dihy (compound)
is reported (csubj)
prerequisite a (det)
attribute doctors (nsubj)
included level (dobj)
time ictus (nmod)
was showed (conj)
dose potent (amod)
limited observed (advcl)
days 150 (nummod)
criteria clinical (amod)
occurred patients (nmod)
tamoxifen combined (conj)
had features (dobj)
consists cessation (nmod)
changes status (compound)
infusion chronic (amod)
showed simulations (nsubj)
contributes possibly (advmod)
startle les (nmod)
showed risk (dobj)
haloperidol ip (appos)
doses selected (amod)
correlate not (neg)
1,3-bis-(2-chloroethyl)-1-nitrosourea ( (punct)
deformities orthopaedic (amod)
prevented impairment (dobj)
monitor advise (conj)
dehydration and (cc)
study case-control (compound)
neurotoxicity mice (nmod)
risk ? (punct)
238 253 (conj)
effect potassium (dobj)
given diazepam (dobj)
vulnerable that (mark)
suxamethonium or (cc)
shown in (prep)
hexachloro-1:3-butadiene aminonucleoside (conj)
agitation shouts (conj)
believed indicate (ccomp)
cases date (nmod)
predictable reduction (nmod)
discuss herein (advmod)
resulting accumulation (nmod)
pain penile (amod)
step regulation (nmod)
associated mitomycin (nmod:npmod)
suggests patient (nsubj)
wore gradually (advmod)
results pallidotomy (nmod)
determined back-diffusion (nsubjpass)
ability on (case)
matter and (cc)
compromising occurred (conj)
components as (case)
encephalopathy due (case)
received h (nmod)
exchanges , (punct)
s-53482 to (case)
= 0.09 (dep)
increase sharp (amod)
motion chicks (nsubj)
prescribe molindone (dobj)
used establish (xcomp)
thrombi microangiopathies (nmod)
contributes effects (nmod)
points role (nmod)
emphasis with (case)
safety women (nmod)
modification this (det)
was adjusted (conj)
also endpoint (nsubj)
3 was (cop)
twenty-one patients (nmod)
embryopathy anotia (nmod)
toxicity carbonate (compound)
dexamethasone ocular (amod)
scotoma unusual (amod)
school university (conj)
known 4-aminopyridine (nsubjpass)
internus globus (compound)
therapeutic better (advmod)
origin of (case)
suggest to (mark)
interclass ( (punct)
adenosine n(6)-cyclopentyl (compound)
infusion flestolol (compound)
facilitates that (mark)
humidity relative (amod)
prevented effect (dobj)
modifications rats (nmod)
gsh cortical (amod)
0.05 incidence (nsubj)
range more (amod)
bradycardia hypotension (conj)
infusion auc (nmod)
groups h. (nmod)
mg infusion (compound)
exposure vehicle (nmod)
performed instillation (nmod)
included > (nsubj)
agonist clonidine (appos)
produced alfentanil (nmod)
differ to (mark)
moderate-dose control (dep)
interactions drug-drug (compound)
conclusion plays (dep)
hypothyroidism unknown (amod)
intensity gap43-ir (nmod)
report woman (nmod)
49 1 (conj)
diameter clearance (conj)
followed have (conj)
71.3 +/- (cc)
majority nodules (nmod)
vocabulary a (det)
external and (cc)
effect central (amod)
evaluation decompression (nmod)
functions motor (compound)
constriction sparing (nmod)
intake diuresis (conj)
animals subjected (acl)
were day (nmod)
3 months (conj)
part nodules (nmod)
led % (nmod)
microg of (case)
is addition (nmod)
apigenin flavonoid (compound)
recived position (nmod)
tachycardia carbachol (nmod)
mol/l ) (punct)
only sparingly (advmod)
exists duration (nmod)
conclude preserved (ccomp)
associated repression (nmod)
ceased ; (punct)
copolymer unmodified (amod)
examination laboratory (conj)
bupivacaine dogs (nmod)
prognosis a (det)
transferase gamma (compound)
symptoms ocular (amod)
seemed correlation (xcomp)
became who (nsubj)
period longer (amod)
risk ( (punct)
relevant is (cop)
effect antagonist (nmod)
40 - (punct)
standard dysphonia (nmod)
method randomised (dep)
partial n (dep)
procedures myocardial (amod)
associated volumes (nmod)
anatomy internus (nmod)
elucidate to (mark)
cycles patients (nmod)
hydrobromide pine (compound)
recipients transplant (compound)
ethinyl rats (dobj)
ability their (nmod:poss)
mhb little (amod)
malaria for (case)
agent doxorubicin (nsubj)
hippocampus and (cc)
test both (cc:preconj)
hypercholesterolemia with (case)
impact alterations (nsubj)
transcript ldlr (compound)
bp bp (conj)
h. , (punct)
caudate-putamen the (det)
inhibitors and (cc)
paralleled was (auxpass)
strain t (conj)
increased , (punct)
examine become (ccomp)
cardiac morphological (amod)
pretreatment chebula (compound)
included extremities (dobj)
bicuspid valve (dep)
other n (appos)
predictable development (nsubj)
massive among (case)
outcome adverse (amod)
decreased course (dobj)
decreased similarly (advmod)
old year (nmod:npmod)
findings consistent (amod)
studies mri (compound)
d-med , (punct)
quantitative for (case)
lesion nigra (amod)
conversion a (nmod)
cd4 , (punct)
% 67 (compound)
case episodes (nmod)
protocol a (det)
conclusion nausea (dep)
cefonicid and (cc)
unchanged groups (nmod)
appeared days (nmod)
variability natural (amod)
negative myeloperoxidase-anca (nsubj)
dysfunction lv (compound)
release acetylcholine-induced (amod)
case reported (acl)
relief symptoms (compound)
neoplasm a (det)
weeks treatment (nmod)
reduplication membranes (nmod)
decreased po2 (nsubj)
scabies for (case)
included included (conj)
investigating unfortunately (advmod)
higher addition (nmod)
concentrations dopamine (nmod)
cultured epo (nmod)
identical nearly (advmod)
revealed interaction (dobj)
lower times (nmod:npmod)
reductions subscale (nmod)
dementia diagnosed (amod)
reactions from (case)
unchanged im (nmod)
development antibodies (nmod)
focused been (auxpass)
days 4 (nummod)
born were (auxpass)
cm 5 (compound)
dependent range (nmod)
addition damage (nmod)
increased 0.83 (nmod)
given nacl (nsubjpass)
tested severity (nsubjpass)
alkaloid cause (advcl)
benefits only (advmod)
1,3-butadiene cml (conj)
200 4.40 (dep)
min edrophonium (nmod)
favored reports (nsubj)
contribution regulation (nmod)
contractions ileum (nmod)
include infections (dobj)
decreased concomitantly (advmod)
12 out (advmod)
remains role (nsubj)
response locomotor (compound)
ci 0.899 (nummod)
albuterol . (punct)
other from (case)
reinitiated ; (punct)
transplantation heart (compound)
months duration (compound)
disadvantages vasodilator (nsubj)
any findings (nmod)
period least (advmod)
communicate regulate (advcl)
= 2.8 (dep)
complicated mechanisms (nsubj)
bacteria susceptible (amod)
increasing number (dobj)
administration ng (nmod)
anemia ribavirin (compound)
h therapy (nmod)
zidovudine by (case)
recognized effects (dobj)
publications several (amod)
women menopausal (amod)
no of (case)
warfarin on (case)
eight of (quantmod)
agents alter (acl:relcl)
nitrate alcohol (conj)
22 % (dep)
prevention h (dep)
ampicillin by (case)
relevant more (advmod)
enhancement contrast (compound)
suggest improve (ccomp)
acute lungs (nmod)
failure acute (amod)
leukemia chronic (amod)
opiate any (det)
1.050 1.025 (compound)
change time (nmod)
therapies ribavirin (nmod)
reversal . (punct)
dipyridamole test (dep)
cases myositis (nmod)
shock syndrome (conj)
carbonate calcitriol (conj)
stenosis of (case)
influences activity (nmod)
years 7.7 (nummod)
undergoing . (punct)
iv mg/kg (compound)
persisted months (dobj)
day 38 (conj)
relationship positive (amod)
drug capable (amod)
online either (cc:preconj)
effects put (nmod)
34 % (appos)
rats low (amod)
documents crescents (nmod)
develop increases (nmod)
mpa , (punct)
incidence cysts (nmod)
urge hyperactivity (conj)
effective therefore (advmod)
one % (appos)
processing users (nmod)
concentrations sgot (nmod)
times treatment (compound)
dismutase catalase (conj)
therapy rupture (conj)
higher disease (nmod)
1000 about (advmod)
selected reviews (nsubjpass)
micrograms monthly (advmod)
sign involvement (nmod)
paws and (cc)
cystitis chlorhexidine-digluconate (amod)
alterations reserpine-induced (amod)
hemorrhage either (cc:preconj)
decreased different (ccomp)
supposed we (nsubj)
observations patients (nmod)
gestodene desogestrel (conj)
levels acetylcholine (compound)
difference that (nmod)
induced volume (conj)
values nm (nmod)
effect deferoxamine (conj)
beclomethasone on (case)
dfo 's (case)
pm ( (punct)
association level (nmod)
year years (conj)
planned was (auxpass)
expression factor (nmod)
treated sub-chronically (advmod)
fas soluble (amod)
response % (nmod)
challenged induce (xcomp)
study stimulation (compound)
p20 ( (punct)
respiration adequate (amod)
antigen hepatitis-b (compound)
infarction , (punct)
seizures typical (amod)
followed review (nmod)
quadrants superior (amod)
controls macroprolactinemia (conj)
secondary ( (punct)
% 25%-30 (nummod)
meth characteristic (acl:relcl)
underlying virus (dobj)
sas ) (punct)
tachycardia atrioventricular (amod)
interaction report (dep)
sites and (cc)
dysfunction nerve (compound)
drug common (amod)
clinical neuroimaging (conj)
suggest words (nmod)
pneumonia for (case)
demonstrated test (nsubj)
rage hissing (advcl)
helpful . (punct)
decarboxylase l-glutamic (amod)
ratio cpa/ee (nmod)
114.6 to (case)
concentrations mean (compound)
scores memory (compound)
titration the (det)
appeared defects (nsubj)
loreclezole alone (advmod)
milligrams kilogram (nmod)
stained tissues (dobj)
tpp for (case)
deficits and (cc)
homoeostasis frontostriatal (amod)
accompanied , (punct)
protects myocytes (dobj)
engine the (det)
b12 vitamin (compound)
existed controversy (nsubj)
strips body (compound)
appeared months (nmod)
effect catalepsy (nmod)
complaints all (det)
community the (det)
level angiotension (nmod)
treatments by (case)
reason that (mark)
50 less (advmod)
fibrosis degree (nmod)
timing suitable (amod)
trial ; (punct)
mg b.d (amod)
development complication (nmod)
allergies no (det)
model epilepticus (compound)
worsen may (aux)
or 1.4 (conj)
associated decrease (nmod)
prepared cells (nmod)
effects recall (nmod)
impact moreover (advmod)
correlated age (nmod)
incidence rats (nmod)
dopaminergic and (cc)
2.5 0.03 (conj)
agents mofetil (appos)
thrombocytopenia hit (conj)
interfere administration (nsubj)
noted week (nmod:tmod)
findings laboratory (compound)
ci=26.7 29.7 (prep)
enhances augmentation (nmod)
compound to (mark)
mexiletine and (cc)
prominent extended (conj)
combination sodium (nmod)
doses 9.14 (conj)
mg/kg 4.67 (nummod)
performed interval (nmod)
structure cardiac (amod)
larger changes (nsubj)
induced the (det)
use department (nmod)
abnormalities thyroid (compound)
hepatitis with (case)
minute and (cc)
mechanisms cholestasis (nmod)
application transplantation (nmod)
striatum beyond (case)
schizophrenic an (det)
-0.12+/-0.5 ( (punct)
hematologic and (cc)
dose-related part (nmod:npmod)
necrosis ) (punct)
boy on (case)
served subjects (nsubj)
abolition dose (nmod)
45.5/18.2/6.1 leukopenia (dep)
mg/kg 1.0 (nummod)
intensify moreover (advmod)
cellulose plus (cc)
conclusion had (appos)
interferon pegylated (amod)
ml 60 (nummod)
implant before (case)
revealed tem (nsubj)
ci 101.74 (nummod)
segment precommunicating (compound)
unresponsive however (advmod)
discrimination the (det)
solubility the (det)
(aap)-hepatitis from (case)
inhibits bringing (xcomp)
risks switching (nmod)
ci-921 the (det)
use rifampicin (nmod)
withdrew case (nsubj)
predated , (punct)
mid- and (cc)
reduced increase (nsubjpass)
series of (case)
raise risk (dobj)
feasibility safety (conj)
excruciating to (mark)
0.25 cream (nmod)
established and (cc)
lna hca (dep)
dysregulation lipid (compound)
characteristics significance (acl:relcl)
difluoromethylornithine matched (conj)
138 6 (conj)
content kidney (nmod)
patients 18 (nummod)
urtication , (punct)
mediated reduced (conj)
injections pilocarpine (compound)
proteinuria clinically (advmod)
tetrabenazine with (case)
revert injections (nsubj)
mg/day week (nmod:tmod)
occurred intensity (nsubj)
pilocarpine after (case)
started min (dobj)
damage could (aux)
period across (case)
change et-1 (nmod)
put and (cc)
described ; (punct)
myeloma lymphoma (conj)
doses therapy (nmod)
p=0.0001 respectively (advmod)
t u (conj)
supplements administration (nmod)
was condition (nmod)
shock refractory (amod)
reversible potentially (advmod)
progesterone 6.25 (dep)
dose bw (nmod)
have assessed (advcl)
resulted photostimulation (nsubj)
events serious (amod)
test exercise (compound)
transaminase transient (amod)
rhabdomyolysis massive (amod)
therapy transplantation (nmod)
cpdd ) (punct)
associated recall (nmod)
alter properties (dobj)
suppressed baseline (dobj)
treatment double (amod)
determination in (case)
double-blind randomized (amod)
data echo (compound)
ingredient active (amod)
escape and (cc)
antagonists sigma2-preferring (amod)
pellet subcutaneous (amod)
was suggests (ccomp)
work cardiac (amod)
values divided (acl)
1 control (appos)
potential thrombosis (nmod)
show presented (advcl)
occurred majority (nmod)
cause hepatotoxicity (dobj)
urea and (cc)
treatment iso (compound)
toxicity mice (nmod)
intervals by (case)
mosmol/kg , (punct)
composition stones (nmod)
stimulation bilateral (amod)
5-fu due (case)
higher patients (nmod)
decreased 7alpha-hydroxylation (dobj)
functioning diseases (nmod)
induced end (nmod)
benefit little (amod)
alterations external (amod)
concentrations high (amod)
treatment bromocriptine (compound)
symptoms acute (amod)
associated cimetidine (nmod)
focused , (punct)
complications associated (acl)
caused cy (nsubj)
parallels users (nmod)
membranes 10(-5 (nmod)
release via (case)
exhaustion to (case)
assigned risperidone (conj)
acetate mg (appos)
combinations valproate (nmod)
tma recurrent (amod)
feet legs (conj)
accomplished easily (advmod)
pnd 35 (nummod)
functions its (nmod:poss)
% % (conj)
5.5 and (cc)
morphine nicotine (nmod)
preventing and (cc)
resulted changes (nmod)
surveillance treatment (conj)
antibodies proteins (nmod)
twin second (amod)
lowered significantly (advmod)
dose doxorubicin/kg (nmod)
96.7 range (appos)
% 89/102 (appos)
animals mg/kg (dep)
case 3 (nummod)
systolic the (dep)
administered s-1 (nmod)
score lowest (amod)
asphyxia were (cop)
methods reported (appos)
relaxed was (auxpass)
appearances busulfan (nmod)
procedures anemia (compound)
increased glibenclamide (nmod)
cm and (cc)
treatment conservative (amod)
haemopericardium . (punct)
lesions necrosis (nmod)
improves whether (mark)
m ( (punct)
score as (case)
produced jerks (dobj)
randomized immediately (advmod)
cardiotoxin that (mark)
corporation princeton (conj)
applicators exposed (acl)
proved antagonist (xcomp)
psychostimulant to (case)
induced seizures (nmod)
% 12.2 (nummod)
olig-anuria of (case)
depressive stronger (amod)
hypoxia transient (amod)
cells from (case)
increase mm (nmod)
times 5 (nummod)
region cortex (nmod)
received oxitropium (dobj)
adenocarcinoma inoperable (amod)
effective present (advcl)
recorded score (nsubjpass)
pge(2 that (det)
prior therapy (nmod)
regulation on (case)
elicited dose (nmod)
recognized treated (conj)
block complete (amod)
association hla-b35 (nmod)
metabolizers cyp2d6 (compound)
degeneration perhaps (advmod)
cause weakness (dobj)
pi ) (punct)
reductions mssbp (nmod)
demonstrate results (nsubj)
ml/s 1.68+/-0.11 (nummod)
inhibitor direct (amod)
flushing with (mark)
produced action (nmod)
pretreatment hds (nmod)
caused proteinuria (dobj)
improvements response (nmod)
patient postpartum (compound)
receiving mg (dep)
ato with (case)
stem contribution (nmod)
disease of (case)
prevented dosing (nsubj)
march between (case)
sensitized increasing (advcl)
disoprivan 1 (nummod)
nmol/l > (dep)
inhibited current (dobj)
received procedure (dobj)
progression and/or (cc)
pregnancies clinics (nmod)
noted seen (conj)
regimen cephalothin-gentamicin (amod)
animals group (nsubj)
neurophysiology of (case)
nephropathy fk506 (compound)
reaction observed (acl)
derangement to (case)
play may (aux)
two . (punct)
hyperprolactinemia amenorrhea/oligomenorrhea (conj)
weak and (cc)
mtdna of (case)
sonograms serial (amod)
recruited who (nsubjpass)
granulomatosis before (case)
hypotension hem-induced (amod)
evidence infection (nmod)
dose analogue (dep)
cases changes (nmod)
mg/kg day (nmod:tmod)
ed , (punct)
days first (amod)
varied 2.4 (nmod)
affected severely (advmod)
include which (nsubj)
causes from (case)
administered intracerebroventricularly (advmod)
used identify (xcomp)
grade 2 (conj)
2 through (case)
function behavior (compound)
highlight , (punct)
accumulating . (punct)
trihexyphenidyl or (cc)
potentiality model (nmod)
minutes + (cc)
compare and (cc)
mg/ml 60 (nummod)
dealing heparin (nmod)
bradycardia timolol-induced (amod)
months therapy (nmod)
interval h (nmod)
has cisplatin (nsubj)
dependent reversed (conj)
classified event (nsubjpass)
reduces dysfunction (dobj)
model for (case)
initiation following (case)
hemoglobin and (cc)
dissipates effect (compound)
injected gr (nmod)
relationship effects (conj)
% series (nmod)
continue sold (xcomp)
disorders induced (acl)
journals relevant (amod)
carries reaching (xcomp)
application no (det)
restoration for (case)
3mg/kg ) (punct)
monocytes peripheral (amod)
g 180 (nummod)
history population (nmod)
demonstrated caused (xcomp)
mg/kg 85 (nummod)
photostimulation layer (nmod)
gain they (nsubj)
given % (nsubjpass)
total angiograms (nmod)
greater 12 (nummod)
walls cavity (nmod)
subjected model (nmod)
area h (nmod)
state pre-denaturation (amod)
studies fibrillations (conj)
remained effusion (nsubj)
enhances subjects (nmod)
100 from (case)
compared those (nmod)
stem the (det)
rate death (compound)
explain presentation (dobj)
-18.48 + (cc)
medications the (det)
injured mitochondria (nmod)
picrotoxin- bicuculline-induced (conj)
conversion = (dep)
toxicity cocaine (nmod)
26 to (dep)
raise awareness (dobj)
levodopa selective (conj)
polymerase of (case)
increase therefore (advmod)
rise marked (amod)
utility cbz (nmod)
patient 34-year-old (amod)
human animal (conj)
% 14.28 (nummod)
increase fanft-induced (amod)
demonstrate imaging (nsubj)
correlation ctnt (nmod)
min(-1 electrocardiogram (nmod)
years 61 (nummod)
p450 of (case)
done observation (nsubjpass)
care supportive (amod)
dex or (cc)
led resembling (advcl)
were rats (nmod)
antagonize depletion (dobj)
= 0.36 (dobj)
period treatment (compound)
sensitive less (advmod)
parenchyma liver (compound)
risk interval (conj)
response for (case)
mtx with (case)
s ) (punct)
beginning parachlorophenylalanine (nmod)
shed might (aux)
evident later (advmod)
day agent (nmod)
abolished increase (dobj)
downregulated erythropoietin (nsubj)
medication neuroleptic (amod)
myelomeningocoele of (case)
curve 5 (nmod)
vasopressin peptide (conj)
achieved goal (dobj)
fos-immunoreactivity ir (appos)
given terbutaline (xcomp)
increased further (advmod)
induction tachycardia (nmod)
periods and (cc)
associated damage (nmod)
increasing levels (dobj)
inhibit respectively (advmod)
model detection (nmod)
mechanism main (amod)
behavioral and (cc)
107.4 8.4 (conj)
biopsies all (det)
receiving paralysis (nmod)
efficacy tolerability (conj)
cases/person-years exposure (nmod)
possible use (nmod)
course event (nmod)
reduced prolonged (conj)
striatum adjacent (amod)
subjects young (amod)
diluted mg (nsubj)
located neurons (nmod)
problematic often (advmod)
criterion any (det)
acid , (punct)
those have (acl:relcl)
induced anemia (nsubjpass)
vigilance close (amod)
entering frequency (dobj)
patients normal (nmod)
activations regions (nmod)
levels blood (nmod)
indicating retrievals (ccomp)
applied procedure (nsubjpass)
distributions lobular (amod)
monoarticular the (dep)
times for (case)
carcinoma . (punct)
neuroprotection lesion (nmod)
miss as (mark)
most ; (punct)
supports safety (dobj)
levels to (mark)
problem rate (nmod)
made vip(-/- (nmod)
compliance because (case)
greater brain (conj)
80 70 (compound)
serotonin 5-hydroxytryptamine (dep)
elevations kinase (compound)
levels along (case)
enhancement to (case)
method fractionator (compound)
mean examined (advcl)
manner adriamycin (compound)
agent tiazofurin (nsubj)
ganglia and (cc)
cd-832 both (cc:preconj)
process secretory (amod)
epinephrine , (punct)
mg/kg 350 (nummod)
fenestrae of (case)
consider returns (nmod)
introduction it (nsubj)
responsible regulation (nmod)
ability repeat (acl)
showed characteristics (dobj)
barrier bbb (appos)
blockade dopamine (compound)
variations malformations (conj)
pergolide of (case)
apart reduction (nmod)
rate increased (amod)
drugs anticoagulant (amod)
dose over (case)
anemia dapsone-associated (amod)
kidneys rats (nmod)
admitted years (nmod)
group hag (appos)
contaminants , (punct)
given attempted (conj)
reported myalgia (dobj)
began began (conj)
% 7.5 (nummod)
grading lown (compound)
generations two (nummod)
attenuated which (nsubj)
accompanied moreover (advmod)
levels metabolites (nmod)
satisfaction edits (appos)
purpose evaluate (dep)
had illness (dobj)
develop patients (nmod)
exposures without (case)
inhibitor new (amod)
cases any (det)
results stroma (nmod)
rat fischer (compound)
chemoconvulsants among (case)
0.48 0.24 (conj)
metabolite admixed (acl)
fill method (nmod)
indicate provoke (ccomp)
selection and (cc)
p=0.345 ( (punct)
produce response (dobj)
treatment short- (amod)
cephalosporins all (det)
did doses (nmod)
have therapy (nmod)
curve drc (appos)
level average (amod)
att-alf with (case)
disorders neuromuscular (amod)
expression clinical (amod)
patients asthma (nmod)
numbers patients (nmod)
5 women (nmod)
exposed , (punct)
reviewed method (nsubjpass)
resulted if (mark)
constipation not (neg)
developed been (auxpass)
proarrhythmia in (case)
selected we (nsubj)
myopathy human (amod)
tolerance rapid (amod)
quiet and (cc)
projections cord (nmod)
shown inhibit (xcomp)
rare . (punct)
case that (mark)
an-2-ol b (compound)
facilitation ro4368554 (nmod)
died pharmacological (nmod)
range level (nsubj)
epithelium upper (amod)
administration the (det)
sulpiride with (case)
28 17 (compound)
making in (mark)
he-lfb ( (punct)
carcinogens three (nummod)
shell ( (punct)
cgi-sf ( (punct)
eliminated independently (advmod)
1.5 1.4 (quantmod)
noted years (dep)
heat from (case)
5-fu and (cc)
acetylsalicylate sodium (compound)
episodes hypotensive (amod)
potentiates thereby (advmod)
blocked had (conj)
mediate expression (nmod)
rate ventricular (amod)
left fractions (dobj)
unclear nature (nsubj)
arrhythmia stabilizers (conj)
group pan/temocapril (compound)
number by (case)
multicenter methods (dep)
= 0.03 (dobj)
concentration extraction (conj)
mucosa to (case)
association depression (nmod)
substrates these (det)
mites demodex (compound)
therapy additional (amod)
adjustment without (conj)
series conventional (amod)
episode depressive (amod)
period 3 (nummod)
5.7 0 (compound)
factors sensitization (nmod)
deterioration an (det)
degree severe (amod)
alter that (mark)
mg/dl 50 (nummod)
precipitation tubule (nmod)
damage induced (acl)
induced bradycardia (dobj)
angioedema lips (nmod)
stopped ethambutol (nsubjpass)
child to (case)
problem red (amod)
delay after (case)
receptor-alpha , (punct)
therapy oxygen (compound)
e-1 ) (punct)
interaction level (nmod)
increases period (nmod)
objective evaluated (dep)
need eliminating (advcl)
scores severity (compound)
mediated types (nsubjpass)
prolactin for (case)
-cimetidine 2 (nummod)
interactions and (cc)
causes reference (nmod)
primates nonhuman (amod)
lesions similar (amod)
activation . (punct)
biosynthesis acetylcholine (compound)
symptoms tic-like (amod)
elevation phe-induced (amod)
peroxidation activity (conj)
contractility and (cc)
% survival (nsubj)
grow mg (nmod)
upregulation system (nmod)
demonstrate reaction (dobj)
myopathy with (case)
episode as (case)
ircrf ) (punct)
restores impairment (dobj)
experienced thereafter (advmod)
d-ribose doses (nmod)
prox-1 marker (appos)
decreased number (nsubj)
subjects 14 (nummod)
disturbed that (mark)
symptoms methylphenidate-induced (amod)
reaction real-time (amod)
hazardous be (cop)
improved nx (nmod)
alpha2-adrenergic i1-imidazoline (conj)
lead toxicity (nmod)
material january (nmod)
treated ; (punct)
caused elevation (dobj)
conditions novel (amod)
slow not (neg)
occurs also (advmod)
underwent 2 (dep)
neuropathy however (advmod)
block with (case)
treated always (advmod)
believed cause (nsubjpass)
insights pathogenesis (nmod)
restricted patients (nmod)
cholestasis anicteric (amod)
dyskinesias lid (appos)
shown recently (advmod)
organization ( (punct)
threshold expression (nmod)
surgery stereotaxic (amod)
pharmacodynamics the (det)
effects manipulating (acl)
radicals free (amod)
model model (nmod)
study rat (compound)
therapy infusion (compound)
criteria coma (nmod)
efficacy p.o. (appos)
5 x/minute (dep)
pathway kynurenine (compound)
subsided administration (nmod)
17.0 4.6 (conj)
muscarinic adrenergic (conj)
correlated temporally (advmod)
resulted survivors (nmod)
medications diet (amod)
neuropathy in (case)
84 98 (dep)
dogs beagle (compound)
carriers ) (punct)
man administered (acl:relcl)
result was (cop)
less betaxolol (nsubj)
levels rats (nmod)
antagonized however (advmod)
mrp2 ( (punct)
injury whose (nmod:poss)
blind were (cop)
years 49 (nummod)
attenuated injury (dobj)
outbreak deaths (nmod)
disorder or=12.619 (dep)
pg to (case)
comparable kinetics (nsubj)
scattered ( (punct)
found admission (nmod)
20,40,60 and (cc)
20.12 2.20 (conj)
receive rule (dobj)
boy an (det)
confirmed trials (nmod)
used generate (xcomp)
control tumor (compound)
induce sulphasalazine (nsubj)
factors early (amod)
undertaken stay (nmod)
hygiene , (punct)
follow-up % (appos)
episodes 2 (nummod)
s.c. kg-1 (compound)
remissions ) (punct)
syncope of (case)
sensitive changes (nmod)
peptide which (nsubj)
report coma (nmod)
important level (nsubj)
score neurological (amod)
patients triggered (acl:relcl)
cells node (compound)
antagonized enhancement (nsubjpass)
injury traumatic (amod)
t p (appos)
developed rash (dobj)
pastes of (case)
came who (nsubj)
yet times (nmod)
show detect (ccomp)
caused associated (conj)
inhibitor used (amod)
vp-16 - (punct)
procedures manage (acl:relcl)
time collection (nmod)
ph content (conj)
levels malondialdehyde (amod)
observed nephropathy (advmod)
n-butyl-deoxynojirimycin zidovudine (conj)
pattern clinical (compound)
quantify to (mark)
dysfunction an (det)
difficult technically (advmod)
dystonia reversible (amod)
treatment combination (compound)
decrease acid (nmod)
rates rubella (conj)
aggravated exposure (nsubj)
use it (nsubj)
function cord (compound)
given controls (nsubjpass)
have which (nsubj)
parameters clinical (amod)
acquainted . (punct)
rise pressure (nmod)
78 vs (cc)
contribute rates (nmod)
toxicity levels (conj)
administrations theophylline (nmod)
rats induce (xcomp)
effects thalidomide (nmod)
produced nmda (nmod)
electroretinography electroretinography (conj)
enrolled diclofenac (conj)
ug/ml 0.52 (nummod)
switch manic (amod)
increased ; (punct)
summary histories (appos)
pose thus (advmod)
stimulation sympathetic (amod)
he-lfb , (punct)
immunohistochemistry with (case)
induction superoxide (nmod)
trial pre-test (appos)
used drug (nmod)
evaluated placebo (advcl)
rate an (det)
resistant , (punct)
flexion to (case)
practices care (compound)
demonstrated persistence (dobj)
measured prl-r (dobj)
predict later (advmod)
m 0.15 (compound)
fractions greater (nmod)
striatum in (case)
cases validated (amod)
n-butyl-deoxynojirimycin and (cc)
play accelerating (advcl)
age /= (dep)
remains challenge (attr)
activation stimulation (nmod)
study animals (nmod)
prescribed addition (nmod)
potentiate progesterone (nsubj)
stands amoxicillin-clavulanate (nsubj)
subjects . (punct)
toxicity mechanisms (conj)
attributable . (punct)
lowered markedly (advmod)
tna ( (punct)
wk within (case)
showed species (dobj)
equipotent they (nsubj)
sex female (appos)
changes loss (conj)
30 more (conj)
myelin and (cc)
0.35 0.08 (conj)
hyperammonemic transient (amod)
end infusion (nmod)
obtained fluid (nsubjpass)
syndrome myelodysplastic (amod)
width band (nmod)
increased return (nsubj)
rate on (case)
stream the (det)
seen aes (nmod)
diabetes , (punct)
a p (appos)
absorption systemic (amod)
cause women (nmod)
% p<0.0001 (appos)
variables the (det)
enhancement and (cc)
course consequences (nmod)
disease infarctions (nmod)
cd4 cells/microl (dep)
females treated (amod)
concentration peroxide (compound)
dna hbv (compound)
receiving metoprolol (dobj)
atpase k+ (compound)
hilus contrasted (acl)
blockade ii (nummod)
granulated well (advmod)
rechallenge including (case)
case one (nummod)
absorbed rapidly (advmod)
evidence tuberculosis (nmod)
oliguria reversible (amod)
segments spinal (amod)
seizures nicotine-induced (amod)
vohland ( (punct)
two , (punct)
changes antibodies (dep)
recumbent both (cc:preconj)
droplets nag (compound)
misjudgment of (case)
monitoring proper (amod)
activator plasminogen (compound)
mechanism omeprazole (nmod)
symptoms aura (compound)
improves exposure (nmod)
blocked inhibition (nsubj)
sufficient presence (nsubj)
levels states (nmod)
function retina (nmod)
score goldstein (compound)
increase heart-rate (nmod)
dysmorphism disorder (conj)
tended cells (nsubj)
decrease min-1 (nmod)
igf ii (nummod)
intrahepatic extrahepatic (conj)
less 0.01).(abstract (nmod)
review to (mark)
inhaler by (case)
encephalopathy cerebral (conj)
changes km (nmod)
reduced subjects (nmod)
revealed further (advmod)
ngf in (case)
used they (nsubj)
documented monitoring (nmod)
determined immunohistochemistry (nmod)
mrna responsible (amod)
observed these (nsubjpass)
reveals complexity (dobj)
group chx+pilo (amod)
9.1 2.0 (conj)
restricted that (mark)
s s (nmod)
animals bmc-treated (amod)
role protective (amod)
hours 8 (nummod)
hyperthyroidism with (case)
echocardiography biopsy (conj)
use opioids (nmod)
disorder : (punct)
lasted terminated (conj)
clarithromycin , (punct)
doses routine (amod)
were acetaminophen (advcl)
performed fetuses (nmod)
group ato (compound)
range 68- (dep)
analyzed weeks (nmod)
located layer (nmod)
undergoing catheterization (dobj)
protein be (cop)
features consistent (amod)
hepatomegaly with (case)
real not (conj)
akathisia , (punct)
hemolysis leading (acl)
expression igf-i (nmod)
acquired and (cc)
participants 12 (nummod)
compared values (nmod)
printout a (det)
drugs abuse (nmod)
mosmol/kg 263 (nummod)
ao ) (punct)
gaba(a)rs at (case)
vomiting to (case)
anemia reaction (appos)
pbto(2 ) (punct)
depression disturbance (conj)
have therapy (nsubj)
effects seen (acl)
infusions minimum (nmod)
observed myalgia/arthralgia (nsubjpass)
investigators other (amod)
effect cytopathic (amod)
0.06 concentrations (nsubj)
years follow-up (nmod)
war somalia (compound)
sequencing mutation (compound)
siat of (case)
evidence histologic (amod)
cefonicid cefazedone)-treated (conj)
resulted ratio (nsubj)
19.3 respectively (advmod)
done 3 (conj)
prescribed inhibitor (nmod)
emulsion with (case)
substratum drugs (conj)
p9605 group (compound)
younger years (nmod)
beginning birth (nmod)
effects misoprostol (nmod)
ratio ci (dep)
experienced gain (dobj)
hemorrhagic were (cop)
patients seen (acl)
gene 5-ht6 (amod)
measuring while (mark)
electroencephalography processed (amod)
specific that (mark)
compare test (conj)
dp/dt(max in (case)
inhibitors not (neg)
syndrome long-standing (amod)
follow-up periodic (amod)
mg/day misoprostol (conj)
dilatation significant (amod)
medicate self (nmod:npmod)
occurred however (advmod)
mitoxantrone , (punct)
indicator be (cop)
g carbachol (nmod)
% compared (prep)
thromboembolic : (punct)
insipidus to (mark)
model akinesia (nmod)
204 volume (nsubj)
antipsychotic patient (nmod)
tested part (nmod)
feared initially (advmod)
obtainable that (mark)
control r2 (conj)
subjects while (case)
incidence unacceptable (amod)
testosterone t (appos)
odds ratio (dep)
found child (nsubjpass)
fluoroacetate or (cc)
activity activity (nmod)
longer p (nmod)
boys syndrome (nmod)
encephalopathy for (case)
consumed who (nsubj)
relieve might (aux)
mg 0.15 (compound)
converted pretreatment (nsubj)
suppression a (det)
reduce order (nmod)
results elicited (dep)
demonstrated augments (ccomp)
treated lindane (nmod)
results occurred (appos)
found comparison (nmod)
octogenarian the (det)
suppressed progression (dobj)
involved shown (conj)
stopped restarted (conj)
3 ) (punct)
treatment optimal (amod)
referred tachycardia (nmod)
investigations neuroradiologic (compound)
started group (nmod)
thickening skin (nmod)
effects their (nmod:poss)
reflect . (punct)
12 of (case)
recruited setting (dep)
stress combined (amod)
apl , (punct)
abolished 4-damp (nsubj)
effective drugs (nsubj)
109 2 (conj)
patient subsequent (amod)
convulsive stimulatory (conj)
consisted growth (nmod)
state amnesia (nmod)
support granulocyte (compound)
osteoid such (case)
nephropathy analgesic (amod)
different used (conj)
b1 and (cc)
safety combination (nmod)
pca via (case)
results flattening (nmod)
akbr biological (conj)
randomized study (nmod)
prolongation tdp (conj)
kinase and (cc)
interactions by (case)
reach stratified (advcl)
lids e.g. (acl)
duration an (det)
dermatitis rosaceiform (compound)
verbal iq (conj)
infants all (appos)
recipients allograft (compound)
carcinoma ) (punct)
medialipid , (punct)
electrocardiogram holter (compound)
neuroprotective acid (nsubj)
mg/kg at (case)
doxorubicin sc/week (appos)
function normal (amod)
one potent (nmod)
patients weeks (nmod)
difficult third (advmod)
regression p (appos)
greater dose (nmod)
lw ( (punct)
receive transplant (dobj)
mmhg kpa (dep)
stroke rhabdomyolysis (compound)
metoclopramide case (appos)
affected transport (nsubjpass)
emerged preceding (xcomp)
had giddiness (conj)
sulpiride estradiol (conj)
given repeatedly (advmod)
l6 % (appos)
esters cholesteryl (compound)
potentiated stereotypies (nsubjpass)
proliferation smooth (amod)
pretreatment mg/kg (nmod)
shunt pulmonary (amod)
cm nonionic (amod)
literature relevant (amod)
thyroxine tri-iodo-thyronine (conj)
incidence morbidity (conj)
ctx ( (punct)
pancreatitis hepatotoxicity (conj)
modification consisting (acl)
identified ultrastructurally (advmod)
different immunosuppressive (dep)
rate rats (nmod)
interviewed personally (advmod)
catechol , (punct)
phenomenon descriptions (nmod)
stores catecholamine (compound)
increased trough-concentrations (nmod)
analysis grade (nmod)
therapy monitored (acl)
drugs for (case)
susceptibility drugs (nmod)
rheumatology neurology (conj)
affected % (nmod)
received dosage (dobj)
preceded effect (nsubjpass)
variations gene (nmod)
relating derives (ccomp)
patients acromegaly (nmod)
received experiment (nmod)
need clinicians (nsubj)
function levels (conj)
antigen surface (compound)
reversed administered (advcl)
study agent (dep)
angioedema moderate (amod)
abnormalities be (cop)
216 - (punct)
covered snr (dobj)
maintained intake (nmod)
flutter delay (nmod)
ng/ml 1955 (nummod)
receive either (preconj)
mutations pre-existing (amod)
suggested be (auxpass)
action of (case)
improve combinations (nsubj)
availability assessment (nmod)
experienced day (nmod)
differences clozapine (nmod)
iii ( (punct)
arterioles to (case)
pressure aortic (amod)
recommended not (neg)
rate mice (nmod)
contributing effect (nmod)
fraction mean (amod)
succinylcholine of (case)
factors disorder (nsubj)
mobilization acid (compound)
treated ratio (nmod)
given which (nsubjpass)
rate complication (compound)
evaluated studies (nsubj)
received appeared (advcl)
represented this (nsubj)
vinorelbine with (case)
changes ( (punct)
individuals rises (nmod)
has and (cc)
application stz-icv (compound)
include factors (nsubj)
attenuate temocapril (nsubj)
demonstrated produce (xcomp)
severe were (cop)
involvement rotation (nmod)
medulla ventrolateral (amod)
opse a (det)
carbimazole methimazole (conj)
malformation a (det)
nephritis ciprofloxacin-induced (amod)
pathogenesis thrombi (nmod)
changes bp (compound)
% 1.7 (dep)
reduces conclusion (dep)
comparable outcomes (nsubj)
investigate using (xcomp)
neurotoxicity verapamil-induced (amod)
enhanced doxorubicin (nmod)
sex diagnosis (conj)
rats (6-ohda)-lesioned (amod)
evaluated incidence (nmod)
= .04 (dep)
disorder receiving (acl)
implies obtained (conj)
impairment loss (nmod)
epilepsy induced (acl)
84+/-3 to (dep)
registry to (case)
cases in (case)
risk time (nmod)
6-months hyperprolactinemia (nmod)
arrest resuscitation (dep)
asked patient (nsubjpass)
hh over (case)
showed ; (punct)
-2.7 to (dep)
bradyarrhythmia of (case)
alters . (punct)
production rats (nmod)
decreased stopped (advcl)
perfused acid (nmod)
iii-v ) (punct)
alpha-tocopherol inactivated (dep)
done tumors (nmod)
months starting (dep)
found 1983 (nmod)
preferable pge1 (nsubj)
difficult assess (xcomp)
discontinuation chloroquine (compound)
differed statistically (advmod)
conducted average (nmod)
malignancy lymphoma (nsubj)
dosings organogenesis (nmod)
discovery defect (nmod)
meshwork similar (amod)
methods treatment (compound)
resulted decreased (advcl)
analgesia that (mark)
inhibitor hydrophilic (amod)
infections infection (nmod)
symptomatology of (case)
system cleavage (compound)
asia in (case)
used whom (nmod)
vomiting no (neg)
drug only (amod)
pharmaceuticals smithkline (compound)
nausea headache (conj)
hospitals delivery (compound)
hemianopsia a (det)
triggered two (nmod)
carcinoma lung (compound)
determined routinely (advmod)
induces behaviour (dobj)
prohibited be (auxpass)
time ti (appos)
fluorthyl- convulsions (dep)
events vinorelbine-related (amod)
eliminates evidence (dobj)
two in (case)
protection deaths (nmod)
age 0.001 (appos)
using time (dobj)
presumed reflect (xcomp)
subjected overexpressing (nsubjpass)
mg/kg was (cop)
placebo-controlled double-blind (amod)
dose-dependent children (nmod)
9.6-fold number (nsubj)
include dehydration (dobj)
parameters study (nmod)
demonstrated defect (dobj)
side or (cc)
ranging mg/kg (nmod)
induces mouse (nmod)
reduced reduced (advcl)
ring by (case)
fev1 hr (appos)
hematological neuropathy (conj)
combination disorder (nmod)
cases few (amod)
occasions history (nmod)
staff , (punct)
developed interval (nmod)
activity adenovirus (nmod)
pap as (case)
% 1.8%-6.1 (nummod)
had prk (dobj)
betaxolol ) (punct)
occupancy of (case)
adjustment dosage (compound)
methylation dna (compound)
9.99 1.00 (compound)
monkeys all (det)
bone , (punct)
occurred proportion (nmod)
illness of (case)
0.086 0.021 (conj)
ft4 ) (punct)
diagnostics roche (compound)
activity values (conj)
wanted cssep (dep)
patients receiving (acl:relcl)
grade organization (compound)
involvement receptor (nmod)
, ratios (dep)
34/45 ) (punct)
gravis myasthenia (compound)
effect tiapride (nmod)
review this (nmod)
other bronchopneumonia (nmod)
percentage subjects (nmod)
role epinephrine (nmod)
236.9 +/- (cc)
0.50 0.19 (compound)
used ischaemia (nsubjpass)
persists withdrawal (nmod)
distributed lobule (nmod)
lower vs (cc)
rtms of (case)
immunohistochemistry assay (conj)
indolamines the (det)
fornix in (case)
loss decrease (appos)
implicated since (mark)
mechanisms subtypes (conj)
movement no (det)
remains associated (advcl)
> and (cc)
supplement is (cop)
admitted due (prep)
admission icu (compound)
before both (cc:preconj)
methoxamine of (case)
dose ethambutol (nmod)
side over (case)
response pigs (nmod)
perform determinations (dobj)
mutations implications (dep)
children young (amod)
remission spontaneous (amod)
alpha2-adrenergic of (case)
flow clearance (conj)
antagonist dihydrothienopyridine (compound)
course postoperative (amod)
diseases certain (amod)
increased dose (nsubjpass)
injections 0.1/mg/kg (nmod)
induced catalepsy (nsubjpass)
attenuated effect (nsubjpass)
host disorders (nmod)
% 20 (compound)
index ( (punct)
had thresholds (dobj)
mg 1 (nummod)
pathway ceruleo-cerebellar (amod)
diagnosed previously (advmod)
marker as (case)
d treatment (nmod)
raised lowering (advcl)
worsening bolus (nmod)
fraction and (cc)
derives experiments (nmod)
reflex marker (nmod)
[ca]o on (case)
dose desipramine (nmod)
predated indices (nsubj)
continuation of (case)
9 8 (compound)
aspects effects (conj)
occur tolerance (nsubj)
epilepsy pilocarpine-induced (amod)
patients 2441 (nummod)
doses clarithromycin (nmod)
pretreatment nicotine (compound)
y-maze tasks (dep)
derived plants (nmod)
positive gamma-gt (amod)
pretreatment morphine (nmod)
edema disc (compound)
agent be (cop)
ninety-nine and (cc)
that p53 (nmod)
events hepatotoxic (amod)
intravitreal data (nsubj)
experienced case (dobj)
remissions ( (punct)
ns the (det)
measured maintained (conj)
randomized ntg (conj)
subdivisions functional (amod)
maneuver hypoventilation (compound)
nephrosis established (amod)
remained 8 (nsubj)
gain will (compound)
shift , (punct)
recognition delayed (amod)
decreased whereas (mark)
kinetics and (cc)
seem have (xcomp)
indicated receives (ccomp)
studies dose (nmod)
failed ) (punct)
used response (nsubjpass)
indicate related (ccomp)
likelihood induced (acl:relcl)
scores medications. (amod)
days for (case)
microg/kg/min reduced (dep)
weeks following (amod)
hypotension captopril-induced (amod)
rage ) (punct)
agonist 1-adrenoceptor (compound)
called consolidation (xcomp)
1,1-dichloro-2,2,2-trifluoroethane and (cc)
weight 100 (nummod)
decrease agents (nsubj)
hundredth potency (dobj)
hdl in (case)
phonological ( (punct)
mean 4.7 (conj)
serious rather (advmod)
used found (parataxis)
excretion despite (case)
oscs the (det)
vol% vol% (conj)
caused nicotine (nmod)
effect dopamine (nmod)
demonstrated research (nsubj)
resulted loss (nsubj)
remains prognosis (nsubj)
transmission nociceptive (amod)
doses amn082 (nmod)
methylprednisolone after (case)
attributed long (advmod)
had age (advcl)
diarrhea 3 (nummod)
decreased abundance (nsubjpass)
implicated , (punct)
history developed (acl:relcl)
similar blocked (conj)
remained controls (advcl)
involved dipyrone (nmod)
repeat to (mark)
epimers group (nmod)
myocet ) (punct)
variability intra- (amod)
control course (nmod)
receive takes (advcl)
db 0.50 (nummod)
induces however (advmod)
attention , (punct)
developed eyes (dobj)
adapt results (dobj)
normalization levels (nmod)
seizures nonischemic (amod)
composed lesion (nsubjpass)
alpha-motoneurons dark-stained (amod)
nerves spinal (amod)
4 6 (conj)
go that (nsubj)
mg/kg weight (appos)
population this (det)
r(2)=0.79 ( (punct)
discontinuation source (nmod)
fpd fpdc (appos)
peak ( (punct)
transaminase toxicities (nsubj)
mg/kg/day ) (punct)
follows percent (dep)
e1 or (cc)
exceeded which (nsubj)
given inoculation (nsubj)
decrease cco-i (nmod)
injection pilocarpine (compound)
interview psychosis (nmod)
based intention-to-treat (nmod)
used bupropion (dobj)
coccidioidomycosis disseminated (amod)
psychostimulant is (cop)
amine a (det)
body a (det)
procedure each (det)
tests , (punct)
year 80 (nummod)
remains mechanism (nsubj)
call cases (nsubj)
rescue no (det)
sections neonates (nmod)
induce whether (mark)
decreased reduction (nmod)
kinetics first-order (amod)
effect uncoupling (compound)
showed ultimately (advmod)
pneumonia ulcers (conj)
type headache (nmod)
initiated propagated (conj)
parameters metabolic (amod)
failure fhf (appos)
-3.7 to (dep)
alone both (cc:preconj)
found randomized (ccomp)
examination radiologic (conj)
studies comparative (amod)
reversed co-administration (nsubj)
cross-react to (mark)
drg in (case)
cause 1985 (nmod)
used require (conj)
aprotinin , (punct)
predicted mortality (dobj)
cytokine interleukin (dep)
hospitalizations included (acl:relcl)
mrna cnp (compound)
effects combination (nmod)
analysed criteria (dobj)
estradiol ee (appos)
prl-r , (punct)
effects potentiation (nmod)
lag 5-year (amod)
infiltrate ptld (compound)
caused syndrome (dobj)
zone the (det)
os a (det)
reversed cholinergic (dobj)
women interval (conj)
suggest necessary (ccomp)
damage heart (compound)
duration onset (conj)
given periods (nmod)
seizures hemiparesis (conj)
carried it (nsubjpass)
cardiac other (amod)
toxicity such (case)
contaminants methotrexate (amod)
present resulting (advcl)
inhibition gamma-aminobutyric (amod)
situations these (det)
acromegaly with (case)
development pharmacotherapy (nmod)
1.1 ( (punct)
contact of (case)
increase oxypurines (nmod)
time average (amod)
tested series (nsubjpass)
sites several (amod)
signs weights (conj)
mg/kg weight (nmod)
period recording (nmod)
had recurrence (dobj)
was groups (nmod)
correlates fluency (nmod)
receptors the (det)
myeloma symptomatic (amod)
preexisting with (case)
components c1q (dep)
return then (advmod)
cessation woman (nmod)
dose ccnu (nmod)
play transporters (nsubj)
gyki-41 of (case)
impact nifedipine (nmod)
24 +/- (cc)
function retinal (amod)
variables clinical (amod)
tolerated treatments (nsubjpass)
did whom (nmod)
apraclonidine % (compound)
activator , (punct)
transplants anemia (nmod)
depressed and (cc)
htr6 and (cc)
mg 2.5 (nummod)
measures by (case)
pregnancy before (nmod)
years 77 (nummod)
demonstrated improvement (nmod)
damage massive (amod)
association duration (nmod)
edema vasogenic (amod)
tract gastrointestinal (amod)
comparable ' (punct)
mm 35 (nummod)
desipramine cinacalcet (conj)
succeeded participant (nsubj)
associated output (nmod)
pr ) (punct)
received thrombin (dobj)
due not (neg)
performed study (nmod)
smaller were (cop)
compared patients (dobj)
similar distributed (conj)
agents antineoplastic (amod)
lesions all (predet)
exposure high-dose (amod)
tem ) (punct)
reducing in (mark)
data patients (nmod)
sc [ (punct)
gem-p cohort (nmod)
attenuates receptors (nmod)
factors statistical (amod)
diuretic and (cc)
aminotransferase the (det)
define report (nmod)
showed arteriography (nsubj)
disease preexisting (amod)
5/8 ( (punct)
prevention cardiotoxicity (nmod)
patients followed (acl)
mater exposed (amod)
pre-administration mg/kg (appos)
clubs characteristic (amod)
responded that (nsubj)
improve overdose (nmod)
pellet microg/day (conj)
decreasing activity (dobj)
instances and (cc)
approach the (det)
administered who (nsubjpass)
mmse ( (punct)
strength muscle (compound)
therapy neuroleptic (amod)
resistance significant (amod)
values lower (amod)
moles/glomerulus % (conj)
therapy medical (amod)
level total (amod)
tachycardia bromocriptine (nmod)
all these (nmod)
center snr (nmod)
induction metallothionein (compound)
piglets newborn (amod)
active well-tolerated (dep)
mechanism compensatory (amod)
hydroperoxides lipid (compound)
clonidine , (punct)
product micrograms (compound)
disposition altered (amod)
higher concentration (nsubj)
considered decline (nsubjpass)
antibiotics beta-lactam (amod)
tended content (nsubj)
mean higher (amod)
enhanced isoproterenol (nmod)
ulcers oral (amod)
altered may (aux)
reported has (aux)
84 of (case)
movement occasional (amod)
death disease (conj)
loss . (punct)
medications concurrent (amod)
identified age (dep)
exposures the (det)
rate oxygenation (conj)
ct brain (compound)
qtp pbo (conj)
2.3+/-1.2 was (cop)
used methods (nsubjpass)
triglyceride and (cc)
myocarditis by (case)
functioning axis (nmod)
become arrhythmic (xcomp)
improves stenosis (nmod)
rediscovery pallidotomy (nmod)
arrest cardiopulmonary (amod)
depends which (nsubj)
women versus (cc)
12 - (punct)
origin myalgia (nmod)
unmask and (cc)
dose 360 (nummod)
lipoprotein high-density (amod)
the + (cc)
shr treated (acl)
dependent receptor (nmod:npmod)
injected site (nmod)
diazinon organophosphate (amod)
increase gssg (nmod)
reason preference (nmod)
patients virtually (advmod)
triggering by (case)
and chronically (advmod)
attenuated dopamine (dobj)
stage high-risk (amod)
recordings action (compound)
30 than (quantmod)
evaluated effects (conj)
intervention received (dep)
months 27 (nummod)
safer require (conj)
proteins to (case)
elevation 117-fold (amod)
abuse cocaine (nmod)
increase vldl (nmod)
output their (nmod:poss)
were apart (advmod)
linked exposure (nsubjpass)
weakly only (advmod)
size leakage (conj)
analysis reaction (compound)
showed 2/3 (nsubj)
effects h. (nmod)
ms ms (conj)
report combination (nmod)
polymorphisms region (nmod)
stimulate intermedius (dobj)
cataracts posterior (amod)
index lvpw (compound)
data by (case)
collected data (nsubj)
ht versus (cc)
bradykinesia particularly (advmod)
dysfunction sensory (amod)
one groups (nmod)
days tdp (compound)
cortex changes (nmod)
a c.695t (compound)
ncr181 fla873 (conj)
found occlusion (dobj)
obtained information (dobj)
ph a (det)
modification test (nmod)
decrease ca(2 (nmod)
ascending of (mark)
analysed had (conj)
propofol with (case)
tissue smear (conj)
agonists of (case)
absence atonic (conj)
induce hypokalemia (nmod)
wall through (case)
asymptomatic reversible (conj)
receiving type (dobj)
administration 4-week (amod)
classifications patients (nsubj)
was cases (nmod)
mrna timp (compound)
mg/day methylphenidate (nmod)
presented both (nsubj)
overload peripheral (amod)
gestation children (conj)
status on (case)
glepp1 ) (punct)
m3 for (case)
referred had (aux)
increase such (predet)
combination ; (punct)
swelling podocytes (nmod)
injection dox (nmod)
report moreover (advmod)
continue . (punct)
controls 0.38 (dep)
pathway mitochondria-dependent (amod)
etoricoxib diclofenac (conj)
word a (det)
caused ages (nmod)
hdl-c of (case)
30 60 (prep)
013 2 (compound)
similar ( (punct)
removed kidneys (nsubjpass)
etoposide , (punct)
protein vitro (advmod)
woman myeloma (nmod)
analysis septal (nmod)
development 2 (nmod)
active former (conj)
decrease control (nmod)
include fever (dobj)
duration administered (acl)
test mice (nmod)
defect a (det)
reflected latency (nsubj)
relationship concentrations (nmod)
cnsb002 of (case)
pretreatment naloxazone (nmod)
pseudomonas four (nummod)
following dbs (nmod)
iqr ( (punct)
demonstrated risk (dobj)
modulation in (case)
gradient osmotic (amod)
mcl , (punct)
t1/2 : (punct)
vocalization rage (dep)
tetracycline and (cc)
showed cross-tolerance (dobj)
i.v. plus (cc)
enrolled who (nsubjpass)
complication . (punct)
contraction fetal (nmod)
caused arrhythmia (dobj)
iu/l alt:122 (compound)
therapy steroid (compound)
suggest patient (nmod)
ligand receptors (nmod)
regimen standard (amod)
mg versus (cc)
agonist dopamine (compound)
obtained way (nmod)
poor and/or (cc)
read expressions (dobj)
catalepsy retention (dep)
gluconate i.v. (amod)
arthrogryposis blockade (nmod)
predictor independent (amod)
adjuvant a (det)
1.52 enalapril (nmod)
distinguish agents (nmod)
apoptotic necrotic (conj)
sinus sss (appos)
zones reactivation (nmod)
similar rates (nsubj)
segment st-t (compound)
pcr quantitative (amod)
inhibition hyperprolactinemic (amod)
microinjections , (punct)
decreased improved (dep)
7.73 - (punct)
caused adriamycin (nmod)
1ml/kg ( (punct)
resorption by (case)
seven five (conj)
reactivity system (nmod)
metabolized . (punct)
ip ( (punct)
disappearance normalization (conj)
sedation deep (amod)
all presentation (nmod)
both ( (punct)
surge the (det)
haplotypes ( (punct)
used study (xcomp)
fluency impaired (amod)
patients cisapride-treated (amod)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine , (punct)
play might (aux)
medications cardiovascular (amod)
reported probable (conj)
ng./ml 20 (nummod)
reported now (advmod)
presence cyanosis (nmod)
concentration patients (nmod)
15 over (advmod)
injury % (appos)
subtypes mglu7 (compound)
model rats (nmod)
cancers of (case)
absorptiometry dual-energy (amod)
dbs the (det)
characteristics pharmacological (amod)
regimens many (amod)
age +/- (cc)
subunits alpha (compound)
stimulation stn (nmod)
hypercholesterolemia and (cc)
bradycardia dysarthria (conj)
lesions one (nummod)
behaviors dose-dependent (amod)
disappeared decreased (advcl)
described as (mark)
marked persistent (conj)
likely likely (conj)
vasodilatation through (case)
substitute the (det)
effects dexmedetomidine (nmod)
triggered cluster (dobj)
enhanced response (dobj)
group treated (acl)
mechanism such (predet)
v2.0 diagnostics (appos)
dose clonidine (nmod)
sedated more (advmod)
encephalopathy presentation (nmod)
presented conclusion (nsubjpass)
occurred weeks (nmod)
thrombosis vascular (amod)
back normal (nmod)
inherent represents (conj)
extract from (case)
relieved alcohol (nsubj)
maximum should (aux)
macroprolactinemia n. (appos)
detected 23 (nmod)
profile or (cc)
> n (dep)
known : (punct)
determined assays (nmod)
testing noninvasive (amod)
effect its (nmod:poss)
necessity recommended (dep)
appears inhibition (xcomp)
midazolan mz (appos)
reduced summed (conj)
employed given (conj)
found had (ccomp)
timolol of (case)
had encephalopathy (nmod)
patients l-dopa-treated (amod)
dose fzp (appos)
transition proper (amod)
five and (cc)
nephropathy aminonucleoside (compound)
ammonia of (case)
syndrome cardiomyopathy (amod)
fzp of (case)
sludge cholecystitis (conj)
recommend administered (ccomp)
effect participants (nmod)
resulted effects (dobj)
likely bupivacaine (nmod)
caused pressure (dobj)
assays laboratories (appos)
bell-shaped , (punct)
combination patients (nmod)
complaints neuropathic (amod)
folinic / (punct)
tobramycin than (case)
suggested complication (dobj)
reported had (aux)
treated interval (nmod)
therapy daptomycin (compound)
animals sacrificed (acl:relcl)
glomeruli nonfiltrating (amod)
62.5 many (advmod)
needle spinal (amod)
caused gain (dobj)
pars of (case)
fall fraction (nmod)
600 900 (conj)
site other (amod)
haart after (case)
gcs ( (punct)
helpful predicting (advcl)
induced respiratory (dobj)
tamoxifen , (punct)
observed primarily (advmod)
rats ovariectomized (amod)
pathway that (nsubj)
received hour (nmod)
review in-depth (amod)
known influence (xcomp)
any ephedrine/propofol/mixtures (nmod)
value control (compound)
lithium . (punct)
fit ) (punct)
epileptogenesis in (case)
results assessment (nmod)
preceded gastrointestinal (nmod)
results or (cc)
carcinogens benzo[a]-pyrene (appos)
picture resembling (acl)
risk the (det)
scavenger species (nmod)
request on (case)
administration prochlorperazine (nmod)
surgery ophthalmic (amod)
icu the (det)
formed were (auxpass)
relate that (nsubj)
syndrome . (punct)
life half (amod)
edema hypertension (conj)
latency sign (nmod)
dyskinesia specific (amod)
disappeared leukocyturia (nsubj)
kg(-1 ) (punct)
insomnia ataxia (conj)
perfusion , (punct)
socs-1 only (advmod)
mice lacking (acl)
changes behind (case)
products damage (compound)
4.7 +/- (cc)
giving and/or (cc)
clotiazepam benzodiazepines (conj)
achieved most (nmod)
doses cinacalcet (nmod)
levels as (cc)
caused hypotension (dobj)
variations the (det)
free not (neg)
finding responsiveness (nsubj)
hypotension sap<90mmhg (appos)
test bpo (nmod)
trial galantamine (nmod)
contain which (nsubj)
sleep resistance (conj)
% 4.9 (nummod)
doses bn (nmod)
isoenzyme cyp (appos)
angioedema the (det)
angiograms patients (nmod)
effects anti-amnesic (amod)
exhibit not (neg)
sas and (cc)
dopaminergic alpha1-adrenergic (conj)
monotherapies hctz (compound)
ag hbs (compound)
vocabulary course (nmod)
patients 36 (nummod)
study neurons (nmod)
ended july (nmod)
248 microg% (punct)
infused dogs (nmod)
11 patients (nmod)
produced % (dep)
rate upon (case)
value at (case)
hyperalgesic allodynic (conj)
was decrease (attr)
classifications risk (nmod)
breath one (nummod)
sites on (case)
mrna-containing ( (punct)
mmt 84 (nummod)
nucleus colliculus (conj)
covariates relevant (amod)
patients 01 (dep)
included materials (nsubj)
g/m2 7 (nummod)
symptoms related (amod)
test open-field (amod)
cause 11th (amod)
ballooning left (amod)
administration amiodarone (amod)
rats effects (dobj)
atropine after (conj)
erdosteine , (punct)
bfu-e of (case)
evaluation pharmacological (amod)
less or (cc)
eighteen rats (nmod)
generalised focal (conj)
estimate to (mark)
case d (nmod)
indicate perspective (dep)
died plugs (nmod)
syndrome neuroleptic (amod)
mg/kg 380 (nummod)
artery disease (dep)
disappeared changes (nsubj)
hyperkalemia n (dep)
course because (case)
mirrored changes (dobj)
quetiapine patients (nmod)
injection h. (nmod)
bradycardia mediated (acl)
delivered palate (conj)
design in (case)
initiating cpr (dobj)
characteristics development (nmod)
gammapathy pre-transplant (amod)
male evidence (nmod)
weeks treatment (dep)
beta-blocking for (case)
lamivudine prophylaxis (nmod)
organs other (amod)
receptors b2 (compound)
infusion doxorubicin (nmod)
hyperthermia body (compound)
synthesis no (compound)
iu/l ast:111 (compound)
designed ) (punct)
dysfunction receptor (compound)
provision with (case)
treated atra (nmod)
protects carvedilol (nsubj)
prognosis with (case)
10-diol ( (punct)
once-daily ) (punct)
fistula complicating (acl)
potassium metoprolol (conj)
controls 1190 (nummod)
lesions tubular (amod)
increased returned (conj)
universal effects (nsubj)
determined amounts (conj)
treatment conditions (nmod)
activity observed (acl)
patients 216 (nummod)
period ] (punct)
= were (ccomp)
treatment blunted (acl)
placed we (nsubj)
hyperactive amphetamine (nmod)
concentration methothexate (compound)
suggested was (auxpass)
involves spasm (nsubj)
frequencies intact (amod)
treatment 5-fu (compound)
properties inotropic (amod)
effect indirect (amod)
administration drug (compound)
state had (conj)
difficulties impotence (conj)
morphine 3.2 (nummod)
regimen at (case)
failed suggestive (xcomp)
clinic at (case)
indicating targeting (dobj)
associated warrant (conj)
administration i.v. (dep)
skf d-1 (amod)
fluoxetine amitriptyline (conj)
133xe i.v. (amod)
returned day (nmod:tmod)
included tachycardia (dobj)
uremia to (case)
followed retardation (nmod)
affect hyperalgesia (nsubj)
died day (nmod)
review anemias (nmod)
appeared microscope (nmod)
5-fluorouracil or (cc)
staining s-100 (compound)
biomembranes of (case)
p100 and (cc)
ptpro ) (punct)
patients tested (acl)
levels development (conj)
testing indocyanine (compound)
concluded interfere (ccomp)
all event (dep)
change variable (nsubj)
spasm patient (nmod)
unaffected , (punct)
observed administration (nmod)
conclude conclusion (dep)
diagnoses the (det)
1.6 ) (punct)
7 5 (conj)
classed patients (nsubjpass)
patients range (dep)
hippocampal and/or (cc)
had rats (nsubj)
medication efficacious (amod)
drug stimulant (amod)
production frs (nmod)
factor claimed (advcl)
levels ros (compound)
120 80 (compound)
model study (acl)
lithium due (case)
high ] (punct)
evaluated behaviors (conj)
rupture for (case)
administered appropriately (advmod)
malformations cardiac (amod)
ganciclovir patients (nmod)
recur did (aux)
summary height (nmod)
cin related (amod)
drugs such (case)
show administration (nsubj)
study propensity-matched (amod)
reported macrolides (nmod)
utilized been (auxpass)
rebound pressure (nmod)
cases 82 (nummod)
rcts fifteen (nummod)
aki with (case)
analysis developmental (amod)
compromising without (mark)
anesthesia mac (appos)
markers signs (nmod)
receptors oligodeoxynucleotide (appos)
microscope electron (compound)
trials , (punct)
treated leucovorin (nmod)
tubule renal (amod)
separated groups (nmod)
immunophilin to (case)
pathways biomarkers (conj)
suggest contractility (nsubj)
l-norepinephrine by (case)
ng/ml level (nsubj)
dilation before (nmod)
hippocampus seizures (nmod)
dose rat (compound)
less 0.25 (nmod)
went courses (nmod)
effect methadone (nmod)
cisplatin paclitaxel (conj)
obvious or (cc)
doses maximum (compound)
psychiatric or (cc)
rodents neonatal (amod)
judiciously the (det)
propranolol micrograms (conj)
gavaged days (nmod)
humans among (case)
identical curves (nsubj)
124 3 (conj)
anuria . (punct)
cases > (compound)
alpha-2b during (case)
believe conclusion (nmod)
induce break (dobj)
comprising cells (dobj)
treated intraperitoneally (advmod)
patients recovered (acl)
similar nearly (advmod)
effects kidney (compound)
bromide theophylline (conj)
specimen the (det)
conclusions cause (appos)
21 +/- (cc)
2.0 20.0mg/kg (conj)
found proliferation (nsubjpass)
engagement coeruleus (nmod)
showed cells (nsubj)
factor . (punct)
points by (case)
reviving is (aux)
months ; (punct)
due death (nsubj)
scores analogue (compound)
drugs psychotropic (amod)
september between (case)
disease stable (dep)
effective gram-positive (nmod)
feared . (punct)
showed = (advcl)
anemia patient (nmod)
mortality large (amod)
treatment gemfibrozil-lovastatin (compound)
treatment antipsychotic (amod)
hyperactivity meth-induced (amod)
alterations permanent (amod)
formation thalamus (conj)
differences hds (nmod)
withdraw after (case)
found that (mark)
% 38.5 (nummod)
toxicity glomerulus (nmod)
use adjuvant (nmod)
studied disease (nmod)
combinations chemotherapy (compound)
behavior their (nmod:poss)
importance development (nmod)
selective thus (advmod)
neurotoxicity disease (conj)
suggest risk (dobj)
esophagitis reflux (compound)
factors only (amod)
invaded , (punct)
performance in (case)
cyclophosphamide c (appos)
antagonism for (case)
citalopram with (case)
controls p<0.02 (appos)
malformations these (det)
pathway liver (nmod)
group ntg (compound)
manifestations influenced (acl:relcl)
affinity sigma2 (nmod)
affected treatment (nmod)
weeks rats (nmod)
disease decompensated (amod)
seconds ) (punct)
proteins striatal (amod)
session during (case)
applies if (mark)
systems abnormalities (conj)
50 40 (quantmod)
analgesia- and (cc)
irrespective history (nmod)
abnormalities extreme (amod)
reduction db (compound)
tachycardia pentamidine (amod)
rats tested (amod)
chemistries and (cc)
favour are (cop)
terminate dysrhythmias (dobj)
rauwolscine with (case)
documents case (nsubj)
variants with (case)
reduce anticholinergic (nsubj)
tissue within (case)
dba/2 c57bl/6 (conj)
history stones (nmod)
predominance ketamine (nmod)
cocs of (case)
decreased leading (advcl)
are entity (advcl)
epiphyses stippled (amod)
proven rechallenge (nmod)
demonstrated experimentally (advmod)
mm 13.1 (conj)
infection acquired (amod)
sed 1.03 (conj)
stable and (cc)
discovered were (auxpass)
infusion s (nmod)
vs + (cc)
cystitis cyp-induced (amod)
evidenced changes (nmod)
interval ) (punct)
acts retarding (advcl)
marker be (cop)
rats fischer-344 (compound)
assigned or (cc)
metoclopramide drug (appos)
complications fewer (amod)
linked to (mark)
constitutes best (nmod)
change no (neg)
experienced urticaria/angioedema (dobj)
comparison toxicology (nmod)
remained elevated (xcomp)
analgesia with (case)
gtn transdermal (amod)
individuals certain (amod)
improvement outcome (compound)
seizure latency (conj)
follow-up quantify (xcomp)
suggest participate (ccomp)
aspects of (case)
2.3 - (punct)
mg/m2 and (cc)
response agents (nmod)
sc-48334 zidovudine (conj)
rats additional (amod)
treatment tests (dobj)
kept ph (nsubjpass)
vacuolation extensive (amod)
substituted bromide (nsubjpass)
oligodeoxynucleotide receptors (nmod)
reductions by (case)
feature another (det)
older all (advmod)
proceed transplant (nsubj)
degree . (punct)
showed sgot (conj)
sustained aminotransferase (advcl)
weeks cholestatic (amod)
prevented alfentanil (advcl)
treatment modulation (conj)
role compensatory (amod)
(att)-associated therapy (nsubj)
s 8.07 (nummod)
administration 3-day (amod)
producing rates (dobj)
patients concerns (compound)
procedure dose (nmod)
e. vitamin (compound)
year 2000 (nummod)
partial complex (conj)
rate clinical (amod)
temperament assessed (acl)
increase be (cop)
x(2 ) (punct)
woman and (cc)
schedule administration (nmod)
mmol/l 3.8 (nummod)
adults older (amod)
possible whenever (advmod)
and minutes (nmod)
conclusions recurrence (dep)
sedative either (det)
naranjo 's (case)
report pain (compound)
load hbv (compound)
admitted icu (nmod)
elevated % (dobj)
mean sem (conj)
strain as (case)
disability dyskinesias (conj)
2.6 stratum (appos)
modulated activation (nmod)
effects oxycodone (nmod)
drugs antagonist (compound)
conclusions disease (dep)
adenocarcinomas cas (dep)
demonstrated tolerated (conj)
is response (attr)
reports prior (amod)
have drugs (nsubj)
chiasmopathy associated (amod)
treatment preventive (amod)
design an (det)
enlargement of (case)
expressions increased (amod)
risk in (case)
abilities control (nmod)
condition good (amod)
kidneys ureters (conj)
seconds minutes (conj)
lomustine ( (punct)
opaque and (cc)
changes functional (amod)
hematoxylin and (cc)
ulceration peptic (amod)
feeling patients (nmod)
caused uptake (nmod)
confirmed which (nsubj)
inhibits stopped (conj)
breath positive-pressure (compound)
chemotherapy perfusion (conj)
patients used (acl:relcl)
responses cgs (appos)
expression type (compound)
bladders the (det)
min 60 (nummod)
hs to (case)
treatment epicondylitis (nmod)
patients cyclosporine-treated (amod)
densities decreased (amod)
subjects schizophrenia (nmod)
doses for (case)
< day (nmod)
chx+pilo and (cc)
carbimazole ptu (appos)
system veris (compound)
suggest is (ccomp)
effects among (case)
precede immediately (advmod)
everolimus rad001 (appos)
noted animals (nmod)
attenuated that (nsubjpass)
ratings pain (compound)
hours infusion (nmod)
3/20 ) (punct)
occurs pain (nsubj)
antigen a (compound)
cells ganglion (compound)
venomotor ) (punct)
astrocytes bergmann (dep)
baseline administration (conj)
specific not (neg)
taken dose (nsubjpass)
cohort risk (appos)
show loss (dobj)
determine produced (ccomp)
hyperkalemia due (case)
occurred mainly (advmod)
thyroid and (cc)
scale syndrome (compound)
cocaine local (conj)
complete necessary (conj)
recognized outcome (conj)
responded tachycardia (nmod)
grade ; (punct)
recorded have (aux)
samples test (compound)
acid n-methyl-d-aspartic (compound)
clinical due (case)
mg/kg benserazide (conj)
mg./kg acrolein (compound)
manifests hepatitis (nmod)
symptoms joint (amod)
hit ( (punct)
triceps muscles (conj)
participant study (compound)
fk506 ; (punct)
tight interrelationship (nsubj)
support empirical (amod)
purpose this (det)
decrease creation (conj)
initiated is (auxpass)
done clinical (nsubjpass)
dose week (nmod)
200 < (dep)
generated one (nmod)
action . (punct)
converted one (nmod)
cardiomyocytes human (amod)
was mechanisms (conj)
plasticity patients (nmod)
rats li-treated (amod)
latency median (amod)
agent ( (punct)
antigen bfgf (conj)
value pmol (appos)
discharge room (compound)
line thp-1 (appos)
68 32 (conj)
interactions patients (nmod)
assay the (det)
increase accompanied (acl)
ps , (punct)
collagen = (dep)
bradycardia a (det)
combinations applied (acl)
% high- (nmod)
% prenatally (advmod)
mi possible (amod)
% 25.35 (nummod)
visits in (case)
increment glutamate (nmod)
alleviated cck-8 (nsubj)
produced vasoconstriction (nsubj)
food supplements (conj)
suppressed sensitization (nmod)
status a (det)
management riha (nmod)
membrane luminal (amod)
kinases and (cc)
studied total (nmod)
14 two (compound)
pd engendered (acl:relcl)
necrosis concentrations (nmod)
concentration gsh (compound)
observed thrombi (nsubjpass)
biopsy and (cc)
microg/ml ) (punct)
compromising cytopenias (nmod)
produced i.p. (advmod)
1.0 risks (nsubj)
expression inos (compound)
play inadequate (conj)
stimulates formation (dobj)
characterize findings (dobj)
interval percent (conj)
days 10 (nummod)
mean teoaes (nsubj)
compared victims (nmod)
fraction with (case)
dizocilpine of (case)
salicylates high (amod)
drugs in (case)
therapy oral (amod)
trial 2 (nummod)
reported nephropathy (nsubjpass)
8th 16th (conj)
shows compound (nsubj)
lumen and (cc)
induce malformations (dobj)
resolved however (advmod)
ct and (cc)
observed hypotension (dep)
woman african (amod)
influence epileptogenesis (nmod)
background available (dep)
undergoing test (dobj)
high disease (nmod)
examination so (advmod)
concluded characteristic (ccomp)
disturbance from (case)
responsible that (nsubj)
women 17 (nummod)
derivative synthetic (amod)
events meta-analysis (dep)
epilepticus massive (amod)
removed permitting (advcl)
67.4 10.2 (appos)
increments the (det)
reductions clearance (nmod)
potential membrane (compound)
rectified was (auxpass)
episodes hypercalcemia (nmod)
adjustment after (case)
evaluate relationship (dobj)
mg/kg were (cop)
received blockers (dobj)
methamphetamine sc (appos)
loss unilateral (amod)
increased reversal (nmod)
stomatitis 18.2/9.1/0 (nummod)
efficacy on (case)
% 38.9 (nummod)
expression activity (conj)
activated complement (nsubjpass)
wk q (det)
pretreatment lidocaine (compound)
guidelines present (amod)
correlates toxicity (nsubj)
evidence serologic (amod)
potency aniracetam (nmod)
trial placebo (compound)
cause that (nsubj)
reporting syncope (nmod)
dysrhythmogenicity epinephrine (nmod)
il-1b and (cc)
simple sensitive (conj)
exhibited phenotype (nsubj)
caspase b. (compound)
hematoma of (case)
out total (nmod)
progestagens third-generation (compound)
syndrome apical (amod)
detected any (nmod)
examined histochemically (advmod)
increased levels (dobj)
turnover to (case)
deprivation and (cc)
reduction deferoxamine (nmod)
binding stereoselective (amod)
response % (conj)
contributed have (aux)
assessed hematoma (nsubjpass)
all above (case)
using ligation- (dobj)
days mesna (nmod)
peptide calcitonin (compound)
achieved levels (dobj)
remains background (dep)
1985 since (case)
evidence lipoprotein (compound)
synaptophysin ( (punct)
doses median (amod)
neurotoxicity 5-fluorouracil (compound)
recorded canine (nmod)
incidence preparations (nmod)
trial stabilized (acl:relcl)
correlated score (nsubjpass)
protocol modified (amod)
time-course action (nmod)
remains thrombocytopenia (nsubj)
saline only (advmod)
perfusion poor (amod)
pharmacology efficacy (conj)
describing effects (dobj)
heparin unfractionated (amod)
acrolein metabolite (compound)
reduction production (nmod)
x 143 (compound)
unaffected feature (nsubj)
shown interfere (ccomp)
retarding in (mark)
tolerate p (dobj)
allocated approval (nmod)
rat 's (case)
protocol standard (amod)
80 +/- (cc)
hours 72 (nummod)
kinetics recovery (compound)
walls the (det)
administration rauwolscine (nmod)
agonists by (case)
using dose (dobj)
treatment hyperthyroidism (nmod)
blockage by (case)
stopped treatment (nsubjpass)
tamoxifen by (case)
clomipramine of (case)
paralyzed was (cop)
rcts ) (punct)
left parietal (conj)
test ) (punct)
findings cohort (nmod)
diet or (cc)
lesions neurons (nmod)
cases fibrosis (conj)
nd ( (punct)
coadministration agent (nmod)
factor arrhythmia (nmod)
gained data (nmod)
use simvastatin (nmod)
recorded computers (nmod)
infection adenovirus (compound)
effect local (amod)
200 328 (conj)
therapy throughout (case)
damage mixed (amod)
consisted seizures (nmod)
arthritis inflammatory (amod)
ventricles normal (amod)
included factors (nsubj)
blocker arb (appos)
13 gestation (nmod)
onset earlier (amod)
number cell (compound)
angiography before (case)
designed assess (xcomp)
interference inadequate (advcl)
inhibitor a (det)
aged . (punct)
one night (nmod)
incorporates clues (dobj)
50 of (case)
inhibition sub-chronic (amod)
stimulating by (mark)
disease ' (case)
day range (dep)
% 0.001 (parataxis)
suggested conclusion (dep)
implicated should (aux)
vigilance for (case)
group 8-wk (amod)
included reactions (nsubj)
effect locomotor (compound)
qtls ( (punct)
hcrh after (case)
lethalities 2 (nummod)
downregulates highlight (conj)
rats mds (conj)
adjustment dose (nmod)
model understanding (acl)
mitochondrial or (cc)
monkey 10th (amod)
skills behaviors (conj)
oral or (cc)
treatment tachyarrhythmias (nmod)
appetite decreased (amod)
put took (conj)
effect level (nmod)
case seizures (nmod)
0.001 and (cc)
neurotoxicity calcineurin-inhibitor-related (amod)
causes . (punct)
-0.12+/-0.5 0.13+/-0.3 (dep)
therapy conventional (amod)
apparatus elevated (amod)
23 +/- (cc)
water c (compound)
prolongation the (det)
london in (case)
patient 40-year-old (amod)
treatment 2(nd)-line (nummod)
proposed has (aux)
107 from (case)
aggressive more (advmod)
acquisition the (det)
germany and (cc)
technology protein-based (amod)
violation for (case)
behaviors binding (conj)
kpa 10.3 (nummod)
contributing presumably (advmod)
750 900 (conj)
preceding onset (dobj)
different epilepsy-associated (dep)
reduction during (case)
kinase integrin-linked (amod)
course steroids (nmod)
treatment forms (nmod)
measured sensitivity (nmod)
rats vehicle-treated (amod)
recording one (nummod)
produced reactions (dobj)
affect risk (dobj)
indicative oedema (nmod)
manifest . (punct)
remission partial (amod)
protected fibrosis (nmod)
myeloma with (case)
irradiation cranial (amod)
optic ethambutol-associated (amod)
hbsag anti-hbc (conj)
reaction secondary (amod)
sedionbel ) (punct)
considered currently (advmod)
patient function (nmod)
trials for (case)
tiopronin antigens (conj)
pakt ) (punct)
syndrome : (punct)
difference due (case)
used not (cc)
elicited sequelae (dobj)
patients measured (acl:relcl)
mg/kg i.p. (punct)
day 30 (nummod)
cause probable (amod)
escalated level (conj)
ip mg/kg (compound)
therapy melanoma (nmod)
responses 18 (nummod)
val and (cc)
attenuation syndrome (nmod)
remained moreover (advmod)
= .0002 (dep)
lead might (aux)
increased dose (nmod)
courses after (case)
injury endothelial (amod)
reduced tended (conj)
selegiline , (punct)
m in (case)
cirrhosis of (case)
zone gyrus (nmod)
ifs ) (punct)
regulation proteins (nmod)
cholecystokinin-octapeptide peptide (acl:relcl)
exposure vigilance (appos)
years 20 (nummod)
amphotericin , (punct)
deal great (amod)
concealed team (nmod)
antibiotics different (amod)
strengthen data (nsubj)
comparison : (punct)
failed sulphate (nsubj)
hyponatremia and/or (cc)
children than (case)
kits elisa (compound)
women study (nmod)
accumulation hr (dep)
failure autonomic (amod)
bradycardia failure (conj)
paroxysms diffuse (amod)
induced and (cc)
use doses (nmod)
0.4-fold 1.3 (dep)
reversed discontinuing (advcl)
mediated arteriosclerosis (nsubjpass)
nephrosis pan (compound)
females than (case)
option an (det)
zuclopenthixol and (cc)
supplementation of (case)
region-specific brain (nmod:npmod)
believe represents (ccomp)
variables prognostic (amod)
myalgia effect (nsubj)
potent , (punct)
distinguishable thickness (nmod)
given can (aux)
wound a (det)
proteinuria any (det)
potter 's (case)
susceptible patients (nsubj)
lost vision (nsubjpass)
role disturbance (nmod)
disease liver (nmod)
drugs aryl-piperazine (amod)
sc ] (punct)
associated reductions (nmod)
samples only (advmod)
secondary drug (nmod)
incidence changes (nmod)
taking patients (nsubj)
defects pattern (compound)
modulates symptoms (dobj)
alprazolam of (case)
tumors associated (acl)
ratio infarction (nmod)
neurotoxicity toxicity (conj)
vancomycin administered (acl)
titer protein (nmod)
ototoxicity exposure (nmod)
polymorphism seven (nummod)
abnormalities cardiac (amod)
performance tests (nmod)
involved alterations (nsubjpass)
deferoxamine with (case)
patients nonsmall (compound)
reinforcement food (compound)
decreased levels (conj)
7 rats (nmod)
cases 35 (nummod)
derivative n-substituted (amod)
transplanted failure (nmod)
nuclei over (case)
inflammation less (amod)
concentrations dopamine (compound)
chloride and (cc)
regardless duration (nmod)
grafts ( (punct)
dosed was (auxpass)
antibiotic offers (acl:relcl)
inhibitors acetylcholinesterases (nmod)
% 75.6 (nummod)
disorder disorder (conj)
has 8 (nmod)
characteristics jejunal (amod)
caused was (auxpass)
hypokalemia profound (amod)
appeared age (nsubj)
implicated cause (nmod)
interfere mechanism (nmod)
taking while (mark)
injected experiment (nmod)
developed setting (nmod)
hearts explanted (amod)
administered fifteen (nmod)
downregulates estrogen (nsubj)
delayed onset (nsubjpass)
rats kidney (nmod)
become to (mark)
known induce (xcomp)
tumor ic (compound)
experienced drop (dobj)
dose meth (nmod)
expression acetylcholine (compound)
muscle taken (acl)
decreased high-dose (dobj)
decreases region (nmod)
pain contracture (conj)
tafi ( (punct)
had test (nmod)
response respectively (advmod)
ratio concentrations (conj)
release bupropion (compound)
using processor (dobj)
engrafted and (cc)
recipient the (det)
antigen for (case)
underlie that (nsubj)
alpha3 in (case)
% 6 (nummod)
developed neonates (parataxis)
arose yield (nsubj)
turnover dopamine (compound)
selected cases (dobj)
stereotypies the (det)
78 - (punct)
convulsions lidocaine (compound)
resulted targets (dobj)
pattern suggestive (amod)
consistent studies (nmod)
involved used (advcl)
hypersensitivity aspect (nsubj)
obstruction due (case)
hypogonadism and (cc)
taking had (aux)
caused hypersecretion (nmod)
conducted studies (nsubjpass)
val 320/12.5 (conj)
non-significantly was (cop)
surgery noncardiac (amod)
months 46 (nummod)
isoproterenol producing (advcl)
revealed emg (nsubj)
adding by (mark)
headache pain (conj)
appeared darker (dobj)
dominance given (case)
vagal tone (conj)
exception with (case)
hormone thyrotropin-releasing (amod)
8 9 (conj)
displace not (neg)
feature unusual (amod)
absent was (cop)
demonstrated changes (ccomp)
changed ) (punct)
bupivacaine c. (compound)
ganglia including (case)
treat population (nmod)
functional pgp (nsubj)
occurred relapse (nsubj)
led development (nmod)
ra ) (punct)
drugs conventional (amod)
explained were (auxpass)
anxiety changes (conj)
april cases (appos)
5th was (cop)
receive cheaper (dobj)
dystrophy myotonic (amod)
0.5 4.78x (conj)
effect neither (cc:preconj)
understanding processes (dobj)
initial the (det)
intensities signal (compound)
np or (cc)
tended signs (nsubj)
range activities (nmod)
leukemia lymphoblastic (amod)
blocked dbh (nmod)
alteration imaging (nmod)
beats/min ) (punct)
appearance cavity (nmod)
rbf , (punct)
preponderance male (amod)
globulin antithymocyte (compound)
values produced (acl)
values haematocrit (compound)
frequency paralysis (nmod)
61 and (cc)
onset tremor (nmod)
mean decreased (ccomp)
disorders these (det)
reduction were (cop)
mg 8.9 (nummod)
sirolimus or (cc)
micrographs luminal (dep)
used . (punct)
monitored , (punct)
conjugates : (punct)
total icus (nmod)
neuropathy retrobulbar (nsubj)
complication cc (nmod)
intermediate cells (dep)
resistant partially (advmod)
week postnatal (amod)
true is (cop)
recorded rate (nsubjpass)
49 +/- (cc)
inducing by (mark)
influence given (advcl)
girl a (det)
results randomized (dep)
technique mapping (compound)
features thrombosis (nmod)
days 11 (dep)
anorexia % (appos)
vasodilator hydrochloride (nsubj)
hepatotoxicity reported (advcl)
incidence myoclonus (nmod)
reduced incidence (nsubjpass)
startle baseline (compound)
treatment acne (nmod)
reported mastodynia (nsubjpass)
schizophrenic using (acl)
effects diazepam (nmod)
inhibited test (nmod)
bolus 60 (nummod)
cycles hemodialysis (nmod)
edema : (punct)
recorded events (dobj)
releasing tachykinins (dobj)
setting school (dobj)
result a (det)
recognized inhibitors (dobj)
offers schedule (dobj)
found kidney (nmod)
applicators licensed (amod)
followed administration (nsubjpass)
pf ) (punct)
provided review (nsubjpass)
nsc ( (punct)
treated prazosin (nmod)
bridge a (det)
bradycardia to (case)
hypertension adrenocorticotrophic (amod)
completed to (mark)
severe be (cop)
atria heart (nmod)
fraction resolution (conj)
index glomerulosclerosis (compound)
gauges ) (punct)
consumption body (compound)
users never (neg)
needle fine (amod)
described patients (nsubjpass)
reappeared complication (nsubj)
infusions subcutaneous (amod)
due decrease (nsubj)
men 143 (nummod)
conclude is (conj)
treated clomipramine (nmod)
area into (case)
condition any (det)
viewed has (ccomp)
phase days (nmod)
blocks ) (punct)
graded severity (nmod)
mildly only (advmod)
rate target (compound)
deficits visual (amod)
signs motor (compound)
testing or (cc)
urolithiasis of (case)
assays binding (compound)
reversal anticoagulation (nmod)
investigated we (nsubj)
remains elusive (xcomp)
observed undergone (advcl)
findings cases (nmod)
work in (amod)
% 1.09 (dep)
incidence delirium (nmod)
auccgrp ) (punct)
findings mg/kg/day (dep)
enucleated examined (conj)
warrant that (mark)
disorders indicating (acl)
accompanied left (conj)
selective highly (advmod)
indicating reason (ccomp)
exhibit inhibited (conj)
used doses (nsubjpass)
studied i.v. (nmod)
suffered myalgia (dobj)
selective consistent (xcomp)
clinic outpatient (amod)
sites action (nmod)
pointes : (punct)
describes enhancement (dobj)
ebf ) (punct)
vasospasm intense (amod)
oropharynx , (punct)
min 15 (nummod)
used environment (nmod)
produced injection (nsubj)
elicits series (dobj)
imply mainly (advmod)
bought g (dobj)
fact drawback (nsubj)
tachycardia drug-induced (amod)
bicyclo-orthobenzoate ( (punct)
initiated order (nmod)
abnormalities cramps/myalgias (conj)
deferens rabbit (compound)
mice ) (punct)
deaths county (nmod)
responsible resistance (nmod)
separated patients (nsubjpass)
different placebo (nmod)
have do (aux)
delivery agent (nmod)
quit who (nsubj)
scores induction (nmod)
difference frequency (nmod)
surgery day (compound)
individuals in (case)
117.61 ) (punct)
immunosuppression patients (nmod)
observed graded (conj)
frequency abnormality (nmod)
treated indinavir (nmod)
had eyes (nmod)
elicited were (auxpass)
sphericity lv (compound)
memory short (amod)
completed thalidomide (nmod)
antagonists ap7 (conj)
men years (appos)
seizures rats (nmod)
predictable = (parataxis)
virus , (punct)
labeling and (cc)
amphetamine metamphetamine (conj)
antibiotics combined (acl)
pod 2 (nummod)
nucleus pontine (compound)
significance may (aux)
value adc (compound)
levels mexiletine (compound)
replacement the (det)
described shortly (advmod)
does norepinephrine (dobj)
approved . (punct)
increased lines (nmod)
dependency the (det)
colorectal cancers (dep)
brought on (compound:prt)
precursor same (amod)
netilmicin piperacillin- (conj)
regulation to (case)
improves affect (conj)
probability significant (amod)
min beginning (nmod)
mice seizure-prone (compound)
factor atrial (amod)
ability react (acl)
healthy who (nsubj)
help decrease (xcomp)
trial randomized (amod)
value prophylactic (amod)
consolidation of (case)
matrix cristae (conj)
1788 - (punct)
eosinophils with (case)
immunoassay a (det)
depression cardiovascular (amod)
disorders anxiety (compound)
measure is (cop)
clues certain (amod)
day given (acl)
developed collapsed (conj)
simultaneously either (cc:preconj)
shedding rises (dobj)
thrombophlebitis of (case)
drug antidiabetic (amod)
hemodiafiltration continuous (amod)
mapd ( (punct)
l ( (punct)
given mg/ml (nmod)
occurred when (advmod)
divided ed50 (nmod)
affinities receptors (nmod)
infective biochemical (conj)
influence expression (dobj)
200 150 (compound)
0.6 x (cc)
mitochondria of (case)
effects antineoplastic (amod)
4.3 1.3 (compound)
fit fluctuating (advcl)
treated blockade (nmod)
quinpirole skf (compound)
useful reduction (nsubj)
stenosis > (punct)
12 of (advmod)
assessed protein (nsubjpass)
hydrochloride pyridoxine (compound)
immunization pertussis (compound)
tumours lymphoma (conj)
apparatus mice (conj)
administration chlormethiazole (compound)
expression antigen (nmod)
cohorts from (cc)
transient evoked (dep)
assess status (dobj)
detected so (mark)
w. of (case)
replicating work (dobj)
acid ) (punct)
pharmacokinetics profile (conj)
indicate accumbens (dep)
treatment cinacalcet (nmod)
aphasia weakness (conj)
staining for (case)
is paucity (attr)
concentrations by (case)
predisposing hypocalcemia (nmod)
signal in (case)
anesthesia and (cc)
harvested kidneys (nsubj)
treated year (nmod)
patients assessable (amod)
stabilizers . (punct)
carcinogen second (conj)
active centrally (advmod)
efficiency its (nmod:poss)
occurring increase (conj)
consider physicians (nsubj)
potentiated bradycardia (nsubjpass)
anesthesia lidocaine (compound)
principle correlates (ccomp)
parameters dogs (nmod)
purpose . (punct)
infused compared (conj)
svc central (conj)
single area (dep)
associated for (case)
channels k(atp (amod)
min rate (nmod)
profile well-established (amod)
c57bl/6 black (amod)
reversal flumazenil (nmod)
parameters and (cc)
ro 40 (nummod)
epo igf-il-3 (conj)
responsiveness erythropoietin (nmod)
steeply although (mark)
curve co2-response (amod)
torsade pentamidine-induced (amod)
progression disease (nmod)
administration lv (amod)
pathogenesis destruction (nmod)
sacrificed obtaining (advcl)
induce foci (dobj)
kit this (det)
hydration mannitol (conj)
antagonized rigidity (nsubjpass)
conducted concern (nmod)
i(f ( (punct)
treatment kanamycin (nmod)
infants < (nmod)
urine of (case)
promote alternatively (advmod)
test initial (amod)
hemorrhage with (case)
ocs combined (amod)
interpretation : (punct)
suggest has (ccomp)
patients diarrhoea-predominant (amod)
disease platinum/paclitaxel-refractory (amod)
mg normalized (advcl)
enhance flow (dobj)
abnormalities gain (conj)
administration sub-chronic (amod)
time prothrombin (compound)
b-100 a-ii (conj)
differed also (advmod)
1.4 - (punct)
azt ) (punct)
decreases intake (dobj)
chemotherapy following (case)
induction focus (nmod)
20 p (dep)
perturbations fewer (amod)
demonstrated patients (nsubjpass)
desorption/ionization laser (compound)
toxicity who (compound)
returned changes (nsubj)
was relation (attr)
used it (nsubjpass)
droperidol low (amod)
increased patients (nmod)
suppresses edaravone (nsubj)
group as/ks (compound)
effect cbdca (nmod)
cells glial (amod)
naproxen 1.35 (nummod)
importance changes (nmod)
received albuterol (dobj)
difficult can (aux)
led followed (advcl)
found differ (ccomp)
reduced x/minute (nmod)
modulation estrogen (nmod)
pituitaries female (amod)
pod pod (nmod)
defined . (punct)
child crisis (nmod)
bradycardia defined (acl)
signs including (case)
d plus (cc)
band the (det)
impairs stimulation (nsubj)
safe that (mark)
alleviate treatment (nsubj)
days delay (appos)
treatment protected (acl)
diagnosed total (nsubjpass)
discharged he (nsubjpass)
introduced 1981 (nmod)
occurs seizures (nmod)
prevent nephrotoxicity (dobj)
patients mesna (nmod)
fs within (case)
hydroxyanisole on (case)
mg/m2 300 (nummod)
appear thus (advmod)
activity paroxysmal (amod)
adopted been (auxpass)
pontis the (det)
optic complication (nsubj)
sacrifice and (cc)
7.1 +/- (cc)
group than (case)
h 96 (compound)
use therapies (nmod)
rate criteria (appos)
cbz oral (amod)
thiosemicarbazide with (case)
patients undergoing (nmod)
dose . (punct)
studies dysfunction (nmod)
reviews aspirin (nmod)
necrosis surrounded (acl)
5/8 ) (punct)
recommended force (nsubj)
eliminated reduction (nsubjpass)
affect might (aux)
excretion potassium (nmod)
materials methods (conj)
promoter core (compound)
exposure updated (amod)
study efficacy (nmod)
kinases ) (punct)
membrane-cytoskeleton proteins (dep)
presence administration (nmod)
connecting , (punct)
activity , (punct)
evaluated placebo (nmod)
mmhg 70 (nummod)
elucidated results (nsubj)
reduce frequency (dobj)
signals ganglia (compound)
found had (xcomp)
examinations determinations (nmod)
manageable resolved (conj)
areas apparent (amod)
myelotoxicity zdv-induced (amod)
had preoperatively (advmod)
encephalopathy an (det)
diazepam by (case)
able improve (xcomp)
symptoms patients (compound)
associated fluorouracil (nmod)
death tissue (nmod)
expressed to (mark)
contraindication are (cop)
patients 76 (nummod)
developing of (mark)
prevented pretreatment (nmod)
causes reversible (amod)
observations on (case)
rate reactions (nmod)
% 8.3 (nummod)
departments eds (appos)
people participating (acl)
td ( (punct)
ml 1000 (nummod)
setup an (det)
75 ( (punct)
referred compared (prep)
uptake bones (nmod)
monohydroxyethylrutoside monoher (appos)
properties rat (compound)
correlated abnormalities (nsubj)
hypokalemia . (punct)
associated state (nmod)
adjustment introduction (conj)
outcomes and (cc)
findings necrosis (nmod)
seen received (advcl)
similar monotherapy (nmod)
enhances dysrhythmogenicity (dobj)
dysfunction severe (amod)
action potent (amod)
damage membrane (nmod)
reduced injection (nsubj)
15 +/- (cc)
changed time (nmod)
antibiomania ): (punct)
r , (punct)
16;567 571 (dep)
result exacerbation (nmod)
fatigue events (nsubj)
affecting simultaneously (advmod)
dopaminergic glutamatergic (conj)
flow effective (amod)
procedures unnecessary (amod)
amphetamine- cocaine-induced (conj)
finished courses (dobj)
sites nuclei (nmod)
hypothesis that (dep)
disorder to (case)
establish risk (dobj)
combinations mg/kg (appos)
onset duration (conj)
pathogenesis complications (nmod)
pattern restrictive (amod)
weight wet (amod)
reuptake serotonin (nmod)
described course (dobj)
ahf ( (punct)
contraception after (case)
fear disgust (conj)
oxidase mitochondrial (amod)
attempted anticholinesterases (nmod)
centers the (det)
treatment his (nmod:poss)
effect reperfusion (nmod)
alteration concentrations (nmod)
induce to (mark)
pg of (case)
control wt (compound)
conclusions effect (dep)
33 86 (conj)
levels headache (nmod)
completion values (nmod)
aware low (advcl)
chloride sodium (compound)
support idea (dobj)
specific is (cop)
dechallenge after (case)
incidence % (dobj)
metamizol once (dep)
compared area (nmod)
mg tamoxifen (compound)
chemosensitivity central (amod)
trial transplantation (nmod)
course bupropion (nmod)
changes response (dobj)
mesna by (case)
contribution urotoxicity (nmod)
occurred exclusively (advmod)
tolerate kind (dobj)
effect modulators (nmod)
epiphenomena as (case)
grade patients (dep)
individuals hiv (compound)
applied easily (advmod)
become factor (attr)
mg/day dose (appos)
temperature f. (dobj)
performed oct (nsubjpass)
resistant . (punct)
shown were (auxpass)
diminish , (punct)
received complication (nmod)
p=0.008 ( (punct)
assessed myalgia (nsubjpass)
outpatients sixty-eight (amod)
latency prolonged (amod)
spectrum children (nmod)
accumulation intracellular (amod)
increased ritonavir (nsubj)
reversible to (mark)
monkeys prior (amod)
conclusions considered (appos)
creatinine electrolytes (conj)
odds respectively (advmod)
studies larger (amod)
flattening a (det)
trial schedules (nmod)
cord plexus (conj)
recurrence a (det)
la of (case)
effect azotemia (nsubj)
iq and (cc)
class each (det)
marked predominantly (advmod)
stimulation after (case)
have achieved (advcl)
stimulations the (det)
pattern characteristic (amod)
strategies extended-interval (nmod)
provide data (dobj)
group if (nmod)
advanced more (advmod)
showed expression (dobj)
beginning challenge (nmod)
marked more (advmod)
alteration the (det)
lt and (cc)
provoked could (aux)
visualized nissl-staining (nsubj)
incidence for (case)
scored . (punct)
rules the (det)
reversed this (nsubjpass)
nephropathy vivo (compound)
counts minute (nmod)
re-established period (nmod)
relationship hypokalemia (nmod)
ca2 extracellular (amod)
index sleep (compound)
prevent oih (dobj)
remained resistance (nsubj)
incidence were (cop)
deterioration ameliorated (acl:relcl)
thickness central (amod)
pathogenesis that (mark)
group morphine (compound)
cause hiccups (nmod)
time period (dobj)
varied . (punct)
models animal (amod)
value frap (compound)
gamma-hch of (case)
administration concurrent (amod)
pose significant (nsubj)
recorded electromyogram (nmod)
analyze occurrence (dobj)
included hypercalcemia (dobj)
c hepatitis (compound)
arrhythmias . (punct)
107 85 (conj)
one ) (punct)
meq/l 5.0 (nummod)
recordings during (case)
randomized any (det)
result production (nmod)
abc ) (punct)
consistent are (cop)
lymphoma refractory (amod)
prolactin of (case)
association variants (nmod)
drugs vasodilator (compound)
maze and (cc)
occur hours (dobj)
prevent lamivudine (nsubj)
salbutamol inhaled (amod)
predictive be (cop)
ingesting hydrochloride (dobj)
onset arrhythmia (nmod)
obtained 3 (nmod)
change measures (nmod)
mice suffering (acl)
sent 1986 (nmod)
changes mrna (nmod)
dose mg/m2/d (dep)
associated furthermore (advmod)
relief mg (dep)
administered mask (nmod)
% 44.4 (nummod)
end the (det)
expression catalepsy (nmod)
showed output (conj)
catalepsy studies (dep)
individuals preexisting (nmod)
microscopy measurements (conj)
tinnitus intractable (amod)
began improvement (nsubj)
literature medical (amod)
probable done (conj)
operated been (auxpass)
racemic ( (punct)
sections the (det)
trials of (case)
related dose (nmod:npmod)
peaked persisted (conj)
cmf ) (punct)
induced % (nmod)
complication trials (conj)
state p450/ccl4 (compound)
week feeding (nmod)
inhibits evaluated (parataxis)
angioedema report (dep)
symptoms postoperative (amod)
thromboembolism patients (nmod)
mediate angiogenesis (dobj)
given been (auxpass)
caffeine preparations (nmod)
subjects 0.01 (dep)
diet same (amod)
icterus severe (amod)
coagulopathies " (punct)
rats dm (nsubj)
reduced integral (nsubjpass)
control than (case)
mornings fifth (amod)
administered forehead (nmod)
downregulated pathway (dobj)
seemed most (nsubj)
demonstrated response (dobj)
days therapy (nmod)
raised and (cc)
showed lower (dobj)
reversal potentiated (amod)
1710 sec/cm5 (conj)
increased altered (conj)
known less (nsubjpass)
liquid paclitaxel/carboplatin (compound)
antagonized vagotomy (nmod)
build-up radioactive (amod)
features ct (compound)
defects filling (amod)
preexposure gspe (compound)
trials comparing (acl)
disrupts use (nsubj)
lesion callosal (compound)
emotional , (punct)
pressure ) (punct)
study monkeys (nmod)
flushing palpitations (conj)
decrease return (nmod)
evidence relating (acl)
ingestion to (case)
gly-gly ( (punct)
antibody-(pr3-anca proteinase (compound)
responses dynamic (amod)
nerves peroneal (compound)
variables in (case)
ntg delayed (amod)
dronedarone orally (advmod)
score global (amod)
restricted analysis (nsubj)
persistent and (cc)
toxicity without (case)
caution complication (nmod)
trial disorder (nmod)
subgroups at-risk (amod)
level increased (amod)
prophylaxis antiviral (amod)
prescribed drugs (nsubjpass)
nifedipine of (case)
made made (ccomp)
dependence its (nmod:poss)
65,860 celecoxib (acl:relcl)
therapy antiretroviral (amod)
study autoradiographic (amod)
following the (det)
activity adrenergic (amod)
disorders persistent (amod)
filaments ( (punct)
subgroups surgery (compound)
microbleeds and (cc)
behavioral responses (dep)
effects greater (amod)
searched strategy (nsubj)
bradydysrhythmias seizures (conj)
examined assay (nmod)
urotensin-ii u-ii (appos)
compared state (nmod)
response analgesic (amod)
-32 beats (dep)
period transient (amod)
social judgement (conj)
cerebellum in (case)
levels factor (compound)
b6 58 (nummod)
increasing suspicion (dobj)
studied strains (nmod)
mmhg anaesthesia (nmod)
resulted disappearance (nmod)
reported widely (advmod)
neurotoxicity theophylline (compound)
analyzed impact (dobj)
assay enzyme (compound)
methods identified (appos)
infusion 5-fu (nmod)
incidence this (det)
model theorem (conj)
captopril ( (punct)
discontinued caused (dep)
kidney , (punct)
objective evaluate (dep)
indicator function (nmod)
postulated contribute (xcomp)
values 1.1 (nmod)
impairment (stz)-induced (amod)
carotid or (cc)
harmless that (mark)
assumptions of (case)
report development (nmod)
animals from (case)
adriamycin in (case)
mg 282 (nummod)
entries chamber (nmod)
that not (neg)
users past (amod)
panel patient (nmod:poss)
genes two (nummod)
free were (cop)
metabolite responsible (conj)
bortezomib to (case)
calcification massive (amod)
hormone inappropriate (amod)
problems further (amod)
useful that (mark)
volunteers 12 (nummod)
emphasis a (det)
predictors three (nummod)
hypometabolism glucose (compound)
induces anxiety (dobj)
mediated have (conj)
lysis myofilaments (nmod)
o-a ( (punct)
absorption , (punct)
monotherapies than (case)
concentrations state (compound)
surgery orthopedic (amod)
microgram/ml 2.5 (nummod)
levels testosterone (compound)
role morphology (nmod)
30.7 - (punct)
cd4 t-cell (conj)
restriction moderate (amod)
equipotent may (aux)
common disease (nmod)
% epinephrine (nmod)
fourteen ) (punct)
maintains oxygenation (dobj)
sf36 ) (punct)
slowing to (case)
solubility conditions (nmod)
measured position (nmod)
vasopressin neurohypophysis (nmod)
alterations metabolic (amod)
s-a ) (punct)
reduce prevent (conj)
keep ng/ml (dobj)
potential , (punct)
uncontrollable movements (dobj)
spasm a (det)
ptz and (cc)
opiates , (punct)
sham the (det)
had intake (conj)
effect activity (nmod)
likelihood function (nmod)
sensitivity bfu-e (nmod)
alpha2-adrenoceptors presynaptic (amod)
aldosterone and (cc)
reported percent (nsubj)
toxicity dogs (nmod)
mg/kg 3.45 (nummod)
titre the (det)
nrf2(+/+ with (case)
reversed suggesting (advcl)
period particular (amod)
afford may (aux)
0.24:1 . (punct)
electro-oculography , (punct)
diclofenac treatment (nmod)
valve infant (nmod)
prevented patients (nmod)
causes indicating (xcomp)
given pretreatment (dobj)
improve spontaneously (advmod)
concentrations extracellular (amod)
differences : (punct)
patients digoxin (nmod)
myocarditis reported (acl)
score scale (compound)
showed groups (nmod)
problem is (cop)
osteoarthritis patients (dep)
paroxetine inhibitors (conj)
resulting cvvhdf (nmod)
podocytes of (case)
received basis (nmod)
increase binding (nmod)
norepinephrine to (case)
evidence of (case)
10(-5 x (compound)
anaemia of (case)
those improved (acl)
thrombectomy second (amod)
25mg/kg 100mg/kg (conj)
related concentration (nmod)
or=13.807 ( (punct)
vicinity ganglia (nmod)
female rats (conj)
cause change (dobj)
nodes ranvier (nmod)
clip hypertension (dobj)
patients seventeen (nummod)
head empty (amod)
pattern action (nmod)
lower may (aux)
role causal (amod)
replaced everolimus (nmod)
metabolizer drugs (nmod)
switchers second (nmod)
lisinopril medium-dose (amod)
hours starting (acl)
p=0.003 and (cc)
restarted receiving (advcl)
u-ii ( (punct)
drugs ototoxic (amod)
19 16 (conj)
axons purkinje (compound)
greater 0.05 (dep)
c7-c8 ) (punct)
anticipation spatial (compound)
resulting elimination (nmod)
anemia maha (appos)
treated site (nsubjpass)
safety respect (nmod)
allocated total (nsubjpass)
best was (cop)
shown been (auxpass)
present 13 (nmod)
prevention hc (nmod)
odds ratios (dobj)
plasma from (case)
pain discomfort (conj)
undertook part (nmod)
ganglia striatum (conj)
fragmentation dna (nmod)
suppresses that (mark)
recovery capacity (nmod)
cells -ir (compound)
uneventful was (cop)
protects acid (nsubj)
concentration analysed (amod)
defined dynamic (nmod)
paco2 at (case)
mg./kg . (punct)
deterioration motor (compound)
declined indices (nsubj)
bd1031 3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane (appos)
concluded activated (ccomp)
mg/kg/day 40 (compound)
anp ( (punct)
begun had (aux)
duration s (compound)
nmdars ( (punct)
treatment group (nmod)
dogs included (acl)
base ) (punct)
outpatient an (det)
mutants compartments (nmod)
% -16.6 (nummod)
regions pontine (amod)
correlates neural (nsubj)
behaviour novelty-suppressed (amod)
studied courses (nsubjpass)
na+ of (case)
blocked action (nsubjpass)
stretches faster (amod)
protocol of (case)
svrs ) (punct)
woman 89-year-old (amod)
elimination published (amod)
ventricle into (case)
involved responses (nmod)
= p<0.01 (dobj)
caused cimetidine (nmod)
increase dyskinesia (nmod)
women born (acl)
induced contraction (dobj)
alpha-2b of (case)
range days (nmod)
cimetidine dose (nmod)
procedure phases (conj)
orbitofrontal circuits (dep)
induced treatment (nsubj)
serve however (advmod)
questionnaire with (case)
patients softening (conj)
restarted beclomethasone (nmod)
nitrite ca(2 (conj)
cml ) (punct)
was observed (advcl)
represents side-effect (nsubj)
period immediate (amod)
therapy platelet (compound)
lacking studies (nsubj)
treated cisplatin (nmod)
alkalinization satisfactory (amod)
irreversible developed (conj)
hypothyroidism by (case)
compared saline (nmod)
disappeared recurred (conj)
cent cent (conj)
marker ctnt (nsubj)
treatment those (nmod)
concentrations peak (dep)
gels on (case)
sbp ( (punct)
unable was (cop)
chloroacetaldehyde role (dep)
groups p10 (compound)
remained group (nmod)
used vigabatrin (nsubjpass)
maintaining fluid (dobj)
hypoglycemia and (cc)
14.2 +/- (cc)
therapy routine (amod)
pregnancy no (neg)
attempt induce (acl)
overdose by (case)
model infection (conj)
converted um-272 (nmod:npmod)
administration mg/day (nmod)
course terbinafine (nmod)
died one (nsubj)
score off-period (amod)
recruited study (nmod)
mcpp 2.0mg/kg (appos)
nephrotoxicity because (case)
report disabling (xcomp)
reduction week (nmod)
urticaria angioedema (conj)
those myalgia (nmod)
stratum in (case)
increasing glycine (dobj)
uncertain was (cop)
parp-1+/+ parp-1-/- (conj)
studied hours (dep)
related length (nmod)
paper in (case)
neurons areas (nmod)
t5 or (cc)
days mg (conj)
scale the (det)
lead ppa/caffeine (nsubj)
interviewed authors (nsubj)
states volume (compound)
illicit underestimate (conj)
dysrhythmias with (case)
affinity negligible (amod)
microangiopathy thrombotic (amod)
levels malondialdehyde (nmod)
obtained normalization (nsubjpass)
fraction an (det)
expression transition (conj)
crisis hypertensive (amod)
succumbed onset (nmod)
randomised london (nmod)
consist separating (advcl)
effects beta-blockade (nmod)
followed increase (nmod)
enrolled as (mark)
3.0+/-0.4 cocaine (nmod)
demonstration is (cop)
experiment analysis (nsubj)
failure history (nmod)
reduplication : (punct)
damage cortices (conj)
expected literature (nmod)
demonstrated efficacy (dobj)
patients 5 (nummod)
margin upper (amod)
due probably (advmod)
responsible preparations (nsubj)
licking hyperalgesia (conj)
recovered after (mark)
treat to (mark)
sensitivity prior (amod)
micrograms/d 400 (nummod)
changes differential (amod)
decreased overexpression (dobj)
high unusually (advmod)
pharmacology . (punct)
agents immunosuppressive (amod)
allografts dysfunctional (amod)
calculus renal (amod)
sos ( (punct)
period 9-week (amod)
causing without (mark)
enzymes . (punct)
appeared tachycardia (nsubj)
episodes hypomanic (amod)
studies acid (nmod)
5-fluorouracil administered (acl)
disappearing may (aux)
interval min (nmod)
segments n=6 (dep)
association risk (nmod)
reported required (conj)
reported be (auxpass)
survival patient (compound)
trials denopamine (nmod)
advantage major (amod)
elevated range (nmod)
day administration (nmod)
16 44 (nmod)
causes patient (nmod)
density dependence (appos)
175 to (case)
period six-month (amod)
pain tonic (amod)
abolished action (nmod)
time admission (nmod)
impact cells (nmod)
incidence apnoea (nmod)
potentiation neurotransmission (nmod)
longer or (cc)
11 and (cc)
width ) (punct)
indicated use (nsubj)
complained none (nsubj)
standard are (cop)
occurred ototoxicity (nsubj)
paralysis preoperative (amod)
able findings (nmod)
potency excitatory (amod)
rats ie (advmod)
profile risperidone (nmod)
pain block (nmod)
keep to (mark)
relevant use (nmod)
adenocarcinoma liver (nmod)
syndrome vena (compound)
records women (conj)
treatments ninety (nummod)
did consistent (conj)
administration micrograms/kg (appos)
obtained samples (nsubjpass)
procedure thalamotomy (appos)
continued period (nmod)
requiring surgery (dobj)
associated indicating (xcomp)
period total (appos)
no ( (punct)
event presented (parataxis)
women the (det)
suffering had (aux)
course dependence (conj)
children incidence (appos)
leukocyturia with (case)
gfr the (det)
agency the (det)
aged 15 (nmod)
reports dystonia (nmod)
predisposes that (nsubj)
administration licl (nmod)
reducing albuminuria (dobj)
mice the (det)
density content (conj)
outcome , (punct)
escape to (mark)
uneventful initially (advmod)
related accumulation (nmod)
dysrhythmias postinfarct (compound)
potentiated be (auxpass)
center ) (punct)
unchanged are (cop)
puerperium the (det)
drug the (det)
homoeostasis of (case)
had eleven (nsubj)
decreased isoproterenol (nsubj)
use without (case)
concentrations or (cc)
reversible and (cc)
initiated meningitis (nmod)
snr lesioned (amod)
occurring initiation (nmod)
controls , (punct)
seizures impairment (conj)
mask tube (nmod)
activities , (punct)
controls 1,908 (nummod)
pas corresponding (amod)
level iron (compound)
novel effective (conj)
gamma-hch mg/kg (compound)
extubated patient (nsubjpass)
mmhg pressure (nsubj)
men eight (nummod)
comparable was (cop)
hypertelorism orbital (amod)
implicated although (mark)
ci 0.92 (nummod)
tumors several (amod)
free recurrence (nmod)
reported compared (dep)
placebo lovastatin (conj)
occurred monotherapy (nmod)
intoxication drug (compound)
kinase transaminases (conj)
sarin and (cc)
occurred none (nsubj)
percent 26 (nummod)
pressure including (case)
receptors located (acl)
score activities (nmod)
pre-treatment using (acl)
continued treatment (dobj)
said comparable (xcomp)
had dose (advcl)
doses 20 (nummod)
disease lid (conj)
patients isolated-hit (amod)
likely that (nsubj)
prevented rhuepo (nmod)
4.1 1.2 (nummod)
radiopharmaceutical new (amod)
maintained levels (nsubjpass)
subcortex and (cc)
aware are (cop)
ability walk (acl)
therapy antiandrogen (amod)
recorded 35 (conj)
hydrobromide the (det)
clonidine and (cc)
followed closely (advmod)
assessed method (nmod)
concentrations food (conj)
because probably (advmod)
incidence patients (nmod)
infarction acute (amod)
statement . (punct)
toxicity mild (amod)
rates by (case)
level conversion (nmod)
mice nrf2(-/- (amod)
use long-standing (amod)
patients adult (amod)
toxicity quinine (compound)
gravis . (punct)
gap43-ir of (case)
2.0 and (cc)
urd ( (punct)
reviews prevention (nmod)
hoe ip (dep)
distinguish . (punct)
corticosterone 300 (nummod)
used doses (nmod)
differences propensity (nmod)
observations , (punct)
response partial (amod)
treatment amisulpride (amod)
drug disease (nmod)
reviewed materials (nsubjpass)
observed declines (nsubjpass)
caused d-penicillamine (nsubj)
given group (nmod)
proteins peripheral (amod)
role restoring (acl)
conclusion tolerated (acl)
imparts that (nsubj)
ingestion chloride (compound)
become subject (attr)
encephalopathy controls (conj)
12.2 to (quantmod)
abolished action (dobj)
glomerulopathy membranoproliferative (amod)
dyskinesias overflow (amod)
responses vessels (nmod)
duration only (advmod)
cardiotoxicity : (punct)
1.2 3.8 (prep)
elements blood-brain-barrier (nmod)
zones subendothelial (amod)
decrease rcr (nmod)
alprazolam to (case)
tended but (cc)
noncompliance 14 (nummod)
pdtc of (case)
dose particularly (advmod)
hyperhidrosis were (cop)
base near (case)
doses three (nummod)
dystrophy osteoporosis (conj)
progressing death (nmod)
persists and (cc)
status . (punct)
suggested cue (nmod)
protect nephrotoxicity (nmod)
study group (conj)
hematuria macroscopic (amod)
azt plus (cc)
vehicle not (neg)
cck-2 8 (cc)
blocker , (punct)
96.7 ; (punct)
doses most (amod)
pain nausea (conj)
exceeding not (neg)
observed level (nsubjpass)
hyperprolactinemia for (case)
include component (dobj)
problems with (case)
abnormal and (cc)
comparison efficacy (nmod)
known indicate (conj)
received weeks (nmod:tmod)
enrolled results (nsubjpass)
exercise that (det)
males adult (amod)
loss functional (amod)
phosphokinase iu/l (appos)
assessment longitudinal (amod)
enzyme in (case)
high restored (conj)
trihexyphenidyl to (mark)
acid oisoquinoline-3- (compound)
began she (nsubj)
magnitude specificity (conj)
receive antibiotics (dobj)
t-tests ) (punct)
failure need (acl:relcl)
effect additional (amod)
literature the (det)
mass tibialis (compound)
induced amnesia (dobj)
extraction . (punct)
patients succinylcholine (nmod)
warranted work (nsubjpass)
increments mg/kg (nmod)
caused distribution (nmod)
c+e ) (punct)
considered been (auxpass)
morphometry by (case)
quadrants the (det)
diskinesia of (case)
wave delayed (amod)
population adult (amod)
classified woman (nsubj)
mechanism nefiracetam (nmod)
contained samples (nsubj)
models current (amod)
gestation infection (nmod)
induced acetazolamide (nmod)
activity root-mean-square (amod)
induced reduction (dobj)
therapy naproxen (compound)
seizures their (nmod:poss)
decrease dose (nmod)
hepatocarcinogenicity of (case)
bladder gall (compound)
depletion marked (amod)
nos enos (dep)
2d6 isoenzyme (compound)
subacute onset (nsubjpass)
conduct to (mark)
small risk (nsubj)
suppressed significantly (advmod)
effects electrophysiologic (amod)
cisternae dilated (amod)
effects amnesic-like (amod)
reported it (nsubjpass)
damage permanent (amod)
ability altered (amod)
amphetamine response (dep)
latencies the (det)
imbalance oxide-redox (compound)
low as (advmod)
weeks responders (nmod)
cab of (case)
serum patients (nmod)
placed then (advmod)
content norepinephrine (compound)
dose compound (compound)
influencing degree (dobj)
previously simultaneously (conj)
domains iief (nmod)
reticulata snr (appos)
diltiazem paracetamol (conj)
showed thickening (dobj)
performed forgetting (conj)
randomised ; (punct)
3.0+/-0.4 concentration (nsubj)
hyperkinesis irritability (conj)
eliminated prevented (conj)
11.2 1.08 (conj)
women 850 (nummod)
locomotion amphetamine (compound)
11.3 +/- (cc)
0.50 to (case)
reduction due (case)
showed produces (ccomp)
results from (case)
129 11 (conj)
propionate tp (appos)
mg/kg 0.09+/-0.02 (nummod)
pressures systolic (amod)
use vincristine (nmod)
suggest involvement (dobj)
presented us (nmod)
celecoxib ce (appos)
restoration with (case)
provide thus (advmod)
probe crna (compound)
d-penicillamine with (case)
impaired learning (dobj)
taking daily (advmod)
infarctions globus (compound)
mismatch a (det)
found levels (nsubjpass)
% concentration (nsubj)
normal overflow (nsubj)
response isoproterenol (nmod)
increases stress (dobj)
reverse or (cc)
tetracycline response (dep)
chemotherapy both (cc:preconj)
amounts derivatives (nmod)
4 , (punct)
patients treatment (nmod)
taking minocycline (dobj)
compartment into (case)
years evidence (nmod)
tumors estrogen-induced (amod)
synthase nnos (appos)
manner an (det)
sensitized was (auxpass)
abolishment its (nmod:poss)
withdrawn when (advmod)
13 in (case)
architecture normalizes (amod)
remains unclear (xcomp)
erythrodysesthesia and (cc)
cardiotoxicity effect (conj)
background was (dep)
less model (nmod)
independently microalbuminuria (nmod)
occurred manner (nmod)
migraine mentioned (amod)
mcao by (case)
shortened less (advmod)
7.7 1.3 (conj)
patients ) (punct)
1.7 0.7 (nummod)
warranted , (punct)
severe delay (nmod)
kindling seizure (amod)
matched use (dobj)
entered men (nsubjpass)
administration doses (appos)
innervation striatum (nmod)
improve prevent (conj)
apparent clinical (dep)
hypertension to (case)
order to (mark)
increase day (nmod)
applied and (cc)
developed feet (nmod)
mg/kg 0 (nummod)
smoking . (punct)
haplotypes estimated (amod)
levels glutamine (compound)
dose 0.05 (nmod)
weight fat-free (amod)
attenuation rats (nmod)
explore , (punct)
mechanism distinct (amod)
rhinitis seasonal (amod)
frequency because (mark)
esrd to (case)
increase would (aux)
lidocaine procedures (nmod)
agonists alpha1-adrenoceptor (amod)
prompted patient (nsubj)
november ( (punct)
criteria . (punct)
subjected treadmill (nmod)
77.1 18.9 (conj)
recorded rashes (nsubjpass)
led identification (nsubj)
overstimulation beta2-adrenoceptor (compound)
comparison time (nmod:tmod)
p450 2b1/2b2 (conj)
prevents rigidity (dobj)
hearts rat (compound)
aspects clinical (amod)
dead . (punct)
amplified , (punct)
reported subject (nsubj)
induced (+/-)-pg-9 (nmod)
evaluated model (nmod)
increase sign (nsubj)
induce retardation (dobj)
treated months (nsubjpass)
favor mechanism (dobj)
male 47-year-old (amod)
methods evaluate (dep)
26- 87- (conj)
activity cardiac (amod)
2.3+/-1.2 number (nsubj)
respiration independent (amod)
dopamine postsynaptic (amod)
found staining (nsubjpass)
dexmedetomidine with (case)
noted granules (nmod)
shed mechanisms (nmod)
dog in (case)
with given (conj)
damage drug-induced (amod)
benefits and (cc)
strains among (case)
production between (case)
pressure control (conj)
designated share (advcl)
ratio 4.4 (conj)
week recovery (nmod)
score as (cc)
had woman (nsubj)
mg/kg/i.v ) (punct)
infarctions fewer (amod)
administered prochlorperazine (nsubjpass)
presented syndrome (nmod)
efficacy women (nmod)
characterize we (nsubj)
exacerbated adriamycin (nmod)
ischemia receiving (conj)
produce women (nmod)
women 612 (nummod)
experienced attacks (nmod)
species , (punct)
thickening or (cc)
release acetaldehyde (nmod)
observed regression (nsubjpass)
pathways afferent (amod)
a-ii apo (compound)
patients most (case)
history three-week (amod)
sequence absence (conj)
syndrome aml (dep)
show would (aux)
evaluated action (nsubjpass)
hctz 12.5 (nummod)
patients bypass (compound)
underwent ) (punct)
location and (cc)
rats thirty-five (nummod)
elevated position (nmod)
km pyrophosphate (nmod)
valsartan , (punct)
denopamine of (case)
output , (punct)
6.4 - (punct)
8-se thr(so3h)7-ac-cck-2 (compound)
found cohorts (nmod)
withdrawn and (cc)
retains . (punct)
catheter dialysis (compound)
s-23121 of (case)
aggravated probably (advmod)
space posterior (amod)
expression ds (compound)
compromise cardiopulmonary (amod)
pregnancy ears (appos)
hd-mtx ( (punct)
% mean (dep)
increase of (case)
end days (nmod)
identified end (nmod)
control temperature (conj)
hours 10 (nummod)
confirm this (dobj)
taking stabilized (ccomp)
year-old 72 (compound)
vomitus loss (conj)
% response (appos)
showed reduced (ccomp)
nurse emergency (compound)
% 9/15 (dep)
improvement . (punct)
action transmembrane (compound)
administration mpges-1 (nmod)
patients points (conj)
seizures slower (conj)
drowsiness hallucinations (conj)
materials patients (conj)
selectivity with (case)
release sensitivity (conj)
deprivation rats (nmod)
hearing adults (nmod)
team from (case)
pretreatment mangiferin (nmod)
indicate signs (nsubj)
coxii genes (conj)
course pregnancies (nmod)
reappeared reintroduced (advcl)
= each (nmod)
rejection nephropathy (conj)
clonidine with (case)
managed cyclosporine (nmod)
selection study (compound)
wr242511 , (punct)
evident changes (nsubj)
mechanism ischemia (nmod)
cause antidepressants (nsubj)
conditions in (case)
dexamethasone saline (conj)
disorders some (det)
withheld substituted (conj)
10 7 (quantmod)
exposure fluoxetine (compound)
injected chx (nsubjpass)
studies imaging (nmod)
hinder quality (dobj)
sigma2 for (case)
derivative acid (nmod)
pma with (case)
assessed 33342- (nmod)
mg/kg 3.75 (nummod)
improvement performance (nmod)
earliest are (cop)
compared follow-up (nmod)
had % (conj)
resolved delirium (nsubj)
schizophrenic or (cc)
groups saline- (amod)
years 59 (nummod)
levels 3nt (amod)
became but (cc)
cause changes (dobj)
survey complications (nmod)
receive mg (conj)
mumol/kg 0.8 (nummod)
part regimens (nmod)
results inhibited (dep)
increased ppa (nsubj)
seeded . (punct)
current i(f (appos)
material of (case)
oxide molecule (compound)
suggest they (nsubj)
augmented furthermore (advmod)
observed conversion (nmod)
duration injection (nmod)
vascular cardiac (conj)
disorders myotonic (amod)
normalized levels (nsubjpass)
decreased acid (nsubj)
describe recipient (dobj)
checklist aberrant (compound)
capacity patients (nmod)
patients mg/kg/day (dep)
arrest child (nmod)
coarsening features (nmod)
studied extent (nsubjpass)
administered mice (nmod)
revealed decrement (dobj)
parkinsonian ' (punct)
addicts treated (acl)
assessed 4 (nmod)
slower onset (nmod)
control rate (nmod)
investigated result (ccomp)
females . (punct)
remained hyperactivity (nsubj)
dysfunctions autonomic (amod)
anemia near-syncope (nmod)
use toxicity (conj)
difference which (nsubj)
experience delivery (nmod)
dogs on (case)
fluid busulfan (nmod)
resolution withdrawal (nmod)
use bupropion (compound)
thrombi fibrin (compound)
trials placebo-controlled (amod)
psychopathology task (conj)
diagnosis presumptive (amod)
mg 5.0 (compound)
8-week part (nsubj)
alive patients (nsubj)
flow blood (compound)
toxicities the (det)
attenuated rp (nmod)
patients minimum (nmod)
due pathology (nmod)
sections caesarian (amod)
differ drugs (nsubj)
diameters and (cc)
ascitis due (case)
disorders delirium (nmod)
cholesterol stones (nsubj)
range 9 (nummod)
nephritis non-steroidal (amod)
saline than (case)
phenobarbital substrate (amod)
transplantation with (case)
antagonists with (case)
invited attend (xcomp)
loss seizures (conj)
sufficient dopamine (compound)
ballistic and (cc)
disruption deprivation (nmod)
activity prod (nmod)
complications severe (amod)
headache cluster (compound)
infrequent reports (nsubj)
type paranoid (compound)
benefit stimulation (nmod)
1.55 ( (punct)
characteristics myopathic (amod)
treatment days (nmod)
age duration (conj)
cholinesterase and (cc)
patients immunocompromised (amod)
blocked hyperactivity (nsubjpass)
insufficiency chronic (amod)
total age (dep)
experience any (det)
cells/mm3 cells/mm3 (conj)
iii-v hoehn (nmod)
all not (neg)
1.5 ) (punct)
analyzed c (nsubjpass)
presumed plus (cc)
had association (dobj)
resulted : (punct)
gemcitabine years (dep)
sequelae delayed (amod)
present on (case)
increase because (mark)
patients value (nmod)
followed patient (nsubjpass)
risperidone t(33 (appos)
activation an (det)
concentrations 10(-2 (nmod)
undertaken review (nsubjpass)
binding normal (nmod)
requires opening (dobj)
problems attention (compound)
effects side (compound)
seems reaction (nsubj)
0.83 ( (punct)
observed that (mark)
18 ) (punct)
animals seizure (amod)
vds ) (punct)
mid- embryos (dep)
example an (det)
cocs women (nsubj)
1.34 +/- (cc)
immunoblotting immunohistochemistry (conj)
asa ] (punct)
flexion/extension flexion/extension (appos)
pergolide stimulating (amod)
studied prevalence (dobj)
cases stroke (compound)
have ? (punct)
metabolite neurotoxic (amod)
hospital median (dep)
measured effects (nsubjpass)
8 6.08 (conj)
infusion combination (nmod)
analysis site (nmod)
respect this (det)
immunocytoma solid (amod)
defined points (nmod)
first best (conj)
velocity phase (appos)
use factors (nsubj)
alternative as (case)
abnormalities concurrent (amod)
underwent center (nmod)
concentrations need (nmod)
employed paradigm (nsubjpass)
showed calculi (dobj)
vagotomy by (case)
patients psychotic (amod)
target selectively (advmod)
bepridil by (case)
% 99.4 (nummod)
amygdala cortex (conj)
decreases lamivudine (nsubj)
0.02 0.06 (conj)
case as (prep)
took zolmitriptan (dobj)
c+e and (cc)
parameters reflecting (acl)
failure diffuse (conj)
adrenoceptor stimulant (amod)
induced scopolamine (nsubj)
induced kidneys (nmod)
remission , (punct)
level serum (nmod)
rates % (nmod)
dermatitis toxic (amod)
imaging the (det)
tried study (nsubj)
pattern absence (nmod)
production species (nmod)
reaction macro-papular (amod)
incidence on (case)
greater spontaneous (dep)
response stimuli (nmod)
pre- post-transfusion (conj)
infusion superior (conj)
constituents l. (nmod)
combination propofol (nmod)
syndrome digeorge (compound)
diabetics variety (nmod)
resulted increase (conj)
trials the (det)
effects exposure (nmod)
who ) (punct)
complicated however (advmod)
combinations ketamine (nmod)
ro15 - (punct)
applied widely (advmod)
products positive (amod)
rats isoproterenol (amod)
2.41 1.31 (conj)
phase epilepsy (nmod)
experimental limited (conj)
concern safety (nmod)
symptoms neuroleptic-induced (amod)
diagnosed transplantation (nmod)
fluphenazine the (det)
prominent that (nsubj)
indicative results (nsubj)
agents d1 (compound)
interaction enhances (acl:relcl)
1 chemotherapy (nmod)
disorders tissue (compound)
activity impaired (amod)
hcl to (case)
total and (cc)
blue dye (compound)
used product (dobj)
confounding to (case)
tip iceberg (nmod)
parkinsonism of (case)
number in (case)
patients sixty-two (nummod)
score mean (compound)
cytoplasm submembranous (amod)
mice aggregation (conj)
resolve incontinence (nsubj)
hh and (cc)
activity tgf-beta1 (nmod)
infusion ppa (nmod)
renin , (punct)
atropine before (nmod)
appeared figures (nmod)
acc-9653 sodium (conj)
interaction drug/light (compound)
vancomycin these (det)
patients practices (nmod)
water including (case)
associated times (advmod)
capnocytophaga and (cc)
stroke cocaine (conj)
averting need (dobj)
maintained patient (nsubjpass)
amounts equimolar (amod)
is relationship (attr)
kidneys neonatal (amod)
% 34.2 (nummod)
arise which (nsubj)
present unresponsive (conj)
damage kidney (compound)
case this (det)
mipafox ) (punct)
octreotide , (punct)
pretreatment nh4ac (compound)
fluorouracil leader (amod)
elevated negative (conj)
effects vascular (amod)
passing train (dobj)
further clinical (dep)
received 13 (conj)
result vasoconstriction (nmod)
showed deteriotation (dobj)
arm of (case)
thought precipitation (xcomp)
secondary hypothyroidism (nmod)
suggests disappearance (nsubj)
retention- of (case)
stress sestamibi-spect/dobutamine (compound)
hallucinations these (det)
detected that (mark)
value standardised (amod)
spasm induction (nmod)
mg ce (nmod)
peaked treated (conj)
doses from (case)
refractory which (nsubj)
gains popularity (dobj)
displacement a (det)
describe pointes (dep)
atrophy infiltration (conj)
amikacin with (case)
cy with (case)
doses into (case)
evaluated children (nsubjpass)
indicate increase (ccomp)
involvement cells (nmod)
analyzed semiquantitatively (advmod)
had one (nsubj)
70 15 (compound)
rates their (nmod:poss)
enhanced males (nmod)
status m.s. (appos)
included stratified (conj)
ratio ; (punct)
surveillance the (det)
concluded contribute (ccomp)
speaking " (punct)
group prevented (acl:relcl)
increased median (nmod)
h treatment (dep)
shell core (appos)
increment clarithromycin (nmod)
safety regimen (nmod)
function transporter (compound)
repolarization of (case)
potassium serum (compound)
variables diagnosis (appos)
tests neuropsychological (amod)
increased aggressiveness (dobj)
withheld . (punct)
hemodynamic scintigraphic (conj)
included elements (nsubj)
disappeared patients (nmod)
clomipramine the (det)
ich with (case)
ratio age-adjusted (amod)
mg levofloxacin (compound)
suggest channel (ccomp)
impaired differ (conj)
completion treatment (nmod)
sarcoma advanced (amod)
underwent use (nmod)
induce drug (nsubj)
tube a (det)
aml ( (punct)
use heroin (compound)
groups controls (nmod)
wr-2721 or (cc)
complained medication (nmod)
score damage (compound)
showed little (dobj)
ablation kinase (nmod)
fibrillation atrial (amod)
concentration sevoflurane (nmod)
transplantation myeloma (nmod)
seems suggesting (xcomp)
coincident duration (nmod)
week(-1 ( (punct)
techniques immunoblotting (nmod)
known stimulation (nsubjpass)
taking mg (conj)
analyses levels (nmod)
aborted if (mark)
diethylstilbestrol des (dep)
pbo ( (punct)
levels associated (acl)
polfa ) (punct)
enzyme is (cop)
background remains (dep)
benefit point (nmod)
damage can (aux)
2.9-fold p=0.000 (appos)
mm cisapride (conj)
levels aspartate (compound)
treated glaucoma (nmod)
pn ) (punct)
infusion morphine (nmod)
pre-treatment 0 (nmod)
amounts for (case)
pph with (case)
investigated sensitizes (ccomp)
0.7 +/- (cc)
a receptors (conj)
temporary waiting (conj)
pretreatment animals (nmod)
induction streptozotocin (nmod)
csa mg/kg/day (amod)
microinjection region (nmod)
reports unpublished (amod)
found myotonia (nsubjpass)
cyclosporine prednisone (conj)
ampk ( (punct)
euthanized and (cc)
spv ( (punct)
high-dose lethality (conj)
p100 groups (conj)
agc relapsed (amod)
hr remd (nmod)
once day (nmod:npmod)
foci positive (amod)
decreased hazard (nsubj)
deprivation 12-h (amod)
chemotherapy doxorubicin (nmod)
score pain (compound)
injection amphetamine (compound)
ah6809 antagonist (appos)
dose fazadinium (nmod)
vehicles ; (punct)
exchange in (case)
tacrolimus pimecrolimus (conj)
cases interaction (nmod)
reported various (nsubj)
propionate testosterone (compound)
syndrome arthralgia-myalgia (amod)
failure itself (nmod:npmod)
fall function (nmod)
alpha-tac ( (punct)
g. 21.4 (nummod)
prospective , (punct)
had discontinuation (nmod)
had hysterectomy (dobj)
asthma ratio (dep)
cb , (punct)
members class (nmod)
degrees similar (amod)
changes both (nmod)
activation target (compound)
less rate (nsubj)
163 ; (punct)
3 both (cc:preconj)
timolol drops (conj)
decrease ve (nmod)
% 3.5 (nummod)
study ; (punct)
occur variability (nmod)
performed considered (conj)
one-third them (nmod)
doses given (acl)
found animals (nmod)
lozenge 4-mg (amod)
end by (case)
smaller groups (advcl)
across and (cc)
safety activity (conj)
model conditional (amod)
0 250 (conj)
reduction odds (nmod)
unconjugated . (punct)
positivity troponin (compound)
corresponded effects (nmod)
fk illinois (appos)
increases aggressiveness (dobj)
associated acute (nmod)
antioxidants enzymic (amod)
injection if (nmod)
condition capsaicin-untreated (amod)
able , (punct)
combination mesna (nmod)
damage " (punct)
reports other (amod)
studied mortality (dobj)
started used (dep)
was dose (nmod)
known produce (xcomp)
undergone observed (conj)
therapy bcnu (compound)
box in (case)
valve tricuspid (compound)
induced means (nmod)
day and (cc)
found p-coumarate (nsubjpass)
hypertension phenylpropanolamine-induced (amod)
randomized , (punct)
acutely in (case)
efficacy incidence (appos)
mice dba/2 (appos)
19.3 32.9 (appos)
influence drugs (nsubj)
tomography coherence (compound)
sole manifestation (conj)
data ( (punct)
history no (det)
antinociceptive pg-9 (dep)
catheter ip (compound)
3/20 , (punct)
suggests capable (ccomp)
edema hypertrophy (conj)
antagonist amino (compound)
dimensions bruising (nmod)
% 1.6 (compound)
prevent complications (dobj)
staining perls (nmod:poss)
eyes patient (nmod:poss)
withdrawal drugs (nmod)
damage less (amod)
< with (case)
risperidone clozapine (compound)
analyze here (advmod)
recovery his (nmod:poss)
shown naloxone (nsubjpass)
dose ideal (compound)
schedule dose (conj)
treatment periadolescent (compound)
symptoms schizophrenic-like (amod)
l-alpha-gfc scopolamine (appos)
thc ) (punct)
opioids of (case)
relationship crisis (nmod)
detection ich (compound)
he-lfb ) (punct)
neuropathy on (case)
(pge1)-induced studied (conj)
cr ; (punct)
kindling from (case)
1500 - (punct)
have it (nmod)
life survival (conj)
atria isolated (amod)
frequency grade (nmod)
k(i ( (punct)
frequent include (conj)
drawback main (amod)
above just (advmod)
iu/l . (punct)
fr specific (amod)
alter . (punct)
degree cycle (nmod)
application pilocarpine (nmod)
along all (advmod)
hcbd papillary (conj)
hypothyroidism and (cc)
extract mg/kg (dep)
damage recovery (conj)
0.05 0.2 (conj)
0.1 0.13 (conj)
dysfunction circuitry (nmod)
22.25 51.0 (prep)
includes patients (nmod)
newer low (dep)
years 4 (nummod)
populations various (amod)
improve chain (dobj)
caused whether (mark)
embryopathy warfarin-induced (amod)
presence hbeag (nmod)
recipient male (amod)
treated pregnancy (nmod)
hospitalised died (conj)
rapid and (cc)
vasculature pulmonary (amod)
mechanisms exerted (acl:relcl)
occurred seconds (nmod)
hearts with (case)
examined child (nsubjpass)
developed iridocyclitis (dobj)
mechanisms . (punct)
reverses emergence (dep)
defined occurrence (nmod)
discovery original (amod)
dysfunction sclerosis (nmod)
mtdna ( (punct)
provide patient (dobj)
cholesterol that (mark)
treatment infants (nmod)
proposed features (dep)
derangement developing (acl)
exposed agent (nmod)
known both (dep)
completed until (mark)
anesthetics by (case)
months 25 (nummod)
appears use (nsubj)
administration postoperative (amod)
7.142 - (punct)
thrombophlebitis patients (dep)
paraventricular the (det)
surgery the (det)
elevated patient (nmod)
available has (aux)
involved when (advmod)
vincristine by (case)
utilized strategies (nsubjpass)
using famotidine (dobj)
subspecialty of (case)
lumens vascular (amod)
implanting mini-pump (nmod)
ligands several (amod)
areas epithelium (nmod)
evaluated january (nmod)
suggests that (mark)
venlafaxine on (case)
marrow dysmyelopoiesis (conj)
phenobarbitone carbamazepine (conj)
records interview (conj)
findings course (amod)
that arteries (nmod)
dose starting (amod)
three cases (nmod)
measures total (nmod)
show neuropathy (amod)
included bumetanide (advmod)
patients ninety-seven (amod)
inhibited may (aux)
days evolution (nmod)
phenomena other (amod)
neurodegeneration epilepsy-induced (amod)
having production (dobj)
preparations molecular (amod)
ppm to (case)
recorded doses (nsubjpass)
fact , (punct)
paracetamol 13 (conj)
span symbol (appos)
occur especially (advmod)
depletion ( (punct)
rate cell (compound)
samples hl60 (compound)
satisfied h (nmod)
thirst osmoregulated (amod)
hyperfiltration and (cc)
rate bradycardia (conj)
reverted weeks (nmod)
s vs. (cc)
contraceptives ocs (appos)
apnoea prolonged (amod)
treatment lines (nmod)
received mg/m2 (nmod)
group ears (appos)
patients divided (acl:relcl)
products line (conj)
grade a (det)
injection a (det)
variations external (amod)
pentylenetetrazol picrotoxin (conj)
potassium sodium (conj)
carbonate of (case)
persistence long-term (amod)
rrmm in (case)
increases iodixanol (nmod)
anorexigens and (cc)
age aneurysms (conj)
junctions barrier (appos)
infarctions mellitus (conj)
occurred intake (nmod)
disorder pyridoxine-dependent (amod)
rate wky (nmod)
aged 1986 (nmod)
case such (amod)
increment pronounced (amod)
controls dihydropyridine (nsubj)
improvements some (det)
achieved remission (dobj)
interfered and (cc)
mg/kg succinylcholine (compound)
response up-regulation (nmod)
administered methotrexate (nsubjpass)
reduced substantially (advmod)
value methylprednisolone (nmod)
protect should (aux)
related escalated (advcl)
selected screening (advcl)
regarded public (nmod)
withdrawal inhibitor (compound)
ratio odds (compound)
minutes seconds (conj)
trees in (case)
hypothesis the (det)
susceptible cells (nsubj)
understanding factors (nmod)
intake dilevalol (amod)
tap with (case)
system sympathetic (amod)
effects ischemia (nmod)
analyzed were (auxpass)
antigen e (compound)
correlated levels (nsubj)
compared duration (nsubjpass)
adjustment appropriate (amod)
resistance rate (conj)
man 70-year-old (amod)
group aspirin (compound)
arrhythmia respiratory (conj)
rationale drug (appos)
administration methylergonovine (nmod)
mice treated (amod)
available cycles (nmod)
administration msg (nmod)
sub-divided was (cop)
causing change (dobj)
expression p-glycoprotein (nmod)
surgery region (nmod)
acting and (cc)
malaysians multiethnic (amod)
tubules into (case)
53 +/- (cc)
users among (case)
factor were (cop)
objective investigate (conj)
3.1 ) (punct)
stage depending (case)
led withdrawal (nmod)
135 119 (compound)
recommenced respiration (nsubj)
mice strain (conj)
considered cause (nsubjpass)
affected . (punct)
2.0 +/- (cc)
placebo mg (conj)
activity induced (acl)
surgery severity (conj)
drug and (cc)
evaluable are (cop)
effect caused (acl)
nucleus caudate (amod)
administration medium (compound)
albuterol : (punct)
related desensitization (nmod)
measured latency (dep)
group ) (punct)
ts , (punct)
low dominating (advcl)
sedation paralysis (conj)
patient concentrations (nmod)
systems these (det)
blunted was (auxpass)
found loss (nsubjpass)
representing ) (punct)
adrenoceptors of (case)
ameliorates , (punct)
administration ouabain (nmod)
evaluable : (punct)
second-generation levonorgestrel (dep)
enzyme variables (conj)
factors postoperatively (advmod)
group years (nmod)
ligation coronary (amod)
identified hepatitis (nmod)
mice dox (compound)
androgen- and (cc)
samples heart (nmod)
administered os (nmod)
first . (punct)
developed implanted (ccomp)
sedative infant (conj)
experience patients (nsubj)
patients fifty-two (nummod)
follow-up markers (nmod)
lp ( (punct)
suggest association (dobj)
supplement inhibitors (dobj)
timing the (det)
% microg/kg (appos)
produced treatment (nsubj)
298+/-7 au (dep)
difference a (det)
calcification detectable (amod)
dnap both (cc:preconj)
studies both (cc:preconj)
concentrations portal (amod)
model penicillin-induced (amod)
examined kidney (nsubjpass)
cent ns (appos)
pills of (case)
minutes gamma (conj)
bleeding massive (amod)
other with (case)
peritoneum the (det)
beta-carboline of (case)
mitigated . (punct)
therapy etoposide (compound)
decreases results (dep)
approximate exposure (dobj)
effect neurons (nmod)
sec 0.001 (appos)
blockade synthesis (nmod)
implicated cases (nmod)
counts range (nmod)
classification , (punct)
prophylaxis disease (compound)
recovered week (nmod)
treated addition (nmod)
protecting rats (dobj)
assessed shown (dep)
effects cardiotoxic (amod)
causes known (amod)
proteins serum (compound)
findings the (det)
abnormalities clinical (amod)
citalopram ) (punct)
concentrations micron (nmod)
shown ) (punct)
related myocarditis (nsubj)
plasticity m1 (nmod)
investigations scans (nmod)
rates loss (nmod)
co-administration anesthetics (nmod)
duct is (cop)
included evaluate (xcomp)
evidence ccr (dep)
allowing maintenance (dobj)
crossover a (det)
changes c2 (nmod)
synthesis enzymes (conj)
secretion lh (compound)
ranged results (nsubj)
di-o-tolylguanidine agonist (compound)
increases if (mark)
microg/kg/min baseline (conj)
blonquist al. (dep)
attenuation and (cc)
bladder liver (conj)
% 2.7%-8.5 (nummod)
level mrna (compound)
warnings adequate (amod)
ingestion the (det)
hour of (case)
drugs cleavage-enhancing (amod)
cox ) (punct)
formulation new (amod)
cases 551 (nummod)
with together (advmod)
investigated performing (advcl)
histopathologic and (cc)
cases tg (nmod)
kg 2.1 (nummod)
cck-8-se ) (punct)
initiated hours (dobj)
acid the (det)
seizure-prone alcohol-na (amod)
edema loss (conj)
marketed was (auxpass)
prolonged minutes (dobj)
dose carbetocin (nmod)
records hospital (compound)
administration amn082 (nmod)
showed period (nmod)
3tc 3tc (conj)
discontinued simvastatinezetimibe (nsubjpass)
controlled again (advmod)
seizure mk-801 (conj)
correlate the (det)
pj34 or (cc)
exercise in (case)
incidence due (case)
supports role (dobj)
replication b (compound)
rats g (dep)
unclear still (advmod)
months 68.3 (nummod)
mb ) (punct)
millions those (appos)
p<0.05 ( (punct)
target protect (acl)
potentials baeps (appos)
38 in (case)
contrary the (det)
useful women (nmod)
female acquired (acl:relcl)
potentials denervation (compound)
rats atherosclerotic (amod)
repeated week (nmod)
hours 2 (nummod)
rodents dogs (conj)
activated was (auxpass)
show did (aux)
development versus (cc)
disease quincke (nmod:poss)
experienced increasing (advcl)
increased pretreatment (nsubj)
ascertain or (cc)
climbing for (case)
cardiomyopathy idiopathic (amod)
little effects (dep)
proteins model (nmod)
plasma human-citrated (amod)
antagonist ly274614 (nsubj)
wistar male (amod)
ability in (case)
recovery bone (compound)
index as (case)
had had (dep)
doses lethal (amod)
os per (case)
fatigue were (cop)
contribute conditions (nmod)
august 1993 (nummod)
catalepsy in (case)
0.01 - (punct)
injections heparin (compound)
edema proliferation (conj)
regardless source (nmod)
inhibitors patients (nmod)
contraceptives interval (conj)
studied trial (nmod)
had seizures (dobj)
increased respectively (advmod)
rises with (case)
acting is (aux)
therapy val (dep)
identify use (conj)
dose employed (acl)
5-hydroxytriptamine , (punct)
phase hypertrophic (amod)
therapy appropriate (amod)
tumours of (case)
increased shortened (conj)
hundred three (compound)
protected way (nmod)
microsomes in (case)
death decline (conj)
women reported (acl:relcl)
higher although (mark)
started placebo-controlled (dobj)
evolution the (det)
controls 32 (nummod)
produced will (aux)
agency mhra (appos)
arag than (case)
significant week (nmod)
decrease renin (nmod)
neuralgia pre-existing (amod)
dose morphine (nmod)
score word (nmod)
mmol/l , (punct)
mpges-1 /+ (conj)
was ; (punct)
death one (nummod)
effective doses (nsubj)
palsy acute (amod)
in mainly (advmod)
literature world (compound)
labetalol metoprolol (conj)
cows control (compound)
cin of (case)
age surgery (conj)
diagnose lacnp (dobj)
identified ; (punct)
mtx cy (conj)
peroxidation enzymes (nmod)
% 4.3 (nummod)
results minutes (dep)
mediated not (neg)
t(33 ( (punct)
determinant is (cop)
died fourfold (conj)
combined carbenicillin (nmod)
blind this (nsubj)
corrected hyperactivity (nsubjpass)
activated , (punct)
fibrillation into (case)
iiib based (dep)
dose times (nmod)
blockade receptor (compound)
atorva mg/kg/day (dep)
inhibitor hypertension (nmod)
classical haloperidol (dep)
binding cortical (amod)
ssri ( (punct)
coexisted lesions (nmod)
had stain (dobj)
design the (det)
effect cataleptic (amod)
scarce patients (nmod)
phenomena underlying (amod)
produces pdn (nsubj)
hyperglycemia glucosuria (appos)
increased that (nsubjpass)
tcr with (case)
underwent taking (advcl)
increased resulting (advcl)
hospitalized psychiatrically (advmod)
studies used (acl:relcl)
correspondence close (amod)
used neonate (nmod)
complications without (case)
caused agent (nmod)
contribute ability (nsubj)
surmountable . (punct)
exceeded was (auxpass)
diagnostic for (case)
increases pain (dobj)
stones octreotide (compound)
use procedures (nmod)
examined methods (dep)
control as (case)
responses toxic (amod)
collection during (case)
drivers on (case)
aspirated contents (dobj)
frequency a (det)
eruptions dermatitis (compound)
green used (acl)
g/dl months (punct)
syndrome stress-mediated (amod)
littermates to (case)
elimination of (case)
injection metoclopramide (nmod)
abnormalities systems (nmod)
activation systems (nmod)
interval and (cc)
discontinuation nd-nmbas (nmod)
seizures ptz-induced (amod)
terminals peripheral (amod)
naloxone 0.3 (dep)
functions in (case)
weeks last (amod)
warfarin and (cc)
block sinoatrial (compound)
simple a (det)
aminoguanidine inhibitor (acl:relcl)
thrombo-embolism was (cop)
improved aminoglycosides (nsubj)
rats be-injected (amod)
8.3 +/- (cc)
tended . (punct)
days over (case)
data cohorts (nmod)
derivative ( (punct)
cancer tomography (nmod)
duration longer (amod)
pointer a (det)
mass pulmonary (amod)
aetiology neuropathy (nmod)
evaluate , (punct)
mean sd (conj)
atropine mecamylamine (conj)
variable for (case)
signs apl (nmod)
bladder rat (compound)
stained red (nmod)
given order (nmod)
synthesis reactive (amod)
frequency duration (conj)
logical it (nsubj)
colocalized that (mark)
years 52 (nummod)
conceivable , (punct)
alfentanil 50 (nummod)
function glomerular (amod)
mice balb/c (compound)
levels alpha5 (nmod)
proteinuria aminoaciduria (conj)
ck-mb and (cc)
plexus lumbar (amod)
adr+los(12 ) (punct)
novel selective (dep)
as significant (amod)
criteria satisfied (amod)
h. after (case)
midbrain the (det)
systems gpi (nmod)
hypokalemia patients (nmod)
effect output (nmod)
analgesic market (conj)
0.63 and (cc)
os ) (punct)
decrease been (cop)
cause inhibition (dobj)
1 or (cc)
aggravation of (case)
o2 myocardial (amod)
onwards ) (punct)
used patients (nsubj)
cultured were (auxpass)
cessation on (case)
atrophy testicular (amod)
methylprednisolone of (case)
exhibited sensitivity (dobj)
isoproterenol weight (appos)
kidney one (nummod)
instituted and (cc)
htr6 ( (punct)
evidence toxicity (nmod)
147 18/88 (conj)
restoration replication (nmod)
fentanyl kg(-1 (appos)
phase chronic (amod)
rural developing (conj)
control rats (dep)
instillations , (punct)
mg terbutaline (compound)
agent may (aux)
fibres even (advmod)
determined determining (advcl)
detection after (case)
c min (appos)
aes gi (compound)
changes bladder (nmod)
role modulating (amod)
treatment thalidomide (compound)
action radical (amod)
lometrexol given (acl)
graded injection (nmod)
effects injections (nmod)
induced ether (nmod)
unnecessary was (cop)
exhibit chemotherapy (nsubj)
epilepticus prolonged (amod)
microgram/ml of (case)
damage dxr-cm (compound)
estimate degree (dobj)
shown that (nsubjpass)
after only (advmod)
allodynia hyperalgesia (conj)
recurarization room (nmod)
precise frequency (nsubj)
transplant and (cc)
electroencephalogram interictal (amod)
hours 24 (nummod)
etomidate . (punct)
anticoagulants drugs (conj)
utility whose (nmod:poss)
treatment as (case)
resulted cessation (nmod)
consistent was (cop)
hypothesized plays (advcl)
dosages mipafox (nmod)
induction dermatitis (nmod)
substituted , (punct)
antagonist prostanoid (amod)
models hyperactivity (nmod)
1- or (cc)
contribute susceptibility (nmod)
decreased metabolism (dobj)
> 0.4 (nummod)
unrelenting . (punct)
kinases ( (punct)
antagonist novel (amod)
citrate regional (amod)
change significantly (advmod)
reye in (case)
subjects 185 (nummod)
play and (cc)
discontinuations diclofenac (amod)
sensitivity area (dep)
comparisons direct (amod)
improve significantly (advmod)
toxocity cats (nmod)
apamin blocker (appos)
measured changes (nsubjpass)
difficult and (cc)
used infrequently (advmod)
advocated carried (advcl)
achieved after (mark)
mg/week to (case)
exerts . (punct)
increased bupivacaine (nsubj)
rationale : (punct)
relationship cause-and-effect (amod)
loss ( (punct)
need transplantation (dobj)
5-hydroxytryptophan of (case)
tended groups (nsubj)
had duration (nsubj)
acne cystic (amod)
occurred injection (nmod)
take replace (advcl)
patient unique (amod)
treatment d-pen (compound)
evaluated findings (nsubjpass)
dysgenesis brainstem (compound)
inhibition no-synthase (nmod)
found reduction (nsubjpass)
enhanced . (punct)
symptoms quality (conj)
time for (case)
neurocognitive long-term (amod)
therapy under (case)
group 15/htn (nummod)
trated were (auxpass)
undergoes inhibited (conj)
elevation sgot (nmod)
cya ( (punct)
% 43 (nummod)
3.6 - (punct)
sodium urinary (amod)
system trespass (nmod)
located circulation (nmod)
prevent kg-1 (dep)
lt before (case)
metabolite triamterene (amod)
index labeling (compound)
those from (case)
treatment amplitude (appos)
amiodarone , (punct)
higher cumulative (dep)
studies normal (amod)
demonstrated megaloblastosis (nmod)
improvement back (advmod)
gained patients (nsubj)
provided sufficient (conj)
efficacy agent (nmod)
palsy superior (amod)
arteries on (case)
levels cocaine (nmod)
degeneration distinct (amod)
hospitalization hydration (nmod)
rats both (cc:preconj)
oliguria of (case)
products second-generation (compound)
concentrations areas (nmod)
mg./kg , (punct)
mothers whose (nmod:poss)
raise extent (nmod)
day of (prep)
recalled patients (nsubj)
emerged recommendation (nmod)
anemia boy (nmod)
week twice (predet)
scanty igg (dep)
hearts resected (amod)
neutropenia and (cc)
atrophy diaphragmatic (amod)
tended circled (conj)
assessment index (nmod)
spectrometry ms (appos)
mitogens to (case)
moran ] (punct)
produced regimen (nmod)
taken been (auxpass)
cases transfusion (nmod)
measured beck (nmod)
blood rats (nmod)
uk in (case)
papaverine after (case)
effects synthesis (nmod)
step did (aux)
evaluation preoperative (amod)
explained hypothesis (nmod)
confirmed echocardiography (nmod)
discontinued rapa (nsubjpass)
induce similarly (advmod)
resulted days (dobj)
isoenzymes experiments (conj)
activity preparation (nmod)
anoxia cerebral (amod)
defined success (nsubjpass)
images over (case)
microl 15 (nummod)
tone muscle (compound)
taking weeks (nmod)
less .001 (nmod)
have liability (nmod)
nodules painful (amod)
frequency ) (punct)
activate human (dobj)
hydrochloride hydrochloride (conj)
once or (cc)
potential hit (nmod)
lithium or (cc)
decreased urate (dobj)
list standardized (amod)
response mediated (acl)
encountered though (mark)
studied 1 (nmod)
patient second (amod)
seems leading (xcomp)
patients using (acl:relcl)
swallowing blocks (conj)
area units (compound)
analysis n=92 (dep)
age of (case)
kindling by (case)
images patients (nmod)
employed but (cc)
course same (amod)
neonate pneumonia (nmod)
5.0 or (cc)
hyperalgesia with (case)
occurs that (mark)
responses bed (compound)
suggested represent (ccomp)
verapamil defined (acl)
proteins weight (nmod)
response vivo (advmod)
used heparin (nsubj)
enantiomer than (case)
bladder of (case)
established firmly (advmod)
mothers to (case)
therapy antidepressant (compound)
tested patients (nsubj)
bfu-e animals (nmod)
tolerant were (cop)
level acetylcholine (compound)
progress grade (dobj)
thickening glomerular (amod)
administered methamphetamine (nsubj)
wave photopic (amod)
treatment malaria (nmod)
syndrome reversed (acl)
mosmol/kg mmol/l (dep)
decrease pain (nmod)
myeloperoxidase- antibody (dep)
illustrated are (auxpass)
are : (punct)
produce products (nsubj)
occurs salbutamol (nmod)
relationship possible (amod)
mg/m(2 gemcitabine (nmod)
antagonism the (det)
length interval (conj)
allows elucidating (advcl)
insult induced (acl)
activities any (det)
fluoroacetate and (cc)
granules on (case)
demonstrated correlated (conj)
mg/kg daptomycin (compound)
complained patient (nsubj)
required patients (nmod)
time interval (conj)
dynamics response (nmod)
used models (dobj)
reached % (nsubj)
intensity migraine (compound)
sinus results (dobj)
classes patients (nsubj)
pge2 ) (punct)
potential b (nmod)
exists established (advcl)
suffer disorders (nmod)
ketamine- of (case)
occur levels (nmod)
malformation chiari (compound)
substances thiobarbituric (amod)
fever syndrome (conj)
rifampin isoniazid (conj)
one % (dep)
produce effects (dobj)
treatment or (cc)
dosage cya (compound)
osmolality urinary (amod)
failed displace (xcomp)
preferred minimize (advcl)
giving therapy (nmod)
400 , (punct)
fed that (nsubjpass)
mg/dl 1.44+/-0.6 (compound)
1000 - (punct)
treatment propranolol (nmod)
mmol/d ) (punct)
classified were (auxpass)
37.4 from (case)
produce complications (dobj)
participating trial (nmod)
different mortality (nsubj)
subendothelial and (cc)
individuals india (nmod)
decreased resistance (dobj)
efficacy olanzapine (nmod)
throat pain (dep)
controls castrated (amod)
bn 1 (nummod)
found incidence (dobj)
cyanide effectively (advmod)
first include (xcomp)
impaired correlated (conj)
studies att-alf (nmod)
convulsions neonatal (amod)
conversion . (punct)
rapid reliable (conj)
increases tri (nsubj)
avoid deficits (dobj)
produced abecarnil (nsubj)
patients developing (acl)
m1 for (case)
followed basis (nmod)
nociceptin 1 (dep)
nurse of (case)
remained vmax (nsubj)
seen disease (nmod)
p 0 (nummod)
group 30-mg (amod)
crossed . (punct)
pain such (case)
toxicity clinical (amod)
suggesting effect (dobj)
parasitosis of (case)
subpopulation neurons (nmod)
permits schedule (nsubj)
received azathioprine (dobj)
session 1 (nummod)
identified component (nsubjpass)
constitutes report (dobj)
coil a (det)
have sensitization (nsubj)
induce oxcarbazepine (nmod)
months 32 (nummod)
effects opioid (nmod:poss)
factor acid (nsubj)
ic30 ) (punct)
administration ivig (nmod)
reversed although (mark)
effects urotoxic (amod)
appear made (advcl)
incorporation the (det)
abolished due (advmod)
alternative lithium (nmod)
intubated bradyarrhythmic (dep)
efficiency swallowing (amod)
cells in (case)
schaeffer hippocampal (compound)
method ventricular (amod)
na of (case)
face a (det)
voltage- atp-sensitive (conj)
potential drug (nmod)
induced amphetamine (nmod)
toxicity therapy (nmod)
5 6 (conj)
70 ( (punct)
hospital academic (amod)
17 of (advmod)
pci ( (punct)
withdrawal both (cc:preconj)
were there (expl)
frequent not (neg)
included dlt (nsubj)
hepatitis toxic (amod)
rats eight (nummod)
seen , (punct)
quantitative and (cc)
risk tachycardia (nmod)
lignocaine with (case)
effect alpha-methyl-para-tyrosine (nmod)
system , (punct)
experiments analogues (nmod)
patients chronic (amod)
collected eyes (nmod)
measuring and (cc)
consumption in (case)
increase incidence (nmod)
show attenuates (ccomp)
those therapy (dep)
develop . (punct)
attempted identify (xcomp)
make treatment (dobj)
syndrome grade (compound)
illness evidence (conj)
model abuse (nmod)
decrease average (amod)
medulla to (case)
onwards ( (punct)
dbs group-1 (compound)
catatonia on (case)
ifosfamide after (case)
event 1 (nummod)
inhibition macrophage-migration (amod)
receptor lipoprotein (compound)
measurements and (cc)
signs regions (nmod)
d after (case)
aware performing (advcl)
hospital fahad (compound)
risperidone . (punct)
at especially (advmod)
developed hour (nmod)
weight 0.015 (nummod)
modulators immune (amod)
rats ec50 (dep)
1.8 to (conj)
justified pretreatment (nsubjpass)
idm ) (punct)
saline isotonic (amod)
history therapy (nmod)
thrombocytopenia hemorrhage (conj)
recruited patients (nsubj)
jj ) (punct)
identify outcome (nsubj)
administration phenylephrine (nmod)
papillary the (det)
pb such (case)
methylprednisolone d15 (conj)
observed signs (nmod)
concentration and (cc)
cause vasculitis (dobj)
proteinuria to (case)
flow rbf (appos)
consistent detectable (advcl)
transplantation an (det)
group ptra (compound)
artery branch (conj)
defects field (compound)
presence infusion (nmod)
results half (appos)
progestagens second-generation (amod)
case dysrhythmias (nmod)
criteria inclusion (compound)
fell mv/s (nmod)
precluded outcomes (nmod)
irritation chronic (amod)
enhancement . (punct)
offered been (auxpass)
response blockage (nmod)
gland parotid (compound)
concentrations subtherapeutic (amod)
rats spontaneously (amod)
brought and (cc)
hepatitis clinical (amod)
trial including (prep)
participants 13 (nummod)
given pg (nsubjpass)
found fdc (nsubjpass)
information site (nmod)
represses induces (conj)
0.05 was (cop)
a-86929 : (punct)
patients leprosy (nmod)
p 0.025 (nummod)
definition dose (compound)
remedies natural (amod)
effect cardioprotective (amod)
stn , (punct)
activation in (case)
hearing db (appos)
epinephrine micrograms.kg-1.min-1 (compound)
irradiation chest (amod)
didanosine , (punct)
considered year (nmod)
% 3.21 (nummod)
relevance receptor (nmod)
pesticide is (cop)
maha ( (punct)
discuss that (mark)
study control (conj)
frequency defects (nmod)
transplanted emergently (advmod)
range treatment (nmod)
characteristics patients (nmod:poss)
used agriculture (nmod)
events thrombotic (amod)
amiodarone efficacious (appos)
abolished effect (dobj)
reflex stimulation (appos)
values ) (punct)
handicapped systems (nsubjpass)
presented animals (nsubj)
resulted conclusions (dep)
assigned randomly (advmod)
= 40 (dep)
agents available (amod)
mtdna in (case)
three thirty (compound)
agent that (mark)
suitable incidence (nmod)
lethality coniine (compound)
diameters/bw es (compound)
1.6 0.2 (conj)
indicator dysfunction (nmod)
14 21 (prep)
age- and (cc)
survival pfs (appos)
twice than (mark)
occurred 1/32 (nmod)
prevent abnormalities (dobj)
2001 and (cc)
= median (dep)
evident that (nsubj)
detected damage (nsubjpass)
effects promotional (amod)
immunosuppressive were (cop)
concentration lithium (compound)
inspired isoflurane (nmod:npmod)
rate as (case)
data accumulated (acl)
recovery with (case)
glutathione and (cc)
grafting for (case)
cpu ( (punct)
prompt ensure (advcl)
teams with (case)
adequate may (aux)
tablets pharm (appos)
chemotherapy cisplatin (compound)
polyneuropathy and (cc)
history ergot (nmod)
altered were (auxpass)
presence group (appos)
cycle dose (nmod)
correspondence activity (nmod)
regimens high-dose (amod)
presented rhabdomyolysis (nmod)
animals with (case)
maintains weight (dobj)
cells mice (nmod)
demonstrates reinstated (ccomp)
candidates are (cop)
shed light (dobj)
general adult (dep)
predictor peptide (nsubj)
model experimental (amod)
same rates (nsubj)
assays biochemical (amod)
incidence hypokalemia (nmod)
lead deficit (nmod)
modulates subtype (nsubj)
focuses . (punct)
studies sodium (nmod)
hemlock ( (punct)
gauges > (dep)
created methods (dep)
overactivation cortical (amod)
ng.ml-1 p (appos)
gd ) (punct)
follow hepatitis (dobj)
diagnosis differential (amod)
achieve and (cc)
treatment terms (nmod)
persons trimethoprim (conj)
addiction drug (compound)
determinant therefore (advmod)
values morphine (nmod)
patients > (nmod)
mortality a (det)
measures ( (punct)
results recorded (dep)
licking gnawing (conj)
toxicity doxorubicin (compound)
safety review (appos)
hundred nine (compound)
concluded is (auxpass)
course treatment (nmod)
insufficiency , (punct)
decreases with (case)
titration with (case)
monotherapies 0.001 (appos)
methods icv (dep)
glomerulosclerosis with (case)
inhaler metered-dose (amod)
dobutamine ) (punct)
discontinued was (advcl)
given compounds (dobj)
interleukin il-3 (appos)
ischemia , (punct)
treated methotrexate (conj)
analysis proteomic (amod)
exclude aetiology (dobj)
mp % (appos)
incidence eps (nmod)
clarified completely (advmod)
day hospitalization (nmod)
cellular nor (cc)
tests mnemonic (amod)
faded used (conj)
achieve reached (advcl)
avoided doses (nsubjpass)
usa in (case)
reduced levels (nmod)
endpoints induced (acl)
fluorouracil gemcitabine (appos)
mm leads (acl)
collected cells (nsubj)
suggesting potentiate (ccomp)
granules of (case)
course syndrome (nmod)
35 25 (compound)
65 , (punct)
cell the (det)
occurring use (nmod)
objective reported (appos)
exhibited isomers (nsubj)
mg/m(2 1500 (nummod)
function global (amod)
discussion using (advcl)
words of (case)
increments 6 (nummod)
measured mmse (nmod)
separation for (case)
consistent although (mark)
inflammation capsule (nmod)
blots in (case)
50 ) (punct)
integrity neuron (compound)
way projection (conj)
cck-5 - (punct)
points sum (compound)
hydrochlorofluorocarbons by (case)
than equal (conj)
sh(6 ) (punct)
days thirty (nummod)
management the (det)
mechanism(s underlying (amod)
exceeded resulting (xcomp)
presented symptoms (nsubj)
group children (nmod:poss)
neurotoxicity severe (amod)
difluoromethylornithine plus (cc)
mg/kg 60 (nummod)
evaluation tissues (nmod)
weight/week body (compound)
episodes investigated (amod)
performed subtests (dep)
linked development (nmod)
indicative cortisol (nsubj)
test on (case)
impact dexamethasone (nmod)
vulnerable subpopulation (nsubj)
medicine folk (compound)
-14.6 ( (punct)
vancomycin , (punct)
examined respectively (advmod)
antipsychotics generation (compound)
advantage the (det)
displayed . (punct)
layer a (det)
medications reported (amod)
l-med 1 (dep)
induction test (nmod)
rbf ) (punct)
affecting nephrolithiasis (dobj)
exposure use (dep)
explanations , (punct)
ng./ml was (cop)
continued dfc (dep)
study assess (advcl)
sub-divided further (advmod)
networks two (nummod)
aggressive highly (advmod)
valproate the (det)
criteria ( (punct)
improvement hyper- (nmod)
ineffectiveness the (det)
aware that (mark)
minutes final (amod)
mg 0.6 (compound)
suppressed (+)-cibenzoline (nsubj)
sces of (case)
prodrugs two (nummod)
deficits discrimination (nmod)
ed in (case)
alf sc (appos)
measured isotypes (nsubjpass)
manoeuvres both (det)
reported we (nsubj)
observed concentration (nsubjpass)
phenotypes wilson (nmod:poss)
resulted death (conj)
arabic gum (amod)
rhythm , (punct)
synthesize hypertrophy (dobj)
monomers of (case)
impair infarction (nsubj)
smoking cigarette (compound)
muscimol , (punct)
volume with (case)
changed morphine (nmod)
stopped treated (ccomp)
cb with (case)
ischemic of (case)
sodium calcium (conj)
antioxidants cerruloplasmin (nmod)
adrenaline.7 of (case)
azelastine of (case)
cystourethrogram for (case)
peptide cck-5 (dep)
involved induction (nmod)
comparing receiving (advcl)
angina ) (punct)
drug pathogenesis (conj)
hours patients (nmod)
8.7 +/- (cc)
rejection rejection (conj)
utilized . (punct)
extended-release/20 of (case)
prevent prescribing (advcl)
stiffness marked (amod)
gave . (punct)
occurrence cataract (nmod)
patients neutropenic (amod)
transaminases in (case)
disease ptld (appos)
34.33 +/- (cc)
renin normal (amod)
factor-alpha tissues (nmod)
implanted rats (nsubj)
found size-dependent (ccomp)
= ( (punct)
n-methyl-d-aspartate nmda (appos)
switch srl (nmod)
hemolysis extravascular (amod)
hp ( (punct)
emissions of (case)
slowing a (det)
psychiatry child (compound)
prevention mice (compound)
months ( (punct)
mg/kg 0.25 (nummod)
ages the (det)
combined design (dep)
reviewed paper (nmod)
vcm plus (cc)
up in (case)
sacrifice icrf-187 (conj)
dropped later (advmod)
injury dili (appos)
expected be (auxpass)
stimulate activity (dobj)
current and (cc)
administration rhigf-i (compound)
resolved mris (nmod)
abnormalities behavioral (amod)
nonusers with (case)
myoclonic institution (nmod)
maximum mg (nmod)
fhf edema (conj)
function inhibition (nmod)
examination histologic (amod)
nigra sn (appos)
achrs of (case)
patients injury (compound)
conclusion plays (ccomp)
betaxolol a (det)
biomarkers peroxidation (compound)
limitation motility (nmod)
suggest support (advcl)
groups bolus (compound)
bilirubin mg/dl (dep)
updrs , (punct)
duration to (case)
rash 4 (nummod)
% studies (nmod)
found months (nmod)
doses clonidine (nmod)
animals in (case)
demonstrates and (cc)
anesthesia the (det)
muscle tibialis (compound)
excluded patient (nsubjpass)
attention induced (acl)
mg/day 600 (nummod)
derivative quetiapine (nsubj)
agonist-induced dopamine (nmod:npmod)
frequency bladder (nmod)
> type (conj)
lining endothelial (amod)
correlate development (nsubj)
lowers that (nsubj)
daily days (nmod)
5-fu/fa/mmc high-dose (amod)
manifested animals (nsubj)
analysis variance (nmod)
regurgitation mild (amod)
machr ) (punct)
conclusion treated (acl)
antagonism hypertension (nmod)
monitoring ekg (compound)
dysfunction injury (conj)
data are (cop)
visit during (case)
cardiotoxicity thought (acl:relcl)
rate improved (amod)
recognition any (det)
arises question (nsubj)
infiltrate associated (acl)
infrequent dysfunction (conj)
areas within (case)
labeled fluorogold (nmod)
has effects (dobj)
fas and (cc)
reassured be (auxpass)
achieve rate (dobj)
administration epinephrine (nmod)
increases > (dobj)
patients cd4 (dep)
outcomes on (case)
third a (det)
disease esophagitis (conj)
oxide endothelium-derived (amod)
malformations for (case)
parkinson idiopathic (amod)
cta of (case)
association : (punct)
m2 for (case)
reducing discharge (advcl)
2 only (advmod)
uncertain mechanism (nsubj)
offers that (nsubj)
effect bleeding (nsubj)
attacks and (cc)
receiving tnss (dobj)
probability the (det)
solution chloride (compound)
interval ischemia (nmod)
woman facility (nmod)
likely received (xcomp)
mechanisms ionic (amod)
% hypaque (compound)
observed had (aux)
patients lymphoma (nmod)
nf-m and (cc)
36.4/6.1/3.0 stomatitis (conj)
blockers serotonin (compound)
studied therefore (advmod)
evidence considering (case)
activated . (punct)
affected how (advmod)
ml = (amod)
frequent group (nmod)
75.9 +/- (cc)
stimulus a (det)
episodes recipients (nmod)
e1 prostaglandin (compound)
present years (nmod)
cats rats (conj)
developing in (mark)
prevalence higher (amod)
% 12.0 (nummod)
sera with (case)
0.025 less (amod)
proteinuria baseline (nmod)
recoveries rate (nmod)
remained levels (nsubj)
exhibited retardation (dobj)
reported pain (ccomp)
treated october (nmod)
uni- and (cc)
quality patients (nmod:poss)
states hypersecretory (amod)
mg group (nmod)
nsaids given (case)
effects observed (amod)
clinicians postcards (nmod)
drug phenytoin (nsubj)
nephrolithiasis triamterene (amod)
0.28 +/- (cc)
response positive (amod)
caused monkeys (nmod)
mg 70 (nummod)
completion successful (amod)
investigated thoroughly (advmod)
ip mg/kg (conj)
lines of (case)
anxiety cocaine-induced (amod)
patients neuropathic (amod)
hypokalemia treatment (nmod)
poison a (det)
assessed combination (nmod)
questionaire a (det)
sadness fear (conj)
artery dog (nmod)
left ventricle (dobj)
interval % (appos)
hypertension renovascular (amod)
manage and (cc)
effects some (det)
vasodilator have (acl:relcl)
examined epilepticus (nmod)
follow-up differentiate (xcomp)
began months (nmod:npmod)
smokers heavy (amod)
measure function (nmod)
1.68 ci (appos)
imaging diffusion-weighted (amod)
decreased latency (dobj)
tends . (punct)
immunosuppressive therapies (dep)
smear blood (compound)
group deep (amod)
comprehensive most (advmod)
hypertension doses (nmod)
0 through (dep)
ug.kg-1 ( (punct)
lines mcf-7 (compound)
assessed times (nmod)
paraparesis increase (nmod)
excretion urine (nmod)
fatal be (cop)
fatal cases (nmod)
conduction on (case)
induced triphosphate (nmod)
vessels renal (amod)
sc-48334 ( (punct)
peptide such (case)
scopolamine depletion (conj)
episodes hypertensive (amod)
oximeters such (case)
included dyskinetic (nsubjpass)
reduces but (cc)
dental or (cc)
secretion and (cc)
observed evidence (nsubjpass)
higher incidence (nsubj)
vegf of (case)
iml in (case)
words repeated (acl)
associated medication (nmod)
attempted but (cc)
inhibited treatment (nmod)
down-regulation beta-adrenergic (amod)
fda by (case)
information available (amod)
proof are (cop)
include thrombi (dobj)
prominent were (cop)
tested required (parataxis)
inputs bladder (nmod)
body ( (punct)
10-weeks-old - (punct)
triggers turn (nmod)
cholesterol greater (amod)
documentation the (det)
toxicity central (amod)
administration children (nmod)
investigation patients (nmod)
= 17.9 (dobj)
events four (nummod)
lumens necrosis (conj)
results suggested (dep)
discontinuation with (case)
objective study (nmod)
cocaine smoking (amod)
determined hippocampus (nmod)
children given (acl:relcl)
cytokine mouse (compound)
sets four (appos)
overactivation motor (compound)
reported were (auxpass)
consequence hypokalemia (nsubj)
zone granular (amod)
imaging heart (compound)
critical signaling (nsubj)
200 mg/kg (dep)
milrinone treatment (nmod)
duration alf (nmod)
reduced ii (dep)
signaling cholinergic (amod)
inhibitor coenzyme (compound)
retention avoidance (compound)
using anaesthesia (dobj)
serum- . (punct)
disturbance mild (amod)
plasticity deficient (amod)
most cancers (nmod)
day later (conj)
valproate ( (punct)
kf17837 10.0 (conj)
mapd on (case)
mm 11 (nummod)
complication injections (nmod)
promotes modafinil (nsubj)
termination to (case)
government each (det)
emphasis special (amod)
days rats (nmod)
cows died (acl:relcl)
fibrosis and (cc)
days 8 (dep)
levels cgrp (nmod)
younger , (punct)
normal 2 (nmod)
stimuli nociceptive (amod)
reason this (nsubj)
movement eye (compound)
treatment mg (appos)
mitochondria cardiac (amod)
had chance (dobj)
lacking , (punct)
less 0.01 (nmod)
morphine rather (cc)
mg./kg ( (punct)
carcinomas carcinoma (conj)
role catalepsy (nmod)
therapy long-term (amod)
caused doses (nsubj)
trespass to (case)
last treatment (nsubj)
anophthalmia aor (dep)
arteriosclerosis coronary (amod)
x/minute 5 (compound)
sod both (cc:preconj)
patients service (nmod)
edema preceded (acl)
(aap)-hepatitis acetaminophen (amod)
rats ma-treated (amod)
induced resulting (advcl)
transitioned ultimately (advmod)
bilayers curved (amod)
manifestations new (amod)
treatment scabies (nmod)
severity greater (amod)
lack association (nmod)
enhanced treatment (nmod)
rare exceedingly (advmod)
haemorrhages of (case)
sulfate netilmicin (compound)
levels of (case)
multicenter parallel-groups (conj)
states 10 (nummod)
2 vs. (cc)
cdt ( (punct)
documentation histopathological (amod)
use setting (acl)
1990s the (det)
increased hexamethonium (conj)
hepatotoxicity halothane (nmod)
1 0.5 (conj)
laboratory transport (compound)
comparable delay (nsubj)
tests tests (conj)
induction vacuoles (nmod)
analyses performed (acl)
given intra-arterially (advmod)
considered challenge (nsubjpass)
episode this (det)
pills " (punct)
use kidneys (nmod)
fractions p2 (compound)
showed received (conj)
raises effect (nsubj)
compared results (nsubjpass)
utility amount (conj)
episode previous (amod)
high produce (dep)
factors related (amod)
tissues gspe+drug (compound)
condensed . (punct)
pirenzepine dicyclomine (conj)
intake metronidazole (compound)
levels busulfan (compound)
0.6 ( (punct)
sd induced (acl)
p .04 (dep)
allows analysis (nsubj)
thromboembolic relationship (nmod)
ctni-positive disease (nmod)
cortex mice (nmod)
treatment during (nmod)
hepatitis methyldopa-induced (amod)
integration inputs (nmod)
min in (case)
c1q and (cc)
changes syndrome (nmod)
dyskinesias either (cc:preconj)
levels rate (conj)
requires also (advmod)
occurred woman (nmod)
moving mice (dobj)
done dose (conj)
% 33.3 (nummod)
wk over (case)
action loreclezole (nmod)
thrombocytopenia . (punct)
systems antioxidant (amod)
affects learning (dobj)
include options (nsubj)
sessions after (case)
overflow kidneys (nmod)
increase association (nmod)
caused blockade (nsubj)
level 2 (nummod)
proliferation hemopoietic (amod)
followed ; (punct)
effusion and (cc)
adr(6 adr(12 (conj)
incidence pseudolithiasis (nmod)
occurred majority (conj)
separated breaks (nmod)
republic democratic (compound)
subjected head-up (nmod)
difficult examine (xcomp)
oxidation heart (dep)
causes phenotype (dobj)
cirrhosis , (punct)
part during (case)
leading deposition (nmod)
inserted pacemaker (nsubjpass)
variables expression (conj)
include fields (nsubj)
produced but (cc)
immunosuppressant . (punct)
maintain decreasing (advcl)
treatments all (det)
developed constellation (dobj)
accumulation in (case)
auc ( (punct)
cefazedone dogs (nmod)
produced acceleration (dobj)
effects chronic (amod)
microscopy on (case)
current , (punct)
lactate alternately (advmod)
safety of (case)
aggravation back-diffusion (nmod)
anova ) (punct)
behavior ergometrine-induced (amod)
dsp4 with (case)
response nicotine-stimulated (amod)
legs the (det)
induce change (dobj)
ccr ) (punct)
risk users (nmod)
injections times/week (dep)
sympathomimetic synthetic (amod)
therapy hyperlipoproteinemias (nmod)
chloride hexamethonium (compound)
reduced were (auxpass)
etoricoxib mg (nummod)
event cellular (amod)
scan abdomen (nmod)
handful cases (nmod)
burning min (dobj)
risk . (punct)
significant were (cop)
postponed angiogram (nsubjpass)
71.3 ) (punct)
involved , (punct)
entered patients (nsubjpass)
fentanyl combination (conj)
preserved however (advmod)
alleviate cardiotoxicity (dobj)
% 4.1 (nummod)
antagonists potent (amod)
controls n. (dep)
-0.12+/-0.5 p=0.014 (appos)
experience therefore (advmod)
identified cases (nsubjpass)
role to (case)
continued uses (nmod)
pacing one (nmod)
micrograms/kg 10 (nummod)
methods measured (appos)
phenomenon limbs (nmod)
rates 2.5 (nummod)
denied was (auxpass)
becoming after (mark)
marker damage (nmod)
prescribed paroxetine (nmod)
toxicities nonhematologic (amod)
compromising . (punct)
12 2 (compound)
supervision be (cop)
vasculature in (case)
measures all (det)
mg/day weeks (nmod)
sectioning nerves (nmod)
solution or (cc)
pravastatin inhibitor (appos)
decreased be (auxpass)
high sufficiently (advmod)
atrophy weight (appos)
control mechanisms (nsubj)
substantiate data (nsubj)
suggest existence (dobj)
sec 3.1 (nummod)
( hour (dep)
cq ) (punct)
mumol/l trough (appos)
effect carteolol (nmod)
fk ) (punct)
rate to (acl)
cd50 respectively (advmod)
mg 26.3 (nummod)
administered tropicamide (nsubjpass)
developed vte (dobj)
appearance by (case)
lists articles (nmod)
smoking time (appos)
seem affect (xcomp)
induced days (nmod)
delayed . (punct)
ana anca (conj)
stress stimuli (nmod)
tissue heart (nmod)
cytological and (cc)
enzymes glycosaminoglycan-degrading (amod)
% 24.3 (nummod)
preserve nimodipine (nsubj)
20 almost (advmod)
discusses mechanisms (dobj)
treated desipramine (nmod)
multicenter this (nsubj)
describe outbreak (dobj)
pharmaceuticals , (punct)
six the (det)
induced use (nmod)
carbachol that (advmod)
decline without (case)
8/27 ( (punct)
study effect (nmod)
human either (cc:preconj)
practice and (cc)
injected perfusion (nmod)
cardiotoxicity higher (amod)
drugs potent (amod)
patients period (conj)
dose droperidol (nmod)
depolarisation membrane (compound)
based weight (nmod)
tolerated although (mark)
metabolites pyrrolidine (compound)
infusion fucoidan (nmod)
startle fear-potentiated (amod)
data compared (case)
patients 1,340 (nummod)
failure who (nsubj)
those symptoms (nmod)
induced morphine (nmod)
reduced activation (dobj)
patients suffered (acl)
increased 1.2 (nmod)
known treated (conj)
contribute disease (nmod)
toxicity renal (compound)
ibuprofen mg (compound)
mepivacaine epinephrine (conj)
chemotherapy carboplatin (compound)
mania bipolar (amod)
cb tetra- (dep)
graded investigator (nmod)
group pci (compound)
infusion 5-fluorouracil (nmod)
angiography during (case)
propylthiouracil developed (acl:relcl)
epicardial , (punct)
suppression responses (nmod)
discussed is (auxpass)
calculated correlates (advcl)
samples plasma (compound)
causes unrelated (amod)
1 than (quantmod)
agent transplantation (nmod)
investigated using (advcl)
side-effect as (mark)
% risk (nsubj)
dose lindane (compound)
reported aplasia (nsubjpass)
given she (nsubjpass)
present while (mark)
smoking index (conj)
maximum sedentary-isoproterenols (nmod)
verapamil mg/kg (appos)
times 7 (nummod)
contain to (mark)
psychosis (meth)-induced (amod)
anticoagulant used (amod)
accompanied na+-extrusion (nmod)
upregulation tr(- (nmod)
patients comprising (acl)
neurons nigrostriatal (amod)
thrombosis thromboembolism (conj)
administration anesthetic (nmod)
resistant chemotherapy (nmod)
assessed effect (dobj)
cystitis (cyp)-induced (amod)
thalidomide . (punct)
recall room (nmod)
preceded effects (nmod)
stress the (det)
screen urine (compound)
% 0.025 (appos)
closed , (punct)
experiments antibody (compound)
methoxamine by (case)
% x2 (appos)
h2o2 ) (punct)
4 serologically (advmod)
use diazinon (compound)
administered ifo (advcl)
stomach , (punct)
estimated postdose (nsubj)
absent ; (punct)
polymorphism debrisoquine/sparteine (compound)
delirium report (dep)
cardiomyocytes damaged (amod)
exposure utero (amod)
ce ) (punct)
showed correlations (dobj)
beating features (nsubj)
inserted loss (nmod)
correlated inversely (advmod)
prevalence cd4 (nmod)
plasma ph (dep)
gave history (dobj)
used acid (nsubjpass)
evidence support (acl:relcl)
insipidus persistent (amod)
injection areas (nmod)
agonists to (case)
tissues studied (acl)
regarded often (advmod)
rate tremor (nmod)
akinetic or (cc)
programs with (case)
chicago north (compound)
% responses (nmod)
epinephrine in (case)
administration vpa (nmod)
administered chemotherapy (nsubjpass)
potential negative (amod)
bladder severe (amod)
mrna subunit (compound)
signs nausea (appos)
averaging ; (punct)
weeks around (case)
anomalies with (case)
% 96 (nummod)
% 19 (nummod)
reintroduction by (case)
interval 3-week (amod)
reaction patient (appos)
4-phenylbutyrate sodium (compound)
operated had (aux)
p of (case)
subjects older (amod)
contained % (dobj)
brainstem subjects (conj)
achieved interval (dobj)
discontinuing for (mark)
obtained recovery (nsubjpass)
woman-years needed (conj)
become rigid (acomp)
substituted sulindac (nsubjpass)
ginsenosides rb1 (nsubj)
stress myocardial (amod)
hospital at (case)
necessary proliferation (nmod)
potentiated also (advmod)
treatment cbz (compound)
degree hypotension (nmod)
acclimatization conditions (nmod)
interleukin mice (nmod)
relationships cin (nmod)
nephropathy aminonucleoside-induced (amod)
node and (cc)
dependence . (punct)
conscious , (punct)
deficiency ) (punct)
using changes (dobj)
useful technique (nsubj)
level patients (nmod)
size lumen (nmod)
depletions 3,4-dihydroxyphenylacetic (amod)
treatment enteropathica (nmod)
antiplatelet and (cc)
investigates effects (dobj)
decrease events (dobj)
schedule 2 (dep)
had % (dep)
effect antiarrhythmic (amod)
offer future (nmod)
g. detection (nmod)
accompanied is (auxpass)
arthrogryposis coniine-induced (amod)
hepatotoxicity subsequent (amod)
warrant follicular (amod)
advantageous . (punct)
alpha-methyldopa levels (nmod)
experienced she (nsubj)
antagonists atropine (dep)
experienced taking (advcl)
test disorder (nmod)
infused . (punct)
observed increased (advcl)
reversible signs (nsubj)
halothane with (case)
changed parvalbumin-staining (nsubj)
induced dobutamine (nmod)
arthralgia i.e. (dep)
loss paracentral (amod)
amount mrna (conj)
peroxidation in (case)
mortality zero (nummod)
produce dyskinesia (dobj)
angiogenesis estrogen-initiated (amod)
marked increased (conj)
fingers his (nmod:poss)
cycles sleep (compound)
step down (compound:prt)
controls hypertensive (amod)
report occurrence (dobj)
suppressed gabapentin (nsubj)
frequencies high (amod)
cholecystitis for (case)
mirtazapine , (punct)
min 0 (nummod)
changes large (amod)
discontinuance patient (nmod)
microg/ml td (nmod)
kindling pentylenetetrazole-induced (amod)
cotrimoxazole metronidazole (conj)
experienced who (nsubj)
neurons motor (compound)
hypotension under (case)
6 ( (punct)
released which (nsubj)
show study (nsubj)
cimetidine than (case)
2nd treatment (conj)
underwent compared (prep)
treatment groups (nmod)
cholesterol or (cc)
suppress significantly (advmod)
model agent (appos)
reduced control (dep)
developing p (dep)
infusion fenoldopam (nmod)
targeting , (punct)
occurred cases (nmod)
weight separation (nmod)
involve actions (dobj)
erythrocytes her (nmod:poss)
spasm humans (nmod)
risperidone both (cc:preconj)
result treatment (nmod)
applied used (advcl)
warrant mechanisms (nsubj)
auc and (cc)
ke . (punct)
normalization level (nmod)
retention passive (amod)
drug disease (conj)
objective intravitreal (conj)
inactivation , (punct)
exposure dermal (amod)
strain was (cop)
receiving initially (advmod)
tested groups (nsubjpass)
regulated which (nsubj)
h 0.9 (nummod)
countries in (case)
task motor (compound)
randomized in (case)
developed level (nmod)
experienced neutropenia (dobj)
learning spatial (amod)
diagnostic in (case)
study smokers (nmod)
therapy cyclical (amod)
sensitivities ng/ml. (amod)
pj34 the (det)
numbers cells (nmod)
diagnosed materials (nsubjpass)
application following (case)
g = (dep)
patient failed (acl:relcl)
degrees 36.98 (nummod)
25/100 formula (dep)
cytometry flow (compound)
apply window (nsubj)
exploration sedation (conj)
fact occur (ccomp)
tool that (mark)
persistent were (cop)
elevated increases (nmod)
model murine (amod)
mechanisms comparison (dep)
effects dosage-dependent (amod)
buffer cold (amod)
intensity headache (nmod)
scales versions (conj)
properties antioxidant (amod)
measured determine (advcl)
study randomised (amod)
database general (compound)
rats ) (punct)
increased infusion (nmod)
% 240 (nummod)
memory impaired (acl)
time % (appos)
dysrhythmias since (case)
observed ineffective (parataxis)
percent median (amod)
excitation . (punct)
mania associated (acl)
virus-related hepatitis (nmod:npmod)
micrograms , (punct)
muscle of (case)
introduction tacrolimus (nmod)
receptors opiate (amod)
exercise- both (cc:preconj)
augment effects (dobj)
steroids stress (compound)
related times (nmod:tmod)
reported induction (nmod)
criteria dms-iii-r (compound)
u/ml 26.8 (nummod)
definition management (conj)
received cyclosporine (dobj)
glutamate uptake (dobj)
effects therapy (nmod)
pretreatment with (nmod)
97.1 + (cc)
taken must (aux)
marker secreted (acl)
alpha-tocopherol alpha-t (appos)
renal interstitial (dep)
site possible (amod)
observed not (neg)
foci/cm2 5 (nummod)
deposits intense (amod)
administered mesna (nsubjpass)
15.3 +/- (cc)
na/k-atpase of (case)
quantitated was (auxpass)
review experience (nsubj)
rate maximum (compound)
rises ranging (acl)
infections due (case)
= -0.99 (dep)
function ability (conj)
correlations volume (nmod)
4.8 +/- (cc)
treatment vpa (compound)
study blind (nmod)
achieved responses (dobj)
gain and (cc)
treated ncq436 (nmod)
layer above (case)
method measurement (nmod)
effect tissue (nmod)
agitation on (case)
epicondylitis of (case)
demonstration symptoms (nmod)
man chinese (amod)
one schedules (nmod)
ratio cholesterol (compound)
receptors pallidal (amod)
treatment fluvastatin (nmod)
territories vascular (amod)
serpiginosa perforans (compound)
responses drug (compound)
available widely (advmod)
survival worse (amod)
glomeruli sclerosis (nmod)
function gaba(a)r (compound)
film an (det)
placebo patients (conj)
months 34.4 (nummod)
represents option (dobj)
taken processed (conj)
availability no (nmod)
day corresponded (acl:relcl)
days prophylaxis (conj)
effect relaxant (amod)
acid epsilon (compound)
followed that (nsubj)
hyperactivity thp (conj)
polyneuropathy rarely (advmod)
normal normal (dep)
immunosuppressant a (det)
bottle containing (acl)
mg/dl thereafter (conj)
bd1063 and (cc)
times 3.5 (nummod)
infiltration refractory (amod)
hematology of (case)
effect relative (amod)
done methods (dep)
symptom neurotoxicity (nmod)
chemotherapy epirubicine-based (amod)
instillation after (case)
activity tumours (nmod)
bond and (cc)
pathophysiology population (nmod)
dronedarone after (case)
practice institution (nmod)
formation lesion (compound)
exposed and (cc)
involved effect (conj)
1.6 ci=1.2 (compound)
six only (advmod)
hyperactivity myocardial (amod)
contraction ventricular (amod)
improvement acuity (nmod)
experiences unable (conj)
retardation psychomotor (compound)
substantial elevation (nsubj)
switched , (punct)
probe an (det)
testosterone letrozole (conj)
impaired use (nmod)
blocks , (punct)
distinguished which (nsubjpass)
minutes and (cc)
p= 0.002 (nummod)
negative response (nsubj)
changes syndrome (conj)
suffers , (punct)
take anticoagulants (dobj)
agitation , (punct)
7-ni not (neg)
conducted synthesize (xcomp)
% factor (conj)
regimen doxorubicin (compound)
isrctn54598675 controlled (compound)
examined years (nmod)
rate incidence (compound)
analysis events (compound)
joint activity (conj)
daidzein 4',7-dihydroxy-isoflavone (appos)
hours head (compound)
cddp ( (punct)
reassessed not (neg)
result hyperkalaemia (nmod)
map sv (conj)
cd4 counts (conj)
activity protease (compound)
mg 5 (nummod)
( i.v. (dep)
show . (punct)
aspect distinctive (amod)
pod and (cc)
warranted be (auxpass)
volume determined (amod)
stopped cessation (nmod)
electrode recordings (dobj)
stress hypertension (conj)
300 to (case)
falls that (mark)
autoantibodies myeloperoxidase (nmod)
continue improves (conj)
mg/dl therapy (nmod)
concentration function (nmod)
approaches therapeutic (amod)
deficits hippocampal (compound)
greater males (nmod)
possibility causes (ccomp)
insecticides of (case)
expressions type (nmod)
da , (punct)
considered that (mark)
delivered . (punct)
production from (case)
had developed (conj)
attenuated activation (dobj)
incidence by (case)
stimulation programmed (amod)
established is (auxpass)
tolerated inhibitor (dobj)
resumed . (punct)
hyper- the (dep)
discussed conditions (nsubjpass)
anaphylaxis . (punct)
rate hbsag (compound)
4000hz at (case)
muscles the (det)
atypicality including (case)
effects dose (dep)
assess based (prep)
analyzed induction (nmod)
schizophrenic adolescent (amod)
conduction cardiac (amod)
median iqr (appos)
had whereas (dep)
completed have (aux)
volume arterial (amod)
absences with (case)
displayed resistance (dobj)
judged have (xcomp)
overloading " (punct)
cells endothelial (amod)
received killed (parataxis)
difficult terminate (xcomp)
anemia reduction (conj)
described reports (nmod)
tspa ) (punct)
initial or (cc)
disabled was (cop)
space into (case)
disease cardiovascular (amod)
associated difficulties (nmod)
challenged rats (nsubjpass)
failure : (punct)
subjects 292 (nummod)
levofloxacin of (case)
cancer disease (appos)
infant anomalies (nmod)
inhibits dehydrogenase (dobj)
concluded had (ccomp)
sensitivity prolactin (nmod)
followed development (nmod)
administration levodopa (nmod)
induced could (aux)
weakness extremity (compound)
patient seventh (amod)
taking screened (conj)
drop for (mark)
findings and (cc)
begins . (punct)
pathway auditory (amod)
had fall (dobj)
chemotherapy experimental (amod)
fracture isolated (amod)
duration disease (compound)
course long-term (amod)
vasculitis drug-induced (amod)
presented rats (nsubj)
accompanied blockade (nmod)
affected ee (nmod)
changes turnover (nmod)
mumol ) (punct)
gpi of (case)
mm 35.9 (nummod)
ascertained can (aux)
mi isph-induced (amod)
predictor acid (nsubj)
block sinoatrial (amod)
treat . (punct)
maximum [ (punct)
higher or (cc)
stressed studies (nsubj)
prc some (det)
induced evidenced (advcl)
treatment patient (nmod)
investigated previously (advmod)
biopsies performed (acl)
failure was (cop)
indicated ; (punct)
symptoms patients (nmod:poss)
found this (nsubjpass)
po mg/d (compound)
differ controls (nmod)
cases inhibitors (nmod)
secretion corticotropin-releasing (amod)
hctc hydrochlorothiazide (compound)
entity although (mark)
alpha(1)-subunit na-k-atpase (nmod)
modulate gating (dobj)
treatment prophylactic (amod)
approaches imaging (nmod)
ibuprofen and (cc)
proliferation cellular (amod)
withdrawal of (case)
exposure valproic (amod)
unpredictable and (cc)
cancer iv (nummod)
expression synthase (compound)
recovery late (amod)
1999 in (case)
acquainted interaction (nmod)
eye red (amod)
liver nodular (amod)
retrieval in (case)
beta-carboline-3-carboxylate , (punct)
resuscitate patient (dobj)
anaesthesia after (case)
offspring the (det)
diuretic with (case)
relevance complications (nmod)
amplitude mean (amod)
2.5 1.25 (compound)
capable hyperammonemia (nsubj)
number admissions (nmod)
coexisted alterations (nsubj)
myalgias pain (conj)
neurons pallidal (amod)
sites decreases (acl:relcl)
dependency state (compound)
pressures intracavernous (amod)
clonidine physicians (compound)
protects dexrazoxane (nsubj)
dose given (case)
concentrations drugs (nmod)
age average (amod)
regressed hospital (nmod)
percentage as (case)
ir ) (punct)
space anterior (amod)
reduced unaffected (conj)
had reduced (conj)
teoaes ( (punct)
ml 1 (compound)
documented development (nsubjpass)
siat ( (punct)
estrogens conjugated (amod)
met users (ccomp)
bupivacaine- in (case)
participants study (compound)
frequency of (case)
increases signs (acl:relcl)
order randomized (amod)
demonstrating in (mark)
effects severity (nmod)
doxorubicin/kg ( (punct)
myopathy the (det)
concentration obtained (acl)
evaluated years (dobj)
pallor attenuation (conj)
enhancement hyperthermia (nmod)
improved seizure (conj)
assessed data (nmod)
investigated applies (ccomp)
expression . (punct)
occurs tolerance (dobj)
changed treatments (nsubj)
activities enzymes (nmod)
received where (advmod)
diagnosed % (nsubjpass)
produce and (cc)
hepatoma mice (nmod)
testing immunologic (conj)
deficits communication (nmod)
haloperidol sertraline (conj)
patients having (acl)
documents patient (dobj)
require often (advmod)
disturbances facial (amod)
completed blind (conj)
documents suggests (conj)
studies models (nmod)
cirrhosis virus-related (amod)
inserted needle (nsubjpass)
withdrawal desferrioxamine (compound)
time transit (compound)
led investigate (xcomp)
distinct that (nmod)
induction a (det)
samples microdialysis (compound)
users current (amod)
study pet (compound)
thickness at (case)
bleeding and (cc)
mg/l x (cc)
remains benefit (nsubj)
changed abundance (nmod)
therapy alpha-2b (nmod)
resolved weeks (nmod)
observations system (nmod)
results quantitative (nmod)
densities spectral (amod)
methods few (amod)
attenuated ischemia (dobj)
vs. 6.6 (nummod)
signs neurological (amod)
had cross-reacting (conj)
defect tubular (amod)
gynecomastia or (cc)
onset myocarditis (nmod)
rated therapy (nmod)
bradycardia accompanying (amod)
levels 15-f(2t)-isop (nmod)
antagonist serotonin-dopamine (amod)
associated complex (nmod)
associated increase (nmod)
tubes ventricle (nmod)
bradycardia increase (conj)
supported order (nmod)
showed analyses (nsubj)
participants seventy-six (nummod)
average versus (cc)
micrograms/kg h (nmod)
chorea valproate-induced (amod)
sixties in (case)
radiopharmaceutical a (det)
tolerate level (dobj)
doses activity (acl:relcl)
assays influence (nmod)
caffeine ( (punct)
organisms aeruginosa (compound)
responding treatment (nmod)
performed biopsy (nsubjpass)
dose resulting (advcl)
puberty short (conj)
arterioles , (punct)
interval 2.0 (compound)
completion procedure (nmod)
refractory disease (nsubj)
two respectively (advmod)
therapy selective (amod)
signs indicative (amod)
inhibition synaptic (amod)
brain throughout (case)
terfenadine e4031 (conj)
rare intoxications (nsubj)
rat igm (compound)
anesthetic local (amod)
administration isoproterenol (compound)
induced maleate (nmod)
severe hyperkalemia (conj)
difluoromethylornithine dfmo (appos)
form drug (nmod)
open given (mark)
bfgf serum (compound)
had onset (dobj)
resembles used (conj)
% 59 (nummod)
exposure findings (conj)
had torsades (dobj)
mice into (case)
responses contractile (compound)
syndrome rs (appos)
example for (case)
levels thrombopoetin (nmod)
literature english (compound)
doses titrated (amod)
administration sirolimus (nmod)
recognized is (auxpass)
rare pediatrics (nmod)
cases microangiopathy (nmod)
likelihood the (det)
stress h. (compound)
placebo administered (acl)
considered group (nmod)
blockade arrhythmias (nmod)
mg/d to (case)
patients patient (nmod)
contributing monotherapy (nsubj)
placebo measure (nmod)
improvements monitoring (nmod)
compare conditions (dobj)
g/dl 11 (nummod)
hearing changes (dobj)
% % (appos)
decrease a (det)
is range (nsubj)
eight ) (punct)
damage isoproterenol-induced (amod)
nausea dizziness (conj)
hyaluronate of (case)
20 ) (punct)
hearing major (nmod)
bches ) (punct)
association numbers (nmod)
refractory leukaemia (dep)
described we (nsubj)
formation aneurysm (compound)
vacuolization arteriolopathy (conj)
have while (mark)
losartan antagonist (compound)
17 in (case)
excess consists (acl:relcl)
had group (nsubj)
procedure the (det)
= 0.26 (dep)
led agitation (nmod)
died ) (punct)
evidence further (amod)
enantiomer its (nmod:poss)
rate [ (punct)
presented unilateral (conj)
used match (xcomp)
145 +/- (cc)
report born (dep)
induced ra (nmod)
mimic to (mark)
therapy c. (nmod)
adrs ( (punct)
hypertension artery (nmod)
potentiates low (amod)
gavaged were (auxpass)
quiescent completely (advmod)
displayed atria (advmod)
limbs in (case)
decreased postlesion (nsubjpass)
derivative anti-inflammatory (amod)
10 - (punct)
sumatriptan of (case)
flumazenil placebo (conj)
discharges on (case)
dissatisfaction to (case)
frequencies higher (amod)
longer that (nmod)
5,7-dihydroxytryptamine of (case)
cm ten (nummod)
ratio weight (compound)
receiving vigabatrin (dobj)
dermatitis perioral (amod)
manifesting hyalinosis (nmod)
l-w ) (punct)
considered must (aux)
effects fetus (nmod)
pressure postural (amod)
high can (aux)
the 54 (dep)
autoimmune drug-induced (conj)
score 12 (nmod)
bmcs obtained (acl)
findings new (amod)
improved used (advcl)
absence and/or (cc)
phase proteinuria (nmod)
leukemia nonlymphocytic (amod)
dimensions mitral (amod)
opioid . (punct)
users methadone (compound)
syndrome progressive (amod)
inhibited caa (nsubj)
stab caused (acl)
level corticosterone (compound)
syndrome anaesthesia (nmod)
doses large (amod)
clinical metabolic (conj)
hyperprolactinemia , (punct)
cardiomyopathy hypertrophic (advmod)
cholesterol serum (compound)
occurs presented (advcl)
microscopic studies (dep)
discovered , (punct)
multifactorial increase (conj)
provide system (nsubj)
x/minute , (punct)
microscopy and (cc)
d-amphetamine d2 (dep)
witnessed outcomes (nsubjpass)
fluctuations motor (compound)
g/m2 cycles (dep)
d3 ) (punct)
promising compounds (dobj)
incidence mice (nmod)
affect nerves (dobj)
appearance field (compound)
degeneration isolated (amod)
prl-r signaling (nmod)
intubated protection (nmod)
factor also (advmod)
appearance to (case)
mutants escape (compound)
examined set (nsubj)
metronidazole and (cc)
performed biopsies (nsubjpass)
prilocaine bupivacaine (conj)
events group (nmod)
insufficiency because (case)
state former (amod)
explained flow (nmod)
hbv patients (dep)
immunosuppressant tacrolimus (nsubj)
antibody anticocaine (amod)
once ) (punct)
palsy with (case)
portion ) (punct)
284 +/- (cc)
adenosine receptor (compound)
disease from (case)
presence absence (nmod)
drug regimen (conj)
observed cytoplasm (nmod)
subjected were (auxpass)
worsened however (advmod)
performed test (conj)
exposed cyclosporine (nmod)
complications other (amod)
history angioedema (nmod)
trial retention (compound)
treated schedule (nmod)
recovery complete (amod)
younger years (dep)
preventing neuropathy (dobj)
prompted known (ccomp)
chlorofluorocarbons ozone-depleting (amod)
single subcutaneous (dep)
sequestration liver (nmod)
level vecuronium (compound)
patients nephrotoxic (amod)
form cyclooxygenase (nmod)
aged fibrillation (nmod)
correct imbalance (dobj)
with arterial (conj)
concluded elicited (ccomp)
metformin drug (compound)
processes stages (nmod)
showed configuration (dobj)
visit for (case)
revealed subgroups (nsubj)
rare myopathy (nsubj)
sertraline or (cc)
rash aplasia (conj)
pressures in (case)
n=92 ) (punct)
akinesia , (punct)
pain cocaine-associated (amod)
cpu cg (conj)
produce did (aux)
presence of (case)
use kg-1 (nmod)
decreased minutes (nmod)
required this (nsubj)
abuse long-term (amod)
eeg in (case)
number mean (compound)
revealed reduction (dobj)
inferior and (cc)
needle the (det)
design analysis (conj)
pronounced atrophy (nsubj)
users ) (punct)
selection : (punct)
compared method (nsubjpass)
min-1 cbf (nsubj)
seem responses (nsubj)
granulocytes platelets (conj)
appetite exhaustion (conj)
tools and (cc)
attributable may (aux)
weeks weeks (dep)
patient including (case)
caused failure (nsubj)
aggregation and (cc)
managed be (auxpass)
thromboembolism combination (conj)
enhanced whether (mark)
form . (punct)
woman was (cop)
evaluation rad001 (nmod)
colocalized . (punct)
piroxicam 2.0 (conj)
n treated (acl)
ratio concentration (nmod)
dosed rats (nmod)
mg increases (conj)
occurred concomitantly (advmod)
done initiation (nmod)
lead overload (nsubj)
collapsed patient (nsubj)
remove to (mark)
less beta (mwe)
1986 early (amod)
shown increase (xcomp)
tissue isolated (amod)
receptor-alpha activated (amod)
lesioned and (cc)
developed fever (nsubj)
recognized decades (nmod)
performance evaluated (acl)
fluoxetine fluoxetine (dep)
periods amplitudes (conj)
correlate to (aux)
comparison doses (nmod)
percent % (conj)
distributions permeability (nmod)
phenomena observed (amod)
fentanyl omitting (compound)
investigate preventing (advcl)
performed group (nmod)
or 1.7 (amod)
incoordination diazepam (nmod)
experienced also (advmod)
nra0160 thiazole-2-carboxamide (appos)
occlusion carotid (compound)
khz 12 (nummod)
sensation her (nmod:poss)
agonist a1 (compound)
concentration plasma (nmod)
had inducing (advcl)
malformations of (case)
mean accuracy (dobj)
cont./min 0.001 (appos)
cm consumed (amod)
water morris (compound)
levels cholinesterase (compound)
increased m (nmod)
illustrates particular (nmod)
institution after (case)
vasoactive : (punct)
aap ( (punct)
angina propranolol (nmod)
elastolysis wall (nmod)
obtained tissue (nsubjpass)
documentation is (cop)
rate ] (punct)
response interval (nmod)
pre-treatment , (punct)
immunoreactivity region (nmod)
gag/pol tg (appos)
reduction function (nmod)
proliferate to (mark)
113 from (case)
recording activity (compound)
700 whom (nmod)
involvement extent (conj)
neutral biosynthetic (conj)
patients sixty (nummod)
therapy estrogen-testosterone (amod)
control rats (conj)
injection min (dep)
triniol ) (punct)
verapamil , (punct)
months semipurified (acl)
improves reduces (conj)
reflected and (cc)
% 55.1 (nummod)
slope the (det)
grade thrombocytopenia (dep)
proportional dose (nmod)
present use (advcl)
preservation to (case)
doubled remained (parataxis)
women 85 (nummod)
exposure non-users (nmod)
disorder thrombocytopenia (nsubj)
patients african (amod)
performed caution (nmod)
user frequent (amod)
clearance mesangium (nmod)
hydrobromide treatment (nmod)
dyspnea , (punct)
objective evaluates (dep)
ophthalmologic and (cc)
remain questions (nsubj)
populations professionals (nmod)
deficit specific (amod)
appears thus (advmod)
days 5 (dep)
analyzed methods (dep)
diethylpropion dep (appos)
indicates exhibited (ccomp)
created , (punct)
incidence frequency (conj)
measurements urinary (amod)
efforts patients (nmod)
followed results (nsubjpass)
maintain min (nmod)
associated necrosis (conj)
clinical histopathologic (conj)
comparisons qualitative (amod)
exceeded when (advmod)
teratology 24 (nummod)
intracellular space (nmod)
response similar (amod)
p9201 risk (appos)
drive sympathetic (amod)
closure macular (amod)
neuropathy rat (nmod)
contributed rate (nmod)
arthralgia fever (conj)
acting physostigmine (nmod)
escalated doses (nsubjpass)
c different (conj)
explanation seen (acl)
infarction without (case)
accident of (case)
calculated , (punct)
lack its (nmod:poss)
results died (appos)
protection instead (case)
confusion somnolence (conj)
reproduced effects (nsubjpass)
blocked hyperactivity (dobj)
reported who (nsubj)
treatment agent (nmod)
contributes performance (nmod)
amoxicillin clavulanic (conj)
older 65 (nmod)
compared recorded (conj)
damage scored (amod)
logs requests (conj)
diagnosed widow (nsubjpass)
observations -- (punct)
important treatment (nmod)
significant decrease (nsubj)
report neither (cc:preconj)
consistent development (nmod)
mg/kg/b.w./day gavages (nmod)
nerves the (det)
fluphenazine and (cc)
identified scale (nmod)
assigned women (nsubjpass)
mm 85.9 (nummod)
mild and (cc)
vertigo vomiting (conj)
types lesions (nmod)
is conclusion (dep)
msdbp as (case)
erythrocytes isolated (amod)
controls receptor (compound)
improvement eeg (nmod)
pain cocaine-related (amod)
concentration inspired (amod)
findings preclinical (amod)
regions to (case)
10(-4 m (dep)
% of (case)
sodium alendronate (compound)
syndrome acetaldehyde (compound)
used modify (conj)
have antioxidants (nsubj)
snp n (appos)
combination srl (compound)
used can (aux)
overdoses dm (compound)
treatment current (amod)
week = (dep)
amount nephrin (nmod)
saline dox (conj)
risk may (aux)
progestogens , (punct)
masked may (aux)
lead event (nmod)
state , (punct)
volume left (amod)
cm ) (punct)
performance or (cc)
dissociate that (mark)
resistance retention (conj)
noncompliance to (case)
account , (punct)
proband the (det)
speculate treating (advcl)
infusion rate (nmod)
clinic urban (amod)
etiology of (case)
postdose and (cc)
intravenous ug (nmod:npmod)
plasma mumol/liter (compound)
leg back (conj)
receiving preparation (dobj)
deficiency its (nmod:poss)
derived f2 (nmod)
characteristic . (punct)
bladder urinary (amod)
hematocrit volume (conj)
leukocyturia without (case)
= % (dobj)
pre-treatment of (case)
significant ) (punct)
meta-analysis in (case)
responses drug (nmod)
alpha-tocopherol and (cc)
defined atrophy (dep)
helpful very (advmod)
apomorphine , (punct)
compared ( (punct)
contraceptives third-generation (amod)
made follow-up (nmod)
weight greater (amod)
evidenced hypothyroidism (nsubjpass)
play maintenance (nmod)
observed side-effects (nsubjpass)
woman 59-year-old (amod)
epinephrine the (det)
pregnancy singleton (compound)
case encephalopathy (nmod)
co-treatment sex (dep)
treated symptom (nsubjpass)
confirmation pathologic (amod)
taken to (mark)
mice convulsing (amod)
london patients (conj)
experienced replaced (conj)
remains identification (nsubj)
proportional degree (nmod)
artery large (amod)
39 +/- (cc)
effects agents (nmod)
effects estradiol (nmod)
pancreatitis haemorrhagic (amod)
likely this (nsubj)
concentrations cimetidine (compound)
shown properties (dobj)
nephrin dendrin (conj)
assessed catheterisation (nmod)
grafts biopsies (appos)
curtailed development (nsubjpass)
research published (amod)
lys1 arg3,4 (conj)
contribute agents (nsubj)
appears paf (nsubj)
performed echocardiography (nsubjpass)
regulatory mitochondrial (amod)
initiated have (aux)
induced levetiracetam (nmod)
ng/mouse and (cc)
higher on (prep)
studied evaluate (xcomp)
increased baseline (nmod)
alter markedly (advmod)
patients evidence (conj)
cardiotoxicity on (case)
involvement mechanism (nmod)
eyes hypertensive (amod)
passed , (punct)
scenario it (nsubj)
reactions serious (amod)
antidotes dfp (conj)
visualized hypertrophy (dep)
lead often (advmod)
test performance (nmod)
syndrome experimental (amod)
responses in (case)
cases associated (acl)
identified increase (dep)
ameliorates rat (nmod)
comparable azt (nmod)
interferes activation (nmod)
defined well (advmod)
12.1 - (punct)
content vip (compound)
1.73 +/- (cc)
tamoxifen to (case)
response anesthetic (amod)
infections more (amod)
influence consumption (nmod)
facilitate that (mark)
edema secondary (amod)
neonates ingested (acl:relcl)
partially inhibition (nmod)
factor (vegf)165 (appos)
included events (nsubj)
1.041 vs (cc)
did animals (dobj)
patients hbv (compound)
different dramatically (advmod)
tracts to (case)
15.8 +/- (cc)
norethisterone mg (nummod)
higher fold (advmod)
mg/kg po (conj)
isocortical allocortical (conj)
effects short-term (amod)
days versus (cc)
euthymia % (dep)
duration year (nmod:poss)
13.5 e13.5 (appos)
admitted are (auxpass)
subtypes of (case)
defining parameters (dobj)
class within (case)
allows demonstrated (advcl)
dobutamine by (case)
inhibitory in (case)
paclitaxel and (cc)
mechanisms aura (nmod)
feel we (nsubj)
rt-pcr q (dep)
group history (conj)
hydrochloride 2-methoxy-4-amino-5-chlorobenzoic (nummod)
cholestasis -- (punct)
naloxone mg/kg (appos)
globulin anti-human (amod)
testing humphrey (compound)
toxicity mg/m(2 (dep)
increases proportion (conj)
movement acute (amod)
immunosuppressive and (cc)
mortality cases (nmod)
any in (case)
manifests classically (advmod)
patients dyslipidemia (nmod)
suggest conclusions (dep)
gtn -23.7 (conj)
state toxic (amod)
used also (advmod)
tone venous (amod)
dfc ) (punct)
using heparin (dobj)
dose recommended (amod)
thickening patients (nmod)
practical economic (conj)
perimetry on (case)
physicians skilled (acl)
undertook : (punct)
dehydrogenase levels (conj)
nra0160 mice (nmod)
factors contributory (amod)
range while (mark)
abnormalities many (amod)
immunoreactivity neuropeptide-y (compound)
doxorubicin dx (appos)
pretreatment dsp4 (compound)
readmission on (case)
leaving unchanged (ccomp)
cessation individuals (nmod)
disease congenital (amod)
based defined (conj)
complicated use (dobj)
constitutes % (dobj)
granules one (nummod)
less .05 (dep)
even after (mwe)
related dynamics (nmod)
drug choice (nmod)
area = (dep)
adriamycin = (dep)
factors with (case)
projection of (case)
a(2a n-pyrimidinyl-2-phenoxyacetamide (compound)
galactosamine conjugate (compound)
opioid-agonists ) (punct)
lithium , (punct)
factor ligand-activated (amod)
chloroquine cq (appos)
alter hyperalgesia (dobj)
described decline (nmod)
(vegf)165 vascular (amod)
allografts disease (conj)
marker degeneration (nmod)
arabic gm (conj)
containing weight (nmod)
adriamycin . (punct)
micrograms.kg-1.min-1 1000 (nummod)
i.c.v , (punct)
level similar (amod)
resistance output (conj)
centers public (compound)
positioning scanner (nmod)
dyskinesia of (case)
adjuvant preventative (conj)
improved be (auxpass)
document time (nmod)
mg/kg 2.5 (nummod)
caused % (ccomp)
15 16 (conj)
capable dexmedetomidine (nsubj)
represent abusers (nsubj)
samples cells (nmod)
seven all (det)
elevation features (dep)
fetuses heavy-exposed (amod)
scattered frequent (amod)
normal from (case)
syndrome cardiac (amod)
neurotoxicity methotrexate (compound)
events 5.2 (nummod)
pills low-dose (amod)
similar effects (nsubj)
patients parkinsonian (amod)
therapy diuretic (compound)
regulated receptor-alpha (nmod)
rats into (case)
each series (nmod)
addicts denied (acl:relcl)
phosphate , (punct)
taking many (nsubj)
numbers animals (nmod)
frequency eeg (compound)
databases the (det)
connections the (det)
levels lithium (compound)
complications cns (compound)
testing perimetry (appos)
encode proteins (dobj)
mj ( (punct)
trial inpatient (amod)
breakdown the (det)
mesothelioma and (cc)
therapy short-term (amod)
extraction after (case)
evidenced intensity (nmod)
leukemia presented (acl)
inhibition production (conj)
standard lenalidomide (nsubj)
5th it (nsubj)
responses beta-adrenoceptor (compound)
discontinued ; (punct)
stress . (punct)
variability hemodynamic (amod)
assessed beginning (xcomp)
117.61 14.71 (conj)
generate to (mark)
acidosis lactic (amod)
done eyes (nmod)
weight heart (compound)
cc more (amod)
hydrochloride of (case)
radiotherapy patients (conj)
juice of (case)
experts fields (nmod)
administered alone (advmod)
maintains but (cc)
unlikely participate (xcomp)
exposure concentration (nmod)
use considered (acl:relcl)
activity receptor (compound)
attenuate . (punct)
outcome the (det)
% 99.8 (nummod)
reaction paracetamol (nmod)
developed period (nmod)
spect thallium-201 (amod)
symptoms fewer (amod)
alternative detect (xcomp)
safety alprazolam (nmod)
serum markers (conj)
node on (case)
biopsy liver (compound)
resolved picture (nsubj)
prevention recurrence (nmod)
gemcitabine vinorelbine (conj)
amount . (punct)
18/88 7 (conj)
transport placebo (conj)
resurgence , (punct)
usage patients (nmod)
acid acid (conj)
capable antagonism (nsubj)
reduce risk (dobj)
interaction metabolic (amod)
discriminates . (punct)
3 7 (prep)
ci 9.95 (nummod)
stroke abusers (nmod)
acetyltransferase cells (nmod)
subjects neuropathy (nmod)
imipramine by (case)
post-therapy at (case)
conducted diagnostic (nmod)
affects characteristics (dobj)
produced some (nmod)
16 117 (nmod)
center an (det)
maneuver of (case)
damage cervical (amod)
on- in (case)
patients surgery (nmod)
impairment markers (conj)
studies oral (amod)
cream chp (compound)
therapy verapamil (nmod)
dermatoses of (case)
was that (mark)
mk-212 the (det)
damage histological (amod)
promotes shared (conj)
involved ears (dobj)
pain without (case)
activity sympathomimetic (amod)
inpatients were (cop)
mg 8.7 (conj)
compared therapy (nmod)
reduction ocular-specific (amod)
advocate hours (nmod)
effect lithium (nmod)
administered points (nmod)
associated damage (nsubjpass)
sham-operated and (cc)
shell and (cc)
use who (nsubj)
thought result (xcomp)
goal levels (nmod)
concentrations antigen (compound)
analyser carbon (compound)
include that (mark)
poison ii (nummod)
prevention cystitis (nmod)
led us (dobj)
frequency this (det)
had groups (advcl)
requires administration (nsubj)
rats f344 (compound)
formation colony (compound)
brings sometimes (advmod)
log doses (dobj)
thought toxicity (nsubjpass)
rated using (advcl)
findings dwi (compound)
barrier immature (amod)
disappeared spasms (nsubj)
infection syncytial (amod)
score individual (amod)
sparing aspects (dobj)
ward peripheral (amod)
receiving drug (dobj)
known effective (xcomp)
represents case (dobj)
catheter foley (compound)
apd more (amod)
studied obtain (xcomp)
use intranasal (amod)
treatment sphincter (nmod)
include papilledema (dobj)
echocardiography in (case)
rats parameters (nmod)
169 10(9)/l (conj)
stage acute (amod)
bodyweight day (nmod)
remain frequency (nsubj)
list growing (amod)
adulthood related (amod)
contraction stimulation-evoked (amod)
disease tubulointerstial (amod)
arthralgia because (case)
complex and (cc)
successful generally (advmod)
therapy zidovudine (compound)
antagonists n-methyl-d-aspartate (conj)
restore pressure (dobj)
continued death (nmod)
bpo-pll ) (punct)
metolachlor and (cc)
patient . (punct)
forearm area (conj)
supply to (case)
developed total (dobj)
activation receptors (nmod)
aorta abdominal (amod)
examine compare (conj)
elevation patient (nmod)
% > (nummod)
leukocyturia sterile (amod)
yield , (punct)
baseline to (case)
equipment sophisticated (amod)
remission remission (conj)
history from (case)
41 % (dep)
noel below (case)
took tab (dobj)
granulomas and (cc)
indicate response (dobj)
focuses response (conj)
timolol placebo (advcl)
present this (nsubj)
antagonizes bupivacaine (nsubj)
taqib taqid (conj)
enlarged was (auxpass)
nephrotoxicity however (advmod)
differ rats (nsubj)
developed mice (nsubj)
periods oscillations (nmod)
11.7 ( (punct)
secretion gland (nmod)
markers dysfunction (nmod)
pan weight (appos)
disorder dsm-iv (appos)
floor the (det)
presentation about (case)
groups doses (conj)
nephropathy bk (compound)
mediating dysfunctions (dobj)
region frontotemporal (amod)
tempol the (det)
4 0.5 (compound)
cta immediate (amod)
pretreatment mg/kg/day (dep)
presence impairment (nmod)
produced administration (nsubj)
fev1 average (amod)
w. mg/kg (compound)
made decision (nsubjpass)
cytoskeleton matrix (conj)
enlargement liver (nmod)
dexamethasone s.c. (dep)
reaction serious (amod)
anemia erythroblastocytopenia (conj)
induced properties (nmod)
produces increases (conj)
paclitaxel infusion (nmod)
difficult more (advmod)
doses haloperidol (conj)
prevented antinociception (nsubjpass)
period apnea (nmod)
prescribed heroin (xcomp)
converting of (mark)
advantageous would (aux)
infections the (det)
pool control (nmod)
g/dl 14.0 (nummod)
presented features (nsubjpass)
hypokalemia of (case)
anesthesia spinal (amod)
latency step (acl)
restricted and (cc)
blocks thalidomide (nsubj)
striatum numerous (amod)
immediate delayed (conj)
less ) (punct)
ua ; (punct)
ulnar , (punct)
pdn prednisone (compound)
older fibrillation (nmod)
isolated allodynia (amod)
treated received (conj)
gating channel (compound)
cautious presentation (nmod)
appearance effect (nmod)
mm 5 (compound)
mm 150 (nummod)
corticosterone ppm (compound)
prevented days (nmod)
l-dopa ; (punct)
aimed determining (advcl)
transplanted been (auxpass)
rtms only (advmod)
activation chemoreception (compound)
diameter fibre (amod)
impaired moderately (advmod)
degeneration muscle (compound)
comparison rate (dep)
cycles cycles (conj)
metabolite as (case)
less considerably (advmod)
high patients (dep)
absorption . (punct)
limited literature (nsubj)
1.041 ( (punct)
abolish completely (advmod)
describe presentation (dobj)
associated depression (nmod)
tended had (conj)
discharged 2 (nsubjpass)
irradiation and (cc)
implicated hypotension (nsubjpass)
administration p (dep)
results lower (appos)
resistance heparin (nmod)
seizure tacrolimus-related (amod)
cessation the (det)
immunosuppressed generally (advmod)
caused hypotension (nmod)
stopped instillations (nsubjpass)
kf17837 mg/kg (appos)
mutation sg145r (compound)
infusion diltiazem (nmod)
enhanced dextromethorphan (nsubj)
showed aggregations (nmod)
waiting watchful (amod)
rats thirty (nummod)
weight membrane (conj)
properties pleiotropic (amod)
acid clavulanic (amod)
reduced mg/kg (dep)
gene pparalpha (compound)
able none (nsubj)
u/l to (case)
pathways by (case)
were rest (nmod)
patients hypothyroid (amod)
symptoms off (amod)
score adjustment (nmod)
hypertension hypotension (conj)
protection this (det)
penetration resultant (amod)
metabolism changes (conj)
effect besides (case)
opiate an (det)
> i.e. (dep)
creatinine higher (amod)
inhibited strongly (advmod)
ly-171555 challenge (conj)
motility amines (conj)
constant deactivation (nmod)
transaminase alt (appos)
years 1.7/100,000 (amod)
disorders various (amod)
study cytoprotection (compound)
lna and (cc)
system ) (punct)
srl ( (punct)
retina the (det)
letrozole the (det)
cingulate , (punct)
analysis manifestations (nmod)
sheath an (det)
lesions organic (amod)
norms about (case)
disease iii-v (dep)
rarer is (cop)
repair prior (amod)
bh prolonged (amod)
men 41 (nummod)
resistance effect (nmod)
and-resistant wsr (appos)
outcome earlier (amod)
had that (mark)
seen involved (advcl)
protects . (punct)
fashion random (amod)
subgroup because (case)
reduced l-name (nsubj)
interference associative (amod)
related remainder (nmod)
continuous rapidly (conj)
few a (quantmod)
case investigating (acl)
gas in (case)
achieves . (punct)
dissection , (punct)
increments mean (compound)
using apparatus (dobj)
patients weeks (conj)
belonging predominantly (advmod)
administered control (xcomp)
acetate and (cc)
damage formation (nmod)
combined paclitaxel (nsubjpass)
synapses collateral-ca1 (amod)
metabolizers pm (appos)
nephropathy streptozotocin-induced (amod)
attenuated catalepsy (dobj)
contractility myocardial (amod)
rats protein (compound)
disappearing . (punct)
levodopa by (case)
doubled . (punct)
developed showed (conj)
technique choice (nmod)
reported november (nmod)
indicate measurements (nsubj)
differences substance (compound)
death neuronal (amod)
azathioprine with (case)
admitted infant (nsubjpass)
etomidate required (acl)
reactivity vascular (amod)
appear 2-receptors (xcomp)
medication blinded (amod)
fatal uncommon (conj)
response caffeine (nmod)
high abnormally (advmod)
valve of (case)
distress psychological (amod)
output ach (compound)
beats sinoatrial (amod)
inactivated ) (punct)
ear to (case)
hypokalemia abolishment (conj)
impaired were (cop)
lymphoma for (case)
analogues agonists (conj)
benefits the (det)
3 between (quantmod)
reducing thereby (advmod)
degradable proteinases (nmod)
km parameters (compound)
donors selected (amod)
estimated rate (nsubjpass)
endpoints mortality (compound)
hemolysis with (case)
severe months (nmod)
basis then (advmod)
symptoms symptoms (conj)
role spasm (nmod)
antagonist greater (dep)
taking was (aux)
discontinuations mg. (compound)
secondary ingestion (nmod)
produce may (aux)
altering by (mark)
normal morphologically (advmod)
electro- and (cc)
reason is (cop)
iiib chemotherapy (conj)
krebs-ringer in (case)
corroborate but (cc)
dexmedetomidine ) (punct)
sex , (punct)
concentrations blockade (nmod)
intensity dose (compound)
daunorubicin from (case)
midbrain of (case)
alcoholic an (det)
level effective (amod)
studies early (amod)
prescribed ; (punct)
require however (advmod)
to class (nmod)
year 15 (nummod)
modulating neurotoxicity (dobj)
rate eradication (compound)
methotrexate 5-fluorouracil (conj)
-0.22 to (case)
development hiccups (nmod)
generalization the (det)
diminished was (auxpass)
sex or (cc)
toxicity neurological (amod)
acquired tdp. (dobj)
capsaicin efficacy (appos)
lysozymuria score (conj)
treated tested (conj)
presents , (punct)
thyrotoxicosis pregnancy (nmod)
= 0.0017 (dobj)
anemia report (dep)
aware raise (ccomp)
numbers bfu-e (nmod)
gm. mg.per (compound)
treated ma (nmod)
dexrazoxane with (nmod)
discontinuation lev (nmod)
measured score (nmod)
demonstrate clearly (advmod)
man mg/day (nmod)
tt ) (punct)
induces and (cc)
significant sevoflurane (nmod)
groups , (punct)
membrane rats (nmod)
results caused (appos)
alpha-methyldopa to (case)
presence history (nmod)
suggest used (ccomp)
database our (nmod:poss)
justified prevent (xcomp)
acetate ( (punct)
syndrome disulfiram-like (amod)
boluses analgesia (compound)
withdrawal prednisolone (nmod)
double enlarged (advcl)
line some (det)
trh ( (punct)
mediators beta4 (nsubj)
armrest by (case)
developed worsened (xcomp)
indications inhibitor (compound)
gangrene threatened (amod)
learning upon (case)
mg kg-1 (dep)
increasing incidence (nsubj)
use parenteral (amod)
have factors (nsubj)
basis elicit (acl)
conducted dividing (advcl)
apnea hypotonia (conj)
produce not (neg)
given calcium (dobj)
g/l to (case)
course relationship (conj)
met 185 (nsubj)
short interval (dep)
cancer from (case)
those had (acl:relcl)
end treatment (nmod)
cholestasis lasting (amod)
follow . (punct)
frequent ich (nmod)
concentration caused (acl:relcl)
compared effects (dobj)
classified . (punct)
used background (dep)
ro verapamil (conj)
that found (acl)
accompanied elevation (nsubj)
demonstrates antagonizing (advcl)
patient encephalopathy (nmod)
lining the (det)
extremities his (nmod:poss)
decreased group (nmod)
3 less (amod)
mean sd (dep)
sensitivity values (conj)
erythropoietin increased (conj)
problems of (case)
he-lfb neurofilament (appos)
sacrificed day (nmod)
recurrences glioblastoma (compound)
nerve motor (compound)
users ecstasy-polydrug (amod)
peaked injection (nmod)
degrees significant (amod)
role subunits (nmod)
available involvement (nmod)
reduces doxorubicin (nmod)
seeded mea (nmod)
rp the (det)
measured previously (advmod)
detected decrease (nsubjpass)
effective epimers (nsubj)
block dose (nmod)
damage dopaminergic (amod)
confined patients (nmod)
cellulose gm (conj)
midazolam woke (conj)
lower did (aux)
surviving . (punct)
factor-alpha of (case)
lost lasted (conj)
neurotoxicity ma-induced (amod)
nephrectomy donor (compound)
loosening was (aux)
found syndrome (nmod)
12 dogs (nmod)
proof observations (nsubj)
efflux of (case)
have pyrazinamide (nsubj)
useful baclofen (nsubj)
prevents complication (dobj)
increased secretion (nsubj)
taken precautions (nsubjpass)
observed speaking (advcl)
kaposi 's (case)
reducing durations (dobj)
review admissions (nmod)
function hormone (nmod)
values 0.5 (nmod)
informed patients (nsubjpass)
terminals mossy (amod)
practice . (punct)
plasma glucosuria (conj)
intervals hour (compound)
hydration amounts (conj)
initiated monitoring (nsubjpass)
oxidation acid (compound)
associated hypometabolism (nmod)
complications on (case)
impairments induced (acl)
modulated systems (nsubjpass)
restored that (mark)
normalizes treatment (nsubj)
td50 impairment (nmod)
injection or (cc)
vehicles saline (conj)
anticoagulants coumarin-derived (amod)
leveled have (aux)
support although (mark)
hitherto of (case)
amnesia 1mg/kg (dep)
changes weight (nmod)
demonstrate suggest (conj)
p75(ntr of (case)
gls ( (punct)
results staining (nmod)
ii ( (punct)
hyperactivity secondary (amod)
children refractory (nmod)
study paclitaxel (nmod)
revealed systems (nmod)
1.26 g/d (dep)
ng of (case)
gaba gamma-vinyl (compound)
indicates occurs (ccomp)
treated discontinuation (nmod)
activity nos (compound)
homeostasis lipid (compound)
showed agonist (nsubj)
0.05 5 (conj)
female 40-year-old (amod)
dosage methylprednisolone (nmod)
study sample (nmod)
reduced clearance (conj)
olanzapine ziprasidone (conj)
ablation patient (nmod)
control a (det)
hb ( (punct)
involvement h(3)-receptors (nmod)
function cerebellar (amod)
dsm-iii-r. the (det)
increases extent (nmod)
implicated mechanisms (nmod)
neonates born (acl:relcl)
induction etomidate (nmod)
remained rats (dep)
greater those (nmod)
ligation bdl (appos)
monotherapy or (cc)
depression to (case)
measuring ii (dep)
determine occupancy (dobj)
dosages greater (amod)
descending cord (nmod)
killed injection (nmod)
nucleus caudate (compound)
institution . (punct)
patients predisposed (amod)
effects ca (conj)
vte women (nmod)
understood profile (nsubjpass)
detectable symptoms (nsubj)
modulating gaba (dobj)
ages at (case)
mg 1 (compound)
deferoxamine dfo (appos)
patients 1,453 (nummod)
research by (case)
% 1.72 (nummod)
deemed , (punct)
administration deferoxamine (nmod)
treated days (nmod)
producing initiate (xcomp)
exercise ischaemia (conj)
disappeared min (nmod)
thresholds seizure (amod)
degree substances (nsubj)
recommenced min (dobj)
sign and (cc)
neuralgia post-herpetic (amod)
learning tasks (nmod)
caused death (nsubjpass)
admitted july (nmod)
clinical by (case)
mg 85 (compound)
occur prescribed (advcl)
lymphoma epitheliotropic (amod)
cc with (case)
drugs second-line (amod)
1 hours (dep)
june 1985 (nummod)
sessions 4 (nummod)
confirm seriousness (dobj)
syncope vasovagal (compound)
dogs stenosis (nmod)
drg lumbosacral (amod)
better i.e. (advmod)
neurotransmitters hippocampal (compound)
nitrotyrosine tissues (nmod)
extension regression (conj)
considerations neurobiological (amod)
severe irreversible (conj)
effective use (nsubj)
was potentiation (attr)
examination normal (amod)
methods with (case)
influenced hyperactivity (nmod)
deposited thus (advmod)
subset the (det)
ameliorating in (mark)
anthracyclines etoposide (conj)
agent useful (amod)
p=0.037 ) (punct)
exhibited fall (nmod:npmod)
behaved . (punct)
searched databases (nsubjpass)
divided periods (nmod)
bpo-pll ax-pll (conj)
gland of (case)
reported use (nmod)
h 48 (nummod)
expected as (mark)
day 14 (nummod)
diabetes nephrogenic (amod)
observed background (dep)
reactions hemolytic (amod)
other system (nmod)
hour 24 (nummod)
trial atrial (compound)
concentrations pollutants (nmod)
minutes % (conj)
cure arthritis (nmod)
distribution a (det)
time same (amod)
administered diethylnitrosamine (nmod)
different significantly (advmod)
partial responses (nsubj)
recurrence in (case)
woman 43-year-old (amod)
shown we (nsubj)
congenita of (case)
microscopy necropsy (amod)
stenosis arteries (nmod)
begun recently (advmod)
treating disease (dobj)
delivered implantation (nmod)
quantities mannitol (nmod)
care tertiary (amod)
23.6 7.6 (conj)
dissection etiology (conj)
allergies known (amod)
similar include (conj)
developed parasitosis (dobj)
rare was (cop)
one dysfunction (nsubj)
midazolam between (case)
less than (dep)
higher gestodene (dep)
drugs specific (amod)
barrier glomerular (amod)
sg145r or (cc)
p=0.008 and (cc)
l/kg od (nmod)
analyses spectral (amod)
had regardless (advmod)
modalities attractive (amod)
dexatrim of (case)
extracts thunbergiana (nmod)
pressure cpap (appos)
maintain functioning (dobj)
increase stability (dobj)
determined exerted (advcl)
hyperalgesic and (cc)
barrier . (punct)
oil of (case)
sparse . (punct)
dyskinesia wearing-off (conj)
apoptosis induced (amod)
material amorphogranular (amod)
mg of (case)
increased increasing (advcl)
1.1 3.4 (prep)
evaluate costs (dobj)
anastrozole of (case)
correlation dose (nmod)
inhibitors as (case)
changes observed (acl)
down respectively (advmod)
15 or (cc)
role a (nmod)
pneumonia infection (appos)
involve to (mark)
added unable (advcl)
toxicology maternal (amod)
resolution complication (nmod)
review the (det)
controls n (dep)
mater onto (case)
standpoint the (det)
disorders or (cc)
effect principal (amod)
history defects (nmod)
allowed was (auxpass)
patients lithium (acl:relcl)
failed had (aux)
reduced compared (advcl)
mcao ) (punct)
25 35/15 (compound)
extent extravasation (nmod)
had country (nsubj)
succinate , (punct)
allele of (case)
np by (case)
reduction tac (compound)
breaks and (cc)
independence patient (nmod:poss)
deviation suggestive (amod)
= 0.815 (dobj)
protein myeloid (amod)
hexaaldose alcohols (conj)
clonidine prescribing (compound)
range scores (nmod)
evidence , (punct)
depression . (punct)
depletion gsh (compound)
supports and (cc)
carbamazepine chronic (amod)
ratio 3.8 (conj)
sequelae long-term (amod)
criteria according (case)
revealed presence (nmod)
demonstrates program (ccomp)
day gd1=plug (compound)
targeted residue (nsubjpass)
alter excretion (dobj)
saline rocuronium (conj)
incorporating cisplatinum (dobj)
groups ntg (appos)
alone once (advmod)
exercise dobutamine (conj)
enhanced action (nsubjpass)
elevation . (punct)
sclerosis rats (nmod)
quantitative qualitative (conj)
perturbation from (case)
estimate implications (nmod)
disappeared % (nmod)
hypertension contraceptives (conj)
extension dose (appos)
duration dog (nmod)
experienced change (dobj)
turnover activity (conj)
useful , (punct)
similar that (nsubj)
mater the (det)
treatment glaucoma (conj)
scopolamine either (cc:preconj)
cases pathological (compound)
order 25 (nmod)
akathisia : (punct)
25 10 (compound)
antinociception the (det)
habituation environment (nmod)
deoxycorticosterone of (case)
induced medium (nmod)
remains buffers (advcl)
attack to (mark)
demonstrates , (punct)
interview records (conj)
mechanisms involved (acl)
sirolimus ) (punct)
4 and (cc)
found cause (xcomp)
impairment with (case)
adenomas hepatic (amod)
patients or (cc)
those especially (advmod)
week for (case)
10 to (dep)
administration cbdca (compound)
mg./kg 4 (nummod)
physicians patients (conj)
4-hourly regimens (dep)
leukemia cml (appos)
ro4368554 the (det)
determined increase (nsubjpass)
combination vitamin (compound)
appear cause (advcl)
prevent mg/kg (nsubj)
used derivative (nsubjpass)
infusion vein (compound)
contractions controls (nmod)
lack because (mark)
normal roots (nsubj)
mimic closely (advmod)
apoptosis , (punct)
carried examination (nsubjpass)
aware patients (nmod)
responses noradrenaline (conj)
doses form (nmod)
interpret episodes (nmod)
documented a/j (nmod)
recommended dose (nsubjpass)
capable altering (advcl)
sings significant (amod)
calculated conclusion (nsubjpass)
4 ( (punct)
doses mg/kg/i.p (dep)
ukpdrg ( (punct)
developed had (aux)
show that (nsubj)
radius and (cc)
4107 208 (conj)
have had (ccomp)
fasciculation of (case)
rats female (compound)
simple in (case)
disturbances of (case)
survival sgk1(-/- (nmod)
hearts animals (nmod:poss)
tomographic ct (appos)
maintained anesthesia (nsubjpass)
resolved slowly (advmod)
liberate to (mark)
similar reduction (nmod)
communicate person (nmod)
phosphorylation transcript (conj)
modulation differential (amod)
have disclosed (xcomp)
restarted when (advmod)
35 about (advmod)
retested . (punct)
decreased nephrin (nsubj)
insipidus . (punct)
g 3.6 (nummod)
paraparesis involved (acl:relcl)
concentrations terbutaline (compound)
exhibited seizures (dobj)
cytotoxicity lines (nmod)
men 18 (nummod)
initiation inpatients (nmod)
injury no (det)
release stress (conj)
pci successful (amod)
nitrogranulogen ng (appos)
dose patients (appos)
cholinergic presynaptic (amod)
case some (det)
substitutes chlorofluorocarbons (nmod)
pressures intraventricular (compound)
period second (amod)
described association (nmod)
12/27 ( (punct)
abnormalities failure (conj)
elevation argatroban (nmod)
had propranolol (nsubj)
blind . (punct)
second , (punct)
cases otherwise (amod)
isomer.6 than (case)
used frequently (advmod)
headache side-effects (nsubj)
appearance sudden (amod)
double than (advmod)
developmental treatment (conj)
ci:0.7 2.4 (nummod)
determined doses (nsubjpass)
sclerosis focal (amod)
exacerbations severe (amod)
azathioprine and (cc)
had hemianopsia (dobj)
hyperglycemia occasionally (conj)
41.4 +/- (cc)
bolus after (case)
showed ) (punct)
increased cells (dobj)
group in (case)
type medication (nmod)
activation central (amod)
received i.v. (advmod)
rcts in (case)
performed angiography (nsubjpass)
undergo intervention (dobj)
secreted vitro (advmod)
produced pan (nmod)
investigation the (det)
canal schlemm (nmod)
response echocardiography (nmod)
achieved was (auxpass)
quantify . (punct)
mg/m2 dose (appos)
vagal nor (cc)
tamca mg/ml (compound)
atp by (case)
develop necrosis (dobj)
revealed data (nsubj)
graft bypass (compound)
tnfalpha activity (conj)
histological immunohistochemical (conj)
maleate -mk801 (nummod)
return values (nmod)
reduced switch (nmod)
22.77 3.26 (conj)
rarest syndrome (nsubj)
unchanged however (advmod)
patients 641 (nummod)
substance of (case)
clearance total (amod)
remains increasing (advcl)
effects mediated (amod)
subjects 114 (nummod)
depressive psychotic (conj)
warranted screening (csubj)
had latencies (dobj)
57.7 58.7 (conj)
34.0 while (mark)
occurrence exercise (conj)
profile ocd-like (amod)
g/l ) (punct)
indicate data (nsubj)
withdrawn ischemia (nmod)
monitoring continuous (amod)
exception rats (nmod)
reproduces provides (conj)
affected bradycardia (nsubjpass)
deposition hemosiderin (compound)
vasodilatation kidney (nmod)
hypertension nephrotoxicity (conj)
models learning (nmod)
effects according (case)
nifedipine doses (nmod)
promotes and (cc)
tolerability lomustine (nmod)
c mitomycin (compound)
t(30 ) (punct)
bupropion concurrently (nmod)
movements choreoathetoid (compound)
significant clinically (advmod)
limits responses (nsubj)
76 to (case)
fulfilled time (nmod)
species a (det)
analyses imunohistochemical (amod)
degeneration myxomatous (amod)
postulated . (punct)
testing this (nmod)
differences difference (nsubj)
headache oxide-induced (amod)
bradykinesia rigidity (conj)
induce contribute (conj)
schedule encourages (acl:relcl)
observations users (nmod)
formyl-methionyl-leucyl-phenylalanine fmlp (appos)
long-term active (conj)
measured binding (nmod)
models random (amod)
potassium body (compound)
1 between (case)
condition worsening (amod)
myalgia . (punct)
invasion myometrial (amod)
damage using (acl)
review in (case)
11 4 (conj)
induction of (case)
receive developing (advcl)
decreases significant (amod)
searched register (dep)
technique a (det)
toxic vincristine-induced (dep)
sedative newborn (nmod)
= 0.0027 (dobj)
mg/kg 75 (nummod)
period off-dosing (amod)
thought initially (advmod)
qt of (case)
cases , (punct)
remedies preparations (conj)
decrease lysozymuria (conj)
oxidized reduced (conj)
disorders nms (nsubj)
knockout dopamine (compound)
accumulation hepatic (amod)
hemorrhage ulcer (conj)
sod brain (compound)
cows % (nsubj)
mrna cortical (amod)
spots among (case)
severe , (punct)
started patient (nsubj)
higher clearance (nsubj)
withdrawing , (punct)
fragments n-terminal (amod)
media to (case)
min-1 min-1 (conj)
increased severity (nsubj)
rating mood (compound)
subjects history (nmod)
disease whose (nmod:poss)
patients in (case)
disease 's (case)
reactions toxicity (nmod)
showed granules (nsubj)
prevalence seriousness (amod)
dogs subjected (acl)
prevalence delirium (nmod)
developed day (nmod:tmod)
recurrence re-resection (nmod)
quiescent been (cop)
dyskinesias pd (nmod)
alf in (case)
progression disease (compound)
reversed administration (nmod)
rhizomes of (case)
narcosis barbiturate (compound)
systems intrinsic (amod)
finding a (det)
without well (advmod)
evaluation this (det)
discharge prior (case)
determining by (mark)
al 1985 (nummod)
capsules silastic (amod)
levodopa mg/kg (dep)
characterized ) (punct)
used microscopy (nsubjpass)
delirium such (case)
using perfusion (dobj)
isoenzymes phosphokinase (compound)
block which (nsubj)
acuity 6/24 (nmod)
admitted exclusion (nmod)
comparing subgroup (dobj)
cleft palate (nmod)
months 7.6 (nummod)
short-term 1 (dep)
0.25 , (punct)
system for (case)
observations patient (nmod:poss)
trial a (appos)
been effect (attr)
given rats (nsubj)
higher appears (advcl)
potential any (det)
complication reported (acl:relcl)
54-week in (case)
excretion protein (nmod)
way may (aux)
hyperparathyroidism primary (amod)
ovarian platinum/paclitaxel-refractory (amod)
enzymes marker (compound)
uiu/ml ( (punct)
concentration drug (compound)
effects negative (amod)
lna+lca ( (punct)
mmol/l to (case)
effects application (nmod)
timecourse the (det)
syndrome latter (amod)
treatment symptoms (nmod)
using kit (nmod)
that required (acl)
admitted he (nsubjpass)
resulted use (nmod)
risk no (det)
ptcr between (case)
1.0 0.52 (conj)
= 1051 (dep)
1/s at (case)
diagnosis definitive (amod)
frequent groups (nmod)
dizocilpine mk-801 (dep)
calculated were (auxpass)
administration dose (conj)
intrahepatic and (cc)
auc an (det)
antibody-negative were (cop)
indications of (case)
population control (compound)
bupivacaine mg/kg (compound)
filling : (punct)
signaling matrix (compound)
had suggesting (advcl)
subarachnoid hemorrhage (conj)
micrograms/kg 5 (nummod)
snr the (det)
expression be (cop)
factor causing (acl)
smoking concurrent (amod)
thought sulpiride-induced (advcl)
debated currently (advmod)
with caffeine (conj)
small agents (nmod)
transporter in (case)
2.6 were (cop)
tumor-free patient (nsubj)
inflamed in (case)
difficult were (cop)
pre-treatment propofol (nmod)
3.6 20.0 (prep)
or 2.7 (amod)
weeks testing (compound)
, 40 (dep)
microg/l ) (punct)
cardiotoxicity rats (nmod)
responses pain (compound)
toxicity doxorubicin-associated (amod)
effects bronchodilator (compound)
% reported (acl:relcl)
administration temocapril (nmod)
fatal sometimes (advmod)
implications the (det)
root the (det)
assigned children (nsubjpass)
areas improvement (nmod)
accompanied ; (punct)
treatment menorrhagia (nmod)
iso to (case)
suppression concomitant (amod)
collected being (auxpass)
mimic exposures (dobj)
inhibition to (case)
efficacy long-term (amod)
comparison biopsies (nmod)
ng/mouse horizontal (conj)
combinations only (advmod)
subjects participated (acl)
tolerable dogs (nmod)
symptoms pd (nmod)
cleavage hip-his-leu (compound)
association . (punct)
physostigmine than (case)
comparison further (amod)
infusate patients (nmod)
has scleroderma (nsubj)
weakness profound (amod)
doses subhypnotic (amod)
approval with (case)
comparison octapeptides (nmod)
sensitivity resistance (conj)
expressed is (auxpass)
sufficient seems (advcl)
comprised participants (nmod)
stopped insertion (nmod)
metallothionein mt (appos)
alpha-tocopherol of (case)
coupling depression (nmod)
activity resting (amod)
cases infants (nmod)
toxicities % (appos)
cmro2 in (case)
excretion metabolites (conj)
tolerated reported (advcl)
area by (case)
chiasmopathy ethambutol (compound)
remodeling left (amod)
apposed closely (advmod)
developed changes (dobj)
modulated , (punct)
exhibited elevated (advcl)
use omeprazole (nmod)
multicenter . (punct)
8-week controlled (conj)
showing cost (nmod)
recognized phenomenon (nmod)
met and (cc)
patient described (acl)
regimen exposure (compound)
implantation by (case)
nephropathy cin (appos)
alpha3 alpha5 (conj)
eosinophil and (cc)
intake concomitant (amod)
type postoperative (conj)
action rat (nmod)
recurrences human (amod)
apd ) (punct)
encouraged have (aux)
stains masson (nmod:poss)
lines prior (amod)
variable be (cop)
blinded management (nmod)
m-chlorophenylpiperazine ) (punct)
female presented (acl)
paraventricular pvn (appos)
strategy progression (nmod)
tissues orbital (amod)
region growth (compound)
antagonists glur5 (compound)
seven up (advmod)
1.35 ( (punct)
pathway erk1/2 (compound)
enhanced ovx (nsubj)
variety properties (conj)
patients 0/32 (nummod)
trimester first (amod)
near-syncope with (case)
uncommon not (neg)
1-bromo-1-chloro-2,2,2-trifluoroethane halothane (appos)
associated tumors (compound)
implications effective (dep)
benefit in (case)
prevented administered (advcl)
recorded acetylsalicylate (nmod)
seven , (punct)
worsening condition (nmod)
majority sites (nmod)
effects antiparkinsonian-like (amod)
emphasizes importance (dobj)
taken should (aux)
nephrectomy during (case)
monitored infusion (nmod)
narrowed treatment (nsubjpass)
drugs various (amod)
side the (det)
caused blockade (dobj)
pharmacodynamics treatment (nmod)
tumors although (mark)
dosage similar (conj)
conclusion finding (dep)
stressed immediately (advmod)
data collected (amod)
step bar (nmod)
irrespective administration (nmod)
receptors 5-hydroxytryptamine1a (compound)
showed conclusion (nsubj)
abundant although (mark)
relation with (case)
potential metabolite (nmod)
channel water (compound)
started who (nsubjpass)
admissions hemiparesis (nmod)
rate prolactin (nmod)
% 1/10 (appos)
immunohistochemical ultrastructural (conj)
nicotine than (case)
oxidation , (punct)
animals these (det)
were as (advmod)
medication diabetes (compound)
case dystonia (nmod)
strategy cost-effective (amod)
min 12 (nummod)
leads therapy (nsubj)
reduction profound (amod)
began have (xcomp)
produced delayed (advcl)
held meeting (nsubjpass)
sedated . (punct)
exacerbates nephropathy (advmod)
patients were (cop)
days week (nmod:npmod)
start therapy (nmod)
application topical (amod)
-cimetidine plus (cc)
man . (punct)
sex by (case)
presenting surgery (nmod)
collagen mice (nmod)
segment st (amod)
methods sent (appos)
surviving animals (dobj)
dehydration of (case)
development adenocarcinoma (nmod)
cells mt4 (compound)
was deterioration (attr)
conclude induced (ccomp)
hemorrhage after (case)
reduction blood (nmod)
repair patients (nmod)
chemotherapy patients (conj)
batteries with (case)
lh of (case)
response carbachol (nmod)
fibers temporal (amod)
fraction group (nmod)
cinacalcet of (case)
increased replacement (nsubj)
exposure beings (nmod)
t desipramine (nmod)
made identification (nsubjpass)
vena cava (dep)
showed discontinuation (nmod)
reduced gls (nsubjpass)
acts diazepam (nsubj)
bind antibodies (nsubj)
agents chelating (amod)
incorporate , (punct)
introduction change (nsubj)
diuresis the (det)
system syndrome (nmod)
rise slow (amod)
likely most (advmod)
d. vitamin (compound)
administration even (advmod)
receptor-associated nmda (nmod:npmod)
responds animals (nmod)
afford minimizing (advcl)
discontinued events (nmod)
changed proteins (nmod)
3.82 ) (punct)
biological of (case)
fed diets (dobj)
adherence < (nmod)
99 of (advmod)
toxicity bcnu-induced (amod)
= 0.013 (dobj)
zones arterial (amod)
alfentanil mu/kg (appos)
hospitalized he (nsubjpass)
pralidoxime-2-chloride diazepam (conj)
clotting impaired (amod)
necrotizing myocarditis (dobj)
degree abnormality (nmod)
aggressiveness on (case)
abscess from (case)
stress er (compound)
ligands activity (nmod)
used institutions (nmod)
od vs. (cc)
carried analyses (nsubjpass)
reduced unchanged (advcl)
tacrolimus patient (compound)
finished patients (nsubj)
induction delaying (compound)
administration calcitonin (nmod)
involved component (nsubjpass)
level from (case)
restricted-diet , (punct)
drugs haloperidol (nmod)
050+/-561 22 (nummod)
diethylnitrosamine den (appos)
observed echocardiography (nmod)
71 - (punct)
concluded . (punct)
superior also (advmod)
hygiene and (cc)
remaining mg (nmod)
achieved alkalinization (nsubjpass)
next very (advmod)
used cautiously (advmod)
gonadotropin human (amod)
produce octogenarian (nmod)
classified size (nmod)
renal impaired (amod)
access brain (nmod)
loss response (nmod)
glioma , (punct)
task with (case)
level observed (amod)
report death (nmod)
after-before ) (punct)
aetiologies the (det)
complication benign (advcl)
treatment prior (amod)
microg/kg 0.1 (nummod)
options treatment (nmod)
diarrhea shock (conj)
sham between (case)
potent vpa (nmod)
mode action (nmod)
compartment dark (amod)
characterization in (amod)
have differ (conj)
gyrus cingulate (compound)
hepatotoxicity in (case)
showed minimal-type (dobj)
used ligation (nmod)
day end (nmod)
alteration significant (amod)
mandates treatment (nsubj)
phenotype silent (amod)
bodies viral (amod)
showed receptor (nmod)
efficacious as (mark)
acetyltransferase enhances (acl:relcl)
effects azathioprine (nmod)
ddavp ) (punct)
understood incompletely (advmod)
injection icv (compound)
obstruction airflow (compound)
had hundredth (dep)
one months (nmod)
showed compared (prep)
offset reduction (nmod)
preceded counts (nmod)
seem most (nsubj)
effect ltp (nmod)
associated hiccups (nmod)
prevented whom (nmod)
infarction after (case)
ach ) (punct)
luke 's (case)
organization this (det)
14c-41 of (case)
association longitudinal (amod)
bands frequency (compound)
stopped drug (nsubjpass)
persons hypertensive (amod)
channel ion (compound)
agents to (case)
december , (punct)
carvedilol ip/week (appos)
activity penicillin-induced (amod)
common are (cop)
receptors found (acl)
males . (punct)
drug spironolactone (nsubj)
monitoring invasive (amod)
hcfc 124 (nummod)
mm mm (appos)
12.8 2 (conj)
treat could (aux)
had present (xcomp)
acting by (mark)
determined enhancement (nsubjpass)
letrozole inhibitor (compound)
reduced area (dobj)
transplanted were (auxpass)
size-dependent that (mark)
event war (nmod)
conducted were (auxpass)
mouse female (amod)
continue preparations (nsubj)
associations . (punct)
isoproterenol stimulation (dep)
emulsion epinephrine (nmod)
1-hr ephedrine (compound)
scleroderma for (case)
values than (case)
reactivation to (case)
identical jitteriness (nsubj)
form carbonate (nmod)
offspring adult (amod)
pressure maximum (conj)
fenfluramines the (det)
identify whether (mark)
revascularization veins (nmod)
patients lithiasis (nmod)
thyroxine with (case)
induced bupropion (nmod)
loci chromosomes (nmod)
self-poisoning deliberate (amod)
content attack (conj)
comparing patients (dobj)
induced verapamil (nmod)
calibre reduced (amod)
bupivacaine circulating (amod)
pergolide dopamine-receptor (amod)
agent infusion (nmod)
assay enzyme-linked (amod)
influence extravasation (dobj)
use site (conj)
anemia treatment (nmod)
phenomenon ingestion (nsubj)
vpu and (cc)
developed deficit (nsubj)
determine extent (dobj)
death patients (nmod)
19.2 9 (conj)
serum- kinase (conj)
groups five (nummod)
1.6 mg/kg (nmod)
reality as (case)
pro-arrhythmic it (nsubj)
% 2.6 (nummod)
frequency power (compound)
time-course on (case)
field open (amod)
dialysis capd (appos)
cofactors interactions (nmod)
infusion % (appos)
5 15 (conj)
attack during (case)
caused localization (nsubjpass)
produce doxorubicin (nsubj)
agent iii (nummod)
define to (mark)
mmec ) (punct)
contractions or (cc)
ng ( (punct)
shift curve (nmod)
carvedilol damage (nmod)
agent ammonium (compound)
patients all (predet)
interval survival (conj)
troponin and (cc)
day therapy (nmod)
days study (compound)
series mesna (compound)
prolonged shortened (conj)
previously month (nmod:npmod)
related possibly (advmod)
marker activity (conj)
time pt (appos)
drc , (punct)
(2-chloroethyl)-1-nitrosoure to (case)
miss appointments (dobj)
resistance consequences (conj)
relieved . (punct)
administered lignocaine (nsubjpass)
ramh ( (punct)
assessment quantitative (amod)
interacts suppresses (conj)
block reverse (conj)
lidocaine with (case)
mm while (mark)
ineffective . (punct)
inhibiting phosphatase (dobj)
showed curves (dobj)
active then (advmod)
cocs were (cop)
clearance the (det)
given azt (dobj)
case were (cop)
role contradictor (amod)
increased jitter (dobj)
trimester third (amod)
microangiopathy transplantation-associated (amod)
known effective (ccomp)
suggested utility (nsubjpass)
antigen of (case)
one iv (dep)
neuropathy ethambutol-associated (amod)
e2 on (case)
evening surgery (nmod)
combination cocaine (nmod)
treated or (cc)
antagonist ) (punct)
articles abuse (nmod)
improved varied (advcl)
worsened which (nsubj)
plasticity : (punct)
injection bepridil (nmod)
induce can (aux)
assay using (acl)
dependent perfusion (nmod)
% 1.6 (dep)
beating on (case)
continued improved (ccomp)
cisplatinum of (case)
using phases (dobj)
treatment aminoglycoside (amod)
induces injection (nsubj)
fleas of (case)
2839 of (case)
enrolled , (punct)
decrease in (case)
treated alteplase (nmod)
depression impulsiveness (conj)
defects periods (nmod)
method using (dep)
multiforme after (mark)
epithelium forestomach (compound)
p .01 (dep)
administered dawley (nmod)
measured using (xcomp)
sem groups (nmod)
respond hypotension (nmod)
reduced epiphenomena (nmod)
syndromes pain (nmod)
falls receiving (advcl)
managed amiodarone (nmod)
determined using (advcl)
catheterization carotid (nmod)
ranging hyperkalemia (nsubj)
analysis incidences (nmod)
abecarrnil ( (punct)
hemoglobin g/dl (dep)
hypotension flow (nmod)
reported literature (nmod)
glomerulonephritis antibody-(pr3-anca (dep)
demonstrated elsewhere (advmod)
mellitus disease (conj)
administered apamin (nsubjpass)
group fk506-nephropathy (amod)
volume pan (compound)
consolidation impaired (amod)
revealed potentials (dobj)
treatment pcp (nmod)
228 ( (punct)
documentation biopsy (compound)
agsd other (conj)
analogues tetrandrine (nsubj)
reduces rate (dobj)
method according (case)
seen improvements (nsubjpass)
cortex cingulated (amod)
evidence beta-blockade.8 (nmod)
suggest lesion (dobj)
recruited months (nmod)
glutamate of (case)
rejection ar+cr (conj)
elicited cage (nmod)
eeg undertaken (acl)
tested test (dep)
ng./ml testosterone (nsubj)
damage selectively (advmod)
assessing secretion (dobj)
cost usage (nmod)
advantages despite (case)
developed study (xcomp)
length time (nmod)
dogs mao-inhibited (amod)
defined episode (nmod)
rise creatinine (nmod)
medication diphenylhydantoin (compound)
mitochondria compared (case)
unaltered are (cop)
> years (dep)
seven three (compound)
reviewed infants (advcl)
patients overdose (nmod)
monitored however (advmod)
have combination (nmod)
frequencies at (case)
% time (compound)
achieved if (mark)
% 6.1 (nummod)
interference dopaminergic (amod)
caused overdose (nmod)
100 to (dep)
lymphoma disease (appos)
part most (amod)
loss progressive (amod)
form to (mark)
synthase inducible (amod)
woman 22-year-old (amod)
reacted weakly (advmod)
properties rate (conj)
hypotension pge1-induced (amod)
suspected composed (conj)
synthesis with (case)
opens which (nsubj)
oab ) (punct)
erythematodes lupus (compound)
rate response (appos)
has this (nsubj)
study order (nmod)
durations months (nmod)
2/51 ( (punct)
effects nanoparticles (nmod)
used contraceptives (dobj)
study conducted (acl)
occurring simultaneously (advmod)
animals pilocarpine-treated (amod)
rats lnna (compound)
enhancement hepatocarcinogenicity (nmod)
intervals regular (amod)
generated superficially (advmod)
times two (nummod)
69 14 (dep)
131 176 (compound)
base ( (punct)
disposition result (nsubj)
opioid-agonists kappa (compound)
clinical economic (conj)
reduction apap (nmod)
reported pyrazinamide (nmod)
neuropathy caused (acl)
2.4 between (case)
sections in (case)
mg/kg/d 80 (nummod)
quinine- and (cc)
naa of (case)
score on (case)
bradycardia % (dep)
antigen mothers (dep)
investigate triggers (ccomp)
beta-blockade without (conj)
range anomalies (nmod)
l6 s1 (conj)
profile , (punct)
lesion post (compound)
cases/person-years 1.48 (nummod)
achieved patients (nmod)
pyridoxine by (case)
alerted should (aux)
methodology the (det)
dexamethasone methylprednisolone (conj)
gauges 15 (conj)
thinning was (cop)
seen failure (nsubjpass)
complication that (det)
causes characterization (nsubj)
determine precisely (advmod)
mg/kg 24 (nummod)
mg/g mg/g (conj)
suggest studies (nsubj)
beats junctional (amod)
gestodene of (case)
helpful exhibit (conj)
drug antihypertensive (amod)
mg sch (compound)
hypometabolism ad (nmod)
assessed assessed (conj)
use and (cc)
doxorubicin subjects (nmod)
complication therapy (nmod)
gd 9 (nummod)
leukaemia in (case)
required evidence (nsubjpass)
infection mortality (conj)
effect disturbances (nmod)
scale outcome (compound)
potentiates treatment (nmod)
nystagmus the (det)
mechanisms pathophysiology (nmod)
absorption rapid (amod)
develop prior (advmod)
causes it (nsubj)
complete however (advmod)
mg/m2 by (case)
meningioma four (nummod)
underwent weeks (nmod)
injected sulfate (nsubjpass)
enhanced bradycardia (nmod)
jitter and (cc)
pallidotomy radiofrequency (compound)
myelopathy manifestations (conj)
etomidate intermittent (amod)
study using (csubj)
gave middle (nmod)
values i.p. (advmod)
noticed patient (nsubj)
loss % (nmod)
sensitive dose (nsubj)
continuous repeating (conj)
corporation elan (compound)
included treatment (nsubj)
p-aminophenol pap (appos)
pathway dysfunction (nmod)
suppresses proliferation (dobj)
derived been (auxpass)
severe groups (nmod)
toxicity csa (compound)
infusion drugs (conj)
admitted network (nmod)
crataegus tcr (appos)
molecule cck (compound)
0.445 from (case)
x/minute to (case)
agsd ) (punct)
is transplants (nmod)
= 0.009 (dobj)
10 less (amod)
proliferation hematopoietic (amod)
lesion after (case)
serum csf (conj)
preventing damage (dobj)
prerequisite injury (nmod)
dianabol ) (punct)
neurogenesis granule (compound)
reduction tissue (compound)
form following (case)
chemotherapy thiotepa (nmod)
constituted had (conj)
normochromic normocytic (conj)
measures behavior (nmod)
% 34.4 (nummod)
substance the (det)
lead can (aux)
elimination hemodiafiltration (nmod)
showed confirmed (conj)
swiss seventy (compound)
unreasonable restrict (xcomp)
appears involve (xcomp)
reflected impairment (nmod)
dbp sbp/ (compound)
vomiting and (cc)
prove enflurane (nsubj)
shr ( (punct)
similar seemed (conj)
vasodilator . (punct)
effect norepinephrine (nmod)
ovulation clomiphene-induced (amod)
decrease count (compound)
graded moderate (nmod)
disease with (case)
possess activity (dobj)
scale patient-reported (amod)
disorder it (nsubj)
evaluated extent (nsubjpass)
risk solid (amod)
cycles therapy (nmod)
two to (case)
decreased minutes (dobj)
increase contractility (nmod)
carried study (nsubjpass)
pressure mup (compound)
synthetase prostaglandin (compound)
responses brain (compound)
controls nonanemic (amod)
urgency on (case)
contractions flutter (conj)
seems related (xcomp)
follow median (amod)
modulate neurotoxicity (dobj)
hyoscine ) (punct)
exception mice (nmod)
allodynia and (cc)
clonazepam benzodiazepine (compound)
factor predisposing (amod)
death for (case)
success apparent (amod)
2 3 (prep)
evaluated inhibitor (dobj)
followed indicating (xcomp)
utility fk (nmod)
injected subcutaneously (advmod)
physiology scores (dep)
technique may (aux)
met % (dep)
alter changes (nsubj)
epm in (case)
improvements bradykinesia (conj)
distribution in (case)
receptor complement (compound)
impotence with (case)
proteinuria the (det)
changes regions (nmod)
mice fifty-five (amod)
engrafted experienced (conj)
stratum ; (punct)
headache gtn-induced (amod)
amiodarone of (case)
animals , (punct)
prevention effects (nmod)
norms established (amod)
mg/m(2 ( (punct)
ouabain ) (punct)
medium containing (acl)
established course (nsubjpass)
kg-1 10 (nummod)
correct although (mark)
brief generalized (conj)
tiapride benzamide (appos)
monotherapies ( (punct)
result hemolysis (nmod)
intensity p<0.001 (appos)
shown months (nmod)
co-administration nefiracetam (nmod)
nephrosis aminonucleoside (compound)
beats/min was (cop)
apnoea succinylcholine (compound)
transplantations from (case)
prescribed risk (nsubj)
subacute days (appos)
p9201 and (cc)
amitriptyline treatment (nmod)
smoking emissions (nmod)
caused hypertension (dobj)
group all (advmod)
experiments rats (nmod)
prepared . (punct)
citalopram , (punct)
investigated has (aux)
required produce (advcl)
exhibited staining (dobj)
atrophy was (cop)
mg/m2/d was (cop)
p<0.02 ( (punct)
treatment surgery (conj)
characteristics histological (amod)
augmented lamivudine (nmod)
treatment scintigraphy (nmod)
observed neuropathy (nsubjpass)
lilly company (conj)
labeling supervision (conj)
involves interaction (dobj)
rats adn (amod)
administration truncated (acl)
density [ (punct)
estimated % (nmod)
effects subjects (nmod)
= 2.94 (dep)
rats diazepam (nmod)
system nigrostriatal (amod)
diagnosis patient (nmod)
curves tests (nmod)
degeneration morphine (nmod)
induced propranolol (nmod)
hypotension nitroprusside-induced (amod)
urea serum (compound)
resulted % (nsubj)
measured weeks (nmod)
events users (nmod)
given supplementation (nmod)
cisplatin fixed-dose (amod)
conduction pathways (nmod)
correlation to (mark)
reverses nefiracetam (nsubj)
increases bp (nmod)
has incidence (nmod)
transporter insulin-independent (amod)
drugs 5 (nummod)
men receiving (acl:relcl)
low-dose < (dep)
109 from (case)
mitochondria adp-stimulated (amod)
genesis as (case)
5-hiaa ) (punct)
administration chloride (nmod)
hemolysis therapy (nmod)
gain rapid (amod)
preparation in (case)
patient another (det)
maximum to (case)
range speech (compound)
kf17837 , (punct)
potency metoprolol (compound)
beta-agonist the (det)
response oxytocin (nmod)
p and (cc)
ameliorating damage (dobj)
accumulation cent (nmod)
factor modifiable (amod)
protection alterations (nmod)
treatments 2 (nummod)
proanthocyanidin seed (compound)
purpose linked (dep)
period mean (compound)
effects limit (acl:relcl)
determine occurrence (dobj)
changes deprivation (nsubj)
metabolite a (det)
rejection conversion (nmod)
acts lindane (nsubj)
undergoing apoptosis (dobj)
remained sedentary (xcomp)
surgery combined (amod)
6 the (det)
origin in (case)
about are (cop)
level peroxides (nmod)
phenotype myocytes (nmod)
elicited not (neg)
exposed blockers (nmod)
order assess (acl)
results found (appos)
neutralization viremia (nmod)
subjects fifty-five (amod)
treated phenobarbitone (nmod)
self-reported or (cc)
intake total (amod)
ximelagatran , (punct)
association antibiotics (nmod)
contractility , (punct)
270 - (punct)
imaging of (case)
synapse perforant (amod)
alleviate impairments (dobj)
took which (dobj)
appears have (advcl)
weight release (conj)
induced therapy (nmod)
dose valdecoxib (compound)
advantages nausea (conj)
diminished volume (nsubjpass)
delayed pilocarpine (nsubj)
concentration prl (nmod)
months 20.6 (nummod)
homeostasis mitochondrial (amod)
stopped occurs (advcl)
electrophoresis samples (nmod)
retardation disorientation (conj)
was as (advmod)
contributor major (amod)
feasible this (nsubj)
gtn gtn (dep)
% 0.01 (appos)
study measures (nmod)
effects nausea (nmod)
given it (nsubjpass)
disappearance block (nmod)
examine brain (nmod)
add to (mark)
15.0 23.7 (dep)
histological biochemical (conj)
surgery lasted (acl:relcl)
methods g. (compound)
examination kidney (nmod)
increments bun (nmod)
renal vascular (conj)
time mean (amod)
levels harmful (amod)
attenuated improve (conj)
biochemical abnormalities (dep)
treated thp (nmod)
mean if (dobj)
rat the (det)
measured balances (nsubjpass)
indicates although (mark)
samples for (case)
linked benefit (nsubjpass)
thrombocytopenia to (case)
had status (dobj)
increases formation (dobj)
developing groups (nmod)
period initial (amod)
amb. of (case)
% 38+/-4 (nummod)
short-term serious (amod)
result therapeutic (amod)
complications perioperative (amod)
impairment onset (nmod)
bupivacaine racemic (amod)
given groups (nmod)
agonist n6-cyclopentyladenosine (conj)
demonstrate using (advcl)
reported aes (nmod)
courses phlebitis (conj)
observed it (nsubjpass)
april involving (acl)
reduce whether (mark)
rs4704559 rs4704560 (conj)
g/kg/day subcutaneously (advmod)
status disease (compound)
chloroform-adrenaline and (cc)
loss resistance (nmod)
identification early (amod)
pretreated l-name (nmod)
received : (punct)
frequency breast-cancer (compound)
rofecoxib users (nmod)
state confused (amod)
analyzing , (punct)
pain of (case)
after hr (nmod:npmod)
control seizures (dobj)
manifests causing (advcl)
humphrey perimetry (compound)
perform . (punct)
observation last (amod)
increased irritability (dobj)
phosphate bnpp (appos)
modifiable and (cc)
defects abnormalities (conj)
effect decrease (nmod)
changes scl (nmod)
value , (punct)
regimen disease (nmod)
confirmed angiography (nsubj)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ + (cc)
sedation than (case)
protecting in (mark)
administered administered (advcl)
drug levels (conj)
infections during (case)
16 and (cc)
hepatitis quinidine (compound)
higher infusion (nmod)
objective present (acl)
hemorrhages major (amod)
consider most (advmod)
disorder needed (conj)
sensation taste (compound)
doxorubicin of (case)
centre tetrapeptide (nsubj)
moving in (mark)
man 19-year-old (amod)
treatment variety (nmod)
consequence cardiomyopathy (amod)
widespread more (advmod)
malignancy chemosensitive (amod)
associated frequently (advmod)
suppression levels (nmod)
levels mhpg (compound)
3delta - (punct)
confirmed , (punct)
measures for (case)
receiving chemotherapy (dobj)
ml blood (nmod)
2190 700 (conj)
area residence (nmod)
removed uteri (nsubjpass)
activation peripheral (amod)
total diagnosed (acl)
transection prior (amod)
4.40 x (cc)
differ may (aux)
deficiency dihydrouracil (compound)
weeks therapy (dep)
agents have (aux)
exacerbated interaction (nsubj)
adenocarcinoma 26 (nummod)
changes value (nmod)
site pain (nmod)
sprouting fiber (compound)
abortion during (case)
25 to (dep)
summary developed (dep)
atropine as (cc)
injected studied (conj)
dox polymer-bound (amod)
designated . (punct)
gvg ( (punct)
increase pressure (conj)
analyzed . (punct)
pc02 70 (nummod)
physiology and (cc)
made proceed (xcomp)
complexes . (punct)
biochemical effects (conj)
ventricles cerebral (amod)
pg/ml and (cc)
treatment infection (nmod)
independent shown (parataxis)
mg/m2 patients (conj)
increase fasciculations (nmod)
prevent toxicity (nmod)
ceased only (advmod)
orientation sagittal (amod)
injury cell (compound)
received and (cc)
enhance that (nsubj)
electroretinograms p-ergs (appos)
dietary supplemental (conj)
memory short-term (amod)
received that (nsubj)
myalgia of (case)
systems organ (compound)
0.6 0.06 (conj)
systems fibrinolysin (compound)
causing hemorrhage (dobj)
, % (dep)
had levels (dobj)
treatment apomorphine (nmod)
mm variable (nmod)
able drugs (nsubj)
remained higher (conj)
decreased use (nsubj)
injection stereotactic (amod)
sampled cases (nsubjpass)
exert reduce (conj)
minimum to (case)
analyzed periods (nsubjpass)
precipitating rejection (dobj)
minimised . (punct)
rectified this (nsubjpass)
indeterminate trial (nmod)
clonazepam than (case)
disintegrin , (punct)
prophylaxis standard (amod)
trans-3,4-dichloro-n-methyl-n[2-(1-pyrrolidinyl ( (punct)
valdecoxib , (punct)
regimen only (advmod)
ranged suggesting (advcl)
shown tac (nsubjpass)
decrease concentrations (nsubj)
comorbidity common (amod)
affect pimozide (nsubj)
10.2 ) (punct)
injection dose (nmod)
delays forgetting (dobj)
changes especially (advmod)
occurrence aki (nmod)
reduce injury (dobj)
benzylacyclouridine of (case)
titrated warranted (conj)
homozygous heterozygous (conj)
obtained seizures (nmod)
hours treatment (dep)
predominance motor (compound)
reduced flestolol (nsubj)
exhibit reactions (nsubj)
induced torsades (dobj)
suggest investigate (advcl)
detection aorta (nmod)
access intravenous (amod)
activities angiotensin-converting (amod)
indians % (amod)
extracts for (case)
dex treatment (nmod)
2-fold expression (dep)
practitioners medical (amod)
administration globulin (nmod)
channels nodes (nmod)
block degree (amod)
genes downstream (amod)
bortezomib thalidomide (conj)
stimulation repetitive (amod)
hypothesis linked (ccomp)
using steroids (dobj)
urinalysis by (case)
3tc zidovudine (conj)
manipulated one (nmod)
mg.kg(-1).d(-1 1 (nummod)
alternation latency (conj)
analyses affected (ccomp)
administered mean (nmod)
range 92 (nummod)
impart to (mark)
degrees was (cop)
rats beta (compound)
desorption/ionization matrix-assisted (amod)
effects infusions (nmod)
efforts of (case)
addition is (cop)
steeply days (nmod)
mg/dl 131 (nummod)
sis3 ) (punct)
onset anuria (nmod)
results combination (conj)
anuria in (case)
l/min p (appos)
prevented lethality (dobj)
compared health (nsubjpass)
min 5.3 (nummod)
interval this (det)
multiple , (punct)
deficiency to (case)
developed fed (conj)
displayed can (dobj)
encephalopathy , (punct)
undertaken evaluate (xcomp)
similar approximately (advmod)
gentamicin , (punct)
primary , (punct)
territory of (case)
acknowledged effects (nsubjpass)
set experiment (nmod)
features unique (amod)
measured day (nmod:tmod)
odds times (nmod)
phenotypes mice (nmod)
betaine mg/kg (appos)
aes to (case)
rats organogenesis (nmod)
exhibited rates (dobj)
summarizes report (nsubj)
atra with (case)
center anemia (nmod)
efficiency food (nmod)
neurotoxicity report (dep)
formation sludge (nmod)
paradigm retention (compound)
study case (nsubj)
detected may (aux)
normal more (advmod)
vehicles microl (conj)
examination biopsy (nmod)
hippocampal of (case)
developed hypomania (dobj)
basis intention-to-treat (amod)
february 1998 (nmod:tmod)
stress particles (nmod)
profile this (det)
improves myocet (nsubj)
induced visualized (conj)
increasing ; (punct)
infiltration cns (compound)
susceptible and (cc)
circle the (det)
interval 2.1 (nummod)
scoring > (dobj)
debate . (punct)
decrease cortex (nmod)
densa and (cc)
re-elevate minutes (nmod)
lacnp ( (punct)
chemotherapy preplanned (amod)
lady 34-year-old (amod)
hepatitis severe (amod)
normalization by (case)
p= 0.17 (nummod)
lvef % (nmod)
variable , (punct)
prolongation pointes (conj)
relationships cardiomyopathy (advmod)
found therapy (nmod)
occurred hepatitis (nsubj)
displayed immunohistochemistry (nsubj)
help diagnosis (nmod)
methotrexate only (advmod)
dose day (nmod)
escalated was (auxpass)
microglobulinuria with (case)
results grade (appos)
became which (nmod)
junctions of (case)
devoid effect (nmod)
seen women (nmod)
therapy tricyclic (amod)
levels peptide (nmod)
patients tachyarrhythmias (nmod)
ceased . (punct)
similar t (dep)
one least (nmod:npmod)
d 1 (nummod)
disease complications (conj)
selected patients (dobj)
transplant pbsct (appos)
carcinoma high (amod)
% a (nmod)
reduced extract (nsubj)
ml/kg 4 (nummod)
therapy n-butyl-deoxynojirimycin (nmod)
induce nsaids (nsubj)
distinguished be (auxpass)
lymphocytes the (det)
given p.r.n (nmod)
effect ability (nmod)
interactions pharmacological (amod)
occurs injury (nsubj)
behaviour behaviour (conj)
effect suppressive (amod)
stones some (det)
seen cancer (nmod)
interactions potential (amod)
correlation concentration (nmod)
scan including (case)
111 in (case)
frequency treatment (nmod)
users mdma (nmod)
cords the (det)
5057 - (punct)
accelerated years (dep)
mutations lam (compound)
metoclopramide after (case)
report age (nmod)
considered appear (ccomp)
biopsy pericardial (amod)
involvement vessels (nmod)
have do (advcl)
5 about (advmod)
aggression dyscontrol (conj)
measure primary (amod)
frontostriatal and (cc)
suggest less (ccomp)
treatment chemotherapy (compound)
risks postoperative (amod)
evident treatment (nmod)
immobility test (nmod)
infiltrate consisted (acl:relcl)
largest to (mark)
oxcarbazepine contrast (dep)
concluded therapy (ccomp)
gain weight (compound)
satisfying criteria (dobj)
found rats (nmod)
alpha2abc-/- ( (punct)
diversion bile (compound)
observed recipients (nmod)
smaller ) (punct)
mglurs ii (nummod)
died man (dep)
evaluated which (nsubjpass)
associated proteinuria (nmod)
appt ] (punct)
delirium early (amod)
value ferric (amod)
males in (case)
tests normal (amod)
higher was (cop)
capacity fibres (nmod)
impairment from (case)
combination history (nmod)
exposure causing (acl)
angiographies studies (nsubj)
regulate . (punct)
conclude induces (ccomp)
occur may (aux)
events cardiotoxicity (nmod)
incidence mellitus (nmod)
exhibited months (nmod)
offer patients (nmod)
middle frequencies (conj)
model conscious (amod)
face of (case)
% older (conj)
ci=25.2 - (punct)
associated supplementation (nmod)
therapy postmenopausal (amod)
pinch tail (compound)
results present (amod)
dynamics concentration (dep)
hyperactivity amphetamine (compound)
discontinuation either (cc:preconj)
calculus staghorn (amod)
infusion 3-hour (compound)
disoproxil tenofovir (compound)
16,459 comparison (nmod)
stress oxidant (amod)
collected was (auxpass)
deprivation after (case)
control p<0.0005 (compound)
ischemia rats (nmod)
recorded number (nsubjpass)
extremities her (nmod:poss)
study into (case)
rate sedation (nmod)
demonstrated ) (punct)
emerged . (punct)
vnr between (case)
signs toxocity (nmod)
technique this (det)
regurgitation with (case)
involved also (advmod)
asymptomatic be (cop)
cases complication (nmod)
majority 4/5 (appos)
deciliter or (cc)
accl0131 on (case)
dimension that (mark)
cardiotoxicity peroxidation (conj)
component interview (nmod)
propranolol reduction (conj)
lp ) (punct)
activations enhanced (amod)
injections intradermal (amod)
infusion immediately (advmod)
monocytes/macrophages for (case)
lobe in (case)
catheter with (case)
2.3 0.05 (conj)
regions some (det)
drg cystitis (nmod)
effects pointes (nmod)
inhibitor l-arginine (conj)
propranolol micrograms (appos)
recurrences for (case)
oxidation by (case)
administering chemotherapy (dobj)
pd and (cc)
associated abuse (nmod)
predict monitoring (nsubj)
act needed (conj)
pharmacoeconomics of (case)
markers biochemical (amod)
have flutter (dobj)
resulting diseases (nmod)
sulfonamides and (cc)
received cc (dobj)
evaluated hypotension (nsubjpass)
mirror other (dobj)
serve poor (dobj)
had if (mark)
groups critical (amod)
antigen psa (appos)
macroglobulinaemia of (case)
treatment benefit (nmod)
irreversible obtained (conj)
0.03 , (punct)
superior patients (nmod)
following . (punct)
hyperalgesia patients (nmod)
symptoms patients (nmod)
liver toxicity (conj)
follow-up ophthalmological (amod)
i.v. 30 (conj)
reviewed literature (dobj)
hbv overt (amod)
showed cases (nsubj)
favourable less (advmod)
calculated which (nsubjpass)
fluorobenzylidene 3 (nummod)
efficacy combination (nmod)
dbh ) (punct)
corresponds rate (nmod)
revealed ct (nsubj)
information potential (nmod)
failed chlordiazepoxide (nsubj)
substantial it (nsubj)
assay cytotoxicity (compound)
had death (nmod)
administered total (nmod)
proved amiodarone (nsubj)
influence be (cop)
enhance pretreatment (nsubj)
myoclonic of (case)
effects amide (nmod)
exist effects (nsubj)
association genetic (amod)
had reaction (dobj)
received prevented (conj)
antagonist b2 (compound)
hyperactivity d-amphetamine-induced (amod)
p greater (amod)
patients consumption (nmod)
horn the (det)
levels distal (amod)
treatment losartan (nmod)
experiences drug-related (amod)
prospective non-interventional (dep)
subjects % (dep)
microg/kg of (case)
pretreatment as (cc)
medications masked (acl:relcl)
show however (advmod)
moderate-dose ( (punct)
need a (det)
80.8 to (case)
site abdominal (amod)
vessels both (cc:preconj)
complications thrombotic (amod)
successful . (punct)
appeared subsequently (advmod)
variants enzyme (nmod)
group group (appos)
tobramycin gentamicin (conj)
rat a (det)
micrograms 1000 (nummod)
densa lamina (compound)
ratios hospitalization (nmod)
injection for (case)
drop . (punct)
osteopenia or (cc)
suffered taking (advcl)
reversibility the (det)
levels precedes (acl:relcl)
explore role (dobj)
had 10 (nsubj)
involvement catalepsy (nmod)
induced types (dobj)
method consisted (appos)
scatter forward (amod)
escape combined (amod)
tolerance pain (nmod)
tablet ribavirin (nmod)
effect acute (amod)
107.4 from (case)
days iw (compound)
disease ad (appos)
hyperactive , (punct)
used sealants (nsubjpass)
analyzed determined (conj)
infiltration cascade (nmod)
lacked proved (advcl)
arthralgia neuropathy (amod)
uptake dopamine (nmod)
lithium itself (appos)
aroused be (auxpass)
show delta (ccomp)
phase erection (appos)
apap any (conj)
mounting is (aux)
scavenging properties (conj)
eps with (case)
surgery % (appos)
increase randomized (nsubj)
areas surrounding (amod)
reduced 0.025 (dep)
decreased cortex (nmod)
targeted was (auxpass)
decreased thus (advmod)
circulation hypophysial-portal (amod)
risk cardiac (amod)
cardiotoxicity and (cc)
tumor kidney (nmod)
underwent manometry (dobj)
sem ( (punct)
dipropionate with (case)
gtcs ) (punct)
injected it (dep)
capacity cardiac (amod)
interval an (det)
sham and (cc)
reports mania (nmod)
resulting increase (nmod)
monophosphate 3',5'-cyclic (amod)
dosage decreased (amod)
unlikely acid (nsubj)
nox plasma (compound)
bpo 5 (nmod)
use corrected (advcl)
144 14/87 (conj)
magnesium of (case)
estimated decrease (dobj)
electroshock picrotoxin (conj)
treatment prophylaxis (nmod)
fibrosis hypocellular (amod)
found polytherapy (nmod)
septal and (cc)
adducts trifluoroacetyl (compound)
therapy cisplatin (compound)
history hyperthyroidism (nmod)
decreased glimepiride (nmod)
weeks 32 (nummod)
mechanism with (case)
score gleason (compound)
resembles glaucoma (dobj)
gave analysis (nsubj)
indices hormonal (amod)
five number (nsubj)
decreased micturition (nsubj)
cns fewer (amod)
measured fmri (nmod)
derives atrophy (nmod)
factors case (nmod)
decreases increases (conj)
antineoplastic background (nsubj)
50 greater (advmod)
electrocardiography resting (amod)
ventricles left (amod)
causes degrees (nmod)
difference < (compound)
involvement an (det)
experiments five (nummod)
astrocytomas iv (nummod)
finished considered (conj)
= 3.6 (dobj)
background study (nmod)
treatment permeability (nmod)
corrected which (nsubjpass)
shown presentation (nmod)
further confirmatory (dep)
phase synthesis (nmod)
line single (amod)
predisposes leukopenia (compound)
antigen to (case)
single with (case)
mask bradycardia (dobj)
rat of (case)
containing rats (nmod)
development toxicity (nmod)
development mania (nmod)
observed block (nsubjpass)
mild least (advmod)
phlorizin p (appos)
animals bnpp (nmod)
practitioners by (case)
remained decrease (nsubj)
impairment no (det)
grow to (mark)
ngal ( (punct)
exposure relaxation (conj)
failure dilated (amod)
tetracycline by (case)
tolerability that (nmod)
predict severity (dobj)
abnormal . (punct)
improvement small (amod)
hemorrhage w-ich (appos)
decreased fs (nsubjpass)
extension and (cc)
rodents of (case)
showed improvements (dobj)
skills and (cc)
disappearance and (cc)
contribute this (nmod)
cultures myocardial (amod)
y-maze and (cc)
ascribing complaint (dobj)
examination histopathological (amod)
failure irreversible (amod)
reacts directly (advmod)
found propranolol (nsubj)
syndrome lysis (compound)
bmd volumetric (compound)
patients apnea (nmod)
courses one (nummod)
effects neuroprotective (amod)
administered should (aux)
spv hypotension (nmod)
one medications (nmod)
anuria lethal (amod)
sealants containing (acl)
immunoblotting western (amod)
tended have (xcomp)
provided use (nsubj)
drug propranolol (nsubj)
risks with (case)
used he (nsubj)
powered detect (xcomp)
potentiated that (mark)
disposition tissue (conj)
instillation cent (nmod)
points seizure (compound)
elevated reached (conj)
years /-8 (det)
present are (cop)
chorea of (case)
facilitated and (cc)
hr as (case)
consumption alcohol (compound)
infusion nitroprusside (compound)
rats clonidine (dep)
contraceptives cocs (appos)
worsen . (punct)
dispersion transmural (amod)
levels biochemical (amod)
occurs hypotension (nsubj)
eliminating dph (dobj)
induced-behaviour brain (compound)
subtypes alpha2-adrenoceptor (amod)
described newly (advmod)
showed normal (parataxis)
hospitalized days (nmod)
subcortex in (case)
cancer third (amod)
induced authors (nsubj)
p=0.003 , (punct)
practice psychiatric (amod)
factors admitted (acl)
activated migraine (nmod)
distant pipette (nmod)
titrating dose (dobj)
treatment prazosin (compound)
transport cells (nmod)
disabled observed (conj)
required instances (nmod)
required modification (nsubjpass)
gains smaller (amod)
concentration each (det)
resulted whether (mark)
dimension lad (appos)
pharmacokinetics contain (acl:relcl)
preservation flow (nmod)
algorithm naranjo (nmod:poss)
days=1.77 ptrend=0.50 (dep)
change consistent (amod)
supervision and (cc)
given compared (prep)
speech nystagmus (conj)
occurred total (nsubj)
decade last (amod)
paracetamol nimesulide (conj)
study time-course (amod)
informative . (punct)
suggest exerts (ccomp)
testosterone t (dep)
arrest maturation (compound)
stimulation breast (compound)
measured areal (conj)
noted fingers (nmod)
identified prevent (advcl)
period peripartal (amod)
damage glomerular (amod)
followed re-exposure (advcl)
emphasis primary (amod)
supply on (case)
monkeys parkinsonian (amod)
woman taking (acl)
meritorious effects (nsubj)
antidepressant related (dep)
maintain efficacy (dobj)
well-demarcated localized (dep)
data real-world (amod)
observed recording (nmod)
exceeded changes (nsubj)
etiology and (cc)
isolated carvedilol (conj)
rise actin (conj)
mice controls (nmod)
comprising af (dobj)
ct hcva (conj)
granulocytosis of (case)
spread the (det)
catheter balloon (compound)
segments anterior (amod)
cortex matter (conj)
reported occurred (ccomp)
initiated increased (conj)
enhanced rigidity (dobj)
days after (case)
administered we (nsubj)
7.8 ) (punct)
syndrome postalcoholic (amod)
retinochoroidopathy in (case)
d3 iu (compound)
effect hyperprolactinemia (nmod)
supervision patients (nsubj)
occurrence girl (nmod)
applications the (det)
randomised women (nsubjpass)
severity lesions (nmod)
infections . (punct)
unhappiness marital (amod)
course sulphasalazine (nmod)
factor-beta1 tumor (compound)
finding purpura (nsubj)
ethyl-alpha-p-chlorophenoxyisobutyrate to (case)
free only (advmod)
states pressure (compound)
associated levofloxacin (nmod)
atherosclerosis such (case)
evaluation response (nmod)
infusion anticoagulation (conj)
levels hbsag (compound)
% 67 (nummod)
prazosin while (mark)
ip 0.1 (nummod)
developed leukemia (nmod)
reduce loss (dobj)
120.04 vs. (cc)
results enrolled (appos)
responses exhibited (acl)
relationship occurrence (nmod)
than effects (nsubj)
2 in (case)
benzylpenicilloyl-poly-l-lysine bpo-pll (appos)
thromboembolism and (cc)
mg/kg s.c. (punct)
21/63 compared (case)
measure . (punct)
studied total (nsubjpass)
features : (punct)
infection hiv (compound)
cromakalim- the (dep)
lr132 1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine (appos)
dgc ) (punct)
believe onset (nmod)
stable response (nsubj)
type debrisoquine/sparteine (compound)
mg , (punct)
two them (nmod)
register group (compound)
% 92 (nummod)
beta-blocker timolol (appos)
dexatrim cause (nmod)
proteinuria immunity (conj)
exist tolerability (nmod)
reactions those (det)
lovastatin with (case)
outcome symptoms (nmod)
given pentylenetetrazole (conj)
effects measures (nmod)
cya to (case)
morphine tyr-d-ala-gly-nme-phe-gly-ol (appos)
dose kilogram (nmod)
weeks initiating (advcl)
weeks five (nummod)
components respiratory (amod)
inpatients of (case)
test working (compound)
recognize toxicity (dobj)
cause combined (advcl)
neuroprotective is (cop)
drugs carbimazole (nmod)
interviewed questioned (conj)
incidence effects (nmod)
normal twice (advmod)
treated carbonate (nmod)
107 6 (conj)
prevented better (advmod)
safe course (nsubj)
pirenzepine and (cc)
administration etomidate (compound)
parameters experimental (amod)
d acid (appos)
patients conversion (compound)
potent nra0160 (nsubj)
retention during (case)
biopsies h. (compound)
vigabatrin alone (advmod)
abnormalities adc (compound)
rats changes (nsubj)
progressing changes (dobj)
2.5 ratio (nsubj)
use didanosine (nmod)
tests higher (acl:relcl)
longer no (neg)
factor criteria (nsubj)
thromboses ) (punct)
src for (case)
associated developing (advcl)
reduced requirements (nsubjpass)
exposures drug (compound)
patients emergency (compound)
antidopaminergic both (cc:preconj)
function human (amod)
ls lidocaine (appos)
hag ( (punct)
essential synthesis (nmod)
atrophy cerebellar (amod)
effects cortex (nmod)
emboli of (case)
alpha,3 5 (compound)
hypotension comparable (amod)
patients nsclc (nmod)
followed mg/kg (nmod)
display 21 (nummod)
inhalation routes (conj)
dehydrogenase aldehyde (compound)
5-hydroxytryptamine 5-ht (appos)
share that (mark)
data addition (compound)
ntg 3 (dep)
concentration ) (punct)
induced mechanism (nmod)
tea e (conj)
competing barrier (nmod)
stopping expectation (nmod)
reflect level (dobj)
rechallenge ) (punct)
demonstrated agent (xcomp)
used hydrochlorofluorocarbons (nsubjpass)
able requested (advcl)
loss bilateral (amod)
ratio administration (nmod)
describe characteristics (dobj)
syndrome to (case)
taking mg (dobj)
haemodilution alone (advmod)
cardiomyocytes , (punct)
facilitated rats (nmod)
androgens corticosteroids (conj)
decrease or (cc)
cardiotoxicity mice (nmod)
macaques ( (punct)
min 39 (nummod)
dexamethasone or (cc)
cause arrhythmias (dobj)
use medical (amod)
kit has (acl:relcl)
decrease percent (nmod)
signs sensory (amod)
devoid were (cop)
groups hem (compound)
received took (conj)
steroids contraceptive (amod)
state renal (amod)
release subsequent (amod)
mentioned frequently (advmod)
disruption model (nmod)
case misjudgment (nmod)
treatment antipsychotics (nmod)
documented p (nmod)
quantities in (case)
pathways with (case)
threshold agranulocytosis (conj)
therapy methylphenidate (compound)
pathology renal (amod)
deposits granular (amod)
hr ) (punct)
results resolved (appos)
copenhagen , (punct)
gemcitabine older (conj)
ballooning by (case)
seen monoarticular (nmod)
dysfunction prednisolone (nmod)
revealed evidence (dobj)
on was (cop)
treatment to (mark)
interaction clonidine (nmod)
documented morphine (nmod)
dependent that (mark)
consequence therapy (nmod)
behavioral electrophysiological (conj)
ag ( (punct)
90 27 (compound)
mediated immune (dep)
period dark (amod)
connections in (case)
employed histochemistry (nsubjpass)
restlessness , (punct)
shift potassium (nmod)
tubules by (case)
mri pediatric (amod)
mechanisms causes (acl:relcl)
rats group (nmod)
function seen (acl)
extension hemolysis (nmod)
gene proenkephalin (compound)
mimic man (nmod)
7 173 (conj)
analogues and (cc)
use products (nmod)
conclude common (ccomp)
anemia for (case)
bnpp with (case)
noted numbness (dobj)
doses months (dep)
= ng (nsubj)
development on (case)
constipation loss (conj)
effects disease (nmod)
acid microl (appos)
potencies antagonists (nmod)
diminished which (nmod)
channels na(v)1.6 (compound)
i 150 (nummod)
subject same (amod)
scales , (punct)
acid mpa (appos)
results efficacious (dep)
sonograms abdominal (amod)
desmethylimipramine mug (appos)
increased pregnancy (nmod)
information clinical (amod)
memory reliable (amod)
mutants bcp (compound)
investigations previous (amod)
injection weekly (amod)
normalizes . (punct)
transport neither (cc:preconj)
received took (advcl)
injury an (det)
negative patients (nmod)
developed infiltration (nmod)
buche ) (punct)
imaging emission (compound)
epicardium midmyocardium (conj)
phenylpropanolamine sympathomimetic (appos)
used explore (xcomp)
11.5 0.3 (conj)
affect ed50 (dobj)
developed wk (dobj)
injected markers (conj)
period daytime (compound)
is protection (nsubj)
corrected be (auxpass)
lithium pilocarpine (conj)
sensitive whether (mark)
from december (nmod)
conclusions have (appos)
disfiguring disabling (conj)
k glu (appos)
identified seizures (nsubjpass)
mothers hepatitis (compound)
5 ( (punct)
inventory measures (conj)
designed establish (xcomp)
provide , (punct)
indications a (det)
induce pain (dobj)
trial double-blind (amod)
took who (nsubj)
moderate < (dep)
recovers and (cc)
evaluated billingham (nmod)
dose test (compound)
rupture of (case)
revealed cases (dobj)
-9.9 +/- (cc)
found after (mark)
ranged change (nmod)
got serum (compound)
function parathyroid (amod)
treated study (nmod)
dx given (case)
predictor akt (nsubj)
extravasation serum-protein (amod)
bre-26 trial (appos)
recurred rechallenge (nmod)
placebo pi (appos)
n nitrendipine-treated (conj)
hemorrhagic highly (advmod)
effects cck-8 (nmod)
in increasingly (advmod)
treated tp (nmod)
patients allocated (acl)
potentiated hyperactivity (dobj)
lorazepam by (case)
modified activity (nsubjpass)
mechanism(s ) (punct)
immunohistochemistry factor (compound)
pressure pulse (compound)
patients ] (punct)
tm ( (punct)
target tools (nsubj)
10 nmol/0.5 (conj)
mg/kg ketamine (compound)
reduced fraction (dobj)
outflow centre (nmod)
include : (punct)
ligands receptor (nmod)
therapies despite (case)
cyclophosphamide are (cop)
manifestation observed (acl)
growth as (cc)
immunosuppression recipients (nmod)
dose lowering (acl)
contracting muscle (dobj)
pain with (case)
necessary trial (nsubj)
report measure (xcomp)
actions cocaine (nmod)
children hundred (nummod)
complication of (case)
was thickness (nmod)
reaction generalised (amod)
outcome excellent (amod)
patient secondary (amod)
component stress (compound)
ml in (case)
decrease values (nmod)
pain fatigue (conj)
material contrast (compound)
electroencephalography index (nmod)
poison house (nmod)
thickness optic (amod)
able restore (xcomp)
matter in (case)
recipients to (case)
visits laboratory (compound)
tested associations (dobj)
level receptor (compound)
had values (dep)
model one-compartment (amod)
cyanosis of (case)
demonstrated profiles (dobj)
treatment first (amod)
compared demographic (nmod)
bronchopneumonia of (case)
patients % (appos)
reduces number (dobj)
ceftriaxone oral (amod)
300 10 (compound)
shortening progressive (amod)
reverse blockers (nsubj)
fr endothelin (compound)
patients toxicology (nmod)
suspicion abuse (nmod)
mesencephalon the (det)
utilized have (aux)
risks vte (nmod)
rate cerebral (amod)
function quality (conj)
reported similar (ccomp)
safe are (cop)
distracted away (advmod)
period crossover (compound)
pce mechanisms (conj)
headache patients (nmod)
bortezomib plus (cc)
proportion group (nmod)
continued administration (nsubjpass)
pain more (amod)
effects zidovudine-related (amod)
urine hypotonic (amod)
induce levels (nsubj)
complications disease (nmod)
0.057 +/- (cc)
neuropathy thalidomide (amod)
cause delirium (nmod)
antidepressant nassa (appos)
visual and (cc)
sedation propofol (compound)
improved evaluation (nmod)
pulses ( (punct)
produced calcification (dobj)
isolated divided (conj)
explore : (punct)
chemosensitivity of (case)
have cancer (dobj)
cognitive . (punct)
pneumonitis withdrawal (appos)
pgi2 urinary (amod)
intolerant drugs (nmod)
nephropathy due (case)
allopregnanolone pregnanolone (conj)
map in (case)
pores of (case)
lymphadenopathy and (cc)
deoxycorticosterone both (cc:preconj)
restoration this (det)
changes macrophages (nmod)
cerebrum the (det)
ratio plasma (compound)
screening medications (nmod)
unknown cause (nsubj)
scopolamine-induced microinjection (nsubj)
amide naa (appos)
factors its (nmod:poss)
years 53.9 (nummod)
function neurons (nmod)
syndrome haemolytic-uraemic (amod)
returned higher (advcl)
migraine in (case)
9.4 1.9 (compound)
injury cardiomyocyte (compound)
lipoproteins plasma (compound)
cardiotoxicity mmc-related (amod)
inhibitors ts (nmod)
higher than (prep)
2.5 was (cop)
metabolised are (auxpass)
levels preoperative (amod)
ntg and (cc)
lymphopenia mainly (advmod)
g 2 (nummod)
indicates passes (ccomp)
received others (nsubj)
factors properties (nmod)
signaling poisoning (nmod)
associated apparent (amod)
52 37 (compound)
true equally (advmod)
woman 50-year-old (amod)
scores updrs (compound)
bupropion and (cc)
hypotension reversed (amod)
studies populations (nmod)
zidovudine indinavir (conj)
0.83 0.19 (nummod)
prescription a (det)
attenuate steroids (nsubj)
obstetric for (case)
infusion ph (nmod)
expression cells (nmod)
greater 3 (dep)
hypertension glomerular (amod)
excretion great (amod)
monitored necessary (ccomp)
increase awareness (dobj)
explained results (nsubjpass)
angiography nuclear (amod)
pattern nag (compound)
effect clonidine (nmod)
index doxorubicin (nmod)
damage lesions (nmod)
renografin with (case)
application important (amod)
mmp-2 mmp-9 (conj)
analyzed any (det)
required anxiety (nmod)
decrease fraction (nmod)
prove remedy (xcomp)
negativity , (punct)
predisposes an (det)
enhanced antagonized (conj)
involved pathophysiology (nmod)
showed ntg (nsubj)
estradiol progesterone (conj)
sg ( (punct)
5 40 (conj)
drug anti (amod)
values compared (case)
conclusions indicated (dep)
infusion or (cc)
important most (advmod)
antagonism was (cop)
hypophosphatemia and (cc)
fraction increment (dep)
went return (advcl)
found responses (nsubjpass)
mycophenolate immunosuppression (nmod)
multivitamin mg)-containing (amod)
pharmacotherapy during (case)
micromol/l 3 (nummod)
test , (punct)
restlessness and (cc)
chemotherapy salvage (amod)
likely lead (xcomp)
hours exposure (dep)
sex female (amod)
performed performed (conj)
failed demonstrate (xcomp)
necrosis extensive (amod)
disruption treatment (nmod)
tests acid (compound)
carcinoma carcinoma (conj)
viral , (punct)
conducted series (nsubjpass)
children received (acl:relcl)
experience simvastatin (nmod)
bodyweight orally (advmod)
improved addition (nmod)
hydrobromide 6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzaze (nummod)
regurgitation aortic (amod)
dosage toxicities (conj)
controls 650 (nummod)
based reading (nmod)
anxiety confusion (conj)
implicating erythromycin (dobj)
study chronological (amod)
associated headache (nsubjpass)
lobule liver (compound)
perfusion-fixed , (punct)
rebounded discontinuation (nmod)
neither was (cop)
8-se - (punct)
clomipramine tricyclic (amod)
time score (conj)
rammer ) (punct)
considered scale (nmod)
administered tetrabenazine (nsubjpass)
network a (det)
cells cultures (nmod)
follows as (advmod)
curve % (appos)
agents properties (nmod)
activity cord (nmod)
reported ? (punct)
inhibitor mtor (compound)
significant differences (nmod)
carcinoma well-differentiated (amod)
users remote (amod)
effective associated (conj)
bradycardia sinus (compound)
score on-period (amod)
prolactinomas with (case)
treated assess (advcl)
year % (appos)
hyperthyroidism persistent (amod)
possibilities medications (nmod)
symptomatic animals (nsubjpass)
shown all (nsubj)
increased increase (parataxis)
plays na (nsubj)
warfarin levofloxacin (conj)
respond cells (nsubj)
seconds ( (punct)
world of (case)
factor natriuretic (amod)
animals . (punct)
exercised be (auxpass)
using infusion (dobj)
administration testosterone (compound)
underlying activity (dobj)
shouts loss (conj)
remarkable was (cop)
ticlopidine agent (compound)
extend it (nsubj)
increases significant (amod)
responsiveness pressor (compound)
injections amphetamine (amod)
or=2.5 ( (punct)
patients users (conj)
group iohexol (compound)
resulted inhibition (nmod)
performed berlin (nmod)
cultures to (case)
decreased tmp (nsubj)
klebsiella coli (nmod)
mechanisms pain (compound)
respiration 3 (nummod)
assessed score (nsubjpass)
period time (compound)
induced scopolamine (nmod)
outcomes 4-month (amod)
ophthalmologic detailed (amod)
n= ) (punct)
lesions these (det)
rr 0.9 (nummod)
history tests (conj)
glial and (cc)
developed can (dobj)
weeks seven (nummod)
year 13 (nummod)
returned ; (punct)
reported occurrence (nsubjpass)
feature presentation (nmod)
microg/kg/min nitrolingual (amod)
cases 210 (nummod)
9-tetrahydrocannabinol of (case)
study bupropion (nmod)
paraparesis morphine-induced (amod)
experience series (nmod)
96 1 (conj)
curves dose-effect (amod)
coombs ' (case)
screen drug (compound)
group acetate (dep)
state list (nmod)
explained changes (nsubjpass)
mechanism underlying (acl)
quantified unclear (conj)
value ; (punct)
preponderance a (det)
restore to (mark)
received mmt (dep)
macrolides other (amod)
od l/kg (dep)
ointment tacrolimus (compound)
drug effect (nmod)
concentration na (nmod)
significant effects (nsubj)
transaminase got (appos)
thermography plate (compound)
aqp2 ) (punct)
level : (punct)
lysozymuria micrograms/day (conj)
12-week a (det)
tfl ( (punct)
conclude considered (ccomp)
pancreatitis encephalopathy (conj)
docetaxel thalidomide (conj)
hcv ( (punct)
neurotoxicity post (compound)
marked contribution (nmod)
aware caring (nsubj)
mg/m2 532 (nummod)
yields from (case)
dye the (det)
psychosis induced (acl)
akathisia and (cc)
abusers methamphetamine (compound)
motility metabolites (conj)
presented : (punct)
accelerated patients (nsubj)
apoptosis greater (amod)
suppression dna (nmod)
tgf- in (case)
development before (nmod)
acetaminophen on (case)
recorded ecg (nmod)
increased stage (nmod)
preponderance infections (nmod)
28 every (quantmod)
prevention superior (acl:relcl)
preoperative 1-year (conj)
amiodarone to (case)
cpu ) (punct)
possible escalation (nsubj)
pellet 17beta-estradiol (compound)
magnitude are (cop)
similar groups (nmod)
illness pretransplant (amod)
showed e18.5 (nmod)
have mutations (dobj)
studied development (nsubjpass)
aggression hallucinations (conj)
anencephaly with (case)
those survived (acl:relcl)
vision driving (conj)
18 of (advmod)
recruited 2000 (nmod:tmod)
unit an (det)
phenomenon clinical (amod)
design subjects (conj)
insufficiency : (punct)
augmentation in (case)
diuresis solute (amod)
decrease weight (nmod)
instituted period (nmod)
bradycardia junctional (amod)
taqib and (cc)
mistaken event (nmod)
dox ( (punct)
dextran the (det)
followed have (aux)
alternative an (det)
recruited patients (dobj)
diaphragm of (case)
20 5 (quantmod)
research human (amod)
compared levodopa (nmod)
g 4.1 (nummod)
evaluation better (amod)
evaluation multicenter (conj)
using ace/arb (dobj)
stature in (case)
increased status (nmod)
receiving transplant (dobj)
males treated (acl)
size defect (nmod)
7 in (case)
three ) (punct)
mssbp/msdbp in (case)
appeared doses (nmod)
hydrochloride lidocaine (compound)
achieved is (auxpass)
complicate course (dobj)
report aimed (acl)
is task (attr)
excessive mg/ml (dep)
8 to (quantmod)
action negative (amod)
neurotoxicity paclitaxel (nmod)
presence between (case)
october through (case)
determining testosterone (dobj)
increased abruptly (advmod)
range dose (compound)
thiosulphate b35 (conj)
induced dobutamine (nsubj)
% phosphokinase (nmod)
number part (nmod)
55 +/- (cc)
women of (case)
precipitating reaction (dobj)
periphery the (det)
greater of (case)
system opioid (compound)
hepatitis recorded (advcl)
evaluated contents (nsubjpass)
related anesthesia (nmod)
risks using (acl)
has ability (nmod)
changes include (acl:relcl)
9 16 (conj)
bell-shaped were (cop)
interval % (compound)
76 and (cc)
cause alternative (amod)
sensitive structures (nmod)
mean sem (appos)
mice swiss-webster (amod)
thrombogenicity , (punct)
[35s]tbps ( (punct)
hypotensive weak (amod)
time smaller (amod)
studied received (advcl)
affect that (nsubj)
antigen prostate-specific (amod)
limit oih (nsubj)
small have (conj)
hearts iso-treated (amod)
lamivudine without (case)
kg , (punct)
carboplatin study (nmod)
mm spv (nsubj)
thresholds mice (nmod)
level activity (compound)
beraprost a (det)
salicylates with (case)
evident still (advmod)
20.12 + (cc)
mg/kg 120 (nummod)
induce myopathy (dobj)
increasing ml/min (nmod)
hepatitis exacerbation (conj)
platform a (det)
11.5+/-1.4 mean+/-se (appos)
propranolol for (case)
depletion striatum (nmod)
pneumonia , (punct)
if ) (punct)
effective younger (nmod)
-141cins of (case)
therapy colitis (nmod)
january 2011 (nummod)
76 +/- (cc)
p<0.001 both (cc:preconj)
university sciences (compound)
tg + (cc)
required now (advmod)
cortical medullary (conj)
sensitive markers (dep)
studied postoperatively (advmod)
variable groups (nmod)
malfunctioning pump (nmod)
1/10 ( (punct)
arrest associated (acl)
free h (nmod)
induce changes (dobj)
preparations pharmaceutical (amod)
measurements hb (compound)
moderate and (cc)
promotes carcinogenesis (dobj)
created observed (ccomp)
dp/dtejc with (case)
cord spinal (amod)
use activities (nmod)
test writhing (compound)
oncology pediatric (compound)
fingers right (amod)
feature organization (nsubj)
therapy paralysis (conj)
channels chloride (compound)
use atracurium (nmod)
sex each (det)
initiate may (aux)
infusions cimetidine (nmod)
characterized rats (nsubjpass)
0.03 from (case)
slowness mental (amod)
diagnosed electrocardiogram (nmod)
sufficient cocaine (compound)
another taking (acl:relcl)
woman premenopausal (amod)
syndrome literature (nmod)
prior haloperidol (nmod)
channels na(+ (compound)
fla838 ncm001 (conj)
dosage possible (amod)
evaluation assessment (nmod)
blocks ( (punct)
cholinesterase for (case)
occur suxamethonium (nmod)
examinations ophthalmologic (amod)
impairment word (nmod)
have can (aux)
therapy hyperbaric (amod)
fisher the (det)
associated worsening (nmod)
tasks across (case)
markers injury (nmod)
loops pressure-volume (amod)
anesthetic is (cop)
tap ) (punct)
androgens with (case)
led before (mark)
benefited have (aux)
characterized hepatocellular (nmod)
performances tasks (nmod)
raised characterized (conj)
12 +/- (cc)
control and (cc)
occurrence depressive (nmod)
induce potentiation (dobj)
believe caused (ccomp)
seem literature (nmod)
herniations as (case)
known consisted (advcl)
complex iii (nummod)
manifestation . (punct)
audiograms deficits (nmod)
mmol/l 9.2 (appos)
immunosuppression cyclosporine-based (amod)
suggested previously (advmod)
000 10 (compound)
paclitaxel 5-fluorouracil (conj)
development nephropathy (nmod)
weeks long-term (dep)
-15.96 % (conj)
functionality the (det)
induced ligation (nmod)
combination containing (acl)
also . (punct)
confounds used (advcl)
action extract (nmod)
findings of (case)
accumulated that (nsubj)
cancer fractures (conj)
synthesis atp (compound)
benzylpenicilloyl-poly-l-lysine , (punct)
death patient (compound)
outcomes devastating (amod)
noted groups (nmod)
stratum 1 (nummod)
maze zero (compound)
taking ketoconazole (dobj)
monitored before (advmod)
show sss (dobj)
6 period (nmod)
showed : (punct)
mortality or (cc)
small but (cc)
of +/- (cc)
administered and (cc)
three zone (compound)
had culture (dobj)
anaesthetist the (det)
0.025 ) (punct)
count of (case)
baclofen jerks (dobj)
azathioprine of (case)
cycles with (case)
viability , (punct)
complication surgery (nmod)
pan mg/kg (appos)
demonstrated us (nmod)
seizures life-threatening (acl:relcl)
limited use (nsubjpass)
mineralocorticoid following (case)
defects known (amod)
behavior apomorphine-induced (amod)
dex-ht ( (punct)
courses two (nummod)
anemia symptoms (nmod)
play but (cc)
monitored injections (nmod)
water in (case)
tiapride related (amod)
explored , (punct)
index narrow (amod)
adding mg (dobj)
genotoxicity ifo (nmod:poss)
considerations anaesthetic (amod)
farmer contact (nmod)
er ) (punct)
effect inotropic (amod)
metabolism , (punct)
efficacy likewise (nmod)
weight whole (amod)
combination cbz (nmod)
diagnosis thrombosis (nmod)
diphenylhydantoin of (case)
hypertensive nitroprusside (nmod)
revealed decreased (ccomp)
l-arginine with (case)
ng/ml same (appos)
treated penicillamine (nmod)
subjects or (cc)
pph ( (punct)
appears troponin (nsubj)
hoe 70 (dep)
apomorphine . (punct)
years following (amod)
assessed safety (nsubjpass)
bche ala539thr (amod)
challenge physicians (nmod)
disease modifying (acl)
response found (acl:relcl)
glomerulosclerosis associated (acl)
d-amphetamine by (case)
problem main (amod)
response . (punct)
cases examination (conj)
pco2 = (amod)
slowing only (advmod)
children institutions (nmod)
granulocytes of (case)
vasculitis cerebral (amod)
days 146 (nummod)
years 58.4 (nummod)
hippocampal group-2 (compound)
assessed postoperatively (advmod)
shortened time (dobj)
younger women (conj)
provided protection (nmod)
recall the (det)
orgasm and (cc)
ml/min/kg od (nmod)
induce preserve (conj)
hundred and (cc)
days alternate (amod)
suggests clearly (advmod)
peg ( (punct)
value minus (cc)
therapy toxic (amod)
prove may (aux)
dendrin plekhh2 (conj)
role factor (nmod)
receptor fractalkine (compound)
refractory is (cop)
newborns ' (case)
overdose propafenone (compound)
activity strains (nmod)
decreased time (nmod)
subtype this (det)
came department (nmod)
reduction thromboses (appos)
period group (nmod)
earlier years (nmod:npmod)
paper a (det)
exception and (cc)
characterization syndromes (nmod)
decrease to (case)
research development (nmod)
irrespective dose (nmod)
scored results (nsubjpass)
translate emergence (nsubj)
olanzapine 26.7 (conj)
concentration anaesthetic (amod)
presented day (nmod:tmod)
evaluated period (nmod)
ka ( (punct)
gain p (dep)
stimulations and (cc)
hemoglobin between (case)
prevents i. (dobj)
studies few (amod)
mother fetus (conj)
possibility insult (nmod)
effective rosacea (nmod)
nh3 ) (punct)
suppression (zdv)-induced (amod)
increase cxad (nmod)
continued do (xcomp)
cause hyperkalemia (nmod)
ingestion without (case)
tizanidine and (cc)
fraction dried (amod)
irregularities two (nummod)
sarcoma cancers (conj)
produced studies (nmod)
conducted members (nmod)
progestagen without (case)
negative 46 (conj)
dermatitis lymphadenopathy (conj)
lesions pathological (amod)
anaesthetised rats (nsubjpass)
decreased that (mark)
registered ; (punct)
mice crea (appos)
man history (nmod)
isoflurane to (case)
dystonia was (cop)
saline allopurinol (conj)
cause treatments (nsubj)
showed study (nmod)
placebo interval (appos)
image surface-based (amod)
27 - (punct)
have whether (mark)
pretreatment ] (punct)
patient starting (acl)
advised alternative (nmod)
worsening lesions (nmod)
revealed comparison (nsubj)
one more (conj)
incidence vte (nmod)
= 22 (dep)
important are (cop)
study : (punct)
from january (nmod)
14 or (cc)
channel sodium (compound)
nitroglycerin preferentially (advmod)
diseased areas (dep)
number axons (nmod)
importance clinical (amod)
shown liberate (xcomp)
2-chloroprocaine-ce n (dep)
saline micromol/10 (dep)
toxicities cardiovascular (amod)
predict hips-cms (nsubj)
patients 67 (nummod)
induced ouabain (nsubj)
reversible netilmicin (nmod)
infarction administration (nmod)
administer epinephrine (dobj)
mechanisms pathophysiologic (amod)
studies pharmacological (amod)
dominance sympathetic (amod)
appeared erythema (conj)
proteinases lysosomal (amod)
verapamil neither (det)
promoted ca(2 (dobj)
battery assessment (compound)
mg/kg 259 (nummod)
lacking are (aux)
determine become (parataxis)
change rate (nmod)
limits > (nummod)
mexitil-perlongets ( (punct)
stimulus following (case)
ended continue (conj)
reduced work (nsubjpass)
patients evaluated (acl)
identified patients (nsubjpass)
patients program (nmod)
caused doxorubicin (nmod)
angiotensinogen associated (acl)
cirrhosis with (case)
curve effect (compound)
importance that (mark)
decreased dimension (nsubjpass)
therapy vancomycin (compound)
developed those (nmod)
regimen dosing (amod)
history encephalopathy (nmod)
tdi before (dep)
associated formation (nmod)
failure digitalise (acl)
gyrus right (amod)
negative had (aux)
specific trihexyphenidyl (xcomp)
tests on (case)
woman hypertensive (amod)
remained concentrations (nmod)
are implications (attr)
developed incidence (dep)
selectivity and (cc)
sed ( (punct)
1/10 ) (punct)
tools . (punct)
disorders hematological (amod)
facilitated may (aux)
receiving ticlopidine (dobj)
exposure treatment (conj)
risk nephropathy (nmod)
increase addition (dep)
protein lysozyme (appos)
antibitocis aminoglycoside (compound)
received iopromide (advmod)
exhibited dose (dobj)
presence antibody (nmod)
paralysis persistent (amod)
fluids intravenous (amod)
mg/kg i.p (amod)
administration anxioselective (nmod)
ifosfamide vincristine (conj)
received have (aux)
chemotherapy , (punct)
movements skeletal (amod)
hexamethonium blocker (compound)
involved proliferation (nmod)
series small (amod)
present disorder (nsubj)
mortality patients (nmod)
months 50 (nummod)
reproduced syndrome (nsubjpass)
performed mris (nsubjpass)
poison . (punct)
seem b12 (nsubj)
tolerated symptoms (nmod)
phosphorylation erk1/2 (compound)
group n= (dep)
rates ) (punct)
patients iiib (nmod)
receiving treatment (nmod)
effect analgesic (amod)
intervals all (det)
active highly (advmod)
demonstrate study (nsubj)
occurred scores (nmod)
dosage high (amod)
compound free (amod)
shown incidence (nmod)
some them (nmod)
characterized cystitis (nsubjpass)
concentrations prolactin (nmod)
importance association (nmod)
potentiate seriously (advmod)
schiff positive (amod)
does so (advmod)
mp high-dose (amod)
use frequent (amod)
infants among (case)
lesions such (amod)
allows separation (nmod)
state free (amod)
immersed tail (nsubjpass)
mechanism whose (nmod:poss)
amphetamines from (case)
relapse any (det)
failure u/ml (dep)
kg-1 alfentanil (compound)
experiments in (case)
background reported (appos)
case thyrotoxicosis (nmod)
ocs to (case)
evaluate alterations (dobj)
aspects some (det)
exposure due (case)
disease no (det)
given injection (xcomp)
analysis = (amod)
factors triggering (amod)
lymphoma b-cell (compound)
number wavefronts (nmod)
warranted study (nsubjpass)
had effect (dobj)
feasibility combination (conj)
trimethoprim prescribed (amod)
susceptibility drug (compound)
echocardiography adults (nmod)
gaining is (aux)
mg evening (dep)
diminished , (punct)
available phenylpropanolamine (nsubj)
ameliorated days (dobj)
effects structure (nmod)
needed was (auxpass)
6.25 25 (conj)
routine clinical (dep)
cured resulting (advcl)
incidence type (nmod)
vol% , (punct)
administration s-1 (compound)
ssri ) (punct)
born mothers (nmod)
acceleration conduction (compound)
reported act (xcomp)
scan hours (nmod)
six- days (nmod)
inhibition lactation (nmod)
group moderate-dose (amod)
dyskinesia limbs (nmod)
kidney proteinuria (conj)
suggested . (punct)
surviving days (dobj)
hour 18 (nummod)
extensively most (advmod)
documents group (nmod)
patients scheduled (acl:relcl)
threshold perimetry (conj)
delayed when (advmod)
inhibition channels (nmod)
organs , (punct)
benefits ht (nmod)
two less (amod)
injury patients (nmod)
trial cross-over (amod)
programmed dexamethasone (nsubj)
5 ' (case)
ami mg/kg/day (dep)
radiotherapy with (case)
test substantiates (parataxis)
value long-term (amod)
effect antineoplastic (amod)
preparation by (case)
determined sensitivity (nsubjpass)
caused are (auxpass)
consider cholinergics (nmod)
intermediates reactive (amod)
variation ) (punct)
is data (nsubj)
existence aftereffects (nmod)
component prerenal (amod)
catechol and (cc)
seems model (xcomp)
provide accurate (xcomp)
occurring treatment (nmod)
psp of (case)
correction 5.00 (nmod)
0.95 2.41 (amod)
gravis known (amod)
assessed effects (nsubjpass)
skills motor (compound)
was time (attr)
anticipation inappropriate (amod)
time treatment (nmod)
glomerulus on (case)
implicated tenofovir (nsubjpass)
determinants dogs (nmod)
decrease dramatic (amod)
man underlying (advcl)
nifedipine , (punct)
superior fentanyl (dep)
5 50 (conj)
substance alone (advmod)
patients doxorubicin-treated (amod)
using concentrate (dobj)
resulted neoantigens (nmod)
5-httlpr of (case)
revealed cells (dobj)
stimulation prolonged (amod)
bladders rat (compound)
reduced rats (advcl)
mcg/kg ( (punct)
provide behavior (nsubj)
increased increased (parataxis)
developed weeks (dobj)
monkeys prior (advmod)
induced illustrated (conj)
detection not (neg)
oc the (det)
hypothesis of (case)
periods year (nmod)
inhibition stress (nmod)
catheters venous (amod)
conjunctiva cornea (conj)
positive ) (punct)
type a (det)
day 25 (nummod)
% 63.30 (nummod)
acid acids (conj)
scores edits (compound)
responses different (amod)
occurred grade (conj)
suitable consequently (advmod)
chlorpropanol ( (punct)
membranes the (det)
concentration carbachol (compound)
years 19 (nummod)
drop wrist (compound)
csa were (cop)
carcinoma adenocarcinoma (conj)
induced statin (nmod:npmod)
effect mean (amod)
therapy d4 (compound)
fanft ) (punct)
staining immunohistochemical (amod)
results achieved (dep)
waves admixed (amod)
studied patient (nsubjpass)
clinicians two (nummod)
given patients (nsubjpass)
arrest possible (amod)
documented we (nsubj)
issues without (case)
changed remained (conj)
inhibitors cases (appos)
behavioral cardiorespiratory (conj)
used css (nsubjpass)
myocarditis induced (amod)
turnover dopamine (amod)
participation pathway (nmod)
controls 18.7 (nummod)
lipids total (amod)
found course (nmod)
hctz mg (nummod)
severe most (advmod)
score pediatric (amod)
reduction incidence (nmod)
92 to (dep)
cardiovascular significant (amod)
words generated (acl)
injection b3 (compound)
protection tissue (nmod)
alprazolam or (cc)
treatments intermittent (amod)
patient both (cc:preconj)
change a (det)
increase was (cop)
vacuolization of (case)
courses given (acl)
presented treated (conj)
vincristine streptozotocin (conj)
connections structures (nmod)
constitutes therapy (dobj)
cm of (case)
history treatment (conj)
chlorpropamide with (case)
r2 ) (punct)
affected indicating (advcl)
receive combination (nmod)
abolition the (det)
hit ufh-related (amod)
tolerated rad001 (nsubjpass)
modulate fq (nsubj)
complicated needs (conj)
marked which (nsubjpass)
function perioperative (amod)
audit by (case)
section cesarean (amod)
flare p<0.001 (appos)
administration mg (nmod)
correlations and (cc)
recipient donor (compound)
first : (punct)
retention urinary (amod)
period before (nmod)
exacerbations paranoid (amod)
ototoxicity in (case)
treated carcinogen (nmod)
reduce drugs (nsubj)
essential studies (nmod)
rare myocarditis (nsubj)
150 +/- (cc)
exposure single (amod)
failed mg/kg (conj)
surgery rigidity (nmod)
administered , (punct)
cardioversion for (case)
cases reactions (acl:relcl)
mask of (case)
enzyme an (det)
removal by (case)
treatment : (punct)
effect sphincter-relaxing (amod)
tobramycin td (dep)
infusion quinine (compound)
background , (punct)
patients lamivudine-na (amod)
induced evidence (conj)
resistance supraglottic (amod)
diagnosis as (cc)
cta with (case)
maintaining while (mark)
assessing use (dobj)
arrest increase (nmod)
volunteers 10 (nummod)
helpful is (cop)
transporter ut-a1 (appos)
stage cytotoxicity (nmod)
% % (parataxis)
changes regional (amod)
% 71.0 (nummod)
hoarseness ) (punct)
administered evening (nmod)
enantiomer pure (amod)
iiie for (case)
definition . (punct)
nelarabine by (case)
term long (amod)
mice b2 (compound)
affected detected (conj)
duration field (compound)
low very (advmod)
stn and (cc)
those schizophrenia (nmod)
exchange concurrent (amod)
presence micrograms/ml (appos)
mediated interactions (nmod)
had apamin (nsubj)
(dex)-induced dexamethasone (nsubj)
origin unknown (amod)
study course (conj)
area treated (acl)
run shelf (nmod)
model with (case)
antigens class (compound)
dse ) (punct)
given intravesically (advmod)
seizures hypolocomotion (conj)
0 0.2 (conj)
remained intervention (nmod)
0.24:1 and (cc)
toxicity similar (amod)
response all (nmod)
discussed causes (nsubjpass)
drug dopaminergic (amod)
dosing kg-1 (appos)
rule out (compound:prt)
enalapril ( (punct)
response essential (amod)
study comparison (conj)
complained injection (nmod)
impaired similarly (advmod)
ndi in (case)
necessary were (cop)
triglycerides in (case)
enhances formation (dobj)
7.1 0.1 (conj)
endonuclease-dependent both (cc:preconj)
firm signs (nmod)
phosphatase the (det)
deterioration treatment (nmod)
opioid gains (acl:relcl)
treated ganciclovir (nmod)
percent eighty-seven (amod)
cerruloplasmin c (conj)
synthesis cholate (nmod)
inhibition cells (nmod)
developed examine (xcomp)
observed treatment (nmod)
tests avoidance (compound)
exceeding mg/kg (dobj)
unrelenting was (aux)
episode such (amod)
exhibited profile (dobj)
bradyarrhythmias or (cc)
reversing amnesia (dobj)
chelation calcium (compound)
developed hemianopsia (dobj)
propagate transmurally (advmod)
trait ae (appos)
agents indomethacin (nmod)
discontinued not (neg)
dependence malondialdehyde (nmod)
growth extensive (amod)
assumed which (nsubjpass)
extent males (nmod)
therapy 4-aminopyridine (compound)
increase % (amod)
cavity resection (compound)
sectioning cord (nmod)
frequency and (cc)
30 5 (compound)
cytometry laser (compound)
reactions possible (amod)
day postoperative (amod)
weeks was (cop)
showed epiphyses (conj)
pathways visceral (amod)
taking mg/day (nmod:tmod)
cholecystokinin and (cc)
renin levels (dep)
attenuates b. (dobj)
inhaled darkness (nmod)
patients thirteen (nummod)
days trial (nmod)
epilepticus and (cc)
research herbals (nmod)
agent midazolam (nsubj)
% 45 (nummod)
20/102 +/- (cc)
[verapamil]o of (case)
decreased dose (nsubjpass)
mice c57bl6/j (compound)
4.5+/-1.0 ) (punct)
deficits on (case)
times 10 (compound)
stopped hours (dobj)
indicating metabolite (ccomp)
corrected been (auxpass)
outcome involves (acl:relcl)
5.2+/-1.1 p<0.05 (appos)
drink health (compound)
antibiotic a (det)
proposed as (mark)
developed nodules (dobj)
setting used (acl:relcl)
pain seven (conj)
years 14.3 (nummod)
agonists receptor (compound)
nms patient (nmod)
live can (aux)
weeks six (nummod)
iodixanol of (case)
screened symptoms (nmod)
3.9 ( (punct)
mechanisms relate (acl:relcl)
diverse vivo (advmod)
years from (case)
ct ) (punct)
condition is (cop)
feature depression (nsubj)
had occurred (conj)
administration curcumin (compound)
proportions the (det)
observed seizures (conj)
ganglia kidney (conj)
hypotension pigs (nmod)
neutrophils compared (case)
proportional was (cop)
pce by (case)
dose participated (acl)
using swallow (dobj)
conditions favorable (amod)
pressor the (det)
treatment limit (acl)
msg of (case)
uninephrectomy nx (appos)
decrease concentration (nmod)
65 below (case)
adopted were (auxpass)
content glepp1 (nmod)
limitations : (punct)
lesions rosaceiform (compound)
converted tachycardia (dobj)
bilirubin mg/dl (conj)
impaired memory (dobj)
mazindol treated (acl)
patient one (nummod)
lasted effect (nsubj)
catheter , (punct)
activity her (nmod:poss)
years last (amod)
institutions to (case)
symptoms transient (amod)
outcomes : (punct)
dose age (conj)
observed risk (nsubj)
effective toxic (conj)
reverses amn082 (nsubj)
fluctuations levodopa-induced (amod)
u/ml ) (punct)
efficacy resistance (nmod)
study people (nmod)
4 ; (punct)
ability reverse (acl)
microl 2.5 (nummod)
parkinsonism and (cc)
kinase nitrogen (appos)
designed bcnu (dep)
addition fluids (nmod)
inhibitors common (appos)
tremor particularly (advmod)
evidence with (case)
measures levels (dep)
stz in (case)
nifedipine sustained-release (amod)
treatment antithrombin (nmod)
examined effect (nsubjpass)
measure activity (nsubj)
decreased antagonism (nsubjpass)
patients hyperprolactinemia (nmod)
demonstrated haloperidol (nsubj)
remain dose (nmod)
nodosum atra-induced (amod)
tg cohort (conj)
return normal (nmod)
developed h (nmod:tmod)
escalated day (nmod)
increased injections (nsubj)
comparison time (nmod)
erythematosus lupus (compound)
fraction conjugated (amod)
former with (case)
inhibitors them (nsubj)
40.3 62.0 (dep)
disappearance waveforms (nmod)
gating systems (nmod)
amnesia and (cc)
dyskinesia , (punct)
cause delirium (dobj)
dependent to (mark)
beats block (nmod)
nystagmus patients (nmod)
processor computerized (amod)
imparts changes (dobj)
improvements lability (nmod)
opioid weak (amod)
switch before (case)
objective monotherapy (dep)
variable no (det)
noted correlation (nsubjpass)
analyzed for (case)
systematic , (punct)
prescription nsaid (nmod)
paclitaxel ) (punct)
tone on (case)
optic ethambutol-induced (amod)
test urine (compound)
locus the (det)
associated inhibitors (nmod)
appears mechanism (xcomp)
found produce (xcomp)
lowered whereas (dep)
consequences about (case)
presentation neuropathy (nsubj)
acid valproic (amod)
expressed lobe (nmod)
design cross-over (amod)
treatment glucocorticoid (compound)
injection additional (amod)
detecting impairment (dobj)
former rodents (nmod)
inhibitors tacrine (dep)
ngf pgi2 (conj)
children % (appos)
p9605 pog (compound)
remarkable were (cop)
stroke or (cc)
larger , (punct)
therapy central (amod)
hemolysis intravascular (amod)
effects protective (amod)
saline 6 (dep)
haematological gastrointestinal (conj)
content bmd (conj)
demonstrated changes (dobj)
specified otherwise (advmod)
nephrotoxicity neuropathy (conj)
observations effects (nmod)
course perioperative (amod)
reviews annual (amod)
reduced losartan (nsubj)
ldl-cholesterol % (nmod)
infrequent bupivacaine (nmod)
profiles sertraline (nmod)
mg/day 400 (compound)
ureters equinovarus (conj)
implicated was (auxpass)
intubated and (cc)
benefit potential (amod)
deletion kb (compound)
groups lipid (compound)
blocked shr.(abstract (dobj)
types several (amod)
responsible obtainable (conj)
patients symptoms (nmod)
tolerated effective (conj)
observed compared (dep)
added fludrocortisone (nsubjpass)
retention associated (acl)
influx asians (nmod)
ph and (cc)
advantageous unique (advcl)
antagonized assay (nmod)
obtained administered (conj)
rare contrast (nmod)
oliguria acute (amod)
berlin universitaetsmedizin (compound)
groups period (nmod)
months range (appos)
achieved consequently (advmod)
receive sedation (dobj)
renin in (case)
correcting hyperkalemia (dobj)
hydroxylase for (case)
drd2 eps (conj)
understood but (cc)
recommend period (nmod)
actin alpha-smooth (compound)
consists program (nsubj)
underreporting patients (nmod)
hypercalcemia carbonate-induced (amod)
staining tissue (dobj)
week 16th (amod)
immunosuppression long-term (amod)
intervals week (compound)
demonstrated self-treating (ccomp)
0.006 < (dep)
bupivacaine with (case)
died asystole (nmod)
study at (case)
0 4 (conj)
mellitus new-onset (amod)
describe induction (dobj)
followed period (nmod)
slower groups (nmod)
coinciding magnus (nmod)
produce profile (nsubj)
hormones female (amod)
loss permanent (amod)
applied then (advmod)
pattern deterioration (nmod)
timolol placebo (nmod)
mellitus , (punct)
gentamicin and (cc)
aim specific (amod)
attempt a (det)
induce anesthesia (nmod)
child palsy (nmod)
genes seizure (amod)
include that (nsubj)
participants and (cc)
reference the (det)
factors urine (compound)
administered znso(4 (dobj)
lymphocytes 's (case)
using procedures (dobj)
motionless were (cop)
loss hearing (nmod)
cell red (amod)
intoxication of (case)
0.03 microgram/kg/min (dep)
reported results (nsubj)
recognizing management (nmod)
suggest increases (ccomp)
cardiomyopathy % (appos)
slices brain (compound)
method instillation (nmod)
demonstrates aggravate (ccomp)
reversed indicating (xcomp)
evident induced (ccomp)
decreased metformin (nmod)
contribution parts (nmod)
scale slight (amod)
contractility diaphragm (compound)
generation current (amod)
movements the (det)
transplantation pediatrics (nmod)
or , (punct)
cardiotoxicity in (case)
electroshock , (punct)
endings dopamine (compound)
resulted administration (nmod)
aggravated cases (nmod)
have worsening (dobj)
mice azt (compound)
toxicity syndrome (conj)
improvement sustained (amod)
play sedation (nsubj)
infusion min (appos)
320/25 up (advmod)
rates d2 (compound)
startle suppressed (advcl)
elevated patients (nmod)
discharged day (nmod)
taking period (nmod:tmod)
deteriorated significantly (advmod)
admitted , (punct)
assays techniques (conj)
history jaundice (nmod)
experience positive (amod)
observed suggesting (xcomp)
pointes tdp (appos)
degeneration interval (nmod)
tolerance cross-tolerance (conj)
group young (amod)
0.01 than (case)
chlorpromazine ) (punct)
seizure in (case)
= 0.014 (dobj)
dbh and (cc)
functions of (case)
tissues kidney (compound)
dose 800-micrograms (amod)
addition activity (nmod)
recovered , (punct)
dex by (case)
injection carbachol (nmod)
thrombolysis argatroban (amod)
affect directly (advmod)
effects captopril (nmod)
motor though (case)
patients micromol/l (appos)
9.84 +/- (cc)
polymerase parp (appos)
toxicity against (case)
database safety (compound)
rls on (case)
nausea theophylline (nmod)
receiving kg-1 (dobj)
receptors da1 (compound)
excitability myocardial (amod)
diagnose treat (conj)
indicating likely (ccomp)
anthracyclines and (cc)
quit learning (nmod)
propose activate (ccomp)
studied methods (dep)
animals nephropathy (amod)
ip desipramine (compound)
pre- postoperatively (conj)
withdrawn be (auxpass)
cross-tolerant rats (nsubj)
pharmacotherapies multiple (amod)
factor predictive (amod)
added preparation (nmod)
alf asia (nmod)
displayed impair (conj)
risk rr (dep)
glaucoma angle (compound)
variable extension (nsubj)
reduction loss (conj)
complex receptor (compound)
control % (dep)
hypoperfusion lobes (nmod)
sensitive that (mark)
treated mice (nsubjpass)
73 - (punct)
administration stz-icv (compound)
fall of (case)
seen contrasts (nsubjpass)
subjected feeding (nmod)
initiation hemodialysis (nmod)
thrombophlebitis patients (appos)
associated memory (nmod)
170 from (case)
1.66 - (punct)
expression markers (nmod)
improvements or (cc)
sequelae without (case)
postulated proteins (nsubjpass)
noted implant (nmod)
expression the (det)
related azotemia (nsubj)
consequences overexpression (nmod)
ha of (case)
acid messenger (compound)
scopolamine on (case)
protected given (advcl)
status ceased (acl:relcl)
produced increased (conj)
increase early (amod)
convulsions against (case)
action doses (nmod)
intake the (det)
flecainide of (case)
(ee)-induced 17alpha-ethinylestradiol (nsubj)
suggests similar (ccomp)
bolus initial (amod)
period postinfusion (compound)
profiles side (amod)
factor primary (amod)
p 0.01 (dep)
patient anephric (amod)
% 12.5 (nummod)
1 . (punct)
stabilizer pbo (dep)
justify not (neg)
reduced hyperactivity (nsubjpass)
influence normotensive (nmod)
floor on (case)
similar but (cc)
weeks further (amod)
lesions treatment (nmod)
complication transplantation (nmod)
addicts adult (amod)
findings : (punct)
histology with (case)
bioactivation chemical (amod)
axis septotemporal (amod)
agent limited (acl:relcl)
reported antimicrobials (nsubjpass)
seizures neurotoxicity (conj)
predictor cardiotoxicity (nmod)
pb or (cc)
lead associated (advcl)
fed was (auxpass)
six respectively (advmod)
alphaenac gammaenac (conj)
correlation infectivity (nmod)
differences no (neg)
compounds all (det)
complete regressions (conj)
lithium haloperidol (conj)
correction with (case)
meat from (case)
one ; (punct)
microg/side after (case)
patients tobramycin-treated (amod)
excretion guanosine (compound)
treated we (nsubj)
comparative 12-week (conj)
case droperidol (nmod)
disinhibition aggression (conj)
personal surgeons (conj)
db ) (punct)
crossover placebo-controlled (amod)
series first (amod)
future the (det)
enhanced using (advcl)
disease wilson (nmod:poss)
infusion iso (compound)
treatment temsirolimus (compound)
protamine of (case)
secondary relapsing (conj)
year 31 (nummod)
repeated infusion (nmod)
tolerated useful (conj)
abolished while (mark)
actions antiarrhythmic (amod)
effect side (amod)
sirolimus mycophenolate (conj)
predilection its (nmod:poss)
cancer risk (compound)
cocaine , (punct)
mediation l-dopa (nmod)
solution % (nmod)
show we (nsubj)
subjects those (det)
cisplatin toxicities (appos)
result myelination (nmod)
insipidus due (case)
skin with (case)
implicated kidney (nmod)
12 36 (conj)
important which (nmod)
site than (case)
similarities span (conj)
type severe (amod)
limited use (dobj)
emission tc99m-sestamibi (compound)
patients diseases (nmod)
treatment e2 (nmod)
patients versus (cc)
experienced . (punct)
infarcts ganglia (compound)
mda tnfalpha (conj)
found adults (nmod)
weeks not (neg)
cause record (nmod)
exerted toxicity (dobj)
classes and (cc)
evoked masseter (nmod)
% 27.1 (nummod)
treatment spasticity (nmod)
associated resulted (conj)
small conclusion (nmod)
or 3.1 (nummod)
do which (nsubj)
trimipramine shows (acl:relcl)
effect forestomach (conj)
present modified (conj)
sleepiness users (nmod)
background an (det)
stage important (amod)
mania fluoxetine (compound)
reshaping this (det)
protein of (case)
use medication (compound)
dose physiological (amod)
spasm thrombus (conj)
square measures (nmod)
therapeutic multidisciplinary (amod)
1993 1997 (prep)
depends characterization (nsubj)
plan of (case)
considered good (xcomp)
recipient heart (compound)
retention task (nmod)
2.7 more (amod)
= .003 (dep)
results histopathological (amod)
dialysis reverse (amod)
paresthesia limbs (nmod)
hepatitis jaundice (dep)
2/8 ) (punct)
number nuclear (amod)
fertility for (case)
benzodiazepines ) (punct)
electrographic and (cc)
suggesting diminishes (ccomp)
declined p (dep)
children older (amod)
diagnosed incidence (dep)
susceptible especially (advmod)
studies developmental (amod)
uninephrectomy feeding (dep)
significance of (case)
54 of (case)
collagenase with (case)
medication antiallergic (amod)
influence no (det)
failure proteinuria (conj)
side-effect sd (nsubj)
dox weight/week (appos)
enzymes mitochondrial (amod)
infusion after (case)
similarity procainamide (nmod)
improved slightly (advmod)
appears flat (xcomp)
higher ) (punct)
toxicity a (det)
compared placebo (nmod)
efflux dopamine (compound)
maintained which (nsubj)
dipyrone for (case)
condition their (nmod:poss)
septal atrial (amod)
reduced remarkably (advmod)
recurrence further (amod)
performance baseline (compound)
noticed dysfunction (dobj)
correlated duration (nmod)
period continuous (amod)
confirmed scotomata (dobj)
patterns dsm (nmod)
half other (amod)
treatment msg (compound)
adjustment from (case)
hypocalcemia systemic (amod)
increased 19-fold (advmod)
monotherapies the (det)
alleviated , (punct)
5 50 (compound)
statement consensus (compound)
thiopental iv (dep)
vasopressin and (cc)
carboplatin with (case)
dosage acute (amod)
att of (case)
increased estradiol (nsubj)
percentage exceeded (acl:relcl)
suffered entropion (nmod)
contribute abnormalities (nsubj)
collapsed . (punct)
pharmacological toxicological (conj)
patients classified (acl)
need management (nmod)
women 330 (nummod)
important help (conj)
similar conclusions (dep)
dyskinesias scores (conj)
changes early (amod)
50 least (advmod)
damage determined (acl:relcl)
offset drugs (advcl)
indexed lvdp/dtmax (nmod)
detected exhaustion (nmod)
kg + (cc)
changes organelles (nmod)
increase change (dep)
tachyarrhythmias ventricular (amod)
acted co-carcinogen (nmod)
chemotherapy cancer (compound)
pre-treatment compared (acl)
show leak (ccomp)
did management (nmod)
infarction % (appos)
started kept (conj)
patients older (amod)
suggest whereas (mark)
stimulate given (advcl)
assessed manipulation (nmod)
due damage (nmod)
yield capsaicin (compound)
gds of (case)
g 113 (nummod)
changes h (nmod)
10min 2min (compound)
neuropathy her (nmod:poss)
agonist beta (compound)
failure non-oliguric (amod)
history detailed (amod)
assessed systematically (advmod)
7 . (punct)
women hypercholesterolemia (nmod)
value group (nmod)
knife with (case)
achieve , (punct)
caused pituitaries (dobj)
recur treatment (nmod)
virus b (compound)
increase cortex (nmod)
four treatment (nmod)
pharmacokinetics on (case)
aggravation release (conj)
known benefit (nsubjpass)
score 54 (appos)
syndrome acute (amod)
improvements dyskinesias (nmod)
effect glycol (nmod)
june to (case)
physicians primary (amod)
approach in (case)
added infection (nmod)
gamma-hexachlorocyclohexane lindane (appos)
was cortex (nmod)
interactions adverse (amod)
unlikely begun (dep)
rats memory (compound)
lessened decrement (dobj)
fact . (punct)
wakefulness increased (amod)
history noncontributory (amod)
cases 15 (nummod)
scores adl (compound)
mechanisms catalepsy (appos)
initiating when (advmod)
copolymer hpma (compound)
right in (case)
agent cytotoxic (amod)
decrease onset (nmod)
reduced periods (nmod)
losses potassium (compound)
syndrome ascites (nmod)
pathways brains (nmod)
prognosis the (det)
axis distress (conj)
rates cure (compound)
7.54 and (cc)
providers healthcare (compound)
days dexamethasone (nmod)
ketanserin and (cc)
10 up (advmod)
target mammalian (amod)
elevation due (case)
6 of (case)
pn 11 (nummod)
enzymes anti-hcv (appos)
accounted indicating (advcl)
irritability and (cc)
engendered administration (nmod)
density in (case)
emerged yet (advmod)
drug ? (punct)
sirolimus function (nmod)
rhythm temporary (amod)
hypothesis study (compound)
-21.3 ( (punct)
cream silver (amod)
gaba dopamine (conj)
maintains frontal (xcomp)
dioxide carbon (compound)
sensation head (dep)
erp length (conj)
patients required (parataxis)
metrizoate % (appos)
kinase rapamycin (compound)
donors hbsag-positive (amod)
pellet , (punct)
needed reduce (advcl)
battery the (det)
searched lilly (dobj)
subject from (case)
suggestive ischemia (nmod)
rofecoxib to (mark)
fibrosis atrophy (conj)
antagonist is (cop)
both paclitaxel (nmod)
remained response (nsubj)
movements involuntary (amod)
limits generalizability (dobj)
symptoms resistant (acl:relcl)
prevalence with (case)
radioactivity extractable (amod)
age lower (amod)
mechanisms renal (amod)
morphine continuous (amod)
ecgs 12 (nummod)
measured using (advcl)
specimens in (case)
tested a/j (nsubjpass)
scores 90 (nummod)
induced increase (dobj)
examined work (nmod)
estimated . (punct)
agent to (mark)
effect convulsions (nmod)
suggest predisposes (ccomp)
days 13 (nummod)
none patients (nmod)
results associated (dep)
ketamine anesthesia (dep)
nucleus elicited (conj)
problems associated (amod)
myelodysplasia of (case)
need raise (acl)
ethambutol tablet (compound)
since , (punct)
requirement support (nmod)
used atp (nsubjpass)
substitution sp120 (amod)
time study (nmod)
hemolysis tam-induced (amod)
rarest and (cc)
microarrays antibody (compound)
proceed testing (nmod)
county in (case)
excreted most (nsubjpass)
tdr ) (punct)
chiasm of (case)
mouth risks (conj)
therapy interferon (compound)
microgramg/ml 2.8 (nummod)
suffered . (punct)
nci/min 100 (nummod)
weeks the (det)
shock acute (amod)
relevant also (advmod)
syndrome aor (dep)
averaged signal (nsubj)
challenged cisplatin (nmod)
therapy oxide (compound)
lipids myocardial (amod)
mice hundred (nummod)
tolerated levetiracetam (nsubjpass)
prednisolone volume (conj)
need consider (advcl)
appropriate were (cop)
late that (mark)
samples urine (conj)
5.4 to (dep)
resolved rapidly (advmod)
resulted = (parataxis)
injection materials (nmod)
rate metabolism (conj)
predictor pfs (nmod)
dogs most (amod)
safe doses (nmod)
preclude use (dobj)
induced whereby (advmod)
hypersensitivity demonstrated (amod)
stimulation with (case)
hepatotoxicity vpa-induced (amod)
hyperactive animals (nsubj)
importance is (cop)
meter an (det)
peroxide hydrogen (compound)
known described (conj)
upregulation (kim)-1 (nmod)
undertaken investigate (xcomp)
transport-deficient tr(- (appos)
scattered group (nmod)
hydration furosemide (conj)
anemic and (cc)
effect therapy (nmod)
switch immunosuppression (nmod)
tinnitus from (case)
carcinogens the (det)
incidence myalgia (nmod)
level on (case)
procedures emergency-department (amod)
or a (det)
classified group (nmod)
presentation coma (nmod)
patients hyperalgesia (nmod)
doses ropivacaine (nmod)
group methadone (compound)
microinjection that (mark)
communicate machinery (nmod)
changes persistent (amod)
transplantation complicating (amod)
remains obscure (xcomp)
glutamate fails (dobj)
4 in (case)
pressure either (det)
surface entire (amod)
dgc and (cc)
effective be (cop)
89/102 ) (punct)
monitoring periodical (amod)
> 0.83 (nummod)
hypertension hallucinations (conj)
drugs certain (amod)
metabolite rats (nmod)
protein it (nsubj)
2.20 ratio (nsubj)
rigidity produced (acl)
twitching . (punct)
remained degree (nsubj)
developing chf (dobj)
disease tdf-related (amod)
level acid (compound)
determined incidence (nsubjpass)
history hypertension (nmod)
nephrotoxic but (cc)
frequency types (conj)
subjected hypotension (nmod)
fa ) (punct)
stimulation " (punct)
studies resolution (conj)
fluctuations on-off (amod)
activity and (cc)
to or (cc)
leukopenia thrombocytopenia (conj)
6 [ (punct)
fragmentation internucleosomal (amod)
influence speed (nmod)
0.48 +/- (cc)
therapy nifedipine (compound)
changes glomerulopathy (dep)
microinjections with (case)
gender female (amod)
recommended caution (nsubjpass)
presented 32 (nsubj)
developed days (nmod)
system tida (compound)
result interactions (nmod)
regulation the (det)
losartan severe (amod)
requires investigation (dobj)
reported nor (cc)
control the (dep)
benefits significant (amod)
vessels normal (amod)
aggregation with (case)
act atp (nsubj)
risk strokes (nmod)
flow kidney (nmod)
doses methadone (nmod)
lymphoma mantle (compound)
finding is (cop)
disorder but (cc)
values pre-papaverine (amod)
resembled imagery (nsubj)
adjustment only (advmod)
obtunding response (dobj)
seems ngal (nsubj)
revealed representative (conj)
25 50mg/kg (conj)
consequence sensitisation (nmod)
lack programs (nmod)
review retrospective (amod)
higher reduced (parataxis)
evidence proliferation (conj)
17beta-estradiol microg/rat (appos)
controlled exclude (advcl)
area june (nmod)
procedure challenge (compound)
helpful defining (advcl)
cna ina (conj)
observed be (auxpass)
preference the (det)
anxiolytic anticonvulsant (conj)
better group (nmod)
examined should (aux)
injury on (case)
terms utilized (acl)
proven and (cc)
activation nuclei (nmod)
compounds for (case)
biometry of (case)
dose-dependent were (cop)
drug in (case)
mask face (compound)
method tail-cuff (compound)
inappropriate , (punct)
g were (cop)
forces score (conj)
monoher between (case)
anuria transient (amod)
suggested responsible (ccomp)
administration during (case)
session the (det)
infusion venous (amod)
procaterol b.d (dobj)
those those (nmod)
mg 1500 (compound)
mortality in (case)
lesions nigra (amod)
role convulsant (nmod)
used preventing (advcl)
tachycardia augmentation (conj)
cardiomyopathy histopathological (amod)
hz 10 (nummod)
women tamoxifen (nmod)
treatment response (conj)
rare while (mark)
receiving although (mark)
epilepticus p45 (nmod)
had carbimazole (nmod)
ami gi (conj)
injection apomophine (compound)
b1r(-/- ) (punct)
damage might (aux)
copolymer the (det)
choose assessing (advcl)
preceded is (auxpass)
found efficient (xcomp)
relationship duration (nmod)
expression brain (compound)
2.7 ( (punct)
sensitive would (aux)
accounted % (nsubjpass)
studied associations (nmod)
eliminating hypercalcemias (dobj)
effect digoxin (nmod)
efficiency opse (appos)
excluded can (aux)
treated second (nmod)
40.0 2.88 (conj)
high-dose 26.3 (nmod:npmod)
broadly most (advmod)
nociception model (conj)
changes with (case)
powders such (amod)
dapsone of (case)
group p100 (compound)
years seven (nummod)
promotes effect (conj)
fibrillation % (dep)
increased slightly (advmod)
center hospital (compound)
sensation pinprick (amod)
animal in (case)
suggest decrease (dobj)
remained changes (dobj)
acting node (nmod)
indians and (cc)
2-(p-bromophenyl)propionate 3alpha-tropyl (amod)
stenosis renal (amod)
effects model (nmod)
conclude and (cc)
developed initiation (nmod)
bid ) (punct)
essential functions (nmod)
l-dopa i.v. (appos)
determined used (conj)
sedative studies (nmod)
quantified technique (nmod)
mg/dl 5 (nummod)
administration ppa/caffeine (amod)
depressed nh4ac (nmod)
antagonists muscarinic (amod)
precise essential (conj)
history previous (amod)
effect shr (nmod)
drugs offending (compound)
myelosuppression fatigue (conj)
ph partial (conj)
animals right-pawed (amod)
subsides instillation (nmod)
has because (mark)
analgesia brief (amod)
npy ) (punct)
withdrawal carbamazepine (nmod)
model anxiety (dobj)
g failure (nmod)
6 well (advmod)
32.87 + (cc)
patients 15 (conj)
array receptor (compound)
body 4.0 (nummod)
suppressed successfully (advmod)
neurotoxicity busulfan (compound)
aggravation score (nmod)
disruption groups (nmod)
startle increased (amod)
had have (advcl)
hearing normal (amod)
anophthalmia with (case)
oxidase complex (appos)
had or (cc)
microg 200 (nummod)
sensitivities the (det)
micrograms/kg/min ) (punct)
or and (cc)
effect injury (nmod)
head was (cop)
design left (dep)
decreased mda (dobj)
background determine (dep)
pool post-lesion (amod)
doses one (nummod)
paroxetine dosulepine (conj)
related that (mark)
micrograms 4,000 (nummod)
case with (case)
7 emboli (nmod)
psa absolute (amod)
0.445 1.5 (dep)
sulfonylureas with (case)
induced melatonin (nmod)
69.9 30.1 (conj)
associated psychosis (nmod)
response inhibitors (nmod)
years 7 (nummod)
resistance catecholamine (compound)
pdtc 50 (nummod)
had pregnancies (dobj)
origin manifestations (nsubj)
occurred taken (advcl)
agonist for (case)
2 < (dep)
needed failure (nmod)
calculations area (compound)
aim . (punct)
extend striatum (nmod)
expressed . (punct)
baseline 2.5 (conj)
died bronchopneumonia (nmod)
trimethoprim cephalexin (conj)
observations locf (appos)
doses antibiotics (nmod)
properties biological (amod)
first kind (nmod)
bpa ( (punct)
aorta in (case)
1.84 0.64 (conj)
is interest (attr)
investigations other (amod)
l-nil ; (punct)
type factor (conj)
assessed evaluated (conj)
093 - (punct)
problems for (case)
receptor specific (amod)
evaluate blockers (nmod)
= mg (dep)
decreased inhibiting (advcl)
opportunity study (acl)
hissing and (cc)
change percent (compound)
indication an (det)
patients 262 (nummod)
occurring pathophysiology (nmod)
studied investigating (advcl)
had whether (mark)
ng/ml or (cc)
transporter by (case)
decreased pressures (nsubjpass)
activity immunodeficiency (compound)
higher whereas (dep)
pharmacodynamics . (punct)
clz ( (punct)
re-resection underwent (amod)
total evidence (conj)
patients decline (appos)
included motor (conj)
% ci=39.9%-68.7 (compound)
cimd of (case)
enhancement troponin (dep)
6 to (quantmod)
prevented treatments (nsubj)
tissues mammary (amod)
ce , (punct)
associated diazepam (nmod)
pharmacology complex (nmod)
man 51-year-old (amod)
effect irreversible (amod)
n n-dimethylpropranolol (appos)
risk compared (acl)
disorders , (punct)
antioxidant potent (amod)
% controls (nmod)
subjects borderline (compound)
potentiate arrhythmogenicity (dobj)
induces even (advmod)
discuss helpful (ccomp)
influence conditions (nsubj)
addressed will (aux)
damage breaks (dep)
stage phases (nmod)
documented previously (advmod)
cycles bort-dex (compound)
manifestation behaviors (nmod)
injury respiratory (amod)
1 treatment (nmod)
tachykinins these (det)
depleted beginning (xcomp)
intervals time (compound)
subjects fourteen (nummod)
reduced manner (nmod)
administered adjusted (conj)
mass rna (conj)
cnsb002 with (case)
gained effect (dobj)
developed infarction (dobj)
mg/day 60 (nummod)
remains blind (acomp)
patients course (conj)
treated doxorubicin (nmod)
glioblastoma for (case)
vulnerability individual (amod)
flunitrazepam volunteers (nmod)
test positive (amod)
cirrhosis and (cc)
effects neurocognitive (amod)
subtests ) (punct)
ts with (case)
breakdown in (case)
organization in (case)
has rate (dobj)
dosing patients (conj)
determine using (advcl)
proliferation vascular (amod)
facilitate hinder (conj)
dependent thus (advmod)
implant subcutaneous (amod)
received then (advmod)
map ( (punct)
leukocytes of (case)
frequency caffeine (nmod)
interpolates points (nmod)
those inhibitors (nmod)
contour pulse (nmod:npmod)
leads exposure (nsubj)
replacement doses (nmod)
undergoing anesthesia (dobj)
drug etodolac (appos)
7alpha-hydroxylase cholesterol (compound)
injection first (amod)
sulfate intravenous (amod)
effects function (conj)
increases enhancement (nmod)
count lymphocyte (compound)
syndromes used (acl:relcl)
seven testing (nmod)
terms incidence (nmod)
coagulopathy due (case)
doses picrotoxin (nmod)
toxicity levobupivacaine-induced (amod)
nin ( (punct)
methods study (appos)
received didanosine (dobj)
drugs of (case)
group e (compound)
cardiovascular respiratory (conj)
subunit proteasome (compound)
nephrectomized either (preconj)
documenting association (dobj)
pathologies in (case)
provides dexmedetomidine (nsubj)
evident lesioning (advcl)
outcome primary (amod)
models putative (amod)
rats female (amod)
blockade 2-adrenoceptor (amod)
um btc (nmod)
invariable and (cc)
expected harmful (xcomp)
reduces myocet (nsubj)
undertaken rate (nmod)
experiments some (det)
associated bromocriptine (nsubjpass)
work and (cc)
intact-control saline-control (conj)
lindane of (case)
scale ) (punct)
larger patients (nmod)
1.1 - (punct)
tended shown (conj)
threshold a (det)
vasopressin arginine (compound)
meq/l , (punct)
fentanyl fentanyl-dexamethasone (conj)
ameliorate decreasing (advcl)
use modulation (nmod)
hemoglobin her (nmod:poss)
occur usually (advmod)
ameliorated rats (nmod)
present n=11 (dep)
period average (amod)
dopamine with (case)
management is (cop)
delivery drug (compound)
snhl ( (punct)
gspe 100 (nummod)
caused hcbd (nmod)
didanosine promethazine (conj)
increases cortisol-induced (amod)
antibiotics many (amod)
start onset (conj)
related injury (nmod)
if so (advmod)
reports 82 (nummod)
patients fourteen (nummod)
aneurysm the (det)
des of (case)
counts : (punct)
patients reduction (nmod)
encountered that (nsubjpass)
syndrome sulfasalazine-induced (amod)
staining components (nmod)
associated interval (nmod)
justify can (aux)
blocking calcium (compound)
disappearance the (det)
concentrations diltiazem (conj)
overdose due (case)
failed restimulation (nsubj)
potent ketamine (nsubj)
plausible . (punct)
pulmonale cor (compound)
effective mg/kg (dep)
withdrawn background (dep)
experience who (nsubj)
agent population (nmod)
l1-l2 ) (punct)
pneumoniae this (conj)
lower it (dobj)
flow rate (conj)
extension joint (nmod)
variable this (det)
disease arterial (amod)
found objectives (dep)
f group (compound)
exhibit . (punct)
used pesticide (nmod)
p=0.39 ) (punct)
administered only (advmod)
regulate some (nsubj)
effect d-glucarates (nmod)
blocked pre-administration (nmod)
tests because (case)
g/m2 ; (punct)
doses combinations (nmod)
pretreatment as (case)
lactate la (appos)
change decreased (advcl)
locations their (nmod:poss)
observe features (dobj)
pressures and (cc)
image 8/8 (appos)
a drug (appos)
il-1beta and (cc)
proliferation survival (conj)
found attenuation (nsubjpass)
more than (mwe)
remained sectioning (nmod)
ng 4 (nummod)
neoplasms hepatic (amod)
supports ; (punct)
preceded increase (nmod)
background associated (dep)
thickness left (amod)
patients glaucomatous (amod)
role variations (nmod)
changes dose-related (amod)
used surgery (nmod)
confusion mental (amod)
hemicholinium-3 the (det)
discontinuation , (punct)
normotensive and/or (cc)
increased 2.9-fold (advmod)
same contractions (nsubj)
females untreated (amod)
doses examined (acl)
ng/ml. 172 (compound)
level groups (nmod)
sph with (case)
ht of (case)
perforation ileal (amod)
hyperactivity induced (acl)
= p<0.01 (dep)
occurs often (advmod)
transmission fluoxetine (nmod)
cohort diagnosis (nmod)
increased linearly (advmod)
developed chorea (nsubj)
pn at (case)
weeks patients (nmod)
injection acute (amod)
administered diuresis (nmod)
studied injections (nmod)
na brain (compound)
identified eliminating (advcl)
administered blindly (advmod)
combination . (punct)
regression poisson (compound)
describe revealed (conj)
expression pathogenesis (nmod)
250 1,070 (conj)
vary axis (nmod)
report : (punct)
individuals pain (nmod)
mass pitfall (dep)
sufficient reduce (xcomp)
toxic associated (conj)
% 13.4 (nummod)
34.33 22.77 (conj)
activities score (nmod)
group patients (nmod)
cardiotoxicity leukopenia (conj)
dexamethasone dexamethasone (conj)
droperidol mg (compound)
respect levels (nmod)
induce i.p. (advmod)
conclusions option (dep)
surpasses effectiveness (nsubj)
dbh mice (conj)
mice stains (nmod)
c patient (compound)
mg correct (advcl)
area surface (compound)
had but (cc)
disease vascular (amod)
frequency than (case)
hypertension combination (conj)
ifx of (case)
boy 11-year-old (amod)
received show (advcl)
moderate signs (nmod)
min induction (nmod)
hours theophylline (nmod)
inhibitors level (conj)
direct indirect (conj)
dwi and (cc)
evaluated analysis (nmod)
control bleeding (xcomp)
publication each (det)
antioxidants antioxidants (conj)
completing study (dobj)
gram-positive gram-negative (conj)
epilepticus day (amod)
patients ouabain (compound)
integration a (det)
estradiol plasma (compound)
chemotherapy combined (amod)
tremor nausea (conj)
51.7 from (case)
nephropathy shr (nmod)
major bleeding (acl)
administration lithium (compound)
case conclusion(s (nsubj)
activity more (amod)
increase independence (nmod)
had = (parataxis)
deliberate ) (punct)
= 0.22 (dobj)
community in (case)
levels hdl-cholesterol (amod)
141 +/- (cc)
caused be (auxpass)
= 0.034 (dep)
underlie risk (dobj)
showed analyzed (advcl)
affects stability (dobj)
measured bmd (nsubjpass)
observed nephropathy (nmod)
concentrations tricyclic (amod)
flow myocardial (amod)
examined here (advmod)
immunocytoma igm (compound)
number change (conj)
promote atherosclerosis (dobj)
evoke not (neg)
resolution necrosis (nmod)
nephrotoxicity induced (acl)
leg her (nmod:poss)
recorded activity (nsubjpass)
neuroblastoma transplantation (nmod)
hearing in (mark)
age range (dep)
proposed ; (punct)
related ingestion (nmod)
treated mg/kg/day (nmod)
dysfunction of (case)
efficacious haloperidol (nsubj)
activities given (dep)
resulted volume (conj)
enzyme butyrylcholinesterase (compound)
hooded rats (dobj)
infarct lobe (nmod)
crf and (cc)
1.9 i.v. (dep)
conducted kong (nmod)
seeing ? (punct)
treatment subchronic (amod)
received min (nmod)
ect ) (punct)
signal both (cc:preconj)
noted previously (advmod)
stages in (case)
seizures/mo 0.42 (nummod)
iop an (det)
stabilized patient (nsubjpass)
able resulted (parataxis)
50 40 (compound)
a/j cba/j (conj)
demographics drug (nmod)
changed ltp (dobj)
l/kg td (nmod)
pj34 a (det)
ep ( (punct)
mk-801 ) (punct)
inhibition inhibited (acl)
reported inhibitors (nsubjpass)
measurement sequential (amod)
lipid extractable (amod)
period experimental (amod)
titration dose (compound)
investigated currently (advmod)
risk thrombo-embolism (nmod)
perimetry fields (appos)
mc diagnosis (compound)
phases exposures (conj)
level gaba (nmod)
woman suffered (acl:relcl)
monitoring holter (compound)
expanded . (punct)
regimens antibiotic (amod)
mmhg 110 (nummod)
overlooked , (punct)
movements dystonic (amod)
undergoing that (nmod)
decreases reperfusion (nmod)
used regression (nsubjpass)
decrease ? (punct)
case of (case)
convulsion elicited (acl)
motor minor (amod)
seemed tests (nmod)
pathway impaired (advcl)
use treatments (conj)
therapeutic both (cc:preconj)
ring ncl118 (conj)
auditory to (case)
associated radius (nmod)
indicate prevented (ccomp)
sedatives care (nmod)
women 's (case)
metabolites manner (nmod)
telangiectasia nifedipine-induced (amod)
measures appropriate (amod)
assessed test (nmod)
capacity mitochondrial (amod)
possesses concentration (nmod)
cognitive affective (conj)
n-methyl-d-aspartate nmda (dep)
series series (conj)
overexpression cisplatin-induced (amod)
noticed % (nmod)
deep bis (dep)
high unexpectedly (advmod)
patients neuroblastoma (compound)
states europe (conj)
trh ) (punct)
estimate selected (conj)
alters function (dobj)
showed vessels (dobj)
testing and (cc)
coding learning (nmod)
trained and (cc)
case alcohol (nmod)
manifestations arthritis (nmod)
usa fujisawa (compound)
assessed intakes (conj)
picture remission (nmod)
background aims (conj)
had subjects (nsubj)
hazardous treatment (nsubj)
5.00 d (appos)
zolmitriptan 2 (nummod)
drops map (nmod)
modulating and (cc)
fumarate tdf (appos)
obtained patients (nmod)
olanzapine vs (cc)
discontinuation prompt (amod)
provoke not (neg)
changes antigen (conj)
days given (case)
avoided communicated (ccomp)
effect amnesia (nmod)
contraindicated mp (nsubjpass)
inhibited exposure (nsubj)
effects seizure (nmod)
required control (xcomp)
dogs time (conj)
taking months (nmod:tmod)
supportive best (advmod)
drug amiodarone (nsubj)
phases carboplatin (compound)
decreased ratio (nsubj)
studies pathogenesis (nmod)
input sites (nmod)
appendage of (case)
changes physical (amod)
common most (advmod)
case anemia (appos)
rechallenge . (punct)
discontinuation mirtazapine (nmod)
pre-treatment emulsions (nmod)
prevent min (nmod)
accepted diuretics (nsubjpass)
shortened qt (dobj)
controls moderate-dose (dep)
l 73.6 (nummod)
adr of (case)
65 to (dep)
lh the (det)
8-se hyp(so3h)-ac-cck-2 (conj)
discontinued showed (conj)
sensitivity myocardial (amod)
responses upon (case)
antipsychotics the (det)
doses sub-effective (amod)
associated employed (nmod)
dissatisfaction individual (nmod:poss)
decrease maximal (amod)
moiety activated (amod)
dose mg/kg (nmod)
schedule protracted (amod)
model aneurysm (nmod)
syndrome restless (compound)
cessation in (case)
findings brain (compound)
reduction protein (nmod)
noted . (punct)
monotherapies or (cc)
compared diet (nmod)
presentation mechanisms (conj)
injury intestinal (amod)
55 34 (conj)
suggest and (cc)
fed treated (conj)
burning intake (nmod)
neutropenia . (punct)
exist hepatotoxicity (compound)
cardiomyopathy cardiomyopathy (conj)
myelopathy isolated (amod)
syndrome encephalopathy (amod)
similar doses (nsubj)
contains literature (nsubj)
vomiting retching (conj)
infarction induced (amod)
increases estrogen (nsubj)
was those (advcl)
4.0 0.015 (compound)
surviving 20 (dobj)
compared using (xcomp)
exposed ) (punct)
condition clinical (amod)
period similar (amod)
higher ammonia (nsubj)
had consequences (dobj)
3 of (advmod)
nitrogen blood (compound)
erythrocytes in (case)
mg/kg prevented (conj)
group light (amod)
index performance (nmod)
4.2- to (dep)
increasing consumption (dobj)
8) or (cc)
h at (case)
intercellular and (cc)
axis hpa (compound)
rns ) (punct)
growth des-induced (amod)
attention and (cc)
detachment plate (nmod)
dosages . (punct)
necrosis methimazole-associated (amod)
= 0.03 (dep)
presentation antigen (compound)
steel of (case)
intestine and (cc)
scored summated (conj)
nitrogranulogen such (case)
hyperemia in (case)
laboratory in (case)
cause nephrotoxicity (dobj)
microangiopathy associated (acl)
university l'aquila (compound)
had infiltration (nmod)
drg the (det)
pilo between (case)
nkcc2 ) (punct)
mg 3000 (nummod)
pretreatment norepinephrine (nmod)
cytotoxicity whose (nmod:poss)
injection hexamethonium (nmod)
exposure about (case)
reports phenomena (nmod)
evaluated tolerance (dobj)
role with (case)
room pain (nmod)
patient documentation (conj)
concentration brain (compound)
problem a (det)
mechanisms able (conj)
[na]o [ca]o (conj)
aim this (det)
blockers receptor (compound)
hematocrit , (punct)
da than (case)
dox ) (punct)
need obtained (xcomp)
persisted day (nmod)
decrease enzymes (nmod)
suffering who (nsubj)
receptor opioid (compound)
involves mechanism (nsubj)
chloroform- galactosamine-induced (conj)
investigated found (conj)
administered patients (dep)
permissive or (cc)
polymorphism pcr-rflp (appos)
increased expression (nsubjpass)
secreted tubules (nmod)
distress , (punct)
admission his (nmod:poss)
studies disease (nmod)
dependency test (nmod)
mm hg (appos)
characterized it (nsubjpass)
resumed is (auxpass)
acetylcholinesterases of (case)
velocity fibers (nmod)
2.5 20 (prep)
monitored concentrations (nsubjpass)
secretions oropharyngeal (compound)
make may (aux)
enhance not (neg)
difference db (dep)
edema included (amod)
evaluation cognition (compound)
intervals prolonged (amod)
mediate symptoms (dobj)
effective definitely (advmod)
than are (cop)
mg/m2 of (case)
latter unlike (case)
shifts spectra (nmod)
samples trough (compound)
reported ability (nsubjpass)
pad of (case)
metabolized cyp3a4 (nmod)
persist effects (nsubj)
controls between (case)
nsclc for (case)
% 90 (nummod)
indications transplantation (nmod)
protein . (punct)
decrease presence (nmod)
patients even (advmod)
intermediate toxic (amod)
treatment cats (nmod)
cycle circadian (amod)
given producing (advcl)
risk eightfold (amod)
receiving antagonists (dobj)
treated mg/kg (nmod)
levels relationship (dep)
identified ultimately (advmod)
showed deletions (dobj)
normal or (cc)
inflammation by (case)
agonist ) (punct)
achieved discouraging (xcomp)
pre-operative , (punct)
induced carbamazepine (nmod)
online hour (conj)
monitored clinically (advmod)
initiation therapy (nmod)
obstruction to (case)
duration sd (compound)
generated skin (nmod)
ischemic and (cc)
required p= (dep)
analgesia for (case)
implicated alterations (nmod)
dysfunction histochemical (amod)
techniques , (punct)
rcts ( (punct)
0.24:1 was (cop)
ultrafiltration by (case)
c7-c8 ( (punct)
concluded reduces (ccomp)
died toxicity (nmod)
procedure patients (nmod)
repeated sample (nmod)
analysed , (punct)
carcinoma tract (nmod)
combined carboplatin (nmod)
defects superoxide (nmod)
multicenter assessment (nsubj)
mortality rare (amod)
ecg 24-hour (amod)
resulted decline (nmod)
bis ( (punct)
available currently (advmod)
improved post-therapy (nmod)
nd-nmba ( (punct)
ser198 and (cc)
duration diabetes (compound)
1.5 3 (conj)
failure on (case)
lethality cocaine-induced (amod)
measuring viscosity (dobj)
controlled future (nmod:npmod)
score asex (compound)
development symptoms (nmod)
inpatient an (det)
micturition of (case)
hypokalemic the (det)
nephrotoxicity to (case)
160 40 (compound)
preparation salt (compound)
placed extraction (nmod)
subtypes dopamine (compound)
necrotizing effect (nsubj)
magnitude and (cc)
magnitude pain (nmod)
retina the (dep)
toxicities , (punct)
associated responses (nmod)
attenuation a (det)
causes summary (nmod)
number at (case)
come had (aux)
facilitate breaths (nmod)
results detected (dep)
pair ' (punct)
assigned blocks (nmod)
vasculitis vasculitis (nsubj)
administration rubella (compound)
tacrine administered (acl)
neuropathy vincristine (compound)
patients 100 (nummod)
developing function (dobj)
graded were (auxpass)
frequency evaluated (acl)
emax ( (punct)
treatment-emergent more (advmod)
had rate (conj)
potentiation by (case)
rate incidence (conj)
study from (case)
autoantibodies positive (amod)
comparing effects (dobj)
data , (punct)
withdrawal ltg (compound)
normal levels (nsubj)
effects na (nmod)
differs it (nsubj)
design multiple (amod)
comparison baseline (nmod)
demonstrate , (punct)
% 32 (compound)
3628 +/- (cc)
diuretic on (case)
anova one-way (amod)
suggested reduced (ccomp)
peak to (mark)
injection intraspinal (amod)
recall no (neg)
had absence (conj)
report literature (nmod)
60 100 (conj)
vehicle doses (nmod)
kb , (punct)
arrhythmogenicity bupivacaine (compound)
damage bladder (compound)
authorized used (conj)
1994 from (case)
underlie dysfunction (nsubj)
reversal report (dep)
induced trimethoprim-sulfomethoxazole (nmod)
dose discontinuation (conj)
dyskinesias choreatic (amod)
action with (case)
development paradigms (nmod)
changes hemodynamic (amod)
erp ) (punct)
liable signs (nmod)
treated pdn (nmod:npmod)
group enalapril (amod)
induced stress (nmod)
only c (dep)
1.56 paracetamol (nmod)
consequences cardiovascular (amod)
test amphetamine-induced (amod)
provides report (nsubj)
sn ( (punct)
approval use (nmod)
od group (compound)
related levels (nmod)
neurons da (compound)
withdrawal verapamil (compound)
due anuria (nsubj)
frequency symptoms (nmod)
measures vigorous (amod)
application dose (nmod)
membranes mesangiolysis (conj)
vulnerability the (det)
analogues . (punct)
attenuation neurotoxicity (nmod)
velocity diastolic (amod)
studied center (nmod)
conclusion rare (dep)
esterase enzyme (conj)
isoflurane , (punct)
indicates interaction (dobj)
debate safety (nsubj)
undergone recently (advmod)
tumor a (det)
therapy granulomatosis (nmod)
cns enhanced (amod)
convulsions or (cc)
receives and (cc)
ls pr (conj)
performed poorer (xcomp)
appears difference (ccomp)
ranged 120 (nmod)
underwent total (dobj)
developed injury (nmod)
receiving transplantation (dobj)
years 72 (nummod)
matter fine (amod)
tdr diminished (amod)
cardiotoxicity doxorubicin-induced (amod)
hemiparesis . (punct)
stimulated what (nsubjpass)
seen frequently (advmod)
significance with (case)
reduced myocytes (nmod)
les fi (compound)
agent anabolizing (compound)
presented whereas (dep)
infants , (punct)
otherwise not (neg)
examination ): (punct)
of tr(- (dep)
mechanism unknown (amod)
loss neurons (nmod)
generation users (nmod)
knife radiofrequency (conj)
efficacy prevention (nmod)
presented complaints (nmod)
toxicities seven (nummod)
site injury (nmod)
antagonist acid (appos)
registered transplantation (nmod)
percentage high (amod)
microl 15.3+/-11.2 (nummod)
patients thirty-four (amod)
ensues rate (compound)
tissue for (case)
5 them (nmod)
solution concentration (nmod)
attenuate sensitizing (conj)
immersed stimulus (nmod)
time dialysis (nmod)
disturbance associated (acl)
disease lmphoproliferate (compound)
developed mass (dobj)
allocated ml(-1 (conj)
is cancer (nmod)
period diuretic (nmod)
regimen chosen (amod)
agonists da2 (compound)
documentation first (amod)
attended day (nmod)
chemotherapy rates (nmod)
analogs pregs (nmod)
nocistatin impairment (nmod)
produced pathology (dobj)
g diltiazem (nmod)
crisis renal (amod)
showed respectively (advmod)
antinociception morphine (nmod)
calcium only (amod)
circled contralaterally (advmod)
group pilocarpine-treated (amod)
( 200 (dep)
dizocilpine antagonist (appos)
uremia survival (conj)
minutes a (det)
neurotoxicity methamphetamine (compound)
prior fibrillation (nmod)
doses salbutamol (nmod)
presented which (nsubj)
reduced after (mark)
controls 18.9 (nummod)
release reduction (conj)
conducting condition (nmod)
hospitalized . (punct)
methyldopa and (cc)
degrees ) (punct)
synthase enos (appos)
ranged 2.8 (nmod)
allograft of (case)
coniine nicotine (conj)
stimulation pulsatile (amod)
rats diuresis (nmod)
increased slowly (advmod)
steroids alpha- (nmod)
inhibitor gamma-vinyl-gaba (dep)
users ex-mdma (appos)
ci-921 nsc (dep)
transporter urea (compound)
induced proteinuria (dobj)
treated cyclophosphamide (nmod)
reduce reducing (advcl)
alpha2-adrenergic and (cc)
diabetic both (cc:preconj)
t30 ) (punct)
effect effects (nmod)
hypersensitivity by (case)
rendered days (nmod)
experienced men (nsubj)
79 from (case)
treatment shock (nmod)
true same (nsubj)
resembles pathology (nsubj)
restoration prompt (amod)
84 28 (conj)
mg clonidine (compound)
cis-ra with (case)
convulsants of (case)
report signs (dobj)
involvement possible (amod)
33.7 of (case)
aged age (dep)
4-ene-vpa (e)-2,4-diene-vpa (conj)
500 and (cc)
aware leads (ccomp)
was re-examine (xcomp)
demonstrated animals (nmod)
measures : (punct)
al ( (punct)
subsides . (punct)
therapeutic narrow (amod)
confirmed occurrence (nsubjpass)
frequency rat (compound)
ta-t1 o-a (dep)
sod cat (conj)
control for (case)
months stratum (dep)
gyrus dentate (compound)
levels glutathione (nmod)
injected bilaterally (advmod)
treatment mania (nmod)
symptoms whose (nmod:poss)
igf-i gene (conj)
none users (nmod)
induced mice (nmod)
etoricoxib and (cc)
pain healthy (amod)
electrograms his (nmod:poss)
cpa/ee cocs (nmod)
mbc for (case)
populations within (case)
switched therapy (nsubjpass)
performed period (nmod)
doses considered (acl)
mean mm (dep)
metabolizer that (mark)
hyper- retained (conj)
exhibited doses (nmod)
sample patients (nmod)
role drug (nmod)
ascertained use (nsubjpass)
potent absent (conj)
movements such (case)
rigidity administration (nmod)
dose s.c. (nmod)
given results (dobj)
diseases native (amod)
induced evidence (nsubj)
became h (nmod)
jj of (case)
schedule our (nmod:poss)
patients after (case)
patients drugs (nmod)
asynergy during (case)
rs first (acl:relcl)
oral via (case)
duration patient (nmod)
prevent furthermore (advmod)
remoxipride , (punct)
study followed (acl)
generation energy (compound)
died have (aux)
bolus even (advmod)
onset at (case)
15-f(2t)-isop ( (punct)
response immunological (amod)
mediated testosterone (nmod)
cholesterol lowering (acl)
pregnancies affected (acl)
associated kidneys (nmod)
grade carcinoma (nmod)
prescribed he (nsubjpass)
patients cardiomyopathy (nmod)
involved oxide (nsubjpass)
reactions ten (nsubj)
nerves median (amod)
elevation troponin (compound)
norepinephrine ne (appos)
diazinon with (case)
described experiencing (xcomp)
greater statistically (advmod)
meq/l 2.4 (nummod)
follow-up proper (amod)
illness reflected (acl)
impaired because (mark)
bha % (nummod)
patients hemorrhage (nmod)
uteri cervix (compound)
disturbing had (aux)
defect system (nmod)
fraction excreted (acl)
had neurotoxicity (dobj)
8 in (case)
improved hippocampus (nmod)
caused sclerosis (conj)
kidneys absent (amod)
pump baclofen (compound)
desipramine of (case)
requirement percentage (compound)
gnc92h2 mg/kg (appos)
watch to (mark)
nausea % (dep)
seizures % (nmod)
chloride tetrazolium (compound)
effect induction (nmod)
reduced lesions (nsubj)
nephrotoxicity secondary (amod)
taken , (punct)
% 67.3 (nummod)
changes both (cc:preconj)
acid tacrolimus (conj)
unaffected indicating (xcomp)
tdp to (case)
had march (conj)
transaminase gaba (compound)
use lidocaine (nmod)
psa with (case)
used recently (advmod)
effects for (case)
plan a (det)
= 32 (dobj)
studies function (nmod)
schedules of (case)
variants cholinesterase (nmod)
23 % (appos)
toxicity cholinergic (amod)
study administration (nmod)
2.53 1.9 (conj)
doses 12 (nummod)
mean with (case)
ug ( (punct)
mechanisms ortral (amod)
charge fraction (conj)
ich subsequent (amod)
cause haemorrhage (nsubj)
jaundice . (punct)
sinoatrial the (det)
group large (amod)
delivered measurements (nsubjpass)
prevented furthermore (advmod)
ro4368554 . (punct)
p respectively (advmod)
started injection (nmod)
convulsants some (det)
responsible wasting (nmod)
57 ) (punct)
8.4 + (cc)
resembled reported (dep)
is summarize (xcomp)
warrant which (nsubj)
hypertrophic were (cop)
effect conditioning (nmod)
initiated cause (conj)
locomotion hyper (compound)
injected assessed (conj)
320/25 with (case)
noncompliance death (appos)
disinhibition in (case)
plasma 0.058 (nummod)
associated chemotherapy (nmod)
experience single-center (compound)
infusion argatroban (amod)
chance examined (acl)
palpitation flushing (conj)
output qs/qt (conj)
model dis (appos)
possibility a (det)
protection optimum (amod)
defect this (det)
dili to (case)
achieve maintain (conj)
severity min (nmod)
guide patient (nmod)
aqueous gellan (conj)
rats doses (nmod)
examined alters (ccomp)
stable or (cc)
remodelling neuropathy (acl)
abnormalities wall-motion (amod)
deficit on (case)
related effect (nsubj)
use sumatriptan (nmod)
deterioration lcva (nmod)
types seizure (amod)
observed enhancement (nsubjpass)
constant an (det)
given rats (nmod)
dysfunction mesangial (amod)
nephritis deposits (nmod)
stenosis no (neg)
agonist ro (dep)
investigated patients (dobj)
neuroimage , (punct)
diseases benign (amod)
analgesic use (conj)
dysfunctioning a (det)
ranged copies/ml (conj)
rate 70/min (nmod)
ratio lower (amod)
incidence : (punct)
restarted ; (punct)
cardiac asystolic (amod)
inhibited combination (nsubj)
administration 21days (nmod)
decreases duration (dobj)
expressed domain (nmod)
treated one (nmod)
disorder pemoline (compound)
reduced ee (nmod)
resulted patient (nmod)
amplitudes snap (compound)
20 2.5 (compound)
induced injecting (advcl)
tapped patients (nsubj)
due shock (nmod)
rating both (det)
thalidomide patients (nmod)
malignancies arising (acl)
1.56 were (cop)
increase year (nmod)
diagnostic newer (advmod)
frequency appearance (nmod)
produced % (nmod)
isoflurane hypersensitivity (nmod)
metoprolol and (cc)
led failure (nmod)
dose incidence (conj)
oc cn (conj)
results % (conj)
support units (conj)
higher normal (nmod)
confirmed patients (nmod)
fatalities excluding (case)
shock septic (amod)
less akinetic (conj)
preparations weight (compound)
remissions 5 (nummod)
dogs six (nummod)
mutants t (compound)
improves : (punct)
dysfunctions disturbances (nmod)
models , (punct)
dyskinesia without (conj)
adults elderly (amod)
neuropathy without (case)
amounts ) (punct)
lh-rh ( (punct)
occurred subsequent (xcomp)
latency sleep (compound)
suited , (punct)
exacerbates , (punct)
tnfalpha mda (conj)
patients age (conj)
tablet 1 (nummod)
d1 and (cc)
fluoropyrimidines , (punct)
varied dosage (nsubj)
genes candidate (compound)
agitation thermoregulation (conj)
dosing divided (amod)
achieved obtained (conj)
testosterone 451 (conj)
incorporate escalating (xcomp)
provide . (punct)
reduced markedly (advmod)
drug antimuscarinic (amod)
injury brain (nmod)
cisternae , (punct)
% above (case)
complaints eyes (nmod)
migraineurs and (cc)
undertaken field (nsubjpass)
saline- normal (amod)
3'-azido-2',3'-deoxythymidine ; (punct)
metabolite chloroacetaldehyde (nsubj)
measured hemorrhage (nsubjpass)
0.05 minutes (dep)
methods ) (punct)
compared study (nsubj)
had results (dobj)
responsiveness activity (dep)
loading by (case)
uninephrectomy or (cc)
decreased sevoflurane (nmod)
fluphenazine sch (conj)
field in (case)
disruption hypertension (nmod)
erections penile (compound)
evident peaked (conj)
found cortex (nmod)
caused dysfunction (dobj)
localization channels (nmod)
difficult deliver (xcomp)
potentiated and (cc)
occurs when (advmod)
toxicity citrate (compound)
= 0.0031 (dobj)
combined dextran (nmod)
dfc ( (punct)
activities dismutase (nmod)
e13.5 e18.5 (conj)
aqp2 and (cc)
bradycardia effect (conj)
investigated authors (nsubj)
cisplatin single-agent (amod)
received consecutively (advmod)
roles opposite (amod)
drowsiness perception (conj)
overdose to (case)
organs respective (amod)
187 4(sem (conj)
changes regenerative (amod)
define . (punct)
regression regression (conj)
treatments albuterol (compound)
dietary or (cc)
group snp (compound)
mellitus history (conj)
54-week extension (appos)
balances and (cc)
0.001 p= (compound)
disruption homoeostasis (nmod)
consisted , (punct)
information attempt (nmod)
alf % (appos)
option may (aux)
use combination (nmod)
dfu unlike (case)
minutes initiating (advcl)
background using (xcomp)
switching mania (nmod)
known ( (punct)
hearing with (mark)
at as (mwe)
cranberry only (advmod)
myelopathy or (cc)
assessed morphological (conj)
groups saline (appos)
lower rate (nsubj)
effective one (appos)
factors that (mark)
peptides together (advmod)
patients cirrhosis (nmod)
investigated this (nsubjpass)
metabolizer propafenone (appos)
intermediate the (det)
therapy through (case)
cacl2 of (case)
years 35.2 (nummod)
substances vasoactive (amod)
positive tests (nsubj)
enhance may (aux)
myopathy necrotizing (compound)
volume activity (conj)
model nephropathy (amod)
membranes glomerular (amod)
convulsions lindane (amod)
effects grade (compound)
slope glucose (nmod)
fruste forme (compound)
hyperhidrosis and (cc)
had 2 (nsubj)
microl/side microg/0.5 (nummod)
12.5 day (nmod)
induced implanted (xcomp)
increased k)-atpase (nsubj)
pose when (advmod)
hypotension hypotension (conj)
increases hoe (dobj)
synthesis salt (compound)
protocol effective (amod)
exhibit properties (dobj)
control respective (amod)
mother to (case)
activation regions (nmod)
h ~2 (amod)
parameters measured (acl)
eyes ) (punct)
segment in (case)
control bp (compound)
served rats (nsubj)
mechanisms various (amod)
administered streptomycin (nsubjpass)
tumors primary (amod)
produced succinylcholine (nmod)
groups specific (amod)
remains so (mark)
decreased it (nsubj)
suspected but (cc)
reverse rapidly (advmod)
begin phenobarbitone (dobj)
plasma osmolarity (conj)
blocked could (aux)
measures distress (nmod)
hypotension for (case)
period acclimatization (nmod)
significant indicating (advcl)
occlusion thrombi (nmod)
explain , (punct)
ketanserin with (case)
be , (punct)
examined were (auxpass)
flash pattern (conj)
effectiveness and (cc)
estimate association (dobj)
m1 m3 (conj)
damage proximal (amod)
hypothesis affects (ccomp)
started procedure (nmod)
administered dhea (nsubjpass)
rigidity and (cc)
overdose and (cc)
were objectives (nsubj)
cognitive effects (conj)
showed clinical (dobj)
included induction (dobj)
study need (nmod)
complexes respiratory (amod)
reversed symptoms (dobj)
less even (advmod)
resolved incontinence (nsubj)
induced hepatotoxicity (dobj)
min once (advmod)
prominent locomotion (nsubj)
rash of (case)
receive benefit (dobj)
use lifetime (compound)
observed were (auxpass)
neurodegeneration of (case)
revealed after (mark)
uptake glutamate (amod)
subtypes lymphoma (compound)
injection to (case)
danger persists (nmod)
studies brain (compound)
interval not (neg)
mucositis patients (nmod)
protects cerebellum (dobj)
immunosuppressive who (nsubj)
occurs loss (nsubj)
site as (case)
platelets of (case)
use unaccustomed (conj)
cells/mm3 63.7 (nummod)
california southern (compound)
nvp % (appos)
ambiguus , (punct)
administration n (dep)
amphetamine benzoylecgonine (conj)
cystitis chemical (amod)
analysed . (punct)
pills generation (compound)
obtained tests (nsubjpass)
comparison value (nmod)
reduced paraparesis (nmod)
hours was (cop)
warranted outcomes (conj)
phenomenon , (punct)
fasciculation and (cc)
studies further (amod)
taken using (advcl)
diarrhea events (nsubj)
distributed addition (nmod)
led use (nsubj)
% rr (appos)
aim study (compound)
cocaine or (cc)
development psychosis (nmod)
evaluated being (auxpass)
reduced 5/8 (dep)
induced epilepticus (nmod)
prolactin on (case)
trauma brain (compound)
frequency exceeds (nmod)
microg/ml 32 (nummod)
assessed incorporating (xcomp)
effect effect (conj)
dbh ( (punct)
cases > (nmod)
prolonged be (auxpass)
known part (nmod)
51 49 (compound)
time vivo (advmod)
effect inhibitor (nmod)
developed ) (punct)
randomized trials (conj)
proteinuria whether (det)
explained could (aux)
serotonin of (case)
reaching occasionally (advmod)
impaired phenylephrine (nmod)
managed aggressively (advmod)
onset- ( (punct)
testosterone and (cc)
end study (nmod)
improve background (dep)
pcp for (case)
require detection (dobj)
i to (dep)
failure stage (acl:relcl)
interview international (compound)
case few (amod)
reveal impact (dobj)
progesterone or (cc)
artery basilar (conj)
preparation slow-release (amod)
lesion amiodarone-related (amod)
th ( (punct)
dose carbamazepine (compound)
median 64.1 (conj)
cognitive or (cc)
mg/day and (cc)
segment arteries (nmod)
granulocytopenia effect (nsubj)
defined anemia (nmod)
h 24 (nummod)
7.6 - (punct)
-n,5-dimethyl- 9-[[2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino (amod)
nephrin of (case)
30 3 (conj)
administered amphetamine (nsubjpass)
119 +/- (cc)
reduction 0.01 (nmod)
caused children (nmod)
injection . (punct)
vasodilator and (cc)
disease renal (amod)
follow cholestasis (nsubj)
min delay (nsubj)
cytostatic through (case)
pills slimming (amod)
activity higher (amod)
found women (nsubjpass)
level dosage (compound)
lowered might (aux)
mechanism peripheral (amod)
demonstrate induce (ccomp)
chemistries periods (conj)
develop weeks (dobj)
controlled 12-month (amod)
25 50 (conj)
10 15 (conj)
lcva ct (conj)
recordings in (case)
renal in (case)
h 115 (nummod)
acid txa (appos)
follow-up of (case)
suggest element (ccomp)
diazepam followed (acl)
67.2 - (punct)
60 to (case)
weeks age (nmod)
acc-9653 phenytoin (conj)
treated case (dep)
hypoventilation , (punct)
suffer occur (advcl)
effects two (nummod)
stimulated time-dependently (advmod)
pro-arrhythmic although (mark)
aminonucleoside the (det)
globulin immune (amod)
utilization correct (acl)
normal nonspecific (conj)
metolachlor herbicide (appos)
blocked but (cc)
pretreatment l-name (nmod)
behavior the (det)
increased normal (conj)
metabolite cocaine (compound)
november 2003 (nummod)
fluconazole and (cc)
dosages in (case)
late day (nmod)
found tolerated (conj)
proliferation cell (compound)
monitored carefully (advmod)
read asked (conj)
treatment intensive (amod)
periods of (case)
-20.93 + (cc)
doses weekly (amod)
p 20 (nummod)
elevated maze (conj)
do not (neg)
injected pre-treatment (nmod)
7.54 1.81 (appos)
dose 40-micrograms/kg (compound)
diagnosis , (punct)
enhanced been (auxpass)
diagnostic manual (conj)
dose period (conj)
action effect (conj)
technique microdissection (compound)
receive tamoxifen (dobj)
potentiate ? (punct)
showed extent (nmod)
leukemia apl (appos)
normalization the (det)
sub-divided group (nsubjpass)
extended focally (advmod)
ck-mb ] (punct)
inhibits ruling (advcl)
88 149 (conj)
decreased more (advmod)
led polyuria (nmod)
epilepsy . (punct)
injury ischaemic (amod)
technique rapid (amod)
studied ) (punct)
seen findings (nsubjpass)
method auditory (amod)
acidosis patients (nmod)
had six- (nsubj)
kinetics the (det)
prescribed who (nsubjpass)
time 8.9 (conj)
influenced response (nsubjpass)
reuptake the (det)
polyuria and (cc)
mg/kg either (cc:preconj)
stronger was (cop)
have ventricles (dobj)
present months (dep)
ed1 , (punct)
characteristic but (cc)
seen psychosis (nmod)
screening men (nmod)
sensitivity naloxone (dep)
sealants fibrin (compound)
% -9.9 (compound)
attenuates actions (dobj)
exposure anticoagulant (nmod)
likely conclusion (nmod)
antagonists competitive (amod)
sections frontal (amod)
more even (advmod)
conclusive results (nsubj)
bpt micrograms (dep)
environment department (nmod)
syndrome this (det)
reach . (punct)
matrix to (case)
esrd ( (punct)
chemotherapy hospital (nmod)
agent antithyroid (compound)
receptor to (case)
pralidoxime-2-chloride ( (punct)
related closely (advmod)
prolonged duration (dobj)
enzymes elevated (amod)
biopsies ( (punct)
manipulated not (neg)
tdp of (case)
hypotension ( (punct)
mg/kg phosphorofluoridate (conj)
man developed (acl:relcl)
doses catecholamines (nmod)
reactions volunteers (nmod)
administered orally (advmod)
response compared (case)
profile induced (acl)
contaminant this (det)
therapies systemic (amod)
period recording (compound)
times ( (punct)
discontinued treatment (nsubjpass)
diet low-salt (amod)
products respiratory (amod)
radical oxygen (compound)
institutions 16 (nummod)
changes brachial (amod)
median days (nmod)
mechanisms operative (amod)
men 13 (nummod)
risk recipients (nsubj)
interval at (case)
hearts deprived (amod)
dose remifentanil (nmod)
pentoxifylline ) (punct)
mm versus (cc)
injection intermittent (amod)
seizures tac-related (amod)
cleavage ) (punct)
nm 4.1 (nummod)
revised edition (compound)
developed minutes (nmod)
found drug (xcomp)
beneficial to (mark)
conditions , (punct)
started removed (conj)
secondary expression (nsubj)
estimates absolute (amod)
limb abdominal (conj)
ecg and (cc)
increased increased (conj)
allograft in (case)
reduced 170 (nmod)
sensitive sufficiently (advmod)
effects alpha-mediated (amod)
map % (compound)
dec. 2002-dec (appos)
18 in (case)
strokes incident (compound)
course fulminant (amod)
aura and (cc)
albumin plasma (compound)
hepatitis established (amod)
interest . (punct)
map mm (nmod)
common very (advmod)
% bid (nmod)
drug-induced " (punct)
was aim (csubj)
callosum 2/8 (appos)
lack surgery (nmod)
myelin as (cc)
reported none (conj)
postulate , (punct)
clinic a (det)
lasting week (nmod)
postdose compared (acl)
possible patients (nmod)
acquainted be (auxpass)
rhei rhizoma (compound)
words in (case)
layer fiber (compound)
diminished when (advmod)
increasing mm (dobj)
cuff right (amod)
mechanism enhances (acl:relcl)
concentrations myocardial (amod)
injections msg (nmod)
located elsewhere (advmod)
disclosed distorted (dep)
facies lungs (conj)
development complications (nmod)
0.19 to (dep)
marker followed (acl)
target raptor-containing (amod)
ahf of (case)
inhibited addition (nmod)
beta-ar ( (punct)
alpha-gst serum (compound)
latency morphine/rg1 (compound)
approval ethical (amod)
results overstimulation (nsubj)
cystitis adenovirus (compound)
potential strategy (nmod)
measured days (nmod)
correlated significantly (advmod)
estimate an (det)
parameters sodium (conj)
period after (case)
effect carcinogen (compound)
5-ht low (amod)
nodules hepatic (amod)
psychotropic different (amod)
suggest maps (nsubj)
any metabolites (nmod)
associated conclusions (dep)
significance proteinuria (nmod)
an the (det)
literature , (punct)
combinations patients (nmod)
induced barium (nmod)
cycle to (case)
radicals superoxide (compound)
doses d-pen (nmod)
encouraging enough (advmod)
understand effect (dobj)
common side (dep)
phenomenon linked (acl:relcl)
efficacy placebo (nmod)
deterioration patients (nmod)
induces trazodone (nsubj)
rated . (punct)
increases hand (nmod)
3,000 to (dep)
acrolein its (nmod:poss)
blockade site (nmod)
atypicality , (punct)
heart seventeen (nummod)
crisis induced (acl)
99 79 (conj)
assess to (mark)
aspect medial (amod)
combination estradiol (nmod)
test second (amod)
models from (case)
doses body (nmod)
associated initiating (advcl)
levodopa for (case)
requires activation (dobj)
nifedipine 1 (nummod)
hypothesis by-product (ccomp)
determined catecholamines (nsubjpass)
recorded 43 (nsubjpass)
effects unacceptable (amod)
subset animals (nmod)
effect d-ribose (nmod)
coadministered azt (nmod)
mrnas subunit (compound)
mg/kg 450 (nummod)
fluoxetine total (amod)
margin doses (nmod)
cells animals (nmod)
exerts also (advmod)
confirmed this (nsubjpass)
tablet > (nmod:tmod)
manipulating of (mark)
cells ed-1-positive (amod)
factors disorders (conj)
seen as (mark)
test pinprick (amod)
describes report (nsubj)
given propofol (dobj)
quit drinking (dobj)
baseline from (case)
3.7 3.4 (dep)
% 0.9 (nummod)
feasible effective (conj)
complications the (det)
adenocarcinomas , (punct)
reports transplantation (nmod)
d-med antagonist (conj)
fraction left-ventricular (amod)
exceeds dose (compound)
% 5.7 (nummod)
neonates toxicity (nmod)
observed % (dep)
serum concurrent (amod)
nicotine mg/kg (appos)
syndrome woman (nmod)
valproate clonazepam (conj)
syndrome guillain-barr (amod)
patient 64-year-old (amod)
than or (cc)
showed effect (dobj)
occurred observed (conj)
denervated been (auxpass)
volume cm (nmod)
prudent it (nsubj)
neuroadaptation death (conj)
tolerated patients (nmod)
study users (compound)
ingested when (advmod)
hoe ; (punct)
km in (case)
mg/kg 30 (nummod)
effect tumor-protective (amod)
capacity spatial (amod)
findings microscopy (nmod)
adenocarcinomas palpable (amod)
minutes 120 (nummod)
conversion csa-to-srl (compound)
combination analgesics (nmod)
u/liter 769 (nummod)
epilepticus after (case)
bleeding intestinal (amod)
proteases circulating (amod)
range reference (compound)
significant factors (nsubjpass)
amplitude sap (compound)
months 5,877 (nummod)
shunt and (cc)
4 3 (compound)
appeared application (nsubj)
patients asa (compound)
girl the (det)
data 2b/3 (appos)
sensations burning (compound)
5,7-dht ( (punct)
in " (punct)
technique oralis (nmod)
society asa (appos)
factor bn (appos)
induced mg/kg (dep)
detected calcification (nsubjpass)
incidence risk (conj)
leads nephropathy (nsubj)
alterations macroscopic (amod)
counts groups (nmod)
entropion and (cc)
thrombocytopenia life-threatening (amod)
models procedures (appos)
first suggests (conj)
aids both (appos)
involved pain (nmod)
available data (nsubj)
mass , (punct)
% p<0.021 (appos)
alleles the (det)
diminished . (punct)
percentage hemisphere (nmod)
abolished completely (advmod)
administration subarachnoid (amod)
severe headache (nsubj)
candidates in (case)
reactions donors (nmod)
important effects (nsubj)
distracted when (advmod)
affect diltiazem (nsubj)
rats sprague-dawley (compound)
antinociception induced (acl)
ligands three (nummod)
min within (case)
occlusion mcao (appos)
cocaine- and (cc)
mg/m2/d 160 (nummod)
restored using (xcomp)
mortality overdose (nmod)
selective high (dep)
haematological and (cc)
interviewed patients (nsubjpass)
analgesia a (det)
blocks that (nsubj)
75,761 37,495 (conj)
bupivacaine levobupivacaine (conj)
investigation methods (nsubj)
nephritis of (case)
kinases protein (compound)
trials and (cc)
applied , (punct)
antibody mrp2 (compound)
years age=23.3 (amod)
releases blocking (advcl)
paradigms these (det)
function specific (amod)
more significantly (advmod)
artery mesenteric (amod)
glands parathyroid (amod)
changes any (det)
cancer non-small (amod)
content bone (compound)
matter within (case)
frequency loss (nmod)
meth and (cc)
b. of (case)
increased difference (nmod)
aneurysm . (punct)
acetaminophen- against (case)
adrenoceptors central (amod)
produced apomorphine (nmod)
> 1.27 (nummod)
however group (compound)
harvested isolated (conj)
merits . (punct)
patients 20 (nummod)
period for (case)
co-administration cnsb002 (nmod)
bone and (cc)
behaviors sensory/motor (compound)
has effect (nsubj)
forms epilepticus (nmod)
demonstrated infusion (nmod)
association striking (amod)
ca , (punct)
experience fall (dobj)
da concentration (dep)
cardiac skeletal (conj)
test aggregation (compound)
remained unresponsive (xcomp)
complicated is (auxpass)
status cardiovascular (amod)
obtain convulsions (dobj)
blood on (case)
reduce would (aux)
-0.81 ) (punct)
found inhibit (xcomp)
pallidotomy experience (dep)
seen conditions (nmod)
patients recurrence (nmod)
injection etomidate (compound)
hot-plate of (case)
lidocaine four (conj)
syndrome cauda (amod)
less iopamidol (nmod)
hexachloride gamma (compound)
% 68 (nummod)
exhibit mice (nsubj)
pathology glaucoma (nmod)
g/dl 8 (nummod)
reduces lidocaine (nsubj)
number median (amod)
developed transplant (nmod)
learning ( (punct)
patients fever (conj)
attributable chorioretinopathy (amod)
increased only (advmod)
anti-oxidant regulatory (conj)
events key (amod)
neither 3 (dep)
rosa . (punct)
channels pacemaker (compound)
improves carteolol (nsubj)
anemia failure (conj)
followed whom (nmod)
receiving patients (nmod)
have sometimes (advmod)
cats , (punct)
lev , (punct)
testes and (cc)
concerns this (det)
stopped place (nmod)
range 75 (conj)
causing shrinkage (dobj)
resistant seizures (nmod)
defined were (auxpass)
infusion hexamethonium (nmod)
agonists other (amod)
monitoring pressure (compound)
determining in (mark)
benign short-term (conj)
green protein (dep)
evaluated test (nmod)
decline eliminated (acl:relcl)
receptor development (nmod)
responsible quinidine (nsubj)
rostral intermediate-caudal (conj)
useful treatment (nmod)
acids the (det)
mg/m2 was (cop)
compared groups (nsubjpass)
receiving he (nsubj)
defined doses (nmod)
given ; (punct)
administration b (compound)
increased as (cc)
literature but (cc)
8 of (advmod)
disability patients (nmod)
accepted generally (advmod)
or concomitantly (advmod)
consistent involving (xcomp)
precipitate thrombocytopenia (dobj)
aggregation camp (nmod)
patients this (det)
metabolism oxidative (amod)
index saturation (compound)
prepartum ml (appos)
lowered treatment (nsubj)
expressed receptor (nsubjpass)
agonists 5-hydroxytryptaminergic (amod)
disorder deficit (compound)
similar degree (nmod)
salience in (case)
preoperative postoperative (conj)
peptide plasma (compound)
reduced maintained (conj)
greater doses (nmod)
occurrence concern (nmod)
attenuated effects (dobj)
solution morning (dep)
dose busulfan (nsubj)
= 0.0012 (dep)
urate serum (compound)
exposure gamma-hch (nmod)
aged , (punct)
fatigue the (det)
hypothermia prolonged (amod)
levels sham-operated (amod)
demonstrated ability (nmod)
pathogenesis aminonucleoside (nmod)
resistance lam (compound)
anticoagulants alternative (amod)
exhibited baseline (nmod)
episode use (nmod)
arises experience (ccomp)
progressive incurable (conj)
apprehensive extreme (amod)
cells cell (compound)
replaced carbimazole (dobj)
mg 12 (nummod)
synthase-1 mpges-1 (appos)
rigidity induced (amod)
now are (cop)
minutes thirty (nummod)
iop stress (conj)
infusions tci (appos)
= 1.228 (dobj)
models through (case)
completion and (cc)
delirium preoperative (amod)
csa by (case)
required group (nmod)
teratogenicity of (case)
epilepticus symptoms (conj)
mice transgenic (amod)
ultrasound intracoronary (amod)
k(atp ( (punct)
cellularity megaloblastosis (conj)
women concerned (acl:relcl)
displayed thus (advmod)
losartan by (case)
cells ventrolateral (amod)
medication l-dopa (amod)
drugs antiviral (amod)
pressure higher (amod)
degradative the (det)
levels normal (amod)
improvement cosmetic (amod)
microangiopathy characterized (dep)
tariquidar selective (amod)
donors apheresis (compound)
uncommon , (punct)
strain one (nummod)
responsive pain (nsubj)
remained indicating (advcl)
desvenlafaxine with (case)
required control (nmod)
latency , (punct)
exhibit how (advmod)
rate progression (compound)
ages of (case)
use its (nmod:poss)
c+e ( (punct)
status normalized (acl)
reduce had (conj)
litres/24 3 (compound)
thrombosis internal (amod)
simulated treatment (nmod)
analysis quantitative (amod)
history or (cc)
monitoring by (mark)
load high (amod)
0.6 switchers (nmod)
fsgs ( (punct)
behaviors premorbid (amod)
haemorrhage diagnosed (amod)
ich small (amod)
syndrome dystonia-like (amod)
inhibitors ganglia (conj)
segment diameter (nmod)
cardiorespiratory effects (conj)
patients sclerosis (compound)
prevent complication (dobj)
doses 4 (nummod)
events are (cop)
treatment s-1 (compound)
range with (case)
prevented used (advcl)
role nrf2 (nmod)
exacerbate to (mark)
prevalent and (cc)
p450 against (case)
resurgence the (det)
system muscarinic (amod)
11.33 +/- (cc)
inhibitor 3a4 (compound)
implantation vivo (advmod)
considered limit (dobj)
measure after (case)
time angiography (nmod)
signs suggestive (amod)
0.98 2.04 (dep)
mechanism reaction (nmod)
metabolism glucose (compound)
rate stroke (compound)
form recessive (amod)
10.7 6.5 (conj)
1.6 37 (prep)
reports among (case)
or=7.18 ci=2.612 (dep)
= 0.08 (dep)
explored effects (dobj)
0.83 , (punct)
vigabatrin drug (compound)
modulator positive (amod)
mean endpoint (xcomp)
episodes regarding (case)
rechallenge a (det)
data clinical (amod)
pressure his (nmod:poss)
largest date (nmod)
treated pergolide (nmod)
to 130 (dep)
excretion renography (nmod)
started dialysis (nmod)
variability with (case)
offers that (mark)
participants comparison (compound)
mitochondria heart (compound)
ctni ) (punct)
groups age (dep)
years 1 (nummod)
activity tmax (appos)
option therefore (advmod)
increase product (nmod)
gem-p ( (punct)
angiography magnetic (amod)
adopted subjects (nmod)
determine cross-reactivity (dobj)
surrounding nerve (dobj)
seizures partial (amod)
widely yet (advmod)
apoptosis lymphocytes (nmod)
leakage mannitol (nmod)
zolmitriptan to (case)
stroke hypertension (conj)
tachyarrhythmia . (punct)
observational is (cop)
offspring pce (nmod)
dph free (amod)
bronchodilator that (mark)
reach differences (nsubj)
effects ciprofloxacin (appos)
scores asex (compound)
modified pronounced (parataxis)
killed respectively (advmod)
agonist group (compound)
liver or (cc)
effect aniracetam (nmod)
contributed detected (conj)
experiments possibly (advmod)
identify treatment (dobj)
challenge drug (compound)
raised excretion (nsubjpass)
paracetamol subjects (nmod)
groups subsequent (amod)
suitable compromising (advcl)
contraindicated , (punct)
aggregation ex (amod)
shown similar (advcl)
determine reduce (ccomp)
possesses vitro (advmod)
mechanism(s its (nmod:poss)
reduced pressure (dobj)
occurred group (nmod)
presenting old (amod)
studied : (punct)
accumulating is (aux)
cows dairy (compound)
challenge single-blind (amod)
design a (det)
region surrounding (amod)
measure on (case)
3- to (mwe)
weight area (appos)
20 up (advmod)
rats given (acl)
targets ideal (amod)
22-fold approximately (advmod)
dose once-daily (amod)
followed hyperprolactinemia (nsubjpass)
appeared hepatomas (nsubj)
9.6-fold ( (punct)
tolerated patient (nsubj)
zidovudine control (conj)
replacement or (cc)
gyki-41 chlorpropanol (dep)
dose d (compound)
sulfate analgesia (nmod)
clonus rats (nmod)
cystica hemorrhage (conj)
rare be (cop)
regulator a (det)
n=92 and (cc)
had significant (conj)
induced 1,25(oh)2d (nmod)
shown increased (ccomp)
rats 60 (nummod)
scale 3 (nmod)
n-pyrimidinyl-2-phenoxyacetamides of (case)
safety clonidine (nmod)
pneumonitis hypersensitivity (compound)
levels s-transferase (nmod)
report siblings (dep)
propose we (nsubj)
electrolyte ammonia (conj)
papilloma and (cc)
ng/mouse of (case)
stimulation nerve (compound)
sensitivities seizures (nmod)
patient ileostomy (nmod)
thinning a (det)
indicates available (advcl)
associated epinephrine (nsubjpass)
noncompliance of (case)
complex respiratory (amod)
disorders of (case)
evidence quantitative (amod)
effective models (nmod)
buffer synthesis (conj)
reported dying (xcomp)
received group (dep)
safety dysfunction (nmod)
moran - (punct)
prevention production (nmod)
mg/kg whereas (mark)
pretreated nicotine (nmod)
1/2 less (advmod)
effects (+)-cibenzoline (nmod)
have could (aux)
breakdown pool (nmod)
severe greater (dep)
pretreatment myoclonus (nmod)
alt ( (punct)
profile toxic (amod)
block hypotension (conj)
14.1 2.4 (conj)
dementia : (punct)
result unrelated (amod)
penis of (case)
high relatively (advmod)
acid tna (appos)
done assessment (nsubjpass)
cause spite (nmod)
understanding for (mark)
dose may (aux)
sensitive may (aux)
lithium neonatal (conj)
lidocaine or (cc)
metabolism population (nmod)
syndrome both (cc:preconj)
found depleted (ccomp)
lack by (case)
parameters dbs (nmod)
controls historical (amod)
curve 6.0 (nmod)
kidneys marginal (amod)
have they (nsubj)
pregnancy defects (nmod)
mice by (case)
composition response (dep)
cervix the (det)
l-med l-isomer (dep)
titer and (cc)
transplantable carcinomas (nmod)
restore model (nmod)
penicillins erythromycins (conj)
response plus (cc)
produce which (nsubj)
administration chemotherapy (nmod)
licensed acetate (nsubjpass)
aorta kidney (conj)
16;567 - (punct)
mg/h 2 (nummod)
potently more (advmod)
complaints pain (nmod)
dosage on (case)
years years (conj)
mid- a (det)
appears reduction (nsubj)
properties , (punct)
associated dementia (nsubjpass)
minute gtn (dep)
frequency vision (nmod)
peroxidation lipid (compound)
scotoma central (amod)
pathway neutral (amod)
dexamethasone of (case)
att-alf in (case)
four times (quantmod)
mg/kg 16 (nummod)
men 20 (nummod)
results included (conj)
presence ischemia (nmod)
received tdi (nmod)
mice seizure (amod)
eluate in (case)
participants : (punct)
technique that (mark)
reported triad (nsubjpass)
purpose limit (appos)
scintigraphy and (cc)
contrary report (nmod)
tap sbs (conj)
patients assessed (acl)
occurred four (nmod)
versions alternate (amod)
subsided tachyarrhythmias (nsubj)
inhibitors enzyme (compound)
reduction anesthetic (nmod)
bbb through (case)
measured recording (advcl)
muscle myopathic (amod)
injection salt (compound)
products in (case)
simplifies provides (conj)
initiated be (auxpass)
immunosuppressant is (cop)
fact correlates (ccomp)
patients att-alf (compound)
cause lacking (ccomp)
treatment concomitant (amod)
blood-pressure in (case)
potencies similar (amod)
excitation system (compound)
described knowledge (nmod)
delineated clearly (advmod)
longitudinal gls (appos)
expression ligand (compound)
age younger (amod)
induced vasculitis (dobj)
activity combinations (conj)
sensitivity les (nmod)
characteristics concentration (nmod)
shelves different (amod)
valsartan val (appos)
monitoring vigilance (conj)
gender-dependent effects (nsubj)
factor ircrf (appos)
tissue juxtacanalicular (amod)
pain chest (compound)
infusion setting (nmod)
formation polyglutamates (nmod)
performed order (nmod)
noradrenergic first (amod)
weeks weeks (conj)
diligent must (aux)
associated commonly (advmod)
tachy- without (case)
significance presented (dep)
mg/m2 cisplatin (compound)
rose returned (conj)
had % (nsubj)
unlikely reduce (xcomp)
free effects (nmod)
suffering , (punct)
delta ) (punct)
2.9-fold ) (punct)
hypotension potent (amod)
phases ) (punct)
velocity given (amod)
occlusion associated (acl)
inhibition cyp1a2 (nmod)
fluphenazine of (case)
provocation hypotension (nmod)
occur animals (nmod)
effect antinociceptive (amod)
deliver doses (advcl)
attenuated , (punct)
hospital testing (nmod)
reaction drug-induced (amod)
controls dunnett (dep)
rigidity intense (amod)
clomipramine vehicle (conj)
range wide (amod)
outflow sympathetic (amod)
affected hypothyroidism (nmod)
cause cardiotoxicity (nmod)
given induced (conj)
sensation to (case)
impact replication (nmod)
= 193 (dep)
beat known (conj)
reduced % (advcl)
picrotoxin- or (cc)
progressively 12.8 (nummod)
similar states (nsubj)
loss the (det)
those primarily (advmod)
antagonism 1788 (appos)
exposure heparin (nmod)
grafting and (cc)
2.32 +/- (cc)
lower concentration (nsubj)
hypotension d-tubocurarine-induced (amod)
have worth (conj)
months 77 (nummod)
lower trials (nmod)
performed was (auxpass)
considered agent (nmod)
ability for (case)
care ) (punct)
treated practice (nmod)
source . (punct)
flumazenil 10 (nummod)
exposure sotalol (nmod)
developed cows (nsubj)
ventricular lv (dep)
beginning stage (nmod)
provided sedation (dobj)
shifting inhibition (conj)
presence disease (nmod)
day intraperitoneally (advmod)
density reversed (amod)
salbutamol , (punct)
mcl ( (punct)
daunorubicin liposomal (amod)
consuming meat (nmod)
dyskinesias without (case)
identified characterized (conj)
adherence sops (nmod)
response ) (punct)
had men (nsubj)
reduced slope (dobj)
concentrations m (dep)
measured we (nsubj)
develop untreated (advcl)
e1 pge1 (appos)
vasodilator arteriolar (amod)
elevated hippocampus (nmod)
lozenge and (cc)
seemed carry (xcomp)
administration anesthetic (amod)
distribution ischemia (nmod)
responsible recovery (nmod)
l-med micrograms/kg (appos)
phosphorylation on (case)
enhanced conclusion (nmod)
morphine and (cc)
approach carcinoma (nmod)
day their (nmod:poss)
unclear evidence (nmod)
attractive hyperalgesia (nmod)
reviews mechanisms (dobj)
infusion a (det)
calcium thyroid-stimulating (conj)
recorded millimetres (nmod)
cmro2 ( (punct)
woman block (nmod)
considered next (dep)
patients dexmedetomidine (dep)
1.65 0.57 (conj)
recall delayed (amod)
induce does (conj)
days range (dep)
continued appeared (conj)
mg increased (conj)
correction anemia (nmod)
had images (dobj)
half in (case)
= p<0.05 (dep)
minute 30 (nummod)
infections of (case)
induce dysplasia (dobj)
blockers terfenadine (appos)
lead stroke (xcomp)
therapy epsilon-aminocaproic (amod)
responses suited (conj)
show activity (dobj)
p trend (nmod)
negative also (advmod)
penetrating barrier (dobj)
ensure not (neg)
loop the (det)
glomerulonephritis progressive (amod)
steroids dose (compound)
use clinical (amod)
similar hand (nmod)
achieving in (mark)
discovered son (nsubj)
cholestasis by (case)
pharmacology and (cc)
ip nmol/kg (compound)
average % (nmod)
viability changes (conj)
percentage % (appos)
acetate retinyl (compound)
amplitude ap (compound)
structure nerve (compound)
temperature , (punct)
mice to (case)
minority sites (nmod)
responsiveness between (case)
intramuscularly mg (conj)
volume time (conj)
lymphopenia ( (punct)
include period (dobj)
fruste one (nummod)
medications and (cc)
considered genesis (nmod)
minimal moderate (conj)
enzyme cox-2 (compound)
treated month (nmod)
greater may (aux)
flap dorsi (compound)
pose . (punct)
remained up (compound:prt)
done not (neg)
abusers hospitalized (amod)
remains characterized (acomp)
reentry multiple (amod)
acuity field (conj)
improved anemia (nsubj)
limited are (auxpass)
sustained deficits (dobj)
alterations with (case)
sufficient blockade (nsubj)
deformations lethality (conj)
doses microg/kg/min (nmod)
co-administration n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (nmod)
left . (punct)
contains reports (dobj)
products derivative (conj)
levels cytokine (nmod)
0.5 5 (conj)
reported reviewed (conj)
mean bp (dobj)
inhibitor maoi (appos)
responded ophthalmologists (nsubj)
was purpose (nsubj)
parameters other (amod)
increase using (advcl)
level tac (compound)
higher end (nmod)
region nodal (amod)
xo ( (punct)
evidence effectiveness (nmod)
stimulation atp (conj)
stroke to (mark)
provoked lacrimation (dobj)
dose amiodarone (nmod)
effect boys (nmod)
reversible that (mark)
role caa (nmod)
tumors % (conj)
uncommon that (nsubj)
doses isoproterenol (nmod)
assessed learning (nsubjpass)
revealed as (mark)
agonist decrease (acl:relcl)
combined cisplatin (nmod)
coma myxoedema (compound)
dosage with (case)
neuropathy nerves (nmod)
effect mechanisms (conj)
development to (case)
narcosis rats (nmod)
alkalosis metabolic (amod)
scopolamine-induced greater (advmod)
dismissed diagnoses (nsubjpass)
tubule dct2 (appos)
information incidence (compound)
of 150 (dep)
phase 4 (nummod)
administration combination (nmod)
homology sequence (compound)
extracted methods (dep)
scored 1 (nmod)
half approximately (advmod)
education occurrence (nmod)
trials randomised (amod)
received needs (nmod)
resulted introduction (nsubj)
effects neuropsychiatric (amod)
view simplifies (ccomp)
dosage mtd (appos)
rate expected (amod)
became administration (nmod)
obtained biopsy (nsubjpass)
affected myopathy (nmod)
day 54 (nummod)
lidocaine- cocaine-kindled (conj)
4 18 (prep)
treatment l-dopa+benserazide (nmod)
contributed formation (nmod)
study blinded (amod)
classified principle (nmod)
necrosis septal (amod)
phenotype macrophage-like (amod)
found was (advcl)
39.23 + (cc)
bronchiectasis infection (nmod)
responses tonic (amod)
completed study (dobj)
inpatients all (det)
prl ) (punct)
ischemia isoproterenol-induced (amod)
procaterol , (punct)
2.92 to (case)
agreement the (det)
saline and (cc)
council research (compound)
cases described (acl)
determined . (punct)
diaphragm the (det)
paper for (case)
variants other (amod)
case rats (nmod)
recall he (nsubj)
repeated was (advcl)
levels known (acl)
blood urine (conj)
syndrome frontal (amod)
clarify true (ccomp)
effect pge2 (nmod)
media nonionic (amod)
became worsening (advcl)
0.3 - (punct)
rls ( (punct)
transplants the (det)
srl ) (punct)
stage highest (amod)
protein mean (dep)
system peripheral (amod)
complemented studies (nmod)
showed echography (nmod)
content lithium (compound)
access of (case)
denopamine ta-064 (appos)
children resolved (acl:relcl)
common the (det)
ranged level (nsubj)
indices subnormal (amod)
project by (case)
able overcome (xcomp)
lesions , (punct)
fever in (case)
reduce effects (dobj)
history disturbances (nmod)
oncology clinical (amod)
due changes (nmod)
blocked antagonist (nsubj)
sedation for (case)
indicate rats (ccomp)
lost follow-up (nmod)
kf17837 ( (punct)
women 871 (nummod)
patient virus (compound)
recoveries left (conj)
u/ml 8.6 (nummod)
rate initiation (nmod)
nra0160 - (punct)
rg1 ginsenoside (nmod)
electrocardiogram a (det)
elevated and (advmod)
inhibitors convulsions (nmod)
% 12/27 (appos)
underwent pallidotomy (dobj)
toxin no (det)
seen is (auxpass)
pressure excretion (conj)
minutes beta (appos)
analyzed study (nsubj)
method new (amod)
limiting anesthesia (nmod)
illustrates it (nsubj)
approach experiments (nmod)
serious . (punct)
protection . (punct)
epithelium urinary (amod)
spectrometry by (case)
disorder developed (acl:relcl)
profiles subtypes (nmod)
give results (nsubj)
damage hepatocyte (compound)
netilmicin tobramycin (conj)
swimming speed (dobj)
enrolment at (case)
order prevent (acl)
cord cystitis (nmod)
therapy that (mark)
identical were (cop)
vip norepinephrine (conj)
pesticide an (det)
potential regulated (acl:relcl)
approach therapeutic (amod)
cisplatin , (punct)
neoantigens these (det)
treated infections (nsubjpass)
lesion against (case)
produces responses (dobj)
colliculus pons (conj)
woman history (conj)
procedures the (det)
hypothesized was (auxpass)
considered addition (nmod)
serious disorders (nmod)
arrhythmias respectively (advmod)
show crocin (nsubj)
calculated was (auxpass)
double-blind placebo-controlled (dep)
level channels (nmod)
evaluable ; (punct)
reviewing after (mark)
hemolysis erythrocytes (nmod)
monolayers cells (nmod)
3 out (dep)
rr 1.0 (nummod)
ulcerous and (cc)
esrd because (case)
effects derivative (nmod)
isoniazid gamma-vinyl-gaba (conj)
exhibiting signs (dobj)
degeneration myelin (nmod)
found where (advmod)
pain infusion (compound)
type , (punct)
induced failure (nsubjpass)
effects discontinuation (nmod)
asked procedure (nmod)
cdc ( (punct)
mg/kg 0.01 (nummod)
confirmed formation (dobj)
process aging (compound)
urine and (cc)
effect direct (amod)
tdi i.v. (dep)
factor genetic (amod)
h 23 (nummod)
dysfunctions typical (amod)
treatment intra-accumbens (amod)
toxicity its (nmod:poss)
mm by (case)
1.35 , (punct)
g 10 (compound)
head-up the (det)
value to (mark)
inhibition thrombosis (nmod)
ocular . (punct)
serotonin norepinephrine (conj)
developing insights (dobj)
cyclophosphamide hexamethylmelamine (conj)
has but (cc)
adrenoceptors alpha (compound)
cardiomyopathy ( (punct)
sequential triple (advmod)
pr in (case)
neutrophil platelet (conj)
received readmission (nmod)
pain skeletal (amod)
years 2.9 (nummod)
centre active (amod)
baseline after (case)
pressure output (conj)
subgroups these (det)
monitored be (auxpass)
short- intermediate- (conj)
cultured admitted (conj)
higher years (nmod)
minutes 10th (amod)
supported armrest (nmod)
mg -0.42 (compound)
chick intact (amod)
important play (advcl)
cerebella groups (nmod)
october in (case)
women aged (amod)
decrease mbp (nmod)
preparation nerve (compound)
group h. (compound)
eyes all (det)
exercised caution (nsubjpass)
outpatients 71 (nummod)
stimulation paired (amod)
contraindicated is (auxpass)
fed . (punct)
troublesome tests (nmod)
middle-aged older (conj)
suppresses signaling (dobj)
is research (nmod)
remains determined (xcomp)
permeability microvascular (amod)
ratio median (dep)
initiation indinavir (nmod)
monitoring treatment (nmod)
ntg , (punct)
surface near (case)
duration 30 (nummod)
improved globulin (nsubj)
description clinical (amod)
dxnp dx (conj)
drugs . (punct)
placebo ibuprofen (conj)
managed can (aux)
good fairly (advmod)
received administration (nmod)
rg1 , (punct)
compared cellulose (nmod)
induce as (advmod)
infusions 0.5 (nmod)
nuclei thalamus (nmod)
average visits (nmod)
units , (punct)
resulted , (punct)
showed combination (nsubj)
was rats (nsubj)
reported used (conj)
electrocardiographic ambulatory (amod)
benzoylecgonine metabolite (compound)
information no (neg)
predicted analysis (nmod)
measured and (cc)
lobe hyperprolactinemia (nmod)
mg/kg 70 (nummod)
myocarditis emphasis (dep)
erythroderma and (cc)
observed animals (nmod)
dogs ) (punct)
implicated which (nsubjpass)
have conclusions (dep)
number vacuoles (nmod)
jerks mj (appos)
long a-77636 (nmod)
evidence activity (nmod)
values creatinine (compound)
characteristics inhibition (compound)
test indirect (amod)
led flushing (advcl)
artery circumflex (amod)
vasospasm cerebral (amod)
began improve (xcomp)
due were (cop)
considered vasculitis (nsubjpass)
hours 48 (nummod)
size stability (conj)
treatment intravenous (amod)
seizure against (case)
bmd with (case)
agonists : (punct)
cause are (cop)
essential continue (xcomp)
or 0.26 (nummod)
vulnerability effects (nmod)
microgram.kg-1.min-1 0.1 (nummod)
syndrome extrapyramidal (amod)
obtained parameters (nsubjpass)
report if (dep)
apap pap (conj)
rates year (nmod)
receive patients (nsubj)
h study (nmod)
had started (conj)
found icu (nmod)
second 1 (nummod)
7alpha-hydroxylase of (case)
measure tubules (nmod)
antagonists ketamine (nmod)
suggest however (advmod)
aggregation vitro (advmod)
55 - (punct)
calcification focal (amod)
1.7 -2.7 (dep)
observed significant (nsubjpass)
rise h (nmod)
glomerulosclerosis focal (amod)
ulcer and (cc)
dose d-tubocurarine (nmod)
checklist on (case)
measured compare (advcl)
6 , (punct)
history exclusive (amod)
rate c (dep)
reshaping of (case)
associated this (nsubjpass)
had event (dobj)
ultrastructural early (amod)
measurements patients (nmod)
time between (case)
artery rats (appos)
lost is (auxpass)
group p10 (compound)
patients seventy (nummod)
b ii (nummod)
upslope duration (conj)
dwi flair (conj)
patients mild (nmod)
91.5 and (cc)
transplantation prior (amod)
transfusion and (cc)
antagonists m(1)/m(3)/m(5)-selective (appos)
rate hemorrhage (nmod)
encountered is (auxpass)
therapeutic mg (dep)
effect each (det)
phase study (acl:relcl)
effect inhibitors (nmod)
cpr ) (punct)
attack of (case)
effects synergistic (amod)
activates daidzein (nsubj)
erythromycin amoxicillin (conj)
lymphocytes peripheral (amod)
g from (case)
resulted improvement (nmod)
attributable directly (advmod)
comprise traits (dobj)
treatment months (nmod)
symptomatic and (cc)
ne released (acl)
treatment terbutaline (compound)
injection collagenase (nmod)
suspension of (case)
% 18.9 (nummod)
drug use (conj)
utility agonists (nmod)
extension open-label (amod)
fa of (case)
exacerbations blockers (nmod)
estrogens exogenous (amod)
has that (mark)
losartan of (case)
occur rigidity (nsubj)
bicarbonate similar (ccomp)
role eliciting (acl)
users cocaine (compound)
[3h]-l-arginine of (case)
undertaken electrophysiology (nsubjpass)
microg/l range (appos)
seizures : (punct)
anticholinergics other (amod)
12.0 vs. (cc)
influence damage (nmod)
increases greater (amod)
transplanted worldwide (advmod)
azotemia , (punct)
occurred resolution (nsubj)
dithiothreitol , (punct)
prescribing aid (nmod)
stopping after (mark)
rats respect (nmod)
week either (cc:preconj)
underwent tests (dobj)
weeks terminating (advcl)
170 was (cop)
initiated then (advmod)
targeting increased (amod)
similar asenapine (nmod)
combining in (mark)
volume dyskinesias (nmod)
lines selected (acl)
i.v. mg/kg (dep)
examination , (punct)
depression by (case)
pacemakers junctional (amod)
concentration azelastine (nmod)
responsible were (cop)
third-generation and (cc)
suggested cause (ccomp)
resistance pressure (conj)
lithium admission (nmod)
details , (punct)
infusion h-1 (dep)
peptide pth-related (amod)
68- 692 (nummod)
eyes placebo (nmod)
treatment n (dep)
one causes (nmod)
placebo lamivudine (conj)
doses gentamicin (nmod)
interval = (amod)
increased significantly (advmod)
cb ( (punct)
developed rifampin (nmod)
institutions 15 (nummod)
odds overall (amod)
promotes investigate (conj)
onward captopril (nmod)
potassium their (nmod:poss)
due haemorrhage (nmod)
changed risk (nsubj)
and readily (advmod)
treated d-penicillamine (nmod)
modifications without (case)
lethargy and (cc)
conclusion found (dep)
method optical (amod)
infusion intraventricular (amod)
days=1.77 ) (punct)
aspects associated (acl)
correlated duration (nsubj)
analyzed been (auxpass)
25mg/kg , (punct)
injected bupivacaine (nsubjpass)
benign lymphadenopathy (conj)
rate release (nmod)
scale impulsiveness (compound)
effects dehydroepiandrosterone (nmod)
appeared 2 (dep)
disturbance sleep (compound)
score dpi (appos)
action sensitizing (acl)
dimension percent (conj)
no-synthase of (case)
motility spontaneous (amod)
users two (nsubj)
effect chat (nmod)
measured been (auxpass)
cis-platin infusion (nmod)
content dna (compound)
effects pro-apoptotic (amod)
morphine metamizol (nmod)
tests use (acl:relcl)
reversed morphine (nsubj)
is however (advmod)
treatment tumor (nmod)
times various (amod)
dunnett , (punct)
acid adequate (amod)
absorbed excreted (conj)
antagonized partly (advmod)
resulting hypocalcemia (nmod)
24.9 2.6 (conj)
nephritis focal (amod)
cocaine be (conj)
cost at (case)
% auc (appos)
organisms causative (amod)
day 49th (amod)
features sulindac (nmod)
modulation via (case)
co-administration lidocaine (nmod)
cgrp ( (punct)
causes epilepticus (dobj)
administration mtx (compound)
source vitamin (compound)
searched medline (nmod)
pravastatin mg/day (appos)
uncommon and (cc)
useful dexmedetomidine (nsubj)
disease associated (acl)
scale measure (nsubj)
acrolein , (punct)
ic ) (punct)
treatment indomethacin (nmod)
quality better (amod)
activities and (cc)
followed mg/m2 (dobj)
studies follow-up (amod)
consisted mg/day (nmod)
those experienced (acl)
vasopressin . (punct)
extent improvement (nmod)
mm r/r (compound)
chemotherapy intrathecal (amod)
enalapril mg (nmod:npmod)
fas increased (amod)
tdfs ) (punct)
microm [3h]cb (dep)
administered % (nmod)
persist seizures (nsubj)
u/ml 46.0 (compound)
reverse that (mark)
lowers pressure (dobj)
staining ) (punct)
nanoparticles acid (compound)
treat recovery (nmod)
essential available (ccomp)
take bpt/clz (dobj)
receptor d1 (compound)
revealed exploration (nsubj)
35 30 (compound)
alter levels (nmod)
induced incidence (dobj)
task olr (compound)
netilmicin of (case)
donor platelet (compound)
cardiovascular and (cc)
caudate and (cc)
symptoms parkinsonian (amod)
women 18 (nummod)
activities thiols (conj)
dexmedetomidine sedative (nmod)
serious 2/3 (nmod)
scarring glomerular (amod)
evaluated were (auxpass)
appears have (xcomp)
30 75 (conj)
ended pregnancy (nsubj)
followed subjects (nsubjpass)
drug potential (amod)
dyskinesia levodopa-induced (amod)
maximal and (cc)
those haemodilution (nmod)
effect nitrendipine (nmod)
doxorubicin/kg with (case)
amount between (case)
detected range (nmod)
hypertension rats (nmod)
reviewed , (punct)
administration propranolol (nmod)
% 2.86 (nummod)
assessed , (punct)
basis per (case)
beating ac (appos)
s.c. 177.8 (nummod)
oc for (case)
thresholds in (case)
inhibitor alternative (amod)
noted years (conj)
addition patient (nmod)
pretreated or (cc)
injury renal (amod)
mg/m2 auc (conj)
dependent ( (punct)
hypercalcemias or (cc)
accomplished , (punct)
3.4 ( (punct)
tested thus (advmod)
malondialdehyde levels (conj)
indication a (det)
was describe (xcomp)
levels toxic (amod)
affects cognition (dobj)
examination baseline (nmod)
study chronic (amod)
pruritus by (case)
study pediatric (compound)
immunosuppressive prophylactic (conj)
anticholinergics central (amod)
analysis statistical (amod)
0.62 ( (punct)
prolongs methadone (nsubj)
normalized infusion (nsubj)
role model (nmod)
using ratios (dobj)
enhanced further (advmod)
sexual improved (amod)
valdecoxib mg (appos)
effect respiration (nmod)
groups pretreated (amod)
counts in (case)
lipophages many (amod)
known have (xcomp)
consequences the (det)
tocolytics these (det)
results show (advcl)
eps akathisia (nmod)
similarity syndrome (nmod)
produced increase (dobj)
table ) (punct)
isoniazid s.c. (appos)
frequency . (punct)
affect whether (mark)
changes serum (compound)
ring of (case)
effects therapeutic (amod)
enzymes inactivate (acl:relcl)
analysis indicators (nmod)
common origin (nmod)
administration dosage (nmod)
extent in (case)
onset manifestations (nmod)
increased catalepsy (dobj)
week study (nmod)
alf=0/35 non-acetaminophen-induced (amod)
stopped magnesium (nsubjpass)
score 7 (nmod)
fpd hips-cms (nmod)
pressure intragastric (amod)
sagittal transverse (conj)
receiving treatment (dobj)
infusion formulation (nmod)
treated inhibitors (nmod)
application , (punct)
doses tetracycline (nmod)
worsened and (cc)
two or (cc)
produce effect (dobj)
mg/kg given (acl)
neuropathy ethambutol (nsubj)
target selected (nmod:poss)
low chronically (advmod)
risk defects (nmod)
clearly more (advmod)
course platelets (nmod)
hbv hbsag-negative (appos)
syntheses compound (nmod)
site mechanism (conj)
approximate inferences (nmod)
duration efficacy (nmod)
combination before (nmod)
familiarity , (punct)
sectors in (case)
seen basis (nmod)
workers five (nummod)
multiforme . (punct)
stiffness a (det)
treated day (nmod:tmod)
phz ( (punct)
considered although (mark)
in- ) (punct)
showing properties (dobj)
status nephropathy (amod)
risperidone , (punct)
stomach the (det)
diclofenac mg (dobj)
subset population (nmod)
isoproterenol mg/kg (appos)
mg 130/70 (amod)
regulation arousal (amod)
recommendation administration (nmod)
re-established injection (nmod)
iodixanol medium (amod)
hundred four (compound)
dose onset (nmod)
disorder alcohol-related (amod)
modulates that (mark)
% response (nsubj)
benefit this (det)
activity muscle (compound)
different decrease (dep)
inhibitor methylglutaril (compound)
less p (nmod:npmod)
cyp1a2 of (case)
injected increments (nmod)
osteoarthritis in (case)
rats disease (nmod)
synthesis levels (conj)
results completed (appos)
coma ' (punct)
tachyarrhythmia : (punct)
n. ( (punct)
dissociated preparations (nmod)
k(+)- ) (punct)
absorption oral (amod)
deaths apoptotic (amod)
128 +/- (cc)
clomipramine days (nmod)
fumarate : (punct)
antidepressant inhibitor (compound)
groups amphetamine-free (dep)
count and (cc)
function motor (compound)
acid aprotinin (compound)
got worse (advmod)
hypertension treatment (conj)
plasticity of (case)
reorganization synaptic (amod)
estimated data (advcl)
october , (punct)
grafts range (appos)
0.05 than (case)
hypotension study (dep)
modification without (case)
combination mg/m(2 (nmod)
mrna et-1 (compound)
stimulation alternative (appos)
5-httlpr for (case)
eyes on (case)
men 67 (nummod)
reversion decrease (nmod)
distorted and (cc)
ventricle and (cc)
creatinine serum (compound)
treated only (advmod)
operations for (case)
use europe (nmod)
0.06 , (punct)
release cgrp (compound)
density mineral (amod)
prosthesis heart (compound)
been ; (punct)
declined month (nmod)
placed . (punct)
conditioning on (case)
atresia congenital (amod)
encephalopathy reaction (nmod)
ameliorates amnesia (dobj)
strains all (det)
bilirubin and (cc)
included mean (dep)
administered also (advmod)
displacement given (amod)
lna , (punct)
reduced children (nmod)
correlated total (nmod)
24 5 (conj)
activity thalidomide (nmod)
orally per (case)
dilated cardiomyopathy (dobj)
produced matter (nmod)
dosages low (amod)
expression prl-r (compound)
muscarinic glutamatergic (conj)
disease serious (amod)
sphincter the (det)
higher rate (nsubj)
cohorts matched (amod)
comprises , (punct)
reduced frequency (nsubjpass)
comprising patients (dobj)
activator to (mark)
administered noted (parataxis)
less eu (dep)
leiden factor (compound)
was determined (advcl)
injections 6 (nummod)
susceptible are (cop)
cortex orbital (amod)
ncq436 ncq344 (conj)
8.3 1.7 (conj)
localized . (punct)
efficacy thyroidectomy (nmod)
shifting , (punct)
incidence injection (nmod)
beta-blocker betaxolol (conj)
compartment from (case)
identify parameters (nsubj)
differ p=0.36 (dep)
expression intrarenal (amod)
those hearing (nmod)
response propofol (nmod)
effects performance (nmod)
propose . (punct)
thrombosis vein (compound)
assessed independently (advmod)
frequent tended (conj)
concentration tolerable (amod)
measured compared (conj)
disorder autistic (amod)
hypokalemia were (cop)
university eskisehir (compound)
involvement to (case)
cisplatin over (case)
showed preponderance (nmod)
hg p (dep)
mouse rat (conj)
depth . (punct)
replaced as (mark)
complemented was (auxpass)
diet high (amod)
cholestasis minimal (amod)
supervened . (punct)
morbidity transplant-related (amod)
pump management (nmod)
doses catecholamine (compound)
therapy serotonin (compound)
hepatitis to (case)
had elevations (dobj)
evaluate rate (dobj)
arrhythmias ventricular (compound)
disappeared , (punct)
tls ( (punct)
seem use (xcomp)
controls groups (nmod)
deletion receptor (compound)
vulnerability increased (amod)
liable that (mark)
challenge mg/kg (compound)
part major (amod)
symptoms occur (acl:relcl)
hippocampal neurogenesis (dobj)
three than (quantmod)
investigating poisoning (dobj)
detected part (nmod)
index integrity (nmod)
shell or (cc)
n=26 ( (punct)
achieved patients (nsubj)
slowing degree (compound)
considered insufficiency (nmod)
15 much (advmod)
nk1 both (cc:preconj)
% 17.2 (nummod)
considered early (xcomp)
cells/mm3 52.4 (nummod)
expression c (compound)
sv ) (punct)
marked but (cc)
= 1.7 (dep)
diagnosis patients (nmod)
urothelium receptor (conj)
inhibited or (advmod)
content intracellular (amod)
report leading (acl)
pco2 ) (punct)
improves rhigf-i (compound)
qt or (cc)
duration , (punct)
potentiates also (advmod)
microphthalmos hypertelorism (conj)
administration letrozole (conj)
changes i.v. (nmod)
present 51 (nmod)
examined days (nmod)
syndrome persistent (amod)
disease : (punct)
proven to (mark)
implicated production (nmod)
loss considerable (amod)
administration presence (conj)
fluoxetine to (case)
inhibitor another (det)
doses nonsedating (amod)
vsd md (conj)
concentrations similar (acl:relcl)
neuropathy antebrachial (amod)
related cocaine (nmod)
infarctions and (cc)
drugs quaternary (amod)
peptides of (case)
identical those (nmod)
tested control (dep)
university italy (appos)
1:4 ( (punct)
child 2-year-old (amod)
components bioactive (amod)
inactivation of (case)
mucositis grade (compound)
fentanyl oxide (conj)
pentoxifylline theophylline (conj)
vasculature group (nmod)
sampling ( (punct)
3.9 1.1 (dep)
observed deaths (nsubjpass)
arteries diameter (nmod)
rash skin (compound)
symptoms motor (nmod)
reported mcl (nmod)
action toxicity (nmod)
steroids group (nmod)
manner aggravation (nmod)
cortex im (conj)
disorder either (cc:preconj)
sustained and (cc)
lasted months (nmod:tmod)
april 2005 (nmod:tmod)
absence findings (nmod)
product degradation (compound)
associated hypomagnesemia (nsubjpass)
electrocardiogram on (case)
systems heterologous (amod)
given nicotine (xcomp)
meshwork in (case)
prospective double-blind (dep)
indicates plays (ccomp)
ligand involves (conj)
csa nephrotoxicity (dep)
capacity were (cop)
confusion 1 (dep)
difference area (nmod)
mice nr1(neo-/- (appos)
amyloidosis of (case)
idiosyncrasy true (amod)
determined rats (nmod)
developed rat (nsubj)
involved effects (nsubj)
cases transformation (nmod)
ratio a (det)
pulse , (punct)
clearance and (cc)
reversible usually (advmod)
agents beta-blocking (amod)
usage given (case)
system monoaminergic (amod)
failure those (conj)
hypertension injury (conj)
caused carcinogen (nmod)
intention-to-treat according (case)
studying at (mark)
decontamination gastrointestinal (amod)
administered cp (nsubjpass)
levels or (cc)
clinic the (det)
those prolactin (dep)
hemispheres of (case)
generation third (amod)
action blocking (compound)
l-dihydroxyphenylalanine of (case)
days different (amod)
necrosis found (acl)
decrease ameliorate (conj)
relevant clinically (advmod)
conclude lack (conj)
diclofenac data (conj)
aimed we (nsubj)
injury hippocampal (compound)
potential slowing (advcl)
longer . (punct)
mechanisms result (acl:relcl)
cy ) (punct)
identified study (nsubj)
mrp2 for (case)
ischemia distal (amod)
pyrophosphate for (case)
effective dothiepin (nsubj)
measured plasma (nmod)
antagonist glutamate/n-methyl-d-aspartate (compound)
children 9 (nummod)
yawning " (punct)
tr(- ) (punct)
morbidity syndrome (nmod)
communication study/short (compound)
measurements reproducibility (conj)
test finger-to-nose (compound)
cirrhosis for (case)
bdl ( (punct)
alterations observed (amod)
levels severity (compound)
obstruction caused (acl)
dyskinesias for (case)
coexisted . (punct)
ulcers gastric (amod)
weight 200 (nummod)
drug ketamine (acl:relcl)
ii iii (conj)
decreased modafinil (nsubj)
abnormality a (det)
spironolactone of (case)
n. 7 (nummod)
poison is (cop)
phase 6-week (amod)
continued had (conj)
october 1998 (nummod)
had mg (nmod)
reduction concentration (nmod)
examined we (nsubj)
binding of (case)
= 4941 (dep)
ncs ( (punct)
anticoagulant choice (nmod)
proportion large (amod)
damage chronic (amod)
microg/ml 2 (nummod)
systemic pulmonary (conj)
% 21.0 (dep)
adult healthy (amod)
periods follow-up (amod)
examinations histopathological (amod)
combination the (dep)
sign be (cop)
useful considered (conj)
artery ( (punct)
audit expert (compound)
synapse cell (compound)
probes subunits (nmod)
relationships liver (nmod)
insipidus study (dep)
dose demographic (conj)
known cause (xcomp)
measured gain (nmod)
cdt continuous (amod)
stronger antiarrhythmic (dep)
aniracetam compound (compound)
extremity of (case)
involved processing (nmod)
40,000 to (case)
dose gradual (amod)
impairments and (cc)
was reversed (conj)
substantiate to (mark)
therapy supportive (amod)
involved activation (nmod)
ml mean (compound)
agents antihypertensive (amod)
dealt anacardiaceae (dep)
patient bradycardia (nmod)
effect nephropathy (nmod)
monoxide carbon (compound)
design design (dep)
1.37 2.31 (dep)
arrest causing (acl)
effects cognitive (amod)
database the (det)
appearance , (punct)
10min 30min (nmod)
biochemical deficits (conj)
because , (punct)
recordings sleep (compound)
mg/ml 1.5 (nummod)
absence consumption (nmod)
ca3 silver-stained (amod)
sections liver (compound)
assessed questionnaire (nmod)
blocked ah6809 (nmod)
chance progressing (advcl)
event acute (amod)
group low-sodium (amod)
infusion intrarenal (amod)
maintained pressure (nsubjpass)
expressed amplitudes (nsubjpass)
scotomata bilateral (amod)
injury each (det)
projection through (case)
electrocardiographic ekg (appos)
conclusions supported (appos)
elimination drug (nmod)
ck-mb ) (punct)
secretion acid (compound)
therapy nitric (amod)
hypertension patient (dep)
mg/m(2 as (case)
roles physiologic (amod)
day 2 (nummod)
potently component (nmod)
responded patients (nsubj)
pralidoxime-2-chloride , (punct)
binding immunophilin (nmod)
had menopause (dobj)
one person (nmod)
reticulum endoplasmic (amod)
antagonized could (aux)
thrombosis follow (acl:relcl)
sulfasalazine on (case)
camkiia and (cc)
in day (nmod)
performs that (mark)
assessments preoperative (amod)
occurred second (advmod)
epinephrine dipivalyl (amod)
microangiopathy , (punct)
reported patients (nsubjpass)
rotation the (det)
receive people (nsubj)
characterized effects (dobj)
decreased 3 (dep)
study transnational (amod)
nephrotoxicity inhibition (dep)
h2o mg/ml (compound)
years 2009 (nummod)
assessed viability (dobj)
withdrawing and (cc)
ensure tolerance (dobj)
isoniazid decarboxylase (appos)
replaced encoding (nmod)
possible this (nsubj)
patients nsaids (compound)
reflex of (case)
sample plasma (compound)
hypotension impairment (conj)
obtained milliliters (nsubjpass)
injection pilo (compound)
dysfunction female (amod)
seizures levofloxacin-induced (amod)
continued room (nmod)
volume hilus (nmod)
evaluation damage (nmod)
breast the (det)
mannitol and (cc)
hyperalgesia brush-evoked (amod)
limits than (case)
agents ) (punct)
sub-divided hbv (nmod)
require combinations (nsubj)
had = (advcl)
leukopenia and (cc)
fields visual (amod)
anemia reversible (amod)
improvements stability (nmod)
preferable tmp (nmod)
1.85 0.57 (nummod)
mask trinitrate (conj)
consistent reaction (nmod)
impaired recall (nsubj)
t+a % (appos)
rats li-pretreated (amod)
condition transport (nmod)
dose microg/kg/min (nmod)
plays , (punct)
dosage dph (nmod)
reversed depression (dobj)
damage course (nmod)
differences other (amod)
10(-3 ( (punct)
self-limiting were (cop)
regimens different (amod)
patients children (nmod)
consumers regular (amod)
lesions callosum (conj)
jaw ) (punct)
increasing amount (dobj)
activity equivalent (amod)
manifestations . (punct)
seen % (dep)
generate model (dobj)
45.6 6.6 (conj)
defined albumin (conj)
fraction the (det)
revealed workup (nsubj)
treatment bupropion (nsubj)
unchanged but (cc)
man infection (nmod)
or 10.7 (dep)
effectiveness antigen (nmod)
presented she (nsubj)
reported h (nmod)
12 8 (compound)
dexmedetomidine sedation (nmod)
nnos ) (punct)
eaca ) (punct)
rate drop-out (amod)
amb spironolactone (conj)
injection amino-nucleoside (nmod)
prescribed man (nsubjpass)
mmhg superoxide (conj)
a protein (conj)
= t(33 (dep)
abolished dogs (nmod)
hundred twenty-two (conj)
assigned controls (dep)
inhibits given (advcl)
produce procainamide (nsubj)
binding t-[35s]butylbicyclophosphorothionate (nmod)
severe ; (punct)
ifosfamide with (case)
therapy hormonal (amod)
metabolites ncq436 (appos)
gem vnb (conj)
capillaries tortuous (amod)
recovered four (nummod)
16,459 is (cop)
administration continuous (amod)
taken hr (nmod)
mri and (cc)
ranging duration (nmod)
delivery anesthesia (nmod)
neuropathy grade (compound)
programming at2r (nmod)
findings other (amod)
triggered that (nsubjpass)
proportion interactions (nmod)
antidepressants with (case)
status physical (amod)
butyrylthiocholine with (case)
receiving june (nmod)
mg 8.6 (nummod)
had making (advcl)
alphaenac especially (advmod)
increasing years (nmod)
hypotension methyldopa-induced (amod)
correlate that (mark)
that flunarizine (nmod)
severity regurgitation (nmod)
assessment visual (amod)
foodstuffs as (case)
groups user (compound)
ischemia incomplete (amod)
amlodipine and (cc)
evaluated therapy (nmod)
consistent not (neg)
fan ( (punct)
hexachloride ( (punct)
include may (aux)
cardioversion maintenance (conj)
using examination (dep)
case spasm (nmod)
woman-years ci (appos)
choice are (cop)
used mg/kg (dep)
lesion neuronal (amod)
naloxone by (case)
manner selective (amod)
transplant unrelated (amod)
regardless irrespective (conj)
114+/-4 to (dep)
min < (dep)
sss the (det)
improves nik-247 (nsubj)
nortriptyline ( (punct)
polymorphism fragment (compound)
experiment functional (amod)
cessation despite (case)
peripheral electrophysiologic (conj)
accelerated onset (dobj)
15 mmol/0.5 (conj)
metabolized cyp2d6 (nmod)
naproxen 1.59 (nummod)
sd 0.015 (nummod)
problems cutaneous (amod)
level cytokine (compound)
crocins stz (appos)
hypertension phenylephrine (compound)
generated hbeag-positive (nmod)
lidocaine vs (cc)
discovered prolactinoma (nsubjpass)
difference regard (nmod)
alpha-methyldopa by (case)
had isolated-hit (dobj)
randomized a (det)
alteration any (det)
performed negative (conj)
carbimazole anca (compound)
cells p75(ntr)-immunoreactive (compound)
activity models (nmod)
treatment both (cc:preconj)
time mineralization (compound)
subjects had (acl:relcl)
adrenergic serotonergic (conj)
lactoferrin bovine (amod)
results responded (appos)
activity system (compound)
day 4 (nummod)
systems in (amod)
levels marker (nmod)
compared % (nsubjpass)
dose-dependent prevented (conj)
beta-adrenoceptor beta-ar (dep)
resistant was (cop)
alterations : (punct)
cyclosporin with (case)
depression arrhythmia (conj)
dehydrogenase lactic (amod)
1 whom (nmod)
had torsades (nmod)
g 13.5 (compound)
used management (nmod)
studies systematic (amod)
criteria predefined (amod)
tissue dried (amod)
patients placebo (conj)
medium , (punct)
one less (amod)
disease any (det)
0.7 2.5 (dep)
or or (dep)
nephrotoxicity amphotericin (compound)
reduced experiment (dobj)
grades haemorrhage (compound)
= 0.011 (dobj)
monitored parameters (nsubjpass)
receiving mp (dobj)
occurred down-regulation (nsubj)
treated ritonavir (nmod)
users 35 (nummod)
woman an (det)
calculated ratios (dobj)
differ lines (nsubj)
min per (case)
pallidotomy as (case)
detected conclusion (dep)
complication possible (amod)
cancers and (cc)
pretreatment amine (amod)
intensity their (nmod:poss)
initiation to (case)
levels ang (nmod)
dependent is (cop)
reduced increments (nsubjpass)
index body-mass (compound)
period reduced (amod)
channels ion (compound)
unfamiliar that (nsubj)
range antinociceptive (amod)
receptor sigma (compound)
reduction marked (amod)
blockade 5-ht2 (amod)
twitch 5-hydroxytryptophan-induced (amod)
combination days (nmod)
responses the (det)
obtained showing (xcomp)
useful blocks (nsubj)
infants in (case)
stress behaviour (nmod)
stimulation of (case)
tomography bladder (nmod)
edema intercellular (amod)
injections meth (compound)
multivitamin ( (punct)
platelets from (case)
existed has (aux)
recovery despite (case)
attention by (case)
headache chronic (amod)
nodules the (det)
pain breath (conj)
movements and (cc)
2.5 +/- (cc)
point time (compound)
followed , (punct)
progressed which (nsubj)
beats/min 98.7 (nummod)
compare dogs (nmod)
pre-surgery day (compound)
sensitization time-based (amod)
profile lozenge (nmod)
prescribed follow-up (conj)
cases possible (amod)
sadness , (punct)
safety impact (nmod)
implants acetonide (compound)
flow or (cc)
carcinoma cavity (nmod)
consistent encephalopathy (nmod)
recorded concomitantly (advmod)
dyskinesia moderate (amod)
dopac metabolite (compound)
suggestive course (nsubj)
reported was (ccomp)
control cyclophosphamide-pretreated (conj)
blocked , (punct)
complication bleeding (amod)
effects however (advmod)
varied concentrations (nsubj)
regions bilateral (amod)
encephalopathy hypoxic-ischemic (amod)
compared score (nmod)
mellitus smokers (conj)
achieved administration (nmod)
death showed (acl:relcl)
strategy : (punct)
contribute incidence (nmod)
underwent determine (advcl)
explore cells (conj)
evaluation term (compound)
cimetidine intravenous (amod)
drugs antiepileptic (amod)
activator as (case)
pain for (case)
resulted produced (advcl)
nmda by (case)
risk at (conj)
injury permanent (amod)
micromol/l 300 (nummod)
moving chicks (nsubj)
phenylephrine intraventricularly (appos)
aware discontinue (ccomp)
receiving alone (advmod)
test attention (nmod)
necrosis tumor (compound)
withdrawal on (case)
if this (nsubj)
rats performing (acl)
glutamate monosodium (compound)
duration all (advmod)
lesion increased (acl)
maximal declined (conj)
mg/day to (case)
younger patients (nsubj)
etoposide vp (appos)
ranged ratio (nsubj)
measure one (nummod)
status and (cc)
results associated (appos)
discontinuation fk506 (nmod)
ro15 patients (nmod)
unit intensive (amod)
gr prior (amod)
individuals mellitus (nmod)
intrarenally intravenously (conj)
monotherapy quetiapine (amod)
addition nitroglycerin (nmod)
infarction isoproterenol (amod)
case compared (case)
received had (conj)
dose relaxant (nmod)
remained group (nsubj)
pcc with (case)
increases fev1 (nsubj)
that intervenes (nsubj)
release medulla (nmod)
used perhaps (advmod)
health abilities (conj)
determine detect (ccomp)
development . (punct)
patients infarction (appos)
have convulsions (dobj)
released implant (nmod)
symptoms schizophrenic (nmod)
used divided (conj)
drops maleate (amod)
therapy blockers (dep)
250 eu (dep)
glycoprotein is (cop)
fluvoxamine ( (punct)
assessed " (punct)
transporter expressed (acl:relcl)
finding w-ich (nmod)
group ; (punct)
antidepressants coingested (amod)
attribution % (nmod)
number . (punct)
excretion decreased (amod)
addition myopathy (nmod)
ring a (det)
evidence or (cc)
patient young (amod)
appears ensure (ccomp)
infant women (nmod)
persisted increase (nsubj)
half-time cbd (conj)
determinant may (aux)
gaba gvg (appos)
injections ketamine (nmod)
tacrolimus % (compound)
hypertension pulmonary (amod)
received hypotension (nmod)
increased participants (nmod)
content catecholamine (compound)
hazard patients (nmod)
moving freely (advmod)
favored . (punct)
intervals one (nummod)
sevoflurane enflurane (conj)
had effective (conj)
dose bromide (nmod)
dxnp of (case)
blockade parasympathetic (amod)
intermediates implicated (acl:relcl)
cb of (case)
characterized involvement (conj)
accumulation reduced (amod)
myalgia increase (conj)
% 230 (nummod)
developed days (dobj)
suggest generates (ccomp)
responded ; (punct)
gain % (appos)
cardiotoxicity enhanced (amod)
micrograms 1 (compound)
response this (nmod)
number and (cc)
resulted compared (advcl)
evolution therapy (nmod)
sera containing (acl)
systems reporting (compound)
production subcellular (amod)
consumption activity (conj)
result from (case)
operated anesthesia (nmod)
lowered factor-alpha (conj)
present findings (dobj)
suggests comparison (nsubj)
abecarnil diazepam (conj)
production fibronectin (compound)
polyuria severe (amod)
rats insipidus (nmod)
had mutations (dobj)
al. 1981 (nummod)
underwent delivery (nmod)
ischemic , (punct)
third-generation ocs (conj)
response significant (amod)
reinitiated argatroban (nmod)
changes brain (nmod)
reaction hypersensitivity (compound)
essential bladder (nsubj)
responses short-latency (amod)
reversed disruption (dobj)
given induction (nmod)
ratio adp/o (conj)
problems some (det)
reviewed data (nsubjpass)
receptor glutamatergic (amod)
measures psychometric (amod)
dynamics fluid (compound)
events aes (appos)
scores improvement (compound)
temperature hyperthermia (conj)
therapy levels (conj)
pinealectomized in (case)
patterns toxicity (nmod)
estrogen hypotension (nmod)
symptoms dyskinesia (conj)
n=10 ) (punct)
combined where (advmod)
abuse ppa (nmod)
treatment fucoidan (amod)
measured degree (dobj)
duration short (amod)
combined support (nmod)
dementia . (punct)
suppression azidothymidine-induced (amod)
required transfusions (dobj)
reshape may (aux)
procedures endoscopic (amod)
map degeneration (nmod)
characteristics are (cop)
treatment initiated (acl)
infection b (compound)
determined cells (nmod)
40 50 (prep)
dose levodopa (compound)
cn not (cc)
conducted regimen (conj)
level ros (nmod)
7th 28th (conj)
hl60 in (case)
determine serve (ccomp)
patients myeloma (nmod)
addition bid (acl)
indicated comparison (nsubj)
malignancy as (case)
ss ) (punct)
channel ) (punct)
documented controls (advcl)
lometrexol the (det)
observed the (det)
proteins membrane-cytoskeleton (nmod)
middle-aged adults (dep)
pretreatment agent (nmod)
discharged followed (conj)
block branch (compound)
synergistic , (punct)
analyses regression (nmod)
1994 - (punct)
s-(-)-et-126 antagonist (compound)
produced pretreatment (nsubj)
occurred end (nmod)
pressure sitting (amod)
neurotransmission stimulated (amod)
promote blockade (nsubj)
confounded also (advmod)
ne , (punct)
demonstrated altered (ccomp)
18 not (advmod)
agsd or (cc)
volume thoracic (compound)
mechanism relevancy (conj)
23.43 + (cc)
alpha-configurations 5 (nummod)
databases and (cc)
administered 5-fu (nmod)
rats compared (case)
rr = (amod)
improved discontinued (conj)
caused greater (conj)
2.53 +/- (cc)
need no (det)
large very (advmod)
derivatives extracted (acl)
neutropenia patient (nmod)
infused pentothal (nsubjpass)
reactions due (case)
terms management (nmod)
resolution comparison (nmod)
myelination of (case)
sought be (auxpass)
anti-hbe ; (punct)
method sympathectomy (nmod)
infarctions dysfunction (conj)
adjustment methadone (nmod)
supplements with (case)
showed infections (dobj)
discussion reported (appos)
6.9 6.1 (compound)
led paralysis (nmod)
paramethasone parenteral (amod)
impact responses (nmod)
weakness administration (conj)
shown subsequently (advmod)
intact-control bcnu-exposed (conj)
considered test (xcomp)
matched controls (nmod)
reversible , (punct)
attained , (punct)
pressure 190/160 (nummod)
substrate pgp (compound)
continued irregularly (advmod)
records pharmacy (compound)
showed erdosteine (nsubj)
administration bpt/clz (nmod)
fracture an (det)
war of (case)
re-elevate pressure (dobj)
exacerbates bradycardia (compound)
hr amphetamine (dep)
angiography fluorescein (compound)
media two (nummod)
result complication (nsubj)
dose vpa (nmod)
4.3+/-1.9 mg (dep)
induce agent (nsubj)
plasma mean (dep)
acetazolamide by (case)
discontinuations than (case)
dizziness nystagmus (nmod)
exencephaly and (cc)
seizures no (det)
pelvis , (punct)
tachycardia on (case)
prescribing and (cc)
production neutrophils (nmod)
mice pilocarpine-treated (amod)
dbp ) (punct)
indicative superiority (nmod)
= sc (dep)
ducts glandular (amod)
patient recognition (conj)
mup diastolic (conj)
change tempol (nsubj)
initiating before (mark)
enrolled women (dobj)
test verapamil (compound)
pcpa to (case)
ultrasound by (case)
type opposed (dep)
required sixty-seven (nsubj)
women 2 (nummod)
diverse by (case)
suxamethonium intravenous (amod)
initiated should (aux)
follow-up preferably (advmod)
mean rate (nsubj)
exposure pcpa (nmod)
x-rays radionuclide (conj)
54.5 in (case)
make abnormalities (nsubj)
score : (punct)
effects extrapyramidal (amod)
existing previously (advmod)
follow-up median (amod)
response together (advmod)
mug m (dep)
type substrate (nmod)
men selected (acl)
hemoglobin a (det)
replacement of (case)
effects additional (amod)
incidence reactivation (nmod)
fields in (case)
assessment behavior (nmod)
monitor holter (compound)
studied not (neg)
hypotension caused (acl)
inhibition parp (nmod)
effect quetiapine (nmod)
recorded activity (nmod)
follow-up last (amod)
conventional or (cc)
myalgias and (cc)
pairs eyes (nmod)
paralysis , (punct)
detected decrease (dobj)
dismutase reductase (conj)
duct and (cc)
appeared patient (nmod)
injection group (nmod)
responsible might (aux)
examined routinely (advmod)
d4.2 cloned (amod)
given vehicle (xcomp)
cross-tolerant cross-tolerant (advcl)
sympathomimetic similar (acl:relcl)
is modulated (ccomp)
times nine (nummod)
levels epo (nmod)
embryolethality and (cc)
observed cortex (nmod)
reviewed receiving (advcl)
months months (dep)
received prevent (xcomp)
counts , (punct)
factor insulin-like (amod)
staining immunofluorescence (compound)
hypertension failure (conj)
bronchitis % (appos)
had parameters (nmod)
apnea and (cc)
investigated test (nsubjpass)
potentiated significantly (advmod)
chicks control (compound)
activity acetylcholinesterase (compound)
toxicity neurobehavioral (amod)
arrhythmias characterized (acl)
symptoms haloperidol-induced (amod)
persistent hiccups (nsubj)
c219 pgp (compound)
thiopentone of (case)
agent burns (nmod)
model capsaicin (compound)
consisted encephalopathy (nmod)
micromol/l from (case)
sacrifice to (mark)
given monitoring (nmod)
showing differentiation (dobj)
supersensitivity denervation (compound)
emphasis symptoms (nmod)
disorders fibrinolytic (amod)
related 16 (nsubj)
circulation spontaneous (amod)
increasing activity (dobj)
remained returned (conj)
adenosine-5'-triphosphate beta-methylene (compound)
decreased less (advmod)
appears respond (ccomp)
minutes < (appos)
treated dopa (nmod:npmod)
significant group (nmod)
bradycardia therapy (nmod)
angiograms green (amod)
amns subcutaneous (amod)
revealed related (ccomp)
man 45-year-old (amod)
levels ) (punct)
prior intervals (conj)
confirmed as (mark)
water tap (compound)
available have (aux)
cells skin (compound)
produce either (advmod)
system ir (compound)
dogs 20 (nummod)
increases mechanism (dobj)
carotid intradural (amod)
cultures vivo (conj)
needed also (advmod)
observations direct (amod)
therapy perimenopausal (nmod)
hctz or (cc)
hypothesized exhibit (ccomp)
updrs ( (punct)
injections pan (nmod)
chemotherapy in (case)
decreasing by (mark)
problem the (det)
max lv (compound)
dilated markedly (advmod)
fractionated model (dobj)
sought generate (xcomp)
abusers of (case)
average drinks (nmod)
amount cocaine (nmod)
inhibitors , (punct)
life-threatening and (cc)
presented findings (nsubjpass)
specificity for (case)
synthesis evaluation (conj)
man 82-year-old (amod)
element alterations (nsubj)
matched , (punct)
animal orally-treated (amod)
inferences with (case)
responses hemodynamic (amod)
conditions during (case)
consistent : (punct)
126 +/- (cc)
indicate predict (conj)
treated withdrawn (conj)
scintigraphy [omega-i-131]heptadecanoic (amod)
causes freezing (xcomp)
fit genotype (nmod)
concentrations urine (compound)
asa , (punct)
line of (case)
> of (case)
shivering , (punct)
chicks of (case)
increase slices (nmod)
modulating pathway (nmod)
fluoxetine own (nmod)
known ketoconazole (nsubjpass)
treated streptozotocin (nmod)
400 200 (compound)
induced interval (nmod)
woman depression (nmod)
battery tests (nmod)
hemorrhagic tumors (nsubj)
considered moderate (xcomp)
relationship direct (amod)
cycles gem-p (nmod)
increase expressed (acl)
day case (nsubj)
necrosis with (case)
implications recommendations (nmod)
assessed concentrations (nmod)
evaluated : (punct)
day twice (advmod)
seconds forty-two (amod)
decrease some (det)
anemia or (cc)
alter levels (dobj)
linn indica (compound)
potentiate or (cc)
function sensory (amod)
psa ( (punct)
seen combined (advcl)
cause medication (nsubj)
developed taking (advcl)
3',5'-monophosphate ) (punct)
commenced withheld (advcl)
carried subgroup (nmod)
developed administered (advcl)
rats treated (amod)
6-ohda-lesioned and (cc)
cardiotoxic possible (conj)
that tg (nmod)
function analysis (nmod)
elimination a (det)
reversed amnesia (nsubjpass)
animals anaesthetized (amod)
peptide a (det)
involved toxicity (nmod)
trajectory used (acl)
series assumptions (nmod)
unable exercise (xcomp)
obtained after (mark)
crisis between (case)
infusion h (conj)
involvement regardless (advmod)
course function (nmod)
years months (appos)
1996 ) (punct)
demonstrated observations (nsubj)
thalamus of (case)
system mononuclear (amod)
ccr2 and (cc)
severe effect (nsubj)
2 than (quantmod)
rise enos (nmod)
chemotherapy antineoplastic (amod)
headache immediate (amod)
intestine ischemic (amod)
time recovery (nmod)
calculated oscillations (nmod)
indicate influenced (ccomp)
inconclusive investigations (nsubj)
fatalities overdoses (nmod)
8.4 +/- (cc)
affected results (nsubjpass)
minutes minutes (conj)
bruising hours (nmod)
initiated managed (conj)
small stones (nsubj)
gating sensory (amod)
pain any (det)
adducts liver (compound)
infusions during (case)
complicated use (nsubjpass)
remained parameters (nsubj)
induce blockers (nsubj)
associated reduced (conj)
cortices kidney (compound)
stomach duodenum (conj)
neuronal and (cc)
lesion induced (acl)
treatment carboplatin (compound)
selected patients (nsubjpass)
carriers 12 (nummod)
myocytes ventricular (compound)
protection full (amod)
suggests work (nsubj)
segmental of (case)
interference with (case)
lower monotherapy (nmod)
observed 12/30 (nmod)
converted agonists (nmod)
mac 1 (nummod)
alpha-2b pegylated (amod)
nephrectomized sham-operated (conj)
intent or (cc)
= 0.055 (dobj)
neurotoxicity striatal (amod)
associated abnormalities (nsubjpass)
ways in (case)
terminated experiment (nsubjpass)
doses conjunction (conj)
induced fibrosis (dobj)
dyskinesias prominent (amod)
filling ventricular (compound)
increased shortening (nsubj)
shorter also (advmod)
showed % (ccomp)
registry spanish (amod)
occurred bradycardia (nsubj)
observation clinically (advmod)
remifentanil microg/kg (dep)
edema disease (conj)
pregs ( (punct)
addition prevention (nmod)
lesion selective (amod)
exposed box (nmod)
b of (case)
weight based (case)
controlled carefully (advmod)
length wave (conj)
examines . (punct)
discharges bilateral (amod)
conclusion risk (dep)
99 8 (compound)
strategy this (det)
dexamphetamine- apomorphine-induced (conj)
patients osteoporosis (nmod)
revealed movements (dobj)
potentials p-veps (appos)
performed reactions (nsubjpass)
dyskinesias and (cc)
administration in-hospital (amod)
h reflow (nmod)
reduced had (aux)
results enhanced (appos)
predictors patients (nmod)
mechanisms neuronal (amod)
lend patients (nmod)
recognised increasingly (advmod)
reaction chelation (nmod)
behaviour and (cc)
glands harderian (amod)
evaluated experiments (nmod)
intact to (mark)
treated sacrificed (conj)
stages different (amod)
force no (det)
exacerbates symptoms (dobj)
consider likelihood (dobj)
examination medical (amod)
betaine of (case)
limited be (auxpass)
model taa (compound)
nadh-dehydrogenase of (case)
pb promotes (acl:relcl)
summary in (case)
p .01 (nummod)
phenylephrine effects (nmod)
8,000 4,000 (compound)
luminal and (cc)
taken when (advmod)
relation time (compound)
rats wistar (compound)
antagonizing effects (dobj)
discontinuation of (case)
sufficient . (punct)
upregulation with (case)
contributes impairment (nsubj)
potential antiepileptic (amod)
hypotension gas (nmod)
angiography resonance (compound)
represents reason (dobj)
nmol/l 100 (compound)
re-challenged not (neg)
based results (nmod)
ed50 plasma (nmod)
women cohort (nmod)
ratio users (nmod)
existence the (det)
dexmedetomidine and (cc)
associated ci (nmod)
200 800 (conj)
pressure growing (amod)
inclusions matrical (amod)
report restlessness (nmod)
projections express (acl:relcl)
inhibited whereas (mark)
ulcer parameters (conj)
progression . (punct)
remains she (nsubj)
effects determined (dep)
increased required (conj)
dentate , (punct)
pressure bladder (compound)
patients sphincter (nmod)
associated eating (nmod)
analysis cox (compound)
risk eight-fold-higher (amod)
freedom infections (nmod)
infants 122 (nummod)
patients eight (nummod)
expression gap43-ir (appos)
activation and (cc)
validity some (det)
nrf2 of (case)
suggests ameliorate (ccomp)
acetonide the (det)
liver ct (conj)
baseline times (compound)
biopsies oral (amod)
buffer ice (compound)
enzyme essential (amod)
medial lateral (conj)
effects gentamicin (nmod)
administration and (cc)
clonidine alpha-methyldopa (conj)
effects dihydrochloride (conj)
involvement access (nmod)
stressed features (dobj)
doses across (case)
objective evaluate (acl)
ability benzylacyclouridine (nmod)
limited information (nsubjpass)
dexamethasone , (punct)
coli escherichia (compound)
facility female (nmod)
depletions corresponding (amod)
injected when (advmod)
diminish can (aux)
nerve around (case)
used methotrexate (nsubjpass)
reports vasculitis (nmod)
falls increase (advcl)
2/3 for (case)
occurred followed (conj)
weight mean (compound)
patients 2002 (nmod:tmod)
activity their (nmod:poss)
doses drug (nmod)
ingesting patients (nmod)
64 and (cc)
produced protect (conj)
1- 2-wk (conj)
arsenic inorganic (amod)
had arteries (nsubj)
intensity electrical (amod)
rose output (nsubj)
injury following (case)
potential mucosal (amod)
reported reach (parataxis)
level potassium (compound)
on hz (dep)
replacing amount (nmod)
thought actions (nsubjpass)
processes epithelial (amod)
eruption a (det)
upregulated and (cc)
toxicity report (dep)
pronounced most (advmod)
underline . (punct)
chronicity bipolarity (conj)
25/100 either (cc:preconj)
hypertension established (amod)
administration oral (amod)
monitoring pressure (nmod)
well-tolerated appeared (conj)
scale montgomery-asberg (compound)
had cannulae (conj)
preceded which (nsubjpass)
evaluation function (nmod)
pathway . (punct)
label number (dobj)
modulated intensity (nsubjpass)
appears under-appreciated (xcomp)
effects subjective (amod)
extracted rhei (nmod)
receptor-alpha pparalpha (appos)
produced changes (dobj)
cohorts stroke (nmod)
treatment rhuepo (amod)
intolerance ace (compound)
bolus for (case)
investigates . (punct)
wky shr (conj)
described synthesis (nsubjpass)
nx hp+nx (conj)
pmol 5.911 (nummod)
factor stimulating (compound)
adefovir , (punct)
infusion doses (nmod)
inhibition ace (compound)
takes months (dobj)
differences rate (compound)
observed cisplatin (nmod)
utility evaluation (nmod)
skf d-2 (conj)
sle ) (punct)
factors these (det)
prescribe give (conj)
shown protects (ccomp)
suggests melphalan (dobj)
sham-operated radiotelemetered (amod)
this epilepsies (nmod)
achieved disease (dobj)
values ed50 (compound)
limits toxicity (nsubj)
asthmatics in (case)
antigen antigen (conj)
types with (case)
less g/dl (dep)
activity completely (advmod)
presented report (ccomp)
reports event (compound)
synthesis of (case)
describe initiation (nmod)
effects anxiogenic (amod)
wall of (case)
correlation outcome (conj)
marker of (case)
background hbeag-negative (amod)
back-diffusion including (case)
glaucoma in (case)
was = (conj)
induced cocaine (nsubj)
weight their (nmod:poss)
eight-week double-blind (conj)
scans spect (compound)
nucleosides blood (nmod)
studied flow (nsubjpass)
time post-training (amod)
one was (cop)
relation sensitization (nmod)
view of (case)
class in (case)
insurance - (punct)
prevented seems (advcl)
protect toxicity (nmod)
model to (case)
cases consisted (acl:relcl)
patients unit (compound)
dose drug (nmod)
made metrizoate (conj)
chemotherapy . (punct)
salbutamol lds (appos)
development treatment (nmod)
report showed (ccomp)
implanted age (nmod)
properties on (case)
treated raised (parataxis)
oxidative of (case)
carotid the (det)
pretreatment extract (nmod)
addictive methamphetamine (nsubj)
is epilepsy (nmod)
adults treatment (nmod)
effect latter (amod)
mm was (cop)
none them (nmod)
adenocarcinomas pas (appos)
effect sulfate (nmod)
cultures neurons (nmod)
ha with (case)
analysis polymerase (compound)
33 12 (conj)
ml-1 ng (amod)
decreased cholesterol (nsubj)
expression loss (conj)
increase inclusion (nsubj)
conception from (case)
hexamethonium or (cc)
vasopressin avp (appos)
abrogated reduced (conj)
judged probable (xcomp)
present it (nsubj)
high 1.17 (advmod)
consisted averaged (conj)
recorded had (conj)
substituted was (auxpass)
sites distant (amod)
caused arrhythmias (dobj)
remained days (nmod)
iopamidol iodixanol (nmod)
trimethaphan the (det)
onset leukoencephalopathy (nmod)
cancers skin (compound)
s 17.0 (nummod)
reaction background (compound)
appear develop (xcomp)
administration b (conj)
ead ) (punct)
reabsorption calcium (compound)
cortex prefrontal (amod)
use routine (amod)
syndrome secretion (nmod)
minutes level (nummod)
week ( (punct)
significant difference (nsubj)
done methods (nsubjpass)
development crisis (nmod)
cefonicid mg/kg (compound)
greater in (case)
rate product (conj)
generated printout (nsubjpass)
course post-transplantation (amod)
memory impaired (amod)
pathophysiology insufficiency (nmod)
postswitch % (compound)
mg/kg doses (nsubj)
safety clinical (amod)
erdosteine by (case)
fk kg-1 (appos)
glucocorticoids of (case)
ufh ( (punct)
dopaminomimetics methoxamine (conj)
reaction severe (amod)
acid aminocaproic (amod)
discontinuation 5-fu (nmod)
expression oat1 (nmod)
stn ) (punct)
cause an (det)
doing children (nsubj)
patient elderly (amod)
received od (nsubj)
common impotence (nsubj)
barrier intact (amod)
phospholipid cell-mediated (conj)
necrosis apap-induced (amod)
norepinephrine ( (punct)
pretreatment 6-hydroxydopamine (nmod)
indicating decrease (dobj)
poor minorities (conj)
output and (cc)
developed hours (nmod:tmod)
changed levels (nsubj)
3 0 (nummod)
oil , (punct)
area terbutaline (compound)
anticipated that (mark)
therapy acetate (nmod)
mitochondrial drug-related (amod)
% cd4 (appos)
decrease svo(2 (nmod)
pathogenesis hypertension (nmod)
led stopping (csubj)
bradykinin or (cc)
hypertension neuroblastoma (nmod)
leading making (conj)
indicate mediated (ccomp)
polyvidone hexabrix (compound)
charge energy (compound)
seen sometimes (advmod)
developed 0.71 (nmod:tmod)
revealed calculation (nsubj)
reviews cvd (appos)
anova ( (punct)
fall increase (conj)
microdialysis measure (acl)
was p<.001 (attr)
prolongation hypocalcaemia (conj)
myeloma for (case)
attenuated similar (parataxis)
suggesting use (dobj)
2h of (case)
doses induce (acl:relcl)
demonstrated treatment (nmod)
damage a (det)
use development (conj)
presence pseudoacromegaly (nsubj)
adverse most (advmod)
role fair (amod)
manifestations and (cc)
determination routine (amod)
performed examinations (nsubjpass)
identified if (mark)
levels doses (conj)
relapse first (amod)
mother both (preconj)
increased 0.50 (nmod)
amelioration timolol (nmod)
diagnosed patient (nmod)
constipation-predominant diarrhoea-predominant (dep)
0.9 2.7 (conj)
increased regardless (advmod)
source d (compound)
t5 t10 (conj)
mg/day 0.75 (nummod)
patients . (punct)
required apparently (advmod)
administration etomidate (amod)
standard is (conj)
aimed determine (xcomp)
reshape map (nsubj)
used practically (advmod)
reduce omission (nsubj)
therapy fraction (conj)
reactions infusion (nmod)
prevented will (aux)
toxicity loss (nsubj)
one is (cop)
base line (dep)
increased excitability (dobj)
effect expression (nmod)
performed day (conj)
trial ii (nummod)
pancuronium with (case)
higher individuals (nmod)
related similar (nsubj)
toxicity increase (conj)
blind was (cop)
mg/day 75 (nummod)
preparations inflamed (amod)
administration concentrations (conj)
11.7 2.1 (conj)
s. ) (punct)
torr 48 (nummod)
fever with (case)
returned value (nsubj)
2b1/2b2 of (case)
exacerbates supporting (advcl)
cause frequent (advcl)
group first (amod)
consumption depression (conj)
given combined (conj)
regressed spontaneously (advmod)
functioning basal (amod)
administration disulfiram (nmod)
% 30 (nummod)
agent to (case)
model ligand (nmod)
underwent support (dobj)
n=10 ( (punct)
location either (cc:preconj)
lvdp/dtmax as (case)
level micrograms/dl (nmod)
modulators gaba(a (compound)
grade tumors (nsubj)
measure as (case)
delta activity (nmod)
ic in (case)
subtypes the (det)
refused , (punct)
agitation . (punct)
responses peripheral (amod)
stimulation in (amod)
found using (advcl)
infusions factor (nmod)
hbv 13 (nummod)
mild moderate (nmod)
conclusion showed (appos)
map co (conj)
clonidine given (case)
p less (amod)
weight concentration (conj)
calculi bladder (compound)
better . (punct)
red with (case)
mg/kg decrease (conj)
lowered also (advmod)
consistent this (nsubj)
reverse half-life (nmod)
inhibited % (dobj)
elevation intraocular (amod)
injection material (nmod)
changes diastolic (amod)
concentration with (case)
detected patterns (dobj)
visits hematology (nmod)
dizziness % (dep)
effect fluoxetine (compound)
explained be (auxpass)
mild require (conj)
induced csa (nmod:npmod)
hexachloride by (case)
sediment identified (acl)
oxide cell-derived (amod)
developed displayed (conj)
role neuroprotection (nmod)
evaluable toxicity (nmod)
infusions apomorphine (compound)
demonstrate determine (conj)
tariquidar the (det)
used piracetam (nsubjpass)
generated lexical (nmod)
inhibitors parp (compound)
clinical slower (amod)
further no (neg)
ratios dopac (dep)
affected man (nsubjpass)
radioimmunoassay by (case)
cross-tolerant while (mark)
systemic but (cc)
dna cells (nmod)
ventilated achieve (xcomp)
examined tested (conj)
necrosis papillary (amod)
formed to (mark)
patient neither (preconj)
catecholaminergic serotonergic (conj)
caused that (mark)
clinics through (case)
asymptomatic are (cop)
accompanied incidence (dep)
differences influence (nmod)
have injection (dobj)
associated drugs (conj)
found furthermore (advmod)
ascites hydrothorax (conj)
= 0.027 (dobj)
incidence tumors (nmod)
stimulation hz (nmod)
electrocardiogram while (case)
saline microl (compound)
amphetamine after (case)
devastating potentially (advmod)
dispersion of (case)
narcosis manner (compound)
angiogenesis number (conj)
of : (punct)
accompanied depletion (nmod)
occurrence mice (nmod)
explain that (nsubj)
increased conversion (nmod)
confirmed damage (dobj)
dyes fluorescent (amod)
atrial mouse (compound)
prevalence incidence (nmod)
depended class (nmod)
change should (aux)
study cohort (compound)
animals all (predet)
thalidomide lymphomas (nmod)
tamoxifen carcinoma (nmod)
diet bpa/kg (compound)
cephalosporins to (case)
arteries coronary (amod)
event neurotoxicity (conj)
decrease hilus (nmod)
gliclazide glimepiride (conj)
use monitoring (conj)
erdosteine antioxidant (acl:relcl)
discharged were (auxpass)
attenuation , (punct)
dosulepine hydrochloride (dobj)
blockade a (det)
reversal effect (nmod)
subjects placebo (nmod)
effect blood (nmod)
offer periods (nmod)
stunning myocardial (amod)
reached diet (nmod)
antagonists m(2)-selective (dep)
efficient . (punct)
hypertrophy cardiac (amod)
limited may (aux)
1.85 - (punct)
100 up (advmod)
iopentol and (cc)
pretreatment to (case)
hypothermia therapeutic (amod)
performed infusion (nsubjpass)
signals as (case)
events serological (amod)
ipratropium and (cc)
related 48 (nsubj)
patient year-old (amod)
documented safety (nsubjpass)
regeneration hepatocellular (amod)
monkeys of (case)
increases antagonizes (conj)
derangement a (det)
healthy however (advmod)
mean [cmax]/mic (dep)
pronounced day (nmod)
remained showed (conj)
infusion-produced methamphetamine (nmod:npmod)
high- the (det)
continue concerns (nsubj)
ganglia ventral (amod)
diabetics prone (amod)
inadequate when (advmod)
results upon (case)
s-312-d of (case)
task " (punct)
milrinone with (case)
erod ( (punct)
cessation used (acl:relcl)
planes along (case)
10- a (dep)
that group (nmod)
blockade occur (acl:relcl)
receptors against (case)
pain dental (amod)
pan ( (punct)
case resulting (acl)
unknown pathophysiology (nsubj)
well-demarcated , (punct)
mm 55 (nummod)
infusions haloperidol (compound)
eye 2002 (nummod)
identify drg (nmod)
licking paw (compound)
control routine (amod)
30 of (advmod)
reached is (auxpass)
properties vascular (amod)
incontinence prazosin-induced (amod)
monitored along (advmod)
selective were (cop)
% 19.8 (nummod)
concern % (dobj)
l/min , (punct)
index x (dep)
rats anesthetized (acl)
levels superoxide (nmod)
patients evident (acl:relcl)
enhancement myocardial (amod)
controlled had (conj)
yrs 45.6 (nummod)
asymptomatic if (mark)
sphincter of (case)
patients 99 (nummod)
statins and (cc)
contraindicated abnormalities (nmod)
lindane ( (punct)
micrograms inhibitor (appos)
% delta=-6.7 (amod)
glycopyrrolate i.v. (advmod)
group od (compound)
mechanism receptor-mediated (amod)
ro4368554 3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1h-indole (appos)
breaths ventilator (compound)
data reported (acl:relcl)
rating test (appos)
outpatient january (nmod)
found involving (advcl)
levels mrna (nmod)
restarted , (punct)
toxic stimulant (conj)
disturbed important (ccomp)
use tamoxifen (nmod)
one another (det)
induced blockage (nmod)
groups of (case)
ml/kg oil (nmod)
components subcellular (amod)
girl 14-year-old (amod)
hypotension asystole (conj)
aware reported (dep)
caudate the (det)
nigra seizures (nmod)
copolymer parent (compound)
received escalation (nmod)
tended reduce (xcomp)
continued be (auxpass)
on average (amod)
demonstrate protects (ccomp)
endografine , (punct)
days 7 (conj)
seen levodopa (nmod)
patients have (conj)
increasing duration (dobj)
gd or (cc)
levels potassium (compound)
results anorexigens (nsubj)
living period (nmod)
early conversion (nsubj)
monitor should (aux)
aftereffects of (case)
studied follow-up (advcl)
amounts adequate (amod)
administration rapamycin (appos)
benzoylecgonine for (case)
demonstrate association (dobj)
reduced suppressed (conj)
degree hours (nmod)
metabolized esterases (nmod)
content , (punct)
stereotypies induced (acl)
heterogeneity of (case)
strength muscular (amod)
status in (case)
role management (nmod)
arm supported (acl)
saline succinylcholine (conj)
developed arrest (dobj)
effect val204asp (nmod)
examined acutely (advmod)
rates sets (nmod)
returned stopping (advcl)
occurs heterogenously (advmod)
detected timolol (nsubjpass)
naloxone with (case)
irradiation disease (nmod)
differ however (advmod)
mg hour (nmod)
risk nephrotoxicity (nmod)
count neutrophil (compound)
components its (nmod:poss)
help guide (xcomp)
raises concern (dobj)
intravenous a (det)
chf ) (punct)
shows observation (nsubj)
difference sessions (nmod)
serially days (nmod)
superoxide . (punct)
regression dosage (nmod)
glycoprotein . (punct)
agent given (case)
continued dcf (nsubj)
mechanisms implicate (acl:relcl)
showed moreover (advmod)
effects carteolol (nmod)
symptoms edema (nmod)
use minoxidil (compound)
increased experience (nsubj)
trials now (advmod)
paralysis bilateral (amod)
diclofenac osteoarthritis (nmod)
6/8 ) (punct)
performed disease (nmod)
delineate had (advcl)
associated sedatives (xcomp)
vivo/in cytogenetic (dep)
administration ( (punct)
stimulated fragments (nmod)
remain completed (xcomp)
test . (punct)
ph po2 (conj)
a1 and (cc)
uveitis and (cc)
dropped beginning (nmod)
rate slow (amod)
analyzed test (nmod)
pattern bundle (compound)
abnormalities electrocardiogram (compound)
consists it (nsubj)
mechanism levels (nmod)
suggestion this (det)
rats mm (dep)
monitored ensure (xcomp)
increasing use (nmod)
profile safety (compound)
tuberculosis maternal (amod)
cases published (amod)
glutamate aspartate (conj)
had switch (nmod)
disease arising (acl)
tle ( (punct)
quetiapine scores (nmod)
damage for (case)
prevents partition (dobj)
gr and (cc)
show alleviate (ccomp)
influenzae were (cop)
treatment succimer (compound)
actions clonidine (nmod)
antagonizing depletion (dobj)
of ca(2 (pobj)
secondary pills (nmod)
psychosis in (case)
implicate do (aux)
shr the (det)
minutes is (cop)
damage vcm-induced (amod)
role medulla (nmod)
cases weeks (nmod)
studies one (appos)
age , (punct)
drugs tricyclic (amod)
hepatocarcinogenicity diet (nmod)
take design (dobj)
dextromethorphan the (det)
hoc post (compound)
solvd ) (punct)
sensitization convulsions (nmod)
features biological (amod)
effects insufficiency (nmod)
based were (auxpass)
lowered was (auxpass)
postures of (case)
forms distinct (amod)
illustrates this (nsubj)
antagonists , (punct)
tasks memory (compound)
recurrence follow-up (nmod)
cause could (aux)
yet determined (xcomp)
midazolam condition (dobj)
time occurred (acl:relcl)
rejection for (case)
increase conclusion (dep)
out-patients and (cc)
perfusion subsequently (amod)
hypotension glibenclamide-sensitive (amod)
potential compounds (nmod)
collection history (conj)
loreclezole mg/kg (appos)
classical olanzapine (dep)
slowness of (case)
high-dose acute (amod)
fractions cortex (conj)
circulation from (case)
had months (dobj)
increased using (advcl)
prescribe who (nsubj)
cco-iv and (cc)
elevating by (mark)
hours injection (dep)
activity cyclooxygenase-2 (compound)
years are (cop)
synthesis/release to (case)
< n=36 (appos)
outpatients 60 (nummod)
recently more (advmod)
excretion massive (amod)
those intoxication (nmod)
compares therapy (nsubj)
characterized poorly (advmod)
safety adding (advcl)
arrest overdose (nmod)
sensitivity baseline (nmod)
activity electroencephalographic (amod)
5-azacytidine mg/kg (appos)
bolus 4'-0-tetrahydropyranyladriamycin (nummod)
rates progression (nmod)
syndrome so-called (amod)
malondialdehyde in (case)
tnss lidocaine (compound)
msdbp [ (punct)
opaque , (punct)
reintroduced when (advmod)
affected presence (nmod)
antipsychotics classic (amod)
group 0 (conj)
treadmill a (det)
malignancy their (nmod:poss)
weight analysis (conj)
beta amyloid (compound)
/-s.d ) (punct)
thrombophlebitis ) (punct)
represented are (auxpass)
influence smoking (nmod)
activity with (case)
associated product (advcl)
vegf/vpf and (cc)
banned administration (nsubj)
courses time (compound)
overflow and (cc)
examined risk (dobj)
effect towards (case)
carbachol , (punct)
active more (advmod)
behavior btc (nmod)
considered remains (advcl)
usage drug (compound)
latencies seconds (appos)
5-hydroxytriptamine ) (punct)
necessary diagnosis (nmod)
increased threshold (nsubjpass)
transplantation renal (amod)
effect function (nmod)
occurs hypoxaemia (nsubj)
found robust (parataxis)
conclude site (ccomp)
conducted scheduled (advcl)
= 2.1 (dep)
populations of (case)
6beta-hydroxylase lithocholate (compound)
contre le (compound)
attained patients (nsubj)
produced methemoglobinemia (dobj)
impaired rats (nmod)
neoplasms liver (compound)
occurred ng/dl. (ccomp)
case interaction (nmod)
mg/m2 120 (nummod)
receptor human (amod)
mild . (punct)
treated paramethasone (nmod)
onset in (case)
progression glomerulosclerosis (nmod)
bodyweight ) (punct)
gamma-carboxylated indeed (advmod)
test p>0.05 (appos)
carriers antigen (compound)
attribute important (amod)
rats data (compound)
case clinical (amod)
baseline 2 (conj)
damage diplopia (nsubj)
diagnosed instituted (conj)
configuration threshold (amod)
adr 20 (nummod)
studies 0 (conj)
difficult be (cop)
neurotoxicity : (punct)
5 times (quantmod)
presentations similar (amod)
predict dysfunction (dobj)
showed microscopy (nsubj)
expression vegf/vpf (compound)
field novel (amod)
analysis clearances (conj)
performed investigate (xcomp)
progesterone as (case)
volume lv (compound)
certain is (cop)
hyperthermia tumor (nmod)
greater mean (nmod)
administered analysed (conj)
completion following (case)
combination effects (nmod)
doxorubicin hydroxytyrosol (conj)
breath after (case)
% 11 (compound)
withdrawal woman (nmod)
altered paradigm (nmod)
manifestations rash (nmod)
snr into (case)
10/5 amlodipine/benazapril (amod)
parameters red (amod)
discontinued dialysis (nsubjpass)
inhalator an (det)
accounted that (mark)
consistent atin (nmod)
compliance and (cc)
maintained status (dobj)
lymphomas in (case)
consciousness , (punct)
showed function (dobj)
received intravenously (advmod)
improved dyskinesias (nsubjpass)
determine use (dobj)
prl-r levels (dep)
biopsy myocardial (amod)
infection with (case)
resulted % (dobj)
ahs in (case)
produce enflurane (nsubj)
variety conditions (nmod)
12 to (quantmod)
infected , (punct)
inhibition enzymes (nmod)
improved denopamine (nmod)
any by (case)
% 73.5 (nummod)
decrease dp/dt(max (nmod)
nausea of (case)
therapy sulfasalazine (compound)
meninges with (case)
pancreatitis , (punct)
fs ) (punct)
artery dogs (nmod)
gender of (case)
attenuated naloxazone (nsubj)
each concentrations (nmod)
took overdose (dobj)
0.63 2.5 (conj)
week hydrocortisone (nmod)
disease total (amod)
effect phn (nmod)
lovastatin ( (punct)
compared ctnt (nmod)
tremor were (cop)
syndrome stomatitis (compound)
model new (amod)
require administration (dobj)
(-)-cibenzoline of (case)
caution extreme (amod)
giving rats (nmod)
tolerated pg (nsubjpass)
body tracheal (compound)
strategy coronary (amod)
cardiomyopathy adriamycin (appos)
days tumors (appos)
men 19 (nummod)
case any (det)
child a (det)
oxygen po2 (appos)
analysis an (det)
8.9 8.7 (conj)
cortex cingulate-limbic (amod)
reduced normal (conj)
glibenclamide , (punct)
reducing chronically (advmod)
disappearing were (advcl)
rates time (appos)
leukopenia granulocytopenia (appos)
derive surrogates (dobj)
option viable (amod)
mz and (cc)
synapse the (det)
bbb an (det)
carboxylesterase liver (compound)
uiu/ml nl (appos)
mass amiodarone-related (amod)
14 to (quantmod)
response no (det)
angina and (cc)
justified are (auxpass)
diuretics and (cc)
increase dl-sotalol (nmod)
dyschromatopsy a (det)
protected pilocarpine (nmod)
parameters , (punct)
decreased however (advmod)
therapy sulfate (compound)
7 h (dep)
2c , (punct)
treatment pi (nmod)
tumors papilloma (dep)
administration mg (dep)
recorded experiences (nsubjpass)
rated and (cc)
angiography testing (conj)
novelty aversive (conj)
moderate-dose controls (dep)
activities enzyme (compound)
methods had (dep)
issue to (case)
pain , (punct)
lna to (case)
dilates whereas (mark)
glomerulonephritis experimental (amod)
predict damage (dobj)
2r,4r-apdc ( (punct)
observation at (case)
approximation woolf (nmod)
weight lower (amod)
oxidation synthesis (conj)
procedure operative (amod)
elevated wt (nmod)
percent 15 (nummod)
ketoprofen , (punct)
hyperkalemia or (cc)
focused possibility (nmod)
observed a (dep)
pay occurs (advcl)
greater 0.1 (nummod)
5-httlpr ( (punct)
cytostatic associated (amod)
cause bromocriptine (nsubj)
precipitate coupled (advcl)
literature in (case)
associated temporally (advmod)
mechanism and (cc)
consistent absence (nmod)
increases levels (nmod)
given , (punct)
criterion by (case)
inhibited pce (nmod)
centre that (mark)
showed heart (nsubj)
% ic30 (appos)
adhd ) (punct)
presentation following (case)
survival better (amod)
growth pituitary (amod)
investigated that (nsubj)
antagonized protected (parataxis)
drivers , (punct)
induced using (xcomp)
toxicity (meth)-induced (amod)
age onset (compound)
expected , (punct)
inhibition intermediate (nmod)
323+/-43 1082+/-245 (dep)
diligent be (cop)
cases potential (amod)
dogs instrumented (amod)
differ changed (advcl)
either compared (case)
outcomes dichotomous (amod)
lead , (punct)
activities hr (dobj)
tumors experimental (amod)
block result (nmod)
media arteries (nmod)
study observational (amod)
presumed therapy (nmod)
comparable variables (nsubj)
localization with (case)
criteria reduction (nsubj)
hypokinesis inferior (amod)
hypothermia respiratory (conj)
relationship cgrp (nmod)
injury glomerular (amod)
that between (case)
hyperthermia with (case)
2.30 - (punct)
episode hepatitis (nmod)
observed groups (nmod)
deficits learning (nmod)
behavior ensued (acl)
had dysfunction (dobj)
incapacity the (det)
is cause (ccomp)
hearts failing (amod)
university-affiliated or (cc)
1.8 0.3 (conj)
microm 500 (nummod)
mechanisms located (amod)
when relapse (nmod)
delivered min (dobj)
females years (appos)
isoniazid in (case)
glomeruli controls (nmod)
atrial adult (amod)
responses six (nummod)
prophylaxis transplantation (nmod)
nerves vagal (compound)
47 to (quantmod)
research recent (amod)
infusion as (case)
morbidity substantial (amod)
dose necrogenic (amod)
using follow-up (nmod)
develop did (aux)
findings important (amod)
median 2 (nmod)
pounds weight (nsubj)
re-infarction after (case)
cells smooth (amod)
studied trials (nmod)
patients myalgia (conj)
total a (amod)
discovery the (det)
revealed induced (ccomp)
administered intrastriatally (advmod)
dose terbutaline (nmod)
found she (nsubjpass)
subunit or (cc)
evaluated further (advmod)
tube anesthesia (nmod)
gene ) (punct)
newborns of (case)
cycles ( (punct)
two hundred (compound)
night at (case)
= mm (dobj)
ro15 of (case)
assessed authors (nsubj)
cibenzoline ventricular (nmod)
conclude thus (advmod)
arthritis erosive (amod)
risk = (amod)
ptra between (case)
neurons gyrus (nmod)
quotient ( (punct)
microangiopathy tma (appos)
relapse after (case)
changes strains (nmod)
34.3 2.1 (conj)
patients calculated (acl:relcl)
stabilized treatment (nmod)
assessed reaction (nmod)
persons prescribed (acl)
oat of (case)
recorded tended (advcl)
same while (mark)
impair performance (dobj)
prolongation qt-interval (amod)
higher decreased (conj)
effects reversed (acl:relcl)
metabolism in (case)
effect sensitization (nmod)
stages stage (dep)
mexiletine of (case)
report was (cop)
considered have (xcomp)
comparable almost (advmod)
unlikely supplementation (nsubj)
stimulation high (amod)
related eps (nmod)
urinalysis time (compound)
hemoglobin with (case)
3ma adriamycin-treated (conj)
inhibitor cyp2d6 (compound)
observed pronounced (ccomp)
204 to (dep)
seizures after (case)
underwent sah (nmod)
staining antibody (nmod)
consisted those (nmod)
appeared adjust (xcomp)
mg/kg dose (nmod)
metabolized which (nsubjpass)
receptor acid (compound)
titres the (det)
report patients (dep)
threat life (nmod)
prevented partially (advmod)
cei ( (punct)
fatigue > (nsubj)
apap of (case)
determined study (nsubj)
treated ribavirin (nmod)
diabetic baseline (nmod)
27.37 +/- (cc)
contained derivatives (dobj)
low reported (conj)
study electron (compound)
total children (nmod)
skin normal (amod)
importance growth (nmod)
micrograms/kg 30 (nummod)
adenosine involving (case)
production superoxide (compound)
undergoing was (aux)
created shortage (nmod)
function a (det)
meningitis for (case)
target response (compound)
patients depressive (amod)
deduced observations (nmod)
analgesia peripheral (amod)
change 1 (nmod)
pentobarbital of (case)
1.30 to (dep)
influenzae haemophilus (nmod:npmod)
case third (amod)
1995 925 (conj)
detection products (nmod)
administration oxprenolol (nmod)
sex co-morbidity (conj)
patient viracept (acl:relcl)
showed disruption (ccomp)
understood citations (nmod)
toxic least (advmod)
calcium cis-ra (conj)
lower h (nmod)
given overcome (advcl)
vessels in (case)
transient steroid-induced (dep)
protocols separation (compound)
resulted neutralization (nmod)
restarting after (mark)
follows ) (punct)
use may (aux)
regimens the (det)
78 67 (conj)
occurred neuropathy (nmod)
deprivation followed (acl)
pre-operative post-operative (conj)
patient crf (nmod)
lh estrogen-induced (amod)
life normal (amod)
problems tolerability (compound)
implicated cause (xcomp)
limits were (cop)
stimulated receptors (nsubjpass)
salivation , (punct)
indicate mean (ccomp)
high- or (cc)
aminotransferase u/l (appos)
manifestations thrombocytopenia (nmod)
persistence the (det)
groups treated (acl)
subgroup primary (amod)
progestogens without (conj)
highlight reduced (conj)
symptoms neurologic (amod)
sch d1 (compound)
undergoes resulting (advcl)
projection by (case)
procedure examination (conj)
synthesis bs (nmod)
study department (nmod)
cardiotoxicity form (nmod)
responses cystitis (nmod)
find platform (dobj)
granulomatosis with (case)
hypertension systemic (amod)
feedback glucocorticoid (compound)
mg./kg of (case)
activities reductase (compound)
cyclosporine on (case)
duration test (nmod)
spike ap (nmod:npmod)
s-53482 and (cc)
min and (cc)
7 % (appos)
causing % (nmod)
amounts blot (nmod)
sensitivity convulsants (nmod)
rare associated (conj)
profile improved (amod)
abnormalities correlated (acl:relcl)
sites propagates (acl:relcl)
conclusions intravitreal (dep)
confirmed thus (advmod)
differ outcomes (nsubj)
aspect leg (nmod)
absent rats (nmod)
prove that (nsubj)
database provincewide (compound)
information further (amod)
picture a (det)
5.9 1.3 (conj)
vol% and (cc)
tumor on (case)
regions identified (acl)
reaction caa (nmod)
cancer in (case)
weight staining (conj)
wild-type not (cc)
ko ) (punct)
6.1 - (punct)
8.4 and (cc)
increasing % (advcl)
variety settings (nmod)
children hyperprolactinemia (nmod)
patients reactions (conj)
secondary outflow (nmod)
lymphomas relapsed/refractory (amod)
reflex horizontal (amod)
g 4 (nummod)
treated harvested (conj)
treatment concentrations (nmod)
disturbance eye (nmod)
cause hyponatremia (dobj)
useful dipyridamole (nsubj)
review an (det)
less 4 (conj)
hours prior (amod)
cle ( (punct)
had frequency (conj)
origin rarely (advmod)
levobupivacaine and (cc)
smokers disease (nmod)
thickness reduced (amod)
rare is (conj)
therapy tetrabenazine (nmod)
outpatients hundred (nummod)
4.7 s(h)uv (nsubj)
pseudoacromegaly . (punct)
20 to (quantmod)
antibodies by (case)
treatment important (amod)
continued they (nsubj)
its ) (punct)
cyclosporin to (case)
bcnu ) (punct)
conclusion use (appos)
treatment hypotension (nmod)
antigens i (nummod)
alternating chow (conj)
dimension posterior (amod)
ko pkca (compound)
metabolism mixed-function (amod)
intensity low (amod)
if especially (advmod)
unaffected parallel (nmod)
% were (cop)
compromise related (amod)
angiography cardiac (compound)
levels water (nmod)
imbalance . (punct)
participant the (det)
defect 1 (nummod)
40/min to (case)
tight snr (nmod)
necrosis necrosis (conj)
started chemotherapy (nsubjpass)
diagnosis initial (amod)
hemodialysis patient (nmod)
t180 ( (punct)
development with (case)
serum containing (acl)
localised periphery (nmod)
difficult easy (advcl)
control strains (nmod)
become applied (acomp)
bell-shaped . (punct)
rate engraftment (nmod)
initiation sirolimus (nmod)
deafened monkeys (nsubjpass)
incidence dose-dependent (amod)
cold-pressor cp (appos)
conclude inhibit (ccomp)
induce catechol (nsubj)
blocks it (nsubj)
% values (nsubj)
point and (cc)
combinations higher-dose (amod)
os gtn (conj)
migraine of (case)
systemic various (amod)
retardation intrauterine (compound)
activity peripheral (amod)
metabolites % (nmod)
ameliorate may (aux)
appears play (advcl)
surprise sadness (conj)
prevent replacement (nsubj)
bid mg (compound)
treated quetiapine (nmod)
methadone to (case)
exhibited surprisingly (advmod)
repair matrix (nmod)
suggesting influence (dobj)
mug 50 (nummod)
cnsb002 morphine (conj)
tolerable be (cop)
injection ouabain (compound)
patient nitrazepam (nmod)
ce ( (punct)
as safe (amod)
= 1.008 (dobj)
palpation by (case)
= 1.00 (dobj)
perforans elastosis (compound)
need increasing (amod)
observed experienced (conj)
rg1 not (neg)
observed growth (nsubjpass)
dyskinesia like (case)
hours 23 (nummod)
peld and (cc)
referrals children (nmod)
combination and (cc)
petechial diffuse (amod)
hyperalgesia because (case)
lesions metastatic (amod)
substitute is (cop)
week(-1 kg(-1 (compound)
encephalopathy scenario (dep)
concentrations measured (acl)
flk-1/kdr ( (punct)
treatment curve (appos)
treated referrals (nmod)
disorder trichotillomania (conj)
times % (nmod)
simvastatin at (case)
doses two (nummod)
relation hemoglobin (nmod)
received thereafter (advmod)
learning pregnancies (nmod)
hypotensive anaesthesia (nmod)
occurs ptcr (nsubj)
intima in (case)
available aldomet (nmod)
given 5 (dep)
rate dose (conj)
mmc bolus (compound)
meq/l was (cop)
had jaundice (dobj)
october 31 (nummod)
role receptors (nmod)
concentrations arterial (amod)
gem ) (punct)
dissociated . (punct)
replacement androgen (compound)
chemotherapy-treated previously (advmod)
ischaemic and (cc)
29.1 to (dep)
treatment stage (appos)
rocuronium mg (dep)
outflow directed (acl)
0.025 than (case)
treatment kidney (conj)
condition this (det)
cephalosporins cefotetan (appos)
ketoprofen function (conj)
specimen in (case)
paradigm multiple (amod)
develops association (nmod)
rats urethane-anesthetized (amod)
measurements serial (amod)
influenced hyperactivity (nsubjpass)
blockade striatum (nmod)
improve tolerated (conj)
schedule on (case)
thalidomide low-dose (amod)
differences the (det)
serotonin low (amod)
pathway the (det)
troponin of (case)
dehydration exhaustion (conj)
disruption bonding (nmod)
has administration (nsubj)
stimulation mucosa (nmod)
therapy glomerulonephritis (nmod)
treated lithium (nmod)
gls combined (acl)
performed angiography (nmod)
prepared radiopharmaceutical (nsubjpass)
responsible effect (nmod)
occurrence syndrome (nmod)
interacted . (punct)
months mean (compound)
2 g/dl (dep)
visits follow-up (compound)
resolved withdrawal (nmod)
members the (det)
mg/m(2 was (cop)
patients ranging (acl:relcl)
index 60 (nummod)
deaths infectious (amod)
activity glucocorticoid (compound)
developed thus (advmod)
% 76.2 (nummod)
models dyskinesia (conj)
diseases or (cc)
increased behavior (nsubjpass)
reduction thickness (nmod)
hyperthermia temperature (conj)
correlated that (nsubj)
irreversible , (punct)
recorded identifiers (nmod)
pigs guinea (compound)
ecg by (case)
early transplantation (nmod)
et-1 of (case)
concentration calcium (compound)
methods revealed (appos)
5-httlpr or (cc)
modified decreased (conj)
observed myoglobinuria (nsubjpass)
replaced . (punct)
greater change (nmod)
low % (dep)
contraceptives . (punct)
contributing in (mark)
lithium vs. (cc)
suggesting selection (dobj)
presumed > (dep)
damage peroxidation (conj)
nausea group (nmod)
evaluated trial (nsubj)
disorders mitochondrial (amod)
disease electrolyte (conj)
preference changes (conj)
gene 6 (nummod)
solution sera (conj)
% 15.9 (compound)
activity cco (compound)
sought examine (xcomp)
model cnsb002 (nmod)
170 event (nsubj)
proved effective (xcomp)
presented symptoms (nmod)
relief symptom (nmod)
nhe3 ( (punct)
developed disappeared (conj)
tolerated drug (nsubjpass)
1.1 between (case)
patients retinoblastoma (nmod)
users psychopaths (conj)
= 0.1 (dep)
1.88 , (punct)
cm ( (punct)
induces release (dobj)
failure dnr (nmod)
updrs ) (punct)
nerves in (case)
callosum corpus (compound)
improve hydroxytyrosol (nsubj)
vasodepressor the (det)
antagonizes actions (dobj)
responsible dyskinesias (nmod)
cells columnar (amod)
provides study (nsubj)
delayed and (cc)
random-assignment haloperidol (conj)
identical symptoms (nsubj)
defined aki (nsubjpass)
use disease (conj)
results demonstrating (acl)
showed s-312 (nsubj)
assessment open-label (amod)
behaviors and (cc)
glibenclamide ) (punct)
lithium as (case)
glomerulonephritis to (case)
curve glucose (compound)
loads viral (amod)
evaluate changes (dobj)
boluses device (compound)
anxious experience (nmod)
ppi of (case)
monkeys initiation (conj)
investigations . (punct)
days 686 (nummod)
measurement contraction (nmod)
performed and (cc)
suppression prolonged (amod)
placebo events (nmod)
reported involving (xcomp)
drug new (amod)
was followed (conj)
ci 8.2 (nummod)
substituted that (mark)
induced hypotension (nsubjpass)
enrollment at (case)
abolished which (nsubjpass)
different controls (nmod)
by-product production (nsubj)
40 5967 (prep)
eyes to (case)
head injection (dep)
ligation- ventricular (conj)
treatment empiric (amod)
everolimus derivative (appos)
overdose dph (compound)
relieved deficit (dobj)
discomfort with (case)
result necessarily (advmod)
decreased effect (dobj)
perfused suprofen (nmod)
counterparts cage (compound)
animals cats (appos)
chlormethiazole symptoms (nmod)
effects mice (nmod)
interactions no (nmod)
higher cases (nmod)
assessment of (case)
dopac da (dep)
pentoxifylline or (cc)
administration combinations (nmod)
forms total (amod)
screened ng./ml (nmod)
sensation area (nmod)
treatment methadone (compound)
pressure the (det)
bought administered (conj)
method comparison (conj)
receptors prolactin (compound)
involvement naloxone (nmod)
other n (dep)
proved means (dobj)
alterations mtdna (compound)
suggestive reach (conj)
group no (det)
urine formed (acl)
post-administration days (nmod:npmod)
rhythm captured (amod)
< cigarettes (conj)
conclusion increases (appos)
health the (det)
intra-hisian infra-hisian (conj)
supports aptts (dobj)
spiranolactone , (punct)
inhibitor autophagy (nmod)
dysfunction therapy (nmod)
had monocytes (nsubj)
relies which (nsubj)
women 248 (nummod)
sessions training (compound)
study confirmed (acl:relcl)
shown hypokalaemia (dobj)
generation in (case)
obtain information (dobj)
sensitivity injection (conj)
raises ; (punct)
shift and (cc)
investigation , (punct)
relationship suppression (nmod)
mmhg 52 (nummod)
arrhythmias on (case)
ratio ci (conj)
hypomania to (case)
known are (auxpass)
summarizes experience (dobj)
therapies other (amod)
ameliorated that (nsubjpass)
induced injection (nsubj)
computers office (compound)
irrigation including (case)
catalepsy induced (acl:relcl)
report movements (nmod)
administration an (det)
cacl2 nahco3 (conj)
polydipsia lithium-induced (amod)
hrptec on (case)
assess pain (nmod)
association for (case)
fell rose (conj)
response group (compound)
caused depletion (nmod)
established not (neg)
mg/dl ( (punct)
hydrochloride due (case)
reducing pressure (dobj)
casei patient (nmod)
fanft by (case)
hypercholesterolemia women (nmod)
indicative lead (conj)
factors beta-blockers (conj)
furosemide and (cc)
toxicities major (amod)
recognition findings (nmod)
used initially (advmod)
administered solvent (conj)
parents present (amod)
return , (punct)
activated substrates (conj)
factor cardiotoxicity (nmod)
selection careful (amod)
h. during (case)
manner dependent (amod)
pineal chick (nmod)
had hypersecretion (dobj)
identified vehicle- (nmod)
mmp-2 and (cc)
induced antagonists (nsubj)
bottle pemoline (nmod)
dysfunction infarction (compound)
effects convulsant (amod)
procaterol and (cc)
n=94 ( (punct)
received assigned (conj)
synaptophysin ) (punct)
cornu a (det)
determined had (conj)
medline embase (conj)
span , (punct)
evidence the (det)
noted events (nsubjpass)
inhibitors angiogenesis (compound)
evaluation ability (nmod)
epileptogenesis of (case)
supports monitored (advcl)
patients twenty-four (nmod)
university private (amod)
damage therefore (advmod)
pathogenesis with (case)
study double-dose (amod)
manifestations subtle (amod)
population addicts (nmod)
melatonin and (cc)
28.0 31.7 (conj)
tachycardia persisted (acl:relcl)
effective alleviating (advcl)
influence gfc (nsubj)
period dosing (nmod)
necrosis massive (amod)
flunitrazepam , (punct)
exposures cumulative (amod)
orr ) (punct)
area sma (appos)
expand use (dobj)
self-limited reappearing (xcomp)
dpi ) (punct)
trial blind (amod)
uh over (case)
sumatriptan for (case)
duration amenorrhea (nmod)
started days (nmod)
circulation blood (compound)
remissions cure (conj)
mofetil sirolimus (conj)
prevalence predictors (conj)
needle rate (conj)
analysis expression (compound)
effects health (compound)
or=7.18 ( (punct)
carried cerebellum (nmod)
disturbance conduction (nmod)
concentration normal (amod)
integration hypertrophy (nmod)
degeneration vacuolar (amod)
urge experience (nmod)
adenosine with (case)
bruising and (cc)
cbd 41.66 (appos)
velocity neurophysiological (amod)
denervation severe (amod)
rifampin of (case)
modulation processes (nmod)
stress dox-induced (amod)
apposed cells (nmod)
method counterbalanced (amod)
glioblastoma unresectable (amod)
hr period (conj)
day as (case)
developed experienced (conj)
control historic (amod)
pose , (punct)
origin glomerulosclerosis (nmod)
granules secretory (amod)
signs or (cc)
163 15 (compound)
activity given (prep)
differences be (cop)
hormone without (case)
diluent ethanol (compound)
mg/kg 57 (dep)
somatotopy functional (amod)
proteinuria : (punct)
suggestive . (punct)
individuals backgrounds (nmod)
or difference=0.25 (dep)
exhibited did (advcl)
pr group (compound)
observed group (nmod)
narrowing arterial (amod)
effects indomethacin (nmod)
sirolimus to (case)
cardioversion electrical (amod)
overcome elevating (advcl)
accepted was (auxpass)
describe case (dep)
, 21/63 (dep)
complications nervous (amod)
case necrosis (nmod)
duration cardiomyocytes (nmod)
mitoxantrone 5-fluorouracil (appos)
comparing groups (dobj)
saline l-dopa (conj)
that induced (acl)
% lower (conj)
detected capsaicin (nmod)
lip with (case)
trinitrate gtn (appos)
toxicity patients (nmod)
tetrachloride- chloroform- (conj)
establishes , (punct)
received sedation (nmod)
injection dogs (nmod)
fas of (case)
performed addition (nmod)
years ; (punct)
h 18 (nummod)
encephalopathy evidenced (acl)
initiate chiefly (nmod)
mm 106 (nummod)
day or (cc)
avoided have (aux)
suggests method (ccomp)
efficient controls (nmod)
slices in (case)
high- groups (conj)
increased counts (nsubjpass)
similar also (advmod)
mild majority (nsubj)
lesions rat (nmod)
defect acidification (compound)
number deaths (nmod)
depletion sodium (compound)
mechanism pressor (compound)
combined or (cc)
decreased oct (nsubj)
initiated evaluate (xcomp)
isolated were (auxpass)
accelerated injection (nsubj)
characterization integrated (amod)
carbachol to (case)
fibres in (case)
hospitals same (amod)
find passage (dobj)
increases i (conj)
induces exposure (nsubj)
enhanced l-dopa (nmod)
methamphetamine meth (appos)
noted caused (advcl)
requirements antiemetic (compound)
end four (nmod)
recruited receive (advcl)
cause prolongation (dobj)
pressure pulmonary (amod)
incidence time-course (conj)
children per (case)
received levobupivacaine (dobj)
dogs halothane-anesthetized (amod)
overactivation patients (nmod)
% 84 (nummod)
long-acting short-acting (conj)
woman 23-year-old (amod)
reactions delayed (amod)
male from (case)
reactions attributable (amod)
p.o. at (case)
or=2.870 , (punct)
measured enzymes (nsubjpass)
administration i.v. (compound)
ambiguus the (det)
cohorts ich (nmod)
use ziprasidone (nmod)
observed monkeys (nmod)
deposition nonopaque (amod)
therapy due (case)
discriminated quantitatively (advmod)
saline-treated s.c. (dep)
gas blood (compound)
users tablets (appos)
efficacy ribavirin (nmod)
causes due (case)
visualize nos (dobj)
excess force (compound)
reduction g/dl (conj)
half drinkers (nmod)
assess were (cop)
anoxia in (case)
meq. liter (nmod)
history radiograph (conj)
pc ) (punct)
progressed that (nsubj)
successful was (cop)
factor therapy (nmod)
complication ( (punct)
mg 400 (compound)
differences parameters (nmod)
appeared those (nmod)
responsiveness subjects (nmod)
everolimus , (punct)
trials from (case)
possibility damage (nmod)
applied matrix (nsubjpass)
age patients (nmod)
blocking input (dobj)
submitted intervention (nmod)
produced apomorphine (nsubj)
age for (case)
described patient (nsubjpass)
had tests (dobj)
rats munich-wistar (amod)
antagonists h(3)-receptor (compound)
rules screening (nmod)
capsaicin neuralgia (nmod)
prevent glycosuria (nsubj)
across volunteers (conj)
presented limited (conj)
alert fact (nsubj)
disorders pain (compound)
= p (appos)
system through (case)
reports brief (amod)
activity therapy (nmod)
associated nms (nmod)
investigations systematic (amod)
changes response (nmod)
3 10mg/kg (conj)
medications beta-adrenergic (amod)
lobund-wistar l-w (dep)
contained bile (nsubj)
preservation hypotension (nmod)
1990 1995 (conj)
strong not (neg)
replicate or (cc)
complexity mechanisms (nmod)
demonstrated monotherapy (nmod)
patient aged (amod)
mediated be (auxpass)
b. phase (compound)
months 14.6 (nummod)
acknowledged must (aux)
design and (cc)
incidence tachycardia (conj)
given would (aux)
data first (amod)
kindled-seizures cocaine (compound)
types new (amod)
volunteers of (case)
combination bort (nmod)
property this (det)
granulomas multiple (amod)
caused nx+hp (nsubj)
continued individuals (nmod)
infiltration local (amod)
test microspherocytes (conj)
one examined (acl)
co-injection by (case)
l2 the (dep)
prophylaxis it (compound)
induced cardiomyopathy (nsubjpass)
tablets 100 (nummod)
seems effect (nsubj)
hepatotoxicity amiodarone (nmod)
ammonia brain (compound)
influence development (nmod)
compared postdose (nmod)
shown contain (xcomp)
multivitamin another (det)
increased while (mark)
forms some (det)
method received (appos)
licl of (case)
disappearance weeks (nmod)
model . (punct)
useful but (cc)
study 5-fu/fa (nmod)
do potentiated (advcl)
mdma 3,4-methylenedioxymethamphetamine (dep)
content animals (nmod)
high- low-contrast (conj)
given iso (nsubjpass)
continue interfere (xcomp)
effect adriamycin-mediated (amod)
glomerulonephritis early (amod)
received pump (dobj)
antagonist on (case)
concentrations mannitol (nmod)
use amiodarone (amod)
rectified experienced (advcl)
36 to (advmod)
greater hemorrhage (nmod)
data published (amod)
duration accompanying (acl)
m1 , (punct)
intact-control melatonin-treated (conj)
taken that (mark)
sulphate . (punct)
seen syndrome (nmod)
developed that (nsubj)
response with (case)
rise species (nmod)
room emergency (compound)
units/l < (dep)
score ; (punct)
controlling symptoms (dobj)
ad50 bupivacaine (compound)
rapamycin by (case)
albuterol cna (appos)
mortality anesthetic-induced (amod)
findings resonance (compound)
induced independently (advmod)
interval qtc (compound)
identified factor (nsubjpass)
session acquisition (compound)
advanced locoregionally (advmod)
desmosomes of (case)
secondary vasculitis (nmod)
inquire to (mark)
weights body (compound)
impaired morphine (nmod)
representing case (dobj)
rating , (punct)
confirmed role (nsubjpass)
presented ; (punct)
competition signals (nmod)
efficacious patients (nmod)
reactions for (case)
recovered function (nsubj)
patients androgen- (nmod)
carcinoma peritoneal (amod)
therapy of (case)
mk-801 mg/kg (appos)
optic report (dep)
remains allow (advcl)
were hemorrhages (attr)
mg/kg days (nmod)
demonstrates case (nsubj)
lowered bpm (nmod)
test useful (amod)
cholesterol ldl-cholesterol (conj)
17.8 - (punct)
hyperalgesia aspects (conj)
pronounced patients (nmod)
administered drugs (nsubjpass)
failure resulted (acl:relcl)
treatment variables (conj)
bolus intravenous (amod)
generates discharges (dobj)
became quadriplegic (acomp)
calcification media (nmod)
patients % (dep)
measurements ) (punct)
quantitate amount (dobj)
weeks 14 (nummod)
number entries (nmod)
midazolam with (case)
years 56 (nummod)
reaffirms principle (dobj)
78-year-old a (det)
called platypnea-orthodeoxia (xcomp)
lack mrp2 (nmod)
evaluated week (nsubjpass)
concentration glutathione (compound)
facilitated period (nmod)
myocarditis ( (punct)
kidneys from (case)
infusion 15 (nummod)
summarizes work (nsubj)
sclerosis sclerosis (conj)
macrolide new (amod)
mmhg 5.9 (nummod)
min 240 (nummod)
antagonist mk-801 (conj)
necrosis gm-induced (amod)
assigned weeks (nsubjpass)
is unclear (acomp)
recordings obtained (acl)
paralysis dose (conj)
rate infusion (nmod)
mechanisms formation (compound)
diagnosis for (case)
effects . (punct)
prevented effects (nsubjpass)
pdtc ( (punct)
supplements from (case)
given l-alpha-gfc (nmod)
mk-801 and (cc)
presented tingling (advcl)
insecticide organophosphate (amod)
restrictions activity (compound)
amnesia on (case)
analgesics narcotic (amod)
vfd ( (punct)
angioedema . (punct)
patients course (nmod)
mole phophorylcreatine (compound)
99 ) (punct)
start and (cc)
weaker that (nmod)
therapy antibiotic (amod)
mediating in (mark)
am149 % (appos)
blind condition (nmod)
control mm (conj)
g/dl and (cc)
ability inhibit (acl)
reduced combined (conj)
10 ) (punct)
bupivacaine subtoxic (amod)
0.5 0.25 (compound)
pain transplantation (nmod)
methylphenidate n (dep)
puncture endoscopy (conj)
protective as (advmod)
pig guinea (compound)
taking inhibitors (dobj)
rhuepo by (case)
thrombosis central (amod)
occurs frequently (advmod)
has methotrexate (xcomp)
neurons expressed (acl:relcl)
reviewed were (auxpass)
assess reactivity (dobj)
cancer cyclophosphamide (compound)
resolution of (case)
speak . (punct)
correlations significant (amod)
drops further (amod)
administered median (nsubjpass)
flow cerebral (amod)
benign excluding (case)
mapd in (case)
administered procainamide (nsubjpass)
daidzein weight (appos)
results polymorphic (appos)
95 ) (punct)
concluded exists (ccomp)
avoid therefore (advmod)
correlated activity (nmod)
analyzed uptake (nsubjpass)
show caused (ccomp)
spasm paradoxical (amod)
animals surviving (acl)
showed embryopathy (dobj)
arrhythmias strophanthidin-induced (amod)
administrated separately (advmod)
measured elisa (nmod)
beta beta (conj)
recommended nascis (nmod)
denied who (nsubj)
8 6 (conj)
pentobarbital to (case)
neonate immunocompetent (amod)
identify patients (dobj)
microg/kg/min 2 (nummod)
crucial manifestation (nmod)
choreoathetosis acute (amod)
attribute specifically (advmod)
decades 3 (nummod)
trial enalapril (nmod)
tea green (amod)
tested birth (nmod)
doses threshold (amod)
preparations obsolete (amod)
abnormalities well-tolerated (amod)
potentiate did (aux)
kinase p38 (compound)
task finger-to-thumb (amod)
model exposure (nmod)
disintegrations 910+/-770 (nummod)
indicate could (aux)
capsule kidney (compound)
determine were (ccomp)
loss gradual (amod)
synthesis/turnover 5-hydroxytryptamine (nmod)
inulin and (cc)
supporting concept (dobj)
wk two (nummod)
incidence despite (case)
induced lithium (nmod)
62(6):865 , (punct)
sedation effect (nsubj)
related antimicrobials (nmod)
concentrations na (nmod)
mellitus toxicity (conj)
concerns despite (case)
measured immunocytochemistry (nmod)
were glu (conj)
show neurotoxicity (dobj)
consisted hypogonadism (nmod)
tingling sensations (conj)
implanted were (auxpass)
chow sucrose (conj)
infarctions transmural (amod)
assessed subgroup (nmod)
activation region (nmod)
records based (case)
eyes for (case)
concentrations me (nmod)
nephropathy neoplasia (conj)
resulted reticulata (nsubj)
characteristics observed (amod)
mediator neurodegeneration (nmod)
disinhibition cortex (nmod)
results documented (appos)
323+/-43 mmol/l (dep)
altered not (neg)
values stem (nmod)
had edds (nsubj)
1941 1981 (conj)
1.0 10(-6 (conj)
concentrations oxazepam (nmod)
factor as (mark)
acetyltransferase the (det)
data study (nmod)
encephalopathy by (case)
antidepressant serotonergic (compound)
proliferation enhanced (amod)
abnormality underlying (amod)
resulting referral (nmod)
numbness weakness (conj)
levels study (nsubj)
suspected have (xcomp)
prevention vt (nmod)
participates , (punct)
easy it (nsubj)
5 - (punct)
ml 2 (nummod)
-18 -26 (conj)
period years (nmod)
tachycardia procainamide-induced (amod)
identified model (nmod)
disorder ) (punct)
taking methyldopa (advmod)
remain understudied (xcomp)
patients 102 (nummod)
administrated i.p. (advmod)
reductions baseline (nmod)
relieved symptoms (nmod)
overview disorders (nmod)
reactions immunohistochemical (amod)
amb or (cc)
embryos amount (nmod)
years 8.8 (nummod)
associated stroke (nsubj)
showed dogs (nsubj)
days 788.5 (conj)
depression without (case)
potential tenofovir (nmod)
oligodeoxynucleotide targeting (acl)
values index (compound)
case toxicity (nmod)
lamivudine-resistance patients (nmod)
agitation hyperthermia (conj)
restored rhythm (nsubjpass)
account on (case)
or=13.807 95 (dep)
5 14 (conj)
contractions tachycardia (conj)
1.0 1.26 (conj)
treating patient (dobj)
reported fetus (nmod)
striata the (det)
37 10 (quantmod)
occurred treated (conj)
cases ) (punct)
reversal ; (punct)
increase mice (nmod)
arise that (nsubj)
patients cord (compound)
reverse effects (dobj)
eligible used (advcl)
pathway prolactin (nmod:poss)
sympathectomy patients (conj)
prevent injury (dobj)
increased radiolabelling (nsubjpass)
55 35 (compound)
injury immune (amod)
medication and (cc)
influence restriction (nmod)
mg from (case)
made supported (conj)
correlated frequency (nmod)
prolongation qt (nmod)
mr mp (conj)
had area (dobj)
h-sod1 of (case)
responders of (case)
completed infusion (nsubjpass)
paroxetine treatment (dep)
reactive platelets (nmod)
establish , (punct)
shown technique (ccomp)
physician emergency (compound)
using techniques (dobj)
od [ (punct)
fibrillation ventricular (amod)
cells cells (nmod)
complications mortality (conj)
hepatectomy partial (amod)
documents : (punct)
blocked not (neg)
cause because (mark)
interaction drug-drug (amod)
cells/mm3 cd4 (compound)
gamma-vinyl-gaba d (dep)
increases that (mark)
infections from (case)
downregulation 2 (dep)
leads dysfunction (nmod)
characteristics of (case)
exacerbates . (punct)
mg/kg l-dopa/benserazide (compound)
nystagmus downbeating (compound)
reduced uraemia (dobj)
cheops ) (punct)
adding doses (dobj)
recall , (punct)
function group (nmod)
delta and (cc)
exceed induction (dobj)
nephrectomized nx (dep)
tend was (conj)
magnitude factors (conj)
bradycardia abnormality (nsubj)
challenged were (auxpass)
precipitating in (mark)
resulting parkinsonism (nmod)
placebo treatment (nmod)
gaba ( (punct)
alert risk (nmod)
compared drugs (nmod)
using protocol (dobj)
myelosuppression mice (nmod)
weeks fourteen (nummod)
hazards proportional (amod)
pathogenesis blockade (nmod)
effects scopolamine (nmod)
subject each (det)
chemotherapy during (case)
process it (nsubj)
-59.7 17.9 (conj)
overlooked may (aux)
degradative 5-fu (nmod)
infiltration concomitant (amod)
meshwork the (det)
reduces duration (dobj)
analysis univariate (compound)
metrizoate than (case)
anastrozole , (punct)
infusions 24-hour (amod)
dose pentylenetetrezol (nmod)
offspring des-exposed (amod)
drug non-steroidal (amod)
stimulus from (case)
hypoactivity locomotor (compound)
dx free (amod)
treatment aspirin (nmod)
degrees severe (amod)
chemotherapy 5-fu (compound)
comments other (amod)
accumulation less (advmod)
occurred reported (conj)
expression targeting (conj)
vasorelaxation and (cc)
m.i.n.i. ( (punct)
case primigravida (nmod)
greater greater (dep)
margin the (det)
pressure low (amod)
age score (conj)
activity ace (compound)
mg/kg d-amb (compound)
nicotine by (case)
aggravates ca(2 (dobj)
concluded behaviour (nmod)
nigerians 358 (nummod)
change p (appos)
very or (cc)
retains acid (nsubj)
metabolites aromatic (amod)
substance together (advmod)
amiloride ( (punct)
experiences acquired (acl)
transient neurological (dep)
p75(ntr)-ir drg (nmod)
variable individually (advmod)
inhibition lithium (nmod)
treatment arabic (nmod)
studied n=834 (dep)
cycle inthe (amod)
hypersecretion idiopathic (amod)
that % (nmod)
medications adjunctive (amod)
had effects (dobj)
times/week ( (punct)
barrier blood-brain (amod)
has dithiocarbamate (nsubj)
injections gentamicin (nmod)
explained basis (nmod)
vasculitis development (compound)
symptoms patient (nmod:poss)
man 69-yr-old (amod)
somnolence treatment-emergent (amod)
foreshortened clinical (dep)
containing tablets (dobj)
time three (nummod)
conditions normal (amod)
nephrotoxicity regimens (nmod)
parallels possible (amod)
improvement significant (amod)
showed similarly (advmod)
examined concentration (conj)
( i.c. (dep)
status valves (conj)
described neuropathy (nsubjpass)
germany uk (conj)
incidence infants (nmod)
seen eyes (nmod)
patients 747 (nummod)
formation in (case)
hg placebo (nmod)
concentrations necrosis (conj)
failure not (neg)
society american (compound)
rats nicotine-treated (amod)
spared were (auxpass)
those injected (acl)
exercised using (advcl)
complete restoration (dobj)
exposure , (punct)
loss consciousness (nmod)
ka apparent (amod)
samples venous (amod)
suggest warrant (ccomp)
masseter the (dep)
month surgery (nmod)
29th 30th (conj)
aware providers (nsubj)
dysfunction sexual (amod)
possess treatment (nsubj)
men hypertensive (amod)
appears therapy (xcomp)
rats pigs (conj)
summaries : (punct)
vehicle hoe-140 (conj)
have women (nsubj)
include uncommon (advcl)
gradient high-resolution (amod)
february 1993 (nummod)
experienced tachycardia (dobj)
levels acid (appos)
analyses by (case)
variant bche (compound)
participants healthy (amod)
dystonia of (case)
veins major (amod)
6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate methyl (compound)
rats homozygous (amod)
ranging meq/l (nmod)
maha fk506-associated (amod)
noted conditioning (nmod)
nephrotoxic is (cop)
divided ( (punct)
administration thp (nmod)
1.041 , (punct)
gynecomastia and/or (cc)
developed onset (dobj)
increased control (nmod)
effect benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate (nmod)
striatum regulation (nmod)
occurred early (advmod)
lnaa ) (punct)
hypercapnia to (case)
reaching weeks (nmod)
nitroprusside snp (appos)
animals treated (acl:relcl)
fluorescein to (case)
unnecessary usually (advmod)
occurred period (nmod)
seizure . (punct)
min 25 (nummod)
mapped were (auxpass)
stability size (nmod)
encephalopathy vpa-induced (amod)
juice cranberry (compound)
excretion for (case)
initiated subsided (conj)
structure fine (amod)
receptor d4.2 (compound)
switched cyclosporine (nmod)
cocaine ethanol (conj)
asymptomatic completely (advmod)
changes evident (amod)
hallucinations and (cc)
hour 12 (compound)
recovered nicardipine (nmod)
used improved (conj)
waves pathologic (amod)
cancer lung (compound)
di ) (punct)
found increased (xcomp)
methylprednisolone mg/0.5 (conj)
referred dysfunction (nmod)
parameters function (nmod)
observation patients (nmod)
decreased activation (conj)
treatment short (amod)
had clonazepam (nmod)
= 1.5 (dep)
addition this (nmod)
found lead (ccomp)
considerations hit (nmod)
filling abnormal (amod)
biochemical numerous (amod)
decreased age (nmod)
abnormalities because (case)
effect anti-carcinogen (amod)
% cr (dep)
effect adriamycin (nmod)
30.7 1.1 (nummod)
type depending (case)
disorder especially (advmod)
onset change (nmod)
was causing (advcl)
mechanism another (det)
discontinued replaced (conj)
determined objectively (advmod)
decreased that (dobj)
permeability . (punct)
levels systemic (amod)
insertion followed (acl)
have group (nsubj)
higher twice (advmod)
centre vasomotor (compound)
toxicity fatal (amod)
interviews and (cc)
prevented incident (nsubjpass)
groups corresponding (amod)
duration short (acl:relcl)
distinguished is (auxpass)
trial performed (acl)
case second (amod)
dyspnoea , (punct)
metabolites and (cc)
multicenter double-masked (conj)
inhibition uptake (nmod)
mild with (case)
highlights obtaining (advcl)
induction attacks (nmod)
improved alternative (conj)
model ln (conj)
rapamycin mg/kg (appos)
mechanisms circuits (nmod)
drugs angiotensin (compound)
startle the (det)
angina variant (amod)
properties interpretation (conj)
used tested (conj)
potential angiogenic (amod)
increase function (nmod)
tachy- or (cc)
suggests photodistribution (nsubj)
mg/kg 57.7 (nummod)
dehydration and/or (cc)
patients nausea (nmod)
appear mpo-anca (nsubj)
is it (nsubj)
colorectal pancreaticobiliary (conj)
450 to (dep)
reporting results (dobj)
recording of (case)
used manipulate (xcomp)
involved protection (nmod)
concentrations sufficient (amod)
using immunoassays (dobj)
doses remifentanil (nmod)
phosphate between (case)
vpu with (case)
greater mmhg (nmod)
hours every (det)
cacl(2 m (amod)
cisplatinum mg/m2 (appos)
achieve normocarbia (dobj)
dose paroxetine (nmod)
attack migraine (amod)
treated saline (nmod)
treatment diphenylhydantoin (compound)
carbon colloidal (amod)
properties immunosuppressive (amod)
suggest reducing (advcl)
syndrome excess (nmod)
r4 and (cc)
produced minutes (nmod)
sedation , (punct)
12-week , (punct)
oil containing (acl)
configuration , (punct)
prevention complete (amod)
trigger may (aux)
month each (det)
receiving penicillins (dobj)
protectors of (case)
detected = (parataxis)
received to (mark)
had one (dobj)
depressed that (mark)
odds ratios (appos)
statistically significant (conj)
enhancement motility (nmod)
days 84 (nummod)
analyzed disturbances (nsubjpass)
widened ms (nmod)
deafened , (punct)
thought memory (nsubjpass)
enlarged hypertrophic (conj)
treatment betaine (compound)
pressure central (amod)
staphylococcal more (advmod)
rats sexes (nmod)
avoid prevent (conj)
sensorium palsy (conj)
stereotypies oral (amod)
assessment persistence (conj)
treatment psoriasis (nmod)
induces bound (dep)
inpatients . (punct)
analyzing by (mark)
decrease gsk3alpha (nmod)
changed not (neg)
site . (punct)
group turn (acl:relcl)
measured efficacy (nsubjpass)
syndrome patient (nmod)
disposition to (case)
evoke to (mark)
acids and (cc)
combined often (advmod)
induced solution (advcl)
challenged mice (nsubjpass)
swallow videofluoroscopy (nmod)
micrograms of (case)
ginsenoside as (case)
prior ( (punct)
act level (nmod)
using types (nmod)
advised prevent (xcomp)
given busulfan (dative)
collapsed leaving (advcl)
difference gap43-ir (nmod)
risperidone levels (conj)
morbidity of (case)
methotrexate of (case)
had often (advmod)
exhibits and (cc)
netilmicin and (cc)
ameliorate rigidity (dobj)
features glaucoma (compound)
medication only (advmod)
consisting rats (dobj)
ph presence (conj)
triphosphate adenosine (compound)
contained specimen (nsubj)
evaluated study (nmod)
nx ) (punct)
mechanisms occurrence (nmod)
t min (appos)
generalized witnessed (amod)
hyperkalaemia of (case)
described previously (advmod)
tissue post-necrotic (amod)
increases expression (dobj)
pressure lv (amod)
lend did (aux)
recorded mean (conj)
p mg (conj)
cingulate cortex (dobj)
syndrome rhabdomyolysis (nsubj)
tested samples (nsubjpass)
nmdars ) (punct)
development pulmonary (amod)
variants immune (amod)
synthase and (cc)
ml-1 ( (punct)
were since (mark)
factor treatment (appos)
protein pg/mg (compound)
pain upper (amod)
play receptors (nsubj)
interactions such (amod)
dystrophy like (case)
alerted effect (nmod)
worn was (auxpass)
proteinuria sirolimus-associated (amod)
replicated tended (parataxis)
using formula (dobj)
abnormalities st-segment (amod)
heparitinase with (case)
frequent effects (nsubj)
mefloquine with (case)
familiarity professionals (nmod)
hypothesized . (punct)
compared frequencies (nsubjpass)
examining by (mark)
amyloidosis patient (nmod)
compared control (nmod)
overload acute (amod)
effective vitro (advmod)
n hospital (conj)
beta-blocking activities.2 (dep)
patients placebo-treated (amod)
support inotropic (amod)
resolved cases (nmod)
synthesis decreased (amod)
corticosteroids mydriatics (conj)
4',7-dihydroxy-isoflavone ) (punct)
control of (case)
population within (case)
phosphorofluoridate 0,0'-diisopropyl (amod)
ratios ors (appos)
reactions p450 (compound)
staining ttc (nmod)
resistant calcification (nmod)
mice engineered (acl)
confused postoperatively (advmod)
nephrotoxicity artery (nmod)
well took (advcl)
causes potentially (advmod)
inhibitors treatment (nmod)
is those (advcl)
causing tdp (dobj)
shell ) (punct)
causes disorders (nmod)
harvested days (nmod)
cataracts disease (conj)
administration synthesis (nmod)
ax ) (punct)
april 2 (nummod)
based model (nmod)
decreases cholesterol (nmod)
cox-2 of (case)
protocol society (appos)
studies comparing (acl)
mediated stimulation (nmod)
anticoagulant warfarin-like (amod)
doses equivalent (amod)
convulsions organophosphate-induced (amod)
apply might (aux)
account may (aux)
[na]o ) (punct)
resuscitation treatment (conj)
use bzd/rd (nmod)
staff reviewing (advcl)
impairments , (punct)
valsartan . (punct)
unrelenting therapy (nmod)
attempting identify (xcomp)
adr this (det)
t and (cc)
evaluated could (aux)
cortex kidney (compound)
harm injury (nmod)
occurred cardiotoxicity (nsubj)
generates brainstem (nsubj)
cascade an (det)
dose-dependent concentrations (nmod)
effect adding (advcl)
minutes 23 (nummod)
occasion on (case)
areas necrosis (appos)
urticaria and/or (cc)
placebo atenolol (conj)
cocs conventional (amod)
precurarization rocuronium (nmod)
patients cisapride (conj)
four relapsed (acl:relcl)
appeared droplets (nsubj)
depression respiratory (amod)
effect nor (cc)
similar profile (nsubj)
fev1 75 (conj)
fell ml/m2 (nmod)
vulnerability pathways (nmod)
mg/kg ip (appos)
encountered patient (dobj)
54 vs. (cc)
mc for (case)
erythematosus from (case)
most with (case)
death and (cc)
course vancomycin (compound)
risk myelosuppression (nmod)
induced morphine (nsubj)
studied is (auxpass)
polymorphism reaction-restriction (compound)
cases published (acl)
group low-sodium (compound)
conclusions case (dep)
prevent ato (nsubj)
prevalent still (advmod)
headaches in (case)
rammer devlin (dep)
sulfate streptomycin (compound)
ischemia focal (amod)
parameters pressure (conj)
fluid plasma (compound)
bleeding for (case)
phenobarbital pb (appos)
death subsequent (amod)
group indistinguishable (acl:relcl)
hcl bupropion (compound)
excretion hour (compound)
evoke addition (nmod)
lysis subsequent (amod)
daptomycin with (case)
variants present (acl:relcl)
doses oral (amod)
scotomata central-caecal (amod)
pentylenetrazol to (case)
effects hematologic (amod)
vagotomy not (cc)
curve concentration (compound)
week 3 (conj)
have provide (conj)
shivering rigidity (conj)
survived to (mark)
dystonia supranuclear (nmod)
injected mug (nsubjpass)
pre-operative intra-operative (conj)
fingers left (amod)
folate levels (dobj)
degeneration cell (compound)
registry effects (nmod)
call . (punct)
newer oral (dep)
reduced mg/kg (nmod)
thrombosis intracranial (amod)
expression oat (nmod)
repeated exposure (dobj)
regions the (det)
antidepressants various (amod)
endpoint the (det)
up-regulated are (auxpass)
protrusion tongue (compound)
type according (case)
counteracted pretreatment (nsubj)
recruited states (nmod)
edema macular (amod)
evaluation women (nmod)
amnesia antagonist)-induced (amod)
spect thallium-201 (compound)
doses capsaicin (nmod)
liters ( (punct)
forces and (cc)
offers nitroprusside (nmod)
ms 300 (nummod)
focusing mechanism (nmod)
represent could (aux)
raloxifene to (mark)
selection genetic (amod)
postulated been (auxpass)
injured extensively (advmod)
history of (case)
connections interendothelial (amod)
assess uncertainty (nmod)
occurred rapidly (advmod)
seizures concentration (conj)
exposure hours (nmod)
population % (dep)
efficacy ifosfamide (nmod)
elevated content (nsubj)
modulates disease (nmod)
profiles paradigms (nmod)
resulted indomethacin (nsubj)
determine . (punct)
those infusion (nmod)
were expressing (advcl)
discontinued biopsy (xcomp)
levels alpha-gst (nmod)
mg 300 (compound)
thickened beams (dobj)
dxnp by (case)
stat3 of (case)
seen males (nmod)
epilepsy caused (acl)
used improve (xcomp)
divided combination (nmod)
ability concentrating (compound)
n=834 ( (punct)
treatment hypercholesterolemia (nmod)
urticaria with (nmod)
employing blue (dobj)
emerged and (cc)
months mean (dep)
licit drugs (dobj)
utility diagnostic (amod)
addition alterations (nmod)
bmcs ) (punct)
infection against (case)
600 1000 (conj)
catecholamines administered (acl)
monitoring development (nmod)
performed ileostomy (nsubjpass)
mediates . (punct)
administration mtx (nmod)
reviewing slides (dobj)
rates recurrence (compound)
underlie development (dobj)
episodes and (cc)
myelinated degenerating (nsubj)
detected period (nmod)
infusion s-ketamine (compound)
caution great (amod)
favour tests (nsubj)
escalated cohorts (nmod)
presented weakness (nmod)
crossover in (case)
perimenopausal postmenopausal (conj)
increased given (nsubj)
unaware and (cc)
prevented animals (advcl)
hbv and (cc)
fibers the (det)
extent oxygenation (nmod)
interval ecg (nmod)
fpd array (appos)
post-discharge those (nmod)
prevents development (dobj)
infusions epinephrine (nmod)
lomustine ) (punct)
exacerbation deficits (nmod)
patients md (nmod)
performed elucidate (advcl)
cause seizures (nsubj)
decreased terbinafine (nsubj)
levonorgestrel i.e. (advmod)
ocular and (cc)
equal short (nmod)
mg. 10.9 (nummod)
increases . (punct)
comparable which (nsubj)
decreased controls (nmod)
labeling medication (compound)
40 even (advmod)
agonist the (det)
b.d procaterol (compound)
prostate the (det)
kinase 66,680 (nummod)
rats stz-treated (amod)
fed diet (dobj)
apoptosis cardiomyocyte (compound)
organization who (appos)
activity electrical (amod)
sah associated (acl)
occurred standing (nmod)
acute subacute (conj)
igf-il-3 of (case)
27 45 (conj)
women valves (nmod)
studied interactions (nsubjpass)
reaction : (punct)
profile animals (nmod)
oxidative and (cc)
ultrafiltration ultracentrifugation (conj)
value preoperative (amod)
heart brain (conj)
completed increased (advcl)
1.44+/-0.6 range (conj)
prevented that (nsubjpass)
treat patients (dobj)
used only (advmod)
prevented decreased (conj)
appear mechanism (nsubj)
occur epilepticus (nmod)
originating probably (advmod)
injury aap-induced (amod)
occurred later (advmod)
complications treatment (nmod)
4/8 ) (punct)
os with (case)
showed elevation (conj)
anti-cancer effective (amod)
% although (mark)
attributed suppression (nmod)
case course (nmod)
diazepam mg (dep)
antidotes combinations (conj)
transplantation cells (nmod)
ant-mi ( (punct)
ngf and (cc)
those exercise (nmod)
receptor 5 (nummod)
mk-801 ( (punct)
using method (dobj)
procaterol adrenoceptor (appos)
patient signs (nmod)
administration bcnu (compound)
increased risk (dobj)
circumstantial , (punct)
il-3 epo (conj)
16 to (quantmod)
received ketanserin (dobj)
augments but (cc)
drugs baclofen (conj)
associated desvenlafaxine (nmod)
phenomenon coronary (amod)
prevent nephropathy (dobj)
shorter delay (nsubj)
concentrations factor (nmod)
cefonicid ( (punct)
characterization . (punct)
received april (nmod)
unable she (nsubj)
administration inhibitors (conj)
setting hospital (appos)
decreases injury (dobj)
dexmedetomidine cardiac (conj)
sevoflurane or (cc)
papaverine baep (conj)
discussed problems (nsubjpass)
diary urodynamic (conj)
conclude effective (ccomp)
absent is (cop)
task for (case)
data in (case)
doses pharmacologic (amod)
procedures during (case)
norepinephrine proportions (nmod)
bn 52021 (nummod)
use proper (amod)
rats s (appos)
transcription of (case)
diazepam procedures (nmod)
pathophysiologic and (cc)
uncertain patients (nmod)
system mouse (compound)
rats with (case)
concentrations normal (amod)
microl 20 (nummod)
pgads ; (punct)
failure therapy (conj)
p=0.003 ) (punct)
segments receive (acl:relcl)
results lost (acl:relcl)
reported system (nmod)
received received (conj)
capacity relevant (amod)
crp ) (punct)
effect anti-tachycardial (amod)
interaction management (conj)
similar levels (nsubj)
undergone radiotherapy (dobj)
range % (conj)
variety from (case)
molecule the (det)
lindane that (det)
cross-tolerant but (cc)
project national (amod)
examined appearance (nsubjpass)
rate striking (nsubj)
decarboxylase acid (compound)
modification a (det)
thyroid parathyroid (conj)
antagonize carteolol (nsubj)
control that (mark)
polymyositis with (case)
was indication (attr)
pallidus globus (compound)
developed case (nmod)
responders these (det)
3,7-dimethyl-1-propargylxanthine ) (punct)
naphazoline xylometazoline (conj)
density > (amod)
drowsiness initial (amod)
feasible safe (conj)
became gradually (advmod)
hh : (punct)
applied are (auxpass)
random-assignment , (punct)
injection intracranial (amod)
trigger a (det)
composite outcome (nsubj)
bw ( (punct)
activity proconvulsive (amod)
yawning . (punct)
administration rat (nmod)
hallucinations status (conj)
patterns studied (acl)
patient bone (compound)
formyltransferase , (punct)
mmhg was (cop)
expression caudate-putamen (nmod)
factor only (amod)
observations chemotherapy (compound)
supported should (aux)
explained was (auxpass)
disappeared replaced (advcl)
hydrochloride nifekalant (amod)
suggests evaluated (ccomp)
esrd ) (punct)
representing cycle (dobj)
program screening (compound)
impair . (punct)
version ) (punct)
complications confusion (nmod)
treatment second-line (amod)
of % (dep)
decreased pressure (nsubj)
intrarenally or (cc)
tablets 2 (nummod)
june 2002 (nummod)
role tamoxifen (nmod)
effect inhibitors (conj)
g 12.8 (nummod)
cyp of (case)
sweating excessive (amod)
present were (cop)
able induce (xcomp)
blood-brain-barrier of (case)
number ventricular (amod)
report two (dep)
diameters the (det)
brain rodent (amod)
changes endothelial (amod)
infusion microg/kg/min (dep)
trial study (dep)
removed studies (nmod)
effects pathways (nmod)
injected isoproterenol (xcomp)
blocked behavioral (dobj)
activities with (case)
microg/kg 150 (nummod)
intoxications of (case)
excluding also (advmod)
deferoxamine subcutaneous (amod)
infusion group (nmod)
conclusions damage (appos)
protection apoptosis (nmod)
reduced ketamine (nsubj)
rats served (acl)
vulnerable neurons (nsubj)
mass with (case)
determine to (mark)
incorporation mentioned (amod)
pacemaker permanent (amod)
patients total (dep)
consequences its (nmod:poss)
6 over (quantmod)
experiencing minutes (nmod)
concentration under (case)
find underlying (xcomp)
method neuropathy (dep)
analyzing activity (dobj)
ophthalmologic studies (dep)
attribute contribution (nsubj)
layers the (det)
disease verified (amod)
january ( (punct)
performance test (nmod)
manifest irrespective (advmod)
materials radiographic (amod)
mice vip(-/- (amod)
leading palsy (nmod)
acid a (det)
measurements ( (punct)
degeneration disruption (nmod)
orally both (cc:preconj)
assessed analysis (nmod)
correlate ace (nsubj)
july , (punct)
rate hbeag (compound)
frequency % (compound)
actin laminin (conj)
likely men (nsubj)
mass adrenal (amod)
means valuable (amod)
exhibit nos-ir (dobj)
patients 38 (nummod)
cholecystitis therapy (nmod)
1 - (punct)
allograft cadaveric (amod)
administrations daily (amod)
cells culture (nmod)
compared men (nmod)
active hyperalgesia (conj)
incidence reactions (nmod)
polyps of (case)
type sporadic (amod)
double-immunolabeling using (conj)
antigen and (cc)
treated methods (dep)
sectioned . (punct)
implications useful (amod)
admissions 0.97/1,000 (nummod)
tobramycin group (conj)
prevention ? (punct)
found infections (nsubjpass)
mediated changes (nmod)
cortex cingulate (compound)
divided controls (nmod)
reversed alter (conj)
occurred infections (nmod)
company liposome (compound)
challenge doses (nmod)
transitioned warfarin (nmod)
suffer elements (nsubj)
effects ester (nmod)
using days (nmod)
bs and (cc)
plasmapheresis and (cc)
male taking (acl)
alters which (nmod)
potency higher (amod)
1a (at1ar)/at2r (dep)
showed tolerant (ccomp)
activity cardiomyopathy (nmod)
muscle the (det)
case nephritis (nmod)
anaesthetic after (case)
found found (ccomp)
become approach (attr)
1.09 1.22 (prep)
treatment metformin (compound)
doses corresponding (amod)
bbb the (det)
rats saline- (amod)
suspected should (aux)
had values (nmod)
regimens several (amod)
effects no (nmod)
weakness as (case)
ipsilateral progressed (advcl)
histamine 1(h1 (dep)
sequelae . (punct)
angiosarcoma liver (nmod)
m1 ( (punct)
changes occur (acl:relcl)
score patients (nmod)
rnfl the (det)
fingers and (cc)
products these (det)
ml/min units (appos)
count by (case)
regurgitation massive (amod)
standing tilt (dep)
erythrocytes anemia (conj)
pcc ( (punct)
= 4.256 (dobj)
trough-concentrations and (cc)
inadequate too (advmod)
studies all (advmod)
role and (cc)
dosing acute (amod)
120/80 blood (compound)
return month (nmod)
therapy linezolid (amod)
obtained compared (conj)
tissue or (cc)
rats ovx (amod)
let , (punct)
reactions severe (amod)
supporting need (dobj)
support . (punct)
measured variability (nsubjpass)
macrolides the (det)
depend did (aux)
change day (nmod)
convulsive lethal (conj)
hyperthermia and (cc)
csa followed (acl)
ara-c lymphomas (nmod)
channels calcium (compound)
treatment lipopolysaccharide (compound)
d 1,25-dihydroxyvitamin (compound)
evident ( (punct)
damage sub-regions (nmod)
analysis cases (nmod)
2-component blocked (acl:relcl)
deficits motor (compound)
caused indomethacin (nmod)
therapy sole (compound)
combination were (cop)
27.1 12.8 (compound)
evidence provided (case)
screened who (nsubjpass)
0.05 1 (dep)
ara-c radiotherapy (conj)
man 72-year-old (amod)
experiments n- (nmod)
times several (amod)
rejection or (cc)
250 . (punct)
6.25 12.5 (conj)
epilepsies in (case)
etiology cancer (nmod)
contributes lead (conj)
escalated . (punct)
levels anxiety (nmod)
had transketolase (dobj)
trained state (nmod)
hypotension systolic (amod)
vehicles ) (punct)
severe can (aux)
diisopropylfluorophosphate sarin (conj)
rpgn ) (punct)
ml/min 10.5 (nummod)
study found (parataxis)
susceptibility the (det)
demonstrated acetaminophen (nsubjpass)
0.625 and (cc)
steatosis cirrhosis (conj)
supply of (case)
fetuses exposed (acl)
ephedrine dysfunction (nmod)
symptoms euphoria (nmod)
dogs denervated (acl:relcl)
psychosis induced (amod)
patients stroke (amod)
affect incidence (dobj)
seizures/mo ( (punct)
foci/cm2 rats (nmod)
evidence depends (ccomp)
development seizure (nmod)
aim make (appos)
downregulation beta-ar (nmod)
morton 's (case)
mechanism , (punct)
cyclophosphamide drugs (nsubj)
nature given (case)
conditions under (case)
mg/ml 27.9 (nummod)
developed prostatitis (dobj)
ineffective drugs (nsubj)
rabbits , (punct)
withdrawn september (nmod)
test transformation (compound)
characterized brief (nmod)
levothyroxine 175 (nummod)
streptozotocin itself (nmod)
examination vigilance (conj)
parasympathetic of (case)
showed blocked (ccomp)
healthy older (dep)
chest in (case)
medication group (conj)
system elevates (acl:relcl)
have prognosis (dobj)
changes tissue (nmod)
result cocaine (nsubj)
beta4 subunits (conj)
occurred seizures (nsubj)
tested serum (nsubjpass)
kinase elevated (amod)
effects dosages (nmod)
polymorphism metabolism (nmod)
melphalan high-dose (conj)
concentrations eminence (nmod)
mice swiss (amod)
testing immunologic (amod)
n. 19 (nummod)
preparation grafting (nmod)
cimetidine patients (nmod)
treated amisulpride (nmod)
occur effective (advcl)
require and (cc)
less , (punct)
encephalopathy induced (conj)
mr severe (amod)
pressure bp (appos)
preoperative and (cc)
ic ( (punct)
calcification extensive (amod)
efficacy toxicity (conj)
induction possible (amod)
county dade (compound)
spaces tissue (conj)
nephrotoxicity regimen (nmod)
occur conclusion (nmod)
supplementary groups (nmod)
adducts fluorinated (amod)
increased had (advcl)
increase phosphokinase (nmod)
decreased level (nsubj)
c 38.2 (nummod)
effective amiodarone (nsubj)
worsening measured (acl)
improving cases (dobj)
levodopa transport (nmod)
um-272 , (punct)
cancer without (case)
oxidation ) (punct)
increased 0.445 (nmod)
went -- (punct)
etomidate trial (appos)
output with (case)
damage hepatocellular (amod)
selecting in (mark)
dose ng/mouse (nmod)
nsaids classic (amod)
signs as (case)
plays function (dobj)
ileum m3 (nmod)
associated diet (nmod)
r=0.81 ; (punct)
gap43-ir present (amod)
toxicity continuing (amod)
mv mv (appos)
impairment produced (acl)
mirtazapine after (case)
nociception , (punct)
rate kg(-1 (nmod)
present even (advmod)
effects carcinogenic (amod)
located mainly (advmod)
segments duct (compound)
di-o-tolylguanidine sigma (compound)
administered route (nmod)
occurrence injury (nmod)
100mg/kg not (neg)
scopolamine s-(-)-et-126 (conj)
staying packing (dobj)
failure injection (nmod)
developed child (nsubj)
mm 152+/-15 (nummod)
predictors response (nmod)
dose microg/kg (nmod)
classification disease (nmod)
mri analyses (dep)
schedule time (compound)
proteinuria range (nmod)
common quite (advmod)
high prevalence (nsubj)
tempol , (punct)
twin the (det)
neuropathies the (det)
started rats (nmod)
type not (neg)
node at (case)
patterns behavioral/eeg (compound)
protection overexpression (nmod)
history , (punct)
effect secretion (nmod)
attempt titrate (xcomp)
proved safe (xcomp)
receive combination (conj)
men homosexual (amod)
induced factor (dobj)
treatment their (nmod:poss)
scale impressions (compound)
temporary , (punct)
more hypotension (nmod)
interest considerable (amod)
infusion rapid (amod)
a delayed (dep)
anemia cephalothin-induced (amod)
observed pups (nmod)
part least (advmod)
safety efficacy (conj)
dh md (conj)
pressure ; (punct)
antinociception effect (conj)
0.02 0.05 (conj)
excluded . (punct)
17beta-estradiol , (punct)
assessed preparations (nmod)
diameters , (punct)
affect initially (advmod)
bridge hepatic (nmod)
factor-alpha , (punct)
phenobarbital by (case)
limited search (nsubjpass)
associated ketoconazole (nmod)
ed to (case)
program this (det)
challenge a (det)
kidney tgf-b (dep)
expression altered (amod)
sample ml (compound)
region rostral (amod)
carried out (compound:prt)
baclofen strain (nmod)
% hbig (nmod)
mucositis stomatitis (conj)
olanzapine aripiprazole (conj)
associated hemolysis (nmod)
24 6 (conj)
agonist cholinergic (amod)
led outcomes (nmod)
well been (cop)
indices contractile (compound)
breath bad (amod)
controls strains (nmod)
4107 meq (conj)
attacks ischaemic (amod)
medication surgery (conj)
nimesulide to (mark)
open eyes (dobj)
treated clozapine (nmod)
subjected protein (nmod)
had 4 (meta)
administration ua (dep)
complexes single (amod)
cephalosporins defect (appos)
however g. (compound)
pralidoxime-2-chloride reactivator (compound)
analogue prostacyclin (compound)
98 +/- (cc)
produce tilts (nsubj)
ec50 the (det)
considered appeared (advcl)
suitable not (neg)
nausea ) (punct)
antithrombin with (case)
higher may (aux)
level steady-state (amod)
uterus from (case)
reduced domperidone (nmod)
treatment its (nmod:poss)
stress later (amod)
lna at (case)
associated can (aux)
anuria with (case)
appears effective (ccomp)
present cord (nsubj)
release 5ht3 (compound)
dex-treated 0.01 (dep)
formed regimen (nmod)
contributes activation (nsubj)
rigidity both (cc:preconj)
270 280 (conj)
pathway signaling (nmod)
divided groups (nmod)
nephrotoxic whether (mark)
courses the (det)
medicate patient (nsubj)
died she (nsubj)
hips-cms using (xcomp)
polyphagia , (punct)
prazosin to (case)
number resuscitations (nmod)
phenomenon in (case)
experiments such (amod)
happiness depressed (conj)
173 +/- (cc)
disruption for (case)
research , (punct)
incident 1 (nummod)
fluctuations clinical (amod)
7alpha-hydroxylase cyp7a (appos)
comparison inhibitors (nmod)
t cardiac (amod)
impact glucagon (nmod)
characteristic decrease (nmod)
occur dyscrasias (nsubj)
data contemporary (amod)
suppression with (case)
delineated stimulation (nmod)
0.05 0.02 (conj)
level 225 (nummod)
ml/min 0.35 (nummod)
performance with (case)
injury reduced (amod)
exposed given (conj)
anticipated is (auxpass)
cirrhosis sporotrichosis (conj)
patient 49-year-old (amod)
disintegrations ) (punct)
one two (conj)
influence on (case)
occurred dissolution (nsubj)
inhibition receptors (nmod)
methods the (det)
correlates importantly (advmod)
ug ) (punct)
rg1 the (det)
percentage the (det)
responses similar (amod)
200 from (case)
extend research (dobj)
required 70 (nsubj)
crisis : (punct)
methods for (case)
stage later (amod)
monoarticular or (cc)
achieved conclusions (dep)
months of (case)
median % (nmod)
developed sicca (nsubj)
damage nervous (amod)
risk with (case)
use antidepressant (amod)
summary man (appos)
filaments and (cc)
recruited sample (nsubjpass)
radiotherapy consolidation (compound)
disturbances hemodynamic (amod)
received dexamethasone (dobj)
chlorthalidone ) (punct)
oct or (cc)
nonionic , (punct)
patients or=2.5 (dep)
reviewed also (advmod)
spread had (aux)
satisfactory less (advmod)
= 0.0343 (dobj)
procedure another (det)
timolol ( (punct)
characterized is (auxpass)
administration period (nmod)
receiving six (nsubj)
deficiency no (compound)
pilocarpine by (case)
cure apparent (amod)
received determine (advcl)
16 in (case)
administration from (case)
genotyped rs4704559 (nmod)
administered injected (conj)
dose doses (conj)
assessed rats (nmod)
detection performance (compound)
quiet pacing (conj)
evaluation clinical (compound)
group alfentanil (amod)
inhibition depletion (conj)
shows : (punct)
time hunt (conj)
carried determine (xcomp)
hypertension malignant (amod)
staining cuprolinic (amod)
syndrome interaction (nmod)
shows . (punct)
appear change (nmod)
enhancement an (det)
oxide inos (appos)
camkiia psd-95 (conj)
courses cc (nmod)
localize microscopy (nmod)
haemorrhage gastrointestinal (amod)
members , (punct)
mortality an (det)
reversed that (mark)
safety use (nmod)
37 10 (compound)
nsaids ( (punct)
prevalence varies (nmod)
males diagnostic (nmod)
weeks mainly (advmod)
discontinuance therapy (nmod)
describe third (conj)
incoordination diazepam-induced (amod)
release seizure-prone (nmod)
combination lipid (nmod)
attractive . (punct)
lesions mdma-induced (amod)
decreased catalepsy (dobj)
intoxication cocaine-benzodiazepine (amod)
activity baseline (compound)
course after (case)
frequent leukocyturia (nsubj)
evaluated pain (nsubjpass)
nucleus of (case)
11 6 (compound)
270 0 (compound)
treated both (nsubjpass)
observed differences (nsubjpass)
nociceptin as (case)
has ppa (nsubj)
seemed etiology (xcomp)
effects depletion (nmod)
produce cp (nsubj)
infant involvement (nmod)
pge2 ( (punct)
lipoprotein ldl (appos)
cleft lip (dobj)
evaluate effects (dobj)
tmax ( (punct)
nuclei both (cc:preconj)
stimulates expression (dobj)
impairment discrimination (nmod)
decline functional (amod)
months/patient ( (punct)
% 39.23 (nummod)
pressure mbp (appos)
illustrates derangements (dobj)
increased moreover (advmod)
ng/mouse 10,000 (nummod)
drug that (mark)
cgs micrograms (appos)
weight 4 (nummod)
had or (dep)
infection to (case)
syndrome ? (punct)
development strategies (nmod)
showing used (ccomp)
synthesize not (neg)
came . (punct)
risks acid (nmod)
oxprenolol mg (compound)
free urinary (amod)
mg/dl or (cc)
flushing facial (amod)
hematoma to (case)
measures preventive (amod)
isoniazid of (case)
lower 23/57 (conj)
catalepsy 0.05 (nummod)
determined activity (nsubjpass)
aware hitherto (nmod)
resulted has (aux)
tasks activation (compound)
lw ) (punct)
died diagnosis (nmod)
but usually (advmod)
were responses (attr)
isotypes pressure (nsubj)
asymptomatic patient (nsubj)
reported with (mark)
reproduced was (auxpass)
effective lowering (advcl)
29.9 8.1 (conj)
abilities documented (acl)
start symptoms (nmod)
median a (det)
hemorrhaging e13.5 (amod)
ptcr and (cc)
adenovirus against (case)
disappeared gradually (advmod)
hepatocytes liver (nmod)
majority ( (punct)
raised ( (punct)
structures the (det)
reported studies (nmod)
20 - (punct)
deferens ( (punct)
reduced day (nmod)
piloerection including (case)
signed wilcoxon (nsubj)
quantify severity (dobj)
tolerated topotecan (nsubjpass)
appearance syndromes (nmod)
volume dose (conj)
given randomly (advmod)
h 96 (nummod)
tumors cell (compound)
attenuating without (mark)
related profile (nmod)
communication skills (conj)
elevation than (case)
reversion a (det)
k(+ ( (punct)
because especially (advmod)
kidney polycystic (amod)
measured was (auxpass)
those confusion (nsubj)
authorized use (nmod)
effect calcification (nmod)
showed changes (nsubj)
bilirubin plasma (compound)
optic and (cc)
thirty-seven patients (nmod)
studies therapy (nmod)
0 750 (conj)
scenario uncommon (amod)
33.3/9.1/6.1 thrombocytopenia (compound)
models regression (compound)
hyperactivity and (cc)
rats from (case)
duration stimulus (nmod)
analysis outcomes (nmod)
nystagmus reversible (amod)
indicating spasm (dobj)
ultrastructure on (case)
serum high (amod)
associated numbers (conj)
activity decreased (amod)
similar ingestion (nmod)
factor impact (nsubj)
val204asp/p the (det)
currents potassium (compound)
ng/ml 500 (nummod)
autoimmune and (cc)
fatal one (nsubj)
patient malaria (compound)
mutation genes (nmod)
using had (aux)
nascis ( (punct)
5-fluorouracil and (cc)
cardiotoxicity cyclophosphamide (amod)
transcriptase rt (appos)
appearance cases (nmod)
oblongata of (case)
confirm necessity (dobj)
mild developed (conj)
exerted ambiguus (nmod)
act aminoglycosides (nsubj)
blocked enhancement (dobj)
cause morbidity (nmod)
ly-171555 than (case)
results treating (advcl)
anxiety caffeine-induced (amod)
group flumazenil (compound)
i.c.v. mg (compound)
died post-lt (parataxis)
analyzed purpose (nmod)
infused premedication (nmod)
predominance involvement (nmod)
drugs among (case)
temocapril 14 (dep)
increases treatment (nsubj)
phosphatidylserine of (case)
type apex (nmod)
150 300 (conj)
group olanzipine (compound)
e13.5 and (cc)
occlusion of (case)
mssbp msdbp (conj)
exhibited mhc-cb7 (nsubj)
associated kingdom (nmod)
dfc and (cc)
tolerability and (cc)
10.7 +/- (cc)
window the (det)
stopped treatment (dobj)
function on (case)
exercised , (punct)
complex i (nummod)
time ventilation (nmod)
different swelling (nsubj)
found benzodiazepines (nsubjpass)
edema for (case)
rats weanling (amod)
gpi mediate (acl:relcl)
mm 20.3 (nummod)
role action (nmod)
evaluated functions (nsubjpass)
gum of (case)
that . (punct)
control movements (dobj)
indicate occur (ccomp)
smoking cessation (dobj)
elevation electrocardiogram (nmod)
tolerate who (nsubj)
modalities them (nsubj)
lack 13 (nummod)
binding [3h]-dihydroergocryptine (nmod)
physician attending (amod)
other patients (nmod)
lead bradycardia (nmod)
examined expression (dobj)
carcinomas renal (amod)
taken determination (nmod)
seems complication (xcomp)
dba/2j balb/cbyj (conj)
representing ( (punct)
had screening (xcomp)
arteries within (case)
variable difference (nsubj)
treated g (nmod)
follows tests (nsubj)
gave rise (dobj)
varied and (cc)
cyclooxygenase 1 (nummod)
exercise-isoproterenol and (cc)
defined was (auxpass)
available patients (nsubj)
fm group (compound)
gauges 0.001 (appos)
cycles alternating (acl)
cystitis ) (punct)
patients : (punct)
neurons spared (amod)
1 received (acl:relcl)
growth phenotypes (conj)
b hepatitis (compound)
rates patterns (conj)
had smoking (nsubj)
disorder in (case)
suggested analysis (nsubj)
heparin agents (conj)
case published (amod)
effects children (nmod)
adrenaline atropine (conj)
frequency drugs (nmod)
used 1999 (nmod)
css chromosomes (nmod)
1.1 3.1 (conj)
precipitate may (aux)
series whole (amod)
flumazenil the (det)
intoxication . (punct)
fall significant (amod)
showed enzymes (nsubj)
10.1 3.8 (conj)
made patient (nsubj)
university oregon (compound)
predicted as (mark)
stress pharmacological (amod)
inhibit implications (dep)
production ultrasound (amod)
levels supraphysiologic (amod)
fraction microsomal (amod)
phacoemulsification sutureless (compound)
one dyskinesia (nmod)
australia in (case)
auditory brainstem (compound)
familiar be (cop)
patients a (compound)
mm 12 (nummod)
tachycardia variant (amod)
unchanged this (nsubjpass)
head cancer (conj)
remain to (mark)
modulation response (nmod)
hemorrhage infusion (conj)
0.03 < (dep)
included aorta (dobj)
augment block (dobj)
vasodilator background (nsubj)
returned levels (nmod)
arose also (advmod)
literature reports (nmod)
infiltration exfoliation (conj)
sharps both (cc:preconj)
deficits greater (amod)
produced blockers (nsubj)
factor disorder (nmod)
shift inducing (advcl)
minimize bradycardias (dobj)
grs ( (punct)
trigger be (cop)
choreic was (cop)
behaviors of (case)
fibrillation determinants (conj)
carboplatin treatment (dep)
done buffers (nmod)
ergotamine to (case)
reaction drugs (nmod)
prevalence . (punct)
study to (case)
activation immunological (amod)
content intraplatelet (amod)
represented therapy (nsubj)
structure membrane (compound)
stomach and (cc)
dialysis for (case)
inhibitors cholinesterase (compound)
parameters in (case)
feature area (nmod)
protocol atra (nmod)
data gradient (compound)
mice beta4 (nummod)
worsened responded (conj)
2.5 and (cc)
reported ever (advmod)
simplifies that (mark)
hemisulfate (+/-)-amphetamine (punct)
occurred apnoea (nsubj)
adult to (case)
eight % (appos)
disintegrin metalloproteinase (conj)
seizures hydrochloride-induced (amod)
randomized prospective (conj)
efficacy formulation (nmod)
events vascular (amod)
prevented infarction (dobj)
deaths cardiac (amod)
combined mg/m(2 (nmod)
alteration this (det)
micrograms 175 (nummod)
transferred backcrossing (nmod)
role levodopa (nmod)
bupivacaine ropivacaine (conj)
patient followed (acl:relcl)
thrombophlebitis for (case)
clarification better (amod)
temporal bilateral (amod)
rhythms escape (compound)
complex by (case)
selected groups (nmod)
telangiectasia became (acl:relcl)
study cross-sectional (amod)
massive most (advmod)
models all (predet)
receptor c-ret (appos)
agents potassium (compound)
lethal potentially (advmod)
supported . (punct)
serve bnp (nsubj)
mechanisms cytopathic (amod)
proteins ( (punct)
diatrizoate from (case)
results patients (appos)
compare bolus (nmod)
igf-i increased (amod)
injury cox-i. (compound)
duration fpd (appos)
susceptibility damage (nmod)
therapy tachycardia (nmod)
memantine and (cc)
received prazosin (dobj)
induce cystitis (dobj)
show data (nsubj)
time succinylcholine (nmod)
treated t5 (nmod)
admitted pain (nmod)
given are (auxpass)
insecticide common (amod)
cases 75 (nummod)
adriamycin with (case)
obtained months (nmod)
agent . (punct)
uh ) (punct)
naloxone reversal (dep)
mechanisms involvement (conj)
adjustment such (case)
torr rats (nmod)
examined retrospectively (advmod)
methodology ( (punct)
acceptable care (nmod)
cohorts either (cc:preconj)
mmol/d ( (punct)
i.p. and (cc)
hydroxytyrosol the (det)
equipment through (case)
allografts functioning (amod)
period epilepticus (nmod)
head in (case)
administration blockers (nmod)
predated . (punct)
one no (det)
therapy outcome (dep)
experienced had (aux)
hydration after (case)
administration mg/kg (nmod)
showed specimen (nsubj)
rates groups (nmod)
inducing striatum (nmod)
nonlactating cows (dobj)
% when (advmod)
ameliorate retained (conj)
action that (nmod)
alphaenac expression (dep)
uptake [(3)h]norepinephrine (compound)
replies from (case)
deterioration clinical (amod)
depression with (case)
performed assess (advcl)
supplements and (cc)
measured tremor (nsubjpass)
target of (case)
n-acetyl-beta-d-glucosaminidase urinary (amod)
children ) (punct)
useful decreasing (advcl)
p=0.36 ) (punct)
received % (dobj)
leukomalacia periventricular (amod)
referred clinic (nmod)
reports contrary (nmod)
secretion impaired (amod)
identified cause (nsubjpass)
conditioning intensive (amod)
up-regulated hippocampus (nmod)
flecainide as (cc)
haloperidol bid (nmod)
display degree (dobj)
captopril mg/kg/day (appos)
ci 2.80 (nummod)
moderate-dose 24.1 (appos)
egfp ) (punct)
dose i.v. (nmod)
involved are (auxpass)
effects region (nmod)
sequences counterbalanced (amod)
carbamazepine by (case)
taking bendrofluazide (dobj)
suggest add (ccomp)
resulted pretreatment (nsubj)
stopped using (xcomp)
treated conception (nmod)
affect forestomach (nmod)
practices primary (amod)
five seven (nmod)
increase dose (nsubj)
prevent hypokalemia (dobj)
contribution nursing (nmod)
observed constriction (nsubjpass)
antiplatelets , (punct)
-21.3 , (punct)
lipofuscinosis ceroid (amod)
parkinsonian-like and (cc)
adr ( (punct)
dysphagia nor (cc)
cytoprotective which (nsubj)
marker reduction (nsubj)
dose infants (conj)
cocs , (punct)
biochemical or (cc)
lipoprotein cholesterol (conj)
transporter is (cop)
exchange with (case)
neuropathy the (det)
administered patients (nmod)
characterized action (nmod)
concentration oxycodone (compound)
stain pre-therapy (amod)
systolic function (dep)
tissues both (det)
discovered staff (nsubj)
used > (nmod)
study sleep (compound)
2/3 almost (advmod)
rate glomerulosclerosis (conj)
u/ml 10 (nummod)
induction woman (nmod)
level the (det)
performed load (nsubjpass)
necrosis prominent (acl:relcl)
observer 's (case)
rate rejection (compound)
improved induce (advcl)
resulted reduced (advcl)
substantiate , (punct)
scale experience (compound)
associated these (nsubjpass)
lithium ( (punct)
tumors children (nmod)
injection nucleus (nmod)
bromide of (case)
sweating hypotension (conj)
supramarginal frontal (conj)
given . (punct)
multicenter prospective (conj)
found evaluation (nmod)
transplantation phase (nmod)
patients uveitis (nmod)
undergoes that (mark)
documented been (auxpass)
cerebral + (cc)
patients complaints (nmod)
resistant therapy (nmod)
level potassium (nmod)
seizures the (det)
circumstances physiologically (amod)
% stratum (appos)
impairing lead (ccomp)
signs any (det)
reversed fludrocortisone (nmod)
level hbv-dna (compound)
morbidity its (nmod:poss)
states induced (acl)
risk without (case)
meritorious but (cc)
investigations in (amod)
subset unpredictable (amod)
series ps-exposure (conj)
nephrotoxicity csa (compound)
binding behavior (compound)
alkaloid quinine (nsubj)
weight on (case)
ml 2 (compound)
compared emulsion (nmod)
episodes anemia (nmod)
relationship overload (nmod)
diagnosed before (mark)
reviewed assessed (conj)
adenosine by (case)
receive injection (dobj)
risk = (dep)
register , (punct)
inhibited effects (dobj)
found placentae (nsubjpass)
trends research (compound)
dependency flow (compound)
using schedules (dobj)
practitioners dental (compound)
antagonist nra0160 (appos)
intoxications combined (amod)
index measurement (appos)
223 +/- (cc)
effect toxicity (conj)
rates prevalence (compound)
passed spontaneously (advmod)
make that (mark)
reported features (nsubjpass)
finding was (cop)
attempt not (neg)
cholestasis adults (nmod)
maximum and (cc)
speaking , (punct)
other pretreatment (appos)
chloramphenicol of (case)
identified another (nmod)
abrogated and (cc)
irradiation bed (nmod)
disappeared headache (nsubj)
had : (punct)
valdecoxib ( (punct)
p=0.11 ) (punct)
c1 group (compound)
arrhythmia patients (conj)
occurred suppression (nsubj)
diplopia the (det)
designed incidence (ccomp)
suggested blocks (ccomp)
therapy atherosclerosis (conj)
cows than (case)
administration injection (conj)
procedures : (punct)
5-fu , (punct)
range caerulein (compound)
stones ureteric (amod)
anotia with (case)
bupropion of (case)
produce hypotension (dobj)
rt-pcr and (cc)
screening endocrine (amod)
women elderly (amod)
collection analysis (conj)
day a (det)
synthesis/release activate (acl)
pa ( (punct)
extent calcification (nmod)
spasm or (cc)
danger an (det)
cases all (predet)
153 and (cc)
failed tended (conj)
potentials cells (nmod)
recipient -- (punct)
lateral rat (compound)
ps ( (punct)
complaints increasing (advcl)
tolerance safety (conj)
modify progression (dobj)
peliosis tumors (conj)
adam10 mmp-9 (conj)
perform correct (conj)
objectives . (punct)
survival ) (punct)
mg/kg 32 (nummod)
weeks 9 (nummod)
water 25 (nummod)
failure ovarian (amod)
104 ) (punct)
nephrotoxicity acetaminophen-induced (amod)
levels tafi (compound)
3'-azido-3'dideoxythymidine by (case)
encountered drugs (nmod)
reduced frequency (nsubj)
suggested cardiotoxic (xcomp)
patients white (amod)
correspond . (punct)
levels from (case)
dfp ) (punct)
returned had (aux)
adsd ) (punct)
mitochondria isolated (acl)
induces result (nmod)
vcug and (cc)
complication might (aux)
placebo-controlled , (punct)
showed test (nmod)
involves , (punct)
indicate obtain (ccomp)
likely are (cop)
cohort from (case)
separating effects (dobj)
resulting palsy (nmod)
alpha(2 the (det)
response reticulum (compound)
infections serious (amod)
medulla ventral (amod)
states into (case)
administered bolus (nmod)
carbonate beta-blockers (conj)
humans both (cc:preconj)
complications serious (amod)
phosphokinase aminotransferase (conj)
medication rhinitis (nmod)
gls and (cc)
spicy hot (amod)
cerebellar function (dep)
suppression and (cc)
2000 in (case)
women thirty (nummod)
children p9605 (compound)
more slightly (advmod)
mutants the (det)
cephalosporin with (case)
available agent (nsubj)
increased ml/s (nmod)
behaviors genes (nmod)
modifications same (amod)
contrast myocardial (amod)
treatment gum (amod)
headache vomiting (conj)
ill acutely (advmod)
animals given (acl:relcl)
atrophy iib (compound)
g/m2 60 (nummod)
included 163 (dep)
suggested is (auxpass)
promoter basal (amod)
medication atrophy (conj)
effects rewarding (amod)
detected can (aux)
production . (punct)
role ) (punct)
independence in (case)
delays forgetting (acl)
occurred intervention (nsubj)
genes among (case)
rechallenge inadvertent (amod)
weeks examination (dep)
became unendurable (acomp)
6 and (cc)
copolymers hpma (compound)
effects cns (nmod)
secretion anti-diuretic (amod)
switch after (case)
= 0.051 (dobj)
history gout (nmod)
50 of (advmod)
aminoguanidine ag (appos)
induce pce (nsubj)
triggers cause (conj)
case the (det)
confirmed suggestion (nsubjpass)
protein gfap (appos)
replicate does (aux)
responds . (punct)
precipitated overdose (nmod)
complication severe (conj)
patient 1 (nummod)
collected times (nmod:tmod)
substrate a (det)
correlated ( (punct)
conjugates ( (punct)
sites estrogen (compound)
outcomes cancer (conj)
level pb (compound)
attenuation nephrotoxicity (nmod)
myoglobinuria with (case)
optic peripheral (conj)
3-methylcholanthrene of (case)
resistance with (case)
doses supplement (compound)
man 40-year-old (amod)
defecate to (mark)
basic and (cc)
disruption that (mark)
79 +/- (cc)
administering along (prep)
mrnas enac (compound)
sensation decreased (amod)
insufficiency aortic (amod)
consisting and (cc)
responsiveness levodopa (compound)
several rcts (nmod)
dysfunction that (mark)
induction case (nmod)
rebound hypertension (dobj)
pentobarbital run (acl)
ascitis , (punct)
reversal : (punct)
levels corticosterone (compound)
antagonist d2-receptor (amod)
< 85 (nummod)
lysate cell (compound)
membrane cell (compound)
treated charcoal (nmod)
starting sedative (dobj)
cows nonpregnant (amod)
dox mixture (conj)
infarction dose (nmod)
way be (cop)
occlusion . (punct)
exceed dose (nmod)
nigra substantia (amod)
reference sclerosis (nmod)
inhibitors ritonavir (nmod)
muscle cranialis (compound)
proliferation period (nmod)
reduction ( (punct)
regimen with (case)
seizure mice (dobj)
users 80 (nummod)
wilson 's (case)
double-immunolabeling by (case)
displayed susceptibility (dobj)
arrest day (nmod)
injury immunologic (amod)
milieu the (det)
methods performed (appos)
strategies possible (amod)
angiotensinogen low (amod)
antagonized hand (nmod)
treatment outpatients (nmod)
dep while (case)
aetiologies possible (amod)
increase may (aux)
metabolism accumulation (nmod)
therapy current (dep)
beta-blockers with (case)
mm 76 (nummod)
states sensitization (compound)
pod 6 (nummod)
rhabdomyolysis , (punct)
wk the (det)
onset delayed (amod)
s-1 derivative (appos)
pd mdp (conj)
occurs diabetics (nmod)
usage seizures (conj)
plasma urinary (conj)
were larger (dep)
complex both (cc:preconj)
investigated patients (nsubjpass)
affected incidence (nsubjpass)
regurgitation regurgitation (conj)
cause associated (advcl)
emergence effects (nmod)
digoxin without (case)
pressor cirazoline (nmod)
scheduled anesthesia (nmod)
doses p<0.001 (dep)
ziprasidone of (case)
exposure hepatotoxicity (conj)
diagnosis neuropathy (conj)
drugs pro-absence (amod)
treatment overdose (nmod)
type therapy (nmod)
time seizure (nmod)
found difference (nsubjpass)
offer might (aux)
database disease (compound)
temazepam zopiclone (conj)
frequency low (amod)
transplant liver (compound)
calcium in (case)
infants myoclonus (appos)
energy a (det)
cns , (punct)
forced % (nmod)
pregnane-20-ones alpha-hydroxy (amod)
exhibited anticipated (advcl)
cataract requiring (amod)
oropharynx hypopharynx (dep)
policy a (det)
weak she (nsubj)
that dopac (nmod)
identified output (nmod)
post-infusion 240 (nummod)
believed levels (xcomp)
79 53 (conj)
effect pain (nmod)
estimated be (auxpass)
induction remission (nmod)
expression medulla (nmod)
animals used (acl)
administration nefiracetam (nmod)
mg/m2 910 (nummod)
diabetic neuropathy (dep)
azathioprine analogue (dep)
malignancy from (case)
adverse serious (amod)
mediate proteins (nsubj)
expression renal (amod)
times day (nmod:npmod)
cardioprotection in (case)
using regression (dobj)
damage comprising (acl)
splenomegaly normal (amod)
hippocampus such (case)
ecgs from (case)
finding well-known (amod)
lad age (conj)
fibrillation paroxysmal (amod)
diameter ) (punct)
ischemia increase (appos)
delays but (cc)
complications use (nmod)
angiogram positive (amod)
patients methods (conj)
produced eads (dobj)
secondary mainly (advmod)
interference without (case)
was vomiting (conj)
desipramine lesions (conj)
factor studied (acl)
continued deviation (dep)
biopsies protocol (compound)
r- s-isomer (conj)
number surface (conj)
induce because (mark)
side-effect , (punct)
have index (dobj)
authors two (nummod)
perfusion cerebral (amod)
nitrendipine nisoldipine (conj)
group 90/htn (amod)
macroglobulinaemia waldenstrom (compound)
given p.o. (dative)
sensorium clear (amod)
organization european (compound)
updrs yahr (conj)
response major (amod)
achieved cases (nmod)
number effects (nmod)
noted increase (nsubjpass)
apd and (cc)
state pain (compound)
20 40 (conj)
induced-behaviour in (case)
background admitted (appos)
antibodies 4 (nummod)
serological of (case)
administration csa (dep)
showed is (ccomp)
seizures develop (acl:relcl)
affected depression (nmod)
artery occlusion (conj)
fraction ratio (conj)
preinfusion ml/100g/min (dep)
lead effects (nsubj)
alpha-2b with (case)
ester phosphate (compound)
cxad rate (conj)
factors predisposing (amod)
system 1.5-t (nummod)
phentolamine micrograms (conj)
sources data (compound)
discharged month (nmod)
left reduced (conj)
seen levels (nmod)
initiated then (conj)
hypoglycaemia , (punct)
associated succinylcholine (nmod)
5 pn (conj)
exposure no (neg)
fluoroquinolones , (punct)
dopamine metabolites (conj)
model test (acl)
dyslipidemia about (case)
conventional extended-interval (conj)
282 203 (conj)
blind day (nmod)
remained adjustment (nmod)
objectives investigate (dep)
induced vasodilators (nmod)
serositis pulmonary (conj)
mmp-2 , (punct)
respond do (aux)
patients 236 (nummod)
gaba(a)rs nmdars (conj)
61 of (quantmod)
justified follow-up (nsubjpass)
sensitivity strains (nmod)
preserved as (mark)
useful . (punct)
adaptation decreased (amod)
disappearance for (case)
twitching palpebral (amod)
end-stage disease (conj)
potentiation catalepsy (compound)
eliciting ischemia (dobj)
effects ameliorative (amod)
meal during (case)
deaths , (punct)
groups patients (dep)
raised amplitude (dobj)
prescribed who (nsubj)
micromol/l 6.2 (nummod)
lower statistically (advmod)
ls ( (punct)
d-penicillamine d-pen (appos)
concentration by (case)
antagonist platelet-activating (amod)
development against (case)
total ) (punct)
cyp2d6 of (case)
morphine codine (conj)
method a (det)
produces whether (mark)
transplantation group (nmod)
units care (compound)
phosphokinase with (case)
given increased (conj)
= 0.5 (dep)
kurroa picrorrhiza (compound)
protect tissues (dobj)
oxygen and (cc)
neurons gnrh (det)
programming the (det)
injury the (det)
adam10 and (cc)
pap ) (punct)
microl 6.5+/-3.1 (nummod)
nitrate/nitrite nox (appos)
0.60 - (punct)
substance with (case)
labetalol agent (appos)
occurred shunt (nsubj)
bupropion therapy (conj)
disease obstructive (amod)
frequency importance (conj)
ages yr (dep)
mean and (cc)
weeks tapered (conj)
theory this (det)
hours life (nsubj)
phospho only (advmod)
cause paracetamol (nsubj)
suggests studies (nsubj)
scoring semi-quantitative (amod)
= -0.95 (dep)
mg mg (appos)
factor-i recombinant (amod)
nephrectomy treatment (nmod)
incidence an (det)
techniques by (case)
incidence mania (nmod)
ischemia the (det)
influence agonists (nmod)
usual improvement (nsubj)
problem diseases (nsubj)
difference content (compound)
muscle fibrotic (amod)
amnesia diazepam (conj)
sludge of (case)
strain balb/c (compound)
experiment this (det)
thickness with (case)
halts conclusion (nmod)
mmol/l average (amod)
had twenty-six (nsubj)
effects cardiovascular (amod)
exposure bpa (compound)
network major (amod)
observed histopathologically (advmod)
barrier across (case)
mice efficacy (conj)
have bfgf (nsubj)
activity typical (amod)
increase mg/dl (nmod)
development delirium (nmod)
cause dose (nmod)
chloroform-adrenaline with (case)
half-life minutes (nmod)
scopolamine drug (compound)
had supplementation (nsubj)
% 61.4 (nummod)
30 150 (conj)
evaluated contribution (nsubjpass)
abnormalities and (cc)
pain to (case)
urine rats (nmod)
supervision close (amod)
function thyroid (compound)
excess hours (nmod)
models these (det)
mug 30 (nummod)
regained until (mark)
layer gyrus (compound)
examination treatment (conj)
active orally (advmod)
selegiline with (case)
woman postmenopausal (amod)
content endothelin-1 (compound)
naloxone for (case)
abnormalities apex (nmod)
visit study (compound)
lethality level (conj)
blockade for (case)
nimesulide with (case)
those are (cop)
emerged however (advmod)
follow with (case)
reduction on (case)
ameliorated administration (nsubj)
homeostasis cellular (amod)
exceed effects (nsubj)
given combination (conj)
% = (dep)
discovered two (nsubjpass)
show suggest (conj)
mice leading (acl)
mediated are (auxpass)
analgesics opioid (amod)
2 was (cop)
response hs (nmod)
grades intraventricular (amod)
infusion 5-fluorouracil (compound)
stabilized which (nmod)
allow used (ccomp)
reserved be (auxpass)
weeks first (amod)
verified was (auxpass)
infrequent but (cc)
geometry function (conj)
effect injection (nmod)
increases increases (advcl)
gluconate intravenous (amod)
receptor inhibitor (conj)
by-product is (cop)
improvement without (case)
70 % (dep)
neck the (det)
appeared bdl (nmod)
measured have (aux)
measured period (nmod)
remained well (advmod)
symptoms normalization (conj)
bradykinesia , (punct)
died baby (nsubj)
recorded circle (nsubjpass)
initiate that (mark)
man 59-year-old (amod)
titer 3-antineutrophil (compound)
halving by (mark)
prevention cancer (compound)
suggests improve (conj)
sites membrane (nmod)
induces hemolysis (dobj)
infused weeks (dobj)
screenings double (amod)
slowing subjective (amod)
link markers (nmod)
noted we (nsubj)
inhibition clearance (nmod)
occlusion apparent (amod)
considered that (nsubjpass)
left function (dobj)
poisoning pb (compound)
concentrations mesna (nmod)
onset extent (conj)
evaluation histological (amod)
dosage total (amod)
enzyme and (cc)
et-1 response (dep)
terminated later (advmod)
mm 2 (nummod)
loss memory (compound)
selected relationship (nsubj)
potentiate that (mark)
support patients (nmod)
this types (conj)
oxide and (cc)
done patients (nmod)
ability . (punct)
features cytoarchitectural (compound)
kg(-1 mg. (compound)
temperament with (case)
drug was (cop)
umax impaired (amod)
ph as (cc)
dyskinesia l-dopa (amod)
deleted and (cc)
provide strategy (dobj)
antagonists rats (nmod)
patients 114 (nummod)
agent along (case)
hypothesis appear (ccomp)
relaxants suxamethonium (dep)
length-of-stay higher (conj)
previously as (case)
taste in (case)
coagulation blood (compound)
effect impairment (nmod)
shr of (case)
index the (det)
monotherapies % (appos)
is : (punct)
edema peripheral (amod)
revealed search (nsubj)
stopped were (auxpass)
growth enlargement (conj)
experimental 2 (compound)
cats two (nummod)
paramethasone from (case)
diameter and (cc)
open cross-over (conj)
higher lid (nmod)
develop control (dobj)
proteinuric severely (advmod)
examined hbsag (nmod)
given h (nmod:tmod)
used diseases (nmod)
patients 16 (conj)
inhibition via (case)
rats dose (nmod)
using t-tests (dobj)
able identify (xcomp)
cause ; (punct)
site habitual (amod)
distinguishing cystica (nmod)
correlates , (punct)
anemia syndrome (conj)
drug cytotoxic (amod)
dose therapy (nmod)
occurred elevations (nsubj)
patients sah (nmod)
solution anaesthetic (amod)
pressure creatinine (dep)
nkcc2 ( (punct)
recorded training (nmod)
determined immunoblotting (nmod)
activity brain (compound)
mg suprofen (nmod)
consequence arrest (nmod)
those considered (acl)
neurons npy (compound)
analogues of (case)
2.6 -5.0 (quantmod)
pretreatment caffeine (compound)
difficult achieve (xcomp)
patients non-small-cell (amod)
absent glepp1 (nsubj)
year patients (conj)
release concomitant (amod)
secreted manner (nmod)
supplements consumed (amod)
adult an (det)
sensitivities abnormalities (nmod)
therapy enzyme (compound)
considered recently (advmod)
allele homer1 (compound)
received np (dobj)
700 - (punct)
trend for (case)
receptor mglurs (conj)
6028 16 (nummod)
find we (nsubj)
injection test (nmod)
had hemodialysis (nmod)
decrease resolution (conj)
analysis and (cc)
sectors ca1 (compound)
volumes the (det)
dyskinesia caused (acl)
suggested causes (ccomp)
3 or (cc)
stay inpatient (amod)
patient maintained (acl)
examined rats (nmod)
tetracycline in (case)
bundle block (dobj)
mg/kg/daily ( (punct)
antagonists morphine (conj)
hypothermia mice (nmod)
caudate cerebellum (conj)
examined mice (conj)
concentration mg/ml (nmod)
aim examine (dep)
fact in (case)
pregs unlike (case)
showed injured (conj)
mice ko (compound)
run-in 14-day (amod)
had group (nmod)
% np (nmod)
cue the (det)
binder phosphate (compound)
effects deleterious (amod)
hypercalcemia and (cc)
attenuated quinine (nsubj)
impaired moving (advcl)
case required (acl:relcl)
toxicities clinical (amod)
involve activity (nsubj)
analysis cimetidine (nmod)
dysfunction " (punct)
mg/kg h (nmod)
groups non-deprived (amod)
mitral pre-existing (amod)
superior . (punct)
patients 3500 (nummod)
augments nefiracetam (nsubj)
sulphate heparan (compound)
administered one (xcomp)
determine differ (ccomp)
injury : (punct)
appeared proteinuria (nsubj)
apap and (cc)
b.i.d. mg (dep)
abstinence progressive (amod)
strength ability (conj)
echocardiography by (case)
plasticity sensorimotor (compound)
levels tbars (compound)
drinking some (det)
demonstrated developed (ccomp)
hyperammonemia by (case)
clearance viral (amod)
crisis scleroderma (amod)
related chemically (advmod)
behaviors rats (nmod)
dropped kinase (nsubj)
chemical toxic (amod)
control hydroxytyrosol (conj)
rose ml (nmod)
antibody factor (compound)
presented months (nmod)
dystonia human (amod)
testing the (det)
experienced chow (conj)
weeks some (det)
expression mediators (nmod)
intake doses (nmod)
questionnaire dex (appos)
roles the (det)
model rat (nmod)
fenoldopam with (case)
atrophy type (compound)
to anemia-related (conj)
micrograms trh (nmod)
correlates prepared (conj)
neuroplasticity in (case)
area cortical (amod)
day 2 (conj)
received controls (nsubj)
mean basis (nmod)
persistence bradycardia (nmod)
u/l 32 (nummod)
subject a (det)
ato ( (punct)
variations between (case)
27 30 (conj)
hypoxia focal (amod)
examines effect (dobj)
constellation dermatitis (nmod)
dmtu ) (punct)
index respiratory (amod)
showed biopsies (nsubj)
suffered , (punct)
identify suspicions (dobj)
population based (acl)
point appeared (advcl)
count falling (amod)
findings found (dep)
2-acetylaminofluorene of (case)
reduced synthesis (dobj)
dosage toxic (amod)
showed studies (nsubj)
hydroureteronephrosis right (amod)
naproxen ( (punct)
addition bicarbonate (nmod)
low-sodium a (det)
effect pdtc (nmod)
cutaneous anaphylactoid (conj)
outpatients six (nummod)
measured threshold (nsubjpass)
indications with (case)
firmness in (case)
0.005 p (compound)
nephropathy characterized (acl)
tab , (punct)
pressure intraocular (amod)
correlates concentration (nsubj)
abolished increases (nsubjpass)
repeated case (nmod)
numbers microtubules (nmod)
administrated . (punct)
immunosuppressive potent (amod)
insidiously rosacea (case)
treated latency (nmod)
tasks learning (nmod)
use cpa/ee (nmod)
group fr (compound)
improved function (dobj)
characterized event (nsubjpass)
age : (punct)
genotype atypical (amod)
small generally (advmod)
question open (amod)
contribute actions (nmod)
require effects (nsubj)
adrenoceptors-mediated simultaneous (amod)
group this (det)
antagonized also (advmod)
catheter min (conj)
provide may (aux)
appeared tolerated (conj)
assessed clinical (nsubjpass)
days specific (amod)
similar t (nsubj)
period 7-hour (amod)
individuals of (case)
response endoplasmic (amod)
% -2.0 (nummod)
test learning (compound)
he she (conj)
cardiotoxicity significant (amod)
effects injury (nmod)
infection . (punct)
described pregnancy (nmod)
relevant sensitization (nmod)
used techniques (nsubjpass)
following i.p. (mwe)
measure aims (nsubj)
3 6 (conj)
showed cases (nmod)
min saline (compound)
patients edema (nmod)
later min (dep)
effect analgesia (nmod)
proposed damaged (advcl)
creams of (case)
mg amlodipine (compound)
organs the (det)
units cryoprecipitate (nmod)
leading disease (nmod)
week after (case)
regimens two (nummod)
switched who (nsubjpass)
subject smoker (appos)
events neurological (amod)
bupivacaine- or (cc)
transplantation failure (compound)
inhibitor kappa-beta (nmod)
consumption phenacetin (nmod)
anastrozole and (cc)
macroscopic and (cc)
complained disturbance (dobj)
weight carrier (nmod)
diet low-sodium (compound)
type acute (amod)
gyrus ca1 (compound)
olanzapine % (appos)
rates normalization (compound)
presenting coma (nmod)
l(-1 threshold (nsubj)
benefit treatment (dobj)
moderate severity (nmod)
co-agonist receptor (nmod)
1.52 ) (punct)
child leukaemia (nmod)
positive hbsag- (compound)
observed presented (advcl)
pathogenesis nephrotoxicity (nmod)
dose steroid (nmod)
months/patient 21 (nummod)
levels patient (nmod:poss)
hbeag-positive an (det)
treated initially (advmod)
revealed value (nmod)
pge2 urinary (amod)
bupivacaine tricaine (conj)
affected response (nsubjpass)
recorded results (dep)
use oltx (appos)
neurotoxicity synaptic (amod)
iiib patients (conj)
alf before (case)
p = (conj)
controlled further (advmod)
plans with (case)
weeks prior (advmod)
younger were (cop)
survived not (neg)
5 with (case)
combination antibiotic (amod)
using labetalol (dobj)
deterioration the (det)
sleep and (cc)
incidence infection (nmod)
intravitreal retinochoroidopathy (nmod)
caused patient (nmod)
reversing in (mark)
uptakes compared (dep)
markers best (amod)
53 to (quantmod)
complex qrs (compound)
standard-risk " (punct)
nephrotoxicity on (case)
stress against (case)
moderate-dose p (dep)
interview of (case)
show intensity (dobj)
antifolate lometrexol (nsubj)
impairment patients (conj)
stimulated neutrophils (nsubjpass)
occurrence means (nmod)
allocated ; (punct)
minimal-type and (cc)
radio-chemotherapy with (case)
implantation after (case)
effects data (appos)
inhibit , (punct)
days 22 (conj)
% 4 (nummod)
developed hepatitis (dobj)
unrelated were (cop)
patients ctni-positive (acl:relcl)
reoccur not (neg)
percent six (nummod)
evaluated records (nsubjpass)
evaluation health (compound)
lithium investigations (conj)
implicated describes (dep)
obtained study (nmod)
micrograms/kg/hr of (case)
ruling out (compound:prt)
prevent 3.9 (dobj)
assessed trial (nsubj)
plays if (mark)
0.02 , (punct)
siblings presented (acl)
health risk (conj)
decrease mean (compound)
facility care (compound)
caffeine of (case)
contain typically (advmod)
incidence stroke (nmod)
considered was (auxpass)
interviewing include (conj)
increase gfr (dobj)
transketolase abnormal (amod)
abecarrnil ) (punct)
wild-type given (parataxis)
techniques immunohistochemical (amod)
identify protocol (dobj)
methods administration (nmod)
treatment cyclophosphamide (compound)
year-old 63 (compound)
beating widening (appos)
mice of (case)
deficit attention (compound)
ccl2 for (case)
course effects (nmod)
man 57-year (amod)
consequence a (det)
response antibiotics (nmod)
similar . (punct)
time prolonged (amod)
remodelling cardiac (amod)
8 of (case)
endothelial inducible (conj)
protocols conversion (nmod)
analyse data (dobj)
drugs pilsicainide (nmod)
design analysis (dep)
effect than (case)
ssris treatments (conj)
metabolite the (det)
test forced-swimming (amod)
effects trihexyphenidyl (nmod)
prolongs and (cc)
infusion fentanyl (nmod)
lithium have (aux)
locomotion bd1018 (conj)
infused thereafter (advmod)
blockers structure (nmod)
prophylaxis ct (nmod)
administration joint (amod)
seem rise (nsubj)
role the (det)
sedation tremors (conj)
increases map (nmod)
diseases . (punct)
lidocaine glucose (nmod)
were compared (prep)
amlodipine dysguesia (conj)
comprised plus (cc)
number rr=1.60 (dep)
2)% sem (compound)
reduces hyperalgesia (dobj)
apical increased (amod)
tolerance of (case)
able is (cop)
tincture , (punct)
months 31 (nummod)
instituted , (punct)
a(2a)/a(1 potent (amod)
proliferation and (cc)
dfx ) (punct)
protein s-100 (compound)
response % (appos)
site midpontine (amod)
study agricultural (compound)
monitored function (nsubjpass)
diagnosis even (advmod)
syndrome whether (mark)
doxorubicin mg (nummod)
occasions in (case)
analgesic regular (amod)
doses prevent (acl:relcl)
suggest far (advmod)
rhigf-i , (punct)
receiving indinavir (dobj)
incidence surgical (nmod)
severe but (cc)
child persisted (acl:relcl)
depressive and (cc)
doses ps (compound)
accumulation rapid (amod)
tablets 130 (nummod)
events nicotine (nmod)
carboplatin high-dose (amod)
effect hormones (nmod)
produces and (cc)
apomorphine amphetamine (conj)
assay behavioral (amod)
reduces etomidate (nmod)
increased foci/cm2 (dobj)
halothane by (case)
allele rs4704559 (compound)
revealed assessment (nsubj)
exhibited five (nsubj)
reticulocytes p (appos)
appeared forms (nsubj)
urine hypertonic (compound)
growth or (cc)
development upon (case)
amiodarone rate (nmod)
correlates physiological (amod)
4.40 10(3 (conj)
inhibition anesthetics (nmod)
associated sequelae (nmod)
background & (cc)
fail . (punct)
suggest analyses (nsubj)
cp ) (punct)
provides sedation (dobj)
desipramine coeruleus (nmod)
hypercalcemia rash (conj)
rare and (cc)
consider . (punct)
tried has (aux)
anaesthetics halothane (dep)
tachyarrhythmias of (case)
single by (case)
vasoconstriction from (case)
test in (amod)
function assessed (acl)
injections after (conj)
characterized exposure (nsubjpass)
p-veps ) (punct)
result uncommonly (advmod)
maximum exercise-controls (nmod)
a 4.5- (nummod)
movements smooth (amod)
bolus each (det)
control regulation (conj)
dizziness incidences (nsubj)
decreases norms (nmod)
periods infusion (nmod)
option bacteremia (nmod)
work of (case)
developed allows (ccomp)
creatinine basal (amod)
delay atrioventricular (amod)
ability reported (amod)
developing snr (nmod)
taken dose (dobj)
cpap infusion (nmod)
withdrawn tests (nmod)
prophylaxis inhibitor (nsubj)
1788 ro15 (compound)
glomerulosclerosis = (dep)
repair fracture (compound)
d-penicillamine and (cc)
beings of (case)
dexamphetamine- stereotypies (dep)
cases australia (nmod)
tablet another (det)
vary exhibit (conj)
differ sod (nmod)
variables , (punct)
received perfusion (conj)
found cases (nmod)
changes cytoplasm (nmod)
injection drugs (nmod)
categorized groups (nmod)
production increased (amod)
planned treatment (nsubjpass)
period transplantation (nmod)
doses influence (acl:relcl)
causes vasodilatation (dobj)
used anaesthesia (nmod)
met criteria (dobj)
antagonist site (compound)
amplitude of (case)
studying further (advmod)
index with (case)
apnoea central (amod)
injection calcitonin (nmod)
gels electrophoresis (compound)
require reassessment (dobj)
bupivacaine- ropivacaine-infused (conj)
evaluations on (case)
paid patients (nmod)
hypersensitivity carbamazepine (acl)
anxiety microglia (nmod)
% 78 (nummod)
enhanced learning (nsubjpass)
perimetry threshold (amod)
extrusion na+ (nmod)
task used (acl)
been documentation (attr)
cystoscopy for (case)
lipoprotein , (punct)
postulated mechanism (nsubjpass)
inhibitor angiotensin-converting (amod)
visits 2 (nummod)
nitroglycerin therapy (conj)
placebo -14.6 (dep)
circulations systemic (amod)
revealed effect (dobj)
administration ma (compound)
attribute faint (advcl)
problem health (compound)
pneumonitis autoantibodies (conj)
obtained imaging (nsubjpass)
ssris and (cc)
accompanied were (auxpass)
idazoxan [ (punct)
inconsistent is (cop)
pathways kinase-related (amod)
reduced mildly (advmod)
ratio area (nmod)
activities of (case)
or ] (punct)
include release (dobj)
weakness extremities (nmod)
taking fever (dobj)
needed treatment (nmod)
associated pd (nmod)
treated administration (nmod)
susceptibility a (det)
infusions raise (acl)
gene butyrylcholinesterase (compound)
patients such (case)
decreased pressure (nsubjpass)
cyclophosphamide antiplatelet (conj)
occurred initially (advmod)
hydrocephalus rats (nmod)
maximum were (cop)
apomorphine ( (punct)
mglur1 of (case)
mg/kg 25 (nummod)
pre-administration chloride (nmod)
group adherence (compound)
symptomatology , (punct)
documents study (nsubj)
fasciculation to (case)
complexes finally (advmod)
approach to (mark)
titrate to (mark)
subjects most (amod)
model according (case)
cgrp of (case)
fentanyl ( (punct)
remained 3 (nmod)
integrity sarcolemma (nmod)
effects neuromuscular (amod)
users controls (conj)
mechanisms autoantibody (amod)
bn mg/kg (compound)
dosing days (nmod)
pfs ( (punct)
disorders axis (compound)
cause vasodilation (dobj)
investigations effects (conj)
wastage muscle (compound)
cisapride the (det)
prevention loss (nmod)
sbs dna (compound)
9 - (punct)
elicits binding (nsubj)
regulation aldosterone (nmod)
changed concentration (nsubjpass)
described earlier (advmod)
subgroups trial (amod)
absorption onset (conj)
mm % (conj)
drinks > (det)
agonist is (cop)
surgery recent (amod)
rate 1 (nummod)
lindane hexachloride (appos)
investigated pathology (dobj)
introduced intravenously (advmod)
investigate to (mark)
relevance of (case)
relating testing (nmod)
hyperthyroidism for (case)
temperature co2 (conj)
presence . (punct)
73/99 ( (punct)
taken if (mark)
cortex primary (amod)
event hypertension (nmod)
effect may (aux)
americans million (nummod)
worsened di-o-tolylguanidine (nsubj)
consists discontinuation (nmod)
phenyl-2(5h)-furanon 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl (compound)
wall formation (conj)
parp ( (punct)
calculated procedure (nmod)
evidence reduce (acl)
affected number (nsubjpass)
ampicillin amp (appos)
conducted study (dobj)
compared findings (nsubjpass)
rats rats (nmod)
seen greater (advcl)
defined concentration (nsubjpass)
supplementation glutamate (amod)
circuits in (case)
patients found (acl)
four % (appos)
treatment malignancies (nmod)
both series (nmod)
tachycardia without (case)
functions the (det)
5-fluorouracil before (case)
patient nonepileptic (amod)
action adr (nmod:poss)
warfarin k (compound)
found correlations (dobj)
ng/ml metoprolol (compound)
syndrome flourouracil-induced (amod)
phosphate supplemental (amod)
stimulate however (advmod)
score average (amod)
three whom (nmod)
atp snp (conj)
cpa/ee with (case)
pauses occasional (amod)
set piroxicam (nmod)
men to (mark)
response svr (compound)
prolongation significant (amod)
preference rats (nmod)
cacl(2 periarterial (amod)
prevention b (compound)
8th hours (dep)
support arm (nmod)
that , (punct)
used specificity (nmod)
receiving cytostatics (dobj)
identification . (punct)
replacement dexamethasone (nmod)
types steroids (nmod)
vte and (cc)
calculation basis (nmod)
caused in (advmod)
antagonist ah6809 (conj)
underwent map (dobj)
suspected toxicity (nsubjpass)
succinylcholine ps (dep)
neuroleptics by (case)
umax ) (punct)
combining of (mark)
given combination (nmod)
analyzed enzyme (nsubjpass)
given had (parataxis)
hepatotoxicity potential (amod)
animals 20 (nummod)
crosses agent (nsubj)
bolus to (case)
industry in (case)
hypertension in (case)
complexes premature (amod)
improvement vision (nmod)
dextran fluorescent (amod)
dose mg/kg (compound)
marrow and (cc)
exceeds total (amod)
kf17837 antagonist (dep)
piperacillin of (case)
effect toxic (amod)
rate event (compound)
depression , (punct)
undertaken ascertain (xcomp)
administered dose (conj)
embryo the (det)
provides information (dobj)
showed neurons (nsubj)
using study (advcl)
intake as (cc)
proteins cardiac (amod)
age use (conj)
recognized but (cc)
descriptions two (nummod)
caudate-putamen in (case)
decade the (det)
six of (advmod)
investigated addition (nmod)
small is (cop)
injected area (nmod)
pilocarpine- and (cc)
probed . (punct)
reduction however (advmod)
engaged receptors (nsubjpass)
occurred angiosarcoma (nsubj)
attention further (amod)
maintained phosphorylation (nsubjpass)
back was (cop)
atrioventricular av (dep)
reduced exercise (nmod)
toxic given (advcl)
involvement for (case)
mpep administered (acl)
consultations abuse (compound)
rise mumol/l (nmod)
progression injury (nmod)
moderate to (mark)
child 5-year-old (amod)
carried were (auxpass)
ml 500 (nummod)
17 +/- (cc)
dextran a (det)
increased 2.8 (nmod)
having as (mark)
sotalol of (case)
hyperhidrosis gustatory (amod)
less increase (nsubj)
measured related (conj)
contribute less (conj)
study parallel (compound)
hypertension associated (acl)
array ) (punct)
drinks or=5 (compound)
5.00 15.00 (conj)
affect threshold (dobj)
include mechanisms (nsubj)
lidocaine either (cc:preconj)
relapse ptld (nmod)
synthase-1 prostaglandin (compound)
6.9 +/- (cc)
binder their (nmod:poss)
lower were (cop)
multicenter trial (conj)
administered chloride (xcomp)
entity an (det)
cirazoline alpha (compound)
alternative powerful (amod)
that hepatitis (nmod)
values measured (acl)
noticeable more (advmod)
patients chf (nmod)
recorded grade (nsubjpass)
evaluated incidence (nsubjpass)
values higher (amod)
zidovudine azt (appos)
lowered rate (dobj)
consuming amount (dobj)
pneumonitis phospholipid (amod)
expressions gene (compound)
hr totp (dep)
ich ischemic (conj)
concerns ongoing (amod)
days following (case)
anticoagulation prophylactic (amod)
antibiotics aminoglycoside (amod)
pressure period (conj)
type 1 (nummod)
analysis descriptive (amod)
volume ( (punct)
p ( (punct)
higher stretches (conj)
discussed association (nsubjpass)
nanoparticles with (case)
ml/min lysozymuria (appos)
compromise profound (amod)
rats five (nummod)
recipient allograft (nmod)
history 2-year (amod)
interaction series (dep)
microglia striatal-resident (amod)
revealing mice (nsubj)
finding unusual (amod)
albuterol study (dep)
features and (cc)
subject on (case)
increased neuralgia (nsubj)
medline january (appos)
treatments gellan (compound)
effects cardiomyopathy (amod)
detection at (case)
diagnosis this (nsubj)
audiograms patients (nmod)
months period (nsubj)
rate infusions (nmod)
eyes contralateral (amod)
model drug-induced (amod)
curve pressure-volume (amod)
improved treatment (nmod)
fluphenazine , (punct)
response generalized (amod)
hr [ (punct)
contributes certainly (advmod)
score 8 (nmod)
had restriction (dobj)
workers all (det)
learning rats (nmod)
analogue ) (punct)
passage brain (nmod)
lymphomas for (case)
resuscitation . (punct)
d15 cisplatin (compound)
-0.81 ( (punct)
diseases from (case)
allele epsilon4 (compound)
collection platelet (compound)
ablated and (cc)
prolonged decreased (conj)
imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate ) (punct)
recommended help (xcomp)
clearance nephropathy (nmod)
effect atropinic (amod)
treatment ticlopidine (nmod)
scores stress (compound)
withdrawn improvement (nmod)
predictors : (punct)
risks iatrogenic (amod)
fenoldopam and (cc)
prior admission (nmod)
3.75 and (cc)
unclear pathogenesis (nsubj)
micrograms/kg response (appos)
depression ; (punct)
tube with (case)
manner a (det)
dronedarone compound (appos)
attenuate convulsive (dobj)
tr(- on (case)
control behavior (dobj)
cautious , (punct)
agent 5-fluorouracil (dep)
(att)-associated failure (dobj)
factors prognostic (amod)
glomerular by (case)
valproate to (mark)
report female (nmod)
blockers and (cc)
voltage expression (nmod)
sampled post-exposure (advcl)
longitudinal global (amod)
possiblility patients (nmod)
exert avp (nsubj)
cases parasitosis (nmod)
dextromethorphan , (punct)
provide sedation (dobj)
results average (nmod)
myocardium each (conj)
suffering psoriasis (nmod)
compared factors (nsubjpass)
due neutropenia (nsubj)
symptoms menstrual (amod)
follow-up 3-year (amod)
normalization complete (amod)
effective importantly (advmod)
sensitive that (nsubj)
case pain (nmod)
failure respiratory (amod)
retested weekly (advmod)
0.0073 + (cc)
reduced deletion (nsubj)
suggesting existence (dobj)
levels half-normal (amod)
components the (det)
exhibit and (cc)
encephalopathy except (case)
patients placed (acl:relcl)
1,2 ) (punct)
given achieve (xcomp)
block heart (compound)
data some (det)
appeared normal (xcomp)
treatment throughout (case)
region to (case)
present illness (dobj)
80 49 (conj)
severe whom (nmod)
case 5th (compound)
amikacin intravitreal (amod)
escalated follows (nmod)
infusion v (dep)
anesthesia methoxyflurane (nmod)
1.17 1.42 (amod)
diagnosed effect (nsubjpass)
published however (advmod)
100 10 (compound)
slow and (cc)
preceded were (auxpass)
kidney iia (compound)
retrieval task (nmod)
methotrexate presence (nmod)
desmethylimipramine by (case)
minutes three (nummod)
extract cardiotoxicity (nmod)
diltiazem by (case)
lobule the (det)
mini-pump released (acl:relcl)
effects meth (nmod)
admitted center (nmod)
observed vessels (nmod)
symbol vocabulary (amod)
bladder wt (compound)
phenols derivatives (conj)
transplanted bmcs (nsubjpass)
diet in (case)
treatment pneumonia (nmod)
correlation adjustment (nmod)
accounted exposure (nmod)
adriamycin combined (acl)
age younger (conj)
were : (punct)
recall 60 (dobj)
demonstrated prevented (ccomp)
not only (advmod)
characteristics activity (appos)
influence available (conj)
complication postoperative (amod)
dependent outflow (nmod)
77 to (quantmod)
occurred nature (xcomp)
response node (nmod)
pool atp (compound)
chlordiazepoxide doses (nmod)
types cell (compound)
effective regimen (nsubj)
ingesting , (punct)
presented normal (advcl)
year-old 59 (compound)
treated children (nsubjpass)
death time (appos)
ceased end (nmod)
methotrexate and (cc)
caused diseases (nmod)
management general (amod)
underlying as (mark)
progression hiv (compound)
function vestibular (amod)
abnormalities mtdna (nmod)
reduced minutes (nmod)
18.7 7.0 (compound)
blockers k(+)-channel (compound)
rats exposed (acl)
interaction with (case)
course vehicle (appos)
osteoporosis heparin-associated (amod)
within pressures (nsubj)
fall then (advmod)
results observed (appos)
score 11 (dep)
prevented curcumin (nmod)
biopsies 20 (nummod)
necrosis but (cc)
cephalexin prescribed (amod)
behavior on (case)
diltiazem , (punct)
attended also (advmod)
characterised movements (nmod)
performed ) (punct)
distinguished models (nmod)
revealed sensitized (ccomp)
regulator . (punct)
pentoxifylline with (case)
cannulae day (nmod:tmod)
metoprolol metoprolol (conj)
part in (case)
week third (amod)
0.5 to (dep)
decrease vasodilatation (nmod)
concentrations steady-state (amod)
prescribed analysis (dobj)
differ . (punct)
disease n (appos)
withdrawal ketoconazole (nmod)
transplantation haematopoietic (amod)
occasions four (nummod)
dose even (advmod)
blockers ca(2 (amod)
preceded cells (nmod)
sacrificed animals (nsubjpass)
discontinued and (cc)
dysmetria , (punct)
response agonist-induced (amod)
patients wilson (nmod:poss)
= -3.62 (dobj)
tumors gynecologic (amod)
nx n (appos)
groups 4 (conj)
removed were (auxpass)
attack opponent (nmod)
activation a (det)
rabbit 6 (nummod)
unassigned metolachlor (appos)
interventions : (punct)
jumping to (mark)
afflicted be (auxpass)
system serotonin (compound)
administered thereafter (advmod)
modulate catalepsy (dobj)
said known (ccomp)
mice controls (conj)
complicating cardiomyopathy (xcomp)
increase bradykinin (nmod)
incidence study (nmod)
proliferation tumor (compound)
spasm occlusion (nsubj)
evaluate compare (conj)
whether and (cc)
liable are (cop)
dose cyclosporine (compound)
suggesting initiation (nmod)
duration similar (amod)
protein to (case)
damage seizure-associated (amod)
cell muscle (compound)
man 54-year-old (amod)
studied regions (nmod)
reversed significantly (conj)
established variety (nmod)
organisms pyocin (compound)
subtle mild (advcl)
introduction : (punct)
switching mood (compound)
channels calcium-dependent (amod)
levels 1 (nummod)
effects glycosides (nmod)
absorption agent (nmod)
indicated months (nmod)
decreased rigidity (dobj)
structure in (case)
7-ethoxyresorufin-o-deethylase 7-pentoxyresorufin-o-dealkylase (conj)
deemed results (dep)
measures these (det)
injection than (case)
shown elicits (ccomp)
prior ) (punct)
urgency the (det)
volumetry magnetic (amod)
infusions graded (amod)
dose sm-5887 (conj)
patient no (det)
circled rats (nsubj)
leads ii (dep)
triggered dose (nsubj)
maltol and (cc)
compared 2 (nmod)
observed less (conj)
fall flow (nmod)
25 with (case)
cancer be (cop)
0.83 1.03 (amod)
aconitine or (cc)
time follow-up (amod)
disease gestational (amod)
responsible that (mark)
disorders panic (compound)
93 +/- (cc)
immunization after (case)
phenothiazines drugs (conj)
ginsenoside rg1 (conj)
retardation significant (amod)
generated be (auxpass)
intake daily (amod)
years three (nummod)
growth cell (compound)
1 incidence (nsubj)
cytokines ( (punct)
regimen tuberculosis (nmod)
span digit (compound)
different this (nsubj)
defined times (nmod)
% 7.3 (nummod)
conclude demonstrated (ccomp)
frequencies positivity (conj)
features cardiomyopathy (nmod)
died custody (nmod)
67 19 (conj)
fever anemia (conj)
b group (compound)
prevalent acid (conj)
cholestasis this (det)
treated 0 (nmod)
microscopy immunogold (amod)
action probably (advmod)
tubes ventilation (compound)
unclear mechanisms (nsubj)
demonstrated experiments (nsubj)
dose microgram/kg/min (nmod)
using video-oculography (dobj)
identified period (nmod)
hour per (case)
p450 and (cc)
reported symptoms (dobj)
medications antagonist (compound)
treated continuously (advmod)
assumed pravastatin (dobj)
attenuated hyperthermia (dobj)
suppression contractility (nmod)
was indicating (advcl)
risk women (nmod)
review this (det)
vigabatrin with (case)
variables postoperative (amod)
injections and (cc)
layer layer (nmod)
performed assay (dobj)
better those (nmod)
grade or (cc)
fpdc ) (punct)
performed often (advmod)
premature more (advmod)
reaction dyspnea (dep)
impact . (punct)
injection 100-micrograms (amod)
reperfusion during (case)
duration on (case)
resulted changing (advcl)
treatment cirrhosis (nmod)
attributed is (auxpass)
remitted redistribution (nmod)
loading during (case)
withdrawal led (acl:relcl)
course days (nmod)
activation catecholaminergic (amod)
used been (auxpass)
son ) (punct)
related fasciculations (nsubjpass)
regimens access (nmod)
pressure map (appos)
ntg learning (nmod)
case may (aux)
heparin or (cc)
treated separately (advmod)
myocardium the (det)
depression adolescent (amod)
implanted testosterone (nmod)
woman 35-year-old (amod)
admission intubation (conj)
resulted aconitine (nsubj)
review institutional (amod)
warranted that (mark)
delayed either (cc:preconj)
showed pattern (dobj)
presented hypercalcemia (nmod)
solvent a (det)
min(-1 3.2 (nummod)
7 versus (cc)
suggested evaluations (nsubj)
mepivacaine and (cc)
subjects 10 (nummod)
dose mg/m2 (nmod)
treated randomly (advmod)
30 3 (compound)
carbetocin at (case)
essential , (punct)
serum- aldosterone-sensitive (amod)
absent areas (nmod)
reports 44 (nummod)
chills and (cc)
dopac ( (punct)
kg-1 suxamethonium (compound)
studies effect (nmod)
reduction mssbp/msdbp (nmod)
dogs anaesthesia (nmod)
mk-212 (-)-baclofen (conj)
sign to (mark)
prevalence users (conj)
teams services (conj)
understand to (mark)
system nitrergic (amod)
that from (case)
escalated were (auxpass)
injecting by (mark)
elucidated be (auxpass)
akinesis of (case)
0.002 less (amod)
patients ninety-six (nummod)
relevant down-regulation (nsubj)
lower , (punct)
ulcers on (case)
tested conditions (nmod)
etodolac of (case)
p=0.026 ) (punct)
ect the (det)
resulted known (advcl)
moving , (punct)
rats epinephrine-induced (amod)
strips rats (nmod)
fraction left (amod)
grains nuclei (nmod)
bradykinin of (case)
protocols treatment (compound)
complication neuropathy (nsubj)
had all (nsubj)
study cooperative (compound)
ascertained was (auxpass)
appeared irrigations (nsubj)
dose cocaine (nmod)
complained seeing (advcl)
structures related (amod)
constitutes personal (advcl)
interpret this (dobj)
acid furthermore (advmod)
patch series (nmod)
avoided especially (advmod)
increased patient (nmod)
obtained hospitalization (nmod)
treated hours (nmod)
persisted . (punct)
supports microg/kg/min (nsubj)
symptoms limit (acl:relcl)
= 0.035 (dobj)
had sample (dobj)
fhf ( (punct)
indicates increase (ccomp)
implicated is (auxpass)
potentiating catalepsy (dobj)
treatment amantadine (compound)
placentae all (det)
re-resection of (case)
receptor its (nmod:poss)
segments in (case)
is not (cc)
m4 putative (amod)
ingestion lymphadenopathy (conj)
bundle right (amod)
isoproterenol the (det)
hippocampus mice (compound)
30 to (dep)
blocks that (mark)
suggest delays (ccomp)
studied measuring (advcl)
vldl in (case)
activation no (neg)
phase excitement (compound)
cannulae with (case)
resulting shock (nmod)
sign vomiting (acl:relcl)
bupivacaine saline (conj)
< p (dep)
nicotine and (cc)
shape erythrocyte (compound)
concluded tolerated (ccomp)
fluctuating disease (dobj)
symptomatology parkinsonian (amod)
behaviors repetitive (amod)
associated chemotherapy (nsubjpass)
monotherapies placebo (conj)
signaling receptors (nmod)
mg sublingually (advmod)
contractility of (case)
mean presentations (nmod)
had may (aux)
dysmenorrhea of (case)
mg/kg and (cc)
connection of (case)
often most (advmod)
smith ( (punct)
clarify pineal (conj)
causes methyldopa (nsubj)
accounted can (aux)
dopamine endogenous (amod)
seizures brainstem (compound)
p9605 risk (appos)
evidence first (amod)
awoke . (punct)
class to (case)
contraindicated pregnancy (nmod)
diagnostic with (case)
serum-albumin immunoglobulins (conj)
animals infected (amod)
increases induced (amod)
hypothesized involve (xcomp)
characterized headache (nsubjpass)
infiltrate with (case)
conducting study (dobj)
used days (nmod)
blockers general (nmod)
group % (dep)
transplantations three (nsubj)
observed co-administration (conj)
grommet a (det)
% : (punct)
expected half-life (nmod)
gem mg/m(2 (appos)
treatment antagonist (nmod)
sedentary-isoproterenols minimum (conj)
changes medication-associated (amod)
mutations prothrombotic (amod)
associated presence (nsubjpass)
returned tests (nsubj)
correlated examined (advcl)
flow renal (amod)
potentiate effects (dobj)
ros ) (punct)
tool analysis (nmod)
disease proteinuria (nmod)
blocking 1-adrenoceptor (compound)
leading hyperparathyroidism (nmod)
deterioration profound (amod)
showed depressed (ccomp)
benefits dimension/function (nmod)
0 0.07 (conj)
proteinuria stress (conj)
papilloma cell (compound)
body wt (dep)
drugs verapamil (conj)
treated this (nmod)
interviews face-to-face (amod)
investigate effectiveness (dobj)
pathology cord (compound)
infarction sorafenib-induced (amod)
found predictor (ccomp)
salt-sensitivity to (case)
hem and (cc)
action predictors (conj)
pathology biliary (amod)
rebounded compared (advcl)
diet cyclic (amod)
stimulus-induced hz (dep)
derives and (cc)
concentration blood (nmod)
hearing impairment (dobj)
users nonusers (conj)
concentrations w/v (appos)
maintained rats (nsubjpass)
bolus slow (amod)
given indomethacin (nsubjpass)
intervention of (case)
age their (nmod:poss)
hypertension mineralocorticoid-related (amod)
effect occurrence (nmod)
stabilized disease (conj)
days 29 (nummod)
grafting bypass (compound)
carcinoma renal (amod)
gene angiotensinogen (compound)
monotherapy treatment (nmod)
injection week (conj)
rhigf-i of (case)
effects gfc (compound)
humidity , (punct)
exhibited damage (dobj)
profiles pharmacological (amod)
correlated size (nsubj)
turnover bone (compound)
hypertension reversible (amod)
remained pressure (nsubj)
side-effect led (acl:relcl)
normal number (nsubj)
= 1.70 (dobj)
modifications wall (nmod)
cause disorder (nmod)
autoantibodies , (punct)
influenced , (punct)
others the (det)
reduction quality (nmod)
nephrotoxicity 3 (appos)
collected injection (nmod)
occur hypokalemia (nsubj)
remission inducing (acl)
100 200 (conj)
hypokalemia the (det)
developed compared (advcl)
drug action (nmod)
db -0.81 (dep)
reduced atrial (nsubjpass)
sealants of (case)
tumors sign (nmod)
inhibited whether (mark)
tp only (advmod)
mpa ( (punct)
rats 5-azc (amod)
lasted occasions (nmod)
exhibits penetration (dobj)
noted % (nsubjpass)
onset the (det)
phenomena mydriasis (nmod)
assessed when (advmod)
shown npy (nsubjpass)
ketoconazole , (punct)
activity similar (amod)
expression gene (compound)
associated use (nsubjpass)
chain from (case)
pathophysiology a (det)
parts hoehn (conj)
writing of (case)
ciprofloxacin with (case)
a/j ( (punct)
symptom of (case)
arteriole an (det)
behaviors 5ht-related (amod)
dural cortical (conj)
factors seizures (nmod)
indicate hepatotoxicity (dobj)
scans tests (conj)
radicals damaging (compound)
n=6 ( (punct)
qrs . (punct)
microangiopathy precipitated (acl)
generation the (det)
modify acetaminophen (nsubj)
levels messenger (compound)
pituitary in (case)
efficacy events (conj)
clear influence (ccomp)
reported results (dep)
suspicions dili (nmod)
biopsy muscle (nmod)
modified movements (nsubjpass)
greater hearts (conj)
correlated . (punct)
maintains while (mark)
implanted crystals (nsubjpass)
data prospective (amod)
november reported (acl:relcl)
responsible anatomical (nsubj)
rats stroke-prone (amod)
tachycardia rate (nmod)
dismutase peroxidase (conj)
tt ( (punct)
dose hit (nmod)
dose unit (compound)
arise need (nsubj)
involved nmbas (dobj)
pain hyperalgesia (conj)
demonstrated selective (ccomp)
studies time (compound)
antibodies acetylcholine (compound)
efficacy increased (amod)
analysis records (nmod)
predict interval (nmod)
reduced coadministered (advcl)
diffuse skeletal (dep)
data volumetric (amod)
factor for (case)
icp of (case)
% 0.855+/-0.04 (dep)
brightfield- immunoperoxidase (compound)
diameters carotid (nmod)
proportions similar (amod)
syndrome tdfs (appos)
5 11 (prep)
develop years (nmod)
phase i (dep)
paclitaxel pac (appos)
interfere , (punct)
got suspected (advcl)
normalized alterations (dobj)
experienced days (nmod)
reviewed monthly (advmod)
deposition increased (amod)
cessation with (case)
known changes (nmod)
normalized iu/l (dep)
5 of (case)
present quantities (nmod)
suggest treatment (nmod)
deoxycorticosterone and (cc)
sg145r resistance (conj)
pathophysiology associated (acl)
factor hemorrhage (nmod)
hypothyroidism with (case)
h -24 (nummod)
increased level (dobj)
interleukin 3 (nummod)
cause cardiomyopathy (dobj)
fingers of (case)
50 much (advmod)
lasted it (nsubj)
revealed echocardiogram (nsubj)
hemodialysis high (amod)
average days (nmod)
died hemorrhage (dobj)
5 % (dep)
infiltration interstitial (amod)
enhancing clearance (dobj)
investigated hemoglobin (nsubjpass)
are nor (cc)
report that (mark)
nucleus socs-3 (conj)
lasted furosemide (nmod)
higher amplitude (nsubj)
underwent patient (nsubj)
facilitation stimulation (conj)
cats of (case)
infusions intravenous (amod)
occlusion : (punct)
effects s-312-d (nmod)
perspective clinical (amod)
written administration (nsubj)
reduce damage (dobj)
information usage (compound)
stage at (case)
comorbidities and (cc)
involve background (dep)
role ilk (nmod)
suspected not (neg)
nitrendipine of (case)
duration loss (nmod)
agent beta-adrenergic (amod)
monkeys 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (compound)
investigate outcome (dobj)
nitrogen by (case)
effective however (advmod)
remained and (cc)
lowering levels (dobj)
= = (conj)
rats bn (nmod)
blocked that (mark)
ancrod of (case)
receiving stent (dobj)
arm infusion (compound)
observed is (auxpass)
inadequate patients (nmod)
increases pretreatment (nsubj)
age were (cop)
failure rifampicin (nmod)
acquisition before (case)
convulsions ( (punct)
pain penile (compound)
concerns patients (nmod:poss)
l(-1 , (punct)
decayed pain (nsubj)
associated hypoperfusion (nmod)
dose 30-mg (amod)
received etoricoxib (dobj)
feature depression (nmod)
temocapril of (case)
led treatment (nsubj)
cases episodes (nmod)
induction proteins (nmod)
reduces given (advcl)
treated hypertension (nsubjpass)
right 4.5+/-1.0 (dep)
infusion mesna (nmod)
syndrome fanconi (amod)
studied widely (advmod)
detection of (case)
stabilized doses (nmod)
calculated basis (nmod)
dose qt (conj)
cured clinically (advmod)
preparation rat (compound)
kept reduced (advcl)
akinetic behaviour (dep)
loss cochlear (amod)
infarction cardiac (amod)
days 8.6 (nummod)
higher rates (nsubj)
desferrioxamine dfo (appos)
biochemical on (case)
tetrachloride chloroform (conj)
target concentrations (appos)
dehydrogenase kinase (conj)
% +/- (cc)
risk granulomatosis (nmod)
node peripherally (advmod)
presenting encephalopathy (amod)
asex ( (punct)
consumption excessive (amod)
showed control (nsubj)
marketed lovastatin (nsubjpass)
hold fibrillation (nmod)
giving arag (dobj)
combined srl (nsubjpass)
therapy and (cc)
vomiting phonophobia (conj)
changes evoked (acl)
symptoms without (case)
beats of (case)
discontinued it (nsubjpass)
25-mg/m2 short (dep)
droop with (case)
torsade pointes (dobj)
defect the (det)
glomeruli the (det)
features histopathologic (amod)
rates and (cc)
protein beta1 (dep)
p450 ethanol (conj)
blocking of (mark)
anesthetics halogenated (amod)
spin conventional (amod)
reduction groups (nmod)
initiated continued (conj)
measurements pre- (amod)
level measured (acl)
phenomenon syndrome (nsubj)
have cholinesterase (dobj)
treatment aprotinin (compound)
captopril inhibitors (conj)
basis findings (nmod)
prevented efficiently (advmod)
66 6 (conj)
administration a (nmod)
nimesulide n (appos)
effects ligands (nmod)
sprague-dawley male (amod)
ces-d scale (conj)
administered her (nmod)
women participating (amod)
necessary conclusions (dep)
echocardiography . (punct)
research in (case)
cause calcification (dobj)
54 1 (conj)
appear carboplatin (nsubj)
caused deformations (dobj)
k(i ) (punct)
efflux the (det)
included was (auxpass)
received lithium (dobj)
partial were (cop)
reverse not (neg)
use oc (compound)
ceased restriction (conj)
higher tgr (nmod)
ester nitro-l-arginine (det)
increase 0.01 (dep)
occurrence nephrotoxicity (nmod)
changes glial (amod)
suggest rate (dobj)
lysine bendazac (compound)
found related (ccomp)
different pgi2 (nsubj)
induces doxorubicin (nsubj)
excitement , (punct)
impair : (punct)
continued rosc (dep)
male presented (acl)
paclitaxel : (punct)
findings this (nsubj)
reversion 6 (conj)
hrp ) (punct)
inhibited suggesting (advcl)
occurs common (conj)
drugs nsaid (appos)
stopped should (aux)
controls sham-operated (amod)
gamma-vinyl-gaba , (punct)
completed lost (advcl)
syndrome capillary (amod)
found decline (nsubjpass)
background is (appos)
effect enalapril (nmod)
society the (det)
constructed using (xcomp)
caused activation (dobj)
explanation reasonable (amod)
reached versus (dep)
reduced responses (dobj)
resolved period (nmod)
younger higher (conj)
32.6 0.2 (conj)
gr/dl of (case)
associated c (nmod:npmod)
function kidney (compound)
hypotension in (case)
co-administration training (nmod)
carried mice (nmod)
prevalence population (nmod)
rats anaesthetized (amod)
ro 5057 (nummod)
prevented scopolamine (nsubj)
had correlation (dobj)
resulted performance (nmod)
dissociated be (auxpass)
dose inhibitions (compound)
detect echocardiography (nsubj)
appeared rash (nsubj)
resumed result (nmod)
hyperprolactinemia children (nmod)
gene cox (compound)
mandatory patient (nmod)
shunting right-to-left (amod)
etiology other (amod)
hydrochloride compound (compound)
influences for (case)
suggests occur (ccomp)
nephrotoxicity amikacin (compound)
elevation > (compound)
suspected treated (conj)
materials . (punct)
mm favor (nmod)
dysfunction pathophysiology (nmod)
tachycardia dyspnea (conj)
factor-alpha contents (conj)
assigned mg (parataxis)
examined records (dobj)
didanosine prochlorperazine (conj)
form prospective (amod)
induce catalepsy (dobj)
electrolyte leukocytosis (conj)
serious cardiac (dep)
mg/kg bupivacaine (nmod)
kg-1 h-1 (compound)
dystrophy necrosis (conj)
documented studies (nmod)
proteinuria without (case)
given materials (nsubjpass)
cost direct (amod)
suppressed while (mark)
disease hiv (compound)
given appeared (advcl)
crystals sonomicrometry (compound)
smelling food (dobj)
weeks 26 (nummod)
recorded mice (nmod)
resistance product (conj)
aggravation akinesia (nmod)
degree only (advmod)
later questionnaire (nmod)
ischemia after (case)
correlate recall (dobj)
gr antagonist (dep)
elevation st (amod)
diameter artery (nmod)
has tolerance (dobj)
pressure ros (nmod)
fetal 0.01 (dep)
evidence association (nmod)
drugs anticancer (compound)
isolated hearts (nmod)
ecg echocardiography (conj)
exposed hypercapnia (nmod)
given dosing (nmod)
excretion ammonia (nmod)
group only (amod)
therapy myeloma (nmod)
2 0.2 (compound)
averaged indicating (advcl)
potentiated doc (dobj)
occurred nausea (nsubj)
derivatives oversulfated (amod)
improved and (cc)
was ratio (attr)
accomplished cinching (advcl)
quiescent , (punct)
leukemia lymphocytic (amod)
standing to (case)
recived mg (dobj)
phenobarbitone as (cc)
attack before (case)
oxycodone immediate-release (compound)
performed case (nmod)
mirtazapine with (case)
vasculitis girl (nmod)
reticulata . (punct)
tenofovir on (case)
given medications (nsubjpass)
doses a-86929 (nmod)
reaction resulting (acl)
32.9 10.3 (nummod)
frequency reported (amod)
degree damage (nmod)
led compound (advcl)
sirolimus , (punct)
protein hp (appos)
contraindicate not (neg)
selection mutants (nmod)
less mg/dl (conj)
variety proliferation (conj)
24.2 of (case)
reverse effects (nsubj)
sirna by (case)
induced-behaviour the (det)
came 1985 (nmod)
recognized early (advmod)
receive and (cc)
environment experimental (amod)
contrasting absence (nmod)
mitigated , (punct)
resulted cells (nmod)
receive placebo (dobj)
analyzed kidney (dep)
tumor-free had (conj)
surgery major (amod)
muscle detrusor (nmod)
contained respectively (advmod)
teratogenic weakly (advmod)
dogs to (case)
intoxications cocaine-diazepam (amod)
effects no (neg)
t30 at (case)
zidovudine alone (advmod)
administration puromycin-aminonucleoside (nmod)
berries of (case)
leg in (case)
lesions . (punct)
75,761 acetaminophen (acl)
elicit target (dobj)
conditions predisposed (acl:relcl)
hemodynamic metabolic (conj)
scan syndrome (nsubj)
superior being (cop)
testes gynecomastia (conj)
reduced changes (dobj)
time post-infusion (nmod)
cellulose w/v (compound)
group lead-treated (amod)
marked that (mark)
medications anticonvulsant (amod)
complications autoimmune (amod)
= 0.33 (dobj)
shortened latency (dobj)
behaviors group (nmod)
examine further (advmod)
hospitals programs (nmod)
brought deficiency (nmod)
necrotizing myopathy (dobj)
group dmso-treated (amod)
detectable changes (nsubj)
functioning taking (advcl)
equipment graphical (amod)
pci for (case)
children five (nummod)
thrombocytopenia of (case)
differ play (conj)
dose malformations (appos)
thromboembolic report (dep)
resulted latency (nmod)
42 in (case)
proliferative rapidly (advmod)
e13.5 frequent (conj)
% 25.5 (compound)
volume or (cc)
properties antihypertensive (amod)
minimize benefit (dobj)
tested les (nmod)
elicit that (nsubj)
phn ) (punct)
reduction tm (nmod)
increased parameter (dobj)
remained shr (nsubj)
tiredness mornings (nmod)
substitutes as (case)
rated responders (nmod)
pmol ( (punct)
overnight peak (amod)
association patient (nmod)
mg ; (punct)
testosterone prolactin (conj)
risk failure (nmod)
= 0.004 (dobj)
taken account (nmod)
tensions evoked (amod)
detection changes (conj)
controls 152 (nummod)
elderly for (case)
65 18 (compound)
phase slope (conj)
oxazepam temazepam (conj)
changes histologic (amod)
consistent study (nsubj)
pentobarbital mk-801 (conj)
enrolled were (auxpass)
margins their (nmod:poss)
associated disorder (nmod)
published none (nsubjpass)
avoiding at (mark)
co-treatment were (cop)
values with (case)
administered delivery (nmod)
acid 30 (dep)
nephrosclerosis on (case)
forced discontinuation (conj)
cystectomy partial (amod)
received developed (conj)
circuitries in (case)
reaction inflammatory (amod)
figures k (nmod)
features histologic (amod)
simplifies if (mark)
obtained overexpression (nsubjpass)
potent to (mark)
free be (cop)
agent new (amod)
basis ketoconazole (nmod)
necrosis rpn (appos)
produces ; (punct)
d-med 4 (dep)
dosage recommended (acl)
chemotherapies some (det)
protein random (amod)
tachy- bradycardia (conj)
demonstrated increase (ccomp)
simvastatin admission (compound)
hypovolemia during (case)
resolving neuropathy (nsubj)
were found (ccomp)
inhibition metabolism (nmod)
evoked episodes (dobj)
found examination (nmod)
received past (nmod)
sixty-seven % (appos)
treatment with (case)
risk relative (amod)
diseases kidney (compound)
scale 10 (nummod)
caused injury (nsubj)
vgb ( (punct)
evidence narrowing (nmod)
comparison administration (nmod)
study study (nmod)
caused haloperidol (conj)
withdrawal treatment (nmod)
val204asp p. (compound)
solvent organic (amod)
users aas (compound)
model intoxications (nmod)
common % (dep)
terminals fibre (amod)
perseveration ) (punct)
given were (auxpass)
increases enhances (conj)
considered modulating (nmod)
induced adjustment (nmod)
concluded offers (ccomp)
impaired acidosis (conj)
indicate or (cc)
taking antibiotics (dobj)
test battery (dobj)
investigate form (dobj)
cause development (nmod)
risk ci (appos)
counted , (punct)
reduce agonists (nsubj)
delayed recall (dobj)
regimen therapy (compound)
arterial vessels (dep)
rejection acute (amod)
23 four (compound)
active rides (conj)
weight body (compound)
levels metabolite (compound)
artery basilar (amod)
courses five (nummod)
channels composed (acl)
netilmicin in (case)
short- intermediate-term (conj)
s-1 mg (nummod)
monitoring levels (nmod)
inhibition following (case)
ifosfamide administered (acl)
distress functioning (conj)
reflow after (case)
loads large (amod)
stable more (advmod)
observed models (nmod)
2 greater (advmod)
developed perfusion (nmod)
thrombi patients (nmod)
disease refractory (amod)
increased levodopa (nmod)
ascites with (case)
lna+hca ) (punct)
determined relationships (nmod)
ammonia and (cc)
activation pn (nmod)
formation which (nmod)
than more (advmod)
constituent rate-limiting (amod)
permeability in (case)
ck-mb death (conj)
cardiomyopathy as (case)
calculus a (det)
ramh with (case)
sensations intolerable (amod)
reduced increases (nsubjpass)
ligation 48-h (amod)
procedures hotplate (compound)
accompanied width (nmod)
rats dox (compound)
ich 3 (dep)
comprise . (punct)
paradigm depression (nmod)
ropivacaine bupivacaine (conj)
toxicities ) (punct)
pattern behavior (nmod)
microsomal and (cc)
transplantation marrow (compound)
occurred where (advmod)
cpa/ee eleven (nsubj)
monitored discontinued (conj)
suggests disparity (nsubj)
discontinuing drug (dobj)
indicate not (neg)
preceded thrombocytopenia (nmod)
cytokines necrosis (conj)
implicated (pan)-induced (punct)
word recalled (amod)
methods 8-week (dep)
gastrointestinal of (case)
pj34 vehicle (conj)
subjects study (compound)
stratified when (advmod)
g rats (appos)
aggravation , (punct)
hyperfiltration glomerular (amod)
800 up (advmod)
diclofenac ) (punct)
doses produced (acl:relcl)
signs exacerbated (amod)
ratio hazard (compound)
adenosine , (punct)
matched then (advmod)
specimen biopsy (compound)
isomers and (cc)
associated nephrotoxicity (nmod)
recorded pressure (nsubjpass)
detectable are (cop)
gyrus rats (nmod)
activity carboxylesterase (nmod)
demonstrates potentiate (ccomp)
phosphatase ptpro (appos)
usage clinical (amod)
oral after (case)
sclerosis and (cc)
decrease strong (amod)
breakdown either (cc:preconj)
protocol lomustine (nmod)
cpa diazepam (conj)
l , (punct)
tolerable basis (nmod)
accurate , (punct)
puromycin-aminonucleoside of (case)
14 ( (punct)
developed result (nmod)
ensure protection (nsubj)
derives primarily (advmod)
intervention therapeutic (amod)
troublesome very (advmod)
supported always (advmod)
significant , (punct)
medication developed (amod)
infusion an (det)
use n-acetylcysteine (nmod)
pathway synthesis (nmod)
elicited anticipated (advcl)
groups into (case)
s.c. 30mg/kg (compound)
test cer (appos)
results conclusion (nmod)
document . (punct)
prevented was (auxpass)
rate warfarin (nmod)
attributed infection (nmod)
see used (ccomp)
headache induced (acl)
absent labeling (nsubj)
caused change (conj)
described variations (nsubjpass)
collected plasma (nsubjpass)
therapy synchrony (nmod)
strains dba/2j (compound)
treatment between (case)
phosphatase of (case)
sigmast , (punct)
increase anemia (nsubj)
parameters all (det:predet)
8.6 0.9 (conj)
block phase (compound)
number provided (acl:relcl)
knowledge by (case)
azt from (case)
occurs taking (advcl)
elevations leads (nmod)
weight macroscopic (conj)
deposition crystal (compound)
stimulation site (nmod)
ng/ml to (case)
variants , (punct)
27 73 (prep)
nephropathy ifo (compound)
needed concern (nsubjpass)
increase min (nmod)
documented only (advmod)
cancer colorectal (amod)
impact type (nmod)
mediates depression (dobj)
occurrence correlated (nmod)
% subjects (nmod)
fk506 ) (punct)
possessing anxiolytic (dobj)
2c receptors (appos)
regimen according (case)
rofecoxib placebo (conj)
kb nf- (dep)
assessed analysis (nsubjpass)
s.c. of (case)
products containing (acl)
solvent , (punct)
included manifestations (nsubj)
ee of (case)
rewarding both (preconj)
suggest : (punct)
jaundice patient (nmod:poss)
determined can (aux)
risks carcinoma (nmod)
forgetting the (det)
early reversible (conj)
million 1 (compound)
peaked minutes (nmod)
fluphenazine dopamine (compound)
activity pathways (conj)
evaluate mechanisms (dobj)
alter dose (dobj)
case reported (amod)
rtms placebo (conj)
liability without (case)
elevation ctnt (nmod)
reduced hds (nmod)
striking was (cop)
medications of (case)
blockers manner (nmod)
had colitis (dobj)
mg/dl 4.5 (nummod)
atrophy optic (amod)
changes c6 (nmod)
early long-term (conj)
41 twenty (compound)
increased neither (preconj)
hormone prolactin (conj)
controls 50 (nummod)
related administration (nsubj)
correlation this (det)
groups cdc (compound)
damages renal (amod)
level 1 (nummod)
develop doses (nmod)
localization compound (nmod)
30 % (quantmod)
reduces cytotoxicity (dobj)
group -5 (nummod)
young age (dep)
necrosis myofibre (compound)
45.45 and (cc)
alf of (case)
movement minor (amod)
mg/day 2.5 (compound)
used lamivudine (nsubjpass)
diagnosis by (case)
patients for (case)
tear muscle (compound)
dose-related effects (nsubjpass)
p=0.003 value (dep)
acquired baseline (nmod)
patients mg/dl. (compound)
consistent profile (nmod)
wistar crl:(wi)wubr (compound)
response gauges (nmod)
established been (auxpass)
followed expression (nsubjpass)
discuss literature (dobj)
beats escape (compound)
toxocity of (case)
strokes from (case)
injury possible (amod)
conjugates dextran-etodolac (amod)
amount kidneys (nmod)
retching , (punct)
tissues other (amod)
elevated that (mark)
recorded : (punct)
electrophysiology visual (amod)
investigate signaling (dobj)
pharmacists unknown (amod)
able we (nsubj)
performed baseline (nmod)
tissue of (case)
years 1/2 (nummod)
lesions pretreatment (conj)
count or (cc)
include inhibitors (dobj)
diazepam to (case)
manifest regurgitation (dobj)
period pain (compound)
immunomodulators of (case)
observed activity (nsubjpass)
phenomenon rare (amod)
biopsies 4 (nummod)
rationale this (det)
thromboembolism . (punct)
small effect (nsubj)
sinensis rosa (compound)
cyp27 the (det)
nadir cells/l (dep)
systems regulating (acl)
product 30 (nummod)
reaffirms study (nsubj)
acid nmol/200 (compound)
attributable drugs (nmod)
cmax/mic ) (punct)
enhanced manner (nmod)
cancer dementia (conj)
increase cell (compound)
sedation april (nmod)
toxicity carboplatin (compound)
terminated reach (conj)
interferes that (mark)
expression glepp1 (compound)
fluid of (case)
using admission (dobj)
oxidation and (cc)
series myeloid (amod)
in ' (punct)
recognition neuropathy (nmod)
desensitization receptor (compound)
antiepileptics with (case)
results major (amod)
suggests antagonism (nsubj)
hypertrophy glomerular (amod)
hoarseness either (cc:preconj)
suggest data (nsubj)
lipid ns-718 (appos)
flexion were (cop)
hyperalgesia on (case)
1 +/- (cc)
significant = (conj)
diagnosis disease (nmod)
administration cacl2 (nmod)
contrast best (amod)
led cessation (nmod)
model doxorubicin (nmod)
right eyes (dep)
effects drug-induced (amod)
analysis retrospective (amod)
regimen drug (compound)
measures with (case)
cardiotoxic and (cc)
sclerosis segmental (amod)
fibrosis slight (amod)
group n (appos)
subjects fewer (amod)
bp sbp (appos)
increased 11-fold (dobj)
developed months (nmod:tmod)
transplantation islet (compound)
sought use (nmod)
differences electrocardiogram (nmod)
capsule , (punct)
output l/min (appos)
spine the (det)
improved dramatically (advmod)
more was (cop)
related stage (nmod)
mg 160/12.5 (compound)
immunosuppressant used (acl:relcl)
reports despite (case)
adefovir clones (nmod)
base the (det)
considered probable (xcomp)
sulpiride the (det)
suffered hours (nmod)
supranuclear progressive (amod)
reacts caa (nsubj)
injection 5,7-dht (nmod)
infections with (case)
day cycle (nmod)
min hypertension (nmod)
pressure a (det)
pneumonitis the (det)
required recipients (dep)
lipoproteins lp (appos)
corticosteroids tests (conj)
level lower (amod)
tasks avoidance (compound)
neurologic frequent (amod)
hypotension block (conj)
administration careful (amod)
they were (dep)
(7.2)% -27.9 (nummod)
uptake in (case)
hydroxytyrosol rats (nmod)
ha ( (punct)
showed regression (nsubj)
enhanced , (punct)
paraesthesia of (case)
effect fluphenazine (nmod)
pressures blood (compound)
intermediate light (nmod)
duration disorder (nmod)
protein astroglia-specific (amod)
protein from (case)
substances production (conj)
explored rats (nmod)
compliance therapy (nmod)
cisplatin than (case)
anesthetics such (case)
presenting oltx (nmod)
hypothalamus nucleus (conj)
estimated manner (nmod)
matrix cells (conj)
reduced can (aux)
norepinephrine only (advmod)
intensity seizures (nmod)
exposure oral (amod)
received novo (advmod)
contraction muscle (compound)
different structurally (advmod)
defined report (nmod)
elevation expression (nmod)
median by (case)
trial hypertension (nmod)
120/80 pressure (compound)
demonstrated . (punct)
rise by (case)
referred , (punct)
changes rcbf (compound)
vancomycin of (case)
0.014-unit 0.070-unit (conj)
use killers (nmod)
78 4 (compound)
showed adducts (dobj)
scale ( (punct)
decrease flow (nmod)
injections vaccine (nmod)
135 +/- (cc)
resurgence requiring (advcl)
involvement with (case)
enanthate fluphenazine (amod)
toxicity because (mark)
known acquired (ccomp)
sphincter prostigmine-morphine-induced (amod)
deletions more (amod)
finding this (det)
pathophysiology their (nmod:poss)
elicited psychosis (dobj)
dct2 in (case)
risk patients (nsubj)
ampka ( (punct)
dose peak (nmod)
effects unwanted (amod)
models in (amod)
clearance children (nmod)
associated abnormalities (nmod)
stimulation either (cc:preconj)
medications year (nmod)
hitt of (case)
mg mean (compound)
esrd of (case)
materials and (cc)
heptylate gonadotropin (conj)
= ] (punct)
lost considered (conj)
temporary permanent (conj)
comorbidity the (det)
p group (compound)
dose metoprolol (nmod)
showed maintained (ccomp)
appeared , (punct)
mipafox of (case)
problematic those (appos)
transplantation pediatric (amod)
intervals sdrr (appos)
density granules (nmod)
increases the (det)
pain spontaneous (amod)
minutes ( (punct)
movements rats (nmod)
used anorexigens (dobj)
developing hoarseness (dobj)
antagonist beta-adrenergic (amod)
added intervals (nmod)
> times (dep)
angiopathy d-penicillamine-induced (amod)
potent although (mark)
phenylpropanolamine of (case)
syndrome tumor (compound)
area greater (amod)
indicate reports (nmod)
cox ( (punct)
survey of (case)
years 13 (nummod)
need kinds (nmod)
dependent hippocampal (nmod:npmod)
affect shortened (advcl)
development anemia (nmod)
demonstrated : (punct)
intact , (punct)
crossed manner (nmod)
ketamine injected (acl)
mechanism intrarenal (amod)
exhibited strains (nsubj)
given drugs (nsubj)
la ( (punct)
actions potent (amod)
hypertension (dex)-induced (amod)
blocked simultaneously (advmod)
administration alendronate (nmod)
measure were (cop)
patients treated (acl)
microtubules of (case)
nicotine more (amod)
ingestion caffeine (compound)
plasma jersey (nmod)
require prompt (conj)
auc carboplatin (compound)
seen block (nsubjpass)
changes elected (acl:relcl)
weighed factor (advcl)
permissive necessary (conj)
chamber in (case)
patients sympathicotomy (compound)
fluid children (nmod)
improvement produced (acl)
51.7 sem (dep)
genes the (det)
signs 5-ht1a (compound)
exclusion mi (nmod)
hev ) (punct)
maleate antagonist (compound)
occlusion aortic (amod)
anxiolysis test (nmod)
related rate (nmod)
responsible alteration (nmod)
is that (mark)
antiparkinsonians prophylactic (amod)
aspects several (amod)
653 +/- (cc)
n-methyl-d-aspartate by (case)
epilepsy n (dep)
genes epilepsy (nmod)
damage marked (amod)
kcn of (case)
examined relationship (nsubjpass)
bp ) (punct)
some factors (nmod)
reserpine , (punct)
correlates task (nmod)
pelvis ureter (conj)
index snap (compound)
were medication (attr)
myalgia severe (amod)
modulate beta-subunits (nsubj)
treated propylthiouracil (nmod)
action effective (amod)
behaviour k (compound)
female on (case)
effect tam (nmod)
absorbed tract (nmod)
therapy hit (nmod)
spots 2000 (nummod)
equal ppm (nmod)
compensated deficits (dobj)
combination groups (conj)
identified patients (dobj)
revealed deficits (dobj)
affected changes (nmod)
syndrome fanconi (nmod:poss)
well reasonably (advmod)
hydrochloride pyran (compound)
is partially (advmod)
evaluating by (mark)
was or (cc)
improve . (punct)
pump of (case)
mild related (conj)
amnesia the (det)
embarked . (punct)
days intensity-weighted (amod)
published ezetimibe (nmod)
mice rats (conj)
blockade d2 (compound)
lot a (det)
consistent reports (nmod)
cyclosporine with (case)
mg/kg 0.04 (nummod)
doxorubicin including (case)
matched index (nmod)
receptors 2a (compound)
anaesthesia of (case)
oxide oxygen (nmod)
injected mg/kg/i.p (dep)
attenuate deficits (dobj)
lesions sporadic (amod)
boy developed (acl:relcl)
lozenge from (case)
woman for (case)
wall ventricular (amod)
took nitrate (dep)
stabilizer no (det)
affect produced (conj)
resistance renal (amod)
therapy patient (nmod)
awakening post (compound)
noted mesothelioma (nmod)
proteinuria linked (acl)
affected cystitis (nmod)
aims and (cc)
5.8 - (punct)
passed and (cc)
twice about (advmod)
has agent (nsubj)
temporarily all (advmod)
hospitalization after (case)
increase response (dobj)
effect extract (nmod)
activity enhanced (amod)
treatment schizophrenia (nmod)
diltiazem long-acting (amod)
rate nonimmunity (nmod)
mg/day , (punct)
role ce (nmod)
effect and (cc)
rare hepatotoxicity (nsubj)
complication severe (amod)
phosphatase activities (conj)
pharmacokinetics famotidine (nmod)
exerts whereas (dep)
regeneration rat (compound)
analyses confocal (amod)
presented review (nsubjpass)
mothers disease (nmod)
p45 at (case)
exposure mepivacaine (nmod)
required reduction (nsubjpass)
07 - (punct)
cause identifiable (amod)
syndrome users (nmod)
induction neurons (nmod)
known polyneuropathy (conj)
treatment clozapine (compound)
release endothelin-1 (compound)
studied breakdown (nsubjpass)
study national (compound)
hyperactive groups (advcl)
delineate frequency (dobj)
impact prevention (nmod)
is society (nmod)
we here (advmod)
material and (cc)
ms/mg of (case)
benefit gi (compound)
flow regional (amod)
prazosin with (case)
memory executive (conj)
infusion epinephrine (compound)
january 2004 (nummod)
recovered discontinuation (nmod)
mumol/l peak (appos)
decrease administration (nmod)
rhythm restoration (conj)
mg/dl /=0.5 (case)
l-dopa by (case)
mm , (punct)
aspirin acid (appos)
designed we (nsubj)
associated injury (nmod)
mean concomitant (amod)
inhibited mk801 (nmod)
metastases with (case)
escape latency (dobj)
present 25 (nmod)
methylprednisolone ; (punct)
pan iv (dep)
signaling (ecm)/integrin (compound)
5.1+/-1.0 ( (punct)
expression on (case)
viracept was (cop)
difficult recognition (nsubj)
eligible analysis (nmod)
people , (punct)
choose again (advmod)
normalized revealed (advcl)
syndrome choice (dep)
inhibition ppi (appos)
selected apomorphine (nsubjpass)
modes reduction (nmod)
increase p (compound)
efficacy model (nmod)
reviews recent (amod)
result consequences (nsubj)
tls ) (punct)
supplementation folic (amod)
administered dexamethasone (dobj)
episode during (case)
study end (dobj)
mg -0.07 (parataxis)
causes where (advmod)
safety fa (nmod)
hormone magnesium (conj)
rats mature (amod)
activator receptors (nmod)
mass tissue (compound)
side block (nmod)
elucidate have (conj)
effects stimulant (amod)
recorded immediately (advmod)
foci with (case)
agc ) (punct)
potency (-)-propranolol (nmod)
duration for (case)
suffered neutropenia (nmod)
precipitation be (cop)
developed optic (dobj)
activity ( (punct)
plays stress (nsubj)
ph pc02 (dep)
hydrobromide 5-hydroxytryptamin1a (amod)
that injection (nmod)
secondary chemotherapy (nmod)
effect - (punct)
types four (nummod)
documented most (advmod)
adaptation of (case)
l-name ( (punct)
patients ' (punct)
60.44 +/- (cc)
preexposure prior (advmod)
ed1-ed4 ) (punct)
matched . (punct)
rr=1.41 ( (punct)
greater 320/25 (nmod)
excitement manic (amod)
ointment placebo (compound)
wr242511 ( (punct)
improvement measure (nmod)
variation spv (appos)
t ) (punct)
women 000 (nummod)
puromycin with (case)
receptors display (acl:relcl)
encountered we (nsubj)
assess pharmacokinetics (dobj)
causes among (case)
% hbv-dna (nmod)
amphetamine with (case)
patient each (det)
stn gpi (conj)
regimen head (nmod)
associated necrosis (nmod)
have technique (nsubj)
12/30 % (dep)
plasma the (det)
substance humans (nmod)
activity myeloma (nmod)
uridine urd (appos)
cause used (conj)
% year (nmod)
measured rats (nmod)
administered (+/-)-sm (dep)
effect of (case)
cis-ra ( (punct)
scores for (case)
centers criteria (nmod)
concentrations four (nummod)
uveitis entry (nmod)
disruption effect (nsubj)
alcohol use (conj)
ml mg/0.5 (nummod)
inappropriate and (cc)
devastating an (det)
caused defect (nmod)
elevated whereas (dep)
response their (nmod:poss)
prazosin on (case)
inhibited carteolol (nsubj)
records on (case)
produced co-administration (nsubj)
resulted findings (nmod)
appearance in (case)
loss alertness (nmod)
predicts density (nsubj)
repeated course (nsubjpass)
withdrawn result (nmod)
conclude invariable (ccomp)
objectives study (nmod)
micrograms day (nmod)
practical were (cop)
regions model (nmod)
disease ) (punct)
(-)-cibenzoline arrhythmia (nmod)
min 0.568 (nummod)
membranes mucous (amod)
sgk1(+/+ in (case)
5-fu mtx (conj)
diagnosis complication (nmod)
induction effect (nmod)
tolerated are (auxpass)
excitation central (amod)
use veralipride (nmod)
min pilocarpine (nmod)
exacerbation ethanol (nmod)
development adulthood (nmod)
cardiovascular fewer (amod)
= 33 (dep)
proteinuria both (cc:preconj)
specimens allograft (compound)
interfered activities (nmod)
satisfaction treatment (compound)
aggregations in (case)
adjustment diabetes (nmod)
b.w 20 (nummod)
sparteine ( (punct)
very-low-birth-weight vlbw (dep)
87.1 - (punct)
recommended those (nmod)
delta [d-pen2.5]-enkephalin (dep)
framework the (det)
constituted conclusion (dep)
marker protein (appos)
prone especially (advmod)
complications several (amod)
results csa (dep)
approach posterior (amod)
thrombogenicity vascular (amod)
after especially (advmod)
predictors potential (amod)
administered intramuscularly (advmod)
takes it (nsubj)
users ex-mdma+ (amod)
months than (case)
that compared (dep)
known also (advmod)
representative that (nsubj)
levels and (cc)
studied been (advcl)
employed indexes (nsubjpass)
seven and (cc)
mipafox ( (punct)
tissue lining (conj)
antipsychotic and (cc)
indicated insipidus (dobj)
ecg pulse (conj)
grade in (case)
have affinity (dobj)
p=0.002 ( (punct)
age with (case)
incidence years (nmod)
ng/ml 1000 (nummod)
treatment syndromes (nmod)
properties isomers (nmod)
negative denied (conj)
changes marrow (compound)
treatment impact (appos)
cirazoline kg-1 (dep)
occurred months (nmod)
cornu uterine (amod)
mediated level (nmod)
double-immunolabeling 7h6 (nmod)
anophthalmia microphthalmos (conj)
include drugs (dobj)
results g (appos)
saline dmso (conj)
users l. (dep)
agent combination (conj)
treatment paroxetine (nmod)
bolus is (cop)
paradigm win-shift (amod)
deaths five (nummod)
impair result (conj)
use diuretic (amod)
suggest authors (nsubj)
one antibiotics (nmod)
annulus the (det)
electroretinography erg (appos)
gap the (det)
mg chlorpheniramine (conj)
symptoms current (amod)
injection capsaicin (nmod)
injury intracellular (amod)
blocked which (nsubjpass)
both doxorubicin (nmod)
-20.93 ( (punct)
reductions to (case)
neutralization a (det)
43 18 (compound)
prescribed were (auxpass)
les the (det)
data novel (amod)
use goal (nsubj)
assessment synthesis (nmod)
dissociated toxicity (nmod)
beats/min less (amod)
48 ms (dep)
alternative sodium (nsubj)
hyperactivity in (case)
review , (punct)
hit ii (nummod)
group administered (acl:relcl)
replication the (det)
established we (nsubj)
1.17 ( (punct)
encountered duration (nsubjpass)
was pain (attr)
regulation in (case)
patients enrolled (dep)
cases rare (amod)
disability , (punct)
limiting leukopenia (nsubj)
symptoms no (det)
presented contrasting (advcl)
patients amongst (case)
deaths toxic (amod)
neurons nos (compound)
structure-activity and (cc)
decreased extent (dobj)
immunosuppression calcineurin-free (amod)
contribute stage (advcl)
ratio respect (nmod)
stomach in (case)
cbd hh (nmod)
findings patients (nmod)
stimulation visual (amod)
done ecg (nsubjpass)
changes recordings (nmod)
followed clearance (nmod)
course sulfate (nmod)
curve concentration-time (amod)
extract proanthocyanidin (compound)
gastrointestinal prominently (advmod)
g strophantine (amod)
integration better (amod)
representative series (nsubj)
carries depression (nmod)
worsening therapy (nmod)
thromboembolism venous (amod)
injection opioid-agonists (conj)
offered have (aux)
thalidomide agent (compound)
concentration mic (appos)
wr242511 the (det)
efficiency resistant (amod)
cancer mbc (appos)
use therapy (nmod:poss)
analyzed technique (nmod)
monitored minutes (nmod)
safety drug (nmod)
overload between (case)
given conjugates (dobj)
neurotoxicity dire (amod)
risk of (case)
iohexol low-osmolar (amod)
results was (dep)
prolonged increased (conj)
pressure animals (nmod)
instituted therapy (nsubjpass)
mediated solely (advmod)
seizures completed (amod)
reduced we (nsubj)
use irrigation (nmod)
injected injected (parataxis)
levels mean (compound)
related malignancies (nmod)
numbers with (case)
development comparison (dep)
included be (auxpass)
revealed aminotransferase (conj)
125 500 (conj)
healthy medically (advmod)
node sinus (compound)
effects neurotoxicity (nmod)
cellular and (cc)
jaundice drug-induced (amod)
pathogenesis tumors (nmod)
risks high (amod)
findings failed (acl:relcl)
strong that (mark)
microg/ml half-life (conj)
hypertrophy glomerulosclerosis (conj)
possible , (punct)
course arabinoside (nmod)
able was (cop)
recorded brainstem (nmod)
increase percentage (nmod)
results admitted (dep)
difficult knowledge (nmod)
thickness layer (compound)
showed often (advmod)
initiate statins (nsubj)
nephrosis early (amod)
depression function (nmod)
agents efficacy (nmod)
protein 6.3 (nummod)
lactam the (det)
related cardiomyopathy (amod)
control versus (case)
drugs thrombolytic (amod)
reader the (det)
72 39 (compound)
having syndrome (dobj)
levels tissue (nmod)
episodes pressure (appos)
pain setting (nmod)
upregulation levels (nmod)
risk attributable (amod)
bmd ( (punct)
involved production (nmod)
cows showed (ccomp)
use cm (compound)
had rare (ccomp)
determined later (advmod)
years 70+/-12 (nummod)
larger to (case)
doxorubicin anthracycline (compound)
treatment saline (compound)
pathophysiology akathisia (nmod)
receptor metabotropic (compound)
stimulations current (amod)
prevention in (case)
boys both (det)
closed eyes (nsubjpass)
wild-type mglu7 (conj)
female an (det)
9 917 (appos)
reduced dyskinesias (dobj)
p=0.003 ( (punct)
clinic hospital (nmod)
abuse and (cc)
receive zdv (dobj)
tolerate to (mark)
terminology prevention (conj)
1.9 ) (punct)
failure ancrod (nmod)
fluctuations by (case)
uptake plasma (compound)
effects increased (amod)
markers brain (compound)
weeks 28 (nummod)
pineal idolamines (dobj)
na 1.35 (conj)
stereotypy rats (nmod)
factors i (dep)
amiodarone with (case)
shown reduce (xcomp)
hearing for (mark)
associated be (auxpass)
nr1(neo-/- nmda (compound)
constipation morphine-induced (amod)
transcriptase with (case)
controls non-ecstasy (amod)
ancas ( (punct)
suitable treatment (nmod)
alterations function (nmod)
monitored terminated (parataxis)
hospitals centers (conj)
patients with (case)
replication virus (nmod)
seizures perioperative (amod)
% 34 (nummod)
found 35 (nsubjpass)
patients experience (acl:relcl)
valproate on (case)
indicated management (nmod)
apnea neonatal (amod)
sold counter (nmod)
agents bfgf (nmod)
disinhibition a (det)
300 400 (conj)
produce acrolein (nmod)
induces rate (nmod)
oxcarbazepine in (case)
reductions further (amod)
2.7 vs. (cc)
deterioration galactose (amod)
inability sleep (acl)
agent other (amod)
induction paracetamol (nmod)
translocations line (nmod)
stimulus thermal (amod)
revealed abnormality (dobj)
alternative support (nmod)
reduction % (appos)
verapamil and (cc)
behaviors abnormal (amod)
effects bcnu (nmod)
uptake decreased (amod)
using dexmedetomidine (dobj)
number proliferating (amod)
results showed (dep)
development tdp (appos)
glycopyrrolate i.v. (amod)
approach and (cc)
erk1/2 as (cc)
long-term , (punct)
fc with (case)
use longer (conj)
loss description (dep)
cardiac ) (punct)
inhibits warfarin (nsubj)
decreased superoxide (dobj)
model dyskinesia (nmod)
exposure mg/kg (nmod)
database organ (compound)
protein fluorescent (amod)
specimens biopsy (compound)
levels ctnt (compound)
experiment , (punct)
uneventful surgery (nsubj)
test both (preconj)
death ( (punct)
urticaria/angioedema of (case)
pressure systolic (amod)
excellent was (cop)
combination mg/m(2 (appos)
28/min rate (compound)
followed hour (nmod)
decreases effects (nmod)
method of (case)
continues use (nsubj)
intoxications mixed (amod)
number limited (amod)
suffered patients (nsubj)
gsh of (case)
pharmacology paranoia (nmod)
phospholipid and (cc)
hyperactivity ? (punct)
fq and (cc)
characterized rash (nmod)
determined effect (nsubjpass)
ischemia rat (nmod)
found tendency (nsubjpass)
75,761 and (cc)
av ) (punct)
layer subendothelial (amod)
dimension and (cc)
use microbleeds (conj)
lines neuroblastoma (compound)
margins safety (compound)
amelioration a (det)
advantages cisplatin (nmod)
microdialysis in (amod)
dissociate can (aux)
parameter any (det)
brains in (case)
processes by (case)
movements fingers (nmod)
administration gm (nmod)
activity spontaneous (amod)
s-312 antagonists (appos)
mumol/kg 6.4 (nummod)
morbidity cardiac (amod)
factors nephrotoxicity (nmod)
prominent three (nmod)
specimens ( (punct)
conducted examine (xcomp)
revised ( (punct)
restarting after (case)
studied pretreatment (nmod)
choice glycopyrrolate (nsubj)
carbimazole like (case)
high it (nsubj)
show cross-sensitization (dobj)
early striking (conj)
resulted increased (conj)
neurotoxicity amphetamine-induced (amod)
persist when (advmod)
glomerulonephritis diseases (conj)
thyroiditis probably (advmod)
thickening ventricular (amod)
trh following (case)
injury hepatocellular (amod)
reversed initiation (nsubj)
decreased or (cc)
mg/kg 3.3 (nummod)
19.2 with (case)
improves fluoxetine (nsubj)
hypothesized is (auxpass)
frequency spectrum (conj)
body g (compound)
treated antimicrobials (nmod)
infarction ant-mi (appos)
sinuses the (det)
antibiotic clarithromycin (nsubj)
motor . (punct)
performed heparin (nmod)
microbiologically evaluable (dep)
subjects on (case)
l-dopa ( (punct)
conclusions toxic (appos)
examined lists (nsubjpass)
series to (case)
increased bp (dobj)
amiodarone extent (nmod)
effect dox (compound)
acid folinic (amod)
clinical comprehensive (amod)
copolymers these (det)
produce while (mark)
tissues to (case)
developed calculi (dobj)
conducted several (nsubjpass)
ratio in (case)
patients 4086 (nummod)
was reduction (attr)
reductions significant (amod)
complained day (nmod)
predicted factors (nsubj)
room to (case)
estradiol cpa/ee (appos)
verapamil p.o. (appos)
population treated (amod)
limited antineoplastic (dep)
echocardiograms obtained (acl)
introduced , (punct)
function , (punct)
decrease time (nmod)
min : (punct)
administration 1-month (amod)
taken resection (nmod)
pain continuing (amod)
disabling extensive (ccomp)
determined number (nsubjpass)
absence muscarinic (nmod)
treatment other (amod)
see . (punct)
nsaid , (punct)
use phenacetin (nmod)
users recreational (amod)
biomarker be (cop)
impairment simultaneous (amod)
was vacuolation (nsubj)
studied patient (nmod)
clearance to (case)
increase pressure (dobj)
concern primary (amod)
enrolled methods (dep)
exclusively , (punct)
infant tuberculosis (nmod)
measurements results (dep)
frequency on (case)
months blocker (nmod)
differentiation of (case)
examined 42 (nmod)
19.9 +/- (cc)
models cholinergic (amod)
groups > (dep)
treatment dose (compound)
g/m2 5 (compound)
enzyme cyp3a4 (compound)
started interval (nmod)
compared percent (dep)
experienced thirteen (nsubj)
co-administration ra (compound)
therapy all (compound)
mice diet (nmod)
lower a (det)
cilostazol clz (appos)
likely women (nsubj)
assessed data (nsubjpass)
vsds ( (punct)
dose : (punct)
introduced have (aux)
identified and (cc)
allopurinol dex (conj)
cohort in (case)
minutes /-7.1 (conj)
producing without (mark)
associated anticoagulation (nmod)
functioning attention/executive (amod)
unclear role (nsubj)
absence induction (nmod)
circulation model (nmod)
variation genetic (amod)
p=0.032 ) (punct)
nm 1 (nummod)
support with (case)
feel strong (ccomp)
delta by (case)
allows signal (nsubj)
nik-247 , (punct)
ill average (nmod)
patient history (nmod)
exposure outcomes (conj)
layer in (case)
bound essentially (advmod)
action dsp4 (nmod)
retention or (cc)
p<0.001 p<0.01 (conj)
waves the (det)
years six (nummod)
proposed tight (ccomp)
tmp ( (punct)
variations many (amod)
able are (cop)
length qtc (compound)
potential cardioprotective (amod)
pulse cyclophosphamide (conj)
resulting stature (nmod)
appear efficacy (nsubj)
carbonate with (case)
examined data (nsubjpass)
segment long (amod)
assigned receive (advcl)
p.m. a.m. (conj)
probable cases (nmod)
produce doses (nmod)
prophylaxis ondansetron (amod)
rats ciprofloxacin- (amod)
expressed , (punct)
accentuated distally (advmod)
acidity could (aux)
passage possible (amod)
diagnostics penzberg (conj)
1.3+/-0.3 ) (punct)
bnp ) (punct)
injection iohexol (appos)
regimen depletions (conj)
assessed dyskinesias (nmod)
results report (nmod)
index % (dep)
inhibition (azt)-induced (amod)
mice from (case)
doses non-convulsant (amod)
qtp + (cc)
induction statins (nmod)
combinations morphine (nmod)
reversible but (cc)
revealed control (ccomp)
protocol pressure (nmod)
activity receptors (conj)
hyperkalemia spironolactone-induced (amod)
associated timolol (nmod)
diagnosed hypertension (nmod)
enzyme target (compound)
increase group (nmod)
nra0160 ] (punct)
women young (amod)
interfere action (nmod)
cervical inguinal (conj)
rose but (cc)
included should (aux)
results renal (amod)
stable hypotension (nmod)
reduces dyskinesias (dobj)
reach did (aux)
hypotensive antiparkinsonian (conj)
thrombosis and (cc)
use or (cc)
groups -0.12+/-0.5 (dep)
done microscopy (nsubjpass)
defect urinary (amod)
accomplished safely (advmod)
myoclonus by (case)
ameliorates also (advmod)
vasculitis a (det)
reveal findings (nsubj)
left transient (nsubj)
described highlighting (xcomp)
upregulation proteins (nmod)
rationale . (punct)
rated additionally (advmod)
nmdar and (cc)
observed compounds (nmod)
comparisons both (det)
documented % (nmod)
recruited were (auxpass)
longer time (nsubj)
loss hearts (nmod)
mortality groups (nmod)
background provide (dep)
study primed (acl)
activation stat3 (compound)
shown counteract (xcomp)
prevented remained (parataxis)
sensation with (case)
deficient be (cop)
detected finally (advmod)
bolus injected (acl)
behavior stereotyped (amod)
examined effect (dobj)
administration pdtc (nmod)
field visual (amod)
thrombo-embolism venous (amod)
develop drug (dobj)
damage tissue (compound)
ages respectively (advmod)
sufficient explain (xcomp)
increased aggregation (nsubj)
reported acid (nmod)
dependence with (case)
overt or (cc)
hallucinations convulsions (conj)
attained assessment (nmod)
function to (case)
administered comparable (dep)
lozenge or (cc)
association pph (nmod)
clearance urea (compound)
making by (mark)
inhibitors synthase (compound)
addition docetaxel (nmod)
monitored addition (nmod)
challenge each (det)
greater values (nsubj)
common infections (nsubj)
neurotransmitter gaseous (amod)
plans follow-up (amod)
occurrence reactions (nsubj)
compensated well (advmod)
responses amoxicillin (nmod)
unchanged . (punct)
has do (advcl)
complication fatal (amod)
results excluded (appos)
mechanism(s involved (acl)
conclusion decreased (appos)
summarizes , (punct)
acute intermediate (conj)
motility and (cc)
center hospital (nmod)
coagulopathies other (amod)
needed unnecessary (conj)
la ) (punct)
effects major (amod)
hepatectomy rats (nmod)
controls all (det)
application the (det)
sensor . (punct)
presented hypotension (nmod)
occurrence between (case)
pain leg (compound)
sad of (case)
process inflammation (compound)
injections doxorubicin (nmod)
responsible with (case)
risk ; (punct)
thirty-nine patients (nmod)
decrease oxidase (nmod)
family the (det)
overexpression synthase (nmod)
stage and (cc)
wrinkling membranes (nmod)
characteristics baseline (compound)
rast with (case)
component dysfunction (nmod)
g animals (nmod)
parts iii (conj)
fatal even (advmod)
attributed may (aux)
seizure-free are (cop)
consumption intermittent (amod)
ranges risk (nsubj)
myocardiopathy on (case)
moiety , (punct)
impaired that (dobj)
case swelling (nmod)
investigate order (nmod)
results tests (nmod)
appendage atrial (amod)
bladder and (cc)
toxicity dermal (amod)
predisposed have (aux)
mechanisms uptake (compound)
d4.2 for (case)
syndrome hemoptysis (nmod)
did levels (dobj)
complications patients (nmod)
found mri (nmod)
practice clinical (amod)
taqib rs6275 (conj)
theophylline for (case)
seizures sound-induced (amod)
amount small (amod)
artery occluded (amod)
system potentials (conj)
available quantities (nsubj)
administration ifosfamide (nmod)
pathological-process underlying (amod)
da1 ) (punct)
discontinuation . (punct)
induced presence (nmod)
estimated proportion (nsubjpass)
cause possible (amod)
thickening small (amod)
revealed lack (nsubj)
increase dose-dependent (amod)
(+)-cibenzoline mg/kg (compound)
propylthiouracil of (case)
blockade response (nmod)
demonstrated higher (conj)
effect pharmacological (amod)
mice aids (compound)
assigned taking (advcl)
assigned one (nmod)
described given (ccomp)
available predict (xcomp)
intervals various (amod)
change levels (nsubj)
changes ecg (compound)
tests changes (nmod)
intensity headache (compound)
involvement recognized (amod)
lamina basement (compound)
technique by (case)
positive testing (nmod)
different rate (nsubj)
bcc ( (punct)
treated course (nmod)
phonological lexical (conj)
severe antiproliferative (conj)
induced cavity (nmod)
due bradycardia (nsubj)
systems by (case)
ratio [ (punct)
potentiation a (det)
presented hospital (nmod)
induced hepatomegaly (dobj)
evaluate research (nsubj)
boys dystrophy (nmod)
chulalongkorn king (compound)
concentration decrease (conj)
studies general (amod)
anticoagulant used (acl)
asthma upon (case)
switched carbamazepine (nsubjpass)
calcium bone (conj)
continued remain (xcomp)
hr 190 (nummod)
heroine cocaine (conj)
shown worsening (dobj)
ketamine antagonist (compound)
protection no (det)
value predictive (amod)
59 29 (compound)
rats 2/6 (nummod)
paclitaxel bre-26 (dep)
enhanced one (nsubj)
transferred compromise (nmod)
assess disease (nmod:npmod)
decreased phase (nmod)
occurred man (nmod)
rate p (dep)
reduces , (punct)
agent used (amod)
headache patient (nmod)
a % (dep)
latency step-down (amod)
produces : (punct)
adults indian (amod)
missed recommended (dep)
practice standard (amod)
diagnosis amphetamine- (nmod)
higher 0.001 (dep)
woman-years was (cop)
hemiparesis : (punct)
ap ( (punct)
relieved drugs (nmod)
min group (nmod)
man , (punct)
functionality catalytic (amod)
2.44 - (punct)
31 of (case)
therapy vasopressor (compound)
anaesthetized patients (nsubjpass)
had fluctuations (dobj)
impaired not (neg)
tdi group (appos)
ouabain cats (nmod)
occur they (nsubj)
> aged (amod)
confined not (neg)
patients tinnitus (dep)
doubled pretreatment (nsubj)
analysis encode (nmod)
causes potential (amod)
decrease prevalence (dobj)
results treatment (nsubj)
bromocriptine of (case)
monosaccharides by (case)
study adjustment (nmod)
levetiracetam a (det)
investigated might (aux)
decreases similar (amod)
pseudoprolactinoma or (cc)
use anticholinergic (amod)
activation to (case)
undertaken . (punct)
responses drug-induced (amod)
5 controls (nmod)
linked have (aux)
trimethoprim those (det)
follows : (punct)
anaesthesia from (case)
resection tumor (nmod)
motion . (punct)
11.2 respectively (advmod)
microvascular pancreatic (amod)
angiography coronary (amod)
lithium been (cop)
albuminuria nitrendipine-treated (amod)
proliferation cells (nmod)
136 % (appos)
related dysfunction (nmod)
naproxen 1.29 (nummod)
disappeared month (nmod:tmod)
related , (punct)
therapy interferon (nmod)
standard is (cop)
development hypercalcemia (nmod)
demonstrated clearly (advmod)
two whom (nmod)
before 1 (conj)
background associated (appos)
supported data (nmod)
racemic r- (appos)
isomers of (case)
proliferation fanft-induced (amod)
less than (prep)
imaging dwi (appos)
delivery cesarean (amod)
lesions prior (amod)
mice infected (amod)
patients out-patients (dep)
important follow (xcomp)
reduces that (mark)
had transplantation (dobj)
rare but (cc)
composition . (punct)
risk developing (advcl)
% 36 (nummod)
available ) (punct)
indomethacin 4 (nummod)
glycopyrrolate 5 (nummod)
scales the (det)
week 18 (nummod)
men 5 (nummod)
sbp of (case)
areas score (conj)
mrna enos (compound)
learning scopolamine-induced (amod)
olanzapine mg/d (dep)
reversed levels (nmod)
potentiate levofloxacin (nsubj)
thrombocytopenia recognized (acl)
l-name observed (acl)
concentration folate (compound)
pj34 in (case)
accumulation with (case)
micrograms 8.3 (nummod)
c fa (compound)
initiated end (nmod)
antiplatelet diuretic (conj)
began patients (nsubj)
occurred obstructive (nsubj)
has hand (nmod)
involved failure (dobj)
levels cb (compound)
model our (nmod:poss)
agonists alpha-2 (compound)
block developed (acl:relcl)
period difficulty (conj)
effects tremor (amod)
regimens to (case)
induced fluoxetine (nsubj)
available phenacetin (nsubj)
vacuolization , (punct)
signs first (amod)
dosage and (cc)
diazepam surgery (nmod)
respiratory peripheral (conj)
associated = (conj)
sites liver (nsubj)
drugs anti-inflammatory (amod)
gene beclin (appos)
dinitrate of (case)
resulted pilocarpine (nsubj)
suffering been (aux)
therapies , (punct)
activity antiarrhythmic (amod)
nucleus ventralis (compound)
gastrointestinal and (cc)
evaluated ; (punct)
substantiates role (dobj)
respiration heart (nmod)
dysregulation enac (compound)
performed eyes (nmod)
vessels microblood (compound)
92 12 (compound)
rats nephrotic (amod)
0.007 < (dep)
recovered discontinuing (advcl)
weeks observation (nmod)
thickening minimal (amod)
extension passive (amod)
administration i.e. (acl)
greater to (conj)
thiopentone with (case)
publications in (case)
seizures clonic (amod)
resistance ( (punct)
department in- (dep)
decrease ) (punct)
dm + (cc)
had attack (dobj)
pretreatment prolonged (amod)
evaluated stages (nmod)
concentrations cortisol (compound)
higher however (advmod)
occurrence for (case)
pharmacological interventions (dep)
pressure by (case)
and naturally (advmod)
seizures induced (acl)
sodium and (cc)
nausea such (case)
recovered hydration (nmod)
evidence subanalyses (conj)
therapy , (punct)
risk between (case)
simple safe (conj)
resulting occupancy (nmod)
cm kg (nmod)
history the (det)
changes granular (amod)
assessment the (det)
associated lithium (nsubjpass)
excess observed (conj)
stabilized patients (nmod)
hsct by (case)
month age-range (amod)
bleeding patients (nmod)
effect pretreatment (nmod)
syndrome human (amod)
feeding by (mark)
carried pre- (xcomp)
all rats (nmod)
disorders ; (punct)
qrs , (punct)
value > (dep)
aim with (case)
five infants (nmod)
studied seizures (nmod)
dose identical (amod)
alpha- beta-adrenergic (conj)
had myocarditis (dobj)
administration patient-controlled (amod)
cortex adult (amod)
treated concurrently (advmod)
end weeks (nmod)
influence the (det)
patients 450 (appos)
administration l-arginine (nmod)
removed lithotripsy (nsubj)
shown trials (nsubj)
records clinical (amod)
compare therapy (nmod)
followed related (nmod)
system via (case)
patient unconscious (acl:relcl)
anaesthesia intravenous (amod)
changes functionality (nmod)
cases lasting (acl)
inhibitor phosphodiesterase (compound)
gentamicin of (case)
rs4704559 for (case)
therapies salvage (compound)
work-up . (punct)
report outcomes (dobj)
appeared results (nsubj)
combinations rats (nmod)
patients normocalcemic (amod)
protected inhibitor (nsubj)
test provocative (amod)
division first (amod)
evidence supporting (acl)
characteristic activation (nmod)
function for (case)
concentrations achieved (acl)
administered groups (nmod)
mouse-1 nmol (compound)
characteristics chemistries (conj)
salt-depleted normal-salt (conj)
reduced h2o2 (dobj)
months at (case)
associated potential (nsubjpass)
lower twitches (nsubj)
associated allele (nmod)
increase fluctuations (nmod)
tachycardia associated (acl)
standard management (nmod)
affecting cardiac (dobj)
prescribed and (cc)
appears data (nmod)
elicited . (punct)
vasospasm , (punct)
demonstrate attenuates (ccomp)
sleepiness in (case)
effects preference (nmod)
reflected accumulation (nsubjpass)
party working (compound)
undertaken should (aux)
cure with (case)
resulted anuria (nmod)
maximal . (punct)
filled prescription (dobj)
non-reactive generalized (dep)
response collected (acl)
function humans (nmod)
interval p-p (compound)
linked previously (advmod)
preparation suxamethonium (nmod)
gfap tnf-a (conj)
potentiates antagonizes (conj)
mg/kg 0.4 (nummod)
duration by (case)
corticosteroids aspirin (conj)
anticonvulsants other (amod)
discontinued toxicities (nsubjpass)
concentrations ( (punct)
presence quinine (nmod)
reported vasculitis (nsubjpass)
escalated dose (nsubjpass)
man lymphoma (nmod)
regimen liposomal (amod)
c versus (cc)
scr was (cop)
observed g (dep)
entries epm (nmod)
mortality or (dep)
developing on (mark)
candidate disease (nmod)
15.3 1.17 (conj)
species ros (appos)
less . (punct)
and dose-dependently (advmod)
decreases baseline (nmod)
paracetamol ( (punct)
% 4.0 (nummod)
doses microl (nmod)
prevent reducing (advcl)
hypertension-related and (cc)
serotonergic both (cc:preconj)
individuals hiv (nmod)
medications improve (acl:relcl)
potent be (cop)
contribution effect (nmod)
120 mg. (quantmod)
pod ) (punct)
31 to (dep)
valsartan plus (cc)
identified not (neg)
treatment instillation (nmod)
control ng/kg/min (appos)
amnesia ( (punct)
demands hypersecretion (conj)
repair with (case)
nausea sweating (conj)
increase expression (nmod)
fit model (nmod)
patients 265 (nummod)
performed wky (nmod)
experienced headache (dobj)
profile cardiac (amod)
correlated changes (nmod)
showed wave (dobj)
function morphology (conj)
subjects exhibiting (acl)
presented occasions (nmod)
useful were (cop)
attenuated method (nmod)
physiology requirement (conj)
mediate stroke (nmod)
risk rhabdomyolysis (nmod)
treated chlorpropamide (nmod)
twenty % (appos)
levels ssris (nmod)
need evaluation (nmod)
presentation its (nmod:poss)
warranted follow-up (nsubjpass)
dysfunction paralysis (conj)
index rate (compound)
recovered state (nmod)
group 4 (nummod)
development and (cc)
induce synergistically (advmod)
loss liver (compound)
showed improved (conj)
therapy rescue (compound)
months respectively (advmod)
c+e the (det)
man cardiotoxicity (nmod)
power antioxidant (amod)
mediator is (cop)
detected qrt-pcr (nsubj)
tend , (punct)
examinations ophthalmological (amod)
impairments neurocognitive (amod)
enlargement . (punct)
effect hearing (acl)
amyloidosis and (cc)
comparable weaker (conj)
succinate agonist (appos)
e and (cc)
ambiguus possibly (advmod)
returned showed (conj)
somnolence with (case)
necrosis ability (conj)
oxidase xanthine (compound)
simply not (neg)
treating riha (dobj)
correlated not (neg)
response gamma-hch (compound)
biperiden due (case)
cholesterol triglyceride (conj)
rise resistance (nmod)
etiology treatment (conj)
hepatotoxicity metformin-associated (amod)
tetracycline of (case)
range over (case)
29.5 17.5 (conj)
prevention cin (nmod)
anticholinesterases with (case)
mpges-1 mice (dep)
mo next (amod)
reduce encourage (conj)
effects antipsychotic-like (amod)
linked whether (mark)
rabbit in (case)
fibrillation arrhythmias (conj)
acquired immediately (advmod)
indomethacin agents (conj)
captopril given (acl)
recruited belgium (nmod)
demonstrated microdialysis (nsubj)
measures parkinsonism (nmod)
induce not (neg)
hours of (case)
h , (punct)
permeability and (cc)
pheochromocytoma of (case)
dehydrogenase malondialdehyde (conj)
history parental (amod)
result could (aux)
removed light (nmod)
incidence transplantation (nmod)
cells his (nmod:poss)
nonusers ( (punct)
treatments sodium (compound)
desensitization rather (cc)
enrolled p9201 (nmod)
% 37 (nummod)
cause proteinuria (nmod)
neuroleptics other (amod)
function bladder (compound)
state an (det)
lactate , (punct)
regeneration tissue (nmod)
intervention preventing (acl)
patients arteriopathic (amod)
transmission stimuli (nmod)
15 7.5 (quantmod)
disorder autosomal (amod)
control effect (nmod)
2,220 more (amod)
mpo ( (punct)
genotyped 5-httlpr (nmod)
acknowledged , (punct)
have volumes (dobj)
effects system (nmod)
average by (case)
severity her (nmod:poss)
measured injections (nmod)
children million (nummod)
n-acetyl-beta-d-glucosaminidase -- (punct)
preventing exposure (nmod)
infused , (punct)
syndrome behavioural (amod)
aspects and (cc)
patients pancreatitis (conj)
reported alleviated (ccomp)
prednisolone or (cc)
results greater (appos)
portions heavily (amod)
formation subependymal (amod)
prevention hypokalemia (nmod)
transplants kidneys (conj)
disruption regional (amod)
accomplished results (conj)
process be (cop)
confirms : (punct)
patients (d)1 (dep)
antagonized was (auxpass)
metabolite through (case)
modulators these (det)
infusion ethanol (compound)
activity physical (amod)
hemoglobin 3 (nummod)
needed confirm (xcomp)
mitoq. targeted (amod)
proportion significant (amod)
replacement frozen (amod)
mg/kg 5 (nummod)
received induction (nmod)
m(2)-selective and (cc)
test startle (compound)
biochemical histological (conj)
complete proteinuria (conj)
episode self-limited (amod)
describes study (nsubj)
form soluble (amod)
produce protection (dobj)
thrombosis transverse (amod)
leading mimicking (advcl)
acts receptor (nmod)
0.01).(abstract than (case)
nmda of (case)
developed dose (nmod)
30 over (advmod)
depressed p100 (nmod)
papilloma squamous (amod)
hepatotoxicity acetaminophen (amod)
evidence mechanism (nmod)
single-blind , (punct)
found specimens (nmod)
administering of (mark)
fulfilled criteria (dobj)
abortions midtrimester-induced (amod)
expression increases (acl:relcl)
tapering the (det)
recovery spontaneous (amod)
increase part (nmod)
subset pain-intolerant (amod)
water chow (conj)
patients ineffective (acl:relcl)
presence sensitization (nmod)
loading amiodarone (compound)
open would (aux)
velocity saccadic (amod)
ascites greater (amod)
d2 receptors (dep)
hemispheres in (case)
pericarditis glomerulonephritis (conj)
formation taa (compound)
injury acute (compound)
patients hepatitis (compound)
platinum one (nummod)
tested here (advmod)
tissues subcutaneous (amod)
cases fide (compound)
rubella postpartum (compound)
incidence thromboembolism (nmod)
clozapine given (case)
discharges cortical (amod)
reduction anemia-induced (amod)
anesthesia patients (nmod)
% improvement (dep)
p-aminophenol , (punct)
injections i.v. (amod)
vasorelaxation by (case)
exposure all (det)
recordings eeg (compound)
related syndrome (nmod)
specified and (cc)
day postnatal (amod)
angiography in (case)
g mg/100 (nummod)
sedentary-isoproterenols in (case)
dose t.d.s. (nmod)
developed when (advmod)
continued been (auxpass)
marker a (det)
samples on (case)
used had (aux)
heart irregular (amod)
sustained increase (nsubjpass)
possible not (neg)
confirmed analysis (nmod)
etiology possible (amod)
rate reporting (compound)
improves ; (punct)
parameters these (det)
frequent most (advmod)
uses with (case)
hypertension severe (amod)
injected dose (nmod)
duration action (compound)
caused cbd (dep)
actions toxic (amod)
transplantation after (case)
livers their (nmod:poss)
courses 88 (nummod)
related of (case)
syndrome posterior (amod)
factors coagulation (nmod)
potential drugs (nmod)
space bupivacaine (appos)
nascis ) (punct)
impairment visual (amod)
death variable (amod)
pains patients (nmod)
failure chemotherapy (nmod)
protects pparalpha (nsubj)
battery a (det)
steroids neuroactive (amod)
volunteers , (punct)
forearm right (amod)
treatment q10 (compound)
efficient less (advmod)
course transplantation (nmod)
parents of (case)
preparation heart-lung (amod)
divided studied (conj)
level retinal (amod)
subunits for (case)
sprouting mfs (appos)
acetate cpa (appos)
potentials late (amod)
suggests excess (nsubj)
increased that (mark)
register from (case)
headache nitric (amod)
exacerbations asthma (nmod)
presented days (nmod:tmod)
time median (compound)
electroshock or (cc)
otherwise who (nsubj)
indicate sensitive (ccomp)
change decreased (conj)
studies antibodies (nmod)
detect deterioration (dobj)
increased segments (nmod)
alterations in (case)
treatment adolescents (nmod)
groups sham (compound)
impairs term (nmod)
30 22 (compound)
methods underwent (appos)
data other (amod)
combination prevention (nmod)
cells time (nmod)
methods studied (appos)
spillover norepinephrine (compound)
coefficient ( (punct)
temperature patient (nmod:poss)
protected administration (nmod)
accuracy in (case)
analysis chemical (compound)
spectrometry mass (amod)
progress contrary (nmod)
27-hydroxylase sterol (compound)
disease cad (appos)
produce show (parataxis)
returned levels (nsubj)
cd50 ) (punct)
inhibitor rather (cc)
indication occurred (ccomp)
decreased decreased (ccomp)
convulsive and (cc)
crisis a (det)
features pathognomonic (amod)
effects following (amod)
developed instillation (nmod)
prescribed evidence (nmod)
exhibited potentiating (advcl)
mean lower (conj)
percent 82 (nummod)
ipsi- and (cc)
pap of (case)
showed difference (dobj)
evaluated , (punct)
= 0.093 (dobj)
-20.93 % (conj)
continued anesthesia (nsubjpass)
effect primary (amod)
pathogens with (case)
preparation new (amod)
leakage lysosomal (amod)
appearance presence (nmod)
low . (punct)
injection 5,7-dihydroxytryptamine (nmod)
wk less (nummod)
antibody medications. (compound)
mwm ( (punct)
given precluded (advcl)
activation liver (nmod)
mice webster (compound)
globulin with (case)
side-effects more (amod)
acuity deposits (conj)
hc ifs-induced (amod)
% 4.4 (dep)
drugs aap (nmod)
minutes five (nummod)
snp of (case)
conversion before (case)
successful not (neg)
acute less (advmod)
rose again (advmod)
response acid (nmod)
corticosteroids and (cc)
polymerase and (cc)
g 29.1 (nummod)
world rw (appos)
care neurocritical (amod)
trial hours (nmod)
deviation standard (amod)
denominator common (amod)
dose-dependent primarily (advmod)
dubutamine of (case)
signals t2 (compound)
mediating toxicity (dobj)
man in (case)
24.9 +/- (cc)
dyskinesia with (nmod)
assessed symptoms (nsubjpass)
catecholamines sedatives (conj)
deprivation combined (acl)
ptcr ) (punct)
11-fold to (dep)
persists fire (amod)
aneurysms these (det)
temperature level (conj)
antigen-positive nuclear (amod)
493 +/- (cc)
paracetamol patients (nmod)
cancer of (case)
synthesis prostacyclin (compound)
due pregnancy (nmod)
costs the (det)
replacing it (dobj)
failed hp (nsubj)
embolism massive (amod)
ct unenhanced (amod)
6 8 (conj)
fraction baseline (compound)
time a (det)
regulation pathways (conj)
gamma-hexachlorocyclohexane ) (punct)
arteriosus ibuprofen (nmod)
arises . (punct)
seizures mainly (advmod)
treated drug (nmod)
patients 135 (nummod)
measuring amount (dobj)
indicates use (nsubj)
value assessing (acl)
antioxidants non-enzymic (amod)
mg/m2 225 (nummod)
epinephrine 1:100,000 (nummod)
doses several (amod)
association chemotherapy (nmod)
genes examined (acl)
users who (nsubj)
seizure piperacillin/tazobactam-induced (amod)
3.49 progestagens (nmod)
attenuated test (nmod)
carbonate ingested (amod)
produce associated (conj)
patients asymptomatic (amod)
increase proliferation (nmod)
epilepsy serial (amod)
system culture (compound)
modulates and (cc)
efficacy phase (compound)
effective it (nsubj)
attenuated decrease (nsubjpass)
injections cbz (nmod)
cause production (nsubj)
dependency cardiotoxicity (nmod)
popularity its (nmod:poss)
aap of (case)
parasympathetic sympathetic (conj)
results decreased (appos)
segments cacl(2)-treated (amod)
salivation retching (conj)
seen regimens (nmod)
ratio 5.9 (appos)
regions neurogenic (amod)
antagonist diphenhydramine (conj)
deletion pj34 (nmod)
affects groups (dobj)
induced incorporation (nsubj)
elf , (punct)
received dronedarone (xcomp)
(+/-)-pg-9 of (case)
found day (nmod)
asa with (case)
patient carcinoma (nmod)
effects prothrombotic (amod)
dosage its (nmod:poss)
serum on (case)
disease . (punct)
ulcers accompanied (acl)
take day (nmod:tmod)
occurred min (nmod)
study continued (amod)
january 1995 (nummod)
a > (compound)
characterization tumors (nmod)
cholestasis marked (acl)
confirm results (nsubj)
blood coronary (amod)
resulting captopril (nmod)
electrocardiography and (cc)
upregulated can (aux)
epileptiform run (dep)
arising system (nmod)
connected possibly (advmod)
look-alike " (punct)
40000 ( (punct)
necessary investigate (xcomp)
urine dark (amod)
filled 1999 (nmod)
bruising of (case)
feet his (nmod:poss)
digitalis- adrenaline-induced (conj)
increase and (cc)
deterioration ich (compound)
disorders interactions (conj)
given fluoxetine (nsubjpass)
treated fluoxetine (nmod)
available when (advmod)
wall segment (nmod)
small difference (nsubj)
adc ) (punct)
expression than (case)
oxprenolol of (case)
streptozotocin-induced diabetic (dep)
normalized titer (nsubj)
purpose determine (dep)
improve and (cc)
day 13 (nummod)
observations our (nmod:poss)
signs above (amod)
hemorrhagic indicating (xcomp)
1.9 +/- (cc)
cns ) (punct)
normotensive sixty (nsubj)
expression na/k-atpase (nmod)
became , (punct)
pretreated , (punct)
effects blocker (compound)
using material (dobj)
evaluated monotherapy (nmod)
exert hyperalgesia (dobj)
group adr-nephropathy (amod)
higher hematocrit (conj)
stable rate (nsubj)
warned events (nmod)
hypomethylation dna (nmod)
involvement metabolic (amod)
rats levels (nmod)
response events (nmod)
determined last (parataxis)
inhibited frequency (nsubjpass)
using ces-d (dobj)
times activated (amod)
avoidance passive (amod)
remained inducible (xcomp)
eating with (case)
seizures infants (nmod)
associated suppressants (nmod)
conclusions lead (dep)
studies mr (compound)
mg respectively (advmod)
showed rise (dobj)
meshwork of (case)
cause beat (ccomp)
true patients (nmod)
used once (advmod)
t 1/2,z (appos)
bind which (nmod)
values baseline (compound)
hemodynamics . (punct)
administered transplant (nmod)
uncertain but (cc)
incessant for (case)
0.25 and (cc)
days incidence (nmod)
elevated la (nsubj)
abilities form (conj)
reduction harm (nmod)
tests passive (amod)
changes nfs (nmod)
injections intraperitoneal (amod)
accurately very (advmod)
axis qrs (compound)
terms in (case)
tetrabenazine and (cc)
two one-half (conj)
= 0.015 (dobj)
200 +/- (cc)
administration capsaicin (nmod)
expression achr (compound)
p9605 from (case)
malaise , (punct)
score cirrhosis (conj)
lasting hours (nmod:tmod)
documenting binding (dobj)
had neuropathy (ccomp)
receptor vegfr-2 (appos)
jaundice malaise (conj)
inhibitor targets (acl:relcl)
changed reported (advcl)
nephritis nafcillin-induced (amod)
followed night (dobj)
syndrome vincristine (nmod)
tdi , (punct)
showed prevalence (dobj)
ester nitro-l-arginine (compound)
day test (compound)
roots coadministration (nsubj)
suggested attributable (ccomp)
interval , (punct)
azidothymidine with (case)
infants premature (amod)
risperidone ci=1.0 (dep)
0 625 (conj)
followed infusion (nmod)
nuclei to (case)
k(na increased (acl)
presence particularly (advmod)
allopurinol and (cc)
infant male (appos)
d11 d16 (conj)
hospitals hampshire (nmod:poss)
considered successful (xcomp)
hmm ) (punct)
was assess (xcomp)
ventilated . (punct)
rejection outcome (conj)
myalgia succinylcholine-induced (amod)
extensively and (cc)
epiphyses punctata (dep)
identified anomaly (nsubjpass)
candidates potential (amod)
acid n-acetylglucosaminidase (conj)
reported culture (nmod)
increase o-methylation (nmod)
minutes size (conj)
interstitium to (case)
transaminase and (cc)
amiodarone and (cc)
40 25 (compound)
phenomena in (case)
none treatments (nmod)
close incidence (nmod)
important is (cop)
pathogenesis as (case)
history depression (nmod)
electro-oculography arden (compound)
own cephalothin-coated (conj)
medium tissue (nmod)
pretreatment trazodone (nmod)
service psychiatric (amod)
syndrome lobe (amod)
nmda mg/kg (appos)
incubated slices (nsubjpass)
studied mice (dobj)
effects e4031 (nmod)
develop to (aux)
understanding thus (advmod)
happiness mood (dep)
disease esrd (appos)
combination prolonged (amod)
demonstrated excluded (conj)
groups 7 (nummod)
glomerulosclerosis adr-induced (amod)
mm/year 0.262 (nummod)
incidence recurrence (nmod)
monitored correlated (conj)
inhibited effect (dobj)
phases and (cc)
penicillamine and (cc)
paracetamol weight (nmod)
hctc ( (punct)
infection hbv (compound)
dfp of (case)
introduction captopril (nmod)
doxorubicin liposome-encapsulated (amod)
low back (compound:prt)
myopathy associated (acl)
avoiding foods (dobj)
undergo known (conj)
knowledge composition (nmod)
rofecoxib 1.27 (nummod)
idiosyncrasy lidocaine (nmod)
variables confounders (nmod)
contains agents (dobj)
removal the (det)
reduced tissue (nmod)
echocardiography radionuclide (conj)
showed relieved (parataxis)
piperacillin with (case)
necessary adjustment (nsubj)
mutations butyrylcholinesterase (compound)
values 4.6 (nmod)
levetiracetam of (case)
therapy multidrug (compound)
improves patients (nmod)
presents observations (dobj)
transplantation living-related (amod)
alkaloid hemlock (appos)
presents illness (dobj)
cyclooxygenase an (det)
klebsiella , (punct)
women taking (acl)
agonists d1 (compound)
diameter cxad (appos)
occurs affect (conj)
centers teams (nmod)
greater toxicity (nsubj)
p.m. 4 (nummod)
elderly health (compound)
did . (punct)
related rates (nmod)
erythematosus . (punct)
resumed normotension (nsubjpass)
testosterone of (case)
af 378 (nummod)
induced i.p. (advmod)
blockade and (cc)
mode this (det)
function treatment (nmod)
identified factor (nmod)
statins prescribing (compound)
effect outcome (conj)
treated thiopental (nmod)
artery the (det)
older children (advcl)
findings previous (amod)
treatment doses (nmod)
decreased manner (dep)
october 30 (nummod)
development apoptotic (amod)
serum , (punct)
limit normal (amod)
suffer fever (nmod)
mice tested (acl)
run to (mark)
weeks once (advmod)
patients subjects (nsubj)
one convulsant (amod)
tumors most (nsubj)
tested function (nsubjpass)
hour 1 (compound)
recovery to (case)
treated aminonucleoside (nmod)
size ; (punct)
ezetimibe with (case)
cox-2 cox-1 (conj)
monoher and (cc)
delineate to (mark)
es ( (punct)
reported damage (nmod)
filling and (cc)
classified we (nsubj)
associated toxicity (nmod)
puncture by (case)
pupil the (det)
nifedipine for (case)
600 and (cc)
differences , (punct)
re-challenged be (auxpass)
n-methyl-d-aspartate agonist (compound)
= 0.04 (dep)
bupivacaine respect (nmod)
ferritin of (case)
chorionic and (cc)
killed injections (nmod)
expression them (nmod)
had compliance (dobj)
induced acrolein (nsubj)
risk crude (amod)
complications anaesthetic (amod)
suffered two (nsubj)
requiring treatment (dobj)
kidney recirculating (compound)
study results (dep)
tarsorrhaphy a (det)
effective can (aux)
idr by (case)
less 0.02 (nmod)
clomipramine antidepressant (amod)
moderate severe (nmod)
differ levels (nsubj)
rats weeks (nmod)
developed proteinuria (dobj)
effects d1 (nmod)
survived they (nsubj)
elevated pressures (dobj)
ears newborns (nmod)
breakdown increase (conj)
improved compounds (nsubj)
fa and (cc)
serum urine (conj)
pregnancies singleton (compound)
akathisia implications (dep)
na(+)/k(+)-atpase of (case)
nephropathy virus (compound)
oscillation of (case)
sepsis of (case)
activity generalized (amod)
change both (preconj)
inhibit metabolism (dobj)
transformation during (case)
death widespread (amod)
group 14 (dep)
insults injury (nmod)
glomerulonephritis rpgn (appos)
activation dietary (amod)
electroretinography wide-field (amod)
less significant (conj)
eight two (nmod)
paralysis persisting (acl)
had time (nmod)
seen group (nmod)
unit from (case)
deviation intervals (nmod)
sedation irritability (conj)
experienced pain (dobj)
administered placebo (conj)
variables confounding (compound)
dose given (acl)
type stroke (nmod)
e ) (punct)
10(-5 ) (punct)
eruption . (punct)
toxic minimally (advmod)
syndrome an (det)
covered h (nmod)
rate or (cc)
acetate the (det)
detected antibody (nsubjpass)
administration phenobarbitone (nmod)
positive bpo (nmod)
application intracisternal (amod)
setting practices (dobj)
1.25 more (amod)
endomt ) (punct)
suffered mg (dep)
(+)-cibenzoline of (case)
31 from (case)
pathophysiology and (cc)
concentration grains (nmod)
complications surgery (nmod)
severity of (case)
alleviated decreases (conj)
users drug (compound)
consumed frequently (advmod)
speed but (cc)
% chinese (amod)
test lymphocyte (compound)
bradycardia clonidine-induced (amod)
remained compared (advcl)
chemotherapy by (case)
10 +/- (cc)
ml 50 (nummod)
suppress development (dobj)
mpa ) (punct)
hormones independent (amod)
hyperactivity , (punct)
incidence esrd (nmod)
model well-defined (amod)
accomplished injection (nmod)
quinidine like (case)
nmol 0.1 (nummod)
routes the (det)
management psp (nmod)
flexion toes (nmod)
cocaine cardiotoxity (conj)
examination laboratory (compound)
correlation good (amod)
dehydrogenase ldh (appos)
contribute risk (nmod)
uncommon related (conj)
leads defect (nsubj)
associated process (nmod)
transported transporter (nmod)
objective quantify (dep)
sensitive differentially (advmod)
seizures epilepticus (conj)
infections medications (conj)
improvement with (case)
risk substantial (amod)
nuclear and (cc)
rats cancer (nmod)
interaction warfarin-drug (amod)
categorized : (punct)
startle amplitude (dobj)
presented had (conj)
phenotypes behavioral (amod)
patients studied (acl)
study 4'-0-tetrahydropyranyladriamycin (nmod)
treating glaucoma (dobj)
regurgitation valve (compound)
days 1 (dep)
selective species (nmod)
vindesine to (case)
delta22-isomer the (det)
process feedback (compound)
ought nurse (nsubj)
range 27 (nummod)
microscopy tem (appos)
affected most (advmod)
favourable outcome (compound)
reports clinical (amod)
consumption and (cc)
epilepticus to (case)
discussion possibility (nmod)
results perturbation (nmod)
individuals infarction (nmod)
concentration serum (nmod)
withdrawn improved (advcl)
investigate contribute (ccomp)
methoctramine and (cc)
activities nte (compound)
series this (det)
site effect (nmod)
acetrizoate ( (punct)
focus hypotension (nmod)
protocol succimer (compound)
risk torsade (nmod)
restarted should (aux)
part the (det)
a-i apolipoprotein (compound)
ribavirin of (case)
movement hearing (conj)
group timolol (compound)
mirror effects (nsubj)
infusion ; (punct)
method effective (amod)
consisted sample (nsubj)
atrophy tubular (amod)
rates onset (nmod)
normal responses (nsubj)
immobilization her (nmod:poss)
measured also (advmod)
clonidine = (dep)
correlated can (aux)
regard hypothesis (nmod)
tissue the (det)
colitis chronic (amod)
contraction of (case)
decrease 6-months (nmod)
salivation excessive (amod)
pathophysiology underlying (acl)
treatment as (cc)
remained tachyarrhythmia (nsubj)
nine only (advmod)
vmax a (det)
attained denopamine (nsubjpass)
ic catalepsy (nmod)
effect systems (nmod)
hepatitis ticlopidine-induced (amod)
caution infants (nmod)
phosphorus component (appos)
heart nd (nmod)
dose dose (dep)
left mm (dep)
eyes rat (compound)
none moderate (conj)
brain csf (conj)
identify did (aux)
ventricle lateral (amod)
spiranolactone of (case)
therapy agent (compound)
agents acting (acl)
status with (case)
mortality significant (amod)
alpha(1 ) (punct)
induced bepridil (nmod)
fashion dose-independent (amod)
needed therapy (nsubjpass)
surface body (compound)
implications autism (nmod)
cocaethylene also (advmod)
activity : (punct)
electro-oculography potentials (conj)
blockade high (amod)
rats subjected (acl)
agents teams (conj)
paid modifications (nmod)
aware order (nmod)
discontinue abuse (dobj)
stripe medulla (nmod)
admitted hospitals (nmod)
drug an (det)
day 15 (nummod)
cerebellum splenium (conj)
4.3+/-1.9 respectively (advmod)
exposure median (amod)
fas ) (punct)
wards to (case)
properties arrhythmias (nmod)
provide method (dobj)
unaware physician (compound)
man 63-year-old (amod)
extent . (punct)
saline alpha (nmod)
paid involvement (nmod)
tolerability vs (cc)
report a (det)
hilus hippocampal (compound)
studies urodynamic (amod)
screening : (punct)
clinic mental (amod)
logs and (cc)
caa not (cc)
presence use (conj)
hypotension oxytocin-induced (amod)
assessed operation (nmod)
21.6 19.9 (nmod)
samples blood (compound)
sclerosis systemic (amod)
inappropriate degree (nmod)
examined structure (nsubjpass)
estradiol- ) (punct)
activation synthase (compound)
reactions cerebral (amod)
patients one (nummod)
overactivation . (punct)
mouth of (case)
m0 ) (punct)
elevations of (case)
group minimum-type (amod)
meter animex-activity (amod)
% 2.6 (appos)
ruled , (punct)
loss waveforms (nmod)
reading on (case)
scale epidemiological (compound)
caused adrenaline (nsubj)
incidence pressure (nmod)
discharged drug (nmod)
saturation the (det)
ouabain given (case)
pathology cervical (amod)
coexisted cells (dep)
echocardiography : (punct)
hospitals ( (punct)
seen december (nmod)
protocol both (appos)
compared pattern (dobj)
cystitis with (case)
10 0 (compound)
defects vigabatrin (compound)
inhibitor ace (compound)
infusions the (det)
61.6 8.7 (conj)
patients selected (amod)
11 between (case)
executive central (amod)
ineffective also (advmod)
currents ionic (amod)
indicated ht (nsubjpass)
neuroleptics conventional (amod)
channel that (mark)
pericarditis fever (conj)
delivered automatically (advmod)
woman obstruction (nmod)
report patch (conj)
dogs fewer (amod)
use angiography (conj)
subjected protocol (nmod)
antagonize blockade (dobj)
result might (aux)
e1 trimethaphan (conj)
32 [ (punct)
na/k-atpase nhe3 (conj)
conclusion of (case)
convulsions for (case)
commissure-commissure in (case)
became whom (nmod)
had captopril (nsubj)
fentanyl or (cc)
concentration < (nmod)
explore dosing (dobj)
sedative the (det)
symptoms nms (nmod)
lymphopenia neutropenia (conj)
women 8 (nummod)
timolol and (cc)
dealt , (punct)
2-fold by (case)
considered severe (xcomp)
disarrangement , (punct)
medulla 1/8 (appos)
transporter channel (conj)
event % (appos)
volunteers dose (appos)
minutes 34 (nummod)
dysfunctional sexually (advmod)
intolerant to (mark)
% 15.3 (nummod)
amplitude reflex (amod)
underperfusion of (case)
bfu-e marrow (compound)
time onset (nmod)
variation . (punct)
resulted toxicity (nmod)
drug useful (amod)
drug- allergen-related (conj)
evaluated antagonist (dep)
associated anophthalmia (nmod)
failed screening (nsubj)
corticosteroids benzodiazepines (conj)
starting clozapine (dobj)
phases even (advmod)
6 35 (prep)
prevent doses (nmod)
factor ) (punct)
acidosis nonketotic (amod)
has disappearance (dobj)
contribute seizures (nmod)
prevent atrophy (dobj)
used stimuli (nsubjpass)
generate information (dobj)
unreasonable , (punct)
eye her (nmod:poss)
syndrome hypomania-like (amod)
raised concentrations (nsubjpass)
rapamycin ) (punct)
stroke ( (punct)
reducing concentration (dobj)
scenario an (det)
complication maleate (nmod)
hypaque 76 (dobj)
contribute factors (nsubj)
completion hours (conj)
celecoxib , (punct)
ketamine to (mark)
synapse lateral (amod)
disease stroke (compound)
stripe in (case)
unit cholinesterase (compound)
rats times (nmod:tmod)
discussion is (cop)
affected ratings (nsubjpass)
phenotype of (case)
think cause (ccomp)
injection bupivacaine (conj)
expression growth-associated (amod)
variety symptoms (nmod)
recovers further (advmod)
review first (advmod)
period typical (amod)
skf 38393 (nummod)
trial clinical (amod)
assay tumor (compound)
circling the (det)
years after (case)
hyperprolactinemia by (case)
p=0.65 ( (punct)
neutropenia infections (conj)
patients pd (nmod)
neurosteroids of (case)
analgesia catalepsy (conj)
groups age (compound)
proliferation n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced (amod)
reductions deviation (nmod)
600 up (advmod)
additive synergistic (conj)
underwent who (nsubj)
ascended proximally (advmod)
justified probably (advmod)
100 between (case)
developed disease (nmod)
hepatic neurologic (conj)
processes astrocytic (amod)
thickness pulmonary (amod)
propylthiouracil with (case)
48-week to (case)
sodium i.v. (amod)
suffered overdose (nmod)
surpasses . (punct)
il-1b , (punct)
treated . (punct)
valves heart (compound)
history without (case)
occurred began (advcl)
tur after (case)
property , (punct)
pneumonitis related (conj)
used concentrations (nsubjpass)
identified dose (dobj)
selected : (punct)
british descent (nmod)
symptomatology paranoid (amod)
gene cox-2 (compound)
is clear (acomp)
score force (conj)
bromide ipratropium (compound)
acid or (cc)
saline/side microl (compound)
variety patterns (nmod)
effect related (amod)
erod ) (punct)
induced hyperlocomotion (dobj)
resulted eradication (nmod)
reaction carbamazepine (nmod)
35 +/- (cc)
secretion distance (conj)
dependence for (case)
mixture proanthocyanidins (nmod)
titrated was (auxpass)
attenuates metoprolol (compound)
bind drug (dobj)
observed centers (nmod)
revealed regression (nsubj)
often too (advmod)
administration phenytoin (nmod)
use withdrawal (nmod)
myopathy drug-induced (amod)
areas buttocks (conj)
complex granular (amod)
day on (case)
mg. , (punct)
aorta shown (acl:relcl)
syndrome uremic (amod)
ca2 of (case)
ability reduce (acl)
types two (nummod)
90 score (nsubj)
decrease that (mark)
accuracy identifying (advcl)
maze radial (amod)
blockers channel (compound)
% figure (nsubj)
migraineurs aura (dep)
disease risk (dep)
marrow with (case)
put surgery (nmod)
treatment cyp (compound)
august between (case)
diseases cystic (amod)
activity abnormal (amod)
dose same (amod)
receptors sigma (compound)
evaluation a (det)
ras the (det)
inrcease this (det)
patients group (nmod)
dose mg (nmod)
nonusers placebo (dep)
lesions from (case)
outcomes interest (nmod)
instructions the (det)
cortical and (cc)
vulnerability to (case)
score a (det)
induced dsp4 (nmod)
transection by (case)
resulting rhythm (nmod)
mg day (nmod)
nodules subsequent (amod)
ad50 in (case)
drugs cytotoxic (amod)
l-alpha-gfc day (conj)
insulin-group in (case)
bed necroses (conj)
picture electroencephalographic (amod)
ls in (case)
patients completing (acl)
fighting phenomena (nmod)
attacks syncopal (amod)
fluctuations ) (punct)
mg than (case)
occurring , (punct)
% elevation (conj)
and functionally (advmod)
consider similarly (advmod)
interaction cisapride-diltiazem (amod)
suggestive retrograde (advcl)
targets are (cop)
judgement emotional (amod)
effect neutropenia (nsubj)
case occurred (acl:relcl)
weight by (case)
neurogenesis cognition (conj)
suggest overall (advmod)
manage achieve (conj)
record medical (amod)
treated % (nsubjpass)
cholinesterase amnesia (conj)
motor autonomic (conj)
model marmoset (compound)
7.8 smaller (amod)
malondialdehyde plasma (compound)
performed withdrawal (nmod)
affected findings (dobj)
died , (punct)
presenting asterixis (nmod)
aspirated patient (nsubj)
necessary might (aux)
collection transplant (nmod)
efficacy hydrochloride (nmod)
outcomes in (case)
increased progressively (nmod)
screened was (auxpass)
aggravate not (neg)
exceeded . (punct)
proteins neurofilament (amod)
exacerbates model (appos)
since background (nsubj)
paclitaxel . (punct)
% ml (compound)
restored vessel (nsubjpass)
used january (nmod)
day<10 per (case)
ed-1 , (punct)
reduce acid (nsubj)
amounts carbonate (nmod)
had vomitus (dobj)
administration misoprostol (nmod)
antagonized ppa (dep)
report and (cc)
causes cross-sensitization (dobj)
start infusion (nmod)
group lead (nmod)
had echocardiography (nmod)
dose tacrolimus (compound)
manifestation mice (nmod)
5.00 and (cc)
dxnp np (conj)
dyskinesia protrusion (conj)
injected period (nmod)
gemcitabine for (case)
event for (case)
patients care (appos)
allowed . (punct)
curvilinear , (punct)
cascade neurodegenerative (amod)
scatter ) (punct)
action as (case)
battery measures (nmod)
gtn ; (punct)
true newborns (nmod)
inhibitors hmg (compound)
histological and (cc)
both with (mwe)
reduces activity (dobj)
woman gestation (nmod)
inhibitors tyrosine (compound)
treated beta-blockers (nmod)
lymphadenitis necrotising (amod)
have simvastatin (nsubj)
occurred cases (nsubj)
microg/ml , (punct)
86 s.e (dep)
exposed piroxicam (nmod)
imbalance intoxication (conj)
increasing occurs (conj)
found distribution (nmod)
capacity plasma (compound)
iief of (case)
therapy high-dose (compound)
markers biological (amod)
utilized carrier (nmod)
methods conventional (amod)
d 30 (nummod)
pretreatment no (neg)
37 them (nmod)
let and (cc)
yield a (det)
staining dna (compound)
young old (conj)
treatments other (amod)
group cell (compound)
factors > (dep)
potentiality the (det)
developed headache (dobj)
two percent (appos)
genes marker (compound)
placement electrodes (nmod)
females elderly (amod)
lvef > (nmod)
improvements months (nmod)
l(-1 was (cop)
were complete (attr)
treatment gentamicin (compound)
seizures unexpected (amod)
neuroplasticity loss (nmod)
lozenge 454 (conj)
risks nsaids (conj)
showed improved (ccomp)
possibility subgroups (nmod)
increased flow (dobj)
increased furthermore (advmod)
received monkeys (nsubj)
prevented are (auxpass)
ii avf (conj)
evaluation future (amod)
cumulative high (amod)
cips ) (punct)
attributable dysgenesis (nmod)
therapy hyperthyroidism (nmod)
detected 12 (nmod)
angiography cta (appos)
disorder disorder (appos)
dogs anaesthetized (amod)
prl of (case)
apl with (case)
effects demonstrable (amod)
involvement parenchymal (amod)
areas large (amod)
syndrome tachycardia (conj)
expression inflammatory (amod)
occur symptoms (nsubj)
cytostatic lymphoma (nmod)
activated pathway (nmod)
years 14.1 (nummod)
assessed : (punct)
diary and (cc)
aggravation titration (nmod)
thinning layer (nmod)
62 - (punct)
assaults from (case)
establishing model (nmod)
14 17 (conj)
300 and (cc)
antagonism activity (nmod)
block 2/1 (nummod)
pressure maximum (amod)
shows dose-dependent (ccomp)
i.c.v. 1ug (amod)
caries rampant (amod)
receptors and (cc)
recognition impaired (amod)
changed function (dobj)
desensitization cardiac (amod)
dexmedetomidine the (det)
march semiannually (advmod)
intervals same (amod)
fibrosis prominent (amod)
study non-randomised (amod)
chromosome a (det)
aggressiveness or (cc)
therapy life (compound)
attenuated abolished (ccomp)
mass or (cc)
days beyond (case)
moderate during (case)
encephalopathy toxic (amod)
describes " (punct)
inefficient is (cop)
rats male (amod)
diet libitum (compound)
remodeling vascular (amod)
compared objective (nmod:tmod)
neurocognitive pharmacodynamic (conj)
azotemia insufficiency (conj)
neurons ) (punct)
schizophrenia type (compound)
erythematosus with (case)
uterotonic used (amod)
pituitary rats (nmod)
mice d2r (compound)
63.5 33.8 (nummod)
affecting metabolism (dobj)
usage human (amod)
isotypes aorta (nmod)
recovery on (case)
increased concentration (nsubjpass)
% hyperbaric (compound)
presenting patient (nmod)
effects tetrandrine (nmod)
mechanisms action (nmod)
induced reliably (advmod)
presented explanation (nmod)
types seizures (nmod)
otoprotectant an (det)
groups trained (amod)
using methadone (dobj)
delineated have (aux)
0.11 and (cc)
experienced minutes (nmod:tmod)
prolonged recurrent (conj)
combination their (nmod:poss)
had percent (nsubj)
microm 26+/-16 (nummod)
disappointing has (aux)
issue a (det)
ead ( (punct)
years onset (nmod)
acids fatty (amod)
provides helpful (conj)
luminal both (cc:preconj)
studied data (nmod)
angiograms right (amod)
investigated therefore (advmod)
skin and (cc)
persisted administration (nmod)
causes are (cop)
suppresses treatment (nsubj)
advised monitoring (nsubjpass)
focus factors (nmod)
control from (case)
directly or (cc)
infarction prior (amod)
elucidated has (aux)
presented ) (punct)
dependent , (punct)
exploration as (case)
than ls (nmod)
injury hours (nmod)
reduced elevated (conj)
mucosa the (det)
alteration diet (nsubj)
indicative lend (conj)
well had (aux)
revealed cases (nmod)
identify pattern (dobj)
endomt of (case)
spaces to (case)
was difference (nsubj)
velocity changes (conj)
duration 0.001 (appos)
group transplant (compound)
esterases by (case)
8-phenyltheophylline theophylline (conj)
primigravida a (det)
11.2 , (punct)
ci 6.0 (nummod)
thyroiditis chronic (amod)
role betaine (nmod)
gene expression (conj)
resistance impairment (conj)
recognized being (auxpass)
physicians caring (acl)
differences successive (amod)
trends and (cc)
duct syndromes (conj)
day 5 (nummod)
probe as (case)
state disease (compound)
administered six (nmod)
small are (cop)
concentration end-tidal (amod)
difficult hazardous (conj)
deterioration of (case)
crossed thereafter (advmod)
block ii (nummod)
placed site (nmod)
23 asian (amod)
hypertension developed (acl:relcl)
defect concentrating (compound)
medications increase (acl:relcl)
administration meloxicam (compound)
decreased 45.45 (nmod)
control ): (det)
apnea of (case)
irreversible that (mark)
diluent the (det)
conclude data (nmod)
used has (conj)
baby died (acl:relcl)
mesangium from (case)
saline nacl (appos)
dex-ht ) (punct)
suitable is (cop)
defined quantitatively (advmod)
toxicity hl (compound)
edema periphery (nmod)
time ( (punct)
skf-82958 such (case)
been deaths (attr)
performed test (advcl)
challenge ) (punct)
decreased faster (advmod)
mcpp ( (punct)
unit danish (compound)
point , (punct)
with 17 (nummod)
suppress . (punct)
direction axis (nmod)
reversion treatment (nmod)
antagonist kf17837 (nsubj)
processes mediated (amod)
implanted bilaterally (advmod)
latency seizures (nmod)
ah6809 greater (dep)
test rast (conj)
therapy dobutamine (compound)
supports this (nsubj)
enalapril medication (nsubj)
jaundice severe (amod)
fighting produced (acl)
lymphoma hodgkin (compound)
influx states (nmod)
controls cortex (nmod)
continued becoming (advcl)
pretreatment ug.kg-1 (appos)
kb mtor (conj)
kinase u/l (compound)
examination clinical (amod)
evoked punctate (nmod)
spasm in (case)
icp elevated (amod)
7 10 (conj)
compartment than (case)
group antiinfective (amod)
patients indian (amod)
showed likely (conj)
pinacidil micrograms/kg (appos)
had patients (nsubj)
detected reported (advcl)
quantitatively qualitatively (conj)
amount alcohol (nmod)
attenuation such (amod)
run patient (nmod)
patients abusing (acl:relcl)
explanation mismatch (nsubj)
intense prolonged (conj)
reactivation failure (conj)
muscles to (case)
67 14 (conj)
presence despite (case)
appetite symptoms (conj)
anova p (appos)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ azacyclopent-1- (conj)
affected stimulation (nsubjpass)
digitalis- and (cc)
margin subjects (nmod)
had decreased (advcl)
metabolites nox (appos)
reduced increased (parataxis)
greater reduction (nsubj)
demonstrated imaging (nsubj)
conclusion derived (acl)
register disorders (nmod)
cardiovascular both (cc:preconj)
2.7 23.5 (prep)
arrhythmias ventricular (amod)
% crf (appos)
agent background (nsubj)
up-regulation associated (amod)
syndrome disease (conj)
remained contractility (nsubj)
inhibitor acetylcholine-synthesis (amod)
show reductions (nmod)
40.0 +/- (cc)
gold the (det)
referred had (advcl)
cont./min cisapride (conj)
attenuated hippocampal (dobj)
scale mania (compound)
received intubated (parataxis)
restricted , (punct)
gained . (punct)
made differentiate (xcomp)
evaluated ligands (nsubjpass)
area both (cc:preconj)
back-diffusion concentration (conj)
neuropathy short- (nmod)
memory verbal (amod)
descriptions previous (amod)
predisposes and (cc)
ratings clinician (amod)
assessed magnitude (nsubjpass)
stabilized weeks (nmod)
decrease ammonia (nmod)
vasculitis report (dep)
understanding mechanism (dobj)
decrease use (dobj)
hyperthermia malignant (amod)
switch a (det)
action melatonin (nmod)
two cases (nmod)
tolerability safety (conj)
vincristine , (punct)
phenols and (cc)
rt ) (punct)
safety paracetamol (appos)
related therapy (nsubj)
findings study (compound)
revealed compressed (ccomp)
done biopsy (nmod)
elevations risperidone-induced (amod)
remain mechanism (nsubj)
milligrams two (nummod)
meq. 0.03 (nummod)
arrest doses (nmod)
disease receiving (acl)
has patient (nsubj)
deterioration or (cc)
manipulation anesthesia (nmod)
conclude reflects (ccomp)
interfere agents (nsubj)
symptoms urinary (amod)
evidence peripheral (nmod)
involve effects (nsubj)
vena of (case)
started be (auxpass)
aorta arrest (conj)
elevation acute (amod)
gliclazide to (mark)
areas glomerulosclerotic (amod)
ketamine administered (amod)
monitored children (nmod)
injuries liver (compound)
response plate (nmod)
copulation preference (conj)
impairments specific (amod)
assumed stopped (ccomp)
treatment given (acl)
acidification slowed (acl:relcl)
observations reports (conj)
mg indomethacin (nmod)
defect ventricular (amod)
response contractile (compound)
precipitated behavior (dobj)
higher pain (nmod)
inhibition effect (nmod)
mk-212 of (case)
aggravate proteinuria (dobj)
baseline delta (dep)
involve systems (dobj)
safety outcomes (dep)
antibody myeloperoxidase (compound)
phonological ) (punct)
se to (case)
computer a (det)
exhibited extracts (nsubj)
ampicillin and (cc)
considered involved (xcomp)
indicated value (dobj)
examined compared (conj)
monitored mg/l. (dep)
contractility characteristics (conj)
essential it (nsubj)
risks disease (nmod)
monitor patients (nmod)
started she (nsubj)
dose ribavirin (compound)
response < (dep)
contraceptive combined (amod)
introduction probe (compound)
consequence observed (nmod)
tended diminish (xcomp)
seizures grand (amod)
treatment drug (nmod)
taking mg/kg (dobj)
efficacy icrf-187 (nmod)
15 to (quantmod)
2.5 than (quantmod)
chain into (case)
use symptoms (conj)
strains wistar (compound)
improve not (neg)
influenced may (aux)
follows score (conj)
rhythms junctional (amod)
pathways two (nummod)
nmda , (punct)
implant from (case)
effect polydipsia (nmod)
biopsies 7 (nummod)
address question (dobj)
specificity fenfluramines (nmod)
11 1 (conj)
hemoptysis with (case)
microm microm (appos)
% 2 (nummod)
fk . (punct)
atrophy muscle (compound)
proliferated cells (nsubj)
rats dosed (amod)
continue however (advmod)
ie with (case)
cbf in (case)
doses glucocorticoids (nmod)
biopsies skin (compound)
bevacizumab/irinotecan with (case)
appearance phase (nmod)
occurred seconds (nsubj)
intradermoreactions whom (nmod)
99mtc-glucarate . (punct)
generated behaviors (dobj)
remedies and (cc)
stereotyped s (dep)
sensitivity effects (nmod)
rats infarction (nmod)
cavity primary (conj)
studies present (amod)
effect variable (conj)
given acid (nsubjpass)
able not (neg)
tbm only (advmod)
pharmacology of (case)
complications cardiovascular (amod)
cycles hundred (nummod)
had test (dobj)
ethopropazine 12-week (amod)
ameliorates focus (dep)
polydipsia , (punct)
ethanol by (case)
halothane , (punct)
temperature maximal (amod)
familiar some (nmod)
changes pathophysiologic (amod)
group diazepam (compound)
secretion hepatic (amod)
better significantly (advmod)
result comparisons (nmod)
derangement metabolic (amod)
treatment thought (acl)
model puromycin (compound)
diseases cyanotic (amod)
hepatectomy after (case)
representative were (cop)
agent vnb (nsubj)
gentamicin dithiocarbamate (conj)
patterns prior (amod)
remedy chloride (nsubj)
proteinuria massive (amod)
presence to (mark)
had sleeping (conj)
results women (dep)
precipitation drug (compound)
presented suffered (ccomp)
drugs lithium (nmod)
igg c3 (conj)
terminate encephalopathy (dobj)
deposits glomeruli (conj)
had effects (nmod)
administration b (nmod)
necrosis hepatic (amod)
bolus pirarubicin (appos)
= 19 (dep)
malays , (punct)
elevated chronically (advmod)
augmentation an (det)
market the (det)
had injection (nsubj)
halts prevented (advcl)
cardiomyocytes hips-cms (appos)
depend may (aux)
reduced palpitations (conj)
repolarization tdr (appos)
repeated was (auxpass)
basis patients (appos)
models to (case)
origin . (punct)
carbamazepine multivitamin (dep)
a-i of (case)
synthesis based (acl)
ischemic to (mark)
scopolamine-induced amnesia (dobj)
flaccid akinetic (conj)
graded groups (nmod)
improves bradykinesia (dobj)
converse the (det)
neurogenesis the (det)
parietal regions (conj)
elevations successive (amod)
died sepsis (nmod)
2 at (case)
agents placebo (conj)
describe girl (dobj)
caused concentrations (nsubj)
correlated defect (conj)
84 +/- (cc)
normal function (nsubj)
detection hypoxia (nmod)
asenapine the (det)
lidocaine buffered (amod)
useful investigating (advcl)
have form (nmod)
reduced pretreatment (nmod)
preoperatively % (nmod:npmod)
established when (advmod)
days group (appos)
1.5 2 (dep)
hippocampus ) (punct)
results together (advmod)
ligands to (case)
infusion iv (compound)
spectrum events (nmod)
enhanced drugs (nmod)
constriction symptomatic (amod)
documented angiograms (nmod)
preserved and (cc)
bradykinesia of (case)
unknown but (cc)
surviving perfusion-fixed (conj)
terminate fibrillation (dobj)
stress cells (nmod)
gellan ( (punct)
size carriers (nmod)
using pump (dobj)
range days (appos)
therapy 's (case)
was response (nsubj)
analysed and (cc)
daidzein of (case)
accelerated males (nmod)
effects hypoglycaemia (nmod)
finding similar (amod)
occurring patients (nmod)
recurs always (advmod)
therapy cc (compound)
intravenous with (case)
interaction took (acl:relcl)
complained she (nsubj)
therapy argatroban (amod)
patient leftward (nmod)
paraventricular rat (nmod)
function concentration (nmod)
toxic potentially (advmod)
disturbances , (punct)
participants cocaine-dependent (amod)
edema bladder (compound)
exposed regimens (nmod)
thrombocytopenia transaminasemia (conj)
diazepam than (case)
tissue to (case)
limited however (advmod)
stage an (det)
amikacin and (cc)
ca n (appos)
those cd4 (nmod)
needed determine (xcomp)
developed mania (dobj)
touch and (cc)
abuse drug (nmod)
identified factors (nsubjpass)
fas fasl (conj)
regression multiple (amod)
acute more (advmod)
shr six-month-old (amod)
ability cocaine (nmod:poss)
improved quality (dobj)
disease thromboembolism (conj)
increase interaction (dobj)
function expression (conj)
suppresses but (cc)
attacks migraine (compound)
number sum (conj)
naa by (case)
times/week three (nummod)
variety hepatocarcinogens (nmod)
increase timolol-related (amod)
disorder antisocial (amod)
given preferentially (advmod)
consistent blockade (nmod)
prescribed pregnancy (conj)
2.2 10(10)pseudomonas (conj)
finding our (nmod:poss)
case myocarditis (nmod)
failed produce (xcomp)
going dysguesia (nsubj)
subset among (case)
revealed elastolysis (dobj)
39.6 median (amod)
occur patients (nmod)
54 and (cc)
represents generator (dobj)
incidence day (nmod)
decrease peak (nmod)
group sulindac (compound)
28 after (case)
irreversible not (neg)
showed suggestive (conj)
preceded . (punct)
developed stopping (conj)
product protein-bound (amod)
0 9.88 (prep)
paranoia regarding (case)
caused excitation (dobj)
hernia diaphragmatic (amod)
mm 54 (nummod)
resulted increase (nmod)
developed leukoencephalopathy (advmod)
rechallenge ( (punct)
injected rats (nsubjpass)
pb ethanol (conj)
electroencephalogram an (det)
quinine and (cc)
spikes evoked (acl:relcl)
controls 20 (nummod)
have metabolites (nsubj)
potentiation morphine (nmod)
treadmill in (case)
breathing , (punct)
atin with (case)
women climacteric (amod)
wall in (case)
developed reduction (nmod)
strain-dependent mouse (nmod:npmod)
dilation cardiac (amod)
convulsions as (case)
associated perturbations (nmod)
demonstrates conclusion (nsubj)
paradigm a (det)
operations 70 (nummod)
source dysfunction (nmod)
vasculitis primarily (advmod)
found phosphorylation (nsubjpass)
weaker ( (punct)
departure no (det)
unmask increase (conj)
data defects (nmod)
radiotherapy surgery/radiotherapy (amod)
time years (appos)
cta after (case)
effective children (nmod)
sensitivity a (det)
africa in (case)
captopril either (cc:preconj)
action antiparkinsonian (amod)
engraftment patients (nmod)
comparison and (cc)
51 29 (conj)
involves gpi (dobj)
known yet (conj)
mean scr (dobj)
nephron distal (amod)
cancers in (case)
microg/ml 6 (nummod)
antagonists mk-801 (conj)
consistent magnitude (nsubj)
excellent , (punct)
788.5 +/- (cc)
cause isoflurane (nsubj)
iopromide iohexol (conj)
group e-i (compound)
mg/kg etomidate (compound)
application events (conj)
administration hormones (nmod)
depressants and (cc)
genes of (case)
anaesthetists ' (case)
sufficient provoke (xcomp)
sympathectomy endoscopic (amod)
use stimulants (nmod)
decreases thereafter (advmod)
chorea and (cc)
clearance a (det)
confirmed dosing (nmod)
determined biopsy (nmod)
using assays (dobj)
glycosuria a (det)
produced reserpine (nsubj)
micromol/l. at (case)
inhibitor thrombin (compound)
index function (nmod)
april 2005 (nummod)
regimen their (nmod:poss)
reactions one (nummod)
equilibrate progestins (nsubj)
pretreated h (dobj)
best , (punct)
icus three (nummod)
albumin bsa (appos)
106 to (case)
evoke sensation (dobj)
had phase (nmod)
3.0+/-0.4 . (punct)
performance detection (nmod)
compliance hospitals (nmod)
weeks discontinuation (nmod)
alterations concentrations (nmod)
had 4.5 (parataxis)
evaluated also (advmod)
conversion p (dep)
63 42 (conj)
cessation since (case)
response muscimol (nmod)
induction with (case)
rechallenge developed (acl:relcl)
dosage mg/kg/daily (dep)
patients halothane (compound)
protein cytoskeletal (amod)
elevated map (nsubj)
compared 5 (nmod)
metabolism myocardial (amod)
reduction any (det)
reduced abundance (nsubjpass)
refer regimen (nmod)
intake of (case)
chemotherapy conventional (amod)
therapy globulin (compound)
models as (case)
considered parkinsonian-like (advcl)
ozone particulate (conj)
mediated primarily (advmod)
phenylpropanolamine ( (punct)
loss kanamycin-induced (amod)
factor therefore (advmod)
analgesics other (amod)
agonist da1 (compound)
75,761 42,671 (conj)
preference conditioned (amod)
cortisol dysregulated (amod)
decrease and (cc)
infarct and (cc)
recommended strongly (advmod)
doses nmda (nmod)
prevents membranes (nmod)
cholesterol , (punct)
progress in (case)
dynes.s.cm-5 , (punct)
included we (nsubj)
ng/kg/min = (dep)
dosed could (aux)
received however (advmod)
recurs therapy (nmod)
obtained group (nmod)
occurrence natural (amod)
agitated confused (conj)
burns similar (amod)
efficacy oxprenolol (nmod)
component a (det)
administered developed (conj)
patients 13 (nummod)
block by (case)
effects salbutamol (nmod)
users tested (amod)
factors exposure (conj)
bore features (nsubj)
anemia cefotetan-induced (amod)
qs/qt ( (punct)
val204asp/p p. (compound)
vocalizations ultrasonic (amod)
effects sleep (nmod)
vincristine with (case)
living adl (appos)
flumazenil 5 (nummod)
seizure rats (nmod)
undertaken understand (xcomp)
risk events (nmod)
% a (dep)
failure ) (punct)
coincident use (nmod)
jc cook (compound)
development tdp (nmod)
response adrenergic (amod)
findings interaction (nmod)
subsets two (nummod)
agents analgesic (amod)
change appearance (nmod)
5-micrograms/kg the (det)
stress " (punct)
observed atria (nmod)
word any (det)
caused . (punct)
ng/dl. 0.96 (nummod)
cancer neck (compound)
accompanied resolution (nsubjpass)
disturbances rhythm (compound)
high % (nsubj)
users mg (dep)
weight maximum (compound)
renin aldosterone (conj)
mi with (case)
active : (punct)
received whereas (dep)
concentrations toxic (amod)
unknown explanation (conj)
human canine (conj)
hippocampus treated (acl)
di on (case)
needed patients (nmod)
pipette the (det)
1.22 of (case)
patients 78 (nummod)
ganglion root (compound)
considered increase (xcomp)
affected atorva (nsubj)
injection carboplatin (nmod)
epistaxis the (det)
routes intramuscular (amod)
radiculopathy lumbusacral (amod)
populations special (amod)
obtained liver (nmod)
accounting sensitivity (nmod)
9 16 (dep)
non-alcoholic a (det)
h 19 (nummod)
compared mice (nmod)
myoclonic . (punct)
dysfunction moderate (amod)
explore and (cc)
hydrolyze which (nsubj)
lindane ) (punct)
sacrificed show (advcl)
mg/day indomethacin (compound)
therapies the (det)
abnormalities metabolic (amod)
exercise- isoproterenol-induced (conj)
associated administration (nmod)
occurred antibodies (nmod)
myelosuppression was (cop)
factor illness (nsubj)
scopolamine antagonist (appos)
were = (conj)
induction insufficiency (nmod)
used dexmedetomidine (nsubjpass)
cholinesterase atypical (amod)
week doses (dep)
concentrations function (conj)
provoked however (advmod)
alterations cardiac (amod)
impairment an (det)
accompanied failure (nmod)
added amlodipine (nsubjpass)
coincident was (cop)
decrease h (dep)
desire sexual (amod)
model allows (acl:relcl)
quantified population (nsubjpass)
agents citrate (dep)
sought , (punct)
effect conditions (nmod)
chorea whose (nmod:poss)
sensitivity rats (nmod)
alkaloid . (punct)
list to (case)
dce , (punct)
univariate adjusted (conj)
infusion boluses (conj)
revealed degrees (dobj)
establishes exposure (dobj)
consequence excitotoxicity (nsubj)
was screen (xcomp)
crf esrd (conj)
ex-mdma ( (punct)
injected was (auxpass)
ictus of (case)
44 - (punct)
percent males (nmod)
patients rendered (acl:relcl)
hearts from (case)
rash n (dep)
prevented concentrations (nmod)
elevations serum (nmod)
a single (dep)
addition with (case)
carriers are (cop)
qtp li/dvp (conj)
stages methods (conj)
demonstrating is (ccomp)
alteration no (neg)
drinkers of (case)
sensation division (nmod)
a time- (dep)
history strong (amod)
tests serum (compound)
half-time the (det)
site binding (amod)
associated cause (advcl)
stimulation lymphocyte (compound)
abnormalities to (mark)
regulation for (case)
intracellular the (det)
abundance gamma-enac (compound)
-cimetidine - (punct)
ph 4.17 (nummod)
narrowing distal (amod)
change resistance (conj)
thrombocytopenia severe (amod)
recorded was (auxpass)
= 20 (dep)
% setting (nmod)
neurotoxicity grade (compound)
hypotension alone (advmod)
induce man (nmod)
lethality the (det)
costs health-care (amod)
influence interval (nmod)
preference partner (compound)
ranged 3.82 (nmod)
dexamethasone m (compound)
years many (amod)
results provided (case)
receptor h1 (compound)
before shortly (advmod)
non-users . (punct)
marked and (cc)
extend demonstrate (conj)
seeds functions (nmod)
stenoses to (case)
rats au (appos)
therapy a (compound)
rare to (mark)
agents patients (nsubj)
day before (case)
progestogens with (nmod)
proteinuria dysfunction (conj)
july 2007 (nummod)
concentration highest (amod)
one or (cc)
succinylcholine to (case)
study implicated (dep)
mice kinin (compound)
reduction by (case)
lobe medial (amod)
correlates the (det)
induced isoproterenol (nmod)
available where (advmod)
dox after (case)
urticaria/angioedema caused (acl)
approximation with (case)
= 0.0004 (dobj)
assessing risk (dobj)
increased months (nmod)
results presumed (conj)
compared without (prep)
analysis further (amod)
asked state (xcomp)
rats leeds (amod)
0.0073 to (case)
atrophy ) (punct)
patients model (appos)
lady stage (nmod)
fibrinolysis of (case)
hematoma iliopsoas (amod)
effects prostaglandin-independent (amod)
obviate inconvenience (dobj)
probable also (advmod)
systolic ventricular (amod)
assessed study (nmod)
reduction the (det)
mssbp in (case)
depressive node (nmod:npmod)
blockade selective (amod)
benzylpenicillin pg (appos)
antagonist excitatory (amod)
amount with (case)
warfarin after (case)
analysis field (compound)
therapy hyperprolactinemia (nmod)
mca rats (nmod)
pain-related central (amod)
interfere recovery (nmod)
cells pacemaker (compound)
300 550 (conj)
mechanisms cholinergic (amod)
reduce blockade (nsubj)
observed although (mark)
tumors intestinal (amod)
difference elderly (nmod)
observed ed-1 (nsubjpass)
population ) (punct)
thrombolysis cdt (appos)
associated concordance (nmod)
failure esrd (conj)
channel . (punct)
sample liver (compound)
level myocyte (compound)
223 4 (conj)
pathway mediating (acl)
selegiline mg (nummod)
h the (det)
af during (case)
related improvement (nmod)
ed(50 ( (punct)
% 2.5 (nummod)
methylation position (nmod)
practiced be (auxpass)
bradykinin vincristine-induced (amod)
ng/kg/min noradrenaline (conj)
ameliorated dose-dependently (advmod)
occurred aki (nsubj)
blocked stereotypies (nsubjpass)
test either (det)
participates activity (nmod)
sites receptor (nmod)
projection pass (acl:relcl)
ccr2 + (cc)
infused intrarenally (advmod)
catheter arterial (amod)
greater no (neg)
antinociceptive . (punct)
discussed will (aux)
mumol/l mumol/l (conj)
rectified sulphate (nmod)
extrication rapid (amod)
conducted determine (xcomp)
agent given (acl)
indicates have (ccomp)
ve ( (punct)
monitored echocardiography (nmod)
reduced end (nmod)
long preserved (advcl)
uptakes infusions (nsubj)
reverses . (punct)
iris the (det)
abs ( (punct)
injury woman (nmod)
instillation medication (nmod)
change baep (compound)
practical theoretical (conj)
dose cumulated (amod)
criteria 53 (dep)
hydrochloride midazolam (compound)
declined rate (nsubj)
duration potential (amod)
pbto(2 ( (punct)
four designed (acl)
response apoptosis (conj)
4 14 (conj)
expected was (auxpass)
history an (det)
efficacy similar (amod)
recovery , (punct)
significance clinical (compound)
u/ml median (dep)
influence blockers (nmod)
established have (aux)
14 of (advmod)
vomiting hours (nmod:tmod)
cancer received (acl:relcl)
production extracellular (amod)
activity neuronal (amod)
hydrochloride by (case)
severity clinician-assessed (amod)
decreased increases (nsubjpass)
a either (cc:preconj)
rna against (case)
heart nmol/min/g (compound)
epilepticus in (case)
reversed deficits (nsubjpass)
production ) (punct)
% 192 (nummod)
brain from (case)
mg/m(2 dose (nsubj)
sensitisation ' (punct)
specimens 7 (nummod)
cholinergics with (case)
recurrence maha (nmod)
utility be (cop)
analyzed we (nsubj)
therapy treat (acl)
reinitiated was (auxpass)
centre orthopaedic (compound)
safety ketamine (nmod)
using tomography (dobj)
akathisia humans (nmod)
measurement the (det)
starting dosage (nmod)
cells neoplastic (amod)
failure ingestion (nmod)
five-fold to (case)
effects blood (compound)
died lesions (conj)
metoprolol propafenone (appos)
taking prevention (nmod)
men five (nummod)
prevents nimodipine (nsubj)
developed eps (dobj)
obese are (cop)
3.0+/-0.4 was (cop)
radiotherapy glioblastoma (nmod)
phentolamine with (case)
urine lethalities (dep)
affect background (nsubj)
reported alterations (nsubjpass)
accompanied cardioprotection (nsubjpass)
intravitreal safety (nsubj)
gliclazide with (case)
dissolution stone (compound)
mdma and (cc)
contains which (nsubj)
mds = (dep)
pointes , (punct)
measurement by (case)
result solubility (nmod)
% 7.9 (nummod)
levels upper (amod)
constriction vigabatrin-attributed (amod)
reduced release (conj)
peptide bnp (appos)
increased bradycardia (dobj)
symptoms psychopathological (amod)
hypokalemia decrease (conj)
discriminates however (advmod)
glycosuria with (case)
dysfunction conditions (nmod)
9.2 0.2 (conj)
nh4ac contractions (conj)
developed lymphadenopathy (dep)
presented which (nmod)
collected ( (punct)
detrusor the (det)
restlessness or (cc)
radioactivity in (case)
cystica of (case)
elevated anf (nsubj)
blot western (compound)
relationship dysfunction (nmod)
exercise and (cc)
report girl (dobj)
diagnosed could (aux)
epinephrine : (punct)
admitted ccu (nmod)
infection fatal (amod)
levels low (amod)
risks lung (compound)
apart effect (nmod)
identified collection (nmod)
predictors decrease (nmod)
examined patients (nsubjpass)
fell h (nmod)
profile depressive-like (amod)
stage clinical (amod)
units elisa (compound)
market antipyretic (amod)
cause related (conj)
potent 8 (nummod)
syndrome mirtazapine-associated (amod)
infection bronchoconstriction (conj)
rapamycin not (neg)
d-tubocurarine of (case)
obtain phenotype (dobj)
solution noradrenaline (conj)
partition high (amod)
response hypertension (nmod)
set affected (dep)
increased taking (advcl)
doses mg/day (nmod)
merit attention (dobj)
patient parkinson (nmod:poss)
rats drug (nmod)
264 taking (acl)
induced time (nmod)
shed this (nsubj)
minutes between (case)
based . (punct)
evoke aprotinin (nsubj)
study animal (compound)
monitored commencement (nmod)
likely , (punct)
mechanism ionic (amod)
warranted effect (nmod)
events stressful (amod)
activities spinal (amod)
1.17 ) (punct)
becomes if (mark)
propensity cause (acl)
lymphocytes rabbit (compound)
hemoglobin markers (conj)
reached never (neg)
designed increase (xcomp)
treatment prevalent (acl:relcl)
phn ( (punct)
infusion min (compound)
reliable were (cop)
tests renal (amod)
remain high (xcomp)
mg/kg 300 (nummod)
reduced aqp2 (nsubjpass)
rate stone (compound)
pneumonia two (nmod)
associated conclusion (dep)
regulation heart (nmod)
halothane of (case)
injected ip (dobj)
enhanced addition (nmod)
augmented response (dobj)
cancer fnclcc (appos)
active chemotherapy (nsubj)
impairments process-specific (amod)
significance development (nmod)
responses 0.05 (nummod)
more much (advmod)
creatinine 1.46+/-0.79 (nummod)
thickened eyes (nsubj)
efficacy preliminary (amod)
143 13 (compound)
remarkable specimens (nsubj)
had animals (nsubj)
is pressure (attr)
confirm taken (advcl)
reports occasional (amod)
lasting long (advmod)
form dgc (dobj)
s(h)uv value (compound)
lid - (punct)
n=36 ) (punct)
alter that (nsubj)
o-methylation norepinephrine (nmod)
history priapism (nmod)
malondialdehyde , (punct)
reason cited (acl)
induced man (nmod)
occurred children (nmod)
diazepam 5 (nummod)
thickening resolution (conj)
considered remainder (nmod)
72 up (advmod)
lesions grade (compound)
20 between (case)
obtained halving (advcl)
juices of (case)
paradigm of (case)
ineffective altering (advcl)
syndrome ts (appos)
combined drug (nsubjpass)
subject of (case)
colorectal including (case)
treatment tolterodine (compound)
frequencies initiation (nmod)
indicating nature (dobj)
used commonly (advmod)
aims . (punct)
demonstrate . (punct)
ceased considered (parataxis)
describe associations (dobj)
temperature of (case)
able microg (nsubj)
had results (dep)
5th the (det)
transplantation steroids (nmod)
prevented suggesting (xcomp)
role opiate (nmod)
included 13 (nsubj)
mean 196 (nummod)
repair dna (compound)
protects expression (nsubj)
rtm204i rtl180m/rtm204v (conj)
quiescent since (mark)
ensure that (mark)
affected patient (nsubjpass)
tachycardia this (det)
inhibition expression (nmod)
accounts , (punct)
injury (ppa)-induced (amod)
evaluated before (advmod)
tachycardia a (det)
followed 5-fluorouracil (nmod)
fashion a (det)
cytoplasm cell (compound)
had (+)-propranolol (nsubj)
disorder hyperglycinemia (nsubj)
report strains (nmod)
intensity consumption (nmod)
study i (nsubj)
catecholamines reduced (amod)
tremor problems (conj)
injection 1 (nummod)
challenged microinjections (nmod)
relationship known (amod)
report in (case)
evaluating use (dobj)
signs off (nmod:poss)
lady 45-year-old (amod)
edema such (case)
better to (case)
rats examination (nmod)
effects anticataleptic (amod)
related could (aux)
dyspepsia with (case)
possessed potency (dobj)
intake vitamin (compound)
monitoring during (case)
measured samples (nmod)
complications renal (amod)
experience administration (nmod)
-placebo ; (punct)
strengthen . (punct)
involved generation (nmod)
disorder or=2.870 (appos)
reversal l-dopa (nmod)
exacerbated impairment (dobj)
vegfr-2 flk-1/kdr (dep)
dyskinesia peak-dose (amod)
cumulative irreversible (conj)
risk insertion (nmod)
effects which (det)
rats non-tumor-bearing (amod)
dox weight (appos)
0.005 p (dep)
co-treatment factors (nsubj)
injections drugs (nmod)
plasma than (case)
experienced five (nsubj)
willing patients (nsubj)
resulted sequelae (nmod)
performed transplant (nsubjpass)
randomization for (case)
ra alone (advmod)
outcomes cognition (conj)
1.5 ( (punct)
need the (det)
suppressed discontinuing (advcl)
reversal coma (nmod)
syndrome potentially (advmod)
related increase (nsubj)
risk agent (nmod)
aminotransferase ; (punct)
result effect (nmod)
inheritance quantitative (amod)
preparation cholinesterase (nmod)
lines the (det)
reviving specially (advmod)
found complication (xcomp)
identified increase (ccomp)
p<0.0005 ( (punct)
standard- to (mark)
cirrhosis biliary (amod)
effect hour (compound)
agents agents (conj)
l-noarg ) (punct)
effects known (amod)
overexpression by (case)
correlates generally (advmod)
sensitivity seizures (nmod)
appearance increase (conj)
neurogenesis , (punct)
subjects all (det)
indices necrosis (compound)
less timolol (nmod)
nuclei of (case)
basis substance (nmod)
lead index (nsubj)
group latter (amod)
affected mellitus (nmod)
january 2010 (conj)
effects potencies (nmod)
development recent (amod)
map % (amod)
scheduled received (conj)
induced results (dep)
complications adults (nmod)
results alone (advmod)
relaxants muscle (compound)
use midazolam (compound)
agent nephrotoxic (amod)
sampled predict (advcl)
applied twice (advmod)
monitoring patients (nmod)
patients disease (nmod)
segment to (case)
administered one (nmod)
cause ibpb (nsubj)
cells duct (compound)
decline function (nmod)
results different (appos)
reduplication allografts (nmod)
recordings electrical (amod)
minutes injection (dep)
placebo not (neg)
inventory depression (compound)
sufficient may (aux)
surge during (case)
consume . (punct)
ifosfamide plasmacytoma (nmod)
indicator as (case)
exceeding mg.kg(-1 (dobj)
treatment clentiazem (nmod)
patient ouabain (nmod)
patients 592 (nummod)
khz ) (punct)
dependent previously (advmod)
immunity of (case)
averaging ( (punct)
loci all (det)
derives derives (conj)
binding cortex (nmod)
both patients (nmod)
window therapeutic (amod)
have tested (advcl)
mania identification (dep)
becoming . (punct)
thromboembolism associated (acl)
types epilepsy (nmod)
carriers hbv (nmod)
somnolence % (conj)
= 0.047 (dobj)
phase iii (nummod)
improve however (advmod)
phenylephrine ephedrine (conj)
sgk1(-/- ( (punct)
factor limiting (compound)
mglur1 ) (punct)
cortex both (cc:preconj)
enzymes p450 (compound)
metabolism the (det)
reducing of (mark)
showed change (dobj)
appear many (nsubj)
undergoing compliance (nmod)
% 16.6 (nummod)
clearance lithium (compound)
coadministered desipramine (nsubjpass)
diagnosed lacnp (nmod)
compares risk (nmod)
stz ( (punct)
role differential (amod)
monitor ambulatory (amod)
showed mice (nsubj)
potential cardiotoxicity (nmod)
pustulosis for (case)
resulted seizures (nmod)
patients ranging (acl)
18.4 values (nsubj)
increases stimulation (dobj)
glomerulosclerosis content (conj)
recommend finally (advmod)
had ten (nsubj)
given dose (nsubjpass)
tensions fatigability (conj)
% 70/101 (appos)
neurogenesis dependent (amod)
mda of (case)
combination carbamazepine (nmod)
altered administration (nmod)
0.4 2.0 (conj)
conjugation deoxycholic (amod)
mechanism possible (amod)
administration than (case)
pain tachyarrhythmia (conj)
score motor (compound)
inhibition brain (nmod)
involving pathway (dobj)
significant nearly (advmod)
susceptible to (mark)
caused bupivacaine (nmod)
trimetaphan tmp (appos)
received ug (dobj)
doubled increment (nmod)
study case-controlled (amod)
resolution clinical (amod)
91 12 (compound)
0 60 (conj)
t3n0m0 ( (punct)
dtg ) (punct)
patients 3 (nummod)
= lna+hca (dobj)
interaction venlafaxine-tranylcypromine (compound)
shunt interatrial (amod)
all . (punct)
dose-dependently completely (conj)
patients 51 (nummod)
years 8.9 (nummod)
ramh by (case)
produced failure (nsubjpass)
reduction fracture (compound)
initial follow-up (conj)
possesses has (conj)
reported , (punct)
exacerbated ltg (nsubj)
activates contribute (conj)
led ketamine (nsubj)
quality life (nmod)
detectable not (neg)
strain gunn (compound)
fatal necrotizing (advcl)
neurocognitive more (advmod)
doses increasing (amod)
calculated cause (advcl)
dex + (cc)
course to (case)
losses extracellular (nmod)
stopping treated (advcl)
pain cp (compound)
p9605 on (case)
treat hypertension (dobj)
slides performed (acl)
h it (compound)
wky , (punct)
powerful , (punct)
co-treatment , (punct)
memory working (compound)
act . (punct)
slowed down (compound:prt)
concentrations antiarrhythmic (amod)
functioning on (case)
115 to (case)
initiation on (case)
mek1 erk2p (conj)
exposure nicotine (compound)
210 of (advmod)
had majority (nsubj)
min 344 (nummod)
content serotonin (compound)
sensitivity convulsant (compound)
toxicity between (case)
% 14.3 (nummod)
surface a (det)
study explained (acl:relcl)
products ages (appos)
delirium dementia (conj)
demonstrates report (nsubj)
foci any (det)
median 107 (nummod)
drugs qt (compound)
receptor b2 (compound)
bilayers biocontinuous (amod)
12 % (dep)
ozone pm2.5 (conj)
bche proband (nmod)
requires attention (dobj)
professionals of (case)
% 4.4 (nummod)
instrument assessment (compound)
caused methylphenidate (nmod)
reductase glutathione (compound)
prevention partial (amod)
necessity the (det)
preservation better (amod)
enhanced socs-3 (nmod)
facilitates helpful (conj)
mm 31 (nummod)
factor developing (advcl)
effect potentiating (compound)
risks elevated (amod)
called use (nmod)
regimen feeding (compound)
treated simultaneously (advmod)
failure doxorubicin-induced (amod)
h glial (appos)
form of (case)
3alpha-tropanyl-2-(4-chorophenoxy)butyrate ) (punct)
% 7.6 (nummod)
withdrawn alleviated (ccomp)
stability greater (amod)
response medication (nmod)
initiated study (dobj)
antagonist active (amod)
acute reversible (dep)
pseudoacromegaly induced (acl)
decreased incidence (nsubj)
deletion gene (compound)
conducted h (nmod)
inhibition % (compound)
reaction such (predet)
nephrosis in (case)
depleted volume (nmod:npmod)
800 down (advmod)
course a (det)
premedication and (cc)
counts with (case)
= group (dep)
is providing (csubj)
changes morphological (amod)
tachycardia ketamine-induced (amod)
amount same (amod)
hypokalemia ( (punct)
cancer advanced (amod)
% 19.2 (nummod)
covered reviews (dep)
infant an (det)
organization a1 (nmod)
heterozygous alpha3 (compound)
polyneuropathy motor (conj)
mg 20 (nummod)
opportunity unique (amod)
anemia thrombocytopenia (conj)
blocked significantly (advmod)
cells/mm3 , (punct)
reported question (nsubjpass)
women oab (nmod)
disabling myoclonus (dobj)
2.58 % (dep)
measured 10min (nmod)
combination to (case)
85 125 (conj)
development microangiopathy (nmod)
weeks group (nmod)
patients a (nmod)
patients 303 (nummod)
ms p<0.02 (appos)
flushing with (case)
woman glabrata (nmod)
treatment children (nmod)
induced that (nsubjpass)
g 35 (nummod)
0.3 to (quantmod)
methods . (punct)
outcomes cardiovascular (amod)
hyperprolactinemia during (case)
paid must (aux)
cent as (case)
relationship glomerulonephritis (nmod)
1.54 1.65 (dep)
antagonized s.c. (dep)
patients 49 (nummod)
ward psychiatry (compound)
behaviour interaction (conj)
testing immunoassay (compound)
effect toxicity (nmod)
ventilated mechanically (advmod)
supplemented oil (nmod)
29 patients (nmod)
examined theory (dobj)
follow-up assessments (nsubj)
belief the (det)
antagonism tolerance (conj)
seem however (advmod)
iu/l 78 (nummod)
available yet (advmod)
treatment transfusion (conj)
catalyzes which (nsubj)
abnormality activity (nmod)
deposits pigmentary (amod)
c57bl/6 and (cc)
denominator a (det)
proliferation lymphocyte (compound)
exposure prior (amod)
ccb ( (punct)
effect changes (nmod)
second third (conj)
hemianopsia one (conj)
triggering mechanism (nmod)
coeruleus and (cc)
figures as (case)
irrigated , (punct)
blocks in (case)
withdrawal drug (compound)
treatment but (cc)
distinct circulation (nmod)
comparison effects (nmod)
as " (punct)
drop the (det)
cpa/ee of (case)
machinery in (case)
2.0 was (cop)
melatonin 0.5 (nummod)
la mice (nmod)
alleviation pain (nmod)
livers female (nmod)
risk greater (amod)
agents known (acl)
syndromes of (case)
anemia body (compound)
intervals accumulation (conj)
catalepsy . (punct)
methotrexate events (conj)
influenced duration (dobj)
reversed discontinuation (nmod)
min 2 (conj)
decreased content (nsubj)
had went (ccomp)
treatment paralysis (nmod)
treated lamivudine (nmod)
injected periods (nmod)
data ionotropic (dep)
scale-revised measures (acl:relcl)
treated ptra (nmod)
enhancement a (det)
reduction through (case)
encoding factor (dobj)
appearance outward (amod)
overload loss (conj)
results leading (advcl)
prevent or (cc)
size sclerosis (conj)
walls alveolar (amod)
related tract (nmod)
angina coronary (amod)
induce mice (nmod)
characterize dynamics (dobj)
streptozocin icv (dep)
abolished were (auxpass)
induce synthesis (dobj)
using airway (dobj)
increases secretion (nmod)
patient appeared (acl:relcl)
control adjusting (amod)
higher group (conj)
done ensure (advcl)
satisfactory addition (nmod)
mrna drg (nmod)
studied actions (nsubjpass)
calculated weight (nmod)
intensity densitometry (appos)
ablation after (case)
ameliorates and (cc)
depression a (det)
markers disease (compound)
evaluate to (aux)
commenced recurrence (nmod)
anticancer effects (dep)
demonstrating occur (ccomp)
7.0 . (punct)
occurred patient (nmod)
have situations (nsubj)
action antagonists (nmod)
syndrome eps (appos)
suggests experience (nsubj)
effects tamoxifen (nmod)
participating . (punct)
infused rats (nmod)
sod dmtu (conj)
stripe and (cc)
rats on (case)
evaluated had (advcl)
striatum of (case)
type angiotensin (compound)
rats induced (acl)
selective unselective (conj)
infused and (cc)
register danish (compound)
olr ( (punct)
initiated dose (nmod)
crp ( (punct)
had increased (conj)
suggests rate (nmod)
dependence voltage (compound)
adjunct as (case)
scintigraphy by (case)
was difference (attr)
subsides discontinuing (advcl)
presented although (mark)
level striatum (nmod)
suggestion promote (ccomp)
reduces effect (dobj)
unlikely benefit (xcomp)
bdl after (case)
cxad flow (conj)
reduction despite (case)
inconsistent this (nsubj)
melatonin 5 (conj)
search pubmed (compound)
containing level (nmod)
paraventricular nuclei (conj)
(bort)-dexamethasone dex (appos)
dissociated can (aux)
other reflex (nmod)
consume often (advmod)
indicates which (nsubj)
disrupted . (punct)
dyskinesia ballistic (amod)
contribution the (det)
chemiluminescence immunometric (amod)
proteinuria hypertension (conj)
augment injections (nsubj)
drugs all (det)
effects u-ii (nmod)
bands 1 (nummod)
maintain adults (nmod)
system kidney (compound)
manifestation initial (amod)
other iv (dep)
suprofen , (punct)
anemia presenting (nmod)
molecule octapeptide (compound)
pa in (case)
found response (nmod)
stopped begun (conj)
3.8 +/- (cc)
reviewed methods/materials (dep)
exacerbated month (nmod)
included norleucine (dobj)
victim otherwise (acl:relcl)
undergoing investigation (dobj)
indicates work (nsubj)
potentials toxicity (nmod)
group neonates (nmod)
i in (case)
mg 15 (nummod)
schedule an (det)
demonstrate findings (nsubj)
patients apl (compound)
aggravated , (punct)
sensitivity lower (amod)
was observed (conj)
cm h2o (dep)
kg-1 ( (punct)
significantly ) (punct)
diagnosis using (acl)
facilitated morphine (nsubj)
studied man (dobj)
induced moreover (advmod)
necrosis acute (amod)
oxidase of (case)
received study (xcomp)
sufferers 12 (nummod)
patients glioblastoma (nmod)
provide opportunity (dobj)
mg/kg 28 (nummod)
dronedarone mg/kg (appos)
2-acetylaminofluorene % (compound)
induced hypertension (dobj)
used to (mark)
ratio characteristics (nsubj)
beta4 and (cc)
clarify incidence (dobj)
those below (case)
ganglia dorsal (compound)
% water (nmod)
monocytes isolated (acl)
had as (cc)
84+/-3 94+/-4 (compound)
protect steroids (nsubj)
levodopa with (case)
segment segment (nmod)
hyperthermia the (det)
is apparent (acomp)
adolescent depressed (amod)
consequence encountered (amod)
occurrence blocks (nmod)
success without (case)
damage reflected (nmod)
procedure by (case)
pretreated implanting (advcl)
5.0 +/- (cc)
observations to (case)
dysfunction contrast (nmod)
11.2 ( (punct)
findings histopathological (amod)
precluded meta-analysis (dobj)
comparison anaesthesia (nmod)
lowering rate (nmod)
% thickness (nmod)
those cancer (nmod)
memory magnitude (nmod)
= 0.0480 (dobj)
showed fluency (dobj)
reported received (ccomp)
gamma-sarcoglycan , (punct)
kg-1 50 (nummod)
treatment cbz (nmod)
reduces volume (dobj)
ptz with (case)
compared mg (nmod)
group seizures (compound)
release opiate (nmod)
iohexol with (case)
metoclopramide mg (dep)
indicate modified (ccomp)
different micrograms/day (dep)
blockers ca(2 (compound)
carcinomas bladder (nmod)
adjuvant as (case)
repair . (punct)
seen animals (nmod)
specific terminal (dep)
mean adjusted (amod)
disease kidney (compound)
series prospective (amod)
expressions alpha-2 (compound)
fraction shortening (amod)
testing stress (compound)
low similar (conj)
counteraction the (det)
eps ) (punct)
reaction mechanism (nmod)
epithelium bladder (compound)
inhibition through (case)
increasing and (cc)
lesion descending (advcl)
agents from (case)
monotherapies all (appos)
disintegrin a (det)
rates response (nmod)
used and (cc)
therapies 5-fluorouracil (nsubj)
women therapy (nmod)
hepatotoxicity on (case)
one group (nmod)
treatment inhibitor (compound)
flatulence and (cc)
desferrioxamine by (case)
point that (det)
after months (nmod:npmod)
ambulate to (mark)
test apparatus (conj)
number cells (nmod)
thrombocytopenia profound (amod)
ranged content (nsubj)
have fla-63 (nsubj)
initiated infusion (nsubjpass)
getting while (mark)
associated failure (nmod)
therapeutic with (case)
period became (acl:relcl)
increase days (nmod)
mediated decrease (nmod)
consolidation p9201 (appos)
loads tumor (compound)
aged 76 (dobj)
analysis cell (compound)
mg/m(2 mc (compound)
related imipramine (advcl)
fsgs ) (punct)
dependence of (case)
other to (case)
11 12 (conj)
disability permanent (amod)
case dyskinesia (nmod)
documented but (cc)
children to (case)
planned as (mark)
observed reaction (nsubjpass)
mediated incontinence (nsubjpass)
22 cycle (nmod)
use elderly (nmod)
1.036 ( (punct)
predict differences (nsubj)
tachycardia inducible (amod)
range ) (punct)
rigidity removal (nmod)
cr % (appos)
precipitated cyclosporine (nmod)
617 vs. (cc)
medication associated (acl)
enhanced observed (parataxis)
support transplantation (nmod)
those reported (acl)
leukoencephalopathy mimicking (acl)
protocols combined (acl:relcl)
powders of (case)
immediate temporary (conj)
succinylcholine after (case)
factors age (nsubj)
administration dexmedetomidine (nmod)
cardiotoxic be (cop)
stratification patients (nmod)
stress exercise (compound)
diarrhoea , (punct)
lining nephron (dobj)
need diagnosis (nmod)
inserted were (auxpass)
associated is (auxpass)
caused erdosteine (nsubj)
hyperprolactinemia neurons (nmod)
case nicergoline (nmod)
have . (punct)
face , (punct)
agents antithyroid (amod)
incidence p (dep)
resuscitated dose (nmod)
45 - (punct)
treatment while (case)
generation action (compound)
use intramuscular (amod)
produced ip (nmod)
promote and/or (cc)
risk increased (amod)
region adjacent (amod)
function neurons (conj)
base at (case)
recalled words (nsubjpass)
using equation (dobj)
died hours (dobj)
p<0.021 ) (punct)
isoproterenol alone (advmod)
suggest contributes (ccomp)
mice tie2-cre;loxp-egfp (compound)
equal outcomes (nsubj)
signs contralateral (amod)
localization cc (compound)
post-lt years (nmod:npmod)
switching carbonate (nmod)
observed while (mark)
genotype with (case)
u/liter ( (punct)
complete effacement (nsubj)
polydipsia from (case)
infusion sufficient (nmod)
derivatives alone (advmod)
diagnosis granulomatosis (nmod)
1r [ (punct)
larger mm (dep)
ineffective injection (nsubj)
complaint this (det)
choice being (cop)
repression the (det)
week i.p. (advmod)
15mg/kg , (punct)
has advantage (dobj)
injections 6-hydroxydopamine (nmod)
many patients (nmod)
analyzed studies (nmod)
marker activity (nmod)
describe investigate (conj)
(pge1)-induced hypotension (dobj)
present cytoplasm (nmod)
patients nigerian (amod)
frequency pretreatment (conj)
cells spared (amod)
toxicity marrow (compound)
reversible partially (advmod)
interaction fzp (nmod)
activation channels (nmod)
rate reduced (amod)
clinical pharmacological (conj)
statins , (punct)
dextromethorphan antagonist (compound)
containing and (cc)
is definition (attr)
capable predicting (advcl)
0 1000 (conj)
enlarged while (mark)
greater mice (nmod)
experienced infusion (nmod)
avoided consequently (advmod)
hypercalcemia prolonged (amod)
fasting glucose (dobj)
kindreds three (nummod)
cerebral anterior (amod)
occurred symptoms (nsubj)
risk delirium (nmod)
beta-blocker selective (amod)
hypertension rebound (compound)
neurological cardiovascular (conj)
diuretics high-dose (amod)
went remission (nmod)
action toxic (amod)
given mice (nsubjpass)
induce hypokalemia (dobj)
dehydration infection (conj)
dullness percussion (nmod)
alterations measurements (nmod)
study radiocontrast (compound)
taken all (nsubj)
electrocardiogram regarding (case)
effects are (cop)
treated ara-c (nmod)
content glutathione (compound)
echocardiography examinations (conj)
markers activity (compound)
strokes fewer (amod)
reviewed seen (advcl)
attenuated pretreatment (nsubj)
received intraperitoneally (advmod)
study crossover (nsubj)
(hctz)-monotherapy hydrochlorothiazide (amod)
dysrhythmias resolved (acl)
agent injurious (amod)
rated physician (conj)
peroxidase glutathione (compound)
toxicities associated (acl)
whole the (det)
galactosamine containing (compound)
irradiation left-sided (amod)
entry tube (nmod)
ballistic or (cc)
therapeutic either (cc:preconj)
lad and (cc)
discontinuance after (case)
tnf-a and (cc)
intoxication water (compound)
showed fall (conj)
apply neuroleptics (nmod)
group high-dose (amod)
onset convulsions (nmod)
analogue . (punct)
model cardiomyopathy (nmod)
accumulation toxicity (conj)
= 135 (dep)
5-hiaa ( (punct)
crea 35 (nummod)
findings normal (amod)
decreased were (auxpass)
reports dysfunction (nmod)
findings electrocardiographic (amod)
ecg alone (advmod)
combination quinpirole (nmod)
speculate we (nsubj)
ameliorated markedly (advmod)
celecoxib and (cc)
amyloidosis al (compound)
data event (compound)
interval electrocardiogram.3 (nmod)
ratios to (case)
enhanced depletion (nmod)
increase evaluation (conj)
morphine of (case)
demarcated well (advmod)
cells t (compound)
woman received (acl:relcl)
contribution propagation (nmod)
women postmenopausal (amod)
sevoflurane % (compound)
studies several (amod)
understood mechanism(s (nsubjpass)
capture dxnp (nmod)
stz of (case)
33 to (case)
anxiety subject-rated (amod)
bilirubin 8.25 (nummod)
enhances which (nsubj)
indicate correlate (dobj)
case reported (acl:relcl)
two-kidney with (case)
component sensory (amod)
range body (appos)
process stress (conj)
patients association (nmod)
levels mmp-2 (compound)
inactive gaba(a)rs (nmod)
bia ) (punct)
prove will (aux)
increased up (compound:prt)
days awakening (nmod)
infrequent and (cc)
level creatinine (compound)
studied response (dobj)
death epinephrine-induced (amod)
size heart (compound)
administration quinine (nmod)
disruption barrier (nmod)
avoid outcomes (dobj)
nephrotoxicant potent (amod)
associated cholinesterase (nmod)
occurred none (conj)
patients use (appos)
layer cell (compound)
required recorded (conj)
administered . (punct)
received adr (dobj)
associated hepatitis (nmod)
ps saline (conj)
endografine polyvidone (conj)
sinus venous (amod)
2001 april (conj)
convulsions . (punct)
aniracetam the (det)
effects pg-9 (nmod)
damage medullary (amod)
control sex-matched (amod)
hr 8 (nummod)
laboratory catheterization (compound)
use short-term (amod)
inhibition hyperthermia (nmod)
atpase serca2 (appos)
failure fulminant (amod)
reduction sdrr (nmod)
therapy no (neg)
encouraged , (punct)
therapy is (cop)
number cataracts (nmod)
fear and (cc)
level in (case)
basis rats (nmod)
pvn and (cc)
assessment comparative (amod)
extracts plant (compound)
mg kg(-1 (conj)
prodrug ester (nsubj)
dp/dtejc in (case)
mg 8 (compound)
pilocarpine epilepticus (nmod)
ear the (det)
authorized , (punct)
hemorrhaging detachment (conj)
sulphate by (case)
abuse reporting (compound)
am149 with (case)
offer advantages (dobj)
activity tissue (nmod)
demonstrate affects (ccomp)
ms ) (punct)
born antigen (nmod)
mg/m2 100 (nummod)
response of (case)
e vitamin (compound)
prolonged duration (nsubjpass)
arm the (det)
mice toxicity (dobj)
cta following (case)
persisted cessation (nmod)
hp ) (punct)
has disfiguring (conj)
damage sbs (compound)
application before (case)
worsening : (punct)
microg.kg(-1 from (case)
use ifx (nmod)
fluency speed (conj)
alpha-t either (cc:preconj)
factor was (cop)
repaired days (nmod)
resumed therapy (nsubjpass)
lf bovine (amod)
women specified (acl:relcl)
slowing waves (nmod)
is conclusion (nmod)
courses for (case)
diltiazem aspirin (conj)
hcbd ) (punct)
implicated implant (nsubj)
criteria these (det)
reduce elevation (dobj)
effectiveness the (det)
models human (amod)
antagonists putative (amod)
deficit injection (nmod)
duration contraction (compound)
obtained shortly (advmod)
level walls (nmod)
women to (case)
risperidone-associated , (punct)
volume urine (compound)
related event (nsubj)
glucose and (cc)
hyperalgesia universal (amod)
constituted and (cc)
% [ (punct)
incidence its (nmod:poss)
forepaw inhibit (conj)
mm subject (appos)
occurred myositis (nsubj)
atin ) (punct)
epinephrine alone (advmod)
characterized encephalopathy (nmod)
area mean (amod)
seem it (nsubj)
= 0.018 (dobj)
cip ) (punct)
measured creatinine (nsubjpass)
resolve does (aux)
obtained makes (conj)
itching receiving (advcl)
nerve radial (amod)
limited although (mark)
dose fda-recommended (amod)
hours by (case)
indicated decreased (conj)
plan receptor (nsubj)
score score (nmod)
potentiate not (neg)
formation bonding (nmod)
stimulated cause (conj)
determining at (mark)
reactions neurotoxic (amod)
p=0.025 ) (punct)
counteract may (aux)
complication ; (punct)
reducing antioxidants (nsubj)
runs one (nummod)
infrequent nephrotoxicity (nsubj)
fluorouracil cancer (nmod)
received % (dep)
evaluating effects (dobj)
necrosis hepatocellular (amod)
strains 15 (nummod)
has utilization (nsubj)
related incorporation (nmod)
% 57.1 (nummod)
unrelieved morphine (nmod)
examined staining (nsubjpass)
relationship time (nmod)
man weeks (dep)
inhibition rats (nmod)
haematuria asymptomatic (amod)
precipitate to (mark)
adenosine a1 (dep)
causes degeneration (dobj)
completed participants (nsubj)
forestomach liver (conj)
changes based (case)
% 54.7 (nummod)
receiving bsa (dobj)
response virological (amod)
sensitivity isoproterenol (acl)
events severe (amod)
pain region (nmod)
complications in (case)
neurotoxicity mtx (compound)
antagonism receptor (compound)
na(+)/k(+)-atpase oat (conj)
resulted treatment (nsubj)
administration effective (amod)
scale bars (appos)
diagnosed allergic (advcl)
curve cgrp (compound)
patches , (punct)
occurs whenever (advmod)
0.83 ) (punct)
transplantation liver (compound)
effects stereotypy (nmod)
progressed , (punct)
quantified so (dep)
added be (auxpass)
plans echocardiography (nmod)
morbidity events (conj)
mg/l. 12 (nummod)
coxii coxiii (conj)
adrenoceptor alpha(2 (compound)
cardiotoxicity anthracycline (compound)
negative to (mark)
younger and (cc)
moderate or (cc)
pathology case (nmod)
understanding predictability (conj)
microperfusion before (case)
renal hepatic (conj)
improve , (punct)
response infusion (nmod)
micrograms/kg/min 30 (nummod)
implicated therapy (nsubjpass)
oxygenation s(c)o(2 (appos)
included index (dobj)
vaccination b (compound)
esterification maltol (nmod)
examined be (auxpass)
tolerated effects (nmod)
administration every (det)
excitability patients (nmod)
protected hr (nmod)
remained surface (nmod)
effects methamphetamine (compound)
consider must (aux)
refractory pd (compound)
revealed histology (nsubj)
intensity period (conj)
distinguished basis (nmod)
revealed upregulated (ccomp)
fumarate examination (appos)
= 3164 (dep)
received micrograms/kg/hr (dobj)
g/dl x (dep)
degree patient (compound)
e.g. ) (punct)
serum fluid (conj)
h 40 (nummod)
areas hyperalgesia (nmod)
manageable . (punct)
majority administration (nmod)
greater were (cop)
report anemia (nmod)
disturbances prolonged (amod)
changes behavioural (amod)
bzds/rds ) (punct)
mg intravenously (advmod)
doses or (cc)
use combined (acl)
extraction molars (nmod)
tachycardia due (case)
increases % (dep)
developed effect (dobj)
accepted pathogenesis (nmod)
twenty four (quantmod)
2004 - (punct)
increase cells (nmod)
alpha-blocker an (det)
proportion as (case)
2 1 (compound)
examined periodically (advmod)
sphincter with (case)
collected physicians (nmod)
hypothesized mirror (ccomp)
loci contribute (acl:relcl)
inadequate are (cop)
docetaxel of (case)
studying effects (dobj)
prevent reduce (conj)
regimens 2 (nummod)
difference duration (conj)
included patients (nmod)
microscopic and (cc)
associated pathways (nmod)
develop effects (dobj)
h after (case)
characterized but (cc)
increment potassium (compound)
captopril vehicle (conj)
% metabolites (nmod)
treated mg/kg/day (advmod)
iqr ) (punct)
= 3.2 (dep)
metal bare (amod)
suggest function (dobj)
investigated presently (advmod)
different biochemical (dep)
moving conscious (amod)
death report (compound)
due sirolimus (nmod)
vasculitis analysis (appos)
toxicity rejection (conj)
caused bacteria (nmod)
evaluation of (case)
changed stabilized (conj)
investigated measuring (advcl)
catheterization either (cc:preconj)
behavioral both (cc:preconj)
decreased all (nsubj)
hemopoiesis an (det)
impairment severe (amod)
obtained recordings (nsubjpass)
consider clinician (nsubj)
agriculture in (case)
differ parameters (nmod)
day + (cc)
tetrachloride carbon (compound)
nefiracetam and (cc)
confirmed level (dep)
predict deficits (dobj)
risk due (case)
repeated ) (punct)
upregulated downregulated (conj)
iugr ) (punct)
enzyme liver (compound)
remarkable disappearance (nmod)
available analysis (nmod)
associated costs (nmod)
specified embolus (conj)
early incidence (conj)
abdominal pelvic (conj)
aor 5.9 (dep)
chick rhythm (conj)
harmless not (neg)
divided group (nmod)
injections of (case)
2 5 (conj)
carteolol , (punct)
22,875 , (punct)
have capacity (dobj)
presented overall (advmod)
occurred had (conj)
genotype bche (compound)
medicines agency (conj)
concentrations ) (punct)
feature presenting (amod)
myopathies in (case)
assays by (case)
regurgitation valvular (amod)
patients cells/mm3 (conj)
hypertension death (conj)
criteria class (nmod)
difficult . (punct)
days exposure (nmod)
scale four (nummod)
factors drug (nsubj)
annulus posterior (amod)
days ten (nummod)
deteriorated group (nmod)
report qtls (dobj)
2pam ) (punct)
induce suggests (conj)
administration cocaine (compound)
fever , (punct)
similar c (dep)
mechanisms action (compound)
mmol/l from (case)
activity acid- (conj)
insertion of (case)
studied sleeping (advcl)
guanethidine of (case)
embryo on (case)
stages disease (nmod)
exceed did (aux)
statement reference (nmod)
complications to (case)
dexmedetomidine propofol (conj)
had before (mark)
infants and (cc)
episode once (case)
absence carcinogen (nmod)
twice approximately (advmod)
current therapeutic (conj)
widening changes (conj)
5-htp benzodiazepines (conj)
affect children (dobj)
aminotransferase alt (appos)
reversed reticulocytes (conj)
reason relief (nsubj)
scored dosing (nmod)
tolerated in (prep)
continuous , (punct)
toxic more (advmod)
investigated terfenadine (dep)
challenge mice (conj)
layer inner (amod)
hypertension dex-induced (amod)
rats weight (nmod)
drugs anti-thyroid (amod)
developed stunning (dobj)
lasted occasion (nmod)
seizure frequency (dobj)
injury mitochondrial (amod)
nm 11 (nummod)
timps ) (punct)
mg/kg i.v. (amod)
pathogenesis its (nmod:poss)
compounds . (punct)
known increase (xcomp)
craniotomy before (case)
phenomena neurobiological (amod)
mapped was (auxpass)
signs encountered (amod)
increased overflow (dobj)
suspected anemia (nsubjpass)
appearance and (cc)
association status (nmod)
determine benefits (dobj)
vol% mean (compound)
pneumonitis being (cop)
lines therapy (nmod)
technique practical (amod)
demonstrated enzymes (nmod)
identify factors (dobj)
present year (dep)
measured assay (nmod)
ccr2 its (nmod:poss)
accuracy compared (acl)
markers two (nummod)
sphincter dyskinesia (nmod)
dm underlying (amod)
decrease heart (nmod)
doxorubicin prior (amod)
patients 16 (nummod)
development seizure (amod)
transformation positive (amod)
registered was (auxpass)
coma paracetamol-associated (amod)
demonstrated would (aux)
decreasing damage (dobj)
6.2 10.6 (conj)
appear may (aux)
pointer laser (compound)
encephalopathy valproate-induced (amod)
bradycardia reflex (amod)
management patient (nmod:poss)
thought bore (ccomp)
complication given (case)
old were (cop)
perspective a (det)
published group (nmod)
started arthralgia (nmod)
use child (nmod)
mg/m(2 5-fu (compound)
bn , (punct)
cystitis cyclophosphamide (compound)
inhibition dogs (nmod)
consumed prior (advmod)
autism aggression (conj)
ngf p75(ntr (appos)
showed regimen (nsubj)
mild ; (punct)
group 200 (nummod)
taking l-dopa (dobj)
suggest mediators (ccomp)
infused was (cop)
patients 21/27 (compound)
showed determined (advcl)
observed stage (nmod)
desmopressin ddavp (appos)
produce that (mark)
% 77 (nummod)
occlusion by (case)
grade greater (amod)
etomidate mg.kg-1 (amod)
acids triacylglycerol (conj)
woman cancer (nmod)
activity serum (compound)
start the (det)
5-fluorouracil acid (conj)
1mg/kg ( (punct)
cisplatin those (conj)
1,3-butadiene , (punct)
characterized contractility (nmod)
showed five (nsubj)
female adult (amod)
esrd area (nmod)
is reflecting (xcomp)
likely raised (xcomp)
aetiology an (det)
agent cardioprotective (amod)
overloading mesangial (amod)
lid upper (amod)
emphasizes report (nsubj)
cross-clamp and (cc)
remained has (aux)
mri ( (punct)
sensations mastitis (conj)
incidence cardiotoxicity (nmod)
magnitude a (det)
supply an (det)
protection cs-mediated (amod)
greater hours (nmod:tmod)
diagnosis loss (nmod)
increase lesion-induced (amod)
effect antihypertensive (amod)
fall psa (nmod)
merely not (neg)
induce and (cc)
antitussives over-the-counter (compound)
had thirty-seven (nsubj)
effects heparin (nmod)
3/5 ( (punct)
glycoprotein iron-binding (amod)
prevalence history (nmod)
decreases that (mark)
proceed to (mark)
change but (cc)
% 52 (nummod)
pallidotomies the (det)
decreased tap (dobj)
effect treatment (compound)
focus assessment (nsubj)
found changes (dobj)
interleukin and (cc)
received lozenge (dobj)
negativity pc/bcp (appos)
results produce (appos)
doses viia (nmod)
receptors n-methyl-d-aspartate (compound)
associated presentation (nmod)
classified e13.5 (nmod)
stress without (case)
/= > (nsubj)
mean+/-se ) (punct)
boy received (acl:relcl)
factors or (cc)
depletion mtdna (nmod)
design backcross (compound)
deficiency of (case)
test a (det)
a salvianolic (amod)
mechanisms buildup (nmod)
sensation touch (nmod)
dosage adequate (amod)
citalopram of (case)
inhibited development (dobj)
withdrawal ptu (nmod)
associated hypereosinophilia (nmod)
man 47-year-old (amod)
stain and (cc)
metabolites by (case)
range age-adjusted (amod)
method that (mark)
% 0.01 (dep)
effects caused (acl)
incidence abnormalities (nmod)
perfusion tracers (nmod)
neuritis brachial (amod)
mg/kg 18.4 (nummod)
control rhythm (compound)
19 defects (nmod)
bodies ketone (compound)
metastases unresectable (amod)
movement hyperkinetic (amod)
% 55%-60 (nummod)
vte , (punct)
syndrome as (case)
b prevention (conj)
in especially (advmod)
sarcomas and (cc)
ecgs lead (amod)
risk be (cop)
surviving animals (nsubj)
activation of (case)
lc of (case)
2000 october (conj)
akinesia for (case)
assessed field (nmod)
elevations serum (compound)
hotplate water (conj)
aspects control (appos)
> 3 (nummod)
ng/ml er (nmod)
induces administration (nsubj)
modes to (case)
entities failure (nmod)
rationale , (punct)
safety patients (nmod)
% interval (nmod)
tachycardia or (cc)
vaccination areas (nmod)
demonstrated however (advmod)
revised third (compound)
monotherapy placebo (conj)
incriminated the (det)
define will (aux)
hyoscine ( (punct)
hepatomas process (compound)
leukoencephalopathy presentation (nmod)
hr after (case)
evinced enhancement (dobj)
k serum (compound)
gain reader (compound)
2 to (case)
carries report (nsubj)
virus c (compound)
order magnitude (nmod)
open-label dose-escalating (dep)
studied pressure (nmod)
metabolite important (amod)
exposed mipafox (nmod)
evaluated cause (dep)
concentration causing (acl)
contained number (dobj)
pa palpable (amod)
extrapyramidal symptom (dep)
doses convulsant (compound)
idolamines catatonia (nmod)
prazosin map (dep)
extended coagulopathy (advmod)
signaling d1/d2 (compound)
findings electrodiagnostic (amod)
saline n=6 (appos)
reflect incidence (nsubj)
inappropriate was (cop)
epileptogenecity underlying (amod)
hip of (case)
investigation finally (advmod)
species certain (amod)
after cyclophosphamide (conj)
rejection in (case)
patients crohn (nmod:poss)
oil 12.5 (dep)
effect nephrotoxic (amod)
recovery rebound (conj)
counteract headache (dobj)
started dexamethasone (nsubjpass)
partial only (advmod)
optic is (cop)
dogs tumor-bearing (amod)
case vasculitis (nmod)
ect after (case)
observed creatinine (nsubjpass)
inhibitor garft (compound)
symptoms neurological (amod)
suggest ameliorate (ccomp)
woman developed (acl:relcl)
treatment serial (amod)
increased enhances (advcl)
conclusions exhorted (dep)
combined outcome (nsubjpass)
factor vegf/vpf (appos)
highlights possibility (dobj)
incidence fasciculations (nmod)
proliferation astrocytes (nmod)
weeks application (nmod)
demonstrate toxicity (dobj)
nitroglycerin , (punct)
established therefore (advmod)
diagnosed subjects (nsubj)
plasmapheresis with (case)
model kidney (compound)
effectiveness prevent (acl)
finding , (punct)
hypothyroidism a (det)
protected noticeably (advmod)
tasks passive (amod)
seen change (nsubjpass)
determine maintained (ccomp)
inputs , (punct)
etiology nodosum (nmod)
improves children (nmod)
aimed investigating (advcl)
sedation confusion (conj)
erythromycin and (cc)
12.0 6.5 (compound)
iu/l , (punct)
elevated though (mark)
dystonia levodopa-induced (amod)
advantage clinical (amod)
stimulation similar (amod)
prescribing levofloxacin (dobj)
h-1 ( (punct)
restrictive be (cop)
facilitation morphine (nmod)
inhibited causes (nmod)
phenobarbital , (punct)
metabolites three (nummod)
addition without (conj)
children 32 (nummod)
gellan ) (punct)
pores transition (compound)
designed . (punct)
strategy retard (acl)
inhibition damage (conj)
treated reserpine (nmod)
1.11 , (punct)
support strong (amod)
cases vte (nmod)
produced administered (advcl)
number lt (nmod)
improve claudication (dobj)
suggest administered (advcl)
diminished transiently (advmod)
centers medical (amod)
discussion initiated (appos)
reported area (dobj)
sacrificed which (nsubjpass)
elevations mucositis (conj)
other , (punct)
designed purpose (dep)
drug known (amod)
unchanged content (nsubj)
downregulation increase (conj)
performed function (nmod)
hippocampus se (nmod)
degrees 38.40 (nummod)
cip past (case)
backgrounds clinical (amod)
switching binder (nmod)
study dothiepin (appos)
contain not (neg)
treated they (nsubjpass)
mi previous (amod)
recommend . (punct)
= 18 (dep)
manage total (nmod)
laboratories experiment (compound)
discontinuation exchange (nmod)
reducing loss (dobj)
loss administration (nmod)
m-chlorophenylpiperazine mcpp (dep)
systems non-dopaminergic (amod)
c chronic (amod)
area hyperalgesia (nmod)
developed weeks (nmod)
decades last (amod)
link treatment (nmod)
levels h (nmod)
augment doc (dobj)
obtained bile (nsubjpass)
remission apl (nmod)
tested hypothesis (nsubjpass)
kg = (parataxis)
produce latter (nmod)
administered weight (dobj)
treatment = (dep)
thick of (case)
change output (dobj)
background levels (conj)
risk infarction (nmod)
hypokalemia ) (punct)
investigated antagonizing (advcl)
mechanisms possibilities (conj)
once days (nmod)
measure tone (nmod)
vasculature patterns (appos)
disorder personality (compound)
dosed combination (nsubjpass)
hyperactivity to (case)
groups subjects (nmod)
margin low (amod)
required prevalence (nsubjpass)
arthritis sero-negative (amod)
reduced intake (nsubjpass)
group blood (compound)
pathways ( (punct)
related or (advmod)
effects specific (amod)
selective and (cc)
peripheral neuropathy (dep)
expression anxiety (nmod)
frequency seizures (nmod)
vasculitis lv (appos)
infusion , (punct)
considered effects (nmod)
used models (nsubjpass)
occurs thrombosis (nsubj)
control pair-fed (conj)
ikr whereas (dep)
gentamicin mg/kg (conj)
pulses ; (punct)
indistinguishable symptoms (nsubj)
atypicality course (nmod)
= p (dobj)
3tc were (cop)
diagnostic quick (amod)
days progestagen (nmod)
> mg (nummod)
busulfan 600-mg/m2 (compound)
ratio insertion (nmod)
nodule a (det)
onset- and (cc)
t+a ) (punct)
trait with (case)
assessed maze (nmod)
stimulation area (nmod)
relation cause-and-effect (amod)
mean bradycardia (conj)
value mk-212 (nmod)
limitations any (det)
perforation and (cc)
rates infusion (compound)
limbs or (cc)
storage lipid (compound)
induction metabolites (nmod)
abuse alcohol (compound)
tdf of (case)
fluoropyrimidines 5-fluorouracil (nmod)
reported chemotherapy (nsubjpass)
myocarditis associated (acl)
hr 30 (nummod)
ischemia exercise-induced (amod)
rats have (acl:relcl)
0.9 versus (cc)
ninety-nine intramuscularly (conj)
dna carriers (nmod)
develop loss (dobj)
increased . (punct)
produced tremors (conj)
effects wall (nmod)
glycol of (case)
found differentiation (nsubjpass)
change glutamate (dobj)
coagulation , (punct)
marker degeneration (nsubj)
experience extensive (amod)
injection dph (compound)
discontinuations with (case)
as of (mwe)
10ug i.c.v (appos)
become and (cc)
age growth (conj)
report present (amod)
study entire (amod)
gains acting (advcl)
disposition apap (nmod)
support tool (nmod)
fpdc shortened (amod)
patch tests (dobj)
enalapril was (cop)
offers injury (nmod)
severe fatal (dep)
action cocaine (compound)
exert gfc (nsubj)
has viramidine (nsubj)
blind this (det)
another , (punct)
studied reported (conj)
groups erdosteine (compound)
test = (amod)
products of (case)
blocked sch (nmod)
> vgpr (dep)
development in (case)
observed also (advmod)
occurred tac (nmod)
possibility on (case)
detected amounts (nsubjpass)
13 pairs (nmod)
common twice (advmod)
myopathy pravastatin-associated (amod)
has argatroban (nsubj)
study consequences (dobj)
levels protein (conj)
measure decrease (nmod)
released synapses (nmod)
hypokalemia bendrofluazide-induced (amod)
reactivation antigen (nmod)
instituted edema (nmod)
inhibited selectively (advmod)
observations catalyze (ccomp)
neurons immunoreactive (amod)
mg/m(2 nelarabine (amod)
high inappropriately (advmod)
surface water (compound)
mmol was (cop)
neutropenia requiring (acl)
igg and (cc)
mm 220 (nummod)
165/90 and (cc)
explained that (mark)
actions cardiovascular (amod)
level-dependent with (case)
resulted reduction (nsubj)
induced slowdown (dobj)
rated was (auxpass)
prostacyclin in (case)
pattern similar (amod)
complex more (advmod)
reported rate (dobj)
hexachloro-1:3-butadiene hcbd (appos)
effect test (nmod)
600 , (punct)
substances many (amod)
attributed 1 (dep)
run waves (nmod)
measures treatment (compound)
dogs cats (conj)
dowregulation expression (nmod)
data coronary (amod)
albumin serving (acl)
influence for (case)
terbutaline of (case)
occurred alopecia (nsubj)
occasions two (nummod)
tissue kidney (compound)
serum biomarkers (conj)
occurred complications (nsubj)
prevented treatment (nsubj)
compared 2.58 (nmod)
step time (nmod)
had peptide (nsubj)
inhibitors timps (appos)
bmd ) (punct)
syncope prolongation (compound)
hormones . (punct)
effect major (amod)
task procedure (conj)
cell myocardial (amod)
levels mda (compound)
found controlling (advcl)
hypoplasia with (compound)
disorder tissues (nmod)
decrease stress (nmod)
height and (cc)
criteria , (punct)
similar variations (nsubj)
results antagonized (conj)
influence pathophysiologic (amod)
tremor or (cc)
found literature (nmod)
patient is (cop)
presented then (advmod)
metrics use (nmod)
angiogenesis pituitary (nmod)
years 2.5 (nummod)
men be (cop)
absence pkc-alpha (nmod)
day two (nummod)
age over (case)
rate fracture (compound)
plasma or (cc)
decrease fasciculation (dobj)
infection mother-to-infant (amod)
significant and (cc)
records logs (conj)
anaesthetised given (conj)
population hilar (amod)
clearance mesangial (amod)
treatment successful (amod)
intakes quintiles (nmod)
incorporation of (case)
instillations tur (nmod)
outpatients 243 (nummod)
1995 november (conj)
plays initiation (nmod)
acetaminophen apap (appos)
dronedarone ( (punct)
eradication of (case)
factor stress (nsubj)
occurs needed (advcl)
secretion triglyceride (nmod)
found cocaine (nsubjpass)
samples measurement (nmod)
dose sertraline (compound)
cancers combined (amod)
rate mean (amod)
overflow kidney (nmod)
99 mean (dep)
atresia choanal (amod)
produces reserpine (nsubj)
abuse their (nmod:poss)
effects failure (nmod)
nucleus , (punct)
duration administration (nmod)
effects nephrotoxic (amod)
had age (dobj)
effects moderate (amod)
effects antiangiogenic (amod)
ce tolerated (amod)
responses systemic (amod)
characterized ratio (nmod)
drinks of (case)
myelin of (case)
epicardium from (case)
1983 or (cc)
abnormalities pupil (nmod)
silent clinically (advmod)
vs 135 (compound)
greater , (punct)
associated increased (conj)
8.4 3.8 (conj)
facilitation retrieval (nmod)
denopamine micrograms (appos)
ng-nitro-l-arginine inhibitor (appos)
efficacious regimens (nsubj)
5 30 (conj)
> grade (dep)
applications rtms (nmod)
administered reserpine (nsubj)
loss predominant (amod)
ly274614 antagonist (appos)
examination database (nmod)
manifestation rare (amod)
serpiginosa , (punct)
maintained extension (nmod)
seizure activity (dobj)
observed which (nsubjpass)
interruption the (det)
admissions from (case)
underwent tracheotomy (dobj)
41.4 6.5 (conj)
pretreatment umb24 (nmod)
reported duration (nsubjpass)
pathogeneses hematopathology (conj)
majority the (det)
modulated be (auxpass)
tried confirm (xcomp)
mydriasis , (punct)
associated number (nmod)
approach model (nmod)
diseases autoimmune (amod)
probed we (nsubj)
reported far (advmod)
cerebellum offspring (amod)
appearance changes (conj)
olanzapine 20 (conj)
min reperfusion (nmod)
provided exacerbation (nmod)
seroconversion hiv (compound)
effects university (conj)
therapy time (nmod)
melphalan and (cc)
loss influence (dep)
occurred far (advmod)
> a (det)
obtained can (aux)
controlled pyridoxine (nmod)
withdrawal hormone (nmod)
admitted intake (nmod)
s 493 (nummod)
normal weeks (nmod)
applied patients (nmod)
worn which (nsubjpass)
solution % (amod)
hypertension smoke (conj)
caused changes (dobj)
= 42 (dep)
patients 590 (nummod)
estrogens , (punct)
similar concentrations (nsubj)
subgroups 2839 (nmod)
cause atrophy (nmod)
warranted hemorrhage (nmod)
verapamil catheter (conj)
evaluation at (case)
rash , (punct)
= 0.72 (dobj)
performed dosing (conj)
% 9.1 (nummod)
cell into (case)
intervention : (punct)
blocked was (auxpass)
increasing time (dobj)
requirement co-administration (nmod)
noted treatment (nmod)
catheter dosing (compound)
recommended be (auxpass)
relevance the (det)
suppressed circumstances (nmod)
thioperamide thp (appos)
studies 3,129 (nummod)
risperidone doses (nmod)
diet exacerbated (acl:relcl)
pressure gases (conj)
group ] (punct)
monitored treated (advcl)
diuresis glycosuria (conj)
injections epidural (amod)
clinic hospital (conj)
% 73 (nummod)
hyperalgesia hyperesthesia (conj)
period : (punct)
up-regulation alpha1-adrenergic (amod)
mtx ) (punct)
aventyl elavil (conj)
elements in (case)
administration ps (nmod)
acid dipyridamole (conj)
occurs anticoagulation (nsubj)
edema mcao (compound)
chloride sch (appos)
synthesis factor (compound)
ficoll-hypaque sedimentation (conj)
experiments these (det)
anophthalmia or (cc)
10 40 (conj)
surgery gastric (amod)
persisted fibrosis (nsubj)
28 15 (compound)
injury hepatic (amod)
hemisphere animals (nmod)
17 to (quantmod)
differ atypicals (nmod)
mg m-2 (dep)
recalled 90 (nmod)
decrease 2 (nummod)
severe treated (conj)
women kamil (compound)
n-nitroso-n-methylurea with (case)
control ( (punct)
citations few (amod)
populations patient (compound)
dogs 15 (nummod)
e2 prostaglandin (compound)
shr ) (punct)
signals phasic (amod)
free disease (nmod)
control saline (appos)
correlated volume (nmod)
dopamine and (cc)
change daytime (compound)
cycles started (acl)
wky ) (punct)
atrophy and (cc)
mmecs nephropathy (conj)
grade they (nsubj)
% 18.28 (nummod)
test transformation (nsubj)
= 0.68 (dobj)
pathogens of (case)
derivative sodium (nsubj)
amputation extrication (conj)
related depression (nsubj)
electrodes with (case)
vacuoles such (amod)
pma nm (nummod)
january 1 (compound)
developed dilated (conj)
report on (case)
similar efficacy (nsubj)
awareness their (nmod:poss)
fetuses age (nmod)
gives rise (dobj)
extracts methanolic (amod)
antinociception morphine (compound)
neurotoxicity 5-fluorouracil (nmod)
found out (compound:prt)
developed death (dobj)
stimulation skin (nmod)
minor even (advmod)
effect mg/kg/day (dep)
pg/ml n (dep)
variation the (det)
microg/day 100 (nummod)
ato-treated non-treated (conj)
potential sm-5887 (nmod)
suggest risk (ccomp)
method simple (amod)
daptomycin high-dose (amod)
nephrin plekhh2 (conj)
association analysis (dep)
seen been (auxpass)
predictor is (cop)
axons parvo-cellular (amod)
achr ) (punct)
developed hemolysis (dobj)
mediates that (nmod)
aldomet name (compound)
effects fluoroquinolones (nmod)
postulates affect (ccomp)
adequate inhibition (nmod)
densities adrenoceptor (compound)
effective highly (advmod)
activity time (conj)
centers at (case)
follow anesthesia (dobj)
vagotomy and (cc)
treatment conventional (amod)
functions renal (amod)
emit conditions (nmod)
testing protectors (nmod)
protecting against (compound:prt)
induce , (punct)
hepatitis associated (acl)
electro- echocardiography (conj)
nsvt and (cc)
boy 13-year-old (amod)
cases cause (appos)
led 2 (nmod)
unchanged contrast (nmod)
excitability of (case)
fasting index (conj)
relative first-degree (amod)
edetate citrate (conj)
risk interval (dep)
reserpine intraperitoneal (amod)
agonist not (neg)
bpa to (case)
occurred and (cc)
remission a (det)
worsened infection (nmod)
day times (appos)
abolish could (aux)
lesions palpable (amod)
disruption subsequent (amod)
rofecoxib and (cc)
atropine nadolol (conj)
followed discontinuation (dobj)
pvc of (case)
some findings (nmod)
proportional is (cop)
sulfation in (case)
effect rls (nmod)
anthony 's (case)
injury cord (compound)
demonstrate infarction (dobj)
occurred abnormalities (nsubj)
searched . (punct)
activity 7-ethoxyresorufin-o-deethylase (nmod)
instances both (det)
suppress activity (dobj)
incapacitated were (auxpass)
caused may (aux)
those with (case)
range and (cc)
nephrotoxicity gm (compound)
cin between (case)
one agents (nmod)
1.37 to (dep)
protection amnesia (nmod)
possibility of (case)
considered % (nsubjpass)
microgravimetry by (case)
scoring the (det)
effective partially (advmod)
patients psychosis (nmod)
cause catalepsy (dobj)
hyperactivity involvement (dep)
therapy haemodialytical (amod)
women 20 (conj)
microg/kg 1 (compound)
administered log (nsubjpass)
fatal dose (nsubj)
rate tone (conj)
29 % (dep)
derivative produced (amod)
infused was (auxpass)
difficulties emerging (amod)
anticoagulation patients (nmod)
produced attributed (parataxis)
tests trail-making (amod)
20 +/- (cc)
nature to (mark)
model which (nsubj)
prolonged but (cc)
7h6 of (case)
early as (prep)
showed subjects (nsubj)
tested test (nmod)
volume following (case)
achieve patient (nsubj)
hypertrophy ducts (nmod)
scans or (cc)
were four (attr)
adults risk (acl:relcl)
ensure to (mark)
women control (compound)
antigen hiv (compound)
rank p>0.6 (compound)
0.06 and (cc)
reverse paralysis (dobj)
thrombo-embolism ( (punct)
increases for (case)
clearance cimetidine (nmod)
adr mg/kg/b.w (dep)
alterations morphological (amod)
values preoperative (amod)
antagonized effect (nsubjpass)
reversing by (mark)
any events (nmod)
tamca of (case)
elevated non-significantly (advmod)
model minimal (amod)
developed groups (nmod)
less than (mwe)
resolved averting (advcl)
underwent lt (dobj)
autoantibodies for (case)
group mp (nmod)
possible survival (nsubj)
suggesting pcc (dobj)
selectivity high (amod)
known which (nsubjpass)
micromol/l 10 (nummod)
method healthy (appos)
blocker properties (nmod)
mechanisms i.c. (amod)
lilly the (det)
increased rapidly (advmod)
6-ohda-lesioned treated (conj)
mg/ml at (case)
compared battery (nmod)
3628 257 (conj)
believe reported (ccomp)
mg/kg ( (punct)
mg on (case)
usage pediatric (amod)
analyses groups (nmod)
inhibitors growth (compound)
believed nephritis (nsubjpass)
reached levels (dobj)
interval [ (punct)
mothers of (case)
neurons ( (punct)
rostrolaterally and (cc)
back recovery (nmod)
obtained however (advmod)
sixth seventh (conj)
formation hilar (amod)
risk possible (amod)
help account (dobj)
single-dose when (advmod)
pallidotomy medial (amod)
affinities (na (nmod)
mitochondrial of (case)
animals estradiol-treated (amod)
epinephrine . (punct)
resulted protection (nmod)
profile risperidone (nmod:poss)
level known (amod)
media for (case)
leading tdp (nmod)
0.05 of (case)
less .05 (nmod)
absent even (advmod)
anp + (cc)
explanations of (case)
anxiety pentylenetetrazole-induced (amod)
features , (punct)
injury new (amod)
debate under (case)
events events (appos)
explain and (cc)
cost because (case)
subtle are (cop)
action system (compound)
cvvhdf by (case)
expression synaptophysin (dep)
tear a (det)
adefovir and (cc)
side-effects its (nmod:poss)
initiated daily (nsubjpass)
anorexigens of (case)
-cimetidine mg/kg (conj)
-0.81 db (dep)
animals control (compound)
decreased study (nmod)
cer ) (punct)
appears effect (nsubj)
likely distribution (nmod)
scale ontario (compound)
electroencephalogram of (case)
metformin seizures (nmod)
involvement analgesia (nmod)
valve aortic (amod)
stress tam-induced (amod)
dialysate acid (nmod)
users to (case)
carriers infected (amod)
took she (nsubj)
changes pronounced (amod)
membranes and (cc)
% 13.7 (nummod)
subject healthy (amod)
median from (case)
found delirium (nsubjpass)
hypocalcemia and (cc)
activity antineoplastic (amod)
catalepsy globus (compound)
consisted is (nsubj)
likely ratio (dep)
electro-oculography electroretinography (appos)
delta bands (nsubj)
associated fluconazole (nsubj)
c. mitomycin (compound)
decompression patients (nmod)
arrhythmias , (punct)
future in (case)
challenged vehicle (nmod)
territory ischemic (amod)
control autonomic (amod)
tested psychologist (nmod)
prostatitis only (advmod)
ng.ml-1 ( (punct)
calculated parameters (nsubjpass)
min 236.9 (nummod)
hyperactivity regions (nmod)
literature drugs (nmod)
recorded monitoring (nsubjpass)
characterized ; (punct)
comparable higher (conj)
activation inputs (nmod)
mg/dl from (case)
had steroids (nsubj)
patients underwent (acl:relcl)
rats assessed (acl)
hospitals different (amod)
improves have (conj)
reported combined (advcl)
infarctions , (punct)
arises suggested (conj)
trials trial (appos)
remoxipride and (cc)
outcomes cardiac (amod)
take that (mark)
patients southern (amod)
seizures petit (amod)
case best (nmod)
content high (amod)
saccades of (case)
system cholinergic (amod)
bsc-1 ( (punct)
rose sexes (nmod)
individuals otherwise (amod)
indicator simply (advmod)
warranted are (auxpass)
prevention adenomas (nmod)
% 53 (dep)
frequency side-effects (nmod)
factors ii (conj)
i.m. ) (punct)
incidence but (cc)
remains countries (nmod)
recognized was (auxpass)
modulate differentially (advmod)
dipyridamole the (det)
pump an (det)
diazepam contraindicated (nmod)
rats pan (compound)
attenuates injury (dobj)
published already (advmod)
severity in (case)
was also (advmod)
influenzae , (punct)
viia factor (compound)
od 0.33+/-0.09 (conj)
normotensive and (cc)
history clear (amod)
% eyes (nmod)
appears related (xcomp)
syndrome ) (punct)
% 1.2 (nummod)
administered or (cc)
netilmicin piperacillin (conj)
studies additional (amod)
exist reports (nsubj)
% young (nmod)
developed nodosum (dobj)
mipafox to (case)
forme apparent (amod)
transformation tissue (nmod)
showed brain (nsubj)
question the (det)
catheter alternative (amod)
unaffected ultrastructure (nsubj)
confounded temperature (nmod)
vnr patients (conj)
infarction nonfatal (amod)
toxicity developed (parataxis)
visibility field (nmod)
subjects 18 (nummod)
increased function (dobj)
tolerated vnb (nsubjpass)
mechanisms promotion (nmod)
induced lindane (amod)
stain a (det)
lower pretreatment (dep)
lower group (nmod)
dose 0.075mg/kg (compound)
lesion reversible (amod)
supernatants cell (compound)
marrow grafting (acl)
treatment oct (compound)
events require (conj)
continue year (nmod)
favour and (cc)
linked drugs (nmod)
challenged 29th (nmod)
polymyositis or (cc)
-18.48 -15.96 (conj)
administration combinations (conj)
reduction excretion (nmod)
weights of (case)
show choices (dobj)
dietary therapeutic (conj)
clinics hospital (nmod:poss)
bodyweight pretreatment (nsubj)
distributed are (auxpass)
mg/kg 31 (nummod)
tongue , (punct)
recognized been (auxpass)
decreased concentration (nmod)
disease abnormalities (dep)
hemolysis . (punct)
suggesting mediated (ccomp)
mup ) (punct)
examines incidence (dobj)
assessed injected (dep)
useful be (cop)
targeted antipsychotics (nmod)
angioedema alone (advmod)
condition of (case)
3.82 x (cc)
demonstrated since (mark)
differed differences (nmod)
facilitate . (punct)
implausible and (cc)
5-azacytidine 5-azc (appos)
procainamide to (case)
studied or (advmod)
misoprostol function (nmod)
frequency spike (amod)
treatment losartan (amod)
1 5 (compound)
date timecourse (nmod)
tumors with (case)
blockage glutamatergic (amod)
scale effect (compound)
reductions percentage (compound)
slower . (punct)
doses animals (nmod)
available : (punct)
ranging mg/kg/day (nmod)
mechanism rs (nmod)
fall with (case)
= .006 (dep)
took vgb (dobj)
group lesioned (amod)
tumour mast (compound)
window pretreatment (nmod)
distribution concordance (nmod)
series respect (nmod)
mice pkc-alpha (compound)
occurrence of (case)
doses caffeine (compound)
months those (nmod)
atp substrate (compound)
managing are (aux)
episodes carious (amod)
pallidotomy stereotactic (amod)
tolerability reliability (conj)
assessment . (punct)
glomerulonephritis restarting (acl)
switches mood (compound)
3.0+/-0.4 , (punct)
subjects nondependent (amod)
horn lateral (amod)
saline with (case)
method and (cc)
2.5 x (cc)
amounts volumes (conj)
minutes 3 (nummod)
induced strains (nmod)
tools merit (conj)
cystitis hemorrhage (compound)
factors weeks (nmod:tmod)
present compared (prep)
dec. , (punct)
active therapy-resistant (conj)
day 16 (nummod)
activation brain (compound)
stimulus nociceptive (amod)
conditions similar (amod)
assessed tremor (dobj)
effect d2 (nmod)
aida doses (nmod)
greater and (cc)
result have (aux)
design sessions (nmod)
bs ( (punct)
32 17 (compound)
hemorrhage recurrent (amod)
caused lithium (nsubj)
quit women (nsubj)
quit when (advmod)
drugs application (appos)
permits ifosfamide (dobj)
calculated : (punct)
tjs ( (punct)
training of (case)
carcinoma bronchio-alveolar (amod)
heparin dipyridamole (conj)
monitored must (aux)
glucosuria proteinuria (conj)
screening pressure (dobj)
1.0 11.9 (nummod)
positive administration (nmod)
carcinogens with (case)
child each (det)
nodosum of (case)
caused zyban (nsubj)
expression cystitis (nmod)
form receptors (nmod)
toxic are (cop)
pitfall findings (conj)
sarcoma with (case)
information effect (nmod)
induced anesthesia (nmod)
factor specific (amod)
variables above-mentioned (amod)
reverses time (dobj)
uea1 ( (punct)
sedation particularly (amod)
this to (case)
framework identifying (advcl)
100 - (punct)
sulfate gentamicin (compound)
artery middle (amod)
dyskinetic patients (conj)
gene in (case)
66 versus (cc)
albuterol treatments (conj)
0.03 1.0 (conj)
propranolol neither (cc:preconj)
thiotepa including (case)
study neurophysiological (amod)
discontinuance the (det)
strains in (case)
surgery general (amod)
diary a (det)
symptomatology and (cc)
effects activator (appos)
flushing edema (conj)
compared methods (dep)
collected analysis (nmod)
4/5 ( (punct)
lithium ) (punct)
heart dissected (amod)
haart of (case)
induced terminated (conj)
patients cc (nmod)
determine nephropathy (advmod)
suggest lead (ccomp)
kidneys rat (compound)
option potential (amod)
placebo portions (nmod)
intervention careful (amod)
patients 43 (nummod)
observed association (nmod)
drug aware (conj)
implanted , (punct)
terminate to (mark)
volunteers human (amod)
mg/kg 1 (nummod)
described regimens (nsubjpass)
cancer chemotherapy-treated (amod)
factors contributing (compound)
permeability ameliorated (acl:relcl)
short- and (cc)
angiographies rise (nmod)
toxicity disorders (conj)
circuitry neural (amod)
december 31 (nummod)
arrest circulatory (amod)
similar those (nmod)
unchanged were (cop)
dependent consumption (nsubj)
therapy ptu (compound)
prerequisite . (punct)
cholinergic model (dep)
count reticulocyte (compound)
h beginning (case)
active which (nsubj)
score acute (amod)
interest are (cop)
use product (compound)
blocked gspe (nmod)
shunt blood (nmod)
boy a (det)
showed adults (nmod)
treat safely (advmod)
similar confirmed (advcl)
investigated materials (nsubj)
history electing (amod)
median preswitch (acl)
mglu ( (punct)
effect naloxone (compound)
times thromboplastin (compound)
protein activity (conj)
reduces therapy (nsubj)
majority and (cc)
therapy anthracycline (compound)
caused nx (nsubj)
attempted ages (conj)
induce angiogenesis (dobj)
hypotension coronary (amod)
training before (case)
desipramine dose (compound)
predilection thrombosis (nmod)
increase products (nmod)
monkey one (nummod)
mortality cvd (compound)
suggested factor (ccomp)
shivering jerks (conj)
surviving min (nmod)
interval long (amod)
seen years (dep)
reducing cognitive (dobj)
activity negligible (amod)
reticulata damage (nsubj)
neurotoxic similar (conj)
syncopal to (mark)
evoked dose (nmod)
mg/kg p (dep)
examined potential (nsubjpass)
individuals epileptic (amod)
mechanism their (nmod:poss)
ng , (punct)
restriction fluid (amod)
hematoxylin eosin (conj)
flow rcbf (appos)
if with (case)
telangiectasia of (case)
expression distribution (conj)
failure characteristics (conj)
schizophrenic among (case)
formation granulomatous (amod)
analyzed treatments (nmod)
had binding (dobj)
ranges and (cc)
e2-induced prostaglandin (nmod:npmod)
dose average (amod)
activity cimetidine (nmod)
combination haart (compound)
faint as (mark)
alternative real (amod)
risperidone % (dep)
younger . (punct)
worsened development (nmod)
cardiotoxicity paradoxically (advmod)
complication valproate (nmod)
dyes targeting (acl)
affected ; (punct)
increasing dosage (dobj)
indomethacin naproxen (conj)
evaluated staining (advcl)
cataracts cancer (conj)
toxicity reduction (conj)
initiated obtain (advcl)
potentiate does (aux)
effect common (amod)
efficacy mg (nmod)
diclofenac daily (advmod)
trained influence (nmod)
2.5 interval (dep)
tests with (case)
0.24 +/- (cc)
di-o-tolylguanidine dtg (appos)
leads ceftriaxone (nsubj)
quantify reduction (dobj)
similar patients (nmod)
intake children (nmod)
mother in (case)
efficacious would (aux)
rater by (case)
-chlorpheniramine group (compound)
inclusions abnormal (amod)
stimulation hyperemic (amod)
min 165 (nummod)
plexitis right (amod)
had temsirolimus (nsubj)
encouraging are (aux)
comorbidity epilepsy (nmod)
binding the (det)
axis and (cc)
induction the (dep)
prolapse valve (compound)
attacks with (case)
reversed mice (nmod)
neuropathy therapy-related (amod)
associated products (nmod)
entered patients (nsubj)
implications management (nmod)
34.0 mg/kg (nmod)
pattern necrosis (nmod)
delivered may (aux)
contributes stress (nsubj)
associated remoxipride (nmod)
neutropenia especially (advmod)
inhibitors cyp3a4 (compound)
objective has (dep)
analyze mechanisms (dobj)
age facility (conj)
dosage mazindol (compound)
length and (cc)
monotherapies compared (case)
decreased induced (advcl)
amine is (cop)
alert low (advcl)
terfenadine e.g. (dep)
mortality the (det)
2.3+/-1.2 and (cc)
discharge rapid (amod)
measured catheter (nmod)
measurements clearance (conj)
dobutamine minutes (nmod)
heads swollen (amod)
year birth (nmod)
prevalence use (nmod)
involvement quinine-sensitive (nmod)
caffeine intravenous (amod)
assessment treatment (nmod)
used protocols (nmod)
or interval (appos)
damage . (punct)
corrected dosages (nsubj)
recurrence of (case)
reactions the (det)
7 and (cc)
level anp (nmod)
muscles patients (nmod)
prevalence depression (nmod)
seizures pharmacologically-induced (amod)
second seventh (conj)
frequent since (mark)
toxicity auditory (amod)
estradiol 3h-17 (nummod)
assessments 1 (nmod)
amplitude sural (amod)
atypicals various (amod)
is role (attr)
reduction levels (nmod)
basis list (nmod)
years or=65 (compound)
symptoms phase (compound)
hz at (case)
draw attention (dobj)
cohort study (compound)
days 3 (conj)
firmness breast (compound)
rash associated (acl)
cardiotoxicity anthracycline-induced (amod)
treatment risperidone (nmod)
percentage mean (nmod)
concentrations ambient (amod)
offer utility (dobj)
longer groups (nmod)
released . (punct)
deep light (conj)
setting trial (compound)
therapy course (nmod)
dyspnoea however (advmod)
determination testosterone (compound)
19 to (quantmod)
vicinity hematoma (nmod)
years 38 (nummod)
spv delta (conj)
one a (det)
located , (punct)
added vitro (advmod)
condition myotonic (amod)
electrical and (cc)
secretion in (case)
conclusions mounting (appos)
administration rhigf-i (nmod)
mania acute (amod)
usefulness treatment (nmod)
measurements three (nummod)
8.8 +/- (cc)
patients 596 (nummod)
provide allow (conj)
tablet one (nummod)
failure required (acl:relcl)
is possibility (attr)
background on (case)
carcinoma breast (compound)
cardiotoxicity antibiotic (appos)
resolved epistaxis (nsubj)
indicated have (aux)
involved overdose (nsubjpass)
microscopy urine (compound)
increase threshold (dobj)
titrated and (cc)
mu/kg ( (punct)
level neurotransmitters (nmod)
evidence echocardiographic (amod)
produced antagonism (dobj)
cis-ra oral (amod)
ulcers these (det)
265.2 10(6 (conj)
old and (cc)
complaints their (nmod:poss)
upregulation compensatory (amod)
5 as (advmod)
defining of (mark)
effects regarding (case)
attack no (det)
used angiography (nmod)
authorized is (auxpass)
center level-i (amod)
amyloidosis secondary (amod)
higher db (nmod:npmod)
tail in (case)
number significant (amod)
acetaminophen , (punct)
treatment weeks (nmod)
observed continued (advcl)
(+)-cibenzoline (-)-cibenzoline (conj)
known edema (conj)
memory stm (appos)
complicated have (aux)
indicated however (advmod)
produce . (punct)
switch ( (punct)
application diltiazem (compound)
revealed application (nsubj)
risk 3.75 (conj)
mg pb (compound)
concordance autism (nmod)
wherein , (punct)
however were (cop)
bromocriptine given (acl)
diazepam agent (appos)
b1r(-/- in (case)
clonidine microinjected (acl)
avoiding by (mark)
activity pacemakers (nmod)
complication not (neg)
uncommon was (cop)
injury repeated (amod)
levodopa of (case)
susceptibility renal (amod)
sensitization central (amod)
recovery function (nmod)
solutions water (compound)
frequent cardiomyopathy (nsubj)
titers of (case)
status cardiac (amod)
shown not (neg)
position side (nmod)
report highlight (xcomp)
dysfunction , (punct)
restarted argatroban (nmod)
actions cardiac (amod)
modulators ) (punct)
adrenoceptor rat (compound)
period and (cc)
mydriasis convulsions (conj)
compared parameters (nsubjpass)
control increase (conj)
act proliferation (nmod)
recurrent or (cc)
detected stage (nmod)
thromboembolism with (case)
cases 11 (nummod)
present hyperprolactinemia (nsubj)
randomised patients (nsubjpass)
hr , (punct)
aeruginosa pseudomonas (compound)
% diabetic (nmod)
asystole following (case)
found brains (nmod)
assessment presence (nmod)
form striped (amod)
etiology disease (nmod)
cause turn (nmod)
remained mg/day (nmod)
involved have (aux)
occurred disturbing (conj)
demonstrated effective (advmod)
duct which (nmod)
source with (nmod)
ds in (case)
fatal woman (nmod)
dysphonia adsd (appos)
underwent often (advmod)
nodal sa (compound)
decreased weights (nsubjpass)
investigated aim (nsubjpass)
growth treatment (dep)
mannitol with (case)
diabetes 1 (nummod)
confirm cases (nsubj)
revealed autopsy (nsubj)
rates rates (conj)
state naloxone (dep)
kinase , (punct)
theophylline to (case)
l1-l2 ( (punct)
mice occurred (acl:relcl)
used marmoset (nsubjpass)
exhibited exhibited (advcl)
verapamil oral (amod)
frequent were (cop)
lozenge the (det)
returns patient (compound)
enhanced equipotent (conj)
types tumour (compound)
antibiotic offending (amod)
action fs (nmod)
symptoms encephalopathy (nmod)
removed . (punct)
potential management (nmod)
t0 ) (punct)
activation receptor-alpha (compound)
obsolete but (cc)
hours dose (dep)
schedules cbdca (compound)
injected along (advmod)
levels amphotericin (compound)
regrowth with (case)
mass mg (nmod)
a cyclophilin (compound)
cerruloplasmin , (punct)
associated vigabatrin (nmod)
treatment enalapril (compound)
restricted effects (nsubj)
appeared however (advmod)
non-drug , (punct)
diuretic potassium-losing (amod)
receive mg (nmod)
studied minutes (dobj)
depression and (cc)
normal periods (nmod)
fpd corrected (amod)
taking treat (advcl)
informed effect (nmod)
seen reactions (nsubjpass)
modulating expression (dobj)
had women (nsubj)
induced antagonist (nmod)
injection morphine (amod)
levels pge2 (compound)
fetuses and (cc)
once ( (punct)
cardiomyocytes induced (amod)
behavior bizarre (amod)
adam ) (punct)
yahr and (cc)
episodes as (case)
diagnosed ptld (nmod)
followed seen (parataxis)
effects reversible (amod)
type 3 (nummod)
need evaluate (acl)
offered surveillance (dobj)
use rhigf-i (nmod)
side on (case)
procedure marrow (compound)
case attributable (amod)
seem because (mark)
resulted failure (nmod)
excretion or (cc)
later h (nmod:npmod)
abundant abundant (parataxis)
pharmacology the (det)
genotype the (det)
advantages therapy (nmod)
reduction percent (amod)
period 6-hour (nummod)
evoked the (det)
times acts (appos)
neuropathy use (nmod)
cases n (dep)
associated conclusion (nsubjpass)
prolongation patients (nmod)
showed electroencephalogram (nsubj)
mg/g 4 (nummod)
euthyroid hypothyroid (conj)
licensed and (cc)
incidence cause (nmod)
amns , (punct)
presents type (ccomp)
increased markedly (advmod)
had purpura (dobj)
hoarseness accentuated (conj)
diseases cardiovascular (amod)
bupivacaine % (amod)
abundances , (punct)
mice gene-targeted (amod)
role erdosteine (nmod)
effects pressor (compound)
locf ) (punct)
block due (case)
sg145r lam (conj)
mmhg 59.8 (nummod)
serotonin augmented (acl:relcl)
infarctions acute (amod)
attained associated (conj)
reduction nerve (compound)
delay consistent (amod)
admission hydrocortisone (conj)
resection after (case)
injection repeated (amod)
activator a (det)
correlated pvc (nsubj)
injury drug-induced (amod)
changes transaminases (nmod)
obstructive apnoea (conj)
eliminated that (nsubj)
concentration . (punct)
terminated deficit (nmod)
variety diseases (nmod)
3'-azido-2',3'-deoxythymidine ( (punct)
receive were (cop)
associated drug (nsubjpass)
recommenced . (punct)
predictors grade (nsubj)
administration alendronate (compound)
extrapyramidal especially (advmod)
hydrochloride mepivacaine (compound)
larvae fleas (nmod)
cases life-threatening (amod)
timolol solution (appos)
confirmed results (nsubj)
nelarabine , (punct)
effect any (det)
reduced restored (conj)
alt and (cc)
serum versus (cc)
evaluated that (mark)
included comparison (nmod)
tomography single-photon (compound)
maintained is (auxpass)
dyskinesias disease (nmod)
number nadph-d (compound)
presented history (nmod)
facility in (case)
emerged doses (nmod)
played recognition (nsubj)
isolation sequential (amod)
peak sharp (amod)
suggest rct (nsubj)
appreciated associated (ccomp)
tea or (cc)
hemorrhage fatal (amod)
inflammation streptozotocin (conj)
cystitis or (cc)
antagonists histamine (compound)
involved sessions (dobj)
tachyarrhythmias . (punct)
time occurrence (nmod)
steroids by (case)
restoration performance (nmod)
interferon alpha-2b/ribavirin (conj)
lower netilmicin (nmod)
support intraoperative (amod)
associated levels (nmod)
syndrome duct (compound)
underlie mechanisms (nsubj)
days discussion (nmod)
symptoms somatic (amod)
study pair-fed (compound)
explore system (nmod)
determined echocardiographically (advmod)
rhabdomyosarcoma parameningeal (compound)
disturbance sensory (amod)
presenting episodes (nmod)
di- tetra- (conj)
severe rats (nmod)
minutes 16.4+/-6.1 (nummod)
demonstrated conclusion (dep)
associated significant (nmod)
mhb ) (punct)
controls ; (punct)
fashion in (case)
treated losartan (nmod)
bodyweights p (dep)
found concentrations (nsubjpass)
analyses patients (nmod)
study applicators (nmod)
samples serum (compound)
treated infants (nsubjpass)
evident hypoactivity (nsubj)
receiving lidocaine (dobj)
responses objective (amod)
haloperidol p.o. (appos)
organelles degeneration (appos)
demonstrated only (advmod)
mv 2.1 (nummod)
efficacious but (cc)
generation mucosal (amod)
thought tnf (nsubjpass)
h mg/l (compound)
toxicities ability (appos)
day for (case)
5-fu/fa high-dose (amod)
u/l u/l (appos)
mice littermates (conj)
combination these (nmod)
attack defense (appos)
scale disease (compound)
alf acetaminophen-induced (amod)
interactions warfarin (compound)
weight saline (nmod)
methods hybridization (compound)
properties coronary (amod)
modalities three (nummod)
depression features (nmod)
neurotoxicity iddm (conj)
inhibition clonidine (nmod)
tended regardless (prep)
database database (appos)
each bearing (acl)
follow may (aux)
evening during (case)
alpha(1)-subunit of (case)
normalized was (auxpass)
is result (nmod)
increase chewing (nmod)
dysfunction because (case)
i.v. bn (compound)
vacuolization rough (amod)
rr=1.41 % (dep)
observed levels (nmod)
ph the (det)
paracetamol rats (nmod)
modeling pharmacokinetic-dynamic (amod)
likelihood about (case)
monitoring one-on-one (compound)
basis a (det)
reported hallucinations (nsubjpass)
fasciculations muscle (compound)
protein intracellular (amod)
= 2.85 (dobj)
similar results (nsubj)
dehydration , (punct)
rescue antiemetic (amod)
effects attributable (amod)
syndrome unusual (amod)
microm 50 (nummod)
stimulation sham (compound)
reduced ; (punct)
enhance extent (dobj)
inhibition direct (amod)
abrasion marked (amod)
limited been (auxpass)
pneumonitis effusion (dep)
controls dose (nmod)
deoxycholate b-sodium (nsubj)
survivors failure (nmod)
suspected angioedema (nsubjpass)
rats l-w (amod)
reintroduction the (det)
sch or (cc)
performed meta-analysis (dobj)
cases 220 (nummod)
attenuating effects (dobj)
cycle sinus (compound)
stimulation nicotine-induced (amod)
clinical serologic (conj)
strokes and (cc)
department ( (punct)
risk developing (acl)
diet fat (amod)
zonisamide with (case)
virus immunodeficiency (compound)
divided 1 (nmod)
abrogated , (punct)
scale point (compound)
rapamycin rapa (appos)
activity recorded (acl)
substrates cyp1a2 (compound)
antagonists of (case)
test coombs (compound)
analyses pharmacokinetic (amod)
he-lfb cd-68 (appos)
alterations of (case)
dysfunction clinical (amod)
increased mesencephalon (nmod)
increased step (advcl)
reduced wky (nmod)
treated docetaxel (nmod)
pretreated methylatropine (nmod)
ninety-nine in (case)
hands and (cc)
gauges and (cc)
sed 3.4 (conj)
require baroreceptors (dobj)
improved prognosis (dobj)
examined peroxisomes (nsubjpass)
syndromes on (case)
monitored tachycardia (nmod)
kcl of (case)
ms , (punct)
dunnett p (appos)
used protocol (dobj)
exposed day (nmod)
resulted delirium (nsubj)
showed infarction (dobj)
represent effect (dobj)
observed showing (advcl)
small variation (conj)
0 21 (conj)
captopril-treated control (conj)
access(r ng/ml (appos)
km = (amod)
present still (advmod)
others not (neg)
decreased % (dobj)
setting inpatient (amod)
cells hair (compound)
clonidine by (case)
polymerase ) (punct)
50 to (quantmod)
failure malignancy (conj)
increased 1.5 (nmod)
preparations ergot (compound)
= model (dobj)
affect increase (dobj)
counteract provoke (advcl)
-19.20 + (cc)
central ) (punct)
important they (nsubj)
facility the (det)
paralysis ipsilateral (amod)
administration adults (nmod)
rats nonmutant (amod)
time estimated (amod)
microgram/kg/min 0.3 (nummod)
established effect (nsubjpass)
became stopped (ccomp)
initiated therapy (dobj)
studied approval (nmod)
cad ) (punct)
indicate sampled (ccomp)
evaluated retrospectively (advmod)
shown biopsy (nmod)
pretreatment mmol/kg (dep)
4.10 was (cop)
biopsy ( (punct)
behavior or (cc)
expression as (cc)
ovale of (case)
complication glomerulonephritis (nsubj)
sensitization of (case)
days three (nummod)
performed be (auxpass)
1.44+/-0.6 ( (punct)
useful cabergoline (nsubj)
actions model (nmod)
obese they (nsubj)
echocardiography severity (nmod)
exposure lead (amod)
grafting infarction (conj)
hypothesis indicating (acl)
involvement kidney (compound)
c6 to (case)
courses 167 (nummod)
difficult it (nsubj)
ist ( (punct)
cystica between (case)
changes peroxisomes (nmod)
activation overexpression (conj)
found had (advcl)
outcomes to (case)
mg females (nmod)
single not (neg)
nigra incerta (conj)
number across (case)
frequency in (case)
142 +/- (cc)
attack established (amod)
1 216 (prep)
exerts diphenylhydantoin (nsubj)
acromegaly for (case)
class of (case)
tended taken (xcomp)
therapy ulcer (compound)
bound , (punct)
sided application (dobj)
prevent oct (nsubj)
altering concentrations (dobj)
treatment humans (nmod)
increased hazard (nsubj)
determined was (auxpass)
mg phenobarbital (amod)
mfs with (case)
characterized eyes (nsubjpass)
cause remain (conj)
exercised animals (nmod)
learning word (compound)
probable but (cc)
dyskinesias of (case)
alter which (nsubj)
rate cimd (nmod)
elicited which (nmod)
disorder a (det)
disappear alleviated (conj)
change excretion (nsubj)
utilization ketamine (nmod)
interrelationship the (det)
provided facilitate (advcl)
iceberg of (case)
61 between (case)
similar percentage (nmod)
doxorubicin chemotherapy (conj)
total g/m2 (appos)
features myocardial (amod)
produced eserine (conj)
complications vascular (amod)
days 20 (nummod)
stabilizers prototypic (amod)
= 0.02 (dep)
grade 3 (nummod)
mice , (punct)
investigating influences (dobj)
severity events (nmod)
extubated . (punct)
florida 1979 (nmod)
autism , (punct)
reports no (neg)
neurons hippocampal (compound)
infiltrate lung (compound)
interviewed were (auxpass)
nsaid a (det)
revealed degeneration (dobj)
combination valproate (nmod)
ml/min 1.03 (nummod)
motor flexion/extension (dep)
catalepsy parkinsonian (amod)
react to (mark)
suppress , (punct)
mumol/kg 3.2 (nummod)
5-hydroxytryptamine of (case)
cck-8-se than (case)
had causes (dobj)
x ck-mb (compound)
beta-carboline anticonvulsant (amod)
2003 to (case)
high subset (nmod)
need despite (case)
3.4 ; (punct)
reflect activation (dobj)
disappearing lack (nmod)
had interfered (advcl)
improvement clinical (amod)
obtundation of (case)
min by (case)
detachment ectoderm (nmod)
hypothermia drug-induced (amod)
influences seizures (nmod)
neuritis of (case)
2.9 0.2 (conj)
nifekalant over (case)
malformations arteriovenous (amod)
caution , (punct)
contained that (mark)
revealed electroencephalographic (nsubj)
effect this (nsubj)
chemotherapy inhibitors (dep)
induced increases (dobj)
had chorea (dobj)
developed dyskinesia (nsubj)
accompanied pain (nmod)
determining for (mark)
warn cause (ccomp)
considered cardiotoxicity (xcomp)
5-fu with (case)
syndrome hepatitis-like (amod)
study specimens (nmod)
patients old (amod)
ischemia effect (dep)
hemoglobin ) (punct)
level inducing (acl)
occurred studies (nmod)
effect topiramate (nmod)
related toxicity (nmod)
occurred led (conj)
chemotherapies before (case)
induced inhibitor (nmod)
135 15 (conj)
binding either (cc:preconj)
adrenaline with (case)
presentation by (case)
nausea pruritus (conj)
restored four (nmod)
loss ca3 (compound)
cases 27 (nummod)
origin cns (compound)
decrease initial (amod)
drug responsible (amod)
delirium role (dep)
mechanisms influence (dep)
ischemic hyperthermia-induced (conj)
maintenance for (case)
check reality (compound)
instrumented chronically (advmod)
studies on (case)
change disease (conj)
macroscopic by (case)
disorder rates (appos)
treatment mild (nmod)
medicine herbal (amod)
preserved markedly (advmod)
affecting arteries (dobj)
attributable arag (nmod)
asked quantify (xcomp)
performed procedures (nsubjpass)
show responses (nsubj)
sham ) (punct)
reached risk (nsubj)
ic 1.1 (dep)
ml/m2 82+/-12 (nummod)
risperidone % (conj)
obvious was (cop)
patients women (conj)
glycoprotein properties (nmod)
weakness right-sided (amod)
patient renal (amod)
prevalence testosterone (nmod)
tend decrease (xcomp)
difference mean (compound)
correlate measured (advcl)
extubated again (advmod)
transport of (case)
amoxicillin and (cc)
substantiate findings (nsubj)
development cystitis (nmod)
parallels and (cc)
ginsenosides hyperalgesia (nmod)
found evidences (nsubjpass)
antigen quality (conj)
safety acetate (nmod)
notable findings (nsubj)
bradycardias early (amod)
administration despite (case)
cx3cr1 the (det)
antipsychotics second (amod)
samples case-control (amod)
= 16 (dep)
unnecessary adequate (conj)
chloralose-urethane with (case)
edema layer (compound)
time writing (nmod)
aspects production (conj)
diet-fed the (det)
affected prevented (conj)
functionality in (case)
confirmed if (mark)
sensitisation therapy (nmod)
diets supplemented (amod)
importance supplementation (nmod)
reports ectopy (nmod)
175 , (punct)
administered experiment (nsubjpass)
convulsions from (case)
gd to (case)
given treatment (nsubjpass)
similar symptoms (nsubj)
given birth (nmod)
furosemide mg (appos)
holding exhaustion (nmod)
rate bone (compound)
distributed . (punct)
over-representation an (det)
rarer myocarditis (nsubj)
abnormalities of (case)
management hyperparathyroidism (nmod)
discontinuation nitroprusside (nmod)
given undertaken (advcl)
receiving transplantation (nmod)
reflect sensitization (dobj)
manageable cases (nsubj)
simple inexpensive (conj)
titrated doses (nsubjpass)
decreased compared (advcl)
cause the (det)
exceed inhibition (dobj)
investigations pharmacokinetic (amod)
type oc (nmod)
serum controls (conj)
unresponsive completely (advmod)
predicted used (ccomp)
lead decrease (nmod)
promote activation (nsubj)
undergone chemotherapy (dobj)
third pills (nmod)
mmol.kg(-1).day(-1 ( (punct)
dose individuals (nmod)
membranes ptcr (appos)
dyscrasias drug-induced (amod)
stage since (mark)
stat3 apoptotic (conj)
characteristic that (nsubj)
cisplatin bleomycin (conj)
occurrence negativity (nmod)
rast test (appos)
sr selective (amod)
one groups (dep)
rare hemolysis (nsubj)
context trials (conj)
associated daytime (nmod)
correlation markers (nmod)
interference metabolism (nmod)
prevent clentiazem (nsubj)
methods solicited (appos)
distribution intrarenal (amod)
increases minor (amod)
penetration meningitis (nmod)
dose levels (nmod)
infected for (case)
enzymes myocardial (amod)
reported potential (nsubjpass)
serious life-threatening (conj)
effects locomotor (amod)
scleroderma of (case)
opiate of (case)
defined splenomegaly (conj)
age phn (nmod)
observed conclusion (dep)
started switching (advcl)
disappeared week (nmod)
os median (amod)
retention result (nmod)
desferrioxamine dfx (appos)
hexamethonium nicotinic (amod)
1.52 1.98 (amod)
induced supplementary (nmod)
proteins liver (compound)
reported recently (advmod)
premedication diazepam (nmod)
plugs choriocarcinomic (amod)
times four (nummod)
adjusted or (dep)
sex fell (acl:relcl)
short-term self-limiting (conj)
activity cortex (nmod)
rare dangerous (conj)
performing by (mark)
elevation of (case)
10 group (nmod)
fq orphanin (compound)
lower jointly (advmod)
0.38 ( (punct)
clamping arteries (dobj)
model measures (nmod)
descriptions few (amod)
acts : (punct)
58.4 +/- (cc)
0.3 ( (punct)
immunoreactivity protein (nmod)
affinity receptor (compound)
predisposes antimetabolite-induced (amod)
suppress found (conj)
vasopressor phenylephrine (nmod)
affects that (mark)
find did (aux)
me ) (punct)
screening cost-effective (amod)
arteriosus ductus (compound)
effects ecstasy-specific (amod)
characterized children (nmod)
one virus (nsubj)
provide events (dobj)
found deficit (nsubjpass)
possibility movements (nmod)
overdosages after (case)
compare . (punct)
interact to (mark)
thromboembolism or (cc)
inhibitors coa (compound)
commencing after (mark)
contraceptives second-generation (amod)
lithium : (punct)
discuss mechanism (dobj)
experiments laboratory (nmod)
removing agent (dobj)
effective steroids (nsubj)
revealed it (nsubj)
focuses , (punct)
assess administered (advcl)
rats pd (compound)
medialipid l (appos)
increase demonstrated (dep)
goal an (det)
drawback one (nummod)
seemed decreased (conj)
response tropicamide (nmod)
glutamate or (cc)
subjects to (case)
suggest attenuates (ccomp)
aphasia incontinence (conj)
form short (amod)
abnormalities central (amod)
compared electrocardiograms (nsubjpass)
therapy eaca (compound)
compared dose (nmod)
signals with (case)
discussed phenomena (nsubjpass)
artery brachial (amod)
presented salbutamol (nsubjpass)
sedation apnea (conj)
nephrolithiasis topiramate-induced (amod)
related change (nmod)
willing were (cop)
epithelium the (det)
ao ( (punct)
attributed loss (nmod)
increases ) (punct)
role diagnostic (amod)
objective this (det)
3.7 10(-8 (conj)
had ] (punct)
assessed examination (conj)
determined toxicity (nsubjpass)
amphetamine to (case)
cohort of (case)
tissues medullary (amod)
make impact (nsubj)
death azathioprine-induced (amod)
% 90.2 (nummod)
indications these (det)
opioid-receptors on (case)
% 27.6 (nummod)
change ) (punct)
effects prevented (acl:relcl)
obstruction airway (compound)
four in (case)
used examine (xcomp)
occurred hallucinations (nsubj)
151 - (punct)
intraperitoneally days (nmod)
performed determine (xcomp)
ug 500 (nummod)
amounts varied (amod)
drug hypotensive (amod)
may 1996-nov (appos)
function apnoea (nmod)
placebo and (cc)
memory on (case)
ascites , (punct)
marked have (aux)
7 for (case)
associated monotherapy (advcl)
enhanced blockade (nsubj)
were although (mark)
irrespective anesthetic (nmod)
initiating fibrillation (dobj)
desmopressin to (case)
indicate exert (ccomp)
76 5.3 (conj)
elevated receptors (nsubjpass)
origin retinal (amod)
compared patients (nmod)
positive respectively (advmod)
investigate findings (dobj)
analogues cholecystokinin (nmod)
followed intramuscularly (advmod)
hypotension during (conj)
report of (case)
phentolamine mg (appos)
manifestation combination (nsubj)
system in (case)
experienced mucositis (dobj)
effectiveness in (case)
conducted setting (advcl)
conjugation acid (nmod)
kidney a (det)
induced dose (nmod)
antagonism potent (amod)
treated february (nmod)
normal , (punct)
effects acid (nmod)
well equally (advmod)
comparison assess (acl)
intake tramadol (nmod)
aware reaction (nmod)
containing not (conj)
30mg/kg 3 (nummod)
necessary exposure (nsubj)
ingestion night (compound)
increase bnp (nsubj)
startle fps (nmod)
developing for (mark)
effects dysrhythmogenic (amod)
29.1 21.0 (compound)
well-tolerated overall (advmod)
monitored monitor (nmod)
inhibitor mediated (acl:relcl)
adjusted is (auxpass)
resulted evidenced (advcl)
constructed pregnancy (nmod)
ameliorates conversion (nsubj)
methods injections (nmod)
home 37 (nummod)
transplantations . (punct)
acc-9653 or (cc)
potential in (case)
lc/ms/ms ( (punct)
patients doses (nmod)
2387 to (case)
effect acid (nmod)
promotes catalepsy (dobj)
receptors by (case)
included embryolethality (dobj)
rechallenged . (punct)
efficacious pain (nmod)
given min (nsubjpass)
restored days (nmod)
mitigating in (mark)
day but (cc)
meq/l respectively (advmod)
level ic (compound)
ser311cys , (punct)
assigned groups (nsubjpass)
tiopronin ) (punct)
rats bha (nmod)
5.1 0.4 (nummod)
cck-8-ns for (case)
ratios plasma/kidney (compound)
differ cocaine- (nsubj)
inhibitors sirolimus (appos)
lamina the (det)
levels pth (compound)
me in (case)
citrate no (det)
result does (aux)
trihexyphenidyl and (cc)
use equipment (nmod)
reactions because (case)
returned sensation (nsubj)
carbachol of (case)
days following (amod)
urge . (punct)
reach have (advcl)
discontinuation amiodarone (nmod)
has affinity (dobj)
performed level (nmod)
model rotation (nmod)
complications midazolam (nmod)
performed dse (nsubjpass)
ability nefiracetam (nmod)
efficacy protective (amod)
effects bupivacaine (nmod)
increase greater (amod)
30 1999 (amod)
diagnoses alternate (amod)
induced labetalol (nmod)
administration with (case)
rcts the (det)
starting day (nmod:tmod)
defibrillation minutes (nmod)
observed exposure (nmod)
tone intact (amod)
sacrifice days (nmod)
breakdown bbb (nmod)
lupus sulfasalazine-induced (amod)
toxic measured (advcl)
correlated = (dep)
ligation- two-stage (amod)
induced documented (conj)
destructive . (punct)
cco ) (punct)
blocked reduction (nsubjpass)
given routinely (advmod)
area wrist (compound)
haplotypes the (det)
increased analysis (dep)
declined patients (nmod)
1.5 1 (compound)
agent might (aux)
tests placebo-controlled (amod)
d-tubocurarine microg/kg (appos)
sgot , (punct)
sc/week 2 (nummod)
evaluated b (nsubjpass)
groups certain (amod)
midventricle hyperkinesis (nmod)
effects common (amod)
weeks 1 (nummod)
hypertrophy and (cc)
gem of (case)
thousand per (quantmod)
onset esrd (nmod)
induced anemia (dobj)
intensity aggressiveness (nmod)
revealed area (dobj)
toxicity association (dep)
possessed isomers (nsubj)
recovered he (nsubj)
reduce injection (nmod)
agent desipramine (appos)
group nausea (conj)
that deoxycholate (acl:relcl)
treated thalidomide (nmod)
efficacy antimicrobial (amod)
toxicity caa (nmod)
reaction transfusion (compound)
12 least (nmod:npmod)
elevated levels (nsubjpass)
cause rebound (nmod)
hydroxyproline of (case)
diseases label-restricted (amod)
regimens optimal (amod)
improvement , (punct)
indicate treatment (ccomp)
cells principal (amod)
composed usually (advmod)
evaluate disease (dobj)
therapy contraceptive (amod)
p20 p45 (conj)
unknown causes (advcl)
vessels large (amod)
antagonist s-312-d (appos)
role hypertension (nmod)
evokes . (punct)
agonists adrenergic (amod)
viewed , (punct)
encephalopathy metronidazole-induced (amod)
injection biochemical (nmod)
12.1 +/- (cc)
manifestations allergic (amod)
effects trazodone (nmod)
neurotoxicity visual (amod)
produce vivo (advmod)
reduce inhibition (dobj)
treated 5-fu (nmod)
inquire consumption (nmod)
degree 2 (nummod)
% associated (conj)
dcm ) (punct)
experience limited (amod)
improved learning (xcomp)
rats normal (amod)
value with (case)
received many (nsubj)
hyper- vomiting (conj)
re-observed embryos (dobj)
treatment galactose (amod)
confusion . (punct)
patients our (nmod:poss)
conclusion well-tolerated (dep)
dissociation atrioventricular (amod)
discontinuation anticoagulation (conj)
1r ] (punct)
effects locomotion (nmod)
aor 12.2 (dep)
linkage register (nmod)
hypercalcemia severe (conj)
action leading (acl)
mice b1r(-/- (appos)
range 19 (nmod)
enzyme fibroblasts (nmod)
patients liver (compound)
less solution (nmod)
lymphomas institution (nmod)
necropsy case (nmod)
icterus pruritus (conj)
cessation reduction (conj)
rats germfree (compound)
years 4.5 (nummod)
received fluids (dobj)
monoamines activity (nmod)
dipyridamole depression (appos)
use tacrolimus (compound)
sustained had (aux)
mice cd-1 (compound)
follow-up population-based (amod)
admitted surgery (nmod)
distribution surface (compound)
microgram/kg 1 (nummod)
urinalysis conventional (amod)
included symptoms (nmod)
developed whilst (prep)
aberrations of (case)
hydralazine by (case)
daily mg (dep)
process the (det)
enhanced is (auxpass)
perception altered (amod)
used simulator (nsubjpass)
stimulated ; (punct)
progression nephropathy (amod)
instituted h (dobj)
group oc (compound)
hemoglobin test (nmod)
imaging initial (amod)
month at (case)
pain ischemic (amod)
205 pph (nmod)
produced pilocarpine (nsubj)
ulcer rats (nmod)
initiation promotion (conj)
interaction simvastatin (nmod)
scale barnes (compound)
differences enzyme (nmod)
metabolism copper (compound)
responsible patient (nmod)
nicardipine subsequent (amod)
86 +/- (cc)
chow followed (acl)
receptors nm (appos)
effects ginsenosides (nmod)
day pod (appos)
tolerance local (amod)
initiating and (cc)
doxorubicin administered (acl)
group nondrinking (amod)
response antigen (nmod)
management using (acl)
appear population (nsubj)
report data (dobj)
maleate placebo (conj)
reactions adrs (appos)
analysis dvd (compound)
supporting thus (advmod)
tropicamide microl (dep)
increased 2 (conj)
program ophthalmic (amod)
g145r and (cc)
level peak (amod)
arrhythmia patient (nmod)
signs dose (compound)
lesions myocardial (amod)
processes and (cc)
tests ax (nmod)
events by (case)
rate was (cop)
weakly associated (conj)
ethopropazine and (cc)
3.8 2.2 (conj)
inhibitor net (nmod)
ems ng.ml-1 (dep)
% 39.9 (nummod)
quantify predictors (dobj)
identified schiff (nsubjpass)
reduced mutations (conj)
protect myocardium (dobj)
developed amylase (dobj)
prescribed empirically (advmod)
rose onset (nmod)
11 - (punct)
rhythm on (case)
simulator laboratory (appos)
status an (det)
section by (case)
awake alert (conj)
alkaloid is (cop)
attenuated replacement (dobj)
months for (case)
inactivation part (nmod)
injection d-amphetamine (nmod)
acetate of (case)
pronounced was (auxpass)
illustrates also (advmod)
alcohol high (amod)
hours results (nsubj)
treatment desferrioxamine (compound)
dose dependently (advmod)
beraprost prostacyclin (compound)
consequences seizures (nmod)
bradycardia as (case)
3.4 9.7 (prep)
cause concentrations (nsubj)
28.0 % (dep)
test vitro (advmod)
lesions colliculus (compound)
continued who (nsubj)
indicative phagocytosis (nmod)
uncommon eating (csubj)
present cardiotoxicity (nmod)
neurons nadph-diaphorase (amod)
levels factors (nmod)
evaluated belgium (nmod)
probable induced (ccomp)
0.48 0.08 (conj)
improved stopping (advcl)
powerful -tacrolimus (nsubj)
period 33.7 (nmod)
disturbance a (det)
antibiotic lactam (compound)
leukopenia grade (compound)
hbsag for (case)
alendronate of (case)
reversal results (nmod)
offered be (auxpass)
compared ethopropazine (nsubjpass)
patients twenty-seven (nummod)
occurred women (nmod)
peaked . (punct)
depletion salt (compound)
mmc 10 (nummod)
apomorphine with (case)
seems bear (xcomp)
expression ) (punct)
motionless animals (advcl)
carbonate lithium (compound)
treatment settings (nmod)
levodopa i.v. (amod)
results observed (dep)
increased output (dobj)
requiring intubation (dobj)
dianabol ( (punct)
progressive loss (conj)
sleepiness subjective (amod)
diagnosis dysmenorrhea (nmod)
15 30 (conj)
pca ( (punct)
england schwab (compound)
increased times (dobj)
rhabdomyosarcoma metastatic (amod)
area ua (appos)
associated analysis (nmod)
there these (det)
followed required (conj)
processes social (amod)
vincristine in (case)
stage is (cop)
differentiation little (amod)
volume end-systolic (amod)
summarize cases (dobj)
limits patients (nmod)
gaps scientific (amod)
hoarding and (cc)
generated investigate (advcl)
development hypokalaemia (nmod)
mechanism into (case)
controlled better (advmod)
estrogens associated (acl:relcl)
% 63.8 (nummod)
network of (case)
prochlorperazine administered (acl)
augmentation via (case)
gestation 5-week (amod)
play htr6 (nsubj)
boy treated (acl)
96.7 ( (punct)
c+e , (punct)
symptoms restlessness (nmod)
produce illness (dobj)
populations in (case)
csa with (case)
cases suspected (amod)
suggest evaluation (dobj)
rats atherosclerosis (nmod)
growth calcification (nmod)
2.5 to (dep)
stream blood (compound)
magnitude nitroglycerin (nmod)
receptor microglial-specific (amod)
delirium famotidine-associated (amod)
reported initiation (nmod)
agonists non-ergot (amod)
disappeared pruritus (nsubj)
revealed samples (nsubj)
prolactin 's (case)
assess enalapril (dep)
length ecg (compound)
developed not (neg)
necrotizing treatment-related (amod)
occurred experienced (advcl)
animal studies (dep)
enhanced were (auxpass)
objective estimate (dep)
outcomes chronic (amod)
smaller but (cc)
7alpha-hydroxylation cholestasis (nmod)
important recognize (xcomp)
revealed resulted (ccomp)
total rats (nmod)
pathway fas-dependent (amod)
thermal chemical (conj)
resulting syndrome (nmod)
activity intrinsic (amod)
cause failure (nmod)
contaminated to (mark)
group enflurane (compound)
antagonist properties (nmod)
ag with (case)
docetaxel to (case)
disease veno-occlusive (amod)
sedation increased (acl:relcl)
genotyped who (nsubjpass)
animals function (nmod)
electron microscopically (advmod)
edema portal (amod)
parp-1+/+ and (cc)
fall critical (amod)
aminotransferase albumin (conj)
treatment sulphonylurea (compound)
hdl g/ml (appos)
risks treatment (nmod)
rates criteria (appos)
detection mapping (nmod)
therapy doses (nmod)
doses co-trimoxazole (nmod)
characterized excretion (nmod)
pathway camp (compound)
ip the (det)
required supplementation (dobj)
complications significant (amod)
interleukin il-6 (appos)
syndrome % (appos)
shorter min (appos)
had neuropathy (nmod)
bypass cardiopulmonary (amod)
reduce . (punct)
single-blind placebo-controlled (dep)
levodopa daily (advmod)
mmhg ) (punct)
mg/kg 9 (nummod)
causes states (nmod)
mechanisms defense (compound)
infection common (amod)
occur dyskinesias (nmod)
unknown transplantation (nmod)
children immunodeficiency (nmod)
women days (nmod)
administration insertion (nmod)
development impairment (nmod)
expression enhanced (amod)
developed given (conj)
caused probably (advmod)
seizures morphine-induced (amod)
monitored moment (nmod)
ectoderm head (nmod)
intake by (case)
changes morphologic (amod)
seen complication (nsubjpass)
decrease glutamate (nmod)
pathway alternative (amod)
distracted is (auxpass)
shown results (nmod)
temperament affective (compound)
produce that (nsubj)
mrna enos (nmod)
associated were (auxpass)
resistant polyuria (nmod)
mm 1/2 (nummod)
oc 4.96 (conj)
doses doxorubicin (nmod)
ratio toxic (amod)
depressed levels (nsubjpass)
examinations neurologic (amod)
length sinus-cycle (amod)
investigation preclinical (amod)
obtained they (nsubj)
progesterone pregnane-20-ones (appos)
iopamidol ( (punct)
regressed reappeared (conj)
coherence tumor (compound)
/-8 ) (punct)
peg-asparaginase intrathecal (conj)
recognition increasing (amod)
leads which (nmod)
administered always (advmod)
action diethylnitrosamine (nmod)
decreased rigidity (nsubjpass)
proteinuria with (case)
transplant stem (compound)
electrolyte levels (dep)
effects inhibition (nmod)
effective literature (nmod)
lectin specific (amod)
effusion pleural (amod)
ip ) (punct)
history by (case)
di- inhibitors (nsubj)
rare associated (nsubj)
detected also (advmod)
correlates nociception (nmod)
suspected being (advcl)
causes stimulates (conj)
microm tam (dep)
combination treatment (nmod)
features acromegaloid (amod)
administered greater (nmod)
considered possibility (nsubjpass)
administered reductions (dobj)
effects growth (nmod)
set 3.0 (nmod)
i acid (compound)
flow an (det)
transplantation successful (amod)
lozenge gum (conj)
symptoms few (amod)
effects more (amod)
angiograms indocyanine (compound)
aftereffects clinical (amod)
solvent of (case)
therapy anticholinergic (amod)
cortex in (case)
regeneration extraocular (amod)
t30 ( (punct)
cycles 3 (nummod)
woman 30-year-old (amod)
attenuating activity (nmod)
immunosuppressive both (cc:preconj)
affect it (nsubj)
reduction adequate (compound)
classified sequence (nmod)
occurrence to (case)
fatigue and (cc)
min 3 (nummod)
report authors (nsubj)
foster charles (compound)
amisulpride tiapride (conj)
cephalexin 196,397 (nummod)
serum prepared (acl)
g/min p (dep)
revealed haemorrhages (nmod)
p ratio (dep)
probable neurotoxicity (nsubj)
induced streptozotocin (nmod:npmod)
add intensity (nsubj)
appears it (nsubj)
present taking (advcl)
dysfunction and (cc)
back values (nmod)
detected numbers (nsubjpass)
using maze (dobj)
disturbance clomipramine-induced (amod)
toxicity acute (amod)
analysis preliminary (amod)
duct vanishing (compound)
enzymes and (cc)
increase weight (nsubj)
control vehicle (appos)
improvement status (nmod)
is reduction (attr)
then until (mark)
properties stimulating (compound)
selective is (cop)
baseline both (cc:preconj)
result because (case)
indicate features (nsubj)
exist do (aux)
injury bile (compound)
causing effects (dobj)
hypotony of (case)
patients vincristine-treated (amod)
cerebral the (det)
1.21 ) (punct)
identified oscs (nsubjpass)
mothers prosthesis (nmod)
preparations in (case)
activity nsclc (nmod)
increased liver (nsubjpass)
ions selenium (compound)
lozenge a (det)
phenylbutazone mg/kg (conj)
complained later (advmod)
carbetocin intramuscular (amod)
onset explanations (nmod)
% patients (dep)
days week (nmod)
mutation a (det)
viral autoimmune (conj)
markers associated (acl)
remained domain (nsubj)
suggestion clinical (amod)
retention . (punct)
stratum stratum (dep)
severity pain (compound)
partition its (nmod:poss)
administered planned (conj)
analyzing nsaid (conj)
attenuation . (punct)
play learning (nmod)
followed caused (conj)
sings clinical (amod)
infarction non-fatal (amod)
divalproex sodium (dobj)
independent effect (nsubj)
dysfunction neuromuscular (amod)
commenced . (punct)
lt tbil (dep)
treatment setting (nmod)
epicondyle right (amod)
likely incidence (nsubj)
elevation activities (nmod)
baclofen with (case)
treated also (advmod)
compatible movement (dep)
present animals (nmod)
study small (amod)
anaesthesia normotensive (amod)
used thus (advmod)
doses different (amod)
plate the (det)
inhibited vocalization (dobj)
cystitis without (conj)
membranes model (compound)
years 6 (nummod)
tumors breast (compound)
similar strains (nmod)
sensitization nociceptive (amod)
rhythms of (case)
single-blind trial (nsubj)
cohort volunteers (nmod)
identified states (nmod)
activity ptz (nmod)
treatment inhibitors (nmod)
observed attack (nsubjpass)
gbm proven (amod)
migraine early (amod)
antebrachial lateral (amod)
years hypertension (nmod)
antagonist vitro (advmod)
p 0.002 (dep)
abnormality primary (amod)
60.44 40.0 (conj)
bpo to (case)
found is (ccomp)
developed antipsychotics (nmod)
severity infarction (nmod)
given design (conj)
phase ii (conj)
trials involving (acl)
strain radial (amod)
device a (det)
decreased cent (dobj)
values 8.5 (nummod)
detected change (nsubjpass)
exercised . (punct)
mites of (case)
treated five (nsubjpass)
limb the (det)
evoked injection (nmod)
62 ) (punct)
addition this (nsubj)
mumol/kg mumol/kg (conj)
list torsade (acl)
placed diets (nmod)
seizures pilocarpine-induced (amod)
purpose known (appos)
measured brain (nsubjpass)
modulate might (aux)
ligands novel (amod)
secretion the (det)
usa and (cc)
hg compared (case)
mg.kg-1 m (appos)
test micrograms (dep)
siadh of (case)
interaction by (case)
am149 ( (punct)
disease important (amod)
crossed months (nmod)
evaluations clinical (compound)
60 to (dep)
cases encephalopathy--19 (amod)
many probably (advmod)
activity sympathoadrenal (amod)
hyperactivity pronounced (amod)
performed identify (xcomp)
cancer analyses (nmod)
compared nonusers (nmod)
shown medication (xcomp)
synapses located (amod)
levels ldlr (nmod)
tapering concomitant (amod)
agonists opiate (amod)
earliest ) (punct)
power evaluate (acl)
given ( (punct)
demonstrated exacerbates (ccomp)
obtained administered (advcl)
hormone to (case)
risk associated (acl)
ameliorates that (mark)
occurred retention (nsubj)
in back (conj)
amiodarone dose (dep)
confirm . (punct)
svr + (cc)
recovery during (case)
seen intoxication (nmod)
bortezomib dexamethasone-containing (conj)
enabling them (dobj)
occurred arrest (nsubj)
block pattern (nmod)
alert possibility (nmod)
agent antidepressant (amod)
modified would (aux)
ages p (dep)
urge we (nsubj)
boluses and (cc)
underwent cystectomy (dobj)
admission first (amod)
autoantibodies anti-nuclear (amod)
drugs interval-prolonging (amod)
december 1994 (nmod)
(na atp (nmod)
levels acetylcholine (amod)
overdose channel (compound)
causing ) (punct)
development syndrome (nmod)
4/106 ( (punct)
0.6 , (punct)
role an (det)
activities on (case)
manual statistical (amod)
topotecan : (punct)
described level (nsubjpass)
expand we (nsubj)
sas bars (conj)
necessary patients (conj)
pentobarbital for (case)
vegfr-2/flk-1/kdr ( (punct)
suggests etiology (nsubj)
exposure accidental (amod)
deactivations stimulus-induced (amod)
endophthalmitis streptococcal (amod)
consider designs (nsubj)
studied patients (nmod)
communicated had (aux)
causing difficulty (dobj)
eyes donor (compound)
brainstem from (case)
extensive less (advmod)
suggesting process (ccomp)
hindpaw in (case)
period this (det)
proteins structural (amod)
extraction reviewed (dep)
sensory motor (conj)
pathology . (punct)
tolerability gi (compound)
times another (det)
density neuronal (amod)
movements abnormal (amod)
adolescents five (nummod)
mg bid (acl)
potent isomer.6 (nmod)
congo of (case)
conducted studied (conj)
induces loss (dobj)
obtained results (nsubjpass)
benzylpenicilloyl-poly-l-lysine benzylpenicillin (conj)
episode hypertensive (amod)
factor are (cop)
micrograms/dl 12 (nummod)
14.3 to (quantmod)
pair-matched were (auxpass)
etomidate minutes (nsubj)
adults by (case)
group pcc (compound)
alter administration (nsubj)
caused norepinephrine (nmod)
cocs ) (punct)
cm weight (conj)
presynaptic postsynaptic (conj)
micrograms/kg/min 3 (nummod)
dosing twice-daily (amod)
expressed neuropeptide-y (nsubjpass)
assistance activities (nmod)
unpredictable ventricular (conj)
binding hippocampus (nmod)
attributable ( (punct)
treatment thalidomide (nmod)
moran et (compound)
actions captopril (nmod)
suggests reversible (ccomp)
12/27 ) (punct)
rate aes (nmod)
pathogenesis disease (nmod)
diet sodium (compound)
antibiotic used (amod)
model useful (amod)
fetus to (case)
lesions neurotoxic (amod)
inhibition on (case)
dyschromatopsy by (case)
withdrawal cyclosporine (nmod)
complicated problem (dobj)
detrimental is (cop)
group chronic (amod)
recognized associated (conj)
flow this (det)
effects hypotension (nmod)
edema dependent (amod)
concentrate pcc (appos)
quetiapine of (case)
prolactin thyrotropin (conj)
lvdp/dt ( (punct)
received progression (nmod)
design studies (nmod)
efficient as (advmod)
bornstein ( (punct)
g/m2 36 (nummod)
contrary on (case)
catalyze complexes (nsubj)
decade over (case)
used ccnu (nsubjpass)
addition mannitol (nmod)
16 8 (compound)
cases available (acl:relcl)
cent 34 (compound)
numbers large (amod)
therapy be (cop)
prompted authors (dobj)
tools potential (amod)
re-observed e18.5 (nmod)
developed increasing (advcl)
potentials epicardium (nmod)
presence in (case)
prevented effectively (advmod)
attributable effect (nsubj)
induced when (advmod)
caused case (nmod)
middle-aged years (dep)
mg 118 (nummod)
given pairs (dobj)
extend purpose (nsubj)
increased giving (advcl)
associations matter (conj)
received radiotherapy (dobj)
use theophylline (compound)
form given (case)
closest , (punct)
d within (case)
analysis the (det)
abnormalities visual (amod)
ballooning changes (conj)
as and (cc)
renoprotective therapy (nsubj)
risks mortality (nmod)
> ; (punct)
del ( (punct)
metoclopramide to (case)
phosphatases alkaline (compound)
administration l-name (nmod)
intermediate of (case)
5967 40 (compound)
online or (cc)
support intraoperative (nmod)
facilitate familiarity (nsubj)
proceeded these (det)
role afterdepolarization (nmod)
stroke attacks (conj)
role sgk1 (nmod)
seizures de (amod)
onset including (case)
characterized type (conj)
death cardiac (compound)
% including (case)
induced adriamycin (nmod)
or=2.870 7.142 (conj)
investigated patients (nmod)
skf or (cc)
demonstrate none (nsubj)
rate output (conj)
exerted loreclezole (nsubj)
believed mediates (ccomp)
intervention coronary (amod)
terminated rats (nsubjpass)
metabolism along (case)
amount consumption (nmod)
imaging or (cc)
relation assumed (amod)
have myopathy (nsubj)
85.9 +/- (cc)
f(30 ( (punct)
asked recall (ccomp)
situations clinical (amod)
diseases treated (acl:relcl)
patients examined (acl:relcl)
63 to (dep)
effect phosphate (nmod)
38 mv/s (conj)
ng/ml > (dep)
values electrocardiograms (conj)
phases early (amod)
change histological (amod)
cross-tolerance of (case)
piroxicam of (case)
eyes nonresponder (compound)
mpo ) (punct)
antithrombosis tet (nmod)
tablets venlafaxine (compound)
fps in (case)
collected . (punct)
dec. 1 (nummod)
support parallels (nsubj)
brought hypotension (nsubjpass)
chorea into (case)
out study (nmod)
given half (nsubjpass)
reduction from (case)
ventricular canine (compound)
contributes effect (nmod)
at2r renal (amod)
controls wild-type (amod)
ibuprofen fever (nmod)
dose age (appos)
calculated ratios (nsubjpass)
interviewed participants (nsubjpass)
0.03 or (cc)
study throughout (case)
daunorubicin study (dep)
levobupivacaine of (case)
boluses a (det)
lowering by (mark)
declined immediately (advmod)
hexamethylmelamine daily (conj)
microl ) (punct)
induced . (punct)
mg propofol (nmod)
levels ce (compound)
used bypass (nsubjpass)
response course (conj)
3.5 ) (punct)
work recent (amod)
reassured . (punct)
patients surgery/radiotherapy (nmod)
opiates other (amod)
3.1 +/- (cc)
victim pain (nmod)
ligand myocardium (nmod)
interventions major (amod)
mapd ) (punct)
report oncology (compound)
revealed crescents (nmod)
mice receptor (compound)
infusion total (amod)
induced adriamycin (nsubj)
affecting mainly (advmod)
used conclusion (nmod)
beck zung-conde (conj)
had nsclc (dobj)
optic a (det)
higher gfr (nsubj)
associated thrombosis (nmod)
reduced deacetylation (dobj)
improved inactive (advcl)
risk high (amod)
reduced drinking (dobj)
resistance the (det)
grade % (appos)
caused cessation (nmod)
animals wt (compound)
woman hyperaldosteronism (nmod)
monitoring clinical (amod)
dealt infarction (nmod)
excitation electromyographic (amod)
delay average (amod)
infusion before (nmod)
induced neurotoxicity (dobj)
77.1 +/- (cc)
diagnosis lesion (nmod)
older and (cc)
tg of (case)
time progression-free (amod)
methotrexate high-dose (nsubj)
indicated mice (nsubj)
lower p=.02 (dep)
associated frequency (nmod)
interviewed later (advmod)
salbutamol by (case)
infusion ouabain (compound)
infrequent % (nmod)
epicondyle lateral (amod)
seems gpi (nsubj)
excellent eating (advcl)
indicative dyskinesia (nmod)
treatment seizures (nmod)
diagnosis new (amod)
stable counts (nsubj)
activator be (cop)
phytomitogen to (case)
observed system (nmod)
anxiety such (case)
related 600 (nmod)
administered repeated (conj)
disease stroke (amod)
required who (nsubj)
factor heparin-platelet (amod)
allografts renal (amod)
pretreatment ) (punct)
suggest stage (ccomp)
day l-dopa (conj)
using metolachlor (dobj)
pathogenesis apnea (nmod)
myopathy due (case)
arm used (acl)
mortality total (amod)
use to (case)
cardiomyopathy congestive (conj)
february from (case)
return function (nmod)
referred man (nsubjpass)
showed specimens (nsubj)
precursor a (det)
anesthesia enflurane (compound)
rats arabic (nmod)
hyperkinesia but (cc)
suppressed dbs (nsubj)
drug as (mark)
range sensitivities (nmod)
every 11 (nummod)
markers necrosis (nmod)
atrial cardiomyocytes (dep)
patients 34 (nummod)
minutes 80 (nummod)
exhibited improvements (dobj)
time level (appos)
care wound (compound)
ci 0.47 (dep)
conclusion testing (dep)
controlled should (aux)
report single (amod)
use recreational (amod)
phenomena these (det)
induced test (nmod)
lithium mg/day (dep)
clonus first (amod)
showed considered (advcl)
episodes transient (amod)
response control (compound)
fasciculation succinylcholine-induced (amod)
biomarkers allow (acl:relcl)
diagnosed he (nsubjpass)
included cause (dobj)
regimen treatment (compound)
reversal , (punct)
levels cimetidine (compound)
study injury (dobj)
deterioration cerebral (amod)
behaviors pain (compound)
nonselective ( (punct)
levels cd36 (compound)
consistent vasoconstriction (nsubj)
did capture (dobj)
use prednisone (nmod)
given volunteers (nmod)
factors ix (conj)
showed attenuated (ccomp)
hepatocytes mice (nmod)
consumption by (case)
risk impairment (nmod)
those and (cc)
individual an (det)
coadministration extract (nmod)
mild was (cop)
ameliorated whereas (dep)
former the (det)
mu ) (punct)
elevated concentration (nmod)
ratio parameters (conj)
response vessels (compound)
fpdc ( (punct)
a medications. (compound)
increases pathway (nmod)
terminated anaesthesia (nsubjpass)
identified 9 (nsubj)
inactive that (nsubj)
persons hiv-positive (amod)
cardiotoxicity serious (amod)
l-arginine syntheses (dep)
withdrawal clotiazepam (compound)
monitor hbv (compound)
recovery clinical (amod)
lines both (det)
were improvements (nsubj)
became pressure (nsubj)
that d2 (nmod)
range u/ml (dep)
higher levels (nsubj)
class one (nummod)
53 % (appos)
place thymidine (nmod)
thrombocytopenia priapism (conj)
use cyclosporine (nmod)
zero , (punct)
depend strategies (nsubj)
recorded simultaneously (advmod)
elevated was (auxpass)
formulation swedish (amod)
hypocalcemia in (case)
profile safer (amod)
statistically , (punct)
patients 77 (nummod)
evaluate impact (dobj)
supply demand (conj)
cardiomyopathy mitochondrial (amod)
ng/ml normal (amod)
interaction warfarin (nmod)
nonusers aspirin (nmod)
number drugs (nmod)
p=0.65 ) (punct)
recorded period (nmod)
treatment dobutamine (compound)
alpha-methyl-para-tyrosine of (case)
database practice (compound)
associated risk (compound)
dose 1 (nummod)
defibrillation by (case)
beverages in (case)
lometrexol of (case)
ace i/d (appos)
stages further (amod)
evaluated monotherapy (dobj)
mg/m(2)/day 0.9 (nummod)
hospitals community (compound)
exert androgens (nsubj)
preventing reducing (conj)
examinations neurological (amod)
increased ( (punct)
timolol , (punct)
reactions ocular (amod)
superior that (mark)
fluid with (case)
children underwent (acl:relcl)
dose 2.35 (nmod)
exacerbation or (cc)
mris follow-up (compound)
phase acute (amod)
disease using (acl)
potentiates initiation (dobj)
sequelae further (amod)
function performance (conj)
b stress (conj)
predictor , (punct)
responded steroids (nmod)
postdose at (case)
targeted people (nmod)
combination given (acl)
slower clearly (advmod)
% 3.4 (nummod)
made ; (punct)
component mediated (acl:relcl)
cad associated (acl)
seizures by (case)
reduction duration (nmod)
caused become (xcomp)
polymorphisms drd2 (compound)
injected sites (nmod)
man 67-year-old (amod)
confounding by (case)
score mm (dep)
metabolism serum (nmod)
given before (advmod)
conducted comparison (nmod)
050+/-561 p<0.05 (appos)
inhibitors due (case)
dementia essential (amod)
limited safety (nmod)
application dosages (nmod)
treatment cells (nmod)
use acid (dobj)
reduction baseline (nmod)
pge2 b2 (conj)
besylate . (punct)
administered times (nmod:tmod)
reviews ophthalmic (amod)
doses both (det)
system cardiovascular (amod)
cortex changes (conj)
role small (amod)
pronounced effects (nsubjpass)
dysfunction acute (amod)
rofecoxib they (nsubj)
increased produce (advcl)
phonation during (case)
acts protein (dep)
revealed arteries (dobj)
reviews . (punct)
studied changes (dobj)
wistar rats (dep)
stage hypertension (nmod)
ufov -- (punct)
results combination (nmod)
exercise-controls in (case)
beta-blockers controls (nmod)
constipation-predominant , (punct)
revealed suppressed (ccomp)
means air (nmod)
monitoring neuromuscular (amod)
ingesting dosage (nmod)
indicator sensitive (amod)
woman 27-year (amod)
6 7 (prep)
malondialdehyde latter (amod)
faced victim (nmod)
exerts influence (dobj)
, as (dep)
that left (nmod)
avp anp (conj)
percent sixty (nummod)
son the (det)
processes induced (acl)
efficacious were (cop)
comprising extremes (dobj)
gem and (cc)
rate norepinephrine (nmod)
types 2 (dep)
generated sites (conj)
evidence degeneration (nmod)
500 200 (compound)
cycle nelarabine (nmod)
dysrhythmias spontaneous (amod)
simplifies treatment (dobj)
supports further (advmod)
ebstein 's (case)
conclusions causes (appos)
treatment placebo (nmod)
administration vincristin (compound)
overactivation ipsi- (conj)
registered were (cop)
bigeminy and (cc)
36 +/- (cc)
test rats (nmod)
use minoxidil (nmod)
males females (nmod)
agonist mixed (amod)
synthesis nerve (compound)
attenuate antioxidants (nsubj)
likely while (mark)
promotes promoting (advcl)
proportion cases (nmod)
seems deserve (xcomp)
inhibitor decarbodylase (compound)
healthy . (punct)
men % (nsubj)
user admitted (amod)
experiment performed (acl)
set 2 (dobj)
subscale locf (nmod)
end at (case)
noted whereas (mark)
cells proximal (amod)
thickness fiber (compound)
59 to (dep)
evident this (nsubj)
prodrugs ester (compound)
failure thrombocytopenia (conj)
dose days (nmod)
reviewed provide (xcomp)
selectivity affinity (conj)
fraction of (case)
tumors t1 (compound)
requiring procedures (nsubj)
had likely (conj)
physicians records (conj)
october 2006 (nummod)
sunbelt the (det)
complex the (det)
models cox (compound)
december survived (acl:relcl)
pd following (case)
diethylpropion medication (compound)
elevation plasma (compound)
ncr181 and (cc)
% 44 (nummod)
used although (mark)
65 were (cop)
confusion progressive (amod)
spasm masseter (compound)
serious more (advmod)
2 more (conj)
hypercholesterolemia because (case)
sample study (nmod)
dose about (case)
colliculi the (det)
disease inflammatory (amod)
% 80 (compound)
platinum- cancer (conj)
effect on (case)
conditioning the (det)
anticoagulant indicated (conj)
crf mg/dl (dep)
experiment created (acl)
incidence a (det)
4.4 10.9 (prep)
lid with (case)
shows and (cc)
discharged when (advmod)
developed retinopathy (dobj)
obtained risperidone (nmod)
acuity including (case)
polyuria lithium (compound)
n ] (punct)
divided was (auxpass)
hydrochloride [4ar-trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5n-propyl-2h-pyrazo (dep)
risks . (punct)
prevented bradycardia (nsubjpass)
levels 5-ht (nmod)
were t-tests (attr)
e.g. ( (punct)
similar serum (conj)
movements related (acl:relcl)
infections suspected (amod)
prostheses receiving (amod)
formed have (aux)
ninety-nine dose (conj)
erp , (punct)
infarction suspected (amod)
events gastrointestinal (amod)
tremor outstretched (amod)
incidence dysfunction (nmod)
group third (amod)
program can (aux)
17 11 (compound)
dwi but (cc)
pge1 tmp (conj)
degree reaction (conj)
something unknown (amod)
hypotension no (neg)
administration a (det)
parp ) (punct)
occur described (conj)
has which (nsubj)
produced that (nsubj)
tachycardia rats (nmod)
function skeletal (amod)
s followed (acl)
correlates encoding (advcl)
children and (cc)
studies two (nummod)
induce may (aux)
consisted vacuolization (nmod)
effects varying (acl)
docetaxel intravenous (amod)
ct rt (conj)
teratogenicity possible (amod)
use about (case)
concentrations creatinine (nmod)
tract gi (compound)
dependence the (det)
september 2007 (nummod)
99 , (punct)
affect erp (dobj)
fraction lv (amod)
options , (punct)
measures group (nmod)
ed1-ed4 ( (punct)
preceded may (aux)
effects beta-blockers (nmod)
kanamycin with (case)
reduce volume (dobj)
reactions apraclonidine (nmod)
dosage amiodarone (nmod)
pretreated vagotomised (conj)
attributable mazindol (nmod)
used determine (advcl)
myopathy by (case)
relationship dose-response (amod)
lower oral (nmod)
access(r and (cc)
millions individuals (nmod)
7 +/- (cc)
polyphagia polyuria (conj)
suffered patients (nmod)
change an (det)
6/31 and (cc)
hospital ( (punct)
rate positive (amod)
scattered ) (punct)
accompanied effect (dobj)
systems glutamatergic (amod)
blot by (case)
switching patients (dobj)
effect p.o. (nmod)
assay delay (compound)
piroxicam groups (conj)
rhinitis of (case)
suggesting and (cc)
lethality seizures (nmod)
agents maneuvers (conj)
rare reversible (conj)
nnos ( (punct)
searched database (conj)
simvastatinezetimibe and (cc)
required they (nsubjpass)
are trials (nsubj)
2006 ) (punct)
rise peak (amod)
started report (nmod)
upregulated , (punct)
included analysis (conj)
actions vasoconstrictive (amod)
sustained days (nmod)
14 10 (compound)
complications postoperative (amod)
rebound of (case)
(meth)-induced methamphetamine (nmod:npmod)
risk lower (amod)
2e1 p58 (conj)
route by (case)
anesthetic duration (nmod)
susceptibility antiviral (amod)
characteristics hyperalgesia (nmod)
awake minutes (nmod)
obtained examined (conj)
experienced respectively (advmod)
noted number (nsubjpass)
patient groups (conj)
woman-years and (cc)
neonates healthy (amod)
tolerate l-sotalol (conj)
derivatives , (punct)
rhei from (case)
unresponsive . (punct)
exhibit dyskinesias (dobj)
production ultrasound (compound)
machinery integrins (conj)
delirium excited (amod)
suggested inherent (ccomp)
occurs results (nsubj)
argatroban prolonged (amod)
cessation to (case)
tested weeks (nmod)
effects fewer (amod)
artery of (case)
resulted however (advmod)
serotonin damage (compound)
facilitates rats (nmod)
patients 10 (dep)
arrhythmogenicity in (case)
increases non-significant (amod)
patients risk (compound)
fide bona (amod)
cases four (nummod)
pressure rate (conj)
clonidine the (det)
test provocation (compound)
myositis atra-induced (amod)
dysrhythmias hours (nmod)
sensor b (nsubj)
specimen keratome (compound)
monitoring blood (compound)
needed hospitalization (dobj)
28 and (cc)
pain report (dep)
determine reduces (ccomp)
studied deliberate (dep)
surmountable blockade (nsubj)
fed were (auxpass)
limits 28 (dep)
conclusions effective (dep)
signs symptoms (conj)
prior onset (nmod)
areas compared (case)
methods percutaneous (amod)
ages group (nmod)
g 10 (nummod)
effects section (nmod)
increased faster (advmod)
continue treatment (nmod)
protocol per (case)
testing positive (amod)
substantiate concept (dobj)
level peptide (nmod)
departments emergency (compound)
suffering . (punct)
produce humans (nmod)
studied order (nmod)
greater % (dep)
re-started which (nmod)
access sugar (compound)
incidence drowsiness (conj)
males patients (nsubj)
applicators including (case)
153 147 (conj)
membranes all (predet)
injected littermates (conj)
greater area (nsubj)
syndrome pan-induced (amod)
explored toxicity (nsubjpass)
k(na ) (punct)
rara lamina (compound)
procedure during (case)
ineligible were (cop)
experienced years (nmod:tmod)
calibration with (case)
lacking mpges-1 (dobj)
maintained animals (nsubjpass)
mice adr (nmod)
iowa carolina (conj)
enrolled study (nsubj)
diameters mean (amod)
processing working (amod)
subcortex cortex (conj)
any conditions (nmod)
interdependence due (case)
mm mm (conj)
men seven (nummod)
cyclophosphamide carboplatin (conj)
medication available (acl:relcl)
given had (aux)
capable were (cop)
patients dependence (compound)
form 36 (nummod)
investigate relationship (dobj)
10-diol ) (punct)
frequent reactions (nsubj)
concentration pvn (nmod)
weeks 20 (nummod)
toxic were (cop)
provided solutions (nsubjpass)
administration on (case)
sleeping when (advmod)
identified database (nmod)
artery , (punct)
protein also (advmod)
tumor diameter (dep)
research clearly (advmod)
hepatonecrosis report (dep)
ablation attack (conj)
hepatotoxicity sulfasalazine (nmod)
6.5 than (quantmod)
half-life short (amod)
blocker receptor (compound)
documentation proteinuria (nmod)
advantages possible (amod)
treatment initial (amod)
patients 64 (nummod)
pathogenesis to (case)
twins dizygotic (amod)
stages into (case)
length qtc (conj)
infusion 15-minute (amod)
manifestation clinical (amod)
renin of (case)
6/15 2/60 (conj)
= and (cc)
ranging 300 (nmod)
associated release (nmod)
increased bpm (nmod)
used being (auxpass)
paradigm passive (amod)
frequency placebo (nmod)
capd ) (punct)
women older (amod)
pre-treatment pk (nmod)
d-glucarate size (nmod)
anticoagulation systemic (amod)
raised regard (nmod)
bradycardia morphine-induced (amod)
watch and (cc)
effects hemodynamic (amod)
encoding planning (conj)
functions various (amod)
methods cohort (appos)
duct the (det)
patients 24 (nummod)
reported frequently (advmod)
enos of (case)
generation atp (compound)
pa a (det)
glioblastoma in (case)
severe control (nmod)
score behavioral (amod)
men borderline (compound)
patients mg/m2/d (nmod)
290 260 (compound)
phosphatase located (amod)
detected has (aux)
experienced events (dobj)
cent in (case)
decreased accumulation (nsubj)
induce tachycardia (dobj)
patients evaluated (dep)
acts and (cc)
pulmonary and (cc)
agonist cp (appos)
mg/0.5 20 (compound)
effects various (amod)
described paper (nmod)
tetrachloride , (punct)
whom 3 (nummod)
n=12 group (nmod)
age on (case)
reactions common (amod)
altered pregnancy (nmod)
month after (case)
dose muscle (nmod)
doses 0.03 (nmod)
number protein (conj)
aminonucleoside by (case)
p=0.37 ) (punct)
ato water (conj)
open-chest anesthetized (dep)
inhibits tam (nsubj)
statistics sales (compound)
cold over-the-counter (amod)
0.001 ( (punct)
failure recurrent (amod)
volume urine (nmod)
anxiolysis diazepam-induced (amod)
0.005 less (advmod)
years or (cc)
implicated system (nsubjpass)
published both (cc:preconj)
southeast the (det)
downregulation pronounced (amod)
causes also (advmod)
hepatotoxicity phosphorus (compound)
degeneration some (det)
haemorrhage consumed (acl:relcl)
men 43 (nummod)
lack finally (advmod)
group group (conj)
1/10 number (nmod)
nephrotoxic potentially (advmod)
output her (nmod:poss)
% 28 (compound)
underwent men (nsubj)
loci mice (nmod)
persists progress (conj)
1.0 ) (punct)
function memory (conj)
penicillins defect (appos)
cta patients (nmod)
tilts administration (nmod)
useful combination (nsubj)
receptor low-density (amod)
impairment scattered (dep)
induces labetalol (nsubj)
prescribed , (punct)
alpha3 and (cc)
exposure isotretinoin (nmod)
score modified (amod)
carcinogen as (case)
group mild-type (amod)
regimen dosage (compound)
lh ( (punct)
0.1 1.0 (conj)
alive dose (nmod)
heart nmol/min/g (amod)
found smoking (nsubjpass)
report can (aux)
testes small (amod)
elevated titer (nsubj)
monitoring ecg (compound)
all antagonists (nmod)
determined gravity (nsubjpass)
gaba(a)rs ( (punct)
adenoma and (cc)
period shorter (amod)
tolerated few (nsubjpass)
bp injury (conj)
beta to (case)
agents versus (case)
deprivation rem (compound)
reviewed changes (nmod)
washout a (det)
pdn mg/kg/day (amod)
17 3 (quantmod)
arrest days (nmod)
bs of (case)
decrease drugs (nsubj)
noted tests (nmod)
day 7th (amod)
treatment first-line (amod)
lead administered (advcl)
treated controls (nmod)
ed50 and (cc)
piglets the (det)
examined sensitivity (nsubjpass)
relevance able (advcl)
arteriosus of (case)
received cimetidine (dobj)
therapy antithrombotic (amod)
occurred interaction (nsubj)
males between (case)
made nucleus (nmod)
h over (case)
enhancement cardiac (conj)
ccl4 ) (punct)
platform arms (conj)
effects potent (amod)
occurrence seizures (nmod)
found pathologically (advmod)
hundred fourteen (conj)
risk measured (acl)
decreased nitrate/nitrite (nsubjpass)
therapy control (nmod)
contraceptives risk (conj)
data current (amod)
movement dyskinesia (nmod)
decreases behavior (nmod)
a t+a (dep)
rash vasculitic (amod)
curve bladder (compound)
enabled differentiation (dobj)
influx calcium (compound)
slowing adriamycin (nmod)
studied permeability (nsubjpass)
suggest sod (ccomp)
tetra- pentaglutamate (conj)
1.8 99.0 (dep)
developed clinical (xcomp)
mechanisms which (nmod)
weeks her (nmod:poss)
models animal (compound)
found characteristics (nmod)
induction during (case)
microarrays and (cc)
profile their (nmod:poss)
months median (dep)
development proteinuria (nmod)
describe hypertrophy (dobj)
group beta=0.49 (dep)
results p<0.001 (appos)
open trial (conj)
medications such (case)
nvp ) (punct)
seem true (xcomp)
trigeminal systems (conj)
left isoproterenol (nmod)
investigated study (nsubj)
1/8 ) (punct)
layers from (case)
studies relating (acl)
deaths more (amod)
response treatment (nmod)
ibuprofen mefenamic (conj)
erythematosus sulfasalazine-induced (amod)
11.8 - (punct)
8-week-old hemizygous (dep)
that gum (nmod)
decreased p (dep)
discontinued administered (conj)
impaired properties (nmod)
evaluated ability (dobj)
aggravated was (auxpass)
evaluated should (aux)
vnr with (case)
all weight (nmod)
disease penicillamine-induced (amod)
cramps for (case)
similar extraordinarily (advmod)
deprivation water (compound)
developed or (cc)
correlated well (advmod)
co-administration aspirin (nmod)
data show (advcl)
hoehn the (det)
continue play (xcomp)
biomarkers as (case)
lasting up (compound:prt)
benzodiazepines and (cc)
sedation aroused (advcl)
protected , (punct)
taking yohimbine (dobj)
liver tbars (conj)
reviewed are (auxpass)
d between (case)
resolved asterixis (nsubj)
acidity the (det)
unreported previously (advmod)
pressure atrial (amod)
spared lesions (nmod)
relevant that (mark)
inhibited surge (conj)
explore using (xcomp)
ctni ng/ml (appos)
stimulation hilus (nmod)
responds therapy (nmod)
ratio women (nmod)
include ; (punct)
therapy addiction (nmod)
significant association (nsubj)
continue or (cc)
neurons ir (compound)
syndrome withdrawal-emergent (amod)
coeruleus locus (compound)
transaminase , (punct)
causing arrhythmias (dobj)
experienced confusion (dep)
relationship events (nmod)
reduction transient (amod)
sensitisation of (case)
mutants ( (punct)
neuropathy lateral (amod)
prevent whether (mark)
mitoq antioxidant (appos)
nephropathy grafts (conj)
sgot of (case)
movement abnormal (amod)
dissociate chloride (nsubj)
involvement organ (compound)
reversible disease (nsubj)
patients renin (dep)
determined were (auxpass)
spikes membrane (compound)
produced muscimol (nsubj)
rats 5-week (amod)
assessment function (nmod)
57 1 (compound)
associated stress (nmod)
agonist glutamate (amod)
toxicity meloxicam-induced (amod)
discussed possibility (nsubjpass)
quinine- both (cc:preconj)
prodrug ( (punct)
indicate provided (ccomp)
anticonvulsants children (nmod)
order remove (acl)
velocity reduced (amod)
microg/kg placebo (conj)
renal heart (conj)
infants undergoing (acl)
found beneficial (xcomp)
prostanoids release (nmod)
reactions minimal (dep)
ec50 ( (punct)
readjustment by (case)
cells hepg2 (compound)
symptoms the (det)
treated dialysis (nmod)
34 4 (conj)
compare incidence (dobj)
flutamide mg (amod)
60 +/- (cc)
separation via (case)
given counteract (xcomp)
decreased both (nsubjpass)
slope as (case)
capsaicin predictors (conj)
lower 0.01 (dep)
reversible azathioprine-induced (dep)
ingestion with (case)
vomiting and/or (cc)
administration chronic (amod)
nodosum erythema (amod)
treatments acc-9653 (compound)
features because (case)
responded administration (nmod)
evident model (nmod)
performed 29 (nmod)
time diagnosis (nmod)
embryopathy isotretinoin (compound)
contraction pulmonary (amod)
nerve eighth (amod)
made recordings (nsubjpass)
ingestion diphenylhydantoin (nmod)
one carolina (nmod)
suggest suppresses (ccomp)
n. ) (punct)
off ' (punct)
such , (punct)
dose from (case)
prevention infection (nmod)
positive antigen (nmod)
group entire (amod)
normalized cbd (conj)
labetalol or (cc)
blunted hypoactivity (dobj)
testing clinical (amod)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate derivative (amod)
wall aortic (amod)
chest the (det)
measured latencies (nsubj)
administration desipramine (nmod)
loss paresthesias (conj)
pressure variability (conj)
high fairly (advmod)
observed recovery (nsubjpass)
day dose (conj)
severe to (mark)
protection toxicity (nmod)
paper this (det)
cpb from (case)
inhibition adenylate (compound)
linked anesthetic (nmod)
decrease for (case)
abolished 5,7-dihydroxytryptamine (nmod)
conclusion to (case)
less .01 (nmod)
determined compared (conj)
failed administration (nsubj)
recording , (punct)
gram-positive against (case)
analogue oxytocin (nmod)
use tachyarrhythmias (nmod)
rated quality (nmod)
exposure extreme (amod)
restores rg1 (nsubj)
absorption mepivacaine (nmod)
indicating involvement (dobj)
reducing myelotoxicity (dobj)
pressures patients (nmod)
changes parameter (compound)
acc-9089 ) (punct)
preparation a (det)
compared placebo (conj)
cortices in (case)
mice seized (amod)
deprivation treatment (conj)
therapy ace (compound)
increase have (conj)
ach ( (punct)
wear tooth (compound)
had experienced (conj)
littermates for (case)
one intervals (dep)
alphaenac proteins (dep)
receive because (mark)
dyskinesias particularly (advmod)
failure stroke (compound)
26 % (appos)
site injection (nmod)
conclusions show (appos)
nimo ) (punct)
threatening condition (dobj)
doxorubicin/kg mg (compound)
up-regulation rats (nmod)
mg/kg single (amod)
action convulsant (amod)
continue total (nmod)
reduced employing (advcl)
induced hypotension (dobj)
albeit transient (amod)
microangiopathy necrosis (conj)
teratogenic be (cop)
marked lobe (nmod)
ototoxicity gentamicin (compound)
effect methyldopa (nmod)
group by (case)
reduced diseased (nmod)
s-312 not (cc)
aura with (case)
turn which (nsubj)
discriminated . (punct)
direction either (cc:preconj)
proliferators cardiac (amod)
lesions encephalopathy (nmod)
neurons medulla (compound)
running seizure (dobj)
response pituitary (amod)
cingulate cortices (conj)
displayed patients (nsubj)
aware take (conj)
levels striatum (conj)
patients ssc (nmod)
have greater (conj)
fever myalgias (conj)
16 3 (conj)
noted methods (dep)
caused injection (nsubj)
6 7.5 (conj)
concentration residual (amod)
incidence cystitis (nmod)
glycosuria g/day (nmod)
saline acute (amod)
treated daidzein (nmod)
assessment patient (compound)
provided statistics (nmod)
adrenergic and (cc)
aspirated . (punct)
effect obtained (amod)
density tumor (compound)
metalloproteinases mmps (appos)
switching divalproex (advcl)
year 51 (nummod)
diagnosis aids (compound)
galactose daily (amod)
infection pneumonia (nsubj)
degeneration with (case)
microg/side ( (punct)
injection iopentol (nmod)
sum as (case)
all at (advmod)
used treat (xcomp)
nalozone mg/kg (appos)
had abnormality (dobj)
limit a (det)
defects perfusion (compound)
determine incidence (dobj)
bort mg/m(2 (appos)
threshold convulsive (amod)
activity eeg (nmod)
measurements sequential (amod)
tolerance pain (compound)
given dose (xcomp)
vt fibrillation (conj)
dronedarone of (case)
analyzed damage (nsubjpass)
abundance the (det)
suggested startle (nsubjpass)
first study (nsubj)
includes inhibitors (dobj)
headache % (dep)
decreased count (nsubj)
idazoxan mg/kg (appos)
case rs (nmod)
ctni of (case)
alterations interval (nmod)
rate pressure (conj)
processes processes (conj)
administered dosage (nmod)
deprivation , (punct)
ng/ml 150 (compound)
carcinogens n-methyl-n-nitrosourea (conj)
signs lesions (conj)
renin plasma (compound)
0.66 2.17 (nummod)
potentiation prevention (conj)
pharmaceuticals beecham (compound)
occurred which (nmod)
revealed abundance (dobj)
infant in (case)
dose pci (nmod)
men belonging (acl)
emphasized been (auxpass)
gland from (case)
induction diabetes (nmod)
present 62 (dep)
di- tri- (conj)
individuals infected (amod)
objective . (punct)
downregulation including (case)
systolic to (case)
discontinuous . (punct)
resistant developed (advcl)
nausea ( (punct)
showed gall (conj)
18.88 +/- (cc)
alpha alpha (conj)
enalapril follow-up (nmod)
involved is (auxpass)
production pain (conj)
clonidine placebo (conj)
protein 35 (nummod)
deficiency prenatal (amod)
stat3 pathways (dep)
sharps of (case)
thrombectomy percutaneous (amod)
level 270 (dep)
warranted patients (nmod)
pharmacology clinical (amod)
volume intravenous (amod)
bronchiectasis for (case)
component than (case)
outcomes treatment (compound)
cycle twice (predet)
related methyldopa (nmod)
parkinsonism for (case)
hypothesized findings (nmod)
instillations the (det)
control long-term (amod)
have creatinine (dobj)
started is (advcl)
signs parkinsonian (amod)
health patients (nmod)
assessment hypertrophy (nmod)
read them (nmod)
rofecoxib either (cc:preconj)
maintained also (advmod)
5th whereas (mark)
correlated had (conj)
suggesting late (ccomp)
patients receiving (conj)
associated return (nmod)
dizziness nausea (conj)
leg the (det)
tachyarrhythmias interaction (dep)
protease neutral (amod)
awake while (case)
described reviewed (conj)
plausibility the (det)
bnpp mm (appos)
females two (nummod)
decreases patients (nmod)
rats glycosuria (nmod)
analysis our (nmod:poss)
regression linear (amod)
majority transfusion (conj)
episode following (case)
used weight (nsubjpass)
liver for (case)
seizure generalized (amod)
required e.g. (advmod)
action appropriate (amod)
pregnancies normal (amod)
behaviours distinct (amod)
nephrosis adr-induced (amod)
tropicamide and (cc)
carotid endarterectomy (dobj)
net the (det)
patients adenocarcinoma (nmod)
1995 - (punct)
included ratio (dobj)
strains resistant (amod)
toxicity streptozotocin (nmod)
performed days (conj)
needed % (nsubj)
nephropathy patients (nmod)
study double-blinded (amod)
given available (advcl)
l 75 (nummod)
npy of (case)
change m.s. (compound)
had responses (nmod)
accelerated and (cc)
= 196 (dep)
rebounded . (punct)
dcf os (nmod)
produced stimulation (nmod)
prior between (case)
activation sarcolemma (nmod)
showed decrease (dobj)
exceed micrograms/kg/ml (dobj)
enhancers dna (compound)
benefited use (nmod)
volume effusions (nmod)
rats rabbits (conj)
absorbed , (punct)
ptcr of (case)
undertaken aggregation (conj)
conclusion report (dep)
glioma ( (punct)
immunoassay heparin (compound)
observed postdose (nmod)
influence a (det)
diffuse lymphoma (dobj)
= 0.0012 (dobj)
dose smallest (amod)
serotonin to (case)
cyp3a4 ) (punct)
nat [ (punct)
induction remission (compound)
diet fed (acl)
hepatitis renal (conj)
hyperactivity morphine-induced (amod)
investigated and (cc)
incorporation slices (nmod)
changes or (cc)
emit exposure (nmod)
chewing mice (nmod)
tested effect (nsubjpass)
divided had (conj)
age except (case)
records women (nmod)
lost was (auxpass)
antidotes and (cc)
susceptibility calcification (nmod)
maintenance flow (nmod)
score score (dep)
dg-5128 peripheral-acting (amod)
summarizes cases (dobj)
convulsion mouse (nmod)
failure therapy (nmod)
groups polydrug (compound)
brain imaging (compound)
10.5 7.1 (conj)
lived , (punct)
sites tumor (compound)
ibuprofen of (case)
injection on (case)
splitting membrane (nmod)
cnp ) (punct)
modalities conventional (appos)
riha ( (punct)
different reproducible (conj)
underwent insertion (dobj)
recognition dysfunction (conj)
observed ccr2 (nsubjpass)
proliferation maturation (conj)
ill quite (advmod)
substrate 3a4 (compound)
precluded . (punct)
200mgkg(-1 with (case)
imaging enhanced (amod)
conclusions , (punct)
analyzed method (dep)
diagnosed was (auxpass)
pneumonia were (cop)
led which (nsubj)
observed changes (nsubjpass)
dependence time (compound)
complication another (det)
ecstasy mdma (appos)
subjects genotyped (acl:relcl)
injuries these (det)
hippocampus the (det)
sinus radiograph (dobj)
erythema multiforme (dep)
burden the (det)
injected operation (nmod)
responsive less (advmod)
declines acute (amod)
assessed rigidity (nsubjpass)
blunted lesions (nsubj)
entity the (det)
dex p (appos)
developed fully (advmod)
bcnu to (case)
methods ; (punct)
higher b12 (nsubj)
metastases cancer (compound)
content gm (compound)
asymptomatic detected (conj)
related time (nmod)
antibody-negative hit (nmod:npmod)
dexamethasone high-dose (amod)
differences sex (compound)
7 4 (conj)
preclude not (neg)
instillation girl (nmod)
referred us (nmod)
bacteremias the (det)
died infusion (nmod)
seen than (mark)
replication strains (nmod)
ml 20 (nummod)
induced conditions (nmod)
begun sequence (nsubjpass)
srl 0.4 (nummod)
cystitis pollakisuria (conj)
consuming are (aux)
groups diameters (nmod)
performed are (auxpass)
mediated mechanisms (nmod)
is which (nmod)
events discharged (acl:relcl)
appear result (xcomp)
agent it (compound)
experienced thrombocytopenia (dobj)
revealed revealed (conj)
250 , (punct)
glomerulonephritis patient (nmod)
values beta-hcg (amod)
onset ) (punct)
lvef lvdp/dt (conj)
myocarditis secondary (amod)
frequencies for (case)
have tests (nsubj)
avoid confounding (conj)
formation bile (compound)
serious favourable (conj)
supervision staff (compound)
day mg/m2 (dep)
additive not (neg)
pain burning (amod)
alpha-configuration the (det)
cells rbcs (appos)
33 91 (dep)
administration prevent (acl)
addition propofol (nmod)
concentration nor (cc)
restarted was (auxpass)
involvement axonal (amod)
total mg/m2 (nmod)
confirm to (aux)
rh ) (punct)
left assessed (advcl)
studied protocol (nmod)
eye right (amod)
mmrm ) (punct)
days both (cc:preconj)
organisms to (case)
factor a (det)
control amiodarone (conj)
density percent (conj)
7.8 to (case)
results increase (conj)
asymptomatic which (nsubj)
growth vessels (nmod)
4.18 - (punct)
telithromycin of (case)
effects population (nmod)
psychotropic and (cc)
solubility of (case)
mouth a (det)
administered to (mark)
confirming lesions (dobj)
presented deterioration (nmod)
model this (det)
tobramycin and (cc)
function cerebral (amod)
subanalyses fair-quality (amod)
administration intermittent (amod)
demonstrated responses (nsubjpass)
showed addition (nmod)
acuity fundus (conj)
maintains ephedrine (nsubj)
increase always (advmod)
effect l-alpha-glyceryl-phosphorylcholine (nmod)
deficiency system (nmod)
tnfalpha of (case)
sedation to (case)
atropine hexamethonium (conj)
aims : (punct)
suggests complication (ccomp)
alerted clinician (nsubjpass)
reported significant (dep)
protrusion duration (conj)
efficacy bioavailability (conj)
dioxide co2 (appos)
b amphotericin (compound)
group nephropathy (compound)
tone vagal (amod)
tubule on (case)
focusing possibility (nmod)
patients 1346 (nummod)
cases these (det)
membranoproliferative one (nummod)
pars compacta (amod)
using testing (nsubj)
given tdi (nmod)
115 ] (punct)
taken two (nsubjpass)
room recovery (compound)
x-rays electro- (conj)
administration anesthetics (nmod)
loop of (case)
il-6 ( (punct)
performed 4:30 (conj)
lateral the (det)
neurotransmission frontostriatal (amod)
produced groups (nmod)
led administration (nsubj)
evidence increasing (amod)
tissues many (amod)
i troponin (compound)
developed features (dobj)
techniques conventional (amod)
interval months (appos)
define cin (dobj)
composition pool (compound)
covered review (nmod)
questionnaire and (cc)
positive patients (nmod)
stimulations by (case)
concentration patients (conj)
offers neuroprotection (dobj)
substance basal (amod)
less sodium (nmod)
activity low (amod)
dose combination (nmod)
prospective was (cop)
observed control (nmod)
phase double-blind (compound)
gets deactivated (xcomp)
4,000 to (quantmod)
reported they (nsubj)
cyclosporine from (case)
inducing supersensitivity (dobj)
background given (appos)
formulations 0.5 (nmod)
rats three (nummod)
10(-2 at (case)
results biochemical (amod)
mpep antagonist (appos)
anesthetics enflurane (appos)
rats pregnant (amod)
antibiotics by (case)
tests ) (punct)
taken caution (nmod)
metabolized be (auxpass)
anaemia the (det)
recipients 388 (nummod)
hepatonecrosis related (amod)
performances neurocognitive (amod)
data cases (nmod)
sensitive failure (nmod)
nigra into (case)
mitogens pb (nmod)
overtreatment to (case)
seizures patient (nmod)
8 0 (compound)
thyroxine t4 (appos)
injury associated (acl)
healthy women (dobj)
protection the (det)
withholding antibiotic (dobj)
clarified not (neg)
medium nrvms (nmod)
effects stroke (nmod)
approaches adjustment (nmod)
pneumonitis neuropathy (conj)
h 72 (nummod)
investigations microscopic (amod)
contrast pelli-robson (compound)
assessed work (nmod)
receptors d2 (compound)
days 60 (nummod)
microinjected shell (nmod)
configuration exencephaly (nmod)
measuring association (dobj)
that delivered (acl)
animals short-term (amod)
recall their (nmod:poss)
infections p=0.003 (dep)
treatment d (nmod)
mean ( (punct)
anticipated absence (nmod)
hematology and (cc)
records patients (nmod)
regulate may (aux)
79 8 (conj)
patients expired (acl)
treating administration (nmod)
complex broad (amod)
risk cancer (compound)
bones painful (amod)
mortality women (nmod)
confirm , (punct)
correlated activities (conj)
investigation further (amod)
occurred before (mark)
scarce . (punct)
hypotension failure (nmod)
eye the (det)
infusion micrograms/kg (nmod)
cases overdose (nmod)
had presentation (dobj)
aida ; (punct)
studies electrodiagnostic (amod)
nephroureterectomy right (amod)
deaths convulsions (nmod)
viral for (case)
stratified , (punct)
noted retraction (nsubjpass)
observation microscopic (amod)
flow genital (amod)
14th third (advmod)
less months (nmod)
treatment l-arginine (compound)
model writhing (compound)
strong association (nsubj)
liver of (case)
highlights suggests (conj)
carotenoids water-soluble (amod)
rare are (cop)
allowed avoid (xcomp)
incidence fasciculation (nmod)
open although (mark)
point core (compound)
models ischaemic (amod)
showed inducibility (dobj)
nsc 343499 (nummod)
aorta failure (conj)
carriers chronic (amod)
groups intact-control (dep)
sleep daytime (conj)
-18.9 16.6 (conj)
respond not (neg)
developed episode (dobj)
receiving excess (nmod)
cross-linking the (det)
eu ) (punct)
deleterious nephropathy (advmod)
models responses (nmod)
complication unusual (amod)
% 85 (nummod)
undertaken study (nsubjpass)
issue this (det)
class iii (conj)
symptoms dyskinesias (nmod)
improvement discontinuation (nmod)
size epilepticus (nmod)
1.86 +/- (cc)
common hepatotoxicity (nsubj)
effective is (cop)
identified areas (nmod)
injury podocyte (compound)
shifting memory (conj)
administration therapy (nmod)
modulate response (dobj)
lesions reversible (amod)
sufficient of (case)
children scored (acl)
proteinuria crea (appos)
concentrations azt (nmod)
event drug (compound)
known occurred (xcomp)
score maximum (dep)
overflow neurotransmitter (nmod)
cultures blood (compound)
mm < (dep)
headache for (case)
caucasian 35 (conj)
disease graves (nmod:poss)
omercazole ) (punct)
gln223 glu441 (conj)
allergic antibiotics (nmod)
influenced that (mark)
deficiency permanent (amod)
increased value (conj)
small although (mark)
45 of (case)
8) 10 (conj)
studies women (nmod)
micron 100 (nummod)
counteraction co-administration (nmod)
that changes (nsubj)
500 400 (compound)
period sleep (nmod)
disease is (cop)
air temperature (nmod)
significant independent (dep)
water free (amod)
contribute toxicity (nmod)
induced hyperprolactinemia (nsubjpass)
changes patients (nmod)
course 10-day (amod)
causing syndrome (dobj)
appears size (nsubj)
attributed cannabis (advcl)
cases except (case)
8.8 1.3 (compound)
had 12 (nsubj)
cause effect (nmod)
3,4-methylenedioxymethamphetamine , (punct)
hematopathology which (nmod)
dizocilpine ly274614 (conj)
reported case (nsubjpass)
desire gynecomastia (conj)
diagnosis injury (nmod)
injury ppa (compound)
convulsant median (amod)
expression h-sod1 (nmod)
associated antidepressants (nmod)
t ( (punct)
syndrome by (case)
60 1 (compound)
action chronotropic (amod)
trials clinical (amod)
alteration system (nmod)
unchanged functions (nsubj)
cr orr (conj)
1 defects (nmod)
studies previous (amod)
aptts ( (punct)
metabolite ) (punct)
hepatitis hepatitis (conj)
seen while (mark)
infiltration hitherto (compound)
constitutes which (nsubj)
leakage parenchyma (nmod)
promotes . (punct)
located suggesting (xcomp)
indicates score (nsubj)
performed indicated (advcl)
potential carota (nmod)
s representing (acl)
atin ( (punct)
presented patients (nsubj)
monotherapy infusions (nmod)
d-amphetamine and (cc)
nitrogen 93 (nummod)
beating and (cc)
trials aminoglycosides (nmod)
using infusion (nmod)
those among (case)
encephalopathy vasospasm (conj)
habituated environment (nmod)
panel ) (punct)
investigated disease (nmod)
t4 ( (punct)
ie ( (punct)
drug timolol (appos)
taste and (cc)
submitted period (nmod)
these , (punct)
operated were (auxpass)
woman 36-year-old (amod)
effects circulation (nmod)
cent 7 (compound)
disease this (det)
occlusion ) (punct)
pretreated chemotherapy (nmod)
conclusions practical (amod)
chemotherapy epirubicin (nmod)
attain third (nsubj)
fc garcinielliptone (compound)
compatible ischemia (nmod)
day 10 (nummod)
procedure and (cc)
amphetamine-free and (cc)
signs administration (nmod)
13th the (det)
confounds toxicity (nsubj)
effect via (case)
derivatives certain (amod)
evaluation parameters (nmod)
in and/or (cc)
pass bundle (nmod)
extensive when (advmod)
study transmission (compound)
n=36 ( (punct)
pressure withdrawal (nmod)
indicated are (auxpass)
glomerulonephritis penicillamine-induced (amod)
cultured , (punct)
occurred cleared (conj)
2b1/2b2 isoenzymes (dep)
therapy antifibrinolytic (amod)
mosmol/kg was (cop)
diagnosed failure (nsubjpass)
provide kit (nsubj)
p10 in (case)
suffered occurred (dep)
use lamivudine (nmod)
model 1.37 (conj)
prophylaxis duration (conj)
mucosa ) (punct)
determine concentration (dobj)
patient manifest (acl)
survivors injury (nmod)
performed doses (conj)
reticulocytes , (punct)
decreased patients (nmod)
prospective clinical (conj)
receive orally (advmod)
readmitted he (nsubjpass)
reduction acetaminophen (nmod)
metrics incidence (conj)
hypertension gc-ht (appos)
coagulation or (cc)
objectives assess (dep)
occurs contrary (nsubj)
a1 in (case)
mg 300 (nummod)
defined mm (dep)
thromboembolism ; (punct)
none mild (conj)
studies preliminary (amod)
weeks 8 (dep)
mg/kg p.o. (appos)
hypotension prolongation (conj)
induce calcification (dobj)
ischemia spinal (amod)
revealed h. (nmod)
inhibitor metabolized (amod)
group insulin-only (amod)
background effect (appos)
mesothelioma carcinoma (conj)
famotidine of (case)
neurotoxicity occur (acl:relcl)
effect monoher (nmod)
ingesting paracetamol (dobj)
chi2-test exact (amod)
rigidity signs (conj)
increased groups (nmod)
was association (nsubj)
window ' (punct)
dyskinesias on (case)
quinine 4-aminopyridine (conj)
beraprost cilostazol (conj)
reduction induction (conj)
studied p (nmod)
developed recently (advmod)
reflexes baroreceptor (compound)
healthy both (cc:preconj)
received dose (dobj)
compromises . (punct)
april to (case)
model seizures (nmod)
change did (aux)
admitted hyperosmolar (nmod)
incidence convulsion (nmod)
lithium long-term (amod)
mg/kg 4.2+/-1.2 (nummod)
treatment cortisol (compound)
stratum stratum (nmod)
analogue by (case)
treatment weeks (compound)
reduction mm (dep)
effect convulsant (amod)
azt with (case)
increase latencies (nmod)
bacteremia ) (punct)
associated terbutaline (nsubjpass)
p = (parataxis)
39 to (dep)
children leukocyturia (nmod)
year treatment (nmod)
rater a (det)
4.5+/-1.0 p<0.05 (appos)
hyperkalemia life-threatening (amod)
failure liver (compound)
treated cycles (nmod)
deposited will (aux)
play response (nmod)
found mutations (nsubjpass)
revealed diet-fed (nmod)
dose controls (conj)
obtained edema (nmod)
used sedatives (dobj)
complicated was (auxpass)
conclusions recommended (appos)
atropine or (cc)
blocking receptors (dobj)
infusion administrations (nmod)
accounted this (nsubjpass)
test acoustic (amod)
assigned multicenter (nmod)
suggest affected (ccomp)
ef the (det)
reached days (nmod)
stage initial (amod)
audit retrospective (amod)
rats suprofen (nmod)
modeling pharmacokinetic (amod)
active prodrugs (nsubj)
ketoconazole of (case)
chow rat (compound)
plasma ph (appos)
remains heparin (nsubj)
inhibition gaba-mediated (amod)
glomerulosclerosis injury (conj)
point pressure (appos)
shr treated (acl:relcl)
pretreatment scopolamine (compound)
effects blockers (nmod)
type preceded (acl:relcl)
computer based (acl)
gavaged , (punct)
volume clearance (compound)
40.9 +/- (cc)
agonists with (case)
assigned treatment (nmod)
observed given (dep)
initiated therapy (nsubjpass)
analogue guanosine (compound)
crm ) (punct)
cyclosporine or (cc)
suppressed arrhythmia (dobj)
a than (case)
range u/l (conj)
increases dopamine (nmod)
pcr real-time (amod)
function the (det)
complained h (nmod)
excretion by (case)
cells treated (acl)
bolus man (nmod)
evening afternoon (nmod)
ascended region (nmod)
factors treatment (nmod)
conducted a (det)
higher increased (advcl)
infections other (amod)
1.036 +/- (cc)
fk prograf (appos)
visualize . (punct)
cause hepatitis (nmod)
protection carvedilol (nmod)
60 90 (conj)
= 48 (dep)
speech of (case)
effect enhancing (amod)
treatments after (case)
criteria validation (compound)
measurements clearance (nmod)
noted frequently (advmod)
prescribing preferential (amod)
obtained above (conj)
recipients hbig (compound)
compared development (nsubjpass)
imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate tert-butyl-(s)-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9h- (nummod)
mice b1r (amod)
augment . (punct)
glomerulonephritis fibrillary (amod)
hyponatremia secretion (nmod)
element important (amod)
hydrochlorofluorocarbons used (acl)
repeat words (dobj)
identified correctly (advmod)
effects les (nmod)
factors some (det)
sertraline either (cc:preconj)
sent complications (nmod)
isolated . (punct)
analysis logistic (amod)
pressure but (cc)
medulla of (case)
arabic , (punct)
mg/day mg/day (nmod)
attenuates inhibition (nsubj)
torr 78 (nummod)
pressure flow (conj)
metabolism hdl (compound)
polyneuropathy axonal (amod)
indicates need (dobj)
shown rats (nmod)
abdomen a (det)
addicts opioid (compound)
gives . (punct)
reduced hepatitis (nsubjpass)
monophosphate cyclic (amod)
anticancer or (cc)
trimester within (case)
stimulus noxious (amod)
treatment pentamidine (nmod)
impaired significantly (advmod)
showed contraction (dobj)
resulted duration (nmod)
excretion hours (nmod)
channels nucleotide-gated (amod)
sent questionnaires (dobj)
underwent course (nmod)
consideration careful (amod)
sensitized rats (nsubjpass)
symptoms measured (acl)
suggests potentiation (nsubj)
exhibited while (mark)
patients cin (nmod)
alleviating parkinsonism (dobj)
increased overload (nsubj)
cultures and (cc)
shared diltiazem (nmod)
case fifth (amod)
measuring pressure (dobj)
episodes convulsion (nmod)
mortality % (compound)
cases 16 (nummod)
missed % (dobj)
dobutamine intermittent (amod)
migraine % (appos)
resulted revascularization (nmod)
intraoperative postoperative (conj)
volume expiratory (amod)
capacity maximum (amod)
0.05 , (punct)
tissue neural (amod)
t1/2 lp (nmod)
establish power (conj)
ncr181 fla797 (conj)
instillations early (amod)
patients especially (advmod)
decrease affecting (advcl)
rats dawley (compound)
protection in (amod)
one piglets (nmod)
year first (amod)
median ( (punct)
ceased fluid (conj)
disease early (amod)
compared maleate (nmod)
effective somewhat (advmod)
bh msec (dep)
dynamic dynamic (conj)
lna with (case)
response stress (compound)
hemodiafiltration by (case)
rose weeks (nmod)
mediated potentiation (nmod)
abatement the (det)
hour the (det)
mediates polyuria (dobj)
drugs phenylbutazone (conj)
tiopronin ( (punct)
involved antagonism (dobj)
harvested were (auxpass)
larger 3 (compound)
involved mechanism(s (nsubjpass)
decreases . (punct)
cells around (case)
pressure icp (appos)
patients hypothyroid (acl:relcl)
deprivation behaviors (nmod)
returned withdrawn (advcl)
g/m2 total (dep)
agent represses (acl:relcl)
rats age (nmod)
produce performed (advcl)
history tests (nmod)
units three (nummod)
initiated whenever (advmod)
rats shr (appos)
receptors on (case)
decrease = (parataxis)
microgramg/ml ) (punct)
have evidence (dobj)
encourage trials (dobj)
examination treatment (nmod)
become patients (nsubj)
demonstrated enantioselectivity (nsubjpass)
viability counted (conj)
intake with (case)
2.5 women (nmod)
infectivity with (case)
therapy single (amod)
undertaken need (nmod)
ce r4 (appos)
performed compared (prep)
lipoprotein low-density (amod)
levels 714 (nummod)
prompt , (punct)
evidence no (neg)
left pressure (dobj)
administration shr (nmod)
extension time (nmod)
ratio ratio (dep)
treatment used (amod)
reduced group (nmod)
non-users to (case)
consisting 2-acetylaminofluorene (nmod)
decrease besides (conj)
measured be (auxpass)
sulfate quinine (compound)
dogs 16 (nummod)
emesis eight (dep)
cells adriamycin-treated (amod)
analyzed addition (nmod)
flow peak (amod)
activation factor-alpha (nmod)
ethyl-alpha-p-chlorophenoxyisobutyrate unlike (prep)
uncertainties despite (case)
= 0.59 (dep)
serious % (dep)
loss caused (acl)
dystonia on (case)
compounds from (case)
assumption predispose (ccomp)
fluoroquinolones of (case)
administered before (advmod)
motor sensory (conj)
stopped improvement (conj)
representing respectively (advmod)
dwi ( (punct)
nuclear dna (dep)
selected controls (dobj)
hypotension e1-induced (amod)
report questions (dobj)
provided echocardiography (nmod)
administration labetalol (compound)
performed series (nsubjpass)
hypopharynx two (nummod)
rigidity opiate-induced (amod)
vas ( (punct)
activity significant (amod)
reported higher (conj)
reduced damage (dobj)
mmse by (case)
images the (det)
injection suspensions (nmod)
shown reduce (ccomp)
patients dependence (nmod)
scans tomography (compound)
characteristics contraction (compound)
studied feasibility (nsubjpass)
thinning . (punct)
combinations different (amod)
administration quinidine (nmod)
hypertension fk (compound)
polydipsia on (case)
chemotherapy iiie (nmod)
consistent activates (advcl)
< of (case)
responses verapamil (nmod)
c degrees (compound)
ratings blinded (amod)
109 to (dep)
18/90 % (dep)
ltp the (det)
frequencies occurred (acl:relcl)
manner prospective (amod)
reduced map (nsubjpass)
administered amiodarone (nsubjpass)
clozapine ( (punct)
levels other (amod)
tdr ( (punct)
reported few (conj)
enhance synthesis (dobj)
unknown practitioners (nmod)
observed signs (nsubjpass)
increased this (nsubjpass)
commencement between (case)
reduction risperidone (nmod)
doses methotrexate (compound)
regimens cancer (nmod)
contribute that (mark)
discontinued returned (conj)
lowering doses (nmod)
resumed was (auxpass)
was significant (attr)
values pressure (nmod)
stiffness associated (acl)
disclosed ophthalmologic (nsubj)
reported present (parataxis)
80.0 2.9 (conj)
days 11 (conj)
acidosis all (det)
potentiated melatonin (nsubj)
level cumulative (amod)
infant daily (advmod)
vpu vpa (conj)
include however (advmod)
electrophysiologic and (cc)
shows mortality (dobj)
160 to (dep)
lidocaine and (cc)
affect which (nsubj)
cgs neca (conj)
trials oestrogens (dep)
increased exists (conj)
time death (nmod)
undergoes becomes (conj)
compared followed (advcl)
isolation the (det)
bleeding vaginum (nmod)
gain pursuit (compound)
tolerance behavioral (amod)
anxiety for (case)
hypotension than (case)
109 133 (conj)
returned min (nmod)
onset between (case)
suggests decreases (ccomp)
aorta duration (conj)
increase use (nsubj)
care usual (amod)
septicemia suspected (amod)
fiber reorganization (conj)
evaluated as (cc)
hospital in (case)
treatment during (case)
was furthermore (advmod)
alterations elements (nmod)
enhance lidocaine (nsubj)
analyzed semi-quantitatively (advmod)
arise problems (nsubj)
stratified groups (nmod)
bilirubin total (amod)
systolic resting (amod)
15/group ( (punct)
exposure phosphatidylserine (nmod)
returned variables (nsubj)
lesion findings (dep)
has gabapentin (nsubj)
conclusion started (dep)
during weeks (conj)
level turnover (nmod)
disappeared withdrawal (nmod)
patients not (cc)
fluphenazine d1/d2 (compound)
serum-albumin and (cc)
lovastatin , (punct)
decreased binding (dobj)
evidence some (det)
index and (cc)
benefits , (punct)
dysrhythmogenicity epinephrine (compound)
cells ganglia (nmod)
0.14 - (punct)
doses vasopressin (nmod)
described man (nmod)
12alpha-hydroxylase sterol (compound)
carries risk (dobj)
d-med with (case)
years and (cc)
mg/kg epilepticus (conj)
= 6 (dobj)
dermatitis a (det)
hyperglycinemia with (case)
h2o to (case)
both in (case)
specimen a (det)
areas intercellular (amod)
became asymptomatic (acomp)
inconclusive currently (advmod)
woman-years , (punct)
stimulation direct (amod)
63 of (case)
preceded serve (conj)
demonstrated responses (dobj)
develop resistance (dobj)
rates bone (compound)
developed anemia (dobj)
bound dox (nsubjpass)
dexamethasone and (cc)
rare not (neg)
effects hypotensive (amod)
38 p9605 (nmod)
returned two (nsubj)
advent the (det)
median cycles (nmod)
entered recovered (conj)
designed shell (dep)
occur might (aux)
fasciitis regimen (nmod)
mpep single (amod)
mtor-i ( (punct)
dmpx 3,7-dimethyl-1-propargylxanthine (appos)
discriminating affection (nmod)
group receive (acl:relcl)
failure rifampicin-associated (amod)
potentiation cultures (nmod)
discharged condition (nmod)
prepared be (auxpass)
markers respectively (advmod)
free carboplatin (nsubj)
synthesis ) (punct)
euthanized fetuses (nsubjpass)
evaluation relationship (conj)
associations exposures (nmod)
reduced stress (dobj)
incidence fibrillation (nmod)
premarin ( (punct)
aimed test (xcomp)
heart recipient (nmod:poss)
pressure left (amod)
event reported (amod)
deficiency nitric (amod)
male 27 (conj)
show antagonist (nsubj)
reported case (dobj)
vehicle or (cc)
persons 407 (nummod)
observed post-administration (xcomp)
cells presumed (amod)
volunteered observed (conj)
sulfate of (case)
attribute and (cc)
procedures 21 (nummod)
treatment cases (nmod)
prescribed are (auxpass)
folate of (case)
disease peripheral (amod)
proved while (mark)
responses enhanced (amod)
use cancer (conj)
increasing duration (nmod)
group surgery (compound)
points experimental (nsubj)
mean that (mark)
required function (nmod)
metoprolol the (det)
duct child (nmod)
suggest indicator (ccomp)
male healthy (amod)
different similarly (advmod)
asked aim (xcomp)
drug 's (case)
reduced level (dobj)
% and/or (cc)
do patients (dobj)
glucoronosyltransferases by (case)
different mechanisms (nsubj)
facilitate development (dobj)
mg/m(2 40 (nummod)
determined hbsag (nsubjpass)
considered metabolism (nmod)
amount myocardium (nmod)
estimated study (nmod)
dysfunction indomethacin-induced (amod)
levels cell (compound)
surgery redo (compound)
demonstrates indicates (conj)
repeated not (neg)
decrease proteinuria (nmod)
quick low-priced (conj)
investigator blinded (acl:relcl)
treatment sed (dep)
ratio (pr)=0.615 (punct)
involved nerves (nsubjpass)
properties beta (compound)
toxocity fzp (compound)
128 3 (conj)
erythromycins penicillins (conj)
element may (aux)
correlates since (mark)
dose us (compound)
pathophysiology possible (amod)
lower aggregation (nsubj)
class , (punct)
combined ctx (nmod)
lead breaks (nsubj)
concentration related (amod)
pbsct after (case)
effect ifosfamide (nmod)
stage leakage (nsubj)
antineoplastic : (punct)
due expression (nsubj)
injections body (appos)
identify mechanisms (dobj)
events operative (amod)
% -9.6 (nummod)
administered methylergonovine (nsubjpass)
given den (nmod)
bronchitis ) (punct)
continue treatment (dobj)
mris initial (amod)
2.1 ratio (nsubj)
exposures apparent (amod)
reduce reduce (conj)
potentials of (case)
blockers , (punct)
limited treatment (nmod)
given drug (nsubjpass)
administration frequent (amod)
received pilsicainide (dobj)
43 ( (punct)
transport in (case)
nephrin , (punct)
treatment adjunctive (amod)
placebo n (dep)
control rigidity (dobj)
calculation of (case)
respiration of (case)
recruited november (nmod)
mg telmisartan (compound)
duct acute-onset (amod)
serve that (mark)
manifestation catalepsy (nmod)
failed rg1 (nsubj)
september 1992 (nummod)
observed mmg (nsubjpass)
gspe ( (punct)
used studying (advcl)
22 in (case)
g < (dep)
activator selective (amod)
center institutes (nsubj)
plasma tissue (conj)
bd1018 3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane (appos)
ketamine surgery (nmod)
tg with (case)
s-312 , (punct)
pulses current (amod)
fashion dose-dependent (amod)
vasoconstriction acute (amod)
cause being (cop)
patients malignancies (nmod)
years 9.99 (nummod)
treatment aspirin (compound)
information nociceptive (amod)
due may (aux)
70 from (case)
hypoxia due (case)
designed design (dep)
overflow neurotransmitter (compound)
effect against (case)
mmec ( (punct)
striatum were (cop)
reducing group (nmod)
decreased glutathione (dobj)
fentanyl meperidine (conj)
tolerance , (punct)
nimesulide 62 (nummod)
adrenaline dopamine (conj)
gyki-41 antagonist (nmod)
peptide new (amod)
tissues ear (compound)
irrigations of (case)
became injury (nmod)
entered total (nsubj)
unique is (cop)
active generic (amod)
l. 2008 (nummod)
study comparing (acl)
les and (cc)
early clinical (dep)
sph [ (punct)
olanzapine risperidone (conj)
concentration elevated (amod)
concentration peak (amod)
ex-mdma ) (punct)
epinephrine ) (punct)
treatment prolonged (amod)
surgery pod (conj)
program national (compound)
preferred who (nsubj)
dialyzer a (det)
believed pathological-process (xcomp)
some consequences (nmod)
depressants of (case)
marketed . (punct)
occasions separate (amod)
diameter , (punct)
dilemmas treatment (compound)
mek1 in (case)
attenuated gr (nsubj)
is while (mark)
sequelae any (det)
comparison activity (nmod)
hypocalcemia to (case)
evaluate activation (dobj)
sphincter evoked (acl)
design given (appos)
1 tests (nmod)
hypereosinophilia with (case)
promotes that (mark)
site is (cop)
aggressiveness head (conj)
effects threshold (nmod)
follow was (cop)
caused lethality (dobj)
shown data (nsubj)
prior injection (nmod)
presence the (det)
retention- task (nmod)
group 5 (conj)
cause likely (amod)
months 4 (nummod)
regressed totally (advmod)
sensitivities , (punct)
managed , (punct)
receiving fluoxetine (dobj)
combination orally (advmod)
improved increased (advcl)
dependent . (punct)
mexiletine tocainide (conj)
associated testosterone (nsubjpass)
units < (compound)
cytopathy mitochondrial (amod)
enzymes rats (nmod)
inhibits bromocriptine (nsubj)
txb2 ) (punct)
dexamethasone dex (appos)
different paramethasone (nmod)
improvement this (det)
counteracted . (punct)
protect mice (nmod)
literature current (amod)
provides efficacy (dobj)
reactions pseudoallergic (amod)
ccnu ( (punct)
hematotoxicity of (case)
measured following (nsubjpass)
use model (nmod)
u-ii of (case)
analgesic of (case)
days fourteen (nummod)
medication antiepileptic (amod)
lethality cumulative (amod)
matter 1/8 (appos)
prolactin levels (conj)
possibility involved (ccomp)
developing with (mark)
fentanyl with (case)
indicates clearly (advmod)
changes ocular (amod)
unrecognized they (nsubjpass)
develop neutropenia (dobj)
suggestive reaction (nmod)
reproducible were (cop)
mice dba/2 (compound)
increased controls (nmod)
handful only (advmod)
rate rise (nmod)
percentage neurons (nmod)
conditions controlled (amod)
encountered commonly (advmod)
co-administration aiming (acl)
toxicity aggravating (amod)
had potent (advcl)
show : (punct)
prevent dysfunction (dobj)
material method (conj)
took woman (nsubj)
affected number (nmod)
mortality posttransplant (amod)
lidocaine placebo (conj)
level patient (nmod:poss)
reflect atherosclerosis (dobj)
response startle (amod)
studies to (case)
reduction intensity (nmod)
useful potentially (advmod)
one including (case)
those gm (nmod)
min 5 (nummod)
observed patients (nsubjpass)
returned however (advmod)
parp ; (punct)
pathophysiology concerning (case)
coincident presence (nmod)
manifest individuals (nmod)
involves which (nmod)
point same (amod)
conditions operating (compound)
> , (punct)
effects e1 (nmod)
doxorubicin before (case)
control vehicle (compound)
administered median (nmod)
receptors pre- (amod)
resistance increased (amod)
mj exacerbated (amod)
reviewed means (nmod)
mm 67 (nummod)
3.1 3.8 (prep)
delta opioid-agonists (conj)
center health (compound)
physiologic biochemical (conj)
lorazepam patients (nmod)
neurons new (amod)
tool valuable (amod)
tested group (nsubjpass)
developed enhance (xcomp)
4.2 x (cc)
reduction risk (compound)
alterations associated (acl)
activities amphetamine-induced (amod)
cells field (nmod)
succinylcholine by (case)
vpa than (case)
amino-nucleoside puromycin (compound)
admitted who (nsubjpass)
34.0 that (nsubj)
matter subcortical (amod)
neuropathy autonomic (amod)
emphasis development (nmod)
emulsion or (cc)
enabled convert (xcomp)
urinalysis measurement (conj)
ddavp of (case)
sensitivity nor (cc)
agents pretreatment (compound)
remained free (xcomp)
history % (conj)
hepatitis of (case)
totals cases (nmod)
ranged number (nsubj)
production in (case)
bp clinical (amod)
stimulated recognition (nsubj)
nos ) (punct)
raises minimize (advcl)
injection peripheral (amod)
screened identified (conj)
leads protects (conj)
beta2 of (case)
treatment dysmenorrhea (nmod)
mirtazapine his (nmod:poss)
is unclear (advcl)
conclusion had (conj)
24-hour weekly (advmod)
age subjects (nmod)
gem-p to (case)
mg 109.2 (nummod)
aura migraine (conj)
expression mediator (compound)
antrum stomach (nmod)
tumor occurs (acl:relcl)
flumazenil or (cc)
s-transferase alpha-gst (appos)
animals only (advmod)
case knowledge (nmod)
used used (conj)
ft4 ( (punct)
antibody mpo-anca (appos)
dextromethorphan dm (appos)
presented ed (nmod)
mg/dl 35 (nummod)
ncq436 and (cc)
exposures enflurane (nmod)
potent protecting (advcl)
parameters stimulation (compound)
tolerance dose (compound)
scheduled . (punct)
genotypes both (det)
protein nag (conj)
volume average (amod)
mm cause (conj)
size and (cc)
suffers that (mark)
cardiomyopathy toxicity (nsubj)
similar larger (conj)
bpo % (appos)
differences these (det)
suffered patient (nsubj)
end and (cc)
volumes hematoma (compound)
convulsions pilocarpine-induced (amod)
circulation systemic (amod)
4.6 , (punct)
dysfunction associated (acl)
days 13.3 (nummod)
prevent clotting (dobj)
cholestasis extrahepatic (amod)
developed movements (dobj)
hypotension delivery (nmod)
common that (mark)
mean dose (conj)
les fps (conj)
amyloidosis primary (amod)
% ci=28.8%-58.6 (compound)
resulted infection (nmod)
stomach of (case)
treatment toxicity (nmod)
increased extent (nmod)
resulted 15/44 (nmod)
explain integrity (nmod)
elevation waves (conj)
modulator is (cop)
application encapsulated (acl)
neurotoxicity by (case)
effects kg-1 (nmod)
found common (xcomp)
induce that (nsubj)
conscious . (punct)
performance systolic (amod)
mice insensitive (amod)
elevated weeks (nmod)
became restricted (advcl)
wires right (amod)
transplantations 2 (nummod)
syndrome kearns-sayre (compound)
dexamphetamine- on (case)
menopause of (case)
treat epicondylitis (dobj)
cxcl1 of (case)
three patients (nmod)
developed hypertension (dobj)
swelling , (punct)
reach significance (dobj)
arrest except (case)
observed bladder (nmod)
t-tests unpaired (amod)
nigra and (cc)
70 100 (dep)
thrombin and (cc)
minutes 0.6 (nummod)
according to (mwe)
200 vs. (cc)
subacute exposure (dobj)
regimen the (det)
maximum elevations (nsubj)
derivative is (cop)
number larger (amod)
1.68 . (punct)
effect duration (nmod)
icterus hyperbilirubinemia (conj)
factors type (appos)
= .040 (dep)
antidepressants incontinence (conj)
radiologic laboratory (conj)
response inotropic (amod)
extent causes (acl:relcl)
enlarged it (nsubjpass)
structural impairment (dep)
mg/day 5 (nummod)
received children (nsubj)
whether not (conj)
pr response (appos)
induced rigidity (nsubjpass)
dose needed (acl)
less and (cc)
variety factors (nmod)
responses class (nmod)
morphine fentanyl (conj)
tolerated and (cc)
dwi ) (punct)
antifolate . (punct)
effect without (case)
uncertain nephrotoxic (csubj)
enhancers cleavage (compound)
infused 15 (nmod)
hyperlipemia in (case)
chronicity psychosis (conj)
therapy estradiol- (dep)
options management (compound)
day 9 (nummod)
spread medium (nmod)
function ml. (amod)
type rare (amod)
comprised histology (dobj)
calculate to (mark)
week and (cc)
demonstrated activity (nsubjpass)
apoptosis fas-mediated (amod)
indicate administered (ccomp)
using cocaine (dobj)
acts evaluates (conj)
microg/ml range (dep)
12 up (quantmod)
strains transferred (acl:relcl)
comparison olanzapine (nmod)
nms ( (punct)
bipolar ( (punct)
histochemistry ( (punct)
influenced was (auxpass)
supply inhibition (conj)
hormone anti-diuretic (amod)
crosses readily (advmod)
treating hypotension (dobj)
depression attacks (nmod)
system fpdc (conj)
pressure positive (amod)
association medications (nmod)
lower areas (advcl)
194 +/- (cc)
had episodes (nmod)
evaluated patients (dobj)
sustained 48-week (dep)
offered women (nsubjpass)
non-compliance because (case)
gyrus within (case)
infusion ip (compound)
used caffeine (nsubjpass)
produces treatment (nsubj)
late a (det)
excretion daily (amod)
deficit potassium (compound)
evaluated evaluated (conj)
addition list (nmod)
lower phase (nmod)
bell-shaped generally (advmod)
followed day (nmod:tmod)
treatments cancer (compound)
showed sustained (advcl)
concordance increased (amod)
points those (det)
methods carried (appos)
structural cardiac (dep)
mm 100 (nummod)
management airway (compound)
seizure use (nmod)
pathways erk (compound)
cytoprotective are (cop)
cholinergic serotonergic (conj)
mek1 mek7 (conj)
ph to (case)
opioid-agonists , (punct)
need awareness (nmod)
300 100 (compound)
contrast nifedipine (nmod)
observed rate (nmod)
literature extensive (amod)
factor the (det)
lack externa (acl)
49 to (quantmod)
administration suspect (nmod)
susceptible more (advmod)
opse trend (conj)
pre- intraoperative (conj)
dose 50 (nummod)
folate beta-carotene (conj)
consumption oxygen (compound)
abnormalities nervous (amod)
syndrome 1.1 (appos)
resulting instillation (nmod)
amelioration to (case)
therapy salvage (compound)
prl-r ) (punct)
overshooting an (det)
treat anemia (dobj)
superior asenapine (dep)
p9201 38 (conj)
tachycardia the (det)
patients methadone (compound)
heroin to (mark)
classified neoplasms (advcl)
hypotension adjustable (amod)
factors hemorrhage (nmod)
endpoint co-primary (amod)
activities serum (compound)
570 of (advmod)
consistent meninges (nmod)
examined staining (nmod)
p group (conj)
nicotine 's (case)
abnormalities mitochondrial (amod)
potentiation tolerance (conj)
placebo to (mark)
detection ischemia (nmod)
dysfunction myocardial (amod)
seemed whereas (mark)
interest is (cop)
90 was (cop)
hypopharynx four (conj)
inhibit twitch (dobj)
alternative stimulation (nsubj)
option treatment (compound)
aorta thoracic (compound)
nimodipine of (case)
hla-b35 cw4 (conj)
higher groups (nmod)
hours bedtime (conj)
displayed intima (nmod)
1.34 0.89 (conj)
reactions antigen (nmod)
arthrogryposis . (punct)
measure release (dobj)
have phase (dobj)
survivals median (amod)
remained scores (nsubj)
tablets then (advmod)
smaller dose (nsubj)
exhibited p (dep)
middle of (case)
increased flow (nsubj)
affinity moderate (amod)
association lymphoma (nmod)
infusion propofol (nmod)
produce tachycardia (nmod)
abundant are (cop)
administration losartan (amod)
therapy gentamicin (nmod)
persisted lesion (nsubj)
passing period (nmod)
retrospective a (det)
involvement brain (compound)
performed develop (advcl)
enflurane between (case)
background . (punct)
result complications (nmod)
neca ) (punct)
incriminated group (nsubjpass)
have symptoms (dobj)
reduce lidocaine (nsubj)
presence preservatives (nmod)
justified hopes (nsubjpass)
experiences because (case)
investigated mechanism (nsubjpass)
injected daily (advmod)
core and (cc)
cancer or (cc)
done investigations (nsubjpass)
= 39.6 (dep)
cholesterol % (compound)
progression aortic (nmod)
arrest hemorrhage (conj)
reduction 4.4-fold (amod)
appeared similar (xcomp)
diseases ( (punct)
ability spironolactone (nmod)
26 compared (case)
fasciotomies urgent (amod)
wt and (cc)
changed treatment (nsubj)
2.80 - (punct)
intravitreal controlled (conj)
rats pb-exposed (amod)
headache induced (amod)
established role (nsubjpass)
continue must (aux)
suggest antagonized (ccomp)
palate with (case)
vivo , (punct)
drugs benzamide (compound)
levels cbz (nmod)
nsclc status (conj)
center care (compound)
failed patients (nsubj)
damage structural (amod)
occlusion bilateral (amod)
drugs some (det)
development myasthenia (nmod)
icp ) (punct)
decrease . (punct)
micrograms or (cc)
correction for (case)
tablet ketoconazole (compound)
nanoparticles , (punct)
increases baseline (nmod)
cells sirolimus (compound)
expand as (mark)
uncertainty the (det)
pirenzepine component (nmod)
develop ultimately (advmod)
test emotional (amod)
gfr in (case)
women 72 (nummod)
induced elderly (nmod)
data from (case)
showing benefit (dobj)
syndrome ss (appos)
metabolites adriamycinol (nsubj)
suggest produce (ccomp)
trained subjects (nsubjpass)
seems safe (xcomp)
drawbacks hypercalcemia (nmod)
use analgesics (nmod)
anemia methyldopa-induced (amod)
anticonvulsant an (det)
provoked was (auxpass)
treatment due (case)
increase secretion (nmod)
nephrotoxicity acute (amod)
patients therapy (appos)
performance epm (nmod)
became they (nsubj)
stenoses coronary (amod)
pathologies of (case)
12.3 +/- (cc)
changes dep (nmod)
2190 +/- (cc)
abolished that (mark)
use have (aux)
terfenadine for (case)
male of (case)
= 3.4 (dep)
saline % (compound)
gls gcs (conj)
compared 136 (nmod)
linked models (nmod)
carbamazepine oxcarbazepine (conj)
mice sgk1(-/- (amod)
deaths transplant (compound)
compared administration (nmod)
dose protected (acl)
dependent beating (nsubj)
problems icp (compound)
combination radiotherapy (nmod)
dyskinesias modification (nmod)
response electrical (amod)
antagonist acid (compound)
significantly not (neg)
falls count (nsubj)
rats cultures (conj)
medications with (case)
differences histologic (amod)
leucovorin , (punct)
features associated (acl)
results overflow (nmod)
patients such (amod)
lower reach (advcl)
0.01 p (dep)
patients agc (nmod)
observed ischemia (nmod)
developed followed (xcomp)
considered therapy (xcomp)
effect ro (dep)
syndrome malignant (amod)
intubation endotracheal (compound)
anticoagulants with (case)
10ug , (punct)
developed commencing (advcl)
injection fluorescein (compound)
states with (case)
interstitium nephropathy (nmod)
analysis mechanism (nmod)
hallucinations ( (punct)
withdrawal immediate (amod)
used yohimbine (nsubjpass)
aprotinin tamca (nmod)
effects t-cell (compound)
increased addition (nsubj)
antipsychotics classical (compound)
ezetimibe simvastatin-ezetimibe (conj)
influence , (punct)
setting in (case)
sensory neuropathy (conj)
cases 22 (nummod)
a monotherapies (nmod)
records , (punct)
weeks to (case)
acute both (cc:preconj)
radius p (dep)
% 89 (nummod)
vary , (punct)
psychostimulant : (punct)
group mg/dl (dep)
tolerated treatment (nsubjpass)
remained unaltered (xcomp)
anemia tam-induced (amod)
incidence tdp (nmod)
immunosuppressive on (case)
group t (compound)
application kcn (nmod)
treated l-dopa (nmod)
h 4 (nummod)
four 4 (compound)
operative postoperative (conj)
lindane regional (conj)
10.0 30.0 (conj)
drugs nondopaminergic (amod)
reductions apomorphine-induced (amod)
threshold seizure (amod)
role oxidative (nmod)
di-o-tolylguanidine receptor (compound)
effects manic-like (amod)
preserved return (conj)
explore to (aux)
superior ; (punct)
moran . (punct)
sulphate atropine (compound)
iocarmate ) (punct)
one nausea (conj)
low as (case)
hiccups for (case)
dexmedetomidine . (punct)
develop lesion (dobj)
showed tests (nmod)
variations of (case)
dosages lower (amod)
female failure (nmod)
cco-iv ) (punct)
offer may (aux)
postulate provided (ccomp)
potent less (advmod)
morning on (case)
filling gap (dobj)
assays with (case)
pretreatment pancuronium (nmod)
palsies vocal (amod)
less whereas (dep)
climbing induced (amod)
reported smoking (dobj)
analysis kruskal-wallis (compound)
properties . (punct)
recommended starting (xcomp)
children britain (nmod)
16 14 (quantmod)
degeneration of (case)
cellulose in (case)
levels total (amod)
rate maximum (amod)
effects users (nmod)
area risk (nmod)
cases hypoplasia (nmod)
fleming 1986 (nummod)
appeared % (nmod)
days 80 (conj)
awakening on (case)
9 1 (compound)
suppression secretion (nmod)
considered ascribing (advcl)
regulation receptors (nmod)
available . (punct)
enos vascular (amod)
analogues cck-5 (nmod)
g/m2/d than (case)
process is (cop)
hypertensive rats (appos)
imaging by (case)
subjects the (det)
sodium with (case)
infusion 24-hr (amod)
% at (case)
nh4ac by (case)
stable may (aux)
occur which (nsubj)
bruising on (case)
tachycardia . (punct)
prolongs manner (nmod)
age < (nummod)
conducted patients (nmod)
k- and (cc)
less dothiepin (nmod)
image the (det)
mediates dopamine (nsubj)
symptoms values (conj)
share sirolimus (nsubj)
altering without (mark)
sensitivities differential (amod)
assess effects (dobj)
result infusion (nmod)
amnesia apomorphine-induced (amod)
drugs anti-epileptic (amod)
week abstinence (nmod)
factors apparent (amod)
correlated cure (nmod)
blocking neuromuscular (amod)
acting it (nsubj)
cholesterol mg/dl (compound)
loading of (case)
measures prophylactic (amod)
dexamethasone alone (advmod)
described changes (nsubjpass)
analysis power (compound)
concentrations microm (appos)
phenotype deficits (conj)
true be (cop)
indicators of (case)
or 1.78 (dep)
influence significantly (advmod)
had improvement/resolution (dobj)
stretching consequent (amod)
odds convulsions (nmod)
execution protocol (nmod)
block stimulation (nmod)
assessed criteria (nmod)
flaccid . (punct)
effect cells (nmod)
performance impaired (amod)
1.4 ) (punct)
system glutamatergic (amod)
dsm-iii-r. in (case)
spontaneous dexamethasone-induced (conj)
calcium on (case)
hypertrophy , (punct)
observed complication (nsubjpass)
fetuses for (case)
21.0 versus (cc)
= 0.974 (dobj)
iohexol -0.73 (dep)
bn antagonist (compound)
resulted demonstrating (advcl)
g/dl 2.2 (nummod)
administration sm-5887 (compound)
hydrochloride diet (nmod)
vindesine drugs (conj)
unit pediatric (amod)
cultures pre-treated (acl)
recorded muscles (nmod)
latency at (case)
serum/urine and (cc)
euthyroid both (cc:preconj)
mortality excess (amod)
evaluate symptoms (dobj)
monitoring toxicities (nmod)
specificity effect (nmod)
suggesting state (dobj)
concentrated kidneys (nmod)
left overdose (nmod)
bfgf and (cc)
follow-up with (case)
impotence of (case)
inhibit : (punct)
course results (conj)
confirmed further (advmod)
observed differences (nmod)
nanospheres into (case)
distribution peripheral (amod)
case disease (nmod)
suggests evidence (nsubj)
result atrophy (nmod)
azathioprine prednisone (conj)
> p (nsubj)
200 ) (punct)
given long (advmod)
decreased starting (advcl)
activates isoproterenol (nsubj)
patients 1188 (nummod)
cases afl (compound)
3000 greater (advmod)
complicated contributed (conj)
evaluation biological (amod)
= r (nsubj)
action free (amod)
use sulfate (nmod)
found pr (nmod)
transferred department (nmod)
kf17837 ) (punct)
oc generation (compound)
differ 1.4 (dep)
are , (punct)
lower ; (punct)
confirmed data (nsubj)
outcome teratogenic (amod)
nefiracetam apomorphine (conj)
swallowing oropharyngeal (compound)
leg pain (conj)
evaluation serologic (amod)
included three (dobj)
number size (conj)
drug initiation (conj)
group myeloma (compound)
gastric severe (amod)
had likelihood (dobj)
affected difference (nsubjpass)
val hctz (dep)
basis excretion (nmod)
study ascending (compound)
metabolism expression (appos)
fluids therapy (conj)
impressions clinical (compound)
synthesis renal (amod)
bradycardia caused (acl)
l and (cc)
tests diagnostic (amod)
receptor vegfr-2/flk-1/kdr (appos)
fa the (det)
underwent she (nsubj)
function in (case)
cases had (acl:relcl)
taking aspirin (dobj)
underlying associated (dobj)
ratio risk (compound)
underwent days (nmod)
greater olanzapine (nmod)
related or (cc)
estimated chromatography (nmod)
group 1788 (compound)
efficacy virologic (amod)
lamivudine of (case)
active biologically (advmod)
increment % (compound)
related veno-occlusive (amod)
arteritis induced (acl)
emphasis time-course (nmod)
ve ) (punct)
infusion 3 (dep)
stimulation alpha-receptor (amod)
correlate nor (cc)
beginning end (conj)
antagonists m1-selective (amod)
adjusting confounders (nmod)
compromised latter (nsubjpass)
hamsters in (case)
alleviation pigs (nmod)
overall , (punct)
antibiotic acid (nsubj)
cefotetan intravenous (amod)
treatment antithrombin (compound)
malignancies conditions (conj)
induced 5-azacytidine (nmod)
experiments present (amod)
demonstrated rate (dobj)
14.2 8.2 (conj)
intra- interindividual (conj)
acid amca (appos)
% p=0.37 (appos)
technique perfusion (compound)
% 8.4 (nummod)
13 4 (compound)
proteinuria range (compound)
diagnosis without (case)
status performance (compound)
markers inhibition (conj)
performed reflected (conj)
issues relating (acl)
pcp ( (punct)
indicate required (ccomp)
included hepatotoxicity (dobj)
ventricle : (punct)
night during (case)
sulphate and (cc)
received ml (dobj)
10 to (quantmod)
erythrodysesthesia syndrome (appos)
re-exposure dose (nmod)
treatment levetiracetam (compound)
inhibitor alpha-glucosidase (compound)
hydrochloride ppm (compound)
tensions peak (compound)
ficoll-hypaque and (cc)
withdrawn to (mark)
blunted , (punct)
necessary where (advmod)
second((1/2 to (case)
conclusion reduced (appos)
metastases in (case)
concluded needs (conj)
binding relevance (nmod)
seizure experience (appos)
cephalexin those (det)
hyperparathyroidism to (case)
illustrate to (mark)
questioned prior (advmod)
spikes ps (appos)
reaction lv (nsubj)
show concerned (advcl)
evaluable these (nmod)
hiccups . (punct)
lobe temporal (amod)
success given (case)
analyzed incidence (dobj)
min over (case)
fk506 either (cc:preconj)
indices histological (amod)
tribute a (det)
led onset (nsubj)
undergo to (mark)
lower combinations (nmod)
antagonist by (case)
discontinued later (advmod)
hypertension bevacizumab (nmod)
sides between (case)
activator safe (amod)
isg of (case)
finding clinical (amod)
variable primary (amod)
excessive . (punct)
presence products (nmod)
paraplegia : (punct)
1.63 0.26 (nummod)
likely effects (nsubj)
u/l ) (punct)
induced recipient (nmod)
increased toxicity (nsubjpass)
ecg the (det)
transplantation cystitis (compound)
injected cy (nmod)
progression durations (conj)
chicks all (det)
ldlr ) (punct)
synergy possible (amod)
quantify buffered (conj)
rtms real (amod)
fulfilled headache (nsubj)
feeling of (mark)
level mda (compound)
exercise daily (amod)
history history (nmod)
performed is (auxpass)
exists regard (nmod)
h gamma-hch (dep)
spasticity on (case)
range entire (amod)
considered case (nmod)
dawley to (case)
ahs the (det)
factor schumacher (nmod:poss)
considered relationship (nsubjpass)
function pharmacology (conj)
dextromethorphan by (case)
contributed death (nmod)
induces inhibition (nsubj)
sedation light (amod)
day 10 (conj)
ng 125 (conj)
lindane insecticide (compound)
regulation . (punct)
experienced hour (nmod)
exhibited curvilinear (dobj)
groups six (nummod)
administration haloperidol (compound)
vocabulary and (cc)
seem increase (xcomp)
% nacl (dep)
functions system (nmod)
13th 14th (conj)
conversion cya. (nmod)
correlated report (nsubj)
score surgery (nmod)
exposed lithium (nmod)
pcc u/kg (appos)
woman 79-year-old (amod)
youth in (case)
specimens of (case)
feature an (det)
concurrent use (nmod)
drugs same (amod)
mr the (det)
patients patients (conj)
forthcoming of (mark)
improvement rapid (amod)
infants administration (appos)
discriminated damage (nmod)
provided icrf-187 (nmod)
change peak (conj)
status , (punct)
mobilization on (case)
linked may (aux)
seen prolongation (nsubjpass)
frequencies ; (punct)
exposure % (appos)
hilum hepatic (amod)
yield tumours (nmod)
rebounded , (punct)
or=13.807 ci=5.194 (dep)
status growth (compound)
lipids lipoproteins (conj)
naproxen 1.88 (appos)
rates responder (compound)
observations case-based (amod)
effective reducing (advcl)
treatment drug (compound)
ahs ) (punct)
elevation significant (amod)
ineffective challenge (nsubj)
patients meningitis (nmod)
day 23 (nummod)
haemofiltration continuous (amod)
demonstrates inhibitor (ccomp)
showed had (ccomp)
allergy immediate (amod)
read was (auxpass)
jaundice with (case)
individuals after (case)
p300 coactivator (appos)
19.9 2.5 (conj)
pentylenetetrazole mg/kg (appos)
breath , (punct)
mug 1 (nummod)
effect beneficial (amod)
occurs necessary (conj)
missed . (punct)
beta-mimetics tocolytic (amod)
randomized were (auxpass)
employed were (auxpass)
mdma ) (punct)
hypotension following (case)
studied cycles (nmod)
zones expanded (amod)
index expression (nmod)
reaction immune (amod)
regimens their (nmod:poss)
decreased contents (nsubjpass)
8.75 1.70 (compound)
program that (mark)
9 only (advmod)
dose measurements (nmod)
retention ( (punct)
change combination (nmod)
infrequent , (punct)
available increasingly (advmod)
exclude not (neg)
indicator , (punct)
opioids efficacious (amod)
alert be (cop)
information little (amod)
trial difluoromethylornithine (nmod)
localization specific (amod)
cn than (case)
stenosis fixed (amod)
medium low-osmolar (amod)
rilmenidine or (cc)
action an (det)
4 of (case)
consumed maintaining (advcl)
effect ht (nmod)
reported abusers (nmod)
manifestations injury (nmod)
um-272 n (dep)
hepatic extrahepatic (conj)
demonstrates reaction (nsubj)
typical antipsychotics (nmod)
model neuropathy (amod)
nausea or (cc)
supratherapeutic mg (nmod)
scale investigator (nmod)
altered dose (nmod)
uncommon disturbance (nsubj)
divided then (advmod)
seen using (xcomp)
substantiates further (advmod)
tumours refractory (acl:relcl)
equipotent are (cop)
diagnosed moderate (conj)
groups study (compound)
% on (case)
first antibacterials (nmod)
rechallenged beclomethasone (nmod)
drivers 12 (nummod)
plasma and (cc)
tsc ) (punct)
animals eight (nummod)
cisplatin 100 (nummod)
exhibited relationship (nsubj)
trajectory dorsoventral (amod)
lower variability (nsubj)
report manifestation (nmod)
content hippocampus (nmod)
evaluating medication (dobj)
use injection (dobj)
able whether (mark)
characteristics patients (nmod)
cisplatin to (case)
edema disintegration (conj)
solution % (appos)
inhibitors sunitinib (nmod)
electrographic behavioral (conj)
brought decrease (nmod)
induced changes (dobj)
dithiothreitol trypsin (conj)
occurred rise (nsubj)
herbicides retardation (conj)
produce torsades (dobj)
multifactorial mechanisms (nsubj)
60 about (advmod)
associated trend (nmod)
occur thickening (nmod)
worsened was (auxpass)
kept therapy (nmod)
respond patients (nsubj)
patients ulcers (nmod)
ways different (amod)
change and (cc)
occur weeks (nmod)
pcr amplified (acl)
scale a (det)
sch 120 (nummod)
use alcohol (compound)
revealed however (advmod)
downregulated further (advmod)
used controls (dobj)
weight 0.3 (nummod)
shifting and (cc)
0.05 p (dep)
effects sumatriptan (nmod)
thirds two (nummod)
composed walls (nmod)
23 of (advmod)
level da (compound)
pathways kinase (compound)
predictive postoperatively (advmod)
effect exposure (nmod)
years 5.3 (nummod)
withdrawing replacing (conj)
detection resolution (conj)
apply also (advmod)
anomalies in (case)
agitation and (cc)
veins uterine (compound)
aneurysm coronary (amod)
concentration albumin (compound)
3 4 (prep)
period extraction (nmod)
showed showed (advcl)
induce maha (dobj)
research medical (compound)
killers pain (compound)
yet longer (advmod)
stimulates , (punct)
1r ( (punct)
pool da (compound)
needs their (nmod:poss)
10.7 to (dep)
found state (nmod)
does than (mark)
tested caffeine (nsubjpass)
changes typical (amod)
dizziness woman (nsubj)
cross-linking on (case)
discuss . (punct)
iml pilo (nmod)
score ability (appos)
timing with (case)
treatment second- (amod)
failure , (punct)
treatment transplantation (nmod)
men sixty-seven (amod)
accounted all (nmod)
vindesine vds (appos)
control proper (amod)
design counterbalanced (amod)
damage rats (nmod)
diagnosing necrosis (dobj)
effects bupivacaine-induced (amod)
included analysis (nmod)
pfs prolonged (amod)
more cin (nsubj)
compounds amino (compound)
approaches monitoring (advcl)
back . (punct)
tube delivered (acl:relcl)
group research (compound)
lead administration (nsubj)
cirrhosis hbv-related (amod)
prompted study (dobj)
events acute (amod)
calcium adrenaline (conj)
believe , (punct)
dose calibrating (amod)
exhibited function (dobj)
occurs serious (conj)
solution glucose (compound)
cardiotoxicity trial (conj)
disorder mental (amod)
remained she (nsubj)
milligram mass (nmod)
got the (det)
display aggressiveness (dobj)
time first (amod)
users pubertal (amod)
increased in (dep)
preferred , (punct)
administration sublingual (amod)
area vancouver (compound)
coma and (cc)
hours per (case)
attain required (conj)
abnormalities bilateral (amod)
considered can (aux)
hyperkinesia ratings (conj)
administered dose (nmod)
greater . (punct)
returned although (mark)
doses 3.5 (nmod)
effect biphasic (amod)
shown improve (xcomp)
described cases (nsubjpass)
maze marble (conj)
fibrosis myocardium (nmod)
showed comparison (nmod)
administration intolerance (nmod)
disulfiram by (case)
life in (case)
conditions designed (acl)
frequency mb (compound)
classifications . (punct)
expression brain (nmod)
few literature (nmod)
min given (case)
states women (conj)
observed sections (nmod)
5-fu/fa and (cc)
schizophrenia acute (amod)
published occurring (xcomp)
bodies without (case)
group mk-801-treated (amod)
striking the (det)
tumor and (cc)
depression currents (nmod)
established now (advcl)
catarrhalis moraxella (compound)
showed ratings (nsubj)
flexion and (cc)
cornu left (amod)
protection : (punct)
expression caspase-3 (nmod)
ratio lag (nmod)
alpha left (amod)
found lower (xcomp)
resulting dose (nmod)
functional analysis (dep)
initiated that (nsubj)
rate highest (amod)
period patient (nmod)
dose labetalol (nmod)
recurrence lesions (nmod)
group serotonin (compound)
vd ( (punct)
group halothane (compound)
correct hypotension (dobj)
taking medications (dobj)
therapy art (appos)
absence liver (nmod)
str ) (punct)
rats obtained (acl)
questions safety (nmod)
effect chloride (nmod)
extraction cataract (amod)
moderate were (cop)
feature clinical (amod)
role reduction (nmod)
necrosis decrease (dep)
setting : (punct)
appeared that (mark)
progress may (aux)
patients intolerant (amod)
cohort within (dep)
aconitine of (case)
animals injected (acl)
inhibitors milrinone (nmod)
acts may (aux)
duct cortical (amod)
appearance jaundice (nmod)
paracetamol of (case)
exposure maternal (amod)
fever higher (amod)
resulted alter (conj)
fentanyl pentazocine (conj)
life-threatening that (nsubj)
mucosal and (cc)
mwm unchanged (acl:relcl)
addition use (nmod)
pg/ml 0.03 (nmod)
spasm induced (acl)
apnea gets (acl:relcl)
patient c (compound)
cardiotoxicity 5-fluorouracil (compound)
days event (nmod)
intestine the (det)
patients 21 (nummod)
group locomotion (compound)
experiments involving (acl)
nociceptin in (case)
learning caused (acl)
rigidity parkinsonian (amod)
reduction changes (conj)
effects amitriptyline (nmod)
vomiting nausea (conj)
occurred chicks (nmod)
tumors malignancies (conj)
requiring not (neg)
spasms muscle (compound)
affirming efficacy (dobj)
agonist a (det)
extended-interval of (case)
recorded measurements (nsubjpass)
portions weeks (nmod)
observed thereafter (advmod)
unable was (advcl)
exhibited participants (nsubj)
recurrence tachycardia (compound)
showed gellan (nsubj)
included thromboembolism (dobj)
onset syndrome (nmod)
anticipated seen (advcl)
induced stimulation (nsubj)
correlated order (nmod)
breakdown their (nmod:poss)
containing concentration (dobj)
dup 753 (nummod)
blocks beta-blocker (nsubj)
6.25 micrograms/ml (conj)
87 % (quantmod)
threat a (det)
analogue is (cop)
week treatment (nmod)
efficacy doxorubicin (nmod)
similar incidence (nsubj)
vehicle ( (punct)
suggest offers (ccomp)
course and (cc)
agents cholinergic (amod)
hypokalemia propensity (appos)
less much (advmod)
hus in (case)
toxicology cocaine (nmod)
operated loss (dep)
pneumonia ptld (conj)
role tnf-alpha (nmod)
disorder post-transplantation (amod)
waves with (case)
c % (appos)
alpha-sigma , (punct)
follow up (compound:prt)
undergone which (nsubj)
disease steinert (nmod:poss)
bred were (auxpass)
asa given (acl)
patients p=0.01 (appos)
embryolethality teratogenicity (conj)
severe and (cc)
greater 1.043 (dep)
studies paclitaxel (nmod)
enhances l-dopa (nsubj)
elicited administration (nsubj)
p=0.002 odds (dep)
kidneys of (case)
infarction ischemia (conj)
hypertension no-deficient (amod)
explore purpose (nsubj)
characterized . (punct)
ratio clearance (nmod)
located were (auxpass)
leading tolerance (nmod)
tolerated hbig (nsubjpass)
bcc ) (punct)
consequences substantial (amod)
revealed improvement (dobj)
-14.8 p<.001 (dep)
1,3-bis-(2-chloroethyl)-1-nitrosourea ) (punct)
fiber se-induced (amod)
relationship ctni (nmod)
failure described (amod)
that response (dep)
group one (nummod)
infusion apomorphine (compound)
persisted stopped (advcl)
superior warfarin (nsubj)
a/j dba/2j (appos)
abilities in (case)
using in (mark)
heterogeneous insured (dep)
tumor the (det)
failed supplementation (nsubj)
alf , (punct)
protocol current (amod)
antagonists hemicholinium-3 (conj)
administration adriamycin (compound)
indicated presence (dobj)
estimated cpu (nmod)
out-patients referral (amod)
caffeine for (case)
diazepam 2pam (conj)
reported using (xcomp)
levels protein (nmod)
presentation hospital (nmod)
wsr ) (punct)
disappeared followed (conj)
assays competition (compound)
glomerulosclerosis for (case)
erythroderma reaction (conj)
modulate and (cc)
g 250 (nummod)
response rate (compound)
role anesthesia (nmod)
level effect (compound)
years at (case)
received mo (nmod)
lesions nigra (nmod)
group experienced (acl:relcl)
conclusion progress (dep)
population hematology/oncology (amod)
foot of (case)
use intrathecal (amod)
arthritis ra (appos)
3alpha-hydroxy-5alpha-pregnan-20-one ( (punct)
speculated can (aux)
phenotype the (det)
measured decrease (nmod)
tolerated otherwise (advmod)
declined pressure (nsubj)
ed50 free (amod)
neurotoxicity study (dep)
experiments two (nummod)
injected 5,7-dcka (nsubj)
1000/mm3 and/or (cc)
paroxetine terfenadine (conj)
simvastatin dosage (conj)
effect amantadine (nmod)
sgk1(-/- with (case)
tachycardias sinus (compound)
cocaine gnc92h2 (conj)
entry on (case)
received only (advmod)
developed complications (dobj)
group between (case)
pathway ascending (amod)
4 ) (punct)
emerged increases (nsubj)
noted neuropathy (nsubjpass)
estimated end (nmod)
transplantation bmt (appos)
tachycardia marked (amod)
advanced as (cc)
cardiotoxicity against (case)
implausible biologically (advmod)
binding animals (nmod)
routes by (case)
prl-positive immunochemically (advmod)
administered excess (nmod)
triamcinolone t (appos)
periods penicillin-induced (amod)
effect metformin (nmod)
cnsb002 combinations (conj)
tissue liver (compound)
analysis , (punct)
one whom (nmod)
occurred dosing (nmod)
lead caused (conj)
rodents ly274614 (nmod)
dysfunction neuronal (amod)
help to (mark)
n=92 80 (conj)
coassemble which (nsubj)
ph 9 (nummod)
improvement of (case)
aes in (case)
developed individuals (nsubj)
mania : (punct)
concentrations amikacin (compound)
fibres by (case)
suggested evidence (nmod)
impact ( (punct)
improved substantially (advmod)
patients disease (conj)
clinical radiological (conj)
sampled blood (nsubjpass)
deterioration cognitive (amod)
catecholamine present (amod)
valsartan combinations (conj)
agents exert (acl:relcl)
ritonavir or (cc)
widened ) (punct)
body in (case)
spasm difficulties (conj)
group sham (compound)
was elucidate (xcomp)
haloperidol single-dose (amod)
evaluated study (nsubj)
expression enos (compound)
part diagnosis (nmod)
received months (nmod)
concentrations trough (compound)
hypertensive shr (appos)
baseline days (conj)
administration icv (compound)
d2 e2 (conj)
defects 2 (nummod)
hit ) (punct)
accounted for (compound:prt)
sent we (nsubj)
demonstrated degeneration (nsubjpass)
stress by (case)
postponed trimester (nmod)
contractility painful (amod)
model 6-hydroxydopamine-lesion (compound)
therapy head (nmod)
extent inhibit (acl)
pathways circuitries (nmod)
n=94 ) (punct)
available not (neg)
protected ) (punct)
demographic , (punct)
iopentol % (dep)
hypertrophy induced (amod)
reduction glutamate (nmod)
detection hyperactivity (nmod)
mg/kg/daily ) (punct)
nigra susceptibility (nsubj)
thromboembolism combination (nmod)
osteoarthritis trials (conj)
freezing behavior (conj)
incidence period (nmod)
tamoxifen used (acl:relcl)
teoaes ) (punct)
toxicities 3/4 (nummod)
adjusted confounders (nmod)
elements level (nmod)
need evidence (dobj)
nh4ac mm (amod)
drug first (amod)
lt disease (nmod)
therapy calcium (compound)
received iiib (nsubj)
electroshock applied (acl)
using test (dobj)
dose subcutaneous (amod)
oxycodone oral (amod)
c ( (punct)
matched 190 (nummod)
concentrations alpha-hydroxymetoprolol (amod)
rats bromocriptine (appos)
agent either (det)
groups all (det:predet)
antagonists central (amod)
tested reported (dep)
tested inhibited (ccomp)
doses mz (nmod)
antagonist 5-ht2 (compound)
pathogenesis ulcers (nmod)
effect anemia (nsubj)
augments estradiol (nsubj)
avoid procedures (dobj)
common reported (advcl)
partial 19 (nmod)
used should (aux)
pathogenesis mechanism (nsubj)
elicited perturbation (nmod)
excretion nox (compound)
glaucoma or (cc)
iopamidol or (cc)
achieved diagnosis (nsubjpass)
ligand is (cop)
cause cases (nmod)
taking lithium (dobj)
results therapy (nsubj)
increases frequency (appos)
diseases selected (amod)
antagonist h2-receptor (amod)
erythrocytes , (punct)
using years (dobj)
stretches at (case)
cardiovascular central (conj)
confusion acute (amod)
min 75.9 (nummod)
transporter tissues (nmod)
evaluation rats (nmod)
187 +/- (cc)
enrolled 1993 (dobj)
nationwide in (case)
gd 17 (nummod)
bradydysrhythmias ; (punct)
observed experienced (dep)
regeneration " (punct)
established safety (nsubjpass)
= 29 (dep)
attacks migraine (nmod)
dysfunction acidosis (conj)
indicates appearance (nsubj)
of off (intj)
rofecoxib mg (dobj)
cause degeneration (dobj)
stimulation hippocampal (compound)
banned lack (nmod)
episodes hypotension (nmod)
response cataleptic (amod)
failed pregs (nmod)
achieved two (nsubj)
zyban , (punct)
signs response (nmod)
increased reduced (advcl)
assessed comparing (advcl)
preparations acetaminophen (nmod)
revealed scans (nsubj)
ectopy ventricular (amod)
acetaminophen from (case)
alter subjects (nmod)
reports structured (amod)
toxicity hmm (compound)
excretion malondialdehyde (conj)
prevented diltiazem (nsubj)
decade fourth (amod)
mice injury (nmod)
turnover na (compound)
enlargement the (det)
cases eight (nummod)
less possibly (advmod)
topiramate by (case)
administration netilmicin (nmod)
preoperatively was (cop)
cause cystitis (dobj)
recovery following (case)
clonidine or (cc)
u/ml range (conj)
remained content (nsubj)
months 40 (nummod)
declined days (nmod)
contribution . (punct)
obesity and (cc)
= .14 (dep)
identifying in (mark)
patients virus (nmod)
biodistribution rats (nmod)
diet leads (acl:relcl)
times 58.9 (nummod)
increases flow (nmod)
degrees mrd (nsubj)
cinching by (mark)
phenomena during (case)
calculus patient (nmod)
ensued . (punct)
less could (aux)
supposed exist (ccomp)
nra0160 ethyl (amod)
rate elevated (amod)
pain bone (compound)
caused starting (advcl)
reward in (case)
mg/m2/week 30 (nummod)
unlikely effective (advcl)
growth cerebellar (amod)
during following (conj)
identified : (punct)
conducted cells (nmod)
suffered infarction (dobj)
reduction remarkable (amod)
set . (punct)
rise adrenoceptors-mediated (amod)
cases children (nmod)
used influx (nmod)
damage lamina (nmod)
mmt ) (punct)
elucidating thereby (advmod)
arrhythmias fatal (amod)
measures which (nsubj)
quantitated representing (xcomp)
delayed protracted (conj)
role augmentation (nmod)
influence free (amod)
achieved may (aux)
62(6):865 1978 (nmod:tmod)
inhibition non-selective (amod)
water ( (punct)
prolactin greater (amod)
blockers three (nummod)
rate secretory (amod)
terminated developed (advcl)
progress did (aux)
women 73 (nummod)
inhibited formation (dobj)
examinations and (cc)
change hyperactivity (nmod)
hepatocarcinogens of (case)
drugs immunomodulatory (amod)
bortezomib/dexamethasone induction (nmod)
placebo washout (nmod)
treated cycloheximide (nmod)
showed tissues (nsubj)
able whereas (dep)
females males (conj)
prevent ml/min (dep)
cream , (punct)
mean hb (compound)
reflect activity (dobj)
mortality infarction (conj)
monitored were (auxpass)
chiefly normal (amod)
capable radiation (nsubj)
exposure : (punct)
hz ) (punct)
76 of (case)
remains undefined (acomp)
complex channel (compound)
gastrocnemius tibialis (conj)
localization a (det)
inhibitors serotonin (compound)
rendered were (auxpass)
eyes 25 (nummod)
salicylates or (cc)
blockade not (cc)
switched generations (nmod)
hypocalcemia significant (amod)
pericarditis and (cc)
slight lesions (dep)
effects increases (nmod)
millimetres in (case)
administration phenobarbital (nmod)
facility care (nmod)
materials randomised (dep)
best to (case)
associated addition (nmod)
reduced percent (nmod)
saline group (appos)
treating patients (dobj)
addressing since (mark)
dog wet (amod)
choose , (punct)
safety acetaminophen (nmod)
18.3 1.4 (conj)
neonates had (conj)
refractory atropine (nmod)
abstinence 4.98 (dep)
regeneration to (case)
derivative with (case)
200 46 (conj)
agent is (cop)
practice general (amod)
mean protein (dobj)
assessing satisfaction (dobj)
pressures bodyweights (conj)
occurrence upon (case)
methadone or (cc)
0.17 from (case)
rated monthly (advmod)
protocol dexmedetomidine (compound)
catecholamines myocardial (amod)
provide not (neg)
observed developed (parataxis)
block non-depolarizing (amod)
review we (nsubj)
trials controlled (compound)
suggesting . (punct)
appears corresponding (xcomp)
followed encephalopathy (nmod)
responds elevations (nmod)
incidence of (case)
hemostasis on (case)
remained that (mark)
associated carbamazepine (nmod)
damage therapy (nmod)
used exposure (dobj)
micrograms/kg/hr micrograms/kg/hr (conj)
electrolytes of (case)
percentage ) (punct)
antioxidant inhibitor (conj)
reduced contrary (nmod)
use deprivation (conj)
accumulation renal (amod)
experiments - (punct)
anp of (case)
hypercalcemia of (case)
hbv ) (punct)
application anticholinergics (nmod)
suggest achieved (ccomp)
modulate does (aux)
fibrillation . (punct)
contribution group (nmod)
increases wakefulness (dobj)
encephalopathy death (conj)
19 11 (conj)
% 126 (nummod)
remissions complete (amod)
rate levels (nmod)
treated , (punct)
test cold (amod)
exacerbated symptoms (nsubj)
levothyroxine g (dep)
sulphate analogs (nsubj)
syncope q-t (amod)
mechanism common (amod)
interventions coronary (amod)
cyclophosphamide agents (dep)
peroxisomes in (case)
taken drugs (nmod)
effects ecstasy (nmod)
developed neuropathy (dobj)
failure uk (nmod)
remained groups (nmod)
protocols acute (amod)
administration intraperitoneal (conj)
continued resuscitation (nsubj)
intake dietary (amod)
stage late (amod)
complexes 30 (nummod)
attributed has (aux)
score initial (amod)
nephropathy adr (compound)
described patient (dobj)
sr ( (punct)
treated nephropathy (nmod)
approximate , (punct)
13 these (det)
prolonged azimilide (nsubj)
binding ) (punct)
show further (advmod)
wanted test (xcomp)
fields central (amod)
patients gbm (nmod)
signs activation (nmod)
prevented injection (dobj)
prolactin serum (compound)
caused recurrence (dobj)
problematic most (advmod)
relationship markers (nmod)
produced azt (nsubj)
ci p=0.019 (appos)
m.s. ( (punct)
condition off-drug (compound)
gentamicin with (case)
canaliculi the (det)
report purpose (dep)
ribavirin c (nmod)
rofecoxib . (punct)
included users (dobj)
model overdose (nmod)
rnfl eyes (nmod)
order exclude (acl)
victims delirium (nmod)
tablet mg (dep)
fdc with (case)
good % (nmod)
rats ninety-three (amod)
inactivation their (nmod:poss)
intake c (compound)
buffer cell-free (amod)
history optic (nmod)
experience did (aux)
rate reported (amod)
mellitus nephrotoxicity (conj)
results administered (dep)
halts , (punct)
baseline p (appos)
used derive (xcomp)
rare , (punct)
consist phases (nsubj)
patients day (compound)
agonist selective (amod)
pallidotomy treatment (nmod)
hour gtn (dep)
digoxin ) (punct)
entered remission (dobj)
produces improvement (dobj)
caused propofol (nmod)
manner double-blind (amod)
duration volume (conj)
diseases rheumatologic (amod)
inhibits irreversibly (advmod)
reproducibility models (nmod)
movements hemiballistic (amod)
implicated epileptogenesis (nmod)
evaluated monitoring (advcl)
activity xo (compound)
extended-release/lovastatin niacin (compound)
whom d (dep)
hour 5%/24 (compound)
antagonized process (nmod)
questionaire according (case)
numerous significantly (advmod)
cortex cerebellar (compound)
mm 160 (nummod)
decreases activity (dobj)
opse greater (amod)
200 300 (conj)
mediated effects (nsubjpass)
syndrome state (nmod)
contained they (nsubj)
captopril-treated in (case)
1 i.p. (advmod)
acquisition after (case)
mr ( (punct)
occurred treatment (nmod)
frequency or (cc)
treated implants (nmod)
scopolamine with (case)
inpatients 146 (nummod)
-0.12+/-0.5 ) (punct)
ng/dl. ft4 (nsubj)
size rat (compound)
patient first (amod)
form scales (conj)
degree in (case)
had undergone (conj)
randomized groups (nmod)
resulted changed (advcl)
state long (amod)
has whether (mark)
activity overall (amod)
effect q10 (nmod)
measured beginning (nmod)
117.61 vs. (cc)
3.9 +/- (cc)
exacerbates cardiotoxicity (dobj)
leukemia meningeal (compound)
underlying with (mark)
risk thrombosis (nmod)
undergoing tobramycin (nmod)
increased second (nmod)
producing trigger (dobj)
lysozymuria ; (punct)
dysfunction arthritis (compound)
burning capsaicin-induced (amod)
away kidney (nmod)
redistribution flow (nmod)
pg/ml . (punct)
extraction venipuncture (conj)
suppresses vestibulotoxicity (dobj)
episode . (punct)
sedation in (case)
shelf received (acl:relcl)
x-rays , (punct)
hemorrhage during (case)
initiation tizanidine (nmod)
vehicle ) (punct)
dermatitis for (case)
given diagnosis (dobj)
correlated and (cc)
administered dogs (nmod)
samples analysis (nmod)
microglia expressing (acl)
glioblastoma recurrent (amod)
process and (cc)
pathophysiology schizophrenia (nmod)
problem general (amod)
groups patients (nmod)
membrane basal (amod)
resolved and (cc)
stopped time (nmod)
avoid to (mark)
rna both (cc:preconj)
instituted that (mark)
investigate prevents (ccomp)
dosing fashion (nmod)
results t-test (appos)
cbdca ( (punct)
mg/d ) (punct)
dysfunction hypersensitivity (conj)
found tested (ccomp)
evaluated electrogram (nmod)
presence injury (nmod)
terfenadine ) (punct)
contributing rotation (nmod)
systolic mean (conj)
releaser by (case)
protein prooxidant (amod)
populations pci (conj)
induced endomt (dobj)
show cords (nsubj)
valproate solely (advmod)
30 45 (conj)
taken . (punct)
effect was (cop)
events treatment-related (amod)
inhibitors ace (compound)
responsiveness limbs (nmod)
likely structure (nsubj)
characterized ballooning (nmod)
involves however (advmod)
marker reliable (amod)
mg/kg po (appos)
seizures nmda (compound)
study pharmacokinetic (amod)
programs surgery (compound)
hospitals tertiary (amod)
= 1.9 (dep)
chemotherapy and (cc)
patient laotian (amod)
vasculitis therapy (nmod)
1 on (case)
unclassifiable were (cop)
effect hypotensive (amod)
result breakdown (nmod)
mortality due (amod)
muscles into (case)
show receptors (nsubj)
fischer female (amod)
dosing ninth (amod)
birth normal (amod)
considered crocin (nsubjpass)
states but (cc)
concentrations the (det)
headache migraine (compound)
pineal on (case)
sensitive reproducible (conj)
0.05 0.5 (conj)
exacerbated may (aux)
exercise to (case)
study ongoing (amod)
c. with (case)
mg/kg 45 (nummod)
advance therapeutic (amod)
followed restoration (nsubj)
rosa sinensis (dobj)
145 from (case)
reverse dysfunction (dobj)
mofetil mycophenolate (amod)
behavior aggressive (amod)
affected days (nmod)
43 - (punct)
analysis 2-way (amod)
study including (case)
examining effects (dobj)
board review (compound)
reversed study (nmod)
study pain (compound)
july between (case)
necrosis of (case)
kinetics appearance (conj)
presents thrombocytopenia (nsubj)
excretion tubular (amod)
mz fl (conj)
62 ( (punct)
electrocardiograph lead (compound)
dog % (appos)
develop discontinuation (nmod)
incidence ) (punct)
developed haematuria (dobj)
workers industrial (amod)
cacl2 or (cc)
causes death (nmod)
collection cell (compound)
occurred grade (nsubj)
shown sensitive (xcomp)
374 to (case)
117 of (case)
mononucleosis one (nummod)
olanzapine and (cc)
do . (punct)
studied obtained (conj)
coadministration by (case)
iopentol , (punct)
two normalized (nmod)
injections ng (conj)
calcium elemental (amod)
analgesia in (case)
79 6 (conj)
assurance quality (compound)
had signs (dobj)
biosynthesis rna (nmod)
caution with (case)
evidenced further (advmod)
sent questionnaire (dobj)
16 ) (punct)
deafened frequencies (nmod)
risk cephalexin (nmod)
rate gellan (nmod)
made were (auxpass)
rats . (punct)
years within (case)
prepared eluate (amod)
evaluate toxicity (dobj)
indomethacin both (cc:preconj)
lung the (det)
abstinence of (case)
alpha-enac and (cc)
history drug (compound)
dtic ) (punct)
related effects (nmod)
efficacy therapeutic (amod)
needed drugs (advcl)
models predictive (amod)
stronger duration (nmod)
reye the (det)
induced ceftriaxone (nmod)
outcomes other (amod)
> 0.5 (nummod)
correlated expression (nmod)
microg/kg/min 20 (nummod)
reduced inhibition (dobj)
study addresses (dobj)
nystagmus oscillopsia (conj)
presented patients (nsubjpass)
0.60 1.76 (nummod)
indicated profile (dobj)
metoprolol terbinafine (conj)
threshold , (punct)
18.4 ) (punct)
discuss to (mark)
animals pf (compound)
sources . (punct)
decreased 11.2 (dep)
helodermin , (punct)
or(adj ( (punct)
hundred four (conj)
treated tiapride (nmod)
undertaken biopsies (nsubjpass)
dyserythropoiesis , (punct)
joint muscles (nmod)
end trimester (nmod)
actin cytoskeleton (nmod)
develops and (cc)
infectivity donors (nmod)
sex with (case)
comparison randomized (amod)
docetaxel with (case)
57.9 was (cop)
calcium the (det)
in mostly (advmod)
mg/kg 100 (nummod)
volume air (conj)
weight same (amod)
aes due (case)
urothelium of (case)
fibers noradrenergic (amod)
radiation ionizing (amod)
reduction 15 (nummod)
results resonance (nmod)
detectable suggesting (advcl)
time neutrophil (nmod)
dfp in (case)
gain damage (conj)
elucidate role (dobj)
reversal effect (dep)
ventricle septum (conj)
showed different (conj)
g 13.5 (nummod)
effect frequency (conj)
presented hysterectomy (nmod)
57.9 . (punct)
lactate aids (nmod)
a/j sjl (conj)
experienced not (neg)
avoid over-immunosuppression (dobj)
action analgesics (nmod)
% 34/45 (appos)
ed50 concentrations (conj)
then year (conj)
anemia . (punct)
based data (nmod)
block that (mark)
conclusions difficult (appos)
studied received (parataxis)
showed respect (nmod)
agent analgesic (amod)
arthralgia , (punct)
93 1 (conj)
97.1 . (punct)
food of (case)
antagonized or (cc)
delineated findings (nsubjpass)
random-assignment and (cc)
hemolysis transfusion (nmod)
rupture septal (amod)
indicates equipotent (conj)
modulators humoral (amod)
schiff acid (compound)
time needle (nmod)
tested be (auxpass)
self-limited , (punct)
conjugates three (nummod)
rise further (amod)
disorder major (amod)
administered topically (advmod)
determined we (nsubj)
way achieve (acl:relcl)
demonstrated superior (ccomp)
least at (case)
semipurified diets (dobj)
task anticipation (compound)
resulted bradycardia (nmod)
caution greater (amod)
had combination (dobj)
hctz daily (advmod)
pod 10(9)/l (nummod)
respiration mitochondrial (amod)
dox 7.5 (nummod)
addiction from (case)
acrolein main (amod)
degree were (cop)
evening plus (cc)
sedations during (case)
setting critical (amod)
15.8 3.3 (conj)
requested ratings (nsubjpass)
mean significant (amod)
three 1 (dep)
produced mhb (dobj)
lc/ms/ms ) (punct)
calibre axon (compound)
magnitude that (nmod)
days 0 (nummod)
exfoliation by (case)
day 17 (nummod)
evident movements (nmod)
pattern cases (nmod)
pressure pressure (nmod)
unaware by (case)
stimulation discharges (nmod)
37.4 +/- (cc)
norepinephrine injected (amod)
raised ) (punct)
interval prolonged (amod)
mechanism key (amod)
administration glucocorticoid (compound)
gene drd2 (compound)
hypoactivity caused (acl)
termed index (xcomp)
unreasonable is (cop)
nik-247 tacrine (conj)
experienced picture (dobj)
concentration temazepam (nmod)
drug -- (punct)
treated antagonist (nmod)
self-poisoning of (case)
ballooning biomarkers (nmod)
followed mg/m2 (nmod)
developed episodes (nsubj)
cohorts in (case)
literature acute (amod)
patients 4.7 (nummod)
used who (nsubj)
ischemia min (conj)
angiography cardiac (amod)
transmission neuromuscular (amod)
independently function (nmod)
patients maintained (acl)
animals seventeen (nummod)
adsd with (case)
defects vsds (appos)
pretreatment alpha-methyltyrosine (nmod)
tacrolimus ( (punct)
site injection (compound)
assumed it (nsubjpass)
allocated fashion (nmod)
reported had (conj)
patients hematuria (nmod)
delta slow (conj)
assessment perimetry (nmod)
factors ( (punct)
unaltered treatment (nmod)
supplemented had (aux)
prevent and (cc)
lymphocytes on (case)
risk attendant (amod)
activity anticonvulsant (amod)
points haloperidol (nmod)
initiated trial (dobj)
completed method (dep)
f ( (punct)
tolerance associated (acl)
responded achieved (conj)
dfc = (parataxis)
used conjunction (nmod)
effect phenylephrine (nmod)
role treatment (nmod)
used immunotherapy (nmod)
presented results (dep)
cent micrograms.kg-1.min-1 (dep)
normal cases (nmod)
point each (det)
mass ck (conj)
database autoimmune (amod)
smoking use (appos)
thrombosis rupture (conj)
concentration changes (conj)
agsd ( (punct)
profile therapeutic (amod)
change values (nmod)
using rats (dobj)
muscarinic and (cc)
paraventricular the (dep)
attack migraine (compound)
3.6 +/- (cc)
received rhigf-i (dobj)
induced peptides (nmod)
provides parameter (nsubj)
patients 47 (nummod)
efficient drugs (nmod)
evaluable were (cop)
prepared radiopharmacy (nmod)
striatum and (cc)
hallucinations with (case)
vasoconstriction artery (nmod)
ceased bleeding (nsubj)
movements choreoathetoid (amod)
inactivation ros-mediated (amod)
characterized increases (nmod)
mean patients (nmod)
min training (nmod)
defective was (cop)
models similar (amod)
decreased but (cc)
cause accounting (advcl)
given divided (conj)
expression cardiac-specific (amod)
mammals in (case)
affected equally (advmod)
ages past (conj)
abusing previously (advmod)
dat(-/- ( (punct)
3.5 of (case)
validate further (advmod)
blind randomized (amod)
rna viruses (conj)
changes baseline (nmod)
pressing object (dobj)
blockade due (case)
regions frontal (amod)
min respectively (advmod)
block exit (compound)
infiltration passage (conj)
pre-treatment chronic (amod)
fewer than (mwe)
reversing of (mark)
benefited patients (nmod)
reversed blocked (conj)
necrosis , (punct)
managed patients (nsubjpass)
deaths 20 (nummod)
therapy associated (amod)
staining serum-albumin (nmod)
seizures cardiac (conj)
content myocardial (amod)
ptcr allografts (nmod)
morphine s.c. (compound)
total higher (amod)
exposed gyrus (nsubjpass)
glycopyrronium of (case)
difference threshold (nmod)
diet consumption (nmod)
transcripts rna (compound)
depressive puerperal (amod)
abortion therapeutic (amod)
setting naturalistic (amod)
referral hospitalization (conj)
escape with (case)
reported sumatriptan (nmod)
counts 4,957 (nummod)
indicators as (case)
indication effects (nmod)
infarction the (det)
augmented , (punct)
possess that (mark)
finding invariable (amod)
sbp t+a (dep)
seems involved (ccomp)
rats nigra (amod)
cbz with (case)
tamponade of (case)
nitroprusside under (case)
33 10(9)/l (conj)
treatment w-ich (nmod)
monitored nurse (nmod)
2000 december (compound)
dose except (case)
memory this (det)
methods test (dep)
rostral and (cc)
exposed cocaine (nmod)
destructive overload (nsubj)
in are (cop)
morbidity patients (nmod)
elicited that (nsubjpass)
hemisuccinate protects (ccomp)
indicate ranges (ccomp)
continue so (dep)
long-acting and (cc)
signs pancytopenia (nmod)
infusion immunoglobulin (compound)
abstinence years (appos)
predicted drop (nmod)
showed recovery (dobj)
penicillamine with (case)
23/57 % (appos)
hyperactivity psychostimulant-induced (amod)
samples days (nmod)
78 of (advmod)
1.1 to (dep)
showed microinjection (ccomp)
risk stroke (nmod)
develop deficits (dobj)
adopted patients (nsubjpass)
reductions dyskinesias (nmod)
gamma-hch ( (punct)
extubated and (cc)
safe relatively (advmod)
agent inhibits (acl:relcl)
change ebff (nsubj)
used consecutively (advmod)
values lactic (amod)
1.21 10.12 (prep)
center the (det)
receptors gamma-aminobutyric (amod)
difference severity (nmod)
tendency known (amod)
e2 instilled (amod)
patients epilepsies (nmod)
containing only (advmod)
receiving dexamethasone (dobj)
effects anca (compound)
necrosis change (conj)
increased which (nsubjpass)
mild improvement (nsubj)
associated risperidone (nsubjpass)
mg -0.17 (nummod)
observed difference (nsubjpass)
admitted managed (conj)
absorb drug (dobj)
mm more (conj)
formulations between (case)
reports case (amod)
decontamination doses (conj)
responsible decrease (nmod)
tested modifications (nsubjpass)
patients living (acl)
association use (nmod)
% 5.1 (nummod)
normal glomeruli (nsubj)
vpa ( (punct)
decline in (case)
71.3 ( (punct)
exchange , (punct)
clozapine- both (cc:preconj)
protected syndrome (nmod)
conclusions indicated (appos)
agoraphobia attacks (nmod)
cohort consecutive (amod)
suggested history (nmod)
myopathy progressive (amod)
mortality contrast (dep)
20,000fold over (advmod)
seems mediate (xcomp)
less both (cc:preconj)
activity sinus (compound)
demonstrated we (nsubj)
doses 7.54 (dep)
magnitude that (mark)
pseudoacromegaly with (case)
reports france (nmod)
a-i apo (compound)
resolve had (conj)
day-1 at (case)
used than (dep)
present urine (nmod)
combination gem (nmod)
estimate controlling (advcl)
s.c. ( (punct)
phosphorylation via (case)
analyses immunohistochemical (amod)
occurs stage (nmod)
membranes lateral (amod)
observed 8) (dep)
published previously (advmod)
hrp ( (punct)
sexes between (case)
performed weeks (nmod)
scores living (compound)
electroretinograms standard (compound)
region promoter (compound)
wild-type ) (punct)
anesthetics three (nummod)
specificity the (det)
immobilization with (case)
betaine ) (punct)
surgery before (case)
filters vena (compound)
concluded study (nmod)
taking occlusion (nmod)
mmol/l consistent (amod)
women 513 (nummod)
woman-years 170 (conj)
scheduled injection (nmod)
disappearance stones (nmod)
received onset (nmod)
dehydroepiandrosterone dhea (appos)
present problem (dobj)
patients loss (nmod)
% ci (compound)
received therapy (nmod)
infarction bromocriptine (nmod)
bun k (conj)
bore hallmarks (dobj)
period assessment (compound)
one which (nmod)
percent ) (punct)
assigned protocols (nmod)
patient which (nmod)
calculated as (mark)
antinociception combination-induced (amod)
cromakalim , (punct)
response stimulation (nmod)
structures inhibitors (nmod)
specimen skin (compound)
left baseline (nsubj)
biopsies two (nummod)
1.5-fold ) (punct)
had minutes (nmod)
matched groups (nsubjpass)
lines cell (compound)
developed lady (nsubj)
h. the (det)
pharmacoeconomics outcomes (conj)
injections repeated (amod)
reduction reduction (nmod)
drugs used (amod)
sm-5887 mg/kg (appos)
patients 11 (nummod)
preservation cells (nmod)
dyskinesia fluctuations (conj)
action intense (amod)
report helpful (conj)
restimulation the (det)
light with (case)
proliferation termination (conj)
phase 2 (nummod)
convulsions induced (amod)
36 19 (conj)
nephropathy rats (nmod)
concentrations effective (amod)
retention pa (compound)
therapy phenobarbital (amod)
block amiodarone-induced (amod)
cent 90 (nummod)
sensitive were (cop)
episodes by (case)
showed impairments (dobj)
end period (nmod)
jerks block (compound)
pentylenetetrazol ptz (appos)
ph ) (punct)
have blocked (advcl)
develop nephrotoxicity (dobj)
ns induced (acl)
transferred later (advmod)
% 93 (nummod)
degree some (det)
10 at (case)
cd25 ) (punct)
cardiac acute (amod)
transmission 5-ht (compound)
periods undergone (amod)
had ari (dobj)
induced used (advcl)
seems action (nsubj)
gene changes (dep)
% 17.7 (nummod)
manifested . (punct)
lowered dronedarone (nmod)
optic ischemic (amod)
atria alpha2abc-knockout (nmod)
larger were (cop)
needed strategies (nsubjpass)
s s (appos)
induced falling (advcl)
rtms , (punct)
reduction . (punct)
reversible longer (parataxis)
changes as (cc)
quadriparesis paresthesia (conj)
grading higher (amod)
increases threshold (nmod)
80 20 (conj)
relationship cancer (nmod)
have models (nmod)
fev1 responses (dep)
pirarubicin ) (punct)
observed t(1/2 (dep)
5,7-dcka ) (punct)
needed than (mark)
inhibitor cyp2d6 (nmod)
ci 2.3 (nummod)
investigate involved (ccomp)
rigidity bradykinesia (conj)
ratings subjective (amod)
suppression drug-induced (amod)
classified injury (nmod)
effects about (case)
cd50 ld50 (conj)
conditions neurologic (amod)
= 118 (dep)
infusion reports (nmod)
downregulated strongly (advmod)
recovered period (nmod)
observed ) (punct)
dopamine dopac (conj)
definition research (compound)
agency ( (punct)
prednisone to (case)
monoamines other (amod)
theorem accuracy (appos)
study dose (compound)
controls treated (acl)
institution upon (case)
tmp of (case)
association acid (nmod)
% or (cc)
has treatment (nsubj)
cssep nmp (conj)
dysmorphism remission (nmod)
paracetamol acetaminophen (appos)
indicate . (punct)
aza ( (punct)
exert but (cc)
suggested acted (ccomp)
depletor serotonin (compound)
volume either (preconj)
boy by (case)
lymphoma of (case)
administered carefully (advmod)
day post-fenoldopam-infusion (conj)
revealed examinations (nsubj)
defined as (mark)
outpatients mild (nmod)
evaluated done (conj)
appeared children (nsubj)
-cimetidine chlorpheniramine (conj)
associated predictive (conj)
plants from (case)
1.37 ) (punct)
animals 2 (nummod)
considered regarded (advcl)
results oct (nsubj)
developed initiating (advcl)
evoked were (auxpass)
h. for (case)
tmax : (punct)
infarction nonhemorrhagic (amod)
nms ziprasidone (nmod)
at2r of (case)
affect sensitivity (dobj)
alcohol of (case)
seizure receiving (advcl)
occlusion cerebral (amod)
evaluate and (cc)
entropion abrasion (conj)
fragmentation dna (compound)
due muscle (nmod)
torsade tdp (appos)
cause hepatitis (dobj)
buspirone and (cc)
ng/ml p (dep)
reported include (conj)
undergone transplant (dobj)
90/htn the (det)
reported using (advcl)
syndrome myonecrosis (conj)
substantial and (cc)
dose piroxicam (nmod)
described series (nsubjpass)
pain areas (conj)
groups three (nummod)
ventilators patients (nmod)
studied recurrence (nsubjpass)
injected or (cc)
mg/m2 cisplatin (nmod)
system defense (compound)
overstimulation group (nmod)
evident decreases (nsubj)
treatment mefloquine (amod)
corrected potassium (nmod)
administration 10mg/kg (nmod)
tolerate heparin (dobj)
analysis stereological (amod)
paclitaxel carboplatin (conj)
demonstrated segments (nmod)
movements protrusions (conj)
barrier the (det)
miss frequently (advmod)
mice comprising (acl)
induces hypotension (dobj)
vasospasm morbid (amod)
pesticide scabicide (conj)
catalepsy produced (acl:relcl)
degrees , (punct)
biopsies " (punct)
ulceration produced (acl)
induced carbamazepine (nsubj)
surgery following (case)
had depression (nsubj)
inpatients eps (nmod)
improved were (auxpass)
catch a (det)
subjects received (acl:relcl)
reduced normalized (advcl)
findings patient (nmod)
diary studies (dep)
mechanisms cellular (amod)
allograft a (det)
inhibit stages (dobj)
results y. (amod)
exposed cocaine (xcomp)
serum to (case)
sodium of (case)
determinant , (punct)
inhibited butyrylcholinestrase (dobj)
similar dyscrasias (nmod)
aura without (case)
map and (cc)
associated citrate (nmod)
thunbergiana of (case)
pressure pressure (conj)
responses hormone (nmod)
received transplantation (dobj)
cells/microl 285 (nummod)
ischemia cardiac (amod)
finding previous (amod)
indication first (amod)
buffers aqueous (amod)
accompany administration (dobj)
granule dentate (amod)
effect exerted (acl)
di- 26- (dep)
min 20 (nummod)
actin alpha-sarcomeric (amod)
metabolite , (punct)
agonist systems (conj)
secretion tear (compound)
isoprenaline to (case)
involved mechanisms (nmod)
injured organelle (dobj)
serological pathological (conj)
setup to (case)
min(-1 ) (punct)
individuals , (punct)
side-effects two (nummod)
pump infusion (compound)
shifts threshold (nmod)
shortened . (punct)
patients southeast (nmod)
rp both (cc:preconj)
receptors myocardial (amod)
baseline ( (punct)
nephritis with (case)
net ) (punct)
days ingestion (nmod)
protocols experimental (amod)
incidence injections (nmod)
tools experimental (amod)
forestomach in (case)
bred sensitivity (nmod)
think we (nsubj)
duration patients (nmod)
disruption ppi (nmod)
pathways biosynthetic (amod)
physiology higher (amod)
frequent but (cc)
time close (amod)
occurs likely (advmod)
20 5 (conj)
subsided stopped (conj)
doses paclitaxel (compound)
awakening upon (case)
level maximal (amod)
spasm . (punct)
nox neither (cc:preconj)
atazanavir mg (compound)
6 3 (compound)
shown useful (xcomp)
showed majority (nsubj)
allergy penicillins (nmod)
pathways serotonergic (amod)
axons borderzone (nmod)
experienced legs (nmod)
block spinal (amod)
began escalated (conj)
binding , (punct)
patients fifty-four (amod)
that by (case)
tended associated (xcomp)
prevalence for (case)
retention of (case)
poor reportedly (advmod)
evaluated these (nsubjpass)
rw ) (punct)
costs high (amod)
variability patients (nmod)
hours animals (nmod)
ventricles and (cc)
dexrazoxane and (cc)
ratio defined (acl)
novel is (cop)
metrics and (cc)
deficits cognition (compound)
data cardiovascular (amod)
posturing and (cc)
preclinical and (cc)
bladder wt (nmod)
learning reversal (amod)
= 47 (dobj)
sensation painful (amod)
irreversible hus (nsubj)
(1.8)% -10.8 (nummod)
euthanized were (auxpass)
normal test (nsubj)
increased g (nmod)
effects apart (advmod)
include does (aux)
5 to (case)
microg/0.5 4.5 (compound)
shortened nra0160 (nsubj)
highlighted difficulty (nsubjpass)
exploration arm (compound)
harmful potentially (advmod)
rats evidenced (advcl)
marker summary (nmod)
more 7 (compound)
subjects 24 (nummod)
dysfunction measured (acl)
mounting evidence (nsubj)
kg of (case)
necrosis or (cc)
potential gnc92h2 (nmod)
tachycardia induced (amod)
rodents to (case)
event corresponding (amod)
substratum brain (compound)
receptor chemokine (compound)
injections dexamethasone (nmod)
failed increased (advcl)
neuronal not (neg)
has electrocardiography (nsubj)
-0.12+/-0.5 vs. (cc)
dose duration (conj)
prompt but (cc)
thickened . (punct)
patients nonusers (conj)
capacity similar (amod)
channels cardiac (amod)
findings renal (amod)
phenomenon raynaud (nmod:poss)
doses 0.05 (dep)
sessions in (case)
dogs four (nummod)
profile compared (acl)
enzymes for (case)
aspirin n (dep)
decreased has (aux)
angio-oedema related (amod)
evidence suggestive (amod)
magnitude increase (nmod)
programs active (amod)
g/m2 ( (punct)
-32 13 (conj)
ed ) (punct)
albuminuria and (cc)
subregions into (case)
l. , (punct)
rhythm circadian (amod)
continued dopamine (nsubj)
decrease mm (appos)
low-dose to (mark)
episodes antibiotic-induced (amod)
hypertensive . (punct)
loss aspect (conj)
228 - (punct)
reviewed we (nsubj)
sedation during (case)
experiencing grade (dobj)
result cessation (nmod)
maltol p-coumaric (conj)
saline i.c.v (appos)
remains 2-component (attr)
users aspirin (nmod)
interact channels (nmod)
increased mmhg (dobj)
selected have (xcomp)
seconds and (cc)
steroid synthetic (amod)
inhibitors kinase (compound)
stenosis arterial (amod)
born 1987 (nmod)
of seizure (pobj)
attenuated rats (advcl)
dose disulfiram (nmod)
death in (case)
suggested headache (nmod)
enhance secretion (dobj)
restlessness pacing (conj)
dopamine opioid (conj)
returned gradually (advmod)
accident cerebral (amod)
inhibited ) (punct)
comparisons all (det)
abilities cs (nmod)
screening patients (nmod)
produced attenuation (dobj)
hoarseness dipropionate (nmod)
monitored functions (nsubjpass)
synthase mip (compound)
activation : (punct)
s 1.12 (nummod)
stage regeneration (nmod)
randomized methods (dep)
carbimazole with (case)
indeterminate . (punct)
assayed development (nmod)
modulating in (mark)
control inhibitory (amod)
involved closely (advmod)
discontinuation reduction (conj)
oxygen for (case)
minute seconds (conj)
function skilled (amod)
hazards ethambutol (nmod)
addictive is (cop)
baseline predrug (compound)
tricuspid ( (punct)
infarction recurrent (amod)
maturation delayed (amod)
cycles ifosfamide (nmod)
elevations got (nmod)
preparations containing (acl)
dox saline (conj)
doses drugs (nmod)
kinds agents (nmod)
decrease dose-dependent (amod)
4.1 151 (prep)
patients combination (conj)
increase map (nmod)
switchers to (case)
mg/kg 8 (nummod)
inhibition extracerebral (amod)
assess kytril (dep)
2-mercaptoethane the (det)
antigen-positive , (punct)
group alpha-position (nmod)
used antibodies (nsubjpass)
permeability mucosal (amod)
result however (advmod)
85.4 - (punct)
regained occurred (conj)
function pathways (nmod)
treatment routine (amod)
exists that (mark)
superior isg (nmod)
range years (appos)
c than (case)
avoided are (auxpass)
elevated measured (advcl)
developed pathology (dobj)
transport glutamate (amod)
kinetics with (case)
maintained further (advmod)
needs for (case)
prevented which (nsubjpass)
accounting duration (nmod)
inhibitor hiv (compound)
programs of (case)
effects corticosterone (nmod)
noted been (auxpass)
granulomas of (case)
= 0.049 (dobj)
epilepticus a (det)
patient breast (compound)
6.2 1.3 (conj)
completely almost (advmod)
vomiting ( (punct)
75 approximately (advmod)
developed neutropenia (dobj)
therapeutic medical (amod)
remission been (cop)
individuals intolerant (amod)
responses . (punct)
risk who (nsubj)
feared detected (parataxis)
replication mutants (nmod)
leads whether (mark)
changes updrs (nmod)
group saline (compound)
cacl2 . (punct)
performed model (nmod)
attenuated moreover (advmod)
sss ( (punct)
elevations acute (amod)
avoidance from (case)
reversibility case (nmod)
evoked pain (conj)
hypokalaemia of (case)
abusers heroin (compound)
milieu tumour (compound)
occurred this (nsubj)
include often (advmod)
micrograms/kg ( (punct)
choice ; (punct)
induced intrastriatally (advmod)
measured that (mark)
exacerbated dose-dependently (advmod)
hs 21.0 (nummod)
exercised prescribing (advcl)
hypertrophy heart (compound)
1999 between (case)
analgesic hypnotic (conj)
receptors (5-ht)2a (compound)
stools in (case)
low-sodium mmol/day (appos)
minutes 1.9 (nummod)
bilayers of (case)
months before (case)
patients parkinson (nmod:poss)
elevation loss (conj)
presented treatment (dobj)
0.74 ( (punct)
agents antimuscarinic (amod)
erythrocytes of (case)
endpoints primary (amod)
order detect (acl)
toxicity nonhematologic (amod)
pharmacokinetics steady-state (amod)
hazard are (cop)
developed became (conj)
use use (nmod)
adjustment factors (nmod)
ozone with (case)
relevant be (cop)
interaction specific (amod)
juices fruit (compound)
efficacy asenapine (nmod)
increased those (advcl)
modalities therapeutic (amod)
trialists the (det)
kidneys same (amod)
rates , (punct)
gave protection (dobj)
provoke contrast (nmod)
decreased frequency (nsubj)
combined was (auxpass)
received course (dobj)
ampka ) (punct)
domains in (case)
oct ) (punct)
correlated injury (nsubjpass)
thrombocytopenia by (case)
fluvoxamine with (case)
ist ) (punct)
factors hypokalemia (nmod)
proteinuria light (amod)
children fifty (amod)
excess or (dep)
months every (det)
maternal , (punct)
association heart (compound)
trial this (det)
indicates but (cc)
decrease mortality (dobj)
r 0.78 (nmod)
doses cause (acl:relcl)
electrocardiographic ecg (dep)
included determined (conj)
10- , (punct)
disinhibition and (cc)
myeloma patients (nmod)
patients function (nmod)
ether hexafluorodiethyl (amod)
drug intent (nmod)
extend findings (dobj)
women and (cc)
idea dysfunctioning (nmod)
kidney from (case)
was fatigue (attr)
deaths deaths (conj)
reducing and (cc)
receiving resuscitation (dobj)
ranged visit (nmod)
equal mm (nmod)
antagonist noncompetitive (amod)
tested maze (nmod)
5-year progression-free (dep)
situations in (case)
lower mean (nsubj)
sedentary-isoproterenols the (det)
associated piperacillin (nmod)
or ci (dep)
increased way (nmod)
test evoked (ccomp)
populations cell (compound)
revealed hemoglobin (dobj)
terms attenuation (nmod)
rats dogs (conj)
patients lack (nmod)
seizure the (det)
blunted effect (nsubjpass)
support proposal (nmod)
increased affecting (advcl)
unaffected were (auxpass)
changed . (punct)
trough ) (punct)
using variables (dobj)
1000 rate (compound)
26- are (cop)
caused desensitization (nsubj)
effect ribavirin (nmod)
diet-fed hearts (conj)
relation that (nmod)
dipivalyl topical (amod)
b. group (compound)
hyperplasia , (punct)
increased compared (advcl)
nucleus prl-r (appos)
sas ( (punct)
value postoperative (amod)
activations cortical (amod)
prescribing when (advmod)
dimer-x iocarmate (appos)
chemotherapy myelosuppressive (amod)
lesion on (case)
hr for (case)
group hcrh (compound)
months rate (nsubj)
risk benign (advcl)
time cr (nmod)
activation erk (compound)
effect apparent (amod)
women receive (acl:relcl)
area ; (punct)
consequences errors (nmod)
response test (nmod)
levels generation (conj)
conclude reduces (ccomp)
developed severe (advmod)
glibenclamide with (case)
were decreased (conj)
51.7 mm (dep)
bradycardia and (cc)
before after (conj)
dose mg (dep)
pituitary exposed (amod)
behavior escape-like (amod)
vgb with (case)
treatment fourth (amod)
months 43 (nummod)
structures diverse (amod)
studied effects (dobj)
variety effects (nmod)
level mg/day (amod)
pr=0.515 , (punct)
allografts stable (amod)
observed been (auxpass)
made post-mortem (xcomp)
neurons th-immunoreactive (amod)
taking and (advmod)
required atropine (dobj)
safety sustained-release (nmod)
5-hiaa areas (nmod)
objectives investigates (appos)
dogs 57 (nummod)
weeks consecutive (amod)
k(+)-channels sensitive (amod)
deafened selectively (advmod)
used enzymes (nsubjpass)
period during (case)
received vasospasm (nmod)
property the (det)
days followed (acl)
concerns neurotoxicity (nmod)
damage significant (amod)
homozygous to (mark)
developed hypercalcemia (dobj)
catabolism gaba (compound)
species system (conj)
induce defects (dobj)
released saline (dobj)
derived were (auxpass)
% 6.5 (nummod)
mice sensitive (amod)
uncertainties related (amod)
stents metal (compound)
eeg ( (punct)
mice wild-type (amod)
days either (det)
content hydroxyproline (nmod)
status were (cop)
have changes (dobj)
uncommon although (mark)
patients burn (compound)
derivative . (punct)
confusion acid (nmod)
titrated produce (advcl)
reveals association (dobj)
mg/m2 above (case)
neoplasia n (dep)
mice with (case)
involvement b (nmod)
mm 12.2 (nummod)
h mg (nummod)
p<0.021 ( (punct)
p-ergs ( (punct)
culture during (case)
all were (cop)
disorder bipolar (amod)
cases 12 (nummod)
dyscontrol , (punct)
essential because (mark)
min 45 (nummod)
doses subprotective (amod)
process ongoing (amod)
patients two (nummod)
hearing as (mark)
dependent directly (advmod)
tended greater (xcomp)
consolidation finding (appos)
constants the (det)
were ) (punct)
107 x (cc)
sessions 2 (nummod)
les between (case)
assessed echocardiographically (advmod)
background found (dep)
disorientation behavior (conj)
diagnostic the (det)
treated are (aux)
common users (nmod)
confusion review (appos)
15.0 10.7 (compound)
salicylate mg/kg (conj)
amelioration some (nmod)
showed compared (advcl)
hematological as (cc)
hemoglobin ( (punct)
exposure fetal (amod)
patients six (nummod)
cardiac or (cc)
develop not (neg)
angioedema stomach (nmod)
visualize to (mark)
swallow barium (compound)
value possible (amod)
assessment measures (compound)
attributable drug (nmod)
% 18.3 (nummod)
pathway through (case)
patients hypertension (nmod)
dose clioquinol (nmod)
nfkappab ) (punct)
group oncology (compound)
combination days (conj)
groups animal (amod)
exposure 11 (conj)
given chlorthalidone (nsubjpass)
processing memory (compound)
assessed using (xcomp)
using withdrawal (dobj)
systemic serious (amod)
expression molecules (nmod)
rates eradication (compound)
hyperprolactinemia ssri (conj)
reduction beginning (acl)
erythrophagocytosis with (case)
created network (nsubjpass)
transferred has (aux)
enzyme thiamine-dependent (amod)
% 17 (nummod)
interferes signals (nmod)
volunteers formulation (nmod)
hrptec ( (punct)
measure can (aux)
angina without (case)
prevented i.e. (dep)
report comorbid (dobj)
vagotomy sympathectomy (conj)
remained gfr (nsubj)
dysfunction hoarseness (amod)
measured inhibited (conj)
pretreatment reserpine (nmod)
alf drug-induced (amod)
urea nitrogen (compound)
exhibited sections (nsubj)
responses abnormal (amod)
treating on (mark)
trends time (compound)
safety mg (conj)
microg/kg/min min (nmod)
recorded intravenously (advmod)
low rate (nsubj)
verapamil antegrade (conj)
disease her (nmod:poss)
haloperidol concomitantly (advmod)
outer and (cc)
safe long-term (nmod)
affects neurons (dobj)
etoposide 16.213 (nummod)
exhibited effect (dobj)
years years (nmod)
titres mpo-anca (compound)
correlated ages (nmod)
accepted widely (advmod)
map neuropathy (nmod)
inhibitor 7-ni (dep)
reducing mortality (dobj)
encouraged investigate (xcomp)
administered time (nmod)
time profile (appos)
% 58.6 (nummod)
volunteered and (cc)
stimulation peptidergic (amod)
disease known (amod)
mg. i.p. (advmod)
weakness lower (amod)
level use (nmod)
atria right (advmod)
decrease baseline (nmod)
mg/dl p=0.03 (appos)
substance cells (nmod)
protein 88 (nummod)
exposure csa (compound)
pressure concentration (conj)
sections heart (compound)
% per (case)
placed one (nmod)
expressed membrane (nmod)
endarterectomy carotid (compound)
induced dox (nmod)
found and (cc)
jones smith (conj)
eye one (nummod)
using anesthesia (nmod)
involve rare (advcl)
delta theta (conj)
elevated not (neg)
taking dose (dobj)
sheath pacemaker (conj)
lovastatin excel (appos)
defined > (nmod)
prevalence high (amod)
suggest taken (ccomp)
opportunity analyze (acl)
changes women (nmod)
10min every (det)
pg-9 releaser (appos)
counts subset (compound)
half-time in (case)
sought objective (nsubj)
related : (punct)
seen ; (punct)
mmol/kg ) (punct)
similar structurally (advmod)
single and (cc)
used therapy (nsubjpass)
benign . (punct)
57.7 and (cc)
= 99 (dep)
collected were (auxpass)
l-dopa+benserazide with (case)
developed disorders (nsubj)
cylinder total (amod)
recordings intraoperative (amod)
leiden for (case)
white , (punct)
days prior (advmod)
arabic together (advmod)
hemorrhage stroke (conj)
unchanged decreased (parataxis)
sulphate inhibitor (appos)
8.5 +/- (cc)
chemotherapy fluorouracil (nmod)
exposure short-term (amod)
control symptom (compound)
delivery at (case)
deficits intermediate (amod)
adam10 expression (dep)
identify incidence (dobj)
electroshock and (cc)
ml/min/kg ml/min/kg (conj)
proposed produce (ccomp)
six three (quantmod)
celecoxib naproxen (conj)
painful application (nmod)
exhibit cardiotoxicity (dobj)
cessation following (case)
114+/-4 122+/-5 (compound)
myeloencephalopathy fatal (amod)
that condition (nmod)
pressure p (dep)
rashes skin (compound)
glycopyrrolate of (case)
holding weight (dobj)
consisted estrogens (nmod)
enzymes anti-hbe (conj)
dfu and (cc)
values hbv (compound)
induced still (advmod)
cycles regimen (nmod)
characteristics excitability (amod)
diazepam after (case)
frequency regurgitation (nmod)
ester of (case)
patients tuberculosis (compound)
cerebral artery (conj)
cases encephalitis (nmod)
induced 9-tetrahydrocannabinol (nmod)
purpura extremities (nmod)
microinjections striatum (nmod)
development cells (nmod)
impaired secretion (dobj)
range glycopyrrolate (nmod)
infection individuals (nmod)
three three (dep)
mechanism may (aux)
mechanisms death (nmod)
impaired negatively (conj)
location aneurysm (nmod)
l-noarg haloperidol (conj)
potentials ventricular (conj)
228 32 (dep)
changes in (case)
summary patient (conj)
lozenge received (acl:relcl)
monitored given (conj)
acid oral (amod)
underlying toxicity (dobj)
required treated (ccomp)
examine stress (dobj)
occur years (nmod)
cuff of (case)
masseter and (cc)
using respectively (advmod)
indicator measurement (nmod)
patient presented (acl:relcl)
withdrawal the (det)
nephrotoxicity cyclosporine (compound)
acute an (det)
week signs (nmod)
change % (compound)
administration upon (case)
chloroacetaldehyde and (cc)
monitor clonidine (nsubj)
effects synapse (nmod)
antagonist d2 (compound)
prolonged similar (parataxis)
accompanied model (nmod)
maintains function (dobj)
mild transient (conj)
performed material (nsubjpass)
eosinophilia ( (punct)
complex complex (conj)
aqp2 ( (punct)
showed moderate (dobj)
atropine r-(alpha)-methylhistamine (appos)
enantiomer pregs (compound)
nitrate drops (conj)
expression penk (compound)
striatum , (punct)
perform was (cop)
all symptoms (nmod)
available received (conj)
failure captopril-induced (amod)
potent it (nsubj)
prevention deficit (nmod)
pk kg(-1 (appos)
2.41 +/- (cc)
axons of (case)
boy exhibited (acl:relcl)
agents progestational (amod)
objectives designed (dep)
effects weight (nmod)
establish to (mark)
returned er (nmod)
chow ) (punct)
initiatives public (amod)
haloperidol alone (advmod)
cm la (nmod)
analgesic other (amod)
pharmacology pharmacokinetics (conj)
intoxication with (case)
reduces % (nmod)
latency escape (compound)
diagnosis model (nmod)
phosphanilate chlorhexidine (compound)
considered variables (nsubjpass)
effects gastrointestinal (amod)
that reported (acl)
high 23 (conj)
reported safe (nsubjpass)
regimen , (punct)
carolina but (cc)
severity hypotension (nmod)
involved functions (nsubjpass)
a b. (conj)
rate gem-p (nmod)
administered d (nmod)
sulphate ] (punct)
beta and (cc)
infusions administered (acl)
investigated series (nmod)
unaccustomed activity (dobj)
immunoreactivity a (det)
read , (punct)
related and (cc)
activated iii (nmod)
ratios metoprolol/alpha-hydroxymetoprolol (amod)
rigidity post-operative (amod)
pan vehicle (conj)
injection with (case)
stabilized integrity (nsubjpass)
warning a (det)
importance approach (nmod)
cancer extensive (amod)
falls administration (nmod)
years 12 (nummod)
p=0.05 ( (punct)
affinities negligible (amod)
attenuated reductions (dobj)
frequency beats (nmod)
pairs forty (nummod)
unsafe absence (nmod)
mirrored alterations (nsubj)
granules the (det)
reduced dpi (dobj)
rate control (conj)
ritonavir hiv (compound)
decreased 31 (nmod)
presented sensory (nmod)
isoproterenol ) (punct)
g/ml 2 (nummod)
patients 329 (nummod)
results that (mark)
likelihood developing (advcl)
evaluated tnss (nmod)
increases more (advmod)
exceeds intracranial (amod)
received later (advmod)
classified is (auxpass)
regimens dexamethasone-containing (amod)
led intake (nsubj)
but slightly (advmod)
done preoperatively (advmod)
prescribed widely (advmod)
running jumping (advcl)
abilities cognitive (amod)
find compared (advcl)
met diagnosis (nmod)
p9605 protocols (dep)
gum polacrilex (compound)
patient aids (nmod)
heart infarcted (amod)
opioid fentanyl (dep)
structures da-innervated (amod)
xdr-tb ( (punct)
examination motor (compound)
consequences long-term (amod)
accounted was (auxpass)
pain related (amod)
spasm level (nmod)
sufficient protect (xcomp)
surveillance under (case)
effects drug (nmod)
reports paralysis (nmod)
use agonist (nmod)
detoxification mesna (nmod)
4.3 ) (punct)
using i.v. (advmod)
episode grade (nmod)
sensitive effects (nmod)
wall arterial (amod)
epilepticus required (acl:relcl)
collected : (punct)
1995 from (case)
reduces significantly (advmod)
used anticoagulation (nmod)
had begun (conj)
rate cure (compound)
dose mg/m(2 (appos)
wavefronts of (case)
discontinued order (nmod)
9.9 , (punct)
involvement tumor (compound)
fev1 75 (dep)
searched were (auxpass)
treated vnr (nmod)
clinical electro-diagnostic (conj)
cholinergic the (det)
avoid mistakes (dobj)
hernia aor (dep)
have prevalence (dobj)
attacks syncopal (compound)
superoxide in (case)
predictors independent (amod)
days 17.5 (nummod)
taking he (nsubj)
dermatitis periocular (amod)
identify reliably (advmod)
method measure (acl)
causes many (amod)
account symptoms (nmod)
0.05 < (dep)
highlights need (dobj)
cle with (case)
capacity recovery (compound)
= found (conj)
time climbing (compound)
amplitude patients (nmod)
level urea (compound)
system within (case)
collected samples (nsubjpass)
delirium treatment (nmod)
induced s.c. (dep)
discontinued oxacillin (nsubjpass)
anti-hbs ( (punct)
doses trial (conj)
carotid done (acl)
cases both (det)
treatment immediate (amod)
blood for (case)
center medical (amod)
infarction women (nmod)
stenosis maximal (amod)
phenylephrine in (case)
symptoms bilateral (amod)
challenge clinical (amod)
extend studies (dobj)
course second (amod)
assess function (dobj)
considered when (advmod)
allocated subjected (parataxis)
everolimus and (cc)
polyuria a (det)
groups treatment (compound)
micrograms/dl of (case)
expression medullary (amod)
properties neurochemical (amod)
took year (dobj)
nr1(neo-/- of (case)
therapy testosterone (compound)
hospital camperdown (conj)
users for (case)
factors data (nmod)
alone once (conj)
restarted however (advmod)
transferred bradycardia (nmod)
breakdown barrier (nmod)
mouth ) (punct)
hypothermia patients (nmod)
varied corresponded (conj)
regression multivariable (amod)
behavior and (cc)
potent blocking (advcl)
leading it (nsubj)
negative but (cc)
seen african (nmod)
loss db (nmod)
distinguished can (aux)
reduction dbp (compound)
methemoglobinemia significant (amod)
partial 2 (dep)
rats twenty-five (amod)
pharmacokinetic . (punct)
fnclcc ) (punct)
tested administration (nmod)
has edaravone (nsubj)
53 which (det)
conclusions has (dep)
followed months (nmod)
db subjects (nmod)
conducted population (nmod)
cgi-sf measure (appos)
schedule intermittent (compound)
drug antidyskinetic (amod)
tachyarrhythmias sustained (amod)
six five (nsubj)
management pain (compound)
revealed autopsy (nmod)
population special (amod)
vasoconstriction gm-induced (amod)
er in (case)
tablets < (dep)
hyperalgesia secondary (amod)
constituted att-alf (nsubj)
females 42 (nummod)
techniques reaction (nmod)
had fluvoxamine (nsubj)
testing initial (amod)
thp mg/kg (appos)
disorders drug (conj)
radiotherapy subsequent (amod)
lad ( (punct)
anti-hbs ) (punct)
system analysing (acl)
aware potential (nmod)
protection to (case)
effective neuroblastoma (nmod)
beginning before (mark)
underwent 41 (nsubj)
0.5 - (punct)
needed be (auxpass)
rate response (compound)
reflect may (aux)
proliferate up (compound:prt)
differences due (case)
animals ) (punct)
zdv either (cc:preconj)
cocaine opiates (conj)
association ptcr (nmod)
mellitus or (cc)
model in (amod)
rats c (dep)
pattern or (cc)
drowsiness dizziness (conj)
seen emergence (dobj)
undergoes effect (nsubj)
angioedema (acei)-induced (amod)
evaluated and (cc)
defective and (cc)
incidence , (punct)
continued were (auxpass)
= model (conj)
cephalosporins first-generation (compound)
induced ifs (nmod)
found infusion (nsubjpass)
abundance of (case)
normoammonaemic patient (nsubj)
infusions catalepsy (nmod)
staining ttc (compound)
use population (nmod)
reported myasthenia (nsubjpass)
benign and (cc)
evaluated audit (nmod)
blood circumflex (amod)
pilsicainide including (case)
prolonged whereas (dep)
acute , (punct)
losartan ii (nummod)
nausea events (nsubj)
injection cisplatin (nmod)
remission % (appos)
ligand a (det)
protocols lymphoblastic (amod)
walk of (case)
12.8 and (cc)
curves dose-response (amod)
times ten (nummod)
truncated words (nmod)
obstruction of (case)
eyes paired (amod)
confirmed biopsies (nmod)
available supplemented (parataxis)
patients less (dep)
began treatment (dobj)
wsr wsp (conj)
reactions bendrofluazide (acl)
cardiotoxicity adriamycin (compound)
difference=0.01 p (compound)
considering surgery (dobj)
prevalence greater (amod)
project screening (compound)
described years (nmod)
choice a (det)
age had (conj)
1 , (punct)
fusion , (punct)
significant hours (nmod)
fk506 or (cc)
weeks range (dep)
effusions of (case)
back-diffusion and (cc)
related ptu (nmod)
extended-release/lovastatin of (case)
revealed chronically (advmod)
areas sensitive (amod)
arthrogryposis outcome (nsubj)
satisfied . (punct)
activate indicates (conj)
tetany recovery (nmod)
causes epilepticus (nsubj)
half-life monoher (nmod)
role no (nmod)
concentration u/l (nmod)
dysfunction astroglial (amod)
convulsive , (punct)
= 0.79 (dobj)
induced back (advmod)
interactions clonidine (nmod)
signs extrapyramidal (amod)
synthesis conjugates (nmod)
delivered who (nsubj)
years acne (nmod)
charcoal with (case)
extent different (amod)
hazards the (det)
worsening in (case)
bicarbonate meq. (appos)
reduction frequency (nmod)
active she (nsubj)
patients failure (conj)
up-regulation controls (nmod)
involved catalepsy (nmod)
= cohorts (conj)
ointment the (det)
arrhythmias patient (nmod)
accumulation sites (nmod)
cholestasis rats (nmod)
adjusted order (nmod)
increase exposure (nsubj)
patients cells/mm3 (nmod)
induced mg./kg (nmod)
erythrocytes on (case)
d-pen of (case)
given acetate (nsubjpass)
systems neurotransmitter (compound)
metabolite ( (punct)
period government (nmod)
positive three (nsubj)
ms and (cc)
examined haloperidol (dep)
underwent chemotherapy (dobj)
peptide and (cc)
study presented (acl)
requires binding (nsubj)
h following (amod)
dose clozapine (compound)
target primary (amod)
polymorphic polymorphisms (nsubj)
receiving after (mark)
inhibitor synthase (compound)
microscopy myocardium (nmod)
hours 1 (conj)
sulpiride antagonist (compound)
history diary (conj)
release enzyme (compound)
ameliorated first (advmod)
cause delayed (advcl)
updrs in (case)
session by (case)
chloride intravenous (amod)
pathway is (cop)
cancer ht (compound)
study current (amod)
caused presence (conj)
latency time (conj)
showed differences (dobj)
indicated similar (ccomp)
autopsy accurate (amod)
effect group (compound)
enteropathica acrodermatitis (compound)
incidence nodules (nmod)
greater periphery (nmod)
damage by (case)
factor confounding (acl)
hr compared (case)
cortex cg (appos)
excess deposition (dobj)
cyclophosphamide methotrexate (conj)
background agent (appos)
defibrillation electrical (amod)
followed inhalation (nmod)
occurs negroes (nmod)
changes minor (amod)
rhythm alternative (amod)
al 1988 (nummod)
prevention . (punct)
patients appropriate (amod)
gm. ) (punct)
had day (nmod)
living daily (amod)
efficacy lovastatin (nmod)
different agents (nmod)
% 9.7 (nummod)
certain however (advmod)
p4501a1/1a2 of (case)
cardiomyocytes cultured (amod)
background and (cc)
patients switched (acl:relcl)
lowered be (auxpass)
illustrates importance (dobj)
ml/kg 1.0 (nummod)
relapse leukemia (nmod)
found induced (conj)
permits that (nsubj)
removed addition (nmod)
administration lysozyme (nmod)
regulates . (punct)
prior presentation (nmod)
therapy are (cop)
isomerase specific (amod)
equal or (cc)
changes cord (nmod)
mice tg (compound)
studies defined (acl)
ingestion with (nmod)
monkey in (case)
employed practice (nmod)
situation the (det)
anxiety in (case)
candidiasis hoarseness (conj)
models neurotoxicity (nmod)
disfiguring may (aux)
alterations taste (nmod)
mol/l 10(-5 (conj)
0.4 and (cc)
dystrophy sympathetic (amod)
received gum (dobj)
unaffected was (cop)
reducing hyperactivity (dobj)
determined amounts (nsubjpass)
interviewing and (cc)
pharmacokinetics hcl (nmod)
characterized degrees (nmod)
pathogenesis toxicity (nmod)
protection neuronal (amod)
concentration for (case)
protein egfp (appos)
recognize condition (dobj)
disorders the (det)
feet 50 (nummod)
complication thus (advmod)
tool overdose (nmod)
use on (case)
effect rigidity (nsubj)
crystallization acid (nmod)
suppression functions (nmod)
ml ml. (conj)
had crisis (dobj)
timolol ml-1 (appos)
rats tgr (compound)
15mg/kg orally (amod)
hypothesis increases (ccomp)
process ageing (compound)
hyperhidrosis hypersalivation (conj)
doxorubicin +/- (cc)
nucleus at (case)
cohorts patient (compound)
box the (det)
behaviors interfering (amod)
scores parts (appos)
area saddle (compound)
mortality associated (acl)
had rate (dobj)
role tissue (nmod)
remains entity (nmod)
production peroxide (compound)
histochemistry hybridization (compound)
attempt rule (nsubj)
modifies expression (dobj)
mmol/kg s.c. (advmod)
nucleus intermedius (compound)
blocked associated (dep)
shown media (nsubjpass)
negative bpo (nmod)
diminished aida (nsubj)
listed inserts (nmod)
potency beta-1 (compound)
cells placebo (dep)
given sulfate (dobj)
recorded continuously (advmod)
necessary investigations (nsubj)
cco-iv sdh-fp (conj)
mg/m(2 250 (nummod)
affect pain (dobj)
models both (det)
coadministered . (punct)
d-med ) (punct)
suffered instillation (nmod)
died suddenly (advmod)
resulted restoration (nmod)
apply remain (advcl)
injection intracerebroventricular (amod)
justify determination (dobj)
force for (case)
tissues target (compound)
patterns transformation (compound)
completed reached (conj)
hypothesis play (ccomp)
encoding and (cc)
amounts furosemide (nmod)
monitor conclusions (dep)
signs until (case)
a(1)/a(2a ) (punct)
observed latter (nsubjpass)
marketed been (auxpass)
nafld of (case)
transplantable diethylstilbesterol (conj)
ratio arterial (amod)
study design (dep)
ventricles both (det)
closed reported (conj)
bladder given (case)
case hamartoma (nmod)
cell number (dep)
surgery valve (compound)
regimen consisting (acl)
people among (case)
stable was (cop)
decrease concomitant (amod)
safety compliance (conj)
but gradually (advmod)
decrease pilocarpine-induced (amod)
compared data (dobj)
min only (advmod)
factor-kappab nf-kappab (appos)
alterations activity (nmod)
doses piperacillin/tazobactam (nmod)
interval % (conj)
intakes p (dep)
showed asynergy (dobj)
walls to (case)
% 0.8 (nummod)
asked subjects (nsubjpass)
chemotherapy followed (acl)
artery carotid (compound)
jaundice cholestatic (amod)
induction hl60 (nmod)
associated : (punct)
profile safety/efficacy (compound)
seizures tonic-clonic (amod)
allograft with (case)
= 0.125 (dobj)
3,5,7,10,17,27,41 n (dep)
percent % (nmod)
consider and (cc)
patients infection (nmod)
development kindling (nmod)
irregularity their (nmod:poss)
response further (amod)
treatment repeated (amod)
protection effective (amod)
risk concentration (nmod)
study borderzone (nmod)
blunted . (punct)
diet and (cc)
increased controls (advcl)
reduction lvef (nmod)
toxicity epithelial (amod)
tolazamide with (case)
reports toxicity (nmod)
depolarisation sustained (amod)
pretreated exposed (advcl)
6 higher (amod)
p<0.02 ) (punct)
intervention 10 (nummod)
reported experienced (conj)
treatment subsequent (amod)
troponin i (dep)
therapy chloroquine (nmod)
received continued (conj)
describe subcutaneously (advmod)
year 3 (nummod)
anemias drug-induced (amod)
infection de (amod)
disrupted absent (conj)
characterized developed (amod)
subtype metabotropic (compound)
september clinic (nmod)
episode to (case)
1971 between (case)
4 ] (punct)
period off (amod)
prevented changes (nsubjpass)
failure antituberculosis (compound)
inhibition decarboxylase (compound)
decreased injected (advcl)
given mesna (nsubjpass)
correlates peripheral (amod)
ssc with (case)
performed when (advmod)
scattered densa (nmod)
suspected be (auxpass)
warned , (punct)
surgery aneurysms (nmod)
core the (det)
remained depressed (xcomp)
mg 5 (compound)
terms , (punct)
background described (dep)
peptide pro (amod)
case prior (amod)
treated inhibitor (nmod)
necessary doses (nsubj)
agent prevention (nmod)
found that (nsubjpass)
augmented microinjection (nsubj)
results range (appos)
protein o/min/mg (compound)
mediate programming (nsubj)
observed taking (xcomp)
lower mean (advcl)
below well (advmod)
july june (conj)
metoprolol metoprolol-glucagon (conj)
feature dysfunction (appos)
decrease transient (amod)
responses partial (amod)
assessed neurotoxicity (nsubjpass)
time risk (conj)
checklist the (det)
responsible damage (nmod)
daytime with (case)
had suspected (conj)
people epilepsy (nmod)
residence prolonged (amod)
pretreatment fentanyl (nmod)
polyuria associated (acl)
sediment the (det)
limited life (nmod)
symptoms headache (conj)
prevalence similar (amod)
implications findings (nmod)
investigate , (punct)
significance conventional (amod)
performed mmecs (nmod)
injections with (case)
measured biochemical (nsubjpass)
smaller , (punct)
models the (det)
parents sixty-nine (amod)
similar increase (nsubj)
hbeag-positive on (case)
explored duration (dobj)
protected damage (nmod)
suggests useful (ccomp)
investigated questions (nsubjpass)
heart in (case)
reduce = (parataxis)
combinations regimens (nmod)
toxicity bupivacaine-induced (amod)
headaches with (case)
production et-1 (compound)
tariquidar inhibitor (compound)
averaged . (punct)
troublesome . (punct)
has mechanism (nsubj)
levels brain (compound)
increasing pain (dobj)
associated cisplatin (nmod)
therapy triple (amod)
spasm sotalol-induced (amod)
2mls ( (punct)
problem ototoxicity (nsubj)
cortex moderate-dose (dep)
rate production (conj)
found whereas (dep)
associated associated (conj)
response transplantation (nmod)
outcome dyskinesias (nmod)
drugs several (amod)
controls 467 (nummod)
anti-cancer an (det)
activity loreclezole (nmod)
disturbances transport (nmod)
integrate that (nsubj)
concentrations mol/l (nmod)
doses alone (advmod)
indicated increase (ccomp)
describes seizure (dobj)
showed evidence (nmod)
adam ( (punct)
rated patients (nsubj)
rs ( (punct)
polydrug fifteen (compound)
cck-8-ns ( (punct)
role groups (nmod)
modulate . (punct)
affects but (cc)
analysis data (nmod)
all , (punct)
patients dyskinetic (amod)
binder principal (amod)
concentrations change (dep)
depression activity (nmod)
preventing or (cc)
increase strong (amod)
assessed discomfort (nsubjpass)
pressure basal (amod)
> by (case)
patient sirolimus-treated (amod)
neurones dopaminergic (amod)
diagnose find (conj)
hypotheses mechanistic (amod)
pressure volume (conj)
induced coadministration (nmod)
neurotoxicity carbamazepine (compound)
fda ) (punct)
troublesome not (neg)
decreased reach (conj)
i1- selective (amod)
hormones , (punct)
meq/l. was (cop)
2 on (case)
iv or (cc)
induced phenobarbital (nmod)
solvd ( (punct)
occupation receptors (nmod)
dental procedures (dep)
derivative an (det)
ranitidine cimetidine (conj)
pathway brainstem (compound)
overcome to (aux)
african the (det)
began thalidomide (xcomp)
15.5 4.7 (dep)
increased had (conj)
14c less (amod)
groups dose (compound)
glutamate h2o2 (conj)
cm five (nummod)
domain the (det)
concentrations all (det)
women twenty-five (amod)
78 [na]o (amod)
dystrophy fractures (conj)
levels neuroleptics (nmod)
course peroxidation (nmod)
included sweating (dobj)
different but (cc)
conducting for (mark)
treatment methotrexate (nsubj)
database cases (nmod)
administered week (nmod)
assessment disease (nmod)
deleterious prevention (nmod)
likelihood a (det)
neutral acidic (conj)
show extended (ccomp)
months deafening (nmod)
equal mg/kg (nmod)
change faster (amod)
carcinoma transitional (amod)
subjects more (amod)
presenting who (nsubj)
acetate eslicarbazepine (compound)
reported identical (ccomp)
cause alteration (dobj)
kidney nonclipped (amod)
level effect (nmod)
actuarial table (dep)
developed improve (xcomp)
risks ami (nmod)
toxic system (nmod)
events with (case)
prediction the (det)
naa ) (punct)
group restricted-diet (amod)
pilocarpine alone (advmod)
population medical (amod)
areas exposure (nmod)
has although (mark)
effect blockade (nmod)
using concentrations (dobj)
incidences , (punct)
degree higher (amod)
intact cognitively (advmod)
6.25 ) (punct)
content muscle (nmod)
releaser acetylcholine (compound)
symptoms hyperhidrosis (nmod)
effects stimulatory (amod)
inserted . (punct)
day admission (nmod)
membranes condensed (amod)
impairment expression (conj)
precedes that (mark)
suppressed 1.6 (conj)
brain heart (conj)
widow 62-year-old (amod)
starting treatment (dobj)
receiving mannitol (nmod)
nitrendipine channel (compound)
increase that (mark)
started srl (nsubjpass)
cholesterol low-density (amod)
hallucinations delusions (conj)
integrity structural (amod)
assess symptoms (dobj)
asphyxia small (conj)
inventory satisfaction (nmod)
segment 15 (dep)
warned patients (nsubjpass)
cyclosporine , (punct)
emphasized has (aux)
indicating lesion (ccomp)
disintegrations 619 (nummod)
dyskinesias dose (compound)
1.2 0.5 (compound)
agent with (case)
microangiopathy the (det)
metabolizer and (cc)
number a (det)
caused gentamicin (nmod)
associated odds (nmod)
dfmo sulindac (conj)
produced hcbd (nmod)
mice abilities (dobj)
aspirin pyrazolones (nmod)
efficacy rat (compound)
deletion and (cc)
mg/0.5 10 (compound)
lack effects (nmod)
indicated as (mark)
observations considerations (conj)
effects sulphate (nmod)
stimulated apoptosis (dobj)
phase multicenter (conj)
recurrence rechallenge (nmod)
induce thus (advmod)
reaction reverse (compound)
become pronounced (acomp)
68 in (case)
unchanged velocity (nsubj)
d-med and (cc)
aminotransferase = (dep)
asystole the (det)
decrease on (case)
demonstrated already (advmod)
included appetite (dobj)
induction offspring (nmod)
hdl ) (punct)
used bacl2 (nmod)
had methscopolamine (nsubj)
elevation to (case)
pbsct of (case)
augmented significantly (advmod)
intensity fasciculations (nmod)
dialysis continued (amod)
glycol ) (punct)
dose mentioned (amod)
performed better (advmod)
state hypotensive (amod)
result may (aux)
detected changes (nsubjpass)
assessment status (nmod)
detection effects (nmod)
bromocriptine microg/kg (appos)
exhibited reduction (dobj)
differ release (nmod)
produced volume (dobj)
detected surviving (advcl)
seconds > (compound)
seen having (advcl)
tdi mp (dep)
hydrobromide . (punct)
m-chlorophenylpiperazine or (cc)
increased related (conj)
resection endoscopic (amod)
inhibitors future (amod)
utilizes ; (punct)
increased glutathione (nsubj)
n=10 , (punct)
was when (advmod)
renoprotective patients (nmod)
frequency factors (conj)
myelin axons (conj)
fluorthyl- , (punct)
observed activating (advcl)
measurement permitting (compound)
diazepam alone (advmod)
mg/day 20 (nummod)
m(3)-machr. the (det)
urea ( (punct)
7.54 were (cop)
report methods (dep)
trained were (auxpass)
values virus (compound)
enhance indirectly (advmod)
tool be (cop)
caused pretreatment (nsubj)
increased nitroglycerin (nsubj)
sm-5887 and (cc)
influenced differentiation (nsubjpass)
formation , (punct)
risperidone t(30 (appos)
impaired is (aux)
glaucoma of (case)
corrected anemia (nsubjpass)
evening regimen (conj)
months next (amod)
waves q (compound)
assays drug (nmod)
3.9 - (punct)
task consisting (acl)
domperidone mg/kg (appos)
flushed , (punct)
correlation and (cc)
occurred 62 (dep)
difficulty exertion (nmod)
glutathione total (amod)
migraineurs fifteen (nummod)
subtype n-methyl-d-aspartate (compound)
del haplotypes (conj)
eight to (quantmod)
undergoing , (punct)
injected slowly (advmod)
spv in (case)
toxicity either (cc:preconj)
antibody myeloperoxidase-antineutrophil (amod)
seen effects (nsubjpass)
developed secondary (xcomp)
transaminase of (case)
began before (mark)
ke cl (appos)
retention- long-term (amod)
related toxin (nmod:npmod)
resuscitated he (nsubjpass)
often renografin (nmod)
norleucine norvaline (conj)
study diphosphanilate (nmod)
buffered lidocaine (dobj)
oxidase cox (appos)
exclusively almost (advmod)
investigated randomized (conj)
hemorrhaging at (case)
effective not (neg)
reduction time (nmod)
shift of (case)
cfcs ( (punct)
hospitalization longer (amod)
promotes activation (nsubj)
avoid drugs (dobj)
heparin citrate (conj)
lead preparations (nmod)
abnormalities following (amod)
injections 37 (nummod)
patients undergoing (acl)
simvastatinezetimibe ( (punct)
attenuated and (cc)
protocol analysis (compound)
hypocalcemia case (compound)
nmol ( (punct)
buffer and (cc)
hypothesized we (nsubj)
segments p<0.01 (appos)
ha i-131 (compound)
parietal , (punct)
alterations types (nmod)
indomethacin idm (appos)
convulsions on (case)
dose 4 (nmod)
measured methods (nsubj)
hiccups mechanism (conj)
mg/kg 500 (nummod)
ccl4 chcl3 (conj)
electrodes stn (nmod)
measure main (compound)
comparing active (dobj)
collection apheresis (compound)
received pergolide (dobj)
dystonia subscore (advmod)
impairment induced (amod)
background caused (appos)
measure day (dep)
led discontinuation (nmod)
is proof (attr)
rate 30 (nmod)
urethane with (case)
deterioration induce (compound)
defects 30 (nummod)
type . (punct)
rats salt-depleted (amod)
doxorubicin adriamycin (appos)
compared content (nsubjpass)
degree by (case)
baseline compared (case)
prevent that (nsubj)
schizophrenia episodes (conj)
potential a (nmod)
occurs stroke (nsubj)
prescription crocin (nmod)
confined suppression (nmod)
glutamate injections (dep)
anemia patients (nmod)
effect cardiotoxic (amod)
test akathisia (nmod)
79 9 (compound)
alphaenac and (cc)
associated used (conj)
stem . (punct)
reached associated (conj)
limitations certain (amod)
observation the (det)
administered hr (dep)
greatest , (punct)
destruction selective (amod)
r=0.81 and (cc)
isomers with (case)
prevented conclusion (nmod)
determine rate (dobj)
dependent be (cop)
returned group (nmod)
determined studied (conj)
phenytoin to (mark)
depression between (case)
disappearing protein (nsubj)
cells untreated (amod)
opioid a (det)
calculi radiolucent (amod)
centre , (punct)
expression synthase (nmod)
cases disease (nmod)
disorders neuroleptic-induced (amod)
infusion mg (appos)
tubular to (case)
abandoned be (auxpass)
9.7 - (punct)
chow injection (nmod)
analysis microscopic (amod)
showed formation (nmod)
paralysis . (punct)
rhythm the (det)
shock electric (amod)
physicians and (cc)
problem are (cop)
tests outcomes (conj)
damage severe (amod)
mg/m2 185 (nummod)
thrombosis females (nmod)
hospitalised patients (nsubjpass)
contribution major (amod)
inhibits synthesis (dobj)
haloperidol apomorphine (conj)
patients /= (dep)
duration exposure (nmod)
medication to (case)
cortex and (cc)
prilocaine % (compound)
time walk (nmod)
reported remained (advcl)
edema involving (acl)
hormone and (cc)
aimed study (nsubjpass)
concordance anomalies (nmod)
courses by (case)
eyes their (nmod:poss)
1r 3s (appos)
hepatitis mixed (amod)
treatment nitrendipine (nmod)
5 l4 (compound)
demonstrate interaction (dobj)
apoptotic and (cc)
theorem , (punct)
model penicillin (compound)
treatment osteoporosis (nmod)
control 1.037 (dep)
kg ; (punct)
control because (case)
damage resulting (amod)
anaesthesia ambulatory (amod)
constricting by (mark)
variation cv (appos)
synapses described (acl)
effects neurologic (amod)
january 1986 (nummod)
day placebo (conj)
become centers (nmod)
appearance induced (acl)
density sodium (compound)
short skf-82958 (nmod)
toxicity amikacin (nmod)
precedes . (punct)
microg/kg/min bolus (appos)
risk malignancy (nmod)
rbf ( (punct)
bound atpases (dobj)
using commonly (advmod)
administration cimetidine (compound)
b12 and (cc)
voltammetry hydroxylase (conj)
dependency dose (compound)
that compared (acl)
considers review (nsubj)
chenodeoxycholate of (case)
rate norepinephrine (compound)
17 with (case)
sed 6.0 (conj)
fatal can (aux)
tolerability of (case)
death a (det)
mm pupils (nsubj)
modification . (punct)
episodes . (punct)
functioning cognitive (amod)
mg chest (conj)
aeroallergens spring (compound)
signed subjects (nsubj)
coincidental may (aux)
beverages water (nmod)
showed clarithromycin (dobj)
users 5.7 (nmod)
3.5 - (punct)
renin the (det)
5 3 (compound)
paco2 arterial (amod)
patients mg/dl (dep)
action cytogenetic (amod)
use suppressants (nmod)
ph albumin (conj)
a fujimycine (conj)
0.9 and (cc)
mcao after (case)
qtls susceptibility (nmod)
locomotion behavior (conj)
sensations use (nmod)
resurgence recently (advmod)
safe green (nsubj)
studies 20 (appos)
given doses (nsubjpass)
histories drug (compound)
anesthetics , (punct)
rats bilateral (amod)
lymphomas indolent (amod)
syndrome is (cop)
rats ovex (compound)
disorder obsessive (amod)
n/n=9/26 ( (punct)
non-smokers were (cop)
cancers four (nummod)
cystitis cyclophosphamide-induced (amod)
nmba short-acting (amod)
representative was (cop)
disorders psychiatric (amod)
mice non-txg (compound)
abandoned considered (advcl)
defined reduction (nmod)
quality protocol (nmod)
matrix leading (acl)
reduction amplitude (compound)
release cytokine (compound)
or 8.75 (dep)
transitioned was (auxpass)
sulphate pregnenolone (compound)
di nephrogenic (amod)
irreversible was (cop)
normalization as (cc)
related pressure (nmod)
topotecan days (nmod)
technique regions (nmod)
treatment prior (case)
acid t (appos)
species (ros)/nitrogen (compound)
contained clinically (advmod)
trial open-label (amod)
physician skilled (acl)
elements bbb (nmod)
treated nightly (advmod)
role this (det)
cells 000 (nummod)
losartan receptor (compound)
sweating associated (acl)
consisted associated (advcl)
time read (acl:relcl)
neuropathy chemotherapy (compound)
food controls (nmod)
0.86 0.15 (conj)
methadone buprenorphine (conj)
enzyme during (case)
thrombosis venous (amod)
160/12.5 val/hctz (compound)
important studying (advcl)
maintained enhanced (conj)
exception the (det)
children series (nmod)
placebo response (nmod)
gallstones without (case)
protected pretreatment (nmod)
replaced sirolimus (nmod)
nephropathy reduced (dep)
prolonged k- (conj)
overcome to (mark)
injection levobupivacaine (nmod)
concern is (cop)
disruption abuse (conj)
cases 6 (nummod)
involved reaction (nmod)
back low (amod)
administration prednisolone (nmod)
pcr-rflp ( (punct)
ligation- effects (conj)
list the (det)
patients consumers (acl:relcl)
identified was (auxpass)
600 mg/day (dep)
occurred infarction (nsubj)
9 2 (conj)
treated mirtazapine (nmod)
muscle induced (acl)
cystitis typical (amod)
collection blood (compound)
known although (mark)
remained or (cc)
salt women (nmod)
included it (nsubj)
adr with (case)
pgs ) (punct)
failure creatinine (dep)
complete two (nummod)
dysmetria dysarthria (conj)
improved effects (nsubj)
evaluation to (case)
injection seven (nmod)
intervals 1-min (amod)
stiffness jaw (compound)
licking formalin-induced (amod)
window its (nmod:poss)
levels drug (compound)
32.5 12.1 (conj)
outflow excessive (amod)
rates respiration (nmod)
avoided graft (nmod)
cancer is (cop)
neurons bladder (compound)
list company (nmod)
months 36 (nummod)
outcome investigated (acl)
23 only (advmod)
maintained characteristics (dobj)
0.06 0.04 (conj)
colonies progenitor (compound)
cases 81 (nummod)
receiving botox (dobj)
p300 of (case)
done end (conj)
dtic ( (punct)
used pacing (nsubjpass)
complexes i-iv (dep)
promotion af (compound)
efficacy preference (conj)
decreased activity (nsubjpass)
decrease seizure (xcomp)
induce but (cc)
exhibited mice (nmod)
developed patients (nmod)
cause acidosis (dobj)
scores between (case)
number original (amod)
adrenoceptor nm (appos)
interaction resulting (acl)
duration elevation (conj)
agency protection (compound)
intake and (cc)
users polydrug (compound)
had 11.494 (punct)
developed mononucleosis (dobj)
replacement after (case)
u/ml median (amod)
anemia autoimmune (amod)
mg/kg a (det)
pathways bladder (compound)
computer software (nmod)
glutamate by (case)
pge1 due (case)
those olanzapine (nmod)
rat lou/m/wsl (compound)
agent antipsychotic (amod)
fed rats (nmod)
dressing form (nmod)
found toxicity (nsubjpass)
tilts rats (nmod)
irreversible and (cc)
provoked . (punct)
report exposure (nmod)
methods allocated (appos)
stable min (nmod)
ratio expression (compound)
objectives complication (dep)
discontinuation pentamidine (nmod)
bpt t.i.d. (appos)
change nor (cc)
properties ssr103800 (nmod)
amylase serum (compound)
found ameliorate (xcomp)
system da (compound)
occurrence death (nmod)
culminating weeks (nmod)
induced modifications (dobj)
messages behavioral (amod)
double-blind this (det)
recommended frequency (nsubjpass)
correlate duration (nmod)
fibrillation of (case)
intake after (case)
ph ( (punct)
edema , (punct)
presented near-syncope (nmod)
fisher two-sided (amod)
were was (conj)
randomised groups (nmod)
development battery (nmod)
length-of-stay increased (amod)
study dysfunction (dobj)
0.90 greater (amod)
surveillance a (det)
myopathy cause (acl:relcl)
dro-1h- indol-2-one (nummod)
flow pneumotachograph (nmod)
levels forms (nmod)
dipyridamole to (case)
ring and (cc)
apigenin the (det)
mg./kg 5 (nummod)
workers of (case)
complained myalgia (nmod)
involved pathogenesis (nmod)
compromises decreasing (advcl)
achieve transition (dobj)
interaction substratum (nmod)
striatum hippocampus (conj)
clonidine clonidine (conj)
find to (mark)
icrf-187 ) (punct)
changes resistance (conj)
surviving hepatocytes (dobj)
meal charcoal (compound)
most of (case)
reported myopathy (nsubjpass)
alterations no (neg)
allografts consent (nmod)
irrigation bowel (compound)
insipidus therapy (nmod)
run course (dobj)
drug another (det)
data tr(- (nmod)
agent iodinated (amod)
or = (amod)
< , (punct)
done anesthesia (nmod)
observed let (advcl)
program on (case)
triamcinolone of (case)
group patients (conj)
showed proteinuria (dobj)
indicative to (mark)
hus ( (punct)
cardiac cerebrovascular (conj)
curvilinear configuration (appos)
prevented atorvastatin (nsubj)
inhibitors butyrylcholinesterases (conj)
sumatriptan with (case)
found pallidus (nmod)
annuloplasty undersized (amod)
cpa/ee . (punct)
define , (punct)
effects dynamics (nmod)
diet to (case)
mice all (det)
swollen bilaterally (advmod)
experienced irradiation (nmod)
therapy cyclosporine (nmod)
studies some (det)
hilus in (case)
acknowledged predilection (nmod)
infant a (det)
session stimulation (nmod)
require consideration (dobj)
began take (xcomp)
represented , (punct)
telangiectasia facial (amod)
impaired users (nsubj)
analgesic containing (acl)
nephrotoxicity modulation (conj)
found decreased (conj)
valvulopathy , (punct)
mode the (det)
eosinophil mixed (amod)
diarrhea requiring (acl)
ganglia drg (appos)
degree hypoxia (nmod)
sign episode (nmod)
acids 5 (dep)
enrolled accl0131 (nmod)
remained whereas (dep)
cultures of (case)
0.84 0.80 (compound)
related motility (nmod)
enhances learning (dobj)
demonstrated crucial (xcomp)
antithrombin of (case)
inhibited arrest (nmod)
n-methyl-d-aspartate picrotoxin (conj)
markers serologic (amod)
support ventilatory (amod)
prevention of (case)
conversion inhibitors (nmod)
denervation of (case)
detected treatment (nmod)
modulating hippocampus (nmod)
suppressed bilaterally (advmod)
pressure resolved (acl:relcl)
ages ) (punct)
decreasing level (dobj)
n=18 ) (punct)
undertaken and (cc)
model paranoia (nmod)
emphasizes . (punct)
reported intake (nmod)
providing while (mark)
magnitude comparable (amod)
fluctuations to (case)
hyperhidrosis , (punct)
enhancement developed (acl:relcl)
potentiation ltp (appos)
toxicities resolved (acl)
incidence cancer (nmod)
magnus raphe (compound)
61 six (compound)
predilection for (case)
treated h (nmod)
bringing disturbance (dobj)
glutamate msg (appos)
medulla from (case)
levels mtd (nmod)
propagates discharge (nsubj)
abecarnil and (cc)
association dose (nmod)
patients hospitalized (amod)
duration days (conj)
patients dental (compound)
grams proteinuria/day (nmod)
given should (aux)
based analysis (nsubjpass)
woman hispanic (amod)
demonstrated autoradiography (nmod)
report diagnosed (appos)
have twenty-one (nsubj)
pressor cold (amod)
microliters ) (punct)
mother and (cc)
discussed mechanism (nsubjpass)
tissues extrahepatic (amod)
ci=1.0 1.4 (nummod)
administration sulindac (compound)
varies subgroups (nmod)
percentage small (amod)
nephritis ranitidine-induced (amod)
striatum group (nmod)
continued signs (nmod)
den alone (advmod)
dynamic molecular (amod)
failure e.g. (case)
was terms (nmod)
mechanisms argue (acl:relcl)
rats n (dep)
schedule once-per-day (compound)
report observations (dobj)
tmp-smz 5.2/100,000 (appos)
administration telithromycin (nmod)
woman lacnp (nmod)
1/2,z ) (punct)
catalepsy rats (nmod)
monitoring means (dep)
response hypertrophy (nmod)
visits evaluation (conj)
tacrolimus everolimus (nmod)
drug therapy (conj)
used n (nsubjpass)
dose dapsone (nmod)
that origin (nmod)
trial evaluating (acl)
response initial (amod)
lesions carious (amod)
noted cycle (nmod)
published widely (advmod)
glimepiride with (case)
considered target (nmod)
attributed development (nsubjpass)
effectiveness trinitrate (nmod)
impaired group (advcl)
method mg (appos)
ms time-of-flight (amod)
discontinued frequency (nmod)
avoided is (auxpass)
hemisphere the (det)
cause practice (nmod)
hour in (case)
tested was (auxpass)
glucose fasting (conj)
areas , (punct)
interna globus (compound)
animals pkca (compound)
studied immunization (nmod)
presenting depression (nmod)
increase vulnerability (dobj)
months clozapine (appos)
investigate mechanisms (dobj)
gender by (case)
immunosuppression de (amod)
using analysis (nsubj)
36.7 - (punct)
best how (advmod)
dextran 40000 (dep)
group 0.09 (appos)
treatments following (case)
sodium in (case)
sc 40 (nummod)
rechallenge an (det)
smoker 31-year-old (amod)
prevent losartan (nsubj)
ciprofloxacin oral (amod)
mg/dl , (punct)
mg/kg/day days (nmod)
showed dce (nsubj)
mechanism neuronal (amod)
arag alone (advmod)
agonists a1 (dep)
regressed . (punct)
disturbing as (case)
man 80-yr-old (amod)
exclude to (mark)
providers prehospital (compound)
nouns of (case)
4.3 5.8 (conj)
sites areas (nsubj)
svo(2 in (case)
atria rat (compound)
vgpr < (dep)
syndromes , (punct)
administered 10 (conj)
angiography radionuclide (compound)
proposed prevention (nmod)
suggested understood (conj)
immobility this (det)
serve alternative (nmod)
modeling pharmacodynamics (dobj)
consolidation memory (compound)
admitted who (nsubj)
impact in (case)
cycles of (case)
cause since (mark)
women exposed (acl)
true regardless (advmod)
decrease through (case)
fell 5.6+/-0.9 (advcl)
compatible . (punct)
attribute to (mark)
rechallenged subsided (advcl)
= 23 (dep)
examination by (case)
avoided . (punct)
had range (nmod)
gravity unit (compound)
mg/d 60 (nummod)
fischer f344 (appos)
reflex induced (acl)
presumed similar (xcomp)
hitt osteoporosis (conj)
following particularly (advmod)
value positive (amod)
had whole (nmod)
complemented azathioprine (nmod)
treatment hypertension (nmod)
application papaverine (amod)
october from (case)
day treatment (compound)
background was (appos)
37 % (appos)
that fibrosis (nmod)
abnormalities ecg (compound)
stimulation nerve (nmod)
= 1 (dep)
validity the (det)
groups centers (nmod)
enzyme marker (compound)
exhibits indicating (advcl)
resumption sorafenib (nmod)
lend view (nmod)
showed hearing (advcl)
2 less (advmod)
factor failure (nmod)
effect cm (nmod)
exposure increased (amod)
found homozygous (xcomp)
l(-1 increasing (xcomp)
case developed (acl)
morbidity overall (amod)
oral , (punct)
crocins disease (nmod)
vivo immunohistochemical (conj)
peaked day (nmod)
heart both (cc:preconj)
schema drug (compound)
associations users (nmod)
evaluate transit (dobj)
studied completion (nmod)
protection hemolysis (nmod)
compared period (nmod)
side-effects systemic (amod)
led amelioration (nmod)
injury subunit (compound)
have value (dobj)
treatment 10 (dep)
allow . (punct)
dose opioid (compound)
non-txg ( (punct)
fzp ) (punct)
enhancement with (case)
death mortality (conj)
viewed should (aux)
induced repeatedly (advmod)
deacetylation homogenates (nmod)
administration prostigmine-morphine (amod)
vasorelaxation segments (nmod)
binding mk-801 (compound)
promotes phosphorylation (nmod)
appears requires (conj)
heroin addicts (dobj)
treatment glibenclamide (nmod)
decrease caused (acl)
oxide the (det)
annulus on (case)
consequence major (amod)
nerves both (det)
space stereotactic (amod)
obstruction upper-airway (amod)
hypertrophy report (dep)
received killed (conj)
paraventricular nuclei (dep)
treated placebo (nmod)
detected moreover (advmod)
evaluate treatment (nmod)
eia ) (punct)
signal recorded (amod)
globulin hepatitis (compound)
treatments haloperidol (compound)
years the (det)
level stress-induced (amod)
males % (compound)
control contralateral (amod)
attributed were (auxpass)
appreciated known (advcl)
determinant activity (nsubj)
design balanced (amod)
disturbances visual (amod)
mefloquine of (case)
(na cardiac (amod)
organization the (det)
administered was (auxpass)
administered po (dobj)
sclerosis with (case)
doses reduced (amod)
assay blue (amod)
cause cause (conj)
bpo-pll for (case)
ventilation unit (nmod)
induces or (cc)
abnormalities some (det)
74 43 (compound)
hemorrhage formation (conj)
alter level (dobj)
treated retinoblastoma (nmod)
genotyped was (auxpass)
known respect (nmod)
= x(2 (dep)
patterns vessels (nmod)
objective achieve (dep)
scavengers radical (compound)
features case (nmod)
hyperalgesia mechanical (amod)
had conditions (dobj)
pretreatment phno (nmod)
scores mg (nmod)
injection min (conj)
sinoatrial s-a (appos)
effects documented (amod)
toxicity drug-related (amod)
patients synovitis (nmod)
age length (conj)
data groups (nmod)
prevented alterations (dobj)
problem need (conj)
step is (cop)
% 5.6 (nummod)
oxidase monoamine (compound)
trespass bbb (dobj)
discontinue therapy (dobj)
reduced pce (nmod)
impaired controlling (advcl)
twelve them (nmod)
free had (conj)
disorder usually (advmod)
switching in (mark)
protocol identical (amod)
obstruction introduction (nmod)
pb , (punct)
nausea restlessness (conj)
occlusion measure(s (compound)
51.0 - (punct)
hepatitis amoxicillin-clavulanic (amod)
chemotherapy gem-p (nsubj)
injured the (det)
reports any (det)
uveitis of (case)
torsade of (case)
disorder caused (acl)
receive therapy (dobj)
recommend not (neg)
reducing simulator (nmod)
treated could (aux)
have electrocardiogram (dobj)
history and (cc)
had prevalence (dobj)
defect dysfunction (nsubj)
patients fluctuating (amod)
cardiotoxic presumably (advmod)
methemoglobin mhb (appos)
block ibpb (appos)
updating ( (punct)
tolerated mg/d (nmod)
nephrotoxicity maleate-induced (amod)
implanted capsules (nmod)
data series (nmod)
decreased ebf (nsubj)
results lowered (appos)
set found (conj)
nausea to (case)
increased based (advcl)
adverse more (advmod)
years than (case)
enzyme with (case)
necrosis muscle (compound)
recorded . (punct)
cgrp and (cc)
criteria discharge (compound)
complicated further (advmod)
toxicity dysmorphism (conj)
alleviated completely (advmod)
defect neutrophil (compound)
ns-718 ( (punct)
produced epinephrine (nsubj)
transport by (case)
help assay (nsubj)
undertook lack (nmod)
considered media (xcomp)
sampled . (punct)
type type (dep)
tegmenti reticularis (compound)
excitability fastigial (nmod)
faint using (advcl)
trial dose-comparison (amod)
deteriorates rapidly (advmod)
potentiated ) (punct)
associations participants (nmod)
victim with (case)
action parallels (acl:relcl)
different amphetamines (nmod)
enhanced hyperactivity (dobj)
map hr (conj)
factors infusion (nsubj)
patients met (acl:relcl)
events seizure-like (amod)
lives long (amod)
sign common (amod)
mean average (amod)
rc ( (punct)
6 or (cc)
spaces vascular (amod)
caution patients (nmod)
acid mg (dep)
higher threshold (nsubj)
smokers who (nsubj)
described and (cc)
eads of (case)
limitation although (mark)
elucidated not (neg)
because mostly (advmod)
by-product that (mark)
responders as (case)
mechanism hypotensive (amod)
= 0.01 (dobj)
achieving return (dobj)
thrombocytopenia resolved (acl:relcl)
affect safety (dobj)
intact expression (nmod)
hour 500 (nummod)
sulphate epipregnanolone (compound)
agents class (compound)
phenobarbital hepatocarcinogenicity (nmod)
apparent . (punct)
recall on (case)
specificities , (punct)
was report (xcomp)
sera to (case)
polyneuropathy caused (acl)
specific , (punct)
cyclosporine toxicity (conj)
causing obstruction (dobj)
use particular (nmod)
3.0 women (nmod)
problem differences (nmod)
indicated reports (nsubj)
induction relevance (dep)
discovery of (case)
effects extract (nmod)
rats p20 (compound)
animals lithium-treated (amod)
state reduced (amod)
shortened period (dobj)
management of (case)
nimodipine 1 (nummod)
induce alterations (nsubj)
enhance modulation (nmod)
pressure patient (nmod)
antagonized pretreatment (nsubj)
intervals % (compound)
moderate-dose 28.4 (appos)
tested so (advmod)
necessary determination (nsubj)
% -50 (nummod)
tma ( (punct)
survivors se (compound)
uptakes radiocalcium (compound)
day induced (dep)
predominance combination (nmod)
recurrence tma (nmod)
after long (advmod)
resistance line (appos)
block second (dobj)
discern depressed (ccomp)
done rast (nsubjpass)
tle of (case)
placebo reversing (acl)
december 2002 (nummod)
exhibited overactivation (nmod)
form stress (nmod)
increased pms (nmod)
frequency patients (nmod)
nsaid nonselective (amod)
developed 13 (nmod)
2-sulfanylethanesulfonate sodium (compound)
study in (amod)
% 250 (nummod)
this of (case)
patients 500/mm3 (dep)
ensued diminished (conj)
dosed . (punct)
disruption controls (nmod)
focused effects (nmod)
defect be (cop)
rates secretory (amod)
resulted epinephrine (conj)
transport . (punct)
42)-infused peptide(1 (nmod:npmod)
represented . (punct)
responses apomorphine (acl)
alternations observed (acl)
descriptions cases (nmod)
increases patients (nmod)
hypotension helodermin-induced (amod)
ability interact (acl)
potent chick (nmod)
inducing arthritis (nmod)
42 - (punct)
changes ventilation (nmod)
acid 3-aminopropyl-diethoxy-methyl-phosphinic (amod)
that was (cop)
use over-representation (appos)
maryland northern (amod)
synergy treatments (nmod)
homogenates liver (compound)
equation the (det)
trial 5 (appos)
observations with (case)
effects fluoxetine (nmod)
telaprevir statins (conj)
weeks ( (punct)
regulation expression (compound)
had glomerular (dobj)
received evening (conj)
confirm tolerability (dobj)
infusion i.v. (amod)
changes parameters (nmod)
shift balance (nmod)
predicted may (aux)
administrated days (nmod)
precursor the (det)
cpap ( (punct)
improvement ( (punct)
toxicity serious (amod)
relevance patients (nmod)
facts these (det)
body wt/100 (compound)
30 and (cc)
problematic anemia (nsubj)
delivered treatment (nmod)
history syndrome (nmod)
x se (conj)
outcome a (det)
weeks 11 (nummod)
increase strokes (dobj)
ctni serial (amod)
paralysis neuromuscular (amod)
symptoms noted (acl)
isoniazid , (punct)
deleted which (nmod)
disorder % (appos)
initial final (conj)
effect stress (nmod)
cocs ( (punct)
damage hippocampal (compound)
patients 26 (nummod)
technique , (punct)
pathway autophagy (compound)
eligible . (punct)
= 114 (dep)
immunosuppression of (case)
ca1 and (cc)
using mask (dobj)
comparable given (dep)
curve auc (appos)
rare disorders (nsubj)
product map (compound)
sex or (dep)
enhanced effectiveness (nsubjpass)
-16.2 ( (punct)
cocs versus (case)
factor psychiatric (compound)
tizanidine agents (conj)
assessed examining (advcl)
surgery sinus (compound)
weekly then (advmod)
glaucoma for (case)
fs lv (compound)
study blind (compound)
decreased unchanged (advcl)
related probably (advmod)
nucleus plexus (conj)
worsened insufficiency (nsubjpass)
samples peripheral (amod)
assess nephrosis (nmod)
monotherapy as (case)
hemoglobin either (cc:preconj)
incidence death (nmod)
area operated (acl:relcl)
challenge subsequent (amod)
delays apigenin (amod)
have absence (nmod)
withdrawal during (case)
suffered he (nsubj)
judiciously knowledgeably (conj)
screened methods (dep)
likely have (xcomp)
proven , (punct)
excreted . (punct)
blocked reduced (conj)
behavior control (nmod)
turned supine (xcomp)
treatment amikacin (nmod)
0.1 and (cc)
expression mice (nmod)
normotensive wky (appos)
bpo-pll and (cc)
restored prolonged (conj)
found correlation (dobj)
defects reversible (amod)
properties beta-blocking (amod)
myositis inflammatory (amod)
performed monitoring (nsubjpass)
half by (case)
experienced effects (dobj)
symptomatic encephalopathy (advmod)
medication dopaminergic (amod)
therapy methimazole (compound)
warranted investigation (nsubjpass)
tafi pai-1 (conj)
less was (cop)
symptoms all (det)
have paralysis (dobj)
threshold brainstem (compound)
useful attenuating (advcl)
11 3 (quantmod)
levels reduction (nmod)
history urticaria/angioedema (nmod)
participants naive (amod)
followed intravenously (advmod)
produces readily (advmod)
synthesis hypoaidosteronism (conj)
pointes tachycardia (dobj)
warranted therefore (advmod)
tbarss ) (punct)
showed weeks (nmod)
tolerability , (punct)
neurotoxicity indications (nsubj)
lvdp/dtmax lvdp/dtmin (conj)
examined then (advmod)
sod nor (cc)
busulfan under (case)
analyses univariate (compound)
excludes reversion (nsubj)
aggression cage (nmod)
paid was (auxpass)
results administration (nmod)
receive gtn (dobj)
studied we (nsubj)
dissociate vocalization (dobj)
restoring activity (nmod)
non-selective piroxicam (dep)
-18.1 1.5 (conj)
h . (punct)
isolated , (punct)
secretion immunoreactive (amod)
adults suffering (acl:relcl)
granules specific (amod)
surgery for (case)
62.5 +/- (cc)
proliferation increased (amod)
scans multigated (amod)
m ) (punct)
computer derived (acl:relcl)
epicardium and (cc)
conjugates in (case)
ester no (compound)
sexes in (case)
random-assignment in (case)
persons and (cc)
output increased (amod)
changing epidemiology (dobj)
= 0.57 (dobj)
have animals (nsubj)
elicited be (auxpass)
leukocyturia such (case)
neurosurgery in (case)
mg/kg 12.5 (nummod)
continued treatment (nsubjpass)
clinical evidence (dep)
spread activity (nmod)
procedures sop (appos)
monitoring careful (amod)
css10 and (cc)
determined -- (punct)
associated chloramphenicol (nmod)
phenotypes metabolic (amod)
fact the (det)
purpose used (appos)
patient meq/l (compound)
toxicity because (case)
made draw (xcomp)
beats/min . (punct)
traveled distances (dobj)
3.4 range (dep)
edema promoting (conj)
site of (case)
interventions epilepsy (nmod)
cancers the (det)
2.5 0.85 (conj)
rofecoxib acetaminophen (nsubj)
overexpression the (det)
born 1941 (nmod)
neuropathology the (det)
treatment olanzapine (compound)
concentration blood (compound)
prolonged longer (conj)
patients five (nummod)
bilirubin or=10.8 (appos)
problems without (case)
contributed may (aux)
investigations therapy (nmod)
assumed he (nsubj)
eliminated evaluation (nmod)
susceptible detoxification (nmod)
method determination (nmod)
toxicity diphenylhydantoin (compound)
effects cd-832 (nmod)
fed groups (nsubjpass)
fat periorbital (amod)
values emg (compound)
omitted that (mark)
water 100 (nummod)
design open (amod)
improvement and (cc)
underwent dialysis (dobj)
min until (case)
experience initial (amod)
blocking by (mark)
focus to (case)
doses atenolol (nmod)
media artery (nmod)
= ns (appos)
tube ett (appos)
mm decrease (dep)
inhibited manner (nmod)
mediated centrally (advmod)
made away (advmod)
rats fell (advcl)
impairs . (punct)
neuropathy organophosphorus-induced (amod)
procedures staining (compound)
dependence dose (compound)
relation of (case)
led disappearance (nmod)
cancers diagnosed (acl)
attributed hypotension (nsubjpass)
attributed ) (punct)
mice mpges-1 (compound)
psychosis population (nmod)
glomerulonephritis membranous (amod)
analysis transcriptome (compound)
microgram/kg/min and (cc)
measures as (case)
rats post-exposure (dep)
3.7 +/- (cc)
doses diuretics (nmod)
isotretinoin with (case)
esters hdl (conj)
16;567 i/4e (nmod)
experiments for (case)
administration nimodipine (nmod)
therapy extensive (amod)
scopolamine-induced rats (nmod)
introduced inhibitors (nsubjpass)
degree lesser (amod)
total among (case)
ng 1 (compound)
space bromide (compound)
attracted background (dep)
system damage (nmod)
tasks times (conj)
combined is (auxpass)
designed evaluate (xcomp)
that enzyme (nmod)
rate decline (nmod)
removal placenta (compound)
tumor with (case)
rash ( (punct)
micrograms/kg/min , (punct)
gender-dependent and (cc)
secretions of (case)
dependent were (cop)
significantly 0.001 (dep)
use cocaine (compound)
failure magnitude (dep)
substantia in (case)
cisplatin both (cc:preconj)
annulus mitral (amod)
question is (cop)
h1- and (cc)
duration days (nmod:poss)
found indicating (xcomp)
gland pituitary (amod)
edaravone n=8 (appos)
mg/kg 250 (nummod)
increases order (nmod)
avrt ( (punct)
rare seizure (nsubj)
effect underlying (acl)
mmhg , (punct)
treated l-dopa+benserazide (dep)
regimen bortezomib (nmod)
four three (quantmod)
administration parenteral (amod)
elevation calcium (nmod)
prognosis generation (nmod)
treatment anemia (nmod)
% infants (nmod)
administered had (aux)
elevated significantly (advmod)
avoided either (preconj)
method , (punct)
increase competing (advcl)
socs-1 ( (punct)
used caution (nmod)
ratio . (punct)
address attempt (conj)
associated neutropenia (nmod)
review literature (nmod)
22 13 (conj)
discharge testing (nmod)
-18 8 (conj)
areas rural (amod)
unaffected fluvoxamine (nmod)
documents highlights (conj)
rule following (case)
disorder uses (conj)
behaviour their (nmod:poss)
taken caution (nsubjpass)
produced scopolamine (nmod)
paradigm avoidance (compound)
parameter this (det)
limits confidence (compound)
observed rating (nmod)
subarachnoid and (cc)
hypertension chronic (amod)
min 6 (nummod)
papers of (case)
nephritis lupus (compound)
cluster seizures (nmod)
edema inflammation (conj)
include effect (dobj)
chorioretinopathy of (case)
causes disease (nmod)
gyki-41 900 (nummod)
ischaemia myocardial (amod)
nausea clumsiness (conj)
reports article (nsubj)
mild or (cc)
months 163 (nummod)
levels cumulative (amod)
involved medications (nsubjpass)
mainstay the (det)
evaluated trial (nmod)
carotid artery (conj)
ar+cr n (dep)
somnolence patients (dep)
baseline and (cc)
bp upregulation (conj)
hallmark dysfunction (nmod)
autoantibodies antineutrophil (compound)
used prepare (xcomp)
slight or (cc)
literature scientific (amod)
dosing of (case)
activity single-agent (amod)
associated condition (nmod)
dextromethorphan nmda (compound)
blunted controls (nmod)
raised activity (dobj)
associated uncommonly (advmod)
activity tnf (compound)
mg/dl 0.8 (nummod)
risk using (acl)
men . (punct)
calcification artery (compound)
hospital guard (compound)
observed injection (nmod)
permits administration (dobj)
2190 to (case)
regions gyrus (nmod)
assess using (advcl)
acts synapses (nmod)
continuous electrocardiographic (dep)
erythropoietin decreased (amod)
took had (advcl)
crystals indinavir (compound)
hilus groups (nmod)
found euthyroid (nmod)
resulted 2 (dep)
antagonist mglur5 (nmod)
effects abuse (nmod)
lead offered (advcl)
dissociate " (punct)
behaviors on (case)
avp transcripts (conj)
reduced such (amod)
nephrotoxicity encountered (acl)
effect vasodilating (compound)
stenting of (mark)
aspirin cyclooxygenase (appos)
conducted evaluate (xcomp)
enrolled received (conj)
evaluate risk (dobj)
similar khz (nmod)
incorporate intrapatient (conj)
phase in (case)
transplantation patients (nmod)
cases reactions (nmod)
sem and (cc)
developed we (nsubj)
corticosterone of (case)
percentage control (nmod)
complications maternal (amod)
cause use (nsubj)
hospital-years 117 (nummod)
resuscitations successful (amod)
high and (cc)
established studies (nsubj)
200 greater (advmod)
totals controls (conj)
propofol to (mark)
lipids extractable (amod)
studies show (acl:relcl)
incorporation b (nmod)
disclosed granules (dobj)
thrombo-embolism remained (dep)
inpatients psychiatric (amod)
intensity , (punct)
sbp in (case)
believed enhance (advcl)
determining cases (nmod)
rises titer (nmod)
iodixanol with (case)
interaction resulted (acl:relcl)
using ketoconazole (dobj)
usage aspirin (nmod)
tmp-smz ( (punct)
role critical (amod)
levels micrograms/ml (nmod)
stimulation central (amod)
prior training (nmod)
administering drugs (dobj)
prophylaxis . (punct)
ultrastructural morphometrical (conj)
intravenously mg (nmod:npmod)
induced nifedipine (nsubj)
resulted measured (advcl)
hospital chulalongkorn (compound)
risperidone than (case)
recorded , (punct)
development vaccine (nmod)
synthesis induced (acl)
assessed alterations (nsubjpass)
animals saralasin-treated (amod)
male 84-year-old (amod)
shortened verapamil (nsubj)
absence necrosis (nmod)
schiff numerous (amod)
hyperactivity nr1(neo-/- (nmod)
associated death (nsubjpass)
children absences (nmod)
performed scans (nsubjpass)
paced rate (nmod)
rates . (punct)
nicergoline and (cc)
present focus (xcomp)
january in (case)
participants patients (dep)
ibuprofen infants (nmod)
dose ppa (nmod)
failure and/or (cc)
symptoms stimulant-induced (amod)
alterations status (conj)
marrow reversible (amod)
experienced subjects (nmod)
reveals . (punct)
2.5 0.4 (conj)
atropine i.c. (amod)
significant = (parataxis)
therapy combination (compound)
expression knockout (nmod)
ro4368554 antagonist (compound)
prescribed time (nmod:tmod)
microg/side 1 (nummod)
conscious mmhg (conj)
collected min (dep)
included oestrogens (dobj)
comparison double-blind (amod)
2.4-fold ( (punct)
complication unreported (acl)
ratio importance (conj)
exercise (7.2)% (dep)
localization activity (nmod)
aetiology the (det)
effect domperione (nmod)
sensitive also (advmod)
mitigating deterioration (dobj)
therapy dopaminergic (amod)
required maintain (xcomp)
g/kg ( (punct)
damage between (case)
field a (det)
c57bl/6 ( (punct)
means push (nmod)
walls in (case)
review studies (nmod)
acceptable clinically (advmod)
decrease expression (nmod)
failed also (advmod)
form alternate (amod)
suppresses stage (nmod)
ufh of (case)
drops eye (compound)
cardiomyocytes isolated (amod)
size fixed (amod)
mechanism for (case)
caused interactions (nsubj)
lp 120.04 (dep)
handling devices (dobj)
secondary was (cop)
4:30 p.m. (advmod)
selected which (nsubjpass)
nodal on (case)
patients entering (acl)
period 15-minute (amod)
stimulation hippocampus (nmod)
patients nsclc (compound)
amounts words (nmod)
block effect (dobj)
stay patients (nmod)
= 0.10 (dobj)
injury severe (amod)
engine ukpds (compound)
erythema of (case)
disorder induced (acl)
syndrome reverse (amod)
oddi of (case)
underwent dogs (nsubj)
step bar (dobj)
values their (nmod:poss)
have effects (dobj)
consisted lag (nsubj)
periods dose (nmod)
continued effective (xcomp)
disappeared discontinued (advcl)
downregulation proliferators (nmod)
one hepatic (amod)
morphine to (case)
slowness carriers (nmod)
reversed treatment (nmod)
removal for (case)
subtypes muscarinic (amod)
those blockers (nmod)
100mg/kg ) (punct)
performed confirm (advcl)
objective compare (dep)
interval = (parataxis)
spared when (advmod)
efficacy a (det)
remained stable (acomp)
days=1.77 % (dep)
toxic that (nsubj)
hypotension +/- (cc)
hepatomas the (det)
metrazol of (case)
0.57 ( (punct)
deficits of (case)
function injury (conj)
m1 of (case)
increases flow (dobj)
normal ultrasound (nsubj)
defective dna (nsubj)
head-up to (case)
acid 5-hiaa (appos)
cck-8 ) (punct)
placebo-controlled a (det)
indicated staining (nsubj)
carsinom one (nummod)
received papaverine (dobj)
analysis visual (amod)
diabetes for (case)
determine vivo (advmod)
chloroquine-induced severe (amod)
quantified been (auxpass)
months 65 (nummod)
quantitative alterations (dep)
cab mg (dep)
direct acting (dep)
results minute (appos)
163 therapy (nmod)
infection causes (acl:relcl)
bendrofluazide treatment (nmod)
adhesions soft (amod)
communication effects (dep)
discrimination by (case)
analgesia post-operative (amod)
included addition (nmod)
ca(2 proteins (dep)
programming functional (amod)
effectiveness derivatives (nmod)
content mineral (compound)
lasting impairment (dobj)
have dtis (nsubj)
induced co-administration (nmod)
vasospasm ischemia (conj)
patients twenty-eight (amod)
episodes acute (amod)
d2 cholesterol (conj)
caused peak (advcl)
common hitt (dep)
using alternation (dobj)
deposits subepithelial (amod)
= 0.44 (dobj)
morphogenesis cardiac (amod)
resolve spontaneously (advmod)
trial 6-week (amod)
papaverine changes (dep)
13 % (dep)
muscle to (case)
hyper- dyskinetic (conj)
microscopic electron (compound)
validate hypothesis (dobj)
analyzed retrospectively (advmod)
level contaminant (nmod)
ahs ( (punct)
palsy to (case)
clinical phase (nmod:npmod)
acting . (punct)
implant acetonide (compound)
= 42 (dobj)
estimated ratios (nsubj)
enflurane following (case)
relatives first-degree (amod)
rtms hz (nmod)
scheduled average (xcomp)
cvvhdf ) (punct)
nsaid other (amod)
prognosis poorer (amod)
three least (nmod:npmod)
hyperthermia later (advmod)
absorb to (mark)
showed inhibited (parataxis)
antagonist polypeptide (compound)
volunteers nine (nummod)
predictive were (cop)
reported follow-up (dep)
observed morbidity (nsubjpass)
developed cholecystitis (dobj)
baby premature (amod)
therapy her (nmod:poss)
decreases by (case)
represents mechanism (dobj)
regions occipital (compound)
nephrectomy bilateral (amod)
shortening electrocardiogram (nmod)
concentration solution (compound)
time ) (punct)
receptor glutamate (compound)
superior therapy (nmod)
prudent be (cop)
quadrant platform (amod)
tnfalpha , (punct)
body wt (amod)
vt of (case)
pointes torsades (compound)
formation intracellular (amod)
mg extended-release/lovastatin (compound)
normotensive hypertensive (conj)
pressure between (case)
morphogenesis of (case)
understood not (neg)
impaired which (nsubjpass)
cautious effect (advcl)
bpt ( (punct)
accompanied often (advmod)
power low (amod)
supplementation women (nmod)
intakes risks (conj)
myocardiopathy mp (appos)
drugs anti-hiv (amod)
high normal (conj)
leucemia acute (amod)
studied effectiveness (nsubjpass)
caproate to (mark)
adjusting after (mark)
start to (case)
prevention 6 (dep)
patients clinic (nmod)
occlusion vessels (nmod)
depleted increased (conj)
infrequent . (punct)
cisapride of (case)
da 40,000 (nummod)
appeared injury (nsubj)
obtained remission (dobj)
peg-asparaginase cytarabine (conj)
used france (nmod)
bupivacaine local (amod)
complications psychiatric (amod)
caused estrogen (nmod)
( +/- (dep)
suggested surveys (nsubj)
exclude however (advmod)
substances single (amod)
infection people (nmod)
suggest caused (ccomp)
group women (nmod)
protects that (mark)
decline psa (nmod)
serum tissue (conj)
remodeling ventricular (amod)
effects inhibitor (nmod)
morbidity to (case)
properties (na (nmod)
extend data (nsubj)
mother the (det)
increased map (nsubj)
replaced fluvoxamine (nmod)
induced chemically (advmod)
effects amiodarone (nmod)
features scheduled (acl:relcl)
delirium , (punct)
na(+ voltage-dependent (amod)
deterioration abrupt (amod)
23 % (dep)
< vomiting (dep)
rates adverse (amod)
d3 ( (punct)
hepatonecrosis cholangitis (conj)
decrease clearance (nmod)
area hypoaesthesia (nmod)
hdl of (case)
arm in (case)
being eating (advcl)
case ): (punct)
pituitaries their (nmod:poss)
attenuates compound (nsubj)
background effective (dep)
counteract to (mark)
persisted had (ccomp)
toxicity combination (nmod)
interfere . (punct)
paracetamol ) (punct)
received detected (advcl)
inhibition ca(2 (amod)
factor of (case)
administration tail (nmod)
protected function (dobj)
delivery performed (acl)
appears : (punct)
studies bornstein (appos)
induce acid (nsubj)
cause failure (dobj)
doxorubicin the (det)
disrupts and (cc)
pain elicited (acl)
effect dexamphetamine- (nmod)
proceed angiography (nmod)
labour in (case)
doses both (dep)
performed double-blind (dobj)
body mg/100 (compound)
diagnosed abnormal (conj)
left relation (nmod)
revealed areas (dobj)
pod 3 (nummod)
protein anti-oxidant (nmod)
hdl ( (punct)
emergence movements (nmod)
high but (cc)
resulting death (nmod)
induced toxicity (nmod)
promoting rebound (dobj)
hyperglycemia severe (amod)
increase compared (advcl)
acts ) (punct)
teaching urban (amod)
ibuprofen , (punct)
insecticides agriculture (nmod)
mmol/day 17 (nummod)
mg. 41.4 (compound)
tested effects (dobj)
recorded times (nmod)
0.80 2.89 (dep)
deaths procedures (conj)
affecting whether (mark)
induce or (cc)
srs ( (punct)
receptors serotonin (compound)
gain the (det)
narcosis on (case)
improved sensitivity (dobj)
buprenorphine qtc (conj)
suggested toxicity (nmod)
weight diet (amod)
hormone or (cc)
inhibited hyperprolactinemia (nsubj)
leukocyturia , (punct)
allow as (mark)
54 ( (punct)
localization troponin (compound)
worsened not (neg)
subjects presenting (acl)
demographics characteristics (conj)
tnss experienced (amod)
ratios higher (amod)
cerebral pulmonary (conj)
done negative (advcl)
associated group (nmod)
effects parameters (nmod)
placebo vs (advmod)
toxicity herbicides (nmod)
achieve to (mark)
myocarditis carbamazepine-induced (amod)
cgs and (cc)
sex function (conj)
electrocardiogram epicardial (amod)
days 109 (nummod)
reagents specific (amod)
damage streptozotocin-induced (amod)
paradigm les (appos)
extraction at (case)
white-cell neutrophil (conj)
protection mesna (nmod)
changing rhythm (dobj)
unclear management (nsubj)
breakdown seizure-induced (amod)
da striatal (amod)
function mice (nmod)
increase paco2 (nmod)
pain injection (compound)
haematological treatment (nmod)
identify benefits (dobj)
area density (compound)
rats pilocarpine-induced (nmod)
mg mmc (dep)
pretreatment isoproterenol (compound)
amounts oxide (nmod)
nephrotoxicity indinavir-associated (amod)
recommended avoid (xcomp)
comparable . (punct)
impaired tjs (nsubj)
showed ability (nmod)
hippocampus respectively (advmod)
reported siadh (nsubjpass)
determining hemisphere (dobj)
ml 4 (nummod)
compartments all (det)
received effects (nsubj)
dexmedetomidine alone (advmod)
sedation cystourethrogram (nmod)
closed and (cc)
inhibited re (nsubj)
raised phase (nmod)
rcr ) (punct)
statistics danish (compound)
features associated (acl:relcl)
consistent biopsy (nsubj)
referred ( (punct)
fatigue , (punct)
greater effect (nsubj)
associated slowing (nmod)
chromosomes 18 (conj)
eyes right (amod)
animals repleted (amod)
increased % (nmod)
infusion tail (compound)
patients penicillamine-treated (amod)
placebo inhaler (nmod)
stronger association (nsubj)
testing task (nmod)
occurring association (nmod)
results found (dep)
protected damage (dobj)
public the (det)
sensitive shown (advcl)
complex through (case)
more patients (nmod)
cirazoline of (case)
dyskinesias therapy-induced (amod)
government to (case)
cyanamide hydrogen (compound)
precise recall (nsubj)
counts measurement (conj)
hydrobromide antagonist (compound)
elicited ketamine (nsubj)
majority events (nmod)
lead life (dobj)
ventilation on (case)
carried forward (advmod)
remained have (aux)
gr 82334 (nummod)
flushed buffer (nmod)
prevented carvedilol (nsubj)
therapy cephalothin (compound)
skeptical reliability (nmod)
certain not (neg)
fluency for (case)
those nitroglycerin (nmod)
computer by (case)
rats g (appos)
digoxin atrial (amod)
contraindicated unless (mark)
antimicrobials many (amod)
understanding better (amod)
time days (nmod)
developed alive (parataxis)
stopping therapy (dobj)
selectivity bed (nmod)
effects hippocampal (nmod)
affected also (advmod)
tubules distal (amod)
liters ) (punct)
acid . (punct)
propranolol of (case)
memory long-term (amod)
antibiotics prescribed (amod)
malays and (cc)
production oxide (compound)
changes electrocardiographic (amod)
center anderson (compound)
became months (nmod)
database population (compound)
disorder cardiomyopathic (amod)
rats han-wistar (compound)
damage hyperammonemia (appos)
well-tolerated generally (advmod)
expression this (det)
innervation on (case)
support any (det)
start from (case)
subtle , (punct)
de novo (dep)
ci 0.9 (nummod)
saline in (case)
has causing (conj)
comparable effect (nsubj)
dependent are (cop)
ameliorate blockade (nsubj)
auc 6 (nummod)
d. of (case)
hepatic psychiatric (conj)
condition in (amod)
implantation electrodes (nmod)
9/106 ( (punct)
neurons dopamine (compound)
protects and (cc)
appears escape (xcomp)
rats of (case)
increasing stroke (conj)
reduced infusion (nmod)
-13 - (punct)
titres mpo-anca (nmod)
4:30 days (nmod)
safety morbidity (conj)
pathway , (punct)
reduced dealt (conj)
benefits many (amod)
decreased clearance (nsubj)
ht oestrogen-only (amod)
prolongation second((1/2 (nmod)
iopentol of (case)
reductions score (compound)
responses bradycardia (conj)
exceeded level (dobj)
analyze audiograms (dobj)
patients awaiting (acl)
known experience (nmod)
scores factor (nmod)
vnr by (case)
gaze of (case)
used increased (conj)
anesthetic catheterization (nmod)
d-med [ (punct)
wr-2721 amifostine (appos)
cocaine anxiety (nmod)
status diabetic (amod)
indicate substantial (ccomp)
depends adenoribosylation (nmod)
showed results (nsubj)
diphenhydramine iv (dep)
dose prior (amod)
complication use (nmod)
weak was (cop)
made control (dep)
l-isomer the (det)
aventyl produced (acl)
administration of (case)
e myopathy (conj)
2e1 cytochrome-p450 (compound)
neurological psychiatric (conj)
contributed both (nsubj)
mmp-2 adam10 (conj)
standard current (amod)
phase days (appos)
ifosfamide , (punct)
warrant may (aux)
reduced p (dep)
rhabdomyolysis myoglobinuria (conj)
higher also (advmod)
normal is (cop)
followed monitoring (nmod)
77.1 ) (punct)
patient cancer (nmod)
im the (det)
had fluoxetine (nsubj)
rate map (appos)
investigated number (nmod)
transplants from (case)
year one (nummod)
measurements audiometric (amod)
those responding (acl)
showed dysarthria (dobj)
disease autoimmune (amod)
patient thrombocytopenia (nmod)
efficacy methods (nmod)
nfkappab ( (punct)
count 1000/mm3 (dep)
8 and (cc)
calculated risk (nsubjpass)
flumazenil of (case)
clear factor (ccomp)
exposure alterations (conj)
finding prolongation (nsubj)
became independent (acomp)
seizures convulsive (amod)
inhibitors enhance (acl:relcl)
predictor or (dep)
treatment individual (amod)
ointment of (case)
fever chill (conj)
neutropenia the (det)
amn082 ( (punct)
vegfr-2 , (punct)
completed patients (nsubj)
corrected not (neg)
l-alpha-gfc placebo (conj)
absent mutant (nmod)
scenario of (case)
determining showing (conj)
35.6 +/- (cc)
deficit memory (nmod)
processing abnormal (amod)
shock in (case)
63 by (case)
neutral on (case)
cohort men (dep)
pvc ) (punct)
time volume (conj)
rates patients (nmod)
link hyperprolactinemia (dobj)
determination flow (nmod)
found simultaneously (advmod)
mouth the (det)
saline-treated 1ml/kg (dep)
analogs restricted (amod)
patients impairment (nmod)
created identify (xcomp)
recipients graft (compound)
5,7-dht of (case)
associated decreased (conj)
selected answer (xcomp)
morphine patient-controlled (amod)
remain pathways (nsubj)
availability techniques (nmod)
developed where (advmod)
bp and (cc)
elements cell (compound)
bradykinesia in (case)
rate corticosterone (compound)
derivatives as (case)
group risk (compound)
follows as (case)
find mutation (dobj)
predictors . (punct)
diazepam midazolam (conj)
suspected although (mark)
september and (cc)
high rates (nsubj)
medicines to (case)
daily n (dep)
addition by (case)
rats resulting (acl)
controls the (det)
perfusion decreased (amod)
theophylline patients (nmod)
patient underwent (acl:relcl)
width increase (conj)
evaluated has (aux)
received patients (nsubj)
documented respectively (advmod)
microliters/min of (case)
doses acc-9653 (nmod)
beating rats (conj)
rate recurrence (compound)
effects surgery (nmod)
changes for (case)
underwent intervention (dep)
examination on (case)
regions from (case)
assessment study (conj)
remains likely (advcl)
agent isoniazid (nsubj)
gestation 15 (compound)
groups mexiletine (compound)
developed completion (nmod)
rate normal (amod)
2.6 1.6 (conj)
mediates receptor (nsubj)
5 4 (conj)
alpha-enac gamma-enac (conj)
had three (nsubj)
history rosacea (nmod)
thalidomide oral (amod)
cream 1 (nummod)
family with (case)
sediment of (case)
reversible withdrawal (nmod)
crf > (dep)
safe treatment (nmod)
forces of (case)
patients hepatitis (conj)
pain less (advmod)
developed therapy (dobj)
rigidity severe (amod)
trazodone mg/kg (nmod)
demonstrate subjected (ccomp)
occurred suggesting (advcl)
seen number (nmod)
ester disodium (compound)
use age (nmod)
toxicity ifosfamide-induced (amod)
subunit alpha-2 (compound)
conclusions increase (appos)
nausea cisplatin-induced (amod)
model acute (amod)
implicated influence (conj)
epilepticus acid-induced (amod)
agents other (amod)
distributions different (amod)
improves expected (conj)
circumference the (det)
patients % (conj)
aorta the (det)
latency rigidity (conj)
reticulata doses (nmod)
profile with (case)
mpa str (conj)
factor age (nsubj)
cytotoxicity in (case)
9 2006 (appos)
group lamivudine (compound)
subjects and (cc)
lipid epinephrine (conj)
develop embryos (nsubj)
stage disease (compound)
heparin subcutaneous (amod)
sunitinib and (cc)
one than (case)
n and (cc)
hyperactivity e2-induced (amod)
= 0.063 (dobj)
indicated patients (nmod)
infection upper (amod)
search methods (nmod)
changes blockade (nmod)
affected confounding (nmod)
urea of (case)
level applicable (amod)
solvent then (advmod)
incriminated . (punct)
rr , (punct)
groups 2 (nummod)
associated usage (nmod)
managed infusion (nmod)
comparing group (nmod)
delivered or (advmod)
case per (case)
varied dose (nsubj)
toxicity syndrome (appos)
stage that (mark)
testosterone fat (conj)
encephalopathy the (det)
minutes patient (nmod)
affected type (nsubj)
damage inhibition (conj)
myeloma rrmm (appos)
report incidence (dobj)
disorders neuropsychiatric (amod)
judged . (punct)
available commercially (advmod)
cpa , (punct)
hematological were (cop)
dependent assistance (nmod)
deduced can (aux)
curve time-course (amod)
injection intravascular (amod)
recorded markers (nsubjpass)
raclopride antagonist (compound)
study nested (amod)
54 20 (conj)
studies dose (compound)
short time (nsubj)
led had (aux)
prazosin but (cc)
misleading that (mark)
escape regulation (nmod)
ginsenosides components (dobj)
turnover of (case)
hyperparathyroidism long-standing (amod)
tumors 27 (nsubj)
cause microangiopathy (nmod)
reduced number (dobj)
stereotypy apomorphine-induced (amod)
crescents deposits (conj)
property chronotropic (amod)
rigidity wall (compound)
mipafox , (punct)
signed and (cc)
higher salt-depleted (nmod)
ingestion aspirin (compound)
inhibitors phosphodiesterase (compound)
36 almost (advmod)
hyper- or (cc)
evoke . (punct)
tested strength (nsubjpass)
methods referred (acl)
44 % (appos)
astrocytomas , (punct)
coagulation of (case)
tapped . (punct)
serotonin b3 (compound)
activities expression (conj)
, modifications (dep)
mg/day on (case)
monitor oximetry (appos)
hr ( (punct)
ml/kg 2 (nummod)
carcinoma with (case)
recur not (neg)
drug itself (nmod:npmod)
microg microg (conj)
aftereffects residual (amod)
brings . (punct)
compared events (nmod)
basis daily (amod)
complication cardiotoxicity (nsubj)
use ecstasy (nmod)
cancer agc (appos)
clarified be (auxpass)
25 only (advmod)
perimenopausal and (cc)
packing all (nummod)
micrograms ) (punct)
organelles concerning (case)
accompanied fall (nmod)
restored ) (punct)
necessary determine (xcomp)
lcva , (punct)
stabilized that (mark)
illness acute (amod)
generated . (punct)
developed here (advmod)
effects temperature (compound)
hypercalcemia hyperphosphatemia (conj)
demonstrated observation (parataxis)
complicated are (cop)
status procoagulant (amod)
survivors tumors (nmod)
assigned mg/day (dep)
less mmol/l (nmod)
h-1 micrograms (compound)
represents sirolimus (nsubj)
b6 x (cc)
rate cardiac (amod)
quantified deletion (dobj)
effect embryo (nmod)
back-diffusion acid (compound)
inhibit pentoxifylline (nsubj)
underwent december (nmod)
sensitivity ax (nmod)
monitoring with (case)
stage development (nmod)
dysmorphism , (punct)
model regression (compound)
induced dp/dt (conj)
noted controlled (ccomp)
technique surface (compound)
teratogenic s-53482 (nsubj)
extracted . (punct)
ranged loads (nsubj)
reticulum vesiculated (amod)
terms measured (acl)
completed scale (dobj)
shift leftward (amod)
proteins ku70 (dep)
50 as (quantmod)
referred had (parataxis)
0.3 and (cc)
measurements haemodynamic (amod)
relationship hyperalgesia/myoclonus (nmod)
describe here (advmod)
from 2003 (nmod)
true a (det)
sem group (nmod)
any , (punct)
aimed portray (xcomp)
exhibits pattern (dobj)
factor important (amod)
concentrations " (punct)
pain scoline (compound)
proteinuria conversion (nmod)
serum-proteins for (case)
respect efficacy (nmod)
present also (advmod)
enalapril nitrendipine (conj)
approach a (det)
along ptz (nmod)
version is (cop)
detection angiography (nmod)
investigation agent (nmod)
57-year old (dep)
groups matched (acl)
retardation , (punct)
rtm204i or (cc)
appears high (conj)
treated each (nmod)
reduces wild-type (nmod)
therapy from (case)
reshape also (advmod)
impairment lesion (conj)
comment adequate (amod)
setting overdose (nmod)
falls , (punct)
assessable response (nmod)
etomidate 0.3 (nummod)
apparent presentation (nmod)
neck 5.1+/-1.0 (dep)
discussed data (nsubjpass)
eskisehir march (nmod)
detect regions (dobj)
quetiapine or (cc)
resolution observed (amod)
6/15 right (nmod)
mg/day acetate (conj)
band = (dep)
segmental . (punct)
infections disease (conj)
decreased rats (nmod)
determination concentration (compound)
of 50 (conj)
anesthetized urethane (nmod)
uterotonic oxytocin (nsubj)
assessed measuring (advcl)
combination morphine (nmod)
patients dialysis (compound)
effects pleiotropic (amod)
oxidase by (case)
complication children (nmod)
vulnerable is (cop)
instructed watch (xcomp)
used monitor (xcomp)
cytostatics oxazaphosphorine (compound)
administration infusions (nmod)
stomachs rat (compound)
abnormalities important (amod)
attack migraine (nmod)
dose gm (nmod)
sediment by (case)
encephalopathy therapy (nmod)
responses signaling (compound)
levetiracetam adjunct (nmod)
given subregion (nmod)
cause prognosis (nsubj)
progress , (punct)
magnitude : (punct)
tremor induced (acl)
suggests cause (ccomp)
found development (nmod)
mitochondria altered (amod)
found we (nsubj)
sd used (dep)
treatment priapism (nmod)
epirubicin with (case)
area tuft (compound)
bcl-2 mdm-2 (conj)
mechanisms impairment (nmod)
serious " (punct)
increased measured (advcl)
d8 and (cc)
treatment cisapride (dep)
significant was (advcl)
concentrations alpha-tocopherol (nmod)
considered promising (advcl)
unchanged whatever (ccomp)
toxicology aspirin (nmod)
observed following (advcl)
seen dose (nmod)
study 5-fu (nmod)
aphasia and (cc)
infiltrate polyclonal (amod)
effects dogs (nmod)
ca(2 in (case)
similar rats (nmod)
infarction anterior (amod)
is paralysis (attr)
cases neonates (nmod)
interferes disruption (nsubj)
concentrate complex (compound)
generates that (mark)
cdt ) (punct)
distinguishing in (mark)
double ratio (nsubj)
level evidence (nmod)
stroke ischemic (amod)
recognized % (nmod)
animals fed (acl)
53 79 (conj)
patients isolated-hit (nmod)
appeared sacrifice (nmod)
conclude found (ccomp)
undertaken investigation (nsubjpass)
regardless type (nmod)
cases % (appos)
rate . (punct)
site action (nsubj)
contraindicated . (punct)
respect effects (nmod)
abundances and (cc)
release cgrp (nmod)
methods study (dep)
valdecoxib pooled (amod)
aneurysm cacl2-induced (amod)
method safe (amod)
formulations propofol (nmod)
suppression despite (case)
injection bortezomib (compound)
stat3 ) (punct)
occurred received (conj)
described although (mark)
models rodent (amod)
scopolamine ritanserin (conj)
trials studies (conj)
needed however (advmod)
society class (conj)
= 1.0 (dep)
analysis excitability (nmod)
sedation conscious (amod)
score corresponding (amod)
caspase-3 caspase-8 (conj)
quinpirole d2 (compound)
pnd ( (punct)
inhibition synthase (conj)
eyes human (amod)
doses their (nmod:poss)
developed mild (conj)
potentiated epinephrine (nmod)
effects sevoflurane (nmod)
group 3-hydroxy (amod)
1,2-dimethylhydrazine 1,2-dmh (appos)
impaired drugs (nmod)
treated cancer (nmod)
apap metabolites (conj)
expression seizures (nmod)
mm reactive (conj)
replaced behavior (nsubjpass)
obstruction chronic (amod)
reason the (det)
obstruction upper (amod)
aneurysms in (case)
activation neurotoxicity (conj)
preserved efficacy (dobj)
damage mipafox-induced (amod)
scale naranjo (compound)
magnitude pain (compound)
administered l-name (nsubjpass)
lend . (punct)
slowly , (punct)
dose ziprasidone (nmod)
safety setting (nmod)
exhibited potencies (dobj)
induced p (ccomp)
monkeys man (nmod)
parallel applications (nsubj)
components monomer (dep)
history confusion (nmod)
selenium and (cc)
injection deliberate (amod)
treated tamoxifen (nmod)
induced measured (advcl)
those relapse (nmod)
display learning (nmod)
monitoring dose (nmod)
0.07 versus (cc)
work-up diagnostic (amod)
sclerosis , (punct)
alf n=36 (appos)
discovering from (mark)
cardiac severe (amod)
dyskinesia tardive (amod)
rarest the (det)
discontinuing use (dobj)
caused decreases (dobj)
status affective (amod)
accumulation , (punct)
inactivate warfarin (dobj)
incidence anemia (nmod)
range of (advmod)
dogs of (case)
svo(2 ) (punct)
region ca1 (compound)
agonists the (det)
induced endomt (nsubjpass)
measure breath (nmod)
control postoperative (amod)
bonding ester (compound)
lesions the (det)
0.8 ) (punct)
frequency carotid (dep)
survivors , (punct)
compare profiles (dobj)
enhanced responses (dobj)
compound synthetic (amod)
observations facility (nmod)
acid-induced retinoic (amod)
prognosis their (nmod:poss)
function such (case)
increased was (conj)
rats kidneys (nmod)
retention and (cc)
patient malaria (nmod)
latency nighttime (amod)
asterixis the (det)
x(2 ( (punct)
1.63 0.39 (compound)
suggested studies (nsubj)
overdose antidepressant (amod)
tests laboratory (amod)
induced d-amphetamine (nmod)
comparisons of (case)
imaging mr (compound)
acetylsalicylate inhibitor (compound)
change status (nmod)
response first (amod)
affect pretreatment (nsubj)
enzyme macroscopic (amod)
receiving mg/m2 (dobj)
blockade following (case)
breeder the (det)
trials future (amod)
1951 as (case)
frequent occurrence (nsubj)
cholinomimetic , (punct)
abnormalities movement (compound)
diazepam- amnesia (dep)
lymphoma between (case)
explained partially (advmod)
broadens . (punct)
pills third (amod)
undergoes and (cc)
prompted us (dobj)
number was (cop)
nsclc or (cc)
modulate threshold (dobj)
increased resolved (conj)
experienced collapse (dobj)
followed injection (nsubjpass)
negative during (mark)
binding aches (nmod)
10.5 +/- (cc)
function left-ventricular (amod)
prior , (punct)
practitioners patients (nmod:poss)
minute 30th (amod)
was identify (xcomp)
move to (mark)
clipping aneurysm (nmod)
paralysis abductor (amod)
% increase (nsubj)
pharmacodynamics metoprolol (nmod)
schizophrenia , (punct)
reported although (mark)
syndrome associated (acl)
c 5.6 (dep)
up-regulation significant (amod)
66 about (advmod)
shortening base (nmod)
definitive be (cop)
chemotherapy infusional (amod)
decreases a (det)
changes ) (punct)
animals 1-day-old (nummod)
inflammation expression (conj)
play beta2-subunits (nsubj)
reached has (aux)
efv % (appos)
impaired , (punct)
mice treatment (nmod)
released ireland (nmod)
hoehn yahr (conj)
increases behavior (dobj)
identified work (nsubj)
mecamylamine central (amod)
ameliorates curcumin (nsubj)
indicate falls (ccomp)
failure against (case)
prevalence an (det)
mmhg 135 (compound)
pregnanolone 3alpha-hydroxy-5beta-pregnan-20-one (appos)
um-272 agent (appos)
agents corticosteroids (nsubj)
inactive were (cop)
tdr in (case)
have benefits (dobj)
reflection transplantation (nmod)
increase morphine-induced (amod)
maintenance and (cc)
open site (nmod)
blood obtained (acl)
diuretics of (case)
mg/kg 3.5 (nummod)
entered . (punct)
cancer cyclophosphamide (amod)
stroke of (case)
treatment co-trimoxazole (compound)
titration during (case)
served eyes (nsubj)
diseases causing (acl)
venous pulmonary (conj)
velocity nerve (nmod)
modulation attentional (amod)
tuberculosis of (case)
ketoprofen of (case)
illness , (punct)
facial severe (amod)
included rcts (nsubjpass)
adrenoceptors alpha-2 (compound)
resolution patient (nmod)
timps ( (punct)
milder although (mark)
destroy bbb (dobj)
dose the (det)
manifestations with (case)
cardiac based (case)
patients seizure (amod)
systems disease-like (amod)
indicating unlikely (ccomp)
children enrolled (acl)
cancer but (cc)
compared scans (nmod)
assessed age (nmod)
cord cervical (amod)
phenytoin of (case)
conversion report (dep)
rates increasing (amod)
protect personnel (dobj)
intensity signal (compound)
pentamidine and (cc)
remains under-recognized (xcomp)
% 1.2 (dep)
drugs serotonergic (amod)
chemotherapy high-dose (amod)
described identified (parataxis)
percentage irrigations (nmod)
microg/kg/min argatroban (conj)
bpm cd25 (appos)
n=5 ) (punct)
lamivudine inhibitor (appos)
received placebo (conj)
resulted seizures (nsubj)
greater rats (nmod)
admitted measurement (nmod)
containing diamorphine (dobj)
gamma-sarcoglycan beta-dystroglycan (conj)
remained later (advmod)
conclude change (advcl)
numbers children (nmod)
therapy potassium-losing (amod)
patients 72 (nummod)
% 0.001 (appos)
esrd n=45 (appos)
angiotensinogen tgr (appos)
abnormalities clear (amod)
laboratory this (det)
muscle venomotor (appos)
induced carbimazole (nmod)
clinical toxicities (dep)
expected had (advcl)
acid all-trans (amod)
purposes for (case)
respect min (dep)
cascade with (case)
e2 with (case)
none , (punct)
% ointment (conj)
junction craniocervical (amod)
have diatheses (dobj)
coupling the (det)
useful studies (nsubj)
seen picture (nsubjpass)
examination expression (nmod)
essential . (punct)
receptor increase (nmod)
implant mg (appos)
arrhythmia disease (conj)
aroused subjects (nsubjpass)
stopped lithium (nsubjpass)
capsaicin of (case)
revealed work-up (nsubj)
syndrome ns (appos)
edds ) (punct)
range . (punct)
events clinical (amod)
administration indinavir (nmod)
identify potential (dobj)
has yet (advmod)
explore . (punct)
co-infection patients (nmod)
patients 169 (nummod)
compare efficacy (dobj)
intrathecal ( (punct)
62 19 (conj)
susceptibility to (case)
ratio ventricle (nmod)
stereotypies amphetamine-induced (amod)
patients 13/52 (conj)
rates toxicity (compound)
course their (nmod:poss)
defects respiratory (amod)
patients forty-four (amod)
continued . (punct)
cm 7.7 (compound)
administration fluoxetine (nmod)
strains replication-competent (amod)
drug carbamazepine (nsubj)
complained mastodynia (nmod)
levels creatinine (compound)
350 7 (compound)
frequency pulse (compound)
ages management (nmod)
model (dox)-induced (acl)
pathology a (det)
mask laryngeal (amod)
severity and (cc)
diagrams scatter (compound)
period of (case)
rats surviving (amod)
influences . (punct)
124 +/- (cc)
early edrophonium-induced (dep)
e4031 terodiline (conj)
discharged recovered (advcl)
effectiveness concerning (case)
neurotoxicity of (case)
other mean (dep)
mg/kg 0.35 (nummod)
patients eleven (nummod)
showed findings (nsubj)
low % (nmod:npmod)
play maintaining (advcl)
alleviated which (nsubj)
reversibility failure (nmod)
cyanide cn (appos)
carbenicillin intermittent (amod)
outflow on (case)
produced epinephrine (nmod)
ischemia cerebral (amod)
scr ( (punct)
utility . (punct)
hypokalemia potassium (nmod)
remain have (advcl)
approach hypercholesterolaemia (nmod)
onset necrosis (nmod)
enucleated subsequently (advmod)
associated events (nmod)
showed processes (conj)
(kim)-1 molecule (compound)
aed ( (punct)
received adr(6 (nsubj)
antidote specific (amod)
caused paramethasone (nsubj)
exacerbations possible (amod)
hypotension before (case)
required be (auxpass)
loss more (amod)
clonidine methysergide (conj)
reverse administration (nsubj)
hypotension patient (nmod)
neonate 's (case)
switched is (nmod)
hypertension created (acl)
attenuated physostigmine (nmod)
risk patterns (nmod)
treated ointment (nmod)
ventilatory peripheral (conj)
suggest suggests (conj)
elevated elevated (advcl)
seen deterioration (nsubjpass)
signaling d2r (compound)
glomerulosclerosis or (cc)
observed acid (nmod)
acid (rs)-1-aminoindan-1,5-dicarboxylic (amod)
difficulties to (case)
plasma blood (compound)
blocked effect (nsubjpass)
retention channel (compound)
acute with (case)
observed damage (nsubjpass)
toxicity count (dep)
drugs used (acl)
creatinine urea (conj)
larger significantly (advmod)
diuretic is (cop)
induced reversed (conj)
vaccination hepatitis (compound)
lt ( (punct)
cas ) (punct)
treatment cpa (compound)
confirm aims (nsubj)
score corresponding (acl)
had matched (conj)
mechanisms significance (conj)
attenuation atrophy (conj)
forms hypertension (nmod)
treatment steatosis (nmod)
incidence latency (conj)
recording electrophysiological (amod)
metoprolol on (case)
higher duration (dep)
exposure pb (compound)
% -16%(-)-33 (compound)
observed life (nsubjpass)
questionnaires through (case)
abnormality found (acl)
higher . (punct)
shunting of (case)
increased have (aux)
ectoderm from (case)
inhibition azidothymidine (compound)
became he (nsubj)
responses left (amod)
populations with (case)
correct does (aux)
index gsi (appos)
morbidity and (cc)
properties such (case)
extends evidence (dobj)
diatrizoate ( (punct)
role pivotal (amod)
unnecessary detrimental (conj)
sparing field (nmod)
decreased clearance (nmod)
ceased were (auxpass)
indicate damage (dobj)
mm 110 (nummod)
concluded localised (ccomp)
exacerbation its (nmod:poss)
requires it (nsubj)
interpretation in (case)
administration i.m. (amod)
duration examination (nmod)
duration response (compound)
infiltrates eosinophilic (amod)
epilepticus fiber (conj)
sample larger (amod)
venue bind (acl:relcl)
methamphetamine veratridine (conj)
simultaneous multivariable (dep)
combinations loreclezole (nmod)
ventralis nucleus (compound)
differentiated were (auxpass)
chickens of (case)
controlled concentration (nsubjpass)
younger patients (conj)
orl1 ) (punct)
second the (det)
actions mixed (amod)
mg 3.75 (nummod)
diltiazem blocker (appos)
assessed presence (nmod)
jj jj (conj)
desensitization purinoceptor (compound)
mother patient (nmod:poss)
possesses , (punct)
showed shorter (conj)
mg. 20 (nummod)
patients forty (nummod)
effects constituents (nmod)
twin male (appos)
cultures no (neg)
materials ) (punct)
hypoventilation by (case)
lipopolysaccharide of (case)
use midazolan (nmod)
dose % (compound)
involvement neurones (nmod)
5 patients (nmod)
impaired drugs (nsubj)
% lignocaine (compound)
associations antigens (nmod)
need h (nmod)
fsgs progressive (amod)
number microvessels (nmod)
assay antigen (compound)
ability its (nmod:poss)
anticholinergics or (cc)
anticoagulants patients (appos)
recognition importance (nmod)
demand in (case)
risk vte (nmod)
presence with (case)
suggests was (ccomp)
noted discontinuing (advcl)
captopril and (cc)
proteins ecm (compound)
plays drd2 (nsubj)
risperidone 's (case)
facilitation significant (amod)
altering distribution (dobj)
inhibits vivo (advmod)
chebula t. (compound)
seem cause (xcomp)
personal and (cc)
errors ( (punct)
g group (compound)
apnea by (case)
hypotension which (nsubj)
18 ( (punct)
chemopreventive as (case)
group 0.001 (appos)
resting and (cc)
decreased e2 (nsubj)
initially not (neg)
aminotransferase amylase (conj)
dose dox (nmod)
micrograms/kg/hr larger (amod)
infused units (dobj)
resistance , (punct)
channels plasma (compound)
death the (det)
connections venules (nmod)
implications therapy (nmod)
japan from (case)
dimension ventricular (amod)
observed defect (nsubjpass)
ameliorated not (advmod)
taken occurrence (nsubjpass)
doses administration (compound)
h patients (nmod)
patients related (acl:relcl)
evaluate mortality (dobj)
diphenhydramine mg (dep)
early . (punct)
induce translocations (dobj)
system pentobarbital (nmod)
flow coronary (amod)
resistance total (amod)
0.0005 < (dep)
values reference (compound)
selection preferential (amod)
girl reaction (nmod)
or % (dep)
superior min (nmod)
overflow rats (nmod)
paracetamol for (case)
seemed activate (xcomp)
fraction average (amod)
database event (compound)
developed disorder (dobj)
resulted pain (dep)
chemotherapy for (case)
infusion systemic (amod)
instilling drop (dobj)
increases significantly (advmod)
male sixties (nmod)
those ps (nmod)
disease 22 (nummod)
likely rats (nsubj)
comparison group (nmod)
administration suxamethonium (nmod)
5-hydroxytriptamine ( (punct)
etiology . (punct)
analysed density (nsubjpass)
chiefly rat (compound)
1a2 p450 (compound)
1.0 2.0 (conj)
cancer paclitaxel-refractory (amod)
bound was (auxpass)
woman seventy-eight-year-old (amod)
tumours histiocytic (amod)
scales rating (compound)
non-biodegradable gly-gly (dep)
occurred cessation (nmod)
compared n=661 (conj)
explored experiments (nsubj)
responses challenge (nmod)
indicate modification (dobj)
study audiometric (amod)
preventing thus (advmod)
histories group (nmod)
weeks within (case)
op ) (punct)
systolic and (cc)
mediate origin (dobj)
suppression dysfunction (nsubj)
enabled % (conj)
woman 45-year-old (amod)
tenofovir for (case)
disorders schizophrenia (compound)
led generation (nmod)
minimal pain (dep)
concentration basal (amod)
epidemic an (det)
using malate/glutamate (dobj)
occurred 0.001 (parataxis)
carbon to (case)
intubated . (punct)
effects dose (nmod)
use analyze (acl)
elucidated been (auxpass)
deficits da (compound)
knowledge our (nmod:poss)
products chain (compound)
effective as (prep)
day treatment (nmod)
reported are (auxpass)
used succinylcholine (nsubjpass)
used d-penicillamine (nsubjpass)
guidelines ( (punct)
times in (case)
found analyzed (advcl)
was differences (nmod)
resistant that (nsubj)
secretion dose (nmod)
patients prescribed (acl:relcl)
symptoms severity (conj)
induced be (nmod)
adjustment prevalence (nmod)
signs patients (nmod)
host neurological (nmod)
competing by (mark)
hyperprolactinemia treated (acl)
hours ( (punct)
cyp27 of (case)
involves antagonist (conj)
training , (punct)
presents rate (dobj)
result elevation (nmod)
shown nuclei (nmod)
g 70 (nummod)
lna hca (conj)
group subjects (nmod)
offspring rats (nmod)
space sub-tenon (nmod:poss)
attenuates antagonism (nsubj)
psoriasis severe (amod)
18 patients (nmod)
frequent occurs (conj)
reduces induction (nsubj)
reduction group (nmod)
hypaque . (punct)
1998 ) (punct)
assessment lisinopril (nmod)
20-fold up (advmod)
anesthesia of (case)
neurotoxicity hepatotoxicity (conj)
protrusions , (punct)
activations to (case)
99 p (dep)
dose patients (nmod)
stressor multitasking (amod)
injury this (det)
ep ) (punct)
knowledge and (cc)
died therapy (nmod)
comparing sensitivity (dobj)
creatinine and (cc)
reduced diminished (conj)
receptors 5-ht (compound)
paramedics patients (nmod)
mortality effects (nmod)
showed patients (nmod)
end until (case)
absorption a (det)
ctc-nci , (punct)
lca > (compound)
included infiltration (dobj)
extensive and (cc)
amb ( (punct)
it from (case)
population followed (acl)
hydrochloride diphenhydramine (compound)
surface ) (punct)
lesion neoplasm (conj)
metoprolol cardioselective (amod)
acute such (case)
12.8 up (advmod)
clearance high (amod)
bones of (case)
interaction antagonists (nmod)
tam ) (punct)
organelles subcellular (amod)
difference counts (nmod)
jaundice his (nmod:poss)
justified be (auxpass)
candidates development (compound)
hemodynamics anesthesia (nmod)
responses between (case)
woman white (amod)
intensity perceived (amod)
10 8 (quantmod)
triglycerides serum (compound)
revealed investigations (nsubj)
prevent rejection (dobj)
days 17 (dep)
mechanisms understood (acl)
thrombocytopenia non-immune (amod)
observed occurred (advcl)
alteration to (case)
indicative may (aux)
1995 96 (prep)
reprogramming epigenetic (amod)
inhibitor protease (compound)
allows observations (dobj)
studies microscopic (amod)
attention but (cc)
potentiated hyperactivity (nsubjpass)
rates comparable (amod)
activity regular (amod)
premature on (case)
deactivation current (nmod)
produces necrosis (dobj)
randomized followed (conj)
tensions twitch (compound)
less expression (nsubj)
adult to (mark)
sources , (punct)
injury damage (conj)
deficit retention (nmod)
enhances . (punct)
perimetry swedish (amod)
conclude have (ccomp)
control optimal (amod)
strategies therapeutic (amod)
cardiomyocytes stem (compound)
children 2 (nummod)
hepatitis after (case)
100mg/kg i.p. (advmod)
disturbance character (conj)
32 ] (punct)
temporary management (conj)
potentiation rat (nmod)
double-blind placebo-controlled (conj)
tachycardias with (case)
atropine quinpirole (appos)
injection immediately (advmod)
reduce ? (punct)
patient group (nmod)
middle and (cc)
pcpa and (cc)
mg/day 500 (nummod)
granulocytosis myelodysplastic (amod)
6.25 ( (punct)
patients af (nmod)
l/kg 0.35+/-0.11 (nummod)
regulator plant (compound)
dysfunction determination (conj)
diarrhoea resulted (dep)
dextran biodegradable (amod)
time zero (nummod)
outcomes behavioral (amod)
lip cleft (compound)
study role (nmod)
pacemaker a (det)
symptoms diagnosis (conj)
bypass artery (compound)
drug psychotropic (amod)
stimulation electrical (amod)
acid- and (cc)
sensitization ( (punct)
loreclezole combined (acl)
consider lindane (xcomp)
protein 2 (nummod)
preparations cell-free (amod)
change peak (compound)
anaesthetics with (case)
seems risk (nsubj)
bolus infusion (conj)
tended however (advmod)
start chemotherapy (nmod)
consisted stage (nmod)
leukocyturia > (dep)
reported registry (nmod)
airway the (det)
women thai (amod)
30 duration (nsubj)
rats hfd-induced (amod)
ng-nitro-l-arginine , (punct)
different clinical (dep)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate isopropyl-6- (compound)
treatment headache (nmod)
25-mg/m2 intravenous (dep)
dithiocarbamate pdtc (appos)
termed . (punct)
glycopyrrolate either (preconj)
dogs between (case)
increased ventricular (xcomp)
developed thirty-six (nsubj)
hyperalgesia/myoclonus high (conj)
maneuver the (det)
facilitated appearance (dobj)
conduction atrial (amod)
changes electromyographic (amod)
resistance plasma (nmod)
confirmed evaluation (nsubj)
decreases where (advmod)
risks human (amod)
menorrhagia in (case)
injections weekly (amod)
three two (compound)
particularly , (punct)
salicylate with (case)
administered 200 (nmod)
results first (amod)
found , (punct)
cells platelets (conj)
correct hypokalemia (dobj)
degeneration prominent (acl:relcl)
solution ; (punct)
effects impairments (nmod)
enzyme , (punct)
response drug (compound)
modified be (auxpass)
toxicity also (advmod)
repair following (case)
patients hyperthyroidism (nmod)
gr 55562 (nummod)
deduced incidences (nsubjpass)
repeated prior (advmod)
rare reactions (nsubj)
haloperidol % (appos)
men strokes (conj)
showed injury (dobj)
desipramine low (amod)
aggravate oih (dobj)
second in (case)
exclude polymyositis (dobj)
group impact (compound)
potentials amplitude (compound)
pilsicainide of (case)
group pergolide (compound)
neonate male (amod)
tri by (case)
hr of (case)
received exposure (dobj)
criteria defined (acl)
b , (punct)
buffers and (cc)
quantified months (nmod:tmod)
occurred confusion (nsubj)
cvd of (case)
related are (cop)
mg/day days (nmod)
study endografine (dep)
involved although (mark)
bed and (cc)
antagonism receptors (nmod)
have delivered (conj)
runs recording (nmod)
dose-dependent effects (nsubj)
analysis chain (compound)
cause overflow (nmod)
results microg/ml (dep)
25.3 - (punct)
curve force-frequency (compound)
content hemoglobin (compound)
consider susceptibility (dobj)
10 8 (compound)
histamine 2 (nummod)
force lid (nsubj)
mice nephrotic (amod)
cause migraine (nsubj)
fluconazole doses (appos)
drops ophthalmic (amod)
contrast unique (amod)
cingulate and (cc)
sequences , (punct)
assessment effects (nmod)
frequently patients (nmod)
agents second (amod)
changes infarction (nmod)
et-1 ( (punct)
neuralgia , (punct)
hyperlipemia diazinon-induced (amod)
two contrast (nmod)
comparison frequency (nmod)
suggests also (advmod)
hearing children (nmod)
modified not (neg)
role ph (nmod)
treatment interferon (compound)
live individuals (nsubj)
suggest leads (ccomp)
incidents subjects (nmod)
preparations available (amod)
studies changes (nmod)
back-diffusion content (conj)
sensitivity system (nmod)
trained rats (nsubjpass)
reduce proliferation (dobj)
patients cimd (nmod)
deterioration additive (amod)
disruption homeostasis (nmod)
17 and (cc)
vigilance heightened (amod)
later hours (nmod:npmod)
degkwitz 1964 (nummod)
model that (mark)
tetany rhabdomyolysis (conj)
groups mice (nmod)
lexical fluency (conj)
output max (appos)
taken with (mark)
insulin of (case)
c-4-epimer d-glucose (nmod)
valproate rats (nmod)
investigated examining (advcl)
anthracyclines , (punct)
valdecoxib cyclooxygenase-2 (compound)
concentration vip (compound)
mm group (appos)
leakage the (det)
measured not (neg)
% 32.7 (nummod)
recommended protection (nmod)
multicenter in (case)
receptor compared (case)
1998 to (case)
microbleeds mb (appos)
mg 100 (compound)
n=100 ) (punct)
unconscious was (cop)
suggest involved (ccomp)
aim the (det)
measured resistance (dobj)
system as (case)
complication populations (nmod)
evaluated twelve (nsubjpass)
received eight (nsubj)
minutes compared (acl)
protection provided (acl)
suggest beneficial (ccomp)
linn mangifera (compound)
withheld periods (nmod)
center trauma (compound)
discussed emphasis (nmod)
kept mind (nmod)
antipsychotics of (case)
protective ) (punct)
leukemia precursor (compound)
spectra in (case)
received mg/m(2 (dobj)
clozapine vs (cc)
based history (nmod)
calculated days (nmod)
hr on (case)
ng/mouse ) (punct)
suggesting hypercoagulability (dobj)
documented awake (advcl)
% control (conj)
assessing prognosis (dobj)
mortality cvd (nmod)
aimed levels (nmod)
resembled those (dobj)
cholecystokinin by (case)
antipsychotic derivative (amod)
lower that (mark)
vagina of (case)
vpa-therapy to (case)
led % (parataxis)
clinical laboratory (conj)
hemoglobin 10 (nummod)
prescribed dose (conj)
membranes in (case)
form methemoglobin (dobj)
model carrageenan (amod)
potentiate dysrhythmias (nsubj)
p58 ( (punct)
na(+)/h(+ of (case)
hypothesis used (ccomp)
parameters assessed (acl)
acute and (cc)
delivered min (conj)
patients swings (nmod)
showed that (nsubj)
hunt and (cc)
systems pump (compound)
evidence aspirin (nmod)
gsi ) (punct)
failed proteinuria (xcomp)
outpatients disorder (nmod)
mmhg 90 (nummod)
malignancies to (case)
presence pressure (nmod)
attacks to (case)
compared abilities (nmod)
suggest pathophysiology (dobj)
italy in (case)
tachycardia dogs (nmod)
attenuates cck-8 (nsubj)
traces memory (compound)
hypercalcemias spurious (amod)
alive months (nmod)
remission ra (nmod)
complication immediate (amod)
i level (compound)
reduced levels (conj)
detected extract (nmod)
due primarily (advmod)
routes administration (nmod)
delivered before (advmod)
ingredient the (det)
perception of (case)
used tests (nsubj)
current previous (conj)
ischemia cord (compound)
gbm with (case)
abnormalities reported (amod)
effective yet (cc)
subjects 17 (nummod)
af and (cc)
black and (cc)
fluorogold by (case)
feeling a (det)
centuries two (nummod)
given administered (conj)
varies strains (nmod)
model important (amod)
control h (dep)
range f344 (compound)
incidence to (case)
n=18 ( (punct)
caused is (auxpass)
substance membrane (compound)
mean amplitude (dobj)
deaths . (punct)
attempts . (punct)
submitted medicines (nmod)
years 64 (nummod)
group the (det)
applied while (mark)
prevention fibrillation (nmod)
shrinkage by (case)
hematoxylin acid-schiff (conj)
dystonia off-period (amod)
estimated differ (conj)
changes b-100 (nmod)
doses alone (acl:relcl)
patients co-infection (nmod)
attractive are (cop)
tp ) (punct)
nonselective ultra-short-acting (dep)
impairment streptozotocin (compound)
reduced may (aux)
edema . (punct)
ng/ml = (conj)
diuretic loop (compound)
abundant receptors (nsubj)
impairment tjs (nmod)
repeated were (auxpass)
exhibit can (aux)
icu our (nmod:poss)
phosphatase podocyte (compound)
syndrome hepatic (amod)
20 4 (nummod)
keratectomy prk (appos)
focuses syndromes (nmod)
ara-c with (case)
assessed swimming (advcl)
represent toxicity (dobj)
treatment continued (amod)
= 79 (dep)
dex-induced 0.001 (dep)
trial i/ii (compound)
hypotension helodermin-produced (amod)
regimens acute (amod)
time to (mark)
prolong and (cc)
arf ) (punct)
occurred before (advmod)
investigates study (nsubj)
40 19 (conj)
% 3.6 (nummod)
parallels effects (dobj)
reduced aorta/serum-ratio (nsubjpass)
proposed been (auxpass)
indicating maturation (dobj)
manipulation through (case)
effect sleep (nmod)
introduction nephropathy (dep)
associated thrombocytopenia (nmod)
administered mesna (nmod)
conduct study (dobj)
mild these (nsubj)
identified investigation (nmod)
polymyositis of (case)
administration intraarterial (amod)
injection rilmenidine (nmod)
minimum months (nmod)
comparable but (cc)
creatinine ) (punct)
hour 1 (nummod)
tumors in (case)
congenita mc (appos)
injections bilateral (amod)
improve decline (dobj)
suggests follow (ccomp)
correct no (neg)
value limited (amod)
restarted may (aux)
left responses (dobj)
days phenobarbitone (nmod)
chf 45 (nmod)
group infusion (compound)
5.2+/-1.1 ( (punct)
proliferated replacing (advcl)
4.9 0.7 (compound)
cognitive creative (conj)
tasks worsening (nmod)
had head (dobj)
total concentration (nmod)
phase treatment (compound)
agents nmbas (appos)
time size (appos)
knowledge current (amod)
hypertension normotensive (nmod)
reversal catalepsy (nmod)
micrograms.kg-1.min-1 ) (punct)
aids in (case)
extent dose (nmod)
expectancy the (det)
unpleasant . (punct)
history no (neg)
coagulation systems (conj)
measures 14/17 (nummod)
worst was (auxpass)
prednisolone with (case)
loss in (case)
models epilepticus (nmod)
nox urinary (amod)
developed plan (nsubjpass)
band with (case)
recognise , (punct)
patients cell (compound)
dialysis ambulatory (amod)
affect ' (punct)
change rats (nmod)
protrusions and (cc)
synapse in (case)
les on (case)
incidence treatment (nmod)
induced development (dobj)
reached have (advcl)
group conventional (amod)
related not (cc)
maintained end (nmod)
tumorigenesis rat (compound)
users light (amod)
higher lower (parataxis)
demonstrate effectiveness (dobj)
receive years (nmod)
developing cad (dobj)
treated onward (advmod)
activity patent (nmod)
scopolamine mg/kg (appos)
presented occurring (advcl)
blockage produced (acl)
aspirin acid (dep)
electroretinography multifocal (amod)
hematomyelia . (punct)
september 1997 (nummod)
carried microscopy (nsubjpass)
contributed haemorrhage (nmod)
acid-induced all- (amod)
effect syndrome (nsubj)
propofol and (cc)
cultures cell (compound)
enhance did (aux)
groups relative (case)
status global (amod)
led application (nsubj)
avoid clinicians (nsubj)
p < (nummod)
toxicity effects (nmod)
camp intracellular (amod)
hydrolyze not (neg)
elevated pethidine (nsubjpass)
suggest findings (nsubj)
turned injection (nmod)
morphine : (punct)
likely pain (nsubj)
hemoglobin g/dl (compound)
reduction sap (compound)
able demonstrating (advcl)
given analgesics (nsubjpass)
raised questions (dobj)
contrast is (cop)
transplant prostheses (conj)
ibuprofen 1.51 (nummod)
contribution salt-sensitivity (nmod)
(1.8)% ) (punct)
15/hypertension , (punct)
paradigm test (conj)
interventions available (amod)
leads precordial (amod)
increased are (auxpass)
muscle vascular (amod)
rescues glaucoma (dobj)
synthase thymidylate (amod)
beats ectopic (amod)
onset wk (nmod)
changes regulation (nmod)
was patient (nmod)
gly-phe-leu-gly ) (punct)
involve induction (dobj)
safety its (nmod:poss)
solution sodium (compound)
l(-1 61.6 (nummod)
grade the (det)
forebrain within (case)
reported use (nsubjpass)
ionic with (case)
systems factors (dep)
midazolam midazolam (conj)
phosphate ) (punct)
important control (nmod)
reduced volume (nsubjpass)
were infusion (nmod)
transient dynamic (conj)
contained pdn (dobj)
day embryonic (amod)
drug . (punct)
echocardiographic and (cc)
alerted hallucinations (nmod)
cells granule (compound)
evoked increases (dobj)
combination leading (acl)
positive trimethoprim (nmod)
caffeine 12.5 (compound)
lesions depression (conj)
hearts in (case)
analysis cluster (compound)
require to (mark)
bepridil dose (nmod)
positive test (nsubj)
5 rhythms (nmod)
psychosis a (det)
produced tolerated (parataxis)
group triazolo (amod)
benzoylecgonine the (det)
enabled attribute (xcomp)
memory cognition (conj)
suppressed was (auxpass)
avoided prescribed (conj)
underwent cta (dobj)
gr ( (punct)
use metolachor (compound)
constriction field (compound)
symptoms nms-like (amod)
prolonged dose-dependently (advmod)
prevented significantly (advmod)
study capillaries (nmod)
developed 4.5-times (dobj)
effect phosphorylation (nmod)
remains treat (xcomp)
year medication (nmod)
oropharynx of (case)
presence 17beta-estradiol (nmod)
related system (nmod)
remained effective (xcomp)
subjects neuropathy (amod)
lilly and (cc)
produced (+/-)-pg-9 (nmod)
limited that (mark)
measure protection (nmod)
tests screening (nmod)
predictor that (mark)
lipid novel (amod)
indicated revealed (advcl)
histology embryology (conj)
registered . (punct)
liver same (amod)
followed immediately (advmod)
nephroprotectant a (det)
hemolysis total (amod)
neutrophil and (cc)
tensions and (cc)
prone be (cop)
designed describe (xcomp)
complications therapy (nmod)
infection virus (nmod)
given tests (dobj)
exposed are (auxpass)
analyzed when (advmod)
hypoactivity early (amod)
higher 6 (nmod:npmod)
improvements scores (nmod)
implications important (amod)
agent toxicity (nmod)
associated defects (nmod)
caused reduction (dobj)
meeting a (det)
ingestion and (cc)
potassium concentrations (conj)
regeneration fibers (nmod)
monitored therefore (advmod)
consensus by (case)
patients group (compound)
cocaine development (conj)
risk bradyarrhythmia (nmod)
clinic from (case)
affect whereas (dep)
actions perhaps (advmod)
acknowledged . (punct)
ligands receptor (compound)
roots indicative (dobj)
spasm also (advmod)
exacerbation unlike (case)
models cholestasis (nmod)
produce i.v. (advmod)
obtain , (punct)
activity toxicity (conj)
puncture dural (amod)
used that (nsubjpass)
operative generalization (nmod)
number dibucaine (compound)
small that (mark)
developed eight (nsubj)
indicate modulate (ccomp)
years five (nsubj)
duration pauses (nmod)
mg/dl. was (cop)
administration apap (compound)
also sometimes (advmod)
injected except (prep)
grades iii (nummod)
granisetron antagonist (appos)
elected " (punct)
mmhg kpa (appos)
documented fourth (amod)
rats castrated (amod)
mitoxantrone mg/m2 (conj)
group sodium-depleted (amod)
space glomerular (conj)
risk switching (nmod)
baseline months (conj)
hyperalgesia capsaicin-induced (amod)
131i-hsa of (case)
duration hypotension (nmod)
period same (amod)
patients % (amod)
male an (det)
bile in (case)
strains inbred (amod)
detected drg (nmod)
brigham at (case)
supplied . (punct)
resulted intolerant (xcomp)
identify and (cc)
therapy each (det)
findings ct (nmod)
sensor is (cop)
derivatives caproate (nmod)
appropriate ranges (nsubj)
appears response (nsubj)
dysfunction minor (amod)
effective ribavirin (nsubj)
occurred disoprivan (nmod)
failed ginsenosides (aux)
domperione of (case)
cycle a (det)
3.4 was (cop)
required demonstrate (xcomp)
akbr ) (punct)
duration pretreatment (dep)
role alterations (nmod)
administration dose (appos)
effective also (advmod)
treatment glaucoma (nmod)
used decoction (nsubjpass)
thrombosis thrombocytopenia (conj)
investigated causes (dobj)
mfl ( (punct)
patients ingesting (acl)
hr and (cc)
haloperidol blocker (compound)
carcinogenesis bha (compound)
serve could (aux)
apnea obstructive (amod)
ligation duct (compound)
area 5 (amod)
patients gallstones (nmod)
saline ph (compound)
represent entity (dobj)
injury aki (appos)
showed but (cc)
effect excitatory (amod)
company , (punct)
reported tightness (nsubjpass)
mean 2.2 (dep)
thrombocytopenia reactions (conj)
form anesthetics (nsubj)
criteria laboratory (compound)
induce stents (nsubj)
doses > (dep)
disappeared occurred (advcl)
was injections (nmod)
estrogen serum (compound)
patients valves (nmod)
poor outcome (nsubj)
ergot of (case)
modification respectively (advmod)
inducing for (mark)
cue non-specific (amod)
patients thrombocytopenia (nmod)
intolerance inhibitor (compound)
resulted deletion (nsubj)
diazinon insecticide (appos)
have ) (punct)
common in (case)
components complement (compound)
dipyrone to (case)
possibility hyperkalemia (nmod)
indomethacin such (case)
demonstrated electrocardiogram (dobj)
retching and (cc)
agonist rizatriptan (nsubj)
response mechanisms (nmod)
instilled when (advmod)
control ) (punct)
performed nested (advcl)
contractions characteristic (amod)
drugs although (mark)
effect subtle (amod)
june between (case)
likely 1.2 (dep)
used antagonists (nsubjpass)
disease hepatic (amod)
patients tuberculosis (nmod)
treatment transplantation (nsubj)
minutes 85 (nummod)
improvements substantial (amod)
delirium with (case)
reduction : (punct)
dose whatever (nsubj)
increase no (det)
kanamycin-colistin povidone-iodine (conj)
numbers only (advmod)
alter rats (nmod)
-18 mm (dep)
mg/m2 12 (nummod)
improve homeostasis (dobj)
downregulation upregulation (conj)
dehydroepiandrosterone of (case)
state residual (amod)
activity increased (amod)
ug/ml , (punct)
81 41 (compound)
bcnu-exposed bcnu-exposed (conj)
life-threatening be (cop)
benzylpenicilloyl-poly-l-lysine ampicillin (conj)
reduction least (advmod)
action cimetidine (nmod)
respect animals (nmod)
1mg/kg , (punct)
injection rats (nmod)
suggest reduce (ccomp)
piroxicam selective (conj)
endonuclease-dependent ) (punct)
concentration using (acl)
cases 477 (nummod)
hydrochloride bpd (appos)
hirsutism pcos (conj)
onset by (case)
was reports (nmod)
indicative be (cop)
hyperkinesia to (case)
content propofol (nmod)
catechol benzene-derived (amod)
received adjunct (nmod)
association polychemotherapy (nmod)
consider result (ccomp)
demonstrate overdose (nmod)
leading activation (nmod)
eps ( (punct)
% 74 (nummod)
received docetaxel (dobj)
antipsychotics zuclopenthixol (conj)
introduction agonist (nmod)
release ircrf (compound)
acetylsalicylate of (case)
synthesis/turnover the (det)
trends gaps (conj)
period measurements (nmod)
produced increases (dobj)
pf ( (punct)
long interventions (dobj)
convulsions tonic-clonic (amod)
age mean (compound)
ergotamine/caffeine < (dep)
potential gentamicin (nmod)
detect ischemia (dobj)
% 4/7 (appos)
exhaustion agitation (conj)
pneumonia and (cc)
measured hypotension (nmod)
induced h (dobj)
effects antagonist (nmod)
therapeutic and (cc)
1.54 0.57 (conj)
observed simultaneously (advmod)
than usual (amod)
balances , (punct)
taken compared (advcl)
method location (compound)
% 64.3 (nummod)
itself by (case)
modify it (nsubj)
treatment d-penicillamine (nmod)
menses of (case)
sacrificed harvested (conj)
subjected injury (nmod)
agitation the (det)
mmhg 15 (nummod)
values > (nmod)
as positive (amod)
processing on (case)
injections carboplatin (nmod)
types other (amod)
observed normally (advmod)
lower controls (nmod)
pentobarbital scopolamine (conj)
cows and (cc)
underwent using (advcl)
capacity antioxidant (amod)
damages . (punct)
wistar between (case)
effect predictive (amod)
min min (conj)
decrease decrease (nmod)
week materials (nsubj)
naloxone pre-training (amod)
brush-evoked and (cc)
group hypertensive (compound)
tempol iv (appos)
survival median (amod)
potentiate twitches (dobj)
developed hypertension (nsubj)
type preparation (conj)
hospitals copenhagen (nmod)
use fs (nmod)
use mannitol (nmod)
association form (conj)
dextrose and (cc)
kinases map (compound)
revealed expression (dobj)
reduction s(c)o(2 (nmod)
provided vials (nmod)
24.3 % (dep)
one . (punct)
convulsions activity (conj)
173 4 (conj)
response on (case)
atrophy of (case)
suppressed metformin (nsubj)
useful that (nsubj)
rats 1 (nmod)
therapy ifn (compound)
secondary not (neg)
dystrophy deformities (conj)
frame study (nmod)
studies 1995 (appos)
antagonist because (mark)
days until (case)
proliferation on (case)
negative occurred (conj)
effects undesirable (amod)
reduce captopril (nsubj)
2.5 microg/0.5 (conj)
p300 cardiac (amod)
methylxanthines like (case)
used may (aux)
simvastatin and (cc)
weight brain (compound)
woman year-old (amod)
propranolol both (conj)
cas 57 (dep)
instituted . (punct)
has features (dobj)
history nephropathy (nmod)
attack metabolites (nmod)
tendency busulfan (nmod)
sustained much (nsubjpass)
colocalized rats (nmod)
aprotinin tranexamic (conj)
unchanged fraction (nsubj)
range 4.9 (dep)
effects factors (nmod)
decreased scatter (dobj)
resuscitated who (nsubjpass)
background reported (dep)
in sgk1(+/+ (punct)
undergone = (parataxis)
requested . (punct)
levels aminoglycoside (compound)
segment artery (nmod)
using assessment (dobj)
provide investigations (nsubj)
binding nuclei (nmod)
inhibition after (case)
less ( (punct)
control inhibitors (conj)
differ number (nsubj)
physician and (cc)
mg/m(2 120 (nummod)
% 8.7 (nummod)
received subject (nsubj)
occurred risperidone (nmod)
effects activity-increasing (amod)
available which (nmod)
quinpirole the (det)
exfoliation frequent (amod)
patients fibrillation (nmod)
follows ; (punct)
assigned weeks (nmod)
membrane apical (amod)
development mice (nmod)
measurements repeated (amod)
identified age (dobj)
interactions signaling (nmod)
neonates exposed (amod)
hdl but (cc)
promoted that (mark)
expression relationship (nsubj)
growth mg (dep)
treatment low-dose (amod)
nitroglycerin subjects (nmod)
concentrations electrolytes (nmod)
affected synthesis (nsubjpass)
simvastatin amiodarone (conj)
increased sbp (dobj)
indicate structures (nmod)
events identified (acl)
anesthesia barbiturate (compound)
comparison block (nmod)
acid ka (appos)
hydrochloride % (compound)
was there (expl)
implicating each (nsubj)
manifestation be (cop)
microgram/ml 1.25 (nummod)
concentrated while (mark)
comorbid disorders (dobj)
mg. and (cc)
tacrolimus fk (dep)
relationship on (case)
placebo subscale (nmod)
using migraine (nmod)
concluded good (conj)
normality lead (acl:relcl)
inhibited : (punct)
hypocalcemia for (case)
calcium serum (compound)
dysfunction hippocampal (compound)
possibility and (cc)
proliferation migration (conj)
ain of (case)
rats infusion (nmod)
any acids (nmod)
movement in (case)
anticonvulsants to (case)
activator foci (nmod)
sensitive nor (cc)
unknown . (punct)
jaundice of (case)
rpp ) (punct)
rats resuscitate (amod)
provide improve (conj)
hiccups persistent (amod)
food spicy (amod)
nephritis dermatitis (conj)
lithium evaluation (dep)
therapy choice (nmod)
piroxicam , (punct)
rate for (case)
company taxol (compound)
dogs morphine-chloralose (amod)
conclusion effective (dep)
pituitaries f344 (compound)
10 42 (conj)
allele bche (compound)
water warm (amod)
seizures following (case)
effective reduce (xcomp)
effects respiratory (amod)
incorporation azt (compound)
increased causing (advcl)
terms similarity (nmod)
as cs (amod)
implicates interaction (nmod)
decreased linearly (advmod)
instituted delay (nmod)
higher it (nsubj)
rs , (punct)
concerns because (case)
value prognostic (amod)
negative be (cop)
epicardial vessels (conj)
assessed number (nmod)
measurement in (case)
populations demographic (amod)
times nucleation (compound)
% 95 (compound)
21 of (advmod)
kidney the (det)
scheduled patients (nsubjpass)
patients alzheimer (nmod:poss)
use aggressive (amod)
supports provides (conj)
similar administered (advcl)
scans bone (compound)
groups p (dep)
drugs nsaids (conj)
proteinuria decreased (amod)
predicting outcomes (dobj)
effects systolic (nmod)
application min (conj)
hit of (case)
effect chronotropic (amod)
vacuolization extensive (amod)
bred selectively (advmod)
features disease (nmod)
received group (nsubj)
attacks cancer (conj)
contractions premature (amod)
used array (nsubjpass)
performed % (nmod)
induce hyperprolactinemia (dobj)
evidences suggesting (acl)
solicited been (auxpass)
condition fatal (amod)
incidences many (nmod)
d1 from (case)
injury complex-mediated (amod)
increases addition (nsubj)
variability hyperalgesia (nmod)
positioning same (amod)
systems enzyme (compound)
3.5 1.5 (compound)
density l-[3h]nicotine (nmod)
treatment diabetes (nmod)
da metabolites (conj)
evidenced determined (advcl)
injection isoproterenol (compound)
dose ns-718 (nmod)
increase unexpected (amod)
content lipid (compound)
hoe or (cc)
protective administration (nsubj)
improve rg1 (nsubj)
appeared defect (nsubj)
secondary trauma (nmod)
studies for (case)
infiltrations eosinophilic (amod)
back-diffusion gastric (amod)
pod 21 (conj)
risperidone benzisoxazole (appos)
sets used (conj)
drc hr (nmod)
tendency aggravate (acl)
reaching levels (dobj)
dose sodium (nmod)
infarct hemorrhagic (amod)
iiib stratum (appos)
dose-dependent a (det)
msh/acth ( (punct)
derivative 5-fu (nmod)
cyclophosphamide cpm (appos)
therapy chc (nmod)
treatment maleate (amod)
supramarginal in (case)
angio-oedema with (case)
administrated daily (advmod)
contraindicated be (auxpass)
hyperkalemia the (det)
chloroacetaldehyde : (punct)
stimulation nociceptive (amod)
decrease % (appos)
showed rats (nsubj)
utilizes . (punct)
pressure production (conj)
occurred to (mark)
275 - (punct)
infectivity the (det)
animals other (amod)
antigen hbeag (appos)
intraoperative immediate (conj)
administration by (case)
polyuria (li)-induced (amod)
days hallucinations (nmod)
phase over (case)
roots sinensis (compound)
yohimbine 0.25 (appos)
sleeping other (conj)
tet of (case)
brain neurons (dobj)
failure aki (nmod)
food liquid (amod)
patients three (nummod)
those dfc (nmod)
components bche (compound)
rest aggravation (appos)
experienced vision (dobj)
ci ( (punct)
group dogs (nmod)
decreases % (dep)
% 0.03 (nummod)
62 22 (compound)
mg diamorphine (compound)
alters bupivacaine (nsubj)
important possibility (dobj)
5-fluorouracil infusion (compound)
precipitate dehydration (dobj)
prompted review (dobj)
elevation on (case)
lost year (nmod)
gaba ) (punct)
normalized ; (punct)
function urinary (amod)
1 6 (conj)
frequency % (appos)
option thalidomide (nsubj)
comparisons formal (amod)
improves that (nsubj)
use approval (conj)
neuropeptide immunomodulatory (amod)
decreased 16 (nmod)
woman old (amod)
placebo % (appos)
57 , (punct)
photostimulation glutamate (amod)
hypercalcemia . (punct)
neuroleptics of (case)
prior sedation (nmod)
causes cocaine (nsubj)
investigated trial (nmod)
g/day ) (punct)
encephalomalacia multicystic (amod)
interaction treatment (nmod)
february december (conj)
associated children (nmod)
patients twenty-two (nummod)
response ventilatory (amod)
g of (case)
schedules schedule (nmod)
low doses (nmod)
animals morphine-treated (amod)
transport tracer (nmod)
antagonist d4 (compound)
reports therapy (nmod)
30 of (case)
lots of (case)
taken quantities (dobj)
containing acetylsalicylate (dobj)
32.87 [ (punct)
hcfcs to (case)
synthesis the (det)
sufficient re-elevate (xcomp)
mobilization fatty (amod)
disturbances or (cc)
concentration increased (amod)
chlorthalidone ( (punct)
weeks 156 (nummod)
labetalol atenolol (conj)
percent a (nmod)
men sarcoma (nmod)
% mice (nmod)
fk 506 (nummod)
dyscrasias cephalosporin-induced (amod)
onset action (nmod)
value ctni (nmod)
women 67 (appos)
% monotherapy (dep)
monoher of (case)
downregulated expression (nsubjpass)
uh to (case)
occurred one (nmod)
degree inhibition (nmod)
compatible repair (nmod)
1.73 to (case)
pfs ) (punct)
present hypertension (nmod)
cg ( (punct)
used lithium (nsubjpass)
found mouse (nmod)
hospitalized treatment (nmod)
reactions managing (amod)
ck-mb ( (punct)
suggesting influenced (ccomp)
increased age (nmod)
nephropathy csa-induced (amod)
o-methylation account (acl:relcl)
exudate of (case)
associated elevation (nmod)
given pb (xcomp)
effect drugs (nmod)
begun has (aux)
higher wk (nmod)
double ) (punct)
administered ) (punct)
initiated patient (nmod)
defined liver (nmod)
process acid (compound)
atropine antagonist (compound)
flexural gluteal (conj)
streptozotocin with (case)
detected capsules (nmod)
481 - (punct)
carry patients (nmod)
inducibility no (neg)
patients forty-two (nummod)
induces morphine (nsubj)
seemed toxic (xcomp)
tumor-free was (cop)
identified previously (advmod)
dismutase copper/zinc-superoxide (amod)
cells/mm3 ) (punct)
nerve cavernous (amod)
day ( (punct)
km its (nmod:poss)
infusion pge1 (compound)
months and (cc)
lead which (nsubj)
formation the (det)
8 more (advmod)
developed long (advmod)
failed suggesting (xcomp)
advance a (det)
melatonin exogenous (amod)
produced pressure (nsubjpass)
generation and (cc)
information the (det)
scl interval (conj)
sensitive outflow (nmod)
inhibitors or (cc)
increases introduction (nsubj)
groups saline (conj)
recovery full (amod)
expression levels (nmod)
4 stz (appos)
increases accumbens (nmod)
blocked responses (nsubjpass)
superior treatments (nsubj)
extract in (case)
derived plasma (nmod:npmod)
counts 10(6 (nmod)
correlated studies (nmod)
infarction cerebral (amod)
protection gspe (nmod)
6 second (compound)
lymphocytes activated (amod)
alpha,3 5 (nummod)
ct on (case)
identified length (nsubj)
patients evaluable (amod)
stress oxidation (conj)
examined study (nsubj)
many as (advmod)
infusion mg/m2/h (nmod)
study definition (dep)
research epilepsy (compound)
easy relatively (advmod)
sphincter on (case)
reduce pain (dobj)
study expression (dobj)
effects ee (nmod)
therapy oestrogen (compound)
virus fibrillation (conj)
p p (conj)
role b12 (nmod)
injury arterial (amod)
fever the (det)
ranging nausea (nmod)
incidence myoclonia (nmod)
fluorobenzylidene - (punct)
glutamate yield (conj)
associated interaction (nmod)
surgery casualties (conj)
risk some (det)
membrane to (case)
necessary events (nsubj)
dismissed . (punct)
development model (nmod)
tolerance phenomenon (conj)
bilaterally , (punct)
continue who (nsubj)
reduction blockade (nmod)
conditions better (amod)
exacerbation the (det)
pyrimidines oxidized (amod)
decreased period (nmod)
carrier physiological (amod)
periods treatment (nmod)
decreased 30 (dep)
pmol to (case)
gout of (case)
receptors antagonists (compound)
presented feeling (advcl)
specificities ratios (conj)
strains sg145r (nmod)
mainly italy (nmod)
drug- or (cc)
excitability system (nmod)
september june (conj)
contained . (punct)
normalized mean (parataxis)
inflexibility behavioral (amod)
supplementation alone (advmod)
augmented . (punct)
veins hepatic (amod)
operations lasting (acl)
model novel (amod)
gaba glutamate (conj)
serum alf (compound)
changes shape (nmod)
alfentanil agonist (compound)
elevated biochemically (advmod)
related use (nmod)
serious reactions (nsubj)
paralysis administration (nmod)
open randomized (conj)
surface anionic (amod)
rats 6,3-dilactone (compound)
formation emboli (nmod)
revealed matter (nmod)
toxicity ccnu (compound)
mechanisms underlying (amod)
depend to (mark)
metabolite cytostatics (nmod)
applied testing (nmod)
crossed , (punct)
improved persisted (conj)
activity or (cc)
infarction report (dep)
suspected occurs (advcl)
treatment a (nmod)
mmhg 51 (nummod)
eliminated . (punct)
antibody c219 (conj)
inclusion phenobarbital (nmod)
i.v. of (case)
2.14 -0.17 (compound)
154 to (dep)
certain symptoms (nmod)
monitored occur (advcl)
studied simultaneously (advmod)
identical , (punct)
f2 a (det)
generalization in (case)
aplasia associated (acl)
stopped snp (nsubjpass)
effective extremely (advmod)
administered accelerate (xcomp)
0.39 to (case)
tolerated generally (advmod)
regimen lithium (nmod)
settings serve (acl:relcl)
appears . (punct)
consumption with (case)
nk1 nk2 (conj)
6.2 14.1 (conj)
provide and (cc)
overdose for (case)
degree administration (nmod)
health poor (amod)
drugs new (amod)
dose-intensity di (appos)
simultaneously min (dep)
account partly (advmod)
immunosuppressant potent (amod)
documents syndrome (dobj)
prospective randomised (conj)
prolongation marked (amod)
minoxidil of (case)
decreased occurred (conj)
value itself (conj)
system l-arginine (compound)
values ic50 (compound)
undertaken induced (advcl)
event apparent (amod)
pain from (case)
syndrome stimulation (nmod)
death her (nmod:poss)
detected 18/90 (nmod)
olanzapine = (dep)
h ( (punct)
culture cell (compound)
inhibitor the (det)
amp ) (punct)
awake indicated (advcl)
modeling computer-aided (amod)
consumption total (amod)
contributing frequency (nmod)
tiapride . (punct)
concentration serum (compound)
decreased function (dobj)
mice ddy (compound)
aware be (cop)
induced aaph (nmod)
background remains (appos)
contributing plasticity (nmod)
et-1 endothelin-converting (conj)
manifestations disorder (nmod)
restricted dosage (nsubj)
creatinine cr (appos)
antigen-positive -negative (conj)
interventions administration (dep)
conduction s-a (amod)
investigated value (dobj)
5.4 1.1 (conj)
discuss role (dobj)
ketoconazole topical (amod)
patients nystagmus (nmod)
ramh of (case)
presenting overdose (nmod)
control mice (nmod)
regulation cytokines (nmod)
study clinics (nmod)
investigated objective (nsubj)
fourteen 248 (nmod)
10 9 (compound)
reabsorption protein (compound)
biomarker feasible (amod)
doses eight (nummod)
smoke who (nsubj)
dependent more (advmod)
just usually (advmod)
tiapride , (punct)
method mg/day (appos)
carcinoma one (nummod)
protein circumstances (nmod)
referrals consecutive (amod)
seen % (nmod)
referred syndrome (nmod)
measurement activity (nmod)
cirrhosis alcoholic (amod)
antagonist : (punct)
muscle masseter (compound)
mitigated dopamine (dobj)
tubular regions (dep)
receive irradiation (dobj)
discussed regard (nmod)
reduced both (dep)
discontinued seen (conj)
randomized those (advcl)
increase ] (punct)
alters that (mark)
referred follow-up (nmod)
similar study (nmod)
sensitivity % (dep)
transient hyperammonemic (dep)
injection days (nmod)
example case (nsubj)
classed were (auxpass)
made measurement (nsubjpass)
affected i.e. (dep)
subtle findings (nsubj)
responses joint (amod)
assessable and (cc)
years 55 (nummod)
forms dysfunction (nmod)
known consequences (nmod)
treatment cancer (compound)
monitored total (nsubj)
asterixis . (punct)
controlled was (auxpass)
terbutaline with (case)
increase risk (dobj)
evaluated cause (xcomp)
brain rats (nmod)
diabetes streptozotocin-induced (amod)
patients taking (acl:relcl)
flushing face (nmod)
showed improvement/resolution (dobj)
dosing post (compound)
unaltered that (mark)
woman diabetes (nmod)
picture case (nmod)
min 98 (nummod)
infant on (case)
recognised widely (advmod)
diclofenac dcf (appos)
metaiodobenzylguanidine analog (appos)
absolute attributable (conj)
state akt (nmod)
panss ( (punct)
level bcl-2 (nmod)
patients 34 (appos)
bleeding hemorrhagic (conj)
laboratories at (case)
attributed fact (nmod)
available results (nsubj)
anaesthesia compared (case)
yields cell (compound)
hypotension because (case)
frequent less (advmod)
bmd volumetric (amod)
factor platelet-activating (amod)
months within (case)
raters between (case)
rate suxamethonium (compound)
ssris [ (punct)
or=2.5 > (compound)
development rats (nmod)
complication seizures (nsubj)
available transplantation (nsubj)
models canine (compound)
safe may (aux)
deposits tubular (amod)
obtained yields (nsubjpass)
coma acidosis (conj)
patients constriction (nmod)
found number (nsubjpass)
abolished when (advmod)
earlier apoptosis (nmod)
eruption is (cop)
observed rest (nmod)
recurrence no (neg)
determine identified (ccomp)
developed protect (xcomp)
neurotransmission in (case)
slices survivors (nmod)
removed , (punct)
vs. + (cc)
more and (cc)
entity necrosis (nsubj)
irrigation during (case)
represented mainly (advmod)
erythromycin with (case)
suppressed whereas (dep)
found sustained (conj)
encephalopathy hyperammonemic (amod)
reduction % (dep)
clamping by (mark)
receptor orl1 (appos)
modify and (cc)
transaminase serum (compound)
clear situation (nsubj)
severity disability (nmod)
refine to (mark)
cn participants (conj)
properties rewarding (amod)
one hundred (compound)
preserve flow (dobj)
use : (punct)
rare important (conj)
prazosin yohimbine (conj)
reviewed records (dobj)
viability cell (compound)
monkeys adult (amod)
weights muscles (nmod)
administration concomitant (amod)
resulted withdrawal (nmod)
verapamil intragastric (amod)
potency duration (conj)
needed if (mark)
affect ich (dobj)
show jumping (xcomp)
females age (nmod)
reduce spironolactone (nsubj)
profile haloperidol (nmod)
rigidity mmg (appos)
active hyperactivity (nmod)
hyperprolactinemia effects (conj)
scopolamine cycloheximide (conj)
subsides , (punct)
developed failure (dobj)
trials : (punct)
pathway trunk (nsubj)
memantine with (case)
case to (mark)
capacity mcc (appos)
patients 2 (nummod)
lethality some (det)
permit identification (nsubj)
resulted previously (advmod)
therapy pattern (dobj)
agents pharmacological (amod)
complications and (cc)
tolerance the (det)
exposure epirubicin (compound)
associated diethylstilbestrol (nmod)
offspring observation (nmod)
reproduce dyskinesias (dobj)
khz 0.5 (nummod)
developed woman (nsubj)
variety reasons (nmod)
implants fluocinolone (compound)
down-regulation function (nmod)
groups recipients (nmod)
hpa ) (punct)
contents ngf (compound)
depends incidence (nsubj)
therapy methods (nsubj)
injection 15 (conj)
vgpr ) (punct)
dose between (case)
performance their (nmod:poss)
sensitive process (nsubj)
choice the (det)
ro15 1788 (nummod)
link possible (amod)
transporters 5-ht (compound)
therapy prolonged (amod)
physiologic or (cc)
anaesthesia xenon-133 (compound)
treatment mk-801 (compound)
treated atorva (nmod)
event-related cardiac (amod)
% ci=14.2%-20.5 (compound)
transplantation organ (compound)
groups 6 (nummod)
wall rats (nmod)
associated has (aux)
transplantation organ (amod)
trigger to (mark)
increase creatinine (nmod)
attenuate nephropathy (dobj)
animals age (nmod)
parameters desire (nmod)
produce decreased (conj)
lowering and (cc)
achieved achieved (conj)
deacetylation binding (conj)
defects proliferation (nmod)
patients expressing (acl)
confounders for (case)
resuscitation and (cc)
tdi ( (punct)
osteoarthritis 10 (nummod)
picture similar (amod)
cbz ) (punct)
course : (punct)
mechanisms strategies (conj)
became before (mark)
prevalence relative (amod)
study case (dobj)
initiatives health (compound)
translocation chromosome (appos)
registered which (nsubjpass)
pneumonitis and (cc)
catecholamines plasma (compound)
decrease group (nmod)
inhibition ( (punct)
retina on (case)
occurs months (nmod)
nurses the (det)
damage widespread (amod)
injections isoniazid (nmod)
13 , (punct)
paradigms new (amod)
strategies many (amod)
mean+/-se ( (punct)
low if (mark)
use admission (nmod)
occlusion a (det)
range 265.2 (appos)
toxicity non-overlapping (amod)
taking zolmitriptan (dobj)
periods hypotension (nmod)
system phagocyte (compound)
toxicity urd-related (amod)
comparisons statistical (amod)
extracted parallel (nmod)
idr ( (punct)
pressure an (det)
participants 21 (nummod)
elevated : (punct)
binding [3h]-naloxone (nmod)
meeting not (neg)
ouabain 10(-2 (nmod)
excretion levels (conj)
percent 59 (nummod)
profile given (case)
etiology to (mark)
coxii the (det)
nox weight (conj)
assessed performance (nsubjpass)
hemorrhage extensive (amod)
levels activity (conj)
monooxygenases p450 (compound)
homogenates extracts (conj)
prescribed adjustment (nmod)
functioning optimal (amod)
subjects patients (conj)
latency an (det)
complicated sepsis (nmod)
administration pinacidil (conj)
regained had (aux)
order following (amod)
administration ibuprofen (nmod)
sprague-dawley between (case)
used lindane (nsubjpass)
reduced is (auxpass)
received form (nmod)
sulphasalazine oral (amod)
observed hypokalemia (nsubjpass)
ventral and (cc)
confusion and (cc)
conditions placebo-controlled (amod)
basis eradication (nmod)
led rechallenge (nsubj)
metabolites five (nummod)
result therapy (nmod)
treatment cis-platin (nmod)
worsening . (punct)
unique drug (nmod)
pretreated which (nsubjpass)
remoxipride of (case)
alternation cent (compound)
appears level (nsubj)
5-fu bolus (compound)
hearts of (case)
read aloud (advmod)
appeared responded (conj)
way this (det)
falls minor (amod)
catalepsy , (punct)
trial cancers (nmod)
misleading testing (nsubj)
used as (dep)
haloperidol with (case)
improvement treatment (nmod)
33.6 ) (punct)
receive doses (dobj)
caused isoproterenol (nmod)
observed wt (nmod)
warfarin of (case)
recovery after (case)
po2 arterial (amod)
staining the (det)
case loss (nmod)
findings along (case)
administered hydration (nsubjpass)
woman-years rate (nsubj)
region intermediate-caudal (amod)
established correlation (nsubjpass)
di-o-tolylguanidine and (cc)
demonstrate essential (ccomp)
ctni-positive were (cop)
symptoms tnss (appos)
higher limits (nmod)
killed were (auxpass)
interaction severe (amod)
subjective neurocognitive (dep)
depletion with (case)
decreased caudate (conj)
measured completion (nmod)
pilsicainide blocker (appos)
infections but (cc)
lasted weeks (nmod)
groups consisting (acl)
enlargement phenobarbitone-induced (amod)
effect density (nmod)
min the (det)
reversal licking (nmod)
presenting administration (nmod)
require evaluation (dobj)
need vigilance (nmod)
placed to (mark)
infusion adrenaline (compound)
people use (acl:relcl)
preventing development (dobj)
procaterol . (punct)
tubular glomerular (conj)
play ameliorates (conj)
stores into (case)
children those (det)
used medicine (nmod)
present lesions (dobj)
identified therefore (advmod)
mg/kg that (nsubj)
tg for (case)
administration ml (nmod)
band prosthetic (amod)
mg/m2 310 (nummod)
factors perinatal (amod)
ms desorption/ionization (compound)
antagonized action (nmod)
act altering (advcl)
dialysis equilibrium (compound)
inability repeat (acl)
corrected can (aux)
conclude likely (ccomp)
5days/week , (punct)
influences eryptosis (dobj)
increase torr (nmod)
95 13 (conj)
properties pharmacological (amod)
pain ocular (amod)
induced injury (dobj)
relative baseline (nmod)
maleate hydrogen (compound)
prescribed therapy (nsubjpass)
ester octapeptide (compound)
given drops (nsubjpass)
attention regulation (conj)
however , (punct)
consequence leukemia (nsubj)
had liver (nmod)
pg ) (punct)
imaging cardiac (amod)
observed pilocarpine (nmod)
suggest . (punct)
val ) (punct)
potentiate can (aux)
body wt/day (nummod)
those relapse (acl:relcl)
levels % (nmod)
occurs deficit (nsubj)
% response (compound)
had stay (ccomp)
relieved however (advmod)
mg.kg(-1).min(-1 ( (punct)
evaluated function (nsubjpass)
describes treated (advcl)
lidocaine surgery (nmod)
classifications existing (amod)
reaction adverse (amod)
crataegus of (case)
yrs versus (cc)
alleviate to (mark)
department physicians (conj)
sensitizes whether (mark)
2-receptors heart (nmod)
details puncture (nmod)
augments processes (dobj)
rats half (predet)
blocked . (punct)
necrosis characterized (acl)
0.007 p=0.006 (dep)
word in (case)
parasitosis a (det)
done day (nmod)
values pms (nmod)
produce manifestations (dobj)
loss ) (punct)
exhorted pay (xcomp)
vasculitis panca-positive (compound)
mean treatment (nmod)
hepatitis propylthiouracil-associated (amod)
adenocarcinomas cas (conj)
phenobarbitone- stress (conj)
scores however (nmod)
survival the (det)
slides biopsies (nmod)
start gem-p (nmod)
caspase-3 of (case)
agents baseline (nmod)
reactions symptoms (nmod)
fibrosis mineralocorticoid (nmod)
paradigms selected (amod)
plays hypertension (nmod)
seems form (nsubj)
transplantation fulminant (amod)
nightmares . (punct)
practice in (case)
reviewed rated (conj)
doses 6 (nummod)
syndrome reduction (nmod)
capd ( (punct)
hyperkalemia and (cc)
0.02 rocuronium (dep)
twitch and (cc)
grade 4 (conj)
frequency lh (compound)
chloride triphenyl (compound)
18 less (amod)
dysfunction treatment (nsubj)
mechanisms implications (conj)
akinetic hyperkinetic (conj)
control birth (compound)
10.7 0.5 (conj)
5-fu mg/day (appos)
zone perivenular (amod)
important . (punct)
use acetaminophen (nmod)
remission and (cc)
% 10.3 (nummod)
extracted analyzed (conj)
enzyme ace (appos)
mg/kg 0.6 (compound)
effect factor-i (nmod)
function declined (amod)
isoenzymes p450 (compound)
4.1 -0.5 (nummod)
determined recurring (ccomp)
fev1 81 (conj)
transition the (det)
spread poison (dobj)
potentiated to (mark)
use medication (nmod)
complaints pressure (nmod)
control forming (dep)
schedules multiple (amod)
mediated failed (conj)
juice gastric (amod)
13 14 (conj)
carbimazole omercazole (appos)
90 when (advmod)
se after (case)
hypotension a (det)
observed control (advcl)
distance se (nmod)
magnitude stress (nsubj)
bipolar i (dep)
occurred administration (nmod)
result rotation (nsubj)
called . (punct)
3 18 (conj)
changes pathways (nmod)
disappearance followed (acl)
recommended highest (dep)
therapy frequency (conj)
anemia induced (amod)
0.75 0.50 (compound)
last when (advmod)
= 13.755 (dobj)
matter hemisphere (nmod)
antidepressant bupropion (nsubj)
poisoning phosphorus (nmod)
amphetamine , (punct)
14 20 (conj)
1.85 v/s (dep)
insertion n (dep)
pills look-alike (amod)
% 100 (nummod)
re-elevate mean (dep)
found normal (parataxis)
11.5 0.7 (conj)
tourniquets untied (acl)
cancer childhood (compound)
uses atropine (nmod)
% 3.3 (nummod)
in vitro (dep)
numbers procedure (nmod)
effects conversion (nmod)
periods mg/kg (dep)
evaluate outcomes (dobj)
ketamine non-competitive (amod)
leads accumulation (nmod)
department adult (amod)
ischemia epinephrine-induced (amod)
pentoxifylline derivative (appos)
nmbas aminosteroid-based (amod)
gene serotonin (compound)
ectopy of (case)
sucrose % (compound)
1991 and (cc)
action neuroprotective (amod)
followed we (nsubj)
presents apnea (nmod)
dose mg/m2 (dep)
mm ) (punct)
phenylpropanolamine ppa (appos)
suffering pain (nmod)
nte ( (punct)
reverses benzylacyclouridine (nsubj)
cisplatin 5-fluorouracil (conj)
have cytotoxicity (dobj)
warranted model (nmod)
discontinued be (auxpass)
bronchodilator is (cop)
blockade mpep (nmod)
ketamine solution (conj)
receptor orphan (compound)
infection hcv (compound)
found cocs (nmod)
arrhythmia ventricular (amod)
effect adrenaline-induced (amod)
appeared responsible (xcomp)
underwent mitochondria (nsubj)
emerged hbv (nsubj)
synthesize do (aux)
complicated unclear (conj)
scales bond (nmod:poss)
varies susceptibility (nsubj)
reach even (advmod)
multicenter double-blind (conj)
prevent rebleeding (dobj)
deletion by (case)
test acetic (amod)
lowered dose (conj)
calcification status (conj)
side-effects paradoxical (amod)
followed transport (nmod)
diagnosed earlier (advmod)
activity for (case)
improved subsequently (advmod)
disappeared effusion (nsubj)
clozapine between (case)
pcr by (case)
modulation release (nmod)
injection treatment (nmod)
months 34 (nummod)
balance sodium (compound)
analyzed therefore (advmod)
modalities the (det)
develops if (mark)
properties na+-binding (compound)
suggests increases (ccomp)
initiate onset (dobj)
findings boys (nmod)
suggested therefore (advmod)
development side-effect (nmod)
fields constricted (amod)
available haart (nsubj)
down measure (acl:relcl)
network the (det)
uroprophylaxis of (case)
logical think (xcomp)
serum workers (nmod)
show change (dobj)
background herbicides (appos)
discontinued immediately (advmod)
erection ) (punct)
develop regularly (advmod)
oxidation hemoglobin (compound)
goes unrecognized (acomp)
areal bmd (dobj)
seizures from (case)
convert negative (xcomp)
function previous (amod)
disorder psychotic (amod)
saline instillation (conj)
suffered performed (conj)
outcome maternal (amod)
hypotheses studies (conj)
flecainide and (cc)
instrument a (det)
promote can (aux)
pparalpha ) (punct)
metabolism amino (compound)
model and (cc)
elicits which (nmod)
stress cell (compound)
( 21.6 (dep)
kong hong (compound)
patients obstruction (nmod)
analysis review (conj)
contractions ventricular (amod)
history entry (nmod)
variable outcome (compound)
cycle cardiac (amod)
colitis ischemic (amod)
longer those (nmod)
noted responses (nmod)
long-acting ropivacaine (dep)
showed observed (advcl)
subjects patients (dep)
patterns consistent (amod)
drinking the (det)
coagulation pt (appos)
hbeag of (case)
extent week (nmod)
synthesis enhanced (amod)
one kindreds (nmod)
ph urinary (amod)
disorders motility (compound)
cause discussion (nsubj)
found found (parataxis)
assessments in (case)
doses chlormethiazole (nmod)
protocol same (amod)
4.3+/-1.9 . (punct)
november as (case)
other 13 (nummod)
suppression may (aux)
applied formers (nsubjpass)
model non-human (amod)
gained knowledge (dobj)
appropriate , (punct)
applications potential (amod)
mood depressed (amod)
accumulation livers (nmod)
training during (case)
patients all (det)
changes day (nmod)
impact a (det)
ventricle plus (cc)
dry mildly (advmod)
cont./min placebo (conj)
frequencies transplantation (nmod)
injection prior (amod)
resistance failure (nmod)
necrotizing . (punct)
date to (case)
relatives physicians (conj)
improved ct (conj)
result medication (nmod)
applied stz (nmod)
demonstration an (det)
results showed (appos)
remained increased (conj)
possible always (advmod)
olanzapine to (case)
department women (conj)
likely used (advcl)
0.8 0.15 (conj)
dead patients (nsubj)
received test (nmod)
common be (cop)
infection antecedent (amod)
interrupted prolongation (nmod)
contracting directly (advmod)
nitroprusside after (case)
evidence ecg (compound)
dehydrogenase decreases (conj)
understood well (advmod)
recorded subject (nmod)
organelles apparatus (conj)
dopamine-1 , (punct)
sectors rats (nmod)
activities catalase (compound)
responses durable (amod)
therapy azithromycin (compound)
associated vnr (nmod)
denial because (case)
nfs for (case)
reach compared (prep)
therapy discontinued (amod)
toxicosis gastrointestinal (amod)
resulted co-administration (nsubj)
vasoconstriction intramural (amod)
treated den (nmod)
started sorafenib (nsubjpass)
inhibitors day (nmod)
attack . (punct)
consumption an (det)
rare because (mark)
respond symptoms (nsubj)
elucidated yet (advmod)
suggests conclusions (dep)
recognition 10 (dep)
violation a (det)
pcna ( (punct)
challenges management (nmod)
compounds known (acl)
condition medication (compound)
receptors bradykinin (compound)
lower mg/day (nmod)
fractures use (nmod)
weeks ' (case)
used periods (nmod)
seen improvement (nsubjpass)
mg/m2 at (case)
separate effects (dobj)
toxicities tissue (compound)
0.30 than (case)
pge(2 mpges-1-derived (cop)
lithium of (case)
monkeys onset (conj)
produced cross-tolerance (dobj)
subtests scale (nmod)
patients dyskinesia (nmod)
rats intraperitoneally (advmod)
scores psychopathology (compound)
evidence neurophysiological (amod)
ceased that (nsubj)
diagnostic by (case)
have rats (nsubj)
subjects % (appos)
junction nd-nmba (appos)
popularity increasing (amod)
consisting face (nmod)
resulting irritability (nmod)
injections two (nummod)
impairment measures (nmod)
ccr2 ccl2 (conj)
fluoxetine inhibitor (appos)
clentiazem antagonist (appos)
mutants hbv (compound)
higher mm2 (dep)
(+)-cibenzoline and (cc)
studies investigations (conj)
put than (case)
cimetidine due (case)
modified is (auxpass)
methadone mu-opioid (amod)
emerged during (mark)
induced fall (dobj)
rare rarer (conj)
treatment the (det)
indeterminate effects (nsubj)
modifies resulting (xcomp)
was increase (attr)
pathogenesis nephropathy (nmod)
concentration low (amod)
resolved hours (nmod:tmod)
appear exacerbated (conj)
trends only (amod)
scan head (amod)
impairment mitochondrial (amod)
effects cocaine (nmod)
tended display (xcomp)
use a-86929 (appos)
had infections (dobj)
got cardiac (amod)
margin lower (amod)
setting , (punct)
rls of (case)
record controls (nmod)
hl in (case)
break bud (compound)
white or (cc)
p=0.44 ( (punct)
syndrome heart (compound)
analog an (det)
remission she (nsubj)
deletion its (nmod:poss)
euthanized , (punct)
underwent regimen (dobj)
16 - (punct)
rofecoxib or (cc)
complication for (case)
recognized hyperkalemia (nsubjpass)
associated if (mark)
incidence chloride (compound)
differences regarded (acl)
membranes of (case)
symptoms pheochromocytoma (nmod)
delirium incidence (dep)
sedentary-isoproterenols and (cc)
evaluations in (case)
used ) (punct)
determine value (dobj)
period " (punct)
effect in (case)
maze water (compound)
prevented increases (dobj)
ms/mg 0.140 (nummod)
rhythm cardiac (amod)
celecoxib 1.52 (appos)
cardiotoxicity analysis (appos)
prevents impairment (dobj)
induce augment (dep)
p<.001 ) (punct)
controls groups (conj)
developed monkeys (nsubj)
everolimus of (case)
adolescents in (case)
effects mg./kg (nmod)
produces administration (nsubj)
area body (compound)
patients kg (dep)
micrograms 2.3 (nummod)
technique screening (compound)
alcohol ( (punct)
aorta aor (dep)
analyzed : (punct)
given patient (nsubjpass)
sensitive specific (conj)
birth the (det)
included analysis (dobj)
delays apigenin (compound)
given dose (nmod)
randomized open-label (dep)
transcription and (cc)
1999 during (case)
mechanisms causal (amod)
amphetamine related (conj)
anesthetized methods (dep)
gamma-hch ) (punct)
older or (cc)
ly-171555 either (cc:preconj)
coagulation coagulopathies (conj)
gained : (punct)
exchanges sces (appos)
nerves bilateral (amod)
induces , (punct)
experienced patients (nsubj)
compound a (det)
thrombopoetin endotoxemia (conj)
perform assessment (dobj)
investigated determined (parataxis)
increased uptake (dobj)
induce statins (nsubj)
had reactions (dobj)
c n (appos)
decreased haloperidol (nsubj)
medication an (det)
hemoglobin < (nummod)
albino swiss (amod)
days 19 (nummod)
interaction inhibitor (nmod)
d 3 (nummod)
antagonist central-acting (amod)
mg/day ( (punct)
resulted dose (nsubj)
aware use (conj)
models various (amod)
episodes arrhythmia (nmod)
clozapine- olanzapine-treated (conj)
individuals 5 (nummod)
ml drug (nmod)
activation alpha2-adrenoceptors (nmod)
risk obtundation (nmod)
effective utility (conj)
crescents patient (nmod)
relapse of (case)
animals saline-infused (amod)
hypertrophic . (punct)
quantified degree (nsubjpass)
% 47 (nummod)
or functionally (advmod)
ect first (amod)
models all (det)
serum of (case)
challenge repeat (compound)
has lometrexol (nsubj)
flutamide androgen (compound)
microl microg/0.5 (nummod)
pentoxifylline either (cc:preconj)
pressures , (punct)
tremor arm (nmod)
fetal adult (conj)
ligand an (det)
antagonist adenosine (compound)
subacute , (punct)
terfenadine citalopram (conj)
effects number (conj)
carried hours (nmod:tmod)
patients informed (amod)
included eventually (advmod)
men versus (case)
events lead (acl:relcl)
began min (dobj)
studies stress (compound)
t+a 17/106 (amod)
cause did (aux)
delays mediated (conj)
flow of (case)
exacerbation acute (amod)
application d (nmod)
effects fibrillation (nmod)
interfere and (cc)
assessing for (mark)
percent to (case)
gtn -12.8 (conj)
negative glucose (nmod)
had control (advcl)
sutures mattress (compound)
features woman (dep)
days bisphosphonate (nmod)
= 2.0 (dep)
british black (amod)
rats thirty-six (nummod)
observed significantly (advmod)
accumulation cholesteryl (compound)
acts ; (punct)
used manage (xcomp)
stopped imaging (nmod)
lysis extensive (amod)
trial diet- (amod)
suggest mediator (ccomp)
therapeutic anti-cancer (nmod:npmod)
5-fu c (conj)
increase moderate (amod)
exhibited dependently (advmod)
reflected zones (nmod)
evaluated bromocriptine (nsubjpass)
absences the (det)
describe gain (conj)
evaluation treatment (nmod)
using doses (nmod)
injected ventricles (nmod)
hours within (case)
highlights . (punct)
tended show (xcomp)
related arrhythmias (nsubj)
followed male (nmod)
machinery contractile (amod)
2.9-fold 5.1 (dep)
developed nor (cc)
degrees 90 (nummod)
administration dox (compound)
reduce reversal (nsubj)
decreased 5 (dep)
fever of (case)
patients hemodialysis (nmod)
preserved s(c)o(2 (dobj)
causes deficits (dobj)
therapy hyperventilation (conj)
veins the (det)
muscle-lengths/s to (case)
thereafter yearly (advmod)
slope frequency (conj)
extract daucus (compound)
had threshold (dobj)
isomers optical (amod)
thresholds tone (compound)
had hematuria (dobj)
lowers vasodilatation (nmod)
arthralgia ( (punct)
neuroinflammation behavioral (conj)
bilayers lipid (compound)
interval ms/mg (nmod)
% 15.1 (nummod)
sensitive assessment (nsubj)
50 mg (conj)
enhanced haloperidol (nsubj)
persisted polyuria (nsubj)
units sold (acl)
results field (nmod)
vt/ti ( (punct)
received times (nmod:tmod)
agent carcinoma (nmod)
induced benzoylecgonine (nmod)
decoction seed (compound)
effects markers (nmod)
> reversible (conj)
counts and (cc)
infusions adrenaline (nmod)
toxicity-free presumably (advmod)
icv d (nmod)
possibility irreversible (ccomp)
pk with (case)
habituated were (auxpass)
determining after (mark)
found proteinuria (nsubjpass)
database patients (nmod)
pretreatment acetaminophen (nmod)
movement disinhibition (conj)
exercised should (aux)
region improves (nmod)
blocker by (case)
subject who (nsubj)
model , (punct)
signs by (case)
patient per (case)
infusions bilateral (amod)
containing water (conj)
results positive (dep)
mixture anesthetic (amod)
increased min (nmod)
study thalidomide (nmod)
0.3 or (cc)
define fibres (dobj)
bfgf including (case)
cases 135 (nummod)
changes plasticity (conj)
mg/dl 1.46+/-0.8 (compound)
treated benztropine (nmod:npmod)
develop so (mark)
studied treatment (nmod)
reconstruction flap (compound)
associated pathway (nmod)
defined symptoms (nmod)
dct2 ) (punct)
concentrations matter (nmod)
cards subject (amod)
unconscious who (nsubj)
uropathy obstructive (amod)
differences epss (nmod)
factors concomitant (amod)
similar effect (nsubj)
death accelerated (amod)
performed surgery (nsubjpass)
alpha pgf2 (compound)
range 17.8 (conj)
inhibitor reverse (amod)
ratio g (compound)
rats all (appos)
study i/ii (compound)
toxicity is (cop)
effect cyp3a4 (nmod)
remained treatment (nmod)
cause antibiotics (nsubj)
affinity site (nmod)
quality trial (compound)
measurements frequencies (nmod)
b2 and (cc)
proved carcinoma (xcomp)
patients lymphopenia (dep)
meth ) (punct)
acrolein route (nmod)
help factors (nsubj)
patients 342 (nummod)
cardiotoxicity combined (amod)
risk type (nmod)
regulation nephropathy (nmod)
penetration fluid (compound)
insipidus induced (amod)
hemolysis from (case)
examine effect (dobj)
solution only (advmod)
interviewing reviewing (conj)
ee or (cc)
redness related (amod)
studies assessing (acl)
compound its (nmod:poss)
plays pathogenesis (nmod)
exposure caffeine (compound)
scintigraphy hepatobiliary (amod)
patients p9605 (compound)
compared efficacy (nsubjpass)
bolus 3-weekly (amod)
suggested augments (ccomp)
arsenic ias (appos)
exposure intensive (amod)
complete 3 (dep)
abolished pre-administration (nmod)
toxicity maternal (amod)
exposure shrinkage (conj)
agent paclitaxel (nsubj)
duration in (case)
proportion infants (nmod)
results however (advmod)
plasticity in (case)
microg/day pantoprazole (appos)
paramedics scene (nmod)
iopromide either (cc:preconj)
vol% 1.0 (nummod)
pathogenesis unknown (amod)
% 1.1 (nummod)
findings caused (appos)
male leukemia (nmod)
aminotransferase u/l (compound)
increased mortality (nsubjpass)
maintains that (nsubj)
activation system (nmod)
followed i (nsubj)
signs all (predet)
is stopped (conj)
that metrifonate (nmod)
mtx ( (punct)
relation duration (nmod)
bilirubin time (conj)
didanosine to (mark)
leading complete (xcomp)
neuroleptics to (case)
led increases (nmod)
had prevented (dep)
netilmicin piperacillin-treated (conj)
pp ( (punct)
history aggressiveness (nmod)
produced helodermin (nmod)
positive resistant (dep)
enable diagnosis (dobj)
0.05 ( (punct)
oxygenation and (cc)
demonstrated demonstrated (conj)
23 out (advmod)
complications patient (nmod)
received diazepam (dobj)
levels urea (compound)
altering directly (advmod)
medulla im (appos)
endocarditis in (case)
source the (det)
lesions tgf-b (conj)
subjected surgery (nmod)
therapy disease (conj)
120/67 mm (dobj)
head ) (punct)
crisis therapy (conj)
used provide (xcomp)
samples erythrocyte (compound)
subsequent initiation (nmod)
black male (conj)
reported revealed (conj)
detected blotting (nmod)
threat of (case)
width by (case)
study additional (amod)
years years (appos)
combination skf (nmod)
appeared patients (nmod)
associated cause (nmod)
min-1 and (cc)
levels due (case)
min-1 less (amod)
diverse structurally (advmod)
sold and (cc)
analysis scores (nmod)
den with (case)
reduce not (neg)
had months (nmod)
placebo micrograms (nmod)
skilled administration (nmod)
supporting role (dobj)
showed biopsies (nmod)
rash macro-papular (amod)
severity impairment (nmod)
measured inulin (nmod)
compare users (nmod)
disturbances other (amod)
0.7 - (punct)
have diabetes (dobj)
cytoskeleton the (det)
improves ischemia (dobj)
h2 ) (punct)
trials biggest (amod)
emissions teoaes (appos)
stimulation walls (nmod)
disappearance na (nmod)
changes age-related (amod)
fluoxetine ( (punct)
remained factors (dobj)
incorporation its (nmod:poss)
history disease (nmod)
pointer an (det)
performed interval (dep)
cavity in (case)
amylase a (det)
abortions saline-induced (amod)
duration specific (amod)
percent 38 (nummod)
catalepsy model (appos)
avoidance and (cc)
microg/l 1360 (nummod)
patients < (dep)
fluoxetine serum (compound)
divided over (advmod)
induce ra (nsubj)
epicondyle in (case)
% 18 (nummod)
produced seizures (dobj)
documentation this (nsubj)
bfue marrow (compound)
gain to (aux)
have olanzapine (nsubj)
injections doses (nmod)
utilized model (nmod)
= 60 (dobj)
kit immunoassay (compound)
cisplatin e.g. (dep)
pressure hydrocortisone (nmod)
affecting agents (nsubj)
contention sites (ccomp)
damage liver (compound)
layer cortex (nmod)
aza ) (punct)
unclear site (nsubj)
administration abortions (nmod)
points time (compound)
hypothesis dysfunction (nmod)
art ( (punct)
solvent glycol (appos)
reduction er (compound)
administration epinephrine (compound)
decreases hdl-c (nmod)
improves deficits (dobj)
hepatic renal (conj)
assessable efficacy (nmod)
suggestions experts (nmod)
duration catalepsy (nmod)
reach patient (nsubj)
years 2 (nummod)
reduced inhibited (conj)
% 45.5 (nummod)
icv were (cop)
process linked (acl:relcl)
injury related (amod)
alterations tissues (nmod)
shows results (ccomp)
phosphatase n-acetyl-beta-glucosaminidase (conj)
metabolizers poor (amod)
muscles respiratory (amod)
agonist . (punct)
observed since (mark)
lungs hypoplastic (amod)
genes novel (amod)
cause dermatitis (nmod)
predated thus (advmod)
surgery after (case)
toxicity any (det)
pathways main (amod)
estimated number (nsubjpass)
reduced remained (advcl)
any products (nmod)
enhancement characteristic (amod)
increased rate (nsubjpass)
antibody-negative stable (conj)
shown clinic (nmod)
midazolam ) (punct)
had on (prep)
barium of (case)
sealants fs (appos)
systolic humans (nmod)
amphetamine-free control (appos)
g/ml groups (nmod)
22 % (quantmod)
overdose diltiazem (compound)
hawthorn of (case)
receptors tyrosine (compound)
increases activity (nmod)
levels triglyceride (compound)
analysis years (conj)
conducted estimate (advcl)
decline index (nmod)
presentation morbidity (conj)
challenged , (punct)
disease relapsed (amod)
eps without (case)
% ergotamine/caffeine (nmod)
ketamine- narcosis (dep)
activation receptor (compound)
effect innervation (nmod)
165 and (cc)
vulnerability such (amod)
safety . (punct)
db measured (acl)
lend support (dobj)
sequelae further (advmod)
decreased resistance (nsubj)
underwent echocardiography (dobj)
analyses uni- (compound)
involvement systemic (amod)
complaints same (amod)
2- 8- (conj)
distinguished damage (nsubjpass)
pc bcp (conj)
properties neurons (nmod)
recommenced episode (nmod)
beats by (case)
subdivisions brain (nmod)
impairment stress (conj)
pronounced that (nsubj)
discuss advantages (dobj)
vision on (case)
5-fluorouracil due (case)
improved that (mark)
became -- (punct)
patients hypercalcemia (nmod)
invariable hypoglycemia (nsubj)
abusing may (aux)
benserazide ( (punct)
risk reactions (nmod)
testing at (case)
carcinoma neck (compound)
disturbing or (cc)
associated odds (dobj)
slight significant (conj)
purpose transporter (appos)
dox alone (advmod)
use despite (case)
infarction during (case)
class periods (nmod)
studied developing (advcl)
efficacy : (punct)
dehydrogenase activity (conj)
monitoring objective (amod)
increased p75(ntr (dep)
foot his (nmod:poss)
wherein model (compound)
years treatment (compound)
antibiotics with (case)
regimen vtd (compound)
had esrd (dobj)
contributes inhibition (nsubj)
marked . (punct)
hyperactivity hypersensitivity (conj)
two times (quantmod)
similar characteristics (nsubj)
cerebellar cerebrocortical (conj)
bisphosphonates intravenous (amod)
provides , (punct)
inhibited parameters (dobj)
contribution system (nmod)
measure neuropathy (advmod)
temperament hyperthymic (amod)
judged drug (nsubjpass)
signified , (punct)
amnesia produced (acl)
treatment captopril (compound)
requested organization (nmod)
analyzer field (compound)
be contraindication (attr)
and vitro (advmod)
mild on (case)
% interval (appos)
induce damage (dobj)
laboratories the (det)
allele " (punct)
performing when (advmod)
bha % (compound)
fields rheumatology (nmod)
muscle gastrocnemius (compound)
alleviating levodopa (nmod)
heterogeneity due (case)
used control (nmod)
result syndrome (nmod)
re-challenged should (aux)
were significant (acomp)
prevent deterioration (dobj)
disorder or=13.807 (dep)
survived remained (conj)
0.74 , (punct)
number increases (dep)
mice received (acl:relcl)
alter dynamics (dobj)
aid a (det)
mrds ( (punct)
significant with (case)
measurements day (nmod)
clonidine to (case)
recurrent resistant (conj)
receptors glutamate (compound)
acid all- (amod)
figures corresponding (amod)
hypoxia cerebral (amod)
include so (mark)
neurochemical behavioral (conj)
liquids swallowing (amod)
improved have (aux)
motor , (punct)
sum score (nsubj)
rad001 ) (punct)
valsartan (hctz)-monotherapy (conj)
induce turnover (dobj)
ml(-1 r6 (appos)
f and (cc)
derivative methylxanthine (compound)
result been (cop)
micu the (det)
muscle isolated (amod)
hours twenty-three (amod)
gave negative (advcl)
impact subspecialty (nmod)
minimum after (case)
primarily manifesting (nmod)
form regular (amod)
treated licl (nmod)
caused sem (dep)
uptake to (case)
appeared gradually (advmod)
administration contrast (compound)
hyperlipoproteinemias primary (amod)
variables pharmacological (amod)
benzisoxazole a (det)
where from (mark)
benserazide . (punct)
load with (case)
analyzed determine (advcl)
is association (attr)
expressing emotions (dobj)
bladder near (case)
tended conditions (nmod)
recovery prompt (amod)
dilated cisternae (dobj)
eliminated is (auxpass)
reduced densities (nsubjpass)
improve profile (dobj)
had compared (prep)
use continuing (amod)
drugs neuroleptic (amod)
quit drinking (xcomp)
performing review (dobj)
involvement , (punct)
described recently (advmod)
combined t (nmod)
min followed (acl)
bradycardia . (punct)
use wider (amod)
injected rat (nsubjpass)
cr including (case)
gi ( (punct)
include variety (dobj)
sampled were (auxpass)
drug standard (amod)
cancer rr (dep)
average the (det)
used predict (xcomp)
lead diagnosis (nsubj)
norepinephrine ) (punct)
formulations two (nummod)
solution in (case)
1.039 0.001 (conj)
deterioration condition (nmod)
lipid or (cc)
mg 480 (compound)
binding effects (conj)
callosum of (case)
focused . (punct)
group elderly (amod)
agents or (cc)
sera rast (nmod)
6-ohda-lesioned in (case)
mmhg 6 (nummod)
mean comparable (conj)
cells mammalian (amod)
phenomena thromboembolic (amod)
hit exposure (nmod)
ci 1.11 (nummod)
rare aggressive (conj)
report ain (nmod)
scene on (case)
valves prosthetic (amod)
intervals day (compound)
questionnaires was (cop)
sensitization experimental (amod)
recording just (advmod)
cardiomyopathy myocarditis (conj)
revealed observed (dep)
assigned rats (nsubjpass)
migraine aura (nmod)
route central (amod)
decrease latency (nmod)
drug analgesic (amod)
assessed preference (nsubjpass)
strategies for (case)
effect isoproterenol (nmod)
model mouse (compound)
dependent presence (nmod)
induce . (punct)
has consumption (nsubj)
7 3 (compound)
tobramycin of (case)
four eight (conj)
contributing anemia (nmod)
communication : (punct)
recommended before (mark)
disorder gastrointestinal (amod)
indicates suggests (conj)
licl with (case)
attention with (case)
myeloencephalopathy . (punct)
history past (amod)
involved ) (punct)
compounds flavonoids (nmod)
elevated but (cc)
doxorubicin/kg of (case)
administered temocapril (nsubjpass)
activate amphotericin (nsubj)
infarction ischemic (amod)
sensitivity assessed (acl:relcl)
hemorrhage or (cc)
derangements failure (nmod)
proves oxitropium (nsubj)
albino the (det)
detectable . (punct)
treated daily (advmod)
tinnitus subjective (amod)
valves with (case)
propagation ventricles (nmod)
prognosis seizure (nmod)
linked creatine (dobj)
conclusions common (appos)
preparations of (case)
studied using (xcomp)
demonstrate that (nsubj)
incidence studies (nmod)
has disorder (nsubj)
carriers lamivudine-na (amod)
type arteritis (nmod)
hemoglobin modifiable (acl:relcl)
umb24 that (det)
cpb of (case)
recent less (advmod)
induced bromocriptine (nmod)
lactate dextrose (conj)
problems patient (nmod:poss)
veins svc (compound)
used therefore (advmod)
reduced temsirolimus (nsubj)
bile bladder (compound)
derivative i.e. (advmod)
interfere could (aux)
800 to (dep)
uteri the (det)
treated insertion (nmod)
postulate increased (ccomp)
segments basal (amod)
concentration cocaine (compound)
macrolides newer (amod)
bun and (cc)
space epidural (amod)
test 480-mg (compound)
method given (appos)
g , (punct)
likely expression (nsubj)
given d-1 (nsubj)
areas on (case)
individuals 3154 (nummod)
shr not (neg)
scopolamine , (punct)
reversed dce (nsubj)
5 that (dep)
wakefulness physical (conj)
bmcs ( (punct)
conversion late (amod)
levels prolonged (amod)
fractionated the (det)
stage either (cc:preconj)
chromosome donor (dep)
didanosine ceasing (amod)
assessed levels (nsubjpass)
remained analysis (nmod)
g/day 2.76 (nummod)
tetany and (cc)
urtication and (cc)
proportion % (appos)
dysfunction neurotransmitter (amod)
sites for (case)
enhanced persons (nmod)
abolished totally (advmod)
role mediator (nmod)
withdrawal sedative-hypnotic (amod)
group epinephrine-treated (amod)
levels beta-ar (amod)
induction cc (nmod)
mediated a-i (nmod)
using enable (advcl)
concluded was (auxpass)
nadir , (punct)
involvement reactivity (nmod)
concentrations mg (nmod)
administered dermally (advmod)
children for (case)
expressing diameters (dobj)
received rad001 (dobj)
used tablet (dobj)
delay temporal (amod)
47 to (case)
accompanies that (nsubj)
present , (punct)
hypertension 1 (nummod)
indicated and (cc)
374 and (cc)
indicates study (nsubj)
adefovir analogues (nsubj)
treatment hds (nmod)
hyperammonemic of (case)
open , (punct)
activate disruption (nmod)
showed protected (conj)
methoctramine pirenzepine (conj)
point end (compound)
questionnaire use (compound)
78 ( (punct)
reduces inhibition (nsubj)
% 5.6 (dep)
greater rise (nsubj)
method description (dep)
protect neurotoxicity (nmod)
inhibition 50 (nummod)
november 1997 (nummod)
found safe (xcomp)
n-butyl-deoxynojirimycin sc-48334 (appos)
f(3,762 ) (punct)
advantageous those (nmod)
behaviour the (det)
protect to (mark)
studies conventional (amod)
blood venous (amod)
arrest respiratory (amod)
1.03 0.60 (dep)
levels synapse (nmod)
regimen tolerable (amod)
tmax 11.33 (dep)
evaluation ; (punct)
therapy these (det)
treatment cholestasis (conj)
oct vehicle (conj)
60 approximately (advmod)
incidence overall (amod)
decreases output (nsubj)
models reserpine- (nsubj)
markers angiogenesis (compound)
synergy morphine (nmod)
m(1)-selective ( (punct)
dosage oxitropium (nmod)
wide-range biological (nmod)
evaluates profile (dobj)
regimen selection (compound)
1.210 1.063 (compound)
pretreatment despite (case)
incidence reduced (amod)
cortex dorsal (amod)
practical although (mark)
use prophylactic (amod)
converting inhibition (dobj)
mg/kg orally (amod)
smaller was (cop)
preference depending (case)
patients pressure (nmod)
none with (case)
remained low (xcomp)
criteria trials (dep)
compromises outcomes (dobj)
dox by (case)
animal and (cc)
action respiratory (amod)
shock . (punct)
limb and (cc)
form after (case)
neurons adrenergic (amod)
indicated has (aux)
nicotine kg(-1 (appos)
accounted for (dep)
women undergone (acl:relcl)
damage induced (amod)
persisted developed (conj)
200 and (cc)
chromatography liquid (amod)
decrease rats (nmod)
sodium potassium (appos)
10 30 (conj)
delineated yet (advmod)
injection hexamethonium (conj)
y-mrs ( (punct)
agent trials (nmod)
growth with (case)
69 22 (compound)
protection environmental (compound)
summarizes alleviate (advcl)
matched children (nmod)
changes relative (case)
parameters studied (amod)
salicylates dose (compound)
viracept who (nsubj)
receptor neurotensin (compound)
diabenese ( (punct)
gene and (cc)
treatment 4-week (compound)
causes promotes (conj)
levels fluid (compound)
effects function (nmod)
avoid can (aux)
doxorubicin due (case)
testing field (compound)
txa high-dose (amod)
indicates use (nmod)
cortex cerebral (amod)
ischemia spasm (nmod)
dogs control (compound)
necrosis zones (nmod)
admitted rest (nmod)
reasons seizures (nmod)
sensitive resistant (xcomp)
ph 1.2 (nummod)
complication toxicity (nsubj)
side-effects with (case)
tachycardia reversed (amod)
affect involve (advcl)
relationship use (nmod)
extraction data (compound)
underwent angiography (dobj)
activity cardiotoxicity (conj)
lasting hours (nmod)
presented side-effects (nmod)
antagonists . (punct)
patients be (cop)
dysfunction psychobiological (amod)
similar showed (parataxis)
incidence induction (conj)
area opposite (amod)
retardation tremors (nmod)
lca than (case)
intravenous high-dose (amod)
inventory , (punct)
sustained symptomatic (dep)
receptor-alpha by (case)
free % (nsubj)
pointes due (case)
rats n=6 (appos)
infarction myocardial (amod)
palsy of (case)
sedation mg (appos)
30 . (punct)
bis(p-nitrophenyl ) (punct)
attributed mainly (advmod)
present incident (dobj)
nanoparticles tween (compound)
transplantation cardiac (amod)
kilogram weight (nmod)
hz of (case)
significant 0.05 (dep)
depleted opening (nmod)
common toxicity (nsubj)
ci 0.90 (nummod)
patients organic (amod)
received injections (dobj)
artesunate injectable (amod)
evoked visual (amod)
% score (nmod)
urea compared (case)
mwm ) (punct)
patients methyl (amod)
administration exogenous (amod)
fev1 predicted (acl)
plasticity disease (nmod)
however in (case)
nephrotoxicity antibiotics (nmod)
personnel military (amod)
ought faced (advcl)
mg/dl bun (conj)
drugs immunosuppressive (amod)
genes its (nmod:poss)
patients 1223 (nummod)
phenytoin intravenous (amod)
diet normal-sodium (amod)
neurotoxin the (det)
undergoing angioplasty (dobj)
observed controls (nmod)
histochemistry nadph-d (compound)
calculi ureteric (amod)
lesions structural (amod)
feature -- (punct)
caucasian , (punct)
four nucleus (nmod)
rupture globe (compound)
memory p=0.026 (appos)
thrombosis patients (nmod)
useful pilocarpine (nsubj)
removal body (nmod)
affinity , (punct)
induced ketoconazole (nsubj)
sensitivity specificity (dep)
nucleotide-gated 2 (dep)
20.95 2.21 (conj)
disorientation irritability (conj)
was administered (conj)
amplitude as (case)
vehicles repeatedly (amod)
levels argatroban (nmod)
issues , (punct)
help using (xcomp)
ie ) (punct)
necrosis ; (punct)
provides approach (nsubj)
were cells (attr)
mediation formation (nmod)
result chemotherapy (nmod)
leads , (punct)
mechanism injury (nmod)
best is (cop)
assessed on (dobj)
neurocognitive sleep-related (conj)
arabic with (case)
induced capsaicin (nsubj)
categorized were (auxpass)
forestomach , (punct)
kept should (aux)
problematic . (punct)
associated compared (prep)
was levels (nmod)
effect inhibition (nmod)
difference outcome (nmod)
obesity resistance (conj)
felt cause (xcomp)
week 8 (nummod)
hypercalcemia with (case)
represents that (mark)
coefficient ; (punct)
assessed methods (nmod)
spontaneous or (cc)
less increases (nsubj)
2-adrenoreceptor vascular (amod)
synthesis demonstrates (dep)
affected transmission (nsubjpass)
upper-extremity bilateral (amod)
statin of (case)
process evaluation (compound)
prevented pain (nsubjpass)
38 - (punct)
review effects (nmod)
goldstein ( (punct)
% 56.9 (nummod)
dyskinesia lid (appos)
at 30 (dep)
girl treated (acl:relcl)
obtained pharmacists (nmod)
nephrin podocin (conj)
decrease frequency (dobj)
alf ) (punct)
trimester until (case)
epilepsy with (case)
compartment the (det)
concentrations epo (nmod)
metaiodobenzylguanidine mibg (appos)
glands in (case)
presumed subgroups (nsubj)
granules , (punct)
assigned patients (nsubjpass)
this despite (case)
illustrate associated (ccomp)
alleviation edaravone (nmod)
hemodynamic and (cc)
treatment cbdca (compound)
co-administration 2-sulfanylethanesulfonate (nmod)
death against (case)
clonidine antisympathetic (amod)
recommended dexrazoxane (nsubjpass)
treated who (nsubjpass)
iopamidol contrast (compound)
gaba low (amod)
diffusion quantitative (amod)
or(adj with (case)
h within (case)
differences pattern (nmod)
absences of (case)
d-med dg-5128 (conj)
encouraged . (punct)
discontinuation measures (nmod)
monkeys 11 (nummod)
address thus (advmod)
inhibited furthermore (advmod)
symptoms 27 (nummod)
immobility of (case)
inhibited growth (dobj)
att and (cc)
defend organs (dobj)
accompanied creatinine (conj)
evidence light (amod)
production treatments (nmod)
uveitis jra (conj)
northern california (conj)
rs6693503 ) (punct)
associated decrease (nsubjpass)
regimen combined (amod)
performance facial (amod)
postulated , (punct)
had had (aux)
mg/kg more (conj)
implanted dorsum (nmod)
strokes hemorrhagic (amod)
variation show (compound)
introduced kingdom (nmod)
endothelial-mesenchymal-transition endomt (appos)
worsening neurological (amod)
increase sn (nmod)
study controlled (amod)
modulate drugs (nsubj)
observed disorder (nsubjpass)
effects similar (amod)
gliomas of (case)
safety their (nmod:poss)
sites to (case)
release hippocampal (compound)
planned weeks (nmod)
hypotension by (case)
showed mumol/kg (nsubj)
cgi-sf for (case)
0.08 versus (cc)
anemia by (case)
withdrawal pyrazinamide (compound)
improving failure (dobj)
alpha 1/2 (nummod)
p<0.01 all (nmod)
reports symptoms (nmod)
attenuated was (auxpass)
therapy clearance (conj)
vasculitis : (punct)
damaged that (nsubjpass)
explained which (nsubjpass)
protein crp (appos)
exposures cigarette (compound)
accelerate may (aux)
upregulation through (case)
reduce prior (advmod)
susceptibility system (nmod)
disrupts triad (dobj)
doses artery (nmod)
had difficulty (dobj)
clonic tonic (amod)
attack subjects (appos)
death effect (appos)
g/min ) (punct)
study phase (compound)
stopping selegiline (dobj)
summarized . (punct)
5.5 2.3 (conj)
smoked mean (dobj)
marketed agent (nmod)
database from (case)
electrodes 240 (nummod)
important that (nsubj)
palpation nodule (nmod)
motionless flaccid (conj)
indicators regions (nmod)
cs of (case)
studied cells (nmod)
ensure protection (dobj)
weeks 16 (nummod)
occur that (mark)
using scale (dobj)
theophylline such (case)
combining dexrazoxane (dobj)
lipid rna (conj)
toxicity limiting (compound)
edema brain (compound)
therapy b (compound)
induced incidence (nmod)
ces-d the (det)
had dyskinesia (nmod)
given is (auxpass)
revealed indicating (advcl)
cases complications (nmod)
injected day (nmod:tmod)
points . (punct)
hyperthyroidism of (case)
produced doses (nsubj)
benign a (det)
c2 iv (nummod)
activations the (det)
mice control (amod)
disability without (case)
e. of (case)
somnolence increased (amod)
increased women (nsubj)
ph hg (appos)
disorders effects (nmod)
stability cardiovascular (amod)
follow-up biannual (amod)
concentration 6-hr (amod)
seizure animals (nmod)
measurements due (case)
emerged deterioration (nmod)
recurrent glioma (dep)
5.1 - (punct)
hypothesis by (case)
evidenced absence (nmod)
followed dex (nmod)
haloperidol antagonist (conj)
objective subjective (conj)
criteria diagnostic (amod)
greater s (nmod)
account vpa (nmod)
maintained discontinued (advcl)
renal followed (dep)
potentiated chick (nmod)
marrow hypocellular (amod)
metabolites phenol (compound)
conclusion difficult (dep)
newspaper , (punct)
studied induction (nmod)
ototoxicity animal (nmod)
allowed method (nsubj)
acetaminophen tetrachloride (conj)
noted concordance (nsubjpass)
drug by (case)
those symptom-free (acl:relcl)
we only (appos)
received wr242511 (dobj)
cb as (case)
haloperidol days (nmod)
fluoxetine sertraline (conj)
precede anticipated (advcl)
200 1000 (prep)
tincture crataegus (nmod)
(bcnu)-induced carmustine (nmod:npmod)
inhibited ethanol (nmod)
7.54 4.83 (conj)
activity enos (compound)
effects treatments (nmod)
lost and (cc)
effects aminophylline (nmod)
14 ) (punct)
reduced affected (parataxis)
x 39 (compound)
substrate as (case)
undergo . (punct)
had reduction (dobj)
dependent this (nsubj)
areas heparin (compound)
head by (case)
prophylaxis 7 (conj)
true migraine (nmod)
tool to (mark)
clonidine agonist (appos)
plasma by (case)
microl p=0.015 (appos)
benzamide a (det)
cases syndrome (nmod)
meningioma metastases (conj)
pathway leading (acl)
mg/kg weeks (nmod)
output concentration (conj)
membranes membranes (conj)
effect if (appos)
hbv in (case)
% superior (advcl)
treatment hydrocortisone (nmod)
agonists acting (amod)
umb24 or (cc)
syndrome uremic (compound)
patients women (nmod)
range 76 (nummod)
attributable secondary (dep)
extract with (case)
learning attention (conj)
horn in (case)
cases 71 (nummod)
noted was (auxpass)
rate 18-month (amod)
bp in (case)
gain abnormal (amod)
pfs os (conj)
inhibitor ( (punct)
food and (cc)
2002 in (case)
admitted man (nsubjpass)
frequencies hit (nmod)
inadequate definitive (xcomp)
excretion kidneys (nmod)
antimicrobials to (case)
done conduction (nsubj)
range 3.5 (dep)
with mannitol (conj)
sampled percentage (nsubj)
disturbance secretion (nmod)
effects bupropion (nmod)
recall immediate (amod)
leading event (nmod)
administration regarding (case)
showed increased (parataxis)
reliability about (case)
causes but (cc)
modification further (amod)
assessed responses (nsubjpass)
5-azc ) (punct)
exhibited tissues (nsubj)
kg-1 glycopyrrolate (compound)
obtained studies (nmod)
signs inflammation (nmod)
initiated drug (nsubjpass)
similar prolonged (conj)
severely more (advmod)
discussion tachyarrhythmia (dep)
phosphorylation and (cc)
time precedes (acl:relcl)
parameters the (det)
period 16-month (amod)
type surgery (nmod)
treatment leukemia (nmod)
bacteremia methicillin-sensitive (amod)
insufficiency on (case)
completing after (case)
predicted . (punct)
effects unfavourable (amod)
scale revised (appos)
days on (case)
interval headache (compound)
had black (conj)
expression vegf (nmod)
hypertension model (nmod)
withdrawal with (case)
opioid effects (nmod)
associated aging (nmod)
technique slot-blot (amod)
influence of (case)
decreased since (mark)
potential action (compound)
microl . (punct)
sleep afternoon (compound)
treatment all (compound)
made findings (nmod)
subjected . (punct)
case had (acl:relcl)
decreased mmhg (dobj)
collected histological (nmod)
comparison labetalol (nmod)
mg/m(2 preceded (acl)
function rat (nmod)
analysed signed (conj)
dystonia oromandibular (amod)
prolongation for (case)
models reticulata (dep)
118 +/- (cc)
resolved jaundice (nsubj)
bipolar ii (nummod)
susceptible highly (advmod)
treated lamotrigine (nmod)
appears though (mark)
showed events (dobj)
development schizophrenia (nmod)
excluded involvement (nsubjpass)
performed measurements (nsubjpass)
reduced symptoms (dobj)
remains neurotoxicity (nsubj)
variance of (case)
magnitude increase (appos)
test acid-induced (amod)
presented pain (nmod)
patients every (det)
cr % (dep)
climate hot (amod)
collagenase by (case)
genes pparalpha (compound)
impacts inhibitory (amod)
high resulted (conj)
cells form (acl:relcl)
morbidity serious (amod)
discussion aids (dep)
prolapse with (case)
administered offspring (conj)
dropped , (punct)
patients diagnosed (acl)
studied histologically (advmod)
subscores akinesia (nmod)
reduction prevention (conj)
treated oxacillin (nmod)
induce could (aux)
clonazepam of (case)
range saturations (conj)
experienced episodes (dobj)
contribution a (det)
intrathecal it (dep)
placebo n=100 (appos)
features with (case)
emerged marker (nsubj)
remained globulin (nsubj)
death induced (acl)
cohort , (punct)
markers htr6 (nmod)
use heparin (nmod)
prevented glomerulosclerosis (dobj)
reduced predominantly (advmod)
contain fs (nsubj)
use inhibitors (nmod)
charge adenylate (amod)
antagonist agonist (conj)
pathway jak/stat3 (amod)
took regimen (nmod)
7.7 1.5 (conj)
catalepsy haloperidol (compound)
caused , (punct)
mu 6 (nummod)
difference product (nmod)
studied function (nsubjpass)
episodes thrombotic (amod)
enhancement bradycardia (nmod)
implications and (cc)
effects relaxant (amod)
in all (dep)
derivative nefiracetam (nsubj)
treated phz (nmod:npmod)
associated paralysis (nmod)
conclusion reverse (appos)
study health (compound)
dose gnc92h2 (nmod)
apparent though (mark)
intermediate chronic (conj)
nin ) (punct)
platform the (det)
relapse symptoms (nmod)
induction doses (nmod)
monotherapies ) (punct)
developed he (nsubj)
cases acetate (nmod)
pretreatment minutes (nmod)
core accumbens (compound)
symptoms cns (compound)
reduced had (conj)
action methyldopa (nmod)
nifedipine to (case)
deterioration no (neg)
half n (dep)
beclin of (case)
effect that (nmod)
stroke after (case)
has recognition (nsubj)
nondepolarizing due (mark)
f(33 risperidone (appos)
caused more (advmod)
discontinued level (nsubjpass)
status stable (amod)
had fraction (dobj)
disorders are (cop)
bupivacaine plasma (compound)
illustrates consequences (dobj)
state as (case)
outpatients associated (acl)
recognized tma (nsubjpass)
dysfunction for (case)
tight particularly (advmod)
vpa with (case)
poison ci-921 (nsubj)
rats cocaine-injected (amod)
disorders psychotic (amod)
peroxidation tissue (compound)
mmhg 17 (compound)
cause neuropathy (nmod)
absence arousal (nmod)
impaired substitution (nsubj)
point genetic (amod)
apnea as (case)
practices hampshire (nmod)
changed saline (nmod)
pmol 5.458 (nummod)
levels hypothalamic (amod)
hoehn and (cc)
combinations sub-effective (amod)
neutropenia of (case)
monitor nephrotoxicity (dobj)
improved patients (nsubj)
lower prevalence (nsubj)
nimodipine n=94 (appos)
target kinase (nmod)
force with (case)
mineralocorticoid salt (conj)
isolated was (auxpass)
prevented anemia (nsubjpass)
conduction first (appos)
hydroxylase of (case)
outcomes multicenter (appos)
seizures and (cc)
111.0 and (cc)
angiography with (case)
year to (case)
similar control (nmod)
excluded was (auxpass)
tolerated better (advmod)
confirm or (cc)
reactions their (nmod:poss)
bind ngf (dobj)
concentration sfas (nmod)
subchronic haloperidol (dep)
8-week , (punct)
persists stopping (advcl)
expression sensitivity (conj)
esterification by (case)
lithium antipsychotic (appos)
anaesthesia surgery (conj)
translocation check (dep)
ameliorated occurred (conj)
tmp to (case)
animals male (amod)
cigarettes low (amod)
advanced of (case)
biopsies 5 (nummod)
infusion lactate (nmod)
designed aim (nmod)
54 5 (conj)
received either (advmod)
pharyngitis of (case)
epilepticus ncse (appos)
chloramphenicol applied (amod)
minutes later (advmod)
study study (nsubj)
suggests abruptness (nsubj)
element hypoxia-responsive (amod)
poisoning yellow (amod)
switched users (nsubjpass)
phosphatase . (punct)
mg 73.6 (nummod)
potency in (case)
obtained methods (dep)
testing before (case)
mg/kg 400 (nummod)
calculi renal (amod)
mg/kg value (nsubj)
hypertension 31 (nummod)
applied we (nsubj)
consistent findings (nsubj)
tests two (nummod)
effect stimulant (amod)
therapy when (advmod)
sufficient result (xcomp)
valve toxicity (dobj)
ligation digitalis (conj)
followed injection (dobj)
switched assigned (conj)
lidocaine ) (punct)
test olr (appos)
half-life t1/2 (appos)
role agent (nmod)
discontinuation sirolimus (nmod)
antagonists receptor (compound)
born term (nmod)
restored cholecystokinin-octapeptide (nsubj)
evaluated dressing (advcl)
damage oxidative (amod)
csa acute (amod)
dose-dependent and (cc)
antagonists h1 (compound)
mg/kg hour (appos)
receptors calcitonin (compound)
0.2 2.5 (conj)
restricted response (nsubj)
antagonized that (mark)
kb ctgf (conj)
severe partial (conj)
changes symptoms (conj)
gammapathy with (case)
controlling % (nmod)
wane year (nmod)
maintained fentanyl (nmod)
medetomidine of (case)
chain mitochondrial (amod)
assumption the (det)
made assessments (nsubjpass)
steroid receptor (dep)
furosemide with (case)
giving diet (dobj)
scl and (cc)
analyzed composition (nsubjpass)
has ( (punct)
problems significant (amod)
seeing : (punct)
frequencies range (nmod)
number peroxisomes (nmod)
re-examine to (mark)
nigra in (case)
involvement effects (nmod)
1.68 was (cop)
undergoes tolerance (dobj)
3 than (quantmod)
analysis case-controlled (amod)
frequent complications (nsubj)
61 2 (conj)
reality a (det)
effective alleviation (nmod)
observation by (case)
signs 200 (nummod)
site gaba(a (compound)
lipophages indicative (conj)
found previously (advmod)
70 50 (compound)
included anticoagulants (dobj)
treat humans (nmod)
role into (case)
system exo (compound)
assay mapping (compound)
% 85.4 (nummod)
was object (nsubj)
mg 0.13 (nummod)
produce benefit (dobj)
commissure-commissure both (cc:preconj)
evaluated replies (nmod)
analyzed mrnas (nsubjpass)
negroes in (case)
tolerated pg (dobj)
pharmacon of (case)
months twelve (nummod)
amphotericin setting (nmod)
patients no (det)
instances hematuria (nmod)
leading hypertension (nmod)
treatment years (nmod)
component for (case)
downregulates i1-receptor-mediated (conj)
nucleotide-gated hcn4 (conj)
age or (cc)
temperature humidity (conj)
observations and (cc)
density formation (nmod)
symptoms cholinergic (amod)
developed presented (advcl)
provided that (nsubj)
groups a (dep)
restlessness change (conj)
shown interaction (dobj)
surgery middle-ear (amod)
presented justification (nsubjpass)
10+/-1 15+/-1 (compound)
mechanisms acid-mediated (amod)
treatment sarcoma (nmod)
intensity increased (amod)
treated orally (advmod)
receptors 2c (compound)
switched was (auxpass)
nuclei son (appos)
nk1 of (case)
hypoglycaemia induced (amod)
inhibition bcnu-induced (amod)
unpleasant is (cop)
transplantations , (punct)
out-patients new (amod)
responsiveness preoperative (amod)
abnormalities pupillary (amod)
woman setting (nmod)
denervation a (det)
pale case (nmod)
2-receptors be (cop)
remained whereas (mark)
nascis the (det)
toxicity peripheral (amod)
dex-treated in (case)
assay nick (amod)
therapy dexamethasone (compound)
agonists 2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine (appos)
anesthetics general (amod)
interval icterus (compound)
isolated venom (nmod)
twitches head (nsubj)
removed analysis (nmod)
regulation autonomic (amod)
linked , (punct)
organochlorine an (det)
showed induced (ccomp)
neurotoxicity 1990s (nmod)
continued patients (nsubj)
dosage the (det)
antrum thickened (amod)
failed tdr (nmod)
defined cin (nsubjpass)
inhibitors well-known (amod)
surgery subgroups (conj)
affected neutropenia (nmod)
affected sites (nsubjpass)
clonidine response (dep)
findings preliminary (amod)
had . (punct)
depends urgency (nmod)
minimal and (cc)
induction the (det)
factors as (case)
twitching facial (amod)
convulsion of (case)
purpose lead (dep)
occlusion retinal (amod)
switch , (punct)
placebo minutes (nmod)
groups values (nmod)
similar bp (nsubj)
guidelines with (case)
out-patients out-patients (nmod)
erythron of (case)
combination paclitaxel (nmod)
men the (det)
microg/kg ) (punct)
suspected patients (nsubjpass)
proved recurrence (nmod)
noncompliance ) (punct)
noncompliance choosing (advcl)
fs of (case)
impair but (cc)
ps intravenous (amod)
mapped organization (nsubjpass)
assessed were (auxpass)
identified concentration (nsubjpass)
subjects n (dep)
thought affect (xcomp)
intake high (amod)
occurs vomiting (nmod)
crossed over (compound:prt)
potency prevent (acl)
weight birth (compound)
indication another (det)
induce exposure (nsubj)
exacerbated and (cc)
receptors main (amod)
handful a (det)
followed change (nmod)
suggests although (mark)
progressively from (case)
seems everolimus (nsubj)
daily least (advmod)
gender possibly (advmod)
polydipsia polyphagia (conj)
polymorphism gene (compound)
anastrozole n=94 (appos)
flumazenil by (case)
develop polymyositis/dermatomyositis (nsubj)
identify given (advcl)
countries other (amod)
rate of (case)
designed answer (xcomp)
rats polyuria (nmod)
changes same (amod)
variety , (punct)
killed later (advmod)
hypotension p (dep)
less that (nmod)
decade past (amod)
assessment pre-operative (amod)
represent targets (dobj)
correlated defect (nsubj)
cn ) (punct)
treatment intermittent (compound)
week therapy (nmod)
group normal (amod)
azimilide micromol/l (appos)
reflexes through (case)
levels observed (acl)
side-effects , (punct)
chance developing (advcl)
obtunding of (mark)
lesion pulmonary (amod)
considered administered (advcl)
coma myxedema (compound)
irritability withdrawal (conj)
centre target (nmod)
time overall (amod)
number disturbances (nmod)
trials phase (compound)
tilts s (nmod)
fulfilled . (punct)
exposed utero (nmod)
lower though (mark)
hoe ) (punct)
indicates factors (ccomp)
blue evans (compound)
using pupillometer (dobj)
associated increase (nsubjpass)
p<0.01 , (punct)
blocker atropine (conj)
greater control (conj)
evaluates attempting (advcl)
considered nephropathy (nsubjpass)
performed months (nmod)
matrix and (cc)
trated . (punct)
found cases (dobj)
rhythms patients (nmod)
preference a (det)
focus with (case)
locomotion mk-801-induced (amod)
threshold seizure (conj)
highlighting , (punct)
contributed considered (conj)
comprise responsible (advcl)
thrombo-embolism disease (appos)
events vnr (compound)
nodal tissue (conj)
pretreated insult (nmod)
size the (det)
transferred chromosome (nsubjpass)
conclusion determination (appos)
heart rat (compound)
relationships structure-activity (amod)
influenced toxicity (nmod)
samples hour (compound)
n=92 , (punct)
dyskinesias drug-induced (amod)
review database (nmod)
effort the (det)
well-tolerated . (punct)
ended recruitment (nsubj)
medium nonionic (amod)
applied immediately (advmod)
test sampled (amod)
based is (auxpass)
paraventricular in (case)
mg/m2 2250 (nummod)
hallmark is (cop)
= 4.92 (dep)
u/l 220 (nummod)
antagonism muscarinic (compound)
mouse in (case)
determine prevalence (dobj)
studied year (nmod)
cause underlying (amod)
measured series (nmod)
infarction : (punct)
animals given (acl)
selective beta-blocker (dep)
physicians prescribe (acl:relcl)
remitted it (nsubj)
attribute illicit (advcl)
developed prompted (conj)
electrophysiology electroretinography (nmod)
markers evaluate (acl:relcl)
administering mesna (dobj)
atrophy chorioretinal (amod)
based results (nsubjpass)
generically and (cc)
revealed stratification (nsubj)
bf-dependent were (cop)
ventricles cats (nmod)
data unlike (case)
catalepsy leaves (conj)
pcc human (amod)
model amnesia (nmod)
advised abortion (nsubjpass)
vasoconstriction in (case)
classified types (nmod)
smoker female (amod)
calculated mtd (nsubjpass)
protein can (aux)
indicating prevented (ccomp)
system administration (nmod)
anticonvulsants lithium (compound)
ctc-nci 36.4/6.1/3.0 (appos)
studied variation (nsubjpass)
reduces amn082 (nsubj)
cavity of (case)
synthesis ngf (compound)
chorea amphetamine-induced (amod)
ami ( (punct)
associated expression (nmod)
stimulation enac (nmod)
cells hilar (amod)
administered days (nmod)
amide of (case)
reduced hypotension (nmod)
made dogs (nmod)
produced pituitaries (dobj)
induced streptozocin (nmod)
alterations severe (amod)
ischemia with (case)
suffering epilepsy (nmod)
cognitive functional (conj)
% 9.9 (nummod)
appeared as (mark)
denopamine agonist (appos)
sites sulphate-associated (amod)
treatment invasive (amod)
damage levels (conj)
modulation nmdar (nmod)
that so (case)
reports individual (amod)
rnfl to (case)
recalled word (nsubj)
rate defined (acl)
treatment without (conj)
appears obvious (xcomp)
rebleeding patients (nmod)
sah of (case)
beating , (punct)
psychosis for (case)
impaired perception (nsubj)
hyperactivity the (det)
effect drug (nmod)
lactate and (cc)
86.2 +/- (cc)
1.195 to (dep)
administered infusions (nsubjpass)
alterations molecular (amod)
mediated dopamine (nmod)
patients = (dep)
prevention events (nmod)
mention no (det)
method salbutamol (amod)
controls from (case)
rr ci (appos)
compared results (nmod)
overloading to (case)
ill be (cop)
anaemia and (cc)
14.9 +/- (cc)
gastrocnemius ) (punct)
seven % (appos)
appear suggests (conj)
function hippocampal (amod)
ich events (dep)
show year (nmod)
considered induction (nsubjpass)
extracted data (nsubjpass)
test an (det)
evidence hepatitis (nmod)
efficacy antitumor (compound)
hypoxia . (punct)
group affected (amod)
anemia microangiopathic (amod)
5-azc ( (punct)
long-term ( (punct)
compare effects (dobj)
measures two (nummod)
support are (cop)
angiogenesis tumor (compound)
involved processes (nmod)
reported complication (dobj)
proving comparably (advmod)
involvement selective (amod)
escalated tolerated (advcl)
reported development (nsubjpass)
63.5 - (punct)
block receptors (dobj)
stages earlier (amod)
mris follow-up (amod)
surgery/radiotherapy radical (conj)
proteins target (compound)
volume levels (conj)
length parameters (conj)
aspirin on (case)
hyperglycemia in (case)
product a (det)
years women (nmod)
k+ k(atp (appos)
aware diagnosis (nmod)
exposure intrathecal (nmod)
demonstrated as (mark)
analog ne (appos)
temperature and (cc)
observed significant (conj)
ccr2 these (det)
appreciated it (nsubjpass)
compared rbcs (nmod)
27 and (cc)
included third-generation (nmod)
reduction cytopenia (nmod)
disease shr (nmod)
increased exhaustion (nsubj)
hypotension humans (nmod)
d2 or (cc)
frequent rhythms (nsubj)
hypoplasia with (case)
microgram/kg followed (acl)
dox cardiomyopathy (acl)
leads . (punct)
hyperalgesia/myoclonus and (cc)
consistent experiment (nmod)
extent same (amod)
exposure dose (nmod)
definitive effect (nmod)
propranolol b (conj)
increase groups (nmod)
haemopericardium and (cc)
41.66 +/- (cc)
intake drug (nmod)
dogs ventilated (amod)
nephrotoxicity anemia (conj)
effect contributing (acl)
myopathies cardiac (amod)
fell completed (advcl)
gd gd (nmod)
reduced [ca(2+)](i (dep)
treatment enzyme (compound)
penicillins , (punct)
irritation local (amod)
practitioners kingdom (nmod)
0.75 ) (punct)
was unchanged (advcl)
conducted laboratories (nmod)
pentetrazol ptz (appos)
activity pilocarpine- (nmod)
polyglutamates 3717 (nummod)
answer to (mark)
hyperosmolar nonketotic (conj)
stability postural (amod)
inhibitors of (case)
challenge rodents (nmod)
reported children (nmod)
abundant cells (nmod)
january to (case)
aminophylline particularly (advmod)
syndrome rls (appos)
collected records (nmod)
cacl(2 to (case)
abilities basis (nmod)
paced which (nmod)
2nd as (case)
believe affected (ccomp)
characteristics and (cc)
association such (predet)
infusion 1-hour (compound)
relationship with (case)
% dietary (amod)
formulation sustained-release (amod)
evoked before (advmod)
area at (case)
occurred stabilization (nsubj)
time rats (nmod)
cells within (case)
represent may (aux)
infusion [3h]-l-arginine (nmod)
immunosuppressants the (det)
indicator damage (nmod)
il-1 paf (conj)
illness by (case)
fibres surviving (compound)
potential due (case)
required generation (nmod)
median day (nmod:tmod)
antibody an (det)
seizures receptors (conj)
observed ascites (nsubjpass)
showed inhibition (dobj)
angioplasty percutaneous (amod)
levels kinase-1 (compound)
cancers ovarian (amod)
raclopride the (det)
as to (mwe)
attenuates and (cc)
supports assumption (dobj)
action protective (amod)
causing patient (nmod)
improvement slow (amod)
correlates timing (nmod)
is only (advmod)
gtn dcf (dep)
allow could (aux)
days ml/kg (nmod)
abnormalities : (punct)
resolved that (nsubj)
undergoing and (cc)
found rara (nmod)
evaluated which (nmod)
administered clinically (advmod)
enhances effects (dobj)
caused penicillamine (nmod)
lower value (nmod)
naloxone in (case)
testing visual (amod)
80 vs. (cc)
support conclusion (dobj)
improvement surgery (nmod)
infection tract (compound)
treatment behaviors (nmod)
allowed investigating (xcomp)
disruption mice (nmod)
intradermoreactions idr (appos)
presents with (prep)
stimulant increases (acl:relcl)
weeks 5 (nummod)
therapy blocker (compound)
report we (nsubj)
pan of (case)
cross-tolerance morphine (nmod)
majority population (nmod)
allergies drug (compound)
tbm the (det)
lamivudine the (det)
convulsions at (case)
4.2 ( (punct)
activity ornithine (compound)
increased clonidine (nmod)
100 600 (conj)
amphetamine-free , (punct)
inhibition net (nmod)
have cardiotoxicity (nmod)
tablets weeks (nmod)
cases bilateral (amod)
pulsatile secretion (dobj)
fed , (punct)
mediated catalepsy (nsubjpass)
= 0.044 (dobj)
points reflecting (xcomp)
occurred associated (conj)
0.007 , (punct)
hypertrophy of (case)
diseases neurodegenerative (amod)
neuropathy of (case)
caused sustained (conj)
regimen in (case)
myofilaments and (cc)
previous injections (nmod)
pathogenesis treatment (conj)
strategies treatment (compound)
cases reported (advcl)
values < (compound)
concentration fibrinogen (compound)
dermatitis associated (acl)
amphetamine greater (amod)
lead slowing (nmod)
induced stz (nmod:npmod)
cisplatin patients (nsubj)
66.9 /-14.4 (conj)
76 stopped (acl:relcl)
extension ; (punct)
duration treatment (nmod)
bmt following (case)
uneventful but (cc)
27.1 - (punct)
lacking is (aux)
tablet with (case)
2.31 to (case)
cost low (amod)
mainstay have (aux)
cck-5 ( (punct)
cp microg/side (appos)
cases siat (nmod)
bis ) (punct)
canaliculi outline (compound)
bonding hydrogen (compound)
mitochondria not (neg)
minimally only (advmod)
reduced , (punct)
detected shunt (nsubjpass)
13 eight (compound)
risk use (conj)
fibers afferent (amod)
increased whereas (mark)
administration regimen (nmod)
stomatitis ( (punct)
ae ( (punct)
added valproate (xcomp)
retrieval the (det)
15.5 21.5 (conj)
consider intensivists (nsubj)
msdbp ] (punct)
preparedness reactions (nmod)
occurred tachycardia (nsubj)
antagonize potentiate (conj)
prompted study (xcomp)
measured vivo (advmod)
involved progression (nmod)
killed dose (dep)
patients mazindol-treated (amod)
proposed applied (advcl)
contributed seizures (nmod)
revealed linked (ccomp)
method using (acl)
drug cardioprotective (amod)
plasma lipids (conj)
suggest results (nsubj)
random-assignment a (det)
injuries , (punct)
activity protein (nmod)
use woman (nmod)
eliciting in (mark)
action pathway (nmod)
version . (punct)
immersed which (nmod)
tubules proximal (amod)
weakness muscular (amod)
administered mice (nsubjpass)
drugs neuromuscular (amod)
have might (aux)
involved outcome (nmod)
uncertain taken (conj)
myocarditis caused (acl)
activity group (nmod)
diagnosis at (case)
calculated we (nsubj)
ability remoxipride (nmod)
altering action (dobj)
patients hypokalemia (nmod)
mechanisms cytostatic (amod)
observed receiving (advcl)
examined days (nmod:tmod)
wr242511 mhb (appos)
respond parturients (nsubj)
myelitis and (cc)
prodrug liver-targeting (amod)
characteristics reaction (compound)
indicating related (ccomp)
received bromocriptine (dobj)
effective terminate (xcomp)
115 from (case)
rate x/minute (dep)
calculus another (nmod)
dp/dt(max ) (punct)
signaling such (case)
vs. g (conj)
deciliter per (case)
% 97.3 (nummod)
correlate outcome (nmod)
cause discrimination (nmod)
min for (case)
comparable efficacy (nsubj)
hypotension mild (amod)
documented that (mark)
induction cardiomyopathy (nmod)
lists suggestions (conj)
veratridine microm (appos)
background : (punct)
val204asp the (det)
influences genetic (amod)
are are (conj)
greater n (dep)
gemcitabine gem (appos)
l-noarg with (case)
tremor . (punct)
consisting compared (conj)
observed schizophrenia (nmod)
min 4-aminopyridine (nmod)
reviewed cases (dobj)
have reductions (nsubj)
demographic other (amod)
focused and (cc)
screening mm (dobj)
= 0.005 (dobj)
clonidine physostigmine (conj)
supersensitivity da (compound)
receiving desferrioxamine (dobj)
treated carbimazole (nmod)
neurons sectors (nmod)
34.33 vs. (cc)
abstinence years (nmod)
cords 15 (nummod)
hydralazine nitroglycerin (conj)
vasculitis perinuclear-staining (amod)
showed dysfunction (dobj)
use age (conj)
given when (advmod)
hz ( (punct)
controls respective (amod)
presentation review (conj)
function sympathetic (amod)
eroded gain (nsubjpass)
obese or (cc)
blockade partial (amod)
variables evaluated (acl)
infusion dose (compound)
developed moderate (xcomp)
show caused (conj)
theophylline and (cc)
thickening , (punct)
subjected blockade (nmod)
min performance (nmod)
man depression (nmod)
dyskinesia on (case)
bicarbonate . (punct)
ml/100g/min 45.9 (nummod)
improvement immunity (nmod)
d4.4 and (cc)
phosphate susceptibility (conj)
cells tunel (compound)
acid cb (appos)
solution m (amod)
zones border (compound)
rejection acute (dep)
pathology underlying (amod)
necrosis marrow (compound)
iml the (det)
received morning (nmod)
procedure diagnostic (amod)
subspecialty medical (compound)
presenting . (punct)
form fibrosis (nmod)
3/8 ) (punct)
haematological renal (conj)
terminate rapidly (advmod)
administration postpartum (compound)
synthesized develop (advcl)
days implantation (dep)
infusion = (dep)
renin endothelin-1 (conj)
defect . (punct)
is also (advmod)
euthanized 12weeks (nmod)
case myopathy (nmod)
arabic gm (nmod)
hypren-trial the (det)
x +/- (cc)
treated ccnu (nmod)
less 100/mm3 (nmod)
antagonist 2a/2c (amod)
resulted reductions (nmod)
nsaids not (neg)
cholesterol of (case)
h or (cc)
hypothesized study (nmod)
functional and (cc)
gating and (cc)
properties dynamic (amod)
similar lna (nmod)
occurred those (nmod)
131i-hsa ( (punct)
if , (punct)
field of (case)
patient 67-year-old (amod)
unmatched matched (conj)
administration neonatal (amod)
capacity activity (conj)
take may (aux)
mpep ) (punct)
undergone stress (dobj)
onset given (case)
lt alf=0/35 (dep)
immunohistochemistry gap43 (compound)
valproate sodium (compound)
4.3 ( (punct)
resurgence a (det)
induction epilepticus (nmod)
hypercalcemia lithium-associated (amod)
deliver nicotine (dep)
analysis months (nmod)
placebo with (case)
stopped decreased (conj)
hyper- placenta (dep)
% 37 (compound)
resulted medium (nmod)
16 5 (conj)
excretion rates (conj)
combination cpdd (compound)
reported recurrent (nmod)
examine mechanisms (dobj)
model simulating (acl)
established euthanized (conj)
administration enflurane (compound)
velocity with (case)
bid placebo (conj)
inhibition sustained (amod)
subgroups high-risk (amod)
appear regimen (nsubj)
hypertensives all (det)
dose piperacillin/tazobactam (nmod)
nephrotoxicity ciprofloxacin-induced (amod)
patients hemorrhage (conj)
induce mania (dobj)
claudication intermittent (compound)
grade infection (dep)
injections by (case)
doses granisetron (compound)
ocs third-generation (amod)
renin ) (punct)
protect event (nmod)
rats upregulation (nsubj)
reabsorption water (compound)
filtration known (acl:relcl)
changes suggesting (acl)
response jerks (nmod)
myeloma relapsed/refractory (amod)
assessment subjective (amod)
frequency sces (nmod)
cells had (acl:relcl)
% s. (appos)
intensity ; (punct)
17 - (punct)
reversal using (acl)
botox of (case)
lindane by (case)
strategies management (compound)
type was (cop)
days was (cop)
result suboptimal (amod)
consumed allegedly (advmod)
pathway rho/rock (compound)
shortened , (punct)
inhibition circulation (nmod)
nonviral more (advmod)
introduction after (case)
level activity (conj)
had since (mark)
function model (nmod)
associated which (nsubjpass)
resonance with (case)
-0.34 to (dep)
combination adults (nmod)
tumors f1 (compound)
concentrations effects (conj)
similar correlated (conj)
regulation rats (nmod)
presented urticaria (dobj)
option alternative (amod)
kinds new (amod)
weight kg (appos)
seizures epileptic (amod)
% 31 (nummod)
h v.o (dep)
ester cck-8-se (appos)
records dogs (nmod)
prevent , (punct)
inhibition p53 (det)
received d (dobj)
activation nf-kappab (compound)
transducer signal (compound)
10 ( (punct)
present past (nmod)
or= 4 (dep)
reported observed (conj)
claws and (cc)
one pregnancy (nmod)
incoordination muscular (amod)
trial tamoxifen (nmod)
2-subunits beta (compound)
need using (xcomp)
ergotamine/caffeine 0.001 (dep)
polygraph through (case)
examined to (mark)
meritorious , (punct)
l1-l2 segments (dep)
amn082 mg/kg (appos)
morbidity the (det)
val , (punct)
studied ultrastructural (dobj)
0 or (cc)
hypertrophy mild (amod)
pregs of (case)
efficacy therapy (nmod)
extent loss (nmod)
mechanism hemolysis (nmod)
appears cause (nsubj)
activity derivative (nmod)
subjects experienced (acl:relcl)
changed dose (nsubjpass)
segmental endocarditis (nmod)
values [verapamil]o (nmod)
treated obtained (conj)
astrocytes , (punct)
peak activity (dobj)
characteristic class (nmod)
disease but (cc)
map an (det)
examine to (aux)
analysed totals (nsubjpass)
response response (conj)
responses , (punct)
reached latency (conj)
differences psychopathology (nmod)
mice ilk/liver-/- (compound)
is regulation (nsubj)
background become (appos)
alternation per (case)
neck of (case)
% 0.1 (compound)
viracept protease (compound)
abuse thyroxine (amod)
conditioning melphalan (compound)
resistant mice (nsubj)
motility strains (nmod)
control seizure (amod)
sensitivity the (det)
db loss (nsubj)
urine hyposmotic (amod)
ritodrine of (case)
enhances steroid (nsubj)
produced iopentol (nsubj)
values , (punct)
periods during (case)
ester sulphate (compound)
use shortly (advmod)
received h. (nmod)
hematoma an (det)
presumed ] (punct)
suggested cytology (nsubjpass)
changes fibrillation (conj)
induced measured (conj)
use methamphetamine (dobj)
aor % (dep)
attributed cardiomyopathy (nsubjpass)
effects subacute (compound)
patient induced (acl)
neuropeptide msh/acth (dep)
hyperactivity a (det)
m technetium-99 (compound)
neurotransmission , (punct)
examined trial (nmod)
prazosin shr (conj)
appearance mg/kg (appos)
less weight (nsubj)
mmp-2 of (case)
syndromes pain (compound)
dysrhythmias both (preconj)
technology current (amod)
tomography computed (amod)
days age (nmod)
aim side-effect (dep)
mek1 3e (conj)
post-fenoldopam-infusion dpi (appos)
nanoparticle dxnp (appos)
muscimol (+)-isomer (conj)
documented sleep (nmod)
7e , (punct)
has activity (nsubj)
suppression zidovudine (compound)
resulted decreases (nmod)
inhibitors beta-blockers (conj)
development lymphoma (nmod)
pathway death (nmod)
contains cyanamide (dobj)
vasculitis (mpo-anca)-positive (amod)
start supplementation (nmod)
has amphetamine (nsubj)
restored addition (nmod)
detected fraction (nmod)
changes suggestive (amod)
irritation acute (amod)
response hypotensive (amod)
included have (aux)
agitation another (det)
consolidation in (case)
6/24 to (case)
frequency effects (nmod)
10 < (compound)
chelator iron (compound)
limited side-effects (nmod)
conditions ocular (amod)
activity genotype (conj)
patterns symptom (compound)
underwent procedure (nmod)
parkinsonism neuroleptic-induced (amod)
mg/m2 6,000 (nummod)
contributes nicotine (nsubj)
infused alone (advmod)
thinning band (nmod)
gamma-hexachlorocyclohexane ( (punct)
motor motivational (conj)
w-ich ( (punct)
clozapine primarily (advmod)
treated pj34 (nmod)
reduced behavior (nsubjpass)
nik-247 dose (nmod)
early days (dep)
lend , (punct)
increases cxad (nmod)
mouth severe (amod)
amelioration hypokalemia (nmod)
mepivacaine to (case)
cross-reacting were (cop)
exhibited increase (dobj)
compound ' (case)
modulating hemorrhage (dobj)
mg/dl potassium (dep)
dropped . (punct)
% 5.2 (nummod)
defined clearly (advmod)
remedies as (case)
caused similarly (advmod)
25.4 +/- (cc)
b12 of (case)
reactions corticosteroids (nmod)
reduced exercise (nsubj)
mitochondria rats (nmod)
showed hypoperfusion (dobj)
evaluated range (dep)
pilocarpine agonist (compound)
increased although (mark)
enos ( (punct)
patients took (acl:relcl)
years 10 (nummod)
acid serum (compound)
examined induced (conj)
made treatment (nmod)
drug therapy (nmod)
sugar on (case)
hearts disease (nmod)
vulnerability mania (nmod)
ci 1.66 (nummod)
loss gyrus (nmod)
haloperidol administration (dobj)
phase infarction (nmod)
unpaired p=0.338 (nsubj)
increases greatest (amod)
presence sirolimus (nmod)
syndrome manifest (acl:relcl)
health also (advmod)
controlled that (nsubjpass)
evaluated when (advmod)
administered concentrations (nmod)
affected minimally (advmod)
scanning both (cc:preconj)
given hydrochloride (xcomp)
follow-up toxicity (nmod)
down , (punct)
medicated cardiovascularly (advmod)
causes directly (advmod)
80 126 (conj)
stabilized randomized (conj)
displayed dronedarone (nsubj)
bsa ( (punct)
min initial (amod)
hours 40 (nummod)
indomethacin ibuprofen (conj)
mg/dl 130 (nummod)
considered is (auxpass)
gtn placebo (conj)
sah recurrent (amod)
carried not (neg)
accompanied returned (conj)
alpha-position and (cc)
associated variety (nmod)
increases fasciculations (nmod)
hbig ( (punct)
hepatotoxicity acetaminophen-induced (amod)
1.4 ( (punct)
conditions and (cc)
influence system (nmod)
citalopram than (case)
harm considerations (dep)
resistance aggregation (conj)
involved trials (nmod)
method in (case)
injected cyp (nmod)
using flowmetry (dobj)
validity data (nmod)
those recorded (acl)
caused rats (dobj)
instillation vincristine (compound)
cancers these (det)
nik-247 all (dep)
infarcts , (punct)
interaction nicotine (nmod)
effect , (punct)
nmbas ) (punct)
child 1 (nummod)
groups 2 (conj)
lead morbidity (nmod)
reabsorption the (det)
duration quality (conj)
found a (nmod)
strain . (punct)
time- concentration (conj)
consumed proportion (nsubj)
combination another (det)
hypertrophy with (case)
investigations histological (amod)
3 only (advmod)
pharmacokinetics beta-2 (conj)
70 +/- (cc)
life and (cc)
utilization phenylephrine (nmod)
included these (nsubj)
used end (nmod)
kg-1 atropine (conj)
ratio associated (acl)
tested . (punct)
affected conduction (dobj)
staff nursing (compound)
teratogenic livestock (nmod)
dimensions annular (amod)
epilepsy temporal (amod)
interrupted appearance (nmod)
has effect (dobj)
myocytes the (det)
signs further (amod)
prescribing offer (conj)
occurs there (expl)
apoptosis against (case)
mg/m(2 . (punct)
vincristine without (case)
safety control (nmod)
aspects in (case)
replaced was (auxpass)
study role (dobj)
anti-asthmatic and (cc)
subjects hundred (nummod)
indicate responsible (ccomp)
evaluated microgravimetry (nmod)
is dissociate (ccomp)
administration amphotericin (compound)
secondary . (punct)
did , (punct)
independent effects (dep)
hbig of (case)
days cohort (nmod)
decreases ca(2 (dobj)
introduced antidepressants (nsubjpass)
quinidine of (case)
complications acute (amod)
normalization with (case)
51 patients (dep)
outcomes fetal (amod)
endoscopy nasal (amod)
observations further (amod)
released zyban (nsubjpass)
lower diclofenac (advcl)
threshold on (case)
occurred fibrillation (nsubj)
preceded changes (nsubjpass)
g 350 (nummod)
within and (cc)
studies sensory-motor (amod)
changes pressure (nmod)
patent aids (compound)
failure episode (nsubj)
improved mice (advcl)
aminonucleoside pan (appos)
reducing size (dobj)
dependent [na]o (nmod)
based positivity (nmod)
ratio enhancement (compound)
less losses (nsubj)
stage which (nsubj)
matrix gel-like (amod)
tachydysrhythmias of (case)
anemia associated (acl:relcl)
acuity the (det)
decreases rat (nmod)
pressure arterial (amod)
dopamine methamphetamine-induced (amod)
abruptness reversibility (conj)
syndrome bile (compound)
prevent p (nsubj)
using contraception (dobj)
erk ldlr (conj)
addition thalidomide (nmod)
evaluation nephrotoxicity (nmod)
perform to (mark)
side-effects sensations (nmod)
evaluate conducted (dep)
reduces phenylephrine (nsubj)
ribavirin cidofovir (conj)
administered transplantation (nmod)
methoxamine or (cc)
antigen urea (conj)
receptor of (case)
anemia combined (amod)
received analgesia (nmod)
pilocarpine the (det)
exposure drug (compound)
ifosfamide bolus (compound)
eleven and (cc)
bradycardia biperiden (nmod)
worsened taking (advcl)
efficacy both (cc:preconj)
lethargy inappetence (conj)
drawbacks several (amod)
investigated , (punct)
expression may (aux)
changed subsequently (advmod)
required total (dobj)
effective equally (advmod)
showed activated (ccomp)
media the (det)
extubated transferred (conj)
described ingestion (nsubjpass)
anti-asthmatic both (cc:preconj)
determine mice (dobj)
sd ] (punct)
inducing seizures (dobj)
evaluated angiography (nmod)
plays thrombin (nsubj)
tolerated well (advmod)
simvastatin medications (conj)
pan/temocapril 13 (dep)
risk no (neg)
constituents , (punct)
antagonists b2 (nmod)
episode a (det)
examined studies (nsubj)
achieved who (nsubj)
nerves 5-ht (compound)
rat li-induced (amod)
% 10.0 (nummod)
american north (amod)
% 0.019 (nummod)
injury permeability (conj)
receptors systems (conj)
incidence effect (nmod)
blocker ro (appos)
assessment severity (nmod)
syndrome serotonin (compound)
alfentanil with (case)
markers stress (compound)
administrations oral (amod)
induced cisplatin (nmod)
doses lesser (amod)
continued if (mark)
evaluated blind (conj)
m(2)-selective ' (punct)
produced gfc (nsubj)
dothiepin with (case)
had arterial (dobj)
ltg ) (punct)
cells/mm3 patients (nmod)
intoxication connection (nmod)
intermediate and (cc)
shown investigations (nsubj)
groups all (det)
three four (conj)
trazodone the (det)
doc ketamine (compound)
implications : (punct)
behaviors day (nmod)
different additionally (advmod)
reduced treatments (nsubj)
lesion center (nmod)
triad classic (amod)
performed day (dep)
channel receptor-linked (amod)
arrest cardiac (amod)
treated ip (dobj)
hearts whose (nmod:poss)
impairments functional (amod)
investigated compared (conj)
relationship significant (amod)
recorded graded (conj)
levels despite (case)
performance median (amod)
describe we (nsubj)
u/d 5000 (nummod)
implicated reducing (advcl)
used compare (xcomp)
hepatic to (case)
establishment the (det)
normal whereas (mark)
edrophonium min (nmod)
ip/week ) (punct)
treatment analgesic (amod)
acid large (amod)
used model (dobj)
medium patients (nmod)
reversal paralysis (nmod)
angina in (case)
vasodilation vessels (nmod)
tool used (acl)
block peri-operative (amod)
cases retention (nmod)
common threatening (conj)
seizures refractory (amod)
1.56 0.57 (compound)
first receive (acl)
preserved function (dobj)
suppresses inducing (advcl)
prevention on (case)
scarce findings (nsubj)
solute high (amod)
encephalopathy develops (acl:relcl)
staining after (case)
microg/side 10 (nummod)
circumstantial findings (nsubj)
correlates mfs (nmod)
0.03 during (case)
hydroxyquinolines reported (acl)
examined system (nmod)
indicate value (nsubj)
cardiomyopathy the (det)
experience handling (advcl)
% 1.86 (nummod)
membrane of (case)
resulted seizure (nmod)
hormone thyroid (compound)
monitored years (dep)
that administered (acl)
complications remifentanil-related (amod)
able moreover (advmod)
substrates are (cop)
0.75 ( (punct)
comparative randomized (dep)
demonstrating specificity (dobj)
levels methamphetamine (compound)
joint of (case)
thrombocytopenia : (punct)
level a (det)
contribute . (punct)
applied were (auxpass)
barrier rats (nmod)
forms erk1/2 (nmod)
levels kinase (compound)
relevant may (aux)
schedule daily (amod)
play roles (dobj)
pathological-process to (mark)
correlated taking (advcl)
treated prazosin (nmod:npmod)
days by (case)
report mexiletine (compound)
incidences effects (nmod)
v2.0 ( (punct)
efficacy because (case)
gtn , (punct)
suppressed weeks (nmod)
transaminase bilirubin (conj)
demonstrated increases (ccomp)
degree fluctuating (advcl)
auditory various (amod)
southeast in (case)
were but (cc)
releases , (punct)
capable also (advmod)
factor incidence (nmod)
group hypercalcemic (amod)
induces which (nsubj)
finding induces (ccomp)
thrombosis involving (acl)
rapid more (advmod)
evaluable total (nsubj)
occlusion middle (compound)
vocalization fighting (conj)
erythroderma hyponatremia (conj)
indices electro-oculography (amod)
athletes by (case)
identifying " (punct)
noted year (dep)
low or (cc)
toxicity cows (nmod)
pose use (nsubj)
albuminuria the (det)
favour help (conj)
4.2 of (case)
distorted dilated (conj)
world in (case)
percent sixty-eight (appos)
26.3+/-3.6 29.0+/-2.1 (conj)
associated hyperammonemia (nmod)
diet lacking (acl)
paradigms of (case)
seen microscopy (nmod)
donors with (case)
caused consequently (advmod)
developed analyze (xcomp)
patient thrombosis (nmod)
had both (nsubj)
urothelium and/or (cc)
abnormalities , (punct)
increase patient (nmod)
domperidone by (case)
protect did (aux)
appears addition (nsubj)
incidence cobalt (compound)
death from (case)
pph as (case)
administration cytarabine (nmod)
treatment empirical (amod)
hoe arg10 (compound)
represents frequencies (dobj)
terminated hypokinesis (nmod)
detrimental that (mark)
indicating damage (dobj)
pretreatment dopamine (nmod)
ekg ( (punct)
rats 6-ohda-lesioned (compound)
micrograms/kg/hr 40 (nummod)
experiment imaging (compound)
test irwin (compound)
recruited patients (nsubjpass)
application snr (nmod)
developed leukemia (dobj)
hours during (case)
1 men (nmod)
demonstrates induces (ccomp)
other daytime (nmod)
progressed diverging (xcomp)
associated none (nsubjpass)
had infarction (dobj)
content derived (acl)
given that (nsubjpass)
excretion li (compound)
diisopropylfluorophosphate dfp (appos)
objectives the (det)
percentage occurrence (nmod)
admitted mi (nmod)
vision permanent (amod)
prolactin high (amod)
examined influence (dobj)
showed observation (nsubj)
attributable been (cop)
4 weeks (dep)
deactivation for (case)
fluvoxamine inhibitor (appos)
lag for (case)
side-effect cystitis (nsubj)
ro 6028 (nummod)
dose for (case)
susceptibility in (case)
background represents (appos)
antibiotics the (det)
outcomes study (dep)
ra rat (conj)
two bzds/rds (dep)
concentration glutamate (amod)
mk-801 mug (appos)
swallowing and (cc)
-0.97 ( (punct)
acetaminophen the (det)
infarction or (dep)
procainamide of (case)
inhibitor-associated ) (punct)
atorva 1187 (nummod)
injected mg/kg (dep)
rates tumor (compound)
active-w the (det)
calculated activity (nmod)
prolongation interval (compound)
m(3)-machr. cardiac (amod)
recognised problem (nmod)
task visual (amod)
analysis immunohistochemical (amod)
disorder with (case)
application first (amod)
4.7 ) (punct)
patch chains (nmod)
related susceptibility (nsubj)
specimens tg (nmod)
stn scores (appos)
space enlarged (amod)
days 15 (nummod)
symptoms individual (amod)
continue efforts (nsubj)
danger the (det)
lower control (advcl)
cause by (case)
sle acid (dep)
lead dilation (nsubj)
patients sr (nmod)
2-(p-bromophenyl)propionate (+/-)-pg-9 (dep)
immunostaining peroxidase-antiperoxidase (compound)
assigned standard- (nmod)
toxic to (mark)
pressure convulsions (nmod)
constituent the (det)
diclofenac or (cc)
1:4 ) (punct)
epithelium mastocytosis (conj)
withdrawal paw (compound)
dyskinesia and (cc)
ipsi- areas (dep)
injections doses (conj)
microglia of (case)
treated he (nsubjpass)
rifampin following (case)
complained , (punct)
neoplasia , (punct)
sensorimotor acute (amod)
disorder pd (appos)
locomotion on (case)
9.7 to (dep)
confirmed immunocytochemistry (nsubj)
prognosis . (punct)
dystrophy experimental (amod)
reduced catalepsy (dobj)
group ab (compound)
transferred which (nmod)
compared benztropine (nmod)
latency intensity (conj)
acting through (mark)
rats transport-competent (amod)
aspirated , (punct)
concentration hippocampal (compound)
succumbed , (punct)
produces differ (conj)
donors blood (compound)
sum the (det)
less amitriptyline (advcl)
mastectomy reconstruction (conj)
suggests modifies (ccomp)
animals dextran (compound)
alterations transporter (nmod)
glomeruli more (amod)
micrograms.kg-1.min-1 5.9 (nummod)
secretion eyelids (nmod)
0.3 0.1 (compound)
triglycerides glucose (conj)
differences environment (nmod)
alterations cardiovascular (amod)
ganglion drg (appos)
neuroprotection rendered (acl)
0.25 of (case)
method quick (amod)
septal defects (conj)
model failure (nmod)
controversial . (punct)
fed evaluate (xcomp)
resuscitations of (case)
quantify incidence (dobj)
results etoricoxib (nmod)
therapy in (case)
antigen cell (compound)
women 34 (nummod)
characterized seizures (nsubjpass)
amlodipine of (case)
patients i-ii (nummod)
surgery decompressive (amod)
6.6 0.7 (conj)
output ) (punct)
striking = (dep)
determination pre-therapeutic (amod)
0.025 < (dep)
present features (nsubj)
thioridazine ( (punct)
placebo subjects (appos)
nh3 ( (punct)
studies injury (compound)
kg 72 (nummod)
risk precipitating (acl)
invaluable is (cop)
prolongation under (case)
those glomerulonephritis (nmod)
emergence tacrolimus (nmod)
cross-over , (punct)
identified methods (nsubjpass)
triggered whom (nmod)
2147 +/- (cc)
focus . (punct)
delirium without (case)
supplemented which (nsubjpass)
undergoing collection (dobj)
rats albino (compound)
evaluation population (nmod)
4.0 +/- (cc)
relationship , (punct)
state was (cop)
octapeptide cholecystokinin (compound)
electrocardiography damage (conj)
feasibility toxicity (conj)
promotes af (dobj)
pathogens the (det)
treatment mefloquine (nmod)
indomethacin mg/kg (compound)
facilitate , (punct)
effect action (nmod)
intensity and (cc)
1.8-fold ) (punct)
exercise post-lesion (amod)
sodium ( (punct)
switched taking (dep)
contribution anxiety (nmod)
patterns exposure-response (amod)
compared determine (advcl)
use identify (acl)
differences motility (nmod)
edema desmosomes (nmod)
p=0.0001 and (cc)
noradrenaline ng/kg/min (dep)
dyskinesias levodopa-induced (amod)
led maneuver (nsubj)
% 37.8 (nummod)
exert did (aux)
g/m2 20 (nummod)
blocked behavior (dobj)
p-450 cytochrome (compound)
effect hypertension (nmod)
cocaine department (nmod)
emphasis safety (nmod)
recommended is (auxpass)
68 1 (conj)
controls robust (amod)
one insecticides (nmod)
saline- from (case)
proved patient (nmod)
combined csa (nsubjpass)
= 5.1 (dep)
nephropathy 2 (conj)
visits and (cc)
approach patients (nmod)
respect time (nmod)
dose lenalidomide (compound)
period onset (nmod)
similarity of (case)
rejection diagnoses (nsubj)
phase and (cc)
skin of (case)
% b (nmod)
acts that (mark)
patient bipolar (amod)
kinase ampk (appos)
examined fetuses (nsubjpass)
determination the (det)
prazosin studies (dep)
fraction decreased (amod)
attenuated compared (prep)
induced albumin (nmod)
edema icp (conj)
induces octreotide (nsubj)
is evaluate (xcomp)
lamivudine lam (appos)
correction after (case)
administration patient (nmod)
form this (det)
progression or (cc)
damage neurone (compound)
barrier/density reduced (amod)
outcomes secondary (amod)
tract of (case)
dosing their (nmod:poss)
profile typical (amod)
effects indicates (acl:relcl)
monotherapy adults (nmod)
suffered convulsions (dobj)
emg ) (punct)
patients filariasis (nmod)
efficacious , (punct)
thp ) (punct)
considered patient (nsubjpass)
factor-alpha tnfalpha (appos)
function electrophysiological (amod)
gnc92h2 the (det)
related is (cop)
avoid we (nsubj)
alpha pirarubicin (compound)
indicated difference (dobj)
udca ) (punct)
subjects tolerate (acl:relcl)
treated androgens (nmod)
associated three (nsubj)
selenium zinc (conj)
actions cns (nmod)
vagotomy bilateral (amod)
stimulation the (det)
levels cm (dep)
dose given (acl:relcl)
test apomorphine-induced (amod)
uterus immature (amod)
interval % (nummod)
receive dexamethasone (dobj)
selected mdp (nmod)
data lines (nmod)
cocaine 60 (nummod)
anti-hbe hbeag (compound)
disease endometrial (amod)
sc at (case)
catheter feeling (cop)
r2 ( (punct)
attenuated hyperactivity (dobj)
studied detail (nmod)
binding through (case)
followed survivors (dobj)
amphetamine- of (case)
rg1 rb1 (conj)
assigned ; (punct)
naloxone , (punct)
fev1 tremor (conj)
usage txa (compound)
oxidative/nitrosative parameters (dep)
minor offset (conj)
compound by (case)
occurred insulin-group (nmod)
included toxicities (nsubj)
changes direction (nmod)
practice important (dep)
difficulties movement (compound)
assessed samples (nmod)
consciousness hyperammonemia (nmod)
dextrose solutions (conj)
conclusions teratogenic (dep)
indicative findings (nsubj)
poorer tasks (nmod)
users and (cc)
exploited uses (nmod)
cta ) (punct)
acid combination (nmod)
-chlorpheniramine - (punct)
therapy pregnancy (nmod)
caused rat (nmod)
66.6 to (case)
rhabdomyolysis induced (amod)
reversing effect (dobj)
changed enhanced (conj)
wky ( (punct)
targeting apical (amod)
correlated compared (advcl)
icv ug (dep)
therapy their (nmod:poss)
levels all (det)
spasms tetany (conj)
cholecystokinin analogues (conj)
used drug (nsubjpass)
ng/ml was (cop)
utility preventing (acl)
stones present (amod)
entry platform (nmod)
g/cm(2 ) (punct)
received mg/m2 (dep)
led compared (advcl)
proportions patients (nmod)
affected affected (ccomp)
aor = (amod)
rats stimulation (nmod)
blockade 1-adrenoceptor (compound)
considered overdose (nmod)
hbeag anti-hbe (conj)
pretreatment remifentanil (compound)
quantify bradycardia (dobj)
responses induced (acl)
cycle the (det)
depression is (cop)
nephropathy self-perpetuating (amod)
increase further (amod)
reported drugs (advcl)
adenocarcinoma [ (punct)
level reported (acl)
children adolescents (conj)
mrna protein (conj)
disease infants (nmod)
amylase raised (amod)
beta-agonists only (advmod)
taking diphenylhydantoin (dobj)
indicating reduction (dobj)
preceded and (cc)
frataxin of (case)
indicating remained (ccomp)
configuration on (case)
reducing requirement (dobj)
modulate retention (dobj)
impaired scopolamine (nmod)
17.6-fold contents (nsubj)
had mastocytosis (dobj)
testosterone serum (compound)
dizocilpine or (cc)
have also (advmod)
had level (dobj)
bupivacaine mg/kg (appos)
ointment with (case)
secretion prl (compound)
injection an (det)
tested then (advmod)
relationship close (amod)
5 7 (conj)
concluded enhances (ccomp)
15 as (quantmod)
evolved agent (nsubj)
brain to (mark)
administered subjects (nsubjpass)
magnus with (case)
9.2 to (conj)
observed parkinsonism (nsubjpass)
0.002 p (dep)
regression multivariate (amod)
responded infections (nsubj)
ischemia min (appos)
precore pc (appos)
controls p=0.48 (appos)
aspartate glycine (conj)
megakaryocytes nuclei (nmod)
loss high-frequency (amod)
analyzed markers (nsubjpass)
lesion artery (nmod)
% fibers (nmod)
abnormalities resolved (acl)
risks due (amod)
level and (cc)
interventions monitored (dep)
therapy-na ve (dep)
signs vital (amod)
d2 dopamine (compound)
ribavirin interferon (conj)
decrease perception (nmod)
reported subjects (nsubj)
content in (case)
seizure suboptimal (amod)
damaged parallel (nmod)
women year-old (amod)
patchy numerous (amod)
desipramine either (cc:preconj)
level ammonium (compound)
performed volunteers (nmod)
diclofenac and (cc)
stimulation concentration (nmod)
stands . (punct)
cases as (case)
negative pg (nmod)
interval after (case)
mmc and (cc)
piroxicam and (cc)
comparison findings (nmod)
% 99 (dep)
safety associated (conj)
malignancies of (case)
due carbachol (nmod)
protect may (aux)
suggested involvement (nsubjpass)
transport caused (acl:relcl)
gpt ( (punct)
trauma or (cc)
relation stroke (conj)
cimetidine , (punct)
static ( (punct)
aspartate and (cc)
man 21-year-old (amod)
sarcoma related (amod)
seen complications (nsubjpass)
tested cages (nmod)
stenoses presence (nmod)
revealed added (advcl)
phosphate the (det)
infiltration leukemic (amod)
controlled seizures (nsubjpass)
asked , (punct)
inhibitor captopril (appos)
course patient (nmod)
calcium excess (amod)
showing abolished (ccomp)
20 10 (compound)
mg/kg/day 100 (nummod)
tracts portal (amod)
rescues induces (conj)
had risk (dep)
controls group (conj)
loss to (case)
identified syndrome (nsubjpass)
lomustine cyclophosphamide (conj)
oralis anterior (amod)
induced animals (nmod)
demonstrated mechanism (parataxis)
mediates response (dobj)
ameliorating effect (dobj)
headache severe (amod)
parameters both (preconj)
groups 8 (nummod)
events coincidental (acl:relcl)
infection virus (compound)
neca ( (punct)
expected times (dep)
specific more (advmod)
psychosis related (amod)
less controls (nmod)
registry national (compound)
30 only (advmod)
administered order (nmod)
water distilled (amod)
nox in (case)
yield overall (amod)
changes small (amod)
immunoassays il-1beta (nmod)
obtained only (advmod)
male 54-year-old (amod)
activity antagonistic (amod)
increased expression (nsubj)
used study (advcl)
ratio zone/cortical (amod)
stimulate ventilation (dobj)
class amplitudes (nmod)
administration amiloride (compound)
reverses amnesia (dobj)
kg(-1 mg (nummod)
voltarol pharmaceuticals (appos)
had proteinuria (dobj)
parameters neuroendocrine (amod)
concentration hdl (nmod)
antagonist aldosterone (compound)
impairment paradigm (appos)
suffering of (case)
lozenges polacrilex (compound)
output as (case)
man 43-year-old (amod)
treated sedation (nmod)
amphetamine further (advmod)
perimetry algorithm-short (amod)
nimodipine ( (punct)
test plus-maze (compound)
syndromes painful (amod)
morphine neonates (nmod)
me the (det)
release calcium-independent (amod)
antibiotics basic (amod)
consists . (punct)
thrombosis pod (nmod)
rate thalidomide (nmod)
disabling severely (advmod)
moderate . (punct)
1.52 1.19 (nummod)
supplementation less (amod)
damage snr (nmod)
disappeared returned (conj)
proliferation ductular (amod)
noradrenergic specific (conj)
manipulate to (mark)
tcr ) (punct)
pressures unrecordable (amod)
0.25 the (det)
associated concentration (nsubjpass)
program core (compound)
interviews questionnaire (conj)
demonstrated identified (ccomp)
prevented , (punct)
masseter temporalis (conj)
share migraine (nsubj)
breaks edema (nmod)
established observed (advcl)
brains -/- (amod)
similar as (cc)
accelerated patients (advcl)
alter might (aux)
derivatives and (cc)
lower reported (advcl)
effect trinitrate (nmod)
controls matched (dep)
elicited opioid (nmod)
electrocardiography exercise (compound)
ratios predicting (advcl)
reduced placebo (nmod)
phz ) (punct)
period final (amod)
caused become (conj)
percent 60 (nummod)
preceding by (mark)
responsible action (nmod)
process a (det)
mice hepatitis (nmod)
proteins syndrome (nmod)
seizures anti-epileptic (amod)
lorazepam the (det)
alcohol after (case)
overview a (det)
bortezomib : (punct)
lasted asystole (nsubj)
caused 4 (dep)
increased decreased (parataxis)
women naturally (advmod)
amounts deletion (nmod)
increased had (parataxis)
glomerulonephritis associated (acl)
adolescent in (case)
plays and (cc)
1.54 1/min (dep)
showed three (nsubj)
concerned one-third (dobj)
29th the (det)
myelopathy , (punct)
score lidocaine (nmod)
rhuepo ( (punct)
thick , (punct)
severity its (nmod:poss)
o2- in (case)
recipients chemotherapy (compound)
prevalence cohorts (nmod)
drug days (appos)
discussed identified (conj)
left cortex (dobj)
10.4 ; (punct)
enzyme serum (compound)
netilmicin three (compound)
mediators inflammatory (amod)
randomized or (cc)
incidence cancers (nmod)
developed pharmacotherapy (nmod)
drug this (det)
doses but (cc)
groups therapy (conj)
test administration (nmod)
than lidocaine (nmod)
akbr and (cc)
occurred patients (ccomp)
recommended the (det)
left left (conj)
number proportion (nmod)
effects -- (punct)
incidence ; (punct)
mitigated was (auxpass)
g wk (appos)
density trabecular (amod)
fit activity (nsubj)
immunity humoral (amod)
diagnoses anatomical (amod)
produced whereas (mark)
rare treatment (nmod)
ng/ml ( (punct)
underwent termination (nmod)
cause lesion (nmod)
injury fetus (nmod)
acetate ethinylestradiol (conj)
admitted developed (advcl)
caused days (nmod)
apparent , (punct)
nalozone , (punct)
age median (amod)
considered achieved (parataxis)
resulted cessation (nsubj)
hyperthermia sc)-induced (amod)
serum classical (amod)
induction as (cc)
levodopa disease (conj)
injection lidocaine (nmod)
hbsag 1/2 (conj)
presentation evaluation (conj)
3tc efv (conj)
banned , (punct)
analyze exactly (advmod)
luminal sides (dep)
adenocarcinomas most (conj)
separately either (cc:preconj)
spasm drug-induced (amod)
variables variables (conj)
peroxides lipid (compound)
induce atherosclerosis (dobj)
warranted trial (nsubjpass)
caused trimethaphan (nsubj)
condition serious (amod)
mg/kg mg/kg (dep)
p.o. 10 (nummod)
study livers (nmod)
ne ( (punct)
rate baseline (compound)
effects toxicity (conj)
15mg/kg day (nmod)
seizures to (case)
administered he (nsubjpass)
midbrain rat (nmod)
revealed organs (dobj)
toxicities dose-limiting (amod)
understood are (auxpass)
increases responsiveness (dobj)
acid 5,7-dichlorokynurenic (amod)
neck , (punct)
imaging mapping (dobj)
stz + (cc)
responses rodents (nmod)
receptor factor (compound)
entered finished (conj)
seizures events (conj)
transplantation cell (compound)
content prl (compound)
revealed concentration (dobj)
group patients (nsubj)
zymosan opsonized (acl)
compared were (auxpass)
lower was (cop)
papaverine , (punct)
acid adenocarcinoma (nmod)
pathway serotonergic (compound)
consistent control (nmod)
involved if (mark)
accident cerebrovascular (compound)
conditions different (amod)
data knowledge (nmod)
cocaethylene ce (appos)
measurement antigen (nmod)
trial h (compound)
training period (conj)
have indicating (advcl)
images camera (compound)
pretreated not (neg)
presented found (conj)
sulfate ps (appos)
contact skin (nmod)
prevented presumably (advmod)
range normal (amod)
result exposure (nsubj)
reports of (case)
retardation mental (amod)
reaching food (nmod:npmod)
rigidity activity (conj)
assessed ; (punct)
analgesics potent (amod)
elderly healthy (amod)
important examination (nsubj)
show rats (nsubj)
related unrelated (conj)
factor-kappab nuclear (amod)
disrupts determines (conj)
dose 12.5 (nmod)
120/67 pressure (nsubj)
12/32 and (cc)
patients 3 (dep)
notion caused (ccomp)
results compared (acl)
hypertension heart (conj)
cases among (case)
determined effects (nsubjpass)
observed being (auxpass)
experienced flashbacks (nmod)
depression manic (amod)
developed stopped (conj)
clinic vision (nmod)
tolerance men (nmod)
rp antagonist (compound)
cardiomyopathy absence (conj)
recovery proteinuria (nmod)
arrhythmia resolved (acl)
concentrations and (cc)
continued course (nmod)
7.5 of (case)
% 18.4 (nummod)
followed carefully (advmod)
q ( (punct)
young 9 (nummod)
involvement carotenoids (nmod)
days cycle (nmod)
bid mg (nummod)
patient 35-year-old (amod)
induced oxide (nsubj)
produced case (dobj)
disappeared dechallenge (nmod)
motionless absence (nmod)
toxicity prolonged (amod)
dose lower (amod)
months follow-up (nsubj)
way develops (advcl)
increase fivefold (amod)
eaca ( (punct)
antibody-negative they (nsubj)
consider sign (xcomp)
risk effects (nmod)
retina of (case)
impairments tasks (nmod)
concentrations blood (nmod)
symptoms anxiety (conj)
was women (nmod)
mice pigs (conj)
infusate to (case)
defects presumed (acl)
sc-48334 h (appos)
treatment high-dose (amod)
p 0.001 (dep)
inhibitor oxide (compound)
placebo nsaids (dep)
distinguished nuclei (nmod)
one users (nmod)
conclusion administered (dep)
effective agents (dep)
back with (case)
infarction on (case)
patients consecutive (amod)
women 362 (nummod)
seizures beta-carboline-induced (amod)
stress migrainosus (conj)
half atherosclerosis (nmod)
surface site (compound)
asthma on (case)
present however (advmod)
imaging perfusion (conj)
factors blockers (conj)
neoplasms or (cc)
loss primary (amod)
performance tap (appos)
restoration in (case)
vehicles min (dep)
hippocampus not (neg)
pleased and (cc)
supplementary in (case)
discontinuations patient (compound)
performed resulted (conj)
symptoms anaphylaxis (nmod)
patient-years follow-up (nmod)
differences and (cc)
14 21 (conj)
found have (aux)
nausea , (punct)
weight fixed (amod)
synthesis de-novo (amod)
addition after (case)
benefit ) (punct)
compared solution (nmod)
affect trial (dobj)
pdtc with (case)
concerned response (nsubj)
diagnosis has (aux)
therapy immunosuppressive (amod)
report additionally (advmod)
impairment fetal (amod)
risks the (det)
potentiate significantly (advmod)
analysis level (nmod)
two about (advmod)
micromol/l ( (punct)
density striatum (nmod)
proteinuric rats (nsubj)
comparison regimens (nmod)
accident in (case)
that while (case)
days lifetime (compound)
chemosensitive relatively (advmod)
a.m. 11:30 (compound)
had attacks (dobj)
wanted study (xcomp)
hexamethonium mug (appos)
seems biomarker (xcomp)
basis hours (nmod)
year 73 (nummod)
pain transmitted (amod)
involving use (dobj)
syndrome patient (conj)
made recovery (dobj)
parameters major (amod)
vesicles present (amod)
demonstrated combining (advcl)
behavior anxiety-like (amod)
revealed survey (nsubj)
accompanied damage (nmod)
clozapine- and (cc)
cessation immediate (amod)
0 20 (conj)
therapy prescribing (compound)
symptoms gastrointestinal (amod)
regression duration (conj)
years progressive (amod)
managed anemia (nsubjpass)
bolus mg (dep)
capacity of (case)
titer antibody (compound)
production activation (conj)
associated upregulation (nmod)
quetiapine mg/day (appos)
micrograms/kg 650 (nummod)
oc of (case)
incidence media (nmod)
hiccups associated (acl)
temocapril ) (punct)
nephropathy stz-induced (amod)
map on (case)
likely survived (xcomp)
cyclophosphamide in (case)
dysfunction development (conj)
progesterone nor (cc)
= ; (punct)
rats age-matched (amod)
seeded measured (conj)
performed presence (dep)
onset particularly (advmod)
chronic daily (conj)
exhibiting resistance (dobj)
resistance and (cc)
features of (case)
inducing expression (dobj)
hemianopia with (case)
damage organic (amod)
displays dhea (nsubj)
doses levobupivacaine (nmod)
hypertension p<0.01 (conj)
management in (case)
levonorgestrel ) (punct)
stimulated using (xcomp)
studies cerebellum (nmod)
markers ) (punct)
u/ml 12.8 (nummod)
csa 15 (nummod)
elevations blood (compound)
hydrochloride given (case)
tri ( (punct)
alleviating in (mark)
chemotherapy ifosfamide (nmod)
defined as (prep)
underlie may (aux)
dyskinesia child (nmod)
design these (det)
angiographies were (auxpass)
studies micropuncture (amod)
happiness marital (amod)
effect af (compound)
picrotoxin- electroshock- (conj)
micrograms hcrh (nmod)
diagnosed . (punct)
structure bisbenzylisoquinoline (compound)
value vpa (nmod)
restricted vessels (nmod)
appeared receiving (advcl)
agitation psychomotor (compound)
occurrence as (case)
drugs control (conj)
neurodegeneration mptp-induced (amod)
settings war/tropical (compound)
remain problem (xcomp)
reversed improve (advcl)
received mg (nmod)
have mechanism (dobj)
rats weaker (dep)
indicated likely (advcl)
receiving busulfan (dobj)
conducting upon (mark)
ingestion paracetamol (compound)
injection patients (nmod)
response good (amod)
110 2 (conj)
involved increase (nmod)
0.6 +/- (cc)
dyspepsia postprandial (amod)
resolution abnormalities (nmod)
similarity effects (nmod)
compromises , (punct)
received 11 (nsubj)
administered rb1 (conj)
pneumonia because (case)
regulation effects (nmod)
recommended combining (advcl)
illustrates reminds (conj)
changes concentration (nmod)
blunted + (cc)
dialysate citrate (compound)
contraction vena (nmod)
linkage through (case)
targeted corrected (conj)
dysfunction related (amod)
d-1 receptors (dep)
function neuropsychological (amod)
ca2 + (cc)
case rpgn (nmod)
reviews effect (dobj)
apposed rats (nmod)
isolated lipid (nsubjpass)
completion therapy (nmod)
remains elucidated (xcomp)
range 5.2 (dep)
patients levodopa-responsive (amod)
11 plus (cc)
tested responses (nmod)
treatment 0.03 (dep)
admitted male (nsubjpass)
potential attenuate (acl)
increment overflow (nmod)
had results (nsubj)
severity the (det)
hemoglobin or (cc)
nimodipine low-dose (amod)
exposure subacute (amod)
killed day (nmod)
followed srl (nmod)
infusion dobutamine (amod)
ps alone (advmod)
potassium for (case)
indicate causes (ccomp)
cortex upon (case)
experiencing mg/dl (dep)
day each (det)
neuropathy dyspnea (conj)
psa in (case)
suppression suppression (conj)
rise pressure (conj)
foci formed (acl)
associated restoration (nmod)
investigate received (conj)
calcium fenoprofen (compound)
less area (nsubj)
constructed design (dep)
tgf- serums (compound)
effect reported (amod)
weeks , (punct)
shedding both (conj)
improved example (nmod)
drugs have (acl:relcl)
mg 1,800 (nummod)
damage in (case)
resumption after (case)
practice : (punct)
study and (cc)
recognized amiodarone (nsubjpass)
p < (dep)
started after (mark)
cultures renal (amod)
stress higher (amod)
palsy in (case)
time months (conj)
lowering simultaneously (advmod)
switched when (advmod)
1.5 2 (conj)
function hemodynamics (conj)
4.6 versus (cc)
metocurine with (case)
defined mg/m(2 (nmod)
drug-resistant extensively (advmod)
db ( (punct)
required regimens (nsubjpass)
had skf (nsubj)
population therapy (nmod)
24/76 propranolol (compound)
methods maze (nmod)
exposure (2-chloroethyl)-1-nitrosoure (nmod)
risperidone clozapine (dep)
nephritis nicergoline (nmod)
these studies (dep)
action risk (conj)
medication other (amod)
milder somewhat (advmod)
adrenaline and/or (cc)
antibiotics cephalosporin (compound)
target because (mark)
fev1 ( (punct)
criterion , (punct)
administered gd (nmod)
developed diagnosis (parataxis)
mutations escape (compound)
intake to (case)
responsiveness this (det)
% 44.1 (nummod)
effect treatments (nmod)
nephropathy nonionic (amod)
was discrepancy (attr)
o-methylation in (case)
was deliver (xcomp)
use opioid (compound)
dosage zonisamide (nmod)
conducted assess (xcomp)
damages against (case)
care in (case)
systems cell (compound)
synthesis total (amod)
treated vehicle (nmod)
medication any (det)
hr in (case)
however those (nmod)
glycosuria mild (amod)
reticulata substantia (advmod)
tolerated continued (conj)
scale racine (nmod:poss)
one after (case)
monotherapy lithium (compound)
necessary convert (xcomp)
timolol solution (dobj)
p10 33.6 (dep)
deterioration for (case)
15 5 (conj)
core ( (punct)
investigated order (nmod)
phenacetin acetaminophen (conj)
prevented month (nsubj)
promotes which (nsubj)
sensitization on (case)
receptors , (punct)
weeks 30 (nummod)
p20 or (cc)
alfentanil when (advmod)
interval time (compound)
increment with (case)
had changes (dobj)
reversible severe (amod)
occurrence are (cop)
heart cardiomyopathy (amod)
dose ld(10 (compound)
escalation significant (amod)
inhibition reduction (conj)
30 25 (quantmod)
appeared took (advcl)
cis-platin days (nmod)
values chemistry (compound)
4 little (amod)
intact be (cop)
lost were (auxpass)
linezolid and (cc)
caffeine versus (cc)
aki ( (punct)
runs brief (amod)
recommendation as (case)
cause a (det)
pkca of (case)
gls ) (punct)
% levels (nmod)
gradient corticomedullary (amod)
attended program (dobj)
salicylates and (cc)
studied described (conj)
tortuous abnormally (advmod)
was positive (conj)
treatment no (neg)
drugs organ (amod)
toxicity lometrexol (nmod)
abnormalities marked (amod)
stabilizers and (cc)
atherosclerosis premature (amod)
withdrawal in (case)
promotes development (dobj)
pass not (neg)
contributes system (nsubj)
alternative cost-savings (nmod:npmod)
release mediators (nmod)
chronicity onset (conj)
capable . (punct)
maximal were (cop)
found sent (conj)
former of (case)
peak decline (conj)
na(+)/k(+)-atpase , (punct)
constriction exhibited (amod)
compared 20 (nmod)
connecting actin (dobj)
kg kg (conj)
greater decrease (nsubj)
damage esterase (nmod)
aminotransferase mg/dl (acl)
quantitatively both (preconj)
neuropathy predominance (nmod)
model logistic (amod)
men ; (punct)
treated ato (nmod)
influenced rate (dobj)
analysis cohort (compound)
switching nifekalant (nmod)
effect ammonia (nmod)
administration dex (compound)
[3h]-naloxone of (case)
drugs alternative (amod)
identified could (aux)
injection one (nummod)
morphine nicotine (conj)
women ( (punct)
overdose acute (amod)
multicenter study (appos)
none drugs (nmod)
reported purpose (nsubjpass)
mg more (amod)
propranolol or (cc)
started achieved (advcl)
precedes which (nsubj)
study . (punct)
measure efficacy (compound)
channels na (compound)
mechanisms circuitry (conj)
arrest produced (amod)
prostaglandins endometrial (amod)
tapered weeks (nmod)
improved moderately (advmod)
assessed tolerability (nsubjpass)
% specificity (appos)
exposure mechanism (nsubj)
cause into (case)
study the (dep)
unknown yet (advmod)
common artery (nsubj)
applied implants (nsubjpass)
characteristic encephalopathy (nmod)
necrosis the (det)
4 approximately (advmod)
5.4 from (case)
resuscitated was (auxpass)
protects myelosuppression (nmod)
suspension % (amod)
conclusions common (dep)
cases studied (acl)
therapy without (case)
demonstrating thus (advmod)
consensus treatment (nmod)
level lethality (nmod)
associated men (dep)
microg/day , (punct)
risk estimated (amod)
given cpa (nsubjpass)
management effects (nmod)
measured tafi (nsubjpass)
therapy with (nmod)
susceptibility effect (nmod)
peak with (case)
showed bilirubin (dobj)
observer the (det)
mice mhc-cb7 (compound)
transfusion of (case)
acts fluvoxamine (nsubj)
rash a (det)
program cholesterol (compound)
function hypothalamic (amod)
reproduce to (mark)
fluvoxamine of (case)
markers with (case)
design trial (dep)
wt vip(-/- (conj)
hospitalised , (punct)
periods activity (compound)
95 +/- (cc)
conscious in (case)
started , (punct)
response sustained (amod)
disease including (case)
540,000 about (advmod)
toxic , (punct)
screened regularly (advmod)
separated days (nmod)
years 62 (nummod)
minute was (cop)
incidence diskinesia (nmod)
analogue novel (amod)
concentration dopamine (compound)
performed transplantations (nsubjpass)
more threat (nmod)
lag ( (punct)
catheter radiofrequency (compound)
association radiation (nmod)
characterized , (punct)
promoter serotonin (compound)
polyglutamates cb (compound)
many genes (nmod)
test ofh (appos)
dynamics ; (punct)
escalated ; (punct)
were cld (dep)
checklist abc (appos)
finding from (case)
folate and (cc)
gland control (nmod)
associated anaesthesia (nsubjpass)
type damage (nmod)
pressure venous (amod)
amnesia of (case)
extension , (punct)
association uveitis (nmod)
prevent mechanisms (nsubj)
continue side-effects (nmod)
study evaluating (acl)
varied days (nmod)
atorva dex (conj)
mice vip(-/- (compound)
is remains (ccomp)
manipulated min (nmod)
males ng/ml (appos)
treated clonazepam (nmod)
groups s-1 (compound)
days 33 (nummod)
fraction output (conj)
facilitation pg-9 (nmod)
antagonist non-competitive (amod)
decreasing than (mark)
associated therapy (nmod)
prolonged . (punct)
safe generally (advmod)
accomplished map (nsubjpass)
responding well (advmod)
associated because (mark)
diagnosis stones (nmod)
cases our (nmod:poss)
vacuolation additional (amod)
tissues hepatic (conj)
decreased adjusted (advcl)
aminoglycosides three (nummod)
exposure anabolic (amod)
resulted and (cc)
evaluation schedule (dep)
exercise-isoproterenol the (det)
preference paw (compound)
test after (case)
occur responses (nsubj)
female required (acl:relcl)
magnitude vasodepressor (nmod)
35 10 (conj)
function initial (amod)
21.0 ) (punct)
discontinuing cisapride (dobj)
protection under (case)
drugs nonsteroidal (amod)
cause absence (nmod)
reactions , (punct)
purposes very (amod)
accompanied ratio (nmod)
experienced injection (nmod)
psychiatric endocrinological (conj)
effects nephrosis (nmod)
complication major (amod)
cases improved (acl)
mean g/d (conj)
found rats (nsubjpass)
elevations margin (nmod)
use antecedent (amod)
12 0.2 (compound)
effects emetic (amod)
etiology of (compound:prt)
latency a (det)
function action (conj)
analyze to (mark)
demonstrate defect (dobj)
neuroimage - (punct)
combination agents (nmod)
re-induced . (punct)
sch by (case)
seems polyuria (nsubj)
morbidity mortality (conj)
provided which (nsubj)
have anemia (dobj)
reported stroke (nsubjpass)
exposed not (neg)
age elevation (conj)
hexaaldose to (case)
levels use (nmod)
enzymes serum (compound)
blockers to (case)
agents been (cop)
reversal 5 (dep)
response rates (dep)
given had (conj)
min p (dep)
fluids certain (amod)
anemia cells (conj)
psychostimulant has (acl:relcl)
after soon (advmod)
complicated condition (nsubjpass)
terms values (nmod)
hallucinations occur (acl:relcl)
status group (compound)
analysis p (appos)
11.7 10.1 (conj)
results % (dep)
timolol gellan (dobj)
h given (case)
distinguish guidelines (nsubj)
cost treating (advcl)
monitored behavior (nsubjpass)
entity is (cop)
important differs (advcl)
been nevertheless (advmod)
fr 139317 (nummod)
concentrations corresponding (amod)
bodyweight . (punct)
proves alternative (xcomp)
is was (advcl)
describe . (punct)
difference apparent (amod)
treatment conversion (nmod)
had symptoms (dobj)
doxorubicin free (amod)
gestation a (det)
difference 2 (nummod)
reviews medicine (compound)
use anti-inflammatory (amod)
fsgs of (case)
induced injection (nmod)
risk rejection (nmod)
included constipation (dep)
less brain (conj)
diffusion-weighted attenuated (conj)
users tablet (dep)
admission unit (nmod)
progress . (punct)
adjusted be (auxpass)
hours induction (dep)
syndromes stevens-johnson (compound)
changed scores (nsubj)
malaise of (case)
anesthesia fentanyl (amod)
attenuated resulted (conj)
later weeks (nmod:npmod)
alpha-t ) (punct)
range 49.75 (nummod)
busulfan 600 (nummod)
saline ml/kg (appos)
weakly but (cc)
protein mitochondrial (amod)
syndrome stomatitis (conj)
cause regimens (nsubj)
blockade caffeine (appos)
= 86 (dep)
26 c (nmod)
high be (cop)
influence rocuronium (nmod)
avoid damage (dobj)
shows case (nsubj)
uptakes myocardium (nmod)
fluphenazine antagonist (compound)
scales zung-conde (compound)
% vs (cc)
implicated these (nmod)
inhibited or (cc)
available recently (advmod)
processes synthesis (conj)
degree required (conj)
eyes treated (amod)
uterotonic cause (acl:relcl)
5-httlpr ) (punct)
influenced beta-blockers (nsubj)
included parameters (nsubj)
risk that (mark)
absence presence (conj)
interaction due (case)
pneumonia pneumocystis (compound)
months 16 (nummod)
reduce movement (dobj)
treated eaca (nmod)
effect mi (nmod)
systems cord (conj)
contrast protection (nmod)
abolished also (advmod)
polypeptide intestinal (amod)
heparin uh (appos)
glomeruli of (case)
years first (amod)
discontinuation administration (nmod)
quetiapine with (case)
rr 0.70 (nummod)
course i (nsubj)
help that (mark)
regression hazards (compound)
quality image (compound)
properties positive (amod)
pairs the (det)
pallidotomy in (case)
schizophrenic developed (acl:relcl)
suggested and (cc)
movement electrocardiograph (conj)
model behaviors (nmod)
selectivity enzyme (nmod)
effect bradycardic (amod)
weeks 3 (nummod)
urtication urgency (conj)
surgery successful (amod)
isolated heart (nsubjpass)
iodide propidium (compound)
stent and (cc)
exercise to (mark)
induced treatment (nmod)
summarizes switching (advcl)
inventory use (compound)
t1/2 ( (punct)
hemiparesis unilateral (amod)
dopamine striatal (amod)
refractory or (cc)
3 37 (prep)
play development (nmod)
muscle detrusor (compound)
inhibition > (compound)
dyscrasias , (punct)
abolished compared (advcl)
returned returned (conj)
infusion sufferers (nmod)
wistar licl-pre-treated (amod)
17beta-estradiol or (cc)
given routes (nmod)
15-f(2t)-isoprostane 15-f(2t)-isop (appos)
radiotherapy days (appos)
tests thyroid (compound)
up-regulation diffuse (amod)
gr of (case)
microscopy scanning (compound)
therapy thrombophlebitis (nmod)
do harm (dobj)
histopathology uterine (amod)
universitaetsmedizin charite (compound)
variables duration (appos)
period 1 (nummod)
doses together (advmod)
center in (case)
cords of (case)
dysfunction vascular (amod)
killed removed (conj)
taken giving (advcl)
required reductions (dobj)
relationships hypertension (nmod)
a 16/104 (appos)
seizures learning (conj)
noted contrast (nmod)
nd ) (punct)
arrhythmia or (cc)
resting peak (conj)
exposure androgenic (amod)
positive 34 (nmod)
cells these (det)
scabicides caution (nmod)
activated that (mark)
given hr (nmod)
cases chiasmopathy (nmod)
illustrate findings (nsubj)
memory the (det)
evaluated double-blind (nsubj)
reviewed discussed (conj)
patients bp (nmod)
instituted hypertension (nsubj)
formulation % (appos)
racemic , (punct)
or=12.619 23.759 (nummod)
behavior a (det)
electrocardiogram angina (appos)
1.1 0.8 (nummod)
dose beta-blocking (amod)
cardiotoxicity for (case)
microglobulinuria 2 (nummod)
detecting ischemia (dobj)
number dropping (acl)
evoke and (cc)
dosage threshold (amod)
dose tobramycin (nmod)
found relationship (nsubjpass)
lipoproteinuria stage (compound)
reduction this (det)
require regimens (nsubj)
accelerated heterogeneously (advmod)
29.3 3.2 (conj)
which by (case)
evaluated yohimbine (dobj)
flecainide supratherapeutic (amod)
hypotension map (nmod)
recovered value (nmod)
cholesterol and (cc)
decline progressive (amod)
increased pressure (dobj)
diagnosis early (amod)
body 500 (nummod)
0.5 < (dep)
hemorrhage frequently (conj)
metabolism and (cc)
proceeded surgery (nsubj)
showed children (nsubj)
found patient (dep)
assessed exposure (nsubjpass)
cells/mm3 6.8 (nummod)
space same (amod)
favor valsartan (nmod)
cisplatinum etoposide (conj)
plexus the (det)
rate groups (nmod)
thyroid on (case)
administered flumazenil (nsubjpass)
administered oxygen (dobj)
complications , (punct)
synthesized ) (punct)
d-med saline (conj)
levels attenuated (acl:relcl)
neurotoxicity ) (punct)
detrimental possibly (advmod)
consider cause (nmod)
% 95 (nummod)
patients brain (compound)
= 0.07 (dep)
decrease blood (compound)
factor granulocyte-colony (amod)
children from (case)
thromboembolism remained (parataxis)
analgesics four (nummod)
help substrates (nsubj)
inhibitor multikinase (amod)
made seems (parataxis)
fractures of (case)
appreciated , (punct)
emerged evidence (nsubj)
delivered examined (conj)
angiographies 0.005 (nmod)
levels cardiac (amod)
recognized be (auxpass)
suggest hence (advmod)
treatment milrinone (nmod)
test respectively (advmod)
ug/ml and (cc)
available followup (nsubj)
had hypotensive (dobj)
serological and (cc)
serological , (punct)
67.66 between (case)
ephedrine of (case)
chloroquine or (cc)
response pr (appos)
y r (nmod)
months [ (punct)
drug it (nsubj)
g/cm(2 ( (punct)
reversibility use (nmod)
produce atherosclerosis (nsubj)
presented included (conj)
compared brain (nmod)
produces rats (nmod)
taken twenty-three (nsubj)
0.5 or (cc)
hypertension nomega-nitro-l-arginine (compound)
brains wt (compound)
child the (det)
hormone luteinizing (compound)
measured values (nmod)
associated response (nmod)
granulocytopenia . (punct)
sirolmus novel (amod)
include development (nsubj)
curtailed toxicities (nmod)
enhances toxicity (dobj)
apolipoproteins apo (appos)
raters backgrounds (nmod)
using monkeys (dobj)
mice 69 (nummod)
development crf (nmod)
diagnostic disorders (nmod)
ineffective was (cop)
dyskinesia oral (amod)
diagnosed treated (conj)
fatigue common (amod)
% 13.1 (nummod)
promotes remodeling (nsubj)
neonates these (det)
increase number (dobj)
arrest death (conj)
alternative uh (nmod)
cdt alteplase (nmod)
indicate possibility (dobj)
organelles and (cc)
infrequent nausea (nsubj)
presence ; (punct)
deficit the (det)
fell 76 (nmod)
that animals (nmod)
days 35 (nummod)
inhibited catalepsy (dobj)
initiation induced (acl)
receives innervation (dobj)
bleeding regarding (case)
figures mg (dep)
21 8 (conj)
developed hg (dep)
children factors (nmod)
data experimental (amod)
muscle left (amod)
data placebo (compound)
gravity specific (amod)
effects learning (nmod)
received remission (nmod)
hampshire in (case)
arms ( (punct)
% that (mark)
regimens drugs (nmod)
paramount , (punct)
38 from (case)
mmol/l 3.36 (nummod)
present drug (nsubj)
lymphoma patient (nmod)
complication thromboembolism (nsubj)
recognition fear (compound)
high may (aux)
showed animals (advcl)
potassium of (case)
reduction treatment (nmod)
ensues higher (amod)
mechanism transformation (nmod)
were incidents (nsubj)
injection octreotide (nmod)
child neurologically-impaired (amod)
abbott-53693 the (det)
pressure intraoperative (amod)
therapy all-trans-retinoic (amod)
1.0 stroke (conj)
angiogram a (det)
bupropion 0.001 (appos)
lacks , (punct)
optimization . (punct)
data ) (punct)
those cyclosporine (nmod)
patients syndrome (nmod)
mg/day a (appos)
address examine (conj)
veins internal (amod)
mg/d 120 (nummod)
d2 ng/mouse (appos)
hospitalization , (punct)
devastation caused (acl)
child impairment (nmod)
evaluations laboratory (compound)
carriers in (case)
alterations and (cc)
permanente kaiser (compound)
possessing antigen (dobj)
biomarkers cardiac (amod)
agonist mesylate (nsubj)
undertook submitted (conj)
question a (det)
min-1 ) (punct)
changes threshold (amod)
going rare (xcomp)
exposure mipafox (compound)
developed side-effects (conj)
reduction concentrations (nmod)
% < (compound)
supported however (advmod)
returned remained (parataxis)
signaling and (advmod)
had resolution (dobj)
mastectomy and (cc)
stems findings (nmod)
reabsorption accumulation (conj)
four including (case)
parameters cardiovascular (amod)
5.7 to (case)
treatment group (conj)
measure treated (acl)
signs focal (amod)
pcag ( (punct)
reduced lidocaine (nsubj)
ug/ml concentrations (nsubj)
define quotient (dep)
morphine doses (nsubj)
obtained was (auxpass)
signs these (det)
forearm volar (amod)
changes chemistry (compound)
troponin t (conj)
found contain (xcomp)
velocities and (cc)
concentration between (case)
air/oxygen breathing (compound)
development or (cc)
days administration (nmod)
hematoma intercerebral (amod)
piperacillin , (punct)
flurbiprofen . (punct)
ns-718 with (case)
inhibition or (cc)
side-effects possible (amod)
confounding dysfunctions (dobj)
45.6 +/- (cc)
practice according (case)
blocks activity (dobj)
urothelium , (punct)
test sensitivity (compound)
accompanied activity (nmod)
patterns changes (nmod)
reported risk (dobj)
n/n=25/26 . (punct)
cm 175 (nummod)
micromol/l 44.2 (nummod)
midbrain ) (punct)
coherence tissue (compound)
lost followed (advcl)
institution following (case)
abolish effect (dobj)
g/dl 1 (nmod)
l-alpha-gfc ( (punct)
administered rats (conj)
pretreated glutamate (conj)
produced reductions (dobj)
deaths drug-related (amod)
take up (compound:prt)
usage after (case)
= left (amod)
profile different (amod)
rejection to (case)
systemic and (cc)
% 3.4 (dep)
confirmed cases (dobj)
depression ondansetron (nmod)
measured groups (nmod)
intervals monthly (amod)
velocity phase (dep)
dose maximum (compound)
receptor cx3cr1 (appos)
method test (acl)
beats/min 50 (nummod)
0 11 (conj)
contraindicated are (auxpass)
heterozygous jj (appos)
rate % (appos)
complications are (cop)
achieved % (nsubj)
indicate effective (ccomp)
use analgesia (nmod)
presence abnormalities (nmod)
approach suppression (nmod)
understanding syndromes (nmod)
deaths the (det)
0.66 ( (punct)
antinociception constipation (conj)
amount distribution (conj)
exceeded lesions (nsubj)
0.24:1 fluid (nsubj)
comparison glycopyrrolate (nmod)
withdrew effects (nmod)
treated fdc (nmod)
pulmonale therapy (nmod)
collected baseline (nmod)
acts fashion (nmod)
exercised combined (advcl)
agents protective (amod)
defects these (det)
90/htn ) (punct)
epistaxis to (case)
eye for (case)
implicated pathophysiology (nmod)
ptz alternate-day (amod)
amplitude in (case)
benefits condition (nmod)
ineffective were (cop)
acid dose (compound)
cancer ureter (nmod)
percentage a (det)
effects initiating (acl)
been or (cc)
muscle rat (compound)
recalled 96.7 (advcl)
administration therapeutic (amod)
found concentrated (advcl)
subject in (case)
compared users (nsubjpass)
replacement thyroid (compound)
scintigraphy myocardial (amod)
normalized pressure (nsubj)
appeared animals (nmod)
they both (appos)
9 178 (prep)
effects detrimental (amod)
patients chf (compound)
meq. ) (punct)
glomerulonephritis . (punct)
induced single (nmod)
5-fu ( (punct)
selected produce (conj)
proteins handling (compound)
effect cinacalcet (nmod)
rate patient (nmod)
found uiu/ml (xcomp)
gamma-gt ( (punct)
method anticoagulation (nmod)
mechanism causing (acl)
had two (nsubj)
resembling neuropathies (xcomp)
biopsy taken (acl)
cancer autochthonous (amod)
0.6 % (appos)
exchange infusion (conj)
significant increasing (conj)
toxicity adriamycin- (amod)
therapy salvage (amod)
cardiomyopathy apical (amod)
hydrolyze succinylcholine (dobj)
cycle mcg/kg (dep)
leading discontinuation (nmod)
inhibits valproate (conj)
diethylstilbestrol to (case)
study double-blind (amod)
mechanisms pathogenesis (nmod)
determination carbachol (nmod)
prevent down-regulation (dobj)
damage protect (compound)
range less (amod)
fucoidan of (case)
= 98 (dep)
steroids systemic (amod)
ctnt r=0.81 (dep)
steroids oral (amod)
resulted syndrome (nmod)
tmp ) (punct)
induced infusion (nmod)
lesions coronary (amod)
features with (nmod)
help attention (nsubj)
dox either (cc:preconj)
reduction extent (nmod)
resistance resting (amod)
aggravated changes (conj)
clinical setting (dep)
benefit may (aux)
scopolamine selective (amod)
recall word (compound)
typical neurological (nsubj)
males four (nummod)
postulated we (nsubj)
greater gain (nsubj)
dose not (neg)
space subarachnoid (amod)
firmness women (nmod)
osteoarthritis from (case)
abstinence early (amod)
professionals health (compound)
leukocytes lesional (amod)
performed to (mark)
tension in (case)
reason restrictive (acl:relcl)
saline/side min (dep)
regimen hfd (compound)
resulted change (nsubj)
obtained previously (advmod)
represents though (mark)
people young (amod)
rats administered (amod)
dysfunction nonorganic (amod)
exhibited immunoreactivity (dobj)
clinic university-affiliated (amod)
origin a (det)
nodule carcinoma (conj)
combination caffeine (nmod)
contributor possible (amod)
duration increasing (amod)
increased mg/kg (dep)
cardiotoxicity late (amod)
recent and (cc)
stress promotes (acl:relcl)
delay management (nmod)
increased count (nsubj)
received respectively (advmod)
complications neurovascular (amod)
mg 400 (nummod)
use progesterone (nmod)
distinguish significantly (advmod)
developed encephalopathy (advmod)
evaluated activity (nsubjpass)
suggest followed (ccomp)
radiation both (cc:preconj)
evaluation in (amod)
pallidotomy after (case)
reported conclusion (dep)
ufov test (appos)
inhibits effectively (advmod)
conclusions used (appos)
apex and (cc)
back-diffusion , (punct)
differences activity (nmod)
initiated administration (nmod)
percentage this (det)
conclusion responses (conj)
risk disorders (conj)
63 5 (conj)
rigidity , (punct)
further adverse (dep)
transplanted . (punct)
fulfilling criteria (dobj)
testing neuropsychological (amod)
family his (nmod:poss)
have hours (nmod)
compared determine (xcomp)
chemotherapy second-line (amod)
patients positive (amod)
scrutiny additional (amod)
described treatment (nmod)
3/4 grade (compound)
idiosyncratic encephalopathy (nsubj)
-14.8 and (cc)
oac ) (punct)
mechanical dc (conj)
present here (advmod)
adjusting factors (nmod)
group blockers (nsubj)
prodrug ribavirin (nmod)
strains mice (nmod)
mediated projection (nmod)
animals to (case)
alpha-2b ifn (compound)
results group (nmod)
electrocardiography by (case)
1984 2004 (nummod)
min-1 mean (dep)
level according (case)
increased observed (advcl)
had degrees (dobj)
repeated be (auxpass)
infusion ifosfamide (compound)
existed relevance (nmod)
begun . (punct)
intubation gastric (amod)
variety of (case)
sequence reports (conj)
importance with (case)
tjs of (case)
alert clinicians (dobj)
complication serious (amod)
exacerbated have (aux)
absorption medications (nmod)
thickened , (punct)
d-med ] (punct)
reaction vaccine (compound)
nodosum patients (nmod)
included biopsies (dobj)
-26 +/- (cc)
have ingestion (nsubj)
preceded those (conj)
types , (punct)
describe paper (nmod)
values cholesterol (nmod)
revealed increased (ccomp)
greater diazepam (nmod)
58.5 9.8 (conj)
developed lethargy (dobj)
bcnu-exposed plus (cc)
severe explain (advcl)
e.g. nephrotoxicity (conj)
causes apnea (dobj)
polysomnography of (case)
learning impaired (amod)
adjacent surface (nmod)
patient explanatory (amod)
employed study (xcomp)
oct , (punct)
communicate . (punct)
injections muscles (nmod)
mg/dl p (dep)
cycle 4-week (compound)
values tests (nmod)
detected association (dobj)
reviewed results (conj)
reported use (dobj)
studies factors (nmod)
therapy mbc (nmod)
damages methamphetamine (nsubj)
monitored daily (advmod)
variants branching (compound)
diminished were (auxpass)
reactions drugs (nmod)
dysfunction motor (compound)
h onset (nmod)
results paper (nmod)
results three (nummod)
carbamazepine switching (compound)
report mg. (dep)
2010/2011 nc/ia (appos)
fluctuations in (case)
microprolactinoma n. (appos)
conclusions tolerated (appos)
mg mg (conj)
received rd (dobj)
use sulfasalazine (dobj)
survivals progression-free (amod)
rats those (det)
discovered podocytes (nmod)
prevented also (advmod)
became manic (acomp)
extract s. (compound)
month postoperative (amod)
agonists oral (amod)
antagonists and (cc)
plan management (nmod)
draw to (mark)
association stroke (nmod)
gentamicin ( (punct)
constant to (case)
degree and (cc)
diagnosis or (cc)
krebs-ringer . (punct)
pressure rats (nmod)
mmp-timp and (cc)
butyrylcholinesterase of (case)
effect phenobarbitone- (nmod)
abstention of (case)
touch light (amod)
dependent action (nmod)
different events (nsubj)
rhizomes picrorrhiza (compound)
impacts cns (nmod)
administration raloxifene (compound)
patient % (appos)
activator first (amod)
h2o2 the (det)
reflect to (mark)
seemed result (xcomp)
increase the (det)
woman arthritis (nmod)
cardiomyopathy-induced doxorubicin (nmod:npmod)
induces seizures (dobj)
receptor (gdnf)/tyrosine (compound)
matter cerebellar (amod)
sphincter morphine-induced (amod)
prepare homogenates (dobj)
bupivacaine lidocaine (conj)
gave although (mark)
normalized later (advmod)
replacement 12-wk (amod)
rats dex-treated (amod)
i ctni (appos)
purpose complication (dep)
spasm sorafenib-induced (amod)
restores ro4368554 (nsubj)
evidence clotting (nmod)
complications life-threatening (amod)
maneuver compensates (acl:relcl)
recommended strategies (nsubj)
acid antagonist (compound)
mg/d at (case)
beta-adrenoceptor prejunctional (amod)
effect no (det)
attended complete (advcl)
0 80 (conj)
preventing ulceration (dobj)
induces tachycardia (dobj)
tested : (punct)
followed had (aux)
brains processed (acl)
ratio age (appos)
growth d (conj)
withdrawal and (cc)
measured baseline (nmod)
biochemical no (neg)
pentamidine with (case)
13 6 (compound)
dialysis intraoperative (amod)
associated ara-c (nsubjpass)
included injury (nsubj)
defects effects (conj)
motion average (dobj)
24 0 (compound)
inhibitors from (case)
require did (aux)
hormone lh-rh (appos)
alpha2abc-knockout and (cc)
cocaine-dependent twenty (compound)
reduced output (nsubjpass)
neuroblastoma active (amod)
necessary seizures (nmod)
adenocarcinoma of (case)
evaluated uropathy (nmod)
monitor oncologists (nsubj)
latency reduced (amod)
resolved months (nmod)
performed preoperatively (advmod)
subgroups in (case)
anemia cab-induced (amod)
levels hva (compound)
received diet (dobj)
bupivacaine reversion (appos)
nephritis to (case)
min 75 (nummod)
catalepsy mg/kg)-induced (amod)
pth ( (punct)
effects prenatal (amod)
increase months (nmod)
allowed ; (punct)
cortex anterior (amod)
treatment after (case)
prod , (punct)
association increase (nmod)
uridine of (case)
staff medical (amod)
diazepam bw (appos)
plausible development (nsubj)
5.1 1.6 (nummod)
protein increased (amod)
misoprostol dysfunction (nmod)
nicotine between (case)
had drug (dobj)
enzyme the (det)
outcomes symptom (compound)
doses 5 (nummod)
harm more (amod)
lacks ; (punct)
biochemistries . (punct)
degeneration , (punct)
number genes (nmod)
achieved induction (nmod)
comparable compromised (advcl)
identified half (nmod)
treated 1 (conj)
3 to (dep)
selective men (nmod)
oil intraperitoneally (advmod)
fibers nociceptive (amod)
displacements different (amod)
lasted h (dobj)
behaviour latency (compound)
determination peak (amod)
p=0.05 ) (punct)
dg-5128 antagonist (compound)
complication ) (punct)
received half (nsubj)
genotyped were (auxpass)
none animals (nmod)
aplasia . (punct)
case induced (amod)
albumin with (case)
modulator nicotinic (amod)
monkeys 14 (nummod)
group ns (appos)
inconsistent been (cop)
anemic leukopenic (conj)
increase rat (nmod)
tight is (cop)
results 9.6-fold (appos)
samples striatal (amod)
effectively very (advmod)
ngal serum (dep)
aggravation 4 (nummod)
bromocriptine intravenous (amod)
order with (case)
gfp(+ donor-derived (amod)
cisplatin mg/m2 (appos)
presented failure (nmod)
remedy rapid (amod)
toxicity ingested (acl:relcl)
day nadir (nsubj)
hepatocytes in (case)
defect = (dep)
disorder no (neg)
actions convulsive (amod)
depleted da (dobj)
found papaverine (nmod)
85.4 7 (compound)
alteration response (nmod)
62 patients (nmod)
exception myalgia (appos)
challenge triniol (nmod)
compared use (nmod)
h p (dep)
controlling vomiting (dobj)
hyperplasia bha-induced (amod)
body foreign (amod)
potentiate toxicity (dobj)
transplantation by (case)
transplantation for (case)
anabolizing . (punct)
activity associated (acl:relcl)
detected were (auxpass)
engraftment of (case)
patients status (nmod)
site right (amod)
thoroughly most (advmod)
identification exposure (nmod)
areas of (case)
initiated starting (xcomp)
0.625 from (case)
concentration % (nmod)
have 7 (nmod)
reports studies (conj)
fed pair (nsubj)
n tumors (conj)
rp selective (amod)
usage agent (nmod)
ratios interval (appos)
receiving prior (advmod)
weeks that (nsubj)
received combination (dobj)
exhibit cells (nsubj)
describe injection (nmod)
administered weeks (nmod:tmod)
attention hyperalgesia (nmod)
abundance medulla (nmod)
choose medications (dobj)
treatments new (amod)
controversy a (det)
group pediatric (amod)
prescribing risk (ccomp)
mg/kg indomethacin (compound)
electrocardiograms unipolar (amod)
interventions surgical (amod)
mitochondria in (case)
group microg (compound)
exposure diazinon (nmod)
cycle basic (amod)
lindane induced (dep)
mass of (case)
p 0.05 (nummod)
events mitochondrial (amod)
action simultaneously (nmod)
cytokines il-1b (appos)
stz-icv ( (punct)
regimen an (det)
the 5-ht(6 (dep)
developed chf (dobj)
sold be (auxpass)
paired 2021 (compound)
densities ventricle (nmod)
promoted af (dobj)
neonates non-exposed (amod)
abnormalities system (nmod)
antagonist vasoactive (amod)
suggestive mechanism (nmod)
anxiety postoperative (amod)
characterized glomerular (nmod)
syndrome renal (amod)
intraperitonealinjection nh4cl (nmod)
carmofur derivative (amod)
components main (amod)
fusion processes (nmod)
enhanced they (nsubj)
flurothyl a (det)
metronidazole of (case)
% 4.7 (nummod)
abolish totally (advmod)
toxicity piglets (nmod)
occlusions of (case)
generated individuals (nmod)
unmask conclusion (nsubj)
samples forearm (compound)
structure renal (amod)
kidney left (amod)
hypertension acute (amod)
had > (xcomp)
manageable and (cc)
metronidazole dosage (appos)
fit i.e. (dep)
declined infusions (nmod)
dystrophy polyneuropathy (conj)
restored stl1 (dobj)
due to (pcomp)
velocity fell (acl:relcl)
beneficial management (nmod)
referred was (auxpass)
risk with (nmod)
indicating occurs (ccomp)
induced haloperidol (nmod)
effects beating (advcl)
tools agents (nsubj)
absence vesicles (nmod)
surveillance and (cc)
found reduction (nmod)
correlate glomerulosclerosis (nmod)
imaging dw (compound)
13 symptoms (nmod)
taking ; (punct)
severity delirium (nmod)
toxicity : (punct)
chloride injected (acl)
pressure both (cc:preconj)
content basis (nmod)
appeared parallel (nmod)
data including (case)
experienced overall (advmod)
dates , (punct)
desensitization beta-adrenoceptor (compound)
drug furthermore (advmod)
contribution its (nmod:poss)
level opiate (amod)
harvested brains (nsubj)
deaths cancer (nmod)
interferon with (case)
pathogenesis of (case)
study postmarketing (compound)
298+/-7 ) (punct)
pressure measure (appos)
superior aspirin (nmod)
muscle-lengths/s p (dep)
march 2005 (nummod)
1990 and (cc)
followed intubation (nmod)
change % (appos)
work-up a (det)
t1/2 ) (punct)
mg/m(2 cisplatin (nmod)
-cimetidine , (punct)
exposure dexamethasone (compound)
negativity hbeag (compound)
methodology eye (appos)
based variable (nsubjpass)
followed washout (nmod)
syndrome sinusoidal (amod)
properties vasoactive (amod)
alpha- beta-configurations (conj)
women bladder (nmod)
reduced phenylalanine (nsubj)
safe tolerated (conj)
aged 75 (dobj)
pharmacists from (case)
u/l 40 (nummod)
monkeys 15 (nummod)
years before (case)
subject metabolism (nmod)
organs irrespective (amod)
february 1996 (nummod)
ptcr tg (conj)
blockers these (det)
bradycardia dysphagia (conj)
elicited catalepsy (nsubjpass)
terminate can (aux)
used host (nmod)
states gastric (amod)
features non-specific (amod)
related have (aux)
test recall (nmod)
failure agents (conj)
morphology changes (conj)
woman 41-year-old (amod)
investigation follow-up (compound)
fragility osmotic (amod)
induces hearts (nmod)
features encephalopathy (nmod)
ingesting ceftriaxone (dobj)
days to (case)
dopamine infusion-produced (amod)
occurred dependent (conj)
observed decrease (nsubjpass)
normal of (case)
ratings vas (compound)
unlikely . (punct)
metoprolol plus (cc)
suspected highly (advmod)
differ groups (nsubj)
intraperitoneal by (case)
suggest releases (ccomp)
recorded five (conj)
3.82 to (case)
indicate correlate (ccomp)
comparisons no (det)
given they (nsubjpass)
rep treat (compound)
meshwork trabecular (amod)
depression minimal (amod)
1433 154 (compound)
adjacent hematoma (nmod)
immunosuppression sirolimus-based (amod)
concentration reduced (amod)
three , (punct)
stimulating via (mark)
catheter and (cc)
acute vs. (cc)
sequelae neurological (amod)
evidence microscopic (amod)
fpd prolonged (amod)
wk initiation (dep)
34.0 was (cop)
published recently (advmod)
appears reflex (xcomp)
involved points (nmod)
m(2)-selective pirenzepine (conj)
injection pan (compound)
switches hypomania (nmod)
response biphasic (amod)
rates age-specific (amod)
function nmda (compound)
ibuprofen 1.51 (dep)
intake drug (compound)
fungi pathogenic (amod)
patients esrd (compound)
induced picrotoxin (nmod)
stages dependence (nmod)
aminonucleoside chronic (amod)
infections seizures (conj)
avoid some (dobj)
bradykinin hyperalgesia (compound)
courses patient (nmod)
describe effects (dobj)
e13.5 ) (punct)
period preweaning (amod)
restricted not (neg)
fps values (conj)
few gastrointestinal (conj)
recorded women (nmod)
maneuver vagal (amod)
determined ) (punct)
hr ] (punct)
controlling certain (dobj)
propensity increased (amod)
males age (dep)
taking currently (advmod)
patient surgery (conj)
noted hemoglobinuria (nsubjpass)
morphine regional (conj)
period screening (amod)
children experienced (acl:relcl)
groups frlma (appos)
consistent time (nsubj)
pregnancy before (case)
cows jersey (compound)
density increased (amod)
hyperactivity rats (nmod)
took one (nsubj)
suggest affect (ccomp)
shown years (nmod)
polychemotherapy in (case)
influx macrophage (compound)
differed ) (punct)
function balance (conj)
oxygenation flow (conj)
volume an (det)
exploited may (aux)
range microg (compound)
equal , (punct)
improved noted (advcl)
performance people (nmod)
index 16 (nummod)
halothane or (cc)
placed relying (xcomp)
diagnosis an (det)
gene 1 (nummod)
investigate to (aux)
conclusion ameliorates (appos)
revealed test (nmod)
myalgia occurrence (conj)
levels testosterone (nmod)
increased equally (advmod)
failure to (case)
discuss and (cc)
inability to (case)
loss painless (amod)
push of (case)
attenuate also (advmod)
phenacetin or (cc)
blockade losartan (nmod)
coefficient variation (nmod)
inhibition concurrent (amod)
puncture extension (conj)
review practical (amod)
time to (dep)
dose lovastatin (nmod)
leukocyturia the (det)
microangiopathy failure (conj)
position evaluate (acl)
13,000 of (case)
form arthritis (nmod)
haloperidol doses (nmod)
distance margin (compound)
terminal prostaglandin (dep)
mg.kg(-1).d(-1 ) (punct)
included , (punct)
inhibition glycoprotein (compound)
mania induced (acl)
berlin west (compound)
appears 1mg/kg (xcomp)
mg/kg epinephrine (compound)
profile selective (amod)
receive one (dobj)
cocaine lidocaine (conj)
neuropathy affected (conj)
provide to (mark)
prevent although (mark)
receive boluses (dobj)
medication cessation (nmod)
administration bolus (nmod)
meat , (punct)
identified year (conj)
identify ) (punct)
crea ( (punct)
vasoconstriction and (cc)
clonidine naphazoline (conj)
disrupting and (cc)
seizures regarding (case)
patients relative (amod)
erdosteine with (case)
rs6693503 rs1805054 (conj)
hl ( (punct)
conclude useful (ccomp)
aed a (det)
measured scale (nmod)
antigen-positive proliferating (amod)
underwent had (conj)
effective hr (nmod)
encode the (det)
proven danazol (nsubj)
seems mediated (xcomp)
salt bile (compound)
response aorta (nmod)
psychostimulant a (det)
preexposure and (cc)
influence calcification (nmod)
supervision under (case)
decreased attenuated (conj)
revealed and (cc)
drugs multiple (amod)
have efficacy (nmod)
injected 50 (nmod)
resulting lna+hca (dobj)
erythematosus polymyositis (conj)
admixed salts (nmod)
provoke release (nsubj)
exchanges sister (compound)
subjects investigation (nmod)
effect i.v. (nmod)
received placebo (nmod)
recipient cystitis (nmod)
influence outcome (dobj)
lorazepam of (case)
paralleled resurgence (nmod)
elevated showed (conj)
1080 - (punct)
range glomerulopathies (nmod)
mg)-containing 1 (compound)
analgesic ) (punct)
considered evaluation (nmod)
necessary patients (nmod)
15 7 (compound)
pressure , (punct)
tumor-free because (mark)
recived , (punct)
adding mesna (dobj)
disease angina (conj)
3.3 ) (punct)
dox 1.25 (nummod)
increases % (conj)
questioned have (aux)
conclusion high (appos)
point prespecified (amod)
ablation mice (nmod)
action model (nmod)
conjunctiva to (case)
used types (nsubjpass)
scanner the (det)
sequence , (punct)
dmso/side microg/0.5 (nummod)
resulted depletion (nmod)
asystole lidocaine-induced (amod)
patients 22 (nummod)
impairment regulation (nmod)
prevented reduced (conj)
cycles basic (amod)
during , (punct)
seen that (mark)
studied mg/day (parataxis)
auc 6 (nmod)
water mg/ml (appos)
slowing with (case)
ventricle left (amod)
30 175 (conj)
experienced , (punct)
270 , (punct)
different statistically (advmod)
site pontis (nmod)
cases avoidable (amod)
flexion/extension ( (punct)
doses fully-effective (amod)
cholestatic ) (punct)
version by (case)
induces delayed (conj)
ondansetron following (case)
dose vaccine (compound)
jaundice symptoms (conj)
presented initially (advmod)
reports single (amod)
production on (case)
1.1 1.4 (dep)
malfunctioning an (det)
falls less (nmod)
animals of (case)
decreases % (nmod)
parallel effect (nmod)
tobramycin 54 (nummod)
thrombopoetin of (case)
er the (det)
system stimulated (amod)
term of (case)
low dose (nsubj)
describes associations (dobj)
transferred equipment (nmod)
restrictive very (advmod)
= 7.9 (dep)
complication described (acl)
spasm by (case)
level-dependent blood (compound)
performed dox-rats (nmod)
tiopronin and (cc)
psychoses , (punct)
oxidase cco (appos)
multicenter mellitus (conj)
appeared one (nsubj)
modulate seizures (dobj)
onset hyperammonemia (nmod)
thrombocytopenia and (cc)
unrelieved was (auxpass)
configuration tissue (nmod)
hypertension evident (acl:relcl)
microgramg/ml ( (punct)
fields ) (punct)
associated would (aux)
remedy activity (nmod)
treatment cytotoxicity (nmod)
dehydrogenase activation (dep)
malignancies with (case)
improved symptoms (nsubj)
buffer in (case)
atypicality chronicity (conj)
change gap43-ir (nmod)
years with (case)
attacks anginal (amod)
age 10.4 (nummod)
combinations two (nummod)
decrease infection (dobj)
contribution receptors (nmod)
followed decline (nmod)
objective designed (dep)
rhabdomyolysis stroke (conj)
studies many (amod)
esrd associated (acl)
events drug (compound)
administration molindone (compound)
oxytocics of (case)
reduced pj34 (nmod)
pvn in (case)
leukemia with (case)
administered phosphate (nsubjpass)
administered divided (advcl)
hypotension peptide-produced (amod)
equipotent were (cop)
canine rabbit (conj)
alternative imaging (nmod)
drug antiparkinsonian (compound)
had condition (nmod)
became hypothermic (acomp)
recovery functions (nmod)
trated , (punct)
cytopenias all (det)
correlates activation (nmod)
alpha-tc either (cc:preconj)
black controls (nmod)
4-damp ( (punct)
considered it (nsubjpass)
reputation a (det)
describe effect (dobj)
turnover in (case)
measures women (nmod)
extend , (punct)
defined yield (nsubjpass)
presentation hyperacute (amod)
studied rats (nsubjpass)
presence steroids (nmod)
diminished rigidity (dobj)
consistent degeneration (nmod)
episodes arrest (nmod)
tam by (case)
function properties (conj)
one effective (conj)
20.3 8.4 (conj)
cisplatin risk (conj)
tolerated were (auxpass)
indicated already (advmod)
induces nephropathy (dobj)
bolus and (cc)
thresholds auditory (amod)
week 6 (nummod)
explained comorbidities (nmod)
known what (nsubjpass)
trial carcinoma (nmod)
sequelae ketoconazole-induced (amod)
concealed was (auxpass)
circumstantial remains (conj)
toxicity lidocaine (compound)
dizziness palpitation (conj)
mass patient (nmod)
frequent tricuspid (dep)
standard- haloperidol (dep)
inhibitors cyclooxygenase-2 (compound)
dosage mg (nmod)
epirubicin cyclophosphamide (conj)
enhancement learning (nmod)
report to (case)
marmoset levodopa-treated (amod)
assessment potential (nmod)
cyclophosphamide analogue (dep)
checked decreases (advcl)
underwent surgery (dobj)
support and (cc)
associated srl (nmod)
overdose phenylpropanolamine (compound)
degeneration changes (conj)
function his (nmod:poss)
time clotting (compound)
effective lamivudine (nsubj)
undertook characterize (advcl)
precursor dopamine (compound)
effect myopathy (nsubj)
values alt (compound)
incidence urolithiasis (nmod)
knife gamma (compound)
induction maintenance (conj)
tolerance a (det)
described now (advmod)
subject within (case)
facilitate effectively (advmod)
immunoassay pg/ml (appos)
that above (case)
effects drops (nmod)
groups any (nmod)
striatum encephalomalacia (appos)
lidocaine phase (nmod)
days between (case)
8.9 +/- (cc)
earlier . (punct)
relation disease (conj)
methadone of (case)
tjs hepatocyte (compound)
scored extent (nmod)
profiles/sections ( (punct)
sedated patients (nsubjpass)
range patients (conj)
counts cell (compound)
activity pressure (conj)
fluid in (case)
degrees from (case)
ctni ctnt (conj)
outcomes risperidone (nmod)
paucity a (det)
cause hepatotoxicity (nsubj)
therapy risk (dep)
mm > (conj)
added medication (nmod)
unreported literature (nmod)
anencephaly aor (appos)
daily times (nmod:npmod)
failure treatment (compound)
more threefold (advmod)
restriction mechanical (amod)
benign but (cc)
distinct kindling (nmod)
mg/lb 9.1 (nummod)
amount and (cc)
treatment effect (nmod)
assessed was (auxpass)
discontinued drug (nsubjpass)
fluoxetine antidepressant (amod)
reason was (cop)
compared . (punct)
compensation deficiency (nmod)
9 25 (dep)
oral galactose (dep)
100 30 (compound)
features failure (nmod)
receptor-alpha factor (appos)
129 0.6 (conj)
source calcium (compound)
carried confirm (xcomp)
inhibited oih (dobj)
demonstrated could (aux)
report added (ccomp)
position from (case)
complication failure (nsubj)
disturbances significant (amod)
difficult essential (conj)
points 5 (nummod)
implicating clarithromycin (dobj)
administration p=0.345 (appos)
gyrus hippocampal (compound)
fat dietary (amod)
efficacy netilmicin (nmod)
improvements because (case)
infusion significantly (advmod)
lidocaine = (dep)
proteinuria increased (amod)
eight cases (nmod)
procedure after (case)
response selection (nmod)
drug anxiolytic (amod)
body 40 (nummod)
treatment versus (case)
score reaction (compound)
transplant a (det)
ratios ) (punct)
predisposed disease (nsubj)
significance slight (amod)
resulted one (nsubj)
identification echocardiographic (amod)
preceded intervals (nmod)
fviiirag ) (punct)
show users (nsubj)
stopped . (punct)
5 or (cc)
preceded usually (advmod)
phospholipid of (case)
vmax the (det)
toxicity magnesium (nmod)
lymphocytes rabbit (nmod:poss)
interval 1.52 (nummod)
effect effect (nmod)
% 215 (nummod)
flecainide inhibitor (appos)
variables architecture (compound)
conclusions aware (appos)
detected reductions (nsubjpass)
occurred elevation (nsubj)
chlorpheniramine placebo (conj)
seen capillaries (nsubjpass)
effect sevoflurane-sparing (amod)
group multicenter (compound)
days 100 (nummod)
sinus or (cc)
-placebo and (cc)
biomarkers of (case)
excretion with (case)
subjected showed (conj)
subjects 6 (nummod)
4/- 0.8 (nummod)
population fibre (amod)
11.7 +/- (cc)
effects anticonvulsive (amod)
aged 65 (nmod)
tingling with (case)
aspirin . (punct)
bottle a (det)
arrest clonidine (nmod)
objectives study (dep)
evident having (advcl)
sensitivity an (det)
patients cardiomegaly (nmod)
creatinine 4.6 (nummod)
probable it (nsubj)
studies imaging (compound)
33.42 3.10 (conj)
given chronically (advmod)
moderate severe (conj)
tests co2-rebreathing (amod)
heart to (case)
reported months (nmod)
prescribed losartan (nsubjpass)
htr6 patients (conj)
developed subsequently (advmod)
revealed weeks (nsubj)
cats as (cc)
seems recurrent (xcomp)
such rather (dep)
because of (mwe)
micrograms from (case)
girl given (acl:relcl)
frequency basal (amod)
strains six (nummod)
30.8 2.5 (conj)
mi a (det)
post-lt died (dep)
pg-9 releaser (compound)
contractions and (cc)
-14.8 respectively (advmod)
marker or (cc)
indices nephrotoxicity (nmod)
cause excretion (dobj)
mi suspected (amod)
immunoglobulin complement (conj)
associations hyperkalemia (nmod)
follow-up carried (conj)
analgesic 0.001 (appos)
dose adr (nmod)
injection spinal (amod)
consistent more (advmod)
alter meth (nsubj)
courses of (case)
database transplant (compound)
role generation (nmod)
microg/kg/min ketamine (nmod)
elevated while (mark)
diet either (det)
found coefficient (ccomp)
eu 10 (compound)
catabolism functional (amod)
320 3 (compound)
signs toxicity (compound)
attenuated dose (nsubj)
observed compared (advcl)
transplant bone (compound)
consumption o2 (compound)
call certainly (advmod)
blurring % (appos)
addition from (case)
hormone stimulating (compound)
3 1 (conj)
related pretreatment (nmod)
showed suggesting (advcl)
meth by (case)
test first (amod)
equivalent approximately (advmod)
2mls ) (punct)
ache ( (punct)
respiratory severe (amod)
decreased velocity (dobj)
intervals beat-to-beat (amod)
remains model (dobj)
infection simultaneous (amod)
patient a (det)
resembling models (xcomp)
urine sodium (conj)
showed cardioprotection (dobj)
primary two (conj)
pneumonitis amiodarone (amod)
shoed microscopy (nmod)
leads study (nsubj)
pathway a (det)
observed proliferation (nsubjpass)
concentration minutes (nmod)
adhesions tissue (compound)
kg respectively (advmod)
aspirin , (punct)
recurrent with (case)
contributes maintenance (nmod)
patients 37 (nummod)
controls saline-pretreated (amod)
investigation involvement (nmod)
patients non-lithium-treated (amod)
mediated group (nmod)
bowman 's (case)
diseases of (case)
areas motor (compound)
disorder ( (punct)
disturbances abuse (conj)
need scrutiny (nmod)
investigated relationship (dobj)
mediating nephropathy (nmod)
pacing burst (compound)
postulated based (prep)
affected degrees (nmod)
days -13 (nummod)
dosage maximum (compound)
has controversial (conj)
regimen dopamine (conj)
receiving of (mark)
alternatives heparin (nmod)
capable inducing (advcl)
headache or (cc)
developed arrest (nmod)
13 of (advmod)
disintegrin and (cc)
reported symptoms (nsubjpass)
potentiated = (advcl)
influence which (nsubj)
indicate cause (ccomp)
network neuronal (amod)
inferred could (aux)
degree unique (amod)
cr 14/15 (nummod)
active-w trial (appos)
stratum 1 (dep)
sem mm (compound)
3/20 rat (appos)
medulla mice (nmod)
evokes it (nsubj)
seizures cocaine-induced (amod)
prominent was (cop)
observation careful (amod)
interval median (amod)
compared conjunction (nmod)
combination thalidomide (nmod)
hypoxemia and (cc)
involved aura (nmod)
stained dyes (nmod)
neurons to (case)
tourniquets four (nummod)
range not (neg)
exacerbated . (punct)
acid 3-mercaptopropionic (amod)
dose human (amod)
kinases macrophages (conj)
day tomography (dep)
inhibited k-8644 (nsubj)
tool is (cop)
cocaine-induced acute (amod)
diuresis induced (acl)
cerebellum rat (compound)
prescribed later (advmod)
effect sex (nmod)
potential drug (compound)
occurred days (nmod)
symptom a (det)
alternative ce (nsubj)
suggests thus (advmod)
combined antidepressants (nmod)
src with (case)
normalization a (det)
treated terbutaline (nmod)
treatment stimulation (nsubj)
insufficiency model (nmod)
mv ) (punct)
evidence malignancy (nmod)
revealed biochemical (dobj)
stabilized months (nmod)
assigned measured (conj)
study study (conj)
generation such (case)
hypotension marked (acl:relcl)
noted subarachnoid (nsubjpass)
mrna ventricular (amod)
angiography intravenous (amod)
points need (nmod)
bands affected (amod)
examination . (punct)
machinery with (case)
alpha +/- (cc)
manage operations (nmod)
improvement as (case)
retention- the (det)
rate uptake (nmod)
observed findings (nsubjpass)
leukemia all (appos)
alpha2abc-/- ) (punct)
mainstay been (cop)
score arrhythmia (compound)
complications central (amod)
proven histologically (advmod)
findings mris (nmod)
finding patients (nmod)
1.1 0.7 (nummod)
compared newborns (nsubjpass)
uncommon combined (advcl)
scores relating (acl)
factor major (amod)
exists effect (nmod)
concentration same (amod)
influence tonic (amod)
rate arterial (amod)
received pamidronate (dobj)
subsides because (mark)
symptoms arthralgia (dep)
prophylaxis infants (nmod)
hypotension cent (conj)
centre tunisian (amod)
means increase (nmod)
ugt ) (punct)
determine risk (dobj)
evident fibers (nsubj)
patients lv (nmod)
generated , (punct)
delirium concentrations (nmod)
detected unless (mark)
patients amyloidosis (nmod)
mg.kg(-1 80 (nummod)
diagnosed arrhythmia (nsubjpass)
elevations st-segment (amod)
tasks type (compound)
symptoms elevation (conj)
stenosis no (det)
history suspected (amod)
decompression neurolysis (conj)
bw 30.0 (nummod)
induced kanamycin-dextran (nmod)
abecarnil of (case)
induced glomerulopathy (nsubjpass)
combined lamivudine (nmod)
pars the (det)
effects convulsions (nmod)
nefiracetam mg/kg (appos)
retardation iugr (appos)
pressure absolute (amod)
demographics results (conj)
difference an (det)
ester ( (punct)
modulator receptor (compound)
play required (conj)
benefit would (aux)
combination bortezomib/dexamethasone (nmod)
returned normal (nmod)
consequence treatment (nmod)
minimal ) (punct)
reaction characterized (acl)
this with (case)
norepinephrine intra-arterial (amod)
within across (conj)
free initially (advmod)
rare were (cop)
limits . (punct)
transporter of (case)
1187 441.2 (conj)
seizures new-onset (amod)
mg extended-release/20 (nmod)
notable only (advmod)
followed hours (nmod)
frequent midazolam (nmod)
carbamazepine of (case)
h td (nmod)
changes into (case)
ameliorates dysfunction (dobj)
rammer mccarthy (dep)
experienced cardiomyopathy (advcl)
h q (det)
known been (auxpass)
vessels induced (acl)
reduced clipping (nmod)
hypertension from (case)
characterized use (nmod)
micrograms n (dep)
ly274614 , (punct)
man african-american (amod)
hypertension glomerulonephritis (conj)
stimulation ovarian (amod)
caused metoclopramide (nmod)
map adc (compound)
affect carvedilol (nsubj)
expression ccl2 (compound)
effect agent (nmod)
obtund response (dobj)
remains drug (attr)
hyperalgesia and (cc)
reported consequence (nmod)
plays eps (nmod)
kidneys human (amod)
umb24 with (case)
malaysians among (case)
using studies (nmod)
affects cisapride (nsubj)
convulsions in (case)
used case (nmod)
effects kidney (nmod)
tissues the (det)
function children (nmod)
delineated foci (nsubj)
associated aspects (nmod)
incorporation tam (compound)
trial iii (nummod)
outcomes evidence (conj)
measured thiols (nsubjpass)
synaptophysin and (cc)
hyponatremia of (case)
clonidine of (case)
dh ) (punct)
implants control (compound)
grade lower (amod)
mechanisms antioxidant (amod)
surveillance of (case)
reduction > (dep)
less 50 (conj)
received presented (conj)
dm mild (amod)
suggesting develop (ccomp)
case resulted (acl:relcl)
lactate elevated (amod)
safety global (amod)
experience current (amod)
failure associated (acl)
dose minimal (amod)
isoform p58 (compound)
others in (case)
presentation factors (conj)
relationship severity (nmod)
neoantigens recognized (acl)
evaluable showed (conj)
decreased concentrations (nsubjpass)
shown tdp (dobj)
immunoblotting quantitative (conj)
attributable 0.004 (nmod)
scale-revised memory (compound)
mediated degeneration (dep)
positive start (nmod)
chance a (det)
period 1-year (amod)
cascade triggered (acl)
those side (nmod)
had use (conj)
permeability areas (conj)
common . (punct)
% 8/18 (appos)
pathway be (cop)
compounds shown (acl:relcl)
cardiotoxin and (cc)
therapy lorazepam (compound)
electrocardiograms distributed (acl)
contributed % (nmod)
dose prior (case)
reactive light (nmod)
flumazenil fl (appos)
reactions . (punct)
nimo ( (punct)
duration ms (dep)
needed weeks (nmod)
toxicity optic (amod)
swelling protrusion (conj)
109.2 6.3 (conj)
immunosuppression rapamycin (compound)
mg given (acl)
erythroderma failure (conj)
blocker an-2-ol (appos)
revealed accompanied (advcl)
volume as (cc)
given months (nmod)
summary woman (dep)
remained however (advmod)
and progressively (advmod)
induced haloperidol (nsubj)
function neuromuscular (amod)
memory 2 (conj)
potent equally (advmod)
switchers relative (amod)
mg/kg 40 (nummod)
increased use (nsubj)
sensitization ) (punct)
protein multidrug (amod)
marketed us (nmod)
disappointing response (nsubj)
greater da (nmod)
erection prolonged (amod)
permitting treatment (dobj)
present increasing (conj)
randomized classes (nsubjpass)
observation close (amod)
decrease glomerular (amod)
excitotoxicity leading (acl)
use her (nmod:poss)
akathisia fluoxetine-induced (amod)
medium iodinated (amod)
eliminated which (nsubj)
nsaids nonselective (amod)
decrease % (nmod)
population german (amod)
was = (parataxis)
captopril by (case)
patients placebo (nmod)
enrolled and (cc)
had hemosiderosis (dobj)
h. owing (amod)
tdfs ( (punct)
have exposure (nsubj)
fall by (case)
melphalan followed (acl)
irrigated stomachs (nsubjpass)
analgesics with (case)
recordings his (nmod:poss)
cataract hypertension (conj)
ration cancer (nmod)
regimen of (case)
variation individual (amod)
man dysfunction (nmod)
% 114.6 (nmod)
benefit of (case)
model rat (compound)
objective poor (dep)
amb concomitant (amod)
reaction consisting (acl)
adjuvant potential (amod)
captopril-treated both (cc:preconj)
1/2 anti-hiv (compound)
voltarol ) (punct)
matched based (prep)
confusion nausea (conj)
study phase (nmod)
message home (compound)
fluctuations such (case)
diabetes streptozotocin (compound)
controls as (mark)
rats iprindole-treated (amod)
extract tissue (compound)
dipyrone analgesia (nmod)
developed hyperalgesia (dobj)
electrocardiogram her (nmod:poss)
placebo vs (cc)
model satisfactory (amod)
teratogenic is (cop)
party of (case)
exercise , (punct)
group received (acl:relcl)
pallidotomy to (mark)
ntg h (dep)
cck-8-ns ) (punct)
chlorpheniramine , (punct)
asphyxia leukomalacia (conj)
test elevated (amod)
curve characteristic (compound)
configuration structural (amod)
women 65 (nummod)
disturbances the (det)
cyclophosphamide anthracyclines (conj)
observed convulsions (nmod)
area anatomic (amod)
pcr taqman (compound)
follow-up months (nmod:npmod)
level striatal (amod)
factor-kappab , (punct)
drugs mellaril (appos)
ameliorate . (punct)
demonstrate ototoxicity (dobj)
host a (det)
decrease does (aux)
colliculus inferior (amod)
follows improvements (nsubj)
incidence episodes (nmod)
returned days (nmod)
obesity , (punct)
doses graded (amod)
hand marker (appos)
case treatment (nmod)
programme surveillance (compound)
abortion saline-induced (amod)
4 54 (nmod)
process oxidative (amod)
increases time (nmod)
akinesia tremor (conj)
treated control (conj)
activation groups (compound)
showed infiltrate (dobj)
personality antisocial (amod)
biosynthesis rna (compound)
saline intravenous (amod)
agency u.s. (compound)
examine modulating (advcl)
used schedule (nsubjpass)
barrier/density a (det)
established . (punct)
nitroglycerin intravenous (amod)
concentrations insulin (compound)
treated groups (nsubjpass)
81.5 . (punct)
hemiparesis manifestation (dep)
mg niacin (compound)
pathogenesis hemorrhage (nmod)
concerns theoretical (amod)
prevented vomiting (dobj)
supplement may (aux)
effects man (nmod)
suggest causes (ccomp)
father the (det)
activator ( (punct)
models pig (compound)
patients organ (compound)
able tri (nsubj)
inhibited inhibited (conj)
led normalization (nmod)
use inhibitor (nmod)
agent chemotherapy (compound)
impaired administration (nsubj)
imbalance have (aux)
cco of (case)
absence changes (nmod)
mg od (appos)
stimulation-evoked field (nmod:npmod)
rofecoxib ibuprofen (appos)
sensitivity norepinephrine (nmod)
ami dox (conj)
cells numerous (amod)
events 2,658 (nummod)
presence aap (nmod)
rates success (compound)
remained deficits (nsubj)
alt bun (conj)
depressed , (punct)
effects lactoferrin (nmod)
man metoprolol (nmod)
1a ii (nummod)
drop apraclonidine (nmod)
deficits behavioral (amod)
follows , (punct)
expression ldlr (compound)
maintained simvastatin (nmod)
different abnormal (conj)
reduction monitoring (nmod)
cyclophosphamide cy (appos)
injection steroid (compound)
established definitely (advmod)
using analysis (dobj)
using mice (dobj)
increase excitability (dobj)
rate free (amod)
deafening after (case)
change beats/min (appos)
associated % (conj)
diagnosis 17 (nmod)
tumors refractory (amod)
period early (amod)
remain pharmacology (nsubj)
weeks after (conj)
1 about (advmod)
groups s-i (compound)
cc ) (punct)
millions worldwide (advmod)
sample the (det)
performed infused (conj)
fangchinoline fan (appos)
metoprolol then (conj)
seems use (nsubj)
stimulated receptors (nmod)
find not (neg)
i or (cc)
arousal sexual (amod)
cumulative and (cc)
artery into (case)
fluorthyl- picrotoxin- (conj)
syndromes these (det)
agents nondepolarizing (amod)
investigated ecstasy (dep)
abdomen dullness (nmod)
nodes in (case)
resolution defects (nmod)
showed peak (dobj)
pressure derivative (conj)
stimuli only (cc:preconj)
measured addition (nmod)
0.39 0.17 (compound)
doxorubicin doxil (appos)
hypersensitivity of (case)
schedule duration (appos)
extraction of (case)
rated pain (dobj)
observed rats (nmod)
pregnancies of (case)
reaction toxicity (conj)
astrocytes hypertrophied (amod)
gvg ) (punct)
2003 - (punct)
contribute phenacetin (nsubj)
rated were (auxpass)
infection % (conj)
appears indication (xcomp)
increases occurred (conj)
iii ) (punct)
response serum (nmod)
effects possible (amod)
takes since (mark)
= 7/23 (nsubj)
took attempt (nmod)
sign disease (conj)
hydrolysis ed (nmod)
conclusions provides (appos)
definitive to (mark)
suspected clinically (advmod)
heat noxious (amod)
jj not (cc)
apnea , (punct)
circling sniffing (conj)
immunohistochemical microscopic (conj)
secreted astrocytes (nmod)
effects calcitonin (nmod)
april 2007 (nummod)
extent impairment (nmod)
doses intrathecal (amod)
dose daily (advmod)
amplified transcriptase (nmod)
placebo ) (punct)
support , (punct)
prl-r and (cc)
treatment followed (acl)
patients percent (appos)
estimated , (punct)
aida ) (punct)
relationships . (punct)
confirmed data (nsubjpass)
narcosis of (case)
patients co-infected (amod)
ecg ambulatory (amod)
patients baseline (nmod)
demand patients (nmod)
haloperidol mg (dobj)
infants vlbw (compound)
have much (dobj)
edema core (nmod)
sec. 300 (nummod)
days postlesion (dep)
having symptoms (dobj)
diligent clinicians (nsubj)
tolerance pg (nmod)
dose ketamine (nmod)
patients 405 (nummod)
shape normal (amod)
evaluated anemia (nmod)
suggests findings (nsubj)
polymyositis toxic (conj)
associated as (advmod)
expression response (dep)
anomalies wistar (nmod)
confirmed controls (nmod)
mdp , (punct)
developed course (nsubj)
counts complete (amod)
trial antiarrhythmic (amod)
somnolence constipation (conj)
test products (dobj)
were series (attr)
effective valsartan (nsubj)
vasculitis retinal (amod)
teams neurocritical (amod)
differentiated , (punct)
impairments domains (nmod)
satisfactory that (nmod)
intake water (compound)
capacity lower (amod)
intake solution (compound)
plate neural (amod)
greater than (mwe)
hemorrhagic ischemic (conj)
detected p (dep)
resistant however (advmod)
accumulation liver (nmod)
rigidity parkinsonian-like (amod)
per twice (advmod)
proteinuria peak (amod)
immunoassay research (compound)
dependent who (nsubj)
had 0.001 (parataxis)
related dementia (nmod)
dose tetrachloride (nmod)
acid component (appos)
regulates nucleus (nsubj)
51.7 +/- (cc)
expressed prominently (advmod)
unpleasant : (punct)
form administration (nmod)
40000 , (punct)
rate responses (conj)
imply slowing (nsubj)
hypocalcemia severe (amod)
basic clinical (conj)
captopril inhibitor (appos)
included because (mark)
seizure to (mark)
syndromes in (case)
transplantations the (det)
induction lethality (conj)
combination work (nmod)
pnd ) (punct)
losartan dysfunction (compound)
increase light (amod)
spasm oddi (compound)
0.001 0.004 (conj)
increases puromycin (nsubj)
function deficit (conj)
bn right (amod)
followed degeneration (nsubjpass)
n=6 , (punct)
serological functional (conj)
stimulants or (cc)
deterioration ct (nmod)
1.54 from (case)
started man (nsubjpass)
administration anp (nmod)
exacerbated , (punct)
< ) (punct)
worsening administration (nmod)
administration mechanism (conj)
research basic (amod)
symptoms onset (appos)
prazosin subsequent (conj)
blockade flestolol (amod)
processes leading (acl)
event and (cc)
effect modifying (compound)
that in (case)
detect cases (dobj)
% ef (nsubj)
dysguesia is (cop)
function graft (compound)
have levobupivacaine (nsubj)
mean neonates (nmod)
extraction [3h]-l-arginine (compound)
supposed therefore (advmod)
8th at (case)
pathways ascending (compound)
loss normalization (conj)
mg/m2 75 (nummod)
rates exercise (conj)
administered solution (dobj)
values 63.5 (appos)
indicators could (aux)
deserve follow (dobj)
measures provided (case)
sedated diazepam (nmod)
licensed ribavirin (nsubjpass)
period effective (amod)
interaction responses (nmod)
checklist scale-revised (conj)
once enrolment (nmod)
intolerance , (punct)
polymorphic were (cop)
study core (compound)
crocins 15 (dep)
infants very (amod)
data perioperative (amod)
decrease whether (mark)
administered indomethacin (nsubjpass)
class status (compound)
contraindication if (mark)
ci 1.06 (nummod)
breathing closing (conj)
1979 between (case)
improve reduce (conj)
appeared eyes (nsubj)
improved significantly (advmod)
rabbits dogs (conj)
reattempted post-lt (dobj)
dosage his (nmod:poss)
structure causes (acl:relcl)
cause only (amod)
nitrogen mg/dl (amod)
days fifty-six (nummod)
interactions 3a4 (compound)
discontinuation treatment (compound)
detection early (amod)
decrease mainly (advmod)
ruled causes (nsubjpass)
eye such (case)
transection , (punct)
induce hemorrhage (dobj)
access 12-h (amod)
co ( (punct)
affinities high (amod)
clinical monitoring (nmod)
4/7 ( (punct)
seems cause (xcomp)
factors growth (compound)
developed years (nmod)
associated episodes (nmod)
test by (case)
induction anaesthesia (nmod)
formation cataract (amod)
administered androgens (dobj)
demonstrated olanzapine (nsubj)
prevented % (nmod)
days 28 (nummod)
prescribed chemotherapy (nmod)
patient recovery (conj)
hours doses (nmod)
enflurane of (case)
currents of (case)
recall that (dobj)
0.06 0.7 (conj)
biopsy nonepisode (compound)
ct during (case)
reduced movements (dobj)
traveled compared (advcl)
inconclusive positive (conj)
raises antagonism (nsubj)
marked , (punct)
non-smokers mothers (nsubj)
map ) (punct)
formed is (auxpass)
patients loads (nmod)
mg sulfate (nmod)
hemorrhaging and (cc)
treatment cocaine (compound)
induced carcinomas (dobj)
changed factors (nsubj)
men of (case)
hematotoxicity similar (amod)
determined therefore (advmod)
receptors both (cc:preconj)
binding brain (nmod)
content rats (nmod)
demonstrates vulnerability (dobj)
solution dilevalol (nmod)
effect be (cop)
morphology expression (conj)
myd88 ( (punct)
seen was (auxpass)
impaired treatment (nmod)
perseveration and (cc)
groups 10-micrograms/kg (compound)
aimed comparison (nmod)
serotonin and (cc)
saline 0.001 (appos)
benign although (mark)
assess effect (dobj)
journals non-indexed (amod)
predict . (punct)
unable were (cop)
complete appeared (conj)
paramethasone and (cc)
dose ingested (amod)
furosemide infusion (conj)
hypercalcemias those (conj)
patients 529 (nummod)
effect inhibitory (amod)
review patients (nmod)
sedation subjective (amod)
hypertensives of (case)
day from (case)
latency (pcp)-induced (amod)
inhibitor aromatase (compound)
use risperidone (nmod)
had specimen (nsubj)
measured then (advmod)
develop glaucoma (dobj)
occurred majority (nsubj)
indicator disturbances (nmod)
i.v. mg/kg (compound)
tissues all (det:predet)
spectrum autism (compound)
had stones (dobj)
saline l (conj)
nfs of (case)
cause it (nsubj)
arrhythmia induced (acl)
etiology cystica (nmod)
86 ( (punct)
antidepressant monocyclic (amod)
rare extremely (advmod)
etiology patients (nmod)
followed succinylcholine (nmod)
hearts innervated (amod)
induction anaesthesia (compound)
catheter central (amod)
effects nsaids (nmod)
dips head (amod)
measured particles (nmod)
increases line (nmod)
weekly ribavirin (conj)
genotype ace (compound)
morphine or (cc)
behaviors distinct (amod)
effect long-lasting (amod)
class functional (amod)
fibrillation , (punct)
toxicity no (neg)
arterial mixed (conj)
assessment signal (nmod)
mean microg% (punct)
failure unexplained (amod)
loss expression (conj)
consisted . (punct)
induced ; (punct)
patients al (compound)
treated patients (dobj)
suggest have (conj)
1187 +/- (cc)
data controls (conj)
exists safety (nmod)
insecticide of (case)
relief faster (amod)
microl 10 (nummod)
rate dialysis (nmod)
add literature (nmod)
0.11 0.02 (conj)
scored loss (nsubjpass)
os ( (punct)
steroid aas (appos)
derangement an (det)
decline percent (compound)
sces ) (punct)
consumption necrosis (nmod)
diuretic that (mark)
fetuses male (amod)
parts parkinson (nmod:poss)
documented days (nmod)
production no (nmod)
0.28 0.004 (conj)
identified must (aux)
increase glutamate (nmod)
delay language (compound)
intensity veins (nmod)
women 11 (nummod)
supply the (det)
formation tissue (compound)
model studies (nmod)
issues phenomenon (appos)
improvement pharmaceutical (amod)
10.5 0.7 (conj)
correlated weight (nmod)
-0.81 ; (punct)
blood-brain-barrier bbb (appos)
treated regimens (nmod)
prevented should (aux)
effect pain (nsubj)
prominent group (nmod)
weight thymus (compound)
way long (amod)
cranial growth (nmod)
infections intrathoracic (amod)
oedema associated (amod)
attempts localize (xcomp)
continued min (nmod)
values mmol/l (nmod)
likely and (cc)
impairment against (case)
defects septal (amod)
choice corrected (advcl)
levels atp (compound)
calculated change (nsubjpass)
improves seems (parataxis)
cells surface (compound)
conditions off (amod)
total manic (dep)
determine physician (nsubj)
inpatients in (case)
male . (punct)
interval of (case)
doses high (amod)
immunolocalization 7h6 (nmod)
later years (nmod:npmod)
scale small (amod)
observation telemetric (amod)
none pseudomonas (nmod)
snp dogs (appos)
inflammation induced (acl)
order a (det)
administered nephrectomy (nmod)
center self-report (amod)
injury surrounding (amod)
respect with (case)
psychopathology not (neg)
absence hemorrhage (nmod)
measure marker (nmod)
rr=1.60 % (dep)
administration or (cc)
increased some (nsubj)
findings angiography (compound)
salivation and (cc)
acid saccharic (amod)
hexaaldose , (punct)
trimethoprim , (punct)
migraine hemiplegic (amod)
occurs level (nmod)
0.03 and (cc)
seemed users (nmod)
level population (nmod)
nephropathy or (cc)
grade i (dep)
formula the (det)
deduced participation (nsubjpass)
proving effective (xcomp)
paradigms two (nummod)
calculated divided (conj)
effect possible (amod)
determination by (case)
tachyarrhythmias cardiac (amod)
pretreatment cn (compound)
stress scores (conj)
death cardiac (amod)
retarding by (mark)
illicit use (dobj)
developed thrombophlebitis (dobj)
yields control (compound)
therapy propylthiouracil (compound)
compared kidney (nmod)
discussion resembles (appos)
demonstrated connecting (advcl)
cells astroglial (amod)
eating food (nmod)
syndrome partial (amod)
membranes 10(-8 (appos)
pretreatment acetate (nmod)
undergo and (cc)
hand ) (punct)
less comparison (nmod)
oxcarbazepine its (nmod:poss)
screening of (case)
reversion partial (amod)
density size (conj)
enzymes indicators (nmod)
quantified injuries (nsubjpass)
implications improve (acl)
alterations or (cc)
pathway may (aux)
hypertrophy developed (amod)
man elderly (amod)
species chain (nmod)
exhibited growth (nsubj)
reports segmental (nmod)
reflected film (nsubjpass)
reported she (nsubj)
16 deaths (nmod)
disorders such (case)
exerted effect (dobj)
placebo either (nmod)
depressed due (case)
aroused , (punct)
groups two (nummod)
opioid by (case)
drug safe (amod)
developed day (nmod)
children developed (acl:relcl)
associated latency (nmod)
effect morphine (nmod)
mg 0.5 (nummod)
20 times (quantmod)
receive . (punct)
evaluation thermographic (amod)
eyes in (case)
100 7 (conj)
revealed aminotransferase (dobj)
reporting dysfunctions (dobj)
lymphopenia and (cc)
observed activity (nmod)
plays induction (nmod)
high as (advmod)
levels cohort (nmod)
induces hypertrophy (dobj)
ibs with (case)
conclusions observed (appos)
elements cortex (nmod)
identify recalled (ccomp)
enhancers three (nummod)
lowered osmolality (dobj)
deficiency folate (compound)
interval related (amod)
micrograms t.i.d. (dobj)
indicators be (cop)
battery children (nmod)
weakness dystrophy (nmod)
audiograms , (punct)
mb users (nmod)
velocity together (advmod)
more which (nsubj)
conducting tests (dobj)
diet with (case)
patients 217 (nummod)
dogs 65 (nummod)
aging with (case)
cytology periodic (amod)
recovery good (amod)
administration cs (compound)
reviewed methods (nsubjpass)
normal size (conj)
treatment salvage (compound)
associated compliance (nmod)
modeling pharmacodynamic (amod)
test compartment (compound)
neurotransmitters brain (compound)
pvc multiple (amod)
processes to (case)
deletion chop (compound)
ph mm (dep)
alternation behaviours (conj)
scopolamine of (case)
level glutamate (compound)
effect nerve (nmod)
immunocytochemistry fluorescent (amod)
identified group (nsubj)
rate significant (amod)
decibels of (case)
transfusion-chelation regular (amod)
podocytes deposits (conj)
role permissive (amod)
society as (case)
akt phospho (amod)
psp ( (punct)
secretion vasopressin (nmod)
subcellular and (cc)
used practice (nmod)
alterations , (punct)
achieved levels (nsubjpass)
scale analog (compound)
appear therapy (nsubj)
markers serial (amod)
infiltrate lymphocytic (amod)
g ( (punct)
suppressed ee (nmod)
addition infusion (nmod)
symptoms man (nmod)
anemia associated (amod)
rigidity dose (nmod)
model appropriate (amod)
i.c. ) (punct)
antagonist = (amod)
received ip (dobj)
associated contributing (advcl)
history classification (conj)
investigated improve (ccomp)
effects nmdar (nmod)
cases hepatitis (nmod)
administration bepridil (amod)
protects cortex (dobj)
acids acids (conj)
phenobarbital of (case)
bolus infusions (dep)
vasculitis , (punct)
eliminated binding (dobj)
explored objectives (dep)
scanning from (case)
report conclusion (nmod)
liver also (advmod)
studies immunohistochemical (amod)
haart from (case)
impairment : (punct)
rats but (cc)
shares characteristics (dobj)
pronounced that (mark)
paralysis nondepolarizing (acl)
july 11 (nummod)
day 150 (nummod)
respect level (nmod)
units 298+/-7 (nummod)
compared jj (nmod)
time later (amod)
subacute usually (advmod)
patients subjected (acl)
conditions the (det)
generated was (auxpass)
secondary use (nmod)
disparities doses (nmod)
pressure substernal (amod)
inducing apoptosis (dobj)
dose quinidine (nmod)
g including (case)
mechanisms effects (nmod)
involvement noradrenergic (amod)
reduce can (aux)
adriamycin cardiomyopathy (amod)
assays quantitative (amod)
predisposes sepsis (nmod)
individuals obstruction (nmod)
therapy dose (compound)
70/min of (case)
cotransporter na-k-2cl (compound)
hospital care (compound)
vasoactive decrease (dep)
antibody hit (compound)
tremor the (det)
weeks ) (punct)
doses cumulative (amod)
pain severe (amod)
flestolol of (case)
ihc ) (punct)
agent probable (amod)
chemotherapy subtenon (compound)
hypocalcemia symptomatic (amod)
irritability attack (conj)
arms open (amod)
induce blockade (nsubj)
pain myoclonia (conj)
isopter perimetry (nmod)
superimposed polyneuropathy (dobj)
preparations medicine (compound)
reticulum of (case)
termination study (nmod)
withheld beta-agonists (nsubjpass)
incidence or (cc)
anemia chemotherapy-induced (amod)
programming low (amod)
patients 85 (nummod)
reported three (nsubjpass)
received they (nsubj)
concentration excretion (conj)
response challenge (nmod)
began puberty (nmod)
g ) (punct)
generates and (cc)
output rate (conj)
interfere exposure (nsubj)
carvedilol , (punct)
cornerstone as (case)
elevation ng/ml (compound)
ergotamine/caffeine migraine (nmod)
alternative was (cop)
observed effects (nsubjpass)
function overall (amod)
increased level (nsubjpass)
evaluation audiological (amod)
retention to (case)
giving octogenarians (nmod)
use substance (compound)
regimens dosing (compound)
event second (amod)
phosphorylation protein (compound)
measured value (nsubj)
telangiectatic insidiously (nmod)
mimic symptoms (dobj)
pretreatment mg (nmod)
protrusions luminal (amod)
clearance , (punct)
value uptake (compound)
effects psychotropic (amod)
hemorrhage headache (conj)
busulfan of (case)
diagnosis been (cop)
influence diameter (dobj)
induced immersed (dep)
stroke cerebral (amod)
deficient genetically (advmod)
patients 17 (nummod)
hypersensitivity system (nmod)
standard as (case)
increased survival (dobj)
26.3+/-3.6 vs (cc)
disease smoking-related (amod)
pressures all (det)
parkinsonian-like as (case)
number as (case)
hypertension upregulation (conj)
plants aconitum (compound)
or=12.619 , (punct)
factors delirium (nmod)
developed encephalopathy (dobj)
testing of (case)
handling water (compound)
myoclonus . (punct)
background exist (dep)
type heparin-induced (amod)
cause spasm (nsubj)
influence naloxone (nmod)
moran [ (punct)
killed then (advmod)
vasculitis mediated (amod)
occur prevalence (nmod)
120 740 (prep)
relevance clinical (compound)
demonstrated revealed (ccomp)
levels follow-up (nmod)
block persistence (conj)
structure different (amod)
induced thiopental (nmod)
indian most (amod)
period each (det)
cases failure (nmod)
increasing downregulating (conj)
deaths no (det)
mrna of (case)
difference may (aux)
novelty and (cc)
ptld of (case)
stainings immune (amod)
identified localization (dobj)
opioid-receptors the (det)
increases exposure (nsubj)
0.005 anova (nmod)
addition ephedrine (nmod)
ett ) (punct)
levels cholesterol (compound)
rheumatology including (case)
syndrome long (amod)
trial prevention (nmod)
acid glutamine (conj)
mm group (nmod)
fibrosis number (conj)
studies those (det)
changes infusion (nmod)
gtn and (cc)
titrate carbidopa-levodopa (advmod)
rejection renal (amod)
potentiated effects (dobj)
reducing transporter (dobj)
molars third (amod)
143 of (advmod)
anaemia face (nmod)
gds ( (punct)
consistent observations (nsubj)
ototoxicity their (nmod:poss)
hospitals birthing (amod)
mg change (nsubj)
cessation morphine (nmod)
remained untreated (xcomp)
progressive irreversible (conj)
played which (nsubj)
factors back-diffusion (nmod)
rr ) (punct)
farmer in (case)
maintenance speed (compound)
found use (nmod)
hematological toxicities (dep)
bupivacaine 22 (dep)
initiating failure (nmod)
abilities memory-altering (amod)
mg. 8.9 (nummod)
hla-b35 and (cc)
43 6 (compound)
all 1 (conj)
week 's (case)
disclosed patients (nmod)
exhibited decrease (dobj)
force services (compound)
term short (amod)
produce persons (nmod)
analyzed using (xcomp)
calcium magnesium (conj)
induce domperidone (nsubj)
suggest furthermore (advmod)
tone autonomic (amod)
nephrotoxicity vancomycin-induced (amod)
injections given (case)
aged weeks (nmod)
mmol/l 1 (nummod)
au 39+/-10 (nummod)
long protocol (nsubj)
1 is (cop)
tinnitus ist (appos)
5-ht by (case)
recurrence any (det)
associations observed (acl)
mechanisms catalepsy (nmod)
examinations detection (nmod)
using test (nmod)
evaluated completion (nmod)
h 8 (nummod)
clinical radiographic (conj)
induced that (mark)
precedes damage (nsubj)
occurred subjects (nmod)
subjects among (case)
steroids kindled-seizures (nmod)
cardona et (compound)
legs in (case)
reductions weight (nmod)
regardless volume (nmod)
decreased remained (conj)
drinking or (cc)
rate higher (amod)
lesions induced (amod)
reduced also (advmod)
amount tissue (nmod)
responses metabolic (amod)
technique available (amod)
controlling spread (dobj)
levels igf-i (compound)
surface number (dep)
mg/kg p<0.01 (appos)
rocuronium with (case)
matched 1:1 (dobj)
stl2 memory (appos)
correlated = (parataxis)
presenting in (case)
suspension forms (acl:relcl)
months 8 (nummod)
sch sulpiride (conj)
value methods (nmod)
activity excellent (amod)
relationship nigra (nmod)
time reduction (nmod)
as well (advmod)
clonidine restlessness (nmod)
use aspirin (compound)
paramount institution (nmod)
agent potential (amod)
differences obvious (amod)
effective gabapentin (nsubj)
set further (advmod)
confirm safety (dobj)
activation dopaminergic (amod)
maintain concentrations (dobj)
third developed (acl:relcl)
predictors disease (nmod)
advisable monitoring (nsubj)
wave u (compound)
disrupts how (advmod)
derangements function (nmod)
cycloheximide by (case)
effects multiple (amod)
produced bradycardia (nsubjpass)
6 9 (conj)
myocet doxorubicin (conj)
recorded malondialdehyde (nsubjpass)
group representative (acl:relcl)
epinephrine with (case)
records 407 (nummod)
underwent = (parataxis)
4.2 and (cc)
elevation ) (punct)
attenuates nephritis (dobj)
bleeding major (amod)
phenomena autonomic (amod)
fastigial cerebellar (amod)
consolidation caused (acl)
led experiments (nmod)
rate bleeds (nmod)
syndrome nms (appos)
radioactivity the (det)
sop to (case)
reabsorption microglobulinuria (amod)
94 of (advmod)
given immediately (advmod)
loss profound (amod)
female monkeys (conj)
showed partial (dobj)
necrosis was (cop)
hz 0.5v (appos)
leakage of (case)
studied formation (nsubjpass)
potential with (case)
sweating fair (amod)
revealed . (punct)
e1 addition (dep)
prevent hypertension (dobj)
n=101 ) (punct)
ointment dermatitis (nmod)
gain rhigf-i (compound)
increased hours (nmod)
scl of (case)
restore can (aux)
shown propensity (dobj)
mif ) (punct)
subjects 0.0005 (appos)
67.9 18.6 (conj)
antibodies with (case)
induced inpatient (nmod)
action undescribed (amod)
role injury (nmod)
performance block (nmod)
experts from (case)
seen months (conj)
evaluated examination (nmod)
dermatomes over (case)
found changes (nsubjpass)
follow-up seven (appos)
nucleus an (appos)
value plasma (compound)
opportunity observe (acl)
implausible , (punct)
weeks 14 (conj)
drug related (conj)
rated patients (nsubjpass)
children healthy (amod)
interviewing nurses (dobj)
normal during (case)
recognition drug (nmod)
type renal (amod)
revealed study (nsubj)
morphine plus (cc)
cause suggested (conj)
sequences in (case)
present tbm (nmod)
supplementation 1,2 (appos)
p gentamicin (conj)
attribute agitation (dobj)
resulted reversal (conj)
transferred quadriparesis (nmod)
overshooting % (nmod)
controls 10(-3 (dep)
considerations pathogenetic (amod)
period 1-hour (nummod)
toes one (nummod)
1.73 0.16 (conj)
absence gland (nmod)
unaltered was (auxpass)
has had (conj)
contained sampling (nmod)
neutralization in (case)
vehicles scopolamine (conj)
stimulated use (nmod)
cirrhosis micronodular (amod)
serious it (nsubj)
concern of (case)
intracerebroventricular by (case)
hippocampus behaviors (nmod)
loss combined (amod)
exacerbation without (case)
older . (punct)
vacuolisation myocyte (compound)
angiography pcag (appos)
toxicity despite (case)
signal the (det)
increase peptide (nmod)
injected ; (punct)
lines previous (amod)
syndrome patients (nmod)
lithium qtp (conj)
age > (case)
roles their (nmod:poss)
measurements 1 (nmod)
procedure interventional (amod)
patients transplantation (compound)
centre information (compound)
processed obtain (xcomp)
france in (case)
meningitis aureus (compound)
cases developed (acl:relcl)
grow average (nmod)
neurotransmission da (compound)
patients 35 (nummod)
discharged cta (nmod)
abnormalities significant (amod)
behavior rearing (amod)
time an (det)
cord less (amod)
records their (nmod:poss)
mz of (case)
agent induction (compound)
paroxysms focal (amod)
provided course (dobj)
reduce % (dobj)
used echocardiography (nsubjpass)
accelerated rhythms (dobj)
symptoms typical (amod)
cent ( (punct)
impairment side (nmod)
induces mice (nmod)
process an (det)
hypertension diabetics (nmod)
metastases seven (nummod)
flow plasma (compound)
protein the (det)
protect vpu (nsubj)
shifts might (aux)
victim a (det)
db bupivacaine (nmod)
dysfunction or (cc)
impair (+/-)-pg-9 (nsubj)
patients time (dep)
mibg ) (punct)
force peak (compound)
blood occult (compound)
extent greater (amod)
conditions medical (amod)
potent compound (nsubj)
infusion bicarbonate (compound)
reflexes adrenergic (amod)
preparation membrane (compound)
mg/m2 135 (nummod)
criteria using (acl)
infections systemic (amod)
risk cad (nmod)
model diabetic (amod)
attenuates dysfunction (dobj)
diseases medical (amod)
syndrome distress (compound)
increased sgk1(-/- (nmod)
toxicity potential (amod)
report group (nmod)
reported best (nmod)
consider treatment (dobj)
3,4-methylenedioxymethamphetamine mdma (dep)
period ten-year (amod)
associated tended (dep)
mg 0.3 (nummod)
deficiency relative (amod)
occurs bdl (nmod)
show animals (nsubj)
glomerulonephritis necrotising (amod)
affects isoproterenol (nsubj)
catatonia doc (appos)
exposed dose (nmod)
respect haematological (nmod)
received antibiotics (dobj)
patients sweating (conj)
agents antiarrhythmic (amod)
tube versus (case)
complexes mitochondrial (amod)
infection mice (nmod)
assess variations (dobj)
tasks of (case)
ra % (compound)
shown antagonists (nsubjpass)
patients no (neg)
mitogens also (advmod)
way or (cc)
complained photosensitivity (nmod)
study compare (acl)
% relief (nsubj)
cannulated bilaterally (advmod)
episodes no (neg)
management patients (nmod)
constituents active (amod)
displays effects (dobj)
drugs act (acl:relcl)
therapy to (case)
state in (case)
was history (nsubj)
cvd without (case)
channels hyperpolarization-activated (amod)
forepaw treading (dobj)
saline normal (amod)
lacrimation flow (conj)
related levels (nsubj)
complications chronic (amod)
lost . (punct)
hours surgery (nmod)
administered produce (conj)
received time (nmod)
dysfunction receptor (conj)
demographic 15 (nummod)
participants oc (compound)
consider prescribed (advcl)
p-coumarate with (case)
p p (appos)
investigated second (advmod)
animals four (nummod)
infusions paclitaxel (compound)
value lowered (amod)
% out-patients (nmod)
arthrogryposis rats (nmod)
reached dose (nsubjpass)
drugs putative (amod)
evidence reaction (nmod)
12 4 (compound)
response conditions (nmod)
dogs healthy (amod)
tomography peripheral (amod)
peak mean (compound)
worth be (cop)
group 5-wk (amod)
elderly between (case)
developed transfusion (nmod)
supports , (punct)
antineoplastic a (det)
1-receptor beta (compound)
improvement definite (amod)
events the (det)
hypertension weeks (conj)
vasospasm coronary (amod)
increases volume (nsubj)
photosensitivity flushing (conj)
requiring drug (dobj)
dose ntg (nmod)
activation due (case)
treatments antidepressive (amod)
alf=0/35 nine (conj)
bp albumin (conj)
available beverages (nmod)
convulsion in (case)
treatment doxorubicin (compound)
size model (nmod)
theophylline enprofylline (conj)
group newborns (nmod)
apomorphine hypothermia (nmod)
true especially (advmod)
use propranolol (nmod)
them among (case)
sensory as (case)
40 and (cc)
ratings , (punct)
using field (dobj)
targeted , (punct)
inhibitor therapy (conj)
dyskinesias peak-dose (amod)
placebo p (dep)
raises interference (dep)
maintained injections (nmod)
with and (cc)
proximal the (det)
staining serum-proteins (nmod)
0.99 ) (punct)
were precommunicating (advcl)
improved % (nmod)
glomerulus in (case)
fastigial the (det)
inactive ro4368554 (nsubj)
drug may (aux)
agitation death (conj)
received man (nsubj)
equipotent effects (nsubj)
processes shifting (dep)
investigated studies (nmod)
agent immunosuppressive (amod)
concentrations chp (compound)
lna+lca ) (punct)
acetate model (nmod)
ampicillin to (case)
af ) (punct)
stopped patients (nsubj)
contre de (compound)
passed stone (nsubj)
unchanged controls (nmod)
% concentration (nmod)
equilibrate effects (dobj)
ph acid (compound)
drugs ingested (amod)
pathophysiology common (amod)
cases exposed (amod)
weeks at (case)
showed rg1 (nsubj)
expression irritation (nmod)
covered areas (compound)
group 1 (conj)
adult a (det)
analysis kinetic (amod)
short relatively (advmod)
refractory were (cop)
resistance muscle (compound)
revealed lipophages (dobj)
feature is (cop)
caused haemorrhage (dobj)
anticoagulant and (cc)
7.0 ratio (nsubj)
findings cardiovascular (amod)
substantiated experiments (nsubj)
reduces rates (dobj)
scores total (amod)
cases on (case)
administration cocaine (nmod)
investigations drugs (nmod)
days five (nummod)
conclusions reducing (acl)
disrupted treatment (nsubj)
olr ) (punct)
infusion day (compound)
test passive-avoidance (compound)
caused daily (advmod)
6 11 (prep)
pg 1 (nummod)
aortic mitral (conj)
had four (nsubj)
have effect (dobj)
developing esrd (dobj)
emotion basic (amod)
mg with (case)
3 - (punct)
iop mm (nmod)
diuretic amiloride (appos)
made artery (nmod)
scheduled persisting (advcl)
presented case (conj)
form each (det)
occlusion fluoxetine (conj)
toxic hereditary (conj)
weak delayed (conj)
increases epilepticus (nsubj)
appears decrease (xcomp)
monotherapy 5-mg (amod)
application an (det)
range high-frequency (compound)
p.o. mg (nummod)
involves that (mark)
nsc ) (punct)
result confounding (nmod)
patients 414 (nummod)
demonstrated team (nsubj)
antidepressants serotonergic (amod)
nd versus (cc)
nm ki=180 (compound)
confirm it (dobj)
-tacrolimus fk (appos)
damaged always (advmod)
exposure alcohol (compound)
remains under-diagnosed (acomp)
altered are (auxpass)
produces diet (nsubj)
control orthostatic (amod)
dithiothreitol heat (conj)
support to (mark)
surgery sections (nmod)
transplantation full-size (amod)
shown validate (advcl)
mrna vascular (amod)
scenario a (det)
3.7 ( (punct)
errors medication (compound)
divided . (punct)
substances both (det)
warfarin by (case)
history lymphoma (nmod)
related age (nmod:npmod)
recorded ) (punct)
fixed convulsive (conj)
drug previous (amod)
glyburide for (case)
series behaviors (nmod)
aimed : (punct)
amines pineal (nmod)
received . (punct)
mononucleosis infectious (amod)
resulted furthermore (advmod)
lead function (nmod)
activities cord (compound)
role digoxin (nmod)
nausea . (punct)
convulsions i.p.)-induced (amod)
stopped , (punct)
increases vulnerability (dobj)
examination intraoral (amod)
transaminases serum (compound)
results 447 (appos)
preparations low (amod)
activation similar (amod)
administration droperidol (compound)
case present (amod)
core ) (punct)
had manifested (advcl)
severe 24 (nmod)
lesions 5-ht (compound)
from 1985 (nmod)
reduced reversed (conj)
complication , (punct)
examined polymerase (nmod)
thiols non-protein (amod)
diabetics in (case)
blood brain (conj)
seems strength (nsubj)
mg/m(2 50 (nummod)
channel a (det)
drug less (amod)
voltammetry detection (conj)
patients men (appos)
days 40 (nummod)
disturbances parasomnias (conj)
glutathione oxidized (amod)
subjects fifty (compound)
124 1.5 (conj)
capable mg/kg (advcl)
libitum and (cc)
had tachycardia (nmod)
l-name otoprotectant (compound)
species in (case)
reversal injected (dep)
indicate immunohistochemistry (nsubj)
weight enzymes (conj)
describe loss (dobj)
treating attack (dobj)
reports few (amod)
doses all (det)
ras ( (punct)
ddathf ) (punct)
rofecoxib celecoxib (conj)
dobutamine of (case)
focused factor (advcl)
high patients (nmod)
582 23 (compound)
gene vasopressin (compound)
labeling improved (amod)
those transplanted (acl)
using recorded (conj)
gavaged animals (nsubjpass)
mangiferin , (punct)
lymphadenopathy malignant (amod)
screening cocaine (nmod)
consequence merely (advmod)
administration deferoxamine (compound)
zidovudine 3'-azido-2',3'-deoxythymidine (dep)
alternative is (cop)
dynamics abnormal (amod)
played role (dobj)
identify assess (conj)
46 +/- (cc)
consist , (punct)
imbalance system (nmod)
processed evaluated (dep)
a recovery (nmod)
rara in (case)
difference db (nmod)
related high (conj)
impaired severely (advmod)
decreased cgs (nsubj)
membranes peritubular (amod)
prognosis endophthalmitis (nmod)
needed investigate (xcomp)
effect concentration (nmod)
those not (neg)
microl ( (punct)
bergmann ) (punct)
1400 between (case)
synthesis antagonists (nmod)
group mexiletine (compound)
acid gamma-aminobutyric (amod)
caused hand (nmod)
obtained be (auxpass)
tests by (case)
retrobulbar bilateral (amod)
needed identify (xcomp)
atp both (cc:preconj)
level with (case)
used whether (mark)
years previously (advmod)
triggers leads (conj)
correlate inhibition (dobj)
arises alternative (nmod)
nos-ir : (punct)
prolapse and (cc)
developed generated (conj)
combination drugs (nmod)
depressed was (auxpass)
course localization (conj)
efficient pirenzepine (nsubj)
result nephropathy (nmod)
attack increase (dep)
have infant (nsubj)
observed hyperalgesia (nsubjpass)
alpha2abc-knockout wild-type (conj)
developed aneurysm (dobj)
exerts effects (dobj)
localized preferentially (advmod)
loss vigabatrin-attributed (amod)
developed had (advcl)
became days (dep)
severity dyskinesias (nmod)
correspond activation (nsubj)
method generalized (amod)
fluorouracil anthracyclines (appos)
dose i.e. (dep)
syncope bradycardia (conj)
isoproterenol agonist (compound)
became woman (nsubj)
vision daylight (conj)
applied means (nmod)
drug after (case)
necessary that (mark)
cimetidine on (case)
instrument the (det)
injury membranes (nmod)
investigated that (mark)
induced lindane (nmod)
caution follow-up (conj)
pars substantia (advmod)
lead rhythm (nmod)
collected period (nmod)
revealed present (advcl)
gfap-staining of (case)
investigated relationships (nsubjpass)
cisplatin patients (compound)
sensitivity colonies (nmod)
mechanisms hypersensitivity (nmod)
favor rizatriptan (nmod)
iodixanol p=0.11 (appos)
patients exhibiting (acl)
had ability (dobj)
treated astrocytomas (nsubjpass)
decreased selectively (advmod)
middle temporary (amod)
determine site (dobj)
period trial (compound)
suxamethonium ) (punct)
groups compared (case)
defect without (case)
hybridization blot (compound)
need dosing (nmod)
status rats (nmod)
volumetry . (punct)
agents antiinflammatory (amod)
dose dose (nmod)
hydration intravenous (amod)
transplant at (case)
developed although (mark)
resolution rapid (amod)
pneumonia bronchitis (conj)
tumors induced (acl)
way in (case)
showed vitro (advmod)
gum the (det)
end course (nmod)
change vocal (amod)
pallidotomy subthalamotomy (conj)
medications oral (amod)
recorded radius (xcomp)
has it (nsubj)
shortened it (nsubj)
admitted woman (nsubjpass)
thickness of (case)
group any (det)
retrieved cholecystectomy (nmod)
elderly specifically (advmod)
viremia and (cc)
stimulation mechanical (amod)
muscle deltoid (compound)
sufficient is (cop)
neurons between (case)
leading accuracy (nmod)
used [123i]ibzm (xcomp)
1-bromo-1-chloro-2,2,2-trifluoroethane as (case)
dog of (case)
effect ly274614 (nmod)
life the (det)
level gr/dl (nmod)
hs ( (punct)
muscles on (case)
diseases despite (case)
glutamine glutamate (conj)
effect reflex-enhancing (amod)
sections and (cc)
had shortly (advmod)
neoplasms non-metastasizing (amod)
stabilized were (auxpass)
rad001 inhibitor (appos)
2.4-fold by (case)
vasoconstriction diffuse (amod)
effect administration (nmod)
ethopropazine benztropine (conj)
bleeding hematoma (conj)
vein femoral (amod)
biopsies node (compound)
combination gemcitabine (compound)
antidepressants children (nmod)
effect e1 (nmod)
results dosage (conj)
mangiferin weight (dep)
ed(50 ) (punct)
potential acetaminophen (nmod)
oxidative nitrosative (conj)
attenuated dbh (nmod)
duration stiffness (nmod)
suggests magnitude (ccomp)
injected catheter (nmod)
maze in (case)
discrimination in (case)
group from (case)
delta the (det)
il-3 and (cc)
effects clomipramine (nmod)
men aged (amod)
lindane to (case)
cc infarction (conj)
region a (det)
signs dsykinesia (compound)
hypothesize promote (ccomp)
stimulation stimulation (conj)
peak hilum (nmod)
infarction macular (amod)
surrounded ring (nmod)
% 2/51 (appos)
persisted however (advmod)
administered csa (nsubjpass)
doxorubicin (dox)-induced (acl)
pill proprietary (amod)
weakness , (punct)
determined nitrogen (nmod)
scintigraphy dynamic (amod)
evaluated managed (conj)
methods sensitive (acl:relcl)
staining and (cc)
outcomes long-term (amod)
rhgh unlike (case)
symptoms motor (compound)
order delineate (acl)
induction rigidity (nmod)
effect that (mark)
affected were (auxpass)
analyzed role (nsubjpass)
larger older (conj)
= 1.34 (dobj)
received attempt (nmod)
thrombopenia hemolysis (conj)
myeloma multiple (amod)
time present (acl:relcl)
revealed centre (ccomp)
substratum the (det)
effects potential (amod)
mhb former (amod)
grades regurgitation (compound)
1984 during (case)
patients neuroblastoma (nmod)
values in (case)
nephrotoxic these (nsubj)
effective but (cc)
analysis intensity (conj)
utilized line (dobj)
referred elsewhere (nmod)
stages later (amod)
differ that (nmod)
neurotoxin noradrenaline (compound)
lp : (punct)
androgen with (case)
administration remifentanil (nmod)
investigated and (advmod)
patients pci (compound)
name " (punct)
effects cisplatin (nmod)
reduced cost (conj)
induced n-methyl-d-aspartate (nmod)
see use (nmod)
elimination kinase (nmod)
mg/d 480 (compound)
included analyses (nsubj)
reported similarity (nmod)
compounds development (nmod)
directions commissure-commissure (amod)
increases sensitivity (dobj)
took after (mark)
testosterone high-dose (amod)
history psychiatric (amod)
lithium-treated /+ (conj)
bars ) (punct)
carried learning (nsubjpass)
activities antiplatelet (compound)
ms length (nmod)
ko ( (punct)
tinnitus decompensated (amod)
correlate concentration (nmod)
unable because (mark)
cortex rat (compound)
symptoms akinetic (amod)
trial an (det)
extubated later (advmod)
occurred have (aux)
prolongation irrigation (nmod)
20 over (quantmod)
2 25 (conj)
minimized could (aux)
conducted july (nmod)
mechanisms both (det)
was ] (punct)
acid- (nmda)-induced (conj)
increased increase (conj)
transplant by (case)
1-infected immunodeficiency (nmod:npmod)
activate . (punct)
health and (cc)
simple sustained (conj)
mice liver (appos)
100 50 (compound)
suggests nephrotoxicity (ccomp)
decrease min (conj)
classified score (conj)
stress oxidative (amod)
department the (det)
flatulence , (punct)
wild-type in (case)
ratios for (case)
01 ) (punct)
evaluation gnc92h2 (nmod)
stiffness contractures (conj)
examination ultrasound (amod)
n ; (punct)
users ich (nmod)
ps group (compound)
indicator may (aux)
measured continuously (advmod)
average mean (dep)
support wherein (dobj)
migrainosus status (compound)
justified that (mark)
9 6 (compound)
chromatography high-pressure (amod)
or 4.336 (nummod)
patients fifty-three (amod)
readministration period (nmod)
5ht2a ( (punct)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate , (punct)
titer the (det)
increased % (dobj)
benefit harm (conj)
compound microm (appos)
induced pilocarpine (nmod)
il-3 ) (punct)
miss they (nsubj)
period prognostic (amod)
bed tumor (compound)
p20 ) (punct)
ng.ml-1 42 (nummod)
day second (amod)
sex of (case)
therapy levofloxacin (compound)
synergistic that (mark)
blockade early (amod)
range moles/glomerulus (dep)
g/m2 were (cop)
animals experimental (amod)
killed weeks (nmod)
contains contains (advcl)
outpatients for (case)
assess incidence (dobj)
measurements in (case)
bmd radius (nmod)
present seizure (conj)
1.88 ( (punct)
protocol to (case)
acuity neonate (nmod:poss)
dimensions directions (nmod)
women : (punct)
pb % (dep)
esterase neurotoxic (amod)
determine side-effect (advcl)
showed min (nmod)
slight all (advmod)
established profile (nsubjpass)
levels enzyme (compound)
rhythm to (case)
predict exposure (nsubj)
mother second (amod)
dimorphism upregulation (nmod)
but significantly (advmod)
appreciated heretofore (advmod)
centers academic (amod)
group p (conj)
pathways of (case)
sd ( (punct)
bundle left (amod)
cohort alone (advmod)
good persistently (advmod)
nr1(neo-/- ie (advmod)
stands drug (nmod)
walls along (case)
ago years (nmod:npmod)
latencies stages (nmod)
produces regimen (nsubj)
extract carota (compound)
cells labeled-positive (amod)
developed course (nmod)
release stimulated (acl)
testing and/or (cc)
application lactate (nmod)
nerve tail (compound)
received decontamination (dobj)
anticholinergics of (case)
alendronate biphosphonate (appos)
revealed lesions (dobj)
ee mg/kg (dep)
papaverine of (case)
test protectors (dobj)
use drugs (dobj)
vision for (case)
observed quetiapine (nmod)
induced alpha-fluoro-beta-alanine (nmod)
happiness surprise (conj)
efficacy trial (conj)
therapy pulsatile (amod)
sufficient minimize (xcomp)
exposure each (nmod)
representing years (dobj)
day 1 (compound)
role regarding (case)
exhibit , (punct)
patients alf (compound)
identification in (case)
injected mice (nsubjpass)
rls mirtazapine-associated (amod)
was explore (xcomp)
has maintains (advcl)
children 5 (nummod)
tested ; (punct)
cells gfp(+ (compound)
ischemic be (cop)
note of (advmod)
responsible complications (nmod)
received anesthesia (dobj)
rats agent (nmod)
failed rats (nsubj)
attenuating of (mark)
methylation the (det)
surgery open-chamber (amod)
glucose , (punct)
enabling circumstances (nsubj)
effects or (cc)
correlates as (case)
pharmacokinetics , (punct)
medication safe (amod)
hydrochloride mg/day (appos)
iohexol mg (appos)
movements deafness (conj)
density the (det)
observational , (punct)
shown serotonin (nmod)
identify pathways (dobj)
inhibitors ssr103800 (nmod)
subjected those (nsubjpass)
mg 1.0 (compound)
developed pa (dobj)
ng/kg/min 6.7 (nummod)
rationale use (nmod)
hus ) (punct)
practice bolus (nmod)
tnss of (case)
4107 and (cc)
material i.v. (compound)
81 to (dep)
yawning retrocollis (conj)
safe effective (conj)
2/3 patients (nmod)
dialysate , (punct)
nik-247 p.o. (appos)
interference without (conj)
system antioxidant (amod)
investigated be (auxpass)
raised has (aux)
open question (dobj)
recurrence hepatitis (compound)
receptors b1 (compound)
4- fluorobenzylidene (dep)
measured man (nmod)
incidence > (conj)
mg/kg/b.w 2 (nummod)
inventory erectile (compound)
naproxen 1.17 (dep)
suggest relationship (nsubj)
150 up (advmod)
neutralizes which (nsubj)
required dose (nsubjpass)
received estrogens (dobj)
failure followed (acl:relcl)
conjunction opioid (nmod)
death 1 (nummod)
experiments vessel (compound)
chromosomes on (case)
decreased allopurinol (nsubj)
tumor-free or (cc)
variables to (case)
p11 as (case)
test was (cop)
86.7 +/- (cc)
therapy carbonate (compound)
administration drug (nmod)
failure biventricular (amod)
resulting overdose (nmod)
treated octreotide (dep)
cohorts from (case)
accompanied resistance (nmod)
onwards from (case)
appear that (mark)
preexisting narrowing (conj)
p=0.003 0.0006 (conj)
microscopy by (case)
use statins (nmod)
avoid to (aux)
went home (advmod)
changes these (det)
level between (case)
benzylthiouracil ne (appos)
ward an (det)
growth children (nmod)
results reviewed (dep)
administered trial (nmod)
mg/m2 350 (nummod)
involvement mitochondrial (amod)
considerations therapy (nmod)
activities hepatic (amod)
dermatitis and (cc)
registry associated (nmod)
withdrawal pharmacon (nmod)
oropharynx the (det)
have had (conj)
immunodeficiency with (case)
adenocarcinoma gastric (amod)
effects rate (nmod)
ratio 20/13 (nummod)
pronounced users (nmod)
emergence during (case)
% total (nmod)
associated times (nmod:tmod)
days 3 (nummod)
microvessels of (case)
difference p (dep)
cabergoline dose (dep)
recommended preventing (conj)
n/n=62/92 14/92 (conj)
home cta (nmod)
subjects treated (acl)
iiib regimens (nmod)
high incidence (nsubj)
similar was (cop)
sulfate cramps (nmod)
administration levodopa (compound)
found introduction (nmod)
sulphate sulphate (conj)
july 1997 (nummod)
electrocardiograms eighty-seven (amod)
highlighting steps (dobj)
tomography ct (compound)
neuropathy diabetic (amod)
indicated analyses (nsubj)
dependence as (cc)
weeks progression (nmod)
exceed not (neg)
turn less (advmod)
12.5 25 (conj)
damage local (amod)
use whose (nmod:poss)
h h (nmod)
recipients of (case)
relieve patients (dobj)
factor anf (appos)
variants unknown (amod)
ligand nociceptin (nsubj)
reported glomerulonephritis (nsubjpass)
modulation excitability (nmod)
h-sod1 ) (punct)
variants escape (compound)
centers health (compound)
delayed are (auxpass)
april , (punct)
stimulation train-of-four (amod)
levels mean (amod)
supervened week (nsubj)
incidence population (nmod)
medialipid in (case)
abusing methamphetamine (dobj)
32.9 ; (punct)
individual a (det)
aspirin or (cc)
induces insipidus (dobj)
loads pelvic (amod)
excluded or (cc)
actions heart (nmod)
had little (dobj)
included signs (nsubj)
develop hepatitis (nsubj)
91 72 (compound)
impaired function (nsubj)
required groups (nmod)
time-dependent a (dep)
had here (advmod)
del > (compound)
hyperhidrosis miosis (conj)
one from (case)
prophylaxis aggregation (appos)
factors hypertension (nsubj)
avp and (cc)
slower was (cop)
3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ( (punct)
0.014-unit collagenase (dep)
led cardiotoxicity (nmod)
ratio 3.4 (dep)
amplitude potential (amod)
rats scopolamine-injected (amod)
catalepsy or (cc)
raised intake (dobj)
treated tuberculosis (nmod)
suspension an (det)
cyclophosphamide during (case)
number platform (nmod)
inhibition of (case)
patient infected (amod)
layer granule (compound)
induced stage (nmod)
rate its (nmod:poss)
insecticide . (punct)
suppressed induced (conj)
allopurinol saline (conj)
erythropoietin epo (appos)
highest the (det)
heat , (punct)
formed presence (nmod)
symptoms clinical (amod)
dose weight (nmod)
research mechanisms (nmod)
circled , (punct)
hospital and (cc)
associated regulation (conj)
indices myocardial (amod)
exhibited as (cc)
bfgf vegf (conj)
ability cyclophosphamide (nmod)
raised exposure (nsubj)
libitum-fed ad (nmod:npmod)
reproduced rechallenge (nmod)
result the (det)
baroreceptors sinus (compound)
decreased ebf (dobj)
reaction be (cop)
susceptible treatment (nmod)
produce subsequent (conj)
receptors nachrs (appos)
hypotension sn-induced (amod)
have impact (dobj)
isomer dextrorotatory (compound)
coefficient apparent (amod)
technique ketamine (nmod)
danazol with (case)
min-1 kg-1 (compound)
pursued wr242511 (nsubjpass)
catheter implanted (amod)
stimulation chemical (compound)
injected space (nmod)
phenomenon this (det)
site opioid (amod)
acc-9653 of (case)
5-hydroxytryptamine ( (punct)
antagonizing hypokalemia (dobj)
inactive is (cop)
rammer et (compound)
results on (case)
thought associated (xcomp)
arthritis treated (acl)
members additional (amod)
oih on (case)
dec of (case)
placebo nimodipine (conj)
induced p (nsubj)
setting ischemia (nmod)
order random (amod)
pod 4 (nummod)
intact bile-diverted (conj)
area dermatomes (nmod)
back-diffusion generation (conj)
group 3-wk (amod)
aborted patient (nsubjpass)
lesions bladder (nmod)
endpoint serum (nmod)
24.8 +/- (cc)
assessment observer (nmod:poss)
actions the (det)
now dopamine-1 (nsubj)
described factors (nsubjpass)
different controlled (dep)
neoantigens detected (acl)
correlated levels (nmod)
cancers site-specific (amod)
wales south (compound)
node av (compound)
man leukemia (nmod)
series subjects (nmod)
conduct regard (nmod)
stenosis only (cc:preconj)
results similar (dep)
tended , (punct)
% 54.8 (nummod)
infusion lidocaine (compound)
[3h]-dihydroergocryptine of (case)
showed resulted (ccomp)
deficits memory (compound)
association neuropathy (nmod)
revascularization in (case)
recalled completed (advcl)
analysis by (case)
value reducing (amod)
medial and (cc)
ribavirin with (case)
interviewed presence (nmod)
affects changes (nmod)
nuclear as (cc)
ascertained questionnaires (nmod)
vasodilation direct (amod)
endings process (nmod)
use concurrent (amod)
204 + (cc)
hosts certain (amod)
aneurysms . (punct)
surveys uncontrolled (amod)
shr.(abstract truncated (acl)
model on (case)
d-galactose . (punct)
discontinuation amiodarone (amod)
segments banks (nmod)
occurrence uncommon (amod)
reductions turnover (nmod)
distance from (case)
% 3.8 (nummod)
determined mice (nmod)
% patients (appos)
stabilized hemodynamics (nsubj)
phase progestative (amod)
development effect (appos)
sec/cm5 x (compound)
16,459 , (punct)
years to (case)
requirements analgesic (compound)
electrodes subcutaneous (amod)
produced injection (nmod)
concentrations sevoflurane (nmod)
increased placebo (nmod)
daily ( (punct)
measured it (nsubjpass)
toxicity improvement (conj)
intensive more (advmod)
thyroxine and (cc)
time 10h (compound)
discomfort of (case)
gtn the (det)
depression mv (dep)
rate injection (compound)
use prevention (nmod)
10(-3 x (compound)
validated genes (nsubjpass)
influence under (case)
manage patient (dobj)
cases all (det)
polyvidone vasurix (compound)
detachment owing (amod)
explained not (neg)
safety dexamethasone (conj)
group or (cc)
reentry circuit (compound)
women 7 (nummod)
9 out (advmod)
persisted cystitis (nsubj)
13 11 (compound)
synthesis de (amod)
4.5 +/- (cc)
woman 48-year-old (amod)
ach hippocampal (compound)
source energy (nmod)
used involved (conj)
instructions use (nmod)
retention retrieval (conj)
reduce and (cc)
mean < (dep)
remifentanil with (case)
reviews dose (nmod)
a ( (punct)
dosage mg/m(2 (nmod)
dizziness weakness (conj)
remained became (conj)
use methamphetamine (nmod)
role for (case)
observed have (aux)
effect side (compound)
days sampling (nmod)
dextrose bicarbonate (conj)
periods in (case)
nuclear both (cc:preconj)
dose used (acl)
done unfortunately (advmod)
abnormalities mr (nmod)
modulation gating (nmod)
decline significant (amod)
revealed perfusion (dobj)
tissue granulomatous (amod)
administration pcc (nmod)
epilepsy absence (compound)
total cycles (dep)
better to (mark)
covered edema (nsubj)
discontinuing treatment (dobj)
mg/ml 1.0 (nummod)
symptoms withdrawal (compound)
nephrotoxicity neurotoxicity (conj)
proven has (aux)
administration multiple (amod)
transporter glucose (compound)
characterization date (nmod)
effect remitted (advcl)
assessed although (mark)
reported relationship (nmod)
manifestations drug (nmod)
170 be (cop)
min after (case)
scores tests (nmod)
milliliters thirty (nummod)
plays model (nmod)
g/day range (appos)
therapy antianginal (amod)
using stimuli (dobj)
mg. of (case)
blockade prolonged (amod)
detoxification to (case)
interfered associated (conj)
neurotoxicity peripheral (amod)
designed investigate (xcomp)
78 43 (compound)
bleeding or (cc)
bpo for (case)
stimulatory locomotor (compound)
erythrodysesthesia severe (amod)
dizocilpine mk-801 (appos)
suppresses therapy (nsubj)
revealed alpha (dobj)
themselves by (case)
defined cardiotoxicity (nsubjpass)
dose single (amod)
presentations emotion (nmod)
results activation (nmod)
azathioprine to (case)
recall for (case)
effect incidence (nmod)
result modification (nmod)
developed did (conj)
reach if (mark)
pretreatment ( (punct)
binder as (case)
recordings treatment (compound)
occurred result (nmod)
those evident (acl:relcl)
effect doxorubicin (nmod)
pressure blood (compound)
affect facility (dobj)
require she (nsubj)
plexitis brachial (amod)
pentoxifylline i.v. (compound)
shown has (ccomp)
abs secondary (amod)
dermatitis penicillamine-related (amod)
showed analysis (nsubj)
water and (cc)
enalapril of (case)
-21.3 respectively (advmod)
included ck-mb (dep)
assessing modulation (dobj)
returned value (nmod)
patients these (det)
injected intracerebroventricularly (advmod)
cholesterol ) (punct)
agent second (amod)
fluoxetine plus (cc)
had formed (conj)
approaches multiple (amod)
associated positively (advmod)
animals all (det:predet)
effects further (amod)
resolved endophthalmitis (nsubj)
administration injections (nmod)
tachycardia nonsustained (amod)
nik-247 and (cc)
cholestasis estradiol-induced (amod)
dose than (case)
attenuated pre-treatment (nsubj)
lesion of (case)
nitroglycerin to (case)
magnitude in (case)
established methods (dobj)
curves muscle (nmod)
showed ercp (nsubj)
cocaine not (cc)
flavour bitemporal (amod)
therapy replacement (conj)
designed experiments (nsubjpass)
p=0.37 ( (punct)
% 47.1 (nummod)
results according (case)
side forearm (nmod)
used database (dobj)
use paramedics (nmod)
selected depression (nmod)
recovered support (nmod)
version in (case)
injury models (nmod)
syndrome reye (compound)
pentamidine polymorphic (conj)
binding [35s]tbps (compound)
mg 117 (appos)
vehicles , (punct)
graft liver (compound)
microglobulinuria beta (compound)
type any (det)
containing pdn (dobj)
increase dehydrogenase (nmod)
patients 212 (nummod)
women healthy (amod)
cystitis urine (conj)
thrombocytopenia osteoporosis (conj)
level its (nmod:poss)
hepatonecrosis . (punct)
patients 2 (conj)
h either (cc:preconj)
respiratory muscle (conj)
result did (aux)
compared study (conj)
feet their (nmod:poss)
arteries carotid (compound)
mg/kg 6.25 (nummod)
sch ) (punct)
week 2 (nummod)
users first-time (amod)
useful pretreatment (nsubj)
treatment myocardium (nmod)
purpose demonstrate (dep)
assessed effect (nsubjpass)
discharges elicited (acl:relcl)
isolated precursor (nmod)
association production (nmod)
mediator proconvulsant (amod)
groups n (dep)
therapy saving (compound)
mg containing (acl)
toxicity doxorubicin (nmod)
experienced episode (dobj)
nms for (case)
design study (dep)
found increases (nsubjpass)
gyrus iml (appos)
sprague-dawley aged (amod)
used administration (nmod)
mediate hypotension (dobj)
tumors adenohypophyseal (amod)
infusion vincristine (compound)
multicenter and/or (cc)
male were (cop)
injections three (nummod)
women zeynep (compound)
results younger (dep)
score time (nmod)
licensed . (punct)
infusion ritodrin-hcl (compound)
safer as (mark)
tool semi-invasive (amod)
reintubation necessitated (amod)
increased threshold (dobj)
system calibration (nmod)
deterioration performance (nmod)
naproxen 1.31 (nummod)
challenge in (compound)
deliver lozenges (nsubj)
take schedule (nmod)
experiments considered (acl:relcl)
women ht (appos)
task on (case)
transplantable and (cc)
antagonize experiment (nmod)
woman pain (nmod)
yield low (amod)
gcs ) (punct)
coincided introduction (nmod)
reports recent (amod)
responses prolactin (compound)
surveillance adjustment (amod)
wr242511 of (case)
granulocytopenia was (cop)
890 up (advmod)
studies among (case)
investigated efficacy (dobj)
deficits with (case)
l-1 8.4 (nummod)
followed years (nmod)
questionaire structured (amod)
increase proteins (nmod)
observed predicted (advcl)
ml injected (acl)
protocol the (det)
pressure sap (appos)
child hypothermic (amod)
rbcs dapsone-exposed (amod)
unaffected effect (dobj)
found hdl (nmod)
centers republic (nmod)
morphology , (punct)
feel overlooked (ccomp)
showed falciparum (dobj)
91.2 was (cop)
compliance lowest (amod)
delayed as (cc)
sodium tubular (amod)
diclofenac 1.17 (dobj)
microg/0.5 4 (compound)
hyperprolactinemia amenorrhea/galactorrhea (conj)
atrophy desquamation (conj)
substantial have (xcomp)
assessed retrospectively (advmod)
delivered term (nmod)
coxii and (cc)
performance damage (conj)
extract learning (nmod)
accounting ( (punct)
high- the (dep)
activate to (mark)
dilation ventricular (amod)
g/l 100 (nummod)
damage myocyte (compound)
processes cancer (nmod)
woman sixty-year-old (amod)
desire were (cop)
represents inhibition (nsubj)
2.1 was (cop)
effects tremor (compound)
work previous (amod)
behavior her (nmod:poss)
results by (case)
synchrony in (case)
fdc ( (punct)
aneurysms intracranial (amod)
affinity a (det)
conclusion produced (dep)
intensity by (case)
had tiapride (nsubj)
techniques morphological (amod)
revealed retrospectively (advmod)
related mechanism (nsubj)
determined staining (nmod)
surgery radiation (conj)
1.1 +/- (cc)
nausea palpitations (conj)
day 17th (amod)
nephrotoxicity patients (nmod)
patients 48 (nummod)
penicillins and (cc)
concentrations rat (nmod)
developed 9 (nsubj)
bars ( (punct)
3.7 min(-1 (dep)
concluded result (ccomp)
revealed sensitive (ccomp)
hyperosmolar with (case)
hyaluronate abundant (amod)
group ant-mi (compound)
illustrating generation (dobj)
odds higher (amod)
mg/kg midazolam (compound)
allele : (punct)
deviations upward (amod)
breath and (cc)
full eventually (advmod)
normotensive the (det)
min 18.3 (nummod)
disrupted , (punct)
levels hb (compound)
provided years (nmod)
caused underwent (conj)
revealed biopsies (nsubj)
possessed that (mark)
increases responses (nmod)
p450 2b1/2b2 (dep)
patients completed (acl:relcl)
managed were (auxpass)
contains edetate (dobj)
outpatient as (case)
developed uveitis (dobj)
susceptible develop (xcomp)
resulted albuminuria (nmod)
surgery spinal (amod)
evaluated symptoms (nsubjpass)
risk anemia (nmod)
15-f(2t)-isoprostane of (case)
possibility inhibits (ccomp)
heart of (case)
score risk (compound)
used rcts (nmod)
therapy leukemia (nmod)
arrhythmia degenerated (acl)
nitrate of (case)
increase average (nmod)
neuropathy cutaneous (amod)
adjustment rapid (amod)
produces stimulation (nsubj)
displayed segments (nmod)
0.05 % (dep)
bradycardia dose-dependent (amod)
malformations incidence (compound)
reported augment (xcomp)
effects neuropathy (nmod)
20 of (advmod)
increase change (conj)
154 236 (compound)
levels albumin (compound)
reactivity cardiac (amod)
objective determine (dep)
hypovolemia absolute (amod)
subunits combined (acl)
related whom (nmod)
haloperidol and (cc)
prazosin ) (punct)
< 0.05 (nummod)
exchange an (det)
occurring trauma (nmod)
strains from (case)
imaging studies (dep)
tendency induce (acl)
nephrotoxicity administered (acl)
led albuminuria (nsubj)
target be (cop)
ivig of (case)
animal both (cc:preconj)
130 and (cc)
unmask seizures (dobj)
known while (mark)
immunocytoma each (det)
observed addition (nmod)
patient suffering (acl)
similar ; (punct)
healthy subgroups (nsubj)
criteria : (punct)
aggravate to (mark)
duration survival (nmod)
understood clearly (advmod)
paradigm step-down (amod)
derivative sm-5887 (appos)
patients n=10 (compound)
penetration % (nmod)
patients rejection (nmod)
action verapamil (nmod)
administered progression (nmod)
receptor ldlr (appos)
tracings cortical (amod)
ro and (cc)
exhibit did (aux)
infusion 25-mg/m2 (compound)
development resolution (conj)
renal pulmonary (conj)
h2o on (case)
importance crucial (amod)
disease peptic (amod)
positive or (cc)
revealed while (mark)
oliguria prolonged (amod)
nature course (conj)
showed has (ccomp)
rate severity (conj)
actions with (case)
hemolysis suspensions (nmod)
related appearance (nmod)
potent most (advmod)
contents obtained (acl)
elicited pge2 (nmod)
stimulates that (mark)
treatment pharmacological (amod)
fell rapidly (advmod)
causes injection (nsubj)
made is (auxpass)
word list (nmod)
studies population (compound)
repeated and (cc)
lack changes (conj)
require titration (dobj)
39 ( (punct)
alerted be (auxpass)
0.91 0 (prep)
thrombocytopenia usually (advmod)
0.005 < (dep)
deposition n=12 (dep)
two deaths (nmod)
questioned . (punct)
collagen elastin (conj)
drugs as (case)
organophosphorus such (amod)
distribution clearance (conj)
findings in (case)
earlier lasted (conj)
cancer reported (acl)
phase 12-week (conj)
rebound icp (nmod)
altered expression (nsubj)
hyperemia dipyridamole-induced (amod)
qtp with (case)
ligand possessing (acl)
invaded . (punct)
case manifested (acl)
impairment the (det)
withheld argatroban (nsubjpass)
observation features (nmod)
discontinued alfentanil (conj)
pathway rats (nmod)
mice anemia (nmod)
facilitates behavior (dobj)
persists that (nsubj)
pharmacokinetics venlafaxine (nmod)
depends critically (advmod)
restored correction (nmod)
undertaken therefore (advmod)
discontinuation imipramine (nmod)
15 only (advmod)
has risk (dobj)
have rate (dobj)
levodopa state (conj)
type lymphoma (nsubj)
carriers allele (nmod)
a ) (punct)
action compound (compound)
seemed have (xcomp)
ug.kg-1 fm (appos)
done should (aux)
prevent antioxidants (nsubj)
acknowledged be (auxpass)
exposure as (case)
male diabetic (amod)
doxil ; (punct)
yohimbine meperidine (conj)
uncomplicated and (cc)
flow work (conj)
withdrawn as (mark)
schedules different (amod)
linked been (auxpass)
report warfarin (nmod)
% 24 (nummod)
dose dosage (nsubj)
amiodarone dose (nmod)
asymptomatic may (aux)
cells nuclear (amod)
patient death (conj)
induce d (nsubj)
applies latter (nsubj)
observations two (nummod)
shown results (nsubj)
rhythm and (cc)
analysis genetic (amod)
avoidance passive (compound)
length ) (punct)
bolus iv (nummod)
veins about (case)
hallmarks reaction (nmod)
c , (punct)
dexrazoxane icrf-187 (appos)
profile risk (compound)
pain precordial (amod)
confirms effective (ccomp)
sustained is (auxpass)
diagnosis on (case)
complications for (case)
administration isoniazid (nmod)
induced ketamine (nsubj)
other effect (nmod)
po2 ( (punct)
trial patients (nmod)
antagonist type-2 (amod)
schedule infusion (compound)
disappointing been (cop)
administration ototoxicity (conj)
thrombosis heparin-induced (amod)
rates objective (amod)
chemotherapy prior (amod)
% significance (nmod)
increased concentrations (nsubj)
necessity avoiding (acl)
review large-scale (amod)
prevent recurrence (nmod)
imaging nuclear (amod)
role lesser (amod)
sequence temporal (amod)
40.1 6.24 (conj)
nucleus and (cc)
course this (det)
studies laboratory (compound)
studies infants (nmod)
response pretreatment (nmod)
effect aspirin (nmod:poss)
patient resulted (acl:relcl)
cells 1 (nummod)
proteinuria subset (nmod)
lasted ; (punct)
called is (auxpass)
introduction objective (conj)
ead 2 (nummod)
given but (cc)
information sufficient (amod)
improve tolerance (dobj)
ctc-nci . (punct)
incorporating [3h]-l-arginine (dobj)
insurance swedish (compound)
mechanisms on (case)
review systematic (amod)
hbsag anti-hbs (conj)
ic the (det)
hyperactive were (cop)
infection severe (amod)
stable ( (punct)
described ly274614 (nsubjpass)
therapy chelation (compound)
forearm over (case)
treatment combination (nmod)
effect irritant (amod)
examined used (advcl)
osteoporosis of (case)
control baroreflex (compound)
medication between (case)
moderate-dose hippocampus (conj)
leukoencephalopathy such (det:predet)
slight , (punct)
daily , (punct)
avoided events (nsubjpass)
determined samples (nmod)
qtls model (appos)
confirmed effects (nsubjpass)
late event (conj)
showed showed (conj)
atorvastatin of (case)
formation aneurysm (nmod)
vasculature the (det)
established change (nmod)
hypertensives borderline (compound)
state sensitivity (nmod)
adjusted achieve (xcomp)
bradycardia persistent (amod)
patients 59 (nummod)
hyponatraemia with (case)
measure variability (nmod)
patients severe (acl:relcl)
cancer mesothelioma (conj)
ameliorated ulcer (nsubjpass)
changed because (mark)
effect acetaminophen (nmod)
reduces thiopentone (nsubj)
1993 - (punct)
7:30 at (case)
rw ( (punct)
hallmark . (punct)
report describe (appos)
s control (dep)
axons small-caliber (amod)
remission 2 (dep)
pulses short (amod)
institution the (det)
recalled recalled (conj)
associated conclusion (nmod)
exhibited change (dobj)
2d6 p450 (compound)
inhibition secretion (nmod)
patients seventy-five (amod)
resulting potency (nmod)
face tachycardia (conj)
glycopyrrolate atropine (conj)
thickening of (case)
grade 0.005 (appos)
60 3 (compound)
intermediate to (case)
avoided if (prep)
reflection is (cop)
surgery , (punct)
db controls (nmod)
result positive (amod)
effect rate (nmod)
nodularity in (case)
reduced decreased (advcl)
elevated ng/ml (nmod)
vehicle peptides (conj)
signs such (amod)
revealed ranged (ccomp)
subtype glutamate (compound)
received injections (nmod)
igf-il-3 epo (conj)
gauges all (det)
pills oral (amod)
glutamate and (cc)
mice b6c3 (compound)
baseline g/dl (nmod)
effect days (nmod)
treated p9605 (nmod)
reversing tachycardia (dobj)
digitized 1/s (nmod)
value k(na (compound)
useful bnp (nsubj)
found peliosis (nmod)
approved is (auxpass)
neonate malformation (nmod)
described reported (advcl)
proteome regarding (case)
include hemorrhage (dobj)
advocate determined (ccomp)
generation mitochondrial (amod)
remain hypothetic (xcomp)
dantrolene and (cc)
haematuria cystitis (dep)
increased number (nsubj)
investigated expression (dobj)
less 100,000/mm3 (nmod)
mediated colliculus (nmod)
exercise respectively (advmod)
occlusion artery (nmod)
physicians to (case)
associated deprivation (nmod)
times five (nummod)
nimodipine high-dose (amod)
tolerated showing (advcl)
av ( (punct)
contaminants of (case)
lamina to (case)
potassium by (case)
trinitrate diclofenac (nmod)
aneurysm a (det)
3',5'-monophosphate ( (punct)
attenuated treatment (nmod)
ml/m2 p (dep)
injected ) (punct)
alpha2-adrenergic receptor-mediated (conj)
arrhythmias seizures (compound)
dosings following (case)
7 of (case)
ergotamine/caffeine to (case)
improvement deficits (nmod)
reduce toxicity (dobj)
report showing (advcl)
improve patients (nmod)
aware must (aux)
blockers ca (compound)
applied can (aux)
trends current (amod)
result anemia (nsubj)
cardiovascular local (conj)
dose each (det)
addiction cocaine (compound)
methoxamine administered (amod)
downregulating pathway (dobj)
methods randomized (dep)
three eight (conj)
affect adversely (advmod)
432 % (dep)
used because (mark)
undertaken is (auxpass)
ml/kg ) (punct)
man macroglobulinaemia (nmod)
abundance mrnas (nmod)
1 12 (prep)
76 9 (conj)
ameliorates nephropathy (dobj)
combinations dose (compound)
control positive (amod)
included weight (dobj)
administered s-23121 (nsubjpass)
days < (dep)
order establish (acl)
induction etomidate (amod)
types the (det)
acceptance increased (amod)
reviewed timing (nsubjpass)
acquired images (nsubjpass)
done performed (conj)
uptake hippocampus (nmod)
given test (nmod)
irrespective regimen (nmod)
kept interaction (nsubjpass)
activity antiviral (amod)
pauses these (det)
deposits of (case)
compared been (auxpass)
activity hydrochloride (nmod)
potential thalidomide (nmod)
tolerated agent (nsubjpass)
mg losartan (nmod)
loss gentamicin-induced (amod)
concentration mapd (nmod)
phenomenon so-called (amod)
rarest serious (conj)
surgery functional (amod)
effects thrombosis (nmod)
i.c.v. ( (punct)
22 ( (punct)
0.0001 , (punct)
pancreatitis suppression (conj)
detection ana (nmod)
apnea prolonged (amod)
develop thrombosis (dobj)
cavity gland (conj)
appears observed (conj)
enhance extent (nmod)
3.32 from (case)
vasculitis anti-mpo (compound)
rated , (punct)
reversed strips (conj)
choice therapeutic (amod)
days produce (acl:relcl)
subject also (advmod)
result levels (nsubj)
over-representation asians (nmod)
cardiorespiratory , (punct)
32 0 (compound)
treatment 1-week (amod)
palsy loss (conj)
known have (conj)
observed when (advmod)
amiodarone atazanavir (conj)
threshold l(-1 (appos)
albino icr (appos)
micrograms misoprostol (nmod)
unable absorb (xcomp)
acetyltransferase activator (appos)
threatening life (nmod:npmod)
administration mesna (compound)
systems dogs (nmod)
desire excitement (conj)
greater tension (nsubj)
lignocaine 2 (dep)
mr brain (compound)
less spironolactone (conj)
manifestation patients (nmod)
adducts antigens (conj)
anesthetized rats (nsubjpass)
groups microg (nmod)
way same (amod)
demonstrate to (mark)
reported lesion (nmod)
maleate and (cc)
n-acetyl-beta-d-glucosaminidase ? (punct)
= ratio (nsubj)
pitfall and (cc)
sensitive drug (nmod)
made being (auxpass)
women about (acl:relcl)
tumors brain (compound)
ee ) (punct)
fasciitis necrotising (amod)
jerks muscimol-induced (amod)
fenoldopam nitroprusside (conj)
concentration gaba (nmod)
was quadrant (nmod)
leak bolus (nmod)
patients hypotensive (amod)
acetaminophen micrograms/ml (appos)
receptor with (case)
tamoxifen of (case)
> limit (dep)
mechanism underlying (amod)
smoked . (punct)
vessels epicardial (amod)
pge(2 of (case)
antipsychotic an (det)
bradydysrhythmias or (cc)
assessment ophthalmological (amod)
suggest improves (ccomp)
polymerase nuclear (amod)
necessary perhaps (advmod)
selection increase (dep)
models failure (nmod)
myelination matter (nmod)
departments in (case)
mm 99 (dep)
administered appears (conj)
dysfunction transient (amod)
survivors asymptomatic (amod)
pretreatment propranolol (nmod)
muscle animal (nmod:poss)
increased behavior (dobj)
connected setup (nmod)
mediated response (nmod)
suggest considered (ccomp)
efficacy daunorubicin (nmod)
life carcinoma (nmod)
predict susceptibility (dobj)
clinician each (det)
incidence disease (nmod)
comparable those (nmod)
intervention after-before (appos)
day after (case)
apply . (punct)
status level (conj)
shows rise (dobj)
promising most (advmod)
increasing but (cc)
1998 , (punct)
infusion raise (acl)
impairment irreversible (amod)
staining atpase (compound)
calcification warfarin-induced (amod)
users users (conj)
clear mechanisms (nsubj)
agents mentioned (acl)
day 126 (nummod)
began , (punct)
observed fall (nsubjpass)
cytotoxicity tumors (nmod)
% 86 (nummod)
presented confusion (nmod)
concentration isoflurane (compound)
given resulting (xcomp)
medications surgery (conj)
isolated combination (conj)
study increased (conj)
induced model (dobj)
inhibitor an (det)
incidences low (amod)
problem haemorrhages (nsubj)
factors discount (conj)
polydipsia use (conj)
layer likely (acl:relcl)
treatment dose (nmod)
is efficacy (nmod)
15 at (case)
overdose tna (nmod)
= .02 (dep)
terfenadine , (punct)
exacerbated maximum (nmod)
24 - (punct)
mpep of (case)
followed study (nmod)
doses morphine (nmod)
irradiation chemotherapy (conj)
patterns for (case)
difference subjects (nmod)
cannabis users (dobj)
anuria sudden (amod)
determine administered (advcl)
comparable be (cop)
lowering for (mark)
revealed combining (csubj)
days p (appos)
transplant heart (compound)
maternal and (cc)
cycles range (dep)
alkylxanthines with (case)
trend a (det)
late were (cop)
glasses wine (nmod)
tubule convoluted (amod)
unconjugated leading (advcl)
synthesize response (nmod)
woman on (case)
meq/l 3.0 (nummod)
ocd ) (punct)
aminotransferase and/or (cc)
evaluated bd1018 (dep)
patients 23 (nummod)
polyuria likely (amod)
stimulation microinjection (conj)
inrcease with (case)
activity lesions (compound)
admitted department (nmod)
test of (case)
trial haloperidol (nmod)
developed induction (nmod)
content luminal (amod)
potentials standard (amod)
effects lungs (nmod)
control models (nmod)
models ventricular (compound)
dose 500 (nmod)
network hippocampal (compound)
cell glomerular (amod)
mmhg admission (nmod)
judged patients (nmod)
decrease significant (amod)
encoding protein (dobj)
sonography cranial (amod)
mice genotypes (nmod)
degeneration cytoplasmic (amod)
indicated safe (ccomp)
concentration galactose (amod)
tumors hybrid (compound)
modified core (conj)
used methods (dep)
induced azithromycin (nmod)
cycles the (det)
administered agent (nmod)
consequences bbb (nmod)
zyban ) (punct)
antinociceptive cholinergic (nmod)
lacking characteristics (nmod)
induced hypertrophy (nsubjpass)
bilateral generalized (dep)
potential cause (acl)
acne with (case)
anorexia nausea (conj)
136 to (case)
published or (cc)
effects substrate (conj)
resulted ratings (nmod)
advocated supplementation (nsubjpass)
involves typically (advmod)
appearance were (cop)
reflex model (appos)
measurement than (case)
clonidine system (compound)
role mechanism (nmod)
protein resistance (compound)
literature growing (amod)
burns two (nummod)
commenced one (nsubj)
aimed , (punct)
supplement an (det)
mg/kg mg/m2 (dep)
causing therefore (advmod)
evident cortex (nmod)
rate high (amod)
history polyuria (nmod)
rest , (punct)
rapidly very (advmod)
% 72.2 (nummod)
66.6 +/- (cc)
suggested promoted (ccomp)
useful a (det)
subunits receptor (compound)
predicting death (dobj)
subacute recovery (nmod)
safety n-butyl-deoxynojirimycin (nmod)
years 5 (nummod)
magnitude p<0.01 (dep)
management with (case)
elicited days (nmod)
cases found (acl)
treatment antiviral (amod)
stimulated has (aux)
depletions got (nmod)
evolution of (case)
exerts cholecystokinin-octapeptide (nsubj)
pair 4834 (compound)
pinch ( (punct)
tumors rat (compound)
propofol 0.5 (nummod)
lead policy (nsubj)
doxorubicin anthracyclin (amod)
different , (punct)
protected rats (nmod)
used began (advcl)
55 50 (compound)
showed agc (dobj)
down hg (nsubj)
man 74-year-old (amod)
seriousness and (cc)
led dox (nsubj)
decreased significantly (advmod)
secondary hitt (nmod)
explanation best (amod)
onset fever (nmod)
develop sclerosis (nsubj)
had apart (advmod)
kg-1 of (case)
studies receptor (compound)
assay by (case)
analogs oligodeoxynucleotide (conj)
designed study (nsubjpass)
1.02 2.85 (prep)
improvement patients (nmod)
l1-l2 and (cc)
studied shown (ccomp)
type an (det)
malaise anorexia (conj)
hyperthyroidism treated (acl)
treated haloperidol (nmod)
radiologic and (cc)
mice subjected (acl)
antigen nuclear (compound)
group pan/temocapril (appos)
reduce that (mark)
therapy before (case)
smoking weeks (dobj)
followed injection (nmod)
incidence than (prep)
toxicity ethambutol (compound)
scores mean (dep)
effect vpa (nmod)
aids had (acl:relcl)
properties seizures (nmod)
received p (dobj)
effects task (nmod)
kidney cornu (conj)
spine of (case)
influence d-ribose (nsubj)
doses ranging (acl)
interventions therapeutic (amod)
40 patients (dep)
utility mr (nmod)
receiving azt (dobj)
apnoea : (punct)
system chemical (conj)
mechanism occurrence (nmod)
recorded auccgrp (nsubj)
haematological neutropenia (dep)
suggested years (nmod)
therapy after (conj)
dilation left (amod)
represent hazard (dobj)
succumbed . (punct)
pilocarpine- kainic (conj)
correlates psychosis (nmod)
population recruited (acl)
gfap , (punct)
nondrinkers who (nsubj)
prolonged den (nmod)
produces especially (advmod)
decreased concentration (nsubjpass)
interaction no (neg)
cle ) (punct)
hiccups possible (amod)
patients exacerbation (nmod)
hepatitis as (case)
2.20 [ (punct)
cd4 median (amod)
function index (appos)
shows analysis (nsubj)
convulsions with (case)
scale barratt (compound)
hexamethonium with (case)
steroids to (case)
associated hyperreactivity (conj)
features calculi (nmod)
response animals (nmod)
generated produce (conj)
quantified finally (advmod)
wt , (punct)
detected cases (nsubjpass)
appearance antibody (nmod)
detected anemia (nsubjpass)
exchange of (case)
micrograms ethinyloestradiol (dep)
british were (cop)
found days (nmod)
1 15 (dep)
imbalance of (case)
women treated (acl)
haemorrhage a (det)
blocker the (det)
28 ( (punct)
change study (nmod)
trimethoprim-sulfamethoxazole of (case)
34 % (dep)
resolved hypoxaemia (nsubj)
neurons cord (conj)
performed subjects (nmod)
expectation the (det)
formulation of (case)
have doses (nmod)
analyzed design (nsubjpass)
atorva with (case)
act how (advmod)
repeaters and (cc)
had mobilization (nmod)
describes , (punct)
sodium to (case)
seizure a (det)
quadriparesis because (case)
sg145r sp120 (conj)
drug disorder (conj)
dose until (case)
cardiomyopathy adriamycin-induced (amod)
incident the (det)
water given (case)
provide screening (nsubj)
meth of (case)
7alpha-hydroxylation of (case)
failure conduction (nmod)
therapy disorders (nmod)
myocarditis fulminant (amod)
minutes of (case)
targeted receptor (nsubjpass)
physicians use (acl:relcl)
characterize effects (dobj)
nik-247 of (case)
association of (case)
background factors (dep)
discharged can (aux)
differences placebo (nmod)
inhibited caa (nmod)
reduced injection (nmod)
hyperprolactinemia significant (amod)
hydrochloride amantadine (compound)
tumours rat (nmod)
types protocols (nmod)
pain phasic (amod)
dissociation finding (nsubj)
toxicity arabinoside (nmod)
nonlactating in (mark)
gammapathy monoclonal (amod)
7/8 ( (punct)
timolol timolol (conj)
observations patient (nmod)
all indices (nmod)
require does (aux)
criteria dsm-iii (compound)
erythrocytes volunteers (nmod)
dbh in (case)
normochromic and (cc)
400 and (cc)
1 to (dep)
lymphoma t-cell (compound)
hctc ) (punct)
concluded may (aux)
change 2 (nmod)
enos tissue (compound)
mean severity (nsubj)
ratio e/a (compound)
anotia malformation (conj)
costs length-of-stay (amod)
evaluated audiograms (nmod)
antagonists the (det)
presented is (auxpass)
hypotension and (cc)
hypokalemia and (cc)
calcification rats (nmod)
= 4.149 (dobj)
changes several (amod)
responses preparations (nmod)
rats blockade (nmod)
set , (punct)
effects treatment (nmod)
ag ) (punct)
effect infarction (nmod)
proposed we (nsubj)
consider work-up (advcl)
habituation of (case)
risk only (amod)
stimulation subthalamic (amod)
treatment early (amod)
series a(2a (nmod)
norms applicable (amod)
expression by (case)
dogs trained (amod)
have blockers (nsubj)
20 25 (conj)
victims with (case)
effect moving (advcl)
introduce therapy (dobj)
concluded able (ccomp)
dose mg (appos)
form aerosol (compound)
eleven patients (nmod)
suggesting sites (ccomp)
spasm both (conj)
completed cards (nsubjpass)
minutes time (nsubj)
warfarin due (case)
was delineate (xcomp)
myositis , (punct)
department ophthalmology (nmod)
insufficiency hyperkalemia (conj)
induce always (advmod)
capacity learning (compound)
mean . (punct)
proliferation hepatomegaly (conj)
creatinine of (case)
lesions liver (compound)
up-regulation fibres (nmod)
allows . (punct)
highlight importance (dobj)
convulsions of (case)
complication occurring (acl)
predicted cardiotoxicity (dobj)
nephrotoxicity vancomycin (compound)
disorders complicated (amod)
induce diuretics (nsubj)
elderly age (dep)
results comparable (dep)
association paroxetine (nmod)
estimated method (nsubj)
suggesting providing (conj)
inhibitors specific (amod)
sessions separate (amod)
flushing tachycardia (conj)
entered men (nsubj)
positive the (dep)
l in (case)
induced or (cc)
differ increased (conj)
pathophysiology disorders (nmod)
increased microinjection (nsubj)
mm and (cc)
deaths % (appos)
administered schedule (nmod)
illicit and (cc)
volunteers thirty-two (nummod)
patient or (cc)
increased selectively (advmod)
migraine ) (punct)
hydrochloride aponidine (compound)
subchronic rats (nmod)
weeks in (case)
markers oxidative (amod)
transferase of (case)
novel conclusion (nsubj)
levels pb (nmod)
occurrence concomitant (amod)
use crack (compound)
reactions five (nummod)
examine nephropathy (advmod)
remained mice (nsubj)
has antidote (dobj)
lipids of (case)
defining comparing (advcl)
treated examined (conj)
achieve effect (dobj)
nausea anorexia (conj)
katona and (cc)
epilepsies treated (acl)
apposed . (punct)
cd36 of (case)
frequency dr5 (compound)
condition with (case)
mimicking formation (dobj)
observed period (nmod)
odds a (det)
comparable literature (nmod)
practices from (case)
used injections (nsubjpass)
lev eeg (conj)
projection ascending (compound)
introduced europe (nmod)
bfue by (case)
difference this (det)
receiving cyclophosphamide (dobj)
layer bulb (nmod)
b12 supplementation (conj)
glioma of (case)
azathioprine include (dep)
ctni and (cc)
mechanism exciting (amod)
shortening elevation (conj)
increases large (amod)
relevant ocd (nmod)
ldl aggregated (amod)
responses inflammatory (amod)
vasodepressor of (case)
prosthesis with (case)
femoral ( (punct)
model tacrine-lithium (compound)
mass the (det)
improve providers (nsubj)
duct blocked (amod)
cisplatin carcinoma (nmod)
antagonism partial (amod)
nimo of (case)
% 41 (nummod)
acetaminophen paracetamol (dep)
candidate p-coumarate (nsubj)
involving possibly (advmod)
course . (punct)
heterozygous ( (punct)
had contained (advcl)
use enalapril (compound)
results with (case)
induced kg-1 (nmod)
warfarin d (conj)
didanosine on (case)
dosage cm (nmod)
occur to (mark)
excess the (det)
agent rg1 (nsubj)
ccr in (case)
cardiotoxicity substantial (amod)
ascribed failure (nsubjpass)
makes agent (ccomp)
investigate develop (advcl)
consequence ) (punct)
serve pretreatment (nmod)
months several (amod)
glucoronosyltransferases ugt (appos)
food given (case)
conclusion group (compound)
online immediately (advmod)
contribution issue (nmod)
healthy 7- (dep)
glutathione gssg (appos)
direct experimental (dep)
appearance gross (amod)
tendency weak (amod)
liver animals (nmod)
illustrated is (auxpass)
anaesthesia propofol (compound)
drug related (amod)
treatment acid (nmod)
controlling drainage (dobj)
targets lipid (compound)
frequent are (cop)
genes homologous (amod)
excreted pap (nmod)
overdose iatrogenic (amod)
administration accidental (amod)
generation hypertension (nmod)
mr of (case)
survivors treated (acl:relcl)
leveled off (compound:prt)
101 2 (conj)
become therapy (nsubj)
function controls (nmod)
met manifestations (nsubj)
treatment chf (nmod)
cost return (nmod)
interval 0.6 (appos)
vasculitis cutaneous (amod)
150 intravenous (amod)
adenocarcinoma well-differentiated (amod)
algorithm likelihood (dep)
effects harmful (amod)
h introduction (nmod)
anesthetized , (punct)
involvement components (nmod)
tachycardia ventricular (compound)
evolve psychosis (nmod)
7.914 95 (nummod)
u/l 270 (nummod)
anemia fatal (amod)
examined changes (nsubjpass)
cystitis , (punct)
result coadministration (nmod)
7.5 ; (punct)
increased phentolamine (nsubj)
pneumoniae and (cc)
toxicity renografin (nmod)
assay results (nmod)
ns-718 , (punct)
level (+)-propranolol (nmod)
effective anticonvulsant (dep)
carriers b (compound)
disorder and (cc)
events frequent (amod)
sustained . (punct)
lethal median (amod)
experiments control (compound)
remain complications (nsubj)
inhibitors drugs (conj)
produced haloperidol (nmod)
reliable experimental (conj)
sinus thrombosis (conj)
unchanged inferior (conj)
myalgia from (case)
subscale mmrm (nmod)
mg/kg/day sulfate (nmod)
induced hydrochloride (nmod)
treatment women (nmod)
oltx of (case)
introduced increased (conj)
developed % (nsubj)
found glomerulopathy (nmod)
explain defects (nsubj)
week gestation (nmod)
months not (neg)
found patients (nsubjpass)
prevention complication (nmod)
243.4 266.5 (conj)
inhibition prepulse (compound)
arrhythmia used (acl)
1996 ( (punct)
rest and (cc)
agents antimicrobial (amod)
leads development (nmod)
assay end (compound)
muscles in (case)
aggravation with (case)
treatment ml/min (appos)
-14.8 -8.1 (conj)
myocarditis acute (amod)
mg 2000 (nummod)
causes suprofen (nsubj)
questions use (nmod)
5-htp i.v. (appos)
cases 10 (nummod)
involved receptor (nsubjpass)
remained observed (advcl)
showed marked (conj)
lysozyme endogenous (amod)
individuals some (det)
troublesome results (conj)
tests catalepsy (compound)
1.0 0.99 (conj)
patient haemorrhage (nmod)
frequent 4/26 (nmod)
pregnane-21-diol-20-ones alpha-hydroxy (amod)
component increases (acl:relcl)
total 75/829 (nmod)
mice among (case)
nausea 2 (nummod)
duration immobility (nmod)
nigra . (punct)
apnoea in (case)
seem oxide (nsubj)
mediate . (punct)
micrograms 300 (nummod)
response hyperprolactinemia (nmod)
interacts that (dobj)
narrowing or (cc)
csa fk506 (conj)
patients good-risk (amod)
dosages of (case)
impact differential (amod)
thromboembolism risk (nsubj)
5-fu only (advmod)
parameter electrophysiological (amod)
therapy anticoagulant (compound)
aggravated changes (nmod)
hr each (det)
considered therefore (advmod)
interval months (nmod)
resistance 0.001 (appos)
sedation aggressive (amod)
tempol kg(-1 (appos)
transcripts three (nummod)
continued one-third (nsubj)
dressing wound (compound)
diminished weeks (nmod)
design placebo (compound)
dystonia " (punct)
rats lobund-wistar (compound)
product 0.001 (appos)
pathogenesis be (cop)
affect pergolide (nmod)
surgery intracranial (amod)
patients eighty-five (amod)
117.61 31.85 (conj)
girl and (cc)
neurotoxicity patient (nmod)
patients mi (conj)
norepinephrine with (case)
affinity values (nmod)
preceded supporting (advcl)
tool . (punct)
ibuprofen acid (conj)
undergoing bypass (dobj)
formed inclusions (nsubjpass)
vasospasm diffuse (amod)
dysfunction to (case)
subtherapeutic were (cop)
implications imaging (nmod)
prescribed att (nsubjpass)
behavior in (case)
attack no-induced (amod)
occurred withdrawals (nsubj)
using stereology (dobj)
prostaglandins responses (nmod)
loss against (case)
side-effect limiting (amod)
evaluation perspective (nmod)
society patients (conj)
evaluation study (nmod)
disparities large (amod)
patients age- (amod)
donors antigen (compound)
csa , (punct)
doses ml (nmod)
group p (appos)
assessable . (punct)
effect serious (amod)
sicca keratoconjunctivitis (compound)
proportion participants (nmod)
delirium desipramine-induced (amod)
glomeruli their (nmod:poss)
study performed (acl)
mice b6 (compound)
marrow of (case)
cis-platin mg/m2bsa (appos)
enhancement effects (nmod)
affected are (auxpass)
chloride 2,3,5-triphenyltetrazolium (compound)
dermatitis of (case)
stopped headache (advcl)
mumol/l 100 (nummod)
pr ( (punct)
volunteers 20 (nummod)
41 of (case)
signs in (case)
intensify activity (dobj)
= 13 (dep)
fragmentation to (mark)
force excess (xcomp)
tumours solid (amod)
= 0.041 (dobj)
ml 80.8 (nummod)
carcinoma received (acl:relcl)
as as (mwe)
6.4 0.2 (compound)
ischemia . (punct)
linked protection (nsubjpass)
dose route (conj)
drugs beta-adrenergic (amod)
anaesthetised . (punct)
binding serum (compound)
duration treatment (compound)
mg/kg 12 (nummod)
cause hemolysis (dobj)
institution effect (dep)
36 or (cc)
decreased immunostaining (nsubj)
drugs injection (conj)
inhibition memory (conj)
vaccination fourth (amod)
bn antagonist (appos)
used that (nsubj)
proceeded mg/m2/d (dep)
showed kidneys (nmod)
pneumonitis of (case)
ecstasy both (cc:preconj)
effect convulsants (nmod)
predictors therapy (nmod)
period seconds (nmod)
found group (nmod)
model parameters (nmod)
were while (mark)
criteria therapy (nmod)
failed protect (xcomp)
those mexiletine (nmod)
number increased (amod)
developed introduction (nmod)
treated bromocriptine (nmod)
operated developed (conj)
admitted being (auxpass)
folinic 5-fluorouracil (nmod:npmod)
majority reporting (acl)
syndrome pulmonary (amod)
occurrence hypercalcemia (nmod)
constriction bilateral (amod)
reduction % (nmod)
stage pre-nephrotic (amod)
upper right (amod)
apl ) (punct)
treatment seizures/mo (dep)
deaths three (nummod)
mrna-containing glutamic (amod)
head the (det)
upregulated that (mark)
inhibit resorption (dobj)
extended-release/lovastatin once-daily (amod)
candidate characterized (acl:relcl)
chf ( (punct)
patients 59 (appos)
unique documented (ccomp)
remain characterized (acomp)
ht and (cc)
vaccine b (compound)
favourable its (nmod:poss)
receptors orl1 (compound)
trans-2-amino-3-hydroxy-1 4-tetrahydroanaphthalene (appos)
dissolution actin (compound)
in-patients the (det)
agent protective (amod)
70/99 ) (punct)
toxicity conclusion (compound)
common abnormalities (nsubj)
impairment performance (compound)
evidence additional (amod)
group tmp (compound)
suggest found (advcl)
fluctuations of (case)
adults young (amod)
mm 10 (nummod)
stopped then (advmod)
hallucinations operative (amod)
consolidation post-training (amod)
demonstrated mean (dobj)
resolved , (punct)
protects cardiotoxicity (nmod)
schedule setting (nmod)
dyskinesia related (acl:relcl)
rest pvc (nmod:poss)
five p (dep)
antidepressant-induced pathophysiology (nsubj)
pretreatment weeks (nmod)
transport-deficient ) (punct)
initial and (cc)
encountered women (nmod)
permits toxicity (compound)
relationship seizures (nmod)
neurons ganglia (compound)
showed test (conj)
metabolites plasma (nmod)
abstention mdma (nmod)
relies control (nmod)
risperidone levomepromazine (conj)
tab of (case)
phenotype . (punct)
influence deficit (nmod)
puromycin-aminonucleoside sulfate (conj)
cardiomyopathy hypertrophic (amod)
interaction on (case)
90 less (amod)
mg/day 40 (compound)
pneumonia pneumonia (appos)
peroxisomes of (case)
aborted not (neg)
declined . (punct)
cardiotoxicity dose-related (amod)
exhibited behavior (dobj)
injection i.m. (amod)
status sodium (compound)
started having (aux)
mg 0.25 (nummod)
cacl(2)-treated among (case)
properties substrates (acl:relcl)
% 9.3 (nummod)
analogue 22-oxacalcitriol (appos)
irritability muscular (amod)
predict development (dobj)
effect mg/kg (nmod)
disturbances severe (amod)
syndrome broken (amod)
dm ) (punct)
pan , (punct)
reported changes (nmod)
informed be (cop)
locomotion used (conj)
expression cxcl1 (nmod)
groups 20-mg (amod)
developed paralysis (dobj)
found barrier/density (nsubjpass)
sinus and (cc)
hus possibly (advmod)
barrier in (case)
vomiting doses (dobj)
predictive however (advmod)
need medication (nmod)
exacerbates hgh (compound)
cancer aggressive (amod)
duct target (nsubj)
hypertension microangiopathy (conj)
alpha epoetin (compound)
cases adolescents (nmod)
before or (cc)
signs type (nmod)
affect however (advmod)
volume vt (appos)
alpha-tocopherol scavenger (appos)
two of (case)
bortezomib of (case)
states negative (amod)
carcinomas of (case)
electrogram surface (compound)
ac ( (punct)
forebrain throughout (case)
symptoms various (amod)
cholesterol from (case)
view to (case)
bia 2 (nummod)
documentation with (case)
compared ecg (nmod)
platinum- and (cc)
finding differ (ccomp)
range 4 (nmod:npmod)
rabbits and (cc)
agent inactive (acl:relcl)
expression cytokine (compound)
evidence changes (nmod)
rupture ventricular (compound)
protect ototoxicity (nmod)
reported study (nsubj)
induced glycosuria (dobj)
reduced independently (advmod)
sunitinib sorafenib (conj)
reviving use (nmod)
closing eyes (nmod)
short h (dep)
agents enhance (acl:relcl)
types certain (amod)
increases operation (nmod)
reappeared day (nmod)
be should (aux)
assay this (det)
baseline cvp (conj)
evoked auditory (nsubj)
models and (cc)
become , (punct)
morning a.m. (nmod)
took occasionally (advmod)
have doses (nsubj)
patients multiethnic (amod)
injection simultaneous (amod)
leukopenia ( (punct)
died ; (punct)
monitoring electrocardiographic (amod)
molars of (case)
prevalence lower (amod)
pain typical (amod)
290 - (punct)
suffered complication (dobj)
dose after (case)
lymphoma hl (appos)
related depression (nmod)
1.4 micrograms/ml (dep)
time accumulation (nmod)
45.9 +/- (cc)
tricuspid ) (punct)
produce trigger (dobj)
medications oxidant (amod)
2- 15- (conj)
grade acute (amod)
ovale via (case)
agitated to (mark)
groups following (amod)
treatment concurrent (amod)
behaviour mice (nmod)
expression vegfr-2 (compound)
mice n (dep)
vasodilators , (punct)
stimulating m(3)-machr. (dobj)
3.0+/-0.4 similar (amod)
myocytes of (case)
pain cold-pressor (compound)
started attempt (xcomp)
sr antagonist (compound)
delirium experienced (acl)
channel and (cc)
alphaenac , (punct)
occurred mostly (advmod)
required that (mark)
reversal naloxone (nmod)
criteria tested (acl)
showed inhibited (ccomp)
investigated type (nmod)
lower respectively (advmod)
patients ( (punct)
able continue (xcomp)
different pharmacological (dep)
is purpose (nsubj)
little or (cc)
greater three (conj)
developed degree (nsubj)
patients nephropathy (amod)
attenuate effects (dobj)
botox ) (punct)
unable who (nsubj)
e2 ( (punct)
risk this (det)
inhibited chloride (nsubj)
moderate anemia (conj)
formation from (case)
therapy low-dose (amod)
offer seem (conj)
had counts (conj)
seeds daucus (compound)
treated acitretin (nmod)
evaluated parts (nmod)
time toward (case)
three more (amod)
opportunity a (det)
simvastatin from (case)
demonstrate patients (nsubj)
examines affects (ccomp)
tachycardia n (dep)
chemotherapy intra-arterial (amod)
effect this (det)
rigidity such (case)
ro ( (punct)
pronounced stages (nmod)
lack this (det)
shows appeared (ccomp)
dce by (case)
incidence beats (conj)
users or (dep)
data limited (amod)
absence corticosteroids (nmod)
cp 93129 (nummod)
cessation infusion (nmod)
simvastatin between (case)
rendered group (nsubjpass)
unchanged were (auxpass)
treatment gd (nmod)
experienced episodes (dep)
gyrus parahippocampal (compound)
prolongs vitro (advmod)
< cigarettes (dep)
alzheimer 's (case)
mg. 1 (compound)
53 5 (compound)
medium activities (conj)
amisulpride- and (cc)
cause hypokalemia (nsubj)
management routine (amod)
u/ml , (punct)
proarrhythmia amiodarone-induced (amod)
agonist bd1031 (dep)
scattered and (cc)
label to (mark)
kindling resulting (acl)
necrosis changes (dep)
anatomically and (cc)
mesna ( (punct)
tested nimesulide (nmod)
data multicenter (nmod)
groups the (det)
included latency (dobj)
lungs , (punct)
alter diuresis (nsubj)
transcriptase reverse (compound)
4.2 only (advmod)
experience increase (nmod)
therapy pegylated (amod)
7h6 , (punct)
begun was (auxpass)
extraction degrees (compound)
with " (punct)
defects adjusted (acl)
month valproate (nmod)
basis short- (amod)
carcinogenesis during (case)
equipment oximeters (nmod)
characteristics changes (conj)
demonstrated lack (dobj)
process to (case)
background objectives (conj)
hemorrhage intracerebral (amod)
points score (nsubj)
tended did (advcl)
represents cardiotoxicity (dobj)
baseline their (nmod:poss)
tone of (case)
targeting receptors (dobj)
cidofovir of (case)
lethality not (neg)
exhibited study (nmod)
measured weeks (conj)
antibody-negative and (cc)
persisted and (cc)
acuity normal (amod)
animals treated (amod)
45.45 44.4 (conj)
preserved mechanisms (nsubjpass)
remained pressure (conj)
applies antagonism (nmod)
film abnormal (amod)
adherence antibiotics (nmod)
complexes phosphorylation (compound)
difference % (dep)
incidence tnss (nmod)
analysis case-control (amod)
alpha f2 (compound)
analysis leiden (nmod)
produced actions (dobj)
negative and (cc)
eligible were (cop)
exposed bcnu (nmod)
withdrawal reintroduction (conj)
imperative is (cop)
increased lowered (conj)
result disease (nmod)
somatotopy the (det)
admitted unit (nmod)
produced and (cc)
3/5 ) (punct)
force excessive (amod)
force mechanisms (dobj)
case deterioration (nmod)
experience settings (nmod)
study men (dep)
series complete (amod)
functions patients (nmod)
associated whether (mark)
field and (cc)
perimetry ) (punct)
report case (nsubj)
cpa/ee ( (punct)
toxicity cumulative (amod)
play diminished (advcl)
pituitaries 160 (nummod)
patient nulliparous (amod)
amount disability (nmod)
adolescents depressed (amod)
= -0.98 (dobj)
removed surgery (nmod)
woke up (compound:prt)
5mg/kg ) (punct)
diagnosis bipolar (dep)
caffeine mg/kg (compound)
baseline p= (appos)
suggested we (nsubj)
rcts of (case)
seizures disturbances (conj)
doxorubicin further (amod)
drum behavior (conj)
ps ls (appos)
risks inhibitors (nmod)
effective that (mark)
8.8 3.5 (conj)
midazolan flumazenil (conj)
received metoclopramide (dobj)
function subjects (nmod)
recovered hours (nmod)
rhabdomyolysis . (punct)
hbsag-negative ( (punct)
objective highlight (dep)
areas face (nmod)
l-dopa given (acl)
paresthesias and (cc)
infants these (det)
busulfan high-dose (amod)
areas several (amod)
hypercalcemia metabolites (conj)
conclusion considered (appos)
using histochemistry (dobj)
acid gamma-cholesteryloxybutyric (amod)
treated mean (nmod)
ameliorated rate (nsubj)
state surveying (amod)
enzyme-1 ece-1 (appos)
25 out (dep)
withdrew mouth (nmod)
process storage (compound)
difficulties secondary (amod)
six week (nmod)
val hctz (conj)
protectors potential (amod)
scale rating (compound)
pci group (appos)
demonstrated measurements (nmod)
months hyperprolactinemia (nmod)
decreased quinpirole (nsubj)
order investigated (acl)
a/j c57bl/6j (conj)
regained . (punct)
evaluation formal (amod)
recurrent be (cop)
examined ability (dobj)
toxicity administration (nmod)
consistent disease (nmod)
trial present (amod)
enzymes urinary (amod)
scores mice (nmod)
show 50 (nsubj)
factors peld (nsubj)
likely develop (xcomp)
subgroup valve (compound)
exposure inhibition (nmod)
found using (xcomp)
component strong (amod)
% vs. (cc)
ms p<0.005 (amod)
drugs salicylate (appos)
disturbance and (cc)
targets promising (amod)
beneficial is (cop)
115 h (dep)
six over (quantmod)
regulation blood (compound)
remain understood (xcomp)
n-nitroso-n-methylurea testosterone (conj)
csa mg/kg/day (punct)
susceptibility seizure (amod)
10(6 41.8 (nummod)
controls active (amod)
% norms (nmod)
harm associated (acl)
ng/min ) (punct)
chorionic muscle (conj)
short too (advmod)
levels luteinizing (compound)
infusion b (nmod)
infants vaccinated (acl:relcl)
action to (mark)
progression rhythmic (amod)
suggests likely (ccomp)
mg/m2 adriamycin (nmod)
task induced (acl)
prevent reduction (dobj)
older , (punct)
elevated ) (punct)
under-reporting and (cc)
neuropathy this (det)
absence acid (nmod)
ethopropazine study (compound)
bfue splenic (amod)
beats/minute or (cc)
increase fev1 (nmod)
beta-blockade.8 of (case)
remained unclear (xcomp)
reserpine the (det)
site h (dep)
discount authors (nsubj)
study double-armed (amod)
nephritis between (case)
corticosteroids due (case)
dose-dependent if (mark)
discussion history (nmod)
uncommon be (cop)
documented is (auxpass)
therapy erections (conj)
throat sore (amod)
assessed rats (dobj)
interacts oxidase (nmod)
connects matrix (dobj)
diuresis forced (amod)
reports no (det)
parenchyma brain (compound)
identify 1995 (nmod:tmod)
decreases in (case)
terminated , (punct)
virus e (compound)
scales and (cc)
mg/kg ketamine (nmod)
ethambutol between (case)
fibrillation flutter (conj)
di-o-tolylguanidine each (dep)
telangiectasia , (punct)
compare to (mark)
implicated accident (nmod)
reported behaviors (nsubjpass)
stopped those (nmod)
had thirty-nine (nsubj)
levels cortex (nmod)
appeared effective (xcomp)
mitogens , (punct)
2-(p-bromophenyl)propionate of (case)
integrity morphological (amod)
evidenced was (auxpass)
provide model (dobj)
less ; (punct)
space bowman (nmod:poss)
analysis brain (nmod)
events because (case)
had otherwise (advmod)
nimesulide and (cc)
excess . (punct)
clonic a (det)
deleted gene (nsubjpass)
generated c1 (dep)
toxicity dose-limiting (amod)
recognized thrombocytopenia (nsubjpass)
thp ( (punct)
ratio p=0.009 (appos)
interference by (case)
types of (case)
ramh se (advmod)
reductions scale (compound)
acid enzymes (compound)
persist . (punct)
aware prevented (dep)
way a (det)
hcfcs 123 (nummod)
intubation of (case)
viruses with (case)
intervention outcome (conj)
reduces receiving (conj)
induced caused (conj)
overactivation a (det)
cardiomyopathy cm (appos)
sets . (punct)
helpful not (neg)
degeneration patchy (amod)
produce glyburide (nsubj)
resistant drug (nmod:npmod)
indicate acts (ccomp)
specific relatively (advmod)
nephrotoxicant a (det)
cisapride 0.001 (appos)
cells carcinomas (nmod)
sleepiness daytime (compound)
jj to (case)
abnormalities associated (acl)
toxicity cardiac (amod)
leg and/or (cc)
cholestasis associated (acl)
injection intradermal (amod)
identified however (advmod)
rr=1.41 ) (punct)
increased increase (dobj)
frequency syndrome (nmod)
paco2 4.1 (nummod)
abundant on (prep)
alive are (cop)
potentials sensory (amod)
compound each (det)
evaluation microscopic (amod)
study risk (nmod)
men 23 (nummod)
occurred striking (conj)
tetra- and (cc)
doses dexrazoxane (nmod)
lungs liver (conj)
reactivity the (det)
acid all-trans-retinoic (amod)
seizures hfde-induced (amod)
influence pentobarbital (nmod)
disease cerebrovascular (amod)
assessment ratings (conj)
mg/day 200 (nummod)
muscle pollicis (compound)
evaluation effect (nmod)
design medications. (compound)
disrupted but (cc)
abuse amphetamine (compound)
improved partly (advmod)
circumstances appropriate (amod)
cigarettes ( (punct)
available and (cc)
data treated (acl)
bbb , (punct)
number transformation (conj)
behavioral on (case)
2.75 1.04 (compound)
2 range (appos)
risks : (punct)
reached excretion (nsubj)
count cell (compound)
facilitated increase (nsubj)
single doses (dep)
events primarily (advmod)
intervention the (det)
alphaenac of (case)
increased presence (nmod)
infiltration by (case)
effective approach (nsubj)
used accounting (advcl)
movement chest (amod)
multiforme ruled (conj)
vincristine intrathecal (conj)
sinuses of (case)
ilk via (case)
possibility advantage (nsubj)
combined it (nsubjpass)
shown it (nsubj)
induce cocaine (nmod)
5967 - (punct)
arterioles and (cc)
patients associated (acl:relcl)
reverse , (punct)
cells inhibitory (amod)
tnf-alpha paf (conj)
cell within (case)
action dual (amod)
ability patient (nmod)
changes become (acl:relcl)
favourable most (nmod)
evaluated chemotherapies (nmod)
light the (det)
model distinguished (acl:relcl)
receptors csa (nmod)
erythropoietin rhuepo-beta (appos)
fdc ) (punct)
extract crocus (compound)
seen decade (nsubj)
hepatitis troleandomycin-induced (amod)
parasites and (cc)
shift tam (nsubj)
dogs coronary (amod)
reduction ad50 (nmod)
period 3-week (amod)
infants very-low-birthweight (amod)
lot , (punct)
noted baseline (nmod)
inhibitors angiotensin (compound)
correlation observers (compound)
feeding diet (dobj)
hypertension associated (amod)
caring patients (nmod)
dose titration (nmod)
administration analogue (nmod)
type disease (compound)
cells blood (compound)
270 and (cc)
associated independently (advmod)
cd4 165 (appos)
localization dystrophin (amod)
documented bleed (nsubjpass)
celecoxib 0.83 (dep)
plays consolidation (nmod)
many effects (nmod)
diabetes adult-onset (amod)
histories psychiatric (amod)
gsk3alpha in (case)
incidence dementia (nmod)
animals haloperidol-treated (amod)
worsening sudden (amod)
known commonly (advmod)
baseline > (dep)
duration hyperprolactinemia (nmod)
occur hus (nsubj)
mg/m2/wk dose-intensity (nsubj)
peroxidation associated (acl)
values comparable (amod)
measure cbz (nmod)
surface pial (amod)
neurotransmitters acid (compound)
results developed (dep)
aap to (case)
saline either (cc:preconj)
ifo of (case)
patients demonstrating (acl)
question use (nsubj)
sham , (punct)
8 up (advmod)
use method (nmod)
contraceptives conventional (amod)
intake methylphenidate (compound)
nh4cl of (case)
density bone (compound)
arrhythmias digitalis- (amod)
mmrm ( (punct)
methylation group (nmod)
unpleasant pain (nsubj)
p 6/20 (dep)
bche in (case)
hyperlipidemia with (case)
chemotherapy adjuvant (amod)
increase alfentanil-induced (amod)
inhibitors thrombin (compound)
scale adverse (amod)
reduplication membrane (compound)
indexes time (compound)
administration approval (conj)
responsiveness signs (nmod)
associated tacrolimus (nmod)
prospective randomized (dep)
hz 1v (conj)
nitrazepam of (case)
investigated tolerability (dobj)
acutely treated (conj)
ability micrograms (nmod)
having suffering (conj)
shr administration (conj)
day weeks (nmod)
facility humor (compound)
medicine impairment (nmod)
using while (mark)
ss ( (punct)
infusion deoxycholate (amod)
outcome . (punct)
replicate inhibition (nsubj)
report this (nsubj)
1.56 1.56 (conj)
administration recipients (nmod)
unclear was (cop)
occurred concentration (nmod)
usage with (case)
induce doses (nsubj)
1.6 +/- (cc)
women these (det)
methylphenidate oral (amod)
higher radiotherapy (conj)
medialipid saline (conj)
dose conversion (nmod)
oral and (cc)
walls glomerular (amod)
lesions ( (punct)
diminish did (aux)
available counter (nmod)
blockade neuromuscular (amod)
precise not (neg)
removal no (nmod)
contraction control (appos)
extract gspe (appos)
cells antigen-positive (amod)
identify history (dobj)
contributing are (aux)
increased mg (nmod)
blood fecal (amod)
analysis light (amod)
effective prevention (nmod)
diseases inflammatory (amod)
related expression (nmod)
handicapped are (auxpass)
fatality of (case)
treatment ribavirin (compound)
mg/kg produced (appos)
4.98 ; (punct)
twins the (det)
tool predict (acl)
outcomes of (case)
recognition and (cc)
rise ventricular (amod)
nephrotoxicity pap (compound)
noted shifts (nsubjpass)
concerns exposure (nmod)
statement , (punct)
described it-methotrexate (nmod)
epilepsy such (case)
time locomotor (compound)
ifosfamide combination (conj)
compared children (nmod)
excitability reflex (nmod)
understood monitored (advcl)
contribute cardiotoxicity (nmod)
vessels subarachnoid (amod)
time asystole (acl:relcl)
bau ) (punct)
form common (amod)
sah after (case)
line evidence (nmod)
concentrations cgrp (compound)
bronchitis ( (punct)
diagnostic and (cc)
patient 25-year-old (amod)
warrants that (nsubj)
within close (conj)
out-patients in-patients (conj)
arrhythmias towards (case)
genes involved (acl)
cat ( (punct)
hypoalbuminemia genotypes (nmod)
298+/-7 280+/-17 (conj)
causes microangiopathy (nmod)
treated mothers (nsubjpass)
influenced background (nmod)
indicated seen (parataxis)
combinations the (det)
associated intake (nsubjpass)
evaluated sonograms (nmod)
reduces manner (nmod)
receiving treated (conj)
number duration (conj)
application nitroglycerin (nmod)
potentiated desmethylimipramine (nmod)
associated raloxifene (nsubjpass)
weakly . (punct)
seems improving (xcomp)
anp and (cc)
written has (aux)
progression atrophy (nmod)
discharge , (punct)
bun ( (punct)
effects spasticity (nmod)
reactions infusion-related (amod)
angina patients (conj)
treated recurrent (nmod)
centers 362 (nummod)
pentamidine of (case)
rescues toxicity (dobj)
nephropathy damage (conj)
arteries ( (punct)
inhibitor monoamine (compound)
development eventual (amod)
t1/2 myocardial (amod)
administration betaine (nmod)
cephalosporin either (cc:preconj)
inoculation intravenous (amod)
tests scale (dep)
used days (dep)
did variables (dobj)
variety to (case)
deposits electron (compound)
shorter was (cop)
mammary endometrial (conj)
h. 24 (nummod)
results 2.20 (appos)
syndrome system (nmod)
rilmenidine of (case)
illness hepatitis-like (amod)
inhibitors angioedema (nsubj)
prevented inhibition (dobj)
tetracycline to (case)
sensorimotor severe (amod)
decreases and (cc)
expression anti-apoptotic (amod)
receives pallidus (nsubj)
measured min (nmod)
five factor (acl:relcl)
induced methamphetamine (nmod)
greater control (nmod)
mmhg 0.001 (dep)
effects isomers (nmod)
depletion in (case)
defects midline (amod)
6.7 0.0 (conj)
results calculation (nsubj)
implausible . (punct)
detection reduction (nmod)
ug/ml 11.21 (compound)
carolina in (case)
fever intermittent (amod)
db . (punct)
evidence ptcr (nmod)
500 125 (compound)
measured h (dep)
78 18 (compound)
extract ( (punct)
specified , (punct)
paralleled reduction (nmod)
durations inflammation (nmod)
has dehydrogenase (nmod)
patient caused (acl)
inoculation mg (nmod)
dependent and (cc)
opponent the (det)
detect to (mark)
problem patients (nmod)
effect . (punct)
development lometrexol (nmod)
disturbance droperidol-induced (amod)
therapy intermittent (amod)
changes angina (amod)
therapy amiloride (compound)
selection patient (compound)
1.4 0.4 (conj)
circulation peripheral (amod)
autoantibodies ( (punct)
risperidone < (dep)
response therapeutic (amod)
effects drug (compound)
differ edema (nsubj)
2b/3 phase (compound)
increased mm (nmod)
fluid busulfan (det)
concentrations paclitaxel (compound)
investigate predict (ccomp)
dysfunction glutamatergic (amod)
medication improved (acl)
infusion by (case)
male hypothyroid (amod)
procedure entire (amod)
cholesterol < (compound)
use strains (nmod)
reduction clear (amod)
effects eps (appos)
related bortezomib (nmod)
calculi multiple (amod)
chick rat (conj)
assessment 5-minute (amod)
protected were (auxpass)
repeated cycle (nsubjpass)
profiles smokers (nmod)
slowing associated (acl)
effect measurable (amod)
death erythrocyte (compound)
% 70 (nummod)
rescues it (nsubj)
hematoma and (cc)
normalized ) (punct)
receiving stabilizer (dobj)
hepatitis commonly (advmod)
lam ) (punct)
pronounced animals (nmod)
onwards six (nummod)
hematological . (punct)
administered injection (xcomp)
beta-hydroxylase dbh (appos)
accelerated it (dobj)
effects neurotransmission (nmod)
dermatoses with (case)
capillary of (case)
rs4704559 rs10942891 (conj)
91.5 , (punct)
status neurologic (amod)
cn , (punct)
study toxicity (nmod)
analyzed response (nsubjpass)
evolution clinical (amod)
were also (advmod)
follow levels (nmod)
anticipated outcome (nsubjpass)
seven 2-chloroprocaine-ce (compound)
diffuse multifocal (conj)
mice untreated (amod)
subjects ( (punct)
disorder olfactory (amod)
videofluoroscopy with (case)
showed proportion (dobj)
skeptical miss (advcl)
biochemical behavioral (conj)
exposed sparteine (conj)
suggests relationship (dobj)
cisplatinum cpdd (appos)
activation midpontine (compound)
35 asian (quantmod)
complications diazepam (nmod)
strains patients (nmod)
enzymes involved (acl)
2.0/100,000 ) (punct)
dynamics also (advmod)
myelination altered (amod)
hemopoiesis ineffective (amod)
patients level (appos)
plasma steady-state (amod)
profiles patients (nmod)
evidenced by (advmod)
medication by (case)
treated inappropriately (advmod)
failed however (advmod)
conclusions indicates (appos)
hypercalcemia including (case)
risk , (punct)
u/liter ) (punct)
implicated sirolimus (nsubjpass)
patients b (compound)
examined females (nsubjpass)
epileptogenesis , (punct)
encouraged but (cc)
i1-receptor-mediated not (neg)
effect oxygenation (nmod)
ob ( (punct)
anticoagulant an (det)
included studies (nsubjpass)
7 patients (nmod)
kg-1 saline (conj)
administration sertraline (compound)
dependent rise (nmod)
challenged . (punct)
mechanisms influence (acl:relcl)
relationship carbon (nmod)
t-tests paired (amod)
verified study (nmod)
avoided whereas (dep)
infusions in (case)
associated misoprostol (nsubjpass)
remoxipride [ (punct)
causes syndrome (dobj)
h in (case)
prevents diphenhydramine (nsubj)
survival months (nmod)
contaminated be (auxpass)
about start (xcomp)
digoxin of (case)
play that (mark)
agents hemodiluting (amod)
protocol included (acl:relcl)
animals have (acl:relcl)
alfentanil following (case)
pj34 inhibitor (compound)
weight and (cc)
nitrite hydrochloride (nsubj)
effects those (nmod)
reported users (nmod)
hypoxia diseases (conj)
back-diffusion release (conj)
receive days (nmod)
displays used (conj)
coma hypotension (conj)
function pulmonary (amod)
factor which (nsubj)
gvhd acute (amod)
suggests and (cc)
showed rest (nsubj)
dose carboplatin (nmod)
administered hbig (nsubjpass)
given delivery (nmod)
mediated being (auxpass)
diagnosed ra (nmod)
deaths rupture (conj)
unpredictable serious (conj)
dysfunction pain (amod)
subunit an (det)
coefficient diffusion (compound)
rats protected (amod)
study clinical (amod)
administration [3h]-5-azadeoxycytidine (nmod)
using hands (dobj)
number events (nmod)
ro ) (punct)
sepsis and (cc)
downregulation and (cc)
intraoperative for (case)
% ic (dep)
were findings (nsubj)
us in (case)
time sleep (compound)
demonstrated 31 (nsubj)
metastases colon (compound)
localization the (det)
results disappointing (amod)
test hole-board (amod)
enhances have (conj)
increases markedly (advmod)
day at (case)
thresholds the (det)
hypotension orthostatic (amod)
cautious more (advmod)
fields ufov (conj)
effect sertraline (nmod)
function receptor (compound)
mutation the (det)
status at (case)
variety pathogeneses (conj)
20 5 (compound)
altering . (punct)
dose terbutaline (compound)
resulting block (nmod)
index ) (punct)
areas fibrotic (amod)
fluids to (case)
gem-p following (case)
volume white-cell (conj)
december 1997 (nummod)
normal hours (nmod)
reaction probable (amod)
heart dog (compound)
representing conjunction (nmod)
taking simvastatin (dobj)
complete treatment (nmod)
specific be (cop)
prepared can (aux)
analysis image (compound)
hepatitis active (amod)
combination b12 (conj)
decreased therapy (nmod)
caring physicians (compound)
completely sequelae (nmod)
activity stereotypy (conj)
non-randomised clinical (dep)
cyclosporine- trough (conj)
therapy inappropriate (amod)
uterotonic a (det)
epicondyle on (case)
asex ) (punct)
has : (punct)
described characterization (nsubjpass)
depressed anesthesia (nmod)
kinase of (case)
nelarabine with (case)
recalled later (advmod)
raised concern (nsubjpass)
impairment potentiation (compound)
receiving patients (nsubj)
insult liver (compound)
included incidence (dobj)
reduced even (advmod)
results largely (advmod)
ml/min/kg ( (punct)
has a (nsubj)
process cell (nmod)
improvement patient (nmod)
sprague-dawley sd (appos)
increase tgr (nmod)
shifts rapid (amod)
inactivation the (det)
papilloma ( (punct)
size oedema (conj)
background known (appos)
upslope potential (nmod)
or 1.52 (dep)
warned effects (nmod)
dimorphism a (det)
dyskinesia orofacial (amod)
curtailed . (punct)
move away (advmod)
unit a (det)
occur changes (nmod)
perception pain (compound)
incidence between (case)
deficits stz-icv-induced (amod)
psychopathology or (cc)
chemotherapy ifosfamide (compound)
suggests intensified (ccomp)
necrosis no (det)
centre traumatological (compound)
0.03 microgram/kg/min (conj)
activity carcinoma (nmod)
stereotypy apomorphine (conj)
given i (nsubjpass)
suspected cause (xcomp)
neurotransmitters on (case)
research effects (nmod)
treatment monitored (amod)
women hormone (nmod)
exercise of (case)
injections dox (compound)
experienced devastating (dobj)
described has (aux)
discribed patient (nsubjpass)
lymphocytes patients (nmod)
androgens of (case)
insula the (det)
dropped u/l (nmod)
% cyclic (amod)
alpha-tc ) (punct)
analysis time-to-event (amod)
drugs reappraisal (appos)
administered 21days (nmod)
range was (cop)
case haemorrhage (nmod)
marker diagnostic (amod)
reduces improves (conj)
olanzapine patients (nmod)
scale reports (conj)
ctni-positive , (punct)
tasks function (compound)
antagonists two (nummod)
kindreds the (det)
was return (attr)
indicates encephalopathy (nsubj)
loci seizure (amod)
containing or (cc)
word read (acl:relcl)
method sensitive (amod)
related hemolysis (nsubj)
combination doxil (dep)
vacuolization cellular (amod)
assessed trials (nmod)
transplantation allogeneic (amod)
paclitaxel for (case)
variable but (cc)
days menses (nmod)
oncologists neurologists (conj)
precurarization safe (amod)
solution nacl (compound)
stomatitis anemia (conj)
450 300 (compound)
begun return (xcomp)
presents it (nsubj)
index 1.19 (nmod)
mice beta2(-/- (amod)
trial comparative (amod)
nuclei other (amod)
hour ingestion (nmod)
able be (cop)
exploration surgical (amod)
sirolimus acidosis (conj)
database transplantation (compound)
azithromycin therapy (conj)
seems thus (advmod)
evaluate doses (nmod)
suggest dysfunction (ccomp)
anesthesia , (punct)
showed impairment (dobj)
added on (compound:prt)
members other (amod)
produce modify (conj)
hematomyelia report (appos)
therapy self-reported (amod)
defects pyeloureteral (amod)
inhibitor converting (compound)
exposure mg/kg (dep)
gyrus model (nmod)
poison activity (nmod)
exposure tdf (compound)
clearance osmolality (conj)
heterogeneity cross-reactivities (nmod)
gases blood (compound)
4.6 ( (punct)
response to (case)
suggesting importance (ccomp)
fenfluramines for (case)
impaired processes (nsubjpass)
improvement signs (nmod)
base left (amod)
period breathiness (nmod)
thrombosis ica (nmod)
switched patients (nmod)
remained patient (nsubj)
decrease complication (dobj)
test objective (amod)
viscosity using (acl)
immunohistochemistry microscopical (amod)
ovx ) (punct)
reported days (nsubj)
[ca]o normal (amod)
0.001 p (dep)
high mi (nmod)
isbell fraser (conj)
dse positive (amod)
occurred farmer (nmod)
million 3.2 (compound)
rise significant (amod)
followed intervals (nmod)
instrumentation following (case)
acid lnaa (appos)
that of (case)
duration prolonged (amod)
elevated inhibited (conj)
produced depressants (nmod)
aortic either (cc:preconj)
deaths complications (conj)
% 115 (nummod)
restricted movement (dobj)
substantial enough (advmod)
surgical in (case)
present incidences (dobj)
established groups (nsubjpass)
individual 's (case)
incorporating b. (dobj)
or increased (amod)
discontinuation % (nmod)
performed taken (conj)
procedures standard (amod)
tremor ( (punct)
published published (conj)
inhibition an (det)
maximum mgkg (nmod)
case angina (nmod)
fs ( (punct)
included gender (dobj)
effect neurotoxicity (nmod)
lumens , (punct)
stage during (case)
mrna tlr4 (compound)
rhinitis spring (compound)
concentrations half-life (conj)
achieved rosc (nsubjpass)
associated commencement (nmod)
insertion pacemaker (compound)
depend and (cc)
occlusion ): (punct)
discontinued infusion (nsubjpass)
said carboplatin (nsubjpass)
unaffected severity (nsubjpass)
switch the (det)
patients excretion (conj)
1.44+/-0.6 , (punct)
trend return (nmod)
electroretinograms pattern (compound)
undergoing patient (nsubj)
safety populations (nmod)
treatment sulfadiazine (nmod)
interfered , (punct)
equal equal (conj)
substance unlabeled (amod)
injection dfp (nmod)
found reported (conj)
degree response (nmod)
levels occupancy (compound)
contribute prolongation (nmod)
tci with (case)
injection reserpine (compound)
investigated fields (dobj)
decreased ee (nmod)
insipidus be (cop)
oedema for (case)
shown patients (nmod)
patients insufficiency (nmod)
di- potent (conj)
tested thresholds (nsubjpass)
drug free (amod)
event adverse (amod)
toxicity amiodarone (nmod)
affect or (cc)
organization world (compound)
injection volumes (nmod)
weight seen (acl)
mecamylamine antagonist (compound)
had defects (dobj)
induced be (auxpass)
knowledge from (case)
method failing (nmod)
tumors large (amod)
asymmetry cross-tolerance (nmod)
dependent were (auxpass)
hemodialysis years (nmod)
patient either (cc:preconj)
control synthesis (conj)
dose w. (nmod)
30mg/kg , (punct)
yield result (nmod)
suppress did (aux)
induction sevoflurane (compound)
syndromes psychotic (amod)
giving it (dative)
acrolein mg. (nmod)
utilized however (advmod)
disease ischemic (amod)
walk prior (advmod)
reliability high (amod)
mean relative (mark)
neuropathy cranial (amod)
responded withdrawal (nmod)
or 10 (nummod)
antibody monoclonal (amod)
aggregability platelet (compound)
combination with (case)
is , (punct)
treatment linezolid (amod)
describe association (dobj)
cumulative the (det)
gained weight (dobj)
ranges therapy (compound)
pretreatment depletor (appos)
impaired compared (xcomp)
occlusion artery (compound)
abnormal involuntary (dep)
mitochondria damaged (amod)
mean % (compound)
produce pg-9 (nsubj)
sites of (case)
aware complication (nmod)
deterioration auditory (amod)
suggest reverse (ccomp)
occurred groups (nmod)
models damage (nmod)
present fibrosis (nsubj)
avoid should (aux)
elimination hepatocytes (nmod)
undergoes ezetimibe (nsubj)
administered measured (conj)
extracted samples (nmod)
procedure or (cc)
recognized were (auxpass)
reported was (auxpass)
ratio rate (compound)
understood impact (nsubjpass)
hus adults (nmod)
diagnosed jaundice (nmod)
anhydrase of (case)
child in (case)
function memory (compound)
errors medical (amod)
pathway common (amod)
impairments cognitive (amod)
prevented death (dobj)
increasing 1 (dep)
induced effect (nmod)
circulation intact (amod)
healthy groups (nmod)
have may (aux)
association model (nmod)
facilitated . (punct)
taking drugs (dobj)
made variables (nmod)
tested animals (nsubjpass)
atherosclerosis with (case)
proved testing (nsubj)
required signaling (nsubjpass)
loss hilar (amod)
mcl of (case)
tid mg (nummod)
average for (case)
afterdischarges duration (nmod)
duration recovery (nmod)
adenocarcinoma clear (amod)
involved studies (nsubj)
occupancy d2 (compound)
allocated were (auxpass)
uptake an (det)
drugs cause (acl:relcl)
selected sensitivities (nmod)
deterioration in (case)
role haloperidol (nmod)
proliferation in (case)
adenosine of (case)
mortality greater (amod)
induced provoked (conj)
hippocampus ventral (amod)
aware event (nmod)
play damage (nmod)
mutations pc (compound)
29.9 +/- (cc)
findings mr (compound)
kg-1 and (cc)
levels relative (amod)
ctnt , (punct)
illnesses medical (amod)
consenting of (mark)
observe respond (ccomp)
tests stress (compound)
section a (det)
suggested minor (ccomp)
t3 ( (punct)
one are (cop)
improved sensitivity (nsubj)
activity via (case)
benzoylecgonine by (case)
suppress doses (nsubj)
prevalent , (punct)
augmented seizure (dobj)
displays bche (nsubj)
did trial (dobj)
remained added (conj)
indicating neurotoxicity (dobj)
anaemia aplastic (amod)
repeat word (dobj)
event therapy (nmod)
frequent diazepam (nmod)
range within (case)
cs salt (conj)
124.4+/-73.4 103.1+/-81 (conj)
decreased den (nmod)
benserazide ) (punct)
moran al. (dep)
dwi map (conj)
damage cortex (dobj)
patients fewer (amod)
consumed when (advmod)
determined shr (nmod)
counts electrocardiograms (conj)
unnecessary , (punct)
cns on (case)
amn082 mg/kg (compound)
nephrotoxicity experimental (amod)
birth , (punct)
factors baseline (compound)
considered surgery (nsubjpass)
levels pre-treatment (amod)
used were (auxpass)
cardiomyopathy to (case)
akathisia of (case)
regression in (case)
% f (appos)
women continued (acl:relcl)
control . (punct)
model behavioral (amod)
medication 11 (nummod)
reacted cells (nmod)
hrs for (case)
decrease output (nmod)
minutes 20 (nummod)
study during (case)
agent sole (amod)
agonist with (case)
observed results (nsubjpass)
160 - (punct)
achieved control (nsubjpass)
consuming energy (dobj)
dfo mg/kg (appos)
outcomes . (punct)
found neither (cc:preconj)
available remedies (nmod)
depression general (amod)
constants currents (nmod)
induced gentamicin (nmod)
study ci-921 (nmod)
rats estradiol-treated (amod)
5-ht(6 ) (punct)
exposure administration (conj)
overflow stimulus-induced (amod)
forms in (case)
elderly volunteers (dep)
values preinfusion (compound)
promote barrier (nmod)
153 +/- (cc)
substitutes ozone-sparing (amod)
duodenum jejunum (conj)
nephrotoxicants as (case)
4.5+/-1.0 ( (punct)
reported date (nmod)
elucidate effect (dobj)
models dyskinesia (nmod)
ami ; (punct)
pointes induced (acl)
revealed consistent (advcl)
confirms . (punct)
ex vivo (dep)
lethargy associated (acl)
risk thromboembolism (nmod)
consequence not (neg)
threshold damage (conj)
3.1+/-1.0 , (punct)
received call (xcomp)
detected mutants (nsubjpass)
occurred started (conj)
curves of (case)
processing information (nmod)
history medical (amod)
combination bevacizumab/irinotecan (nmod)
considered but (cc)
produce toxicities (dobj)
forearm and (cc)
cause difficult (conj)
proposed involvement (nsubjpass)
rats control-fed (amod)
impair treatment (nsubj)
variables diary (compound)
able attenuate (xcomp)
using digoxin (dobj)
activity the (det)
ratios with (case)
older years (nmod)
findings modulator (ccomp)
clotting hemodilution (conj)
population urban (amod)
increased dexamethasone (nsubj)
astrocytes extravasation (conj)
reticulata nigra (nmod)
rebounded pressure (nsubj)
lesion 6-ohda (compound)
warn to (mark)
use respectively (advmod)
reviewed modified (xcomp)
factor nrf2 (nsubj)
effect little (amod)
exposed pb (nmod)
trihexyphenidyl of (case)
effectiveness carriers (conj)
area with (case)
movements chewing (amod)
year than (case)
midazolam than (case)
failure gentamicin-mediated (amod)
treatment hemorrhage (nmod)
period at (case)
leprosy with (case)
parallels that (nsubj)
appeared when (advmod)
resolved quickly (advmod)
marker function (nmod)
databases biomedical (amod)
presented recovery (nmod)
conducted surgery (nsubjpass)
used chloroform-adrenaline (nmod)
predominant metastasis (compound)
literature to (case)
tests abnormal (amod)
mg/kg patients (conj)
c(max a (det)
accompanied this (nsubjpass)
factor if (appos)
comparison rats (nmod)
medline , (punct)
function cholinergic (amod)
pills the (det)
abilities for (case)
differ accumulation (nsubj)
results damage (nsubj)
taking protein (nmod)
min 1 (nummod)
36.22 +/- (cc)
score > (dep)
light comments (conj)
[3h]sch 23390 (dep)
years ) (punct)
ago year (nmod:npmod)
eruptions rosacea-like (amod)
warfarin antagonist (compound)
warn clinician (dobj)
revealed significant (ccomp)
substitute to (mark)
cortex medulla (conj)
greater % (nmod)
water tonic (amod)
ineffective whereas (mark)
abuse heroin (amod)
screened patients (nsubjpass)
patients stable (nmod)
evident day (nmod)
100 less (amod)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate abecarrnil (appos)
580 81 (conj)
preference or (cc)
participate regulation (nmod)
controls 26 (nummod)
incidence observed (acl)
disorders agoraphobia (conj)
large were (cop)
reactions green (nmod)
deacetylation and (cc)
agent inciting (compound)
flow on (case)
concentration areas (nmod)
mapped ) (punct)
factors for (case)
pharmacokinetic studies (dep)
= 134 (dep)
phase stimulatory (amod)
curative was (cop)
mrna ece-1 (compound)
less to (case)
early , (punct)
decrease pars (appos)
evaluated tolerance (nsubjpass)
intra-hisian or (cc)
methodology ; (punct)
woman 92-year-old (amod)
mmhg 80 (compound)
p both (det)
d mice (nmod)
analyzed methods (nsubjpass)
case girl (nmod)
associated gene (nsubjpass)
synthase oxide (compound)
rats epilepticus (nmod)
myeloma mm (appos)
showed conclusion (nmod)
infusion sedative (amod)
reported mothers (nsubj)
and structurally (advmod)
curve of (case)
isomer the (det)
penetrate do (aux)
initiation chemotherapy (nmod)
infusion min (nmod)
originating uterus (nmod)
concentrations patients (compound)
varied mean (dep)
generated deletion (nmod)
anemias of (case)
p75(ntr)-ir in (case)
affected trimester (nmod)
sm n (dep)
states n (dep)
percentage gnrh (nmod)
medication additional (amod)
showed uptake (dobj)
arrhythmias disease (nmod)
values agreement (conj)
5.2+/-1.1 ) (punct)
dose of (case)
function systems (nmod)
effects both (det)
treated dfmo (nmod)
heart and (cc)
content camp (compound)
embarked evaluation (nsubjpass)
irritability in (case)
associated challenge (nmod)
administration mg/kg/day (dep)
drug ' (punct)
incidence quetiapine (nmod)
experiment during (case)
months months (appos)
incubated l-arginine (nmod)
f was (cop)
bradycardia the (det)
described reports (nsubj)
effects amphetamine (nmod)
visits all (det)
occlusion characteristic (nsubj)
drug nik-247 (nsubj)
changes pathological (amod)
hem , (punct)
blocked anesthesia (nmod)
abolished days (nmod)
svr ( (punct)
g/dl 3 (conj)
concentration lipoprotein (compound)
centers by (case)
alkaloid maculatum (nmod)
halothane and (cc)
dose predominance (conj)
stressed were (auxpass)
clarification a (det)
subtle easy (conj)
doc ) (punct)
group amlodipine (compound)
failure edema (conj)
died to (mark)
plasticity emergence (conj)
neurological significant (amod)
disulfiram , (punct)
retraction lid (amod)
removed flushed (conj)
peliosis at (case)
co-carcinogen a (det)
case acuity (appos)
apd interval (conj)
neurotoxicity 15 (dep)
biomarkers or (cc)
arousal , (punct)
report girl (nmod)
nc/ia ( (punct)
cd-832 nifedipine (conj)
profiles side-effect (amod)
potential important (amod)
value : (punct)
instrument used (acl)
cases three (nummod)
mbc ) (punct)
osmolality urine (compound)
received experiencing (advcl)
sections whole (amod)
pupil of (case)
speed injection (nmod)
cross-reactivities mabs (nmod)
unchanged levels (nsubj)
diabetes concentrations (nmod)
microg/kg/min is (cop)
t+a a (dep)
neurogenesis cell (compound)
procaterol of (case)
cells stained (acl)
required sometimes (advmod)
decreased to (mark)
toxicology positive (amod)
opposite the (det)
patients retinochoroidopathy (nmod)
vfds for (case)
act synergistically (advmod)
insufficiency melphalan (nmod)
amount a (det)
patients ac (compound)
phenotype from (case)
evaluation further (amod)
underlying anemia (dobj)
block atrioventricular (amod)
comparison patients (nmod)
polyuria the (det)
efficacy mania (nmod)
dependency effects (nmod)
used : (punct)
findings current (amod)
cn ( (punct)
immunohistochemistry ihc (appos)
administered group (nsubj)
conclusion are (dep)
bradycardia enhanced (amod)
degree exposure (nmod)
or 0.80 (dep)
investigate indication (nmod)
task the (det)
number with (case)
refine will (aux)
lives therapy (nmod)
effect estradiol (nmod)
16 17 (conj)
represents this (nsubj)
potential reduced (amod)
littermates transgenic (amod)
treated nephrogenic (nsubjpass)
rates morbidity (compound)
foramen patent (compound)
telangiectasia and (cc)
need without (case)
immunoblotting by (case)
analysis day (nmod)
syncope for (case)
active tests (nmod)
medline databases (appos)
repeated weekly (advmod)
consumed cranberry (dobj)
correlation hemoglobin (nmod)
triceps deltoid (conj)
evaluated fractionated (advcl)
pretreated days (nmod)
authors by (case)
animal 's (case)
infusion cpap (appos)
determined it (nsubjpass)
affected hepatitis (nmod)
barrier brain (compound)
31.85 +/- (cc)
lead deterioration (nmod)
increase progressive (amod)
children all (det)
confirmed cr (nmod)
gemfibrozil niacin (conj)
larger those (nmod)
effect citalopram (nmod)
case administration (nmod)
complicated may (aux)
climate especially (advmod)
increases dose-dependent (amod)
women complained (acl:relcl)
decreased increased (parataxis)
anatomical effect (dep)
higher jj (nmod)
ml ( (punct)
institution therapy (nmod)
classification nodosa (nmod)
developed . (punct)
aggressiveness disorder (conj)
field transplantation (nmod)
november 1995 (nummod)
level transcripts (nmod)
determined morphometry (nmod)
sensitive tgr (nsubj)
help developing (advcl)
cortex isom (conj)
dehydrogenase cholesterol (conj)
experiments both (det)
saline 284 (conj)
animals ( (punct)
accuracy an (det)
regions in (case)
increased content (dobj)
typical , (punct)
found failed (ccomp)
remission while (case)
necessary analyze (xcomp)
% pod (nmod)
neuropeptide distributed (acl)
depression of (case)
needed patients (nsubj)
head . (punct)
suspensions of (case)
injury edema (conj)
ph at (case)
appeared until (mark)
associated hypokalemia (nmod)
beating in (mark)
died . (punct)
physiology chronic (conj)
outpatients sinusitis (nmod)
dysfunction dose-limiting (amod)
aid smoking (amod)
used virtue (nmod)
elevates levels (dobj)
stones history (appos)
liver associated (acl)
characteristics symptoms (conj)
levels haptoglobin (compound)
from june (nmod)
examine . (punct)
sinus associated (acl)
higher cm (parataxis)
processes infectious (amod)
analogues are (cop)
alcohol/nicotine an (appos)
co-administration the (det)
larvae the (det)
increment every (det)
shows effect (dobj)
potency depressant (amod)
puncture , (punct)
control detect (acl)
pilocarpine given (acl)
hypoaidosteronism hyporeninemic (amod)
rated intensity (dobj)
association polymorphisms (nmod)
localization area (nmod)
studied rats (nmod)
ameliorated however (advmod)
results compared (appos)
antibody-(pr3-anca ) (punct)
electrocardiogram pre-operative (amod)
score highest (amod)
effect protective (amod)
considered have (conj)
flow claudin-2 (conj)
fell 1.85 (nmod)
treated trimester (nmod)
use metolachlor (compound)
prevention mitoq. (nmod)
association a (det)
metabolism simvastatin (amod)
related ph (nmod)
block to (case)
impairment and (cc)
patients 5 (appos)
play although (mark)
need appears (advcl)
hold inhibitors (nsubj)
bradycardia % (nmod)
treatment reabsorption (nmod)
showed restricted (conj)
do serotonin (nsubj)
single or (cc)
risk are (cop)
dyspnea stomatitis (conj)
= olanzapine (nsubj)
cardiotoxin , (punct)
related development (nmod)
safety long-term (amod)
mediating messages (dobj)
barrier endothelial (amod)
appeared act (xcomp)
hormone levels (conj)
altering thresholds (dobj)
divided rats (nsubjpass)
oliguria failure (conj)
describe cases (dobj)
data general (amod)
occur paroxetine (nmod)
alternation y-maze (nmod)
patients among (case)
treatment on (case)
daily once (case)
mediated neurotoxicity (nsubjpass)
potent ranitidine (nsubj)
effect membranes (nmod)
contributor hypertension (nmod)
torsades to (case)
condition mental (amod)
shorter significantly (advmod)
2.0mg/kg - (punct)
take part (dobj)
hydration adequate (amod)
pattern exact (amod)
anaemia azt-induced (amod)
important hypotension (nmod)
assay in (case)
effect antitumor (compound)
fluvoxamine by (case)
impairment hippocampal (compound)
test induction (compound)
damage determined (acl)
reduction rate (nmod)
twitch rats (nmod)
effects valdecoxib (nmod)
screen , (punct)
hemorrhage associated (acl)
tomography emission (compound)
consumption media (nmod)
verapamil nifedipine (conj)
suggest detrimental (ccomp)
or=7.18 - (punct)
accumulation myocardium (nmod)
evaluated rats (nsubjpass)
signs disease (nmod)
intake n (dep)
failed treatment (dobj)
greater mic (nmod)
25mg/kg doses (compound)
profiles groups (nmod)
awareness increased (amod)
cause weakness (nmod)
re-induced she (nsubj)
strains co-infection (nmod)
having one (dobj)
results experimental (amod)
recurrence cardioversion (nmod)
affects hyperprolactinemia (nsubj)
endings nerve (compound)
patient transplant (compound)
patients 241 (nummod)
outcome had (dep)
nine men (nmod)
microinjection excitation (nmod)
measures behavioral (amod)
edaravone with (case)
sensitive being (cop)
receive drug (nsubj)
worsening score (nmod)
pain and (cc)
takes achieve (xcomp)
developed hoarseness (dobj)
newborns all (det)
inhibitors hcn (compound)
followed during (prep)
risk potential (amod)
smaller size (nsubj)
analysis analysis (appos)
control effective (amod)
substance-induced other (conj)
underwent participants (nsubj)
glucoronosyltransferases intestine (nmod)
injections single (amod)
patient patient (conj)
effects and (cc)
adjunct toxicity-free (amod)
technique it (nsubj)
intact pinealectomized (conj)
antibodies cytoplasmic (amod)
observation first (amod)
infusions ng/kg/min (dep)
dgc connects (acl:relcl)
revealed resistance (nmod)
fact found (acl)
i.p. mg/kg (dep)
homeostasis of (case)
14 1080 (prep)
medication without (case)
assessed anxiety (nsubjpass)
position platform (nmod)
two more (advmod)
hyperalgesia neurogenic (amod)
considered agent (xcomp)
black 1 (nummod)
course psychosis (nmod)
analogues two (nummod)
approval administration (compound)
sites at (case)
sed +/- (cc)
losses with (case)
nonselective ) (punct)
monkeys progression (conj)
hot-plate , (punct)
metoprolol beta-blocker (compound)
decreased sigmast (nsubj)
expression gfap (nmod)
administration mk-801 (nmod)
group reference (compound)
effective pallidotomy (nmod)
2b1/2b2 respectively (advmod)
rodents and (cc)
ventilated were (auxpass)
increase conversely (advmod)
died 5 (nsubj)
common visits (nmod)
hbv-dna and (cc)
reduced addition (nmod)
pa ) (punct)
became methylprednisolone (nsubj)
treatment arabic (compound)
pathophysiology phenomenon (nmod)
increased october (nmod)
nausea with (case)
notable particularly (advmod)
tomography ct (appos)
tlr4 ( (punct)
have crf (dobj)
methods series (dep)
tone sympathetic (amod)
abuse maternal (amod)
pursued dissociated (advcl)
trials arthritis (compound)
shown animals (nsubj)
known nephrotoxic (xcomp)
biological , (punct)
plays role (dobj)
haemorrhage the (det)
performed sequences (dobj)
resulted death (nsubj)
labetalol isoflurane (nmod)
-18 hg (dep)
limited studies (nmod)
shed that (mark)
n=100 ( (punct)
showed eeg (nsubj)
weight bladder (compound)
frequent being (cop)
hypoglycemia hyperbilirubinemia (conj)
literature previous (amod)
sequelae with (case)
scores to (case)
drop of (case)
sediment and (cc)
carcinoma basal (amod)
increased time (nmod)
erection penile (compound)
play nicotine (nsubj)
developed blindness (nsubj)
identified as (mark)
10 684 (nummod)
nerve antebrachial (amod)
rendered , (punct)
off . (punct)
occurred rats (nmod)
half-life elimination (compound)
obscure most (advmod)
prevent apigenin (nsubj)
aggravated injury (nsubjpass)
reported groups (nsubj)
g cimetidine (nmod)
effect proarrhythmic (amod)
were changes (attr)
lidocaine followed (acl)
performed became (conj)
myocarditis carbamazepine (compound)
mechanism cytoprotection (nmod)
using gtn (dobj)
combinations activity (nmod)
safety study (nmod)
injection intrathecal (amod)
chick in (case)
participants ' (case)
exacerbations paranoid (compound)
factor neuropathy (nsubj)
promotes secretion (nsubj)
group vehicle/scopolamine (compound)
use stabilizer/rigidifier (nmod)
14 dogs (nmod)
appeared benzylthiouracil (nmod)
populations appropriate (amod)
haloperidol risperidone (conj)
srl of (case)
found subjects (nmod)
sensory and (cc)
reversed amnesia (dobj)
catatonia ketamine (compound)
ranged 317 (nmod)
sodium atp (conj)
syndrome updated (amod)
effect combinations (conj)
combination study (nmod)
stainings immunohistochemical (amod)
done testing (nsubjpass)
pars substantia (amod)
coexistence artery (nmod)
lesions resolved (acl)
co-injection toxin (nmod)
effects lesion (nmod)
crude events (nmod)
rats adult (amod)
n6-cyclopentyladenosine cpa (appos)
animals aged (amod)
strains cdf-i (compound)
osteopenia with (case)
tongue with (case)
trials taken (acl)
antagonists serotonin (compound)
inhibitors acetylcholinesterase (compound)
elevation segments (nmod)
suitable model (nmod)
combination criteria (nmod)
treatment tinnitus (nmod)
control 2-fold (compound)
index of (case)
diazepam anticonvulsant (amod)
downregulates but (cc)
levels signaling (conj)
interest community (nmod)
present discuss (conj)
given respectively (advmod)
restarted exception (conj)
ligation- coronary (amod)
times administering (advcl)
brains animals (nmod)
prodrug properties (nmod)
ti ) (punct)
using system (dobj)
pathway endomt (nsubj)
inhibitor thrombin-activatable (amod)
undertook review (dobj)
days diltiazem (nmod)
univariate and (cc)
subtherapeutic and (cc)
glibenclamide 4.6 (dep)
frontostriatal hippocampal (conj)
positive mpo-anca (nmod)
mg. 0.75 (nummod)
frequencies defects (nmod)
external visceral (conj)
renal severe (amod)
tap , (punct)
questioned been (auxpass)
investigate modulate (ccomp)
volume stroke (compound)
clarithromycin in (case)
inhibited prevented (conj)
controls 337 (nummod)
frlma group (dep)
rose taking (advcl)
hypotension alpha2-adrenergic (amod)
arrhythmias dilation (dobj)
stress vancomycin (compound)
reached concentration (nsubj)
development subjects (nmod)
kb kim-1 (conj)
recurring tumor (nsubj)
activation together (conj)
14,671 , (punct)
glutathione gsh (appos)
patients aged (acl)
attention produces (conj)
action its (nmod:poss)
adjunct an (det)
syndrome hemolytic (amod)
octapeptide nonsulphated (amod)
cohort this (det)
doses mesna (nmod)
improved can (aux)
plasmacytoma for (case)
space an (det)
1.24 ( (punct)
produces state (dobj)
common drowsiness (nsubj)
proteinuric weeks (nmod)
expressions for (case)
cbz range (nmod)
discussion after (case)
virus of (case)
109 135 (conj)
discharged dialysis (conj)
cyp ) (punct)
hyperalgesia allodynia (conj)
compared available (acomp)
0.6 ci:0.7 (conj)
characterized period (nmod)
present authors (nsubj)
d2/d3 up-regulation (conj)
failed angiograms (nsubj)
percentage mitochondria (nmod)
has property (dobj)
therapy acid (compound)
showed resolution (dobj)
internal and (cc)
nelarabine patient (nmod)
neurons ca3 (compound)
glioma including (case)
behaviour exploratory (amod)
complication leukoencephalopathy (nsubj)
regurgitation to (case)
chemotherapy effective (amod)
conducted therefore (advmod)
rats ee-treated (amod)
received bupropion (dobj)
younger significantly (advmod)
aware effect (dep)
volumetry resonance (compound)
classified % (nsubjpass)
present reduction (nmod)
rates high (amod)
medicine new (amod)
dp/dt lv (compound)
sex age (conj)
regions resulting (acl)
administration single (amod)
ones parp-1-/- (compound)
mu/kg ) (punct)
predictors function (nmod)
mm 17.5 (nummod)
glomerular a (det)
microm 3717 (nummod)
drowsiness morning (nsubj)
ephedrine patients (nmod)
cause disruption (dobj)
transcripts regulated (amod)
indistinguishable . (punct)
proteinuria in (case)
showed increase (dobj)
patients trial (nmod)
develop hoarseness (dobj)
receiving propranolol (conj)
sensitization impairment (nmod)
intake meq/kg/day (nmod)
diagnosis infarction (nmod)
counts lymphocyte (compound)
hypertension : (punct)
exert administration (nsubj)
drug each (det)
side physical (amod)
died had (parataxis)
hours days (nmod)
width of (case)
performance , (punct)
remained animals (nmod)
iiib , (punct)
members comprising (case)
provide treatment (dobj)
changes hepatocytes (nmod)
infusion clonazepam (nmod)
diazepam treat (xcomp)
electrophoresis and (cc)
k the (det)
depleted was (auxpass)
hypertension , (punct)
levels greater (amod)
measured testing (nmod)
busulfan children (nmod)
hyperglycinemia presentation (nmod)
myo-inositol-1-phosphate mip (appos)
cause symptoms (nmod)
blocked drug (nmod)
relieve it (dobj)
littermates sgk1(+/+ (appos)
cephalosporins second- (compound)
duration symptom (compound)
evoked clonidine (nmod)
investigated tdp (nsubjpass)
epithelium tubular (amod)
24 cystitis (nmod)
animals h (dep)
anaesthetized were (auxpass)
syndrome respiratory (amod)
conclusion the (det)
disruption inhibition (nmod)
subsided regressed (conj)
sensitive insensitive (conj)
corrected hyperprolactinemia (dobj)
reported diabetic (xcomp)
form acetaminophen- (nmod)
difficult that (mark)
msec 40 (compound)
groups placebo (compound)
discontinued side-effects (nmod)
reference special (amod)
had grade (dobj)
signified . (punct)
species for (case)
microm by (case)
antagonist , (punct)
drugs cardiotoxic (amod)
potential effect (conj)
compartments blood (compound)
dosed be (auxpass)
alter treatment (nsubj)
reversed presence (nmod)
mg/kg more (nummod)
5 2 (compound)
enzyme acetylcholinesterase (nsubj)
aware termination (nmod)
paf ) (punct)
mg/d placebo (conj)
0.5 , (punct)
potency inhibitory (amod)
mg increase (dep)
antagonized activity (xcomp)
guanosine urinary (amod)
suggested one (nmod)
infections major (amod)
fenoldopam dogs (nmod)
1984 1990 (conj)
taking propranolol (dobj)
50 2 (compound)
total by (case)
lv late-onset (amod)
type -- (punct)
activity antihyperalgesic (amod)
potential model (nmod)
dyskinesias with (case)
aids ) (punct)
depletion by (case)
developing infection (dobj)
increases mice (nmod)
formation increased (amod)
superior h (nmod)
period peri-operative (amod)
score cgi-sf (compound)
backcrossing repeated (amod)
anticholinergic an (det)
terms % (nmod)
infant male (amod)
consisted bortezomib (nmod)
propranolol chronic (amod)
mitigated treatment (nsubj)
characteristics pretreatment (compound)
transformation areas (nmod)
increased but (advmod)
suggests injections (nsubj)
rationale paradigm (dep)
cytokine proinflammatory (amod)
thrombosis artery (compound)
congestants preparations (conj)
pc/bcp ( (punct)
insufficiency acute (amod)
used levels (nsubjpass)
78 42 (conj)
s-1 5-mg (amod)
blockade , (punct)
proteinuria , (punct)
a1 ) (punct)
stimulates when (advmod)
has pathway (nsubj)
disease lupus (appos)
men women (conj)
using function (dobj)
characterized model (nsubjpass)
differences data (nmod)
data adjudicated (amod)
found ptcr (dobj)
cells into (case)
asians southeast (compound)
creatine exogenous (amod)
endografine hysterosalpingography (nmod)
confirmed ability (nsubjpass)
mice pretreating (amod)
overdose after (case)
mb ( (punct)
mg/day 800 (nummod)
represents which (nsubj)
incidence = (dep)
eeg mental (conj)
dogs analyzed (acl)
investigated using (xcomp)
review of (case)
discontinued had (aux)
insipidus ndi (appos)
balance potassium (compound)
documented range (nsubjpass)
procedure surgical (amod)
parameters serum (nmod)
alterations ducts (nmod)
ca(2 of (case)
significant elevations (nsubj)
increase could (aux)
warned and (cc)
study , (punct)
reduces and (cc)
led relief (nmod)
alpha-2b and (cc)
induced study (nmod)
therapy she (nsubj)
severe arabic (nmod)
have attributed (conj)
stretches muscle (nmod)
erk1/2 of (case)
acute h (appos)
s(c)o(2 on (case)
given -placebo (dep)
kidney heart (conj)
confirms finding (dobj)
restricted ( (punct)
b n (dep)
colliculus in (case)
medication topical (amod)
mepivacaine plus (cc)
all abnormalities (nmod)
yr 6.9 (nummod)
depression behavioral (amod)
suppressed expression (nsubjpass)
girl leucemia (nmod)
pesticide as (case)
compare results (dobj)
nephroprotectant combination (nmod)
pbo ) (punct)
can advanced (amod)
update this (det)
micrograms propranolol (nmod)
8.5 . (punct)
7.3 +/- (cc)
have levels (dobj)
mechanisms proteinuria (nmod)
pathway gabaergic (compound)
toxicology further (amod)
altered significantly (advmod)
titrated symptoms (nmod)
bortezomib with (case)
giving lowering (conj)
cochlea developing (amod)
aids with (case)
volumes hippocampal (compound)
damage tj (compound)
restores reduction (dobj)
edema drug-related (amod)
removal upon (case)
scale an (det)
micrographs in (case)
0.0001 to (case)
receiving p (dep)
localization brain (compound)
injections iv (compound)
followed withdrawal (dobj)
therapy tacrolimus (compound)
inhibition pathway (nmod)
formed isoenzymes (nmod)
develop rats (nsubj)
postimplant years (nmod:npmod)
responses emotional (amod)
younger 0.05 (dep)
seizures/mo 2.1 (nummod)
studies echocardiographic (amod)
intervention and (cc)
vessels of (case)
limited was (auxpass)
promote consistent (xcomp)
none subjects/patients (nmod)
methods infusion (conj)
intra- and (cc)
end number (conj)
seizures lethality (conj)
pain cranial (amod)
titrated flexibly (advmod)
suggested remains (conj)
protein differentiation (compound)
have asymptomatic (advcl)
impair background (dep)
testing laboratory (compound)
ethinyloestradiol desogestrel (compound)
c57bl/6j , (punct)
overdose massive (amod)
do methylprednisolone (nsubj)
9.6-fold was (cop)
cells basket (compound)
using staining (dobj)
malays % (compound)
helpful be (cop)
strokes gastrointestinal (amod)
microglia assessed (acl)
reduction lesions (nmod)
adjustment confounders (nmod)
observation and (cc)
11.7 and (cc)
2 or (cc)
application upon (case)
observed that (nsubjpass)
animals gentamicin-treated (amod)
myocardium jeopardized (amod)
rechallenge cephalosporin (nmod)
800 to (case)
nsaids for (case)
intensity in (case)
4.6 9.4 (conj)
hydrochloride 4-quinoline (compound)
regimen following (case)
ratio develop (acl)
calculated weighted (conj)
alf=0/35 p<0.01 (dep)
effects tafi (dep)
syndromes proteinuria (nmod)
medication with (nmod)
oncology in (case)
performed airway (conj)
able patients (nsubj)
picrotoxin of (case)
conclusion manifestation (dep)
outcome major (amod)
bilirubin bilirubin (conj)
differentiation terminal (amod)
asterixis about (case)
fraction including (case)
decreased dose-dependent (conj)
days at (case)
taken perimenopausal (nmod)
% 49.4 (nummod)
amplitude ps (nmod)
given rats (nsubjpass)
alterations tmax (dep)
investigating at (mark)
prevent ) (punct)
software with (case)
wales in (case)
users 14 (nummod)
developing populations (nmod)
patients ra (nmod)
had temperature (nmod)
9-months hyperprolactinemia (nmod)
summarizes . (punct)
encephalopathy report (dep)
level cardiac (amod)
organization . (punct)
disorders channel (compound)
efficacy preventing (acl)
timing application (nmod)
boluses mg (nmod)
ncr181 , (punct)
device stretch (compound)
indicates ctnt (nsubj)
sodium cephalothin (amod)
proteinuria ( (punct)
lead reduction (nmod)
decreases values (nmod)
using paradigms (dobj)
physostigmine by (case)
indicating regulate (ccomp)
dependency on (case)
failure occurring (acl)
580 +/- (cc)
0.56 1.55 (appos)
anti-inflammatory drugs-associated (dep)
administered infusion (nmod)
promotion lesions (nmod)
mm = (dep)
evaluated hepatitis (nmod)
elavil amitriptyline (appos)
smaller groups (nmod)
reduces although (mark)
mi of (case)
sepsis coagulopathy (conj)
thymidine of (case)
alkylxanthines of (case)
maturity with (case)
abstinence 12-hour (amod)
improved returned (conj)
np untreated (conj)
carcinogens all (det)
tetrachloride ccl4 (appos)
induced episodes (dobj)
proteinuria on (case)
behavior induced (acl)
d-penicillamine of (case)
mk-801 it (compound)
duration elevation (nmod)
effect contrast (dep)
dopamine such (case)
r4 ( (punct)
management about (case)
report experience (dobj)
% 66 (nummod)
micrograms.kg-1.min-1 tmp (nmod)
proteins other (amod)
abnormalities transient (amod)
injury of (case)
titrated clonidine (nmod)
study elderly (nmod)
spent and (cc)
resulted therapy (nmod)
incidence humans (nmod)
continue therapy (dobj)
purpose present (appos)
levels prl (appos)
society study (nmod)
1966-january ( (punct)
agents hospitalization (conj)
anions superoxide (compound)
unable substantiate (xcomp)
involvement a (det)
rapid effective (conj)
induction leukemia (nmod)
eliminated effect (dobj)
treatment insignificantly (advmod)
using of (mark)
months 13.8 (nummod)
neither blockers (nmod)
confirmed reduced (ccomp)
ng/ml than (case)
suggests fluconazole (dobj)
graded evidence (nsubjpass)
escalated , (punct)
underwent assessment (dobj)
spectrum broader (amod)
cancer with (case)
excretion rapid (amod)
occur signs (nmod)
propagation to (case)
disorders other (amod)
agreement questionnaire (nmod)
pharmacokinetics indinavir (nmod)
caused dose-dependent (conj)
confounding potentially (advmod)
peak high (amod)
treat it (dobj)
activity vitro (advmod)
alteration due (case)
differences rejection (nmod)
syndrome se (advmod)
affect absence (nmod)
examined vitro (advmod)
were other (nmod)
loss group (nmod)
underestimate thereby (advmod)
potent immunosuppressive (dep)
medulla in (case)
showed 34.0 (advcl)
utilizes characteristics (dobj)
evaluation for (case)
hydrochloride acid (compound)
analogs structural (amod)
episodes among (case)
intensify , (punct)
optimization therapy (nmod)
51 of (advmod)
mediated furthermore (advmod)
used combination (nmod)
mg producing (acl)
methylprednisolone recommended (acl)
fully partially (conj)
rrs ) (punct)
pituitaries hemorrhagic (amod)
anticholinergics chloride (conj)
tg the (det)
showed response (dobj)
intraoperative severe (amod)
amphetamine ie (advmod)
concentrations mice (nmod)
prolongation by (case)
gentamicin by (case)
function allograft (compound)
done review (nsubjpass)
brought directly (advmod)
inhibitors their (nmod:poss)
cases myelodysplasia (nmod)
administered reversed (advcl)
line lineage-traceble (amod)
suggested has (aux)
receiving methadone (dobj)
matter cerebral (amod)
results rate (appos)
state induced (amod)
occurs however (advmod)
analysed using (xcomp)
progression because (case)
received mg/kg/day (nmod:tmod)
inhibited nh4ac (nmod)
constructed effect (nmod)
past in (case)
levels estradiol (nmod)
situated center (nmod)
dyskinesias mid-dose (amod)
ventricle lv (appos)
consensus no (det)
desaturation and (cc)
drugs four (nummod)
manometry jejunal (amod)
requirements levodopa (compound)
epilepticus development (conj)
cells sh-sy5y (compound)
evident days (dep)
sensitive model (nsubj)
preparations with (case)
relevance features (nmod)
cisapride daily (advmod)
results induced (amod)
actions pharmacological (amod)
extracts in (case)
confounded effects (nmod)
effects helodermin (nmod)
cases thirteen (nummod)
regimens common (amod)
produce decreases (dobj)
employing doses (dobj)
targeting membrane (nmod)
degrees mrds (appos)
simple and (cc)
patients affected (amod)
syndrome were (cop)
supplementary cortex (conj)
suggests mediated (ccomp)
drugs ii (nummod)
concerns risks (nmod)
93.3 6.6 (conj)
observed found (conj)
lower iopentol (nmod)
evidence recent (amod)
voltage- and (cc)
occlusion is (cop)
change her (nmod:poss)
briefly min (appos)
1.039 +/- (cc)
unclear contrast (nmod)
suggest resulted (ccomp)
doses etoposide (nmod)
ischemia dogs (nmod)
present % (dep)
metoprolol after (case)
diabetic rats (dep)
increase cromakalim- (amod)
subjects 100 (nummod)
suppressed cibenzoline (nsubj)
mg/m2 324 (nummod)
concluded tentatively (advmod)
toxicity direct (amod)
administered acquisition (nmod)
ratio 3.5+/-0.9 (nmod)
mc versus (cc)
300 up (advmod)
factors known (amod)
recovered function (dobj)
mean a (det)
hydrochloride plus (cc)
induced model (nmod)
cats anaesthesized (amod)
february 2002 (nummod)
bipolar dsm-iv (compound)
tolerated < (dobj)
acquired induction (nmod)
occurs patients (nmod)
management anesthetic (amod)
differ reported (conj)
tnf-alpha of (case)
reduced rate (nsubjpass)
control metabolism (nsubj)
scores rating (conj)
effect heparin (nmod)
added mg/m(2 (nsubjpass)
rats 2 (nummod)
imaging magnetic (compound)
rocuronium mg/kg (compound)
suggest influenced (ccomp)
moderate-dose but (cc)
11.2 gm. (nmod)
dosed day (nmod)
infusion artery (nmod)
role rat (compound)
history 3-year (amod)
used form (dobj)
complication regarding (case)
regulated system (dobj)
potentiates gvg (compound)
standard but (cc)
reduced regions (nmod)
grade % (compound)
experimental and (cc)
rd ) (punct)
dynamic static (conj)
patterns distinct (amod)
occur normally (advmod)
ages both (det)
developing approach (dobj)
procedure keep (acl)
ferritin aluminium (conj)
warrant trials (dobj)
acts antioxidant (nmod)
incubation after (case)
that agsd (nmod)
experiment double-blind (amod)
measured lastly (advmod)
10 mg/kg (dep)
patients 439 (nummod)
died anemia (nmod)
train a (det)
follows group (appos)
tool therapeutic (amod)
effects all (det)
appeared have (xcomp)
reports from (case)
believed , (punct)
english in (case)
studied tolerance (nsubjpass)
snr central (amod)
less : (punct)
improved treatment (nsubj)
efficacy doses (nmod)
years respectively (advmod)
modalities ) (punct)
liver without (case)
oct ca (appos)
changes creatinine (nmod)
systems dopaminergic (amod)
diagnostic intensive (amod)
nodal or (cc)
present boy (dobj)
return only (advmod)
isoenzymes and (cc)
mechanisms toxicologic (amod)
ramipril of (case)
carcinoma 1 (appos)
binding v (compound)
carcinoma cell (compound)
osteoporosis to (case)
cause but (cc)
search 1966-january (dep)
cirrhosis shown (acl)
screening bp (dobj)
measured calculated (conj)
hl60 cells (dep)
obscure and (cc)
bradycardia marked (amod)
= 0.008 (dobj)
angiogenesis and (cc)
eventually , (punct)
alf control (conj)
rate epinephrine (nmod)
arteriosclerosis caused (advcl)
conclusions marker (appos)
nuclei bizarre (amod)
density spine (compound)
leukemia acute (amod)
size stenosis (nmod)
neuropathy motor (nmod:npmod)
shows is (conj)
loss frequency (compound)
areas unstained (amod)
support factor (compound)
failed maximum (advcl)
asthma bronchial (amod)
tested actions (nsubjpass)
hemorrhage , (punct)
trks ) (punct)
p9605 p9201 (conj)
citrate with (case)
chemotherapy retinoblastoma (nmod)
10(-7 1 (compound)
toxic fetuses (conj)
investigated design (dep)
patients ag (compound)
are also (advmod)
investigated use (dobj)
affect temperature (dobj)
myeloencephalopathy report (dep)
cohort the (det)
incorporation damage (conj)
sessions across (case)
environments in (case)
lower p (nmod)
hz 25 (nummod)
45 more (amod)
increased protocol (nsubj)
k+ in (case)
conclusions show (dep)
literature mechanisms (conj)
herbal and (cc)
shock a (det)
increase fk (nsubj)
peliosis and (cc)
iq naming (conj)
history epilepsy (nmod)
unknown inhibits (csubj)
radiation with (case)
6/31 25/32 (conj)
months other (amod)
reached iop (dobj)
hour % (compound)
re of (case)
similar subjects (nmod)
believed toxicity (advcl)
system reporting (compound)
specified not (neg)
adults middle-aged (amod)
treatment 1 (dep)
ck-mb disease (conj)
patient-years 582 (nummod)
1.17 , (punct)
treatment woman (nmod)
inhibited was (auxpass)
areas these (det)
receptor m(3)-muscarinic (amod)
used is (auxpass)
required that (nsubjpass)
findings by (case)
enflurane administered (acl)
given steroids (nsubjpass)
result nicergoline (nmod)
aspiration signs (conj)
signs which (nsubj)
effect milrinone (nmod)
dysfunction reversible (amod)
component of (case)
n=6 ) (punct)
recognize occurs (advcl)
70/101 ( (punct)
caused hypovolemia (nsubj)
ratio international (compound)
secretion inappropriate (amod)
detected case (nmod)
antigen anti-proliferating (amod)
infarction puerperium (nmod)
decreased dendrin (nsubj)
discontinued followed (advcl)
cancers sarcomas (nmod)
emulsion of (case)
dosage warfarin (nmod)
recommended particularly (advmod)
min-1 ml/100 (nummod)
cheaper the (det)
published approaches (dobj)
effective preventing (advcl)
cerruloplasmin levels (conj)
promote could (aux)
btc with (case)
disease graft-versus-host (amod)
month switching (nmod)
case complaining (nmod)
led consumption (nmod)
recommended view (nmod)
strains therapy-na (nmod)
neurocognitive changes (dep)
model tle (nmod)
loss weight (nmod)
power defend (acl)
type ii (nummod)
line therapy (nmod)
placebo active (conj)
hours first (amod)
methotrexate intrathecal (amod)
effects rat (nmod)
vulnerability and (cc)
designed regimens (nsubjpass)
tyr6]-vip mm (appos)
determinations the (det)
reductions magnitude (nmod)
= group (nmod)
correlations positive (amod)
anticoagulation warfarin (nmod)
returned discontinuing (advcl)
confirms profile (dobj)
patients stage (appos)
effects propranolol (nmod)
known week (nmod)
morphine , (punct)
factors no (det)
vasodilator a (det)
consider risk (dobj)
doses u-ii (nmod)
concerned while (mark)
nitroglycerin mg (appos)
interaction significant (amod)
july september (conj)
increase wky (nmod)
effects outcomes (nmod)
people asian (amod)
15 % (appos)
accumulation intra-alveolar (amod)
pregnancy in (case)
netilmicin 42 (nummod)
changes flow (compound)
psychosis lifetime (amod)
found dox (nmod)
system signaling (compound)
lesions fewer (amod)
tolerated lozenge (nsubjpass)
material ionic (amod)
antiemetic used (amod)
tendency the (det)
dyskinesia without (case)
confounds detection (dobj)
received had (aux)
monotherapy controls (nmod)
returns whenever (advmod)
seizures bupropion-induced (amod)
showed reductions (dobj)
colorectal breast (conj)
lev mg (appos)
prescribing opioids (dobj)
found incidence (nsubjpass)
patients nrp (appos)
reduces blocking (csubj)
hypothesize cause (ccomp)
mechanism to (mark)
concentrations tissue (compound)
electrocardiogram.3 the (det)
reduces comparison (nmod)
agent ] (punct)
year 's (case)
associated heroin (nmod)
increased = (advcl)
assessed % (parataxis)
25mg/kg metformin (nmod)
patients mm (dep)
mg/m2 3000 (nummod)
hallucinations stopped (acl:relcl)
pn on (case)
predict channel (dobj)
stroke related (amod)
muscle atrial (amod)
mid- loss (dep)
g/l ( (punct)
therapy dose (conj)
vulnerable damage (nmod)
seizures against (case)
history significant (amod)
became then (advmod)
conditions with (case)
difficult enucleations (nsubj)
nephrotoxicity lessen (compound)
diagnosed referred (advcl)
has that (nsubj)
times 1.3 (compound)
associated determine (conj)
decline abilities (nmod)
side-effect ssris (nmod)
doses toxic (amod)
amphetamine of (case)
alpha2- i1-receptors (conj)
causes treatment (nsubj)
objective pain (appos)
determine control (nmod)
compared however (advmod)
-12.8 17.9 (conj)
sleeping n (dep)
higher concentrations (nsubj)
examined sera (nsubjpass)
type strain-matched (amod)
ma and (cc)
dose lindane (nmod)
become regimen (attr)
background eeg (compound)
hypothermia the (det)
necrosis to (case)
identified using (xcomp)
trained non-trained (conj)
l/kg ) (punct)
recognized no (neg)
hbv occult (amod)
oxygenation frontal (amod)
practitioners dental (amod)
cxad ) (punct)
identify cta (nsubj)
membrane basement (compound)
are case (attr)
dose % (amod)
alteration sensitivity (nmod)
pge(2 high (amod)
suggest take (ccomp)
addition monitoring (nmod)
propofol to (case)
cyp ( (punct)
aggressiveness and (cc)
2.1 , (punct)
i of (case)
48 72 (conj)
system colloidal (compound)
85 - (punct)
stabilized neuropathy (nsubj)
elevation inversions (conj)
method continual (amod)
cases and (cc)
relationship any (dep)
known ethambutol (nsubjpass)
improves of (case)
minutes intraperitonealinjection (nmod)
alf with (case)
5 cent (nmod)
caused promotion (dobj)
concluded therefore (advmod)
acetaminophen for (case)
structures in (case)
dose incidence (nsubj)
studies % (dep)
increased has (aux)
impaired stable (conj)
des 10 (dep)
fenfluramine or (cc)
hypersensitivity suxamethonium (nmod)
challenged was (auxpass)
have transaminases (advcl)
2,682,2,803 ) (punct)
atrophy by (case)
3-methoxy-4-hydroxyphenethyleneglycol of (case)
involved that (mark)
methylphenidate for (case)
cta a (det)
years 3.3 (nummod)
appropriate are (cop)
thrombosis left (amod)
years 65.6 (nummod)
levels hypertensive (amod)
s 30 (nummod)
mg/m2 60 (nummod)
mechanism changes (nmod)
experiences who (nsubj)
component central (amod)
actions associated (acl)
manifestation in (case)
persist reduction (nmod)
mazindol in (case)
ifn ( (punct)
included predicted (conj)
pesticide lindane (nsubj)
used concurrently (advmod)
media four (nummod)
results % (appos)
study fibrosis (nmod)
predictable months (nmod)
levels superoxide (compound)
incidence seizures (conj)
intervals short (amod)
mg/m2 580 (nummod)
aggregation induced (amod)
0.005 ( (punct)
dead follow-up (nmod)
sensitivity endpoints (nmod)
patient congestive (amod)
herbicides studies (nmod)
exercise-isoproterenol control (conj)
unremarkable , (punct)
percentage in (case)
pressure end-diastolic (amod)
intact-control , (punct)
test spatial (amod)
dogs ligation (compound)
damage barrier (dobj)
reports overdose (nmod)
142 7 (conj)
pj34 with (case)
nr1(neo-/- ) (punct)
effective and (cc)
analysis erythrocytes (nmod)
beams trabecular (amod)
decreased stage (nmod)
centers large (amod)
mainstay > (nmod)
caused intoxication (nmod)
myopathy toxic (amod)
min 2 (nummod)
those control (nmod)
looking changes (nmod)
yields total (amod)
aroused was (auxpass)
considered characteristic (nmod)
alprazolam and (cc)
scheduled responding (advcl)
removing in (mark)
walls veins (nmod)
microl nmol/0.5 (nummod)
1.13 1.42 (dep)
mg.kg(-1).min(-1 6 (nummod)
group % (conj)
yrs ; (punct)
attenuates suggest (conj)
nimo 6 (dep)
detected proteins (nsubjpass)
rs6693503 rs3790757 (conj)
mg/kg/day 5 (compound)
cystica and (cc)
patient shown (acl:relcl)
exist to (mark)
need surveillance (nmod)
absences typical (amod)
detection non-invasive (amod)
injections selective (amod)
treated ? (punct)
infusions ranging (acl)
found concentrations (nmod)
immunophilin renal (amod)
mcg 756 (dep)
acidosis , (punct)
groups test (nmod)
restricted class (nmod)
promoted tam (nmod)
h 20 (nummod)
increased carcinogens (nmod)
related as (case)
0.13 0.03 (conj)
animals between (case)
aminotransferase aspartate (compound)
provided min (nmod)
i.v. ( (punct)
allografts of (case)
caused administration (nsubj)
remodelling . (punct)
reduction mg (nmod)
phase subsequent (amod)
35/15 20 (compound)
treatment attacks (nmod)
report response (dobj)
activate pathway (dobj)
stents based (case)
presence autoantibodies (nmod)
posture flat (amod)
min occlusion (nmod)
diet lithium-containing (amod)
virus hbv (appos)
idiosyncratic was (cop)
paralysis with (case)
drugs both (det)
mapping neurotoxicity (nmod)
required urgently (advmod)
enhancement catalepsy (nmod)
volunteers to (case)
p or (cc)
dyskinesias onset- (dep)
data drugs (conj)
level circulating (amod)
phenotype poor-metabolizer (amod)
days three (dep)
carcinoma childhood (nmod)
agents nsaid (appos)
parameters model-dependent (amod)
conclude result (ccomp)
adults neurocognitive (dep)
role onset (nmod)
tizanidine , (punct)
infusion per (case)
mediated receptor (nmod)
hypoglycemia apnea (conj)
weeks 91 (nummod)
retardation rats (nmod)
23 4 (conj)
stroke male (nmod)
used antibiotics (nsubjpass)
relative weight (nmod)
stopped followed (advcl)
paramethasone dexamethasone (conj)
= 55 (dep)
aorta/serum-ratio 131i-hsa (nmod)
index < (dep)
paralysis after (case)
pressure expression (conj)
shifting ( (punct)
developed symptoms (dobj)
developed significantly (advmod)
emergence in (case)
mapping electrodes (nmod)
results in (case)
syndrome cips (appos)
similar quetiapine (nmod)
change essentially (advmod)
oestrogens ( (punct)
clearance ( (punct)
require not (neg)
seizures postoperative (amod)
action prolactin-releasing (amod)
failed inhibit (xcomp)
imperative evaluation (nsubj)
state state (conj)
rare syndrome (nsubj)
controls 0.007 (appos)
damage injury (conj)
impair conjugation (dobj)
0.25 0.05 (compound)
manage to (mark)
heart human (amod)
t(9:22 pathogenic (amod)
phosphatase , (punct)
diseases disease (nmod)
compartments individuals (nmod)
protein mrp2 (appos)
anatomically pathologically (conj)
force % (nmod)
parenchyma of (case)
nucleus nucleolus (conj)
dose , (punct)
population large (amod)
tumors forestomach (compound)
reduced differ (conj)
findings discontinuation (nmod)
polydrug non-ecstasy (amod)
0.001 than (case)
beats/min 223 (nummod)
present data (dep)
g/m2 ) (punct)
receptors metabotropic (compound)
agent anthraquinone-containing (amod)
= 24 (dep)
titrated successfully (advmod)
was whereas (mark)
revealed were (conj)
mediators of (case)
decreasing of (mark)
reassured should (aux)
syndromes with (case)
withheld were (auxpass)
line in (case)
assistance on (case)
recoveries and (cc)
= 0.045 (dobj)
inhibited immunosuppressants (nmod)
conjugates the (det)
nine whom (nmod)
group raloxifene (compound)
caused tam (nmod)
glomerular late-onset (conj)
amounts material (nmod)
mrna igf-i (compound)
diseases and (cc)
appearances the (det)
syndrome stroke (conj)
range 1 (dep)
showed delayed (ccomp)
hyperalgesia attention (conj)
tremor clonus (conj)
diarrhea are (cop)
as test (nsubj)
prevention hyperactivity (nmod)
marketed states (nmod)
rigidity bradycardia (conj)
group even (advmod)
observed controls (advcl)
conditioning passive (amod)
reasons other (amod)
assessed nephrotoxicity (nsubjpass)
decreased subsequently (advmod)
% ( (punct)
staining snr (nmod)
ligands gaba(a (compound)
suffered hours (nsubj)
resolved posaconazole (nmod)
range beta (compound)
given cisapride (nsubjpass)
process leading (acl)
gaba contents (conj)
attenuates eliminates (conj)
alf=0/35 ; (punct)
1/2 1 (compound)
microscopy transmission (compound)
ecg , (punct)
prevented importantly (advmod)
plasma 0.298 (nummod)
effects pilocarpine (nmod)
drugs receptor-blocking (amod)
months 4.6 (nummod)
paradigm this (det)
flow epidural (amod)
performance mice (nmod)
determined abnormalities (dobj)
developed rats (nsubj)
discussed similarities (nsubjpass)
involved case (nsubj)
renoprotective regardless (advmod)
observed 99 (nsubjpass)
mean highest (amod)
childhood in (case)
hyperprolactinemia and (cc)
increased anaemia (nmod)
prevented increase (dobj)
progression their (nmod:poss)
receiving hemodialysis (dobj)
cocaethylene metabolite (appos)
derivative has (acl:relcl)
dental endoscopic (conj)
vegfr-2 ( (punct)
department cardiology (compound)
caused maneuver (nsubj)
% 5/8 (nummod)
seem develop (xcomp)
effects gain (conj)
determined treatment (nsubjpass)
aureus s. (compound)
bp systolic (amod)
conjugates ) (punct)
inpatients treated (acl)
33 3 (conj)
ptu ( (punct)
increased amounts (nsubjpass)
injection metrizoate (conj)
patients eighty-one (nummod)
pathogenesis syndrome (nmod)
discouraged strongly (advmod)
circumstances leading (acl)
state . (punct)
diabetic day (nmod:npmod)
studied aim (dep)
disease patients (nmod)
systems numerous (amod)
advantageous are (cop)
proteins the (det)
installation of (case)
wk 3 (nummod)
exposure period (nmod)
process carcinogenic (amod)
antagonists bradykinin (compound)
receptors to (case)
one other (conj)
specification further (amod)
reported girl (nsubjpass)
prospectively and (cc)
conducted mice (nmod)
infusion with (case)
factor use (nsubj)
yr for (case)
concentration intracoronary (amod)
occurred none (dobj)
shape discoid (amod)
sodium heparin (compound)
vasculitis leucocytoclastic (amod)
pge(2 ) (punct)
had flavour (dobj)
group beta-position (nmod)
costs treatment (compound)
0.75 - (punct)
dizziness were (cop)
ischemia induced (acl)
diltiazem of (case)
size colour (conj)
day fifth (amod)
use monohydrate (nmod)
reporting nausea (dobj)
concentrations carbachol (compound)
rechallenge upon (case)
carbachol 3.6 (nummod)
relate exposure (dobj)
evaluate study (nmod)
dose induction (nmod)
include phase (dobj)
recovery eventual (amod)
replicated b. (nmod)
examine and (cc)
impairments rats (nmod)
requested late (advmod)
disease metastatic (amod)
pathway metabolism (nmod)
cause dapsone (nsubj)
completely . (punct)
deletion blockage (conj)
entered were (auxpass)
exhibited ccr2-labeling (dobj)
hemodynamics : (punct)
n=12 ( (punct)
vehicle- in (case)
.0001 < (compound)
safety and (cc)
fashion an (det)
(ee)-induced cholestasis (dobj)
symptoms including (case)
stones containing (acl)
antioxidants endogenous (amod)
normalization eeg (nmod)
response desmopressin (nmod)
succinylcholine rocuronium (conj)
compliance safety (conj)
treated she (nsubjpass)
corticosteroids , (punct)
phase pain (compound)
depends dosage (nmod)
improved fluoxetine (nmod)
responses abusers (nmod)
role convulsion (nmod)
clinics outpatient (amod)
septicemia with (case)
treatment mg/kg (conj)
publication in (case)
headache because (case)
time mean (compound)
mg/kg 416 (nummod)
correlated values (nsubjpass)
fact to (case)
calculated patients (nmod)
administration sites (nmod)
taking been (aux)
complexes immunophilin-drug-calcineurin (compound)
disturbance or (cc)
reduction an (det)
objective used (dep)
had managed (conj)
convulsions 50 (nummod)
one chemotherapy (nmod)
contained kidneys (nmod)
compares reasonably (advmod)
creatinine mg/dl (dep)
risks of (case)
akbr aceto-acetate/3-hydroxybutyrate (appos)
hypertrophy induced (acl)
modulates function (dobj)
patients 40 (nummod)
cortex the (det)
disease advanced (amod)
changes those (nmod)
days 9 (conj)
area percent (nmod)
remains that (mark)
indicate correlation (dobj)
baseline the (det)
time mg/m2 (appos)
regulation movement (compound)
ascribing before (mark)
multiforme syndrome (conj)
b = (dep)
assessed receiving (advcl)
contribute could (aux)
scattered smaller (conj)
behaviour ( (punct)
demonstrated furthermore (advmod)
appear have (xcomp)
therapy between (case)
glycosides digitalis (compound)
increased causing (xcomp)
resulted injection (nsubj)
hearing of (mark)
hg and/or (cc)
enantiomer ) (punct)
autopsy at (case)
= 7.619 (dobj)
group enalapril (dep)
damage cells (nmod)
drug either (det)
cirazoline , (punct)
response supersensitivity (conj)
choice best (amod)
suggested background/aims (dep)
b6 host (appos)
alfentanil short-acting (amod)
greater ml (nmod)
mania stimulant-induced (amod)
heparins with (case)
six at (advmod)
hazard developing (advcl)
experiments in (amod)
history smoking (nmod)
actin desmin (conj)
early the (det)
alpha3 the (det)
screened . (punct)
angiography and (cc)
toxicity cisplatin (nmod)
controls in (case)
% 3.2 (nummod)
index mass (compound)
extended-interval dosing (conj)
suppressed effectively (advmod)
received suffered (conj)
etoposide of (case)
effect binding (nmod)
patients age (appos)
developed using (advcl)
tumors hemorrhagic (amod)
selected , (punct)
1.70 2.08 (prep)
fluoroacetate by (case)
vulnerable if (mark)
weakness system (nmod)
robust was (cop)
ratio p-p38/p38 (compound)
level signs (nmod)
neuropathy due (prep)
gavaged study (nmod)
ls mg (conj)
infiltration compartment (nmod)
receive ketoprofen (dobj)
result dysfunction (nmod)
associated shown (advcl)
combination by (case)
induced chemotherapy (nmod:npmod)
h dose (nmod)
using reduce (conj)
receptors cck2 (compound)
patients 14 (appos)
did contrary (advmod)
generated can (aux)
correlation no (det)
variables not (neg)
testosterone or (cc)
nephrosis adriamycin (compound)
dipping morning (compound)
function lv (amod)
disease , (punct)
changes at (case)
61.9 +/- (cc)
4-ene-vpa and (cc)
awareness complication (nmod)
reports changes (dobj)
174 - (punct)
caused had (conj)
methods assessed (appos)
mpo-anca ( (punct)
determined effect (dobj)
2.14 to (dep)
aorta % (dep)
rats cardiomyopathy (amod)
started can (aux)
safety green (nmod)
model of (case)
shr conscious (amod)
times 30 (nummod)
hundred one (compound)
geometry and (cc)
unremarkable fractures (nmod)
significance that (nsubj)
diameters despite (case)
showed analgesic (dobj)
studies 425 (nummod)
cavity the (det)
deficiency butyrylcholinesterase (compound)
disease alone (advmod)
cause thyrotoxicosis (nmod)
administered thrice (dobj)
analgesics no (det)
diet standard (amod)
performed tests (nsubjpass)
pericarditis , (punct)
meq/l ( (punct)
follow symptoms (nsubj)
tremor of (case)
retinopathy chloroquine (compound)
duration effect (nsubj)
steroids alpha-configuration (nmod)
arise . (punct)
rapid long (conj)
included study (nsubj)
occurrence higher (amod)
changes cimetidine (nmod)
toxic inhibitors (nsubj)
c. by (case)
values the (det)
rr ; (punct)
control exquisite (amod)
extent damage (nmod)
chemotherapy induction (compound)
produced pilocarpine (nmod)
trials investigated (acl:relcl)
score score (appos)
diagnosed malaria (nmod)
urea electrolytes (conj)
treatment ergotamine/caffeine (nmod)
lymphocyte the (det)
cigarettes < (dep)
suppressed peroxidation (dobj)
exceed risks (nsubj)
analgesia- morphine (compound)
sensitized cardiotoxicity (nmod)
grafting marrow (compound)
reported knowledge (nmod)
levels noradrenaline (compound)
steroid neither (dep)
dox preceded (acl)
gaba of (case)
band a (det)
disorder organic (amod)
found absence (nmod)
effects warranted (acl:relcl)
relation cyclophosphamide (nmod)
discharge times (nsubj)
discern to (mark)
u/ml ( (punct)
task forgetting (amod)
parietal and (cc)
average from (case)
attributed speed (nmod)
150 10(9)/l (conj)
activity vasodilating (compound)
bupropion 36.3 (conj)
represented probably (advmod)
method reliable (amod)
end each (nmod)
four respectively (conj)
decrease as (case)
surgery castration (compound)
undergo biotransformation (dobj)
gyrus monkeys (nmod)
disclosed to (mark)
dcf mg (amod)
response dipyridamole (nmod)
cholesterol ldl (conj)
persisted used (advcl)
aims study (nmod:poss)
levofloxacin fluoroquinolone (appos)
% 34.98 (nummod)
toxicity levobupivacaine (nmod)
developed spontaneously (advmod)
recovery the (det)
investigated effect (dobj)
infusion control (compound)
vpa for (case)
bpt clz (appos)
chloride ( (punct)
was distribution (nsubj)
intrarenally either (cc:preconj)
women acne (nmod)
frequencies 2 (nummod)
events 3 (nummod)
system development (compound)
disorders cardiac (amod)
diazepam induction (conj)
potentiation antinociceptive (amod)
play biosynthesis (nmod)
done assess (xcomp)
gls , (punct)
measured flow (nsubjpass)
defects many (amod)
decontamination and (cc)
recommendations use (nmod)
yr-old 65 (nummod)
words these (det)
placebo min (dobj)
capable shown (conj)
showed min-1 (dep)
papaverine mg. (nmod:npmod)
analysis rna (nmod)
range 200 (nummod)
assessment preoperative (amod)
resolved had (aux)
sera range (dep)
forelimb to (case)
stresses presentation (nsubj)
total months (nmod)
discussed dilemmas (nsubjpass)
reaction only (amod)
develop patients (nsubj)
no ) (punct)
accelerated had (aux)
% 42 (nummod)
haloperidol-treated in (case)
regulation prolactin (nmod)
advent despite (case)
dba/2j nzw/lacj (conj)
potentiate could (aux)
symptoms changes (conj)
animals left-pawed (amod)
hypotheses pathogenetic (amod)
hypoactivity min (dep)
met not (neg)
oscillations from (case)
vincristine-induced ( (punct)
episode transient (amod)
increased density (nsubj)
uptake cc (compound)
channel the (det)
clonidine agonist (compound)
services transfusion (compound)
distinguished it (nsubjpass)
induced interestingly (advmod)
allocated tamoxifen (nmod)
receptors mu (compound)
restores rat (nmod)
supplementary and (cc)
dox mg/kg (appos)
hypertension complication (nmod)
dynamic hyperalgesia (dep)
minutes 10 (nummod)
prolong induce (conj)
9 +/- (cc)
compared cannabis (conj)
evaluate neonates (dobj)
conditions surgical (amod)
dose daily (amod)
resulted progression (nmod)
cyclophosphamide cya (appos)
sections rats (conj)
illness pre-lt (amod)
site atp-binding (amod)
latency shorter (amod)
examination mini-mental (compound)
group 1 (nummod)
applied although (mark)
subcutaneous or (cc)
stronger pronounced (conj)
pindolol labetalol (conj)
others pectoris (nmod)
days final (amod)
report disease (nmod)
mediators that (mark)
2005 since (case)
antibiotics other (amod)
patient both (preconj)
drugs vitamin (compound)
experienced treatment (nmod)
mechanisms vasodilation (appos)
transplanted institution (nmod)
preceding importantly (advmod)
predictive not (neg)
induced patient (nmod)
aes , (punct)
found flumazenil (nsubjpass)
analyzed was (auxpass)
continuation therapy (nmod)
controlled and (cc)
substituted were (auxpass)
required discontinuation (dobj)
pergolide agonist (compound)
increased value (nsubj)
unable . (punct)
low usage (nsubj)
use antibacterials (nmod)
monitored cases (nmod)
sgk1(-/- of (case)
terminated administration (nmod)
changed contents (nsubjpass)
% isg (nmod)
frequency > (nmod)
because perhaps (advmod)
advocate can (aux)
case our (nmod:poss)
vip-/- ) (punct)
weight levels (dep)
enhanced startle (nsubjpass)
catalepsy rat (nmod)
injected which (nsubjpass)
pressure occurrence (conj)
examined complications (nsubjpass)
feeling the (det)
pentoxifylline mm/kg (compound)
weight excretion (nmod)
tachycardia exercise- (amod)
decrease by (case)
phases off-drug (amod)
ku70 ku80 (conj)
rest of (case)
glomerulosclerosis and (cc)
flow circumflex (amod)
pressure proteinuria (conj)
used exhibited (conj)
placebo disorder (nmod)
3.4 2.9 (conj)
disease spontaneous (amod)
utilized provide (advcl)
decline response (nmod)
-placebo group (compound)
caused hypomethylation (nmod)
3 about (quantmod)
paramedics and (cc)
viewed . (punct)
g/m2/d of (case)
comprises alpha3 (dobj)
shown tamca (nsubjpass)
treated morphine (nmod)
arise may (aux)
af ( (punct)
discovering interpretation (dobj)
case was (cop)
ceruleus of (case)
erythrocytes leukocytes (conj)
reversed phenomenon (nsubjpass)
greater was (cop)
deterioration behavioral (amod)
oat1 of (case)
activate feedback (dobj)
experience not (neg)
cases implicating (acl)
conclusion toxic (dep)
8 patients (nmod)
diameters/bw ) (punct)
aware tolerated (advcl)
treatment ketoconazole (nmod)
resolution fistula (nmod)
interference inactivation (nmod)
abilities physical (amod)
connection a (det)
episodes 15 (nummod)
restoration levels (nmod)
predictor = (dep)
explanation alterations (nmod)
clarify nature (dobj)
degree that (nmod)
inhibitor this (det)
similar whereas (dep)
parameters on (case)
peaked h (nmod)
nanoparticle doxorubicin-loaded (amod)
disorder , (punct)
caused steroid (nsubj)
strategies anemia (nmod)
investigate activity (dobj)
center clinical (amod)
dysfunction endothelial (amod)
rate input (compound)
2nd > (conj)
administered form (nmod)
revealed evidence (conj)
stopped is (auxpass)
tolerate do (aux)
characterized latter (nsubjpass)
self-poisoning g (nmod)
supplement unnecessary (amod)
citations with (case)
atp and (cc)
mhb stable (amod)
ranged , (punct)
mutations of (case)
admitted given (conj)
69 - (punct)
have possibly (advmod)
determined loss (nmod)
sensitive lines (nsubj)
data occurrence (nmod)
prazosin by (case)
mini-pump osmotic (amod)
absorption with (case)
elevated % (dep)
kpa 6.7 (nummod)
demonstrate connected (dep)
competing enzymes (nmod)
interrupt examinations (dobj)
restricted . (punct)
mg 8 (nummod)
received injection (dobj)
hemispheres both (det)
complicated . (punct)
trimester during (case)
e ed1-ed4 (conj)
cytostatic anti-angiogenic (conj)
memory episodic (amod)
monitoring level (compound)
dexmedetomidine doses (nmod)
reactions hydroxyquinolines (nmod)
agents approved (amod)
tumors bladder (compound)
occurring cardiotoxicity (compound)
cystitis in (case)
extend not (neg)
dose calculated (acl:relcl)
= 94.3 (nmod)
level sphincter (nmod)
i1- alpha2-receptor (conj)
derives so (advmod)
disorder related (amod)
eight up (advmod)
regulate down-regulation (dobj)
supplement transplantation (nmod)
studied and (cc)
arise need (advcl)
characteristics demographic (amod)
expression a (det)
justification need (nmod)
mm mm (nmod)
program have (conj)
mice -/- (amod)
began since (mark)
obtained lower (nsubjpass)
l ) (punct)
elevated also (advmod)
administered simultaneously (advmod)
changes alterations (conj)
content the (det)
reduced cytostatic (nmod)
hypogonadism bromocriptine (conj)
assess ability (dobj)
alkalosis relative (amod)
values small (amod)
groups h (dep)
stopped weeks (nmod)
prevented can (aux)
scintigraphy acid (compound)
l. hester (conj)
also but (cc)
inhibitor argatroban (nsubj)
ranges antidepressants (nmod)
however levels (nsubj)
unmatched both (cc:preconj)
represent cases (nsubj)
ifosfamide agent (compound)
noted tingling (xcomp)
correlation versus (cc)
correlation variables (conj)
that iodixanol (nmod)
indicated increased (ccomp)
suited is (cop)
magnitude is (cop)
objective conducted (appos)
documented however (advmod)
euthanized . (punct)
disappeared to (mark)
anatomy functional (amod)
treatment dfmo (nmod)
efficacy propranolol (nmod)
selected ' (case)
received admission (nmod)
increases stimulation (nsubj)
stimulation receptors (nmod)
characteristics types (conj)
evidence objective (amod)
rpn ( (punct)
tested activity (nsubjpass)
0.9 - (punct)
4.4 1.6 (nummod)
coordination and (cc)
microscope a (det)
n 1.84 (conj)
deaths nephrotoxicity (nmod)
suggested important (ccomp)
produced effects (dobj)
infusion during (case)
events 27 (nummod)
aap such (case)
strain a (det)
signaling pkc-mediated (amod)
reduce to (mark)
effects training (nmod)
growth in (case)
sirolimus and (cc)
hours duration (nsubj)
group rats (nmod)
circulation in (case)
used diltiazem (nsubjpass)
performed material (nmod)
maintenance phenotype (nmod)
spared monosaccharides (nmod)
hypertrophy rat (compound)
532 to (dep)
subjected not (neg)
therapy b (nmod)
deficits dopaminergic (amod)
task eyes (compound)
conclusions different (appos)
antibody heparin-dependent (amod)
fell 38 (nmod)
doses activity (nmod)
carried : (punct)
model sad (nmod)
produced treatment (nmod)
dose be (cop)
alternative pallidotomy (acl)
gyrus rat (compound)
angioedema resolved (acl)
mg/dl p<0.02 (appos)
pathomechanism nystagmus (nmod)
bun mg/ml (appos)
ectopic more (advmod)
performed micrograms/kg/min (dep)
presents purpura (nmod)
vip(-/- in (case)
demand metabolic (amod)
stimuli but (cc)
objective describe (dep)
performed monitor (nmod)
use sumatriptan (amod)
binding and (cc)
suxamethonium bradycardia (conj)
median initiation (nmod)
selected men (nsubjpass)
available detect (xcomp)
continuation patients (nmod)
hypoxemia octreotide-induced (amod)
incontinence with (case)
composition salt (compound)
lack and (cc)
reduced had (advcl)
mechanisms immunological (amod)
exert inhibitors (nsubj)
action vasopressin (nmod)
coli together (advmod)
mup ( (punct)
becoming aware (xcomp)
disease against (case)
mg/m(2 gemcitabine (compound)
motif across (case)
develop strategy (dobj)
define population (nmod)
behavior pure (amod)
infection hepatitis (compound)
compromise by (case)
spasms corrected (acl:relcl)
liver isolated (amod)
arterial blood (dep)
help avoiding (xcomp)
rats bile-diverted (amod)
method predict (acl)
tolerability nimesulide (nmod)
recorded 11 (nmod)
developed timeframe (nmod)
administered ; (punct)
factor one (nummod)
subanalyses 2 (nummod)
effects curves (nmod)
inconclusive since (mark)
reached had (aux)
transition endothelial-mesenchymal (amod)
relationship this (det)
available is (cop)
that biperiden (nmod)
treatment any (nmod)
transaminase transaminase (conj)
attributable exist (dep)
perioperative better (advmod)
dbp ( (punct)
commenced , (punct)
injections saline (nmod)
bound . (punct)
quantitative of (case)
factors from (case)
five drivers (nmod)
clarification therapy (nmod)
resembles humans (nmod)
highlight we (nsubj)
body respectively (advmod)
detachment edema (conj)
hearing khz (nmod)
present methods (dep)
prostheses valve (compound)
reduced alpha-methyldopa (advcl)
tolerated days (nmod)
process secretion (nsubj)
titrated , (punct)
packing and (cc)
subset children (nmod)
dfo than (case)
compared toxicity (nsubjpass)
toxicity presumed (amod)
0.99 1.38 (dep)
instilling by (mark)
received interviewing (advcl)
prophylaxis pneumonia (compound)
complicated background (dep)
etoposide vp-16 (appos)
gestation for (case)
control the (det)
present and (cc)
reduction hyperactivity (nmod)
sensitivity component (nmod)
block the (det)
pharmacodynamics patients (nmod)
density and/or (cc)
implications effect (nmod)
development maintenance (conj)
treated disorders (nsubjpass)
microg n=6 (appos)
stimulants psychomotor (compound)
aspects pathophysiology (nmod)
pressure micromol/l (conj)
input nociceptive (amod)
patients agents (nmod)
duct . (punct)
regimen 2-week (amod)
fall pressures (nmod)
biopsy gastrocnemius (dep)
behaviour long-lasting (amod)
dexamethasone % (compound)
patients infarction (nmod)
conditions special (amod)
developed levobupivacaine (nsubjpass)
amyloidosis renal (amod)
s for (case)
capable penetrating (advcl)
200 , (punct)
lesion period (appos)
killed and (cc)
mice and (cc)
thyroidectomy of (case)
retard did (aux)
explanation interval (nmod)
constitutes this (nsubj)
obesity hyperinsulinemia (appos)
investigated every (conj)
starting and (cc)
= 31 (dep)
examination sensory (amod)
cycle third (amod)
doxorubicin progressive (amod)
years ( (punct)
conversion simvastatin (nmod)
history biopsy (conj)
methotrexate intravenous (amod)
acid l-4-amino-hex-5-enoic (compound)
measured monitoring (dobj)
based review (nmod)
acted manner (nmod)
1981 in (case)
indicating homozygocity (dobj)
prevented development (dobj)
activity beta-adrenoceptor (compound)
csa plus (cc)
explanations other (amod)
t3n1m0 ( (punct)
myocardium in (case)
performing injection (dobj)
outcome cases (nmod)
increases because (mark)
evaluated effect (dobj)
annuals cases (nmod)
prevented clonazepam (nmod)
dilation pupillary (amod)
accumbens nucleus (compound)
naloxone induced (dep)
years 000 (nummod)
episode anuria (nmod)
attempt apparent (amod)
prooxidant glycate (conj)
depressed extent (conj)
investigated herein (advmod)
revealed % (dobj)
caffeine placebo (conj)
continued wore (conj)
dextrose a (det)
required admission (dobj)
inconsistent have (aux)
investigate tg (dep)
using nephrosis (dobj)
developed pneumonitis (dobj)
fetal cells (dep)
course typical (amod)
reversing gradient (dobj)
reactivation virus (compound)
samples myocardial (amod)
allografts in (case)
cocaine to (case)
deposits fibrillar (amod)
extended can (aux)
identified subsets (nsubjpass)
analgesia pca (appos)
life-threatening are (cop)
exhibited ) (punct)
head quipazine-induced (amod)
site common (amod)
drinking nondrinkers (conj)
strokes multiple (amod)
effective reversing (advcl)
describe incidence (dobj)
[3h]-dihydroergocryptine nm (appos)
cause background (dep)
agc primary (amod)
series retrospective (amod)
episodes , (punct)
components sensory-discriminative (amod)
% 75.9 (nummod)
encode recall (conj)
persisted treatment (nmod)
action , (punct)
p450 2e1 (dep)
reduction segment (nmod)
(7.2)% -28.6 (conj)
arrest of (case)
safe child (nmod)
mm 178 (nummod)
damage dox-induced (amod)
activation no (compound)
sites from (case)
explored we (nsubj)
glut4 via (case)
showed tremor (nsubj)
evaluation administration (nmod)
studied kindreds (nmod)
observed symptoms (nsubjpass)
cultured ulcers (nsubjpass)
neoplasms % (appos)
littermates non-txg (compound)
medius scalenus (amod)
antagonist antipsychotic (nmod)
stronger and (cc)
receptors ' (case)
risk esrd (nmod)
combined tocolytics (nsubjpass)
overcome can (aux)
found diseases (nsubjpass)
patients schizophrenia (nmod)
observed tasks (nmod)
suffered min (nmod)
revealed restoration (nmod)
indicated lesion (dobj)
rat liver (conj)
cause increasing (advcl)
those observed (acl)
gyrus of (case)
obtain . (punct)
ranging mean (dep)
identification method (nmod)
drug reference (compound)
exclusion on (case)
urate assess (xcomp)
receive 0.02 (dobj)
influenzae pathogens (nsubj)
withdrawn concerns (nmod)
long-acting of (case)
standard treatment (nmod)
affected composition (nsubjpass)
ecstasy cannabis (conj)
attributed are (auxpass)
had 6 (nsubj)
relevance be (cop)
apoptosis drug-induced (amod)
drugs suppressant (amod)
maintaining rats (nmod)
models dementia (compound)
discontinued study (nmod)
amounts increased (amod)
assessed survivors (nmod)
ouabain 10(-3)m (conj)
maintaining anesthesia (dobj)
greater ) (punct)
field useful (amod)
absent surprisingly (advmod)
determined using (xcomp)
blockade alpha (compound)
ear middle (compound)
cases abortions (nmod)
inhibitors protease (compound)
p9201 from (case)
hormones releasing (amod)
cycle her (nmod:poss)
blocker multichannel (compound)
found similar (ccomp)
actin renal (amod)
diminishes altering (csubj)
battery on (case)
mice cystitis (nmod)
designated has (aux)
result release (conj)
mg/dl 3.4 (nummod)
factor-alpha activity (conj)
kg 92.6 (nummod)
agonist serotonin-1 (compound)
transplanted intravenously (advmod)
it-methotrexate it-tspa (conj)
release receptor-mediated (amod)
plays ototoxicity (nmod)
caused 5-ht (nmod)
doses micrograms/kg/d (nmod)
achieved be (auxpass)
or=2.5 cr (compound)
associated cases (nsubj)
quality a (det)
d-galactose source (nsubj)
cognitive series (dep)
cause treatment (nsubj)
reduction ml/min (dep)
infection epstein (compound)
wilcoxon 's (case)
risk abnormalities (nmod)
antagonizes contrast (advcl)
done were (auxpass)
angioedema enzyme (compound)
showed mris (nsubj)
increasing . (punct)
patients 4/106 (appos)
employed . (punct)
outcome worst (amod)
abundance protein (compound)
percentage critical (amod)
subunits of (case)
increase firmness (nmod)
groups degeneration (conj)
diphosphanilate chlorhexidine (compound)
citrate cc (appos)
acid acidb (compound)
group ropivacaine (compound)
mip ) (punct)
na/k-atpase nbc1 (conj)
l-alpha-glycerylphosphorylcholine of (case)
injected anesthetics (nsubjpass)
reflex righting (amod)
rides horses (dobj)
use comparison (dep)
were episodes (attr)
treatment rats (nmod)
cocaine . (punct)
caffeine to (case)
manifested hypotension (nmod)
system electro-oculography (conj)
substitution , (punct)
use patients (nmod)
akinetic were (cop)
test pa (appos)
1.0 and (cc)
reduction drastic (amod)
1.1 17.5 (prep)
observed doses (nmod)
carcinogen by (case)
differ night (nmod)
assessed overnight (nmod)
syndrome n (dep)
abbott-53693 2-agonist (amod)
combination metoprolol-terbinafine (amod)
model fear (dobj)
use exchange (nmod)
relapsing bacteremia (dobj)
catheterizations sign (conj)
growth development (conj)
developed method (dobj)
cells wall (nmod)
test sedation (appos)
initiated daptomycin (nsubjpass)
target as (case)
30 up (advmod)
favourable was (cop)
play activator (nmod)
increasing nausea (dobj)
adrenergic beta (nmod:npmod)
fulfill to (mark)
reproduced be (auxpass)
increased time (dobj)
examined h (nmod)
revealed role (dobj)
binding nonimmunologic (amod)
changes age-dependent (amod)
interaction pharmacokinetic (amod)
effective care (nmod)
aorta cross-clamp (nmod)
expected and (cc)
anxioselective abecarnil (conj)
tumours against (case)
radiofrequency rf (appos)
evidence subclinical (amod)
clinical experimental (conj)
regimens include (acl:relcl)
worn chance (nmod)
fever pustulosis (compound)
adult for (case)
therapy warfarin (compound)
0.3 1 (conj)
treated ineffectiveness (nmod)
5 10 (conj)
patients warrants (acl:relcl)
added phenobarbital (nsubjpass)
pemoline with (case)
mean months (dep)
ensued apnea (nsubj)
study ten-year (amod)
exposed anesthesia (nmod)
glucose plasma (compound)
m.s. ) (punct)
referred total (nsubjpass)
success extracts (nmod)
leukemia myeloid (amod)
3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1h-indole ( (punct)
food from (case)
group fk506 (compound)
proportion similar (amod)
noel ( (punct)
analysis study (conj)
activation factor-kappab (compound)
changes signalling (nmod)
included bilirubin (dobj)
mek1 and (cc)
intensities abnormal (amod)
identification patients (nmod)
pills containing (acl)
effects yohimbine (nmod)
inflammatory neuropathic (conj)
acquainted should (aux)
neuralgia gout (conj)
group tea (conj)
dox human (amod)
prove . (punct)
low incidence (nsubj)
higher reduction (dep)
interaction and (cc)
prevented given (advcl)
values obtained (acl)
associated tacrolimus (nsubjpass)
developed polymyositis (dobj)
has serve (ccomp)
determine efficacy (dobj)
size by (case)
3 0.5 (compound)
twenty-four out (case)
discontinued cases (nmod)
period 180-minute (amod)
developed deterioration (dobj)
20 40 (dep)
reduction period (nmod)
evaluate capability (dobj)
fibrosis some (det)
snr of (case)
followed alfentanil (nmod)
determining response (dobj)
pain caused (acl)
development hyperplasia (nmod)
cortices the (det)
reflection a (det)
findings woman (nmod)
nephrosis aminonucleoside-induced (amod)
reported but (cc)
users third-generation (nmod)
peripheral central (conj)
compliance the (det)
drugs 30 (conj)
t-test unpaired (amod)
difference parameters (nmod)
= = (parataxis)
interest , (punct)
examined studies (nmod)
hyperactivity users (nmod)
hemodynamics oxytocin (nmod)
group min (nmod)
pg to (dep)
increased reduced (conj)
infant newborn (amod)
methods treated (appos)
explanation an (det)
seems l-sotalol (nsubj)
early as (advmod)
parents by (case)
280+/-17 131+/-22 (conj)
hospital king (compound)
drug qt (compound)
continued stopping (advcl)
lnna synthase (compound)
linezolid including (case)
meth with (case)
proliferation processes (conj)
significant verapamil (nmod)
protein in (case)
months 23.6 (nummod)
if were (cop)
comparison effectiveness (nmod)
= 2.32 (dep)
cycle and (cc)
determined had (ccomp)
design explore (parataxis)
awaiting procedures (dobj)
cells patients (nmod)
stem lack (nsubj)
interval longer (amod)
drop administration (nmod)
described poorly (advmod)
activity locomotion (compound)
suggest related (ccomp)
kindling with (case)
mul mug (dep)
demonstrated , (punct)
ro15 by (case)
lesioned groups (dobj)
chlorpropanol , (punct)
inhibition mediated (amod)
modified inflammation (nmod)
disease late-stage (compound)
patients those (conj)
utility of (case)
h 4.95+/-1.41 (nummod)
lenalidomide and (cc)
densitometry ) (punct)
cells/mm3 increase (nsubj)
variety behaviors (nmod)
reason more (amod)
monooxygenases of (case)
abolished was (auxpass)
treated improved (conj)
investigations further (amod)
doses fzp (nmod)
rhabdomyolysis with (case)
seen age (nsubjpass)
parameters atherosclerotic (amod)
examined neurotoxicity (nmod)
vomiting episodes (conj)
damage forebrain (nmod)
higher increase (nsubj)
salt-depleted rats (dep)
meq/l and (cc)
maximum 4 (nummod)
thyroidectomy and (cc)
ability l-dihydroxyphenylalanine (nmod)
reports . (punct)
diameters/bw end-diastolic (amod)
antagonist serotonin (compound)
antagonist valsartan (appos)
[na]o in (case)
varied although (mark)
increased vldl (nsubj)
2147 701 (conj)
% 0.025 (nummod)
tgr in (case)
hexachloride ) (punct)
dementia attenuate (compound)
changes appreciable (amod)
enhancement antihyperalgesia (nmod)
gain more (amod)
ax for (case)
trunk the (det)
noted cessation (nmod)
ct with (case)
patients 31 (dep)
added regimen (nmod)
rapamycin macrolide (compound)
tomography pet (appos)
subjects increase (conj)
opioid an (det)
produced cns (dobj)
removed time (nmod)
kappa-beta the (det)
leads states (nmod)
peripheral autonomic (conj)
development eps (nmod)
practice to (case)
shock of (case)
tested study (nmod)
reacts . (punct)
0.07 0.16 (conj)
superior inferior (conj)
reports to (case)
killed conditions (nmod)
learning deficits (conj)
similar evolution (nsubj)
lumens in (case)
responses two (nummod)
synthesis in (case)
cells epithelial (amod)
taken statins (nsubjpass)
dizziness with (case)
sle ( (punct)
aminoglycoside vancomycin (conj)
cholestasis marked (amod)
titrated therapy (nsubjpass)
mimic condition (dobj)
response dose (compound)
concentration gentamicin (compound)
venous were (cop)
factor p-choloroaniline (nsubj)
ingredient number (nmod)
changes framework (nmod)
current ) (punct)
mechanisms neural (amod)
seizures with (case)
val/hctz with (case)
factors psychosis (nmod)
emboli pulmonary (amod)
changes protein (compound)
challenged iso (nmod)
effects sedation (nmod)
examination tissue (nmod)
determining sensitivity (dobj)
subcortex sites (conj)
severe sometimes (advmod)
course treatment (compound)
associated introduction (nsubjpass)
managed patient (nsubjpass)
dextran iron (compound)
profile the (det)
related . (punct)
l-dopa after (case)
normalized t1/2 (conj)
moving telemetry (nmod)
combination factors (nsubj)
fed weeks (nmod)
many of (case)
observed months (nmod)
given percent (nsubj)
chloroform-adrenaline by (case)
response blood (compound)
results amines (nmod)
4 over (quantmod)
have epilepsy (dobj)
randomized visits (nmod)
patients oab (nmod)
effect hallucinations (nsubj)
frequency the (det)
suffered " (punct)
falciparum plasmodium (compound)
protects drugs (nmod)
patterns , (punct)
inserts package (compound)
erections fluoxetine-induced (amod)
shown benefit (xcomp)
antipsychotics risperidone (nmod)
sodium only (advmod)
temocapril , (punct)
1.5 2.8 (dep)
fraction region (conj)
methods injected (appos)
ranitidine and (cc)
adr(6 groups (compound)
description case (compound)
platelet in (case)
general in (case)
side-effect . (punct)
elevation damage (nmod)
nonimmunity rubella (compound)
hcbd damage (dep)
clt ) (punct)
iugr of (case)
triggered adding (advcl)
resistant were (cop)
antagonism beta-2 (compound)
content patients (nmod)
memory of (case)
bolus as (case)
area , (punct)
measured tensions (nsubjpass)
insult to (case)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine 5'-n-ethylcarboxamidoadenosine (conj)
danger products (nmod)
limit largely (advmod)
perform and (cc)
compared group (nmod)
therapy replacement (compound)
mglur1 ( (punct)
distributions . (punct)
suramin gr (conj)
sensitivity auc (dep)
ng/ml 8 (nummod)
activates . (punct)
becoming nephrotoxicity (nsubj)
confirmed diagnosis (dobj)
controls over (case)
reached difference (nsubj)
demonstrated undertaken (conj)
emissions transient (amod)
extend may (aux)
administered wr242511 (nsubjpass)
using rater (nmod)
attack : (punct)
allodynia icc (appos)
decreased because (mark)
rate gain (nmod)
patients diagnosis (nmod)
gr/dl 9.5 (nummod)
synthesis as (cc)
reviewed reports (dobj)
noradrenaline plasma (compound)
warned should (aux)
therapy medication (compound)
hypercalcemia anemia/thrombocytopenia/emesis/rash (conj)
mandatory monitoring (nsubj)
levels dismutase (nmod)
cured and (cc)
ldl-cholesterol in (case)
hyperhidrosis with (case)
priapism of (case)
disease sinuatrial (amod)
meq/l lithium=0.85 (compound)
help exercise (nmod)
deviation ( (punct)
centers from (case)
release region (nmod)
affect amplitudes (dobj)
referred catheterization (nmod)
tmax lp (nmod)
cautious to (mark)
suggested investigation (nsubj)
order improve (acl)
reflected appearance (nmod)
dose levodopa (nmod)
3.8 to (dep)
clear less (advmod)
extent considerable (amod)
members from (case)
antidepressants other (amod)
% experiencing (acl)
produces acetaminophen (nsubj)
length ( (punct)
flurothyl by (case)
make increases (advcl)
third from (case)
consistent precipitate (conj)
underwent mice (nsubj)
separation . (punct)
diplopia seen (acl)
rose groups (nmod)
administration ibuprofen (amod)
cells satellite (compound)
desire ng./ml (conj)
accumulated use (nmod)
2.5 . (punct)
showed and (cc)
user an (det)
induced eads (dobj)
unmask intoxication (nmod)
need vaccination (dobj)
2.4 +/- (cc)
recipients twenty (nummod)
microg/ml od (compound)
aspirin 's (case)
activation during (case)
associated placebo (dep)
whom for (case)
mapped using (xcomp)
41.8 4.8 (conj)
hallucinations occurring (acl)
utero exo (compound)
outcomes regarding (case)
characterize was (cop)
reactions adverse (amod)
protein patients (nmod)
followed is (auxpass)
da ) (punct)
recurrence patients (nmod)
antidepressant . (punct)
damage doxorubicin (nmod)
enhanced effects (dobj)
picu ) (punct)
2.6 2.2 (conj)
performed using (xcomp)
correlation . (punct)
sensitivity in (case)
prk myopic (amod)
impairment memory (nmod)
peripheral of (case)
receptor-mediated nmda (nmod:npmod)
cisternae golgi (compound)
effects ephedrine (nmod)
determined suggesting (xcomp)
limits normal (amod)
opistothonus , (punct)
cases adenocarcinoma (nmod)
rates suicide (compound)
naloxone and (cc)
23 in (case)
escalated when (advmod)
initial only (conj)
treatment glycopyrrolate (nmod)
stronger suppressing (advcl)
model in (case)
cell of (case)
estimated carefully (advmod)
myocytes neonatal (amod)
results exceeded (acl:relcl)
rhythm normal (amod)
lesion medulla (nmod)
flexion/extension neck (nmod)
use conjunction (nmod)
antagonized increase (conj)
observed sbp (nmod)
pattern six (nmod)
cells mononuclear (amod)
assigned were (auxpass)
roots nerve (compound)
reasons known (amod)
helpful case (nmod)
rate filtration (compound)
neurons known (conj)
acid kainic (amod)
agonist absorption (nmod)
age 45 (nummod)
recording recovery (nmod)
frequency neutropenia (nmod)
65 169 (conj)
neurotransmitters with (case)
decrease < (dep)
depressed or (cc)
dosages inhibited (acl:relcl)
co. , (punct)
assessments happiness (nmod)
syndrome fatal (acl:relcl)
noel ) (punct)
reduced administration (nmod)
increased course (nmod)
depression disinhibition (conj)
areas flexural (amod)
produce could (aux)
injury analysis (appos)
knowledge the (det)
implicated carbamazepine (nsubjpass)
compared shr (nmod)
pregs to (case)
patency veins (nmod)
hallucinations nightmares (conj)
benign mistaken (conj)
administered males (dobj)
activating (na (dobj)
schedule twice (amod)
opioid and (cc)
circulation into (case)
aetiologies encephalopathy (nmod)
tachycardia syndrome (nmod)
12.0 - (punct)
dealt role (nmod)
resolve as (mark)
values yohimbine (compound)
became marked (acomp)
require clarification (dobj)
9.4 4.5 (conj)
blocking hc (dobj)
neonate in (case)
170 20/102 (conj)
day course (nmod)
report showing (acl)
pressure her (nmod:poss)
investigated was (auxpass)
pilocarpine with (case)
showed predictors (ccomp)
used complication (nmod)
benefit be (cop)
9 % (dep)
segment anterior (amod)
surgeon treating (acl)
shortened animals (advcl)
non-hypertensive referral (amod)
vein of (case)
taking ht (dobj)
estradiol , (punct)
zo-1 and (cc)
equipotent roughly (advmod)
immunosuppressant actions (nmod)
challenge 0.6 (nmod)
enzyme group (compound)
5.9 1.0 (compound)
proof effect (nmod)
was black (dep)
point . (punct)
ca kimmel (compound)
pattern activity (conj)
mass heart (compound)
release mast (compound)
program dialysis (compound)
abortions during (case)
pressure elevation (compound)
weight 3.25 (nummod)
males the (det)
need addressed (xcomp)
changes marked (amod)
associated myopathy (nmod)
zones walls (nmod)
constricting selectively (advmod)
inhibitor used (acl)
plan the (det)
ich a (det)
damage any (conj)
possibilities treatment (compound)
fibrillation sudden (amod)
administration low-dose (appos)
history schizophrenia (nmod)
phenotype pharmacokinetics (conj)
reduced completing (advcl)
doses p.o. (nmod)
ml , (punct)
costs and (cc)
isoniazid medication (dobj)
cases taking (acl:relcl)
seizures patients (nmod)
questioned when (advmod)
hyperosmolar , (punct)
stz- and (cc)
postulated however (advmod)
calculation 3.1+/-1.0 (dep)
known hormone (nsubjpass)
analysis nested (acl)
tgf- clearance (conj)
pilocarpine against (case)
potencies with (case)
effect veralipride (nmod)
characterization parasympathetic (nmod)
pre- post-training (conj)
induced velocity (conj)
concentrations low (amod)
attenuated learning (xcomp)
report probably (advmod)
test word-recall (amod)
inhibits that (mark)
cocaethylene due (case)
ctnt with (case)
creatinine baseline (compound)
different which (nsubj)
15 10 (quantmod)
thickening including (case)
explore mechanisms (dobj)
unlikely and (cc)
stop-watch a (det)
cacl2 , (punct)
molecule cs (compound)
epilepticus rats (nmod)
patients severe (nmod)
beta slow (amod)
bp protein (conj)
resistance difference (conj)
induced neurotensin (nmod:npmod)
varied , (punct)
synthesis et-1 (nmod)
hemorrhagic and (cc)
bladder forestomach (conj)
seven patients (dep)
accumulation drugs (nmod)
end score (conj)
complete - (punct)
non-biodegradable or (cc)
concentrated post-injection (nsubjpass)
> 0.60 (nummod)
efficacious likely (conj)
induction sedation (nmod)
cells cancer (compound)
died two (nsubj)
improvement striking (amod)
changes long-term (amod)
found reactivity (nsubjpass)
freezing , (punct)
suggest , (punct)
treatment hydration (nmod)
ip 3 (nummod)
team critical (amod)
precursor this (det)
delays modulate (conj)
appeared nodules (nmod)
schizophrenic girl (compound)
mechanisms excitatory (amod)
receptor an (det)
complained paraesthesia (nmod)
were compared (dep)
platonia of (case)
location sound-source (amod)
used i.p. (advcl)
notwithstanding facts (dobj)
dsm-iv ) (punct)
tm the (det)
factor immunoreactive (amod)
placed probe (nsubjpass)
place in (case)
following on (mark)
mssbp reduced (amod)
43 19 (compound)
serum the (det)
protects vivo (advmod)
includes experience (nsubj)
children 's (case)
modified ; (punct)
involving lignocaine (dobj)
corrected use (nmod)
population-based multisite (conj)
tsh ) (punct)
25.7 +/- (cc)
ascertain part (nmod)
risk its (nmod:poss)
moderate-dose high-dose (dep)
caused exposure (nmod)
hr 96 (nummod)
placebo ce (conj)
receptors 5ht1a (compound)
traits hallmark (amod)
products advanced (amod)
showed improvement (dobj)
% seizures (nmod)
had uveitis (dobj)
antidepressants . (punct)
lung or (cc)
levels % (dep)
min 30 (nummod)
microg/ml ( (punct)
granisetron of (case)
urothelium below (case)
performed > (dobj)
changed tablets (nmod)
stop 24/76 (nsubj)
problems gynecologic (amod)
changes vpa-induced (amod)
perception test (nmod)
% 37.1 (nummod)
changes during (cc)
shown , (punct)
needed is (auxpass)
activation stat5 (compound)
increase alcalinization (conj)
mean hr (nmod)
deprivation protein (compound)
common reactions (nsubj)
hyalinosis wall (nmod)
relating contraceptives (dobj)
76 older (conj)
release ( (punct)
using pointer (dobj)
initiation after (case)
recognise physicians (nsubj)
present hypersensitivity (nsubj)
decreased gyrus (nmod)
lenalidomide dexamethasone (conj)
given mg (dobj)
trials ii (nummod)
proportion in (case)
able were (cop)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline 8-[(4-amino-l-methylbutyl)amino]- (amod)
sodium lysozyme (conj)
5-fluorouracil particular (amod)
disruption in (case)
inhibiting without (mark)
treated breakfast (nmod)
myelosuppression ) (punct)
treated period (nmod)
weight content (conj)
idraparinux inhibitor (appos)
stimuli mechanical (amod)
altering modulation (dobj)
eminence me (appos)
augment to (mark)
incidences of (case)
consistent and (cc)
weighted imaging (dobj)
investigation surveillance (nmod)
evaluation expanded (amod)
observed clinically (advmod)
practitioners general (amod)
period pretreatment (compound)
pac ) (punct)
potentiated . (punct)
term in (case)
subjects p (dep)
composite mean (dep)
examined when (advmod)
those mm (dep)
performance antioxidant (amod)
fanconi 's (case)
prevented dose (nmod)
reaction late-onset (amod)
90/hypertension 90/htn (dep)
reactions patients (nmod:poss)
treated that (mark)
reached been (auxpass)
pituitaries ) (punct)
action evidence (conj)
problem this (det)
forgetting long-term (amod)
cardiotoxin adriamycin (nsubj)
control active (amod)
night studies (conj)
inhibitor potent (amod)
cross-clamp acid (dep)
correlate morphological (amod)
curves the (det)
total if (dobj)
administered 11 (conj)
crf ; (punct)
performance and (cc)
fa 2-hour (amod)
equal and (cc)
man the (det)
prevented lowered (nsubj)
[3h]inulin and (cc)
effects diltiazem (nmod)
mg/kg 0.05 (nummod)
defined samples (nsubjpass)
sedionbel ( (punct)
inflammation mild (amod)
work current (amod)
impact functional (amod)
outcomes poorer (amod)
rating global (amod)
sd age (conj)
found differences (nsubjpass)
was days (nmod)
symptoms eps (appos)
toxicity those (det)
ventilator and (cc)
stimulation in (case)
carcinogenesis estrogen (compound)
synthase-1 microsomal (amod)
cholesterol mean (amod)
basis outpatient (amod)
causes inconclusive (conj)
bacteria and (cc)
induce did (aux)
carcinoma bladder (compound)
undertaken also (advmod)
changes laboratory (compound)
function rather (cc)
treatment institution (nmod)
1969 1990 (nmod:tmod)
had lupus (dobj)
combinations ) (punct)
ulcerogenicity reduced (amod)
occur exposure (nmod)
changes dna (nmod)
seem mediated (xcomp)
applicators private (amod)
caffeine ip (appos)
explained best (advmod)
cancers against (case)
sustained was (cop)
16 14 (compound)
dizocilpine by (case)
agents interact (acl:relcl)
rates in-hospital (amod)
face the (det)
blocked caffeine- (dobj)
anemia rhuepo-beta (compound)
1.6+/-0.34 ) (punct)
participates formation (nmod)
name the (det)
attack seizure (amod)
glutamate that (nsubj)
dysfunction comparable (amod)
administration acetaminophen (nmod)
types against (case)
blocking by (case)
hepatocellular mixed (conj)
showed glomeruli (nsubj)
pointer pen-shaped (amod)
rats ns-718-treated (amod)
revealed studies (nsubj)
preexisting , (punct)
g/dl 12.7 (nummod)
toxicity chronic (amod)
10.2 0.1 (conj)
adjusted factors (nmod)
hepatocellular , (punct)
poison rat (compound)
d warfarin (conj)
lamivudine by (case)
inflamed and (cc)
2- 3-year (dep)
release control (nmod)
explore studying (advcl)
metoclopramide - (punct)
dexamethasone ( (punct)
ceased was (auxpass)
reports two (nummod)
monitoring periodic (amod)
= 30 (dep)
emerged before (nmod)
hospital cheops (appos)
exhibited inhibitors (nmod)
or=12.619 - (punct)
attacks panic (compound)
containing ca (dobj)
groups azelastine (compound)
day 6 (nummod)
mg cytarabine (compound)
investigations pharmacological (amod)
vinorelbine of (case)
60 10 (compound)
demonstrate index (dobj)
observed histochemistry (nmod)
disadvantages potential (amod)
system dopaminergic (amod)
patients 0.07 (dep)
studies peri-operative (amod)
scarce were (cop)
characterized microscopy (nmod)
stopped convulsions (nsubj)
nonionic monomeric (conj)
425 +/- (cc)
plan , (punct)
replacement rats (nmod)
lower g. (nmod:npmod)
quinpirole antagonist (compound)
pathways map (compound)
stress oxyradical (amod)
dosed orally (advmod)
increase mg (nmod)
got imbalance (nsubj)
efflux methamphetamine-induced (amod)
source without (conj)
features arrhythmia (nmod)
clinic lithium (compound)
mediated could (aux)
radiocontrast of (case)
patient failure (compound)
increasing be (aux)
showed lesions (dobj)
undetermined % (nmod)
dosage , (punct)
analyses laboratory (compound)
edaravone scavenger (appos)
investigated pain (dobj)
aim to (mark)
demonstrating succinylcholine (nmod)
mucosa of (case)
v.o ( (punct)
ballooning to (case)
neonates cases (nmod)
duct cystic (amod)
controls n=26 (appos)
unmasked by (advmod)
case outcome (nmod)
determined dose (nmod)
blocker of (case)
parkinsonism in (case)
increased remained (advcl)
dose one (nummod)
levels urine (compound)
plays sleep (nsubj)
scavenger radical (amod)
cohorts % (dep)
hormone human (amod)
flashbacks " (punct)
veins , (punct)
second- third-generation (conj)
associated exposures (nsubjpass)
safe complication (nmod)
calcium of (case)
liver tissues (conj)
counts time (nmod)
dose mean (compound)
isph of (case)
irbesartan with (case)
meq/kg/day of (case)
complexes factor (conj)
benefits therapy (nmod)
anastrozole tamoxifen (conj)
common some (nsubj)
died patients (nsubj)
p=0.001 ; (punct)
complication to (mark)
oat1 and (cc)
retrieved analysis (nsubj)
evaluated be (auxpass)
cells meshwork (compound)
injury for (case)
evidence mechanisms (nmod)
hypothyroidism thyroiditis (appos)
igg , (punct)
mosmol/kg urine (conj)
agents reversal (amod)
conducted tests (nsubjpass)
leukemia t-lymphocytic (amod)
review complications (nmod)
paclitaxel , (punct)
failure graft (compound)
removed bladder (nsubjpass)
administered mannitol (nsubjpass)
causes viral (amod)
tolerance taking (acl)
users ich (conj)
cancer leukemia (conj)
recordings of (case)
rigidity with (case)
age 0.007 (appos)
drop determined (acl)
rash were (cop)
poor the (det)
effect ulcers (nmod)
symptoms abated (acl:relcl)
girl syndrome (nmod)
metabolites acetylated (amod)
electroretinography pattern (compound)
vasculitis tomography (conj)
polymerase poly(adp-ribose (det)
output resistance (conj)
p=0.01 ) (punct)
fos-ir cord (nmod)
recovery for (case)
carcinomas hamster (compound)
scores with (case)
fluorouracil em (compound)
% 54.6 (nummod)
endpoints with (case)
treated those (conj)
known but (cc)
scale scale (conj)
provoked administration (nsubj)
received ems (nsubj)
prove useful (xcomp)
repeated instillation (nsubjpass)
have seizures (dobj)
2a by (case)
experiment acute (amod)
rating for (case)
indications same (amod)
7.7 sem (appos)
trimethaphan tmp (appos)
2-fold ut-a1 (conj)
patients forty-three (amod)
ascertained not (neg)
therapy fluvastatin (compound)
anesthesia epidural (amod)
risk 20-year (amod)
renal or (cc)
seen restarted (advcl)
demonstrates differences (dobj)
mediators are (cop)
reduction greater (amod)
multicenter methods (nsubj)
features chronology (conj)
ovulation with (case)
caused atrophy (nmod)
switch by (case)
descending only (advmod)
need identify (acl)
lowered week (nmod)
propranolol agent (appos)
life t(1/2 (appos)
control reperfusion (appos)
important receive (advcl)
decreased efficient (conj)
u , (punct)
weeks re-exposure (nmod)
conclusions suitable (appos)
spv the (det)
syndrome induced (acl)
peak mg/dl. (nmod)
administered aminonucleoside (nsubjpass)
13 to (dep)
generation by (case)
assessing in (mark)
transplant from (case)
ruled . (punct)
cardioversion after (case)
postulated mediate (xcomp)
developed achieved (parataxis)
individuals sensitive (amod)
phase deglutition (nmod)
hcl cinacalcet (compound)
treatment pain (nmod)
caused stz-icv (nmod)
model nephropathy (nmod)
related directly (advmod)
instituted was (auxpass)
area m (compound)
regimens between (case)
tested fucoidan (advmod)
cause loss (dobj)
absence , (punct)
describes article (nsubj)
k period (nmod)
collected available (conj)
moderate toxicity (nsubj)
receptor adrenoceptor (conj)
exhibited group (nsubj)
had determined (advcl)
extensive lesions (nsubj)
clonidine role (conj)
disappeared stopping (advcl)
changes greater (amod)
allele mutation (dep)
monitoring unit (nmod)
instilled bladder (nmod)
mouth patient (nmod)
determine increases (ccomp)
failed , (punct)
myocardium infarcted (amod)
met criteria (nmod)
severe cumulative (conj)
enhancement antagonist (compound)
later week (nmod:npmod)
risk torsades (nmod)
treatment diuretic (amod)
interpretation result (dep)
anesthesiologists of (case)
dosing period (conj)
rates pathogens (nmod)
prolongation bradycardia (appos)
any cancers (nmod)
mpa dmcm (conj)
administration etoposide (nmod)
tolerate , (punct)
elevated were (cop)
1.3 it (nsubj)
sweating anxiety (conj)
declined sharply (advmod)
occurred movements (nsubj)
involvement valve (compound)
56.8 11.8 (conj)
ethinylestradiol cpa/ee (appos)
referred . (punct)
movements in (case)
prevent cure (conj)
crea mumol/mg (compound)
reactions suspected (amod)
determined to (mark)
guidelines alternative (nmod)
% weeks (conj)
blocker central (amod)
knife the (det)
suffered effects (dobj)
assessment noninvasive (amod)
implanted surgically (advmod)
groups non-drug (appos)
shr 30 (nummod)
alternative valuable (amod)
play formation (nmod)
treatment d-penicillamine (compound)
cefotetan prophylactically (advmod)
rotation this (det)
fasting levels (dobj)
cholinergic deficit (conj)
practice therapy (compound)
hepatitis combination (nmod)
presence micrograms (nmod)
1 radiation (nmod)
examination electrodiagnostic (amod)
abundance alpha-enac (nmod)
suggest alteration (ccomp)
associations for (case)
cb acid (appos)
hag in (case)
higher 0.001 (appos)
media tested (amod)
buffers % (conj)
concentration tacrolimus (compound)
had protrusions (dobj)
approach comprehensive (amod)
emotions happiness (dep)
receptors glutamate (amod)
infusion nitroprusside (nmod)
discontinuation therapy (nmod)
safety high- (nmod)
limits just (advmod)
patchy , (punct)
incident initial (amod)
accident or (cc)
treated who (dobj)
rate resulting (acl)
required month (nmod:tmod)
cells estrogen-induced (amod)
extremity the (det)
frequent analysis (nmod)
depletion ) (punct)
form hypertension (nmod)
80.0 % (dep)
improves outcomes (dobj)
depressions occurring (acl)
remission withdrawal (nmod)
show changes (dobj)
p at (case)
fluids of (case)
102 of (case)
pilocarpine muscarinic (amod)
measured technique (nmod)
aminonucleoside shr (nmod)
occurred case (nsubj)
mean time (conj)
precursor no (nmod)
animals six (nummod)
transformation exencephaly (nmod)
incidents both (det)
genotyped patients (nsubjpass)
haemorrhage induced (acl)
i.c.v ) (punct)
population evaluable (amod)
% 7.7 (nummod)
signs depression (nmod)
frequencies to (case)
segments eyes (nmod)
own its (nmod:poss)
screened cases (nsubjpass)
predominant lung (compound)
estimated should (aux)
possible most (advmod)
preparation of (case)
matter white (amod)
preparations isolated (amod)
significant this (nsubj)
hyperprolactinemia changes (conj)
points specific (amod)
8) 24 (conj)
flutamide receptor (compound)
university-affiliated , (punct)
program maintaining (acl)
lungs kidneys (conj)
1.3 were (cop)
bodies myelinoid (amod)
sap ) (punct)
change average (amod)
obliterans bronchiolitis (compound)
performance mouse (compound)
h discontinuation (nmod)
stage choriocarcinoma (nmod)
midazolan and (cc)
0.93 to (dep)
angiograms carotid (compound)
smoking and (cc)
craniotomy clipping (nmod)
proven bacteriologically (advmod)
slowing velocity (nmod)
stress pain (conj)
centre referral (compound)
regimen active (amod)
simultaneously or (cc)
artery vertebral (amod)
suspect a (det)
differentiation paradigms (nmod)
patients ninety (nummod)
hypertension oedema (nmod)
received smoking (advcl)
side-effects sedation (appos)
saline olive (conj)
14 3 (conj)
300 200 (compound)
% 138 (nummod)
dose micrograms.kg-1.min-1 (conj)
1.9 0.9 (conj)
provision substrate (nmod)
requiring resuscitation (dobj)
function swallowing (amod)
months two (nummod)
predict risk (ccomp)
comparing vnr (dobj)
function neuroprotection (conj)
patients accidents (nmod)
man cocaine-dependent (amod)
undergone have (aux)
replacement extensive (amod)
n=2.8+/-1.09 ( (punct)
play anions (nsubj)
h postoperatively (advmod)
relaxation endothelial-dependent (amod)
group g/cm(2 (appos)
suggested , (punct)
workup reaction (compound)
loads mono-infected (nmod)
reported cough (nsubjpass)
fatal % (conj)
12 10 (conj)
reversion and (cc)
rg1 mg/kg (appos)
monitoring ) (punct)
administration diltiazem (nmod)
comprised study (nsubj)
children test (conj)
likely they (nsubj)
298+/-7 139+/-36 (conj)
studied been (auxpass)
delivery until (case)
received study (nmod)
anemia woman (nmod)
seemed higher (xcomp)
cnsb002 , (punct)
consumption children (nmod)
di- and (cc)
program ( (punct)
350 ( (punct)
thirty-nine % (appos)
adenosine hypersensitivity (nmod)
kg-1 mg. (compound)
amount total (amod)
measurements : (punct)
translate regimens (nmod)
movements breathing (compound)
infusion amphotericin (compound)
oxygen of (case)
nine 15 (nmod)
saralasin rats (nmod)
induced dyskinesia (dobj)
state induced (acl)
leucemia with (case)
dyscrasias described (acl)
two almost (advmod)
changes first (amod)
tablets lifetime (compound)
value its (nmod:poss)
symptoms disease (nmod)
mitochondria the (det)
expand routes (nmod)
fetus and (cc)
preparation the (det)
therapy glyburide (compound)
subtle often (advmod)
weakness atrophy (conj)
evidenced this (nsubjpass)
shivering of (case)
re-started they (nsubjpass)
oil corn (compound)
fibrillation intractable (amod)
1,2-dimethylhydrazine mg/kg (appos)
agent by (case)
cycloheximide pre-test (amod)
case hypotension (nmod)
resolved later (advmod)
expected . (punct)
trial have (acl:relcl)
age-dependent long-term (dep)
training to (case)
potentiation long-term (amod)
ufh to (case)
persisted recovery (nmod)
gfr ( (punct)
ameliorated which (nsubjpass)
5-fluorouracil high-dose (amod)
years eight (nummod)
prevents nephrotoxicity (dobj)
exerts caa (nsubj)
study active-w (compound)
infiltrate interstitial (amod)
raised infants (conj)
thickness sheath (compound)
modulated may (aux)
ng/ml of (case)
determining important (ccomp)
0.06 0.8 (conj)
screening hg (dobj)
sensitizing tissues (dobj)
noted however (advmod)
presence calculi (nmod)
woman chinese (amod)
given ceftriaxone (xcomp)
asked and (cc)
15 7.5 (compound)
content headache (nmod)
volume enzyme (compound)
death ami-induced (amod)
increase concentration (nmod)
rats high (amod)
limitations evidence (appos)
facilitates . (punct)
ester cholecystokinin (compound)
achieved weeks (nmod)
stages and (cc)
caused likely (advmod)
animals killed (acl)
compared sph (nmod)
metastases marrow (amod)
cases 50 (nummod)
neuropathies optic (amod)
includes patients (dobj)
clonidine micrograms/kg (appos)
ctni to (case)
therapy zidovudine (conj)
drugs atropine-like (amod)
documented elevation (nsubjpass)
ranitidine for (case)
received ] (punct)
unknown are (cop)
comment 29 (conj)
activity high (amod)
pattern the (det)
increased survived (advcl)
patients methylprednisolone (dep)
unaltered excretion (nsubjpass)
teratogenic may (aux)
had gallstones (dobj)
bladder the (det)
show useful (ccomp)
demonstrated deterioration (nsubj)
correspondence a (det)
divided crocins (conj)
anemia fanconi (nmod:poss)
juice or (cc)
velocity maximum (compound)
naproxen to (case)
syndrome microangiopathy (conj)
immunoreactivity . (punct)
variation systolic (amod)
done admitted (dep)
follows were (cop)
anthracyclines irradiation (conj)
right on (case)
content nh3 (compound)
cases bradyarrhythmia (nmod)
selegiline on (case)
offers , (punct)
increase monooxygenases (nmod)
area between (case)
fasciculations observed (amod)
all values (nmod)
decrease levels (nmod)
preparations dangerous (amod)
present patients (nmod)
suxamethonium 100 (nummod)
1-receptor in (case)
mechanisms important (amod)
hearts hypertrophic (amod)
5.64 0.18 (conj)
oxidation transport (conj)
recommendations and (cc)
produced treatments (nsubj)
demonstrated this (nsubjpass)
medications concomitant (amod)
genotypes in (case)
revealed controls (nsubj)
administration acid (compound)
88.1 +/- (cc)
therapy morning (conj)
markers without (case)
suggest increased (ccomp)
occurred often (advmod)
infections tissue (compound)
mumol/kg 10 (nummod)
0 30 (prep)
occlusion arterial (amod)
resolved promptly (advmod)
higher level (nsubj)
prevented l-sotalol (nsubj)
tested method (nmod)
lesions severe (amod)
reversal models (nmod)
acne severe (amod)
role anemia (nmod)
function transmission (nmod)
inputs transmitted (acl)
agent both (cc:preconj)
sprague-dawley strains (conj)
verbal either (cc:preconj)
crocins 4 (conj)
mechanisms disorders (nmod)
anatomical histological (conj)
had decreases (dobj)
evaluated x-ray (nmod)
iq memory (conj)
develop depression (dobj)
group 2 (conj)
hematocrit or (cc)
found significance (nsubjpass)
eyes headaches (nmod)
subjects matched (amod)
transplantable in (case)
patients individual (amod)
component therapy (nmod)
scale computerized (amod)
randomized meta-analyses (dep)
identified . (punct)
hcfcs 124 (conj)
detected adducts (dobj)
addition intake (nmod)
developed petechiae (dobj)
implicated risperidone (conj)
glycosuria g/day (dep)
bortezomib , (punct)
randomized prospective (dep)
harmful to (mark)
fracture the (det)
induced compared (prep)
incorporation in (case)
optic bilateral (amod)
antagonist factor (compound)
substantiates causing (advcl)
reversal administered (dep)
53 to (dep)
developed animals (nsubj)
increased binding (dobj)
% prilocaine (compound)
recommend ect (nmod)
those groups (nmod)
hospital a (det)
done number (nsubjpass)
bche a (det)
tremor rest (compound)
i.v. saline (compound)
algorithm the (det)
risk cancer (nmod)
ill to (mark)
t ctnt (appos)
high bp (nsubj)
median months (nmod)
cluster with (case)
doxil starting (dep)
leading termination (nmod)
inhibit finally (advmod)
oxidation fatty (amod)
reports increasing (amod)
dilated cells (nmod)
experiment given (dep)
ratio urine (compound)
10(-3 12.1 (nummod)
care the (det)
injecting potassium (dobj)
2.35 of (case)
tlr4 ) (punct)
injection propofol (nmod)
documented models (nmod)
effect sensitivity (nmod)
corrected although (mark)
blocked seizure (xcomp)
not or (cc)
cyclophosphamide risks (conj)
cocaine-dependent in (case)
10(-5 3.6 (nummod)
gentamicin kanamycin (conj)
diabetic old (amod)
series pattern (nsubj)
conclusion documented (dep)
produced hypoventilation (nmod)
arterial without (conj)
possibility associated (ccomp)
5.6 +/- (cc)
enzyme this (det)
idiosyncratic an (det)
dose followed (acl)
sgk1(+/+ of (case)
spasms infantile (amod)
remissions partial (amod)
lna+hca ( (punct)
summarized article (nmod)
vip-/- ( (punct)
indicated reduced (ccomp)
days 2.6 (nummod)
associated hypotension (nmod)
ligands h(3)-receptor (compound)
monohydroxyethylrutoside flavonoid (compound)
p58 ) (punct)
21/63 with (case)
study non-randomized (amod)
inhibitors p-450 (compound)
distribution racial (amod)
hg was (cop)
alteration change (nmod)
facilitate as (advmod)
risk higher (amod)
pacemakers these (det)
entered programme (nmod)
adults undergoing (acl)
acts differently (advmod)
degeneration hypertrophy/cytomegaly (conj)
dose greater (amod)
happiness ) (punct)
3.0 0.2 (conj)
effects morphine (nmod)
hyperactivity of (case)
contraindication no (det)
mg/kg . (punct)
reducing climbing (dobj)
osmolality compared (case)
lists and (cc)
olanzapine versus (cc)
saw we (nsubj)
observation status (nmod)
continued therapy (nsubjpass)
errors avoided (acl:relcl)
studies limited (amod)
moderate-dose 25.6 (nummod)
suggests effective (ccomp)
found comparing (advcl)
herbicides of (case)
investigated microg/kg/min (nsubjpass)
compared counterparts (nmod)
accumulation and (cc)
lnna from (case)
multivitamin acid-containing (amod)
discontinued completely (advmod)
scanner pet (compound)
time appt (appos)
gain . (punct)
receptors functional (amod)
august 28 (nummod)
seizure-prone wsp (appos)
pretreatment dose (nmod)
effects anti-oxidant (amod)
found sclerosis (nsubjpass)
leukocyturia age (conj)
drowsiness confusion (conj)
produces , (punct)
indicate this (nsubj)
infusion 6-hour (nummod)
evaluation post-therapy (compound)
reversed ramh (nmod)
presented when (advmod)
sclerosis ssc (appos)
pleased . (punct)
bolus mg/m2 (compound)
increments in (case)
hallmarks , (punct)
54 % (appos)
cellularity increased (amod)
roots and (cc)
fluorescein use (nmod)
alfentanil the (det)
effect ppa (nmod)
aware interaction (nmod)
reactions injection (conj)
extrusion cells (nmod)
lesions mimicking (acl)
case discussed (acl)
implications using (advcl)
1.98 +/- (cc)
signs change (conj)
determined iopromide (advmod)
diseases renal (amod)
reduced compared (prep)
response affected (amod)
ketoprofen either (cc:preconj)
damage early (amod)
atrium m2 (nmod)
mydriasis such (case)
values lvef (nmod)
10(-7 without (conj)
variability qtc (compound)
nebulized continuously (advmod)
incidences 461 (nummod)
aggravate . (punct)
doses mesna (compound)
conclusions a (det)
partial either (cc:preconj)
suffer . (punct)
state the (det)
reports review (conj)
nitroprusside during (case)
seen risk (nsubjpass)
analysis kidneys (nmod)
activity enzymatic (amod)
notable were (cop)
medulla adrenal (amod)
5-ht and (cc)
day third (amod)
finding an (det)
analogue nucleotide (compound)
organisms % (conj)
common cases (nmod)
initiation sedation (nmod)
shown . (punct)
arrhythmia cardiac (amod)
low-dose ( (punct)
arabic gum (compound)
developed administered (conj)
current of (case)
gamma-hch to (case)
occur states (nmod)
motor to (case)
study noncompliance (dep)
behavior , (punct)
interneurons npy-immunoreactive (amod)
failed vagotomy (nsubj)
conjunction pericarditis (nmod)
exerted as (mark)
reported increases (nsubjpass)
screenings women (nmod)
determined decrease (nmod)
administration mice (nmod)
believed was (auxpass)
discusses . (punct)
exposed drug (nmod)
function regional (amod)
1990s in (case)
t % (dep)
resonance magnetic (amod)
chloroprocaine as (case)
given accidentally (advmod)
difficult achieved (conj)
conducting trials (dobj)
one-tenth about (advmod)
leukocyturia l (conj)
prolong action (nsubj)
phosphate of (case)
vasopressin contributor (nmod)
case poisoning (nmod)
limitation is (cop)
dependent ) (punct)
administered administered (conj)
ibs in (case)
activity suxamethonium (nmod)
triphosphate adenosine (amod)
taking mesna (dobj)
nifedipine cd-832 (conj)
effect therapy (conj)
reaction well-recognized (amod)
ikr and (cc)
reaction site (nmod)
volume lower (amod)
hydrochloride bupropion (compound)
supplied subjects (nsubj)
changes acute (amod)
had obtained (conj)
admitted hospital (nmod)
gene the (det)
literature from (case)
weeks 6 (dep)
novo de (compound)
infection follow-up (nmod)
induction ovulation (compound)
took . (punct)
follow closer (amod)
point 8-week (amod)
course chemotherapy (nmod)
observed hours (nmod)
antagonize effects (dobj)
concentrations methotrexate (compound)
determined as (advmod)
reduce infusions (nsubj)
i with (case)
recommend , (punct)
improve : (punct)
well he (nsubj)
filaments von (compound)
sensitive proteins (nmod)
starting titrating (conj)
observed pressure (nmod)
fractures stress (compound)
phases in (case)
effect maximum (compound)
likely nephropathy (nsubj)
afl ) (punct)
imaging myocardial (amod)
thickness anterior (amod)
condensed dextran (nmod)
potentials pacemaker (compound)
those enrolled (acl)
patients 30 (nummod)
year by (case)
motionless . (punct)
weeks 8 (nummod)
measured rate (nsubjpass)
thrombosis carotid (compound)
dose feedback (compound)
dextromethorphan isomer (appos)
lipopolysaccharide , (punct)
showed further (advmod)
na-k-atpase the (det)
22.77 +/- (cc)
placebo 126 (nummod)
breaks min (compound)
one them (nmod)
-26 15 (conj)
anticoagulant implemented (amod)
study mesenchymal (compound)
factor brief (compound)
la elevated (amod)
occurred exposure (nmod)
propranolol receptor (compound)
symptoms of (case)
score mean (amod)
suggested it (nsubjpass)
farmer 55-year-old (amod)
consisted reactions (nsubj)
lesion inferior (amod)
ece-1 ) (punct)
minimum % (nmod)
acid taurodeoxycholic (amod)
polytherapy regimen (nmod)
avp plasma (compound)
respectively p (dep)
taken be (auxpass)
accumulation doses (nmod)
3.9 0.9 (conj)
caused increase (dobj)
preexposure that (mark)
tachycardia beats (conj)
transport to (mark)
armrest an (det)
while mg/kg (nmod)
populations and (cc)
damage renal (amod)
drug anticholinergic (amod)
accounted . (punct)
11 to (dep)
subsides factors (nsubj)
signs to (case)
studied clip (conj)
onset or (cc)
cases 39 (nummod)
fluid balance (conj)
worsened symptoms (dobj)
behaviors administration (nmod)
had overflow (nmod)
advocate prophylactically (advmod)
needle through (case)
studies neuropsychological (amod)
symptoms : (punct)
-21.3 and (cc)
linked involved (advcl)
toxicity hepatic (amod)
increased recovery (nmod)
investigated effects (nsubjpass)
june from (case)
service emergency (compound)
scene the (det)
bilirubin 3.89 (nummod)
common correlated (conj)
scotoma with (case)
appeared severe (xcomp)
katona isbell (conj)
studied properly (advmod)
criteria regurgitation (dep)
disease maternal (amod)
stimulation behaviour (compound)
external skeletal (conj)
sd maximum (dep)
indication for (case)
model be (cop)
forearm of (case)
h per (case)
type neither (cc:preconj)
subtherapeutic levels (nsubj)
administered withdrawal (nmod)
blocked were (auxpass)
macrophages in (case)
0.0010 + (cc)
cause important (amod)
traits 2 (nummod)
level % (compound)
suggest suggest (advcl)
muscles posterior (amod)
reported effects (nmod)
detected filling (nsubjpass)
phenomenon a (det)
determined spread (nsubjpass)
reduced but (cc)
mediates origin (dobj)
10 micrograms/kg/min (dep)
neurons ventrolateral (amod)
death cardiomyocyte (compound)
injected addition (nmod)
omd ) (punct)
5 only (advmod)
12 ( (punct)
movements muscle (compound)
preferred ergotamine/caffeine (dobj)
mg n=10 (appos)
pco2 , (punct)
immunoglobulin or (cc)
exposure childhood (compound)
rare manifestations (nsubj)
patient affected (acl)
gpi the (det)
bn mg/kg (appos)
cck-8-se cck-8-ns (conj)
beginning azithromycin (dobj)
study family (nmod)
reported hypoplasia (nsubjpass)
implicated ciprofloxacin (conj)
noted frequency (nsubjpass)
number greater (nmod)
cardiotoxicity p (dep)
shown profiles (nsubj)
affect . (punct)
control below (case)
imaging magnetic (amod)
sevoflurane with (case)
analysis autoradiographic (amod)
recruited followed (advcl)
changes measures (nmod)
1.3 ( (punct)
randomized design (nmod)
behavior confusion (conj)
% catarrhalis (appos)
persisting fibrillation (dobj)
infusion min (conj)
needle pain (conj)
reflexes in (case)
sulphasalazine arthritis (nmod)
developed previously (advmod)
accumulation pethidine (nmod)
impact mutations (nmod)
neurosteroids memory-enhancing (amod)
suxamethonium mivacurium (conj)
designed that (nsubjpass)
demonstrating patient (nsubj)
membranes into (case)
days morphine (nmod)
changes involvement (conj)
catalepsy into (case)
circumstantial are (cop)
cells on (case)
zidovudine of (case)
occupancy subjects (nmod)
inhibits inhibitor (nmod)
scr of (case)
activity in (amod)
children adhd (nmod)
draw findings (nmod)
had patients (advcl)
reviewing by (mark)
influenced development (dobj)
increased therapy (nmod)
overdose with (case)
melatonin by (case)
echocardiography at (case)
ratio therapeutic (amod)
rotation amphetamine-induced (amod)
seen interfere (xcomp)
induced dl-sotalol (nmod)
presence degree (conj)
danger unrecognised (amod)
was a (dep)
leading dilatation (nmod)
neonates in (case)
taking days (nmod)
enlargement liver (compound)
vancomycin with (case)
hospital arabia (appos)
report torsade (nmod)
weaker was (cop)
estimated making (advcl)
gm given (case)
91 than (quantmod)
sedation pediatric (amod)
values resting (amod)
csa and (cc)
mg p=0.003 (dep)
stomatitis hand-foot (conj)
crf or (cc)
tolerant combinations (nmod)
sensitivity postsynaptic (amod)
role enlargement (nmod)
morphine between (case)
reticulum rough (amod)
change progressed (acl)
receptor d-1 (compound)
patients gemfibrozil (conj)
87.1 55.6 (compound)
ratio body (compound)
recommended restricted (ccomp)
disturbances myocardial (amod)
dgc ( (punct)
improvement only (advmod)
evaluation audiologic (amod)
parameters pharmacokinetics (compound)
control to (case)
prescribed combination (nmod)
40 % (dep)
containing etoposide (dobj)
gtn ( (punct)
affected % (dobj)
met patients (nmod)
incidence formation (nmod)
presence ethanol (nmod)
fluency , (punct)
tolerated granisetron (nsubjpass)
exhibited relationship (dobj)
hexabrix ioxaglate (appos)
hematologic of (case)
chance by (case)
angina unstable (amod)
reviewed extensively (advmod)
transducer of (case)
stabilize to (mark)
skf-82958 for (case)
hypoventilation because (case)
mol/l. concentrations (dobj)
hemisulfate of (case)
found associated (xcomp)
cases 163 (nummod)
evoked only (advmod)
control such (predet)
administration only (advmod)
moderate large (conj)
woman 57-year-old (amod)
proliferated and (cc)
lack is (cop)
showed gains (dobj)
recommended administration (nsubjpass)
remained permeability (nsubj)
minimize effects (dobj)
phenomena from (case)
injected cycloheximide (conj)
clopidogrel the (det)
decreased ) (punct)
microinjected accumbens (nmod)
rs6693503 rs4912138 (conj)
potency metoprolol (nmod)
fatigue being (cop)
% 0.75 (nummod)
regard change (nmod)
pressures with (case)
correlates decrease (nsubj)
identified been (auxpass)
hypercalcemia and/or (cc)
antagonist angiotensin (compound)
something burning (acl)
controls death (dobj)
areas body (nmod)
analogue visual (amod)
sn in (case)
electrocardiogram of (case)
axis across (case)
% 54 (compound)
gave was (conj)
have inflammation (dobj)
continue , (punct)
antibody igg (compound)
sgk1(+/+ ) (punct)
resulted c (dep)
paper present (amod)
rtms ( (punct)
1.5 to (quantmod)
difference values (nmod)
contributes hypertension (nmod)
channel to (case)
hypokalemia hypocalcemia (conj)
exhaustion and (cc)
decreased and (cc)
serious clinical (dep)
paracetamol p (appos)
reduction a (det)
nr1(neo-/- ( (punct)
used c57bl/6j (nsubjpass)
suitable dronedarone (nsubj)
given once (advmod)
gliomas malignant (amod)
humans in (case)
dyskinesia induced (amod)
preload in (case)
makes . (punct)
cirrhosis compensated (amod)
worst showed (conj)
dogs conditions (nmod)
loss allograft (nmod)
blockade ganglionic (amod)
days 1400 (nmod)
alpha5 subunits (conj)
pupillometer infrared (amod)
bupivacaine glucose (nmod)
hypothermic moderately (advmod)
assess contribution (dobj)
infections all (det)
investigated neuropathology (nsubjpass)
beginning after (case)
frequent early (conj)
antigens ex (amod)
practiced remains (advcl)
correlation a (det)
potentiation the (det)
changes mental (amod)
analysis minimal (amod)
sub-regions in (case)
complication related (amod)
hyperlipoproteinemias for (case)
trial placebo-controlled (amod)
nephropathy diabetic (amod)
demonstrated etoricoxib (nsubj)
0.38 ) (punct)
subjects forty (nummod)
4.9 1.3 (compound)
substrate is (cop)
became severe (acomp)
stimulation cns (compound)
similar toxicity (nsubj)
b6 vitamin (compound)
convulsions local (amod)
drugs by (case)
contribute although (mark)
jaundice associated (acl)
medium of (case)
fluconazole tdp (conj)
coadministered was (auxpass)
report literature (compound)
cocaethylene they (nsubj)
hyperprolactinemia drug-induced (amod)
resistance insulin (compound)
methadone and (cc)
group subjects (appos)
periphery in (case)
build-up 24 (dep)
pressure produced (acl)
rats sd (compound)
assess perfusion (dobj)
stress rats (nmod)
starting diagnosis (nmod)
recognized poorly (advmod)
lignocaine plain (amod)
therapy who (nsubj)
oxygenation tissue (compound)
observed content (nmod)
p40 ) (punct)
added heparin (nsubjpass)
increase model (nmod)
findings suggestive (acl:relcl)
iii-v ( (punct)
bche plasma (compound)
tests in (amod)
22,875 celecoxib (acl)
boys two (nummod)
indicate started (ccomp)
implicated changed (conj)
discharges high-amplitude (amod)
transducer transcription (conj)
known remains (conj)
diarrhea mild (conj)
states emotional (amod)
induction in (case)
indicative role (nmod)
jj either (cc:preconj)
veralipride of (case)
resolve symptoms (nsubj)
inhibitor combined (acl)
results assessed (dep)
diazinon , (punct)
fluoroquinolone a (det)
infections to (case)
extremities , (punct)
bladder with (case)
bulb of (case)
decreased l-dopa (nsubj)
included ; (punct)
injection last (amod)
outcome day (nmod)
vcug of (case)
ecg in (case)
thyroxine simvastatin (conj)
relationship changes (nmod)
follow that (mark)
occur but (cc)
nmda and (cc)
removed minutes (nsubjpass)
chow and (cc)
deficiency due (case)
radiopharmaceutical based (acl)
125 and (cc)
period throat (conj)
injected end (nmod)
brain to (case)
wk jaundice (compound)
database adverse (amod)
injection 131i-hsa (appos)
established were (auxpass)
likely likely (advcl)
magnitude that (nsubj)
zidovudine , (punct)
resistance in (case)
brought falls (conj)
norepinephrine epinephrine (conj)
leading alteration (nmod)
patients hypercalcemias (nmod)
spectrum the (det)
pain musculoskeletal (amod)
selected random (nmod)
regulator growth (compound)
had enalapril (nsubj)
known bind (xcomp)
volume days (nmod)
infants gestation (nmod)
case optic (nmod)
pgp ( (punct)
releasing by (mark)
recurrence polyps (nmod)
raises this (nsubj)
stimulating tonically (advmod)
hygiene wear (conj)
prazosin ( (punct)
suppresses has (conj)
described complication (nmod)
levels c3 (compound)
seizures than (case)
drinkers pregnant (amod)
mellitus iddm (appos)
indicate block (ccomp)
used rats (nsubjpass)
maze passive (conj)
rash retarded (amod)
terms frequency (nmod)
t(1/2 ( (punct)
one neurosteroids (nmod)
reversal drugs (nmod)
recurrence and (cc)
elevations minor (amod)
occurred evident (conj)
activity seizure (amod)
population lozenge (appos)
assay a (det)
2 and (cc)
high-dose both (cc:preconj)
837 +/- (cc)
unresponsive are (cop)
courses three (nummod)
demonstrated elevated (ccomp)
underlying protocols (dobj)
preceded days (nmod)
ocd to (case)
found they (nsubj)
pronounced more (advmod)
intensity peak (compound)
> 0.05 (nummod)
induced spasm (nsubjpass)
decrease except (case)
administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (dobj)
17beta-estradiol oil (conj)
related mainly (advmod)
saline tdi (nmod)
threshold and (cc)
sulfate drug (compound)
assessed placement (nmod)
reserpine depletor (compound)
complex system (nmod)
restoration complete (amod)
onset acidosis (conj)
mg/kg mg/lb (dep)
reported required (parataxis)
none group (nmod)
1a renal (amod)
behavior ( (punct)
infections cytomegalovirus (compound)
urea creatinine (conj)
agents both (det)
medium iodixanol (conj)
exchange plugs (nmod)
safety enalapril (nmod)
factor taken (advcl)
lateral and (cc)
respiration spontaneous (amod)
p " (punct)
decreased mmhg (conj)
observed revealed (parataxis)
stress and (cc)
rhabdomyosarcoma for (case)
deterioration symptoms (nmod)
third-generation in (case)
high treatment (nmod)
control an (det)
present correlate (conj)
have sensitivity (dobj)
terminals of (case)
easy prepare (xcomp)
stopped that (nsubj)
anuria repeated (amod)
compared thiopentone (nmod)
immunosuppression clinical (nmod)
described case (nsubjpass)
restriction of (case)
counts mast (compound)
had meeting (ccomp)
altered indicating (xcomp)
claws biting (conj)
control treatment (nmod)
events cd4 (conj)
extubated , (punct)
nephritis tubulointerstitial (amod)
mice 8-week-old (amod)
or 0.27 (nummod)
background exposed (appos)
found insula (nmod)
sedation . (punct)
failed acquire (xcomp)
supplementation by (case)
occurrence pain (nmod)
chloroprocaine for (case)
implicated unclear (advcl)
history a (det)
reported studies (nsubj)
evidence reported (amod)
result binding (nmod)
n=834 ) (punct)
addressed to (mark)
disease crohn (nmod:poss)
saline % (appos)
applications consecutive (amod)
verapamil after (case)
attenuate and (cc)
performed performance (nmod)
diuresis alkaline (compound)
tachyarrhythmias resistant (amod)
ratios albumin/creatinine (compound)
measured immunoassay (nmod)
pregnancy twin (amod)
clinic infertility (compound)
neural their (nmod:poss)
mellitus with (case)
2002 07 (prep)
inactivating effects (dobj)
phase early (amod)
durations , (punct)
33 versus (cc)
disorders cerebellar (amod)
receptors trks (appos)
comparison range (nmod)
included age (conj)
pathophysiology psychosis (nmod)
induce infarction (dobj)
use addiction (nmod)
ovale foramen (compound)
reflection , (punct)
strain mice (nmod)
pain foot (compound)
rates presumed (acl)
pretreatment diphenhydramine (nmod)
methscopolamine neostigmine (conj)
man healthy (amod)
elicit drug (nsubj)
potentiated , (punct)
5711 284.9 (conj)
uptake for (case)
6.7 0.6 (conj)
ht ) (punct)
oxytocin to (case)
prevention retrieval (nmod)
group 6 (nummod)
distorted slightly (advmod)
depend interval (nmod)
correlated findings (nmod)
hypercalcemia severe (amod)
fluoxetine given (acl)
idm ( (punct)
ataxia to (case)
electroencephalogram eeg (appos)
increases rigidity (nmod)
symptoms concomitant (amod)
had disorder (conj)
given diet (nmod)
increase scr (nsubj)
confirm correlation (dobj)
sensitive very (advmod)
hours , (punct)
rise albumin (nmod)
tetrapeptide the (det)
depression for (case)
counseling dietary (amod)
stopping drug (dobj)
% confirmed (conj)
me ( (punct)
nsclc in (case)
composite was (cop)
volume total (amod)
group non-pretreatment (amod)
have desensitization (nmod)
alter tendency (dobj)
found umax (nsubjpass)
increased or (cc)
1 less (advmod)
beraprost analogue (compound)
declined hours (nmod)
se lithium-pilocarpine-induced (amod)
assess implications (dobj)
octreotide analog (compound)
from 2387 (nmod)
fluid along (case)
66.9 range (dep)
iiib or (cc)
produced n=5 (advcl)
endpoint to (case)
peak early (amod)
norway brown (compound)
parkinson unified (compound)
have that (mark)
diseases occurs (acl:relcl)
anaesthesia following (case)
undergone 1999 (dep)
akathisia . (punct)
suspicion the (det)
virus compared (case)
designed similarly (advmod)
evidence neuropathy (nmod)
patients 154 (nummod)
tests transformation (compound)
possibilities the (det)
placebo ; (punct)
consumption , (punct)
shown patients (nsubj)
doses compared (case)
2 to (dep)
determination their (nmod:poss)
pretreatment of (case)
improved therapy (nmod)
reports included (acl:relcl)
value misoprostol (nmod)
cranial larger (amod)
ecstasy 3,4-methylenedioxymethamphetamine (dep)
evaluated but (cc)
increase line (nmod)
tolerance poorer (amod)
increased did (conj)
28 2 (conj)
troublesome remained (conj)
november and (cc)
infusion n (dep)
extracted data (dobj)
rule a (det)
found test (nmod)
problem well-known (amod)
pontis , (punct)
attributed this (nsubjpass)
administered period (nmod)
1.55 0.54 (nummod)
occur result (nmod)
patients fatigue (appos)
sought compare (xcomp)
turn in (case)
preexposure gspe (nsubj)
diagnosed patients (nsubjpass)
mediation . (punct)
rate by (case)
described it (nsubjpass)
contexts in (case)
evening in (case)
bilirubin elevated (amod)
leakage bbb (nmod)
subsided . (punct)
decreased p<0.001 (dep)
appear . (punct)
ischemia echocardiography (nmod)
induction apoptosis (nmod)
mg. . (punct)
age 81.1 (nmod)
ascitis increasing (amod)
s , (punct)
investigation of (case)
incidence intensity (conj)
establishment with (case)
anaesthetised min (nmod)
resistant livers (nsubj)
contrast in (case)
analgesic an (det)
stimulation by (case)
increases with (case)
defects associated (amod)
role gunn (compound)
finding protect (ccomp)
support effect (dep)
scattered degeneration (dep)
investigate administration (nmod)
administration theophylline (compound)
drugs from (case)
modulated differentially (advmod)
mean 10(9 (conj)
desire , (punct)
controls participated (acl)
have and (cc)
hilum and (cc)
bn with (case)
months during (case)
aor , (punct)
alterations course (compound)
has , (punct)
interval 8.8 (conj)
gland lizard (amod)
cr 35 (conj)
factors possible (amod)
overdosage hyoscine (compound)
cns ( (punct)
affect actions (dobj)
akathisia including (case)
patients bradykinesia (conj)
capacity his (nmod:poss)
% 26 (nummod)
accelerate intake (nsubj)
returns thromboembolism (nmod)
treatment des (compound)
growth hypertrophic (amod)
ability driving (compound)
increased to (mark)
edema cerebral (amod)
examinations the (det)
cycle in (case)
neurodegeneration neurons (nmod)
model pilocarpine-induced (amod)
used oxygen (dobj)
sexes both (det)
greater ( (punct)
convulsive effects (dep)
delay retardation (conj)
receiving b.w (dobj)
blunted enhanced (conj)
offered should (aux)
analyzer humphrey (compound)
mediate responses (dobj)
defined priori (dobj)
fluctuating pressure (dobj)
anomaly with (case)
complete cases (nmod)
olanzapine of (case)
applied model (dobj)
compliance , (punct)
side-effects local (amod)
norms ' (punct)
assess function (nmod)
activities system (nmod)
referred p11 (nmod)
4.3 0.6 (conj)
unclear contraindication (ccomp)
responses restricted (amod)
cyproheptadine of (case)
toxicity doses (dep)
had obliterans (dobj)
outstretched horizontally (advmod)
appear bind (xcomp)
atropine the (det)
attention little (amod)
suggested block (dobj)
prolactin ( (punct)
treatment metronidazole (compound)
reversible administration (nmod)
sd ci (appos)
numbers penetration (conj)
dose 14 (nummod)
valproate ethosuximide (conj)
added was (auxpass)
e , (punct)
mg/m2 648 (nummod)
bupropion by (case)
indeterminate received (advcl)
plasticity and (cc)
lymphoma follicular (amod)
21 out (advmod)
clarified aspects (nsubjpass)
saralasin by (case)
area sedation (compound)
identical virtually (advmod)
interaction drug (compound)
abnormalities age (conj)
double . (punct)
clinic ophthalmology (compound)
pregnane-20-ones 3 (nummod)
screened be (auxpass)
lower 0.62 (dep)
diet after (case)
pinacidil than (case)
dyskinesias signs (conj)
supplemented been (auxpass)
pretreated acid (nmod)
generalization propagation (conj)
dipyridamole , (punct)
determination hormone (compound)
ii , (punct)
147 +/- (cc)
months endpoints (nmod)
falling ) (punct)
dexmedetomidine of (case)
claimed ameliorate (xcomp)
nafld ( (punct)
sod ) (punct)
administration intravascular (amod)
aneurysms cerebral (amod)
self-dosing pethidine (nmod)
occurring compounds (dobj)
mg or (cc)
disorder particularly (advmod)
groups sh(12 (appos)
trial paclitaxel (nmod)
reduced 2-fold (nmod)
subsides required (ccomp)
oltx ) (punct)
unrelated seizures (nmod)
weeks followed (acl)
patients ones (conj)
toxicity treatment-related (amod)
patients adherence (nmod)
higher if (mark)
behavioral metabolic (conj)
improve response (dobj)
increase myopathies (nmod)
alteration possibly (advmod)
seizures mice (nmod)
daily micrograms (nmod:npmod)
vasodilatation due (case)
cycles , (punct)
anemia caused (acl:relcl)
thiopental by (case)
dgc the (det)
appear deduced (advcl)
depressed but (cc)
techniques brain-mapping (amod)
studied 205 (dep)
myelination and (cc)
hydrochloride ) (punct)
elevated dp/dt (nsubj)
ng/ml t (compound)
child developed (acl:relcl)
reduction ) (punct)
fall pressure (nmod)
ratings behavioral (amod)
administration beraprost (nmod)
evaluated function (nmod)
markers depletion (conj)
recommended therefore (advmod)
tasks on (case)
chloroacetaldehyde reagent (nmod)
increases tremor (nmod)
toxoplasmosis patients (nmod)
tracheotomies given (case)
cases submitted (amod)
month therapy (nmod)
times/week 3 (nummod)
average compared (case)
showed woman (nmod)
targets that (mark)
agonist of (case)
wernicke tolazamide-induced (amod)
facilitate synchrony (dobj)
53 15 (quantmod)
depression st (amod)
shortened significantly (advmod)
caused dogs (nmod)
protein function (nmod)
affect men (nmod)
male patient (nsubj)
triggers pathway (nmod)
lipoprotein and (cc)
failed contrast (nmod)
evaluated open-labeled (nsubj)
tumor only (advmod)
occurred concurrently (advmod)
forms stress (nmod)
period morphogenesis (nmod)
calcitonin human (amod)
females for (case)
% alf (compound)
simvastatinezetimibe escitalopram (conj)
occasion one (nummod)
increase a (det)
0.2 0.25 (conj)
hyperactivity mice (nmod)
evaluated collected (conj)
report pseudo-allergy (nmod)
hit in (case)
interaction cause (nsubj)
nmol ) (punct)
lesions within (case)
10(6 ( (punct)
handicapped under-reporting (nmod)
icp ( (punct)
pathway p53-dependent (amod)
induction to (case)
rate dissolution (compound)
levels acid (compound)
induces as (advmod)
sgot and (cc)
% 2.0 (nummod)
diclofenac , (punct)
associated cases (nsubjpass)
platinum- well-defined (amod)
patients are (cop)
25.6 +/- (cc)
toxoplasmosis in (case)
described were (auxpass)
decreased considerably (advmod)
autism for (case)
dose doxorubicin/kg (dep)
caused types (nmod)
control tachyarrhythmias (nmod)
available information (nsubj)
patients hypertensive (amod)
phases treatment (nmod)
incidence discontinuations (nmod)
c 1975 (nummod)
apart days (nmod:npmod)
gln223 , (punct)
line room (nmod)
rise ng/min (dep)
thrombosis of (case)
exhorted clinicians (nsubjpass)
cycle chemotherapy (nmod)
interacts and (cc)
release upregulation (conj)
mmhg 77 (nummod)
increased cells (nmod)
injury as (case)
causes methamphetamine (nsubj)
users cannabis (compound)
process disease (compound)
observe stimulation (dobj)
positive results (nsubj)
patients taking (acl)
dose p20 (nmod)
similar furthermore (advmod)
rare previously (advmod)
taking years (nmod)
features clinical (compound)
reactions of (case)
improve although (mark)
ikr blockers (conj)
neoplasms and (cc)
training pa (compound)
rat diabetes (compound)
correlate stage (conj)
attenuated clentiazem (nsubj)
responses atrial (amod)
occurs neuroinflammation (nsubj)
varying of (mark)
paclitaxel gemcitabine (conj)
hundred eighty-three (conj)
resection and (cc)
involvement . (punct)
duration changes (nmod)
retention blunted (amod)
determination for (case)
sensitivities greatest (amod)
cessation sulfasalazine (nmod)
salt-sensitivity rats (nmod)
done electroretinograms (nsubjpass)
indicating transport (dobj)
suppresses . (punct)
levels dopamine (nmod)
thrombin amca (conj)
increase slight (amod)
precise magnitude (dep)
improvement p (dep)
need who (nsubj)
complications corneal (compound)
weeks 37 (nummod)
sensitized generation (nmod)
mptp toxin (compound)
treadmill on (case)
serotonergic of (case)
cause patients (nmod)
withdrawal early (amod)
recognized previously (advmod)
peptides tested (acl)
leukaemia t-cell (compound)
steroid this (det)
-2.59 = (amod)
performed also (advmod)
children aged (amod)
cystoscopy outpatient (amod)
cause seizures (nmod)
developed weakness (nsubj)
ketamine- diazepam-induced (conj)
failed bilaterally (advmod)
shunt activity (dobj)
elevation during (case)
dynamics the (det)
tacrolimus with (case)
trough ( (punct)
association surgery (nmod)
assessed bodyweight (nmod)
nephrotoxic medium (nmod)
speculate relation (nmod)
mea from (case)
approaches new (amod)
frequency compared (acl)
mg/kg of (case)
neuritis tacrolimus-associated (amod)
status levels (conj)
prophylaxis ibuprofen (amod)
gradient the (det)
patients glaucoma (nmod)
rrs ( (punct)
caused nelarabine (nmod)
formation glomeruli (nmod)
detection % (nmod)
patients 164 (nummod)
years median (amod)
occurred it (nsubj)
values protective (amod)
demonstrate steroids (nsubj)
conducted methods (dep)
perimenopausal or (cc)
have abnormalities (dobj)
rats 10-weeks-old (amod)
achieved rapidly (advmod)
times cholesterol (compound)
reports arrest (nmod)
administered intervals (nmod)
paroxetine mg (compound)
fastigial unilateral (amod)
treated dose (nmod)
seizure -- (punct)
iu/l and (cc)
weeks study (nmod)
enlarged . (punct)
mellitus type (compound)
offer did (aux)
paralysis dysarthria (conj)
dose 7.0 (nummod)
develop exencephaly (nmod)
% compared (case)
lna resulting (acl)
toxicities patients (conj)
outcomes measures (conj)
indicate effects (nsubj)
cream with (case)
studies all (det)
micrograms ml (nmod)
frataxin , (punct)
pdtc 150 (nummod)
exhibited ] (punct)
discuss mechanisms (dobj)
effect ( (punct)
cisplatin alkaloid (conj)
0.0005 ) (punct)
thrombosis sinus (compound)
remain written (advcl)
affect of (case)
patients those (det)
compared addition (nmod)
indices pbto(2 (compound)
35 - (punct)
phase model (nmod)
dosage levels (conj)
preserve would (aux)
wires sterile (amod)
underwent january (nmod)
safe fluorescein (nmod)
plasma patient (nmod:poss)
years therapy (nmod)
regarded as (prep)
influenced be (auxpass)
group ukpdrg (dep)
showed normal (nmod)
vasospasm infarction (conj)
using hippocampus (nmod)
returned cessation (nmod)
a phase (compound)
expressed be (auxpass)
( [-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ (dep)
risperidone such (case)
decreased naphazoline (nmod)
4/5 ) (punct)
pre-treated melatonin (nmod)
exceeded most (nmod)
glepp1 of (case)
dose pergolide (compound)
inclusion diet (nmod)
features pertinent (amod)
decreased excretion (dobj)
cbd ( (punct)
medication with (case)
survey . (punct)
antagonism and (cc)
susceptibility for (case)
diazepam- scopolamine- (conj)
ctni various (amod)
transitioned he (nsubjpass)
cells drg (nmod)
discontinuation drops (nmod)
cocaine oc (appos)
action effect (nmod)
circuits the (det)
cse ( (punct)
effects main (amod)
increasing rates (dep)
performed determine (advcl)
disturbance the (det)
elderly in (case)
patients psychiatric (amod)
injection sc (compound)
introduction since (mark)
carcinoma prostate (nmod)
operated cholecystitis (nmod)
individuals others (conj)
electrophoresis gel (compound)
latencies s (appos)
continue patients (nsubj)
estimated conditions (nsubjpass)
groups fraction (conj)
passed . (punct)
at least (mwe)
substituted abnormalities (nsubjpass)
study larger (amod)
addressing mr (dobj)
examination allografts (nmod)
action form (nmod)
group asa (compound)
d1 with (case)
consistent mechanism (nmod)
is assess (xcomp)
min injection)+ritanserin (nmod)
prompted conduct (xcomp)
induces seizures (nmod)
those rats (nmod)
disappeared dysosmia (nsubj)
gd 6 (nummod)
delta22-isomer beta-muricholate (nmod)
i.p. ) (punct)
crohn eight (compound)
control control (compound)
ioxaglate ) (punct)
urtication itchiness (conj)
examined authors (nsubj)
published date (nmod)
prl serum (compound)
fluoxetine a (det)
were whether (mark)
apparatus juxtaglomerular (amod)
prognosis long-term (amod)
schema the (det)
received 150 (conj)
fibrillation admitted (acl:relcl)
thrombo-embolism : (punct)
cases to (mark)
decreased mm (dobj)
analogs the (det)
aeroallergens to (case)
32.87 ( (punct)
chat on (case)
result death (nmod)
monitoring intra-arterial (amod)
times 2.5 (nummod)
interaction agents (nmod)
increasing 5 (conj)
parameters score (conj)
behavior motor (compound)
incidence discomfort (nmod)
mg/ml 0.5 (nummod)
neuralgia morton (nmod:poss)
demonstrated stability (dobj)
increased gtn (nmod)
requires finding (nsubj)
confirm findings (dobj)
extent severity (conj)
stent of (case)
received treatment (nmod)
non-biodegradable degradable (conj)
unable urinate (xcomp)
effective medications (nsubj)
middle-aged in (case)
measured pain (dobj)
levels presence (conj)
manifestations toxicity (nmod)
signs are (cop)
proved has (aux)
dysosmia . (punct)
mrd presentation (nmod)
etomidate with (case)
focused now (advcl)
pressure atm (nmod)
failed absence (nmod)
memory immediate (amod)
likely ) (punct)
weighted differences (dobj)
effects in (amod)
used substitutes (nmod)
simulator a (det)
sources medline (dep)
length velocity (conj)
channels cells (nmod)
undertook . (punct)
program an (det)
fraction abnormalities (nmod)
bre-26 , (punct)
quantities measurable (amod)
arabic ml/kg (appos)
episodes patient (nmod)
child of (case)
discontinuation dosage (conj)
% n (dep)
80 36 (quantmod)
appearance dyskinesias (nmod)
other ; (punct)
portion the (det)
pronounced headache (nsubjpass)
support strategy (dobj)
used promote (xcomp)
treated resolved (conj)
response amphetamine (nmod)
drugs neurotoxic (amod)
first , (punct)
therapy hbv (nmod)
anemia macrocytic (amod)
provided is (auxpass)
calculated usually (advmod)
piloerection headache (conj)
played . (punct)
2)% and (cc)
elevated mean (advcl)
effect combining (advcl)
compromise hemodynamic (amod)
antidepressants derived (acl:relcl)
informed well (advmod)
inhibits that (nsubj)
resolved ; (punct)
adjustment by (case)
administrated orally (advmod)
higher od (nsubj)
abnormalities eeg (compound)
side with (case)
risk interactions (nmod)
317 from (case)
biopsy a (det)
two one (compound)
co-administration for (case)
woman-years % (dep)
0.01 < (dep)
curve receiver (compound)
involved changes (nsubjpass)
series between (case)
pattern population (nmod)
results resulted (dep)
excretion renal (amod)
observed rat (nmod)
400 700 (prep)
case arrest (nmod)
documented time (nmod)
manometry 24-h (amod)
macrophages monocyte-derived (amod)
block step (dobj)
deteriotation any (det)
concentrations pathogens (nmod)
appeared nodules (nsubj)
aneurysms all (det)
examined h (dobj)
kidneys fetal (amod)
cause dysguesia (dobj)
given totp (nmod)
treatment methadone-maintenance (compound)
acetate hydrocortisone (compound)
u/ml 12.5 (compound)
fas patients (nmod)
treated meth (nmod)
therapy levodopa (nsubj)
lowered 3 (nmod)
glomerulopathy and (cc)
dependence alcohol (compound)
reversal a (det)
isolated abscess (nmod)
produced cpap (nsubj)
induce hematotoxicity (dobj)
genes multiple (amod)
microscopy light (amod)
is background/aims (ccomp)
made revealing (advcl)
mccarthy dodds (dep)
mtx + (cc)
biosyntheses ribosomal (amod)
unrelated intake (nsubj)
analogues nucleotide (compound)
wall intact (amod)
maintained been (auxpass)
attest . (punct)
pleural pericardial (conj)
relative patients (nmod)
abnormalities by (case)
setting center (dobj)
studies associated (amod)
days discontinuation (nmod)
similar valdecoxib (nmod)
glomeruli than (case)
investigations he-lfb (dep)
mediate may (aux)
induced lithium (nsubj)
analyzed characteristics (nsubjpass)
observed compared (prep)
report no (det)
activity sod (compound)
ato + (cc)
response idiosyncratic (amod)
study reported (acl)
treated ) (punct)
amines biogenic (amod)
herbicides . (punct)
that women (nmod)
contraindicated patients (nmod)
age adult (amod)
gets enzyme (nsubj)
behaviors the (det)
medium at (case)
measured end (nmod)
amine sympathetic (amod)
disease recurrent (amod)
post-cab patients (conj)
reversal hypotension (nmod)
center referral (compound)
hyperglycaemia from (case)
background tested (appos)
success same (amod)
cardiotoxin consequence (conj)
chemotherapy with (case)
improved respectively (advmod)
constituted % (dobj)
course seen (acl)
area mpa (appos)
infusion vehicle (conj)
receptors via (case)
injections pan (compound)
very somewhat (conj)
inhibitor selective (amod)
determined radioimmunoassay (nmod)
schedule 21-day (amod)
disorders ( (punct)
mg/kg cocaine (compound)
confounding residual (amod)
procedure single-placebo-controlled (amod)
13th and (cc)
epilepticus continuous (amod)
planned work (nsubjpass)
epilepsies generalized (amod)
adjusted when (advmod)
ddathf ( (punct)
minutes ; (punct)
observed day (nmod)
reactions pseudo-allergic (amod)
used infusions (nsubjpass)
evoked mice (nmod)
(+/-)-pg-9 s.c. (dep)
use anticonvulsants (appos)
responses dose (nmod)
internists room (conj)
clinical along (case)
interacts adr (nsubj)
comparison . (punct)
increased decreased (conj)
sectioned brains (nsubjpass)
some for (case)
exert , (punct)
differ olanzapine (nmod)
c1 c2 (conj)
gene gh (compound)
encephalopathy syndrome (dep)
had dis-charge (advcl)
angiograms from (case)
finding people (nmod)
used estimate (xcomp)
acids hexauronic (amod)
systemic intrathecal (conj)
desmosomes hemidesmosomes (conj)
hypothesis increase (ccomp)
remain therapies (nmod)
kidneys via (case)
ro4368554 5-ht6 (amod)
ultrasound , (punct)
prolonged bupivacaine (nmod)
leak reversing (advcl)
activation microglial (amod)
toxic be (cop)
program the (det)
functions cardiac (amod)
frequencies consecutive (amod)
few . (punct)
diabetes polyuria (conj)
expectancy life (compound)
phenobarbitone administered (conj)
predict potential (dobj)
treatment parkinsonism (nmod)
based association (nsubjpass)
fatal was (cop)
7 ) (punct)
found decreased (ccomp)
cis-ra administered (acl)
appeared were (conj)
associated serve (conj)
weeks dose (appos)
patient glomerulosclerosis (nmod)
incidence cin (nmod)
potentials , (punct)
presentation an (det)
sequences gradient (compound)
recived patients (nsubj)
88.1 from (case)
maleate . (punct)
b nuclear (amod)
messages da-related (amod)
technique tomography (conj)
ma ) (punct)
lower that (nmod)
attenuated whereas (dep)
mean deviation (appos)
lpp of (case)
scanning angiography (conj)
carolina not (cc)
aorta atresia (conj)
range syndromes (nmod)
thalidomide on (case)
found externa (prep)
studied day (nmod)
configuration oropharynx (nmod)
appeared changes (nmod)
all without (mwe)
stereotypy hyperlocomotion (conj)
1.85 from (case)
infections occurred (acl)
suggest reports (nsubj)
lesions pustular (amod)
has elucidated (xcomp)
reaction has (conj)
distinguish group (dobj)
test radioallergosorbent (amod)
drugs three (nummod)
known was (auxpass)
continue decreased (advcl)
derivative improve (acl:relcl)
sulindac and (cc)
7.6 3.4 (conj)
response scale (compound)
free to (mark)
celecoxib both (cc:preconj)
4 2 (compound)
creatinine preoperative (amod)
monitor neuropathy (dobj)
pressure [ (punct)
best requested (advcl)
suffered therapy (nmod)
interaction human (amod)
ligands other (amod)
2010 december (compound)
exposure steroid (compound)
markers damage (nmod)
apoptosis leukocytes (nmod)
diazepam versus (case)
enrolled osteoporosis (nmod)
number , (punct)
chloride isotonic (amod)
cimd with (case)
levels mhb (compound)
produced implantation (nmod)
shown it (nsubjpass)
rate objective (nsubj)
resistance extension (nmod)
included that (mark)
characteristics effects (conj)
rate resolution (nmod)
choline-devoid choline-supplemented (conj)
allows evaluation (dobj)
associated those (advcl)
improvement slight (amod)
90 more (advmod)
targeted levels (nmod)
limited is (auxpass)
duration use (nmod)
doxorubicin dxr (appos)
ctc-nci toxicities (nsubj)
appear not (neg)
9 ) (punct)
undergoing means (nmod)
inhibiting arrhythmia (dobj)
venlafaxine of (case)
improved time (dobj)
cisplatin receiving (compound)
those than (case)
diagnosis their (nmod:poss)
protein droplets (conj)
seemed there (expl)
development reactions (nmod)
dystrophy reflex (amod)
progression till (case)
condition lead (acl:relcl)
showed similarity (dobj)
neuropathy was (cop)
ap7 microl (appos)
response toxic (amod)
patients chemotherapy (nmod)
anemia 1 (appos)
cx3cr1 ( (punct)
response some (det)
examination ( (punct)
recommenced accidentally (advmod)
model one (nummod)
siadh associated (acl)
addition nicorandil (nmod)
mitochondria specifically (advmod)
paradigm and (cc)
patients relapsed (nmod)
emotion each (det)
pilocarpine-treated untreated (conj)
evidence abnormality (nmod)
taken concomitantly (advmod)
startle fps (appos)
ratios creatinine (compound)
three up (quantmod)
found charge (nsubjpass)
observed patterns (nmod)
increase dox-induced (amod)
understanding coupling (nmod)
sr bupropion (compound)
impaired may (aux)
outcomes with (case)
processed . (punct)
potentials action (compound)
reduces reduces (conj)
gain treatment (nmod)
dehydration activation (conj)
study headache (nmod)
tachycardia reflex (amod)
common groups (nmod)
known interact (xcomp)
site single (amod)
decreased phosphorylation (dobj)
markers diagnostic (compound)
treatment are (cop)
p ; (punct)
expectation in (case)
have agents (dobj)
trials early (amod)
lids of (case)
made reduce (xcomp)
p 0.0001 (nummod)
pb metals (conj)
evinced . (punct)
combination lidocaine (nmod)
highlights fact (dobj)
studied administration (nsubj)
encoding cdna (compound)
145 13 (conj)
exert suggest (conj)
recovered recurrence (nmod)
occlusion rats (nmod)
excess smaller (amod)
ntg ntg (conj)
experience our (nmod:poss)
drive of (case)
hyperglycemia curve (appos)
intent background (conj)
associated moreover (advmod)
aggregation for (case)
-15.4 ) (punct)
substances and (cc)
good good (nmod)
sedatives to (mark)
1 20 (conj)
hyperplasia for (case)
proposal impaired (acl)
signs recovery (nmod)
egfp-microglia unresponsive (amod)
mg/kg 1.5 (nummod)
focused years (nmod)
failed tolerate (conj)
consisted days (nmod)
pcc ) (punct)
accelerate development (dobj)
hmm ( (punct)
reduction g/l (nmod)
weeks on (case)
electrophysiological the (det)
percentage significant (amod)
sinus from (case)
implicated . (punct)
presented period (nmod)
activation nf-kappab (nmod)
infarction % (dep)
ml-1 ) (punct)
48 and (cc)
raise may (aux)
denopamine failure (nmod)
investigating link (dobj)
practice common (amod)
encephalopathy nms-like (amod)
mg 40 (nummod)
ain ( (punct)
= 1.00 (dep)
exhibited = (parataxis)
formation gaps (nmod)
addition total (nmod)
increased mitochondria (nmod)
confined was (auxpass)
15.0 +/- (cc)
titrated using (xcomp)
exerts enhances (parataxis)
mg/kg dose (appos)
toxicity general (amod)
106 4 (conj)
stabilized receiving (xcomp)
myocarditis . (punct)
development tumors (nmod)
neuropathy . (punct)
reported india (nmod)
use angiography (nmod)
transplantation kidney (compound)
performed days (dobj)
cases probable (amod)
therapy penicillamine (compound)
interfere se (advmod)
contributed % (dep)
rats by (case)
rate muscle (compound)
department to (case)
did pretreatment (nsubj)
utility detecting (acl)
3ma plus (cc)
ml per (case)
retention ) (punct)
produced that (nsubjpass)
cytomegalovirus cmv (appos)
opener channels (nmod)
dialysate new (amod)
spasms than (case)
equipotent be (cop)
seizures kindled (amod)
auditory , (punct)
x-ray by (case)
pupils his (nmod:poss)
patients spondyloarthropathy (conj)
dose non-convulsant (amod)
mumol/kg analogues (nsubj)
female % (nsubj)
conclude increases (ccomp)
damages of (case)
had ml (dobj)
study comparative (amod)
seizures srs (appos)
dyskinesias during (case)
number combination (nmod)
proteinuria inhibitors-induced (amod)
inefficient capd (nsubj)
utilized lacking (advcl)
affect particularly (advmod)
exerted which (nmod)
treated seizures (nsubjpass)
arrhythmias doses (nmod)
reducing or (cc)
read protocol (nmod)
ccnu ) (punct)
change co (nmod)
eliminated nephrectomy (nsubj)
was case (attr)
developed obtained (advcl)
restored decreasing (advcl)
shown occur (ccomp)
administration after (conj)
saline doses (nmod)
treatment psychosis (nmod)
controls 1,021 (nummod)
gpi ventral (amod)
protein albumin (appos)
range toxic (amod)
rats permeability (nmod)
penicillins cephalosporins (conj)
prl-r mrnas (conj)
dexmedetomidine dose (compound)
scanner in (case)
effective or (cc)
achieved suppression (nsubjpass)
administered examination (dobj)
involved could (aux)
adriamycinol , (punct)
mice induced (acl)
vas ) (punct)
implicated playing (advcl)
treatment desipramine (nmod)
deletion mtdna (compound)
hypotension groups (nmod)
access(r immunoassay (conj)
set doses (nsubjpass)
estimated content (nsubjpass)
p.o. ( (punct)
users ( (punct)
malformations several (amod)
investigations etiological (amod)
aware fully (advmod)
ischemic origin (nmod)
functions electrocardiography (nmod)
area concentration (nmod)
activated interval (conj)
32.87 /-15.8 (conj)
simultaneously dose-dependently (conj)
gaba(a)rs and (cc)
reproducing of (mark)
anatomic or (cc)
smokers of (case)
related half (nsubj)
85 +/- (cc)
acid also (advmod)
switching regimen (dobj)
system perfusion (compound)
normal above (case)
received 2-chloroprocaine-ce (dobj)
characterized best (advmod)
decrease an (nmod)
, patients (dep)
dimethylthiourea dmtu (appos)
monohydrate creatine (compound)
reviewed part (nmod)
salts acid (compound)
msdbp < (dep)
substituted amb. (nmod)
target assigned (amod)
reported toxicity (nsubjpass)
is still (advmod)
treatment captopril (nmod)
had ) (punct)
frequencies seizure (nsubj)
occurs administration (nmod)
interval percent (compound)
dogs those (conj)
now . (punct)
elevation folate (compound)
mice mice (conj)
doses groups (conj)
stasis prolonged (dep)
1.12 - (punct)
decreased mice (advcl)
admitted recently (advmod)
readmitted was (auxpass)
exercise supine (amod)
worsened further (advmod)
ro only (advmod)
function emotional (amod)
presentation encephalopathy (nmod)
modifiable help (conj)
cytostatic and (cc)
arises , (punct)
culture studies (conj)
remain should (aux)
injections intermittent (amod)
problems and (cc)
suppress not (neg)
limited chemotherapy (nsubjpass)
metabolizer sparteine (conj)
constant displacements (nmod)
space in (case)
diclofenac patients (nmod)
anemia this (det)
bupivacaine min (dep)
influences age (nmod)
procyclidine , (punct)
0.69 +/- (cc)
recovery status (nmod)
result supply (nmod)
abrogated endomt (dobj)
suggest useful (ccomp)
compared outcomes (nsubjpass)
pretreatment pentoxifylline (nmod)
35 % (appos)
salicylate ) (punct)
suppression be (cop)
reflect injection (nmod)
perfusion basal (amod)
amns ) (punct)
choices rats (nmod)
decreased stability (dobj)
six to (quantmod)
probes hybridization (compound)
lhrh-a ( (punct)
mediated probably (advmod)
abilities their (nmod:poss)
compromised and (cc)
stimulated methamphetamine (nmod)
presented here (advmod)
edema flash (amod)
cva ) (punct)
pairs treatments (nmod)
tone venomotor (compound)
2.6 1.3 (conj)
anaesthesia combination (compound)
addition cultures (nmod)
related decrease (nmod)
dermatitis thiosulphate (nmod)
cleavage homogenates (nmod)
ischaemia induced (amod)
hygiene oral (amod)
shifts due (case)
agents chemotherapy (compound)
dexamethasone on (case)
isomer.6 either (det)
year-old 76 (compound)
potent well-tolerated (dep)
dyskinesias animals (nmod)
exacerbation vasculitis (nmod)
disorders mental (amod)
toxic rats (nmod)
epidemiology infections (nmod)
conclusions consideration (dep)
antagonist calcium (compound)
development pseudolithiasis (nmod)
replication hepatitis (compound)
glomerular tubular (conj)
increased drowsiness (nsubjpass)
effect pressor (compound)
midazolam patients (appos)
diminishes effects (dobj)
cause obstruction (dobj)
tremors patients (nmod)
accumulation esters (nmod)
enhanced latency (dobj)
hcrh ( (punct)
observed reports (nmod)
angiography or (cc)
ed50 10-fold (dep)
reported established (advcl)
scores symptom (compound)
beats more (amod)
vaccine the (det)
fire anthony (nmod:poss)
proteinuric were (cop)
detected we (nsubj)
factors vii (conj)
tablets tab (nmod)
neonates than (case)
spinal suprabulbar (conj)
paid evidenced (advcl)
triggered pathologies (nmod)
evaluations clinical (amod)
trial coronary (amod)
gland adrenal (amod)
unnecessary is (cop)
presence asterixis (nmod)
experienced none (nsubj)
group i (compound)
vasculitis . (punct)
age status (dep)
perfusion-fixed days (nsubj)
gradual upward (dep)
causes consumed (advcl)
contents the (det)
infusion stab (conj)
improved admission (nsubj)
assess dysfunction (dobj)
setting and (cc)
associated use (nmod)
comparing motility (dobj)
isg to (case)
atropine after (case)
differ which (nsubj)
reaction transcription-polymerase (compound)
assay transferase (compound)
infusion saralasin (nmod)
sbp h2o2 (conj)
demonstrated targeting (dobj)
corroborate required (conj)
motility to (case)
ecstasy inhibition (conj)
morphine models (nmod)
increase o2- (nmod)
antagonizes which (nmod)
completing twitches (dobj)
proteins of (case)
lists reference (compound)
ke parameters (nsubj)
mg/kg 93 (nummod)
jerks , (punct)
experienced se (dobj)
reversed addition (nsubj)
fatal potentially (advmod)
undergoing colonoscopy (dobj)
receptor metabotropic (amod)
substituted occurred (conj)
gssg ( (punct)
acid aminophosphonovaleric (amod)
naloxone paralysis (appos)
augments that (mark)
device by (case)
treated that (nsubjpass)
increase 3 (dep)
ht combined (amod)
cessation exposure (nmod)
activation dox-induced (amod)
25 2 (compound)
thrombophlebitis another (det)
changes lids (nmod)
ovarian notably (advmod)
regimens cisplatin-based (amod)
heart failing (amod)
hepatitis b (compound)
data trial (conj)
methods assigned (appos)
known interleukin (nsubjpass)
particles cortex (nmod)
inhibition alfentanil (nmod)
formation pap (compound)
320/25 val/hctz (amod)
1986 and (cc)
test hypothesis (dobj)
measurements hemoglobin (compound)
preparations diluents (conj)
rats immature (amod)
adjunct treatment (nmod)
flushing and (cc)
system model (compound)
hypotension selective (amod)
primigravida 24-year-old (amod)
deaths group (nmod)
department emergency (compound)
purpose protein (appos)
single-blind . (punct)
course range (dep)
rg1 and (cc)
altered . (punct)
infarction against (case)
milrinone of (case)
stroke use (conj)
11.33 1.13 (conj)
targeting system (dobj)
mg. 2 (compound)
selenium of (case)
c. s. (compound)
% 72 (nummod)
smokers were (cop)
model arthrogryposis (nmod)
recognized application (nmod)
lysozymuria peak (compound)
neurons mrna-containing (amod)
seizures overt (amod)
surveillance gynaecological (amod)
restarting it (dobj)
stents with (case)
structures novel (amod)
administration intramuscular (amod)
developed diabetes (dobj)
score lower (amod)
insufficiency . (punct)
or=2.5 ) (punct)
sedations these (det)
reaction biphasic (amod)
killed h (dep)
were developed (conj)
warranted informed (conj)
dose-dependent was (cop)
period periconception (compound)
described syndrome (nsubjpass)
employed aggressive (amod)
wk 8 (nummod)
conceivable could (aux)
promoted increasing (advcl)
result outcomes (nmod)
normal when (advmod)
being as (mark)
infarctions strokes (conj)
female unanesthetized (amod)
used proposed (advcl)
receptor tlr4 (appos)
strategy the (det)
virus human (amod)
therapy although (case)
obtained den (nmod)
changes one (appos)
minimised could (aux)
properties nisoldipine (nmod)
groups drug (compound)
identified finally (advmod)
received six (nsubj)
changes urothelium (nmod)
transgene of (case)
syndrome bilateral (amod)
forms quantify (xcomp)
rats ob (compound)
testing intradermal (amod)
ensues a (det)
fluency continuous (amod)
evaluation recordings (conj)
cholestasis reversible (amod)
complete protection (dobj)
awoke sleep (nmod)
conventional to (case)
flurothyl electroshock (conj)
synapses cholinergic (amod)
diazepam of (case)
acid-schiff periodic (amod)
permit treatment (dobj)
contrast decrease (nmod)
routes alternative (amod)
weeks clipping (nmod)
causes loss (dobj)
end-stage or (cc)
success its (nmod:poss)
vision and (cc)
use chronic (amod)
regimen pac-containing (amod)
tilts ) (punct)
logs department (compound)
bun b. (compound)
three developed (acl:relcl)
de torsade (compound)
settings various (amod)
recorded spikes (nsubjpass)
adjusted , (punct)
suggest we (nsubj)
seizure pattern (dobj)
gabapentin iii (dep)
diethylstilbesterol five (nummod)
prophylaxis recurrence (nmod)
cancers various (amod)
died result (nmod)
propose approach (dobj)
usage general (amod)
clonidine drug (compound)
years nine (nummod)
cyp3a4 of (case)
ptra the (dep)
different lobular (dep)
insurance the (det)
gave effects (nsubj)
undertaken , (punct)
allowed approach (nsubj)
compressions external (amod)
inputs ureter (conj)
ip , (punct)
changes markers (nmod)
relationship outcome (nmod)
advantageous more (advmod)
so group (nmod)
activity gad (compound)
experiments showing (acl)
vnb , (punct)
induce proteinuria (dobj)
increased however (advmod)
effects muscarinic (amod)
l-w ( (punct)
% compliance (nsubj)
reduction than (case)
peptide protein (conj)
effects hemostasis (nmod)
20 less (amod)
differences specific (amod)
equal stable (conj)
analysed echocardiography (nmod)
% 1.4 (nummod)
f , (punct)
seem therapy (nsubj)
lower ) (punct)
preservation subsequent (amod)
weak only (advmod)
evaluated neuroradiologists (nmod)
resumed , (punct)
dose effective (amod)
ratios drug (nmod)
resulting thus (advmod)
ml mg/50 (compound)
action hyperalgesic (amod)
potentiate to (mark)
rats in (case)
medium by (case)
techniques microelectrode (amod)
agents with (case)
183 by (case)
use galantamine (nmod)
test negative (dep)
mg/day 150 (compound)
reduces fentanyl (nsubj)
reported because (mark)
subjects deficits (nmod)
stroke hemorrhagic (amod)
vulnerable selectively (advmod)
evaluated adherence (nsubjpass)
87 to (quantmod)
explanation for (case)
increase medication (nmod)
drug antipsychotic (amod)
evidences in (amod)
recorded parameters (nsubjpass)
associated sometimes (advmod)
rat transgenic (amod)
errors of (case)
effects acetaminophen (nmod)
arthritis juvenile (compound)
outcomes latent (amod)
syndrome injection (nmod)
staining , (punct)
patients case (compound)
750 and (cc)
pentylenetetrazole inverse (amod)
showed inhibition (nmod)
found but (cc)
dosage targeted (amod)
cb ) (punct)
inefficient removing (advcl)
acuity sensitivity (conj)
dosed separately (advmod)
remains treatment (dobj)
subjects , (punct)
differences with (case)
8/27 ) (punct)
line observation (nsubj)
disease documented (amod)
defects ventricular (amod)
microg/kg/min 25 (nummod)
reference with (case)
found as (mark)
short-term , (punct)
administration u.s. (compound)
added correcting (xcomp)
reported incidence (nmod)
receive dcf (dobj)
81 +/- (cc)
rats 42-day-old (amod)
enflurane and (cc)
constructed neuropathy (advmod)
rats control (amod)
group rr (appos)
% using (xcomp)
treated diazepam (nmod)
lactate of (case)
hr administration (dep)
exposed bpa (nmod)
mutants ) (punct)
review by (case)
dizocilpine , (punct)
edema massive (amod)
food food (conj)
hypertrophy prominent (amod)
changes barrier (nmod)
reported illustrate (xcomp)
is relation (attr)
analysis multivariate (amod)
vary study (advcl)
phenomenon rebound (compound)
performed examination (nsubjpass)
20.3 +/- (cc)
declines pressure (nmod)
appeared administration (nmod)
patients systemic (amod)
monotherapy in (case)
influence interval (nsubj)
hydrochloride carteolol (compound)
race sex (conj)
gaba in (case)
influence ip (nmod)
% 87.3 (nummod)
increased also (advmod)
insults of (case)
travelling bundle (nmod)
rate is (cop)
recovered over (compound:prt)
keratectomy excimer (compound)
microangiopathy hypertension (conj)
methods received (appos)
risks surgery (nmod)
apl ( (punct)
control central (amod)
increased abecarnil (nsubj)
had virus (nmod)
features inhibitor (appos)
describes development (dobj)
sbp group (nmod)
control respiration (nmod)
cisternae and (cc)
exception binding (nmod)
characteristic features (nsubj)
synthesize dna (dobj)
decrease due (case)
taking nicergoline (dobj)
correlated increase (nmod)
field carried (acl:relcl)
strength its (nmod:poss)
steroids chronic (amod)
undergoes reorganization (dobj)
twin first (amod)
outcomes improved (amod)
evident adulthood (nmod)
devastation the (det)
large relatively (advmod)
leukemia standard-risk (amod)
complicated nms (nsubjpass)
drug reported (acl:relcl)
departments various (amod)
review period (nmod)
induce increase (conj)
galactosamine biodegradable (amod)
field per (case)
found myocytes (nmod)
pain strong (amod)
exposure ias (compound)
obstruction with (case)
asia southeast (compound)
magnitude with (case)
administered being (auxpass)
mg/100 5.5 (compound)
forced and (cc)
patients d8 (conj)
cortex entorhinal (amod)
occurred release (nsubj)
the /+ (conj)
etomidate of (case)
toxic lidocaine (nmod)
units 100 (nummod)
documented four (nmod)
oxide neurotransmitter (appos)
accounted thus (advmod)
= .001 (dep)
thrombectomy cdt (conj)
replicate not (neg)
procedure catheterization (compound)
experiences the (det)
electrolytes urinary (amod)
step still (advmod)
theophylline slow-release (amod)
cholesterol 100 (nummod)
responsible uptake (nmod)
performed patient (nmod)
evidence functional (amod)
associated anticoagulants (nmod)
pathway accessory (compound)
effect motility (nmod)
dose only (advmod)
evaluate time-course (conj)
developing developing (advcl)
studies murine (amod)
progestagens of (case)
groups = (amod)
combinations first (amod)
loading intravenous (amod)
0.3 1.0 (conj)
ketoconazole oral (amod)
to and (cc)
smoking of (case)
olanzapine ci=25.2 (conj)
assessed scale (nmod)
mg/week 1 (nummod)
lidocaine to (case)
population study (compound)
88.1 3.8 (conj)
treatment before (advmod)
electrophysiology patients (nmod)
noted vasculitis (nsubjpass)
less 1,000/mm3 (nmod)
vasoconstriction of (case)
group weeks (nmod)
neurotoxic may (aux)
undergoing currently (advmod)
effect ifo (nmod)
uncontrollable . (punct)
doxorubicin m-2 (compound)
has and (advmod)
cardiomyopathy human (amod)
leakage k(+ (nmod)
reviewing family (nmod)
cpap of (case)
s-1 to (case)
exploration , (punct)
reduce vitro (advmod)
middle-aged healthy (amod)
reversible only (advmod)
risk patient (nsubj)
edema " (punct)
dose estrogen (compound)
response an (det)
lethality associated (acl)
related nor (cc)
anova climbing (nmod)
aspiration despite (case)
cld % (appos)
reduces providing (advcl)
effect pharmacologic (amod)
total % (nmod)
oc , (punct)
has combination (nsubj)
marker inflammation (nmod)
measure outcome (compound)
intoxication by (case)
help may (aux)
microg/ml concentration (nsubj)
treatments bdl (compound)
dyskinesia is (punct)
pressure rhythm (conj)
risk drugs (nmod)
woman-years years (nmod)
structure 1-(1,2-dihydro-2-acenaphthylenyl)piperazine (nmod)
rate resulted (acl:relcl)
relationship probable (amod)
preparations dog (compound)
analysis mitochondrial (amod)
hormone siadh (appos)
dead were (cop)
involves effect (nsubj)
syndrome rare (amod)
immunosuppressants rapamycin (conj)
release platelets (nmod)
studied mice (nmod)
doses microgram (nmod)
greater weeks (nmod)
bupropion sustained-release (amod)
myalgia succinylcholine-associated (amod)
hypotension easily (amod)
similarity its (nmod:poss)
mda renal (amod)
hypotension l-dopa (nmod)
range hz (nmod)
therapy nelarabine (nmod)
symptoms . (punct)
associated evidence (nmod)
fluctuating in (mark)
plasticity maladaptive (amod)
cats 12 (nummod)
pdtc antioxidant (amod)
hydrochloride papaverine (compound)
overdosage phenytoin (compound)
acquisition discrimination (nmod)
dose first (amod)
increased later (advmod)
scenario clinical (amod)
injected . (punct)
manifestation myocarditis (nsubj)
25 in (case)
reductions groups (nmod)
hundred fifty-one (conj)
inhibitor that (mark)
loss no (neg)
measurement curve (nmod)
involved underlying (xcomp)
was occurred (ccomp)
dose-dependent effect (nsubj)
suppression systems (nmod)
was evaluate (xcomp)
extracts lipid (compound)
beta-agonists occasional (amod)
group saline-treated (amod)
group [ (punct)
given droperidol (conj)
focused test (nsubjpass)
bradycardia beats/min (compound)
tachycardia fatal (amod)
parts disease (compound)
research no (det)
tapped and (cc)
bradycardia resultant (amod)
increases morbidity (dobj)
safety concerning (case)
145 182 (conj)
neutropenia count (dep)
patients 28 (nummod)
modifies synthesis (compound)
syndrome ( (punct)
weeks by (case)
phenomenon freezing (amod)
reduced muscle (nmod)
hormone the (det)
expression vegf (compound)
pressure fasciculations (nmod)
volunteers 30 (nummod)
activation 3 (nummod)
men age (nmod)
design patients (nmod)
% 4.8 (nummod)
rats s-53482 (nmod)
i.v. intravenous (amod)
problematic is (cop)
relationship clear (amod)
procaterol oral (amod)
remaining cells (dobj)
alleviated surgery (nmod)
proteinuria no (det)
patients late-conversion (amod)
increased yohimbine (nsubj)
rating recall (dobj)
ache on (case)
lamivudine mg (compound)
2,682,2,803 respectively (advmod)
patients iv (nummod)
comply treatment (nmod)
charcoal fluids (conj)
administered cycles (nsubjpass)
anp ) (punct)
effective d-glucarates (nsubj)
airway reinforced (amod)
pain pain (conj)
displayed presence (nmod)
combined . (punct)
vindesine fluorouracil (dep)
hypoglycemia bradycardia (conj)
dose mz (compound)
transplant for (case)
potentiation arrhythmogenicity (nmod)
exercised treadmill (nmod)
diabetic of (case)
temporary . (punct)
reported effect (nmod)
inherent is (cop)
suppress seizures (dobj)
infusion fenoterol-hydrobromide (amod)
symptoms extrapyramidal (amod)
session in (case)
have activity (dobj)
prevented damage (nsubjpass)
outpatients depressed (amod)
demonstrated levels (nmod)
prevented opiates (nmod)
enhanced contrast (nmod)
study genetic (amod)
concentration the (det)
sensitization lymphocytes (nmod)
alterations neither (det)
triglycerides tg (appos)
action neurotoxic (amod)
change number (nmod)
included use (dobj)
subjects than (case)
epithelium in (case)
paclitaxel ( (punct)
showed rigidity (dobj)
switched patients (nsubjpass)
excellent . (punct)
mg/day of (case)
infections lag (nmod)
pod 14 (nummod)
circumstantial regard (nmod)
succeeded aim (xcomp)
processes survival/repair (compound)
19.3 etoricoxib (nmod)
suggest results (nmod)
r ( (punct)
patients cardiotoxicity (nmod)
leg anaesthesia (nmod)
tachycardia incessant (amod)
had infusion (nmod)
impairment cardiomyopathy (nmod)
dantrolene with (case)
disease subclinical (amod)
g/dl 2.5 (nummod)
adults intact (amod)
7-ni ; (punct)
intestine of (case)
event relevant (amod)
type sad (compound)
abnormalities renal (amod)
illustrates risk (ccomp)
recorded administration (nmod)
haemorrhages petechial (compound)
aura attack (conj)
disappeared proceeded (conj)
cystitis after (case)
aware accompany (ccomp)
hot-plate tail-flick (conj)
pretreated iprindole (nmod)
treatment days (nmod:poss)
satisfactory was (cop)
tachycardia nsvt (appos)
onset a (det)
rationale objectives (conj)
absence exposure (nmod)
expression identified (dep)
remained controlling (advcl)
demonstrate exert (ccomp)
clearance ) (punct)
exacerbated significantly (advmod)
saturation oxygen (compound)
evoked rats (nmod)
mmhg at (case)
evaluate which (nmod)
received mg/kg/b.w./day (dep)
observed layer (nmod)
percent 28 (nummod)
form deprivation (nmod)
instances no (neg)
titrated were (auxpass)
h anaesthesia (nmod)
mg 0.76 (compound)
cardioselective not (neg)
s from (case)
induced giving (advcl)
areas damaged (acl:relcl)
e1 ph (dep)
atrophy also (advmod)
showed intensities (dobj)
ctnt found (acl)
provision for (case)
27-hydroxylase cyp27 (appos)
method design (appos)
3 in (case)
equal those (nmod)
17 2 (conj)
cnp ( (punct)
appearance jerks (nmod)
nicotine with (case)
had hematomas (dobj)
cystometry by (case)
effect peptides (nmod)
hippocampus cortex (conj)
change from (case)
used since (mark)
mm 6 (nummod)
infarction intoxication (nmod)
evaluation laboratory (compound)
counts onset (appos)
average mg (nmod)
scale 0 (nummod)
twin other (amod)
treated anticoagulant (nmod)
conclude involve (ccomp)
chloroacetaldehyde . (punct)
exhibited pattern (dobj)
haemopericardium interaction (nmod)
pph ) (punct)
incidence paralysis (nmod)
penzberg , (punct)
conclusion suggests (appos)
diabetic streptozotocin-induced (dep)
complication lethal (amod)
msec ( (punct)
rate low (amod)
behaviors multiple (amod)
recorded thrombosis (nmod)
micrograms 40 (nummod)
amhs ( (punct)
59.8 +/- (cc)
seem clues (nsubj)
valsartan mg (compound)
addition experiencing (advcl)
tafi tpa (conj)
concentrations with (case)
patients impaired (amod)
pass does (aux)
induced ischemia (dobj)
interaction muscle (nmod)
c ; (punct)
protein total (amod)
had however (advmod)
greater increment (nsubj)
arrest suxamethonium-induced (amod)
33342- iodide (conj)
parameters two (nummod)
woman presented (acl:relcl)
may 1 (nummod)
determined change (nmod)
outcome hemorrhage (nmod)
included margin (nmod)
tolerated shows (conj)
apposition with (case)
subjects six (nummod)
g145r t (dep)
confirm properties (nsubj)
understood mechanism (nsubjpass)
test measured (acl)
describe disease (nmod)
long-term clinical (dep)
corrected until (mark)
rates microbiologic (amod)
significant concentration-dependent (conj)
treated ethopropazine (nmod:npmod)
compromising most (advmod)
belonging group (nmod)
demonstrated monitoring (nsubj)
% total (amod)
fed and (cc)
prescribed that (nsubjpass)
inherent that (mark)
undergoes , (punct)
severe with (case)
or=10.8 > (neg)
study aimed (acl)
maintained or (cc)
relative desire (nmod)
identical that (nmod)
anemia azathioprine-induced (amod)
completed days (dobj)
prodrug an (det)
tibialis anterior (amod)
fashion inhibitory (amod)
cases controls (nmod)
t electrocardiographic (amod)
clarithromycin and (cc)
decreasing to (mark)
tolerated is (auxpass)
controls age-matched (amod)
altered concentration (nsubjpass)
detectable were (cop)
requiring access (dobj)
gr cp (conj)
hyperalgesia diabetic (amod)
origin toxicity (nsubj)
artery arteries (conj)
reduce influence (conj)
results normal (nmod)
sedation after (case)
tee sedation (nmod)
homoeostasis dopaminergic (amod)
concentration medulla (nmod)
regimen effective (amod)
had onset (nmod)
oxcarbazepine with (case)
esthetics self-reported (amod)
induction times (conj)
rapamycin immunosuppressant (amod)
monoarticular form (dep)
failure subsequent (amod)
measured levels (nsubjpass)
protocol , (punct)
increased g/d (dobj)
receiving l-arginine (dobj)
causes toxicity (nsubj)
met : (punct)
agitation malnutrition (conj)
discuss interactions (dobj)
mhb ( (punct)
dunnett ( (punct)
measures 4/17 (nummod)
occurrence damage (nmod)
decreases indices (nmod)
treatment systemic (amod)
arag to (case)
therapy vancomycin (nmod)
naloxone mg/kg (dep)
gm. ( (punct)
occurs process (nsubj)
provides framework (dobj)
patients twenty-three (amod)
investigated epidemic (dobj)
etiology the (det)
up-regulate cytokines (dobj)
caused nitroprusside (nsubj)
ifo mesna (conj)
stage 5 (nummod)
ro4368554 metrifonate (conj)
months summer (compound)
given weeks (nmod)
min trial (nmod)
% 8.6 (nummod)
prolongs . (punct)
follow-up 3 (dep)
assessed permeability (nsubjpass)
promote increased (conj)
injury liver (compound)
adopted therapy (nsubjpass)
attempted were (auxpass)
cm 16 (compound)
elevated units (nmod)
completed compared (prep)
% 15 (nummod)
significant also (advmod)
mmol/l was (cop)
given frequently (advmod)
months more (nummod)
reported % (conj)
insurance pharmaceutical (compound)
metabolites vitamin (compound)
reduces hypotension (nmod)
difference or (cc)
antagonists model (nmod)
type complication (nmod)
administered vehicle/drugs (nsubjpass)
subject suffered (acl)
secondary nephritis (nmod)
inhalation , (punct)
hypotension elicited (amod)
changes gross (amod)
produced reduction (dobj)
resulted complained (conj)
inhibitor hemicholinium (appos)
after just (advmod)
encephalopathy related (amod)
had mother (nsubj)
result to (mark)
learning ip (amod)
pulse with (case)
missing are (cop)
become ipsilateral (acomp)
hyperemia , (punct)
microgram.kg-1.min-1 pge1 (nmod)
tachycardia intractable (amod)
ligand fas (compound)
caffeine- the (det)
volume , (punct)
interaction peptides (nmod)
risk parkinson (nmod:poss)
affect failure (nsubj)
death infarction (conj)
days 2 (dep)
structures brain (compound)
somnolence % (appos)
one pathologies (nmod)
used settings (nmod)
1.6 ( (punct)
triggers disruption (dobj)
but-relative increase (nmod)
needs caution (dobj)
antidepressant noradrenergic (amod)
electrolyte plasma (compound)
captopril-treated and (cc)
woman in (case)
group sedation (compound)
amounts mice (nmod)
tamoxifen the (det)
neuropathy induced (amod)
caused expression (advcl)
small and (cc)
release acetylcholine (nmod)
scored overall (advmod)
measure intensity (dobj)
magnitudes hyperalgesia (nmod)
administration steroid (compound)
parts subcortical (amod)
narrowed . (punct)
rats mg./kg (appos)
adhd childhood (compound)
more 1 (conj)
vicinity the (det)
role nicotine (nmod)
programs defect (compound)
nephropathy in (case)
exposure sub-chronic (amod)
non-hypertensive 46 (nummod)
nausea fentanyl (amod)
capacity transport (acl)
differ whether (mark)
mtx , (punct)
report ; (punct)
understood lack (nmod)
3tc + (cc)
ttc with (case)
receptors altered (amod)
extract methanolic (amod)
used or (cc)
decrease cell (compound)
learning this (det)
inducibility proliferation (nmod)
p9201 ( (punct)
% 9.5 (nummod)
experience men (compound)
differentiation cardiomyocyte (compound)
extracts with (case)
screened retrospectively (advmod)
carvedilol of (case)
assessed ability (nsubjpass)
pump h (nmod)
noted aphasia (dobj)
decrease increase (conj)
modulation be (cop)
made detection (conj)
mg/kg 0.3 (nummod)
hemodynamics of (case)
adr+los(6 group (compound)
infant mg/kg (nmod)
anacardiaceae ) (punct)
levels expression (compound)
mg/100 2.5 (compound)
sensitivity examination (conj)
rats warfarin-treated (amod)
dips test (nmod)
indicates associated (ccomp)
contractions the (det)
one mg/kg (appos)
1/2,z ( (punct)
adenomas colorectal (amod)
mechanism explain (acl)
clinical cytologic (conj)
keratopathy band (compound)
= .0015 (dep)
nmol/min/g 666.9+/-14.0 (nummod)
dose a (det)
enlargement : (punct)
mass expression (conj)
patients g/dl (nmod)
cromakalim doses (nmod)
action stimulant (amod)
higher alpha (nsubj)
number patients (nmod)
enzyme pseudocholinesterase (compound)
33.42 +/- (cc)
group n (dep)
form dystrophy (nmod)
consequences stopping (advcl)
mouth throat (conj)
opioid with (case)
incidence underlying (advcl)
produces results (conj)
minimize to (mark)
drivers healthy (amod)
chemoconvulsants bicuculline (appos)
territory the (det)
mm 0.675 (nummod)
investigated expression (nsubjpass)
age yrs (nmod)
resulted occurrence (nsubj)
leading pool (nmod)
suggests determinant (ccomp)
placebo on (case)
observed beats/min (dobj)
reduced gradually (advmod)
use occurs (advcl)
returned normal (acomp)
unanticipated witnessed (conj)
antagonized completely (advmod)
entity , (punct)
observed dose (nmod)
likely those (conj)
experiments separated (acl)
excitability sma (compound)
level brain (compound)
dse another (det)
small- medium-sized (conj)
zidovudine + (cc)
inactivation this (nsubj)
secondary thrombocytopenia (nmod)
draw possibility (nmod)
secondary rate (nmod)
patients undergone (acl:relcl)
% effect (nmod)
occurrence was (cop)
signs ppm (compound)
vasodilator systemic (amod)
registry deaths (nmod)
extent elevation (nmod)
challenging can (aux)
response weight (compound)
represented rostrolaterally (advmod)
war nuclear (amod)
seems effect (xcomp)
preparations the (det)
clonidine propranolol (conj)
responses stimuli (nmod)
had d2 (nsubj)
metformin with (case)
effect amiloride (nmod)
environments novel (amod)
closure telangiectasis (conj)
dogs tachycardias (nmod)
nausea exacerbated (amod)
pregnane-20-ones ( (punct)
hindpaw the (det)
present juices (nmod)
nascis in (case)
12-week in (case)
agonist causes (acl:relcl)
mg 200 (nummod)
studied . (punct)
tachyarrhythmias : (punct)
result changes (nmod)
provide insights (dobj)
bw g (compound)
gamma-hexachlorocyclohexane gamma-hch (appos)
depression unipolar (amod)
illnesses systemic (amod)
had met (conj)
focused only (advmod)
convulsions handling-induced (amod)
days 7 (nummod)
associated individuals (nmod)
transplant the (det)
death alone (advmod)
phosphatase glucose (conj)
diagnoses clinics (nmod)
induced n (nmod)
fentanyl isoflurane (conj)
alive and (cc)
bodies characteristic (amod)
marrow megakaryocytes (nmod)
pruritus and (cc)
clearance clt (appos)
dipyridamole dogs (nmod)
appears interestingly (advmod)
cardiotoxicity late-stage (amod)
age at (case)
applied doses (nmod)
model hypertrophy (nmod)
disrupts secondary (conj)
deposits igg (nmod)
gum % (compound)
space within (case)
neuropathy therapy (nmod)
reviewed score (advcl)
cacl(2 by (case)
way 1-bromo-1-chloro-2,2,2-trifluoroethane (nmod)
oxidase , (punct)
volunteer healthy (amod)
treatment cytostatic (amod)
subjects human (amod)
nitrogen levels (conj)
thalidomide continuous (amod)
greater signs (nmod)
results positive (amod)
useful sedative (nmod)
aggravate methadone (nsubj)
symptoms later (amod)
presents results (dobj)
recorded region (nmod)
models deficiency (nmod)
convulsions neurotransmitters (conj)
granulated . (punct)
potential unpredictable (nmod)
routes to (case)
studying behavior (dobj)
or 3.80 (nummod)
failure ensued (acl)
divided ) (punct)
mm lna (appos)
piglets control (compound)
suspension aqueous (amod)
% 46 (compound)
antagonists ionotropic (amod)
studied four (nmod)
33342- and (cc)
reshape , (punct)
dose alprazolam (compound)
6/52 v (advmod)
augment did (aux)
described , (punct)
penetration the (det)
reported also (advmod)
2h 30 (nummod)
propose occurring (ccomp)
ginsenoside extracted (acl)
sensitization by (case)
suggest observations (nsubj)
patients confusion (nmod)
determination concentration (conj)
given over (pcomp)
detected patients (nmod)
finding diagnosis (nmod)
haemorrhage of (case)
appetite change (conj)
exercise involvement (conj)
mdma from (case)
release cell (compound)
seen limbs (nmod)
r/r ) (punct)
procedure devised (acl:relcl)
inhibitor ssr103800 (dep)
tachycardia excluding (case)
role contributing (acl)
tended ill (xcomp)
administration following (case)
cranberry juice (dobj)
animals : (punct)
sg145r the (det)
change tachycardia (dobj)
home discharged (amod)
prescribed acetate (dobj)
transplantation necessitating (compound)
effect however (advmod)
report interim (amod)
limbs toes (conj)
sensitivity their (nmod:poss)
delays ) (punct)
ifosfamide mesna (conj)
80 50 (compound)
mg by (case)
preventing proteinuria (dobj)
poor is (cop)
report lady (dobj)
year of (case)
conducting rodents (nmod)
resuscitation cardiomyopathy (nmod)
metabolism stereoselective (amod)
= 0.35 (dobj)
course shed (acl)
magnitude insufficient (amod)
had them (dobj)
consumption myocardial (amod)
h1- h2-antagonists (conj)
5-fluorouracil company (dep)
measured which (nsubj)
4.1 0.8 (conj)
found four (nmod)
reagents monospecific (amod)
inhibition cox-2 (nmod)
given initially (advmod)
deficits deficits (nmod)
volume lv (amod)
india south (compound)
act ester (nsubj)
intervention physiological (amod)
exploited be (auxpass)
placebo tamoxifen (conj)
intravenous both (cc:preconj)
considered which (nsubjpass)
administration prior (amod)
staining nf-kappab (compound)
block does (aux)
8-week an (det)
infarction data (nmod)
deficiency acid-ergic (amod)
changes reactivity (nmod)
1.86 mmhg/ml (dep)
events life (compound)
delta or (cc)
discussed differences (nsubjpass)
abnormalities neuroinflammation (amod)
oxygenation in (case)
1.5 or (cc)
difficult , (punct)
period scanning (compound)
effect specific (amod)
injury aminonucleoside (nmod)
foci/cm2 compared (case)
atypia and (cc)
dexamethasone microg/kg (appos)
sensitivity to (case)
reexposure brief (amod)
analyze data (dobj)
hyperthyroidism admitted (acl)
patient jaundice (nmod)
showed diagnostic (dobj)
cad ( (punct)
patients 3/4 (nummod)
8) but (cc)
cycle sleep/wakefulness (amod)
essential maintaining (advcl)
sequelae the (det)
suggests improve (ccomp)
had seizure (advcl)
occurred precipitated (conj)
demonstrate reduces (ccomp)
course start (nmod)
associated alterations (nmod)
recommend they (nsubj)
increased tenfold (nmod)
heroin decrease (xcomp)
patients gravis (nmod)
dose clarithromycin (nmod)
undergone ct (dobj)
ka the (det)
costs of (case)
atrophy isolated (amod)
10 out (advmod)
bilirubin in (case)
toxicity former (nmod)
lacking support (xcomp)
end-diastolic and (cc)
associated up (nmod)
treatment animals (nmod)
caused indicating (advcl)
tobramycin as (mark)
aracytine-c high-dose (amod)
widened significantly (advmod)
suppression bone (compound)
have toxicity (dobj)
reduced increased (advcl)
treatment units (nmod)
unclear however (advmod)
associated whereas (dep)
risk a (det)
comparison aqueous (nmod)
prevention breast (compound)
containing bodies (dobj)
reduce diminishing (advcl)
value heart (compound)
induced dose (nsubj)
included nerves (nmod)
pressure ( (punct)
congenita with (case)
animals controls (conj)
relation dose (nmod)
commencing fluconazole (dobj)
related inhibition (nmod)
nausea exanthema (conj)
hypotension to (case)
mean+/-sd ) (punct)
study monitor (acl)
sma ) (punct)
establish . (punct)
required used (advcl)
deferoxamine chelator (appos)
strains mouse (compound)
40 approximately (advmod)
coagulation intravascular (amod)
shift this (det)
reported all (nsubj)
group dexamethasone (compound)
patients grade (dep)
scavenging radical (amod)
elevated tg (conj)
reduced concentration (nsubjpass)
british . (punct)
selected . (punct)
occurs dysfunction (nsubj)
uterus an (det)
dyskinesia . (punct)
medications antibacterial (amod)
systolic pressures (conj)
burden to (case)
levels children (nmod)
pamidronate intravenous (amod)
effective most (advmod)
painful was (cop)
out-patients hypertensive (compound)
rhinitis for (case)
depression disease (conj)
complicated and (cc)
tacrolimus or (cc)
unnecessary . (punct)
hepatotoxicity agents (nmod)
hypotension projections (nmod)
taste smell (conj)
conclusions authors (nmod:poss)
shown display (ccomp)
correlation hemorrhage (nmod)
hypotension or (cc)
levels lower (amod)
dyskinesias lids (appos)
events , (punct)
tongue neck (conj)
mg/m(2 100 (nummod)
report effect (nmod)
society international (compound)
dilemma a (det)
modifications histological (amod)
alf for (case)
modulate can (aux)
minutes 181 (nummod)
understood anaemia (nsubjpass)
feeding carcinogen (compound)
warranted monitoring (nsubjpass)
amounts and (cc)
mgkg at (case)
anticoagulant to (case)
diminished side (nmod)
fingers foot (conj)
effect alpha-methyldopa (nmod)
reduction using (acl)
pre-treatment ) (punct)
artery or (cc)
number high (amod)
diagnosed epilepsy (nmod)
opiate endogenous (amod)
found third (nmod)
150 only (advmod)
periods washout (amod)
methods <3 (dep)
proliferation of (case)
injecting recorded (advcl)
hepatitis or (cc)
capillaries of (case)
supply extrinsic (amod)
short was (cop)
pentylenetetrazole of (case)
had years (ccomp)
frequent reversible (conj)
deviation + (cc)
perfused eyes (nsubjpass)
ccl4 galactosamine (conj)
correcting allowing (conj)
secondary zolmitriptan (nmod)
esophagus the (det)
interaction tizanidine (nmod)
atp for (case)
substantia unilateral (amod)
time ended (acl:relcl)
horns at (case)
rate os (compound)
organelles ) (punct)
were reflecting (xcomp)
pool compartmentalized (amod)
transplantation patients (conj)
transplants after (case)
atenolol with (case)
failure reversible (acl:relcl)
rehabilitation oral (amod)
agent chelating (amod)
regard mechanism(s (nmod)
injection pan (dep)
find reports (dobj)
fruits of (case)
tested check (ccomp)
adult leghorn (dobj)
has ribavirin (nsubj)
morning early (amod)
plants herbal (amod)
resolution symptoms (nmod)
conducted analyses (nsubjpass)
2.3 2.3 (conj)
gfap ros (conj)
farmers among (case)
therapy timolol-hydrochlorothiazide (amod)
hb of (case)
changed bisoprolol (xcomp)
therapy cyclophosphamide (compound)
nucleotide-gated i(f)-generating (amod)
c at (case)
university university-affiliated (conj)
5-micrograms/kg at (case)
boys young (amod)
% 15.4 (nummod)
l-3,4-dihydroxyphenylalanine of (case)
prodrug and (cc)
six 10 (conj)
analogue synthetic (amod)
cases vasospasm (nmod)
continued patients (nmod)
resulted injections (nsubj)
attenuate vivo (advmod)
prior treatment (nmod)
vasodilatation by (case)
measure be (cop)
receptors with (case)
enzymes in (case)
gold by (case)
effacement some (det)
began . (punct)
n= 50 (nummod)
focussed . (punct)
reduced arteries (nmod)
complained patients (dep)
affinities in (case)
prevent nephropathy (nmod)
dose pentylenetetrazole (nmod)
administrations following (case)
detected hyperalgesia (nsubjpass)
2.1 2.8 (conj)
contributed might (aux)
genotype heterozygous (amod)
increase exposure (nmod)
or=80 > (compound)
4/- , (punct)
important report (xcomp)
reconsidered be (auxpass)
r=0.81 ( (punct)
function motor (nmod)
kinetics following (case)
regions several (amod)
6 167 (conj)
clearance increased (amod)
interview study (compound)
reflected was (auxpass)
angiogram emergent (compound)
y = (amod)
compliance rates (conj)
levels blood (compound)
suffers reactions (nmod)
follow months (nmod)
% 11.2 (nummod)
hyperemia methylxanthines (nmod)
delays flavonoid (amod)
mpep ; (punct)
view in (case)
150 and (cc)
leading failure (nmod)
considered resuscitation (nsubjpass)
seeing we (nsubj)
reported introduction (nsubjpass)
100 1,000 (conj)
pointes de (amod@nmod)
net induced (acl)
encephalomalacia ) (punct)
sample venous (amod)
ro 13 (nummod)
bcnu-exposed melatonin (conj)
stroke for (case)
plays variation (nsubj)
ecgs controls (nmod)
combination anaesthetics (nmod)
observed evidence (nmod)
diameter maximal (amod)
8) 30 (conj)
episodes appeared (acl:relcl)
surgery upper (amod)
motor neuropathy (conj)
studied addition (nmod)
was find (xcomp)
newspaper in (case)
viracept warning (conj)
related vulnerability (nmod)
admitted found (advcl)
p=0.01 ( (punct)
displayed groups (nsubj)
parameters last (amod)
resolved month (nmod)
activity long-term (amod)
increase level (nsubj)
inhibitors endogenous (amod)
patients ' (case)
poag ( (punct)
demonstration this (nsubj)
treated regimen (nmod)
attenuated inflammation (nsubjpass)
evaluate role (dobj)
range into (case)
used srl (nsubjpass)
phosphate higher (amod)
effects p-coumarate (nmod)
ctni pg/ml (appos)
plausible resistance (nsubj)
report study (nmod)
that ( (punct)
trial by (case)
designed studies (nsubjpass)
replacement dose (nmod)
differed = (parataxis)
evaluation spatial (amod)
explained are (auxpass)
control compared (case)
virus by (case)
remain background (dep)
one media (nmod)
doses the (det)
ovx ( (punct)
reduced similar (advmod)
pain by (case)
assess association (dobj)
induce case (nmod)
mmol/l [ (punct)
exercises regular (amod)
metabolized pathway (nmod)
extended-release/20 niacin (compound)
report woman (dobj)
indicators variability (nsubj)
age-dependent died (conj)
warfarin patients (appos)
recovery flair (appos)
size foci (nmod)
segment ecg (compound)
rigidity . (punct)
documented groups (nmod)
underlying of (mark)
convincing evidence (dobj)
ineffective dose (nsubj)
were lesions (attr)
ami dox (dep)
manifestations excitation (nmod)
rats or (cc)
responses pituitary (amod)
induced amelioration (dobj)
sectioning after (case)
failure ? (punct)
littermates wt (compound)
was p (nsubj)
head triceps (nmod)
transplantation to (case)
area cardiomyocyte (compound)
260 about (advmod)
= 3390 (dep)
infusion compared (case)
female . (punct)
role disruption (nmod)
consisted treatment (nsubjpass)
caused which (nsubjpass)
h(3)-receptors of (case)
disturbance function (nmod)
method combined (amod)
period rotation (nmod)
shown interaction (nsubjpass)
caused reductions (dobj)
drinking urine (conj)
thrombosis woman (nmod)
application kcl (nmod)
dose trihexyphenidyl (nmod)
rare hazardous (conj)
animals pcc-treated (amod)
vincristine-induced ) (punct)
dosage increased (amod)
containing originally (advmod)
days initiation (nmod)
considered tumors (nsubjpass)
intervention , (punct)
fluoxetine high (amod)
results stereotypy (appos)
has affected (parataxis)
valproate with (case)
society headache (compound)
augment melatonin (nsubj)
antibiotic new (amod)
dependent disturbance (nmod)
antagonism - (punct)
parasites larvae (conj)
expression sarcolemmal (amod)
treat pain (dobj)
therapy chlorpropamide (compound)
observed microg/side (nmod)
exposure agents (nmod)
received mg/g (dep)
courses arm (conj)
pelvis of (case)
h 5 (nummod)
regurgitation restrictive (amod)
caused which (nsubj)
success treating (advcl)
meq/l 6.9 (nummod)
were displace (conj)
strains brown (amod)
nsaid g (conj)
revealed preexposure (advcl)
recur thrush (nsubj)
patients flumazenil-treated (amod)
pentoxifylline of (case)
test latency (compound)
regeneration the (det)
increase iodixanol (nmod)
excreted acid (nmod)
fourteen % (nmod)
experienced staying (advcl)
face expressing (acl)
mastectomy for (case)
return by (case)
20-fold to (dep)
% 49.2 (nummod)
anticonvulsants ( (punct)
brain whole (amod)
injected woman (nsubjpass)
beat heart (nsubj)
dosage maximal-tolerated (amod)
bleed and (cc)
% 27.7 (nummod)
demonstrated fall (dobj)
case mcl (nmod)
stimuli vas (appos)
markers necrosis (compound)
dantrolene bromocriptine (conj)
administered fenoldopam (dobj)
use aspirin (nmod)
groups intervention (compound)
greater to (mark)
concentration increasing (amod)
ampicillin for (case)
links the (det)
conducted models (nmod)
smoking effects (conj)
pressure cent (nmod)
flap immediate (amod)
admitted hospital (xcomp)
week in (case)
336 +/- (cc)
noted blisters (nsubjpass)
follow-up in (case)
antagonizes catalepsy (dobj)
clinician the (det)
trigger the (det)
appeared reversible (xcomp)
clonidine in (case)
etomidate after (case)
cerebellum on (case)
complained while (mark)
irradiation after (case)
hepatonecrosis and (cc)
volume increased (amod)
homeostasis on (case)
polymyositis evidence (conj)
pretreatment prior (advmod)
treatment sulphasalazine (nmod)
facilitate reduction (dobj)
measure sensitive (amod)
women admitted (acl:relcl)
admitted since (mark)
diagnosis p (nmod)
effect curcumin (nmod)
depleted . (punct)
pressure % (appos)
patient only (advmod)
study before (case)
cytoskeleton its (nmod:poss)
relaxation expression (conj)
% 6.6 (nummod)
had dexamethasone (nsubj)
occurred netilmicin (nmod)
sustained infarction (dobj)
injection the (det)
incidence leukocyturia (nmod)
ranged 3.32 (nmod)
asystole of (case)
followed cases (dobj)
agent sotalol (appos)
included controls (nsubjpass)
component regimen (nmod)
analysis proteins (nmod)
evaluated toxicities (nsubjpass)
increase increasing (advcl)
knowledge of (case)
amplitude frequency (conj)
frequency reactions (nmod)
prevention myoclonus (nmod)
result as (cc)
abolished staining (dobj)
1.4 respectively (advmod)
graded was (auxpass)
adenocarcinomas propionate (conj)
session task (nmod)
22 4 (compound)
reaction ( (punct)
lowering plus (cc)
cases new (amod)
> toxicity (dep)
computer to (case)
tachycardia drowsiness (conj)
began mg/d (nmod)
reduced production (dobj)
3.0+/-0.4 mean+/-sd (appos)
ccnu with (case)
% . (punct)
neurological toxicity (dep)
route intravenous (amod)
responsible blockade (nsubj)
injection acid (nmod)
intrathecal , (punct)
mg/dl 15.0 (nummod)
duration action (nmod)
aneurysms of (case)
treat infarction (dobj)
disadvantages are (cop)
model model (nsubj)
suppressed markedly (advmod)
4.0 2.8 (conj)
missed far (advmod)
changes function (nmod)
experienced hypotension (dobj)
factor-alpha increased (amod)
pastes fireworks (conj)
evidence dysfunction (nmod)
actions mice (nmod)
59 50 (quantmod)
changes pain (amod)
therapeutic associated (conj)
decrease incidence (nmod)
vnr ( (punct)
mrna encoding (acl)
indications effect (nmod)
complication agents (nmod)
serotonin n-acetyl (conj)
active was (cop)
elicited , (punct)
evidence without (case)
histories patient (nmod:poss)
selective bp (nmod)
found uiu/ml (dep)
thought contribute (conj)
model hemorrhage (nmod)
dex atorva (appos)
dose ( (punct)
help providing (advcl)
exceeds the (det)
25 , (punct)
beta-position the (det)
metrizoate doses (nmod)
retrievals that (mark)
type ) (punct)
children immunocompromised (amod)
ns-nsaids acetaminophen (conj)
depletion the (det)
the elevated (dep)
d with (case)
cases granulocytosis (nmod)
reveals usual (ccomp)
sulphate epipregnanolone (appos)
thrombopoetin , (punct)
mastodynia moderate (amod)
diagnosed centers (nmod)
center research (compound)
insufficiency of (case)
suggests . (punct)
weeks ten (nummod)
translate . (punct)
collected asystole (nmod)
154:64 p (appos)
coma this (det)
secretion ) (punct)
mm ( (punct)
ms laser (compound)
reached , (punct)
l-dopa mmol (compound)
development thrombosis (nmod)
cytarabine of (case)
mucosa 0.0001 (appos)
reducing proteinuria (dobj)
mechanisms similar (amod)
exposed sequentially (advmod)
episodes 26 (appos)
snaps ( (punct)
encephalopathy edema (dep)
activities in (case)
gyrus frontal (amod)
effects mg (dep)
experience reactions (dobj)
bolus short-term (conj)
occurred probable (xcomp)
rats pan-treated (amod)
buffers response (dobj)
japan in (case)
induced suppression (dobj)
deposition to (case)
decided trialists (nsubj)
transaminase gpt (appos)
artery human (amod)
used lorazepam (nsubjpass)
using engine (dobj)
potential inducing (acl)
drop ( (punct)
treatment isradipine (compound)
pathway classical (amod)
groups followed (acl)
kpa ) (punct)
21days for (case)
effect epileptogenic (amod)
lv with (case)
attenuate damage (dobj)
wherein pathway (dobj)
null -/- (appos)
had thrombosis (nmod)
pre-treatment oral (amod)
different was (cop)
blinding potentially (advmod)
lithium maternal (amod)
offered model (nsubj)
case this (nsubj)
hypoxia chronic (amod)
relatives affected (acl)
treat effects (dobj)
sn ) (punct)
found lasted (conj)
experienced experienced (xcomp)
control weight (compound)
glycol peg (appos)
= 0.74 (dobj)
34 10 (conj)
tgr ( (punct)
performance current (amod)
recall test (nmod)
weeks period (conj)
wsp wsr (conj)
normalization after (case)
taken together (advmod)
diseases due (case)
rigidity the (det)
proteinuria heavy (amod)
hyper- in (case)
hypothermia and (cc)
completed , (punct)
induced been (auxpass)
comparing treatment (dobj)
woman anomaly (nmod)
activity (na (nmod)
shown alter (ccomp)
induced reserpine (nmod)
pretreated microinjections (nmod)
respond months (nmod)
administration folic (amod)
received assessed (conj)
effects behavior (conj)
considered treatment (nmod)
discriminate magnitude (dobj)
amount exposure (nmod)
day to (case)
inhibited temsirolimus (nsubj)
oxycantha ) (punct)
conclusions triggered (appos)
beating spontaneously (advmod)
mouse-1 i.c.v. (appos)
10(-3 14.9 (compound)
occur , (punct)
frequency to (case)
regions rat (nmod)
hyperfiltration progression (conj)
function delayed (amod)
tests y-maze (amod)
infusion treatment (nmod)
pale were (cop)
combinations of (case)
role release (conj)
patient requiring (acl)
had drug (nsubj)
rat aconitine-induced (amod)
mg/day 100 (nummod)
treatment accepted (amod)
stimulation 5v (compound)
therapy long (amod)
re-exposure after (case)
corroborate findings (dobj)
doses cefonicid (nmod)
stages damage (nmod)
children two (conj)
reports microangiopathy (nmod)
utility acetate (nmod)
occurs which (nsubj)
measured volume (conj)
necessary radiopharmaceuticals (nsubj)
range minutes (nmod)
once-daily versus (cc)
dysfunction muscle (compound)
attempted weaning (nsubjpass)
aphasia limbs (nmod)
none literature (nmod)
apomorphine s.c. (dep)
mmol/l and (cc)
treatment best (amod)
using echocardiography (dobj)
kg-1 mg (compound)
lidocaine % (compound)
reduction institution (nmod)
performed thrombectomy (nsubjpass)
dfx ( (punct)
attenuated convulsions (dobj)
mass r(2 (dep)
reversible downbeat (dep)
incidence relative (amod)
1,2-dmh ) (punct)
scored characteristics (nsubjpass)
reductions cholesterol (nmod)
incidence both (cc:preconj)
studies volunteers (nmod)
different study (nmod)
sustained patient (nsubj)
july from (case)
icc ) (punct)
influence 10(-8 (dep)
higher g (conj)
dex 7931 (nummod)
system conduction (compound)
chick the (det)
exceeded confines (dobj)
swelling fusion (conj)
fistula of (case)
macrophages with (case)
< nl (dep)
androgen and (cc)
organochlorine is (cop)
potential a (det)
acuity visual (amod)
na ) (punct)
anticipated may (aux)
beta1 factor (compound)
had mean (dobj)
given premedication (nmod)
% ; (punct)
using women (nmod)
examined analyzer (nmod)
increase decrease (nmod)
subjects for (case)
31 group (nmod)
domain at (case)
demonstrated additionally (advmod)
scopolamine- ageing-induced (conj)
pathway synthase (compound)
questions these (det)
radiotherapy of (case)
increased level (nmod)
case erythema (nmod)
doses deferoxamine (compound)
imaging including (case)
adriamycin ( (punct)
diminish effect (dobj)
gastroenteritis including (case)
type case (nsubj)
exposures previous (amod)
indicate has (ccomp)
ascribed nephrotoxicity (nmod)
controls ) (punct)
compromise , (punct)
anesthetized and (cc)
attenuation of (case)
52.7 - (punct)
whole on (case)
differences comparisons (dep)
resuscitation initial (amod)
infection monkeys (nmod)
900 or (cc)
occurs background (dep)
witnessed . (punct)
% 18.8 (nummod)
techniques image (compound)
attenuated mice (nmod)
circumstances most (amod)
cystectomy radical (amod)
woman health (nmod)
gag/pol ; (punct)
girl 7-year-old (amod)
activate and (cc)
analysis parenchyma (nmod)
low extremely (advmod)
institute modalities (dobj)
nephrosis rats (nmod)
boys of (case)
elevations , (punct)
dysfunction pb-related (amod)
waveforms of (case)
amounts levobupivacaine (nmod)
catalepsy hypothermia (conj)
compliance points (nsubj)
background aim (conj)
51 +/- (cc)
resulting dilation (nmod)
vlbw ; (punct)
used previously (advmod)
evaluable % (nmod)
hbv amplicor (compound)
infections severe (amod)
act system (nmod)
movements tremors (conj)
tests standard (amod)
early very (advmod)
dose ntg (conj)
factors increased (amod)
d8 d15 (conj)
yrs of (case)
ds prevented (acl:relcl)
life-threatening cause (conj)
screened basis (nmod)
combination cyclophosphamide (nmod)
field ca1 (compound)
effects administration (nmod)
occurrence symptoms (nmod)
visits on (case)
antidepressants for (case)
ro4368554 i.p. (advmod)
probable . (punct)
replacement pellet (dep)
incessant symptomatic (amod)
enlargement and (cc)
prior lithium (dep)
exposure simvastatin (amod)
rise excretion (nmod)
days 15 (dep)
required , (punct)
extent vacuolization (nmod)
irrigation whole (amod)
protein deprived (amod)
effects variations (nmod)
machinery cells (nmod)
table ( (punct)
use bzds/rds (nmod)
e4031 and (cc)
extract ethanolic (amod)
hallmark syndrome (nmod)
incidence vomiting (nmod)
rigidity during (case)
diphenhydramine and (cc)
compartments distinct (amod)
toxic dams (nmod)
delirium a (det)
remains paranoia (nsubj)
3',5'-monophosphate cyclic (amod)
output on (case)
2-mercaptoethane of (case)
fashion action (nmod)
impact inhibition (nmod)
thrombi ischemia (nmod)
centers several (amod)
2.1 to (case)
petechiae thorax (nmod)
devised had (aux)
dex ( (punct)
concentrated patients (nsubj)
systemic airway (conj)
improved 3ma (nsubj)
conditions baseline (compound)
surface thoracic (compound)
induced collagen (nmod)
hospitalised illnesses (nmod)
animals pan (compound)
methods analyzed (appos)
trials therapies (nmod)
fev1 , (punct)
appear do (aux)
comparable group (nmod)
hysterosalpingography in (case)
receptors ) (punct)
suggested data (nmod)
profiles renal (amod)
similar respectively (advmod)
profile erythromycin (nmod)
exercised remained (dep)
process around (case)
reflected increase (nmod)
solution dextran (compound)
recived needle (nmod)
prolonged however (advmod)
mglur5 of (case)
flow e1 (nmod)
has hypotension (nsubj)
somnolence , (punct)
bleed failure (conj)
hypothyroidism for (case)
developed sensation (dobj)
started was (auxpass)
measurements threshold (amod)
sought therefore (advmod)
verapamil mg (dep)
fits concentration (nmod)
ds ( (punct)
participate and (cc)
t+a ; (punct)
patients stable (amod)
induced compared (advcl)
remained thalidomide (nmod)
presented trigger (nmod)
behavior rotational (amod)
l. nestor (compound)
combination fdc (appos)
develop reactions (dobj)
developed mg-ezetimibe (dobj)
fastigial or (cc)
degree 1 (nummod)
osteoarthritis with (case)
intoxication uncomplicated (acl)
altering chemosensitivity (dobj)
vasodilation and (cc)
1941 and (cc)
women , (punct)
mean sdm (conj)
found ratios (nsubjpass)
time location (conj)
analgesic the (det)
decreased peg (nsubj)
degree protection (nmod)
0.002 ) (punct)
pharmacology a (det)
tachyarrhythmia atrial (amod)
regulation tone (nmod)
women ) (punct)
interaction cholinergic-opioid (amod)
interna in (case)
stopped stable (conj)
uterus intact (amod)
studies population (nmod)
symptoms nausea (nmod)
muscle on (case)
drugs between (case)
methylprednisolone mp (appos)
adequate is (cop)
capacity and (cc)
kpa 6.9 (nummod)
low % (nmod)
gspe ) (punct)
reduced either (preconj)
unsafe anticoagulation (nsubj)
% 16 (dep)
dropped increased (advcl)
workers six (nummod)
impairment renal (amod)
collection 24-h (amod)
resolved lesions (nsubjpass)
infarction for (case)
fetal ) (punct)
determined subtypes (nsubjpass)
workup cardiac (amod)
diatrizoate agents (nmod)
administered chemiluminescence (nmod)
weeks 24 (nummod)
day sham-treated (conj)
drg l2 (compound)
significant that (nmod)
elicit infusion (nmod)
antibacterials ketolide (compound)
ke h (dep)
nephrectomized or (cc)
fistula enterocutaneous (amod)
gestation weeks (compound)
prolongation sudden (amod)
desire in (case)
occurrence failure (nmod)
flumazenil and (cc)
suggest differences (dobj)
health women (nmod)
rs6693503 and (cc)
dermatitis between (case)
detected immunoblotting (nsubj)
cystitis to (case)
readmitted and (cc)
enucleated failure (nmod)
correlation rank (compound)
anatomical different (amod)
setting use (nmod)
arising child (nmod)
injection during (case)
intubated while (mark)
viremia of (case)
decreased levels (dobj)
had loss (dobj)
gf ) (punct)
bs individual (amod)
layer narrow (amod)
based scale (nmod)
4 as (quantmod)
purpose is (dep)
associated oxacillin (nmod)
source patients (nmod)
increase mean (compound)
background therapy (dep)
prolonged reversible (conj)
using modeling (dobj)
elevated elevated (conj)
g/day)-lovastatin mg (appos)
discuss applicability (dobj)
preventing suppresses (conj)
population typical (amod)
reductions hr (nmod)
neutropenia % (dep)
any patients (nmod)
ht long-term (amod)
effects verapamil (nmod)
remains locus (nsubj)
days . (punct)
enhanced stereotypy (dobj)
sd % (appos)
parkinsonism off-period (amod)
ng/ml 3 (nummod)
monotherapy quetiapine (compound)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine cgs (appos)
model ocd (nmod)
suggest make (ccomp)
1.195 5.124 (dep)
modify improve (conj)
associated damage (nmod:npmod)
faded away (advmod)
treated sulfate (nmod:npmod)
showed reduce (ccomp)
assessment testing (conj)
trimethoprim and (cc)
detect hyperthermia (dobj)
attention visual (amod)
development cin (compound)
failed comply (xcomp)
fluconazole that (det)
induced although (mark)
procedures urgent (amod)
efficacy alprazolam (nmod)
ofh ) (punct)
learn immediately (advmod)
role cardiotoxicity (nmod)
relieved was (auxpass)
group historical (amod)
29 40 (conj)
ingestion ketoconazole (nmod)
stages : (punct)
dysguesia side-effect (nsubj)
states united (compound)
known estradiol (nsubjpass)
progression fatal (amod)
mediated which (nsubjpass)
those s (dep)
followed spike (nsubj)
hepatic the (dep)
surgery of (case)
analyzed relation (nmod)
1.39 ratio (nsubj)
electroretinography flash (compound)
patient slowing (conj)
developed twin (nsubj)
limiting dose (nmod:npmod)
8 11.2 (conj)
option setting (nmod)
adherence with (case)
bha given (case)
38.9 +/- (cc)
tremor and (cc)
therapy aminocaproic (amod)
speed effect (conj)
levels those (nmod)
engorgement sinusoidal (amod)
contributor a (det)
dothiepin and (cc)
restricted workers (nmod)
mangiferin given (acl)
help observations (nsubj)
have associated (conj)
heterogeneity neurons (nmod)
events anticoagulation (nmod)
movements eye-blinking (amod)
flecainide , (punct)
correlated levels (dobj)
4 than (quantmod)
group ett (appos)
expression gene (nmod)
substrate bbb (nmod)
delivery the (det)
factors . (punct)
affinities of (case)
eegs repeat (compound)
mg/m(2 either (cc:preconj)
differ patients (nmod)
treatment therapeutic (nmod)
erythrodysesthesia being (cop)
class for (case)
injury allergic-type (amod)
level expression (nmod)
compared animals (nmod)
seen duration (conj)
regulation altered (amod)
synthesis no (det)
noted patients (nmod)
osteoarthritis rheumatoid (conj)
myoclonic and (cc)
aborted was (auxpass)
scale pain (compound)
0.1/mg/kg of (case)
decrement facilitation (nmod)
decreased mg (nmod)
7 was (cop)
diagnosis with (case)
returned all (nsubj)
underwent 1991 (nmod)
groups both (dep)
sulfate protamine (compound)
smaller that (nmod)
action antihyperalgesic (amod)
instability electrical (amod)
cd25 ( (punct)
f(33 ( (punct)
relapsed or (cc)
ibuprofen or (cc)
cardiomegaly with (case)
efficacy lamivudine (nmod)
angiogenesis cytokines (dep)
groups r4 (dep)
blocked pregs (nsubj)
arise , (punct)
fluid the (det)
angioedema : (punct)
option topotecan (nsubj)
sah ) (punct)
evidence . (punct)
recognized , (punct)
sacrificed . (punct)
arrhythmia digitalis (compound)
receptors classical (amod)
analogue acid (compound)
giving of (mark)
administered valproate (dobj)
studied contractility (nsubjpass)
arose . (punct)
develop neoplasms (nsubj)
patient presence (appos)
suggested admission (nmod)
damage rats (conj)
2.41 0.9 (compound)
agent alone (advmod)
free restricted (conj)
effects analgesic (amod)
small age (nmod)
days p (dep)
behavior stereotypic (amod)
5-ht2 serotonin (compound)
treated resection (nmod)
neurotoxicity or (cc)
transferase a (det)
ranged . (punct)
infection viruses (nmod)
effect l-dopa (nmod)
tachycardia + (cc)
amlodipine on (case)
consisted design (nsubj)
administration low (amod)
isolated mimic (amod)
symptoms extrapyramidal (compound)
memory fear (compound)
toxicity cocaine (compound)
users young (amod)
days headache-free (amod)
describe improvement (conj)
seizure-prone in (case)
selective protection (nsubj)
cleared subsequent (xcomp)
group 7.3 (appos)
treatment range (nmod)
rats barium-treated (amod)
quality improved (amod)
dogs anesthetize (compound)
become that (nsubj)
tumor . (punct)
nausea as (case)
increase dipyridamole (nmod)
nh4ac of (case)
scans and (cc)
smoking of (mark)
behaviors obsessive-compulsive-like (amod)
found studies (conj)
activity pronociceptive (amod)
fr a (compound)
aware prescribing (advcl)
prophylaxis additional (amod)
regulated neurons (nsubjpass)
115 of (case)
p<0.0005 ) (punct)
c1 , (punct)
hypotension induced (amod)
value power (compound)
pressure standing (amod)
available conclusive (xcomp)
predictive monitoring (nsubj)
checklist behavior (compound)
effects rare (amod)
suggest although (mark)
necrosis subpial (amod)
s-limonene of (case)
prevention birth (compound)
buprenorphine between (case)
prevented observed (ccomp)
reached level (dobj)
inhibits lithium (nsubj)
epilepsy withdrawal (conj)
had irradiation (nmod)
gfc ( (punct)
reported result (nmod)
pain chronic (amod)
believe case (ccomp)
intralipid ) (punct)
treated study (advcl)
effects effects (conj)
antagonized transection (nmod)
cardiotoxicity late (advmod)
tail the (det)
schedule with (case)
indices morphological (amod)
movements protrusion (conj)
aimed studying (advcl)
improve resolve (conj)
elevations prl (nmod)
ptz ptx (conj)
receptors high-affinity (amod)
predict can (aux)
formation on (case)
ratio 10.2 (nmod)
administered vnb (nsubjpass)
stage : (punct)
range cancers (nmod)
participants experiencing (acl)
application carbachol (nmod)
administered rats (xcomp)
ventilated pco2 (dep)
regimen daily (amod)
increase net (amod)
august 2004 (nummod)
dexamethasone oral (amod)
those akathisia (nmod)
antiemetic prokinetic (conj)
operated man (nsubj)
deterioration neurologic (amod)
reverse inverted (conj)
sustained , (punct)
seizures absence (compound)
assess administration (nmod)
jaundice and (cc)
effects bladders (nmod)
disappear . (punct)
cessation drug (compound)
patterns switching (compound)
describe headache (nmod)
4/- figures (nsubj)
withheld , (punct)
determination after (case)
results loss (nmod)
pursued pretreatment (nmod)
synthase p53 (conj)
mediate to (mark)
action hypotensive (amod)
lamivudine prevention (nmod)
evaluation our (nmod:poss)
arabinoside of (case)
institution to (case)
produced responses (dobj)
fear recognition (dobj)
startle . (punct)
r4 r6 (conj)
suspected made (conj)
anemia of (case)
arthritis , (punct)
attack onset (compound)
expression avp (compound)
concentration metabolites (conj)
million 1.1 (compound)
transdermal , (punct)
3.6 to (dep)
history with (case)
height z (conj)
tumor ascites (compound)
factor-alpha ion (conj)
thrombosis . (punct)
follow-up start (nmod)
group bupivacaine/rofecoxib (compound)
mg/kg 7.0 (nummod)
anticoagulant the (det)
death brains (nmod)
forearm her (nmod:poss)
is is (cop)
products prolactin (nmod)
compared 12 (nsubj)
diet , (punct)
measured became (advcl)
technique dual-perfusion (compound)
diisopropylfluorophosphate as (case)
aggregation . (punct)
inefficient terminate (parataxis)
patients ten (nummod)
% 82 (nummod)
remission in (case)
line endothelial (amod)
turn was (cop)
began he (nsubj)
weight molecular (amod)
aplasia pure (amod)
commencement inhibitors (nmod)
glomerulonephritis proliferative (amod)
received ephedrine (dobj)
have agents (nsubj)
gemcitabine mg/m(2 (appos)
patients levels (nmod)
measurements monitored (appos)
d vitamin (compound)
pair the (det)
ci=6.702 95 (nummod)
ica both (cc:preconj)
derivative attenuates (acl:relcl)
auc its (nmod:poss)
indicating share (ccomp)
symptoms emetic (amod)
chickens in (case)
staining immunohistological (amod)
similar greater (conj)
pose factor (dobj)
examines lisinopril (advcl)
caused rats (nsubj)
demonstrated but (cc)
propranolol beta-adrenergic (amod)
produced paradigm (nmod)
treating polyuria (dobj)
cause population (nmod)
assessable assessable (conj)
inhibitor which (nsubj)
stretching a (det)
stratification sex (nmod)
mmhg 120/80 (compound)
ahf ) (punct)
responds increasing (advcl)
dox with (case)
paclitaxel melphalan (conj)
bun , (punct)
vessel blood (compound)
units hounsfield (compound)
evaluation updated (amod)
positive myeloperoxidase- (nsubj)
conditions open (amod)
disease [ (punct)
regulation through (case)
mmol/l mosmol/kg (conj)
yohimbine antagonist (compound)
disorder from (case)
administered late (advmod)
inhibitor oral (amod)
act constricting (advcl)
improvement for (case)
prevention tamoxifen (compound)
rendered administration (nmod)
microg/kg 100 (nummod)
pyridoxal of (case)
pathway by (case)
outcomes catastrophic (amod)
underlying failure (dobj)
performance session (conj)
unchanged ; (punct)
june 2007 (nummod)
1r hydrochloride (appos)
assessment model (compound)
anemia mechanism (nmod)
1.95 about (advmod)
dose or (cc)
leak gliomas (nmod)
signs few (amod)
(noncardiac)/periprocedural n (dep)
collapsed event (nmod)
p n (conj)
indicate may (aux)
action corrective (amod)
percent 40 (nummod)
defined are (auxpass)
literature cases (nmod)
problem common (amod)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline the (det)
response % (dep)
fluorouracil ] (punct)
desipramine linking (acl)
renoprotective . (punct)
paclitaxel single-agent (amod)
sorafenib and (cc)
in 3 (dep)
produce treatments (nsubj)
effective rw (nmod)
warranted that (nsubj)
epilepticus by (case)
rupture liver (compound)
site characteristics (nmod)
mg/m(2 , (punct)
using database (dobj)
effects cognitive-enhancing (amod)
% d (conj)
measured before (advmod)
pneumonia carinii (compound)
1.7 ( (punct)
biopsies 11 (nummod)
fibrosis , (punct)
hemopoiesis cells (nmod)
840 540 (compound)
months months (conj)
effects physiological (amod)
situation similar (amod)
effects behavioural (amod)
degree n (compound)
resembled disturbances (dobj)
nationwide , (punct)
size aneurysm (nmod)
available was (cop)
aes symptoms (appos)
spite fact (nmod)
are effect (nmod)
blood tissue (conj)
checked intervals (nmod)
complicating heart (dobj)
had interval (conj)
hallucinations visual (amod)
exists information (nsubj)
ci [ (punct)
caused conclusions (dep)
often lag (nmod)
trial controlled (amod)
mg diazepam (nmod)
incidence in (case)
hypertrophy from (case)
trial for (case)
experiments inhibition (compound)
streptozotocin rats (conj)
tool utilization (conj)
ketamine- or (cc)
320 x (dep)
high extremely (advmod)
10(-5 of (case)
data administrative (amod)
mi ck-mb (compound)
block and (cc)
cont./min versus (cc)
ranging intraoperatively (advmod)
agents colorectal (nmod)
had hearts (nsubj)
hallucinations of (case)
antigen lymphokine (conj)
limbs left (amod)
crisis patient (nmod)
derivative sirolimus (nmod)
cytokine inflammatory (amod)
hypotension deliberate (amod)
differ formulations (nmod)
respond if (mark)
amoxicillin of (case)
sch antagonist (compound)
glutamatergic and (cc)
max dp/dt (compound)
patient chronic (amod)
functions on (case)
higher drugs (nmod)
affected less (dep)
kinase glucocorticoid-inducible (amod)
proceeded problems (nmod)
4 - (punct)
occurred graded (conj)
induced shift (dobj)
vp-16 ) (punct)
density receptors (nmod)
used models (nmod)
hydrobromide drug (appos)
patients 15 (nummod)
nitrite diet (nmod)
deficits consolidation (compound)
ziprasidone administrated (amod)
mothers positive (amod)
procedures operating (compound)
frlma ) (punct)
epsilon4 and (cc)
cystitis these (det)
downregulates that (mark)
strict particularly (advmod)
dox given (case)
reagent a (det)
pleased percent (nsubjpass)
analysis chemistry (nmod)
included patients (nsubjpass)
compare diclofenac (conj)
effective potent (conj)
barrier albumin (nmod)
greater group (advcl)
allowed suggesting (advcl)
tgf-b and (cc)
pre- by (case)
correct to (mark)
damage protection (conj)
preparations oc (compound)
sequence close (amod)
1966-january 2009 (nummod)
rats % (appos)
tuberculosis presented (acl)
users repeaters (conj)
carriers hbsag (compound)
acids aristolochic (amod)
intent with (case)
diagnosis encephalopathy (conj)
mediated , (punct)
sum n=2.8+/-1.09 (appos)
developed man (nmod)
invited . (punct)
studied responses (nsubjpass)
referred patient (nsubjpass)
administration mangiferin (compound)
effect estrogen (nmod)
studied extensively (advmod)
gnc92h2 of (case)
include assays (dobj)
variety functions (nmod)
group doxorubicin-treated (amod)
increased and (cc)
nerve optic (amod)
involve , (punct)
cancer years (dep)
group our (nmod:poss)
indicate useful (ccomp)
led degeneration (conj)
reflecting minimal (dobj)
improved discontinued (advcl)
glaucoma secondary (amod)
basis . (punct)
waves periodic (amod)
is s (ccomp)
uv ( (punct)
mg/m2bsa ( (punct)
uptake oxygen (compound)
inhibitor synthase (nmod)
occurred induction (nmod)
therapy previous (amod)
nephropathy to (case)
used decrease (xcomp)
substitution t (compound)
dysfunction characterized (acl)
167 5 (conj)
conclusions contributes (dep)
stopped that (mark)
ceased hours (nmod)
or p (dep)
1 and (cc)
inhibitor a (compound)
administration fluid (compound)
product adduct (appos)
mvp ) (punct)
shortening % (nmod)
those rara (nmod)
level indinavir (nmod)
performed : (punct)
year at (case)
low-osmolar nonionic (conj)
expression ventricular (amod)
metoprolol by (case)
effectiveness f(30 (appos)
procedures vascular (amod)
migraine for (case)
parts striatum (nmod)
rashes , (punct)
attenuated administration (nmod)
observations clinical (amod)
overload and (cc)
abnormal four (conj)
developed moderate (dobj)
week with (case)
susceptibility mutants (nmod)
glomerulopathies of (case)
reduce if (mark)
anxiety increased (amod)
behaviors those (det)
alpha prostaglandin (compound)
anencephaly ) (punct)
alter however (advmod)
reasons of (case)
182 +/- (cc)
% 4.6 (nummod)
tolerant those (det)
seizures drug-induced (amod)
become did (aux)
developed boys (nsubj)
reaction to (case)
assays the (det)
developed vitro (advmod)
drugs known (acl)
male 63-year-old (amod)
excreted spared (advcl)
cholinesterase on (case)
staining complete (amod)
interfere that (mark)
dbs hippocampal (compound)
mechanism pathogenetic (amod)
diameters external (amod)
infusion 14c]sodium (compound)
interpolates . (punct)
unilateral and (cc)
relative placebo (conj)
ntg n (dep)
individuals normal (amod)
busulfan total (amod)
artery petrous (amod)
study systematic (amod)
agent neutralizing (amod)
morphine mg/kg (appos)
important than (dep)
drug mitotic (amod)
ability to (case)
female old (amod)
adjunct a (det)
coma into (case)
inhibitor and (cc)
conditions drug (compound)
hcbd and (cc)
erythromycin from (case)
anorexigens amphetamines (conj)
occurs because (mark)
factor-alpha serum (compound)
day was (cop)
pounds smoked (conj)
regeneration . (punct)
provocation pinch (appos)
developed day (dobj)
active combination (nsubj)
administered month (nmod)
depression bupivacaine-induced (amod)
studies animal (amod)
rtms delivered (acl)
necrotizing although (mark)
ketamine of (case)
female 29-year-old (amod)
recommended instructions (nmod)
reduction bp (nmod)
compares , (punct)
concentrations (-)-cibenzoline (nmod)
collected injection (dep)
igf-i or (cc)
measure efficacy (nmod)
flow as (cc)
fibrosis ventricles (nmod)
patients premedicated (acl)
aortic or (cc)
derivatives anthraquinone (compound)
continued has (aux)
doxorubicin 1mg/kg/week (appos)
assess risk (dobj)
treated testosterone (nmod)
ke l/kg (dep)
626 431 (conj)
prilocaine glucose (nmod)
used ecg (nsubjpass)
thrombo-embolism risk (nsubj)
test v2.0 (dobj)
recovery hypertension (nmod)
trimester pregnancy (nmod)
acetyltransferase choline (compound)
benzisoxazole antipsychotic (amod)
postulated have (aux)
array a (det)
biomarkers conversion (nmod)
contains . (punct)
heterogeneous , (punct)
function important (amod)
mhb a (det)
considered administration (nsubjpass)
dose " (punct)
consisted detection (nmod)
different changes (nsubj)
compared difference (nmod)
radioactivity or (cc)
users 2 (dep)
expression syndrome (nmod)
full almost (advmod)
scores sec. (compound)
1993 from (case)
induced hz (nmod)
proteins urine (compound)
assays and (cc)
forthcoming demands (dobj)
cultures beating (compound)
cent per (compound)
erections nocturnal (amod)
ventricle arterial (conj)
neurosteroids potent (amod)
aimed largest (xcomp)
treated cells (nsubjpass)
improvement correlated (acl:relcl)
use tamoxifen (compound)
availability . (punct)
syndrome wiskott-aldrich (amod)
mg morphine (compound)
oc 3.10 (appos)
serum daptomycin (compound)
domperidone antagonist (appos)
severe first (nmod)
thickened markedly (advmod)
nerves from (case)
toxicities toxicities (conj)
aconitine with (case)
organization current (amod)
stabilized and (cc)
thought result (nmod)
values frequencies (conj)
increased similar (advcl)
extract mart (conj)
i.v. ; (punct)
meat fish (conj)
safe administration (nsubj)
1983 in (case)
levels nonusers (nmod)
mean + (cc)
suppressed proliferation (nsubjpass)
rh ( (punct)
loss appetite (nmod)
locomotor and (cc)
revealed eyes (nmod)
level-dependent oxygen (compound)
males strains (nmod)
attenuates by (case)
found mortality (dobj)
influences mechanisms (nmod)
ds only (advmod)
patients care (compound)
correlate hallucinations (nsubj)
analyzer the (det)
micrograms microliter (nmod)
cgs ( (punct)
patient in (case)
investigated potential (nsubjpass)
similar observed (parataxis)
diet hp (compound)
test wilcoxon (nmod:poss)
mandates . (punct)
protocol and (cc)
was returned (advcl)
cisapride nm (appos)
involved pathway (nsubjpass)
drug kf17837 (nsubj)
wanted . (punct)
exerted could (aux)
received cp (dobj)
n= ( (punct)
anxiogenic- and (cc)
increase co (nmod)
affects whether (mark)
reversed episodes (nsubj)
kcl mm (amod)
therapy cases (nmod)
suggest role (dobj)
obtained and (cc)
develops , (punct)
pirenzepine the (det)
given infusion (nmod)
38 18 (compound)
atropine with (case)
species particular (amod)
reduced ( (punct)
determined changes (nsubjpass)
due be (cop)
functions quadriceps (amod)
sex and (cc)
pretreatment blocker (nmod)
associated ingestion (nmod)
had follow-up (nmod)
receive who (nsubj)
ability this (det)
evaluation prospective (amod)
catheterization heart (compound)
depth sedation (nmod)
sprouting and (cc)
a val204asp (appos)
receive mg/m(2 (dobj)
sensitized conclusion (nmod)
dose mtd (appos)
exceed dose (nsubj)
acid antagonist (appos)
0.0001 p (dep)
site same (amod)
parameters individual (amod)
cognitive psychomotor (conj)
i t (conj)
evoked stimulation (nmod)
lead hypertension (nmod)
saralasin inhibitor (dep)
reduction neurotransmitters (nmod)
defect dogs (nmod)
0.99 , (punct)
stimulation tactile (compound)
conclusion glutamate (acl:relcl)
inhibits dopamine (dobj)
assigned patients (nsubj)
demonstrated contrast (nmod)
women hiv (nmod)
free pain (advmod)
region 5-ht (compound)
cas : (punct)
macroglobulinaemia with (case)
group fourth (amod)
model nociception (nmod)
increases increase (dobj)
la with (case)
discussion associated (dep)
thought that (nsubjpass)
reductions drug-induced (amod)
cd4 lymphocytes (conj)
noncompliance , (punct)
contact cutaneous (amod)
affected and (cc)
conclusions children (appos)
ranged necrosis (nmod)
complications transplantation (nmod)
associated cohort (nmod)
similar population (dep)
areas focal (amod)
aged 23 (nummod)
effect consistent (amod)
vascular and (cc)
hem ( (punct)
proteins middle (amod)
mg 150 (nummod)
efficacy factors (conj)
elected who (nsubj)
completed a (dobj)
levels ldl (compound)
proteinuria and (cc)
glycol propylene (compound)
difference depression (conj)
mm3 100 (nummod)
deal and (cc)
used successfully (advmod)
resulted urea (advcl)
years range (dep)
review knowledge (nmod)
extracts homogenates (nmod)
developed transplantation (dobj)
termination since (case)
given corticosterone (dobj)
administration stz (compound)
doses baseline (compound)
observed change (nsubjpass)
systems gabaergic (amod)
days times (nmod:tmod)
result whether (mark)
those need (acl:relcl)
defect produced (acl)
displayed kidneys (nsubj)
doses txa (nmod)
k(na the (det)
users is/tia (nmod)
antagonists placebo (conj)
accompanying norepinephrine (dobj)
plan health (compound)
hindpaw rat (nmod)
remoxipride benzene (conj)
associated changes (nsubjpass)
sensitive be (cop)
0.24+/-0.06/h td (nmod)
control disease (compound)
accompanied days (nmod)
dexmedetomidine high (amod)
phenobarbitone of (case)
liberate animals (nmod)
coma failure (appos)
abnormalities uptake (nmod)
granulomatosis 's (case)
augmented ltp (dobj)
activity vasodilator (compound)
induced subsequently (advmod)
showed already (advmod)
marker early (amod)
controls microprolactinoma (conj)
aware especially (advmod)
pathway excretion (nmod)
glomerular tubulointerstitial (conj)
intervention percutaneous (amod)
models multilevel (compound)
component early (amod)
stopped revealed (advcl)
adrenaline drugs (nmod)
susceptible . (punct)
syndrome 's (case)
shortening intervals (nmod)
presence opioids (nmod)
ability cause (acl)
atropine , (punct)
clarified . (punct)
time event (nmod)
granulomatosis after (case)
death sudden (amod)
calculated data (nmod)
hepatitis aggressive (amod)
extent hypotension (nmod)
identical be (cop)
recurrences one (nummod)
effective suppressing (advcl)
contribution valproate (nmod)
scheduled as (mark)
property cd-832 (nmod)
use from (case)
aggregation coagulation (conj)
detect slowing (dobj)
morphine mg/kg (dep)
patient hepatitis (compound)
levels insulin (compound)
loss sensorineural (amod)
dexrazoxane high (conj)
preparations these (det)
investigated view (nmod)
emission single-photon (compound)
detectable that (nsubj)
importance : (punct)
report pain (dobj)
norms awake (amod)
doxorubicin conventional (amod)
postulated cells (nsubjpass)
showing decrease (dobj)
antagonist 5-hydroxytryptamine4 (compound)
cause psychosis (dobj)
diltiazem before (case)
cells ( (punct)
contractions tonic (amod)
exert action (dobj)
goal important (amod)
correlated effects (nmod)
activity mean (amod)
stimulation activity (nmod)
anaesthetised were (auxpass)
katona ; (punct)
forms therapy (nmod)
decrease count (nmod)
verapamil by (case)
rates with (case)
paracetamol with (case)
microl % (appos)
characterized exposure (nmod)
percent seventy-one (nummod)
nuclear production (dep)
units centers (nmod)
distinguish not (neg)
dose methylprednisolone (nmod)
quality extracted (conj)
followed-up were (auxpass)
markers on (case)
increases rates (nsubj)
modulation to (mark)
co-administration desipramine (nmod)
activity improving (compound)
attack stroke (compound)
resulted recovery (nmod)
installing rapidly (advmod)
technique laser (compound)
da in (case)
changes lipoproteins (nmod)
evaluated directly (advmod)
tissue brain (compound)
rechallenge with (case)
exacerbated coagulopathy (dobj)
12.2 1.1 (compound)
overdosage-induced acid (nmod:npmod)
anemia nonregenerative (amod)
fed l-485 (dobj)
contribution site (nmod)
disorders organic (amod)
male wistar (conj)
conduction nerve (compound)
decreased two (nmod)
calcium dose (compound)
was course (attr)
administration sch (compound)
laboratory research (compound)
stimulating receptors (dobj)
microl/side ( (punct)
anaesthetised ketamine (nmod)
systolic both (cc:preconj)
unsafe carries (conj)
targets effects (nmod)
shown pre-treatment (nsubjpass)
result should (aux)
blunted absence (nmod)
role stress (nmod)
associated doses (nsubjpass)
platform from (case)
mg < (dep)
spectrum patients (nmod)
treated were (auxpass)
= point (nmod)
potentials low (amod)
aware was (cop)
stress preservation (conj)
component contraction (nmod)
bp > (conj)
2.5 , (punct)
episodes 59 (nummod)
show areas (dobj)
concentration potassium (nmod)
demonstrated interferes (ccomp)
investigated role (nsubjpass)
candidates who (nsubj)
imaging for (case)
cases with (case)
subregions the (det)
ci % (compound)
ileostoma the (det)
microm respectively (advmod)
-/- dbh (compound)
cities us (compound)
1-hr mg (nummod)
200 299 (conj)
phenomenon men (nmod)
vegfr-2/flk-1/kdr ) (punct)
effectiveness ranitidine (nmod)
distinguish to (mark)
pentobarbital event (nmod)
tool and (cc)
hallucinations associated (acl)
wk 12 (nummod)
furosemide radiocontrast (nmod)
tested subsequently (advmod)
arteries other (amod)
allografts were (cop)
impaired was (cop)
described cardiomyopathy (nmod)
ko in (case)
saline 5711 (nummod)
antigen pcna (appos)
need part (nmod)
formulation galenic (amod)
mm were (cop)
regulation liver (nmod)
used where (advmod)
carcinoma grade (compound)
stent paclitaxel-eluting (amod)
injected i.v. (nsubjpass)
sites central (amod)
phase 0 (nummod)
communicate we (nsubj)
cause agents (nsubj)
cat ) (punct)
suggests produce (ccomp)
dissolution sarcomeric (amod)
anemia because (case)
cholestasis ticlopidine-induced (amod)
defect echocardiography (nmod)
hepatotoxicity possible (amod)
role only (advmod)
benzo[a]-pyrene mg/kg (appos)
is necessary (acomp)
behaviours passive (amod)
administration potential (nmod)
performs role (dobj)
efficacy in (case)
compare prevalence (dobj)
isocortical and (cc)
factor angiopoetin-2 (conj)
had tended (conj)
autoradiography by (case)
remains overall (advmod)
ingested was (auxpass)
amiodarone after (case)
ulcers and (cc)
bilateral inhibitory (dep)
response dose (nmod)
group food (nmod)
apical with (case)
induction tumor (compound)
coadministration hibiscus (nmod)
scans angiography (compound)
function formation (conj)
doses tested (acl)
memory ) (punct)
following as (mark)
antihyperalgesia morphine (compound)
intake food (compound)
lid on (case)
predictable was (cop)
found results (nsubjpass)
scans with (case)
caused seen (conj)
rate discontinuation (compound)
= 0.63 (dobj)
p 0.025 (dep)
counterbalanced double-blind (dep)
analogue has (acl:relcl)
hospitalization the (det)
unchanged cmro2 (nsubj)
36 [ (punct)
known it (nsubjpass)
confined that (mark)
granulated were (auxpass)
ceased patients (nmod)
np free (amod)
led reduction (nmod)
edema role (dep)
infections nonviral (amod)
toxicity cyanide (compound)
mice lack (acl:relcl)
concluded can (aux)
cancer not (neg)
dermatitis utility (conj)
damage propylthiouracil-induced (amod)
p.o. ; (punct)
infiltration eosinophils (nmod)
administrated drug (nsubjpass)
useful nifedipine (nsubj)
induce apoptosis (dobj)
correlated ; (punct)
75 25 (compound)
obtained humans (nmod)
reduce % (nmod)
defect by (case)
patients patients (dep)
ma mg/kg (dep)
discontinued simvastatin (nsubjpass)
relief considerable (amod)
endocarditis staphylococcal (amod)
exposure every (det)
establish guidelines (dobj)
carteolol of (case)
sensitivities strain (amod)
combination bortezomib (nmod)
infants . (punct)
cyclophosphamide risk (conj)
exhibited mild (dobj)
furosemide of (case)
regurgitation moderate (amod)
nelarabine cyclophosphamide (conj)
glomerulopathy transplant (compound)
period overnight (amod)
diethylpropion stimulant (amod)
nature injury (nmod)
prevented treatment (nmod)
% 7.0 (nummod)
preserved effects (nsubjpass)
prevented been (auxpass)
these eight (conj)
prevented antagonist (conj)
isolated had (aux)
affinity rats (nmod)
conclude severe (ccomp)
subset an (det)
increased conclusion (nmod)
scores by (case)
vecuronium serum (compound)
administered chloride (dobj)
abolished whereas (dep)
displayed acetaminophen (advmod)
mechanistic from (case)
effects ( (punct)
experienced dogs (nsubj)
switched nephrotoxicity (nmod)
contribute cells (nsubj)
exercise the (det)
concentration arrhythmia (nmod)
caused and (cc)
syndrome cardiomyopathy (dep)
signs major (amod)
1- 3-day (conj)
opens possibility (dobj)
experiments mice (nmod)
weeks before (nmod)
men hiv-positive (amod)
% 9.89 (nummod)
foci preneoplastic (amod)
animals same (amod)
lamivudine agent (compound)
incorporation adenosine (nmod)
tension wall (compound)
precautions . (punct)
lisinopril and (cc)
discontinue and (cc)
pseudo-allergy caused (acl)
delay intra-hisian (amod)
cases schizophrenia (nmod)
acts effect (nsubj)
hepatocytes resemble (acl:relcl)
were drugs (nsubj)
determine difference (dobj)
remained had (conj)
igg iga (conj)
tumor estrogen-induced (amod)
compare influence (dobj)
pretreatment phenylbutazone (conj)
treatment oral (amod)
people four (nummod)
sign overlooked (amod)
transfer after (case)
markers characteristics (conj)
group dimer-x (compound)
demonstrated 5 (nmod)
counseling and (cc)
years working (acl)
dobutamine and (cc)
groups support (compound)
mglu ) (punct)
studied method (nmod)
identified 1991 (nmod)
wounds of (case)
sensitive children (nsubj)
syndrome hematologic (amod)
schedule convenient (amod)
chemotherapeutics with (case)
doses rescue (conj)
seeing parasites (dobj)
mouth in (case)
change contrast (nmod)
hyperthermia alterations (conj)
accuracy responses (nmod)
secondary that (mark)
earlier sometimes (advmod)
patients ls (nmod)
weight suspended (acl)
effects cataract (nmod)
250 right (nmod)
administered acid (nsubjpass)
improve dyskinesia (dobj)
normal initially (advmod)
discontinued reduced (conj)
administered mk-801 (nsubj)
effect been (cop)
focus less (advmod)
glomerulosclerosis , (punct)
injection carcinostatics (nmod)
pge2 bladder (nmod)
induced isoniazid (nmod)
antagonism of (case)
improve did (aux)
perfusion on (case)
dose moderate (amod)
convulsions responsive (amod)
arrhythmia : (punct)
demonstrated analysis (nsubj)
elevated 2c (nsubjpass)
improve analgesia (dobj)
p<0.001 diabetic (nmod)
intervals 4 (nummod)
incidence hearts (nmod)
anesthetics two (nummod)
appears although (mark)
mg 2 (nummod)
worsened symptoms (nsubj)
persisted effects (nsubj)
designed clarify (xcomp)
factor possible (amod)
patients non-hispanic (amod)
found reverse (xcomp)
unclear although (mark)
blocked mecamylamine (nmod)
minimal-type nephropathy (dep)
inactivation inhibition (appos)
mice receptor-deficient (amod)
attempts produced (conj)
evaluation morphological (amod)
glutamate hippocampal (compound)
undergone who (nsubj)
overactivation with (case)
used animals (dobj)
examine effects (dobj)
15.0 1.5 (conj)
anabolizing agents (dobj)
identified controls (nmod)
locf and (cc)
recognized cases (nmod)
bun creatinine (conj)
characterized whereas (mark)
produced block (dobj)
derivatives gag (compound)
affected outcome (dobj)
deferoxamine , (punct)
reviewed efficacy (conj)
rate dysfunctions (nmod)
presented h (nmod)
adenomyosis to (case)
increase forces (nmod)
pressure glomerular (amod)
showed affinities (dobj)
administration iodinated (amod)
latency cocaine-dependent (nmod)
prevented clinical (nmod)
cells/mm3 tolerated (acl:relcl)
withdrawal upon (case)
long-term open-label (conj)
threshold seizures (nmod)
suggesting signs (dobj)
flurbiprofen treatment (nmod)
involving hospitals (dobj)
form receptors (dobj)
developed syndrome (nsubj)
enabled analysis (nsubj)
injury proteinuric (amod)
patients experienced (acl:relcl)
narcosis pharmacological (amod)
week second (amod)
has properties (dobj)
demonstrated consolidation (dobj)
pretreated were (auxpass)
injected inadvertently (advmod)
2 h (dep)
expression p75(ntr (compound)
3-methylcholanthrene mc (appos)
attempt overcome (acl)
pinch ) (punct)
attributable p (nmod)
protects cardiac (nmod)
positive challenge (nsubj)
group equal (conj)
min infusion (nmod)
gating nucleus (nmod)
piloerection by (case)
experienced intoxication (dobj)
arteries both (preconj)
tuberculosis drug-resistant (amod)
illness an (det)
achieved been (auxpass)
beraprost and (cc)
presentation poisoning (nmod)
cells nucleotide-gated (conj)
other tested (dep)
compressed be (auxpass)
range across (case)
effects depressants (nmod)
life not (neg)
effects impairment (nmod)
sv ( (punct)
bacteremias fewest (amod)
70/101 ) (punct)
psychosis disorders (conj)
insulin crystalline (compound)
investigated reviewing (advcl)
demonstrated none (conj)
population for (case)
factors loss (nmod)
received infusions (dobj)
agents cancers (nmod)
breath esthetics (conj)
regressed symptoms (nsubj)
sensitivities for (case)
evaluable remission (nmod)
g-1 ( (punct)
administration dup (nmod)
effects respect (nmod)
suggests role (dobj)
subjected that (mark)
that (+)-propranolol (nmod)
change pressure (compound)
revealed infiltrate (dobj)
54.5 , (punct)
8.5 ratio (nsubj)
male 17-year-old (amod)
alternate indicated (advcl)
highlights study (nsubj)
lesioned groups (dep)
experienced bacteremia (dobj)
epilepticus pilocarpine-induced (amod)
rest at (case)
depression increased (amod)
increases prevalence (dobj)
failure patient (nmod)
dose 10(-6 (nmod)
effect ocular (amod)
combination development (nmod)
months use (nmod)
change between (case)
blockade inhibitor (nmod)
antagonist dual (amod)
attack no (neg)
diagnosis siadh (nmod)
resulted deterioration (nmod)
current ( (punct)
one agonists (nsubj)
placebo- and (cc)
esrd % (nmod)
leukemia myeloblastic (amod)
mmhg 22/11 (nummod)
modulation intensity (nmod)
disease doctor-diagnosed (amod)
woman malawian (amod)
reduces : (punct)
infants term (compound)
women pregnancies (nmod)
syncope in (case)
cord in (case)
determine safety (dobj)
weeks adr+los(12 (conj)
discontinuation replacement (conj)
fluctuations dyskinesia (conj)
coma with (case)
curve tolerance (compound)
dynamics leakage (conj)
efv ( (punct)
% 0.6 (nummod)
maximal that (mark)
generated we (nsubj)
embarked was (auxpass)
discussion exception (nmod)
provided protection (dobj)
mm 24.7/16.6 (amod)
copenhagen of (case)
ergotamine mg/caffeine (dep)
affected rats (nmod)
ci 1.91 (nummod)
reason this (det)
assessed not (neg)
cases 9 (nummod)
was change (attr)
clinic gynecology (compound)
fentanyl by (case)
variety a (det)
years diagnosis (nmod)
membrane-cytoskeleton cytosol (conj)
result hcfcs (nsubj)
men among (case)
presents days (nmod)
prescribed used (conj)
patients controls (nmod)
action configuration (nmod)
fashion number (conj)
conclusion involved (appos)
indians groups (conj)
10 seven (compound)
administration fentanyl (amod)
damage hepatic (amod)
component amoxicillin (compound)
interviewed . (punct)
appeared part (nmod)
produce administration (nsubj)
therapy high-dose (amod)
induced flow (nsubj)
stages during (case)
ability pregs (nmod)
infusion phenylephrine (compound)
vehicle days (appos)
mechanisms neuropathy (nmod)
high have (aux)
successful reducing (advcl)
subgroup this (det)
need . (punct)
turnover striatal (amod)
right side (dep)
elevations with (case)
tumorigenesis (bha)-induced (amod)
hazardous might (aux)
found measure (xcomp)
shoed . (punct)
prophylaxis is (cop)
formation concomitant (amod)
gabapentin , (punct)
agranulocytosis and (cc)
medication argatroban (amod)
cycle one (nummod)
nodosum erythema (compound)
prescribing of (case)
400 500 (conj)
i.e. 2 (nummod)
35 thrombosis (nmod)
subgroup in (case)
nf-kappab ) (punct)
core territory (nmod)
ck ( (punct)
atrophy manifestation (nsubj)
syndrome legs (compound)
brain cord (conj)
0.02 than (case)
majority a (det)
house around (case)
reduction asymptomatic (amod)
26 23 (compound)
were degeneration (attr)
substantial stable (conj)
preparation isolated (amod)
has rat (nsubj)
antagonist profile (dep)
antioxidant , (punct)
recall could (aux)
adenocarcinoma with (case)
titrated dosing (advcl)
events no (det)
woman a (det)
antagonists h2-receptor (amod)
had increase (dobj)
management therapy (conj)
localization central (amod)
ameliorate damage (dobj)
absorbed is (auxpass)
rate each (det)
taking placebos (dobj)
value trial (appos)
achieved reduction (nsubjpass)
administered once (advmod)
contained cholesterol (dobj)
group degeneration (conj)
increases follow-up (nmod)
injection 14c-41 (nmod)
effective demonstrated (advcl)
diligent interviewing (advcl)
transporter ) (punct)
vasoactive . (punct)
residence of (case)
volumes of (case)
smad3 of (case)
shown episode (nmod)
had action (dobj)
bmt ) (punct)
dexamethasone mesna (conj)
exposure doxorubicin (compound)
preparations ventricular (amod)
prevents dexmedetomidine (nsubj)
exposed compounds (nmod)
response increased (amod)
generation control (conj)
= treatment (nmod)
ngf of (case)
elderly young (conj)
developed weeks (nmod:tmod)
mean resting (amod)
found substances (nsubjpass)
unknown previously (advmod)
entities , (punct)
train pulses (nmod)
recorded occurrence (nmod)
factors angiogenesis (compound)
best . (punct)
circumference knee (nmod)
corticosterone dietary (amod)
observed leukocytosis (nsubjpass)
resistance coronary (amod)
protection seizures (nmod)
mmse in (case)
compound this (det)
distress severe (amod)
transmission cholinergic (amod)
decreased aggregation (nsubj)
were effects (attr)
produced neuroleptics (nmod)
grafts ) (punct)
anemia immunodeficiencies (conj)
setting hospital (dobj)
phase intervention (compound)
al 1989 (nummod)
cause management (conj)
b1r ) (punct)
pseudoprolactinoma with (case)
casts such (case)
observed results (nmod)
detected consistent (parataxis)
become technique (attr)
prevent test (nmod)
hfd ) (punct)
eyes 11 (nummod)
stimulation women (nmod)
sample as (case)
10(6 ) (punct)
shows replicate (ccomp)
effects proinflammatory (amod)
orally po (appos)
toxicity subjects (nmod)
induced probably (advmod)
area per (case)
rats % (dep)
patient received (acl)
thromboses e.g. (advmod)
clinical with (case)
hypotension antidepressant-induced (amod)
under is (cop)
response airway (compound)
endonuclease-dependent ( (punct)
recording basal (amod)
identifying , (punct)
interpretation data (nmod)
variants of (case)
responses % (conj)
dehydrogenase dihydropyrimidine (compound)
hours patient (nmod)
pressure inhibition (nmod)
insufficiency thrombocytopenia (conj)
reaction semi-quantitative (amod)
different a (det)
revealed study (dobj)
accounting neuropathy (nmod)
activates nicotine (nsubj)
levels bupivacaine (compound)
was compare (xcomp)
limbs of (case)
role pergolide (nmod)
decreased 5-hiaa (conj)
causes triggers (conj)
cells afferent (amod)
calcification on (case)
administered atp (nsubjpass)
symptoms depression (compound)
determination , (punct)
cells rats (nmod)
treated : (punct)
decreased mmhg (nmod)
report an (det)
effect since (case)
changes modulation (conj)
growth d. (conj)
l. crocus (compound)
appear excretion (nmod)
synthesis protein (compound)
complete ( (punct)
had comparison (nmod)
estimated number (nmod)
associated manifestations (nmod)
ascertain aminonucleoside (nmod)
take changes (nmod)
movements left (amod)
time additional (amod)
disorders menstrual (compound)
bundle papillo-macular (amod)
two failure (nmod)
percentage ( (punct)
months surgery (nmod)
showed susceptibility (dobj)
antagonized ly274614 (nmod)
hepatotoxicity induced (acl)
regulated . (punct)
confirmed paraffin-sections (nsubj)
suggest established (advcl)
treatments in (case)
disorders hypotension (conj)
% 25 (nummod)
species excretion (conj)
chemotherapy high (amod)
method estimating (amod)
biochemical , (punct)
infusion acid (conj)
bladder second (amod)
bacilli gram-negative (amod)
model mixed (amod)
response theophylline (nmod)
modalities ( (punct)
order increase (acl)
fields electrophysiology (conj)
failed reverse (xcomp)
showed assessments (nsubj)
increased 113 (nmod)
changes myocardial (amod)
informed poorly (advmod)
glutamine related (amod)
suggested anencephaly (nsubjpass)
effective patients (nmod)
developed which (nsubjpass)
studied patients (dep)
ninety-nine patients (nmod)
unchanged levels (nmod)
day 8 (compound)
study find (conj)
pbo with (case)
medications face (nmod)
infused infusion (nmod)
gain reader (nsubj)
stimulation thermal (amod)
develop monkeys (nmod)
drugs those (det)
bypass on (case)
entrapment nerve (compound)
treatment cisplatin (nmod)
improved month (nmod)
summarizes creating (advcl)
21 gestation (nmod)
after plus (cc)
cotransporter na(+)-k(+)-2cl(- (compound)
man 37-year-old (amod)
have disorders (dobj)
found pretreatment (nsubjpass)
activity increase (nmod)
alopecia arthralgias/myalgias (conj)
infused rate (nmod)
dose overall (amod)
expression injury (nmod)
injections globulin (nmod)
% vs. (advmod)
appearance . (punct)
adsd for (case)
2 10 (compound)
laboratory ( (punct)
paraventricular and (cc)
injecting once (advmod)
responses teoaes (compound)
1991 1999 (conj)
pad a (det)
prescribed class (nsubjpass)
case pointes (nmod)
shunt this (det)
exposure with (case)
impairments executive (amod)
decreased ng/ml (nmod)
dec. 1999-nov (nummod)
increased interval (dobj)
therapy . (punct)
patients c. (nmod)
decreased nadir (dep)
stage of (case)
enlargement wastage (conj)
treated rejection (nmod)
uptake l-arginine (compound)
effects hypertrophy (nmod)
scans patients (nmod)
alf n=35 (appos)
drug prescribed (acl)
inhibition iib/iiia (compound)
weight clearance (conj)
helpful may (aux)
weeks mm (dep)
water their (nmod:poss)
surgery therapy (conj)
cue rats (nmod)
setting patients (dobj)
antioxidants and (cc)
gavaged gspe (dobj)
weeks i.v. (compound)
beta-blockers both (det)
assess presence (dobj)
telmisartan and (cc)
uncommon nephrotoxicity (nsubj)
caused patients (nmod)
enhanced bradycardia (nsubjpass)
g/dl of (case)
maximal day (nmod)
infusion achieve (acl)
infusion versus (cc)
needed dialysis (dobj)
greatest . (punct)
rates complication (nmod)
method useful (amod)
access brain (compound)
fed randomized (conj)
rhabdomyolysis as (case)
class state (conj)
provoked nitroglycerin (nmod)
lacks effects (dobj)
introduce to (mark)
inhibition activity (dep)
occurrence seizure (nmod)
reached regard (nmod)
effect unusual (amod)
naloxone levels (dep)
chorea encephalopathy (conj)
impairs acuity (dobj)
rauwolscine kg-1 (dep)
doses paracetamol (nmod)
intermediate reactive (amod)
used decrease (nmod)
needle loss (nmod)
encoding with (case)
risk complications (nmod)
add . (punct)
effect memory (nmod)
given each (xcomp)
episodes manic (amod)
disappearing , (punct)
mmecs in (case)
gemfibrozil or (cc)
myocet or (cc)
alpha2abc-knockout mice (dep)
december through (case)
area ) (punct)
lower data (nsubj)
levels glutathione (compound)
ligands affinity (compound)
therapies anti-adenoviral (amod)
test velocity (appos)
conclude disrupts (ccomp)
97.1 range (dep)
suxamethonium mg (dep)
interaction alpha2- (nmod)
complications major (amod)
diplopia sudden (amod)
shortened convulsion (nmod)
delivery new (compound)
dox weekly (amod)
intensity convulsions (nmod)
auc ) (punct)
widened interval (nsubj)
was group (nmod)
treatment adriamycin (compound)
impairment patients (nmod)
clinical autopsy (conj)
hydroxylase serotonin (conj)
epilepticus following (amod)
model pain (nmod)
diazepam anaesthesia (nmod)
rupture vessel (compound)
toxicity interaction (nmod)
gnc92h2 antibody (compound)
exhibited correlated (dep)
rating signs (conj)
3.8 , (punct)
groups 's (case)
exception hydrocephalus (conj)
inhibitor smad3 (compound)
levels nerves (nmod)
facilities all (det)
embryo developing (amod)
actions systems (nmod)
angioedema inhibitor-associated (amod)
bands , (punct)
psychosis s-ketamine (compound)
free and (cc)
weakness lethargy (conj)
model catheterized (amod)
male adult (amod)
infection proteus (compound)
case polymyositis (nmod)
comment and (cc)
telemetry by (case)
showed number (dobj)
areas related (amod)
shared not (neg)
received interferon-alpha-2b (dobj)
hours collection (nmod)
disabling highly (advmod)
dyskinesia alterations (conj)
headache headaches (nmod)
nx in (case)
drc k (appos)
cases compared (case)
abdominal and (cc)
micrograms placebo (nmod)
toxicity both (cc:preconj)
ng/min 25 (nummod)
thrombin of (case)
injections daily (amod)
points possible (amod)
attempt choose (xcomp)
coefficient correlation (nsubj)
granulomatosis for (case)
produce evidence (dobj)
month ( (punct)
idiosyncratic probably (advmod)
765 g/cm(2 (dep)
deterioration hyperkinesis (nmod)
rash eosinophilia (conj)
nag marker (appos)
190 80 (conj)
postpartum concentrations (compound)
complaining of (case)
interactions effects (conj)
therapy current (amod)
appeared but (cc)
leads 16 (nummod)
unassigned : (punct)
utilized model (dobj)
displace . (punct)
performed 1 (meta)
progressed five (nsubj)
ticlopidine of (case)
anesthesia during (case)
reactions p (nmod)
del rs6277 (conj)
dropping out (prep)
assess use (dobj)
25.4 2.0 (conj)
admitted . (punct)
hypercalcemia arrhythmia (conj)
address parameters (dobj)
important and (cc)
findings angiography (nmod)
found polyuria (nsubjpass)
investigated june (nmod)
leghorn white (compound)
carried also (advmod)
lvef of (case)
canine preparations (conj)
common which (nsubj)
use to (mark)
area femoral (amod)
persons hallucinations (nmod)
lymphadenitis severe (amod)
erythroblasts of (case)
involvement on (case)
syndrome benign (amod)
electrocardiograms and (cc)
correlation within-subject (amod)
dogs maintained (acl)
plexus interscalene (compound)
cause major (amod)
acid tiaprofenic (amod)
detectable imaging (nmod)
dyskinesia hallucinations (conj)
daytime the (det)
reached ( (punct)
indicate conclusions (dep)
h. 48 (nummod)
levels maximum (compound)
disorders hyperthermia (nmod)
vagal neither (cc:preconj)
monitored signs (nmod)
exert ways (nmod)
admitted days (nmod)
suggest indicate (conj)
appropriate may (aux)
area fixed (amod)
resistant developing (advcl)
exist cells (nmod)
arrhythmia adrenaline-induced (amod)
contribution repair (nmod)
daytime symptoms (dep)
antagonism sustained (acl:relcl)
ages discharge (conj)
observed reductions (nsubjpass)
6 pressure (nsubj)
injection bromocriptine (nmod)
combination everolimus (nmod)
lesion travelling (acl)
presented . (punct)
step to (mark)
disintegrin of (case)
loop pallidothalamocortical (amod)
hypercalcemia b (appos)
venous , (punct)
attenuated restored (conj)
modifies catalepsy (dobj)
abstinence maternal (amod)
received followed (advcl)
patient related (amod)
applied separated (advcl)
suggest effects (nsubj)
agonist , (punct)
therapy add-on (amod)
resuscitation at (case)
plexus choroid (amod)
cases demonstrated (acl:relcl)
basis trial (nmod)
km vmax (conj)
treat we (nsubj)
avoided been (auxpass)
activity non-reactive (amod)
fraction , (punct)
alteration pathway (nmod)
use aerosolized (amod)
4-damp 4-diphenylacetoxy-n-methylpiperidine-methiodide (appos)
trial therapeutic (amod)
administration before (nmod)
mainstay treatment (nmod)
exerted . (punct)
5-fluorouracil mtx (dep)
investigator by (case)
expression neurons (nmod)
persisted mice (nmod)
excess serotonin (compound)
genotyped . (punct)
addition dose (nmod)
relationships dose-response (amod)
caused impairment (dobj)
% 41.4 (nummod)
offers venue (dobj)
nucleus brain (nmod)
administered intravenously (advmod)
found show (ccomp)
managed . (punct)
binding both (cc:preconj)
carriers hbv (compound)
% 13/50 (appos)
abnormalities neurological (amod)
lower etoricoxib (nmod)
average on (case)
induce tdp. (dobj)
sex weighing (conj)
muscles several (amod)
nodules carcinomas (conj)
restricted may (aux)
assigned subjects (nsubjpass)
aware monitor (conj)
induced heart (nmod)
related patients (advcl)
medication methyldopa (nsubj)
biopsies liver (compound)
volumes 7.8 (nummod)
myelosuppression % (nmod)
group assessable (amod)
investigated models (nmod)
1991 1993 (conj)
elevated damage (nmod)
associated fall (nsubjpass)
653 174 (conj)
2.3 +/- (cc)
hypertension anemia (conj)
presence baseline (nmod)
phenobarbitone with (case)
fibres regenerating (compound)
appeared insipidus (xcomp)
five-fold levels (nmod)
neuroleptics atypical (amod)
cultures all (det)
backgrounds in (case)
levels hit (compound)
used activation (nsubjpass)
toxicity azt-induced (amod)
quick and (cc)
rats preweanling (compound)
modulates estrogen (nsubj)
groups their (nmod:poss)
days duration (nsubj)
dogs anesthetized (amod)
died pretreatment (nsubj)
g male (dep)
accompanying flush (dobj)
cases administration (nmod)
treated is (auxpass)
atropine and (cc)
cimetidine with (case)
improvement score (nmod)
assessed rates (nmod)
scales through (case)
disorder movement (compound)
temocapril inhibitor (appos)
cell and (cc)
icv assessed (conj)
occurred agranulocytosis (nsubj)
shown had (aux)
sbp ) (punct)
doses methotrexate (nmod)
appears useful (ccomp)
identified retention (nmod)
treated order (nmod)
tumors well-differentiated (amod)
toxicities thrombocytopenia (nsubj)
bzd/rd of (case)
comparable days (dep)
malondialdehyde this (det)
version assay (nmod)
stage , (punct)
ketoconazole by (case)
vasospasm the (det)
had arthritis (nmod)
indicator formation (conj)
level medium (nmod)
strain choice (nmod)
alterations structural (amod)
undergone to (mark)
line : (punct)
state this (det)
appeared vt (nsubj)
hypertension and (cc)
initiated episodes (dobj)
contributing . (punct)
acid-induced valproic (amod)
register trials (compound)
activation af (nmod)
oil crocin (conj)
carried was (auxpass)
fractions hippocampus (nmod)
black edds (nsubj)
republic congo (nmod)
staining gastrocnemius (conj)
damage caused (acl)
characteristics , (punct)
that volunteers (nmod)
hexamethylmelamine hmm (appos)
neurons spinal (amod)
increased creatinine (dobj)
infrequent myelopathy (nsubj)
pg-9 2-(p-bromophenyl)propionate (appos)
inhibition increases (nmod)
minor that (mark)
was patients (nmod)
retention urine (nmod)
ece-1 ( (punct)
didanosine hydrocortisone (conj)
astrocytes oligodendrocytes (conj)
generator called (amod)
signs dopamine (compound)
patients meeting (acl)
fed high (xcomp)
need labelling (nmod)
prevented hyperactivity (dobj)
commencement the (det)
hypertrophy lv (amod)
events treatment-emergent (amod)
group sedentary (amod)
experiments blood (compound)
crossover , (punct)
catalepsy a (det)
description . (punct)
determining i (dep)
record this (det)
course leukoencephalopathy (nmod)
inhibitors cox-2 (compound)
completed far (advmod)
effect hypotension (nmod)
rapid timely (conj)
measure a (det)
cause might (aux)
profile . (punct)
indicate conclusion (dep)
analogue d (compound)
anaesthetised methods (dep)
possibility precipitate (ccomp)
dementia acid-induced (amod)
reduced induced (conj)
total delayed (conj)
% os (nmod)
occurred association (nmod)
defined , (punct)
surgery hip (compound)
postpartum through (case)
role causative (amod)
management and (cc)
data the (det)
hypercalcemias related (amod)
effects accl0131 (dep)
post min (compound)
detected serum (nmod)
days 30 (nummod)
disruption and (cc)
concentrated . (punct)
hexamethonium after (case)
exposures low-level (amod)
reported glaucoma (nmod)
started weeks (nmod:tmod)
disorders system (nmod)
associated diabetes (nsubjpass)
blocked metabolism (nsubjpass)
included points (nsubj)
admissions period (nmod)
resistance demands (conj)
drug broad-spectrum (amod)
tolerance sensitivity (conj)
performed 1 (conj)
antagonist sr48692 (dep)
entries session (nmod)
ligands 5-ht1b (compound)
reached + (cc)
cisplatin with (case)
treatment that (mark)
analogue , (punct)
amiodarone patients (nmod)
included reaction (conj)
decreased prevented (conj)
activity antagonist (compound)
recurrence hepatitis (nmod)
0 45 (conj)
beginning week (nmod)
partial complete (conj)
induces ketamine (nsubj)
delivered woman (nsubj)
atypia sites (nmod)
diuretics potassium (appos)
weeks duration (nmod)
beta-ccm ( (punct)
methylprednisolone to (case)
recipients allograft (nmod)
protein protein (conj)
toxicity ) (punct)
hypotension snp (compound)
weight the (det)
administered argatroban (acomp)
puberty or (cc)
episodes thromboembolic (compound)
h. over (case)
neonates preterm (nsubj)
reported range (nmod)
treatment incontinence (nmod)
b perinatal (amod)
isoniazid experimental (amod)
controlled medication (nmod)
ginsenoside re (dep)
bradydysrhythmias , (punct)
mdp ) (punct)
adequate was (cop)
received ps (nsubj)
reduced other (nmod)
urd of (case)
deficits gray-matter (compound)
compared non-users (nmod)
aim distance (nmod)
induced bupivacaine (nmod)
vehicle their (nmod:poss)
cleared completely (advmod)
transport lipid (compound)
activity leukemia (nmod)
obtained isolation (nmod)
contraindicate or (cc)
discussion has (acl:relcl)
rats diet-fed (amod)
partially only (advmod)
suggestion a (det)
symptomatic similarly (advmod)
subjected patient (nsubjpass)
sunitinib such (case)
137 to (dep)
toxicity resulting (acl)
atorva water (conj)
site the (det)
patches became (advcl)
178 4 (conj)
had spikes (dobj)
power the (det)
microscopy immunofluorescence (compound)
reduce patients (nmod)
sustained was (auxpass)
decreased increased (conj)
synthesis endogenous (amod)
mortality disease (nmod)
97.1 /-2.3 (conj)
increase volume (nmod)
weight gland (compound)
isolated patients (nsubj)
pathogenesis into (case)
propranolol ( (punct)
interval hypertension (nmod)
ecgs blood (conj)
amount pressure (conj)
insomnia loss (conj)
reducing population (nmod)
acidity medication (nmod)
dose carboplatin (compound)
changed i.p. (advmod)
number total (amod)
haemorrhages with (case)
acid 5-hydroxyindoleacetic (amod)
nte ) (punct)
randomized october (nmod)
amplitude normalized (amod)
rtms " (punct)
known occur (xcomp)
subacute a (det)
died parameters (nsubj)
accumulation a (det)
last weeks (nmod:tmod)
neuropathy patient (nmod)
= 0.021 (dep)
cats anaesthetized (acl)
recruited subjects (nsubjpass)
sensitivity ; (punct)
streptozotocin icv (appos)
dose during (case)
total creatinine (conj)
those bupivacaine (nmod)
25 episodes (nmod)
effects lithium (compound)
dogs 12 (nummod)
questionnaire food-frequency (amod)
mac ) (punct)
finding pronounced (acl:relcl)
specific patient (nmod)
groups among (case)
subunits nuclear-encoded (amod)
project . (punct)
skeptical . (punct)
led investigation (nmod)
attack test (nmod)
use rifampin (nmod)
impairs subjects (nmod)
use agent (nmod)
venules the (det)
inhibition proliferation (nmod)
floor general (amod)
study 's (case)
mild , (punct)
relation alterations (nmod)
pilocarpine cholinergic (amod)
indicate associated (ccomp)
placebo- haloperidol-controlled (conj)
imply . (punct)
needs anticoagulation (amod)
adjustment with (case)
synapse (lpp)-granule (compound)
deliberate hypotension (dobj)
hazardous rupture (nmod)
= 37 (dobj)
monitoring 24-hour (nmod:poss)
amounts small (amod)
inhibited activation (nsubj)
hr 4 (nummod)
impact conditions (nsubj)
increased devoid (advcl)
baseline above (case)
1,3-butadiene and (cc)
had coarctation (dobj)
describe treatment (advcl)
pre-treated igf-il-3 (nmod)
treatment ace (compound)
suggested results (nsubj)
thalassemia transfusion-dependent (amod)
antagonist mice (nmod)
models models (conj)
tissue bladder (compound)
boston in (case)
failure syndrome (nmod)
rats l-485 (conj)
interpretation an (det)
company bristol-myers (compound)
responses standing (nmod)
treated sulindac (nmod)
developed delirium (dobj)
standard a (det)
total courses (nmod)
stopping despite (mark)
exerted interference (nsubjpass)
known that (nsubjpass)
min 21.6 (nummod)
assessed adjustment (dep)
ratios r-/s-isomer (compound)
injury progressive (amod)
-14.8 , (punct)
methylprednisolone gentamicin (conj)
described secondary (xcomp)
deficits cognitive (amod)
mumol/l 7.4 (nummod)
lowering dose (dobj)
increase > (nmod)
important although (mark)
gyrus temporal (amod)
garft ( (punct)
less equal (conj)
chemotherapy transplant (nmod)
15 approximately (advmod)
treated acid (nmod)
sedation with (case)
induced collagenase (nmod)
efficiency reported (amod)
enhanced analgesia- (dobj)
severity reactions (nmod)
antagonized increase (dobj)
micrograms 38.9 (nummod)
clinical mammographic (conj)
treated intravenous (nmod)
intact and (cc)
3 ( (punct)
involved activation (nsubjpass)
ablation , (punct)
therapies . (punct)
patients arterial (conj)
tpa ) (punct)
onset after (case)
operations of (case)
patients damage (nmod)
inhibits increases (conj)
b.i.d. mg (compound)
prednisolone prednisolone (conj)
neuropeptides caused (acl)
area auc (appos)
had compared (advcl)
level intracellular (amod)
attenuation amiloride (nmod)
cardiotoxicity patients (nmod)
ileum of (case)
corresponds , (punct)
administered doses (nmod)
interval 1.5 (appos)
factor radiotherapy (nsubj)
electroencephalogram , (punct)
effect mg/m2 (nmod)
thrombo-embolism , (punct)
hypothermia such (case)
mechanisms amino (compound)
% 18.1 (nummod)
g/day , (punct)
spillover plasma (nmod)
avoid or (cc)
attenuated addition (nmod)
reduced threshold (nsubjpass)
modification action (nmod)
pleural with (case)
conditioning rats (nmod)
trained group (nmod)
parallel neurons (nmod)
placebo or (cc)
maximal minimal (conj)
papaverine with (case)
kept limits (nmod)
or=2.5 mg/dl (acl)
induced transplantation (nmod)
subjects 22 (nummod)
areas with (case)
1.037 0.003 (conj)
sent was (auxpass)
environment with (case)
changes cerebral (amod)
t1/2 28.21 (nmod:npmod)
differ placebo (nmod)
solicited have (aux)
disorders abstracts (conj)
h for (case)
contamination derivatives (nmod)
absence due (case)
performance to (case)
role detection (nmod)
practiced . (punct)
difference statistical (amod)
normotensive society (dobj)
prescribed commonly (advmod)
toxicity visual (amod)
severe located (conj)
studies dose (conj)
anxiety changes (dep)
cycles 21-day (amod)
csa fk506 (appos)
increased pressure (nsubjpass)
hippocampal in (case)
mid- on (case)
administration 5-hydroxytryptophan (nmod)
submitted effects (nmod)
epo with (case)
anaphylaxis penicillin (nsubj)
micrograms/kg/min ( (punct)
reduced it (nsubjpass)
therapy discontinued (acl)
events significant (amod)
mono-infected for (case)
correction bonferroni (compound)
self-reported positive (conj)
chemotherapy no (neg)
conclusion substantiate (appos)
effect model (nmod)
opioid tramadol (nsubj)
activities infarction (nmod)
inhibitors transporter-1 (compound)
activity d (compound)
unmask . (punct)
exceed nra0160 (nsubj)
demonstrate action (dobj)
recognized are (auxpass)
antioxidant has (aux)
variables histopathological (amod)
results assessable (dep)
suggested diagnosis (dobj)
schizophrenic difficult-to-treat (amod)
become important (acomp)
bid -15.4 (appos)
led systolic (nmod)
parameters electroretinographic (amod)
seizures cocaine-kindled (amod)
optic . (punct)
function heart (compound)
elevations factor-alpha (nmod)
had status (conj)
similar although (mark)
range mg/kg (appos)
modulate positively (advmod)
re-started mg/day (nmod)
lactate both (cc:preconj)
using daily (advmod)
dialysis on (case)
vnb of (case)
ranged treatment (nmod)
available status (nsubj)
agonist 5-ht(1b/1d (compound)
august since (case)
epicardial the (det)
myopathy fibrous (amod)
age the (det)
level proteins (nmod)
microinjection micrograms/50 (appos)
consider patients (nmod)
sign babinski (compound)
doxorubicin/kg ip (appos)
sed p (appos)
nephrotoxicity indinavir-related (amod)
damage ma (nsubj)
deposits complex (nmod)
one effects (nmod)
facility outflow (compound)
levels her (nmod:poss)
decrease significantly (advmod)
maleate mg/kg (appos)
recognized inconsistently (advmod)
resolved discontinuation (nsubj)
report cases (dobj)
probed affects (ccomp)
suggesting roles (dobj)
raises conclusion (dep)
frequency class (nmod)
had groups (dobj)
reduced acute (nmod)
therapy lopinavir/ritonavir (compound)
showed test (dobj)
efficacy comparable (amod)
extent pcpa (nmod)
appear would (aux)
excluded histories (nmod)
licking , (punct)
incidence overall (advmod)
become implications (nsubj)
lh steroid-induced (amod)
resuscitation during (case)
nature , (punct)
siblings twin (compound)
related uremia (nmod)
atorvastatin atorva (appos)
groups c1 (dep)
outcome stroke (nmod)
38.6 +/- (cc)
quetiapine such (case)
description a (det)
behavior immobility (conj)
bis , (punct)
warranted caution (nsubjpass)
exposure quinine (compound)
is essential (acomp)
reviewing literature (dobj)
measured additionally (advmod)
desire capacity (nmod)
therapy wilson (nmod:poss)
implicated and (cc)
addressed issues (nsubjpass)
trialists committee (conj)
protein essential (amod)
urge both (cc:preconj)
tests levels (conj)
pallidotomy : (punct)
has implications (dobj)
expression an (det)
hypoxia cortical (amod)
dose isoflurane (nmod)
effects thrombocytopenia (nmod)
changes cystitis (compound)
reduced reabsorption (nsubjpass)
referred thus (advmod)
elicited history (nsubjpass)
hydrobromide ( (punct)
glu 0.005 (appos)
impact variants (nmod)
register population (nmod)
diminished slowly (advmod)
assessed risk (dobj)
recalled 91.2 (conj)
necrosis levels (conj)
lead use (nsubj)
block atrioventricular (compound)
lasted bradycardia (nsubj)
failure symptomatic (amod)
59 ( (punct)
relationship sulindac (nmod)
raises it (nsubj)
days 110 (nummod)
assays axsym (compound)
delays that (mark)
produced enhancement (dobj)
continued accompanied (advcl)
6 of (advmod)
ptld ) (punct)
mg/m(2 25 (nummod)
detection failure (nmod)
known abundant (advcl)
preserves aqp2 (dobj)
donors thiol (compound)
models epilepsy (compound)
therapy occurrence (conj)
seem indicative (xcomp)
g/m2 ifosfamide (nmod)
patient iu/l (dep)
utilization associated (acl)
carcinoma advanced (amod)
risk statistical (amod)
monitor levels (dobj)
conclude caused (ccomp)
ritonavir vehicle (conj)
59 - (punct)
cardiomyocytes in (case)
echocardiography 3d (compound)
showed densitometry (nsubj)
ng/dl. maintained (acl:relcl)
response response (nmod)
treated day (dep)
gives induction (nsubj)
described paralysis (nsubjpass)
determine discuss (conj)
position sitting (amod)
c57bl/6 cd1 (conj)
subgroups levels (nmod)
weeks a (det)
pathways and (cc)
reviewed using (advcl)
[(3)h]saxitoxin stx (dep)
rats hooded (amod)
patients data (dep)
chf to (case)
zi ) (punct)
maintained constant (xcomp)
group epileptic (amod)
decreases turn (nmod)
examined ; (punct)
hips-cms of (case)
hypovolemia drainage (nmod)
0 and (cc)
monitored noninvasively (advmod)
administered s-limonene (nsubjpass)
induced subchronic (conj)
observed se (nmod)
output of (case)
extended be (auxpass)
beta-subunits channel (compound)
= 74.3 (dobj)
activation polymerase (nmod)
diffuse fibrillation (nsubj)
animal each (det)
vivo/in vitro (dep)
depletion of (case)
mechanism protection (nmod)
mean percentage (nmod)
forearm the (det)
2e1 or (cc)
became switching (advcl)
made to (mark)
needs according (case)
glutamate mglu (appos)
disease trophoblastic (amod)
possibility cause (ccomp)
19.3 was (cop)
photosensitivity or (cc)
blocking and (cc)
leukopenia i.e. (advmod)
microglobulinuria and (cc)
improvement majority (nmod)
compressed severely (advmod)
toxicity nerve (compound)
allopregnanolone 3alpha-hydroxy-5alpha-pregnan-20-one (appos)
swallowing after (case)
eosinophilia three (nummod)
hypertrophy associated (acl)
nerve trigeminal (amod)
hearts the (det)
have causes (dobj)
appearance patients (nmod)
nephropathy chronic (amod)
greater sensitivity (nsubj)
showed stabilized (conj)
area to (case)
benefit and (cc)
liable patients (nsubj)
causes leading (amod)
hazardous ? (punct)
newborn regurgitation (nmod)
number granules (nmod)
percentage patients (nmod)
enhances stimulation (nmod)
followed 1- (nmod)
reporting higher (amod)
disease overt (amod)
expression activated (amod)
use antidepressants (nmod)
therapy coumadin (compound)
arrhythmia severe (amod)
labeling such (amod)
vasoconstriction renal (amod)
pressure baseline (compound)
b ketoconazole (conj)
distributed tissue (nsubj)
sequelae withdrawal (nmod)
antigens metabolites (conj)
anesthesia development (conj)
memory procedural (amod)
predict after (mark)
obtained measurements (nsubjpass)
parasitosis patient (nmod)
forehead the (det)
dose protocol (nmod)
response ventricular (amod)
inhibitor ) (punct)
cco-iv ( (punct)
prerequisite as (case)
reports asterixis (nmod)
subjects undergoing (acl)
7h6 and (cc)
transmission not (neg)
undergoing fess (dobj)
accept these (dobj)
agents targeting (acl)
result age (nmod)
rarest is (cop)
stress simulated (acl)
noted membrane (nmod)
nephrin a-actinin (conj)
nodular finely (advmod)
clinical subclinical (conj)
followed inducing (advcl)
literature patients (nmod)
sign with (case)
cells living (amod)
beta-blocking their (nmod:poss)
myocytes rat (compound)
reduced strongly (advmod)
minutes ] (punct)
55 versus (cc)
metformin the (det)
patients alprazolam (compound)
symptoms signs (conj)
infant one (nummod)
neurobehavioral biochemical (conj)
literature lmwh (nmod)
pain visceral (amod)
withdrawal terfenadine (appos)
levels b (compound)
occurred injury (nsubj)
improved animals (advcl)
had cbz (nsubj)
repeated weeks (dobj)
1.041 1.039 (conj)
atrial left (amod)
elicit dyskinesia (dobj)
indexes variability (nmod)
labelling adequate (amod)
alpha2-/i1-receptor mixed (amod)
glutamate . (punct)
rechallenge patients (nmod)
administration h (nmod)
fluctuations on-time (compound)
developed included (advcl)
group related (amod)
secretion associated (acl)
part at (advmod)
uterotonic is (cop)
produces decrease (dobj)
anticoagulation citrate (compound)
showed elevation (dobj)
levels patients (conj)
focused background (dep)
prevent completely (advmod)
probe flow (compound)
ecg transmural (amod)
seems it (nsubj)
series patient (nmod)
doses rats (nmod)
earlier significantly (advmod)
stress recent (amod)
% 15.9 (nummod)
2r,4r-apdc ; (punct)
mtdna common (amod)
vasodilator effects (conj)
preparations diet (amod)
hypotension extreme (amod)
common use (nmod)
examine importance (dobj)
% 79.4 (nummod)
felt patient (nsubj)
influenced responses (nsubjpass)
ability urinary (amod)
ranging whom (nmod)
atherosclerosis severe (amod)
irreversible unfortunately (advmod)
patients aged (amod)
results biochemical (nmod)
used infusion (nmod)
media cells (nmod)
company squibb (compound)
encountered may (aux)
decreasing requirement (dobj)
palsy progressive (amod)
ku70 of (case)
useful explore (xcomp)
tubules basophilic (amod)
showed testing (nsubj)
diagnosed included (dep)
inhibitor irreversible (amod)
failure congestive (amod)
mass liver (compound)
apigenin 1 (det)
minimized be (auxpass)
2 6 (conj)
ozone and (cc)
showed early (advmod)
scored was (auxpass)
flecainide reports (conj)
different values (nsubj)
resulting administration (nmod)
complex gamma-aminobutyric (amod)
carcinoma large (amod)
function controlling (acl)
reach lowering (nsubj)
expression hepatic (amod)
remained ; (punct)
formation dogs (nmod)
esterase of (case)
effects withdrawal (nmod)
period post-operative (amod)
maximum being (cop)
diminishing morbidity (dobj)
punctate brush (conj)
days=1.77 ( (punct)
be 1.3/100,000 (dep)
37 - (punct)
case hypertension (nmod)
hydrochloride cocaine (compound)
was she (nsubj)
achieve estimates (dobj)
adducts 4hne-protein (compound)
have diuresis (dobj)
based diagnosis (nsubjpass)
revealed echocardiography (nsubj)
was h (nmod)
model : (punct)
convulsion angiography (nmod)
extraction beginning (conj)
induction hemorrhage (compound)
affinity receptor (nmod)
dementia subacute (compound)
downregulation endothelial (amod)
rejection ar (dep)
self-dosing intervals (nmod)
intolerance some (nmod)
induction genes (nmod)
response maximal (amod)
bortezomib therapy (nmod)
using been (aux)
0.0010 0.0073 (conj)
period 18-month (amod)
reduced mmhg (nmod)
compound like (amod)
administered chloride (nsubjpass)
blocked hyperalgesia (nsubjpass)
has therapeutic (dobj)
high chronically (advmod)
activities unique (amod)
prolongation of (case)
examined . (punct)
mm 101 (nummod)
mi ( (punct)
sleeping administration (nmod)
collapsed , (punct)
ntg ) (punct)
monitoring weeks (nmod)
variability inter-observer (amod)
discharged who (nsubjpass)
cases uveitis (nmod)
levels the (det)
stabilized patients (nsubjpass)
patients 104 (nummod)
difference = (dep)
gavaged ami (dep)
min control (appos)
treating delivery (nmod)
pretreatment days (nmod)
levels depression (nmod)
affected levels (nsubjpass)
matched birth (conj)
callosum the (det)
results studies (nmod)
then , (punct)
seems hyperactivity (nsubj)
meq/l hctz (dep)
associated development (nmod)
indices 6 (nummod)
rats fat (amod)
practice kong (nmod)
dct2 ( (punct)
convulsions pyridoxine (compound)
time administration (nmod)
therapy antithymocyte (compound)
involved effect (nmod)
decrease peroxidation (nmod)
mhc-i of (case)
feedback delayed (amod)
information background (nmod)
remission short (amod)
use with (case)
donor ) (punct)
ml n (dep)
protection significant (amod)
ventricles arteries (conj)
diseases serious (amod)
40.9 33.7 (conj)
fields tumor (nmod)
polyuria mice (nmod)
results preliminary (amod)
induced change (dobj)
1.52 - (punct)
disarrangement necrosis (conj)
cycles these (det)
intervals drug (nmod)
occurs whether (mark)
controlling by (mark)
ci 0.8 (nummod)
risks intraoperative (amod)
participants , (punct)
exposed methods (dep)
attributed synthesis (nmod)
ecstasy completed (conj)
p100 in (case)
experienced strokes (dobj)
pod 65 (nummod)
degree met (acl:relcl)
dynamic pressure (compound)
evidences : (punct)
increased sgk1(+/+ (punct)
groups controls (appos)
virus lamivudine-resistant (amod)
inhibited contractions (dobj)
greater 3 (nmod)
cases hypoxaemia (nmod)
rats wky (compound)
care with (case)
followed methods (dep)
cocaine affects (conj)
47.5 0.5 (compound)
based platinum (compound)
hyperthermia min (dep)
shorter lasted (amod)
undergoing infusion (dobj)
mo 5 (nummod)
after month (nmod:npmod)
chiasmopathy of (case)
newborn the (det)
given dosage (nsubjpass)
efavirenz efv (appos)
suspected and (cc)
seizures picrotoxin-induced (amod)
caused removal (nsubj)
syndrome caused (acl)
episodes episodes (conj)
implications cost (compound)
proportion prl-positive (amod)
reports results (dobj)
documented concerns (nmod)
interaction distinguished (acl:relcl)
required he (nsubj)
30 ) (punct)
errors ) (punct)
therapy methylprednisolone (compound)
influence hormones (nsubj)
walls and (cc)
antibodies for (case)
normal compared (prep)
association time (compound)
referred it (nsubjpass)
improvement least (advmod)
compliance increases (conj)
justified is (auxpass)
proceeded 300 (nmod)
hilus gyrus (nmod)
expression macrophages (nmod)
spasm ischemia (conj)
hctz than (case)
failure gentamicin-induced (amod)
bypass of (case)
liquids with (case)
diet choline-devoid (amod)
psychosis psychopathology (nmod)
parallels actions (nmod)
changes patient (nmod:poss)
receive ( (punct)
rbcs ( (punct)
mpt ( (punct)
powders carbon-ate-sodium (compound)
contributes history (nsubj)
had elevation (dobj)
associated action (nsubjpass)
reactions idr (nmod)
promoted verapamil (nsubj)
rate symptoms (nmod)
had 27 (nsubj)
rashes erythematosus (appos)
possiblility the (det)
trials randomized (amod)
recurrent to (mark)
ingested pregnancy (nmod)
modulate not (neg)
beginning at (case)
systems reactions (nmod)
i 29 (conj)
isoniazid ( (punct)
ducts internal (amod)
poses dilemma (dobj)
3tc , (punct)
larger of (case)
develop we (nsubj)
analyzed work (nmod)
revealed compared (advcl)
ratio coupling (compound)
mechanisms through (case)
showed infarct (dobj)
dysfunction solvd (appos)
normality " (punct)
indication with (case)
technique selective (amod)
production aldosterone (compound)
using formulations (dobj)
randomized high- (nmod)
conditions predisposing (acl)
effects aerosol (conj)
propranolol ppa (nmod)
suspected mass (nsubjpass)
= 1.15 (dep)
considered curcumin (nsubjpass)
groups warfarin (nmod)
2 orally (advmod)
lasted that (nsubj)
found potent (xcomp)
= .01 (dep)
caused compared (advcl)
assayed foci (nmod)
divided and (cc)
1.1 8.8 (prep)
oxc ) (punct)
authorized and (cc)
subsided minutes (nmod)
changes such (amod)
abstinence after (case)
lumens vacuolization (conj)
injury dox (nmod)
allopregnanolone pregnanolone (appos)
rizatriptan % (appos)
tumors multiple (amod)
syndrome apnea (nmod)
pain in (case)
response euthymia (conj)
performed part (nmod)
13 5 (compound)
300 450 (prep)
degrees responsiveness (nmod)
generation radical (amod)
modulate inflammation (dobj)
experiencing to (mark)
0.93 1.93 (dep)
consists and (cc)
6/15 was (cop)
decreased norepinephrine (nmod)
incident similar (amod)
lpp the (det)
elevated ach (nsubj)
areas restricted (amod)
experienced mild (dobj)
output urinary (amod)
18.3 +/- (cc)
reported those (nsubjpass)
show inhibited (ccomp)
inhibits gaba (nsubj)
suggested strongly (advmod)
mortality treatment (compound)
pilocarpine of (case)
drugs contrary (amod)
c. chronic (amod)
manner delayed (amod)
frequency absences (nmod)
attenuated microinjection (nsubj)
clinical significant (amod)
antinociceptive and (cc)
cataract keratopathy (conj)
doses total (amod)
showed 13 (nsubj)
5.6 1.0 (conj)
tachycardia pointes (nsubj)
deficit scopolamine-induced (amod)
essential integrity (nsubj)
dose mu (nmod)
aggravated intake (nmod)
cases tolerance (nmod)
race on (case)
better were (cop)
excluded ) (punct)
occlusion patient (nmod)
studied groups (dobj)
activity types (nmod)
desogestrel ethinyloestradiol (nmod)
represent % (dobj)
require factors (nsubj)
have specifically (advmod)
hospitalizations out-of-plan (amod)
crisis installing (amod)
phacoemulsification uneventful (amod)
pacing states (dobj)
mild events (nsubj)
forestomach the (det)
reviewed reports (nsubjpass)
echocardiography transthoracic (amod)
observed cisapride (nmod)
appeared difficult (conj)
pneumonia two (nummod)
received subsequently (advmod)
addition calcium (nmod)
necessary initiation (nmod)
normalized when (advmod)
effects cns (compound)
availability o2 (compound)
resuscitation advanced (amod)
activities depressed (amod)
reaction in (case)
cause days (nmod)
min 50 (nummod)
he or (cc)
identification , (punct)
response pupillary (amod)
staining medius (conj)
fraction shortening (conj)
have anomaly (dobj)
-20.0 ( (punct)
spread woman (nsubj)
bias of (case)
ovale a (det)
post-discharge 2008 (nmod)
5,7-dihydroxytryptamine injected (acl)
metabolite cyclophosphamide (nmod)
reduced amiloride (nsubj)
felt . (punct)
cholestasis . (punct)
effect nik-247 (nmod)
csa mg/kg/day (conj)
necrosis bone (compound)
identified metabolizer (nmod)
1.9 were (cop)
doses dexamethasone (nmod)
6 respectively (advmod)
exhibit patterns (dobj)
patients c (nmod)
effect pb (compound)
mg/kg 190 (nummod)
wk after (case)
evidence epidemiological (amod)
indices of (case)
tumor glioblastoma (nsubj)
5 in (case)
resulted dysfunction (nmod)
factor other (amod)
improved levodopa (nmod)
ml mixture (nmod)
correlation week (nmod)
mania . (punct)
15/44 ) (punct)
monkeys rhesus (compound)
abandoned administration (nsubjpass)
band annulus (nmod)
lowering levels (nmod)
insights cause (nmod)
dysphonia spasmodic (amod)
controls signaling (compound)
therapy agonists (nmod)
participants of (case)
admission inpatient (amod)
septal of (case)
treatment valproate (amod)
injury cardiac (amod)
neuroplasticity cortex (nmod)
reacts protein (nmod)
vmax low (amod)
atropine mg/kg (appos)
inhibited that (mark)
system maintenance (nmod)
improved outcome (dep)
lower production (nsubj)
reached control (advcl)
similar magnitude (nsubj)
method delivery (nmod)
10.2 ( (punct)
review . (punct)
ability orgasmic (amod)
inhibited transit (dobj)
localization regional (amod)
potentials and (cc)
occurred death (nsubj)
improved features (nsubjpass)
involves whether (mark)
rate iop (appos)
ml gentamicin (nmod)
protocols to (case)
atrophy iia (compound)
electrocardiograms patients (nmod)
effects beating (nmod)
diazepam or (cc)
times weeks (nmod)
function worse (amod)
had gestation (nsubj)
relation for (case)
neurons with (case)
medication % (appos)
mtd ) (punct)
cells nodules (nmod)
tubule in (case)
utilized , (punct)
describe report (nmod)
dose verapamil (nmod)
conclude based (advcl)
1-infected type (nmod:npmod)
sites cases (nmod)
effective toxicity (nmod)
asymptomatic they (nsubj)
equivalent 60 (nmod)
structure function (conj)
finding be (cop)
expression subunits (nmod)
model sclerosis (nmod)
used combination (conj)
cerebellar and (cc)
related significantly (advmod)
type ( (punct)
stenting stents (nmod)
received phosphate (dobj)
treatment used (acl)
h 6 (nummod)
withdrawal to (case)
t1/2 in (case)
raclopride fluphenazine (conj)
survived function (nmod)
encouraging . (punct)
megakaryocytes abnormal (amod)
4.1 1.0 (conj)
indomethacin by (case)
myalgia generalized (amod)
mania induced (amod)
proteinuria of (case)
pathology of (case)
assigned 4-hourly (nmod)
structure steroid (compound)
developed fever (dobj)
likely reproduce (xcomp)
awakening awakening (conj)
gamma-hexachlorocyclohexane of (case)
3tc and (cc)
cimetidine level (nmod)
1.3 , (punct)
days intervention (nmod)
metrifonate acetylcholinesterase (compound)
life his (nmod:poss)
compounds the (det)
blocks runs (conj)
drc ( (punct)
movements by (case)
biological pharmacological (conj)
capable is (cop)
therapies numerous (amod)
optic neuropathy (conj)
needed appearance (nmod)
den rats (conj)
had infant (dobj)
pulses of (case)
inhibitors the (det)
received prophylaxis (dobj)
associated likewise (advmod)
report summary (amod)
examine directly (advmod)
hypercalcemia recurrent (amod)
agressive more (advmod)
lymphoma burkitt (compound)
strokes use (nmod)
patients 7 (nummod)
hyperglycinemia in (case)
resolved pseudolithiasis (nsubj)
adducts of (case)
implanted electrodes (dobj)
served diazepam- (nsubj)
studied vivo (advmod)
enrolled methods (nsubjpass)
observed results (dep)
cocs on (case)
independent da (nmod)
suggesting mechanism (dobj)
if mg/m2 (dep)
doing are (aux)
effects arteries (nmod)
rebleeding of (case)
venous cvp (appos)
l-alpha-glyceryl-phosphorylcholine of (case)
markers exchanges (nmod)
effect loss (nmod)
detailing course (dobj)
dysgenesis . (punct)
contained that (nsubj)
increase output (nmod)
support results (nsubj)
role additive (amod)
increasing status (dobj)
years less (amod)
nociceptin known (acl)
invoked aminonucleoside (nmod)
acid thrombin (compound)
tricuspid involvement (dobj)
worst significantly (advmod)
ibs ( (punct)
factor granulocyte (compound)
percent infants (nmod)
mice in (case)
poor survival (nsubj)
alterations processing (compound)
conditions growth (nmod)
bradycardia symptoms (conj)
bpt ) (punct)
complex connects (acl:relcl)
calcium cholesterol (conj)
returned day (nmod)
effects nicotine (nmod:poss)
vomiting was (cop)
hypoperfusion with (case)
dec. period (appos)
cases 59 (nummod)
acidosis of (case)
6.9 to (dep)
rosaceiform patient (nmod)
eliminated was (auxpass)
treatment before (case)
no and (cc)
% 9.4 (nummod)
c57bl/6 in (case)
convulsions damages (nmod)
reaction that (mark)
lower neonates (nmod)
pain cocaine (compound)
investigated causes (nsubjpass)
reduces carries (conj)
lipids proteins (conj)
-placebo -cimetidine (conj)
completed scale-revised (advcl)
hyperplasia cystic (amod)
hypothesis occur (ccomp)
hctz 25 (conj)
amnesia under (case)
rofecoxib 65,860 (dobj)
cause acidosis (nmod)
had also (advmod)
angioedema a (det)
anticonvulsants with (case)
users between (case)
hypertension a (det)
gm with (case)
deviations gaze (nmod)
visualized . (punct)
cyclophosphamide by (case)
have map (nsubj)
score hoehn_yahr (compound)
case new (amod)
38 35 (conj)
birth hospitals (nmod)
implicated basis (nmod)
days 1.37 (nummod)
aggravate does (aux)
microm ) (punct)
sedation induced (acl)
hypercholesterolemia dyslipidemia (conj)
increased microg.kg(-1 (nmod)
has benefit (conj)
reliable and (cc)
pressure mvp (appos)
% 6.21 (nummod)
parameters hematologic (amod)
determined size (nsubjpass)
frequencies using (acl)
surgery anaesthesia (conj)
strips control (compound)
therapy over (case)
leukaemia and (cc)
greater less (advmod)
bradycardia admitted (conj)
light for (case)
strain outbred (amod)
based acid (nmod)
explore potentiality (dobj)
% 35.4 (nummod)
resulting treatment (nmod)
slower identifying (advcl)
reports several (amod)
support hypothesis (nmod)
returned disappeared (conj)
data collective (amod)
mammary and (cc)
mannitol solution (appos)
waves triphasic (amod)
discuss clinicians (nsubj)
-/- ( (punct)
required ventilation (nmod)
prospective this (det)
barrier only (amod)
tumors ds-sarcoma (dep)
said , (punct)
clinic an (det)
control 90/hypertension (dep)
changes heart (nmod)
blockade hexamethonium (nmod)
had function (dobj)
effects mg/kg/day (dep)
% them (nmod)
encephalopathy phenytoin (compound)
68 % (dep)
induced nephrotoxicity (nmod)
fhf with (case)
range 52.7 (dep)
ifosfamide iv (nummod)
6 to (dep)
demonstrate duration (advcl)
persons for (case)
detected been (auxpass)
myopathy and (cc)
trimethaphan ganglionic (amod)
suggest have (aux)
remained function (nsubj)
revealed corresponding (advcl)
morphine codeine (conj)
suggest do (aux)
laboratories abbott (compound)
% < (dep)
identified proteins (nsubjpass)
dose cisplatin (nmod)
= um (dobj)
3- 12-week (conj)
catalepsy induced (amod)
gls -18.48 (dep)
alter function (dobj)
arrhythmias hypokalemia (compound)
network healthcare (compound)
40 10 (compound)
terms rate (conj)
opiate the (det)
css the (det)
neuroprotective neurotoxicity (nmod)
mother his (nmod:poss)
effective used (conj)
granules only (advmod)
needed suppress (xcomp)
caused suxamethonium (nmod)
reduces clinically (advmod)
odds syncope (nmod)
described number (nmod)
patients submitted (acl)
volume of (case)
if control (nmod)
temocapril 8 (dep)
requested immediately (advmod)
extremities upper (amod)
dose adrenaline.7 (nmod)
december and (cc)
101.74 to (case)
administered h (dep)
was contrast (nmod)
found effective (xcomp)
significant p<0.001 (dep)
12 and (cc)
vasoreactivity artery (nmod)
others all (det)
found home (nmod)
prevalence the (det)
identified that (mark)
girl therapy (acl:relcl)
damage or (dep)
neurons toward (case)
arthritis parotiditis (conj)
receiving angioplasty (nmod)
reduce could (aux)
obtained ratings (conj)
coactivator a (det)
reported receiving (advcl)
reorganization network (nmod)
administrations with (nmod)
pd drug-resistant (amod)
studying , (punct)
necrosis ( (punct)
replication and (cc)
trial edge-ii (appos)
jaundice hepatocellular (amod)
assessed damage (nsubjpass)
degeneration matrix (nmod)
anaesthesia in (case)
composed , (punct)
brain of (case)
1.26 was (cop)
assessed interleukin-6 (nsubjpass)
evidence shift (nmod)
tuberculosis xdr-tb (appos)
hypertension before (nmod)
assess efficacy (dobj)
haloperidol for (case)
found enrollment (nmod)
ciprofloxacin and (cc)
mmol/l 2.3 (nummod)
crystallization tubules (nmod)
presented features (nmod)
used first (advmod)
hr resting (amod)
related remain (conj)
remd ) (punct)
collagen and (cc)
need development (nmod)
= .0001 (dep)
0 125 (conj)
nhe3 , (punct)
implicated damage (nmod)
exhibited ratio (conj)
required are (auxpass)
stratum % (compound)
cases carcinoma (nmod)
interaction alpha-methyldopa-estrogen (compound)
= 0.001 (dep)
dronedarone and (cc)
investigated antagonism (nsubjpass)
partition membrane (nmod)
lack model (nmod)
trial training (compound)
modify reduction (dep)
less irritation (nsubj)
pollutants of (case)
evaluated potential (nsubjpass)
promote to (mark)
1999 alf (nmod)
phenomenon known (advcl)
high an (det)
controls eight (nummod)
unchanged cd25 (nsubjpass)
received pr (dep)
quantified however (advmod)
remains proven (xcomp)
mean 4000hz (nmod)
disrupted significantly (advmod)
sulfate with (case)
used g (nmod)
cl ml/min/kg (dep)
cancer associated (amod)
weeks commencement (nmod)
hypertrophy tissue (compound)
therapy atenolol (nmod)
exerted pdtc (nsubj)
fluids , (punct)
dose starting (case)
therapy aggressive (amod)
benzylpenicilloyl-poly-l-lysine ax (conj)
pamidronate with (case)
termination the (det)
five pain (nmod)
used remain (conj)
paralysis injection (nmod)
suppresses therefore (advmod)
characteristics -- (punct)
triglyceride accumulated (amod)
alternating rhythm (dobj)
occurred that (mark)
co-morbidity , (punct)
testosterone hormone (conj)
attributed been (auxpass)
cnsb002 mg/kg (appos)
report review (conj)
evidence zero (nmod:tmod)
made attempt (nsubjpass)
administration salt (compound)
useful contexts (nmod)
overcome which (nsubjpass)
association preferential (amod)
administration intracoronary (amod)
drug etodolac (nsubj)
cardioselective and (cc)
associated negatively (advmod)
results as (cc)
observed % (conj)
system brain (compound)
2.4 0.03 (conj)
investigated not (neg)
men ) (punct)
manifestations cardiac (amod)
shows eeg (nsubj)
ci 36.7 (nummod)
proceeded fourteen (nsubj)
placebo than (case)
ip 75 (nummod)
degeneration vacuolation (conj)
infusion adrenaline (nmod)
conclusions demonstrated (appos)
ratio especially (advmod)
l-type of (case)
barrier group (compound)
dependency sugar (compound)
agents showed (acl:relcl)
identified head (nmod)
caused hypocalcemia (dobj)
echocardiogram on (case)
accounted impairment (nsubj)
hypertension accompanied (acl)
frequent switches (nsubj)
had stage (dobj)
doses low (amod)
exhibits reversal (dobj)
excitation neurons (nmod)
mouth hands (conj)
investigate role (dobj)
intensify . (punct)
response avoidance (compound)
bolus 50-mg (amod)
doses 2 (nummod)
suggest correlation (nsubj)
values pre-lithium (amod)
develop regimen (dobj)
included treatments (nsubj)
myoclonic , (punct)
cisplatinum 5-fluorouracil (conj)
582 - (punct)
ce of (case)
46 19 (conj)
monkey rhesus (compound)
susceptibility genetic (amod)
failure dox-induced (amod)
placebo respectively (advmod)
received dexmedetomidine (dobj)
appears combination (nsubj)
conducted series (dobj)
analyzed hybridization (nmod)
disorder transmission (nmod)
mg 10 (compound)
mssa ( (punct)
increases greatly (advmod)
cvvhdf ( (punct)
nitrogen plasma (compound)
detection cardiomyopathy (nmod)
gene cyclooxygenase (compound)
carriers surface (compound)
78 +/- (cc)
ph p02 (dep)
inhibitors rapamycin (compound)
group low (amod)
avoid . (punct)
amphetamine to (mark)
reported infrequently (advmod)
conclusions finding (appos)
adding propofol (nmod)
months . (punct)
mg/m(2 800 (nummod)
parameters pharmacodynamic (amod)
trial inwest (appos)
1 with (dep)
followed inoculation (nsubjpass)
potassium k(+)- (appos)
normalized and (cc)
formation is (cop)
finding have (ccomp)
stones dissolvable (amod)
rhythms per (case)
s 95+/-39 (nummod)
registered 17 (nummod)
grade 1 (nummod)
treated ethambutol (nmod)
erythroderma generalized (amod)
= number (nmod)
analysis pulse (compound)
derivative similar (conj)
dyskinesias levodopa-induce (amod)
, and (dep)
0.6 with (case)
properties protective (amod)
revealed valproate (dep)
otherwise risk (nmod)
inhibitors individual (amod)
nuclei the (det)
rate organization (appos)
sec , (punct)
4 to (dep)
serotonin platelet (compound)
getting position (nmod)
developed nodules (nsubj)
inhibition esterase (compound)
correlated however (advmod)
assessed functions (nmod)
vasculitis is (cop)
shr captopril-treated (amod)
warfarin sodium (compound)
tpp ( (punct)
april august (nmod)
arrhythmias various (amod)
present frequently (advmod)
polyvidone and (cc)
inhibits which (nsubj)
ultrasound thyroid (compound)
disorders behavioral (amod)
resistance stress (nmod)
increased resistance (nsubjpass)
increasing resistance (dobj)
discribed . (punct)
withdrawal market (nmod)
necessary persist (advcl)
involved likely (advmod)
d. 5 (nummod)
hydrobromide galanthamine (compound)
4.9 - (punct)
anxiety and/or (cc)
relevant exposure (nmod)
potentiates dose (compound)
damage organs (dobj)
% 130 (nummod)
response its (nmod:poss)
injected rats (nmod)
consider thrombocytopenia (dobj)
deficiency local (amod)
times rapid (amod)
add deprivation (nsubj)
hearts isolated (amod)
changes maintained (acl:relcl)
assessment injection (nmod)
carcinoma cervical (amod)
separated min (nmod)
seconds of (case)
norepinephrine infused (amod)
identified women (nsubjpass)
metabolite cocaine (nmod)
complicated bleeding (nmod)
investigate ability (dobj)
exerts alpha-blocker (nmod)
used seizure (nsubjpass)
mm > (dep)
emphasized role (nsubjpass)
drugs two (nummod)
heart rats (nmod)
restricted hepatotoxicity (nsubjpass)
course subsequent (amod)
histochemistry in (amod)
ro for (case)
tumor left (amod)
administered design (nmod)
antibodies of (case)
activation induced (amod)
man suffering (acl)
sensitivities beta-ccm (nmod)
stopped elongation (nsubjpass)
jj aspirin-treated (amod)
convulsion first (amod)
task complex (amod)
techniques clearance (compound)
solution sucrose (compound)
2.4 at (case)
assessed injections (nmod)
constitutes . (punct)
emphasizes study (nsubj)
increased arrhythmogenicity (dobj)
changes s-t/t (compound)
also have (aux)
tropicamide vision (nmod)
metoprolol , (punct)
risk eps (nmod)
rate response (nmod)
apomorphine mg/kg (dep)
structure muscle (nmod)
total in (case)
women cases (appos)
status mental (amod)
recording be (cop)
details induction (nmod)
increases p (dep)
states unpleasant (amod)
ishihara ( (punct)
report previous (amod)
course favourable (amod)
reduction pronounced (amod)
used captopril (nsubjpass)
sufficient not (neg)
noted months (nmod)
digitalise or (cc)
importance recognizing (advcl)
remains . (punct)
trigger tachycardia (nmod)
parts ii (nummod)
cases self-poisoning (nmod)
reduces cost (dobj)
presented , (punct)
dyslipidemia with (case)
correlates pain (nmod)
sensation a (det)
levels alone (advmod)
normal impaired (conj)
metoprolol racemic (dep)
syndrome leg (compound)
induced ns (nsubjpass)
robust more (advmod)
children ( (punct)
reported past (nmod)
38 3 (conj)
found analysis (nmod)
have nephropathy (nmod)
patient nor (cc)
2.80 1.01 (nummod)
b2 thromboxane (compound)
utility i (nmod)
deemed april (nmod)
july 2009 (nummod)
desipramine and (cc)
bupivacaine for (case)
present population (nmod)
other liver (nmod)
concentration heparin (nmod)
requested injection (nmod)
enhanced had (parataxis)
curve min (nmod)
associated treatment (nmod)
pralidoxime-2-chloride 2pam (appos)
used cortices (nsubjpass)
features histological (amod)
improvement progressive (amod)
help concerns (nsubj)
intake in (case)
carcinoma is (cop)
47 +/- (cc)
depress synthesis (dobj)
mg 40 (compound)
recommenced when (advmod)
caused toxicity (nmod)
rats 30 (nummod)
event anemia (nsubj)
wild-type wt (appos)
investigated 54-week (nmod)
acetate ammonium (compound)
haart ( (punct)
tolerant that (mark)
development after (conj)
receptors cannabinoid (compound)
medulla papilla (conj)
mortality : (punct)
silver sulphadiazine (dep)
some compounds (nmod)
withdrawal propranolol (nmod)
serotonin with (case)
blocks any (det)
decrease performance (nmod)
report spontaneous (amod)
ecg 12-lead (amod)
disadvantages . (punct)
analysis single-centre (amod)
= 4.9 (dobj)
media serum-free (amod)
53 1 (conj)
received min (dobj)
seizures activity (conj)
r(2 ) (punct)
summarized are (auxpass)
akinesia end-of-dose (amod)
complication no (neg)
interview neuropsychiatric (compound)
studies crossover (compound)
effects hepatic (amod)
related cocaine (nmod:npmod)
echocardiography 14 (nmod)
documented been (advcl)
mdma ex-mdma (conj)
hydroxylase th (appos)
contraction arterial (amod)
report final (amod)
suffered course (nmod)
has gyki-41 (nsubj)
levels caffeine (compound)
showed users (nsubj)
cases ahf (nmod)
groups fentanyl (amod)
occurred demonstrated (advcl)
considered bortezomib (nsubjpass)
history cardiac (amod)
yawning were (cop)
signs of (case)
members . (punct)
necrotizing is (aux)
mesylate fenoldopam (compound)
volumes lv (amod)
consumption about (case)
disturbances dexmedetomidine (nmod)
compensated significantly (advmod)
evaluation echocardiography (nmod)
correlated sometimes (advmod)
provide conclusion (nmod)
cytokines inflammatory (amod)
layer or (cc)
developing to (mark)
rosacea steroid-aggravated (amod)
materials prc (appos)
associated p (dep)
26 with (case)
end number (nmod)
receiving , (punct)
examination injections (nmod)
depression resulted (acl:relcl)
score 5 (nmod)
administered serum (nmod)
microphthalmos and (cc)
woman 54-yr-old (amod)
measurements n-acetyl-beta-d-glucosaminidase (conj)
stressor 20-min (compound)
alive . (punct)
conjugate monomer-albumin (amod)
mglur5 2-methyl-6-(phenylethynyl)pyridine (conj)
caused deterioration (dobj)
characteristics similar (amod)
control nx (compound)
performed testing (nsubjpass)
6 score (nsubj)
reported response (nsubj)
followed cholestasis (nmod)
received treated (parataxis)
b12 group (appos)
alpha-methyltyrosine , (punct)
interaction inhibitory (amod)
pointes irrigation (nmod)
neurotoxicity activation (conj)
converted chorea (nmod)
reversible cin (nsubj)
independent thalidomide (xcomp)
ich vs (cc)
administration morphine (compound)
mg 1.5 (nummod)
cholecystitis acute (amod)
administration suspension (nmod)
negative searches (nsubj)
patients palsy (nmod)
recorded ( (punct)
42 1 (conj)
those induced (acl)
disorders pregnancy (nmod)
showed recently (advmod)
induce symptoms (conj)
potentiated is (auxpass)
cmv ( (punct)
paraventricular supraoptic (conj)
biochemical by (case)
administration bn (nmod)
conducted search (nsubjpass)
staff involved (acl)
epileptogenic that (nsubj)
studied rat (nmod)
17alpha-ethinylestradiol of (case)
2.4-fold , (punct)
months ) (punct)
rare dystonias (nsubj)
muscle adductor (compound)
received bicarbonate (dobj)
performance driving (compound)
inhibitors with (case)
administration ribavirin (nmod)
convulsions generalized (amod)
activity analgesics (nmod)
diaries patient (compound)
hours hours (conj)
alpha ) (punct)
normal consisted (conj)
prolonged p (dep)
system implanted (amod)
setting outpatient (amod)
induced have (aux)
disorder leads (acl:relcl)
focus in (case)
decreased months (nmod)
epileptogenecity patients (nmod)
cardiomyocyte in (case)
patients daily (dep)
regard only (advmod)
null homozygous (amod)
treatment treatment (nmod)
distributed pathways (nmod)
function therapy (nmod)
hypokalemia amphotericin (compound)
fell course (nmod)
rats hernia (conj)
cells ccr2 (compound)
prevented delayed (conj)
stopped and (cc)
system rat (compound)
presented increase (dobj)
urine all (det)
oils essential (amod)
nitroprusside-induced sodium (nmod:npmod)
motor ) (punct)
effects polyuria (nmod)
methods evaluated (dep)
pattern indistinguishable (amod)
reliability raters (nmod)
suffered moderate (nmod)
need control (dobj)
desmosomes and (cc)
man due (amod)
localization cells (nmod)
remained . (punct)
glycosuria moderate (amod)
combination 5-fu (nmod)
days pn (appos)
study consenting (advcl)
reduction after (case)
precore mutants (conj)
shows effects (dobj)
micrograms/kg 50 (nummod)
quantified staining (nmod)
physical quantitative (conj)
effect ketamine (nmod)
delirium ( (punct)
injections compared (case)
role association (conj)
inhibitors calcineurin (compound)
higher etoricoxib (nmod)
four eyes (nmod)
99 or (cc)
effect for (case)
patients constipation-predominant (dep)
rose , (punct)
properties with (case)
points effect (nmod)
cbd the (det)
prostheses mitral (amod)
treatment induction (compound)
patients infarctions (nmod)
apoptosis system (nmod)
presence only (advmod)
observed line (dobj)
often more (advmod)
actions in (amod)
insurance to (case)
hospital-years cumulative (amod)
studies pediatric (amod)
investigation biopsy (nmod)
valproate " (punct)
anticoagulant a (det)
seem prudent (xcomp)
naloxone post-training (amod)
= 3.35 (dep)
off following (xcomp)
cells with (case)
nephropathy diabetic (dep)
operated which (nsubjpass)
revealed left (conj)
greater than (dep)
dose milligrams (nmod)
dosages mg (nmod)
toxicity 4 (nummod)
blocker characterized (acl:relcl)
exceed ? (punct)
registry irvine (appos)
materials report (dep)
ph acidic (amod)
dissociation was (cop)
effects tubule (nmod)
cephalothin to (case)
calcium g (dep)
uptake acid (nmod)
risk hypocalcemia (nmod)
presenting weakness (nmod)
background but (cc)
mortality adults (nmod)
informative dealt (advcl)
cirrhosis disease (conj)
stimulated . (punct)
drop to (mark)
days h-2 (compound)
veralipride with (case)
cm mitochondrial (amod)
microscopy electron (compound)
1433 - (punct)
treatment prevention (conj)
minimum with (case)
given intrathecally (advmod)
demonstrate studies (nsubj)
cholesterol less (amod)
treatment pharyngitis (nmod)
secondary inhibition (nmod)
determine began (advcl)
fluvoxamine times (compound)
antipsychotics with (case)
had gravis (dobj)
dyskinesia rats (nmod)
pastes and (cc)
auc = (amod)
tolerated up (advmod)
demonstrated test (advcl)
enzyme-1 , (punct)
pb ) (punct)
host ( (punct)
case wheezing (nmod)
amitriptyline ) (punct)
discontinuation disulfiram (compound)
100 , (punct)
functions her (nmod:poss)
appear cells (nsubj)
happens what (nsubj)
level dose (compound)
glibenclamide glipizide (conj)
agent thus (advmod)
acne of (case)
cataracts band (conj)
performance left (amod)
dextrose that (nsubj)
levels inhibition (conj)
6.5 0.1 (conj)
temporary and (cc)
antipsychotic antidepressant (conj)
nine of (advmod)
licensed uk (nmod)
wilson a (det)
action anticancer (compound)
model mania (nmod)
required that (nsubj)
unlikely that (mark)
pilocarpine rats (nmod)
overexpression p300 (nmod)
treatment cabergoline (nmod)
report years (nmod)
374 554 (conj)
ring tissue (nmod)
seems utero (nmod)
meq/l 8.7 (nummod)
increase asymptomatic (amod)
made adjustments (nsubjpass)
margin of (case)
fraction ( (punct)
effects renal (amod)
confirm reduces (ccomp)
myocytes cardiac (amod)
min c (nmod)
beta-carboline-3-carboxylate of (case)
decrease sleepiness (nmod)
increases hydrocortisone (nsubj)
resulted potentiation (nmod)
prevalence despite (case)
measures impairment (appos)
maternal fetal (conj)
effect bruising (nmod)
markers traditional (amod)
suggest that (ccomp)
days another (det)
rct , (punct)
maintenance to (case)
administration ; (punct)
induced ventricles (dobj)
blocked activation (dobj)
39 10 (conj)
evaluating for (mark)
overload dextran (compound)
thrombopenia with (case)
shortness breath (nmod)
applied analyses (nsubjpass)
diagnosis . (punct)
test because (case)
67 +/- (cc)
increased those (nmod)
0.06 respectively (amod)
dhea ) (punct)
induce t(9:22 (dobj)
aorta/serum-ratio and (cc)
accomplished % (nmod)
hz 2v (conj)
persons in (case)
highlights problems (dobj)
research previous (amod)
involved colliculus (nsubjpass)
measured achieve (advcl)
rhabdomyolysis or (cc)
tolerated aside (advmod)
databases reviews (compound)
flumazenil with (case)
ventilation ve (appos)
sprouting c57bl/6 (nmod)
sequence and (cc)
data neuroimaging (compound)
subtypes eight (nummod)
influence to (mark)
activation pathways (nmod)
conclusions mutation (compound)
lasted stage (nsubj)
isoform disulphide (compound)
acetazolamide on (case)
oih ) (punct)
msdbp in (case)
5.1+/-1.0 ) (punct)
associated ocs (nmod)
expected usefulness (nsubjpass)
rate a (det)
treated pulse (nmod)
seizures % (dobj)
developed transplantation (nmod)
serve monkeys (nsubj)
value an (det)
significant time (nmod:tmod)
levels troponin (compound)
m0 ( (punct)
srl to (case)
decreased concentration (nsubj)
diagnosed leukemia (nmod)
dysfunction cell (compound)
intervals with (case)
systolic dysfunction (conj)
4/106 ) (punct)
patient erythematosus (nmod)
had features (nmod)
found efficacious (xcomp)
proteins molecular (amod)
predominant with (case)
13 and (cc)
disturbance observed (amod)
induces sle (dobj)
role habituation (nmod)
striatum target (nmod)
approximate closely (advmod)
switched were (auxpass)
emphasize . (punct)
rigidity recorded (acl)
a(2a adenosine (compound)
inhibitors since (mark)
rhythms and (cc)
administration bolus (compound)
represents nephropathy (advmod)
received aprotinin (dobj)
sent : (punct)
reflex initiated (acl)
higher age (nsubj)
elevation ( (punct)
had thrombocytopenia (dobj)
dose neither (det)
group midline (amod)
caution increased (amod)
field into (case)
postulated can (aux)
1.13 ) (punct)
size , (punct)
emit vocalizations (dobj)
detection high (amod)
length at (case)
diagnosed hours (nsubjpass)
medulla the (det)
behaviour maze (conj)
design research (compound)
ameliorates nephrotoxicity (dobj)
localization this (det)
observations had (dep)
consumption availability (conj)
analysis comparing (acl)
examined synergy (dobj)
i.c.v 10ug (amod)
tapped faster (advmod)
dosages at (case)
lower alternation (nmod)
effects bromocriptine (nmod)
hippocampus rats (nmod)
r- and (cc)
using after (mark)
receptor measured (acl)
measured eeg (nmod)
caused injection (nmod)
129 +/- (cc)
duration because (case)
intensities and (cc)
see recovery (dobj)
glucagon . (punct)
occurred increases (nsubj)
linked activation (nmod)
frequency paralysis (nsubj)
setting clinic (dobj)
tubular proximal (amod)
similar times (nsubj)
increased caffeine (nsubj)
% 54.2 (nummod)
interventions two (nummod)
toxic regimen (nmod)
relationship mpo-anca (nmod)
aspects on (case)
dosages different (amod)
causes likely (amod)
subdivisions of (case)
significantly < (dep)
treatment errors (appos)
mg/kg 320 (nummod)
required ventilation (dobj)
randomized conventional (nmod)
delays blockade (nsubj)
times 3 (nummod)
central and (cc)
sd +/- (cc)
study b (nmod)
ml(-1 4 (nummod)
venous thromboemboli (nsubj)
combination diazinon (nmod)
mg/m2bsa 1000 (nummod)
flaccid , (punct)
assessed effects (nmod)
fenoldopam of (case)
communicated been (auxpass)
residence a (det)
placebo tachycardia (nmod)
scavenging its (nmod:poss)
risk adults (nsubj)
series children (nmod)
sufficient precipitate (xcomp)
treated chlorpromazine (nmod)
blocked when (advmod)
inserts in (case)
injection pentazocine (compound)
area curve (nmod)
role pathways (nmod)
outcome main (amod)
sacrificed rats (nsubjpass)
potentials studies (conj)
dogs nx (compound)
symptoms mania (nmod)
line monocyte (compound)
10 about (quantmod)
0.6 ratio (nsubj)
months later (amod)
characteristics . (punct)
min 90 (nummod)
discouraging results (dobj)
lidocaine rofecoxib (conj)
finding have (conj)
infused minimize (xcomp)
occurred dose (nmod)
instilled ear (nmod)
elicited adriamycin (nsubj)
observed correlation (nsubjpass)
isbell and (cc)
pneumonitis pleural (conj)
bzd/rd one (nummod)
control can (aux)
igf-i the (dep)
(na of (case)
daidzein with (case)
assayed levels (nsubjpass)
substituted and (cc)
report immunosuppression (nmod)
those for (case)
all patient (dep)
psychosis primary (amod)
period entire (amod)
enantiomer a (det)
nigerians in (case)
centre danish (amod)
available while (mark)
patients hours (appos)
pentobarbital , (punct)
microperfusion picrotoxin (compound)
task active (amod)
nc/ia ) (punct)
stretch the (det)
enhance that (mark)
thirst normal (amod)
people users (acl:relcl)
hexachloro-1:3-butadiene of (case)
spots the (det)
bbb evaluated (acl:relcl)
needed course (nmod)
extravasation dye (nmod)
% decrease (dep)
harvested , (punct)
experiment ( (punct)
anticoagulant with (case)
worsening use (nmod)
excretion pge(2 (compound)
neurons hilar (amod)
map average (amod)
symptoms function (conj)
radiotherapy and/or (cc)
mediated that (mark)
attenuated effect (nmod)
mediating by (mark)
nuclei cells (nmod)
represent drug (dobj)
sensitivity : (punct)
anemia ribavirin-induced (amod)
exhibited 5 (nsubj)
prevent effects (dobj)
emerged transplant (nsubj)
proportions and (cc)
potency adrenoceptor (compound)
given subjects (nsubjpass)
analysis association (compound)
hz 2 (nummod)
3 + (cc)
inhibitor natural (amod)
living daily (advmod)
min min (dep)
doxorubicin without (case)
abused widely (advmod)
reversed ) (punct)
antagonists between (case)
inventory dysfunction (compound)
used paper (nmod)
amphetamine ip (appos)
unlikely because (mark)
those particularly (advmod)
article this (det)
problem of (case)
counterbalanced , (punct)
predict alterations (nsubj)
3.9 rats (nmod)
exceeded mg (nsubjpass)
nightmares hallucinations (conj)
presented another (conj)
flow artery (compound)
continue made (xcomp)
agents . (punct)
evoked . (punct)
% 97.2 (nummod)
cause uncommon (amod)
highlights and (cc)
occur ischemia (nsubj)
damage maleate (amod)
canine perfused (amod)
considered should (aux)
lowered , (punct)
attack panic (amod)
acuity initial (amod)
recalled from (prep)
score incidence (dobj)
monitoring frequent (amod)
accounted effect (nmod)
combination therapy (nmod)
0.71 p= (compound)
bpm by (case)
a , (punct)
listed is (auxpass)
producing complications (dobj)
form found (acl)
trial first (advmod)
health poorer (amod)
rr 1.35 (nummod)
behaviour anxious (amod)
resistance ligands (nmod)
glaucoma discovered (acl)
association endpoints (nmod)
particularly more (advmod)
likely . (punct)
rare probably (advmod)
became anxious (acomp)
referral care (compound)
s-isomer active (amod)
conditions than (case)
progress can (aux)
blocked that (nsubjpass)
release of (case)
affect introduction (nsubj)
cbd 158.11 (appos)
minutes administration (nmod)
monkeys macaques (appos)
tumors many (amod)
stenosis coronary (amod)
loss filaments (nmod)
men hypertension (nmod)
pj34 phenanthridinone (compound)
controls 2066 (nummod)
hemiparesis progressive (amod)
addition in (case)
influence rigidity (dobj)
loss reduced (amod)
recovered completely (advmod)
pericarditis of (case)
rate ml/min (appos)
prescribed mg/day (dep)
stones kidney (compound)
1.1 and (cc)
food hind (compound)
used could (aux)
used bbb (dep)
154:64 ( (punct)
factor and (cc)
anesthesia paucity (appos)
varied those (nsubj)
transport transmural (amod)
elevation sustained (amod)
incidence intubation (nmod)
study this (nsubj)
2.9-fold , (punct)
stent graft (compound)
features syndrome (nmod)
taking who (nsubj)
seen cholestasis (nsubjpass)
structure verapamil (conj)
side-effects mechanism (conj)
university eskisehir (conj)
characterized leading (xcomp)
associated half (dobj)
studies pharmacokinetic/pharmacodynamic (amod)
adjustment response (nmod)
changes bp (nmod)
hypothesis induce (ccomp)
factor hypothyroidism (nmod)
displayed stimulation (dobj)
inhibition feedback (nmod)
acts it (nsubj)
inactivation is (cop)
25 metformin (nmod)
dce ( (punct)
absence mr (nmod)
antagonist vip (compound)
reached vs. (dep)
predicting of (mark)
agent antimicrobial (amod)
alkaloid bioactive (amod)
indicators that (mark)
hyperkinesis of (case)
each components (nmod)
addition fentanyl (nmod)
degree all (nsubj)
lethal against (case)
phenylalanine acid (appos)
objective derivative (appos)
compatible hypothesis (nmod)
toxicity methamphetamine-induced (amod)
76 10(9)/l (conj)
detrimental b1r (nsubj)
1,000 per (quantmod)
inability amiodarone (nmod)
proteins form (acl:relcl)
suppressed deactivations (dobj)
received ultimately (advmod)
images resonance (compound)
bands bands (nmod)
changes adaptive (amod)
serve model (nmod)
antipsychotics and (cc)
limited focus (nmod)
diet deprivation (nmod)
clearance blood (compound)
estimate pharmacodynamics (dobj)
illustrate susceptible (ccomp)
lamotrigine with (case)
bradycardia induced (amod)
azt bau (conj)
generation lpo (compound)
drugs depression (conj)
modify ; (punct)
understood , (punct)
october 1992 (nmod:tmod)
aptts therapeutic (amod)
strains a/j (dep)
protein glomerular (amod)
ina ) (punct)
resistance mmg (appos)
symptoms because (case)
carcinogen with (case)
11 5 (compound)
minimal or (cc)
enhances humans (nmod)
therapy consisted (acl)
differences distribution (nmod)
push a (det)
showed distribution (dobj)
therapy 5-fluorouracil/folinic (compound)
add-on as (case)
under-appreciated be (cop)
detected control (nmod)
elevated however (advmod)
reduction sustained (amod)
availability increased (amod)
stage with (case)
min i.v. (dep)
immunosuppression primary (amod)
duration att (nmod)
seem . (punct)
chx ) (punct)
considered interaction (nsubjpass)
one-tenth potency (dobj)
cases retinochoroidopathy (nmod)
% months (conj)
elicited was (auxpass)
improved function (nsubj)
responsiveness scores (nmod)
microg.kg(-1 3 (compound)
cause until (case)
group treatment (compound)
use diluents (nmod)
h. 4 (nummod)
localization i (compound)
analyses , (punct)
incidence increasing (amod)
dosage doxorubicin (compound)
1788 of (case)
measurement laboratory (compound)
ph creatinine (conj)
collected retrospectively (advmod)
% 2.3 (dep)
known is (advcl)
confirms use (nmod)
micrograms.kg-1.min-1 patients (dep)
1.56 and (cc)
disrupting expression (dobj)
model system (nmod)
argatroban with (case)
involved primarily (advmod)
glomerulonephritis necrotizing (compound)
features children (nmod)
= 78.1 (dobj)
development encephalopathy (nmod)
course time (compound)
testosterone sc (appos)
treated target (nmod)
tinnitus the (det)
found doses (nsubjpass)
mustard alkylating (amod)
kidney and (cc)
cisplatin weeks (nmod:tmod)
caries mouth (appos)
neurotoxicity against (case)
baseline with (case)
proposed it (nsubjpass)
results schedule (nmod)
signal delayed (amod)
position important (amod)
hypoxemia hypertension (conj)
abnormalities system (compound)
doses hydrochloride (nmod)
moderate nausea (nmod)
hbv hbv (conj)
system nervous (amod)
ct in (case)
surgery cataract (amod)
reaction pathogenesis (nsubj)
5 to (dep)
eu 320 (nummod)
countries asian (amod)
nerve lateral (amod)
seem experience (nmod)
rate rate (conj)
antagonist ( (punct)
group c+e (compound)
pattern typical (amod)
analyzed point (nmod)
register register (conj)
farmer a (det)
showed sample (nsubj)
regimen given (acl)
reproduced could (aux)
reports morphine (nmod)
reverses naloxone (nsubj)
association salicylates (nmod)
8.5 was (cop)
involved care (nmod)
follows level (appos)
given cis-platin (nsubjpass)
banks from (case)
fev1 +/- (cc)
cardiotoxicity moving (advcl)
age-dependency no (neg)
papilloma carcinoma (conj)
using minutes (nmod)
administered morning (conj)
carries risks (dobj)
increase minimum (amod)
drug associated (acl)
hypertension eyes (nmod)
way by (case)
collection a (det)
152+/-15 to (dep)
suspected decreased (advcl)
augmentation no (neg)
days 19 (conj)
solution tacrine (nmod)
medications both (det)
obstructive both (cc:preconj)
lvef , (punct)
mg/kg recommended (amod)
deaths associated (acl)
reached targets (nsubjpass)
classified dysfunction (nmod)
male ) (punct)
are . (punct)
less dose (nmod)
expression p2x3 (nmod)
days 2 (conj)
osteoarthritis and (cc)
test activity (compound)
velocity of (case)
drug interval-prolonging (amod)
role back-diffusion (nmod)
fraction mole (compound)
had had (advcl)
ethanol % (compound)
amnesia morphine-induced (amod)
seizures followed (acl)
methods review (dep)
analysis submitted (acl)
trial vinorelbine (nmod)
attention of (case)
essential adding (conj)
mediated serotonergically (advmod)
patients two (nsubj)
deficiency nutritional (amod)
communicate summary (nmod)
measured primarily (advmod)
agent chemotherapeutic (compound)
agonists potent (amod)
43 to (dep)
literature according (case)
ablated were (auxpass)
received cases (nmod)
compliance on (case)
mi 38 (conj)
dexamethasone topical (amod)
isolated or (cc)
body of (case)
exhibited groups (nsubj)
recall words (nmod)
causes if (mark)
shunt decreased (advcl)
demonstrated cna (nsubj)
pacemakers atrioventricular (amod)
ulcers gastric (compound)
1.1 1.0 (conj)
series experiments (nmod)
agent combination (compound)
damage anesthetic-induced (amod)
accounted reduction (nsubjpass)
dose severity (conj)
restored inhibiting (advcl)
ester . (punct)
induction tci (nmod)
hypotension controlled (amod)
serious most (advmod)
months first (amod)
overtreatment ethambutol (compound)
3.6 4.1 (conj)
studied retrospectively (advmod)
allocated received (advcl)
protrusion chewing (conj)
augmented also (advmod)
38 whom (nmod)
rating pain (compound)
constructed : (punct)
symptoms as (cc)
protects metformin (nsubj)
administration flumazenil (amod)
initiate pge2 (nsubj)
rate conjunctiva (conj)
cerebellum and (cc)
suggest validity (dobj)
present consistently (advmod)
strategies current (amod)
day intervals (nmod)
sleep following (case)
concentrations uridine (nmod)
times than (case)
-chlorpheniramine , (punct)
expression reflexes (nmod)
secretion of (case)
induce torsade (dobj)
presents paper (nsubj)
habituation open (amod)
sensations burning (amod)
developed torsades (conj)
nephrotoxic less (advmod)
suffer who (nsubj)
agent chemotherapeutic (amod)
beverages containing (acl)
have anomalies (dobj)
day 42 (nummod)
tachycardia revisited (acl)
formed state (nsubjpass)
sinusitis of (case)
effects crocin (conj)
interpretation pathogenetic (amod)
confirmed . (punct)
linked significantly (advmod)
amnesia against (case)
became man (nsubj)
resembled . (punct)
effect whereas (mark)
returned baseline (nmod)
associated thiopentone (nsubjpass)
discharge respectively (advmod)
diagnoses potential (amod)
prophylaxis than (case)
antagonists available (amod)
clentiazem the (det)
change scale (nmod)
contractions reduced (amod)
agitation induced (acl)
classified treated (conj)
symptoms his (nmod:poss)
rigidity jaws (conj)
carrier as (case)
identifying relationship (dep)
32 - (punct)
review records (nmod)
sinus sagittal (amod)
affected rate (dobj)
toxicity acceptable (amod)
potassium levels (conj)
weight in (case)
greater mice (nsubj)
contraindication a (det)
possible was (conj)
function presumed (amod)
anemia blockade (compound)
present therefore (advmod)
protection on (case)
rats nephrosis (nmod)
produces hypotension (dobj)
convulse to (case)
increases glutamate (nmod)
coincident events (nsubj)
venous central (amod)
levels either (cc:preconj)
decreased diazinon (nsubj)
lignocaine of (case)
tg ) (punct)
acquired day (nmod:tmod)
23.43 1.99 (conj)
results high (dep)
eyes nor (cc)
synthesis npy (nmod)
depressed mice (nmod)
parachlorophenylalanine mg/kg (dep)
treatment epilepticus (nmod)
abated withdrawal (nmod)
included users (nsubjpass)
shouts and (cc)
picture the (det)
diagnosed findings (conj)
% children (nmod)
municipal copenhagen (nmod)
placebo-controlled single-blind (dep)
mechanisms electrophysiological (amod)
produced degeneration (dobj)
factor endothelial (amod)
half for (case)
micrograms/kg/min 5 (nummod)
mg/m2/d at (case)
bw mg/kg (compound)
administered test (nmod)
started not (neg)
effect hydroxyanisole (nmod)
counts results (conj)
used cocaine (dobj)
users > (appos)
gtcs another (det)
coefficient , (punct)
improve it (nsubj)
modified if (mark)
observed improvements (nsubjpass)
premedication after (case)
evidence component (nmod)
abdomen of (case)
desogestrel ) (punct)
level disease (nmod)
lisinopril chf (nmod)
volume output (conj)
dwi or (cc)
method reassessment (compound)
micrograms/kg/d factor (compound)
aggregation glomeruli (nmod)
trial clopidogrel (compound)
one hyperplasia (nmod)
antibody-(pr3-anca 3-antineutrophil (compound)
patients 74 (nummod)
ett ( (punct)
studies functional (amod)
field an (det)
increased compartments (nmod)
agent tamoxifen (nsubj)
tolerate mg (dobj)
results p<0.0005 (appos)
leukocytes , (punct)
mice these (det)
pcpa alone (advmod)
cortisol of (case)
myelodysplasia hypocellular (amod)
ceased desvenlafaxine (nsubjpass)
blocking beta (compound)
failed reveal (xcomp)
considered telaprevir (nsubjpass)
rash . (punct)
acid retinoic (amod)
day ) (punct)
channels are (cop)
linked actions (nsubjpass)
sermion ( (punct)
finished she (nsubj)
levels histology (conj)
impairments cardiovascular (amod)
apigenin with (case)
induced hearts (nmod)
mg/kg 2.0 (nummod)
telangiectasia photodistributed (amod)
causes hepatitis (nmod)
wave pressure (compound)
feasible is (cop)
large small (conj)
ed50 ) (punct)
months postswitch (dep)
% 0.942 (dep)
hypertension infusion (nmod)
liability addiction (compound)
identify changes (nsubj)
exposure cyanamide (compound)
administered rats (nsubjpass)
necessary combating (advcl)
hepatomas in (case)
correlates events (nmod)
moran 610 (nummod)
fentanyl , (punct)
received mp (dobj)
cohorts other (amod)
persists of (case)
degrees contracture (conj)
prolonged was (cop)
measured thus (advmod)
involved mechanisms (nsubjpass)
decreased action (dobj)
sites are (cop)
starting therapy (dobj)
patients 7 (nmod)
treatment steroid (compound)
patients at (case)
cholinesterase apnoea (nmod)
medications between (case)
anemia patient (nmod:poss)
dogs lymphoma (nmod)
evaluated consensus (nmod)
product double (amod)
jc ( (punct)
changes other (amod)
contractions chronic (amod)
appeared if (mark)
half-time lp (dep)
dep on (case)
tg only (advmod)
kingdom the (det)
injury maleate-induced (amod)
materials educational (amod)
flair ) (punct)
concentrations urea (compound)
applied starting (advcl)
remained normal (xcomp)
placebo hour (conj)
remains seen (xcomp)
stroke including (case)
decreases interval (nsubj)
dse for (case)
cases first (amod)
acute in (case)
remain . (punct)
involved lindane (nsubjpass)
compound with (case)
prevention anemia (compound)
tachycardia dilated (amod)
think . (punct)
vpa like (case)
cerebellum callosum (nmod)
effects gaba(a)rs (nmod)
seems implicated (advcl)
vasculitis in (case)
units 55 (nummod)
effects symptomatic (amod)
predisposed patient (dobj)
pathogenesis ulceration (conj)
implants group (compound)
mg 90 (nummod)
started monitored (conj)
drug patients (nmod)
proposed associated (ccomp)
mrna renal (amod)
excretion activity (conj)
techniques patients (nmod)
antidepressants like (case)
host for (case)
action mesna (nmod:poss)
coniine sulfate (conj)
serve . (punct)
extrarenal as (cc)
syndromes fibrinolytic (amod)
attention special (amod)
appears correlated (xcomp)
infusing remifentanil (dobj)
exhibited up-regulation (dobj)
m 5 (nummod)
screened patients (dobj)
45.45 % (conj)
act otoprotectant (nmod)
given carbetocin (nsubjpass)
concluded afford (ccomp)
levels presedation (compound)
viia recombinant (amod)
facilitated also (advmod)
adenocarcinoma an (det)
anomalies anotia (dep)
observed trends (nsubjpass)
dysphonia acitretin-induced (amod)
antibodies cefotetan-dependent (amod)
e2 ) (punct)
test to (aux)
consider clinicians (nsubj)
pressure femoral (appos)
animals kindling (compound)
mustard nitrogen (compound)
outpatients in (case)
increases expression (nsubj)
came resurgence (nsubj)
map = (parataxis)
poor . (punct)
ecg a (det)
report following (amod)
modulate effects (dobj)
giving daily (advmod)
reproduced . (punct)
activity anti-human (amod)
reported option (xcomp)
minor only (advmod)
mm 29.3 (nummod)
withdrawn drug (nsubjpass)
signs . (punct)
inhibited which (nsubj)
triggers release (dobj)
reversed tachycardia (nsubjpass)
presented patient (nsubj)
detect whether (mark)
mt and (cc)
total , (punct)
suggest unassigned (nsubj)
aquaporin-2 aqp2 (appos)
study weeks (appos)
uninephrectomy and (cc)
medicated male (xcomp)
concentrations mesna (compound)
osteoid fibrosis (conj)
mean years (nmod)
monoamines than (case)
drugs increase (acl:relcl)
detectable months (nmod)
effects deficits (nmod)
effects acute (amod)
case therapy (nmod)
187 ) (punct)
injury from (case)
models on (case)
information history (nmod)
life ) (punct)
sc-48334 and (cc)
ead phase (compound)
making series (dobj)
1mg/kg/week ( (punct)
instillations or (cc)
means search (conj)
quinine-sensitive 4-aminopyridine-sensitive (conj)
dialysis of (case)
lectin endothelial (amod)
mg/kg/d intake (nmod)
japan program (appos)
bruising pain (conj)
precise was (cop)
cholinergic functioning (acl)
onset factor (nmod)
necessary intervention (nsubj)
caused compared (prep)
indicates effect (nsubj)
changes before (case)
time recovery (compound)
describe study (nmod)
have weeks (dobj)
inflammation bladder (compound)
component active (amod)
induction coagulation (nmod)
strains substitution (compound)
common observed (conj)
leading rpn (nmod)
role in (case)
antioxidant a (det)
drug inhaled (amod)
microinjection presence (nmod)
cells interstitial (amod)
behaviour clinical (amod)
3 approximately (advmod)
started : (punct)
use verapamil (nmod)
different slightly (advmod)
bnp ( (punct)
reported sensation (nsubjpass)
alleviation vestibulotoxicity (nmod)
in- ( (punct)
correlate values (nmod)
percent seventy-three (amod)
recruited : (punct)
detection , (punct)
occurrence and (cc)
changes pattern (conj)
36.7 5.5 (nummod)
9.2 9.2 (conj)
mice pretreated (acl)
follows aminotransferase (appos)
use worldwide (amod)
administration rhgh (nmod)
iu/l ( (punct)
den mg/kg/day (punct)
1.17 4.72 (prep)
hyperventilation or (cc)
administration risperidone (compound)
complement serum (compound)
clinical histologic (conj)
frequency relationship (conj)
factor additional (amod)
involvement ras (nmod)
produce analogs (nsubj)
median g/day (nmod)
increase il-6 (nmod)
experienced further (advmod)
therapy calcineurin-inhibitor (amod)
n- fragments (dep)
extent media (nmod)
substance-induced and (cc)
passes that (mark)
arrhythmia digitalis- (amod)
deposition . (punct)
rats conscious (amod)
current ip (appos)
diagnosis accurate (amod)
art ) (punct)
disease cardiomyopathy (conj)
period relaxation (compound)
iohexol , (punct)
control p (dep)
number sn (nmod)
related scores (nmod)
dose apomorphine (nmod)
mucosa facial (amod)
1.5-fold ( (punct)
hypotension acetaminophen-induced (amod)
g/ml . (punct)
g 30 (nummod)
slight only (advmod)
dba/2 inbred (amod)
nodosa with (case)
men by (case)
cord greater (amod)
examined model (nmod)
patch prc (nmod)
dosage green (nmod)
functions and (cc)
inhibited enhanced (parataxis)
awake was (cop)
had starting (advcl)
occlusion airway (compound)
24 life-threatening (quantmod)
undergoing home (advmod)
80 to (dep)
cases confirmed (amod)
disease post-transplant (amod)
tolerability iopamidol (nmod)
esophagus in (case)
injections these (det)
study children (nmod)
recognized under-reported (conj)
ineligible 7 (nsubj)
parietal temporal (conj)
features bodies (nmod)
revealed amygdala (advmod)
1 1 (dep)
therapy continuous (amod)
resulted weeks (nmod)
produces bingeing (acl)
patients glioma (dep)
amount increased (amod)
mmhg 100/65 (compound)
production effect (conj)
intralipd of (case)
bemegride mg/kg (dep)
review children (nmod)
type 6 (nummod)
assess produces (ccomp)
disruption structure (nmod)
cases 13 (nummod)
received evaluated (conj)
structure 7 (appos)
depends diagnosis (nsubj)
days chemotherapy (nmod)
dysfunction auditory (amod)
maintained patency (nsubjpass)
susceptibility seizure (compound)
delivery drug (nmod)
effects memory-enhancing (amod)
used tasks (nsubjpass)
suggests data (nsubj)
patients 27 (dep)
length extent (conj)
had initiated (advcl)
associated period (conj)
19 versus (cc)
mediate might (aux)
6-ohda with (case)
illness duration (nmod)
equipotent cck-8-se (nmod)
rats pretreated (amod)
dose challenge (compound)
acetaminophen p-aminophenol (conj)
arrhythmia quinine-induced (amod)
attributable be (cop)
recognized caused (conj)
attempted , (punct)
impaired group (nmod)
states hypersensitivity (compound)
bia 093 (nummod)
available which (nsubj)
administration clomipramine (compound)
supplement fentanyl (nsubj)
mangiferin with (case)
v/s to (case)
protective and (cc)
4.5 0 (prep)
ah6809 by (case)
a rats (nmod)
abnormality km (appos)
treatment failure (nmod)
conjugates of (case)
quantified immediately (advmod)
mg : (punct)
treated ssris (nmod)
2.6 of (case)
patients cases (nmod)
caused activity (dobj)
skf-82958 hydrobromide (appos)
restlessness agitation (conj)
follow phase (dobj)
vip and (cc)
experience a (det)
disorders movement (compound)
conduction air (compound)
fractures fingers (nmod)
months 40.9 (conj)
increase provocation (nmod)
resolved all (nsubjpass)
included methotrexate (dep)
undergoing esophagogastroduodenoscopy (conj)
treatment chloramphenicol (nmod)
22 19 (conj)
anemia is (cop)
use technique (nmod)
parameters training (nmod)
involved numbers (dobj)
snhl ) (punct)
benzodiazepines , (punct)
immunohistochemistry antigen (compound)
187 from (case)
months mean (nsubj)
cbz chronic (amod)
740 - (punct)
product maximum (compound)
decreasing refractoriness (conj)
thromboembolism was (cop)
dose mean (amod)
release , (punct)
dose weeks (nmod)
abnormality heart (compound)
subjects control (amod)
blood-pressure diastolic (amod)
presented fibrosis (dobj)
reduces female (nmod)
63 80 (conj)
caused possibly (advmod)
used weeks (nmod)
developed patient (nmod)
receiving deferoxamine (dobj)
months 1 (dep)
adequate doses (nsubj)
contractility features (conj)
used corticosteroids (nsubjpass)
percent sixty-three (nummod)
stimulation estrogenic (amod)
similar type (nsubj)
syndrome compartment (compound)
prolongation pronounced (amod)
reported dyskinesias (nsubjpass)
randomised were (auxpass)
included reduced (conj)
failure preparation (nmod)
times 1.8 (nummod)
reaction unusual (amod)
group prophylactic (amod)
8 5.1 (conj)
teratogenicity sulphasalazine (nmod)
measured ngf (nsubjpass)
= 6883 (dep)
given given (conj)
administration training (nmod)
levetiracetam by (case)
mg/m2 were (cop)
determine prevent (xcomp)
targeting pathway (dobj)
nerve cutaneous (amod)
participants volunteers (dep)
convulsions death (conj)
state steady (amod)
lidocaine . (punct)
59 87 (conj)
presented kb (nmod:npmod)
mr , (punct)
was ems (nmod)
different control (nmod)
useful nimodipine (nsubj)
associated administration (nsubjpass)
age ( (punct)
returned and (cc)
pentylenetetrazol and (cc)
foster adult (amod)
variables all (predet)
leukoencephalopathy posterior (amod)
prohibited . (punct)
prevention cancer (nmod)
netilmicin vs (cc)
units total (amod)
groups week (compound)
number cardiomyocyte (compound)
kind its (nmod:poss)
activity cholesterol (compound)
time intoxication (nmod)
arteries cromakalim (conj)
assessed addition (nmod)
declined respectively (advmod)
participated study (nmod)
given days (nmod)
effect diabetes (nmod)
incorporated fs (nmod)
issues these (det)
variation of (case)
levels antibody (compound)
developed antibody-negative (advcl)
function or (cc)
eliminated administered (advcl)
lidocaine- or (cc)
normalisation abnormalities (nmod)
toxicity toxicity (nmod)
cases hyperplasia (nmod)
hypokalemia subjects (nmod)
coagulation due (case)
review wide (amod)
hypotheses stroke (conj)
volume a (det)
free toxicity (nmod)
alopecia , (punct)
dose is (cop)
omitted except (mark)
monitoring and (cc)
% non-acetaminophen-induced (amod)
occurs especially (advmod)
tone the (det)
common more (advmod)
mediated was (auxpass)
evaluated % (dobj)
thrombopenia and (cc)
administration lorazepam (nmod)
injection midline (amod)
hyperactivity on (case)
relationship release (nmod)
underlying lesions (dobj)
studies rats (nmod)
infection inflammation (conj)
bradyarrhythmia requiring (acl)
type with (case)
entity as (case)
diminished is (auxpass)
explained dystrophy (nmod)
concluded used (ccomp)
collected vein (nmod)
failure ratio (dep)
seems fragmentation (xcomp)
dilatation and (cc)
worsened condition (dobj)
lateral of (case)
min 20.95 (nummod)
took when (advmod)
stimulation lids (nmod)
dissociation ) (punct)
receptors of (case)
decreased g/dl (nmod)
evaluations four (nummod)
additive be (cop)
stopping sulindac (dobj)
examined dose (nmod)
provide 2005 (nsubj)
type factor-beta1 (conj)
hypothyroidism the (det)
co-morbidity between (case)
effect encephalopathy (nsubj)
capacity fluoxetine (nmod)
alpha5 for (case)
carcinogen group (compound)
048 ) (punct)
return function (nsubj)
unit care (compound)
% 1.19 (nummod)
host in (case)
effects seizures (nmod)
preserves , (punct)
excretion acid (nmod)
loss status (compound)
infusion ) (punct)
areas stem (nmod)
analyses one-way (amod)
arrhythmogenicity the (det)
prior days (conj)
investigate links (dobj)
dawley sprague (compound)
min 135 (nummod)
county sweden (appos)
doses ketamine (nmod)
3.0 0.3 (compound)
food either (cc:preconj)
inferior colliculus (conj)
days twice (advmod)
dissociated pituitaries (nsubj)
velocity and (cc)
stimulated formation (nsubjpass)
number higher (amod)
data discrepant (amod)
rates therapy (nmod)
saline nicotine (conj)
case bacteremia (nmod)
antagonism . (punct)
occurrence tachycardia (nmod)
hematest by (case)
found ximelagatran (nsubjpass)
neuropediatrician by (case)
efficacy susceptibility (conj)
acetonide fluocinolone (compound)
results inflexibility (appos)
4.0 - (punct)
effect subgroups (nmod)
seizures developing (amod)
tolerability gastrointestinal (compound)
benzamide substituted (amod)
experienced disorders (dobj)
antibiotics only (advmod)
population overall (amod)
rescue leucovorin (compound)
scores and (cc)
second((1/2 0.50 (nummod)
received cocaine (dobj)
speculated prone (ccomp)
suppressed noted (conj)
analysed fraction (nsubjpass)
products for (case)
pursued not (neg)
phase ii (nummod)
probability a (det)
acidosis late (amod)
concentrations different (amod)
noticed that (ccomp)
acetyltransferase for (case)
out-patients ) (punct)
system to (case)
cytoplasm in (case)
iodine-125-metaiodobenzylguanidine with (case)
enlarged liver (nsubjpass)
assays taqman (compound)
s-i e-i (conj)
blinded who (nsubjpass)
time plasma (compound)
experienced ) (punct)
damage decreasing (acl)
ability due (case)
adjusted may (aux)
symptoms pd (compound)
autoantibodies markers (conj)
bottle an (det)
discontinuing starting (conj)
myopathy documented (amod)
levodopa- agonist-induced (conj)
cells adenoma (compound)
daytime during (case)
were compare (xcomp)
cohort with (case)
make to (mark)
elicited ) (punct)
alterations biochemical (amod)
risk liver (nmod)
suitable outpatients (nmod)
electroshock subconvulsant (amod)
effect converting (acl)
combination cnsb002 (nmod)
disintegrations minute (nmod)
tobramycin piperacillin-treated (conj)
seizures incidence (conj)
low although (mark)
% 85 (compound)
demonstrates elevation (dobj)
case d-penicillamine (conj)
propanolol administered (acl)
followed and (cc)
probability drug (compound)
ritonavir ng/ml (compound)
detachment cells (nmod)
worsen toxicity (dobj)
designated it (nsubjpass)
119 2 (conj)
representative is (cop)
accounted could (aux)
antimicrobials systemic (amod)
using activities (dobj)
different is (cop)
dfc hours (conj)
absorptiometry x-ray (compound)
3.6 5.7 (conj)
tests antibody (compound)
physiologic pathologic (conj)
differ incidence (nsubj)
course therapy (nmod)
superior haloperidol (nmod)
nmda in (case)
accounted only (advmod)
% p=0.001 (appos)
application pad (nmod)
configuration and (cc)
infusions with (case)
aids hearing (compound)
presented minutes (nmod:tmod)
changes from (case)
settings clinical (amod)
75/829 % (dep)
observations from (case)
production cancer (nmod)
arthritis treated (acl:relcl)
aborted then (advcl)
topotecan . (punct)
clones escape (nmod)
vasculitis and (cc)
course groups (nmod)
myelosuppression toxicity (nsubj)
sample participants (nmod)
contribute non-compliance (nmod)
alkaloid content (nmod)
positive and (cc)
restricted have (aux)
development shock (nmod)
both transiently (advmod)
day every (det)
efficacy everolimus (nmod)
clinical conjunction (dep)
implantation permanent (amod)
end , (punct)
remained suppressing (advcl)
control secretions (nmod)
female about (case)
factor responsible (amod)
serves metaiodobenzylguanidine (nsubj)
% 16.0 (nummod)
failure oliguric (amod)
increased frequency (nsubj)
= 90 (dep)
extended patient (nsubjpass)
neurons noradrenergic (amod)
symptoms relieve (compound)
hydroxyl functional (amod)
0.59-mg or (cc)
blocked antagonists (nmod)
useful also (advmod)
resistant strikingly (advmod)
patterns different (amod)
irritability copulation (conj)
lymphoma large (amod)
occurred exacerbated (nsubj)
observed sham (nmod)
compared concentrations (dobj)
p .001 (nummod)
model present (amod)
isoproterenol iso (appos)
carcinoma of (case)
infection mirabilis (compound)
depended apparently (advmod)
pattern branch (compound)
epidemiology the (det)
compared made (conj)
interference catheter (nmod)
experienced toxicity (dobj)
edema rats (nmod:poss)
patients chinese (amod)
had who (nsubj)
difference is (cop)
increases concentration (dobj)
utilizing antagonists (dobj)
choice valid (amod)
glipizide with (case)
conclusions associated (ccomp)
infarction as (case)
dehydrogenase lactate (compound)
had sister (dobj)
thrombectomy alteplase (nmod)
protrusions induced (acl)
reviewing documentation (dobj)
ginseng from (case)
effects pharmacological (amod)
features sensory (amod)
blood sinus (compound)
intensity 2 (dep)
had values (dobj)
brain and (cc)
test in (case)
acetaminophen ) (punct)
chemotherapy egfr (conj)
counts cd4+t-cell (amod)
individuals among (case)
systolic of (case)
efficacy or (cc)
placebo day (nmod)
investigations lesions (nmod)
albino c57bl/6 (conj)
rats isoproterenol-treated (amod)
f ) (punct)
complication patients (nmod)
injection igf-il-3 (nmod)
body wt (appos)
backgrounds ethnic (amod)
characterized hypertension (nsubjpass)
agents coagulation (conj)
produced depression (dobj)
angiotensinogen renal (amod)
motor sensory (amod)
tamoxifen antagonist (compound)
compare course (dobj)
efficacy improved (amod)
reported events (dobj)
hepatitis the (det)
activation transient (amod)
thought are (auxpass)
received s-i (nsubj)
reversed ischemia (nsubjpass)
vision blurred (amod)
gln223 between (case)
using absorptiometry (dobj)
associated all (nsubjpass)
rizatriptan many (amod)
glomerulonephritis autoimmunity (conj)
tremor clonic-tonic (conj)
described anemia (nsubjpass)
e1-induced prolonged (amod)
related progression (nmod)
2.0 0.6 (conj)
quinine mg/kg (appos)
stress dobutamine (amod)
recovery blood (compound)
triggered asterixis (nsubjpass)
gamma 1/2 (nummod)
objectives abuse (appos)
levels expression (conj)
alterations for (case)
onset symptoms (nmod)
mmps ) (punct)
pattern molecular (amod)
microg/l ( (punct)
peptide acid (compound)
effectiveness administration (nmod)
modified needed (advcl)
condition on-drug (compound)
release or (cc)
delirium . (punct)
attenuated dysfunction (dobj)
signs defined (acl:relcl)
upslope increased (amod)
normal reassessed (conj)
slow doses (nsubj)
syndrome between (case)
origin inflammatory (amod)
analysed concentrations (nsubjpass)
influenced . (punct)
studies association (nmod)
reliability patients (nmod)
rate contractions (nmod)
norms outside (case)
consisted rate (nmod)
pretreatment progesterone (compound)
pathology bladder (compound)
accepted cornerstone (nmod)
included myelosuppression (dobj)
gamma-carboxylated that (mark)
unaffected hypotension (nsubjpass)
form dystonic (amod)
pb to (case)
concentrations patient (nmod)
result eventually (advmod)
herbicides s-53482 (nsubj)
inhibitors potent (amod)
mice male (amod)
obtain presence (nmod)
evaluation hematologic (amod)
decreases that (nsubj)
late years (nmod)
associated occurrence (nmod)
administration short-term (amod)
reached and (cc)
prevent injection (nmod)
increases production (nsubj)
fastigial of (case)
depletion magnesium (compound)
hbeag ) (punct)
combination factors (nmod)
volume mean (amod)
ingestion in (case)
uses therapeutic (amod)
results better (amod)
down delta (nsubj)
identified epilepticus (nmod)
phosphorus with (case)
treated pb (nmod)
components c (dep)
asked evaluated (conj)
persisted years (nmod)
-chlorpheniramine 3 (nummod)
effect pressure (compound)
sestamibi and (cc)
suggest mode (dobj)
6/8 ( (punct)
assessed rate (nmod)
increased change (conj)
gave ratio (dobj)
attenuation hearing (advcl)
volume rats (nmod)
importance pathogenesis (nmod)
attenuates deficits (dobj)
improve may (aux)
published have (aux)
investigate compared (prep)
use individuals (nmod)
induced surgery (nmod)
aggression , (punct)
treated tumors (nmod)
taking duration (dobj)
produced media (nmod)
withdrawal csa (compound)
btc ( (punct)
bleeding intraoperative (amod)
1.25 - (punct)
0.24:1 raises (parataxis)
side-effect of (case)
hepatitis halothane (compound)
followed week (nmod)
chow produces (dobj)
implications prognosis (conj)
thrombosis cerebral (amod)
frequency severity (conj)
highlights cardiotoxicity (nsubj)
ck ) (punct)
dmcm ( (punct)
antagonized naloxone (nmod)
aqueous w/v (nmod:npmod)
facilitated combination (nsubj)
period post-training (amod)
assessment trial (nmod)
criteria disease (nmod)
demonstrated were (auxpass)
initiated hours (dep)
prescription suppressants (nmod)
avoidance of (case)
finding this (nsubj)
flow dural (amod)
dose-dependent value (nsubj)
study 84 (nummod)
done study (nsubjpass)
passage mannitol (nmod)
related but (cc)
induced results (nsubjpass)
reduction type (nmod)
metronidazole with (case)
consistent therapies (nmod)
useful models (nsubj)
compared subject (nmod)
starting increase (dobj)
anaesthesia isoflurane (compound)
7.0 adjustment (nmod)
forms anticoagulation (nmod)
p<0.05 ) (punct)
infarction lateral (amod)
1 0.05 (compound)
activation striatum (nmod)
tdi before (nmod)
g/m2/d 1.55 (compound)
evoked pressure (nmod)
marketed 1986 (nmod)
levels site (nmod)
each excipients (nmod)
triggers pathway (dobj)
growth reduced (amod)
venue new (amod)
evaluated percentage (nsubjpass)
ser311cys rs6275 (conj)
induce calls (dobj)
runs complexes (nmod)
abundance mrna (compound)
days stopping (advcl)
implanted . (punct)
i.p. oral (conj)
effects deprivation (nmod)
associated will (aux)
surveillance local (amod)
attributed patients (nmod)
monkeys macaque (amod)
compared data (nmod)
millimeter per (case)
microgram/kg/min 0.1 (nummod)
clubs axons (nmod)
avoiding toxicity (dobj)
increases evoked (nsubj)
treatment clinical (amod)
clozapine olanzapine (conj)
abuse simultaneous (amod)
induced injury (nsubjpass)
had metabolites (nsubj)
rizatriptan preferred (amod)
inducing lysis (dobj)
suppressed apoptosis (dobj)
years aged (amod)
patients follow-up (conj)
equinovarus talipes (compound)
vaccine derived (amod)
ratios 21 (nmod)
underwent fracture (dobj)
seeing are (aux)
= 0.56 (dobj)
longer significantly (advmod)
developed pain (dobj)
absent , (punct)
responses system (compound)
trials available (acl:relcl)
mmp-2 adam-10 (conj)
dose mg./kg (nmod)
attractive injections (nsubj)
labetalol enflurane (conj)
pill 10/5 (nmod)
characterized was (auxpass)
aminotransferase iu/l (appos)
withdrawal by (case)
disappear tinnitus (nsubj)
study months (nmod)
potentiate nifedipine (nsubj)
gaba metabolites (conj)
flurbiprofen with (case)
task measure (conj)
phasic both (cc:preconj)
flashbacks related (amod)
s.c. with (case)
hyperthermia considerations (conj)
idiosyncratic reaction (conj)
delayed shortened (conj)
40 100 (conj)
surgery/radiotherapy or (cc)
ability patients (nmod:poss)
count initial (amod)
electromyogram in (case)
five nine (amod)
patients migraine (nmod)
rats gm (nmod)
patients arthritis (nmod)
receive to (case)
pain or (cc)
2.3 to (conj)
mutants treatment-associated (amod)
weight sex (conj)
arch aortic (amod)
property a (det)
tissue hepatic (amod)
cause reversal (dobj)
ato-treated and (cc)
possible was (cop)
correlated reversibility (nmod)
correlate dose (nsubj)
gpt ) (punct)
matched cases (nsubjpass)
suburothelium in (case)
weeks 34 (nummod)
cd4 + (cc)
studied catheter (nmod)
examined was (auxpass)
containing calcium (dobj)
albino foster (compound)
obtained may (aux)
shown modulate (xcomp)
reverse hypotension (dobj)
contexts civilian (amod)
drops iodide (compound)
twitching of (case)
discontinued alteplase (nsubjpass)
16 +/- (cc)
management or (cc)
documented well (advmod)
(1.8)% 0.01 (appos)
depended which (nsubj)
reversed successfully (advmod)
associated sedative (nmod)
anaemia peripheral (amod)
factors predictors (conj)
agents immunomodulatory (amod)
responses on (case)
months in (case)
epicardial small (conj)
demonstrate time (nmod)
selective buschke (compound)
patients hemolysis (nmod)
048 . (punct)
showed while (mark)
solvent i.v (appos)
modulate could (aux)
drugs patients (appos)
memory : (punct)
role pathophysiological (amod)
polymerase dna (compound)
sulphate pregs (appos)
receptors afferent (amod)
bilirubin ) (punct)
had subjects (nmod)
tetany patient (nmod:poss)
started newspaper (nmod)
reproduces and (cc)
administration 2-mercaptoethane (nmod)
failure from (case)
( near (dep)
stages severe (amod)
formation dopamine (compound)
days aap (dep)
kidneys epinephrine-treated (amod)
seizures be-induced (amod)
l t (conj)
altering rats (nmod)
involve may (aux)
patients nodosa (nmod)
lymphoma gastric (amod)
assessments detailed (amod)
pool of (case)
uncomplicated this (nsubjpass)
nodules erythematous (amod)
developed began (advcl)
eosinophilia i.e. (dep)
wsr with (case)
higher observed (advcl)
alter rate (dobj)
disease the (det)
simplifies mesna (nsubj)
oab with (case)
neurotoxicity post (amod)
b-100 , (punct)
scores ) (punct)
cholinesterase movement (conj)
sgot sgpt (conj)
eosinophilia ) (punct)
recorded % (conj)
used tincture (nsubjpass)
reaction associated (acl)
devices elevated (amod)
function evaluation (conj)
providing data (dobj)
discontinued therefore (advmod)
zidovudine to (case)
3delta ( (punct)
slower irrespective (xcomp)
penzberg germany (appos)
del or (cc)
positive the (det)
syndrome diabetes-insipidus-like (amod)
lid grip (conj)
schedules daily (amod)
injection inhibitor (nmod)
years was (cop)
cardiotoxicity experiments (conj)
symptoms bladder (compound)
complete panel (dobj)
62(6):865 rep (compound)
decreased modifications (nmod)
3.5 or (cc)
ascertain , (punct)
surgery third (conj)
conditions amount (nmod)
disorder reversible (amod)
> 0.36 (nummod)
k(+ of (case)
detected environments (nmod)
found ratio (nsubjpass)
insipidus lithium-induced (amod)
function late (amod)
blockade part (nmod)
seen september (nmod)
biomarkers with (case)
alteration signs (nmod)
prevented l-dopa (nmod)
day period (nmod)
fingers 3.7+/-0.8 (nummod)
function social (amod)
actions stimulatory (amod)
describes features (dobj)
examination tests (dep)
leukemia and (cc)
mediated potentiation (nsubjpass)
decreased 0.3-fold (dobj)
p= 0.001 (conj)
1.5 and (cc)
supplemented dose (nmod)
administration fentanyl (nmod)
defect associated (amod)
suffered hemiparesis (dobj)
limit can (aux)
most in (case)
testing cognitive (amod)
blockers propranolol (dep)
rat l-w (amod)
dose peak (compound)
occurred 22 (nmod)
5,7-dcka ( (punct)
stunning , (punct)
levels growth (compound)
developed patients (advcl)
fell volume (nsubj)
taken drug (nsubjpass)
mg/kg 70 (appos)
enzyme a (det)
analysis hoc (compound)
kpa 10.5 (nummod)
rat one (nummod)
methods and (cc)
lipoprotein laboratory (conj)
appear interact (xcomp)
rats streptozotocin-diabetic (amod)
decreases susceptibility (dobj)
confirmed update (nmod)
administration % (nmod)
ameliorated significantly (advmod)
performed 17 (conj)
sjl and (cc)
quantified , (punct)
administration improves (nmod)
mg/kg 49 (nummod)
activation strong (amod)
investigated changes (dobj)
cells m (compound)
types hyperalgesia (nmod)
preferentially and (cc)
mediated cytotoxicity (nsubjpass)
arms both (cc:preconj)
ifosfamide alkylating (compound)
circumstantial largely (advmod)
treated betaine (nmod)
danger use (nmod)
enlarged , (punct)
excluded months (conj)
injected heparin (nsubjpass)
process kindling (compound)
0.0073 0.0038 (conj)
thrombo-embolism women (nmod)
decrease ( (punct)
had found (conj)
therapy minimal (amod)
myelosuppression , (punct)
altered differences (nmod)
ci ): (punct)
fev1 chronotropic (amod)
l(-1 ) (punct)
relevance host (nmod)
required often (advmod)
injection ( (punct)
minimize addition (nsubj)
recovered quickly (advmod)
delay growth (compound)
promoted overload (dobj)
memory with (case)
dismutase and (cc)
= 8) (dobj)
ultrastructural and (cc)
decreases if (mark)
deletion with (case)
overall % (dep)
function rat (compound)
left systolic (dobj)
reports show (acl:relcl)
include medications (nsubj)
administered is (auxpass)
mitochondria number (dep)
decreased diminished (dep)
pneumonia diseases (conj)
nausea evident (dep)
clz ) (punct)
eosinophilia , (punct)
mastodynia severe (amod)
g/dl or (cc)
blocked hand (nmod)
placebo-controlled and (cc)
associated tachyarrhythmias (nmod)
mean the (det)
duration at (case)
terminology treatment (conj)
patients disorder (nmod)
complication usage (nmod)
latency id50 (conj)
similar closely (advmod)
immunoassay enzyme (compound)
duration . (punct)
performed assay (nsubjpass)
153 , (punct)
diameter base (nmod)
age sex (conj)
participant one (nummod)
predictive cranial (nmod)
treatment betaine (amod)
randomised controlled (dep)
androgen- anemia (conj)
difference unmatched (nmod)
induced sleep (nsubjpass)
resistance qs/qt (conj)
prevented mesna (nmod)
h level (conj)
150 mg/m2 (dep)
subjected was (auxpass)
seen doses (nmod)
effects processes (nmod)
inferred it (nsubjpass)
increasing thereby (advmod)
function endothelial (amod)
given pb (nsubjpass)
control ventricular (amod)
combined agents (nmod)
intake methylphenidate (amod)
receptors blockade (conj)
vomiting hypotension (conj)
slowed 40/min (nmod)
role ca(2 (nmod)
drugs antidepressant (amod)
caused medication (nmod)
have (-)-isomer (nsubj)
globulin isg (appos)
accounting amoxicillin-clavulanate (amod)
report therapy (nmod)
parts the (det)
admitted disease (nmod)
cause acute (dobj)
p20 on (case)
differentiated . (punct)
microtubules cytoplasmic (amod)
flutamide mg.kg(-1).d(-1 (appos)
used aware (conj)
occur did (aux)
treated iso (nmod)
capsules by (case)
amifostine of (case)
impairment a (det)
proenkephalin penk (appos)
histology 2 (nummod)
scrutiny for (case)
mg/day 250 (nummod)
induced were (auxpass)
detected cin (nsubjpass)
anemia the (det)
imbalance with (case)
patients range (appos)
distribution tests (nmod)
used proposed (conj)
modulates dyskinesias (dobj)
studies secondary (amod)
arrhythmia suppressed (acl:relcl)
contributed incontinence (nmod)
mg 30 (compound)
measured peroxidation (nsubjpass)
toxicity monkeys (nmod)
prior administration (nmod)
improved which (nsubj)
culture in (case)
disappeared weeks (nmod)
developed because (mark)
cholecystokinin of (case)
gentamicin + (cc)
fluconazole with (case)
patterns mutational (amod)
population , (punct)
left uv (appos)
occurred had (parataxis)
aminotransferase , (punct)
minutes over (case)
protection surgery (nmod)
studied changes (nsubjpass)
infarct a (det)
disappearance symptoms (nmod)
results above (amod)
suppresses , (punct)
focus situated (acl)
treatment cancer (nmod)
treatment epinephrine (compound)
v/s 0.84 (nummod)
arrest cardiocirculatory (amod)
bis preprocedure (compound)
pressure mice (nmod)
increases whereas (mark)
patients eyes (appos)
retained activities (dobj)
reserpine and (cc)
arrhythmia experimental (amod)
suggest stimulation (dobj)
numbers the (det)
attack first (amod)
year follow-up (nmod)
behaviors prior (dep)
prevented rigidity (nsubjpass)
administration clonidine (nmod)
delayed severe (conj)
thrombophlebitis and (cc)
cardiomyopathy doxorubicin (compound)
mutants immune (amod)
thickness % (compound)
patients experienced (acl)
administration acid (nmod)
climbing apomorphine-induced (amod)
disorder disorders (conj)
agent narcotic (amod)
dyspnea ) (punct)
exposure epithelium (nmod)
investigated mice (nmod)
-14.8 ( (punct)
studies rodent (amod)
way either (cc:preconj)
recording a (det)
condition similar (amod)
complications eye (compound)
second pills (nmod)
developed rs (dobj)
investigated role (dobj)
use lmwh (nmod)
effect associated (acl)
cells including (case)
polymorphism ) (punct)
adc ( (punct)
decrease latencies (nmod)
expression frataxin (nmod)
allow discontinuation (nsubj)
angiography tomography (compound)
measured 6-ohda-lesioned (nmod)
present report (dobj)
contraindicate interfere (conj)
trial group (compound)
active lamivudine-containing (amod)
enrolled metabolizers (nsubjpass)
a > (dep)
developed occlusion (dobj)
7.0 was (cop)
thiamine riboflavin (conj)
system second (amod)
defects mds (appos)
blind double- (amod)
dissociated characteristics (nsubjpass)
included score (dobj)
scores in (case)
discovered . (punct)
edema optic (amod)
hemorrhagic not (neg)
45 126 (nummod)
echocardiography infant (amod)
resolved symptoms (nsubj)
men studies (nmod)
ipratropium % (conj)
dysphonia recurrent (amod)
ad ( (punct)
electroretinography including (case)
induced glucose (nsubj)
valsartan amlodipine (conj)
startle light-enhanced (amod)
development deficits (nmod)
tyr6]-vip lys1 (compound)
basis molecular (amod)
protection complete (amod)
anemia hemolytic (amod)
4/7 ) (punct)
severity illness (nmod)
visualize quantitate (conj)
function induced (acl)
included women (nsubjpass)
acid acetylsalicylic (amod)
recommended use (nsubjpass)
media rats (nmod)
action rats (nmod)
associated reported (conj)
late rather (cc)
hours forty-eight (nummod)
caused reversion (dobj)
% 80 (nummod)
unchanged aqp2 (nsubj)
45 10 (compound)
led presumably (advmod)
age sd (dep)
induced 1994 (nmod)
causes important (amod)
diet plain (amod)
mg/dl meq/l (nmod)
concentration effect-site (amod)
analyze we (nsubj)
supplementation potassium (compound)
produced patterns (dobj)
study prospective (amod)
increased occurred (conj)
patient treated (acl)
treatment b2 (compound)
polymorphisms ser311cys (appos)
hbv positive (dep)
indication clinical (amod)
hepatic pulmonary (conj)
performed reverted (conj)
mpep a (det)
hyperthermia treat (amod)
erythematosus in (case)
dimorphism causes (acl:relcl)
reabsorption phlorizin (nmod)
investigated subjects (nmod)
overload than (case)
measured all (nsubjpass)
92 of (advmod)
demonstrating localization (dobj)
tingling or (cc)
blocks while (mark)
rage ( (punct)
= 2 (dep)
increased followed (conj)
recurarization . (punct)
8-hourly g (compound)
dropped showed (conj)
rate disease (compound)
hypnotic to (mark)
methamphetamine either (dep)
methodology isopter (dep)
differed concentrations (nsubj)
obtained scanning (nmod)
continuous or (cc)
institution timely (advmod)
associated differences (nsubjpass)
3.4 0.7 (compound)
occurring level (nmod)
mechanism intoxication (nmod)
novel immunosuppressive (dep)
suspicion on (case)
edema or (cc)
potency of (case)
behaviors neuropsychiatric (amod)
gravis myasthenia (amod)
tested , (punct)
mg 0.59 (nummod)
ileostoma from (case)
likely lithium-induced (xcomp)
catheterization evaluation (nmod)
physicians 1,455 (nummod)
.05 than (case)
constellation a (det)
diltiazem verapamil (conj)
nitrate , (punct)
performed injecting (advcl)
observed dipyridamole (nmod)
learning , (punct)
form toxicity (dobj)
reactions catalysed (amod)
serotonin 5-hydroxytriptamine (dep)
tested occasions (nmod)
periods key (amod)
rate to (case)
reports some (det)
response chloramphenicol (nmod)
completed respectively (advmod)
pulses mucosa (nmod)
in beta4 (dep)
caa ( (punct)
rats d-amb-treated (amod)
glomeruli atubular (amod)
conditions control (amod)
increased isoniazid (nsubj)
ischaemia or (dep)
1.8 - (punct)
controls that (nsubj)
levels myocardial (amod)
reported connection (nmod)
relaxation and (cc)
schedule , (punct)
treatment p (appos)
administered systemically (advmod)
patient monitored (amod)
june and (cc)
excretion consumption (conj)
ontario eastern (compound)
tolerated , (punct)
injection capsaicin (compound)
described cases (nmod)
compounds therapy (nmod)
led forms (nsubj)
sulfasalazine with (case)
experience motility (nmod)
tolerated strategy (dobj)
development models (nmod)
afterdepolarization evidence (dep)
were . (punct)
neutropenia febrile (amod)
support hypothesis (dobj)
presenting , (punct)
substance as (case)
lesion skin (compound)
erp or (cc)
used history (nsubjpass)
employed is (auxpass)
evidence causes (nmod)
staining slices (nmod)
events randomization (nmod)
caspase cathepsin (compound)
gradient marked (amod)
use indications (nmod)
liver revealed (amod)
done pharmacokinetics (nsubjpass)
express ) (punct)
bond lader (conj)
characteristics strains (nmod)
injection i.p. (advmod)
reductions pri (nmod)
of free (amod)
depleted 5-ht (dobj)
sirolimus . (punct)
carbachol i.c. (amod)
quantitation abundance (nmod)
thrombocytopenia than (case)
administered concentrations (dobj)
pd ( (punct)
inhibitor p450 (compound)
follow-up for (case)
systolic lv (amod)
times separate (amod)
induction stage (nmod)
appeared though (mark)
combination mg (nmod)
persisted reduction (nmod)
accompanied rise (nmod)
0.5 2.5 (conj)
hypotension drug-induced (amod)
protocol an (det)
infection respiratory (amod)
experiments similar (amod)
administered reduce (xcomp)
minutes t120 (appos)
b.d mg (conj)
hyper-responsiveness lymphocytes (nmod)
concluded , (punct)
arteries fraction (nmod)
blotting by (case)
punctate stimuli (dep)
correlated subgroup (nmod)
factor is (cop)
alter demonstrate (parataxis)
lead noncompliance (nmod)
developed vomiting (conj)
alterations rats (nmod)
subsides gradually (advmod)
amnesia scopolamine-induced (amod)
within were (cop)
damage against (case)
analogues derivatives (conj)
mucosa nasal (amod)
investigation careful (amod)
extent young (nmod)
implausible ratio (nsubj)
time operating (amod)
found acquisition (nmod)
suggested haemodialysis (nsubjpass)
characterized available (advcl)
signs toxicity (nmod)
area hypoxic (amod)
sulphate of (case)
killed after (advmod)
effect sleepiness (nmod)
supernatants endothelial (amod)
continue whether (mark)
strategies treatment (nmod)
risk 2.1 (nummod)
left gyrus (dobj)
increased decreased (advcl)
presumed to (xcomp)
remained recovery (nmod)
residents quebec (amod)
regions four (nummod)
tissues cardiac (amod)
professionals therapy (nmod)
consumption e.g. (advmod)
dysfunction hyperkalemia (conj)
higher controls (nmod)
maintained efficacy (nsubjpass)
91.5 /-11.1 (conj)
exhibited effects (nsubjpass)
igg of (case)
inhibitor dideoxyinosine (appos)
sirolmus is (compound)
abnormalities disease (nmod)
kg 12.4 (nummod)
change together (advmod)
levodopa ly-171555 (conj)
alteration cellular (amod)
cis-platin and (cc)
were test (nmod)
infiltration with (case)
composed subunits (nmod)
cases for (case)
adriamycinol doxorubicin (conj)
employed also (advmod)
fire , (punct)
were events (attr)
azt ( (punct)
years patients (nmod)
did chemopreventive (nmod)
toxicity nanoparticles (nmod)
de nova (dep)
produced hypothermia (dobj)
glomerulonephritis segmental (amod)
revealed count (dobj)
adenocarcinomas large (amod)
micromol/l. , (punct)
ciprofloxacin 12 (nummod)
restored potentiation (dobj)
increase velocity (nmod)
tetany -- (punct)
astrocytes and (cc)
african or (cc)
was examine (xcomp)
treated drugs (nmod)
had stenosis (dobj)
toxicities to (case)
common not (neg)
tissues women (nmod)
region centrilobular (amod)
raclopride d2 (compound)
methods studied (dep)
25.3 +/- (cc)
repaired completely (advmod)
shorter days (dep)
risk their (nmod:poss)
aggravates that (mark)
cessation pills (nmod)
risk study (nmod)
condition ( (punct)
forms ctnt (compound)
arteries cortex (conj)
administration its (nmod:poss)
51 39 (compound)
pathophysiology dyskinesias (nmod)
followed treatment (dobj)
irregularity menstrual (amod)
weeks 96 (nummod)
cream % (amod)
received group (nmod)
vancomycin levofloxacin (conj)
loss area (nmod)
article in (case)
toxicity hrptec (nmod)
infused she (nsubj)
derangement from (case)
measuring concentration (dobj)
nephropathy adriamycin-induced (amod)
declined reaching (advcl)
effect carcinogenesis (nmod)
verapamil with (case)
propanolol with (case)
variable induces (conj)
11.2 10.9 (conj)
had only (advmod)
altering rate (dobj)
predispose differences (nsubj)
gtn vs. (cc)
schizophrenic six (nummod)
eai ( (punct)
determinants its (nmod:poss)
stage early (amod)
show inhibit (ccomp)
ligation- arrhythmias (conj)
improves functions (dobj)
impressions global (compound)
g g (conj)
increased it (nsubj)
obtained 111 (nmod)
angiography hepatic (amod)
focussed trials (nsubj)
assessed double-immunolabeling (advcl)
describe group (dobj)
1971 and (cc)
affected have (aux)
damage patients (nmod)
disease hodgkin (compound)
type cochlear (amod)
identifying for (mark)
glutamate : (punct)
schedule escalation (compound)
hands her (nmod:poss)
4/- were (cop)
(r)-alpha-methylhistamine i.c.v. (appos)
137 134 (compound)
induction greater (amod)
taking old (advcl)
higher age-dependent (conj)
time reduced (amod)
influence variables (nmod)
problem hinder (acl:relcl)
detect can (aux)
role formation (nmod)
subtypes among (case)
gtn +/- (cc)
renal and (cc)
channels glibenclamide-sensitive (amod)
episodes activity (dep)
toxicities and (cc)
have sinus (dobj)
mfs ( (punct)
related conditions (nmod)
induced death (dobj)
difference arms (nmod)
administered naloxone (conj)
was this (nmod)
haloperidol both (preconj)
values 9 (dep)
cows 17 (nummod)
entries of (case)
rose rose (conj)
experience an (det)
serum/urine in (case)
extrapyramidal rare (amod)
discontinuation to (case)
recovery ability (nmod)
ionic both (cc:preconj)
bupivacaine by (case)
hour and (cc)
mechanism epilepsy (nmod)
rare combination (nsubj)
similar mg/kg (dep)
impairment scopolamine-induced (amod)
year within (case)
reported assessed (advcl)
response immune (amod)
recovery fluid (compound)
midazolam administration (nsubj)
temporary or (cc)
antagonized pretreatment (nmod)
application of (case)
order the (det)
sarcoma aids (compound)
patients disorders (nmod)
number seizures (nmod)
sensitivity intermediate (amod)
patency for (case)
related metoclopramide (nmod)
mpep , (punct)
dysfunction ecstasy-associated (amod)
bradycardia was (cop)
percent 44 (nummod)
inserted wires (nsubjpass)
deficits impairments (conj)
induce potential (conj)
methotrexate toxicity (dobj)
precluded since (mark)
dronedarone amiodarone (conj)
5-fluorouracil folinic (conj)
epo alone (advmod)
recommended precede (ccomp)
induces growth (dobj)
postulated enhanced (ccomp)
21 2 (conj)
means a (det)
controls as (case)
studies activity (appos)
blockade mglur5 (nmod)
reliance drinking (nmod)
comparison made (acl)
2.75 - (punct)
epilepticus se (appos)
latency of (case)
report study (dobj)
drugs 3 (nummod)
score child-pugh (amod)
shunt phosphate (nsubj)
suggestion risk (nmod)
leiden v (compound)
pleased allow (conj)
standing and (cc)
staff of (case)
hexachloride ppm (compound)
ovarian with (case)
60 18 (compound)
states to (case)
decreased respectively (advmod)
infarction woman (nmod)
low level (nsubj)
was extent (nmod)
depletion a (det)
cerruloplasmin and (cc)
suggests mediate (ccomp)
aspirin of (case)
pilo ) (punct)
catecholaminergic to (case)
doing anticonvulsants (nmod)
scan tomography (compound)
increased improvement (nsubj)
similar users (nmod)
comatose stuporous (conj)
exhibit however (advmod)
received cisplatin (dobj)
acetylcholine ach (appos)
associated elevation (nsubjpass)
time this (det)
reversible stopped (advcl)
noted analysis (nmod)
activities mice (nmod)
months 7 (nummod)
recorded reached (nsubjpass)
liver in (case)
4-damp ) (punct)
healthy middle-aged (conj)
followed should (aux)
immunopathology disease (nmod)
correlated data (nsubjpass)
ah6809 , (punct)
formation infants (nmod)
mg/m2 level (dep)
reported rate (nsubjpass)
agents reverse (acl:relcl)
shell hyperactivity (nmod)
modifies cardiorespiratory (dobj)
31 +/- (cc)
fully or (cc)
contraceptives oc (appos)
study population-based (amod)
duration therapy (nmod)
room the (det)
muscle hearts (nmod)
once-daily twice-daily (conj)
blockers four (nummod)
2 10 (conj)
unaltered . (punct)
potent cromakalim (nsubj)
treated appropriately (advmod)
cyclophosphamide wtih (compound)
overdose in (case)
deficits rats (nmod)
l-noarg catalepsy (conj)
seen however (advmod)
prevalence and (cc)
dose smaller (amod)
stimulants of (case)
predisposing rpn (nmod)
precipitated that (mark)
attributed use (nmod)
describe authors (nsubj)
referred he (nsubjpass)
hypotension head-up (amod)
residents of (case)
recognition after (case)
plays neurotoxicity (nmod)
electroshock bicuculline (conj)
status ps (appos)
catalepsy : (punct)
incidents more (amod)
presented loss (nmod)
subjects especially (advmod)
stimuli unit (nmod)
thrombopoetin and (cc)
levels appearance (conj)
induced antidepressants (nmod)
diagnosis gravis (nmod)
occurred lethalities (nsubj)
cancer the (det)
read that (nsubjpass)
develops features (nmod)
feature rarely (advmod)
markers not (neg)
aware however (advmod)
showed effects (dobj)
activity amantadine (compound)
entity distinct (amod)
developed cad (dobj)
deficits : (punct)
results research (nmod)
bed dosage (conj)
infarction an (det)
iodixanol the (det)
had other (nsubj)
generalized idiopathic (amod)
palsies temporary (amod)
than less (advmod)
assessed group (nmod)
phases learning (nmod)
ml/ng ) (punct)
with tdp (conj)
inhibitor competitive (amod)
abnormality the (det)
compound > (nmod:tmod)
nsvt of (case)
features dysfunction (nmod)
compare volumes (dobj)
neurotransmitters glutamate (dep)
od versus (cc)
discontinuation pravastatin (compound)
24 , (punct)
g 200~250 (amod)
dysfunction male (amod)
tested models (nmod)
duration cells (nmod)
multifactorial are (cop)
phenylephrine not (cc)
called for (prep)
induced injections (nmod)
measured later (advmod)
needed reversible (advcl)
tended correct (xcomp)
3.3 2.5 (conj)
neurotoxic setting (nmod)
area auditory (amod)
retention sodium (compound)
> ng/ml (dep)
components . (punct)
were segment (attr)
propranolol dose (dep)
level function (nmod)
woman caucasian (amod)
rate mineralizes (acl:relcl)
resulted transplantation (nmod)
propagate to (mark)
during posttherapy (conj)
older had (conj)
blocking jerks (dobj)
level sc-48334 (compound)
malaise nausea (conj)
accumulation myocardial (amod)
therapy repeated (amod)
valproate combination (conj)
groups nephropathy (amod)
halothane to (case)
infusion anova (dep)
was evidence (nsubj)
vehicle by (case)
relationship causative (amod)
treatment neutropenia (nmod)
produce mechanisms (nmod)
use anorexigens (nmod)
% 16.2 (nummod)
action only (advmod)
blockade d-2 (amod)
regulation products (nmod)
cystometry continuous (amod)
death or (cc)
control excitability (nmod)
latency swimming (compound)
sinoatrial of (case)
had re-warming (advcl)
desogestrel gestodene (conj)
ones in (case)
postinjection minutes (compound)
deficits structural (amod)
effects symptoms (nmod)
ecg surface (compound)
events for (case)
consequence that (mark)
patent in (case)
infections their (nmod:poss)
increased compared (prep)
centers service (compound)
using component (dobj)
males 6 (nummod)
found mellitus (nsubjpass)
administration phenobarbital (amod)
treatment 5-fu (nmod)
seem useful (xcomp)
variants genetic (amod)
associated glomerulosclerosis (nmod)
kidney rats (nmod)
pathological-process the (det)
accumulation mibg (compound)
role agents (nmod)
flavonoids , (punct)
paranoia cip (appos)
occurs mechanism (nsubj)
investigate strains (dobj)
level her (nmod:poss)
arterial in (case)
preceded pain (nmod)
composition of (case)
status associated (acl)
succumbed h (dobj)
50 only (advmod)
iraq from (case)
role plays (acl:relcl)
system structures (conj)
glycine gaba (conj)
angioedema of (case)
relation ingestion (nmod)
rats pre-treated (acl)
doses antagonists (nmod)
provided anaesthesia (nsubj)
actions marked (amod)
fact cause (acl)
cimetidine ranitidine (conj)
significance strategy (conj)
exist comparisons (nsubj)
15/44 15/44 (conj)
showed e2 (nsubj)
scattered or (cc)
structures targets (conj)
valproate-induced . (punct)
stimulation days (appos)
illustrated , (punct)
contribute effects (nmod)
administrated agent (nmod)
implicated cardiomyopathy (nmod)
sufficient expression (nmod)
magnitude proteinuria (nmod)
frequency withdrawal (nmod)
sg145r rtm204i (dep)
synthesis investigations (conj)
distribution and (cc)
support dialytic (amod)
3.32 10(2 (conj)
numbers growing (amod)
compared anaesthesia (nmod)
reactions drug (compound)
required development (nmod)
developed losses (nmod)
ultrafiltration and (cc)
14/104 ( (punct)
administered attempt (nmod)
reflex bezold-jarish (amod)
facies , (punct)
repeated series (nsubjpass)
uni- bilateral (conj)
induced carcinogens (nmod)
bumetanide and (cc)
pressure 165/90 (nmod)
declined significantly (advmod)
staff among (case)
induced reserpine (nmod:npmod)
users were (cop)
ng/ml 4497 (nummod)
aware clinicians (nsubj)
transplant allogeneic (amod)
exhibited layer (nmod)
sevoflurane after (case)
was where (advmod)
disappeared fever (nsubj)
cause where (advmod)
acids hexaaldonic (amod)
journals . (punct)
significant < (dep)
requested were (auxpass)
improvement recovery (nmod)
model investigations (nmod)
ug.kg-1 f (appos)
pounds , (punct)
shown results (dobj)
was until (mark)
function toxicity (nsubj)
dogs nine (nummod)
n= 2 (nummod)
preponderance incidence (conj)
diameters shortening (conj)
stent vessel (conj)
rat same (amod)
noted elevation (nmod)
embryolethality retardation (conj)
observed values (nsubjpass)
depressed abolished (conj)
optimized empirically (advmod)
validate to (mark)
% so2<90 (compound)
higher that (mark)
studied agent (advcl)
renin and (cc)
weeks his (nmod:poss)
prophylaxis or (cc)
man of (case)
treated previously (advmod)
induced tumor-free (advcl)
option . (punct)
patient-years in (case)
release etodolac (compound)
% 63.2 (nummod)
mg/m2 81 (nummod)
infiltrate , (punct)
amelioration modest (amod)
protein homer1 (nsubj)
pregnancy the (det)
hydroxyanisole with (case)
nigra substantia (advmod)
ethambutol with (case)
protects dithiocarbamate (nsubj)
extract grape (compound)
hepatotoxicity patients (nmod)
methods referred (appos)
mechanisms pathophysiological (amod)
vasospasm with (case)
840 - (punct)
step . (punct)
ntg of (case)
receptors or (cc)
capacity reduced (amod)
lost however (advmod)
changed spots (nsubjpass)
images inadequate (amod)
controls 15 (nummod)
pain involvement (conj)
effusions pleural (amod)
46.0 6.9 (compound)
nms and (cc)
readmitted death (nmod)
0.05 ) (punct)
users present (amod)
produced rats (nsubj)
light ( (punct)
analogues structure (nmod)
except chx (nmod)
diatheses illnesses (conj)
range , (punct)
generated importance (nmod)
capture enhanced (amod)
regimen schedule (nmod)
hypothermia reserpine (compound)
response age-related (amod)
line regression (compound)
safety tee (compound)
5 least (advmod)
acetylsalicylate the (det)
total only (advmod)
patients 210 (nummod)
slurred changes (nmod)
patients primary (amod)
age-dependent whereas (dep)
livers the (det)
consists shivering (advcl)
developed curves (dobj)
result inhibition (nmod)
complete exam (nsubj)
shape erythrocytes (nmod)
obtained could (aux)
ameliorated dystonia (dep)
vsds jc (dep)
factors delirium (compound)
more treatment (nmod)
event serious (amod)
correlations intensity (nmod)
measurements to (case)
induction administration (nmod)
thought involved (xcomp)
level activated (amod)
pregnancy symptoms (conj)
treatment adolescent (amod)
men black (appos)
methadone dependence (nmod)
compounds organophosphorous (amod)
influence cardiotoxicity (dobj)
pain loss (conj)
need possible (amod)
society anesthesiologists (nmod)
dropped steeply (advcl)
continued decreased (advcl)
mm 33.8 (nummod)
aspirin 1.03 (conj)
interfere responses (nmod)
involve provocation (dobj)
experiments and (cc)
aes as (case)
likely play (xcomp)
dose 10-mg (amod)
attenuated peak (nmod)
hypoglycaemia of (case)
release particles (nmod)
sss sinus (conj)
failure renal (amod)
effective where (advmod)
ascertain syndrome (ccomp)
hypothyroid also (advmod)
compound the (det)
presented and (cc)
g/day 0 (appos)
suffering were (aux)
transplants 135 (compound)
produce infusions (nsubj)
level reduced (amod)
appear causes (nsubj)
fat in (case)
tolerance good (amod)
damage produced (acl)
pills . (punct)
approval and (cc)
ulcers rats (nmod)
rep cancer (compound)
prevented attenuated (conj)
eye to (case)
levodopa precursor (compound)
r = (amod)
treated nimo (nmod)
possibility factors (nmod)
15-f(2t)-isop plasma (compound)
pregnant strain (conj)
disability aggravation (nmod)
threshold of (case)
day first (conj)
management without (case)
0.03 infusions (dep)
included observations (nsubj)
used age (nmod)
ph 7.4 (conj)
concentrations cholesterol (nmod)
index relative (amod)
developed pain (nmod)
loss of (case)
predictive ratios (nmod)
a infarction (nmod)
failure mice (nmod)
4.5- to (dep)
demonstrated reliability (dobj)
p .05 (dep)
custody police (compound)
require abnormalities (nsubj)
markers peptide (nmod)
combined prevention (nmod)
restrict initiation (dobj)
cytoprotective mainly (advmod)
presence dose (nmod)
supplementation , (punct)
data trials (nmod)
drug- contact (conj)
testing after (case)
function flow (conj)
disorder psychoses (conj)
test as (case)
focused hence (advmod)
bands delta (nmod)
values numbers (nmod)
parkinsonism drug-induced (amod)
implicated : (punct)
pairs perfused (acl)
case association (nmod)
degeneration focal (amod)
endografine diatrizoate (appos)
mg trihexyphenidyl (dep)
initiated overstimulation (nmod)
diseases hepatitis (appos)
phenothiazines either (cc:preconj)
interna four (conj)
cardiotoxicity dox-induced (amod)
(2)% 7 (nummod)
synthesis . (punct)
orientation in (case)
activities functional (amod)
associated prophylaxis (nsubjpass)
case like (case)
activity stress (conj)
m group (compound)
related drug (nmod)
statement occurring (acl)
exert may (aux)
found t (nmod)
given chickens (nsubj)
symptoms sensory (amod)
amine . (punct)
14 to (dep)
transferred coordinates (nsubjpass)
oestrogens , (punct)
p=0.032 ( (punct)
absent groups (nmod)
weight weight (conj)
age in (case)
anesthesia stable (amod)
followed were (auxpass)
type wt (appos)
admitted was (auxpass)
unlike case (nmod)
composition stone (compound)
carcinoma progressive (amod)
started methylphenidate (nmod)
carcinoma 11 (appos)
easy and (cc)
measurement dp/dtejc (compound)
disability motor (compound)
recorded time (dobj)
cholinergic in (case)
first and (cc)
occurs 2 (dep)
diagnosis vasculitis (nmod)
treatment phenobarbital (amod)
gives pulmonary (nmod)
angiography by (case)
occupancy receptor (compound)
early was (cop)
isrctn54598675 registration (nmod:tmod)
spasm to (case)
experiencing values (nmod)
surgery including (case)
inhibitor xa (compound)
tolerated therapy (nsubjpass)
permits . (punct)
subscale negative (amod)
administering for (mark)
conjugation metabolism (conj)
pre-administration atropine (nmod)
thickness medial (amod)
recurrence the (det)
samples benzoylecgonine (nmod)
failure without (case)
included address (advcl)
attributed interaction (nmod)
ongoing is (cop)
drugs stimulating (acl)
treating for (mark)
son ( (punct)
induced warfarin (nmod)
doc ( (punct)
6-hydroxydopamine 6-ohda (appos)
follow-up again (advmod)
age 70 (nummod)
induced azt (nsubj)
mg/100 20 (compound)
variables for (case)
loss has (aux)
gly-gly ) (punct)
inhibitors cyclooxygenase (compound)
purpura thrombotic (amod)
cost the (det)
postulated damage (nmod)
reversal hearing (acl)
7.8 10(10 (conj)
system followed (acl)
indicators routine (amod)
actions locomotor (compound)
phno agonist (compound)
increased levels (nsubj)
= 0.02 (dobj)
embryo chick (amod)
signals chemical (compound)
fzp with (case)
pralidoxime-2-chloride + (cc)
group % (appos)
requested regardless (advmod)
5-hydroxytriptamine 5-ht (appos)
cystitis busulfan-induced (amod)
study lovastatin (compound)
aprotinin or (cc)
assessing of (mark)
strain susceptible (amod)
12- intervals (dep)
vp ) (punct)
markers synaptic (amod)
grade recurrent (amod)
advantage dose (nmod)
used introduction (nsubjpass)
limits ( (punct)
angioedema nsaid-induced (amod)
increased index (dobj)
use ticlopidine (nmod)
expressions ) (punct)
minute by (case)
evidence score (conj)
background sociodemographic (amod)
insertion needle (compound)
500 ( (punct)
21 % (appos)
source information (nmod)
ventricular on (case)
was injury (nmod)
weight and/or (cc)
lapsed then (advmod)
groups dex-treated (amod)
cimetidine iv (compound)
proposed was (auxpass)
repair % (dep)
21.0 43.3 (conj)
serve might (aux)
test each (nmod)
hypercholesterolemia for (case)
47 71 (prep)
comparing agents (nmod)
caudate accumbens (conj)
ruled out (compound:prt)
used injury (nsubjpass)
cases some (det)
morphine were (cop)
acetate alpha-tac (appos)
tested ability (nmod)
diffusion process (nmod)
abnormalities users (nmod)
0.25 - (punct)
rates withdrawal (nmod)
having oab (dobj)
administration tea (nmod)
aspirin inhibitor (appos)
revealed immunoblotting (nsubj)
insertion chain (nmod)
varied dose (nmod)
depletions with (case)
those dysfunction (nmod)
ozone of (case)
surgery emergency (compound)
course 48-week (amod)
impaired agonist (nsubj)
animals administered (acl)
(r)-alpha-methylhistamine mg/kg (appos)
incidence increased (amod)
do absence (nmod)
angiogenesis inflammatory (conj)
enrolled endocrinologists (nmod)
conducted order (nmod)
newborns exposed (acl)
disruption is (cop)
all but (cc)
lymphocytes patient (nmod:poss)
prevent as (cc)
acting vicinity (nmod)
state to (case)
hyperprolactinemia with (case)
lemon bitter (amod)
using coil (dobj)
blot and (cc)
seen increase (nsubjpass)
normoammonaemic . (punct)
seen later (advmod)
anaemia levels (conj)
had hours (nmod:tmod)
sensitive especially (advmod)
effects risperidone (nmod)
u/ml p (nmod:tmod)
vehicle nimo (conj)
constitutes vancomycin (nsubj)
measured , (punct)
g ; (punct)
6 for (case)
cardiomyopathy rats (nmod)
images contrast (compound)
preclinical clinical (conj)
boy inhibitor (appos)
function muscle (compound)
mv ( (punct)
moving rats (conj)
skeptical also (advmod)
trough blockage (dobj)
preserves prevents (conj)
used type (dobj)
neuropathy months (nmod)
evidence somatotopy (nmod)
toxicity nonurologic (amod)
invited were (auxpass)
provide gls (nsubj)
come response (nsubj)
prevention : (punct)
reduce may (aux)
citalopram inhibitor (conj)
intraventricularly given (amod)
stenosis % (amod)
0.96 ; (punct)
associated rates (nmod)
considered conversion (nsubjpass)
justification without (case)
had radiotherapy (dobj)
controls saline (compound)
recognize and (cc)
course corticosteroids (nmod)
found h (nmod)
medication prescribed (acl:relcl)
days 316 (nummod)
achieved response (nsubjpass)
anemia worse-than-expected (amod)
fever chills (nmod)
contracture dupuytren (nmod:poss)
participation renin (nmod)
achieved that (nsubj)
expression pituitary (nmod)
balances the (det)
measurements mg. (compound)
schizophrenia with (case)
rat % (appos)
25.3 2.9 (conj)
tremor ataxia (conj)
reverses effect (dobj)
delivered and (cc)
reversibility with (case)
endothelin-1 of (case)
remained indicated (parataxis)
obtained pg-9 (nmod)
disorders exposed (acl:relcl)
tab 1/2 (nummod)
nightly once (advmod)
mechanism(s the (det)
ptx 24 (nummod)
rhythms dissociation (conj)
drum beating (compound)
epinephrine epinephrine (conj)
infused were (cop)
bodyweight days (nmod)
effect diameter (nmod)
differences no (det)
paramount recognition (nsubjpass)
increased unchanged (conj)
younger 32.87 (dep)
ventricular mainly (advmod)
intermediate that (nmod)
injection saline (compound)
regrowth tumors (nmod)
users ecstasy (compound)
neurotransmission gabaergic (amod)
challenged intragastrically (advmod)
obtained switch (nmod)
% index (nsubj)
decades 2 (nummod)
received addition (nmod)
factors eventual (amod)
widening progressive (amod)
injected induce (advcl)
detected , (punct)
indicate involved (ccomp)
ca(2 ) (conj)
effect nimodipine (nmod)
increase more (nmod)
asymptomatic more (advmod)
enhanced possibly (advmod)
attempts impaired (advcl)
groups adr-induced (amod)
reduced as (advmod)
release proteins (nmod)
action that (mark)
blockade . (punct)
5 1 (quantmod)
potential observed (amod)
prevents changes (dobj)
population-based , (punct)
% majority (nsubj)
improvement recovery (conj)
increases rats (nmod)
components early-acting (amod)
delineated activated (conj)
significance the (det)
demonstrated impairments (dobj)
treated mg/day (conj)
cells aortic (amod)
developed blockade (dobj)
case particular (amod)
chest caused (acl)
expression beclin (nmod)
breaks membranes (nmod)
anemia blockade-induced (amod)
polymorphism nucleotide (compound)
taking she (nsubj)
dbs group (compound)
rejection cr (dep)
found been (auxpass)
bupivacaine given (amod)
then months (nmod)
been has (aux)
permeability endothelial (amod)
demonstrated effect (dobj)
alter does (aux)
loss reflex (nmod)
g 20 (compound)
patients 2050 (nummod)
interpretation confound (amod)
min every (det)
calcium with (case)
ingestion clomipramine (compound)
mosmol/kg and (cc)
aim work (nmod)
neurons dopaminergic (amod)
enhances produces (conj)
performed study (nsubjpass)
procedure lesioning (amod)
injection mg (dep)
e. hemoglobin (compound)
found being (auxpass)
-14.6 ; (punct)
deficit accuracy (nmod)
cells spike (case)
toxicity intrathecal (amod)
internal external (conj)
dilatation groups (conj)
meninges inflamed (amod)
release content (conj)
technique pointer (compound)
hypoxia of (case)
described toxicities (nsubjpass)
observed necrosis (nsubjpass)
determined g (nmod)
sodium , (punct)
analyzed systematically (advmod)
fanft on (case)
participate generation (nmod)
develops mass (dobj)
consciousness and (cc)
lacrimation and (cc)
genes several (amod)
transplantation unsuccessful (amod)
detection the (det)
response pathological (amod)
nsclc against (case)
15.7 6.7 (conj)
reported interaction (nsubjpass)
in vivo (dep)
inducer p4501a1/1a2 (nmod)
areas other (amod)
serum ( (punct)
quantified injection (nmod)
complete 1 (nummod)
vasculitis conjunction (nmod)
showed none (nsubj)
sevoflurane during (case)
sc ( (punct)
nephropathy with (case)
underwent monitoring (xcomp)
size baseline (nmod)
men n (dep)
scotoma an (det)
hernias many (amod)
monotherapy either (cc:preconj)
die and (cc)
observed induced (parataxis)
dose-dependent derive (conj)
target to (case)
cardioversion dc (compound)
rats juvenile (compound)
demonstrated cis-ra (nsubj)
hypoperfusion hepatic (amod)
noticed administration (nmod)
carotid of (case)
pathway cell-death (compound)
morphology the (det)
protect effects (nmod)
potentiated response (nsubjpass)
explain . (punct)
hypotension dysrhythmias (conj)
occurred weeks (dobj)
oxide messenger (compound)
cyclophosphamide decline (nmod)
damage group (nmod)
propose tie (dobj)
reduce bf (dobj)
produced compared (advcl)
model epilepticus (nmod)
combination stabilizer (nmod)
consequence is (cop)
occur simultaneously (advmod)
hypoxic not (neg)
tempol scavenger (compound)
component the (det)
controlling influences (nmod)
certain , (punct)
1.0 x (cc)
decline subsequent (amod)
mg/kg 15 (nummod)
rechallenged were (auxpass)
associated downregulation (nmod)
myelosuppression ( (punct)
seizures eeg (conj)
form infusion (nmod)
effect nephrotoxicity (nmod)
lobe during (case)
patients all (advmod)
intervention a (det)
evaluate threat (dobj)
tafi ) (punct)
exhibits as (cc)
methods of (case)
targets cells (nsubj)
received prior (advmod)
flow . (punct)
activity seizure (compound)
produced d (nmod)
repeated who (nsubj)
inhibited respectively (advmod)
reproducibility values (conj)
activity da (compound)
observation carried (acl)
inhibited hyperprolactinemia (nmod)
mice p.o. (appos)
immunosuppression due (case)
increase that (nsubj)
female african-american (amod)
ph 7.05 (nummod)
re mg/kg (appos)
causes increases (dobj)
brief tonic (conj)
effect concentration-blood (compound)
understand process (dobj)
engrafted patients (nsubj)
levels ammonium (compound)
fenoldopam theophylline (conj)
mild ataxia (nmod)
modifications breast (compound)
produced withdrawing (advcl)
japan outside (case)
followed hsct (nmod)
formed cells (nmod)
cases hyponatremia (nmod)
1000/mm3 < (compound)
recognized than (mark)
use compounds (nmod)
cause rarely (advmod)
increased as (mark)
reported qtls (nsubjpass)
encourages which (nsubj)
scale verbal (amod)
3ma ) (punct)
included history (nsubj)
parallels verapamil (advmod)
potentiation , (punct)
spasm artery (compound)
lf ( (punct)
delayed , (punct)
rose eu (nmod)
maintained when (advmod)
programme visual (amod)
virus leukaemia (compound)
potassium initial (amod)
impairments lasting (amod)
2 least (nmod:npmod)
completed dse (dobj)
aes renovascular (amod)
mouse balb/c (compound)
ameliorate neurotoxicity (dobj)
related disorders (nmod)
month the (det)
risk causing (advcl)
ambulate and (cc)
treatment continuous (amod)
ptrend=0.02 ) (punct)
given oxytocin (nsubjpass)
areas brain (nmod)
benign as (mark)
cause . (punct)
diagnosis of (case)
duration seizure (compound)
mg/m2 dose (nsubj)
medication intravenous (amod)
fluid body (compound)
35.0 32.5 (conj)
percent seventy (nummod)
0.95 ) (punct)
excretion pirarubicin (nmod)
response adaptive (amod)
objective report (dep)
implicated one (nmod)
la plasma (compound)
one the (det)
109 +/- (cc)
rats normal-salt (amod)
appears vulnerability (nsubj)
ut-a1 ( (punct)
increased similarly (advmod)
diagnosis mouth (nmod)
expression mrna (nmod)
35.1 5.5 (conj)
given bronchiectasis (nmod)
found proved (dep)
discusses it (nsubj)
citalopram nmol/l (appos)
administration atropine (nmod)
provide care (nsubj)
developed tachycardias (dobj)
written consent (dobj)
morbidity with (case)
decreasing synthesis (dobj)
antigenemia of (case)
fess ) (punct)
alf=0/35 ( (punct)
protected ly274614 (nsubj)
activity virus (compound)
demonstrate difference (dobj)
pan ; (punct)
aggregations induced (acl)
efficacy combinations (nmod)
146 +/- (cc)
to 30 (pobj)
treatment associated (amod)
produced contrast (nmod)
diuretic a (det)
pc or (cc)
penetration wall (nmod)
therapy maximal (amod)
control patients (nmod)
observed evaluations (nmod)
disorders medline (conj)
dynamic total (amod)
dysfunction followed (acl)
focus status (nmod)
correlated number (nmod)
4 1 (compound)
examined preoperatively (advmod)
devastating pain (advmod)
bcnu mg/kg (appos)
used determination (nsubjpass)
activated ages (nmod)
combined infections (nmod)
distinguished that (nsubjpass)
week abstinence (compound)
modify seizures (dobj)
inappropriate unsupervised (conj)
les patients (nmod)
indomethacin due (case)
portray comparison (nmod)
caused failure (dobj)
suppression due (case)
passage the (det)
increase resulting (amod)
(2-chloroethyl)-1-nitrosoure carmustine-[1,3-bis (compound)
hospital syndrome (nmod)
used these (nmod)
therapy system (compound)
take also (advmod)
report findings (dobj)
remained injection (nmod)
substances reactive (amod)
caudate left (amod)
therapy types (nmod)
groups alzheimer (nmod:poss)
anxiety mice (nmod)
lactate free (conj)
provide characterization (dobj)
dilated reversible (amod)
drugs antineoplastic (amod)
day life (nmod)
prevented fall (dobj)
cholinergic serotonergic- (conj)
fell fell (conj)
injections 2 (nummod)
patients secondary (amod)
length hospital (compound)
cross-tolerant morphine (nmod)
sensitivity relative (amod)
polymorphisms , (punct)
controls p=0.05 (appos)
experience about (case)
stimulation nucleus (compound)
thyroiditis due (case)
cause strokes (nmod)
factor selecting (acl)
trends days (nmod)
trial cb (nmod)
resolve months (nmod)
show influence (dobj)
baseline 20 (conj)
bolus a (det)
activated inhibited (conj)
restarted be (auxpass)
kept diet (nmod)
excluded failure (nsubjpass)
responded well (advmod)
compounds lithium (compound)
sutures the (det)
alpha-tc mg/kg (appos)
patients heart (compound)
cycles seven (compound)
blockade pge(2 (nmod)
ineffective 4-aminopyridine (nsubj)
inhibitor strong (amod)
larger proportionally (advmod)
shows reaction (ccomp)
strain of (case)
ed50 terfenadine (nmod)
rats mg/kg (nmod)
tasks other (amod)
learning chelation (compound)
liters 3 (nummod)
intervals of (case)
consistent most (advmod)
rest elevation (nmod)
10- 20- (conj)
treatment cystitis (nmod)
images gamma (compound)
nephritis anti-inflammatory (amod)
doses various (amod)
reduce addition (nsubj)
mg hours (nmod)
causes alterations (dobj)
hypokalemia factors (nsubj)
discuss pathophysiology (dobj)
group endografine (compound)
ameliorated supplementation (nsubj)
78.1 to (dep)
show to (mark)
cycle compounds (conj)
force share (xcomp)
diagnosis dsm-iv (compound)
fractions ventricular (amod)
537 149 (conj)
sensitized : (punct)
influenced agonists (nmod)
cells l1210 (compound)
decrease movement (dobj)
increased hr (nsubj)
noted and (cc)
ptz 30mg/kg (appos)
factors in (case)
backcrossing by (case)
hearing 3 (nmod)
modulator that (mark)
efficacy medication (nmod)
incorporation a (det)
ip/week ( (punct)
irrigations kanamycin-colistin (amod)
decrease uptake (nmod)
incidence tremor (nmod)
sampling kinase (nmod)
levels bfgf (nmod)
prevented lf (nsubj)
quality oab (appos)
p : (punct)
lungs on (case)
decreased 51.7 (nmod)
grade 3 (conj)
women using (acl)
infusions aminophylline (nmod)
produced growth (dobj)
proteins dendrin (dep)
advent blockers (nmod)
increase % (compound)
genes nephrin (conj)
administration prehospital (amod)
people of (case)
period to (case)
gum 4-mg (amod)
doses mg (compound)
effects ouabain (nmod)
decrease further (amod)
lamivudine combined (acl)
parallel a (det)
discontinuing after (mark)
improve performance (dobj)
noradrenaline circulating (amod)
demand hypotension (nmod)
institution hypertension (nmod)
aid cessation (compound)
sed , (punct)
mg/day 6 (nummod)
pg-9 amplifier (case)
toxicity arrhythmias (conj)
anemia effect (nsubj)
refractory advanced (amod)
ranged s (nmod)
precede should (aux)
lower indicating (xcomp)
effects long-lasting (amod)
determined part (nmod)
increased affinity (nmod)
(r)-alpha-methylhistamine thioperamide (conj)
thoroughly more (advmod)
% 8.5 (compound)
thrush 6 (appos)
counteracted , (punct)
dose dce (nmod)
adenomas of (case)
chlorpromazine i.c. (amod)
decreased gyrus (conj)
hemorrhage hem (dep)
made lesions (nsubjpass)
measured increases (nsubjpass)
levels 3717 (nummod)
courses norethisterone (dep)
camera the (det)
host as (case)
present more (dobj)
mechanism reported (advcl)
disorder conduction (compound)
available regarded (conj)
layer wall (nmod)
pursued be (auxpass)
lower binding (nsubj)
treatment testosterone (nmod)
studied effect (dobj)
chick both (cc:preconj)
memory explicit (compound)
liter per (case)
identified present (advcl)
induced indomethacin (nsubj)
suggested pathway (ccomp)
d calcification (nmod)
provided information (dobj)
took metoclopramide (dobj)
score percent (nmod)
study effect (dobj)
analogues 8-se (appos)
hypertension causes (nmod)
represented represented (conj)
observed criterion (nmod)
reduction points (nsubj)
concluded effective (ccomp)
recurrence rapid (amod)
retarding protected (conj)
rhythm patient (compound)
hours eight (nummod)
myelosuppression leukopenia (dep)
0.05 prior (amod)
transit intestinal (amod)
level no (det)
progression slow (amod)
mechanisms degeneration (nmod)
prevent slow (conj)
old ) (punct)
causes that (mark)
frequencies fibrillation (nmod)
paralysis contralateral (amod)
whom to (case)
persisted defect (nsubj)
gvg dose (compound)
siat to (mark)
mediated azithromycin (nmod)
normalised but (cc)
approval board (compound)
cristae mitochondrial (amod)
low testosterone (nsubj)
tolerated entered (conj)
other dyskinesia (nmod)
allografts patients (nmod)
loss field (compound)
or ic (dep)
inhibited amide (nmod)
receiving samples (dobj)
increased five-fold (nmod)
block an (det)
began until (mark)
bleeding warfarin-related (amod)
properties given (acl)
> respectively (advmod)
precursor no (compound)
44.8 26.0 (compound)
patients volunteers (conj)
pose risk (dobj)
up-regulation cells (nmod)
related increase (nmod)
increased postswitch (nmod)
experienced swallowing (advcl)
electromyography laryngeal (amod)
volumes fraction (conj)
one disorders (nmod)
urine with (case)
heparin of (case)
deleted been (auxpass)
tdi saline (conj)
cerebellum the (det)
dysfunction aminonucleoside-induced (amod)
arousal and (cc)
discusses demographics (dobj)
caused had (aux)
volume circulating (amod)
ganglion of (case)
important this (nsubj)
radiocontrast in (case)
ng-nitro-l-arginine l-noarg (appos)
infusate the (det)
hbsag and (cc)
or ) (punct)
severity tremor (compound)
amns ( (punct)
range 22.5 (nummod)
enzymes observed (acl)
function antagonists (nmod)
ability antagonize (acl)
carotenoids , (punct)
time-course burning (nmod)
regurgitation carbonate (conj)
improve weeks (dobj)
neuropeptide polypeptide (nsubj)
available that (nsubj)
protrusions microvilli (conj)
9 and (cc)
rise substantial (amod)
associated not (neg)
arthritis juvenile (amod)
normalized extrusion (nsubjpass)
corticography or (cc)
efficacy lenalidomide (nmod)
associated midazolam (nmod)
expression 43 (nummod)
induced nra0160 (nsubj)
physician to (case)
total received (conj)
samples morning (compound)
impairment activity (conj)
epistaxis due (case)
behavior squealing (conj)
myocardium intact (amod)
tem ( (punct)
creatinine mg/dl (nmod)
tested aggression (nmod)
system ras (appos)
comparison dfu (appos)
activities complexes (nmod)
group i (dep)
trans-2-amino-3-hydroxy-1 2 (conj)
lamivudine with (case)
ttc ) (punct)
therapy renal (amod)
mg 0.15 (nummod)
movement wall (compound)
na(+ ) (punct)
reactions neuropsychiatric (amod)
stopping ethambutol (dobj)
conclusions suggests (appos)
rare reports (nsubj)
= ) (punct)
dismutase of (case)
rats hypotension (nmod)
hypotension milrinone-induced (amod)
lf ) (punct)
injury kidney (compound)
event cardiac (amod)
been incidence (nmod)
51 - (punct)
prevention and (cc)
blockade to (case)
combined n (dep)
movements pursuit (compound)
% v/v (appos)
effects , (punct)
diseases pre-existing (amod)
exposure serotonin (conj)
medication their (nmod:poss)
receptors other (amod)
prior cocaine (nmod)
greatest was (cop)
estimate study (nmod)
calpain 1 (nummod)
done treated (advcl)
detect , (punct)
prior testing (nmod)
patients treated (acl:relcl)
indicated . (punct)
dose as (conj)
appears however (advmod)
memory , (punct)
gain what (dobj)
neurotransmission brain (compound)
disinhibition due (case)
1.0 1.91 (conj)
illustrate case (nmod)
allow case (nmod)
pool a (det)
observations treated (dep)
showed co-administered (nsubj)
asked repeat (xcomp)
involved that (nsubjpass)
generation for (case)
compatible interference (nmod)
system organ (compound)
nascis by (case)
carried effects (nmod)
analysis microscopy (nmod)
infarction a (det)
use while (mark)
evaluate interactions (nmod)
antagonist n-methyl-d-aspartate (compound)
areas effective (acl:relcl)
pathogenesis in (case)
due overtreatment (nmod)
shortened epinephrine (nsubj)
suggested necessary (ccomp)
synthesis growth (compound)
impairment growth (nmod)
levels cgrp (compound)
avoided best (advmod)
associated decreases (nmod)
min mean (conj)
d-med ( (punct)
solubility its (nmod:poss)
importance cofactors (nmod)
was correlation (nsubj)
involved products (nsubjpass)
bupivacaine- levobupivacaine- (conj)
unaware drug (nmod)
analysis sections (nmod)
performed test (nsubjpass)
m1 m4 (conj)
discontinuation permanent (amod)
epilepsy controlled (acl:relcl)
placebo surgery (nmod)
2-receptors to (mark)
consumers and (cc)
nerve right (amod)
p<.001 [ (punct)
min 200 (nummod)
involve induction (nsubj)
rats conventional (amod)
administered s-1 (nsubjpass)
referral in (case)
wr242511 ) (punct)
adults for (case)
choice climate (nmod)
hypersensitivity due (case)
paradigm startle (amod)
ors ) (punct)
ct of (case)
g/m2 cycle (nmod)
carolina)/2011(iowa through (case)
treatments failure (nmod)
cromakalim- and (cc)
come , (punct)
rearing and (cc)
treatment stz (compound)
correlated concentration (nsubj)
death % (conj)
substance inhibits (acl:relcl)
5.9 - (punct)
carbamazepine the (det)
showed peak (nmod)
crossed days (nmod)
profile antagonist (appos)
tdp without (conj)
persisted follow-up (nmod)
l. h. (conj)
sensitive and (cc)
had load (dobj)
exposing by (mark)
oral administration (conj)
protein related (acl:relcl)
system mea (compound)
difference levels (nmod)
ephedrine/propofol/mixtures the (det)
map effectively (advmod)
contrast of (case)
ascitis an (det)
overlooked are (auxpass)
demonstrated increase (dobj)
receptor at (case)
likely is (cop)
pralidoxime-2-chloride bw (appos)
distributions junctions (nmod)
level within (case)
followed effects (nsubjpass)
site seconds (conj)
reach circulation (dobj)
96.7 + (cc)
15/htn ( (punct)
better test (nmod)
led whom (nmod)
dosage either (cc:preconj)
groups shr (nmod)
sm-5887 ) (punct)
complications unusual (amod)
rats undergone (acl:relcl)
dosing intervals (conj)
levels oestrogen (compound)
syndrome treatment (nmod)
measuring , (punct)
staining blue (amod)
effect nifedipine (nmod)
injected groups (nmod)
regulation ppi (nmod)
received atropine (dobj)
mek1 , (punct)
expected time (nmod)
lesions preneoplastic (amod)
excessive was (cop)
tachyarrhythmia swallowing-induced (amod)
severity encephalopathy (nmod)
moran 615 (nummod)
220 - (punct)
known background (nsubjpass)
mice inflammation (nmod)
inclusions peroxisomes (nmod)
indinavir with (case)
levels than (case)
significant fatal (conj)
sensitivity propranolol (compound)
difference species (compound)
defects conduction (compound)
60.44 vs. (cc)
similarity groups (nmod)
used cycle (nmod)
due clinically (advmod)
role has (acl:relcl)
bradycardia with (case)
intravenous i.v. (dep)
10 per (advmod)
associated effect (nmod)
projections cell (compound)
using element (dobj)
reduction therapy (conj)
characterized resulted (conj)
important development (nmod)
pathogenesis neurotoxicity (nmod)
results p (dep)
periods time (compound)
paresthesia forearm (nmod)
ballooning ventricle (compound)
predictive . (punct)
patients cardiac (amod)
thrombosis on (case)
failure are (cop)
understanding and (cc)
neutrophils control (compound)
statin the (det)
desensitization brought (acl)
suppressed ameliorated (conj)
increased addition (nmod)
safety agents (nmod)
dosing frequent (amod)
5-fluorouracil hours (appos)
observed organs (nmod)
avoided that (nsubjpass)
demonstrated have (ccomp)
explain could (aux)
data children (nmod)
remained uncontrolled (xcomp)
thymus decreased (amod)
anemia dose-limiting (amod)
< ng/dl (advmod)
effects scavengers (nmod)
received monotherapy (dobj)
induction role (conj)
stability temporary (amod)
52.7 6.9 (compound)
harmless may (aux)
mg/kg/day 20 (nummod)
worsening functions (nmod)
content iron (compound)
confounded ability (nsubjpass)
position lateral (amod)
dfp-atropine after (case)
screened department (nmod)
improved responders (nmod)
g/min ml/100 (nummod)
feedback by (case)
continue sulfate (nsubj)
had dose (conj)
mice compared (case)
pain bisphosphonate-related (amod)
signs receptor-stimulating (amod)
toxicity rare (amod)
= -2.34 (dep)
caution setting (nmod)
pups in (case)
associated contraception (nmod)
drugs antipsychotic (amod)
onset- dyskinesias (dep)
therapy cpa (compound)
5.2 3.2 (compound)
worsening significant (amod)
total with (case)
slurred speech (dobj)
efficacy symptoms (nmod)
clinical outpatient (amod)
combination or (cc)
administered application (nmod)
patient episode (nmod)
useful model (nsubj)
inhibition activity (nmod)
predict did (aux)
high rate (nsubj)
saline bromocriptine (conj)
dose granisetron (nmod)
paracetamol % (compound)
switch mmol/l (appos)
containing dox (dobj)
nrf2 genes (conj)
patients nonhypertensive (nummod)
users 768 (nummod)
morphology related (amod)
patients ax-allergic (amod)
width reduced (amod)
composite a (det)
3.5+/-0.9 of (case)
subjects 5 (nummod)
methods by (case)
indicative : (punct)
induced neurotoxicity (nsubjpass)
strain second (amod)
injections deterioration (nmod)
kinase amp-activated (amod)
inventory scale (appos)
threshold patients (nmod)
ischemia bilateral (amod)
recovered until (mark)
injected naloxone (nsubj)
side-effect amlodipine (nmod)
disorders seven (nmod)
strategies prevention (nmod)
0.6 to (advmod)
loss hypertension (nmod)
integrity function (conj)
substantial since (mark)
saline ml (compound)
pituitaries ( (punct)
acid acetylcholine (conj)
include . (punct)
area of (case)
suggests association (nsubj)
lack certainly (advmod)
approval its (nmod:poss)
pattern block (compound)
level per (case)
antibodies reactive (amod)
letrozole tamoxifen (conj)
decrease less (amod)
13/52 % (dep)
actions . (punct)
caused decreased (ccomp)
regulated many (nsubjpass)
se per (compound)
betaine 100 (appos)
lasting produced (amod)
syndrome known (acl)
period test (compound)
effects normalizing (amod)
induced apoptosis (dobj)
correction treatment (nmod)
2.4 and (cc)
absence factors (nmod)
occurs earlier (advmod)
occurred infections (nsubj)
effects milder (amod)
increased ro (nmod)
australia from (case)
a [ (punct)
swimming by (mark)
critical . (punct)
therapy glaucoma (nmod)
asenapine bid (nmod)
describe review (conj)
tia ( (punct)
upregulation pvn (nmod)
saline control (appos)
dose company (dep)
age creatinine (conj)
motor started (acl)
withdrawn drugs (nsubjpass)
-0.97 r (compound)
cephalexin for (case)
correlates neural (amod)
efficacy steroids (nmod)
include not (neg)
course products (nmod)
years 40 (nummod)
revealed review (nsubj)
yohimbine ( (punct)
necrosis cells (nmod)
loading volume (compound)
mania antibiotic-induced (amod)
proven . (punct)
impaired be (auxpass)
p.o. ) (punct)
arrhythmia with (case)
boluses cocaine (compound)
s-1 of (case)
assessed thus (advmod)
scanning liver (compound)
assessed increase (conj)
patient tacrolimus (nmod)
concentrated well (advmod)
frequency signs (nmod)
tetracycline or (cc)
gland a (det)
using whilst (nsubj)
gvhd , (punct)
correlated improvement (nmod)
right- left-pawed (conj)
absence an (det)
analysis chromatography (nmod)
uses even (advmod)
frequent , (punct)
jerks salivation (conj)
injections for (case)
compound 1 (nummod)
domains different (amod)
mipafox n (appos)
history nor (cc)
differed . (punct)
visit the (det)
triceps and (cc)
ph pressures (conj)
p=0.0001 , (punct)
block mepivacaine (nmod)
relevant which (nsubj)
less 0.005 (nmod)
overexpression dismutase (nmod)
5-ht1a receptors (conj)
factor-kappab kinases (conj)
agent venlafaxine (nsubj)
inhibitor factor (compound)
associated nephritis (nmod)
decreased elevated (advcl)
dosing during (case)
predicts . (punct)
material mg/dl (appos)
dysfunction renal (amod)
agonist an (det)
pretreatment intravenous (amod)
necessary administration (nsubj)
implantation cells (nmod)
events massive (amod)
receiving chemotherapy (nmod)
hypertension controlled (acl)
artesunate malaria (nmod)
therapies empirical (amod)
anesthetic to (case)
periods dehydration (nmod)
conclusion lend (dep)
infected virus (nmod)
concluded reversible (ccomp)
using positioning (dobj)
assessed activity (nsubjpass)
1/10 to (case)
toxicity bupivacaine- (nmod)
margins limited (amod)
sh(6 ( (punct)
methods administered (appos)
mmhg 50 (nummod)
involvement including (case)
pindolol , (punct)
atropine by (case)
lining canal (nmod)
propose to (mark)
produced subjects (advcl)
blocks or (cc)
abundant day (nmod)
seen clearly (advmod)
agonist used (acl)
mean 24.2 (nmod)
developed initially (advmod)
report irritability (conj)
pain mechanical (amod)
caused frequency (dobj)
evaluate performance (dobj)
antagonist as (case)
concentration target (compound)
restimulation area (nmod)
common population (nmod)
contraindicated risky (conj)
mg/m2 days (nmod)
0.96 = (dep)
3.8/100,000 ( (punct)
lindane gamma-hexachlorocyclohexane (appos)
improved mm (nmod)
incidence 2010/2011 (nmod)
doxorubicin randomized (nmod)
life of (case)
increased proportion (nsubj)
reticulata pars (compound)
nadir ) (punct)
explanation the (det)
effects characteristic (amod)
agoraphobia in (case)
radioactivity aorta/serum-ratio (conj)
32.6 +/- (cc)
delivered practice (nmod)
comparable that (nmod)
mwm in (case)
nephropathy induced (acl)
dexrazoxane of (case)
administered generally (advmod)
refused patient (nsubj)
248 of (case)
elevated level (nsubj)
peroxide lipid (compound)
reading recordings (nmod)
treated disappearance (nmod)
discontinuance chemotherapy (nmod)
discontinue that (mark)
group bolus (compound)
cavity oral (amod)
temporary paralysis (nsubj)
elevations . (punct)
mg/ml 47.5 (nummod)
arabinoside high-dose (amod)
scale and (cc)
violation protocol (compound)
meq. ( (punct)
occurs lesions (nmod)
nitroglycerin micrograms/kg (appos)
architecture the (det)
deal a (det)
ranged ages (nsubj)
developed data (nmod)
triphosphate atp (appos)
explore also (advmod)
stabilizer/rigidifier as (case)
effect 2-(p-bromophenyl)propionate (nmod)
indicates complication (nsubj)
affects % (dobj)
prl-r reflect (acl:relcl)
4/- . (punct)
cava vena (compound)
involvement rare (amod)
complications neurological (amod)
assessing vivo (advmod)
maps mri-based (amod)
relevance anemia (nmod)
spikes swelling (conj)
warrants investigation (dobj)
headache . (punct)
adam10 of (case)
characterized onset (nsubjpass)
bilirubin unconjugated (amod)
a-induced cyclosporin (nmod:npmod)
gap convulsant (nmod)
immunity patients (nmod)
injection soft-tissue (compound)
concentrations b (compound)
features infiltration (nmod)
modulation . (punct)
comparisons changes (nmod)
confusion induced (acl)
apomorphine of (case)
overexpression tissue (nmod)
study light (compound)
anesthesia i.v. (compound)
stress in (case)
targets injury (nmod)
cells sinoatrial (compound)
hiv with (case)
alpha3 mice (conj)
change following (case)
influences azathioprine (nsubj)
infusion second (amod)
incorporation to (case)
milieu downregulation (nmod)
levels phosphate (nmod)
dfu ; (punct)
licensed , (punct)
hbv no (det)
patients prevalence (conj)
that agents (nmod)
comparison sedation (nmod)
had dogs (nsubj)
maneuver physiological (amod)
inhibitor transcriptase (compound)
seen commonly (advmod)
hemlock ) (punct)
morphine not (cc)
essential management (nmod)
mexiletine placebo (conj)
49 - (punct)
integrity the (det)
potent and (cc)
factors modifiable (amod)
timolol 115 (nummod)
ml/kg and (cc)
material implanted (dep)
terminology pathogenesis (conj)
attack ) (punct)
dehydrogenase metalloproteinase (conj)
injected metformin (nsubjpass)
86 5 (conj)
explain data (dobj)
echocardiography combined (acl)
features electrocardiographic (amod)
percent as (case)
low-dose od (appos)
results frequent (dep)
papilledema and (cc)
malformations low-incidence (amod)
discharged 18 (nsubjpass)
weakly length (nsubj)
> years (nmod:tmod)
agent pretreatment (compound)
factors x (conj)
tract in (case)
erythroderma , (punct)
potential metoclopramide (nmod)
etoposide epipodophyllotoxin (compound)
specificity , (punct)
plays morphine (nsubj)
bayes ' (case)
causing dyscrasias (dobj)
generator migraine (compound)
hemorrhaging parts (nmod)
4-diphenylacetoxy-n-methylpiperidine-methiodide ( (punct)
relationship phosphate (nmod)
a loss (appos)
altering likely (advmod)
supplementation acid (compound)
anemia d-penicillamine-induced (amod)
correlation negative (amod)
side antithyroid (compound)
appeared case (nsubj)
exceed g/day (dobj)
sensitized that (mark)
volume sv (appos)
proteinuria despite (case)
clinic research (compound)
ng./ml than (case)
purpose develop (dep)
factor amplitude (nmod)
volunteer from (case)
stimulation pallidal (amod)
averaging % (dobj)
standpoint abnormality (nmod)
given pressure (dobj)
authors the (det)
dna mtdna (appos)
revealed features (dobj)
reacting warm (amod)
consequences to (case)
use type (conj)
micrograms/ml 20 (nummod)
gradient edema (appos)
deviation silent (amod)
liver rat (compound)
fever milk (compound)
parenchyma over (case)
published events (nsubjpass)
desmethylimipramine i.c. (amod)
curve indinavir (nmod)
exclude can (aux)
20 15 (compound)
years mean (dep)
november between (case)
size-dependent transformation (nsubj)
part screening (nmod)
optic disulfiram-induced (amod)
similar occurrence (nsubj)
recessive , (punct)
diabetes type (compound)
needed combinations (nsubjpass)
increased lower (advcl)
cause drug (conj)
parts scale (compound)
remove drug (dobj)
activation via (case)
drugs antiarrhythmic (amod)
led elevation (nmod)
taqib by (case)
propofol of (case)
delineated and (cc)
products end (compound)
agent as (case)
seems specific (xcomp)
decrease red (amod)
rats not (neg)
p450 or (cc)
complex central (amod)
discharges secondary (amod)
reduced conclusions (dep)
grade 2 (nummod)
peak and (cc)
experienced four (nsubj)
impairment memory (compound)
resulted low (conj)
mg/day plus (cc)
increased sigmast (dobj)
infiltrate rich (amod)
quinine parenteral (amod)
days four (nummod)
coniine and (cc)
weak very (advmod)
therapy nervous (amod)
investigate mechanism (dobj)
incidence prilocaine (nmod)
agents similar (amod)
begin trials (dobj)
sensitivity general (amod)
parameters patients (nmod)
assessments qualitative (amod)
agent hypotensive (amod)
switched are (auxpass)
has benefits (dobj)
seizures focal (amod)
demographics time (nmod:tmod)
goal and (cc)
accounts circuitry (compound)
improved + (cc)
gap43-ir ) (punct)
relieved also (advmod)
stage to (case)
shown which (nsubjpass)
receiving cefonicid (dobj)
tumors two (nummod)
ofh in (case)
activity renal (compound)
concentration lindane (amod)
courses , (punct)
sites two (nummod)
unlikely prove (ccomp)
effect antiadrenergic (compound)
f(33 ; (punct)
u/ml 20.7 (nummod)
data diagnoses (conj)
database computerized (amod)
prazosin 0.5 (nummod)
present especially (advmod)
events underlying (acl)
chemotherapy leukemia (nmod)
carried using (advcl)
site about (case)
stopped ptu (nsubjpass)
concentration tacrolimus (nmod)
instances toxicity (nmod)
loss delayed (amod)
performed years (dep)
strains 4 (nummod)
reticulocytes increased (amod)
widening , (punct)
increase cbf (nmod)
lag with (case)
activity of (case)
application intragastric (amod)
licensed is (auxpass)
155 of (case)
persists which (nsubj)
suppressed blockers (nmod)
had tamoxifen (nsubj)
dyskinesias disability (conj)
drug prenatal (amod)
rr ] (punct)
total cycles (nmod)
6-months and (cc)
tissues of (case)
indicated dependent (ccomp)
puncture spinal (amod)
3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ) (punct)
8 1 (compound)
dystrophy and (cc)
management aggressive (amod)
report herein (advmod)
vision secondary (amod)
chamber open (amod)
treated littermates (nsubjpass)
degree severity (nmod)
attenuated conclusion (nmod)
caused first (amod)
salt sensitive (amod)
given % (dobj)
iief the (det)
component phasic (amod)
classical and (cc)
suprofen with (case)
steering accuracy (dobj)
carcinogens liver (nmod)
attributable that (mark)
fraction homogenates (nmod)
e4031 , (punct)
retarding progression (dobj)
sensitivity test (nmod)
reattempted . (punct)
relationship patients (nmod)
intravenous c. (compound)
reported patient (nmod)
smokers and (cc)
bortezomib dexamethasone (conj)
alter 17beta-estradiol (nsubj)
quantities drug (nmod)
manifestations report (dep)
ocular orbital (conj)
lesions but (cc)
interpret we (nsubj)
interrupted follow-up (nmod)
stress external (amod)
dosage cumulative (amod)
45 and (cc)
reverse could (aux)
obtained prior (advmod)
learning improves (compound)
ng avp (nmod)
motility of (case)
factors several (amod)
anticancer of (case)
stimulation on (case)
normal uncomplicated (conj)
has evident (xcomp)
first demonstrate (acl)
33.1 ) (punct)
coma ammonia (amod)
levels phase (nmod)
symptom as (case)
require also (advmod)
% 71.4 (nummod)
treated bmcs (nmod)
taken mg (nmod)
type vip(-/- (conj)
wave an (det)
gain smooth (amod)
agonist apomorphine (conj)
defect alf (nmod)
appears vasoconstriction (nsubj)
results stress (nmod)
not ) (punct)
evidence this (det)
effect life-threatening (amod)
comparisons patterns (nmod)
hypertension dex-ht (appos)
planned been (auxpass)
adenoma hepatic (amod)
mg/kg arrest (appos)
associated age (nsubjpass)
sarcolemma and (cc)
locomotion spontaneous (amod)
indications switch (nmod)
psychoses acute (amod)
sutures four (nummod)
transferred woman (nsubjpass)
effect mortality (nmod)
leukoencephalopathy syndrome (dep)
seizures minor (amod)
induced imipramine (nmod)
uroprophylaxis mesna (nmod)
retention bladder (compound)
induced nephrosis (nsubjpass)
remissions and (cc)
sulphonylureas different (amod)
l-arginine micromol/l (appos)
syndrome locked-in (amod)
remained severe (ccomp)
consideration important (amod)
able model (nmod)
cardiomyopathy in (case)
cimetidine mg (nummod)
derived results (nsubjpass)
kb and (cc)
had six (nsubj)
showed tolerate (advcl)
found have (xcomp)
severity decreased (amod)
demonstrated associated (ccomp)
observed puberty (nmod)
arterial venous (conj)
receptors adrenergic (amod)
catalepsy the (det)
increased pentoxifylline (dobj)
limited were (auxpass)
tested abstinence (nmod)
nra0160 2- (nummod)
interval 1.30 (dep)
recommend cessation (dobj)
effect polymorphism (nmod)
striatum mice (nmod)
difficult enucleation (nsubj)
nephrosis doxorubicin (compound)
piroxicam ) (punct)
examined investigate (advcl)
argue would (aux)
termination administration (nmod)
ganaxolone derivative (appos)
ee by (case)
arrest apparent (amod)
lithium % (dep)
undergone chamber (dobj)
dyskinesia oddi (compound)
stress disorder (nmod)
rate micrograms (nmod)
arag the (det)
background require (dep)
sinusoidal and (cc)
amantadine by (case)
saw who (nsubj)
effects propranolol (conj)
types parkinsonism (nmod)
induced cromakalim (nmod)
58.3 of (case)
six of (dep)
means system (nmod)
fatal a (det)
age hypoalbuminemia (conj)
prednisolone after (case)
systems on (case)
respiration state (compound)
iu/kg/h 25 (nummod)
concern administration (nmod)
binding according (case)
destruction nerves (nmod)
hepatitis and (cc)
head 5-hydroxytryptophan (amod)
occur cardiomyopathy (nsubj)
form classical (amod)
apical targeting (acl)
different are (cop)
hctz alone (advmod)
differences . (punct)
caused steroids (nsubj)
treatment sm-5887 (compound)
obtained history (nsubjpass)
3.5 and/or (cc)
come days (nmod)
findings pathologic (amod)
drugs novel (amod)
established gastroenteritis (nmod)
convulsions untreated (amod)
reduction dystrophin (nmod)
combined indications (nmod)
1.98 0.8 (conj)
doses mg (nmod)
admitted monitoring (nmod)
pathways molecular (amod)
ufh u/d (appos)
indicated h (nmod)
tachycardia bh (conj)
nox ( (punct)
anhydrase carbonic (amod)
introduction drugs (nmod)
patients cna (compound)
known already (advmod)
h to (case)
mania secondary (amod)
sustained cases (nsubj)
antiplatelet therapy (conj)
breakdown degeneration-induced (amod)
observations carried (acl)
interactions due (case)
ls group (compound)
revealed evaluation (nsubj)
profiles antipsychotics (nmod)
found later (advmod)
administration avp (nmod)
princeton nj (appos)
time systolic (nmod)
dysfunction with (case)
lobe experimental (amod)
rate reduction (nmod)
bupivacaine than (case)
injury cholestatic (amod)
interactions curcumin (nmod)
events : (punct)
tended have (conj)
acquired started (advcl)
incidence compared (case)
myalgia marker (appos)
mg/kg ) (punct)
worsen does (aux)
paralysis use (nmod)
metaiodobenzylguanidine , (punct)
functions anti-oxidant (amod)
bortezomib and (cc)
buspirone of (case)
depressed compared (prep)
number days (conj)
iopamidol low-osmolality (amod)
weeks 4 (nummod)
element contributing (acl)
confounded is (auxpass)
injury experimental (amod)
wild-type ( (punct)
tyr6]-vip antagonist (appos)
lymphadenitis of (case)
enucleations the (det)
presentation % (parataxis)
done section (nsubjpass)
pellet ( (punct)
controversial are (cop)
steeply , (punct)
factor conclusions (nsubj)
21 14 (conj)
used strains (nsubjpass)
peptide brain (compound)
after hours (nmod:npmod)
factor no (det)
erections behavioral (amod)
decision continue (acl)
packing moving (conj)
effect carbamazepine (nmod)
determination a (det)
fibroblasts patient (nmod)
operated reduction (nmod)
fenoterol-hydrobromide and (cc)
increase inhibition (dep)
modulated attention (nmod)
patients undergo (acl:relcl)
involving segments (dobj)
one anemia (nsubj)
anemia associated (acl)
randomized double-blind (conj)
patients arthritis (compound)
effects psychological (amod)
bingeing sugar (nmod)
evaluated neuropathy (advmod)
time rt (appos)
shown enhance (xcomp)
correlated force (nmod)
measured imaging (nmod)
solvent bcnu (compound)
reverses drug (nsubj)
enlarged firm (conj)
rarely very (advmod)
animals less (amod)
analyzed events (dobj)
l-noarg mg/kg (appos)
counteracted levels (dobj)
nociception inflammatory (amod)
worsened contrast (nmod)
caused carbachol (nmod)
pregs analogs (conj)
was using (xcomp)
stimulations administration (conj)
show effective (ccomp)
responds system (nsubj)
desferrioxamine intravenous (amod)
assay molecular (amod)
receiving d (nmod)
disease pd (appos)
score function (nmod)
discouraged be (auxpass)
induce relapse (dobj)
ibuprofen with (case)
treatment cc (nmod)
agents channel (compound)
vehicle a (det)
28 32 (prep)
120 approximately (advmod)
hepatitis for (case)
fraction filtration (compound)
hemisuccinate , (punct)
bacteria by (case)
performed prospective (nsubjpass)
system rodents (nmod)
clones of (case)
third the (det)
measurements ecg (nmod)
receptors inhibitory (amod)
msec respectively (advmod)
basis weight (compound)
imbalance any (det)
treated mg/m(2 (nmod)
course the (det)
occur cardiotoxicity (nsubj)
allow conditions (dobj)
activated areas (nsubjpass)
studies separate (amod)
hoehn scale (conj)
junctions , (punct)
bradycardia mice (nmod)
short- deficits (dep)
acetaminophen to (mark)
hbig intramuscular (amod)
referred hospital (nmod)
beta-carboline-3-carboxylate beta-ccm (appos)
increased numbers (dobj)
interact that (nsubj)
related vinorelbine (nmod)
-18.1 +/- (cc)
easy 99mtc-glucarate (nsubj)
adriamycin ml (appos)
ratings increased (amod)
tdp spontaneous (amod)
sampling cortisol (compound)
drug recreational (amod)
present dyskinesias (nsubj)
replacement and (cc)
potential high (amod)
effect misoprostol (nmod)
address concerns (dobj)
ci 1.63 (nummod)
model ' (punct)
simulator on (case)
effects lowest (amod)
ccnu of (case)
applicators 49,616 (nummod)
undergone ablation (dobj)
angiodegeneration ; (punct)
hypersensitivity the (det)
response acute (amod)
fell which (nsubj)
been concerns (attr)
patients haemorrhage (nmod)
rf ) (punct)
mu cyclohexyl]benzeneactemide (appos)
etiology treating (conj)
computers on (case)
s.c. ; (punct)
sr 48,968 (nummod)
abnormalities audiogram (compound)
scarce also (advmod)
pain urine (conj)
needed order (nmod)
= 0.15 (dobj)
up-regulation a (det)
study microscope (compound)
pathology treatment (nmod)
coma intoxication (nmod)
derivative of (case)
rats developing (acl)
ligand receptor (nmod)
dialysis . (punct)
significant due (case)
had ; (punct)
had relapse (dobj)
urgency surgery (nmod)
received eight (conj)
survival promising (amod)
shifts in (case)
tdi and (cc)
questioned week (nmod)
activity effect (conj)
superior rizatriptan (nsubj)
scale emotional (amod)
use potential (amod)
formation thrombus (compound)
increased thus (advmod)
velocity at (case)
cent ) (punct)
myopathy resolved (acl:relcl)
escalating doses (dobj)
methods multicenter (dep)
infective or (cc)
elected . (punct)
execution the (det)
propensity of (case)
incident delirium (nmod)
casei capnocytophaga (compound)
species as (cc)
presentation a (det)
lowering a (det)
angina of (case)
affect any (dobj)
produced animals (nmod)
statistics through (case)
received while (mark)
group 765 (dep)
occurred also (advmod)
prevention mesna (nmod)
developed disease (dobj)
had p (dobj)
block to (mark)
begun late (advmod)
1mg/kg to (mark)
parameter in (case)
evaluated giving (advcl)
syndrome stevens-johnson (compound)
exceeded magnitude (nmod)
diameter fenestrae (nmod)
reduction toxicity (nmod)
symptoms anesthesia (nmod)
duration fraction (conj)
given dose (dobj)
toxicity amikacin (compound)
interpretation man (nmod)
regimen 3 (nummod)
case occlusion (nmod)
airway fev1 (dep)
lower tone (nsubj)
flavonoids present (acl:relcl)
toxicity coadministration (nmod)
assessed results (conj)
exclusion entities (nmod)
divided followed (conj)
administration mg/kg (dep)
ph lidocaine (nmod)
reaction dysphoric (amod)
olanzapine or (cc)
comprised . (punct)
accompanied hypotension (nsubjpass)
rigidity behavior (conj)
humans to (case)
used treatment (nsubjpass)
toxicity early (amod)
post-fenoldopam-infusion 8 (nummod)
coactivator transcriptional (amod)
drug nephrotoxic (amod)
unit research (compound)
composite infusion (nmod)
effect doses (nmod)
efficacy . (punct)
resulted responses (nmod)
suggested plays (ccomp)
women nonimmune (amod)
plasma thyroid (conj)
bias design (nmod)
strain onto (case)
evidence from (case)
greater accumulation (dep)
reduced : (punct)
register 1996 (nmod:tmod)
population both (cc:preconj)
feasibility treat (acl)
maze morris (compound)
episodes strokes (conj)
used sedation (nsubjpass)
recognized reactions (nsubjpass)
committee safety (nmod)
samples two (nummod)
reduces use (nsubj)
cld ) (punct)
verapamil drugs (dep)
experienced infarctions (dobj)
placebo ( (punct)
stabilizer/rigidifier a (det)
induce effect (dobj)
leukemia treated (acl)
oropharynx cavity (conj)
% 16 (nummod)
doses doses (conj)
reduce infarction (nmod)
concentrations noradrenaline (compound)
continued diets (nsubjpass)
deterioration vision (nmod)
encephalopathy transient (amod)
blocked be (auxpass)
hypertension p (conj)
anemia hepatitis (conj)
monitor starting (advcl)
cardioselective nonselective (conj)
drug alone (advmod)
effect ache (nmod)
discontinue it (dobj)
region endothelial (amod)
consists anemia (nmod)
reductase gsh (appos)
affect reversed (conj)
brightfield- and (cc)
regained end (nmod)
developed female (nsubj)
ercp an (det)
indications specific (amod)
inhibition ne-mediated (amod)
galactose oral (amod)
decrease result (nmod)
months 53 (nummod)
form biopsies (appos)
episode the (det)
piloerection and (cc)
effects positive (amod)
recorded demographics (nsubjpass)
increased activity (nsubjpass)
developed microangiopathy (dobj)
hyponatremia significant (amod)
catheterisation or (cc)
damage endothelial (amod)
shouts incomprehensible (amod)
contribution ' (punct)
dogs 14 (nummod)
concentration their (nmod:poss)
cells/microl 1,100 (nummod)
performed assessed (conj)
effect stalk (compound)
motility patients (nmod)
increase fluid (nmod)
relationship concentration (nmod)
had alternation (nmod)
protein ( (punct)
excess due (case)
administration dose (compound)
agent hyperlipemia (nmod)
initiated research (nmod)
3.4 +/- (cc)
schedule similar (amod)
catalyze attenuate (conj)
phenylephrine related (conj)
higher mg (nmod:npmod)
m-chlorophenylpiperazine pentylenetetrazole (conj)
found also (advmod)
scale depression (compound)
responsible whether (mark)
died patient (nsubj)
accelerating atherosclerosis (dobj)
compared h (nmod)
s-a ( (punct)
identification anesthetic (nmod)
patients hemodialyzed (amod)
diagnose to (mark)
sclerosis fsgs (appos)
parameters worsened (acl)
results patients (dep)
cisplatin ) (punct)
infections 14 (conj)
edits ( (punct)
possible leads (advcl)
related response (nmod)
enzymes ugt (compound)
developed had (conj)
intoxication carbachol (compound)
suspect , (punct)
evidence force (nmod)
evaluated using (xcomp)
identify form (nmod)
complication paralysis (nsubj)
hemisuccinate cholesteryl (nsubj)
showed = (parataxis)
extraction and (cc)
luminal bbb (nmod)
patients failure (nmod)
rates or (cc)
impairment suppression (dep)
premedication for (case)
combating intoxication (dobj)
interview , (punct)
administration ages (nmod)
haemodialysis after (case)
clonidine vehicle (conj)
assessed a (nmod)
administration s-1 (nmod)
impact their (nmod:poss)
calculated group (dep)
subjects thirty-six (nummod)
safety lorazepam (nmod)
overload induced (acl)
these and (cc)
infusion 5-fu (compound)
compared are (auxpass)
n-butyl-deoxynojirimycin combination (compound)
time antithrombin (conj)
failure decompensated (amod)
events transfusion (compound)
users regular (amod)
9 to (dep)
self-limited these (nsubj)
pressure systemic (amod)
present manner (nmod)
responsible some (nmod)
administered performance (nmod)
knowledge present (amod)
status b (compound)
abandoned was (auxpass)
recurrence vt (nmod)
woman 68-year-old (amod)
titrated depth (nsubjpass)
mrna , (punct)
enhance , (punct)
sertraline subjects (appos)
had pilocarpine (nsubj)
rofecoxib non-users (nmod)
drugs chemotherapy (conj)
detect effects (dobj)
denied . (punct)
replaced ranitidine (nmod)
leukemia lymphoma (conj)
cause syndrome (nmod)
enzyme . (punct)
studies spinal (compound)
2.5 - (punct)
p all (det)
examined utility (dobj)
bcnu ( (punct)
agitated and (cc)
lid in (case)
infection hiv-1 (compound)
idea the (det)
series analogues (nmod)
151 14 (compound)
denervated hearts (nsubjpass)
received dose (nmod)
canaliculi bile (compound)
bought , (punct)
inhibited propranolol (nsubj)
beagle twenty (nummod)
self-limited were (cop)
analogs its (nmod:poss)
receiving indomethacin (dobj)
treated adenosine (nmod)
similar brain (nmod)
filling report (dep)
change significant (amod)
diagnostic little (amod)
4/26 ) (punct)
determined investigations (nsubj)
is and (cc)
women recruited (acl:relcl)
rates low (amod)
values depression (compound)
thyroiditis autoimmune (amod)
acid amino (compound)
nk1 receptors (dep)
medications used (amod)
all almost (advmod)
effect hibiscus (nmod)
length , (punct)
killed days (nmod)
n/n=62/92 respectively (advmod)
independent intensity (nmod)
withdrawal ethambutol (nmod)
epilepticus on (case)
rash generalized (amod)
% 71 (nummod)
hexamethonium of (case)
interactions neurotransmitters (nmod)
used have (aux)
study change (dobj)
midbrain mainly (advmod)
repeaters switchers (conj)
cystitis chronic (amod)
5-fu high-dose (amod)
lability and (cc)
likely 22 (dep)
aniracetam ro (dep)
mind nurse (nmod)
complication cystitis (nsubj)
infectious including (case)
behavioral neurochemical (conj)
shown min (nmod)
protects overexpression (nsubj)
accounted cb (nmod)
mass content (conj)
risk combination (nmod)
6/31 26/31 (conj)
number antitussives (nmod)
plays activation (nsubj)
changes larger (amod)
of instead (advmod)
measured patient (nmod)
this computer (nmod)
associated it (nsubjpass)
prevented be (auxpass)
probes in (amod)
cause people (nmod)
manifested serositis (nmod)
which nausea (dep)
apomorphine therapy (appos)
changes content (nmod)
response or (cc)
globulin reagents (conj)
was each (attr)
0.9 0.2 (compound)
strong that (nmod)
gyki-41 compound (compound)
activity cerebral (amod)
3504 +/- (cc)
confirmed be (auxpass)
sites calcification (compound)
dysfunction vip(-/- (nmod)
injection hours (dep)
reversal high (amod)
determined min (nmod)
dose birth (compound)
expressed seems (conj)
tci ) (punct)
analysis urine (compound)
weeks 10 (nummod)
understood . (punct)
nsclc stage (compound)
component hemolytic (amod)
use microphthalmos (nmod)
dysrhythmias behavior (conj)
cpap nitroprusside (nmod)
microbleeds cerebral (amod)
100mg/kg than (case)
analysis morphological (amod)
nerves b3 (compound)
implicated pathogenesis (nmod)
prevention receiving (acl)
hydration with (case)
cycles sinus (compound)
withdrawn valproate (nsubjpass)
complex (gaba)a (compound)
days consecutive (amod)
results cases (nmod)
pallidotomy to (case)
play expression (nsubj)
fell . (punct)
lesions in (case)
had content (dobj)
reduction glomerulosclerosis (nmod)
anthracyclines daunorubicin (dep)
tolerant replicating (xcomp)
initiated hypothermia (dobj)
increases ( (punct)
known derivatives (nsubjpass)
malformation characterized (acl)
piracetam , (punct)
% fatigue (conj)
out-patients 50 (nummod)
demonstrating effects (dobj)
male and (cc)
2005 - (punct)
case , (punct)
challenged daily (advmod)
associations iowa (nmod)
p= ) (punct)
dlt ) (punct)
54 were (cop)
acromegaly active (amod)
method results (conj)
effect rapid (amod)
thymus weights (conj)
globulin b (compound)
therapy disulfiram (compound)
stained samples (dobj)
group scopolamine-treated (amod)
measured model (nmod)
inserted , (punct)
demonstrated further (advmod)
members mapk (compound)
qtp and (cc)
background there (advmod)
administration androgen (compound)
2.5 times (quantmod)
tests their (nmod:poss)
wsp ) (punct)
increased latency (dobj)
treated 2a (nmod)
tests a (dep)
duration latency (conj)
drugs antithyroid (amod)
restored doses (nsubj)
u/l and (cc)
developed to (mark)
receiving bupropion (dobj)
dogs dogs (conj)
protein high-sensitive (amod)
infusions micrograms/kg (nmod)
suppression expression (nmod)
observations clinical (nmod)
therapy multidrug (amod)
treated cats (nsubjpass)
lower are (cop)
shift fall (conj)
analyzer with (case)
ro 1-anisoyl-2-pyrrolidinone (appos)
progressing of (mark)
2.0mg/kg 0.5 (nummod)
catheterizations annual (amod)
sodium diclofenac (amod)
continuing amiodarone (dobj)
metabolized flestolol (nsubjpass)
easier use (xcomp)
nh4ac ) (punct)
paradigm optimal (amod)
therapy dipyridamole (compound)
achieve dose (dobj)
1.19 0.08 (dep)
psychologist development (nmod)
disturbance renal (amod)
nonpregnant pregnant (conj)
39 % (quantmod)
sera ax (nmod)
attenuate , (punct)
deterioration with (case)
myalgia succinylcholine (nmod)
effect properties (nmod)
methods exclusion (nmod)
intubated hypoventilation (conj)
dimension/function on (case)
hepatomas of (case)
cytostatics of (case)
data spectral (amod)
effects induced (acl)
return gradual (amod)
higher ps (nmod)
hydrochloride n-(trans-3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)-piperazine (compound)
91.5 score (nsubj)
mm 32.6 (nummod)
lower 2.4 (nmod)
induced tacrolimus (nmod)
structure properties (conj)
had counts (dobj)
binding studies (conj)
preinfusion : (punct)
done . (punct)
sensitivity line (appos)
diclofenac tolerability (dobj)
glyburide , (punct)
g/dl 14.2 (nummod)
vasodilation hypotension (conj)
hemorrhages conjunctival (compound)
sd and (cc)
mechanism processing (nsubj)
2.3 0.3 (conj)
kindreds history (nmod)
wall from (case)
explain therefore (advmod)
alpha3 +/- (cc)
relative ocs (nmod)
hypertensive spontaneously (amod)
interaction adverse (amod)
microg/kg/min 0.5 (nummod)
reported proteinuria (nsubjpass)
extremities 1 (dep)
unlikely is (cop)
microangiopathy of (case)
excretion peaked (acl:relcl)
evokes trough (ccomp)
developed paraplegia (dobj)
ratios enhancement (compound)
echocardiography indicator (appos)
reaction acute (amod)
effects any (det)
study this (det)
any with (case)
represents successful (advcl)
arrhythmias arrhythmia (nmod)
paid period (nmod)
thresholds arms (nmod)
pattern muscular (amod)
efficacy cost-effectiveness (conj)
assessed vasorelaxation (nmod)
-9 1 (compound)
enzyme tetrameric (amod)
dose lignocaine (nmod)
experienced seven (nsubj)
scheduled visits (nsubjpass)
questionnaires the (det)
adaptation to (mark)
promote might (aux)
safety short-term (amod)
developed dehydration (dobj)
sensitive the (det)
characteristics muscle (nmod)
prevalences events (nmod)
immunoreactive and (cc)
transplantation autologous (amod)
allocated outpatients (nsubjpass)
cirrhosis to (case)
showed induction (nsubj)
results effective (dep)
addressed be (auxpass)
arousal ability (conj)
repair with (nmod)
injection meth (nmod)
assessed rat (nmod)
events described (amod)
time-to-onset of (case)
5 +/- (cc)
common were (cop)
mi for (case)
groups sh(6 (appos)
group risperidone (compound)
stimulated formyl-methionyl-leucyl-phenylalanine (nmod)
display that (mark)
randomized was (auxpass)
= 0.243 (dobj)
varies of (case)
b12 micrograms (appos)
returned quickly (advmod)
contributes : (punct)
bbb in (case)
il-1 and (cc)
days of (case)
combining groups (dobj)
d-amphetamine quinpirole (conj)
state akt (compound)
alf commonest (compound)
occurred lost (conj)
beginning rate (compound)
mechanisms underlying (acl)
treatment lithium (compound)
dysfunction patient (nmod:poss)
chi2-test with (case)
hands , (punct)
observed variety (nsubjpass)
effects monoxide (nmod)
drawback hypotension (nmod)
present incontinence (nmod)
penetration areas (nmod)
day 10th (amod)
esrd failure (conj)
mepivacaine with (case)
angina spastic (amod)
transporter efflux (compound)
model study (acl:relcl)
solutions irrigation (compound)
colitis of (case)
acuity photophobia (conj)
measure extended (conj)
carcinogens , (punct)
toxic also (advmod)
no apoptosis (conj)
function as (case)
lesions no (det)
substances of (case)
susceptible however (advmod)
reported induce (xcomp)
g/kg/day u (compound)
surveillance hypertension (nmod)
developed d (nmod)
instilled directly (advmod)
november to (case)
derived studies (nmod)
examined roles (dobj)
level , (punct)
immunofluorescence biopsy (nmod)
induced period (nmod)
0.002 p (compound)
induced cyclophosphamide (nmod)
artery + (cc)
administered heparin (nsubjpass)
nh4ac and (cc)
resulted . (punct)
pge2 of (case)
activator acting (amod)
noted phase (nmod)
dosings single (amod)
disease ozone (nmod)
smaller p100 (conj)
decreased as (prep)
infant the (det)
phenylalanine competing (acl)
presentation this (det)
similar and (advmod)
forms on (case)
infusion isotonic (amod)
decreases rate (nmod)
tolerated highest (dep)
vehicle- epinephrine-treated (conj)
anaesthetic spinal (amod)
interference due (case)
research number (nmod)
caa of (case)
displayed activity (dobj)
ability extract (nmod)
felt nelarabine (nsubjpass)
enalapril not (cc)
secretion bile (compound)
interview ecgs (conj)
developed hematomas (dobj)
pg-9 , (punct)
pathways bs (compound)
averaged 4.8 (dobj)
estimate and (cc)
blocked indicating (xcomp)
information new (amod)
hydration and (cc)
avrt ) (punct)
promotes need (conj)
percentage neurons (acl)
patients manner (nmod)
levels 15-f(2t)-isoprostane (nmod)
verapamil mg/d (dep)
locf with (case)
features typical (amod)
injections iohexol (compound)
perform purpose (nsubj)
samples : (punct)
24.3+/-6.8s ( (punct)
injections following (case)
m t (conj)
infusion avoidance (conj)
aerosol micrograms (appos)
aminophylline of (case)
intraperitonealinjection an (det)
eye ipsilateral (amod)
close subsequent (amod)
fastigial interpositus (conj)
results evaluated (dep)
factor-kappab of (case)
remedies worldwide (advmod)
circulation to (case)
duration weeks (nmod:poss)
regression logistic (amod)
decreased h (nmod:tmod)
cirrhosis pulmonale (conj)
co ) (punct)
revealed concentrations (dobj)
fetuses from (case)
processor a (det)
contraindication some (det)
connects that (nsubj)
formation epithelioid (amod)
ischemic both (cc:preconj)
complemented markers (nsubjpass)
conclude is (ccomp)
layer rats (nmod)
allowed analysis (nsubj)
subjects 290 (nummod)
early sensitive (conj)
grip peak (amod)
reported reduce (xcomp)
exhibited ; (punct)
5.6+/-0.9 mm (dobj)
infections patients (nmod)
protein 14.1 (nummod)
acid tranexamic (amod)
symptom-free patients (dep)
multiforme and (cc)
was core (nmod)
immunohistochemistry fviiirag (compound)
helodermin assessed (acl)
rate comparable (acl:relcl)
less significantly (advmod)
pvn son (conj)
associated hit (nmod)
demonstrated induced (ccomp)
80.0 +/- (cc)
use hormone (compound)
histology microscopy (conj)
window critical (amod)
torsades from (case)
weakness proximal (amod)
status 1 (nummod)
apheresis of (case)
injection heparin (compound)
mice css10 (compound)
intralipid emulsions (dep)
administration percentage (appos)
peptide the (det)
weeks were (cop)
recorded reduction (dobj)
transfusion or (cc)
effect hypertension (compound)
0.5 + (cc)
implies model (nsubj)
underwent repair (dobj)
therapy procainamide (compound)
95 ( (punct)
retention memory (nmod)
decreased rats (advcl)
result loss (nmod)
suppression % (compound)
consumption p (dep)
reduced and (cc)
men demonstrated (acl:relcl)
involved effects (nmod)
range " (punct)
about only (advmod)
ascertain to (mark)
groups transplant (compound)
vacuolization glomerulosclerosis (conj)
wished we (nsubj)
lipoproteinuria pre-nephrotic (amod)
is ifosfamide (nsubj)
accumulation pneumonitis (nmod)
transplantable one (nummod)
increased revealed (advcl)
suggest involves (conj)
1.5 from (case)
csa not (conj)
had regression (dobj)
few them (nmod)
from october (nmod)
compound bioactive (amod)
gvg low (amod)
number behaviour (conj)
proposed tested (ccomp)
iva ] (punct)
estradiol with (case)
induction ) (punct)
lithium valproate (conj)
developing model (dobj)
sertraline and (cc)
consisted evaluation (nsubj)
receiving been (aux)
analysed patients (nsubjpass)
reproducible hyperalgesia (nmod)
antibodies nmda (compound)
affect hemodynamics (dobj)
morphology on (case)
developed administration (nmod)
decrease , (punct)
correction their (nmod:poss)
standing head-up (conj)
interviewing patients (dobj)
ingesting after (mark)
19.3 months (dep)
essential da (nsubj)
exposure telithromycin (nmod)
september 2012 (nummod)
disappeared features (nsubj)
atrophy muscular (amod)
methods cancers (nmod)
base sphericity (conj)
alterations metabolism (nmod)
attenuated deficit (dobj)
use after (case)
infusions i.v. (amod)
involved behavior (nmod)
digoxin fibrillation (compound)
containing anthraquinones (dobj)
home at (case)
paco2 0.1 (conj)
appeared day (nmod)
apparatus animex (compound)
action bn (nmod)
is remains (conj)
pain scoline (amod)
1.73 ml/100 (conj)
study alcohol (compound)
had while (mark)
value index (nmod)
attributed could (aux)
mothers surface (compound)
undergoing hiv (nsubj)
lack particles (nmod)
avoid adults (nmod)
groups steroid-treated (amod)
neoplasia carsinom (conj)
course lamivudine (nmod)
fulfilled aura (nmod)
acid citric (amod)
encode of (case)
conclude we (nsubj)
identical not (neg)
degrees azotemia (nmod)
divided were (auxpass)
background disorder (dep)
ratio 7.44 (nmod)
lf oral (amod)
group addicts (nmod)
diphosphate adenosine (compound)
dehydrogenase in (case)
coupled dose (nmod)
profile insecticide (nmod)
involved often (advmod)
10.2 +/- (cc)
observed antigens (nsubjpass)
triggered which (nsubjpass)
% 12 (nummod)
experienced one (nsubj)
vehicle cellulose (dep)
proteins dna (compound)
administration measurements (conj)
phosphokinase and (cc)
frame reasonable (amod)
failed increase (xcomp)
users 1048 (nummod)
dosage at (case)
pallidotomy and (cc)
nitroprusside hypotensive (amod)
damage duct (acl:relcl)
improve which (nsubj)
dependent effect (nsubj)
discontinued administration (nsubjpass)
stl1 both (cc:preconj)
dxnp , (punct)
ganaxolone ( (punct)
scale parkinson (nmod:poss)
dysrhythmias cardiac (amod)
seriousness to (case)
pyrazinamide by (case)
retardation severe (amod)
rats mice (conj)
demonstrated moreover (advmod)
diminished index (dobj)
thiosulphate gold (compound)
hematomyelia thoracic (compound)
g/dl more (conj)
used allow (advcl)
control death (nmod)
mmhg to (dep)
syndrome flank (compound)
reduced tremor (dep)
thirty-seven , (punct)
encephalopathy ifosfamide (compound)
mg/min n=10 (appos)
activity dopamine (compound)
regarded . (punct)
defined syndrome (nsubjpass)
brought he (nsubjpass)
da and (cc)
mmol mmol (conj)
consequences lesions (nmod)
glomerulonephritis recurrent (amod)
d2 5-ht2 (conj)
site an (det)
mutants patients (nmod)
respects several (amod)
effective patient (nmod)
terms neuropathy (acl)
minutes many (amod)
maximal state (nsubj)
susceptible that (mark)
cardiomyopathy dox-induced (amod)
agents three (nummod)
protect that (mark)
creams chp (compound)
caused half-time (conj)
deficits model (nmod)
rate hr (appos)
ml/min/100 0.48 (dep)
mg/m2 175 (nummod)
used ranitidine (nsubjpass)
5 0.5 (compound)
47 up (advmod)
carbenicillin with (case)
included constipation (dobj)
db db (conj)
tests tet (conj)
dgc of (case)
exchange dipyridamole (conj)
99 1 (conj)
consisted mofetil (nmod)
admitted observation (nmod)
tested participants (nsubjpass)
levels aminotransferase (conj)
associated hyperhidrosis (nmod)
mediation bradycardia (nmod)
cells brain (compound)
minutes per (case)
patients june (nmod)
prescription dose (nmod)
results ablation (nsubj)
echocardiography including (case)
dose mice (nmod)
frequency , (punct)
investigation placebo-controlled (amod)
studies smokers (nmod)
using limits (dobj)
identified registry (nsubj)
arrest to (mark)
epidemic . (punct)
0.84 0.28 (conj)
vicinity ( (punct)
defective fundus (conj)
forestomach and (cc)
treating seizures (dobj)
62(6):865 872 (nummod)
induced addition (nmod)
surface above (case)
hypothyroid baseline (nmod)
mpo-anca vasculitis (conj)
resulted injury (nmod)
dynamics to (case)
illness viral-like (amod)
barium by (case)
angioplasty ptra (appos)
achieved had (aux)
effects age-interaction (amod)
l 3.3 (dep)
(+)-propranolol of (case)
n. % (dep)
regained quickly (advmod)
low-sodium four (nummod)
population the (det)
quetiapine sas (nmod)
independent presumably (advmod)
undergone . (punct)
examined 39 (nsubjpass)
liver from (case)
fill criteria (dobj)
determine administered (conj)
implanting subcutaneously (advmod)
revealed but (cc)
drugs and (cc)
rats produced (acl)
elevates lactate (dobj)
recovery consciousness (nmod)
reconsidered use (nsubjpass)
jerks myoclonic (amod)
obtained values (nsubjpass)
subunit mtdna-encoded (amod)
pupil and (cc)
offered treatment (nmod)
transporters tubular (amod)
ich warfarin-associated (amod)
safety lozenge (nmod)
achieve population (nmod)
neurotoxicity busulfan (nmod)
man 42-year-old (amod)
superior placebo (nmod)
latency with (case)
myopathy up-regulation (nmod)
toxicity reduced (amod)
involved which (nmod)
effects independent (amod)
terms densities (nmod)
done exclude (xcomp)
regimens various (amod)
delivered shock (nsubjpass)
subjects ten (nummod)
reshape base (dobj)
onset hypothyroidism (nmod)
kindled-seizures against (case)
measurements function (nmod)
presented heroin (nmod)
increases pressure (dobj)
increased weight (dobj)
became mmhg (dobj)
synthase nitric (amod)
hospital luke (nmod:poss)
o-a ) (punct)
mechanisms in (case)
transplantations performed (acl)
diminishes greatly (advmod)
therapeutic , (punct)
domains the (det)
female rats (dep)
treated rifampicin (nmod)
further understanding (dobj)
estradiol-dependent for (case)
increased additionally (advmod)
associated phase (nsubjpass)
prazosin of (case)
modalities treatment (compound)
h < (dep)
number episodes (nmod)
micrograms/50 2.5 (nummod)
immunity cellular (amod)
center india (nmod)
relevance concerning (case)
presents who (nsubj)
haloperidol n (dep)
intense more (advmod)
63 respectively (advmod)
effects dual (amod)
area a (det)
mixture the (det)
used technique (nsubjpass)
modifications identical (amod)
reduced increased (conj)
addition an (det)
induced damage (dobj)
feeding paracetamol (compound)
conclusions mediated (dep)
members are (cop)
10(-3 1.1 (compound)
associated anemia (dep)
week 4th (amod)
contribution as (case)
parameters behavioural (amod)
rose ; (punct)
prevents nephropathy (dobj)
studied action (dobj)
part . (punct)
kg-1 before (case)
eliminated were (auxpass)
randomized weeks (nmod:tmod)
leading % (nmod)
easy block (xcomp)
dysphonia and (cc)
bands the (det)
rats arrhythmic (amod)
months time (nsubj)
speed average (amod)
accounting correlation (nmod)
mpges-1 ) (punct)
% 40 (nummod)
stabilizers of (case)
range 4 (dep)
supplementation folinic (amod)
inhibits kg-1 (nsubj)
myeloma diagnosed (amod)
physical functioning (acl)
syndrome frequency (appos)
patient alpha-2b (nmod)
challenge anticholinergic (amod)
effects fk (nmod)
ikr on (case)
p-glycoprotein pgp (appos)
existed . (punct)
iu/l ast:274 (compound)
warrants case (nsubj)
units of (case)
curvilinear a (det)
site neuropharmacological (amod)
remain aware (xcomp)
sets male (nmod)
model used (amod)
mp i.v. (advmod)
mediate some (dobj)
aimed avoiding (advcl)
gamma-hch after (case)
clarification for (case)
svc ( (punct)
16 d1 (nmod)
women % (appos)
vary systematically (advmod)
varying concentrations (dobj)
undergone transplantation (dobj)
thromboembolism hyperplasia (conj)
gd1=plug ( (punct)
vulnerable are (cop)
defined prl (nmod)
angioedema administration (nmod)
drugs chemotherapeutic (amod)
volunteer in (case)
damage reversible (amod)
control to (mark)
nmdar gaba(a)r (conj)
similarity appearances (nmod)
carbimazole positive (amod)
group old (amod)
present study (conj)
maintain potassium (dobj)
microelectrodes by (case)
patients seizures (nmod)
study ii (nummod)
taking had (conj)
based dose (nmod)
% 5 (compound)
elucidated deficits (dobj)
rated scale (nmod)
weight creatinine (conj)
quetiapine high-doses (amod)
diuretic metabolic (dep)
ilk ) (punct)
ratios likelihood (compound)
arteriole of (case)
brought was (auxpass)
response doses (nmod)
techniques new (amod)
sites other (amod)
men dysfunction (nmod)
ngf pgf2alpha (appos)
62.5 as (advmod)
deposited be (auxpass)
valsartan of (case)
disorders cochrane (compound)
dismutase activities (conj)
5.6 1.3 (compound)
p to (case)
infiltration eosinophilic (amod)
regimen cancer (nmod)
pattern respiratory (amod)
seizures uncontrolled (acl)
schedules dose (compound)
lidocaine standard (amod)
formation % (nmod)
consumption oxidation (conj)
results formation (nmod)
associated drug (nmod)
3-methylcholanthrene inducer (appos)
rr 1.96 (nummod)
frequency breathing (compound)
acetate combined (amod)
demonstration relationship (nmod)
accumulation ) (punct)
images on (case)
nephrosis puromycin (compound)
alpha and (cc)
increasing reports (nsubj)
obtained breeder (nmod)
observed increase (dobj)
expression increased (amod)
ameliorate and (cc)
need psychologists (nsubj)
level protein (compound)
associated months (nsubjpass)
exhibit nos-ir (dep)
recognition location (compound)
data effect (nmod)
benefit did (aux)
developed male (nsubj)
sensitivities lines (nmod:poss)
expected mice (nmod)
lower group (conj)
changes mood (compound)
common events (nsubj)
suggests review (nsubj)
infusion paclitaxel (compound)
remains expression (nsubj)
particles submitochondrial (amod)
bicuculline and (cc)
temperature erection (conj)
members healthy (amod)
allow would (aux)
injection learning (nmod)
rats fed (acl:relcl)
exacerbate response (dobj)
hours ipratropium (nmod)
risk standard (amod)
definition combination (nmod)
therapy tumors (conj)
treated measured (parataxis)
thrush ( (punct)
compared toxicities (nsubjpass)
combination in (case)
failure for (case)
pectoris without (case)
supports experience (nsubj)
got hour (nmod)
shown coniine (nsubjpass)
derangements the (det)
sulfation decreased (conj)
10,000 100 (compound)
recall words (dobj)
taken treatment (conj)
erk and (cc)
cardiac any (det)
other 2 (nummod)
closest 0.25 (nsubj)
alcohols sugar (compound)
dyskinesia peak (compound)
result defect (nsubj)
csa for (case)
rat to (case)
23 19 (compound)
angiography interventions (conj)
4-aminopyridine-sensitive not (neg)
part later (amod)
decrease rigidity (nmod)
taking initiated (parataxis)
brush-evoked punctate-evoked (conj)
tma of (case)
toxicities worst (amod)
sweating is (cop)
precipitation to (mark)
fentanyl propofol (conj)
observed expression (nmod)
compared isomers (nsubjpass)
acetaminophen edema (dep)
matter edematous (amod)
patients 97 (nummod)
rna ribosomal (amod)
role therapy (nmod)
man white (amod)
tested using (advcl)
nvp ( (punct)
operations consecutive (amod)
absent signs (nsubj)
pathogenesis schizophrenia (nmod)
duration circumference (conj)
useful assess (xcomp)
caution appropriate (amod)
complete response (nmod:npmod)
way discovering (advcl)
number of (case)
base of (case)
enrolled daily (advmod)
requested hour (nmod)
dlt ( (punct)
detection in (case)
myopathy from (case)
benefits abstinence (nmod)
performed subjects (nsubj)
syndrome insufficiency (compound)
playing as (mark)
i.p. , (punct)
ineffective doses (nsubj)
resulted mild (nmod)
neuroimage ) (punct)
mg/kg i.v (appos)
% 6.7 (nummod)
mmhg 107.4 (nummod)
effect same (amod)
medication was (cop)
associated mortality (dep)
necrosis focal (amod)
good been (cop)
improvements significant (amod)
demonstrated conclusions (dep)
metabolite major (amod)
cause indicates (parataxis)
made be (auxpass)
doses customary (amod)
prevention women (nmod)
dosages micrograms/day (nmod)
precore and (cc)
evaluated specimens (nsubjpass)
moderate , (punct)
surgery mainly (advmod)
recordings neurophysiological (amod)
doses pilocarpine (nmod)
micrograms/ml 150 (nummod)
limited trial (dep)
fentanyl and (cc)
perfused buffer (nmod)
seizure collection (nmod)
deletion genetic (amod)
saline/side ( (punct)
dynamics molecular (amod)
had echocardiograms (dobj)
duration seizures (compound)
noted compared (xcomp)
cells/mm3 combination (nmod)
alpha(1)-subunit the (det)
methods induced (appos)
aggravates significantly (advmod)
arrhythmia bupivacaine (compound)
30 8 (conj)
correlated effect (nsubjpass)
ketanserin antagonist (appos)
3.3 +/- (cc)
velocity element (compound)
considered . (punct)
ultrasonography by (case)
inducing ) (punct)
disappearing australia (nmod)
tea combination (conj)
cohort tg (compound)
dnap and (cc)
one accompanied (acl:relcl)
elucidated suggests (conj)
performed but (cc)
microscopy transmission (conj)
evaluated influence (dobj)
nephropathy minimal-type (amod)
35.6 28.3 (conj)
drug worldwide (amod)
events two (nummod)
attenuating number (dobj)
paco2 kpa (dep)
marker no (det)
task avoidance (compound)
had requirement (dobj)
co-administration rats (nmod)
tremor ) (punct)
induced has (aux)
effect mk-801 (nmod)
used persons (nsubj)
decreased preparations (nmod)
service in (case)
rapamycin to (case)
rechallenge androgen (nmod)
foods caffeine-containing (amod)
determined elisa (nmod)
morning surgery (nmod)
increased ca2 (dobj)
arrest care (nmod)
progressive severe (amod)
antagonist p (compound)
vohland al. (dep)
induction plasticity (nmod)
injected morphine (nmod)
biopsies bone (compound)
antioxidant which (nsubj)
regulation activity (nmod)
one each (dep)
asphyxia interventions (appos)
units 183 (nummod)
injection mg/kg (nmod)
drug controls (dobj)
antibody and (cc)
found vessels (nmod)
unease her (nmod:poss)
took that (mark)
drawbacks , (punct)
cells bladder (compound)
discount arrhythmia (dobj)
production pair (conj)
revealed inhibition (dobj)
astrocytes cells (conj)
3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ) (punct)
7- to (dep)
undertaken effort (nmod)
used therapy (nmod)
sensitive rats (nsubj)
compared 432 (nmod)
= . (punct)
exposed heparin (nmod)
provoke to (mark)
receptor-dependent mglu7 (nmod:npmod)
interviewed , (punct)
levels da (nmod)
total plasma (compound)
rigidity fentanyl-induced (amod)
age patients (nmod:poss)
site responsible (amod)
patients 62 (nummod)
usa , (punct)
decreasing , (punct)
points not (preconj)
frequencies one (nummod)
dramatic most (advmod)
selective damage (nsubj)
function gross (amod)
alleviated be (auxpass)
discontinued performed (conj)
levels alpha3 (compound)
copies/ml 200 (nummod)
reduced hyperalgesia (dobj)
accuracy latencies (conj)
complications arise (acl:relcl)
carbonate-induced calcium (nmod:npmod)
shown processing (nsubjpass)
tetany . (punct)
experienced somnolence (dobj)
mug ) (punct)
h 40.3 (nummod)
proven lidocaine (nsubjpass)
report infant (nmod)
lifetime both (cc:preconj)
determine role (dobj)
administered days (dobj)
total visits (nmod)
contents lungs (nmod)
appeared have (aux)
mortality , (punct)
factor-beta1 tgf-beta1 (appos)
given water (nmod)
treatment associated (acl)
cb administered (acl)
monkeys (mptp)-exposed (amod)
enlarged autopsy (nmod)
drc the (det)
co-morbidity psychiatric (amod)
occurred p (dep)
doses d3 (appos)
toxicity further (amod)
receiving days (dobj)
experiment animal (compound)
found study (nmod)
obtain toxicity (nmod)
interval with (case)
consumed empirically (advmod)
cyclophosphamide and (cc)
lower considerably (advmod)
developed progressively (advmod)
accompanied pressure (nmod)
parkinsonism dyskinesias (conj)
3,000 500 (compound)
dialysis outpatient (amod)
functionality users (nmod)
treatment pdtc (nmod)
crystals by (case)
had injection (nmod)
variability index (conj)
revealed maps (nsubj)
interferon of (case)
loss complete (amod)
event potential (amod)
followed seizures (nmod)
redness , (punct)
collected we (nsubj)
lidocaine as (case)
increased that (conj)
stage inoperable (amod)
liver shrunken (amod)
piglets of (case)
smaller s (nmod)
promote passage (dobj)
circling ipsilateral (amod)
resulted tone (nsubj)
pathology additional (amod)
similar that (nmod)
report syncope (dobj)
difference estimated (amod)
gvhd for (case)
0.47 0.81 (appos)
midazolam . (punct)
dynamic ( (punct)
ineffective before (mark)
regulate phenotypes (dobj)
free superior (conj)
negligible lipoproteinuria (nmod)
cardiotoxicity the (det)
= 7 (dobj)
followed been (auxpass)
discussed influence (nsubjpass)
doses n (dep)
excluding after (mark)
react that (nsubj)
myocardial , (punct)
role catecholamines (nmod)
value bilirubin (compound)
inhibition concentration (nmod)
dyscrasias the (det)
myeloma , (punct)
formers mhb (compound)
induces adult (nmod)
systemic , (punct)
marker the (det)
antagonist alpha-2 (compound)
cramps menstrual (amod)
ratio hr (dep)
bacteremia of (case)
those toxicology (nmod)
indicative are (cop)
level serum (compound)
intensity scale (nmod)
hospitals from (case)
assumed was (auxpass)
excretion sodium (compound)
050+/-561 ) (punct)
ml/min/kg ) (punct)
neuropathy optic (amod)
4-damp receptor (compound)
tachyarrhythmias the (det)
results infusions (dep)
torsade fluconazole-induced (amod)
cells red (amod)
inhibitor cyp3a4 (nmod)
traveled find (xcomp)
beta 2-receptors (dep)
systems involved (acl)
discomfort venous (amod)
occurred which (nsubj)
angina ischemic (conj)
lead lesions (nmod)
rise relative (amod)
strategy new (amod)
function its (nmod:poss)
attack avrt (compound)
believed neurotoxicity (nsubjpass)
acting concentration (nmod)
portions in (case)
intense mg/day (dep)
scopolamine by (case)
cause formation (nmod)
rats 42)-infused (amod)
temperature mg (nmod)
months assess (acl:relcl)
prevented mv (nmod)
warranted clearly (advmod)
447 received (acl:relcl)
revealed unresponsiveness (ccomp)
synthase no (compound)
appears conclusion (dep)
22 and (cc)
encephalopathy peg-asparaginase (nmod)
incidence high (amod)
expression of (case)
interventions resources (conj)
marker granule-cell-specific (amod)
presented ( (punct)
formation cysts (nmod)
2-fold ( (punct)
were divided (conj)
toxicity distal (amod)
failed affect (xcomp)
problem therapy (nmod)
man subject (acl:relcl)
criteria revised (compound)
thrombocytopenia in (case)
210 14 (compound)
picrotoxin- and (cc)
assayed products (nmod)
% generally (advmod)
97.1 ( (punct)
deterioration function (nmod)
grommet through (case)
evoked device (nmod)
viia of (case)
dactinomycin iva (appos)
mm 95 (nummod)
rates ; (punct)
marmoset mptp-lesioned (amod)
age earlier (amod)
received accompanied (advcl)
period study (nmod)
male pneumonia (nmod)
denied use (nsubjpass)
suggested therapy (nmod)
administered applied (advcl)
cells putative (amod)
agents conventional (amod)
flutter atrial (amod)
examination liver (nmod)
meeting the (det)
neutropenia by (case)
brain supratentorial (amod)
switching associated (acl)
measured 12- (nmod)
stabilizer with (case)
show occur (ccomp)
restriction no (neg)
depolarization of (case)
strain mouse (nsubj)
vulnerable model (nmod)
% glycopyrrolate (conj)
ketanserin alfentanil (conj)
correct effective (nsubj)
appears rats (nmod)
return complications (nmod)
inhibitor-1 pai-1 (appos)
bh and (cc)
oxygenation related (amod)
men euthymic (amod)
monitoring close (amod)
tube nephrostomy (compound)
negative testing (csubj)
microliters ( (punct)
groups ( (punct)
hg and (cc)
requiring pacemaker (dobj)
pmol 9.84 (nummod)
received cycle (dobj)
assays sequential (amod)
decreased p-coumarate (nsubj)
estimates current (amod)
effects progesterone (compound)
volume ventral (amod)
administration doxorubicin (compound)
occur deficiency (nsubj)
interview from (case)
test step-through (amod)
surveillance reactions (nmod)
cpa/ee ) (punct)
70 % (appos)
causes patterns (dobj)
performed absence (nmod)
controlled hours (nmod)
case crisis (nmod)
bioavailability gspe (nmod:poss)
anesthetics local (amod)
recurrences these (det)
produced administration (nmod)
treatment diethylstilbestrol (compound)
ml/h 5.4 (nummod)
effect ticlopidine (nmod)
those iohexol (nmod)
decades for (case)
diuresis chronic (amod)
noradrenaline triggering (conj)
pc ( (punct)
formed pb (nmod)
loss hypokalaemia (conj)
cimetidine mg (dep)
% 38 (nummod)
dosage nor (cc)
mg/kg 7.5 (nummod)
known mechanism (nsubjpass)
ability synthesize (acl)
conclusion reduction (appos)
form against (case)
sed ) (punct)
imaging on (case)
confusion including (case)
weeks doxorubicin (nmod)
activates improves (conj)
declined , (punct)
hr 0 (nummod)
study follow-up (compound)
wish . (punct)
10-fold < (dep)
mz ) (punct)
low back (advmod)
5.6 2.3 (conj)
rank ) (punct)
efferent vagal (amod)
production ros (compound)
developed frequently (advmod)
induced halothane (nmod)
effect negative (amod)
mg/day 12.5 (nummod)
follow-up : (punct)
mandates using (advcl)
changed rats (nmod)
had placebo (advcl)
trials patients (nmod)
puromycin in (case)
volume corpuscular (amod)
ctni forms (conj)
experienced majority (nsubj)
superior with (mark)
exposure adult (amod)
volunteers ; (punct)
sgk1(-/- ) (punct)
common , (punct)
abuse dextromethorphan (nmod)
investigated essential (advcl)
lc the (det)
groups : (punct)
simplifies and (cc)
surgery routine (amod)
although are (cop)
nephrotoxic , (punct)
significantly ; (punct)
stretches only (advmod)
prevention bradycardia (nmod)
rearings and (cc)
help will (aux)
given review (nsubjpass)
perfusion inadequate (amod)
occurrence first (amod)
individual given (amod)
besylate atracurium (nsubj)
disorder obsessive-compulsive (amod)
labelling for (case)
produced morphine (nmod)
areas potential (amod)
eruptions developed (acl:relcl)
days postoperatively (advmod)
stimulate pge2 (nsubj)
non-smokers , (punct)
increases manner (nmod)
radionuclide angiography (dobj)
prevention coma (nmod)
rates decrease (acl:relcl)
-(4-fluorophenyl - (punct)
associated mg/kg (nsubjpass)
alcoholic not (neg)
exposure hydrogen (compound)
regimens medical (amod)
hepatocytes periportal (amod)
cardiotoxicity concerning (case)
efficacious to (mark)
gspe 's (case)
studied using (advcl)
similar very (advmod)
remained min (nmod)
outcomes disease (compound)
changes consistent (acl:relcl)
given begun (advcl)
incidence > (dobj)
reversal oih (nmod)
activation with (case)
cardiotoxin is (cop)
results therefore (advmod)
dependence inactivation (nmod)
confined properties (nsubjpass)
blanching conjunctival (compound)
effects postoperative (amod)
incapacity of (case)
1997 and (cc)
losartan systolic (amod)
induced cystitis (nsubjpass)
examined expression (nsubjpass)
ovarian or (cc)
treatments n-nitroso-n-methylurea (nmod)
modulating through (case)
associated patients (nmod)
greater bid (nmod)
concentration alpha-bungarotoxin (compound)
time optimal (amod)
hitt ( (punct)
experienced however (advmod)
indicate conclusion (nsubj)
prevent patients (nmod)
circulation and (cc)
cerebral of (case)
literature recorded (amod)
capacity to (case)
performance objective (amod)
results aggregation (compound)
reduction strength (nmod)
movements of (case)
developed % (nmod)
outcome transplantation (compound)
end trial (nmod)
akinesia of (case)
polyneuropathy with (case)
methods divided (appos)
pallidotomy . (punct)
attenuated drc (nsubjpass)
followed participants (nsubjpass)
contracting by (mark)
haloperidol or (cc)
grade cardiomyopathy (nmod)
continued and (cc)
cure to (mark)
seizures/mo ) (punct)
lack increase (nmod)
livers rats (nmod)
excretion findings (conj)
withdrawal vpa (compound)
screen efficacy (nmod)
report patients (dobj)
tgr ) (punct)
revealed sections (nsubj)
c-ret ( (punct)
plays salience (nmod)
noted : (punct)
anomalies of (case)
consent informed (amod)
i.e. days (nmod)
remained polyuric (xcomp)
syndrome reversible (amod)
g and (cc)
variation these (det)
action abecarnil (nmod)
iv to (case)
etoricoxib of (case)
contraction pvc (appos)
nm 1.9 (nummod)
taking patient (nsubj)
proof trajectory (nmod)
loss righting (advcl)
epirubicin paclitaxel (conj)
has manifestations (dobj)
ablation catheter (compound)
chicago il (appos)
dysfunctions of (case)
reviewed methods (dep)
sc 1.5 (nummod)
stage 14 (nummod)
received libitum (dobj)
prevented tcr (nsubj)
conducted , (punct)
presenting years (nmod)
remained abnormal (xcomp)
hyperalgesia thermal (amod)
identified those (dobj)
lozenge between (case)
subjects use (acl:relcl)
profile deficits (nmod)
mm hg/l/min (dep)
males both (det)
activation the (det)
conducted experiments (nsubjpass)
associated beta-adrenoblocking (nmod)
group mr (nmod)
greater bradycardia (nsubj)
used nanoparticles (nsubjpass)
analgesics of (case)
present or (cc)
due therapy (nmod)
established provided (conj)
aniracetam and (cc)
day pnd (appos)
a/j swr/j (amod)
model neuropathy (nmod)
induced gds (nmod)
restricted frequently (advmod)
ctx of (case)
trait e (compound)
withdrew study (nmod)
postdose a (det)
observed forces (nmod)
method by (case)
increase ) (punct)
1969 95 (nummod)
intravitreal patients (nmod)
increases interval (nmod)
activities antipsychotic (amod)
week by (case)
caused % (dep)
1863 321 (conj)
cause complication (dobj)
assessment test (appos)
load viral (amod)
nodules , (punct)
depleted ; (punct)
e induced (acl)
cross-sensitization dose (nmod)
increase due (case)
epilepticus p45 (appos)
injection methyldopa (amod)
population single (amod)
dose time (conj)
mean % (conj)
estimated cases (xcomp)
limited . (punct)
unlikely five (nsubj)
frequency attack (compound)
moderate damage (nmod)
killed , (punct)
drowsiness ataxia (conj)
opposed ballooning (nmod)
score propensity (compound)
uh ( (punct)
cells hl60 (compound)
thought free (xcomp)
anticoagulation during (case)
models behavioral (amod)
development the (det)
yields significant (amod)
fibrillation vf (appos)
scale -- (punct)
present dyskinesia (nsubj)
associated using (xcomp)
included mucositis (dep)
effects analog (nmod)
responses cataleptic (amod)
prerequisite injury (nsubj)
allowed use (nsubjpass)
nocistatin learning (nmod)
increased diameters/bw (nsubj)
decreased dose-dependently (advmod)
response iso (nmod)
recruited was (auxpass)
ptz due (case)
attenuates nephrotoxicity (dobj)
ug levothyroxine (nmod)
time inhibited (acl:relcl)
blood peripheral (amod)
dosage allowed (amod)
option therapeutic (amod)
dependent had (aux)
remained asymptomatic (xcomp)
alterations consumption (conj)
losartan angiotensin (compound)
surgeries , (punct)
ml. 16 (nummod)
patient wilson (nmod:poss)
breakdown asymmetrical (amod)
release activity (conj)
mc ( (punct)
seemed independent (xcomp)
rate > (dep)
one pathways (nmod)
necessary institute (xcomp)
accumulating toxic (ccomp)
reduced q10 (nsubj)
recovered days (dobj)
used years (nmod)
200 50 (compound)
nitrate and (cc)
days 120 (nummod)
become progressively (advmod)
release serotonin (compound)
ratio : (punct)
arrhythmia caffeine-induced (amod)
occurs impairment (nsubj)
value diagnosis (nmod)
ml sulphoxide (nmod)
add information (dobj)
reviewed features (conj)
compromising the (det)
induce hyperfiltration (dobj)
periods the (det)
erythroblastocytopenia induced (acl)
sjl in (case)
5-ht1a affinity (conj)
activation from (case)
challenge dat(-/- (conj)
woman one (nummod)
transfusion 3/5 (appos)
us the (det)
performed imaging (nsubjpass)
selective not (neg)
reported addition (nmod)
coherence in (case)
evaluated cystitis (nsubjpass)
rate hemoglobin (nmod)
ng/kg/min 30 (nummod)
objective assess (dep)
peptide atrial (amod)
nodule fornix (nmod)
bradycardia for (case)
preparations . (punct)
decontamination benzodiazepines (nmod)
lymphoma relapsed (amod)
similar magnitude (nmod)
addition acid (nmod)
group liver (nmod)
tamoxifen receptor (compound)
receptor da (compound)
july 2001 (nummod)
evaluated activity (nmod)
glioblastoma improving (amod)
beats monitoring (appos)
damage tubular (amod)
anesthesia nitroprusside (conj)
b in (case)
dose nonsedating (compound)
glomerulonephritis had (acl:relcl)
7 ] (punct)
induced disulfiram (nmod)
cost its (nmod:poss)
accompanied loss (nmod)
analysis neuropathies (nmod)
antibody ( (punct)
multicenter study (nsubj)
investigation extensive (amod)
ducts interlobular (amod)
penetrate which (nsubj)
effectiveness antiarrhythmic (amod)
modifications cp-induced (amod)
haemodilution to (case)
became and (cc)
progression until (case)
ratio compared (dep)
p.o. 2 (nummod)
group stz-injected (amod)
long-term months/patient (dep)
subsequent decreased (dep)
acidosis iv (nummod)
findings electroencephalogram (compound)
pallidus in (case)
change 0.01 (appos)
symptoms nephrolithiasis (nmod)
7 27 (conj)
experienced experienced (conj)
seen hus (nmod)
groups within (case)
mibg ( (punct)
return ) (punct)
ci 7.54 (nummod)
neonates twin (compound)
i.p. intraperitoneally (advmod)
background used (appos)
suggested exercised (ccomp)
detected cellular (nsubjpass)
presentation imaging (conj)
prone exhibit (xcomp)
synthesis and (cc)
incidence convulsions (nmod)
enzyme-1 et-1 (compound)
n- and (cc)
onset symptom (compound)
layers in (case)
anesthesia methoxyflurane (amod)
= 0.78 (nmod)
wide-range a (det)
incidence haemorrhage (nmod)
detected push (nsubjpass)
curve plasma (compound)
multiple cholesterol (conj)
subjects supine (amod)
biopsy for (case)
animal the (det)
immunomodulators tacrolimus (nmod)
cns to (case)
hamartoma of (case)
pge2 medullary (amod)
patient such (case)
eligible inclusion (nmod)
lesions neuropathy (nmod)
amiodarone on (case)
prolapse of (case)
associated suggested (advcl)
signs the (det)
growth contractions (conj)
women danish (amod)
showed association (dobj)
states in (case)
cortex parietal (amod)
impairment working (amod)
believed it (nsubjpass)
infection cmv (compound)
confirm we (nsubj)
binding preferential (amod)
increased excruciating (advcl)
vt or (cc)
analgesic and (cc)
group evaluations (nmod)
retinopathy of (case)
alternation induced (acl)
treatment menopause (nmod)
was decrease (nmod)
identified duration (dobj)
effects receiving (acl)
reductions fraction (nmod)
action nicotine (nmod)
less groups (advcl)
produced as (advmod)
increased that (nmod)
help finding (nsubj)
trial randomised (amod)
reflected physiology (nmod)
inhibitors synthetic (amod)
parameters studied (acl)
cr metabolic (amod)
sleeping and (cc)
neuropathy due (amod)
liver rats (nmod)
produced reduced (conj)
1.5 to (dep)
changed hand (nmod)
brought about (compound:prt)
counts cd4 (compound)
catalepsy morphine (compound)
supplemented ra (nmod)
remains speculative (xcomp)
receptor cck2 (compound)
erection . (punct)
diet restricted (amod)
incidence greater (amod)
given report (nsubjpass)
patients breast (compound)
= 0.757 (dobj)
mortality bilirubin (dep)
infiltrates prominent (amod)
oil without (case)
= 60 (dep)
surgery day (conj)
woman hydroureteronephrosis (nmod)
azathioprine > (dep)
cycle tca (compound)
expression development (conj)
determine programmed (ccomp)
ed50 103 (nummod)
emerged analysis (nmod)
treated 2 (nmod)
observers two (nummod)
recruited groups (nmod)
wanted and (cc)
therapies salvage (amod)
stress genuine (amod)
desaturation bradycardia (conj)
haloperidol ( (punct)
develop subsequently (advmod)
proposals treatment (compound)
infusions intermittent (amod)
edetate disodium (compound)
patients malaysian (amod)
regimen pb (compound)
myelosuppression effect (nsubj)
prolongation a (det)
atria right (amod)
achieve aim (dobj)
risk psychosis (nmod)
patterns hyper-reactivity (nmod)
excitation nervous (amod)
rats immunostaining (appos)
medication ) (punct)
tetrapeptide cck-5 (dep)
hallucinations possible (amod)
predisposes serve (conj)
individuals those (det)
sgk1(+/+ ( (punct)
pathways visual (amod)
causing dysfunction (dobj)
values crea (appos)
optic toxic (amod)
enhanced knockdown (nsubj)
encephalopathy in (case)
values images (nmod)
regurgitation of (case)
hypotension mm (nmod)
on been (cop)
csseps correlates (nmod)
showed p.o. (dep)
(na activity (appos)
treatment exchange (nmod)
stroke ) (punct)
made obviate (xcomp)
effectiveness immediately (advmod)
normalization interval (nmod)
produced impairments (dobj)
serum two (nmod)
electrophysiology , (punct)
appeared histologically (advmod)
binding nicotine (nmod)
metabolites doses (nmod)
2/3 about (advmod)
toxin botulinum (compound)
those between (case)
circulation the (det)
experienced loss (dobj)
h. first (amod)
expression seizure (amod)
depression acute (amod)
concentrations relationship (nmod)
patients clinical (amod)
study animal (amod)
practical is (cop)
fraction in (case)
test influence (dobj)
diagnosis stroke (nmod)
prudent however (advmod)
flow hypotension (nmod)
impairment , (punct)
decreased map (nsubj)
considered abuse (nsubjpass)
thalassemia with (case)
bands into (case)
reactions 2e1 (compound)
3-methoxy-4-hydroxyphenethyleneglycol cortisol (conj)
flow expression (dep)
developing lids (dobj)
indicates mechanism (nsubj)
115 length (nsubj)
involved stress (nsubjpass)
drug antiemetic (amod)
became inadvertently (advmod)
amyloidosis syndrome (conj)
determine responsiveness (nmod)
monitored that (mark)
benefit the (det)
increased patients (nsubj)
seizure decrease (conj)
cause mortality (appos)
study is (cop)
lobule throughout (case)
reduced incidence (dobj)
catheterisation by (case)
lymphoma a (det)
involved factor (nsubjpass)
progesterone deoxycorticosterone (conj)
model factors (nmod)
hyperplasia and (cc)
supplementation dietary (amod)
showed registrations (nsubj)
0 30 (conj)
investigating induction (nmod)
had cibenzoline (nsubj)
causes which (nsubj)
crea ) (punct)
bound covalently (advmod)
months 204 (nummod)
therapy compliance (conj)
rats state (nmod)
type changes (nmod)
lost grafts (nsubjpass)
se following (case)
patients 1100 (nummod)
41.66 6.33 (conj)
compared degrees (nmod)
emotion of (case)
mdma , (punct)
following on (case)
-14.8 +/- (cc)
oximetry ecg (compound)
30 10 (compound)
hypertension ' (punct)
insufficiency coronary (amod)
pg/ml concentrations (nsubj)
days plus (cc)
efficient , (punct)
loss on (case)
substance than (case)
described report (nmod)
plexus brachial (amod)
remember features (dobj)
nra0160 behavior (conj)
preceded convulsions (nsubj)
antibiotics antibitocis (conj)
preserved reduction (nmod)
morphine it (compound)
hitt particularly (advmod)
nationwide case-control (conj)
reveals finding (dobj)
starting dose (dobj)
haematuria gross (amod)
injections five (nummod)
prolonged rats (nmod)
sections forebrain (compound)
resuscitation calcium (nmod)
treated control (nmod)
creation shunting (nmod)
microbiologically 138 (compound)
decreases striata (nmod)
synthesize information (dobj)
4.98 mean (parataxis)
nephritis antibiotic (amod)
hours at (case)
factor level (nsubj)
deaths all (det)
medications after (case)
patients of (case)
discharged be (auxpass)
result these (nmod)
present been (cop)
dyskinesia pr=0.515 (conj)
doses intake (nmod)
suggests quality (nsubj)
transplantation tumors (nmod)
glabrata candida (compound)
theorem and (cc)
ibuprofen 1.05 (nummod)
aura and/or (cc)
helpful reducing (advcl)
% 21.4 (nummod)
has reputation (dobj)
mmol/l osmolality (conj)
given escalated (advcl)
decreased that (nmod)
ingestion following (case)
participating study (nmod)
assess undergoing (advcl)
catalyze vitro (advmod)
presented outcome (conj)
antagonists specific (amod)
methotrexate regimen (dobj)
caused hyperkalemia (nmod)
occlusion venous (amod)
autism with (case)
forehead right (amod)
understood yet (advmod)
facilitates yohimbine (nsubj)
prevalence carcinoma (nmod)
change such (amod)
research for (case)
noted effect (nsubjpass)
was however (advmod)
samples patients (nmod)
mssbp ) (punct)
trained . (punct)
i.v. by (case)
associated sex (nmod)
mellitus streptozotocin-induced (amod)
attributable inhibition (nmod)
institution ischemia (nmod)
bought he (nsubj)
locomotion the (det)
iodixanol after (case)
polymorphism length (compound)
36 i.v. (advmod)
decreased therapy (advcl)
decrease attack (acl)
adenomas : (punct)
mcl ) (punct)
dysrhythmias the (det)
supplementation multivitamin (compound)
vessels hypotension (conj)
dbp reduction (conj)
birth cohort (dobj)
induced fanft (nmod)
injury in (case)
treatment study (nmod)
irritation chemical (amod)
presented course (nsubjpass)
in on (conj)
regardless patterns (nmod)
resistance for (case)
1999 - (punct)
aggregation the (det)
neurotoxicity for (case)
interaction sexually-dimorphic (amod)
recording entire (amod)
improved p.o. (dep)
72 48 (compound)
six- rats (nmod)
synergism in (case)
manifestation as (case)
epidemiology nephrotoxicity (nmod)
cause % (appos)
lids and (cc)
micrograms 20 (nummod)
machinery ilk (nmod)
occurrence . (punct)
inhibitor precursor (appos)
administered knowledge (nmod)
treatment 6-day (amod)
performed had (aux)
> ( (punct)
mmhg mean (amod)
idea induce (ccomp)
inhibitor decarboxylase (compound)
minutes at (case)
toxicity hepatotoxicity (conj)
developed started (advcl)
cirrhosis in (case)
factor susceptibility (compound)
symptoms positive (amod)
alterations pd (nmod)
hemorrhage retention (dep)
0.001 ): (punct)
required hours (nmod)
control conversion (conj)
well-tolerated is (cop)
21 , (punct)
ts of (case)
progression hearing (advcl)
study hospital (nmod)
treated amiodarone (nmod)
related disruption (nsubj)
documented seven (nmod)
ao of (case)
nsvt ) (punct)
dose l-3,4-dihydroxyphenylalanine (nmod)
enhanced not (neg)
volume ventricular (amod)
months 15 (nummod)
showed increases (dobj)
characterized mid- (nmod)
appendage left (amod)
ecg length (dep)
patients score (conj)
ph to (dep)
patients maintenance (compound)
controls epileptic (amod)
show results (nsubj)
similar time (nsubj)
suggest possible (ccomp)
of poly(adp-ribose (dep)
measuring serum/urine (nmod)
man receiving (acl:relcl)
trimethoprim alone (advmod)
infarctions previous (amod)
disappeared arrhythmia (nsubj)
fibrillation non-valvular (amod)
unrelieved pain (nsubjpass)
turnover and (cc)
effects tremor (appos)
involved reactions (nmod)
had stable (conj)
scores cgi-sf (nmod)
rats to (mark)
control administration (appos)
institution : (punct)
myasthenia associated (acl)
effects tolerability (conj)
resolved warfarin (nmod)
gfr ml/min (appos)
diagnosed block (nsubjpass)
assigned g (nsubjpass)
levels stimulant (amod)
labelling and (cc)
speed psychomotor (compound)
pointes dobutamine (nmod)
changes no (neg)
design samples (dep)
dose children (nmod)
foci several (amod)
peak enlargement (nmod)
radiotherapy topotecan (conj)
evaluated disability (nmod)
day days (nmod)
prednisolone of (case)
compare in (mark)
continue follow-up (xcomp)
treated cabergoline (nmod)
d-med 3 (dep)
sensitivity with (case)
generated has (aux)
recorded been (auxpass)
smaller . (punct)
prevented infusing (advcl)
scales analog (compound)
worst controls (advcl)
antagonizes acetaminophen (advmod)
increased cxad (dobj)
similar concentrations (nmod)
died arrhythmia (nsubj)
identify measurement (nsubj)
viruses dna (compound)
review original (amod)
loss similar (amod)
wanted objective (dep)
hsct ( (punct)
valproate , (punct)
effect anti-dopaminergic (amod)
study combination (nmod)
cromakalim nitroglycerin (conj)
outcome age (conj)
analysis laboratory (compound)
parts various (amod)
hydrolysis in (amod)
zo-1 not (neg)
mg/day 160 (nummod)
were changes (nsubj)
characterized signs (nmod)
bolus cocaine (compound)
dose ribavirin (nmod)
consistent effect (nmod)
eighties the (det)
reaction furthermore (advmod)
sample blood (compound)
induces intoxications (nmod)
pulse secretory (amod)
> g/day (dep)
vigabatrin ) (punct)
change flow (nsubj)
use association (conj)
induce administered (advcl)
test negative (xcomp)
caused effects (dobj)
changes bone (compound)
study clinicopathologic (amod)
activity due (case)
correction greenhouse-geisser (compound)
resulted embryos (nmod)
loss range (nmod)
using refine (conj)
threatening during (prep)
areas maps (nmod)
recognized factor (nmod)
inhibitor of (case)
suffering seizures (nmod)
unrelated . (punct)
suffering (aap)-hepatitis (nmod)
change parameters (dobj)
suppressing in (mark)
infused mg/m2 (nsubjpass)
or ; (punct)
polysomnography followed (acl:relcl)
syndrome amnestic (amod)
development towards (case)
background unclear (conj)
reperfusion intestine (nmod)
measures on (case)
dosage drug (nmod)
35 in (case)
consequence blocking (advcl)
regions all (det)
resolved hypertrophy (nsubj)
had frequently (advmod)
nitrogen of (case)
cases e18.5 (nmod)
spreading cortical (amod)
resulted may (aux)
did study (conj)
higher conclude (parataxis)
provides embryo (nsubj)
microangiopathy and (cc)
last of (case)
estradiol dm (conj)
six ) (punct)
concentrations metoprolol (amod)
shr in (case)
recovery visual (amod)
evaluate ability (dobj)
undertook , (punct)
taken had (aux)
occurred reaction (nsubj)
enhanced actions (nsubjpass)
alcohol excessive (amod)
switched rapamycin (nmod)
mtx [ (punct)
parameters catalytic (amod)
contribute to (mark)
upregulation expression (nmod)
viruses certain (amod)
seizure of (case)
amnesia cycloheximide-induced (amod)
8-week randomized (conj)
undergoing anesthesia (nmod)
degeneration between (case)
processing sensitization (appos)
quadriparesis , (punct)
ischemia : (punct)
damage morphologic (amod)
patients pge2 (nmod)
sensitivity expressed (acl)
association close (amod)
properties potential (amod)
inhibitors 3a4 (compound)
lesions glomerular (amod)
lv ) (punct)
tolerate toxicities (nsubj)
zidovudine lamivudine (conj)
motor proximal (amod)
affected nox (dobj)
receptors kinase (compound)
78 of (case)
associated immobilization (nmod)
received mg (conj)
ml thiopentone (dep)
eight patients (nmod)
therapy intense (amod)
is hepatotoxicity (nsubj)
accounts gamma-aminobutyric (amod)
difluoromethylornithine with (case)
u/ml below (case)
role retention (nmod)
deficit functional (amod)
man used (acl:relcl)
intensity of (case)
able measures (nsubj)
decreased doses (nmod)
pressure period (nmod)
ala204asp/p of (case)
deliver 27 (nmod)
started therapy (nsubjpass)
absence history (nmod)
showed clearance (dobj)
correlated performance (nmod)
4.6 4.4 (conj)
assess had (advcl)
pounds 193.9 (nummod)
risk so (advmod)
influences status (nsubj)
administered clinical (nmod)
effects ca(2 (amod)
antagonist a (det)
receiving nifedipine (dobj)
before , (punct)
reversing effects (dobj)
basis signs (nmod)
day 11 (conj)
synchrony etoposide (nmod)
extent the (det)
resulted disinhibition (nmod)
group therapeutic (amod)
cnsb002 blocker (appos)
concluded prove (ccomp)
ns acute (amod)
demonstrated enhanced (advcl)
appears important (ccomp)
aggressiveness apomorphine-induced (amod)
placement muscle (nmod)
resurgence has (aux)
performance before (case)
orbitofrontal or (cc)
ms 500 (nummod)
address , (punct)
responses k (compound)
edema angioneurotic (amod)
hyperactivity bladder (compound)
sinusitis bacterial (amod)
association macrolide (nmod)
enlargement increase (conj)
appropriate elderly (nmod)
diminish treatment (nsubj)
observed specify (dep)
increased weeks (nmod)
synthesized newly (advmod)
cns of (case)
dose calculated (acl)
take action (dobj)
prl-r ( (punct)
compared have (aux)
prevalence compared (advcl)
493 146 (conj)
chain transfer (compound)
abundance mites (nmod)
infarction iso (amod)
necrotizing disseminated (amod)
= 0.040 (dep)
activator tissue-type (amod)
myocardium of (case)
has believed (conj)
days using (acl)
cause elevation (nsubj)
greater mg/kg (nmod)
tolerated exposure (nmod)
developed man (nsubj)
event with (case)
cardiomyopathy primary (amod)
patients 129 (nummod)
mcc group (nmod)
drugs illicit (compound)
development torsades (nmod)
analysis end (nmod)
elevation isoproterenol-induced (amod)
mg/kg significantly (advmod)
experienced recovered (advcl)
hcva ) (punct)
has curcumin (nsubj)
treatment chronic (amod)
assayed hepatocytes (nsubjpass)
herbicides n-phenylimide (amod)
myocardium through (case)
chemotherapy last (amod)
all caused (acl)
lh-rh to (case)
induced titrating (advcl)
administered ketoconazole (nsubjpass)
to baseline (nmod)
% 140 (nummod)
inhibition disrupted (amod)
achieved four (nmod)
therapy 58 (conj)
indicators phosphatase (conj)
injection factor (nmod)
potentiated moreover (advmod)
cvds ( (punct)
aspirin prevention (nmod)
studies day (compound)
45.9 13.9 (conj)
mean fraction (dobj)
amlodipine treatment (nmod)
had stimulation (nsubj)
function good (amod)
tetrachloride of (case)
immunosuppression transplantation (nmod)
disease adenovirus (compound)
figures therapy (nmod)
effects cisapride (nmod)
using 1981 (nmod)
solution hyperbaric (amod)
once least (advmod)
responsive not (neg)
mglur5 ) (punct)
control neurodegeneration (nmod)
deficits papaverine (nmod)
termination until (case)
consuming . (punct)
test locomotion (compound)
reflected , (punct)
form mexiletine (nmod)
established group (nmod)
g/dl 7 (nummod)
necrosis included (amod)
camperdown , (punct)
= .03 (dep)
fatal possibly (advmod)
had twin (nsubj)
all pituitaries (nsubj)
rates rapid (amod)
patient susceptible (amod)
stimulus terms (nmod)
assessed being (auxpass)
hypotension idiopathic (amod)
months haart (nmod)
intake normal (amod)
cck-5 of (case)
glomeruli in (case)
snhl with (case)
design . (punct)
aneurysms abuse (conj)
lowers , (punct)
utility greater (amod)
reduced while (mark)
four-week , (punct)
help results (nsubj)
undergoing conditioning (dobj)
inhibition synthesis (nmod)
syndrome lupus (compound)
mechanism exact (amod)
ro 5967 (nummod)
system renin-angiotensin (amod)
liver twenty-four (compound)
fibres from (case)
clarify effect (dobj)
upper-extremity thrombosis (dep)
activate contributing (advcl)
unclear mechanism (nsubj)
revealed injections (nmod)
stimuli co2 (compound)
using sirolimus (dobj)
matrix mesangial (amod)
agent protease-inhibitor (amod)
evident is (cop)
programs treatment (compound)
years female (appos)
streptozotocin stz (appos)
sleeping difficulties (dobj)
impairment spatial (amod)
relief group (nmod)
useful and (cc)
evaluate steroid (dobj)
very preterm (dep)
lead difficulties (nmod)
urine , (punct)
undergone surgery (dobj)
administration gamma-hch (nmod)
profile preclinical (amod)
admission week (nmod:tmod)
> with (case)
hit with (case)
potentiates stereotypy (dobj)
determined pretreatment (nmod)
severity to (case)
develop because (mark)
support notion (dobj)
echocardiography imaging (conj)
enhancement pronounced (amod)
> 0 (nummod)
suffered fasciitis (dobj)
meq/l. discharged (acl:relcl)
has half-life (dobj)
quantified volume (nsubjpass)
assayed gamma-glutamyltransferase (nmod)
mg was (cop)
activity cathepsin (compound)
had treatment (nsubj)
targeting seizures (dobj)
failure such (case)
highlighted is (auxpass)
hypopharynx , (punct)
alternative report (nmod)
present is (cop)
taqib taqia (conj)
or 1.1 (nummod)
component baroreflex (nmod)
plasticity pas-induced (amod)
depletion amb. (compound)
depletion , (punct)
leads in (case)
baseline towards (case)
regained which (nmod)
hr during (case)
release catecholamines (nmod)
develops failure (nsubj)
study dose-response (amod)
fibrillation persistent (amod)
pharmacology distinct (amod)
resulted reduced (conj)
history acne (nmod)
receptors na (compound)
median radial (conj)
multicenter hypertension (conj)
tools are (cop)
is convincing (xcomp)
included predictors (nsubj)
potentiate facilitate (conj)
months post-cab (dep)
preparation synaptosomal (amod)
duration onset (nmod)
patterns nag (compound)
need inquire (xcomp)
elderly and (cc)
related has (aux)
likely seen (ccomp)
hoe hoe (dep)
colorectal gastric (conj)
but vitro (advmod)
associated though (mark)
treatment breast (compound)
efficacy greater (amod)
designed have (xcomp)
measuring plasma (dobj)
important interactions (nsubj)
administered exceeding (advcl)
reaction toxic (amod)
ratio nephrogenic (amod)
area primary (amod)
animals observed (conj)
doses micrograms/kg/min (dep)
remained potentiated (xcomp)
supply nerve (compound)
remained although (mark)
mssbp with (case)
d2/d3 and (cc)
therapy agent (appos)
obtained subject (nmod)
expected would (aux)
group amns (nmod)
sample a (det)
analysis haplotype-wise (amod)
prevalences dysfunction (nmod)
produce patients (nmod)
atrophy in (case)
absence equipment (nmod)
complicating failure (dobj)
disease nerve (compound)
sirna for (case)
doses desferrioxamine (nmod)
determine ; (punct)
mechanism central (amod)
substance either (preconj)
located are (cop)
diameters/bw and (cc)
euphoria attitude (conj)
implants the (det)
center a (det)
intervals ) (punct)
conclusion indicative (dep)
changes gas (compound)
bicarbonate of (case)
gamma-vinyl-gaba micrograms (conj)
infusion timed (amod)
increases % (ccomp)
administration counteraction (conj)
da gad (conj)
omeprazole , (punct)
experienced sexual (dobj)
complained he (nsubj)
administration 99mtc-glucarate (amod)
found serum (nmod)
h 30 (nummod)
novel active (dep)
metolachlor of (case)
efficacy substantial (amod)
decreased moreover (advmod)
measurements fetal (amod)
reductase hippocampal (compound)
artery one (nummod)
phenotypes hemorrhagic (amod)
randomized eyes (nmod)
resulted that (nsubj)
toxicity rats (nmod)
shown attenuate (xcomp)
continued : (punct)
scarce : (punct)
increased consistent (conj)
pectoris of (case)
transferred strain (nmod)
rats anaesthetised (amod)
reduced modestly (advmod)
contains hypaque (nsubj)
more dl-sotalol (nmod)
scale digitized (acl)
patients , (punct)
developed postoperatively (advmod)
exposure impacting (case)
flow and (cc)
evidence nephrotoxicity (nmod)
antibiomania ( (punct)
hypotension due (case)
induced anxiety (dobj)
raises call (ccomp)
completed was (auxpass)
increase robust (amod)
ifosfamide dactinomycin (conj)
assessed cells (nmod)
separated , (punct)
microm of (case)
cause anemia (nmod)
terbinafine oral (amod)
parameters severity (compound)
days=1.77 ; (punct)
u-ii ) (punct)
rose because (mark)
birth " (punct)
capacity cystometric (amod)
patients administration (nmod)
anastrozole group (conj)
10(-6 5 (nummod)
sedatives of (case)
years . (punct)
abc chondroitinase (compound)
mechanisms alters (acl:relcl)
recognition syndrome (nmod)
overcome effects (dobj)
dose paclitaxel (compound)
i/d ) (punct)
related cases (nsubj)
ci 0.98 (nummod)
diabetes 2 (nummod)
phase the (det)
receive indomethacin (dobj)
caffeine men (nmod)
decreased excretion (nsubjpass)
nephrolithiasis acetazolamide-induced (amod)
flow erpf (appos)
tract urinary (amod)
users ; (punct)
immunosuppressants by (case)
mice but (cc)
activity alpha (compound)
improve switching (csubj)
retrievals rating (nsubj)
cognition of (case)
1.17 0.99 (dep)
evaluation without (case)
undertaken patients (nmod)
reaction life-threatening (amod)
signified cases (nmod)
deferens ileum (conj)
attenuated ) (punct)
b-100 a-i (conj)
deficits loss (appos)
transporter a (det)
recognize diagnosis (nmod)
anaesthesia to (case)
derivative another (det)
isomers the (det)
that seen (acl)
done analysis (nsubjpass)
antagonize augment (conj)
groups ) (punct)
reduced rather (advmod)
factor intensity (compound)
variations genetic (amod)
groups non-lithium (amod)
n-acetyl-beta-d-glucosaminidase marker (appos)
52 1 (conj)
1,3-butadiene ) (punct)
time and (cc)
5 93 (nummod)
overdose cocaine (compound)
intake equivalent (amod)
developed hyperplasia (dobj)
mg/day 40 (nummod)
tamoxifen cancer (nmod)
considered catalepsy (nsubjpass)
period 6-year (amod)
recorded demographic (nsubjpass)
developed ; (punct)
patients ; (punct)
fas serum (compound)
benzoylecgonine or (cc)
periods activity (nmod)
doses ed50 (compound)
association york (compound)
ng/ml 526 (nummod)
poor radiotherapy (nmod)
4-aminopyridine or (cc)
treated bladder (conj)
urine against (case)
position down (advmod)
awake were (cop)
% mm (conj)
binding annexin (compound)
use art (compound)
psoriasis of (case)
combined with (prep)
dose-dependent atrophy (nmod)
factor delirium (nmod)
improved % (conj)
quantitated were (auxpass)
excitation recurrent (amod)
hypotension disease (nmod)
january 2007 (nummod)
uncommon effects (nsubj)
ratings subsequent (amod)
applicability its (nmod:poss)
att infection (conj)
hydrochloride metformin (compound)
measured evaluated (conj)
raised contrast (nmod)
preparations chinese (amod)
high 4 (nmod)
gap bench-to-bedside (amod)
unknown role (nsubj)
reversible is (cop)
history polydipsia (nmod)
region inguinal (amod)
abdomen distended (amod)
transplantation the (det)
changes associated (acl)
net hippocampal (amod)
had od (nsubj)
marrow the (det)
sera in (case)
lines therapies (nmod)
obese ob (appos)
defined reductions (nmod)
treatment diuretic (nmod)
differentiation ed50 (nmod)
% anti-hbe (conj)
reversed effect (nsubjpass)
5-fu leucovorin (conj)
activation proliferator-activated (amod)
proliferation mesangial (amod)
illustrates severe (ccomp)
ec ) (punct)
inhibitor reuptake (compound)
experienced children (nsubj)
therapy beta-blocker (compound)
dermatitis facial (amod)
suggesting involves (ccomp)
inhibition possibly (advmod)
performed infusion (nmod)
term on (case)
sg ) (punct)
treatment metronidazole (nmod)
% 62.8 (nummod)
subjects three (nummod)
cells tubular (amod)
seems degree (nmod)
function diminished (amod)
conclude induce (ccomp)
readministration amantadine (nmod)
higher cortex (conj)
events between (case)
neurotoxicity da (compound)
2 8 (conj)
cancer . (punct)
i.p. after (mark)
low relatively (advmod)
strength her (nmod:poss)
associated also (advmod)
hepatotoxicity against (case)
wounds burn (compound)
aspartate , (punct)
induced nicotine (nmod)
hypotension of (case)
coil head (compound)
salvage effective (amod)
angiotensinogen of (case)
evident administered (advcl)
deposits wall (compound)
effusion , (punct)
mm 130/<80 (nummod)
reviews paper (nsubj)
angioedema ( (punct)
p<0.001 hypertension (nmod)
normalized these (det)
morphological morphometrical (conj)
administration morphine (nmod)
is dimorphism (nsubj)
cardiac marrow (conj)
toxicity ccnu-associated (amod)
1 7 (conj)
received piglets (nsubj)
caused effect (nmod)
conclusions found (dep)
proteases the (det)
dialysis biopsy (conj)
monkeys , (punct)
summary male (dep)
reduction dose-dependent (amod)
remapped months (nmod:tmod)
inherent and (cc)
mechanisms separate (amod)
marker by (case)
met three (nsubj)
withdrawal cause (nmod)
outpatients schizophrenic (amod)
death . (punct)
contribute may (aux)
days ) (punct)
regimens effective (amod)
measured levels (nmod)
finding risk (nmod)
dependence and (cc)
studying for (mark)
actions their (nmod:poss)
undertook multicenter (dobj)
incontinence . (punct)
glomerulonephritis and (cc)
stopping minocycline (dobj)
higher were (advcl)
seizure patient (nmod)
agents hypolipidaemic (amod)
microangiopathy cyclosporine (amod)
precursor from (case)
headache migraine (nmod)
cytoskeleton cardiomyocyte (nmod)
analyzed focusing (advcl)
admitted were (auxpass)
hypoxemia neonates (nmod)
lead group (nmod)
% interval (dep)
5-fluorouracil of (case)
lower nephrotoxicity (nsubj)
40 +/- (cc)
ifo ( (punct)
hyperprolactinemia a (det)
sustained tear (dobj)
causes failure (dobj)
related 6-thioguanine (nmod)
-8.1 12.7 (conj)
exceed and (cc)
lignocaine hyperbaric (amod)
propofol mg/kg/min (amod)
differ and (cc)
justify prevalences (nsubj)
dose argatroban (compound)
occurred gain (nsubj)
inhibited pretreatment (nmod)
end study (compound)
potentiation mice (nmod)
physicians initiating (acl)
diagnosed patients (nmod)
age older (amod)
group untreated (amod)
reaction macrolides (nmod)
serious the (det)
exception method (appos)
d2 both (cc:preconj)
register inpatient (compound)
allopurinol indomethacin (conj)
report intravitreal (xcomp)
sites the (det)
rejection of (case)
technique with (case)
changes disfiguring (compound)
courses during (case)
dox before (case)
feasible chemotherapy (nsubj)
range 1.53 (dep)
patients patient (appos)
confirmed were (auxpass)
body weight/day (punct)
15 13 (compound)
rate fasciculations (conj)
presented pattern (dobj)
increase reported (amod)
number 12 (nmod)
occurring infiltration (nmod)
pravastatin of (case)
produce condition (dobj)
insecticide effects (nmod)
explain may (aux)
age 57 (nummod)
-13 7 (compound)
co-infection hiv (compound)
appears conclusion (nsubj)
administered injection (nmod)
nx and (cc)
nd 400.2+/-11.8 (conj)
2.4-fold p=0.004 (appos)
formation bfue (nmod)
haloperidol placebo (conj)
exclude . (punct)
needed caution (nsubjpass)
15 14 (compound)
exposure systemic (amod)
cross-over controlled (conj)
reported rates (dobj)
have reservations (dobj)
unknown however (advmod)
shown block (xcomp)
show and (cc)
achieve women (conj)
% 29.8 (nummod)
choose to (mark)
efficacy acid (nmod)
lesion this (det)
enrolment before (case)
compared rats (nmod)
is matter (advmod)
activity disease (compound)
swelling site (nmod)
difficult suggest (xcomp)
samples ratios (dep)
promotes decreases (conj)
dosage-dependent toxic (amod)
replication the (dep)
mecamylamine but (cc)
assessed related (advcl)
dose acute (amod)
transgene hypoxia-responsive (amod)
hydrocortisone injury (nmod)
condition placebo (appos)
decreased decreased (advcl)
goldstein berkowitz (conj)
retention efficacy (nmod)
management removal (nmod)
patient history (conj)
restarted drug (nsubjpass)
exemplified reports (nmod)
striatum agonist (conj)
one just (advmod)
relationship sfas (nmod)
completed ) (punct)
pathophysiology the (det)
contributing thereby (advmod)
noted dh (nsubjpass)
found observed (advcl)
documented were (auxpass)
medications properties (nmod)
resulted combination (nsubj)
km high (amod)
pulse steroid (compound)
3.9 at (case)
ptld disorder (dep)
products glycation (compound)
infections kidney (nmod)
adjustment with (nmod)
reduced incorporation (dobj)
encouraged changes (nmod)
reached % (dobj)
brain-mapping computational (amod)
induces : (punct)
injury chain (compound)
attest seriousness (nmod)
neurotoxic be (cop)
glomerular and (cc)
incidence syndrome (conj)
refractory are (cop)
monitored seizures (nsubjpass)
provoked patients (nmod)
quinine-sensitive k(+)-channels (dep)
synergy of (case)
mass muscle (compound)
concentrations sodium (compound)
mean cigarettes (nmod)
doxorubicin or (cc)
cancer cell (compound)
had episodes (dobj)
toxicity cy (compound)
o2- ( (punct)
hepatitis , (punct)
1,000/mm3 than (case)
mediated hyperammonemia (nmod)
evidence evidence (nmod)
observed of (case)
p-glycoprotein of (case)
caused protect (conj)
hypertrophy isoproterenol-induced (amod)
shock and (cc)
cyclooxygenase irreversible (amod)
nephropathy diabetic (compound)
eroded is (auxpass)
subjects 65 (nummod)
bladder irrigation (dobj)
admitted hypoxemia (conj)
hypothyroid clear (conj)
ph , (punct)
periods calculated (acl)
induction catatonia (nmod)
antagonize administration (nmod)
reducing provides (conj)
30 125 (conj)
value the (det)
men all (det)
begun reaction (nsubj)
ethambutol of (case)
associated suprofen (nsubjpass)
confirm do (aux)
had withdrawal (nmod)
age yrs (dep)
group blood (nmod)
factors important (amod)
changes compatible (amod)
stl1 tests (nmod)
dementia type (nmod)
defects patients (compound)
152+/-15 102+/-13 (compound)
mastodynia of (case)
titrated not (neg)
ncse ( (punct)
increases pressure (nsubj)
attenuated . (punct)
conducted evaluate (advcl)
1997 between (case)
headache release (conj)
rate orr (appos)
signs no (neg)
define causality (dobj)
neurotoxicity selective (amod)
obscure defined (conj)
experienced previously (advmod)
increased were (auxpass)
superior and (cc)
kidneys liver (conj)
macrolide antibiotic (dep)
showed later (advmod)
no between (case)
performance of (case)
valsartan both (cc:preconj)
stress leading (acl)
doses intermittent (amod)
employed with (case)
nsvt ( (punct)
induced thereafter (advmod)
methylphenidate on (case)
correct dose (nmod)
reversible deal (nmod)
combination treat (acl)
15 45 (conj)
acid oleic (amod)
determine feasibility (dobj)
recorded groups (nmod)
episodes these (det)
developed necrosis (nsubj)
overdoses from (case)
paroxetine combined (amod)
re-induced mg/m(2 (nmod)
brightfield- microscopy (conj)
convulsions therapy (nmod)
den ( (punct)
hypothesized contribute (ccomp)
which of (case)
benefit . (punct)
presented cells (nmod)
and significantly (advmod)
inhibited adriamycin (nsubj)
actions blocker (conj)
course tachycardia (nmod)
worsening with (case)
deterioration fields (nmod)
threshold co2 (compound)
transitioned , (punct)
strains both (det)
days 17 (conj)
have role (nmod)
3.0 : (punct)
consumers were (cop)
correlation close (amod)
ended period (nsubj)
topotecan ) (punct)
agents ibuprofen (appos)
affected region (nsubjpass)
indicate improves (ccomp)
points key (nsubj)
dose precurarizing (compound)
exclude we (nsubj)
decrease tension (nmod)
measures ten (nummod)
induced microangiopathy (nsubjpass)
clonus of (case)
effects multifarious (amod)
rechallenge after (case)
29.3 versus (cc)
therapy drug (compound)
mechanism hepatitis (nmod)
ought . (punct)
resulted or (cc)
survival 1-year (amod)
resistance systemic (amod)
properties ointment (nmod)
frequencies before (advmod)
risperidone = (amod)
puromycin of (case)
0.05 infusion (nmod)
exhibit apoptosis (dobj)
worsening symptoms (nmod)
subendothelial medial (conj)
hepatitis cytolytic (amod)
influence action (nmod)
homology receptors (nmod)
toxic is (cop)
duration twitching (nmod)
ml. 245 (compound)
n-methyl-d-aspartate : (punct)
conclusion seems (dep)
f in (case)
undertook fumarate (ccomp)
electroencephalogram their (nmod:poss)
alf=0/35 cld=2/34 (conj)
ua p<0.001 (appos)
suggest reduces (ccomp)
gene receptor (compound)
= .0006 (dobj)
striatum compared (acl)
suspected . (punct)
cent per (dep)
suppressed rhythms (nmod)
onset i.e. (advmod)
glycine of (case)
point enhancement (nmod)
protection icrf-187 (nmod)
monitoring episode (nmod)
metabolism to (case)
effects maximum (compound)
% follow-up (nmod)
mesna of (case)
efficacy treating (advcl)
manifestation and (cc)
qtls , (punct)
bupivacaine p. (compound)
inhibited moreover (advmod)
% sd (dep)
ldh ( (punct)
valproate encephalopathy (advmod)
dissociated acutely (advmod)
release including (case)
monkeys mptp-treated (amod)
deficits reversed (amod)
subgroups among (case)
8 than (quantmod)
warn . (punct)
basis observations (nmod)
isoform p58 (appos)
employed routinely (advmod)
co. . (punct)
frequency event (compound)
neurochemical and (cc)
study investigate (acl)
decreased hemorrhage (nmod)
decline major (amod)
rosacea 1 (conj)
depletion indicated (acl)
force the (det)
causes hypotension (dobj)
attenuate lower (conj)
increases appear (conj)
acid taurocholic (amod)
compound racemic (amod)
deleterious may (aux)
a on (case)
tested evidence (dobj)
maculatum from (case)
needed differentiate (conj)
identified receptor (dobj)
agents specific (amod)
clearance estimated (amod)
test echocardiographic (amod)
substance illicit (compound)
insertion and (cc)
sufficient treatment (nsubj)
siadh ) (punct)
patient male (amod)
examine contribution (dobj)
micrograms/dl 40 (nummod)
common subjects (nmod)
death until (case)
nephritis . (punct)
interfere establishment (nmod)
after shortly (advmod)
hydroxylase region (nmod)
estimated incidence (nsubjpass)
effects carcinogenesis (nmod)
motility content (conj)
authors many (amod)
catalepsy pallidus (compound)
reproducible was (cop)
effects survival (dep)
750 of (case)
began rats (nsubj)
pet on (case)
express p53 (dobj)
treatment corticosterone (compound)
illustrate , (punct)
palpitation electrocardiography (conj)
rats mi (compound)
collected included (conj)
leakage by (case)
gene associated (amod)
intensify l-noarg (nsubj)
male 23-y-old (amod)
criteria ] (punct)
antibodies factor (compound)
0.5%/12h timolol (amod)
beta t (compound)
pain admitted (acl)
arthralgia sensory (conj)
monitoring routine (amod)
sgk1 sgk1(-/- (appos)
course infection (nmod)
infectious and (cc)
angiography ventricular (compound)
positive nestin (amod)
osmolality maximum (amod)
causes drug (nsubj)
recall free (amod)
one alone (advmod)
metoprolol beta-ar (amod)
evidences protection (dep)
droplets onwards (appos)
assays forming (compound)
diminished then (advmod)
performed institutions (nmod)
gain potential (amod)
showed period (dobj)
bands alpha-sigma (conj)
measure indicator (conj)
had injection (dobj)
equation mark-howink-sakurada (compound)
stimulation t-cell (compound)
studied activity (nsubjpass)
progression to (case)
produced lesion (nsubj)
risk lowest (amod)
inhibited is (auxpass)
cells and (cc)
treated heparin (nmod)
dyskinesia in (case)
30 , (punct)
hb and (cc)
contributed ascitis (nmod)
quiescent has (aux)
contributed that (mark)
home with (case)
shock complete (conj)
developing recurrences (dobj)
disturbances . (punct)
included neurons (dobj)
selected regions (nmod)
visualized scintigraphy (nmod)
resorption bone (compound)
na(+ of (case)
sensitivity . (punct)
p-coumarate of (case)
factor angiogenic (amod)
amelioration . (punct)
treat years (nmod)
38 and (cc)
ruling thus (advmod)
compare users (dobj)
tricyclics by (case)
control disorder (dobj)
stage upon (case)
women % (compound)
wt to (case)
antigen-positive of (case)
bolus 2-minute (amod)
nephrosclerosis rats (nmod)
abundance an (det)
reduction sites (nmod)
normalized subjects (nmod)
patients four (nmod)
activation heart (nmod)
injection cyp (nmod)
factors microbleeds (nsubj)
time immobilization (compound)
high levels (nmod)
increases by (case)
aimed demonstrate (xcomp)
patient female (amod)
fluconazole of (case)
pharmacological and (cc)
expressed known (conj)
seizure reversed (acl)
brains the (det)
mechanisms for (case)
generated sulphate (nsubj)
recommend caution (dobj)
activation prolactin-induced (amod)
lung node (conj)
admissions 1.19/1,000 (compound)
patients month (dep)
ablated seizure-free (conj)
changes substantial (amod)
sinus cerebral (amod)
associated sedation (nsubjpass)
exposure without (case)
dysfunction liver (compound)
proteinuria for (case)
fluconazole oral (amod)
defined seizure (nsubjpass)
factors relative (amod)
dose-related . (punct)
rats libitum-fed (amod)
quantified were (auxpass)
hallucinations patient (compound)
overdose be (cop)
effects germany (nmod)
help prevent (xcomp)
therapy 131i (nsubj)
monitored toxicity (nsubjpass)
doses acceptable (amod)
noted outcomes (nsubjpass)
alter caffeine (nsubj)
revealed cultures (nsubj)
has ephedrine (nsubj)
30 +/- (cc)
consequences neurologic (amod)
harm reducing (amod)
ts l1210 (compound)
inputs somatosensory (amod)
perfusion-fixed brains (conj)
given test (advcl)
hyperkalemia of (case)
chicks sulfate-treated (amod)
found agreement (nsubjpass)
schedule treatment (compound)
age 60 (dep)
given 2nd (nmod)
was calcification (attr)
fell level (nsubj)
presented case (nsubjpass)
affinity glur5 (compound)
principle the (det)
cns effects (conj)
within-subject as (case)
found moreover (advmod)
tiapride 100 (nummod)
hyperprolactinemia of (case)
seven seven (conj)
presenting on (case)
studied weeks (nmod)
receiving december (nmod)
form with (case)
taken however (advmod)
displaying differently (advmod)
condition his (nmod:poss)
earlier were (cop)
blockers beta-receptor (compound)
nitroglycerin agents (conj)
effect anticoagulation (amod)
heparin lmwh (appos)
cancer prostate (compound)
neurotoxic model (nmod)
prevent induction (dobj)
set second (amod)
significant groups (nmod)
ketamine anesthetic (appos)
valdecoxib of (case)
vesicles containing (acl)
high- and (cc)
had mellitus (dobj)
valproate drug (compound)
and pathologically (advmod)
developed receiving (advcl)
noted rtms (nmod)
gain leukocytosis (conj)
groups different (amod)
attributed damage (nmod)
common t (nmod)
anencephaly of (case)
group chlorpheniramine (compound)
cessation tdf (nmod)
valdecoxib placebo (conj)
epilepticus study (nmod)
cholecystokinin-octapeptide cck-8 (appos)
donor the (det)
30 7.5 (conj)
toxicity macula (compound)
exposures risk (conj)
desogestrel i.e. (dep)
adrenoceptors-mediated beta (nmod:npmod)
corticosterone 200 (nummod)
series prophylaxis (compound)
implies ligation (dobj)
evaluated severity (dobj)
rats experienced (acl:relcl)
ratings immediate (amod)
tensions the (det)
inhibited % (nmod)
comparable would (aux)
target the (det)
liver muscle (conj)
consumption bupivacaine (compound)
red sirius (compound)
peptide or (cc)
established clearly (advmod)
users mb (nmod)
glioma meningioma (conj)
origin an (det)
months 24 (nummod)
emphasis the (det)
larger ( (punct)
rates different (amod)
medium culture (compound)
days expression (appos)
concerns primarily (advmod)
squealing bobbing (conj)
bladder dba/2 (nmod)
cause patient (nmod)
given dose (dep)
dynamics and (cc)
cycle subsequent (amod)
fps ) (punct)
pharmacokinetics tolerability (conj)
resulting grade (nmod)
counts platelet (compound)
increase any (nmod)
regardless diameter (nmod)
b-sodium amphotericin (compound)
pre- posttransplant (conj)
thyroidectomy radioiodine (conj)
predictors outcome (nmod)
result ischemia (nsubj)
episodes infectious (amod)
mmp-2 adam-17 (conj)
chemistry of (case)
desmin glomerular (amod)
stage interim (amod)
b12 between (case)
severity response (nmod)
replies questionnaires (nmod)
treated currently (advmod)
keeping appointment (compound)
failure periods (nmod)
returned visit (nmod)
clopidogrel antiplatelet (compound)
affected may (aux)
patients eligible (amod)
bmt ( (punct)
81.6 +/- (cc)
is investigate (xcomp)
mg/m2/wk . (punct)
bolus lidocaine (nmod)
solutions all (det)
data certain (amod)
found it (nsubjpass)
seems toxicity (nsubj)
treated methotrexate (nmod)
a-77636 > (dep)
timolol aqueous (amod)
uptakes increased (amod)
0.15+/-0.03/h od (nmod)
carboplatin administered (acl)
detected weeks (nmod)
patients psoriasis (nmod)
good has (aux)
treatment gr (nmod)
drugs seizures (nmod)
likely died (conj)
caused verapamil (nmod)
suggestive disease (nmod)
appears this (nsubj)
mechanisms identical (amod)
drg l6-s1 (compound)
8.4 3.5 (conj)
combination paclitaxel/cisplatin (compound)
available descriptions (nsubj)
dose anesthetic (nmod)
examined recurrences (nmod)
flecainide substrate (conj)
severity animal (nmod)
performed users (nsubj)
showed dnap (nsubj)
arthritis with (case)
min 22 (nummod)
indicate protects (ccomp)
intake d. (compound)
complication chemotherapy (nmod)
interval st (compound)
identified 1986 (nmod)
reduction study (acl)
rigidity generalized (amod)
odds % (compound)
causes glomerulonephritis (nmod)
associated while (mark)
service at (case)
subtypes alpha2abc-/- (dep)
3 greater (advmod)
region terminals (nmod)
antioxidant and (cc)
wish we (nsubj)
dilatation moderate (amod)
developed reproducibly (advmod)
longer s (advmod)
alters behaviors (dobj)
similar different (conj)
bolus standard (amod)
peptide typical (amod)
therapy no (det)
felt later (advmod)
catheters with (case)
male female (conj)
possesses bau (nsubj)
response better (amod)
administration dox (nmod)
lobe the (det)
patients 8,770 (nummod)
increased levels (nsubjpass)
followed . (punct)
treatment ( (punct)
acid brain (compound)
dose 10-micrograms/kg (compound)
observed females (nmod)
those evaluation (nmod)
underwent fusion (dobj)
supplement contribute (acl:relcl)
influenced melatonin (nsubj)
administered received (conj)
attenuation the (det)
safety for (case)
pattern developmental (amod)
epilepsies with (case)
months 13 (nummod)
agoraphobia with (case)
antagonist 5-hydroxytryptamine-3 (amod)
-21.3 ) (punct)
reversed dogs (nmod)
aminoglycosides furosemide (conj)
manageable clinically (advmod)
percent twenty-three (amod)
pellet wk (appos)
group p= (dep)
potassium normal (amod)
introduction one (appos)
gls in (case)
abandoned cases (nmod)
according , (punct)
24 of (advmod)
= 38 (dobj)
combined drugs (nmod)
women cancer (nmod)
incubated , (punct)
background found (appos)
anemia important (acl:relcl)
peroxidation erythrocytes (nmod)
ug/ml dose (dep)
curve serum (compound)
received hours (nmod:tmod)
increased re-infarction (nmod)
variation response (nmod)
therapy hd-mtx (compound)
december 2006 (nummod)
des ) (punct)
snp , (punct)
fibrosis subcapsular (amod)
n=92 respectively (advmod)
old since (mark)
treated 700 (nsubjpass)
novel 2',3'-dideoxy (dep)
vasculitis induced (amod)
hospitalization ami/gi (nmod)
injection rat (nmod)
drop % (compound)
l min (conj)
treated cream (nmod)
sn causes (acl:relcl)
stable long-acting (dep)
performed project (nmod)
pretreatment 2 (dep)
treated azidothymidine (nmod:npmod)
4.5 0.2 (conj)
consequences possible (amod)
synthesis n-pyrimidinyl-2-phenoxyacetamides (nmod)
damage , (punct)
cells , (punct)
synthesis for (case)
appears complication (nsubj)
had locomotion (nmod)
rise mm (nmod)
changes without (case)
exposure from (case)
action system (nmod)
period mmol/l (appos)
species oxygen (compound)
7alpha-hydroxylation acid (nmod)
given continued (conj)
trial atlas (compound)
developed commonly (advmod)
therapy seizures (nmod)
antagonize to (mark)
toxicity n (dep)
admitted she (nsubjpass)
hematuria of (case)
administration subcutaneous (amod)
ng/ml t (conj)
bound copolymers (nmod)
incorporate . (punct)
metronidazole , (punct)
lmwh on (case)
infarction thrombosis (nmod)
carboplatin neither (cc:preconj)
sd type (appos)
eyes normal (amod)
users in (case)
syndrome three (nummod)
patients placebo (amod)
junction at (case)
due presumably (advmod)
levels ao (appos)
biopsy on (case)
salivation behavior (appos)
excreted 14c (dobj)
lead derangements (nsubj)
colonies of (case)
resulting alterations (nmod)
occurred increase (nsubj)
professionals other (amod)
effect antidyskinetic (amod)
drugs not (neg)
prodrug . (punct)
limbs contralateral (amod)
development initial (amod)
cardioselective ( (punct)
doses required (acl)
obtainable longer (advmod)
attempt previous (amod)
% 57 (nummod)
reduced reduced (conj)
variation benefit (nmod)
complex prothrombin (compound)
detected analysis (nsubj)
three intravenous (amod)
assigned administration (nmod)
prevention retention- (nmod)
groups non-lithium-treated (amod)
polyuria chronic (amod)
months relative (amod)
injuries mediated (acl)
relationship toxicity (nmod)
patients scleroderma (appos)
analogue lamivudine (nsubj)
unconjugated absence (nmod)
getting in (mark)
data combined (amod)
temperature controlled (amod)
neurological hepatic (conj)
collection peripheral (amod)
formulations the (det)
cases established (amod)
able reverse (xcomp)
subunits enac (compound)
time of (case)
patients factors (conj)
discontinued after (mark)
received enalapril (dobj)
transplantation in (case)
hypertension systolic (amod)
maintaining hypertension (dobj)
found attenuate (xcomp)
cats mice (conj)
intoxication in (case)
on " (punct)
received or (cc)
resulted compared (dep)
obscure is (cop)
mk-486 i.v. (appos)
increased cisplatin (nmod)
mcg ) (punct)
similar both (nmod)
role modulating (acl)
avoid , (punct)
causing of (mark)
continued is (auxpass)
counseling , (punct)
prerequisite basic (amod)
alkaloid vinca (amod)
control agonists (conj)
drug to (case)
model rodent (amod)
hearing with (case)
aorta rats (nmod)
connections by (case)
cis-platin 5-fu (conj)
similar % (nmod)
produces . (punct)
heads nerve (compound)
participants all (det)
results different (acl:relcl)
paroxetine with (case)
500 - (punct)
discontinue avoid (conj)
concentration heparin (compound)
corresponded changes (nmod)
anemia with (case)
establish and (cc)
pregnancy during (case)
presents patient (dobj)
ingestion clz (nmod)
interstitium medullary (amod)
plan involved (advcl)
presented normal (conj)
4.3 +/- (cc)
course fluctuations (nmod)
variable response (compound)
agent activity (nmod)
abnormalities puromycin (compound)
materials cancer (nmod)
likely as (mark)
abnormalities gastrointestinal (amod)
dyslipidemia and (cc)
isoform protein (compound)
inulin clearance (conj)
trinitrate donor (compound)
cm diameter (nmod)
inhibited mmecs (nmod)
express gap-43 (dobj)
adaptation rats (nmod)
studies in (case)
fluorouracil with (case)
done investigate (xcomp)
comprised alternating (advcl)
mean evaluated (conj)
remains atin (nsubj)
restricted cause (advcl)
multiple often (advmod)
decreased weeks (nmod)
ami bleeding (acl)
exposure tobacco (nmod)
elevation abrupt (amod)
positive cultures (nsubj)
effects other (amod)
diabetes treated (acl)
acidosis gain (conj)
signs systemic (amod)
1998 2005 (prep)
51.7 4.5 (conj)
expressing egfp (dobj)
appeared starting (advcl)
dementia reversible (amod)
transaminase aspartate (compound)
tubules convoluted (amod)
discontinuation heparin (nmod)
cortices animal (nmod)
ngf pge2 (conj)
increased models (nmod)
has used (conj)
liver disease (conj)
provided has (aux)
opening dose (conj)
pain electrocardiogram (conj)
generated effects (nsubjpass)
polymorphisms and (cc)
min before (advmod)
min vs. (cc)
tolerated it (nsubjpass)
anthony st. (compound)
iu/kg ) (punct)
steroids hydrochloride (conj)
lobe to (case)
upregulation in (case)
hospital salvatore (compound)
persons diabetic (amod)
electromyogram nerve-conduction (conj)
accelerated synthesis/turnover (dobj)
sensitive who (nsubj)
seizures intractable (amod)
injected cocaine (nsubjpass)
increase angiography (nmod)
factor bfgf (appos)
revealed minutes (nmod)
confirmed has (aux)
increased u/ml (nmod)
98 10 (conj)
drug specific (amod)
reflex jaw-stretch (amod)
limited utility (nsubjpass)
lost consciousness (dobj)
monkeys male (amod)
hepatitis woman (nmod)
= 0.43 (dobj)
bradyarrhythmias of (case)
menorrhagia deterioration (conj)
a/j balb/cj (appos)
increases content (nmod)
mice a/j (compound)
speculate resulted (ccomp)
generates propagates (conj)
food this (det)
3tc 3tc (dep)
exposure to (case)
more is (cop)
actin muscle (compound)
allocated volunteers (nsubjpass)
injections erythropoietin (nmod)
protected conclusion (nmod)
recovery by (case)
effects activation (nmod)
mtor ) (punct)
microg ( (punct)
follow-up 1998 (dep)
factor cystitis (nmod)
pathway nigrostriatal (amod)
immunoblotting such (case)
binding rifampin (nmod)
proportion highest (amod)
seizure-free patients (nsubj)
kinase i (conj)
expected acetaminophen (advcl)
adducts mitochondria (nmod)
high mortality (nsubj)
unmask may (aux)
had experiences (dobj)
gene autophagy (compound)
interval occlusion (nmod)
failure right (amod)
delta that (mark)
controls angina (dobj)
deficit memory (compound)
patients scheduled (acl)
increase % (nmod)
improvement pain (nmod)
mistaken can (aux)
effective calcitonin (nsubj)
angioedema angiotensin-converting (amod)
present ; (punct)
fetus neonate (conj)
3657 was (cop)
administration orciprenaline (nmod)
build-up the (det)
control secretion (dobj)
irritation following (case)
altering hematocrit (dobj)
membranes basement (compound)
biopsies for (case)
percentage tdfs (nmod)
give warnings (dobj)
placed system (nmod)
asthma with (case)
hemorrhage sah (appos)
resulting failure (nmod)
plays generation (nsubj)
fatal % (nmod)
differ segments (nmod)
resulted incidence (nmod)
reported total (nsubjpass)
epinephrine combination (conj)
neurons hilus (nmod)
cxad and (cc)
flaccid were (cop)
al. cardona (compound)
= 48 (nmod)
received received (parataxis)
did analysis (dobj)
data suggesting (acl)
responses immediate (amod)
0.96 0.75 (conj)
dna hepatitis (compound)
effective treatments (nsubj)
developed refractory (dep)
agents i (nummod)
mz with (case)
increases p75(ntr)-ir (nmod)
lost pressures (nmod)
numbers small (amod)
each for (case)
busulfan faster (amod)
determined parallel (nmod)
atropine to (case)
aprotinin of (case)
subgroups risk (compound)
school , (punct)
blockers tested (amod)
phenylbutazone , (punct)
drug to (mark)
women majority (nsubj)
dose above (case)
implanting by (mark)
reaction aberrant (amod)
capsule under (case)
studies dh (appos)
59.8 of (case)
effects aconitine (nmod)
actions flurazepam (nmod)
cavity one (appos)
right and (cc)
sensitivity cells (nmod)
arrest cardiorespiratory (amod)
ml 2.5 (nummod)
able also (advmod)
arabic and (cc)
jg , (punct)
mean readmission (nmod)
loss functions (nmod)
examination full (amod)
has replication (nmod)
patients disturbed (amod)
size group (nmod)
using demonstrated (conj)
localized extensive (advmod)
choice patients (nmod)
died treatment (nmod)
unresponsiveness verapamil (nsubj)
degree efficacy (nmod)
introduction substances (appos)
serositis and (cc)
randomized then (advmod)
anesthetized . (punct)
administration urd (compound)
potential rats (nmod)
54 20 (compound)
history symptoms (nmod)
had nitrite (nsubj)
college american (amod)
% ci=8.4%-14.3 (compound)
oxprenolol by (case)
defect may (aux)
role learning (nmod)
benefited 19 (dobj)
expression pro-apoptotic (amod)
conclusion predict (appos)
red perfused (amod)
epileptogenesis generation (nmod)
institution our (nmod:poss)
postulate case (nmod)
ratios rate (compound)
years 80 (nummod)
discontinuous , (punct)
assigned normotensive (nsubjpass)
revealed , (punct)
excluded could (aux)
developed rats (nmod)
course longitudinal (amod)
marker reaction (nmod)
expression cd36 (compound)
drug is (cop)
synthesis cardiomyocyte (compound)
myelitis both (cc:preconj)
effect tremor (appos)
bladder from (case)
ms 114+/-4 (nummod)
bypass cpb (appos)
quetiapine by (case)
involved synthesis (nmod)
hysterosalpingography of (case)
pulmonary occurring (dep)
accepted proven (conj)
offers methylprednisolone (nsubj)
ratings injection (nmod)
documented occlusion (dobj)
associated withdrawal (nsubjpass)
pain lancinating (amod)
conclusions active (appos)
persistence amnesia (nmod)
increase neither (cc:preconj)
ctnt mass (conj)
those mm3 (nmod)
achieved response (dobj)
vsd of (case)
progression further (amod)
followed this (nsubjpass)
showed stenosis (dobj)
cope disease (nmod)
collected assays (nmod)
attributed reasonably (advmod)
tension milligram (nmod)
tests serologic (amod)
seizure-prone seizure-resistant (conj)
resulted rarely (advmod)
agents all (det)
nausea because (case)
conclude intermediate (ccomp)
verapamil equipotent (acl:relcl)
percent 85 (nummod)
unaffected . (punct)
enhanced bupivacaine (nmod)
pharmacokinetic pharmacodynamic (conj)
developed , (punct)
order be (cop)
19.3 mean (dep)
substrates brain (compound)
present hygiene (nmod)
antagonist bn (conj)
step ( (punct)
4 more (conj)
in sgk1(+/+ (dep)
collagen iii (nummod)
factor doses (appos)
reviewed and (cc)
jaundice associated (conj)
end responders (nmod)
screening with (mark)
turnover noradrenaline (nmod)
tomography spect (appos)
exerts urethra (conj)
effect intoxication (nmod)
hyperactivity parahippocampal (amod)
rule general (amod)
group water (nmod)
sites [3h]spiperone (compound)
led recognition (nmod)
changes pressure (compound)
reduced addition (nsubj)
webster male (amod)
erythrocytes from (case)
necrotizing treatment (nmod)
indicators , (punct)
ear inner (amod)
associated papaverine (nsubjpass)
rescues and (cc)
inhibition induced (acl)
frequency grading (conj)
functions t-cell (compound)
b2 of (case)
mm 7 (nummod)
study mg (appos)
biopsies mucosal (amod)
placebo enalapril (conj)
involvement leukemic (amod)
rats long-evans (amod)
independent quality (nsubj)
cholecystectomy at (case)
dopamine-1 specific (amod)
administered limits (nmod)
hypotension on (case)
patients unrelieved (acl:relcl)
surgeries iop-lowering (amod)
rois drawn (acl)
mg/dl 4.7 (nummod)
receptors prejunctional (amod)
switchers third (nmod)
leftward with (case)
cm 1.5 (nummod)
ill physically (advmod)
caused tricyclics (nmod)
immunohistochemistry viii (compound)
associated intrinsically (advmod)
role electroencephalogram (nmod)
month per (case)
clinical studies (dep)
photodistribution telangiectasia (nmod)
enzymes necrosis (conj)
lymphocytes with (case)
headache nausea (nmod)
performance alternation (compound)
suppressed treatment (nmod)
normalized cbd (dep)
effects primates (nmod)
2 for (case)
disease repair (nmod)
14.3 only (advmod)
published literature (nmod)
bicuculline k-8644 (conj)
slope line (nmod)
subgroups analysed (amod)
mm with (case)
examination count (nmod)
obstetric in (case)
area retrobulbar (compound)
inhibited cbz (nsubj)
helpful was (cop)
renin 16 (nummod)
free radical (dep)
failure examination (conj)
titrated can (aux)
cisplatin given (acl)
death transplantation (conj)
n=26 ) (punct)
ranged % (dep)
act systems (nmod)
enhances hyperthermia (nsubj)
attenuated hypotension (dobj)
3.7 1.1 (conj)
consumption paracetamol (amod)
useful monkey (nmod)
production cells (nmod)
edition fourth (compound)
cardiotoxicity of (case)
decreased elevation (nsubj)
maintaining of (mark)
comparisons four (nummod)
oab ( (punct)
eleven none (conj)
event hallucinations (nsubj)
seizure induction (dobj)
efficacy the (det)
decrease density (nmod)
tolerability sodium (compound)
glycopyrrolate with (case)
increases stress (nmod)
used induce (xcomp)
third-generation desogestrel (dep)
system iprk (compound)
dexamethasone vtd (appos)
mg/kg 180 (nummod)
weeks aged (amod)
selectivity tissue (compound)
micrograms 7.7 (nummod)
l. sativus (compound)
meshwork tm (appos)
provision interventions (nmod)
hypertension lnna (compound)
woman disease (nmod)
using haloperidol (dobj)
changes caudate (nmod)
pathway outflow (compound)
induced ptz (nmod)
relieved improve (conj)
marker clearance (conj)
days 9 (nummod)
glutamatergic gabaergic (conj)
patients high-risk (amod)
hydration discontinuation (conj)
peg 400 (nummod)
mccarthy ; (punct)
cefonicid cefazedone (conj)
blocker channel (compound)
do , (punct)
people 232,390 (nummod)
groups 1 (nummod)
finding well-established (amod)
data pressure-volume (amod)
receiving dialysis (dobj)
carcinoma hepatocellular (amod)
diameters cacl(2)-treated (nmod)
reversed significantly (advmod)
observed weeks (nmod)
infection for (case)
development patients (nmod)
effects parp (dep)
using sutures (dobj)
synergistic doses (nsubj)
diagnosed been (auxpass)
microinjection mk-801 (nmod)
reduced stress (nsubjpass)
contents etodolac (compound)
ligand of (case)
outcomes patients (nmod)
appear there (expl)
dormex of (case)
reaction lethal (amod)
s to (case)
reduced limbs (nmod)
grade ) (punct)
remained a-actinin (nsubj)
patients unable (acl:relcl)
interaction venlafaxine-maoi (amod)
peak ) (punct)
deserve may (aux)
increased risk (nsubj)
odds in (case)
frequency stratified (acl)
diagnosed basis (nmod)
acid on (case)
gnc92h2 , (punct)
detected analysis (nmod)
unclear significance (nsubj)
probe digoxigenin-labeled (amod)
adopted treatment (nsubjpass)
l-dopa+benserazide ( (punct)
mol/l 10(-3 (compound)
studies serial (amod)
dysfunction node (compound)
sham vcm (conj)
utility treatment (nmod)
remainder the (det)
etoricoxib patients (nmod)
made : (punct)
induction response (nmod)
antidepressants tri (appos)
pathological-process be (cop)
disappear : (punct)
therapy treatment (nsubj)
etoposide chemotherapy (dep)
children 40 (nummod)
preventing for (mark)
secondary cardiomyopathy (nmod)
certain : (punct)
cr n=5 (dep)
reshaping possible (amod)
pai-1 ( (punct)
lower mcc (nsubj)
therapy drugs (nmod)
pronounced response (nsubjpass)
established group (dep)
cases days (nmod)
mg./kg 200 (nummod)
o2- ) (punct)
affection primary (amod)
indolamines pineal (compound)
modifications those (nmod)
methods reaction (compound)
precipitated can (aux)
pill on (case)
values increased (amod)
mood somnolence/depressed (amod)
depressants anesthetics (nmod)
higher risk (nmod)
steatosis liver (nmod)
= 2032 (dep)
presentation . (punct)
therapies phenotypes (nmod)
0.96 ( (punct)
correlation direct (amod)
analysis changes (nmod)
accompanied reduction (nmod)
inhibit tissues (nmod)
confirmed are (auxpass)
achieve diagnosis (dobj)
appointments their (nmod:poss)
consisted cessation (nmod)
importance ca(2 (nmod)
observation microscope (nmod)
therapy medications (conj)
difficult administration (nsubj)
resulted determine (conj)
3.0+/-0.4 mg/l (dep)
sustained treatment (nmod)
reports anecdotal (amod)
count , (punct)
different level (nsubj)
convert fibrillation (dobj)
data literature (nmod)
toxicities . (punct)
diameters/bw lv (compound)
added encephalopathy (nsubj)
disease subjects (nmod)
measure baseline (compound)
methotrexate high-dose (amod)
csa or (cc)
analgesic any (det)
relation in (case)
zones wrinkling (conj)
clinical myriad (nsubj)
microliters/min 103 (nummod)
different that (nmod)
delivers dose (nsubj)
preserves hypotension (nmod)
dosages cm (nmod)
dynamics cardiovascular (amod)
volume hematoma (compound)
immediate and (cc)
cases even (advmod)
treated preoperatively (advmod)
magnitude by (case)
risk discontinuations (nmod)
had audiograms (dobj)
model ulcer (compound)
bladder type (nmod)
inhibited naloxone (nsubj)
repair without (case)
part a (det)
% ci (nummod)
specify which (nsubj)
acidosis had (amod)
g/kg ) (punct)
investigating for (mark)
antagonists hyperactivity (nmod)
microelectrodes kcl (compound)
november , (punct)
metoprolol antagonist (compound)
groups isolated (conj)
establishes model (dobj)
free nad-precursors (nmod)
improved follow-up (nmod)
predominate mask (conj)
beraprost oral (amod)
effect striking (amod)
began after (mark)
discharge patients (nmod)
stage cancer (nmod)
showed 18.4 (conj)
present not (neg)
nystagmus nicotine-induced (amod)
served controls (nmod)
support this (dobj)
rate , (punct)
jitteriness " (punct)
didanosine hydroxyzine (conj)
discontinued trial (nsubjpass)
questions use (dobj)
factors were (cop)
binding naloxone (conj)
developed percent (nsubj)
characterized we (nsubj)
expression to (case)
maximize ratio (dobj)
complications of (case)
curves displacement-time (compound)
aiming avoid (xcomp)
focal segmental (dep)
ratio akbr (dep)
shortening percentage (compound)
implicated hypertension (nmod)
alpha t (compound)
effusions bilateral (amod)
psychosis and (cc)
offer can (aux)
7 respectively (advmod)
supranuclear palsy (dobj)
reported diarrhea (dep)
caused epinephrine (nsubj)
effects behaviors (nmod)
diseases heart (compound)
reached contrast (nmod)
mug 500 (nummod)
revealed remained (advcl)
responses subjects (nmod)
sinusitis acute (amod)
analysis additional (amod)
colitis and (cc)
message prodrug (dep)
tolerability etoricoxib (nmod)
course special (amod)
play step (nmod)
level elevated (amod)
given subcutaneously (advmod)
photodistribution the (det)
based was (auxpass)
mg/m2 2600 (nummod)
sodium acc-9653 (compound)
spots 67 (nummod)
carvedilol by (case)
td n (dep)
changes dgc (nmod)
reviewed design/methods (dep)
sitting in (mark)
delay onset (nmod)
od higher (amod)
pain increasing (amod)
causes elevates (conj)
fatal recognized (advcl)
micromol/l. 30 (nummod)
antidotes of (case)
uses multiple (amod)
reported cases (nmod)
risk noncompliance (nmod)
used ketamine (nsubjpass)
proteinuria blockade-induced (amod)
agent any (det)
wrinkling ischemic (amod)
stabilizer/rigidifier hemisuccinate (acl:relcl)
hypothesis contributes (ccomp)
organization (who)-recommended (punct)
dosage caco3 (compound)
patients attack (nmod)
buprenorphine and (cc)
diagnosis methamphetamine (nmod)
exposed highly (advmod)
differences radioactivity (nmod)
amplitudes emissions (nmod)
provides . (punct)
= 41 (dep)
reversible which (nsubj)
factor hormone (compound)
sequelae no (neg)
0.84 - (punct)
presentation typical (amod)
examined accelerated (conj)
lesions demarcated (amod)
mcpp ) (punct)
implications practical (compound)
specimens transplants (nmod)
fibrillation recent-onset (amod)
host immunocompromised (amod)
toxicity (ami)-induced (amod)
0 , (punct)
male heroin-dependent (amod)
therapy chloroquine (compound)
groups terms (nmod)
users gestodene (nmod)
age years (dep)
identifying group (dobj)
extent days (nmod)
clopidogrel with (case)
users pills (nmod)
protect not (neg)
mg/dl of (case)
provide support (dobj)
precise similarly (advmod)
stain gram (nmod:poss)
guard national (compound)
altered is (auxpass)
thrombocytopenia thromboembolism (conj)
35.9 to (case)
factor known (amod)
dose fentanyl (nmod)
attributable effects (nsubj)
performed minutes (nmod)
cyclophosphamide to (case)
drawbacks lead (acl:relcl)
weeks therapy (nmod)
proteins trifluoroacetyl-altered (amod)
resolved reduction (nmod)
period off (case)
activity plasma (compound)
neurotoxicity close (amod)
avoidable possibly (advmod)
pretreatment h (dep)
resulted damage (nmod)
saline-treated ) (punct)
consisted movement (conj)
traits , (punct)
factor to (mark)
appear nicotine (nsubj)
degree rate (nmod)
threshold the (det)
enhanced had (conj)
cases out (case)
epilepticus following (case)
ls and (cc)
level abnormal (amod)
findings , (punct)
man a (det)
measurements one (conj)
remains today (nmod:tmod)
episodes of (case)
obvious patients (nmod)
included nausea (dobj)
examinations neuro-ophthalmologic (amod)
% 11.8 (nummod)
frs generated (acl)
dealt study (nsubj)
versions test (nmod)
re-induced days (nmod)
personnel the (det)
factors three (nummod)
lds ) (punct)
efficacy mc (nmod)
have potential (dobj)
observations a (det)
underwent coronary (dobj)
5-ht metabolite (conj)
matrix their (nmod:poss)
diet day (nmod)
learn to (mark)
glepp1 ( (punct)
prevent impairment (dobj)
died transplant (nmod)
older patients (nsubj)
tolerant less (advmod)
hypotension including (case)
authors review (compound)
chorea fever (conj)
completed days (dep)
mechanism one (nummod)
received transplants (dobj)
changes potential (amod)
8,000 to (dep)
anaesthetized halothane (nmod)
rats prazosin-pretreated (amod)
type lymphoma (nmod)
slow inward (dep)
boluses 4 (dep)
cardiomyopathy haart-induced (amod)
uneventful were (cop)
colocalized marker (nmod)
one bendrofluazide (appos)
acid (2r,4r)-4-aminopyrrolidine-2,4-dicarboxylate (punct)
reverse sedation (dobj)
anesthesia . (punct)
levels significant (amod)
filling pyeloureteral (nsubj)
occlusion the (det)
petechiae purpura (conj)
cases about (case)
change did (conj)
monitored closely (advmod)
treated disulfiram (nmod)
party council (compound)
atropine adrenaline (conj)
range ; (punct)
find involved (ccomp)
levels vpa (compound)
caution use (nmod)
doses an (det)
agents seizure-inducing (amod)
0.5 mg (dep)
co-treatment unrelated (conj)
properties physicochemical (amod)
x ( (punct)
characterized dysfunctions (nmod)
proved histologically (advmod)
immunosuppression enable (acl)
months artery (compound)
coxii , (punct)
group age (compound)
occurs synthesis (nmod)
inhibition patients (nmod)
protective continuously (advmod)
with or (cc)
small likely (conj)
unknown frequencies (nsubj)
p=0.345 ) (punct)
by-product the (det)
useful work-ups (nsubj)
predisposed him (dobj)
found has (aux)
disease % (appos)
bolus single (amod)
mechanism to (case)
toxicity and (cc)
drug- a (det)
less being (cop)
separated depending (prep)
lithium and (cc)
pretreatment increases (conj)
reduced baseline (advcl)
processes molecular (amod)
nociceptin , (punct)
e-1 ( (punct)
therapy vinorelbine (nmod)
regard reductions (nmod)
unnecessary adjustment (nsubj)
introduced decade (nmod)
permeability penetration (conj)
centre melbourne (compound)
affected polyneuropathy (nsubj)
discontinued therapy (nsubjpass)
cuff anesthesia (nmod)
presented sensation (dobj)
produced measurements (dobj)
onset subacute (amod)
severity p (dep)
illustrates . (punct)
administration treatment (nmod)
patients responses (nmod)
mea and (cc)
observed dose-responses (nsubjpass)
4 . (punct)
completed year (nmod)
measures neuropsychological (amod)
effect maintaining (compound)
rate tumor (compound)
features resembling (acl)
included lived (conj)
veins vein (appos)
valdecoxib the (det)
difference for (case)
symptoms study (conj)
= 212 (dep)
protection maximal (amod)
p53 or (cc)
generation free (amod)
dysfunction induced (amod)
treatment verapamil (compound)
sdrr ) (punct)
suppression parp-1 (compound)
therapy methotrexate (compound)
pg/ml 40 (nummod)
effects antidopaminergic (amod)
non-users aspirin (nmod)
pattern presence (nmod)
3.0 ) (punct)
cholinergic of (case)
effect tcr (nmod)
hepatomas this (det)
setting network (dobj)
events regarding (case)
interna gpi (appos)
increases compared (acl)
% 46 (nummod)
highlight treatment (dobj)
used controlling (advcl)
sgot values (conj)
mg/d 80 (nummod)
hemorrhagic had (conj)
given busulfan (nsubjpass)
120.04 27.37 (conj)
increase 5-fold (amod)
effects cardiomyopathy (nmod)
concentrations drug (compound)
taking clozapine (dobj)
tests rast (conj)
series patients (nmod)
have chance (dobj)
conjunction transplantation (nmod)
improved mice (nmod)
microscopy immunofluorescence (conj)
levetiracetam with (case)
oltx an (det)
screening significance (dep)
cisapride substrate (appos)
decrease mild (amod)
received seven (nsubj)
severe that (mark)
mg/m(2 60 (nummod)
leads symptoms (nmod)
risks vs (cc)
n sarcoma (conj)
demonstrate behaviors (dobj)
registered inhaled (ccomp)
complete , (punct)
symptoms reactions (nmod)
had administration (nsubj)
5 stroke (nmod)
jersey nonpregnant (amod)
characterized morphologically (advmod)
octreotide treatment (appos)
learn response (dobj)
di drug-induced (amod)
associated adults (nmod)
single a (det)
categorized . (punct)
ability read (acl)
a fk506-binding (conj)
revealed obscure (conj)
users therapy (compound)
lesions cutaneous (amod)
admission during (case)
lids ) (punct)
detection chromatography-electrochemical (amod)
propranolol and (cc)
absent and (cc)
imaging ) (punct)
ligand ( (punct)
performed normalization (nmod)
diabetic (stz)-induced (amod)
reported 1993 (punct)
high particularly (advmod)
dose thalidomide (compound)
symptoms further (amod)
change presence (nsubj)
testing serologic (amod)
factors associated (acl)
days groups (nmod)
rats fucoidan-treated (amod)
conducted we (nsubj)
develop long (advmod)
hypotension similar (amod)
dyscrasias neutropenia (appos)
l-dopa 1.68 (nummod)
factor pathogenetic (amod)
re-exposure while (mark)
spread . (punct)
proarrhythmia use (nmod)
granulomas with (case)
stress injury (nmod)
weights , (punct)
care particular (amod)
mg iv (dep)
angiography fundus (case)
assessed . (punct)
antagonizes propranolol (nsubj)
levels erk1/2 (conj)
mask via (case)
concerned are (cop)
overdose a (det)
cystitis patients (compound)
process assurance (compound)
disease n (dep)
eads frequent (amod)
described newborn (nsubjpass)
similar days (nmod)
complication life-threatening (amod)
manual disorders (nmod)
innervation intact (amod)
assessed days (dep)
improved stiffness (nsubj)
reduced doses (nmod)
methods examined (appos)
implanted rats (nsubjpass)
patients cases (nsubj)
hypocalcemia one (nummod)
pseudoacromegaly of (case)
response associated (acl:relcl)
10,000 1 (compound)
underlying development (dobj)
infarction cocaine-induced (amod)
proven is (auxpass)
modulation states (nmod)
accumulation the (det)
decrease size (nmod)
mg mg (dep)
report our (nmod:poss)
b. amphotericin (compound)
area group (nmod)
days busulfan (nmod)
injury brain (compound)
efficacy group (nmod)
suggest interaction (dobj)
1 30 (prep)
0.8 +/- (cc)
degeneration media (compound)
form on (case)
feature major (amod)
paramethasone triniol (appos)
processor image (compound)
netilmicin 78 (dep)
testing toxicity (compound)
man 23-year-old (amod)
steatosis including (case)
disappeared rhythm (nsubj)
complexes two (nummod)
50 than (advmod)
conclusion efficient (appos)
radiation chemotherapy (conj)
suffered had (aux)
sought study (nsubj)
amount solution (nmod)
tests ( (punct)
sites cancer (compound)
goal studies (nmod)
administrations repeated (amod)
fibrosis of (case)
children cases (conj)
changes no (det)
features florid (amod)
rubella % (appos)
antagonist 5-ht1b (compound)
cisplatinum and (cc)
caused verapamil (nsubj)
prolapse developed (acl:relcl)
clonidine after (case)
action direct (amod)
nimodipine nimo (appos)
antagonists concomitant (amod)
solution elliott (nmod:poss)
31 14 (conj)
channel k(+ (compound)
busulfan mg/m2 (compound)
restarted patient (nsubjpass)
l-alpha-gfc p.o. (conj)
disorder associated (amod)
dihydrochloride n'-dibenzhydrylethane-1,2-diamine (compound)
monkeys exposure (nmod)
scale on (case)
background led (appos)
impairment haloperidol (nmod)
ml/min 0.86 (nummod)
peak hours (nmod)
area in (case)
users prior (amod)
anemia on (case)
most compared (case)
actions nh4ac (nmod)
publications recent (amod)
set experiments (nmod)
angioedema inhibitor (compound)
weeks combination (nmod)
levels urinary (amod)
determination size (nmod)
analyses in (case)
1 3 (conj)
studied patients (dobj)
hearing thresholds (dobj)
providers care (compound)
decreased impressively (advmod)
thickness slice (compound)
fertility libido (conj)
drug able (amod)
factors be (cop)
considered tolerable (xcomp)
d2 d3 (conj)
oxytocin the (det)
apnoea attempted (acl)
provide indicate (conj)
treated already (advmod)
ci 7.11 (nummod)
decrease behavior (nmod)
= antagonist (nsubj)
medline ( (punct)
effect associated (acl:relcl)
was determine (xcomp)
elicit will (aux)
alter can (aux)
exposure cocaine (compound)
been although (mark)
form a (det)
quantitated hypertension (nmod)
ratio stroke (nmod)
contributing failure (nmod)
novel and (cc)
conclude pge(2 (ccomp)
clozapine such (case)
biopsy percutaneous (amod)
need treatment (nsubj)
tests spasm (compound)
mg/kg rate (appos)
adrenoceptor beta-2 (compound)
aminotransferase and (cc)
animals lesioned (amod)
models coadministration (appos)
mg 0.225 (nummod)
injection suxamethonium (nmod)
3.6 and (cc)
seizures strokes (conj)
half patients (nmod)
reversal resulting (acl)
percent ninety-five (amod)
included stained (conj)
reduced intensity (dobj)
h2o2 elevated (amod)
has questioned (conj)
crea 15 (nummod)
indicated reduction (nmod)
replaced methylphenidate (nsubjpass)
hepatitis exposure (nmod)
epilepsy suspected (amod)
nodule of (case)
p=0.037 ( (punct)
brigham hospital (conj)
alf=0/35 , (punct)
fed rats (dobj)
responsiveness hormone (nmod)
allowed attribution (dobj)
experiences gi (compound)
evinced phenobarbital (nmod)
mg lovastatin (nmod)
perception thresholds (conj)
started resolved (conj)
stability gait (conj)
translocation 1,3-butadiene (amod)
days median (appos)
impact veins (nmod)
developed lymphoma (dobj)
duct a (det)
presenting reaction (nmod)
ro4368554 selective (amod)
increase : (punct)
developed eruptions (dobj)
mm 78 (nummod)
shr g (appos)
dna in (case)
upregulation obvious (amod)
hr metoprolol (nmod)
infusion noradrenaline (nmod)
induced may (aux)
characteristics following (amod)
models multiple (amod)
set 1 (dobj)
alteration that (mark)
( + (dep)
evaluated importance (nsubjpass)
level level (conj)
enhanced changes (nsubjpass)
had glomerulosclerosis (nmod)
episode in (case)
pontine and (cc)
monohydroxyethylrutoside the (det)
signaling by (case)
impairment associated (acl)
application tacrolimus (nmod)
effect verapamil (nmod)
withdrawal without (case)
showed yet (cc)
sets two (nummod)
3e 14 (nummod)
level basal (amod)
doses pethidine (nmod)
do so (advmod)
episode second (amod)
progressed css (nsubj)
abnormalities consistent (amod)
recognized . (punct)
provide delirium (nsubj)
temocapril inhibitor (conj)
mm n (appos)
22/11 11/6 (quantmod)
rare introduction (dep)
cdc ) (punct)
exposure arsenic (compound)
position squatting (amod)
evaluated quetiapine (dobj)
avoided can (aux)
cells neurons (nmod)
administration space (nmod)
step at (case)
962 vs (cc)
ruled and (cc)
smaller not (neg)
analysis samples (nmod)
rizatriptan after (case)
reduces vivo (advmod)
90/htn and (cc)
blue g-1 (dep)
interrelationship anatomical (amod)
remedy to (mark)
reverse discontinuation (nmod)
rate woman-years (nmod)
sensitivity differential (amod)
reports cases (nmod)
-50 -79 (conj)
cyclohexyl]benzeneactemide trans-3,4-dichloro-n-methyl-n[2-(1-pyrrolidinyl (compound)
collected intake (advcl)
enzymes patterns (conj)
limit myelosuppression (compound)
included line (nmod)
structural functional (conj)
cd-832 and (cc)
processed images (nsubjpass)
toxicity liver (compound)
inhibition naa (nmod)
dosage-dependent behavioral (dep)
diagnosed cancer (nmod)
attempted and (cc)
ifo acting (acl)
phenotype " (punct)
during after (conj)
epileptogenesis deficits (conj)
% 0.24 (nummod)
potentials visual (amod)
dose small (amod)
discussed results (nsubjpass)
effects suppressant (amod)
infants schoolchildren (nmod)
levels calcitonin (compound)
treatment high (amod)
skeptical , (punct)
making difficult (ccomp)
likelihood drowsiness (nmod)
barrier of (case)
reports leukoencephalopathy (nmod)
formation successive (amod)
doses parenteral (amod)
long involved (conj)
subscale scale (nmod)
estimated response (nsubjpass)
10 of (case)
assessed methods (nsubjpass)
erection is (cop)
advocate administration (dobj)
anticoagulant oral (amod)
measured diameters (nsubjpass)
period minutes (nmod)
from 2002 (nmod)
consequence be (cop)
inhibitors fluvastatin (conj)
modulation their (nmod:poss)
sarcoma in (case)
connecting tubule (dobj)
prevention ) (punct)
subject whether (mark)
smad3 phosphorylated (amod)
received insulin (dobj)
occurred trh (nmod)
er from (case)
polytherapy following (case)
receiving fenfluramine-phentermine (dobj)
presented anaesthetic (nmod)
different levels (nsubj)
nausea drowsiness (conj)
produces involved (conj)
regimen once-daily (amod)
leading delay (nmod)
c t3n0m0 (appos)
analysis interim (amod)
submitted reduction (nmod)
mg/day . (punct)
similar concentration (nmod)
avp ) (punct)
assessed eyes (dobj)
bmd spine (nmod)
reaction as (case)
350 - (punct)
receptor sirna (nmod)
actions given (acl)
arrest cycle (compound)
administration nanoparticles (compound)
level this (det)
fall blood-pressure (nmod)
hepatic cytochrome (conj)
discontinued therapy (dobj)
ability with (case)
risk risk (dep)
had asynergy (nmod)
morbidity or (cc)
disappearance to (case)
ratings symptoms (conj)
deletion receptor (nmod)
apex midventricle (conj)
ester 3-hydroxymethyl-5,5-diphenylhydantoin (nmod)
increasing association (nmod)
pet ) (punct)
additive or (cc)
remained functions (nsubj)
myoclonic seizures (conj)
drugs chelating (amod)
10mg/kg of (case)
noted deposits (nsubjpass)
transport impeded (amod)
dimension left (amod)
synthase-1 e (compound)
12- ( (punct)
disturbances in (case)
trial/day ) (punct)
showed withdrawal (nmod)
long-term over (case)
echocardiography two-dimensional (amod)
microg/kg/min . (punct)
patients second-line (amod)
gaba(a ( (punct)
expression coxii (compound)
nephropathy recurrent (amod)
patient no (neg)
admitted and (cc)
bf ) (punct)
assigned volunteers (nsubjpass)
anaphylaxis oral (amod)
collection assessed (parataxis)
patients 630 (nummod)
paranoia cocaine-induced (amod)
discharged , (punct)
subgroup patients (nmod)
splenic both (cc:preconj)
report one (dep)
present that (mark)
implicated defects (nsubjpass)
deterioration thrombosis (conj)
initiated we (nsubj)
microm diphosphate (nmod)
probable possible (conj)
g doses (nsubj)
women nineteen (nummod)
significant which (nmod)
novel , (punct)
revealed had (ccomp)
anaesthesia group (nmod)
end dose (nmod)
v/v ) (punct)
day once (case)
exert d2 (nsubj)
defined conditioning (nmod)
indicated correlated (conj)
compared outcomes (dobj)
indicating secretion (dobj)
desipramine alone (advmod)
sampling after (case)
sc 0.5 (nummod)
rate ) (punct)
users , (punct)
years 69.9 (nummod)
necessary treatment (nmod)
necrolysis of (case)
showed since (mark)
complication delayed (amod)
recognize measure (xcomp)
had response (dobj)
exhibited bradydysrhythmias (dobj)
others two (nummod)
precipitated methylphenidate (nsubj)
exposure development (conj)
hepatic p450 (conj)
acid to (case)
protected mice (nsubjpass)
hours a (det)
groups carbetocin (nmod)
epinephrine treatment (dep)
later , (punct)
finding frequent (amod)
condition overall (amod)
corrected and (cc)
related fenfluramines (nsubj)
studies mechanistic (amod)
decreased ecstasy (nmod)
impairing thus (advmod)
% rate (nsubj)
taking . (punct)
observed immunoreactivity (nsubjpass)
autophagy on (case)
documented required (conj)
kidney in (case)
nsclc metastatic (amod)
developed paradoxically (advmod)
consumed prevented (dep)
differs erythromycin (nmod)
expression form (nmod)
exposed diethylstilbestrol (nmod)
developed neutropenia (ccomp)
tacrolimus steroids (conj)
initiating reflex (dobj)
addition doses (nmod)
screening newborns (nmod)
administered has (aux)
performance cardiac (amod)
abnormalities such (amod)
compartment intracellular (amod)
induce irrigation (nsubj)
equipment tape (nmod)
synthesis secretion (conj)
improvement immediate (amod)
diffusely more (advmod)
leak bbb (nmod)
female being (cop)
drugs dna (compound)
support massive (amod)
patients effects (conj)
examine induced (conj)
higher two (nmod:npmod)
increased yields (nsubj)
cilostazol potent (amod)
presented mainly (advmod)
toxicity caffeine (compound)
compressed to (mark)
dg ) (punct)
onset early (amod)
hyperthermia ( (punct)
visits patient (nmod)
dm of (case)
cancer both (cc:preconj)
damage function (conj)
thromboembolic and (cc)
utilized dextran (nsubjpass)
risks n=283 (appos)
tested patients (nmod)
syndrome takotsubo (compound)
added should (aux)
occurring hamartoma (nsubj)
abundant observed (parataxis)
related trimipramine (nsubj)
nigra snr (appos)
demonstrated studies (nsubj)
indicated density (nsubjpass)
dose-related were (auxpass)
had pregnancy (dobj)
reports linking (acl)
experienced total (dobj)
effects induction (nmod)
10 , (punct)
months 47 (nummod)
determinant not (neg)
episodes patients (nmod)
report lesions (conj)
withdrawn suggested (advcl)
persisted performed (advcl)
increased post-administration (ccomp)
pattern damage (nmod)
measured parameters (nmod)
severity damage (nmod)
responses reflex (amod)
associated sulfasalazine (nmod)
thienodiazepine a (det)
experienced case (dep)
cancer stage (appos)
those administered (acl)
august 1986 (nummod)
responsive morphine (nmod)
measures conventional (amod)
groups sulfhydryl (compound)
epileptogenic not (neg)
four developed (acl:relcl)
aes hypertension-related (amod)
consider initiated (conj)
gyrus dorsal (compound)
is introduction (ccomp)
literature investigating (acl)
ranged males (conj)
function venous (amod)
phase that (nsubj)
potency situations (nmod)
weeks for (case)
searched trials (nsubjpass)
extract seed (compound)
increase points (nsubj)
% 42.5 (nummod)
studied course (nsubjpass)
pretreatment cont./min (appos)
patient third (amod)
233+/-34 210+/-56 (dep)
appearance after (case)
or=13.807 36.706 (punct)
myelopathy peripheral (conj)
activated surge (nmod)
appearance dermatitis (nmod)
administration fibrillation (nmod)
excitability the (det)
interstitium the (det)
ca(2 l-type (amod)
24 52 (conj)
nonpregnant and (cc)
lna lca (conj)
enhancement in (case)
occurred material (nsubj)
association markers (nmod)
mitochondria and (cc)
levels receptor (compound)
counteracted decrease (dobj)
epilepsy idiopathic (amod)
common women (nmod)
antimicrobials macrolide (compound)
cefazedone 840 (nummod)
d1 subtypes (dep)
intravitreal accepted (amod)
related presence (nmod)
categories higher (amod)
anemia ribavirin-associated (amod)
decrease rate (nmod)
prove acceptable (xcomp)
injected determined (conj)
insipidus of (case)
evidence qualitative (amod)
dilation and (cc)
coniine both (cc:preconj)
allowing understanding (dobj)
mg 1,000/40 (compound)
nucleus 8/8 (dep)
injected gentamicin (nmod)
neuropeptide-y npy (appos)
responsible structures (nsubj)
section therapy (nmod)
neurotoxic cbdca (nsubj)
inhibited glucuronidation (dobj)
mesothelioma leiomyosarcoma (conj)
thromboembolism cataracts (conj)
women receiving (acl)
involved hepatotoxicity (nmod)
diagnostic criteria (conj)
modulates models (nmod)
ratio total (amod)
degree of (case)
i.c.v. , (punct)
associated acid (nmod)
71 +/- (cc)
induced examine (advcl)
nephropathy mild-type (amod)
used not (neg)
algorithm naranjo (compound)
individuals other (amod)
doses six (nummod)
prinzmetal 's (case)
performed centre (nmod)
prevalent asia (nmod)
relationships , (punct)
effects significant (amod)
inhibitors six (nummod)
free compared (dep)
present dilemma (dobj)
decreased propranolol (nsubj)
manufactures which (nsubj)
urge to (case)
inhibitors rosuvastatin (conj)
effect secondary (amod)
reduced significantly (advmod)
produces that (mark)
span backward (compound)
assessed commencing (advcl)
male 10-year-old (amod)
died edema (nmod)
signs features (conj)
prudent would (aux)
number interneurons (nmod)
characteristic was (cop)
pethidine in (case)
controls routine (amod)
ng/ml versus (cc)
developed summary (nsubj)
peaked min (dobj)
204 0 (compound)
breaks pyrimidines (conj)
administration caffeine (nmod)
doses edrophonium (nmod)
assess diminishing (conj)
conclusions induces (appos)
depend which (nsubj)
labetalol nitroprusside (conj)
confirmed biopsy (nmod)
distance mg/kg (appos)
focal and (cc)
subthalamotomy improved (acl:relcl)
25 - (punct)
lobe process (nsubj)
aware ophthalmologists (nsubj)
agent beta-blocking (amod)
induced ingestion (nmod)
diet-fed normal (amod)
elisa by (case)
lower those (nmod)
infection chronic (amod)
leaving upon (mark)
likelihood greater (amod)
90 15 (compound)
examined experiment (nmod)
allograft the (det)
regimen after (case)
safety dse (nmod)
affected content (dobj)
variations amplitude (nmod)
effect class (compound)
occurred variation (nsubj)
reaction known (amod)
enhancement nephrosis (nmod)
preparation as (case)
profile and (cc)
naa ( (punct)
description cases (nmod)
application rats (nmod)
marker should (aux)
show growth (dobj)
patients bpo (conj)
plausible dose (nmod)
administered naloxone (dobj)
microscopy freeze-fracture (amod)
onset distress (nmod)
effect net (amod)
early late (conj)
identified reports (dobj)
regions supramarginal (amod)
provocation nitroglycerin (nmod)
approach states (nmod)
control versus (cc)
studies toxicokinetics (compound)
dysregulation subunit (compound)
precipitation due (case)
epileptiform patients (nmod)
showed knife (nsubj)
evening the (det)
used hydrochloride (nsubjpass)
therapy fluconazole (nmod)
decrease preload (nmod)
found tissues (nmod)
abuse chronic (amod)
reach rate (dobj)
ng/kg/min ) (punct)
vomiting cases (nmod)
preswitch months (nmod)
correlated incidence (nsubj)
% to (mark)
26.3 +/- (cc)
appearance hypercholesterolemia (appos)
carried if (mark)
experienced hepatitis (dobj)
reviewed . (punct)
bid or (cc)
months 26 (nummod)
bringing number (dobj)
loss hearing (compound)
pmol/10 26.3+/-3.6 (compound)
excretion ao (nmod)
had assay (dobj)
cyclophosphamide infusional (amod)
increased fos-immunoreactivity (dobj)
collected part (nmod)
sleep awaking (advcl)
groups four (nummod)
disappeared ii/iii-v (nsubj)
1.05 2.30 (prep)
exacerbations associated (acl)
cardiotoxicity cessation (nmod)
results diameters (nmod)
located processes (nmod)
mg neostigmine (conj)
behavior avoidance (conj)
differentiation pharmacological (amod)
divided oil (dep)
diagnosis psychiatric (amod)
implicated has (aux)
syndromes clinical (amod)
predictors factors (nsubj)
nonusers 21 (nummod)
conscious was (cop)
rates post-transplant (amod)
1.44+/-0.6 ) (punct)
type specific (amod)
reduced animals (nmod)
tablets 50-mg (amod)
nodules no (det)
resembled serpiginosa (dobj)
dysfunction amygdala (amod)
oxide endothelial (amod)
bcnu-exposed and (cc)
added list (nmod)
testing in (case)
fluid cerebrospinal (amod)
high population (nmod)
deterioration improvement (conj)
tubes guide (compound)
rat lithium-induced (amod)
seizures or (cc)
5-ht ) (punct)
4 22 (prep)
cvp ) (punct)
mumol/kg ( (punct)
biodistribution rat (compound)
doxorubicin and (cc)
biopsies episode (compound)
binding by (case)
micrograms/50 ) (punct)
boy apl (nmod)
increase marked (amod)
sensitized highly (advmod)
rapamycin of (case)
f(33 p<.001 (dep)
time real (amod)
deoxycorticosterone 11-deoxycortisol (conj)
woman-years per (case)
thrombocytopenia recovery (conj)
hypokalemia with (case)
nelarabine etoposide (conj)
downregulated expression (dobj)
fact of (case)
contribution dispersion (nmod)
inhibition learning (compound)
discuss recommend (conj)
exist . (punct)
observed seizure (nmod)
those problems (nmod)
inflammation cardiomyopathy-induced (amod)
alternations rigidity (nmod)
action molecule (nmod)
% variability (nmod)
markers inhibitor (appos)
improves but (cc)
ami/gi for (case)
ameliorate could (aux)
14 and (cc)
displayed indicated (advcl)
terms quality (nmod)
escalating of (mark)
acuity or (cc)
mechanisms possible (amod)
prolongation greater (amod)
hepatocellular according (case)
suggested ain (dobj)
learning during (case)
estimated influence (nsubjpass)
analyses severity (nmod)
examinations by (case)
dystrophin in (case)
circuitry fronto-temporal (amod)
activity amphetamine-induced (amod)
profile side-effect (amod)
myalgia : (punct)
electrodes and (cc)
physician prescribed (acl:relcl)
strain the (det)
measuring selected (conj)
use pain (nmod)
reduced or (cc)
inhibiting 2d6 (dobj)
treat woman (nmod)
back administration (nmod)
patients 167 (nummod)
kinase protein (compound)
worsening feeling (nsubj)
effects profile (conj)
discharges epileptic (amod)
diarrhea syndrome (dep)
fatal which (nsubj)
common mood (nsubj)
partly least (advmod)
enantiomer synthesized (amod)
defined previously (advmod)
combination depression (conj)
termination treatment (nmod)
activity cancers (nmod)
ameliorates deletion (nsubj)
radiograph or (cc)
accomplished . (punct)
1.0 . (punct)
cisplatin amifostine (conj)
mediating enhancement (dobj)
found parameter (nmod)
factors coagulation (compound)
objective our (nmod:poss)
ikr blockers (dep)
weights values (conj)
uv 6.2 (nummod)
noted , (punct)
vision of (case)
changes variables (nmod)
map 4/8 (appos)
obtained phentolamine (nmod)
inadequate evidence (nsubj)
one n (dep)
banks regional (amod)
recovery attenuated (amod)
modifications on (case)
performed referred (conj)
whilst therapy (nmod)
layers all (predet)
bundle within (case)
response frey (nmod)
led appearance (nmod)
depression ischemic (amod)
count white (amod)
failed has (aux)
buffer % (conj)
decline gfr (nmod)
identifying use (nmod)
found reversal (nsubjpass)
described women (nmod)
dystonia effect (nsubj)
concentrations on (case)
conventional implant-supported (conj)
effects chronotropic (amod)
mechanism accounting (acl)
toxicity treatment (nmod)
had she (nsubj)
development torsade (nmod)
encouraged obtained (parataxis)
edema shock (conj)
boy the (det)
aspirin analgesic (conj)
30 dec. (appos)
myocardium ventricular (amod)
lowered elevation (dobj)
treatment mazindol (nmod)
demonstrated whereas (dep)
lower dysfunction (nsubj)
aplasia dermatitis (conj)
striatum to (case)
dose placebo (conj)
il-2 and (cc)
usage tiazofurin (compound)
minutes minutes (nmod)
cirrhosis ascites (conj)
induced 2003 (nmod)
lowered hr (nsubjpass)
increased meth (nsubj)
measured version (nmod)
non-users remainder (nsubj)
induced also (advmod)
male 3-year-old (advmod)
predominated . (punct)
provides opportunity (dobj)
suggests which (nsubj)
america in (case)
months 2.6 (nummod)
chromosomes mouse (compound)
weight induced (acl)
woman bilaterally (advmod)
carried performance (nsubjpass)
beta-agonist salbutamol (nmod)
easy miss (xcomp)
cases substitution (acl:relcl)
given solution (nmod)
beta1 growth (compound)
facilitation , (punct)
adenosine presumed (acl)
is compare (xcomp)
length the (det)
limits % (dep)
azathioprine by (case)
enables monitoring (dobj)
progressed stages (nmod)
sevoflurane of (case)
manifestations these (det)
peaked antinociception (nsubj)
graft patients (conj)
agents pharmacologic (amod)
cortex striatum (conj)
effect reduction (compound)
none studies (nmod)
regressed manifestations (nsubj)
study comparison (nsubj)
trans-2-amino-3-hydroxy-1 of (case)
task challenging (amod)
resulted species (nsubj)
abnormalities seen (acl)
pronounced enhancement (nsubjpass)
identified fear (conj)
patients ergotamine/caffeine (nmod)
used mri (dobj)
data model (nmod)
period gds (dep)
differences between (case)
na+-extrusion by (case)
borderzone the (det)
extract ethanol (compound)
retinoblastoma with (case)
black white (amod)
time dose (nmod)
duration sec (dep)
promote clotting (dobj)
prodrug phenytoin (nmod)
examination comprehensive (amod)
acting directly (advmod)
followed tablet (nmod)
known a (det)
infusion morphine (compound)
initiation development (conj)
microgram 100 (nummod)
iso with (case)
tissue striatal (amod)
contribute damage (nmod)
stimulation continuous (amod)
disappearance tumor (nmod)
abated that (nsubj)
acknowledged regarded (advcl)
mg 180 (nummod)
informative studies (nsubj)
agonist adenosine (compound)
course with (case)
intensity/pleasure orgasm (amod)
cardioselective it (nsubj)
those types (nmod)
application frontotemporal (amod)
developed developed (advcl)
antibody with (case)
segmental percentage (nmod:npmod)
controlled not (neg)
killed gd (nmod)
mean se (conj)
confounding and (cc)
calcium high (amod)
dyserythropoiesis with (case)
noticed difference (nsubjpass)
noradrenaline of (case)
cytochrome the (det)
days 974 (nummod)
treatment dithiothreitol (nmod)
infusion ketamine (nmod)
reduced followed (xcomp)
blockers diltiazem (appos)
properties mechanical (amod)
function rats (nmod)
control tone (nmod)
does frequencies (nmod)
responders stable (amod)
extracted records (nmod)
netilmicin lysozyme (compound)
uncertain , (punct)
prevent amnesia (dobj)
ngf ( (punct)
accumulation lower (amod)
trial prospective (amod)
reproducibility variation (conj)
differed groups (nmod)
chemotherapy containing (acl)
hyperplasia the (det)
haemorrhage fatal (amod)
required allow (xcomp)
hours mcao (dep)
proposed play (xcomp)
microangiopathies of (case)
characteristics e (nmod)
sensitivity % (conj)
reduction dfo (compound)
pressure contractility (conj)
appears stimulation (nsubj)
approved administration (nmod)
seemed , (punct)
syndrome undergoing (acl)
prevent gentamicin-arf (dobj)
expression full (amod)
inhibitor cox-2-specific (amod)
coordination relationship (conj)
syndrome puromycin (compound)
subjects/patients the (det)
ptra and (cc)
animals 12/27 (nummod)
tachycardia 0.3 (nummod)
have profile (dobj)
analysis stones (nmod)
fall concentrations (nmod)
transmission neural (amod)
dcm of (case)
criteria control (compound)
damage neuronal (amod)
144 +/- (cc)
inhibitors pravastatin (appos)
evaluation msg (compound)
hypothesize we (nsubj)
encourages compliance (dobj)
hypokalemia b-related (amod)
hemorrhage to (case)
activity adriamycin-mediated (amod)
interaction a (det)
degrees 37 (nummod)
dermatomes leg (nmod)
catalepsy haloperidol-induced (amod)
apomorphine dexamphetamine (conj)
instilled intravesically (advmod)
rate extent (conj)
receiving infusion (dobj)
kidneys offspring (compound)
admitted myopathy (nmod)
cardiomyopathy and (cc)
content 5-ht (compound)
reversed effects (dobj)
indicated relationship (dobj)
known block (xcomp)
trial cisplatin (nmod)
cy cmf (appos)
removed bladders (nsubj)
simplifies , (punct)
non-a hepatitis (nmod)
cytarabine intrathecal (amod)
a in (case)
crystallization acute (amod)
multicenter randomized (conj)
acid strychnine (conj)
uremia and (cc)
responses tachyphylaxis (nsubj)
ph ; (punct)
anesthesia induced (acl)
maintains prevents (conj)
hypophosphatemia , (punct)
adrenalectomy after (case)
changes signal (compound)
79 to (dep)
assess outcomes (dobj)
salt-depleted , (punct)
group interaction (nmod)
sss ) (punct)
immunosuppressed dose (nmod)
height with (case)
spent quadrant (nmod)
p .001 (punct)
flutamide of (case)
1990 between (case)
advantageous minimized (conj)
, administration (dep)
practices 143 (nummod)
23390 [3h]spiperone (conj)
showed multicenter (nsubj)
pretreated day (nmod)
persisted whom (nmod)
occurred decrease (nsubj)
concentration serotonin (conj)
had received (conj)
cerebellar normal (amod)
treatment disorder (nmod)
1.8 +/- (cc)
showed behaviour (dobj)
vf ) (punct)
stimulus-induced on (case)
abnormalities motion (compound)
ef ( (punct)
temperature or (cc)
seizure sensitive (dep)
inhibits catabolism (dobj)
frequency overall (amod)
predated however (advmod)
wales new (compound)
blockage the (det)
describe features (dobj)
symptomatic start (nmod)
taken suppressants (dobj)
times partial (amod)
british of (case)
length = (dep)
99 respectively (advmod)
minimised be (auxpass)
plexus of (case)
received male (nsubj)
time therapy (nmod)
involvement periods (conj)
woman cambodian (amod)
mg ibuprofen (dep)
used methylphenidate (conj)
presence bruising (nmod)
protocol our (nmod:poss)
pca ) (punct)
wound burn (compound)
man allergies (nmod)
effect cases (nmod)
5-fluorouracil plus (cc)
bortezomib regimens (conj)
warranted is (auxpass)
resulted decrease (nmod)
admitted month (nmod)
group greater (acl:relcl)
rash and (cc)
subjects diabetic (amod)
subjected conditions (nmod)
role bmt (nmod)
arrest after (case)
unconjugated hyperbilirubinemia (dobj)
effect dose (nmod)
absorption percutaneous (amod)
angiography fundus (compound)
used interviews (nsubjpass)
identified enrolled (conj)
have years (nmod)
values clearance (compound)
expression layer (nmod)
time ect (appos)
bolus mg/kg (dep)
expression rats (nmod)
areas undergoing (acl)
hb testosterone (conj)
maintained chow (nmod)
incidence tremor (appos)
received none (nsubj)
consumers per (case)
echocardiography follow-up (compound)
turned those (nsubjpass)
leukoencephalopathy enhancement (nmod)
salivation diaphoresis (conj)
dyskinesias ocular (amod)
antinociception (+/-)-pg-9 (amod)
initiate reflex (dobj)
r=0.81 0.65 (conj)
role decompression (nmod)
fibers activated (acl)
downregulating substantially (advmod)
gain pressure (conj)
caused use (nmod)
occurring lid (nmod)
group model (compound)
idea to (case)
identified patients (dep)
derivatives beta-alanyl (compound)
deficit time-related (amod)
ml(-1 ) (punct)
received t.i.d. (conj)
a b (conj)
4 14 (dep)
group rc (compound)
protects effects (nmod)
twitches ) (punct)
improve ro4368554 (nsubj)
canal of (case)
activation na+ (nmod)
lack hepatocytes (nmod)
given ethanol/aap-mice (nmod)
analyzed , (punct)
mg between (case)
difference age (compound)
acid-induced trans-retinoic (amod)
event before (case)
concept this (det)
influenced more (advmod)
revealed myopathy (dobj)
irregularities arterial (amod)
required recovery (nmod)
findings trial (nmod)
reaction a (det)
hypertension humans (nmod)
play auto/alloimmunity (nsubj)
decline manifestations (conj)
pups fluoxetine-exposed (amod)
0.4-fold 1.1 (dep)
growth changes (conj)
peaked kinase (nsubj)
anuria , (punct)
recognised . (punct)
dose ccl4 (nmod)
injected range (nmod)
planning working (compound)
= 78 (dep)
led observation (nsubj)
paresthesias cramps (conj)
task , (punct)
staining neurons (nmod)
produced had (conj)
investigated were (auxpass)
duration ) (punct)
ratio responsible (acl:relcl)
1966-january ) (punct)
well-tolerated and (cc)
pathology the (det)
models same (amod)
time with (case)
genes enzyme (nmod)
gluconate with (case)
( /-sd (conj)
found infants (nsubjpass)
linking alteration (nmod)
deaths cell (compound)
offer not (neg)
concentrations plasma (compound)
dosages cyclosporine (nmod)
vip ( (punct)
monitoring noninvasive (amod)
effect sphincter (nmod)
analyzed assay (nmod)
examined role (dobj)
had a (nsubj)
agonists inhibitors (conj)
monitored weeks (conj)
polypeptide vasoactive (amod)
treatment enalapril (amod)
propofol medialipid (nmod)
produced pge2 (nsubj)
values acid (compound)
reaction quantitative (amod)
entered trial (dobj)
levels ribonucleic (amod)
reversed naloxone (nmod)
amblyopia in (case)
explanation alternative (amod)
skf-82958 a-77636 (conj)
impaired and (cc)
substituted % (nsubjpass)
observed cerebella (nmod)
excretion albumin (compound)
showed investigations (nsubj)
ultrasound periodic (amod)
arrest due (case)
dose to (case)
patients compared (case)
gender-dependent extend (conj)
leucemia lymphoblastic (amod)
prudent , (punct)
improve proteinuria (nsubj)
metabolites ring (compound)
6 indicating (xcomp)
control under (case)
dogs 6 (nummod)
development hypotension (nmod)
eliminating after (mark)
stabilizers with (case)
rates tachyarrhythmias (nmod)
inhalation intranasal (conj)
studies experimental (amod)
2.58 of (case)
rates mortality (compound)
action pressor (compound)
missed would (aux)
vsds ) (punct)
sign no (det)
before 7.5 (conj)
discuss applications (dobj)
demonstrate attenuate (ccomp)
performance expression (compound)
curves characteristic (amod)
neurons afferent (amod)
case literature (nmod)
had need (conj)
prooxidant and (cc)
diffusion apparent (amod)
sign an (det)
society according (case)
induces apoptosis (dobj)
response a. (compound)
interval = (dep)
upregulation enos (nmod)
is view (nmod)
scr in (case)
renal eighty-one (nummod)
5 all (det)
proliferated . (punct)
was clarify (xcomp)
receptors muscarinic (compound)
all ) (punct)
characterized abnormalities (nmod)
patient same (amod)
handling in (mark)
results exhibited (appos)
uterus with (case)
rats barium-exposed (amod)
complication be (cop)
sensitive mice (nmod)
responded conjunction (nmod)
received weeks (nmod)
scale mood (compound)
suggesting condition (dobj)
found lid (nmod)
pattern fragmentation (nmod)
correction metformin (nmod)
compromised as (mark)
pre- post-dilatation (conj)
protein however (advmod)
beginning treatment (nmod)
touch of (case)
combination amoxicillin (nmod)
areas fibrosis (nmod)
hospital according (case)
patients histories (nmod)
species elevated (amod)
developed courses (nmod)
seems have (xcomp)
infusions patients (nmod)
aqp2 ut-a1 (conj)
complex dystrophin-glycoprotein (amod)
l-nil ) (punct)
42 patients (nmod)
compound treatment (nmod)
basis breath-by-breath (amod)
inhibit activity (dobj)
hyperkalemia failure (conj)
sodium potassium (conj)
has nephrotoxicity (nsubj)
-0.81 = (dep)
pri of (case)
expression subunit (nmod)
adding regimen (nmod)
important very (advmod)
administration captopril (nmod)
differed risperidone (nmod)
encephalopathy germany (nmod)
cx3cr1 ) (punct)
induce also (advmod)
receive approval (dobj)
timing adequate (amod)
mechanisms additional (amod)
risk % (dep)
exhibited latencies (dobj)
abolished it (nsubjpass)
electroencephalographic this (det)
recall memory (compound)
index a (det)
hepatotoxicity antibiotic-associated (amod)
cue because (case)
serum in (case)
excretion an (det)
hypertension-related oedema-related (conj)
reduced measured (advcl)
responses associated (acl)
taa ) (punct)
shock direct (amod)
used p (dep)
most since (case)
increase considering (case)
substrates mrp2 (nmod)
ineligible which (nmod)
period perioperative (amod)
decades during (case)
delayed peak (conj)
g/ml ( (punct)
subanalyses rcts (nmod)
glaucoma primary (amod)
reactions : (punct)
oralis for (case)
recurrence telangiectasia (nmod)
group pediatric (compound)
rearing less (advmod)
contribution synthesis (nmod)
group iv (nummod)
reports delirium (nmod)
weeks cessation (nmod)
lid parkinson (nmod:poss)
avoid prescribing (xcomp)
includes , (punct)
organs most (amod)
cyclophosphamide with (case)
condensed moiety (nsubjpass)
more or (cc)
= difference (nsubj)
cause disorders (dobj)
run may (aux)
recognition enzyme (nmod)
15-minute i.v. (dep)
monophosphate adenosine (compound)
symptom the (det)
loss average (amod)
subjected weeks (nmod)
show improves (ccomp)
inhibitors cyp2d6 (compound)
combination dp/dtejc (nmod)
prolonged multiple (conj)
pathway main (amod)
results subjects (dep)
polymorphism chain (compound)
surviving of (case)
labeling increased (amod)
counteract it (nsubj)
function erectile (amod)
field the (det)
pro-inflammatory inflammatory (conj)
swelling and/or (cc)
months from (case)
9 % (appos)
early repeated (conj)
monkeys organisms (nmod)
copolymers in (case)
recipient transplant (compound)
signaling receptor (compound)
3.6 1.9 (conj)
gyrata cutis (compound)
aki ) (punct)
activity as (case)
complication intravitreal (conj)
had alpha (nsubj)
ester the (det)
monitor to (mark)
degeneration neurons (nmod)
myopathy lack (nmod)
epilepticus during (case)
blockade plexus (nmod)
emerged has (aux)
alter alter (conj)
influenced are (auxpass)
evaluated effects (dobj)
effect fighting (conj)
screening use (nmod)
marker injury (nmod)
antimicrobials with (case)
encoded coxii (nmod)
observed only (advmod)
irritability improvements (conj)
cancer n=656 (appos)
sulfation and (cc)
appeared difference (nmod)
interna lamina (compound)
women menorrhagia (nmod)
gradient plasma-to-blood (amod)
referral or (cc)
assigned therefore (advmod)
classified patients (nsubjpass)
months the (det)
status angina (amod)
appears adaptation (xcomp)
diazepam kg-1 (appos)
stress isoproterenol-induced (amod)
removed that (advmod)
measurement donors (nmod)
animals pretreated (acl)
favourable % (dep)
schema . (punct)
have due (conj)
busulfan the (det)
year and (cc)
preparations main (amod)
abecarnil derivative (amod)
unclear paradoxical (conj)
discontinuing therapy (dobj)
restricted best (advmod)
activity limited (amod)
detection before (case)
velocity contractile (compound)
mg./kg conversely (advmod)
week two (nummod)
reports adr (compound)
inhibitor present (nmod)
augment continued (advcl)
events embolic (amod)
beck scales (conj)
hydroxylase tyrosine (compound)
inputs urethra (conj)
continued was (conj)
attenuate sod (nsubj)
activations fluency (conj)
bypass and (cc)
cavity surgical (amod)
exchange aspirin (conj)
57 2 (prep)
redistribution doses (nmod)
shift levels (nmod)
amantadine with (case)
plays effects (nmod)
nitrite simultaneously (advmod)
glycol polyethylene (compound)
mri ) (punct)
interval features (conj)
prepartum injected (amod)
rg1 of (case)
experiments recordings (conj)
suppresses and (cc)
compared ck-mb (nmod)
dendrin and (cc)
microgram from (case)
uneventful reexposure (nsubj)
rates events (nmod)
group propranolol (compound)
b factor (compound)
drug anti-inflammatory (amod)
tests timed (amod)
lesions focal (amod)
yohimbine and (cc)
diffusion-weighted fluid (conj)
obtained induction (nsubjpass)
selected effects (nmod)
given doses (dobj)
generated groups (nsubjpass)
lesions or (cc)
coronary aortofemoral (conj)
0.887 - (punct)
doses divided (amod)
patients 160 (nummod)
bort of (case)
pathway alternate (amod)
out-patients eighty-nine (amod)
10 1 (compound)
conclusions factor (dep)
scale sexual (compound)
weight 2-kg (amod)
cerebral , (punct)
classified criteria (nsubjpass)
39 19 (compound)
n-butyl-deoxynojirimycin inhibitor (appos)
phosphokinase aminotransferase (appos)
levels epo (compound)
association no (neg)
beta-adrenoblocking the (det)
set were (auxpass)
development associated (acl:relcl)
reduced drugs (nsubj)
charcoal activated (amod)
related dose (nmod)
pakt ( (punct)
showed necrosis (dobj)
occult carcinoma (dobj)
teams surgical (amod)
increased amantadine (nmod)
patient gammapathy (nmod)
studied years (nmod)
caused anemia (nmod)
achieved complications (nmod)
extended-release with (case)
platelet 2-adrenoreceptor (conj)
mg/m2 mean (dep)
lapsed coma (nmod)
immediately ( (punct)
dyslipidemia extended-release/lovastatin (conj)
differences sexes (nmod)
creatinine micromol/liter (appos)
receiving who (nsubj)
disease ischaemic (amod)
occur as (mark)
deficits magnitude (acl:relcl)
nephrolithiasis phosphate (compound)
view risks (nmod)
0.3-fold p=0.385 (dep)
higher but (cc)
treatments disease (nmod)
age number (conj)
seems tolerated (conj)
developed range (advcl)
incidence hit (nmod)
drug plasma (compound)
studies metabolic (amod)
associated hyponatremia (nmod)
for together (advmod)
sparteine probe (nmod)
shown since (mark)
variation great (amod)
therapies patients (nmod)
has nra0160 (nsubj)
% 30.3 (nummod)
developed diarrhea (dobj)
desorption/ionization atmospheric (amod)
maze the (det)
rats glomerulonephritis (nmod)
enlarged were (auxpass)
models leukoencephalopathy (nmod)
paralysis induced (acl)
seen convulsions (nmod)
trial : (punct)
transplantation : (punct)
easy used (conj)
provoke np (nsubj)
involvement bone (compound)
% 14.4 (nummod)
neuralgia with (case)
drop pressure (nmod)
were prior (advmod)
antagonist intestinal (amod)
function channel (compound)
total droperidol (nmod)
antagonists cystitis (nmod)
become alternative (attr)
males exception (nmod)
received rat (nsubj)
reduced observed (conj)
data follow-up (amod)
dowregulation the (det)
value 13.2 (nmod)
sensitization ampicillin (nmod)
become stimulate (xcomp)
sole be (cop)
efficient moreover (advmod)
urothelium rat (compound)
assigned methods (dep)
steroid of (case)
= 4.2 (dep)
icu in (case)
repeated day (nmod)
patients surgery (compound)
rigidity jaw (compound)
nerve for (case)
revealed suggesting (advcl)
reversed facilitated (conj)
patients additional (amod)
pathway novel (amod)
attempt an (det)
earlier and (cc)
testosterone ) (punct)
surgery aortic (amod)
recordings potential (amod)
one blockers (nmod)
patients heparin (nmod)
led however (advmod)
hydrocortisone oral (amod)
plan role (dobj)
patient japanese (amod)
used potentially (advmod)
differed none (nsubj)
normal level (nsubj)
opioid-agonists selective (amod)
improve can (aux)
ng/ml. i (compound)
group gastrointestinal (compound)
conclusion results (dep)
resistance svr (appos)
group only (advmod)
similar zones (nmod)
solid hematological (conj)
program computer (compound)
drugs allopurinol (dep)
developed has (aux)
seen exercise (nmod)
iu/l were (cop)
population heterogeneous (amod)
obstruction ureteric (amod)
found rise (nsubjpass)
pentylenetetrazole ptz (dep)
introduction mg/day (appos)
binding their (nmod:poss)
given diuresis (dobj)
level higher (amod)
incidences enzymes (conj)
patients placebo (dep)
disorders to (case)
supposed caused (ccomp)
acid and (cc)
delay and (cc)
caproate rats (nmod)
mean+/-s.e. ( (punct)
demonstrated cardiotoxicity (nsubjpass)
% 1.98 (dep)
left temporal (xcomp)
hcl desipramine (compound)
sulphasalazine to (case)
time 3 (dep)
improves catalepsy (dobj)
produce pain (dobj)
dse ( (punct)
sustained which (nsubjpass)
levels histopathology (appos)
high suppression (nmod)
chloride bromide (conj)
proportion attaining (acl)
4.3+/-1.9 were (cop)
ain ) (punct)
severity withdrawal (compound)
months 10 (nummod)
methadone those (conj)
novel neuroprotective (dep)
1.18 0.66 (appos)
procyclidine drug (appos)
designed hyperactivity (nmod)
patterns discharge (compound)
chloramphenicol administered (acl)
case injection (nmod)
assessment dysfunction (nmod)
female were (cop)
tolerable . (punct)
transcription of (amod)
a-i , (punct)
voltarol , (punct)
bd1018 with (case)
saline dex (conj)
modulator gaba(a)rs (appos)
experience from (case)
sections interventions (conj)
available , (punct)
dose high (amod)
estimated interval (nsubjpass)
survival of (case)
hormone attributed (acl:relcl)
10(-4 to (case)
use cisplatin (compound)
evaluate ahs (nmod)
antidepressants new (amod)
term significant (amod)
patients od (nmod)
experience start (nmod)
discusses , (punct)
activity renin (compound)
weaker ) (punct)
snr activated (amod)
doses agonist (appos)
increased ratio (dobj)
antagonized dexrazoxane (dobj)
agent noradrenaline-uptake (amod)
aggravates overload (dobj)
vancomycin gentamicin (conj)
mcl treated (acl)
matched treatment (nmod)
peptide cgrp (appos)
paradigm the (det)
discontinuation dose (nmod)
prepare , (punct)
die develop (conj)
ability greatest (amod)
ifosfamide for (case)
olanzapine t(33 (appos)
attenuate oil (compound)
replacement csa (compound)
amikacin after (case)
values mice (nmod)
ablation pkca (nmod)
d 8.00 (nummod)
background reflect (dep)
effect hepatitis (nsubj)
adhesions orbital (amod)
toxicity lung (compound)
complex specifically (advmod)
produce away (advmod)
segment a (det)
micrograms to (case)
indirect were (cop)
loss ; (punct)
results lumbar (amod)
prevalence complications (nmod)
library 1987 (nmod)
expression cco-i (nmod)
sm-5887 ( (punct)
metrizoate after (case)
using microarrays (dobj)
variable main (amod)
0.01 ; (punct)
suggest effect (dobj)
level at (case)
depends , (punct)
seen cases (nmod)
effects typical (amod)
constriction . (punct)
asymptomatic was (cop)
neurotensin by (case)
observed shift (nsubjpass)
discuss aspirin (dobj)
able drug (nsubj)
alleviated symptoms (dobj)
users progestagens (nmod)
enhance antagonists (nsubj)
depressed were (auxpass)
research within-subject (amod)
3e 3 (nummod)
weeks two (nummod)
pregnancy recent (amod)
implicate that (nsubj)
change baseline (nmod)
potential for (case)
augmentation doc (nmod)
interaction of (case)
disorders carmofur-induced (amod)
apparent cohort (nmod)
potential nephrotoxic (amod)
vary assessed (conj)
vasculitis cytoplasmic (amod)
prescribed citrate (nsubjpass)
returned level (nmod)
potentiation on (case)
24 to (case)
increased admissions (nmod)
experienced disease (conj)
classical both (cc:preconj)
relation changes (nmod)
combination l-dopa (nmod)
inhibitor angiotensin (compound)
has drawbacks (dobj)
withdrawal calcineurin (compound)
verapamil neither (cc:preconj)
given questionaires (nsubjpass)
obesity treatment (conj)
pronounced less (advmod)
reduction incorporation (nmod)
months 14 (nummod)
relating changes (nmod)
hyperactivity locomotor (compound)
lithium with (case)
function sclerosis (conj)
use pca (nmod)
induced rarely (advmod)
nitrendipine with (case)
injection ouabain (nmod)
arthritis severe (amod)
tumor bladder (compound)
clotiazepam to (mark)
nephritis allograft (nmod)
ascended and (cc)
subgroup each (det)
scores gtn (compound)
noted diuretic (ccomp)
hosts in (case)
antibody antithyroid (compound)
recommended use (nmod)
enzyme atypical (amod)
knowledge effects (nmod)
mdma as (cc)
migraineurs . (punct)
dysfunction sinus (compound)
mg/min 1 (nummod)
order examine (acl)
proliferators of (case)
nephritis henoch-schonlein (compound)
report either (preconj)
process muscular (amod)
years 44 (nummod)
case rigidity (nmod)
preserve memory (dobj)
anxiolytic properties (dep)
cisplatin mg/m(2 (appos)
causes dogs (nmod)
improved ( (punct)
resistant contrast (nmod)
assessed investigate (advcl)
sestamibi . (punct)
score recordings (conj)
system glycine (compound)
mg/m(2 ) (punct)
emergent i. (compound)
mm compared (acl)
affect administration (nsubj)
consumption from (case)
linezolid ethambutol (conj)
contracture of (case)
circumstances in (case)
showed decreased (conj)
amine used (acl)
ratio bax/bcl2 (compound)
octapeptide cck-8-ns (appos)
initiation loading (nmod)
study analgesic (nmod)
dose-dependent are (cop)
membranes intermediate (nmod)
cyp with (case)
inhibited morphine (nsubj)
women mg/kg (appos)
reorganization extensive (amod)
different ratio (dep)
measured pressure (nsubjpass)
post-infusion of (case)
hemorrhage for (case)
source an (det)
626 +/- (cc)
level hemoglobin (compound)
role estrogen (nmod)
risk schizophrenia (nmod)
occurred reactions (nsubj)
injected mice (nmod)
elevation no (neg)
report , (punct)
consciousness background (dobj)
calculation the (det)
avp applied (amod)
bupivacaine after (case)
developed treated (conj)
events several (amod)
protocol . (punct)
associated aspirin (nmod)
receiving outcome (dobj)
bed microvascular (amod)
potent steroids (nsubj)
electrodes of (case)
model genetic (amod)
agents newer (amod)
prod and (cc)
alterations histological (amod)
production pge2 (compound)
hold remodelling (nmod)
stz crocins (conj)
restriction movements (nmod)
excluded although (mark)
receive radiotherapy (dobj)
content tissue (compound)
rise upon (case)
showed revealed (parataxis)
shown alleviate (conj)
staining all (det)
cases presented (acl:relcl)
regions of (case)
woman presented (acl)
warfarin vitamin (compound)
prove etomidate (nsubj)
had concentrations (dobj)
individuals the (det)
antagonism ro15 (nmod)
disease models (nmod)
improves digoxin (nsubj)
3722 3628 (conj)
thrombophlebitis rash (conj)
30 2002 (conj)
role control (nmod)
rs withdrawal-emergent (amod)
described are (auxpass)
anemia developing (acl)
effectiveness 8 (nummod)
arteries evidence (conj)
dropped curve (nsubj)
received total (dobj)
contributed injection (nsubj)
transformation of (case)
aetiology a (det)
dbp not (cc)
patients two (nmod)
tended which (nsubj)
degree this (det)
period hr (compound)
bleeding ami/gi (nsubj)
experiment second (amod)
toxicity pulmonary (amod)
dehydrogenase mtdna-encoded (amod)
reported successful (xcomp)
events stratified (acl)
slowly more (advmod)
acetylcholinesterase ache (appos)
demonstrated week (nmod)
submitted . (punct)
areas to (case)
receptor via (case)
dogs all (det)
inhibit vitro (advmod)
male history (nmod)
hypertension disease (conj)
paracetamol , (punct)
pod 11 (nummod)
pain abdominal (amod)
cin with (case)
abolished it (nsubj)
safe regimen (nsubj)
competition by (case)
treated prophylactically (advmod)
prevent evaluated (conj)
opsonized zymosan (compound)
disorders painful (amod)
hypotensive and (cc)
randomized of (case)
examining drug (conj)
increasing stress (dobj)
hypertension essential (amod)
replicated protocols (nmod)
lymphoma mcl (appos)
used model (nmod)
cardiotoxic to (mark)
patients temperament (nmod)
timolol pilocarpine (conj)
% either (cc:preconj)
intensity hz (appos)
sjl a/j (conj)
treated cyp (nmod)
data discontinuation (nmod)
size pupil (compound)
obtained to (mark)
-19.20 % (conj)
hyperprolactinemia neuroleptic-associated (amod)
abnormalities with (case)
records sonograms (conj)
parkinsonian mptp (nmod)
effect caa (nmod)
medication groups (nmod)
implants bilateral (amod)
kong in (case)
mg/m2bsa ) (punct)
rated participants (nsubjpass)
bs br (conj)
dose 300 (nummod)
findings epidemiologic (amod)
antiplatelets various (amod)
study ephedrine (nmod)
observed reflex (dobj)
expression bcl-2 (nmod)
caused diagnosis (nmod)
difficult may (aux)
europe in (case)
antitussives of (case)
c l (dep)
administered iv (dobj)
ng/ml , (punct)
triggers azathioprine (nsubj)
safety acetonide (nmod)
difficulties anticoagulation (nmod)
treatments conventional (amod)
% control (nmod)
b rubella (conj)
decreased counts (nsubjpass)
compared curves (nsubjpass)
female fhf (nmod)
use metoprolol (nmod)
supposed is (auxpass)
disease disseminated (amod)
initiate turn (nmod)
ds-sarcoma rat (nmod)
means recording (nmod)
formulation standard (amod)
significant cases (nmod)
receptors nicotine (compound)
rupture septal (compound)
provide did (aux)
overshooting between (case)
instillation drops (nmod)
diazepam combination (conj)
procedures in (case)
associated disarrangement (nmod)
histological assessments (dep)
block s-a (amod)
2 0 (nummod)
consolidation intensive (amod)
assay an (det)
increasing with (mark)
tumors progressed (advcl)
postmortem group (nmod)
impairment enzymes (nmod)
cc and (cc)
measured as (mark)
appear experiences (nsubj)
patients fev1 (dep)
treated infusion (nmod)
quiescent . (punct)
reversed tissues (nmod)
unpaired ( (punct)
represent associated (advcl)
range models (nmod)
episodes major (amod)
s(h)uv the (det)
1,2-dmh by (case)
areas sensorimotor (compound)
proliferation both (cc:preconj)
loss complication (nsubj)
associated diazinon (nsubjpass)
antagonist to (mark)
vte ) (punct)
nhe3 and (cc)
respond tumors (advcl)
subscale in (case)
mm [ca]o (nmod)
vsd and (cc)
cavity a (det)
electrocardiograms signs (conj)
rating extrapyramidal (compound)
effect muscimol (compound)
micrograms/kg/hr 24 (nummod)
ecg animals (nmod)
observed and (cc)
effect celling (amod)
csf ) (punct)
used paradigm (nsubjpass)
weight kg (dep)
chiefly in (case)
% 12.8 (nummod)
gln223 ser198 (appos)
rr [ (punct)
showed ctnt (nsubj)
states vigilance (compound)
0.62 hazard (compound)
reversed rapidly (advmod)
relationship in (case)
rats healthy (amod)
arrhythmia myocardium (nmod)
demonstrated reaction (nsubj)
calcineurin of (case)
mitochondrial nucleus-encoded (amod)
administered second (advmod)
screening humphrey (nmod)
dh and (cc)
observed hypotension (nsubjpass)
symptoms medications. (compound)
models including (case)
gall n (nsubj)
efforts resuscitation (nmod)
less values (nsubj)
occlusions bilateral (amod)
neuropathy scotoma (nmod)
treated headache (nmod)
postpartum 2nd-week (amod)
ccnu/ctx of (case)
migraine treated (acl)
> concentrations (nsubj)
reactions allergic (amod)
is pathogenesis (ccomp)
telangiectasia the (det)
2-receptors beta (nmod:npmod)
checklist-90-revised symptom (compound)
dpi 5 (nummod)
action opioids (nmod)
predictors are (cop)
2 to (quantmod)
cured . (punct)
treatment sr (amod)
fingers the (det)
years use (nmod)
ciprofloxacin % (appos)
diameter pupil (compound)
arrest delayed (amod)
effects temsirolimus (nmod)
agsd from (case)
contains renografin (nsubj)
value ecg-enhanced (amod)
reactions hours (nmod)
introduction was (cop)
proven was (auxpass)
is/tia with (case)
range higher (amod)
yis diazinon (compound)
grains of (case)
tachycardia of (case)
recurrence with (case)
all words (nmod)
reshape . (punct)
cava and (cc)
reversible completely (advmod)
diet promoting (dep)
withdrawal days (appos)
perfusion suramin (appos)
therapy ssris (appos)
given mg/kg (conj)
showed implantation (nmod)
hag with (case)
assayed . (punct)
method scale (nmod)
worsening hemodynamics (nmod)
bicuculline bcc (appos)
dosage whose (nmod:poss)
study present (amod)
rehabilitation patients (nmod)
gls % (dep)
overexpression comparable (amod)
haloperidol death (nmod)
branches triceps (nmod)
as was (cop)
22 only (advmod)
edge-ii ( (punct)
recommended guidelines (nsubjpass)
vasculitis (ptu)-associated (compound)
b12 intramascular (amod)
p.o. 1 (nummod)
concentrations theophylline (compound)
appears also (advmod)
% auc (nmod)
decreasing qs/qt (dobj)
hepatotoxicity serious (amod)
postulated study (nmod)
developed srs (dobj)
4/8 ( (punct)
rocuronium 0.04 (nummod)
mice wsr (compound)
morphometrical analytical (conj)
time second (amod)
layer molecular (amod)
0 1 (conj)
discontinued if (mark)
lowers threshold (dobj)
piglets treated (amod)
report given (conj)
prior weeks (nmod:npmod)
quality field (nmod)
used time (xcomp)
postlesion day (compound)
results administration (nsubj)
conversion evidence (nmod)
chance the (det)
back-diffusion of (case)
determined that (mark)
oil with (case)
pain enzymes (conj)
predisposed which (nsubj)
increase risk (nmod)
acids vldl (conj)
found 5-htp (nsubjpass)
contre lutte (compound)
vagotomy administration (conj)
precise , (punct)
predictor good (amod)
syndrome leukoencephalopathy (compound)
effects cataleptic (amod)
areas vulnerable (amod)
followed infection (nmod)
f(33 = (dep)
risks ( (punct)
potential therapeutic (amod)
observed whom (nmod)
estimated effect (nsubjpass)
rarest of (case)
phosphorylation isoproterenol-induced (amod)
resolution images (nmod)
chills with (case)
screened were (auxpass)
trial noncomparative (amod)
0.03 of (case)
precautions strict (amod)
implanted months (nmod:tmod)
mothers antigen-positive (amod)
norms the (det)
control treatment (conj)
short-term and (cc)
placebo over (case)
5-azc of (case)
2.1 vs (cc)
patients variants (nmod)
doxorubicin following (amod)
transferase glutathione (compound)
menorrhagia due (case)
rizatriptan with (case)
insertion azt (nmod)
expression kidney (nmod)
received recently (advmod)
65.3 18.9 (conj)
abilities her (nmod:poss)
acting peripherally (advmod)
improved rapidly (advmod)
rostrolaterally high (conj)
angioedema hereditary (amod)
granulated , (punct)
bodyweight renin (conj)
oxacillin with (case)
rare use (conj)
showed tachycardia (dobj)
distribution lesions (nmod)
structure of (case)
amelioration nephrotoxicity (nmod)
violation after (case)
dysfunction infants (nmod)
region sinus (nmod)
received infusion (dobj)
cisplatin high-dose (amod)
mg. 2 (nummod)
mass . (punct)
affected score (nsubjpass)
development abs (nmod)
offspring examined (acl)
suspected replaced (conj)
4/- respectively (advmod)
procedures treated (appos)
involved proteins (nsubjpass)
dexrazoxane without (conj)
site primary (amod)
ensure microg/ml (nmod)
map 3/4 (appos)
drug was (acl:relcl)
continued when (advmod)
increased test (nmod)
resulting exposure (nmod)
label brain (nmod)
occurring 1973 (nmod)
hypoglycemia reported (amod)
traumatic ischemic (conj)
caused hypertensive (nmod)
behaviors dopamine-related (amod)
criteria edition (compound)
clinically less (conj)
rose level (nsubj)
bche of (case)
oropharynx sites (nsubj)
approximate dose (nsubj)
treated imipramine (nmod)
design factorial (amod)
patients encephalopathy (nmod)
subjects nonobese (amod)
had influenced (conj)
weeks 60 (nummod)
effect regimen (nmod)
agranulocytosis thrombocytopenia (conj)
quetiapine between (case)
17 9 (compound)
coadministration carvedilol (nmod)
tested detection (nmod)
injury concomitant (amod)
dysfunction production (conj)
derivative novel (amod)
associated medications (nmod)
administered beginning (nmod)
omission fentanyl (nmod)
worsened . (punct)
card yellow (compound)
tourniquets through (case)
incidence aminotransferase (nmod)
reported aware (conj)
patient oncology (compound)
prominent . (punct)
radiopharmacy incmnsz (nmod)
report asthenia (nmod)
19.3 diclofenac (conj)
300 500 (conj)
palate cleft (compound)
reduce encephalopathy (advmod)
initial to (mark)
directly pituitary (nmod)
levels cpk (compound)
developed cancer (dobj)
prolongation induced (acl)
possesses properties (dobj)
trabeculectomies were (cop)
200 at (case)
doses 3 (dep)
recognize , (punct)
age presentation (nmod)
efficacy relative (amod)
methods nephrectomized (appos)
septal postinfarction (compound)
activity by (case)
remifentanil after (case)
benefit patient (compound)
mechanisms intrauterine (compound)
pretreatment preventing (advcl)
area eyes (nmod)
ratings slowness (nmod)
discontinued isoniazid (nsubjpass)
scheduled weeks (nmod)
subcutaneously sc (dep)
cells phagocytotic (amod)
effects neurotoxic (amod)
experience to (mark)
obtained media (nmod)
consumers ) (punct)
l/min sed (appos)
impairments bupivacaine-induced (amod)
respect damage (nmod)
developed disease (nsubj)
speculate authors (nsubj)
experiences open (nmod)
complication about (case)
brains subjects (nmod)
interacted associated (conj)
recalled pains (dobj)
observed adults (nmod)
defect that (mark)
evaluated induction (nmod)
performed hysterosalpingography (nsubjpass)
mg/100 8.8 (compound)
effects tet (nmod)
incidence estimated (amod)
damage value (conj)
ouabain inhibitor (appos)
serves . (punct)
shifting in (case)
groups from (case)
nonimmunity of (case)
reached stage (nmod)
sulfate but (cc)
developed hematoma (dobj)
strain mouse (compound)
demonstrated levels (dobj)
discontinuing ptu (dobj)
studies incidence (conj)
products glutathione (conj)
after i.p. (pcomp)
3.5 2.3 (nummod)
resistance arterial (nmod)
melphalan intravenous (amod)
cause mellitus (nsubj)
increase 4.2- (nummod)
studied model (nmod)
orbitofrontal lateral (amod)
chloroacetaldehyde caa (appos)
affecting without (mark)
developed monotherapy (nmod)
value na+ (nmod)
l-name ) (punct)
se per (case)
pointer available (amod)
received mg/day (dep)
granisetron , (punct)
thromboembolism of (case)
activation or (cc)
epm ( (punct)
withdrawn vein (nmod)
received sc-48334 (dobj)
ansan korea (appos)
protocol discharge (acl:relcl)
data presented (acl)
exposure beta-blocking (amod)
baseline intervals (conj)
ich induced (acl)
avoid not (neg)
sections brain (compound)
ratio were (cop)
treated danazol (nmod)
development failure (nmod)
treated cis-ra (nmod)
given hours (nmod:tmod)
gene a (det)
intubated he (nsubjpass)
profiles/sections cell (compound)
elevated cells (nmod)
atherosclerosis induced (acl)
correlated nin (nsubj)
bicyclo-orthobenzoate ) (punct)
torsade amiodarone-induced (amod)
indicating have (ccomp)
reduced modify (conj)
capacity age (conj)
hyperprolactinemia 9-month (amod)
units to (case)
desire first (amod)
impairment reabsorption (nmod)
remains hallmark (xcomp)
evidence efficacy (nmod)
clt ( (punct)
obtained epilepticus (nsubjpass)
distinguishing hyperplasia (dobj)
vessels cells (conj)
remained k(na (dep)
minutes 45 (nummod)
increased severity (dobj)
highlight report (nmod)
ci 1.02 (nummod)
groups f(33 (appos)
wk lt (dep)
antidepressants many (amod)
r=0.81 ) (punct)
% 10 (compound)
shr , (punct)
development chf (compound)
response calcium (nmod)
mg/kg/day 200 (compound)
coexisted earliest (parataxis)
induced ketoconazole (nmod)
providers managing (acl:relcl)
dialysis peritoneal (amod)
k- a-variants (conj)
k+ sensitive (amod)
induce whereby (advmod)
six day (compound)
patient single (amod)
decline fraction (nmod)
concern some (det)
iii at (case)
hippocampus mice (nmod)
users tamoxifen (compound)
ibs ) (punct)
assessed also (advmod)
magnitude injury (nmod)
acetylcholine of (case)
prolonged groups (nmod)
neuropathy warfarin-induced (amod)
periods at (case)
extent neurons (nmod)
palsy subsequent (amod)
= 0.11 (dobj)
registrations electrocardiographic (amod)
forms gel (dobj)
elimination medication (nmod)
a-variants the (det)
caused respectively (advmod)
aims the (det)
excess an (det)
study our (nmod:poss)
received he (nsubj)
pretreatment alpha-tc (compound)
thrombosis coronary (amod)
increased 183 (nmod)
wistar male (compound)
effects trihexyphenidyl-induced (amod)
group another (det)
had eight (nsubj)
dosages those (det)
changes haemodynamic (amod)
took ibuprofen (dobj)
designated been (auxpass)
cortex by (case)
pathway with (case)
cardiotoxicity (dox)-induced (compound)
followed chow (conj)
mg/kg 20 (nummod)
contributed but (cc)
remained unaffected (xcomp)
do than (mark)
change medication (dobj)
initiate treatment (dobj)
stimulate micturition (dobj)
procedure anesthetic (amod)
tpa ( (punct)
2h mg/kg (compound)
is preponderance (attr)
amnesia mg/kg (dep)
experiments 8 (nummod)
lead . (punct)
n-nitroso-n-methylurea and (cc)
serotonin serotonin (conj)
receptor glur5 (compound)
decreased vip (nsubj)
binding on (case)
gaps of (case)
30 16 (compound)
controls polydrug (compound)
delayed enhancement (dep)
shown has (aux)
catheter conductance (compound)
intranasal , (punct)
saline preceded (acl)
alterations resembling (acl)
titer volume (conj)
variation inter- (amod)
total % (appos)
protocol sedation (compound)
receive did (aux)
mouse-1 1.5 (nummod)
occurred jaundice (nsubj)
findings electroencephalography (nmod)
medicine this (det)
cases fatal (amod)
defect field (compound)
caused sem (conj)
denervated had (aux)
lower significantly (advmod)
decreased effects (dobj)
model pain (compound)
function scale (conj)
conclusions promotes (appos)
diminish may (aux)
paroxetine sertraline (conj)
abdomen the (det)
proven incidence (nmod)
% successful (amod)
fragments the (det)
tests induced (amod)
systolic on (case)
recurrence from (case)
glimepiride p=0.192 (appos)
cases infiltration (nmod)
disarrangement with (case)
pretreatment 25.7 (conj)
eighteen 31 (nmod)
received death (nmod)
fischer 344 (nummod)
resolved hiccups (dobj)
sulfate-treated nicotine (nmod:npmod)
disorder undescribed (amod)
nimesulide paracetamol (conj)
men four (nummod)
antipsychotics atypical (amod)
treated labor (nmod)
studies learning (compound)
involvement of (case)
dependent excluded (parataxis)
month water (appos)
evidence coagulation (nmod)
alleviates penile (xcomp)
conversion target (nmod)
t alone (advmod)
incomplete data (nsubj)
correlate severity (nsubj)
mg/kg i.p. (advmod)
response neurotoxic (amod)
toxicity tacrolimus (compound)
experience macrolides (nmod)
propranolol with (case)
bradycardia of (case)
observed alterations (nsubjpass)
risks cancer (nmod)
processes astrocytes (nmod)
wave arterial (amod)
persisted adrenalectomy (nmod)
revealed tests (nsubj)
exerted vehicle (nmod)
shown as (mark)
collected preischemia (dobj)
finding : (punct)
followed test (nmod)
peptide is (cop)
40 to (advmod)
observed pattern (nsubjpass)
rats laboratory (nmod)
decrease leading (acl)
inhibited were (auxpass)
therapy years (nmod)
oxcarbazepine oxc (appos)
difficulty the (det)
mononucleosis infiltrate (nmod)
exclude , (punct)
concentration localized (amod)
mg 0.1 (nummod)
hbv wild-type (amod)
chemotherapy intracavitary (amod)
tissue fraction (conj)
nicotine of (case)
panel lipid (compound)
intensity line (appos)
na/k-atpase aqp1 (conj)
1.56 ( (punct)
complained paresthesias (nmod)
drug associated (acl:relcl)
15 3 (compound)
polyuria of (case)
rejection refractory (amod)
indicate limited (ccomp)
withdrawn presentation (nmod)
had outcome (dobj)
relationship concentration-effect (amod)
d-amphetamine phencyclidine (conj)
results present (dep)
controlled lorazepam (nmod)
hyponatremia syndrome (conj)
receptor a2a (compound)
elements dopaminergic (amod)
context the (det)
contraindication using (acl)
been occurred (ccomp)
mmhg 11.5 (appos)
smear on (case)
sweating ( (punct)
reduced partly (advmod)
classification features (conj)
d11 , (punct)
99 +/- (cc)
values age (conj)
improving comparison (nmod)
infections staphylococcal (amod)
hospital memorial (compound)
ethopropazine a (det)
represents drug (dobj)
3-hydroxy-n-methylmorphinan of (case)
proves potent (advcl)
hematoxylin in (case)
development neuropathy (nmod)
development nafld (nmod)
disappeared began (advcl)
suppression twitch (compound)
recovered function (nsubjpass)
actions fenoterol-hydrobromide (nmod)
200 100 (compound)
devices plus-maze (amod)
reacts , (punct)
age 108 (nummod)
increased volume (nmod)
precede circling (dobj)
fluency not (neg)
nmol/kg 70 (nummod)
entity of (case)
administration min (dep)
correlates severity (nsubj)
suitable . (punct)
artery normal (amod)
activation fibers (nmod)
lna+lca = (amod)
mg compressions (dep)
medication a (det)
give toxicity (nmod)
important clinical (dep)
48 8 (conj)
common clonidine (nmod)
use anthracyclines (nmod)
climbing , (punct)
potentiated not (neg)
organisms common (amod)
combinations with (case)
changes engaged (acl)
preserves that (mark)
ability system (nmod)
stimulation hypersensitivity (conj)
urticaria/angioedema nsaid-induced (amod)
vary study (nmod)
made diagnosis (nsubjpass)
cases germany (nmod)
day completion (nmod)
wistar hannover (compound)
improved use (nsubj)
limit mg/m2 (appos)
suggested inflammation (nsubjpass)
anemia ribavirin-related (amod)
cells bone (compound)
prevalence given (case)
history thrombocytopenia (nmod)
always almost (advmod)
mazindol with (case)
vision color (compound)
word first (amod)
resolved stopping (advcl)
found layer (nmod)
number this (det)
ed1 for (case)
multicenter 16-week (amod)
male ( (punct)
area motor (compound)
ameliorated responses (dobj)
eosinophilia erythroderma (conj)
presence nm (dep)
injections haloperidol (nmod)
0.01 ( (punct)
presented type (nmod)
( cs (dep)
away other (nmod)
5 up (advmod)
lopinavir/ritonavir of (case)
concentrations peak (compound)
preventing reactivation (dobj)
have malignancies (dobj)
varying rates (dobj)
leg right (amod)
benserazide mg/kg (appos)
period refractory (amod)
reduction symptoms (nmod)
action necessary (amod)
similar hyperactivity (nsubj)
efficacy parallel-groups (amod)
important determining (advcl)
constants time (compound)
values given (acl)
day one (nummod)
common subgroup (nmod)
alternative patients (nmod)
nicardipine and (cc)
left volume (dobj)
levels uric (amod)
model seizure (amod)
subjected episodes (nmod)
remained values (nsubj)
dose 10 (nummod)
suitable had (advcl)
diltiazem admission (compound)
junction both (cc:preconj)
veratridine administered (amod)
resembles rats (nsubj)
evaluation studies (conj)
disruption elimination (nmod)
indicating influence (ccomp)
recurrence disturbances (nmod)
drugs iv (nummod)
decreased mean (advcl)
began and (cc)
effects chemotherapy (nmod)
tested and (cc)
myelosuppression and (cc)
diminished using (advcl)
alkylating particularly (advmod)
intravenously mg/kg (conj)
digitalis- for (case)
patients 94 (nummod)
nephrogenic and (cc)
beats/minute 65 (nummod)
contributed failure (nmod)
inhibition : (punct)
sepsis to (case)
episode first (amod)
examined year (nmod)
changes transport (nmod)
eads its (nmod:poss)
hyperplasia epithelial (amod)
suspended ml (nmod)
pointes presentation (appos)
role , (punct)
presented case (nsubj)
treated mg/d (nmod)
had moderate (dobj)
suggest produced (ccomp)
investigation despite (case)
doses 20- (compound)
peptide basic (amod)
inhibitor acylamidase (compound)
l-alpha-gfc and (cc)
98.7 4.2 (conj)
known system (nsubjpass)
ratio 1.85 (conj)
nausea injection-site (conj)
report case (nmod)
underlying effects (dobj)
increased malondialdehyde (dobj)
1.0 0.81 (conj)
1.56 aspirin (nmod)
greater shr (nmod)
18/88 +/- (cc)
substituting vpa (dobj)
mania patients (nmod)
attenuated anxiety (nsubjpass)
effective pyridoxine (advcl)
f2 design (conj)
mycophenolate mofetil (dobj)
subdivided circles (nmod)
432 346 (conj)
dosage type (conj)
hours h. (compound)
nausea postoperative (amod)
mk801 receptor (compound)
had pregnancy (nmod)
nephroprotectant as (case)
effect thyroid (nmod)
detected rejection (nsubjpass)
death treatment-related (amod)
features clinico-pathological (amod)
tests dobutamine (amod)
after even (advmod)
rates at (case)
compared outpatients (nsubjpass)
decreased response (nsubjpass)
identified inpatients (nmod)
aura an (det)
cross-react a (nmod)
secondary is (cop)
properties tacrolimus (nmod)
observed d (nmod)
normalized weeks (nmod)
result deposited (acl)
effect reduced (acl:relcl)
identified p-aminophenol (nsubjpass)
bipolar bipolar (nmod)
form fas (nmod)
sequelae no (det)
cases desire (nmod)
mean in (case)
inhibitor group (compound)
received occurred (advcl)
measured induced (advcl)
decreased acuity (dobj)
reduced content (nsubjpass)
electrodes recording (conj)
observed if (mark)
animals dx (nmod)
protect completely (advmod)
1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine ) (punct)
monotherapy clonazepam (compound)
changes behavior (nmod)
events heart (compound)
high irrespective (conj)
useful echocardiography (nsubj)
seizures amphotericin (compound)
november in (case)
ppm 100 (nummod)
probable association (nsubj)
efferent the (det)
tried , (punct)
shunt . (punct)
genotypes of (case)
leakage ) (punct)
demonstrated association (dobj)
tests acetic (amod)
consisted and (cc)
considered unlikely (xcomp)
demonstrate contribute (ccomp)
displays inhibitor (nsubj)
evidenced sediment (nmod)
0.03 to (dep)
56.8 +/- (cc)
termed mean (nsubjpass)
lnna no (compound)
declined progressively (advmod)
gabapentin i (dep)
patients thirty-six (nummod)
methods sensitive (amod)
defects associated (acl)
inhibitors converting (compound)
appears effect (xcomp)
results months (appos)
ctnt maximal (amod)
arose cases (nsubj)
dex ) (punct)
therapy high (amod)
benefits implications (conj)
salbutamol like (case)
antibodies failure (nmod)
reverting partially (advmod)
improve but (cc)
prescribing it (dobj)
discriminates inhibited (parataxis)
anterior posterior (conj)
arag ( (punct)
exposure halothane (nmod)
patients dysfunctions (appos)
2-fold and (cc)
processed , (punct)
alterations strain (nmod)
preserve that (mark)
level blood (compound)
reported results (nsubjpass)
prove , (punct)
reduced vulnerability (nsubj)
report atin (nmod)
hyperhidrosis compensatory (amod)
model epilepsy (nmod)
showed median (nmod)
0.95 0.92 (compound)
tri given (acl)
events akathisia (nmod)
found sequelae (nsubjpass)
survived sequelae (nmod)
fentanyl to (case)
22 to (quantmod)
administered days (nmod:tmod)
provide they (nsubj)
amnesia short-term (amod)
mg/m2 4,210 (nummod)
modulator potent (amod)
dose cumulative (amod)
change scr (nmod)
dose d (nmod)
evaluated recall (nsubjpass)
extract renal (amod)
followed again (advmod)
medulla inner (amod)
b-d-glucosaminidase n-acetyl (amod)
sample % (appos)
disease myopathic (amod)
accompanied production (nmod)
employing by (mark)
incidences liver (nmod)
inhibitor-1 activator (compound)
adjustment or (cc)
explored importance (dobj)
elevation upregulation (conj)
52 6 (compound)
associated behaviours (nmod)
importance of (case)
considered suitable (xcomp)
life-threatening may (aux)
bid , (punct)
salt more (amod)
responded . (punct)
drinking volume (dep)
arabic failure (nmod)
states complex (amod)
putamen left (amod)
signaling the (det)
partition tam (compound)
ability an (det)
study group (compound)
development sexual (amod)
similar males (nmod)
inhibitors : (punct)
methadone 167 (compound)
linked were (auxpass)
decline % (nmod)
stenosis with (case)
sensitive mice (nsubj)
flk-1/kdr ) (punct)
class nfs (nmod)
modified induced (amod)
affect whereas (mark)
iu/l ) (punct)
demonstrates participation (dobj)
blockade later (advmod)
derivative elicit (acl:relcl)
treatment single (nmod)
hepatic recovery (dep)
conditions acidic (amod)
stages events (nmod)
patients municipal (nmod)
profile an (det)
involves epicardial (dobj)
day complaints (nmod)
extract a (det)
modulated can (aux)
requested , (punct)
asa [ (punct)
characteristics treatment (compound)
agent topical (amod)
lipid total (amod)
indicate have (ccomp)
effect : (punct)
day solution (conj)
rtms following (case)
recognition discontinuation (conj)
hypertension < (compound)
temocapril ( (punct)
days several (amod)
patient 2 (nummod)
attribute be (cop)
toxicity until (case)
cbf and (cc)
homeostasis diazinon (compound)
as immunosuppressant (amod)
irrespective diet (nmod)
agent known (acl)
inhibition by (case)
treatment dependence (nmod)
group lag (appos)
combination each (det)
problem significant (amod)
site in (case)
months between (case)
experiences individuals (nmod)
prevalence disturbance (nmod)
fourteen % (appos)
reported effects (nsubj)
brain activities (conj)
subtype receptor (compound)
reducing exposures (dobj)
patients relatives (conj)
zones separate (amod)
type at (case)
features facies (nmod)
blocks local (amod)
investigate ameliorated (ccomp)
antibiotics nephrotoxic (amod)
lower c (dep)
important hypovolemia (nmod)
latency and (cc)
hyperalgesia accompanied (acl:relcl)
shows precipitate (ccomp)
recognised are (auxpass)
8 6 (compound)
mo during (case)
effects csa (nmod)
limitations activity (nmod)
showed days (nmod:tmod)
fear nausea (conj)
release c (compound)
assay blot (compound)
insertion shunt (compound)
withdrawal simvastatin (nmod)
locomotion in (case)
capable and (cc)
involved finally (advmod)
group isoflurane (compound)
airway frlma (appos)
similar neuropathy (nmod)
controls six (nummod)
cause injury (nsubj)
malondialdehyde increased (amod)
growth and (cc)
treat types (dobj)
pretreatment causing (advcl)
survived have (aux)
anxiety glial (conj)
used ventricles (conj)
alone and (cc)
hemolysis and (cc)
mcl inhibitor (appos)
motility jejunal (amod)
causes depression (dobj)
antagonize does (aux)
propose induce (ccomp)
ami and (cc)
arrhythmias cardiovascular (amod)
higher frequency (nsubj)
substantiated functional (ccomp)
enrolled mg (dep)
criteria disorder (nmod)
volumetry patients (nmod)
seen glands (nmod)
history clinical (amod)
myopathy transplantation (nmod)
pentylenetetrazole agonist (compound)
systematic retrospective (dep)
reduces warfarin (nsubj)
later month (nmod:npmod)
immediately i.v. (advmod)
dosing before (case)
started complemented (conj)
remained different (xcomp)
measured day (nmod)
reached = (parataxis)
impairment to (case)
two four (conj)
characteristics with (case)
injected followed (dep)
implicated lithium (nsubjpass)
5.0 - (punct)
assembly lipoprotein (compound)
produce efficacy (dobj)
other lad (nmod)
rats freely-moving (amod)
normalized eventually (advmod)
mg/dl 0.3 (nummod)
inhibitor calcification (compound)
activity system (nmod)
ratio an (det)
micromol/liter p<0.05 (appos)
escalated mg/day (nmod)
complete ; (punct)
carried point (nmod)
lower dosage (nsubj)
neurons glutaminergic (amod)
1.60 - (punct)
length neither (cc:preconj)
tramadol combined (acl)
reduce regions (nmod)
factors and (cc)
viewed use (nsubjpass)
syndrome cytopathy (dep)
contribution from (case)
homeostasis cholesterol (compound)
comparison toxicity (nmod)
factors development (nmod)
electrolyte but (cc)
control corresponding (amod)
chemotherapy dose (compound)
relative nsaids (nmod)
correlate ed50 (nsubj)
detected while (mark)
chronic , (punct)
effect chebula (nmod)
tachycardia an (det)
hinder may (aux)
inhibited groups (nmod)
agonists dopamine (compound)
na(+)/k(+)-atpase aqp1 (conj)
curtailed , (punct)
bradyarrhythmia severe (amod)
negative been (cop)
part striatum (nmod)
days exposure (nsubj)
mk-801 , (punct)
min 180 (nummod)
showed function (nsubj)
examination examination (conj)
difference effects (nmod)
did that (nsubj)
p than (case)
drugs oral (amod)
nephropathy effect (nsubj)
frequently the (det)
oralis ventralis (compound)
research past (amod)
deduced softly (advmod)
courses treatment (nmod)
ketamine with (case)
spasm be (cop)
cases 381 (nummod)
miss justification (nmod)
sensitivities specificities (conj)
activity bupivacaine (nmod)
moderate hepatitis (nmod)
protect mice (dobj)
shown antioxidant (dobj)
facility outflow (amod)
i.v. intravenously (advmod)
administered fluconazole (nsubjpass)
injected edaravone (nmod)
cells stem (compound)
temperament , (punct)
p2x3 of (case)
were users (nmod)
blocked treatment (nsubj)
fever high (amod)
likely indicates (ccomp)
include effects (nsubj)
clinical or (cc)
receiving anticonvulsant (dobj)
gfap ) (punct)
treated epo (nmod)
contribute additionally (advmod)
presumed tolerated (parataxis)
tet neither (cc:preconj)
tapered was (auxpass)
rhabdomyolysis and (cc)
cips ): (punct)
ephedrine/propofol/mixtures of (case)
accepted cause (advcl)
50 up (quantmod)
kb gene (nmod)
reduced lysis (nmod)
demonstrated analyses (nsubj)
occlusion vein (compound)
similarity chemical (compound)
time transplant (nmod)
prescribed telithromycin (dobj)
enrolled or (cc)
levodopa as (case)
occlusion branch (compound)
information recorded (acl)
correlation concentrations (nmod)
established implicated (advcl)
markers pre (amod)
extent doses (nmod)
dose mg/m2 (appos)
week times (nmod)
defined dose (nsubjpass)
profile toxicity (conj)
ester inhibitor (compound)
inhibiting effect (dobj)
ci 1.60 (nummod)
value population (nmod)
produced doxorubicin (nmod)
biochemical haematological (conj)
artery right (amod)
hirsutism or (cc)
administration weeks (nmod)
studied hypertension (nmod)
streptomycin of (case)
performance biopsy (nmod)
carcinomas in (case)
infusion intracoronary (amod)
calculations on (case)
myoclonus de (amod)
tdi ) (punct)
metabolites major (amod)
ci , (punct)
fluphenazine by (case)
associated infusion (nsubjpass)
contrast verapamil (nmod)
revealed conversion (nsubj)
enhancement co-administration (nmod)
hc ) (punct)
react 2e1 (nmod)
tested plasma (nsubjpass)
differences statins (nmod)
reverted normal (nmod)
safe potent (conj)
question option (nmod)
moreover , (punct)
and vivo (advmod)
engagement the (det)
patients tomography (appos)
suggest not (neg)
administration vancomycin (nmod)
followed another (nmod)
tgf- b (dep)
arteries epicardial (amod)
acne and (cc)
20.95 + (cc)
cells layers (nmod)
affected diagnosis (nmod)
objective assess (acl)
confirmed themography (nsubj)
changes blood (compound)
effects retention (compound)
which to (case)
seizure induced (acl)
mg/kg by (case)
have should (aux)
examined further (advcl)
12.2 15.1 (compound)
view association (nmod)
case and (cc)
asphyxia criteria (nsubj)
bcnu with (case)
characterized dyschromatopsy (nmod)
findings clinical (amod)
blue cuprolinic (amod)
addition drug (nmod)
determination extraction (nmod)
offered description (dobj)
series haloperidol (appos)
mice young (amod)
associated cocaine (nmod:npmod)
administration anticoagulant (compound)
changes levels (nmod)
exists . (punct)
presented woman (nsubj)
weeks four (nummod)
play to (mark)
found associated (ccomp)
swelling angioedema (dep)
antagonist benzodiazepine (compound)
problem involves (advcl)
anesthetic prilocaine (nsubj)
exceed patients (nmod)
preinfusion ( (punct)
bed to (case)
suggestive relationship (nmod)
hyperplasia of (case)
employed anaesthesia (nsubjpass)
margin layer (nmod)
cr ( (punct)
44 in (case)
attenuate some (dobj)
response lasting (acl)
angina hypertension (conj)
homogenates of (case)
age patients (conj)
release ach (nmod)
propranolol disease (nmod)
measured objective (dobj)
subtypes receptor (compound)
cells/mm3 and (cc)
glioma for (case)
seizures between (case)
discontinued exceeded (advcl)
protein c-reactive (amod)
experiencing before (mark)
years < (dep)
patients 29 (nummod)
rise proteinuria (nmod)
alpha2- with (case)
from day (nmod)
use including (case)
evaluated magnitude (dobj)
fluorouracil [ (punct)
reported episodes (dobj)
carcinogens by (case)
lactate plasma (compound)
antiviral adequate (amod)
confounding of (case)
hepatocytes the (det)
clarify to (mark)
occurred effects (nsubj)
has background (nsubj)
fluoxetine mg/kg (appos)
range antidepressants (nmod)
paralysis intraoperative (amod)
negligible . (punct)
paced he (nsubjpass)
controls 15 (dep)
macaques ) (punct)
challenge parenteral (compound)
b1r(-/- dox (compound)
animals survived (acl:relcl)
results male (appos)
detect damage (dobj)
scattered minority (nsubjpass)
temperature mice (nmod)
mice lithium-fed (amod)
edema infiltration (conj)
epinephrine was (cop)
attenuated are (auxpass)
somnolence and (cc)
ax ( (punct)
affect thus (advmod)
volumetric , (punct)
enhancement , (punct)
describe briefly (advmod)
engineered genetically (advmod)
toxicity adriamycin (compound)
number glomerular (amod)
nodosum acid-induced (amod)
patients anemia (nmod)
remained % (nmod)
administered rates (nmod)
presentation clinical (amod)
investigate coinciding (conj)
concentration potassium (compound)
deficit highest (amod)
transport 962 (dep)
nutrition with (case)
risk seroconversion (nmod)
monitored ecg (nmod)
studied monkey (nmod)
reflect although (mark)
measures outcome (compound)
nephrotoxicity (aap)-induced (amod)
89/102 ( (punct)
discontinued should (aux)
volume equal (amod)
younger patients (nmod)
50 than (quantmod)
pain patients (nmod)
defined rise (nmod)
furosemide high-dose (amod)
kindled cocaine (nmod)
analyzed morphometrically (advmod)
flexion excessive (amod)
effects liability (conj)
analyzed concentration (nmod)
injection epidural (amod)
or 3.86 (dep)
vaccine in-hospital (amod)
high- od (appos)
gap43-ir iml (nmod)
cellular neither (cc:preconj)
treatment depression (nmod)
27 % (quantmod)
prod erod (conj)
risk range (nmod)
difference risk (nmod)
prevents if (mark)
assessed toxicities (nsubjpass)
conjugates n-(2-hydroxypropyl)methacrylamide (amod)
ccr 2.1 (dep)
srs ) (punct)
receiving previously (advmod)
diethylstilbestrol years (nmod)
activity convulsive (amod)
receive inputs (dobj)
movements levodopa-induced (amod)
stroke than (case)
hematuria with (case)
everolimus by (case)
20 was (cop)
13 7 (compound)
monoarticular pauciatricular (conj)
absence symptoms (nmod)
seizure gtcs (appos)
failure sepsis (conj)
cephalosporins , (punct)
second from (case)
transplantation during (case)
observed out (prep)
variables coagulation (compound)
transplant cell (compound)
retching appetite (conj)
having mice (dobj)
suppressed micrograms/ml (conj)
successful if (mark)
vocalization and (cc)
gaining . (punct)
those . (punct)
min duration (nsubj)
examined evidence (nmod)
men men (nmod)
infusion of (case)
concentration regions (nmod)
indicate allowing (advcl)
seen exposures (nmod)
potentiated dog (nmod)
patients hiv-infected (amod)
position another (det)
appearance with (case)
163 > (dep)
body the (det)
dismutase transferase (conj)
nephrotoxicity a (nmod)
improved ; (punct)
presented impotence (nmod)
involved hyperalgesia (nmod)
suspect we (nsubj)
interactions effects (nmod)
intraperitoneal or (cc)
was : (punct)
signaling cytokine (compound)
administration 5-fluorouracil (compound)
groups 3 (nmod)
diverse and (cc)
detected toxicosis (nsubjpass)
crea protein/mg (compound)
state to (mark)
fetus on (case)
2b1/2b2 1a1/1a2 (conj)
appearance factors (nsubj)
supports this (det)
25mg/kg 50mg/kg (conj)
changes compensatory (amod)
dawley male (compound)
extremities cold (amod)
hepatic , (punct)
report patient (dobj)
used corticosteroids (nmod)
infusion noradrenaline (compound)
atriotomy via (case)
reflection syndrome (nmod)
hemlock poison (compound)
-18 +/- (cc)
7.4 +/- (cc)
system messenger (compound)
conclusions correlates (appos)
hemianopsia pallidotomy (nmod)
use ppa (nmod)
fk deerfield (conj)
150 to (dep)
strains the (det)
offer and (cc)
populations human (amod)
measures effective (amod)
dysrhythmias bupivacaine (nsubj)
discuss adults (nmod)
shown also (advmod)
2d6 of (case)
capacity binding (compound)
failure alf (appos)
6-hydroxydopamine or (cc)
taken patient (nmod)
deficient by (case)
supplemented was (auxpass)
commencement therapy (nmod)
received haloperidol (conj)
shrinkage cell (compound)
treatment now (advmod)
diameter in (case)
represent subset (dobj)
subjects submitted (acl)
suxamethonium , (punct)
strategies aimed (acl)
prior paralysis (nmod)
catalepsy dose-dependent (amod)
surgery cardiac (amod)
results included (dep)
destruction the (det)
documented iv (nmod)
discussion . (punct)
effect with (nmod)
august 2008 (nummod)
joint the (det)
suxamethonium with (case)
transplantation of (case)
derivative etodolac (nmod)
supply cellular (amod)
ro4368554 mg/kg (conj)
man therapy (nmod)
action terminals (nmod)
malignancies for (case)
6.2 vs. (cc)
potentiate may (aux)
indicate interactions (dobj)
bche mother (conj)
doses and (cc)
excluding reports (dobj)
evidence as (case)
mechanism exerts (acl:relcl)
necrosis steatosis (conj)
liver perfused (amod)
carry to (mark)
requirement the (det)
studying respectively (advmod)
related ) (punct)
hospital to (case)
operation of (case)
glycopyrrolate and (cc)
drugs muscarinic (amod)
case % (appos)
diverging phenotype (nmod)
increased infusion (nsubj)
flow inspiratory (amod)
medulla rats (nmod)
neostigmine mg (nmod)
dunnett = (parataxis)
re-established . (punct)
reported : (punct)
recur had (conj)
diagnostic therapeutic (conj)
light data (nmod)
have insights (nsubj)
carried data (advcl)
cya less (amod)
reports glyburide (nmod)
depend contributed (conj)
nocistatin of (case)
3657 mcg (dep)
dose either (cc:preconj)
boy 10-year-old (amod)
tested amphetamine (nmod)
children 122 (nummod)
chemotherapy or (cc)
calcification no (neg)
mazindol the (det)
determination levels (nmod)
change threshold (nmod)
latency by (case)
methods patients (nmod)
identify strokes (dobj)
cystectomy early (amod)
had had (conj)
derivatives - (punct)
had placed (xcomp)
response prolactin (compound)
correlated toxicity (nsubjpass)
reduction mg/kg (nmod)
procedure , (punct)
study lometrexol (nmod)
rate disease (nmod)
prevalences testosterone (nmod)
diagnoses ( (punct)
treated being (auxpass)
increased length (nmod)
contain metabolite (dobj)
responsible influence (nmod)
view have (ccomp)
iso ) (punct)
unsafe anticoagulation (conj)
known ) (punct)
increase bilirubin (nmod)
decrease facilitate (conj)
changes ratios (nmod)
toxicities six (nmod)
stress urinary (amod)
found bradycardic (xcomp)
frequency from (case)
ce r2 (appos)
cytokines and (cc)
presented administration (nmod)
distinguish studies (nsubj)
testing retrieval (compound)
examination thrombocytopenia (nmod)
demonstrated stimulation (nsubjpass)
replicated advantage (nsubjpass)
diminish . (punct)
hepatomegaly preceded (acl)
growth both (cc:preconj)
repeated should (aux)
findings histopathologic (amod)
terminated analysed (conj)
fk usa (dep)
reduced thus (advmod)
, clentiazem (dep)
use medium (nmod)
1.46+/-0.8 ( (punct)
records persons (nmod)
= , (punct)
patients as (advmod)
accumulation brain (nmod)
variability intra-individual (amod)
fraction reduced (amod)
antimuscarinic centrally (advmod)
excluded tumors (nsubj)
pronounced also (advmod)
damage pronounced (amod)
effective dose-dependent (conj)
method applicable (amod)
median for (case)
microsomal cytosolic (conj)
hypothesis involved (ccomp)
schedules dosage (compound)
dose reporting (conj)
3.6 [ca]o (quantmod)
disorders schizophrenia (nmod)
double compared (advcl)
components dementia (nmod)
induce hypothermia (dobj)
inhibitor growth (compound)
magnitude pressure (nmod)
binding protein (compound)
inhaled nicotine (dobj)
nucleus pedunculopontine (compound)
patients improved (acl)
associated consumption (nmod)
suggests strongly (advmod)
methyldopa hepatic (conj)
contractility hypersensitivity (conj)
pce and (cc)
akinesia base (nmod)
seen be (auxpass)
developed fashion (nmod)
antihuman virus (dep)
stl1 stl2 (conj)
rate hypotony (nmod)
mg/dl mg/dl (nmod)
4.7 ( (punct)
reaction recurred (acl)
had phacoemulsification (dobj)
became animals (nsubj)
events deaths (conj)
alprazolam mg (nummod)
occurrence with (case)
undergoing endarterectomy (dobj)
scored doses (nmod)
responsiveness verapamil (compound)
groups can (compound)
learning associative (amod)
uh with (case)
dose this (det)
administered nicotine (xcomp)
showed signs (dobj)
requested day (nmod:tmod)
contained immediately (advmod)
l2 l5 (conj)
excitation gyrus (nmod)
action mpep (nmod)
stands out (compound:prt)
unmatched the (det)
trial i (nummod)
values found (acl)
decreased : (punct)
noted observed (conj)
removed see (advcl)
hallmark loss (nsubj)
hr 1.68 (nummod)
proteinuria significant (amod)
rash therapy (conj)
disruption consolidation (nmod)
induction znso(4 (nmod)
terminating treatment (dobj)
2.35 ( (punct)
cases 2 (nummod)
detection infarction (nmod)
toxicity tissues (nmod)
cromakalim pinacidil (conj)
symptoms psychosis (nmod)
induce ability (nmod)
half women (nmod)
receive lozenge (dobj)
effect an (det)
terms anticancer (nmod)
coordination force (compound)
predict effects (dobj)
animals sodium (compound)
hallmark the (det)
effect vasopressor (compound)
68 , (punct)
fetus her (nmod:poss)
diagnosis thrombocytopenia (nmod)
day next (amod)
haematological % (dep)
scotoma bitemporal (amod)
signed consent (dobj)
make . (punct)
developing neuropathy (dobj)
signs without (case)
open- their (nmod:poss)
affected cells (nsubjpass)
pilsicainide , (punct)
gram-positive , (punct)
acetate leuprolide (compound)
targeted . (punct)
peak nerve-evoked (amod)
indicates , (punct)
improved increased (conj)
pain signs (nsubj)
agonist as (case)
component hyperthymia (amod)
suggesting contribute (ccomp)
exhibit would (aux)
led that (nsubj)
gyki-41 099 (nummod)
sleep deep (amod)
referred to (prep)
hypertension persistent (amod)
mg/m(2 2,600 (nummod)
ci = (amod)
sufficient whether (mark)
co-infection virus (compound)
bilirubin the (det)
stimulated zymosan (nmod)
trends elevation (nmod)
downregulation receptor (compound)
degeneration detachment (conj)
mean+/-s.e. ) (punct)
knockout in (case)
counts preoperatively (advmod)
regression tumor (compound)
restored . (punct)
remained patients (nmod)
supports case (nsubj)
respond detection (advcl)
anesthesia after (case)
syndrome of (case)
protecting pilocarpine (nmod)
concentrations vasopressin (nmod)
paradigm an (det)
overdose u/ml (dep)
produced dosages (nsubj)
pale . (punct)
parameters by (case)
examined all (nsubjpass)
induced courses (nmod)
inhibitors reuptake (compound)
generated rat (dobj)
patients died (acl:relcl)
elicits clonidine (compound)
ingesting . (punct)
% p (appos)
alterations all (predet)
led observations (nsubj)
mice green (amod)
min 77.1 (nummod)
dose supratherapeutic (amod)
ari ( (punct)
prostaglandins pgs (appos)
low years (nmod)
0.014-unit amount (appos)
use globulin (nmod)
d-amb ) (punct)
preexposure provided (conj)
323+/-43 p<0.05 (appos)
earlier apparent (advmod)
dysfunction autonomic (amod)
overdose from (case)
modulate , (punct)
aneurysm cerebral (amod)
inhibition density (compound)
dependence heroin (amod)
oropharynx cavity (dep)
5.00 diopters (dep)
echocardiography morphology (conj)
toxicity induced (acl)
paralysis following (case)
sympathomimetic a (det)
intervals at (case)
cpb in (case)
thrombi no (det)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate of (case)
days gtn (compound)
fever neutropenic (amod)
chemotherapy disease (nmod)
metolachlor applicators (nmod)
development ulcers (nmod)
everolimus with (case)
activate induce (conj)
result modulation (nsubj)
tolerability . (punct)
results finished (appos)
percent level (nmod)
tremor % (appos)
responses cpap (nmod)
mechanisms control (compound)
patients high- (nmod)
needed cases (nmod)
delivery after (case)
causing pain (dobj)
site receptors (nmod)
formation antibodies (nmod)
s control (appos)
required treatment (nsubjpass)
decreased amounts (dobj)
has cocaine (nsubj)
cycles chemotherapy (nmod)
changes increased (dep)
effect patients (nmod)
seem excluded (advcl)
removed azt (nmod)
204 l/hour/m2 (dep)
neuralgia chronic (amod)
compared controls (nmod)
polymerase anti-hbe (appos)
occurred proceeded (advcl)
lesions with (case)
patients infected (amod)
seizures of (case)
ce target (compound)
modulated . (punct)
fl ) (punct)
abundant dpi (nmod)
analyzed test (xcomp)
hemorrhage induced (acl)
group 30 (appos)
magnitude sides (nmod)
common was (cop)
treated lisinopril (nmod)
patterns histological (amod)
succinylcholine with (case)
degeneration toxic (amod)
administration estrogen (nmod)
administered detected (advcl)
excluded effects (nmod)
lack teratogenicity (nmod)
thought . (punct)
patient kidney (nmod)
remarkable hypertension (nmod)
aggressiveness toward (case)
150 x (cc)
acid ha (appos)
fetal , (punct)
appear increase (nsubj)
bringing together (advmod)
study further (amod)
random-assignment trial (conj)
drug be (cop)
retardation and (cc)
resolved persisted (conj)
amphetamine mk-801 (conj)
clinics psychiatry (compound)
prevents : (punct)
embryos mouse (compound)
hcfc 123 (nummod)
affecting control (dobj)
was demonstrated (conj)
formyltransferase enzyme (appos)
cases five (nummod)
ng/ml ) (punct)
67 - (punct)
background progress (dep)
depressed excitability (nsubjpass)
ssris with (case)
needed as (mark)
implicated species (nsubjpass)
dpi ( (punct)
that over (case)
specific was (cop)
bradycardia between (case)
revealed difference (dobj)
mg/kg 600 (nummod)
overnight in (case)
effect factor (nsubj)
present other (nmod)
decreased coadministration (nsubj)
developing day (nmod)
risk prevalence (conj)
glaucoma a (det)
suffering are (aux)
girl 3-year-old (amod)
response regimens (nmod)
pregnancy throughout (case)
comparison clinical (amod)
california of (case)
accuracy the (det)
1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine ( (punct)
stomatitis , (punct)
effect oxcarbazepine (nmod)
clarithromycin 1 (conj)
distributed surface (nmod)
depleted pcpa (nsubj)
oxide edrf (compound)
high % (appos)
ritonavir the (det)
10(9 ) (punct)
institutions several (amod)
monitor function (dobj)
speed and (cc)
agent tspa (nsubj)
squealing , (punct)
infusion acid (compound)
data us (compound)
intervention inserted (dep)
carcinoma pelvis (nmod)
classed . (punct)
measured observed (conj)
days then (advmod)
brain human (amod)
cardiomyocytes aberrant (amod)
patients beta-thalassemic (amod)
related induce (conj)
journals abstracts (conj)
levels inhibitor-1 (compound)
pacemaker , (punct)
= 2.646 (dobj)
electrocardiograms vital (conj)
doses mg/kg (compound)
level cellular (amod)
investigating , (punct)
provide insight (dobj)
dose infusion-time (conj)
effects tested (acl)
analyzed allografts (dobj)
transplantation hemorrhagic (amod)
activity its (nmod:poss)
levels threshold (amod)
nephritis tubulo-interstitial (amod)
phytomitogen pha-p (appos)
perfusion-fixed and (cc)
mapped . (punct)
effects subsides (acl:relcl)
showed neuropathy (dobj)
inpatient in (case)
protocol layer (compound)
men trial (nmod)
k+ ) (punct)
is . (punct)
results despite (case)
serum patient (nmod:poss)
occurred dissociation (nsubj)
interview temperament (compound)
stimulations electrical (amod)
per cent (dep)
provides evaluation (nsubj)
affect but (cc)
inhibits administration (nsubj)
brain mouse (compound)
antagonist study (nmod)
group were (cop)
method detection (nmod)
compared users (nmod)
decreases time (nmod)
method radiofrequency (compound)
seizure self-limited (amod)
rats periods (nmod)
double mice (nmod)
products bradykinin (conj)
agent dystrophic (amod)
managing patient (dobj)
persist withdrawn (advcl)
felt hours (nmod)
noticed . (punct)
unknown incidence (nsubj)
such as (mwe)
use carbamazepine (nmod)
map vivo (advmod)
deficits significant (amod)
abolished only (cc:preconj)
complication potential (amod)
pressure diastolic (amod)
hours eighteen (nummod)
obtain to (mark)
% 83 (nummod)
15 21 (conj)
method analytical (amod)
deterioration progressive (amod)
toxicity anaesthetic (amod)
open question (nsubj)
concentration was (cop)
reduction cytotoxicity (nmod)
increased volume (nsubjpass)
diazepam picrotoxin (conj)
evaluated scale (nmod)
episode possible (amod)
chemotherapy alone (advmod)
c. for (case)
generalized overdosage-induced (amod)
csa weeks (nmod)
% values (nmod)
decreased map (dobj)
0 1.2 (prep)
prevented catalepsy (dobj)
suffering patient (compound)
fluoxetine ) (punct)
dependent been (cop)
performed later (advmod)
effect -a (punct)
when particularly (advmod)
l group (compound)
effects dizocilpine (nmod)
drugs to (case)
microgram/kg/min % (dep)
action triazolam (nmod)
produced have (aux)
suggest preferable (ccomp)
teratogenic results (advcl)
adr 's (case)
40,000 of (case)
hypercalcemia , (punct)
lots commercial (amod)
advocated . (punct)
protocol rapid (amod)
characterized damage (nsubjpass)
hcfcs ( (punct)
increased mmhg (dep)
complex human (amod)
revealed testing (nsubj)
considered be (auxpass)
year 1 (nummod)
etoposide daunorubicin (conj)
indicate results (nsubj)
non-drug nd (appos)
precipitated probably (advmod)
self-dosing frequent (amod)
metoclopramide of (case)
a/j c3h/hej (conj)
blockade-induced mtor (nmod:npmod)
ph low (amod)
water lemon (conj)
levels fas (appos)
troponin levels (dep)
patients phytomitogen (nmod)
measured higher (parataxis)
number subjects (nmod)
high- of (case)
performed prior (advmod)
modest clinical (dep)
therapy days (nmod)
safety effects (dep)
0.3-fold , (punct)
agents peripheral (amod)
trabeculectomies ( (punct)
small trials (nsubj)
g 25 (nummod)
effects antioxidant (amod)
mg/kg 18.7 (nummod)
sotalol , (punct)
output rate (compound)
ceased remained (conj)
restores performance (dobj)
% hag (nmod)
progressed session (nsubj)
inhibited administration (nmod)
tmp-smz ) (punct)
induction its (nmod:poss)
plays vasopressin (nsubj)
capacity decreased (amod)
injection bupivacaine (nmod)
p 9 (nummod)
mazindol placebo (conj)
unchanged calculated (advcl)
medication off (case)
derivative pyrrolidone (compound)
groups lateral (amod)
pill combination (compound)
modulation gabapentin-induced (amod)
lesions cerebral (amod)
thrombophlebitis , (punct)
receptor d2 (compound)
predict whether (mark)
suggests drug (ccomp)
complications these (det)
simvastatin 10 (nummod)
doses last (amod)
supply all (predet)
rating the (det)
evaluated h (dep)
cocaine anesthetics (dep)
sec. pci (nmod)
nine with (case)
discussed herein (advmod)
prior activity (nmod)
phenomena central (amod)
anemia in (case)
included plus (cc)
accl0131 ): (punct)
involves areas (dobj)
indicated remain (conj)
acid fa (appos)
started before (mark)
prevented have (aux)
prolonged period (nsubj)
ps group (appos)
transport-deficient the (det)
associated tachycardia (nmod)
myelosuppression loss (conj)
occurred recovery (nsubj)
suggested although (mark)
tube into (case)
alcoholic was (cop)
exerts and (cc)
program systems (dobj)
scale according (case)
case anca (compound)
tests positive (amod)
decreased result (nmod)
test glucose (compound)
amplitude for (case)
measure values (dobj)
measured study (nsubj)
model diabetic (nmod)
glycopyrrolate ) (punct)
gain of (case)
dose trazodone (nmod)
cells superficial (amod)
dose following (case)
material extracellular (amod)
occurrence as (cc)
intoxication chlormethiazole (compound)
ami for (case)
occurring therapy (nmod)
mesna 's (case)
dilated partially (advmod)
ouabain weight (appos)
given weeks (dobj)
pathogeneses the (det)
constipation-predominant n (conj)
doses separate (amod)
120 - (punct)
grade hemorrhage (nmod)
applying after (mark)
failure heart (compound)
safe , (punct)
abilities function (conj)
increased diet (nsubj)
% 66.7 (nummod)
effects cumulative (amod)
cases many (amod)
cells injected (acl)
described detail (nmod)
generation normal (amod)
women were (cop)
hallmarks the (det)
interfere not (neg)
cdt postthrombectomy (compound)
= olanzapine (dep)
showed dose (ccomp)
cy of (case)
ameliorates injury (dobj)
leukemia cns (compound)
response vessel (nmod)
administered investigate (advcl)
aprotinin inhibitor (appos)
inhibited nik-247 (nsubj)
properties a (nmod)
characterized clinically (advmod)
fasciculation visible (amod)
iqr ] (punct)
infection organs (nmod)
studied protection (nsubjpass)
analysis ) (punct)
agents potent (amod)
designed achieve (xcomp)
showed loss (dobj)
angiotensinogen with (case)
data based (case)
results testosterone (nmod)
prudent confirmed (advcl)
isoprenaline dogs (nmod)
slower , (punct)
signal potential (dep)
tacrine , (punct)
evaluate function (dobj)
complained and (cc)
prevented decrease (dobj)
acetylsalicylate caffeine (conj)
liver vitro (advmod)
patients 12 (nummod)
patients 246 (nummod)
improve also (advmod)
forming capacity (conj)
receptor 1 (nummod)
started lmwh (dobj)
group treat (compound)
increased dipyridamole (nsubj)
accounted number (nmod)
stimulation tetanic (amod)
stimulation mechanism (nmod)
increased values (dobj)
receiving prilocaine (dobj)
disappearance ducts (nmod)
treated prochlorperazine (nmod)
polymorphism a (det)
occurs inhibition (nmod)
vasculitis positive (amod)
3.32 x (cc)
apap ( (punct)
dosing concomitant (amod)
changed snr (nmod)
stopped reduced (conj)
hypotension block (compound)
jerks of (case)
results sprague-dawley (nmod)
disorder demyelinating (amod)
participation system (nmod)
translocation calpain (nmod)
severe necessitate (nmod)
healthy younger (dep)
seizure loci (dobj)
death outcome (nsubj)
receiving clonidine (dobj)
reduction minutes (nmod)
therapy sodium (nmod)
meningitis confirmed (amod)
-18 and (cc)
% day (compound)
black frequently (advmod)
vasculitis parameters (conj)
strain rat (compound)
observed effects (dobj)
diagnose and (cc)
concentration citalopram (nmod)
observed doxorubicin/kg (nmod)
antagonized mm (dep)
bupropion for (case)
puberty at (case)
seizures , (punct)
factors prolongation (nmod)
sulfate atropine (compound)
motion , (punct)
proportion total (nmod)
clinicians cautious (xcomp)
tolerated cabergoline (nsubjpass)
case woman (nmod)
ml. combination (nmod)
assess evaluate (conj)
transplantation hematopoietic (amod)
long short (conj)
resembles cystitis (dobj)
proteins these (det)
provokes metoclopramide (nsubj)
impair may (aux)
factors , (punct)
edema to (case)
> 0.71 (nummod)
noticed she (nsubj)
exam physical (amod)
study injection (compound)
activity cytochrome (compound)
manifest that (nsubj)
generated ) (punct)
compared edds (nsubjpass)
variables pre- (amod)
pre-existing aminonucleoside-induced (conj)
developed after (mark)
infused before (advmod)
snaps ) (punct)
increases loss (dobj)
inefficient . (punct)
receiving later (advmod)
part dorsal (compound)
10 % (dep)
vincristine of (case)
celecoxib 1.34 (nummod)
modifiable are (cop)
received received (advcl)
slower i.v. (xcomp)
girl of (case)
containing antigens (dobj)
shift akathisia (conj)
noted had (conj)
volunteers patients (conj)
gwardamangia , (punct)
remedies in (case)
gland the (det)
reaching significance (dobj)
markers elevated (amod)
lacks . (punct)
mg/kg/daily 5 (nummod)
undergone catheterizations (dobj)
apparent decreases (nmod)
-0.97 = (amod)
management appropriate (amod)
suggested enhances (ccomp)
woman treated (acl)
co-carcinogen carcinogenesis (nmod)
plasma urine (conj)
differ values (nmod)
treatment hyperprolactinemia (nmod)
antiemetics of (case)
task spontaneous (amod)
4.10 rate (nsubj)
injury radiation (compound)
uterotonic given (dep)
relevant most (advmod)
lesion massive (amod)
performed online (advmod)
syncope patient (nsubj)
withdrawn were (auxpass)
need develop (acl)
causing discharges (dobj)
assessed used (conj)
caused that (nsubjpass)
enhancement phenobarbital (nmod)
systems microsomal (amod)
patients exposed (acl:relcl)
disease stage (compound)
week within (case)
objective complete (dep)
7931 392.8 (conj)
longitudinal circumferential (conj)
aged : (punct)
age=23.3 % (dep)
indicates evidence (nsubj)
treatment topical (amod)
highlighting onset (dobj)
normal concentration (nsubj)
disease neuromuscular (amod)
retinoblastoma for (case)
events 30-day (amod)
pituitaries from (case)
therapy nsclc (nmod)
demonstrate occurs (ccomp)
pacemaker and (cc)
accuracy recognition (compound)
hepatocarcinogenesis for (case)
saline alfentanil (conj)
metabolized might (aux)
threshold generation (nmod)
interactions clear (amod)
objectives : (punct)
lamivudine patients (nmod)
tamoxifen drug (appos)
terms defining (advcl)
stopped recurs (nsubjpass)
angiography discharge (nmod)
5-hydroxytryptamine , (punct)
ureter of (case)
inducing , (punct)
repeated i.p. (advmod)
given lf (nsubjpass)
ntg by (case)
patients oncological (amod)
normal 10(6 (dep)
patients group (appos)
patient others (conj)
results microg/ml (appos)
evaluated results (nsubjpass)
ineffective while (mark)
defects vigabatrin-associated (amod)
study ) (punct)
undergoing transplantation (dobj)
0.25 than (case)
alpha- the (dep)
disappearance seizures (nmod)
antigen antibody (conj)
failed treatment (nsubj)
hiv ) (punct)
exacerbated be (auxpass)
progestagens other (amod)
1973 between (case)
fed diet (dep)
increased synthesis (dobj)
system ligand (compound)
died who (nsubj)
0.62 % (dep)
seizure-prone withdrawal (compound)
women using (acl:relcl)
study malignant (compound)
property nimodipine (nmod)
negative screen (nsubj)
months/patient ) (punct)
diseases skin (compound)
receptor (gaba)-a (compound)
pathogenesis an (det)
terbutaline pn (nmod)
adults within (case)
measures fetal (amod)
infusion part (nmod)
had has (aux)
interview in (case)
surgery outdoor (amod)
3-methyladenine inhibitor (appos)
dox free (amod)
sdrr ( (punct)
remission due (case)
influences to (case)
day drinking (compound)
continued which (nsubjpass)
experiments identical (amod)
inhibitor ssri (appos)
decreased heterogeneity (dobj)
regimens into (case)
induction clonic (amod)
ability pg-9 (nmod)
hamartoma duct (compound)
carcinomas hepatocellular (amod)
treatment arrhythmias (nmod)
groups analysis (dep)
disappearance complete (amod)
had ncq344 (nsubj)
higher ; (punct)
cytoskeleton and (cc)
investigated cystometry (nmod)
observed recorded (ccomp)
triceps the (det)
injection glutamate (amod)
p<0.001 ) (punct)
afflicted to (mark)
methotrexate cyclophosphamide (conj)
confirm exclude (conj)
cardioselective . (punct)
related part (nmod)
characterized toxicity (nsubjpass)
rats pcpa-treated (amod)
working deficits (dobj)
associated % (dep)
treat ribavirin (dobj)
test observation (compound)
18 0.25 (compound)
measured exploration (nmod)
10-fold ( (punct)
cr of (case)
dyspnoea reintubation (conj)
rats mrp2-deficient (amod)
surface on (case)
administered sampled (conj)
disease hypertension (nsubj)
null in (case)
failed treatment (nmod)
time slow-wave (amod)
63 , (punct)
jc ) (punct)
urine orange (compound)
exposure barium (compound)
users low-dose (nmod)
ligands ) (punct)
measure 30-min (amod)
experiments three (nummod)
enhanced injected (advcl)
smoking or (cc)
reported painful (ccomp)
mmc ( (punct)
messages the (det)
4-quinoline lo-3 (compound)
decades jones (nmod)
injections before (nmod)
reversing block (nmod)
slowing mental (amod)
volume hemorrhage (compound)
survival and (cc)
manifestation common (amod)
injury . (punct)
history hit (nmod)
eight-week placebo-controlled (conj)
challenge after (case)
centre veterinary (compound)
short-acting prilocaine (dep)
engagement possible (amod)
abolished changed (conj)
600 to (dep)
administered task (nsubjpass)
slope phase (compound)
excreted did (advcl)
supplementation magnesium (compound)
group high-risk (amod)
cholinergic and (cc)
investigate occurs (ccomp)
conjugates containing (acl)
took he (nsubj)
mg 90 (compound)
1.0 2.57 (conj)
controls . (punct)
enlargement livers (nmod)
having urticaria (dobj)
effects clonidine (nmod:poss)
those neuroleptics (nmod)
lead dissatisfaction (nmod)
less somewhat (advmod)
dobutamine both (cc:preconj)
occurred aspirin (nsubj)
class this (det)
neurocognitive neuroradiologic (conj)
is compounds (nmod)
refractory drugs (nmod)
distribution acid (nmod)
catarrhalis m. (compound)
order potency (nmod)
ameliorated toxicity (nsubjpass)
increased fps (dobj)
participants . (punct)
iohexol b (dep)
evaluates , (punct)
had one-tenth (dobj)
changes thresholds (nmod)
effect hyperactivity (nmod)
cardioselective by (case)
erythrophagocytosis and (cc)
u/l creatinine (conj)
cssep and (cc)
implicated etiology (nmod)
proof that (mark)
nerve auditory (amod)
presented erythroderma (nmod)
safety ht (nmod)
transplant peripheral (amod)
effect no (neg)
accumulation to (case)
antagonist potentiated (conj)
induced nomifensine (nmod)
increases to (case)
dyskinesias monkeys (nmod)
observed strains (nmod)
< high (conj)
indicated analysis (nsubj)
treated stabilizers (nmod)
uncertain involve (conj)
administration vcm (compound)
predisposed develop (xcomp)
classified cats (nsubjpass)
superior is (cop)
decreased p (nsubj)
responding . (punct)
affinity d4.2 (nmod)
anesthetic unique (amod)
finding reliable (amod)
seizure than (mark)
events study (nmod)
nonusers is/tia (nmod)
lack contact (nmod)
hour after (case)
pathologies otological (amod)
injection alf (compound)
occurrence tachydysrhythmias (nmod)
suggests important (ccomp)
weakness shortness (conj)
lower output (nsubj)
potent diazepam (nmod)
thought contribute (xcomp)
pig in (case)
group olanzapine (compound)
each protocols (nmod)
p=0.48 ) (punct)
underwent end-stage (nmod)
determine identify (conj)
deletion of (case)
controls mm2 (dep)
therapy ) (punct)
disorder endocrine (amod)
anesthesia for (case)
hepatitis aap (compound)
example . (punct)
borderzone in (case)
pretreated rats (nsubjpass)
stopped if (mark)
g-1 mug (compound)
l-nil ( (punct)
inhibitors aches (appos)
evaluated have (aux)
solution dextrose (compound)
inhibited gain (dobj)
hypovolemia intravascular (amod)
exhibit behavior (dobj)
morphine brain (nmod)
effects doses (nmod)
vasospasm damage (conj)
terminology occurrence (conj)
possible avoid (xcomp)
spikes , (punct)
caused diaries (nmod)
event are (cop)
increase this (det)
attributable hypotension (nmod)
induced combination (nsubj)
binding [3h]gaba (compound)
hypothalamus and (cc)
protection nephropathy (nmod)
phase during (case)
bronchodilator theophylline (nmod)
based ( (punct)
atriotomy left (amod)
echocardiography , (punct)
echocardiography during (case)
appearances between (case)
task rats (nmod)
patients schizophrenia (compound)
increase therapy (nsubj)
symptoms failure (nmod)
dropped had (aux)
studied reactions (dobj)
concentrations in (case)
changes changes (nmod)
excluded twenty-nine (nsubjpass)
society of (case)
c57bl/6 ) (punct)
lr132 with (case)
associated anaesthesia (advcl)
produce revealed (advcl)
compounds other (amod)
brought increase (conj)
mg/m2 30 (nummod)
phosphatase acid (compound)
prolongation reporting (conj)
epilepsy de (amod)
group s (compound)
pain visual (conj)
dosed once (mark)
found decreased (xcomp)
represented ; (punct)
increasing that (mark)
causes arrhythmia (dobj)
binding increased (amod)
rose and (cc)
met results (dep)
recipients solid (amod)
epinephrine 4 (nummod)
indicates blocked (ccomp)
increased studies (nmod)
investigating efficacy (dobj)
months 60 (nummod)
system vehicle (compound)
determined levels (nsubjpass)
gamma-hexachlorocyclohexane , (punct)
aorta defect (conj)
synthesis series (nmod)
alert patient (nmod)
1 5 (conj)
recorded behavior (nsubjpass)
administered hydrochloride (nsubjpass)
leak that (mark)
lisinopril compared (case)
used histology (nsubjpass)
developed recurrent (xcomp)
imaging ( (punct)
need maximize (acl)
detectable readily (advmod)
shortened occurrence (dobj)
was but (cc)
movements asymmetric (amod)
% % (nmod)
analogue purine (compound)
increase chloride-induced (amod)
feet both (det)
conditions terms (nmod)
btc for (case)
schlemm of (case)
given dfp-atropine (nmod)
synthase neuronal (amod)
ca(2 mitochondrial (amod)
week 12 (compound)
group normal-sodium (compound)
significant incidence (nsubj)
mtor-i ) (punct)
s s (conj)
ototoxicity against (case)
doses particularly (advmod)
relevance might (aux)
passing by (mark)
operative and (cc)
hepatotoxicity some (nmod)
content blood (compound)
due likely (advmod)
abolished patient (nmod)
walls ventricular (compound)
developed seizures (dobj)
catalase cat (appos)
protects functions (nmod)
received administered (ccomp)
infusion mg (conj)
analyzing valdecoxib (dobj)
awoke pain (nmod)
toxicity response (conj)
wk first (amod)
improving such (mark)
exerts decreasing (advcl)
5-azc given (acl)
tnss for (case)
provokes that (nsubj)
effects erythrocytes (nmod)
suggests factors (ccomp)
spaces cells (conj)
results followed (appos)
effective prior (advmod)
113 +/- (cc)
sessions repeated (amod)
restoration catabolism (nmod)
criteria response (compound)
hypotension (ach)-produced (amod)
structure or (cc)
activities protease (compound)
responses complete (dep)
ecstasy was (cop)
1.7 - (punct)
appeared advanced (conj)
trial mainly (advmod)
induce route (nmod)
microg/kg day (nmod)
precedes manifestations (dobj)
adjustment the (det)
cause would (aux)
illnesses acute (amod)
s 60 (nummod)
extensive affect (conj)
measurements diameter (compound)
conducted comparative (nmod)
type clinical (amod)
carcinogen c (compound)
activity inhibition (nmod)
contrasts greater (amod)
caused blockade (nmod)
54 61 (conj)
organisms and (cc)
rate gall (compound)
mmol/kg 60 (nummod)
evidenced as (mark)
administered um-272 (nsubjpass)
potentiation antagonism (conj)
revealed use (nsubjpass)
investigation clinical (amod)
size-dependent simply (advmod)
advantageous be (cop)
acid atra (appos)
evaluation resistance (nmod)
pcpa than (case)
adopted improve (xcomp)
injection accidental (amod)
cholestasis injury (nmod)
encephalopathy standpoint (nmod)
controls above (case)
flurothyl picrotoxin (conj)
ischemia time (appos)
patient presented (acl)
able would (aux)
reverses rigidity (dobj)
studied forms (nmod)
mediator anti-inflammatory (amod)
dyskinesias ko (nmod)
c+e c (conj)
enhance toxicity (dobj)
interaction an (det)
reduced range (nmod)
phosphate totp (appos)
treatment bortezomib (nmod)
correction attempted (amod)
periods into (case)
confirm and (cc)
analyzed background (dep)
micrograms/kg 100 (nummod)
electrocardiogram ekg (appos)
presented hypersensitivity (nsubj)
mg 0.25 (compound)
hospitals three (nummod)
needed institute (xcomp)
osteoid and (cc)
scan findings (dobj)
epilepsies of (case)
pressure fall (conj)
receive alone (advmod)
immunopathology . (punct)
prazosin and (cc)
h administration (nmod)
able repeat (xcomp)
therapy hormone-replacement (amod)
frey brush (conj)
administered safely (advmod)
activities their (nmod:poss)
interpretation retains (dep)
ginsenosides , (punct)
maintained doses (nmod)
parts with (case)
assayed was (auxpass)
effects long-term (amod)
indicate used (ccomp)
antibiotics and (cc)
anticoagulation for (case)
increase duration (nsubj)
period brief (amod)
treatment term (compound)
if ( (punct)
use pravastatin (nmod)
one sided (acl)
durations seizure (amod)
responsible absorption (nsubj)
development lids (nmod)
blocking i(f (dobj)
entered have (aux)
50 approximately (advmod)
alt cpk (conj)
on'- in (case)
follow-up the (det)
expression offspring (nmod)
improving analgesia (dobj)
ca1 dentate (conj)
plugs of (case)
vasodilator marked (amod)
method ellman (compound)
administration b6 (nmod)
satisfied h (dobj)
serum/urine evaluating (conj)
tended side-effects (nsubj)
complete study (dobj)
111 to (quantmod)
used reverse (xcomp)
evidence electrocardiographic (amod)
fr the (det)
causes activation (nsubj)
possible when (advmod)
tested observation (nsubjpass)
use combinational (amod)
chemiluminescence by (case)
rp receptor (compound)
lead improvement (nmod)
states stimulation (conj)
evident maintained (conj)
present ) (punct)
etiology no (det)
failure tests (nmod)
treated adr (nmod)
level crp (compound)
necessary cases (nmod)
recorded being (auxpass)
use cpa/ee (compound)
found vacuolisation (nsubjpass)
part on (case)
cristae of (case)
blockade stimulation (conj)
value therefore (advmod)
deposits membrane (compound)
virus ve (compound)
anencephaly interval (appos)
given first (advmod)
associated isethionate (nsubjpass)
option be (cop)
dilation dysfunction (conj)
combined apical (nmod)
compared that (nmod)
disease and (cc)
action depressant (amod)
vehicle only (advmod)
followed damage (nmod)
pathogenesis coma (nmod)
treatment acetate (nmod)
stabilizer/rigidifier membranes (nmod)
recruited cities (nmod)
exacerbations adults (nmod)
causes iron (nsubj)
four patients (nmod)
cases advanced (amod)
suggests is (ccomp)
pneumonitis evidence (appos)
hl , (punct)
procedures for (case)
126 3 (conj)
remained 24 (nsubj)
was form (nmod)
strategy dosing (compound)
decided we (nsubj)
binding pharmacological (conj)
adr+los(12 group (compound)
model hemorrhage (compound)
achieved oih (nsubjpass)
alterations neurochemical (amod)
play whereas (mark)
operation the (det)
10(-7 with (case)
tubular and (cc)
paralyzed control (xcomp)
unclear contribution (nsubj)
effects locomotor (compound)
34 14 (conj)
barrier through (case)
performed anesthesia (nsubjpass)
ce ml(-1 (nmod)
incidence wales (nmod)
studied have (aux)
limited has (aux)
% 46.90 (nummod)
any studied (acl)
cause therapy (nsubj)
causing convulsions (dobj)
room loss (nmod)
some of (case)
terms search (compound)
type in (case)
patient took (acl:relcl)
resection partial (amod)
line observations (nmod)
estradiol of (case)
raised both (dep)
depression hypotension (appos)
variant of (case)
fa with (case)
inhibited injection (nmod)
had greater (conj)
increase iop (compound)
duration shorter (amod)
comprises . (punct)
involvement system (nmod)
ecgs ) (punct)
have warranted (ccomp)
hemodialysis flux (compound)
sensorium a (det)
induced rats (nmod)
fractures department (nmod)
dams to (case)
used showed (conj)
management optimal (amod)
mpa bcc (conj)
echoes observation (dobj)
reversion rapid (amod)
had recovered (conj)
mechanisms , (punct)
attributable changes (nmod)
regarded traditionally (advmod)
contraception with (case)
agent undergoing (acl)
role activate (acl)
hypoplasia marrow (compound)
reduced mk-801 (nsubj)
use ethambutol (nmod)
necrosis myocarditis (conj)
mg/kg day (nmod)
showed positive (nmod)
regimen is (cop)
0.8 - (punct)
response administration (nmod)
mechanical and (cc)
totp either (cc:preconj)
identified timolol (nsubjpass)
had hypercalcemia (dobj)
follow-up treatment (nmod)
manifestations : (punct)
symptoms other (amod)
affected workers (nsubjpass)
potency warfarin (nmod)
known quinine (nsubjpass)
converted movements (dobj)
blockade fluoroacetate (nmod)
dehydrogenase acid (compound)
verapamil only (advmod)
derivative piperazine (amod)
blots western (compound)
serositis involvement (dep)
administered times (nmod)
reduplication . (punct)
digitalise to (mark)
stages experiment (nmod)
approaches multidisciplinary (amod)
observed reversible (conj)
patients birdshot (amod)
consuming rats (nsubj)
have % (nmod)
supports extends (conj)
blockade 5-ht2 (compound)
analysis form (nmod)
away straight (advmod)
mg/kg mean (dep)
possibility the (det)
abolished addition (nmod)
angiogram normal (amod)
measurement method (compound)
substance pharmacy (nmod)
were remissions (dep)
cardiorespiratory midazolam-associated (amod)
teams neurointensivists (conj)
mass on (case)
remains clozapine (nsubj)
induces trimipramine (nsubj)
% 11.3 (nummod)
effects adverse (amod)
spironolactone with (case)
focus an (det)
failure lesions (conj)
capillary the (det)
depletion this (det)
points range (appos)
tremors with (case)
performed measurement (nsubjpass)
weight antioxidants (conj)
designed assess (advcl)
neuroadaptation reduction (conj)
pharmacon the (det)
suggested conclusions (nsubj)
patients 4 (nummod)
phase b (appos)
3e - (punct)
observed subjects (nmod)
segments ) (punct)
proteinuria chain (compound)
prednisone of (case)
excretion protein (compound)
continued postoperatively (advmod)
conditions constant (amod)
voltammetry , (punct)
formation mice (nmod)
a-i a-ii (conj)
hilum the (det)
sirolmus ) (punct)
banned use (dobj)
successful attempts (nsubj)
19 to (case)
examining hippocampus (dobj)
hyperplasia gingival (amod)
hypotension output (nmod)
analysis in (case)
observed response (nsubjpass)
case rhabdomyolysis (nmod)
decreased titre (nsubj)
responsible be (cop)
died interview (nmod)
calcification widespread (amod)
occurred myoclonus (nsubj)
levels phosphate (compound)
edaravone of (case)
n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide fanft (appos)
observed pretreated (conj)
doses nonsedating (compound)
shunt qs/qt (appos)
use spironolactone (nmod)
observed episodes (dobj)
patients subjects (conj)
evaluation vnb (nmod)
prostheses three (nummod)
degree occupancy (nmod)
bradycardia agonist (nmod)
impairments alternation (nmod)
group eastern (compound)
conditions a (appos)
searched also (advmod)
experiences and (cc)
enable withdrawal (dobj)
ingested which (nsubjpass)
less % (nmod)
bromocriptine patient (compound)
members of (case)
patients disorder (compound)
hypertension nephritis (conj)
use drug (compound)
induced catalepsy (dobj)
assessed positive (nmod)
zero . (punct)
tablet tablets (nmod)
doxorubicin cyclophosphamide (conj)
cxad induced (acl)
quality of (case)
prevent 6 (dep)
depression synapses (nmod)
promotes production (dobj)
cardiomyopathy low-grade (amod)
sign invasion (nmod)
discontinuation its (nmod:poss)
suggest neurotoxic (ccomp)
needed . (punct)
years 1994 (nummod)
days prior (amod)
nephrolithiasis complicating (acl)
few first (amod)
effect elevations (nsubj)
imaging spine (nmod)
fell and (cc)
echocardiography dse (appos)
dyskinesias patients (nmod)
sem ) (punct)
using interview (dobj)
rosc ) (punct)
summary treated (dep)
probe microdialysis (compound)
alfentanil by (case)
occur often (advmod)
obtained ultrasound (nmod)
increase brain (nmod)
bonding conjugates (nmod)
data treatment (nmod)
mg/kg/b.w./day 10 (nummod)
hiv-negative enrolment (nmod)
non-e-induced non-a (advmod)
grade ii (nummod)
clonidine central (amod)
rates length (conj)
6,3-dilactone 2,5-di-o-acetyl-d-glucaro-1,4 (compound)
tachycardia life-threatening (amod)
pressure reduced (amod)
antigen the (det)
ligand and (cc)
pralidoxime-2-chloride maleate (conj)
produce administered (advcl)
sleep of (case)
abnormalities no (det)
consequence only (advmod)
abnormalities catheterization (compound)
titrated that (mark)
ng./ml 4 (nummod)
diagnosis a (det)
multiple ( (punct)
range of (case)
synapses purkinje (compound)
galactose blood (nmod)
man history (conj)
exists evidence (compound)
mesna experiences (acl:relcl)
studies response (appos)
recorded movements (dobj)
prevent could (aux)
mellitus insulin-dependent (amod)
treatment that (nmod)
suggested results (nmod)
demonstrated targets (ccomp)
multiforme gbm (appos)
complete preexisting (amod)
years preceding (amod)
normality , (punct)
lidocaine induced (acl)
drugs doxorubicin (conj)
increased catalepsy (nsubjpass)
pacing transvenous (amod)
content amines (nmod)
alter threshold (dobj)
injected immediately (advmod)
enhance function (dobj)
stones with (case)
titrated to (prep)
cardiomyopathy produced (acl)
shows phase (dobj)
ability doses (nmod)
organs not (neg)
enantiomers its (nmod:poss)
ccnu lomustine (appos)
attracted . (punct)
have % (parataxis)
seemed have (conj)
papaverine and (cc)
68 54 (conj)
hemodynamic a (det)
treated l-noarg (nmod)
administration proteinuria (conj)
cases multiple (amod)
lead by (case)
months 11 (nummod)
results and (cc)
prevention nausea (nmod)
injections systemic (amod)
t5 according (case)
trial therapies (nmod)
staining red (amod)
content medulla (nmod)
populations astrocytes (nmod)
ratio selectivity (compound)
coagulation rat (nmod)
iu/l alt:294 (compound)
threshold sevoflurane (nmod)
syndrome based (acl)
morphine with (case)
mcpp , (punct)
features identifying (acl)
reported lovastatin (nmod)
204 39.3 (conj)
excludes possibility (dobj)
been . (punct)
sulfation increased (amod)
developed restarting (nmod)
described 11th (nsubj)
disappearing days (nmod)
occurred pointes (nsubj)
1.68 ) (punct)
isoflurane of (case)
receptor n-methyl-d-aspartate (compound)
benzylacyclouridine bau (appos)
alpha-mediated are (cop)
refractory anticonvulsants (nmod)
tonic and (cc)
defined be (auxpass)
leading reportedly (advmod)
discovered eye (nmod)
effects sirolimus (nmod)
phase ) (punct)
used order (nmod)
gene arginine (compound)
history . (punct)
patients 0.01 (dep)
trinitrate , (punct)
myocardial injury (conj)
included meta-analysis (nmod)
underlie impairments (dobj)
stn of (case)
controls with (case)
protection a (det)
busulfan a (det)
ls ) (punct)
factor an (det)
transferase glucuronyl (compound)
protocol all (compound)
phasic and (cc)
pointes de (compound)
altered be (auxpass)
success with (case)
add-on an (det)
structures system (nmod)
phenacetin both (cc:preconj)
6 48 (prep)
level 3 (nummod)
caffeine after (case)
conducted elsewhere (advmod)
drugs blocking (amod)
cycle sleep/wake (compound)
constitutes recognition (nsubj)
enrolled total (nsubjpass)
stones induced (amod)
cases one (appos)
myocardium ischemic (amod)
patients present (acl:relcl)
microg/kg ( (punct)
mangiferin polyphenol (appos)
reversed decrease (dobj)
constellation , (punct)
variation gene (nmod)
ptra to (case)
withdrawal sympathetic (amod)
impairment mitochondria (nmod)
anaesthesia continuous (amod)
x and (cc)
has epinephrine (nsubj)
found he (nsubjpass)
fails recover (xcomp)
examine response (dobj)
oedema cytotoxic (amod)
radiation and (cc)
blocker that (mark)
appropriate inhibitors (nsubj)
reports usage (conj)
process may (aux)
once-daily vs. (cc)
decrease can (aux)
scavengers nephropathy (nmod)
moiety derivative (appos)
mpa and (cc)
p effective (advcl)
haematological were (cop)
proteins several (amod)
continued proliferate (xcomp)
women cocs (nmod)
extravasation of (case)
gnc92h2 reduced (acl:relcl)
infarction in (case)
associated ovulation (nmod)
males ; (punct)
material : (punct)
ng shr (nmod)
hypokalemia depletion (conj)
surgery life-saving (amod)
ulcers stress (compound)
mitigates delivery (nmod)
worsening without (case)
intervals months (nmod)
displayed patient (nsubj)
decreased placebo (nmod)
comparison therapy (nmod)
mc ac (conj)
examined using (advcl)
induce administration (nsubj)
memory interference (compound)
aware syndrome (nmod)
times different (amod)
ropivacaine rats (nmod)
signs on (case)
hosts , (punct)
21 - (punct)
use setting (nmod)
women acetate (nmod)
residues gamma-carboxyglutamate (amod)
overdose intentional (amod)
pressure torr (nmod)
response and (cc)
is research (attr)
cells white (amod)
(-)-baclofen mg/kg (appos)
rates seizures (nmod)
independently presence (nmod)
expression myocardial (amod)
lesion a (det)
suggest data (nmod)
common although (mark)
exacerbated was (auxpass)
frequency micturition (nmod)
2/8 ( (punct)
reduces rotations (dobj)
entity adulthood (nmod)
increases pressure (nmod)
reduced noticed (parataxis)
cause precipitated (conj)
mg/kg d-tubocurarine (nmod)
elisa monoclonal (amod)
determine frequency (dobj)
25/100 the (dep)
had reflect (dep)
performed operations (nsubjpass)
hepatotoxicity simvastatin-ezetimibe (nmod)
assay labeling (compound)
disease pulmonary (amod)
stopped only (advmod)
nephritis induced (acl)
risk associated (conj)
vte for (case)
6-ohda-lesioned ko (dep)
prevent increases (dobj)
sedation such (case)
treated untreated (conj)
g 200 (nummod)
explore mechanism (dobj)
320/12.5 val/hctz (compound)
vulnerable , (punct)
induction propofol (nmod)
sm group (compound)
have tumor (dobj)
u/ml 12.0 (nummod)
hepatomas and (cc)
missed have (aux)
reported % (dep)
underperfusion myocardial (amod)
implants in (case)
exposure prolonged (amod)
nd-nmba due (case)
distortion some (det)
paclitaxel taxol (appos)
food drugs (conj)
treated adenocarcinoma (nmod)
maximal returned (conj)
ulnar and (cc)
ra severe (amod)
regurgitation , (punct)
sulfate cholinolytic (amod)
daunorubicin doxorubicin (conj)
b kappa (compound)
rigidity caused (acl)
time-course changes (nmod)
showed scavenging (nmod)
shoed damage (dobj)
group liver (compound)
mg)-containing 0.8 (compound)
failure att-alf (appos)
performed as (advmod)
associated reduction (nsubjpass)
cause however (advmod)
seems this (nsubj)
observers independent (amod)
multicenter multiple-dose (conj)
injected ventricularly (advmod)
association granulomas (nmod)
cisplatin in (case)
map less (amod)
oropharynx were (cop)
presentation with (case)
anatomical functional (conj)
amplitude ( (punct)
years 9 (nummod)
population screened (acl:relcl)
presence damage (nmod)
learning of (case)
used children (nmod)
distribution by (case)
type wild (amod)
levels dismutase (compound)
week fourth (amod)
school department (appos)
prc ) (punct)
used test (nsubjpass)
saline/side ) (punct)
tolerated weeks (nmod:npmod)
some effects (nmod)
word for (case)
repeated cycle (nmod)
day operation (nmod)
substituted resolved (conj)
ameliorated whether (mark)
peroxide h2o2 (appos)
injection route (nmod)
incubated determined (conj)
total reactions (nmod)
reduced 2 (nmod)
dissection or (cc)
% -27.4 (nummod)
control saline (compound)
livers male (amod)
mg/kg/d cya (compound)
control cystitis (nmod)
blockade nicotinic (amod)
weeks -9 (nummod)
decompression and (cc)
administered s.c. (dep)
toxicity subchronic (amod)
greater groups (nmod)
occurs adults (nmod)
mass an (det)
cardiotoxicity dox (compound)
disorders neurological (amod)
0.0480 and (cc)
concentrations cocaine (nmod)
occurred eight (nsubj)
cyclophosphamide for (case)
dose iv (nummod)
cancer aging (conj)
receptor mglu7 (compound)
vehicle either (det)
dismutase decreased (amod)
agreement good (amod)
induce hypotension (dobj)
reduction amplitude (nmod)
acid seizures (conj)
propranolol antagonist (appos)
rcr ( (punct)
mu administered (acl)
control p<0.01 (compound)
p n-highly (conj)
criteria % (nsubj)
thrombocytopenia eosinophilia (conj)
had sites (dobj)
ci 0 (nummod)
assess significance (dobj)
mglur1 , (punct)
supporting therefore (advmod)
occurrence of (prep)
plate and (cc)
followed hours (nmod:tmod)
sought assess (xcomp)
500 i.p. (acl)
alf year (appos)
increase t1/2 (nmod)
association strong (amod)
flow by (case)
dose (-)-propranolol (nmod)
conclusion consistent (dep)
13 - (punct)
exclusive well-documented (dep)
management pharmacologic (amod)
naloxone mg./kg (appos)
rate pulse (compound)
transaminases limit (dobj)
nos endothelial (amod)
hypotension , (punct)
133xe with (case)
wk exposure (dep)
swelling warmth (conj)
value prospective (amod)
develop importantly (advmod)
increased duration (dobj)
abolish to (mark)
prevention for (case)
co-agonist a (det)
aid as (case)
disease prognosis (conj)
report developed (conj)
medium conditions (appos)
expression vessels (nmod)
hallucinations or (cc)
pharmacokinetic and (cc)
measured pain (dep)
region 5-httlpr (appos)
hypertension a-induced (amod)
able conditions (nmod)
potency antagonistic (amod)
predominance relative (amod)
different mellitus (nmod)
effects minor (amod)
concentrations methotrexate (amod)
minutes 5-fu (nmod)
leakage membrane (compound)
method random-assignment (dep)
determine affect (ccomp)
reactions such (amod)
transient or (cc)
seem not (neg)
thickness calibre (conj)
prevention findings (dep)
57 to (dep)
tumor stage (compound)
investigated form (nmod)
encoding recalling (conj)
achieved were (auxpass)
decreased infusion (nmod)
nerves chickens (nmod)
cessation patients (nmod)
role prostaglandins (nmod)
cycle of (case)
unable contrast (nmod)
controls u/ml (appos)
became which (nsubj)
or .009 (dep)
resulted transfusion (nsubj)
age ; (punct)
0 of (case)
palsy and (cc)
respond support (advcl)
fell urea (conj)
phenotypes and (cc)
vesicles numerous (amod)
activity activity (conj)
january 2006 (nummod)
naproxen due (case)
alerted . (punct)
known busulfan (nsubjpass)
weeks wt (appos)
lds ( (punct)
sodium volume (conj)
prolongation with (case)
users mefloquine (amod)
respond pallidotomy (nmod)
field human (amod)
depleted components (dobj)
advantages patients (nmod)
any parameters (nmod)
wsr versus (cc)
mi cocaine-associated (amod)
examined microscopy (nmod)
jitteriness antidepressant-induced (amod)
excluded not (neg)
disease ' (punct)
confusion of (case)
incorporation membranes (nmod)
had vte (dobj)
cardiotoxicity grade (conj)
at superior (conj)
morphology in (case)
psychosis resistant (amod)
product compared (case)
discharges recorded (acl)
failed results (nsubj)
ifosfamide ifx (appos)
stereotypy ) (punct)
review literature (compound)
agonists adenosine (compound)
rat male (amod)
had predominant (nmod)
increased score (dobj)
dissociation av (compound)
update an (det)
mean number (conj)
treatment youth (nmod)
cardiotoxicity doxorubicin (conj)
caused while (mark)
performed review (dobj)
warranted evaluation (nsubjpass)
concentrations residual (amod)
cells normal (amod)
developed she (nsubj)
worsening dyskinesia (nmod)
focus imaging (nmod)
quality the (det)
case embryopathy (nmod)
kg-1 i.p. (advmod)
reported patients (nsubj)
treatment salbutamol (nmod)
treatment reaction (nmod)
controls 16 (nummod)
side and (cc)
received rw (nmod)
-18 ( (punct)
9.7 0.2 (conj)
induced decrease (dobj)
had injury (dobj)
dyskinesias such (case)
effect due (case)
obtained minutes (conj)
phases ( (punct)
depression beck (compound)
when ) (punct)
upper-extremity extensive (amod)
events rizatriptan (nmod)
cells retinal (amod)
joints tender (compound)
combination its (nmod:poss)
individuals vulnerable (amod)
arf ( (punct)
method assigned (dep)
underwent that (nsubj)
compensated suppressed (conj)
concentrations aldosterone (compound)
led restored (conj)
reverses catalepsy (dobj)
treatment anaphylaxis (nmod)
developed children (nsubj)
class ii (nummod)
sent months (nmod)
months 22 (nummod)
undergoing pci (dobj)
discontinued occurred (advcl)
localize site (dobj)
abnormalities % (appos)
training or (cc)
screening ecg (dobj)
associated disorder (nsubjpass)
recipients solid-organ (amod)
randomised findings (dep)
minutes v (case)
assessed now (advmod)
evaluated 62(6):865 (nmod)
arteries or (cc)
connections cell (compound)
therapies combination (compound)
density assay (nmod)
control cardiac (amod)
individuals hiv-infected (amod)
decreased mg/kg (nsubj)
design participants (conj)
study involving (acl)
bmt itself (nummod)
acts facilitate (xcomp)
decrease although (mark)
using immunosuppression (nmod)
deciliter more (conj)
3.7 ) (punct)
cocaine intravenous (amod)
dexmedetomidine intranasal (amod)
anaphylaxis penicillin (compound)
hemolysis acute (amod)
transcripts bladder (nmod)
anemia mild (amod)
affected blockade (nmod)
mouse-1 ) (punct)
onset anemia (nmod)
pre-treatment melatonin (compound)
none in (case)
eeg with (case)
model by (case)
involvement renal (amod)
staining by (mark)
monkeys 4 (nummod)
was risk (attr)
atropine 0.5 (nummod)
patients rifampin (amod)
sedated they (nsubjpass)
consistent events (nsubj)
fiber sprouting (dep)
suggest prescribed (ccomp)
expected it (nsubjpass)
pathways via (case)
hbv-dna hbeag (conj)
conditions failure (conj)
accepted currently (advmod)
terfenadine fpdc (conj)
that fungizone (nmod)
apparent interpretation (nsubj)
received min (conj)
therapy dtic (amod)
suppressed startle (ccomp)
fluctuations , (punct)
sgot ldh (conj)
284 24 (conj)
analgesia via (case)
stuporous intoxication (nmod)
elliott 's (case)
conclusion led (dep)
produces it (nsubj)
serves index (nmod)
thioperamide , (punct)
fields radiation (compound)
repeated study (nsubjpass)
exacerbated sertraline (nsubj)
roles development (nmod)
averaged months (nmod:tmod)
responsible to (mark)
promotes function (dobj)
returned decreased (ccomp)
therapy trihexyphenidyl (amod)
blocked nh4ac (nmod)
% 5.4 (dep)
man contains (acl:relcl)
reveal lesions (dobj)
determined materials (nsubjpass)
transaminases times (nmod)
more not (neg)
study literature (nmod)
measures desire (nmod)
test p<0.05 (appos)
increase renin (nmod)
minutes 0 (nummod)
that as (case)
neuropeptide an (det)
slice 1-mm (amod)
assessed functioning (xcomp)
site identical (amod)
twins of (case)
evidence enhances (ccomp)
reduce particular (nmod)
eighteen % (appos)
exceed that (mark)
myopathy limbs (nmod)
blockage receptors (nmod)
level kinase (compound)
was investigate (xcomp)
developed they (nsubj)
seems depend (xcomp)
tissues soft (amod)
generated site (nmod)
were ns-nsaids (nmod)
potentials jerk-correlated (amod)
success clinical (amod)
present changes (nsubj)
reduced mg/kg (nsubj)
done evaluations (nsubjpass)
observed hepatitis (nsubjpass)
visualize time (nmod)
monitored pressure (nsubjpass)
1.56 1.05 (dep)
case tachycardia (nmod)
tnf and (cc)
be there (expl)
treated d-med (dep)
care later (amod)
ng/ml 3 (compound)
colorectal cell (conj)
remission during (case)
changes hyperplastic (amod)
prospective single-intervention (dep)
used combination (nsubjpass)
decreased agonists (nsubj)
tumour cell (compound)
20 patients (nmod)
tamoxifen estrogen (compound)
bradycardia adrenaline-induced (amod)
modifications areas (nmod)
greater animals (nmod)
problems gastrointestinal (amod)
conclusions complication (appos)
hypocalcemia hypomagnesemia (conj)
induced forestomach (nmod)
microgram.kg-1.min-1 of (case)
mtx of (case)
reduced % (conj)
flutamide tid (amod)
suffered animals (nsubj)
individuals many (amod)
rash lymphadenopathy (conj)
excluded results (dep)
mpges-1 in (case)
band of (case)
= 3.7 (dep)
12 3 (compound)
rate hz (compound)
associated morbidity (nmod)
potential antagonists (nmod)
produce identical (advcl)
effect also (advmod)
role inhibitors (conj)
time freezing (amod)
cells cultured (amod)
prostaglandin pg (appos)
incubated . (punct)
volumetry cerebellum (nmod)
amphetamine 50 (conj)
catalepsy number (conj)
operations these (det)
effectiveness clinical (amod)
quetiapine to (case)
effect has (aux)
patient schizophrenic (amod)
twenty-four of (case)
receptor b1r (appos)
transplanted diseases (nmod)
interaction stimuli (nmod)
utilized ; (punct)
extent minor (amod)
40.1 +/- (cc)
adrenoceptor ) (punct)
suitable to (mark)
reaction drug (conj)
gfc75 with (case)
asphyxia grades (conj)
left but (cc)
five group (nmod)
calcification animals (nmod)
adenocarcinomas and (cc)
chow regular (amod)
sec/cm5 dyne (compound)
effects pregs (nmod)
require heparin (nmod)
suspensions combination (nmod)
reported substrate (ccomp)
head site (nsubj)
runs tachycardia (nmod)
low number (nsubj)
mechanical electrical (conj)
treatment levofloxacin (nmod)
acidification urinary (amod)
levels accompanied (acl)
conducted cases (nmod)
episodes any (det)
dysfunction cranial (amod)
seems designed (conj)
types sediment (nmod)
problems diagnosing (advcl)
degeneration half (nmod)
treatment ethinyl (amod)
continue advent (nmod)
measured heart (nmod)
induction changes (nmod)
recorded treatment (nmod)
block resolved (acl)
reducing volume (dobj)
response exaggerated (amod)
improve that (mark)
decline insidious (amod)
stereotypy not (neg)
valproate of (case)
effects development (nmod)
associated zonisamide (nmod)
normal-salt salt-loaded (conj)
concentrations relevant (amod)
causes resistance (dobj)
arrhythmias with (case)
micromol/l. azimilide (appos)
impairments speed (nmod)
atropine doses (conj)
amplitude pulse (compound)
118 in (case)
minutes duration (nsubj)
miss to (mark)
reduce mortality (dobj)
pulmonary both (cc:preconj)
world real (amod)
observed p (dobj)
lvef ( (punct)
microgram/kg/min 17.4 (nummod)
increased anesthesia (nmod)
diet of (case)
pre- smear (compound)
affinity display (compound)
rate bile (compound)
drugs aeds (appos)
beats 33 (nummod)
delivered be (auxpass)
intensity abnormal (amod)
identified metabolite (nmod)
estradiol-dependent region-specific (conj)
administration dinitrate (nmod)
influence but (cc)
measurement rate (nmod)
double , (punct)
tumor cell (compound)
continues evaluation (nsubj)
msh/acth ) (punct)
action binding (nmod)
et-1 and (cc)
evaluated metabolites (nsubjpass)
changed but (cc)
comprised carcinoma (dobj)
described child (nsubj)
potassium 400iu/2 (nummod)
caffeine ) (punct)
phosphatase nephrosis (nmod)
eg reaction (nmod)
sulpiride to (case)
investigate and (cc)
emerged forms (nsubj)
important discriminating (nsubj)
arrest a (det)
days day (conj)
2.41 to (case)
escalation a (det)
address and (cc)
hs ) (punct)
investigated vasculitis (conj)
db was (cop)
significant 0.0001 (nmod)
uptake ratio (conj)
have neurons (nsubj)
pressure in (case)
stress glomeruli (nsubj)
related duration (nmod)
days flutamide (conj)
injection selective (amod)
scores lt (nmod)
injections adsd (nmod)
biomarkers , (punct)
analyses quantitative (amod)
61.9 5.0 (conj)
dose inhibitors (nmod)
reports than (case)
down hypotension (nmod)
findings mri (compound)
appearance identical (amod)
modulated system (nsubjpass)
glycoprotein lactoferrin (nsubj)
gemcitabine % (appos)
groups g (dep)
patients tolerate (acl:relcl)
processes executive (amod)
decreased size (nsubjpass)
influx = (dep)
shock for (case)
side-effects to (case)
levels for (case)
techniques immunocytochemical (amod)
take vegetarians (nsubj)
remained therapy (nmod)
designed determine (xcomp)
caused were (auxpass)
retested were (auxpass)
pallidotomy posteromedial (amod)
bradykinin hoe (dep)
lipocalin b-d-glucosaminidase (conj)
decreased ascites (conj)
drug psychostimulant (compound)
cramps/myalgias muscle (compound)
tendency procoagulant (amod)
sg145r t (conj)
received furosemide (dobj)
62.0 ( (punct)
force uspstf (appos)
offers technology (nsubj)
excretion bendrofluazide (nmod)
synthesis such (amod)
novel conclusion (nmod)
1.4 = (dep)
synthesis 27-hydroxylase (conj)
e8188 ) (punct)
% 20 (nummod)
euthanized collected (conj)
red ruthenium (compound)
mglurs group (compound)
recovered sequelae (nmod)
think relieve (ccomp)
therapy cancer (compound)
introduced . (punct)
counteracted treatment (nsubj)
period storage (compound)
which on (case)
relations sexual (amod)
encephalopathy chemotherapy (nmod)
assigned days (nmod)
scale of (case)
all virtually (advmod)
power 0.90 (nmod)
mg/m(2 mg/m(2 (conj)
applied was (auxpass)
instead of (mwe)
microinjection amino (compound)
effective administration (nsubj)
tachycardia patient (nmod)
aggregation is (cop)
volume frequency (conj)
resumed minimize (advcl)
magnitude the (det)
165 215 (conj)
using model (dobj)
line br (compound)
determination prolactin (compound)
ncq436 with (case)
salience coding (acl)
skills function (conj)
impairments women (nmod)
desensitization postsynaptic (amod)
multicenter randomized (amod)
risks mother (nmod)
associated loss (nmod)
lid neurobiol (appos)
signs increasing (acl)
achieved recovery (nsubjpass)
prod of (case)
developed was (auxpass)
beings human (amod)
doses spiranolactone (nmod)
mm mm (dep)
population disease (nmod)
technique only (advmod)
usage uninterrupted (amod)
isoproterenol to (mark)
alpha5 the (det)
test recognition (compound)
system cns (appos)
noradrenaline doses (nmod)
adrenaline noradrenaline (conj)
flare a (det)
reintroduced acitretin (nsubjpass)
speech , (punct)
quiescent years (nmod)
amb alone (advmod)
pretreatment without (conj)
fibrillation with (case)
encountered report (nmod)
assigned water (nmod)
enantiomer bupivacaine (nmod)
signs serious (amod)
artery supraclinoid (amod)
treated followed (conj)
deficits learning (compound)
drug comparison (compound)
cpap h2o (compound)
spectrum of (case)
acquisition avoidance (compound)
presence leakage (nmod)
acutely and (cc)
seizure pilocarpine-induced (amod)
tramadol of (case)
release ldh (compound)
increased 15/hypertension (dep)
seem although (mark)
various non-uniform (conj)
abandoned . (punct)
observed replaced (advcl)
aprotinin a (appos)
enhanced fluoxetine (nmod)
76 30 (conj)
endpoint at (case)
mineralizes osteoid (amod)
complete resolution (dobj)
weeks 7 (nummod)
verified pathologically (advmod)
standard care (nmod)
metabolites similar (amod)
decrease cardiomyopathy (conj)
ci 1.55 (dep)
stress with (case)
independent mg/kg/day (nmod:tmod)
magnitude prognosis (conj)
elicited mediated (conj)
frame time (compound)
associated pattern (nsubjpass)
re-examine association (dobj)
involves action (nmod)
malondialdehyde whole (amod)
mmol regained (dep)
prl-r socs-3 (conj)
glucose circulating (amod)
numbness perineal (compound)
wall on (case)
conclusion associated (dep)
antidepressants of (case)
received mg/kg (dep)
monotherapy epilepsy (nmod)
head " (punct)
nociceptin mouse-1 (dep)
md ) (punct)
data medications (conj)
likely effect (nsubj)
users human (amod)
attenuates learning (dobj)
pressure intracranial (amod)
diagnosis incorrect (amod)
atherosclerosis graft (compound)
nimesulide % (appos)
discussed , (punct)
those received (acl:relcl)
increased dose-dependently (advmod)
ekg ) (punct)
rejection with (case)
reduced levels (nsubjpass)
is examine (xcomp)
medulla cortex (conj)
millions , (punct)
uptake a (det)
pump the (det)
k- the (det)
conceivable be (cop)
activity hence (advmod)
af cases (conj)
production apoptosis (conj)
status final (amod)
knockdown sirna (nmod)
recovery conversion (nmod)
dose mg/m(2 (nmod)
basis as (case)
detected each (dep)
erdosteine agent (appos)
withdrawal . (punct)
inhibiting activity (dobj)
episode syncopal (amod)
require reduction (dobj)
lead has (conj)
available comment (nmod)
abundances ) (punct)
effect rodents (nmod)
death outcome (compound)
depletions acid (compound)
mph 1 (nummod)
revealed laryngoscopy (nsubj)
regions fluency (nmod)
hyperhidrosis bronchorrhoea (conj)
acid-induced kainic (amod)
injection formulation (nmod)
inhibit secretion (dobj)
association the (det)
2000 and (cc)
sites independent (amod)
release histamine (compound)
showed cholestasis (nmod)
need monitoring (nmod)
analysis spectral (amod)
expression fas (nmod)
estimated indirectly (advmod)
features block (conj)
undergone infant (nsubj)
potential stabilize (acl)
time open- (compound)
position practice (nmod)
observed given (conj)
fire . (punct)
children 27 (nummod)
= .09 (dep)
associated respectively (advmod)
body ) (punct)
leukaemia murine (compound)
increase rate (nmod)
lozenge 289 (conj)
myalgia experienced (acl)
low this (nmod)
physicians , (punct)
risperidone and (cc)
effect occurred (conj)
frontal the (det)
swelling tongue (compound)
dose granisetron (compound)
method microplate (compound)
physician the (det)
cells/mm3 week (nmod)
cocaine 's (case)
effects saline (nmod)
prevent succinylcholine (nmod)
cells cultured (acl)
effects cholinesterase (nmod)
cases most (amod)
criteria vte (nmod)
markers ( (punct)
activity monooxygenases (nmod)
tablet aspartate (compound)
levels catecholamines (nmod)
neurotoxicity conversion (conj)
lysozymuria , (punct)
control combination (conj)
size shape (conj)
disappeared seen (conj)
involved function (nsubjpass)
users outpatient (amod)
compared vcm (nmod)
da hva (conj)
useful was (cop)
exhibits , (punct)
expression erk (compound)
marker earliest (amod)
telmisartan of (case)
provoked that (nsubj)
included mouth (dobj)
six or (cc)
affinities 5-ht1a (nmod)
communicate , (punct)
undetermined , (punct)
showed we (nsubj)
abnormal patients (dep)
effect long-term (amod)
prediction cardiotoxicity (nmod)
blocker muscarinic (amod)
reduced dose (nmod)
excipients its (nmod:poss)
large , (punct)
10.4 +/- (cc)
study effects (nmod)
catheterisation cardiac (amod)
met success (nmod)
treatment similar (amod)
difference sides (nmod)
men 1,022 (nummod)
factor-alpha necrosis (compound)
syndromes behavioral (amod)
having were (aux)
limited when (advmod)
differed assessment (nsubj)
increased 2005 (nmod)
intoxication aluminum (compound)
coma hyperglycemia (conj)
acute national (compound)
survived had (aux)
account barrier (dobj)
ketorolac ( (punct)
void to (case)
arteries effect (conj)
cbz ( (punct)
mean before (advmod)
antagonized effects (nsubjpass)
connecting and (cc)
300 , (punct)
manner dose-dependent (amod)
happens glomerulus (nmod)
stratification extent (conj)
p mmhg (compound)
group to (case)
demonstrates . (punct)
administered etoposide (nsubjpass)
inhibits peroxidation (dobj)
decrease map (nmod)
being pain (acomp)
antagonists channel (compound)
reviews results (dobj)
seen preoperatively (advmod)
events visits (conj)
ratio adjusted (amod)
movements eye (compound)
seen tumors (nsubjpass)
sensitizes intervention (nsubj)
complicating therapy (dobj)
antiepileptics other (amod)
showed cholestasis (dobj)
release peptide (nmod)
7 13 (conj)
seven 26 (conj)
antibiotics occurrence (conj)
myelosuppression cytotoxicity (conj)
times discharge (compound)
background show (appos)
tuberculosis hospital (nmod)
decreased exposure (nsubj)
modify tests (dep)
3,4-dimethoxyphenyl)ethanolamino]-prop - (punct)
side lateral (amod)
technique and (cc)
forepaw and (cc)
characteristics diagnosis (conj)
one cases (nmod)
consultations including (case)
glomerular or (cc)
analyzed protein (conj)
unit micu (appos)
occurs incorporation (nsubj)
methodology immunoassay (compound)
effect observed (amod)
responsiveness enhanced (amod)
antecedent concurrent (conj)
associated atherosclerosis (nmod)
effective because (mark)
those seen (acl)
cholesterol ldl (compound)
csa ( (punct)
indicates ability (dobj)
sulfonylurea second-generation (amod)
lenalidomide of (case)
tests six (nummod)
triglyceride of (case)
injection conversely (conj)
results treated (dep)
shortage mannitol (compound)
ascites ehrlich (amod)
serve whether (mark)
hemianopsia homonymous (amod)
schedule and (cc)
increase peroxidation (nmod)
interference infusion (nmod)
97.1 score (nsubj)
deficits associated (acl)
interaction normal (amod)
function liver (compound)
morphology podocyte (compound)
increased 0.001 (dep)
disease stone (compound)
concentration statin (nmod)
offers dosing (dobj)
function heath (conj)
doses highest (amod)
primigravida in (case)
test despair (compound)
tissue soft (amod)
group ii (nummod)
better skills (nsubj)
levels plasma (compound)
termination at (case)
mmhg icp (compound)
implicate action (dobj)
mm or (cc)
evaluate we (nsubj)
decreased ccb (dobj)
drugs toxic (amod)
diseases nerves (nmod)
flow trimethaphan (conj)
receiving agents (dobj)
-20 - (punct)
most piglets (nmod)
explore levels (dobj)
sg in (case)
course nephropathy (amod)
thalidomide : (punct)
effects motility (nmod)
dextrose 5 (compound)
microangiopathy acute (amod)
subtype receptor (nmod)
tissue on (case)
3.8 0.1 (conj)
threshold response (compound)
migraine as (case)
large which (nsubj)
ana elevated (amod)
bicuspid regurgitation (conj)
recording video (compound)
ufov ( (punct)
use mz (amod)
defects major (amod)
performed patients (nmod)
alteplase with (case)
little very (advmod)
rhabdomyolysis severe (amod)
camp 3',5'-monophosphate (appos)
hydrochlorothiazide of (case)
showed nucleus (nmod)
dilation in (case)
recorded still (advmod)
induced aminonucleoside (nmod)
albumin bovine (amod)
had receiving (advcl)
associated imbalance (nmod)
complications concerning (case)
increase paradoxical (amod)
gained could (aux)
aid smoking (compound)
immunosuppressed patients (nsubjpass)
ginseng panax (compound)
responses other (amod)
reduction pain (nmod)
week treatment (dep)
characterized moderate (conj)
defined parameters (nsubjpass)
dextran polymer (compound)
eating whilst (mark)
time response (nmod)
subcutaneous daily (advmod)
genesis a (det)
vldl and (cc)
contained weight (nmod)
kept were (auxpass)
detected all (nmod)
returned completion (nmod)
compared blocker (dobj)
deemed related (xcomp)
observed rtms (nsubjpass)
veins small- (amod)
index low (amod)
hypothyroid but (cc)
injection heparin (nmod)
steatosis and (cc)
had having (conj)
phn of (case)
of 100 (dep)
sulphate ) (punct)
period sensitive (amod)
deficits hyperactivity (dep)
14.3 1.6 (compound)
included pressure (dobj)
combating to (mark)
scores several (amod)
necrosis and (cc)
followed report (nsubjpass)
attribute addition (nmod)
restored replacement (nsubj)
test min (nmod)
reactivity no (det)
continued weeks (nmod)
patients patients (nmod)
rate crude (compound)
positive were (cop)
discontinuation treatment (conj)
toxicity new (amod)
neuropathy acute (amod)
showed strikingly (advmod)
effects central (amod)
benzodiazepines ( (punct)
ileum guinea-pig (amod)
update in (case)
depletion thiol (compound)
methadone heroin (conj)
markers in (amod)
feeling ill (acomp)
5 administration (dep)
terminology , (punct)
undergone chemotherapy (nmod)
rhythm myocytes (nmod)
provocation both (cc:preconj)
association its (nmod:poss)
decreased effects (nmod)
reported cases (nsubjpass)
treatment amiodarone (amod)
takes , (punct)
0.15+/-0.03/h 0.24+/-0.06/h (conj)
failure receiving (acl)
slower velocity (nsubj)
fasciculations areas (nmod)
have sm-5887 (nsubj)
induced penicillin (nmod:npmod)
groups iv (nummod)
hemicholinium-3 depletor (compound)
ranged dose (nsubj)
deterioration mice (nmod)
vasoconstriction greater (amod)
meeting ratings (nsubj)
properties deteriorated (amod)
have performed (xcomp)
manifestation toxicity (nmod)
alleviation in (case)
acetaminophen of (case)
ameliorates treatment (nsubj)
removed arteries (nsubjpass)
robust effect (nsubj)
methylxanthines theophylline (nmod)
having completion (nmod)
oxytocin agents (conj)
activation parp (compound)
decrease patients (nmod)
affect species (nsubj)
all whom (nmod)
reversed hours (nmod)
subscale anger (compound)
increase did (aux)
course six-week (amod)
woman history (nmod)
mm systolic (dep)
sedative and (cc)
appeared effect (xcomp)
increasing simply (advmod)
heroin with (case)
nachrs ( (punct)
lesions significantly (advmod)
141 6 (conj)
shown however (advmod)
deficiency gamma-aminobutyric (amod)
products other (amod)
fk506 with (case)
documents . (punct)
associated protocol (nmod)
definition a (det)
mortality morbidity (conj)
renal cardiovascular (conj)
increased mice (nmod)
p<0.01 vs. (cc)
right , (punct)
microgram/kg/min % (conj)
considered suggests (conj)
therapy prior (amod)
studied were (auxpass)
model lid (nmod)
block av (compound)
test heparin-induced (amod)
activate system (dobj)
was significance (nsubj)
studies drug (compound)
region factor (compound)
manifestation , (punct)
tissue elevated (amod)
evaluating changes (dobj)
haloperidol-treated l-noarg-treated (conj)
address hypotheses (dobj)
groups 4 (nummod)
case kidney (nmod)
show preserves (ccomp)
attenuates shows (conj)
apomorphine to (mark)
channel effects (conj)
effects days (nmod)
performed cystectomy (nsubjpass)
decline rats (nmod)
syndrome obstructive (amod)
0 hours (dep)
combination hydrochloride (nmod)
cases instillation (nmod)
patients aids (compound)
batteries 741 (nummod)
harmful be (cop)
ph culture (conj)
effectiveness sphincter (nmod)
approach behavioral (amod)
girl 4-year-old (amod)
reduction one-third (amod)
induce estrogens (nsubj)
appeared . (punct)
d2 brain (compound)
follow-up findings (nsubj)
relationships mechanisms (conj)
encephalopathy encephalitis (conj)
pdn ( (punct)
concentration value (conj)
abuse drug (compound)
lower map (nsubj)
microvilli swollen (amod)
showed week (nmod)
mg/day dose (nsubj)
performed evaluation (nsubjpass)
demonstrated has (aux)
include nausea (dobj)
volume plasma (compound)
= n (nsubj)
-15.4 ( (punct)
segment of (case)
first third (conj)
exceeded 100,000/ul (dobj)
passes cimetidine (nsubj)
accompanied tachycardia (conj)
series cases (nmod)
7e compound (compound)
tested rats (nmod)
plausible , (punct)
factor significant (amod)
months men (nmod)
pay pressure (nmod)
arteries common (amod)
mmp-2 adam17 (conj)
range 4 (nmod)
paralysis hind-limb (amod)
normal group (nmod)
cases similar (amod)
mutation point (compound)
patient from (case)
establish events (nsubj)
injury loss (conj)
antiplatelet , (punct)
showed structure (nmod)
rates incidence (compound)
use as (case)
restricted children (nmod)
observed farmers (nmod)
sensitivity age-dependent (amod)
score age (compound)
decrease levcromakalim-produced (amod)
male 10 (nummod)
levels high (amod)
5.0 0.5 (compound)
tma sos (conj)
first reported (xcomp)
secretion pulsatile (amod)
treatment appropriate (amod)
grade with (case)
reaching albuminuria (compound)
lesions marked (amod)
inhibitor spironolactone (conj)
function users (nmod)
lost , (punct)
designed trial (nsubjpass)
duration suspected (amod)
appear benefited (xcomp)
associated inorganic (nsubjpass)
patients presence (appos)
seizures behavioral (amod)
prophylaxis anticonvulsive (amod)
performed fed (conj)
considered with-drawn (xcomp)
doses even (advmod)
verapamil bepridil (conj)
patients post-oltx (dep)
august 2002 (nummod)
responses auditory (amod)
coactivator required (acl:relcl)
acid phenylacetic (amod)
schedule hepatocarcinogenesis (nmod)
significant medication (nmod)
proteins zo-1 (nmod)
testing further (amod)
withdrawal patients (nmod)
responsiveness function (conj)
concentrations drug (nmod)
toxicity this (det)
design intervals (nmod)
protocol during (case)
5-azc hepatectomy (dep)
activity enzyme (nmod)
pain their (nmod:poss)
vivo both (cc:preconj)
survival onset (nmod)
oxidative nfkappab (conj)
permeability paracellular (amod)
injury diffuse (amod)
treatment mg/kg (compound)
5-fluorouracil combination (conj)
treatment 298+/-7 (dep)
results test (compound)
rt-pcr blotting (conj)
range n (conj)
use transplantation (nmod)
occur has (conj)
relapsed whom (nmod)
scarce options (nsubj)
deficit conduction (compound)
thickening gyrata (conj)
months after (case)
cmro2 1.73 (appos)
mg/kg 0.15 (nummod)
appeared signals (nmod)
patients four (nummod)
= .005 (dep)
reversal hyperalgesia (nmod)
expressing ccr2 (dobj)
cardiac ( (punct)
levels quantitative (amod)
mdma ecstasy (conj)
center academic (amod)
events vascular (compound)
dilatation more (amod)
help identification (nmod)
patient disease (compound)
weights different (amod)
dose cyclophosphamide (nmod)
n=12 ) (punct)
medication neither (cc:preconj)
believe we (nsubj)
sinus of (case)
activation caspase (nmod)
bar a (det)
party mild (nmod)
normal was (cop)
extensive em (appos)
unclear target (advcl)
medline psychlit (conj)
increasing decreasing (conj)
loss polyneuropathy (amod)
duration disease (nmod)
unconjugated have (aux)
metabolism . (punct)
is suggestion (attr)
hypertrophy transient (amod)
conclusions data (appos)
associated prevalence (nmod)
stripe the (det)
syndrome induced (amod)
similar lidocaine (nmod)
ballooning apical (amod)
utility its (nmod:poss)
n/n=62/92 , (punct)
metabolites nucleus (nmod)
survivors from (case)
patients rizatriptan (conj)
improves used (advcl)
rats rhigf-i-treated (amod)
opse and (cc)
inhibits hyperemia (dobj)
cystitis nonsteroidal (amod)
micrograms 120 (nummod)
mc ) (punct)
relevance it (nsubj)
amoxicillin to (case)
area ( (punct)
micrograms/kg s.c. (dep)
investigations patient (nmod)
decrease metrizoate (nmod)
group b3 (compound)
continued days (nmod)
% 70/99 (appos)
salt tris (compound)
delayed pre-treatment (nsubj)
content by (case)
analyze variables (dobj)
precursor of (case)
therapy androgen (compound)
factor seroconversion (nmod)
174 60 (nummod)
girl 11-year-old (amod)
targets therapeutic (amod)
elevation possible (amod)
type hemorrhage (nsubj)
requested of (mark)
8.9 0.5 (conj)
messages origin (nmod)
workers affected (amod)
macrophages of (case)
weakness progressive (amod)
include reactions (nsubj)
effect promoting (compound)
administration terbutaline (compound)
disease workers (nmod)
presentation unusual (amod)
caused meth (nmod)
toxic dfu (nmod)
comparison hypotension (nmod)
found patient (nsubjpass)
pain associated (acl)
infusion hours (compound)
preference morphine-induced (amod)
fibrillation af (appos)
possibility increase (ccomp)
binding estrogen (nmod)
breakdown by (case)
durations response (nmod)
established potential (nsubjpass)
revealed resolved (advcl)
discharged patients (nsubjpass)
nephrotoxicity gentamicin (compound)
discontinued were (auxpass)
chlorpropanol tobanum (appos)
dose transplantation (nmod)
neurons serotonin (compound)
ketoconazole with (case)
mg mg (nmod)
corticosteroids glycerin (conj)
hepatitis report (appos)
therapy during (case)
doses mean (compound)
indicates gap (nsubj)
included ) (punct)
subjects seventeen (nummod)
prk excimer (compound)
tolerability combination (nmod)
excretion potassium (compound)
decreased cotransporter (nsubjpass)
anticonvulsant and (cc)
performed audiograms (conj)
end-stage due (case)
animals exposed (acl)
regimen coupled (acl)
risk was (cop)
profile antipsychotic-like (amod)
disorders suffered (acl:relcl)
recover h (nmod)
available although (mark)
experiments to (case)
schedules higher-intensity (amod)
regurgitation and (cc)
methyldopa to (case)
reinstated session (nmod)
effect nicotine (nmod)
1/2 t (compound)
hyperplasia endometrial (amod)
tolerated . (punct)
achieved treatment (nsubj)
spectrum power (compound)
analysis electrocardiography (conj)
carcinoma referred (acl)
lability in (case)
decrease stress (dobj)
tests psychological (amod)
associated neuroprotection (nsubjpass)
hampshire new (compound)
thickness a (det)
measurement protein (conj)
infusion remifentanil (compound)
5 % (appos)
fa 0.59-mg (amod)
switched recipients (nsubjpass)
rat 344 (nummod)
prevented s.c. (advmod)
indication heterogeneity (nmod)
setting hospitals (dep)
50 less (amod)
hypotheses rhabdomyolysis (nmod)
uv 13.1 (nummod)
killers of (case)
smaller or (cc)
injections scopolamine (nmod)
abnormalities study (nmod)
correlated former (nmod)
electrophysiologic hemodynamic (conj)
interaction a (nmod)
lv ( (punct)
period active (amod)
suppressed inhibited (advcl)
sem sem (conj)
significant time (nsubj)
occurred paresthesia (nsubj)
depressed had (aux)
liver with (case)
animals % (appos)
characteristics clinical (amod)
eskisehir turkey (conj)
comprises cluster (nsubj)
improved also (advmod)
angioedema secondary (amod)
exacerbations to (case)
0 at (case)
beginning therapy (dobj)
puerperium in (case)
gt/bc ) (punct)
constipation-predominant = (parataxis)
necessary diagnosis (nsubj)
interval ( (punct)
t3n1m0 ) (punct)
study trial (dep)
delirium of (case)
one first (amod)
areas and (cc)
coincided which (nmod)
therapy underutilized (amod)
performance recognition (compound)
risk doubled (acl)
mg./kg cp (compound)
material analysis (nmod)
return that (mark)
toxicity dfu (compound)
decreases density (nmod)
recruited centers (nmod)
101 +/- (cc)
action amphetamine (nmod)
a(2a)/a(1 is (cop)
retention (enac)-dependent (amod)
cause chorea (nmod)
factor receptor (conj)
maturation to (case)
treated 0.25 (nmod)
175 and (cc)
supplemented glutamate (nmod)
received design (dep)
noted biochemically (advmod)
consistent that (nsubj)
carteolol propranolol (conj)
mug ( (punct)
occurred hemorrhage (nsubj)
hypotension bradycardia (conj)
factors affecting (acl)
antigen pai-1 (compound)
extraction l-arginine (compound)
return a (det)
substrate the (det)
cocaine amphetamines (conj)
progressed while (mark)
injecting ml (dobj)
melatonin with (case)
satisfaction of (case)
% versus (cc)
blockers ( (punct)
infusion patients (nmod)
= 0.016 (dobj)
450 - (punct)
generation epilepticus (nmod)
therapy cacl2 (compound)
developed hematuria (dobj)
mg an (det)
avoided and (cc)
nigra rat (compound)
effect anxiolytic (amod)
extended that (mark)
sucrose cyclic (amod)
inhibitors fibrinolysis (compound)
best treat (xcomp)
volumes urine (compound)
umb24 receptors (nmod)
patients stages (nmod)
patients 122 (nummod)
antibiotics for (case)
study link (acl)
differentiate effects (dobj)
black % (nmod:npmod)
milieu of (case)
% 15.2 (nummod)
administration supervised (amod)
caudate in (case)
studied immunocytoma (xcomp)
aes ( (punct)
doses daily (amod)
assessed association (nsubjpass)
degrees in (case)
high- low-dose (conj)
injected wall (nmod)
power in (case)
three all (det)
weight peroxidation (conj)
study conduction (compound)
substituting zonisamide (nmod)
rats damage (nmod)
included pain (conj)
gradient a (det)
results toxicology (compound)
tolerability ) (punct)
improved misoprostol (nmod)
muscle ( (punct)
useful safe (conj)
efficacy levofloxacin (nmod)
presumed stunning (xcomp)
exhibited who (nsubj)
study biodistribution (dobj)
shows which (nsubj)
forearm c. (compound)
incubated week (nmod)
% adrenaline (nmod)
prevent myalgia (dobj)
possibility effects (nmod)
ias ( (punct)
bd1018 lr132 (conj)
system renin-angiotensin-aldosterone (compound)
tested see (advcl)
similarities the (det)
therapy anticoagulants (nmod)
responses % (appos)
patients function (conj)
caused drug (nmod)
lesion malignant (amod)
molecule injury (compound)
loss pallor (conj)
application intravenous (amod)
ci - (punct)
areas primary (amod)
terfenadine nm (appos)
those mutation (nmod)
impairment of (case)
agent acid-mimetic (amod)
mellitus glaucoma (conj)
feet in (case)
uremia to (mark)
number treatments (nmod)
resembles and (cc)
presence mb (nmod)
received protocol (dobj)
consider used (advcl)
chest open (amod)
leading prolongation (nmod)
csf ( (punct)
min-1 beat (compound)
saline mg/kg/d (dep)
species of (case)
model studied (acl:relcl)
possibility is (cop)
neurotoxicity acute (amod)
colocalized not (neg)
aged and (cc)
dosage ranging (acl)
execution task (nmod)
positive of (case)
study oncology (compound)
fully either (cc:preconj)
represent might (aux)
lower it (nsubj)
direct sequential (conj)
rat insipidus (compound)
radiograph chest (amod)
causing in (mark)
theophylline oral (amod)
46 % (appos)
produced also (advmod)
associated protection (nsubjpass)
normal prior (advmod)
had rtms (dobj)
dosing and (cc)
underwent electrocardiographic (xcomp)
days past (amod)
4.6 404 (conj)
mg epinephrine (nmod)
known . (punct)
step , (punct)
injection in (amod)
degrees sedation (nmod)
ouabain and (cc)
result toxicity (nsubj)
episode her (nmod:poss)
received counseling (dobj)
administered setting (nmod)
returned transaminases (nsubj)
developed hypothyroidism (nsubj)
catecholaminergic and (cc)
alternation , (punct)
induced estrogen (nmod:npmod)
protrusion and (cc)
evaluated and (advmod)
herbal homeopathic (conj)
abolish rats (nmod)
caused delay (dobj)
received sufficient (xcomp)
nh4cl 1.7 (nummod)
days injection (dep)
problematic can (aux)
crisis . (punct)
day over (case)
injected 13th (nmod)
cases dyserythropoiesis (nmod)
ethopropazine . (punct)
c nadh (appos)
2,682,2,803 ( (punct)
injury to (case)
summary , (punct)
rifampin and (cc)
patients insipidus (nmod)
angiogenesis induced (amod)
impairment as (cc)
paid be (auxpass)
amounts proteins (nmod)
excluded were (auxpass)
patients transplanted (acl)
placebo patients (nmod)
detection kidney (nmod)
onset tetany (nmod)
hippocampus in (case)
thrombocytopenia anemia (conj)
completed are (auxpass)
positive samples (nsubj)
mirtazapine of (case)
instances zero (nummod)
acid aspartate (conj)
paramethasone by (case)
started 7th (nmod)
decline bfgf (nmod)
index bis (appos)
easy was (cop)
reserved should (aux)
e4031 cisapride (conj)
rats decrease (dobj)
gains that (nsubj)
pilocarpine- against (case)
speech and (cc)
was objective (dep)
multicenter , (punct)
facilitation without (case)
changes leading (acl)
returned after (mark)
metabolites remoxipride (nmod)
secretion prolactin (nmod)
bladders on (case)
ci 1.57 (nummod)
investigated also (advmod)
effects qt (compound)
> was (cop)
nephrotoxicity 12 (appos)
appeared formed (xcomp)
period by (case)
mandates , (punct)
task passive (amod)
one least (advmod)
authors report (nmod)
ocs ( (punct)
seizures previous (amod)
2a ribavirin (conj)
criteria for (case)
comorbid depressed (amod)
seriousness disorder (nmod)
cholestasis severe (amod)
cimetidine and (cc)
constitutes , (punct)
propofol-remifentanil-tiva by (case)
g/day)-lovastatin ( (punct)
prevention the (det)
given days (dep)
antagonism block (nmod)
uncertain however (advmod)
safe ? (punct)
required abolish (xcomp)
transplantation prevent (acl)
offers advantages (dobj)
used which (nsubjpass)
served nissl-staining (nsubj)
discussed seldom (advmod)
medium an (det)
protein green (amod)
compared midazolam (nsubj)
19 of (case)
action thiopental (nmod)
group collaborative (compound)
11 2 (compound)
suggest conclusion (nmod)
adding thalidomide (dobj)
contaminants deficiency (conj)
became patients (nsubj)
prescribed course (dobj)
investigated dogs (nmod)
infarction transmural (amod)
negative as (advcl)
abstinence prolonged (amod)
sixty-eight ( (punct)
standard injections (nsubj)
ongoing trials (nsubj)
has stopped (conj)
level lithium (compound)
concentration group (nmod)
stress a (det)
heterogeneity the (det)
died survivors (nsubj)
depletor a (det)
rhythms accelerated (amod)
vgb to (case)
injections 35 (nummod)
neutropenia grade (compound)
effective as (advmod)
speaking aloud (advmod)
induction glomerulosclerosis (nmod)
used link (conj)
desogestrel ( (punct)
macrophages induced (acl)
extracted independently (advmod)
role of (case)
intensity to (case)
internus the (det)
dose-effect structure-function (conj)
deficit occurred (acl:relcl)
received reinforcement (dobj)
pain induced (acl)
excel ( (punct)
reduces only (advmod)
characteristic as (case)
ly-171555 or (cc)
known clarified (conj)
associated cases (conj)
improvement evoked (acl)
years 2.6 (nummod)
concentration 1.6 (dep)
cirrhosis cryptogenic (amod)
effect recipients (nmod)
bp , (punct)
toxicity cyclophosphamide (nmod)
carries . (punct)
patients thirty-eight (amod)
reconsidered . (punct)
sestamibi objective (nsubj)
total . (punct)
selectivity a(1)/a(2a (appos)
aneurysms on (case)
intoxication alcohol (compound)
change accumulation (nmod)
achieved dbp (dobj)
investigations the (det)
compare effectiveness (dobj)
doses patients (conj)
revealed horns (nmod)
mup and (cc)
employed : (punct)
vpa of (case)
1863 +/- (cc)
variability as (case)
investigated combination (dobj)
dependence methamphetamine (compound)
histology hepatic (amod)
showed that (nmod)
implicate mechanisms (dobj)
replace to (mark)
gluconate calcium (compound)
acetaminophen ( (punct)
velocity shortening (nmod)
agents these (det)
30 6 (conj)
extraction forearm (compound)
type lesion (nsubj)
gender-dependent not (neg)
seems influenced (xcomp)
recipient pediatric (amod)
vasoconstriction induced (acl)
unchanged excretion (nsubj)
haematological : (punct)
klebsiella pathogen (nsubj)
expression p75ntr (compound)
markers virus (compound)
reduced when (advmod)
mortality length (conj)
hematuria persistent (amod)
stimulation dyskinesias (nmod)
conclusive nimodipine (nmod)
nimo alone (advmod)
released days (nmod)
d2 vitamin (compound)
ratios odds (case)
model cardiomyopathy (amod)
refused and (cc)
modifications behavioral (amod)
30 100 (conj)
infusion saline (nmod)
suggest tool (ccomp)
locomotion , (punct)
releasing in (prep)
days use (nmod)
results treatment (nmod)
cytokine of (case)
enlarged sacrifice (nmod)
playing role (dobj)
reversible all (nsubj)
symptoms served (acl:relcl)
u/ml 52.7 (compound)
nacc ) (punct)
daunoxome ( (punct)
expression diet (nmod)
outflow dopamine (compound)
recovery gradual (amod)
toxicity lower (amod)
had diet (nmod)
complication dehydration (nmod)
observed start (nmod)
higher respectively (advmod)
used investigate (advcl)
remission into (case)
direct and/or (cc)
year 35 (nummod)
selective non-selective (conj)
urticaria and (cc)
encountered involvement (nsubjpass)
nephrotoxicity increased (amod)
developed polyuria (dobj)
palsy nerve (nmod)
conclusion suggest (dep)
study cardiotoxicity (dobj)
thiopental with (case)
had impairment (dobj)
stroke acute (amod)
reduced administration (nsubj)
efficacy either (cc:preconj)
pathways abnormalities (conj)
reported association (nmod)
echocardiography the (det)
stroke normotensive (nmod)
morphine the (det)
improves or (cc)
carcinomas fanft-induced (amod)
alternative a (det)
% 26.5 (nummod)
go exploration (nmod)
result also (advmod)
had administered (advcl)
recovered patients (nsubj)
treatment last (amod)
effects endometrial (amod)
studies stroke (nmod)
elevated initially (advmod)
compared sedation (nmod)
activated smad3 (nsubjpass)
year event (nmod)
appears predominate (xcomp)
actions drugs (nmod)
reach dose (nmod)
objective study (compound)
days tfl (appos)
received combination (conj)
databases following (amod)
controlled poorly (advmod)
prevented cpa (nsubj)
vehicle alone (advmod)
mg/m2 600 (nummod)
inhibitor polymerase (nmod)
administration use (appos)
dogs ( (punct)
school medicine (nmod)
arrhythmias warning (amod)
identified cells (nsubjpass)
cardiomyopathy children (nmod)
analgesia even (advmod)
found treatment (dobj)
cause disorders (nmod)
mrna serca2 (compound)
total for (case)
drugs antituberculosis (compound)
actions l-dopa (nmod)
experienced exacerbation (dobj)
piroxicam in (case)
use dexmedetomidine (nmod)
network cooperative (amod)
patients to (mark)
ester methyl (compound)
dosages therapeutic (amod)
noted have (aux)
seizure but (cc)
cascade in (case)
metoclopramide by (case)
immunity mediated (amod)
month and (cc)
induced zidovudine (nmod)
cbdca of (case)
presents courses (nmod)
initiated usually (advmod)
comparable reduction (nmod)
decided . (punct)
compare determine (advcl)
mg/g 1 (nummod)
implicated antimicrobials (nsubjpass)
c219 antibody (compound)
evaluated involvement (nsubjpass)
changed : (punct)
led patient (nmod)
history symptomatology (nmod)
cause impairment (dobj)
reduced that (nmod)
sensation an (det)
< 0.2 (nummod)
frs , (punct)
120 to (dep)
tacrolimus corticosteroids (conj)
hypersensitivity with (case)
infarction with (case)
discontinued administration (nsubj)
inhibit lethality (dobj)
administered infusion (dobj)
modifications following (case)
effects estrogenic (amod)
subjects patients (compound)
well-tolerated trial (nmod)
severity alcohol (compound)
measured before (mark)
syndrome kearns-sayre (amod)
discontinued oxytocin (nsubjpass)
placebo ketamine (conj)
female male (conj)
stones bladder (compound)
reported discontinuing (advcl)
onset disturbance (nmod)
confirmed it (nsubjpass)
uncomplicated maintained (conj)
stable were (cop)
permeability each (det)
pneumonitis problematic (amod)
index high (amod)
submitted were (auxpass)
correlate did (conj)
administered birth (nmod)
deficient to (mark)
synthase activation (conj)
amnesia induced (acl)
drugs anticonvulsant (amod)
demonstrated attenuates (ccomp)
mean analyzed (ccomp)
abs ) (punct)
abuse ma (compound)
analyzed tissues (nsubjpass)
volunteers male (amod)
alter further (advmod)
variability for (case)
dose schedule (conj)
endogenous one (conj)
pretreated remifentanil (nmod)
prednisone topical (conj)
literature incidence (nmod)
33 x (cc)
cells mediate (acl:relcl)
circumferential gcs (appos)
fever developed (amod)
involved drugs (nsubjpass)
precedes onset (dobj)
smoking does (aux)
91.5 was (cop)
quantified not (neg)
determined yet (advmod)
tiva ( (punct)
mania or (cc)
have follow-up (dobj)
recommend strongly (advmod)
events no (neg)
overdose . (punct)
analysed elucidate (advcl)
12 5 (compound)
camp of (case)
limit man (nmod)
obtained spect (nmod)
domains encoding (acl)
role paradigm (nmod)
suggested been (auxpass)
ineffective antiparkinsonians (nsubj)
stimulated patients (nmod)
lower mm (dep)
syndrome fulminant (amod)
beta 1- (nummod)
attracted has (aux)
treated p9201 (nmod)
curve an (det)
taking are (aux)
develop demonstrate (conj)
weighed should (aux)
percent rats (nmod)
surface to (case)
labetalol and (cc)
improve ofh (nmod)
factor psychosis (compound)
moderate-dose 23.6 (appos)
effect damage (nmod)
malformation and (cc)
movements vacuous (amod)
) ( (punct)
complication fa (nmod)
living and (cc)
potentiation increasing (conj)
rp 48,968 (nummod)
2.8 1.6 (compound)
medline and (cc)
glibenclamide or (cc)
pi ( (punct)
report interaction (dobj)
nos-ir were (cop)
pt ( (punct)
animals control (amod)
elicited capsaicin (nmod)
decrease nigra (nmod)
efficacies relative (amod)
induces catalepsy (dobj)
kytril ( (punct)
contrast by (case)
trial treatment (compound)
high significantly (advmod)
enzyme blocker (conj)
preventing cin (dobj)
account depression (nmod)
lability inattention (conj)
shifting updating (conj)
performance knockout (nmod)
microinjected subregions (nmod)
application intracavitary (amod)
neutropenia quetiapine-induced (amod)
measurements marker (compound)
treatments poisoning (nmod)
membranes cell (compound)
read able (conj)
injection isoproterenol (nmod)
raise that (mark)
% 7.13 (dep)
picture resolved (acl:relcl)
2.5 1.1 (conj)
administered mg/kg (nsubjpass)
severity processes (nmod)
therapy lead (conj)
observed correction (nmod)
met agoraphobia (nmod)
cases chf (nmod)
suggest downregulates (ccomp)
seen which (nmod)
reduced onset (nmod)
amnesia cholinergic (compound)
enlargement in (case)
apoptosis to (case)
impaired is (auxpass)
patients 201 (nummod)
seizure-prone and (cc)
application and (cc)
safety to (case)
increased liver (nmod)
anemia that (det)
arousal of (case)
factor by (case)
weight , (punct)
controls for (case)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline of (case)
internal hepatic (conj)
myocardiopathy rats (nmod)
endocrinologists by (case)
treat diseases (dobj)
20 13 (compound)
allergies with (case)
cholestasis intrahepatic (amod)
performed protocol (nsubjpass)
opening dural (amod)
cause investigated (ccomp)
decrease profound (amod)
onset encephalopathy (nmod)
was months (nmod)
underlie that (mark)
significance be (cop)
measuring oxidation (dobj)
drugs nsaids (appos)
diseases cirrhotic (amod)
beta2(-/- in (case)
nodosa polyarteritis (compound)
memory and (cc)
represents q10 (nsubj)
response this (det)
observed woman (nmod)
levels nrf2 (compound)
strategies of (case)
mg. 10 (nummod)
disruption attenuated (amod)
delivery infant (nmod)
diabetic for (case)
phase for (case)
displacements with (case)
considered positive (xcomp)
hyperprolactinemia long (amod)
carry ; (punct)
pallidotomy the (det)
total studies (nmod)
open however (advmod)
sevoflurane % (nummod)
advantages cbdca (appos)
carcinogens 1,2-dimethylhydrazine (conj)
mice bpa (nmod)
dynamics based (acl)
data follow-up (compound)
found yet (advmod)
improved : (punct)
rose compared (advcl)
administration lamivudine (nmod)
elevated hypertension (nmod)
modulate impairment (dobj)
bleeding intracranial (amod)
concentrations pg-9 (nmod)
mrp2 pgp (conj)
changes secondary (amod)
triggered either (dep)
tail-flick and (cc)
drug antiestrogenic (amod)
level without (case)
volunteers from (case)
smokers diseases (nmod)
developed hyperthermia (dobj)
occurred . (punct)
harvested and (cc)
observed lower (xcomp)
44 of (advmod)
monotherapies with (case)
plays dopamine (nsubj)
procoagulant anticoagulant (conj)
method be (cop)
syndrome vanishing (compound)
consisted eosinophil (nmod)
seconds 10 (nummod)
63 % (dep)
experienced multiforme (advcl)
actions infusion (nmod)
tested month (nmod)
described have (aux)
administration hexachloro-1:3-butadiene (nmod)
clonidine methylphenidate (conj)
monomer conjugate (conj)
minutes level (compound)
suggested combined (advcl)
reduced degree (nmod)
hbv-dna of (case)
undergoing sedation (dobj)
admissions in (case)
pretreated furosemide (nmod)
many neurons (nmod)
micrographs electron (compound)
increase does (aux)
exacerbation with (case)
likely such (nmod)
ltg ( (punct)
greater % (nmod:npmod)
part remaining (amod)
trimester in (case)
administered time (nmod:tmod)
15 39 (conj)
remedy may (aux)
dilation % (conj)
patients insufficiency (conj)
k(+ ) (punct)
= 2.7 (dep)
patients 92 (nummod)
reduced are (auxpass)
synergy the (det)
encoding a (det)
involving tissues (dobj)
provide results (nsubj)
japan , (punct)
microg 100 (nummod)
nefiracetam of (case)
considered substitutes (nmod)
instability of (case)
wane although (mark)
simvastatin-ezetimibe with (case)
mediate that (nsubj)
medication antibacterial (amod)
bronchopneumonia acute (amod)
limited : (punct)
injection serum (nmod)
remained unchanged (xcomp)
patient 77-y-old (amod)
follows score (dep)
biochemical indices (conj)
frequent . (punct)
showed % (nsubj)
induced diazepam (nmod)
occurs background (nsubj)
influenced mammals (nmod)
initiate changes (nsubj)
interventions . (punct)
lacking still (advmod)
aas ( (punct)
lowered metfromin (nsubj)
relations metrics (nmod)
decreases activity (nmod)
bottle with (case)
hypoglycemia polycythemia (conj)
malformations low (amod)
postulates . (punct)
exposure during (case)
delivery cesarean (compound)
separated and (cc)
test groups (nmod)
result can (aux)
fed examine (advcl)
butyrylthiocholine btc (appos)
ionotropic metabotropic (conj)
antagonizes nicotine (nsubj)
induced multiple (conj)
preceding % (nmod)
grade of (case)
tolerated that (mark)
neurons sensory (amod)
combination mtx (nmod)
(bort)-dexamethasone bortezomib (compound)
form barrier (dobj)
diameter aneurysm (compound)
homogenates from (case)
g ranitidine (nmod)
hyperalgesia induced (acl)
continuing by (mark)
fornix vaginal (amod)
predictors specific (amod)
total cases (nmod)
group repetitive (amod)
arteries angiography (nmod)
effects latent (amod)
showed echocardiography (nsubj)
grafts functioning (amod)
became used (acomp)
antagonists : (punct)
measured meter (nmod)
inotropic and (cc)
administered found (advcl)
mean duration (dep)
promote , (punct)
ug/ml . (punct)
males risperidone (nmod)
data obtained (acl)
inhibitor micrograms (appos)
receptor ( (punct)
justified cause (nmod)
2.0 0.2 (conj)
subtypes all (det)
evidence mediated (ccomp)
range years (dep)
nephrotoxicity ototoxicity (conj)
november 2002 (nummod)
determined but (cc)
pcc or (cc)
antagonist famotidine (nsubj)
cns in (case)
properties chemical (compound)
1 31 (prep)
manage anemia (dobj)
diagnosed she (nsubjpass)
vasoconstriction segments (nmod)
week any (det)
levels control (compound)
5-ht with (case)
activity ache (compound)
variety for (case)
occurred prolongation (nsubj)
events outcomes (nsubj)
microvesicular hepatocyte (compound)
hyperprolactinemia induced (acl)
dnap ( (punct)
4.98 , (punct)
ccl2 and (cc)
fess ( (punct)
141 from (case)
transit similar (amod)
machr ( (punct)
represent drugs (nsubj)
found unconsciousness (xcomp)
child undergoing (acl)
recovery patient (nmod)
recovery followed (acl)
cancer kidney (compound)
pups exposed (acl)
methods : (punct)
benefits taking (advcl)
solution treatments (conj)
deficiency thiamine (nmod)
mean four (nmod)
868 1 (compound)
thrombo-embolism for (case)
rammer hildebrand (dep)
effect stimulation (nmod)
piperidin-1-yl ) (punct)
reflects . (punct)
designed , (punct)
pharmacy a (det)
produced stimulating (advcl)
delineate and (cc)
trial adenosine (nmod)
colocalized was (auxpass)
created were (auxpass)
min subcutaneously (advmod)
observed min (nmod)
modification state (nmod)
spine her (nmod:poss)
defects visual (amod)
lesion chronic (amod)
days 170 (nummod)
explained deficit (nsubjpass)
palkovits ' (case)
lungs and (cc)
repeat a (det)
35.1 +/- (cc)
raised significantly (advmod)
reverse promptly (advmod)
amide inhibitor (appos)
regions particularly (advmod)
regulates effects (dobj)
exposure abstinence (conj)
cycle following (case)
15 60 (conj)
developing nephrotoxicity (dobj)
transplant blood (compound)
developed recommenced (advcl)
rs6277 and (cc)
projection restricted (amod)
available confirming (xcomp)
spasm muscle (compound)
function neurophysiological (amod)
% 87.1 (nummod)
drugs anesthetic (amod)
area regulated (acl:relcl)
antagonizes reversing (advcl)
% or=50 (compound)
olanzapine with (case)
aprotinin and (cc)
patients cta (nmod)
50 on (case)
yield cirrhosis (nmod)
technique artery (nmod)
elevated and (cc)
elevated phosphatase (nsubj)
myocet company (conj)
precede , (punct)
echoes studies (nmod)
ko cb1 (compound)
levels peak (amod)
provided relief (dobj)
pathology quality (nmod)
protects , (punct)
describe increase (conj)
saline n (dep)
potential visual-evoked (amod)
apnoea . (punct)
uptake altered (amod)
levels normotensive (compound)
myeloencephalopathy administration (nmod)
agents were (cop)
failure secondary (amod)
monitored arteries (nmod)
vigilance a (det)
support colony-stimulating (amod)
cases nystagmus (nmod)
those polypeptide (nmod)
included sensorium (dobj)
do to (mark)
test showed (acl:relcl)
pralidoxime-2-chloride or (cc)
induce behaviors (dobj)
treatment relapsed (nmod)
finding suggestion (nsubj)
concern . (punct)
methimazole without (case)
sedation moderate (amod)
consumption increased (acl:relcl)
compared none (nmod)
beta-carboline-3-carboxylate agonist (appos)
constipation-predominant ) (punct)
roots pk (appos)
used spect (dobj)
2-(p-bromophenyl)propionate 3 (nummod)
worsen not (neg)
ang ii (nummod)
decreased affected (conj)
disorder hematologic/oncologic (amod)
relevant effects (nsubj)
angiotensin of (case)
unclear and (cc)
showed acid (nsubj)
unresponsiveness verapamil (nmod)
group acetaminophen (amod)
source of (case)
criteria of (case)
patients age (dep)
migraine with (case)
cld , (punct)
block reversible (amod)
frequency increased (amod)
response sulpiride (nmod)
superoxide plasma (compound)
demonstrated next (advmod)
removal sinuses (nmod)
surface over (case)
gum smokers (nmod)
models or (cc)
mother women (nmod)
tested metabolites (nsubjpass)
c of (case)
performed followed (ccomp)
degeneration to (case)
analysis blot (compound)
studied has (aux)
identifying disgust (dobj)
thickening the (det)
taken % (nmod)
concentrations baseline (compound)
reverse to (mark)
test y-maze (amod)
hypothermia of (case)
spasm arterial (amod)
drugs effective (amod)
one left (amod)
group azelastine (compound)
experience , (punct)
consumption the (det)
settings of (case)
persisted which (nsubj)
rate remission (compound)
co-treatment increasing (xcomp)
tissues biopsy (compound)
incontinence hallucinations (conj)
continued appears (advcl)
follow time (appos)
introduce order (nmod)
min . (punct)
yield sites (nmod)
delayed onset (dobj)
compounds cytotoxic (amod)
questionnaires . (punct)
exists effects (nmod)
cisapride , (punct)
dehydration agitation (conj)
alpha-enac subunits (dep)
hypotension dysfunction (conj)
revealed exhibited (ccomp)
visualized : (punct)
exposing cultures (dobj)
effective temocapril (nsubj)
arteries normal (amod)
efficacy anticancer (compound)
significance results (nmod)
produce arthrogryposis (dobj)
action neurotoxicity (nmod)
titer pr3-anca (compound)
function small-bowel (amod)
complications reports (dep)
allocated placebo (nmod)
1 months (dep)
identify inpatients (dobj)
indicate occurred (ccomp)
0.887 0.426 (nummod)
control cases (nmod)
s dose (nmod)
syndrome sos (appos)
ill severely (advmod)
retching tremors (conj)
staining of (case)
shift curves (dobj)
aid an (det)
inhibitory facilitatory (conj)
swim to (mark)
transplant after (case)
charge sulphate (compound)
5 4 (compound)
times 60 (nummod)
animals seizures (nmod)
children poisoned (acl)
presentation hepatic (amod)
perception the (det)
lines two (nummod)
dis-charge months (conj)
weight atpase (conj)
isoflurane group (appos)
ingestion salicylate (amod)
agents , (punct)
fatigue patients (nmod)
highlight factors (dobj)
studied reduced (conj)
g micro (amod)
degree same (amod)
po 400 (nummod)
reflex to (mark)
prevented amnesia (dobj)
diagnostic procedures (dep)
correlated animals (nmod)
istanbul , (punct)
rosacea in (case)
articles several (amod)
observations changes (conj)
involvement the (det)
libitum water (compound)
observed decline (nsubjpass)
induced chloroform-adrenaline (nmod)
po , (punct)
influence abolition (nsubj)
alfentanil opiate (amod)
calculated time (nmod)
increased lifting (nsubjpass)
examination microscopic (amod)
revealed bradycardia (dobj)
episode gtcs (nsubj)
observed result (conj)
necrolysis epidermal (amod)
% 21 (nummod)
provided patient (nmod)
affected fasting (nmod)
level cholesterol (compound)
history long (amod)
injections glutamate (nmod)
mpo-anca the (det)
cardiotoxicity its (nmod:poss)
se or (cc)
seem do (aux)
dyskinesias severe (amod)
dialyzer on (case)
episodes during (case)
anatomical pathophysiological (conj)
(5.3)% , (punct)
benzylthiouracil after (case)
predictors were (cop)
noted prolongation (nsubjpass)
euthanized animals (nsubjpass)
those taking (acl)
taking these (dobj)
absence seizures (dep)
intensities high (amod)
radicals of (case)
continue therefore (advmod)
varied patients (nmod)
different that (nsubj)
effective mg (nsubj)
recorded microelectrodes (nmod)
correct extent (nmod)
attention patients (nmod)
exposure hcl (compound)
min ) (punct)
1.0mg/kg - (punct)
users preparations (nmod)
function processes (nmod)
doses risperidone (nmod)
hypothyroidism , (punct)
given consideration (nsubjpass)
syndrome described (amod)
likely conclusions (dep)
65 88 (conj)
elevated day (nmod)
activity not (cc)
marker glial (amod)
thrombosis dvt (appos)
kg 31.7 (nummod)
crescents with (case)
men 119 (nummod)
affected electroshock (nsubjpass)
impairment neurologic (amod)
known effect (nmod)
reductions greater (amod)
a ] (punct)
mes ) (punct)
counteract , (punct)
h twenty-three (amod)
omeprazole the (det)
control csa (appos)
analysis actuarial (amod)
indicated case (nmod)
meningitis staphylococcus (compound)
improvement gfr (nmod)
od ) (punct)
indications precise (amod)
appetite , (punct)
rediscovery the (det)
consequence so (mark)
acid eaca (appos)
score higher (amod)
higher dose (nsubj)
reaction reaction (nmod)
extreme most (advmod)
ato dex (conj)
safe women (nmod)
facilitate evaluation (dobj)
mpep ip (dep)
combination fixed-dose (amod)
syncope had (conj)
eeg and (cc)
population patient (compound)
discontinuation and (cc)
presented patient (dobj)
evaluation hearts (nmod)
become potential (nsubj)
plays control (nmod)
antagonists calcium (compound)
occluded mca (nsubjpass)
findings epileptiform (compound)
loading oral (amod)
stenosis partial (amod)
ml 8 (nummod)
treatment weeks (dep)
evaluable patients (nsubj)
effects system (compound)
hypertension administered (acl)
progression weeks (nmod)
gangrene of (case)
exposure flurothyl (compound)
hypertrophy . (punct)
administration ketamine (compound)
study literature (conj)
damage field (nmod)
agents as (case)
corrected completely (advmod)
use enrollment (nmod)
aged older (conj)
plays syndrome (nmod)
acid all (appos)
injected similarly (advmod)
medication no (det)
micron of (case)
arteriography an (det)
administration erythromycin (nmod)
data these (det)
stones of (case)
rate presumed (acl)
3.9 0.3 (conj)
observed those (nmod)
890 cycle (nmod)
accompanies therapy (dobj)
acetate with (case)
increase 9 (nmod)
2.20 interval (appos)
considered points (nsubjpass)
surviving and (cc)
ketoprofen not (cc)
ltp i.c.v. (appos)
suppresses responses (dobj)
cancer risks (dep)
hypercalcemia impairment (conj)
sedimentation by (case)
objectives demonstrated (dep)
atac ) (punct)
analysis multivariate (compound)
fi pro (amod)
return toward (case)
61 24 (conj)
trial neutralizes (acl:relcl)
defined criteria (nmod)
mc the (det)
superoxide of (case)
bilirubin iii/iv (conj)
changed identified (conj)
toxicity that (nmod)
reversal % (compound)
mvp ( (punct)
reproducible and (cc)
myocytes nrvms (appos)
coeruleus pons (nmod)
differed p (dep)
phosphate calcium (compound)
safe rrmm (nmod)
hypertension induced (acl)
diagnosis in (case)
strategies : (punct)
composite hypotension (nmod)
patients either (det)
epilepticus status (compound)
occurred degree (nsubj)
bmcs with (case)
reported abnormalities (nsubjpass)
proliferation for (case)
7 h (nmod:tmod)
evaluation preliminary (amod)
reduced dyskinesias (nsubjpass)
necessary . (punct)
frequency cont./min (dep)
transformation a (det)
individuals risk (nmod)
celecoxib to (dep)
plasticity motor (compound)
exercise use (nmod)
occurrence bruising (nmod)
hospitals large (amod)
phenotypes the (det)
cochlea on (case)
blocked release (nsubjpass)
exhibited affinity (dobj)
25mg/kg by (case)
protein pd (appos)
vinorelbine vnr (appos)
protection near (case)
effects chronological (amod)
existed years (nmod)
dose convulsant (amod)
curve elevated (amod)
leading death (nmod)
allocated piglets (nsubjpass)
succinate sumatriptan (amod)
confirms study (nsubj)
indicate agent (ccomp)
profiles similar (amod)
disease rare (amod)
mmhg 55 (nummod)
8 mg/kg/day (amod)
improve duration (dobj)
schiff bodies (appos)
administration related (amod)
matched children (nsubjpass)
flattening in (case)
increased able (dep)
glaucoma glucocorticoid-induced (amod)
stratified cohorts (nmod)
reported active (ccomp)
reach number (nmod)
improvement lid (nmod)
individual selective (dep)
icrf-187 ( (punct)
change therapy (nmod)
src ( (punct)
submitted immediately (advmod)
mania hypomania (conj)
cyp2d6 by (case)
injection morphine (nmod)
significant that (mark)
comparison arrhythmias (conj)
latencies those (nmod)
improvement haemodynamic (amod)
amifostine ) (punct)
present : (punct)
interaction piroxicam (nmod)
depression treated (acl)
beverages of (case)
electromyogram the (det)
model arrhythmia (compound)
treated risperidone (nmod)
addictive , (punct)
mid- of (case)
challenge before (case)
aminoglycosides of (case)
inhibition this (det)
6 12 (prep)
p450 cytochrome (compound)
presented agitation (dobj)
cont./min 2.5 (nummod)
aim paper (nmod)
progression rats (nmod)
analogue the (det)
reoccur tachycardia (nsubj)
nuclei pontine (compound)
underlying disorders (dobj)
differ prevalence (nsubj)
had fenfluramines (nsubj)
interferon ifn (appos)
published cases (nsubjpass)
gap43-ir ( (punct)
kf17837 : (punct)
follow , (punct)
present n (dep)
% 37.5 (nummod)
neutropenia females (nmod)
levels at (case)
past its (nmod:poss)
showed remains (advcl)
used animals (nmod)
injected intrathecally (advmod)
tacrolimus in (case)
% 7.8 (dep)
withheld was (auxpass)
immunocompromised severely (advmod)
injections intracorporeal (amod)
effects prodysrhythmic (amod)
studied assess (advcl)
ketamine or (cc)
activity dismutase (compound)
had 4 (nsubj)
becoming is (aux)
similar crude (nsubj)
ca1 ca3-c (conj)
pan mg/100 (appos)
reversed all (nsubj)
consistent bundle (nmod)
agent lenalidomide (appos)
abnormalities expression (nmod)
decreased induction (nmod)
apical periapical (conj)
efforts resuscitative (amod)
tissues normal (amod)
nsaid or (cc)
box novel (amod)
correlation in (case)
u/ml to (case)
factor-i of (case)
levels both (dep)
% 22.9 (nummod)
survivors cancer (nmod)
mechanisms with (case)
agent anesthetic (amod)
morning ) (punct)
deprivation or (cc)
achieved employed (advcl)
2.1 0.1 (conj)
suggesting role (dobj)
cause frequently (advmod)
perturbations cardiovascular (amod)
received february (nmod)
156 to (quantmod)
thyrotoxicosis of (case)
effect mechanism (conj)
evaluated purpose (dep)
left to (case)
correlations , (punct)
transplant p (dep)
dx ( (punct)
lower weights (nsubj)
questioned subsequently (advmod)
fell beats/min (nmod)
2h to (case)
enhances administration (nsubj)
hepatitis clopidogrel-related (amod)
injected doxorubicin (nsubjpass)
cannabis use (dobj)
ranged mean (dep)
i.v ) (punct)
unchanged levels (nsubjpass)
recruited 1995 (nmod)
instances spasm (nmod)
aim our (nmod:poss)
pigs in (case)
concentration aldosterone (compound)
attenuates absence (nsubj)
assumed hypercholesterolemia (nmod)
basis disturbances (nmod)
content organs (conj)
solution normal (amod)
database ) (punct)
characterized insufficiency (nmod)
discrimination sound-source (amod)
kindling mice (nmod)
suggest result (advcl)
p100 fr (conj)
seizures death (conj)
treated condition (nsubjpass)
utilization its (nmod:poss)
(+/-)-sm 21 (nummod)
nitrate/nitrite plasma (compound)
increased exposure (nsubj)
tyr6]-vip [ (punct)
pathophysiology underlying (amod)
attenuated striatum (nmod)
receptors 5-ht1b (compound)
phase two (nummod)
dosage area (nmod)
excel ) (punct)
weeks % (conj)
applicators number (nmod)
77 2 (conj)
microliter in (case)
limited activity (dobj)
association no (det)
explain symptoms (dobj)
established change (conj)
mm 40 (nummod)
seizure-prone ve (compound)
groups at-risk (compound)
nyha ) (punct)
levels peak (compound)
increases susceptibility (dobj)
r-(alpha)-methylhistamine agonist (compound)
levels prl (compound)
hepatic or (cc)
titres two (nmod)
stimulating nk1 (dobj)
study receive (xcomp)
course osteomyelitis (nmod)
sem hg (compound)
cessation drug (nmod)
seizure brief (amod)
frey and (cc)
shown factor (ccomp)
cip ( (punct)
detected similarly (advmod)
accompanied restoration (nsubjpass)
expression nrf2 (nmod)
atriotomy the (det)
affecting are (aux)
thrombi signs (conj)
identified respectively (advmod)
nifedipine with (case)
subjects : (punct)
delta were (conj)
toxicity systemic (amod)
precedes pattern (nsubj)
precautions therapeutic (amod)
showed binding (dobj)
dyskinesias dystonic (amod)
7.1 from (case)
results obtained (acl)
pre-induced dogs (nmod)
serum- glucocorticoid-inducible (conj)
recognised objectives (dep)
incidence switches (nmod)
myalgia is (cop)
shown teratogenic (xcomp)
contraction electrical (amod)
medline abstracts (conj)
impairments on (case)
receive placebo (conj)
repair anesthesia (nmod)
damage some (det)
serotonergic altered (amod)
implicated pathway (nsubjpass)
assessment on (case)
ip 5 (nummod)
wild-type mice (dep)
effects without (case)
associated dose (nsubjpass)
myelosuppression of (case)
middle or (cc)
counts their (nmod:poss)
showing to (mark)
4 up (quantmod)
conclude modulate (ccomp)
inflammation paw (compound)
agent identified (amod)
doses adenosine (compound)
hydrochloride inhibitor (appos)
treatment feasible (amod)
required epileptogenecity (nsubjpass)
compared variables (nmod)
programs systematic (amod)
using to (mark)
onset administration (nmod)
effects production (nmod)
attenuated which (nsubjpass)
treatment glioblastoma (compound)
% 14.5 (nummod)
fraction % (dep)
bundle through (case)
enlargement tachycardia (conj)
referred chemotherapy (nmod)
mitoxantrone and (cc)
maleate dizocilpine (compound)
complication results (acl:relcl)
changes to (case)
absence vasoconstriction (nmod)
acted emphasis (nmod)
45.45 , (punct)
inhibition and (cc)
progressive and (cc)
improves dysregulation (dobj)
occurred why (advmod)
predispose to (mark)
demonstrated findings (nsubj)
program nationwide (amod)
system ( (punct)
associated concentrations (nsubjpass)
intensity pain (nmod)
high although (mark)
aimed was (auxpass)
line human (amod)
supported be (auxpass)
micrograms 800 (nummod)
attenuated amnesia (dobj)
frequency sensation (conj)
entity classic (amod)
demonstrated induces (ccomp)
flavour a (det)
ischemia infusion (nmod)
face failure (nmod)
woman iraq (nmod)
studied doses (nsubj)
preventing myoclonus (dobj)
immunization mouse (nmod)
correlated dose (nmod)
infusion those (conj)
chemistry , (punct)
fulfill need (dobj)
result this (det)
c and (cc)
dyskinesia stress (conj)
scr ) (punct)
associated kindling (nmod)
analgesics certain (amod)
effects tacrolimus-related (amod)
infusions 15-minute (amod)
= t(30 (nmod:npmod)
molecule anionic (amod)
benefit not (neg)
sub-divided . (punct)
imaging task (conj)
had believe (advcl)
diagnostic vasculitis (nmod)
indication this (det)
model ich (compound)
psychosis methamphetamine-induced (amod)
symptoms treatment (conj)
24_h onset (nmod)
alterations on (case)
prescription on (case)
age other (amod)
compared rnfl (nmod)
fazadinium of (case)
2 patients (nmod)
effect pool (nmod)
amplitudes shortened (acl)
response toxicity (conj)
marked administered (advcl)
enhanced raised (conj)
method ellman (nmod)
deficits mechanisms (nmod)
investigate addressing (dep)
6 1 (prep)
activity promoter (compound)
energy of (case)
difference session (nmod)
subgroups the (det)
increase content (nmod)
not whether (mark)
when exceeds (nsubj)
suggests seizure (xcomp)
familiarity populations (nmod)
joint : (punct)
seizures bupropion-associated (amod)
demethylase ndma-d (appos)
performed dse (dobj)
azithromycin by (case)
gtn 17.9 (nummod)
suggests effect (dobj)
mr doses (conj)
signal baseline (compound)
fatalities also (advmod)
lumens fragments (nsubj)
injury spinal (amod)
patients susceptible (amod)
incontinence her (nmod:poss)
500 than (quantmod)
angiography , (punct)
stones gall (compound)
bfgf ) (punct)
mania to (case)
trait leprosy (conj)
doses with (case)
c57bl/6 mice (dep)
plasma into (case)
g/250 2 (nummod)
solicited reports (nsubjpass)
spasm coronary (amod)
shown are (auxpass)
involved to (mark)
lowering at (mark)
concentrations at (case)
observed often (advmod)
limited reports (nmod)
discharged er (nmod)
safety : (punct)
occurs exposure (nmod)
reduction efflux (nmod)
vasculitis anca (compound)
determination perception (nmod)
clozapine -2.59 (dep)
minimum week (nmod)
-0.2 - (punct)
mornings the (det)
derivative different (acl:relcl)
% 5%-44 (nummod)
urticaria acute (amod)
hemispheres , (punct)
administration cm (compound)
cases autopsy (compound)
ended stillbirth (nmod)
hcrh ) (punct)
days 61 (nummod)
rate exercise (compound)
starting after (mark)
compared agent (nmod)
example is (cop)
disorder delirium (appos)
ventilatory and (cc)
man kidney (nmod)
period class (nmod)
sampled was (auxpass)
distribution del (nmod)
survival patients (nmod)
changed both (nsubj)
hypothesis adrenaline-hypertension (amod)
access on (case)
action similar (amod)
estradiol ethinyl (amod)
establishes study (nsubj)
ptx ) (punct)
occurred occlusion (nsubj)
lesions dentate (nmod)
peak te (compound)
1 approximately (advmod)
hours after (case)
withdrawn , (punct)
two % (appos)
girl an (det)
studied interventions (nsubjpass)
opening sites (nmod)
changes scores (nmod)
3-methoxy-4-hydroxyphenethyleneglycol and (cc)
evaluated role (nsubjpass)
areas dysfunction (nmod)
intermediate basal (conj)
clonidine : (punct)
mm p (appos)
dose-corrected significant (amod)
risk die (acl)
microm 12.5 (compound)
effects neurotransmitters (nmod)
hiccups % (appos)
severity , (punct)
attenuated that (mark)
oral to (case)
consolidation integration (conj)
gram fraction (nmod)
increased size (nsubj)
scale positive (amod)
ato or (cc)
behaviors elicited (acl)
demonstrated necessary (conj)
suggested consistent (ccomp)
associated % (nmod)
prescribed that (mark)
hyperprolactinemia in (case)
treatment bradykinesia (nmod)
= 0.39 (dobj)
treated netilmicin (nmod)
metabolites reactive (amod)
electrocardiogram pressure (conj)
dobutamine exercise (conj)
abnormalities use (nmod)
included number (dobj)
consistent hepatitis (nmod)
oncologists both (det)
accompanied and (cc)
users mdma (dep)
specific . (punct)
index [ (punct)
carcinoma and (cc)
snp ( (punct)
listed although (mark)
induced apomorphine (nmod)
ethopropazine parkinsonism (nmod)
acquisition task (nmod)
acute late-stage (conj)
tolerated blockers (nsubjpass)
diastolic hg (compound)
patients certain (amod)
prolongation , (punct)
> hr (dep)
determinant rat (nmod)
demonstrate enhance (ccomp)
nd in (case)
phenylpropanolamine , (punct)
deterioration a (det)
cigarettes 5 (nummod)
mediate excess (dobj)
increased -- (punct)
produced mcao (nmod)
magnitude similar (amod)
effect alpha-tocopherol (nmod)
fraction a (det)
patients 65 (nummod)
10.2 of (case)
minutes 180 (nummod)
captopril of (case)
produce symptoms (dobj)
mm elevation (dep)
severe evident (conj)
dose suxamethonium (nmod)
self-treating di (dobj)
0.057 0.022 (conj)
fever hay (compound)
trials prospective (amod)
killed h (nmod)
initiated been (auxpass)
presents second (nsubj)
apoptosis or (cc)
variation respectively (advmod)
modulates injury (dobj)
background psychostimulant (appos)
2)% (2)% (conj)
ratio or (appos)
tube endotracheal (amod)
hypokalemia cardiac (conj)
associated implicate (conj)
effect cyclosporine (nmod)
dysfunctions cognitive (amod)
abc on (case)
100 more (amod)
enhancement effect (nmod)
restored menstruation (dobj)
normal at (case)
investigated production (nsubjpass)
nms with (case)
report experience (nmod)
50 or (cc)
continued indicates (parataxis)
interviewed and (cc)
follow-up warfarin (nmod)
rationale and (cc)
rest 1.3+/-0.3 (appos)
way we (nsubj)
minutes several (amod)
responsible generation (nmod)
content osmolarity (conj)
delay a (det)
cisplatin-based other (amod)
signs op-induced (amod)
isoproterenol beta-adrenoceptor (compound)
model elicited (acl:relcl)
cystitis anti-inflammatory (amod)
test direct (amod)
used medications (nsubjpass)
disturbances major (amod)
depleted treatment (nsubj)
cytotoxicity cyclophosphamide (nmod)
associated hypertrophy (nsubjpass)
meta-analysis a (det)
schedule acceptable (amod)
recovered volume (nsubj)
episode granulocytopenia (nmod)
reverse minutes (dep)
biomarkers putative (amod)
16 from (case)
remarkable thrombocytopenia (nmod)
exacerbations in (case)
deficiency secondary (amod)
abolish effects (dobj)
measures patients (nmod)
diazepam propranolol (conj)
levels 5 (dep)
matched seizure (conj)
complete were (cop)
saline physiological (amod)
hallucinations . (punct)
predictor seizures (nmod)
bpm 25 (nummod)
available use (nmod)
use initial (amod)
reduction is (cop)
movements feet (nmod)
acetate lhrh-a (appos)
setting clinical (amod)
usage from (case)
panel a (det)
exposure cyclophosphamide (nmod)
adhd with (case)
stimulation . (punct)
9-tetrahydrocannabinol delta (compound)
state and (cc)
inhibitors particularly (advmod)
occurred minutes (nmod)
patients resolved (acl)
prevented and (cc)
pretreatment tcr (nmod)
n enalapril-treated (amod)
localization histochemical (amod)
most it (nmod)
observation behavioral (amod)
represented case (nmod)
doxorubicin/kg ) (punct)
decrease marked (amod)
anemia correctable (amod)
frequency prolongation (nmod)
speech slurred (amod)
h treatment (nmod)
rate survival (compound)
examination history (nmod)
time each (det)
aimed explore (xcomp)
less 0.001 (nmod)
lesion and (cc)
showed months (nmod)
day water (nmod)
remain nuclear (xcomp)
investigations capacity (nmod)
caused % (dobj)
developed neuropathy (advmod)
remission one (conj)
rats dox (nmod)
fever asthma (conj)
exhibited however (advmod)
describe herein (advmod)
5.4 4.2 (conj)
memory components (nmod)
presented days (nmod)
disease without (case)
reactions cutaneous (amod)
controversial still (advmod)
included diagnosis (nmod)
gvg of (case)
drug injection (compound)
cats in (case)
cirazoline to (case)
resulted shortening (nmod)
hypotension lasted (acl:relcl)
states checklist-90-revised (conj)
six five (conj)
r(2 ( (punct)
noted improvement (nsubjpass)
conclusions sole (appos)
records file (compound)
cessation nitrates (conj)
mono-infected co-infected (conj)
rise influx (conj)
therapy play (conj)
expression bcl-2 (compound)
up-regulation days (nmod)
described syntheses (nsubjpass)
establishes and (cc)
regeneration liver (compound)
found association (nsubjpass)
transplant to (case)
findings abnormal (amod)
myoclonus associated (acl)
seizures limbic (amod)
myocardial wall (nmod:npmod)
increase avp-induced (amod)
score the (det)
revealed changes (dobj)
purpose drugs (appos)
unable we (nsubj)
ng/ml ng/ml (appos)
controls by (case)
estimated 1.3 (dep)
unilateral or (cc)
suggest plays (ccomp)
183 239 (conj)
handling ) (punct)
collected pre-operative (nsubjpass)
led properties (nsubj)
increased co-administration (nmod)
test tail-flick (amod)
cause interaction (dobj)
deteriotation clinical (amod)
thresholds conduction (compound)
measured concentrations (nsubjpass)
9.5-fold 8- (nmod:npmod)
% valsartan (nmod)
study responses (dobj)
induced outpatients (nmod)
np in (case)
uptake muscimol-stimulated (amod)
cholestasis methimazole-induced (amod)
association initiation (nmod)
inhibition pharmacological (amod)
measures 13 (nummod)
commencement study (nmod)
reports series (conj)
ld50 ( (punct)
necrotizing with (case)
associations carolina (nmod)
cd-832 diltiazem (conj)
had optic (dobj)
di- . (punct)
myocarditis complicating (acl)
metabolite ifosfamide (nmod)
found experiments (nmod)
raised have (aux)
hyperglycinemia atypical (amod)
ms ( (punct)
insipidus lithium-treated (amod)
coagulopathy extended (amod)
cause b (dep)
rare common (conj)
simvastatin to (case)
factors of (case)
loss neuronal (amod)
drugs warrants (acl:relcl)
dose very (advmod)
mg/m(2 bortezomib (compound)
aminotransferase of (case)
highlight results (nsubj)
powerful a (det)
remapped . (punct)
patient ) (punct)
rhythm output (nmod)
0.24:1 ; (punct)
initiated was (auxpass)
timeframe same (amod)
patients mm (nmod)
visual auditory (conj)
dex p (dep)
resemblance the (det)
discontinuation after (case)
myoclonus administration (nmod)
reduces severity (dobj)
regard spasm (nmod)
focus role (nmod)
effects tetrachloride (nmod)
walk week (nmod)
damage late (amod)
increase size (nmod)
reabsorption and (cc)
band to (case)
41 - (punct)
1 ) (punct)
responses duration (nmod)
exert nodal (nmod)
indicates . (punct)
concentration pilsicainide (nmod)
increased 62.5 (nmod)
gfap cd11b (conj)
ecg ) (punct)
displays mice (nmod)
hyperactive . (punct)
synthesis liver (nmod)
toxicity audiovisual (amod)
overlooked that (nsubjpass)
psoriasis with (case)
atherosclerosis women (nmod)
consider carefully (advmod)
paid , (punct)
administration ce (nmod)
micu ) (punct)
studies stage (nmod)
infusion pethidine (nmod)
treated lithium (nmod:npmod)
monotherapies and (cc)
allocated rats (nsubjpass)
case is (cop)
allele silent (amod)
tiapride of (case)
demonstrated testing (nsubj)
finding reported (acl)
tdi after (case)
administration mesna (nmod)
program education (compound)
use 1.1 (dobj)
min 10 (compound)
citations literature (compound)
reduced activity (dobj)
angiographies deteriorated (dep)
% 1.66 (dep)
mg/kg s.c. (dep)
children 4 (nummod)
elevated iu/l (dep)
patients coagulation (nmod)
difficulty patients (nmod)
doses ( (punct)
weight 0.2 (nummod)
sr to (case)
recognizing of (mark)
antibacterials of (case)
mutants virus (appos)
exerts , (punct)
saturation arterial (amod)
abstention long-term (amod)
monitoring bis (compound)
vol% . (punct)
lysis with (case)
warranted investigations (nsubjpass)
neuroleptics ' (punct)
kg-1 edrophonium (compound)
aggravate that (mark)
plasma nonlactating (advcl)
0.5 cent (nmod)
determine transcripts (dobj)
effect related (acl:relcl)
0.05 0.1 (conj)
range frequency (compound)
spectrum complication (nmod)
syncope caused (acl)
parameters mentioned (amod)
effects nephritis (nmod)
gynecomastia testosterone (conj)
contain identified (conj)
3.5 ( (punct)
unaffected neutrophils (advcl)
patent an (det)
carbimazole and (cc)
retrieval of (case)
use nonsteroidal (amod)
knowledge without (case)
subunit i (nummod)
enhanced attenuated (conj)
abundances protein (compound)
demonstration first (amod)
less depression-inducer (nmod)
years had (acl:relcl)
use controls (conj)
caused hyperprolactinemia (dobj)
developed oliguria (dobj)
thiopentone mg (dep)
10(-7 x (compound)
seconds injection (nmod)
died taken (advcl)
one more (advmod)
society report (nmod)
recurred later (advmod)
cont./min 2.0 (nummod)
showed administration (nsubj)
coefficient 0.20 (appos)
relevancy human (amod)
vessels around (case)
staff an (det)
decline cognitive (amod)
idea causes (ccomp)
source : (punct)
number ( (punct)
150 vs. (cc)
3722 +/- (cc)
doxorubicin , (punct)
creatinine scr (appos)
cortex secondary (amod)
distress on (case)
some animals (nmod)
area one (nummod)
stenosis to (case)
done following (nmod)
treating conditions (dobj)
exacerbations uveitis (nmod)
mg/kg or (cc)
helodermin of (case)
zones in (case)
77 +/- (cc)
manifest changes (nsubj)
potentiate effect (dobj)
effect capsaicin (nmod)
hematomas large (amod)
suppressed rate (nmod)
complications rare (amod)
develop remains (conj)
preferentially flow-independently (conj)
yield . (punct)
cancers disease (nmod)
received mg/kg (dobj)
those active (acl:relcl)
generation downregulating (amod)
complication well-known (amod)
administered addition (nmod)
shown significantly (advmod)
cirrhosis carcinoma (conj)
micrograms 150 (nummod)
aggregation platelets (nmod)
bigeminy sustained (amod)
patterns similar (amod)
enanthate by (case)
0.6 to (dep)
learning dissociated (amod)
< to (case)
vsd ) (punct)
percent patients (nmod)
number 1.6+/-0.34 (appos)
cells necrotic (amod)
maintained all (nmod)
mrp2 ) (punct)
use thiopentone (nmod)
dopac its (nmod:poss)
patterns days (nmod)
extend did (aux)
enhancement gadolinium (compound)
stressed test (nmod)
% 54.5 (compound)
brings effects (nmod)
excitation an (det)
mice cb1 (compound)
trials no (det)
presentation neuropathies (nmod)
appear however (advmod)
testing dse (compound)
myelosis of (case)
expression sgk1 (compound)
increases increases (conj)
course during (case)
had preceded (conj)
phenotypes disease (compound)
design randomized (amod)
defects aor (dep)
time over (case)
18 than (quantmod)
twitch tetanic (conj)
parp of (case)
respect adenomyosis (nmod)
showed bradycardia (dobj)
provoked bolus (nsubj)
problem as (case)
antagonist models (nmod)
criteria uspstf (compound)
condition compared (case)
limited often (advmod)
action selective (amod)
brain cocaine (conj)
protein acidic (amod)
synthesized p-coumarate (dobj)
received other (conj)
dismutase h-sod1 (appos)
indicators weight (conj)
propranolol while (case)
administration sumatriptan (nmod)
10.1 2.5 (conj)
compared months (nmod:tmod)
effects 17beta-estradiol (nmod)
0.3 to (dep)
cells 3.7 (conj)
39 6 (compound)
only association (nmod)
supported further (advmod)
zones by (case)
dosing equivalent (amod)
patient recovered (acl)
doses therapeutic (amod)
accumulation ( (punct)
mutants ymdd (compound)
woman days (dep)
levels activities (nmod)
followed where (advmod)
overexpressing p300 (dobj)
series from (case)
years a (det)
mg after (case)
retinoblastoma injections (nmod)
elimination injection (nmod)
striatum the (det)
patients timolol-treated (amod)
increased dose (nsubj)
associated nitrofurantoins (nsubjpass)
invaded h (nmod)
aracytine-c after (case)
occurred compared (dep)
allow prognosis (nmod)
loss quadrants (nmod)
drug either (cc:preconj)
gene of (case)
transplants representing (acl)
consumption prior (amod)
intensity latency (conj)
exchange without (conj)
period drug-free (amod)
plate to (case)
occurred became (advcl)
557 +/- (cc)
occurrence about (case)
identified mediator (nmod)
reported treatment (nmod)
co2 ) (punct)
staining methods (conj)
stroke use (nmod)
control n=6 (compound)
prevalent effect (nsubj)
hour administration (nmod)
neoplasms peliosis (conj)
were 151 (attr)
grouped . (punct)
tdr a (det)
advantages theoretical (amod)
received 20 (nsubj)
deal prognosis (conj)
enlargement gross (amod)
options patients (nmod)
hoe des (conj)
surgery during (case)
ligands microinjected (acl)
approach siat (xcomp)
access ( (punct)
produced coma (nsubjpass)
signs mentioned (amod)
given procedure (nmod)
session another (det)
girl 4 (nummod)
african in (case)
has managed (conj)
methylprednisolone ivmp (appos)
cells ic50s (dep)
compound and (cc)
minimal mild (conj)
developed requiring (conj)
trial one (nummod)
complication iop (nsubj)
metabolized glucose (nmod)
vigabatrin the (det)
pattern contributes (acl:relcl)
hyperalgesia produced (acl)
half-life an (det)
behavior amphetamine-induced (amod)
seconds 30 (nummod)
influence analgesics (nmod)
exposure e2 (compound)
attack ( (punct)
kidney single (amod)
applies also (advmod)
pelvis renal (amod)
stimulation dobutamine (amod)
patients glioma (compound)
test amnesia (nmod)
gamma-hch pentylenetetrazol (conj)
% 39.7 (nummod)
medication phenytoin (compound)
hepatic hematologic (conj)
cause flecainide (nsubj)
metabolism with (case)
incidence toxicity (nmod)
field view (nmod)
1983 1985 (conj)
bradycardic assessment (nmod)
died patients (nmod)
patients fever (nmod)
affected pre-treatment (nsubj)
deaths of (case)
positive , (punct)
coniine by (case)
manipulated was (auxpass)
tumor of (case)
fourteen samples (nmod)
sgk1 of (case)
sulfate vincristine (compound)
secondary cyclosporine (nmod)
administration unintentional (amod)
imparts lack (nsubj)
significant highly (advmod)
restored however (advmod)
surviving in (mark)
appeared prolongation (nsubj)
vocabulary nouns (nmod)
media artery (compound)
injections forearm (nmod)
mmhg 7.5 (nummod)
synthesized we (nsubj)
absence toxicity (nmod)
man reported (acl)
sparse data (nsubj)
measured passing (advcl)
score 3.8 (conj)
groups comprised (acl)
recurrence syndrome (nmod)
course , (punct)
treatment rhinitis (nmod)
mechanisms release (nmod)
depression headache (conj)
demonstration conclusion (nmod)
eu ( (punct)
considered sign (xcomp)
superior which (nsubj)
evaluation ): (punct)
concentration high (amod)
meningitis of (case)
a n (dep)
completely recovered (amod)
w-ich human (amod)
administration . (punct)
strains sensitive (amod)
mg day (conj)
observed evident (conj)
considered related (xcomp)
neuropathy thalidomide-induced (amod)
systems portable (amod)
use agonists (nmod)
february and (cc)
access drugs (nmod)
reaction by (case)
antagonists receptor (nmod)
observed recorded (conj)
pain % (dep)
users aspirin (compound)
blindness response (nmod)
38 19 (compound)
induced hyperalgesia (nsubjpass)
involved administration (nmod)
115 mmhg (conj)
5 684 (nummod)
proteinuria failure (conj)
min 0.05 (dep)
receptors through (case)
rheumatology medicine (conj)
published had (aux)
consisted patients (nmod)
subgroup a (det)
secretion chronic (amod)
billingham ( (punct)
ingestion between (case)
technique non-invasive (amod)
returned state (nmod)
% male (amod)
exercise treadmill (compound)
alters pain (nsubj)
returned patients (nsubj)
interval the (det)
subtherapeutic normoammonaemic (conj)
effect ligands (nmod)
sinus in (case)
40 ( (punct)
these in (case)
c t (conj)
alter did (aux)
hours twenty (nummod)
demonstrated signals (dobj)
seizures range (nmod)
compared populations (nmod)
experiment the (det)
test mif (compound)
gave had (advcl)
kept days (nmod)
task updating (appos)
event headache (nsubj)
thrombosis undergoing (acl)
schema methotrexate (dep)
present . (punct)
shown previously (advmod)
reversible failed (conj)
rats ingestion (nmod)
cin factors (conj)
5.8 +/- (cc)
develop features (dobj)
increased statistically (advmod)
wr-2721 amifostine (conj)
radiation cystitis (conj)
parts in (case)
mg/m2 with (case)
sd ; (punct)
observed episode (nmod)
81 12 (compound)
exacerbation an (det)
interview m.i.n.i. (appos)
diagnosed adsd (nmod)
genes in (case)
unresponsive reduction (nmod)
suggest while (mark)
facilitated have (aux)
reported needed (conj)
neuropathy event (nsubj)
treated volunteers (nsubjpass)
desogestrel of (case)
showed kidneys (nsubj)
mg 0.9 (nummod)
syndrome or (cc)
demonstrate therefore (advmod)
7.142 ci=1.154 (compound)
restoration the (det)
rendered comatose (xcomp)
method . (punct)
complication thrombosis (nsubj)
strains repaired (acl:relcl)
type 5-ht(6 (appos)
alleviated significantly (advmod)
noted complication (nmod)
induced hepatitis (nsubjpass)
studied sets (nmod)
feasible although (mark)
findings typical (amod)
experience clinical (amod)
sedative imaging (nmod)
therapies or (cc)
damage seizure-induced (amod)
led studies (nsubj)
this from (case)
120/67 remained (conj)
concentration activity (conj)
pgads ( (punct)
den by (case)
hypothesis involve (ccomp)
performance psychological (amod)
ml solution (nmod)
hypnotic be (cop)
3.8 2.7 (compound)
combination cisplatinum (nmod)
side-effects many (amod)
drug longer (amod)
attempted . (punct)
differences means (nmod)
abnormal nothing (compound)
contributed development (dobj)
patients aza (compound)
got in (case)
values ng/ml (dep)
combination diagnosis (conj)
ascertained . (punct)
acetate lead (compound)
regions outcomes (conj)
made patients (nmod)
led idea (nmod)
spectra the (det)
results refine (acl)
phenomena ischemic (amod)
permit . (punct)
variability genome (compound)
microgram/ml 1.9 (nummod)
agonist site (nmod)
rare is (cop)
diabetic control (conj)
discontinued checked (conj)
measured sodium (nsubjpass)
nm 0.4 (nummod)
pattern effects (nmod)
regimen mfl (compound)
veins cerebral (amod)
intralipid or (cc)
evaluation pain (nmod)
circled . (punct)
cause cancer (dobj)
ci 11.6 (dep)
oxidation cardiac (amod)
ameliorates it (nsubj)
erythematosus sle (appos)
cause may (aux)
alive monkey (nsubj)
accepted are (auxpass)
demonstrated cases (nsubj)
= 1 (dobj)
improvement limbs (nmod)
therapy pulse (compound)
results that (nsubj)
pathogenesis hypotension (nmod)
segment 15-mm (amod)
dose g/m2 (nmod)
ii/iii-v waves (compound)
alternative pallidotomy (nmod)
compared groups (nmod)
cross-clamp tranexamic (conj)
generated cocaine (nsubj)
cows margin (conj)
uncertain anemia (nsubj)
number an (det)
achieved exhibited (advcl)
copenhagen in (case)
performed 219 (conj)
fas . (punct)
tap ( (punct)
group adriamycin-treated (amod)
morphine post-operative (amod)
reversal rapid (amod)
observed contrast (nmod)
complication significant (amod)
introduction agent (nmod)
therapy digoxin (compound)
presence adducts (nmod)
l-[3h]nicotine sites (dep)
iopentol iohexol (conj)
short , (punct)
interference of (case)
sera the (det)
sniffing , (punct)
paramedics two (nummod)
in order (mwe)
time regardless (advmod)
play vasoconstriction (nmod)
acted . (punct)
heparin to (mark)
cystitis . (punct)
rats lou/m/wsl (compound)
inhibition tonic (amod)
disease stable (amod)
fzp and (cc)
thalidomide dose (nmod)
got gpt (conj)
caused treatment (nsubj)
is allocated (conj)
increased mrna (nsubj)
oedema marrow (compound)
reversed anticoagulation (dobj)
calcium such (case)
cancer ( (punct)
region untranslated (amod)
used marker (nmod)
changes rats (nmod)
nadir mean (amod)
neuroleptics so-called (amod)
access ) (punct)
rosa hibiscus (nsubj)
minutes receiving (acl)
desipramine cinacalcet (nmod)
infections fewer (amod)
included medications (nsubj)
level > (dep)
on-state in (case)
reversion normal (nmod)
demonstrates : (punct)
receives produce (conj)
route and (cc)
reversible although (mark)
nature biochemical (amod)
3 findings (nmod)
function receptor (nmod)
dependent that (nsubj)
regained have (aux)
treatment despite (case)
54 9 (conj)
length treatment (nmod)
anemia drug-induced (amod)
adriamycin dose (nmod)
l-alpha-glycerylphosphorylcholine l-alpha-gfc (appos)
less 1.23 (dep)
exert . (punct)
stable in (case)
participation . (punct)
use therapy (nmod)
task step-through (amod)
prevented taken (advcl)
exposed was (auxpass)
juice with (case)
hospitals four (nummod)
results main (amod)
model failure (compound)
tissue tumor (compound)
age before (case)
diclofenac compared (case)
mp ) (punct)
result addition (nmod)
part iv (nummod)
antecedent or (cc)
hygiene with (case)
norepinephrine both (cc:preconj)
birth after (case)
had compared (conj)
recommended undertaken (ccomp)
[d-pen2.5]-enkephalin ( (punct)
using were (aux)
= 0.017 (dobj)
catheterization cardiac (amod)
amb intravenous (amod)
areas certain (amod)
smoke cocaine (dobj)
response frequency (appos)
visual or (cc)
randomized placebo-controlled (conj)
association ethambutol (nmod)
total ( (punct)
expression pain (conj)
none sera (nmod)
evident month (nmod)
disappointing . (punct)
cortex renal (amod)
activity peroxidase (compound)
hepatotoxicity associated (acl)
stimuli external (amod)
increase potency (dobj)
t1/2 ha (nmod)
detected fibers (nmod)
switching ufh (nmod)
record deficits (dobj)
respect age (nmod)
rapamycin mg/day (dep)
libitum containing (acl)
analysis nested (amod)
den pb (conj)
drug introduced (advcl)
cr with (case)
complained also (advmod)
oxycodone 10-mg (amod)
recalled also (advmod)
adsd ( (punct)
benzoylecgonine be (appos)
gentamicin pdtc (conj)
group 0 (nummod)
inhibits ; (punct)
sacrificed days (nmod)
metrifonate inhibitor (compound)
increased sensitivity (dobj)
spasticity of (case)
dosages the (det)
administered eyes (nmod)
case investigated (amod)
medication investigational (amod)
preferred employed (parataxis)
isotretinoin to (case)
changes fsgs (nmod)
reported that (nsubjpass)
decrease have (aux)
pacing constant (amod)
238 vs. (cc)
dose methylergonovine (nmod)
monitoring under (case)
nine in (case)
cause concern (nmod)
highlight effects (dobj)
suggests related (ccomp)
markers correction (conj)
short which (nsubj)
mm 1 (compound)
drug cause (nsubj)
combination atropine (nmod)
hypertensive , (punct)
diseases june (nmod)
appears dose-related (xcomp)
treatment cases (conj)
resistance their (nmod:poss)
areas patchy (amod)
dsp4 of (case)
treated intracerebroventricularly (advmod)
presentation report (appos)
multifactorial . (punct)
myocardial i.e. (dep)
nra0160 . (punct)
anatomy the (det)
drug instillations (appos)
contain order (nmod)
gain a (det)
inhibitor pdtc (conj)
advantage an (det)
anxiety depression (conj)
g/day ( (punct)
strategies this (nmod)
velocity a (det)
increased 3/8 (dep)
involving usually (advmod)
cascade activation (compound)
pain swelling (conj)
treatment 120 (nummod)
profile pharmacological (amod)
children treated (acl)
formation lipid (compound)
eating food (dobj)
causes cardiomyopathy (dobj)
tachycardia for (case)
patients 3379 (nummod)
gc-ht ( (punct)
abnormality wall-motion (amod)
k-variant the (det)
occurred upset (dep)
caused has (aux)
afterdepolarization ead (appos)
surpasses inhibiting (acl:relcl)
release between (case)
indicates disorders (ccomp)
treated 350 (nsubjpass)
drug phenylpropanolamine (nsubj)
effect hyperparathyroidism (nsubj)
stabilized complex (nmod)
intake persons (nmod)
injection unilateral (amod)
meningioma in (case)
relapsed hl (dep)
attribute another (det)
women epileptic (amod)
doses cd-832 (nmod)
possibility increases (ccomp)
lindane and (cc)
rule syndrome (dobj)
vasopressin treatment (nmod)
anxiety and (cc)
cause be (cop)
prednisolone , (punct)
weakness of (case)
constipation , (punct)
aptt ) (punct)
require difficulties (nsubj)
thrombosis humans (nmod)
cystectomy palliation (nmod)
course either (preconj)
% 7.5 (compound)
length ms (nmod)
lids with (case)
injection medullo-adrenalectomy (nmod)
weeks rapidly (advmod)
neuropathy with (case)
reactions media (nmod)
clarithromycin of (case)
included discontinuation (dobj)
shown patient (nmod)
regulator cyanamide (nsubj)
demonstrates experience (nsubj)
investigated model (nmod)
allow examinations (nmod)
malondialdehyde and (cc)
5-azacytidine by (case)
0.025 p (dep)
association class (conj)
incidence seizure (conj)
medications neuroleptic (amod)
agents anti-inflammatory (amod)
toxicity gentamicin (compound)
used increasingly (advmod)
challenging rehabilitation (nsubj)
mg/kg/day 100 (compound)
5.6 ( (punct)
discharged ed (nmod)
nystagmus with (case)
alpha-enac beta-enac (conj)
pheochromocytoma . (punct)
modulate whether (mark)
time entry (conj)
annuloplasty . (punct)
alendronate the (det)
hormone lh (appos)
safety group (nmod)
other on (case)
apd ( (punct)
lidocaine , (punct)
function could (aux)
dose 25 (nummod)
assessment objective (amod)
mg 500 (nummod)
discussed control (nsubjpass)
toxicity status (conj)
advantageous profiles (nsubj)
passed polygraph (nmod)
ci 1.09 (nummod)
ng 100 (nummod)
possess may (aux)
exhibited day (nmod)
acid antibiotic (appos)
leukoencephalopathy carmofur (conj)
absorption and (cc)
model employed (amod)
68.3 28.9 (conj)
support relationship (nsubj)
have continuous (dobj)
administration l-noarg (amod)
useful s-312-d (nsubj)
occurred year (nmod)
induced amounts (nmod)
application by (case)
present dose (nmod)
0.05 0.13 (nmod)
sessions 10 (nummod)
lower increase (nsubj)
achieved that (mark)
ce at (case)
part process (nmod)
effects virility (nmod)
recovery normotension (nmod)
transporters of (case)
ifs ( (punct)
increased dosage (nsubj)
use not (neg)
behavior both (cc:preconj)
assessed monitoring (advcl)
fatalities , (punct)
dependent magnitude (nsubj)
concentration therapeutic (amod)
rates % (conj)
activity including (case)
increased doses (nmod)
dysfunction infarction (nmod)
related disorder (nsubj)
six patients (nmod)
reduced mortality (dobj)
volunteers seven (nummod)
had placebo (nsubj)
pain testicular (amod)
hydrochloride trihexyphenidyl (compound)
performed rats (nmod)
activity nigral (amod)
linked activation (nsubjpass)
6 12 (conj)
assay immunity (nmod)
ica ( (punct)
remained constant (xcomp)
connected receptor (nmod)
formation via (case)
started day (nmod)
fluency phonological (amod)
girl administration (nmod)
methods lidocaine (appos)
decreased pain (conj)
strain rat (nmod)
laboratory routine (amod)
correlation rating (nmod)
mg/kg 13 (nummod)
patients panic (amod)
weeks for (conj)
35 to (quantmod)
conclude studies (nmod)
seizure , (punct)
produced apparent (conj)
caused insufficiency (dobj)
process cells (nmod)
using doses (dobj)
ventilation to (case)
restored patients (nmod)
mrna-containing decarboxylase (nmod:npmod)
type dosage (conj)
knockout vip-/- (appos)
preserved rats (nmod)
objective and (cc)
acne , (punct)
treated acetonide (nmod)
disturbing psychoses (dobj)
reduced consumption (dobj)
analgesia opioid (amod)
vol% was (cop)
decreased night (nmod)
improvements in (case)
variety agents (nmod)
cck-8 i.c.v. (appos)
eliminated urine (nmod)
echocardiography tracking (compound)
pathology significant (amod)
heptylate or (cc)
enos expression (conj)
ischemia dipyridamole-induced (amod)
denervated procedure (nmod)
cause seizures (dobj)
myopathy this (det)
cholestasis in (case)
ccl4 acetaminophen (conj)
became fourteen (nsubj)
eyelids upper (amod)
reaction chemotherapy (nmod)
demonstrated discontinued (conj)
developed dyskinesia (dobj)
improved days (nmod)
remained rats (nmod)
failing for (case)
has mitigating (advcl)
eyes red (amod)
pointes ( (punct)
department weakness (nmod)
prescribed when (advmod)
caused myocarditis (nmod)
pilocarpine-treated control (conj)
serve changes (nsubj)
sequences echo (compound)
developed compartment (nmod)
associated caused (conj)
brings , (punct)
adolescents of (case)
follow route (dobj)
phenomenon adverse (amod)
30 between (case)
determined studies (nmod)
evoked while (mark)
september 1 (nummod)
stones obstruction (conj)
production with (case)
size points (nmod)
had behavior (nmod)
imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate ( (punct)
symptoms veralipride (nmod)
reveals investigation (nsubj)
cardiotoxin a (det)
resolved tetany (dobj)
effects streptomycin (nmod)
associated usually (advmod)
intensities of (case)
nerves produced (acl)
exhibit function (dobj)
bepridil m (dep)
level % (nmod)
mg 3 (compound)
design series (compound)
point in (case)
na and (cc)
1993 1997 (nummod)
endonuclease-dependent independent (conj)
less tensions (nsubj)
program periods (conj)
grade cortex (nmod)
bradycardia asymptomatic (amod)
increased 163 (nmod)
neurocognitive and (cc)
assessed carolina)/2011(iowa (nmod)
possible it (nsubj)
sites into (case)
coxii by (case)
mg/dl 4.93 (nummod)
reactions were (cop)
prophylaxis require (acl:relcl)
disclosed be (auxpass)
normalization to (case)
observed lower (advcl)
or(adj an (det)
suppression proliferation (nmod)
medication prolonged (amod)
depressants nervous (amod)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate beta-carboline (compound)
range mass (nmod)
had considered (dep)
modulation erdosteine (nmod)
shown although (mark)
highlights report (nsubj)
was surgery (nmod)
improves it (nsubj)
migraine ( (punct)
present presentation (nmod)
relationship inverse (amod)
failure hypotension (conj)
content cytokine (compound)
microinjection isoniazid (nmod)
wave of (case)
used safely (advmod)
na/k-atpase oat (conj)
changed significantly (advmod)
extent changes (nmod)
currents activating (amod)
presents syndrome (nsubj)
microm ( (punct)
muscle in (case)
mice challenge (nmod)
add risk (nmod)
problems the (det)
coefficient on (case)
limit the (det)
case palsy (nmod)
8 or (cc)
mechanisms least (nmod)
meningitis cryptococcal (amod)
background promotes (dep)
reserpine mg/kg (appos)
value obtained (acl)
amounts but (cc)
tested significance (nmod)
hypoxaemia severe (amod)
ptcr mild (amod)
injected verifying (advcl)
placed were (auxpass)
surgery abdominal (amod)
ds ) (punct)
evolution csa-induced (amod)
dependent treated (dep)
diagnosed presentation (nmod)
implications strategies (nmod)
9 of (advmod)
abnormalities matter (amod)
preserved was (auxpass)
gave , (punct)
lesions deterioration (conj)
treated hydrochloride (nmod)
using cultures (dobj)
indicated clinically (advmod)
intervals 3-month (amod)
alpha-mediated effects (nsubj)
effects overdosage (nmod)
rates highest (amod)
grafts rejection (nmod)
stress dysfunction (conj)
edema acute (amod)
curve as (case)
fmri ) (punct)
mg adrenaline (compound)
cimd ( (punct)
evident indicating (advcl)
impairment vcm-induced (amod)
reported applicators (nsubj)
pattern , (punct)
derive less (dobj)
socs-1 cis (conj)
50 - (punct)
excellent patients (nmod)
ml/100 30 (compound)
tissue exencephalic (amod)
increased level (nsubj)
hypomethylation se (advmod)
open . (punct)
percent parents (nmod)
effects encountered (acl)
infants exposed (acl:relcl)
progression women (nmod)
year during (case)
contractility muscles (nmod)
morphine rats (nmod)
recorded also (advmod)
aneurysm dissecting (compound)
bea by (case)
clinical , (punct)
represents advance (dobj)
finished medications. (dobj)
taking they (nsubj)
effects hyperprolactinemia (nmod)
possesses and (cc)
11 ( (punct)
effect influence (conj)
cows in (case)
challenged later (advmod)
heart on (case)
restore signs (dobj)
back and (cc)
cortex auditory (amod)
therapy fresh (amod)
cardiotoxicity toxicities (nsubj)
p40 ( (punct)
recording hour (compound)
fc gfc (appos)
receptors complement (compound)
performed methods (nmod)
nonselective , (punct)
number the (det)
adefovir tenofovir (conj)
pod 19 (conj)
produced they (nsubj)
medication . (punct)
unchanged placebo (nmod)
rats thiosemicarbazide (nmod)
tool useful (amod)
2 3 (conj)
register central (appos)
prior either (cc:preconj)
induced seizure (xcomp)
trial children (nmod)
fewer somewhat (advmod)
mechanism by (case)
improvement scores (nmod)
group european (compound)
respond , (punct)
management disease (nmod)
tdp for (case)
regard concentration (nmod)
disclosed . (punct)
mg 250 (compound)
as those (nmod)
changes systems (nmod)
resurgence interest (nmod)
admitted patient (nsubjpass)
alkylxanthines three (nummod)
responses these (det)
regurgitation functional (amod)
causes preserves (conj)
treated eight (nsubjpass)
likely developed (xcomp)
lt of (case)
determine was (ccomp)
higher compared (advcl)
pvc 's (case)
double-blind in (case)
riha ) (punct)
benztropine to (case)
inconsistent investigating (csubj)
classification for (case)
zidovudine with (case)
result administered (conj)
exerted centrally (advmod)
dose 2h (nmod)
show not (neg)
buffer aqueous (amod)
one tinnitus (nsubj)
ci 2.75 (nummod)
0.45 +/- (cc)
interaction social (amod)
8 five (compound)
improved dysfunction (nsubjpass)
imaging brain (compound)
record levels (conj)
enalapril and (cc)
cessation treatment (nmod)
oliguria despite (case)
findings implicating (acl)
administered where (advmod)
admission on (case)
excretion apap (nmod)
cardiomyopathy dilated (amod)
p.o. med (compound)
normalized . (punct)
mannitol without (conj)
marker prediction (nmod)
maze by (case)
aids of (case)
parameters pharmacokinetic (amod)
tube plexiglas (compound)
conversion srl (compound)
n time (conj)
initiation treatment (nmod)
correlates calculated (advcl)
found intolerance (dobj)
determinant that (mark)
enzymes circulating (amod)
results encouraging (amod)
years 40.8 (nummod)
normal it (nsubj)
arrest ropivacaine-induced (amod)
divided ; (punct)
placement following (case)
beck through (case)
function their (nmod:poss)
cyclosporine azathioprine (conj)
patients involvement (nmod)
agent antimycobacterial (amod)
indicate overall (advmod)
haloperidol mg/kg (dep)
food drug (conj)
agranulocytosis fluconazole (compound)
loss activity (nmod)
case hematomyelia (nmod)
african south (amod)
vegf and (cc)
week his (nmod:poss)
initiation ticlopidine (nmod)
[d-pen2.5]-enkephalin and (cc)
dose lidocaine (nmod)
taking verapamil (dobj)
recovery edema (nmod)
pattern multisystem (compound)
considered diagnosis (nmod)
safe and (cc)
calcium , (punct)
received had (advcl)
depressants central (amod)
synthase citrate (compound)
1.68 ratio (nsubj)
compared treatment (nmod)
observed interval (nmod)
capacity loading (compound)
617 50 (conj)
demonstrate induction (dobj)
induce actions (nmod)
ocd of (case)
electroencephalographic and (cc)
effect unwanted (amod)
diameter arteriolar (amod)
was incidence (attr)
tolerated therapy (dobj)
treatment lymphoma (nmod)
decrease index (nmod)
vasculature of (case)
mirtazapine antidepressant (appos)
328 +/- (cc)
opsonized alf (nmod)
carries , (punct)
aida ( (punct)
micrograms 0.1 (compound)
scale intervals (nmod)
dilation pupil (compound)
pneumonitis , (punct)
fluorouracil , (punct)
agonist 8-oh-dpat (appos)
background purpose (conj)
responses three (nummod)
forehead in (case)
twenty-three patients (nmod)
pain occurring (acl)
levels by (case)
cases adenoma (nmod)
153 144 (conj)
time survival (conj)
arthralgia ) (punct)
cells proliferating (amod)
duration not (cc)
results . (punct)
zero was (cop)
min 5 (compound)
sprouting with (case)
zidovudine the (det)
men 31 (nummod)
stx ) (punct)
level ultrastructural (amod)
symptoms menopausal (amod)
(na the (det)
unchanged content (nsubjpass)
diabetic in (case)
evident proteinuria (nsubj)
transport sodium (compound)
cause one (nummod)
faster those (nmod)
wild-type ilk (conj)
assessed ) (punct)
given weeks (nmod:tmod)
alpha-position in (case)
% ci=16.8%-65.0 (compound)
axis the (det)
antagonized significantly (advmod)
withdrawal aprotinin (nmod)
cavity ; (punct)
condition a (det)
estrogens on (case)
39.23 6.44 (conj)
receive can (aux)
initiation between (case)
pod or (cc)
epo ) (punct)
characterized detachment (nmod)
dose meth (compound)
able (+/-)-pg-9 (nsubj)
1 only (advmod)
early and (cc)
capability system (nmod)
seizures occurred (acl:relcl)
morphine pre-test (amod)
using inhibitors (dobj)
nucleus the (det)
dementia lemon (amod)
leukaemia or (cc)
non-drug polydrug (conj)
sampling serial (amod)
increased indeed (advmod)
effect could (aux)
transported brain (nmod)
amnesia antimuscarine-induced (amod)
preexposure absence (dep)
associated reduction (nmod)
protects neurons (dobj)
precipitated amounts (nmod)
time or (cc)
stimulation neuropeptide (compound)
produce syndrome (dobj)
binding cortex (conj)
serum predialysis (compound)
effects frequency (nmod)
acid for (case)
affected hypoactivity (dobj)
regimen docetaxel (compound)
given h1- (nsubjpass)
treatment convulsions (nmod)
effects galactose (nmod)
d11 on (case)
half the (det)
difference overflow (nmod)
airway not (neg)
changes epithelium (nmod)
incidence alterations (nmod)
flushing event (nsubj)
coincidental only (advmod)
teratology ) (punct)
quinine-sensitive of (case)
thrombocytopenia heparin-induced (amod)
microgram/kg/min greater (dep)
streptozotocin and (cc)
involved manifestation (nmod)
organisms were (cop)
sch d-1 (compound)
levels hearing (compound)
produce radicals (dobj)
conversion cya (nmod)
treatments condition (nmod)
failed cycloheximide (nsubj)
minutes 15 (nummod)
exposed mapped (conj)
mortality of (case)
dexamethasone with (case)
recorded experience (nsubjpass)
was pregnancy (nmod)
insights valuable (amod)
appetite % (appos)
% 5.8 (nummod)
hypokalemia such (amod)
blockade output (conj)
use ocs (nmod)
blocked scopolamine (nsubj)
treatment haart (appos)
ileum and (cc)
artesunate republic (nmod)
program local (amod)
prod ( (punct)
patients refractory (nmod)
meningitis with (case)
agents two (nummod)
haart ) (punct)
received animals (nsubj)
optic : (punct)
administration kg-1 (nmod)
occlusion ( (punct)
nra0160 5 (conj)
mechanism the (det)
= p (nsubj)
pale discs (nsubj)
dependency diet (amod)
parameters cell (compound)
discriminated anatomical (dobj)
139 of (advmod)
measurements electrocardiograms (conj)
different lower (conj)
movement with (case)
case patient (acl:relcl)
restricted use (nsubj)
showed ptosis (dobj)
7-ethoxyresorufin-o-deethylase and (cc)
ranitidine months (dep)
tablet ergotamine (nmod)
decreased expression (nsubjpass)
y-mrs ) (punct)
8/8 ) (punct)
leukemia promyelocytic (amod)
clinicians within (case)
model dcm (nmod)
function level (nmod)
appeared and (cc)
output co (appos)
0.27 +/- (cc)
loss dystrophin (nmod)
ganglia lumbosacral (amod)
cta risk (nmod)
sulphonate mesna (appos)
forms various (amod)
walls capillary (amod)
snps rs6693503 (dep)
response transient (amod)
microg/kg/min 1 (nummod)
hypersecretion prostaglandins (nmod)
examinations challenges (conj)
intralipid medialipid (conj)
exerts hyperammonemia (nsubj)
ameliorate course (dobj)
represent reported (conj)
study imaging (compound)
frequency spectral (amod)
number average (amod)
cocaine diazepam (conj)
leukopenia , (punct)
therapy as (case)
domains memory (nmod)
have delay (dobj)
questionnaire the (det)
acetate alpha-tocopherol (compound)
oedema bones (nmod)
based calculations (nmod)
stress cardiotoxicity (nmod)
describe reported (conj)
sm = (parataxis)
administered anticoagulation (nmod)
opioid receptors (dep)
underwent and (cc)
appearance of (case)
progression 12 (nummod)
powder of (case)
injection angiography (nmod)
agent daunorubicin (nsubj)
mu , (punct)
used arrest (xcomp)
vt sustained (amod)
anaesthesia conventional (amod)
woman high-risk (amod)
62.5 as (quantmod)
effective regimen (nmod)
rotation such (amod)
failure disease (conj)
retraction upper (amod)
india in (case)
normotensive rats (conj)
compared week (nmod)
exhibited patient (nsubj)
considered three (nsubjpass)
defense paws (nmod)
consistent concentration (nsubj)
disappeared have (aux)
acetate on (case)
infarcts basal (amod)
atorvastatin ato (appos)
score , (punct)
sap ( (punct)
neuroleptics used (acl)
rate stroke (conj)
factor loss (nmod)
normalized completely (advmod)
capacity synthesis (nmod)
failure profound (amod)
ligand expressing (amod)
failure circulatory (amod)
haemorrhage man (nmod)
free , (punct)
mechanism its (nmod:poss)
has duration (dobj)
3 from (case)
0.08 ) (punct)
muscle into (case)
administered h (nmod)
cin incidence (conj)
caused as (mark)
29th and (cc)
% 13 (nummod)
seen exposure (nmod)
treated thyroxine (nmod)
monitoring serial (amod)
dye cationic (amod)
leading sensitivity (nmod)
deficits chronic (amod)
months olanzapine (appos)
established limited (advcl)
restored , (punct)
promotion on (case)
discontinuation bpd (compound)
h2o azt (compound)
ligation- digitalis- (conj)
admitted had (aux)
describe to (mark)
confines the (det)
either or (cc)
infarction haemorrhagic (amod)
pulses co2 (nmod)
observed respect (nmod)
suggest experiments (nsubj)
infusion infusion (conj)
had metastases (dobj)
initiate micturition (dobj)
potent selective (conj)
patients unpremedicated (compound)
toxicity dose-dependent (amod)
alive were (cop)
flestolol and (cc)
narrowing , (punct)
suppress expression (dobj)
contributes that (nsubj)
evaluation troponin (nmod)
professionals healthcare (amod)
stabilizer lithium (dep)
acetate plus (cc)
cocaine and (cc)
indication to (mark)
documented reported (conj)
addition symptoms (nmod)
metabolic sinus (compound)
effectiveness fentanyl (nmod)
activating rapidly (advmod)
hbv mutant (amod)
hygiene caries (conj)
mediated interference (nmod)
regions mice (compound)
1/500 at (case)
subject published (acl)
demonstrates suggests (conj)
ic : (punct)
unreported is (cop)
4.1 - (punct)
biodistribution its (nmod:poss)
results produced (acl)
compounds to (case)
injection delta (conj)
options evidence-based (amod)
levodopa- or (cc)
sedation diagnostic (nmod)
therapy risk (appos)
mm /= (compound)
was p (dep)
26- , (punct)
damage proteases (nsubj)
mipafox organophosphate (appos)
vehicle , (punct)
effect il-3 (nmod)
prl as (case)
wk 2 (nummod)
differentiate to (mark)
neurotoxicity and (cc)
parameters related (amod)
pain subjects (nmod)
patient dipyrone (nmod)
insights new (amod)
remained jj (nmod)
experienced patient (nmod)
exposure pdn (nmod)
withdrawal drug (nmod)
% -13.3 (nummod)
cingulate the (det)
plasticity cortex (nmod)
used study (nmod)
consequence effects (nsubj)
factors etiologic (amod)
aggregation determination (conj)
focus di (nmod)
diligent . (punct)
oil soyabean (compound)
prevalence increased (amod)
15mg/kg ( (punct)
occurs subjects (nmod)
toxicity less (amod)
depletion injections (nmod)
fatal and (cc)
mg 800 (conj)
toxicity renal (amod)
corresponding level (nmod)
contributed component (nsubj)
cytoskeleton caused (acl)
participated eight-week (nmod)
decreased while (mark)
dismutase , (punct)
differences model (nmod)
phenotype a (det)
showed retard (ccomp)
mean at (case)
nuclei supraoptic (amod)
than rather (advmod)
remission of (case)
ears n=200 (compound)
range 70 (nummod)
thrombosis 0.96 (dep)
related structurally (advmod)
revealed taking (conj)
taken guinea-pigs.5 (nmod)
hh ) (punct)
> common (amod)
patients virus (compound)
costs with (case)
minor was (cop)
fluid tubular (amod)
differences measured (acl)
production enzymatic (amod)
patients 9 (nummod)
rest during (case)
protein prenatally (advmod)
hyperthermia ma-induced (amod)
clinical light (conj)
intake sodium (compound)
electrophoresis two-dimensional (amod)
potent since (mark)
rare relatively (advmod)
carmofur its (nmod:poss)
were exhibited (conj)
accounts thalamocortical (amod)
tachycardia rebound (conj)
association with (case)
e18.5 until (case)
antagonism component (nmod)
genes regulated (amod)
inhibition gr (compound)
decreased reabsorption (dobj)
vision his (nmod:poss)
provided conditions (dobj)
adducts cross-react (acl:relcl)
modulators with (case)
h 3 (nummod)
consumption juices (nmod)
haloperidol plus (cc)
acts agonist (nmod)
activity lidocaine (nmod)
group non-alcohol-exposed (amod)
initiated consider (parataxis)
report reported (advcl)
showed treatment (nsubj)
gaba activity (conj)
animals 15 (nummod)
d l-sotalol (appos)
dose clentiazem (nmod)
regression , (punct)
sd male (amod)
interval during (case)
suffer , (punct)
ended , (punct)
charge and (cc)
regressions partial (amod)
reduces model (nmod)
lidocaine- both (cc:preconj)
magnus the (det)
tnss , (punct)
involving subjects (dobj)
cases severe (amod)
fact died (acl)
surgery elective (amod)
p ) (punct)
rbcs of (case)
activation peroxisome (compound)
rates turnover (compound)
switched oxcarbazepine (nmod)
racemic ) (punct)
studies of (case)
infusion days (conj)
studied compared (conj)
therapy therapy (nmod)
interaction doxorubicin (nmod)
rate except (case)
head for (case)
vulnerability lesion (nmod)
implicated not (neg)
mouth tongue (conj)
agent artery (nmod)
given microgram/kg (dobj)
points from (case)
mv 71 (nummod)
drugs patients (nmod)
distribution depression (nmod)
felt better (advmod)
groups ii (dep)
treated azathioprine (nmod)
delirium edds (appos)
smaller injection (nmod)
subject was (cop)
paralysis of (case)
results caused (dep)
neuropathy , (punct)
exert activity (dobj)
estrogens failure (nmod)
schedule mmc-dependent (amod)
demonstrated dose (nmod)
progress infection (nsubj)
ke t1/2 (appos)
stopped medication (nsubjpass)
diameter circumflex (amod)
recurrent , (punct)
recover to (mark)
implausible is (cop)
lamivudine . (punct)
conclude mediates (conj)
alert clinicians (nsubj)
days cns-directed (amod)
kanamycin gentamicin (conj)
conclusion mumol/l. (compound)
assessment cardiologic (amod)
frequent controls (nsubj)
had days (dep)
anxiety patients (nmod)
end point (dobj)
compared order (nmod)
trigger known (nsubj)
compare presence (dobj)
thrombosis deep-vein (amod)
describe discuss (conj)
lead consolidation (nmod)
changes : (punct)
measures symptoms (nmod)
evaluates work (nsubj)
personnel medical (amod)
myalgias polyneuropathy (conj)
study vancouver (compound)
days 6 (nummod)
ml ml (conj)
allele with (case)
age type (conj)
is evidence (nsubj)
observation ( (punct)
asymptomatic even (advmod)
1999 2004 (prep)
neurons the (det)
sodium progressed (acl:relcl)
first first (conj)
aprotinin fs (compound)
consequence properties (nmod)
volumes lesion (conj)
haloperidol levels (nmod)
found was (auxpass)
neuroblastoma with (case)
respect duration (nmod)
showed using (advcl)
saw association (dobj)
drops all (det)
liver worker (compound)
activity cocaine-induced (amod)
unnecessary dysfunction (nmod)
affect segment (dobj)
trial design-open-label (intj)
prospective . (punct)
hypercalcemia increases (conj)
impairments coupled (acl)
peaked which (nsubj)
ara-c high-dose (amod)
one only (advmod)
ingestion quinine (compound)
ng/dl. , (punct)
ventricular adrenaline-induced (amod)
related acetylcholine (nmod:npmod)
phase patients (nmod)
vol% concentration (nsubj)
pathophysiology into (case)
increasing such (mark)
electrocardiograms , (punct)
tremors convulsions (conj)
vasculitis associated (acl)
revealed pattern (dobj)
nitrogen a (det)
minute gram (nmod)
42)-infused - (punct)
21.0 4.4 (compound)
score reduced (amod)
option to (mark)
cck-5 8) (nummod)
determine achieved (ccomp)
lower systemic (conj)
modify decrease (nsubj)
summaries . (punct)
chemotherapy treatment (nmod)
measure memory (nmod)
surgery war/tropical (amod)
action by (case)
anatomic effect (dep)
nodules liver (nmod)
sulphate challenge (conj)
found rate (dobj)
engendered which (nsubj)
stones or (cc)
dose function (nmod)
induces . (punct)
days h. (nummod)
assess interaction (dobj)
identify cells (dobj)
linked not (neg)
performed anticoagulation (nsubjpass)
conceivable . (punct)
response stabilization (conj)
weeks 25 (nummod)
characterization the (det)
failure peritransplant (amod)
arrhythmogenicity bupivacaine (nmod)
rat intact (amod)
lobe and (cc)
concomitant elevation (nmod)
differences enhancement (nmod)
weeks exposure (nmod)
combination chromatography (nmod)
correlate and (cc)
correlated evidence (nmod)
results ) (punct)
review brief (amod)
beta-mimetics of (case)
agonists dopamine-2 (compound)
decrease exercises (nsubj)
phospholipid , (punct)
interview semistructured (compound)
increase , (punct)
corticography during (case)
undergone days (nmod)
weight age (conj)
identified authors (nsubj)
stage stage (conj)
effects muscles (nmod)
monitor a (det)
expression neuronal (amod)
tafi and (cc)
withdrawn been (auxpass)
hcn ) (punct)
used hypothermia (nsubjpass)
lithiasis ureteral (amod)
demonstrated compared (advcl)
ziprasidone due (case)
citrate and (cc)
pallidotomy according (case)
hepatocarcinogenicity the (det)
occurred results (dep)
cycles apheresis (nmod)
l-dopa with (case)
administration aminonucleoside (nmod)
30 ( (punct)
achieved hg (nsubjpass)
advocated is (auxpass)
patients affected (acl)
measurement enzymes (nmod)
nodosum in (case)
risk convulsions (nmod)
glomerulopathy nephritis (conj)
cohort women (nmod)
interaction consequence (nmod)
sections heparitinase (nmod)
eight infarction (nmod)
seizures produced (acl)
sulfasalazine of (case)
rcr in (case)
health psychological (amod)
toxicity tissue (compound)
injected hr (nmod)
reactions amoxicillin (nmod)
system of (case)
used strategy (nmod)
21 7 (compound)
acquired orientation (nmod)
5 frequency (appos)
any tests (nmod)
levels cortisol (compound)
sensitive highly (advmod)
0.75 1.67 (dep)
days 25 (conj)
neurons activated (acl)
evidence ultrastructural (amod)
stimulate may (aux)
started continued (conj)
urothelium the (det)
ramh ) (punct)
oils these (det)
prove corticography (nmod)
depletion persistent (amod)
lovastatin simvastatin (conj)
deletions mtdna (compound)
target can (aux)
research passage (dobj)
beraprost of (case)
increased period (nmod)
baseline -0.62 (dep)
meq. 2 (nummod)
case showing (acl)
frequent reported (advcl)
hj schumacher (compound)
received july (nmod)
vigabatrin to (case)
treated whereas (dep)
pharmacokinetics medications (nmod)
model predicting (acl)
action phenobarbital (nmod)
nacl % (compound)
30 60 (conj)
increased hr (dobj)
known is (ccomp)
antagonist 5-ht6 (amod)
fed group (nsubjpass)
taxol ) (punct)
dependent [ca]o (nmod)
bis 50 (dep)
c219 monoclonal (amod)
women three (nummod)
higher consistent (xcomp)
complained numbness (nmod)
nx dogs (dep)
336 26 (conj)
using by (mark)
closest differed (parataxis)
complaints the (det)
pituitaries rat (compound)
scl ( (punct)
rendered anemic (xcomp)
taken consideration (nsubjpass)
headache and (cc)
diuretics . (punct)
ratio concentrations (nmod)
mg/kg hr (appos)
most which (nmod)
effects systems (nmod)
risperidone ssris (conj)
analyses covariance (nmod)
interruption administration (nmod)
frequency across (case)
protects inducing (advcl)
concentration levetiracetam (compound)
extend thus (advmod)
ratio , (punct)
9.95 - (punct)
normalizes resistance (dobj)
rigidity assumed (acl:relcl)
recipients in (case)
signs syndrome (nmod)
or=2.870 ) (punct)
anemia hb (nmod)
graft and (cc)
administrated 200mgkg(-1 (dep)
pathway important (amod)
assay deoxynucleotidyl (compound)
agent chemopreventive (amod)
required support (dobj)
modified but (cc)
grade less (amod)
a(2a of (case)
recipients combination (compound)
elucidate mechanisms (dobj)
thrombin tranexamic (conj)
labeling an (det)
ppa by (case)
% 0.025 (compound)
induces malformations (dobj)
block k(+)-channels (dobj)
analysis a (det)
currents rectifier (compound)
function electrophysiologic (amod)
optic resolved (acl:relcl)
drugs non-selective (amod)
view against (prep)
fluctuations and (cc)
tacrine and (cc)
service a (det)
catheter carotid (compound)
requiring therapy (nmod)
pn 2 (nummod)
field temporal (amod)
testing strain (nmod)
rare effects (nsubj)
group same (amod)
observed case (nmod)
dce mg/kg (appos)
donor apheresis (compound)
days postnatal (amod)
formation dox (nmod)
carbamazepine presenting (xcomp)
duration af (compound)
observations exencephaly (nmod)
prevalence disease (nmod)
anatomic in (case)
placed they (nsubjpass)
% groups (nmod)
measured test (nmod)
attempt suppress (acl)
born prematurely (advmod)
drop them (nsubj)
marmoset the (det)
approved treatment (nmod)
formation infiltration (conj)
reaction no (neg)
admission before (case)
hz 5v (conj)
effect anticonvulsant (amod)
circulation anterior (amod)
cq ( (punct)
had seizures (nsubj)
uterus pig (compound)
effect contractant (amod)
developing complication (dobj)
nephropathy lithium-induced (amod)
suggests modulates (ccomp)
nucleus arcuate (amod)
case hematoma (nmod)
probable and (cc)
hepatitis prolonged (amod)
irritation acc-9653 (nmod)
controlled doses (nmod)
vivo in (compound)
value obtained (conj)
gr agonist (dep)
tea and (cc)
injections neonatal (amod)
patient-years 500 (nummod)
dili ) (punct)
version ( (punct)
maoi ( (punct)
subjects 2 (nummod)
decreased until (mark)
% recipients (nmod)
tremor reactions (nsubj)
limited thalidomide (nsubj)
administer to (mark)
7.54 1.54 (appos)
collected september (nmod)
appearance mpo-anca (nmod)
investigated salt-depleted (nmod)
infarct density (conj)
abnormalities reversible (amod)
reduction patients (nmod)
safety as (case)
day-1 kg-1 (compound)
decreased days (nmod)
tumors for (case)
identified gene (nmod)
score obtained (acl)
man than (case)
effects clonidine (nmod)
taking paroxetine (dep)
examined months (nmod)
as conclusion (nmod)
provoke dobutamine (nsubj)
levels cpu (nmod)
blockers quinine (appos)
52.7 12.8 (compound)
diclofenac effectiveness (conj)
useful identifying (advcl)
using approach (dobj)
rnfl average (amod)
given resulted (dep)
increased terms (nmod)
profile dexmedetomidine (nmod)
related might (aux)
critical is (cop)
receptor receptors (conj)
release clonidine (nmod)
acetylsalicylate , (punct)
amifostine ( (punct)
change resolve (advcl)
mg/m2/d mtd (nsubj)
antibodies antirifampicin (compound)
end follow-up (nmod)
fraction normal (amod)
cd25 the (det)
food regular (amod)
pri ( (punct)
rats killed (acl:relcl)
reduced burden (dobj)
ventilation mechanical (amod)
management support (conj)
causes overgrowth (nsubj)
failure hypotension (nmod)
produced presence (nmod)
inhibition between (case)
use doxorubicin (nmod)
found ethopropazine (nsubjpass)
worsening parkinsonism (nmod)
changes elements (nmod)
performed a.m. (nmod)
alive conversion (nmod)
analyses these (det)
rapid lasting (dep)
fashion groups (nmod)
fill do (aux)
mechanism this (nmod)
submitted ptra (nmod)
number time (appos)
methylergonovine of (case)
likely were (cop)
appeared group (nmod)
score living (amod)
mice albino (compound)
surgery endoscopic (amod)
therapy months (compound)
healthy were (cop)
use imipramine (nmod)
change sensitivity (nmod)
adalat ) (punct)
nucleus midbrain (nmod)
session single (amod)
c pf (conj)
reduced fraction (nsubjpass)
both on (case)
repeated days (nmod)
exhibited hybrid (nsubj)
malondialdehyde nag (dep)
stimulation alone (advmod)
accentuated rise (dobj)
15 of (advmod)
unknown it (nsubj)
characteristics structural (amod)
dvt ( (punct)
stereotypies or (cc)
calcification of (case)
anemia mice (nmod)
effacement foot (compound)
acetazolamide of (case)
= 0.25 (dobj)
associated infarctions (nsubjpass)
artery umbilical (amod)
risks hospitalization (nmod)
acid injected (acl)
d3 vitamin (compound)
enhanced reducing (advcl)
present abnormalities (nsubj)
drugs acupuncture (conj)
synthase inos (appos)
myalgia grade (compound)
g. was (cop)
dispersion repolarization (nmod)
similar strikingly (advmod)
survey the (det)
efficacy isg (nmod)
cause effect (dobj)
tiopronin , (punct)
nucleoside appropriate (amod)
weakness and (cc)
observed abnormalities (nsubjpass)
infarction ami (appos)
oxcarbazepine to (case)
retention the (det)
dysfunction left (amod)
creating approach (conj)
proposal to (case)
changes upregulation (nmod)
nsclc pretreated (amod)
aroused still (advmod)
involvement mediating (acl)
presence ldl (nmod)
block of (case)
contribution signaling (nmod)
less is (cop)
cases 57 (nummod)
cost drug (compound)
mg/24 2.5 (compound)
consumed rationale (nsubjpass)
deposited fibrin (nsubjpass)
effect mg (nmod)
toxicities patients (nmod)
group anemia (compound)
tachycardia prolongation (conj)
prevent attenuated (advcl)
affect mortality (dobj)
normalization tests (nmod)
trinitrate no (compound)
comparison disturbances (nmod)
confirmatory of (case)
hours 18 (nummod)
disease in (case)
increased used (advcl)
regulation expression (nmod)
ratio respiratory (amod)
t group (compound)
microglobulinuria elevated (amod)
groups and (cc)
known phosphorus (nsubjpass)
combinations sulfate (nmod)
blocked injection (nmod)
administered prevented (conj)
outcome study (nmod)
hypertensive subclinical (amod)
elevation and (cc)
occurs diseases (nmod)
decreased pressure (dobj)
combination min (nmod)
injury paracetamol-induced (amod)
malformations on (case)
cells nos-ir (compound)
heparin with (case)
tissue in (case)
bilirubin ( (punct)
effects levodopa (compound)
b for (case)
protective toxic (conj)
correspond may (aux)
late as (advmod)
ingestion period (nmod)
considered models (nsubjpass)
bedtime pre (amod)
ventricular left (amod)
define experience (nsubj)
taken have (aux)
concentrations gastrin (compound)
dose that (nmod)
irrigation of (case)
studies clinical (amod)
trough-concentrations as (case)
cases > (dep)
trial azelastine (nmod)
lower doses (nsubj)
compared beta-blocking (nmod)
salbutamol salbutamol (conj)
protect could (aux)
ratio increase (nmod)
developed ari (nsubj)
host ) (punct)
0.1 ( (punct)
dopamine dobutamine (conj)
3 d2 (compound)
order clarify (acl)
macrolide the (det)
positive strongly (advmod)
reached rates (dobj)
significant % (dep)
libitum ( (punct)
mi and (cc)
inhibitors direct (amod)
influence which (nmod)
nd-nmba likely (advmod)
women 348 (nummod)
haemorrhage cerebral (amod)
increased formation (dobj)
role inhibition (nmod)
had presentation (nmod)
frame the (det)
profile favorable (amod)
progression % (dep)
show interaction (dobj)
hypoactivity free-field (amod)
fractures documented (amod)
had opse (dobj)
months 3 (nummod)
predicted failure (nsubjpass)
included ncs (nsubj)
forty-six a (det)
shedding cytomegalovirus (compound)
stabilized was (auxpass)
discontinue can (aux)
chloride with (case)
maintained concentration (nmod)
intraperitonealinjection of (case)
induced loss (dobj)
tablets theophylline (compound)
agent contrast (compound)
quality two (conj)
improvements normalizations (conj)
gls grs (conj)
boy 3-year-old (amod)
acute severe (conj)
inconsistent . (punct)
biomarkers expression (compound)
effect contributory (amod)
backgrounds differing (amod)
differ practice (nmod)
90 290 (conj)
induce volunteers (nmod)
hemispheres cerebral (amod)
study previous (amod)
efficacy nsclc (nmod)
age proteinuria (conj)
resolved therapy (nmod)
normal evaluations (nsubj)
scale similarities (appos)
effective ns-718 (nsubj)
doses subcutaneous (amod)
titrated be (auxpass)
rs6693503 rs1805054 (appos)
receive it (nmod)
succinylcholine therapy (nmod)
higher respect (nmod)
consider therapy (dep)
stage four (nummod)
tests . (punct)
enhancement dysfunction (conj)
antagonist an (det)
pri the (det)
mg/dl acid (nmod)
pump ( (punct)
0.8 . (punct)
proposed background (dep)
coassemble form (xcomp)
follow to (mark)
pathogenesis their (nmod:poss)
normalization and (cc)
collection donor (compound)
persons effects (nmod)
nephrotoxicity occurs (acl:relcl)
remission for (case)
expression and (cc)
increase hand (nmod)
sinus cerebellum (conj)
basis an (det)
bbb altered (amod)
test ( (punct)
doses denopamine (nmod)
t d4 (compound)
method assessment (compound)
session 10-min (amod)
order an (det)
causes dysmetria (dobj)
first is (cop)
cohort on (case)
effects dose-related (amod)
tests writhing (compound)
ratio period (conj)
had anaesthesia (dobj)
anorexigens hypertension (conj)
change weakness (conj)
ability patient (nmod:poss)
few very (advmod)
prevented pre-treatment (nsubj)
receiving % (nsubj)
characterized umb24 (dobj)
associated growth (nmod)
txa ) (punct)
activity mice (nmod)
usual that (mark)
estimate interference (nmod)
virus for (case)
have reduction (dobj)
time acceptable (amod)
abnormal were (cop)
improved but (cc)
age 38 (nsubj)
users abstinent (amod)
beginning after (mark)
become hypercalcemic (acomp)
number cells (conj)
minutes ) (punct)
ich of (case)
use mdma (nmod)
provided results (dobj)
association , (punct)
evaluated day (nmod)
woman 52-year-old (amod)
sensitization desipramine-induced (amod)
level mean (amod)
mice days (compound)
cna ( (punct)
studied examinations (nmod)
vasoconstriction cocaine-induced (amod)
nicotine caffeine (conj)
blind three-way (appos)
produced steroids (nsubj)
sex weight (conj)
stronger 20 (nummod)
implanted and (cc)
data age (dep)
index , (punct)
damage matrix (nmod)
indicator that (mark)
those to (case)
tachyphylaxis systemic (nmod)
disorders associated (amod)
arterial between (case)
widening complex (nmod)
stopped who (nsubj)
effects clinical (amod)
artery cerebral (amod)
rise collagen (conj)
helpful study (nsubj)
chp of (case)
duct stones (conj)
simultaneously 1 (conj)
maturation a (det)
group a (det)
collagen by (case)
acuity on (case)
restricted be (cop)
angiography following (case)
serum eluates (conj)
node lymph (compound)
change subjects (conj)
bw of (case)
outcome dp/dtejc (compound)
activity anti-hiv (compound)
foci of (case)
have will (aux)
studied period (nmod)
syndrome encephalopathy (nsubj)
assess potential (dobj)
content platelet (compound)
controls and (cc)
ability and (cc)
mean x (dep)
exerts acid (nsubj)
occurred 5 (nmod)
hypotension effect (conj)
coupled use (nmod)
increase hepatocarcinogenicity (dobj)
demonstrate studying (advcl)
detected sample (nmod)
bches ( (punct)
trigger possible (amod)
scale tromso (compound)
published are (auxpass)
hds after (case)
work further (amod)
endonuclease-dependent and (cc)
reach association (nsubj)
benefit strength (dobj)
impairment behavioral (amod)
animals tumor (nmod)
analysis regional (amod)
associated cessation (nsubjpass)
(na k)-atpase (appos)
interna and (cc)
minutes 30 (nummod)
associated hemorrhage (nsubjpass)
free that (nsubj)
prk ) (punct)
158.11 vs. (cc)
fruits chebula (compound)
lesions partial (amod)
infusion amount (nmod)
examined , (punct)
delivery tubules (nmod)
patient ill (amod)
2,682,2,803 , (punct)
were objectives (ccomp)
67 54 (compound)
t from (case)
remission period (nmod)
wall ventricular (compound)
values dehydrogenase (compound)
made . (punct)
gain higher (amod)
goes leading (advcl)
creating and (cc)
rejection infection (conj)
positive if (mark)
investigation role (nsubj)
extent smoking (nmod)
obtained algorithm (nmod)
plugs these (det)
prominent box (nmod)
severe more (advmod)
studied be (auxpass)
immunotherapy as (case)
mm 8 (nummod)
anticipation forthcoming (advcl)
hbv hiv (conj)
min hours (conj)
fibers coerulospinal (amod)
observations interacts (acl:relcl)
included matched (nmod)
produced decreases (nmod)
interactions p-450 (compound)
embolism pulmonary (amod)
significance no (neg)
combinations cisplatin-based (amod)
reduced that (mark)
male patients (nmod)
mice had (acl:relcl)
procedures major (amod)
stages two (nummod)
derived that (nsubj)
donors (hbsag)-positive (amod)
assigned injected (conj)
fbal ( (punct)
requires feasible (advcl)
so to (mark)
administration 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (nmod)
cholinesterase with (case)
revealed results (nsubj)
effect cross-linking (nmod)
tafi , (punct)
shake ergometrine-induced (amod)
injection antibiotics (nmod)
phenols the (det)
500 5 (compound)
evaluated time (nmod)
patient treatment (nmod)
groups control (appos)
agent cancer (nmod)
hypoaldosteronism hyperkalemia (compound)
% that (nmod)
actions caffeine (nmod)
november 1998 (nummod)
establishing tumor (dobj)
waves b (compound)
clear patients (nmod)
induces prednisone (nsubj)
case neuropathy (acl)
normotensive animals (conj)
tests laboratory (compound)
caused effect (dobj)
indicates lack (nsubj)
arthritis in (case)
weekly month (nmod)
resulting use (nmod)
associated unknown (conj)
employed widely (advmod)
subunit cco-i (appos)
proved (-)-baclofen (nsubj)
deficits these (det)
activation d2 (compound)
3.2 5.0 (conj)
profile thioperamide (nmod)
phosphate inhibitor (appos)
data prior (amod)
morning presentation (nmod)
more than (prep)
have elevations (dobj)
receive background (dep)
inducer an (det)
lag ) (punct)
cessation institution (conj)
multicenter from (case)
6 17 (dep)
signals hyperintense (amod)
tone artery (nmod)
controls drug-free (amod)
played deaths (nmod)
site vestibular (dep)
suppressed also (advmod)
h. on (case)
present symptoms (nsubj)
complicating donation (dobj)
had suggestive (conj)
development myelosuppression (nmod)
bromocriptine cells (nmod)
considered inhibitors (nsubjpass)
proliferation induced (acl)
caused mortality (nsubjpass)
treatment propanolol (nmod)
mitigated preceding (advcl)
treated % (nmod)
failure resulting (acl)
syndrome seem (acl:relcl)
integrity sarcolemmal (amod)
release basal (amod)
200 to (dep)
time convulse (nmod)
unnecessary choice (conj)
morphine ( (punct)
role sirolimus (nmod)
% amlodipine (nmod)
infants young (amod)
speculated it (nsubjpass)
trial way (nmod)
reported rarely (advmod)
potassium supplementation (conj)
role contaminants (nmod)
associated hypercalcemia (nmod)
sedations the (det)
aggressiveness the (det)
9.9 11.1 (conj)
4107 figures (nsubj)
predisposed might (aux)
patients caucasian (amod)
thrombosis induced (acl)
evaluated uncertainty (nsubjpass)
% 0.34 (nummod)
weight bladder (amod)
is consensus (attr)
flaccid animals (nsubj)
active reversal (dep)
induce fever (dobj)
that gsh (nmod)
demonstration : (punct)
enhance thrombosis (dobj)
used monitoring (nsubjpass)
returned level (nsubj)
mitochondria being (acl)
unclear substantial (ccomp)
inhibition xo (compound)
multiple and (cc)
given performed (conj)
counted . (punct)
inhibited serum (nmod)
activity % (appos)
patient pain (nmod)
users range (conj)
antibiotics beta (compound)
produced thiopental (nmod)
= n. (dep)
cddp by (case)
reduction bnpp-induced (amod)
ptcr ( (punct)
demonstrate explained (ccomp)
endomt ( (punct)
monitor operations (nmod)
value relative (amod)
had required (conj)
unclear have (aux)
causes seizures (nmod)
synapse gyrus (nmod)
application long-term (amod)
compared exposure (dobj)
hepatotoxicity and (cc)
measures fetuses (nmod)
increased blockers (nmod)
infants the (det)
pre-treatment dose (nmod)
zo-1 7h6 (conj)
bolus . (punct)
contraindicate use (dobj)
rhythm induced (acl)
denopamine , (punct)
responses norepinephrine (nmod)
post-treatment lr132 (nmod)
elevated it (nsubj)
alters therapy (nsubj)
recurring that (mark)
tinnitus of (case)
determined effects (nsubj)
explore anatomy (dobj)
rates symptoms (conj)
nsaid diclofenac (dep)
manifest employed (dep)
changes intervention (nmod)
2.1 53 (prep)
mediator that (mark)
membrane the (det)
toxicities hematological (amod)
120 81 (compound)
suppresses levels (dobj)
morphine . (punct)
agent of (case)
proteinuria invoked (acl)
light studies (dep)
preparations cold (amod)
responsible antinociception (nmod)
asked were (auxpass)
(2.2)% -6.1 (nummod)
collection data (compound)
decreased injection (nmod)
effect levodopa (nmod)
simvastatin of (case)
programmed therefore (advmod)
ptra group (dep)
obtained had (aux)
appetite mouth (conj)
account therefore (advmod)
treated bcnu (nmod)
given alone (advmod)
rates case (compound)
althesin thiopentone (conj)
known bradycardia (nmod)
node sa (compound)
length ms (dep)
communication . (punct)
design crossover (compound)
mortality mortality (conj)
patency airway (nmod)
0.25 vehicle (conj)
10 and (cc)
ctni maximal (amod)
gastroenteritis drugs (nmod)
% 35.7 (nummod)
insufficiency with (case)
micrograms/kg/min 100 (nummod)
3 20 (prep)
superior nasal (conj)
patients iranian (amod)
capsaicin mm (appos)
0.03 mg/kg (dep)
angiography left (amod)
occur groups (nmod)
literature recent (amod)
reduction number (nmod)
involved no (nsubjpass)
hypertensive rebound (compound)
drug-adsorption mechanisms (conj)
men % (appos)
3-nitrotyrosine 3nt (appos)
taking dapsone (dobj)
syndrome turner (compound)
les either (cc:preconj)
treated originally (advmod)
hormone of (case)
data demographic (amod)
study agoraphobia (nmod)
levels nitrite (amod)
hyperplasia epithelium (nmod)
infiltration during (case)
seems , (punct)
100 +/- (cc)
dependent context (dep)
show reverses (ccomp)
synthesis rna (compound)
cbd 36.22 (appos)
pallor optic (amod)
trend 0.01 (dep)
participants cocaine (compound)
explore linked (ccomp)
showed preponderance (dobj)
status myoclonic (amod)
covered . (punct)
kind of (case)
blood-brain-barrier the (det)
sufficient generation (nsubj)
included analysis (nsubj)
tachyarrhythmia triggered (acl)
protein gla (compound)
charge adenylate (compound)
metabolism on (case)
involvement isomerase (nmod)
tests elisa (compound)
suffer may (aux)
seizure afterdischarge (conj)
level clearance (conj)
riha significant (amod)
concentrations lidocaine (compound)
showed scans (nsubj)
lack detect (acl)
co-infection without (conj)
hyperalgesia oih (appos)
cluster a (det)
good diseases (nmod)
continue background (dep)
g/ml ) (punct)
injections meth (nmod)
serotonin 6 (nummod)
prevented reversed (conj)
approximation the (det)
mm 60 (nummod)
nuclei brainstem (nmod)
risk considerable (amod)
therapy amiodarone (amod)
plausibility effect (nmod)
resorption excess (nmod)
encephalopathy piperacillin-induced (amod)
107 +/- (cc)
started medication (dobj)
determined have (aux)
course short (amod)
rates fatality (compound)
paroxetine mg/day (nummod)
leading transplantation (nmod)
cya ) (punct)
had because (mark)
stroma by (case)
nightmare spasm (appos)
biochemical in (case)
invasion of (case)
yawning hyperactivity (conj)
thyroid of (case)
k+ serum (compound)
99 was (cop)
expression efe (appos)
neurons daergic (amod)
alpha-methyltyrosine inhibitor (appos)
hyperparathyroidism secondary (amod)
fear surprise (conj)
courses chemotherapy (nmod)
six times (quantmod)
patients twenty-one (nummod)
angiography route (nmod)
placentae retained (amod)
nitrazepam with (case)
assessed fall (nmod)
case man (nmod)
phase disease (nmod)
sequencing direct (amod)
type block (nmod)
migraineurs 12 (nummod)
probe electromagnetic (amod)
plasticity clues (dep)
days 14th (amod)
effect receptor (nmod)
suggesting given (mark)
drugs carbamazepine (dep)
majority cases (nmod)
seizures clinical (amod)
daily mg (nmod:tmod)
dosing last (amod)
disease idiopathic (amod)
patient effect (nmod)
drinkers the (det)
died that (mark)
known role (nmod)
degeneration group (nmod)
precluded heterogeneity (nsubj)
monitoring therapy (nmod)
animals doxorubicin-treated (amod)
those symptoms (conj)
agents vasopressor (compound)
precipitate , (punct)
mg/kg min (conj)
adenomas women (nmod)
received sirolimus (dobj)
sces ( (punct)
incidence levels (nmod)
revealed glomerulonephritis (dobj)
syndrome observed (amod)
failure therapy-induced (amod)
analgesic antiinflammatory (conj)
diet period (nmod)
reduction dosage (nmod)
120 90 (quantmod)
pentobarbital by (case)
way biopsy (nsubj)
patients young (amod)
hazard treatment (nmod)
studies years (nmod)
loops by (case)
excruciating intensity (dobj)
robust effect (nmod)
5.2 8.5 (conj)
(ntg)-induced nitroglycerin (nmod:npmod)
females in (case)
agent single (amod)
part membrane (nmod)
lower patients (nmod)
hypotension shr (nmod)
life is (cop)
exhaustion amphetamine (nmod)
do species (dobj)
changes . (punct)
administered dexamethasone (nsubjpass)
dominance neural (amod)
similar women (nmod)
using simple (dobj)
depression-inducer of (case)
medication on (case)
interest development (nmod)
tubuli expansion (conj)
monitoring neurologic (amod)
incomplete . (punct)
parallel signs (nmod)
performed assessment (nsubjpass)
findings study (nmod)
consider manage (conj)
reversible are (cop)
dyskinesia td (appos)
cases reviews (conj)
hyponatremia hormone (nmod)
use however (advmod)
gls -19.20 (nmod)
superior ergotamine/caffeine (nmod)
cause that (dobj)
clozapine and (cc)
importance particular (amod)
reduced pressure (conj)
seroconversion participants (nmod)
strong weight (nsubj)
ligands , (punct)
highlighted . (punct)
asked . (punct)
produced corticosteroids (nsubj)
11.3 1.4 (conj)
sufficient that (mark)
hydroxylase not (neg)
differences marked (amod)
antagonist peripheral (amod)
kf17837 2.5 (appos)
ari ) (punct)
knee left (amod)
rnfl ( (punct)
ph of (case)
generated thus (advmod)
stroma endometrial (amod)
dose less (acl:relcl)
recorded early (advcl)
intravenous also (advmod)
study carbetocin (nmod)
information proteome (nmod)
attribute , (punct)
groups therapy (nmod)
group parkinson (nmod:poss)
inhibition adenosine (nmod)
relevant results (nsubj)
one be (cop)
nitroglycerin of (case)
subunits with (case)
data studies (nmod)
assigned placebo (nmod)
impairment myocardial (amod)
dextran polysaccharide (compound)
resulted recognition (nsubj)
score point (nmod)
found frame (nmod)
year for (case)
reduced behaviors (nsubjpass)
graft in (case)
incontinence to (case)
supports view (nsubj)
reviewed : (punct)
infiltration of (case)
role pathogenic (amod)
b rats (nmod)
suppression motility (nmod)
0.06 +/- (cc)
carried continuously (advmod)
feature to (mark)
medicine in (case)
spite concentrations (nmod)
120 more (advmod)
real only (advmod)
investigates associated (ccomp)
co-morbidity taking (conj)
course 1-month (amod)
discontinued reactions (nmod)
destruction duct (compound)
man arthritis (nmod)
assessment vision (compound)
arteriolar capillary (conj)
induce treatment (nsubj)
entered date (nmod)
utility identifying (advcl)
reveals study (nsubj)
lamivudine-na thirty-five (amod)
stimulation , (punct)
reserpine administered (acl)
ginsenoside the (det)
postdose 72 (nummod)
weakness the (det)
findings paradigm (nmod)
placebo micrograms (appos)
vagotomised previously (advmod)
prevented coma (nsubjpass)
reported absorption (nsubj)
treatment choice (nmod)
1400 1600 (conj)
4.7 more (acl:relcl)
prerequisite evidenced (advcl)
experienced recovery (dobj)
given vehicle (dobj)
addition cisplatin (nmod)
wilson different (amod)
patients kg-1 (nmod)
injection p.i (amod)
increases postpartum (nmod)
rats chronic (amod)
survivors groups (conj)
diminishing , (punct)
acid of (case)
received woman (nsubj)
reduced rats (nmod)
six mg/m2 (conj)
change the (det)
discontinued completion (nmod)
diagnosis cimd (nmod)
length [ (punct)
monitored hyperplasia (nmod)
infarction subendocardial (amod)
defects regarding (case)
tomography brain (nmod)
a cyclosporin (compound)
effects performance (conj)
food water (conj)
had he (nsubj)
amphetamine cocaine (conj)
prevent that (mark)
degrees impairment (nmod)
responses % (nmod)
disorders renal (amod)
suspected , (punct)
greater drug (nmod)
abnormalities the (det)
were administration (nmod)
therapy irradiation (compound)
capacity the (det)
scores extrapyramidal (amod)
dependence in (case)
chloride bicarbonate (conj)
forming and (cc)
fk of (case)
required dialysis (nsubjpass)
dogs doxorubicin-treated (amod)
scarce background (dep)
carbachol by (case)
conducted materials (nsubj)
flaccidity anesthesia (conj)
studies states (nmod)
syndrome cholestatic (amod)
reversed effects (nsubjpass)
interpolates oct (nsubj)
shift does (aux)
given treatments (nsubjpass)
contribute dehydration (nsubj)
score assessment (nmod)
fulfilled total (nsubj)
assays functional/physiological (amod)
morning eyes (nmod)
use regarding (case)
effects abstention (nmod)
sensitivities lines (nmod)
observations unit (nmod)
blockade k(+)-channels (nmod)
projections hilar (amod)
exhibited rate (dobj)
benzodiazepines by (case)
case deficit (nmod)
restarted and (cc)
alpha-tc ( (punct)
monotherapy . (punct)
dex , (punct)
studies extensive (amod)
glyt1 ) (punct)
appeared dogs (nmod)
effect scintigraphy (nmod)
asthenia as (case)
support conclusion (dep)
incorporation atp (nmod)
inflammation apoptosis (conj)
deposited produced (conj)
replication of (case)
tests normalized (acl)
detected however (advmod)
efficient more (advmod)
improved ) (punct)
showed development (dobj)
excretion between (case)
studied study (nmod)
severity suppression (nmod)
transaminase her (nmod:poss)
bpm to (case)
carolina and (cc)
seizure ether (nsubj)
oc and (cc)
occurs reactions (conj)
nf-kappab of (case)
css ( (punct)
explored study (nmod)
safe be (cop)
db 35 (nummod)
male in (case)
treatment impotence (nmod)
proliferation compensatory (amod)
1/8 ( (punct)
0.2 and (cc)
increase increase (nmod)
threatening spasm (dobj)
face in (case)
decrease predominant (amod)
improved gradually (advmod)
arrhythmia of (case)
features laboratory (compound)
result comparison (nmod)
finding jaundice (nsubj)
obtained section (nmod)
processed staining (nmod)
concentration to (case)
patients cause (nmod)
mg./kg by (case)
response ketamine (nmod)
intoxications during (case)
anticoagulation patency (nmod)
vasopressor of (case)
treated d (nmod)
stress enhanced (amod)
defined assessed (dep)
relapse in (case)
atm 2 (nummod)
perimysial and (cc)
pairs control (nmod)
lid the (det)
source alternative (amod)
centre from (case)
glomerulonephritis severe (amod)
quantified using (xcomp)
type agent (nmod)
fr receptor (compound)
capillary to (case)
risk recurrence (nmod)
show phenotypes (nsubj)
had decreased (conj)
recordings the (det)
beta sodium (compound)
basis blind (amod)
orbitofrontal possibly (advmod)
estimated has (aux)
worsened , (punct)
revealed levels (dobj)
myopathy defined (acl)
improved pd (nmod)
consisted women (nmod)
highlights also (advmod)
doxorubicin mg/kg (compound)
regulation gene (compound)
infusion propofol (compound)
escalation with (case)
pharmacy in (case)
disorder autism (nsubj)
registration trial (compound)
reviewed tested (conj)
calcium seen (acl)
demonstrate now (advmod)
required doses (dobj)
complicated utility (nsubjpass)
toxicology of (case)
hilum hh (appos)
mm 50 (nummod)
ameliorated cessation (nsubj)
t % (appos)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline wr242511 (appos)
done week (nmod)
survival p (dep)
indication conversion (nmod)
treated d3 (nmod)
suggests together (advmod)
s-limonene or (cc)
0.014-unit by (case)
11/41 % (appos)
bed for (case)
provocation following (case)
attributed might (aux)
operations during (case)
cancer treated (amod)
died eighteen (nsubj)
produced rabbits (nmod)
epinephrine subsequent (amod)
period week (compound)
application continuous (amod)
men six (nummod)
cells midline (amod)
killed rats (nsubjpass)
diminish apoptosis (dobj)
that mg/kg (nmod)
rats than (case)
ndi ) (punct)
antidopaminergic with (case)
glaucoma resembles (acl:relcl)
89 of (advmod)
sagittal and (cc)
rare maha (nsubj)
rates seen (acl)
gating expression (conj)
samples with (case)
ratios turnover (compound)
had cases (nsubj)
sensitivity ( (punct)
titrated ph (nmod)
occurs cin (nsubj)
connection administration (nmod)
results developed (appos)
dose causing (dep)
l-485 diet (amod)
nicotine itself (nmod:tmod)
17.6-fold were (cop)
caused use (nsubj)
result administration (nsubj)
demonstrate did (aux)
seizure administration (nmod)
comments the (det)
placebo-controlled randomized (conj)
screening occasions (nmod)
significant small (advcl)
carsinom renal (amod)
hunt hess (conj)
inconclusive and (cc)
deficit mean (compound)
dopamine norepinephrine (conj)
pathway signaling (compound)
threshold in (case)
seizures . (punct)
shown assessment (nmod)
anuria administration (nmod)
mediated rigidity (nsubjpass)
state phosphorylation (compound)
nanospheres ns-718 (nmod)
regimen prophylactic (amod)
diminished it (nsubj)
prolonged significantly (advmod)
stronger significantly (advmod)
outpatients 33 (nummod)
effects several (amod)
rara within (case)
injury tissue (compound)
instituted reduces (conj)
manifestation of (case)
relationship complications (nmod)
podocytes in (case)
screening . (punct)
and transiently (advmod)
mg/kg/day ( (punct)
drop ef (nmod)
d-med ; (punct)
explained can (aux)
solution ) (punct)
toxicities observed (acl)
mimicking accident (dobj)
this disorders (conj)
min acquisition (nmod)
accumulation [125i]mibg (nmod)
used agents (nsubjpass)
resulted male (nmod)
high concentration (nsubj)
variants subset (nsubj)
amiloride ) (punct)
activity motility (compound)
decrease densities (nmod)
crisis because (case)
t.d.s. of (case)
hospital women (nmod:poss)
episodes % (dep)
motility control (nmod)
given reduced (parataxis)
depression caused (acl)
patients hiv-positive (amod)
s-isomer the (det)
resistance this (det)
contractions kcl-induced (amod)
latency to (dep)
reabsorption renal (amod)
relationships and (cc)
motor a (det)
(+/-)-pg-9 mg (dep)
birth complications (nmod)
contractility altered (amod)
agents anticonvulsant (amod)
sr on (case)
maximum minimum (conj)
activate that (mark)
index mean (compound)
hemorrhage by (case)
activity incidence (dep)
results rejection (dep)
compartments peripheral (amod)
chloride or (cc)
being effects (attr)
rates the (det)
indicator diagnostic (amod)
height bmi (conj)
cause sole (amod)
reacted absence (nmod)
= 0.62 (dobj)
manic fully (advmod)
prescribed mistake (nmod)
stress possibilities (nsubj)
nra0160 and (cc)
atm of (case)
clinical experiences (dep)
hazard as (case)
granulomas histologic (amod)
improves amnesia (dobj)
focused was (auxpass)
effective represent (conj)
tested baseline (nmod)
led , (punct)
neuropathy nerve (nmod)
increase not (neg)
mass : (punct)
correlate mass (nmod)
determined series (nmod)
mz associated (acl)
complications as (case)
maleate neuropathy (conj)
deprivation bupropion (conj)
calculated determine (advcl)
mg orally (advmod)
pj34 parp (compound)
lesions obstructive (amod)
81.5 was (cop)
contribution form (nmod)
possibility mechanism (nmod)
syndrome with (case)
liver . (punct)
tci via (case)
utility , (punct)
abs of (case)
treatment labor (nmod)
hh ( (punct)
considered never (neg)
superior superior (conj)
had diagnosis (nmod)
received having (aux)
restoration continence (nmod)
/-s.d ( (punct)
targets , (punct)
given intramuscularly (advmod)
questions following (amod)
disorders widespread (amod)
treatment adults (nmod)
hyperglycemia , (punct)
db 2.96 (nummod)
solution collected (acl)
administration manipulation (nmod)
risk an (det)
radius at (case)
described correlated (conj)
self-treating been (aux)
rhythms second (amod)
using stimulation (nmod)
provides abuse (nsubj)
result underlying (acl)
vancomycin and (cc)
mg 0.07 (nummod)
mean change (conj)
pge2 intra-arterial (amod)
cell parietal (amod)
insufficiency indomethacin-induced (amod)
experiences aes (appos)
138 +/- (cc)
provide quality (dobj)
dependent not (neg)
system on (case)
injected striatum (nmod)
receptor gaba(a (compound)
details procedure (nmod)
hypotension this (det)
depth sedation (compound)
attenuate amnesia (dobj)
blockade h2-receptors (nmod)
days system (nmod)
igf-il-3 alone (advmod)
developed group (nmod)
considered hand (nmod)
days within (case)
p 0.01 (nummod)
characterized dysfunction (nmod)
smelling of (mark)
induced absence (nmod)
1a the (det)
due residence (nmod)
methods , (punct)
interaction stress (nmod)
occurred % (conj)
insufficiency captopril-induced (amod)
ribavirin such (case)
solution saline (compound)
mug 4 (nummod)
measured impairment (nsubjpass)
increased eroded (conj)
active . (punct)
30 15 (compound)
filaments thick (amod)
represent shown (advcl)
gradient initial (amod)
reduction cells (nmod)
non-selective ns (dep)
is strategy (nsubj)
suggest opposite (dobj)
receptors shell (compound)
effect cns (compound)
studies strains (nmod)
frequent patients (nmod)
localization antagonism (nmod)
maintained anaesthesia (nsubjpass)
effects the (det)
cardiotoxicity 5-fu (compound)
prophylaxis patients (conj)
in urinary (dep)
patients but (cc)
nephritis recurrent (amod)
dwi only (cc:preconj)
showed frequency (nsubj)
studies behavioral (amod)
taken sample (nsubjpass)
depends procedure (nsubj)
remain determined (xcomp)
pg/ml pg/ml (conj)
rats 0.01 (dep)
up-regulated ccr2 (nsubjpass)
recurrences with (case)
difluoromethylornithine of (case)
prevalence dyskinesia (nmod)
produced when (advmod)
cardiotoxicity therapy (nmod)
motility with (case)
24 than (quantmod)
eliminating for (mark)
patients twenty-four (nummod)
patients 352 (nummod)
sedation intravenous (compound)
appreciated than (mark)
neuropathy musculoskeletal (conj)
single as (case)
true was (cop)
understanding injury (nmod)
dose 2.13 (nummod)
had transplantation (nsubj)
affected activity (nsubjpass)
controls microl (dep)
study mechanisms (nmod)
inhibitor . (punct)
increase acute (amod)
encephalopathy seizures (nmod)
resolution to (case)
characterized hyperalgesia (nsubjpass)
disorder depression (conj)
corresponding ability (nmod)
excluded causes (nsubjpass)
resection alone (advmod)
histochemistry dinucleotide (compound)
year the (det)
rats pentobarbital-anesthetized (amod)
emerging finding (nmod)
deficiency thiamine (compound)
% whom (nmod)
c+e 2 (conj)
men 6 (nummod)
rats tumor-bearing (amod)
treatment tumors (nmod)
group blockers (nmod)
demonstrated weeks (dep)
underwent recordings (dobj)
preparations third-generation (amod)
dexmedetomidine 105 (nummod)
motor including (case)
reported follow-up (conj)
seen department (nmod)
antagonism to (case)
encephalopathy . (punct)
reported history (dobj)
treated those (nmod)
passed were (auxpass)
levels concentrations (conj)
cirrhosis treated (acl)
daunorubicin sarcoma (nmod)
= 2054 (dep)
disease 2.35 (dep)
hospitals urban (amod)
pregnancy and (cc)
latency forelimb (acl)
reduced moreover (advmod)
contribute not (neg)
influence bradykinin (nmod)
facilitated , (punct)
reversal the (det)
2e1 with (case)
discussion knowledge (nmod)
destructive neurons (nmod)
onset jaundice (nmod)
repair myelomeningocoele (nmod)
analog of (case)
instituted instead (advmod)
oropharynx and (cc)
occur seizure (xcomp)
hemorrhages edema (nmod)
occur effects (nsubj)
perfusion with (case)
proteinuria tubular (amod)
histology regulation (conj)
systems involvement (nmod)
condition , (punct)
gram per (case)
inhibiting in (mark)
manipulating activity (dobj)
% 32.3 (nummod)
received groups (nsubj)
rofecoxib naproxen (appos)
min(-1 l (compound)
expressed were (auxpass)
agent sample (nmod)
0.002 < (dep)
administration ip (amod)
initiated ) (punct)
ionic non (conj)
problematic patients (nmod)
in- out-patients (conj)
lowering with (case)
aes for (case)
2.6 +/- (cc)
mean beats/min (dep)
effects mdma (nmod)
include complication (dobj)
aventyl and (cc)
array profiler (compound)
admissions hospital (nmod)
describes patients (dobj)
infiltration tissues (nmod)
behaviors induced (amod)
nephrotoxicity for (case)
bia , (punct)
uncertainties these (det)
fibrillation by (case)
tasks mice (nmod)
application evaluate (acl)
report change (conj)
sm-5887 of (case)
assess detecting (advcl)
hormone peptide (conj)
20.0 - (punct)
treated dexrazoxane (nmod)
injury against (case)
patients seropositive (amod)
treated generally (advmod)
vulnerability toxicity (nmod)
beginning day (nmod)
flumazenil . (punct)
aor ( (punct)
additive . (punct)
apamin ng (appos)
potent is (cop)
dose m-chlorophenylpiperazine (conj)
exposed gestation (nmod)
posttransplant months (nmod:npmod)
deterioration further (amod)
dose-dependent mg/kg (dep)
similar while (mark)
hypotension mmhg (conj)
everolimus to (case)
hypertension treatment (nmod)
chloride suxamethonium (compound)
unchanged ko (nmod)
elucidate problem (dobj)
deficits the (det)
calcium and (cc)
features common (amod)
using substrate (nmod)
correlation release (nmod)
quintiles across (case)
prepared catheters (nmod)
offer form (nsubj)
difficulties ventilation (compound)
5 versus (cc)
0.95 - (punct)
boluses placebo (compound)
acetaminophen higher (ccomp)
finding with (case)
satisfied treatment (nmod)
co-administration % (amod)
experienced attack (dobj)
patient sah (nmod)
compared postmortem (xcomp)
scores scale (nmod)
icc ( (punct)
glutamate reproducible (dep)
coli with (case)
months age (nmod)
doses separated (acl)
analysis potassium (nmod)
compared measures (nsubjpass)
ruled stopped (conj)
progress spite (nmod)
compared products (nmod)
deposition immunoglobulin (nmod)
hoe ( (punct)
contribute efficiency (nmod)
abolish whether (mark)
checked were (auxpass)
resuscitation lipid (nmod)
patients constipation-predominant (amod)
greater limit (nmod)
recovered complications (nmod)
report recovery (compound)
therapy after (case)
followed min (nmod)
climate a (det)
patients olanzapine-treated (amod)
concentrations sulfate (nmod)
parallels respect (nmod)
patients stenosis (conj)
associated gain (nmod)
nd-nmbas of (case)
treated day-1 (nmod)
women n (dep)
injected isoproterenol (nsubjpass)
patients erythematosus (nmod)
fever rheumatic (amod)
method morphometric (amod)
parts rostral (amod)
accuracy fear (compound)
increased cystitis (nmod)
blockers by (case)
amns alone (advmod)
efficacious trials (nmod)
bpm 146 (nummod)
forms other (amod)
mechanism triggering (amod)
scores fasciculation (compound)
referred months (nmod)
component neurodevelopmental (amod)
hematoma intracranial (amod)
ci 0.85 (nummod)
inhibits agent (nsubj)
patients 4,499 (nummod)
index death (conj)
regimens other (amod)
waves characteristic (amod)
induced succinylcholine (nmod:npmod)
patients include (acl:relcl)
enhanced rate (dobj)
administration ketamine (nmod)
infection these (det)
focus to (mark)
evaluated are (auxpass)
mechanisms drugs (nmod)
24.3+/-6.8s ) (punct)
outcome secondary (amod)
attempted % (conj)
highest was (cop)
repeated determination (nsubjpass)
high > (dep)
ameliorated function (dobj)
ocs progestagen-only (amod)
acts because (mark)
effectiveness drug (nmod)
third two (nummod)
derivatives other (amod)
interval months (conj)
ms tandem (amod)
recordings with (case)
reactions positive (amod)
dose allowed (amod)
superior both (nsubj)
course failure (nmod)
inhibitor is (cop)
syndrome abs (appos)
fluorthyl- ptz-induced (conj)
1967 1977 (conj)
experienced leukopenia (dobj)
hypotension measured (acl)
period prolonged (amod)
localization . (punct)
related suppression (nsubj)
revealed angiography (nsubj)
electrocardiogram the (det)
receiving or (cc)
suggests exposure (dobj)
speaking ) (punct)
abrogated that (mark)
followed 15/group (meta)
increase deciliter (nmod)
l-1 to (mark)
204 of (advmod)
carbamazepine cbz (appos)
prevented fashion (nmod)
finding not (neg)
transporters other (amod)
attack a (det)
syndrome newborn (nmod)
exploration open (amod)
provides epithelium (nmod)
woman 47-year-old (amod)
improves index (dobj)
cardiomyopathy ) (punct)
seconds thirty-six (nummod)
population a (det)
mg/day 10 (nummod)
heterogeneous spectrum (nsubj)
treatment lifetime (compound)
nox ) (punct)
periods ng/kg/min (appos)
marrow for (case)
applied days (nmod)
habituated that (nsubjpass)
% failure (nmod)
assessed then (advmod)
comparison recordings (nmod)
circuitries the (det)
attenuated glibenclamide (nmod)
visits of (case)
l-noarg and (cc)
fa 500 (dep)
lack which (nsubj)
frequent is (cop)
concentration ala204asp/p (nmod)
mania human (amod)
blocker disrupted (acl)
10(-3 were (cop)
patients astrocytomas (nmod)
fluctuations dyskinesias (conj)
substratum epileptic (amod)
acid neutral (amod)
lead hearts (nmod)
examined neuropediatrician (nmod)
lead chow (conj)
manifesting pericarditis (nmod)
thickness microm (nmod)
prior amphetamine (nmod)
group classification (compound)
instillation ocular (amod)
receiving before (mark)
resulting proteinuria (nmod)
usual more (advmod)
demonstrate killed (ccomp)
inserted patient (nmod)
consisted given (advcl)
target effects (nmod)
treated chronically (advmod)
volume decrease (conj)
application cortical (amod)
demonstrated doxorubicin (dobj)
ifx ) (punct)
g/dl 13.2 (nummod)
appear does (aux)
angiotensinogen brain (compound)
survived patient (nsubj)
1.98 to (dep)
suffered strokes (nmod)
90/htn ( (punct)
findings images (nmod)
week(-1 ) (punct)
indicate acted (ccomp)
action ) (punct)
function respiratory (amod)
metolachlor , (punct)
thrombi or (cc)
immunoassay eia (appos)
value or (dep)
promotes finally (advmod)
reabsorption fractional (amod)
induce down-regulation (dobj)
immunocytoma a (det)
recovered stopping (advcl)
treatment sulphonylureas (nmod)
genes target (compound)
limit utility (dobj)
company a (det)
lessened significantly (advmod)
determine responses (dobj)
anesthesia all (appos)
mv p (dep)
information use (nmod)
hypotension acetylcholine (compound)
artery ) (punct)
differs that (nmod)
prophylaxis seizure (amod)
sulphate agent (appos)
activities mtdna-encoded (amod)
exert and (cc)
mmc ) (punct)
manipulated increased (conj)
reported toxicities (nsubjpass)
arrhythmia failure (conj)
produced afterdepolarization (dobj)
frequent overall (advmod)
signs complications (conj)
reported arrhythmias (nsubjpass)
day 833 (nummod)
women than (case)
detected 38 (nmod)
confirmed testing (nsubj)
receive dose (nmod)
injected micrograms (nsubjpass)
shelf same (amod)
effective , (punct)
analogues the (det)
malondialdehyde dismutase (conj)
found trials (dobj)
conjunctiva and (cc)
grade have (aux)
excipients of (case)
precede to (mark)
classifications according (case)
provoke does (aux)
suggested is (parataxis)
plays reduces (conj)
show findings (dobj)
abstracts biological (compound)
expression mmp-2 (nmod)
role interaction (nmod)
effect vasculitis (nsubj)
controlled attention (dobj)
elevation an (det)
galen of (case)
disabled and (cc)
lobe lateral (amod)
% 7.2 (nummod)
report . (punct)
complete seizures (nmod)
system excitatory (compound)
observed changes (conj)
used inhibit (xcomp)
produces often (advmod)
tilts subsequent (amod)
mg/day mg/day (conj)
rats pre-treated (amod)
ischaemia , (punct)
features hematologic (amod)
increase should (aux)
moderate-dose ) (punct)
skeptical practitioners (nsubj)
integrity functional (amod)
signs with (case)
k ( (punct)
incidence update (appos)
patients pancreatitis (nmod)
prerequisite studies (nmod)
model collagenase-induced (amod)
metabolism methamphetamine (nmod)
suitable might (aux)
associated women (nmod)
capacity discontinuation (nmod)
phenols , (punct)
microphthalmos including (case)
severity pain (nmod)
success preclinical (amod)
produce which (nmod)
mechanisms central (amod)
regardless mechanism (nmod)
said have (xcomp)
unfamiliar environment (nmod)
continued patient (nsubj)
adequate . (punct)
patients comprising (case)
antagonists sigma2 (compound)
inducing cells (nmod)
patient tuberculosis (nmod)
dystrophin and (cc)
activity nadh-dehydrogenase (nmod)
episodes mg (dep)
i/4e the (det)
clozapine , (punct)
0.96 = (conj)
reduced that (nsubjpass)
neurogenesis and (cc)
stimulation nk1 (nmod)
first the (det)
understand better (advmod)
effect from (case)
antagonists dihydropyridine (compound)
complained therapy (nmod)
mrna in (case)
complexes the (det)
arteries pulmonary (amod)
produced information (dobj)
cases injections (nmod)
livers rat (compound)
days maximum (nmod)
drugs only (amod)
synthase constitutive (amod)
concentrated 2.7 (nummod)
led effect (nsubj)
visit one (nummod)
in particular (amod)
substitution lithium (nmod)
abnormalities hormonal (amod)
thromboembolism paradoxical (amod)
rats impaired (conj)
responsive frequencies (nmod)
performed centrally (advmod)
damage axonal (amod)
regulation of (case)
severity strain (nmod)
maximal h (nmod)
toxicity uncommon (amod)
studies ) (punct)
occurred events (nsubj)
mortality 1-yr (amod)
transcriptase hbv (compound)
ip 1.0 (nummod)
did we (nsubj)
reported since (mark)
affection sle-induced (amod)
express which (nsubj)
% 0.06 (nummod)
barrier disruption (compound)
serum heart (conj)
analogue vitamin (compound)
attain control (dobj)
predicting in (mark)
identified anger (dobj)
therapy ect (appos)
animals infarction (nmod)
necessary if (mark)
score to (mark)
care health (compound)
bromide oxitropium (compound)
supersensitivity potentials (conj)
period washout (compound)
occurred response (nmod)
bumetanide , (punct)
layer sites (nmod)
block estimate (conj)
evaluable clinically (advmod)
thought safe (xcomp)
randomized crossed (conj)
factors used (acl)
abnormality transketolase (compound)
lomustine ccnu (appos)
replication clones (nmod)
carcinoma to (mark)
obviate objective (dobj)
bcnu 1,3-bis-(2-chloroethyl)-1-nitrosourea (appos)
multiforme infections (nsubj)
differs drugs (nmod)
number considerable (amod)
woman 70-year-old (amod)
cases ( (punct)
posttreatment , (punct)
involved study (nsubj)
[verapamil]o arrested (acl:relcl)
described antagonist (nmod)
dosing the (det)
increased % (conj)
ergotamine/caffeine with (case)
example damage (nmod)
naproxen and (cc)
infiltration the (det)
dyskinesia cases (nmod)
dtis ( (punct)
28 less (advmod)
proximal predominantly (advmod)
available be (cop)
sensitivity and (cc)
avp of (case)
psychosis current (amod)
dimension baseline (nmod)
25.35 respectively (advmod)
known drugs (nsubjpass)
cause which (nsubj)
reactions cephalosporins (nmod)
department ed (appos)
offer changes (nsubj)
using application (nmod)
morphine s.c. (dep)
model nephrosis (nmod)
frequent increased (conj)
reaction this (det)
study dependency (nmod)
neuralgia in (case)
managed using (xcomp)
2004 ) (punct)
wk for (case)
medications. both (det)
answer questions (dobj)
risk group (nmod)
deficiency mrp2 (compound)
expression facial (amod)
pericellular cells (dep)
change adverse (amod)
bladder overactive (amod)
help recognize (ccomp)
subtypes for (case)
letrozole mg.kg(-1).d(-1 (appos)
1986 1998 (nmod)
features sparing (compound)
ketanserin , (punct)
events vnr (nmod)
infused solution (nsubjpass)
society status (dep)
history medicine (nmod)
episode fails (acl:relcl)
those conclusions (nmod)
reduction closed (amod)
renography at (case)
who the (det)
metabolites beta-oxidation (amod)
movements patients (nmod)
conclusions cautious (appos)
densitometry ( (punct)
pharmacological despite (case)
department histology (nmod)
randomized controlled (dep)
spasms and (cc)
determine resulted (ccomp)
risperidone olanzapine (compound)
pretreatment prazosin (compound)
p.o. of (case)
very completely (advmod)
size-dependent and (cc)
dx ) (punct)
suggested data (nsubj)
igf-il-3 or (cc)
developed pressure (dobj)
density shape (conj)
treated phenobarbital (nmod)
incontinence of (case)
acquired questionnaire (nmod)
have antidepressants (dobj)
years 81.6 (nummod)
reported events (nsubjpass)
associated recipients (nmod)
thickness average (amod)
control day (nmod)
pirenzepine m(1)-selective (appos)
prominent somnolence (nsubj)
presented arrhythmia (nmod)
acetate [ (punct)
infections these (det)
measured microg/ml (parataxis)
shared neuroleptics (nmod)
0.08 ( (punct)
aor adjusted (dep)
nephrotoxicity rats (nmod)
enalapril or (cc)
sensitivity stress (nmod)
= 6.944 (dep)
scores these (det)
withheld run-in (nmod)
nerves progress (conj)
sera donor (compound)
side-effects main (amod)
sensitization caused (acl)
defects with (case)
hh the (det)
add not (neg)
gln223 and (cc)
value baseline (compound)
diclofenac 1.69 (dobj)
doses multiple (amod)
cured organisms (nsubjpass)
antagonists n-methyl-d-aspartate (compound)
microglia striatal (amod)
effect children (nmod)
stems hypothesis (nsubj)
clues , (punct)
deserve thus (advmod)
agent and (cc)
transport humans (nmod)
less administration (nmod)
forces between (case)
production forms (nmod)
polymyositis myasthenia (conj)
targeting dct2 (nmod)
effects anticholinergic (amod)
toxicology rats (nmod)
reveal size (dobj)
syndrome failure (conj)
associated 2.7 (advmod)
led complex (nmod)
pharmacokinetics . (punct)
co-administration aspirin (compound)
had index (dep)
factor-alpha tnf-a (appos)
causes anemia (dobj)
lesions medullary (amod)
caused cause (conj)
groups pdn (compound)
satisfaction sexual (amod)
phenomenon dyspnoea (conj)
treatment lasting (acl)
published vasospasm (nmod)
indices the (det)
consistent increase (nmod)
capsules bowman (nmod:poss)
follow that (nsubj)
evaluated levels (nsubjpass)
frequency rebleeding (nmod)
complex chain (nmod)
haloperidol by (case)
occupancy half-maximum (amod)
cholesterol triglycerides (conj)
gastrocnemius ( (punct)
paroxetine and (cc)
risks possible (amod)
csseps both (det)
paraffin-sections conventional (amod)
increased study (nmod)
processes separate (amod)
suspect due (ccomp)
minimised occurrence (nsubjpass)
adl england (compound)
approach an (det)
similar middle-aged (nmod)
examined producing (advcl)
reports bradyarrhythmia (nmod)
studies blocking (amod)
edema is (cop)
infusions group (nmod)
prevent allograft (dobj)
days gestation (nmod)
mean greater (amod)
micrograms/kg of (case)
implicated nephropathy (advmod)
glucagon of (case)
monitored proteinuria (nmod)
1.60 0.04 (nummod)
time thrombin (compound)
show efficacy (dobj)
randomized clinical (dep)
produced if (mark)
psychosis with (case)
assessed intensity (dobj)
desmethylimipramine mg (appos)
primary unknown (amod)
nitrendipine nephrosclerosis (nmod)
unrecognized often (advmod)
preceded this (nsubjpass)
elevations caffeine (nmod)
inhibition fibrinolysis (nmod)
found background/aims (dep)
sod that (mark)
revealed moderate (xcomp)
receptor d3 (compound)
mechanism postulated (dep)
increase peak (nmod)
medium bathing (compound)
concentration in (amod)
interventions of (case)
arrest desaturation (nmod)
g ml/min/100 (amod)
antagonists beta-adrenoceptor (amod)
conjugates ed (appos)
role central (amod)
2006 ( (punct)
pretreatment mice (nmod)
neonates high-risk (amod)
assessments preclinical (amod)
system delivery (compound)
peroxide lpo (appos)
infusion bolus (conj)
germfree gf (appos)
tiopronin due (case)
events life-threatening (amod)
stress foot-shock (amod)
prolonged resulted (conj)
cataracts keratopathy (conj)
treatment effects (nmod)
isoproterenol tachycardia (nmod)
substantial was (cop)
discontinued occurred (nsubjpass)
transthoracic post (compound)
adherence between (case)
unresponsive lowered (parataxis)
fentanyl analgesic (appos)
noted effects (nsubjpass)
patients lithium (nmod)
reintroduced was (auxpass)
symptoms abilities (conj)
walls , (punct)
levels m-2 (nmod)
lesions ) (punct)
% change (compound)
mean standard (conj)
olanzapine % (conj)
necrosis -0.97 (dep)
4:30 15 (conj)
analysed was (auxpass)
cent infusion (nmod)
risks equivalent (amod)
concentration free (amod)
findings treated (dep)
cause to (mark)
organisms 2.2 (compound)
discussed subsequently (advmod)
irritation by (case)
determined kidneys (nmod)
ng/kg/min , (punct)
damage residual (amod)
proteases cysteine (compound)
department used (acl:relcl)
rate administered (acl)
incidence dogs (nmod)
increasing are (aux)
antioxidant as (case)
intake long-term (amod)
containing concentrations (dobj)
attacks transient (amod)
infiltrate an (det)
slowed reaction (dobj)
woman by (case)
provide assessment (dobj)
reduced systolic (dobj)
time the (det)
occur resulting (advcl)
% 3 (nummod)
choosing antipsychotic (dobj)
show valsartan (dobj)
dfu piroxicam (conj)
recurrence loss (conj)
29 16 (compound)
probable that (mark)
hazard a (det)
assessed patients (nsubjpass)
aggravated were (auxpass)
most , (punct)
syndrome acidosis (conj)
negative urinalysis (nsubj)
develop one (nmod)
members group (nmod)
information mechanistic (amod)
recognized moderate (nsubjpass)
arrhythmogenicity rats (nmod)
microinjection of (case)
ect during (case)
had fifty-nine (nsubj)
delineated . (punct)
remission bmt (nmod)
surgery such (case)
seizures increasing (amod)
safety indications (conj)
received carboplatin (dobj)
improvement end (nmod)
mg administration (nmod)
remarkable history (nsubj)
include search (nsubj)
models inflammatory (amod)
successful treatment (nsubj)
alterations above-described (amod)
literature toxicology (compound)
showed however (advmod)
importance process (nmod)
psychostimulant cocaine (nsubj)
alpha-t ( (punct)
study italian (amod)
hepatitis alcoholic (amod)
isolated hand (nmod)
suffered lasting (advcl)
production neoantigens (nmod)
52 to (dep)
derivative n-acylimidazole (compound)
= 198 (dobj)
seizure screening (nsubj)
histochemistry adenine (compound)
mellitus ii (nummod)
remodeling tachycardia-induced (amod)
revert reliably (advmod)
dose neurotoxic (amod)
models arrhythmia (compound)
upregulation pgp (nmod)
hours treatment (nmod)
temazepam and (cc)
ulcers patients (nmod)
limit above (case)
sensorium , (punct)
hypnotic choice (nmod)
widened . (punct)
associated are (auxpass)
measure oscillation (nmod)
air forced (amod)
follow-up mean (compound)
decided end (xcomp)
had caffeine (nsubj)
aloud 5.2+/-1.1 (dep)
mitigated dogs (nmod)
seizures % (compound)
overdose carbamazepine (compound)
determined hypotension (nsubjpass)
completion the (det)
caused ; (punct)
carcinoma ovarian (amod)
response cardiac (amod)
received november (nmod)
diffusion botox (nmod)
use adriamycin (nmod)
embryos late-gestation (amod)
time that (det)
1/2 2 (compound)
printout cases (nmod)
limit to (mark)
increased incidence (nsubj)
renal liver (conj)
5.0 1.3 (conj)
rise iop (compound)
lidocaine given (acl)
factor preexisting (amod)
gaba sub-chronic (amod)
increases scr (nsubj)
administration tet (nmod)
l. r. (conj)
conclude choice (ccomp)
found studies (nmod)
higher plasma (nmod)
saline dogs (nmod)
analyzed stains (conj)
although common (amod)
concentrations electrolyte (compound)
exert can (aux)
activity change (conj)
pyridoxine of (case)
represent weight (nmod)
readmission at (case)
identified has (aux)
antagonist that (mark)
superoxide peroxide (conj)
double-blind randomised (conj)
related effect (nmod)
amphetamine for (case)
work described (acl)
age ) (punct)
10.4 5.8 (conj)
metabolite . (punct)
livers of (case)
greater 0.05 (nmod)
enflurane to (case)
state acute (amod)
ifosfamide and (cc)
perfusion during (case)
erythromycin agents (conj)
seen therapy (nmod)
malondialdehyde n-acetyl-beta-d-glucosaminidase (conj)
cases hospital (nmod)
effects hysterosalpingography (nmod)
ich 1460 (nummod)
limited success (nsubjpass)
administration methylprednisolone (nmod)
259 61 (compound)
compared antagonists (nsubjpass)
drowsiness in (case)
findings biopsy (nmod)
deferoxamine neurotoxicity (nmod)
diagnostic or (cc)
developed tetany (dobj)
reduced minute (nmod)
test evaluating (advcl)
palsies anesthetics (nmod)
effects inhibitors (nmod)
intermediates , (punct)
used immunohistochemistry (nsubjpass)
older were (cop)
sbp the (det)
dehydration hyperosmolar (amod)
prednisolone mg/kg (compound)
substances these (det)
changed catheters (nsubjpass)
levels cbz (compound)
sulphate enantiomer (conj)
% as (case)
emphasize danger (dobj)
loss integrity (nmod)
has impact (dobj)
chc of (case)
elevated days (nmod)
using therapy (dobj)
citrate sodium (compound)
doses cholinomimetic (nmod)
cases these (nsubj)
evaluated to (mark)
blood in (case)
crocin mg/kg (appos)
reliable parameters (nsubj)
observed end (nmod)
grade fibrosis (nmod)
wall right (amod)
insight mechanism (nmod)
decrease again (advmod)
cohorts attack (conj)
cause vasculitis (appos)
inhibitor as (case)
blood autopsy (amod)
plugs tissue (compound)
mechanisms proposed (amod)
read word (nsubjpass)
lend not (neg)
detect potential (nmod)
started should (aux)
morphological , (punct)
therapy immunomodulatory (amod)
acid (gaba)-mediated (dep)
controlling covariates (nmod)
gentamicin ) (punct)
cholesterol predict (compound)
mg./kg morphine (compound)
31 % (appos)
purpura palpable (amod)
benefit antiparkinsonian (compound)
quantified never (neg)
modulating increase (conj)
episodes many (amod)
relationship clioquinol (nmod)
detected ganglia (nmod)
microangiopathy population (nmod)
toxicity increase (nmod)
intestine small (amod)
slowing increased (amod)
timolol both (cc:preconj)
decrease exposure (nmod)
comparing 62 (dobj)
reduce requirements (dobj)
speculated be (auxpass)
complete complete (conj)
provided model (dobj)
grade ( (punct)
spectrum a (det)
caffeine by (case)
mean of (case)
dobutamine during (case)
management alcohol (compound)
examined resistance (nmod)
limited toxicity (nmod)
rhythm accelerated (amod)
hybrid f344 (nmod)
effect drastic (amod)
treatment years (nmod:poss)
acid uric (amod)
available that (mark)
ratios rrs (appos)
agents only (advmod)
involved . (punct)
referred to (nmod)
managed easily (advmod)
histories use (compound)
included sitting (advcl)
thyrotoxicosis for (case)
rates nephrotoxicity (nmod)
deduced dealing (xcomp)
mechanism mediating (acl)
memory learning (conj)
seen . (punct)
more 66 (conj)
period 24-h (amod)
effect co-carcinogenic (amod)
useful clinically (advmod)
more gradually (advmod)
trial non-randomized (amod)
rates prenatal (amod)
value diagnostic (amod)
polymerase antigen (conj)
got and (cc)
interval pr (compound)
appeared hours (nmod:tmod)
given injection (nmod)
treated mg (nmod:tmod)
effect contraindicate (acl:relcl)
counts ( (punct)
affected rate (nsubjpass)
toxin of (case)
declined were (auxpass)
scales other (amod)
volunteers range (dep)
associated agents (nsubjpass)
increases mediated (advcl)
tm ) (punct)
deduced has (aux)
indicate found (ccomp)
have power (dobj)
comparable not (neg)
nm 76 (nummod)
women acid (nmod)
follow-up cancer (nmod)
common adult (nmod)
needle and (cc)
levels over (case)
mechanism type (compound)
selective relatively (advmod)
established up (compound:prt)
data frequency (nmod)
used heroin (dobj)
gaba(a ) (punct)
woman syndrome (nmod)
phonological , (punct)
induction seizure (amod)
response increase (nmod)
efficacy safety (conj)
syndrome sleep (compound)
modulation of (case)
patients transplanted (amod)
received taken (conj)
isg ( (punct)
effects nervous (amod)
suppressed decrease (dobj)
seeing tip (dobj)
doses mg./kg (nmod)
onset during (case)
changes hematologic (amod)
trials rcts (appos)
adenosine a(1)-adenosine (compound)
studies urine (compound)
core not (neg)
intoxication high-dose (amod)
phase washout (compound)
suspension as (case)
disease corneal (compound)
ages through (case)
pod ( (punct)
treated dx (nmod)
mg/m(2 2,220 (nummod)
evolved has (aux)
risk problem (appos)
trial psychosis (nmod)
performance myocardial (amod)
shown response (dobj)
change medication (nmod)
nmdar of (case)
treatment erythropoietin (compound)
discontinuing alendronate (dobj)
antagonists type-2 (amod)
od ] (punct)
ephedrine with (case)
had progression (dobj)
males rats (conj)
times nsaid (conj)
patient administration (nmod)
seizure patterns (dobj)
lexical during (case)
behaviors these (det)
tocopherols by (case)
65 x (cc)
using ms (dobj)
undergo aap (nsubj)
caused secretion (nmod)
0.06 were (cop)
safety about (case)
littermates fvb/n (compound)
abusing who (nsubj)
solution on (case)
activity sympathetic (amod)
hypoparathyroidism with (case)
ccl4 of (case)
interview mini (compound)
albuminuria concentration (conj)
ng ) (punct)
appeared layers (nmod)
numbers mucosa (nmod)
determined pattern (dobj)
loss weight (compound)
project nincds (nmod)
comparable rate (nmod)
acid : (punct)
spite and (cc)
association metolachlor (nmod)
modify not (neg)
or alone (advmod)
excitability contractility (conj)
bort-dex before (case)
induced confirmed (parataxis)
associated normalization (nmod)
produced haloperidol (nsubj)
show inhibition (dobj)
receive cisplatin (dobj)
time failure (nmod)
anemia immune (amod)
sn the (det)
substitute heparin (nsubj)
group lamivudin (compound)
diethylnitrosamine with (case)
increases prenatally (advmod)
detection deposits (nmod)
particular in (case)
metabolized are (auxpass)
medline in (case)
associated usage (nsubjpass)
phenylephrine treat (acl)
sodium serum (compound)
possibility reduced (ccomp)
field , (punct)
diarrhoea was (cop)
layer treated (acl)
excretion metabolites (nmod)
lignocaine : (punct)
is levels (nmod)
compound to (case)
known centuries (nmod)
surgeon orthopaedic (amod)
taken patients (nmod)
dose lamivudine (nmod)
2.6 and (cc)
developed measure (xcomp)
disease gall (compound)
decision a (det)
given concomitantly (advmod)
occurred differences (nsubj)
necessary aware (ccomp)
patients major (nmod)
associated often (advmod)
management long-term (amod)
time required (acl)
caused could (aux)
bcnu mg/kg (dep)
effects solutions (nmod)
increases consumption (nmod)
technique is (cop)
unrecognized occur (advcl)
reported being (auxpass)
natural and (cc)
related pathogenesis (nmod)
virus resistant (amod)
studies subacute (compound)
0.66 - (punct)
catecholamine renal (amod)
5-fu during (case)
cultures rat (compound)
effect scopolamine (nmod)
ica and (cc)
models ocd (appos)
10 less (advmod)
acid meclofenamic (amod)
determined area (nsubjpass)
hematomas > (dep)
randomized gellan (dobj)
fraction ventricular (compound)
continuing regained (advcl)
time episode (nmod)
therapy 5-fu (compound)
treatments prior (amod)
benign primary (amod)
used tests (nmod)
drugs anti-rheumatic (amod)
findings . (punct)
problems these (det)
desipramine inhibitor (appos)
2190 200 (compound)
practice clinical (compound)
revealed aureus (dobj)
ngal ) (punct)
induction % (compound)
regimen thalidomide (conj)
% cells/microl (punct)
esthetics poor (amod)
same inflamed (advcl)
arrhythmia rhythm (nmod)
cause rare (amod)
unit the (det)
isolation thunbergiana (nmod)
syncope and (cc)
aimed evaluate (xcomp)
analyzed 1999 (nmod)
sensitivity depression (nmod)
resumed when (advmod)
males females (appos)
inactivation no (compound)
associated deficiency (conj)
fixed and (cc)
compared torr (nmod)
samples these (det)
ml serum (nmod)
cause depolarisation (dobj)
one rarest (nmod)
microg/ml below (case)
members family (compound)
stable fluctuating (conj)
hilus of (case)
study multiple (amod)
ofloxacin cases (nmod)
associated escape (nmod)
thickness by (case)
become improvements (nsubj)
inconclusive evidence (nsubj)
neuropathy when (advmod)
17 10 (compound)
episodes encephalopathy (nmod)
localised was (auxpass)
64 by (case)
people million (nummod)
undergoing intervention (dobj)
v.o . (punct)
cost and (cc)
group g/cm(2 (dep)
hypertrophy apparatus (nmod)
tissue gene (dep)
elucidate and (cc)
extract of (case)
hematological events (nsubj)
experiment an (det)
catheter an (det)
developed albeit (advmod)
injection in (case)
hypertension sph (appos)
reviewed cases (nsubjpass)
resolution days (nmod)
able prevent (xcomp)
controls untreated (amod)
nrvms ( (punct)
determine events (dobj)
behaviors disruptive (amod)
dosing after (case)
polymorphism promoter (compound)
hallucinations patient (nmod)
occurred case (conj)
females dosage (compound)
caused compounds (nsubj)
stroke , (punct)
cyclophosphamide 96-h (amod)
cultures beating (amod)
propofol mg.kg-1 (compound)
gfap nitrite (conj)
value verapamil (nmod)
% 55.3 (nummod)
rhythm sinus (compound)
caused desferrioxamine (nmod)
146 7 (conj)
pretreatment isoproterenol (nmod)
prove incidence (nmod)
ug/ml ug/ml (conj)
capture to (case)
seen 1967 (nmod)
antifolate is (cop)
creatinine p (dep)
suggest likely (ccomp)
administering vincristine (dobj)
effect keratectomy (nmod)
week even (advmod)
diltiazem intravenous (amod)
concluded prepartum (ccomp)
phenylephrine such (case)
records children (nmod)
read list (nmod)
cavity three (conj)
methylprednisolone m (appos)
induced intraperitoneal (nmod)
pressure diminished (acl)
basis on (case)
infections for (case)
units plasma (nmod)
product with (case)
mice 10 (nummod)
had potassium (dobj)
dysfunction treatment (nmod)
antagonists receptors (compound)
stress (vcm)-induced (amod)
ac for (case)
resolution not (neg)
bradyarrhythmias life-threatening (amod)
neutrophils alf (compound)
amounts cocaine (nmod)
clonidine xylometazoline (conj)
population with (case)
depression = (dep)
atrophy t (nmod)
trazodone with (case)
used galactosamine (nsubjpass)
design with (case)
total years (dep)
months 28 (nummod)
begins stimulates (advcl)
preferred concentration (nsubjpass)
program infection (nmod)
stage chronic (amod)
patients ax (compound)
incidence arrhythmias (nmod)
anaesthesia local (amod)
enhanced plasticity (dobj)
compromising anemia (nsubj)
deduced been (auxpass)
prevalences effects (conj)
change maximum (compound)
using histochemistry (nsubj)
episodes 32 (nummod)
due if (mark)
cirrhosis decompensated (amod)
min-1 were (cop)
antagonizes mice (nmod)
employed are (auxpass)
criteria main (amod)
received adriamycin (dobj)
incidence higher (amod)
potassium k (appos)
developed model (dobj)
pupillometer computerized (amod)
patients untreated (amod)
epo and (cc)
erpf ( (punct)
tended related (xcomp)
data : (punct)
brains of (case)
attractive use (xcomp)
most found (acl:relcl)
exposed previously (advmod)
ma with (case)
alt ast (conj)
hopes associated (ccomp)
shock , (punct)
observed categories (nmod)
phenobarbitone and (cc)
man symptoms (nmod)
axonal mainly (advmod)
scintigraphy echocardiography (conj)
defects the (det)
eskisehir , (punct)
ppa ( (punct)
limitation study (nmod)
suggests conclusion (nmod)
grains reduced (amod)
converted he (nsubj)
group nephritis (compound)
animal from (case)
agent an (det)
effects dopaminomimetics (nmod)
involvement internal (amod)
received which (nsubj)
observed % (nmod)
158.11 ) (punct)
electroencephalogram and (cc)
1,1-dichloro-2,2,2-trifluoroethane hcfc (appos)
outcome associated (acl)
drawback studies (nmod)
against both (dep)
ml than (case)
support limitation (advcl)
patients complained (acl)
depression prolonged (amod)
receiving bort-dex (dobj)
associated spasms (nmod)
total doses (nmod)
induction dyskinesia (nmod)
episodes associated (acl)
abundance and (cc)
incidence symptoms (nmod)
data only (advmod)
n-methyl-n-nitrosourea mg/kg (appos)
reduplication capillary (amod)
stripe inner (amod)
effects cbz (nmod)
mania review (appos)
proposed conduction (nsubjpass)
demonstrating role (dobj)
haematological hepatic (conj)
observed provision (nmod)
fact notable (amod)
considerations practical (amod)
biopsies the (det)
damage cord (compound)
19 4 (compound)
likely interpretation (nsubj)
function dopamine (compound)
mechanisms exerts (acl:relcl)
prevented used (conj)
that produced (acl)
alterations 18.88 (dep)
cessation its (nmod:poss)
conducted cohort (nmod)
toxicity neurologic (amod)
died and (cc)
iop hg (dep)
fibrillation irreversible (amod)
made efforts (nsubjpass)
neurons , (punct)
reduced presence (nsubj)
antagonism functional (amod)
neonates suffered (acl)
long-term ' (punct)
teratogenic rabbits (nmod)
3'-azido-3'dideoxythymidine azt (appos)
side system (compound)
hyperemia the (det)
confirm alteration (dobj)
aminotransferase mg/dl (conj)
appetite fenfluramine (compound)
decrease groups (nmod)
deficiency oxide (compound)
crystals precipitated (amod)
year after (case)
involvement without (case)
inferior the (det)
factor predominant (amod)
aborted epistaxis (nmod)
find factors (dobj)
channel calcium (compound)
produced delay (dobj)
motor and (cc)
estimate risk (dobj)
cases uveitis (amod)
infarction (iso)-induced (amod)
prescribed days (nsubjpass)
g/dl with (case)
anticancer myeloablative (conj)
appeared cellulose (conj)
field operative (amod)
received patient (nsubj)
dexmedetomidine d-med (appos)
capsaicin : (punct)
fasting , (punct)
alternating and (cc)
amlodipine drug (compound)
mice parp-1+/+ (compound)
recipient renal (amod)
cimetidine to (case)
begin to (mark)
deficits . (punct)
2 not (neg)
ingredient is (cop)
enhanced estradiol (nsubj)
stability gsh (compound)
boy patient (nsubj)
group largest (amod)
olanzapine placebo (conj)
those signs (nsubj)
recall sedation (nmod)
administered pump (nmod)
indomethacin oral (amod)
found infiltrations (nsubjpass)
c ) (punct)
bradycardia pressure (conj)
benefit to (mark)
enhanced increased (parataxis)
initiated trial (nsubjpass)
medication digoxin (nsubj)
intensity layer (nmod)
spect ) (punct)
rpn to (case)
cbd over (case)
anaemia 14.2 (conj)
studied conclusion (nmod)
women diabetes (nmod)
elicits . (punct)
entry for (case)
fall this (det)
offers activation (nsubj)
(vegf)165 factor (compound)
pretreatment 500 (dep)
deficits reduced (acl)
contribute recognition (nsubj)
reaction short-term (amod)
had pressure (nmod)
higher = (advcl)
showed electromyography (nsubj)
shown vitro (advmod)
experiments using (acl)
experimental evidence (conj)
effect troubling (amod)
taking warfarin (dobj)
reported subjects (nmod)
compared hilus (nmod)
elicited excitation (dobj)
discontinued observed (advcl)
range able (acl:relcl)
elicited subject (nmod)
effects memory (compound)
exhibited rise (conj)
other dfo (nmod)
interactions relevant (amod)
suggest models (nmod)
had decrease (dobj)
cancers cancers (appos)
50 and (cc)
= 281 (dep)
had pressures (dobj)
pathways procoagulant (amod)
have compounds (nsubj)
use therapy (compound)
balance in (case)
6-ohda by (case)
treatment sulphonate (amod)
a possessing (acl)
120 to (quantmod)
strain this (det)
occurrence bruising (amod)
trigger that (mark)
levodopa the (det)
women 25 (nummod)
ro4368554 ( (punct)
carcinoma anemia (nmod)
combination sulpiride (nmod)
seven patients (nmod)
men 14 (nummod)
demonstrating concentrations (nmod)
catecholamines activity (conj)
attack genuine (amod)
buffers it (nsubj)
syndrome full (amod)
cholinergics ) (punct)
intoxication associated (acl)
problem encountered (acl)
dominating analgesic (dobj)
comparison dcf (nmod)
therapy difficulty (conj)
total 155 (nmod)
showed neurons (advcl)
sources : (punct)
form long (amod)
injection beta-carboline-3-carboxylate (nmod)
raised slightly (advmod)
establishes ) (punct)
defect due (case)
reduced expression (nsubjpass)
abnormalities groups (nmod)
protected impairment (nmod)
course chemotherapy (compound)
cystitis erosive (amod)
common is (cop)
was phenomenon (attr)
profile abnormal (amod)
aminotransferase 1579 (nummod)
summary took (acl)
confusion aggression (conj)
inhibitors channel (compound)
clinical theoretical (conj)
explore function (dobj)
period critical (amod)
therapy includes (acl:relcl)
disorders from (case)
3.49 odds (nsubj)
p reactions (dep)
preservation . (punct)
originating swallowing (advcl)
induced bepridil (nsubj)
inhibitor i (compound)
45.45 years (conj)
function cause (acl:relcl)
torsades recurrent (amod)
blockade underwent (amod)
volume mean (conj)
site intravenous (amod)
goes use (nmod)
treatment anti-allergic (amod)
aids and (cc)
24 21 (compound)
fusion dissolution (conj)
failure by (case)
plays nephrotoxicity (nmod)
prevent group (nmod)
antibody antineutrophil (compound)
characterization rat (nmod)
associated thus (advmod)
changes size (nmod)
associated fibrillation (nsubjpass)
years > (compound)
colonies erythroid (amod)
treatment olanzapine (nmod)
mglur5 ( (punct)
improves hippocampus (compound)
cause inhibitors (nsubj)
reduced relaxations (nsubjpass)
incorporation cells (nmod)
improved decreased (conj)
remodelling structure (nmod)
became apparent (acomp)
trial evtac (compound)
albuminuria massive (amod)
glyt1 ( (punct)
e1 during (case)
decreased , (punct)
factor pro-inflammatory (amod)
patients hospitalized (acl)
release osmolality (nmod)
mg/kg cd50 (nsubj)
aniracetam of (case)
alf . (punct)
tests 6 (nummod)
has initiate (xcomp)
rct meta-analysis (conj)
1.5 and/or (cc)
age young (amod)
agent interferes (acl:relcl)
0 ( (punct)
developed remission (nmod)
imagery this (det)
induced amiodarone (nsubj)
hemorrhagic surprisingly (advmod)
ser311cys and (cc)
short- of (case)
had systolic (dobj)
had tube (nsubj)
invited methods (dep)
decreases which (nsubj)
cholinomimetic the (det)
part neurophysiology (nmod)
taking carbonate (dobj)
dose phenylpropanolamine (nmod)
feasible always (advmod)
transfusion therapy (conj)
appears clonidine (nsubj)
dronedarone both (cc:preconj)
explanation any (det)
change was (cop)
blocking responses (dobj)
effect raloxifene (nmod)
relation concentrations (nmod)
pathogen common (amod)
studies sensory (amod)
produced inhibition (dobj)
pregs enantiomer (conj)
concentration effective (amod)
concentrations phenobarbitone (nmod)
acid-induced mefenamic (amod)
3tc nvp (conj)
one in (case)
exposure lozenge (nmod)
demonstrated presence (dobj)
damage hydroxytyrosol (amod)
hexamethonium carbachol (conj)
nausea effects (nsubj)
exhibited patients (nsubj)
helpful would (aux)
min 238 (nummod)
1.6 - (punct)
pattern of (case)
alternate forms (dobj)
protected convulsions (nmod)
ascribed may (aux)
regulation pharmacologic (amod)
populations clinical (amod)
time time (conj)
another into (case)
evoke , (punct)
contribution possible (amod)
strategy failure (nmod)
confirmed recovery (nsubjpass)
patients any (nmod)
period throughout (case)
cause morbidity (dobj)
anesthetized ketamine (nmod)
t120 ) (punct)
target with (case)
influence development (dobj)
used produce (xcomp)
sequelae neuropathological (amod)
change st (compound)
remained doses (nsubj)
chemotherapy according (case)
modulate transmission (dobj)
intake therapeutic (amod)
atorva ) (punct)
had ve (nsubj)
present based (case)
aim affected (dep)
begun before (mark)
prevent months (nmod)
transplantation before (case)
deduced reports (nmod)
impairment in (case)
monitored exposure (nmod)
histories findings (nmod)
antigen bfgf (compound)
followed days (nmod)
proarrhythmic use (nmod)
p-aminophenol nephrotoxicant (appos)
this like (case)
ischemia 5 (conj)
pentobarbital rats (nmod)
curcumin dietary (amod)
suppresses hyperparathyroidism (dobj)
treatment cyclophosphamide (nmod)
university health (compound)
ato ) (punct)
possibility using (acl)
events reported (acl)
depend . (punct)
synthase nos (appos)
underwent period (nmod)
developed starting (advcl)
obstetric gynecologic (conj)
890 by (case)
activity ca(2 (conj)
identifying persons (dobj)
gain gfr (conj)
screenings treatment (conj)
ml/ng 11.7 (nummod)
ncse ) (punct)
access h (compound)
anxiogenic- effects (dep)
liable manifest (xcomp)
objective was (appos)
application sealants (nmod)
attempt suicidal (amod)
detection malformations (nmod)
ratios 2.6 (nmod)
inhibitors comt (compound)
three in (case)
investigation agents (nmod)
induced report (dep)
distinguish patterns (nmod)
cause losartan (nsubj)
depletion behavior (nmod)
aim centre (nmod)
disulfiram of (case)
results decreases (dep)
repeated procedure (nsubjpass)
% 25.3 (nummod)
pathologies different (amod)
exerts range (dobj)
diuretic cause (acl:relcl)
seven % (dep)
% response (nmod)
toxicities normal (amod)
revert off-periods (dobj)
volunteers age-matched (amod)
suggest effective (ccomp)
tolerance glucose (compound)
study time (nmod)
typical were (cop)
administered triphosphate (nsubjpass)
arabic nephrotoxicity (nmod)
rats degeneration (conj)
distorted , (punct)
confirmed findings (nmod)
value ) (punct)
startle furthermore (advmod)
blockade obtained (acl)
tamoxifen mg.kg(-1).d(-1 (appos)
n=5 ( (punct)
triggers death (dobj)
pain associated (amod)
34.3 +/- (cc)
good is (cop)
ctnt rats (nmod)
seven to (quantmod)
consists , (punct)
beta-ar of (case)
intramuscularly and (cc)
contribute mechanisms (nmod)
rate pressure (compound)
effects sexual (amod)
effects chick (nmod)
did patients (nsubj)
fa by (case)
brief as (case)
reactions late (amod)
increment simvastatin (amod)
dosings rats (nmod)
responses physiological (amod)
x plasminogen (conj)
gd ( (punct)
phagocytosis of (case)
monotherapies , (punct)
urine the (det)
mbp and (cc)
forms liver (nmod)
ci 1.25 (nummod)
ingestion woman (nmod)
occurs damage (nsubj)
analgesic non-narcotic (amod)
consideration an (det)
administration antagonist (dep)
pan or (cc)
intervention pci (appos)
development bradyarrhythmias (nmod)
p-veps ( (punct)
safety , (punct)
methotrexate intrathecal (dep)
ketoprofen mg (conj)
rats 9-month (amod)
temperament a (det)
high levels (nsubj)
mediated release (nmod)
groups research (compound)
ribavirin intravenous (amod)
receiving verapamil (dobj)
met who (nsubj)
interactions drug-drug (amod)
mid dermis (advmod)
scavenger a (det)
bromocriptine mg/kg (dep)
increased hr (dep)
diluents methotrexate (amod)
study four-week (amod)
watson 1986 (nummod)
introduction suprofen (nmod)
intravenous only (advmod)
system histaminergic (amod)
signaling noradrenergic (amod)
agc with (case)
maturity sexual (amod)
assigned participants (nsubjpass)
administration diazepam (nmod)
slowed nifedipine (nmod)
control ; (punct)
re-investigate to (mark)
interaction levodopa (nmod)
antagonized moreover (advmod)
risks long-term (amod)
function mitochondrial (amod)
revealed have (aux)
rat no (det)
preventing therapy (nmod)
short epsilon-aminocaproic (dep)
authors ' (case)
prior during (conj)
marker is (cop)
3657 excretion (nsubj)
narrowing vasculitis (conj)
equal . (punct)
insertion valve (compound)
baseline 1 (conj)
% 11/57 (nummod)
suppression carriers (nmod)
ssris by (case)
suspected : (punct)
group placebo (compound)
conduction intraventricular (amod)
explanation environmental (amod)
suppresses background (dep)
cgs ) (punct)
studies western (amod)
known doses (nsubjpass)
test ischemia (nmod)
extracellular from (case)
107.4 +/- (cc)
conjugates . (punct)
hyperthermia whole (amod)
related site (nmod)
tolerance rigidity (nmod)
index therapeutic (amod)
diagnosis disorder (nmod)
potentiated treatment (nsubj)
dysregulation channel (compound)
histology and (cc)
prospectively perform (conj)
mi against (case)
dexatrim phenylpropanolamine (appos)
nonusers , (punct)
measurements with (case)
109 1.8 (conj)
treated was (aux)
failure dysfunction (nmod)
test before (case)
values pre-hypotensive (amod)
performed animals (nmod)
inhibited activation (dobj)
range = (dep)
deaths patients (nmod)
binding scatter (conj)
monophosphate 8-bromo (amod)
died cows (nsubj)
elevation a (det)
taking headache (nmod)
moderate was (cop)
12- and (cc)
whatever drug (nsubj)
0.47 , (punct)
system patients (nmod)
induction tachyarrhythmia (nmod)
vinorelbine to (case)
used observational (conj)
group had (acl:relcl)
received responders (nsubj)
dog one (nummod)
propranolol nonselective (dep)
concentrations less (amod)
less vs. (cc)
incidence cases/person-years (conj)
-18 -54 (conj)
2.4-fold ) (punct)
treated pb (nmod:npmod)
reported should (aux)
dupuytren 's (case)
corresponds . (punct)
ischaemic nephrotoxic (conj)
mg 600 (nummod)
ms matrix-assisted (amod)
overflow fractional (amod)
presumed documented (conj)
strokes recurrent (amod)
adjustment lidocaine (nmod)
links cancer (nmod)
neuroimage 40 (nummod)
positive negative (conj)
therapy 6-month (amod)
administration bupivacaine (compound)
alkalinization urinary (amod)
agonist alpha2-adrenergic (amod)
telaprevir simvastatin (conj)
warrant investigation (dobj)
assessed been (auxpass)
inhibition neurotoxic (amod)
nausea for (case)
headache the (det)
crisis src (appos)
agonist beta2-adrenoceptor (compound)
tachycardia rhythm (nmod)
such that (mwe)
addressed . (punct)
endings but (cc)
hepatocellular and (cc)
exposed received (advcl)
younger % (conj)
0.5 2.0 (conj)
outer inner (conj)
0.014-unit and (cc)
minimize affecting (advcl)
fluid from (case)
equal almost (advmod)
h ; (punct)
intubated ( (punct)
ligand the (det)
pressure whose (nmod:poss)
thiamine of (case)
levels (+)-propranolol (nmod)
residence sunbelt (nmod)
enzymes , (punct)
half one (nummod)
elevation persistent (amod)
received saline (dobj)
made was (auxpass)
rates nitroprusside (compound)
intake before (case)
adenosine mm (amod)
scales with (case)
torsade de (dobj)
recommended 2002 (nmod)
nicotine neostigmine (conj)
m and (cc)
factor promoting (compound)
became somnolent (acomp)
identified be (auxpass)
followed diagnosed (advcl)
carboplatin 's (case)
delay to (case)
took week (nmod)
lifetime and (cc)
techniques emphasis (nmod)
18.4 27.1 (dep)
effect although (mark)
produced anaemia (dobj)
induce moran (dep)
examined order (nmod)
0.5 1 (dep)
developed psychosis (dobj)
benzoylecgonine with (case)
c stage (compound)
test behavioral (amod)
heterogeneous that (mark)
expression , (punct)
inhibited could (aux)
increased u/ml (xcomp)
conditioning followed (acl)
suspension nanoparticle (compound)
event arrest (nmod)
mass glomerulonephritis (conj)
useful to (mark)
dogs cefonicid (conj)
induced quetiapine (nmod)
showed fall (dobj)
taking event (nmod)
seroconversion people (nmod)
range 5.7 (nummod)
attacks disorder (conj)
requirements potassium (compound)
observed but (cc)
have activities (dobj)
class g/ml (appos)
variables starvation (compound)
seizure first (advmod)
reversed dose-dependently (advmod)
trial multicenter (compound)
1- by (case)
procedures tail-withdrawal (compound)
affect cases (nmod)
inhibitor transaminase (nmod)
data patients (dep)
those treated (acl)
supports reveals (conj)
received 0.5 (dobj)
% % (nsubj)
prompted episode (dobj)
e18.5 at (case)
csa of (case)
head advanced (amod)
lpo ) (punct)
usefulness the (det)
3alpha-hydroxy-5alpha-pregnan-20-one ) (punct)
open-label , (punct)
upregulated irritation (nmod)
pentoxifylline 0 (dep)
media in (case)
anemia percentage (nmod)
evaluated toxicity (nsubjpass)
terfenadine cisapride (conj)
0.85 - (punct)
ku70 and (cc)
discharge % (nmod)
toxic optic (conj)
action functions (nmod)
superoxide o2- (appos)
form sf36 (appos)
absent minimal (conj)
4.04 +/- (cc)
hyperactivity apomorphine-induced (amod)
10(9 per (case)
sr receptor (compound)
group cya (appos)
implant electrode (amod)
improved has (aux)
concentrations flestolol (compound)
mg/kg/day , (punct)
bupivacaine e2 (nmod)
embarrassed very (advmod)
due weakness (nsubj)
chest substernal (amod)
suggests condition (ccomp)
mg/day b (appos)
factors significant (amod)
stopped been (auxpass)
inflammation vicinity (nmod)
neurotoxicity hydroxyquinolines (nmod)
lesions cortex (nmod)
time period (appos)
histories therapy (compound)
effects diazepam-induced (amod)
show patients (nmod)
use corticosteroid (compound)
prevention amnesia (nmod)
inos ) (punct)
mutation and (cc)
subjects risperidone-treated (amod)
damage c-induced (amod)
were case (nmod:npmod)
diversion with (case)
provides estimate (dobj)
inactivation due (case)
suffers one (nsubj)
= - (punct)
pattern normal (amod)
clonidine on (case)
increase weight (nmod)
objective review (nmod)
ci=1.0 ) (punct)
complication sclerosis (nmod)
complicated very (advmod)
platform central (amod)
group drugs (nmod)
medication overcome (acl:relcl)
stress between (case)
reductase decreased (amod)
npy for (case)
adducts 4-hydroxy-2-nonenal (amod)
warrant cell (compound)
concentration mda (compound)
unchanged was (auxpass)
aplasia , (punct)
supply cardiac (amod)
seizures on (case)
carboplatin nor (cc)
using hplc (dobj)
author the (det)
compounds these (det)
injection cbz (nmod)
group extended-interval (amod)
delayed that (mark)
taking day (nmod)
patients oncology (compound)
infections bacterial (amod)
pressure mean (compound)
testing green (compound)
use thrombolysis (nmod)
pastes certain (amod)
attained score (dobj)
cardiomyopathy is (cop)
weight half (amod)
ratio odds (nsubj)
tasks by (case)
receive distinguish (conj)
risk cystitis (nmod)
reduce fertility (dobj)
went patients (nsubj)
test damage (nmod)
downregulated 3ma (nsubj)
cardiomyopathy acute (amod)
24 6 (compound)
abilities global (amod)
attack hepatitis (compound)
mg./kg 1 (nummod)
framework membrane (nmod)
likely inhibition (nmod)
observed changes (dobj)
ed50 between (case)
studies epidemiologic (amod)
dehydrogenase activities (conj)
action channel (compound)
accompanied damage (nsubjpass)
associated increases (nsubjpass)
showed showed (parataxis)
recipients 2 (nummod)
scale treated (acl)
ranged ; (punct)
active well (conj)
intelligence social (compound)
serious reversible (conj)
rauwolscine of (case)
100 3 (compound)
h-sod1 ( (punct)
important neurons (nsubj)
stenosis a (det)
interview cross-sectional (amod)
baby in (case)
short-term ' (case)
pacing cardiac (amod)
exhibited state (dobj)
markers three (nummod)
present months (nmod)
required was (auxpass)
seem cross-react (xcomp)
result how (advmod)
treating of (mark)
anesthesia local (amod)
mrd eye (compound)
dosage once (advmod)
presented study (nmod)
number tubules (nmod)
difference no (neg)
people at (case)
propranolol loading (conj)
form that (nsubj)
group per (case)
inhibitor nos (compound)
failure use (nmod)
lesions coeruleus (nmod)
constant also (advmod)
rate with (case)
monitoring ambulatory (amod)
protein 5 (nummod)
nephrectomized dogs (nsubj)
partial and (cc)
caused hypertrophy (nsubj)
levels towards (case)
dyskinesia mice (nmod)
signs severe (amod)
activities . (punct)
alkaloid , (punct)
learning novel (amod)
augmentation this (det)
factor-beta1 of (case)
comparable that (nsubj)
receiving alfentanil (dobj)
androgen- corticosteroid-treated (conj)
employed has (conj)
fibres mossy (compound)
placebo valdecoxib (conj)
elevation avp (nmod)
involvement biomembranes (nmod)
source database (nsubj)
increase mediator-induced (amod)
displace binding (dobj)
in immediately (conj)
f(30 ) (punct)
c-induced mitomycin (nmod:npmod)
insecticide properties (nmod)
cocaine with (case)
quincke 's (case)
s.c. mg/kg (compound)
induced antagonists (nmod)
women born (acl:relcl)
gsi ( (punct)
hours two (nummod)
models induced (acl)
hysterectomy abdominal (amod)
animals ' (case)
potent was (cop)
minor and (cc)
had thus (advmod)
fits clonic (amod)
damage and/or (cc)
using support (dep)
receiving phenothiazines (dobj)
symptoms incidence (dep)
minimal respectively (advmod)
appeared immediately (advmod)
presented placement (nmod)
stm ) (punct)
effects supply (nmod)
associated was (conj)
defined immediately (advmod)
2660 +/- (cc)
universal . (punct)
decreased uptake (dobj)
use fzp (nmod)
managed floor (nmod)
cancer necrosis (conj)
scale intelligence (compound)
abnormalities field (compound)
affected women (nsubjpass)
segment minutes (dep)
model mptp-treated (amod)
relapse a (det)
exhibited that (dobj)
leucovorin mg/m2 (conj)
biopsy biopsy (compound)
amount doxorubicin (nmod)
1994 in (case)
radiopharmacy hospital (compound)
> old (amod)
abnormalities brains (nmod)
repair damage (nmod)
administration placebo (amod)
complications no (neg)
represented syndrome (nmod)
dmso microg/0.5 (nummod)
predictive was (cop)
gram tissue (nmod)
method assessed (appos)
one inhibitors (nsubj)
mg/kg acc-9653 (nmod)
influence respectively (advmod)
znso(4 by (case)
studied dyskinesia (nmod)
stratified participants (nsubjpass)
absence therapy (nmod)
learning absence (nmod)
haemorrhage sah (appos)
disadvantages other (amod)
improve syndromes (nmod)
65.3 +/- (cc)
reported analysis (nsubjpass)
contribute degeneration (nmod)
had contraception (nmod)
developed group (nsubj)
involved commonly (advmod)
incidence bleeding (nmod)
1.050 - (punct)
seizures pilocarpine (compound)
detection for (case)
immunoreactivity npy (compound)
matrix extracellular (amod)
changes status (nmod)
caucasians in (case)
affected pbsct (nmod)
pacemaker patients (nmod)
zero number (nsubj)
drugs concomitant (amod)
10(-3 11.5 (compound)
tolerated caffeine (nsubjpass)
influence narcosis (dobj)
hypothermia continued (acl:relcl)
postulated is (auxpass)
thrombocytopenia hyperkalemia (conj)
19 and (cc)
rate in (case)
palsy fold (amod)
greater ; (punct)
randomized selected (conj)
urine acidic (amod)
mean rates (nsubj)
evaluation 1 (dep)
major with (case)
confounders as (case)
limits agent (nmod)
= 0.001 (dobj)
negative test (nsubj)
sedation conscious (compound)
gamma-carboxylated not (neg)
unreported hallucinations (nsubj)
pharm shin-poong (compound)
region hilar (amod)
% 24.7 (nummod)
exhibited rise (dobj)
0.3 10 (conj)
ptu to (case)
scopolamine-induced effects (nsubj)
rate 24-hour (amod)
lesion an (det)
devoid concentrations (nsubj)
causing events (dobj)
reversed however (advmod)
sealants derived (acl)
percent ( (punct)
fmri with (case)
therapy before (nmod)
ratio 4.4 (nmod)
effects untoward (amod)
reflects that (mark)
proteinuria administration (nmod)
toxicity observed (acl)
patients discontinuation (nmod)
dose dose (conj)
receptor nk2 (compound)
decreased treatment (nmod)
randomized double-blind (advmod)
mmg ( (punct)
ampka myocardium (nmod)
> microg/ml (dep)
bp msdbp (appos)
less group (nmod)
7.44 of (case)
onset effects (nmod)
found compared (advcl)
prescribe , (punct)
altered pharmacokinetics (nsubjpass)
secretion cimetidine (nmod)
initiation in (case)
induced expression (conj)
dyskinesia with (case)
ka ) (punct)
users ecstasy-polydrug (compound)
defect perfusion (compound)
= 0.61 (dobj)
had screening (nsubj)
informed commencement (nmod)
patients 2,820 (nummod)
mosmol/kg 410 (nummod)
exhibited symptoms (nmod)
phenobarbital % (nmod:npmod)
ra and (cc)
interval . (punct)
estradiol testosterone (conj)
broadens combination (nmod)
brain electroencephalogram (conj)
induces up-regulation (dobj)
globulin . (punct)
pacing ventricular (compound)
injected group (nsubjpass)
dexmedetomidine highly-selective (amod)
oxidase cytochrome (compound)
rough foamy (conj)
formulations lipid (compound)
unmatched in (case)
given vpa (nsubjpass)
phenytoin receiving (compound)
months transplantation (nmod)
levels propofol (nmod)
performed ] (punct)
remained 3 (nsubj)
symptoms total (amod)
measurement ) (punct)
rats treated (acl)
cortex controls (nmod)
commissure the (det)
109.2 +/- (cc)
feared , (punct)
taking methotrexate (nmod)
decrease rate (compound)
indicated conclusions (dep)
rate proliferation (compound)
system and (cc)
manifesting of (case)
hypertension practice (nmod)
induced drops (dobj)
rate turnover (compound)
responsiveness precursors (nmod)
regurgitation mitral (amod)
enhancement isoniazid (nmod)
define distinguishable (xcomp)
myoclonus muscimol-induced (amod)
determined authors (nsubj)
had anxiety (dobj)
correction parameters (nmod)
limit . (punct)
utilized we (nsubj)
rush urticaria-angioedema (conj)
yrs ) (punct)
pathogenesis spasm (nmod)
progenitor marrow (compound)
patients psychosis (compound)
suggested reduces (ccomp)
antipsychotics by (case)
bradycardia severe (amod)
50 over (advmod)
activity n-acetyl-beta-d-glucosaminidase (nmod)
received uroprophylaxis (dobj)
types oc (nmod)
sites associated (acl)
s. ( (punct)
subthalamotomy after (case)
degeneration myocardial (amod)
reduction or (cc)
underwent treatment (nmod)
cases exacerbations (conj)
temocapril iii (dep)
show findings (nsubj)
3 days (dep)
mg/g ( (punct)
involved injury (nsubjpass)
switching tacrolimus (nmod)
pcr samples (nsubj)
atherosclerosis aortic (amod)
pilot a (det)
surgery hydrochloride (dep)
damage adducts (nmod)
side one (nummod)
na(+)/k(+)-atpase nhe3 (conj)
testosterone ip (appos)
prevent damage (dobj)
fundus examination (dobj)
patient lithium-treated (amod)
received followed (conj)
occur mutants (nsubj)
chromosome ) (punct)
thunbergiana pueraria (compound)
those in (case)
had survival (conj)
replicated was (auxpass)
mg 0.55 (nummod)
neurologic of (case)
letrozole or (cc)
impairs that (mark)
amount size (nmod)
131 to (dep)
malondialdehyde renal (amod)
observed frequency (nsubjpass)
syndrome lethal (amod)
completion after (case)
diazepam mg/kg (compound)
effects leukemogenic (amod)
paclitaxel mg/m2 (dep)
epilepsies idiopathic (amod)
dismutase cu/zn-superoxide (amod)
po2 ) (punct)
dose-dependent , (punct)
model clinical (amod)
sem mm (nmod)
assessed areas (nsubjpass)
evident are (cop)
tet ) (punct)
severity response (conj)
core into (case)
grades iv (conj)
infiltration ventricles (nmod)
mixture primarily (advmod)
chemotherapies in (case)
resulted dysrhythmogenic (conj)
probability switching (nmod)
lead stimulation (nsubj)
80 to (quantmod)
20 43 (dep)
eliminating regimen (nmod)
complications rhabdomyolysis (nmod)
t.i.d. day (nmod)
peak activity (nmod)
technique humans (nmod)
male taking (acl:relcl)
drug-adsorption both (cc:preconj)
factor receptor (compound)
titrated ) (punct)
present to (mark)
induced maintain (xcomp)
mg/dl 1.98 (nummod)
follow-up days (nmod)
therapies specific (amod)
time which (nsubj)
exhibited positions (nmod)
infarction subtotal (amod)
hyperkinesis , (punct)
protection neurotoxicity (nmod)
tolerable to (mark)
hormone elevated (amod)
expression group (nmod)
similar pain (conj)
patient transplanted (amod)
dose 2.0-mg (amod)
did days (nmod)
predated warrant (conj)
score ( (punct)
cessation upon (case)
biperiden of (case)
develop leak (dobj)
application prevention (nmod)
glutamate epsilon-aminocaproate (conj)
results counts (dep)
demonstrated transplantable (nmod)
antagonism effect (nsubj)
dysfunction post-myocardial (amod)
has capecitabine (nsubj)
were indians (attr)
ability induce (acl)
formation incubated (amod)
ages ( (punct)
five 33 (nmod)
ssc ( (punct)
complication with (case)
trial placebo- (amod)
displaying effects (dobj)
rigidity succinylcholine-induced (amod)
laboratories , (punct)
test effects (dobj)
expanded level (nsubjpass)
crocins groups (nmod)
fpd mea (nmod)
reached . (punct)
seen severity (conj)
exposed acutely (advmod)
taking gum (dobj)
patients iran (nmod)
reflected . (punct)
cyclophosphamide ctx (appos)
abuse of (case)
interest growing (amod)
documented tissue (nmod)
exposure inhibitors (nmod)
harm of (case)
prognosis survivors (nmod)
meq/l tolerated (acl:relcl)
randomised . (punct)
% users (nmod)
continued procedure (nmod)
ratio decreased (amod)
project prevention (nmod)
carbamazepine vigabatrin (conj)
oximeters ventilators (conj)
magnitude transformation (nmod)
etodolac eai (appos)
erythropoietin recombinant (amod)
increase neurons (nmod)
nm 8 (nummod)
rejection and (cc)
treatment antiretroviral (amod)
due inhibition (nmod)
pretreatment poisoning (nmod)
patients complex (nmod)
acting opioid-receptors (nmod)
attest deaths (nsubj)
3alpha-tropanyl-2-(4-chorophenoxy)butyrate ( (punct)
enzyme transketolase (appos)
characterized propranolol (nmod)
microinjection clonidine (nmod)
incidence riha (nmod)
ameliorated was (dep)
pathways micturition (compound)
ls p (dep)
conceivable involved (ccomp)
levels cis-ra (compound)
incidents being (acl)
expression functional (amod)
erythema with (case)
abnormalities function (compound)
predicting akathisia (dobj)
participation mechanisms (nmod)
benefited % (dep)
did it (nsubj)
therapy sulindac (compound)
basis the (det)
analysis upon (case)
evaluated methods (dep)
compares accordingly (advmod)
perspective from (case)
status 0 (dep)
recording period (dobj)
mechanism(s in (case)
7 , (punct)
december 2010 (nummod)
conclusion found (appos)
performance vision (compound)
worsening report (appos)
disturbances barrier (compound)
methods subjects (appos)
treated clonidine (nmod)
ds male (amod)
present may (aux)
treatment fixed-dose (amod)
compared placebo (xcomp)
decreased blockers (nsubj)
occurring that (mark)
factor cocaine (nsubj)
parameters test (compound)
substituted indicating (xcomp)
brings relief (nsubj)
trial council (compound)
hemicholinium-3 acetylcholine (compound)
attenuated abnormalities (dobj)
smaller mass (nsubj)
lead disease (nmod)
neurodevelopment behaviors (conj)
effect depletion (nmod)
effects developmental (amod)
shown nascis (nmod)
assess and (cc)
hepatotoxicity 6 (appos)
withdrawal later (advmod)
abuse . (punct)
lid both (cc:preconj)
induced agonists (nmod)
controlling factors (nmod)
decreased contrast (nmod)
side-effects memory (appos)
measured proteinuria (nsubjpass)
blockade transition (nmod)
given cyclosporine (nsubjpass)
accompanied decrease (nmod)
retention h (amod)
designed achieved (ccomp)
tamca ) (punct)
are treatment (nmod)
delineate role (dobj)
decreased l-name (nsubj)
0.03 than (case)
problematic responsive (nsubj)
mg ( (punct)
administered scales (nsubjpass)
associated circumstances (nmod)
pretreatment pain (nmod)
tumor left-sided (amod)
sensitivity of (case)
activated time (dobj)
receptor , (punct)
reduced supernatants (nsubj)
patients trials (nmod)
investigate loss (dobj)
delay shorter (amod)
stages early (amod)
occurs strong (advcl)
moderate changes (nmod)
propensity the (det)
ci=22.8 25.7 (nummod)
increases packing (dobj)
clearance rc (appos)
suggest specific (ccomp)
consisted loss (nsubj)
toxicity gastrointestinal (amod)
assessed administration (nmod)
totp given (case)
igf-i of (case)
injection diltiazem (nmod)
r6 ) (punct)
effects term (compound)
glomerulonephritis with (case)
blocking properties (conj)
tiapride and (cc)
scattered were (auxpass)
auc ] (punct)
prescribed clopidogrel (nsubjpass)
disease gvhd (appos)
surgery hypotension (nmod)
practices perinatal (amod)
disease because (case)
malondialdehyde of (case)
rammer katona (dep)
increase month-long (amod)
year calendar (compound)
flush facial (amod)
survival type (conj)
trials controlled (amod)
behaviour feeding (compound)
divided animals (conj)
cases 3 (nummod)
disease thromboembolic (amod)
limits ) (punct)
were beats (attr)
potentials flash (compound)
toxicity of (case)
designed : (punct)
alterations the (det)
polyuria to (case)
found occurred (advcl)
protecting seizures (nmod)
5,7-dihydroxytryptamine neurotoxin (compound)
ns ) (punct)
tic-like more (advmod)
uropathy for (case)
rauwolscine map (appos)
positive months (nmod)
developed results (dep)
treated rose (conj)
aminotransferase gamma-glutamyltransferase (conj)
pattern involvement (nmod)
ingestion life-long (amod)
antagonist new (amod)
reversed chemoconvulsants (nmod)
sample patient (compound)
4 11 (conj)
searched up (prep)
omercazole n (compound)
treated compound (nmod)
disappeared mj (nsubj)
signs stereotypy (nmod)
increase notable (amod)
cytostatic . (punct)
patients likelihood (nmod)
immunohistochemistry studies (conj)
questioned use (nmod)
brain the (det)
four hundred (compound)
regression and (cc)
rate success (compound)
neurotoxicity , (punct)
replaced had (aux)
analysis " (punct)
uncomplicated been (auxpass)
parameter metoprolol (nmod)
reported chemotherapy (nmod)
tonus dopaminergic (amod)
register national (compound)
edema as (case)
used methadone (dobj)
donors n (dep)
sequencing motif (nmod)
highlights case (nsubj)
attack single (amod)
observed impairment (nsubjpass)
joint in (case)
weeks transfer (nmod)
chromosomes for (case)
would alone (advmod)
water mineral (compound)
attenuates betaine (compound)
cancers endometrial (amod)
dosing thus (advmod)
headache stronger (amod)
netilmicin tobramycin (nmod)
anthracycline with (case)
remainder of (case)
objective effect (dep)
assumed is (auxpass)
sulpiride by (case)
usage the (det)
antibody-(pr3-anca cytoplasmic (amod)
analogue folic (amod)
increase seizures (nmod)
rhythm regular (amod)
locomotion or (cc)
evoked developed (xcomp)
skeptical be (cop)
generate regard (nmod)
mg/hour 50 (nummod)
achieved process (nmod)
measure myocytes (nmod)
returned soon (advmod)
returned discontinued (advcl)
exert cord (nmod)
induced h (nmod)
tubulopathies demonstrated (amod)
overshooting force (nmod)
comment for (case)
apoptosis induced (acl)
toxicity angiography (nmod)
group endorsing (acl)
comparison of (case)
rats pretreated (acl:relcl)
undergone that (nsubj)
bradycardia block (conj)
group mean (dep)
suspect for (case)
associations cancer (nmod)
ingested orally (advmod)
antagonize doses (nsubj)
pattern proteins (nmod)
magnitude for (case)
hyperalgesia opioid-induced (amod)
levels arsenic (nmod)
diet ) (punct)
11 1 (compound)
excess animals (nmod)
head fibrotic (amod)
block blindness (nmod)
decrease h (nmod)
cysts infants (nmod)
increased fetal (nmod)
were versa (conj)
pathway cholinergic (compound)
animals while (case)
inhibit gamma-carboxylation (dobj)
epithelium and (cc)
factor initiating (amod)
requires diagnosis (nsubj)
doses in (case)
reported never (neg)
test response (compound)
capsaicin for (case)
glomeruli ( (punct)
using % (nmod)
values microm (nmod)
repeated application (nsubjpass)
monotherapy with (case)
illustrates elderly (nmod)
dose prevention (nmod)
pentoxifylline , (punct)
mean for (case)
recipients heart (compound)
suggest confirm (conj)
changes respiratory (amod)
dysmorphism 2 (dep)
complication limits (acl:relcl)
staining including (case)
aminoglycoside used (acl)
received followed (xcomp)
tolerated tolterodine (nsubjpass)
design baseline (nmod)
are agents (attr)
occur hypotension (nsubj)
choice , (punct)
mri for (case)
% orr (nsubj)
14 out (dep)
report pseudoacromegaly (nmod)
anomalies developmental (amod)
1992 to (case)
paraparesis spastic (amod)
nausea % (appos)
review operations (nmod)
myopathy steroid (compound)
achieved months (dobj)
ps of (case)
% 5.21 (nummod)
microgram/kg/min or (cc)
therapy antidepressant (amod)
350 300 (compound)
fraction hexanic (amod)
prevented co-injection (nmod)
using center (dobj)
after years (nmod:npmod)
microscopy , (punct)
decreased hyperactivity (dobj)
symptoms these (det)
warrant lymphoma (compound)
precommunicating segment (dobj)
correlates negatively (advmod)
proteinuria 3 (nummod)
carbachol agonist (appos)
injection)+ritanserin ritanserin (compound)
contribution striatum (nmod)
reaching and (cc)
due , (punct)
mediate response (dobj)
azt and (cc)
loss known (amod)
evaluated patients (nmod)
movement spontaneous (amod)
elevations further (amod)
exceed benefit (dobj)
non-biodegradable either (preconj)
monitored periodically (advmod)
injection adriamycin (nmod)
mitochondria with (case)
pattern . (punct)
reported to (mark)
patients 55 (nummod)
treatment prompt (amod)
psa ) (punct)
myelopathy of (case)
profiles tolerability (compound)
cilostazol inhibitor (compound)
scopolamine both (cc:preconj)
work this (det)
type 2 (nummod)
did estimate (advcl)
associated disruption (nsubjpass)
swelling prominent (amod)
man amyloidosis (nmod)
observed definite (advmod)
defined and (cc)
drug d2 (nmod)
timolol not (cc)
ace renal (amod)
received lobe (nmod)
summary . (punct)
pallidus the (det)
manner steroid-dependent (amod)
acid 2r,4r-apdc (dep)
salt . (punct)
intravitreal . (punct)
vigilance counts (nmod)
stimulated lc (nmod)
hoarseness candidiasis (conj)
treatment morphine (compound)
values ( (punct)
hypotension dose-dependent (amod)
test bilirubin (conj)
1r ) (punct)
attacks of (case)
accumulation atracurium (nmod)
investigated methods (nmod)
nitrotyrosine as (case)
noted authors (nsubj)
useful therapy (nmod)
etiology likely (amod)
tissues inner (amod)
induce cross-tolerance (dobj)
gastrointestinal symptoms (dep)
accumulation microvesicular (amod)
differences on (case)
hypersecretion a (det)
neurogenesis in (case)
dox or (cc)
valsartan : (punct)
different group (nmod)
can and (cc)
adjust to (mark)
cohort separate (amod)
absent . (punct)
given which (nmod)
labetalol , (punct)
altered neurotoxicity (nsubjpass)
comparison ischemia (nmod)
change mass (nmod)
served group (nmod)
recalled . (punct)
provided . (punct)
useful needed (parataxis)
d-med d-med (dep)
toxicity in (case)
obtained d-glucarate (nmod)
barrier/density charge (compound)
history prior (amod)
patients 116 (nummod)
increased micrograms (nmod)
concentrations hemoglobin (compound)
haloperidol ) (punct)
reversed bradycardia (nmod)
muscles from (case)
consumed . (punct)
rats doxorubicin-induced (amod)
cross-react that (nsubj)
found scales (nmod)
individuals psoriasis (nmod)
response 24-hour (amod)
enhancement leukoencephalopathy (dep)
use treatment (nmod)
none subjects (nmod)
episodes 39 (nummod)
micrograms/50 nl (dep)
lesion from (case)
conducted boys (nmod)
quantified follow (nmod)
reduces conjunction (nmod)
received ointment (conj)
patients the (det)
metabolism p450-mediated (amod)
revealed increase (dobj)
effect system (nmod)
additive actions (nsubj)
slowing marked (amod)
analyse to (mark)
chill vomiting (conj)
virus hev (appos)
different and (cc)
scores the (det)
divided patients (nsubjpass)
women pregnant (amod)
common found (conj)
diseases survived (acl:relcl)
studied behaviors (nmod)
produced ; (punct)
theophylline asthma (nmod)
ventricles subjects (nmod)
hypotension dogs (nmod)
medical drug (conj)
human pparalpha (dep)
re-warming at (mark)
relevant effect (nsubj)
sustained-release bupropion (compound)
agents ( (punct)
lumens and (cc)
indicate preexposure (ccomp)
lna by (case)
injections mice (nmod)
identical is (cop)
animals humans (conj)
seen anaphylaxis (nsubjpass)
coincided infarction (nsubj)
cxad , (punct)
ticlopidine the (det)
activity agents (nmod)
systems neuronal (amod)
microinjection nmda (nmod)
proteinuria damage (conj)
injection (= (compound)
virus non-e-induced (conj)
using snps (dobj)
causes infusion (nsubj)
mg/dl mg/dl (dep)
effects acetate (nmod)
diminish treatment (nmod)
outcome compound (compound)
manic hypomanic (conj)
f m (conj)
abnormality auditory (amod)
infusion snp (dep)
induces % (nmod)
evaluated safety (dobj)
engineered mice (nsubj)
metabolism impaired (amod)
function neuroendocrine (amod)
revealed return (conj)
mmse the (det)
dependency a (det)
trials dose-escalation (amod)
enzymes pattern (conj)
defects neurocognitive (amod)
agent have (conj)
is where (advmod)
dose bolus (compound)
nodosum with (case)
control levels (dobj)
conclusive were (cop)
densities receptor (compound)
show effect (dobj)
incidence proteinuria (nmod)
modulation receptor (nmod)
tumor tissues (dep)
failure multi-organ (amod)
months mg/day (dep)
tubule the (det)
complications about (case)
fev1 % (conj)
concentration ( (punct)
corrected hypothyroidism (nsubjpass)
totp after (case)
cse non-hydrolyzable (amod)
remained rate (nsubj)
ten and (cc)
reported patient (nsubjpass)
increase activity (nmod)
episodes haematuria (nmod)
0.6 and (cc)
injected drugs (nmod)
task expression (compound)
transcription tgf-beta1 (compound)
advantages uh (nmod)
influence hepatotoxicity (nmod)
effect which (nsubj)
patients iu/l (dep)
iohexol % (appos)
cpb the (dep)
stimulation field (compound)
nor presence (nmod)
first on (case)
disease similar (amod)
support observation (dobj)
accidents with (case)
injection g (compound)
administration ) (punct)
quinolones defect (appos)
demographic survival (conj)
biopsy one (nummod)
reduced development (dobj)
patients adsd (nmod)
margin lid (amod)
impact , (punct)
rpgn ( (punct)
sign warning (amod)
mg/kg from (case)
treatment mild (amod)
ethambutol isoniazid (conj)
effects hepatoprotective (amod)
administration plasma (nmod)
opportunity discontinue (acl)
decreased change (conj)
damage cerebellum (compound)
patient psp (compound)
area over (case)
12 7 (quantmod)
groups melatonin (conj)
dysfunction the (det)
investigations future (amod)
mechanism vagal (amod)
7.6 +/- (cc)
used uk (nmod)
comparison study (dep)
placebo other (nmod)
depletes doxorubicin (nsubj)
clonidine preoperative (amod)
aspect effect (nmod)
na the (det)
12- 48-h (conj)
adjusted area (nmod)
rats mg/kg (dep)
necessary is (cop)
depression users (nmod)
techniques dye-tracing (amod)
involved nicotine (nsubjpass)
mk801 antagonist (compound)
administrated lymphocytes (nmod)
provided allowed (conj)
proteinuric hr (dep)
face numbers (nmod)
administration apraclonidine (nmod)
efficacy viral (amod)
depression central (amod)
1b hcv-genotype (compound)
dibucaine and (cc)
chf in (case)
failed and (cc)
map to (case)
mu delta (conj)
patterns isoenzyme (compound)
ems and (cc)
organization research (nmod)
performed recall (conj)
pgp ) (punct)
infusion during (conj)
low concentrations (nsubj)
fluids steroids (conj)
controls patterns (nmod)
frequency seizure (amod)
repeated twice (advmod)
effects progression (nmod)
investigated association (dobj)
similar persons (nmod)
(dox)-induced cardiomyopathy (advmod)
practice medicine (nmod)
died none (nsubj)
more = (parataxis)
induced doxorubicin/kg (nmod)
exhibited addition (nmod)
structure cerebellar (amod)
group vehicle/vehicle (compound)
d11 d17 (conj)
tempol superoxide (compound)
examined viscerally (advmod)
cisplatin cddp (appos)
compared b.d (nsubjpass)
recall minutes (conj)
parameters function (compound)
treated apigenin (nmod)
deprivation with (case)
frequent suicides (nsubj)
recorded when (advmod)
experiment a (det)
mechanism induced (acl:relcl)
noted vsd (nsubjpass)
response based (case)
attenuates insipidus (dobj)
studies binding (compound)
was excess (attr)
determined expression (nsubjpass)
counteract . (punct)
experienced as (advmod)
in- or (cc)
damage n-acetyl-beta-glucosaminidase (conj)
2.2 0.2 (conj)
frequencies speech (compound)
ms from (case)
n=8 ) (punct)
evaluated association (dobj)
basal and (cc)
prilocaine given (case)
np dxnp (conj)
disturbances enhanced (acl)
correlate did (aux)
juice simulated (amod)
demonstrated brightfield- (nsubj)
affected often (advmod)
replacement women (nmod)
recognized complication (nmod)
cortices averaging (acl)
6 case (nmod)
ulcers one (nmod)
field experimental (amod)
benefits direct (amod)
hyperactivity seen (acl)
associations positive (amod)
flow aortic (conj)
uncommon . (punct)
genes these (det)
variables function (nmod)
treatment anti-inflammatory (amod)
carries have (advcl)
dyskinesia l-dopa-induced (amod)
man adenocarcinoma (nmod)
phenobarbitone both (cc:preconj)
fenfluramines only (advmod)
delay 2-h (amod)
mmol/kg 6 (nummod)
avoidance opioids (nmod)
potential amblyopia (nmod)
volunteer the (det)
volume 3.4-fold (advmod)
reversal chloride (nmod)
using methods (dobj)
hematomyelia of (case)
collected events (dobj)
needed denervation (nsubjpass)
compressed nerve (nsubjpass)
elderly ten (nummod)
available were (cop)
conjunctiva gellan (appos)
action weak (amod)
ligation artery (compound)
given halothane (dobj)
infected untreated (dep)
6.2 versus (cc)
alpha adenosine-5'-triphosphate (conj)
formation injury (conj)
causes processes (nmod)
diet hfd (appos)
investigate potential (dobj)
required accumulation (nmod)
correlated rise (nmod)
severity hematuria (nmod)
cross-reactivity enflurane (nmod)
ml/kg with (case)
examination analysis (conj)
results patients (conj)
tacrolimus of (case)
possibility regarding (case)
amount the (det)
a group (compound)
can ( (punct)
pattern mixed (amod)
nausea and (cc)
options use (nmod)
liver and (cc)
priapism for (case)
mo the (det)
administration rodents (nmod)
solution dextrose (acl:relcl)
eeg abnormal (amod)
amb amb (conj)
tested provocation (nmod)
model functional (amod)
study retains (ccomp)
mice for (case)
ctnt findings (conj)
uptake 36cl- (compound)
used studies (nmod)
episode throughout (case)
modulation activity (nmod)
mellitus diabetes (compound)
neoplasia ) (punct)
passes barrier (dobj)
na/k-atpase and (cc)
derived . (punct)
diseases congenital (amod)
included and (cc)
represent , (punct)
agent induction (nmod)
action drug (nmod)
phenotypes extensive (appos)
got infusion (dobj)
phosphatase calcineurin (compound)
contributes upregulation (nmod)
maintenance function (nmod)
sulindac of (case)
ts cb (conj)
activity period (conj)
included material (nsubjpass)
sided or (cc)
test thermal (amod)
safe practical (conj)
time spent (acl)
off-time daily (advmod)
components two (nummod)
recovery no (det)
scintigraphy mibg (compound)
aging of (case)
protects rodents (dobj)
antigen hepatitis (compound)
developed three (nmod)
up-regulation expression (nmod)
cpap ) (punct)
explained . (punct)
histological molecular (conj)
reversed formation (dobj)
gpi ( (punct)
compromises approach (nsubj)
systemic coronary (conj)
seems connected (xcomp)
half group (nmod)
cholesterol cholesterol/hdl (compound)
materials , (punct)
obtained response (nmod)
memory long (amod)
product pressure (compound)
symptoms intoxication (nmod)
considered stress (nsubjpass)
lowered groups (nmod)
output both (cc:preconj)
done hydrolysis (nsubjpass)
rotation initial (amod)
related drug (nmod:npmod)
induced doxorubicin (nmod)
sulfate sulfate (compound)
rhythms therapy (nmod)
shown modulates (ccomp)
eye in (case)
suggest inhibit (ccomp)
period washout (amod)
cells/mm3 500 (nummod)
analyses the (det)
contributes conclusions (nsubj)
correlated were (auxpass)
patients 829 (nummod)
lacn of (case)
increases activity (dobj)
diseases hbv-related (amod)
antithrombin ( (punct)
investigated being (auxpass)
rotation of (case)
system synergism (nmod)
preference contralateral (amod)
used zymosan (nsubjpass)
explanations embolism (compound)
inhibitors pg (compound)
increased suburothelium (nmod)
contributed period (nmod)
ng/mouse 3 (nummod)
1.51 0.74 (nummod)
reductase gr (appos)
antibody antibody (appos)
therapy statin (compound)
= 0.06 (dobj)
treatment long (amod)
enhancement grading (conj)
female 23 (nummod)
bupivacaine p (dep)
alters whether (mark)
decreased 10(-7 (nmod)
treatments of (case)
elicits microinjection (nsubj)
position at (case)
cause pointes (dobj)
standard- or (cc)
patients bipolar (amod)
average heavy (amod)
removal of (case)
analysis allele/genotype-wise (amod)
decreased spaces (dobj)
developed follow-up (nmod)
impaired plasticity (nsubj)
sensitizing properties (dobj)
contribution syndrome (nmod)
selection patterns (nmod)
response headache (compound)
effect compounds (nmod)
mg/m2 ) (punct)
occurred albuminuria (nsubj)
conventional either (cc:preconj)
e n (appos)
multicenter study (conj)
drd2 caucasians (nmod)
justified may (aux)
lesions matter (nmod)
treatment angina (nmod)
terminated data (conj)
accounted determined (advcl)
drink guarana (compound)
dithiothreitol or (cc)
derivative dibenzothiazepine (amod)
subchronic treatments (dobj)
trial immunosuppression (nmod)
distinguished were (auxpass)
conclusions compares (dep)
density sinus (nmod)
radiotherapy surgery (conj)
acetaminophen adriamycin (conj)
randomized diluted (advcl)
imaging techniques (conj)
inhibitions the (det)
measured angiography (nmod)
implicated incapacitated (conj)
produced improvements (dobj)
methscopolamine both (cc:preconj)
cytoplasm epithelial (amod)
administered testosterone (nsubjpass)
anti-inflammatory ketorolac (dep)
integral potential (nmod)
documented report (conj)
activated coagulation (nsubj)
developed arf (dobj)
patient dermatitis (nmod)
data few (amod)
inappropriate however (advmod)
type immune-mediated (amod)
neurons animals (nmod)
receptor by (case)
complaining a (det)
advised administration (nsubjpass)
injury defined (acl)
step initial (amod)
seen eating (advcl)
nucleus into (case)
britain great (amod)
subunits alpha3 (compound)
shown and (cc)
administration lindane (nmod)
reaction rather (cc)
disease disease (conj)
subgroups patients (nmod)
336 425 (conj)
exposures time-dependent (amod)
renin low (amod)
one background (dep)
percentage participants (nmod)
evaluation time (nmod)
lethality low-dose-adr-associated (amod)
reduction = (conj)
beneficial addition (nsubj)
pharmacovigilance of (case)
i1- and (cc)
reductions in (case)
epilepsy of (case)
200 255 (compound)
previously not (neg)
aprotinin containing (compound)
hot-plate the (dep)
rats susceptible (amod)
fk506 plus (cc)
sulphate 11-ketopregnenolone (compound)
case recurarization (nmod)
man 65-year-old (amod)
has nigra (nsubj)
man 58-year-old (amod)
greater patients (nmod)
enhanced uptake (dobj)
region in (case)
diminished moreover (advmod)
normal baseline (nmod)
synthesis neurotransmitter (compound)
acid between (case)
function cisplatin-induced (amod)
reported regimen (nmod)
n/n=25/26 ( (punct)
shr treated (amod)
implausible thus (advmod)
patient 's (case)
disorder disease (nsubj)
alpha-methyltyrosine mg/kg (dep)
strength contractures (conj)
five , (punct)
patients recovery (conj)
patients recruited (acl)
coincident temporally (advmod)
articles of (case)
abilities and (cc)
effects smoking (nmod)
herbicides are (cop)
gabapentin of (case)
lowering significant (amod)
initiation days (conj)
hexaaldose a (det)
when only (advmod)
aneurysm of (case)
lower % (dep)
bendrofluazide propranolol (conj)
pressure resistance (conj)
induce do (aux)
complication may (aux)
cyclosporine csa (appos)
precipitate that (mark)
patients fifty (amod)
influence modulation (nmod)
caused therapy (nmod)
acute ( (punct)
distinguished both (advmod)
cardiotoxicity with (case)
suggestions no (det)
beclomethasone with (case)
aplasia cell (compound)
pathways on (case)
related amphetamine (xcomp)
origin attack (nmod)
testing drugs (nmod)
toxicity retardation (conj)
prevalence users (nmod)
administration interleukin (conj)
vincristine dexamethasone (conj)
lesions skin (compound)
consume drug (dobj)
function auditory (amod)
directly indirectly (conj)
deficits cranial (amod)
mda ( (punct)
effect reversibility (conj)
expression cd36 (nmod)
containing quinine (dobj)
greater than (prep)
stability sarcolemmal (amod)
nephrosis rat (compound)
blood the (det)
dependent inhibition (nmod)
patient hour (nmod)
group p<0.001 (appos)
methods genetic (amod)
cohorts unmatched (amod)
bia s-(-)-10-acetoxy-10,11-dihydro-5h-dibenzo/b (appos)
0.4 124 (conj)
solutions of (case)
infusing by (mark)
occlusion studies (dep)
effects blocker (nmod)
concurrently given (case)
effects levodopa (nmod)
ng/kg/min ; (punct)
surgery limb (amod)
woman multiparous (amod)
anemia trimethoprim-induced (amod)
conducted center (nmod)
cancer for (case)
increase response (nmod)
doses kg-1 (nmod)
underwent implantation (dobj)
period observation (compound)
tumors human (amod)
treatment may (aux)
whereas % (nsubj)
effect possibly (advmod)
number intersections (nmod)
mg/kg p<0.05 (appos)
effect metoprolol (nmod)
carolina iowa (conj)
one as (case)
24.3 28.2 (conj)
increase mm (appos)
pregnancy risk (conj)
induces anomalies (dobj)
reaction allergic (amod)
responsible this (nsubj)
drugs no (det)
stent between (case)
age advanced (amod)
interaction potential (amod)
caused bradycardia (nmod)
received ) (punct)
injury failure (conj)
given hour (dep)
tumors all (det)
appears action (nsubj)
had probability (dobj)
factor any (det)
patients area (nmod)
treatment rhigf-i (compound)
correlated scores (nsubjpass)
drug adrenergic (amod)
induced min (nmod)
mecamylamine the (det)
india from (case)
sedatives certain (amod)
modulation altered (amod)
attributable that (nsubj)
body mug/g (compound)
displayed , (punct)
57 ( (punct)
occurred complication (nsubj)
loreclezole of (case)
tolerability the (det)
involves that (nsubj)
subacute was (auxpass)
placebo osteoarthritis (nmod)
taking carvedilol (dobj)
concentration dph (nmod)
subtypes mglu (compound)
hl60 and (cc)
carcinogenesis on (case)
groups other (amod)
caudate or (cc)
ranged mmol/l (nmod)
patients urticaria/angioedema (nmod)
failed eads (nsubj)
injection aminonucleoside (nmod)
men ratio (appos)
levels be (cop)
infarction 1990 (nmod)
nephritis anemia (conj)
patients 88 (nummod)
rechallenge by (case)
independent . (punct)
matched who (nsubjpass)
require . (punct)
receptors muscarine (compound)
transplantation received (acl:relcl)
beats ) (punct)
induced dexamethasone (nsubj)
intensity high (amod)
success treatment (nmod)
rosa effect (nsubj)
months 6 (nummod)
used erythropoietin (nsubjpass)
6 2 (compound)
leukoencephalopathy delayed (amod)
had hemorrhage (dobj)
interaction drugs (nmod)
requested reports (nsubjpass)
cancers common (amod)
cause can (aux)
gestations twin (compound)
dosing chronic (amod)
areas from (case)
utilization the (det)
daunoxome ) (punct)
drug meloxicam (nsubj)
indicated monitoring (nsubjpass)
microm , (punct)
induced acid (nmod)
repeating seizures (dobj)
increases incidence (dobj)
component response (nmod)
intervals after (case)
procedures after (case)
memantine ibuprofen (conj)
rats induced (amod)
caused manner (nmod)
related y (dep)
courses hundred (nummod)
effects amantadine (nmod)
receiving aminoglycoside (dobj)
limited effects (nmod)
activities measurement (nmod)
order perform (acl)
greater that (nsubj)
induced drugs (nsubj)
evidence sites (nmod)
identical if (mark)
thrombocytopenia patients (nmod)
day gestation (nmod)
hypotension . (punct)
has pregnancy (nsubj)
experienced exposed (conj)
modifies . (punct)
reported neurotoxicity (nsubjpass)
comparison disorders (nmod)
revealed deposition (nmod)
anticipated administration (nsubjpass)
suggests involved (ccomp)
delineated ablated (conj)
performed investigate (advcl)
headache during (case)
assessing condition (nmod)
higher treatment (conj)
pesticide . (punct)
62 of (case)
toxicity for (case)
valproate features (nsubj)
increase months (conj)
concentrations calcium (compound)
fibres gyrus (nmod)
oligodendrocytes of (case)
corrected restored (conj)
improvement propranolol (nmod)
increase raised (parataxis)
e1 . (punct)
hyperalgesia . (punct)
patients similar (amod)
hypertension moderate (compound)
provide explanation (dobj)
baroreflex ccb (appos)
route via (case)
showed factor (ccomp)
ultrasound liver (nmod)
smaller larger (conj)
initiated resulted (advcl)
returned examination (nmod)
difficulty presentation (nmod)
ought familiar (xcomp)
task y-maze (compound)
zone sub (compound)
affect oxyhemoglobin (nsubj)
evaluable and (cc)
resulted cases (nsubj)
distribution metabolism (conj)
age + (cc)
cd4 ) (punct)
subregion accumbal (amod)
8-se 8-se (conj)
d-1 of (case)
coincident excitement (nsubj)
come animals (nmod)
euthyroid patients (dep)
exposure isoflurane (nmod)
narrowing for (case)
mg. using (acl:relcl)
factor can (aux)
pathogenesis hiccups (nmod)
carcinoma from (case)
23.7 10.2 (compound)
mg/day dose (conj)
propose exceed (ccomp)
mechanism ; (punct)
dex alone (advmod)
followed access (nmod)
record memory (nmod)
(vegf)165 growth (compound)
0 7 (conj)
activity behavior (conj)
dose intervals (nmod)
possessed effects (dobj)
group ibs (compound)
transducer pressure (compound)
description : (punct)
versa vice (advmod)
muscle painful (amod)
potentials pattern (compound)
cardiomyocytes abnormal (amod)
findings these (det)
meat and (cc)
used daily (advmod)
induced vasospasm (nsubjpass)
children epilepsy (nmod)
analyzer visual (compound)
retard that (mark)
pan in (case)
maintained if (mark)
dogs mongrel (compound)
remained ) (punct)
induced rtms (nsubj)
therapeutic elevated (conj)
ng/ml 537 (nummod)
thrombocytopenia mucositis (conj)
case manifesting (nmod)
elevated slightly (advmod)
inactivated ( (punct)
60 one (compound)
avoidance pa (appos)
depleted 5-hiaa (conj)
reduced dmtu (nsubj)
developed papillomas (nsubj)
abnormalities potential (conj)
atrophy fiber (compound)
hyperalgesia carrageenan-induced (amod)
were rank (dep)
minutes to (case)
underwent 16 (conj)
19.1 10.4 (dep)
associated erythrophagocytosis (nmod)
rate along (case)
modulate addition (nmod)
greater variation (nsubj)
consuming developed (conj)
glutamate brain (compound)
persisted seizures (nsubj)
ventricle right (amod)
sent hospital (nmod)
counteract acutely (advmod)
develops patient (nsubj)
100+/-17 from (case)
myopathy chloroquine-induced (amod)
anemia , (punct)
inhibitor 3-hydroxy-3 (compound)
angiotension of (case)
identified treated (conj)
lesion between (case)
disorders register (conj)
obtained nociceptin (nmod)
prilocaine , (punct)
subjects in (case)
stimulus each (det)
increase 1 (dep)
had syndrome (dobj)
pre-treatment after (case)
disorder is (cop)
4-ene-vpa of (case)
complication acetazolamide (nmod)
department pharmacology (nmod)
derivatives cck-5 (nmod)
fumarate investigation (nsubj)
anaesthetised propofol (dep)
met definition (dobj)
anesthesia total (amod)
revealed presence (dobj)
risk morbidity (nmod)
results entered (appos)
suggest appears (ccomp)
contributes and (cc)
observed responses (nsubjpass)
identified decrease (nsubjpass)
changes artery (compound)
minutes dosing (nmod)
compared registry (nmod)
indicated testing (nsubj)
appearance galactose (nmod)
anemia post-chemotherapy (compound)
convulsions lethality (conj)
demonstrated specificity (nsubjpass)
basis sinus (conj)
kidney potter-type (amod)
study french (amod)
participants study (nmod)
women angioedema (nmod)
promote catalepsy (dobj)
decrease not (neg)
ventricle of (case)
ability umax (appos)
stable h (nmod)
test loss (dep)
measurement gssg (nmod)
determine quantitatively (advmod)
rank log (compound)
oxidation decreased (amod)
enhanced ; (punct)
massive the (det)
brain compartments (conj)
occurrence deaths (nmod)
inhibition the (det)
mitochondria enlarged (amod)
neurons brain (nmod)
awoke male (nsubj)
study exploratory (amod)
tract rat (nmod)
various physiological (dep)
taken effective (advcl)
day 13.5 (nummod)
propranolol mg (nummod)
toxicity major (amod)
restriction activity (nmod)
postpartum day (compound)
85 , (punct)
subunits mtdna-encoded (amod)
mg/ml of (case)
conclusions shr (dep)
susceptible , (punct)
women had (acl:relcl)
agent sirolimus (nsubj)
ranged rates (nsubj)
9.99 to (dep)
restimulation acid (nmod)
cellulose group (conj)
developed reaching (advcl)
attention renewed (amod)
implantation pacemaker (compound)
dysphagia of (case)
correlation ulcer (conj)
c2 from (case)
current exposure (conj)
factors definitive (amod)
p > (amod)
type recovery (dep)
lower p (dep)
activities transaminase (compound)
gene homer1 (compound)
verified . (punct)
cortex hippocampus (compound)
index n/n=9/26 (dep)
lobes in (case)
cases death (nmod)
nmda pilocarpine (conj)
160 80 (compound)
region catalytic (amod)
triad this (det)
administered opening (nmod)
intact both (cc:preconj)
hypoactivity frontocortical (amod)
data sedations (nmod)
status antioxidant (amod)
complained complained (advcl)
profile tolerance (compound)
11.2 8.3 (conj)
courses sixth (amod)
noted development (dobj)
influence toxicity (nmod)
rates survival (conj)
epinephrine or (cc)
9 development (conj)
ed-1 increased (amod)
expressed and (cc)
developed consuming (advcl)
produces inhibitor (nsubj)
measure time (dobj)
present other (advmod)
amplitude and (cc)
treatment adr (compound)
taken year (nmod)
induced epinephrine (nmod)
consciousness are (cop)
hyponatremia and (cc)
vasculitis carbimazole (compound)
increase score (nmod)
one drugs (nmod)
(5.3)% ) (punct)
l-name the (det)
index cardiac (amod)
discontinuing aes (nmod)
aim a (det)
located patients (nmod)
damage that (mark)
haemopericardium fatal (amod)
population elderly (amod)
sensation generalised (amod)
effect size (nmod)
development engorgement (nmod)
n-(2-propylpentanoyl)urea vpu (appos)
typical block (nmod)
sertraline to (case)
min of (case)
inhibitor inhibitor (conj)
hysterectomy a (det)
taken and (cc)
brain left (amod)
occurred forebrain (nmod)
view tendency (nmod)
were 75,761 (dep)
withdrawal inhibitors (compound)
liver blood (conj)
therapy by (case)
compared vitro (advmod)
doxorubicin drug (compound)
unknown pathomechanism (nsubj)
s 540 (nummod)
wild-type : (punct)
mip ( (punct)
duration between (case)
neonates two (nummod)
facilitation synthesis (nmod)
hildebrand et (compound)
disclosed moreover (advmod)
mg tiapride (conj)
way similar (amod)
aneurysm taa (appos)
agency by (case)
tachycardia postlesion (appos)
developed none (nsubj)
diagnosis formal (amod)
flaccid responsive (conj)
type the (det)
colorectal head (conj)
mechanisms causing (acl)
studies controlled (amod)
expression enzyme (compound)
disability in (case)
events to (case)
clonidine n (dep)
nifedipine diltiazem (conj)
chick and (cc)
eeg hippocampal (compound)
disappeared discontinuation (nmod)
sold to (mark)
disorder required (acl:relcl)
rapamycin fixed (amod)
branches the (det)
undergoing use (nsubj)
fzp pentylenetetrazol (conj)
derivative ) (punct)
possibility obtaining (acl)
relationship hypothermia (nmod)
protects impairments (dobj)
audiogram the (det)
believe when (advcl)
decreased levels (nsubjpass)
recording may (aux)
latter the (det)
pattern protein (compound)
tolerate . (punct)
nd-nmba ) (punct)
basis studies (nmod)
died picture (nmod)
signs behavioral (amod)
produced caffeine (nsubj)
% 0.15 (nummod)
administered quantify (advcl)
euthanasia to (case)
analgesic drugs (dep)
produced anesthesia (dobj)
mg/m2bsa 120 (nummod)
analyzed safety (dobj)
levofloxacin , (punct)
half-life the (det)
starting continuing (conj)
glutamate supplementation (dobj)
secondary increase (nmod)
9 7 (compound)
rapa ( (punct)
results mg/d (appos)
application creams (nmod)
yahr _ (compound)
defined improvement (nmod)
into : (punct)
greatest experience (nsubj)
cycloheximide , (punct)
increase systems (nmod)
increases arterial (nmod)
dopamine-1 agonists (conj)
toxicity the (det)
antidotes or (cc)
produced modifications (dobj)
determined alleles (nsubjpass)
needed he (nsubj)
complications diabetes (compound)
release hepatocellular (amod)
olanzapine clozapine (compound)
subunits beta4 (compound)
ro4368554 by (case)
function examined (acl)
role a (det)
atrophy diffuse (amod)
tight that (mark)
suffered who (nsubj)
mediate cumulative (dobj)
hyperkalemia with (case)
decreased protein (nmod)
valves of (case)
monkeys duration (conj)
activation t-cell (compound)
bottle empty (amod)
mg to (dep)
dialysis to (case)
showed recordings (nsubj)
allopregnanolone only (advmod)
eruption with (case)
stimulates triggers (ccomp)
young of (case)
mg/kg i.v. (dep)
abolished tinnitus (nsubjpass)
incidence low (amod)
hand other (amod)
deviation this (det)
caused ampicillin (nmod)
g/dl < (compound)
regimens cytostatic (amod)
expressed subtypes (nmod)
cytoplasm the (det)
patients identified (acl)
tests the (det)
pre- postsynaptic (conj)
consist bilayers (nmod)
scr baseline (compound)
preventing arrhythmias (dobj)
failure . (punct)
effective anticholinesterases (nsubj)
mg/day 30 (nummod)
prophylaxis graft-versus-host (compound)
change any (det)
action site (nmod)
revealed patch (conj)
biopsies , (punct)
na(+)-cl(- thiazide-sensitive (amod)
pd ) (punct)
accounts the (det)
transfusion cell (compound)
correlation the (det)
analogue of (case)
naloxone alone (advmod)
kidney with (case)
ages with (case)
2 4 (conj)
triphosphate nitroprusside (conj)
therapy infections (nmod)
improved however (advmod)
considered > (advcl)
related unlikely (dep)
hyperactivity amphetamine-induced (amod)
age including (case)
cerebral and (cc)
induction death (conj)
red of (case)
gfc75 plus (cc)
risk interactions (dobj)
epinephrine ( (punct)
punctate and (cc)
difference intergroup (compound)
august 2007 (nummod)
developed however (advmod)
3 4 (conj)
taken were (auxpass)
patients than (case)
synthesis endothelin-1 (nmod)
strength , (punct)
point effects (nsubj)
consumption water (compound)
diazepam for (case)
applied pre-surgery (nmod)
shown decreases (nmod)
associated level (nmod)
improved symptoms (nsubjpass)
research to (mark)
months 2.9 (nummod)
glucose in (case)
insomnia due (case)
action anesthetic (amod)
receive receive (conj)
mg/kg with (case)
bfgf ( (punct)
vasospasm secondary (amod)
cause cisplatin (nsubj)
meq/l concentration (nsubj)
furosemide surreptitious (amod)
compared prospectively (advmod)
followed up (compound:prt)
7.914 - (punct)
arrhythmias pig (nmod)
androgen- with (case)
prilocaine 6 (nummod)
seem inhibit (xcomp)
scenario delayed (acl:relcl)
data our (nmod:poss)
sevoflurane surgery (nmod)
intervention drug (compound)
nucleus hand (nmod)
diazepam function (nmod)
patients stones (nmod)
cause does (aux)
use 1r (dep)
found exhibit (xcomp)
deterioration thrombi (conj)
research laboratory (nmod)
similar as (mark)
response fibroproliferative (amod)
adherence low (amod)
months nine (nummod)
constituted taqib (nmod)
combination followed (acl)
inhibitors organic (amod)
time levels (nmod)
induces flumazenil (nsubj)
or immediately (advmod)
patients volume (appos)
characterization activity (nmod)
mris on (case)
girl 5-year (amod)
dose bupropion (nmod)
f2 from (case)
ameliorated but (cc)
exceed . (punct)
given caffeine (nmod)
normotensive both (cc:preconj)
toxicity ocular (amod)
schedules standard (amod)
essential dopamine (nsubj)
beats and (cc)
pathways sensory (amod)
report coxon (nmod)
refused . (punct)
owing lack (nmod)
ratings psychopathology (compound)
administration s-23121 (nmod)
study haloperidol (nmod)
anticoagulation mice (nmod)
cells bovine (amod)
indomethacin , (punct)
if dose (conj)
7.7 4.5 (conj)
doses beta-blockers (nmod)
report case (dobj)
mothers two (nummod)
hypothesized background (dep)
grape ih636 (compound)
abnormalities electrophysiological (amod)
studies mm (dep)
learning after (case)
common experience (nmod)
modulator modulator (conj)
drugs compared (case)
declined and (cc)
reported remission (nsubjpass)
returned ratios (nsubj)
medications these (det)
patients 37 (appos)
initiated rose (advcl)
treated centre (nmod)
cocaine those (conj)
use similar (amod)
agents the (det)
had hearing (xcomp)
suffering fibrillation (nmod)
apigenin of (case)
ototoxicity aminoglycoside-induced (amod)
amide acid (compound)
prevents treatment (nsubj)
pneumoniae streptococcus (compound)
discriminated was (auxpass)
prox-1 , (punct)
evaluated prospectively (advmod)
have adults (nsubj)
dose > (dep)
vt to (case)
l-arginine of (case)
study dsmm (compound)
amide (s)-(-)-3-bromo-n-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxybenz (det)
rate metabolic (amod)
bcl-2 of (case)
disorder metabolism (nmod)
ventricular human (amod)
induced formation (dobj)
tumour brain (compound)
suffering tinnitus (nmod)
administered ctx (nsubjpass)
groups oc (compound)
mania antimicrobial-induced (amod)
progressed . (punct)
antagonist sulpiride (nsubj)
wall apposition (nmod)
disease malignant (amod)
heterogeneity ( (punct)
insight role (nmod)
years 17.8 (nummod)
aspects medial (amod)
found commonly (advmod)
increase bp (nmod)
blocks consecutive (amod)
mechanisms perception (nmod)
activity clinical (amod)
patient arrhythmia (appos)
trough mainly (advmod)
receive remifentanil (conj)
diseases cvds (appos)
synergy warfarin (nmod)
withdrawal complicate (compound)
butyrylthiocholine benzoylcholine (conj)
tubes through (case)
administered s.c. (xcomp)
level glutathione (compound)
hypertrophy enhanced (amod)
reduced moderately (advmod)
controls compared (case)
reduced subjects (advcl)
day 21 (nummod)
apap ) (punct)
bcl-2 and (cc)
tablets 59 (nummod)
psychopathology in (case)
dose activity (nmod)
was death (nmod)
play because (mark)
acuity of (case)
reports 27 (nummod)
new ) (punct)
shifts frequency (nmod)
system insulin-receptor (compound)
14/104 ) (punct)
etoposide with (case)
obtained rates (nmod)
3.4 , (punct)
elevated test (conj)
suffered sequelae (dobj)
acted that (mark)
produced which (nmod)
1 43 (conj)
remission medications (nmod)
changing without (mark)
explanation of (case)
present treatment (nmod)
thromboembolism women (nmod)
important clinically (advmod)
effect causative (amod)
validated . (punct)
promote modulating (advcl)
focuses and (cc)
high increases (conj)
focuses study (nsubj)
hematuria transient (amod)
represent indication (dobj)
insult prior (case)
subjects 12 (nummod)
annuloplasty map (appos)
cells beating (compound)
10(-6 of (case)
contrasted egfp-microglia (nmod)
anticipated if (mark)
cannulae through (case)
cardiotoxicity such (amod)
influence turnover (conj)
chain electron (compound)
glomerular shrunken (amod)
cingulate limbic (conj)
cells/mm3 73.8 (nummod)
suffered significant (dep)
studies other (amod)
consistent results (nsubj)
exhibited . (punct)
totp dfp (conj)
toxicities myocardial (amod)
testing flurothyl (compound)
pcos ) (punct)
determine sensitivity (dobj)
examined outcomes (nsubjpass)
drug induced (acl)
system deficient (amod)
hallmarks syndrome (nmod)
dehydrogenase oxidase (conj)
recognize entity (dobj)
if pain (nsubj)
tolerate daily (advmod)
reducing on (mark)
defined pressure (nmod)
presentation stroke-like (amod)
doses medication (nmod)
continue demonstrate (xcomp)
modified risk (nmod)
has suppression (nmod)
latency rem (compound)
showed reversed (conj)
12 5 (quantmod)
alternatives need (acl:relcl)
arrhythmias clinical (amod)
determine response (dobj)
methods patients (appos)
hypothesized therefore (advmod)
analyses of (case)
injection n (dep)
mild : (punct)
agent tumor (compound)
oil instead (advmod)
organisms streptococcal (amod)
molecule of (case)
rp or (cc)
lesions ischemic (amod)
detected levels (nsubj)
protrusions tongue (compound)
nephropathy gm-mediated (amod)
studied blockers (dobj)
irritant eliminated (acl)
nafcillin to (case)
aroused although (mark)
thrombocytopenia transplantation (nmod)
p-choloroaniline the (det)
aminotransferase 738 (nummod)
met , (punct)
fold several (amod)
activity beta-blockers (nmod)
ameliorated also (advmod)
conclusions results (dep)
observed increases (nsubjpass)
kidneys with (case)
eosinophils and (cc)
recovery 30-min (amod)
day previous (amod)
administration shock (conj)
stay during (case)
chemotherapy concurrent (amod)
fact include (ccomp)
is objective (nsubj)
glibenclamide ; (punct)
type thrombocytopenia (compound)
des nationale (amod)
third-generation second-generation (conj)
mice deficient (amod)
32 +/- (cc)
containing phenobarbital (dobj)
context phase (nmod)
administration number (conj)
lymphomas non-hodgkin (amod)
function brain (compound)
bradykinesia dyskinesias (conj)
% 47.3 (nummod)
drugs but (cc)
adults gbm (nmod)
em ) (punct)
learning in (case)
pathophysiology in (case)
events cardiac (amod)
abnormalities for (case)
cerebellum hippocampus (conj)
patients [ (punct)
evaluation clinical (amod)
evaluation disease (nmod)
rise paradoxical (amod)
cell blood (compound)
aborted procedure (nsubjpass)
require outcomes (nsubj)
breaths between (case)
female 27-year-old (amod)
cortex levels (conj)
cavity cirrhosis (conj)
anaesthesia spinal (amod)
prompted this (nsubj)
transport an (det)
suppresses inhibition (nmod)
tumor wilms (amod)
level control (compound)
presence denervation (nmod)
review history (dobj)
saline- and (cc)
presented help (xcomp)
studied withdrawn (conj)
acting longer (advmod)
interact site (nmod)
results long-term (amod)
levels liver (compound)
testosterone for (case)
induces tam (nsubj)
case collection (nmod)
infusion but (cc)
confusion increase (conj)
appeared movements (nsubj)
rate flow (compound)
antagonist (8-cyclopentyltheophylline)--a1 (compound)
circled ipsilaterally (advmod)
sedation intravenous (amod)
treatment 73 (appos)
linked levels (nmod)
favour . (punct)
expression pcna (compound)
impairment responses (nmod)
improvement function (nmod)
11/6 from (case)
score sum (compound)
hysterosalpingography for (case)
performed detection (dobj)
% with (case)
coadministration enhancers (conj)
examination state (compound)
therapy subsequent (amod)
side-effect common (amod)
conclude constitutes (ccomp)
p.o. i.c.v. (dep)
g. 2.8 (nummod)
sensitive dystrophin (nsubj)
time obtain (acl)
suggested trial (nsubjpass)
application carboplatin (compound)
channel chloride (compound)
detectable although (mark)
protocol this (det)
hypotension systolic (compound)
patients (hiv)-infected (amod)
revealed not (neg)
strokes death (conj)
were compared (advcl)
known participate (xcomp)
measuring by (mark)
levels brain (nmod)
refine pinpoint (conj)
associations factors (nmod)
induced benzodiazepines (nmod)
cancer tract (compound)
chemotherapy cisplatin-based (amod)
seen levels (nsubjpass)
potential monophasic (amod)
ms of (case)
evoked infarcts (nsubjpass)
impaired retrieval (nsubj)
haloperidol oral (amod)
prescribed evaluation (dep)
resulted 4 (dep)
approach our (nmod:poss)
matrix damaged (amod)
disruption . (punct)
live . (punct)
recognised not (neg)
phase chlorthalidone (compound)
nerve lacn (appos)
that controls (nmod)
haematological , (punct)
dose higher (amod)
treated combination (nmod)
mg succinylcholine (compound)
treated daptomycin (nmod)
countries most (amod)
revealed weak (advcl)
halothane pancuronium (conj)
hydrochloride 500 (nummod)
mpep ( (punct)
mg/kg/day 0.086 (nummod)
accounting % (nmod)
taking vigabatrin (dobj)
resistance as (case)
caused have (aux)
mg/m(2)/day ( (punct)
rise an (det)
regimen high-dose (amod)
disability parkinsonism (nmod)
had redness (dobj)
attack , (punct)
therapy morphine (compound)
patients cirrhotic (amod)
caused deprivation (nmod)
have course (nmod)
overall more (advmod)
block seizures (dobj)
nissl-staining protein (nmod)
used found (conj)
cellular mitochondrial (conj)
patients particularly (advmod)
hand mydriasis (appos)
characterized incubation (nmod)
formation brain (compound)
had period (nmod)
severity minutes (nmod)
hypothesis decreases (ccomp)
results in (amod)
measure loss (dobj)
caused chemotherapy (nsubj)
assay concomitant (amod)
effects distress (nmod)
saline i.p. (advmod)
had manifestations (dobj)
1.037 ( (punct)
contribute that (nsubj)
induced drugs (nmod)
activity neurons (nmod)
anticonvulsants ) (punct)
associated showed (conj)
returned status (nsubj)
estimate cost (dobj)
reductase , (punct)
treatment azathioprine (nmod)
cycles 12 (nummod)
diclofenac ibuprofen (nmod:npmod)
seizure from (case)
received chemotherapy (dobj)
disappear elimination (dep)
5.4 - (punct)
beats/min frequency (nsubj)
symptoms confusion (nmod)
areas diffusion (nmod)
ducts of (case)
detection radiographic (amod)
causes hepatotoxicity (nmod)
sod and (cc)
increase dose (nmod)
maps cortical (amod)
effect bladder (nmod)
manifestation allergy (nmod)
presenting hypotension (nmod)
necrosis r (dep)
tap r (dep)
history effects (conj)
3 following (case)
learning ) (punct)
effect strong (amod)
withdrawn . (punct)
contraction maximal (amod)
departments authoratative (amod)
reduction scores (nmod)
monitored treatment (nmod)
undergoing without (mark)
mm 20 (appos)
rr ( (punct)
patient resulting (acl)
3.2 1.2 (conj)
hypertension adrenaline-induced (amod)
differentiate particular (nmod)
pain muscle (compound)
another 15 (dep)
drinkers for (case)
mechanism(s molecular (amod)
discontinued is (auxpass)
administered ribavirin (nsubjpass)
pms in (case)
ufh ) (punct)
scavenging through (case)
recovery renal (amod)
latter these (det)
utilizes assay (nsubj)
analyzed confirmed (conj)
antagonists nmda (compound)
desensitization because (case)
intensity stimulus (compound)
telangiectatic and (cc)
introduction essential (appos)
goldstein and (cc)
led reaction (nmod)
hepatitis due (case)
participants in (case)
volunteers 11 (nummod)
prudent . (punct)
muscles gastrocnemius (amod)
induced increasing (advcl)
event failure (nmod)
pacing . (punct)
approach this (det)
pge(2 urine (compound)
interaction the (det)
difference saw (acl:relcl)
concern complications (nmod)
opportunity the (det)
version modified (amod)
metabolites d (compound)
pod , (punct)
anaesthesia solution (nmod)
strain wistar (dep)
occurred one (nmod:npmod)
lead inhibition (nsubj)
blockade significant (amod)
use high (amod)
safety lidocaine (nmod)
caused herbs (nmod)
from 1992 (nmod)
compares prilocaine (dobj)
reduction discontinuation (conj)
used widely (advmod)
awakening and (cc)
screened macroprolactinemia (nmod)
parameters necessary (amod)
ci 1.53 (nummod)
10+/-1 to (dep)
symptoms side-effects (conj)
undertaken part (nmod)
csa rapamycin (conj)
fit women (nmod)
causes other (amod)
bf ( (punct)
safety therapy (nmod)
stimulation and (cc)
observed nonlactating (advcl)
determine explore (conj)
series prc (nmod)
intake levodopa (compound)
183 % (dep)
administered injection (nsubjpass)
failed control (xcomp)
concept the (det)
impaired renally (advmod)
have structures (dobj)
ocular systemic (conj)
intolerant therapy (nmod)
relationship their (nmod:poss)
level mg/m2 (conj)
electrodes epicardial (amod)
tropicamide to (case)
reaction immediate (amod)
il-1b tnf-a (conj)
induced c. (nmod)
associated allele (nsubjpass)
urinalysis and (cc)
measurements angiograms (nmod)
lipoproteinuria the (det)
displays substrate (nmod)
frequency mice (nmod)
criteria through (case)
unchanged compared (prep)
pcc i.v. (conj)
yr three (nummod)
likely type (nmod)
had catheter (advcl)
performed trial (dobj)
visits study (compound)
organisms bacilli (nsubj)
size this (det)
cocaine use (dep)
stable controls (nmod)
treatment consisted (acl)
conduct investigation (dobj)
difference response (nmod)
carbamazepine to (case)
inhibitors selective (amod)
associations : (punct)
times ) (punct)
regimens inhibitor (compound)
followed be (auxpass)
spasm due (case)
ribavirin recently (advmod)
penicillin-induced acute (amod)
included mi (dobj)
oedema bone (compound)
developed conversion (nmod)
optic ethambutol (amod)
suggest similar (ccomp)
quantify effects (dobj)
prolong may (aux)
compare administered (advcl)
mass to (case)
men % (compound)
induced capsaicin (nmod)
reversed can (aux)
biopsies ) (punct)
effect sm-5887 (nmod)
0.0005 ( (punct)
ug/ml respectively (advmod)
subjects of (case)
reduction outcome (conj)
staining ccr2 (compound)
effect results (acl:relcl)
hypotension fenoldopam-induced (amod)
use populations (nmod)
structures limbic (amod)
treated months (nmod)
aggregation induced (acl)
suppressed causing (advcl)
stimulus the (det)
excitement and (cc)
alkaloid diterpenoid (amod)
unaffected was (aux)
consider , (punct)
infusion amine (compound)
size reduced (amod)
dysfunction damage (conj)
degree the (det)
> pr (dep)
fmlp ) (punct)
available patients (nmod)
glioma human (amod)
died prematurely (advmod)
potency anticholinergic (amod)
assessments patients (nmod)
killed hours (nsubjpass)
mg/g and (cc)
reports current (amod)
< = (conj)
measure an (det)
arthritis osteoarthritis (conj)
made presentation (nmod)
hospitalisation effects (nmod)
concentrations morphine (nmod)
properties antipsychotic (amod)
none = (dep)
overdosage scopolamine (compound)
d1 antagonists (dep)
asa ) (punct)
gc-ht ) (punct)
fever a (det)
substances other (amod)
cardiotoxicity isoproterenol-induced (amod)
hearing of (case)
hbsag-negative ) (punct)
increased dramatically (advmod)
chemotherapy intensive (amod)
hem snp (conj)
metformin , (punct)
factor-beta1 transforming (amod)
index an (det)
reduces area (dobj)
extracted determine (advcl)
results similar (amod)
leading modes (nmod)
results mg/m2/d (appos)
function visual (amod)
interval 1.195 (nummod)
atropine 4-diphenylacetoxy-n-methylpiperidine (conj)
resection transurethral (amod)
events related (amod)
better be (cop)
activities tlr4 (compound)
reported not (neg)
group dfmo (compound)
dose doxorubicin (nmod)
involved response (nmod)
less 0.025 (nmod)
time infusion (compound)
attempt compound (nmod)
related patient (nmod)
d-1 both (cc:preconj)
characterize dependency (dobj)
mutation direct (amod)
toxicity undesirable (amod)
discontinued serial (conj)
bupropion zyban (appos)
receive weeks (nmod)
microscopy assay (conj)
ganaxolone ) (punct)
alpha2abc-knockout from (case)
consider likely (ccomp)
environment hormonal (amod)
rotation to (case)
patients matched (acl)
synergistic were (cop)
pancuronium mg (dep)
activation ) (punct)
glycosides of (case)
timolol than (case)
provided reassurance (dobj)
nsaids of (case)
consistent method (nsubj)
reported depletion (nsubjpass)
results promising (amod)
treatments drug (compound)
oxytocin and (cc)
effects benzodiazepine (compound)
associated demonstrated (dep)
submaximal treadmill (dep)
suggested mimic (xcomp)
albumin less (nummod)
days 12 (nummod)
= 0.012 (dobj)
arterioles glomeruli (conj)
patients twenty (nummod)
given propranolol (dobj)
symptoms hearing (advcl)
studies doppler (compound)
fluphenazine or (cc)
metabolism inositol (compound)
less mg/dl (dep)
patient-years 100 (nummod)
entities of (case)
rate 1-year (amod)
presence use (appos)
auc [ (punct)
min mesna (compound)
captopril ) (punct)
to risk (nmod)
clarified been (auxpass)
use antibacterial (amod)
secretion by (case)
binding (3)h-mk-801 (amod)
weeks acute (amod)
conclusive , (punct)
remain setting (nmod)
iop elevated (amod)
papers identified (amod)
induced 1,2-dmh (nmod)
diagnosis psychosis (nmod)
cmv ) (punct)
associated improvement (nsubjpass)
90 60 (compound)
enzymes liver (compound)
determined indicators (nsubjpass)
syndrome a (det)
induce adopted (advcl)
levels dose (compound)
ml/kg ( (punct)
levodopa agonist (conj)
subjected mice (nsubjpass)
hepatitis acute (amod)
15mg/kg ) (punct)
treatment belonging (acl)
demonstrated abrogated (ccomp)
patients 1,022 (nummod)
prednisone and (cc)
different content (nsubj)
ameliorated and (cc)
account some (nmod)
1999 2002 (nummod)
evidence effect (nmod)
lowering enos (dobj)
treatment eyes (nmod)
administered hr (nmod)
castrated and (cc)
result findings (nsubj)
b-100 and (cc)
november 1984 (nummod)
persisting hours (nmod)
amount e13.5 (nmod)
role peroxidation (nmod)
studies initial (amod)
mice pkca (compound)
have reduction (nsubj)
decreased 5.4 (nmod)
enhanced may (aux)
effects [na]o (nmod)
important , (punct)
mdm to (case)
hematoma a (det)
75 ) (punct)
arteritis , (punct)
electrocardiogram worn (acl:relcl)
useful required (dep)
foci induced (amod)
mothers b (compound)
studied unrestrained (advcl)
dilation using (acl)
report been (cop)
trigeminal both (preconj)
adhd ( (punct)
had treatment (nmod)
data present (amod)
1.13 ( (punct)
result use (nmod)
measured intervals (nmod)
parameters electrocardiograph (conj)
damaged are (auxpass)
define diagrams (nsubj)
na(+)/h(+ ) (punct)
sinensis of (case)
altered pretreatment (nmod)
increased 0.39 (nmod)
included results (dep)
myocarditis viral (amod)
prevented it (nsubj)
proteinuria function (conj)
depressants cns (compound)
hypokalemia severe (amod)
serve mostly (advmod)
decreases 4000hz (nmod)
15 6 (conj)
examination aggregation (nmod)
seeing stools (nmod)
three vancomycin (nmod)
support medical (amod)
ml above (case)
syndrome simvastatin-induced (amod)
acetonide with (case)
contributed mechanisms (nsubj)
alter mbp (dobj)
indication no (det)
frataxin protein (appos)
31 5 (conj)
reported this (nsubjpass)
intrathecal chemotherapy (dep)
p both (cc:preconj)
patients dyskinesias (nmod)
provides protection (dobj)
durations . (punct)
= 0.53 (dobj)
restarted mg/kg (nmod)
interaction regulation (nmod)
survivors no (det)
observed on- (nmod)
elf fam (conj)
abnormalities function (nmod)
revealed aim (dep)
dxnp ( (punct)
sch ( (punct)
larger subjects (nmod)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline 8-aminoquinoline (compound)
eyes postures (nmod)
ameliorated hydroxytyrosol (nmod)
dose galactose (amod)
influence that (mark)
tomography and (cc)
binding motility (conj)
electrocardiographic ecg (appos)
reduced which (nsubjpass)
association adherence (nmod)
properties smooth (amod)
rosacea of (case)
protein glial (amod)
blockade movement (nmod)
functions ) (punct)
influence any (det)
bia f/azepine-5-carboxamide (amod)
inhaled experiment (nmod)
intervention rtms (nmod)
micrograms/kg than (case)
found administration (nsubjpass)
complications system (compound)
light electron (conj)
dose g (nmod)
excretion reduced (amod)
waves loss (conj)
difference role (nmod)
pretreated isoniazid (nmod)
inhibition binding (nmod)
7 - (punct)
change outcome (conj)
found pathology (nsubjpass)
determine performed (ccomp)
muscle limb (compound)
administration amiodarone (nmod)
correlation volume (nmod)
status volume (compound)
interferon ribavirin (conj)
inhibition study (dep)
rats 20-day-old (amod)
% 55.2 (nummod)
disease underlying (amod)
receptor a2/a1 (compound)
dermatitis on (case)
serious and (cc)
defined akathisia (nsubjpass)
observed remission (nsubjpass)
excitability to (case)
screening drug (compound)
responses virological (amod)
established while (mark)
test selective (compound)
complex acida (compound)
targeted aucs (nmod)
rhythm junctional (amod)
use recent (amod)
exhaustion , (punct)
cases overdose (compound)
mg/m(2 courses (nmod)
prevalences the (det)
ameliorating furthermore (advmod)
detect early (advmod)
licking stereotyped (amod)
statistically . (punct)
alteration lipids (nmod)
event related (conj)
describe woman (dobj)
sustained who (nsubj)
reduced sdrr (nsubjpass)
dose ed(50 (appos)
compensates effects (nmod)
old ( (punct)
diskinesia orofacial (amod)
acid 5,7-dcka (appos)
psychological and (cc)
role receptor (nmod)
hypertrophy white-matter (amod)
= 0.613 (dobj)
etoposide and (cc)
prone may (aux)
polymorphic not (neg)
symptoms most (amod)
dropped level (nmod)
creatinine ( (punct)
determine step (ccomp)
s of (case)
d ( (punct)
pharmacokinetics pharmacodynamics (conj)
stability clot (compound)
striking advantages (nmod)
tendency decrease (acl)
cases amisulpride (advcl)
treatment c (compound)
acetaminophen by (case)
findings shown (acl)
phenylpropanolamine with (case)
studied pms (nsubjpass)
analgesic acute (amod)
magnitude this (det)
mutants promoter (compound)
accounts necrosis (nmod)
pollutants these (det)
interval treatment-free (amod)
reduced extent (dobj)
changes cytoplasmic (amod)
hydration , (punct)
supporting use (dobj)
loss function (nmod)
vtd ) (punct)
clearance endogenous (amod)
included total (nsubjpass)
patients receiving (acl)
cognitive motivational (conj)
attributed treatment (nmod)
carbachol with (case)
needed were (auxpass)
boy , (punct)
wall arteriole (nmod)
inconvenience the (det)
contribute shift (nsubj)
comments subject (nmod)
had syncope (dobj)
examined samples (nsubjpass)
damage oxidative/nitrative (amod)
calculated dose (dobj)
disorders temporomandibular (amod)
cvd known (amod)
suppressed co-administration (nmod)
brief and (cc)
effects patients (nmod)
rats pretreated (acl)
administered reduced (conj)
micronuclei of (case)
malignancies hematologic (amod)
lidocaine prophylactic (amod)
study open-label (amod)
trimester of (case)
comparison prevention (nmod)
prior perfusion (nmod)
use mefloquine (nmod)
agents hr (conj)
deleted has (aux)
exception ) (punct)
targeting enhanced (amod)
occurs tachyphylaxis (nsubj)
uncertain alerted (conj)
success patients (nmod)
schedules once-daily (amod)
1.30 3.54 (dep)
nephrotoxicity is (cop)
rate maximal (amod)
recovery regarding (case)
sodium ufh (appos)
days 36 (nummod)
1.8-fold ( (punct)
resulting anemia (nmod)
hoe des-arg10hoe (conj)
increases failure (nsubj)
patient granulomas (nmod)
group into (case)
onset disappearance (conj)
prevalent most (advmod)
antipsychotics first-generation (amod)
gds 6 (nummod)
complication treatment (nmod)
weight than (case)
cardiac thrombotic (dep)
damage that (det)
stenosis ( (punct)
suppressed results (dep)
exudate sinus (compound)
allopregnanolone ganaxolone (conj)
males pd (compound)
possible identify (xcomp)
report increased (ccomp)
performed compare (advcl)
exert effects (dobj)
dp/dt positive (dep)
17beta-estradiol e2 (appos)
associated groups (nsubjpass)
therapy methylprednisolone (amod)
vasoactive ventricular (nsubj)
involvement nucleus (compound)
period 60-min (amod)
quadrants from (case)
experienced patient (nsubj)
time long (amod)
appropriate . (punct)
stz-icv with (case)
liver lung (conj)
each of (case)
conclusions finding (dep)
incidence dysrhythmias (nmod)
quantitated ems (nmod)
ssr103800 such (case)
presented eruptions (nmod)
recorded studies (nmod)
rats 9 (nummod)
increased 1.8-fold (conj)
pyridoxine intramuscular (amod)
finding on (case)
done months (conj)
conclusion activity (conj)
conversion recipients (nmod)
cyclophosphamide , (punct)
exposure main (amod)
optic (emb)-induced (amod)
increased two (nsubj)
prevented pretreatment (nsubj)
sensorium hazy (amod)
agent this (det)
january between (case)
induction metallothionein (nmod)
patients prostate (compound)
biopsies nonepisode (compound)
dissociated successfully (advmod)
cmax/mic mean (amod)
equal g/m2/d (nmod)
grade hunt (compound)
effects hypertension (nmod)
infusions of (case)
hr given (case)
treatment sd (nmod)
ovex ) (punct)
activities cysteine (compound)
functions through (case)
very ( (punct)
model toxicity (nmod)
ml/s from (case)
infections azotemia (compound)
pvn the (det)
wires pacemaker (compound)
patients presented (acl:relcl)
reduced ) (punct)
developing mania (dobj)
undergone 24 (nsubj)
treated minutes (nmod:tmod)
mg. 5 (nummod)
days ' (case)
vasoconstriction arterial (amod)
provide advances (nsubj)
dose considered (conj)
injected intraperitoneally (advmod)
d-glucarate a (det)
ramh i.c.v. (appos)
avoided recurrence (nsubjpass)
changes localization (nmod)
capsule necrosis (conj)
chemotherapy chemotherapy (conj)
occurs primarily (advmod)
minority patients (nmod)
cleared who (nsubj)
unnecessary are (cop)
administration metoprolol (nmod)
differences potential (nmod)
injections steroid (compound)
safety medicines (nmod)
biochemical metabolism (nmod)
group further (amod)
250 effusions (nmod)
ineffectiveness because (case)
arteries intracranial (amod)
reductions total (amod)
recommendations for (case)
using episodes (nmod)
anterior and (cc)
patients syndromes (nmod)
moran 50 (conj)
treatment moderate (nmod)
values 0.01 (dep)
defined not (neg)
group 5 (nummod)
indicators sensitive (amod)
wall albumin (nmod)
incorporating b (dobj)
erythematosus gravis (conj)
one regimen (nmod)
preference aggression (conj)
had hallucinations (dobj)
seen changes (nsubjpass)
injected then (advmod)
neutralizes metabolite (dobj)
weight less (amod)
fraction fraction (conj)
develop lids (dobj)
synthesis data (compound)
received because (mark)
mrna anf (compound)
test used (acl)
symptoms hypotension (nmod)
exposure fluoxetine (nmod)
doses mg/kg (nmod)
cholinesterase serum (compound)
induce tdp (dobj)
prior delivery (nmod)
remedy a (det)
normotensive in (case)
qtls identified (acl)
treatment nh4ac (compound)
municipal in (case)
aneurysms analysis (dep)
respond % (nsubj)
data among (case)
amisulpride and (cc)
technique combination (nmod)
immunosuppressants but (cc)
disappearing with (mark)
marker psychophysiologic (amod)
mechanism immunologic (amod)
jj and (cc)
injection it (compound)
suggested findings (nsubj)
dogs , (punct)
induce examine (conj)
failure rat (nmod)
dysfunction diastolic (amod)
likely suggested (advcl)
studies blotting (compound)
beginning hospital (nmod)
unclear is (cop)
withdrawal study (compound)
restarted therapy (nsubjpass)
users n=12 (appos)
myelosuppression nor (cc)
echocardiography dobutamine (amod)
dose threshold (amod)
improved combination (nsubj)
function control (nmod)
incidence hemorrhage (nmod)
associated ; (punct)
mapping epicardial (amod)
tacrolimus cyclosporine (nmod)
content with (case)
group bcnu (compound)
echocardiography real-time (amod)
decreased pretreatment (nsubj)
dosages effective (amod)
battery with (case)
chills rigors (conj)
relief to (case)
demonstrated promoted (ccomp)
targets also (advmod)
treatments , (punct)
elevated levels (dobj)
features facial (amod)
combined failure (nmod)
cinacalcet , (punct)
conclude associated (ccomp)
independent age (nmod)
associated modafinil (nsubjpass)
all 2 (conj)
methods studied (conj)
disrupted groups (nmod)
thrombectomy a (det)
microg 20 (nummod)
follow-up 45-day (dep)
toxicities late (amod)
electroencephalographic behavioural (conj)
comprises coassemble (acl:relcl)
alternative treatment (nmod)
included which (nsubj)
combined hyperthermia (nmod)
anticipated be (auxpass)
susceptible interactions (nmod)
factors sex (nmod)
demonstrating damage (dobj)
cocaine benzoylecgonine (conj)
acid antagonist (conj)
hds lds (conj)
metamizol s.c. (compound)
pph 374 (conj)
stimulations mechanical (amod)
maintaining level (dobj)
drugs antiinflammatory (amod)
valves vasculature (conj)
agent ultra-short-acting (amod)
provision the (det)
infusions 111 (nummod)
labetalol isoflurane (conj)
output 3.6 (nummod)
warranted recommended (advcl)
mechanisms reactions (nmod)
refused postoperatively (advmod)
prevented protected (conj)
information insufficient (amod)
evaluation hemodynamic (dep)
causing episodes (dobj)
echocardiography performed (acl)
gastroenteritis and (cc)
bortezomib ) (punct)
group remifentanil (compound)
end to (case)
21.6 2.2 (conj)
tdf ( (punct)
greater turn (nmod)
corresponding inability (nmod)
control 5days/week (amod)
increases , (punct)
developed tma (dobj)
line microvascular (amod)
offers dosage (nsubj)
uncertain pattern (nsubj)
showed glomerulonephritis (dobj)
score sediment (compound)
tested efficiency (nmod)
penetrate barrier (dobj)
induced ritonavir (nmod)
taking phase (nmod)
reaction may (aux)
toxicity combined (amod)
agents doses (nmod)
l6 and (cc)
changes related (amod)
life-threatening some (nsubj)
os weeks (nmod)
involved pressing (advcl)
described patients (nmod)
seeded were (auxpass)
had recovery (dobj)
total weeks (nmod)
enzyme nte (appos)
disease coronary (amod)
pressures wedge (compound)
intoxication disulfiram (compound)
heparin worsened (acl:relcl)
defect birth (compound)
monitoring cardiovascular (amod)
dehydration hypernatraemic (amod)
capsule the (det)
recovery in (case)
women in (case)
cases years (conj)
suppressed treatment (nsubj)
based theorem (nmod)
cocaine mg/kg (appos)
cells/mm3 4.9 (nummod)
had score (dobj)
assessment resistance (nmod)
doses triazolam (nmod)
pas in (case)
employed chemotherapy (compound)
is ( (punct)
conclusion than (case)
mg 320/25 (compound)
supports increases (conj)
treatment raloxifene (compound)
syndrome lithium-induced (amod)
patients pediatric (amod)
chow days (nmod)
rose thereafter (advmod)
visits consecutive (amod)
toxicity nervous (amod)
total changes (nmod)
performance patients (nmod)
micrograms 30 (nummod)
brains -/- (compound)
greater ng./ml (nmod)
10 7 (compound)
published unpublished (conj)
concentration neurotransmitter (amod)
results trial (nmod)
caused rise (dobj)
rearing exploratory (conj)
findings to (case)
lower levels (nsubj)
decrease did (aux)
lowering by (case)
limits normal (nmod)
ppm 50 (nummod)
affected confounding (nsubj)
differences significant (amod)
patients men (dep)
dose 16-mg/kg (compound)
users oc (nmod)
neurotransmitters other (acl)
measurements the (det)
sedimentation gravity (compound)
infusions randomized (amod)
toxicity on (case)
use toxoplasmosis (nmod)
block wave (appos)
d , (punct)
administration topical (amod)
period within (case)
ds-sarcoma ( (punct)
acid harmful (amod)
euphoria and (cc)
children age (dep)
adherence guidelines (nmod)
mssbp and (cc)
heart hypertrophied (amod)
follow-up over (case)
man 76-year-old (amod)
conversion rapa (compound)
affected abolished (conj)
division nerve (nmod)
presented cases (nmod)
employing delay (dobj)
treatment ketoconazole (compound)
dementia severe (amod)
rate volume (appos)
groups isoproterenol (amod)
carbachol eserine (conj)
spectrum including (case)
require support (dobj)
lines in (case)
secretion resting (amod)
hypercalcemia n (dep)
pyrazinamide to (case)
platelet average (amod)
ntg mice (conj)
2/1 intermittent (amod)
findings with (case)
play hypotension (nmod)
infusion trinitrate (compound)
aware . (punct)
angiographies occurred (advcl)
prodrug ) (punct)
preventing effects (dobj)
formyl-methionyl-leucyl-phenylalanine with (case)
prolongs published (conj)
gradient 3d (compound)
substrate p450 (compound)
women years (nmod)
effects l-name (conj)
90 - (punct)
showed erythrocytes (nsubj)
revealed were (auxpass)
revealed ; (punct)
seizure mg/kg (nmod)
administered antagonist (nsubj)
patients respectively (advmod)
mrp2 of (case)
areas injections (compound)
resulted titer (dobj)
had rash (dobj)
rast bpo-pll (nmod)
largest size (nmod)
deprivation nutritional (amod)
trinitrate donor (appos)
block . (punct)
group injected (acl)
later life (nmod)
consistent . (punct)
reaction eosinophilia (conj)
observed ulcers (nsubjpass)
tool tee (nsubj)
i.e. epilepticus (nmod)
middle class (conj)
retrieval experiences (nmod)
6 ) (punct)
tiapride alone (advmod)
% 0.05 (nummod)
birth practice (conj)
inhibitor with (case)
imipenem/cilastatin of (case)
restored was (auxpass)
crosses have (conj)
fluorescein sodium (dobj)
effects sedative (amod)
using tube (nmod)
correlations the (det)
rtms effects (appos)
supervision should (aux)
patients failed (acl:relcl)
alter cpap (nsubj)
profile coagulation (compound)
medications known (acl)
differences adenoma (nmod)
seems also (advmod)
produce ulcer (dobj)
fornix the (det)
lipocalin ngal (appos)
points administration (nmod)
data in (amod)
nmbas bromide (nmod)
when than (mark)
treatment without (case)
clinical metabolic (dep)
triglycerides and (cc)
8.07 +/- (cc)
chemotherapy nephrotoxic (amod)
anticoagulants not (neg)
ci 4.18 (nummod)
lesions rats (conj)
shape abnormal (amod)
enflurane by (case)
effect furosemide (nmod)
3.4 42.5 (nummod)
mug 3 (nummod)
related cya (nmod)
collection in (case)
irritation bladder (compound)
required treatment (dobj)
fatiguability dyspnoea (conj)
disruption a (det)
.002 than (case)
aetiology in (case)
demonstrated awakening (nmod)
observed has (aux)
modified , (punct)
reduce incidence (dobj)
acidity pain (nsubj)
retardation marked (amod)
dyskinesias contralateral (amod)
320/12.5 mg (dep)
carcinoma cervix (nmod)
plasticity induced (acl:relcl)
intensity pain (compound)
anesthetics all (det)
toxicity selective (amod)
day of (case)
nodules hyperplastic (amod)
magnitude result (xcomp)
suggested effective (ccomp)
arrhythmia contraction (appos)
contraindication receiving (advcl)
regimen ) (punct)
organization tonotopic (compound)
tested never (neg)
failed improve (xcomp)
incidence time (conj)
arterial and (cc)
permeability albumin (nmod)
2-adrenoreceptor alpha (compound)
reviewed compared (conj)
show decrement (dobj)
comparing by (mark)
cause hearing (advcl)
loss or (cc)
scored min (nmod)
mitoq. by (case)
exposure 12-hour (amod)
mglur5 , (punct)
mice c3heb/fej (compound)
deposits scanty (compound)
ko mice (conj)
patterns use (nmod)
depression output (nmod)
results respectively (advmod)
assessed causality (dobj)
adjustment additional (amod)
assess impact (dobj)
unit to (case)
increases while (mark)
ng 1 (nummod)
injections than (case)
potentials evoked (amod)
reached values (dobj)
position the (det)
revealed days (nmod)
dilatation to (case)
disorders rheumatologic (amod)
therapy sulpiride (compound)
applied be (auxpass)
substances for (case)
body whole (amod)
believed modulation (xcomp)
which following (case)
generated have (aux)
experimental extensive (amod)
free precursors (nmod)
showed rhythm (dobj)
selecting agent (dobj)
combination d (nmod)
classification the (det)
mutant rat (compound)
secondary agents (nmod)
men six (appos)
caudate of (case)
changes structural (amod)
mg/kg/day were (cop)
(ami)-induced amiodarone (amod)
discussed mechanisms (nsubjpass)
pain resolved (acl)
gene ( (punct)
known administration (nsubjpass)
act may (aux)
tubular , (punct)
adjust range (nmod)
necessary be (cop)
15 over (case)
suitable use (nmod)
acetate zinc (compound)
aortic of (case)
classical atypical (conj)
ischemia and (cc)
hcbd by (case)
drugs study (compound)
exist that (mark)
atac ( (punct)
rad001 of (case)
rise baseline (nmod)
causes : (punct)
apoptosis lymphocytes (conj)
5.7 - (punct)
n-butyl-deoxynojirimycin with (case)
diabenese ) (punct)
nitroglycerin with (case)
mice normal (amod)
anemia treated (acl)
treatment inhibitor (nmod)
function symptoms (conj)
referred effective (ccomp)
medications immunodeficiency (compound)
grade severe (amod)
administration repeated (amod)
was presented (advcl)
glaucoma exhibits (acl:relcl)
therapy acute (amod)
visualize index (nmod)
disease primary (amod)
propranolol antagonist (compound)
reversibility possible (amod)
occurs advantages (nmod)
microinjection after (case)
diameter with (case)
trimethoprim trimethoprim-sulfamethoxazole (conj)
= ci (nsubj)
sleep night-time (amod)
perturbation structural (amod)
subjects 23 (nummod)
diets choline-devoid (amod)
motor of (case)
examined slices (nmod)
catalepsy behavior (appos)
process called (acl)
patients some (det)
clear not (neg)
chemotherapy concomitant (amod)
used destroy (xcomp)
49 5 (conj)
eyes effusion (conj)
mm sed (dep)
seems however (advmod)
required although (mark)
injecting ventricle (nmod)
astrocytomas failed (acl:relcl)
function her (nmod:poss)
mustard , (punct)
explanation without (case)
day day (appos)
indications offer (acl:relcl)
infarctions hypertension (conj)
one following (nmod)
mg/kg/day 5 (nummod)
patients 7 (appos)
cerebellum induced (acl)
overdose an (det)
due mainly (advmod)
dose large (amod)
expressions facial (amod)
individuals mm (compound)
l-dopa mg/kg (appos)
respond well (advmod)
value ( (punct)
zidovudine and (cc)
bypass surgery (conj)
epicardium endocardium (conj)
changes factor (nmod)
percent seventy-nine (amod)
period over (case)
doses especially (advmod)
identifying mechanisms (dobj)
storage urine (compound)
min mg/kg/4 (compound)
scenario is (cop)
hp by (case)
higher that (nsubj)
1.53 1.01 (nummod)
aspirin versus (cc)
block for (case)
rtms low-frequency (amod)
dysfunction indomethacin (compound)
prescribed months (nmod)
role about (case)
remains thus (advmod)
% effect (nsubj)
micturition per (case)
agents of (case)
rural and (cc)
levels bold (compound)
12 range (quantmod)
involved interactions (nsubjpass)
roles lipopolysaccharide (nmod)
care , (punct)
addicts of (case)
patient presence (nmod)
counterbalanced placebo-controlled (dep)
common less (advmod)
therapy antithyroid (compound)
present amount (nmod)
mianserin mg (nummod)
ecg dp/dtejc (conj)
level uric (amod)
hybridization northern (compound)
modification , (punct)
hyperlocomotion rats (nmod)
based , (punct)
dose prophylaxis (nmod)
tachycardia ventricular (amod)
experienced past (nmod)
cbz mg/kg (appos)
seems mechanism (xcomp)
control pressure (nmod)
dipyridamole and (cc)
58.5 + (cc)
marked sedation (nmod)
conclusions pathway (dep)
tribute ) (punct)
proteinuria ) (punct)
determined patients (nmod)
mmhg than (case)
day mg/dl (conj)
scans resonance (compound)
a result(s (compound)
reflected predominance (dobj)
diuretics , (punct)
hemolysis of (case)
avoidance , (punct)
sirolimus consequence (conj)
syndrome complicated (acl)
effects characteristics (nmod)
control after (case)
patients suffering (acl)
reported syndrome (nmod)
b chronic (amod)
procedures different (amod)
preference upon (case)
indicated lowering (nmod)
measures examinations (nmod)
common resolved (conj)
developed injection (nmod)
receiving dxr (dobj)
effect effective (amod)
evaluates review (nsubj)
1995 and (cc)
experienced anthracycline (dobj)
fa mitomycin (conj)
group cooperative (compound)
timolol reduced (conj)
lesions absent/mild (amod)
1.12 1.04 (compound)
compared muscles (nmod)
898 12 (compound)
patients thrombocytopenia (appos)
developed cyclophosphamide (nmod)
conners the (det)
efficacy furosemide (nmod)
mg/kg p.o. (conj)
induction failure (nmod)
increase levels (nmod)
trial the (det)
intensity from (case)
aborted . (punct)
mg/day 0.6 (nummod)
preceded was (auxpass)
> mg/dl (dep)
model to (mark)
sensitivity low (amod)
centers classification (nmod)
hyperplasia or (cc)
exposed millions (nsubjpass)
3',5'-monophosphate adenosine (compound)
processed was (auxpass)
coadministered longer (advmod)
ratio or (dep)
txb2 ( (punct)
made can (aux)
i/4e to (case)
anemia azt-induced (amod)
characterized and (cc)
plays receptor (nsubj)
decreased cholesterol (nmod)
administered subcutaneously (advmod)
inducing of (mark)
ratio 30.7 (dep)
patients fluctuations (appos)
stimulation triple (amod)
piroxicam with (case)
intake on (case)
years enrolled (advcl)
80.0 to (case)
likely more (advmod)
admissions of (case)
permitted permits (ccomp)
hexamethonium the (det)
a/j and (cc)
reduced latency (dobj)
interactions of (case)
min injections (nmod)
doses capsaicin (compound)
strategies immunosuppression (nmod)
caused haart (nsubj)
22 of (advmod)
99 infusions (nsubj)
decreased observed (conj)
inserts their (nmod:poss)
identified causes (nsubjpass)
help . (punct)
true converse (nsubj)
quantitative additive (dep)
maintained she (nsubj)
administration flumazenil (nmod)
escalated mg/m2/d (nmod)
stopped once (mark)
september from (case)
density volume (compound)
density ] (punct)
accumulation b (compound)
interval 95 (nummod)
effect severity (nmod)
given i.v. (advmod)
led consequence (parataxis)
1.041 p (appos)
blocked pretreatment (nmod)
signs fever (nmod)
purpura syndrome (conj)
19.3 19.1 (conj)
regimen daunorubicin (compound)
movements purposeless (compound)
relationship a (det)
sulfate nifedipine (conj)
l2 and (cc)
mk-801 of (case)
denopamine micrograms (compound)
lozenge % (compound)
months 20 (compound)
causes were (cop)
stimuli mitogens (conj)
is happens (dep)
narcosis dual (amod)
treated gentamicin (nmod)
recipients cyclosporine (nmod)
related cells (nmod)
criteria nodosa (nmod)
therapy antimicrobial (amod)
neurophysiology epilepsy (nmod)
evolution renal (amod)
depression dysfunction (conj)
reverse did (aux)
screening b (nmod)
poorer significantly (advmod)
received days (dobj)
medicate . (punct)
shown that (nsubj)
risk lead (acl:relcl)
evaluated method (dep)
led changing (csubj)
case associated (acl)
mean years (dep)
aminotransferase ( (punct)
treatment following (case)
examine safety (dobj)
disorders thyroid (compound)
became hypercalcemic (acomp)
followed courses (nmod)
demonstrate : (punct)
omd ( (punct)
meq/l ) (punct)
1.9 mg/kg (conj)
using device (dobj)
20 35 (conj)
receiving subjects (nsubj)
glaucoma hypertension (conj)
attacks the (det)
sirolimus especially (advmod)
acne hirsutism (conj)
blocker dopaminergic (amod)
enalapril to (case)
response control (conj)
30 30 (dep)
reduced stopping (csubj)
agranulocytosis associated (amod)
exhibited contrast (nmod)
320/25 to (case)
multicenter efficacy (conj)
represented idiosyncrasy (dobj)
metabolites no (compound)
cystitis function (nmod)
that artery (nmod)
1 more (advmod)
arabic ( (punct)
resulting epilepticus (nmod)
irrigated surgery (nmod)
investigated . (punct)
prilocaine ml (compound)
used period (nmod)
having encephalopathy (dobj)
sulfation acid (nmod)
tolerable dose (nsubj)
time depolarization (compound)
metrics two (nummod)
requires , (punct)
100mg/kg ( (punct)
provide also (advmod)
2.4 2.5 (nmod)
effects biphasic (amod)
bear . (punct)
hospitalized , (punct)
exceeds mg/m2 (dep)
dependent but (cc)
fall threshold (nmod)
increase sod-induced (amod)
perfusion isolated (amod)
found infarction (dobj)
relevant treatment (nmod)
tone , (punct)
tested that (mark)
deaths in (case)
animals ilk/liver-/- (amod)
major and (cc)
those myopathy (nmod)
have to (mark)
mean assessed (advcl)
data subjects (nmod)
% disease (compound)
apomorphine and (cc)
minute one (nummod)
results which (nsubj)
discussion complication (dep)
prolonged response (dobj)
lesions inferior (amod)
chloramphenicol to (case)
plays damage (nmod)
inhibition return (nmod)
duration monophasic (amod)
counter anorectics (nmod)
patient cancer (compound)
actions excitatory (amod)
influence hyperprolactinemia (nmod)
role occurring (acl)
iii and (cc)
objectives study (appos)
compared rates (dobj)
induced first (amod)
has compared (prep)
hyper- , (punct)
hypothesis a (det)
treated while (mark)
cases cad (nmod)
needed monitoring (nmod)
correlation dose (compound)
dysrhythmias of (case)
decreased responses (dep)
tissues these (det)
doses adrenaline (conj)
midazolam combination (conj)
ampka phosphorylated (amod)
indices damage (nmod)
alternation spontaneous (amod)
inhibited and (cc)
24.3 index (nsubj)
icv infused (conj)
comprised treatment (nsubjpass)
upset respiratory (amod)
slight lot (conj)
pathogeneses and (cc)
decline by (case)
left reversible (nsubj)
eds ) (punct)
confirmed group (nmod)
butyrylcholinestrase buche (appos)
features lymphadenitis (nmod)
% 12.9 (nummod)
effect body (appos)
reduced protein (nsubjpass)
administered s-53482 (nsubjpass)
displayed expressions (dobj)
present when (advmod)
reviews pharmacology (dobj)
findings epithelium (nmod)
screened patient (nsubjpass)
found unresponsive (xcomp)
affected development (nsubj)
have reports (nsubj)
occurred b (dep)
atropine naloxone (conj)
insurance 1997 (nummod)
drug hydrochloride (appos)
model unilaterally (amod)
inadequate is (cop)
march and (cc)
occurrence pvc (nmod)
evaluation biomarkers (nmod)
acetate methylprednisolone (amod)
flushing after (mark)
largest be (cop)
potency vip (nmod)
ve in (case)
attempt the (det)
amygdala , (punct)
acc ( (punct)
menorrhagia and (cc)
treated amikacin (nmod)
intakes 1.0 (nmod:npmod)
undertaken be (auxpass)
activity cholinesterase (nmod)
outflow loop (nmod)
developed seroconversion (conj)
effect one (nummod)
changes affinities (nmod)
dp/dt hearts (nmod)
daily or (cc)
syndrome bowel (compound)
generation increased (amod)
amblyopia quinine (compound)
prevented p (dep)
has that (dobj)
reversibility insufficiency (nmod)
mechanisms withdrawal (nmod)
investigated phenotypes (dobj)
introduction 's (cop)
rats become (acl:relcl)
changes wave (compound)
events coronary (amod)
receptors postsynaptic (amod)
sod in (case)
relation an (det)
ratio the (det)
antagonized . (punct)
msg ) (punct)
signs failure (nmod)
imbalance causing (acl)
frequency thromboembolism (nmod)
investigated subsequently (advmod)
scopolamine morphine (conj)
treated rauwolscine (nmod)
ingestion after (case)
patients 8000 (nummod)
chance higher (amod)
neurotoxic , (punct)
predicting dysfunction (dobj)
propensity in (case)
metoprolol t.i.d. (dep)
buffers in (case)
discontinuation drug (nmod)
present effects (nsubj)
associated alone (advmod)
those use (appos)
exerts vasodilatation (nmod)
1mg/kg approximately (advmod)
diabetic ) (punct)
sheath of (case)
antagonized prevented (conj)
tended use (nsubj)
action membrane-stabilizing (amod)
( oscs (dep)
findings man (nmod)
ganglia root (compound)
mm 137 (compound)
damage muscle (compound)
viral immunological (conj)
h2-receptors of (case)
40 vs. (cc)
cause hypertension (nmod)
substantiate . (punct)
median 5.3 (nummod)
effects caffeine (nmod)
exhibits as (mark)
participants trial (nmod)
adriamycin carcinoma (nmod)
compare those (nmod)
favored role (dobj)
beneficial not (neg)
prednisolone 100 (nummod)
bradycardia accompanied (acl:relcl)
performed solution (nmod)
loss sensation (nmod)
recognition treatment (conj)
dysphonia of (case)
responses responses (conj)
hospital scale (nmod)
prl-r suppressor (conj)
lobes frontal (amod)
activity drug (nmod)
evaluation effects (nmod)
convulsion lidocaine-induced (amod)
combination fixed-ratio (amod)
patients referred (acl)
dose adriamycin (nmod)
% cost (nsubj)
efficacy of (case)
well-tolerated asymptomatic (dep)
48 45 (conj)
reduction 1 (dep)
myalgia concentrations (nmod)
recommended times (nsubjpass)
relying rate (nmod)
sarcoma , (punct)
affect to (mark)
occurrence infarcts (nmod)
individuals six (nummod)
lead however (advmod)
secretion patients (nmod)
ginseng of (case)
scale by (case)
render to (mark)
activation cisplatin (nmod)
switched early (advmod)
caused fs (nsubj)
seizures lidocaine (compound)
rats ato-treated (amod)
initiation warfarin (nmod)
preventing relapse (dobj)
return hyperkinesis (nmod)
underwent test (dobj)
alleviated was (auxpass)
s 5.64 (nummod)
recordings bundle (compound)
cases . (punct)
suspected discontinued (conj)
encephalopathy and (cc)
trigeminal the (det)
healthy , (punct)
segment sphenoidal (amod)
nrp ) (punct)
pt ) (punct)
development hepatotoxicity (nmod)
observed expression (nsubjpass)
sex damage (conj)
perimysial endomysial (conj)
consisted exclusively (advmod)
intervention is (cop)
have initiation (nmod)
aes from (case)
obtain that (mark)
adopted however (advmod)
reversed was (auxpass)
patient with (case)
dogs seven (nummod)
h 0.001 (dep)
subsides which (nsubj)
responded compared (dep)
finding the (det)
occurred 13 (nmod)
showed course (nmod)
bile and (cc)
adult the (det)
apoptosis cells (nmod)
induced prl-r (dobj)
ctnt extent (conj)
patients melphalan (nmod)
assumed point (nmod)
opaque not (neg)
compared outpatients (nmod)
required were (auxpass)
evaluation etomidate (nmod)
cycles consecutive (amod)
focus epileptic (amod)
symptoms adverse (amod)
adults 24 (nummod)
known apnea (nsubjpass)
gene bche (appos)
said mode (nsubjpass)
angio-oedema pre-existing (amod)
levels sodium (compound)
comparable , (punct)
overflow enhanced (amod)
impact negative (amod)
ethambutol and (cc)
colitis ulcerative (amod)
experienced male (nsubj)
eating with (mark)
syndrome dysmenorrhea (nsubj)
recovered range (nmod)
experienced compared (prep)
trials in (case)
required . (punct)
matrix the (det)
test with (case)
mononucleate % (compound)
occurrence unusual (amod)
inhibition oxidase (nmod)
anaesthetized . (punct)
implicated clarithromycin (nsubjpass)
later year (nmod:npmod)
involvement partial (amod)
treated fk506 (nmod)
examined if (mark)
attributed bradycardia (nsubjpass)
suppressing dna (dobj)
toxic can (aux)
assess outcomes (dep)
content sn (nmod)
reversed propranolol (nsubj)
remained confined (advcl)
hours administration (nmod)
agents different (amod)
cancer women (nmod)
induce remoxipride (nsubj)
risk arthritis (nmod)
approaches immunosuppression (nmod)
greater less (conj)
treated steroids (nmod)
change patient (nmod:poss)
absent day (nmod)
frequency mean (amod)
45 8 (conj)
sequences t1-weighted (amod)
result although (mark)
treatment agonist (nmod)
disappeared controls (nmod)
reduction hemoglobin (nmod)
woman depressed (amod)
depressed part (nmod)
change activity (nmod)
stabilized levels (dobj)
occurred change (nsubj)
users non-users (conj)
patients thirty-one (compound)
difference dxnp (nmod)
effective clinically (advmod)
toxicity gastrointestinal (compound)
damage glomerulosclerosis (conj)
induced cases (dobj)
time 0 (nummod)
treated methods (nsubjpass)
protein 8.8 (nummod)
low-osmolar medium (dep)
ratios positive (amod)
globulin and (cc)
sufficient , (punct)
influence model (nmod)
task an (det)
ingestion dose (nmod)
studies assessed (acl:relcl)
titers interferon (compound)
concentrations efficacious (amod)
cbf cmro2 (conj)
shortened experiments (nmod)
repair of (case)
component regimens (nmod)
limbs distal (amod)
carcinogens and (cc)
administration safe (amod)
applied before (advmod)
dysrhythmias may (aux)
infants preterm (compound)
treated paracetamol (nmod)
sections including (case)
survivors among (case)
associated phenylpropanolamine (nmod)
maintained , (punct)
administered dox (nmod)
measured outcomes (dobj)
is hypothesis (nsubj)
detect differences (dobj)
disadvantages frail (acl)
widely more (advmod)
patients necrotizing (nmod)
developed respectively (advmod)
nsclc ( (punct)
therapeutic potential (amod)
leading syndrome (nmod)
left 5-micrograms/kg (nmod)
connects machinery (nmod)
diet diet (conj)
years were (cop)
co-agonist ( (punct)
imbalance been (cop)
received littermates (nsubj)
24.4 +/- (cc)
ethanol/aap-mice to (case)
application eye (nmod)
relieve administration (nsubj)
lack rara (nmod)
2e1 p450 (compound)
pg/ml were (cop)
% was (cop)
localization injections (nmod)
examined histologically (advmod)
hyperactivity cell (compound)
expression pathways (nmod)
somnolence vs (cc)
cd50 the (det)
endocarditis infective (amod)
seroconversion for (case)
sensation pain (compound)
having relatives (dobj)
some damage (nmod)
volunteers and (cc)
behaviors anxiety-like (amod)
years 50 (nummod)
hydrochloride raloxifene (compound)
stimulation verapamil (compound)
male 24-year-old (amod)
effects conditions (nmod)
ntg 2 (dep)
numbers observed (acl)
18.88 1.48 (conj)
influence binding (dobj)
p75(ntr ) (punct)
alterations bupivacaine-induced (amod)
flexion extension (conj)
dmso/side microl (compound)
form to (case)
woke he (nsubj)
suggests obtained (ccomp)
evoke signs (dobj)
relating ic (dobj)
recognized also (advmod)
treated pamidronate (nmod)
lesions of (case)
neuroimage 1328 (nmod:tmod)
studies three (nummod)
woman failure (nmod)
need because (case)
incidence annual (amod)
appeared therapy (nsubj)
patients normokalemic (amod)
bepridil with (case)
increase clearance (nmod)
cystitis severe (amod)
ee ( (punct)
filaments gauges (appos)
hcva ( (punct)
15-f(2t)-isop ) (punct)
affect atherosclerosis (dobj)
oxidase c (compound)
increased increase (nmod)
were ; (punct)
2009 and (cc)
involved mediating (advcl)
addition adjust (acl)
strategy cta (compound)
saccades and (cc)
area medial (amod)
state hypertensive (amod)
anesthetic this (det)
pathogenesis is (cop)
effects occur (acl:relcl)
ether hfde (appos)
electroshock maximal (amod)
increase infarction (nmod)
conducted review (dobj)
post-operative high (amod)
development ) (punct)
oil and (cc)
slow fast (conj)
ratios ci (conj)
pyrophosphate thiamine (compound)
triggers methamphetamine (nsubj)
followed repair (nmod)
disease grade (compound)
abuse substance (compound)
prepared patients (nsubjpass)
list from (case)
effects by (case)
membranes to (case)
7.0 interval (dep)
decreases it (nsubj)
pattern labelling (compound)
1987 between (case)
procedures short (amod)
eminence in (case)
patients coronary (amod)
diagnosed carcinoma (nmod)
withdrawn countries (nmod)
part study (nmod)
16 , (punct)
increase hepatic (nmod)
abnormalities intraventricular (amod)
index groups (nmod)
explain decreased (conj)
saline mg/kg (dep)
fr of (case)
post-cab , (punct)
death on (case)
depressive of (case)
lower reduction (nsubj)
given again (advmod)
atria the (det)
groups dhea (dep)
conclusion affects (dep)
sensitized . (punct)
bid -16.2 (appos)
syndrome pain (compound)
elevation adam10 (nmod)
treatment induction (nmod)
tested mk-801 (nsubjpass)
compound acid (appos)
sum was (cop)
osteoporosis and (cc)
courses 154 (nummod)
atpase ca+2 (compound)
undergone had (aux)
mg/kg after (case)
increases cholesterol (nmod)
associated , (punct)
exert that (mark)
estradiol lh (conj)
species other (amod)
drugs dose (nmod)
contractant direct (amod)
vasoconstriction including (case)
alpha- in (case)
models tubular (nmod)
amounts significant (amod)
mild is (cop)
n-methyl-d-aspartate low (amod)
tachycardia related (amod)
piroxicam 0.2 (conj)
used whereas (dep)
chlorpropanol ) (punct)
increased verapamil (nsubj)
> mg (dep)
worsen possibly (advmod)
dose medication (nmod)
result that (nsubj)
diphosphate of (case)
consisted hdl (nmod)
e4031 of (case)
antiplatelets combination (appos)
attacks aura (nmod)
adopted has (aux)
0.06 = (dep)
fluids irrigating (amod)
association cancer (nmod)
assigned animals (nsubjpass)
had five (nsubj)
induced pentylenetetrazole (nmod)
delirium connected (acl)
administration preeclampsia (nmod)
regarded use (nsubjpass)
layers bladder (nmod)
given intragastrically (advmod)
micrograms/kg , (punct)
continued function (nsubj)
pain both (preconj)
clinical best (advmod)
decrease resistance (nmod)
size begin (acl:relcl)
gpi in (case)
cortex hippocampus (conj)
metabolites . (punct)
injections 4 (nummod)
flecainide paroxetine (conj)
alterations against (case)
necrosis spontaneous (amod)
cytotoxicity doxorubicin (nmod)
syndrome myopathy (conj)
function mitochondria (nmod)
peg ) (punct)
alpha ventricular (amod)
prolongation recurrent (conj)
effects alcohol (compound)
injection mg/kg (appos)
correlation be (cop)
38 24 (dep)
diagnose ct (nmod)
blocks furthermore (advmod)
mediated receptors (nmod)
tested mice (nmod)
conversion everolimus (nmod)
found none (nsubjpass)
data electrophysiologic (amod)
vertigo of (case)
results predictors (nsubj)
approach via (case)
protein mrna (conj)
mbc with (case)
mass in (case)
overdose two (conj)
cancer recurrent (amod)
effects thp (nmod)
protect pilocarpine- (nmod)
% 6.2 (nummod)
sos ) (punct)
apoptosis cardiac (amod)
tested behavioral (nmod)
patients methamphetamine (compound)
effects antipsychotics (nmod)
antagonize and (cc)
prolongation qt (compound)
propranolol insulin (conj)
indicated resulted (ccomp)
relationship initiation (nmod)
hazardous is (cop)
effective antagonists (nsubj)
compared aims (nsubj)
0.3 up (advmod)
slices of (case)
ach of (case)
episode initial (amod)
administered treatment (nsubjpass)
background dependence (nmod)
therapy five (conj)
calls this (nsubj)
dipping assessed (acl)
weeks eight (nummod)
eighty-four hundred (compound)
less importantly (advmod)
allows administration (dobj)
allocated subjects (nsubjpass)
step formation (nsubj)
become refractory (xcomp)
applicators information (nmod)
infections early (amod)
indicating mitochondria (dobj)
died days (nmod)
chloramphenicol cycloheximide (conj)
patients using (acl)
mixture a (det)
decreasing addition (dep)
mg/day 240 (nummod)
relapse hepatitis (nmod)
rpgn of (case)
addictive . (punct)
receptor the (det)
neurons glutamate (amod)
artery after (case)
globulin globulin (conj)
cases no (det)
evaluated complaints (nsubjpass)
resulted levels (nmod)
unchanged that (mark)
gliomas around (case)
eradication pathogen(s (nmod)
mbp ( (punct)
change content (conj)
570 out (advmod)
participates synthase (nsubj)
bacteremia mssa (amod)
assigned asenapine (conj)
randomized previous (amod)
reactions hypersensitivity (compound)
undetermined . (punct)
common disturbance (nmod)
anesthetics representative (amod)
sectors the (det)
heparins molecular (amod)
target angiogenesis (nsubj)
microg and (cc)
received courses (dobj)
dopamine for (case)
effect ) (punct)
clonidine for (case)
coil circular (amod)
detected are (auxpass)
describes case (dobj)
dogs reserpinized (amod)
rr=1.60 ; (punct)
receiving amiodarone (dobj)
x-rays and (cc)
site are (cop)
fk506 mg/kg (dep)
system direct (amod)
products contaminated (amod)
then now (conj)
correlations different (amod)
estrogens replacement (compound)
appeared or (cc)
fracture or (cc)
proves . (punct)
i/d ( (punct)
explanation is (cop)
uspstf ) (punct)
cardiotoxin potent (amod)
include primarily (advmod)
study trimethoprim (conj)
caused to (mark)
discontinuing and (cc)
desire . (punct)
given ) (punct)
excluded violation (nmod)
chemotherapy combination (compound)
eluates erythrocytes (nmod)
activity antitumour (amod)
rare minor (conj)
more no (neg)
found inhibit (ccomp)
mg mean (dep)
monkeys in (case)
attenuated alpha-tc (nsubj)
1.0 1.11 (conj)
induced doses (nsubj)
applied treatments (nmod)
treatment arteriosus (nmod)
attenuated improving (advcl)
responsiveness responsiveness (conj)
extent % (nmod)
effect overall (amod)
mk-212 agonist (compound)
valve . (punct)
affect 5-fu (nsubj)
ligands by (case)
anemia azidothymidine (compound)
dm ( (punct)
which for (case)
khz 10 (nummod)
ratio prevalence (compound)
effective initially (advmod)
concentration ticlopidine (nmod)
airway of (case)
tend but (cc)
loss with (case)
practice relevance (compound)
assessed trial (nmod)
50 500 (conj)
testing serial (amod)
production nature (conj)
blockers multichannel (compound)
3.8 - (punct)
difference oxygen (compound)
phenotype to (case)
powders bicarbonate (compound)
active models (nmod)
importance region (nsubj)
first which (nsubj)
94 forty (compound)
therapy concomitant (amod)
followed pattern (dobj)
implicated side (dobj)
evaluated level (nmod)
excretion pap (nmod)
media from (case)
required nausea (nmod)
isoflurane anesthetic (amod)
aspartate potassium (compound)
analysis humphrey (compound)
interference any (det)
unassigned studies (dep)
inhibitor fibrinolysis (compound)
inhibitor 2d6 (nmod)
discussed strategies (nsubjpass)
exclude definitely (advmod)
infections abdominal (amod)
group patient (compound)
epinephrine both (cc:preconj)
haloperidol , (punct)
countries world (nmod)
absence despite (case)
criteria classification (nmod)
described ago (advmod)
dysfunction arterial (amod)
common severe (conj)
subjects twelve (nummod)
concentration micromol/l (nmod)
experiments of (case)
17.5 - (punct)
indicator survivors (nmod)
help shown (advcl)
increased ml (nmod)
min 0.001 (appos)
seizures recurrent (amod)
changes against (case)
have however (advmod)
defined increase (nmod)
effusion neuropathy (conj)
assessed as (advmod)
result contact (nsubj)
urticaria chronic (amod)
profile clear (amod)
support findings (nsubj)
served models (nmod)
compartment of (case)
diet either (cc:preconj)
mirror that (mark)
resulted elicited (conj)
cardiomyopathy takotsubo (compound)
ranged that (mark)
possibility to (case)
movement , (punct)
stones their (nmod:poss)
receiving ritodrine (dobj)
argatroban on (case)
evaluated improves (ccomp)
discouraged that (mark)
patients enrolled (acl)
anti-oxidant chaperone (conj)
hormone parathyroid (amod)
% 72.4 (nummod)
elevation mv (nmod)
intervention patients (conj)
treatment zonisamide (compound)
staining immunofluorescent (amod)
resolved it (nsubj)
50 45 (compound)
progression as (case)
practice our (nmod:poss)
torsade with (case)
knockout beta-hydroxylase (compound)
have findings (nsubj)
effect proteinuria (nsubj)
reference as (case)
included methods (dep)
csa ) (punct)
days 523.5 (nummod)
cycles two (nummod)
evaluated had (parataxis)
resolved administration (nsubj)
conclusion alternative (dep)
g 0.001 (appos)
mind in (case)
stones associated (acl)
treatment alpha (appos)
treated icu (nmod)
12.8 15.0 (conj)
produced haemodilution (nsubjpass)
infusion mg.kg(-1).min(-1 (appos)
96 . (punct)
apap to (case)
mazindol or (cc)
hyperthermia methamphetamine-elicited (amod)
infrequent limited (conj)
it-tspa on (case)
relationship effects (nmod)
effects attributed (acl:relcl)
specificity staining (nmod)
evaluate mg (dep)
has ) (punct)
involving drugs (dobj)
l-noarg ip (dep)
rhabdomyolysis brain (conj)
programs cardiovascular (amod)
morphine mg/kg (compound)
pallidotomy posteroventral (amod)
killed end (nmod)
appeared toxicity (nsubj)
induced indomethacin (nmod)
study directed (acl)
suggested disturbed (ccomp)
medium iso-osmolar (amod)
mitoq. antioxidant (amod)
follow the (det)
drug of (case)
77.1 80.0 (dep)
done group (nmod)
protocol immunosuppressive (amod)
include toxicity (dobj)
examined show (ccomp)
responses therapeutic (amod)
years 8.4 (nummod)
system implantable (amod)
ability by (case)
observed increment (nsubjpass)
% 31.4 (nummod)
> 100 (nummod)
effective becomes (advcl)
different % (dep)
lesions outer (amod)
quotient ) (punct)
diseases underlying (amod)
woman dose (nmod)
observed excess (nsubjpass)
reduced pressure (nsubjpass)
in well (advmod)
course modifications (nmod)
veins on (case)
therapy hctz (compound)
values and (cc)
facilitated increased (conj)
54-week , (punct)
ileum uterus (conj)
minimize dysfunction (nsubj)
clonidine ii (dep)
eliminated causes (nsubjpass)
phosphatase tyrosine (compound)
deep or (cc)
gender-dependent . (punct)
sensor participates (conj)
association psychosis (nmod)
longer m (nmod)
cases paralysis (nmod)
microm 100 (nummod)
provides cardiomyopathy (nsubj)
dox dox (conj)
showed deficits (dobj)
years 52.7 (nummod)
transplantation and (cc)
sulindac or (cc)
frequency predictability (conj)
toxicity d3 (compound)
animals overloaded (amod)
bear resemblance (dobj)
epidemics gangrene (nmod)
5v sec (nmod)
is evidence (attr)
chlorpromazine mug (appos)
3.75 , (punct)
cause damage (dobj)
relationship prostaglandins (nmod)
learning performance (conj)
discussed contribution (nsubjpass)
development aki (nmod)
deliver % (dobj)
4 less (amod)
degree function (nmod)
daidzein as (case)
right- and (cc)
injected injection (nmod)
showed produced (ccomp)
target inhibitors (nmod)
increase gradual (amod)
confirmed examinations (nsubj)
unconjugated , (punct)
demonstrating abnormalities (dobj)
examined period (nmod)
clues onset (nmod)
saccades multidirectional (compound)
bupropion g (compound)
shift marked (amod)
similar frequency (nsubj)
defects eligible (amod)
gained purpose (dep)
venom the (det)
records obtained (acl)
intolerance for (case)
considered preferred (conj)
detected animals (nmod)
placebo , (punct)
six ( (punct)
use infections (nmod)
research further (amod)
treated weeks (conj)
cardiac serological (amod)
loads hbv (compound)
cardiomyocytes of (case)
indicates and (cc)
emissions otoacoustic (amod)
developed coccidioidomycosis (nmod)
old older (conj)
loosening and (cc)
albumin to (case)
received dox (dobj)
pattern its (nmod:poss)
reported receiving (conj)
inappropriate reticulocytosis (nsubj)
depressants system (compound)
flurothyl pentetrazol (conj)
gfr erpf (conj)
medication topiramate (nsubj)
vasodilation dependency (conj)
suggestion earlier (amod)
age rat (compound)
studies systems (nmod)
caffeine- pentylenetetrazole-induced (conj)
attack ischemic (amod)
myocet of (case)
influenzae pneumoniae (conj)
conclusions affect (dep)
developed sooner (dobj)
blockade autonomic (amod)
sites that (mark)
reviewed pharmacokinetics (nsubjpass)
tasks or (cc)
sensitivity injury (nmod)
same were (cop)
metabolites total (amod)
fat the (det)
% fat (amod)
shifts predominance (nmod)
depression impulsiveness (appos)
ppa before (case)
suggest selection (dobj)
suggest relevant (ccomp)
suspected reaction (nsubjpass)
1.2 12.1 (prep)
agency regulatory (compound)
injection even (advmod)
challenge ptz (compound)
0.01 less (advmod)
levels . (punct)
trials cisplatin (nmod)
adrenaline interaction (conj)
novel multiple (dep)
insomnia , (punct)
two the (det)
retrieved showed (conj)
increased consumption (nmod)
lowers thus (advmod)
likely not (neg)
using ever (advmod)
119 2 (compound)
picrotoxin ptx (appos)
attenuated fluid (dep)
observation with (case)
larger which (nsubj)
children 74 (nummod)
protection syndrome (nmod)
assess value (dobj)
classes chf (dobj)
antibiotics of (case)
observed consistent (conj)
surgery ablation (conj)
symptoms hepatitis (nmod)
affecting or (cc)
treatment ritonavir (compound)
baeps ( (punct)
= 8.439 (dobj)
punctata ) (punct)
patients 150 (dep)
indicative health (nmod)
withdrawn recently (advmod)
residence fluid (nmod)
interpretation increase (appos)
department at (case)
2a alpha (compound)
hl60 hbmp (conj)
grade neutropenia (dep)
vasopressin of (case)
questionnaire between (case)
p53 of (case)
attributed usually (advmod)
improves crocin (nsubj)
motion in (case)
investigation in (case)
19.3 , (punct)
functional is (cop)
serious frequent (dep)
improved metrifonate (nsubj)
circles in (case)
matter ventricles (nmod)
hypopharynx ; (punct)
ccr2 increased (amod)
influence did (aux)
known is (auxpass)
agent effective (amod)
effect non-specific (amod)
mm hg (dep)
acid deoxycholic (amod)
scores units (nmod)
studied volunteers (dobj)
cessation smoking (compound)
antipsychotic effective (amod)
g : (punct)
diagnosed ; (punct)
trends . (punct)
1.4 0.1 (conj)
function dose (nmod)
increase high (amod)
protein accumulated (acl:relcl)
combination , (punct)
women million (nummod)
resection with (case)
suppress blockers (nmod)
number lots (nmod)
suppression the (det)
patients infected (acl)
discharges pathological (amod)
performance models (nmod)
ns-nsaids and (cc)
mean mean (conj)
side dramatic (amod)
greatest levels (nmod)
indicate and (cc)
fit generally (advmod)
dependent has (conj)
radiograph panoramic (amod)
hours 4 (nummod)
edema aggravate (amod)
mucosal dermatologic (conj)
given prior (advmod)
integrity and (cc)
difference groups (nmod)
fed developed (conj)
aneurysms malformations (conj)
appeared pathway (nsubj)
or probably (advmod)
investigated study (dep)
complication crisis (nsubj)
toxicity associated (acl)
zymosan with (case)
establish had (ccomp)
62.0 ) (punct)
lesion response (nmod)
use alone (advmod)
properties and (cc)
2/51 ) (punct)
episodes 125 (nummod)
rodents in (case)
induction hepatomegaly (conj)
complete was (cop)
increase constants (nmod)
rats control (compound)
administration inhibitor (nmod)
effects s-limonene (nmod)
elicits descending (advcl)
discuss we (nsubj)
complication are (cop)
institute therapy (dobj)
procedure this (det)
secretion growth (compound)
positive hbsag (compound)
play , (punct)
tolerability diclofenac (conj)
levels lead (compound)
del -141cins (compound)
epicardial and (cc)
signalling in (case)
recurrences of (case)
increases pb-related (amod)
readministration motility (conj)
locus vasoconstriction (nmod)
subject regulation (nmod)
period observation (conj)
graded . (punct)
mg/kg 150 (nummod)
effects changes (nmod)
cells positive (amod)
ecg pressure (conj)
application paclitaxel (nmod)
use . (punct)
evaluate potential (dobj)
scheduled therapy (nmod)
types arrhythmia (nmod)
damage cns (compound)
changes oxidation (compound)
scarce are (cop)
reversible clinically (advmod)
volume terbutaline (compound)
> block (conj)
result treatment (nsubj)
osmolality clearance (conj)
factor-alpha interleukin (conj)
investigate reversible (ccomp)
subjected 2 (meta)
experienced worsening (dobj)
tapered then (advmod)
theorem on (case)
systemic dose-dependent (amod)
discharges with (case)
examined ultrasonography (nmod)
effect nephrotoxicity (nsubj)
use vincristine (compound)
impairment motor (compound)
tried practical (advcl)
threatening cardiotoxicity (dobj)
sera also (advmod)
studies short-term (amod)
nicotine mg/kg (dep)
foci pas (compound)
demonstrate taken (advcl)
drugs considered (acl:relcl)
had most (nsubj)
reversed nra0160 (nsubj)
damage criteria (appos)
biosynthesis in (case)
confused initiation (nmod)
beta-agonists inhaled (amod)
seriousness increasing (conj)
mofetil of (case)
effect impairments (nmod)
mg/kg respectively (advmod)
mg/kg cnsb002 (compound)
potentiated lna (nmod)
palsy nerve (compound)
accompanied : (punct)
5-micrograms/kg infusion (nmod)
reduction neuropil (compound)
produced can (aux)
pseudoprolactinoma in (case)
course nephropathy (nmod)
conditions hyperventilation (compound)
meq/l 4.5 (nummod)
method treating (acl)
responsible largely (advmod)
therapy symptomatic (amod)
disruption fragmentation (conj)
rose significantly (advmod)
kidneys native (amod)
degeneration scattered (amod)
development further (amod)
cholestasis of (case)
patient aids (compound)
rs4704560 discrimination (nmod)
underwent ct (dobj)
glomerulonephritis crescentic (amod)
146 than (quantmod)
are there (expl)
databases several (amod)
capillaries cortex (nmod)
taking diltiazem (dobj)
tasks verbal (amod)
hypotension methylprednisolone (nmod)
catabolism of (case)
uterotonic . (punct)
displays behavior (dobj)
expression with (case)
agonist d1-like (amod)
terminated . (punct)
number dips (nmod)
iodixanol iso-osmolality (compound)
pathways , (punct)
characterized which (nsubjpass)
effective strikingly (advmod)
monitored injury (nsubjpass)
cause ever (advcl)
test inhibition (compound)
sirolimus by (case)
man injection (dep)
mg 0.4 (nummod)
analyses safety (compound)
hypothesized selective (advcl)
nimodipine ) (punct)
have lipofuscinosis (dobj)
perturbation membrane (nmod)
promote . (punct)
fluoxetine of (case)
breaks subsequent (amod)
macrophages containing (acl)
determine lead (ccomp)
drugs appetite (amod)
nephritis one (nummod)
gelatinase-associated neutrophil (nmod:npmod)
metalloproteinases matrix (compound)
had girl (nsubj)
evident areas (nmod)
streptozotocin on (case)
groups dfu-exposed (amod)
blotting analysis (conj)
% they (nsubj)
undergoing chemotherapy (dobj)
those obtained (acl)
colliculus the (det)
october 2009 (nummod)
values od (compound)
sporotrichosis disseminated (amod)
drugs non-steroidal (amod)
patients conditions (nmod)
level his (nmod:poss)
1a angiotensin (compound)
involved might (aux)
provided education (dobj)
influenced that (nsubjpass)
syndrome secondary (acl)
creatinine mg/dl (amod)
reduced able (conj)
university at (case)
administered not (neg)
discrepancy amount (nmod)
recovery cell (compound)
suggest facilitates (ccomp)
surmountable increasing (advcl)
absent may (aux)
hypoxaemia significant (amod)
measured access(r (nmod)
buffers ( (punct)
g 60 (nummod)
changes motility (compound)
demographic response (conj)
2.6 , (punct)
scale young-mania (compound)
medicines the (det)
differences similarities (conj)
exchange spaces (nmod)
yohimbine of (case)
evaluation ratio (nmod)
contaminant for (case)
group 16 (dep)
up daily (advmod)
difference patients (nmod)
target unavailable (ccomp)
if mic (conj)
abnormality intracranial (amod)
reduces dexrazoxane (nsubj)
effect mass (nmod)
observations of (case)
loss fields (conj)
increased children (nmod)
female ( (punct)
model impairment (compound)
higher be (cop)
nodules preneoplastic (amod)
hours 2.9 (nummod)
administration without (conj)
property anti-arrhythmic (amod)
recognise should (aux)
cross-sensitization behavioral (amod)
co-administration by (case)
component on (case)
indication have (ccomp)
13.1 1.5 (conj)
published propose (conj)
control ec (appos)
advocated administration (nsubjpass)
novel demonstration (nsubj)
stenosis artery (nmod)
inhibitor any (det)
sedation of (case)
patients solid (nmod)
received phenylephrine (dobj)
models disease (nmod)
patients warfarin (compound)
follow-up 2-year (compound)
threshold fibrillation (compound)
hfd ( (punct)
production and (cc)
conceivable seem (advcl)
phenomenon new (amod)
reached non-significantly (conj)
caused rats (nmod)
thyroid ion (conj)
disturbances experienced (acl)
15 ( (punct)
children an (det)
glut4 transporter (compound)
nicardipine treatment (conj)
evident it (nsubj)
injections 2r,4r-apdc (amod)
contrasted sharply (advmod)
rats lithium (compound)
system daergic (amod)
results influenzae (appos)
antibodies antineutrophil (compound)
degree reaction (dobj)
arabinoside cytosine (compound)
suggested demonstration (xcomp)
had risk (nsubj)
reversible remission (nmod)
d 15 (nummod)
included group (nsubj)
subjects from (case)
included contrast (conj)
memory utilized (amod)
detection rapid (amod)
augments activation (dobj)
ceased drugs (nsubjpass)
unresponsive effects (nmod)
received manoeuvres (nmod)
results consisted (appos)
output in (case)
brain metabolic (conj)
have band (dobj)
weeks . (punct)
91.2 ) (punct)
practical doses (nsubj)
induced breathing (advcl)
left mass (dobj)
mg 3.5 (nummod)
doxorubicin body (appos)
ages received (conj)
describe developed (conj)
nifedipine ( (punct)
evidence vte (nmod)
produced finally (advmod)
children prolactinomas (nmod)
absence explanation (nmod)
clonidine 5-mdot (conj)
rats corresponding (amod)
bones in (case)
young 21 (conj)
understand utility (dobj)
0.07 0.12 (conj)
concentration , (punct)
nitrogen serum (compound)
effect pathway (nmod)
measurements hemodynamic (amod)
absorption in (case)
appropriate degree (nmod)
meat products (conj)
effect dysfunction (nmod)
increasing while (mark)
paranoia days (nmod)
den den (conj)
decrease p (dep)
element key (amod)
0.96 +/- (cc)
relation causal (amod)
associated to (mark)
subtypes 3 (nummod)
region gene (compound)
illness and (cc)
l-1 be (cop)
noted episodes (nmod)
calculated infusion (nmod)
increasing by (mark)
function group (appos)
hypotension marked (amod)
clotting the (det)
received globulin (dobj)
order block (acl)
coadministration and (cc)
undertook study (dobj)
cells fat (amod)
drug treatment (nmod)
reduced patients (nsubjpass)
2.4 1.2 (dep)
reported japan (nmod)
taqib ser311cys (conj)
ovariectomized previously (advmod)
seen often (advmod)
carota daucus (compound)
hypertension hctc (nmod)
system iris (nmod)
analysis pooled (amod)
infant remaining (amod)
dithiothreitol with (case)
fasciitis . (punct)
disease aggressive (amod)
effective more (advmod)
showed used (ccomp)
model stz-induced (amod)
shows also (advmod)
tincture extract (appos)
lowering while (mark)
one with (case)
rats 24 (nummod)
responses cardiovascular (amod)
toxicities hematologic (amod)
attack tia (appos)
chemotherapy before (case)
associated seizure (nsubj)
% or (conj)
dyslipidemia mixed (amod)
rate parameters (nmod)
epilepticus induced (amod)
consequences injection (nmod)
protidogram the (det)
had correction (nmod)
vessels to (case)
potent receptor (advcl)
exposure gvg (compound)
entropion from (case)
encephalopathy range (dep)
superior prevention (nmod)
administered craniotomy (advcl)
sc group (compound)
when ( (punct)
showed admission (nmod)
movements as (case)
thickening coarsening (conj)
disabled patient (nsubj)
high because (mark)
hyperactivity nicotine-induced (amod)
temperature rate (conj)
cardiac associated (acl)
recognized if (mark)
limited areas (nmod)
tolerate not (neg)
autoantibodies associated (acl)
jaundice ( (punct)
trial italian (amod)
fasciculation muscle (compound)
melphalan high-dose (amod)
found regard (nmod)
seizure-prone and-resistant (dep)
years age (compound)
vasospasm of (case)
related this (nsubj)
scale visual (amod)
1.0 were (cop)
suppressed mcpp (nsubj)
hypertrophy both (cc:preconj)
lidocaine by (case)
reductions the (det)
inputs of (case)
cystitis chemical (compound)
primed exhibit (xcomp)
occurs % (nmod)
ability azt (nmod)
duration incidence (conj)
effective although (mark)
profiles lozenge (nmod)
although , (punct)
mortality baseline (nmod)
history his (nmod:poss)
expressing preference (dobj)
under-appreciated intensive (conj)
cases reported (acl)
isolated cardiomyocytes (nsubjpass)
ndi ( (punct)
initiate contracting (advcl)
effective were (cop)
resting of (case)
concentrations minimum (amod)
survival relapse-free (amod)
occurred hyper-responsiveness (dobj)
provided were (auxpass)
cohort patients (nmod)
diagnostics , (punct)
rigidity group (nmod)
features ultrasound (amod)
symptoms stereotypies (conj)
diarrhea grade (compound)
investigations and (cc)
study of (case)
recorded differ (conj)
purpose ; (punct)
month , (punct)
implicated reports (nmod)
effect up (prep)
episodes ischemic (amod)
etiology as (case)
potentiation blockade (conj)
sham-operated in (case)
model rats (conj)
related extrarenal (nmod)
treatment haloperidol (nmod)
suspected having (advcl)
mediating stimulation (dobj)
deletion nuclear (amod)
serum free (dep)
syndrome neuropathy (nmod)
had p (dep)
suppressed that (nmod)
ventilation rats (nmod)
(7.2)% and (cc)
evaluate caused (ccomp)
prodrug oral (amod)
reports with (case)
sensitized downregulation (nmod)
68 7 (conj)
rats jj (compound)
impact plasticity (dobj)
32 of (advmod)
confirmed ultrastructurally (advmod)
contain . (punct)
adopted . (punct)
oct microg/kg (appos)
patients remaining (amod)
suppressed are (auxpass)
symptoms ophthalmological (amod)
showed actions (dobj)
avoid paralysis (dobj)
mg/sq 200 (nummod)
failure increase (acl)
rate states (nmod)
influenced count (nmod)
transplant infections (conj)
31.85 3.99 (conj)
pemoline experienced (acl:relcl)
effective antipsychotics (nsubj)
reductions ions (nmod)
diets on (case)
tapering infusion (nmod)
omission the (det)
received morphine (dobj)
artery coronary (amod)
diagnosis neurological (amod)
exposed organogenesis (nmod)
hours 50 (nummod)
ke were (cop)
children two (nummod)
[3h]-l-arginine nmol/l (compound)
points was (cop)
that antigen (nmod)
weeks warfarin (nmod)
paid studied (advcl)
potentiated [verapamil]o (nsubjpass)
rare introduction (nmod:npmod)
cards symptom (compound)
diuresis with (case)
approach in (amod)
group isolated-hit (amod)
produced deterioration (dobj)
effects testosterone (nmod)
symptoms on-period (amod)
> ml (conj)
time cut-off (amod)
increase activation (nmod)
mechanisms independent (amod)
course disease (compound)
rise adriamycin (nmod)
nausea in (case)
rats sham (compound)
nicotine to (case)
rats lifetime (amod)
deactivated poisons (nmod)
erection ( (punct)
prevented d-1 (nsubj)
relative or (cc)
2- rats (conj)
indicative were (cop)
creating review (dobj)
properties non-selective (amod)
diagnosed day (nmod)
300 30 (compound)
0 500 (conj)
immediate gradual (conj)
findings radiographic (amod)
developed provide (conj)
similar treatment (nmod)
binding [(3)h]saxitoxin (compound)
included results (nsubjpass)
exhibited level (nmod)
formulation the (det)
review addition (nmod)
fall rats (nmod)
affinity the (det)
beta-blockade with (nmod)
regulate that (mark)
randomized total (nsubjpass)
caused inhibition (nmod)
observations staff (nmod)
indicative and (cc)
pronounced enhancement (nsubj)
genes three (nummod)
drugs anthracyclines (nsubj)
administration halothane (compound)
eliminated completely (advmod)
benefit information (nsubj)
flushing hypotension (conj)
a b (nmod)
decreases outflow (dobj)
accounted % (nmod)
alpha3 beta4 (conj)
alpha-tac ) (punct)
effects receptors (nmod)
used analyses (nsubjpass)
level mg/m2 (dobj)
s-i animals (conj)
arsenic of (case)
concluded anticipated (ccomp)
suffered suffered (conj)
dithiocarbamate pyrrolidine (compound)
induced non-alcoholic (nmod)
hip the (det)
collection , (punct)
age hepatic (conj)
recurred re-exposure (nmod)
interrupt to (mark)
offer which (nmod)
laitinen by (case)
activities % (nmod)
rare individual (nmod)
node of (case)
drugs the (det)
system scoring (compound)
awareness scenario (nmod)
level i (appos)
wales australia (appos)
hours and (cc)
technique hybridization (compound)
manifestation pericarditis (nsubj)
reduced prazosin (nmod)
or adjusted (amod)
coma deep (amod)
that tachycardia (nmod)
trial before (case)
proteinuria mtor (compound)
medication of (case)
observed toxicities (nsubjpass)
iso induced (dep)
choreic , (punct)
causes streptozotocin (nsubj)
man epilepsy (nmod)
therapy ketoconazole (compound)
d4.2 human (amod)
effective alendronate (nsubj)
shown consistently (advmod)
percent a (det)
perfused media (nmod)
defects by (case)
minutes 2.5 (nummod)
growth limb (nmod)
step end (nmod)
chemotherapy incorporating (acl)
donor no (compound)
pill herbal (amod)
participate mechanisms (nsubj)
obtainable freely (advmod)
inhibition assay (nmod)
basis long-term (amod)
duration symptoms (nmod)
preserved cases (nmod)
lower be (cop)
study administration (compound)
9.4 times (quantmod)
pressure women (nmod)
receive saline (dobj)
3.51 to (case)
ingestion alcohol (nmod)
tested administered (xcomp)
vagotomy prior (amod)
hours given (case)
inhibit reuptake (dobj)
nephropathy li-induced (amod)
edaravone by (case)
preceded often (advmod)
observed similarly (advmod)
pay to (mark)
concern a (det)
ne ) (punct)
infusion gtn (compound)
clearly most (advmod)
antagonism observed (amod)
incerta zi (appos)
produce together (advmod)
quetiapine , (punct)
auc of (case)
establish model (dobj)
papaverine micrograms (conj)
took over (compound:prt)
decreased 76 (nmod)
rtms for (case)
injection single (amod)
maintained level (dobj)
assessed mrna (nsubjpass)
treated temsirolimus (nmod)
injected left (conj)
microscope electronic (amod)
fact however (advmod)
serotoninergic brain (compound)
concentrations endpoint (nmod)
incidence use (nmod)
technique of (case)
function cells (nmod)
hyperaldosteronism with (case)
exceed risk (nsubj)
necessary and (cc)
threshold hindpaw (nmod)
2.21 was (cop)
predictors month (nsubj)
ta-064 ( (punct)
ischemia (iso)-induced (punct)
ps-exposure binding (appos)
role acetaminophen (dep)
hyperactivity distance (appos)
women on (case)
population as (case)
rats strain (compound)
i.c.v. 5 (nummod)
patients 50 (nummod)
drop compensatory (amod)
% volume (nmod)
implicated are (auxpass)
state headache (compound)
exerts instilled (advcl)
tumors pituitary (amod)
syncope qt (conj)
nausea hiccups (conj)
enhanced have (aux)
program ) (punct)
therapy promising (amod)
important cognitive (conj)
line bort-dex (nmod)
supplementation mg)-containing (amod)
designed randomized (conj)
dose received (acl)
microg/rat ) (punct)
2.7 1.9 (conj)
process pharmacological (amod)
advised treatment (nmod)
metoprolol glucagon (conj)
stage c (dep)
associated sulfonamides (nsubjpass)
night and (cc)
risperidone olanzapine (conj)
affects vary (conj)
min plasma (dep)
denopamine complete (dep)
(1.8)% -5 (conj)
amount dox (nmod)
show after (mark)
ascended included (conj)
vacuoles intracellular (amod)
clarified trials (nmod)
impact development (nmod)
resulted mice (advcl)
enhanced anaesthesia (nmod)
avoidance the (det)
risk studied (acl)
changed and (cc)
showed recording (nsubj)
ineffective , (punct)
performed nifedipine (conj)
prevented that (mark)
the greater (dep)
treated db (nmod)
spect perfusion (compound)
diphenhydramine oral (amod)
interleukin-6 marker (nmod)
effect synergistic (amod)
sprague-dawley the (det)
those remaining (acl)
preinfusion . (punct)
micrograms/ml 3.5 (nummod)
infusion stenosis (nmod)
infiltration sub-tenon (nmod:poss)
included auc (dobj)
raise considerations (dobj)
carbamazepine to (mark)
block blocks (advcl)
2b1/2b2 and (cc)
mechanisms ' (punct)
revealed necrosis (dobj)
responsiveness to (case)
carried observations (nmod)
decided , (punct)
crf of (case)
catheters resulting (acl)
efficacy their (nmod:poss)
oxidative/nitrosative and (cc)
patients their (nmod:poss)
cd4 cells/microl (punct)
adding order (nmod)
necrosis bridging (compound)
testing attenuates (conj)
race , (punct)
centers 24 (nummod)
reduced chlorpromazine (nmod)
inhibit rats (nmod)
recognition incorporates (acl:relcl)
increased kanamycin (nsubj)
alpha-enac of (case)
examining consolidation (dobj)
wavefronts simultaneous (amod)
employed reagents (nsubjpass)
site major (amod)
reach to (mark)
ssris ) (punct)
patients both (det)
woman 33-year-old (amod)
processes enlarged (amod)
began months (nmod)
disease complications (dep)
lowers . (punct)
derangements pathways (nmod)
na+-extrusion depressed (amod)
calcineurin-inhibitor the (det)
commissure dorsal (compound)
tetany diltiazem-induced (amod)
trained in (case)
assessed factors (nsubjpass)
importance field (nmod)
history on (case)
group td (compound)
convulsive the (det)
recruited studied (conj)
given who (nsubjpass)
differed agsd (nmod)
difficult obstruction (nsubj)
manifestation is (cop)
oxygenation on (case)
granulomatosis in (case)
effects vasomotor (compound)
effects propofol (nmod)
sbp . (punct)
radiofrequency standard (amod)
treatment changes (conj)
acquired exacerbates (nsubj)
antagonist substance (compound)
followed improvement (nsubj)
aura ( (punct)
administration protection (nmod)
hemorrhage major (amod)
amiloride of (case)
sufficient was (cop)
suggests observation (nsubj)
salicylates ingestion (conj)
responses conditions (nmod)
abusers ma (compound)
manifestation first (amod)
startle startle (conj)
combination of (case)
demonstrated patients (nsubj)
pain cocaineassociated (amod)
0.24:1 indicates (conj)
sr ) (punct)
midbrain ( (punct)
affect observed (conj)
ephedrine , (punct)
results showing (acl)
females five (nummod)
heart for (case)
alter physiology (dobj)
number courses (nmod)
lost returned (conj)
p20 saline (compound)
recovery inversion (compound)
protein factor (nmod)
sleep nocturnal (amod)
parameters calcium (nmod)
cells transfected (amod)
role parp (nmod)
present appreciated (advcl)
constituted : (punct)
report autopsy (amod)
impairment activity (nmod)
precipitated persons (nmod)
hyperplasia heart (nmod)
specific vigabatrin (nmod)
non-ecstasy polydrug (nmod:npmod)
secretion luteinizing (compound)
female period (nmod)
stimulation at (case)
mg cyproheptadine (nmod)
comparable magnitude (nmod)
paper measuring (compound)
degrees radial (amod)
pathogenesis failure (nmod)
sensitized due (prep)
10.4 33.1 (dep)
testing duction (compound)
hypertension either (cc:preconj)
killed harvested (conj)
tet fan (conj)
ten the (det)
regarded generally (advmod)
encephalopathy of (case)
women used (acl:relcl)
consolidation overnight (amod)
points end (compound)
liver kidney (conj)
resumed we (nsubj)
starting immediately (advmod)
500 , (punct)
somnolence respectively (advmod)
involvement metabolism (nmod)
time hcl (nmod)
myocarditis of (case)
associated nsaids (conj)
lymphoma lymphoplasmacytic (amod)
h during (case)
activities for (case)
detected a (nsubjpass)
inhibition . (punct)
loiasis of (case)
response previous (amod)
retention fluid (amod)
brush-evoked dynamic (dep)
users fenfluramine (nmod)
alterations cytological (amod)
effects dysplasia (nmod)
received markers (dep)
bupivacaine % (compound)
seems stimulation (nsubj)
screened all (dep)
ward internal (amod)
documented anxiety (nsubjpass)
pdn no (det)
group , (punct)
therapy menorrhagia (nmod)
presence absence (conj)
dysfunctions vascular (amod)
exposed trimester (nmod)
register trials (nmod)
adults response (nmod)
cells undergoing (acl)
7931 +/- (cc)
dopamine depletions (conj)
users ocs (nmod)
micrograms/kg at (case)
tolerate could (aux)
conditions such (amod)
onset of (case)
conducted up (compound:prt)
m-2 or (cc)
created . (punct)
models as (cc)
studies address (acl:relcl)
mm 14.1 (nummod)
delineate structures (dobj)
resulted loss (nmod)
0 to (dep)
injections ip (compound)
nephropathy caused (acl)
placebo rr (appos)
receptors concentration (conj)
occasions nine (nummod)
haemodilution groups (nmod)
administration clioquinol (nmod)
data challenge (compound)
appears finally (advmod)
tomography serially (conj)
increased pressure (nsubj)
less danazol (nmod)
increase tdr (nmod)
saline ( (punct)
d1 5 (nummod)
decreased had (aux)
potential caffeine (nmod)
time tt (appos)
clinic community (compound)
mirrored additionally (advmod)
provoked dose (nmod)
pontis structures (appos)
aggregation factor (nsubj)
24 least (advmod)
hypertensive previously (advmod)
cyclophosphamide metabolized (acl:relcl)
that to (case)
receiving lithium (dobj)
neurons hippocampal (amod)
visit at (case)
distribution the (det)
conjugation capacity (conj)
lowered and (cc)
suspicion of (case)
malformation taussig-bing (amod)
results died (dep)
ccl4 , (punct)
nephrotoxicity mice (nmod)
response inflammatory (amod)
treatment srl (compound)
min 6.2 (nummod)
experiment resonance (compound)
antagonist flumazenil (appos)
transcript of (case)
mmhg rate (conj)
recognized cause (nmod)
reported and (cc)
time dwell (compound)
i.v. 3 (conj)
(1.8)% ( (punct)
protein elevated (amod)
correction level (nmod)
reduced dose-dependently (advmod)
bobbing head (compound)
e. in (case)
contributes cardiotoxicity (nmod)
accumulation triglyceride (nmod)
ci=22.5 25.3 (nummod)
hemiparesis with (case)
displays profile (dobj)
remains there (expl)
analyzed factors (nmod)
demonstrated erythrodysesthesia (ccomp)
induce regarding (mark)
combination intralipd (nmod)
derivative pemoline (nsubj)
microliters 40 (nummod)
period year (nmod)
foci epileptic (amod)
cessation an (det)
= 16.22 (dep)
days with (case)
( ymdd (dep)
reduction observed (acl)
result delay (nsubj)
associated hyperprolactinemia (nmod)
case reaction (nmod)
continue reduction (nmod)
range weights (nmod)
jaws clenched (amod)
antibody cytoplasmic (amod)
developed lapsed (conj)
paralysis ascending (amod)
cases 8 (nummod)
used oncology (nmod)
herniations cell (nmod)
human anthracycline-induced (dep)
had represented (conj)
lower scores (nsubj)
enalapril prazosin (conj)
aware were (cop)
killed processed (conj)
associated literature (nmod)
statins possibility (conj)
patients 5000 (nummod)
testing function (compound)
modulation due (amod)
levels hepatic (amod)
cessation lesions (nmod)
nephrotoxicity and (cc)
well as (advmod)
induced electroshock (nmod)
t+a [ (punct)
evaluated beginning (nmod)
novel both (cc:preconj)
mapping surface (compound)
hypersensitivity capsaicin-evoked (amod)
stronger compared (advcl)
18 since (case)
posaconazole after (case)
neuropathy motor (compound)
e1 without (conj)
cardiotoxicity treatment (nmod)
controls than (case)
measured again (advmod)
beta=0.49 p=0 (appos)
characterized begin (advcl)
pilo groups (conj)
results cases (dep)
prevalence hypotension (nmod)
deficits neural (conj)
rated parents (nmod)
using , (punct)
weight < (dep)
progression retarded (amod)
u/l 1695 (nummod)
toxicity study (dep)
consistent process (nmod)
need urgent (amod)
haloperidol i.e. (advmod)
nonmutant compared (case)
increase sensitivity (dobj)
changes " (punct)
-59.7 +/- (cc)
er ( (punct)
b1r ( (punct)
-1 - (punct)
disorder of (case)
microinjection area (nmod)
cytochrome-p450 liver (compound)
bdl ee (conj)
ng/ml area (nsubj)
beating effects (nsubj)
symptoms minor (amod)
cycle 14-day (amod)
evoke forepaw (conj)
magnitude induction (nmod)
correlated correlated (conj)
death his (nmod:poss)
cells sinoatrial (amod)
plasticity m1 (compound)
approach treatment (nmod)
commonly less (advmod)
treatment h (appos)
prescribed trimethoprim-sulfamethoxazole (dobj)
administration castration (conj)
that patients (nmod)
leukemia childhood (compound)
papaverine between (case)
receive preparation (nmod)
occurred minute (nmod)
angina with (nmod)
ciprofloxacin cases (conj)
best knowledge (nmod)
pleased were (auxpass)
play regulation (nmod)
taken samples (nsubjpass)
resolve , (punct)
studied effect (nsubjpass)
failed propagate (xcomp)
results toxicity (nmod)
possibility capacity (nmod)
transmission synaptic (amod)
chemotherapy is (cop)
bradycardia considerable (amod)
cells lining (acl)
changes dose-corrected (amod)
mg/dl more (conj)
c57bl/6 the (det)
improvement parameters (nmod)
april since (case)
doses necessary (amod)
suspensions tested (amod)
placebo given (case)
using simultaneously (advmod)
injected were (auxpass)
appeared akathisia (nsubj)
role pathogenesis (nmod)
increase dietary (amod)
venous arterial (conj)
role agonist (nmod)
extract seeds (nmod)
failed have (aux)
contractility caused (acl)
n=283 ( (punct)
induces isoproterenol (nsubj)
findings together (advmod)
observation produce (ccomp)
% theophylline (nmod)
amputation and (cc)
degeneration and (cc)
days trial/day (appos)
attributable combination (nmod)
considered protective (xcomp)
reports clopidogrel (nmod)
patients simultaneously (nmod)
therapy third-line (amod)
assessment clinical (amod)
increased 2.4-fold (nmod)
purpose : (punct)
were and (cc)
bolus ( (punct)
gvhd ) (punct)
showed whereas (dep)
low potential (nsubj)
% 47.9 (nummod)
complications life-threatening (acl:relcl)
antibiotic properties (nmod)
concern more (amod)
heart lung (conj)
acid fusidic (amod)
severe to (case)
activation neuroinflammation (conj)
associated dbp (nsubjpass)
sought . (punct)
days 45 (nummod)
decreased whereas (dep)
neoantigens of (case)
engorgement of (case)
pretreatment whereas (dep)
determined study (nmod)
cochlea the (det)
odds adjusted (amod)
failed . (punct)
infusion decreased (acl:relcl)
evaluated microscopy (nmod)
decreased severely (advmod)
activity cardiodepressant (amod)
foot right (amod)
screening prior (advmod)
treatment daily (advmod)
antagonist be (cop)
determined protection (nsubjpass)
technique new (amod)
baseline thereafter (conj)
had micrographs (nmod)
caused doses (nmod)
prevent clentiazem (nmod)
benefits potential (conj)
features patients (nmod)
mitoq. the (det)
septal midline (conj)
characteristics resolved (acl:relcl)
value management (nmod)
latency variable (amod)
associated disruption (nmod)
daily orally (advmod)
= 7 (dep)
responses system (nmod)
sodium piperacillin (compound)
parameters for (case)
extension failure (conj)
ulcers corneal (compound)
cardiovascular renal (conj)
pretreatment np (appos)
postinjection wr242511 (nmod)
persisted minutes (nmod)
thirsty and (cc)
cortex posterior (amod)
mixture to (case)
january 1996 (conj)
preferable anaesthesia (nmod)
lithiasis for (case)
creatinine a (det)
restriction dietary (amod)
6/31 vs (cc)
trial pilot (compound)
control same (amod)
1.88 ) (punct)
canaliculi to (case)
drug underlying (amod)
increase isoproterenol-induced (amod)
tested investigation (nmod)
damage neuropathic (amod)
administration agonist (nmod)
octreotide ) (punct)
perseveration ( (punct)
csseps central (nmod)
hospital riyadh (nmod)
acid choleretic (appos)
received g/m2 (dep)
hfde ( (punct)
developed necessitating (advcl)
assessed graded (conj)
3-methyladenine , (punct)
chf iv (nummod)
44 15 (compound)
suppressed , (punct)
interviewed persons (dobj)
inhibit antidepressants (nsubj)
rise immediate (amod)
enac ( (punct)
lna the (det)
response rats (nmod)
infusion the (det)
hepatomas induced (acl)
chemotherapy acid (conj)
patients 3 (conj)
foods spicy (amod)
prolongation population (nmod)
development seizures (nmod)
infection barr (compound)
releases that (mark)
patient severe (amod)
increases due (case)
killed animals (nsubjpass)
dyspnea loss (conj)
infections neoplasia (conj)
patchy well-limited (dep)
protection rnase (compound)
intraperitoneal single (amod)
confusion papilledema (conj)
secretion on (case)
= 0.49 (dobj)
% by (case)
patients cured (acl:relcl)
groups individual (amod)
veins from (case)
advantage substantial (amod)
increase persistent (amod)
stimulated a (dep)
population total (amod)
lam ( (punct)
presented slight (dobj)
extent infarction (nmod)
degree homology (nmod)
fasciculation including (case)
20 10 (conj)
effect hyperglyceridemic (amod)
impairs competition (nmod)
higher % (dep)
teratogenic administered (advcl)
adrenoceptors through (case)
mg/kg both (cc:preconj)
therapies of (case)
nitrite , (punct)
clinical various (amod)
models experimental (amod)
occlusion preceded (acl)
achr ( (punct)
fentanyl mg/kg (appos)
ester ) (punct)
administration oxytocics (nmod)
considered effects (nsubjpass)
complication drug (compound)
weeks 28 (dep)
nephrotoxicity toxicity (conj)
children receiving (acl)
fraction as (cc)
was review (xcomp)
effect rat (nmod)
release dopamine (compound)
pregnant rats (dobj)
method described (acl)
hypersecretion by (case)
contribution with (case)
1984 between (case)
score disease (compound)
inputs and (cc)
lymphoma diffuse (amod)
rate between (case)
patient and (cc)
hospitalized was (auxpass)
patients dosage (nmod)
assessed testing (nmod)
received minimum (dobj)
recorded myoclonus (nsubjpass)
obstruction junction (compound)
elevation map (compound)
pacemaker wires (conj)
patients 115 (nummod)
hours four (nummod)
tone basal (amod)
factor controls (acl:relcl)
open still (advmod)
conclude results (nmod)
noradrenaline norepinephrine (dep)
rare patients (nmod)
defects group (nmod)
chlorpromazine by (case)
investigate action (dobj)
harvested 2 (nmod)
response patient (compound)
curve under (case)
shown dwi (nmod)
tests skin (compound)
delivery sodium (compound)
frey to (case)
iop model (nmod)
changes ischemic (amod)
selective tissue-specific (conj)
antithrombin iii (nummod)
type lesion (nmod)
contained microcrystals (dobj)
action metrazol (nmod)
stimulation excessive (amod)
1710 2190 (conj)
person , (punct)
barium modified (amod)
serum and (cc)
effect variable (amod)
asterixis induced (acl)
0.5 x (cc)
inhibitors acid (nmod)
significant to (mark)
elevated even (advmod)
pain : (punct)
ophthalmologic audiologic (conj)
assessed complications (nsubjpass)
mechanism activation (nsubj)
found population (nmod)
injection systemic (amod)
included study (nmod)
biochemical isoniazid-induced (amod)
use alcohol (dobj)
size receptor (conj)
greater direction (nmod)
vagal cardiac (amod)
ratio bcl-2/bax (nmod)
counter over (case)
treatment procyclindine (compound)
toxicity transaminase (conj)
failure dexmedetomidine (nmod)
less highest (advcl)
defects ribs (conj)
elevated plus (cc)
determined pcr (nmod)
eps of (case)
levels level-dependent (amod)
had groups (nmod)
2660 1200 (conj)
seen have (aux)
compounds both (det)
conditions known (amod)
diagnosis after (case)
indicate marked (ccomp)
muscle ventricular (compound)
uncommon toxicities (nsubj)
negative which (det)
prominent cells (nmod)
ns-nsaids 14,671 (nummod)
maintained panel (nsubjpass)
bortezomib . (punct)
gentamicin-arf decrease (dep)
evaluation assigned (acl:relcl)
abolish tachycardia (dobj)
shown treatment (nmod)
arteries cava (conj)
regardless therapy (nmod)
caused size (nsubjpass)
accompanied syndrome (nsubjpass)
adult contrast (dep)
ccr baseline (compound)
doses amiodarone (nmod)
employed needle (nsubjpass)
cinacalcet with (case)
relation its (nmod:poss)
report documenting (acl)
drug verapamil (nsubj)
falling mv (nmod)
completion course (nmod)
9 in (case)
vestibulotoxicity streptomycin-induced (amod)
leukemia in (case)
injury seizure-induced (amod)
dysfunction rats (nmod)
21days rats (nmod)
partial , (punct)
taken history (nsubjpass)
isomer 3-hydroxy-n-methylmorphinan (nmod)
paclitaxel plus (cc)
prolongation increase (conj)
development offspring (nmod)
immunohistochemistry nf-m (conj)
features microangiopathy (nmod)
quantitative , (punct)
transport hospital (nmod)
decreases % (conj)
used prevent (xcomp)
decline with (case)
encephalopathy severe (amod)
degrees 18 (dep)
ventral dorsal (conj)
drugs related (amod)
agent process (nmod)
postcards regular (amod)
withdrawn androgens (nsubjpass)
mitochondria interfibrillar (amod)
catalepsy mice (nmod)
trazodone 's (case)
need this (det)
studied formed (conj)
show constitutively (advmod)
administration clonidine (compound)
self-treating developed (conj)
impairments memory (compound)
6-hydroxydopamine unilateral (amod)
tested volume (nsubjpass)
area a1 (nmod)
died children (nsubj)
evaluated levels (nmod)
containing mm (dobj)
factors no (neg)
consequence withdrawal (nmod)
conditions surgery (nmod)
associated week (nmod)
carried i.v. (nmod)
effects direct (amod)
modulates pain (nsubj)
fails that (nsubj)
loss ataxia (conj)
synthesized , (punct)
crf creatinine (appos)
nicotine effects (nmod)
5 more (amod)
spikes population (compound)
than rats (nmod)
administered intraperitoneally (advmod)
stimulation ventricular (amod)
abilities differ (acl:relcl)
hospitalizations for (case)
microinjections acid (nmod)
apposed were (auxpass)
objective examine (dep)
nephrotoxic to (mark)
research future (compound)
remain appear (advcl)
release catecholamine (compound)
duct drug-associated (amod)
values ecg (compound)
capable mg/kg (conj)
catechol hydroquinone (conj)
meter with (case)
search the (det)
effect detrimental (amod)
use immunomodulators (nmod)
from only (advmod)
chromosomes and (cc)
-12.8 +/- (cc)
train gated (amod)
odds increased (amod)
activation brain (nmod)
hours administering (advcl)
method equation (compound)
conclusions % (appos)
dystrophy neuralgia (conj)
noted group (nmod)
immunoblotting , (punct)
non-users were (cop)
cocaine-dependent healthy (conj)
use risk (conj)
5-httlpr gender (conj)
= .01 (dobj)
safe suppression (nmod)
tolerable generally (advmod)
hepatitis e (compound)
rats habituated (acl:relcl)
p450 2e1 (conj)
perfusion renal (amod)
safety infusion (nmod)
have indicating (xcomp)
died commencement (nmod)
occlusion during (case)
increased progressively (advmod)
responded required (parataxis)
increase concomitant (amod)
variant a (det)
connective muscular (conj)
domperidone i.v. (amod)
improve pressure (dobj)
k-8644 bicuculline (compound)
hearing patients (nmod)
increasing sedative (nmod)
reported been (auxpass)
reports fentanyl (amod)
treatment atherosclerosis (nmod)
duration longer (advmod)
doses by (case)
algorithm by (case)
administration metoclopramide (nmod)
case history (nmod)
undertaken examine (xcomp)
observed arrhythmias (nsubjpass)
transition dose (nmod)
proceeded . (punct)
movements neck (nmod)
regulation pituitary (nmod)
cgmp ( (punct)
transplantation hsct (appos)
focused have (aux)
hypothesis involvement (nmod)
investigated induces (ccomp)
call patients (nmod)
risk than (case)
syndrome ovary (amod)
rats mg/kg)-treated (amod)
rifampicin with (case)
ischemia dobutamine-induced (amod)
strain in (case)
form coffee (compound)
contraceptives compared (case)
induce systems (dobj)
reduce but (cc)
reduces nausea (dobj)
occurs if (mark)
shifts negative (amod)
reentry nodal (amod)
response injections (nmod)
frequency manifestations (nmod)
predispose course (nmod)
demonstrated showing (xcomp)
placebo daily (advmod)
metabolized , (punct)
indicate induces (ccomp)
isomers propranolol (nmod)
necessary however (advmod)
injury hyperalgesia (appos)
1 % (appos)
methotrexate the (det)
neuropathies toxic (amod)
terms changes (nmod)
hepatomegaly and (cc)
= 10 (dobj)
proteins especially (amod)
evoked potential (dobj)
benzodiazepines health (conj)
ingestion of (case)
cells cells (conj)
loss ability (nmod)
objective describe (appos)
losartan ( (punct)
aims therapeutic (appos)
contain does (aux)
cardiotoxicity 5-fu-induced (amod)
changes membrane (compound)
activated were (auxpass)
4107 , (punct)
atresia for (case)
feet on (case)
deformations the (det)
poisoning of (case)
aim study (nmod)
safe therapy (nmod)
h injections (nmod)
showed ultrasound (nsubj)
theorem model (conj)
suggests differences (dobj)
taking cimetidine (dobj)
number large (amod)
months treatment (nmod)
decreased stress (dobj)
mg 100 (nummod)
lend basis (nmod)
criteria rifle (compound)
mi ctni (conj)
culture primary (amod)
method alternative (amod)
heparin weight (compound)
relationship particular (nmod)
sinusoidal between (case)
np ( (punct)
tachyarrhythmia the (det)
solution placebo (compound)
inhibition cck-8-ns (nmod)
avoided reduction (dep)
tubules renal (amod)
alter , (punct)
function physical (amod)
got . (punct)
restore replication (dobj)
area periventricular (amod)
tilt head-up (compound)
generated were (auxpass)
reduced contrast (nmod)
order obtund (acl)
status e (compound)
diagnosis diabetes (nmod)
hospital center (conj)
complication nephrolithiasis (nsubj)
infusion following (case)
snps tagging (amod)
balances activity (conj)
discharged conclusions (dep)
anticoagulant citrate (compound)
refused treated (conj)
mk-801 antagonist (appos)
software custom (compound)
stiffness myalgia (conj)
di-o-tolylguanidine well-characterized (amod)
mg p=0.001 (dep)
hypokalemic but (cc)
effects umb24 (nmod)
cases excellent (amod)
recognized antibodies (nmod)
% 93.4 (nummod)
likely participate (xcomp)
pressure levels (conj)
3.45 2.45 (conj)
nucleus putamen (conj)
constipation patients (nmod)
suppressants of (case)
succinylcholine or (cc)
determine changed (ccomp)
amenorrhea = (dep)
given hours (nmod)
alteration an (det)
patient anaesthetist (conj)
potencies preparation (nmod)
safety nimesulide (conj)
association gene (nmod)
defined diagnostic (nmod)
phenytoin hypothermia (conj)
showed variables (nsubj)
schizophrenia treated (acl)
most rats (nmod)
rash by (case)
rbcs ae (compound)
agonist histamine (compound)
patients nonjaundiced (amod)
hold . (punct)
block a (det)
g/day 0.23 (nummod)
ml/min/kg 0.86+/-0.29 (nummod)
control gspe (conj)
hemoglobin , (punct)
decrease affinity (nmod)
disturbance visual (amod)
magnitude , (punct)
suffered 78-year-old (nsubj)
allocated trial (nmod)
epithelium for (case)
rnfl accumulated (acl)
toxicity ami/gi (compound)
1.27 1.13 (dep)
salivation confusion (conj)
excluded been (auxpass)
groups these (det)
draw conclusions (dobj)
10 about (advmod)
have that (nsubj)
implausible confounding (dep)
progress cirrhosis (nmod)
tests markers (conj)
s-312 s-312-d (conj)
able subjects (nsubj)
groups eight (nummod)
used half (nsubj)
patients all (det:predet)
thickness retinal (amod)
paralysis absence (nmod)
insufficiency % (appos)
weight 15mg/100 (nummod)
nausea commonly (advmod)
e-fortified vitamin (nmod:npmod)
negativity t (conj)
incidence with (case)
generated are (auxpass)
inhibited , (punct)
association alcohol (nmod)
remained 40 (nmod)
inputs afferent (amod)
sole hallucinations (nsubj)
increased coadministered (advcl)
treatment resolution (conj)
produce concentrations (nsubj)
phenomenon pressure (nmod)
reactions % (dep)
developed life (dobj)
represent expression (nsubj)
efficacy anticraving (amod)
required case (nmod)
dysrhythmogenicity dogs (nmod)
tubules the (det)
inhibition end-product (amod)
property negative (amod)
can proteinuria (conj)
use estradiol (nmod)
treatment t (compound)
phase active (amod)
yrs > (conj)
complexes mitochondria (nmod)
20 or (cc)
preferred toxicity (nsubjpass)
groups sh (compound)
acceleration similar (amod)
trial assess (acl)
hemodynamics the (det)
thrombophlebitis developed (amod)
attempt antagonize (acl)
sarcomas gynecologic (conj)
enhanced it (dobj)
activation 1-receptor (amod)
consolidation memory (nmod)
confined subgroups (nmod)
need an (det)
confirmed findings (nsubjpass)
males and (cc)
type-1 ii (compound)
injection captopril (nmod)
indicated results (nsubj)
become thus (advmod)
efficacy infusion (nmod)
assessing through (mark)
women old (amod)
iief ) (punct)
were 0.001 (dep)
identification substitute (acl)
reversal secondary (amod)
drug given (case)
years 8 (nummod)
events changes (conj)
monohydrate of (case)
patient tenth (amod)
segment middle (nmod)
reported administered (ccomp)
measure : (punct)
enabled % (dobj)
results prolactin (compound)
restored responses (dobj)
variability of (case)
54 of (advmod)
transport l-arginine (compound)
cause concern (dobj)
thermal or (cc)
dosages isoproterenol (nmod)
found correlation (nsubj)
reduced effects (dobj)
reduced leaving (advcl)
obtaining activity (dobj)
enrolled 42 (dep)
salt-depleted and (cc)
study conclusion (nsubj)
detected exercise (nsubjpass)
removed remained (conj)
analyses restricted (amod)
gastrointestinal by (case)
isoflurane agent (appos)
stage final (amod)
disorder or=3.299 (amod)
session hemodialysis (nmod)
abnormalities degeneration (conj)
echocardiography thickness (conj)
d-med or (cc)
discussed some (nsubjpass)
developed upper-extremity (dobj)
therapy median (amod)
stabilized mg (dep)
state lasting (amod)
carotid anesthesia (nmod)
rats restricted-diet (amod)
dose was (cop)
used ancrod (nsubjpass)
responders the (det)
papilledema inexorable (amod)
response hypertensive (amod)
used effective (conj)
pill chinese (amod)
phenomenon described (acl)
effect antithyroidmedications (nmod)
ci % (dep)
behavior apprehensive (amod)
treated doses (nmod)
had bicuspid (dobj)
impairment use (nmod)
conclusion complication (dep)
initiated rescue (nsubjpass)
effect hiv-induced (amod)
agc ( (punct)
lack the (det)
kainic acid-induced (dep)
pbsct ) (punct)
a cya (appos)
blunted prevent (conj)
using procedure (nmod)
toxicity inhibitors (nmod)
association therapy (nmod)
grade % (dep)
bh intervals (conj)
population among (case)
promoted aconitine (nsubj)
diazepam mg (conj)
modulates . (punct)
matrix interstitial (amod)
dysfunctioning receptor (nmod)
alleviate that (mark)
guidelines safer (amod)
neuroplasticity detrimental (amod)
response pharmacological (amod)
experienced experienced (parataxis)
cause and (cc)
night 1 (nummod)
impairment 7alpha-hydroxylation (nmod)
1 0.01 (compound)
disorders substance-induced (amod)
use antithrombotic (amod)
lowering 4 (nmod)
reduction more (amod)
stem brain (compound)
change as (cc)
isoproterenol and (cc)
excess compared (acl)
tachycardia compensatory (amod)
membrane tubular (amod)
conclude cause (ccomp)
enzymes both (preconj)
determined clearance (conj)
product rpp (appos)
incidence hypertension (nmod)
myopathy an (det)
immunosuppression to (case)
50 30 (compound)
db = (parataxis)
mm angiogram (dep)
titrated doses (nmod)
delirium : (punct)
dna : (punct)
choose anaesthesia (dobj)
dextran with (case)
five . (punct)
situation a (det)
seizures refractory (acl:relcl)
gbm unresectable (amod)
range therapeutic (amod)
velocity ( (punct)
refractory treatment (nmod)
encouraging begin (xcomp)
risks rr=1.41 (dep)
paroxetine after (case)
drug non-nephrotoxic (amod)
aspects specific (amod)
bronchodilator potent (amod)
sdrr in (case)
valdecoxib % (conj)
1.043 +/- (cc)
recovery waves (nmod)
version task (nmod)
expanded was (auxpass)
analyzed hematoxylin (nmod)
circuits neural (amod)
recall pictures (nmod)
mg/d 1200 (nummod)
entering program (dobj)
complication causing (advcl)
was ng/ml. (dep)
management recommended (amod)
patients neuropathy (nmod)
administration long-term (dep)
oxidase or (cc)
atrophy from (case)
high-frequency to (mark)
mechanism different (amod)
had or (dobj)
beats/min from (case)
levels reduced (amod)
concentrations than (case)
different concentrations (nsubj)
using lidocaine (dobj)
related interaction (nmod)
1.37 ( (punct)
options the (det)
alopecia phlebitis (conj)
deletion cardiomyocyte-restricted (amod)
interrupted . (punct)
carbimazole between (case)
1 min (conj)
atresia aor (dep)
used woman (nmod)
risperidone > (compound)
newborns for (case)
dynamic on (case)
consecutive chemotherapy-naive (dep)
response reference (compound)
appeared method (dobj)
neurotensin pallidal (amod)
line intravenous (amod)
170 patient (nmod)
introduced orally (advmod)
stains six (nummod)
social and (cc)
self-treating and (cc)
velocity number (conj)
investigate diagnoses (dobj)
performed allografts (nmod)
hyperemia coronary (amod)
widening failure (nmod)
normal with (case)
agents dopamine (nmod)
accompanied evidence (nmod)
susceptible genetically (advmod)
demonstrated toxicity (nsubjpass)
poisoning in (case)
aroused suspicion (nsubjpass)
relationship cirrhosis (nmod)
variety indications (nmod)
dosage neurotoxic (amod)
urine potassium (conj)
higher study (nmod)
assaults toxic (amod)
blockade rats (nmod)
reported commonly (advmod)
delineated damages (nsubjpass)
posturing abnormal (amod)
bladder mouse (nmod)
function depressed (amod)
pain vein (nmod)
stretching with (case)
induced anesthesia (nsubjpass)
pointes and (cc)
peripheral interrelated (amod)
subtypes other (amod)
appeared safe (xcomp)
study single-blind (amod)
scheduled were (auxpass)
benzodiazepines abilities (conj)
confirmed acetaminophen (nmod)
clioquinol to (case)
administration increase (nmod)
b part (compound)
picture described (dep)
portray to (mark)
metastases brain (compound)
sulphoxide dimethyl (amod)
acute glomerulopathy (conj)
progesterone and (cc)
99 but (cc)
fields ( (punct)
ca3 of (case)
165/90 between (case)
cause rammer (dep)
fibrillation lone (amod)
encephalopathy chorea (conj)
lacking receptors (dobj)
marker that (mark)
4.18 1.60 (nummod)
received day (nmod)
edema aracytine-c (nmod)
similar had (advcl)
case following (amod)
that procaine (nmod)
3.4-fold that (nmod)
frequently literature (nmod)
regimen rate (dep)
had both (dobj)
therapy esrd (compound)
two which (nmod)
co-morbidity psychosis (conj)
went results (nsubj)
rats ingesting (acl)
syndrome presented (acl:relcl)
observed oc (nmod)
potentiate syndrome (dobj)
were signs (attr)
manifestations occurring (acl)
drug with (case)
evident week (nmod)
damage = (dep)
phosphanilate , (punct)
influence motility (dobj)
escalated observed (advcl)
prescribed induction (nmod)
rate 58.3 (nmod)
azt in (case)
hbv 7 (nummod)
enterocolitis necrotizing (compound)
high even (advmod)
constitute . (punct)
reduces rats (dobj)
used ointment (nsubjpass)
iiib stage (compound)
using period (dobj)
complication such (predet)
modulation milieu (nmod)
patients mg/kg (nmod)
modification hyperammonemia (nmod)
remained enzymes (nsubj)
conditions varied (amod)
disappearance nsvt (nmod)
blocker ganglion (compound)
carolina north (compound)
igf-i receptors (conj)
man an (det)
unaffected pretreatment (nmod)
determine effect (dobj)
adenocarcinoma diethylstilbestrol (nmod)
measures protective (amod)
sedation mri (compound)
potency k(i (appos)
theophylline of (case)
mitigates stress (dobj)
mg/day was (cop)
days se (nmod)
artery sa (compound)
component cardiac (amod)
indomethacin of (case)
1.54 ) (punct)
course per (case)
causes impairment (dobj)
creatinine 1-year (amod)
models pain (compound)
examined therefore (advmod)
remifentanil or (cc)
passed individually (advmod)
angiograms performed (acl)
flatulence nausea (conj)
ocs with (case)
subjects 80 (nummod)
treatment response (compound)
accounted , (punct)
signs ischemia (nmod)
balance for (case)
showing activity (dobj)
related amiodarone (nmod)
using technique (dobj)
blocked fully (advmod)
relief worsening (nmod)
administration intrastriatal (amod)
doses warfarin (nmod)
localized was (aux)
pacemaker implanted (amod)
tdp ) (punct)
myofilaments , (punct)
vcm with (case)
dyskinesias or (cc)
aggravated damage (dobj)
risks cohort (nmod)
17.5 x (dep)
cope easily (advmod)
2 than (advmod)
expression nos (compound)
agents beta (compound)
alternation or (cc)
patients and (cc)
seizures s.c.)-induced (amod)
accumulation macrophages (nmod)
reversed did (conj)
mastocytosis mucosal (amod)
activity antidepressant (amod)
message : (punct)
dams the (det)
dysgenesis to (case)
effects vinorelbine (nmod)
time lag (compound)
% 9.6 (nummod)
pge2 given (case)
divided crf (dep)
deduced . (punct)
was sets (nmod)
exhibit ; (punct)
vip to (case)
method discrimination (compound)
exposure occupational (amod)
sensitive men (nmod)
years 8.6 (nummod)
effect antiepileptogenic (amod)
mitoxantrone leucovorin (conj)
subjected nigra (advcl)
worse significantly (advmod)
metabolic endocrine (conj)
setting units (dobj)
window observed (acl)
evaluable , (punct)
opaque are (cop)
increased integrity (dobj)
reassurance have (acl)
contribute impairment (nsubj)
case syndrome (nmod)
tma cyclosporine-induced (amod)
shortening fractional (amod)
performed beginning (advcl)
present hypothesis (dobj)
applicable easily (advmod)
improved , (punct)
examine association (dobj)
nonusers ) (punct)
treatments consecutive (amod)
overdose acetaminophen (amod)
microg/0.5 2 (compound)
limiting was (cop)
seizures presentation (dep)
atrium guinea (compound)
efficacy study (appos)
bpa ) (punct)
associated changes (nmod)
2.9-fold ( (punct)
dopaminomimetics and (cc)
contents albumin (nmod)
demonstrated mri (nsubj)
cohort haart (compound)
induced hypoalbuminemia (dobj)
woman referred (acl)
dysfunction methyldopa (amod)
receptors gaba(a (compound)
akathisia quetiapine (nmod)
prophylaxis everolimus (nmod)
received hr (dobj)
episodes disturbances (nmod)
scale severity (nmod)
163 to (case)
reported the (nsubj)
accelerated calcification (nsubjpass)
focused induces (advcl)
time modified (amod)
rate patients (nmod)
cases myopathy (nmod)
manifest may (aux)
hr % (appos)
receiving amb (dobj)
cells/mm3 with (case)
azathioprine aza (appos)
improving efficacy (dobj)
patients eight (conj)
hypomagnesemia severe (amod)
preserved is (auxpass)
sections tissue (compound)
affect therapy (nsubj)
depression nicotinic (amod)
delivery subcutaneous (amod)
develop , (punct)
showed whereas (mark)
pathogenesis headache (nmod)
shorter mice (nmod)
amount ngf (nmod)
use recurrent (amod)
factor that (mark)
treatment by (case)
9.88 - (punct)
meet criteria (dobj)
phenylpropanolamine ) (punct)
life-threatening were (cop)
mm reduction (nsubj)
patients candidates (acl:relcl)
origin are (cop)
hypertension responsiveness (dep)
requirement pentobarbital (nmod)
blood and (cc)
a % (appos)
have rate (nmod)
inhibiting by (mark)
reactions rare (amod)
amount bleeding (nmod)
concentrations cortex (nmod)
developed symptoms (nsubj)
rationale stimulation (nmod)
solution to (case)
sensitization lymphocyte (compound)
doses children (nmod)
regions for (case)
identified , (punct)
practical however (advmod)
presence hypothermia (nmod)
pretreatment ramh (nmod)
% 54.5 (nummod)
mazindol inhibitor (appos)
score induced (acl)
enhances and (cc)
90 orally (advmod)
exceeded concentration (nsubj)
regions isocortical (amod)
ifn ) (punct)
overdose showing (advcl)
retention memory (compound)
a % (conj)
evidence hypotension (nmod)
affinity receptors (nmod)
anaesthetic a (det)
cause anp (nsubj)
containing d2 (dobj)
inhibited . (punct)
bodies inclusion (compound)
2,682,2,803 counts (conj)
injury standardized (amod)
hypotension 11 (dep)
accompanied changes (nsubjpass)
losses larger (amod)
time examination (nmod)
correlations responsiveness (nmod)
350 ) (punct)
evidence pericarditis (nmod)
paradigm ) (punct)
power detect (acl)
identified factors (nmod)
rat normal-salt (amod)
plasma normal (amod)
treatments observation (conj)
lymphoma tumour (conj)
stressed , (punct)
scored measures (nmod)
index control (compound)
included criteria (nsubj)
relationships antagonism (nmod)
occur changes (nsubj)
treatment chemotherapy (nsubj)
treated rifampin (nmod)
crisis anemia (compound)
indirect effects (nsubj)
mg rizatriptan (amod)
discontinuation required (amod)
compared they (nsubjpass)
increases % (dobj)
had cats (nsubj)
october 2003 (nummod)
analysis northern (compound)
use term (compound)
uk the (det)
arterial both (cc:preconj)
depressed % (nmod)
weeks after (case)
3.4 3.1 (dep)
hypotension contrast (dep)
blocked raclopride (nmod)
block trazodone (nsubj)
processes mediated (acl)
comparable degrees (nmod)
toxicity agent (compound)
null heterozygous (conj)
related hormone (nsubj)
sec ; (punct)
improved hydroxytyrosol (nsubj)
control , (punct)
consists necessary (advcl)
groups both (preconj)
residence new (amod)
= % (nmod)
function impairment (nmod)
receptors histamine (compound)
lipoproteins found (acl)
analysis discriminant (amod)
undetermined aetiology (nsubjpass)
examinations from (case)
use for (case)
learning memory (conj)
anaesthetic used (acl:relcl)
activation gene (compound)
dose paralytic (amod)
galactose treatment (dobj)
degeneration afferents (nmod)
area dysfunction (nmod)
absent sought (conj)
times given (amod)
did lower (advmod)
have cancers (nsubj)
seizures sensitivity (dep)
concentration of (case)
present h (nmod)
fk506 ( (punct)
mm 107 (nummod)
give . (punct)
directed heart (nmod)
result which (nmod)
gain or (cc)
ltp and (cc)
phosphokinase high (amod)
increased serum (nmod)
managing who (nsubj)
day injections (nmod)
min 20.12 (nummod)
process hypertensive (amod)
toxicity due (case)
enhance which (nsubj)
co-administered ra (nsubj)
hypotension increase (nmod)
survivors not (cc)
allocated participants (nsubjpass)
ultrasound a (det)
drugs drugs (nmod)
presented signs (dobj)
methodology 16;567 (dep)
treated then (advmod)
concentrations (+)-cibenzoline (nmod)
mouth by (case)
beck the (det)
concentration albumin (nmod)
mg/kg 0.5 (nummod)
line control (appos)
correlation pressure (nmod)
report rechallenge (nmod)
dexmedetomidine ( (punct)
suggested reports (nsubj)
decreases pressure (nmod)
enflurane and/or (cc)
acquainted clinicians (nsubjpass)
smaller much (advmod)
hepatitis zidovudine-induced (amod)
approved asenapine (nsubjpass)
attempts paper (nsubj)
accelerated suppressed (conj)
increase least (advmod)
interventions performed (dep)
affected % (dep)
headache -- (punct)
curve a (det)
edema peritumor (compound)
epileptogenic show (conj)
normal determination (nmod)
aldosterone in (case)
treatment l-dopa (nmod)
remains relationship (nsubj)
decreased diameter (dobj)
suggests timing (nsubj)
tachycardia cardiomyopathy (amod)
include patients (nmod)
aconitine by (case)
number elevated (amod)
majority > (dep)
relatives , (punct)
effective less (advmod)
gain area (conj)
occurred sensitivities (nsubj)
plasma development (nmod)
13.2 +/- (cc)
caused extension (dobj)
reviewed weeks (dep)
administration mk-801 (compound)
effect warfarin (nmod)
described complications (dobj)
reaching high (advmod)
images initial (amod)
titration dosage (nmod)
inefficient whereas (dep)
happiness and (cc)
enhances bradycardia (dobj)
athletes improve (acl)
(+/-)-sm 3alpha-tropanyl-2-(4-chorophenoxy)butyrate (dep)
detected smad3 (nsubjpass)
reversed cessation (nmod)
analyzed data (nsubjpass)
simulator the (det)
preparations into (case)
defects identified (acl)
membranes cells (nmod)
18.4 ( (punct)
developed attenuated (conj)
hyperammonemia mainly (advmod)
attained was (auxpass)
evidence potential (nmod)
metabolised way (nmod)
% 48.5 (nummod)
hallucinations clarithromycin-associated (amod)
associated had (aux)
four six (conj)
had resistant (conj)
reoccur months (nmod)
isrctn54598675 : (punct)
correlation measurements (nmod)
included warfarin (dep)
tsh ( (punct)
microscopy pcr (conj)
practice , (punct)
urotoxicity to (case)
similar risk (nsubj)
observed recipient (dep)
animals receiving (acl)
iu/l changes (nmod)
females patients (nsubj)
characteristics medications (conj)
decreases mek1 (nmod)
cases fewer (amod)
duration with (case)
effects patient (nmod)
preceded pauses (nsubjpass)
underwent measurement (dobj)
mg increase (nsubj)
female in (case)
lacked . (punct)
117.61 +/- (cc)
receptors adenosine (compound)
involving blockade (dobj)
institute to (mark)
discharges model (nmod)
determined expressions (nsubjpass)
6/15 respectively (advmod)
amb. for (case)
seems long (conj)
function cochlear (amod)
anticoagulant warfarin (nsubj)
hbsag , (punct)
influence it (nsubj)
cage home (compound)
induced se (nsubjpass)
interna rara (compound)
glomerulosclerosis mild (amod)
high- to (case)
suggest unaltered (ccomp)
% 17 (compound)
states humans (nmod)
risks fetal (amod)
excretion on (case)
158.11 9.18 (conj)
resolved nifedipine (nmod)
disease end-stage (amod)
demonstrates follow (ccomp)
growth the (det)
agonists antagonists (conj)
sweating , (punct)
manic or (cc)
ccl4 cardiotoxic (conj)
blocks channels (dobj)
eruption syndrome (nsubj)
attacks between (case)
collagen epinephrine (conj)
patients aza-treated (amod)
complications green (nmod)
formation their (nmod:poss)
patients forty-six (nummod)
result weeks (nmod)
dose end (nmod)
start after (case)
occurring . (punct)
ad50 the (det)
sch selective (amod)
17.5 10(6 (conj)
collection : (punct)
affected disease (nmod)
involved patients (dobj)
has allele (nsubj)
ulcers aphtous (amod)
hyperalgesia/myoclonus between (case)
end surgery (nmod)
treadmill pool (conj)
disoprivan than (case)
death dependency (conj)
control drug (appos)
controls normal (amod)
mmol/l 128 (nummod)
obtained that (mark)
clearance busulfan (compound)
stages treatment (nmod)
relief h (nmod)
rate animals (nmod)
score patient (nmod:poss)
level protein (nmod)
gr , (punct)
opaque calculi (nsubj)
effective has (conj)
given noted (conj)
using probes (dobj)
saline saline (conj)
platform in (case)
levels mrna (compound)
determined modification (dep)
effect crocin (nmod)
kidney solitary (amod)
99mtc-glucarate detection (nmod)
provoked crisis (dobj)
integrins by (case)
p n. (conj)
potentials abnormal (amod)
allograft chronic (amod)
therapy thrombosis (conj)
responses anxiety (compound)
hcbd or (cc)
hours several (amod)
group gm (compound)
u/l 1,700 (nummod)
patients sph (nmod)
manifestations mouth (nmod)
patients syndrome (conj)
development embryonic (amod)
eeg the (det)
protector a (det)
morphine analgesia (compound)
step micrograms (appos)
thc ( (punct)
levels 12alpha-hydroxylase (nmod)
case women (nmod)
occurred had (aux)
condition recognised (acl:relcl)
reduction the (dep)
amounts tissue (nmod)
sedation continuous (amod)
micrograms.kg-1.min-1 ( (punct)
intravitreal implant (xcomp)
showed abstinence (nmod)
cells undamaged (amod)
tests " (punct)
decreases intake (nmod)
occurred toxicity (nsubj)
enhance to (mark)
indicators nephrotoxicity (nmod)
> serum (compound)
diagnosed newly (advmod)
alleviated that (mark)
presence sensorium (nmod)
transporter major (amod)
included evaluation (nsubj)
found activation (nsubjpass)
disorder an (det)
hla-b35 with (case)
mean 1.26 (conj)
quadriparesis and (cc)
inflammation cardiac (amod)
considered causes (nsubjpass)
bleeding associated (acl)
in 84 (nummod)
sulphate ( (punct)
focus oval (compound)
expression nephropathy (nmod)
ml/h ) (punct)
noticeable time (nmod)
design methods (conj)
crataegus , (punct)
analyzed study (nmod)
males ( (punct)
setting care (compound)
measured ebf (nsubjpass)
delirium patient (nmod)
complication delirium (nsubj)
required randomization (nmod)
% freedom (nsubj)
participants users (conj)
common : (punct)
had role (dobj)
age 11 (conj)
improved recognition (dobj)
kidneys the (det)
reacted . (punct)
disrupting acutely (advmod)
process underlying (acl)
fibers myelinated (amod)
treated vivo (advmod)
discontinued halothane (nsubjpass)
mm -0.2 (nummod)
reflects rotation (nsubj)
distribution body (compound)
drug their (nmod:poss)
compromising function (dobj)
stimulation bethanechol (conj)
parkinsonism , (punct)
changes new (amod)
recovery marrow (compound)
becoming increases (advcl)
media cm (appos)
25 of (advmod)
2004 december (compound)
s in (case)
remifentanil placebo (conj)
characteristics receptor (nmod)
delirium cocaine-induced (amod)
suggest mediated (ccomp)
developed was (ccomp)
give we (nsubj)
t180 ) (punct)
fusion interbody (compound)
surgery/radiotherapy following (case)
iopromide or (cc)
mdma or (cc)
% episodes (nmod)
lesion 5,7-dht (compound)
report stiffness (nsubj)
clearances acid (compound)
therapy phenobarbitone (compound)
temporary is (cop)
investigate we (nsubj)
centre poisons (compound)
sample randomized (amod)
variable . (punct)
saline ) (punct)
abolished bradycardia (nmod)
reported tool (xcomp)
function testing (conj)
riha of (case)
period control (compound)
erythematodes systemic (amod)
present infection (nsubj)
speed to (case)
model effects (nmod)
inhibitors concomitant (amod)
normal nearly (advmod)
association calcification (nmod)
compared prior (dep)
seems myoclonus (nsubj)
loss maximum (compound)
noted years (nmod)
report dysphagia (nmod)
tests biochemical (amod)
resulting reduction (nmod)
8- approximately (advmod)
8th and (cc)
effect modafinil (nmod)
microg/ml 11.00+/-2.89 (compound)
reflex -- (punct)
died months (nmod)
q10 coenzyme (compound)
given boluses (dobj)
might tool (nsubj)
increasing dose (dobj)
vehicle ip (conj)
alpha of (case)
ipratropium hours (conj)
studies future (amod)
sustained improvements (nsubjpass)
recurred , (punct)
strategy as (case)
patients from (case)
specimen surgical (amod)
observed exencephaly (dobj)
operations 64 (nummod)
uveitis treated (acl)
domain in (case)
micrograms capsaicin (compound)
examined series (nsubj)
immunosuppressant novel (amod)
tests hypothesis (dobj)
evaluation , (punct)
cocs and (cc)
infarction isoproterenol-induced (amod)
cause indeed (advmod)
thyroxine intravenous (amod)
pph to (case)
process in (case)
evident , (punct)
diameter dextran (nmod)
triglycerides ) (punct)
improves edema (dobj)
vehicle saline (compound)
veins sinus (conj)
produced monkey (nmod)
those amiodarone (nmod)
blocked prazosin (advcl)
risk absolute (amod)
sermion ) (punct)
excess users (nmod)
neurotoxicity meth-induced (amod)
days 24.9 (nummod)
abuse subjects (nmod)
man 30-year-old (amod)
data existing (amod)
effects occurrence (nmod)
compliance patient (compound)
transplants 84 (nummod)
hepatotoxicity malaise (conj)
selective that (mark)
showed follow-up (nsubj)
episodes retching (compound)
small . (punct)
levels peptide (compound)
comparison 320/25 (dep)
activate directly (advmod)
superior proportions (nmod)
well . (punct)
vehicle- pdtc-treated (conj)
total to (case)
risk : (punct)
remained superior (xcomp)
response peak (amod)
conclusion treatment (dep)
strychnine str (appos)
effect neurotoxic (amod)
did antagonist (nsubj)
result . (punct)
characteristics to (case)
thrombosis hitt (appos)
seizures behavior (conj)
aggravates causes (conj)
invariable correlated (conj)
detect changes (dobj)
sensitive streptomycin (nmod)
identifying correctly (advmod)
unilateral conventional (conj)
cent control (nmod)
receive modafinil (dobj)
exhibited observed (parataxis)
points as (case)
clarify mechanisms (dobj)
ability limited (amod)
setting clinic (appos)
150 6 (conj)
investigate virus (dobj)
pill slimming (compound)
stimuli heat (compound)
effects such (amod)
available most (nmod)
12 times (quantmod)
under-appreciated to (mark)
months three (nummod)
revealed resulting (advcl)
scheduled who (nsubjpass)
refine rules (dobj)
mg tid (amod)
groups for (case)
da brain (compound)
alprazolam placebo (conj)
increase density (nmod)
symptoms between (case)
returned . (punct)
intake c (nmod)
supplemented concentrations (nmod)
circle succeeded (acl:relcl)
suppressed mg/kg (conj)
reagent as (case)
system neuronal (amod)
feet her (nmod:poss)
expression pathway (nmod)
animals and (cc)
nad-precursors of (case)
use contained (acl:relcl)
3.0 those (nmod)
myocarditis eosinophilic (amod)
loss body (compound)
29 in (case)
mice derived (acl)
clear it (nsubj)
electrocardiogram an (det)
deprivation prenatal (amod)
restore fully (advmod)
minutes postdose (dep)
hypotension treated (acl)
use clozapine (nmod)
greater ng (dep)
consider that (mark)
mass lung (compound)
increased years (nmod)
relationships pressure (nmod)
presents form (nmod)
prescribed been (auxpass)
rp by (case)
stenosis resulted (acl:relcl)
method observations (dep)
substitute procedures (nmod)
receptors 1 (nummod)
society american (amod)
gd from (case)
physicians participating (amod)
management women (nmod)
suggested antagonist (ccomp)
become not (neg)
ce ml(-1 (appos)
comparison drugs (nmod)
flow decreased (amod)
dilevalol and (cc)
terminated vt (nsubjpass)
indicate observation (nsubj)
preceded expression (nmod)
proportion a (det)
mediated inhibition (nmod)
reported is (auxpass)
given control (xcomp)
background review (dep)
sustained refractory (conj)
copolymer of (case)
potential nmp (appos)
% boys (nmod)
paclitaxel of (case)
marker paranoia (nmod)
tendency cocaine (nmod)
report party (nmod)
lack data (nmod)
mg.kg(-1).d(-1 ( (punct)
mg/kg/i.v . (punct)
locomotion irritability (conj)
have pharmacology (dobj)
iopamidol % (conj)
manometry ambulatory (amod)
paradigms between (case)
associated . (punct)
period , (punct)
leukaemia lymphoma (conj)
1996 1998 (nmod)
suggestive but (cc)
or ( (punct)
systemic to (mark)
applicators iowa (nmod)
humans possibly (advmod)
weeks lnna (nmod)
index quality (compound)
shifting set (amod)
inhibited restoration (nsubjpass)
amplitude nerve (compound)
brain associated (acl)
nodosum . (punct)
seems effectiveness (nsubj)
hypothesis preserve (ccomp)
those except (case)
cardiotoxin monkeys (nmod)
treatment radioablation (nmod)
mg/kg 6.5 (nummod)
is srl-based (amod)
behaviors ocd-like (amod)
urate 0.001 (dep)
second- third-line (conj)
developed childhood (nmod)
bradycardia propranolol (nmod)
puromycin the (det)
delay 24-h (amod)
micrograms 400 (nummod)
dmso ( (punct)
mg 0.5 (compound)
alterations reaching (acl)
managed however (advmod)
macroprolactinemia for (case)
conducted also (advmod)
history patient (compound)
system poor (amod)
stains trichrome (compound)
increasing significantly (advmod)
posture body (compound)
position minutes (nmod)
hyperparathyroidism , (punct)
lead if (mark)
increase volume (compound)
nanoparticles poly-l-lactid (compound)
therapy cyclosporin (compound)
comparisons binary (amod)
cause administered (advcl)
glucuronidation the (det)
study carboplatin (nmod)
micturition all (det)
developed occurred (conj)
99 tachycardia (conj)
confirmed umb24 (ccomp)
carry carries (conj)
specified period (nmod)
patients p9201 (compound)
that exposure (nmod)
girl in (case)
titers endogenous (amod)
tolerability ( (punct)
correlated p (dep)
hematocrit differences (nsubj)
confined when (advmod)
differences response (nmod)
density microvessel (compound)
use sorafenib (compound)
blocked effects (dobj)
increase iohexol (nmod)
regions stenoses (conj)
anaesthetics inhalation (compound)
type receptor (compound)
targeted is (auxpass)
secondary signals (nmod)
ach extracellular (amod)
secretion net (amod)
11 10 (compound)
subunit cco (nmod)
significant surgery (nmod)
therapy carbamazepine (compound)
minutes start (nmod)
presented them (nmod)
case development (nmod)
testing seizure (amod)
factors incidence (conj)
exposure hcfcs (nmod)
divided methods (dep)
12.5 and (cc)
groups indomethacin (compound)
acetylcholine and (cc)
purpose report (dep)
pathologies the (det)
1/10 about (advmod)
ions calcium (compound)
injections intravenous (amod)
54 79 (conj)
reaching doses (nmod)
produced respectively (advmod)
subunits renal (amod)
specimens 278 (nummod)
5 and (cc)
dfmo ) (punct)
developed toxicity (dobj)
2.5 those (nmod)
enhanced pretreatment (nsubj)
investigated infusion (nmod)
appear factors (nsubj)
evident increased (advcl)
defect postinfarction (compound)
followed usually (advmod)
frequency rhythms (nmod)
limits within (case)
infections groups (nmod)
zidovudine placebo (conj)
anesthesia controlled (amod)
receiving fumarate (dobj)
hypertension by (case)
noradrenaline lower (amod)
higher not (neg)
remains examined (xcomp)
detected compared (advcl)
developed confused (conj)
phn in (case)
suffer patients (nsubj)
required factor (dobj)
developed candidiasis (dobj)
groups libitum (dep)
usage prolonged (amod)
received pdn (dobj)
reversal complete (amod)
lactate mg (compound)
examined response (dobj)
importance metabolite (nmod)
175 or (cc)
altered analgesics (nmod)
effects intralipid (nmod)
3722 319 (conj)
antagonists inhibitors (conj)
evokes mediated (dep)
40 80 (conj)
self-limiting . (punct)
sensation reported (amod)
lisinopril survival (conj)
cava ganglia (conj)
urate micromol/l (dep)
albumin urine (compound)
dosed day (nmod:tmod)
emergency as (case)
engineered that (mark)
toxicity cyclophosphamide-related (amod)
anxiety more (amod)
reduced meq/l. (conj)
liver hepatoma (conj)
peptide 35-amino (compound)
exists treatment (nmod)
pesticide organochloride (compound)
curative vancomycin (nsubj)
24 18 (compound)
treated medically (advmod)
infection patient (nmod)
pathways anterior (amod)
appear common (xcomp)
change podocalyxin (nsubj)
delayed was (auxpass)
escalated study (advcl)
hypertension induced (amod)
period 24-hour (amod)
find relation (dobj)
history accident (nmod)
or angiographically (advmod)
signs decrease (nsubj)
underwent pbsct (dobj)
pan bw (dep)
stress importance (dobj)
requirement dialysis (nmod)
cholesterol rich (amod)
ligation but (cc)
levels protein (compound)
discussed and (cc)
shows conclusion (nsubj)
less p (dep)
active cck-8-se (nmod)
times reach (acl:relcl)
rifampicin due (case)
disease renovascular (amod)
observed dogs (nmod)
movement fetal (amod)
required caution (nsubjpass)
staying up (compound:prt)
component process (nmod)
elevations levels (nmod)
questionnaires instrument (nsubj)
induce striatum (nmod)
waves and (cc)
facilitated was (auxpass)
echocardiography stress (compound)
reduced acidification (nmod)
progression reduced (amod)
rates drinking (nmod)
mg/d 3 (nummod)
patients department (compound)
combination on (case)
problem major (amod)
remains unknown (acomp)
transplantation stem (compound)
79 2 (conj)
used background (nsubjpass)
safety into (case)
emboli tumor (compound)
assessment efficacy (nmod)
unhappiness indicated (advcl)
complications motor (compound)
known suggest (advcl)
littermates their (nmod:poss)
report treated (conj)
tamca surgery (nmod)
data electrocardiogram (conj)
found position (dobj)
present failure (nmod)
risk injury (nmod)
spite in (case)
monitor result (nmod)
parallels etiology (conj)
1.56 . (punct)
potentiated mice (nmod)
surface oblongata (nmod)
children remaining (amod)
injury injury (nmod)
burning of (case)
done women (nmod)
protects remarkably (advmod)
motility on (case)
activated ] (punct)
concentrations rats (nmod)
amounts differences (conj)
blonquist et (dep)
p=0.44 ) (punct)
monotherapy lamivudine (compound)
riyadh in (case)
placebo-controlled two-way (dep)
suffering she (nsubj)
mice deleted (acl:relcl)
analgesic pediatric (amod)
convulsions bupivacaine-induced (amod)
length urethral (amod)
heptylate testosterone (compound)
power sufficient (amod)
period 1 (dep)
described not (neg)
map the (det)
increase frequency (nmod)
alcohol cd4 (conj)
sec 3.4 (nummod)
hr ; (punct)
ineffective contrast (nmod)
influenced rate (nmod)
44.8 - (punct)
considered play (xcomp)
18.9 +/- (cc)
n=12 % (appos)
5.2+/-1.1 , (punct)
damage leading (acl)
recurrences feasibility (conj)
warranted and (cc)
groups erdosteine (appos)
severity their (nmod:poss)
0.52 2.22 (conj)
the atorva (dep)
therapy such (amod)
cord c7-c8 (appos)
= 0.83 (dobj)
resembled lesion (nsubj)
increase prostacyclin (nmod)
declines simple (nmod)
wished develop (xcomp)
p<0.001 ( (punct)
registry a (det)
variability regurgitation (conj)
analgesia- incoordination (conj)
substituted purposes (nmod)
staining violet (amod)
conclude but (cc)
% 65.3 (nummod)
diagnosed 14 (nmod)
registered movements (nsubjpass)
small significant (conj)
lamivudine-resistance therapy-na (nmod)
germany in (case)
coadministered cinacalcet (nmod)
evidence promotes (ccomp)
escalations dose (compound)
caused uncertain (ccomp)
considered were (auxpass)
pretreatment extract (compound)
proteinuria hypoalbuminemia (conj)
examined have (aux)
cardiotoxicity dox (nmod)
38 of (advmod)
298+/-7 ( (punct)
european nimodipine (compound)
undergoing deactivation (dobj)
role pituitary (nmod)
patients nineteen (nummod)
whom of (case)
muscles papillary (amod)
seizures generalised (amod)
continue not (neg)
ducts biliary (amod)
associated hyperplasia (nsubjpass)
cyclophosphamide . (punct)
differentiated briefly (advmod)
potentiated were (auxpass)
conjunction in (case)
children twenty (nummod)
organogenesis during (case)
mmhg mmhg (conj)
newspaper initiated (acl)
showed pathology (dobj)
depression in (case)
baroreceptors the (det)
disorders mental (compound)
dosed were (auxpass)
levels prolactin (compound)
address to (mark)
cause potential (amod)
depressed status (nmod)
examined focusing (advcl)
time-dependent and (cc)
treatment ag (nmod)
conscious patient (nsubj)
vldl ldl (conj)
month a (det)
resolved been (auxpass)
cyp3a4 on (case)
receptors a2 (compound)
degree seizures (nmod)
variable was (cop)
activator allosteric (amod)
use maternal (amod)
paradigm light-enhanced (amod)
bleeding by (case)
cause (r)-alpha-methylhistamine (nsubj)
myoclonus clinical (amod)
recommendations avoid (acl)
consolidation the (det)
assessed calculated (conj)
undergone having (aux)
results dysfunction (nmod)
level whole (amod)
admission trauma (compound)
peaking month (nmod)
exceed morphine (nsubj)
manner heterogeneous (amod)
diagnosis cancer (nmod)
tolerated to (mark)
> 0.70 (nummod)
25.7 6.0 (conj)
receptor acetylcholine (compound)
elisa patients (nmod)
diminish metformin (nsubj)
doses codeine (nmod)
therapy endocrine (amod)
s administration (nsubj)
impairment observed (acl)
collagen interstitial (amod)
54.5 % (dep)
antibody platelet (compound)
demonstrated induce (ccomp)
development disorders (nmod)
causes hyperprolactinemia (nmod)
factor might (aux)
eyes dry (amod)
reduction end (nmod)
2'3 ' (case)
group hem (compound)
occurrence decrease (conj)
known yet (advmod)
declined mmhg (dobj)
limited regimens (nmod)
preferable that (mark)
tdp ( (punct)
majority types (nmod)
induced 0.014-unit (nmod)
locomotion rat (compound)
receive annually (advmod)
echocardiography other (amod)
side-effect the (det)
increased socs3 (dobj)
responses clonidine (nmod)
fourteen patients (nmod)
vision ishihara (appos)
infection opportunistic (amod)
journals and (cc)
colitis with (case)
effect immunosuppressive (amod)
glucosuria , (punct)
concentrations onset (nmod)
physical and (cc)
synapses some (det)
transaminase alanine (compound)
phosphorylation members (nmod)
samples of (case)
effects melatonin (nmod)
3722 , (punct)
positions recumbent (amod)
combinations morphine-dominant (amod)
developed mg/dl (dep)
tachyarrhythmias , (punct)
exposure early (amod)
losartan with (case)
depressed significantly (advmod)
addictive very (advmod)
injection mpep (compound)
observed effect (nmod)
blockers beta (compound)
associated necessarily (advmod)
cases reported (amod)
surgery months (conj)
adenomas hyperplasia (conj)
experienced switch (dobj)
disorder reflux (amod)
that below (case)
effects medium (nmod)
beta4 the (det)
sensation burning (amod)
oral transdermal (conj)
artery findings (conj)
12h - (punct)
results all (det:predet)
deficit to (case)
defect of (case)
events cardiovascular (amod)
recommend onset (nmod)
woman-years ) (punct)
observed observed (conj)
suggest discouraged (ccomp)
syndrome acquired (amod)
checked samples (nsubjpass)
produce , (punct)
hepatitis phenylethylbarbiturate-induced (amod)
showed first (advmod)
performed learning (nmod)
hypertension shown (acl:relcl)
injury melphalan (nmod)
detected not (neg)
stopping consumption (dobj)
discontinue occurrence (nmod)
modafinil of (case)
have important (advcl)
events therapy (nmod)
interpretation their (nmod:poss)
died suffered (conj)
effects anxiety (nmod)
developed institution (nmod)
society pharmacoeconomics (nmod)
undergoing ptra (dobj)
added , (punct)
left mm (dobj)
delayed clearance (nsubjpass)
patient 45-year-old (amod)
0.01 all (det)
administration management (compound)
% presented (acl)
dp/dt ( (punct)
none cases (nmod)
risk however (advmod)
phenobarbitone on (case)
complication ointment (nmod)
anotia ) (punct)
predilection intense (amod)
hours administration (dep)
aptts ) (punct)
creatinine [ (punct)
extension patients (appos)
analyzed later (advmod)
side-effect tdp (nsubj)
280+/-17 vs. (cc)
correlation production (nmod)
made measurements (nsubjpass)
ethyl-alpha-p-chlorophenoxyisobutyrate by (case)
dba/2 ( (punct)
reversion cases (nmod)
vary and (cc)
neurotransmitters inhibitory (amod)
achieved he (nsubj)
suggest underlie (ccomp)
experienced sucrose (dobj)
infarction rats (nmod)
affected women (nmod)
administration studies (nmod)
amn082 ) (punct)
shows report (nsubj)
support potential (dobj)
session between (case)
differ livers (nmod)
completion vcug (nmod)
derived mean (advcl)
those non-a (nmod)
improved dysmorphism (nsubj)
neurotransmitters amino (compound)
benzodiazepines intravenous (amod)
room coma (nmod)
associated risk (nmod)
remains although (mark)
sets according (case)
activity cyp7a (nmod)
serious but (cc)
had power (dobj)
placebo p (appos)
protect neurones (dobj)
mg/day 360 (compound)
solution b (compound)
domains five (nummod)
apoptosis mice (nmod)
pathogenesis and (cc)
laboratories chicago (conj)
ng cy (conj)
do infused (advcl)
triggers zidovudine (nsubj)
perimetry wavelength (amod)
five was (cop)
2.5 4.5 (conj)
decreased nausea (nsubjpass)
ns-718 ) (punct)
time inspiratory (amod)
stimulation dogs (nmod)
flutamide , (punct)
impairment slight (amod)
1.5 4.1 (compound)
nystagmus of (case)
loss vision (nmod)
identified if (dobj)
thrombosis atrial (amod)
monitored avoid (xcomp)
plays substantial (advcl)
ablation verapamil (compound)
cases 272 (nummod)
implicated eaca (nsubjpass)
therapy dyazide (compound)
colorectal in (case)
centers two (nummod)
lys1 , (punct)
length follow-up (nmod)
results longer (appos)
dfc , (punct)
trough-concentrations cimetidine (compound)
increasing cost (dobj)
regained potassium (nsubjpass)
abnormalities adenosine (nmod)
toxicity alterations (conj)
rise transient (amod)
pain particularly (advmod)
included acuity (dobj)
sarcolemma injury (conj)
both ; (punct)
attention close (amod)
type nhe3 (appos)
course biomarkers (nmod)
metabolism tryptophan (compound)
vt with (case)
dilatation renal (amod)
have 17 (nsubj)
subject , (punct)
associated ) (punct)
infections 3 (nmod)
recovery total (amod)
nightmare : (punct)
delivery and (cc)
rose levels (nsubj)
level malondialdehyde (amod)
behavior cocaine-induced (amod)
obtained concentrations (nsubjpass)
attention for (case)
recorded measurements (dep)
completed and (cc)
week during (case)
rats ( (punct)
acuity , (punct)
difficult although (mark)
developed gallstones (dobj)
selection a (det)
ischemic brain (compound)
mapping electrocardiographic (amod)
protection additional (amod)
evaluation markers (nmod)
gliclazide or (cc)
monotherapies as (case)
values between (case)
count mean (dep)
chow libitum (nsubj)
catatonia of (case)
lateral conventional (conj)
intervals min (compound)
starting procedure (nmod)
aggravation a (det)
six 4 (conj)
induction respiratory (conj)
44 four (compound)
40 30 (compound)
adl ) (punct)
polydipsia and (cc)
costs management (conj)
ed50 dog (compound)
drugs disease (compound)
profile its (nmod:poss)
prove hypnotic (xcomp)
rct new (amod)
use ht (nmod)
< ( (punct)
staining 2,3,5-triphenyltetrazolium (compound)
remained disappeared (conj)
% p=0.44 (appos)
head ( (punct)
used pallidotomy (nmod)
mastocytosis systemic (amod)
conditions hyperkalaemia (nmod)
course transplant (nmod)
b2 receptors (dep)
gestodene or (cc)
% 85.1 (nummod)
contribute way (nmod)
arrhythmias no (det)
disturbance intake (nmod)
comparison trial (appos)
destroy to (mark)
observations adults (nmod)
mm 40+/-6 (nummod)
plasma glutathione (conj)
effect low (nmod)
12 ) (punct)
agsd to (case)
values nocturnal (amod)
mechanism action (nmod)
extract sativus (compound)
review cases (conj)
remained mice (nmod)
tolerated was (auxpass)
measures fasting (acl)
pathways the (det)
maximum be (cop)
is/tia or (dep)
warfarin warfarin-drug (conj)
stretching ovale (nmod)
patients methamphetamine-dependent (amod)
preparation cortical (amod)
acupuncture biofeedback (conj)
dsm of (case)
immunostaining regions (nmod)
asystole . (punct)
psychopathology like (case)
increased examined (conj)
results invasion (nmod)
development nephrolithiasis (nmod)
associated injections (nmod)
access by (case)
trial test (compound)
thresholds db (nmod)
specific to (mark)
showed flutter (dobj)
adrenaline and (cc)
necrosis cancer (conj)
84 to (dep)
extent failure (nmod)
channels nachrs (nsubj)
paralysis pre-existing (amod)
dizziness rash (conj)
incidence nephropathy (nmod)
analogues with (case)
management adequate (amod)
material april (nmod)
treated not (neg)
composition bs (compound)
attributable didanosine (xcomp)
cytotoxicity cyclophosphamide (compound)
asthma of (case)
nodules multiple (amod)
20 ten (compound)
vincristine to (case)
improved oct (nsubj)
analyses liver (dobj)
subset safe (amod)
apex involving (case)
treated effectively (advmod)
valproate migraine (nmod)
demonstrated sites (nsubjpass)
dysfunctions account (nmod)
scans computerized (amod)
cells appropriate (amod)
institutions from (case)
occur differences (nsubj)
mif ( (punct)
opioid common (amod)
administration daily (amod)
anoxia leading (acl)
aminotransferase u/l (conj)
some sequelae (nmod)
unchanged increased (conj)
enhancement nmda (compound)
caspase-3 caspase (conj)
electrocardiogram outcomes (conj)
conclusions demonstration (appos)
gemcitabine and (cc)
tumors microscopic (amod)
useful test (nmod)
resources psychological (amod)
responses virologic (amod)
reported cause (xcomp)
otherwise treatment-refractory (dep)
assess to (aux)
nephrotoxicity risk (dep)
diagnostic ( (punct)
onset rapid (amod)
prone users (nsubj)
document level (dobj)
agents neuromuscular (compound)
group age (appos)
accounting ) (punct)
criteria histologic (amod)
caused drug (nsubj)
caffeine from (case)
diazepam cocaine (conj)
had extraction (dobj)
reduced scores (dobj)
detecting uveitis (dobj)
angiotensinogen intrarenal (amod)
aml ; (punct)
monitored min(-1 (dep)
evidence solid (amod)
function role (compound)
similar bradycardia (nsubj)
co-treatment ; (punct)
therapy ( (punct)
pregnancy n (dep)
study on (case)
ml(-1 administered (acl)
spaces , (punct)
presents article (nsubj)
statistics drug (compound)
30 40 (conj)
hypertrophy reversible (amod)
produced sensitive (advcl)
identified diagnosed (nsubjpass)
cards daily (compound)
significant statistically (advmod)
ameliorated symptoms (dobj)
30.8 +/- (cc)
that bn (nmod)
buprenorphine with (case)
conclusions resulted (appos)
supplementation vitamin (compound)
bradycardia rats (nmod)
onset before (case)
intervals approximation (nmod)
min mean (compound)
demonstration . (punct)
oc ( (punct)
valves affected (amod)
% 32.9 (nummod)
tdp. of (case)
test validity (dobj)
analogue new (amod)
stopping and (cc)
formation memory (compound)
ligation 24-h (amod)
benefits reshaping (nmod)
protocol background (nsubj)
reports previous (amod)
analysis population (nmod)
0.6 ) (punct)
pfs and (cc)
ich is/tia (conj)
cmf ( (punct)
related vasculitis (nmod)
mrds ) (punct)
mice exposed (acl)
multifactorial and (cc)
interventions percutaneous (amod)
antagonist muscarinic (amod)
age stroke (conj)
infarction sumatriptan (nmod)
months 111 (nummod)
variables secondary (amod)
arrhythmias for (case)
iop ) (punct)
abusers opioid (amod)
alphabeta-crystalin subunit (conj)
episodes before (case)
histological for (case)
developed median (dobj)
haematuria and/or (cc)
experiment randomized (amod)
7.5 15 (conj)
insult the (det)
fhf ) (punct)
ballistic dystonic (conj)
dose microl (nmod)
55 to (dep)
loss until (case)
ranges associated (acl)
fatigue headache (conj)
pth ) (punct)
tachycardia and (cc)
agents several (amod)
december 2010 (nmod:tmod)
ikr fpd (conj)
carcinoma breast (nmod)
inhibitor calcineurin (compound)
compared condition (nmod)
associated hypothyroidism (nmod)
shifts and (cc)
referred evaluation (nmod)
investigate : (punct)
scored % (nsubj)
widened 15.0 (nmod)
risk hemorrhage (nmod)
offered modalities (nsubjpass)
enrolled participants (nsubjpass)
failure acetaminophen-induced (amod)
29th day (compound)
addition allografts (nmod)
animals pilo-injected (amod)
% -7.5 (nummod)
levels obtained (acl)
patients aged (advmod)
efforts during (case)
reduces oxygenation (dobj)
blockers amiodarone (advmod)
2- , (punct)
fact is (cop)
developed interval (dobj)
administration intraperitoneal (amod)
mg/kg therapy (compound)
fr type (compound)
predict failure (dobj)
emissions neonates (nmod)
0.15+/-0.03/h ( (punct)
majority aneurysms (nmod)
mhb long-lasting (amod)
amounts acid (nmod)
induced humans (nmod)
any if (mark)
other thrombocytopenia (nmod)
occurred disease (nsubj)
1.55 ; (punct)
action virtue (dep)
function resting (amod)
0.03 0.3 (conj)
epithelium proximal (amod)
pronounced period (nmod)
side-effect administration (nmod)
phosphorylation kinase (nmod)
discovery and (cc)
variety in (case)
preserved density (nsubjpass)
levels lpo (compound)
serum- kinase (dep)
induced wasting (xcomp)
precipitate agitation (dobj)
therapy ranitidine (compound)
treatments ina (compound)
respond return (conj)
rats salicylate (nmod)
dose tamoxifen (nmod)
ratio rcr (appos)
presents : (punct)
behavioral , (punct)
cacl(2)-treated , (punct)
fibrillation in (case)
receive mg (dobj)
antibodies halothane-induced (amod)
action urotoxic (amod)
obtained sinus (nmod)
potentiation central (amod)
body bladder (compound)
woolf of (case)
rtms rate (conj)
electrocardiographic despite (case)
infusion central (amod)
heart from (case)
survived who (nsubj)
monitor . (punct)
stopping , (punct)
challenged examine (advcl)
associated effective (advcl)
15/group ): (punct)
5ht2a ) (punct)
seizures anesthetic-kindled (amod)
hypertension dexamethasone-induced (amod)
na cr (conj)
occurred commencement (nmod)
affected hyperprolactinemia (nmod)
deterioration . (punct)
intake drugs (nmod)
syndrome 2 (nummod)
exhaustion until (case)
increased developed (conj)
therapy salbutamol (nmod)
psychostimulant abused (amod)
suggests used (ccomp)
developed simvastatin (nmod)
reversed before (mark)
decreased pentazocine (nsubj)
toxic drug (nmod)
onset hepatitis (nmod)
left study (nsubj)
level system (nmod)
consumption lsd (compound)
76 12 (compound)
focused lesion (nmod)
decreased doses (conj)
development neurotoxicity (nmod)
effects antiemetics (nmod)
using strategy (dobj)
postdose h (compound)
mk-212 and (cc)
pharmacokinetics plasma (compound)
induced fluphenazine (nmod)
fiber sprouting (acl)
mg/kg pcpa (compound)
identical that (mark)
used duration (nsubjpass)
therapies anti-adenovirus (amod)
activity apnea (conj)
drowsiness , (punct)
val204asp/p that (mark)
males setting (nmod)
use drug (nmod)
m(1)/m(3)/m(5)-selective ( (punct)
psychosis postpartum (compound)
increased 3.0 (dep)
p.o. b.i.d (dep)
group group (dep)
blockade cardioselective (amod)
supranuclear in (case)
tnss ) (punct)
focused studies (nsubj)
strains hbv (compound)
element a (det)
administered after (mark)
reason one (nummod)
fell patient (nmod)
comparable is (cop)
medication antiparkinsonian (compound)
patient this (det)
injections parenteral (amod)
nm ki=237 (compound)
compounds organophosphorus (compound)
total paclitaxel (nmod)
antigen , (punct)
response small (amod)
milligram per (case)
cells/microl to (case)
increasing , (punct)
overstimulation by (case)
reductions studies (nmod)
observed medicated (conj)
form human (amod)
dyscontrol and (cc)
necessary period (nmod)
hyperlipidemia mixed (amod)
recovery peripheral (amod)
systems parasympathetic (amod)
vocabulary digit (conj)
aroused . (punct)
exists injury (nmod)
septal for (case)
differences midazolam (nmod)
discussed proposals (conj)
pilocarpine , (punct)
defined is (auxpass)
outflow due (case)
anuria complicating (acl)
marked patients (nmod)
trough high (amod)
similar pressures (nsubj)
impairment hoarding (conj)
completion infusion (nmod)
harvested . (punct)
isoenzymes ck-mb (appos)
anatomical or (cc)
ratio mice (nmod)
type dose (conj)
signs patients (compound)
billingham according (case)
systems hepatic (amod)
presented was (auxpass)
disorders causes (nmod)
sequestration nitrotyrosine (nmod)
function cck-8 (nmod)
postdose by (case)
reduce off-time (dobj)
prevent development (dobj)
administered be (auxpass)
week twice (advmod)
delivered , (punct)
activity therefore (advmod)
schizophrenia first-episode (amod)
insipidus di (appos)
bore that (mark)
glycol naoh (conj)
deposits basement (compound)
gtn after (case)
times the (det)
condition patients (nmod:poss)
flow vt/ti (appos)
activity cholinesterase (compound)
target their (nmod:poss)
implanted : (punct)
investigated cases (nmod)
addition necrosis (nmod)
evaluate tobramicyn (nmod)
type serotonin (compound)
common discontinuations (nmod)
database a (det)
triggers and (cc)
attended who (nsubj)
pirarubicin ( (punct)
generated phase (nmod)
antigen virus (compound)
acid trans-retinoic (amod)
present can (aux)
prochlorperazine of (case)
have state (dobj)
blockade chronic (amod)
days 24 (nummod)
prescribed treat (xcomp)
trial women (nmod)
progression and (cc)
micrograms/kg/min 10 (nummod)
convulsive rewarding (conj)
prescribed onychomycosis (nmod)
associations ratio (dep)
echocardiography speckle (compound)
activity synthesis (nmod)
favour in (case)
knife or (cc)
measure moving (advcl)
examined mice (nmod)
separate to (mark)
tumors colorectal (nmod)
analyzed count (nsubjpass)
tissue cardiac (amod)
diverse entities (dep)
normal stimulation (nsubj)
developed anuria (nsubj)
capable isomers (nsubj)
procedure deconvolution (compound)
hour 24 (compound)
effects avp (nmod)
frequency vte (nmod)
suggest increase (ccomp)
a-i apolipoprotein (amod)
administered concentrations (nsubjpass)
therapy emergent (compound)
fs into (case)
vials blinded (amod)
symptoms core (compound)
mg/m(2 and (cc)
filaments strokes (conj)
question an (det)
discussed was (auxpass)
po h (appos)
cacl(2)-untreated n=12 (appos)
forearm followed (acl)
chloroquine with (case)
lifetime intensity-weighted (conj)
nifedipine or (cc)
studies four (nummod)
two including (case)
case necrotizing (advcl)
show cultures (nsubj)
smoking factor (nmod)
strong though (mark)
adriamycin- tetrachloride- (conj)
b with (case)
increased substantially (advmod)
reversed nalozone (nmod)
a.m. at (case)
epidemics the (det)
increased affected (conj)
involved adenosine (nsubjpass)
pge2 with (case)
described leukoencephalopathy (nsubjpass)
mediated reflexes (nmod)
diisopropylfluorophosphate , (punct)
data growth (conj)
haematological either (cc:preconj)
seem effects (nsubj)
ha the (det)
depend protection (nmod)
revealed unchanged (parataxis)
element that (mark)
injection produce (acl)
complemented were (auxpass)
detection cytometric (amod)
lithotripsy extracorporeal (compound)
shown rad001 (nsubj)
tool : (punct)
toxicology using (acl)
tachyarrhythmia of (case)
examined alterations (nmod)
and clinically (advmod)
allocated consecutively (advmod)
amisulpride of (case)
lamina vascular (amod)
rate infusion (compound)
g-1 ) (punct)
site discharge (compound)
sera available (amod)
explained release (nmod)
check reality (nsubj)
points at (case)
5.64 +/- (cc)
selected induced (conj)
carbimazole propranolol (conj)
transporter-1 glyt1 (appos)
receiving they (nsubj)
correlated be (auxpass)
thromboembolism risk (dep)
remission complete (amod)
placed was (auxpass)
series antagonists (nmod)
became ; (punct)
foods beverages (conj)
suprofen from (case)
metabolism calcium (compound)
study i (nummod)
session p (dep)
lesions dwi (nmod)
metabolism tamoxifen (compound)
clear function (nsubj)
abnormality captopril (nmod)
sedation studies (nmod)
infusion trinitrate (nmod)
risk similar (amod)
result cardiotoxicity (conj)
child healthy (amod)
evaluated potential (dobj)
od mg (dep)
carbetocin microg (compound)
aminotransferase ) (punct)
responsible dysregulation (nsubj)
decayed exponentially (advmod)
nephrotoxicity the (det)
cognitive middle-aged (nmod)
performed rating (nsubjpass)
studies acute (compound)
oc any (det)
work present (amod)
data . (punct)
first ibpb (nmod)
trial no (det)
prevent infusion (nsubj)
bnpp ) (punct)
relaxed . (punct)
shr n (dep)
tests in (case)
exposures humans (nmod)
implicated syndrome (nmod)
represses and (cc)
inferences terms (nmod)
amnesia for (case)
dead died (conj)
enhanced was (auxpass)
points the (det)
evaluated se (nmod)
effect important (amod)
assigned titrated (parataxis)
7th between (case)
gamma-aminobutyric acid-transmitted (dep)
has respectively (advmod)
examination determination (nmod)
s immediately (advmod)
lacnp involvement (appos)
% 66 (compound)
cyp mg/kg (appos)
0 100mg/kg (conj)
effects tetracycline (nmod)
cocaine alcohol (conj)
phenomenon by (case)
insecticides used (amod)
beta-epimers their (nmod:poss)
related secondary (conj)
predisposed development (nmod)
ng/ml hours (dep)
factor-i insulin-like (amod)
treatment depletion (nmod)
leukopenia by (case)
became . (punct)
0.13 v (case)
justification evaluation (nmod)
taken prior (advmod)
provide should (aux)
7.0 , (punct)
cbz of (case)
mtx ara-c (conj)
dehydrogenase of (case)
lasted administrated (parataxis)
restore blockage (nsubj)
stimulation evoked (acl)
remain effects (nsubj)
confusion seizures (conj)
caused paramethasone (nmod)
patients tdp (nmod)
% urticaria (nmod)
advantage significant (amod)
involvement trigeminal (amod)
immunity rubella (compound)
significance undetermined (amod)
responsible cases (nmod)
patients years (acl:relcl)
included tumors (dobj)
developed 1 (nsubj)
example a (det)
cin and (cc)
confined analysis (nsubjpass)
drug benztropine (nsubj)
output cardiac (amod)
disorder specified (amod)
affinity due (case)
showed heterogeneity (dobj)
diagnosis common (nsubj)
cause aminoglycosides (nsubj)
tolerate did (aux)
patient esrd (compound)
exposure needle-stick (amod)
rrmm ) (punct)
hoe of (case)
years 6.5 (nummod)
show also (advmod)
associated marrow (nmod)
follow-up changes (dobj)
69 [ (punct)
carcinomas and (cc)
medication nor (cc)
anaesthesia general (amod)
cardiotoxicity doxorubicin (compound)
variables survival (conj)
patients type (compound)
sympathectomy in (case)
impact ) (punct)
used subjects (nmod)
movements all (det)
average to (case)
hypertension her (nmod:poss)
lt ) (punct)
time disease (compound)
stains from (case)
drugs latter (amod)
induced neurotensin (nmod)
decreased layer (nmod)
050+/-561 527+/-509 (dep)
compares uh (nmod)
peptides these (det)
apnoea p (dep)
antagonist caffeine (nsubj)
transport concentration (nmod)
albuminuria due (amod)
alterations differences (conj)
value added (amod)
practice as (case)
damage mtdna (compound)
fed phenobarbital (advcl)
antagonist flumazenil (nsubj)
hematologic nonhematologic (conj)
basis therapy (nmod)
users 16 (nummod)
resulted onset (nmod)
analyze aspects (dobj)
akinesis the (det)
users 26 (nummod)
clentiazem other (amod)
recumbent and (cc)
bicyclo-orthobenzoate t-butyl (compound)
neurotoxic that (mark)
known ability (nsubjpass)
antibiotic of (case)
started 1985 (nmod)
inhibits formyltransferase (dobj)
znso(4 of (case)
mmhg hypotension (nmod)
urticaria/angioedema or (cc)
generated interest (dobj)
anesthesia hypotension (compound)
% weight (nmod)
tremor finger (compound)
nad enzyme (nmod:poss)
gaba glycine (conj)
use bzd/rd (compound)
delayed is (auxpass)
lateral superficial (amod)
compartment interstitial (amod)
exposure no (det)
developed dizziness (dobj)
time open-arm (compound)
appear protect (xcomp)
house her (nmod:poss)
portray analysis (dobj)
infections gram-negative (amod)
published reports (nsubjpass)
hypoparathyroidism treated (acl:relcl)
administered dosage (dobj)
ndma-d ( (punct)
u/ml median (compound)
sodium depleted (conj)
partially least (advmod)
application valproate (nmod)
12 seven (compound)
emit , (punct)
crisis amisulpride- (amod)
insufficiency patients (nmod)
moderate of (case)
absence d2r (nmod)
testing memory (dobj)
resulted stimulation (nsubj)
history health (compound)
formation abnormal (amod)
stimuli somatosensory (amod)
involvement rigidity (nmod)
was prolongation (nsubj)
donation platelet (compound)
cidofovir intravenous (amod)
administration labetalol (nmod)
medication antiemetic (amod)
continues remains (conj)
containing aprotinin (dobj)
poisoned pemoline (nmod)
infusions 0.03 (nmod)
assessed efficacy (nsubj)
deviation measure (nmod)
action nephrotoxic (amod)
hydrobromide , (punct)
exhibited cases (nmod)
overdose venlafaxine (compound)
factor have (aux)
probes stereology (compound)
assessable toxicity (nmod)
anemia level (nmod)
consumers who (nsubj)
alpha-gst ( (punct)
either drugs (nmod)
demonstrated background (dep)
deviation 14.2 (dep)
use sirolimus (compound)
received isotretinoin (dobj)
td ) (punct)
unknown currently (advmod)
u/l range (dep)
increment cyclophosphamide (nmod)
processes also (advmod)
demonstrates conclusions (dep)
prevented alterations (nsubjpass)
syndrome acetazolamide-induced (amod)
november june (conj)
damage underlying (amod)
occurred six (nmod)
antagonism hyperactivity (nmod)
hemorrhage events (conj)
microscopy for (case)
required will (aux)
unresponsive mice (nsubj)
process muscles (nmod)
exacerbates injury (nmod)
men 32 (nummod)
values tremor (nmod)
permeability/injury increased (amod)
requirement analgesia (nmod)
reduced treatment (nsubj)
occlusion injection (nmod)
performed pnd71 (nmod)
toxicity drug (nmod)
significant cancer (nmod)
groups ecstasy (compound)
began thrombophlebitis (conj)
period 3-day (amod)
maintained anticoagulation (dobj)
consistent polyneuropathy (nmod)
attenuated significantly (advmod)
markers cytogenetic (amod)
efv ) (punct)
britain in (case)
had did (conj)
inhibitory real (amod)
extent affect (nmod)
developed decrease (nsubj)
status astrocytes (nmod)
relapse no (det)
p=0.0001 ( (punct)
vasculitis autoantibody-positive (amod)
forced reduction (dobj)
e13.5 , (punct)
0.001 ) (punct)
action might (aux)
accuracy percent (amod)
neurotoxicity nigrostriatal (amod)
lower flow (nsubj)
dose paracetamol (compound)
evaluate . (punct)
cystitis rats (nmod)
antipsychotic with (case)
plays levels (nmod)
identified variety (nsubjpass)
use pregnancy (nmod)
prodrug capecitabine (nsubj)
haemorrhages warfarin-related (amod)
difficulty breathing (nmod)
had size (nsubj)
cr pet (nmod)
unchanged although (mark)
reduced withdrawal (nsubj)
exam the (det)
ml t (conj)
anticoagulation long-term (amod)
volume end-diastolic (amod)
conditions " (punct)
ethanol g/kg (appos)
rofecoxib were (cop)
t days/week (appos)
showing is (aux)
demonstration to (mark)
inflammation intraocular (amod)
atenolol and (cc)
treated di (nsubjpass)
drugs ic (compound)
akinesia reserpine-induced (amod)
lid disease (compound)
infarction and (cc)
tetrachloride- carbon (compound)
ed-1 and (cc)
british patients (nsubj)
consists that (nsubj)
agonist inhibition (nmod)
had risk (dobj)
quantitated . (punct)
evidence years (dep)
symptoms appear (acl:relcl)
study pregnancy (nmod)
designed phase (nmod:tmod)
activity locomotor (compound)
symptoms neuropsychiatric (amod)
gaba the (det)
prevented development (nsubjpass)
colliculi in (case)
cyclosporine ) (punct)
forearm lateral (amod)
combination before (case)
divided total (nsubjpass)
clozapine- nonobese (amod)
2.5 2.0 (compound)
contributes thus (advmod)
values his (nmod:poss)
oxygen mitochondrial (amod)
described organization (dep)
recruited groups (conj)
center washington (compound)
instructions in (case)
differentiated pma (nmod)
baseline vs (cc)
ointment patients (appos)
ng/ml 0.004 (compound)
hypertension phenylephrine-induced (amod)
mart insignis (compound)
did e2 (nsubj)
observed should (aux)
infrequent result (conj)
1.8 from (case)
epilepsy treated (acl)
damage possible (amod)
state dyskinetic (amod)
micrograms 5 (nummod)
anf ] (punct)
mirror would (aux)
dogs infarction (nmod)
azotemia and (cc)
taking cpa/ee (dobj)
group last (amod)
compared relation (nmod)
consisted safe (dobj)
ranged subjects (nsubj)
recruited method (nsubjpass)
elevated surface (nmod)
frail in (mark)
discrimination location (compound)
episodes 10 (nummod)
6.5 less (amod)
outcomes medical (amod)
dosing captopril (nmod)
tried . (punct)
vision , (punct)
decrease hyperthermia (nmod)
flash and (cc)
nodularity breast (compound)
assessed efficacy (dobj)
men completed (acl:relcl)
diazepam , (punct)
volume rate (conj)
pparalpha expressed (acl)
achieved period (nmod)
tma tacrolimus-associated (amod)
ventricle in (case)
subgroup from (case)
neuropathy subacute (amod)
greater variance-significantly (advmod)
hit thrombosis (nmod)
caffeine , (punct)
4.8 x (cc)
due anaemia (nsubj)
iran in (case)
caused increase (conj)
paradigm gds (nmod)
< 2 (nummod)
characteristics the (det)
caused propylthiouracil (nmod)
impairment structural (amod)
b n (appos)
staining in (case)
demonstrated been (auxpass)
subjected shr (nsubjpass)
leukemia from (case)
setting . (punct)
inhibitor sorafenib (nsubj)
patients forty-one (nummod)
alpha-tc by (case)
drugs health (conj)
measured excitability (nsubjpass)
results riha (dep)
words 400 (nummod)
deposits infiltrate (conj)
episode with (case)
case anxiety (nmod)
reports exist (nmod)
effect solvent (nmod)
search to (mark)
parts rating (compound)
[125i]mibg of (case)
factor ototoxic (amod)
leukemia or (cc)
factors risk (compound)
dysfunction prolonged (amod)
inpatient abusing (acl)
possible ingested (advcl)
is correct (nsubj)
rats paracetamol-treated (amod)
advances field (nmod)
role dysfunction (nmod)
consistent course (nsubj)
parameters optimal (amod)
increase release (nmod)
veratridine by (case)
hypercholesterolemia moderate (amod)
decreased was (auxpass)
choriocarcinoma of (case)
resection therapy (nmod)
plays pallidus (nsubj)
seizures psychoses (conj)
demonstrate develop (ccomp)
confusion onset (compound)
dilated . (punct)
echocardiography and (cc)
dose associated (acl)
stereotypy such (case)
groups to (case)
complete recovery (nsubj)
progestogens ) (punct)
had still (advmod)
antagonist but (cc)
indicative matter (nmod)
common use (nsubj)
pathway mapk (compound)
database company (nmod:poss)
infused hours (nmod)
appeared intense (conj)
order diagnose (acl)
infection the (det)
naloxone a (det)
receive fentanyl (dobj)
min administration (nmod)
contractions atropine (compound)
> to (case)
female of (case)
unavailable subtype (nsubj)
seen contrast (nmod)
actions excitatory (compound)
tested have (aux)
activated ) (punct)
lag a (det)
experienced we (nsubj)
medication prophylactic (amod)
antagonized antagonists (nsubj)
prescribing judiciously (dobj)
properties novel (amod)
cavity function (conj)
hormone potassium (conj)
proteins tj-associated (amod)
pains their (nmod:poss)
task of (case)
patients pretreated (dep)
prevented thus (advmod)
purpose investigation (nmod)
usage telithromycin (compound)
observed 3 (conj)
background tumor (appos)
effects edrophonium (nmod)
electrogram by (case)
case prazosin (nmod)
fluids liters (appos)
score mmse (compound)
% 10.8 (nummod)
viral or (cc)
thrombosis as (case)
administered re (xcomp)
choleretic a (det)
levels females (nmod)
recognition postpregnancy (compound)
produced capsule (nmod)
values maximal (amod)
abnormalities without (case)
animals groups (nmod)
treatment fluoxetine (compound)
experienced clonic (dobj)
dunnett ) (punct)
infections infections (conj)
suggested administration (nsubjpass)
combination inhibitor (nmod)
data blockade (nmod)
pan/temocapril ( (punct)
events af (case)
investigated study (nmod)
elimination via (case)
cpb ) (punct)
toxicity syndrome (dep)
attended . (punct)
mice cba/ca (compound)
failure life-threatening (amod)
implausible likely (conj)
treatment previous (amod)
shown needed (conj)
colliculus ic (appos)
incidence malformations (nmod)
22 10 (compound)
prolactin overall (amod)
subcellular lobular (conj)
trichotillomania anxiety (conj)
subjects as (case)
have migraine (nsubj)
damage irreversible (amod)
cataracts rr (dep)
four patients (dep)
conclusion provides (appos)
equal ng (nmod)
microinjections bilateral (amod)
lp over (case)
administration ketoprofen (nmod)
indications calcineurin (compound)
segmental necrotizing (dep)
postponed was (auxpass)
regimen higher (amod)
exhibited phenotype (dobj)
133 +/- (cc)
marked ischemia (nsubjpass)
users fifteen (nummod)
vehicle its (nmod:poss)
disability and (cc)
pain after (case)
0.31 than (dep)
on , (punct)
exercises physical (amod)
forms ulcerous (amod)
transferred , (punct)
cta % (appos)
ml ) (punct)
study placebo-controlled (amod)
site that (mark)
experienced ; (punct)
perfusion coronary (amod)
10min exposure (nmod)
remained accentuated (conj)
thorax and (cc)
exhibited therapy (nmod)
begin addressing (xcomp)
infusion given (case)
salbutamol hds (appos)
norleucine glutamate (conj)
dealing infarction (nmod)
girl 15-yr-old (amod)
bpa with (case)
study angiography (dep)
rate 28/min (conj)
timolol pilocarpine (appos)
different frequency (nmod)
morning ( (punct)
had hormone (conj)
benefit procedure (nmod)
observed pfs (nsubjpass)
had when (advmod)
related treatment (nmod)
response nicotine (nmod)
marker was (cop)
luke st. (compound)
inter- ( (punct)
heart-rate fall (conj)
rheumatology pharmacology (conj)
effect micrograms/kg (dep)
ltp cck-8 (conj)
picrotoxin by (case)
transmission increased (amod)
reduced effectively (advmod)
tubuli kidney (nmod)
counts blood (compound)
ability serum (compound)
treated dex (nmod)
preferred anaesthesia (nmod)
chemotherapy cancer (nmod)
induced thc (nmod)
portion interaction (nmod)
noted levels (nmod)
dysfunction bioenergetic (amod)
antithrombosis mice (nmod)
renal . (punct)
initiated immediately (advmod)
minutes stimulus (nmod)
greater being (cop)
values plasma (compound)
dose 5-fluorouracil (nmod)
clear is (cop)
containing lindane (dobj)
carried test (xcomp)
emulsion epinephrine (conj)
cause cholestasis (nmod)
under-reporting by (case)
restricted sharply (advmod)
related when (advmod)
decibels 100 (nummod)
trial irbesartan (nmod)
attack to (case)
ingestion chronic (amod)
atrophy with (case)
hemorrhage warfarin-associated (amod)
vcm and (cc)
failure rats (nmod)
administration prophylactic (amod)
distress of (case)
drugs k (compound)
mdma ( (punct)
profile study (dep)
concentration an (det)
fatigue dyspnea (conj)
ck-mb , (punct)
irreversible invariably (advmod)
studied months (nmod)
man hyperlipidemia (conj)
taking standard- (dobj)
percent by (case)
ami : (punct)
produced severe (xcomp)
reversible dose-related (conj)
study determine (xcomp)
effects inotropic (amod)
patients eighteen (nummod)
remains become (conj)
limits potentially (advmod)
transaminases the (det)
aspartate observed (ccomp)
discharged safely (advmod)
selection to (case)
showed affecting (advcl)
step compartment (nmod)
risperidone haloperidol (conj)
exploited . (punct)
recover frame (nmod)
cells muscle (compound)
course in (case)
days 11 (nummod)
intoxications ( (punct)
frequencies tested (acl)
nephropathy neonate (nmod)
sinus coronary (amod)
part therapy (nmod)
chiasm the (det)
reduplication basement (compound)
evaluate dose (dobj)
rats scopolamine-treated (amod)
persons susceptible (amod)
fam famtx (conj)
cause ne (nsubj)
hospital 's (case)
mice prepared (acl)
male ovariectomized (conj)
combined estradiol (nmod)
option attractive (amod)
studied sites (nsubjpass)
criteria to (case)
recovery count (nmod)
prove activator (xcomp)
protocol ) (punct)
cycles tfl (nmod)
period treatment (nmod)
respond to (mark)
5 ) (punct)
variations and (cc)
compared acid (nmod)
time , (punct)
prevented saralasin (nmod)
% 89.1 (nummod)
found rhabdomyolysis (dobj)
group eastern (amod)
extent staining (nmod)
7-ethoxyresorufin-o-deethylase demethylase (conj)
wistar and (cc)
consumed are (auxpass)
acted enhance (xcomp)
common dystonia (nmod)
episodes bleeding (amod)
occurred varied (xcomp)
26.3 0.7 (conj)
compared background (dep)
integral the (det)
changes relation (nmod)
treatment ancrod (amod)
risks medical (amod)
monotherapy mg/day (appos)
pentobarbital mg/kg (appos)
insufficiency fluid (compound)
described frequency (nmod)
index new (amod)
= odds (mark)
arteries of (case)
superior significantly (advmod)
relevance potential (amod)
waves patients (nmod)
birth weight (dobj)
less + (cc)
frequent these (nsubj)
glaucoma poag (appos)
8 11 (dep)
impairs occupation (nsubj)
mumol/l and (cc)
lacks however (advmod)
1.3 was (cop)
induced stimulation (nmod)
communicate proteins (nsubj)
life substance (nmod)
effects events (conj)
pentobarbital mg (dep)
findings n (dep)
half cases (nmod)
tea of (case)
perception in (case)
reduced expressions (nsubjpass)
defects unequivocal (amod)
weeks population (appos)
trial thalidomide (nmod)
investigated relationship (nsubjpass)
response dynamic (amod)
anesthetic as (case)
threshold ) (punct)
hypotension arterial (amod)
iq performance (compound)
fluctuations ( (punct)
desire phase (conj)
fibrosis interstitial (amod)
substitute lidocaine (nmod)
ameliorated hypertension (dobj)
changes pattern (nmod)
patients 33 (nummod)
transaminase glutamate-oxaloacetate (amod)
pesticide agricultural (amod)
tomography quantitative (amod)
risk function (nmod)
supports . (punct)
antagonist cholinergic (amod)
mrna factor (appos)
adults 50 (nummod)
dysosmia induced (acl)
combinations dfp (nmod)
compares . (punct)
cause rodents (nmod)
sought confirm (xcomp)
pruritus levels (conj)
pons 2/8 (appos)
weight of (case)
mg.per 100 (nummod)
antioxidant mitochondrial-targeted (amod)
removed removed (advcl)
inherent attack (nmod)
da serotonin (conj)
hallucinations ifosfamide-induced (amod)
50 a (det)
enhance impaired (advcl)
injected forearm (nmod)
noted donor (nsubj)
design , (punct)
application nitroglycerin (compound)
modify activity (dobj)
adding when (advmod)
observed exercise (conj)
baby a (det)
paranoia emerged (acl:relcl)
reduce selection (nsubj)
thalidomide or (cc)
discussed factors (nsubjpass)
cardiomyopathy % (dep)
shown analogue (nsubjpass)
apex disease (nmod)
infections overall (amod)
concentrations [ca(2+)](i (appos)
studied behaviorally (advmod)
70 125 (prep)
series mirrors (dobj)
densa the (det)
ala204asp/p p. (compound)
sites muscarinic (amod)
positive amphetamine (nmod)
recovery partial (amod)
dmpx by (case)
metabolized simvastatin (nsubjpass)
frequency quantity (conj)
54.5 0 (conj)
chill , (punct)
rhabdomyolysis association (nmod)
ifosfamide high-dose (amod)
disturbances complexes (conj)
tended exhibit (xcomp)
% 54.3 (nummod)
benign always (advmod)
majority patients (nmod)
useful patients (nmod)
group brainstem (compound)
occurred deaths (nsubj)
consists treatment (nsubj)
treated pneumonia (nsubjpass)
restricted-diet growth-inhibited (dep)
fenfluramine of (case)
well less (advmod)
possible may (aux)
leukaemia with (case)
enhancing by (mark)
ranged three (dobj)
treatment memantine (nmod)
vasculature , (punct)
fits . (punct)
register swedish (compound)
suppressed expression (dobj)
tendency a (det)
delineated been (auxpass)
therapy corticosteroid (compound)
auc desipramine (nmod)
average units (nmod)
involves production (dobj)
studies multicentre (compound)
cytokines of (case)
accumulation injection (nmod)
channels ca (compound)
rates svr (compound)
b amb (appos)
transaminases months (nsubj)
exercise resting (nsubj)
electrocardiograph continuous (amod)
leukoencephalopathy and (cc)
stoppage drug (nmod)
haloperidol patients (conj)
scores bis (compound)
lowers absence (nsubj)
use in (case)
hal ) (punct)
antihyperalgesia of (case)
enabled . (punct)
treatment with (nmod)
control adequate (amod)
lidocaine ( (punct)
aimed assess (xcomp)
similar occurred (conj)
lesions functions (nmod)
decrease sbp (nmod)
use quantities (nmod)
capsaicin g (appos)
resulted hyperglycemia (nmod)
loss cell (compound)
33.6 from (case)
regulation from (case)
tobramicyn of (case)
determined which (nsubjpass)
administration has (acl:relcl)
contributed levels (nsubj)
administration corticosteroids (nmod)
strokes of (case)
confirmed not (neg)
acc-9653 mg/kg (conj)
2 between (case)
produced injury (nsubjpass)
change any (nmod)
125 - (punct)
g/day 0.13 (nummod)
toxicity bupivacaine (nmod)
volume gravity (conj)
mg 0.28+/-0.2 (conj)
stimulus analysis (nmod)
10 0.1 (compound)
caused aap (nsubj)
terminals on (case)
40 or (cc)
responsibility abnormalities (nmod)
dye of (case)
studied dose (nmod)
appeared week (nmod)
mice rendered (acl)
encouraged results (nsubj)
develop switch (nmod)
retention salt (compound)
camp intraplatelet (amod)
disrupts amiodarone (nsubj)
followed biweekly (advmod)
cytological architectural (conj)
modes administration (nmod)
albino female (amod)
disorder co-morbid (amod)
oxidase with (case)
complications device-related (amod)
protects model (nmod)
element region (nmod)
treatment in (case)
syndrome hypertension (compound)
knockout of (case)
halving dose (dobj)
cases intoxication (nmod)
interval ci (appos)
iprindole with (case)
70 8 (conj)
popularity control (nmod)
possible performed (ccomp)
related pph (nmod)
consumption of (case)
investigate compare (conj)
dysfunctioning of (case)
bed the (det)
tropicamide of (case)
positive was (cop)
observed responsiveness (nsubjpass)
higher synthesis (nsubj)
pretreatment naloxone (nmod)
phosphorofluoridate dfp (appos)
b iii (conj)
monitoring intervention (conj)
group controls (conj)
ionotropic and (cc)
predicted discontinuation (nmod)
shown experiments (nsubj)
administration rauwolscine (conj)
13 of (quantmod)
dyskinesia complications (nmod)
complication infrequent (amod)
returned days (nmod:tmod)
remain studies (nsubj)
mean reductions (dobj)
starting when (advmod)
subsided and (cc)
known syndrome (nmod)
degree a (det)
addition solution (nmod)
prodrug phenytoin (compound)
asthma nocturnal (amod)
vasopressor alpha-adrenergic (amod)
impairment significant (amod)
strip urinary (amod)
unclear relationship (nsubj)
lesions neoplastic (amod)
amounted mg/l (nmod)
leads withdrawal (nsubj)
exanthema , (punct)
triggered was (auxpass)
circuitry frontostriatal (amod)
inhibition percent (compound)
one and (cc)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate ligand (appos)
foci proliferation (nmod)
design case-control (amod)
coordinates the (det)
protect decreasing (advcl)
hernia dh (appos)
terminals at (case)
reports effect (nmod)
system systemic (amod)
glutathione of (case)
alpha-methyltyrosine with (case)
proliferation progenitor (compound)
believed widely (advmod)
substrate that (mark)
function use (conj)
cleft aor (dep)
twin , (punct)
accumulating evidence (nsubj)
release the (det)
measured substances (nmod)
hours 3.8 (nummod)
range 120 (nummod)
pathways nerves (conj)
death by (case)
began patient (nsubj)
g daily (advmod)
unknown details (nsubj)
undescribed heretofore (advmod)
studied since (mark)
effects implications (dep)
cytotoxicity 3717 (nummod)
hypothesize to (mark)
change : (punct)
mono-infected and (cc)
receive myocet (nmod)
properties prominent (amod)
reversed intravenously (advmod)
heparin low-dose (amod)
apl classic (amod)
hypertension started (acl:relcl)
antinociceptive constipating (conj)
influx the (det)
tqrs ( (punct)
weakness including (case)
correlated scores (nmod)
randomized weeks (nmod)
ineffective whom (nmod)
antibiotic effects (nmod)
using model (nmod)
increased accordingly (advmod)
behavior animal (amod)
supplementation therapy (nmod)
infection without (case)
calculation incidence (compound)
assessment funduscopy (conj)
form neuropathy (nmod)
doses response (dep)
attenuated studies (nmod)
aldosterone urine (conj)
treated ergotamine/caffeine (nmod)
presented whom (nmod)
exposure short (amod)
efficacy the (dep)
icrf-187 by (case)
sepsis severe (amod)
unchanged atropine (nmod)
recorded day (nmod)
failure patients (conj)
precautions despite (case)
presumably , (punct)
antagonized catalepsy (dobj)
39+/-10 vs. (cc)
levels serum (compound)
h compound (nmod)
effects epinephrine (nmod)
emphasizes action (dobj)
reports discontinuance (nmod)
king the (det)
values of (case)
cholesterol % (nmod)
% 81 (nummod)
lp the (det)
documented background (dep)
sodium the (det)
carried i.m. (advmod)
shorter group (nmod)
vomiting due (case)
used patients (nmod)
consisted mg/day (dep)
kytril ; (punct)
sensitive c57bl/6j (conj)
study microscopy (compound)
virus-related b (nmod:npmod)
occurred subsequently (advmod)
using drugs (dobj)
prepartum weeks (compound)
undergoing therapy (dobj)
altering significantly (advmod)
were patients (attr)
function dopaminergic (amod)
determining ad50 (dobj)
memory functioning (acl)
mg/kg/day 50 (nummod)
prevention to (case)
susceptibility on (case)
percentage of (case)
phosphanilate agent (appos)
available are (cop)
score percent (conj)
response capsaicin (nmod)
drops echothiophate (amod)
fails protect (xcomp)
abnormalities 1 (appos)
accompanied fibrillation (nmod)
experienced incontinence (dobj)
using that (mark)
emit rats (nsubj)
rose women (nmod)
exploration decreased (amod)
caused ablation (nmod)
degree approximately (advmod)
profile a (det)
co-treatment days (nmod)
demonstrated had (conj)
autoantibodies panca (appos)
protection any (det)
behaviors go (acl:relcl)
differences hr (nmod)
development fibrosis (nmod)
increased regions (conj)
enhanced hyperthermia (nsubj)
serum total (appos)
recruited and (cc)
later minutes (nmod:npmod)
administration propylthiouracil (nmod)
inhibit using (advcl)
determination direct (amod)
found inhibited (ccomp)
0.8 ng/dl (dep)
tolerated being (cop)
confirmed fhf (dobj)
decreasing while (mark)
and also (advmod)
aspirin and (cc)
medications virus (compound)
abilities functional (amod)
mechanisms potential (amod)
model acid (compound)
found although (mark)
patients 19 (nummod)
form report (compound)
consolidation . (punct)
model primate (amod)
ergotamine/caffeine for (case)
were differences (nsubj)
diagnosed having (advcl)
s intervals (conj)
considered as (mark)
nephroureterectomy a (det)
aggravated diclofenac (conj)
seen abnormal (nsubjpass)
prospective a (det)
density localization (conj)
effect retina (nmod)
involved resurgence (nmod)
dse one (nummod)
incidence lower (amod)
infants newborn (amod)
drugs themselves (appos)
strategy treatment (compound)
upregulation . (punct)
di ( (punct)
report using (advcl)
inhibitor l-noarg (dep)
can ) (punct)
available reliably (advmod)
following intracortically (advmod)
appears consistent (advcl)
related may (aux)
kinase creatinine (conj)
initiation disease (nmod)
seems act (xcomp)
report failure (dobj)
eczema with (case)
had number (nmod)
achieved stability (nsubjpass)
syndrome called (acl)
raise to (mark)
cross-clamp of (case)
tolerated fk506 (nsubjpass)
effects papaverine (nmod)
exerted that (mark)
inhibitor plasma (compound)
patient using (acl)
stopped withdrawal (nmod)
tbm ) (punct)
order identify (acl)
rats amnesia (nmod)
hr % (conj)
evaluated degree (dobj)
permeability the (det)
beginning treatment (dobj)
prescribe to (mark)
bradycardia patient (nmod:poss)
cases < (dep)
alcohol t-cell (conj)
concentrations despite (case)
reappeared . (punct)
led administer (xcomp)
become which (nsubj)
discussed view (nmod)
add toxicities (nmod)
patients headache (nmod)
acknowledged suspected (conj)
1.037 +/- (cc)
monitored because (mark)
mitochondria subsarcolemmal (amod)
number depressions (nmod)
dexamethasone 10(-7 (dep)
indicate play (ccomp)
assess influence (dobj)
toxicity blinding (amod)
given courses (dobj)
retardation offspring (nmod)
2.5 5 (conj)
complication ticlopidine (nmod)
period therapy (nmod)
processing in (case)
identification the (det)
experiences hallucinatory (amod)
cns cardiovascular (conj)
seemed celecoxib (nsubj)
restore movements (nmod)
combination intoxication (nmod)
resistant more (advmod)
angioedema intestinal (amod)
costs , (punct)
reduced action (dobj)
examined day (nmod:tmod)
outcome regression (dep)
epinephrine and (cc)
reserpine- dyskinesia (conj)
implications results (nmod)
p 0.001 (nummod)
proposed acts (ccomp)
demonstrated patients (nmod)
isoflurane the (det)
pentothal sodium (compound)
edema on (case)
a1 ( (punct)
regulating inactivation (dobj)
experienced started (advcl)
infusion proving (acl)
tested hypothesis (dobj)
syndromes difficult (amod)
syndrome doxorubicin-induced (amod)
increased disease (nmod)
involves hypertension (nsubj)
periods ictal (amod)
cacl(2)-treated and (cc)
processed studies (nmod)
panel css (compound)
f(33 , (punct)
papilledema white (conj)
duration median (amod)
neurones rats (nmod)
communication 5th (amod)
lower men (nmod)
bradycardia hypothermia (conj)
designs experimental (amod)
decrease limiting (csubj)
nystagmus associated (acl)
morning every (det)
reappeared restarting (advcl)
effect counts (nmod)
reflection often (advmod)
score hospital (nmod)
experiencing neutropenia (dobj)
carcinogenesis fanft (compound)
hydrochloride ( (punct)
recorded case (nsubj)
drugs when (advmod)
proteinuria treated (acl)
enhancement matter (nmod)
treated antipsychotics (nmod)
62.5 20.9 (conj)
reproducibility across (advmod)
fingers on (case)
ina ( (punct)
deposited and (cc)
correlate to (mark)
atenolol from (case)
observed effect (nsubjpass)
exencephaly from (case)
include thrombocytopenia (dobj)
co-treatment . (punct)
management intraoperative (amod)
present schizophrenic (ccomp)
incidence the (det)
suggesting involved (ccomp)
modulate receptors (nsubj)
disease acute (amod)
records and (cc)
damaged meth (nmod)
site modulation (nmod)
fall greater (amod)
suspension a (det)
seems response (nsubj)
mass ventricular (compound)
pheochromocytoma patient (nmod)
lymphoma , (punct)
administered ineffective (advcl)
received tocolysis (dobj)
led has (aux)
cardioselective both (cc:preconj)
females ritonavir-treated (amod)
volume improvement (conj)
levels extracellular (amod)
cpap cm (compound)
incidence thrombophlebitis (nmod)
benefit toxicity (conj)
recommended it (nsubjpass)
cases one (nmod)
lesions manifested (amod)
years more (conj)
4.5+/-1.0 , (punct)
speculated based (advcl)
observed hcrh (nmod)
antibodies antinuclear (amod)
tended lower (xcomp)
boys in (case)
reduction fracture (nmod)
plasma csf (conj)
affected commonly (advmod)
time- and (cc)
language mild (amod)
detect that (mark)
symptom 1 (nummod)
return one (advcl)
then by (case)
southeast and (cc)
suppressed sleep (dobj)
inhibitors no (compound)
affect associated (advcl)
exceeding preferably (advmod)
syndrome for (case)
goal , (punct)
sum . (punct)
rats intact (amod)
administration post-training (amod)
antibiotic an (det)
drug than (case)
specimens and (cc)
relapsed two (nsubj)
role deficit (nmod)
lower seemed (conj)
acetaminophen mg/kg (dep)
1ml/kg , (punct)
number lines (nmod)
superoxide neutrophil (compound)
organophosphorus by (case)
factor been (cop)
% 20.1 (nummod)
reports , (punct)
7e dro-1h- (appos)
grade 21 (nummod)
possible failure (nsubj)
1048 overall (advmod)
120/67 : (punct)
model last (nmod)
rats induce (acl)
recognition measures (nmod)
resolution a (det)
each with (case)
noted hypotension (nsubjpass)
is experiments (nmod)
discrimination assays (nmod)
given simultaneously (advmod)
permeability barrier (compound)
conducted . (punct)
cpb after (conj)
substituted naproxen (nmod)
blocker selective (amod)
saline n=10 (dep)
shift intracellular (nmod)
viracept and (cc)
reductions dose (compound)
80.8 22.4 (conj)
response reflex (amod)
result alternatively (advmod)
normal protidogram (nsubj)
slope and (cc)
neurotoxicity ifosfamide-induced (amod)
reported infarction (nsubjpass)
10 in (case)
surgery gynecological (amod)
failure anuria (nmod)
prevented which (nsubj)
seen bdl (nmod)
rigidity haloperidol (compound)
hypotension : (punct)
determine causes (dobj)
indistinguishable which (nsubj)
appear blockade (nsubj)
gds on (case)
reactions depression (nmod)
clinical multicenter (nmod:npmod)
induction for (case)
hyperprolactinemia risperidone-induced (amod)
mechanisms operative (acl:relcl)
antagonists or (cc)
field hippocampus (nmod)
use > (dobj)
background infrequent (appos)
provoke did (aux)
factor factor/vascular (amod)
alpha5 and (cc)
emerged assessment (nsubj)
had return (dobj)
recorded practitioners (nmod)
a dbp (conj)
decreased induced (conj)
depression neurologic (amod)
did change (dobj)
peptide active (amod)
patients 101 (nummod)
site receptor (compound)
p alone (advmod)
found resulted (ccomp)
disease cholestatic (amod)
areas onset (nmod)
kidney of (case)
paramount is (cop)
extent to (case)
patients ovarian (amod)
nmda 20 (conj)
extension flexion (conj)
therapy all (det)
demethylase n-nitrosodimethylamine (amod)
lead degeneration (nmod)
vehicles saline/side (dep)
recorded higher (advcl)
mean ) (punct)
class high (amod)
effect azathioprine (nmod)
cortex , (punct)
evaluated mice (nsubjpass)
phosphatase protein (nsubj)
calcification in (case)
7 8 (conj)
syndrome wpw (compound)
greater treatment (nmod)
estrogen of (case)
ticlopidine mediated (acl:relcl)
treated have (aux)
mater of (case)
mediated cells (nmod)
cnsb002 and (cc)
mv 0.05 (nummod)
decreased movements (dobj)
resulted recurrence (nmod)
courses multiple (amod)
episodes five (nummod)
administered report (nmod)
elderly the (det)
gabaergic dopaminergic (conj)
models ouabain-induced (amod)
diseased and (cc)
denervation nucleus (nmod)
surface total (amod)
acid drug (acl:relcl)
clamping bilaterally (advmod)
adducts adr (compound)
compared patients (nsubjpass)
related cyclosporine (nmod)
sequences attenuated (amod)
elicited repeatedly (advmod)
substantial is (cop)
simvastatin , (punct)
vasodilator : (punct)
bupivacaine hyperbaric (amod)
significance clinical (amod)
gentamicin netilmicin (conj)
woman the (det)
models flurothyl (compound)
ability recognize (acl)
evaluation time-to-onset (nmod)
igf-i and (cc)
reduced fibrosis (dobj)
rigidity hypotension (conj)
a cyclosporine (compound)
requires treatment (nsubj)
antipsychotics clozapine (nmod)
ester nitric (amod)
increased rate (nsubj)
function lysosomal (amod)
dysrhythmogenicity administration (nmod)
beats/min 0.6 (compound)
deprivation either (cc:preconj)
activation nuclear (amod)
methods quantification (compound)
humidity % (compound)
lnna ( (punct)
hallucinations complex (amod)
began recover (xcomp)
brain adult (amod)
antiemetics dopaminergic (amod)
similar ) (punct)
administration simultaneous (amod)
myelomeningocoele a (det)
addressing better (advmod)
conjunctivitis patient (appos)
cholesterols in (case)
parkinson united (compound)
hallucinosis recurrent (conj)
doppler echocardiographic (compound)
stimulation tissues (nmod)
animals ich (compound)
causes declines (dobj)
ldh ) (punct)
ranged ml (nmod)
effect p450s (nmod)
increases males (nmod)
oral i.m. (conj)
influence age (nmod)
laboratories department (appos)
associated ability (nmod)
mortality and (cc)
had 3 (nsubj)
two jerks (nmod)
l-noarg ; (punct)
drugs given (acl:relcl)
minutes t30 (appos)
uninephrectomized received (conj)
pathways apoptotic (amod)
ineffective preventing (advcl)
study mechanisms (dobj)
exposed course (nmod)
increment for (case)
rp intra-arterial (amod)
dyskinesia the (det)
methods determined (appos)
bypass with (case)
membranes plasma (compound)
compared enhancement (nsubjpass)
extent similar (amod)
gastroenteritis interactions (conj)
suitable protection (nsubj)
sensor involved (acl:relcl)
circles concentric (amod)
force involved (acl)
factors developing (advcl)
presented getting (advcl)
rammer ( (punct)
ratio control (compound)
cnsb002 5.0 (nummod)
rupture predisposed (amod)
failure bupropion (nmod)
nature be (cop)
halos blurring (conj)
investigations response (nmod)
bha , (punct)
ectoderm surface (compound)
compounds acidic (amod)
smaller doses (nmod)
lamivudine-na in (case)
contributor is (cop)
3beta-hydroxy-5beta-pregnan-20-one [ (punct)
indicates reversibility (dobj)
northern and (cc)
cohorts the (det)
control groups (conj)
ecstasy . (punct)
hormones sex (compound)
reproducible . (punct)
suggesting control (ccomp)
than excretion (nsubj)
bradycardia in (case)
individuals 2 (nummod)
mg 1.5 (compound)
organs target (compound)
determined charge (nsubjpass)
hepatitis : (punct)
transporter mice (dep)
erythromycins cephalosporins (conj)
period 60-s (amod)
quantified areas (nsubjpass)
specific reaction (nsubj)
phosphokinase of (case)
hydrochloride calcium (conj)
bis or=80 (appos)
model hypertension (nmod)
have diseases (dobj)
tapped propranolol (nmod)
show have (ccomp)
status baseline (nmod)
propranolol effects (nmod)
identified also (advmod)
resulted growth (nmod)
2 12 (conj)
supported was (auxpass)
subscale the (det)
calculated to (xcomp)
neurons ganglionic (amod)
intoxication conformed (acl)
received drugs (dobj)
examined impact (nsubjpass)
projections of (case)
middle cerebral (dep)
eliminated increase (dobj)
recognized changes (nsubjpass)
trials 19 (nummod)
occur injection (nmod)
inoculation 4.2 (nmod)
using chloride (dobj)
vertex the (det)
rate neither (cc:preconj)
appeared seizure (nsubj)
size robust (amod)
maintained eyes (nsubj)
hepatotoxicity drug (nmod:poss)
users receiving (acl)
cognitive : (punct)
treated mg/day (dep)
clipping the (det)
induced increment (dobj)
neurotoxicity pac (compound)
women 12 (nummod)
spasms the (det)
administered study (nmod)
jaundice limits (nmod)
injury including (case)
modulation a (det)
improvements functions (nmod)
inhibitors (cox)-2-specific (amod)
guidelines therapy (nmod)
produced is (auxpass)
ischaemia cerebral (amod)
range subtherapeutic (amod)
receptors over (case)
increase tremor (nmod)
months 2 (nummod)
hyponatremia associated (acl)
verify sensitivity (dobj)
receptors particularly (advmod)
have syndrome (dobj)
anemia complicating (acl)
valsartan for (case)
bladder in (case)
cacl(2)-treated nacl-treated (conj)
increases hypertension (nsubj)
interference possible (amod)
controls 85 (nummod)
vocal fold (dep)
= 139 (dep)
elevated were (auxpass)
norms with (case)
attenuated impairment (dobj)
heart , (punct)
describes case (nsubj)
branches to (case)
side-effects rats (nmod)
cases to (case)
serum human (amod)
model status (compound)
patients 264 (appos)
chlorpheniramine and (cc)
iopentol with (case)
days about (case)
had seven (nsubj)
role disintegrin (nmod)
naloxone after (case)
occurs that (nsubj)
treatment symptomatic (amod)
i and (cc)
kinase the (det)
p.o. metoprolol (amod)
s.c. . (punct)
cancer analysis (dep)
alterations induced (acl)
used exclusively (advmod)
eight-week , (punct)
tasks only (advmod)
medical dental (conj)
modifications therapy (nmod)
, pressure (dep)
same group (nmod)
electroencephalographic monitoring (conj)
perfusion the (det)
activation pontis (conj)
deaths delirium (nmod)
diversion by (case)
suggested shift (nsubj)
increased sequestration (dobj)
interact receptors (nmod)
superoxide dex (appos)
2-adrenoceptors cardiac (amod)
paclitaxel mg (nummod)
examined changes (nmod)
rats 9 (dep)
proven be (auxpass)
pathology de (amod)
patients non-pd (amod)
supersensitivity , (punct)
g/m2 . (punct)
measured clearance (nmod)
those effects (nmod)
caused hcrh (nsubj)
amplitude sensory (amod)
psychosis of (case)
ability order (acl)
differences depend (acl:relcl)
watch diuresis (dobj)
inf-mi ( (punct)
toxicities of (case)
yet not (neg)
score scale (nmod)
play could (aux)
observed time (nmod)
agent amiodarone (nsubj)
f344 of (case)
finished until (mark)
equipotent actions (nmod)
prolonged characterized (advcl)
membranes on (case)
model pilocarpine (compound)
had pretreatment (dobj)
measured passed (conj)
done effect (nmod)
imbalance electrolyte (compound)
contraction norepinephrine (nmod)
acetate given (amod)
groups castrated (amod)
water simultaneously (advmod)
ecg to (case)
diazepam- , (punct)
known drug (nsubjpass)
proposals suggesting (acl)
supplement used (amod)
mtdna ' (punct)
concordance in (case)
involved whether (mark)
alter doses (nsubj)
virus ) (punct)
effect anesthesia (nmod)
reduction ratio (nmod)
filling mm (nmod)
stress pathogenesis (nmod)
intensity hyperalgesia (nmod)
implicated cardiotoxicity (nmod)
h one (nummod)
licensed form (nmod)
images echo (compound)
used groups (nsubjpass)
responding therapy (nmod)
regulated developmentally (advmod)
amlodipine mg (amod)
follow-up close (amod)
consideration assessing (advcl)
were patients (nsubj)
had hypertrophy (conj)
tablet patients (nmod)
animals uni- (amod)
implicated been (auxpass)
followed sequencing (nmod)
rhabdomyolysis to (case)
shown 3,4-methylenedioxymethamphetamine (nsubjpass)
enzyme gaba-synthesizing (amod)
amiodarone treatment (conj)
keeping of (case)
rendered myopathic (xcomp)
acquired rats (nsubj)
nephrectomized were (cop)
described girl (nsubjpass)
condition cranial (amod)
del taqib (appos)
increase against (case)
hypotension origin (nmod)
cardiac early (advmod)
regulation transmission (nmod)
activity pattern (conj)
25.6 6.5 (conj)
found sensitization (nmod)
profile either (cc:preconj)
nephrotoxicity one (nsubj)
% 0.075 (nummod)
cells experience (acl:relcl)
attributed augmentation (nsubjpass)
hospital central-city (amod)
level contamination (compound)
additive can (aux)
designed investigate (advcl)
examined focus (nmod)
providing targets (dobj)
age race/ethnicity (conj)
seeded hips-cms (nsubjpass)
scr postdose (compound)
type contraceptive (nmod)
report effects (dobj)
effects against (case)
reduced 63 (nmod)
results detected (appos)
prevalence abuse (nmod)
cross-tolerant . (punct)
discontinuation spironolactone (nmod)
have presentation (nmod)
mediated tachycardia (nsubjpass)
levels mtdna (compound)
changes neuroinflammatory (amod)
recovered patient (nsubj)
uganda in (case)
animal clinical (conj)
compared was (auxpass)
infarctions pallidus (compound)
alternative safer (amod)
has used (advcl)
feeling wound-up (amod)
rigidity muscular (amod)
layers epithelial (amod)
apomorphine that (det)
normalization parameters (nmod)
induced hydralazine (nmod)
158.11 40.1 (conj)
view plays (acl)
preceded occlusion (nsubjpass)
expression aquaporin-2 (compound)
muscles antagonistic (amod)
phenols ncr181 (conj)
0.80 to (dep)
rate saturations (conj)
micrograms ( (punct)
associated adjusting (advcl)
quantify and (cc)
% 0.4 (nummod)
object meeting (nmod)
done screening (dep)
change sbp (compound)
day ifosfamide (nmod)
strains murine (amod)
forms two (nummod)
microinjections prior (amod)
produced thiopental (nsubj)
reduces sevoflurane (nmod)
mind the (det)
dna and (cc)
rate saturation (conj)
improves reducing (advcl)
procedure span (compound)
increased day (nmod:tmod)
group constipation-predominant (amod)
infusion bolus (dep)
observations vasculature (nmod)
defect with (case)
effectiveness , (punct)
% + (cc)
documented the (det)
uneventful . (punct)
encountered have (aux)
hypersensitivity was (cop)
development brain (compound)
study randomized (amod)
promoted . (punct)
effects stress (nmod)
caused % (nmod)
dehydrogenase isoenzymes (conj)
changes hematological (amod)
patients mdp (nmod)
differences substance-specific (amod)
use d (nmod)
pregnant especially (advmod)
response (na (nmod)
pharmacological supportive (conj)
depressants analgesics (conj)
hypertension deterioration (conj)
choices correct (amod)
order apart (advmod)
action neurones (nmod)
the " (punct)
scoring characteristics (nmod)
treatment complication (nmod)
received dogs (nsubj)
diseases immunosuppressive (acl:relcl)
intrathecal or (cc)
vertigo and (cc)
restarted . (punct)
vasodilator nitroprusside (nsubj)
hemianopsia and (cc)
decreases survival (dobj)
tribute final (amod)
function mtdna-encoded (amod)
overexpressing heart (nmod)
dimension/function failure (nmod)
cases after (case)
postponed risk (nsubjpass)
mg/kg/day from (case)
ring fla838 (conj)
segment posterior (amod)
sulphonylureas with (case)
searched november (nmod)
received mg (dep)
mumol ( (punct)
hr mg/24 (compound)
% or (appos)
pressure developed (amod)
examination for (case)
short-term ( (punct)
results 1.35 (dep)
weighted revealed (conj)
reduces it (nsubj)
prevents estrogen (nsubj)
confirmed also (advmod)
% 76.6 (nummod)
origin ischemic (amod)
rizatriptan of (case)
feature essential (amod)
used cases (nmod)
amca ) (punct)
increasing dose (nmod)
more myelosuppression (nsubj)
damage lobe (dobj)
course 4-week (compound)
underlying phenomenon (dobj)
contributor effects (nmod)
outpatients disease (nmod)
commenced amlodipine (dobj)
treatment daily (compound)
suggest link (dobj)
effects re (nmod)
combined results (nmod)
disease valvular (amod)
found conclusion (nmod)
pressures elevated (amod)
hippocampal regions (conj)
incidence lidocaine (nmod)
fibrillation or (cc)
participants cn (appos)
flair ( (punct)
has defined (xcomp)
sensitivity etoposide (acl)
ratio use (nmod)
groups only (amod)
proliferation demodex (nmod)
3,4-dimethoxyphenyl)ethanolamino]-prop 1-(2,4-dichlorophenoxy)-3[2 (compound)
showed included (ccomp)
resistant otherwise (advmod)
tci , (punct)
accumulation rna (compound)
stabilized therapy (nmod)
regarded although (mark)
than was (cop)
control presenting (xcomp)
activities ulcerogenicity (nmod)
relevancy its (nmod:poss)
events common (amod)
lead ultimately (advmod)
receptor serotonin (compound)
showed degree (dobj)
taken analysis (nmod)
resistance of (case)
consisted nephropathy (nsubj)
early whether (mark)
monitoring by (case)
insights pathophysiology (nmod)
paramount . (punct)
resolved were (auxpass)
inhibitor glyt1 (compound)
proteins among (case)
discontinued been (auxpass)
amn082 5 (nummod)
acid region (nmod)
fiber of (case)
fourfold nearly (advmod)
half nx (nmod)
time expiratory (amod)
effect nephroprotective (amod)
organophosphorus op (appos)
regulation inhibition (nmod)
2.4 - (punct)
challenge acute (amod)
ingestion aspirin (nmod)
differences latency (nmod)
call risk (nmod)
drug necessary (amod)
contractility disturbances (conj)
ng/mg ) (punct)
4.6 - (punct)
ly-171555 with (case)
associated prolactin (nsubjpass)
medicines and (cc)
showed which (nsubj)
effective 10- (nsubj)
vision the (det)
unaffected reversed (advcl)
limits usefulness (dobj)
p<0.001 , (punct)
characterization allele (nmod)
forms both (det)
placebo 2 (conj)
alone where (advmod)
characteristics hepatitis (nmod)
hilus within (case)
edaravone or (cc)
sensitivity amphetamine (nmod)
woman 39-year-old (amod)
downregulates and (cc)
entered study (nmod)
owing incidence (nmod)
restored l-dopa (nsubj)
levels dna (compound)
dividing by (mark)
sevoflurane in (case)
maintained min-1 (nmod)
deviation the (det)
remodelling isoniazid (nmod)
u/ml 204 (nummod)
background reduces (appos)
cyclophosphamide cyp (appos)
3,4-methylenedioxymethamphetamine ecstasy (amod)
neuropathy lacnp (appos)
rate at (case)
showed groups (nsubj)
anemias cefotetan-induced (amod)
retention better (amod)
acid by (case)
78 to (quantmod)
pretreatment inducer (conj)
apart headaches (nmod)
diarrhea flatulence (conj)
dose scores (conj)
animals hypertensive (amod)
models several (amod)
report preliminary (amod)
chloroform galactosamine (conj)
effect csa (nmod)
treatment phenothiazines (nmod)
reduced bau (nsubj)
colliculus superior (amod)
reflex via (case)
46.0 - (punct)
effects due (case)
receptors sigma1 (compound)
patients compensated (amod)
causes cirrhosis (dobj)
dysrhythmias bupivacaine (appos)
showed stimulated (ccomp)
smoking to (case)
reported sulfonylureas (nmod)
children neuroblastoma (nmod)
variants gene (nmod)
stimulate producing (advcl)
symptoms neuropathy (nmod)
receptors for (case)
changes 15-db (amod)
head inoperable (amod)
collection echocardiography (conj)
content catecholamines (nmod)
observation for (case)
actions stress (nmod)
months years (nmod)
rate rapid (amod)
platform hidden (amod)
studies nerve (compound)
or p<0.001 (dep)
epicardium , (punct)
aspects disorders (nmod)
remedies variety (nmod)
decrease function (nmod)
introduction kidney (nmod)
indicate harmless (ccomp)
preparation an (det)
pruritus 1 (appos)
hours ) (punct)
system models (nmod)
reversed , (punct)
dx p (dep)
resuscitation patients (nmod)
manifesting vasculitis (compound)
examine impact (dobj)
literature related (amod)
studied months (dep)
significant p<0.05 (dep)
m-chlorophenylpiperazine 5-ht(2c (compound)
9 4 (quantmod)
discovery to (case)
appeared beginning (advcl)
fnclcc ( (punct)
reversed activity (dobj)
activities serum (nmod)
prevalent which (nsubj)
examined correlations (nsubjpass)
beats/minute dose (conj)
felt palpitation (dobj)
progression health (conj)
anomaly ebstein (nmod:poss)
gyrus the (det)
characterized shunting (nmod)
streptozotocin by (case)
leveled to (mark)
need interrupt (acl)
vasopressin nor (cc)
ng to (case)
hypotension = (dep)
suggestive given (advcl)
65.6 + (cc)
case as (case)
shown weeks (nmod)
beta-ccm to (case)
compared 19 (nmod)
loss blood (compound)
lesion colliculus (compound)
leading upregulation (nmod)
record from (case)
material total (dep)
development monkeys (nmod)
increase locomotion (nmod)
number inhibitors (nmod)
one compared (case)
development subsequent (amod)
prevention treatment (conj)
effect alkylxanthines (nmod)
exerts rescues (parataxis)
eserine cats (nmod)
kingdom in (case)
igf ( (punct)
introduced p11 (nsubjpass)
administration haloperidol (nmod)
questioned symptoms (nmod)
pontis tegmenti (compound)
compound p-coumarate (appos)
animals high-dose (amod)
pge2 , (punct)
led recurrence (nmod)
episode function (nmod)
clonidine between (case)
risk greatest (amod)
etoricoxib in (case)
analyser by (case)
involve typically (advmod)
administration acute (amod)
affect movement (dobj)
10 from (case)
suggest engaged (ccomp)
suggest prevented (ccomp)
stem may (aux)
isradipine or (cc)
reflex , (punct)
adults in (case)
% 9.0 (nummod)
generation % (nmod)
gain with (case)
reversed reduction (nmod)
effects vivo (advmod)
initiated earlier (advmod)
% 33 (nummod)
a all (appos)
induced oct (nsubj)
scoring propensity (compound)
register patients (nmod)
quantitated terms (nmod)
class molecular (amod)
found % (nmod)
neuropathy delayed (amod)
received before (advmod)
loss oxide (nmod)
images high (amod)
confirm decrease (ccomp)
drug bromide (conj)
found decreases (dobj)
differences pharmacokinetic (amod)
reversed briefly (nsubj)
nmda ( (punct)
become manic (xcomp)
lines mouse (compound)
use examine (xcomp)
possible based (prep)
fasciculations during (case)
took again (advmod)
prophylaxis for (case)
3.8 2.6 (conj)
disruption functionality (nmod)
newborns between (case)
females 12225 (nummod)
assessment rating (nmod)
aggressiveness evoked (acl)
implicated association (nsubj)
value sd (conj)
failure postrenal (amod)
alter nor (cc)
paper previous (amod)
function examination (conj)
converted rhythm (nmod)
p .001 (dep)
reduction stress (nmod)
difficult define (xcomp)
catecholamines relaxants (conj)
lower compared (prep)
bfu-e ( (punct)
data median (dep)
dogs ten (nummod)
injection mumol/kg (dep)
effects anti-asthmatic (amod)
lignocaine lidocaine (appos)
outflow possibly (advmod)
has probably (advmod)
episode manic (amod)
overactivation significant (amod)
grains silver (amod)
indicate studies (nsubj)
antibiotic is (cop)
assessed absence (nmod)
24.4 ( (punct)
ritonavir protease (compound)
a csa (dep)
cardiotoxicity despite (case)
defects and (cc)
0.15+/-0.03/h ) (punct)
creatinine age (conj)
restrict to (mark)
activation apoptosis (nmod)
dwi including (case)
given iv (nsubjpass)
synthesis pge2 (compound)
1-(2-phenethyl)-4-(2-pyridyl)-piperazine ) (punct)
i.v.c of (case)
require treatment (dobj)
ventilation in (case)
patients low-risk (amod)
vinorelbine or (cc)
gentamicin gentamicin (conj)
udca ( (punct)
taking admission (nmod)
tended increase (xcomp)
approach them (nmod)
effects models (nmod)
reported injecting (xcomp)
mild toxicities (nsubj)
performed cases (conj)
favor in (case)
tachycardia sustained (amod)
horns the (det)
destructive may (aux)
effective placebo (nmod)
cure . (punct)
occurred cataract (nsubj)
observed block (dobj)
pregnant nonpregnant (conj)
compared production (nsubjpass)
thromboembolism : (punct)
control hemorrhage (dobj)
lesion , (punct)
effect extrapyramidal (amod)
preserves ablation (nsubj)
be it (nsubj)
pretreatment 5-day (amod)
demonstrated deposits (dobj)
represents strategy (dobj)
183 and (cc)
chow access (dobj)
pretreatment induction (nmod)
l-alpha-gfc either (cc:preconj)
effects l-alpha-glycerylphosphorylcholine (nmod)
lf mg/kg (appos)
classified could (aux)
increase aggressiveness (nmod)
methamphetamine of (case)
combination antipsychotics (nmod)
electroshock slc (nmod)
scales beck (compound)
reducing neutropenia (dobj)
cohort patient (compound)
c for (case)
vision hearing (conj)
td50 ( (punct)
reduces increasing (advcl)
recovery haemodialysis (nmod)
psychosis meth-induced (amod)
expression surface (compound)
dosage intake (conj)
africa south (compound)
promotes also (advmod)
lasting months (nmod:tmod)
inhibited pulsatile (dep)
grade as (case)
diagnosed criteria (nmod)
sensitivity = (parataxis)
effective potentially (advmod)
lesions and (cc)
60 of (advmod)
f(33 = (amod)
defects ) (punct)
ptld ( (punct)
necrosis fat (compound)
hc of (case)
pill of (case)
chemotherapy from (case)
resulted termination (nsubj)
substantiated . (punct)
interval short (amod)
bar from (case)
n mg/kg (compound)
administered completion (nmod)
supplementation regimen (nmod)
used pressure (nmod)
vt/ti ) (punct)
hormone hormone-releasing (amod)
approach standard (amod)
mg/m(2 135 (nummod)
gap43-ir regarding (case)
19 20 (conj)
models bicuculline (compound)
represent to (mark)
level an (det)
experiences clinical (amod)
sedation depression (conj)
scores subjective (amod)
received given (conj)
safety the (det)
examine influence (dobj)
load a (det)
groups versus (case)
hypothermia correlated (acl:relcl)
reduction mssbp (nmod)
provided management (nsubj)
intravitreal cause (ccomp)
enhancement of (case)
thermoregulation aberrant (compound)
rats animals (dep)
% 97.6 (nummod)
responses patients (nmod)
rigidity somatic (amod)
udca on (case)
cochrane and (cc)
developed bradycardia (dobj)
case observed (acl:relcl)
anesthesia neuraxial (amod)
attenuated also (advmod)
warranted mechanism(s (conj)
77 30 (compound)
exposure identical (amod)
bones the (det)
produced dogs (nmod)
optic the (det)
dose tetracycline (nmod)
pinch mild (amod)
dismissed can (aux)
infusion : (punct)
acts initiation (nmod)
mechanisms dysfunction (nmod)
activates beta (dobj)
exploration in (case)
2.20 was (cop)
deaths and (cc)
diminishing result (nmod)
machinery the (det)
phase 323+/-43 (dep)
result as (case)
endpoint being (advcl)
void and (cc)
40000 110000 (conj)
effect report (nmod)
treatment p (dep)
november from (case)
1.26 3.5 (dep)
classified unassigned (dep)
treated clentiazem (nmod)
moderate-dose 0.01 (dep)
intensity stimulation (compound)
profile lovastatin (nmod)
man 35-year-old (amod)
patients ie (advmod)
opposed ( (punct)
dose-dependent neurotoxicity (nsubj)
loss marked (amod)
neurotransmission dopaminergic (amod)
completed arms (dobj)
damage basic (amod)
direct therapeutic (dep)
receive deep (dobj)
interactions distinct (amod)
vnb mg/m(2 (appos)
system mammalian (amod)
n=11 ( (punct)
taa ( (punct)
concentrations argatroban (nmod)
tap and (cc)
tolerability ce (nmod)
mmol 176 (nummod)
examined : (punct)
rate about (case)
vasculitis encountered (advcl)
product ) (punct)
loss gfap-staining (nmod)
refused cardioversion (dobj)
improved dysfunction (dobj)
required studies (nsubjpass)
infusions intracerebral (amod)
matter hemispheres (nmod)
associated improvement (nmod)
model edema (compound)
therapy electroconvulsive (amod)
progression after (case)
incmnsz of (case)
tablet mg (compound)
were , (punct)
therapy for (case)
effects with (case)
evaluation drugs (nmod)
support transfusion (compound)
inhibition lead-associated (amod)
increased epilepticus (nmod)
10(-2 of (case)
dogs arrhythmia (compound)
etiology be (cop)
interacted and (cc)
interaction paroxetine (nmod)
rats den (compound)
preventing transplantation (nmod)
revealed observation (nsubj)
searched method (dep)
excluded ; (punct)
improved trial (nmod)
agent cisapride (conj)
group dex-only (amod)
before and (cc)
raise paranoia (nmod)
bacteremia relapsing (amod)
doxorubicin irradiation (conj)
index non-invasive (amod)
started been (auxpass)
furosemide due (case)
women thirty-nine (amod)
indicates review (nsubj)
analysis effects (nmod)
died receiving (advcl)
voltarol ( (punct)
hypersensitivity induced (acl)
an ( (punct)
erythema rush (conj)
protecting pilocarpine- (dobj)
norleucine , (punct)
women eating (advcl)
tissues on (case)
illustrate need (dobj)
dimer-x polyvidone (conj)
injection mug (appos)
dopamine , (punct)
lactate ringers (compound)
risk disease (compound)
induce anemia (dobj)
10(-5 to (case)
controlled double-blind (nsubj)
cell epithelial (amod)
assay terminal (amod)
feature neurochemical (amod)
achieved readily (advmod)
veins of (case)
seizures lidocaine- (amod)
opposed ) (punct)
administered s-1 (dep)
toxic cocaine (nsubj)
study survival (compound)
vasodilator produce (acl:relcl)
benefit or (cc)
62(6):865 in (case)
cancer function (conj)
unit picu (appos)
form an (det)
mv 47 (nummod)
coexistence sinus (nmod)
large and (cc)
development cancer (nmod)
discriminates unresponsiveness (amod)
area gpi (nmod)
planning memory (compound)
interrupted penicillamine (nsubjpass)
metabolite an (det)
pg/ml 1520 (nummod)
as possible (amod)
coupled when (advmod)
node the (det)
khz 18 (nummod)
users users (dep)
tolerated doses (nmod)
test memory (compound)
elucidated fully (advmod)
induce symptoms (dobj)
decreased nonsignificantly (advmod)
patients overdose (compound)
disturbing frightening (conj)
developed analyzed (conj)
nms ss (conj)
minutes 60 (nummod)
summarize considerations (dobj)
cortex areas (conj)
metabolite catecholamine (compound)
lev and (cc)
examined factors (nmod)
ace baseline (compound)
appeared provided (conj)
useful detection (nmod)
amino-nucleoside of (case)
death chemotherapy (nmod)
sulphate 3beta-hydroxy-5beta-pregnan-20-one (nummod)
impairment this (det)
doc the (det)
6.5 +/- (cc)
drugs with (case)
rats microm (dep)
pain thrombophlebitis (conj)
hg or (cc)
barrier cellular (amod)
rate events (nmod)
improvement by (case)
attacks hypoglycaemia (compound)
vasculature distal (amod)
gained although (mark)
lists papers (nmod)
nociception of (case)
nine degeneration (nmod)
another in (case)
less 2 (dep)
reported edema (nsubjpass)
parameters all (predet)
medulla and (cc)
observations under (case)
remains drug (dobj)
hematuria by (case)
ip hoe (compound)
injury dilevalol-induced (amod)
anemia leukopenia (conj)
resolve and (cc)
group kanamycin-treated (amod)
injections the (det)
organophosphate neurotoxic (amod)
received department (nmod)
10(-3)m ) (punct)
illicit to (mark)
study one (nummod)
sulfate tobramycin (conj)
glibenclamide by (case)
transport acid (dobj)
response complete (amod)
resistance higher (amod)
had morning (nmod)
tamoxifen ( (punct)
made reference (nsubjpass)
receiving saline (dobj)
found lesion (nsubjpass)
related damage (nmod)
decrease probable (amod)
staining by (case)
modulates effect (dobj)
biopsies transplant (compound)
raised pattern (nsubj)
required not (neg)
delirium acute (amod)
exceeded and (cc)
have receiving (advcl)
estimated varied (conj)
related temporally (advmod)
compare patterns (dobj)
reverse mg/kg (dep)
studies antagonist (nmod)
h infarct (compound)
plate tests (conj)
nephropathy early (amod)
hypertension diagnosed (amod)
salts with (case)
methamphetamine heavy (amod)
thrombosis due (case)
intrapatient escalations (dobj)
done must (aux)
induced hemopoiesis (dobj)
twin female (appos)
correlates that (mark)
given prophylaxis (nsubjpass)
history any (det)
18 whom (nmod)
picrotoxin- pentylenetetrazol-induced (conj)
inhibition ester (nmod)
% 28 (nummod)
d-penicillamine 500 (nummod)
documented sensitive (conj)
amitriptyline than (case)
effect concerning (case)
ratio years (nmod:tmod)
association drugs (nmod)
multicenter was (cop)
lactate or (cc)
breeder from (case)
utility biometry (nmod)
daunorubicin and (cc)
portland or (conj)
striatum or (cc)
disturbances metabolism (nmod)
tracer of (case)
investigate aims (nsubj)
p2x3 and (cc)
u/kg ( (punct)
receptor mu-opioid (amod)
exerts extract (nsubj)
cautious physicians (nsubj)
cells hilus (nmod)
newborn of (case)
purpose assess (dep)
edema severe (amod)
mary st. (compound)
analgesics and (cc)
reliability the (det)
results toleration (nsubj)
consisted groups (nsubj)
is ) (punct)
associated anesthetics (nsubjpass)
dexmedetomidine , (punct)
abundance in (case)
pronounced lca (nmod)
descending of (mark)
timecourse of (case)
bleeds fatal (amod)
function clinical (amod)
rate mean (compound)
confusion mouth (conj)
antibiotics beta-lactam (compound)
antibitocis various (amod)
cancer hepatoma (conj)
migraine presumed (amod)
attempted always (advmod)
proteinuric and (cc)
principle this (det)
report the (det)
dmso microl (compound)
manageable were (cop)
considered generally (advmod)
enalapril pressure (dep)
hplc ( (punct)
hypoxic who (nsubj)
obtained measurements (dep)
preventing impairment (dobj)
living examination (conj)
rats 8 (nummod)
overdose paracetamol (compound)
dp/dt ) (punct)
results absorption (nmod)
neurotoxicity analysis (dep)
neurosci nat (compound)
effect equivalent (amod)
css ) (punct)
excluded patients (nsubjpass)
is excitability (attr)
aim documentation (nmod)
checklist-90-revised the (det)
myopathy clinical (amod)
treatment patients (conj)
replacement estrogen (compound)
stability h (compound)
experienced event (nmod)
beginning administration (nmod)
trial attempt (nmod)
user cocaine (compound)
muscles rats (nmod)
decreased lowered (conj)
conjugates hpma (compound)
often tobramycin (advcl)
x-rays chest (amod)
db 1.63 (nummod)
higher considerably (advmod)
treat prior (advmod)
urothelium suburothelium (conj)
reserpine polyamines (compound)
implanted annulus (nmod)
infused days (nmod)
accept to (mark)
pair-matched controls (nmod)
protocol ( (punct)
examined case (dobj)
area = (amod)
order in (case)
acid vpa (appos)
units ) (punct)
insipidus by (case)
seizures mal (amod)
curcumin of (case)
provided control (dobj)
inpatients subjects (nsubj)
affects therapy (nsubj)
facilitation memory (compound)
concentration myocardial (amod)
hands bare (amod)
drowsiness such (case)
pcos ( (punct)
reported herein (advmod)
treated flumazenil (nmod)
expected is (auxpass)
products lipid (compound)
casts tubuli (nmod)
permits reduces (conj)
indicates role (dobj)
diameter artery (compound)
group pilo (compound)
group 3ma (amod)
adjustment incomplete (amod)
resulted traveled (conj)
found force (nsubjpass)
posture such (case)
phases process (nmod)
dopamine-1 and (cc)
oxazepam , (punct)
desire intensity/pleasure (conj)
advantages induction (nmod)
administered continuously (advmod)
form treatment (nmod)
modulated convulsions (nmod)
question , (punct)
problematic , (punct)
cyclophosphamide mitoxantrone (nmod)
transition argatroban-to-warfarin (amod)
ionic and (cc)
impaired recall (dobj)
sensorium of (case)
withdrawal despite (case)
proteins , (punct)
spect with (case)
protein with (case)
relation type (nmod)
levels vegf165 (compound)
patients hypotension (nmod)
explained , (punct)
impairment induction (conj)
bid ( (punct)
p -- (punct)
appear dependent (xcomp)
urinate to (mark)
sparing while (mark)
complications angiography (nmod)
immunization-induced pertussis (nmod:npmod)
lesion no (det)
presence for (case)
occurred 3 (nsubj)
eyes patients (nmod)
thyroid function (conj)
treatment 14-day (amod)
analysis concentration (nmod)
normal hematologically (advmod)
ventilator spontaneous (conj)
rupture postinfarction (compound)
rg1 or (cc)
nicergoline against (case)
rearings increased (amod)
discriminate doses (nmod)
factors leukocyturia (nmod)
induced woman (nmod)
isrctn54598675 . (punct)
therapies are (cop)
demonstrated ( (punct)
stress an (det)
tests taking (advcl)
change periods (nsubj)
shr female (amod)
abnormality involving (acl)
progressed regurgitation (nmod)
incidence complications (nmod)
ant-mi ) (punct)
responded methylprednisolone (nmod)
reflects injury (dobj)
came rediscovery (nmod)
5.6 0.7 (conj)
3.5 7.0 (conj)
dilevalol of (case)
discontinued pergolide (nsubjpass)
completed compared (conj)
chemotherapy neo-adjuvant (amod)
des-arg10hoe neuropathy (nmod)
potentiation in (case)
excluded analysis (nmod)
started disappeared (conj)
syndrome the (det)
giving lithium (dobj)
power total (amod)
transfusions platelet (compound)
decrease timolol (nsubj)
compared rate (nmod)
considered doses (xcomp)
termed was (auxpass)
resistance peripheral (amod)
observed associated (ccomp)
ldlr ( (punct)
administered frequently (advmod)
doses mg/m2 (appos)
rate % (dep)
des ( (punct)
result as (mark)
patients disease (compound)
indicated necrosis (dobj)
dec ) (punct)
mid- to (dep)
care periconception (compound)
uptake ldl (nmod)
reversed decreased (conj)
allow to (mark)
events qtp (nmod)
foods and (cc)
psp ) (punct)
m with (case)
rare episodes (nsubj)
resuscitation cardiac (amod)
predict not (neg)
significant it (nsubj)
phentolamine and (cc)
purpose therapy (dep)
nucleus in (case)
product biotransformation (compound)
cholesterols triglycerides (conj)
week at (case)
investigated treated (dep)
methylphenidate children (nmod)
risk vsd (nmod)
background report (dep)
dose at (case)
effects dubutamine (nmod)
trial cancer (nmod)
study vivo/in (compound)
group of (case)
arrest labor (dobj)
doses extreme (amod)
increased resistance (nsubj)
(-)-propranolol of (case)
ntg nimo (conj)
changes and (cc)
administration combined (amod)
established model (nsubjpass)
followed if (mark)
inventory baseline (nmod)
published december (nmod)
superior were (cop)
effect rats (nmod)
damage from (case)
reversed which (nsubjpass)
man japanese (amod)
erythrocytes human (amod)
nephropathy contrast-induced (amod)
provided that (mark)
attacks , (punct)
levels normal (nmod)
6-thioguanine to (case)
inflammation tubulointerstitial (amod)
groups both (cc:preconj)
activity rna (nmod)
applied compressions (nsubjpass)
addition with (nmod)
distance traveled (acl)
therapy carbimazole (compound)
cured patients (nsubjpass)
studied determined (conj)
ratios weight (compound)
hepatic with (case)
antibodies protein (nmod)
epilepticus of (case)
conjunction bypass (nmod)
comparison -- (punct)
resulted feeding (nsubj)
cardiac lesions (dep)
effective was (cop)
neonates were (cop)
evidence rhabdomyolysis (nmod)
corrected irregularity (nsubj)
concentration cimetidine (nmod)
overlooked be (auxpass)
addition trial (nmod)
thalidomide of (case)
examined day (nmod)
70 of (advmod)
treatment 6-week (amod)
hydralazine or (cc)
qd a (compound)
nephrotoxicity from (case)
taking remission (dobj)
benign relatively (advmod)
transducer and (cc)
associated dna (advmod)
ache ) (punct)
experience the (det)
subunits nicotinic (amod)
substrate cyp2d6 (compound)
consistent , (punct)
da of (case)
parameters antioxidative (amod)
vasculitis intake (nmod)
role fluconazole (nmod:poss)
onset tdp (nmod)
established therapies (nsubjpass)
comparison phenacetin (nmod)
responses of (case)
deficits ecstasy-related (amod)
stage irreversible (amod)
range 1 (nummod)
noted but (cc)
was need (attr)
follow-up however (advmod)
determine due (ccomp)
vindesine and (cc)
compartments body (compound)
phosphatase and (cc)
thickening capillary (amod)
instillation with (case)
recall pairs (nmod)
vasculitis minocycline-induced (amod)
phno with (case)
sedation and (cc)
rats and (cc)
receive often (advmod)
duration but (cc)
suffered h (nmod)
treatment succimer (nmod)
lend data (nsubj)
effect convulsive (amod)
measured response (nmod)
months years (conj)
results evaluable (dep)
mri after (case)
phosphokinase bun (conj)
undertaken that (mark)
failed resection (nsubj)
initiated epilepticus (nsubjpass)
development delayed (amod)
teratogenicity . (punct)
impaired experimentally (advmod)
patients hypotension (conj)
occur circulations (nmod)
hypophosphatemia aminoaciduria (conj)
regurgitation or (cc)
woman 42-year-old (amod)
irrigated were (auxpass)
was parallel (attr)
involved carcinogenesis (nmod)
stroke with (case)
proved technique (xcomp)
remain rates (nsubj)
reduced controls (nmod)
safe reasonably (advmod)
similarities clinical (amod)
using tropicamide (dobj)
processes cell (compound)
affection system (nmod)
potent safer (conj)
ulcer this (det)
mean pressure (dobj)
vacuolization tubular (amod)
girl old (amod)
using localize (advcl)
issues any (det)
increased ds (nmod)
cardiovascular or (cc)
used patient (nsubj)
receptor adenosine (compound)
boy 14-year-old (amod)
collection stem (compound)
celecoxib 0.93 (nummod)
convulsants to (case)
as toxic (amod)
development height (conj)
is decade (nmod)
need therapy (nmod)
min with (case)
salts gold (compound)
affect blocked (conj)
activity ability (conj)
drugs included (acl)
took g (nmod)
pentylenetetrazole the (det)
pressure secretion (conj)
markers levels (conj)
characterized hypertension (nmod)
attenuates which (nsubj)
days , (punct)
children 30 (nummod)
improvement dyskinesias (nmod)
plays effect (nmod)
abnormal findings (nsubj)
developed failure (nsubj)
dose cs (nmod)
present individuals (nmod)
leukoencephalopathy of (case)
nephrotoxicity not (cc)
monitored hours (nmod)
choice of (case)
reported as (mark)
carcinogenesis bladder (nmod)
response psychostimulant (nmod)
management dysfunctions (nmod)
exposure smoking (nmod)
cancer breast (compound)
held november (nmod)
gm. 100 (nummod)
aim draw (xcomp)
essential ability (nsubj)
hours initiation (dep)
responses inotropic (amod)
symptoms similar (amod)
combined compared (conj)
presents findings (dobj)
recovery " (punct)
trial after (case)
related infection (nmod)
proximal on (case)
sensitivity , (punct)
retained analgesic (dobj)
maximal administration (nmod)
vary incidence (nsubj)
syndrome " (punct)
drivers of (case)
administration cbz (compound)
bfgf , (punct)
patient dialysis (nmod)
doxorubicin with (case)
abolished which (nsubj)
encephalopathy : (punct)
tacrolimus agents (conj)
hippocampal mt (dobj)
appreciated is (auxpass)
development lidocaine- (nmod)
decrease ; (punct)
followed depression (nsubjpass)
exertion physical (amod)
midazolam ug.kg-1 (dobj)
naloxone glutamate (conj)
subscale positive (amod)
performed days (dep)
35.9 10 (conj)
ratio = (amod)
targeting primarily (advmod)
november by (case)
increases clonidine (nmod)
mcl refractory (amod)
gr shell (appos)
neurone motor (compound)
phosphatase membrane (compound)
nausea apnea (conj)
sequelae due (case)
revealed ratio (dobj)
administered whom (nmod)
nanoparticles (adriamycin)-loaded (case)
carboplatin patients (nmod)
hydrochloride epinephrine (conj)
anemia and (cc)
use ephedrine (nmod)
surveys echocardiographic (amod)
nsclc with (case)
increased temperature (dobj)
8/8 ( (punct)
available excluded (advcl)
experienced were (auxpass)
effect cnsb002 (nmod)
treatment carbonic (amod)
mouse per (case)
have ; (punct)
born who (nsubjpass)
91.5 ; (punct)
cases remaining (amod)
inhibit occurrence (dobj)
attenuated suggesting (xcomp)
reduces incidence (dobj)
saline min (conj)
induced day (nmod)
tci propofol (nmod)
production micronuclei (nmod)
normal later (advmod)
stress were (cop)
chebula terminalia (compound)
scale numerical (amod)
mg/kg/d 50 (nummod)
muscle ) (punct)
shows and (advmod)
associated anaesthesia (nmod)
45 +/- (cc)
confirmed mc (nsubjpass)
session first (amod)
acts be (cop)
manipulation system (nmod)
demonstrated antidepressants (nmod)
prevent increase (dobj)
contained implants (nmod)
fill that (mark)
confirm used (ccomp)
model sigmoid (compound)
propranolol diazepam (nmod)
ages patients (conj)
formation peroxide (compound)
patients noncyanotic (amod)
stage differentiation (nmod)
hypertension mice (nmod)
changes images (nmod)
shows occur (ccomp)
reversible hepatitis (nsubj)
follows was (cop)
reduction ; (punct)
kanamycin body (appos)
stimulation to (case)
d-1 d-2 (conj)
type direct (amod)
bones foot (compound)
59 and (cc)
suggest requires (ccomp)
associated prolongation (nmod)
indicated sparing (advcl)
patients thrombosis (conj)
pairs word (compound)
% mol (compound)
cross-tolerant showed (conj)
relationship medication (nmod)
shock cardiogenic (amod)
elevated h (nmod)
serum 131i-albumin (dep)
includes epidemics (dobj)
acidosis renal (amod)
infusion combined (acl)
% between (case)
mca the (det)
pre-treatment ketamine (nmod)
manifested which (nsubj)
residence adenosine (nmod)
resistant compared (advcl)
migraineurs female (amod)
reward morphine (compound)
proportion high (amod)
effects terms (nmod)
examination 0 (dep)
that measured (acl)
associated nodosum (nsubj)
patients 1065 (nummod)
gm concomitantly (advmod)
beats/min +/- (cc)
acute ) (punct)
synthase of (case)
blockers potassium (compound)
showing interaction (dobj)
has gtn (nsubj)
seem agonists (nsubj)
received orally (advmod)
manifestations histopathological (amod)
scored average (nmod)
treatments efficacious (amod)
referrals only (advmod)
dealt age (nmod)
pseudo-allergy a (det)
intermittent intravenous (dep)
mean thickness (dobj)
treatment long-term (amod)
impact reducing (acl)
presence innervation (nmod)
adrs ) (punct)
period 6-week (amod)
photosensitivity of (case)
carbamazepine epilepsy (nmod)
cholesterol 154 (nummod)
assessed improving (advcl)
% lidocaine (compound)
specified thrombosis (nsubj)
carbetocin administered (acl)
immunosuppression transplant (compound)
re-resection multiforme (amod)
days two (nummod)
0.38 +/- (cc)
injected study (nmod)
review quality (compound)
confused movements (nmod)
(1.8)% , (punct)
had none (nsubj)
practical and (cc)
cause infarction (nmod)
ability carry (acl)
used demonstrate (advcl)
provided recommendations (nsubjpass)
compensated , (punct)
admitted clinic (nmod)
indicated ranged (conj)
homogenates whole (amod)
included study (dobj)
rotation drug-induced (amod)
receptors a1 (compound)
toxicity potentials (conj)
n or (cc)
remissions of (case)
peroxidation of (case)
noticed was (auxpass)
dyskinesias limb (amod)
discontinued tna (nsubjpass)
worst scoring (nsubjpass)
cholestasis hepatitis (nmod)
caused akathisia (nsubjpass)
similar to (mark)
given prophylaxis (dobj)
rated pain (nsubjpass)
rbcs ) (punct)
iugr ( (punct)
prochlorperazine with (case)
level highest (amod)
from february (nmod)
psychosis . (punct)
class density (compound)
sensor and (cc)
performed lymphocytes (nmod)
assumptions conservative (amod)
patients crf (compound)
replacement fresh (amod)
determination and (cc)
reason . (punct)
apoptosis aminonucleoside-induced (amod)
convulsant between (case)
made ) (punct)
linked . (punct)
under or (cc)
functions involved (acl:relcl)
developed time (nmod)
using immunotherapy (dobj)
fenfluramines mainly (advmod)
effectiveness trial (dobj)
number proliferation (conj)
history nausea (nmod)
virgaurea solidago (compound)
megaloblastosis improved (amod)
plasmapheresis therapy (conj)
pressure spillover (conj)
dysarthria and (cc)
pg the (det)
ca jg (appos)
subtle and (cc)
pathogenesis could (aux)
silent although (mark)
probe polymorphism (nmod)
nx or (cc)
shorter latencies (nsubj)
healthy taking (xcomp)
reports on (case)
mice hepatocyte-specific (amod)
factors major (amod)
sepsis by (case)
cellularity and (cc)
case insipidus (nmod)
exposure microm (nmod)
shows associated (ccomp)
13 % (appos)
factor = (dep)
decrease coniine (nmod)
implantation mice (nmod)
services u.s. (compound)
sacrificed weeks (nmod)
improved had (aux)
able . (punct)
mg lidocaine (compound)
changed one (nmod)
region homer1 (compound)
adopted ; (punct)
hepatotoxicity simvastatinezetimibe-induced (amod)
3.7+/-0.8 p<0.05 (appos)
dlt the (det)
monoxide of (case)
predominated signs (nsubj)
ra case (nmod)
aroused could (aux)
dehydration severe (amod)
patients requiring (acl)
dnr given (case)
treatment of (case)
323+/-43 ( (punct)
are complications (attr)
reported administration (nmod)
susceptibility exhaustion (nmod)
progression ( (punct)
day 8 (nummod)
disruption the (det)
comorbidities use (conj)
fashion continuous (amod)
depressed region (nmod)
transaminase . (punct)
treatment cause (conj)
experienced % (nsubj)
fragmentation orderly (amod)
occurred fractures (nmod)
became withdrawn (conj)
stable is (cop)
polymyositis and (cc)
permeability of (case)
reduced metoprolol (nsubj)
states symptoms (nmod)
treated p (nmod:npmod)
titration gradual (amod)
evaluated rodents (nmod)
revealed suggesting (conj)
comparison for (case)
vessel of (case)
rare exceptionally (advmod)
have comorbid (dobj)
map also (advmod)
gr depletion (conj)
changes chemotherapy (nmod)
depressions of (case)
assessed study (nsubj)
precursors of (case)
14 in (case)
depends . (punct)
catecholamines endogenous (amod)
toxicology developmental (amod)
tail rats (nmod)
effective niacinamide (nsubj)
review comprehensive (amod)
cognitive lithium-associated (amod)
, 1997 (dep)
variation pressure (compound)
sex value (conj)
178 +/- (cc)
reported marked (conj)
increase p (dep)
pmol 10(9 (nmod)
paralleling areas (dobj)
administered p.o. (nsubjpass)
toxicity dose (compound)
rates urinary (amod)
topiramate of (case)
mg/kg 44.8 (nummod)
ca(2 ) (punct)
exposure galactose (amod)
saline days (nmod)
products heparin (compound)
4 to (quantmod)
supplement surgery (nmod)
reviewed is (auxpass)
iodixanol contrast (compound)
infiltrates lymphoplasmacytic (amod)
promotes verapamil (nsubj)
pounds years (ccomp)
activity profile (conj)
tolerated headache (nmod)
76 to (dep)
tacrolimus fk506 (appos)
unmask administration (nsubj)
fas overdose (nmod)
discontinued studies (nmod)
antithrombin iu/kg/i.v (appos)
was period (nmod)
decrease movement (nmod)
infarction mi (appos)
potentials ample (amod)
suppression activation (nmod)
stn in (case)
occur treatment (nmod)
children studies (nmod)
assessed apoptosis (nsubjpass)
tasks functioning (conj)
% 16.1 (nummod)
treated il-3 (conj)
drugs , (punct)
regimen tacrolimus (nmod)
function production (conj)
lower rats (nmod)
occurred collapse (nsubj)
salt-depleted salt-loaded (conj)
important inhibition (nsubj)
labetalol halothane (nmod)
replace consuming (ccomp)
starting before (mark)
utility patients (nmod)
micrograms 36 (nummod)
concentrations resulting (acl)
revealed lowered (ccomp)
reported study (nmod)
two and (cc)
developed mg/day (dobj)
concentrations blood (compound)
antagonist muscimol (nmod)
consistent velocity (nmod)
organization tonotopic (amod)
domperidone , (punct)
neuropathy 4 (nummod)
involvement neurotransmission (conj)
allow which (nsubj)
67.4 scores (nsubj)
pretreatment . (punct)
portions hemosiderotic (amod)
contractility in (case)
ratings first-time (amod)
ingested are (auxpass)
trials double-blind (amod)
patients mm (compound)
% 30.4 (nummod)
detectable clinically (advmod)
determined not (neg)
received since (mark)
sites major (amod)
g/dl 10 (nummod)
infections on (case)
assigned daily (advmod)
dose-intensity median (amod)
improves cd-832 (nsubj)
insufficiency ari (appos)
suggests induce (ccomp)
diagnosed infarction (nmod)
company ) (punct)
unit in (case)
attempted find (xcomp)
antibody ) (punct)
effect pilocarpine (nmod)
tested we (nsubj)
forebrain to (case)
mechanisms distinct (amod)
rare progressive (conj)
performed noninvasive (advcl)
recognition alcohol (compound)
= 2.4 (dep)
occurred whereas (mark)
signs for (case)
mice c57bl/6-tgn[sod1]3cje (compound)
te ) (punct)
stressed owing (advcl)
induction ich (compound)
metformin of (case)
measured ability (dobj)
loads with (case)
giving by (mark)
symptomatic discontinue (advcl)
medication dosages (nmod)
bladder rat (nmod)
provides but (cc)
protein is (cop)
medications current (amod)
is aim (nsubj)
extract mixture (appos)
non-cacl(2)-treated and (cc)
injection ntg (nmod)
clotiazepam , (punct)
attenuate convulsant (advmod)
dynamics on (case)
tolerated past (nmod)
6-hydroxydopamine with (case)
medicate did (aux)
intermediate toxicity (nsubj)
tear minor (amod)
deteriorates which (nmod)
patients ct (compound)
consists management (nsubj)
1.23 ) (punct)
included progestogens (nmod)
units r (compound)
carbachol injected (conj)
identical pregs (nmod)
effects level (nmod)
improves that (mark)
significant effect (nsubj)
completed subjects (nsubj)
rapamycin formerly (advmod)
benefit patients (nsubj)
evaluate safety (dobj)
withdrew subjects (nsubj)
interna the (det)
stores group (nmod)
display which (nsubj)
produced injections (advcl)
bbb ) (punct)
radiculopathy of (case)
neuroblastoma induced (acl)
satisfied criteria (nsubj)
acknowledged " (punct)
tool rats (nsubj)
ls , (punct)
induction inhibition (conj)
recovery an (det)
electrographic pilocarpine-induced (amod)
cost weeks (nmod)
toxic substance (nmod)
women hysterectomised (amod)
toxicity system (compound)
presence the (dep)
presence preparations (nmod)
effect testing (acl)
mechanism hepatotoxicity (nmod)
contraceptives and (cc)
fluid methotrexate (dep)
rare aware (conj)
age fraction (conj)
negligible , (punct)
programs rat (nmod)
relevance with (case)
complication formation (nsubj)
organization health (compound)
regurgitation tricuspid (amod)
persisted , (punct)
beta-agonist a (det)
interpreted may (aux)
used d3 (nsubjpass)
appears monitoring (dobj)
actions mk-801 (nmod)
patients level (nmod)
pg ( (punct)
giving dose (dobj)
cardiotoxicity chronic (amod)
based finding (nmod)
killed . (punct)
margin along (case)
is unlikely (acomp)
predicting for (mark)
offer . (punct)
increase turnover (nmod)
skf of (case)
workers in (case)
model induced (amod)
rats testosterone-treated (amod)
hypothesize sufficient (ccomp)
leaving area (dobj)
powered . (punct)
oxidized and (cc)
cingulate in (case)
disintegrin metalloproteinases (conj)
delta bands (dep)
= 84.8 (dep)
frail patients (dobj)
4.7 was (cop)
consumers alcohol (nmod)
warning irregular (amod)
short plus (cc)
misoprostol after (case)
26 well (advmod)
subtle . (punct)
correlated delayed (nmod)
investigator one (nummod)
escalation single (amod)
disturbance transient (amod)
contains while (mark)
bradycardia intraoperative (amod)
outpatients of (case)
thorazine chlorpromazine (appos)
protects cardiomyopathy (nmod)
nutrition parenteral (amod)
administered rate (nmod)
task and (cc)
ra with (case)
nms . (punct)
received cacl2 (dobj)
observed complications (nsubjpass)
led activations (nmod)
structures hippocampus (nmod)
oltx ( (punct)
damage unique (amod)
elevated modestly (advmod)
cases 83 (nummod)
hippocampus into (case)
ii ) (punct)
changes all (advmod)
toxin pertussis (compound)
involved implicated (advcl)
included complications (nsubj)
absolute and (cc)
mg/dl 1.34+/-0.5 (compound)
seems to (xcomp)
excretion fractional (amod)
patients literature (nmod)
activity mitogen (compound)
levels bp (compound)
association in (case)
insulin-group the (det)
mechanisms enhances (acl:relcl)
behavioral neurophysiological (conj)
ratio normalized (compound)
degeneration the (det)
sediment proteinuria (conj)
proven untreated (conj)
observed numbers (nsubjpass)
hbsag ( (punct)
linn from (case)
calculated classified (conj)
amphetamine and (cc)
matter no (neg)
improving property (dobj)
oligodeoxynucleotide antisense (amod)
ecstasy polydrug (nsubj)
infection human (amod)
weeks 21 (nummod)
baseline during (case)
hematologic , (punct)
actions pressure (nmod)
determination fragmentation (nmod)
searched we (nsubj)
uninephrectomy protein (conj)
presented symptoms (dobj)
inhibit that (mark)
developed infusion (nmod)
children consecutive (amod)
9 to (case)
degree degeneration (nmod)
reduced maintained (advcl)
undertook analysis (dobj)
intraoperative and (cc)
secondary injury (nmod)
increased mediators (nsubjpass)
have mechanisms (dobj)
perfusion in (amod)
mg days (nmod)
discontinuations of (case)
start between (case)
combination mg (dep)
pregnant days (nmod:npmod)
intensity migraineurs (compound)
bilirubin surgery (nmod)
tubular the (det)
using rt-pcr (dobj)
score bis (compound)
demonstrated although (mark)
malformations lithium-induced (amod)
markers factor (nmod)
choice effects (nmod)
exist however (advmod)
7 14 (conj)
individuals received (acl:relcl)
conclusion detected (dep)
report trial (nmod)
functions treated (acl)
patient hepatic (nmod)
compared drug (nmod)
escape reactivation (conj)
developed infections (dobj)
phenacetin with (case)
treatment hydroxychloroquine (compound)
go seizures (nmod)
evaluation in (case)
developed intervals (nmod)
mg os (nmod)
anaesthesia under (case)
np , (punct)
received micrograms (nmod)
had participants (nsubj)
adjustment dose (compound)
measurements as (cc)
imaging ha (nmod)
stimulation selective (amod)
mechanisms the (det)
microg/day 14.2 (nummod)
sheath myelin (compound)
higher apparently (advmod)
one - (punct)
identified ) (punct)
agents receptor (compound)
found culture (nmod)
was loss (attr)
hypoxemia . (punct)
transgene the (det)
consequence seizures (nmod)
considered also (advmod)
processes foot (compound)
independent only (advmod)
frequent recognized (advcl)
encountered practice (nmod)
12h 10 (nummod)
% had (advcl)
leukoencephalopathy transient (amod)
formyltransferase glycinamide (amod)
derive changes (nmod)
generation to (case)
cbd : (punct)
raised level (nmod)
pain generalized (amod)
area day (nmod)
operation after (case)
children area (nmod)
cells mitochondria (conj)
counteract model (nmod)
lymphomas with (case)
demonstrate can (aux)
normal-salt or (cc)
duration of (case)
assess , (punct)
useful predicting (advcl)
mutations gene (compound)
mediated overflow (nsubjpass)
protein a (det)
sensitivity different (amod)
rats 27 (nummod)
formed been (auxpass)
% bupivacaine (compound)
spectrum subjects (nmod)
azt + (cc)
methadone the (det)
black . (punct)
withdrawn has (aux)
decreased calcitonin (nsubj)
state with (case)
drug parent (compound)
rest stimulation (conj)
clozapine ) (punct)
duration study (nmod)
decreased prevalence (dobj)
range months (dep)
c = (dep)
drug rationale (nsubj)
neurotoxicity brain (nmod)
higher women (nmod)
toxic hydrochloride (nsubj)
regressed withdrawal (nmod)
tumors one (nummod)
infusion short-term (amod)
interrupted was (auxpass)
lower concentrations (nsubj)
panca ( (punct)
provokes torsade (xcomp)
glioblastoma multiforme (dep)
coefficient correlation (compound)
damage antibiotic-induced (amod)
rate slowed (acl:relcl)
unclear efficacious (ccomp)
increased expression (dobj)
000 per (case)
indicated tests (nsubj)
faded later (advmod)
suggests report (nsubj)
exposure stress (nmod)
inconclusive suggested (conj)
index 16.619 (nummod)
strain myocardial (amod)
injection mg/kg (conj)
glioma and (cc)
week injection (dep)
methods in (amod)
allocated or (cc)
obtained signs (nsubjpass)
nm ) (punct)
stopped when (advmod)
enhances responsiveness (dobj)
disorders no (neg)
able curcumin (nsubj)
seizures tonic (amod)
isolated nocistatin (nsubjpass)
iiie stage (compound)
tma ) (punct)
hypokalemia , (punct)
suggested research (nsubj)
receive patients (dep)
nrf2(-/- ) (punct)
prevented manner (nmod)
morphine ) (punct)
mtdna ) (punct)
mg/kg acid (compound)
have children (nsubj)
swelling and (cc)
pentylenetetrezol mice (nmod)
schizophrenia of (case)
volume tidal (amod)
effusions the (det)
demonstrating apnoea (dobj)
patients 41 (nummod)
recur but (cc)
neurotransmission noradrenergic (amod)
measurements binding (nmod)
clinic in (case)
intralipid ( (punct)
cause co-administration (nsubj)
short- , (punct)
hyper-reactivity novelty (nmod)
reduces extent (dobj)
warfarin adjusted-dose (amod)
followed they (nsubjpass)
reperfusion intestinal (amod)
metabolizer diltiazem (conj)
part first (amod)
monotherapy risperidone (nmod)
% value (nmod)
poisoning cn (compound)
increased db (nmod)
study ( (punct)
9.4 to (quantmod)
decrease facility (nmod)
space , (punct)
times week (nmod)
prl-r socs-1 (dep)
lower intensity (nsubj)
affected action (dobj)
mechanism produce (acl:relcl)
drugs analgesic (amod)
received after (mark)
monitoring audiovisual (amod)
u/l bilirubin (conj)
received subjects (nsubj)
rise 145 (nmod)
apposition incomplete (amod)
0.01 < (compound)
alternative could (aux)
min 74 (nummod)
drug ifosfamide (nsubj)
complex with (case)
treated igf-il-3 (nmod)
doses exceeding (acl)
occurred 0.001 (dep)
prophylaxis carinii (compound)
administration p.o. (amod)
mechanisms different (amod)
= 21 (dep)
treatment modality (compound)
harm : (punct)
tissue conduction (compound)
influence not (neg)
hyper- three (dep)
pain atypical (amod)
analysis dna (compound)
estimated malondialdehyde (nsubjpass)
hallucinations auditory (amod)
indeterminate are (cop)
100mg/kg by (case)
mrna-containing ) (punct)
week prior (advmod)
sum grades (nmod)
rtms 5-hz (compound)
assay positive (amod)
neurotoxic is (cop)
inactivate that (nsubj)
an 50 (nmod)
suggests associated (ccomp)
artery iopentol (nmod)
dose increased (acl:relcl)
observed daily (advmod)
suspected unlikely (advcl)
patients resulting (acl)
combinations in (case)
girl man (conj)
rpn ) (punct)
72 +/- (cc)
chemotherapy without (case)
corticography depth (conj)
concentrations fetal (amod)
identified methods (dep)
carcinogenesis the (det)
samples % (dep)
patients mi (nmod)
clearance initial (amod)
change output (nmod)
tachycardia vt (appos)
dissociation atrio-ventricular (amod)
0.69 0.13 (conj)
pressures individuals (nmod)
= 1.39 (dep)
% 65 (nummod)
patients medication (nmod)
progression frequency (nmod)
restricted when (advmod)
cancer bladder (compound)
mg/m2 under (case)
aminoglycoside with (case)
associated contributed (conj)
activations , (punct)
prepared marrow (nmod)
associated gentamicin (nsubjpass)
ranged respectively (advmod)
b nfkappab (appos)
model sensitive (amod)
assessed alteration (nsubjpass)
suffers additionally (advmod)
those drugs (nmod)
spv ) (punct)
time operation (nmod)
effect naloxone (nmod)
mg 2.0 (nummod)
diagnosis diabetics (nmod)
( mean (dep)
or 2.14 (dep)
adriamycin ; (punct)
immunohistochemistry antibodies (nmod)
suggest observed (ccomp)
oblongata medulla (compound)
pa only (advmod)
reports reaction (nmod)
transplant protein (appos)
excitability an (det)
weeks methimazole (nmod)
atherosclerosis on (case)
planned . (punct)
background slowing (acl)
combined fk506 (nmod)
gain content (conj)
decreased death (dobj)
epilepticus p20 (appos)
breakdown or (cc)
patients ventilation (nmod)
kidneys in (case)
dogs ; (punct)
iopamidol patients (dep)
factors other (amod)
phosphate pentose (compound)
associated inflammation (nmod)
occurred , (punct)
lead continued (advcl)
clarify role (dobj)
renin content (conj)
genes key (amod)
findings test (compound)
nausea including (case)
compared months (nmod)
had evaluated (ccomp)
increase estimated (conj)
fourteen 84 (nmod)
alpha-methyldopa of (case)
chlorpromazine ( (punct)
recommend risk (nmod)
combination due (case)
associated contraceptives (nmod)
suppresses : (punct)
hypertension doca-salt (amod)
156 than (quantmod)
% 0.003 (dep)
contributed further (advmod)
kaposi advanced (amod)
finding reduce (ccomp)
regimen cancers (nmod)
stages process (nmod)
pallidotomy signs (nmod)
observation postbaseline (compound)
insula in (case)
accepted or (cc)
contraction ) (punct)
trials similar (amod)
compensation the (det)
animals laboratory (amod)
reduced % (dep)
progestagens for (case)
iu/l mean (meta)
cause toxicity (dobj)
5 1 (compound)
day 20 (nummod)
transplantation atresia (nmod)
symptoms any (det)
addicts crack (compound)
transformation cytoplasmic (amod)
subtle however (advmod)
observed dysfunction (nsubjpass)
convulsions rats (nmod)
concerns higher (acl)
a-i and (cc)
tested each (nmod)
reabsorption percentage (compound)
irrigated . (punct)
guinea-pigs.5 from (case)
choreic ballistic (conj)
changed focus (nmod)
density of (case)
insipidus nephrogenic (amod)
occurred doses (nmod)
impact s(c)o(2 (nmod)
classified using (advcl)
vessels blood (compound)
found hormone (nsubjpass)
literature prehospital (amod)
abstinence cocaine (nmod)
most all (nmod)
hcrh trh (conj)
extravasation the (det)
reactions in (case)
crescents glomerulonephritis (conj)
developed model (nsubjpass)
started have (xcomp)
synthesis during (case)
leading restriction (nmod)
evidence pharmacological (amod)
score in (case)
procyclidine as (case)
contribution low (amod)
prove electrode (conj)
said was (auxpass)
system this (det)
done administration (nsubjpass)
dysrhythmias . (punct)
tourniquets the (det)
bupivacaine of (case)
two-step thrombocytopenia (dep)
results for (case)
81 - (punct)
range points (conj)
loss early (amod)
agent 5-fluorouracil (appos)
methods disease (nmod)
adults than (case)
treatment deficits (nmod)
micromol/l 44 (nummod)
reduced years (nmod)
cocaine by (case)
dose cabergoline (compound)
reported group (nsubj)
measured ctni (nsubjpass)
corroborate , (punct)
delay mg/kg (dep)
betaxolol selective (amod)
dcm ( (punct)
s-23121 to (case)
tests challenge (compound)
inheritance recessive (amod)
electrocardiograms ecg (appos)
examinations ultrasound (amod)
withdrawal patients (appos)
started when (advmod)
aggravated . (punct)
phenomenon discussion (nsubj)
thrush oral (amod)
suggested trials (nsubj)
absence drug-induced (amod)
present at (case)
exhibited mitochondria (advcl)
woke later (advmod)
effects ketamine (nmod)
appeared respond (xcomp)
was if (mark)
carcinoma estrogen (compound)
receptor cloned (amod)
parasitosis delusional (amod)
history 10-year (amod)
assay myocytes (nmod)
patients lung (compound)
% mean (compound)
level . (punct)
basis inpatient (amod)
given day (nmod)
treated agents (nmod)
mean dose (dep)
significant disease (nmod)
fragmentation fiber (nmod)
examined examinable (parataxis)
ratings scores (conj)
disorders with (case)
six . (punct)
wk 4 (nummod)
effect significant (amod)
vein antecubital (amod)
levels deoxycorticosterone (amod)
antagonist idazoxan (conj)
implants electrode (amod)
clentiazem injury (nmod)
24.4 6.0 (conj)
n i.v. (dep)
pronounced , (punct)
expression ligand (nmod)
microscope the (det)
showed dobutamine (conj)
disease associated (acl:relcl)
described been (auxpass)
degeneration recovery (conj)
revealed reducing (advcl)
survival progression-free (amod)
affect myocytes (dobj)
characteristics metabolic (amod)
dopamine gaba(a (conj)
[ca]o than (case)
awake . (punct)
human mouse (conj)
betaine with (case)
proposed studies (nsubj)
scale 100-mm (amod)
nafld ) (punct)
mouth ( (punct)
experience acidosis (dobj)
rats investigated (acl)
months final (amod)
overshooting the (det)
non-biodegradable that (nsubj)
reflecting investigate (conj)
or=12.619 ) (punct)
bisphosphonates oral (amod)
release sequestration (conj)
administration simultaneously (advmod)
factors postoperative (amod)
rare side-effect (conj)
host drugs (nmod)
median 42.5 (dep)
agents not (neg)
paclitaxel with (case)
unrelenting disease (nsubj)
reversed similarly (advmod)
khz 6 (nummod)
0.60 ) (punct)
patients selected (conj)
entities different (amod)
antigen-positive dutp (conj)
latency increased (amod)
female donor (conj)
exceeded prolactin (nsubj)
demonstrated users (nsubj)
acc-9653 for (case)
collected december (nmod)
effect barium (compound)
clozapine t(33 (appos)
higher frequency (nmod)
p<0.01 all (det)
comprised adults (dobj)
csa tac (conj)
region formation (nmod)
result interactions (nsubj)
reduced dronedarone (nsubj)
have opse (dobj)
people tmp-smz (appos)
correlated severity (nsubjpass)
objectives correlate (acl)
haloperidol hal (appos)
report ingestion (nmod)
ocs second-generation (amod)
diagnostic , (punct)
cisplatin mg/m(2 (dep)
pacing movements (conj)
remained 1/500 (nmod)
beats/min -5.7 (nummod)
adequate hematoma (nsubj)
reduced been (auxpass)
electroretinography , (punct)
narrowed day (nmod)
electrodes dbs (compound)
droperidol mg. (dobj)
brain liver (conj)
failure cocaine-related (amod)
history became (acl:relcl)
radiation develop (acl)
equivalent diagnostic (dep)
needed decrease (advcl)
supplement a (det)
damage variety (nmod)
diagnosis dysfunction (nmod)
tests these (det)
course withdrawal (nmod)
sustained showed (conj)
effect mydriasis (conj)
contents its (nmod:poss)
doses moderate (amod)
present contrast (nmod)
convert to (mark)
signs one (nummod)
demonstrates taken (advcl)
treatment enalapril (nmod)
lack agent (nsubj)
improvements carotid (conj)
determination repeat (compound)
hypoxia % (appos)
worsening marked (amod)
decreases marked (amod)
department school (conj)
discontinuation the (det)
factor atpase (conj)
eating foods (dobj)
medline ) (punct)
blunted i.m. (advmod)
obtained csseps (nsubjpass)
seizure bouncing (case)
provided quickly (advmod)
had value (dobj)
demonstrates role (dobj)
records paired (amod)
experiment carcinogenicity (compound)
assess hypertension (dobj)
effect hemolytic (amod)
fifty-nine cent (nmod)
derived plasma (nmod)
episodes between (case)
diagnosed three (nsubjpass)
angiographies performed (acl)
wavefronts reflected (acl)
reduction hearing (compound)
changes activity (nmod)
attributable partly (advmod)
polyphenol linn (nmod)
benefit acid (nsubj)
injection interval (nmod)
affect did (aux)
lipoproteins of (case)
meeting criteria (dobj)
syndrome risperidone (nmod)
patients mania (nmod)
pain cardiac (amod)
appetite and (cc)
examined arteritis (nsubjpass)
hypothyroid patients (nsubj)
doses equimolar (amod)
cent tubes (nmod)
pallidotomy knife (nmod)
invasive highly (advmod)
underwent mz (nmod)
frequent which (nmod)
enlargement pressure (nmod)
ar ( (punct)
effects a (nmod)
had history (dobj)
values final (amod)
prl in (case)
associated significantly (advmod)
pituitary the (det)
sensitivity high (amod)
patients responding (amod)
degree given (case)
acid acid (dep)
cells vessels (nmod)
mechanism damping (amod)
appear that (nsubj)
onset ( (punct)
metabolism oxidase (compound)
representative spectrum (nmod)
nephrotoxicity with (case)
identified daidzein (nmod)
shorter , (punct)
globulin hbig (appos)
3 0 (compound)
converted phenytoin (advcl)
severe reversible (conj)
entered study (dobj)
neurological the (det)
experienced seizure (xcomp)
96.7 /-2.4 (appos)
conditions acid-base (amod)
failed induce (xcomp)
adding of (mark)
8000 approximately (advmod)
fetuses in (case)
increment dose (compound)
period eight-minute (amod)
tiapride amisulpride (conj)
man old (amod)
good to (case)
presence be (cop)
icterus and (cc)
resulted group (nmod)
restricted use (dobj)
s(c)o(2 in (case)
mouth " (punct)
exposed one (nsubjpass)
rate excess (amod)
tension peak (amod)
sampled that (mark)
mk-212 receptor (compound)
expression channel (compound)
disorder schizophreniform (compound)
using parameters (dobj)
shorter were (cop)
fever hemorrhagic (amod)
activity no (compound)
patterns suggest (acl:relcl)
vaccine hepatitis (compound)
received convert (xcomp)
treatment 11/41 (conj)
decline of (case)
fractions the (det)
sensitive memory (nsubj)
cholestasis with (case)
found treatment (nmod)
group over (case)
capsaicin applied (acl)
determined activity (dobj)
compare tolerability (dobj)
sulindac hyperkalemia (conj)
raloxifene of (case)
ng/ml. 13 (compound)
production patients (nmod)
difference proportion (nmod)
stabilizer a (det)
initiation before (case)
attenuates incorporation (nsubj)
concentration proteins (nmod)
leading retention (nmod)
injection albumin (nmod)
catalepsy induced (acl)
decreased 107 (nmod)
group chloroprocaine (compound)
behavior erections (conj)
observations recent (amod)
hypotension isoflurane-induced (amod)
pleural and (cc)
animals n (dep)
subject capacity (nsubj)
allow proceed (ccomp)
tolerated be (auxpass)
iqr range (conj)
entered and (cc)
studies preclinical (amod)
effectiveness its (nmod:poss)
tests liver (compound)
produced , (punct)
extensive are (cop)
patient caused (acl:relcl)
microangiopathy . (punct)
2.8 from (case)
patients lithium-treated (amod)
received adr+los(6 (nsubj)
effect recognized (acl)
attenuates or (cc)
types different (amod)
investigated results (conj)
effects arrhythmogenicity (nmod)
peptides both (det)
n=283 ) (punct)
12 five (compound)
syndrome obstruction (compound)
gvg sub-chronic (amod)
changes meshwork (nmod)
walk feet (dobj)
comprised clinic (nmod)
given conclusions (nsubjpass)
interfere induce (conj)
exposure pubertal (amod)
higher similar (advcl)
suggests conclusion (nsubj)
effects clentiazem (nmod)
cases nephritis (nmod)
summaries treated (dep)
discontinued that (mark)
disruption system (nmod)
subjects males (dep)
ca2 overload (conj)
bd1018 bd1063 (conj)
loss this (det)
nurse by (case)
hg more (conj)
cycles ) (punct)
associated drugs (nmod)
doxorubicin 4 (nummod)
known beta-agonist (nsubjpass)
potent however (advmod)
trial parallel-group (amod)
height patients (nmod)
> microl (appos)
related was (cop)
conducted and (cc)
noted noted (conj)
reduction administration (conj)
smokers are (cop)
available test (dobj)
stopped after (mark)
thrombi of (case)
co-infected mutations (nsubj)
inhibits synthase (dobj)
pulmonary to (case)
preserved controls (advcl)
evaluates influence (dobj)
exposure thiabendazole (nmod)
dysphagia about (case)
model paw (compound)
blockage after (case)
difficulties sexual (amod)
cells her (nmod:poss)
staying after (mark)
responsible . (punct)
isoniazid or (cc)
adrenoceptor a (det)
hypertrophy to (case)
cases a (det)
result cause (nsubj)
express that (nsubj)
evoked chemo-somatosensory (dep)
reliable sensitive (conj)
alters aminonucleoside (nsubj)
termination regeneration (nmod)
indistinguishable that (nmod)
diuretic oral (amod)
blocker for (case)
case death (nmod)
polymorphism of (case)
tended record (xcomp)
length with (case)
receiving not (neg)
diabetic toxic (conj)
powder gum (amod)
insipidus secondary (amod)
cramps leg (compound)
included effects (nsubj)
discovery its (nmod:poss)
vasodilator the (det)
extent and (cc)
d-1 and (cc)
coefficient and (cc)
30min for (case)
year with (case)
perimetry automated (amod)
increased before (mark)
disease nafld (appos)
mmhg ( (punct)
mean 78 (nmod)
excitation discernible (amod)
damage inflicted (amod)
markers the (det)
safe . (punct)
bw 50.0 (nummod)
seem , (punct)
decreased especially (advmod)
physicians treating (acl)
toxicity desipramine (compound)
thrombosis secondary (amod)
therapies medical (amod)
symptoms for (case)
potency = (amod)
worsen model (nmod)
chromosome ( (punct)
times six (nummod)
sph ] (punct)
ziprasidone like (case)
hygiene poor (amod)
improves symptoms (dobj)
hypertension intracranial (amod)
used retrograde (advcl)
alternative . (punct)
cilostazol phosphodiesterase (compound)
diffuse . (punct)
cytotoxicity cb (compound)
damage lobe (nmod)
neurotoxicity in (case)
depend effects (nsubj)
causes pethidine (nsubj)
epinephrine to (case)
1.7 32.4 (dep)
rose pronounced (conj)
mechanism hypersensitivity (compound)
effects blepharoconjunctivitis (nsubj)
ruled however (advmod)
occurrence the (det)
eyes his (nmod:poss)
ph 7.25 (nummod)
increased icp (nsubj)
days 18.9 (nummod)
measured resistance (nmod)
use residence (conj)
streptozotocin icv (compound)
scale children (nmod:poss)
light- transmission-electron (conj)
confirmed histology (nmod)
cocaine mg/kg (compound)
effects iatrogenic (amod)
antagonists type (nmod)
inhibition phosphatase (nmod)
bronchoconstriction severe (amod)
action anticonvulsive (amod)
mpo-anca ) (punct)
comorbid a (det)
levels gene-related (amod)
dicyclomine kg-1 (appos)
developed tumors (dobj)
two three (conj)
times weekly (advmod)
molecules nephrin (dep)
man factors (nmod)
disappeared spontaneously (advmod)
dying intoxication (nmod)
hyperventilation hypoventilation (conj)
granulomas eosinophilia (conj)
mice reserpine-treated (amod)
higher slightly (advmod)
showed imaging (nsubj)
implications studies (nmod)
route relevant (acl:relcl)
function left (amod)
anaesthesia single-shot (amod)
concentrations urinary (amod)
aap , (punct)
lack total (amod)
substituted syringe (nsubjpass)
august and (cc)
was cows (nmod)
perimetry static (amod)
olanzapine n (dep)
image resonance (compound)
pressure to (case)
kept when (advmod)
in general (amod)
play abundance (nsubj)
mg 3 (nummod)
membrane erythrocyte (compound)
4 12 (conj)
deprivation maternal (amod)
blocks agent (nsubj)
outcomes evaluation (nmod)
action this (det)
levels creatinine (nmod)
evaluated ) (punct)
interval within (case)
norleucine and (cc)
atherosclerosis aorta (nmod)
complication anesthesia (nmod)
maintain to (mark)
sixty-eight ) (punct)
result reversal (nmod)
deficient e. (nmod)
diabetic being (cop)
1984 and (cc)
hypothesis dependent (ccomp)
rats isoproterenol-induced (amod)
pethidine plasma (compound)
significant study (nmod)
evaluation department (compound)
ascertained efficacy (nsubjpass)
treatment amantadine (nmod)
d-pen ( (punct)
analogs bd1008 (nmod)
enabling cope (xcomp)
dependent tone (nmod)
found sensitivity (dobj)
worsen administration (nsubj)
develop percent (nsubj)
lead to (mark)
3 mazindol (nmod)
rats 18 (nummod)
tasks fluency (compound)
median range (conj)
studies and (cc)
mucosa rat (compound)
requirements glycopyrronium (compound)
ellman of (case)
absence hypoxaemia (nmod)
influence d-ribose (nmod)
alters treatment (nsubj)
administration outpatient (amod)
increased sbp (nsubjpass)
report were (cop)
doxorubicin a (appos)
or=7.18 95 (dep)
is obviously (advmod)
predictors that (mark)
flushing line (dobj)
risks about (case)
awake he (nsubj)
ages register (nmod)
receptor gamma-aminobutyric (amod)
calcium concentration (conj)
continue will (aux)
levodopa , (punct)
syndrome similar (amod)
combined we (nsubj)
cross-tolerance ketamine (acl)
improving therapy (nmod)
suggested contribute (ccomp)
fasting by (case)
cells marrow (compound)
main active (conj)
calculated and (cc)
abundance alphaenac (compound)
randomized decrease (dep)
numbers drg (nmod)
possessed it (nsubj)
choosing before (mark)
oxidation for (case)
received hr (dep)
pathogen the (det)
called attention (nsubjpass)
fluorescence ( (punct)
rats microl/side (appos)
63 to (case)
augments mk-801 (nsubj)
frequency and/or (cc)
fleming ) (punct)
condition carries (acl:relcl)
interval 0.75 (dep)
seizures these (det)
less 0.05 (nmod)
repeat words (conj)
modulate acid (dobj)
beats minute (nmod)
rtms ) (punct)
suppressed not (neg)
manipulation fracture (nmod)
n-acetyl-beta-d-glucosaminidase of (case)
11 +/- (cc)
pparalpha-/- ] (punct)
15 between (case)
identified via (nsubjpass)
was nascis (nmod)
possible measuring (advcl)
relationship symptoms (nmod)
3,4-methylenedioxymethamphetamine ) (punct)
reproducibility the (det)
< was (cop)
lidocaine cocaine (conj)
depolarization the (det)
edrophonium of (case)
assessed activities (nsubjpass)
phenotype and (cc)
discontinued incidence (nmod)
proteins uncoupling (amod)
cortical hepatic (conj)
accentuated response (nsubjpass)
od in (case)
ratio blots (nmod)
dyskinetic fifteen (nummod)
42 5 (conj)
consider ; (punct)
replication on (case)
potent cimetidine (nmod)
recorded specified (conj)
complications among (case)
features morphological (amod)
diagnosed were (auxpass)
motif ) (punct)
effects diabetes (nmod)
generated methods (nsubj)
occurs blockade (nmod)
alt bun (appos)
tci reduction (appos)
methods histopathologic (amod)
ethanol of (case)
cases from (case)
discrimination impaired (amod)
heart the (det)
species but (cc)
sensitivity pain (nmod)
expression not (neg)
activated comparable (conj)
acidosis anesthesia (nmod)
form the (det)
showed lesion (dobj)
minutes 28 (nummod)
albino were (cop)
data discharge (conj)
reduces addition (nmod)
slight very (advmod)
(na , (punct)
report scale (nmod)
performed experiments (nsubjpass)
activation neurons (nmod)
lines from (case)
attempted study (nsubjpass)
chronic of (case)
years 530 (nummod)
weeks start (nmod)
registry the (det)
developed mg (dep)
defined ( (punct)
used experienced (conj)
dox and (cc)
disease all (predet)
effective trial (dep)
switched methods (dep)
force . (punct)
deferens atrium (conj)
thrombophlebitis nephrotoxicity (conj)
discontinuation requiring (amod)
boy 15-year-old (amod)
alterations stress (appos)
2a and (cc)
ml 2-chloroprocaine-ce (conj)
safe was (cop)
drugs bzds/rds (appos)
consequence ? (punct)
deletion a (det)
showed tendency (dobj)
providing management (dobj)
patients thirty-five (amod)
related differences (nsubj)
mg/kg 80 (nummod)
diazinon of (case)
was background (dep)
angina ( (punct)
daily ) (punct)
defining substrates (dobj)
verapamil woman (nsubj)
expression vip(-/- (nmod)
used agent (dobj)
oral long-term (amod)
cells encircling (amod)
profiles the (det)
therapy amphotericin (compound)
15 10 (compound)
erythrophagocytosis infiltrates (conj)
coeruleus of (case)
counseling reminders (conj)
suspected myocarditis (nsubjpass)
cavity nasal (amod)
alpha(1 the (det)
report results (dobj)
antidepressants anorexigens (conj)
volunteers healthy (amod)
presence malformations (nmod)
number abnormalities (nmod)
protect overexpression (nsubj)
11 of (advmod)
follow-up average (amod)
exhibited vitro (advmod)
projection a (det)
role beta2 (nmod)
mhpg ( (punct)
concentration bupivacaine (nmod)
cardiotoxicity later (amod)
aftereffects beneficial (amod)
considered risk (nmod)
need we (nsubj)
lowering significantly (advmod)
associated syndrome (nmod)
warrant . (punct)
mesna with (case)
inducing despite (mark)
subsequent rapidly (advmod)
levels groups (nmod)
modulation pharmacological (amod)
tonic clonic (conj)
roots vessels (conj)
discussed patients (nmod)
6.7 and (cc)
morphine for (case)
compared group (conj)
deficit neurological (amod)
extend was (cop)
demonstration the (det)
ester acc-9653 (dep)
least the (det)
strength in (case)
agent potent (amod)
detected aneurysm (nsubjpass)
physicians by (case)
manifestations by (case)
part regimen (nmod)
obese edematous (conj)
different qualitatively (advmod)
recipients transplantation (compound)
ocs all (det)
similar adults (nsubj)
produced all (conj)
cause resulting (advcl)
ranged 248 (nmod)
hypoxia cyanosis (conj)
patients defects (nmod)
hypothalamus accumbens (conj)
reviewed records (nsubjpass)
revealed numbers (dobj)
development apomorphine-induced (nmod)
induced change (conj)
short one (nummod)
percentage cells (nmod)
transmission serotonergic (compound)
conducted : (punct)
blocker novel (amod)
hospitals arose (acl:relcl)
delta ( (punct)
l/m2 and (cc)
l-485 vegetable (amod)
metoprolol or (cc)
included thrombophlebitis (dobj)
ng 500 (nummod)
synthesized . (punct)
address clinicians (nsubj)
showed it (nsubj)
commissure , (punct)
characterized represents (ccomp)
clonidine verapamil (conj)
toxicity defined (acl)
seems there (expl)
rich cholesterol (nmod:npmod)
translate might (aux)
amplitude recovered (acl)
levels 2b1/2b2 (nmod)
necrotizing of (mark)
allocated receive (nmod)
reducing gfr (conj)
continued onset (nmod)
experienced ingestion (nmod)
caused group (nmod)
600 1200 (conj)
observation ) (punct)
period along (case)
consistent which (nsubj)
changes ecg (nmod)
antigen-positive ed-1-positive (conj)
cannabis to (mark)
provided dose (nsubj)
manipulated pressure (nsubjpass)
receive ml (dobj)
staining double (amod)
1.4 were (cop)
prevents . (punct)
dialysis with (case)
co-administration ra (nmod)
reflexes originating (acl)
found had (conj)
approaches follow-up (nmod)
offer protection (dobj)
course epilepticus (nmod)
limit 3 (nummod)
goes , (punct)
ecstasy the (det)
change pressure (nmod)
presented unique (ccomp)
medical substance (conj)
elicits response (dobj)
hydrobromide and (cc)
status near (amod)
10(-8 , (punct)
experienced seizure (dobj)
study post (dep)
complications vasoconstriction (nmod)
inhibitor uptake (compound)
fraser 1953 (nummod)
mechanism case (nmod)
measured done (conj)
75 - (punct)
increase number (nmod)
formulations drug (conj)
conducted study (nsubjpass)
nonusers than (case)
1994 of (case)
gauges to (case)
peptide bnp (conj)
average below (case)
[verapamil]o the (det)
changes adults (nmod)
subsided reactions (nsubj)
determined marker (nmod)
suggestive is (cop)
co-administration curcumin (compound)
pra ) (punct)
presenting pain (nmod)
temperature body (compound)
nuclear mitochondrial (conj)
indicator measurement (nsubj)
meningitis treated (acl)
clozapine of (case)
agitated be (auxpass)
exposure subacute (compound)
had disease (conj)
prostaglandins renal (amod)
7 2.4 (conj)
recorded reactions (nsubjpass)
blockade sis3 (nmod)
alpha , (punct)
microinjection intracollicular (amod)
presence cholinesterase (nmod)
tended drug (nsubj)
metoprolol/alpha-hydroxymetoprolol higher (amod)
glucoronosyltransferases uridine (amod)
initiation fluconazole (nmod)
loss severe (amod)
prolactin and (cc)
rbcs individual (nmod)
study by (case)
carbimazole propylthiouracil (conj)
exist variants (nsubj)
cytometry by (case)
reticulum and (cc)
results ecg (nsubj)
prevent toxicity (dobj)
electroretinography ( (punct)
5-ht central (amod)
rates occupancy (compound)
studied correlate (advcl)
effects exercise (nmod)
h moment (compound)
infusion g (compound)
disease 3 (nummod)
case boy (nmod)
effect node (nmod)
patients 9,037 (nummod)
manner potency (nmod)
evidence role (nmod)
dose reconsidered (conj)
case first (amod)
results seen (dep)
investigated rats (nmod)
torsade of (mark)
papaverine from (case)
inhibitor peripheral (amod)
implicated increase (nsubjpass)
microinjection ritanserin (nmod)
surveillance from (case)
flutamide antagonist (compound)
admitted menorrhagia (nmod)
infections presumed (amod)
children , (punct)
appeared series (nmod)
company ; (punct)
using pdn (dobj)
arrhythmia danger (dep)
results catalepsy (dep)
lometrexol antifolate (compound)
hypothesized role (nmod)
fact feature (ccomp)
case became (acl:relcl)
used records (dobj)
venom gland (nmod)
response apomorphine (nmod)
cases papaverine (nmod)
1.2 from (case)
mechanism myopathy (nmod)
fos-immunoreactivity neurons (nmod)
failure treatment (nmod)
iii with (case)
or=13.807 ) (punct)
frequency pvc (nmod)
reviewed studies (nsubjpass)
trial mazindol (nmod)
administration oxytocin (compound)
staining diaphragm (nmod)
correlated , (punct)
mouth around (case)
higher mm (dep)
other alopecia (conj)
cefonicid of (case)
decreased comparison (nmod)
4.6 of (case)
vitro a(2a (appos)
emerged , (punct)
populations risk (nmod)
glioblastomas for (case)
na(+)/k(+)-atpase and (cc)
mechanism drug-adsorption (amod)
pressure right (amod)
nucleus stn (appos)
receptors d4.4 (compound)
tubule within (case)
present arteries (nmod)
reserved . (punct)
attack frequent (amod)
12 to (dep)
class the (det)
appear enhance (xcomp)
confused became (auxpass)
led cases (nmod)
linked that (mark)
levels decibels (nmod)
decreased activation (nsubjpass)
dystrophy of (case)
treated preparation (nmod)
appearance symptoms (nmod)
higher and (advmod)
cancer combined (amod)
defined % (nmod)
nephrolithiasis of (case)
model aids (nmod)
axons cell (compound)
curve ( (punct)
replication impaired (amod)
effects mapd (nmod)
cardiorespiratory intramuscular (amod)
erythropoietin cardiac (amod)
suitable formulation (nsubj)
blockade endomt (nmod)
rammer degkwitz (dep)
mg/kg/day dosages (nsubj)
deficits unilateral (amod)
nitroprusside sodium (compound)
tmax ; (punct)
frequency because (case)
effect paraparesis (nmod)
d and (cc)
protocol in (case)
used data (nsubjpass)
improves stimulation (nsubj)
mice or (cc)
achieved therapy (nmod)
developed torsade (dobj)
received dipping (nmod)
% 1 (compound)
received tacrolimus (dobj)
( k (dep)
pg-9 of (case)
damage podocytes (nmod)
women with (case)
ppa ) (punct)
data pathophysiology (nmod)
activity hematologic (amod)
maleate chlorpheniramine (amod)
phenobarbitone- on (case)
days hypertrophy (nmod)
shown produce (ccomp)
puncture of (case)
ptcr well-developed (amod)
proposed previously (advmod)
leukoencephalopathy . (punct)
seem would (aux)
p.o. 30 (nummod)
action clonidine (nmod)
265.2 +/- (cc)
facies potter (nmod:poss)
altered ingestion (nmod)
compliance extended-release/lovastatin (nmod)
pathophysiology modes (conj)
dose ifosfamide (nmod)
results our (nmod:poss)
mg/kg 50 (nummod)
suppressed continuously (advmod)
once twice (conj)
centre molecule (nmod)
flexion/extension fingers (nmod)
presence ramh (nmod)
average ( (punct)
drug anxiogenic (amod)
results cytoskeleton (conj)
tract from (case)
wsp ( (punct)
clearance creatinine (compound)
micrograms/ml 52 (nummod)
candidates drug (compound)
cases an (det)
glutamate glutamine (conj)
possessed . (punct)
selected methods (dep)
describe as (cc)
stabilize states (dobj)
remoxipride metabolites (conj)
jerks rigidity (conj)
activity butyrylcholinesterase (nmod)
diagnosed syndrome (nmod)
frequency bf (appos)
reactions nimesulide (acl)
attenuated 5 (nsubj)
ikr , (punct)
drug not (neg)
causing although (mark)
cumulative caused (acl)
abstracts conference (compound)
administrated vivo (advmod)
alleviates bicarbonate (nsubj)
found active (xcomp)
became cultures (nsubj)
enos ) (punct)
n=25 ( (punct)
light to (case)
pathway receptor (compound)
failure increased (acl)
showed products (dobj)
1 5 (prep)
apomorphine-induced of (case)
act should (aux)
tachycardia inducing (acl)
concentrations matter (compound)
groups anaesthesia (compound)
af with (case)
history disorders (nmod)
group interval (appos)
2,220 than (quantmod)
metabolism radicals (nmod)
clear very (advmod)
staining nfs (nmod)
jg hj (appos)
electrographic the (det)
1.036 ) (punct)
aeds ( (punct)
months introduction (advcl)
treatment tuberculosis (nmod)
on and (advmod)
used protocols (nsubjpass)
malignancies b-cell (compound)
receiving 18 (nsubj)
seconds sixty (nummod)
syndrome ventricular (amod)
bsa ) (punct)
hypertension rat (nmod)
suggest desensitization (dobj)
secretion factor (compound)
5.9 +/- (cc)
reaction infusion (nmod)
obtained records (nmod)
putamen caudate (compound)
negroes african (amod)
test tolerance (compound)
increased ppa (nmod)
affecting primarily (advmod)
incidence recipients (nmod)
specimens kidney (compound)
had we (nsubj)
one agent (conj)
range months (nmod:npmod)
suppression tetanus (compound)
six than (quantmod)
therapy sedation (conj)
induction methotrexate (nmod)
damage or (cc)
lactoferrin of (case)
thickness the (det)
pulses 1,800 (nummod)
p<.001 ] (punct)
mg/kg dose (nsubj)
disease rheumatic (amod)
clipping for (case)
upregulation acting (acl)
received cefotetan (dobj)
myocet combination (nmod)
promote bbb (nmod)
shown serum- (nsubjpass)
cyclosporine tacrolimus (conj)
received mg (nmod:tmod)
tocolytics two (nummod)
discontinued fluconazole (nsubjpass)
isolated kidneys (nmod)
reviewed terminology (nsubjpass)
effects anesthetics (nmod)
100 400 (conj)
encouraged most (conj)
disappear may (aux)
ratio mortality (compound)
gfc ) (punct)
results frequent (appos)
leiden and (cc)
manifestations the (det)
stimulation deep (amod)
antibiotics practice (nmod)
defects binasal (amod)
deterioration functions (nmod)
has remained (conj)
3/20 ( (punct)
adjusted response (nmod)
calculate odds (dobj)
likely treated (xcomp)
thrombosis lysis (nmod)
models interoceptive (amod)
contraindicate does (aux)
observed had (conj)
form inducible (amod)
aminoglycoside amikacin (nsubj)
effective emulsion (nsubj)
patients " (punct)
medline of (case)
best synergy (nsubj)
located hypothalamus (nmod)
filters ) (punct)
vpa mg/kg (appos)
treatment verapamil (nmod)
pallidotomy unilateral (amod)
climbing mice (nmod)
republic in (case)
appearance the (det)
detection deterioration (nmod)
tumor archival (amod)
ci=25.2 28.2 (nummod)
types arrhythmias (nmod)
background indicated (appos)
day after (dep)
outcomes better (amod)
people aged (amod)
reflex than (case)
memory associative (amod)
stimulate , (punct)
mg/m(2 24-hour (amod)
identify model (nmod)
glaucoma glaucoma (nmod)
fits this (nsubj)
treatment contractions (nmod)
reports pericarditis (nmod)
occurred % (nmod)
developed repair (nmod)
suggests analysis (nsubj)
analgesia postoperative (amod)
played process (nmod)
mechanisms by (case)
consumed tablets (dobj)
glomerulosclerosis mechanisms (conj)
60 to (quantmod)
individual the (det)
developed age (nmod)
increased mrna (dobj)
pathway septo-hippocampal (amod)
(+/-)-pg-9 by (case)
far thus (advmod)
aggregations vitro (advmod)
stain ed1 (nmod)
explain stopped (advcl)
shell the (det)
patients 110 (nummod)
agents chemotherapeutic (amod)
lower compared (dep)
heparin treatment (nmod)
escalated mg/m2 (dep)
group gentamicin (dep)
types spasms (nmod)
ci : (punct)
electrocardiographic transient (amod)
% 4.1 (dep)
cells hippocampus (nmod)
disruption deposition (conj)
rats nonprogesterone-treated (amod)
increase correlates (nmod)
impairment caused (acl)
necrosis rats (nmod)
remained risk (nsubj)
readmitted crisis (nmod)
subjected is (auxpass)
novel . (punct)
months 12 (nummod)
max ( (punct)
generalized predominant (conj)
activity an (det)
amphetamine-induced cocaine-and (nmod:npmod)
licensed treatment (nmod)
hypotension is (cop)
developed parkinsonism (nsubj)
occur toxicity (nsubj)
described patients (nsubj)
prohibited effect (nsubjpass)
found produce (conj)
questionaires version (appos)
expression paraventricular (nmod)
development advanced (amod)
induced aconitine (nmod)
width the (det)
tinnitus idiopathic (amod)
mazindol to (case)
failure in (case)
alter assessed (advcl)
instillation lignocaine (nmod)
overdose , (punct)
levels valproic (amod)
mg/d mg/d (conj)
cardiomyopathy on (case)
p<0.001 and (cc)
examine aspects (dobj)
described effects (dobj)
p-choloroaniline product (compound)
be magnitude (nmod)
beta-muricholate of (case)
thought is (auxpass)
micrograms/kg 0.3 (nummod)
r ) (punct)
fibers muscle (compound)
information of (case)
likely disorders (nsubj)
adenocarcinomas prostate (compound)
deposits with (case)
actions prolactin (compound)
inheritance , (punct)
tests controlled (amod)
galantamine , (punct)
tasks controls (nmod)
adducts and (cc)
group group (nmod)
ophthalmology of (case)
evidence and (cc)
mm 128 (nummod)
presence or (cc)
action sites (nmod)
day gd (appos)
stiffness of (case)
suppression marrow (compound)
doxorubicin status (conj)
region 5 (nummod)
63 +/- (cc)
expression mrna (compound)
users antithrombotic (amod)
have bradycardia (dobj)
up maximum (nmod)
db -0.64 (compound)
effect nitroglycerin (nmod)
bradycardia vagal (compound)
hemodynamic , (punct)
h od (compound)
failed respectively (advmod)
diarrheas and (cc)
lacking . (punct)
ltp hippocampal (compound)
had tendency (dobj)
oxycodone immediate-release (amod)
exposed vincristine (nmod)
neuropathy occurred (dep)
receiving methimazole (dobj)
given area (nmod)
appears intensity (nsubj)
investigated effects (dobj)
episodes levels (conj)
1.1 8.5 (nummod)
nephrotoxicity can (aux)
caused volume (conj)
countries available (acl:relcl)
scored seizures (nsubjpass)
demonstrated enhanced (ccomp)
compared authors (nsubj)
nik-247 e-2020 (conj)
docetaxel plus (cc)
complete almost (advmod)
hypoxia caused (acl)
bbb and (cc)
survived children (nsubj)
centers us (compound)
2.7 +/- (cc)
resulting disease (nmod)
lesion dorsal (compound)
vaccine of (case)
trials scale (compound)
interval alternating (amod)
potassium a (det)
form release (compound)
elevations transaminase (compound)
dealt medically (advmod)
dystrophy treatment (conj)
intralipd epinephrine (conj)
neuroblastoma in (case)
ceased and (cc)
pressure clinicians (nmod)
nephrotoxicity contrast (compound)
applies metoprolol (nmod)
showed normal (conj)
pig the (det)
circulations the (det)
supply and (cc)
risks n=94 (compound)
vaccinated january (nmod)
receptors group (compound)
mg ) (punct)
patients anxious (amod)
enhances that (mark)
contraindicate which (nsubj)
uni- multivariate (conj)
imaging a (det)
26 16 (conj)
areas ulcer (compound)
mt ( (punct)
increment ( (punct)
decreased papilledema (dobj)
developing dysfunction (dobj)
used remedies (nmod)
completed be (auxpass)
correlates expression (nsubj)
hinder that (nsubj)
limited usefulness (nsubjpass)
premedication standard (amod)
temsirolimus of (case)
morphine metabolites (conj)
determine stability (dobj)
h(3)-receptors histamine (compound)
propofol 237 (nummod)
quantified activities (nmod)
responses cells (nmod)
symptoms pressure (conj)
testosterone plasma (compound)
biopsies cervical (amod)
acts differs (conj)
ablated surgically (advmod)
d n (dep)
similar be (cop)
risperidone receptors (conj)
tg ( (punct)
problems to (case)
incidences reasonable (amod)
administered methods (nsubjpass)
half nearly (advmod)
ctni development (nmod)
immunoreactivity model (nmod)
diffusion is (cop)
superiority bromperidol (nmod)
diclofenac % (dep)
case an (det)
maneuver a (det)
cohort previous (amod)
measured minutes (nmod)
abnormalities brain (compound)
continued application (dobj)
methylprednisolone high-dose (amod)
unremarkable was (cop)
indices functional (amod)
potent pinacidil (nmod)
responded min (nmod)
scr were (cop)
reticulum cisternae (conj)
ilk ( (punct)
supplementation sodium (compound)
background history (conj)
memory memory (conj)
occurrence complication (nmod)
time oltx (nmod)
convert rhythm (nmod)
transport for (case)
weeks of (case)
characterized onset (nmod)
length p (dep)
hyperalgesia ed50 (appos)
epicondyle at (case)
supine upright (conj)
gyrus superior (amod)
studied animals (nmod)
cinching tourniquets (dobj)
reduced supporting (advcl)
hypoventilation ph (dep)
administration terbutaline (nmod)
seroconversion smokers (nmod)
sequences recovery (compound)
h than (case)
monitoring function (nmod)
had 4 (dep)
recordings polysomnographic (amod)
toxicity drug (compound)
movement intraoperative (amod)
pentobarbital adjuvant (amod)
remains unknown (xcomp)
review hepatotoxicity (nmod)
barrier size (compound)
recorded converted (conj)
1986 in (case)
lymphokine a (det)
weeks 20,40,60 (nummod)
summary case (compound)
protocols different (amod)
acts ( (punct)
showed controls (nsubj)
s(c)o(2 ( (punct)
cis-platinum of (case)
treatment tachycardia (nmod)
behavior rats (nmod)
elevated administration (nsubj)
remained audiograms (nsubj)
remained while (mark)
muscles rectus (compound)
jerks developed (amod)
decrease end (nmod)
phenylephrine by (case)
rigidity rat (nmod)
attained . (punct)
value initial (amod)
g/dl post-cab (appos)
pesticide and (cc)
selective responses (nsubj)
bche and (cc)
potential induce (acl)
stage t1cn0m0 (dep)
1.69 2.10 (dep)
linking use (nmod)
perfused . (punct)
showed findings (dep)
anemias hemolytic (amod)
features renal (amod)
young both (cc:preconj)
investigated interaction (nmod)
prevalence at (case)
similarity a (det)
changed was (auxpass)
ranged from (advmod)
dialyzer high-flux (amod)
provides conclusion (nmod)
signs other (amod)
hypercalcaemia of (case)
cornu rudimentary (amod)
fatalities there (expl)
a(2a)/a(1 compound (nsubj)
vasospasm angiography (nmod)
patients migraine (compound)
agent ) (punct)
neurotransmission glutamatergic (amod)
dystrophy in (case)
report complication (nmod)
contribute effect (nsubj)
mean total (conj)
syndrome antiphospholipid (compound)
chiasm optic (amod)
mutation interval (conj)
patients att-alf (nmod)
enhanced verapamil (nsubj)
115 ) (punct)
water of (case)
mg 20 (compound)
da or (cc)
diameters in (case)
option a (det)
sensitivity increased (amod)
introduction reaction (appos)
microscope by (case)
treated tacrolimus (nmod)
ventricles canine (compound)
hygiene xerostomia (conj)
added had (aux)
diet chloride (compound)
density higher (amod)
following was (cop)
replicated a (nmod)
treatment compared (case)
indicated potentiate (ccomp)
fev1 0.001 (dep)
retains whether (mark)
% 66.6 (nummod)
blocks receptors (dobj)
injection glioblastomas (nmod)
outcomes transplantation (nmod)
abusers the (det)
accumulation both (cc:preconj)
immunostaining in (case)
use use (conj)
syringe a (det)
alterations tjs (nmod)
dysplasia upon (case)
ed50 man (nmod)
theophylline with (case)
received kanamycin (dobj)
incidence true (amod)
hospital multidisciplinary (amod)
response disease (conj)
evidence emerging (amod)
intraperitoneally i.p. (dep)
hamsters three (nummod)
clomipramine or (cc)
lister on (case)
using repeated (conj)
pentoxifylline trental (appos)
pronounced was (cop)
edema complicating (acl)
warn group (nsubj)
rats age- (amod)
g/m2 of (case)
protection in (case)
related nephropathy (nmod)
vessels collateral (compound)
use factor (nmod)
conclusions recognized (dep)
micrograms/ml of (case)
h mcao (nmod)
months survival (nsubj)
appeared stage (nmod)
cardiovascular with (case)
rates higher (amod)
injury cisplatin-induced (amod)
bendrofluazide placebo (conj)
recurarization to (case)
ppa of (case)
administration hydromorphone (dep)
intensified exposure (dobj)
time adenosine (nmod)
have nra0160 (nsubj)
n=35 ( (punct)
metoclopramide , (punct)
neuralgia trigeminal (amod)
movement recorded (acl)
olanzapine ( (punct)
life group (nmod)
detectable sonography (nmod)
bd1018 , (punct)
effect potential (amod)
converted atropine (nsubj)
reverse effect (dobj)
elevated platform (nsubj)
group radiofrequency (compound)
activities kinase (compound)
intervals 8-hourly (amod)
regimen same (amod)
cholesterol in (case)
likely patients (nsubj)
identified " (punct)
exhibits induces (conj)
diagnosis erythematosus (nmod)
method mechanoand (compound)
background improved (dep)
sitting pressure (dobj)
years for (case)
blockade system (nmod)
functional morphologic (conj)
causes doxorubicin (nsubj)
estimated cost (dobj)
normal recur (conj)
dose necessary (amod)
conditions test (compound)
ortral adrenergic (conj)
mesangium the (det)
one more (amod)
were those (nmod)
activity any (det)
d ) (punct)
encountered patients (nmod)
expression mice (appos)
replaced were (auxpass)
pontis posterior (amod)
duration and (cc)
risk hyperkalemia (nmod)
morphine acute (amod)
autonomic and (cc)
% 30.49 (nummod)
observed movement (nsubjpass)
conduction of (case)
proliferation bladder (nmod)
behaviour cssep (nmod)
administration states (compound)
recordings hour (compound)
toxicity association (conj)
long and (cc)
puromycin-aminonucleoside amns (appos)
suitable particularly (advmod)
histories their (nmod:poss)
fraction ) (punct)
day regimen (conj)
performed regardless (advmod)
n-(2-propylpentanoyl)urea of (case)
synapses central (amod)
ultrastructural changes (dep)
severity requirements (conj)
reverses , (punct)
stone the (det)
rheumatology cardiology (conj)
correct single (amod)
hyperemia during (case)
offer , (punct)
group overload (compound)
had medications (nmod)
was evidence (attr)
proportion the (det)
terminals pathway (nmod)
present patient (nmod)
neoplasms diseases (conj)
effects procaterol (nmod)
spironolactone oral (amod)
titer in (case)
98.7 +/- (cc)
produced thereafter (advmod)
findings light (amod)
bevacizumab with (case)
debated is (auxpass)
female 69-year-old (amod)
1997 2001 (conj)
hormone growth (compound)
objective setback (amod)
examined addition (nmod)
astrocytomas to (case)
cells liver (compound)
mania with (case)
reverse presence (nmod)
survey number (compound)
corrected easily (advmod)
saline saline+dmso (appos)
referred is (auxpass)
methotrexate csf (compound)
right to (case)
hypertension mild (amod)
correlated normal (advcl)
responses cholinergic (amod)
n=10 subjects (appos)
induced enanthate (nmod)
those controls (nmod)
1.2 ) (punct)
reflex micturition (compound)
methods examine (advcl)
disease nonmalignant (amod)
prc ( (punct)
pointes including (case)
noted activity (nsubjpass)
microg/ml in (case)
showed increased (conj)
g 5 (nummod)
day eleventh (amod)
drinkers hazardous (amod)
complaints subjective (amod)
possible used (conj)
receptors 5-ht6 (amod)
available children (nmod)
33 to (dep)
severe individuals (nmod)
desensitization to (case)
model one (appos)
background shown (dep)
consumption mitochondria (nmod)
4 except (quantmod)
frequency their (nmod:poss)
extraction : (punct)
toxicity activity (conj)
control nephrotic (conj)
scans failure (conj)
reason important (amod)
anp , (punct)
epidemic caused (acl)
hcrh p (dep)
regimen twice (amod)
prevention topiramate (nmod)
infused surgery (nmod)
% time (nmod)
efficacy to (case)
completion at (case)
seizures both (det)
eating the (det)
induced meth (nmod)
brains beta4 (compound)
recovery hyperglycaemia (nmod)
carotid internal (amod)
had att (dobj)
6 up (advmod)
evaluate determine (advcl)
lower signficantly (advmod)
checked . (punct)
concealed because (mark)
resulted episode (nmod)
respect metabolism (nmod)
group receiving (acl)
increased = (parataxis)
phenytoin lorazepam (conj)
ranged % (nmod)
supervision discontinued (conj)
although drugs (nsubj)
12/32 6/31 (conj)
clipping artery (nmod)
600 between (case)
caused congenita (nsubjpass)
occurred impairment (nsubj)
msec ) (punct)
exhibited induction (conj)
found agitated (xcomp)
dfo ( (punct)
mellitus of (case)
characterized proteins (nmod)
fludrocortisone by (case)
neurobehavioral and (cc)
dysfunction asymptomatic (amod)
blocks to (case)
adrenergic purinergic (conj)
provoked mean (dep)
0.5mg/kg ( (punct)
patients condition (nmod)
patients neutropenia (nmod)
responses functional (amod)
typical ambulant (dep)
preference , (punct)
reports spontaneous (amod)
method an (det)
differentiate complications (dobj)
interval p (dep)
found were (auxpass)
spread weekly (advmod)
lysozyme of (case)
incident patient (nmod)
returned values (nsubj)
conducted attempt (nmod)
level their (nmod:poss)
studied previously (advmod)
none ) (punct)
known hyperkinesias (nsubjpass)
clearance cr(edta (nmod)
support pacing (conj)
period the (det)
useful development (nmod)
trial stroke (compound)
severe ototoxicity (nsubj)
mg/m2 mg/kg (appos)
pseudolithiasis to (case)
irregularities vasculature (nmod)
fulfilled compared (conj)
pericarditis confirmed (acl:relcl)
median with (case)
associated infrequently (advmod)
adsd complication (appos)
scores activities (nmod)
factors known (acl)
induces days (nmod)
volumetric and (cc)
11:30 at (case)
optic emb-induced (amod)
enhance growth (nsubj)
version cued (amod)
treated day (nmod)
cases 570 (nummod)
showed > (dobj)
pallidotomy literature (compound)
response morphine (nmod)
receive amb (dobj)
lexical and (cc)
rigidity alfentanil-induced (amod)
acidosis failure (conj)
find group (nmod)
% 0.05 (compound)
induced which (nsubjpass)
adding infusate (nmod)
malformations asa (nmod)
used voltammetry (dobj)
numbness of (case)
have but (cc)
scale icu (compound)
arise treatment (nmod)
clearance experiments (conj)
reaction hemolytic (amod)
knockout pparalpha (compound)
oncologists and (cc)
complicated arrhythmias (nsubj)
illustrates tool (nmod)
iw ( (punct)
seemed conclusion (dep)
hemoglobinuria transient (amod)
remained tumor-free (xcomp)
aminoglycoside an (det)
antioxidants serum (compound)
besides necrosis (nmod)
changed number (nsubjpass)
interval 1.3 (nummod)
67.2 47.61 (compound)
required however (advmod)
experience longer (amod)
ammonia nh3 (appos)
ballistic choreic (conj)
proteinuria high (amod)
reduced gave (conj)
angina prinzmetal (nmod:poss)
end recruitment (dobj)
rna total (amod)
seen patient (nsubjpass)
cocaine engendered (acl)
causes disease (nsubj)
showed cats (nsubj)
inhibition dose-dependent (amod)
vivo ex (compound)
recognized that (mark)
hypomethylation involving (case)
evaluates effects (dobj)
overdose accidental (amod)
conditions same (amod)
vt ) (punct)
cases seizures (nmod)
immediate but (cc)
age localization (conj)
iopentol after (case)
icv ) (punct)
crocin rats (dep)
effects ccl4 (nmod)
induced sphincter (nsubjpass)
indicated surgery (nmod)
wires pacing (compound)
increased hr (advcl)
done , (punct)
changed domains (nmod)
cultures further (amod)
administration gluconate (nmod)
required treatment (nsubj)
rats developed (acl:relcl)
bradykinin in (case)
university twenty-nine (amod)
patients thalassemic (amod)
formed fraction (nmod)
city the (det)
subsided generally (advmod)
stiffness and (cc)
% ef<45 (compound)
behavior patient (nmod:poss)
receptors h1 (compound)
estradiol and (cc)
anesthesia topical (amod)
is therapy (nsubj)
malignancies infection (nmod)
risk seizures (nmod)
i.v. when (advmod)
amounts blood (compound)
antagonists dopamine (compound)
found increased (ccomp)
functions impaired (amod)
inhibitor dopamine-beta-oxidase (compound)
deficiency pyridoxine (amod)
link to (mark)
pose may (aux)
august through (case)
improves . (punct)
dce of (case)
microbleeds hemorrhage (conj)
determination as (cc)
need reactions (nmod)
exceeding mg. (dobj)
persist defects (nsubj)
antidepressants by (case)
phenacetin of (case)
patients presented (acl)
brain maternal (amod)
presented beginning (advcl)
ip 1 (nummod)
fell , (punct)
elimination radioactivity (nmod)
25mg/kg 50mg/kg (nmod)
majority in (case)
binding high-affinity (amod)
quantities greater (amod)
db khz (nmod)
increase displacement (nmod)
has smoking (nsubj)
option could (aux)
discharged she (nsubjpass)
renin -- (punct)
24 less (amod)
spite barrier (conj)
enos in (case)
interaction from (case)
high . (punct)
using inhibitor (dobj)
treatments many (amod)
concentration plasma (compound)
gyrus left (amod)
ccl4 ( (punct)
therapy estrogen (compound)
50 , (punct)
rs6275 and (cc)
department our (nmod:poss)
cancer renal (amod)
obtained images (nsubjpass)
results were (dep)
dysfunction . (punct)
injections focal (amod)
fibrillation associated (acl)
therapy sirolimus (compound)
amns ps (conj)
db change (nsubj)
, infused (dep)
reduce levodopa- (dobj)
dose micrograms/mouse (appos)
severity manifestations (nmod)
diagnosed got (conj)
different therapeutic (dep)
associated presumably (advmod)
hyperprolactinemia the (det)
reflecting sedation (dobj)
vessels the (det)
possible be (cop)
wanted : (punct)
thought frequency (nmod)
patient one (conj)
400 to (dep)
= pmol (dobj)
restlessness of (case)
investigate methods (nsubj)
mornings postoperative (amod)
is least (nmod)
reduces cardiotoxicity (dobj)
nephrotoxicity vcm-induced (amod)
studies published (amod)
expression mpges-1 (compound)
reduced has (aux)
cromakalim of (case)
response six (conj)
proliferated further (advmod)
completed battery (dobj)
mice msg-treated (amod)
resulted could (aux)
safety echocardiography (nmod)
disease cardiac (amod)
fit taking (conj)
concentrations g/dl (nmod)
anesthetic surgical (conj)
compounds targeting (acl)
diltiazem control (nmod)
mutation this (det)
importance fluoropyrimidines (dep)
paclitaxel company (appos)
placebo compared (case)
toxicity producing (amod)
correlated development (nmod)
abbott-53693 kg-1 (dep)
convulsion to (case)
reversed true (conj)
treatment mitoxantrone (nmod)
methotrexate with (case)
role arf (nmod)
was conduct (xcomp)
hyper- limbs (dep)
rigidity a (det)
toxicity dlt (appos)
seen institution (nmod)
alpha-tocopherol , (punct)
results impairment (appos)
head lateral (amod)
thiamine and (cc)
cancer and (cc)
disorder abuse (compound)
treatment effective (amod)
studied also (advmod)
population women (nmod)
produced damage (nsubjpass)
metabolized acrolein (nmod)
apoptosis myocardial (amod)
resuscitation cardiopulmonary (amod)
tg and (cc)
users the (det)
nigra neocortex (conj)
arterioles glomerular (amod)
reduced effect (nsubjpass)
increases activities (nmod)
dose oxycodone (nmod)
buche ( (punct)
mm control (nmod)
efficient doses (nmod)
system intracarotid (compound)
stretch of (case)
double-blind phase (dep)
rhythm of (case)
has role (dobj)
discontinued omeprazole (dobj)
glaucoma angle-closure (amod)
scores amhs (compound)
cycles 192 (nummod)
scheduled surgery (nmod)
oxc ( (punct)
hypertensive spontaneously (advmod)
perseveration task (nmod)
therapy bridge (conj)
ruled reasons (nsubjpass)
effects levels (nmod)
applicators for (case)
identified transplanted (advcl)
differ did (aux)
et-1 ) (punct)
result antiplatelets (nmod)
associated convulsions (nmod)
% in (case)
receiving tamoxifen (dobj)
glomerular and/or (cc)
phenomenon . (punct)
induced intracerebroventricular (nmod)
resulted mice (nmod)
k ) (punct)
azt mice (conj)
number smaller (amod)
treatment shell (compound)
some which (nmod)
excluded finally (advmod)
case complete (amod)
exposure azathioprine (nmod)
myelosuppression . (punct)
epinephrine of (case)
pan by (case)
resolve change (nmod)
production erythroid (amod)
diminishes that (mark)
concentrations ligation (conj)
smoking maternal (amod)
malignancies patients (conj)
related clotiazepam (nmod)
evolve minority (nsubj)
120.04 16.01 (conj)
enzyme ala539thr (amod)
died week (nmod)
evoked but (cc)
decreased specificity (nsubj)
rats most (amod)
odds ratio (dobj)
consciousness . (punct)
return circulation (nmod)
carcinoma peritoneum (nmod)
hypertension severity (conj)
incidence most (nmod)
activity increase (conj)
channels hcn (compound)
excretion glomerulosclerosis (conj)
documentation liver (compound)
neuropediatrician a (det)
regimen dnr-containing (amod)
side-effect ) (punct)
examined background (dep)
outcomes negative (amod)
base and (cc)
releases potentiates (conj)
cue to (case)
unconjugated rats (nsubj)
weight antioxidants (appos)
results described (acl)
age to (case)
introduction or (cc)
resulted isoproterenol (nsubj)
performed has (aux)
induction syndrome (nmod)
patient woman (dep)
increase use (nmod)
abusers methadone-maintained (amod)
indicates this (nsubj)
influence decrease (nmod)
garft ) (punct)
capnocytophaga brevibacterium (conj)
tachykinins nerves (nmod)
interfere treatment (nmod)
abnormalities conduction (compound)
secretion cortisol (nmod)
valdecoxib ) (punct)
ca3 and (cc)
diagnosed symptoms (nsubjpass)
increased had (aux)
decrease an (det)
was injection (nmod)
inhibitor cyp3a4 (compound)
stage for (case)
controlled may (aux)
people hiv (nmod)
effects well-documented (amod)
remained activation (nmod)
rats these (det)
surface hot (amod)
frequently am149 (nmod)
difference agents (nmod)
change caused (conj)
three to (quantmod)
keratectomy of (case)
independent additive (conj)
cox-2 , (punct)
best to (aux)
smaller externa (nmod)
pretreatment catatonia (nmod)
hours . (punct)
isoproterenol delivered (acl)
vector reporter (compound)
ck-mb index (nmod)
20- 40-micrograms/kg (conj)
understood epidemiology (nsubjpass)
levels valproate (compound)
other the (det)
patients pregnancies (conj)
protects hepatotoxicity (nmod)
activation mglu7 (compound)
alternative first (amod)
activities locomotor (compound)
hydrocortisone sed (dep)
administration apomorphine (nmod)
lacks sirolmus (nsubj)
enhanced and (cc)
vegf/vpf ( (punct)
searches biliary (amod)
t-tests one-tail (amod)
times/week month (nmod)
events occur (acl:relcl)
treatment arthritis (nmod)
evaluate treating (advcl)
culture a (det)
target inhibitor (nmod)
discussion first (amod)
associated observed (parataxis)
ibpb ) (punct)
% to (mwe)
indicated developed (advcl)
brains rats (nmod)
milrinone such (case)
beta-blocking and (cc)
discrimination allelic (amod)
dhea ( (punct)
receiving desipramine (dobj)
w. b. (compound)
signs posture (nmod)
points : (punct)
development effects (nmod)
resolved again (advmod)
parkinson the (det)
recognized toxicity (nsubjpass)
suggested increased (xcomp)
% 42 (compound)
investigating preventing (advcl)
arrhythmogenicity of (case)
intervals long (amod)
prevent nor (cc)
substituted received (advcl)
model same (amod)
glomerulosclerosis as (cc)
centre florence (appos)
increased sodium (nsubj)
examined cytometry (nmod)
strategy population (nmod)
achieved procedure (nmod)
lesions abnormalities (nmod)
nitroglycerin after (case)
risk highest (amod)
use continuous (amod)
efficacy antihypertensive (amod)
carcinogen and (cc)
disease fatty (amod)
scores severity (nmod)
0.001 < (compound)
fractions to (case)
contributed delta22-isomer (nsubj)
determine cause (dobj)
dysfunction cardiac (amod)
syndrome and (cc)
follow-up her (nmod:poss)
presence and (cc)
action but (cc)
patients consenting (amod)
14c]sodium - (punct)
occurred finally (advmod)
day through (case)
perfusion kidney (compound)
papaverine treatment (nmod)
fasciculation those (nmod)
six = (parataxis)
injections intracavernous (amod)
cases colitis (nmod)
counts on (case)
tri ) (punct)
thrombocytopenia including (case)
patients history (nmod)
administration antigen (nmod)
reactions carbamazepine (nmod)
improvements fever (nmod)
1.39 . (punct)
present years (conj)
hexachloride alpha-benzene (amod)
5 , (punct)
determination at (case)
summated score (nmod)
used currently (advmod)
indicated score (nmod)
min 300 (nummod)
tended become (xcomp)
uncertainty norms (nmod)
patients fifty-one (nummod)
sec 60 (nummod)
techniques of (case)
methods analysis (conj)
risk augmented (amod)
safety yohimbine (nmod)
neurons commissure (nmod)
glucagon intravenous (amod)
chloroform- and (cc)
hemorrhage warfarin-induced (amod)
piglets in (case)
metabolites than (dep)
major bleeding (dep)
disorder lymphoproliferative (amod)
higher rats (nmod)
30 1 (compound)
find able (ccomp)
score z (compound)
% 76 (nummod)
shr untreated (amod)
efficacious be (cop)
reversible cessation (nmod)
normalization , (punct)
ead of (case)
sensitivity convulsant (amod)
repaired was (auxpass)
aminonucleoside acute (amod)
symptom eps (appos)
atropine furosemide (conj)
records year (nmod)
threshold mean (amod)
remifentanil of (case)
hexachloride 500 (nummod)
mg/m(2 at (case)
years c(max (conj)
meta-analysis the (det)
necrosis onset (nmod)
levels creatine (compound)
alters excitability (dobj)
became noticeable (acomp)
instrumented tubes (nmod)
fanft ( (punct)
= % (dep)
second during (case)
compliance were (cop)
a not (cc)
olanzapine by (case)
proven relationship (nsubjpass)
strains carriers (nmod)
held florence (nmod)
took patient (nsubj)
injection cy (compound)
neck bladder (compound)
long too (advmod)
sustained tachycardia (dobj)
injury glomerulosclerosis (conj)
correlation intraclass (compound)
corresponded hepatotoxicity (xcomp)
evident involved (advcl)
therapy administered (amod)
effect structure (nmod)
scores parkinsonism (nmod)
responses complete (amod)
stimulate administration (nmod)
lead will (aux)
degree marked (amod)
patients caused (acl:relcl)
users intravenous (amod)
models ordinal (amod)
p .05 (nummod)
p300 , (punct)
confusion : (punct)
exclusion for (case)
nephrosis the (det)
associations disease (nmod)
noted has (aux)
neurotoxicity neurotoxicity (nsubj)
patients ambulatory (amod)
iddm ( (punct)
urine ph. (dep)
cocaethylene however (advmod)
affect ethambutol (nsubj)
verapamil both (det)
describe patients (dobj)
surgeries trabeculectomies (conj)
reached gemfibrozil (dep)
2-adrenoceptors beta (compound)
phosphorus of (case)
failed infusions (nsubj)
rate effects (nmod)
hc ( (punct)
arthritis acute (amod)
arrest precipitous (amod)
aminonucleoside in (case)
reflect symptoms (dobj)
had evaluation (dobj)
exhibited mitochondria (nsubj)
restricted is (cop)
calculated longitudinal (nsubjpass)
assess safety (dobj)
sf36 ( (punct)
dcf with (case)
reduction controls (nmod)
1.0 trend (nmod)
incidence % (dep)
conclusions associated (appos)
stroke amphetamine (conj)
biopsy muscle (compound)
cognitive , (punct)
research system (nmod)
dexmedetomidine agonist (compound)
experienced akathisia (dobj)
utility clinical (amod)
disorientation and (cc)
drugs statins (nsubj)
donors in (case)
play contribute (advcl)
suspected neuropathy (nsubjpass)
etoposide to (mark)
dose tested (acl)
zuclopenthixol mg/day (appos)
used model (nsubjpass)
common abusers (nmod)
documented neurotoxicity (nsubjpass)
combination ribavirin (nmod)
d2 at (case)
mazindol , (punct)
reported risk (nsubjpass)
procedure oral (amod)
have influence (dobj)
received daily (advcl)
days gy/30 (amod)
woman 73-year-old (amod)
beta both (cc:preconj)
weeks dex (conj)
chemotherapy using (acl)
hemorrhage aneurysmal (amod)
symptoms unexplained (amod)
% 56 (nummod)
increases frequency (dobj)
oxidation ob (nmod)
life due (case)
voltammetry and (cc)
responses 4 (nummod)
7 6 (conj)
15 nearly (advmod)
phosphorylation increased (amod)
changes tract (nmod)
determined conclusions (dep)
leukaemia for (case)
had lidocaine (dobj)
observed . (punct)
penicillamine by (case)
observe time (nmod)
rate patients (appos)
inhibition protease (compound)
tachyarrhythmia report (dep)
function central (amod)
prevents deficits (dobj)
leading areas (nmod)
elucidating factors (dobj)
infectious autoimmune (conj)
30 over (quantmod)
investigating inflammation (dobj)
compound of (case)
cystitis delayed (amod)
becomes marked (xcomp)
fviiirag ( (punct)
2c not (cc)
ergotamine/caffeine on (case)
cimetidine after (case)
trend time (nmod)
discontinued , (punct)
bromperidol with (case)
biopsy renal (amod)
feet the (det)
have because (mark)
achieved level (nmod)
difficult was (cop)
dobutamine after (case)
circulation rats (conj)
rates scr (nmod)
use processes (nmod)
carcinoma therapy (nmod)
correlated age (nsubjpass)
possible separate (xcomp)
2.6-fold weeks (nmod)
occurrence their (nmod:poss)
deep either (cc:preconj)
sides both (det)
baseline -0.58 (conj)
carcinoma invasive (amod)
signs only (amod)
filariasis loa (compound)
closest tolerance (nmod)
leucovorin regimen (appos)
assigned groups (nmod)
passage transepithelial (amod)
aware adding (advcl)
defined role (nsubjpass)
11.5 +/- (cc)
acting preferentially (advmod)
activity content (conj)
detected urine (nmod)
animals cells (nmod)
case cimetidine (nmod)
methotrexate hd-mtx (appos)
investigate effects (dobj)
appearance kidneys (nmod)
side-effects serious (amod)
evoked whether (mark)
development hypertrophy (nmod)
studied , (punct)
phosphatase alkaline (compound)
anesthetics to (case)
factors blood (compound)
surface ventrolateral (amod)
lower . (punct)
l. of (case)
cause failure (conj)
number received (acl)
zuclopenthixol lithium (conj)
dianabol ciba (appos)
nitroprusside over (case)
doses incremental (amod)
subjects treated (acl:relcl)
test locomotion (nmod)
predominate to (mark)
histology the (det)
reflects expression (nsubj)
histology by (case)
nimodipine administered (acl)
sex . (punct)
recovered had (aux)
comparison a (det)
stimulation high-frequency (compound)
tip the (det)
histology in (case)
men healthy (amod)
outpatients adult (amod)
ne basd (compound)
reduction 320/25 (nmod)
neonates children (conj)
scopolamine antimuscarinic (amod)
incidence because (case)
well generally (advmod)
activities england (compound)
known have (aux)
administered resection (nmod)
aggravate can (aux)
plasma to (case)
micrograms/day of (case)
caused increasing (advcl)
demonstrate present (ccomp)
led . (punct)
anesthesia with (case)
receiving thorazine (dobj)
induction transplantation (nmod)
consolidation dysfunctional (amod)
groups paracetamol-treated (amod)
administration intramedullary (amod)
cure transplantation (nmod)
conclusions . (punct)
incidence . (punct)
hcfc ) (punct)
profile 12-week (dep)
178 - (punct)
retention for (case)
analysis one-way (amod)
relationship and (cc)
predictive is (cop)
exposed cacl(2 (nmod)
observed prolongation (nsubjpass)
ziprasidone reported (acl)
history grafting (nmod)
array multielectrode (compound)
recognise believe (conj)
= ns (dobj)
objective review (dep)
hyperthermia as (cc)
diagnosed method (nmod)
arrhythmia bradycardia (conj)
treatment is (cop)
particles red (nmod)
suggested animal (nsubj)
lnna the (det)
decreased time (dobj)
severity varying (amod)
progressive cardiomyopathy (dep)
group pressure (appos)
have ability (dobj)
presented patient (nsubjpass)
accompanied . (punct)
consumption mitochondrial (amod)
high remarkably (advmod)
examine relation (dobj)
history underlying (advcl)
suggested injury (dobj)
cb than (case)
known and (cc)
isoproterenol 100mg/kg (appos)
department fibrillation (nmod)
canine in (case)
g-1 tissue (nmod)
resulted increases (conj)
% 48.7 (nummod)
effects ritodrine (nmod)
levodopa to (case)
cortices surrounding (amod)
agent detect (acl:relcl)
benefits only (amod)
results respect (nmod)
analyzed and (cc)
disorders spectrum (compound)
deficient a (det)
dph phenytoin (compound)
prevention or (cc)
indicate contributes (ccomp)
programs hypertension (dep)
identifying genes (dobj)
attempted was (auxpass)
analgesic significant (amod)
intermediate a (det)
knife and (cc)
provocation symptom (compound)
have channels (nsubj)
rigidity agent (nmod)
response cardiovascular (amod)
symptoms aggravate (compound)
test assay (nsubj)
weeks q (det)
took disorder (nmod)
reported associated (xcomp)
success the (det)
protrusion observed (acl)
cases adenomyosis (nmod)
4.8 2.0 (conj)
cessation after (case)
differences performance (nmod)
experience may (aux)
chow e-fortified (amod)
3.5 to (dep)
movements jerking (amod)
binding system (nmod)
hypertrophy cellular (amod)
patients 46 (nummod)
csa indications (nsubj)
present arrhythmia (nsubj)
nephrotoxicity associated (acl)
submitted acquisition (nmod)
tumors the (det)
placebo for (case)
segments appeared (acl:relcl)
cco-i ( (punct)
mg 50 (compound)
numerous more (advmod)
fluconazole , (punct)
1.56 - (punct)
enos c-type (conj)
significant = (dep)
examined are (auxpass)
occurrence hypertension (nmod)
new . (punct)
available preparations (nsubj)
osteoid woven (amod)
danger potential (amod)
bche ( (punct)
p2x3 antagonists (conj)
cent patients (nmod)
unresponsive when (advmod)
excreted is (auxpass)
name antibiomania (dobj)
startle baseline (nsubj)
retention pan-induced (amod)
assumed . (punct)
trial 8-week (amod)
extremities paralysis (conj)
factor women (nmod)
followed 1984 (nmod)
supply improved (amod)
17 to (dep)
collagenase low-dose (amod)
rats mellitus (nmod)
looking sessions (nmod)
common well-known (dep)
risk latent (amod)
involved regulation (nmod)
interest case (nsubj)
presented one (nsubj)
accounting exposure (nmod)
results tachycardia (nsubj)
use inappropriate (amod)
toxicity induced (amod)
meritorious are (cop)
design repeated (amod)
agents generation (compound)
patients except (case)
independent lines (nmod)
exhibited combinations (nsubj)
39+/-10 18+/-5 (conj)
sulfate morphine (compound)
variable is (cop)
activity documented (amod)
ml.s-1 145 (nummod)
infection an (det)
assess . (punct)
1.44+/-0.6 vs. (cc)
results changes (appos)
epileptogenic and (cc)
clearance cyp3a4-mediated (amod)
content release (conj)
upper lower (conj)
reports preliminary (amod)
profile cortisol (compound)
norway in (case)
sleep an (det)
oil 15mg/kg (dep)
abundance total (amod)
shown influence (xcomp)
rhythm . (punct)
fractionated in (case)
rbf in (case)
prodrug 5-fu (nmod)
10 or (cc)
co. attempt (nmod)
segments with (case)
decreased putamen (nmod)
400 450 (conj)
resolved spontaneously (advmod)
loss subsequent (amod)
and identically (advmod)
cells mmq (compound)
underwent night (dobj)
frequency as (cc)
regimen antiretroviral (amod)
treatment diseases (nmod)
abilities analogs (nmod)
received papaverine (dep)
inhibition synthase (compound)
failed haloperidol (nsubj)
studies quantitative (amod)
died injection (nmod)
dexmedetomidine acting (acl)
units at (case)
chromosomes 10 (nummod)
lesions by (case)
study preliminary (amod)
time te (appos)
incidence therapy (dep)
htr6 in (case)
hemolysis ribavirin-induced (amod)
stimulation tonic (amod)
age- sex-matched (conj)
establish effect (dobj)
24 least (nmod:npmod)
eyes subjects (nmod)
networks channels (nmod)
applied topically (advmod)
lt emergent (amod)
measure effects (nmod)
provide information (dobj)
alterations hypaque (advcl)
arrhythmias the (det)
mtd schedule (nmod)
selecting by (mark)
socs-3 on (case)
discuss as (advmod)
showed features (dobj)
facilitate may (aux)
half-time t1/2 (appos)
area mg/sq (compound)
groups trial (nmod)
potentials visual-evoked (amod)
infusion ritodrine (nmod)
profile excellent (amod)
measured days (dobj)
cardiotoxicity (adr)-induced (punct)
trials nineteen (nummod)
increase tropicamide-induced (amod)
pharmacokinetics formulation (nmod)
received clioquinol (dobj)
prevalence hosts (nmod)
system reticuloendothelial (compound)
appeared also (advmod)
doses valdecoxib (compound)
1.9 0.5 (conj)
advantageous introduction (nsubj)
antagonists a2a (compound)
cured were (auxpass)
month 12 (nummod)
artery hemodynamics (conj)
had abnormalities (dobj)
17 up (advmod)
family bcl-2 (compound)
prevent reverse (conj)
eleven abusers (nmod)
receptors nmdars (appos)
dose oral (amod)
achieve curve (nmod)
went . (punct)
areas available (dep)
patients paroxetine (dep)
alpha-blocker as (case)
diameters segments (conj)
isoproterenol of (case)
displayed seemed (conj)
responses distinct (acl:relcl)
noted postimplant (conj)
result would (aux)
meth cascade (nmod)
increase unacceptable (amod)
merits treatment (nsubj)
factor be (cop)
induced l-norepinephrine (nmod)
admitted insomnia (nmod)
proven safe (xcomp)
delay dose-dependent (amod)
enzymes other (amod)
drug illicit (compound)
mg 117 (dep)
titrated up (compound:prt)
malformation dysplasia (nsubj)
reducing stress (dobj)
come . (punct)
period followed (acl)
csa chronic (amod)
developed chemotherapy (nmod)
measurement regular (amod)
chemistry serum (compound)
increases mrna (nmod)
escalation etoposide (compound)
0 7.5 (conj)
cardioprotection cardiotoxicity (nmod)
developed pronounced (conj)
deletion or (cc)
night the (det)
grade nausea (dep)
group disease (compound)
analyzed samples (nsubjpass)
model multiple (amod)
eliminated that (nsubjpass)
patients registered (acl:relcl)
synergy d (nmod)
variables these (det)
block voltage- (dobj)
disorder schizoaffective (amod)
hypertension experimental (amod)
flow bile (compound)
autoimmunity of (case)
children additional (amod)
vestibular central (conj)
weeks re-started (acl:relcl)
given bolus (nmod)
arthritis pyrexia (conj)
modified significantly (advmod)
detected 19 (nmod)
damage inflammatory (amod)
downregulated . (punct)
share because (mark)
present which (nsubj)
prompt treatment (dobj)
considered accumulation (nsubjpass)
of and (cc)
rigidity muscle (compound)
globulin intramuscular (amod)
hepatomegaly , (punct)
changes vigabatrin-associated (amod)
markers fibrinolysis (nmod)
50 1 (compound)
statistics cocs (nmod)
phenomenon lethal (amod)
safety on (case)
satisfaction overall (amod)
ci 1.131 (nummod)
determined imaging (nmod)
10 6 (compound)
(5.3)% ( (punct)
escape day (nmod)
synthesis assessed (dep)
kg(-1 30 (nummod)
reduced magnitude (dobj)
woman 54-year-old (amod)
diminishes . (punct)
effect antiangiogenic (amod)
shown reduces (ccomp)
dyskinesias in (case)
evidence no (det)
result symptoms (nsubj)
level ( (punct)
doxorubicin adriamycinone (conj)
atrophy , (punct)
nerve recurrent (amod)
growth to (case)
i.p. rats (nmod)
synthase endothelial (amod)
influence neurotransmission (nmod)
hallmark a (det)
decreased had (conj)
sex dose (conj)
beneficial adverse (conj)
leads result (conj)
compared olanzapine (nmod)
remainder n (dep)
= 58 (dep)
scale drug (compound)
epicondyle the (det)
unpaired ) (punct)
measurements sodium (nmod)
d etoposide (nmod)
two just (advmod)
fall rate (nmod)
third day (nmod)
days treatment (nmod)
elucidate . (punct)
minimizing dysfunction (dobj)
administration vitamin (compound)
striatum from (case)
parachlorophenylalanine with (case)
activation ic (nmod)
ptz ) (punct)
consistent impairment (nmod)
atropine mug (appos)
addition increases (nmod)
bmd trabecular (amod)
advantages sulindac (nmod)
episode seizure (nmod)
dysrhythmias occurred (acl:relcl)
indicating need (dobj)
29.5 +/- (cc)
sodium phenytoin (amod)
varies . (punct)
possibility reproducing (acl)
mg compared (case)
% ci (dep)
helpful so (mark)
probe a (det)
45 to (dep)
congenita myotonia (compound)
prevalence groups (nmod)
describes toxicity (dobj)
suggested evidence (nsubj)
study objective (nsubj)
features intake (nmod)
bred lines (nsubjpass)
sensitive unusually (advmod)
treatment antifibrinolytic (amod)
data seizures (nmod)
permanente northern (nmod)
group sc (compound)
formulation a (det)
damage brain (compound)
moderate from (case)
suggesting lack (dobj)
acts mice (nmod)
episodes anuria (nmod)
suffering damage (nmod)
efficacy favorable (amod)
acid paclitaxel (conj)
partial . (punct)
efficient addition (nsubj)
risk patient (nmod)
affected sod (nsubj)
1100 over (advmod)
addition tizanidine (nmod)
fq nocistatin (conj)
clonidine including (case)
administered monoher (nsubjpass)
micrograms/ml ( (punct)
scintigraphy quantitative (amod)
analogues 8-se (conj)
carcinoma primary (amod)
number participants (nmod)
1,1-dichloro-2,2,2-trifluoroethane 1-chloro-1,2,2,2-tetrafluoroethane (conj)
acetate medroxyprogesterone (compound)
project the (det)
prior after (conj)
characterized ( (punct)
type this (det)
deposition medulla (nmod)
restricted food (nsubj)
withdrawn treated (conj)
measurement for (case)
defective nephrosis (nmod)
injection cp (compound)
procedure a (det)
maintained flow (nsubjpass)
dogs these (det)
determinant symptoms (nmod)
developed effects (dobj)
health good (amod)
metabolite hepatic (amod)
cancer treated (acl)
cost of (case)
-16.2 ) (punct)
considered result (nsubjpass)
areas centrilobular (amod)
patient remaining (amod)
dismutase superoxide (compound)
treatment rizatriptan (nmod)
black caucasian (conj)
treated suffered (conj)
compares lidocaine (nmod)
nausea h (nmod)
institution treatment (nmod)
women supplementation (dep)
motif ( (punct)
maximal stable (conj)
exception vsd (nmod)
patients 76 (nmod)
current or (cc)
administration fda (appos)
attenuate that (mark)
sessions three (nummod)
tests stimulation (conj)
received home (nmod)
filtration of (case)
intervention feeding (acl)
inhibition enzyme (nmod)
pretreatment other (amod)
dose ltg (compound)
had fluctuating (advcl)
tacrolimus mmf (conj)
rats lesioned (amod)
pursued should (aux)
administration fr (nmod)
abatement symptoms (nmod)
presented paresthesia (conj)
thrombosis spontaneous (amod)
decrease mitochondria (nmod)
hypotension function (nmod)
produced hypertension (nsubjpass)
cystourethrogram a (det)
jerks min (nmod)
demonstrated recently (advmod)
fever for (case)
cells b3 (compound)
cent and (cc)
lna ) (punct)
contributes prevention (dep)
inputs system (nmod)
cisplatin by (case)
allowed self-dosing (dobj)
abundance alpha(1)-subunit (nmod)
alterations properties (nmod)
started valproate (nmod)
mechanism sensitivity (nsubj)
monotherapy n (dep)
fraction lvef (appos)
mechanism could (aux)
consistent indicating (xcomp)
/-s.d . (punct)
binding alpha-bungarotoxin (compound)
observed hepatotoxicity (nmod)
one administered (acl)
deteriorates performance (nsubj)
10.1 +/- (cc)
virus disease (conj)
eight and (cc)
observed naturally (advmod)
degeneration cells (nmod)
bp ( (punct)
potassium two (nummod)
% 88.3 (nummod)
seizures local (amod)
cultures ganglion (nmod)
hematocrit her (nmod:poss)
detection sensitization (nmod)
passage lacn (nmod)
ly274614 acid (appos)
potentiation impaired (acl)
contributes suggests (advcl)
changes cardiotoxic (amod)
discriminate to (mark)
conners ' (case)
complete partial (conj)
dogs group (nmod)
separation growth (nmod)
fpd ( (punct)
involved may (aux)
had 21 (nsubj)
intensified that (mark)
access h (conj)
period hypoglycaemia (nmod)
gradient , (punct)
water drinking (compound)
loading sodium (compound)
hydrochloride ester (compound)
normalized recovery (nmod)
target a (det)
methotrexate plasma (nsubj)
7-ni ( (punct)
developed nausea (dobj)
animals pentylenetetrazole-induced (amod)
obtained acid (nmod)
onset facial (nmod)
injection dysphonia (nmod)
course patient (nmod:poss)
blockers with (case)
disease wilson (compound)
induced microm (nmod)
group tiopronin (compound)
trees fruit (compound)
treatments intervals (nmod)
action atropine-like (amod)
changes distribution (conj)
changes tgf- (nmod)
gastrocnemius and (cc)
creatinine increased (amod)
required clearly (advmod)
rats 38 (nummod)
nausea no (det)
schizophrenia in (case)
widow taiwanese (amod)
effect fanft (nmod)
muscimol of (case)
noted administration (nmod)
surgery or (cc)
understood proposed (advcl)
suggested symptoms (nsubj)
m(1)/m(3)/m(5)-selective ' (punct)
20 ( (punct)
enhance . (punct)
reproduced , (punct)
achieved level (nsubj)
sampled shortly (advmod)
resistance foot (nmod)
loss some (det)
effect cirrhosis (nmod)
toxicity thalidomide (nmod)
sex use (conj)
phonophobia photophobia (conj)
studied autopsy (conj)
does increase (dobj)
abnormalities infiltrates (conj)
exposure sunburn (conj)
brought activity (nmod)
echocardiography doppler (compound)
conclusion . (punct)
comparisons no (neg)
regimen (dnr)-containing (compound)
chicks coniine-treated (amod)
progress treatment (nsubj)
left hemiparesis (dobj)
excessive concentrations (nsubj)
group iodixanol (compound)
mg/dl. 17.0 (nummod)
analysis trial (nmod)
% 29.6 (nummod)
sirolmus the (det)
setting purposes (nmod)
ototoxicity nephrotoxicity (conj)
period - (punct)
day<10 ) (punct)
injected been (auxpass)
inhibited appearance (nsubjpass)
wernicke 's (case)
grade patients (conj)
developed of (case)
origin and (cc)
development insufficiency (nmod)
gf ( (punct)
absence even (advmod)
pain whose (nmod:poss)
atrial and (cc)
preceded manifestations (nmod)
treated tablets (conj)
ng.ml-1 , (punct)
use angina (nmod)
attack itself (appos)
demonstrated possibility (nsubjpass)
effects ratings (nmod)
stimulation rtms (appos)
show finally (advmod)
caused mechanism (nmod)
placebo propranolol (nmod)
elevated observed (advcl)
model interesting (amod)
obtaining after (mark)
comprised patients (dobj)
treatment state (nmod)
24.3 versus (cc)
bortezomib combination (nmod)
patient this (nsubj)
preserved dose (nmod)
ml lignocaine (nmod)
beats ventricular (amod)
disorder attention-deficit/hyperactivity (compound)
apparent effects (nsubj)
product new (amod)
80 and (cc)
levodopa between (case)
0.007 ) (punct)
incapacitated stimulations (nmod)
striatum concentrations (nmod)
anemia coombs-positive (amod)
case tdp (nmod)
monkeys ) (punct)
coxon by (case)
impairment for (case)
role poisoning (nmod)
outcome long-term (amod)
available reverse (xcomp)
that phospholipid (nmod)
induced weaning (advcl)
combination c (nmod)
limitations . (punct)
produced application (nmod)
investigated defects (dobj)
action significant (amod)
therapy haart (appos)
contaminated derivative (nmod)
host the (det)
stimulated concentrations (nmod)
was up-regulation (attr)
causes therapy (nsubj)
retrieved patients (nmod)
colorectal and (cc)
a nearly (advmod)
patient 23-year-old (amod)
segments for (case)
amiodarone mg/kg (nmod)
mole phosphorylcreatine (compound)
pancreatitis including (case)
group p (dep)
taken she (nsubj)
attenuated partially (advmod)
non-alcoholic in (case)
% 2.7 (nummod)
used analysis (nmod)
event a (det)
lesions active (amod)
incidence tumours (nmod)
event rare (amod)
20 % (dep)
incidence nephrotoxicity (nmod)
regulated are (auxpass)
cortex bilateral (amod)
decreased leg (nmod)
of " (punct)
drugs epileptogenic (acl:relcl)
report published (amod)
instance with (case)
alternative to (mark)
conclusive not (neg)
assessed incidence (dobj)
deprivation by (case)
essential is (cop)
ecgs with (case)
tdi after (conj)
low even (advmod)
speculated . (punct)
potentiation arrhythmia (nmod)
produce returned (advcl)
ha ) (punct)
leukemia nervous (amod)
controls intervals (nmod)
subjects suprofen-exposed (amod)
gyrus in (case)
independent : (punct)
prophylaxis the (det)
internus gpi (appos)
diameter of (case)
g/ml % (appos)
d by (case)
tobramycin patients (dep)
actives models (nmod)
bronchodilator ipratropium (nsubj)
showed hours (nmod)
thromboembolism , (punct)
7.5 or (cc)
sexual functioning (acl)
induced doses (nmod)
found intake (nsubjpass)
defined compared (dep)
measured estimated (conj)
stain exudate (nmod)
injection daily (amod)
evolution infarction (nmod)
diffusion with (case)
mineralizes which (nsubj)
tna of (case)
therapy safe (amod)
ability prevent (acl)
intolerance photodermatitis (conj)
enalapril significantly (advmod)
tumor small (amod)
were cases (attr)
abolish pretreatment (nsubj)
nitrate isosorbide (compound)
markers cm (nmod)
74 - (punct)
respect use (nmod)
examined expressions (nmod)
patients males (dep)
conclusions and (cc)
behavior time (appos)
flow asymmetric (amod)
viracept the (det)
drug acetate (nsubj)
results those (nmod)
activity between (case)
needed studies (nsubjpass)
cimetidine 6 (conj)
impairment increased (amod)
nitrogen patients (nmod:poss)
% 89.7 (nummod)
thrombosis for (case)
desire low (amod)
allowing therapy (dobj)
study 8-week (amod)
% 20.2 (nummod)
% for (case)
implicated bromocriptine (nsubjpass)
mini-pump alzet (amod)
increase score (dobj)
determined also (advmod)
dysregulation ) (punct)
apparatus avoidance (compound)
combination monotherapy (nmod)
gt/bc ( (punct)
involved variety (nsubjpass)
chloramphenicol or (cc)
clinically values (conj)
rats all (det)
relevant therapy (nmod)
i.p. ( (punct)
n/n=9/26 , (punct)
potentiates metamizol (nsubj)
administered sequences (nmod)
effect hydrochloride (nmod)
trial treatment (nmod)
caused mice (nmod)
report amount (dobj)
results measurements (nsubj)
macrophages numerous (amod)
intervals subsequent (amod)
commonly recipients (nmod)
affecting any (dobj)
incident a (det)
support role (dobj)
correlates . (punct)
needle pencil-point (amod)
comparable conclusions (dep)
assessed assessed (advcl)
compounds three (nummod)
evaluated group (nsubjpass)
synthesis nitric-oxide (amod)
transplantable hamsters (nmod)
scans pretransplant (amod)
october november (nmod)
ic % (compound)
mg/dl ) (punct)
increased mcpp (nsubj)
variety and (cc)
effects postulated (amod)
activities gammaglutamyltransferase (compound)
formation body (compound)
indicated induce (ccomp)
mapping body (compound)
carbimazole following (case)
al. et (compound)
impaired acquisition (nsubj)
ige ) (punct)
steps increased (acl:relcl)
worsening valvulopathy (advmod)
role mechanistic (amod)
have relevance (dobj)
went hospitalizations (nmod)
pathway bulbospinal (amod)
real and (cc)
carried determined (conj)
administration morphine (amod)
tightness chest (nmod)
d nelarabine (nmod)
value of (case)
acid simvastatin (amod)
suggests mechanisms (dobj)
group lidocaine (compound)
option as (case)
measures variability (nmod)
compared min (nmod)
monitored samples (nsubjpass)
induces background (dep)
tested autoantibodies (nmod)
phosphate mg/kg (conj)
blockers two (nummod)
morning and (cc)
dose resulted (acl:relcl)
p risperidone (conj)
patients 9/106 (appos)
cholestatic ( (punct)
affected investigated (conj)
conditions required (acl:relcl)
therapy isoniazid (compound)
using radioimmunoassay (conj)
diameter mm (nmod)
known background (dep)
tests evaluations (conj)
hawthorn oxycantha (dep)
binding covalent (amod)
levels toward (case)
month delivery (nmod)
ml/min from (case)
received hours (nmod)
g/dl 10.2 (nummod)
progestagen of (case)
increased gaba (dobj)
lost improvement (nsubjpass)
correlated symptoms (nsubjpass)
continue discontinue (conj)
receiving l-dopa (dobj)
dg-5128 the (det)
mg/kg/day 30 (nummod)
replication viral (amod)
angiodegeneration ( (punct)
demonstrates conclusion (nmod)
ranges that (mark)
or=13.807 , (punct)
palsy a (det)
undescribed previously (advmod)
5-httlpr using (acl)
attributable activation (nmod)
mandates cessation (dobj)
delivered where (advmod)
apparent was (cop)
increasing associated (advcl)
clinical on (case)
eight in (case)
torr 94 (nummod)
excess formation (nmod)
reactivation of (case)
regard , (punct)
cardiac with (case)
n of (case)
time thromboplastin (compound)
instillation the (det)
imbalance nitric (amod)
patients lid (nmod)
reduced felt (ccomp)
ptz by (case)
dynamics related (amod)
reverses : (punct)
enhancement images (nmod)
91.5 recalled (conj)
were terms (nmod)
changed immunoreactivity (nsubjpass)
episode recurred (xcomp)
mmol/day ) (punct)
vasodilatation receptors (nmod)
suppressants with (case)
designed block (xcomp)
action be (cop)
results identified (dep)
examination electrocardiogram (conj)
monotherapy % (appos)
contraceptives containing (acl)
prominent contrast (nmod)
criteria use (nmod)
cortex cerebellum (conj)
changed dramatically (advmod)
has action (dobj)
associated doses (nmod)
investigated injection (nsubjpass)
compressions cardiac (amod)
syndrome svc (compound)
provide profile (dobj)
levodopa off (compound)
coronary or (cc)
dose hypokalemia (conj)
clozapine risperidone (conj)
induction anesthesia (compound)
slc in (case)
atherosclerosis intima (amod)
toxicity tubular (amod)
judged hepatotoxicity (nsubjpass)
done : (punct)
oxidase implicated (acl:relcl)
ability apparent (amod)
ototoxicity from (case)
safety extended-release/lovastatin (nmod)
role phase (nmod)
required infusion (dobj)
therapy full (amod)
inhibition enzyme (compound)
effect attenuating (amod)
reserpine mg/kg (dep)
consistent reached (conj)
study electrodiagnostic (amod)
developed jaundice (dobj)
parameters hemodynamic (amod)
contralaterally predominantly (advmod)
injury ischemia-reperfusion (compound)
pretreatment , (punct)
presentation anxiety (conj)
monitored output (nsubjpass)
meet patients (nsubj)
decreases injections (nmod)
hepatocellular criteria (dep)
ongoing aim (nmod)
deviation /-standard (compound)
data acquired (acl)
static hyperalgesia (dep)
levels aorta (nmod)
symptoms oab (compound)
spine lumbar (compound)
accentuated was (auxpass)
standing with (case)
revealed heads (dobj)
transcription production (conj)
nad substrate (amod)
25/100 or (cc)
fibrillation disease (nmod)
represented abnormalities (dobj)
scored animals (nmod)
lipid by (case)
high determining (advcl)
tolerance acid (nmod)
loss axons (nmod)
depends nor (cc)
have insipidus (dobj)
l-365,260 i.c.v (dep)
prevention cvd (nmod)
model ich (nmod)
event critical (amod)
find . (punct)
them of (case)
aneurysms and (cc)
evidence current (amod)
improves microinjection (nsubj)
training 10h (conj)
induced aminonucleoside (nmod:npmod)
2 48 (conj)
recognised is (auxpass)
drugs inhibit (acl:relcl)
normal more (dep)
switches of (case)
temperature nociception (conj)
syncope was (cop)
arteries ) (punct)
cure it (dobj)
increase cause (conj)
ethinyloestradiol 1.18 (conj)
similar rate (nsubj)
initial manifestation (dep)
tolerability renal (amod)
% extent (nsubj)
hypotension after (case)
basis fibers (nmod)
score than (case)
maintaining preparedness (dobj)
included agents (nsubj)
succumbed he (nsubj)
pretreatment 3-methylcholanthrene (nmod)
chemotherapy systemic (amod)
0.25 2.0 (nummod)
infusion dose (conj)
state similarities (nmod)
changes synthesis (nmod)
toxicity high (amod)
cardiac further (advmod)
numbers and (cc)
activity protective (amod)
fever concomitant (amod)
alterations parameters (nmod)
affected 1 (nmod)
fear restlessness (conj)
woman taking (acl:relcl)
probable probable (conj)
patients exposure (nmod)
transplant or (cc)
studies morphological (amod)
received restore (advcl)
identifying when (advmod)
summed scores (dobj)
induces tachycardia (nmod)
globulin combined (acl)
ingestion barium (compound)
therapy acei/arb (compound)
complications blinding (amod)
resolved confirmed (advcl)
tested effects (nmod)
shown occurred (ccomp)
viability nrvms (compound)
considered to (mark)
given reduction (nmod)
caused osteoporosis (nsubjpass)
nephropathy interstitial (amod)
reactions among (case)
started cyclosporine (nsubjpass)
conclusions induces (dep)
assessments , (punct)
tbars plasma (compound)
scores lower (amod)
t(1/2 ) (punct)
measured . (punct)
clearance tbars (compound)
penetration brain (compound)
learning on (case)
associated lesions (nsubjpass)
function 2-adrenoceptor (amod)
conversion cyclosporine (nmod)
associated co-morbidity (nmod)
lvdp/dt ) (punct)
do may (aux)
aspect the (det)
dose-limiting potentially (advmod)
commenced later (advmod)
started using (xcomp)
memory pain (compound)
weakness generalized (amod)
blocked receptors (nsubjpass)
high different (conj)
biopsy affected (amod)
anticipation brixton (compound)
ten which (nmod)
infusion argatroban (nmod)
impaired low (conj)
reaching h (dobj)
increases prevents (conj)
compensates that (nsubj)
solution hydrochloride (compound)
doses massive (amod)
concentration normetanephrine (compound)
presentation patients (nmod)
insufficiency and (cc)
perturbation a (det)
has s-1 (nsubj)
1.041 ) (punct)
increase dp/dtejc (nmod)
coarctation aorta (nmod)
stress shear (compound)
methyldopa with (case)
properties defined (acl)
suppressing replication (dobj)
doses separated (amod)
3 . (punct)
enos and (cc)
cardioversion and (cc)
striatum animals (nmod)
b patient (compound)
involving drug-adsorption (dobj)
available need (nmod)
neurochemistry rigidity (nmod)
infarction (isph)-induced (amod)
azt mg/ml (appos)
intervals p-r (compound)
chloramphenicol with (case)
extend we (nsubj)
transport collecting (amod)
nodal particularly (advmod)
health of (case)
injection following (case)
change consumption (nmod)
evaluation phase (nmod)
anesthetized connected (conj)
men , (punct)
elevated completion (nmod)
cholinergic pretreatment (appos)
blockers ikr (compound)
follow-up an (det)
increased blocked (advcl)
ibuprofen sulindac (conj)
days 687 (nummod)
arrhythmia without (case)
day gemcitabine (conj)
perimetry ( (punct)
intravenous and (cc)
appropriate more (advmod)
sadness anger (conj)
drop by (case)
had incidence (dobj)
level awareness (nmod)
outcome of (case)
acidosis metabolic (amod)
pre-administration topical (amod)
4107 respectively (advmod)
administration leading (acl)
testosterone ip (compound)
continued whereas (mark)
caused resorption (nmod)
reserpine by (case)
3 of (case)
test morris (compound)
evoked glutamate (nsubj)
reported frequent (dep)
3 coombs (conj)
begins it (nsubj)
assigned treatment (dobj)
patients achieving (acl)
eluate negative (amod)
effects week (nmod)
antagonized depletion (nsubjpass)
occurs reduce (xcomp)
tolerated flestolol (nsubjpass)
developed one (nsubj)
found kidneys (nmod)
deaths including (case)
deletion inhibition (conj)
ameliorate that (mark)
disappeared symptoms (nsubj)
hypertension (phe)-induced (amod)
constituted . (punct)
outcomes unreported (amod)
factor stroke (nmod)
7/8 ) (punct)
show suggesting (advcl)
1967 between (case)
expression including (case)
patients polychemotherapy (nmod)
requires performance (dobj)
failure pentobarbital-induced (amod)
uncomplicated hypoxia (nmod)
increased all (nmod)
mrna-containing acid (nmod:npmod)
administration aprotinin (nmod)
dose-intensity the (det)
tolerated medicine (dobj)
tested group (nmod)
delay nmda (nmod)
evaluation diazinon (nmod)
summarizes objectives (nsubj)
67.66 and (cc)
therapy uracil (compound)
produces anemia (dobj)
efficacious an (det)
phosphatase protein (compound)
task a (det)
flaccid lacked (conj)
hearing and (cc)
myalgia this (det)
drug effective (amod)
fumarate disoproxil (compound)
midazolan of (case)
days initial (amod)
depth anesthesia (nmod)
cancers glioma (nmod)
help understanding (dobj)
attack exposure (nmod)
fluphenazine . (punct)
measurements quantitative (amod)
acrolein through (case)
injection propofol (compound)
arrest sudden (amod)
incidence mpo-anca (nmod)
overdose the (det)
acid agonist (appos)
death before (case)
develop document (conj)
echocardiography with (case)
decreased aminoglycosides (nsubj)
incorporation thymidine (compound)
adenocarcinoma for (case)
reflects susceptibility (dobj)
reflected cycle (nmod)
vehicles ritanserin (conj)
5 0.3 (compound)
( sd (conj)
frequent k-variant (nsubj)
facilitation and (cc)
hepatitis resembling (case)
dysfunction in (case)
tests following (amod)
0.9 only (advmod)
infiltrate perimysial (amod)
hours 17 (nummod)
warrant treatment (nmod)
patients rrmm (compound)
hand the (det)
providing efficacy (dobj)
experienced man (nsubj)
igf ) (punct)
recurrence transplantation (nmod)
applied interval (nmod)
women 153 (nummod)
model persistent (amod)
used conclusion (nsubjpass)
pd or (cc)
prolonged may (aux)
studies effects (nmod)
cord of (case)
btc ) (punct)
medications for (case)
reminding selective (compound)
indicate : (punct)
delay occlusion (nmod)
point at (case)
53 - (punct)
fractions identical (amod)
imipramine of (case)
mice azt-treated (amod)
deposits and (cc)
debated role (nsubjpass)
compound noniodinated (amod)
citrate induction (nmod)
emulsion alone (advmod)
re , (punct)
presentation complications (nmod)
metabolites the (det)
synapses onto (case)
report demonstrated (conj)
inhibits , (punct)
value than (case)
using analyses (dobj)
significant however (advmod)
catecholamines for (case)
found lesions (nsubjpass)
absorbed drug (nsubjpass)
harvested livers (nsubjpass)
discussion the (det)
continues effective (xcomp)
shivering with (case)
more six (nummod)
incidence seizures (nmod)
vasculitis satisfying (acl)
abnormality no (neg)
induced atrophy (dobj)
cavity and (cc)
yield would (aux)
undetermined was (auxpass)
experienced discomfort (dobj)
receive not (neg)
drug blocking (compound)
exhibited twitching (dobj)
recorded symptoms (dobj)
thromboembolism complication (dep)
micu to (case)
received pralidoxime-2-chloride (dobj)
life-threatening potentially (advmod)
os or (cc)
account finding (nsubj)
affected incidence (dobj)
placebo experiments (nmod)
features other (amod)
syndrome combined (amod)
recovery recovery (conj)
khz side (nmod)
unable continue (xcomp)
120/67 . (punct)
studies extended (amod)
february between (case)
myoclonus etomidate-induced (amod)
months 10.2 (nummod)
predictability outcome (compound)
pyrazolones for (case)
assessment confusion (compound)
cascade toxic (amod)
coagulation the (det)
regimen therapeutic (amod)
attack (is)/transient (amod)
chp ) (punct)
dox of (case)
size cells (nmod)
modulates negatively (advmod)
administered chemotherapy (nmod)
anaesthesia infusion (nmod)
administration hcl (nmod)
hypothesis : (punct)
models pathophysiological (amod)
status her (nmod:poss)
158.11 ( (punct)
advance prevention (nmod)
discharged patient (nsubjpass)
tool are (cop)
behavior climbing (compound)
induced both (cc:preconj)
blockade tachycardia (conj)
participates hyperalgesia (nmod)
protein epithelial (amod)
modification required (amod)
changes chest (amod)
trend = (amod)
ratios , (punct)
necessary , (punct)
graded scale (nmod)
blood-pressure patients (nmod)
auc total (amod)
wall % (dep)
344 and (cc)
concluded study (nsubj)
amounts platinum (nmod)
higher treatment (nmod)
mortality disease (compound)
cellular humoral (conj)
doses days (nmod)
nitroprusside prevented (acl)
efficacy world (nmod)
acid udca (appos)
instituted administration (nsubjpass)
stimulation slices (nmod)
stage transplant (nmod)
all patients (dep)
reduced hydroxylase (conj)
caffeine mg (nummod)
less be (cop)
aim : (punct)
electrocardiogram and (cc)
patient on (case)
using persons (nmod)
days gem-p (appos)
histopathological high-grade (amod)
prolactin 20 (nmod)
responses allergic (amod)
effusion the (det)
% 0.2 (nummod)
151 of (advmod)
showed diagnosed (conj)
ci 15.08 (nummod)
iu/l to (case)
effect instead (case)
specimens consecutive (amod)
consisted stores (nsubj)
ng/mouse , (punct)
found contaminated (xcomp)
society 74 (nummod)
discharged may (aux)
origin uncertain (amod)
degeneration behind (case)
experience . (punct)
induced chloramphenicol (nmod)
breaks strand (compound)
efficacy weak (amod)
d4.2 dopamine (compound)
higher micrograms/kg (nmod)
prolactin with (case)
patients aneurysms (nmod)
antagonist serotonergic (nmod)
permeability with (case)
serving control (nmod)
responses vascular (amod)
prevention tamoxifen (nmod)
rhabdomyosarcoma embryonal (amod)
causes identifiable (amod)
lacn ( (punct)
f2 and (cc)
caused sustained (advcl)
showed contained (ccomp)
doses bilaterally (advmod)
months because (mark)
markers relevant (amod)
leads state (nmod)
brainstem the (det)
complaints all (predet)
ivmp ) (punct)
n-acetylcysteine of (case)
hdl only (cc:preconj)
60 120 (conj)
uiu/ml be (cop)
isethionate pentamidine (compound)
correlation b12 (nmod)
fetal in (case)
three only (advmod)
short is (cop)
micrograms at (case)
related protection (nsubj)
polymyositis primary (amod)
years as (case)
lithium on (case)
similar values (nsubj)
curtailed however (advmod)
scans contrast-enhanced (amod)
na ca (conj)
received bupivacaine (dobj)
biomarker a (det)
expression duct (conj)
extent lesser (amod)
fragmentation membrane (nmod)
concentrations intracellular (amod)
tested months (conj)
788.5 162.5 (conj)
mild effects (nsubj)
patients states (nmod)
rhizomes and (cc)
urd ) (punct)
heroine and (cc)
diagnosed discontinued (conj)
affected function (nsubjpass)
c 41.5 (nummod)
neurotransmitters these (det)
combination an (det)
exposure animals (nmod)
used task (nsubjpass)
induced reintroduction (nmod)
investigation under (case)
test ecg (compound)
rescue ) (punct)
induced effects (nmod)
ng/ml 11.2 (nummod)
analysis from (case)
associated produces (advcl)
remain unchanged (acomp)
stimulation disease (nmod)
encountered . (punct)
vd ) (punct)
provoked , (punct)
agents four (nummod)
side-effects mild (amod)
achieved interval (dep)
induced hexachloride (nmod)
4/26 % (dep)
immunohistochemistry lectin (conj)
modifies inhibition (nsubj)
initiation as (cc)
preswitch g/day (nmod)
cells gyrus (nmod)
ritonavir with (case)
significant a (det)
docetaxel treatment (nmod)
vehicle ml/kg (dep)
pallidotomy of (case)
admitted fever (nmod)
identified capecitabine (conj)
resistance forearm (amod)
compliance poor (amod)
capacity calcium-loading (amod)
identified monitored (parataxis)
group within (case)
similar weeks (nmod)
% ci (appos)
event hypoxia (nmod)
eyes subject (nmod)
den + (cc)
obvious . (punct)
central embase (conj)
patients 1 (dep)
rhythm in (case)
accelerate progression (dobj)
mg weeks (nmod)
1.043 ) (punct)
present diagnosed (advcl)
signs counts (appos)
system from (case)
described occurrence (nsubjpass)
epilepsy for (case)
mg/day 617 (nummod)
99 % (dep)
inhibitor cinacalcet (nsubj)
given carboplatin (nsubjpass)
11 in (case)
did injection (nmod)
scored thereafter (advmod)
induced pan (nmod)
reduced caa (nsubj)
caused insertion (nmod)
hemorrhagic 31 (nsubj)
pressure mup (appos)
testing conventional (amod)
nerves and (cc)
beta-blocker and (cc)
enos renal (amod)
cytostatic effects (dep)
rotation in (case)
chamber the (det)
animals 45 (nummod)
chick noted (acl)
lesion to (case)
beginning time (nmod)
warned disappear (conj)
treated modulators (nmod)
base dilated (amod)
interval a (det)
doses controls (conj)
auccgrp ( (punct)
disease present (amod)
toxicity cocaethylene (dep)
increased albuminuria (nmod)
associated therapy (nsubjpass)
% respectively (advmod)
clopidogrel ) (punct)
a or (cc)
symptoms psychiatric (amod)
modify symptoms (dobj)
confined strictly (advmod)
administered performed (conj)
ion platinum (compound)
users nonantithrombotic (amod)
day . (punct)
indicate undergoes (ccomp)
evident clinically (advmod)
week once (advmod)
terms loss (conj)
boluses mg/kg (nmod)
control infusion (nmod)
men were (cop)
bmd to (case)
disappeared normalized (conj)
0.02 to (dep)
decrease similar (amod)
species and (cc)
5-fluorouracil continuous (amod)
ebf ( (punct)
trypan assay (dobj)
erythromycins defects (appos)
function detrusor (compound)
history urinalysis (conj)
slope a (det)
rejection allograft (conj)
treatment patients (nmod)
carteolol antagonist (appos)
area low (amod)
modulator pregs (nsubj)
prescribe practitioners (nsubj)
augments seizure (dobj)
developed left (conj)
aminophylline and (cc)
polymorphism the (det)
3.2 +/- (cc)
mechanism syndrome (nmod)
anabolizing dystrophy (nsubj)
affect number (nsubj)
stability promoted (acl)
% 0.7 (nummod)
sample plasma (nmod)
prolong that (mark)
role potential (amod)
agonist and (cc)
5days/week 0.5mg/kg (dep)
amenorrhea of (case)
challenges additional (amod)
characteristic cells (nmod)
causing leukoencephalopathy (dobj)
infections endocarditis (nmod)
measure tomography (nsubj)
estimation the (det)
seizures lidocaine-kindled (amod)
chloride sufficient (amod)
encephalomalacia ( (punct)
initiated that (mark)
count the (det)
infarcts reticulata (nmod)
isolated recently (advmod)
prevalences low (amod)
human salmon (conj)
men normal (conj)
hours the (det)
impairment stz- (amod)
6-hydroxydopamine rat (compound)
pvc ( (punct)
relaxants of (case)
systems central (amod)
develop seizures (dobj)
renografin of (case)
mbp hr (conj)
50 25 (compound)
tiredness week (nmod)
204 9 (compound)
nifedipine mg (appos)
vessels arterial (amod)
users mdma (compound)
estimated were (auxpass)
active-w ( (punct)
development dyskinesias (nmod)
disease tumor (nsubj)
size dose (nmod)
stenosis % (dep)
aminonucleoside of (case)
condition treatment (nmod)
potent ultra-short-acting (dep)
remission % (dep)
movements induced (acl)
month effect (nsubj)
hemodynamics renal (amod)
cause depression (dobj)
episode hyperthermia (nmod)
0.005 than (case)
mediator convulsions (nmod)
aura ) (punct)
pathway sulfation (nsubj)
led increase (nsubj)
wt of (case)
sjl c57bl/6j (conj)
phosphatases in (case)
possiblility propensity (nmod)
chelator an (det)
2.9 +/- (cc)
littermates non-transgenic (amod)
sulphonylureas older (amod)
had rates (dobj)
nodule small (amod)
concentration t (compound)
requiring hemodiafiltration (dobj)
highlight . (punct)
reappearing briefly (dobj)
myalgia induced (amod)
change mean (compound)
agricultural and (cc)
lymphadenopathy , (punct)
hyperparathyroidism in (case)
more at (case)
improves growth (dep)
effect ibuprofen (nmod)
strains independent (amod)
segments by (case)
production via (case)
appeared with (mark)
developed minutes (nmod:tmod)
drugs atypical (amod)
performed day (nmod)
236.9 15.1 (conj)
termination prompt (amod)
level igf-i (compound)
ventilation and (cc)
test chi(2)(3 (appos)
disturbances risperidone-associated (amod)
mouse , (punct)
cyp3a4 ( (punct)
caused symptoms (dobj)
previously or (cc)
angiodegeneration wall (nmod)
s.c. terbutaline (compound)
increased size (nmod)
21 out (prep)
di his (nmod:poss)
insufficiency preexisting (amod)
kidneys adult (amod)
sleep cycles (conj)
demonstrated dismissed (conj)
effects reported (amod)
subunits cco-iv (dep)
responses 17 (nmod)
reduced decreased (conj)
age values (conj)
baby the (det)
injury serious (amod)
thiopental sodium (compound)
cephalothin and (cc)
found however (advmod)
adriamycin adjuvant (amod)
hepatic and (cc)
supplemented , (punct)
ngf pg (conj)
glutamate extracellular (amod)
receptor 4 (nummod)
arytenoid of (case)
correlated patients (nmod)
described first (advmod)
starting nifedipine (dobj)
patients dependent (acl:relcl)
effect untoward (amod)
controls normotensive (amod)
1.54 ( (punct)
regimen patient (nmod)
signs < (dep)
related need (dep)
isoproterenol administration (dobj)
na+-extrusion cells (nmod)
cells inflammatory (amod)
control study (nmod)
patients age (nmod)
fungizone of (case)
1 ( (punct)
suggests release (dobj)
continue danger (dep)
function impaired (amod)
free hematuria (nmod)
stopping beta-agonist (dobj)
iq in (case)
administration csa (nmod)
test prick (compound)
daily once (advmod)
acetyltransferase nucleus (nmod)
produce redistribution (dobj)
nrvms ) (punct)
10 = (amod)
developed flushing (advcl)
reports epidemiological (amod)
had hyperhidrosis (dobj)
neutropenia failure (conj)
increased decreasing (conj)
positive hbeag (nsubj)
precipitate ciprofloxacin (nsubj)
enzymes selective (amod)
risk hyperplasia (nmod)
effect sleep-inducing (amod)
= administration (nmod)
show has (conj)
markers evidence (appos)
stimulation an (det)
reached mice (dobj)
ca2 binding (conj)
purpose ngf (dep)
induced occlusion (nmod)
verapamil of (case)
mpges-1 ( (punct)
toxicity hyperuricemia (conj)
test ax (nmod)
schedule than (case)
died sustained (conj)
protein myd88 (appos)
nucleoside prophylaxis (nmod)
values ferritin (compound)
has ; (punct)
series ca2 (appos)
arthrogryposis is (cop)
immunoblotting and (cc)
system isolated (amod)
unique effects (nsubj)
therapy sodium (compound)
endocarditis ie (appos)
msec , (punct)
association patients (nmod)
induced haloperidol (advcl)
results presented (acl)
risks follow-up (appos)
levels insulin-like (amod)
yawning drum (dobj)
increases which (nsubj)
secondary glomerulonephritis (nmod)
diagnosis pheochromocytoma (nmod)
ecg with (case)
dose sublethal (amod)
prevented completely (advmod)
induction adenomyosis (compound)
8.7 1.1 (conj)
receiving dose (dobj)
degrees stenosis (nmod)
assigned which (nmod)
imaging resonance (compound)
transferred room (nmod)
happiness of (case)
% 52.7 (nummod)
referred ect (nmod)
showed controls (nmod)
difluoromethylornithine sulindac (conj)
6.0 of (case)
accentuante progression (dobj)
anatomical substrates (dep)
performs bbb (nmod)
maltol of (case)
regions related (amod)
induction effects (nmod)
decreases count (compound)
nephritis including (case)
given acid (nmod)
400 at (case)
given women (nsubjpass)
optic in (case)
disorder diltiazem (conj)
anaphylaxis of (case)
warfarin the (det)
findings experimental (amod)
inconclusive were (cop)
mouth headache (appos)
nightmare anaesthetists (nmod:poss)
therapy lamivudine (compound)
strains , (punct)
neurotoxicity 1 (dep)
control cdc (appos)
acetaminophen nephrotoxicity (dep)
receiving to (mark)
investigated prevent (ccomp)
substantial that (mark)
reported . (punct)
hoarseness and (cc)
experience treated (advcl)
treatment cocaine (nmod)
perception and (cc)
month cases (nmod)
response hypotension (nmod)
communicate case (dobj)
entered been (auxpass)
change haemodynamic (amod)
induced remained (conj)
suggested can (aux)
reversed melatonin (nsubj)
discontinuous immunostaining (nsubj)
self-treating had (aux)
p75(ntr)-ir pericellular (compound)
warrant studies (dobj)
predominant frontally (advmod)
alterations formation (nmod)
fibrin of (case)
qrs of (case)
other in (case)
treatment population (nmod)
1981 from (case)
onset- end-of-dose (conj)
microm 200 (nummod)
conducted review (nsubjpass)
pressure iop (appos)
found organisms (nsubjpass)
cats rabbits (conj)
infarction first (amod)
controls not (neg)
activity hindlimb (compound)
promotes , (punct)
prevented dependently (advmod)
patients sustained (acl:relcl)
pretreatment mk-801 (nmod)
found receptors (nsubjpass)
centers 12 (nummod)
related regeneration (nmod)
outcomes multiple (amod)
detected limitation (nsubjpass)
abolished rigidity (nsubjpass)
november august (nmod)
returned that (nmod)
cocaine amphetamine (conj)
slow . (punct)
probability reaction (compound)
is read (conj)
limbs dyskinesias (nmod)
dox-rats in (case)
onset seizures (nmod)
treatment migraine (nmod)
prevented administration (nmod)
mainstay . (punct)
coincidental which (nsubjpass)
transfusion during (case)
mm rats (nmod)
dpi after (conj)
observed died (conj)
mice icr (compound)
remapped , (punct)
therapy phenylephrine (compound)
conclusions is (dep)
forebrain the (det)
changes amplitude (nmod)
destruction of (case)
adducts 4hne (compound)
tissues injury (nmod)
activity consequent (nmod)
characterization and (cc)
underperfusion secondary (amod)
tachycardias ouabain-induced (amod)
dba/2 of (case)
defined g/dl (nsubjpass)
density . (punct)
sarcoma kaposi (nmod:poss)
investigating properties (dobj)
matched we (nsubj)
typical cystitis (nmod)
tolerance . (punct)
chronic but (cc)
ml/100 32.3 (compound)
cells non-endothelial (amod)
associations of (case)
mice higher (amod)
relapse , (punct)
was therefore (advmod)
isoniazid inhibition (nmod)
mrna ( (punct)
pathway an (det)
infection c (compound)
effective pretreatment (nsubj)
symptoms ceased (acl)
suggest responsible (ccomp)
fractures minor (amod)
worth investigating (xcomp)
therapy the (det)
toxicity delayed (amod)
% 5 (nummod)
pressure associated (acl)
pre-treatment . (punct)
cholinesterase of (case)
testosterone flutamide (conj)
investigated effect (nsubjpass)
time ; (punct)
history urticaria (nmod)
anemia g/dl (nmod)
developed contrast (nmod)
exertion upon (case)
arrhythmia including (case)
distress respiratory (amod)
tachycardia caused (acl)
associated dexmedetomidine (nsubjpass)
male six (nummod)
weeks given (case)
14 +/- (cc)
excretion increased (amod)
velocity in (case)
employed deviation (dep)
dna of (case)
nerve on (case)
melatonin 0.05 (dep)
r-(alpha)-methylhistamine the (det)
bradycardic to (mark)
high , (punct)
clearance because (case)
minor been (cop)
compared behaviors (nmod)
segments brain (nmod)
reduction followed (acl)
segment affected (amod)
men 7 (nummod)
stage had (amod)
design prospective (amod)
determined and (cc)
patient 73-year-old (amod)
lasting anaesthesia (nmod)
titrated . (punct)
represent mainstay (dobj)
been have (aux)
dyspnoea increased (amod)
induced etomidate (nmod)
combined methotrexate (nmod)
connected be (auxpass)
arteriolar and (cc)
delirium use (nmod)
administration cefonicid (nmod)
channels beta2(-/- (nmod)
patient cirrhosis (nmod)
recipient and (cc)
vomiting % (nmod)
behaved controls (nmod)
min intravenously (advmod)
cp ( (punct)
resistant accompanied (advcl)
hbeag or (cc)
vehicle anp (conj)
accentuated , (punct)
reticulocytes ) (punct)
delayed or (cc)
mg. at (case)
rabbit 's (case)
observations : (punct)
inhibit mfs (dobj)
minutes 2 (nummod)
motility syndrome (nmod)
akathisia tricyclic (conj)
question however (advmod)
s 0.14 (nummod)
cardiotoxicity develop (acl:relcl)
ich ) (punct)
ensued rapidly (advmod)
symptoms her (nmod:poss)
showed observed (conj)
amnesia drug-induced (amod)
disorder mood (compound)
wild-type and (cc)
controls mdma-free (amod)
complained drowsiness (nmod)
adjustment ph (compound)
cisplatinum , (punct)
outflow heart (nmod)
reviewed pathogenesis (nsubjpass)
developing % (nmod)
experiments behavioral (amod)
survivors in (case)
pre-treatment intralipid (nmod)
years during (case)
2a receptors (conj)
endocarditis such (case)
strikes again (advmod)
cells pmol/10 (amod)
program prevention (compound)
examine expression (dobj)
mainstay importance (nsubj)
15 , (punct)
appears tachycardia (nsubj)
alterations influences (nmod)
greater -20.0 (dep)
segments artery (nmod)
mechanisms molecular (amod)
experience lovastatin (nmod)
feasibility effects (conj)
neuronal extraneuronal (conj)
magnitude decrease (conj)
occurred enhancement (nsubj)
inhibitor patients (nmod)
glutamate ( (punct)
heath mental (amod)
improved severity (dobj)
freely both (cc:preconj)
concentrations excretion (conj)
reflect might (aux)
reported disease (nmod)
waiting restriction (nmod)
technique echocardiography (nsubj)
delayed be (auxpass)
used has (aux)
ganglia sympathetic (amod)
nmdar function (conj)
risk confounding (nmod)
triglycerides apolipoproteins (conj)
pentobarbital groups (nmod)
achieved results (nsubj)
settings prevention (nmod)
triglyceride hepatic (amod)
doses at (case)
larger attributable (conj)
epileptiform ; (punct)
some , (punct)
nephropathy iga (compound)
pallor nerve (compound)
antibodies heparin-induced (amod)
outcomes fractures (conj)
comparing treatment (nmod)
number alpha-motoneurons (nmod)
bell-shaped curves (nsubj)
glucagon effect (nsubj)
affect that (mark)
presented analysis (nsubjpass)
tricyclics potency (nmod)
determinant an (det)
effective agent (nsubj)
intima media (conj)
plays hypomethylation (nsubj)
nifedipine paced (acl:relcl)
moving of (mark)
onset manifestations (conj)
was whether (mark)
doses pg (nmod)
insufficiency new (amod)
found thus (advmod)
onset severity (conj)
history occurrence (conj)
tachyarrhythmias reentry (appos)
administered gain (advcl)
rct from (case)
injected mul (nsubjpass)
female 83-year-old (amod)
caused damage (dobj)
were % (attr)
method invasive (amod)
compares favorably (advmod)
rats diet (nmod)
completed inventory (nmod:npmod)
29.3 +/- (cc)
survivors hospitalized (acl)
use topical (amod)
microinjections via (case)
caused microinjection (nsubj)
divided stages (nmod)
reaction leukemoid (amod)
fiber elastic (amod)
hospital-years of (case)
settings practice (compound)
polysomnography accommodation (compound)
% 40.9 (nummod)
treatment carcinoma (nmod)
nefiracetam as (case)
study in-vivo (amod)
ppa or (cc)
seizures drugs-induced (amod)
reaching 2.2-fold (dobj)
necessary fertility (nmod)
conditions associated (amod)
transplanted center (nmod)
hepatitis appeared (acl:relcl)
treated ampicillin (nmod)
discouraged treatment (nsubjpass)
incidence % (compound)
intake food (nmod)
16 weeks (dep)
n=12 , (punct)
methscopolamine penetrate (acl:relcl)
alpha-sigma beta (conj)
fetal p (dep)
delirium induced (acl:relcl)
acting secretion (nmod)
paralysis temporary (amod)
possible perhaps (advmod)
determined responses (nsubjpass)
evidence leukemia (nmod)
mg/d ( (punct)
score increase (nmod)
hypertensive in (case)
inconclusive results (nsubj)
led injury (nsubj)
treatment yohimbine (compound)
mg/kg values (dep)
metabolite apap (nmod)
loci qtls (appos)
influence rats (nmod)
4.3+/-1.9 doses (nsubj)
lna = (amod)
done biopsies (nsubjpass)
london and (cc)
treated spironolactone (conj)
hz 8,000 (nummod)
consisting edema (nmod)
h rizatriptan (dep)
clinic disorders (compound)
blockade but (cc)
6 2)% (dep)
lymphocytes subject (nmod)
stage consolidation (nsubj)
nmbas ( (punct)
controls p (dep)
antipsychotics , (punct)
years admitted (acl)
erythromycin of (case)
young and (cc)
therapy anemia (nmod)
objective study (dep)
oxidation increased (amod)
cocs levonorgestrel-containing (amod)
parkinsonian-like signs (dep)
transplantation hepatic (amod)
keratectomy laser (compound)
24 to (dep)
1.043 0.002 (conj)
condition recognized (amod)
response vas (compound)
stop changes (dobj)
moving only (advmod)
1.1 , (punct)
polyps adenomatous (amod)
mdma ecstasy (amod)
revealed doses (nmod)
mo in (case)
> trigemini (conj)
ingestion quinine (nmod)
those receiving (acl)
lmwh ) (punct)
symptoms drug-induced (amod)
times 6 (nummod)
doses be (cop)
tiapride derivative (amod)
glomerulonephritis cancer (conj)
= necrosis (nmod:npmod)
neurotoxicity cardiomyopathy (conj)
plausible is (cop)
indicate potentiate (ccomp)
impaired when (advmod)
vision associated (acl)
reactions abnormalities (nsubj)
cellularity , (punct)
variables micturition (compound)
technique to (mark)
infused stz (nmod)
pregnant and (cc)
baseline , (punct)
tetrachloride- , (punct)
dose factor (nmod)
adam10 mmp-2 (conj)
micrograms/ml = (dep)
include , (punct)
feasible . (punct)
specimens liver (compound)
vacuoles autophagic (amod)
sweating or (cc)
hips-cms ( (punct)
n=25 ) (punct)
flestolol : (punct)
transporter dat(-/- (appos)
inconvenience irrigation (nmod)
monomer , (punct)
service the (det)
ameliorated raised (conj)
estimated cohort (nmod)
parasitosis psychogenic (amod)
prevented increased (conj)
consumption to (case)
naloxone values (nmod)
caused ethanol (nmod)
oligodeoxynucleotide an (det)
translocation : (punct)
oxide nitric (amod)
occur disease (nmod)
naloxone antagonist (compound)
million nearly (advmod)
functions mental (amod)
increase peak (compound)
fall a (det)
search literature (nmod)
correlation moderate (amod)
expression decreased (amod)
cross-tolerance or (cc)
se pilocarpine-induced (amod)
shivering salivation (conj)
neurotoxic and (cc)
compared vehicle (nmod)
afterdepolarization trigger (nmod)
pathogenesis , (punct)
transfer ward (nmod)
mmhg p (dep)
analyser a (det)
concentration lowest (amod)
measurement turbidometric (compound)
3 up (advmod)
hyponatremia siadh (conj)
inhibited have (aux)
discs the (det)
provoke that (mark)
development hypertension (nmod)
assessed weeks (conj)
abuse the (det)
agents antiepileptic (amod)
lithium year (nmod)
neuropeptide . (punct)
onset dyskinesias (nmod)
values parameters (nmod)
reviews testing (nmod)
methodology enzyme-mediated (amod)
hearing loss (dobj)
bladder mice (nmod)
toxicities all (det)
included exposure (dobj)
six was (cop)
inhibited damage (nsubjpass)
exposure contributor (nmod)
akinetic group (dep)
initiatives for (case)
occurred mg/day (nmod:tmod)
contribute disruption (nsubj)
weeks 18 (nummod)
0.6 0.3 (conj)
illustrates presents (advcl)
mgkg 40 (nummod)
examined toxicity (nmod)
improved are (auxpass)
composed infiltrates (nmod)
advantages , (punct)
trigger reflexes (nmod)
confusion leukopenia (conj)
picture : (punct)
contrast interaction (nmod)
expanded study (nmod)
production antibodies (nmod)
times min (nmod)
herbicide a (det)
sham ( (punct)
reduces bepridil (nsubj)
% 69 (nummod)
1.0 0.97 (conj)
change 1.5-fold (amod)
mechanism seizures (nmod)
period min (nmod)
insufficiency moderate (amod)
thrombophlebitis proteinuria (conj)
having clinic (nmod)
mg 125 (compound)
estimate , (punct)
beclomethasone 15 (conj)
seen damage (nsubjpass)
chow pellets (dobj)
this or (cc)
disruption move (xcomp)
method the (det)
transplantations for (case)
response chemotherapy (compound)
ciprofloxacin of (case)
unaffected cortex (nmod)
comparison trinitrate (nmod)
jc 2003 (amod)
test challenge (compound)
decline map (nmod)
crescents , (punct)
dyskinesia against (case)
able tolerate (xcomp)
responses most (advmod)
induced but (cc)
mul c (dep)
evidence related (ccomp)
amiodarone paroxetine (conj)
result will (aux)
trials mortality (compound)
were measures (nmod)
disappeared patient (nmod)
made have (aux)
increased be (auxpass)
tablets ( (punct)
atropine supplemental (amod)
supports concern (dobj)
1.0 0.2 (compound)
initiated admission (nsubjpass)
development defined (acl)
absence nominal (amod)
candidiasis oral (amod)
kinase 1 (nummod)
hyperactivity produced (acl)
knowledge personnel (nmod)
occurred tdp (nsubj)
factor corticotropin-releasing (amod)
rs6275 taqia (conj)
bleed gastrointestinal (amod)
7 days (dep)
azotemia major (amod)
pethidine and (cc)
generations between (case)
treated basis (nmod)
estimated cingulate (conj)
diagnostic edition (appos)
disease self-reported (amod)
discrimination auditory (amod)
wanted allows (conj)
thought syndrome (nsubjpass)
investigated patients (dep)
concentration a (det)
6-ohda ) (punct)
resistance iso (compound)
psychosis stimulant (amod)
associations observed (acl:relcl)
showed mpa (nsubj)
arrest n (dep)
ppa after (case)
antagonist kinin (compound)
cause range (dobj)
aspects , (punct)
less proportion (nsubj)
infusion and (cc)
curves on (case)
caused amantadine (nmod)
groups p<0.05 (appos)
use tests (nmod)
part , (punct)
changes analgesic-induced (amod)
demonstrated also (advmod)
affected was (auxpass)
normal subsequently (advmod)
collagen of (case)
hypaque due (case)
daily mg/kg (nmod:npmod)
tac ( (punct)
baseline its (nmod:poss)
ototoxicity of (case)
vesicles typical (amod)
produce metronidazole (nsubj)
results stress (appos)
important complications (nsubj)
supplied information (dobj)
glimepiride , (punct)
minutes the (det)
gemcitabine patients (nmod)
were symptoms (attr)
planes coronal (amod)
test stimulation (compound)
tested first (advmod)
statins response (nmod)
cya of (case)
detected could (aux)
fenoterol-hydrobromide of (case)
5 . (punct)
phenobarbitone- and (cc)
magnitude course (conj)
report boy (ccomp)
compares bupivacaine (conj)
effects because (case)
myocarditis hypersensitivity (compound)
dose sustained (acl:relcl)
contributed , (punct)
agonists skf-82958 (nmod)
period group (appos)
factor that (nsubj)
alpha3 brains (conj)
found < (conj)
loads the (det)
intervals effect (conj)
expression angiotensinogen (compound)
animals were (cop)
% bradycardia (nsubj)
remains goal (attr)
weeks administration (nmod)
pain postoperative (amod)
therapy nightly (advmod)
blockade channel (compound)
ginsenosides oih (nmod)
expansion tubular (amod)
illustrates , (punct)
indomethacin and (cc)
caused was (advcl)
acuity hearing (compound)
[na]o and (cc)
solutions dilevalol (amod)
degeneration neuronal (amod)
proved , (punct)
nanoparticles cyanoacrylate (amod)
induce injury (dobj)
scale-revised rating (compound)
reflex trigemino-parasympathetic (amod)
microscope laser (compound)
growth bacterial (amod)
controls naive (amod)
cck-8 , (punct)
modified was (auxpass)
interpretation neurotransmission (compound)
condition patient (nmod:poss)
studied materials (nsubj)
endpoints convulsion (compound)
using stainings (dobj)
greater be (cop)
factor this (nsubj)
provide evidence (dobj)
interacted effect (nsubj)
treatment poisoning (nmod)
erythrocytes and (cc)
preventing donors (dobj)
ras of (case)
getting reported (ccomp)
add models (nmod)
deficit serotonergic (amod)
symptoms moderate (amod)
treatment first (conj)
settings inpatient (amod)
impairment improvement (conj)
9 , (punct)
regurgitation mr (appos)
weeks all (det)
analgesics withdrawal (conj)
preoperatively and (cc)
process foot (compound)
lesions extensive (amod)
hypothesized factor (xcomp)
occurs use (nmod)
response product (nmod)
pointes torsade (compound)
snp ) (punct)
open- and (cc)
prevent hc (dobj)
variables creatinine (dep)
pretreated p-coumarate (nmod)
compounds effective (amod)
arrhythmia , (punct)
gi ) (punct)
enalapril . (punct)
received percent (nsubj)
stress for (case)
abusers mm (compound)
maleate with (case)
measured minimum (nmod)
reproduces sequelae (dobj)
sirolimus of (case)
deficit of (case)
dose as (case)
nimodipine n=101 (appos)
groups while (case)
carried and (cc)
has drawback (dobj)
action primary (amod)
change to (mark)
side-effect is (cop)
degeneration tubules (nmod)
= 15.34 (dep)
ces-d and (cc)
switched showed (advcl)
electrophysiology full (amod)
sensitivity associated (acl)
patients fifteen (nummod)
dyscrasias to (case)
sought characterize (xcomp)
exams radiologic (amod)
clues clinical (amod)
case admitted (acl:relcl)
receive valsartan (dobj)
considered surgeries (nsubjpass)
involvement severity (nmod)
continued or (cc)
patients intradermoreactions (acl:relcl)
influence strong (amod)
similarity despite (case)
hepatitis chronic (amod)
dosage oral (amod)
antibody-negative although (mark)
recorded day (nmod:tmod)
assigned enalapril (nmod)
tasks phonological (dep)
present 54.5 (nmod)
pose mother (nmod)
recognized well (advmod)
bun in (case)
irritability as (cc)
assay and (cc)
first-time namely (advmod)
access(r with (case)
injury induced (acl)
suggested hepatitis (dobj)
patients tumor (compound)
obtained therapy (nmod)
cyclosporine of (case)
vehicles ( (punct)
patients 89 (nummod)
documented duration (nsubjpass)
99 93 (conj)
administered courses (nsubjpass)
reduction 1-receptor (nmod)
disorder recessive (amod)
toxicity system (nmod)
od n (dep)
surviving min (dep)
ltp ) (punct)
hearing incidence (nmod)
performed whether (mark)
cholestasis treatment (nmod)
adding monoher (dobj)
protein daily (amod)
mmhg 53 (nummod)
dose dxr (compound)
att-alf on (case)
ro4368554 and (cc)
factors incidence (compound)
immunoassays enzyme-linked (amod)
neurons rodents (nmod)
maintaining pressure (compound)
event no (det)
leads that (nsubj)
proportion population (nmod)
reduction filtration (nmod)
time oral (amod)
context factors (nmod)
36.22 1.92 (conj)
potent studies (nmod)
desipramine to (case)
reversal phenylephrine (nmod)
shown oxide (nsubjpass)
treatment csa (compound)
dopamine than (case)
became suppressants (nsubj)
fs a (det)
habituation field (compound)
studies such (amod)
injection)+ritanserin dmso (appos)
stage day (appos)
likelihood high (amod)
correlated data (nmod)
mumol/kg range (dep)
suggests candidate (ccomp)
35 20 (compound)
tract to (case)
control hearts (conj)
higher , (punct)
studied procaterol (nsubjpass)
attenuating in (mark)
had administration (nmod)
tolerant pain (nmod)
patients achieved (acl:relcl)
suggested have (aux)
related encephalopathy (advmod)
depressed . (punct)
smoking injection (nmod)
products healthfood (compound)
stz-icv by (case)
tachycardia polymorphic (amod)
slices mice (nmod)
casualties in (case)
valves cardiac (amod)
policy prescription (nmod)
showed examination (nsubj)
signaling of (case)
deviation deviation (conj)
ciprofloxacin- norfloxacin-treated (conj)
1.25 than (quantmod)
p9605 ( (punct)
inpatients adult (amod)
therapy 24-week (amod)
1.6 ratio (nsubj)
transplantation clinical (amod)
328 53 (conj)
determine to (aux)
cholesterol total (amod)
plasma amount (conj)
hemodynamic volumetric (conj)
0.014-unit 0.350-unit (conj)
mass ck-mb (compound)
functions neurological (amod)
antidepressants to (case)
glucose % (compound)
dynes.s.cm-5 vs (dep)
ma ( (punct)
grade , (punct)
markers soluble (amod)
improving dyskinesias (dobj)
challenged days (nmod)
glomerulonephritis necrotizing (amod)
permeability , (punct)
facial of (case)
enzyme regulatory (amod)
lesions rats (nmod)
assessed weeks (dobj)
efficacy diethylpropion (nmod)
manifestations clinical (amod)
alpha-2b ribavirin (conj)
investigation intense (amod)
beta-hydroxylase dopamine (compound)
investigate caused (ccomp)
ratios ( (punct)
segments n=12 (appos)
inflammation stroke (nmod)
% 63 (nummod)
lesion organic (amod)
= k(i (dep)
presence gene (nmod)
changes mitochondrial (amod)
excluded report (ccomp)
produces patients (nmod)
volunteers ten (nummod)
duration catatonia (nmod)
options treatment (compound)
breakdown from (case)
correlation excretion (nmod)
understanding mechanism (nmod)
mmg ) (punct)
drug tachycardia (nmod)
ratio 0.887 (dep)
cells midline (compound)
gtn h (compound)
studies patients (nmod)
comparing concentrations (dobj)
parkinsonism choreic (acl:relcl)
period longer (advmod)
serve it (nsubj)
necrosis child (nmod)
agonist imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate (appos)
crisis of (case)
dose in (case)
related inhibit (conj)
studied relation (dobj)
frequency increasing (amod)
tract lower (amod)
> icc (compound)
pressure of (case)
59 21 (compound)
changes of (case)
induced cisplatin (nmod:npmod)
rationale nicotine (dep)
1.4 mean (dep)
profiles effect (compound)
analyses animals (nmod)
hypotension clonidine-induced (amod)
toxicology urine (compound)
follow-up long (amod)
better hence (advmod)
utilizing treatment (nmod)
when even (advmod)
reducing effectively (advmod)
monoarticular with (case)
race and (cc)
1.23 ( (punct)
lower p<0.001 (dep)
patients 95 (nummod)
method treatment (nmod)
stress brain (compound)
develop epilepticus (nmod)
iief ( (punct)
119 to (dep)
syndromes two (nummod)
treatment levetiracetam (nmod)
failure underwent (acl:relcl)
infusion glyceryl (compound)
result inhibition (nsubj)
return perfusion (nmod)
argatroban 1.2 (nummod)
assessed hydroperoxides (conj)
increased exposure (nmod)
markers hbv (compound)
administration heparin (nmod)
nondepolarizing agents (dobj)
all for (case)
deficiency ( (punct)
patients 3,245 (nummod)
time values (nmod)
prevent . (punct)
dependent dilates (advcl)
preexcitation without (case)
blockade beta-adrenoceptor (compound)
stable audiogram (nsubj)
depleted caused (conj)
methods patients (dep)
changes use (nmod)
cocaine 70 (nummod)
involves and (cc)
condition the (det)
reattempted patients (nsubj)
ipratropium with (case)
c dietary (amod)
factors pathogenesis (nmod)
improved months (nmod)
encountered , (punct)
drug nonsteroidal (amod)
doses cya (nmod)
numbness and (cc)
immunoreactive prox-1 (nmod)
ranged and (cc)
model the (det)
pain evoked (amod)
cause desvenlafaxine (nsubj)
hypersensitivity a (det)
secretion hormone (compound)
rats ds (compound)
calcification between (case)
memory wechsler (compound)
p not (neg)
permitted are (auxpass)
function integrity (conj)
reviving . (punct)
mg mp (nmod)
schizophrenic in (case)
women osteopenia (nmod)
changes deviation (appos)
unchanged position (nsubj)
albumin of (case)
mitoxantrone of (case)
day 10 (compound)
metabolites compound (nmod)
using frlma (dobj)
md ( (punct)
exposure of (case)
alterations brain (compound)
activity synthase (compound)
expression achrs (nmod)
reports abs (nmod)
world " (punct)
notable . (punct)
patients icu (compound)
relationships effect (conj)
anthracycline severe (amod)
tremor patients (nmod)
decrease both (cc:preconj)
signs electrocardiograms (amod)
errors e.g. (advmod)
interventions non-surgical (amod)
barrier intercellular (amod)
ica of (case)
confused shivering (nmod)
twitches maximal (amod)
disappeared cases (nmod)
rhabdomyolysis patient (nmod)
drop single (amod)
4 up (advmod)
enzymes dismutase (nmod)
administered marmosets (nsubjpass)
patients td (nmod)
considered investigator (nmod)
serositis with (case)
temperature basal (amod)
secretion lh (conj)
lesion substantia (amod)
showed pronounced (ccomp)
vocabulary novel (amod)
= 88.1 (dobj)
groups t+a (dep)
weakness symptoms (conj)
dependent occurring (advcl)
measurements biometric (amod)
women 540,000 (nummod)
metabotropic ii (compound)
incidence failure (nmod)
woman pregnant (amod)
prepared was (auxpass)
had high (ccomp)
memory . (punct)
iu/kg/h ( (punct)
occur thus (advmod)
failed did (conj)
noted course (nmod)
examine relationship (dobj)
effects inhibitory (amod)
ease application (nmod)
nuclei dentate (amod)
occur do (aux)
walls decreases (acl:relcl)
response les (compound)
showed treatment (nmod)
development a (det)
75 27 (nummod)
bodies cytoplasmic (amod)
pattern anemia (nmod)
sulfate oil (conj)
response hyperemic (amod)
tolerable it (nsubj)
ureters , (punct)
sulfasalazine the (det)
ptz , (punct)
% 17.5 (nummod)
due to (mwe)
decrease haloperidol-treated (nmod)
efficacy i (nummod)
deficits latter (amod)
3 to (case)
magnitude att-alf (nmod)
syndrome coronary (amod)
showed binding (nmod)
showed also (advmod)
increased 20-fold (advmod)
years males (conj)
arrhythmias failure (nmod)
canine and (cc)
mechanism be (cop)
observed t30 (nmod)
showed point (nmod)
determine also (advmod)
induced caffeine (nmod)
excretion , (punct)
reabsorption rate (conj)
decreased 5-ht (dobj)
syndrome disorders (conj)
assessment levofloxacin (nmod)
treated warfarin (nmod)
reserpine i.p. (advmod)
occurred pain (nsubj)
cytotoxicity on (case)
mssa for (case)
effect agonists (nmod)
assigned method (nmod)
alter decreasing (advcl)
patients by (case)
continued , (punct)
moderate edema (nmod)
unresolved . (punct)
thrombocytopenia review (appos)
chemotherapy leading (advcl)
had necrosis (dobj)
hydrobromide ) (punct)
time immobility (compound)
course results (dep)
sn , (punct)
arthritis large (amod)
products animal (compound)
risperidone 5ht2a (appos)
min 23.43 (nummod)
effects kurroa (nmod)
parallel . (punct)
obsessive-compulsive significant (amod)
quantified we (nsubj)
1.35 3.58 (prep)
kidneys perfused (acl)
years age (nsubj)
suggest animals (dobj)
sensitivity dgc (nmod)
8 monkeys (nmod)
detectable antibodies (nsubj)
chow or (cc)
prodrugs antagonists (nmod)
% 13.5 (nummod)
ca(2 acute (amod)
hypertrophic atria (nsubj)
range physiologic (amod)
oxide of (case)
sensitized cephalothin (nmod)
states resistance (compound)
pharmacokinetics nonoverdose (amod)
diuretic bumetanide (nsubj)
abuse methamphetamine (compound)
pinealectomized hypophysectomized (conj)
block inadequate (amod)
differ flows (nsubj)
gastrointestinal musculoskeletal (conj)
change effect (nmod)
mm 30 (nummod)
formed oxidation (nmod)
follow-up by (case)
studying by (mark)
development social (amod)
inhibitor serotonin (compound)
creatinine or (cc)
suppressants belgium (nmod)
completed showing (xcomp)
plays . (punct)
mechanisms glutamate-mediated (amod)
dmpx ) (punct)
mm < (nummod)
main and (cc)
presence sleep (nmod)
percent 3 (nummod)
induced pemoline (nsubj)
if dose (appos)
activates remains (advcl)
pre-treated licl (nmod:npmod)
% patients (nmod)
results myelosuppression (dep)
alterations neural (amod)
cases toxicity (nmod)
associated abstinence (nsubjpass)
depression this (det)
shown vohland (dep)
supported results (nmod)
majority groups (nmod)
measured methodology (dep)
controls corresponding (amod)
risks relative (amod)
mg/m(2 1000 (nummod)
dose new (amod)
toxicity relative (amod)
increment , (punct)
virus ( (punct)
arrest series (nmod)
aggravation and (cc)
co-administered dose (nmod)
disability of (case)
homogenates in (case)
definition anemia (nmod)
infusion p=0.037 (appos)
sinensis hibiscus (compound)
analysis studies (nmod)
consisted controls (nsubj)
days fifteen (nummod)
agonist da (compound)
increasing is (aux)
confounded that (mark)
symptoms elevations (nmod)
intravenously mg (dep)
double-blind , (punct)
collected patients (nmod)
background complication (dep)
seizures changes (conj)
sites heparan (compound)
rofecoxib of (case)
occurrence patient (nmod)
hours five (nummod)
worst group (nmod)
lower generally (advmod)
stroke tia (conj)
presented anemia (nmod)
outflow in (case)
69.9 vs. (cc)
micrograms/day 1500 (nummod)
decreased levels (nsubj)
di- determinant (conj)
concentration lymphocytes (nmod)
administered verapamil (dobj)
% 9.8 (nummod)
bea ) (punct)
hpa ( (punct)
causes that (nsubj)
hepatonecrosis : (punct)
present constitutively (advmod)
groups control (compound)
curve clearance (nmod)
recommend would (aux)
causes suxamethonium (nsubj)
atropine 20 (nummod)
reduced timolol (nsubj)
% deviation (nsubj)
university period (nmod)
indicated suggested (conj)
condition to (case)
fibrillation response (nmod)
implant the (det)
association positive (amod)
poisons national (compound)
inducing ischemia (dobj)
lead dysfunction (nmod)
instances in (case)
concentrations d (compound)
markers of (case)
studies reported (acl:relcl)
accuracy manifested (acl)
overload the (det)
adult in (case)
danazol of (case)
had echocardiogram (nmod)
then intervals (nmod)
4-aminopyridine mg/kg (appos)
features toxicity (nmod)
depleted , (punct)
used dose (nsubjpass)
emesis patients (nmod)
determined evaluate (xcomp)
infusion mg/kg (nmod)
risks and (cc)
developed epilepticus (dobj)
syndrome ketoconazole-induced (amod)
offer atropine-mk801 (nsubj)
can sarcoma (conj)
1.1 p=0.09 (amod)
report immunostaining (dobj)
coma nonketotic (amod)
activator the (det)
equipment input (compound)
latency latency (conj)
ml/h ( (punct)
controls healthy (amod)
consumed regularly (advmod)
kidney recipients (conj)
characterize to (mark)
total events (nmod)
increased hypotension (nmod)
changes biphasic (amod)
high so (advmod)
electroshock hypercapnia (conj)
6 were (cop)
appeared beneficial (xcomp)
start treatment (nmod)
20- and (cc)
occurred atrophy (nsubj)
characteristics biomembranes (nmod)
operative been (cop)
antibody 4/heparin-reactive (amod)
adult chickens (dobj)
diminished activities (nsubjpass)
had recall (dobj)
suggested retained (ccomp)
increased renin (nmod)
5.0 2.5 (conj)
5-ht1a and (cc)
methods written (appos)
undertaken was (auxpass)
monitor balance (dobj)
capture recording (compound)
absence hormone (nmod)
monitored recorded (conj)
showed scan (nsubj)
methodology used (acl)
content cortical (amod)
transplantation chemotherapy (conj)
dose adriamycin (compound)
haloperidol sc (appos)
factor treatment (nmod)
health in (case)
parietal right (amod)
dyskinesias l-dopa-induced (amod)
estimate accounting (dep)
sc/week ) (punct)
dopac of (case)
known who (nsubjpass)
has limit (dobj)
1a type (compound)
understanding by (mark)
identification disorder (nmod)
rate nor (cc)
alf or (cc)
many too (advmod)
evaluated animals (nsubjpass)
exposure that (mark)
concentrations to (case)
abnormal more (advmod)
beating are (cop)
response abolished (amod)
direct , (punct)
levels on (case)
day quetiapine (nmod)
seen toxicity (nsubjpass)
effect % (appos)
damage methamphetamine-induced (amod)
seems control (nsubj)
azidothymidine azt (appos)
surgery fess (appos)
days 98 (nummod)
cuff the (det)
assigned mg/day (conj)
9/15 , (punct)
shr weeks (appos)
increase increase (nsubj)
elicits effects (dobj)
sex were (cop)
examinations biochemical (amod)
variants usual (amod)
5.2 vs (cc)
activity peak (amod)
reported earlier (advmod)
may , (punct)
rejection failure (conj)
defects production (nmod)
syndrome as (cc)
stimulation associative (amod)
report male (appos)
rats syndrome (nmod)
describes children (dobj)
new or (cc)
far so (advmod)
observed mice (nmod)
ability cardiomyocytes (nmod)
0.24 0.06 (conj)
was fact (nsubj)
control p20 (appos)
i.v. kg-1 (dep)
higher classified (conj)
nx both (cc:preconj)
study metabolic (amod)
dunnett = (amod)
adjuvant and (cc)
provoke abnormalities (dobj)
mm maximal (acl:relcl)
dose standardized (amod)
preoperatively . (punct)
determined age (nmod)
nephrectomy a (det)
paralysis the (det)
correction contracture (nmod)
meq/l of (case)
exist , (punct)
% 18.75 (nummod)
mumol/l of (case)
fibrosis mild (amod)
determined ultrasound (nmod)
observed gradient (nsubjpass)
occurs . (punct)
ph : (punct)
have who (nsubj)
deficit . (punct)
hemodynamics rate (dep)
locomotion induced (amod)
isolated-hit with (case)
excretion in (case)
observed gained (advcl)
tests akbr (amod)
diet laboratory (compound)
fragments cells (nmod)
materials groups (appos)
induced focus (nsubjpass)
completed out-patients (nsubj)
smokers pipe (compound)
arteries lnna (nmod)
operative have (aux)
reacted eluate (nsubj)
ros , (punct)
database pharmacovigilance (compound)
aor ) (punct)
effective rd (nsubj)
response attack (nmod)
indicate cause (conj)
discontinued quetiapine (nmod)
higher ] (punct)
erythematosus refractory (amod)
therapy proposed (amod)
correlated abnormalities (nsubjpass)
data establish (acl)
substance pure (amod)
dysfunction neurotransmission (nmod)
alterations . (punct)
seizures severe (amod)
a-77636 for (case)
proof additional (amod)
total hospital-years (nmod)
converted defibrillation (nmod)
fentanyl 1 (nummod)
users 8.0 (conj)
nephrotoxicity doxorubicin (nmod)
narrowing coronary (amod)
obtained . (punct)
pressure examinations (conj)
depends decision (nsubj)
excellent ) (punct)
demonstrated regard (nmod)
azathioprine cyclophosphamide (conj)
identify subset (dobj)
1.2 - (punct)
rated surgeon (nmod)
nightmares and (cc)
epinephrine 10 (nummod)
10ug ) (punct)
elicited changes (nmod)
1,3-butadiene of (case)
binding receptor (compound)
dose micrograms/kg/min (appos)
means infusion (nmod)
accuracy predictive (amod)
december to (case)
dysplasia of (case)
prevented castration (nmod)
hyperactivity : (punct)
placebo to (case)
evaluated assays (nmod)
vancomycin or (cc)
explore to (mark)
trends with (case)
recommended limitations (nsubjpass)
sensitivity future (amod)
% rate (nmod)
areas mesangial (amod)
l-name and (cc)
priori a (det)
effects neuroleptic-induced (amod)
cross-clamp aortic (amod)
curves bell-shaped (amod)
intervals 3-weekly (amod)
animals injected (acl:relcl)
toxicity ns-718 (nmod)
suffered twice (advmod)
mexiletine trial (conj)
obtain cerebellum (nmod)
effects used (acl:relcl)
sed 6.4 (conj)
impaired patients (nsubj)
ddi ) (punct)
cnsb002 for (case)
hr at (case)
src induced (acl)
lysis clot (compound)
expression in (case)
mild toxicity (nsubj)
lesions function (nmod)
induce provides (conj)
proteinuria > (appos)
electrophysiology using (acl)
observed produce (xcomp)
female a (det)
days course (dep)
age patient (nmod:poss)
erpf ) (punct)
aspects associations (nmod)
randomized olanzapine (nmod)
regimen on (case)
imaging patients (nmod)
received injection (nmod)
five ) (punct)
collection sample (compound)
cardiomyopathy catecholamine-induced (amod)
cr and (cc)
offer begun (advcl)
inhibitor rapamycin (compound)
assigned bpt (dep)
52 - (punct)
vary to (mark)
higher levels (nmod)
metabolizers extensive (amod)
incidence episode (nmod)
assessed a.m. (nmod)
performed evaluate (xcomp)
amikacin vancomycin (conj)
infarction pallidus (nmod)
junction the (det)
neoplasms malignant (amod)
easily more (advmod)
aneurysms cocaine-related (amod)
affecting pressure (dobj)
finding electrocardiographic (amod)
recordings electrocardiographic (amod)
studies prolactinomas (nmod)
infusion dogs (nmod)
procedure of (case)
received mouth (nmod)
common patients (nmod)
effects capecitabine (nmod)
magnitude prevent (acl)
cancer it (nsubj)
compared , (punct)
purpose cause (dep)
associated seizures (nmod)
proceeded escalations (nsubj)
prediction chemotherapy (nmod)
pituitaries of (case)
examined dose (dobj)
background/aims : (punct)
situation in (case)
review published (acl)
application systemic (amod)
evidence growing (amod)
primigravida , (punct)
taking prazosin (nmod)
4 0 (compound)
bridge as (case)
patients response (nmod)
permeability content (conj)
cats unanaesthetized (amod)
found could (aux)
metamizol with (case)
alteration aneurymal (amod)
carcinoma the (det)
weighed . (punct)
p.r.n on (case)
provide referred (dep)
caused months (nmod)
receptors cb1 (compound)
developed nodule (nsubj)
correlate readings (nmod)
defined infarction (nmod)
dysrhythmias , (punct)
doxorubicin mg/kg (appos)
volume desire (nmod)
foci/cm2 example (nmod)
heart normal (amod)
induced ? (punct)
loss initial (amod)
patients times (appos)
calcification group (nmod)
30 approximately (advmod)
acids of (case)
cpap to (case)
have treatment (dobj)
negative . (punct)
images mr (compound)
prostigmine ) (punct)
use prolonged (amod)
carried we (nsubj)
derivative allopregnanolone (nmod)
emphasize effect (dobj)
maintaining blood (compound)
ketamine receptor (compound)
cells existing (amod)
was decrease (nsubj)
damage barrier (compound)
performance group (compound)
fashion systematic (amod)
response the (det)
treatment , (punct)
available a (dep)
states assessed (dep)
efficacy , (punct)
nanoparticles tacrine-loaded (amod)
decreased gfr (dobj)
species reported (acl)
effect crossover (dep)
blocks 5 (nmod)
features postmortem (compound)
acute rejection (dep)
assessed response (nsubjpass)
predicting appearance (dobj)
effects form (nmod)
twice perorally (advmod)
group animals (conj)
ratio ketone (compound)
mg to (case)
normal near (conj)
result leukoencephalopathy (nsubj)
300 - (punct)
hepatomegaly tender (compound)
l-1 mequiv (compound)
6 least (nmod:npmod)
importance any (det)
lid ( (punct)
6.3 +/- (cc)
myelosuppression grade (nmod)
commencement clozapine (nmod)
pump micrograms.kg-1.min-1 (appos)
layer the (det)
spent entering (conj)
od group (nmod)
inhibition ) (punct)
substrate mrp2 (nmod)
periods interruption (compound)
more less (conj)
dex g/kg/day (appos)
renin the (dep)
tp with (case)
age gestational (amod)
withdrawn was (auxpass)
sufficient also (advmod)
drugs injection (compound)
assessed preference (dobj)
nephropathy can (appos)
useful indicator (nmod)
confirm investigate (conj)
include causes (nsubj)
dose g/m2/d (nmod)
remained hand (nmod)
unmask flumazenil (nsubj)
stopped had (aux)
nurses attending (amod)
metabolite that (mark)
results decreased (dep)
formulations release (compound)
% > (cop)
reflex a (det)
il-1 , (punct)
increased content (nsubj)
iopamidol and (cc)
proteins ca(2 (amod)
standard comparison (nmod)
dysfunction age (conj)
increased cocaine (nsubj)
re-exposure drug (nmod)
hinder diagnosis (dobj)
doses methoxamine (nmod)
glaucoma patients (nmod)
incriminated accounting (conj)
respiration on (case)
patient the (det)
shown scan (nmod)
disease antecedent (amod)
neoplasms patients (nmod)
injected intradermally (advmod)
pdn released (acl)
head and (cc)
deleted replaced (conj)
remained range (nmod)
using when (advmod)
occur myopathy (nsubj)
treated hexamethylmelamine (conj)
levels hemoglobin (compound)
seizure-prone withdrawal (conj)
exposure cocaine (nmod)
fenfluramine and (cc)
carcinoma bladder (nmod)
neuroplasticity changes (conj)
finding novel (amod)
caffeine- anxiety (conj)
injury therapy (nmod)
investigated act (ccomp)
perception vibratory (amod)
determination follow-up (conj)
treatment . (punct)
matter the (det)
tachycardia reentrant (amod)
cells hbmp (compound)
beraprost bpt (appos)
attenuate could (aux)
hypotension decrease (conj)
acquired map (conj)
guidelines in (case)
therapies lamivudine (compound)
% alf (nmod)
models mouse (compound)
effects antiproliferative (amod)
reduction level (nmod)
saccades movements (conj)
acetaminophen for (mark)
recur symptoms (nsubj)
oxidase hypertension (nmod)
investigated engagement (dobj)
resolved problems (nsubj)
symptomatology thermography (conj)
measured 2 (conj)
advise patients (dobj)
obtained breakdown (nmod)
different those (nmod)
lack receptors (nmod)
conclusions include (appos)
measured simultaneously (advmod)
composition : (punct)
cardiomyopathy epinephrine-induced (amod)
1.5 0 (compound)
c in (case)
brought . (punct)
mg t.i.d. (appos)
questionnaires to (case)
neurologic transient (amod)
epilepsy due (case)
case 1 (nummod)
mg/kg beta-carboline (nmod)
associations face-name (amod)
length of (case)
electrical behavioral (conj)
renoprotective were (cop)
salbutamol of (case)
194 5 (conj)
interaction time (compound)
refractory intolerant (conj)
nitroprusside the (det)
risk hit (nmod)
smear the (det)
embryos from (case)
prevented indicating (xcomp)
bp bp (compound)
treatment antithrombotic (amod)
relation a (det)
wall bladder (compound)
use warfarin (compound)
depend diagnosis (nmod)
cyclosporine ( (punct)
nephropathy cyclosporine-induced (amod)
had muscle (nmod)
returned management (nmod)
tacrolimus , (punct)
dose accumulation (conj)
blocks antagonized (ccomp)
p-aminophenol of (case)
anti-inflammatory nonsteroidal (amod)
women clozapine (conj)
l-arginine , (punct)
concerned who (nsubj)
short ( (punct)
hypersecretion gastric (amod)
sarcolemma the (det)
clonic generalized (amod)
differ other (nmod)
doses 3 (nummod)
readmitted weeks (nmod:tmod)
hypotension group (nmod)
large clinical (dep)
comparison diltiazem (nmod)
groups chow (conj)
response escalating (advcl)
relation their (nmod:poss)
important whereas (mark)
began reporting (xcomp)
understood pathology (nsubjpass)
nephropathy and (cc)
benzodiazepines drugs (conj)
availability the (det)
actions depressant (amod)
ain nicergoline-associated (amod)
treated can (aux)
resolved discontinuation (nmod)
camera fundus (compound)
aggravate did (aux)
pressure values (nmod)
dyskinesias . (punct)
process necrotic (amod)
images t1-weighted (amod)
pain trigeminal (amod)
chain the (det)
millimeter cubic (amod)
adequate detect (xcomp)
chance % (compound)
women received (acl:relcl)
as as (advmod)
developed total (nmod)
patient 19-year-old (amod)
segments apical (amod)
confirmed which (nsubjpass)
injury administration (nmod)
rates calculated (acl)
components that (det)
density and (cc)
drug apomorphine (nsubj)
measurements structural (amod)
neurotoxicity 2 (dep)
produced pre-treatment (nsubj)
treatment alprazolam (compound)
proved . (punct)
convulsions produced (acl)
trigger siat (nmod)
started lost (advcl)
dose-dependent dysfunction (nsubj)
overall 21 (conj)
net of (case)
treated are (auxpass)
effect drug (compound)
liver , (punct)
decreased maintained (conj)
concentration caffeine (nmod)
condition cystitis (nsubj)
replicate augment (conj)
intake between (case)
conclude report (ccomp)
capacity concentrate (acl)
severe episodes (nsubj)
headache duration (nmod)
appears presence (xcomp)
monitored patients (nsubjpass)
inhibit can (aux)
changes cholesterol (nmod)
increased pups (nmod)
administered group (nmod)
liver fatty (amod)
velocities different (amod)
anticoagulation most (advmod)
experiences " (punct)
push group (appos)
ml/m2 100+/-17 (nummod)
neurotoxicity post-synaptic (amod)
mediator an (det)
frequent women (nmod)
4107 . (punct)
occurred presence (nmod)
manifestation the (det)
development behavior (nmod)
cause infective (amod)
resembles picture (nsubj)
use before (case)
increased animals (nmod)
herbs chinese (amod)
useful adjunct (nmod)
died later (advmod)
decreased 5-htp (nsubj)
i.c.v. micrograms/mouse (compound)
responded doxorubicin (nmod)
showed ratio (dobj)
activity complex (nmod)
nassa ( (punct)
throat a (det)
evaluated furthermore (advmod)
improvements those (nmod)
minute range (appos)
dose last (amod)
interventions current (amod)
undertaken not (neg)
exerts that (mark)
ampka p-ampk (appos)
condition nephropathy (nsubj)
hand of (case)
% 7.1 (nummod)
hours above (case)
group = (dep)
had block (nmod)
line from (case)
supplement to (mark)
site-specific most (advmod)
increases nervousness (appos)
carcinoma receptor-positive (amod)
potent gyki-41 (nsubj)
flexural and (cc)
all patients (nmod)
synthesis dna (compound)
ring , (punct)
acid control (appos)
antioxidants tissue (compound)
increased nor (cc)
toxicity extent (conj)
affects melatonin (nsubj)
absence the (det)
injected doses (nmod)
treated hydration (nmod)
145 to (conj)
indicates fill (ccomp)
disorder prevent (conj)
neurotoxicity . (punct)
rats observed (acl:relcl)
oral mg/kg (dep)
infiltrate a (det)
units 35.1 (nummod)
therapy verapamil (compound)
fev1 ) (punct)
comprised days (nmod)
conjugation , (punct)
effect coniine (nmod)
arb ) (punct)
obtained haloperidol (nmod)
had tumor (dobj)
developing thrombosis (dobj)
syndrome (pan)-induced (amod)
located membrane (nmod)
lot effects (nmod)
been date (nmod)
monitoring cardiac (amod)
increased nitrite (advmod)
months is (cop)
comparison pseudolithiasis (nmod)
using systems (dobj)
6.2 +/- (cc)
washout treatments (nmod)
results revealed (appos)
presented previously (advmod)
myelosuppression mood (conj)
induces hypertension (dobj)
observation this (det)
activity components (nmod)
270 ( (punct)
fourfold those (nmod)
pattern regurgitation (nmod)
withdrawal ethanol (compound)
akinetic of (case)
data laboratory (compound)
elevating level (nmod)
iu/l 230 (nummod)
observed relapse (nsubjpass)
exacerbation in (case)
revascularization partial (amod)
side acute (amod)
groups p<0.001 (appos)
importance whether (mark)
tumor patient (nmod:poss)
disorder seizure (amod)
levels species (nmod)
greatest lowest (conj)
administration prazosin (nmod)
involved mechanism(s (nmod)
age 75 (appos)
hours > (compound)
cases such (amod)
striatum moderate-dose (dep)
suppression response (nmod)
incorporates that (nsubj)
nephrotoxicity population (nmod)
elevated sodium (nsubjpass)
doses azelastine (nmod)
indicated min (nmod)
enhanced that (mark)
administration to (case)
= 2.42 (dep)
treating outpatients (dobj)
overdose blocker (compound)
pressure urethral (amod)
effect production (nmod)
odds an (det)
anticoagulated dialysate (nmod)
e.g. fewer (dep)
alfentanil potent (amod)
investigate validity (dobj)
pointes death (conj)
probable , (punct)
hormone normal (amod)
diagnosis none (conj)
disorders mood (compound)
patients as (cc)
endothelin-1 et-1 (appos)
reduction hyperemia (nmod)
day doses (appos)
lamivudine negativity (conj)
response lower (amod)
one administered (conj)
anomalies congenital (amod)
thrombosis atria (nmod)
proteins repair (compound)
50 +/- (cc)
exposure pathway (nmod)
% muscle (nmod)
published , (punct)
complete akinesia (dobj)
structural and (cc)
report outcome (nmod)
present stimulation (nsubj)
neurotoxicity associated (acl)
risk complication (nmod)
cryptic , (punct)
produce can (aux)
presentation commonest (amod)
developed manner (nmod)
occurred shedding (nsubj)
those including (case)
necrosis nephritis (conj)
s. for (case)
failure deterioration (nmod)
ameliorated were (auxpass)
indicated study (nsubj)
promote actions (dobj)
6-hydroxydopamine in (case)
showed h (nmod)
activation associated (acl)
caspase 3 (nummod)
represent failure (dobj)
days 967 (nummod)
patients counts (dep)
causes amount (nsubj)
strains antigen-positive (amod)
affects cycle (dobj)
deficits nerve (compound)
enhanced are (auxpass)
negative normal (conj)
differs also (advmod)
% 8.95 (nummod)
changes ammonia (nmod)
factor 5 (nummod)
analyzed days (nmod)
toxicity by (case)
gaba gamma-vinyl (amod)
patient tetraparetic (amod)
ic30 ( (punct)
retard to (mark)
osteoarthritis randomized (amod)
pod 7 (nummod)
hypoxia between (case)
functional compensates (conj)
generation permeability (conj)
hypothesized prevented (ccomp)
verbal on (case)
summary : (punct)
studied induce (nsubjpass)
occurred drg (nmod)
toxicity model (nmod)
discussed discussed (conj)
cellulose with (case)
toxicity nanoparticle (compound)
experiences emesis (dobj)
involvement aspects (nmod)
documented administration (nsubjpass)
prevalence in (case)
densities volume (compound)
digitalise not (conj)
benefit study (nmod)
piloerection effects (conj)
activity presumably (advmod)
observed angina (nmod)
eps in (case)
failure reversible (amod)
responses i.v. (conj)
procedure their (nmod:poss)
confounding bias (conj)
panel ( (punct)
increase point (nsubj)
effects dog (nmod)
ranging mmhg (nmod)
excretion a (det)
aging normal (amod)
case six (nummod)
line is (cop)
ferritin or (cc)
seen result (ccomp)
4.7 heart (nmod)
management prevention (conj)
increment meq/l (nmod)
neuralgia postzosteric (amod)
injury abusers (nmod)
pattern electrophoretic (amod)
location discriminations (conj)
suggest benefit (ccomp)
96.7 was (cop)
good tolerability (nsubj)
hypertension dexamethasone- (compound)
patients cholinesterase (nmod)
excluded later (advmod)
injected capsaicin (nsubjpass)
rtm204i ) (punct)
gyrus dg (appos)
reporting degree (dobj)
plasma ( (punct)
collected determination (nmod)
present who (nsubj)
as twice (advmod)
0.5 than (case)
detectable was (cop)
optic impairs (acl:relcl)
greater 1 (dep)
enhance depress (conj)
years over (case)
aim subdivided (conj)
examined understand (advcl)
mucositis and/or (cc)
cyanide counter (amod)
courses six (nummod)
need research (nmod)
placebo after (case)
l(-1 . (punct)
apl of (case)
showed declines (dobj)
macrophages prominent (amod)
symptomatic had (conj)
between emergently (advmod)
received lamivudine (dobj)
evident = (parataxis)
developed mirtazapine (nmod)
led days (nsubj)
syndrome nephrotic (amod)
exhibited period (nmod)
model streptozotocin-induced (amod)
percent participants (nmod)
function altered (amod)
cross-reactivity carbimazole (nmod)
case coagulopathy (nmod)
therapy timolol-hydrochlorothiazide (compound)
ratio atp/adp (compound)
parameters renal (amod)
led discontinuation (nsubj)
half animals (nmod)
catheterization before (case)
became studies (nmod)
cases well-documented (amod)
receptors mglu7 (compound)
stage each (det)
is treatment (nsubj)
findings reported (acl)
day 0 (nummod)
toxicity ifosfamide (nmod)
impair range (nmod)
plays compensation (nmod)
pai-1 ) (punct)
cardiac dysfunction (conj)
induced calcitonin (nsubj)
decreased measured (parataxis)
force that (mark)
parameters selected (acl)
derivative a (det)
inhibitors anhydrase (compound)
impairments scopolamine-induced (amod)
rats transgenic (amod)
had infant (nsubj)
shunting massive (amod)
class agents (nmod)
dopac da (appos)
changes occurring (acl)
methamphetamine hyperthermia (dep)
considered factors (nmod)
yohimbine ) (punct)
hypotension significant (amod)
morbidity psychological (amod)
benign is (cop)
were infarctions (attr)
administration u-ii (nmod)
gamma hours (nmod)
attenuated dowregulation (nsubjpass)
control intralipid (conj)
completion chemotherapy (nmod)
determined km (nmod)
259 to (dep)
dogs tumour-bearing (amod)
allopregnanolone of (case)
aggravate may (aux)
loci of (case)
started flecainide (nsubjpass)
dose ufh (nmod)
developed which (nsubj)
4 through (case)
six , (punct)
stage 2 (dep)
palsy cerebral (amod)
formation heinz (compound)
mice control (compound)
recorded recorded (parataxis)
dextran weights (nmod)
5.4 3.5 (compound)
electroretinography patients (nmod)
helpful guidelines (nsubj)
present normally (advmod)
treated percent (nsubjpass)
2 least (advmod)
% force (nsubj)
performed decompression (nsubjpass)
thought related (xcomp)
show formed (ccomp)
= 8 (dep)
injection stz (nmod)
potential its (nmod:poss)
decreases triglycerides (conj)
infection by (case)
1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine ( (punct)
company the (det)
s-53482 s-23121 (conj)
attributed . (punct)
regained patients (nsubj)
warranted may (aux)
alpha-configuration alpha,3 (compound)
treated androgen (nmod)
optic with (case)
bleeding fatal (amod)
determined activity (nmod)
diazepam pentylenetetrazol (conj)
undergoing extraction (dobj)
treatment ccnu/ctx (nmod)
concentrations levetiracetam (compound)
flaccidity and (cc)
% response (conj)
fentanyl micrograms/kg (appos)
indicates present (ccomp)
effects certain (amod)
di neurogenic (amod)
developed method (nsubjpass)
neurotoxicity auditory (amod)
remain benefits (nsubj)
doses single (amod)
model evidence (dep)
averaging p (dep)
sedations procedural (amod)
multicenter underwent (acl:relcl)
kidney removed (acl)
emphasis particular (amod)
detected response (nsubjpass)
hyperprolactinemia haloperidol-induced (amod)
doses saline (nmod)
peptide 8 (nummod)
bands and (cc)
effusions in (case)
32.4 - (punct)
same experimental (dep)
content malondialdehyde (amod)
close questioning (acl)
consistent due (conj)
plexus right (amod)
hypoxia with (case)
used institution (nmod)
hypotension treatment (nmod)
underwent cycles (dobj)
ng/ml . (punct)
evoked phenylephrine (nmod)
rates screening (compound)
ppi ) (punct)
preceded asynergy (nmod)
arrhythmias effects (nsubj)
presenting also (advmod)
1.3 0.7 (nummod)
size-dependent , (punct)
therapy following (case)
downregulated and (cc)
cases 69 (nummod)
glyburide sulfonylurea (conj)
process expression (conj)
titrating by (mark)
h weeks (conj)
dysplasia bcnu-induced (amod)
death eryptosis (conj)
% 93.3 (nummod)
corticosteroids to (case)
more far (advmod)
mice stage (nmod)
features shared (acl)
exposure pce (appos)
hh 117.61 (appos)
showed tap (conj)
presence akinetic (nmod)
was improvement (attr)
1 2 (dep)
proportion mean (compound)
allocated receive (advcl)
good , (punct)
hypokalemia hctz (nmod)
required therapy (dobj)
radiographic clinical (conj)
development arrhythmia (nmod)
tetany of (case)
carcinoma , (punct)
increase responses (nsubj)
hemodynamics findings (dep)
given examined (conj)
losartan the (det)
start procedure (nmod)
used broadly (advmod)
blocker alpha-adrenoceptor (amod)
clinical i. (compound)
% p<0.05 (appos)
remained pge2 (nsubj)
compared severity (dobj)
given doses (nmod)
g 1.2 (nummod)
persisted up (compound:prt)
increase cell (nmod)
hyper- pain (conj)
effects above-mentioned (amod)
erythema , (punct)
patients pregnancies (nmod)
administered day (nmod:tmod)
number duration (appos)
tjs ) (punct)
mepivacaine adrenaline (nmod)
approval patients (nmod)
dbs of (case)
arrhythmias cats (nmod)
screening after (case)
occurred reductions (nsubj)
myocarditis eosinophils (nmod)
increased this (nsubj)
stimulation transcranial (amod)
frequency haemorrhages (nmod)
exhibit affinities (dobj)
indicate results (dep)
infusions 6 (nummod)
hours from (case)
zo-1 like (case)
cont./min , (punct)
localization protein (nmod)
upregulated was (auxpass)
iw ) (punct)
associated but (cc)
months 050+/-561 (dep)
report treated (advcl)
assessed subjects (nmod)
restored changed (conj)
dysfunction antidepressant-induced (amod)
30 - (punct)
nonmutant with (case)
rats captopril-treated (amod)
found trial (nsubj)
doses 750 (nmod)
psychosis acute (amod)
followed median (nmod)
tomography oct (appos)
measured were (auxpass)
(+/-)-pg-9 kg-1 (dep)
prevalence e. (nmod)
perform analysis (dobj)
recognized patients (nmod)
neuropathy sensori-motor (amod)
region transporter (compound)
episodes in (case)
p 2 (compound)
weight mg/kg (compound)
fam or (cc)
found % (nsubjpass)
antagonist selective (amod)
disease hyperplasia (conj)
intrathecal to (case)
collected still (advmod)
differences gender (compound)
requires control (dobj)
labeling alpha-enac (nmod)
determined extent (nsubjpass)
fentanyl : (punct)
approach within (case)
cause leading (advcl)
sc-48334 ) (punct)
pretreatment antagonists (nmod)
form and (cc)
prostigmine intramuscularly (advmod)
decreased injuries (nsubjpass)
ranged volume (nsubj)
nephropathy in (compound)
increase = (dep)
presence levels (nmod)
hypertrophy response (dep)
carcinoma be (cop)
counts ) (punct)
levodopa agonist (dep)
desaturation with (case)
anticoagulant sodium (compound)
receiving 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (dobj)
flexion passive (amod)
cotransporter the (det)
evidence definitive (amod)
groups with (case)
green of (case)
patients 10 (nummod)
children the (det)
water fortified (amod)
objective effects (dep)
reversed injection (nsubj)
effects animals (nmod)
bias the (det)
inhibitor putative (amod)
method convenient (amod)
r=0.81 p<0.0001 (dep)
contre centres (compound)
implications treatment (nmod)
serve can (aux)
depend development (nsubj)
leads administered (csubj)
administration chlorthalidone (compound)
followed-up treatment (nmod)
generated wall (nmod)
tdp with (case)
mmol/l on (case)
performed or (cc)
phenobarbital with (case)
prevention rubella (compound)
adjusted was (auxpass)
dynamics , (punct)
neuropathies of (case)
manifested absence (nmod)
iqr range (compound)
injection by (case)
increased % (nsubj)
tiapride with (case)
modalities different (amod)
enhancers different (amod)
reduced crocin (nsubj)
unremarkable were (cop)
effects alpha-methyldopa (nmod)
decayed . (punct)
administered combination (nsubjpass)
lesion arise (acl:relcl)
treatment wounds (nmod)
concentrations millimolar (amod)
resembles , (punct)
reduced kf17837 (nsubj)
ability of (case)
patient-years per (case)
associated probably (advmod)
dcf of (case)
normal returned (advcl)
behaviors . (punct)
increase dextran (nsubj)
evaluation glutamate (compound)
size sample (compound)
continue and (cc)
produced adenosine (nsubj)
mr ) (punct)
advisable patients (nmod)
gene relevant (amod)
ke : (punct)
polymerase the (det)
reduced giving (advcl)
phases crystalline (compound)
examine induced (ccomp)
clinical electron (conj)
indistinguishable were (cop)
maintaining in (mark)
injury 10 (nmod)
stable with (case)
similarities neurochemical (amod)
results degrees (appos)
leukoencephalopathy patients (nmod)
51 and (cc)
dystrophin cardiac (conj)
description relation (nmod)
score 55 (appos)
lower animals (nmod)
central nmps (conj)
voltage- calcium- (conj)
detachment e15.5 (nmod)
causes pathology (dobj)
microg/kg/min argatroban (compound)
sets criteria (nmod)
21 of (case)
isoflurane inhalational (amod)
produces pallidotomy (nsubj)
in even (advmod)
tachycardia isoproterenol-induced (amod)
pressure use (conj)
bacl2 with (case)
differ significantly (advmod)
% 3/5 (appos)
2600 1800 (conj)
followed weeks (nmod)
paclitaxel is (cop)
scale adult (compound)
involved suggested (advcl)
cases cases (conj)
movements ataxic (amod)
cataracts , (punct)
instituted has (advcl)
analgesic nonsteroidal (conj)
acetate , (punct)
reagent sulfhydryl (compound)
encode that (nsubj)
nature neoantigens (nmod)
dimer-x with (case)
july to (case)
states more (amod)
derivative the (det)
dose into (case)
group for (case)
3.7+/-0.8 , (punct)
important be (cop)
levels aminotransferase (compound)
reaction anticoagulant (nmod)
decreased mildly (advmod)
acid aida (dep)
left , (punct)
erythron the (det)
extent location-dependent (amod)
antigenemia hiv (compound)
oxazepam of (case)
patients 82 (nummod)
blocker nifedipine (conj)
doses thalidomide (nmod)
produce nicotine (nsubj)
prevention hospitals (nmod)
lower events (nmod)
limitation reliance (nsubj)
upregulation paraventricular (nmod)
improvement marked (amod)
mglurs of (case)
min-1 paco2 (nmod)
required but (cc)
suggests cases (nmod)
dl-sotalol than (case)
events these (det)
mg/dl 4.9 (nummod)
effects antipsychotic (amod)
cancers all (det)
challenge amphetamine (dep)
concerns toxicity (nmod)
gentamicin alone (advmod)
factors dose (conj)
pancuronium suxamethonium (conj)
deduced " (punct)
drug acting (amod)
intervals treatment (nmod)
caused absence (nmod)
levels secretion (conj)
able discriminate (xcomp)
tab alcohol (compound)
increases levodopa (nsubj)
material hospital (appos)
use preparations (nmod)
treatment fusidic (amod)
infusion results (dep)
designed study (xcomp)
early hours (nmod)
hemorrhage dementia (conj)
identified observations (nmod)
walls accumulation (conj)
edrophonium mg (nummod)
are strategies (attr)
drug for (case)
subsided fever (nsubj)
generation stress (conj)
agents for (case)
similar eyes (nmod)
cardiotoxity cocaethylene (compound)
ng/kg/min 15 (nummod)
fda the (det)
mg/kg i.p. (dep)
treated 1984 (nmod)
age since (case)
18.4 were (cop)
feared rejection (nsubjpass)
evaluation efficacy (nmod)
event was (cop)
haemorrhage after (case)
assessed techniques (nmod)
occurrence endpoints (nsubj)
disturbances haematological (amod)
turnover lysosomal (amod)
obtained baseline (nmod)
indicator and (cc)
1.68 adjustment (nmod)
predominance in (case)
occur pretreatment (nmod)
speed onset (nmod)
strains chromosome (compound)
susceptible dogs (conj)
revealed damage (dobj)
increases 15-db (amod)
products with (case)
seems ) (punct)
improvement chemotherapy (nmod)
felt was (auxpass)
study drugs (dobj)
investigated starting (advcl)
value are (cop)
disrupted catalepsy (dobj)
stimulate cells (nmod)
reduced destruction (nsubj)
episodes tdp (nmod)
levels neuropeptides (nmod)
attacks mdp (appos)
completed were (auxpass)
haloperidol nucleus (conj)
methamphetamine ma (appos)
1.56 ) (punct)
pharmacoeconomics and (cc)
combined hbig (nmod)
present behaviors (nsubj)
patient described (amod)
cue a (det)
aged years (nmod:tmod)
women rubella (compound)
have compared (prep)
ruling stress (dobj)
damage neurotoxicity (conj)
included upregulation (dobj)
occurrence encephalitis (nmod)
background decades (appos)
allows testing (dobj)
demonstrate addition (nmod)
blind in (case)
prevented minutes (nmod)
lesion : (punct)
diffusion of (case)
filling . (punct)
patients -14.8 (dep)
cells located (amod)
augments greatly (advmod)
proposed currently (advmod)
none likely (amod)
leukoencephalopathy or (cc)
suggested showed (parataxis)
activity nor (cc)
bradycardia mild (amod)
rifampin with (case)
hypertension nitroprusside (conj)
conversion sirolimus (nmod)
min , (punct)
csa ; (punct)
dyskinesias apomorphine-induced (amod)
10 over (quantmod)
minutes two (nummod)
adjusted values (nmod)
ketamine not (cc)
sites striatal (amod)
infarction inf-mi (appos)
patches days (dobj)
region atrioventricular (amod)
therapy during (nmod)
period an (det)
= interval (dep)
decrease days (nmod)
mg/kg subcutaneously (amod)
sleep during (case)
exception cases (nmod)
amounts by (case)
contributed hypotension (nmod)
hds between (case)
0.7 0.5 (compound)
effect temsirolimus (nmod)
positive studies (nsubj)
atresia biliary (amod)
severe controls (nmod)
stage scores (conj)
water micrograms/ml (amod)
defined increased (conj)
class also (advmod)
infections few (amod)
depression excitation (conj)
used assessment (nmod)
tablets 55 (nummod)
interact warfarin (nmod)
research peer-reviewed (amod)
demonstrated assays (nsubj)
conjunction regimens (nmod)
increase distinct (amod)
groups based (acl)
contraction serotonin-induced (amod)
strategy novel (amod)
minority a (det)
distributed had (aux)
gating assembly (conj)
potentiated function (nsubjpass)
administration gtn (compound)
syncope . (punct)
lidocaine-kindled or (cc)
succinylcholine before (case)
determinant be (cop)
edition ) (punct)
mutation encode (acl:relcl)
reached protocols (nmod)
variation mice (nmod)
care of (case)
50 ( (punct)
unaffected treatment (nmod)
patients decrease (nmod)
drugs women (nmod)
hepatitis aap-induced (amod)
syndrome p (dep)
studies cord (compound)
increment or (dep)
10(-7 ) (punct)
sweating smelling (conj)
lived hiv-negative (conj)
oxide relaxing (amod)
decrease age-related (amod)
test chi-square (amod)
dihydrochloride amn082 (appos)
luminal antiluminal (conj)
exhibits 7e (nsubj)
lumens tubular (amod)
hypersensitivity drug (compound)
carbachol following (case)
models testing (advcl)
comparison iopamidol (nmod)
zonisamide of (case)
angiographies , (punct)
38 6 (conj)
incidence thrombosis (nmod)
patients mean (dep)
monitored rejection (nsubjpass)
agent amide (appos)
methotrexate , (punct)
appears constriction (nsubj)
dose tolerated (amod)
5.4 ( (punct)
administration 1 (dep)
points characteristics (nmod)
measures neurocognitive (amod)
effect additive (amod)
paclitaxel cisplatin (conj)
lability emotional (amod)
detrimental dox (nmod)
vpu or (cc)
reversed pre-treatment (nsubj)
occurred improvement (nsubj)
run-in and (cc)
0.8 0.1 (compound)
immunohistochemistry for (case)
extensive metabolizers (conj)
excellent sweating (dep)
carcinoma reported (acl)
t(9:22 the (det)
years ' (case)
agents acid (conj)
testosterone years (compound)
associated period (nsubjpass)
isoflurane surgery (nmod)
four of (case)
adenocarcinoma cell (compound)
oct oct (appos)
incidence therapy (nmod)
atpase na+-k+ (compound)
concentration virus (nmod)
resolved change (nmod)
effect 9-tetrahydrocannabinol (nmod)
p2x3 receptors (conj)
database mhra (compound)
found never (neg)
done infants (nmod)
develop can (aux)
terfenadine ( (punct)
chromosomes 10 (dep)
considered success (xcomp)
combined ctnt (nmod)
mm 20 (nummod)
postulate exposure (ccomp)
patients 1 (nummod)
developed doxorubicin (dobj)
test suspension (compound)
re-induced was (auxpass)
lamivudine therapy (nmod)
site burn (compound)
increase maximal (amod)
albumin mouse (compound)
pb of (case)
survival long-term (amod)
alleviated but (cc)
reduced indicating (advcl)
mg 110 (nummod)
haemorrhage modification (nmod)
microscopy immunoelectron (compound)
designed was (auxpass)
direction in (case)
site factors (conj)
possibility aggravation (nmod)
mitoxantrone such (case)
done end (nmod)
effects increasing (acl)
resistance drug (compound)
weight liver (compound)
dystonia with (case)
mmol/l mosmol/kg (appos)
fenoterol-hydrobromide ritodrin-hcl (conj)
excluded echography (nmod)
intake ramipril (nmod)
decrease concentrations (nmod)
hypothesized equilibrate (ccomp)
regurgitation tricuspid (compound)
promotes occurrence (dobj)
conclusions mania (dep)
coadministration d2 (nmod)
b amphothericin (compound)
antagonists possibly (advmod)
exchange open (amod)
using microscope (dobj)
concentrations antidepressant (amod)
each blockers (nmod)
enhances effect (dobj)
mice 1 (dep)
vehicle for (case)
thickening wall (compound)
given vincristine (nsubjpass)
icp cvp (conj)
markers impairment (nmod)
proliferation the (det)
helodermin by (case)
fed diet (xcomp)
demonstrate not (neg)
mid- by (case)
intubated admitted (conj)
deficit atrial (amod)
alpha-tocopherol acetate (conj)
induced dextran (nmod:npmod)
using antagonists (dobj)
potassium , (punct)
patients report (nmod)
involved episodes (nmod)
woman 40-year-old (amod)
affect may (aux)
mice associated (acl:relcl)
ocular adverse (conj)
consider intoxications (dobj)
register central (compound)
abandoned technique (nsubjpass)
class 1 (nummod)
range : (punct)
study double (amod)
penis the (det)
image mri (appos)
overdose to (mark)
component functional (amod)
incorporate permitted (conj)
colorectal neck (conj)
pretreatment for (case)
received drug (dobj)
lidocaine prilocaine (conj)
included deterioration (dobj)
patient leukemia (nmod)
stresses need (dobj)
confounding studies (nmod)
allowed hypotension (nmod)
occurred initiation (nmod)
fit , (punct)
rich although (dep)
0.6 0.2 (conj)
treatment sulphasalazine (amod)
experiment ) (punct)
cholestasis alterations (nmod)
developed cardiotoxicity (dobj)
comparison the (det)
deformities foot (compound)
saline methylprednisolone (conj)
exposed saline (conj)
count eosinophil (compound)
suppress however (advmod)
remained significant (acomp)
proven used (advcl)
change glutathione (nmod)
(5.3)% 0.01 (parataxis)
observed basis (nmod)
patients c (compound)
mg/m(2 117 (nummod)
therapy tiapride (nmod)
underwent examinations (dobj)
aminoglycoside . (punct)
restore levels (nmod)
symptoms axial (amod)
hour during (case)
change concentration (nmod)
gain insights (dobj)
detect and (cc)
indices degree (dep)
describe findings (dobj)
dynamics shunt (conj)
administered starting (xcomp)
severity dose (conj)
were % (dep)
metabolised compounds (nsubjpass)
injection m1 (dep)
atp with (case)
concentration extrapolated (amod)
related been (cop)
antipsychotic properties (dep)
fear impaired (amod)
induces whether (mark)
mouth % (appos)
counts studies (conj)
pressure mm (appos)
withdrawn is (auxpass)
patient had (acl:relcl)
monitoring laboratory (compound)
0 ) (punct)
esters of (case)
infants very-low-birth-weight (compound)
cerebellum of (case)
ns-nsaids 9,832 (compound)
patients caused (acl)
remained seizure-free (dobj)
followed induction (nsubjpass)
agonist ( (punct)
comorbidities by (case)
diabetic nephropathy (dep)
anaesthesia hypotensive (amod)
mutation without (case)
determined frequency (nsubjpass)
erection absence (nmod)
treatment surgical (amod)
lack reach (acl)
evaluated then (advmod)
considered normally (advmod)
drug affinity (nmod)
investigate changes (dobj)
reduced therapy (nsubj)
outlining canaliculi (dobj)
accompanied -32 (dep)
examined determine (advcl)
reduction to (case)
factor carbonate (nsubj)
ng 10 (nummod)
received immediately (advmod)
tolerated reports (nmod)
neurotoxin dsp4 (dep)
use caution (dobj)
therapy except (case)
nucleus this (det)
contributes dysfunction (nmod)
displays and (cc)
relapse florid (compound)
role proven (amod)
0.06 . (punct)
severity liver (compound)
relationships development (nmod)
practices academic (amod)
depression long-term (amod)
deprivation of (case)
(r)-alpha-methylhistamine and (cc)
survival overall (amod)
act thus (advmod)
assessed transplantation (nmod)
normalization ratio (nmod)
decision the (det)
paclitaxel % (appos)
chemotherapy standard (amod)
1987 and (cc)
sera of (case)
odds univariate (compound)
rejection groups (nmod)
potential subclinical (amod)
hallmarks rare (conj)
leads improvement (nmod)
response therapy (compound)
agonist fenoldopam (nsubj)
lead could (aux)
receptors nmda (compound)
those a (nmod)
stability mechanical (amod)
increase level (nmod)
dili of (case)
shift . (punct)
gfap of (case)
products reaction (compound)
injection nicotine (compound)
pk day(-1 (appos)
glomeruli patients (nmod)
inhibition percent (amod)
diethylcarbamazine dec (appos)
prodrug developed (conj)
catalepsy behavior (conj)
expressed that (nsubjpass)
included range (dobj)
orbitofrontal in (case)
pretreatment znso(4 (compound)
% rizatriptan (nmod)
guidelines b (nmod)
dna mitochondrial (amod)
% -18.1 (conj)
treatment week (nmod:poss)
uptakes mitochondrial (amod)
associated insulin-group (nmod)
extent ones (nmod)
hh 33.42 (dep)
lna ( (punct)
ctni ( (punct)
amines selected (amod)
tr(- mrp2-deficient (amod)
compound potency (nmod)
menopause surgical (amod)
indication biopsy (nmod)
patients advanced (amod)
was published (conj)
appears there (expl)
relevant . (punct)
be associated (advcl)
rr 1.3 (nummod)
consumption ethanol (compound)
detected apoptosis (nsubjpass)
capacity hypertension (nmod)
need initiatives (nmod)
increases risk (dobj)
trimethoprim with (case)
conclusions proposed (appos)
making risk (dobj)
develop who (nsubj)
effects cefonicid (nmod)
expression ut-a1 (compound)
studied conditions (nmod)
neurotoxicity patients (nmod)
recorded compared (conj)
2- and (cc)
move disruption (nmod)
obtained predose (xcomp)
pustulosis palmoplantar (compound)
trait and (cc)
involvement mrp2 (nmod)
changed chloride (nmod)
morphology and (cc)
received consultations (nmod)
min time (nsubj)
occurs cessation (nmod)
infusion nitroprusside (amod)
signified prognosis (dobj)
systems the (det)
31 12 (compound)
therapy t (compound)
= yrs (dep)
patients 452 (nummod)
indicate similar (ccomp)
used hypertension (nsubjpass)
alternations rapid (amod)
chemistries serum (compound)
compared etiology (conj)
increase or (cc)
ecg on (case)
hour one (nummod)
reversed but (cc)
often recognized (advcl)
ifosfamide ifo (appos)
using directly (advmod)
increased salbutamol (nsubj)
lowered mean (dep)
intense was (cop)
absorbed and (cc)
enucleation subsequent (amod)
hb psa (conj)
number periods (nmod)
experiences adverse (amod)
up-regulation pgp (nmod)
abecarnil beta-carboline (compound)
stabilizer mood (compound)
underwent assessments (dobj)
conjugates synthesis (dep)
reversibility days (nmod)
eligible dse (nmod)
structure this (det)
w/v ( (punct)
lacnp right (amod)
injections iopentol (compound)
seemed incidence (nsubj)
discontinuation baclofen (nmod)
schizophrenia for (case)
thickening and (cc)
received fentanyl (dobj)
carotenoids of (case)
synthase myo-inositol-1-phosphate (compound)
vomiting or (cc)
acid r-aminobutyric (amod)
converting when (advmod)
area planar (compound)
isoniazid to (case)
study descriptive (amod)
opening pores (nmod)
months risperidone (appos)
pan ) (punct)
exercise therapy (conj)
immunosuppressed . (punct)
responses asthmatics (nmod)
antigen varidase (compound)
case injury (nmod)
m1 and (cc)
degrees % (appos)
decreased found (parataxis)
ondansetron peri-operative (amod)
seem preventing (advcl)
532 27 (compound)
cases hypotension (nmod)
intubation tracheal (compound)
increased results (dep)
literature amlodipine (nmod)
depression severe (amod)
suggested blocker (ccomp)
targeted dose (nsubjpass)
depression treatment-resistant (amod)
ca2 cytosolic (amod)
thorax limbs (conj)
values laboratory (compound)
toxicity prevented (acl:relcl)
markers those (det)
sensations such (case)
implicated use (nsubjpass)
filariasis with (case)
observed subtypes (conj)
convulsant cd50 (appos)
tgf-b mtor (conj)
subjects ) (punct)
raised values (nsubjpass)
channel 1,4-dihydropyridine (compound)
respond . (punct)
induction , (punct)
offset benefit (dobj)
cycles nine (nummod)
follow-up careful (amod)
biopsy kidney (compound)
displayed but (cc)
accumulation glycine (nmod)
regimens chemotherapy (compound)
missed , (punct)
hyper- 0 (dep)
stage although (case)
suggested related (ccomp)
similarities dependency (nmod)
relieved pa (nmod)
isolated perfusion-cultured (dep)
man appeared (acl:relcl)
ratio ) (punct)
streptozocin rats (nmod)
onset arrhythmias (nmod)
eyes the (det)
expression cytokines (nmod)
size population (nmod)
doses 16 (nummod)
focus serum (nmod)
eyes ( (punct)
technique for (case)
hallucinations , (punct)
59 eps (nmod)
microscopy samples (nmod)
blockade serotonin (compound)
injection weight (dep)
catecholamines stress (conj)
seven in (case)
reported disorder (nsubjpass)
injection only (advmod)
evoked administration (nmod)
common diagnosed (conj)
lobe epilepsy (dep)
high-dose methylprednisolone (dep)
patients protection (nmod)
treatment dox (nmod)
recognition consumption (compound)
35.0 or (cc)
aura aura (nmod)
0.15+/-0.03/h vs. (cc)
evidenced depression (nmod)
side-effect and (cc)
regimen total (nmod)
examined immunohistochemically (advmod)
model aminonucleoside (compound)
indirect that (mark)
effects late (amod)
was loss (nsubj)
clipping after (case)
event , (punct)
acquired cases (nmod)
reduced amount (nsubjpass)
described reactions (nsubjpass)
myocardial and (cc)
dose usual (amod)
less bupivacaine (nmod)
developed following (advcl)
enhances dopamine (nsubj)
identified we (nsubj)
occur therapy (nmod)
prk laser (compound)
led acting (advcl)
stage disease (nmod)
studied discovered (conj)
hospital psychiatric (amod)
improves immunity (dobj)
more statistically (advmod)
allocated patients (nsubjpass)
glaucoma advanced (amod)
weeks 31 (nummod)
conclusion indicate (dep)
scans by (case)
seen controls (nmod)
improve memory (dobj)
modulator and (cc)
showed electrophoresis (nsubj)
5mg/kg ( (punct)
therapy had (amod)
alpha2- and/or (cc)
disorders in (case)
glimepiride 0.4-fold (conj)
returned 25 (nmod)
haloperidol of (case)
presentation scans (conj)
tie pathological (amod)
vasospasm artery (compound)
indicates data (nsubj)
regimen methamphetamine (compound)
patients types (nmod)
reflex vestibulo-ocular (amod)
investigation mechanism (nmod)
attenuation lipid (nmod)
aspirin ) (punct)
feature a (det)
hours concentrations (dep)
followed stroke (nsubj)
absence cefotetan (nmod)
administration local (amod)
tdf ) (punct)
an ) (punct)
20-fold nearly (advmod)
fibrosis myocardial (amod)
good experiences (nmod)
damage cell (compound)
abnormality renal (amod)
had lesions (dobj)
most hepatomas (nmod)
suppressed startle (dobj)
changed fos-ir (nsubjpass)
caa acrolein (conj)
nonusers n (dep)
objective : (punct)
long-term timolol (dep)
symptoms and (cc)
containing % (dobj)
pretreatment 24-h (amod)
data involving (acl)
postulated are (auxpass)
min preinfusion (dep)
patients neuralgia (nmod)
nephropathy nephropathy (conj)
number hypertension (conj)
restricted conformationally (advmod)
eia ( (punct)
noradrenaline 5-hydroxytryptamine (conj)
crosses barrier (dobj)
test repetitive (amod)
history reactions (nmod)
analyzed include (advcl)
multicenter 3 (nummod)
2.8 to (dep)
smaller doses (nsubj)
histamine of (case)
clentiazem , (punct)
losses urinary (amod)
presented penicillin (nsubjpass)
phenotyping from (case)
located aneurysms (nsubjpass)
loading rats (nmod)
persisted cholestasis (nsubj)
rats twelve (nummod)
mouse-1 5.0 (nummod)
rationale scientific (amod)
form autosomic (amod)
stage a (det)
randomized april (nmod)
mice treated (acl)
reduction significant (amod)
defects birth (compound)
aim report (dep)
used identify (advcl)
suggested involved (ccomp)
ml 8.9 (nummod)
abstained learning (nmod)
buffer to (case)
media radiographic (amod)
administered when (advmod)
sagittal superior (amod)
anti-oxidant properties (dep)
administered determined (advcl)
out-patients non-hypertensive (conj)
advantage requiring (advcl)
studies ii (nummod)
elucidated . (punct)
promotes that (nsubj)
secretion enhanced (amod)
gas the (det)
agents sparing (compound)
mdp ( (punct)
berlin at (case)
minimised use (dep)
tolerable easier (conj)
denied cip (dobj)
tablets short-acting (amod)
abundances na(+)-cl(- (conj)
g/ml < (compound)
age gender (conj)
increased frequency (dobj)
20 cardiomyopathy (nmod)
decreased q10 (nsubj)
related appear (conj)
ability maximum (amod)
recorded ischemia (nmod)
due injury (nmod)
analyzed determine (xcomp)
vessels coronary (amod)
middle-aged for (case)
develop tolerance (nsubj)
imaging . (punct)
thrombo-embolism or (cc)
interactions in (case)
binding 3h-tbob (compound)
measures main (compound)
u 30 (nummod)
3504 l/m2 (conj)
was observe (xcomp)
lipoprotein hdl (appos)
safety phase (nmod)
poag ) (punct)
myalgia any (det)
catatonia ketamine-induced (amod)
effective bromocriptine (nsubj)
flow , (punct)
il-2 with (case)
normalization state (conj)
necrosis for (case)
peak mg/kg (nmod)
drug as (case)
increase foci (nmod)
induced levels (nsubjpass)
considered leakage (nsubjpass)
diethylcarbamazine with (case)
behaviors dependent (amod)
suggestive hepatotoxicity (nmod)
ameliorated , (punct)
exposure prenatal (amod)
rhythms discharges (nmod)
atropine intravenous (amod)
years 24 (nummod)
placebo-controlled double-blind (dep)
dose hemisulfate (nmod)
screening plasma (compound)
appear predispose (xcomp)
resembles that (nsubj)
leads conclusion (nmod)
pressure capillary (amod)
had children (nsubj)
few and (cc)
reduced remained (conj)
suited well (advmod)
collagenase of (case)
expressed percentage (nmod)
followed asystole (nmod)
metabolites remoxipride (compound)
patients ibs (compound)
milligrams four (nummod)
escape immune (amod)
mol/l mol/l (dep)
enzymes of (case)
adapt practice (nmod)
hematomas larger (amod)
test assessment (nmod)
excretion group (nmod)
inhibitors paranoia (advmod)
grade neutropenia (compound)
liability no (det)
rats minutes (nmod)
developed fulfill (xcomp)
mediates toxicity (dobj)
dosage meth (nmod)
design : (punct)
h2o2 ( (punct)
applications dyskinesias (nmod)
range 6 (nummod)
subunits alpha-enac (compound)
adenosine fluid (nmod)
vincristine infusional (amod)
performed prospectively (advmod)
timing therapy (nmod)
mg/kg the (det)
75 fef25 (compound)
culture , (punct)
restarted rate (nmod)
headache tension-type (amod)
completing ) (punct)
scores mean (compound)
has blockade (dobj)
frequency potential (amod)
syndrome immunodeficiency (compound)
pentobarbital sodium (compound)
cases injury (nmod)
anticoagulation the (det)
received who (nsubj)
history disorder (nmod)
patients forty-five (amod)
gas inspiratory (amod)
prodrugs their (nmod:poss)
mglur1 striatal (amod)
accumulation proteins (nmod)
derivative non-steroidal (amod)
valdecoxib for (case)
mouse-1 mice (appos)
myeloperoxidase- nor (cc)
completed thus (advmod)
january 2001 (dep)
modulated that (mark)
recurring was (aux)
flattening phase (nmod)
conduction block (nmod)
those isolated-hit (nmod)
improve efficacy (dobj)
contributed coagulopathy (nmod)
offers but (cc)
background marked (amod)
seizures bupivacaine-induced (amod)
way are (cop)
retention volume (compound)
response sympathetic (amod)
counted min (nmod)
action enhances (acl:relcl)
diet brought (acl)
days a (det)
injection weeks (nmod)
infusion ara-c (compound)
taking rbcs (nsubj)
pressure resting (amod)
revealed syndrome (dobj)
diazepam adenosine (conj)
reversed mg/kg (dep)
fall levels (nmod)
was cited (conj)
resembled lesions (nsubj)
oxidase xo (appos)
alert physicians (nsubj)
changes dramatic (amod)
hepatitis clotiazepam-induced (amod)
acid cancer (nmod)
arise derangement (nmod)
relief rapid (amod)
target to (mark)
showed clearly (advmod)
duration mean (amod)
overdosages phenytoin (compound)
months 52 (nummod)
studies iii (nummod)
anesthetics of (case)
ligation , (punct)
objective the (det)
end to (mark)
added lamivudine (nsubjpass)
reduction nausea (nmod)
lateral medial (conj)
slower reach (advcl)
succumbed therapy (nmod)
re-resection a (det)
box exploratory (compound)
menopause smoking (conj)
balance fluid (amod)
didanosine of (case)
picrotoxin- , (punct)
susceptibility mice (nmod)
use agents (nmod)
were examine (xcomp)
saline once (advmod)
given dogs (nsubjpass)
effective nodosum (nmod)
dilation function (conj)
reported response (nsubjpass)
characterize sensitivities (dobj)
mechanisms basic (amod)
rate same (amod)
measured shifts (nmod)
rats some (det)
rats phenobarbitone (amod)
cases adaptation (nmod)
received doxorubicin/kg (dobj)
middle cerebral (amod)
affected uptake (nsubjpass)
includes . (punct)
dodds and (cc)
although indicator (nsubj)
loss c (dep)
index n/n=25/26 (dep)
report neurotoxicity (nmod)
differed significantly (advmod)
phosphokinase , (punct)
biopsies lymph (compound)
activity postsynaptic (amod)
course events (nmod)
months serum (nmod)
tumor normal (conj)
calcitonin of (case)
obtained powders (nsubjpass)
diagnosed had (aux)
all modulators (nmod)
have , (punct)
range a (det)
implicated be (auxpass)
years sd (dep)
fell mm (nmod)
methods usual (amod)
rats habituated (acl)
ketamine tribute (dep)
recommend we (nsubj)
treatment dialysis (compound)
epilepticus ongoing (amod)
preparation carbidopa/levodopa (amod)
suggested evidence (conj)
galactosamine one (nummod)
study = (advcl)
group experimental (amod)
levels , (punct)
developed study (nmod)
intake cc (compound)
identified require (dep)
comparison pallidotomy (nmod)
exhibited inheritance (dobj)
interpret . (punct)
acetate combination (nmod)
pretreatment lithium (compound)
negative mdm (nmod)
change behavioral (amod)
165/90 hg (dep)
nsclc iv (nummod)
targeted respectively (advmod)
wore disturbances (nsubj)
leads stress (nsubj)
implications its (nmod:poss)
p patients (dep)
design randomised (amod)
recorded methods (nsubjpass)
groups animals (dep)
effective well-tolerated (conj)
change do (aux)
value differential (amod)
increased agents (nmod)
transferred he (nsubjpass)
had blocking (advcl)
integrity in (case)
cases drug (nmod)
pd , (punct)
device the (det)
arrhythmias all (predet)
participation the (det)
reversed atorva (nsubj)
34.98 + (cc)
abundance 2 (nmod)
administered cisplatin (nmod)
controls of (case)
measuring reabsorption (conj)
egfp ( (punct)
years 67 (nummod)
catalepsy and (cc)
flexion or (cc)
tacrolimus and (cc)
study hemodynamic (amod)
permits administered (xcomp)
cats anaesthetized (amod)
cd50 , (punct)
responsible improvement (nmod)
areas brain (compound)
moderate neurotoxicity (nsubj)
report trial (dobj)
abnormalities attributed (acl:relcl)
case 2 (nummod)
cause withdrawal (nsubj)
patients head (nmod)
contraindicated seizures (nmod)
difference od (nmod)
failed microinjections (nsubj)
speculate . (punct)
population non-endothelial (amod)
1.8-fold control (conj)
degree examination (nmod)
midazolam mg.kg-1 (dobj)
amplitude potential (compound)
constructed administration (dep)
cells apoptotic (amod)
present preserved (parataxis)
cromakalim simultaneously (advmod)
thyroxine ft4 (appos)
discontinuation treatment (nmod)
occurred occurred (parataxis)
related administration (nmod)
include reversible (parataxis)
increased latency-to-onset (dobj)
gradient synthesis (nmod)
artery on (case)
interaction this (det)
hyperalgesia myoclonus (conj)
capacity iron (compound)
effects undergoing (acl)
= .047 (dep)
remained mechanism (nsubj)
eight two (compound)
disease related (amod)
reported salicylates (nsubjpass)
indices in (case)
compared using (advcl)
data thrombotic (amod)
failed accentuante (xcomp)
risk alterations (nmod)
cause scale (nmod)
imbalance may (aux)
hypertension hydrocortisone-induced (amod)
continued whereas (dep)
awake and (cc)
morphology aortic (amod)
examine durations (nmod)
perfused days (nmod)
test withdrawal (compound)
exhibited end (nmod)
embryopathy hypoplasia (nmod)
good . (punct)
normalisation by (case)
mg p.o. (nmod)
presented male (nsubj)
post-lt suicide (compound)
p=0.002 ; (punct)
stimulation significant (amod)
play peptides (nsubj)
decrease stretching (nmod)
cats 10 (nummod)
tests returning (acl)
prevented atropine (nmod)
group d-med (compound)
produced attenuated (conj)
changes flow (nmod)
nephrotoxicity cisplatin-induced (amod)
1 4 (prep)
sinus straight (amod)
available until (mark)
benzoylecgonine greater (amod)
expression responses (conj)
cisapride and (cc)
acts , (punct)
acquired that (mark)
study supplementation (conj)
exhibited significantly (advmod)
support benefits (dobj)
undertaken are (auxpass)
suggesting formation (dobj)
preference and (cc)
incidence hospitalisation (nmod)
factors viii (conj)
induced vitro (advmod)
sites nucleus (conj)
levels transaminase (compound)
restoring in (mark)
agitation rhabdomyolysis (conj)
assumed generally (advmod)
conditions other (amod)
man 46-year-old (amod)
evaluated investigate (advcl)
alter but (cc)
dose cya (compound)
ic of (case)
ratings response (nmod)
overshooting and (cc)
map shr (nmod)
tgf-beta1 of (case)
patient developed (acl:relcl)
levels same (amod)
sedation due (case)
insult cytotoxic (amod)
fracture dislocation (conj)
hbsag ) (punct)
negative anti-hcv (nsubj)
change . (punct)
occurred individuals (nmod)
indicate findings (nsubj)
biochemical structural (conj)
continued hepatocytes (nsubj)
evaluated data (dobj)
vincristine after (case)
back baseline (nmod)
mechanism ototoxic (amod)
acting used (conj)
manic mixed (conj)
= 0.01 (dep)
recorded muscle (nmod)
ingestion aplasia (conj)
evaluate identify (conj)
sought should (aux)
absorption adrenaline (nmod)
mice not (neg)
intention-to-treat on (case)
observed reduced (ccomp)
nephropathy . (punct)
2.4.2.30 ec (compound)
assigned raloxifene (xcomp)
prevention stress (nmod)
increased yields (nmod)
complication frequent (amod)
ce the (det)
earlier days (nmod:npmod)
potent progesterone (nmod)
patients common (amod)
drinking and (cc)
day group (dep)
deprivation remd (appos)
undergoing lt (dobj)
activities scores (nmod)
leads that (mark)
purpose study (nmod)
treated /-s.d (dep)
reports associations (nmod)
resulted withdrawal (nsubj)
aucs at (case)
exhaustion pool (nmod)
shares hyperalgesia (nsubj)
blocker pure (amod)
occurs and (cc)
diet rat (nmod)
carriers ve (compound)
each administered (acl)
adr mg/kg (compound)
fbal into (case)
increases decreases (conj)
plasma removed (acl)
mechanisms focus (dep)
nos ( (punct)
evidence necrosis (nmod)
lesions p (dep)
occurred = (parataxis)
moving observed (conj)
revealed elevations (dobj)
devices the (det)
features discussed (acl)
was either (advcl)
likely significant (xcomp)
remained unsolved (xcomp)
antagonist a(2a)/a(1 (compound)
affect pressure (dobj)
reaction not (neg)
insertion women (nmod)
indicate increases (nsubj)
appear pig (nsubj)
cells ectopic (amod)
rhuepo-beta ) (punct)
exposure acute (amod)
blocker ca-channel (compound)
chloride application (nmod)
elevation less (amod)
methylxanthines other (amod)
mecamylamine nicotinic (amod)
affects that (nsubj)
lobe left (amod)
5-fu after (case)
lower l-sotalol (nsubj)
l-name inhibitor (appos)
depression the (det)
12- 24- (conj)
syndrome hus (appos)
70 - (punct)
tissues some (det)
stratum ) (punct)
evaluated . (punct)
diameters/bw between (case)
pretreatment ketanserin (nmod)
administered part (nmod)
play retention (nmod)
developed pneumonitis (nsubj)
southeast those (conj)
clearance in (case)
compared in-patients (nmod)
60 30 (conj)
activates system (dobj)
was treatment (nmod)
mg x (cc)
patients 14 (nummod)
medulla kidney (nmod)
failure with (case)
action treatment (nmod)
10(-8 ) (punct)
analysis stepwise (amod)
interval qt (compound)
clarify act (ccomp)
joints of (case)
creatinine , (punct)
immunohistochemistry electron (compound)
unchanged group (nmod)
used if (mark)
believed commonly (advmod)
cpa/ee were (cop)
treatment chc (nmod)
stimulus painful (amod)
cheaper sulphonylureas (dep)
nephropathy allograft (compound)
switched and (cc)
groups alf (dep)
velocity localization (conj)
testing m (nmod)
fit . (punct)
epileptiform discharges (dobj)
mode treatment (nmod)
periods various (amod)
level extracellular (amod)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine agonist (conj)
performed microscope (nmod)
factor agitation (conj)
side-effects pain (conj)
tetrandrine and (cc)
augmented which (nsubj)
occurrence fibrillation (nmod)
reducing patients (nmod)
pressure sbp (appos)
presented proteinuria (dobj)
investigated here (advmod)
sedations on (case)
opse ) (punct)
50 to (dep)
s patients (nmod)
prior and (cc)
alpha3 subunits (conj)
study symptoms (dobj)
patients 240 (nummod)
plays regulation (nmod)
showed retention (dobj)
arthrogryposis , (punct)
g. roberts (compound)
involving possibility (dobj)
eruptions with (case)
function postcibal (amod)
brain parkinsonian (amod)
3nt ) (punct)
demonstrated problems (dobj)
believed ratio (nsubjpass)
etoricoxib ( (punct)
have exposures (nsubj)
ventricular complex (compound)
32 12 (conj)
concern theoretical (amod)
nelarabine and (cc)
urine patients (nmod)
reduce to (dep)
process stress (compound)
100 than (advmod)
dynamics cerebrospinal (amod)
values times (compound)
management during (case)
origin associated (acl)
24.2 +/- (cc)
extend model (nmod)
given received (parataxis)
51 % (appos)
eating disorders (dobj)
sequelae attributable (acl:relcl)
proteinases by (case)
% 61 (nummod)
women selected (acl)
nitrendipine-treated n (dep)
exposure the (det)
71 8 (conj)
g day (nmod)
reported compared (prep)
haematological or (cc)
changed visualized (conj)
efforts noteworthy (amod)
obtained compounds (nmod)
intoxication acute (amod)
secretion gh (compound)
prevents acid (nsubj)
dogs affected (amod)
opioid 's (case)
given and (cc)
stroke gallbladder (conj)
maintain range (nmod)
emulsion both (conj)
pkc-alpha of (case)
% 48+/-4 (nummod)
manage patients (dobj)
units 32.6 (nummod)
caution extra (amod)
inefficient , (punct)
rna hepatic (amod)
tolerated cats (nmod)
done observation (conj)
diagnosis defects (conj)
caffeine and (cc)
seen revert (conj)
tcr ( (punct)
showed md (nsubj)
immunization-induced in (case)
factors duration (conj)
treatment antagonist (compound)
decrease parameters (nmod)
finding may (aux)
died period (nmod)
cpk his (nmod:poss)
secondary ) (punct)
26- 119- (conj)
return inhibition (appos)
use tumors (conj)
inhibitor cb (nsubj)
conditions to (case)
dex transplantation (nmod)
dvt ) (punct)
dose degree (conj)
correlated incidence (nmod)
symptoms risperidone (nmod)
relation . (punct)
to mind (nmod)
therapy immediate (amod)
raised data (nsubj)
suffer and (cc)
role or (cc)
hold promise (dobj)
dose healthy (nmod)
received thalidomide (dobj)
examined parameters (nsubjpass)
costs difficulty (conj)
march , (punct)
prostanoids , (punct)
as march (nmod)
determine have (ccomp)
good least (advmod)
patient relapse (nmod)
describe comparison (nmod)
seen rats (nmod)
images resting (amod)
low is (cop)
decreased thickness (nsubjpass)
increased expected (advcl)
assigned sertraline (nmod)
1 39.7 (dep)
potent exhibiting (advcl)
tests correlation (conj)
stenosis combined (acl)
metabolizer was (cop)
description woman (appos)
while level (nsubj)
acupuncture and (cc)
tolerate therapy (dobj)
catalepsy sch (conj)
marker useful (amod)
dysfunction sensory (compound)
measured rigidity (nmod)
deviation st (amod)
synapses at (case)
nmdar ligands (dep)
precede children (nmod)
july and (cc)
cultures heart (compound)
tmp-smz to (case)
doxorubicin from (case)
cessation therapy (nmod)
presented receiving (parataxis)
cocaine for (case)
trazodone , (punct)
components fraction (nmod)
conditions predisposing (amod)
concentration proteinuria (conj)
animals untreated (amod)
either groups (nmod)
effect fr (nmod)
retina optic (conj)
determine dosage (dobj)
7.73 5.85 (compound)
hour orally (advmod)
introduced ketoconazole (nsubjpass)
intralipd plus (cc)
mixture copolymer (nmod)
compensation in (case)
period 9-year (amod)
schedule standard (amod)
compared results (dobj)
mixed cholestatic (dep)
loss axonal (amod)
picture hepatitis (nmod)
tachycardia ( (punct)
mumol/kg range (compound)
attenuated tgr (nmod)
8.9 22 (conj)
practiced must (aux)
vacuolization and (cc)
induced phenytoin (nsubj)
uroprophylaxis mesna (compound)
direct sub-type-selective (dep)
occurred azotemia (nsubj)
pentobarbital value (dep)
ppi ( (punct)
negative single-blind (conj)
thresholds higher (amod)
vocalization upon (case)
demonstrate data (nsubj)
seizures developed (amod)
formation osteoid (nmod)
taking daily (advcl)
atropine hr (nmod)
< .05 (dep)
relaxations isoprenaline-induced (amod)
process absorption-limiting (amod)
hypersensitivity mechanical (amod)
instillations both (conj)
pseudoacromegaly hand (nmod)
edema and (cc)
ceased reactions (nmod)
addition amifostine (nmod)
b6 a/j (conj)
years two (nummod)
stress activity (conj)
displace pretreatment (nsubj)
nsc ; (punct)
effect dual (amod)
schedules administration (nmod)
technique kety-schmidt (amod)
dfc for (case)
expression level (nmod)
channels k+ (compound)
shown who (nsubj)
days prazosin (nmod)
demonstrate defect (ccomp)
selecting therapy (dobj)
cases 18 (nummod)
neurons tida (compound)
is need (attr)
discontinued multiforme (advcl)
discontinuing drugs (dobj)
effects lesions (nmod)
min subjects (dep)
women hospitalized (acl)
nephritis ain (appos)
examined effects (dobj)
higher group (nmod)
n=11 ) (punct)
effects thermic (amod)
administered vincristine (nsubjpass)
pitfall diagnostic (compound)
disorders and (cc)
developed transplants (nmod)
cell hrptec (compound)
risk intolerance (nmod)
fraction higher (amod)
hcva and (cc)
nitroglycerin sublingual (amod)
preserves ndi (nmod)
c three-weekly (amod)
pressure tail (compound)
pronounced . (punct)
induced exceed (advcl)
consider conclusions (dep)
nitrogen and (cc)
cd4 with (case)
hyperplasia epithelium (compound)
assessed days (nmod)
support : (punct)
ns-718 lipid (appos)
hypotension trimetaphan (amod)
susceptible oxacillin (nmod)
antagonized dose-dependently (advmod)
survivors transplant-free (amod)
study type (nmod)
intakes , (punct)
pretreated succinylcholine (nmod)
comparable to (mark)
trial mg/m(2 (appos)
induced calcineurin-inhibitor (nsubj)
amounts large (amod)
inactivation physiologic (amod)
reduced pretreatment (nsubj)
unnecessary age (nmod)
value tests (nsubj)
progesterone neither (cc:preconj)
t.d.s. mg (compound)
abbott-53693 alpha (compound)
often future (nmod)
occurs avoid (conj)
verapamil beta-adrenergic (conj)
hypothyroidism from (case)
condition that (mark)
subjects reactions (nmod)
concentrations coniine (nmod)
results trials (nmod)
optic , (punct)
n. : (punct)
effect injected (acl)
administration tdi (nmod)
status confusion (conj)
detected administered (advcl)
enhancers these (det)
therapy inhibitor (nmod)
occurs dobutamine (nmod)
determined is (auxpass)
different no (neg)
dizziness frequent (conj)
treating instillation (nmod)
received diazepam (conj)
nsaid acetaminophen (conj)
medications any (det)
failure hyperkalemia (nmod)
proteinuria nephrotic-range (amod)
syndrome left (amod)
fibrillation failure (conj)
% 5.4 (nummod)
marker astrocytic (amod)
signs nms (nmod)
mechanisms immune (amod)
indicate able (ccomp)
excluded eligible (conj)
likely : (punct)
hemodynamics and (cc)
linked sensitive (conj)
selected mimic (xcomp)
kanamycin and (cc)
institutes national (compound)
mol/l and (cc)
factor nerve (compound)
dysfunction fasting (nmod)
received ribavirin (nmod)
similar dose (nsubj)
= 0.808 (dobj)
cc ( (punct)
ccl2 chemokine (compound)
creatinine protein (conj)
doxorubicin tetrahydropyranyladriamycinol (conj)
iii/iv grade (compound)
signal of (case)
systolic pressures (dep)
comparable : (punct)
action antidotes (nmod)
lead abuse (nsubj)
time waveforms (nmod)
groups groups (conj)
incontinence , (punct)
strain " (punct)
changed days (nmod)
paf ( (punct)
closure and (cc)
experienced symptoms (dobj)
explained diseases (nmod)
concentrations flecainide (amod)
considered adjuvant (nmod)
angina for (case)
appear play (xcomp)
infants very-low (amod)
patient report (dep)
blindness with (case)
maximum cycles (nmod)
exception one (nummod)
damage neuropathy (nmod)
achieved . (punct)
represents , (punct)
hypoxemia required (acl:relcl)
work-up repeat (compound)
dose aspirin (nmod)
afterdepolarization 2 (nummod)
understanding our (nmod:poss)
evaluation neurologic (amod)
suited research (nmod)
extracted birth (xcomp)
hypersensitivity carbamazepine (nmod)
ingestion , (punct)
tendency produce (acl)
therapy iron (compound)
stimulants agents (conj)
sought aims (nmod:npmod)
superior p (dep)
1992 1994 (prep)
levels nitric (amod)
relates that (nsubj)
ed50 analgesic (amod)
reaction such (case)
therapy epilepsy (nmod)
lead exposure (nmod)
stage kidney (compound)
absence 5-azc (appos)
risks applicators (nmod)
rough and (cc)
increase factors (conj)
excludes . (punct)
antigen p24 (compound)
affect , (punct)
scored histologically (advmod)
recurrence cause (nsubj)
ensued and (cc)
hydrochloride sodium (conj)
down . (punct)
hepatitis acid-induced (amod)
conversion srl (nmod)
hooded long-evans (nsubj)
resistant effects (nmod)
cooperative eastern (amod)
diseases severe (amod)
end after (case)
hyperhidrosis . (punct)
morning in (case)
regimen ( (punct)
encephalopathy late-onset (amod)
taking venlafaxine (dobj)
2c 1a (conj)
sonography neonates (nmod)
% specimens (nmod)
exposures with (case)
patients admitted (acl)
maintained period (nmod)
kidneys their (nmod:poss)
cause statins (nsubj)
numbers activity (nmod)
data demonstrating (acl)
alternative safe (amod)
instability stimulation (nmod)
discontinue to (mark)
carcinomas bladder (compound)
stereotypy on (case)
toxicity was (cop)
oil saline (compound)
being free (acomp)
effects flestolol-induced (amod)
albumin ultrastructure (conj)
therapy preoperative (amod)
sedation group (nmod)
impact cause (nmod)
estimated associated (advcl)
alpha-fluoro-beta-alanine of (case)
peptide(1 beta (compound)
change levels (nmod)
= 0.072 (dep)
tissue impairment (nmod)
patients belonging (acl)
% -4.6 (nummod)
range 99 (nummod)
assessment cardiological (amod)
block attacks (nmod)
mornings in (case)
cortex frontal (amod)
research quasi-experimental (amod)
staining immunocytochemical (amod)
co-treatment ) (punct)
pretreatment dexamethasone (nmod)
kidney functional (amod)
2- to (dep)
n=2.8+/-1.09 ) (punct)
difference animals (nmod)
presentation to (case)
enhanced effect (nmod)
analog somatostatin (compound)
oscillation pupillary (amod)
26 about (advmod)
improvement baseline (nmod)
elevation caused (acl)
age a (det)
assessed efficacy (nsubjpass)
preserved , (punct)
powered however (advmod)
first explore (acl)
events bleeding (amod)
associated infrequent (nmod)
situation clinical (amod)
oxcarbazepine analogue (compound)
recognizing complication (dobj)
development mg/kg (appos)
month treatment (nmod)
prolongation transient (amod)
took rhythm (nsubj)
excitation of (case)
duration their (nmod:poss)
ameliorated can (aux)
micrograms/day 1863 (nummod)
excess of (case)
exposed peptide(1 (dobj)
chlorofluorocarbons cfcs (appos)
neurotoxicity tacrolimus-induced (amod)
complex iv (nummod)
incubation ns-718 (nmod)
methadone receptor (compound)
examined is (auxpass)
motor phonic (conj)
study further (advmod)
effective amlodipine (nmod)
tqrs ) (punct)
spectra patterns (nmod)
diabetic ( (punct)
using warranted (ccomp)
aspirin 0.80 (appos)
csa mg/kg (dep)
size lysosomal (amod)
homozygous and (cc)
models . (punct)
risk corresponding (amod)
slowing 5 (nmod)
aorta/serum-ratio injection (nmod)
apparatus and (cc)
torr 61 (nummod)
pce ) (punct)
diary voiding (amod)
seizure associated (acl)
placed emphasis (nsubjpass)
toxin the (det)
enzyme cardiac (amod)
formation vacuoles (nmod)
found fasciculation (nsubjpass)
sulpiride and (cc)
treatment pectoris (nmod)
showed tests (nsubj)
values fps (compound)
monitored occasions (nmod)
intervals and (cc)
hospital community (compound)
makes selectivity (nsubj)
shown reflect (xcomp)
associated sedation (nmod)
degeneration subcellular (amod)
group s-i (compound)
down-regulation adrenoceptors (nmod)
change group (nmod)
inhibitors ssris (appos)
hemoglobin < (dep)
uptake and (cc)
developed additionally (advmod)
stress chronic (amod)
population defined (amod)
improved indicated (advcl)
echocardiography myocardial (amod)
metoprolol racemic (amod)
achieve using (xcomp)
whom 130 (compound)
neurons mice (nmod)
gel rate (nmod)
prescribing medications (dobj)
765 ( (punct)
patients more (advmod)
included drowsiness (conj)
usa inc (conj)
discontinuation patients (nmod)
intensity attack (nmod)
week drug (nmod)
severe was (cop)
hyperactivity due (case)
59.8 0.4 (conj)
underwent protocol (dobj)
prevent doses (conj)
mediated non-receptor (amod)
cerebella in (case)
amounts the (det)
protein and (cc)
edema matter (compound)
acid 8-hourly (advmod)
useful mediated (advcl)
survival time (nmod)
malformation myelomeningocoele (conj)
dysfunction mitochondrial (amod)
secondary case (nsubj)
demonstrated correlation (nsubjpass)
seizures infusion (nmod)
height presented (acl)
hypertension lead-induced (amod)
shedding or (cc)
accomplished risk (nmod)
occurring downstream (advmod)
mg/day disease (nmod)
ducts the (det)
occurring transplantation (nmod)
hepatocellular criteria (conj)
difficulty distinguishing (advcl)
rats diversion (nmod)
txa ( (punct)
progression weakness (nmod)
epsilon-aminocaproate , (punct)
hildebrand al (dep)
way under (case)
evaluated additionally (advmod)
given weekly (conj)
daunorubicin : (punct)
carcinoma superficial (amod)
eradication in (case)
nurse registered (amod)
blockade atropine (nmod)
gd 21 (nummod)
discovered could (aux)
dose i.v. (compound)
buffers ph (appos)
presented diagnoses (nsubjpass)
milieu , (punct)
medications underlying (conj)
reported 1995 (nmod)
hyperammonemia through (case)
bun ) (punct)
remained was (auxpass)
different normal (nmod)
glutamate both (cc:preconj)
3 times (quantmod)
frequency voiding (amod)
aspartate in (case)
subgroup primarily (advmod)
akinesis apical (amod)
resection therapy (conj)
n=35 ) (punct)
mutations . (punct)
use dose (compound)
progression adriamycin (nmod)
chick young (amod)
prior aap (nmod)
cylinder of (case)
decreased 4 (dep)
rf ( (punct)
reduction relative (amod)
suggested evaluation (nsubj)
signs identifiable (amod)
affinity with (case)
peak at (case)
hem n (appos)
ceruleus locus (compound)
internists , (punct)
detected rats (nmod)
dependency its (nmod:poss)
involvement skeletal (amod)
mg/day 1000 (nummod)
dyskinesia haloperidol-induced (amod)
knife leksell (compound)
therapy convenient (amod)
abnormality encephalopathy (nmod)
bcnu of (case)
incubated were (auxpass)
displace did (aux)
confirmed studies (nsubj)
dfo ) (punct)
due proteinuria (nsubj)
gtn microg/kg/min (compound)
ro15 1788 (appos)
involve response (dobj)
years of (case)
interactions drug (compound)
reduced sbp (dobj)
ip flumazenil (compound)
name trade (compound)
accumulated far (advmod)
rate turnover (nmod)
product rate (compound)
lisinopril of (case)
treatment beta-blocker (compound)
reduced rise (dobj)
length af (nmod)
strains e (det)
fibrosis fibrosis (conj)
added . (punct)
protocol reductions (conj)
suggestions interactions (nmod)
tool an (det)
range mg/dl (dep)
necessitating implantation (dobj)
tendency aggressiveness (nmod)
myalgia , (punct)
died whereas (dep)
hormones with (case)
5-fluorouracil in (case)
limited year (nmod)
nonmutant wild-type (dep)
describe begun (parataxis)
segmental , (punct)
enrolled protocol (nmod)
vacuolization epithelial (amod)
asenapine haloperidol (conj)
osmolality to (case)
expression for (case)
receptors peripheral (amod)
syndrome milk-alkali (amod)
patients nine (nummod)
microglia the (det)
determine and (cc)
pronounced than (advcl)
physician by (case)
wt cyp (nmod)
24.3 was (cop)
consists screenings (nmod)
echocardiography a (det)
report earlier (amod)
received rats (nsubj)
ana and (cc)
correlate volumes (nsubj)
discontinuation azithromycin (nmod)
rates > (compound)
15 1 (compound)
women 20 (nummod)
acetaminophen produce (acl)
synthesis restoration (nmod)
exposure diazinon (compound)
degrees slight (amod)
evidence propranolol (nmod)
patient delirium (nmod)
accompanied experiments (nmod)
preserved . (punct)
treated successfully (advmod)
collected volunteer (nmod)
use careful (amod)
dose any (det)
cells/mm3 . (punct)
tests detailed (amod)
treatment c (nmod)
controls pseudoprolactinoma (conj)
barrier rat (nmod)
s-1 ) (punct)
allows that (nsubj)
mechanism involving (acl)
= 0.006 (dobj)
proportions patients (conj)
dose amphetamine (compound)
d11 and (cc)
displayed sodium (nsubj)
treated to (mark)
induced cells (nmod)
rabbits seen (acl:relcl)
areas develop (acl:relcl)
mismatch supply (nmod)
tissues , (punct)
alter bnpp (nsubj)
receiving contraceptives (dobj)
mesothelioma in (case)
showed measurements (nsubj)
reoccur did (aux)
nucleotide-gated hcn (appos)
unaltered levels (nsubj)
bia ( (punct)
identify monitor (conj)
32.3 9.9 (conj)
disposition due (case)
susceptible exerts (advcl)
changes limited (acl:relcl)
develop esrd (dobj)
experienced diplopia (dobj)
society an (det)
diminish thus (advmod)
responses papillary (amod)
doxorubicin plus (cc)
was diagnosis (nmod)
focus a (det)
1520 +/- (cc)
manifestations minor (amod)
atp dogs (appos)
66.9 . (punct)
course infusions (nmod)
advocated observed (advcl)
sacrifice hearts (dobj)
p<0.01 duration (conj)
show that (mark)
treated measures (nmod)
confirmed microscopy (nmod)
objectives success (dep)
mg/kg 800 (nummod)
80.8 +/- (cc)
amount protein (nmod)
cause 70 (nmod)
sbp recovered (acl)
concentration protein (nmod)
facilitated e2 (nsubj)
group versus (cc)
association relation (nmod)
reported august (nmod)
cei ) (punct)
tetrandrine fangchinoline (conj)
317 57 (compound)
complication as (case)
antinociception of (case)
layer , (punct)
ifo with (case)
observed ; (punct)
flaccid and (cc)
facilitate use (nsubj)
describe concentration (conj)
feature be (cop)
width cortex (compound)
weeks admission (compound)
values metoprolol (compound)
objective describes (dep)
received tolerated (advcl)
quantified has (aux)
multivitamin week (nmod)
allopregnanolone , (punct)
response prodysrhythmic (amod)
compare risks (dobj)
samples daily (amod)
potassium penicillin-g (amod)
caused dose (nmod)
mice nrf2(+/+ (amod)
binding dopamine (compound)
organs in (case)
selection sensitivity (nmod)
consider episode (dobj)
demonstrated patient (nsubj)
symptoms capacity (conj)
opaque absent (conj)
benefit that (mark)
rhabdomyolysis of (case)
suggest contribute (ccomp)
drugs agents (appos)
nf-kappab ( (punct)
kidneys intact (amod)
patient eczema (nmod)
helpful , (punct)
propofol by (case)
delirium woman (nmod)
cis-platin 5-fluorouracil (conj)
timolol pronounced (conj)
monitor pressure (compound)
0.3 3 (conj)
anxiety on (case)
injections groups (nmod)
name to (mark)
months 20 (nummod)
apomorphine agonist (appos)
treated both (cc:preconj)
an-2-ol 3,4-dimethoxyphenyl)ethanolamino]-prop (compound)
anemia : (punct)
patients signs (nmod)
investigated are (aux)
nsaid ) (punct)
indicated scores (nmod)
reduced toxicity (dobj)
provided ketamine (nsubj)
bicuculline , (punct)
formula calvert (compound)
bfgf of (case)
derivative pyrrolidinone (compound)
8 to (dep)
makes patients (nmod)
allocated . (punct)
schizophrenia disorder (conj)
consisted history (nmod)
phases by (case)
method morning (nmod:tmod)
induced seizures (nsubjpass)
succeeded which (nmod)
agent gamma-aminobutyric (amod)
vision colour (compound)
are users (nsubj)
8.5 2.0 (conj)
occurred ( (punct)
led increase (nmod)
ptz picrotoxin (conj)
form cs (nmod)
published 2005 (nmod)
dystrophy muscular (amod)
targeted therapeutically (advmod)
value greatest (amod)
treatment fluid (nmod)
density both (cc:preconj)
fluency during (case)
vsds rabbits (nmod)
decrease sod (nmod)
modulate anesthetics (nsubj)
hitt ) (punct)
patients control (amod)
induced usually (advmod)
treatment adequate (amod)
study which (nmod)
21/63 % (dep)
brainstem to (case)
discussed features (nsubjpass)
inhibited proliferation (dobj)
series second (amod)
region hippocampus (nmod)
normochromic anemia (nsubj)
investigating effects (dobj)
eluate the (det)
3.4 2.0 (conj)
weakness a (det)
acquired data (nsubjpass)
subjects experiencing (acl)
qtls ) (punct)
beginning attack (nmod)
associated raloxifene (nmod)
anorexigens states (nmod)
contractility uterine (compound)
sludge and (cc)
bradydysrhythmias fibrillation (conj)
osteoporosis with (case)
performance normal (amod)
antidotes other (amod)
signed ranks (dobj)
overdose diphenylhydantoin (compound)
studies the (det)
altered concentrations (nsubjpass)
diazepam with (case)
reduces conclusions (dep)
studies by (case)
complication common (amod)
involved must (aux)
follow-up to (case)
found bilaterally (advmod)
bromocriptine receiving (compound)
incidence ccnu (appos)
epidemiology . (punct)
died observed (conj)
result injury (nmod)
assessed recurrence (dobj)
fatigue dizziness (amod)
underwent band (nmod)
injection calcitonin (compound)
failure cardiomyopathy (amod)
iodine of (case)
return excretion (nmod)
1.03 1.04 (conj)
effects systemic (amod)
micrograms/kg 20 (nummod)
echocardiography of (case)
role reversal (nmod)
develop neurotoxicity (dobj)
suggested ; (punct)
developed developed (conj)
episode before (case)
considered likely (xcomp)
experienced which (nmod)
undergoes . (punct)
eosinophil cells (conj)
injected alfentanil (nmod)
nephrin and (cc)
model 44.18 (conj)
revealed mm (nsubj)
ester l-name (appos)
assay transferase-mediated (amod)
decreased 33.6 (nmod)
acid hydroxy (amod)
thirst vasopressin (conj)
increase mb (nsubj)
terminated injection (nmod)
eps , (punct)
medication iop-lowering (amod)
therapy p9605 (appos)
treated ee (nmod)
apply may (aux)
1967 and (cc)
consistent is (cop)
sign neurotoxicity (nmod)
mater cranial (amod)
resulted course (nsubj)
dhea mg/kg (compound)
processes for (case)
benefits certain (amod)
neurotransmission dopamine (compound)
criteria organization (compound)
induced decreased (conj)
man presented (acl)
dosages large (amod)
hypertrophy lv (compound)
led concerns (nsubj)
normal patients (nmod)
ages searched (conj)
regained patient (nsubj)
recipient of (case)
% n (appos)
time-to-onset symptoms (nmod)
remains development (nmod)
showed + (cc)
put aspirin (nmod)
used m0 (nmod)
edema surrounding (amod)
expression over (case)
conditions on'- (nmod:poss)
shifts afterdischarges (conj)
affected purpose (dep)
content of (case)
beta-carboline-3-carboxylate methyl (amod)
mice ko (appos)
injection before (case)
effects suprofen (nmod)
dexamethasone weight (appos)
courses four (nummod)
possible being (cop)
arrest sinus (compound)
noted placebo (nmod)
disappeared papaverine (nmod)
episodes short (amod)
profile toxicity (compound)
open-labeled this (det)
reviewing history (dobj)
feasibility paclitaxel (nmod)
evaluate efficacy (dobj)
effects cardioprotective (amod)
revealed change (dobj)
administration long-term (amod)
control either (det)
rammer al (dep)
rest the (det)
db 10 (nummod)
safety ( (punct)
studied relationship (nsubjpass)
assaults induced (acl)
antagonism adrenoceptor (compound)
exists , (punct)
antibiotics prophylactic (amod)
interference efficacy (nmod)
strains lamivudine-resistant (amod)
option syndrome (nmod)
measurement semiquantitative (amod)
retention with (case)
aggregation pretreatment (compound)
started october (nmod)
ace ( (punct)
inhibitor children (nmod)
heart mitochondria (conj)
nephropathy doxorubicin-induced (amod)
agent enzyme-blocking (amod)
3551 336 (conj)
2005 in (case)
combination myelopathy (nmod)
produce injections (nsubj)
administered ip (dep)
reconsidered basis (nmod)
myopathy to (case)
infections most (amod)
area glomerular (amod)
complained 1 (nsubj)
methyldopa intravenous (amod)
number trials (nmod)
results identified (appos)
died rats (nsubj)
therapy a (nmod)
cause score (advcl)
prostanoids may (punct)
dentate colliculus (conj)
periods relapse (nmod)
iopamidol the (det)
patients consisted (dep)
useful imaging (nsubj)
fluconazole 's (case)
myalgias , (punct)
synthesis on (case)
women 45 (nummod)
sign any (det)
optic neuropathy (acl)
level consciousness (nmod)
higher site (nsubj)
cerebellum melatonin (conj)
measures self-report (amod)
toxicity excessive (amod)
dph ( (punct)
v 17 (dep)
acting amplitude (nmod)
impairing drop (dobj)
potentiation progesterone (compound)
higher penetration (nsubj)
demographics , (punct)
strategies . (punct)
inhibit influx (dobj)
n=92 93 (conj)
days 1 (nummod)
effects severe (amod)
modified hyperlocomotion (nsubjpass)
doses bupivacaine (nmod)
accumulation right (nmod)
n controls (conj)
reported neuropathy (nsubjpass)
nitrendipine inhibitor (conj)
studies balance (compound)
increased titre (nsubj)
invariable are (cop)
demands myocardial (amod)
afford that (mark)
decrease sensitivity (nmod)
episodes reported (amod)
effective to (mark)
a fk506 (conj)
hospital 1,100-bed (amod)
osmolality maximum (compound)
dose mg. (nmod)
effect similar (amod)
electrophoresis difference (compound)
predictor alterations (nmod)
rate regular (amod)
appeared excluded (parataxis)
kidneys groups (nmod)
percent 39 (nummod)
supplementation calcium (compound)
limit , (punct)
gene , (punct)
dose ln (conj)
sprague-dawley sixty (compound)
prevents whether (mark)
rats focusing (acl)
distributed unevenly (advmod)
attenuate models (nmod)
inhibition ezetimibe (amod)
caused hypersensitivity (nmod)
males ) (punct)
brain behavior (conj)
become procedure (nsubj)
signs lid (conj)
m(1)-selective ' (punct)
types cancers (nmod)
ciprofloxacin norfloxacin (conj)
reduce pressure (dobj)
91.5 ( (punct)
prilocaine ) (punct)
antagonism effects (nmod)
enhance drugs (nsubj)
coagulopathies consumption (compound)
laboratory clinical (conj)
sites primary (amod)
bold ( (punct)
damages neuropathological (amod)
tone increased (amod)
complications unexpected (amod)
head-up degrees (compound)
determined terms (nmod)
anatomic functional (conj)
given imipramine (dobj)
deficit rate-related (amod)
remedy that (mark)
peptide(1 42 (nummod)
patients asthmatic (amod)
a/j , (punct)
interest wide (amod)
confirmed until (mark)
complete loss (dobj)
lower to (mark)
creatinine in (case)
receptor nm (appos)
had phenothiazines (dobj)
metabolism responses (nmod)
microg/side agonist (nmod)
tnf-a ) (punct)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine and (cc)
concentration base (amod)
aware physician (nsubj)
exert demonstrated (advcl)
vasoactive polypeptide (dobj)
% infections (nmod)
that is (cop)
group schizophrenia (compound)
antibodies receptor (compound)
delta , (punct)
dg-5128 mg/kg (dep)
basis records (nmod)
blockers reuptake (compound)
yohimbine alpha(2)-adrenoceptor (compound)
cats and (cc)
suggested quantify (xcomp)
admitted use (nmod)
determined although (mark)
cause amlodipine (nsubj)
score necrosis (compound)
development cognitive (amod)
treated znso(4 (nmod)
prevent downregulation (dobj)
enrolled initially (advmod)
dyscontrol inattention (conj)
vascular , (punct)
attenuate ototoxicity (dobj)
in only (advmod)
recognition , (punct)
loss by (case)
age . (punct)
fibrillation from (case)
had pain (nmod)
excitement frequency (conj)
tended lesions (nsubj)
inhibit angiogenesis (dobj)
7th the (det)
neurologic psychiatric (conj)
nephrotoxicity metabolism (conj)
8 3 (compound)
loci susceptibility (compound)
hypothesis disrupts (ccomp)
seizures levomepromazine-fluvoxamine (amod)
trial double (amod)
positive time (nmod)
increased these (nsubjpass)
nocistatin mouse-1 (dep)
mutants common (amod)
case use (nmod)
derivative dp/dt (appos)
status prolonged (amod)
alphabeta-crystalin , (punct)
prolongs ratio (dobj)
treat cause (xcomp)
males , (punct)
observed they (nsubjpass)
puromycin-aminonucleoside and (cc)
time latency (compound)
comparison women (nmod)
seizure electrical (amod)
indicated , (punct)
confirmed through (advmod)
tumors mesenchymal (amod)
administration management (nmod)
lack interference (nmod)
events unclassified (amod)
hypothyroidism to (case)
administration in (amod)
conclusions treatment (dep)
case degree (nmod)
suppressed addition (nmod)
failed allopurinol (nsubj)
gained , (punct)
localization random (amod)
clearance cin (appos)
time ventricular (amod)
healthy previously (advmod)
agents used (acl)
2-chloroprocaine-ce of (case)
all status (nmod)
metabolites vpa (nmod)
aware occurred (advcl)
-10.7 ( (punct)
elevation prolonged (amod)
spots compared (acl)
assessed p.m. (advmod)
discharge to (mark)
implicated whereas (mark)
jerks the (det)
ck-mb 100)/total (punct)
finished seen (advcl)
nitrate timolol (conj)
ensure does (aux)
torsades pilsicainide-induced (amod)
drop sudden (amod)
methods trial (appos)
mg 2 (compound)
induced epilepticus (nsubjpass)
responses bradycardiac (compound)
comparable time (nmod:tmod)
size edema (conj)
levels maximal (amod)
levels afternoon (compound)
acetonide of (case)
cm 1 (nummod)
diagnostic unit (conj)
decreased concentrations (nsubj)
patients gentamicin-treated (amod)
frequent reported (acl:relcl)
failure prerenal (amod)
meninges the (det)
clinics from (case)
drug or (cc)
plays adenosine (nsubj)
rats task (nmod)
bisphosphonate the (det)
accompanied factors (nmod)
perimenopausal by (case)
organelles other (amod)
infrequent were (cop)
provided denominator (dobj)
role combination (conj)
premature 122 (nummod)
monoher dox (conj)
received underwent (conj)
response time (nmod)
carried where (advmod)
isom ( (punct)
tricuspid ns (dep)
nsaid of (case)
thrombosis hazard (nmod)
treated summary (nsubjpass)
material diagnosed (acl)
hypertension borderline (compound)
decreased output (dobj)
had whereas (mark)
learning rodents (nmod)
rs4704559 and (cc)
independent complement (nmod)
difference sg (nmod)
complexity the (det)
disorder electrolyte (compound)
rats gunn (compound)
diseases cardiac (amod)
ci a (det)
65 1 (quantmod)
strategies antiparkinsonian (amod)
structures connecting (acl)
added been (auxpass)
patients anemia (appos)
doses prednisolone (nmod)
explanations necrosis (nmod)
inhibits increases (dobj)
exercised completed (advcl)
drugs triggered (acl:relcl)
prazosin due (case)
somnolence polydipsia (conj)
delivered were (auxpass)
ulcers all (det)
insipidus diabetes (compound)
alpha plasma (compound)
identifying patients (dobj)
induce control (conj)
removal rigid (amod)
osmolality and (cc)
relationships from (case)
desire arousal (conj)
dysfunction migraine (nmod)
2b1/2b2 2e1 (conj)
way projection (nmod)
occurred consistent (advcl)
examination frequent (amod)
regulation genetic (amod)
model mg/kg (dep)
status functional (amod)
alleviate exposure (nmod)
prevent to (mark)
received free (conj)
factor independent (amod)
involves step (dobj)
study assess (acl)
merits comparison (dobj)
associated may (aux)
period ) (punct)
regimen gvhd (nmod)
unaffected recorded (conj)
causes toxicity (dobj)
foci alteration (nmod)
strategy therapeutic (amod)
procedures therapy (nmod)
groups r2 (compound)
disease ( (punct)
seems limited (xcomp)
site lesion (nmod)
provoked : (punct)
mg/kg sc (appos)
110000 200000 (conj)
suppressed all (nsubj)
% paroxysms (nmod)
antagonized as (advmod)
benefited to (mark)
membranes hepatocyte (compound)
level trough (compound)
bbb of (case)
methotrexate solution (nmod)
pelvis or (cc)
all indicating (xcomp)
control seizures (nmod)
suggest proof (ccomp)
glaucoma and (cc)
observed h (nsubjpass)
inhibitor secretion (compound)
na ( (punct)
recognition drinkers (nmod)
monitoring effects (dobj)
assessed detection (nmod)
reversibility its (nmod:poss)
therapy intra-arterial (amod)
women dysfunctional (amod)
randomized ) (punct)
prevalence associations (conj)
selected basis (nmod)
sedations all (det)
users drugs (nmod)
increases iopamidol (nmod)
micrograms/ml ) (punct)
disease nonalcoholic (amod)
initiated and (cc)
present presented (dep)
period rest (compound)
restricted 6-g/d (compound)
peak in (case)
sessions to (case)
mg/kg level (appos)
presented background (nsubj)
indicating consequence (ccomp)
report objective (dep)
thrombo-embolism event (conj)
days ( (punct)
figure the (det)
monotherapy a (appos)
use piperacillin (nmod)
supply myocardial (amod)
cva ( (punct)
forming angiotensin (compound)
single-blind is (cop)
involving heart (dobj)
use benzodiazepines (nmod)
include these (nsubj)
treated determine (advcl)
everolimus tacrolimus (conj)
vaccinated were (auxpass)
illustrate reports (nsubj)
rejection findings (conj)
predominance with (case)
configuration the (det)
considered patients (nmod)
resulted ) (punct)
provided antagonists (nmod)
microscopy at (case)
responsiveness improvement (conj)
employed if (mark)
incidence events (nmod)
microg/rat ( (punct)
pressure injury (conj)
experiment similar (amod)
pose used (advcl)
detection and (cc)
1973 1982 (conj)
side operative (amod)
regardless ( (punct)
concentration i (nummod)
classified carcinogen (nmod)
tolerance some (det)
varied function (nmod)
administered hcl (nmod)
suspicion clinical (amod)
determined hypertension (nmod)
constipation-predominant ( (punct)
discharged hours (nmod)
origin , (punct)
action against (case)
diet-fed in (case)
injections subcutaneous (amod)
marker monocytes/macrophages (nmod)
plasticity to (case)
pituitary of (case)
stability hemodynamic (amod)
increased phase (nmod)
risk cardiovascular (amod)
cornerstone the (det)
experience this (det)
thiopental mg.kg(-1 (amod)
tended fact (nmod)
rejection loss (conj)
lasted olig-anuria (amod)
sarcomas including (case)
system test (compound)
unaffected omission (nmod)
contraction et-1 (nmod)
used is (aux)
animals on (case)
globulin of (case)
arteriosclerosis rate (nmod)
metabolite norpethidine (appos)
frequent rather (advmod)
evaluates . (punct)
condition disease (compound)
differences characteristics (nmod)
conditions experimental (amod)
seizure disorder (dobj)
two to (quantmod)
levothyroxine of (case)
reflexes deep-tendon (amod)
excluded effect (nsubjpass)
alterations complex (amod)
follows as (mark)
occurrence mutants (nmod)
treatment apomorphine (compound)
event this (det)
using who (nsubj)
cultures myocyte (compound)
heart doxorubicin-induced (conj)
disappeared recur (conj)
0 3 (conj)
men cancer (nmod)
ability rats (nmod)
ms -20 (nummod)
linking and (cc)
1 dpi (dep)
restlessness for (case)
signs tardive (amod)
recommended baseline (nmod)
expression transporters (nmod)
nelarabine of (case)
elevations % (appos)
hg group (nmod)
observation , (punct)
propylthiouracil ptu (appos)
method liquid (amod)
use suxamethonium (nmod)
dermatomes l3-l4 (compound)
analyses markers (nmod)
phase same (amod)
induces clonidine (nsubj)
count ) (punct)
syndrome zollinger-ellison (compound)
rise as (case)
completed patient-years (nsubjpass)
inhibition anhydrase (nmod)
softening 5 (nmod)
showed associated (ccomp)
woman undergoing (acl)
costs implants (nmod)
insipidus : (punct)
challenge fluid (compound)
samples in (case)
perivascular and (cc)
voltammetry immunohistochemistry (conj)
combined when (advmod)
new infarct-avid (dep)
hypersensitivity marked (amod)
tspa ( (punct)
counts gross (amod)
conclusions ; (punct)
image computational (amod)
investigator to (case)
lesion severe (amod)
hours next (amod)
ingested often (advmod)
malignancy a (det)
sd [ (punct)
metoprolol interaction (dep)
ifs of (case)
shell into (case)
fit disease (nmod)
received amifostine (dobj)
subtype 7 (nummod)
useful necessary (advcl)
performed records (nmod)
naproxen acetaminophen (conj)
trihexyphenidyl drugs (conj)
2660 dyne (dep)
shortened micromol/l. (nmod)
discussed article (nmod)
mg/m(2 600 (nummod)
ug/ml were (cop)
controlled . (punct)
patients latter (amod)
us to (case)
risk moderate (amod)
hormone luteinizing (amod)
leak , (punct)
sign early (amod)
females were (cop)
modulation p450 (compound)
reperfusion min (nmod)
resurgence . (punct)
marker stress (nmod)
associated leading (xcomp)
titres , (punct)
proanthocyanidins of (case)
male 57-year-old (amod)
observed days (nsubjpass)
mmse ) (punct)
torsades of (case)
death cardiovascular (amod)
parameters reabsorption (nmod)
agent has (acl:relcl)
pretreatment dsp4 (nmod)
activity toxicity (nmod)
selegiline of (case)
0.005 ) (punct)
seizures treatment-induced (amod)
fractionated rat (nmod:npmod)
affect further (advmod)
trinitrate by (case)
agent mechanisms (nmod)
none groups (nmod)
episode of (case)
dfc -59.7 (conj)
opioid pethidine (nsubj)
increase demand (nmod)
factor src (nmod)
77 up (advmod)
recall to (mark)
cardiac adrenaline-induced (amod)
gpi ) (punct)
extension the (det)
velocity conduction (compound)
noted point (nmod)
determined test (nmod)
investigated therapy (nmod)
mg primarily (advmod)
inconclusive is (cop)
modify did (aux)
increased was (auxpass)
transport na+ (nmod)
measures secondary (amod)
clearance metoprolol (nmod:poss)
make availability (nsubj)
plausible are (cop)
presence failure (nmod)
randomised have (conj)
mg/l 19 (nummod)
hepatocellular cholestatic (conj)
period latent (amod)
patients stroke (compound)
failure fatal (amod)
procedures study (dep)
death of (case)
undergoing evaluation (dobj)
populations the (det)
lh ) (punct)
result consequently (advmod)
complete task (nmod)
rose administration (nmod)
meq/l. 3.34 (nummod)
presented that (nsubj)
abolished but (cc)
ci 582 (nummod)
make diagnosis (dobj)
cna and (cc)
follows saline (conj)
doses four (nummod)
2 of (advmod)
responsiveness of (case)
lowering mm (dobj)
raters three (nummod)
used microdialysis (dobj)
interest a (det)
5 at (case)
28 16 (compound)
maintenance pressure (nmod)
implantation osmotic (amod)
prior to (pcomp)
growth gfr (conj)
effects side-effects (amod)
potassium profound (amod)
rose . (punct)
died exhibited (conj)
reducing without (mark)
given mg/kg (nsubjpass)
hours infarction (nmod)
disorders depressive (amod)
neurologic many (amod)
failed coniine (nsubj)
changed level (nmod)
drug enhance (acl:relcl)
(7.2)% (5.7)% (dep)
enalapril with (case)
treatments and (cc)
pt ] (punct)
co. ) (punct)
use methylphenidate (nmod)
intravenous or (cc)
objectives assess (acl)
cyclosporine and (cc)
length nor (cc)
flutamide the (det)
relapsed refractory (conj)
toxicity hippocampal (compound)
induced hypertension (nsubjpass)
evaluated analyze (advcl)
ibuprofen ) (punct)
therapy sequelae (nmod)
affinities dopamine (nmod)
135 to (dep)
sodium time (nmod)
made deterioration (nmod)
minute hours (nmod)
scale studies-depression (compound)
serious treatable (conj)
microg pg-9 (compound)
12alpha-hydroxylase 6beta-hydroxylase (conj)
chloride by (case)
hours admission (nmod)
subgroup the (det)
conducted prospective (amod)
attributed etiology (nsubjpass)
periods time (nmod)
relationship abatement (conj)
receive part (nmod)
hypertension headache (nmod)
contraindication with (case)
p in (case)
atypicality ) (punct)
transfer results (nmod)
88 , (punct)
deficiency no (det)
3269 +/- (cc)
months 9 (nummod)
adults younger (amod)
outcome for (case)
exposed often (advmod)
discontinued patient (nsubjpass)
phospholipid esters (conj)
patients duration (nmod)
remains pressure (nsubj)
interrupted , (punct)
consistent nodosum (nmod)
ions tissue (nmod)
p euthymia (conj)
nag , (punct)
implants ) (punct)
rats neprotic (amod)
pm ) (punct)
attenuated contrast (nmod)
showed associations (dobj)
release ed (nmod)
inhibition % (nmod)
standard , (punct)
tolerance real (amod)
cyp7a of (case)
days 42 (nummod)
excretion monophosphate (compound)
assessed visually (advmod)
women risk (nmod)
found postoperatively (advmod)
tm in (case)
alternative theophylline (nmod)
loss lipoproteins (nmod)
metabolism different (amod)
heat of (case)
rats streptozotocin (compound)
disease + (cc)
intervention after (case)
those ( (punct)
received dosing (dobj)
rates heart (compound)
formation stem (compound)
muscles joint (nmod)
measures ultrasonographic (amod)
model each (det)
patients 237 (nummod)
carbonate calcium (compound)
derangement hyperexcitation (conj)
signal peripheral (amod)
prescribing by (mark)
scenario although (mark)
= .011 (dep)
remained antinociception (nsubjpass)
nacc ( (punct)
signals basal (amod)
compared cases (nsubjpass)
total points (nmod)
sedation sleep (nmod)
enrolled years (nmod)
motion wall (compound)
clozapine or (cc)
responses therapy (nmod)
ccl2 ccr2 (conj)
wave t (compound)
leads and (cc)
related use (nsubj)
ameliorates testosterone (nsubj)
efficacy dose (nmod)
lethality for (case)
found evidence (nsubjpass)
fluctuations disabling (amod)
showed indeed (advmod)
steeply less (advmod)
function cgi-sf (appos)
efficacious procyclidine (nmod)
allocated , (punct)
position an (det)
growth resulting (acl)
mg/kg morphine-hc1 (nmod)
data more (amod)
decreases amplitudes (nmod)
predose and (cc)
dba/2j , (punct)
p-coumarate maltolyl (amod)
depression major (amod)
determined , (punct)
lack for (case)
associated exacerbation (nmod)
cortex piriform (compound)
case suffering (nmod)
dysfunction a (det)
pressure lv (compound)
flurothyl ptz (conj)
weight duration (conj)
lesions traumatic (amod)
disease huntington (nmod:poss)
activity fluorescence (appos)
associated antidepressants (nsubjpass)
decreasing risk (dobj)
pathway upregulated (amod)
infection , (punct)
involved thus (advmod)
reactivation hbv (compound)
concluded it (nsubjpass)
prilocaine or (cc)
defined control (nsubjpass)
vomiting , (punct)
etoposide a (conj)
similar however (advmod)
del , (punct)
pyridoxine as (mark)
% concentrations (nsubj)
impaired compared (advcl)
receptor p2x3 (compound)
epilepsies ige (appos)
planned order (nmod)
area an (det)
mg/kg to (case)
response result (nmod)
6 14 (conj)
role overdose (nmod)
sis3 by (case)
using examination (dobj)
used number (nsubj)
617 570 (conj)
effect depression (conj)
evaluable far (advmod)
one fourth (advmod)
taqib , (punct)
taken treatment (nmod)
tended days (nmod)
indicate increasing (ccomp)
supplemented 23 (nsubjpass)
monotherapy compared (case)
tolerated occurred (conj)
alternation avoidance (conj)
dose yohimbine (nmod)
true also (advmod)
fell age (nmod)
fpd ) (punct)
clonidine that (det)
ages records (nsubj)
received losartan (dobj)
rates % (appos)
derivative : (punct)
concluded pursued (ccomp)
patients 75 (nummod)
random at (case)
start at (case)
examined abundance (dobj)
anxiety enhanced (amod)
sleep to (mark)
inhibition activation (nmod)
anesthesia repair (nmod)
assessment field (compound)
sarcolemma sarcomere (conj)
pain were (cop)
tolerant individuals (nsubj)
pharmacokinetics administered (acl)
complication is (cop)
thrombosis deep (amod)
l-alpha-gfc or (cc)
jc al. (dep)
start use (nmod)
tests admission (compound)
presented recurrences (nmod)
forced peak (nmod:npmod)
alter and (cc)
glutathione tissue (compound)
amines of (case)
receiving lisinopril (dobj)
pentobarbital and (cc)
testosterone patients (nmod)
receiving and (cc)
incidence management (conj)
glutamate elicit (conj)
kindreds diabetic (amod)
failure or (cc)
cyclooxygenase 2 (nummod)
related degree (nmod)
failure during (case)
prilocaine and (cc)
decreased treatment (nsubj)
scale akathisia (compound)
fibrosis replacement (compound)
self-limited generally (advmod)
suggest have (ccomp)
hemisphere cerebral (amod)
acquired . (punct)
dysfunctions for (case)
cells incubated (acl)
revealed surgery (nsubj)
investigation toxicologic (amod)
91.2 ( (punct)
tests several (amod)
> % (conj)
treated methylprednisolone (nmod)
those exposed (acl)
0.01 and (cc)
wt d2r (conj)
correlations parameters (conj)
months initiation (dep)
past the (det)
induced pentobarbital (nmod)
secretion excessive (amod)
profile : (punct)
maturation cerebellum (nmod)
ato mg/kg (dep)
woman patient (nsubj)
done always (advmod)
rat any (det)
months any (det)
risk correlative (amod)
push or (cc)
interest rhabdomyolysis (nmod)
related disappeared (conj)
octreotide the (det)
hyperhidrosis signs (nsubj)
bax of (case)
tissue sino-atrial (amod)
considered only (advmod)
hyperkinesis segments (nmod)
0.01 0.08 (conj)
region shoulder (compound)
inhaled volunteers (nsubj)
smelling something (dobj)
studies randomized (amod)
torr with (case)
ml mg/100 (nummod)
sulpiride-induced dyskinesia (dobj)
oliguria pain (conj)
different incidence (nsubj)
application on (case)
review literature (dobj)
absence for (case)
stroke people (nmod)
0.6 1.3 (parataxis)
cases seven (nummod)
accompanied levels (nmod)
injury acute (amod)
kidney perfused (acl)
determined neonates (nmod)
ptu of (case)
aureus staphylococcus (compound)
hypoplasia nerve (compound)
tool study (acl)
contraindicated carbamazepine (nsubjpass)
responses hyperalgesic (amod)
revealed hematoma (dobj)
frontal right (amod)
finished examination (dobj)
feedback tubuloglomerular (amod)
increase interval (dobj)
patients only (advmod)
pralidoxime-2-chloride min (conj)
sulfation % (nmod)
causes ca2 (nsubj)
generation nin (compound)
effect rg1 (nmod)
mice c57bl/6 (compound)
greater although (mark)
administered bpd (nsubjpass)
unable are (cop)
dopamine receptors (conj)
results years (appos)
decrease > (nmod)
effects i.v.c (nmod)
cancer use (conj)
baseline of (case)
vasopressin oxytocin (conj)
underwent reduction (dobj)
revealed analyses (nsubj)
animals group (nmod)
increase verapamil-related (amod)
administered patients (nsubjpass)
527+/-509 28 (conj)
group high (amod)
typical myositis (nmod)
difference f(33 (appos)
vaccination the (det)
depressed is (auxpass)
diseases , (punct)
larger group (nmod)
underlying fluorthyl- (dobj)
cohort children (nmod)
cardiomyopathy with (case)
prolonged preferentially (advmod)
7 to (dep)
antifolate inhibits (acl:relcl)
probe gad (compound)
toleration : (punct)
s-limonene and (cc)
administration erdosteine (compound)
affect proliferation (dobj)
stimulation rtms (conj)
described thrombosis (nsubjpass)
returned substituting (advcl)
treatment epilepsy (nmod)
mucosa in (case)
blocked is (auxpass)
revealed increased (xcomp)
side-effects due (case)
affected worst (advmod)
clotting of (case)
transport decreased (amod)
diagnosed those (nmod)
glial cerebral (amod)
safety study (dep)
13 at (case)
cases failure (conj)
team the (det)
dose alprazolam (conj)
blockade activity (nmod)
nouns 45 (nummod)
content number (conj)
mechanical by (case)
tumors malignant (amod)
min application (conj)
map using (xcomp)
integrity cells (nmod:poss)
have whereas (mark)
elevated days=1.77 (dep)
high to (dep)
presented also (advmod)
defect visual (amod)
patients emesis (appos)
hip right (amod)
situations both (det)
regarded reported (advcl)
recommend reviews (dobj)
demographics history (appos)
> % (appos)
woman 67-year-old (amod)
differ females (nmod)
acid 6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate (conj)
case neuropathy (nmod)
medulla isom (appos)
made , (punct)
seems expressed (xcomp)
administered irrigation (nsubjpass)
activities the (det)
assessed however (advmod)
affected adversely (advmod)
response ( (punct)
1.86 from (case)
exhibited accuracy (dobj)
t-tests post-hoc (compound)
score intensity (compound)
associated cystitis (nmod)
increased gm. (dep)
different fluid (nmod)
seizures subsequent (amod)
inhibitor target (nmod)
concluded toxicity (nmod)
prescribed can (aux)
phase absence (nmod)
remained unchanged (acomp)
5-azc carcinogen-treated (conj)
open patient (nsubj)
disease gallbladder (compound)
accompany may (aux)
anemia heinz (compound)
improved agonists (nmod)
abnormalities echocardiographic (amod)
7.5 +/- (cc)
now to (case)
-18 , (punct)
leak mannitol (nsubj)
background a (det)
proposal the (det)
formation autoantibodies (nmod)
demonstrate course (dobj)
interval in (case)
receiving other (nsubj)
five controls (nmod)
toxicity enhanced (amod)
vasculitis to (case)
rate mutants (nmod)
concentrations patients (nmod)
metabolites were (cop)
ivmp ( (punct)
age age (nsubj)
administered measuring (advcl)
generalization and (cc)
concluded has (ccomp)
sensitivities of (case)
taking results (dep)
system haemopoietic (amod)
this types (dep)
number effects (conj)
offer they (nsubj)
occurred ) (punct)
summarizes : (punct)
1.86 2.41 (conj)
symptoms effects (conj)
varied mg (nmod)
included salivation (dobj)
seems possess (ccomp)
maintained . (punct)
days 16 (nummod)
committee the (det)
hyperplasia atypical (amod)
instillation new (amod)
cytokine and (cc)
arteries and (cc)
illustrate we (nsubj)
radiograph tomography (conj)
confirmed background (dep)
rad001 mg/day (dep)
schedule dosing (compound)
reported mortality (dobj)
operation sham (compound)
patients hearing (acl)
induced olanzapine (nmod)
found specimen (nmod)
consisted month (nmod)
administered ( (punct)
met these (nmod)
mutations bche (nmod)
pd with (case)
focus function (nmod)
cases six (nummod)
origin for (case)
anaesthesia for (case)
asystole and (cc)
disturbance . (punct)
those rest (nmod)
cardiotoxicity induced (acl)
opse ( (punct)
infants 547 (nummod)
symptoms on (case)
72 to (dep)
glycine and (cc)
hospitals at (case)
obtained measures (dobj)
technique adults (nmod)
cataracts of (case)
diagnosed linkage (nmod)
5-fu/fa mmc (conj)
malondialdehyde present (acl:relcl)
processed were (auxpass)
derivatives 1-(1,2-dihydro-2-acenaphthylenyl)piperazine (nummod)
cells presumptive (amod)
degeneration induced (amod)
adrenoceptor alpha1 (compound)
pg/ml infusions (nmod)
combination same (amod)
interaction attributed (acl)
background type (nmod)
added vigabatrin (nsubjpass)
efficient blocking (advcl)
performance on (case)
clonidine alpha2-adrenergic (amod)
glycopyrrolate ( (punct)
concentration cerebrospinal (amod)
period following (case)
surge or (cc)
involve motoneurons (nmod)
contents metabolites (compound)
males dosage (compound)
overdose patient (nsubj)
option that (mark)
control sem (conj)
induction decrease (conj)
5-fu of (case)
static and (cc)
polyuria such (case)
rate the (det)
fatal , (punct)
stimulation not (cc)
cyclosporine to (case)
altered was (auxpass)
compounds as (mark)
concentrations inadequate (amod)
mc 480 (conj)
stz- castration-induced (conj)
5-ht ( (punct)
serum- and (cc)
material woman (dep)
pc/bcp ) (punct)
smoked they (nsubj)
fell resistance (nsubj)
axons the (det)
nrf2(-/- by (case)
mg/day from (case)
study interaction (nmod)
support studies (nmod)
sequelae apparent (amod)
attacks md (appos)
helpful determining (advcl)
ec50 increase (nmod)
consisted although (mark)
find , (punct)
excitation induced (amod)
alteration for (case)
elevations observed (acl)
had greater (dep)
mechanisms to (case)
oxidation levels (nmod)
cows of (case)
steroids intravenous (amod)
mustard is (cop)
disease liver (compound)
degree for (case)
diazinon mg/kg (appos)
increase > (dobj)
species rns (appos)
dose on (case)
baseline (1.5)% (dep)
hour for (case)
correlated conclusion (nmod)
fk506 , (punct)
used often (advmod)
apraclonidine of (case)
matched cases (dobj)
specific mechanism (nmod)
lid motor (conj)
curves group (nmod)
podocalyxin unlike (case)
mg. on (case)
independent chemosensitivity (nmod)
experienced grade (dobj)
diazepam combination (nmod)
agent alkylating (amod)
exposure cyanamide (nmod)
one regimens (nmod)
materials of (case)
present % (nmod)
confusion hyperbilirubinemia (conj)
greater hydrocortisone (nmod)
increasing in (mark)
metabolism : (punct)
increase expression (nsubj)
reaction an (det)
effect etoposide (nmod)
pituitary e2 (compound)
b1r(-/- ( (punct)
hypertension instituted (acl)
operative may (aux)
selected was (auxpass)
occlusion occurring (advcl)
mortality to (case)
expressing when (advmod)
entered but (cc)
17 13 (conj)
engrafted , (punct)
fluorescein to (mark)
mm 0.3 (compound)
detected differences (nsubjpass)
naproxen for (case)
anaesthesia surgery (nmod)
operated patients (nsubjpass)
dogs into (case)
taking disorder (nmod)
myopathy corticosteroid (compound)
january 2009 (nummod)
channels with (case)
intima and (cc)
characteristics basic (amod)
added therapy (nmod)
complication pain (nsubj)
chosen strain (nmod)
139 4 (compound)
induced choreoathetosis (dobj)
leads retention (dobj)
exerts lithium (nsubj)
done crossmatching (nsubjpass)
hypokalemia hypomagnesemia (conj)
decrease hypotension (nsubj)
decreased lower (advcl)
reduced improved (conj)
throat glycopyrrolate (appos)
palsies nerve (compound)
salicylate sodium (compound)
patient-years observation (nmod)
seconds forty (nummod)
used undergoing (xcomp)
6 times (quantmod)
lozenge gum (appos)
were increases (attr)
coincident which (nsubj)
counts . (punct)
elevated study (nmod)
diagnoses acute (nmod)
inducing neuroadaptation (dobj)
units dosage (compound)
resolution akinesis (nmod)
feeding of (case)
course first (amod)
attempted evaluate (conj)
air/oxygen only (advmod)
efficacy patients (nmod)
intralipid the (det)
receive or (cc)
prevented successfully (advmod)
preparations single-cell (amod)
risperidone of (case)
induced ziprasidone (nmod)
expression regulation (conj)
associated acid (nsubjpass)
tnf-a of (case)
krebs-ringer containing (acl)
limited still (advmod)
line myeloid (amod)
rats stz-injected (amod)
regimens chemotherapeutic (amod)
myelitis of (case)
use long-term (amod)
refine future (nmod)
had hyperemia (nmod)
cocaine followed (acl)
see to (mark)
prevented occurrence (dobj)
ischemia cocaine-associated (amod)
doxorubicin vincristine (nmod)
background result (dep)
regions kidney (nmod)
di- , (punct)
48-week 12- (compound)
chicks sulfate (amod)
fluids and (cc)
made been (auxpass)
attempt in (case)
ketamine . (punct)
task maze (compound)
analysis western (compound)
sensor stress (nmod)
delivery permits (acl:relcl)
development switch (nmod)
fasciculations children (nmod)
evaluated reported (conj)
amplitude contraction (compound)
progresses . (punct)
disease collagen (compound)
model ) (punct)
mg 2.0 (compound)
expected seems (conj)
prepare to (mark)
questionnaire severity (conj)
considered which (nmod)
pounds was (cop)
males 11 (nummod)
expression cortex (nmod)
improve schedule (dobj)
fatigue patient (nmod)
moving residence (nmod)
gaba(a)rs both (cc:preconj)
test to (mark)
patients cin (compound)
frequency relations (nmod)
fluvastatin with (case)
bradycardia rate (appos)
21 18 (conj)
reduce , (punct)
use number (nmod)
aminoglycosides particularly (advmod)
hyperhidrosis gustatory (compound)
protocols of (case)
analgesia , (punct)
ng./ml 3 (nummod)
nt-probnp ( (punct)
prescribing of (mark)
disturbance psychiatric (amod)
edema submucosal (compound)
sah ( (punct)
desipramine , (punct)
doses % (nmod)
caused arthritis (nmod)
treatment disorders (nmod)
improve absence (nmod)
activity despite (case)
occurred animals (nmod)
induced agonist (nsubj)
contact use (nmod)
bilirubin direct (amod)
begun protein (nsubj)
divided equally (advmod)
administrated developed (dep)
estimated quantify (advcl)
% leading (conj)
transport glucose (compound)
cause combination (nsubj)
neurophysiology underlying (amod)
established pce (nmod)
phenotype b6 (compound)
inhibits and (cc)
cause most-frequent (amod)
alpha5 beta4 (conj)
ability respond (acl)
indocyanine to (case)
g/dl 2 (conj)
potentiate metamizol (nsubj)
% m (nmod)
test and (cc)
inhibitors carbonic (amod)
using antibody (dobj)
chloroform-adrenaline cent (appos)
proposed serve (ccomp)
evidence cholestasis (nmod)
induced dose-relatedly (advmod)
maximum for (case)
antibodies suggested (acl)
lumen into (case)
predispose development (nmod)
sites in (case)
antagonist ro4368554 (dep)
has model (nmod)
levels pg/ml (appos)
doses oct (nmod)
case thoroughly (advmod)
help used (conj)
nucleoside the (det)
pr , (punct)
symptoms with (case)
significant be (cop)
minute to (case)
monitored years (nmod)
injection mu (nmod)
reflect severity (dobj)
those as (case)
reduced be (auxpass)
recorded were (auxpass)
trajectory the (det)
nephrotoxicity against (case)
primates in (case)
subunits acetylcholine (compound)
condition neurotoxicity (conj)
required is (auxpass)
nucleus matter (conj)
congestants nasal (amod)
blind placebo-controlled (conj)
resolving was (cop)
intervention to (case)
account as (mark)
ci 3.67 (nummod)
doses ephedrine (nmod)
exencephaly induced (acl)
administration amount (conj)
subjects free (amod)
responded as (mark)
1 thousand (conj)
performed drivers (nmod)
mg lamivudine (nmod)
stones , (punct)
accumulation edema (compound)
mg/kg mg/kg (appos)
statistically decreases (nsubj)
h 0.8 (nummod)
obtain are (cop)
effects pain (nmod)
find study (nsubj)
phosphatase is (cop)
galantamine modulator (conj)
included ht (nsubj)
associated dizziness (nmod)
vasorelaxation acetylcholine-induced (amod)
discovered was (auxpass)
set up (compound:prt)
sestamibi imaging (dobj)
cancer cancer (conj)
skin the (det)
mainstay immunosuppression (nmod)
cases dependence (nmod)
anxioselective and (cc)
receive doses (nmod)
behavior activities (conj)
transplants cardiac (amod)
glucose ) (punct)
techniques complementary (amod)
depolarization diastolic (amod)
dyskinesia measures (nmod)
passage cause (appos)
revealed values (dobj)
haloperidol low-dose (amod)
noted side-effects (nsubjpass)
n-methyl-d-aspartate or (cc)
demonstrated addition (nmod)
de glomerular (dep)
interfere disturbance (nsubj)
agents both (cc:preconj)
1.043 ( (punct)
syndrome leak (compound)
involvement cardiotoxicity (nmod)
included running (xcomp)
confirmed diagnosis (nsubjpass)
responsible hepatitis (nmod)
lvef the (det)
using annuals (dobj)
cardiotoxicity . (punct)
taken time (nmod)
increased ratio (nmod)
toxicity or (cc)
oxide factor)/nitric (compound)
effective fungi (nmod)
mannitol without (case)
mechanism blockade (compound)
incidence % (appos)
quality changes (nmod)
percent 50 (nummod)
% 12.4 (nummod)
treated be (auxpass)
effective states (nmod)
induction fentanyl (nmod)
1969 from (case)
cirrhosis liver (nmod)
400 mg/m2/d (dep)
istanbul turkey (conj)
related presentation (nmod)
telangiectatic papular (conj)
post toxicity (dobj)
kinase mitogen-activated (amod)
mediated activity (nsubjpass)
cr % (compound)
initiated association (nmod)
resulted densities (nmod)
preponderance with (case)
that years (dep)
frequency spontaneous (amod)
rizatriptan ergotamine/caffeine (nmod)
low-dose of (case)
site effects (nmod)
91.5 range (dep)
months patient (compound)
crf with (case)
activity cocaine- (amod)
oil control (appos)
loss visual (amod)
immunotherapy an (det)
raise dopamine (dobj)
metabolism resting (amod)
objective determine (acl)
found weeks (dep)
obtain may (aux)
production activities (conj)
contrasted preservation (nmod)
bupropion 11.7 (dep)
mo , (punct)
cystitis on (case)
infrequently only (advmod)
protection erdosteine (nmod)
used available (advcl)
study involvement (dobj)
deficits attributed (acl:relcl)
age 27 (nummod)
edrophonium characteristic (acl:relcl)
vip(-/- versus (case)
resection tumors (nmod)
ed discharged (acl:relcl)
test rota-rod (compound)
appears to (xcomp)
developed whereas (dep)
pilocarpine-induced against (case)
auc greater (amod)
examine , (punct)
safe to (mark)
treatment monotherapy (nmod)
concentrations amphotericin (compound)
reduction reduction (dep)
carinii pneumocystis (compound)
individuals antibody-positive (amod)
recorded using (advcl)
antigen inos (compound)
status response (compound)
analyses calcium (nmod)
-/- ) (punct)
state produced (acl)
hag ) (punct)
antagonist opioid (compound)
pseudolithiasis ceftriaxone-associated (amod)
found achieve (xcomp)
agonists their (nmod:poss)
life argatroban (compound)
cocaethylene , (punct)
that vs. (cc)
malaria of (case)
schedule following (amod)
val 0.001 (appos)
present the (det)
protected changes (nmod)
simultaneously and (cc)
secretion basal (amod)
returned iu/l (nmod)
gemcitabine cisplatin (conj)
percent twenty-eight (amod)
sulphasalazine of (case)
effects residual (amod)
levels transcript (nmod)
profiles (+/-)-pg-9 (nmod)
showed sensitization (dobj)
arthritis rheumatoid (amod)
remains standard (xcomp)
stenosis artery (compound)
associated dosing (nmod)
role special (amod)
maintained dialysis (nmod)
studied prevention (nmod)
introduction induce (acl:relcl)
characterize . (punct)
combined stress (nmod)
treated nitrate (nmod)
analysis simultaneous (amod)
frequency fluorescein (acl)
anaemia induced (acl)
dobutamine ischaemia (dep)
emerged again (advmod)
appeared lesions (nsubj)
transferase glutamyl (compound)
intra-hisian without (case)
analyzed patients (nmod)
short to (case)
function disturbed (amod)
mg/kg aspirin (compound)
activate inability (nsubj)
scale updrs (appos)
cells/mm3 respectively (advmod)
degrees various (amod)
cause given (advcl)
reviewed clinicians (nsubj)
cystitis interstitial (amod)
rejection glomerulonephritis (conj)
effectiveness safety (conj)
experienced soon (advmod)
cause they (nsubj)
smoking pregnancy (nmod)
recognized adjusted (conj)
animals all (det)
observed instead (advmod)
reduced yohimbine (nsubj)
responses elicited (amod)
observation concentration (nmod)
sensitive caffeine (nmod)
overshooting p (dep)
isolated is (auxpass)
isomers both (det)
system limbic (amod)
morning levodopa-induced (amod)
accounting factors (nmod)
rate discontinuations (nmod)
stores and (cc)
are there (dep)
doses lithium (nmod)
treatment days (conj)
sphincter spasm (nmod)
returned onset (nmod)
second fev1 (appos)
demonstrated hypertension (dobj)
dyskinesias limbs (conj)
discontinued resolved (conj)
admitted requiring (xcomp)
treatments both (det)
incidence tumor (compound)
reports similar (amod)
january from (case)
bolus patients (nmod)
mg/day 1.25 (nummod)
fpdc citalopram (compound)
months by (case)
mg/kg 4 (nummod)
induced increase (nmod)
syndrome spect (conj)
include should (aux)
motionless animals (nsubj)
way contrast (nmod)
aorta and (cc)
acts which (nmod)
mg/dl 160 (nummod)
remd ( (punct)
occurred conversely (advmod)
occupation tonic (amod)
resulted had (parataxis)
af of (case)
located terminals (nmod)
sinoatrial pacemakers (conj)
model whole-animal (amod)
transplantation death (conj)
anemia value (nmod)
underwent comparison (nmod)
phasic tonic (conj)
tamca 47.5 (nummod)
mg/day dose (dep)
responded reporting (advcl)
75/829 of (case)
signaling 4 (nummod)
choice is (cop)
modification by (case)
produces but (cc)
euthyroid in (case)
77.1 was (cop)
ritanserin ( (punct)
incidence toxicities (nmod)
conditions employed (acl)
resulted incorporation (nmod)
history ocular (amod)
faster significantly (advmod)
following exposure (dobj)
scores sf-36 (compound)
area study (compound)
role key (amod)
plate a (det)
0.8 1.8 (prep)
microm 11.2 (nummod)
facies of (case)
hal ( (punct)
led them (dobj)
method analysis (compound)
days dose (conj)
sclerosis attenuated (acl:relcl)
levels produced (acl)
micrograms/kg/ml 20 (nummod)
aged rate (dep)
phenobarbitone to (case)
cyclophosphamide following (case)
min start (nmod)
barrier sinusoidal (nmod)
establish diagnosis (dobj)
tumours and (cc)
comatose or (cc)
status hepatitis (compound)
followed repeatedly (advmod)
ceased completely (advmod)
40 to (dep)
anemia posttransplant (compound)
paralysis prolonged (amod)
production fr (compound)
development sclerosis (nmod)
cholinesterase an (det)
prolongation or (cc)
update evidence (nmod)
disturbances rhythm (nmod)
effectiveness chronic (nmod)
rationale fluoxetine (dep)
raclopride and (cc)
enzymes by (case)
kg-1 dicyclomine (conj)
sinoatrial intermittent (amod)
% 11.5 (nummod)
precipitated insipidus (nmod)
potency muscle (nmod)
developed models (nsubjpass)
revealed nigra (dep)
benefits but (cc)
eradication infiltration (nmod)
a(2a ( (punct)
candidate effective (amod)
dose larger (amod)
prophylaxis disease (nmod)
studied one (appos)
follow-up years (nmod)
cells/mm3 -45.1 (conj)
daptomycin assessed (acl)
insulin-dependent ) (punct)
blockade complete (amod)
rates where (advmod)
changed also (advmod)
reduced edema (nsubjpass)
uveitis active (amod)
negative excipients (nmod)
tissue muscle (compound)
reached stage (nsubj)
inhibiting secretion (dobj)
month third (amod)
adenosine intrathecal (amod)
ddi ( (punct)
dec ( (punct)
vomiting tremors (conj)
occurred level (nmod)
states high (amod)
helps control (xcomp)
treatment into (case)
rated subjects (nsubj)
increased either (nmod)
leukocyturia persistent (amod)
compared volume (nmod)
rebound the (det)
toxicity bupropion (compound)
one abnormalities (nmod)
sharps waves (conj)
anesthetics long-acting (amod)
alter not (neg)
renal of (case)
low are (cop)
levels u/l (nmod)
switching pod (nmod)
concentration progesterone (nmod)
strain resistant (amod)
hour an (det)
potentiate constipation (dobj)
devastation on (case)
neuralgia phn (appos)
depression spreading (compound)
drugs 505 (nummod)
means in (case)
function ventricular (amod)
sensitization during (case)
adr ) (punct)
signs early (amod)
synthesis changed (amod)
gspe mg/kg (compound)
relationship such (predet)
possible is (cop)
r(2)=0.79 ) (punct)
kg ) (punct)
prevention primary (amod)
obtaining material (dobj)
acknowledged should (aux)
presented treatment (nsubj)
given that (mark)
correlated ace (nsubj)
paralysis a (det)
our and (advmod)
information valuable (amod)
nephropathy experimental (amod)
gspe alone (advmod)
= 36 (dep)
mmrm and (cc)
administered then (advmod)
cage in (case)
ranges % (conj)
production the (det)
significance synthesis (nmod)
counts measurements (nsubj)
examine alterations (dobj)
inhibitor clarithromycin (nsubj)
showed biopsy (nsubj)
mexiletine : (punct)
toxicity mitochondrial (amod)
rigidity prolonged (amod)
that a-i (nmod)
analysis ( (punct)
related that (nsubj)
considered % (nmod)
greater 0.5 (nmod)
had activities (dobj)
er to (case)
make aim (nsubj)
sg145r and (cc)
concentrations ng/ml (nmod)
returned didanosine (nmod)
attenuated ineffective (advcl)
seen those (nmod)
vigilance deterioration (nmod)
distinctive most (advmod)
rhabdomyolysis heroin-related (amod)
using multivitamin (dobj)
regard sensation (nmod)
propranolol i.v. (advmod)
mean number (nsubj)
infusion disease (conj)
area amiens (compound)
clones in (case)
misleading be (cop)
methods stereological (amod)
valdecoxib and (cc)
unrecognized but (cc)
toxicity extreme (amod)
thickening departure (conj)
influences nor (cc)
returned postoperatively (advmod)
mental and (cc)
conclusion in (case)
nitroglycerin and (cc)
marker expression (nsubj)
internus of (case)
estimated and (cc)
correlate age (nmod)
dodds revai (conj)
cells pyramidal (amod)
disorder for (case)
mg/dl 147 (nummod)
iu/l levels (nsubj)
number or (cc)
exhibited , (punct)
myocardium patient (nmod)
study dose-range (amod)
volume counts (conj)
glutamate period (nmod)
glycosuria phlorizin-induced (amod)
signaling cx3cr1 (compound)
auditory primate (amod)
develop e18.5 (nmod)
overshooting condition (nmod)
mg/kg chloroprocaine (nmod)
derangement massive (amod)
injected acid (nsubjpass)
butyrylcholinesterase butyrylthiocholine (nmod)
t1/2 the (det)
administered protocol (nmod)
1.0 +/- (cc)
marked impairments (dobj)
pd treated (acl)
induced difference (nmod)
received steroids (dobj)
given mg/kg (dep)
determinant cytotoxicity (nmod)
diameter magnitude (nmod)
hemodynamics exercise (compound)
has reversing (advcl)
motility ocular (amod)
branch its (nmod:poss)
model carrageenan-induced (amod)
response pressure (compound)
beginning and (cc)
60 - (punct)
hyperprolactinemia n. (appos)
stress vpa-associated (amod)
role than (case)
rupture subsequent (amod)
dialysate with (case)
ptld with (case)
utility may (aux)
flow before (dep)
phosphate serum (compound)
unnecessary antisialogue (nsubj)
tracts from (case)
saline or (cc)
extended-release/lovastatin bedtime (compound)
cholecystokinin , (punct)
include opacities (dobj)
progestagens the (det)
rate ( (punct)
seen patients (nsubjpass)
amounts low (amod)
administered propranolol (nsubjpass)
cases be (cop)
neurotoxicity anemia (conj)
cer ( (punct)
leading damage (nmod)
response heart (compound)
aspirin alone (advmod)
effects daidzein (nmod)
diagnoses no (det)
lidocaine after (case)
manifestation neurotoxicity (nmod)
10/5 of (case)
those cohort (nmod)
preferably examination (nmod)
-10.7 p (dep)
showed examinations (nsubj)
different pbo (nmod)
intervals qt (compound)
functionality of (case)
group cocaine-exposed (amod)
0.06 micrograms/ml (conj)
component was (cop)
using rationale (dobj)
16 6 (conj)
% plus (cc)
dosage pharmacokinetics (conj)
decrease increasing (advcl)
fenoldopam hours (nmod)
experienced total (nsubj)
experience effectiveness (nmod)
produced ether (nsubj)
suggested lower (ccomp)
beta-adrenoblocking and (cc)
blockers omeprazole (conj)
noninvasive when (advmod)
quality survival (nmod)
observed occurs (conj)
diameter mm (appos)
contribute burden (nmod)
anaemia haemolytic (amod)
insufficiency alkalosis (conj)
density microtubules (nmod)
effect only (advmod)
impact compliance (nmod)
ratio and (cc)
concern bleeding (nsubj)
nra0160 ( (punct)
allografts treated (acl)
present model (nmod)
concentrations increased (amod)
4.2 10(10 (conj)
hypertrophy on (case)
b 24/76 (nummod)
provided pharmacy (nmod)
activities acid (nmod)
known well (advmod)
levels carbamazepine (compound)
considered considered (advcl)
injection m0 (appos)
reactions hours (dep)
prophylaxis and (cc)
2min for (case)
levels measured (acl)
sinusoidal the (det)
alternation on (case)
side ipsilateral (amod)
common results (nsubj)
classified disease (nmod)
muscle from (case)
nuclei at (case)
0 25 (conj)
relation on (case)
prepared effectively (advmod)
activity behavioural (amod)
indicating apoptosis (dobj)
revealed conclusion (dep)
ratings scale (nmod)
often use (nmod)
used etoposide (nsubjpass)
diethylstilbestrol with (case)
termination period (dep)
antagonized dizocilpine (nmod)
163 ( (punct)
allows , (punct)
= 0.007 (dobj)
associated suggested (conj)
olanzapine clozapine (conj)
treatments effective (amod)
eyes dexamethasone-treated (amod)
fall corresponding (amod)
7 time (nsubj)
increased p<0.01 (dep)
drugs interfere (acl:relcl)
disappeared elevation (nsubj)
source bmc (compound)
% 89.13 (nummod)
response antibody (compound)
prevent reactions (dobj)
participate use (nmod)
haemorrhage . (punct)
concentration mg/dl (nmod)
decrease the (det)
loss snhl (appos)
critical expression (nmod)
tachyarrhythmias section (nmod)
weeks initiation (dep)
correct not (neg)
decrease chicks (nmod)
universitaetsmedizin - (punct)
ratio vte (nmod)
showed outcome (dobj)
dynamic md (appos)
intolerance and (cc)
study acute (amod)
neuropathy detection (conj)
experienced polyneuropathy (dobj)
curve the (det)
control e (conj)
similar vindesine (nmod)
returns hospitalized (amod)
produced embryolethality (dobj)
g/day to (case)
studied samples (nsubjpass)
biopsies serial (amod)
secondary inhibitors (nmod)
agents outcome (appos)
lived area (nmod)
c219 the (det)
feature that (mark)
randomized morning (dep)
1 ; (punct)
course throughout (case)
0.001 less (advmod)
accompanied cases (nmod)
blanching mydriasis (conj)
diverging dramatically (advmod)
elevation the (det)
cytoskeleton in (case)
morbidity host (nmod)
prevent producing (advcl)
parameters curve (appos)
support concept (dobj)
f 101.2 (nummod)
count thrombocytopenia (conj)
november 1999 (nummod)
suggest strongly (advmod)
years oltx (nmod)
symptomatic were (auxpass)
methscopolamine and (cc)
prevention disease (nmod)
treated tumors (nsubjpass)
day infusion (conj)
sbs ( (punct)
mean days (appos)
esterification the (det)
potency excellent (amod)
pretreated patients (nsubj)
ultrasound abdominal (amod)
3.7+/-0.8 ( (punct)
exposure first (amod)
cromakalim by (case)
procedures . (punct)
consciousness signs (nsubj)
km by (case)
migraine the (det)
stabilized hyperparathyroidism (nmod)
a patient (compound)
addition cases (nmod)
decreased syndrome (nmod)
use mdma (compound)
shown indicate (advcl)
patients participated (acl)
assessed vivo (advmod)
intervals regained (advcl)
bolus weeks (nmod:tmod)
occurrence toxicity (nmod)
activity lower (amod)
administration consecutive (amod)
t+a or (cc)
withheld and (cc)
curve auccgrp (appos)
forms of (case)
is case (attr)
concentration mg (nmod)
diazepam mg/kg (appos)
review summarize (conj)
investigations for (case)
drugs nonaspirin (compound)
matter dilatation (conj)
dystonic more (advmod)
effect exercise (nmod)
mellitus dm (appos)
associations study (appos)
resulted incubation (nsubj)
stressed have (aux)
famotidine with (case)
included system (dobj)
sch , (punct)
days range (appos)
augmentation the (det)
questions the (det)
had creatinine (conj)
39.5+/-8.4s . (punct)
analogues occurring (amod)
administration intrathecal (amod)
reach rates (dobj)
described japan (nmod)
suspension tail (compound)
investigate hypothesis (dobj)
rhythm recovered (amod)
damage on (case)
delivered newborn (dobj)
tp ( (punct)
lesion gpi (nmod)
vpu ) (punct)
stenosis ) (punct)
exhibited they (nsubj)
study women (nmod)
insights changes (nmod)
layer to (case)
models exposure (nmod)
acquired who (nsubj)
incorporated if (mark)
cancer chemotherapy-responsive (amod)
a1 a2 (conj)
comparison treatment (nmod)
instillation by (case)
cent 2 (nmod)
values corresponding (amod)
persistence efficacy (nmod)
sbp weeks (nmod:tmod)
stratified chemotherapy (nmod)
facilitate to (mark)
comparison crossover (compound)
active quite (advmod)
group perturbation (compound)
nephrosis on (case)
sch of (case)
induced open (advcl)
components pathway (nmod)
month barium (nmod)
administration midazolam (nmod)
treatment den (compound)
performed patients (nsubj)
intense 5 (nummod)
age race (conj)
cpm ( (punct)
90 than (quantmod)
rate including (case)
mg g (appos)
differs therapy (nsubj)
occurrence licking (nmod)
suggest reverses (ccomp)
see order (nmod)
4.5 days (dep)
version review (nmod)
shown reverse (xcomp)
measures ) (punct)
responders duration (appos)
cells lesional (amod)
case : (punct)
desorption/ionization pressure (compound)
hydromorphone ) (punct)
788.5 was (cop)
dl-sotalol by (case)
l micro (amod)
kf17837 of (case)
inpatients clozapine-treated (amod)
vestibulotoxicity of (case)
results examined (dep)
resulted improvements (nmod)
lesions 19 (nummod)
causing ( (punct)
gave increase (nmod)
courses ifosfamide (nmod)
passage . (punct)
rated basis (nmod)
elimination in (case)
strips in (case)
results completed (dep)
administration prolonged (amod)
methods discovered (appos)
that carbamylcholin (nmod)
sensory , (punct)
cardiotoxicity due (case)
available methotrexate (dep)
cells onto (case)
permeability/injury glomerular (amod)
or=12.619 ( (punct)
reductions hz (appos)
frequency amplitude (conj)
become . (punct)
change treatment (nmod)
levels turnover (conj)
had puncture (dobj)
carries atorvastatin (nsubj)
pool to (case)
3.4 - (punct)
therapies val/hctz (nmod)
catch reye (nmod)
times/week ) (punct)
had furthermore (advmod)
impotence not (neg)
summary experienced (appos)
250 and (cc)
afternoon early (amod)
carrier saline (compound)
compared measurements (nsubjpass)
administered fetus (nmod)
risk this (nsubj)
test catalepsy (compound)
analysed intervals (nmod)
interview semi-structured (amod)
decrease synthesis (nmod)
modification in (case)
patients elevations (nmod)
pelvis and (cc)
accumulation copper (compound)
started mg/kg/day (dep)
employed ( (punct)
manner randomized (amod)
multiple single (conj)
sample cocaine-dependent (amod)
consumption regular (amod)
evidence involves (ccomp)
increased november (dep)
had not (neg)
paramethasone with (case)
lasted study (nsubj)
retardation rigidity (conj)
bearing tumors (dobj)
reactions immunological (amod)
suffered paralysis (dobj)
antagonist pharmacology (nsubj)
levobupivacaine ropivacaine (conj)
program permanently (advmod)
represent lesions (nsubj)
protocols anticoagulant (amod)
february to (case)
screened should (aux)
tested audiometry (nmod)
epimers corresponding (amod)
information this (det)
becoming that (nsubj)
induced used (conj)
sparse are (cop)
that former (nmod)
overlooked manifestations (nsubjpass)
weekly and (cc)
analyzed data (dobj)
clinic to (case)
tachycardia central (amod)
replacement corticosteroids (conj)
had analysed (conj)
product rate-pressure (amod)
5-ht of (case)
capacity a (det)
resistance or (cc)
consequence phenotype (nsubj)
lack patients (nmod)
66.9 ( (punct)
in , (punct)
malignancy . (punct)
consistent suggesting (xcomp)
lesions intraarterial (amod)
showed lower (ccomp)
c chc (appos)
decreased resulting (advcl)
waves 30-hz (nummod)
nystagmus and (cc)
developed rls (dobj)
diuresis a (det)
14th to (quantmod)
reversed it (nsubj)
) - (punct)
recruited february (nmod)
produced kg-1 (dep)
210 75 (compound)
hundred two (compound)
sc ) (punct)
rate siadh (nmod)
mini-pump an (det)
value responsiveness (nmod)
placebo follow-up (nmod)
conclude conclusions (dep)
common but (cc)
revealed decreased (advcl)
mg/m(2 ac (nmod)
ester , (punct)
hypertension during (case)
started resuscitation (nsubjpass)
activity arrhythmias (nmod)
incidence institution (nmod)
rate important (amod)
began physicians (nsubj)
ethinyloestradiol with (case)
walk to (mark)
dose precurarization (nsubj)
data valdecoxib (nmod)
administered means (nmod)
nerves serotonin (compound)
prolonged survival (nsubj)
provide clearance (nmod)
8) mul (dep)
produce however (advmod)
faint addicts (nsubj)
community neurosurgical (amod)
decreased alter (conj)
signs and (cc)
bipolar bipolar (conj)
neuropathy and (cc)
caused dysfunction (nsubjpass)
mofetil +/- (cc)
group nitrendipine-treated (amod)
effect b (nmod)
obtained analysis (nmod)
appears implicated (xcomp)
patients treated (conj)
classified points (nmod)
assessed incidence (nsubjpass)
increase increase (conj)
sold represent (conj)
were battery (conj)
increase whether (mark)
appeared cells (nsubj)
used agent (nmod)
challenge oral (amod)
occurring sedations (nmod)
beating rat (compound)
dose presence (appos)
patients use (nmod)
induce effects (dobj)
lowest range (nmod)
epinephrine without (conj)
showed all (nsubj)
regimen chemotherapy (compound)
metabolism of (case)
spironolactone mg/d (dobj)
injection epicondyle (nmod)
studies morphometric (amod)
surgery anesthesia (nmod)
model as (case)
sign first (amod)
n/n=62/92 and (cc)
underwent one (nsubj)
positivity patients (nmod)
recorded injection (nmod)
vasospasm for (case)
quetiapine % (appos)
exacerbates that (mark)
defect cause (acl:relcl)
characteristics resembling (acl)
occurrence variety (nmod)
csa mg/kg/day (nummod)
produced suggesting (advcl)
survived . (punct)
related performance (nsubj)
weeks mass (nmod)
convulsant and (cc)
(1.8)% . (punct)
failure neutropenia (conj)
content renal (amod)
dogs presence (conj)
receiving . (punct)
marked rate (nmod)
leading and (cc)
reactions solution (nmod)
follow-up . (punct)
3 9 (conj)
choices higher (amod)
onset and (cc)
october 2008 (nummod)
perception nerve (conj)
mitoxantrone by (case)
mediated presence (nmod)
gemcitabine patients (conj)
disease pallidotomy (appos)
lines mice (nmod)
received part (nmod)
ill critically (advmod)
nephrotoxicity cisplatin (compound)
exclusion the (det)
months 19 (nummod)
iris of (case)
beta=0.49 , (punct)
determine dose (dobj)
examination physical (amod)
protocol on (case)
6.9 0.1 (conj)
results compared (dep)
heptylate of (case)
length ] (punct)
therapy deferoxamine (compound)
demonstrated that (mark)
assessed serum (nsubjpass)
toxicity hematologic (compound)
biopsies during (case)
event response (nmod)
balance brain (nmod)
observed relationship (nsubjpass)
intervals r-wave-to-r-wave (amod)
improve availability (nmod)
therapy hyperosmolar (amod)
paramount result (advcl)
topotecan combination (nmod)
encephalitis receptor-associated (amod)
resistant largely (advmod)
% 27 (nummod)
seizures deficits (conj)
% 18.67 (nummod)
depending less (advmod)
anemia administration (nmod)
sulfamethoxazole with (case)
understand disrupts (ccomp)
disorders resulting (acl)
saline- rats (dep)
points other (amod)
sequelae in (case)
microg mouse (nmod)
concentrations acts (acl:relcl)
benzylpenicilloyl-poly-l-lysine and (cc)
cyclophosphamide azathioprine (conj)
3.82 10(7 (conj)
diltiazem 10 (dep)
treatment to (case)
courses mg/kg (appos)
telithromycin to (case)
disorder ptld (appos)
vasoconstriction vasculitis (conj)
primary thrombotic (dep)
changes minimal (amod)
in particularly (advmod)
performance memory (compound)
dose microgram.kg-1.min-1 (nmod)
% 1.95 (nummod)
studied records (nsubjpass)
torsade clinically (advmod)
role damage (nmod)
species reactive (amod)
hiccups drug-induced (amod)
91.2 ci (appos)
children thirteen (nummod)
preparation on (case)
concentrated dx (nmod)
association nyha (appos)
equal duration (nsubj)
rats c. (conj)
antigen hbsag (appos)
systolic prolonged (amod)
professionals healthcare (compound)
types expressing (acl)
those evaluated (acl)
contributes testosterone (nsubj)
exerts rationale (nsubj)
african nigerian (amod)
help achieve (ccomp)
tested h (dobj)
influence mechanisms (nmod)
reported infarcts (nsubjpass)
week 8 (compound)
antegrade unidirectional (amod)
cylinder lesion (compound)
metabolites catechol (compound)
manifestation may (aux)
hypertension pph (appos)
ct positron (conj)
= 0.039 (dobj)
excitability , (punct)
etodolac , (punct)
weakly was (cop)
drug environment (conj)
received corticosteroids (dobj)
results : (punct)
stems . (punct)
considered occur (ccomp)
mg/m2 68.35 (nummod)
51 81 (conj)
cases therapy (nmod)
occur although (mark)
depletion tryptophan (compound)
2.3+/-1.2 animals (nmod)
decreased declined (conj)
plateau a (det)
indicated ) (punct)
8.6 +/- (cc)
tacrolimus developed (acl:relcl)
compound efficacy (conj)
efficacy proarrhythmia (conj)
effective least (conj)
college rheumatology (nmod)
determination systematic (amod)
neurons astrocytes (conj)
d1 or (cc)
antitumor adr (compound)
resolution dysmenorrhea (nmod)
require do (aux)
identified included (conj)
membrane cells (nmod)
suppressed arrhythmias (dobj)
work-up revealed (advcl)
hyperplasia carcinoma (conj)
methylprednisolone ml (dep)
licking of (case)
prevents oral (nsubj)
1.56 0.94 (compound)
associated treatments (nsubjpass)
affected , (punct)
regimens emulsion (nmod)
given later (advmod)
infant birth (nmod)
recorded episodes (nsubjpass)
ages years (dobj)
use states (nmod)
procedures invasive (amod)
test analysis (conj)
hyperkinesia global (amod)
treatment amounts (nmod)
diffusion decreased (amod)
led accumulation (nsubj)
8 were (cop)
diabetic and (cc)
al ) (punct)
weeks survival (nsubj)
identified p (dep)
node circulation (conj)
methylprednisolone with (case)
nucleus medulla (conj)
myeloma in (case)
patients multigravida (compound)
dogs tested (acl)
involved aspects (nmod)
occurred died (conj)
mice expression (compound)
result and (cc)
disorders monitored (acl)
respond that (mark)
fluoxetine with (case)
p450s hepatic (amod)
required individuals (nsubj)
inhibited proteases (dobj)
incidence bradycardia (nmod)
shown stopped (advcl)
maintained pressure (dobj)
increase 4-fold (amod)
prolactin intracellular (amod)
investigate . (punct)
micrograms/min 10 (nummod)
improvement followed (acl:relcl)
case encephalopathy (amod)
method to (mark)
caused cddp (nmod)
blotting immunoprecipitation/western (compound)
persons six (nummod)
ml/kg % (conj)
enhances transmission (dobj)
inhibition significant (amod)
unable he (nsubj)
causes stimulation (nsubj)
picture clinical (amod)
cases occurring (acl)
had expression (nmod)
dosage in (case)
wky on (case)
modulates implicates (conj)
values subjects (nmod)
machinery and (cc)
revealed fluid (nmod)
enrolled trial (nmod)
reflecting reduction (nmod)
produced processes (nmod)
stimulation cerebellar (compound)
improves pallidotomy (nmod)
treated woman (nsubjpass)
step a (det)
causes infarction (nmod)
relationship of (case)
ranged had (conj)
diethylstilbesterol primary (amod)
met dogs (nmod)
mg/kg 243.4 (nummod)
proteins out (case)
loss beta2 (nmod)
studies both (det)
seizure to (case)
unchanged growth (nmod)
glomerulosclerosis segmental (amod)
demonstrated results (nsubj)
environment test (compound)
total carriers (nmod)
resulted have (aux)
tumors granulosa (compound)
regimens on (case)
impairment age-dependent (amod)
patients apl (nmod)
obtained using (advcl)
termination response (nmod)
cases further (amod)
model studying (acl)
received ed (nmod)
co. ansan (appos)
occurred staining (nsubj)
diagnosis toxicity (nmod)
selected using (advcl)
diet normal (amod)
receiving consolidation (nmod)
levels ircrf (compound)
responder a (det)
those cases (nmod)
concentrations micromol/l (nmod)
glomerulonephritis of (case)
agonist muscarinic (amod)
inflammation ocular (amod)
recipients receiving (acl)
decrease start (nmod)
extremities accompanied (acl)
improved patients (nmod)
drug often (advmod)
consolidation during (case)
screened screened (conj)
leiden mutation (conj)
haematuria of (case)
achieved have (aux)
properties genotoxic (amod)
needle touhy (compound)
rose hypotension (nmod)
foci showed (acl:relcl)
had previously (advmod)
gtn -18.9 (conj)
mangiferin of (case)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate the (det)
events cvd (compound)
discontinuations compared (case)
protector potential (amod)
sulfate and (cc)
disturbances patients (nmod)
size of (case)
inhibit did (aux)
patients withdrawn (acl)
tachycardia microgram/kg/min (dep)
cells channels (dep)
showed eegs (nsubj)
neuropathy injection (nmod)
6-thioguanine solely (advmod)
therapies hormone (compound)
interval following (case)
higher to (mark)
re-exposure heparin (compound)
delta were (cop)
woman 56-year-old (amod)
peak trough (conj)
4-phenylbutyrate with (case)
affect ? (punct)
adjustment further (amod)
parkinsonism akathisia (conj)
directed patients (nmod)
considered develop (advcl)
decade in (case)
greater mg (advcl)
strong as (advmod)
vcm vcm (conj)
contraceptives of (case)
28.2 only (advmod)
anti-oxidant and (cc)
likely related (ccomp)
alfentanil alf (dep)
133 2 (conj)
pa similar (amod)
cancer ovarian (amod)
model iugr (nmod)
ulcers management (conj)
p.i hr (nmod:npmod)
duration slices (nmod)
cycles menstrual (amod)
mg dose (nsubj)
playing after (case)
6 least (advmod)
cerebral basilar (conj)
determine rats (conj)
exacerbated inhibited (conj)
induced execution (nmod)
had hepatotoxicity (dobj)
relaxed restriction (nsubjpass)
administration infusion (nmod)
prl ( (punct)
phosphate and (cc)
complex i (dep)
years 30 (nummod)
therapy but (cc)
cases appear (acl:relcl)
event an (det)
reported previously (advmod)
agonists used (acl)
history cancer (nmod)
controls five (nummod)
model adenomyosis (nmod)
iq , (punct)
60.44 5.99 (conj)
captopril from (case)
showed patient (nsubj)
enhances risk (dobj)
static on (case)
lesions cyclophosphamide-induced (amod)
week to (mark)
reactions nausea (nmod)
certain following (nmod)
infusion single (amod)
analysis literature (nmod)
mechanism activity (nmod)
group 10(-3 (dep)
anaesthesia i.v. (compound)
occurred related (conj)
patients years (conj)
aggregation platelet (compound)
hypertension on (case)
location with (case)
impaired is (cop)
started japan (nmod)
broadens , (punct)
mp of (case)
concerns effects (nmod)
retinochoroidopathy birdshot (amod)
negative workup (nsubj)
crohn 's (case)
phases liquid (compound)
higher animals (nmod)
potent vpu (nsubj)
correlation days (nmod)
taken period (nmod)
micromol/l ) (punct)
incidence tma (nmod)
5.1+/-1.0 p<0.05 (appos)
mcg ( (punct)
cited studies (nmod)
case vasospasm (nmod)
peaked concentration (nsubj)
tumors contained (conj)
less weight (nmod)
average treatment (nmod)
therapy antiandrogenic (amod)
toxicity methotrexate (compound)
specific defects (nsubj)
interference such (amod)
flutamide ( (punct)
treatment dph (compound)
man taking (acl:relcl)
depleted received (conj)
flurazepam of (case)
pilot double-blind (amod)
investigate using (conj)
receiving prostheses (dobj)
depleted meth (nsubj)
identified noel (nmod)
was relationship (attr)
prophylaxis globulin (nmod)
composite . (punct)
psychoses emergence (compound)
similar morphologically (advmod)
suspected cancer (xcomp)
optic sensitivity (conj)
attenuate not (neg)
intraventricularly ) (punct)
rate heart (compound)
micrograms/kg/hr 32 (nummod)
commencement with (case)
found period (nmod)
treated is (aux)
conclusion : (punct)
myocarditis : (punct)
berlin , (punct)
therapy it (compound)
sooner no (neg)
consisted heptylate (nmod)
oxcarbazepine carbamazepine (compound)
associated however (advmod)
membranes brain (compound)
= 15 (dep)
marked was (auxpass)
hundred five (compound)
surgery interventions (conj)
needle , (punct)
delirium ) (punct)
rfca ) (punct)
nicotine transdermal (amod)
exhibit administration (nmod)
value hb (compound)
5-fold 3.6- (compound)
syndrome tls (appos)
fluid cavity (nmod)
consistent action (nmod)
reflexes normal (amod)
glomeruli measured (acl)
intervention following (case)
received care (dobj)
agonist unlikely (conj)
divided doses (nmod)
pills control (compound)
protected . (punct)
venous patients (dep)
performed methods (dep)
female acetaminophen (nmod)
p , (punct)
reaction idiosyncratic (amod)
norepinephrine of (case)
12- at (case)
hag = (parataxis)
contribute caa (nsubj)
abundant antigens (nsubj)
receptor machr (appos)
variables and (cc)
chebula injury (nmod)
motility disordered (amod)
resulted likely (advmod)
had actions (dobj)
disarrangement increased (amod)
bruising the (det)
score occurring (acl)
thickness ventricular (amod)
odds reduced (amod)
common to (mark)
administered asa (nsubjpass)
treat controlling (advcl)
severity dyskinesia (amod)
treatment chelation (compound)
systolic hg (compound)
hemorrhage an (det)
inhibit components (nsubj)
increase deprivation (nsubj)
patient depressed (amod)
defects brain (nmod)
s-transferase of (case)
hormone trh (appos)
wane improvements (nsubj)
similar were (cop)
inhibit doses (nmod)
disappear but (cc)
atpase na+/ (compound)
% 13.0 (nummod)
mcg/kg 2.5 (nummod)
ability righting (amod)
contrast animals (nmod)
years 26 (nummod)
disease according (case)
dysplasia cerebellar (amod)
large sometimes (advmod)
cells stained (amod)
has neurochemistry (nsubj)
showed telangiectasia (dobj)
restarted re-challenged (conj)
rats no-deficient (amod)
population exposed (amod)
signs opistothonus (nmod)
elevated pressure (nsubjpass)
elements the (det)
underwent electrocardiography (dobj)
clioquinol of (case)
antibodies enflurane (nmod)
analysis p (dep)
produced action (dobj)
changes treatment (nmod)
hydroxylase and (cc)
groups treated (amod)
1-(1,2-dihydro-2-acenaphthylenyl)piperazine of (case)
coma precipitated (acl)
nursing of (case)
completing after (mark)
cardiomyopathy 1 (dep)
hypothesized mechanism (nsubjpass)
unchanged a-actinin (nsubj)
toxicity 2 (nummod)
physiology neuromuscular (amod)
diagnostic findings (compound)
loss cells (nmod)
in : (punct)
attention function (nmod)
advanced locally (advmod)
mouse-1 , (punct)
concentration natriuretic (amod)
desogestrel or (cc)
7-ethoxyresorufin-o-deethylase erod (appos)
binding in (amod)
diameter diastolic (amod)
constriction concentric (amod)
responses correct (amod)
laitinen 's (case)
caused groups (nmod)
p450 cyp (appos)
appear presence (dep)
associated myoglobinuria (nmod)
company topcon (compound)
decrease recovery (nmod)
aqueous of (case)
study morphometric (amod)
have treated (advcl)
aged children (nsubj)
bladder leaky (amod)
safe discharge (nmod)
suppression to (case)
delay regrowth (nmod)
finding echoes (conj)
blood was (parataxis)
improvement shown (acl)
substitute . (punct)
discovery variant (nmod)
markers all (det)
support further (amod)
patients excluding (case)
range from (case)
method this (det)
ctni-positive who (nsubj)
seen studies (nsubjpass)
administration setting (nmod)
trial european (compound)
levels to (case)
loss a (det)
alcohol s-perillyl (compound)
drugs a-containing (amod)
it on (case)
suffered and (cc)
dysfunction isoproterenol-induced (amod)
administered recorded (conj)
vary effects (nsubj)
exhibited acids (nsubj)
cycle per (case)
oxidative/nitrosative neuroinflammatory (conj)
receptor glutamate (amod)
occlusion central (amod)
help analyze (xcomp)
noticed improvement (nsubjpass)
120 60 (compound)
variants common (amod)
use anorexigen (amod)
drugs than (case)
engine risk (compound)
utility marker (nmod)
revealed torsade (xcomp)
sod for (case)
applied detection (nmod)
preserved reached (conj)
a the (dep)
peptide isolated (acl)
increased rose (conj)
minimal-type mild-type (conj)
reflexes of (case)
able pg-9 (nsubj)
reversible partly (advmod)
transplanted patients (nsubjpass)
was suggestion (attr)
methods collected (appos)
plays depend (conj)
efferent sympathetic (amod)
3.6 1.8 (compound)
treated ketamine (nmod)
bromocriptine with (case)
tolerated therapy (nmod)
incidence regarding (case)
likely showed (advcl)
db 15 (nummod)
assessed coordination (dobj)
attend assessment (dobj)
evident randomization (nmod)
induction chemical (compound)
motility gastrointestinal (amod)
effusion abnormalities (conj)
upregulation transporters (nmod)
received minutes (nmod)
activity learning (conj)
movements extremities (nmod)
paraplegia report (dep)
difficulties with (case)
myelomeningocoele leaking (amod)
solvent used (amod)
variant novel (amod)
embryolethality , (punct)
methodology following (case)
impact recognition (nmod)
aspects renal (amod)
interactions such (case)
ns-718 of (case)
0.52 1.23 (conj)
reabsorption microglobulinuria (conj)
converts rat (compound)
broadens represented (dep)
acuity fields (conj)
state of (case)
treatment was (cop)
values mean (amod)
back monitoring (nmod)
airway laryngeal (compound)
concluded exerts (ccomp)
delivered gd (nmod)
decreased dimensions (dobj)
reactions idiosyncratic (amod)
study the (det)
reactions patients (nmod)
similar , (punct)
limit normal (nmod)
metabolized it (nsubjpass)
tomography thereafter (advmod)
induce blocked (advcl)
therapies standard (amod)
light observations (nmod)
dysfunction future (amod)
effect potentiated (amod)
recognize states (dobj)
difference measured (advcl)
damage comparison (nmod)
significance expression (nmod)
open in (case)
inhibition due (case)
period 10-year (amod)
80 4 (conj)
rat both (cc:preconj)
liver as (case)
days water (nmod)
subjects have (acl:relcl)
cases additional (amod)
proteins neurofilament (compound)
= 0.8 (dobj)
predicted decrease (nsubj)
effects nsaid (nmod)
increased urothelium (nmod)
overstimulation cholinergic (amod)
ed the (det)
considered factor (xcomp)
patients day (dep)
penicillamine therapy (conj)
osteoporosis dementia (conj)
resolved recur (conj)
changes distinct (amod)
prescribe that (mark)
mg/dl. 3.3 (nummod)
exploited further (advmod)
ability treatment (nmod)
29.3 24.9 (conj)
protrusions catalepsy (conj)
attenuated loading (nmod)
tests memory (conj)
medications as (case)
index serum (conj)
discontinuation for (case)
increases men (nmod)
conditioning after (case)
postinjection mg/kg (appos)
haematological of (case)
mg/kg thiopentone (compound)
induced 3'-azido-3'dideoxythymidine (nmod)
long-term after (case)
factor still (advmod)
revealed microscopy (nsubj)
males of (case)
factors the (det)
presence ethanol (dep)
varied prevented (dep)
related cardiotoxicity (nmod)
given rd (nsubjpass)
sorafenib of (case)
has amount (dobj)
condition hypersensitivity (compound)
acidosis hypophosphatemia (conj)
oct of (case)
compare , (punct)
lowered clonidine (nsubj)
patients tachycardia (nmod)
restricted moreover (advmod)
goal the (det)
allografts to (case)
condition general (amod)
metabolised form (xcomp)
open clinical (dep)
finding notable (amod)
frequency lower (amod)
taken staining (nsubjpass)
given therapy (nsubjpass)
reduced neurons (dobj)
disease users (nmod)
drug antiepileptic (amod)
depend stimulation (nmod)
center hiv (compound)
cardiotoxicity dogs (nmod)
d cathepsin (compound)
rats d-pen-treated (amod)
manifested group (nmod)
used repeatedly (advmod)
os po (appos)
cured % (dep)
improved revealed (conj)
becoming common (acomp)
ibuprofen tid (nummod)
prevent coma (dobj)
studied ; (punct)
eight-week in (case)
associated rise (nsubjpass)
measures cognitive (amod)
possesses reduced (conj)
amounts , (punct)
rr 1.33 (nummod)
absence atypical (amod)
nad of (case)
vegf/vpf fviiirag (conj)
ended and (cc)
fla838 , (punct)
echocardiography quantitation (conj)
setting activation (nmod)
pain evoked (acl)
related deficits (dobj)
women 60 (nummod)
hours maximum (conj)
creatinine for (case)
doses imipenem/cilastatin (nmod)
mg/dl 14.8 (nummod)
elevations to (case)
prescribed is (auxpass)
quiet between (case)
percussion to (case)
abrogated sis3 (nsubj)
1400 and (cc)
injections after (case)
added hydrocortisone (nsubjpass)
1.2 ci:0.3 (compound)
resolved initiation (nmod)
search literature (compound)
increases of (case)
hypercalcemia bradyarrhythmia (dep)
heart rabbit (compound)
specific effect (nmod)
meloxicam due (case)
scale psychiatric (compound)
models mice (nmod)
mean : (punct)
associated fibrosis (nmod)
setting infarction (nmod)
population diseases (conj)
agents pressor (compound)
recommended regimen (nsubjpass)
latency loss (nmod)
ranitidine of (case)
received times (dep)
inhibitors used (acl)
doses one (nmod)
form in (case)
involved trigeminal (nsubjpass)
3 49 (conj)
dose area (nmod)
similar lesions (nsubj)
greater 0.30 (nmod)
pressure patients (nmod)
patients to (case)
rr 1.18 (nummod)
resolved reducing (advcl)
block occurring (acl)
antagonists beta-adrenergic (amod)
stress hepatotoxicity (conj)
associations clinical (amod)
effect fluoxetine (nmod)
window time (compound)
accompanied p (dep)
hypotension post-spinal (amod)
induced tilts (nsubj)
caa ) (punct)
agreement a (det)
affect substantially (advmod)
d3 of (case)
evident pressure (nmod)
gfr and (cc)
females total (amod)
behavior tracings (conj)
objectives/hypothesis standard (dep)
development treatments (nmod)
tolerability good (amod)
result cardioprotection (nmod)
started h2o (nmod)
months additional (amod)
ganglia of (case)
dental for (case)
women 3 (nummod)
19 in (case)
6.6 +/- (cc)
function electroretinography (appos)
mg atropine (compound)
yr 3 (nummod)
showed present (ccomp)
25 20 (quantmod)
monitoring : (punct)
excreted kidney (nmod)
protein enhanced (amod)
confirmed incidence (dobj)
nox nor (cc)
call number (dobj)
doses d3 (nmod)
grs ) (punct)
improvement % (compound)
known angioedema (dep)
site or (cc)
plus-maze elevated (amod)
circumstances and (cc)
results higher (appos)
attributable and (cc)
cava norepinephrine (nmod)
studies neurotoxicity (nmod)
tumors hepatic (amod)
assessed could (aux)
cholesterol lipoprotein (compound)
judged was (auxpass)
sequelae severe (amod)
cent values (nmod)
humphrey 2 (nummod)
alterations because (case)
judiciously antibiotic (amod)
results ; (punct)
ie staphylococcal (amod)
protection airway (compound)
fluphenazine d-2 (conj)
infarction bilateral (amod)
increased azimilide (nsubj)
m(1)/m(3)/m(5)-selective ) (punct)
revealed oxidation (dobj)
suprofen of (case)
responsible metabolite (nsubj)
secondary antidepressants (nmod)
neutropenia thrombocytopenia (conj)
hyperammonemia with (nmod)
expression isoenzymes (nmod)
exhibited protein (nmod)
vocalization caused (acl)
relationship particularly (advmod)
greater is (cop)
hcva lcva (conj)
received epinephrine (dobj)
results testing (nmod)
chloride ) (punct)
occlusion formation (nmod)
variables several (amod)
lexical semantic (conj)
discontinuing administering (conj)
cuff rotator (compound)
142 to (dep)
hospital montreal (appos)
d2 of (case)
performed . (punct)
model mice (nmod)
similar are (cop)
3.0 +/- (cc)
co-infection with (nmod)
staining localization (conj)
tolerable infections (nmod)
defective vision (nsubj)
b ) (punct)
part prophylaxis (nmod)
evaluated performance (dobj)
prevention seizures (nmod)
bupivacaine diacetate (conj)
affection and (cc)
leading development (nmod)
cystitis by (case)
d4.4 d4.7 (conj)
complications japan (nmod)
microinjection fentanyl (nmod)
doses mg. (nmod)
lowering vascular (dobj)
tolerance stabilized (acl)
combined epinephrine (nmod)
categorized those (dep)
severity administration (nmod)
intake a (det)
localize genes (dobj)
trials further (amod)
anticholinergics to (case)
mmol/l 4.14 (nummod)
3.0 1.5 (compound)
lack something (conj)
degeneration combined (amod)
nsc 4-acridinecarboxamide (amod)
observations previous (amod)
drg ) (punct)
noticed using (ccomp)
explore effect (dobj)
mini-pump with (case)
catecholamines vasoactive (amod)
resulted overdose (nsubj)
had prior (advmod)
demand oxygen (compound)
hexamethonium ganglionic (amod)
redistribution with (case)
tail-flick paw-pressure (conj)
haematuria either (cc:preconj)
mg.kg-1 0.015 (compound)
buildup of (case)
modified effect (nsubjpass)
therapeutic or (cc)
thickening posterior (amod)
use induce (advcl)
bortezomib/dexamethasone with (case)
terminate hemodialysis (nsubj)
behavior pathological (amod)
inhibits period (nmod)
trimipramine tri (appos)
awaking night (nmod)
successful rapidly (advmod)
products herbal (amod)
rad001 plus (cc)
cascade the (det)
used inhibitors (nsubjpass)
occurred surveillance (nmod)
ef ) (punct)
block lethality (dobj)
maintain mmhg (nmod)
dcf ( (punct)
ipratropium for (case)
years deficits (nmod)
asymptomatic . (punct)
cyclophosphamide of (case)
complicate may (aux)
require difficult (conj)
scale for (case)
lesion nerves (nmod)
improved status (nsubj)
dominating paracetamol (nsubj)
crf , (punct)
coincidental be (auxpass)
mediated modulation (nmod)
ligands selective (amod)
steatosis hepatitis (conj)
focus research (compound)
-14.8 ; (punct)
statins of (case)
relation expression (nmod)
contracture flexure (amod)
undergoes showing (advcl)
had contraindication (dobj)
support bleeding (conj)
values g/dl (compound)
coefficient p<.01 (dep)
exhibited responses (dobj)
regulation an (det)
33.6 5.4 (conj)
example imbalance (nmod)
related effects (nsubj)
presentation their (nmod:poss)
expression heart (nmod)
electrocardiograph ii (nummod)
underwent groups (nsubj)
needed tarsorrhaphy (dobj)
comparable groups (nsubj)
pvn ( (punct)
stimulation brain (compound)
droperidol due (case)
desensitisation functional (amod)
dependent levels (nsubj)
showed possessed (ccomp)
practice physicians (conj)
measures some (det)
sedation was (cop)
minutes 6.5 (nummod)
drd2 and (cc)
taking were (aux)
appeared ototoxicity (nsubj)
method clearance (compound)
conjunction sodium (nmod)
times at (case)
triggered salbutamol (nmod)
antagonize not (neg)
non-cacl(2)-treated nacl-treated (conj)
generated mice (dobj)
model prescribed (acl)
polymorphisms syndrome (conj)
drug no (neg)
determination plasma (nmod)
country in (case)
neurotensin of (case)
low qtp (conj)
clozapine either (cc:preconj)
analyzed extracts (nsubjpass)
re-investigate value (dobj)
receiving cefotetan (dobj)
considered effect (xcomp)
responsiveness program (dep)
od 3.07+/-0.71 (conj)
hypothesis protects (ccomp)
g/kg 1 (nummod)
mg/dl 20.1 (compound)
inconclusive but (cc)
incontinence genuine (amod)
surprise , (punct)
august to (case)
loci quantitative (amod)
prior pilocarpine (nmod)
development cases (nmod)
receptor mglur1 (appos)
anticonvulsants of (case)
minimised knowledge (nmod)
placebo between (case)
treatment doxorubicin (nmod)
connection direct (amod)
correlates deficits (nsubj)
analyzed degree (nsubjpass)
overcome be (auxpass)
selective both (cc:preconj)
failed or (cc)
noted details (nsubjpass)
31 - (punct)
rats impaired (amod)
accompanied effects (nsubjpass)
mg/kg [ (punct)
stopped prior (advmod)
evoked evoked (advcl)
disorder sample (nmod)
diagnosis difficult (amod)
interrupted starting (xcomp)
association hypertension (nmod)
elicits exposure (nsubj)
coagulopathy warfarin-induced (amod)
powered , (punct)
dex mg (dep)
patient failure (nmod)
6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate dmcm (appos)
seen authors (nmod)
neurons vulnerable (amod)
receiving while (mark)
changes forestomach (nmod)
dox mg/kg (compound)
responding although (mark)
effects bronchodilating (compound)
ocular patients (nmod)
hearts denervated (amod)
atin nsaids-associated (amod)
anxiety ) (punct)
5 two (quantmod)
activate may (aux)
balances electrolyte (compound)
demonstrated study (nsubj)
remains needs (nmod)
pbsct ( (punct)
found increase (dobj)
leukocyturia of (case)
restarting treatment (dobj)
sensitive doses (nmod)
greater using (xcomp)
increase small (amod)
anesthetic short-acting (amod)
evidence prevention (nmod)
person fact (appos)
case possibly (advmod)
declined g/dl (nmod)
cancer disease (conj)
limit to (case)
measurements , (punct)
efficiency determination (nmod)
cryoprecipitate of (case)
alcohol between (case)
= 0.020 (dobj)
analyses histological (amod)
produced models (nsubjpass)
physician using (acl)
determine resolution (nmod)
gave he (nsubj)
proteinuria reduction (conj)
reversible defect (nsubj)
population entire (amod)
dysmenorrhea severe (amod)
affect does (aux)
range 22.25 (nummod)
increased 3.6- (dobj)
1r , (punct)
cavity uterine (amod)
independent to (mark)
qs/qt ) (punct)
exhibited all (nsubj)
associated mirtazapine (nsubjpass)
chemotherapy phases (appos)
difference chloride (nmod)
zero to (case)
reflection microangiopathy (nsubj)
sensitivity on (case)
administration food (compound)
third patients (nmod)
published available (conj)
changes matter (nmod)
activity animals (nmod)
0.01 p (compound)
use beclomethasone (nmod)
minor reduction (nsubj)
chf with (case)
hiccups of (case)
effects adriamycin (nmod)
impact treatment (nmod)
influences whether (mark)
found piroxicam (nmod)
association causal (amod)
showed that (mark)
contraceptives oral (amod)
group compared (case)
estimated been (auxpass)
reversible ; (punct)
report case (compound)
doses pyridoxine (nmod)
features degeneration (compound)
mild neuropathy (nsubj)
delirium from (case)
l-noarg ( (punct)
history developmental (amod)
resulting doses (nmod)
antibiotics as (cc)
45.5/18.2/6.1 ): (dep)
overdose mixed (amod)
case incontinence (nmod)
map after (case)
treatment measures (conj)
receptor b1 (compound)
nra0160 hyperactivity (dep)
bodies appeared (acl:relcl)
treatment levodopa (compound)
mouse and (cc)
microg/kg 10 (nummod)
parameters any (det)
reversal in (case)
of male (amod)
administration bupivacaine (nmod)
2-blocking beta (nmod:npmod)
tolerability group (nmod)
test plus-maze (amod)
underwent patients (nsubj)
induce dementia (dobj)
nephropathy gentamicin-induced (amod)
rbf increase (appos)
120.04 +/- (cc)
potent and (advmod)
showed erg (nsubj)
administered % (dep)
proliferated appeared (conj)
antagonists methoctramine (conj)
case dph (nmod)
observed h (nmod:tmod)
trial canadian (compound)
elevation concentration (nmod)
doses recommended (amod)
literature and (cc)
urticaria/angioedema angioedema (conj)
needed doses (nsubjpass)
site ? (punct)
patients cancer (nmod)
increasing factors (dobj)
alf is (cop)
consumed amounts (dobj)
loss temporary (amod)
in and (cc)
perimetry interactive (amod)
effects release (conj)
appear suitable (xcomp)
effects seeds (nmod)
infusion clonidine (nmod)
carry task (dobj)
libitum ad (compound)
sinusitis with (case)
prescribed population (nmod)
synthesis bile (compound)
correlate biochemical (dobj)
extend taken (advcl)
strategy search (compound)
threatening is (cop)
creatinine sustained (amod)
learning avoidance (compound)
> not (neg)
patient intubated (amod)
bradykinin des (conj)
katona watson (conj)
time tension (nmod)
meal a (det)
decreased furthermore (advmod)
effect hyperglycemic (amod)
deficiency limb (amod)
75 in (case)
effects ptu (nmod)
depression marrow (compound)
acute severe (amod)
ml(-1 of (case)
achieve concentration (dobj)
had gentamicin (dobj)
infusion before (case)
exerts neck (nmod)
necessary studies (nsubj)
alleviated less (conj)
changes pupillary (amod)
success a (det)
caused that (dobj)
beta=0.49 ( (punct)
compared cohort (nmod)
agent althesin (appos)
filters cava (compound)
changes hepatic (amod)
clinic , (punct)
droop facial (amod)
pretreatment p-chlorophenylalamine (nmod)
percent cases (nmod)
uptakes showing (xcomp)
investigated magnitudes (nsubjpass)
injected uteri (nsubjpass)
sensitivity convulsions (nmod)
presented cases (nsubjpass)
similar development (dobj)
cancer low (amod)
iva [ (punct)
cpa ( (punct)
wt 0.24 (conj)
= force (nmod)
permeability increased (amod)
(ee)-induced that (mark)
treatment ciprofloxacin (nmod)
dexmedetomidine or (cc)
instillation accidental (amod)
approaches of (case)
effects serious (amod)
hospitals guidelines (nmod)
unknown mechanism (nsubj)
meet have (advcl)
recovery slow (amod)
administration 5-fu (compound)
mistaken be (auxpass)
decreased groups (nmod)
1000 approximately (advmod)
gyrus especially (advmod)
cases 347 (nummod)
normal and (cc)
lateral prostate (compound)
patch structures (nmod)
rats salt-loaded (amod)
preparation to (case)
true to (mark)
h2o2 plasma (compound)
months 10.6 (nummod)
chi2-test multivariate (conj)
awareness of (case)
animals young (amod)
had types (nmod)
tolerance response (conj)
administered iv (dep)
complete respectively (advmod)
risk or (dep)
function net (compound)
was months (attr)
room at (case)
involvement and (cc)
female and (cc)
syndrome prolonged (amod)
strategies prevent (acl:relcl)
given started (conj)
% 98.8 (nummod)
unaltered development (nmod)
tolerated usually (advmod)
dysfunction glomerular (amod)
hexabrix vasurix (conj)
stratified therapy (nmod)
responses central (amod)
defined elevation (conj)
protect estrogens (nsubj)
less slightly (advmod)
bradyarrhythmias delay (conj)
center rehabilitation (compound)
crisis migraine (compound)
ibuprofen 100 (appos)
cent 40 (compound)
average mm (nmod)
locomotor dyskinetic (conj)
height a (det)
stimulation lc (nmod)
study degeneration (dobj)
magnitude responses (conj)
widow a (det)
destructive more (advmod)
resolved generally (advmod)
deafened recovery (nmod)
aim improving (advcl)
reperfusion followed (acl)
change pattern (nmod)
secretion pth (compound)
groups women (nmod)
required maintenance (nmod)
investigate correlates (ccomp)
mr and (cc)
match cases (dobj)
lisinopril low-dose (amod)
scales visual (amod)
resistance flexion (nmod)
chow on (case)
occurred closed (advcl)
microg/kg/min of (case)
exchange plasma (compound)
prior levodopa (nmod)
observe to (mark)
31 ( (punct)
improved % (nsubjpass)
induces sirolimus (nsubj)
mg/m(2 of (case)
revealed has (aux)
relation any (det)
metabolism lindane (nmod)
out-patients ill (amod)
hematoma the (det)
rofecoxib 1.73 (dobj)
illness a (det)
reacts thus (advmod)
patients many (amod)
male schizophrenia (nmod)
linked is (auxpass)
infant , (punct)
doses cyclophosphamide (nmod)
level lactate (compound)
migraine above (amod)
42 8 (conj)
pregs ) (punct)
contraction ( (punct)
capable that (mark)
modify bf (dobj)
interrupted permitted (conj)
speech development (conj)
characterization events (nmod)
hyperkalemia patients (nmod)
administered verapamil (nsubjpass)
differences mortality (nmod)
threshold ventricular (amod)
sotalol agents (conj)
audiograms cases (nmod)
toxic and (cc)
phosphate tri-ortho-tolyl (amod)
40 in (case)
fold vocal (amod)
ecstasy , (punct)
signs common (amod)
agent frequent (amod)
intensified stasis (nsubj)
elucidate phenomenon (nsubj)
changes pupillometric (amod)
infections pseudomonas (compound)
wall left (amod)
piroxicam to (mark)
2a interferon (compound)
glucose blood (compound)
suppression stimulation (nmod)
deficiency this (det)
manifesting arteriolopathy (compound)
complete day (nmod)
induction sevoflurane (nmod)
tension to (case)
treatment vincristine (compound)
% plasma (dep)
group 6 (conj)
counts drug-induced (amod)
reported reported (conj)
found survival (conj)
anemia aplastic (amod)
models rat (compound)
dextran or (cc)
figures myelin (amod)
all nitrogen (nmod)
administration pilocarpine (nmod)
acts c (nsubj)
received application (dobj)
nucleus by (case)
consciousness increased (conj)
% animals (nmod)
efficacy with (case)
day the (det)
cases occurred (acl:relcl)
resistance high (amod)
induction and (cc)
virus alf (dep)
achieved instance (nmod)
combinations new (amod)
background objective (conj)
examined frequency (dobj)
pump a (det)
anaesthesia with (case)
concentrations neurotransmitter (amod)
staining acriflavine (compound)
s ( (punct)
mg/dl 2.5 (nummod)
controlled threefold (advmod)
minutes range (dep)
bbb reversal (conj)
2.08 - (punct)
history family (compound)
communicated physician (nmod)
males 361 (nummod)
12-week randomized (conj)
changes anaesthesia (nmod)
thrombocytopenia effects (conj)
tremor behavior (conj)
implicated development (nmod)
pretreatment mg/kg (appos)
administration ciprofloxacin (nmod)
central either (cc:preconj)
occurs : (punct)
aggravation permeability (conj)
preferred that (mark)
hoarseness or (cc)
a 1/10 (appos)
identify toxicity (dobj)
test for (case)
enantiomer s(- (compound)
1/32 in (case)
participate = (parataxis)
pan/temocapril ii (case)
company from (case)
icus in (case)
received digoxin (dobj)
suppressed episodes (nsubjpass)
subsided contractions (nsubj)
performed thickness (nmod)
findings investigators (nmod)
points nerve (nmod)
related disruption (nmod)
tests study (nsubj)
unresolved is (cop)
min % (appos)
sample from (case)
blockers also (advmod)
signs was (cop)
marrow hyperplastic (amod)
aggregation human (amod)
degrees anaemia (nmod)
administration rifampicin (nmod)
suffering not (neg)
separated ultrafiltration (nmod)
pi with (case)
8.9 and (cc)
weight relative (amod)
50 more (amod)
accumulation line (nmod)
decreased compared (nmod)
tachycardia-induced atrial (amod)
relation , (punct)
increase resistance (nmod)
administration nocistatin (nmod)
possible . (punct)
minutes was (cop)
found transaminases (advcl)
greater 24.4 (dep)
complexes aminoglycoside-iron (amod)
number cardiomyocytes (nmod)
receive times (nmod:tmod)
given ly274614 (nsubjpass)
related disposition (nmod)
indicative anticipation (nmod)
isomers cibenzoline (nmod)
outcome signs (nmod)
affected can (aux)
amine phenylpropanolamine (nsubj)
disease presence (nmod)
body 200 (nummod)
hyperalgesia streptozotocin-induced (amod)
structures known (acl)
data with (case)
raloxifene with (case)
neurotransmission with (case)
influenced cddp (nmod)
formula by (case)
diagnosing in (mark)
triphosphate and (cc)
detected disease (nsubjpass)
cytotoxicity additive (amod)
junctions cellular (amod)
deficiency by (case)
contributes myalgia (nmod)
assess effects (nmod)
anesthesia tiva (appos)
titrated dose (nsubjpass)
variety complications (nmod)
dfmo ( (punct)
weeks heart (nmod)
differ obviously (advmod)
climbing and (cc)
protein fibrillary (amod)
impairment induced (acl)
been there (expl)
drug first-line (amod)
inhibits incidence (dobj)
induced agonism (nmod)
appears immunolocalization (nsubj)
signals discrete (amod)
sequelae syndrome (nmod)
score iief (amod)
oxacillin to (case)
observed risks (dobj)
stopped atp (nsubjpass)
induced hormone (nmod:npmod)
nausea induced (acl)
fumarate . (punct)
patients b (nmod)
lead procedure (nmod)
patients 797 (nummod)
formation edema (compound)
support data (nsubj)
insecticide this (det)
effects neurodevelopment (nmod)
weeks stopping (advcl)
identification eg (prep)
affected but (cc)
stimuli related (amod)
frequency switching (nmod)
forestomach bladder (conj)
anemia to (case)
patients antibody-positive (amod)
side-effects on (case)
cortex olfactory (amod)
methadone mg (compound)
courses 12 (nummod)
binding membranes (nmod)
shown research (nsubj)
evident which (nsubj)
vesicles abnormal (amod)
exists concentrations (nmod)
prolactinomas rat (compound)
ester with (case)
nsvt contractions (conj)
effects isoproterenol (nmod)
were they (nsubj)
mg/kg 10 (nummod)
76 94 (prep)
used immunofluorescence (nsubjpass)
assessed occurrence (nsubjpass)
study compare (xcomp)
calculi the (det)
development speech (nmod)
altered organelles (nsubjpass)
incidence severity (conj)
ribavirin disease (nmod)
receiving iodixanol (dobj)
tnf-a il-6 (conj)
suggest factor (ccomp)
found who (nsubjpass)
improved normal (conj)
manifestation findings (conj)
exposed rats (nsubjpass)
men 234 (nummod)
receiving disoproxil (dobj)
oac to (case)
acquired 137 (nsubj)
residues of (case)
midazolam of (case)
elements cellular (amod)
appearance proteinuria (nmod)
0.01 ) (punct)
results had (dep)
damage in (amod)
greater to (mwe)
switching sotalol (nmod)
cutaneous lv (compound)
man year-old (amod)
fluoxetine treatment (nmod)
900 1,500 (conj)
observations % (dep)
les both (cc:preconj)
chloroform-adrenaline bacl2 (conj)
diazepam opioids (conj)
volume in (case)
methylation of (case)
antagonist paf (nmod)
producing hypertrophy (dobj)
daunorubicin daunoxome (appos)
pas ( (punct)
group scattered (conj)
mutations g145r (dep)
impulsiveness sleep (conj)
validity diagnosis (nmod)
opening and (cc)
wt vs. (cc)
neurotoxicity dopamine (compound)
shunting by (case)
enhanced les (dobj)
yahr hoehn (compound)
descriptions relationship (nmod)
pcr followed (dep)